<SEC-DOCUMENT>0001104659-23-002376.txt : 20230110
<SEC-HEADER>0001104659-23-002376.hdr.sgml : 20230110
<ACCEPTANCE-DATETIME>20230109200401
ACCESSION NUMBER:		0001104659-23-002376
CONFORMED SUBMISSION TYPE:	S-4/A
PUBLIC DOCUMENT COUNT:		54
FILED AS OF DATE:		20230110
DATE AS OF CHANGE:		20230109

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Sesen Bio, Inc.
		CENTRAL INDEX KEY:			0001485003
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				262025616
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-4/A
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-267891
		FILM NUMBER:		23519486

	BUSINESS ADDRESS:	
		STREET 1:		245 FIRST STREET
		STREET 2:		SUITE 1800
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02142
		BUSINESS PHONE:		617-444-8550

	MAIL ADDRESS:	
		STREET 1:		245 FIRST STREET
		STREET 2:		SUITE 1800
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02142

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Eleven Biotherapeutics, Inc.
		DATE OF NAME CHANGE:	20100223
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-4/A
<SEQUENCE>1
<FILENAME>tm2227887-11_s4a.htm
<DESCRIPTION>S-4/A
<TEXT>
<html>
  <head>
    <title>tm2227887-11_s4a - block - 125.188065s</title>
  </head>
  <body style="margin-left:auto;margin-right:auto;width:775.71pt;">
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8.5pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:27.85pt;margin-bottom:21.86pt;margin-left:27pt;width:541.31pt;">

          <div style="text-align:center; width:541.31pt; line-height:10.5pt;font-weight:bold;">
            <font style="letter-spacing:-0.17pt;">As filed with the Securities and Exchange Commission on January 9, 2023</font><font style="font-weight:normal;letter-spacing:0.17pt;"> </font>
          </div>

        <div style="margin-left:20pt; margin-top:0.7pt; text-align:right; width:521.31pt; line-height:10.5pt;font-weight:bold;font-size:8.8pt;">
          <font style="letter-spacing:-0.176pt;">Registration No. 333-267891</font>&#8203;</div>
        <div style="margin-top:4.333pt; width:541.31pt;">
          <div style="margin-left: 0pt; width: 541.31pt; margin-top: 4.33333333333333pt; font-size: 2pt; line-height: 0pt; border-bottom: 2pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:2.7pt; width:541.31pt;">
          <div style="margin-left: 0pt; width: 541.31pt; margin-top: 2.7pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:5.51pt; text-align:center; width:541.31pt; line-height:15.5pt;font-weight:bold;font-size:14pt;">
          <font style="letter-spacing:-0.28pt;">UNITED STATES</font>
          <br >
          <font style="letter-spacing:-0.28pt;">SECURITIES AND EXCHANGE COMMISSION </font>
          <br >
          <font style="font-size:9pt;letter-spacing:-0.18pt;">Washington, D.C. 20549</font><font style="font-weight:normal;letter-spacing:0.28pt;"> </font>
        </div>

          <div style="margin-top:1pt; text-align:center; width:541.31pt; line-height:10.5pt;font-weight:bold;font-size:8.8pt;">
            <font style="letter-spacing:-0.176pt;">Amendment No. 3</font>
            <br >
            <font style="letter-spacing:-0.176pt;">to</font><font style="font-weight:normal;letter-spacing:0.176pt;"> </font>
          </div>

        <div style="margin-top:1.7pt; text-align:center; width:541.31pt; line-height:16pt;font-weight:bold;font-size:14pt;">
          <font style="letter-spacing:-0.28pt;">FORM S-4</font>
        </div>
        <div style="margin-top:1.7pt; text-align:center; width:541.31pt; line-height:10.5pt;font-style:italic;font-weight:bold;font-size:8.8pt;">
          <font style="font-style:normal;letter-spacing:-0.176pt;">REGISTRATION STATEMENT</font>
          <br >
          <font style="letter-spacing:-0.176pt;">UNDER </font>
          <br >
          <font style="letter-spacing:-0.176pt;">THE SECURITIES ACT OF 1933</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.176pt;"> </font>
        </div>
        <div style="margin-top:2pt; text-align:center; width:541.31pt; line-height:16pt;font-weight:bold;font-size:14pt;">
          <font style="letter-spacing:-0.28pt;">SESEN BIO, INC.</font>
        </div>
        <div style="margin-top:-1.3pt; text-align:center; width:541.31pt; line-height:10pt;font-size:8pt;">
          <font style="letter-spacing:0.16pt;">(Exact name of registrant as specified in its charter)</font><font style="font-size:8.8pt;">&#8203;<font style="letter-spacing:0.176pt;"> </font></font>
        </div>
        <table style="width:541.31pt;margin-top:7pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8.5pt;">
          <tr style="line-height:9pt;white-space:normal;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:172.44pt;">
              <div style="text-align:center;font-weight:bold;font-size:8.5pt;">
                <font style="letter-spacing:-0.17pt;">Delaware</font>
              </div>
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">(State or other jurisdiction of</font>
                <br >
                <font style="letter-spacing:0.16pt;">incorporation or organization)</font><font style="font-size:8.5pt;">&#8203;</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:172.44pt;">
              <div style="text-align:center;font-weight:bold;font-size:8.5pt;">
                <font style="letter-spacing:-0.17pt;">2834</font>
              </div>
              <div style="text-align:center; line-height:8pt;">
                <font style="letter-spacing:0.16pt;">(Primary Standard Industrial</font>
                <br >
                <font style="letter-spacing:0.16pt;">Classification Code Number) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:172.43pt;">
              <div style="text-align:center;font-weight:bold;font-size:8.5pt;">
                <font style="letter-spacing:-0.17pt;">26-2025616</font>
              </div>
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">(I.R.S. Employer</font>
                <br >
                <font style="letter-spacing:0.16pt;">Identification Number)</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:5.71pt; text-align:center; width:541.31pt; line-height:10.5pt;font-weight:bold;font-size:8.8pt;">
          <font style="letter-spacing:-0.176pt;">245 First Street, Suite 1800 </font>
          <br >
          <font style="letter-spacing:-0.176pt;">Cambridge, MA 02142</font>
          <br >
          <font style="letter-spacing:-0.176pt;">(617) 444-8550</font>
        </div>
        <div style="margin-top:1.7pt; text-align:center; width:541.31pt; line-height:8.5pt;font-size:8pt;">
          <font style="letter-spacing:0.16pt;">(Address including zip code, and telephone number, including</font>
          <br >
          <font style="letter-spacing:0.16pt;">area code, of registrant&#8217;s principal executive offices)</font><font style="font-size:8.8pt;">&#8203;<font style="letter-spacing:0.176pt;"> </font></font>
        </div>
        <div style="margin-top:2pt; text-align:center; width:541.31pt; line-height:10.5pt;font-weight:bold;font-size:8.8pt;">
          <font style="letter-spacing:-0.176pt;">Thomas R. Cannell, D.V.M.</font>
          <br >
          <font style="letter-spacing:-0.176pt;">President and Chief Executive Officer</font>
          <br >
          <font style="letter-spacing:-0.176pt;">Sesen Bio, Inc.</font>
          <br >
          <font style="letter-spacing:-0.176pt;">245 First Street, Suite 1800</font>
          <br >
          <font style="letter-spacing:-0.176pt;">Cambridge, MA 02142</font>
          <br >
          <font style="letter-spacing:-0.176pt;">(617) 444-8550</font>
        </div>
        <div style="margin-top:1.7pt; text-align:center; width:541.31pt; line-height:10pt;font-size:8pt;">
          <font style="letter-spacing:0.16pt;">(Name, address, including zip code, and telephone number, including area code, of agent for service)</font><font style="font-size:8.8pt;">&#8203;<font style="letter-spacing:0.176pt;"> </font></font>
        </div>
        <div style="margin-top:2pt; text-align:center; width:541.31pt; line-height:10.5pt;font-style:italic;font-weight:bold;font-size:8.8pt;">
          <font style="letter-spacing:-0.176pt;">Copies to:</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.176pt;"> </font>
        </div>
        <table style="width:541.31pt;margin-top:4pt;border-collapse: collapse;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8.5pt;">
          <tr style="line-height:10.2pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8.5pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; width:172.44pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.17pt;">Steven J. Abrams</font>
                <br >
                <font style="letter-spacing:0.17pt;">Tiffany Posil</font>
                <br >
                <font style="letter-spacing:0.17pt;">Jessica A. Bisignano</font>
                <br >
                <font style="letter-spacing:0.17pt;">Hogan Lovells US LLP</font>
                <br >
                <font style="letter-spacing:0.17pt;">1735 Market Street, 23</font><font style=" position:relative; bottom:3.5pt;font-size:6.5pt;letter-spacing:0.13pt;">rd</font><font style="letter-spacing:0.17pt;"> Floor</font>
                <br >
                <font style="letter-spacing:0.17pt;">Philadelphia, PA 19103</font>
                <br >
                <font style="letter-spacing:0.17pt;">(267) 675-4600 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; width:172.44pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.17pt;">Steven Kelly</font>
                <br >
                <font style="letter-spacing:0.17pt;">President and Chief Executive Officer</font>
                <br >
                <font style="letter-spacing:0.17pt;">CARISMA Therapeutics Inc.</font>
                <br >
                <font style="letter-spacing:0.17pt;">3675 Market Street, Suite 200</font>
                <br >
                <font style="letter-spacing:0.17pt;">Philadelphia, PA 19104</font>
                <br >
                <font style="letter-spacing:0.17pt;">(267) 491-6422 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; width:172.43pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.17pt;">Brian A. Johnson</font>
                <br >
                <font style="letter-spacing:0.17pt;">Hal J. Leibowitz</font>
                <br >
                <font style="letter-spacing:0.17pt;">Christopher D. Barnstable-Brown</font>
                <br >
                <font style="letter-spacing:0.17pt;">Wilmer Cutler Pickering Hale and Dorr LLP</font>
                <br >
                <font style="letter-spacing:0.17pt;">7 World Trade Center</font>
                <br >
                <font style="letter-spacing:0.17pt;">250 Greenwich Street</font>
                <br >
                <font style="letter-spacing:0.17pt;">New York, NY 10007</font>
                <br >
                <font style="letter-spacing:0.17pt;">(212) 230-8800</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:9.7pt; width:541.31pt; line-height:10.5pt;font-size:8.8pt;">
          <font style="font-weight:bold;letter-spacing:-0.176pt;">Approximate date of commencement of proposed sale of the securities to the public:</font><font style="letter-spacing:0.176pt;"> As soon as practicable after the effectiveness of this registration statement and the satisfaction or waiver of all other conditions under the Merger Agreement described herein. </font>
        </div>
        <div style="text-indent:20pt; margin-top:2pt; width:541.31pt; line-height:10.5pt;font-size:8.8pt;">
          <font style="letter-spacing:0.176pt;">If the securities being registered on this Form are being offered in connection with the formation of a holding company and there is compliance with General Instruction G, check the following box. &#9744; </font>
        </div>
        <div style="text-indent:20pt; margin-top:2pt; width:541.31pt; line-height:10.5pt;font-size:8.8pt;">
          <font style="letter-spacing:0.176pt;">If this Form is filed to register additional securities for an offering pursuant to Rule&#160;462(b) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. &#9744; </font>
        </div>
        <div style="text-indent:20pt; margin-top:2pt; width:541.31pt; line-height:10.5pt;font-size:8.8pt;">
          <font style="letter-spacing:0.176pt;">If this Form is a post-effective amendment filed pursuant to Rule&#160;462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. &#9744; </font>
        </div>
        <div style="text-indent:20pt; margin-top:2pt; width:541.31pt; line-height:10.5pt;font-size:8.8pt;">
          <font style="letter-spacing:0.176pt;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule&#160;12b-2 of the Exchange Act. </font>
        </div>
        <table style="width:421.31pt;height:30.39pt;margin-left:60pt;margin-top:6pt;border-collapse: collapse;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8.5pt;">
          <tr style="line-height:8.5pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8.5pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:128.51pt;">
              <div style=" float:left; line-height:8.5pt; text-align:left; width:120pt;white-space:nowrap;">
                <font style="letter-spacing:0.17pt;">Large accelerated filer</font>
                <br >
              </div>
              <div style=" line-height:8.5pt; text-align:left; margin-left:120pt;">
                <font style="letter-spacing:0.17pt;">&#9746; </font>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
            </td>
            <td style="padding:0pt; width:82.15pt;">&#8203;</td>
            <td style="padding:0pt; width:82.15pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:128.5pt;">
              <div style=" float:left; line-height:8.5pt; text-align:left; width:120pt;white-space:nowrap;">
                <font style="letter-spacing:0.17pt;">Accelerated filer</font>
                <br >
              </div>
              <div style=" line-height:8.5pt; text-align:left; margin-left:120pt;">
                <font style="letter-spacing:0.17pt;">&#9744; </font>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.5pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8.5pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:1.99pt 0pt 0.5pt 0pt; width:128.51pt;">
              <div style=" float:left; line-height:8.5pt; text-align:left; width:120pt;white-space:nowrap;">
                <font style="letter-spacing:0.17pt;">Non-accelerated filer</font>
                <br >
              </div>
              <div style=" line-height:8.5pt; text-align:left; margin-left:120pt;">
                <font style="letter-spacing:0.17pt;">&#9744; </font>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
            </td>
            <td style="padding:0pt; width:82.15pt;">&#8203;</td>
            <td style="padding:0pt; width:82.15pt;">&#8203;</td>
            <td style="padding:1.99pt 0pt 0.5pt 0pt; width:128.5pt;">
              <div style=" float:left; line-height:8.5pt; text-align:left; width:120pt;white-space:nowrap;">
                <font style="letter-spacing:0.17pt;">Smaller reporting company</font>
                <br >
              </div>
              <div style=" line-height:8.5pt; text-align:left; margin-left:120pt;">
                <font style="letter-spacing:0.17pt;">&#9746; </font>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.5pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8.5pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:128.51pt;">&#8203;</td>
            <td style="padding:0pt; width:82.15pt;">&#8203;</td>
            <td style="padding:0pt; width:82.15pt;">&#8203;</td>
            <td style="padding:1.99pt 0pt 0.5pt 0pt; width:128.5pt;white-space:normal;">
              <div style=" float:left; line-height:8.5pt; text-align:left; width:120pt;white-space:nowrap;">
                <font style="letter-spacing:0.17pt;">Emerging growth company</font>
                <br >
              </div>
              <div style=" line-height:8.5pt; text-align:left; margin-left:120pt;">
                <font style="letter-spacing:0.17pt;">&#9744;</font>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:-3.2pt; width:541.31pt; line-height:10.5pt;font-size:8.8pt;">
          <font style="letter-spacing:0.176pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;7(a)(2)(B) of the Securities Act. &#9744; </font>
        </div>
        <div style="margin-left:20pt; margin-top:2pt; width:521.31pt; line-height:10.5pt;font-size:8.8pt;">
          <font style="letter-spacing:0.176pt;">If applicable, place an X in the box to designate the appropriate rule provision relied upon in conducting this transaction: </font>
        </div>
        <div style="margin-left:20pt; margin-top:2pt; width:521.31pt; line-height:10.5pt;font-size:8.8pt;">
          <font style="letter-spacing:0.176pt;">Exchange Act Rule&#160;13e-4(i) (Cross-Border Issuer Tender Offer) &#9744; </font>
        </div>
        <div style="margin-left:20pt; margin-top:2pt; width:521.31pt; line-height:10.5pt;font-size:8.8pt;">
          <font style="letter-spacing:0.176pt;">Exchange Act Rule&#160;14d-1(d) (Cross-Border Third-Party Tender Offer) &#9744; </font>
        </div>
        <div style="text-indent:20pt; margin-top:2pt; width:541.31pt; line-height:10.5pt;font-weight:bold;font-size:8.8pt;">
          <font style="letter-spacing:-0.176pt;">The Registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the Registrant shall file a further amendment which specifically states that this registration statement shall thereafter become effective in accordance with Section&#160;8(a) of the Securities Act of 1933, as amended, or until the registration statement shall become effective on such date as the Securities and Exchange Commission, acting pursuant to said Section&#160;8(a), may determine.</font><font style="font-weight:normal;letter-spacing:0.176pt;"> </font>
        </div>
        <div style="margin-top:4.433pt; width:541.31pt;">
          <div style="margin-left: 0pt; width: 541.31pt; margin-top: 4.43333333333339pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:2.8pt; width:541.31pt;">
          <div style="margin-left: 0pt; width: 541.31pt; margin-top: 2.79999999999995pt; font-size: 2pt; line-height: 0pt; border-bottom: 2pt solid #000000; ">&#8203;</div>
        </div>
      </div>
      <hr >
    </div>
    <div style="position:relative;overflow-x:hidden;min-height:775.71pt;page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="position:absolute;top:738.83pt;left:48.66pt;height:30.02pt;width:706pt;transform-origin:0pt -0pt;transform:rotate(-90deg) translate(0%, 0%);">
        <div style="text-align:justify; width:706pt; line-height:9.5pt;font-weight:bold;color:#FC0014;font-family:Helvetica, Arial, sans-serif;font-size:8pt;">
          <font style="letter-spacing:-0.08pt;">The information in this proxy statement/prospectus is not complete and may be changed. These securities may not be sold until the registration statement filed with the Securities and Exchange Commission is effective. This proxy statement/prospectus is not an offer to sell these securities and it is not soliciting an offer to buy these securities in any state where the offer or sale is not permitted.</font><font style="color:#000000;letter-spacing:-0.08pt;"> </font>
          <br >
        </div>
      </div>
      <div style="margin-top:27.85pt;min-height:706pt;margin-left:87.66pt;width:456pt;">

          <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;color:#FC0014;">
            <font style="letter-spacing:-0.2pt;">Subject to completion, dated January 9, 2023</font><font style="font-weight:normal;color:#000000;letter-spacing:0.2pt;"> </font>
          </div>

        <table style="width:456pt;margin-top:5pt;border-collapse: collapse;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="height:96pt;white-space:normal;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:222pt;">
              <div style="position:relative;text-align:center;">
                <img src="lg_sesenbio-4c.jpg" alt="[MISSING IMAGE: lg_sesenbio-4c.jpg]" height="117" width="197" >
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:36pt 0pt 20pt 0pt; width:222pt;text-align:left;vertical-align:bottom;">
              <div style="position:relative;text-align:center;">
                <img src="lg_carismatherapeutics-4c.jpg" alt="[MISSING IMAGE: lg_carismatherapeutics-4c.jpg]" height="53" width="200" >
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:11.7pt; text-align:center; width:456pt; line-height:11.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">PROPOSED MERGER</font>
          <br >
          <font style="letter-spacing:-0.2pt;">YOUR VOTE IS VERY IMPORTANT</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:3pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">To the stockholders of Sesen Bio, Inc. and CARISMA Therapeutics Inc.: </font>
        </div>

          <div style="text-indent:20pt; margin-top:3pt; width:456pt; line-height:11pt;">
            <font style="letter-spacing:0.2pt;">Sesen Bio, Inc., a Delaware corporation, or Sesen Bio, and CARISMA Therapeutics Inc., a Delaware corporation, or Carisma, entered into an Agreement and Plan of Merger and Reorganization on September&#160;20, 2022, which was subsequently amended on December 29, 2022, collectively referred to herein as the Merger Agreement, pursuant to which a wholly-owned subsidiary of Sesen Bio will merge with and into Carisma, with Carisma surviving as a wholly-owned subsidiary of Sesen Bio, which transaction is referred to herein as the merger. We refer to the surviving corporation following the merger as the combined company. </font>
          </div>


          <div style="text-indent:20pt; margin-top:3pt; width:456pt; line-height:11pt;">
            <font style="letter-spacing:0.2pt;">At the effective time of the merger, each outstanding share of Carisma capital stock (including shares of Carisma common stock issued in connection with the Carisma pre-closing financing described below) will be converted into the right to receive a number of shares of Sesen Bio common stock equal to the exchange ratio described in more detail in the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Merger Agreement&#8201;&#8212;&#8201; Exchange Ratio</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tTMAER">172</a> of the accompanying proxy statement/prospectus. Also at the effective time of the merger, each outstanding option to purchase shares of Carisma common stock will be assumed by Sesen Bio and will be converted into an option to purchase shares of Sesen Bio common stock, with necessary adjustments to reflect the exchange ratio. Based on Sesen Bio&#8217;s capitalization and Carisma&#8217;s capitalization as of December 29, 2022, the date the Merger Agreement Amendment was executed, the exchange ratio is estimated to be approximately 37.7924 shares of Sesen Bio common stock for each share of Carisma capital stock, which exchange ratio does not give effect to the proposed reverse stock split described in the accompanying proxy statement/prospectus. The final exchange ratio is subject to adjustment prior to the closing of the merger based on Sesen Bio&#8217;s net cash at the closing of the merger and the aggregate proceeds from the sale of Carisma common stock in the Carisma pre-closing financing and, as a result, Sesen Bio stockholders could own more, and Carisma stockholders (including, for this purpose, investors in the Carisma pre-closing financing) could own less, or vice versa, of the combined company.</font>
          </div>


          <div style="text-indent:20pt; margin-top:3pt; width:456pt; line-height:11pt;">
            <font style="letter-spacing:0.2pt;">Immediately prior to the consummation of the merger, certain investors have agreed to purchase shares of Carisma common stock, at a purchase price of $15.60 per share, for an aggregate purchase price of approximately $30.6&#160;million. We refer to this transaction as the Carisma pre-closing financing. The closing of the Carisma pre-closing financing is conditioned upon the satisfaction or waiver of the conditions to the closing of the merger set forth in the Merger Agreement. The shares of Carisma common stock that are issued in the Carisma pre-closing financing will be converted into the right to receive a number of shares of Sesen Bio common stock equal to the exchange ratio described in more detail in the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Merger Agreement&#8201;&#8212;&#8201;Exchange Ratio</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page&#160;<a href="#tTMAER">172</a> of the accompanying proxy statement/</font>&#8203;<font style="letter-spacing:0.2pt;">prospectus.</font></div>


          <div style="text-indent:20pt; margin-top:3pt; width:456pt; line-height:11pt;">
            <font style="letter-spacing:0.2pt;">Each share of Sesen Bio common stock, each option to purchase Sesen Bio common stock and each Sesen Bio restricted stock unit that is outstanding at the effective time of the merger will remain outstanding in accordance with its terms and such shares of common stock, options and restricted stock&#160;units, subject to the proposed reverse stock split, will be unaffected by the merger. Immediately after the merger, pre-merger Sesen Bio stockholders are expected to own approximately 25.2% of the outstanding shares of capital stock of the combined company and pre-merger Carisma stockholders, after taking into account shares of Carisma common stock purchased in connection with the Carisma pre-closing financing and the conversion of Carisma&#8217;s $35.0&#160;million outstanding convertible note, are expected to own approximately 74.8% of the outstanding shares of capital stock of the combined company, subject to certain assumptions, including Sesen Bio&#8217;s net cash as of closing of the merger being at least $75.0&#160;million. </font>
          </div>


          <div style="text-indent:20pt; margin-top:3pt; width:456pt; line-height:11pt;">
            <font style="letter-spacing:0.2pt;">Additionally, at or prior to the effective time of the merger, Sesen Bio will enter into a Contingent Value Rights Agreement and, as provided in the Merger Agreement, Sesen Bio will declare a dividend payable to Sesen Bio stockholders of record as of a date agreed to by Sesen Bio and Carisma prior to the effective time of the merger with respect to the receipt of one contingent value right, or a CVR, for each outstanding share of Sesen Bio common stock held by such stockholders on such date. Each CVR will </font>
          </div>

      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:27.85pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">

          <div style="width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">represent the contractual right to receive contingent cash payments upon the receipt by Sesen Bio of certain proceeds payable by F. Hoffmann-La Roche Ltd and Hoffman-La Roche Inc., or collectively, Roche, if any, pursuant to the Asset Purchase Agreement by and among Sesen Bio and Roche, or the Roche Asset Purchase Agreement, upon the achievement by Roche of a specified milestone set forth in the Roche Asset Purchase Agreement as well as proceeds from any sale of Sesen Bio&#8217;s legacy assets, including Vicineum, subject to certain customary deductions, including for expenses and taxes. </font>
          </div>


          <div style="text-indent:20pt; margin-top:3pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">In addition, prior to the closing of the merger, Sesen Bio will, in addition to the CVRs, declare a special cash dividend to Sesen Bio stockholders of record prior to the merger, which would be contingent upon Sesen Bio stockholder approval of Proposal Nos. 1 and 2 and the satisfaction or waiver of other customary closing conditions to the merger. The amount of the special cash dividend will be the amount by which Sesen Bio&#8217;s estimated net cash as of the closing of the merger exceeds $75.0 million. </font>
          </div>


          <div style="text-indent:20pt; margin-top:3pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Sesen Bio common stock is currently listed on the Nasdaq Capital Market under the symbol &#8220;SESN.&#8221; Sesen Bio has filed an initial listing application for the combined company with the Nasdaq Capital Market. After completion of the merger, Sesen Bio is expected to be renamed &#8220;Carisma Therapeutics Inc.&#8221; and to trade under the symbol &#8220;CARM.&#8221; On January 6, 2023, the last trading day before the date of the accompanying proxy statement/prospectus, the closing sale price of Sesen Bio common stock was $0.6316 per share. </font>
          </div>


          <div style="text-indent:20pt; margin-top:3pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Sesen Bio stockholders are cordially invited to attend the special meeting of Sesen Bio stockholders, or the Sesen Bio special meeting, which is being held in order to obtain the stockholder approvals necessary to complete the merger and related matters. The Sesen Bio special meeting will be held at &#8199;&#8199;&#8199;&#8199;&#8199;, Eastern Time, on&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199; &#8199;&#8199; , &#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199; &#8199;&#8199;, 2023, unless postponed or adjourned to a later date, for the purpose of considering and voting upon the matters set forth in the Notice of Special Meeting of Stockholders and the accompanying proxy statement/prospectus. The Sesen Bio special meeting will be a virtual meeting held exclusively via live webcast. Sesen Bio stockholders will be able to attend the meeting online, vote during the meeting until polls are closed, and submit questions during the meeting by registering in advance at www. &#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;. </font>
          </div>


          <div style="text-indent:20pt; margin-top:3pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">As described in the accompanying proxy statement/prospectus, certain Carisma stockholders (solely in their respective capacities as Carisma stockholders) holding approximately 97.23% of the outstanding shares of Carisma capital stock as of January 4, 2023 (subject to customary cutbacks in the event of certain triggering events) and certain Sesen Bio stockholders (solely in their respective capacities as Sesen Bio stockholders), are parties to support agreements with Carisma and Sesen Bio whereby such stockholders have agreed, subject to the effectiveness of the registration statement on Form&#160;S-4, to vote their shares in favor of the transactions contemplated therein, including, with respect to such Carisma stockholders, adoption of the Merger Agreement and approval of the merger and, with respect to such Sesen Bio stockholders, the issuance of Sesen Bio common stock in the merger pursuant to the Merger Agreement, subject to the terms of the support agreements. Following the effectiveness of the registration statement on Form S-4, of which the accompanying proxy statement/prospectus is a part, and pursuant to the Merger Agreement and the support agreements, Carisma stockholders holding a sufficient number of shares of Carisma capital stock to adopt the Merger Agreement and approve the merger and related transactions are expected to execute written consents providing for such adoption and approval, subject to the terms and limitations set forth in the support agreements. </font>
          </div>

        <div style="text-indent:20pt; margin-top:3pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">After careful consideration, each of the Sesen Bio and Carisma boards of directors have approved the Merger Agreement and have determined that it is advisable to consummate the merger. The Sesen Bio board of directors has approved the proposals described in the accompanying proxy statement/prospectus and unanimously recommends that its stockholders vote &#8220;FOR&#8221; the proposals described in the accompanying proxy statement/prospectus. </font>
        </div>

          <div style="text-indent:20pt; margin-top:3pt; width:456pt; line-height:11.5pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">More information about Sesen Bio, Carisma, the Merger Agreement and the transactions contemplated thereby and the proposals being considered at the Sesen Bio special meeting is contained in the accompanying proxy statement/prospectus. Sesen Bio urges you to read the accompanying proxy statement/prospectus carefully and in its entirety. IN PARTICULAR, YOU SHOULD CAREFULLY CONSIDER THE MATTERS DISCUSSED UNDER THE SECTION ENTITLED &#8220;RISK FACTORS&#8221; BEGINNING ON PAGE&#160;<a href="#tRIFA">26</a> OF THE ACCOMPANYING PROXY STATEMENT/PROSPECTUS.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>

        <div style="text-indent:20pt; margin-top:3pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio and Carisma are excited about the opportunities the proposed merger brings to both Sesen Bio&#8217;s and Carisma&#8217;s stockholders, and thank you for your consideration and continued support. </font>
        </div>
        <table style="width:436pt;height:40pt;margin-left:20pt;margin-top:4.60000000000002pt;border-collapse: collapse;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:212pt;">
              <font style="letter-spacing:0.2pt;">Thomas R. Cannell, D.V.M. </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:212pt;">
              <font style="letter-spacing:0.2pt;">Steven Kelly </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:italic;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:212pt;">
              <font style="letter-spacing:0.2pt;">President and Chief Executive Officer</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:212pt;">
              <font style="letter-spacing:0.2pt;">President and Chief Executive Officer</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:212pt;">
              <font style="letter-spacing:0.2pt;">Sesen Bio, Inc. </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:212pt;">
              <font style="letter-spacing:0.2pt;">CARISMA Therapeutics Inc.</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:27.85pt;min-height:706pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy of the accompanying proxy statement/</font>&#8203;<font style="letter-spacing:-0.2pt;">prospectus. Any representation to the contrary is a criminal offense.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font></div>

          <div style="text-indent:20pt; margin-top:3pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">The accompanying proxy statement/prospectus is dated &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2023, and is first being mailed to Sesen Bio stockholders on or about &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2023.</font>
          </div>

      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:3pt;margin-left:69.66pt;width:456pt;">
        <div style="position:relative;text-align:center; width:456pt;">
          <img src="lg_sesenbio-4c.jpg" alt="[MISSING IMAGE: lg_sesenbio-4c.jpg]" height="117" width="197" >
        </div>
        <div style="margin-top:17pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">SESEN BIO, INC.</font>
          <br >
          <font style="letter-spacing:-0.2pt;">245 First Street, Suite 1800</font>
          <br >
          <font style="letter-spacing:-0.2pt;">Cambridge, MA 02142</font>
          <br >
          <font style="letter-spacing:-0.2pt;">(617) 444-8550</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">NOTICE OF SPECIAL MEETING OF STOCKHOLDERS</font>
            <br >
            <font style="letter-spacing:-0.2pt;">TO BE HELD ON &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2023</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>

        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Dear stockholders of Sesen Bio, Inc.: </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On behalf of the board of directors of Sesen Bio, Inc., a Delaware corporation, or Sesen Bio, we are pleased to deliver this proxy statement/prospectus for a special meeting of stockholders of Sesen Bio, including any adjournment or postponement thereof, or the Sesen Bio special meeting, and for the proposed transactions between Sesen Bio and CARISMA Therapeutics Inc., a Delaware corporation, or Carisma, pursuant to which Seahawk Merger Sub, Inc., a Delaware corporation and wholly-owned subsidiary of Sesen Bio, or Merger Sub, will merge with and into Carisma, with Carisma surviving as a wholly-owned subsidiary of Sesen Bio, or the merger. </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">The Sesen Bio special meeting will be a virtual meeting held exclusively via live webcast on &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2023 at &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Eastern Time for the following purposes: </font>
          </div>


          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">1.</font>
            <br >
          </div>
          <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
            <font style="letter-spacing:0.2pt;">to consider and vote upon a proposal to approve, for purposes of Nasdaq Listing Rule&#160;5635(a) and (b), the issuance of shares of Sesen Bio common stock, $0.001 par value per share, or Sesen Bio common stock, to stockholders of Carisma pursuant to the terms of the Agreement and Plan of Merger and Reorganization, dated as of September&#160;20, 2022, or the Original Merger Agreement, and as amended by the First Amendment thereto, dated as of December 29, 2022, or the Merger Agreement Amendment and, together with the Original Merger Agreement, the Merger Agreement, by and among Sesen Bio, Merger Sub and Carisma, copies of which are attached as </font><font style="font-style:italic;letter-spacing:0.2pt;">Annex A-1</font><font style="letter-spacing:0.2pt;"> and </font><font style="font-style:italic;letter-spacing:0.2pt;">Annex A-2</font><font style="letter-spacing:0.2pt;">, respectively, to the accompanying proxy statement/prospectus, and the change of control of Sesen Bio resulting from the merger; </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">2.</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:0.2pt;">to consider and vote upon a proposal to approve an amendment to the restated certificate of incorporation of Sesen Bio, as amended, or the Sesen Bio Certificate of Incorporation, to (a) effect a reverse stock split of the issued and outstanding shares of Sesen Bio common stock, at a ratio of 1-for-20, with the implementation and timing of the reverse stock split to be determined in the discretion of the Sesen Bio board of directors and as agreed to by Carisma at or prior to the closing of the merger, or in the sole discretion of the Sesen Bio board of directors if Proposal No. 1 is not approved, and (b) if and when the reverse stock split is effected, reduce the number of authorized shares of Sesen Bio common stock to 100,000,000, in the form attached as </font><font style="font-style:italic;letter-spacing:0.2pt;">Annex G</font><font style="letter-spacing:0.2pt;"> to the accompanying proxy statement/prospectus; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">3.</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:0.2pt;">to consider and vote upon a proposal to approve an amendment and restatement of the Sesen Bio, Inc. 2014 Stock Incentive Plan, as amended, or the 2014 Incentive Plan, to, among other things, (a)&#160;increase the number of shares of Sesen Bio common stock reserved for issuance under the 2014 Incentive Plan, and (b)&#160;extend the term of the 2014 Incentive Plan to the tenth (10</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">th</font><font style="letter-spacing:0.2pt;">) anniversary of the closing of the merger; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">4.</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:0.2pt;">to consider and vote upon a proposal to approve an amendment to the Sesen Bio, Inc. 2014 Employee Stock Purchase Plan, as amended, or the 2014 ESPP, to increase the number of shares </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:40pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">of Sesen Bio common stock reserved for issuance under the 2014 ESPP to 6,568,655 shares of Sesen Bio common stock; </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">5.</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:0.2pt;">to consider and vote upon a proposal to approve an adjournment of the Sesen Bio special meeting, if necessary, to solicit additional proxies if there are not sufficient votes in favor of Proposal Nos. 1 and 2; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">6.</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:0.2pt;">to transact such other business as may properly come before the Sesen Bio special meeting or any adjournment or postponement thereof. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">The Sesen Bio board of directors has fixed &#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199; &#8199;&#8199; , 2023 as the record date for the determination of Sesen Bio stockholders entitled to notice of, and to vote at, the Sesen Bio special meeting and any adjournment or postponement thereof, or the record date. Only holders of record of shares of Sesen Bio common stock at the close of business on the record date are entitled to notice of, and to vote at, the Sesen Bio special meeting. At the close of business on the record date, Sesen Bio had&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;shares of common stock outstanding and entitled to vote. </font>
          </div>

        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Sesen Bio special meeting will be a virtual meeting held exclusively via live webcast. You may attend the Sesen Bio special meeting, vote your shares and submit questions electronically during the Sesen Bio special meeting. Whether or not you expect to attend the Sesen Bio special meeting, you are respectfully requested to promptly either (i)&#160;sign, date and return the enclosed proxy card or voting instruction form, or (ii)&#160;vote via telephone or the internet by following the instructions provided on the enclosed proxy card or voting instruction form. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In order to attend the Sesen Bio special meeting, you must register in advance at www.&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199; . After completing your registration, you will receive further instructions via email, including a unique link that will allow you to access the Sesen Bio special meeting and to vote and submit questions during the Sesen Bio special meeting. As part of the registration process, you must enter the control number located on your proxy card or voting instruction form. If you are a beneficial owner of shares registered in the name of a broker, bank or other nominee, you will also need to provide the registered name on your account and the name of your broker, bank or other nominee as part of the registration process. Please be sure to follow the instructions found on your proxy card or voting instruction form. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Your vote is important. The affirmative vote of a majority in voting power of the votes cast by the holders of all shares of Sesen Bio common stock present or represented by proxy at the Sesen Bio special meeting and entitled to vote on the matter is required for approval of Proposal Nos. 1, 3, 4 and 5. The affirmative vote of the holders of a majority of the outstanding shares of Sesen Bio common stock on the record date for the Sesen Bio special meeting entitled to vote on the matter is required for approval of Proposal No. 2.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Proposal No. 1 is conditioned upon the approval of Proposal No. 2, and the merger cannot be consummated without the approval of Proposal Nos. 1 and 2. Proposal Nos. 3 and 4 are conditioned upon the approval of Proposal Nos. 1 and 2. Proposal No. 2 is not conditioned on the approval of any other proposal.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Even if you plan to attend the Sesen Bio special meeting, Sesen Bio requests that you sign and return the enclosed proxy card or voting instruction form to ensure that your shares will be represented at the Sesen Bio special meeting if you are unable to attend.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">THE SESEN BIO BOARD OF DIRECTORS HAS DETERMINED AND BELIEVES THAT EACH OF THE PROPOSALS OUTLINED ABOVE IS ADVISABLE TO, AND IN THE BEST INTERESTS OF, SESEN BIO AND ITS STOCKHOLDERS AND HAS APPROVED EACH SUCH PROPOSAL. THE SESEN BIO BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS THAT SESEN BIO STOCKHOLDERS VOTE &#8220;FOR&#8221; EACH SUCH PROPOSAL.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:240pt; margin-top:8pt; width:216pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">By Order of the Sesen Bio Board of Directors, </font>
        </div>

          <div style="margin-left:240pt; margin-top:8pt; width:216pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Mark Sullivan</font>
            <br >
            <font style="font-style:italic;letter-spacing:0.2pt;">General Counsel and Corporate Secretary</font>
            <br >
            <font style="letter-spacing:0.2pt;">Cambridge, Massachusetts</font>
            <br >
            <font style="letter-spacing:0.2pt;">&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199; &#8199;&#8199;, 2023 </font>
          </div>

      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;height:660pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">EXPLANATORY NOTE</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The issuance of all shares of Sesen Bio common stock in exchange for each outstanding share of Carisma capital stock, other than shares of Sesen Bio common stock issued in exchange for shares of Carisma common stock issued in connection with the Carisma pre-closing financing, is intended to be covered by this registration statement on Form S-4 of which the accompanying proxy statement/prospectus is a part. There is no difference between the Sesen Bio common stock that will be issued in exchange for each share of Carisma common stock issued in the pre-closing financing and the Sesen Bio common stock that will be issued in exchange for each other outstanding share of Carisma capital stock, except that the shares of Sesen Bio common stock that will be issued as transaction consideration in exchange for each share of Carisma common stock issued in the pre-closing financing will not be registered under the Securities Act of 1933, as amended, or the Securities Act, and will be subject to restrictions on resale. </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">REFERENCES TO ADDITIONAL INFORMATION</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">This proxy statement/prospectus incorporates important business and financial information about Sesen Bio that is not included in or delivered with this document. You may obtain this information without charge through the Securities and Exchange Commission, or the SEC, website (www.sec.gov) or upon your written or oral request by contacting the Corporate Secretary of Sesen Bio, Inc., 245 First Street, Suite&#160;1800, Cambridge, MA 02142 or by calling (617) 444-8550. </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">To ensure timely delivery of these documents, any request should be made no later than &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; , 2023 to receive them before the Sesen Bio special meeting.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">For additional details about where you can find information about Sesen Bio, see the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Where You Can Find More Information</font><font style="letter-spacing:0.2pt;">&#8221; on page <a href="#tWYCF">404</a> of this proxy statement/prospectus. </font>
          </div>

      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;height:660pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ABOUT THIS PROXY STATEMENT/PROSPECTUS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">This proxy statement/prospectus, which forms part of a registration statement on Form S-4 filed with the SEC by Sesen Bio (File No. 333-267891), constitutes a prospectus of Sesen Bio under Section&#160;5 of the Securities Act with respect to shares of Sesen Bio common stock to be issued pursuant to the Merger Agreement. This document also constitutes a notice of meeting and a proxy statement under Section&#160;14(a) of the Securities Exchange Act of 1934, as amended, or the Exchange Act, with respect to the Sesen Bio special meeting at which Sesen Bio stockholders will be asked to consider and vote on, among other matters, a proposal to approve the issuance of shares of Sesen Bio common stock pursuant to the Merger Agreement. </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">No one has been authorized to provide you with information that is different from that contained in, or incorporated by reference into, this proxy statement/prospectus. This proxy statement/prospectus is dated &nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2023. The information contained in this proxy statement/prospectus is accurate only as of that date or, in the case of information in a document incorporated by reference, as of the date of such document, unless the information specifically indicates that another date applies. </font>
          </div>

        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">This proxy statement/prospectus does not constitute an offer to sell, or a solicitation of an offer to buy, any securities, or the solicitation of a proxy, in any jurisdiction in which or from any person to whom it is unlawful to make any such offer or solicitation in such jurisdiction.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The information concerning Sesen Bio contained in this proxy statement/prospectus or incorporated by reference has been provided by Sesen Bio, and the information concerning Carisma contained in this proxy statement/prospectus has been provided by Carisma. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">All references in this proxy statement/prospectus to &#8220;Sesen Bio&#8221; and &#8220;Carisma&#8221; refer to Sesen Bio, Inc. and CARISMA Therapeutics Inc., respectively. All references in this proxy statement/prospectus to &#8220;Merger Sub&#8221; refer to Seahawk Merger Sub, Inc., a newly formed, wholly-owned subsidiary of Sesen Bio. All references in this proxy statement/prospectus to the &#8220;combined company&#8221; refer to Sesen Bio and its wholly-owned subsidiary, Carisma, following completion of the merger. Except as otherwise noted, references to &#8220;we,&#8221; &#8220;us&#8221; or &#8220;our&#8221; refer to both Sesen Bio and Carisma. All references in this proxy statement/prospectus to &#8220;Sesen Bio common stock&#8221; refer to the common stock of Sesen Bio, $0.001 par value per share, and all references in this proxy statement/prospectus to &#8220;Carisma common stock&#8221; refer to the common stock of Carisma, $0.0001 par value per share.</font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="TOC">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:3.5pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">TABLE OF CONTENTS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <table style="width:456pt;height:602.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:419.63pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;text-align:center;" colspan="4">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Page </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.25pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <a href="#tQAAA"><font style="letter-spacing:0.2pt;">QUESTIONS AND ANSWERS ABOUT THE MERGER </font></a>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
                <font style="letter-spacing:0.2pt;"><a href="#tQAAA">1</a></font> <a href="#tQAAA"></a></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <a href="#tPRSU"><font style="letter-spacing:0.2pt;">PROSPECTUS SUMMARY </font></a>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
                <font style="letter-spacing:0.2pt;"><a href="#tPRSU">11</a></font> <a href="#tPRSU"></a></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <a href="#tMPAD"><font style="letter-spacing:0.2pt;">MARKET PRICE AND DIVIDEND INFORMATION </font></a>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
                <font style="letter-spacing:0.2pt;"><a href="#tMPAD">25</a></font> <a href="#tMPAD"></a></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <a href="#tRIFA"><font style="letter-spacing:0.2pt;">RISK FACTORS </font></a>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
                <font style="letter-spacing:0.2pt;"><a href="#tRIFA">26</a></font> <a href="#tRIFA"></a></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
                <div style="margin-left:10pt;">
                  <a href="#tRRTT"><font style="letter-spacing:0.2pt;">Risks Related to the Merger </font></a>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
                <font style="letter-spacing:0.2pt;"><a href="#tRRTT">26</a></font> <a href="#tRRTT"></a></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
                <div style="margin-left:10pt;">
                  <a href="#tRRTT1"><font style="letter-spacing:0.2pt;">Risks Related to the Proposed Reverse Stock Split </font></a>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
                <font style="letter-spacing:0.2pt;"><a href="#tRRTT1">31</a></font> <a href="#tRRTT1"></a></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
                <div style="margin-left:10pt;">
                  <a href="#tRRTS"><font style="letter-spacing:0.2pt;">Risks Related to Sesen Bio </font></a>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
                <font style="letter-spacing:0.2pt;"><a href="#tRRTS">32</a></font> <a href="#tRRTS"></a></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
                <div style="margin-left:10pt;">
                  <a href="#tRRTC"><font style="letter-spacing:0.2pt;">Risks Related to Carisma </font></a>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
                <font style="letter-spacing:0.2pt;"><a href="#tRRTC">57</a></font> <a href="#tRRTC"></a></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <a href="#tCSCF"><font style="letter-spacing:0.2pt;">CAUTIONARY STATEMENT CONCERNING FORWARD-LOOKING STATEMENTS </font></a>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
                <font style="letter-spacing:0.2pt;"><a href="#tCSCF">118</a></font> <a href="#tCSCF"></a></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <a href="#tTSMO"><font style="letter-spacing:0.2pt;">THE SPECIAL MEETING OF SESEN BIO STOCKHOLDERS </font></a>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
                <font style="letter-spacing:0.2pt;"><a href="#tTSMO">121</a></font> <a href="#tTSMO"></a></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <a href="#tTHME"><font style="letter-spacing:0.2pt;">THE MERGER </font></a>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
                <font style="letter-spacing:0.2pt;"><a href="#tTHME">125</a></font> <a href="#tTHME"></a></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
                <div style="margin-left:10pt;">
                  <a href="#tBOTM"><font style="letter-spacing:0.2pt;">Background of the Merger </font></a>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
                <font style="letter-spacing:0.2pt;"><a href="#tBOTM">125</a></font> <a href="#tBOTM"></a></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
                <div style="margin-left:10pt;">
                  <a href="#tSBRF"><font style="letter-spacing:0.2pt;">Sesen Bio Reasons for the Merger </font></a>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
                <font style="letter-spacing:0.2pt;"><a href="#tSBRF">134</a></font> <a href="#tSBRF"></a></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
                <div style="margin-left:10pt;">
                  <a href="#tCRFT"><font style="letter-spacing:0.2pt;">Carisma Reasons for the Merger </font></a>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
                <font style="letter-spacing:0.2pt;"><a href="#tCRFT">137</a></font> <a href="#tCRFT"></a></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
                <div style="margin-left:10pt;">
                  <a href="#tOOSB"><font style="letter-spacing:0.2pt;">Opinion of Sesen Bio&#8217;s Financial Advisor </font></a>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
                <font style="letter-spacing:0.2pt;"><a href="#tOOSB">139</a></font> <a href="#tOOSB"></a></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
                <div style="margin-left:10pt;">
                  <a href="#tCUFP"><font style="letter-spacing:0.2pt;">Certain Unaudited Financial Projections </font></a>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
                <font style="letter-spacing:0.2pt;"><a href="#tCUFP">145</a></font> <a href="#tCUFP"></a></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
                <div style="margin-left:10pt;">
                  <a href="#tIOSB"><font style="letter-spacing:0.2pt;">Interests of Sesen Bio Directors and Executive Officers in the Merger </font></a>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
                <font style="letter-spacing:0.2pt;"><a href="#tIOSB">148</a></font> <a href="#tIOSB"></a></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
                <div style="margin-left:10pt;">
                  <a href="#tIOCD"><font style="letter-spacing:0.2pt;">Interests of Carisma Directors and Executive Officers in the Merger </font></a>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
                <font style="letter-spacing:0.2pt;"><a href="#tIOCD">153</a></font> <a href="#tIOCD"></a></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
                <div style="margin-left:10pt;">
                  <a href="#tFOTM"><font style="letter-spacing:0.2pt;">Form of the Merger </font></a>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
                <font style="letter-spacing:0.2pt;"><a href="#tFOTM">156</a></font> <a href="#tFOTM"></a></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
                <div style="margin-left:10pt;">
                  <a href="#tETOT"><font style="letter-spacing:0.2pt;">Effective Time of the Merger </font></a>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
                <font style="letter-spacing:0.2pt;"><a href="#tETOT">156</a></font> <a href="#tETOT"></a></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
                <div style="margin-left:10pt;">
                  <a href="#tMCAE"><font style="letter-spacing:0.2pt;">Merger Consideration and Exchange Ratio </font></a>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
                <font style="letter-spacing:0.2pt;"><a href="#tMCAE">156</a></font> <a href="#tMCAE"></a></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
                <div style="margin-left:10pt;">
                  <a href="#tSBFN"><font style="letter-spacing:0.2pt;">Sesen Bio&#8217;s Final Net Cash </font></a>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
                <font style="letter-spacing:0.2pt;"><a href="#tSBFN">158</a></font> <a href="#tSBFN"></a></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
                <div style="margin-left:10pt;">
                  <a href="#tPFEC"><font style="letter-spacing:0.2pt;">Procedures for Exchanging Carisma Stock Certificates </font></a>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
                <font style="letter-spacing:0.2pt;"><a href="#tPFEC">159</a></font> <a href="#tPFEC"></a></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
                <div style="margin-left:10pt;">
                  <a href="#tREAP"><font style="letter-spacing:0.2pt;">Regulatory Approvals </font></a>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
                <font style="letter-spacing:0.2pt;"><a href="#tREAP">160</a></font> <a href="#tREAP"></a></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
                <div style="margin-left:10pt;">
                  <a href="#tMUFI"><font style="letter-spacing:0.2pt;">Material U.S. Federal Income Tax Consequences of the Merger </font></a>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
                <font style="letter-spacing:0.2pt;"><a href="#tMUFI">160</a></font> <a href="#tMUFI"></a></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
                <div style="margin-left:10pt;">
                  <a href="#tMUFI1"><font style="letter-spacing:0.2pt;">Material U.S. Federal Income Tax Consequences of the Special Cash Dividend </font></a>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
                <font style="letter-spacing:0.2pt;"><a href="#tMUFI1">162</a></font> <a href="#tMUFI1"></a></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
                <div style="margin-left:10pt;">
                  <a href="#tNALI"><font style="letter-spacing:0.2pt;">Nasdaq Listing </font></a>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
                <font style="letter-spacing:0.2pt;"><a href="#tNALI">165</a></font> <a href="#tNALI"></a></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
                <div style="margin-left:10pt;">
                  <a href="#tAAT"><font style="letter-spacing:0.2pt;">Anticipated Accounting Treatment </font></a>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
                <font style="letter-spacing:0.2pt;"><a href="#tAAT">166</a></font> <a href="#tAAT"></a></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
                <div style="margin-left:10pt;">
                  <a href="#tARAD"><font style="letter-spacing:0.2pt;">Appraisal Rights and Dissenters&#8217; Rights </font></a>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
                <font style="letter-spacing:0.2pt;"><a href="#tARAD">166</a></font> <a href="#tARAD"></a></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
                <div style="margin-left:10pt;">
                  <a href="#tLRTM"><font style="letter-spacing:0.2pt;">Litigation Related to the Merger </font></a>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
                <font style="letter-spacing:0.2pt;"><a href="#tLRTM">169</a></font>
              </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <a href="#tTMA"><font style="letter-spacing:0.2pt;">THE MERGER AGREEMENT </font></a>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
                <font style="letter-spacing:0.2pt;"><a href="#tTMA">171</a></font> <a href="#tTMA"></a></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <a href="#tARTT"><font style="letter-spacing:0.2pt;">AGREEMENTS RELATED TO THE MERGER </font></a>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
                <font style="letter-spacing:0.2pt;"><a href="#tARTT">192</a></font> <a href="#tARTT"></a></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
                <div style="margin-left:10pt;">
                  <a href="#tCVAG"><font style="letter-spacing:0.2pt;">CVR Agreement </font></a>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
                <font style="letter-spacing:0.2pt;"><a href="#tCVAG">192</a></font> <a href="#tCVAG"></a></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
                <div style="margin-left:10pt;">
                  <a href="#tSAAW"><font style="letter-spacing:0.2pt;">Support Agreements and Written Consents </font></a>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
                <font style="letter-spacing:0.2pt;"><a href="#tSAAW">197</a></font> <a href="#tSAAW"></a></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
                <div style="margin-left:10pt;">
                  <a href="#tSUAG"><font style="letter-spacing:0.2pt;">Subscription Agreement </font></a>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
                <font style="letter-spacing:0.2pt;"><a href="#tSUAG">198</a></font> <a href="#tSUAG"></a></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
                <div style="margin-left:10pt;">
                  <a href="#tLOAG"><font style="letter-spacing:0.2pt;">Lock-Up Agreements </font></a>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
                <font style="letter-spacing:0.2pt;"><a href="#tLOAG">199</a></font> <a href="#tLOAG"></a></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <a href="#tMBST"><font style="letter-spacing:0.2pt;">MATTERS BEING SUBMITTED TO A VOTE OF SESEN BIO STOCKHOLDERS </font></a>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
                <font style="letter-spacing:0.2pt;"><a href="#tMBST">201</a></font> <a href="#tMBST"></a></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:2.167pt 0pt 1.5pt 0pt; width:419.63pt;white-space:normal;text-align:left;">
                <div style="margin-left:20pt; text-indent:-10pt;">
                  <a href="#tPN1A"><font style="letter-spacing:0.2pt;">Proposal No. 1: Approval, for purposes of Nasdaq Listing Rule&#160;5635(a) and (b), the issuance of shares of Sesen Bio common stock to Carisma stockholders pursuant to the terms of the Merger Agreement and the change of control of Sesen Bio resulting from the merger </font></a>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
                <font style="letter-spacing:0.2pt;"><a href="#tPN1A">201</a></font> <a href="#tPN1A"></a></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
          </table>

      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">i</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="TOC2">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">

          <table style="width:456pt;height:650.5pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:419.63pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;text-align:center;" colspan="4">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Page </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:2.75pt 0pt 0.5pt 0pt; width:419.63pt;white-space:normal;text-align:left;">
                <div style="margin-left:20pt; text-indent:-10pt;">
                  <a href="#tPN2A"><font style="letter-spacing:0.2pt;">Proposal No. 2: Approval of an amendment to the Sesen Bio Certificate of Incorporation to effect the reverse stock split and reduce the number of authorized shares of Sesen Bio common&#160;stock </font></a>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.75pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.75pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
                <font style="letter-spacing:0.2pt;"><a href="#tPN2A">203</a></font> <a href="#tPN2A"></a></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:419.63pt;text-align:left;">
                <div style="margin-left:10pt;">
                  <a href="#tPN3A"><font style="letter-spacing:0.2pt;">Proposal No. 3: Approval of an amendment and restatement of the 2014 Incentive Plan </font></a>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
                <font style="letter-spacing:0.2pt;"><a href="#tPN3A">212</a></font>
              </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:419.63pt;text-align:left;">
                <div style="margin-left:10pt;">
                  <a href="#tPN4A"><font style="letter-spacing:0.2pt;">Proposal No. 4: Approval of an amendment to the 2014 ESPP </font></a>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
                <font style="letter-spacing:0.2pt;"><a href="#tPN4A">224</a></font>
              </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:419.63pt;text-align:left;">
                <div style="margin-left:10pt;">
                  <a href="#tPN5A"><font style="letter-spacing:0.2pt;">Proposal No. 5: Approval of possible adjournment of the Sesen Bio special meeting </font></a>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
                <font style="letter-spacing:0.2pt;"><a href="#tPN5A">229</a></font>
              </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:419.63pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <a href="#tSBB"><font style="letter-spacing:0.2pt;">SESEN BIO BUSINESS </font></a>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
                <font style="letter-spacing:0.2pt;"><a href="#tSBB">230</a></font>
              </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:419.63pt;text-align:left;">
                <div style="margin-left:10pt;">
                  <a href="#tOVE"><font style="letter-spacing:0.2pt;">Overview </font></a>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
                <font style="letter-spacing:0.2pt;"><a href="#tOVE">230</a></font>
              </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:419.63pt;text-align:left;">
                <div style="margin-left:10pt;">
                  <a href="#tCUST"><font style="letter-spacing:0.2pt;">Current Strategy </font></a>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
                <font style="letter-spacing:0.2pt;"><a href="#tCUST">230</a></font>
              </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:419.63pt;text-align:left;">
                <div style="margin-left:10pt;">
                  <a href="#tSBHP"><font style="letter-spacing:0.2pt;">Sesen Bio&#8217;s Historical Pipeline Product Candidates </font></a>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
                <font style="letter-spacing:0.2pt;"><a href="#tSBHP">231</a></font>
              </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:419.63pt;text-align:left;">
                <div style="margin-left:10pt;">
                  <a href="#tCOM"><font style="letter-spacing:0.2pt;">Competition </font></a>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
                <font style="letter-spacing:0.2pt;"><a href="#tCOM">233</a></font>
              </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:419.63pt;text-align:left;">
                <div style="margin-left:10pt;">
                  <a href="#tSAM"><font style="letter-spacing:0.2pt;">Sales and Marketing </font></a>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
                <font style="letter-spacing:0.2pt;"><a href="#tSAM">234</a></font>
              </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:419.63pt;text-align:left;">
                <div style="margin-left:10pt;">
                  <a href="#tMAN"><font style="letter-spacing:0.2pt;">Manufacturing </font></a>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
                <font style="letter-spacing:0.2pt;"><a href="#tMAN">234</a></font>
              </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:419.63pt;text-align:left;">
                <div style="margin-left:10pt;">
                  <a href="#tINPR"><font style="letter-spacing:0.2pt;">Intellectual Property </font></a>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
                <font style="letter-spacing:0.2pt;"><a href="#tINPR">234</a></font>
              </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:419.63pt;text-align:left;">
                <div style="margin-left:10pt;">
                  <a href="#tSBOB"><font style="letter-spacing:0.2pt;">Sesen Bio&#8217;s OUS Business Development Partnering </font></a>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
                <font style="letter-spacing:0.2pt;"><a href="#tSBOB">235</a></font>
              </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:419.63pt;text-align:left;">
                <div style="margin-left:10pt;">
                  <a href="#tGORE"><font style="letter-spacing:0.2pt;">Government Regulation </font></a>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
                <font style="letter-spacing:0.2pt;"><a href="#tGORE">236</a></font>
              </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:419.63pt;text-align:left;">
                <div style="margin-left:10pt;">
                  <a href="#tEMP"><font style="letter-spacing:0.2pt;">Employees </font></a>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
                <font style="letter-spacing:0.2pt;"><a href="#tEMP">246</a></font>
              </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:419.63pt;text-align:left;">
                <div style="margin-left:10pt;">
                  <a href="#tCOIN"><font style="letter-spacing:0.2pt;">Corporate Information </font></a>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
                <font style="letter-spacing:0.2pt;"><a href="#tCOIN">246</a></font>
              </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:419.63pt;text-align:left;">
                <div style="margin-left:10pt;">
                  <a href="#tLEPR"><font style="letter-spacing:0.2pt;">Legal Proceedings </font></a>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
                <font style="letter-spacing:0.2pt;"><a href="#tLEPR">247</a></font>
              </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:419.63pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <a href="#tCABU"><font style="letter-spacing:0.2pt;">CARISMA BUSINESS </font></a>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
                <font style="letter-spacing:0.2pt;"><a href="#tCABU">249</a></font>
              </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:419.63pt;text-align:left;">
                <div style="margin-left:10pt;">
                  <a href="#tOVE1"><font style="letter-spacing:0.2pt;">Overview </font></a>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
                <font style="letter-spacing:0.2pt;"><a href="#tOVE1">249</a></font>
              </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:419.63pt;text-align:left;">
                <div style="margin-left:10pt;">
                  <a href="#tCATE"><font style="letter-spacing:0.2pt;">Carisma&#8217;s Team </font></a>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
                <font style="letter-spacing:0.2pt;"><a href="#tCATE">252</a></font>
              </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:419.63pt;text-align:left;">
                <div style="margin-left:10pt;">
                  <a href="#tCAST"><font style="letter-spacing:0.2pt;">Carisma&#8217;s Strategy </font></a>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
                <font style="letter-spacing:0.2pt;"><a href="#tCAST">252</a></font>
              </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:419.63pt;text-align:left;">
                <div style="margin-left:10pt;">
                  <a href="#tBAC"><font style="letter-spacing:0.2pt;">Background </font></a>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
                <font style="letter-spacing:0.2pt;"><a href="#tBAC">254</a></font>
              </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:419.63pt;text-align:left;">
                <div style="margin-left:10pt;">
                  <a href="#tMAD"><font style="letter-spacing:0.2pt;">Manufacturing and Delivery </font></a>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
                <font style="letter-spacing:0.2pt;"><a href="#tMAD">286</a></font>
              </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:419.63pt;text-align:left;">
                <div style="margin-left:10pt;">
                  <a href="#tINPR1"><font style="letter-spacing:0.2pt;">Intellectual Property </font></a>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
                <font style="letter-spacing:0.2pt;"><a href="#tINPR1">287</a></font>
              </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:419.63pt;text-align:left;">
                <div style="margin-left:10pt;">
                  <a href="#tCOM1"><font style="letter-spacing:0.2pt;">Competition </font></a>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
                <font style="letter-spacing:0.2pt;"><a href="#tCOM1">292</a></font>
              </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:419.63pt;text-align:left;">
                <div style="margin-left:10pt;">
                  <a href="#tGORE1"><font style="letter-spacing:0.2pt;">Government Regulation </font></a>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
                <font style="letter-spacing:0.2pt;"><a href="#tGORE1">293</a></font>
              </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:419.63pt;text-align:left;">
                <div style="margin-left:10pt;">
                  <a href="#tEAHC"><font style="letter-spacing:0.2pt;">Employees and Human Capital Resources </font></a>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
                <font style="letter-spacing:0.2pt;"><a href="#tEAHC">309</a></font>
              </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:419.63pt;text-align:left;">
                <div style="margin-left:10pt;">
                  <a href="#tFAC"><font style="letter-spacing:0.2pt;">Facilities </font></a>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
                <font style="letter-spacing:0.2pt;"><a href="#tFAC">309</a></font>
              </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:419.63pt;text-align:left;">
                <div style="margin-left:10pt;">
                  <a href="#tLEPR1"><font style="letter-spacing:0.2pt;">Legal Proceedings </font></a>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
                <font style="letter-spacing:0.2pt;"><a href="#tLEPR1">309</a></font>
              </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:419.63pt;white-space:normal;text-align:left;">
                <div style="margin-left:10pt; text-indent:-10pt;">
                  <a href="#tSBMD"><font style="letter-spacing:0.2pt;">SESEN BIO MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS </font></a>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
                <font style="letter-spacing:0.2pt;"><a href="#tSBMD">310</a></font>
              </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:419.63pt;white-space:normal;text-align:left;">
                <div style="margin-left:10pt; text-indent:-10pt;">
                  <a href="#tCMDA"><font style="letter-spacing:0.2pt;">CARISMA MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS </font></a>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
                <font style="letter-spacing:0.2pt;"><a href="#tCMDA">326</a></font>
              </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:419.63pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <a href="#tMFTM"><font style="letter-spacing:0.2pt;">MANAGEMENT FOLLOWING THE MERGER </font></a>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
                <font style="letter-spacing:0.2pt;"><a href="#tMFTM">342</a></font>
              </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:419.63pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <a href="#tSBEC"><font style="letter-spacing:0.2pt;">SESEN BIO EXECUTIVE COMPENSATION </font></a>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
                <font style="letter-spacing:0.2pt;"><a href="#tSBEC">349</a></font>
              </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:419.63pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <a href="#tCEC"><font style="letter-spacing:0.2pt;">CARISMA EXECUTIVE COMPENSATION </font></a>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
                <font style="letter-spacing:0.2pt;"><a href="#tCEC">360</a></font>
              </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:419.63pt;white-space:normal;text-align:left;">
                <div style="margin-left:10pt; text-indent:-10pt;">
                  <a href="#tRPTO"><font style="letter-spacing:0.2pt;">RELATED PARTY TRANSACTIONS OF DIRECTORS AND EXECUTIVE OFFICERS OF THE COMBINED COMPANY </font></a>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
                <font style="letter-spacing:0.2pt;"><a href="#tRPTO">368</a></font>
              </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:419.63pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <a href="#tUPFC"><font style="letter-spacing:0.2pt;">UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION </font></a>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
                <font style="letter-spacing:0.2pt;"><a href="#tUPFC">372</a></font>
              </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:419.63pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <a href="#tDOSB"><font style="letter-spacing:0.2pt;">DESCRIPTION OF SESEN BIO CAPITAL STOCK </font></a>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
                <font style="letter-spacing:0.2pt;"><a href="#tDOSB">383</a></font>
              </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:419.63pt;text-align:left;">
                <div style="margin-left:10pt; text-indent:-10pt;">
                  <a href="#tCORO"><font style="letter-spacing:0.2pt;">COMPARISON OF RIGHTS OF HOLDERS OF SESEN BIO STOCK AND CARISMA </font>
                    <br >
                    <font style="letter-spacing:0.2pt;">STOCK </font></a>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
                <font style="letter-spacing:0.2pt;"><a href="#tCORO">386</a></font>
              </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
          </table>

      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">ii</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="TOC3">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:287.5pt;margin-left:69.66pt;width:456pt;">

          <table style="width:456pt;height:323.5pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:419.63pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;text-align:center;" colspan="4">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Page </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.25pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <a href="#tPSOS"><font style="letter-spacing:0.2pt;">PRINCIPAL STOCKHOLDERS OF SESEN BIO </font></a>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">
                <font style="letter-spacing:0.2pt;"><a href="#tPSOS">395</a></font>
              </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <a href="#tPSOC"><font style="letter-spacing:0.2pt;">PRINCIPAL STOCKHOLDERS OF CARISMA </font></a>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">
                <font style="letter-spacing:0.2pt;"><a href="#tPSOC">397</a></font>
              </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <a href="#tPSOT"><font style="letter-spacing:0.2pt;">PRINCIPAL STOCKHOLDERS OF THE COMBINED COMPANY </font></a>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">
                <font style="letter-spacing:0.2pt;"><a href="#tPSOT">400</a></font>
              </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;letter-spacing:0.2pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <a href="#tLEMA">LEGAL MATTERS</a>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">
                <a href="#tLEMA">&#8203;</a>
              </td>
              <td style="padding:0pt; width:6pt;">
                <a href="#tLEMA">&#8203;</a>
              </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">
                <a href="#tLEMA">&#8203;</a>
              </td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">
                <a href="#tLEMA">&#8203;</a>
              </td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">
                <a href="#tLEMA">403</a>
              </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">
                <a href="#tLEMA">&#8203;</a>
              </td>
              <td style="padding:0pt; width:0pt;">
                <a href="#tLEMA">&#8203;</a>
              </td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;letter-spacing:0.2pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <a href="#tEXP">EXPERTS </a>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">
                <a href="#tEXP">&#8203;</a>
              </td>
              <td style="padding:0pt; width:6pt;">
                <a href="#tEXP">&#8203;</a>
              </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">
                <a href="#tEXP">&#8203;</a>
              </td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">
                <a href="#tEXP">&#8203;</a>
              </td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">
                <a href="#tEXP">403</a>
              </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">
                <a href="#tEXP">&#8203;</a>
              </td>
              <td style="padding:0pt; width:0pt;">
                <a href="#tEXP">&#8203;</a>
              </td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;letter-spacing:0.2pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <a href="#tWYCF">WHERE YOU CAN FIND MORE INFORMATION </a>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">
                <a href="#tWYCF">&#8203;</a>
              </td>
              <td style="padding:0pt; width:6pt;">
                <a href="#tWYCF">&#8203;</a>
              </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">
                <a href="#tWYCF">&#8203;</a>
              </td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">
                <a href="#tWYCF">&#8203;</a>
              </td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">
                <a href="#tWYCF">404</a>
              </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">
                <a href="#tWYCF">&#8203;</a>
              </td>
              <td style="padding:0pt; width:0pt;">
                <a href="#tWYCF">&#8203;</a>
              </td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;letter-spacing:0.2pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <a href="#tTRNO">TRADEMARK NOTICE </a>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">
                <a href="#tTRNO">&#8203;</a>
              </td>
              <td style="padding:0pt; width:6pt;">
                <a href="#tTRNO">&#8203;</a>
              </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">
                <a href="#tTRNO">&#8203;</a>
              </td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">
                <a href="#tTRNO">&#8203;</a>
              </td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">
                <a href="#tTRNO">405</a>
              </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">
                <a href="#tTRNO">&#8203;</a>
              </td>
              <td style="padding:0pt; width:0pt;">
                <a href="#tTRNO">&#8203;</a>
              </td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <a href="#tOTMA"><font style="letter-spacing:0.2pt;">OTHER MATTERS </font></a>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">
                <font style="letter-spacing:0.2pt;"><a href="#tOTMA">406</a></font>
              </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <a href="#fISCF"><font style="letter-spacing:0.2pt;">Index to Sesen Bio&#8217;s Consolidated Financial Statements </font></a>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">
                <font style="letter-spacing:0.2pt;"><a href="#fISCF">F-1</a></font>
              </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <a href="#fISCS"><font style="letter-spacing:0.2pt;">Index to Carisma&#8217;s Consolidated Financial Statements </font></a>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">
                <font style="letter-spacing:0.2pt;"><a href="#fISCS">F-70</a></font>
              </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <a href="#tAAPM"><font style="letter-spacing:0.2pt;">Annex A-1&#8201;&#8211;&#8201;Agreement and Plan of Merger and Reorganization </font></a>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">
                <font style="letter-spacing:0.2pt;"><a href="#tAAPM">A-1-1</a></font> <a href="#tAAPM"></a></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <a href="#tFAAP"><font style="letter-spacing:0.2pt;">Annex A-2&#8201;&#8211;&#8201;First Amendment to Agreement and Plan of Merger and Reorganization </font> </a>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">
                <a href="#tFAAP"><font style="letter-spacing:0.2pt;">A-2-1</font></a>
              </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <a href="#tANNB"><font style="letter-spacing:0.2pt;">Annex B&#8201;&#8211;&#8201;Opinion of SVB Securities LLC, dated December 29, 2022</font></a>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">
                <font style="letter-spacing:0.2pt;"><a href="#tANNB">B-1</a></font>
              </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <a href="#tANNC"><font style="letter-spacing:0.2pt;">Annex C&#8201;&#8211;&#8201;Form of Carisma Support Agreement </font></a>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">
                <font style="letter-spacing:0.2pt;"><a href="#tANNC">C-1</a></font>
              </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <a href="#tANND"><font style="letter-spacing:0.2pt;">Annex D&#8201;&#8211;&#8201;Form of Sesen Bio Support Agreement </font></a>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">
                <font style="letter-spacing:0.2pt;"><a href="#tANND">D-1</a></font>
              </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <a href="#tANNE"><font style="letter-spacing:0.2pt;">Annex E&#8201;&#8211;&#8201;Form of Lock-Up Agreement </font></a>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">
                <font style="letter-spacing:0.2pt;"><a href="#tANNE">E-1</a></font>
              </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <a href="#tANNF"><font style="letter-spacing:0.2pt;">Annex F&#8201;&#8211;&#8201;Form of Contingent Value Rights Agreement </font></a>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">
                <font style="letter-spacing:0.2pt;"><a href="#tANNF">F-1</a></font>
              </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <a href="#AnnexG"><font style="letter-spacing:0.2pt;">Annex G&#8201;&#8211;&#8201;Certificate of Amendment for the Reverse Stock Split </font></a>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">
                <font style="letter-spacing:0.2pt;"><a href="#AnnexG">G-1</a></font>
              </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <a href="#tANNH"><font style="letter-spacing:0.2pt;">Annex H&#8201;&#8211;&#8201;Appraisal Rights (Section&#160;262 of the Delaware General Corporation Law) </font></a>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">
                <font style="letter-spacing:0.2pt;"><a href="#tANNH">H-1</a></font>
              </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <a href="#tAnnexI"><font style="letter-spacing:0.2pt;">Annex I &#8201;&#8211;&#8201; Amended and Restated 2014 Stock Incentive Plan</font></a>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">
                <font style="letter-spacing:0.2pt;"><a href="#tAnnexI">I-1</a></font>
              </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.63pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <a href="#tAnnexJ"><font style="letter-spacing:0.2pt;">Annex J&#8201;&#8211;&#8201;Amendment No. 2 to the 2014 Employee Stock Purchase Plan</font></a>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">
                <font style="letter-spacing:0.2pt;"><a href="#tAnnexJ">J-1</a></font>
              </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
          </table>

      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">iii</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tQAAA">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">QUESTIONS AND ANSWERS ABOUT THE MERGER</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-style:italic;">
            <font style="letter-spacing:0.2pt;">Except where specifically noted, the following information and all other information contained in this proxy statement/prospectus does not give effect to the proposed reverse stock split described in the section entitled &#8220;Matters Being Submitted to a Vote of Sesen Bio Stockholders&#8201;&#8212;&#8201;Proposal No. 2: Approval of an amendment to the Sesen Bio Certificate of Incorporation to effect the reverse stock split and reduce the number of authorized shares of Sesen Bio common stock&#8221; beginning on page <a href="#tPN2A">203</a> of this proxy statement/prospectus.</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
          </div>

        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following section provides answers to frequently asked questions about the merger. This section, however, provides only summary information. For a more complete response to each of these questions and for additional information, refer to the cross-referenced sections in this proxy statement/prospectus. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Q:</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">What is the merger?</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="font-weight:bold;letter-spacing:-0.2pt;">A:</font>
            <br >
          </div>
          <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
            <font style="letter-spacing:0.2pt;">Sesen Bio, Inc., or Sesen Bio, Seahawk Merger Sub, Inc., or Merger Sub, and CARISMA Therapeutics Inc., or Carisma, entered into an Agreement and Plan of Merger and Reorganization, or the Original Merger Agreement, on September&#160;20, 2022, and entered into the First Amendment thereto on December&#160;29, 2022, or the Merger Agreement Amendment, and together with the Original Merger Agreement, the Merger Agreement. The Merger Agreement contains the terms and conditions of the proposed business combination of Sesen Bio and Carisma. Under the Merger Agreement, Merger Sub will merge with and into Carisma, with Carisma surviving as a wholly-owned subsidiary of Sesen Bio, or the merger. After the completion of the merger, Sesen Bio will change its corporate name from &#8220;Sesen Bio, Inc.&#8221; to &#8220;Carisma Therapeutics Inc.&#8221; as contemplated by the Merger Agreement. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>


          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">At the effective time of the merger, or the effective time, each outstanding share of Carisma common stock and Carisma preferred stock, or collectively, Carisma capital stock, including shares of Carisma common stock issued in connection with the Carisma pre-closing financing as defined below, will be converted into the right to receive a number of shares of Sesen Bio common stock equal to an exchange ratio, or the exchange ratio, described in more detail in the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Merger Agreement&#8201;&#8212;&#8201;Merger Consideration</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tTMA">171</a> of this proxy statement/prospectus. </font>
          </div>

        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Also at the effective time, each outstanding option to purchase shares of Carisma common stock, or a Carisma option, will be assumed by Sesen Bio and will be converted into an option to purchase shares of Sesen Bio common stock, with necessary adjustments to reflect the exchange ratio. </font>
        </div>

          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Each share of Sesen Bio common stock, each option to purchase Sesen Bio common stock, or a Sesen Bio option, and each Sesen Bio restricted stock unit convertible into Sesen Bio common stock (including both time-based restricted stock&#160;units and performance-based restricted stock&#160;units), or a Sesen Bio RSU, that is outstanding at the effective time will remain outstanding in accordance with its terms and such shares of Sesen Bio common stock, Sesen Bio options and Sesen Bio RSUs, subject to the proposed reverse stock split, will be unaffected by the merger. Immediately after the merger, pre-merger Sesen Bio stockholders are expected to own approximately 25.2% of the outstanding shares of capital stock of the combined company, and pre-merger Carisma stockholders, after taking into account shares of Carisma common stock purchased in connection with the Carisma pre-closing financing and the conversion of Carisma&#8217;s $35.0&#160;million outstanding convertible note, or the Carisma convertible note, are expected to own approximately 74.8% of the outstanding shares of capital stock of the combined company, subject to certain assumptions, including Sesen Bio&#8217;s net cash as of closing of the merger being at least $75.0 million. </font>
          </div>

        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Q:</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Why are the two companies proposing to merge?</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="font-weight:bold;letter-spacing:-0.2pt;">A:</font>
            <br >
          </div>
          <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
            <font style="letter-spacing:0.2pt;">Sesen Bio and Carisma believe that the merger will provide Carisma with substantial capital resources, positioning it to become a pre-eminent clinical-stage biopharmaceutical company focused on advancement of Carisma&#8217;s proprietary cell therapy platform that utilizes engineered macrophages and monocytes to potentially transform the treatment of cancer and other serious disorders. For a discussion of Sesen Bio&#8217;s and Carisma&#8217;s reasons for the merger, see the sections entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Merger&#8201;&#8212;&#8201;Sesen Bio Reasons for the Merger</font><font style="letter-spacing:0.2pt;">&#8221; and &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Merger&#8201;&#8212;&#8201;Carisma Reasons for the Merger</font><font style="letter-spacing:0.2pt;">&#8221; beginning on pages&#160;<a href="#tSBRF">134</a> and <a href="#tCRFT">137</a>, respectively, of this proxy statement/prospectus. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">1</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; line-height:12pt; text-align:left; width:20pt;white-space:nowrap;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Q:</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:20pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Why am I receiving this proxy statement/prospectus?</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">A:</font>
          <br >
        </div>
        <div style=" margin-top:8.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">You are receiving this proxy statement/prospectus because you have been identified as a Sesen Bio stockholder as of the record date and you are entitled to vote at the Sesen Bio special meeting to approve the matters set forth herein. This document serves as: </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">a proxy statement of Sesen Bio used to solicit proxies for the Sesen Bio special meeting to vote on the matters set forth herein; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">a prospectus of Sesen Bio used to offer shares of Sesen Bio common stock in exchange for shares of Carisma capital stock (excluding shares of Sesen Bio common stock issued as transaction&#160;consideration in exchange for shares of Carisma common stock issued in the Carisma pre-closing financing) in the merger. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Q:</font>
          <br >
        </div>
        <div style=" margin-top:8.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">What is the Carisma pre-closing financing?</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="font-weight:bold;letter-spacing:-0.2pt;">A:</font>
            <br >
          </div>
          <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
            <font style="letter-spacing:0.2pt;">On September&#160;20, 2022, immediately prior to the execution and delivery of the Original Merger Agreement, Carisma entered into a subscription agreement with certain investors named therein, or, as subsequently amended and restated, the subscription agreement, pursuant to which such investors agreed to purchase shares of Carisma common stock at an aggregate purchase price of approximately $30.6&#160;million, or the Carisma pre-closing financing. Immediately after the merger, the shares of Carisma common stock issued in the Carisma pre-closing financing are expected to represent approximately&#160;8.4% of the outstanding shares of capital stock of the combined company. The closing of the Carisma pre-closing financing is conditioned upon the satisfaction or waiver of the conditions to the closing of the merger set forth in the Merger Agreement. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Q:</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">What will Sesen Bio stockholders receive in the merger?</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">A:</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">At the effective time, Sesen Bio stockholders will continue to own and hold their existing shares of Sesen Bio common stock. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">All outstanding and unexercised Sesen Bio options granted (i)&#160;pursuant to the Sesen Bio, Inc. 2014 Stock Incentive Plan, as amended, or the 2014 Incentive Plan, or the Eleven Biotherapeutics, Inc. 2009 Stock Incentive Plan, as amended and restated, or the 2009 Incentive Plan, or (ii)&#160;as an inducement grant under Nasdaq Listing Rule&#160;5635(c)(4) will remain in effect pursuant to their terms and will be unaffected by the merger. All outstanding and unvested Sesen Bio RSUs granted pursuant to the 2014 Incentive Plan or the 2009 Incentive Plan will remain in effect pursuant to their terms and will be unaffected by the merger. All outstanding and unexercised warrants to purchase Sesen Bio common stock, or Sesen Bio warrants, immediately prior to the effective time (other than certain Sesen Bio warrants that Sesen Bio may be required to repurchase at such warrant holder&#8217;s option as of a result of the merger) will remain in effect pursuant to their terms and will be unaffected by the merger. </font>
        </div>

          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Additionally, at or prior to the effective time, Sesen Bio will enter into a Contingent Value Rights Agreement, or the CVR Agreement, and, as provided in the Merger Agreement, Sesen Bio intends to declare a dividend payable to Sesen Bio stockholders of record as of a date agreed to by Sesen Bio and Carisma prior to the effective time with respect to the receipt of one contingent value right, or a CVR, for each outstanding share of Sesen Bio common stock held by such stockholders on such date. Each CVR will represent the contractual right to receive contingent cash payments upon the receipt by Sesen Bio of certain proceeds payable by F. Hoffmann-La Roche Ltd and Hoffman-La Roche Inc., or Roche, if any, pursuant to the Asset Purchase Agreement by and among Sesen Bio and Roche, or the Roche Asset Purchase Agreement, upon the achievement by Roche of a specified milestone set forth in the Roche Asset Purchase Agreement as well as proceeds from any sale of Sesen Bio&#8217;s legacy assets, including Vicineum, subject to certain customary deductions, including for expenses and taxes. For a more detailed description of the CVRs and the CVR Agreement, see the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Agreements Related to the Merger&#8201;&#8212;&#8201;CVR Agreement</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tCVAG">192</a> of this proxy statement/prospectus. </font>
          </div>


          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Further, prior to the closing of the merger, Sesen Bio will, in addition to the CVRs, declare a special cash dividend, or the special cash dividend, to Sesen Bio stockholders of record prior to the merger, which would be contingent upon Sesen Bio stockholder approval of Proposal Nos. 1 and 2 and the satisfaction </font>
          </div>

      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">2</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">

          <div style="margin-left:20pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">or waiver of other customary closing conditions to the merger. The amount of the special cash dividend will be the amount by which Sesen Bio&#8217;s estimated net cash as of the closing of the merger exceeds $75.0 million. </font>
          </div>

        <div style=" float:left; line-height:12pt; margin-top:8.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Q:</font>
          <br >
        </div>
        <div style=" margin-top:8.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">What will Carisma stockholders and Carisma optionholders receive in the merger?</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; line-height:12pt; margin-top:8.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="font-weight:bold;letter-spacing:-0.2pt;">A:</font>
            <br >
          </div>
          <div style=" margin-top:8.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
            <font style="letter-spacing:0.2pt;">Carisma stockholders will receive shares of Sesen Bio common stock, and Carisma optionholders will receive options to purchase Sesen Bio common stock. Applying the exchange ratio, immediately after the merger, pre-merger Sesen Bio stockholders are expected to own approximately 25.2% of the outstanding shares of capital stock of the combined company and pre-merger Carisma stockholders, after taking into account shares of Carisma common stock purchased in connection with the Carisma pre-closing financing and the conversion of the Carisma convertible note, are expected to own approximately 74.8% of the outstanding shares of capital stock of the combined company, subject to certain assumptions, including Sesen Bio&#8217;s net cash as of the closing of the merger being at least $75.0&#160;million. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In connection with the merger, each outstanding and unexercised Carisma option will be assumed by Sesen Bio and converted into an option to purchase Sesen Bio common stock, with the number of shares and exercise price being appropriately adjusted to reflect the exchange ratio between Sesen Bio common stock and Carisma common stock determined in accordance with the Merger Agreement. </font>
        </div>

          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">For a more complete description of what Carisma stockholders and optionholders will receive in the merger, see the sections entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Merger Agreement&#8201;&#8212;&#8201;Merger Consideration</font><font style="letter-spacing:0.2pt;">&#8221; and &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Merger Agreement&#8201;&#8212;&#8201;Exchange Ratio</font><font style="letter-spacing:0.2pt;">&#8221; beginning on pages <a href="#tTMA">171</a> and <a href="#tTMAER">172</a>, respectively, of this proxy statement/</font>&#8203;<font style="letter-spacing:0.2pt;">prospectus. For a description of the effect of the Carisma pre-closing financing on current Sesen Bio and Carisma stockholders, see the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Agreements Related to the Merger&#8201;&#8212;&#8201;Subscription Agreement</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tSUAG">198</a> of this proxy statement/prospectus. </font></div>

        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Q:</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">What will happen to Sesen Bio if, for any reason, the merger does not close?</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">A:</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">If, for any reason, the merger does not close, the Sesen Bio board of directors may elect to, among other things, review and evaluate another strategic transaction like the merger, attempt to sell or otherwise dispose of the various assets of Sesen Bio, resume its research and development activities and continue to operate the business of Sesen Bio or dissolve and liquidate its assets. If Sesen Bio decides to dissolve and liquidate its assets, Sesen Bio would be required to pay all of its debts and contractual obligations, and to set aside certain reserves for potential future claims. There can be no assurances as to the amount or timing of available cash left, if any, to distribute to Sesen Bio stockholders after paying the debts and other obligations of Sesen Bio and setting aside funds for reserves. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Q:</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">What is required to consummate the merger?</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">A:</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Pursuant to the terms of the Merger Agreement, in order for the merger to close, the following proposals must be approved by the requisite vote of Sesen Bio stockholders at the Sesen Bio special meeting: </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="font-weight:bold;letter-spacing:-0.2pt;">Proposal No. 1:</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;to consider and vote upon a proposal to approve, for purposes of Nasdaq Listing Rule&#160;5635(a) and (b), the issuance of shares of Sesen Bio common stock to Carisma stockholders pursuant to the terms of the Original Merger Agreement, as amended by the Merger Agreement Amendment, copies of which are attached as </font><font style="font-style:italic;letter-spacing:0.2pt;">Annex A-1</font><font style="letter-spacing:0.2pt;"> and </font><font style="font-style:italic;letter-spacing:0.2pt;">Annex A-2</font><font style="letter-spacing:0.2pt;">, respectively, to this proxy statement/prospectus, and the change of control of Sesen Bio resulting from the merger; and </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Proposal No. 2:</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;to consider and vote upon a proposal to approve an amendment to the Sesen Bio Certificate of Incorporation, to (a) effect a reverse stock split of the issued and outstanding shares of Sesen Bio common stock at a ratio of 1-for-20, with the implementation and timing of the reverse stock split to be determined in the discretion of the Sesen Bio board of directors and as agreed to by Carisma at or prior to the closing of the merger, or in the sole discretion of the Sesen Bio board of directors if Proposal No. 1 is not approved, and (b) if and when the reverse stock split is effected, reduce the number of authorized shares of Sesen Bio common stock to 100,000,000, in the form attached as </font><font style="font-style:italic;letter-spacing:0.2pt;">Annex G</font><font style="letter-spacing:0.2pt;"> to this proxy statement/prospectus. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">3</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma stockholders must adopt the Merger Agreement, thereby approving the merger and the related transactions. The adoption of the Merger Agreement and the approval of the merger and related transactions by the Carisma stockholders requires the affirmative vote (or written consent) of the holders of a majority of the Carisma capital stock, voting together as a single class, (ii)&#160;at least two-thirds of the Carisma Series&#160;A preferred stock, Carisma special voting preferred stock, Carisma Series&#160;B preferred stock and Carisma Series&#160;B special voting preferred stock, voting together as a single class, (iii)&#160;a majority of the Carisma Series&#160;A preferred stock and Carisma special voting preferred stock, voting together as a single class and (iv)&#160;at least two-thirds of the Carisma Series&#160;B preferred stock and Carisma Series&#160;B special voting preferred stock, voting together as a single class. </font>
        </div>

          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">As of January 4, 2023, certain Carisma stockholders (solely in their respective capacities as Carisma stockholders) holding approximately 97.23% of the outstanding shares of Carisma capital stock (subject to customary cutbacks in the event of certain triggering events) are parties to support agreements with Sesen Bio and Carisma, whereby such stockholders have agreed, subject to the effectiveness of the registration statement on Form S-4, to vote their shares in favor of, among other things, the adoption or approval of the Merger Agreement and the transactions contemplated therein, subject to the terms of the support agreements. In addition, following the effectiveness of the registration statement on Form&#160;S-4, of which this proxy statement/prospectus is a part, and pursuant to the conditions of the Merger Agreement and the support agreements, Carisma stockholders who are party to the support agreements will each execute written consents approving the merger and related transactions, subject to the terms and limitations set forth in the support agreements. Therefore, holders of a sufficient number of shares of Carisma common stock required to adopt the Merger Agreement, thereby approving the merger, have agreed to adopt the Merger Agreement via written consent, subject to the terms and limitations set forth in the support agreements. Carisma stockholders, including those who are parties to support agreements, are being requested to execute written consents providing such approvals. </font>
          </div>


          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">In addition to the requirement of obtaining the stockholder approvals described above, each of the other closing conditions set forth in the Merger Agreement must be satisfied or waived. For a more complete description of the closing conditions under the Merger Agreement, see the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Merger Agreement&#8201;&#8212;&#8201;Conditions to the Completion of the Merger</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page&#160;<a href="#tCCM5">176</a> of this proxy statement/prospectus. </font>
          </div>

        <div style=" float:left; line-height:12pt; margin-top:7.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Q:</font>
          <br >
        </div>
        <div style=" margin-top:7.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">What stockholder votes are required to approve the proposals at the Sesen Bio special meeting?</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; line-height:12pt; margin-top:7.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="font-weight:bold;letter-spacing:-0.2pt;">A:</font>
            <br >
          </div>
          <div style=" margin-top:7.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
            <font style="letter-spacing:0.2pt;">Approval of Proposal Nos. 1, 3, 4 and 5 each requires the affirmative vote of a majority in voting power of the votes cast by the holders of all shares of Sesen Bio common stock present or represented by proxy at the Sesen Bio special meeting and entitled to vote thereon. Approval of Proposal No. 2 requires the affirmative vote of the holders of a majority of the outstanding shares of Sesen Bio common stock on the record date,&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199; &#8199;&#8199; , 2023, for the Sesen Bio special meeting, or the record date, entitled to vote on the matter. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Votes will be counted by the inspector of election appointed for the Sesen Bio special meeting, who will separately count &#8220;FOR&#8221; and &#8220;AGAINST&#8221; votes, abstentions and broker non-votes. Abstentions and broker non-votes will be treated as shares of Sesen Bio common stock present for the purpose of determining the presence of a quorum for the transaction of business at the Sesen Bio special meeting. Abstentions and broker non-votes will have the same effect as &#8220;AGAINST&#8221; votes for Proposal No. 2, but will have no effect on the outcome of Proposal Nos. 1, 3, 4 and 5. Proposal Nos. 2 and 5 are matters on which Sesen Bio expects brokers, banks or other nominees to have authority to vote uninstructed shares and, therefore, broker non-votes are not expected with respect to these proposals. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Q:</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Who will be the directors of the combined company following the merger?</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">A:</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Immediately following completion of the merger, the combined company&#8217;s board of directors is expected to be composed of seven directors, consisting of six directors designated by Carisma and one director designated by Sesen Bio. It is anticipated that Thomas R. Cannell will be the Sesen Bio designated director following the closing of the merger, and that all other current Sesen Bio directors will resign as of the closing of the merger. Carisma will appoint the remaining directors to the Sesen Bio board of directors to fill the resulting vacancies. It is anticipated that Sanford Zweifach, Regina </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">4</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Hodits, Briggs Morrison, Bj&#246;rn Odlander, Chidozie Ugwumba and Steven Kelly will be appointed to the board of directors of the combined company by Carisma. Sanford Zweifach is expected to be appointed as chair of the board of the directors of the combined company. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The staggered structure of the Sesen Bio board of directors will remain in place for the combined company following the completion of the merger. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:7.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Q:</font>
          <br >
        </div>
        <div style=" margin-top:7.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Who will be the executive officers of the combined company immediately following the merger?</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:7.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">A:</font>
          <br >
        </div>
        <div style=" margin-top:7.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Immediately following completion of the merger, the combined company&#8217;s executive management team is expected to consist of the members of Carisma&#8217;s executive management team prior to the merger, including: </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <table style="width:436pt;height:53.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:212pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Name </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:212pt;text-align:center;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Title </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:212pt;">
              <font style="letter-spacing:0.2pt;">Steven Kelly </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:212pt;">
              <font style="letter-spacing:0.2pt;">President and Chief Executive Officer </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:212pt;">
              <font style="letter-spacing:0.2pt;">Richard Morris </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:212pt;">
              <font style="letter-spacing:0.2pt;">Chief Financial Officer </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:212pt;">
              <font style="letter-spacing:0.2pt;">Michael Klichinsky, Pharm.D., Ph.D. </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:212pt;">
              <font style="letter-spacing:0.2pt;">Chief Scientific Officer</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:7.71pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Q:</font>
          <br >
        </div>
        <div style=" margin-top:7.71pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">What are the material U.S. federal income tax consequences of the merger to Sesen Bio stockholders?</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">A:</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio stockholders will not sell, exchange or dispose of any shares of Sesen Bio common stock as a result of the merger. Thus, there will be no material U.S. federal income tax consequences to Sesen Bio stockholders as a result of the merger. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Q:</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">What are the material U.S. federal income tax consequences of the merger to Carisma U.S. holders?</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="font-weight:bold;letter-spacing:-0.2pt;">A:</font>
            <br >
          </div>
          <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
            <font style="letter-spacing:0.2pt;">Subject to the qualifications and limitations set forth in the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Merger&#8201;&#8212;&#8201;Material U.S. Federal Income Tax Consequences of the Merger,</font><font style="letter-spacing:0.2pt;">&#8221; in the opinion of Wilmer Cutler Pickering Hale and Dorr LLP, or WilmerHale, and Hogan Lovells US LLP, or Hogan Lovells, the merger will qualify as a &#8220;reorganization&#8221; within the meaning of Section 368(a) of the Internal Revenue Code of 1986, as amended, or the Code, and a Carisma U.S. holder (as defined on page <a href="#tUSHCA">161</a>) will not recognize gain or loss for U.S. federal income tax purposes upon the receipt of shares of Sesen Bio common stock in exchange for shares of Carisma capital stock in the merger, except to the extent such a Carisma U.S. holder receives cash in lieu of a fractional share of Sesen Bio common stock. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>


          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">See the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Merger&#8201;&#8212;&#8201;Material U.S. Federal Income Tax Consequences of the Merger</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tMUFI">160</a> of this proxy statement/prospectus for a more complete description of the material U.S. federal income tax consequences of the merger to Carisma U.S. holders. </font>
          </div>

        <div style=" float:left; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Q:</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">What are the material U.S. federal income tax consequences of the receipt of CVRs to Sesen Bio U.S. holders?</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; line-height:12pt; margin-top:7.81pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="font-weight:bold;letter-spacing:-0.2pt;">A:</font>
            <br >
          </div>
          <div style=" margin-top:7.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
            <font style="letter-spacing:0.2pt;">The U.S. federal income tax treatment of Sesen Bio U.S. holders&#8217; (as defined on page <a href="#tMUFI3">193</a>) receipt of the CVRs is unclear. Sesen Bio intends to report the issuance of the CVRs to Sesen Bio U.S. holders under the terms expressed in the form of the CVR Agreement included in </font><font style="font-style:italic;letter-spacing:0.2pt;">Annex F</font><font style="letter-spacing:0.2pt;"> to this proxy statement/</font>&#8203;<font style="letter-spacing:0.2pt;">prospectus as a distribution of property with respect to Sesen Bio common stock. In such case, each Sesen Bio U.S. holder will be treated as receiving a distribution in an amount equal to the fair market value of the CVRs issued to such Sesen Bio U.S. holder on the date of the issuance. This distribution should be treated first as a taxable dividend to the extent of the Sesen Bio U.S. holder&#8217;s pro&#160;rata share of Sesen Bio&#8217;s current or accumulated earnings and profits (as determined for U.S. federal income tax purposes and after taking into account the special cash dividend paid to Sesen Bio U.S. holders, if any, as described below), then as a non-taxable return of capital to the extent of the Sesen Bio U.S. holder&#8217;s basis in its Sesen Bio common stock, and finally as capital gain from the sale or exchange of Sesen Bio common stock with respect to any remaining value. Sesen Bio currently has negative accumulated earnings and profits and expects no or a small amount of current earnings and profits for the relevant taxable year. Thus, Sesen Bio expects most or all of this distribution to be treated as other than a dividend for U.S. federal income tax purposes. See the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Agreements Related to the Merger&#8201;&#8212;&#8201;CVR Agreement&#8201;&#8212;&#8201;Material U.S. Federal Income Tax Consequences of the Receipt of CVRs</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tCVAG">192</a> of this proxy statement/prospectus for a more complete description of the </font></div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">5</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">material U.S. federal income tax consequences of the receipt of CVRs to Sesen Bio U.S. holders, including possible alternative treatments. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The tax consequences to you of the receipt of CVRs will depend on your particular facts and circumstances. You should consult your tax advisors as to the specific tax consequences to you. </font>
        </div>

          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; line-height:12pt; margin-top:8.6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-style:italic;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Q:</font>
            <br >
          </div>
          <div style=" margin-top:8.6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-style:italic;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">What are the material U.S. federal income tax consequences of the special cash dividend that Sesen Bio will declare and pay to Sesen Bio U.S. holders?</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>


          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; line-height:12pt; margin-top:8.6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="font-weight:bold;letter-spacing:-0.2pt;">A:</font>
            <br >
          </div>
          <div style=" margin-top:8.6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
            <font style="letter-spacing:0.2pt;">In connection with the merger, the Sesen Bio board of directors will declare and pay a special cash dividend to Sesen Bio stockholders of record prior to the effective time consisting of Sesen Bio&#8217;s available cash in an aggregate amount expected to be approximately $70.0&#160;million, assuming Sesen Bio&#8217;s net cash as of the closing of the merger (after taking into account the proposed cash dividend) is $75.0&#160;million. The U.S. federal income tax consequences of the Sesen Bio U.S. holders&#8217; receipt of a special cash dividend generally should be treated first as a taxable dividend to the extent of the Sesen Bio U.S. holder&#8217;s pro&#160;rata share of Sesen Bio&#8217;s current or accumulated earnings and profits (as determined for U.S. federal income tax purposes), then as a non-taxable return of capital to the extent of the Sesen Bio U.S. holder&#8217;s basis in its Sesen Bio common stock, and finally as capital gain from the sale or exchange of Sesen Bio common stock with respect to any remaining amount. Sesen Bio currently has negative accumulated earnings and profits and expects no or a small amount of current earnings and profits for the relevant taxable year. Thus, Sesen Bio expects most or all of the special cash dividend to be treated as other than a dividend for U.S. federal income tax purposes. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>


          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12.5pt;">
            <font style="letter-spacing:0.2pt;">See the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Merger&#8201;&#8212;&#8201;Material U.S. Federal Income Tax Consequences of the Special Cash Dividend</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tMUFI1">162</a> of this proxy statement/prospectus for a general description of the tax consequences of the special cash dividend that Sesen Bio may pay. </font>
          </div>

        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The tax consequences to you of the special cash dividend will depend on your particular facts and circumstances. You should consult your tax advisors as to the specific tax consequences to you. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:8.49pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Q:</font>
          <br >
        </div>
        <div style=" margin-top:8.49pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">What are the material U.S. federal income tax consequences of the proposed reverse stock split to Sesen Bio U.S. holders?</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; line-height:12pt; margin-top:8.5pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="font-weight:bold;letter-spacing:-0.2pt;">A:</font>
            <br >
          </div>
          <div style=" margin-top:8.5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
            <font style="letter-spacing:0.2pt;">Sesen Bio intends to report the proposed reverse stock split as a &#8220;recapitalization&#8221; within the meaning of Section&#160;368(a)(1)(E) of the Code. In general, and subject to the qualifications and limitations set forth in the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Proposal No. 2: Approval of an amendment to the Sesen Bio Certificate of Incorporation to effect the reverse stock split and reduce the number of authorized shares of Sesen Bio common stock&#8201;&#8212;&#8201;Material U.S. Federal Income Tax Consequences of the Reverse Stock Split</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#MUIT6">209</a> of this proxy statement/prospectus, if the proposed reverse stock split qualifies as a &#8220;recapitalization&#8221; within the meaning of Section&#160;368(a)(1)(E) of the Code, a Sesen Bio U.S. holder should not recognize gain or loss upon the proposed reverse stock split, except to the extent a Sesen Bio U.S. holder receives cash in lieu of a fractional share of Sesen Bio common stock. As discussed in more detail in the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Proposal No. 2: Approval of an amendment to the Sesen Bio Certificate of Incorporation to effect the reverse stock split and reduce the number of authorized shares of Sesen Bio common stock&#8201;&#8212;&#8201;Material U.S. Federal Income Tax Consequences of the Reverse Stock Split</font><font style="letter-spacing:0.2pt;">&#8221; on page&#160;<a href="#MUIT6">209</a> of this proxy statement/prospectus, these consequences assume that distribution of the CVRs and any cash distributed pursuant to a special cash dividend will be treated for U.S. federal income tax purposes as separate and distinct from the proposed reverse stock split. See the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Proposal No.&#160;2: Approval of an amendment to the Sesen Bio Certificate of Incorporation to effect the reverse stock split and reduce the number of authorized shares of Sesen Bio common stock&#8201;&#8212;&#8201;Material U.S. Federal Income Tax Consequences of the Reverse Stock Split</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page&#160;<a href="#MUIT6">209</a> of this proxy statement/</font>&#8203;<font style="letter-spacing:0.2pt;">prospectus for a more complete description of the material U.S. federal income tax consequences of the proposed reverse stock split to Sesen Bio U.S. holders. </font></div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The tax consequences to you of the proposed reverse stock split will depend on your particular facts and circumstances. You should consult your tax advisors as to the specific tax consequences to you. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">6</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; line-height:12pt; text-align:left; width:20pt;white-space:nowrap;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Q:</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:20pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">As a Sesen Bio stockholder, how does the Sesen Bio board of directors recommend that I vote?</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8.3pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">A:</font>
          <br >
        </div>
        <div style=" margin-top:8.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">After careful consideration, the Sesen Bio board of directors unanimously recommends that Sesen Bio stockholders vote &#8220;FOR&#8221; all of the proposals described in this proxy statement/prospectus. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8.29pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Q:</font>
          <br >
        </div>
        <div style=" margin-top:8.29pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">What risks should I consider in deciding whether to vote in favor of the merger?</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; line-height:12pt; margin-top:8.3pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="font-weight:bold;letter-spacing:-0.2pt;">A:</font>
            <br >
          </div>
          <div style=" margin-top:8.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
            <font style="letter-spacing:0.2pt;">You should carefully review the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Risk Factors</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tRIFA">26</a> of this proxy statement/prospectus which sets forth certain risks and uncertainties related to the merger, risks and uncertainties to which the combined company&#8217;s business will be subject, and risks and uncertainties to which each of Sesen Bio and Carisma, as independent companies, are subject. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

        <div style=" float:left; line-height:12pt; margin-top:8.3pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Q:</font>
          <br >
        </div>
        <div style=" margin-top:8.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Who can vote at the Sesen Bio special meeting?</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; line-height:12pt; margin-top:8.29pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="font-weight:bold;letter-spacing:-0.2pt;">A:</font>
            <br >
          </div>
          <div style=" margin-top:8.29pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
            <font style="letter-spacing:0.2pt;">Only Sesen Bio stockholders of record at the close of business on the record date will be entitled to vote at the Sesen Bio special meeting. The Sesen Bio board of directors has fixed&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199; &#8199;&#8199;, 2023 as the record date for the Sesen Bio special meeting. As of the record date, there were &#8199;&#8199;&#8199;&#8199;&#8199; shares of Sesen Bio common stock outstanding and entitled to vote. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Stockholder of Record: Shares Registered in Your Name</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If, at the close of business on the record date, your shares of Sesen Bio common stock were registered directly in your name with Sesen Bio&#8217;s transfer agent, Computershare Trust Company, Inc., then you are a Sesen Bio stockholder of record. As a Sesen Bio stockholder of record, you may vote virtually at the Sesen Bio special meeting or vote by proxy. Whether or not you plan to attend the Sesen Bio special meeting, please vote as soon as possible by completing and returning the enclosed proxy card or vote by proxy over the telephone or on the internet as instructed on the proxy card to ensure your vote is counted. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio stockholders are invited to attend the special meeting, which will be a virtual meeting held exclusively via live webcast. In order to attend the Sesen Bio special meeting, you must register in advance at &#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199; &#8199;&#8199;. After completing your registration, you will receive further instructions via email, including a unique link that will allow you to access the Sesen Bio special meeting and to vote and submit questions during the Sesen Bio special meeting. As part of the registration process, you must enter the control number located on your proxy card. </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Beneficial Owner: Shares Registered in the Name of a Broker, Bank or Other Similar Organization</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If, at the close of business on the record date, your shares of Sesen Bio common stock were not held in your name, but rather in an account at a brokerage firm, bank, dealer or other similar organization, then you are the beneficial owner of shares held in &#8220;street name&#8221; and these proxy materials are being forwarded to you by that organization. The organization holding your account is considered to be the stockholder of record for purposes of voting at the Sesen Bio special meeting. As a beneficial owner, you have the right to direct your broker or other agent how to vote the shares in your account. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">You are also invited to attend and vote at the Sesen Bio special meeting. After completing your registration in advance at &#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199; &#8199;&#8199;, you will receive further instructions via email, including a unique link to access the Sesen Bio special meeting. As part of the registration process, you must enter the control number located on your voting instruction form. You will also need to provide the registered name on your account and the name of your broker, bank or other nominee as part of the registration process. You may be instructed to obtain a legal proxy from your broker, bank or other nominee and to submit a copy in advance of the meeting. Further instructions will be provided to you as part of your registration process. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:8.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Q:</font>
          <br >
        </div>
        <div style=" margin-top:8.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">How many votes do I have?</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">A:</font>
          <br >
        </div>
        <div style=" margin-top:8.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">On each matter to be voted upon, you have one vote for each share of Sesen Bio common stock you own as of the record date. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">7</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; line-height:12pt; text-align:left; width:20pt;white-space:nowrap;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Q:</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:20pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">What is the quorum requirement?</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:7.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">A:</font>
          <br >
        </div>
        <div style=" margin-top:7.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">A quorum of Sesen Bio stockholders is necessary to hold a valid meeting. A quorum will be present if Sesen Bio stockholders holding at least a majority in voting power of the shares of Sesen Bio common stock outstanding and entitled to vote at the Sesen Bio special meeting are present or represented by proxy at the Sesen Bio special meeting. As of the record date, there were &#8199;&#8199;&#8199;&#8199; shares of Sesen Bio common stock outstanding and entitled to vote. Your shares of Sesen Bio common stock will be counted toward the quorum at the Sesen Bio special meeting only if you attend the Sesen Bio special meeting or are represented by proxy at the Sesen Bio special meeting. Abstentions and broker non-votes will be counted towards the quorum requirement. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:7.71pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Q:</font>
          <br >
        </div>
        <div style=" margin-top:7.71pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">What are &#8220;broker non-votes?&#8221;</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:7.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">A:</font>
          <br >
        </div>
        <div style=" margin-top:7.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">If you hold shares beneficially in &#8220;street name&#8221; and do not provide your broker, bank or other nominee with voting instructions, your shares may constitute &#8220;broker non-votes.&#8221; Broker non-votes occur on a matter when banks, brokers and other nominees are not permitted to vote on certain non-discretionary matters without instructions from the beneficial owner and instructions are not given. These matters are referred to as &#8220;non-routine&#8221; matters. Proposal Nos. 1, 3 and 4 are anticipated to be non-routine matters, and Proposal Nos. 2 and 5 are anticipated to be routine matters. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:7.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Q:</font>
          <br >
        </div>
        <div style=" margin-top:7.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If my shares of Sesen Bio common stock are held in &#8220;street name,&#8221; will my broker, bank or other nominee vote my shares for me?</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:7.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">A:</font>
          <br >
        </div>
        <div style=" margin-top:7.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Unless your broker, bank or other nominee has discretionary authority to vote on certain matters, your broker will not be able to vote your shares of Sesen Bio common stock on matters without instructions from you. If you do not give instructions to your broker, your broker can vote your shares of Sesen Bio common stock with respect to discretionary, routine items but not with respect to non-discretionary, non-routine items. Brokers are not expected to have discretionary authority to vote for any of the proposals other than Proposal Nos. 2 and 5. To make sure that your vote is counted, you should instruct your broker to vote your shares, following the procedures provided by your broker. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:7.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Q:</font>
          <br >
        </div>
        <div style=" margin-top:7.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">How can I view the list of Sesen Bio stockholders eligible to vote at the Sesen Bio special meeting?</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:7.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">A:</font>
          <br >
        </div>
        <div style=" margin-top:7.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">The list of Sesen Bio stockholders of record entitled to vote at the Sesen Bio special meeting will be made available for ten days prior to the Sesen Bio special meeting, at the Sesen Bio offices at 245 First Street, Suite 1800, Cambridge, MA 02142. Please contact Sesen Bio&#8217;s Corporate Secretary at (617) 444-8550 if you wish to inspect the list of stockholders eligible to vote at the Sesen Bio special meeting prior to the Sesen Bio special meeting. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:7.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Q:</font>
          <br >
        </div>
        <div style=" margin-top:7.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">When do you expect the merger to be consummated?</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; line-height:12pt; margin-top:7.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="font-weight:bold;letter-spacing:-0.2pt;">A:</font>
            <br >
          </div>
          <div style=" margin-top:7.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
            <font style="letter-spacing:0.2pt;">Sesen Bio and Carisma currently anticipate that the merger will close in the first quarter of 2023, but the companies cannot predict the exact timing. For more information, see the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Merger Agreement&#8201;&#8212;&#8201;Conditions to the Completion of the Merger</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tCCM5">176</a> of this proxy statement/prospectus. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

        <div style=" float:left; line-height:12pt; margin-top:7.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Q:</font>
          <br >
        </div>
        <div style=" margin-top:7.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">What do I need to do now?</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">A:</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio urges you to read this proxy statement/prospectus carefully, including its annexes, and to consider how the merger affects you. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If you are a Sesen Bio stockholder of record, you may provide your proxy instructions in one of three ways prior to the Sesen Bio special meeting: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Over the internet.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;You may vote your shares over the internet by following the instructions in the enclosed proxy card. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">By telephone.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;You may vote your shares by telephone by following the instructions in the enclosed proxy card. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">By mail.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;You may vote your shares by completing, dating and signing the proxy card and promptly mailing it in the postage-paid envelope provided. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">8</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Please provide your proxy instructions only once, unless you are revoking a previously delivered proxy instruction, and as soon as possible so that your shares can be voted at the Sesen Bio special meeting. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:8.3pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Q:</font>
          <br >
        </div>
        <div style=" margin-top:8.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">When and where is the Sesen Bio special meeting and may I vote in person?</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; line-height:12pt; margin-top:8.29pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="font-weight:bold;letter-spacing:-0.2pt;">A:</font>
            <br >
          </div>
          <div style=" margin-top:8.29pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
            <font style="letter-spacing:0.2pt;">The Sesen Bio special meeting will be a virtual meeting held exclusively via live webcast at &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, Eastern Time, on&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199; &#8199;&#8199;, 2023. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In order to attend the Sesen Bio special meeting, you must register in advance at www. &#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;. After completing your registration, you will receive further instructions via email, including a unique link that will allow you to access the Sesen Bio special meeting and to vote and submit questions during the Sesen Bio special meeting. As part of the registration process, you must enter the control number located on your proxy card. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If your shares are held in &#8220;street name&#8221; by a broker, bank or other nominee, you are also invited to attend and vote your shares at the Sesen Bio special meeting. After completing your registration in advance at www. &#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;, you will receive further instructions via email, including a unique link to access the Sesen Bio special meeting. As part of the registration process, you must enter the control number located on your voting instruction form. You will also need to provide the registered name on your account and the name of your broker, bank or other nominee as part of the registration process. You may be instructed to obtain a legal proxy from your broker, bank or other nominee and to submit a copy in advance of the meeting. Further instructions will be provided to you as part of your registration process. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Even if you plan to attend the Sesen Bio special meeting, Sesen Bio requests that you sign and return the enclosed proxy card or voting instruction form to ensure that your shares will be represented at the Sesen Bio special meeting if you become unable to attend. Please be sure to follow the instructions found on your proxy card or voting instruction form. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:8.3pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Q:</font>
          <br >
        </div>
        <div style=" margin-top:8.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">What if I have technical difficulties or trouble accessing the Sesen Bio special meeting?</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8.3pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">A:</font>
          <br >
        </div>
        <div style=" margin-top:8.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Technical assistance will be available one hour prior to and during the Sesen Bio special meeting. Information related to technical assistance will be provided in the email you receive with your unique link that will allow you to access the Sesen Bio special meeting. We recommend that you log in at least 15 minutes before the Sesen Bio special meeting to ensure you are logged in when the Sesen Bio special meeting starts. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8.3pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Q:</font>
          <br >
        </div>
        <div style=" margin-top:8.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">What happens if I do not return a proxy card or otherwise provide proxy instructions, as applicable?</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8.3pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">A:</font>
          <br >
        </div>
        <div style=" margin-top:8.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">If you are a Sesen Bio stockholder of record, the failure to return your proxy card or otherwise provide proxy instructions will have the same effect as voting &#8220;AGAINST&#8221; Proposal No. 2, and will have no effect with respect to Proposal Nos. 1, 3, 4, and 5. If your shares of Sesen Bio common stock are held in &#8220;street name,&#8221; and you do not provide voting instructions, your broker, bank or other nominee may still vote your shares of Sesen Bio common stock with respect to discretionary, routine items, but may not vote your shares of Sesen Bio common stock with respect to non-discretionary, non-routine items. Brokers are not expected to have discretionary authority to vote for any of the proposals other than Proposal Nos. 2 and 5. To make sure that your vote is counted, you should instruct your broker to vote your shares, following the procedures provided by your broker. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8.29pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Q:</font>
          <br >
        </div>
        <div style=" margin-top:8.29pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">May I change or revoke my vote after I have submitted a proxy or provided proxy instructions?</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8.3pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">A:</font>
          <br >
        </div>
        <div style=" margin-top:8.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio stockholders of record may change or revoke their vote at any time before their proxy is voted at the Sesen Bio special meeting by doing any one of the following things: </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">submitting a new proxy via the internet or telephone by following the instructions on the enclosed proxy card; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">signing another proxy card and arranging for delivery of that proxy card by mail by &#8199;&#8199;&#8199;&#8199;&#8199;, Eastern Time, the day before the Sesen Bio special meeting; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">9</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:63pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">giving Sesen Bio&#8217;s Corporate Secretary a written notice before the Sesen Bio special meeting that you want to revoke your proxy; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">voting during the Sesen Bio special meeting. Your attendance at the Sesen Bio special meeting alone will not revoke a previously submitted proxy. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If a Sesen Bio stockholder who owns shares of Sesen Bio common stock in &#8220;street name&#8221; has instructed a broker to vote its shares of Sesen Bio common stock, the stockholder must follow directions received from its broker to change those instructions. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Your vote will be counted in accordance with the last instruction received prior to the closing of the polls, whether your instruction is received by internet, telephone, mail or at the Sesen Bio special meeting. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Q:</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Who is paying for this proxy solicitation?</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">A:</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio and Carisma will share equally the cost of printing and filing this proxy statement/</font>&#8203;<font style="letter-spacing:0.2pt;">prospectus and the proxy card. Sesen Bio also may be required to reimburse banks, brokers and other custodians, nominees and fiduciaries or their respective agents for reasonable expenses incurred in forwarding proxy materials to beneficial owners of Sesen Bio common stock. </font></div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio has engaged MacKenzie Partners, Inc., or MacKenzie Partners, to assist in the solicitation of proxies and provide related advice and informational support. Sesen Bio will pay the fees of MacKenzie Partners, which Sesen Bio expects to be approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, plus reimbursement of out-of-pocket expenses. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Q:</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Who can help answer my questions?</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">A:</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">If you would like to request documents from Sesen Bio or Carisma, please send a request in writing or by telephone to either Sesen Bio or Carisma at the following addresses: </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <table style="width:416pt;margin-bottom:5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; width:202pt;">
              <div style="text-align:center;">
                <font style="font-weight:bold;letter-spacing:-0.2pt;">Sesen Bio, Inc.</font>
                <br >
                <font style="letter-spacing:0.2pt;">245 First Street, Suite 1800</font>
                <br >
                <font style="letter-spacing:0.2pt;">Cambridge, Massachusetts 02142</font>
                <br >
                <font style="letter-spacing:0.2pt;">Telephone: (617) 444-8550</font>
                <br >
                <font style="letter-spacing:0.2pt;">Attn: Corporate Secretary</font>
                <br >
                <font style="letter-spacing:0.2pt;">Email: ir@sesenbio.com </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; width:202pt;">
              <div style="text-align:center;">
                <font style="font-weight:bold;letter-spacing:-0.2pt;">CARISMA Therapeutics Inc</font><font style="letter-spacing:0.2pt;">.</font>
                <br >
                <font style="letter-spacing:0.2pt;">3675 Market Street, Suite 200</font>
                <br >
                <font style="letter-spacing:0.2pt;">Philadelphia, PA 19104</font>
                <br >
                <font style="letter-spacing:0.2pt;">Telephone: (267) 491-6422</font>
                <br >
                <font style="letter-spacing:0.2pt;">Attn: Corporate Secretary</font>
                <br >
                <font style="letter-spacing:0.2pt;">Email: info@carismatx.com</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If you are a Sesen Bio stockholder and would like additional copies, without charge, of this proxy statement/prospectus or if you have questions about the merger, including the procedures for voting your shares, you should contact Sesen Bio&#8217;s proxy solicitor: </font>
        </div>
        <div style="position:relative;margin-top:10pt; text-align:center; width:456pt;">
          <img src="lg_mackenziepartners-bw.jpg" alt="[MISSING IMAGE: lg_mackenziepartners-bw.jpg]" height="57" width="192" >
        </div>
        <div style="margin-top:13pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">MacKenzie Partners, Inc. </font>
          <br >
          <font style="letter-spacing:0.2pt;">1407 Broadway, 27th Floor </font>
          <br >
          <font style="letter-spacing:0.2pt;">New York, New York 10018 </font>
          <br >
          <font style="letter-spacing:0.2pt;">(800) 322-2885 </font>
          <br >
          <font style="letter-spacing:0.2pt;">proxy@mackenziepartners.com</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">10</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tPRSU">&#8203;</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;margin-left:12pt;width:456pt;">
          <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">PROSPECTUS SUMMARY</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>

            <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;font-style:italic;">
              <font style="letter-spacing:0.2pt;">This summary highlights selected information from this proxy statement/prospectus and may not contain all of the information that is important to you. To better understand the merger, the proposals being considered at the Sesen Bio special meeting, you should read this entire proxy statement/prospectus carefully, including the Original Merger Agreement, attached as Annex A-1, the Merger Agreement Amendment, attached as Annex&#160;A-2, the opinion of SVB Securities LLC, or SVB Securities, attached as Annex B and the other annexes to which you are referred herein. For more information, see the section entitled &#8220;Where You Can Find More Information&#8221; on page <a href="#tWYCF">404</a> of this proxy statement/prospectus. Except where specifically noted, the following information and all other information contained in this proxy statement/prospectus does not give effect to the proposed reverse stock split described in the section entitled &#8220;Matters Being Submitted to a Vote of Sesen Bio Stockholders&#8201;&#8212;&#8201;Proposal No. 2: Approval of an amendment to the Sesen Bio Certificate of Incorporation to effect the reverse stock split and reduce the number of authorized shares of Sesen Bio common stock&#8221; beginning on page <a href="#tPN2A">203</a> of this proxy statement/prospectus.</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
            </div>

          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">The Companies</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Sesen Bio, Inc.</font> <br ><font style="letter-spacing:0.2pt;">245 First Street, Suite 1800</font> <br ><font style="letter-spacing:0.2pt;">Cambridge, MA 02142</font> <br ><font style="letter-spacing:0.2pt;">(617) 444-8550 </font></div>

            <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
              <font style="letter-spacing:0.2pt;">Sesen Bio is a late-stage clinical company focused on targeted fusion protein therapeutics for the treatment of patients with cancer. Sesen Bio&#8217;s most advanced product candidate, Vicineum&#8482;, also known as VB4-845, is a locally-administered targeted fusion protein composed of an anti-epithelial cell adhesion molecule antibody fragment tethered to a truncated form of Pseudomonas exotoxin A for the treatment of non-muscle invasive bladder cancer, or NMIBC. On July&#160;15, 2022, Sesen Bio made the strategic decision to voluntarily pause further development of Vicineum in the United States. The decision was based on a thorough reassessment of Vicineum, which included the incremental development timeline and associated costs for an additional Phase&#160;3 clinical trial, following Sesen Bio&#8217;s discussions with the United States Food and Drug Administration, or FDA. Sesen Bio has turned its primary focus to consummating a strategic transaction with the goal of maximizing shareholder value. As a result of such decision and Sesen Bio&#8217;s subsequent decision to enter into the proposed merger with Carisma, Sesen Bio no longer plans to pursue regulatory approval of Vicineum for NMIBC in the European Union, or the E.U., and has started to wind down certain of its manufacturing operations and business development partnerships. Additionally, Sesen Bio is seeking a partner for the further development of Vicineum and has engaged a financial advisor for the potential sale of Vicineum. If the merger is consummated, the combined company does not expect to pursue further development of Vicineum.</font>
            </div>

          <div style="margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">CARISMA Therapeutics Inc.</font> <br ><font style="letter-spacing:0.2pt;">3675 Market Street, Suite 200</font> <br ><font style="letter-spacing:0.2pt;">Philadelphia, Pennsylvania 19104</font> <br ><font style="letter-spacing:0.2pt;">(267) 491-6422 </font></div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Carisma is a biopharmaceutical company dedicated to developing a differentiated and proprietary cell therapy platform focused on engineered macrophages, cells that play a crucial role in both the innate and adaptive immune response. The first applications of the platform, developed in collaboration with the University of Pennsylvania, are autologous chimeric antigen receptor macrophages for the treatment of solid tumors. </font>
          </div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Seahawk Merger Sub, Inc.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Merger Sub is a wholly-owned subsidiary of Sesen Bio, formed solely for the purposes of carrying out the merger. </font>
          </div>

            <div style="margin-top:8pt; width:456pt; line-height:12pt;">
              <font style="font-weight:bold;letter-spacing:-0.2pt;">The Merger</font><font style="letter-spacing:0.2pt;"> (see page <a href="#tTHME">125</a>) </font>
            </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">If the merger is completed, Merger Sub will merge with and into Carisma, with Carisma surviving as a wholly-owned subsidiary of Sesen Bio. After the completion of the merger, Sesen Bio will change its corporate name from &#8220;Sesen Bio, Inc.&#8221; to &#8220;Carisma Therapeutics Inc.&#8221; as contemplated by the Merger Agreement. </font>
          </div>
        </div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">11</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;margin-left:12pt;width:456pt;">

            <div style="text-indent:20pt; width:456pt; line-height:12pt;">
              <font style="letter-spacing:0.2pt;">At the effective time, each outstanding share of Carisma capital stock will be converted into the right to receive a number of shares of Sesen Bio common stock equal to the exchange ratio described in more detail in the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Merger Agreement&#8201;&#8212;&#8201;Exchange Ratio</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tTMAER">172</a> of this proxy statement/prospectus. Based on Sesen Bio&#8217;s capitalization and Carisma&#8217;s capitalization as of December 29, 2022, the date the Merger Agreement was executed, the exchange ratio is estimated to be approximately 37.7924 shares of Sesen Bio common stock for each share of Carisma capital stock, which exchange ratio does not give effect to the proposed reverse stock split. The final exchange ratio is subject to adjustment prior to the closing of the merger based on Sesen Bio&#8217;s net cash at the closing of the merger and the aggregate proceeds from the sale of Carisma common stock in the Carisma pre-closing financing and, as a result, Sesen Bio stockholders could own more, and Carisma stockholders (including, for this purpose, investors in the Carisma pre-closing financing) could own less, or vice versa, of the combined company.</font>
            </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Also at the effective time, each outstanding Carisma option will be assumed by Sesen Bio and will be converted into an option to purchase shares of Sesen Bio common stock, with the number of shares and exercise price being appropriately adjusted to reflect the exchange ratio between Sesen Bio common stock and Carisma common stock determined in accordance with the Merger Agreement. </font>
          </div>

            <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
              <font style="letter-spacing:0.2pt;">Each share of Sesen Bio common stock, each Sesen Bio option and each Sesen Bio RSU that is outstanding at the effective time will remain outstanding in accordance with its terms and each such share of Sesen Bio common stock, Sesen Bio option and Sesen Bio RSU, subject to the proposed reverse stock split, will be unaffected by the merger. Immediately after the merger, pre-merger Sesen Bio stockholders are expected to own approximately 25.2% of the outstanding shares of capital stock of the combined company and pre-merger Carisma stockholders, after taking into account shares of Carisma common stock purchased in connection with the Carisma pre-closing financing and the conversion of the Carisma convertible note, are expected to own approximately 74.8% of the outstanding shares of capital stock of the combined company, subject to certain assumptions, including Sesen Bio&#8217;s net cash as of the closing of the merger being at least $75.0 million. </font>
            </div>


            <div style="margin-top:12pt; width:456pt; line-height:12pt;">
              <font style="font-weight:bold;letter-spacing:-0.2pt;">Reasons for the Merger</font><font style="letter-spacing:0.2pt;"> (see page <a href="#tSBRF">134</a>) </font>
            </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">After consideration and consultation of its senior management, consultants and advisors, outside legal counsel and financial advisor, the Sesen Bio board of directors unanimously determined that the Merger Agreement, the merger and other transactions contemplated thereby are advisable and in the best interests of Sesen Bio and Sesen Bio stockholders. The Sesen Bio board of directors considered various reasons to reach its determination. For example: </font>
          </div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">the financial condition and prospects of Sesen Bio and the risks associated with continuing to operate Sesen Bio on a stand-alone basis, particularly in light of Sesen Bio&#8217;s July&#160;2022 decision to voluntarily pause further development of Vicineum for the treatment of NMIBC and reduce its workforce, which was based on a thorough reassessment of Vicineum following FDA feedback on the requirements for an additional Phase&#160;3 clinical trial, the evolving competitive landscape and the resulting financial analysis; </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">that the Sesen Bio board of directors and its financial advisor undertook a comprehensive and thorough process of reviewing and analyzing potential strategic alternatives and merger partner candidates and Sesen Bio board of directors&#8217; view that no alternatives to the merger, including a liquidation and dissolution of Sesen Bio and the distribution of any available cash, were reasonably likely to create greater value to Sesen Bio stockholders; </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">the Sesen Bio board of directors&#8217; conclusion that the merger would provide existing Sesen Bio stockholders a significant opportunity to participate in the potential growth of the combined company following the merger, which will focus on Carisma&#8217;s product pipeline, while also potentially receiving certain cash payments following the closing of the merger on account of the CVR Agreement and the special cash dividend; </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">the Sesen Bio board of directors&#8217; belief, after a thorough review of strategic alternatives and discussions with Sesen Bio&#8217;s senior management, outside legal counsel and financial advisor, that the merger is more favorable to Sesen Bio stockholders than the potential value that might have resulted </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        </div>
        <div style="clear:both;font-size:0pt;">&#8203;</div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">12</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;margin-left:12pt;width:456pt;">
          <div style="margin-left:30pt; width:426pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">from other strategic alternatives available to Sesen Bio, including a liquidation and dissolution of Sesen Bio and the distribution of any available cash; </font>
          </div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">the Sesen Bio board of directors&#8217; belief, after thorough discussion with Sesen Bio management and Sesen Bio&#8217;s consultants and advisors, that a potential liquidation and dissolution was not reasonably likely to create greater value for Sesen Bio stockholders than a strategic alternative transaction based on, among other things, the need to hold back a meaningful amount of the Company&#8217;s current cash balance to cover current and potential future liabilities, including those triggered by a liquidation strategy; </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">the Sesen Bio board of directors&#8217; belief that, as a result of arm&#8217;s length negotiations with Carisma, Sesen Bio and its representatives negotiated the highest exchange ratio to which Carisma was willing to agree, and that the other terms of the Merger Agreement include the most favorable terms to Sesen Bio in the aggregate to which Carisma was willing to agree; and </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">the Sesen Bio board of directors&#8217; positive view, based on the scientific, regulatory and technical due diligence conducted by Sesen Bio management and advisors, of the regulatory pathway for, and potential significant market opportunity of, Carisma&#8217;s product candidates, which will be the focus of the combined company. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">After consideration and consultation with Carisma senior management, its financial advisors and legal counsel, and consideration of a wide variety of factors, the Carisma board of directors concluded that a merger with Sesen Bio, together with the additional financing committed from the Carisma pre-closing financing, was the best option to generate capital resources to support the advancement of Carisma&#8217;s pipeline and fund a combined organization. The Carisma board of directors considered various reasons to reach its determination. For example: </font>
          </div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">the merger will provide current Carisma stockholders with greater liquidity by owning publicly-traded stock, and expanding both the access to capital for Carisma and the range of investors potentially available as a public company, compared to the investors Carisma could otherwise gain access to if it continued to operate as a privately-held company;</font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">the potential benefits from increased public market awareness of Carisma and its pipeline;</font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">the historical and current information concerning Carisma&#8217;s business, including its financial performance and condition, operations, management and pre-clinical and clinical data;</font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">the competitive nature of the industry in which Carisma operates;</font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">the Carisma board of directors&#8217; fiduciary duties to Carisma stockholders;</font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">the Carisma board of directors&#8217; belief that no alternatives to the merger were reasonably likely to create greater value for Carisma stockholders, after reviewing the various financing and other strategic alternatives that were considered by the Carisma board of directors; and</font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

            <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
            <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
              <font style="letter-spacing:0.2pt;">&#8226;</font>
              <br >
            </div>
            <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
              <font style="letter-spacing:0.2pt;">the projected financial position, operations, management structure, operating plans, and anticipated cash burn rate of the combined company, including the ability to support the combined company&#8217;s current and planned clinical trials and operations), as further discussed in the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Carisma Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8201;&#8212;&#8201;Liquidity and Capital Resources&#8201;&#8212;&#8201;Funding Requirements</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tFUNDRE1">335</a> of this proxy statement/</font>&#8203;<font style="letter-spacing:0.2pt;">prospectus.</font></div>
            <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;font-style:italic;">
            <font style="font-style:normal;letter-spacing:0.2pt;">For additional information, see the sections entitled &#8220;</font><font style="letter-spacing:0.2pt;">The Merger&#8201;&#8212;&#8201;Sesen Bio Reasons for the Merger</font><font style="font-style:normal;letter-spacing:0.2pt;">&#8221; and &#8220;</font><font style="letter-spacing:0.2pt;">The Merger&#8201;&#8212;&#8201;Carisma Reasons for the Merger</font><font style="font-style:normal;letter-spacing:0.2pt;">&#8221; in this proxy statement/prospectus. </font>
          </div>

            <div style="margin-top:12pt; width:456pt; line-height:12pt;">
              <font style="font-weight:bold;letter-spacing:-0.2pt;">Opinion of Sesen Bio&#8217;s Financial Advisor</font><font style="letter-spacing:0.2pt;"> (see page <a href="#tOOSB">139</a>) </font>
            </div>


            <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
              <font style="letter-spacing:0.2pt;">Sesen Bio retained SVB Securities as its financial advisor in connection with the merger and the other transactions contemplated by the Merger Agreement. On December 29, 2022, SVB Securities rendered to the Sesen Bio board of directors its oral opinion, which was subsequently confirmed by delivery of a written opinion to the Sesen Bio board of directors dated December 29, 2022 that, as of such date and based upon and subject to the various assumptions made, and the qualifications and limitations upon the review </font>
            </div>

        </div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">13</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;margin-left:12pt;width:456pt;">
          <div style="width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">undertaken by SVB Securities in preparing its opinion, the exchange ratio proposed to be paid by Sesen Bio pursuant to the terms of the Merger Agreement was fair, from a financial point of view, to Sesen Bio. </font>
          </div>

            <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
              <font style="letter-spacing:0.2pt;">The full text of the written opinion of SVB Securities, dated December 29, 2022, which describes the assumptions made and the qualifications and limitations upon the review undertaken by SVB Securities in preparing its opinion, is attached as </font><font style="font-style:italic;letter-spacing:0.2pt;">Annex B</font><font style="letter-spacing:0.2pt;"> to this proxy statement/prospectus and is incorporated herein by reference. </font><font style="font-weight:bold;letter-spacing:-0.2pt;">SVB Securities&#8217; financial advisory services and opinion were provided for the information and assistance of Sesen Bio board of directors (in their capacity as directors and not in any other capacity) in connection with and for purposes of the Sesen Bio board of directors&#8217; consideration of the merger and the opinion of SVB Securities addressed only the fairness, from a financial point of view, as of the date thereof, to Sesen Bio of the exchange ratio proposed to be paid by Sesen Bio pursuant to the terms of the Merger Agreement. The opinion of SVB Securities did not address any other term or aspect of the Merger Agreement or the merger and does not constitute a recommendation to any stockholder of Sesen Bio as to whether or how such holder should vote with respect to the merger or otherwise act with respect to the merger or any other matter.</font><font style="letter-spacing:0.2pt;"> </font>
            </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">The full text of the written opinion of SVB Securities should be read carefully in its entirety for a description of the assumptions made and the qualifications and limitations upon the review undertaken by SVB Securities in preparing its opinion.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Overview of the Merger Agreement</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>

            <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
              <font style="font-weight:bold;letter-spacing:-0.2pt;">Merger Consideration </font><font style="letter-spacing:0.2pt;">(see page <a href="#tTMA">171</a>)</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
            </div>


            <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
              <font style="letter-spacing:0.2pt;">At the effective time, each outstanding share of Carisma capital stock will be converted into the right to receive a number of shares of Sesen Bio common stock equal to the exchange ratio described in more detail in the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Merger Agreement&#8201;&#8212;&#8201;Exchange Ratio</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tTMAER">172</a> of this proxy statement/prospectus. Based on Sesen Bio&#8217;s capitalization and Carisma&#8217;s capitalization as of December 29, 2022, the date the Merger Agreement was executed, the exchange ratio is estimated to be approximately 37.7924 shares of Sesen Bio common stock for each share of Carisma capital stock, which exchange ratio does not give effect to the proposed reverse stock split. The final exchange ratio is subject to adjustment prior to the closing of the merger based on Sesen Bio&#8217;s net cash at the closing of the merger and the aggregate proceeds from the sale of Carisma common stock in the Carisma pre-closing financing and, as a result, Sesen Bio stockholders could own more, and Carisma stockholders (including, for this purpose, investors in the Carisma pre-closing financing) could own less, or vice versa, of the combined company.</font>
            </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Also at the effective time, each outstanding Carisma option will be assumed by Sesen Bio and will be converted into an option to purchase shares of Sesen Bio common stock, with the number of shares and exercise price being appropriately adjusted to reflect the exchange ratio between Sesen Bio common stock and Carisma common stock determined in accordance with the Merger Agreement. </font>
          </div>

            <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
              <font style="letter-spacing:0.2pt;">Immediately after the merger, pre-merger Sesen Bio stockholders are expected to own approximately 25.2% of the outstanding shares of capital stock of the combined company and pre-merger Carisma stockholders, after taking into account shares of Carisma common stock purchased in the Carisma pre-closing financing and the conversion of Carisma&#8217;s $35.0&#160;million outstanding convertible note, are expected to own approximately 74.8% of the outstanding shares of capital stock of the combined company, subject to certain assumptions, including Sesen Bio&#8217;s net cash as of the closing of the merger being at least $75.0 million. </font>
            </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-style:italic;">
            <font style="font-style:normal;letter-spacing:0.2pt;">For a more complete description of the merger consideration, see the sections entitled &#8220;</font><font style="letter-spacing:0.2pt;">The Merger Agreement&#8201;&#8212;&#8201;Merger Consideration</font><font style="font-style:normal;letter-spacing:0.2pt;">&#8221; and &#8220;</font><font style="letter-spacing:0.2pt;">The Merger Agreement&#8201;&#8212;&#8201;Exchange Ratio</font><font style="font-style:normal;letter-spacing:0.2pt;">&#8221; in this proxy statement/</font>&#8203;<font style="font-style:normal;letter-spacing:0.2pt;">prospectus. </font></div>

            <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
              <font style="font-weight:bold;letter-spacing:-0.2pt;">Treatment of Sesen Bio Equity Awards and Warrants </font><font style="letter-spacing:0.2pt;">(see page <a href="#tTMAER7">174</a>)</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
            </div>

          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
            <font style="letter-spacing:0.2pt;">Sesen Bio Equity Awards</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">At the effective time, all outstanding and unexercised Sesen Bio options granted pursuant to the 2014 Incentive Plan or the 2009 Incentive Plan or as an inducement grant under Nasdaq Listing Rule&#160;5635(c)(4) </font>
          </div>
        </div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">14</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;margin-left:12pt;width:456pt;">
          <div style="width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">will remain in effect pursuant to their terms and will be unaffected by the merger. The number of shares of Sesen Bio common stock underlying the Sesen Bio options and the exercise prices for such Sesen Bio options will be appropriately adjusted to reflect the proposed reverse stock split, if approved and implemented. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">At the effective time, all outstanding Sesen Bio RSUs granted pursuant to the 2014 Incentive Plan or the 2009 Incentive Plan will remain in effect pursuant to their terms and will be unaffected by the merger. The number of shares of Sesen Bio common stock underlying the Sesen Bio RSUs will be appropriately adjusted to reflect the proposed reverse stock split, if approved and implemented. </font>
          </div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
            <font style="letter-spacing:0.2pt;">Sesen Bio Warrants</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">At the effective time, all Sesen Bio warrants (other than certain Sesen Bio warrants that Sesen Bio may be required to repurchase at such warrant holder&#8217;s option as of a result of the merger) will remain in effect pursuant to their terms and will be unaffected by the merger. The number of shares of Sesen Bio common stock underlying such Sesen Bio warrants and the exercise prices for such Sesen Bio warrants will be appropriately adjusted to reflect the proposed reverse stock split, if approved. </font>
          </div>

            <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
              <font style="font-weight:bold;letter-spacing:-0.2pt;">Treatment of Carisma Options and Carisma Plan </font><font style="letter-spacing:0.2pt;">(see page <a href="#tTMAER9">174</a>)</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
            </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">At the effective time, Sesen Bio will assume the CARISMA Therapeutics Inc. 2017 Stock Incentive Plan, as amended, or the Carisma Plan, and each Carisma option in accordance with the terms of the Carisma Plan and the terms of the stock option agreement by which such Carisma option is evidenced but with such changes to such documents as Carisma and Sesen Bio mutually agree are appropriate to reflect the substitution of each Carisma option for a Sesen Bio option. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">At the effective time, each Carisma option outstanding and unexercised immediately prior to the effective time, whether or not vested, will be converted into a Sesen Bio option. From and after the effective time, each Carisma option assumed by Sesen Bio may be exercised for such number of shares of Sesen Bio common stock as is determined by multiplying the number of shares of Carisma common stock subject to the Carisma option, as in effect immediately prior to the effective time, by the exchange ratio and rounding that result down to the nearest whole number of shares of Sesen Bio common stock. The per share exercise price of the converted Carisma option will be determined by dividing the per share exercise price of the Carisma option, as in effect prior to the effective time, by the exchange ratio and rounding that result up to the nearest whole cent. </font>
          </div>

            <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
              <font style="font-weight:bold;letter-spacing:-0.2pt;">Conditions to the Completion of the Merger </font><font style="letter-spacing:0.2pt;">(see page <a href="#tCCM5">176</a>)</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
            </div>


            <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
              <font style="letter-spacing:0.2pt;">To complete the merger, Sesen Bio stockholders must approve Proposal Nos. 1 and 2 and Carisma stockholders must adopt the Merger Agreement and approve the merger and the related transactions. Additionally, each of the other closing conditions set forth in the Merger Agreement must be satisfied or waived (including Sesen Bio having net cash as of the closing of the merger greater than or equal to $75.0&#160;million). </font>
            </div>


            <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
              <font style="font-weight:bold;letter-spacing:-0.2pt;">No Solicitation</font><font style="letter-spacing:0.2pt;">(see page <a href="#tNSON">179</a>)</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
            </div>


            <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
              <font style="letter-spacing:0.2pt;">Each of Sesen Bio and Carisma agreed that during the period commencing on the date of the Original Merger Agreement and continuing until the earlier to occur of the termination of the Merger Agreement and the effective time, or the pre-closing period, except as described below, Sesen Bio and Carisma will not, nor will either party authorize any of the directors, officers, employees, agents, attorneys, accountants, investment bankers, advisors or representatives retained by it or any of its subsidiaries to, directly or indirectly: </font>
            </div>

          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">solicit, initiate or knowingly encourage, induce or facilitate the communication, making, submission or announcement of, any &#8220;acquisition proposal&#8221; or &#8220;acquisition inquiry&#8221; &#8203;(each as defined in the Merger Agreement) or take any action that could reasonably be expected to lead to an acquisition proposal or acquisition inquiry; </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">furnish any non-public information regarding the party and its subsidiaries to any person in connection with or in response to an acquisition proposal or acquisition inquiry; </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        </div>
        <div style="clear:both;font-size:0pt;">&#8203;</div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">15</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;margin-left:12pt;width:456pt;">
          <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">engage in discussions or negotiations with any person with respect to any acquisition proposal or acquisition inquiry; </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">approve, endorse or recommend an acquisition proposal; </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">execute or enter into any letter of intent or any contract contemplating or otherwise relating to any &#8220;acquisition transaction&#8221; as defined below (other than a confidentiality agreement permitted by the Merger Agreement); or </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.91pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.91pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">publicly propose to do any of the above. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

            <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
              <font style="font-weight:bold;letter-spacing:-0.2pt;">Termination of the Merger Agreement </font><font style="letter-spacing:0.2pt;">(see page <a href="#tTMAER10">188</a>)</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
            </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Either Sesen Bio or Carisma can terminate the Merger Agreement under certain circumstances, which would prevent the merger from being consummated. </font>
          </div>

            <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
              <font style="font-weight:bold;letter-spacing:-0.2pt;">Termination Fees</font><font style="letter-spacing:0.2pt;">(see page <a href="#tTERFEE123">190</a>)</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
            </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">If the Merger Agreement is terminated under certain circumstances, Sesen Bio may be required to pay Carisma a termination fee of $7.6&#160;million and/or reimburse Carisma&#8217;s expenses up to a maximum of $1.75&#160;million, and Carisma may be required to pay Sesen Bio a termination fee of $5.49&#160;million and/or reimburse Sesen Bio&#8217;s expenses up to a maximum of $1.75&#160;million. </font>
          </div>

            <div style="margin-top:12pt; width:456pt; line-height:12pt;">
              <font style="font-weight:bold;letter-spacing:-0.2pt;">CVR Agreement</font><font style="letter-spacing:0.2pt;"> (see page <a href="#tCVAG">192</a>) </font>
            </div>


            <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
              <font style="letter-spacing:0.2pt;">Pursuant to the Merger Agreement and the CVR Agreement, Sesen Bio stockholders of record as of a date agreed to by Sesen Bio and Carisma prior to the effective time will receive one CVR for each share of Sesen Bio common stock held of record as of immediately prior to the effective time. Each CVR will represent the right to receive contingent cash payments (i) upon the occurrence of a certain triggering event, entitling CVR holders to a pro rata portion of the $30.0 million milestone payment to be made by Roche to Sesen Bio upon Roche&#8217;s initiation of a Phase 3 clinical trial with legacy IL-6 antagonist antibody technology previously owned by Sesen Bio for a certain indication if initiated prior to December 31, 2026, pursuant to the Roche Asset Purchase Agreement, less certain permitted deductions and (ii) from proceeds from any sale of Sesen Bio&#8217;s non-cash assets, subject to certain customary deductions, including for expenses and taxes.</font>
            </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">The sole right of the holders of the CVRs is to receive cash from Sesen Bio, if any, through the rights agent in accordance with the CVR Agreement. The CVRs are not transferable, except in certain limited circumstances, will not be certificated or evidenced by any instrument and will not be registered with the SEC or listed for trading on any exchange. The CVRs will not have any voting or dividend rights, will not represent any equity or ownership interest in Sesen Bio or its subsidiaries, and interest will not accrue on any amounts payable on the CVRs. The CVR Agreement will be effective prior to the closing of the merger and will continue in effect until the earlier of March&#160;31, 2027 or the payment of all amounts payable thereunder, unless and until earlier termination of the Merger Agreement. </font>
          </div>

            <div style="margin-top:12pt; width:456pt; line-height:12pt;">
              <font style="font-weight:bold;letter-spacing:-0.2pt;">Support Agreements and Written Consents</font><font style="letter-spacing:0.2pt;"> (see page <a href="#tSAAW">197</a>) </font>
            </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">In order to induce Sesen Bio to enter into the Merger Agreement, certain stockholders of Carisma (solely in their respective capacities as Carisma stockholders) are parties to a support agreement with Sesen Bio and Carisma pursuant to which, among other things, each such stockholder has agreed (a)&#160;to vote all of his, her or its shares of Carisma capital stock (subject to customary cutbacks in the event of certain triggering events) in favor of (i)&#160;adoption and approval of the Merger Agreement and the transactions contemplated thereby; (ii)&#160;adoption and approval of an amendment to Carisma&#8217;s certificate of incorporation, or the Carisma Certificate of Incorporation, to increase the authorized shares of Carisma common stock; (iii)&#160;acknowledgement that the approval given thereby is irrevocable and that the stockholder is aware of the stockholder&#8217;s rights to demand appraisal for its shares pursuant to Section&#160;262 of the Delaware General Corporation Law, or the DGCL; and (iv)&#160;acknowledgement that by the stockholder&#8217;s approval of the merger, the stockholder is (a)&#160;waiving its appraisal rights under the DGCL with respect to its shares, and (b)&#160;waiving any notice that may have been or may be required relating to the merger or any other transactions contemplated thereby. Additionally, each such signatory has agreed, solely in his, her or its capacity as a </font>
          </div>
        </div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">16</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;margin-left:12pt;width:456pt;">
          <div style="width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Carisma stockholder, to vote against (subject to customary cutbacks in the event of certain triggering events) any such competing acquisition proposal and any action in furtherance of any competing acquisition proposal. These signatories have also granted an irrevocable proxy to Carisma and its designee to vote their respective shares of Carisma common stock in accordance with the support agreements. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">In addition, in order to induce Carisma to enter into the Merger Agreement, certain stockholders of Sesen Bio (solely in their respective capacities as Sesen Bio stockholders) are parties to a support agreement with Sesen Bio and Carisma pursuant to which, among other things, each such stockholder has agreed, to vote all of his, her or its shares of Sesen Bio common stock in favor of (i)&#160;adoption and approval of the Merger Agreement and the transactions contemplated thereby; (ii)&#160;the issuance of shares of Sesen Bio common stock to Carisma stockholders in connection with the Merger Agreement and the transactions contemplated thereby; (iii)&#160;the change of control of Sesen Bio resulting from the merger pursuant to Nasdaq rules; (iv)&#160;the approval of the equity plan amendment proposals; and (v)&#160;a waiver of any notice that may have been or may be required relating to the merger or any other transactions contemplated thereby. Additionally, each such signatory has agreed, solely in his, her or its capacity as a Sesen Bio stockholder, to vote against any competing acquisition proposal and any action in furtherance of any such competing acquisition proposal. These signatories have also granted an irrevocable proxy to Sesen Bio and its designee to vote their respective shares of Sesen Bio common stock in accordance with the support agreements. </font>
          </div>

            <div style="margin-top:12pt; width:456pt; line-height:12pt;">
              <font style="font-weight:bold;letter-spacing:-0.2pt;">Lock-Up Agreements</font><font style="letter-spacing:0.2pt;"> (see page <a href="#tLOAG">199</a>) </font>
            </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">As a condition to the closing of the merger, certain stockholders of each of Sesen Bio and Carisma and their affiliates have entered into lock-up agreements, pursuant to which such parties have agreed not to, except in limited circumstances, and among other restrictions, offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, make any short sale or otherwise transfer or dispose of or lend, directly or indirectly, any shares of Sesen Bio common stock or any securities convertible into, exercisable or exchangeable for or that represent the right to receive Sesen Bio common stock (including, Sesen Bio common stock or such other securities which may be deemed to be beneficially owned by the signatory in accordance with the rules and regulations of the SEC and securities of Sesen Bio which may be issued upon exercise of a Sesen Bio option, Sesen Bio RSU or Sesen Bio warrant) during the period commencing at the effective time and continuing until the date that is 180&#160;days after the effective time. </font>
          </div>

            <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
              <font style="letter-spacing:0.2pt;">Certain directors and executive officers of both Sesen Bio and Carisma are party to a lock-up agreement. Carisma stockholders who have executed lock-up agreements, as of January 4, 2023, beneficially owned in the aggregate approximately 97.23% of the outstanding shares of Carisma capital stock on an as converted to Carisma common stock basis. </font>
            </div>


            <div style="margin-top:12pt; width:456pt; line-height:12pt;">
              <font style="font-weight:bold;letter-spacing:-0.2pt;">Subscription Agreement</font><font style="letter-spacing:0.2pt;"> (see page <a href="#tSUAG">198</a>) </font>
            </div>


            <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
              <font style="letter-spacing:0.2pt;">On September&#160;20, 2022, immediately prior to the execution and delivery of the Original Merger Agreement, Carisma entered into a subscription agreement with certain investors named therein, pursuant to which such investors have agreed to purchase shares of Carisma common stock at an aggregate purchase price of approximately $30.6&#160;million. The subscription agreement contains customary representations and warranties of Carisma and also contains customary representations and warranties of the purchasers party thereto. </font>
            </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">The subscription agreement may not be changed, waived, amended or modified, except by an instrument in writing executed by Carisma and the purchasers then committed to purchase a majority of the shares to be sold in the Carisma pre-closing financing. The subscription agreement will terminate upon the earlier to occur of (i)&#160;such date and time that the Merger Agreement is terminated in accordance with its terms, (ii)&#160;upon the mutual written agreement of Carisma and the purchasers then committed to purchase a majority of the shares to be sold in the Carisma pre-closing financing (provided that Carisma and a purchaser may terminate the commitment of the applicable purchaser without the consent of any other party), and (iii)&#160;if the closing of the merger has not occurred on or before January&#160;31, 2023 (as such date may be extended in the event that a request for additional information is made by any governmental body or in the event that the SEC has not declared the registration statement on Form S-4, of which this proxy statement/prospectus is a </font>
          </div>
        </div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">17</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;margin-left:12pt;width:456pt;">
          <div style="width:456pt; line-height:12.5pt;">
            <font style="letter-spacing:0.2pt;">part, effective under the Securities Act by the date which is 60&#160;days prior to the end date), other than as a result of a willful breach of a purchaser&#8217;s obligations under the subscription agreement. </font>
          </div>

            <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
              <font style="letter-spacing:0.2pt;">On December 29, 2022, immediately prior to the execution and delivery of the Merger Agreement Amendment, Carisma entered into an amended and restated subscription agreement with the investors party to the original subscription agreement, pursuant to which the parties thereto clarified that shares of Carisma common stock issued in the pre-closing financing will not be registered under the Securities Act and will be subject to restrictions on resale and agreed, among other things, to enter into a registration rights agreement to provide for the registration of the resale of the shares of common stock purchased by such investors in connection with the Carisma pre-closing financing.</font>
            </div>


            <div style="margin-top:12pt; width:456pt; line-height:12pt;">
              <font style="font-weight:bold;letter-spacing:-0.2pt;">Nasdaq Stock Market Listing</font><font style="letter-spacing:0.2pt;"> (see page <a href="#tNALI">165</a>) </font>
            </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
            <font style="letter-spacing:0.2pt;">Sesen Bio has filed an initial listing application for the combined company with Nasdaq. If such application is accepted, Sesen Bio anticipates that the combined company&#8217;s common stock will be listed on the Nasdaq Capital Market following the closing of the merger under the trading symbol &#8220;CARM.&#8221; </font>
          </div>

            <div style="margin-top:12pt; width:456pt; line-height:12pt;">
              <font style="font-weight:bold;letter-spacing:-0.2pt;">Management Following the Merger</font><font style="letter-spacing:0.2pt;"> (see page <a href="#tMFTM">342</a>) </font>
            </div>


            <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
              <font style="letter-spacing:0.2pt;">The following table lists the names, ages as of January 4, 2023 and positions of the individuals who are expected to serve as executive officers and directors of the combined company following completion of the merger. </font>
            </div>


            <table style="width:456pt;height:173.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
                <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:198pt;text-align:left;">
                  <div style="white-space:nowrap;">
                    <font style="letter-spacing:-0.16pt;">Name </font>
                  </div>
                </td>
                <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
                <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
                <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:36pt;">
                  <div style="white-space:nowrap; text-align:center;">
                    <font style="letter-spacing:-0.16pt;">Age </font>
                  </div>
                </td>
                <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
                <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
                <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:198pt;">
                  <div style="white-space:nowrap; text-align:center;">
                    <font style="letter-spacing:-0.16pt;">Position </font>
                  </div>
                </td>
                <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
              </tr>
              <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:italic;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
                <td style="padding:3.25pt 0pt 1.5pt 0pt; width:198pt;">
                  <font style="letter-spacing:-0.2pt;">Executive Officers</font>
                </td>
                <td style="padding:0pt; width:6pt;">&#8203;</td>
                <td style="padding:0pt; width:6pt;">&#8203;</td>
                <td style="padding:0pt 0pt 0.5pt 0pt; width:36pt;text-align:center;">&#8203;</td>
                <td style="padding:0pt; width:6pt;">&#8203;</td>
                <td style="padding:0pt; width:6pt;">&#8203;</td>
                <td style="padding:0pt 0pt 0.5pt 0pt; width:198pt;">&#8203;</td>
                <td style="padding:0pt; width:0pt;">&#8203;</td>
              </tr>
              <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
                <td style="padding:3.5pt 0pt 1.5pt 0pt; width:198pt;">
                  <font style="letter-spacing:0.2pt;">Steven Kelly </font>
                </td>
                <td style="padding:0pt; width:6pt;">&#8203;</td>
                <td style="padding:0pt; width:6pt;">&#8203;</td>
                <td style="padding:3.5pt 0pt 1.5pt 0pt; width:36pt;text-align:center;">
                  <div style="text-align:center;">
                    <font style="letter-spacing:0.2pt;">57 </font>
                  </div>
                </td>
                <td style="padding:0pt; width:6pt;">&#8203;</td>
                <td style="padding:0pt; width:6pt;">&#8203;</td>
                <td style="padding:3.5pt 0pt 1.5pt 0pt; width:198pt;">
                  <font style="letter-spacing:0.2pt;">President and Chief Executive Officer </font>
                </td>
                <td style="padding:0pt; width:0pt;">&#8203;</td>
              </tr>
              <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
                <td style="padding:3.5pt 0pt 1.5pt 0pt; width:198pt;">
                  <font style="letter-spacing:0.2pt;">Richard Morris </font>
                </td>
                <td style="padding:0pt; width:6pt;">&#8203;</td>
                <td style="padding:0pt; width:6pt;">&#8203;</td>
                <td style="padding:3.5pt 0pt 1.5pt 0pt; width:36pt;text-align:center;">
                  <div style="text-align:center;">
                    <font style="letter-spacing:0.2pt;">49 </font>
                  </div>
                </td>
                <td style="padding:0pt; width:6pt;">&#8203;</td>
                <td style="padding:0pt; width:6pt;">&#8203;</td>
                <td style="padding:3.5pt 0pt 1.5pt 0pt; width:198pt;">
                  <font style="letter-spacing:0.2pt;">Chief Financial Officer </font>
                </td>
                <td style="padding:0pt; width:0pt;">&#8203;</td>
              </tr>
              <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
                <td style="padding:3.5pt 0pt 1.5pt 0pt; width:198pt;">
                  <font style="letter-spacing:0.2pt;">Michael Klichinsky, Pharm.D., Ph.D. </font>
                </td>
                <td style="padding:0pt; width:6pt;">&#8203;</td>
                <td style="padding:0pt; width:6pt;">&#8203;</td>
                <td style="padding:3.5pt 0pt 1.5pt 0pt; width:36pt;text-align:center;">
                  <div style="text-align:center;">
                    <font style="letter-spacing:0.2pt;">33 </font>
                  </div>
                </td>
                <td style="padding:0pt; width:6pt;">&#8203;</td>
                <td style="padding:0pt; width:6pt;">&#8203;</td>
                <td style="padding:3.5pt 0pt 1.5pt 0pt; width:198pt;">
                  <font style="letter-spacing:0.2pt;">Chief Scientific Officer </font>
                </td>
                <td style="padding:0pt; width:0pt;">&#8203;</td>
              </tr>
              <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:italic;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
                <td style="padding:3.5pt 0pt 1.5pt 0pt; width:198pt;">
                  <font style="letter-spacing:-0.2pt;">Non-Employee Directors</font>
                </td>
                <td style="padding:0pt; width:6pt;">&#8203;</td>
                <td style="padding:0pt; width:6pt;">&#8203;</td>
                <td style="padding:0pt 0pt 0.5pt 0pt; width:36pt;text-align:center;">&#8203;</td>
                <td style="padding:0pt; width:6pt;">&#8203;</td>
                <td style="padding:0pt; width:6pt;">&#8203;</td>
                <td style="padding:0pt 0pt 0.5pt 0pt; width:198pt;">&#8203;</td>
                <td style="padding:0pt; width:0pt;">&#8203;</td>
              </tr>
              <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
                <td style="padding:3.5pt 0pt 1.5pt 0pt; width:198pt;">
                  <font style="letter-spacing:0.2pt;">Sanford Zweifach </font>
                </td>
                <td style="padding:0pt; width:6pt;">&#8203;</td>
                <td style="padding:0pt; width:6pt;">&#8203;</td>
                <td style="padding:3.5pt 0pt 1.5pt 0pt; width:36pt;text-align:center;">
                  <div style="text-align:center;">
                    <font style="letter-spacing:0.2pt;">66 </font>
                  </div>
                </td>
                <td style="padding:0pt; width:6pt;">&#8203;</td>
                <td style="padding:0pt; width:6pt;">&#8203;</td>
                <td style="padding:3.5pt 0pt 1.5pt 0pt; width:198pt;">
                  <font style="letter-spacing:0.2pt;">Director, Chair of the Board </font>
                </td>
                <td style="padding:0pt; width:0pt;">&#8203;</td>
              </tr>
              <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
                <td style="padding:3.5pt 0pt 1.5pt 0pt; width:198pt;">
                  <font style="letter-spacing:0.2pt;">Thomas R. Cannell, D.V.M. </font>
                </td>
                <td style="padding:0pt; width:6pt;">&#8203;</td>
                <td style="padding:0pt; width:6pt;">&#8203;</td>
                <td style="padding:3.5pt 0pt 1.5pt 0pt; width:36pt;text-align:center;">
                  <div style="text-align:center;">
                    <font style="letter-spacing:0.2pt;">61 </font>
                  </div>
                </td>
                <td style="padding:0pt; width:6pt;">&#8203;</td>
                <td style="padding:0pt; width:6pt;">&#8203;</td>
                <td style="padding:3.5pt 0pt 1.5pt 0pt; width:198pt;">
                  <font style="letter-spacing:0.2pt;">Director </font>
                </td>
                <td style="padding:0pt; width:0pt;">&#8203;</td>
              </tr>
              <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
                <td style="padding:3.5pt 0pt 1.5pt 0pt; width:198pt;">
                  <font style="letter-spacing:0.2pt;">Regina Hodits, Ph.D. </font>
                </td>
                <td style="padding:0pt; width:6pt;">&#8203;</td>
                <td style="padding:0pt; width:6pt;">&#8203;</td>
                <td style="padding:3.5pt 0pt 1.5pt 0pt; width:36pt;text-align:center;">
                  <div style="text-align:center;">
                    <font style="letter-spacing:0.2pt;">53</font>
                  </div>
                </td>
                <td style="padding:0pt; width:6pt;">&#8203;</td>
                <td style="padding:0pt; width:6pt;">&#8203;</td>
                <td style="padding:3.5pt 0pt 1.5pt 0pt; width:198pt;">
                  <font style="letter-spacing:0.2pt;">Director </font>
                </td>
                <td style="padding:0pt; width:0pt;">&#8203;</td>
              </tr>
              <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
                <td style="padding:3.5pt 0pt 1.5pt 0pt; width:198pt;">
                  <font style="letter-spacing:0.2pt;">Briggs Morrison, M.D. </font>
                </td>
                <td style="padding:0pt; width:6pt;">&#8203;</td>
                <td style="padding:0pt; width:6pt;">&#8203;</td>
                <td style="padding:3.5pt 0pt 1.5pt 0pt; width:36pt;text-align:center;">
                  <div style="text-align:center;">
                    <font style="letter-spacing:0.2pt;">63 </font>
                  </div>
                </td>
                <td style="padding:0pt; width:6pt;">&#8203;</td>
                <td style="padding:0pt; width:6pt;">&#8203;</td>
                <td style="padding:3.5pt 0pt 1.5pt 0pt; width:198pt;">
                  <font style="letter-spacing:0.2pt;">Director </font>
                </td>
                <td style="padding:0pt; width:0pt;">&#8203;</td>
              </tr>
              <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
                <td style="padding:3.5pt 0pt 1.5pt 0pt; width:198pt;">
                  <font style="letter-spacing:0.2pt;">Bj&#246;rn Odlander, M.D., Ph.D. </font>
                </td>
                <td style="padding:0pt; width:6pt;">&#8203;</td>
                <td style="padding:0pt; width:6pt;">&#8203;</td>
                <td style="padding:3.5pt 0pt 1.5pt 0pt; width:36pt;text-align:center;">
                  <div style="text-align:center;">
                    <font style="letter-spacing:0.2pt;">64 </font>
                  </div>
                </td>
                <td style="padding:0pt; width:6pt;">&#8203;</td>
                <td style="padding:0pt; width:6pt;">&#8203;</td>
                <td style="padding:3.5pt 0pt 1.5pt 0pt; width:198pt;">
                  <font style="letter-spacing:0.2pt;">Director </font>
                </td>
                <td style="padding:0pt; width:0pt;">&#8203;</td>
              </tr>
              <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
                <td style="padding:3.5pt 0pt 1.5pt 0pt; width:198pt;">
                  <font style="letter-spacing:0.2pt;">Chidozie Ugwumba </font>
                </td>
                <td style="padding:0pt; width:6pt;">&#8203;</td>
                <td style="padding:0pt; width:6pt;">&#8203;</td>
                <td style="padding:3.5pt 0pt 1.5pt 0pt; width:36pt;text-align:center;">
                  <div style="text-align:center;">
                    <font style="letter-spacing:0.2pt;">40 </font>
                  </div>
                </td>
                <td style="padding:0pt; width:6pt;">&#8203;</td>
                <td style="padding:0pt; width:6pt;">&#8203;</td>
                <td style="padding:3.5pt 0pt 1.5pt 0pt; width:198pt;">
                  <font style="letter-spacing:0.2pt;">Director</font>
                </td>
                <td style="padding:0pt; width:0pt;">&#8203;</td>
              </tr>
            </table>


            <div style="margin-top:12.5pt; width:456pt; line-height:12pt;">
              <font style="font-weight:bold;letter-spacing:-0.2pt;">Interests of Sesen Bio Directors and Executive Officers in the Merger</font><font style="letter-spacing:0.2pt;"> (see page <a href="#tIOSB">148</a>) </font>
            </div>


            <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
              <font style="letter-spacing:0.2pt;">In considering the recommendation of the Sesen Bio board of directors with respect to issuing shares of Sesen Bio common stock as contemplated by the Merger Agreement and the other matters to be acted upon by Sesen Bio stockholders at the Sesen Bio special meeting, Sesen Bio stockholders should be aware that certain members of the Sesen Bio board of directors and certain Sesen Bio executive officers have interests in the merger that may be different from, or in addition to, the interests of Sesen Bio stockholders, including, among others, severance benefits, the acceleration of equity vesting, continued indemnification and the potential ability to sell an increased number of shares of common stock of the combined company in accordance with Rule&#160;144 under the Securities Act. As of January 4, 2023, Sesen Bio&#8217;s directors, executive officers and affiliates of Sesen Bio&#8217;s directors and executive officers, owned, in the aggregate, less than 1% of the shares of Sesen Bio common stock, which for purposes of this subsection excludes any Sesen Bio common stock issuable upon exercise of Sesen Bio options or vesting of Sesen Bio RSUs held by such individual. As of January 4, 2023, Sesen Bio&#8217;s directors and current executive officers owned, in the aggregate, (i)&#160;unvested Sesen Bio options covering 3,499,202 shares of Sesen Bio common stock and vested Sesen Bio options covering 8,215,261 shares of Sesen Bio common stock and (ii)&#160;unvested Sesen Bio RSUs covering 3,559,892 shares of Sesen Bio common stock. Each of Sesen Bio&#8217;s executive officers and directors have </font>
            </div>

        </div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">18</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;margin-left:12pt;width:456pt;">
          <div style="width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">also entered into a support agreement in connection with the merger, whereby such executive officers and directors have agreed to vote their shares in favor of the proposals described in this proxy statement/</font>&#8203;<font style="letter-spacing:0.2pt;">prospectus. </font></div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Further, Thomas R. Cannell, D.V.M., Sesen Bio&#8217;s President and Chief Executive Officer and a member of the Sesen Bio board of directors, is expected to continue as a member of the combined company&#8217;s board of directors following the merger. The compensation arrangements with Sesen Bio&#8217;s directors and executive officers are discussed in greater detail in the sections entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Merger&#8201;&#8212;&#8201;Interests of Sesen Bio Directors and Executive Officers in the Merger</font><font style="letter-spacing:0.2pt;">&#8221; and &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Sesen Bio Executive Compensation</font><font style="letter-spacing:0.2pt;">&#8221; in this proxy statement/</font>&#8203;<font style="letter-spacing:0.2pt;">prospectus. </font></div>

            <div style="margin-top:12pt; width:456pt; line-height:12pt;">
              <font style="font-weight:bold;letter-spacing:-0.2pt;">Interests of Carisma Directors and Executive Officers in the Merger</font><font style="letter-spacing:0.2pt;"> (see page <a href="#tIOCD">153</a>) </font>
            </div>


            <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
              <font style="letter-spacing:0.2pt;">In considering the recommendation of the Carisma board of directors with respect to approving the merger and related transactions, Carisma stockholders should be aware that certain members of the Carisma board of directors and certain Carisma executive officers have interests in the merger that may be different from, or in addition to, the interests of Carisma stockholders. As of January 4, 2023, Carisma&#8217;s current directors and executive officers owned, in the aggregate, approximately 2.36% of the outstanding shares of Carisma capital stock, excluding, for this purpose any Carisma shares issuable upon exercise or settlement of Carisma stock options held by such individuals. Each of Carisma&#8217;s executive officers and the majority of Carisma&#8217;s directors have also entered into a support agreement in connection with the merger, whereby such executive officers and directors have agreed to vote their shares in favor of adoption of the Merger Agreement and approval of the merger. </font>
            </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Further, certain Carisma directors and executive officers are expected to become directors and executive officers of the combined company following the merger. The compensation arrangements with Carisma&#8217;s directors and executive officers are discussed in greater detail in the sections entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Merger&#8201;&#8212;&#8201;Interests of Carisma Directors and Executive Officers in the Merger</font><font style="letter-spacing:0.2pt;">&#8221; and &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Carisma Executive Compensation</font><font style="letter-spacing:0.2pt;">&#8221; in this proxy statement/prospectus. </font>
          </div>

            <div style="margin-top:12pt; width:456pt; line-height:12pt;">
              <font style="font-weight:bold;letter-spacing:-0.2pt;">Material U.S. Federal Income Tax Consequences of the Merger</font><font style="letter-spacing:0.2pt;"> (see page <a href="#tMUFI">160</a>) </font>
            </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Subject to the qualifications and limitations set forth in the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Merger&#8201;&#8212;&#8201;Material U.S. Federal Income Tax Consequences of the Merger</font><font style="letter-spacing:0.2pt;">,&#8221; in the opinion of WilmerHale and Hogan Lovells, the merger will qualify as a &#8220;reorganization&#8221; within the meaning of Section 368(a) of the Code, and a Carisma U.S. holder will not recognize gain or loss for U.S. federal income tax purposes upon the receipt of shares of Sesen Bio common stock in exchange for shares of Carisma capital stock in the merger, except to the extent such a Carisma U.S. holder receives cash in lieu of a fractional share of Sesen Bio common stock. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">If the merger does not qualify as a &#8220;reorganization&#8221; within the meaning of Section&#160;368(a) of the Code, then each Carisma U.S. holder would recognize gain or loss upon the exchange of shares of Carisma capital stock for Sesen Bio common stock in the merger equal to the difference between the fair market value of the shares of Sesen Bio common stock received in exchange for the shares of Carisma capital stock (plus any cash received in lieu of a fractional share) and such Carisma U.S. holder&#8217;s adjusted tax basis in the shares of Carisma capital stock surrendered. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Since the Sesen Bio stockholders will not sell, exchange or dispose of any shares of Sesen Bio common stock as a result of the merger, there will be no material U.S. federal income tax consequences to Sesen Bio stockholders as a result of the merger. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">See the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Merger&#8201;&#8212;&#8201;Material U.S. Federal Income Tax Consequences of the Merger</font><font style="letter-spacing:0.2pt;">&#8221; for a more complete description of the material U.S. federal income tax consequences of the merger to U.S. holders of Carisma capital stock. </font>
          </div>

            <div style="margin-top:12pt; width:456pt; line-height:12pt;">
              <font style="font-weight:bold;letter-spacing:-0.2pt;">Material U.S. Federal Income Tax Consequences of Receipt of CVRs</font><font style="letter-spacing:0.2pt;"> (see page <a href="#tARTT">192</a>) </font>
            </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">The U.S. federal income tax treatment of the Sesen Bio U.S. holders&#8217; receipt of the CVRs is unclear. Sesen Bio intends to report the issuance of the CVRs to Sesen Bio U.S. holders under the terms expressed in the form of the CVR Agreement included in </font><font style="font-style:italic;letter-spacing:0.2pt;">Annex F</font><font style="letter-spacing:0.2pt;"> to this proxy statement/prospectus as a distribution </font>
          </div>
        </div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">19</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;margin-left:12pt;width:456pt;">

            <div style="width:456pt; line-height:11.5pt;">
              <font style="letter-spacing:0.2pt;">of property with respect to Sesen Bio common stock. In such case, each Sesen Bio U.S. holder will be treated as receiving a distribution in an amount equal to the fair market value of the CVRs issued to such Sesen Bio U.S. holder on the date of the issuance. This distribution should be treated first as a taxable dividend to the extent of the Sesen Bio U.S. holder&#8217;s pro&#160;rata share of Sesen Bio&#8217;s current or accumulated earnings and profits (as determined for U.S. federal income tax purposes after taking into account the special cash dividend as described below), then as a non-taxable return of capital to the extent of the Sesen Bio U.S. holder&#8217;s basis in its Sesen Bio common stock, and finally as capital gain from the sale or exchange of Sesen Bio common stock with respect to any remaining value. Sesen Bio currently has negative accumulated earnings and profits and expects no or a small amount of current earnings and profits for the relevant taxable year. Thus, Sesen Bio expects most or all of this distribution to be treated as other than a dividend for U.S. federal income tax purposes. See the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Agreements Related to the Merger&#8201;&#8212;&#8201;CVR Agreement&#8201;&#8212;&#8201;Material U.S. Federal Income Tax Consequences of the Receipt of CVRs</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page&#160;<a href="#tARTT">192</a> of this proxy statement/prospectus for a more complete description of the material U.S. federal income tax consequences of the receipt of CVRs to Sesen Bio U.S. holders, including possible alternative treatments. </font>
            </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">The tax consequences to you of the receipt of CVRs will depend on your particular facts and circumstances. You should consult your tax advisors as to the specific tax consequences to you. </font>
          </div>

            <div style="margin-top:12pt; width:456pt; line-height:12pt;">
              <font style="font-weight:bold;letter-spacing:-0.2pt;">Material U.S. Federal Income Tax Consequences of Receipt of the Special Cash Dividend</font><font style="letter-spacing:0.2pt;"> (see page <a href="#tMUFI1">162</a>) </font>
            </div>


            <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
              <font style="letter-spacing:0.2pt;">In connection with the merger, the Sesen Bio board of directors will declare and pay a special cash dividend to Sesen Bio stockholders of record prior to the effective time consisting of Sesen Bio&#8217;s available cash in an aggregate amount expected to be approximately $70.0&#160;million, assuming Sesen Bio&#8217;s net cash as of closing of the merger is $75.0&#160;million. The U.S. federal income tax consequences of the Sesen Bio U.S. holders&#8217; receipt of such special cash dividend generally should be treated first as a taxable dividend to the extent of the Sesen Bio U.S. holder&#8217;s pro&#160;rata share of Sesen Bio&#8217;s current or accumulated earnings and profits (as determined for U.S. federal income tax purposes), then as a non-taxable return of capital to the extent of the Sesen Bio U.S. holder&#8217;s basis in its Sesen Bio common stock, and finally as capital gain from the sale or exchange of Sesen Bio common stock with respect to any remaining amount. Sesen Bio currently has negative accumulated earnings and profits and expects no or a small amount of current earnings and profits for the relevant taxable year. Thus, Sesen Bio expects most or all of the special cash dividend to be treated as other than a dividend for U.S. federal income tax purposes. </font>
            </div>


            <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
              <font style="letter-spacing:0.2pt;">See the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Merger&#8201;&#8212;&#8201;Material U.S. Federal Income Tax Consequences of the Special Cash Dividend</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tMUFI1">162</a> of this proxy statement/prospectus for a general description of the tax consequences of the special cash dividend that Sesen Bio will pay in connection with the consummation of the merger, subject to Sesen Bio having net cash as of the closing of the merger greater than or equal to $75.0&#160;million. </font>
            </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">The tax consequences to you of the special cash dividend will depend on your particular facts and circumstances. You should consult your tax advisors as to the specific tax consequences to you. </font>
          </div>

            <div style="margin-top:12pt; width:456pt; line-height:12pt;">
              <font style="font-weight:bold;letter-spacing:-0.2pt;">Material U.S. Federal Income Tax Consequences of the Reverse Stock Split</font><font style="letter-spacing:0.2pt;"> (see page <a href="#MUIT6">209</a>) </font>
            </div>


            <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
              <font style="letter-spacing:0.2pt;">Sesen Bio intends to report the proposed reverse stock split as a &#8220;recapitalization&#8221; within the meaning of Section&#160;368(a)(1)(E) of the Code. In general, and subject to the qualifications and limitations set forth in the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Proposal No. 2: Approval of an amendment to the Sesen Bio Certificate of Incorporation to effect the reverse stock split and reduce the number of authorized shares of Sesen Bio common stock&#160;&#8212; Material U.S. Federal Income Tax Consequences of the Reverse Stock Split</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#MUIT6">209</a> of this proxy statement/prospectus, if the proposed reverse stock split qualifies as a &#8220;recapitalization&#8221; within the meaning of Section&#160;368(a)(1)(E) of the Code, a Sesen Bio U.S. holder should not recognize gain or loss upon the proposed reverse stock split, except to the extent a Sesen Bio U.S. holder receives cash in lieu of a fractional share of Sesen Bio common stock. As discussed in more detail in the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Proposal No. 2: Approval of an amendment to the Sesen Bio Certificate of Incorporation to effect the reverse stock split and reduce the number of authorized shares of Sesen Bio common stock &#8201;&#8212;&#8201;Material U.S. Federal Income Tax Consequences of the Reverse Stock Split</font><font style="letter-spacing:0.2pt;">&#8221; on page <a href="#MUIT6">209</a> of this proxy statement/prospectus, these consequences assume that distribution of the CVRs and any cash distributed pursuant to a special cash </font>
            </div>

        </div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">20</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;margin-left:12pt;width:456pt;">

            <div style="width:456pt; line-height:11.5pt;">
              <font style="letter-spacing:0.2pt;">dividend will be treated for U.S. federal income tax purposes as separate and distinct from the proposed reverse stock split. See the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Proposal No. 2: Approval of an amendment to the Sesen Bio Certificate of Incorporation to effect the reverse stock split and reduce the number of authorized shares of Sesen Bio common stock&#8201;&#8212;&#8201;Material U.S. Federal Income Tax Consequences of the Reverse Stock Split</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#MUIT6">209</a> of this proxy statement/prospectus for a more complete description of the material U.S. federal income tax consequences of the proposed reverse stock split to Sesen Bio U.S. holders. </font>
            </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">The tax consequences to you of the proposed reverse stock split will depend on your particular facts and circumstances. You should consult your tax advisors as to the specific tax consequences to you. </font>
          </div>

            <div style="margin-top:12pt; width:456pt; line-height:12pt;">
              <font style="font-weight:bold;letter-spacing:-0.2pt;">Risk Factors</font><font style="letter-spacing:0.2pt;"> (see page <a href="#tRIFA">26</a>) </font>
            </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Both Sesen Bio and Carisma are subject to various risks associated with their businesses and their industries. In addition, the merger poses a number of risks to each company and its respective stockholders, including the possibility that the merger may not be completed and the following risks: </font>
          </div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Risks Related to the Merger</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">The exchange ratio will not change or otherwise be adjusted based on the market price of Sesen Bio common stock as the exchange ratio depends on the Sesen Bio net cash at the closing of the merger and not the market price of Sesen Bio common stock, so the merger consideration at the closing of the merger may have a greater or lesser value than at the time the Merger Agreement was signed. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">Sesen Bio stockholders and Carisma stockholders may not realize a benefit from the merger commensurate with the ownership dilution they will experience in connection with the merger and the Carisma pre-closing financing and the conversion of the Carisma convertible note. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">Failure to complete the merger may result in either Sesen Bio or Carisma paying a termination fee to the other party and could significantly harm the market price of Sesen Bio common stock and negatively affect the future business and operations of each company. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.11pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.11pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">The issuance of Sesen Bio common stock to Carisma stockholders pursuant to the Merger Agreement and the resulting change in control from the merger must be approved by Sesen Bio stockholders, and the Merger Agreement and transactions contemplated thereby must be approved by the Carisma stockholders. Failure to obtain these approvals would prevent the closing of the merger. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.11pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.11pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">Some Sesen Bio and Carisma executive officers and directors have interests in the merger that are different from the Sesen Bio stockholders and Carisma stockholders and that may influence them to support or approve the merger without regard to the interests of the Sesen Bio stockholders and Carisma stockholders. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.11pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.11pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">If the conditions to the merger are not satisfied or waived, the merger will not occur. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Risks Related to Sesen Bio</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">If the merger is not completed, the Sesen Bio board of directors may decide to pursue a liquidation and dissolution of Sesen Bio. In such an event, there can be no assurances as to the amount or timing of available cash left, if any, to distribute to Sesen Bio stockholders after paying its debts and other obligations and setting aside funds for reserves. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

            <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
            <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
              <font style="letter-spacing:0.2pt;">&#8226;</font>
              <br >
            </div>
            <div style=" margin-top:5.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
              <font style="letter-spacing:0.2pt;">Sesen Bio stockholders may not receive any payment on the CVRs from the proceeds related to either the Roche Asset Purchase Agreement or any sale of Sesen Bio&#8217;s non-cash assets and therefore the CVRs may expire valueless, result in lower returns than anticipated or none at all. </font>
            </div>
            <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">Sesen Bio is substantially dependent on its remaining employees to facilitate the consummation of the merger. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.11pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.11pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">Sesen Bio has incurred significant losses since its inception and anticipates that it will continue to incur losses for the foreseeable future if the merger is not completed. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">With the exception of specified regulatory, development and commercial milestones under the Roche Asset Purchase Agreement, Sesen Bio currently has no potential source of revenue and may never become profitable. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        </div>
        <div style="clear:both;font-size:0pt;">&#8203;</div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">21</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;margin-left:12pt;width:456pt;">
          <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">If the merger is not completed and Sesen Bio resumes clinical development of Vicineum, Sesen Bio will need substantial additional funding. If Sesen Bio is unable to raise capital when needed, Sesen Bio could be forced to delay, reduce or eliminate its product development programs or commercialization efforts. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">If Sesen Bio is unable to regain compliance with the listing requirements of the Nasdaq Capital Market, Sesen Bio common stock may be delisted from the Nasdaq Capital Market which could have a material adverse effect on Sesen Bio&#8217;s business and could make it more difficult for Sesen Bio stockholders to sell their shares of Sesen Bio common stock. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Risks Related to Carisma</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">Carisma has incurred significant losses since its inception. Carisma expects to continue to incur significant expenses and operating losses for the foreseeable future and may never achieve or maintain profitability. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">Carisma has never generated revenue from product sales and may never achieve or maintain profitability. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">Carisma is heavily dependent on the success of its lead product candidate, CT-0508, which will require significant clinical testing before it can seek marketing approval and potentially launch commercial sales. If CT-0508 does not receive marketing approval or is not successfully commercialized, or if there is significant delay in doing so, Carisma&#8217;s business will be harmed. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">Carisma will need substantial additional funding for its continuing operations. If Carisma is unable to raise capital when needed or on acceptable terms, it could be forced to delay, reduce or eliminate its discovery or product development programs or commercialization efforts. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">Cell therapy is a rapidly evolving area of science, and the approach Carisma is taking to discover and develop product candidates by utilizing genetically modified macrophages is novel and may never lead to approved or marketable products. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">Even if any of Carisma&#8217;s product candidates receives marketing approval, it may fail to achieve the degree of market acceptance by physicians, patients, third-party payors and others in the medical community necessary for commercial success, and the market opportunity for any of its product candidates, if approved, may be smaller than it estimates. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">Carisma relies, and expects to continue to rely, on third parties to conduct its clinical trials, and those third parties may not perform satisfactorily, including failing to meet deadlines for the completion of such trials, which may prevent or delay Carisma&#8217;s ability to seek or obtain marketing approval for or commercialize its product candidates or otherwise harm its business. If Carisma is not able to maintain these third-party relationships or if these arrangements are terminated, it may have to alter its development and commercialization plans and its business could be adversely affected. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">If Carisma is unable to obtain, maintain and enforce patent protection for its technology and product candidates or if the scope of the patent protection obtained is not sufficiently broad, its competitors could develop and commercialize technology and products similar or identical to Carisma&#8217;s, and its ability to successfully develop and commercialize its technology and product candidates may be adversely affected and Carisma may not be able to compete effectively in its market. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Risks Related to the Ownership of the Common Stock of the Combined Company</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.91pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.91pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">The market price of the combined company&#8217;s common stock is expected to be volatile, and the market price of the combined company&#8217;s common stock may drop following the merger. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">The combined company will incur additional costs and increased demands upon management as a result of complying with the laws and regulations affecting public companies. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">Once the combined company is no longer a &#8220;smaller reporting company&#8221; or otherwise no longer qualifies for applicable exemptions, the combined company will be subject to additional laws and regulations affecting public companies that will increase the combined company&#8217;s costs and the demands on management and could harm the combined company&#8217;s operating results. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        </div>
        <div style="clear:both;font-size:0pt;">&#8203;</div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">22</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;margin-left:12pt;width:456pt;">
          <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">Provisions that will be in the combined company&#8217;s certificate of incorporation and bylaws and provisions under Delaware law could make an acquisition of the combined company, which may be beneficial to its stockholders, more difficult and may prevent attempts by its stockholders to replace or remove its management. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">An active trading market for the combined company&#8217;s common stock may not develop and its stockholders may not be able to resell their shares of common stock for a profit, if at all. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11pt;">
            <font style="letter-spacing:0.2pt;">These risks and other risks are discussed in greater detail under the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Risk Factors</font><font style="letter-spacing:0.2pt;">&#8221; in this proxy statement/prospectus. Sesen Bio and Carisma both encourage you to read and consider all of these risks carefully. </font>
          </div>

            <div style="margin-top:12pt; width:456pt; line-height:12pt;">
              <font style="font-weight:bold;letter-spacing:-0.2pt;">Regulatory Approvals</font><font style="letter-spacing:0.2pt;"> (see page <a href="#tREAP">160</a>) </font>
            </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">In the U.S., Sesen Bio must comply with applicable federal and state securities laws and the rules and regulations of Nasdaq in connection with the issuance of shares of Sesen Bio common stock and the filing of this proxy statement/prospectus with the SEC. Sesen Bio does not intend to seek any regulatory approval from antitrust authorities to consummate the transactions. </font>
          </div>

            <div style="margin-top:12pt; width:456pt; line-height:12pt;">
              <font style="font-weight:bold;letter-spacing:-0.2pt;">Anticipated Accounting Treatment</font><font style="letter-spacing:0.2pt;"> (see page <a href="#tAAT">166</a>) </font>
            </div>


            <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
              <font style="letter-spacing:0.2pt;">The merger is expected to be accounted for as a reverse recapitalization under U.S. generally accepted accounting principles, or U.S. GAAP, because the primary assets of Sesen Bio are cash, cash equivalents and marketable securities. For financial reporting purposes, Carisma has been determined to be the accounting acquirer based upon the terms of the merger including: (i)&#160;Carisma stockholders and holders of securities convertible into Carisma common stock are expected to own approximately 66% of the combined company (based on estimates made at the time of signing the Original Merger Agreement), (ii)&#160;Carisma will hold the majority (six of seven) of board seats of the combined company and (iii)&#160;Carisma management will hold all key positions in the management of the combined company. Accordingly, the merger is expected to be treated as the equivalent of Carisma issuing stock to acquire the net assets of Sesen Bio. As a result of the merger, the net assets of Sesen Bio will be recorded at their acquisition-date fair value in the consolidated financial statements of Carisma and the reported operating results prior to the merger will be those of Carisma. See the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Unaudited Pro Forma Condensed Combined Financial Information</font><font style="letter-spacing:0.2pt;">&#8221; in this proxy statement/prospectus for additional information. </font>
            </div>


            <div style="margin-top:12pt; width:456pt; line-height:12pt;">
              <font style="font-weight:bold;letter-spacing:-0.2pt;">Appraisal Rights and Dissenters&#8217; Rights</font><font style="letter-spacing:0.2pt;"> (see page <a href="#tAAT">166</a>) </font>
            </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Holders of Sesen Bio common stock are not entitled to appraisal rights in connection with the merger under Delaware law. Holders of Carisma capital stock are entitled to appraisal rights in connection with the merger under Delaware law. For more information about such rights, see the provisions of Section&#160;262 of the DGCL attached as </font><font style="font-style:italic;letter-spacing:0.2pt;">Annex H</font><font style="letter-spacing:0.2pt;"> and the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Merger&#8201;&#8212;&#8201;Appraisal Rights and Dissenters&#8217; Rights</font><font style="letter-spacing:0.2pt;">&#8221; in this proxy statement/prospectus. </font>
          </div>

            <div style="margin-top:12pt; width:456pt; line-height:12pt;">
              <font style="font-weight:bold;letter-spacing:-0.2pt;">Comparison of Stockholder Rights</font><font style="letter-spacing:0.2pt;"> (see page <a href="#tCORO">386</a>) </font>
            </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Both Sesen Bio and Carisma are incorporated under the laws of the State of Delaware and, accordingly, the rights of the stockholders of each are currently, and will continue to be, governed by the DGCL. If the merger is completed, Carisma stockholders will become stockholders of Sesen Bio, and their rights will be governed by the DGCL, Sesen Bio&#8217;s amended and restated bylaws, or the Sesen Bio Bylaws, and the Sesen Bio Certificate of Incorporation, as may be further amended by Proposal No. 2 if approved by the Sesen Bio stockholders at the Sesen Bio special meeting. The rights of Sesen Bio stockholders contained in the Sesen Bio Certificate of Incorporation and Sesen Bio Bylaws differ from the rights of Carisma stockholders under the Carisma Certificate of Incorporation, and Carisma&#8217;s bylaws, or the Carisma Bylaws, as more fully described under the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Comparison of Rights of Holders of Sesen Bio Stock and Carisma Stock</font><font style="letter-spacing:0.2pt;">&#8221; in this proxy statement/prospectus. </font>
          </div>

            <div style="margin-top:12pt; width:456pt; line-height:12pt;">
              <font style="font-weight:bold;letter-spacing:-0.2pt;">Litigation Related to the Merger</font><font style="letter-spacing:0.2pt;"> (see page&#160;<a href="#tLRTM">169</a>)</font>
            </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Sesen Bio received two letters on October 21, 2022 and one letter on November 4, 2022 on behalf of purported stockholders demanding that Sesen Bio amend this proxy statement/prospectus to provide </font>
          </div>
        </div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">23</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;min-height:660pt;margin-left:12pt;width:456pt;">

            <div style="width:456pt; line-height:12pt;">
              <font style="letter-spacing:0.2pt;">additional disclosures that such stockholders allege were improperly omitted from this proxy statement/</font>&#8203;<font style="letter-spacing:0.2pt;">prospectus, including information regarding the financial projections with respect to Carisma, the financial analyses performed by SVB Securities in support of its fairness opinion, and the background and process leading to the execution of the Merger Agreement. In addition, Sesen Bio received a books and records demand, dated November 18, 2022, on behalf of a purported stockholder of Sesen Bio, seeking access to certain relevant books and records of Sesen Bio, pursuant to Section 220 of the DGCL, in connection with the merger and the securities and derivative litigations arising out of the CRL that Sesen Bio received from the FDA. Further, on November 28, 2022, a purported Sesen Bio stockholder filed a complaint in the U.S. District Court for the Southern District of New York against Sesen Bio and the Sesen Bio board of directors, captioned </font><font style="font-style:italic;letter-spacing:0.2pt;">Keller v. Sesen Bio, Inc., et al.</font><font style="letter-spacing:0.2pt;">, Case No. 1:22-cv-10085 (S.D.N.Y.). Subsequently, on December 20, 2022, the purported stockholder voluntarily dismissed the complaint and on December 21, 2022, filed a new complaint as a putative class action in the Court of Chancery for the State of Delaware, captioned </font><font style="font-style:italic;letter-spacing:0.2pt;">Keller v. Sesen Bio, Inc., et al.</font><font style="letter-spacing:0.2pt;">, Case No. 2022-1186 (Del. Ch. Dec. 21, 2022). The demand letters assert claims against Sesen Bio and the Sesen Bio board of directors under Section 14(a) of the Exchange Act and Rule 14a-9 promulgated thereunder for allegedly false and misleading statements in this proxy statement/</font>&#8203;<font style="letter-spacing:0.2pt;">prospectus and under Section 20(a) of the Exchange Act for alleged &#8220;control person&#8221; liability with respect to such allegedly false and misleading statements. The putative class action asserts claims against Sesen Bio and the Sesen Bio board of directors for breach of fiduciary duty based on the same allegedly false and misleading statements. Sesen Bio believes that the allegations in these stockholder demands and the complaint are without merit. At this time, no assessment can be made as to the likely outcomes or whether the outcomes will be material to Sesen Bio. See the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Merger Agreement &#8212; Litigation Relating to the Merger</font><font style="letter-spacing:0.2pt;">&#8221; in this proxy statement/prospectus for additional information.</font></div>

        </div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">24</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tMPAD">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:212pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">MARKET PRICE AND DIVIDEND INFORMATION</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Sesen Bio common stock is listed on the Nasdaq Capital Market under the symbol &#8220;SESN.&#8221; Carisma is a private company and shares of Carisma common stock are not publicly traded. The closing price of Sesen Bio common stock on September&#160;20, 2022, the last trading day prior to the public announcement of the merger, was $0.6692 per share, and the closing price of Sesen Bio common stock on January 6, 2023, the last practicable trading day prior to the date of this proxy statement/prospectus, was $0.6316 per share, each as reported on the Nasdaq Capital Market. Because the market price of Sesen Bio common stock is subject to fluctuation, the market value of the shares of Sesen Bio common stock that Carisma stockholders will be entitled to receive in the merger may increase or decrease. </font>
          </div>

        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Assuming stockholder approval of Proposal Nos. 1 and 2 and successful application for initial listing on the Nasdaq Capital Market, following the consummation of the merger, the Sesen Bio common stock will trade on the Nasdaq Capital Market under the new name, &#8220;Carisma Therapeutics Inc.,&#8221; and new trading symbol &#8220;CARM.&#8221; </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">As of&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199; &#8199;&#8199;, 2023, the record date for the Sesen Bio special meeting, there were approximately&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199; &#8199;&#8199;holders of record of Sesen Bio common stock. As of&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199; &#8199;&#8199;, 2023, there were &#8199;&#8199;&#8199;&#8199;&#8199; holders of record of Carisma capital stock. This number does not include stockholders for whom shares were held in &#8220;street name.&#8221; For detailed information regarding the beneficial ownership of certain Sesen Bio stockholders upon consummation of the merger, see the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Principal Stockholders of the Combined Company</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tPSOT">400</a> of this proxy statement/prospectus. </font>
          </div>

        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Dividends</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Sesen Bio has never declared or paid any cash dividends on the Sesen Bio common stock and does not anticipate paying cash dividends on the Sesen Bio common stock for the foreseeable future, other than the special cash dividend that Sesen Bio will pay to Sesen Bio stockholders in connection with the consummation of the merger, subject to Sesen Bio having net cash as of the closing of the merger greater than or equal to $75.0 million. Carisma has never declared or paid any cash dividends on the Carisma common stock and does not anticipate paying cash dividends on the Carisma common stock for the foreseeable future. Notwithstanding the foregoing, any determination to pay cash dividends subsequent to the merger will be at the discretion of the combined company&#8217;s then-current board of directors and will depend upon a number of factors, including the combined company&#8217;s results of operations, financial condition, future prospects, contractual restrictions, restrictions imposed by applicable law and other factors the then-current board of directors deems relevant. </font>
          </div>

      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">25</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tRIFA">&#8203;</a><a name="tRRTT">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">RISK FACTORS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-style:italic;">
            <font style="letter-spacing:0.2pt;">The combined company will be faced with a market environment that cannot be predicted and that involves significant risks, many of which will be beyond its control. In addition to the other information contained in this proxy statement/prospectus, you should carefully consider the material risks described below and those described in the section entitled &#8220;Cautionary Statement Concerning Forward-Looking Statements&#8221; beginning on page <a href="#tCSCF">118</a> of this proxy statement/prospectus before deciding how to vote your shares of Sesen Bio common stock.</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
          </div>

        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Risks Related to the Merger</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The exchange ratio will not change or otherwise be adjusted based on the market price of Sesen Bio common stock as the exchange ratio depends on the Sesen Bio net cash at the closing of the merger and not the market price of Sesen Bio common stock, so the merger consideration at the closing of the merger may have a greater or lesser value than at the time the Merger Agreement was signed.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">The Merger Agreement has set the calculation of the exchange ratio for the Carisma capital stock, and the exchange ratio is based on the fully-diluted capitalization of Carisma and Sesen Bio, in each case immediately prior to the closing of the merger (after giving effect to the Carisma pre-closing financing) as described in the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Merger Agreement&#8201;&#8212;&#8201;Exchange Ratio</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tTMAER">172</a> of this proxy statement/prospectus. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">The closing price of Sesen Bio common stock on September 20, 2022, the last trading day prior to the public announcement of the merger, was $0.6692 per share. The Merger Agreement does not include a price-based termination right. Therefore, if before the completion of the merger the market price of Sesen Bio common stock declines from the market price on the date of the Original Merger Agreement, then Carisma stockholders could receive merger consideration with substantially lower value than the value of such merger consideration on the date of the Original Merger Agreement. Similarly, if before the completion of the merger the market price of Sesen Bio common stock increases from the market price of Sesen Bio common stock on the date of the Original Merger Agreement, then Carisma stockholders could receive merger consideration with substantially greater value than the value of such merger consideration on the date of the Original Merger Agreement. Because the exchange ratio does not adjust as a direct result of changes in the market price of Sesen Bio common stock, changes in the market price of Sesen Bio common stock will change the value of the total merger consideration payable to Carisma stockholders pursuant to the Original Merger Agreement. </font>
          </div>

        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Stock price changes may result from a variety of factors, including changes in Sesen Bio&#8217;s or Carisma&#8217;s respective businesses, operations and prospects, reductions or changes in U.S. government spending or budgetary policies, market assessments of the likelihood that the merger will be completed, interest rates, federal, state and local legislation, governmental regulation, legal developments in the industry segments in which Sesen Bio or Carisma operate, the timing of the merger, and general market, industry and economic conditions, including pandemics and other public health emergencies. Recent events surrounding the global economy, geopolitics and the COVID-19 pandemic continue to evolve and have introduced unusually high levels of volatility into financial and stock markets, and may affect the value of Sesen Bio common stock. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Sesen Bio stockholders and Carisma stockholders may not realize a benefit from the merger commensurate with the ownership dilution they will experience in connection with the merger and the Carisma pre-closing financing and the conversion of the Carisma convertible note.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If the combined company is unable to realize the full strategic and financial benefits currently anticipated from the merger, Sesen Bio stockholders and Carisma stockholders will have experienced substantial dilution of their ownership interests in their respective companies, including as a result of the Carisma pre-closing financing and the conversion of Carisma&#8217;s $35.0&#160;million outstanding convertible note, without receiving any commensurate benefit, or only receiving part of the commensurate benefit to the extent the combined company is able to realize only part of the strategic and financial benefits currently anticipated from the merger and the Carisma pre-closing financing. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">26</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Failure to complete the merger may result in either Sesen Bio or Carisma paying a termination fee to the other party and could significantly harm the market price of Sesen Bio common stock and negatively affect the future business and operations of each company.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If the merger is not completed and the Merger Agreement is terminated under certain circumstances, Sesen Bio may be required to pay Carisma a termination fee of $7.6&#160;million and/or reimburse Carisma&#8217;s expenses up to a maximum of $1.75&#160;million, and Carisma may be required to pay Sesen Bio a termination fee of $5.49&#160;million and/or reimburse Sesen Bio&#8217;s expenses up to a maximum of $1.75&#160;million. Even if a termination fee or reimbursement of expenses of the other party are not payable in connection with a termination of the Merger Agreement, each of Sesen Bio and Carisma will have incurred significant fees and expenses, which must be paid whether or not the merger is completed. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, if the Merger Agreement is terminated and the Sesen Bio board of directors or Carisma board of directors determines to seek another business combination, there can be no assurance that either Sesen Bio or Carisma will be able to find a partner and close an alternative transaction on terms that are as favorable or more favorable than the terms set forth in the Merger Agreement. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The issuance of Sesen Bio common stock to Carisma stockholders pursuant to the Merger Agreement and the resulting change in control from the merger must be approved by Sesen Bio stockholders, and the Merger Agreement and transactions contemplated thereby must be approved by the Carisma stockholders. Failure to obtain these approvals would prevent the closing of the merger.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Before the merger can be completed, the Sesen Bio stockholders must approve, among other things, the issuance of Sesen Bio common stock to Carisma stockholders pursuant to the Merger Agreement and the resulting change in control from the merger, and Carisma stockholders must adopt the Merger Agreement and approve the merger and the related transactions. Failure to obtain the required stockholder approvals may result in a material delay in, or the abandonment of, the merger. Any delay in completing the merger may materially adversely affect the timing and benefits that are expected to be achieved from the merger. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The merger may be completed even though certain events occur prior to the closing of the merger that materially and adversely affect Sesen Bio or Carisma.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">The Merger Agreement provides that either Sesen Bio or Carisma can refuse to complete the merger if there is a material adverse change affecting the other party between September&#160;20, 2022, the date of the Original Merger Agreement, and the closing of the merger. However, certain types of changes do not permit either party to refuse to complete the merger, even if such change could be said to have a material adverse effect on Sesen Bio or Carisma, including: </font>
          </div>

        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">general business, economic or political conditions or conditions generally affecting the industries in which Sesen Bio or Carisma, as applicable, operates; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">any natural disaster, epidemic, pandemic (including COVID-19), certain COVID-19 measures or responses, any acts of war, armed hostilities or terrorism; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">with respect to Sesen Bio, any change in the trading price or trading volume of Sesen Bio common stock, excluding any underlying effect that may have caused such change, unless such effect is otherwise exempt from causing a material adverse effect under the Merger Agreement; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">any change in, or any compliance with or action taken for the purpose of complying with, applicable laws or U.S. GAAP, or interpretations thereof; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">with respect to any product or product candidate of Sesen Bio or its subsidiaries or Carisma or its subsidiaries, as applicable, the request of the FDA to refile, amend, or temporarily delay making any regulatory application or filing related to such product or product candidate or the protocol for any clinical trial relating to such product or product candidate, unless in the event of repeated or continued adverse decisions with respect to the applicable party&#8217;s product or product candidates by the FDA; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the taking of any action or failure to take action by Sesen Bio or Carisma, as applicable, expressly required to comply with the terms of the Merger Agreement. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">27</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If adverse changes occur and Sesen Bio and Carisma still complete the merger, the market price of the combined company&#8217;s common stock may suffer. This in turn may reduce the value of the merger to the Sesen Bio stockholders, Carisma stockholders or both. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Some Sesen Bio and Carisma executive officers and directors have interests in the merger that are different from the Sesen Bio stockholders and Carisma stockholders and that may influence them to support or approve the merger without regard to the interests of the Sesen Bio stockholders and Carisma stockholders.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Certain executive officers and directors of Sesen Bio and Carisma participate in arrangements that provide them with interests in the merger that are different from the interests of the Sesen Bio stockholders and Carisma stockholders, including, among others, severance benefits, the acceleration of equity vesting, continued indemnification and the potential ability to sell an increased number of shares of common stock of the combined company in accordance with Rule&#160;144 under the Securities Act. Further, Thomas R. Cannell, D.V.M., Sesen Bio&#8217;s President and Chief Executive Officer and a current member of the Sesen Bio board of directors, is expected to continue as a member of the combined company&#8217;s board of directors following the merger. The compensation arrangements with Sesen Bio&#8217;s executive officers and directors are discussed in greater detail in the sections entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Merger&#8201;&#8212;&#8201;Interests of Sesen Bio Directors and Executive Officers in the Merger</font><font style="letter-spacing:0.2pt;">&#8221; and &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Sesen Bio Executive Compensation&#8201;&#8212;&#8201;Director Compensation</font><font style="letter-spacing:0.2pt;">&#8221; beginning on pages&#160;<a href="#tIOSB">148</a> and <a href="#tSBEC">349</a>, respectively, of this proxy statement/prospectus. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">These interests, among others, may influence the executive officers and directors of Sesen Bio and Carisma to support or approve the merger. For more information concerning the interests of Sesen Bio&#8217;s and Carisma&#8217;s respective executive officers and directors, see the sections entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Merger&#8201;&#8212;&#8201;Interests of Sesen Bio Directors and Executive Officers in the Merger&#8221;</font><font style="letter-spacing:0.2pt;"> and &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Merger&#8201;&#8212;&#8201;Interests of Carisma Directors and Executive Officers in the Merger</font><font style="letter-spacing:0.2pt;">&#8221; beginning on pages <a href="#tIOSB">148</a> and <a href="#tIOCD">153</a>, respectively, of this proxy statement/</font>&#8203;<font style="letter-spacing:0.2pt;">prospectus. </font></div>

        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The market price of the combined company&#8217;s common stock following the merger may decline as a result of the merger.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The market price of the combined company&#8217;s common stock may decline as a result of the merger for a number of reasons, including if: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.51pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.51pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">investors react negatively to the prospects of the combined company&#8217;s product candidates, business and financial condition following the merger; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.51pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:4.51pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the effect of the merger on the combined company&#8217;s business and prospects is not consistent with the expectations of financial or industry analysts; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.51pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:4.51pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the combined company does not achieve the perceived benefits of the merger as rapidly or to the extent anticipated by financial or industry analysts. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:11.02pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Sesen Bio stockholders and Carisma stockholders will have a reduced ownership and voting interest in, and will exercise less influence over the management of, the combined company following the closing of the merger as compared to their current ownership and voting interest in the respective companies.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">If the merger is completed, the current Sesen Bio stockholders and Carisma stockholders will own a smaller&#160;percentage of the combined company than their ownership in their respective companies prior to the merger. Immediately after the merger, pre-merger Sesen Bio stockholders are expected to own approximately 25.2% of the outstanding shares of capital stock of the combined company and pre-merger Carisma stockholders, after taking into account shares of Carisma common stock purchased in connection with the Carisma pre-closing financing and the conversion of Carisma&#8217;s $35.0&#160;million outstanding convertible note, are expected to own approximately 74.8% of the outstanding shares of capital stock of the combined company, subject to certain assumptions, including Sesen Bio&#8217;s net cash as of closing being $75.0 million. </font>
          </div>

        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Raising additional capital may cause dilution to the combined company&#8217;s stockholders, restrict its operations or require it to relinquish rights to its technologies or product candidates.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Until such time, if ever, as the combined company, operating as Carisma, can generate substantial revenues from product sales, Carisma expects to finance its cash needs through a combination of public and </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">28</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">private equity offerings, debt financings, collaborations, strategic alliances and marketing, distribution or licensing arrangements. Although Carisma may receive future payments under its collaboration with Moderna&#160;Inc., or Moderna, Carisma does not currently have any other committed external source of funds. The terms of any financing may adversely affect the holdings or the rights of the combined company&#8217;s stockholders and the issuance of additional securities, whether equity or debt, by the combined company, or the possibility of such issuance, may cause the market price of the combined company&#8217;s shares of common stock to decline. To the extent that the combined company raises additional capital through the sale of equity or convertible debt securities, the ownership interest of the combined company&#8217;s stockholders will be diluted, and the terms of those securities may include liquidation or other preferences that adversely affect the rights of such stockholders. Debt financing and preferred equity financing, if available, would increase the combined company&#8217;s fixed payment obligations and may involve agreements that include covenants limiting or restricting the combined company&#8217;s operations and ability to take specific actions, such as incurring additional debt, making acquisitions, engaging in acquisition, merger or collaboration transactions, selling or licensing the combined company&#8217;s assets, making capital expenditures, redeeming its stock, making certain investments, declaring dividends or other operating restrictions that could adversely impact the combined company&#8217;s ability to conduct its business. The combined company could also be required to meet certain milestones in connection with debt financing and the failure to achieve such milestones by certain dates may force the combined company to relinquish rights to some of its technologies or product candidates or otherwise agree to terms unfavorable to the combined company which could have a material adverse effect on the combined company&#8217;s business, operating results and prospects. The combined company also could be required to seek funds through arrangements with collaborators or otherwise at an earlier stage than otherwise would be desirable. If the combined company raises funds through additional collaborations, strategic alliances or marketing, distribution or licensing arrangements with third parties, the combined company may have to relinquish valuable rights to its intellectual property, future revenue streams, discovery programs or product candidates, grant licenses on terms that may not be favorable to the combined company or grant rights to develop and market product candidates that the combined company would otherwise prefer to develop and market itself, any of which may have a material adverse effect on the combined company&#8217;s business, operating results and prospects. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">During the pendency of the merger, Sesen Bio and Carisma may not be able to enter into a business combination with another party on more favorable terms because of restrictions in the Merger Agreement, which could adversely affect their respective business prospects.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Covenants in the Merger Agreement impede the ability of Sesen Bio and Carisma to make acquisitions during the pendency of the merger, subject to specified exceptions. As a result, if the merger is not completed, the parties may be at a disadvantage to their competitors during such period. In addition, while the Merger Agreement is in effect, each party is generally prohibited from soliciting, initiating or knowingly encouraging, inducing or facilitating any inquiries, indications of interest, proposals or offers that constitute or may reasonably be expected to lead to certain transactions involving a third party, including a merger, sale of assets or other business combination, subject to specified exceptions. Any such transactions could be favorable to such party&#8217;s stockholders, but the parties may be unable to pursue them. For more information, see the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Merger Agreement&#8201;&#8212;&#8201;No Solicitation</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tNSON">179</a> of this proxy statement/prospectus. </font>
          </div>

        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Certain provisions of the Merger Agreement may discourage third parties from submitting alternative takeover proposals, including proposals that may be superior to the transactions contemplated by the Merger Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The terms of the Merger Agreement prohibit each of Sesen Bio and Carisma from soliciting alternative takeover proposals or cooperating with persons making unsolicited takeover proposals, except in limited circumstances when the Sesen Bio board of directors or the Carisma board of directors, as applicable, determines in good faith that an unsolicited alternative takeover proposal is or is reasonably likely to result in a superior takeover proposal and that failure to cooperate with the proponent of the proposal is reasonably likely to be inconsistent with the applicable board&#8217;s fiduciary duties. Any such transactions could be favorable to Sesen Bio stockholders or Carisma stockholders, as applicable. In addition, if Sesen Bio terminates the Merger Agreement under certain circumstances, including terminating because of a decision of Sesen Bio to enter into a definitive agreement with respect to a superior offer, Sesen Bio would be required to pay a termination fee of $7.6&#160;million to Carisma and/or reimburse Carisma&#8217;s expenses up to a </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">29</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">maximum of $1.75&#160;million. This termination fee described above may discourage third parties from submitting alternative takeover proposals to Sesen Bio stockholders, and may cause the Sesen Bio board of directors to be less inclined to recommend an alternative takeover proposal. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Because the lack of a public market for Carisma common stock makes it difficult to evaluate the value of Carisma common stock, the Carisma stockholders may receive shares of Sesen Bio common stock in the merger that have a value that is less than, or greater than, the fair market value of Carisma common stock.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The outstanding common stock of Carisma is privately held and is not traded in any public market. The lack of a public market makes it extremely difficult to determine the fair market value of Carisma. Because the&#160;percentage of Sesen Bio common stock to be issued to Carisma stockholders was determined based on negotiations between the parties, it is possible the value of Sesen Bio common stock to be received by Carisma stockholders will be less than the fair market value of Carisma, or the value of Sesen Bio&#8217;s common stock to be received by Carisma stockholders may be more than the aggregate fair market value for Carisma. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If the conditions to the merger are not satisfied or waived, the merger will not occur.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Even if the transactions contemplated by the Merger Agreement are approved by Sesen Bio stockholders and Carisma stockholders, certain other specified conditions set forth in the Merger Agreement must be satisfied, to the extent permitted by applicable law, or waived to complete the merger, including approval from Nasdaq to maintain the listing of the Sesen Bio common stock on the Nasdaq Capital Market following the merger and the listing of the shares of Sesen Bio common stock being issued in the merger and the conversion of the Carisma convertible note. These conditions are set forth in the Merger Agreement and each material condition to the completion of the merger is described in the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Merger Agreement&#8201;&#8212;&#8201;Conditions to the Completion of the Merger</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tCCM5">176</a> of this proxy statement/</font>&#8203;<font style="letter-spacing:0.2pt;">prospectus. Sesen Bio and Carisma cannot assure you that all of the conditions will be satisfied or waived. If the conditions are not satisfied or waived, the merger will not occur or will be delayed, and Sesen Bio and Carisma each may lose some or all of the intended benefits of the merger. </font></div>

        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The merger may fail to qualify as a &#8220;reorganization&#8221; for U.S. federal income tax purposes, resulting in recognition of taxable gain or loss by Carisma stockholders in respect of their Carisma capital stock.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Sesen Bio and Carisma intend for the merger to qualify as a &#8220;reorganization&#8221; within the meaning of Section&#160;368(a) of the Code, as described in the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Merger&#8201;&#8212;&#8201;Material U.S. Federal Income Tax Consequences of the Merger</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tMUFI">160</a> of this proxy statement/prospectus. In the event that the merger does not qualify as a &#8220;reorganization,&#8221; the merger would result in taxable gain or loss for each Carisma stockholder, with the amount of such gain or loss determined by the amount that each Carisma stockholder&#8217;s adjusted tax basis in the Carisma capital stock surrendered is less or more than the fair market value of the Sesen Bio common stock and any cash in lieu of a fractional share received in exchange therefor. Each Carisma stockholder is urged to consult with his, her or its own tax advisor with respect to the tax consequences of the merger. </font>
          </div>

        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Future sales of shares by existing stockholders could cause the combined company&#8217;s stock price to decline.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">If existing Sesen Bio stockholders and Carisma stockholders sell, or indicate an intention to sell, substantial amounts of the combined company&#8217;s common stock in the public market after the merger, the trading price of the common stock of the combined company could decline. Based on shares outstanding as of December 29, 2022, the date the Merger Agreement Amendment was executed, and taking into account the consummation of the Carisma pre-closing financing, the conversion of Carisma&#8217;s $35.0 million outstanding convertible note and an assumed exchange ratio of 37.7924, the combined company is expected to have outstanding a total of approximately 883,803,409 shares of common stock (prior to giving effect to the proposed reverse stock split) immediately following the completion of the merger. Not all shares of Sesen Bio common stock will be freely tradable, without restriction, in the public market. For example, an aggregate of 265,069,468 shares of the combined company&#8217;s common stock will be subject to the lock-up agreements required under the Merger Agreement as of the closing of the merger. </font>
          </div>

      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">30</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tRRTT1">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The historical unaudited pro&#160;forma condensed combined financial information may not be representative of the combined company&#8217;s results after the merger.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The historical unaudited pro&#160;forma condensed combined financial information included elsewhere in this proxy statement/prospectus has been presented for informational purposes only and is not necessarily indicative of the financial position or results of operations that actually would have occurred had the merger been completed as of the date indicated, nor is it indicative of future operating results or financial position. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Lawsuits have been filed, and additional lawsuits may be filed in the future, against Sesen Bio, the members of the Sesen Bio board of directors, Carisma and/or the members of the Carisma board of directors arising out of the merger, which may delay or prevent the merger.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Additional putative stockholder complaints, including stockholder class action complaints, and other complaints may be filed against Sesen Bio, the Sesen Bio board of directors, Carisma, and/or the Carisma board of directors in connection with the transactions contemplated by the Merger Agreement. For example, in December 2022, a complaint was filed in the Court of Chancery for the State of Delaware against Sesen Bio and the members of its board of directors. The outcome of litigation is uncertain, and Sesen Bio and Carisma may not be successful in defending against any such future claims. Lawsuits that may be filed against Sesen Bio, the Sesen Bio board of directors, Carisma, and/or the Carisma board of directors could delay or prevent the merger, divert the attention of the management teams and employees of Sesen Bio and Carisma from day-to-day business and otherwise adversely affect the business and financial condition of Sesen Bio, Carisma or the combined company. </font>
          </div>

        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Risks Related to the Proposed Reverse Stock Split</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The proposed reverse stock split may not increase the combined company&#8217;s stock price over the long-term.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">One of the purposes of the proposed reverse stock split is to increase the per-share market price of the Sesen Bio common stock. It cannot be assured, however, that the proposed reverse stock split will accomplish this objective for any meaningful period of time. While it is expected that the reduction in the number of outstanding shares of Sesen Bio common stock will proportionally increase the per-share market price of Sesen Bio common stock, it cannot be assured that the proposed reverse stock split will increase the per-share market price of Sesen Bio common stock by a multiple of the proposed reverse stock split ratio, or result in any permanent or sustained increase in the per-share market price of Sesen Bio common stock, which is dependent upon many factors, including the combined company&#8217;s business and financial performance, general market conditions and prospects for future success. Thus, while the stock price of the combined company might meet the continued listing requirements for the Nasdaq Capital Market initially, it cannot be assured that it will continue to do so. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The proposed reverse stock split may decrease the liquidity of the combined company&#8217;s common stock.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Although the Sesen Bio board of directors believes that the anticipated increase in the per-share market price of the combined company&#8217;s common stock as a result of the proposed reverse stock split could encourage interest in the combined company&#8217;s common stock and possibly promote greater liquidity for stockholders of the combined company, such liquidity could also be adversely affected by the reduced number of shares outstanding after the proposed reverse stock split. The reduction in the number of outstanding shares may lead to reduced trading and a smaller number of market makers for the combined company&#8217;s common stock. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Should the market price of the combined company&#8217;s common stock decline after the proposed reverse stock split, the&#160;percentage decline may be greater, due to the smaller number of shares outstanding, than it would have been prior to the proposed reverse stock split. The proposed reverse stock split may be viewed negatively by the market and, consequently, may lead to a decrease in the combined company&#8217;s overall market capitalization. If the per-share market price does not increase in proportion to the exact ratio of the proposed reverse stock split, then the value of the combined company, as measured by its stock capitalization, will be reduced. In some cases, the per-share market price of companies that have effected reverse stock splits subsequently declined back to pre-reverse split levels, and accordingly, it cannot be assured that the total market value of the combined company&#8217;s common stock will remain the same after the </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">31</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tRRTS">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">proposed reverse stock split is effected, or that the proposed reverse stock split will not have an adverse effect on the price of the combined company&#8217;s common stock due to the reduced number of outstanding shares after the proposed reverse stock split. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Risks Related to Sesen Bio</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If the merger is not completed, the Sesen Bio board of directors may decide to pursue a liquidation and dissolution of Sesen Bio. In such an event, there can be no assurances as to the amount or timing of available cash left, if any, to distribute to Sesen Bio stockholders after paying its debts and other obligations and setting aside funds for reserves.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">While Sesen Bio has entered into the Merger Agreement with Carisma, the closing of the merger may be delayed or may not occur at all and there can be no assurance that the merger will deliver the anticipated benefits Sesen Bio expects or enhance stockholder value. If the merger is not completed and the Merger Agreement is terminated under certain circumstances, Sesen Bio may be required to pay Carisma a termination fee of $7.6&#160;million and/or reimburse Carisma&#8217;s expenses up to a maximum of $1.75&#160;million. Even if a termination fee is not payable in connection with a termination of the Merger Agreement, Sesen Bio will have incurred significant fees and expenses, which must be paid whether or not the merger is completed. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If, for any reason, the merger does not close, the Sesen Bio board of directors may elect to, among other things, attempt to complete another strategic transaction like the merger, attempt to sell or otherwise dispose of the various assets of Sesen Bio, resume its research and development activities and continue to operate the business of Sesen Bio. Any of these alternatives would be costly and time-consuming and would require that Sesen Bio obtain additional funding. Sesen Bio expects that it would be difficult to secure financing in a timely manner, on favorable terms or at all. Sesen Bio can make no assurances that it would be able to obtain additional financing or find a partner and close an alternative transaction on terms that are as favorable or more favorable than the terms set forth in the Merger Agreement or that any such alternatives are possible or would be successful, if pursued. To the extent that Sesen Bio seeks and is able to raise additional capital through the sale of equity or convertible debt securities, Sesen Bio stockholders&#8217; ownership interest will be diluted, and the terms of these securities may include liquidation or other preferences that adversely affect their rights as a common stockholder. Debt financing or preferred equity financing, if available, may involve agreements that include covenants limiting or restricting Sesen Bio&#8217;s ability to take specific actions, such as incurring additional debt, making capital expenditures or declaring dividends. If Sesen Bio raises funds through strategic transactions or marketing, distribution, or licensing arrangements with third parties, Sesen Bio may have to relinquish valuable rights to its technologies, future revenue streams, research programs or product candidates or to grant licenses on terms that may not be favorable to it. Even if Sesen Bio is able to pursue such alternatives, the failure to complete the merger may result in negative publicity and/or a negative impression of Sesen Bio in the investment community, could significantly harm the market price of Sesen Bio common stock and may affect Sesen Bio&#8217;s relationship with employees and other partners in the business community. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If the merger is not completed, the Sesen Bio board of directors may decide that it is in the best interests of the Sesen Bio stockholders to dissolve the company and liquidate its assets. In that event, the amount of cash available for distribution to the Sesen Bio stockholders would depend heavily on the timing of such decision and, ultimately, such liquidation since the amount of cash available for distribution continues to decrease as Sesen Bio funds its operations and incurs fees and expenses related to the merger. In addition, if the Sesen Bio board of directors were to approve and recommend, and the Sesen Bio stockholders were to approve, a dissolution of Sesen Bio, it would be required under the DGCL to pay its outstanding obligations, as well as to make reasonable provision for contingent and unknown obligations, prior to making any distributions in liquidation to the Sesen Bio stockholders. As a result of this requirement, a portion of Sesen Bio&#8217;s assets may need to be reserved pending the resolution of such obligations. In addition, Sesen Bio may be subject to litigation or other claims related to a liquidation and dissolution of the company. If a liquidation and dissolution were pursued, the Sesen Bio board of directors, in consultation with its advisors, would need to evaluate these matters and make a determination about a reasonable amount to reserve. Accordingly, the Sesen Bio stockholders could lose all or a significant portion of their investment in the event of a liquidation and dissolution of Sesen Bio. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">32</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">

          <div style="width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Sesen Bio stockholders may not receive any payment on the CVRs from the proceeds related to either the Roche Asset Purchase Agreement or any sale of Sesen Bio&#8217;s non-cash assets and therefore the CVRs may expire valueless, result in lower returns than anticipated or none at all.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">The right of Sesen Bio stockholders to receive future payment on the CVRs from the proceeds related to the Roche Asset Purchase Agreement will be contingent upon the occurrence of a certain triggering event, entitling CVR holders to a pro rata portion of the $30.0 million milestone payment to be made by Roche to Sesen Bio upon Roche&#8217;s initiation of a Phase 3 clinical trial with legacy IL-6 antagonist antibody technology previously owned by Sesen Bio for a certain indication if initiated prior to December 31, 2026, pursuant to the Roche Asset Purchase Agreement, less certain permitted deductions. Sesen Bio may not receive any future payment pursuant to the Roche Asset Purchase Agreement after the closing of the merger. If this milestone is not achieved for any reason within the time period specified in the CVR Agreement or the consideration received is not greater than the amounts permitted to be retained or deducted by Sesen Bio, no payments will be made under the CVRs from the proceeds related to the Roche Asset Purchase Agreement, resulting in a lower return for Sesen Bio stockholders with respect to the CVRs. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">The right of Sesen Bio stockholders to receive future payment on the CVRs from the proceeds from any sale of Sesen Bio&#8217;s non-cash assets (net of customary deductions) existing as of the date of the Original Merger Agreement is dependent on Sesen Bio finding a partner to which, it can sell, transfer, license, assign or otherwise divest such non-cash assets. The Sesen Bio board of directors may elect not to divest any of Sesen Bio&#8217;s non-cash assets, resulting in a lower return for Sesen Bio stockholders with respect to the CVRs. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Further, if Sesen Bio does not receive any future payment pursuant to the Roche Asset Purchase Agreement and it does not divest any of its non-cash assets, Sesen Bio stockholders will not receive any payments on the CVRs and the CVRs will expire valueless.</font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Furthermore, the CVRs will be unsecured obligations of the combined company and all payments under the CVRs, all other obligations under the CVR Agreement and the CVRs and any rights or claims relating thereto will be subordinated in right of payment to the prior payment in full of all current or future senior obligations of the combined company. For more information about the CVR Agreement, see the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Agreements Related to the Merger&#8201;&#8212;&#8201;CVR Agreement</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tCVAG">192</a> of this proxy statement/prospectus. </font>
          </div>

        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The U.S. federal income tax treatment of the CVRs is unclear and there can be no assurance that the Internal Revenue Service would not assert, or that a court would not sustain, a position that could result in adverse U.S. federal income tax consequences to holders of the CVRs.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The U.S. federal income tax treatment of the CVRs is unclear. There is no legal authority directly addressing the U.S. federal income tax treatment of the receipt of, and payments on, the CVRs, and there can be no assurance that the Internal Revenue Service, or the IRS, would not assert, or that a court would not sustain, a position that could result in adverse U.S. federal income tax consequences to holders of the CVRs. </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">As discussed in the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Agreements Related to the Merger&#8201;&#8212;&#8201;CVR Agreement&#8201;&#8212;&#8201;Material U.S. Federal Income Tax Consequences of the Receipt of CVRs,</font><font style="letter-spacing:0.2pt;">&#8221; Sesen Bio intends to treat the issuance of the CVRs as a distribution of property with respect to its stock. However, there is no authority directly addressing whether contingent value rights with characteristics similar to the CVRs should be treated as a distribution of property with respect to the corporation&#8217;s stock, a distribution of equity, a &#8220;debt instrument&#8221; or an &#8220;open transaction&#8221; for U.S. federal income tax purposes. Although Sesen Bio will estimate the value of the CVRs for purposes of reporting on Form 1099 to Sesen Bio stockholders, the value of the CVRs is uncertain and the IRS or a court could determine that the value of the CVRs at the time of issuance was higher. In such case, the Sesen Bio stockholders could be treated as having additional income or gain upon receipt of the CVRs as described further in the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Agreements Related to the Merger&#8201;&#8212;&#8201;CVR Agreement&#8201;&#8212;&#8201;Material U.S. Federal Income Tax Consequences of the Receipt of CVRs</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page&#160;<a href="#tCVAG">192</a> of this proxy statement/prospectus. Further, notwithstanding Sesen Bio&#8217;s position that the receipt of CVRs, the receipt of any cash distributed pursuant to a special cash dividend and the proposed reverse stock split are appropriately treated as separate transactions, it is possible that the IRS or a court could </font>
          </div>

      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">33</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">

          <div style="width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">determine that the Sesen Bio stockholders&#8217; receipt of the CVRs, the receipt of any cash distributed pursuant to a special cash dividend and the proposed reverse stock split constitute a single &#8220;recapitalization&#8221; for U.S. federal income tax purposes. No assurance can be given that the IRS would not assert, or that a court would not sustain, a position contrary to Sesen Bio&#8217;s position, which could result in adverse U.S. federal income tax consequences to holders of the CVRs. The tax consequences of such alternative treatments are described below under the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Agreements Related to the Merger&#8201;&#8212;&#8201;CVR Agreement&#8201;&#8212;&#8201;Material U.S. Federal Income Tax Consequences of the Receipt of CVRs,</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tCVAG">192</a> of this proxy statement/prospectus. </font>
          </div>

        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Sesen Bio is substantially dependent on its remaining employees to facilitate the consummation of the merger.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">As of January 4, 2023, Sesen Bio had 17 full-time employees. Sesen Bio&#8217;s ability to successfully complete the merger depends in large part on its ability to retain certain remaining personnel. Despite Sesen Bio&#8217;s efforts to retain these employees, one or more may terminate their employment with Sesen Bio on short notice. The loss of the services of certain employees could potentially harm Sesen Bio&#8217;s ability to consummate the merger, to run its day-to-day business operations, as well as to fulfill its reporting obligations as a public company. </font>
          </div>

        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Sesen Bio has never paid and, other than in connection with the merger, does not intend to pay any cash dividends in the foreseeable future.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Sesen Bio has never paid cash dividends on any of its capital stock. Pursuant to the terms of the Merger Agreement, Sesen Bio will, in addition to the CVRs, declare and pay a special cash dividend to its stockholders of record prior to the merger, which would be contingent upon Sesen Bio stockholder approval of Proposal Nos. 1 and 2 and the satisfaction or waiver of other customary closing conditions to the merger. The amount of the special cash dividend will be the amount by which Sesen Bio&#8217;s estimated net cash as of the closing of the merger exceeds $75.0 million. Other than such special cash dividend in connection with the closing of the merger, Sesen Bio does not currently anticipate declaring or paying cash dividends on its capital stock in the foreseeable future. </font>
          </div>

        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Sesen Bio may not be able to enter into a transaction with a suitable acquiror or licensee for Vicineum or any transaction entered into may not be on terms that are favorable to Sesen Bio.</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On July 15, 2022, Sesen Bio made the strategic decision to voluntarily pause further development of Vicineum in the United States. As a result of such decision, the primary paths available to derive value from the Vicineum asset are to find a suitable acquiror or licensee for the asset. Supporting diligence activities conducted by potential acquirors or licensees and negotiating the financial and other terms of an agreement or license are typically long and complex processes, and the results of such processes cannot be predicted. There can be no assurance that Sesen Bio will enter into any transaction as a result of this effort or that any transaction entered into will be on terms that are favorable to Sesen Bio. Furthermore, if Sesen Bio enters into and completes a transaction relating to Vicineum, Sesen Bio cannot predict the impact that such transaction might have on its stock price. Sesen Bio also cannot predict the impact on its stock price if Sesen Bio fails to enter into and complete a transaction relating to Vicineum.</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">In connection with Sesen Bio&#8217;s strategic decision to voluntarily pause further development of Vicineum in the United States, Sesen Bio may become involved in disagreements or disputes with its licensees, licensors and other counterparties relating to the development and/or commercialization of Vicineum, which may be time consuming, costly and could divert its efforts and attention from consummating the merger and harm Sesen Bio&#8217;s efforts to seek a partner to continue development of Vicineum.</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio has entered into various agreements and licenses with licensees, licensors and other counterparties related to the development and/or commercialization of Vicineum. These agreements and licenses impose a variety of obligations on Sesen Bio and the counterparties to such agreements and licenses. On July 15, 2022, Sesen Bio made the strategic decision to voluntarily pause further development of Vicineum in the United States. As a result of such decision and Sesen Bio&#8217;s subsequent decision to enter into the Merger Agreement, Sesen Bio has begun the process of winding down its operations relating to Vicineum, Sesen Bio is seeking a partner for the further development of Vicineum and has engaged a financial </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">34</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">

          <div style="width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">advisor for the potential sale of Vicineum. In addition, on December 23, 2022, Sesen Bio terminated the Qilu License Agreement, upon which Sesen Bio regained the rights to develop, manufacture and commercialize Vicineum in Greater China. However, Sesen Bio does not plan to develop or commercialize Vicineum in that region or any other, as it is pursuing the merger with Carisma. Disagreements and disputes between Sesen Bio and certain counterparties have arisen related to such wind-down efforts and additional disagreements or disputes may arise in the future between Sesen Bio and its counterparties regarding each parties&#8217; obligations under the respective agreement or license relating to Vicineum.</font>
          </div>

        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Any such disagreement or dispute could become time consuming, costly and could divert Sesen Bio&#8217;s efforts and attention from consummating the merger and could harm its efforts to seek a partner to continue development of Vicineum. Any disagreements or disputes with such parties that lead to litigation, arbitration or similar proceedings will result in Sesen Bio incurring significant legal expenses, as well as potential significant legal liability.</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Further, any disagreements or disputes over Sesen Bio&#8217;s obligations or intellectual property that it has licensed or acquired may prevent or impair its ability to maintain its current arrangements on acceptable terms. If Sesen Bio fails to meet its obligations under these agreements or licenses in a material respect, the respective counterparty may have the right to terminate the respective agreement or license and to re-obtain the related technology as well as aspects of any intellectual property controlled by Sesen Bio and developed during the period the agreement or license was in force that relates to the applicable technology. While Sesen Bio would expect to exercise its rights and remedies available to it in the event Sesen Bio fails to meet its obligations under such agreement or license in any material respect and otherwise seek to preserve its rights under the technology licensed to or acquired by it, Sesen Bio may not be able to do so in a timely manner, at an acceptable cost or at all. Any uncured, material breach under any agreement or license relating to Vicineum could result in Sesen Bio&#8217;s loss of rights and may lead to a complete termination of the respective agreement or license. Termination of one of these agreements or licenses for any reason could prevent Sesen Bio from completing a transaction to sell or license Vicineum.</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Risks Related to Sesen Bio&#8217;s Financial Position and Need for Additional Capital if the Merger is Not Completed </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Sesen Bio has incurred significant losses since its inception and anticipates that it will continue to incur losses for the foreseeable future if the merger is not completed.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio is a specialty pharmaceutical company with a limited operating history. Over the past few&#160;years, Sesen Bio has focused primarily on developing its lead product candidate, Vicineum for the treatment of NMIBC. On July&#160;15, 2022, Sesen Bio made the strategic decision to voluntarily pause further development of Vicineum in the U.S. to conserve cash while considering strategic alternatives. Since its inception, Sesen Bio has received no revenues from sales of its products, has incurred significant operating losses and expects to continue to incur operating losses for the foreseeable future. Sesen Bio had net losses of $0.3&#160;million, $22.4&#160;million and $107.5&#160;million for the&#160;years ended December&#160;31, 2021, 2020 and 2019, respectively. Sesen Bio incurred negative cash flows from operating activities of $68.9&#160;million, $30.8&#160;million and $37.5&#160;million for the&#160;years ended December&#160;31, 2021, 2020 and 2019, respectively. As of September&#160;30, 2022, Sesen Bio had cash, cash equivalents and marketable securities of $184.9&#160;million, net working capital (current assets less current liabilities) of $157.7&#160;million and an accumulated deficit of $328.6&#160;million. Sesen Bio has financed its operations to date primarily through private placements of its common stock, preferred stock, common stock warrants and convertible bridge notes, venture debt borrowings, its initial public offering, its follow-on public offerings, sales effected in at-the-market, or ATM offerings, and its out-licensing and outside the U.S., or OUS, business development partnership agreements. The majority of Sesen Bio&#8217;s revenue to date has been from milestone payments received under its out-licensing and OUS business development partnership agreements. If the merger is not completed and Sesen Bio does not pursue a liquidation and dissolution or alternative strategic transaction and despite the 2022 restructuring plan, as defined below, Sesen Bio expects to continue to incur significant expenses and operating losses for the foreseeable future. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio expects to incur losses for the foreseeable future, and Sesen Bio expects these losses to continue as it: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">addresses its ongoing securities litigation; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">35</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">maintains, expands and protects its intellectual property portfolio; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">reduces its personnel and incurs related severance and employee-related costs in connection with the restructuring plan announced following the decision to pause further development of Vicineum in the U.S., or the 2022 restructuring plan; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">winds down activities with its contract manufacturing organizations, or CMOs; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">explores, evaluates and pursues a liquidation and dissolution or alternative strategic transaction if the merger is not completed. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">With the exception of specified regulatory, development and commercial milestones under the Roche Asset Purchase Agreement, Sesen Bio currently has no potential source of revenue and may never become profitable.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio is a late-stage clinical company with a limited operating history. Sesen Bio&#8217;s ability to become and remain profitable depends on its ability to generate revenue. Although Sesen Bio may be entitled to certain payments under the Roche Asset Purchase Agreement, Sesen Bio has not commercialized any of its product candidates. On July&#160;15, 2022, Sesen Bio made the strategic decision to voluntarily pause further development in the U.S. of Vicineum. This decision enables Sesen Bio to conserve cash while it prepares to consummate the merger. There can be no guarantee that the merger will be completed within the anticipated timing or at all. If Sesen Bio resumes clinical development of Vicineum for the treatment of NMIBC, it does not expect to generate significant revenue unless and until Sesen Bio or one of its business development partners, if any, obtains marketing approval for, and commercializes, Vicineum for the treatment of NMIBC. If Sesen Bio resumes clinical development of Vicineum for the treatment of NMIBC, Sesen Bio&#8217;s ability to generate revenue from Vicineum will depend on a number of factors, including: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio&#8217;s ability to obtain regulatory approval for, and successfully commercialize, Vicineum for the treatment of NMIBC; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio&#8217;s ability to complete and submit applications to, and obtaining regulatory approval from, non-U.S. regulatory authorities; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the size of the markets in the territories for which Sesen Bio or its business development partners, if any, gain regulatory approval; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio&#8217;s ability to find a suitable contract sales organization, or CSO, to help it market and promote Vicineum, if approved; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio&#8217;s ability to develop and maintain effective medical affairs, sales, marketing and distribution to market and sell Vicineum, if approved; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio&#8217;s ability to enter into and maintain commercially reasonable agreements with wholesalers, distributors and other third parties in its supply chain; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio&#8217;s success in establishing a commercially viable price for Vicineum, if approved; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio&#8217;s success in defending against potential competition and other developments in its market generally; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio&#8217;s ability to manufacture commercial quantities of Vicineum at acceptable cost levels; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio&#8217;s ability to obtain coverage and adequate reimbursement from third-party payors, including government payors; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio&#8217;s or any business development partners&#8217; ability to successfully complete development activities, including necessary clinical trials, for Vicineum for the treatment of NMIBC. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Even if Sesen Bio resumes clinical development of Vicineum for the treatment of NMIBC and Vicineum is approved for commercial sale, Vicineum may not gain market acceptance or achieve commercial success. If Sesen Bio&#8217;s addressable market is not as significant as Sesen Bio estimates, the indication approved by regulatory authorities is narrower than Sesen Bio expects or the treatment population is narrowed by competition, physician choice or clinical practice guidelines, Sesen Bio may not generate significant revenue from sales of Vicineum. In addition, if Sesen Bio resumes clinical development of </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">36</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Vicineum for the treatment of NMIBC, Sesen Bio would anticipate incurring significant costs associated with commercializing Vicineum, if approved. Sesen Bio may not achieve profitability soon after generating product sales from Vicineum, if ever. If Sesen Bio is unable to generate product revenues from Vicineum, Sesen Bio may not become profitable and may be unable to continue operations without continued funding. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Even if Sesen Bio achieves profitability, it may not be able to sustain or increase profitability on a quarterly or annual basis. Its failure to become and remain profitable would depress the value of Sesen Bio and could impair its ability to raise capital, expand its business, maintain its development efforts, obtain drug approvals, diversify its offerings or continue its operations. A decline in the value of Sesen Bio could also cause you to lose all or part of your investment. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If the merger is not completed and Sesen Bio resumes clinical development of Vicineum, Sesen Bio will need substantial additional funding. If Sesen Bio is unable to raise capital when needed, Sesen Bio could be forced to delay, reduce or eliminate its product development programs or commercialization efforts.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio has devoted substantial financial resources to clinical trial for Vicineum for the treatment of NMIBC and functions associated with operating as a public company. If the merger is not completed, Sesen Bio expects to continue to spend substantial amounts if it were to continue the clinical development of Vicineum for the treatment of NMIBC, and, if approved, commercialize Vicineum. Accordingly, Sesen Bio would need to obtain substantial additional funding in connection with its continuing operations if the merger is not completed. If Sesen Bio is unable to raise capital when needed or on attractive terms, Sesen Bio could be forced to delay, reduce or eliminate its research and development programs or any future commercialization efforts. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio&#8217;s future capital requirements will depend on many factors, including: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the costs and timing of continuing the clinical development of Vicineum for the treatment of NMIBC; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the success of its commercialization of Vicineum for the treatment of NMIBC, if approved; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the outcome, timing and cost of the regulatory approval process for Vicineum for the treatment of NMIBC by the FDA and comparable non-U.S. regulatory authorities, including the potential for the FDA to require that Sesen Bio perform more studies and clinical trials than those Sesen Bio currently expects; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the costs and timing of the implementation of commercial-scale manufacturing activities; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio&#8217;s ability to establish and maintain commercial arrangements on favorable terms, if at all, particularly manufacturing, marketing and distribution arrangements for Vicineum for the treatment of NMIBC; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the costs and timing of preparing, filing and prosecuting patent applications, maintaining and enforcing Sesen Bio&#8217;s intellectual property rights and defending any intellectual property-related claims; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio&#8217;s obligation to make milestone, royalty and other payments to third-party licensors under its in-licensing agreements; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the extent to which Sesen Bio in-license or acquire rights to other products, product candidates or technologies; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.19pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the effect of competing technological and market developments. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio cannot be certain that additional funding will be available when needed on acceptable terms, or at all. If Sesen Bio is unable to raise additional capital in sufficient amounts, when required or on acceptable terms, Sesen Bio also could be required to: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">seek out-licensing or commercialization partners to assist in the clinical development or commercialization of Vicineum for the treatment of NMIBC in the U.S. and other markets; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">37</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">delay, limit, reduce or terminate the clinical development of Vicineum for the treatment of NMIBC; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">significantly curtail Sesen Bio&#8217;s operations. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Risks Related to Clinical Development and Regulatory Approval of Vicineum if the Merger is Not Completed</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Sesen Bio has been dependent on its lead product candidate, Vicineum for the treatment of NMIBC. If Sesen Bio resumes clinical development of Vicineum and is unable to obtain marketing approval for or successfully commercialize its lead product candidate, either alone or through an out-license or OUS business development partnership, or experiences significant delays in doing so, its business could be materially harmed.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio currently has no products approved for sale and has invested a significant portion of its efforts and financial resources in the development of Vicineum. On July&#160;15, 2022, Sesen Bio made the strategic decision to voluntarily pause further development of Vicineum in the U.S. The decision was based on a thorough reassessment of Vicineum, which included the incremental development timeline and associated costs for an additional Phase&#160;3 clinical trial, following Sesen Bio&#8217;s discussions with the FDA. As a result of this decision, Sesen Bio no longer plans to pursue regulatory approval of Vicineum for NMIBC in the E.U. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If the merger is not completed and even if Sesen Bio resumes clinical development of Vicineum for NMIBC, Sesen Bio may be unable to address the issues identified in the complete response letter, or CRL, from the FDA or resubmit a biologics license application, or BLA, for Vicineum, or address the concerns identified in the European Medicines Agency, or EMA, Withdrawal Assessment Report or resubmit its marketing authorization application, or MAA, for Vysyneum, including because of a lack of capital or otherwise. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Even if the issues identified in the CRL or the concerns identified in the EMA Withdrawal Assessment Report are resolved to the satisfaction of the FDA or the EMA, respectively, the FDA and the European Commission retain the right not to approve a BLA or MAA, respectively, or to require additional information, or to raise additional issues with regard to regulatory approval, which could further delay or prevent its approval or limit product labelling claims. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If the merger is not completed and Sesen Bio resumes clinical development, Sesen Bio&#8217;s prospects would be substantially dependent on its ability to obtain marketing approval for and commercialize Vicineum for the treatment of NMIBC. In addition, either the substance of the issues identified by the FDA in the CRL, or the CRL itself, or the concerns identified in the EMA Withdrawal Assessment Report could have an adverse impact on future efforts to obtain marketing authorization for Vicineum from other non-U.S. regulatory authorities, or on Sesen Bio&#8217;s future efforts to commercialize Vicineum and gain acceptance of Vicineum from third-party payors. The success of Vicineum would depend on several factors, including the following: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">successfully completing the clinical development of Vicineum for the treatment of NMIBC; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">addressing the issues identified in the CRL that Sesen Bio received from the FDA and the concerns identified in the EMA Withdrawal Assessment Report; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">receiving marketing approvals from the FDA, the European Commission or comparable non-U.S. regulatory authorities, including Sesen Bio&#8217;s ability to address the issues identified by the FDA in the CRL or the EMA Withdrawal Assessment Report; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">developing and maintaining the commercial manufacturing supply and distribution chain for Vicineum; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">performance of future out-licensing or OUS business development partners (if any); </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the extent of any required post-marketing approval commitments to applicable regulatory authorities; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">obtaining and maintaining patent, trade secret protection and regulatory exclusivity, both in the U.S. and internationally; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">protecting Sesen Bio&#8217;s rights in its intellectual property portfolio; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">38</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">launching commercial sales, if and when marketing approval is received; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">demonstrating an acceptable safety profile prior to and following any marketing approval; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">obtaining marketplace acceptance, if approved, by patients, the medical community and third-party payors; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">establishing and maintaining pricing sufficient to realize a meaningful return on Sesen Bio&#8217;s investment; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">competition with other therapies. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If Sesen Bio is unable to develop, receive marketing approval for, or successfully commercialize Vicineum or experience delays as a result of any of these factors or otherwise, its business could be materially harmed. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If additional clinical trials of Vicineum for the treatment of NMIBC fail to demonstrate safety and efficacy to the satisfaction of the FDA, the EMA or other non-U.S. regulatory authorities or do not otherwise produce favorable results, Sesen Bio will be unable to complete the development and potential commercialization of Vicineum for the treatment of NMIBC. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If Sesen Bio resumes clinical development of Vicineum for the treatment of NMIBC and additional clinical trials of Vicineum fail to demonstrate safety and efficacy to the satisfaction of the FDA, the EMA or other non-U.S. regulatory authorities or do not otherwise produce favorable results, Sesen Bio will be unable to complete the development and potential commercialization of Vicineum for the treatment of NMIBC.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Before obtaining marketing approval from regulatory authorities for the sale of Vicineum for the treatment of NMIBC, Sesen Bio must complete pre-clinical development and conduct extensive clinical trials to demonstrate the safety and efficacy of Vicineum in humans. In order to address the issues identified in the CRL that Sesen Bio received from the FDA for the BLA for Vicineum and the concerns identified in the EMA Withdrawal Assessment Report, Sesen Bio would need to complete one or more additional clinical trials. Such trials would require Sesen Bio to incur substantial additional costs and would delay the potential commercialization of Vicineum for the treatment of NMIBC. Clinical testing is expensive, difficult to design and implement, can take many&#160;years to complete and is uncertain as to outcome. A failure of one or more clinical trials can occur at any stage of testing. Further, the outcome of pre-clinical studies and early clinical trials may not be predictive of the success of later clinical trials, and preliminary results of a clinical trial do not necessarily predict final results. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Even if such clinical trials are successfully completed as planned, the results may not support approval of Vicineum for the treatment of NMIBC under the laws and regulations of the FDA, the European Commission or comparable non-U.S. regulatory authorities. Even if Sesen Bio resumes clinical development of Vicineum, Sesen Bio cannot be certain that additional clinical data will demonstrate Vicineum is both safe and effective for its intended uses to the satisfaction of the FDA, the EMA or comparable non-U.S. regulatory authorities. Pre-clinical and clinical data and analyses are often able to be interpreted in different ways. Even if Sesen Bio views its results favorably, it may be unable to demonstrate safety and efficacy of Vicineum for the treatment of NMIBC to the satisfaction of the FDA, the EMA or other non-U.S. regulatory authorities. If a regulatory authority has a different view, Sesen Bio may still fail to obtain regulatory approval of Vicineum. This, in turn, would prevent Sesen Bio from commercializing Vicineum and its ability to generate revenues in the future would be materially impaired. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If Sesen Bio resumes clinical development of Vicineum for the treatment of NMIBC and Sesen Bio experiences delays or difficulties in the enrollment of patients in clinical trials, its receipt of necessary regulatory approvals could be delayed or prevented.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Even if Sesen Bio resumes clinical development of Vicineum for the treatment of NMIBC, Sesen Bio may not be able to initiate or continue clinical trials for Vicineum if Sesen Bio is unable to locate and enroll a sufficient number of patients to participate in these trials as required by the FDA or similar non-U.S. regulatory authorities. Sesen Bio has previously experienced difficulties with clinical trial enrollment and retention, which led to the early termination of its Phase&#160;3 trial of Vicineum for the treatment of squamous </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">39</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">cell carcinoma of the head and neck, or SCCHN, in 2008, and Sesen Bio may experience difficulties in patient enrollment in its clinical trials in the future for a variety of reasons. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Subject enrollment is affected by a number of factors, including: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the severity of the disease under investigation; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the eligibility criteria for the clinical trial in question; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the size of the patient population for the disease; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the size of the patient population required for statistically significant analysis of the clinical trial&#8217;s primary endpoints; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the design of the clinical trial; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.91pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.91pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the clinicians&#8217; and patients&#8217; perceived risks and benefits of the product candidate under study, including relative to alternative treatments; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the efforts to facilitate timely enrollment in clinical trials; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the patient referral practices of physicians; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">any ongoing clinical trials conducted by competitors for the same indication; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the risk that patients enrolled in clinical trials will drop out of the clinical trials before completion; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the ability to monitor patients adequately during and after treatment; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the proximity and availability of clinical trial sites for prospective patients. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Further, Sesen Bio&#8217;s ability to successfully initiate, enroll and complete a clinical trial in any country outside of the U.S., should Sesen Bio decide to do so, is subject to numerous risks unique to conducting business in such countries, including: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">difficulty in establishing or managing relationships with contract research organizations, or CROs, and physicians; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">different or additional standards for the conduct of clinical trials; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">absence in some countries of established groups with sufficient regulatory expertise for review of the protocols associated with Vicineum; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">ensuring that clinical trial quality is sufficient to meet the standards of the FDA or other regulatory authorities; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.91pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.91pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio&#8217;s inability to locate qualified local consultants, physicians and partners; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the potential burden of complying with a variety of non-U.S. laws, medical standards and regulatory requirements, including the regulation of pharmaceutical and biotechnology products and treatments. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In addition, Sesen Bio&#8217;s clinical trials would compete with other clinical trials for other product candidates that are in the same therapeutic areas as Vicineum, and this competition will reduce the number and types of patients available to Sesen Bio, because some patients who might have opted to enroll in Sesen Bio&#8217;s trials may instead opt to enroll in a trial being conducted by one of its competitors. Since the number of qualified clinical investigators is limited, Sesen Bio expects to conduct some of its clinical trials at the same clinical trial sites that some of its competitors use, which will reduce the number of patients who are available for Sesen Bio&#8217;s clinical trials in such clinical trial site. Moreover, because Vicineum represents a departure from more commonly used methods for cancer treatment, potential patients and their doctors may be inclined to use conventional therapies, such as chemotherapy, rather than enroll patients in any of Sesen Bio&#8217;s clinical trials. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio&#8217;s inability to enroll a sufficient number of patients for its clinical trials would result in significant delays, could require Sesen Bio to abandon one or more clinical trials altogether and could delay or prevent its receipt of necessary regulatory approvals. Enrollment delays in its clinical trials may result </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">40</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">in increased development costs for its product candidates, which would cause the value of the company to decline and limit its ability to obtain additional financing. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If Sesen Bio resumes clinical development of Vicineum for the treatment of NMIBC, Vicineum for the treatment of NMIBC may cause undesirable side effects, serious adverse events or have other properties that could delay or halt clinical trials, delay or prevent its regulatory approval, limit the commercial profile of its labeling, if approved, or result in significant negative consequences following any marketing approval.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If Sesen Bio resumes clinical development of Vicineum for the treatment of NMIBC, undesirable side effects or serious adverse events caused by Vicineum for the treatment of NMIBC could cause Sesen Bio or regulatory authorities to interrupt, delay or halt respective clinical trials and could result in a restrictive label or the delay or denial of regulatory approval by the FDA or other comparable non-U.S. regulatory authorities. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">There were no Grade 4 or Grade 5 serious adverse events that were considered by the clinical investigators to be related to Vicineum during the Phase&#160;1 and Phase&#160;2 clinical trials of Vicineum for the treatment of bacillus Calmette-Gu&#233;rin, or BCG, unresponsive NMIBC. There was one Grade 5 serious adverse event, or death, which was determined by the clinical investigator to be unrelated to Vicineum. The most common reported treatment-related adverse events were an abnormally frequent passage of small amounts of urine, blood in the urine and painful urination, the majority of which were considered to be mild or moderate in severity. No patients discontinued treatment due to a Vicineum-related adverse event during the Phase&#160;1 and Phase&#160;2 clinical trials. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As of the May&#160;29, 2019 data cutoff date, in patients across all cohorts (n=133) of Sesen Bio&#8217;s Phase&#160;3 VISTA Trial of Vicineum for the treatment of BCG-unresponsive NMIBC, 88% experienced at least one adverse event, with 95% of adverse events being Grade 1 or 2. The most commonly reported treatment-related adverse events were dysuria (14%), hematuria (13%) and urinary tract infection (12%)&#8201;&#8212;&#8201;all of which are consistent with the profile of bladder cancer patients and the use of catheterization for treatment delivery. These adverse events were determined by the clinical investigators to be manageable and reversible, and only four patients (3%) discontinued treatment due to an adverse event. Serious adverse events, regardless of treatment attribution, were reported in 14% of patients. There were four treatment-related serious adverse events reported in three patients including acute kidney injury (Grade 3), pyrexia (Grade 2), cholestatic hepatitis (Grade 4) and renal failure (Grade 5 or death). There were no age-related increases in adverse events observed in the VISTA Trial. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In addition, side effects and serious adverse events or further safety or toxicity issues that Sesen Bio may experience in its clinical trials or in post-marketing experience, if approved, could lead to the FDA&#8217;s or other comparable non-U.S. regulatory authority&#8217;s imposition of a risk evaluation and mitigation strategy, or REMS, or other post-marketing obligations, which could hinder Sesen Bio from generating revenues or achieving profitability. Results of Sesen Bio&#8217;s clinical trials could reveal an unacceptably high severity and prevalence of side effects or serious adverse events. As a result, Sesen Bio&#8217;s clinical trials could be suspended or terminated, and the FDA or comparable non-U.S. regulatory authorities could order Sesen Bio to cease further development or deny approval of Vicineum for the treatment of NMIBC. The related drug-side effects or serious adverse events in Sesen Bio&#8217;s clinical trials could affect clinical trial patient recruitment or the ability of enrolled patients to complete the clinical trial or result in potential product liability claims. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Additionally, even if Sesen Bio resumes clinical development of Vicineum for the treatment of NMIBC and receives marketing approval, and Sesen Bio or others later identify undesirable side effects or serious adverse events caused by Vicineum, a number of potentially significant negative consequences could result, including: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio may suspend or be forced to suspend marketing of Vicineum for the treatment of NMIBC; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio may be obliged to conduct a product recall or product withdrawal; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">regulatory authorities may suspend, vary, or withdraw their approvals of Vicineum for the treatment of NMIBC; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">regulatory authorities may order the seizure or recall of Vicineum; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">41</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">regulatory authorities may require additional warnings on the label or a REMS or other post-marketing obligations that could diminish the usage or otherwise limit the commercial success of Vicineum for the treatment of NMIBC; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio may be required to conduct post-marketing studies; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio could be sued and held liable for harm caused to patients; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio could be required to pay fines and face other administrative, civil and criminal penalties; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio&#8217;s reputation may suffer. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Any of these events could prevent Sesen Bio from achieving or maintaining market acceptance of Vicineum for the treatment of NMIBC, if approved. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The marketing approval process is expensive, time-consuming and uncertain. As a result, even if Sesen Bio resumes clinical development of Vicineum for the treatment of NMIBC, it cannot predict when or if it, or any licensees or partners, if any, will obtain marketing approval to commercialize Vicineum for the treatment of NMIBC.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Securing marketing approval requires the submission of extensive pre-clinical and clinical data and supporting information to regulatory authorities for each therapeutic indication to establish the product candidate&#8217;s quality, safety, and efficacy. The process of obtaining marketing approvals, both in the U.S. and abroad, is expensive and may take many&#160;years, especially if additional clinical trials are required, if approval is obtained at all. On July&#160;15, 2022, Sesen Bio made the strategic decision to voluntarily pause further development of Vicineum in the U.S. The decision was based on a thorough reassessment of Vicineum, which included the incremental development timeline and associated costs for an additional Phase&#160;3 clinical trial, following its discussions with the FDA. As a result of this decision, Sesen Bio no longer plans to pursue regulatory approval of Vysyneum for the treatment of NMIBC in the E.U. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Securing marketing approval also requires the submission of information about the product manufacturing process to, and inspection of manufacturing facilities by, the regulatory authorities. If Sesen Bio resumes clinical development of Vicineum for the treatment of NMIBC, the FDA or other comparable non-U.S. regulatory authorities may determine that Vicineum is not safe, effective or of appropriate quality, is only moderately effective or has undesirable or unintended side effects, toxicities or other characteristics that preclude Sesen Bio obtaining marketing approval or prevent or limit commercial use. Any marketing approval Sesen Bio ultimately obtains may be limited or subject to restrictions or post-approval commitments that render the approved product not commercially viable. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The different requirements and expectations of the non-U.S. regulatory authorities compared with the FDA may lengthen the regulatory review process, require Sesen Bio to conduct additional studies or clinical trials, increase its development costs, lead to changes in regulatory positions and interpretations, delay or prevent approval and commercialization of these product candidates or lead to significant post approval limitations or restrictions. If Sesen Bio resumes clinical development of Vicineum for the treatment of NMIBC and experiences delays in obtaining regulatory approvals, the commercial prospects for its product candidates may be harmed and its ability to generate revenues will be materially impaired. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If Sesen Bio resumes clinical development of Vicineum for the treatment of NMIBC, failure to obtain marketing approval in non-U.S. jurisdictions would prevent Vicineum for the treatment of NMIBC from being marketed abroad, and any approval Sesen Bio may be granted for Vicineum for the treatment of NMIBC in the U.S. would not assure approval of product candidates in non-U.S. jurisdictions.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In order to market and sell any product candidate that Sesen Bio may develop outside of the U.S., Sesen Bio or its third-party licensees or commercialization partners, if any, must obtain separate marketing approvals and comply with numerous and varying regulatory requirements. The approval procedure varies among countries and can involve additional testing. The time required to obtain approval may differ substantially from that required to obtain FDA approval. The regulatory approval process outside the U.S. generally includes all of the risks associated with obtaining FDA approval. In addition, in many countries </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">42</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">outside the U.S. it is required that the product be approved for reimbursement before the product can be sold in that country. Sesen Bio or these third parties may not obtain approvals from regulatory authorities outside the U.S. on a timely basis, if at all. For example, on March&#160;5, 2021, Sesen Bio submitted its MAA to the EMA for Vicineum for the treatment of BCG-unresponsive NMIBC under the EMA&#8217;s centralized procedure. On August&#160;20, 2021, Sesen Bio withdrew its MAA to the EMA for Vysyneum for the treatment of BCG-unresponsive NMIBC. Additionally, on October&#160;20, 2021, the EMA issued its Withdrawal Assessment Report relating to Sesen Bio&#8217;s MAA for Vysyneum, as is consistent with the EMA&#8217;s standard practice when an MAA is withdrawn. The Assessment Report reflects the initial assessment and corresponding questions from the EMA and identifies major objections in the areas of quality, good clinical practice, efficacy and safety. On July&#160;15, 2022, Sesen Bio made the strategic decision to voluntarily pause further development of Vicineum in the U.S. The decision was based on a thorough reassessment of Vicineum, which included the incremental development timeline and associated costs for an additional Phase&#160;3 clinical trial, following its discussions with the FDA. As a result of this decision, Sesen Bio no longer plans to pursue regulatory approval of Vysyneum for the treatment NMIBC in the E.U. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Approval by the FDA does not ensure approval by regulatory authorities in other countries or jurisdictions, and approval by one regulatory authority outside the U.S. does not ensure approval by regulatory authorities in other countries or jurisdictions or by the FDA. If Sesen Bio resumes clinical development of Vicineum for the treatment of NMIBC, Sesen Bio may not be able to file for marketing approvals and may not receive necessary approvals to commercialize its products in any market. If Sesen Bio is unable to obtain approval of its product candidates by regulatory authorities in other jurisdictions, the commercial prospects of its product candidates may be significantly diminished, and its business prospects could decline. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If Sesen Bio resumes clinical development of Vicineum for the treatment of NMIBC, Sesen Bio would face substantial competition, which may result in others discovering, developing or commercializing products before or more successfully than Sesen Bio does.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The development and commercialization of new biologics products is highly competitive. If Sesen Bio resumes clinical development of Vicineum for the treatment of NMIBC, Sesen Bio would face competition from both large and small pharmaceutical, biopharmaceutical and biotechnology companies, academic institutions and other research organizations. There are a number of large pharmaceutical, biopharmaceutical and biotechnology companies that currently market and sell products or are pursuing the development of products for the treatment of NMIBC. For instance, in January&#160;2020, the FDA approved Merck &amp; Co., Inc.&#8217;s Keytruda (pembrolizumab) as a systemic monotherapy to treat patients with BCG-unresponsive NMIBC with non-muscle invasive carcinoma in situ, or CIS, with or without papillary tumors who are ineligible for or have elected not to undergo cystectomy. In addition, FerGene Inc. is developing Adstiladrin (nadofaragene firadenovec (rAd-IFN/Syn3) for BCG-unresponsive NMIBC for the U.S. market. On May&#160;17, 2020, the FDA issued a CRL that indicated outstanding questions regarding chemistry, manufacturing and controls, or CMC, issues of Adstiladrin. In September&#160;2020, CG Oncology (CG0070, a recombinant adenovirus type&#160;5, same type as Adstiladrin) initiated a Phase&#160;3 study for the treatment of BCG-unresponsive patients with expected primary and study completion dates of December&#160;2022 and December&#160;2024, respectively. A combination trial with CG0070 and pembrolizumab was initiated in December&#160;2020 (active not recruiting) with a primary completion date of June&#160;2023. In December&#160;2020, ImmunityBio (Anktiva/N-803 in combination with BCG) released preliminary Phase&#160;2 data for the CIS cohort and filed its BLA with the FDA in May&#160;2022. However, the Phase&#160;2 trial did not include a BCG only control arm. The BLA for Anktiva was accepted by the FDA in July&#160;2022 and a PDUFA date of May&#160;23, 2023 has been set. In May&#160;2020, the preliminary results of the Phase&#160;2 study of Tecentriq for the treatment of BCG-unresponsive CIS patients were presented at American Society of Clinical Oncology, or ASCO, by the National Cancer Institute, or the NCI, which sponsored the trial. The data showed that the trial did not meet its primary endpoint and further development of Tecentriq remains uncertain. Finally, another route of administration for checkpoint inhibitors is currently being evaluated by Pfizer with the subcutaneous administration of Sasanlimab (PF-06801591) for the treatment of BCG-unresponsive NMIBC patients. There is intense and rapidly evolving competition in the biotechnology, biopharmaceutical and antibody fragment and immuno-oncology therapeutics fields. Some of these competitive products and therapies are based on scientific </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">43</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">approaches that are similar to Sesen Bio&#8217;s approach, and others are based on entirely different approaches, including the emerging use of generic intravesical chemotherapy agents, such as mytomycin-C, Gemcytabine and Gemcytobine + Docetaxel. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If Sesen Bio resumes clinical development of Vicineum for the treatment of NMIBC, its commercial opportunity could be reduced or eliminated if its competitors develop and commercialize products that are safer, more effective, have fewer or less severe side effects, are more convenient or are less expensive than product candidates that Sesen Bio may develop. Sesen Bio&#8217;s competitors also may obtain FDA or other regulatory approval for their products more rapidly than Sesen Bio may obtain approval for Vicineum, which could result in its competitors establishing a strong market position before Sesen Bio is able to enter the market. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, Sesen Bio&#8217;s ability to compete may be affected in many cases by insurers or other third-party payors, particularly Medicare, seeking to encourage the use of generic drug products. Generic products are currently being used as part of the standard of care for the indications that Sesen Bio has been pursuing, and additional products are expected to become available on a generic basis over the coming&#160;years. If Sesen Bio resumes clinical development of Vicineum for the treatment of NMIBC and Vicineum achieves marketing approval, Sesen Bio expects that it will be priced at a significant premium over competitive generic products. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">More established companies may have a competitive advantage over Sesen Bio due to their greater size, cash resources and institutional experience. Compared to Sesen Bio, many of its competitors may have significantly greater financial, technical and human resources. As a result of these factors, its competitors may obtain regulatory approval of their product candidates before Sesen Bio is able to, which may limit its ability to develop or commercialize its product candidates. Sesen Bio&#8217;s competitors may also develop drugs that are safer, more effective, more widely used and less expensive than Sesen Bio&#8217;s and may also be more successful than Sesen Bio in manufacturing and marketing their products. These appreciable advantages could render Vicineum obsolete or non-competitive before Sesen Bio can recover the expenses of development and commercialization. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Risks Related to Sesen Bio&#8217;s Dependence on Third Parties if the Merger is Not Completed</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Sesen Bio has historically relied on third parties to conduct its pre-clinical studies and clinical trials. If Sesen Bio resumes clinical development of Vicineum for the treatment of NMIBC and if these third parties do not successfully carry out their contractual duties or meet expected deadlines, Sesen Bio may not be able to obtain regulatory approval for or commercialize Vicineum for the treatment of NMIBC.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio relies on domestic and international third-party CROs to monitor and manage data for its pre-clinical and clinical programs. Sesen Bio relies on these parties for execution of its pre-clinical studies and clinical trials, and Sesen Bio controls only some aspects of their activities. Nevertheless, Sesen Bio is responsible for ensuring that each of its pre-clinical studies and clinical trials is conducted in accordance with the applicable protocol and legal, regulatory and scientific standards, and its reliance on the CROs does not relieve Sesen Bio of its regulatory responsibilities. Sesen Bio also relies on third parties to assist in conducting its pre-clinical studies in accordance with the FDA&#8217;s current Good Laboratory Practice, or GLP, and the Animal Welfare Act requirements. Sesen Bio and its CROs are required to comply with U.S.&#160;federal regulations and current Good Clinical Practices, or GCP, which are international standards meant to protect the rights and health of patients and assure the credibility of clinical trial data that are enforced by the FDA and comparable non-U.S. regulatory authorities for all of its product candidates in clinical development. Regulatory authorities enforce GCP through periodic inspections of trial sponsors, principal investigators and trial sites. If Sesen Bio or any of its CROs fail to comply with applicable GCP, the clinical data generated in its clinical trials may be deemed unreliable and the FDA or comparable non-U.S. regulatory authorities may require Sesen Bio to perform additional clinical trials before approving its marketing applications. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On October&#160;27, 2021, the FDA published a Warning Letter, or the FDA Warning Letter, issued to a former clinical investigator in Sesen Bio&#8217;s VISTA trial for Vicineum arising from a 2021 FDA inspection related to the review of Sesen Bio&#8217;s BLA for Vicineum for the treatment of BCG-unresponsive NMIBC. Sesen Bio discontinued use of the clinical site and the clinical investigator over four&#160;years ago when it learned of professional misconduct by the clinical investigator that was unrelated to the VISTA trial. The FDA Warning Letter indicated that the clinical investigator did not comply with applicable statutory requirements and </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">44</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">applicable regulations regarding conduct of clinical investigations. The clinical investigator&#8217;s medical license was temporarily suspended on May&#160;29, 2017, due to inaccurate recordkeeping, which was unassociated with Sesen Bio and the patients in the VISTA trial. Sesen Bio notified the FDA of the misconduct at that time. There was no evidence found that patients were harmed by the clinical investigator&#8217;s actions. Sesen Bio included the corresponding patient data from the clinical site in the BLA submission to the FDA, which were thoroughly analyzed and discussed during the BLA review. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio cannot assure you that upon inspection by a given regulatory authority, such regulatory authority will determine that any of its clinical trials comply with GCP requirements. In addition, its clinical trials must be conducted with product produced under current good manufacturing process, or cGMP, requirements. Failure to comply with these regulations may require Sesen Bio to repeat pre-clinical studies and clinical trials, which would delay the regulatory approval process. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio&#8217;s CROs are not its employees, and except for remedies available to Sesen Bio under its agreements with such CROs, Sesen Bio cannot control whether or not they devote sufficient time and resources to its ongoing clinical, non-clinical and pre-clinical programs. If CROs do not successfully carry out their contractual duties or obligations or meet expected deadlines or if the quality or accuracy of the data they obtain is compromised due to the failure to adhere to its protocols, regulatory requirements or for other reasons, its pre-clinical studies and clinical trials may be extended, delayed or terminated and Sesen Bio may not be able to obtain regulatory approval for or successfully commercialize its product candidates. As a result, its results of operations and the commercial prospects for its product candidates would be harmed, its costs could increase and its ability to generate revenues could be delayed. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Because Sesen Bio relied, and will continue to rely, on third parties, its internal capacity to perform these functions is limited. Outsourcing these functions involves risk that third parties may not perform to its standards, may not produce results in a timely manner or may fail to perform at all. In addition, the use of third-party service providers requires Sesen Bio to disclose its proprietary information to these parties, which could increase the risk that this information will be misappropriated. Sesen Bio currently has a small number of employees, which limits the internal resources Sesen Bio has available to identify and monitor its third-party providers. To the extent Sesen Bio is unable to identify and successfully manage the performance of third-party service providers in the future, its business may be adversely affected. Though Sesen Bio carefully manages its relationships with its CROs, there can be no assurance that Sesen Bio will not encounter challenges or delays in the future or that these delays or challenges will not have a material adverse impact on its business, financial condition and prospects. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If Sesen Bio resumes clinical development of Vicineum for the treatment of NMIBC, Sesen Bio would likely be dependent on third-party manufacturers, as well as third parties for Sesen Bio&#8217;s supply chain, which would expose Sesen Bio to a number of risks that may delay development, regulatory approval and commercialization or result in higher product costs.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In connection with Sesen Bio&#8217;s decision to voluntarily pause further development of Vicineum, Sesen Bio terminated its agreements with its CMOs and requested that such manufacturers cease all work under the respective agreements and refrain from incurring any additional costs or expenses. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If Sesen Bio resumes clinical development of Vicineum for the treatment of NMIBC, Sesen Bio would likely be dependent on third-party manufacturers, as well as third parties for Sesen Bio&#8217;s supply chain. Sesen Bio&#8217;s reliance on third-party manufacturers would expose it to certain risks that it would not be subject to if Sesen Bio manufactured Vicineum itself, including: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">It may be difficult or impossible for Sesen Bio to find replacement manufacturers on acceptable terms quickly, or at all. Identifying alternate manufacturers may be difficult because the number of potential manufacturers that have the necessary expertise to produce biologics is limited. Additionally, the FDA must approve any alternative manufacturer before Sesen Bio may use the alternative manufacturer to produce clinical supply of Vicineum. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">The development of manufacturing capabilities to produce clinical supply of Vicineum may require Sesen Bio&#8217;s third-party manufacturers to invest substantial additional funds and to hire and retain </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">45</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:30pt; width:426pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">technical personnel who have the necessary manufacturing experience. Sesen Bio&#8217;s third-party manufacturers may fail to devote sufficient time and resources to develop the capabilities to manufacture Vicineum. </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Because of the complex nature of Vicineum, Sesen Bio&#8217;s third-party manufacturers, or other third parties it relies on, may encounter difficulties in achieving the volume of production needed to satisfy its clinical supply demands, may not be able to achieve such volume at an acceptable cost, may experience technical issues that impact comparability, quality, or compliance with applicable regulations governing the manufacture of biological products, and may experience shortages of qualified personnel to adequately staff production operations. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio&#8217;s third-party manufacturers could default on their agreements with Sesen Bio to meet its requirements for supply of Vicineum, or they may terminate or decide not to renew their agreements with Sesen Bio, based on their own business priorities, at a time that is costly or damaging to Sesen Bio. If Sesen Bio&#8217;s third-party manufacturers were to terminate its arrangements or fail to meet its manufacturing demands, Sesen Bio may be delayed in its ability to obtain and maintain regulatory approval of Vicineum for the treatment of NMIBC. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">If any third-party manufacturer makes improvements in the manufacturing process for Vicineum, Sesen Bio may not own, or may have to share, the intellectual property rights to such improvements. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">A third-party manufacturer may gain knowledge from working with Sesen Bio that could be used to supply one of its competitors with a product that competes with Sesen Bio&#8217;s. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio&#8217;s reliance on third-party manufacturers reduces its control over production and supply of Vicineum but does not relieve Sesen Bio of its responsibility to ensure compliance with applicable legal and regulatory standards. The FDA and other non-U.S. regulatory authorities require that Sesen Bio&#8217;s product candidates and any products that it may eventually commercialize be manufactured according to cGMP and similar non-U.S. standards. Methods of manufacture as well as validation of manufacturing procedures and quality control systems are reviewed by regulatory authorities, such as the FDA and other comparable non-U.S. regulatory authorities, to determine their effect on the quality, purity and potency of product candidates. All such manufacturing procedures, validation programs and quality assessment activities must be properly documented in accordance with regulatory requirements. Any failure by Sesen Bio&#8217;s third-party manufacturers to comply with cGMP or similar non-U.S. standards, including any failure to deliver sufficient quantities of product candidates in a timely manner, could lead to a delay in or failure to obtain regulatory approval of Vicineum for the treatment of NMIBC if Sesen Bio resumes clinical development of Vicineum. For example, Sesen Bio may be unable to resolve the issues raised in the CRL pertaining to a recent pre-approval inspection and product quality. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, a failure by Sesen Bio&#8217;s third-party manufactures to comply with cGMP or similar non-U.S. standards could be the basis for the FDA or any other non-U.S. regulatory authorities to issue a warning or untitled letter, withdraw approvals for product candidates previously granted to Sesen Bio or take other regulatory or legal action, including recall or seizure, total or partial suspension of production, suspension of ongoing clinical trials, refusal to approve pending applications or supplemental applications, detention of product, refusal to permit the import or export of products, injunction, imposing administrative or civil penalties or pursuing criminal prosecution. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If Sesen Bio resumes clinical development of Vicineum for the treatment of NMIBC and if Sesen Bio or its third-party manufacturers fail to comply with environmental, health and safety laws and regulations, Sesen Bio could become subject to fines or penalties or incur significant costs.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If Sesen Bio resumes clinical development of Vicineum for the treatment of NMBIC and engages third-party manufacturers, such manufacturers would be subject to numerous environmental, health and safety laws and regulations, including those governing laboratory procedures and the handling, use, storage, treatment and disposal of hazardous materials and wastes. Any such operations may involve the use of hazardous and flammable materials, including chemicals and biological materials, and may produce hazardous waste products. Historically, Sesen Bio has generally contracted with third parties for the disposal of these materials and wastes. Sesen Bio cannot eliminate the risk of contamination or injury from these materials. In the event of contamination or injury resulting from its use of hazardous materials, Sesen Bio could be held </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">46</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">liable for any resulting damages and any liability could exceed its resources. Sesen Bio also could incur significant costs associated with civil or criminal fines and penalties for failure to comply with such laws and regulations. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Although Sesen Bio maintains workers&#8217; compensation insurance to cover it for costs and expenses it may incur due to injuries to its employees resulting from the use of hazardous materials, this insurance may not provide adequate coverage against potential liabilities. Sesen Bio does not maintain insurance for environmental liability or toxic tort claims that may be asserted against it in connection with its storage or disposal of biological, hazardous or radioactive materials. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, if Sesen Bio resumes clinical development of Vicineum, Sesen Bio may incur substantial costs in order to comply with current or future environmental, health and safety laws and regulations. These current or future laws and regulations may impair its research, development or production efforts. Sesen Bio&#8217;s failure to comply with these laws and regulations also may result in substantial fines, penalties or other sanctions. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Further, with respect to the operations of third-party contract manufacturers, if any, it is possible that if they fail to operate in compliance with applicable environmental, health and safety laws and regulations or properly dispose of wastes associated with its products, Sesen Bio could be held liable for any resulting damages, suffer reputational harm or experience a disruption in the manufacture and supply of its product candidates or products. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Risks Related to Sesen Bio&#8217;s Intellectual Property if the Merger is Not Completed</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If Sesen Bio resumes clinical development of Vicineum for the treatment of NMIBC and is unable to obtain and maintain patent protection for its technology or products, or if its licensors are unable to obtain and maintain patent protection for the technology or products that Sesen Bio licenses from them, or if the scope of the patent protection obtained is not sufficiently broad, Sesen Bio&#8217;s competitors could develop and commercialize technology and products similar or identical to theirs, and its ability to successfully commercialize it technology and products may be impaired.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If Sesen Bio resumes clinical development of Vicineum for the treatment of NMIBC, Sesen Bio&#8217;s success depends in large part on the ability of both it and its licensors&#8217; to obtain and maintain patent protection in the U.S. and other countries with respect to Vicineum and its other proprietary technology and product candidates. Sesen Bio and its licensors have sought to protect Sesen Bio&#8217;s proprietary position by filing patent applications in the U.S. and abroad related to its novel technologies and product candidates. The patent prosecution process is expensive and time-consuming, and Sesen Bio may not be able to file and prosecute all necessary or desirable patent applications in jurisdictions of interest at a reasonable cost or in a timely manner. It is also possible that Sesen Bio will fail to identify patentable aspects of its research and development output before it is too late to obtain patent protection. Moreover, in some circumstances, Sesen Bio does not have the right to control the preparation, filing and prosecution of patent applications, or to maintain the patents, covering technology that it licenses from third parties. Therefore, these patents and applications may not be prosecuted and enforced in a manner consistent with the best interests of Sesen Bio&#8217;s business. If such licensors fail to maintain such patents, or lose rights to those patents, the rights Sesen Bio has licensed may be reduced or eliminated. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The patent position of biotechnology and pharmaceutical companies generally is highly uncertain, involves complex legal and factual questions and has in recent&#160;years been the subject of much litigation. As a result, the issuance, scope, validity, enforceability and commercial value of Sesen Bio&#8217;s and its licensors&#8217; patent rights are highly uncertain. Sesen Bio&#8217;s and its licensors&#8217; pending and future patent applications may not result in patents being issued which protect its technology or products or which effectively prevent others from commercializing competitive technologies and products. In addition, the laws of non-U.S. countries may not protect Sesen Bio&#8217;s rights to the same extent as the laws of the U.S. For example, European patent law restricts the patentability of methods of treatment of the human body more than U.S. law does. Publications of discoveries in the scientific literature often lag behind the actual discoveries, and patent applications in the U.S. and other jurisdictions are typically not published until 18&#160;months after filing, or in some cases not at all. Therefore, Sesen Bio cannot know with certainty whether it or its licensors were the first to make the inventions claimed in its owned or licensed patents or pending patent applications, or </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">47</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">that Sesen Bio or its licensors were the first to file for patent protection of such inventions. As a result, the issuance, scope, validity, enforceability and commercial value of Sesen Bio&#8217;s owned or licensed patent rights are highly uncertain. Sesen Bio&#8217;s pending and future patent applications may not result in patents being issued which protect its technology or products, in whole or in part, or which effectively prevent others from commercializing competitive technologies and products. In particular, during prosecution of any patent application, the issuance of any patents based on the application may depend upon Sesen Bio&#8217;s ability to generate additional pre-clinical or clinical data that support the patentability of its proposed claims. Sesen Bio may not be able to generate sufficient additional data on a timely basis, or at all. Moreover, changes in either the patent laws or interpretation of the patent laws in the U.S. and other countries may diminish the value of Sesen Bio&#8217;s patents or narrow the scope of Sesen Bio&#8217;s patent protection. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Moreover, Sesen Bio may be subject to a third-party preissuance submission of prior art to the U.S. Patent and Trademark Office, or the USPTO, or become involved in opposition, derivation, reexamination, inter partes review, post-grant review or interference proceedings challenging its patent rights or the patent rights of others. An adverse determination in any such submission, proceeding or litigation could reduce the scope of, or invalidate, Sesen Bio&#8217;s patent rights, allow third parties to commercialize its technology or products and compete directly with Sesen Bio, without payment to it, or result in Sesen Bio&#8217;s inability to manufacture or commercialize products without infringing third-party patent rights. In addition, if the breadth or strength of protection provided by Sesen Bio&#8217;s patents and patent applications is threatened, it could dissuade companies from collaborating with Sesen Bio to license, develop or commercialize current or future product candidates. In addition, invalidation of Sesen Bio&#8217;s patent rights by third parties could jeopardize the anticipated revenue streams from current licensees. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Even if Sesen Bio&#8217;s owned and licensed patent applications issue as patents, they may not issue in a form that will provide Sesen Bio with any meaningful protection, prevent competitors from competing with Sesen Bio or otherwise provide Sesen Bio with any competitive advantage. Sesen Bio&#8217;s competitors may be able to circumvent Sesen Bio&#8217;s owned or licensed patents by developing similar or alternative technologies or products in a non-infringing manner. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The issuance of a patent is not conclusive as to its inventorship, scope, validity or enforceability, and Sesen Bio&#8217;s owned and licensed patents may be challenged in the courts or patent offices in the U.S. and abroad. Such challenges may result in loss of exclusivity or freedom to operate or in patent claims being narrowed, invalidated or held unenforceable, in whole or in part, which could limit Sesen Bio&#8217;s ability to stop others from using or commercializing similar or identical technology and products, or limit the duration of the patent protection of its technology and products. Given the amount of time required for the development, testing and regulatory review of new product candidates, patents protecting such candidates might expire before or shortly after such candidates are commercialized. As a result, Sesen Bio&#8217;s owned and licensed patent portfolio may not provide it with sufficient rights to exclude others from commercializing products similar or identical to Sesen Bio&#8217;s. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Sesen Bio may not be able to protect its intellectual property rights throughout the world.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If Sesen Bio resumes clinical development of Vicineum for the treatment of NMIBC, filing, prosecuting and defending patents on Vicineum and Sesen Bio&#8217;s other product candidates and technologies throughout the world would be prohibitively expensive, and Sesen Bio&#8217;s or its licensors&#8217; intellectual property rights in some countries outside the U.S. can be less extensive than those in the U.S. In addition, the laws and practices of countries outside the U.S. do not protect intellectual property rights to the same extent as federal and state laws in the U.S. Moreover, the intellectual property laws of the U.S. change over time. For example, several United States Supreme Court cases have redefined what is considered to be patentable subject matter. Consequently, if Sesen Bio resumes clinical development of Vicineum for the treatment of NMIBC, Sesen Bio and its licensors may not be able to prevent third parties from practicing Sesen Bio&#8217;s and its licensors&#8217; inventions in all countries inside or outside the U.S., or from selling or importing products made using Sesen Bio&#8217;s and its licensors&#8217; inventions in and into the U.S. or other jurisdictions. Competitors may use Sesen Bio&#8217;s technologies in jurisdictions where it has not obtained patent protection to develop their own products and may export infringing products to territories where Sesen Bio or its licensors have patent protection, but where enforcement is not as strong as in the U.S. These products may compete with Sesen Bio&#8217;s products in jurisdictions where it does not have any issued patents and Sesen Bio&#8217;s patent claims or other intellectual property rights may not be effective or sufficient to prevent them from so competing. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">48</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Many companies have encountered significant problems in protecting and defending intellectual property rights in non-U.S. jurisdictions. The legal systems of certain countries, particularly certain developing countries, do not favor the enforcement of patents and other intellectual property protection, particularly those relating to biopharmaceuticals, which could make it difficult for Sesen Bio to stop the infringement of Sesen Bio&#8217;s or its licensor&#8217;s patents or marketing of competing products in violation of Sesen Bio&#8217;s proprietary rights generally in those countries. If Sesen Bio resumes clinical development of Vicineum for the treatment of NMIBC, proceedings to enforce Sesen Bio&#8217;s patent rights in non-U.S. jurisdictions could result in substantial cost and divert its efforts and attention from other aspects of its business, could put Sesen Bio&#8217;s and its licensors&#8217; patents at risk of being invalidated or being interpreted narrowly and put Sesen Bio&#8217;s and its licensors&#8217; patent applications at risk of not issuing and could provoke third parties to assert claims against Sesen Bio or its licensors. Sesen Bio or its licensors may not prevail in any lawsuits that Sesen Bio or its licensors initiate, and the damages or other remedies awarded, if any, may not be commercially meaningful. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The laws of certain countries outside of the U.S. may not protect Sesen Bio&#8217;s rights to the same extent as the laws of the U.S., and such laws may also be subject to change. For example, methods of treatment and manufacturing processes may not be patentable in certain jurisdictions, and the requirements for patentability may differ in certain countries, particularly developing countries. Furthermore, generic and/or biosimilar product manufacturers or other competitors may challenge the scope, validity or enforceability of Sesen Bio&#8217;s or its licensors&#8217; patents, requiring Sesen Bio or its licensors to engage in complex, lengthy and costly litigation or other proceedings. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Generic or biosimilar product manufacturers may develop, seek approval for, and generic versions or biosimilar versions, respectively, of Sesen Bio&#8217;s products. The FDA has published several guidance documents on biosimilar product development. If a biosimilar product is also found to be interchangeable with a reference product, it may be substituted for the reference product. Complexities associated with the larger, and often more complex, structures of biological products, as well as the process by which such products are manufactured, pose significant hurdles to implementation, which are still being worked out by the FDA. If Sesen Bio resumes clinical development of Vicineum for the treatment of NMIBC, and if Vicineum is approved by the FDA, the approval of a biologic product biosimilar to or interchangeable with Vicineum could have a material impact on Sesen Bio&#8217;s business. In particular, a biosimilar could be significantly less costly to bring to market and priced significantly lower than Sesen Bio&#8217;s products, if approved by the FDA. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Many countries, including E.U. countries, have compulsory licensing laws under which a patent owner may be compelled under certain circumstances to grant licenses to third parties. In those countries, Sesen Bio and its licensors may have limited remedies if patents are infringed or if Sesen Bio or its licensors are compelled to grant a license to a third party, which could materially diminish the value of those patents. This could limit Sesen Bio&#8217;s potential revenue opportunities. Accordingly, Sesen Bio&#8217;s and its licensors&#8217; efforts to enforce intellectual property rights around the world may be inadequate to obtain a significant commercial advantage from the intellectual property that Sesen Bio owns or licenses. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Sesen Bio has been dependent on its license agreements with the University of Zurich, or Zurich, Micromet AG, or Micromet, and XOMA Ireland Limited, or XOMA, and if Sesen Bio cannot meet the requirements under the agreements, it could lose important rights to Vicineum, which could have material adverse effect on Sesen Bio&#8217;s business if it resumes clinical development of Vicineum for the treatment of NMIBC.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio has an exclusive license agreement with Zurich, or the Zurich License Agreement. Pursuant to the Zurich License Agreement, Sesen Bio was granted an exclusive license, with the right to sublicense, under certain patents primarily relating, in part, to Sesen Bio&#8217;s targeting agents, EpCAM chimera and immunoconjugates (including aspects of Vicineum for the treatment of NMIBC and Vicineum for the treatment of SCCHN) and methods of use, to make, use, sell and import products that would otherwise infringe such patents in the field of the treatment, stasis and palliation of disease in humans. If Sesen Bio resumes clinical development of Vicineum for the treatment of NMIBC, and if Sesen Bio fails to meet its obligations under the Zurich License Agreement, Zurich may have the right to terminate Sesen Bio&#8217;s license, and upon the effective date of such termination, Sesen Bio&#8217;s right to use the licensed Zurich patent rights would end. To the extent such licensed technology or patent rights relate to Sesen Bio&#8217;s product candidates, Sesen Bio would expect to exercise all rights and remedies available to it, including attempting to cure any </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">49</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">breach by Sesen Bio, and otherwise seek to preserve its rights under the patent rights licensed to Sesen Bio, but it may not be able to do so in a timely manner, at an acceptable cost to Sesen Bio or at all. Any uncured, material breach under the Zurich License Agreement could result in Sesen Bio&#8217;s loss of rights to practice the patent rights licensed to it under the Zurich License Agreement, and to the extent such patent rights and other technology relate to its product candidates or other of its compounds, it could have a material adverse effect on Sesen Bio&#8217;s ability to complete a sale of its Vicineum asset to a potential partner. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio also has a license agreement with Micromet, or the Micromet License Agreement, which grants it non-exclusive rights, with certain sublicense rights, for know-how and patents allowing exploitation of certain single chain antibody products. If Sesen Bio resumes clinical development of Vicineum for the treatment of NMIBC, and if Sesen Bio fails to meet its obligations under the Micromet License Agreement, Micromet may have the right to terminate Sesen Bio&#8217;s license, and upon the effective date of such termination, Sesen Bio&#8217;s right to use the licensed Micromet patent rights would end. To the extent such licensed technology or patent rights relate to Sesen Bio&#8217;s product candidates, Sesen Bio would expect to exercise all rights and remedies available to it, including attempting to cure any breach by Sesen Bio, and otherwise seek to preserve its rights under the patent rights licensed to it, but Sesen Bio may not be able to do so in a timely manner, at an acceptable cost to Sesen Bio or at all. Any uncured, material breach under the Micromet License Agreement could result in Sesen Bio&#8217;s loss of rights to practice the patent rights licensed to it under the Micromet License Agreement, and to the extent such patent rights and other technology relate to its product candidates or other of its compounds, it could have a material adverse effect on Sesen Bio&#8217;s ability to complete a sale of its Vicineum asset to a potential partner. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio also has a license agreement with XOMA, or the XOMA License Agreement, which grants Sesen Bio non-exclusive rights, with certain sublicense rights, to certain XOMA patent rights and know-how related to certain expression technology, including plasmids, expression strains, plasmid maps and production systems. If Sesen Bio resumes clinical development of Vicineum for the treatment of NMIBC, and if Sesen Bio&#8217;s fails to meet its obligations under the XOMA License Agreement, XOMA may have the right to terminate Sesen Bio&#8217;s license, and upon the effective date of such termination, Sesen Bio&#8217;s right to use the licensed XOMA patent rights and related know-how would end. To the extent such licensed technology or patent rights relate to Sesen Bio&#8217;s product candidates, Sesen Bio would expect to exercise all rights and remedies available to it, including attempting to cure any breach by Sesen Bio, and otherwise seek to preserve its rights under the patent rights licensed to it, but Sesen Bio may not be able to do so in a timely manner, at an acceptable cost to Sesen Bio or at all. Any uncured, material breach under the XOMA License Agreement could result in Sesen Bio&#8217;s loss of rights to practice the patent rights licensed to it under the XOMA License Agreement, and to the extent such patent rights and other technology relate to Sesen Bio&#8217;s product candidates or other of its compounds, it could have a material adverse effect on Sesen Bio&#8217;s ability to complete a sale of its Vicineum asset to a potential partner. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Sesen Bio may become involved in lawsuits to protect or enforce its patents or other intellectual property, which could be expensive, time consuming and unsuccessful.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If the merger is not completed and Sesen Bio does not pursue a liquidation and dissolution or alternative strategic transaction, competitors may infringe Sesen Bio&#8217;s issued patents or other intellectual property. To counter infringement or unauthorized use, Sesen Bio may be required to file infringement claims, which can be expensive and time consuming. Any claims Sesen Bio asserts against perceived infringers could provoke these parties to assert counterclaims against it alleging that Sesen Bio infringes their patents, trademarks or other intellectual property. In addition, in a patent infringement proceeding, a court may decide that a patent of Sesen Bio&#8217;s is invalid or unenforceable, in whole or in part, construe the patent&#8217;s claims narrowly or refuse to stop the other party from using the technology at issue on the grounds that Sesen Bio&#8217;s patents do not cover the technology in question. An adverse result in any litigation proceeding could put one or more of Sesen Bio&#8217;s patents at risk of being invalidated or interpreted narrowly. In a trademark infringement proceeding, Sesen Bio could be enjoined from continued use of a trademark deemed to be infringing and forced to rebrand product packaging, product inserts, market and advertising materials, resulting in a loss of sales and established goodwill in that name or mark. In addition, Sesen Bio could be found liable for monetary damages, including treble damages and attorneys&#8217; fees if it is found to have willfully infringed a trademark. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">50</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Furthermore, because of the substantial amount of discovery required in connection with intellectual property litigation, there is a risk that some of Sesen Bio&#8217;s confidential information could be compromised by disclosure during this type of litigation. Even if resolved in Sesen Bio&#8217;s favor, litigation or other legal proceedings relating to intellectual property claims may cause Sesen Bio to incur significant expenses and could distract its technical and management personnel from their normal responsibilities. In addition, there could be public announcements of the results of hearings, motions or other interim proceedings or developments and if securities analysts or investors perceive these results to be negative, it could have a substantial adverse effect on the price of Sesen Bio&#8217;s common stock. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Third parties may initiate legal proceedings alleging that Sesen Bio is infringing their intellectual property rights, the outcome of which would be uncertain and could have a material adverse effect on the success of Sesen Bio&#8217;s business.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio&#8217;s only prospective revenue streams currently depends upon the ability of Roche to develop, manufacture, market and/or sell certain of Sesen Bio&#8217;s legacy technology without infringing the proprietary rights of third parties. There is considerable intellectual property litigation in the biotechnology and pharmaceutical industries. Sesen Bio or Roche may become party to, or threatened with, future adversarial proceedings or litigation regarding intellectual property rights with respect to Sesen Bio&#8217;s current or former products and technology, including interference or derivation proceedings before the USPTO. The risks of being involved in such litigation and proceedings may increase as Sesen Bio gains the greater visibility associated with seeking strategic alternatives. Third parties may assert infringement claims against Sesen Bio or Roche based on existing patents or patents that may be granted in the future. Sesen Bio may not be aware of all such intellectual property rights potentially relating to its former product candidates and their uses. Thus, Sesen Bio does not know with certainty that any product candidate, or commercialization thereof, does not and will not infringe or otherwise violate any third party&#8217;s intellectual property. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If Sesen Bio or Roche are found to infringe a third party&#8217;s intellectual property rights, Sesen Bio could be required to obtain a license from such third party to continue developing and marketing Sesen Bio&#8217;s products and technology. However, Sesen Bio may not be able to obtain any required license on commercially reasonable terms or at all. Even if Sesen Bio were able to obtain a license, it could be non-exclusive, thereby giving its competitors access to the same technologies licensed to Sesen Bio. Sesen Bio or Roche could be forced, including by court order, to cease commercializing the infringing technology or product. In addition, Sesen Bio or Roche could be found liable for monetary damages, including treble damages and attorneys&#8217; fees if Sesen Bio or Roche is found to have willfully infringed a patent. A finding of infringement could prevent Roche from commercializing Sesen Bio&#8217;s former product candidates. Claims that Sesen Bio has misappropriated the confidential information or trade secrets of third parties could have a similar negative impact on Sesen Bio&#8217;s ability to profit from the Roche Asset Purchase Agreement. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Risks Related to Regulatory Compliance if the Merger is Not Completed</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Sesen Bio&#8217;s failure to comply with data protection laws and regulations could lead to government enforcement actions and significant penalties against Sesen Bio, and adversely impact its operating results.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The regulatory environment surrounding information security, data collection, and privacy is increasingly demanding. In the U.S., Sesen Bio is subject to a number of data protection laws and regulations (i.e., laws and regulations that address privacy and data security) at both the federal and state levels. The legislative and regulatory landscape for data protection continues to evolve, and in recent&#160;years there has been an increasing focus on privacy and data security issues. Numerous federal and state laws, including state data breach notification laws, state health information privacy laws, and federal and state consumer protection laws, such as Section&#160;5 of the Federal Trade Commission Act, govern the collection, use, and disclosure of health-related and other personal information. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In addition, Sesen Bio may obtain health information from third parties that are subject to privacy and security requirements in the U.S. under the Health Insurance Portability and Accountability Act, or HIPAA. Although Sesen Bio is not directly subject to HIPAA&#8201;&#8212;&#8201;other than potentially with respect to providing certain employee benefits&#8201;&#8212;&#8201;Sesen Bio could be subject to criminal penalties if Sesen Bio knowingly obtains, uses or discloses individually identifiable health information maintained by a HIPAA-covered entity in a </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">51</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">manner that is not authorized or permitted by HIPAA. Finally, a data breach affecting sensitive personal information, including health information, could result in significant legal and financial exposure and reputational damages that could potentially have an adverse effect on Sesen Bio&#8217;s business. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In addition to U.S. data protection laws and regulations, Sesen Bio also may be subject to European and other international data protection requirements, such as the E.U. General Data Protection Regulation. Sesen Bio failures to comply with data privacy and security laws and regulations, or changes in the way in which these laws are implemented, could lead to unfavorable outcomes, including increased compliance costs, delays or impediments in the development of new products, increased operating costs, diversion of management time and attention, regulatory liability as a result of government enforcement actions and significant penalties against Sesen Bio, civil liability as a result of claims initiated by data subjects (including claims initiated as class actions) contracting parties or other third parties as a result of non-compliance with data protection laws and/or contractual obligations, and adverse publicity that could negatively affect Sesen Bio&#8217;s operating results, financial condition and Sesen Bio&#8217;s overall and business. Federal regulators, state attorneys general, and plaintiffs&#8217; attorneys, including class action attorneys, have been and will likely continue to be active in this space. Such liabilities could adversely impact Sesen Bio&#8217;s results of operations, financial condition and its overall business. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If Sesen Bio resumes clinical development of Vicineum for the treatment of NMIBC, laws and regulations governing any international operations Sesen Bio may have in the future may preclude Sesen Bio from developing, manufacturing and selling certain products outside of the U.S. and require Sesen Bio to develop and implement costly compliance programs.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If the merger is not consummated and Sesen Bio does not decide to pursue a liquidation and dissolution or alternative strategic transaction, Sesen Bio must dedicate additional resources to comply with numerous laws and regulations in each jurisdiction in which Sesen Bio operates. The Foreign Corrupt Practices Act, or the FCPA, prohibits any U.S. individual or business from paying, offering, authorizing payment or offering of anything of value, directly or indirectly, to any non-U.S. official, political party or candidate for the purpose of influencing any act or decision of the non-U.S. entity in order to assist the individual or business in obtaining or retaining business. The FCPA also obligates companies whose securities are listed in the U.S. to comply with certain accounting provisions requiring Sesen Bio to maintain books and records that accurately and fairly reflect all transactions of the corporation, including international subsidiaries, and to devise and maintain an adequate system of internal accounting controls for international operations. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Compliance with the FCPA is expensive and difficult, particularly in countries in which corruption is a recognized problem. In addition, the FCPA presents particular challenges in the pharmaceutical industry, because, in many countries, hospitals are operated by the government, and doctors and other hospital employees are considered non-U.S. officials. Certain payments to hospitals in connection with clinical trials and other work have been deemed to be improper payments to government officials and have led to FCPA enforcement actions. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Various laws, regulations and executive orders also restrict the use and dissemination outside of the U.S., or the sharing with certain non-U.S. nationals, of information classified for national security purposes, as well as certain products and technical data relating to those products. If the merger is not consummated and Sesen Bio does not decide to pursue a liquidation and dissolution or alternative strategic transaction, and if Sesen Bio expands its presence outside of the U.S., it will require Sesen Bio to dedicate additional resources to comply with these laws, and these laws may preclude Sesen Bio from developing, manufacturing, or selling certain products and product candidates outside of the U.S., which could limit Sesen Bio&#8217;s growth potential and increase its development costs. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The failure to comply with laws governing international business practices may result in substantial civil and criminal penalties and suspension or debarment from government contracting. The SEC also may suspend or bar issuers from trading securities on U.S. exchanges for violations of the FCPA&#8217;s accounting provisions. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If the merger is not consummated and Sesen Bio does not decide to pursue a liquidation and dissolution or alternative strategic transaction, Sesen Bio&#8217;s employees may engage in misconduct or other improper </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">52</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">activities, including non-compliance with regulatory standards and requirements, which could cause significant liability for Sesen Bio and harm its reputation. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If the merger is not consummated and Sesen Bio does not decide to pursue a liquidation and dissolution or alternative strategic transaction, Sesen Bio could be exposed to the risk of employee fraud or other misconduct, including intentional failure to comply with FDA regulations or similar regulations of comparable non-U.S. regulatory authorities, failure to provide accurate information to the FDA or comparable non-U.S. regulatory authorities, including the competent authorities of the E.U. member states, failure to comply with manufacturing standards Sesen Bio has established, if any, failure to comply with federal and state healthcare fraud and abuse laws and regulations and similar laws and regulations established and enforced by comparable non-U.S. regulatory authorities, and failure to report financial information or data accurately or disclose unauthorized activities to Sesen Bio. Employee misconduct could also involve the improper use of information obtained in the course of clinical trials, which could result in regulatory sanctions and serious harm to Sesen Bio&#8217;s reputation. It is not always possible to identify and deter employee misconduct, and the precautions Sesen Bio takes to detect and prevent this activity may not be effective in controlling unknown or unmanaged risks or losses or in protecting Sesen Bio from governmental investigations or other actions or lawsuits stemming from a failure to be in compliance with such laws, standards or regulations. If any such actions are instituted against Sesen Bio, and it is not successful in defending itself or asserting its rights, those actions could have a significant impact on its business and results of operations, including the imposition of significant fines or other sanctions. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Risks Related to Sesen Bio&#8217;s Business if the Merger is Not Completed</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Sesen Bio relies significantly on information technology and any failure, inadequacy, interruption or security lapse of that technology, including any cyber security incidents, could materially adversely affect its business.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In the ordinary course of business, Sesen Bio relies on information technology networks and systems, some of which are provided, hosted or managed by third parties, to collect, store, process and transmit electronic data. In addition, Sesen Bio handles certain data, including proprietary business information and personal information that is subject to data protection laws and regulations. Despite the implementation of security measures, Sesen Bio&#8217;s internal computer systems and those of third parties with which it contracts are vulnerable to damage from cyber-attacks, computer viruses, unauthorized access, natural disasters, terrorism, war and telecommunication and electrical failures. System failures, accidents or security breaches could cause interruptions in Sesen Bio&#8217;s operations and could result in a material disruption of its clinical and commercialization activities, if Sesen Bio resumes clinical development of Vicineum for the treatment of NMIBC, and business operations, in addition to possibly requiring substantial expenditures of resources to remedy. The loss of clinical trial data could result in delays in Sesen Bio&#8217;s regulatory approval efforts, if Sesen Bio resumes clinical development of Vicineum for the treatment of NMIBC, and significantly increase its costs to recover or reproduce the data. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Although Sesen Bio has implemented processes, procedures, and controls to help mitigate the risks associated with a cyber security incident, there can be no assurance that these measures will be sufficient for all possible situations. Even security measures that are appropriate, reasonable, and/or in accordance with applicable legal requirements may not be able to protect the networks, systems and information that Sesen Bio maintains and those of third parties with which Sesen Bio contracts. Unauthorized parties, whether within or outside Sesen Bio, may disrupt or gain access to its systems, or those of third parties with whom Sesen Bio does business, through human error, misfeasance, fraud, trickery or other forms of deceit, including break-ins, use of stolen credentials, social engineering, phishing, ransomware, computer viruses or other malicious codes, and similar means of unauthorized and destructive tampering. Even the most well-protected information, networks, systems and facilities remain potentially vulnerable because the techniques used in such attempted cyber security incidents evolve and generally are not recognized until launched against a target. Accordingly, Sesen Bio may be unable to anticipate these techniques or to implement adequate security barriers or other preventative measures, making it impossible for Sesen Bio to entirely mitigate this risk. While Sesen Bio has experienced, and expects to continue to experience, threats and disruptions to its information technology infrastructure, none of them to date has had a material impact on its business or operations. To the extent that any disruption or security breach were to result in a loss of, or damage to, its data or applications, or inappropriate disclosure of confidential or proprietary information, </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">53</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">its clinical development of Vicineum for the treatment of NMIBC could be delayed if Sesen Bio resumes such clinical development, or Sesen Bio could be subject to regulatory and other government investigations, enforcement actions, or incur liability, substantial fines or costs, any of which could materially adversely affect its business, its reputation, results of operations and financial condition. Although Sesen Bio maintains insurance coverage for various cyber security risks, there can be no guarantee that all costs or losses incurred will be fully insured. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Sesen Bio and certain of its officers have been named as defendants in three pending securities class action lawsuits. These lawsuits, and potential similar or related lawsuits, could result in substantial damages, divert Sesen Bio management&#8217;s time and attention from Sesen Bio&#8217;s business, and have a material adverse effect on Sesen Bio&#8217;s results of operations. These lawsuits, and any other lawsuits to which Sesen Bio is subject, will be costly to defend and are uncertain in their outcome.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On August&#160;19, 2021, August&#160;31, 2021, and October&#160;7, 2021, three substantially identical securities class action lawsuits captioned </font><font style="font-style:italic;letter-spacing:0.2pt;">Bibb v. Sesen Bio, Inc., et. al.</font><font style="letter-spacing:0.2pt;">, Case No. 1:21-cv-07025, </font><font style="font-style:italic;letter-spacing:0.2pt;">Cizek v. Sesen Bio, Inc., et.&#160;al.</font><font style="letter-spacing:0.2pt;">, Case No. 1:21-cv-07309 and </font><font style="font-style:italic;letter-spacing:0.2pt;">Markman v. Sesen Bio, Inc. et al.</font><font style="letter-spacing:0.2pt;">, Case No. 1:21-cv-08308 were filed against Sesen Bio and certain of its officers in the U.S. District Court for the Southern District of New York. The three complaints alleged violations of Sections&#160;10(b) and 20(a) of the Exchange Act and Rule&#160;10b-5 promulgated thereunder based on statements made by Sesen Bio concerning its BLA for Vicineum for the treatment of BCG-unresponsive NMIBC. The three complaints sought compensatory damages and costs and expenses, including attorneys&#8217; fees. On October&#160;29, 2021, the court consolidated the three cases under the caption </font><font style="font-style:italic;letter-spacing:0.2pt;">In re Sesen Bio, Inc. Securities Litigation</font><font style="letter-spacing:0.2pt;">, Master File No. 1:21-cv-07025-AKH, or the Securities Litigation, and appointed Ryan Bibb, Rodney Samaan, Lionel Dreshaj and Benjamin Dreshaj as the lead plaintiffs, or collectively, the Lead Plaintiffs, under the Private Securities Litigation Reform Act. On November&#160;1, 2021, two stockholders filed motions to reconsider asking the court to appoint a different lead plaintiff. On November&#160;24, 2021, defendants filed a motion to transfer venue to the U.S. District Court for the District of Massachusetts. That motion was fully briefed as of December&#160;13, 2021, but the court has not ruled on that motion. On December&#160;6, 2021, the Lead Plaintiffs filed an amended class action complaint, or the Amended Complaint. The Amended Complaint alleges the same violations of Sections&#160;10(b) and 20(a) of the Exchange Act and Rule&#160;10b-5 promulgated thereunder on the same theory as the prior complaints. The defendants moved to dismiss the Amended Complaint on March&#160;7, 2022, and that motion was fully briefed on May&#160;6, 2022. On June&#160;3, 2022, before the court ruled on the motion to dismiss, the parties requested that the court hold any decision on the motion to dismiss in abeyance to provide the parties with an opportunity to engage in mediation. On June&#160;30, 2022 and July&#160;6, 2022, Sesen Bio and the plaintiffs engaged in mediation sessions in an attempt to resolve the Securities Litigation and continued to discuss a potential settlement over the following weeks. On July&#160;19, 2022, the parties reached an agreement in principle to settle the Securities Litigation. Pursuant to that agreement, Sesen Bio and the individual defendants will pay or cause to be paid to members of the class who submit timely and valid proofs of claims. In exchange, the Lead Plaintiffs will dismiss the action and all class members who do not timely and validly opt-out of the settlement will provide broad customary releases to Sesen Bio and the individual defendants. On August&#160;3, 2022, the parties entered into a Stipulation and Agreement of Settlement to settle the Securities Litigation, which was filed with the court on August&#160;17, 2022. The Stipulation and Agreement of Settlement related to the Securities Litigation provides for a settlement payment of $21.0&#160;million to the class and the dismissal of all claims against Sesen Bio and the other defendants. The settlement payment is being funded by Sesen Bio and its insurance carriers. On September&#160;1, 2022, the U.S. District Court for the Southern District of New York issued an order denying the motions to appoint a different lead plaintiff. On September&#160;28, 2022, the court issued an order granting preliminary approval of the proposed settlement of the Securities Litigation. The court has set a final settlement approval hearing for January&#160;23, 2023 at 10:00&#160;a.m. local time. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio, the Sesen Bio board of directors and the individual defendants continue to deny all allegations of any wrongdoing, but are seeking to settle the Securities Litigation to avoid the uncertainty, risk, expense and distraction of protracted litigation. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio may be the target of similar litigation in the future. The market price of its common stock has experienced and may continue to experience volatility, and in the past, companies that have experienced volatility in the market price of their stock have been subject to securities litigation. Any future litigation could result in substantial costs and divert Sesen Bio management&#8217;s attention from other business concerns, </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">54</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">which could seriously harm its business. Sesen Bio maintains liability insurance; however, if any costs or expenses associated with the pending lawsuits or any other litigation exceed Sesen Bio&#8217;s insurance coverage, Sesen Bio may be forced to bear some or all costs and expenses directly, which could adversely affect its business, financial condition, results of operations or stock price. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Risks Related to Ownership of Sesen Bio Common Stock if the Merger is Not Completed</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If Sesen Bio is unable to regain compliance with the listing requirements of the Nasdaq Capital Market, Sesen Bio common stock may be delisted from the Nasdaq Capital Market which could have a material adverse effect on Sesen Bio&#8217;s business and could make it more difficult for Sesen Bio stockholders to sell their shares of Sesen Bio common stock.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio common stock is listed on the Nasdaq Capital Market, and Sesen Bio is therefore subject to Nasdaq&#8217;s continued listing requirements, including requirements with respect to the market value of publicly-held shares, market value of listed shares, minimum bid price per share, and minimum stockholders&#8217; equity, among others, and requirements relating to board and committee independence. If Sesen Bio fails to satisfy one or more of the requirements, it may be delisted from the Nasdaq Capital Market. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On January&#160;24, 2022, Sesen Bio received notice from Nasdaq that it was not currently in compliance with the $1.00 minimum bid price requirement for continued listing on the Nasdaq Global Market, as set forth in Nasdaq Listing Rule&#160;5450(a)(1). The Nasdaq notice indicated that, consistent with Nasdaq Listing Rule&#160;5810(c)(3)(A), Sesen Bio had 180 calendar days, or until July&#160;25, 2022, to regain compliance with the minimum bid price requirement by having the closing bid price of Sesen Bio common stock meet or exceed $1.00 per share for at least ten consecutive business days. On July&#160;26, 2022, Sesen Bio received approval to transfer the listing of Sesen Bio common stock from the Nasdaq Global Market to the Nasdaq Capital Market. As a result, Sesen Bio was granted a second 180-day grace period, or until January&#160;23, 2023, to regain compliance with the minimum bid price requirement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If Sesen Bio does not regain compliance by January&#160;23, 2023, it will receive notification from Nasdaq that Sesen Bio common stock is subject to delisting. At that time, Sesen Bio may then appeal the delisting determination to a Nasdaq hearings panel. Such notification will have no immediate effect on Sesen Bio&#8217;s listing on the Nasdaq Capital Market, nor will it have an immediate effect on the trading of Sesen Bio common stock pending such hearing. However, there can be no assurance that Sesen Bio will be able to regain compliance with Nasdaq&#8217;s minimum bid price requirement. If Sesen Bio regains compliance with Nasdaq&#8217;s minimum bid price requirement, there can be no assurance that Sesen Bio will be able to maintain compliance with the continued listing requirements for the Nasdaq Capital Market or that Sesen Bio common stock will not be delisted from the Nasdaq Capital Market in the future. In addition, Sesen Bio may be unable to meet other applicable listing requirements of the Nasdaq Capital Market, including maintaining minimum levels of stockholders&#8217; equity or market values of Sesen Bio common stock in which case, Sesen Bio common stock could be delisted notwithstanding Sesen Bio&#8217;s ability to demonstrate compliance with the minimum bid price requirement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Delisting from the Nasdaq Capital Market would adversely affect Sesen Bio&#8217;s ability to consummate the merger and may adversely affect Sesen Bio&#8217;s ability to raise additional financing through the public or private sale of equity securities, significantly affect the ability of investors to trade Sesen Bio common stock, or negatively affect the value and liquidity of Sesen Bio common stock. Delisting also could have other negative results, including the potential loss of employee confidence, the loss of institutional investors or interest in business development opportunities. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If Sesen Bio is delisted from Nasdaq and Sesen Bio is not able to list Sesen Bio common stock on another exchange, Sesen Bio common stock could be quoted on the OTC Bulletin Board or in the &#8220;pink sheets.&#8221; As a result, Sesen Bio could face significant adverse consequences including, among others: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">a limited availability of market quotations for Sesen Bio common stock; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">a determination that Sesen Bio common stock is a &#8220;penny stock&#8221; which will require brokers trading in Sesen Bio common stock to adhere to more stringent rules and possibly result in a reduced level of trading activity in the secondary trading market for Sesen Bio&#8217;s securities; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">55</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">a limited amount of news and little or no analyst coverage for Sesen Bio; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.11pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.11pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio would no longer qualify for exemptions from state securities registration requirements, which may require Sesen Bio to comply with applicable state securities laws; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">a decreased ability to issue additional securities (including pursuant to short-form registration statements on Form S-3) or obtain additional financing in the future. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If Sesen Bio common stock becomes subject to the penny stock rules, it would become more difficult to trade shares of Sesen Bio common stock.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The SEC has adopted rules that regulate broker-dealer practices in connection with transactions in penny stocks. Penny stocks are generally equity securities with a price of less than $5.00, other than securities registered on certain national securities exchanges or authorized for quotation on certain automated quotation systems, provided that current price and volume information with respect to transactions in such securities is provided by the exchange or system. If Sesen Bio does not retain its listing on Nasdaq and if the price of Sesen Bio common stock is less than $5.00, Sesen Bio common stock may be deemed a penny stock. The penny stock rules require a broker-dealer, before a transaction in a penny stock not otherwise exempt from those rules, to deliver a standardized risk disclosure document containing specified information. In addition, the penny stock rules require that before effecting any transaction in a penny stock not otherwise exempt from those rules, a broker-dealer must make a special written determination that the penny stock is a suitable investment for the purchaser and receive: (i)&#160;the purchaser&#8217;s written acknowledgment of the receipt of a risk disclosure statement; (ii)&#160;a written agreement to transactions involving penny stocks; and (iii)&#160;a signed and dated copy of a written suitability statement. These disclosure requirements may have the effect of reducing the trading activity in the secondary market for Sesen Bio common stock, and therefore stockholders may have difficulty selling their shares of Sesen Bio common stock. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Provisions in the Sesen Bio Certificate of Incorporation and the Sesen Bio Bylaws and under Delaware law could make an acquisition of Sesen Bio, which may be beneficial to Sesen Bio stockholders, more difficult and may prevent attempts by Sesen Bio stockholders to replace or remove Sesen Bio&#8217;s current management.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Provisions in the Sesen Bio Certificate of Incorporation and the Sesen Bio Bylaws may discourage, delay or prevent a merger, acquisition or other change in control of Sesen Bio that Sesen Bio stockholders may consider favorable, including transactions in which Sesen Bio stockholders might otherwise receive a premium for their shares of Sesen Bio common stock. These provisions could also limit the price that investors might be willing to pay in the future for shares of Sesen Bio common stock, thereby depressing the market price of Sesen Bio common stock. In addition, because the Sesen Bio board of directors is responsible for appointing the members of Sesen Bio&#8217;s management team, these provisions may frustrate or prevent any attempts by Sesen Bio stockholders to replace or remove Sesen Bio&#8217;s current management by making it more difficult for Sesen Bio stockholders to replace members of the Sesen Bio board of directors. Among other things, these provisions: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">establish a classified board of directors such that only one of three classes of directors is elected each year; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">allow the authorized number of directors to be changed only by resolution of the Sesen Bio board of directors; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.11pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.11pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">limit the manner in which stockholders can remove directors from the Sesen Bio board of directors; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">establish advance notice requirements for stockholder proposals that can be acted on at stockholder meetings and nominations to the Sesen Bio board of directors; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">require that Sesen Bio stockholder actions must be affected at a duly called stockholder meeting and prohibit actions by Sesen Bio stockholders by written consent; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.01pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.01pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">limit who may call stockholder meetings; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">authorize the Sesen Bio board of directors to issue preferred stock without stockholder approval, which could be used to institute a &#8220;poison pill&#8221; that would work to dilute the stock ownership of a potential hostile acquirer, effectively preventing acquisitions that have not been approved by the Sesen Bio board of directors; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">56</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tRRTC">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">require the approval of the holders of at least 75% of the votes that all Sesen Bio stockholders would be entitled to cast to amend or repeal specified provisions of the Sesen Bio Certificate of Incorporation or Sesen Bio Bylaws. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Moreover, because Sesen Bio is incorporated in Delaware, Sesen Bio is governed by the provisions of Section&#160;203 of the DGCL, which prohibits a person who owns in excess of 15% of Sesen Bio&#8217;s outstanding voting stock from merging or combining with Sesen Bio for a period of three&#160;years after the date of the transaction in which the person acquired in excess of 15% of Sesen Bio&#8217;s outstanding voting stock, unless the merger or combination is approved in a prescribed manner. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Risks Related to Carisma</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Risks Related to Carisma&#8217;s Financial Position and Need for Additional Capital</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Carisma has incurred significant losses since its inception. Carisma expects to continue to incur significant expenses and operating losses for the foreseeable future and may never achieve or maintain profitability.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Since inception, Carisma has incurred significant operating losses. Carisma&#8217;s net losses were $40.8&#160;million for the year ended December&#160;31, 2021 and $28.3&#160;million for the year ended December&#160;31, 2020. As of September&#160;30, 2022, Carisma had $70.6&#160;million in cash, cash equivalents and marketable securities and an accumulated deficit of $141.5&#160;million. To date, Carisma has not yet commercialized any products or generated any revenue from product sales and has financed its operations primarily with proceeds from sales of Carisma&#8217;s preferred stock, proceeds from Carisma&#8217;s collaboration with Moderna, research tax credits and convertible debt financing. Carisma has devoted substantially all of its financial resources and efforts to pursuing discovery, research and development of its product candidates. Carisma is still in the early stages of development of its lead product candidate, CT-0508, and initiated its first clinical trial in 2021. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma expects to continue to incur significant expenses and operating losses for the foreseeable future. Upon the closing of the merger, Carisma will also incur additional costs associated with operating as a public company. Carisma anticipates that its expenses will increase substantially if and as it: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">enhances the capabilities of its CAR-M platform; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">conducts its ongoing Phase&#160;1 clinical trial of CT-0508; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">prepares for, initiates and conducts a planned clinical trial utilizing CT-0508 in combination with pembrolizumab; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">develops other CT-0508 combination studies; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">advances CT-0508 for additional indications or any other product candidate into clinical development; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">prepares for, initiates and conducts a planned clinical trial of CT-0525 for solid tumors that overexpress HER2;</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">prepares for, initiates and conducts a planned clinical trial of CT-1119 for advanced mesothelin-positive solid tumors; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">prepares for, initiates and conducts a planned clinical trial of CT-0729 for PSMA positive castrate resistant prostate cancer; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">conducts discovery and pre-clinical testing of the development of </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;"> CAR-M therapeutics for up to twelve oncology targets, as well as multiple other targets and indications; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">conducts discovery and pre-clinical testing of its autologous cell therapy pipeline to gather information to apply to the development of off-the-shelf engineered macrophage therapeutics; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">develops iPSC-derived iCAR-M, or iCAR-M, and other macrophage therapies; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">develops </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;"> reprogrammed LNP/mRNA CAR-M therapies for cancer; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">develops viral vectors to effectively engineer human monocytes and macrophages, including the Vpx lentiviral vector and Carisma&#8217;s Ad5f35 vector; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">57</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">conducts discovery and pre-clinical testing of other product candidates; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">seeks marketing approval for CT-0508 or any other product candidate if it successfully completes clinical trials; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">scales up its external manufacturing capabilities and capabilities to support clinical trials of CT-0508 or any other product candidates and for commercialization of any product candidate for which it may obtain marketing approval; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">establishes a sales, marketing and distribution infrastructure to commercialize any product candidate for which it may obtain marketing approval; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">in-licenses or acquires additional technologies or product candidates; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.91pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.91pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">makes any payments under its existing or future strategic collaboration agreements, global exclusive rights licensing agreements or sponsored research agreements, including with Moderna, University of Pennsylvania and New York University; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">maintains, expands, enforces and protects its intellectual property portfolio; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">hires additional clinical, regulatory, manufacturing, quality control, development and scientific personnel; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">adds operational, financial and management information systems and personnel, including personnel to support its discovery, product development and planned future commercialization efforts and its operations as a public company. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Because of the numerous risks and uncertainties associated with pharmaceutical product development, Carisma is unable to accurately predict the timing or amount of increased expenses or when, or if, it will be able to achieve or maintain profitability. Carisma&#8217;s expenses could increase beyond its expectations if, among other things: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Carisma is required by regulatory authorities in the United States, Europe or other jurisdictions to perform trials or studies in addition to, or different than, those that it currently expects; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">there are any delays in establishing appropriate manufacturing arrangements for or completing the development of any of Carisma&#8217;s product candidates; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">there are any third-party challenges to Carisma&#8217;s intellectual property or Carisma needs to defend against any intellectual property-related claim. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Even if Carisma obtains marketing approval for and is successful in commercializing one or more of its product candidates, Carisma expects to incur substantial additional discovery and product development and other expenditures to develop and market additional product candidates or to expand the approved indications of any marketed product. Carisma may encounter unforeseen expenses, difficulties, complications, delays and other unknown factors that may adversely affect its business. The size of Carisma&#8217;s future net losses will depend, in part, on the rate of future growth of its expenses and Carisma&#8217;s ability to generate revenue. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Carisma has never generated revenue from product sales and may never achieve or maintain profitability.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Carisma only recently initiated clinical development of its lead product candidate, CT-0508, and is in the pre-clinical testing stages for its other product candidates. Carisma expects that it will be a number of&#160;years, if ever, before it has a product candidate ready for commercialization. To become and remain profitable, Carisma must succeed in completing development of, obtaining marketing approval for and eventually commercializing, one or more products that generate significant revenue. The ability to achieve this success will require Carisma to be effective in a range of challenging activities, including completing clinical development of CT-0508, completing discovery, pre-clinical testing and clinical development of CT-0508 in the combination setting and for additional indications, timely filing and receiving acceptance of its Investigational New Drug applications, or INDs, in order to commence its planned or future clinical trials, including for CT-0525, CT-1119 and, CT-0729, successfully enrolling subjects in, and completing, its ongoing and planned clinical trials, scaling up its manufacturing processes and capabilities to support clinical trials </font>
          </div>

      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">58</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">of CT-0508 or of other product candidates, obtaining marketing approval for CT-0508 or any other product candidates, manufacturing, marketing and selling any products for which Carisma may obtain marketing approval and maintaining a continued acceptable safety profile of its products following approval. Carisma may never succeed in these activities and, even if it does, may never generate revenues that are significant enough to achieve profitability. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Even if Carisma does achieve profitability, it may not be able to sustain or increase profitability on a quarterly or annual basis. Carisma&#8217;s failure to become and remain profitable would depress the value of its company and could impair its ability to raise capital, expand its business, maintain its discovery and product development efforts, diversify its pipeline of product candidates or even continue its operations. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Carisma is heavily dependent on the success of its lead product candidate, CT-0508, which will require significant clinical testing before it can seek marketing approval and potentially launch commercial sales. If CT-0508 does not receive marketing approval or is not successfully commercialized, or if there is significant delay in doing so, Carisma&#8217;s business will be harmed.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma only recently initiated its first clinical trial, has no products that are approved for commercial sale and may never be able to develop marketable products. Carisma expects that a substantial portion of its efforts and expenditures for the foreseeable future will be devoted to CT-0508 and related combination sub-studies of the synergistic potential and utility of CT-0508. Carisma&#8217;s business currently depends heavily on the successful development, marketing approval and commercialization of CT-0508 and the success of related combination sub-studies. Carisma cannot be certain that CT-0508 or any combination therapy will achieve success in ongoing or future clinical trials, receive marketing approval or be successfully commercialized. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If Carisma were required to discontinue development of CT-0508, or if CT-0508 does not receive marketing approval for one or more of the indications Carisma pursues, fails to achieve significant market acceptance, or fails to receive adequate reimbursement, Carisma may be delayed by many&#160;years in its ability to achieve profitability, if ever, and may not be able to generate sufficient revenue to continue its business. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Carisma will need substantial additional funding for its continuing operations. If Carisma is unable to raise capital when needed or on acceptable terms, it could be forced to delay, reduce or eliminate its discovery or product development programs or commercialization efforts.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma expects to devote substantial financial resources to its ongoing and planned activities, particularly as it conducts its ongoing clinical trial of CT-0508 and pursues related combination strategies, prepares for, initiates and conducts its planned clinical trials of CT-0525, CT-1119 and CT-0729 and advances its discovery programs and continues its product development efforts. Carisma expects its expenses to increase substantially in connection with its ongoing activities, particularly as it advances its pre-clinical activities and clinical trials. In addition, if Carisma obtains marketing approval for CT-0508 or any other product candidate it is developing or develops in the future, it expects to incur significant commercialization expenses related to product manufacturing, sales, marketing and distribution. Furthermore, upon the closing of the merger, it expects to incur additional costs associated with operating as a public company. Accordingly, Carisma will need to obtain substantial additional funding in connection with its continuing operations. If Carisma is unable to raise capital or obtain adequate funds when needed or on acceptable terms, it may be required to delay, limit, reduce or terminate its discovery and product development programs or any future commercialization efforts or grant rights to develop and market product candidates that it would otherwise prefer to develop and market itself. In addition, attempting to secure additional financing may divert the time and attention of Carisma management from day-to-day activities and distract from its discovery and product development efforts. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma&#8217;s future capital requirements will depend on many factors, including: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the progress, costs and results of its ongoing clinical trial of CT-0508 and other planned and future clinical trials; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the scope, progress, costs and results of pre-clinical testing and clinical trials of CT-0508 for additional combinations, targets and indications; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">59</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the number of and development requirements for additional indications for CT-0508 or for any other product candidates; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the success of its collaborations with Moderna or others; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">its ability to scale up its manufacturing processes and capabilities to support clinical trials of CT-0508 and other product candidates it is developing and develops in the future; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the costs, timing and outcome of regulatory review of CT-0508 and other product candidates it is developing and may develop in the future; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">potential changes in the regulatory environment and enforcement rules; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">its ability to establish and maintain strategic collaborations, licensing or other arrangements and the financial terms of such arrangements; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the payment of license fees and other costs of its technology license arrangements; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the costs and timing of future commercialization activities, including product manufacturing, sales, marketing and distribution, for CT-0508 and other product candidates it is developing and may develop in the future for which it may receive marketing approval; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">its ability to obtain and maintain acceptance of any approved products by patients, the medical community and third-party payors; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the amount and timing of revenue, if any, received from commercial sales of CT-0508 and any other product candidates it is developing or develops in the future for which it receives marketing approval; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">potential changes in pharmaceutical pricing and reimbursement infrastructure; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the availability of raw materials for use in production of its product candidates; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the costs and timing of preparing, filing and prosecuting patent applications, maintaining and enforcing its intellectual property and proprietary rights and defending any intellectual property-related claims; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the extent to which it in-licenses or acquires additional technologies or product candidates. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma management has concluded that there is substantial doubt about Carisma&#8217;s ability to continue as a going concern. As a result, Carisma management has included disclosures in Note 2 of the consolidated financial statements and Carisma&#8217;s independent auditor included an explanatory paragraph in its report on Carisma&#8217;s consolidated financial statements as of and for the year ended December&#160;31, 2021 with respect to this uncertainty. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As of September&#160;30, 2022, Carisma had cash, cash equivalents and marketable securities of $70.6&#160;million. Immediately prior to the consummation of the merger, certain investors have agreed to purchase shares of Carisma common stock for an aggregate purchase price of approximately $30.6&#160;million. Carisma believes that following consummation of the pre-closing financing and the merger, it will have cash, cash equivalents and marketable securities sufficient to sustain its operating expenses and capital expenditure requirements at least through the end of 2024. However, Carisma has based this estimate on assumptions that may prove to be wrong, and its operating plan may change as a result of many factors currently unknown to Carisma. In addition, changing circumstances could cause Carisma to consume capital significantly faster than it currently anticipates, and Carisma may need to spend more than currently expected because of circumstances beyond its control. As a result, Carisma could deplete its capital resources sooner than it currently expects. In addition, because the successful development of CT-0508, CT-0525, CT-1119, CT-0729 and any combination studies or other product candidates that it pursues is highly uncertain, at this time Carisma cannot reasonably estimate or know the nature, timing and costs of the efforts that will be necessary to complete the development of any product candidate. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Identifying potential product candidates and conducting pre-clinical testing and clinical trials is a time-consuming, expensive and uncertain process that takes&#160;years to complete, and Carisma may never generate the necessary data or results required to obtain marketing approval and achieve product sales. In addition, Carisma&#8217;s product candidates, if approved, may not achieve commercial success. Carisma will not generate </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">60</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">commercial revenues unless and until it can achieve sales of products, which it does not anticipate for a number of&#160;years, if at all. Accordingly, Carisma will need to obtain substantial additional financing to achieve its business objectives. Adequate additional financing may not be available to Carisma on acceptable terms, or at all, and may be impacted by the economic climate and market conditions. For example, market volatility resulting from the COVID-19 pandemic, any other future infectious diseases, epidemics or pandemics or general U.S. or global economic or market conditions could also adversely impact Carisma&#8217;s ability to access capital as and when needed. Alternatively, Carisma may seek additional capital due to favorable market conditions or strategic considerations, even if it believes it has sufficient funds for its current or future operating plans. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Carisma&#8217;s limited operating history may make it difficult for you to evaluate the success of Carisma&#8217;s business to date and to assess the combined company&#8217;s future viability.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma was formed as Carma Therapeutics LLC, a Pennsylvania limited liability company, in April&#160;2016 and converted to a Delaware corporation in May&#160;2017. Carisma is a clinical-stage cell therapy company with a limited operating history. Cell therapy product development is a highly speculative undertaking and involves a substantial degree of risk. Carisma&#8217;s operations to date have been limited to organizing and staffing its company, business planning, capital raising, establishing and maintaining its intellectual property portfolio, building its pipeline of product candidates, conducting drug discovery activities, undertaking pre-clinical studies, manufacturing process development studies, conducting early-stage clinical trials, and providing general and administrative support for these operations. Carisma&#8217;s prospects must be considered in light of the uncertainties, risks, expenses and difficulties frequently encountered by companies in their early stages of operations. Carisma has not yet demonstrated its ability to successfully develop any product candidate, obtain marketing approvals, manufacture a commercial scale product or arrange for a third party to do so on its behalf, or conduct sales, marketing and distribution activities necessary for successful product commercialization. Consequently, any predictions you make about the combined company&#8217;s future success or viability may not be as accurate as they could be if Carisma had a longer operating history or a history of successfully developing, obtaining marketing approval for and commercializing products. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In addition, as Carisma&#8217;s business grows, Carisma may encounter unforeseen expenses, difficulties, complications, delays and other known and unknown obstacles. Carisma will need to transition at some point from a company with a discovery and pre-clinical and clinical focus to a company capable of supporting commercial activities. Carisma may not be successful in such a transition. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As Carisma continues to build its business, Carisma expects its financial condition and operating results to fluctuate significantly from quarter to quarter and year to year due to a variety of factors, many of which are beyond Carisma&#8217;s control. Accordingly, you should not rely upon the results of any quarterly or annual periods as indications of future operating performance. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The COVID-19 pandemic may affect Carisma&#8217;s pre-clinical studies and clinical trials, disrupt regulatory activities, disrupt Carisma&#8217;s manufacturing and supply chain or have other adverse effects on Carisma&#8217;s business and operations.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The COVID-19 pandemic has caused many governments to implement measures to slow the spread of the virus through quarantines, travel restrictions, heightened border scrutiny and other measures. The pandemic and government measures taken in response have also had a significant impact, both directly and indirectly, on businesses and commerce, as worker shortages have occurred; supply chains have been disrupted; facilities and production have been suspended; and demand for certain goods and services, such as medical services and supplies, has spiked, while demand for other goods and services, such as travel, has fallen. The future progression of the pandemic and its effects on Carisma&#8217;s business and operations are uncertain. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma and the third-party manufacturers and clinical research organizations that it engages may face disruptions that could affect Carisma&#8217;s ability to initiate and complete pre-clinical studies or clinical trials, including disruptions in procuring items that are essential for Carisma&#8217;s discovery and product development activities, such as, for example, raw materials used in the manufacturing of its product candidates, laboratory </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">61</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">supplies for its ongoing and planned pre-clinical studies and clinical trials, or animals that are used for pre-clinical testing, in each case, for which there may be shortages because of ongoing efforts to address the pandemic, or disruptions in Carisma&#8217;s ability to obtain necessary site approvals or other delays at clinical trial sites. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As a result of the COVID-19 pandemic, Carisma may experience further disruptions that could severely impact Carisma&#8217;s business, including: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">disruptions related to Carisma&#8217;s ongoing and planned clinical trials or future clinical trials arising from delays in completing pre-clinical studies required to begin clinical development; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">manufacturing disruptions; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the inability to obtain necessary site approvals or other delays at clinical trial sites; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">diversion of healthcare resources away from the conduct of clinical trials, including the diversion of hospitals serving as Carisma&#8217;s clinical trial sites and hospital staff supporting the conduct of Carisma&#8217;s clinical trials; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">interruption of key clinical trial activities, such as clinical trial site data monitoring, due to limitations on travel imposed or recommended by foreign, federal or state governments, employers and others; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">interruption of clinical trial subject visits and study procedures, which may impact the integrity of subject data and clinical study endpoints; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">interruption or delays in the operations of the FDA, or other regulatory authorities, which may impact review and approval timelines; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">limitations on employee resources that would otherwise be focused on the conduct of Carisma&#8217;s pre-clinical studies and clinical trials, including because of sickness of employees or their families or the desire of employees to avoid contact with large groups of people; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">difficulties recruiting or retaining patients for Carisma&#8217;s clinical trials if patients are affected by the virus or are fearful of visiting or traveling to clinical trial sites because of the virus; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">risk that participants enrolled in its clinical trials will acquire COVID-19 while the clinical trial is ongoing, which could impact the results of the clinical trial, including by increasing the number of observed adverse events and refusal of the FDA, to accept data from clinical trials in these affected geographies. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The response to the COVID-19 pandemic may redirect resources with respect to regulatory and intellectual property matters in a way that would adversely impact its ability to pursue marketing approvals and protect its intellectual property. In addition, Carisma may face impediments to regulatory meetings and potential approvals due to measures intended to limit in-person interactions. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Furthermore, third parties, including manufacturers, medical institutions, clinical investigators, contract research organizations and consultants with whom Carisma conducts business, are similarly adjusting their operations and assessing their capacity in light of the COVID-19 pandemic. If these third parties continue to experience shutdowns or business disruptions, Carisma&#8217;s ability to conduct its business in the manner and on the timelines presently planned could be materially and negatively impacted. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The COVID-19 pandemic continues to evolve and has already caused significant disruptions in the financial markets, and may continue to cause such disruptions, which could impact Carisma&#8217;s ability to raise additional funds through public offerings and may also impact the volatility of Carisma&#8217;s stock price and trading in its stock. Moreover, it is possible the pandemic will further significantly impact economies worldwide, which could result in adverse effects on Carisma&#8217;s business and operations. Carisma cannot be certain what the overall impact of the COVID-19 pandemic will be on its business, and it has the potential to materially and adversely affect Carisma&#8217;s business, financial condition, results of operations and prospects. To the extent the COVID-19 pandemic adversely affects Carisma&#8217;s business, financial condition and results of operations, it may also have the effect of heightening many of the other risks and uncertainties described in this &#8220;Risk Factors&#8221; section. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">62</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Changes in tax law may adversely affect Carisma or its investors.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The rules dealing with U.S. federal, state and local income taxation are constantly under review by persons involved in the legislative process and by the IRS and the U.S. Treasury Department. Changes to tax laws (which changes may have retroactive application) could adversely affect Carisma or holders of Carisma&#8217;s common stock. In recent&#160;years, many such changes have been made and changes are likely to continue to occur in the future. It cannot be predicted whether, when, in what form or with what effective dates tax laws, regulations and rulings may be enacted, promulgated or issued, which could result in an increase in Carisma&#8217;s or its stockholders&#8217; tax liability or require changes in the manner in which Carisma operates in order to minimize or mitigate any adverse effects of changes in tax law. Prospective investors should consult their tax advisors regarding the potential consequences of changes in tax law on Carisma&#8217;s business and on the ownership and disposition of Carisma common stock. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Carisma&#8217;s ability to use its net operating loss carryforwards, or NOLs, and research and development tax credit carryforwards to offset future taxable income may be subject to certain limitations.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma has a history of cumulative losses and anticipates that it will continue to incur significant losses in the foreseeable future. As a result, Carisma does not know whether or when it will generate taxable income necessary to utilize its NOLs or research and development tax credit carryforwards. As of December&#160;31, 2021, Carisma had federal, state and local NOLs of $76.4&#160;million, $76.4&#160;million and $71.2&#160;million, respectively, and federal research and development tax credit carryforwards totaling $3.9&#160;million. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In general, under Section&#160;382 of the Code and corresponding provisions of state law, a corporation that undergoes an &#8220;ownership change,&#8221; generally defined as a greater than 50&#160;percentage point change (by value) in its equity ownership by certain stockholders over a three year period, is subject to limitations on its ability to utilize its pre-change NOLs and research and development tax credit carryforwards to offset future taxable income. Carisma has not conducted a study to assess whether any such ownership changes have occurred. Carisma may have experienced such ownership changes in the past and may experience such ownership changes in the future (which may be outside its control). As a result, if and to the extent Carisma earns net taxable income, its ability to use its pre-change NOLs and research and development tax credit carryforwards to offset such taxable income may be subject to limitations. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Risks Related to Carisma&#8217;s Discovery Programs and Research and Development of Carisma&#8217;s Product Candidates</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Cell therapy is a rapidly evolving area of science, and the approach Carisma is taking to discover and develop product candidates by utilizing genetically modified macrophages is novel and may never lead to approved or marketable products.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Cell therapy has yet to be broadly applied to solid tumors, inflammatory disease, fibrotic disease or neurodegeneration. The discovery, research and development of engineered macrophages to treat disease is an emerging field and Carisma&#8217;s CAR-M platform, which is the first CAR-M to be evaluated in a human clinical trial, is a relatively new technology. Carisma&#8217;s future success depends on the successful development of this novel therapeutic approach. The scientific evidence to support the feasibility of developing product candidates based on these discoveries is both preliminary and limited. Carisma has only preliminary results from its Phase&#160;1 clinical trial of CT-0508 and expects clinical updates in the next 18&#160;months. As such, there may be adverse effects or limited favorable results from treatment with any of Carisma&#8217;s current or future product candidates that it cannot predict at this time. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma&#8217;s success also depends on its successful application of its proprietary macrophage engineering platform in the combination setting and to other indications by reprogramming the target specificity of its CAR-M cell product and developing product candidates against a plethora of tumor associated antigens, including in therapeutic areas beyond oncology. However, Carisma&#8217;s macrophage engineering platform may not allow it to generate new INDs to expand its pipeline on Carisma&#8217;s anticipated timeline or in a cost-efficient manner or at all, which could cause the potential value of Carisma&#8217;s business to decline and materially harm Carisma&#8217;s business prospects. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">63</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As a result of these factors, it is more difficult for Carisma to predict the time and cost of product candidate development, and Carisma cannot predict whether the application of macrophage engineering platform will result in the development and marketing approval of any products. Any development problems Carisma experiences in the future related to its macrophage engineering platform or any of its discovery programs may cause significant delays or unanticipated costs or may prevent the development of a commercially viable product. Any of these factors may prevent Carisma from completing its clinical trials or pre-clinical studies or commercializing any product candidates it may develop on a timely or profitable basis, if at all. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Carisma is early in its development efforts. If Carisma is unable to commercialize its product candidates or experiences significant delays in doing so, its business will be materially harmed.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Carisma is early in its development efforts. Carisma initiated its first Phase&#160;1 clinical trial of CT-0508 in 2021 and expects to evaluate a combination of CT-0508 with pembrolizumab in an upcoming Phase&#160;1 clinical trial. Carisma expects to submit INDs for CT-0525 in the third quarter of 2023 and for CT-1119 in 2025. CT-0729 is still in the discovery stage. </font>
          </div>

        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma&#8217;s ability to generate revenues from product sales, which it does not expect will occur for a number of&#160;years, if ever, will depend heavily on the successful development, marketing approval and eventual commercialization of CT-0508, including in the combination setting, or one or more of its other product candidates, which may never occur. The success of CT-0508 and Carisma&#8217;s other product candidates will depend on several factors, including the following: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">successfully completing pre-clinical studies; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">successfully initiating future clinical trials; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.09pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.09pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">successfully enrolling patients in and completing clinical trials; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">scaling up manufacturing processes and capabilities to support clinical trials of CT-0508 and any other product candidate; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">applying for and receiving marketing approvals from applicable regulatory authorities; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">obtaining and maintaining intellectual property protection and regulatory exclusivity for CT-0508 and any other product candidates it is developing or may develop in the future; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">making arrangements with third-party manufacturers, or establishing commercial manufacturing capabilities, for both clinical and commercial supplies of its product candidates; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">establishing sales, marketing and distribution capabilities and launching commercial sales of its products, if and when approved, whether alone or in collaboration with others; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">acceptance of CT-0508 and any other product candidates, if and when approved, by patients, the medical community and third-party payors; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">effectively competing with other therapies; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">obtaining and maintaining coverage, adequate pricing and adequate reimbursement from third-party payors, including government payors; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">maintaining, enforcing, defending and protecting its rights in its intellectual property portfolio; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">not infringing, misappropriating or otherwise violating others&#8217; intellectual property or proprietary rights; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.09pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.09pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">maintaining a continued acceptable safety profile of its products following receipt of any marketing approvals. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If Carisma does not achieve one or more of these factors in a timely manner or at all, it could experience significant delays or an inability to successfully develop and commercialize its product candidates, which would materially harm Carisma&#8217;s business. As a company, Carisma has limited experience in clinical development, having only recently advanced CT-0508 into an early-stage clinical trial. Any predictions </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">64</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">about the future success or viability of CT-0508 or any product candidates Carisma is developing or may develop in the future may not be as accurate as they could be if Carisma had a history of conducting clinical trials. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Drug development involves a lengthy and expensive process, with an uncertain outcome. The results of pre-clinical studies and early clinical trials may not be predictive of future results. Carisma may incur additional costs or experience delays in completing, or ultimately be unable to complete, the development and commercialization of CT-0508 or its other product candidates.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma only recently initiated its first clinical trial of CT-0508 and its other product candidates are in pre-clinical development. The risk of failure for CT-0508 and Carisma&#8217;s other product candidates is high. It is impossible to predict when or if CT-0508 or any of Carisma&#8217;s other product candidates will prove effective or safe in humans or will receive marketing approval. Before obtaining marketing approval from regulatory authorities for the sale of a product candidate, Carisma must complete pre-clinical development and then conduct extensive clinical trials to demonstrate the safety and efficacy of such product candidate in humans. Clinical trials may fail to demonstrate that CT-0508 or any of Carisma&#8217;s other product candidates are safe for humans and effective for indicated uses. Even if the clinical trials are successful, changes in marketing approval policies during the development period, changes in or the enactment or promulgation of additional statutes, regulations or guidance or changes in regulatory review for each submitted product application may cause delays in the approval or rejection of an application. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Before Carisma can commence clinical trials for a product candidate, it must complete extensive pre-clinical testing and studies, manufacturing process development studies, and analytical development studies that support its planned INDs and other applications to regulatory authorities in the United States or similar applications in other jurisdictions. Carisma cannot be certain of the timely completion or outcome of its pre-clinical testing and studies and cannot predict if the outcome of its pre-clinical testing and studies will ultimately support the further development of its current or future product candidates or whether regulatory authorities will accept its proposed clinical programs. As a result, Carisma may not be able to submit applications to initiate clinical development of product candidates on the timelines Carisma expects, if at all, and the submission of these applications may not result in regulatory authorities allowing clinical trials to begin. Furthermore, product candidates are subject to continued pre-clinical safety studies, which may be conducted concurrently with Carisma&#8217;s clinical testing. The outcomes of these safety studies may delay the launch of or enrollment in future clinical trials and could impact Carisma&#8217;s ability to continue to conduct its clinical trials. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Clinical testing is expensive, difficult to design and implement, can take many&#160;years to complete and is uncertain as to the outcome. Carisma cannot guarantee that any of its clinical trials will be conducted as planned or completed on schedule, or at all. A failure of one or more clinical trials can occur at any stage of testing, which may result from a multitude of factors, including, among other things, flaws in study design, dose selection issues, placebo effects, patient enrollment criteria and failure to demonstrate favorable safety or efficacy traits. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Moreover, pre-clinical and clinical data are often susceptible to varying interpretations and analyses, and many companies that have believed their product candidates performed satisfactorily in pre-clinical studies and clinical trials have nonetheless failed to obtain marketing approval of their products. Furthermore, the failure of any of Carisma&#8217;s product candidates to demonstrate safety and efficacy in any clinical trial could negatively impact the perception of its other product candidates or cause regulatory authorities to require additional testing before approving any of its product candidates. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma may experience numerous unforeseen events during, or as a result of, clinical trials that could delay or prevent its ability to receive marketing approval or commercialize any product candidates, including: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">regulators or institutional review boards, or IRBs, may not authorize Carisma or its investigators to commence a clinical trial or conduct a clinical trial at a prospective trial site or at all; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Carisma may experience delays in reaching, or fail to reach, agreement on acceptable clinical trial contracts or clinical trial protocols with prospective trial sites; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">regulators may determine that the planned design of Carisma&#8217;s clinical trials is flawed or inadequate; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">65</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">clinical trials of Carisma&#8217;s product candidates may produce negative or inconclusive results, and Carisma may decide, or regulators may require Carisma, to conduct additional clinical trials or abandon product development programs; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Carisma may be unable to establish clinical endpoints that applicable regulatory authorities consider clinically meaningful, or, if Carisma seeks accelerated approval, biomarker efficacy endpoints that applicable regulatory authorities consider likely to predict clinical benefit; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">pre-clinical testing may produce results based on which Carisma may decide, or regulators may require Carisma, to conduct additional pre-clinical studies before it proceeds with certain clinical trials, limits the scope of its clinical trials, halt ongoing clinical trials or abandon product development programs; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the number of patients required for clinical trials of Carisma&#8217;s product candidates may be larger than it anticipates, enrollment in these clinical trials may be slower than Carisma anticipates or participants may drop out of these clinical trials at a higher rate than Carisma anticipates; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">third-party contractors may fail to comply with regulatory requirements or meet their contractual obligations to Carisma in a timely manner, or at all; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Carisma may decide, or regulators or IRBs may require Carisma, to suspend or terminate clinical trials of its product candidates for various reasons, including noncompliance with regulatory requirements or a finding that the participants are being exposed to unacceptable health risks; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">regulators or IRBs may require Carisma to perform additional or unanticipated clinical trials to obtain approval or Carisma may be subject to additional post-marketing testing requirements to maintain marketing approval; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">regulators may revise the requirements for approving Carisma&#8217;s product candidates, or such requirements may not be as it anticipates; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the cost of clinical trials of Carisma&#8217;s product candidates may be greater than it anticipates; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the supply or quality of Carisma&#8217;s product candidates or other materials necessary to conduct clinical trials of its product candidates may be insufficient or inadequate; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Carisma&#8217;s product candidates may have undesirable side effects or other unexpected characteristics, causing Carisma or its clinical investigators, regulators or IRBs to suspend or terminate the trials; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">regulators may withdraw their approval of a product or impose restrictions on its distribution; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">business interruptions resulting from the COVID-19 pandemic may result in adverse effects on Carisma&#8217;s business and operations. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If Carisma is required to conduct additional clinical trials or other testing of its product candidates beyond those that it currently contemplates, if Carisma is unable to successfully complete clinical trials of its product candidates or other testing, if the results of these trials or tests are not positive or are only modestly positive, if there are safety concerns or if Carisma determines that the observed safety or efficacy profile would not be competitive in the marketplace, it may: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">incur unplanned costs; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">be delayed in obtaining marketing approval for its product candidates; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">not obtain marketing approval at all; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">obtain marketing approval in some countries and not in others; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">obtain approval for indications or patient populations that are not as broad as intended or desired; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">obtain approval with labeling that includes significant use or distribution restrictions or safety warnings; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">be subject to additional post-marketing testing requirements; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">have the product removed from the market after obtaining marketing approval. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">66</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma&#8217;s product development costs will also increase if it experiences delays in pre-clinical studies or clinical trials or in obtaining marketing approvals. Carisma does not know whether any of its pre-clinical studies or clinical trials will begin as planned, will need to be restructured or will be completed on schedule, or at all. Carisma may also determine to change the design or protocol of one or more of its clinical trials, including to add additional patients or arms, which could result in increased costs and expenses or delays. Significant pre-clinical study or clinical trial delays also could shorten any periods during which Carisma may have the exclusive right to commercialize its product candidates or allow its competitors to bring products to market before Carisma does and impair Carisma&#8217;s ability to successfully commercialize its product candidates and may harm Carisma&#8217;s business and results of operations. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Further, cancer therapies are sometimes characterized as first-line, second-line, or third-line, and the FDA often approves new therapies initially only for second-line or third-line use. When cancer is detected early enough, first-line therapy, usually hormone therapy, surgery, radiation therapy or a combination of these, is sometimes adequate to cure the cancer or prolong life without a cure. Second- and third-line therapies are administered to patients when prior therapy is not effective. For any of Carisma&#8217;s products that prove to be sufficiently beneficial, Carisma would expect to seek approval potentially as a first-line therapy, but any product candidates Carisma develops, even if approved, may not be approved for first-line therapy, and, prior to any such approvals, Carisma may have to conduct additional clinical trials. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The results of early-stage clinical trials and pre-clinical studies may not be predictive of future results. Initial success in clinical trials may not be indicative of results obtained when these trials are completed or in later stage trials.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The outcome of pre-clinical testing and early clinical trials may not be predictive of the success of later clinical trials, and preliminary or interim results of a clinical trial do not necessarily predict final results. In addition, initial success in clinical trials may not be indicative of results obtained when such trials are completed. In particular, the small number of patients in Carisma&#8217;s ongoing early clinical trials may make the results of these trials less predictive of the outcome of later clinical trials. For example, even if successful, the results of Carisma&#8217;s Phase&#160;1 clinical trial of CT-0508 may not be predictive of the results of further clinical trials of CT-0508 or any of Carisma&#8217;s other product candidates. Carisma&#8217;s product candidates may also fail to show the desired safety and efficacy in clinical development despite positive results in pre-clinical studies or having successfully advanced through initial clinical trials. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Moreover, pre-clinical and clinical data are often susceptible to varying interpretations and analyses, and many companies that have believed their product candidates performed satisfactorily in pre-clinical studies and clinical trials have nonetheless failed to obtain marketing approval of their products. Carisma&#8217;s current or future clinical trials may not ultimately be successful or support further clinical development of any of its product candidates and Carisma cannot assure you that any clinical trials that it may conduct will demonstrate consistent or adequate efficacy and safety to support marketing approval. There is a high failure rate for product candidates proceeding through clinical trials. Many companies in the biopharmaceutical industry have suffered significant setbacks in late-stage clinical trials even after achieving promising results in pre-clinical testing and earlier-stage clinical trials, and Carisma cannot be certain that it will not face similar setbacks. Any such setbacks in Carisma&#8217;s clinical development could materially harm Carisma&#8217;s business and results of operations. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Interim and preliminary results from Carisma&#8217;s clinical trials that it announces or publishes from time to time may change as more participant data become available and are subject to audit and verification procedures, which could result in material changes in the final data.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">From time to time, Carisma may announce or publish interim or preliminary results from its clinical trials, including its Phase&#160;1 clinical trial of CT-0508. Interim results from clinical trials that Carisma may complete are subject to the risk that one or more of the clinical outcomes may materially change as participant enrollment continues and more participant data become available. Carisma also makes assumptions, estimations, calculations, and conclusions as part of its analyses of data, and Carisma may not have received or had the opportunity to fully evaluate all data. Preliminary or interim results also remain subject to audit and verification procedures that may result in the final data being materially different from the preliminary data Carisma previously published. As a result, interim and preliminary data should be viewed with </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">67</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">caution until the final data are available. Adverse differences between preliminary or interim data and final data could be material and could significantly harm Carisma&#8217;s reputation and business prospects and may cause the trading price of Carisma common stock to fluctuate significantly. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If Carisma experiences delays or difficulties in the enrollment of patients in its clinical trials for CT-0508 or any of its other product candidates, its receipt of necessary marketing approvals could be delayed or prevented.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Identifying and qualifying patients to participate in clinical trials for CT-0508 and any other product candidates in the future is critical to Carisma&#8217;s success. Successful and timely completion of clinical trials will require that Carisma enroll a sufficient number of patients who remain in the trial until its conclusion. Carisma may not be able to initiate or continue clinical trials for its product candidates if it is unable to locate and enroll a sufficient number of eligible patients to participate in these trials as required by the FDA or similar regulatory authorities outside of the United States. In particular, group 2 for Carisma&#8217;s Phase&#160;1 clinical trial of CT-0508 is currently open for enrollment with an additional nine patients to be dosed in the study and Carisma is preparing to advance other products into clinical development. In addition, some of Carisma&#8217;s competitors have ongoing clinical trials for product candidates that treat the same indications as Carisma&#8217;s product candidates, and patients who would otherwise be eligible for Carisma&#8217;s clinical trials may instead enroll in clinical trials of Carisma&#8217;s competitors&#8217; product candidates. Carisma cannot predict how successful it will be at enrolling subjects in future clinical trials. Patient enrollment is affected by a variety of other factors, including: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the prevalence and severity of the disease under investigation; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:4.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the eligibility criteria for the trial in question; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:4.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the perceived risks and benefits of the product candidate under trial; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:4.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the requirements of the trial protocols; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:4.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the availability of existing treatments for the indications for which Carisma is conducting clinical trials; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:4.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the ability to recruit clinical trial investigators with the appropriate competencies and experience; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:4.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the efforts to facilitate timely enrollment in clinical trials; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:4.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the ability to identify specific patient populations based on specific genetic mutations or other factors; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:4.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the patient referral practices of physicians; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:4.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the ability to monitor patients adequately during and after treatment; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:4.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Carisma&#8217;s ability to obtain and maintain patient consents; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:4.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the proximity and availability of clinical trial sites for prospective patients; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:4.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the conduct of clinical trials by competitors for product candidates that treat the same indications or address the same patient populations as Carisma&#8217;s product candidates; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:4.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the cost to, or lack of adequate compensation for, prospective patients; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:4.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the impact of the ongoing COVID-19 pandemic. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma&#8217;s inability to locate and enroll a sufficient number of patients for its clinical trials would result in significant delays, could require it to abandon one or more clinical trials altogether and could delay or prevent its receipt of necessary marketing approvals. Enrollment delays in Carisma&#8217;s clinical trials may result in increased development costs for its product candidates, which could cause the value of Carisma&#8217;s business to decline and limit its ability to obtain additional financing. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If serious adverse events, undesirable side effects or unexpected characteristics are identified during the development of CT-0508 or any of Carisma&#8217;s other product candidates, Carisma may need to abandon or limit its further clinical development of those product candidates.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Enrollment in group 1 of Carisma&#8217;s first in human Phase&#160;1 clinical trial of CT-0508 has been completed with nine patients successfully dosed and group 2 is currently open for enrollment with nine additional </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">68</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">patients to be dosed in the trial. If CT-0508 or any other product candidate is associated with serious adverse events or undesirable side effects in clinical trials or have characteristics that are unexpected in clinical trials or pre-clinical testing, Carisma may need to abandon development of such product candidate or limit development to more narrow uses or subpopulations in which the serious adverse events, undesirable side effects or unexpected characteristics are less prevalent, less severe or more acceptable from a risk-benefit perspective. In pharmaceutical development, many compounds that initially show promise in early-stage or clinical testing are later found to cause side effects that delay or prevent further development of the compound. For example, while CT-0508 has been generally well tolerated based on preliminary clinical results from Carisma&#8217;s Phase&#160;1 clinical trial, such results may not be predictive or indicative of the successful development, marketing approval and eventual commercialization of CT-0508. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Additionally, if results of Carisma&#8217;s clinical trials reveal undesirable side effects, Carisma, regulatory authorities or the IRBs at the institutions in which Carisma&#8217;s studies are conducted could suspend or terminate its clinical trials, regulatory authorities could order Carisma to cease clinical trials or deny approval of its product candidates for any or all targeted indications or Carisma could be forced to materially modify the design of its clinical trials. Treatment-related side effects could also affect patient recruitment or the ability of enrolled patients to complete any of Carisma&#8217;s clinical trials or result in potential liability claims. In addition, these side effects may not be appropriately recognized or managed by the treating medical staff. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If Carisma elects or is forced to suspend or terminate any clinical trial of its product candidates, the commercial prospects of such product candidate will be harmed, and Carisma&#8217;s ability to generate revenues from sales of such product candidate will be delayed or eliminated. Any of these occurrences could materially harm Carisma&#8217;s business. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If any of Carisma&#8217;s product candidates receives marketing approval and Carisma, or others, later discover that the drug is less effective than previously believed or causes undesirable side effects that were not previously identified, Carisma&#8217;s ability to market the drug could be compromised.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma only recently initiated clinical development of its lead product candidate, CT-0508, and is in the pre-clinical testing stages for its other product candidates. Clinical trials will be conducted in carefully defined subsets of patients who have agreed to enter into clinical trials. Consequently, it is possible that Carisma&#8217;s clinical trials may indicate an apparent positive effect of a product candidate that is greater than the actual positive effect, if any, or alternatively fail to identify undesirable side effects. If one or more of Carisma&#8217;s product candidates receives marketing approval, and Carisma, or others, later discover that they are less effective than previously believed, or cause undesirable side effects, a number of potentially significant negative consequences could result, including: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">withdrawal or limitation by regulatory authorities of approvals of such product; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">seizure of the product by regulatory authorities; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">recall of the product; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">restrictions on the marketing of the product or the manufacturing process for any component thereof; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">requirement by regulatory authorities of additional warnings on the label; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">requirement that Carisma implement a risk evaluation and mitigation strategy or create a medication guide outlining the risks of such side effects for distribution to patients; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">commitment to expensive post-marketing studies as a prerequisite of approval by regulatory authorities of such product; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the product may become less competitive; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">initiation of regulatory investigations and government enforcement actions; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">initiation of legal action against Carisma to hold it liable for harm caused to patients; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">harm to Carisma&#8217;s reputation and resulting harm to physician or patient acceptance of its products. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">69</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Any of these events could prevent Carisma from achieving or maintaining market acceptance of a particular product candidate, if approved, and could significantly harm Carisma&#8217;s business, financial condition, and results of operations. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Carisma may expend its limited resources to pursue a particular product candidate or indication and fail to capitalize on product candidates or indications that may be more profitable or for which there is a greater likelihood of success.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Because Carisma has limited financial and managerial resources, it focuses on discovery programs and product candidates that it identifies for specific indications. As a result, Carisma may forego or delay pursuit of opportunities with other product candidates or for other indications that later prove to have greater commercial potential. Carisma&#8217;s resource allocation decisions may cause it to fail to capitalize on viable commercial products or profitable market opportunities. Carisma&#8217;s spending on current and future discovery and product development programs and product candidates for specific indications may not yield any commercially viable products. If Carisma does not accurately evaluate the commercial potential or target market for a particular product candidate, it may relinquish valuable rights to that product candidate through collaboration, licensing or other royalty arrangements in cases in which it would have been more advantageous for Carisma to retain sole development and commercialization rights to such product candidate. Failure to allocate resources or capitalize on strategies in a successful manner will have an adverse impact on Carisma&#8217;s business. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Carisma may develop CT-0508 in combination with other drugs. If the FDA or similar regulatory authorities outside of the United States do not approve these other drugs, revoke their approval of such drugs, or if safety, efficacy, manufacturing or supply issues arise with the drugs Carisma chooses to evaluate in combination with CT-0508, Carisma may be unable to obtain approval of CT-0508 or market CT-0508.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In September&#160;2022, Carisma submitted a clinical protocol amendment to the CT-0508 IND for a CAR-M / anti-PD-1 (CT-0508 and pembrolizumab) combination strategy. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma did not develop or obtain marketing approval for, nor has Carisma manufactured or sold, any of the currently approved drugs that it may study in combination with CT-0508. If the FDA or similar regulatory authorities outside of the United States revoke their approval of any drug or drugs in combination with which Carisma determines to develop CT-0508, Carisma will not be able to market CT-0508 in combination with such revoked drugs. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If safety or efficacy issues arise with any of these drugs, Carisma could experience significant regulatory delays, and the FDA or similar regulatory authorities outside of the United States may require Carisma to redesign or terminate the applicable clinical trials. If the drugs Carisma uses are replaced as the standard of care for the indications it chooses for CT-0508, the FDA or similar regulatory authorities outside of the United States may require Carisma to conduct additional clinical trials. In addition, if manufacturing or other issues result in a shortage of supply of the drugs with which Carisma determines to combine with CT-0508, it may not be able to complete clinical development of CT-0508 on its current timeline or at all. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Even if CT-0508 were to receive marketing approval or be commercialized for use in combination with other existing drugs, Carisma would continue to be subject to the risks that the FDA or similar regulatory authorities outside of the United States could revoke approval of the drug used in combination with CT-0508 or that safety, efficacy, manufacturing or supply issues could arise with these existing drugs. Combination therapies are commonly used for the treatment of cancer, and Carisma would be subject to similar risks if it develops any of its other product candidates for use in combination with other drugs or for indications other than cancer. This could result in Carisma&#8217;s own products being removed from the market or being less successful commercially. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Carisma may not be successful in its efforts to identify or discover additional potential product candidates.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">A key element of Carisma&#8217;s strategy is to apply its macrophage engineering platform to address a broad array of indications and targets to generate next-generation therapeutics, including three programs for indications outside of oncology. The discovery efforts that Carisma is conducting may not be successful in identifying product candidates that are useful in treating cancer or other diseases. Carisma&#8217;s discovery </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">70</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">engine may initially show promise in identifying potential product candidates, yet fail to yield product candidates for clinical development for a number of reasons, including: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">potential product candidates may, on further study, be shown to have harmful side effects or other characteristics that indicate that they are unlikely to be drugs that will receive marketing approval or achieve market acceptance; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">potential product candidates may not be effective in treating their targeted diseases. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Discovery programs to identify new product candidates require substantial technical, financial and human resources. Carisma may choose to focus its efforts and resources on a potential product candidate that ultimately proves to be unsuccessful. If Carisma is unable to identify additional suitable product candidates for pre-clinical and clinical development, it will limit its potential to obtain revenues from sale of products in future periods, which likely would result in significant harm to Carisma&#8217;s financial position and adversely impact its stock price. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Adverse public perception of genetic medicine, and gene therapy in particular, may negatively impact regulatory approval of, or demand for, Carisma&#8217;s potential products.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The clinical and commercial success of Carisma&#8217;s potential products will depend in part on public acceptance of the use of gene therapy for the prevention or treatment of human diseases. Public attitudes may be influenced by claims that gene therapy is unsafe, unethical, or immoral, and, consequently, Carisma&#8217;s products may not gain the acceptance of the public or the medical community. Adverse public attitudes may adversely impact Carisma&#8217;s ability to enroll clinical trials. Moreover, Carisma&#8217;s success will depend upon physicians prescribing, and their patients being willing to receive, treatments that involve the use of product candidates that Carisma may develop in lieu of, or in addition to, existing treatments with which they are already familiar and for which greater clinical data may be available. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Risks Related to the Commercialization of Carisma&#8217;s Product Candidates</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Even if any of Carisma&#8217;s product candidates receives marketing approval, it may fail to achieve the degree of market acceptance by physicians, patients, third-party payors and others in the medical community necessary for commercial success, and the market opportunity for any of its product candidates, if approved, may be smaller than it estimates.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If any of Carisma&#8217;s product candidates receives marketing approval, it may nonetheless fail to gain sufficient market acceptance by physicians, patients, third-party payors and others in the medical community. For example, current cancer treatments, such as chemotherapy and radiation therapy, are well established in the medical community and doctors may continue to rely on these and similar treatments. Efforts to educate the medical community and third-party payors on the benefits of Carisma&#8217;s product candidates may require significant resources and may not be successful. If Carisma&#8217;s product candidates do not achieve an adequate level of acceptance, Carisma may not generate significant revenues from product sales and it may not become profitable. The degree of market acceptance of Carisma&#8217;s product candidates, if approved for commercial sale, will depend on a number of factors, including: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the efficacy and potential advantages of Carisma&#8217;s product candidates compared to the advantages and relative risks of alternative treatments; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the effectiveness of sales and marketing efforts; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Carisma&#8217;s ability to offer its products, if approved, for sale at competitive prices; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the clinical indications for which the product is approved; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the cost of treatment in relation to alternative treatments; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the convenience and ease of administration compared to alternative treatments; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the willingness of the target patient population to try new therapies and of physicians to prescribe these therapies; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the strength of marketing and distribution support; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">71</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the timing of market introduction of competitive products; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the availability of third-party coverage and adequate reimbursement, and patients&#8217; willingness to pay out of pocket for required co-payments or in the absence of third-party coverage or adequate reimbursement; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">product labeling or product insert requirements of the FDA, the EMA or other regulatory authorities, including any limitations or warnings contained in a product&#8217;s approved labeling; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the prevalence and severity of any side effects; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">support from patient advocacy groups; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">any restrictions on the use of Carisma&#8217;s products, if approved, together with other medications. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma&#8217;s assessment of the potential market opportunity for its product candidates is based on industry and market data that it obtained from industry publications, research, surveys and studies conducted by third parties and Carisma&#8217;s analysis of these data, research, surveys and studies. Industry publications and third-party research, surveys and studies generally indicate that their information has been obtained from sources believed to be reliable, although they do not guarantee the accuracy or completeness of such information. While Carisma believes these industry publications and third-party research, surveys and studies are reliable, it has not independently verified such data. Carisma&#8217;s estimates of the potential market opportunities for its product candidates include a number of key assumptions based on its industry knowledge, industry publications and third-party research, surveys and studies, which may be based on a small sample size and fail to accurately reflect market opportunities. While Carisma believes that its internal assumptions are reasonable, no independent source has verified such assumptions. If any of Carisma&#8217;s assumptions or estimates, or these publications, research, surveys or studies prove to be inaccurate, then the actual market for any of its product candidates may be smaller than it expects, and as a result Carisma&#8217;s revenues from product sales may be limited and it may be more difficult for Carisma to achieve or maintain profitability. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If Carisma is unable to establish sales, marketing and distribution capabilities or enter into sales, marketing and distribution agreements with third parties, it may not be successful in commercializing its product candidates if and when they are approved.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma does not have a sales or marketing infrastructure and has no experience as a company in the sale, marketing or distribution of biopharmaceutical products. To achieve commercial success for any product for which Carisma may obtain marketing approval, it will need to establish a sales, marketing and distribution organization, either itself or through collaborations or other arrangements with third parties. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma currently expects that it would build its own focused, specialized sales and marketing organization to support the commercialization in the United States of product candidates for which it receives marketing approval and that can be commercialized with such capabilities. There are risks involved with Carisma establishing its own sales, marketing and distribution capabilities. For example, recruiting and training a sales force is expensive and time-consuming and could delay any product launch. If the commercial launch of a product candidate for which Carisma recruit a sales force and establish marketing capabilities is delayed or does not occur for any reason, Carisma would have prematurely or unnecessarily incurred these commercialization expenses. These efforts may be costly, and Carisma&#8217;s investment would be lost if it cannot retain or reposition its sales and marketing personnel. In general, the cost of establishing and maintaining a sales and marketing organization may exceed the cost-effectiveness of doing so. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Factors that may inhibit Carisma&#8217;s efforts to commercialize its products on its own include: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">its inability to recruit, train and retain adequate numbers of effective sales, marketing, coverage or reimbursement, customer service, medical affairs and other support personnel; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">its inability to equip sales personnel with effective materials; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">its inability to effectively manage a geographically dispersed sales and marketing team; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the inability of sales personnel to obtain access to physicians or persuade adequate numbers of physicians to prescribe any future products; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">72</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the inability of reimbursement professionals to negotiate arrangements for formulary access, reimbursement and other acceptance by payors; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the inability to price its products at a sufficient price point to ensure an adequate and attractive level of profitability; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">restricted or closed distribution channels that make it difficult to distribute its products to segments of the patient population; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the lack of complementary products to be offered by sales personnel, which may put Carisma at a competitive disadvantage relative to companies with more extensive product lines; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">unforeseen costs and expenses associated with creating an independent sales and marketing organization. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If Carisma is unable to establish its own sales, marketing and distribution capabilities and it enters into arrangements with third parties to perform these services, Carisma&#8217;s revenues from product sales and its profitability, if any, are likely to be lower than if it were to market, sell and distribute any products that it develops itself. In addition, Carisma may not be successful in entering into arrangements with third parties to sell, market and distribute its product candidates or may be unable to do so on terms that are acceptable to Carisma. Carisma likely will have little control over such third parties, and any of them may fail to devote the necessary resources and attention to sell and market its products effectively. If Carisma does not establish sales, marketing and distribution capabilities successfully, either on its own or in collaboration with third parties, it will not be successful in commercializing its product candidates. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Carisma faces substantial competition, which may result in others discovering, developing or commercializing products before or more successfully than it does, thus rendering Carisma&#8217;s products non-competitive, obsolete or reducing the size of its market.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The biopharmaceutical industry, and in particular the cell therapy field, is characterized by intense investment and competition aimed at rapidly advancing new technologies. Carisma&#8217;s platform and therapeutic product candidates are expected to face substantial competition from multiple technologies, marketed products and numerous other therapies being developed by third parties that use protein degradation, antibody therapy, inhibitory nucleic acid, gene editing or gene therapy development platforms and from companies focused on more traditional therapeutic modalities, such as small molecule inhibitors. The competition is likely to come from multiple sources, including biopharmaceutical companies, academic research institutions, governmental agencies and private research institutions that conduct research, seek patent protection and establish collaborative arrangements for research, development, manufacturing and commercialization. The competition is likely to come from multiple sources, including major pharmaceutical, specialty pharmaceutical and biotechnology companies, academic institutions, government agencies and public and private research institutions. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma is aware of a number of companies generally pursuing the development of myeloid cell therapies, including, among others Myeloid Therapeutics, Shoreline Biosciences, Inceptor Bio, Thunder Bio, Resolution Therapeutics, CellOrigin, Sirpant Therapeutics, and others. Carisma is also facing competition from companies pursuing autologous T-cell therapies, allogenic T-cell therapies, NK and other cell therapies, direct </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;"> reprogrammed cell therapies and other macrophage-targeted oncology therapeutics. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Many of the companies against which Carisma is competing or against which it may compete in the future have significantly greater financial resources and expertise in research and development, manufacturing, pre-clinical testing, conducting clinical trials, obtaining marketing approvals and marketing approved products than Carisma does. These competitors also compete with Carisma in recruiting and retaining qualified scientific and management personnel and establishing clinical trial sites and patient registration for clinical trials, as well as in acquiring technologies complementary to, or necessary for, its development programs. Carisma&#8217;s commercial opportunity could be reduced or eliminated if its competitors develop and commercialize products that are safer, more effective, have fewer or less severe side effects, are more convenient or are less expensive than any products that Carisma may develop. Carisma&#8217;s competitors also may obtain FDA or other marketing approval for their products more rapidly than Carisma may obtain approval for its products, which could result in Carisma&#8217;s competitors establishing a strong market position </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">73</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">before Carisma is able to enter the market. In addition, Carisma&#8217;s ability to compete may be affected in many cases by insurers or other third-party payors seeking to encourage the use of generic products. There are generic products currently on the market for certain of the indications that Carisma is pursuing, and additional products are expected to become available on a generic basis over the coming&#160;years. If Carisma&#8217;s product candidates are approved, it expects that they will be priced at a significant premium over competitive generic products. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Technology in the biopharmaceutical industry has undergone rapid and significant change, and Carisma expects that it will continue to do so. Any products or processes that Carisma develops may become obsolete or uneconomical before it recovers any expenses incurred in connection with their development. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Mergers and acquisitions in the biopharmaceutical industry may result in even more resources being concentrated among a smaller number of Carisma&#8217;s competitors. Smaller and other early-stage companies may also prove to be significant competitors, particularly through collaborative arrangements with large and established companies. These third parties compete with Carisma in recruiting and retaining qualified scientific and management personnel, establishing clinical trial sites and patient registration for clinical trials, as well as in acquiring technologies complementary to, or necessary for, Carisma&#8217;s programs. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma has pursued and may in the future pursue the in-license or acquisition of rights to complementary technologies and product candidates on an opportunistic basis. However, Carisma may be unable to in-license or acquire any additional technologies or product candidates from third parties. The acquisition and licensing of technologies and product candidates is a competitive area, and a number of more established companies also have similar strategies to in-license or acquire technologies and product candidates that Carisma may consider attractive. These established companies may have a competitive advantage over Carisma due to their size, cash resources and greater development and commercialization capabilities. In addition, companies that perceive Carisma to be a competitor may be unwilling to assign or license rights to Carisma. Carisma also may be unable to in-license or acquire the relevant technology or product candidate on terms that would allow Carisma to make an appropriate return on its investment. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Even if Carisma is able to commercialize any product candidates, the products may become subject to unfavorable pricing regulations, third-party coverage or reimbursement practices or healthcare reform initiatives, which could harm its business.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The regulations that govern marketing approvals, pricing, coverage and reimbursement for new drug products vary widely from country to country. Current and future legislation may significantly change the approval requirements in ways that could involve additional costs and cause delays in obtaining approvals. Some countries require approval of the sale price of a drug before it can be marketed. In many countries, the pricing review period begins after marketing or product licensing approval is granted. To obtain reimbursement or pricing approval in some countries, Carisma may be required to conduct a clinical trial that compares the cost effectiveness of its product candidate to other available therapies. In some foreign markets, prescription pharmaceutical pricing remains subject to continuing governmental control even after initial approval is granted. As a result, Carisma might obtain marketing approval for a product in a particular country, but then be subject to price regulations that delay its commercial launch of the product, possibly for lengthy time periods, and negatively impact the revenues, if any, Carisma is able to generate from the sale of the product in that country. Adverse pricing limitations may hinder Carisma&#8217;s ability to recoup its investment in one or more product candidates, even if its product candidates obtain marketing approval. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma&#8217;s ability to commercialize any product candidates successfully also will depend in part on the extent to which coverage and adequate reimbursement for these products and related treatments will be available from government health administration authorities, private health insurers and other organizations. The availability of coverage and adequacy of reimbursement by governmental healthcare programs such as Medicare and Medicaid, private health insurers and other third-party payors are essential for most patients to be able to afford medical services and pharmaceutical products, including Carisma&#8217;s product candidates. Government authorities and third-party payors, such as private health insurers and health maintenance organizations, decide which medications they will pay for and establish reimbursement levels. A primary trend in the U.S. healthcare industry and elsewhere is cost containment. Government authorities and third-party </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">74</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">payors have attempted to control costs by limiting coverage and the amount of reimbursement for particular medications. Increasingly, government authorities and third-party payors are requiring that drug companies provide them with predetermined discounts from list prices and are challenging the prices charged for medical products. Coverage and reimbursement may not be available for any product that Carisma commercializes and, even if these are available, the level of reimbursement may not be satisfactory. Reimbursement may affect the demand for, or the price of, any product candidate for which it obtains marketing approval. Obtaining and maintaining adequate reimbursement for Carisma&#8217;s products may be difficult. Carisma may be required to conduct expensive pharmacoeconomic studies to justify coverage and reimbursement or the level of reimbursement relative to other therapies. If coverage and adequate reimbursement are not available or reimbursement is available only to limited levels, Carisma may not be able to successfully commercialize any product candidate for which it obtains marketing approval. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">There may be significant delays in obtaining coverage and reimbursement for newly approved drugs, and coverage may be more limited than the purposes for which the drug is approved by the FDA or similar regulatory authorities outside of the United States. Moreover, eligibility for coverage and reimbursement does not imply that a drug will be paid for in all cases or at a rate that covers its costs, including research, development, intellectual property, manufacture, sale and distribution expenses. Interim reimbursement levels for new drugs, if applicable, may also not be sufficient to cover Carisma&#8217;s costs and may not be made permanent. Reimbursement rates may vary according to the use of the drug and the clinical setting in which it is used, may be based on reimbursement levels already set for lower cost drugs and may be incorporated into existing payments for other services. Net prices for drugs may be reduced by mandatory discounts or rebates required by government healthcare programs or private payors and by any future relaxation of laws that presently restrict imports of drugs from countries where they may be sold at lower prices than in the United States. Third-party payors often rely upon Medicare coverage policy and payment limitations in setting their own reimbursement policies. Carisma&#8217;s inability to promptly obtain coverage and adequate reimbursement rates from both government-funded and private payors for any approved products that it develops could have a material adverse effect on its operating results, its ability to raise capital needed to commercialize products and its overall financial condition. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">No uniform policy for coverage and reimbursement for products exists among third-party payors in the United States. Therefore, coverage and reimbursement for products can differ significantly from payor to payor. As a result, the coverage determination process is often a time-consuming and costly process that will require Carisma to provide scientific and clinical support for the use of its product candidates to each payor separately, with no assurance that coverage and adequate reimbursement will be applied consistently or obtained in the first instance. Furthermore, rules and regulations regarding reimbursement change frequently, in some cases on short notice, and Carisma believes that changes in these rules and regulations are likely. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">There can be no assurance that Carisma&#8217;s product candidates, even if they are approved for sale in the United States, in the European Union or in other countries, will be considered medically reasonable and necessary for a specific indication or cost-effective by third-party payors, or that coverage and an adequate level of reimbursement will be available or that third-party payors&#8217; reimbursement policies will not adversely affect Carisma&#8217;s ability to sell its product candidates profitably. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Clinical trial and product liability lawsuits against Carisma could divert its resources and could cause Carisma to incur substantial liabilities and to limit commercialization of any products that it may develop.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma faces an inherent risk of clinical trial and product liability exposure related to the testing of its product candidates in human clinical trials and will face an even greater risk if it commercially sells any products that it may develop. While Carisma currently has no products that have been approved for commercial sale, the ongoing, planned and future use of product candidates by Carisma in clinical trials, and the sale of any approved products in the future, may expose Carisma to liability claims. These claims might be made by patients that use the product, healthcare providers, pharmaceutical companies or others selling such products. On occasion, large judgments have been awarded in class action lawsuits based on products that had unanticipated adverse effects. If Carisma cannot successfully defend itself against claims that its product candidates or products caused injuries, it will incur substantial liabilities. Regardless of merit or eventual outcome, liability claims may result in: </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">75</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">decreased demand for any product candidates or products that it may develop; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">termination of clinical trials; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">withdrawal of marketing approval, recall, restriction on the approval or a &#8220;black box&#8221; warning or contraindication for an approved drug; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">withdrawal of clinical trial participants; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">significant costs to defend any related litigation; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">substantial monetary awards to trial participants or patients; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">loss of revenue; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">injury to Carisma&#8217;s reputation and significant negative media attention; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">reduced resources of Carisma management to pursue its business strategy; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">distraction of management&#8217;s attention from Carisma&#8217;s primary business; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the inability to commercialize any products that Carisma may develop. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma currently holds $10.0&#160;million in product liability insurance coverage in the aggregate, with a per incident limit of $10.0&#160;million, which may not be adequate to cover all liabilities that it may incur. Carisma may need to increase its insurance coverage as it expands its clinical trials or if it commences commercialization of its product candidates. Insurance coverage is increasingly expensive. Carisma may not be able to maintain insurance coverage at a reasonable cost or in an amount adequate to satisfy any liability that may arise. If a successful clinical trial or product liability claim or series of claims is brought against Carisma for uninsured liabilities or in excess of insured liabilities, its assets may not be sufficient to cover such claims and its business operations could be impaired. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Risks Related to Carisma&#8217;s Dependence on Third Parties</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Carisma relies, and expects to continue to rely, on third parties to conduct its clinical trials, and those third parties may not perform satisfactorily, including failing to meet deadlines for the completion of such trials, which may prevent or delay Carisma&#8217;s ability to seek or obtain marketing approval for or commercialize its product candidates or otherwise harm its business. If Carisma is not able to maintain these third-party relationships or if these arrangements are terminated, it may have to alter its development and commercialization plans and its business could be adversely affected.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma relies, and expects to continue to rely, on third-party clinical research organizations, in addition to other third parties such as research collaboratives, clinical data management organizations, medical institutions and clinical investigators, to conduct its ongoing Phase&#160;1 clinical trial of CT-0508 and related combinations studies, its planned clinical trials of CT-0525, CT-1119 and CT-0729 and any other clinical trials it conducts. Carisma does not plan to independently conduct clinical trials of its product candidates or any other product candidates that it may develop. These contract research organizations and other third parties play a significant role in the conduct and timing of these trials and subsequent collection and analysis of data. These third-party arrangements might terminate for a variety of reasons, including a failure to perform by the third parties. If Carisma needs to enter into alternative arrangements, its product development activities might be delayed. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma&#8217;s reliance on these third parties for discovery and product development activities reduces its control over these activities but does relieve Carisma of its responsibilities. For example, Carisma will remain responsible for ensuring that each of its clinical trials is conducted in accordance with the general investigational plan and protocols for the trial. Moreover, the FDA requires Carisma to comply with standards, commonly referred to as good clinical practices, or GCPs, for conducting, recording and reporting the results of clinical trials to assure that data and reported results are credible and accurate and that the rights, integrity and confidentiality of trial participants are protected. Regulatory authorities in Europe and other jurisdictions have similar requirements. Regulatory authorities enforce these GCPs through periodic inspections of trial sponsors, principal investigators and trial sites. If Carisma or any of its contract research organizations or trial sites fail to comply with applicable GCPs, the clinical data generated in its clinical </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">76</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">trials may be deemed unreliable, and the FDA or comparable foreign regulatory authorities may require Carisma to perform additional clinical trials before approving its marketing applications. Carisma is also required to register ongoing clinical trials and post the results of completed clinical trials on a government-sponsored database, ClinicalTrials.gov, within specified timeframes. Failure to do so can result in fines, adverse publicity and civil and criminal sanctions. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If these third parties do not successfully carry out their contractual duties, meet expected deadlines or conduct Carisma&#8217;s clinical trials in accordance with regulatory requirements or Carisma&#8217;s stated protocols, Carisma will not be able to obtain, or may be delayed in obtaining, marketing approvals for its product candidates and will not be able to, or may be delayed in its efforts to, successfully develop and commercialize its product candidates. Furthermore, these third parties may also have relationships with other entities, some of which may be Carisma&#8217;s competitors. In addition, principal investigators for Carisma&#8217;s clinical trials may serve as scientific advisors or consultants to Carisma from time to time and may receive cash or equity compensation in connection with such services. If these relationships and any related compensation result in perceived or actual conflicts of interest, or the FDA concludes that the financial relationship may have affected the interpretation of the trial, the integrity of the data generated at the applicable clinical trial site may be questioned, and the utility of the clinical trial itself may be jeopardized, which could result in the delay or rejection of any marketing application Carisma submits to the FDA. Any such delay or rejection could prevent Carisma from commercializing its product candidates. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If any of Carisma&#8217;s relationships with these third parties terminate, it may not be able to enter into arrangements with alternative third parties or do so on commercially reasonable terms. Switching or adding additional contract research organizations, investigators and other third parties involves additional cost and requires management time and focus. In addition, there is a natural transition period when a new contract research organization commences work. As a result, delays can occur, which could materially impact Carisma&#8217;s ability to meet its desired clinical development timelines. The COVID-19 pandemic and government measures taken in response have also had a significant impact on many contract research organizations. Although Carisma plans to carefully manage its relationships with its contract research organizations, investigators and other third parties, it may nonetheless encounter challenges or delays in the future, which could have a material and adverse impact on Carisma&#8217;s business, financial condition and prospects. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Carisma relies on third-party contract manufacturing organizations for the manufacture of both drug substance and finished drug product of its product candidates for pre-clinical and clinical testing and expect to continue to do so for commercialization. This reliance on third parties increases the risk that Carisma will not have sufficient quantities of its product candidates or products or such quantities at an acceptable cost or quality, which could delay, prevent or impair Carisma&#8217;s development or commercialization efforts.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma does not own or operate, and currently has no plans to establish, any manufacturing facilities. Carisma relies, and expects to continue to rely, on third-party contract manufacturing organizations for both drug substance and finished drug product, as well as for commercial manufacture if any of its product candidates receive marketing approval. Carisma also currently relies on these third parties for the manufacture of plasmid and viral vectors, patient leukapheresis material logistics, as well as packaging, labeling, sterilization, storage, distribution and other production logistics. This reliance on third parties increases the risk that Carisma will not have sufficient quantities of its product candidates or products or such quantities at an acceptable cost or quality, which could delay, prevent or impair Carisma&#8217;s development or commercialization efforts. Carisma may be unable to establish any agreements with third-party manufacturers or to do so on acceptable terms. Even if Carisma is able to establish agreements with third-party manufacturers, reliance on third-party manufacturers entails additional risks, including: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.09pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.09pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">reliance on the third party for regulatory compliance and quality assurance; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the possible breach of the manufacturing agreement by the third party; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the potential failure to manufacture Carisma&#8217;s product candidate or product according to its specifications; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the potential failure to manufacture Carisma&#8217;s product candidate or product according to its schedule or at all; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">77</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the possible misappropriation of Carisma&#8217;s proprietary information, including its trade secrets and know-how; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the possible termination or nonrenewal of the agreement by the third party at a time that is costly or inconvenient for Carisma. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma or its third-party manufacturers may encounter shortages in the raw materials or active pharmaceutical ingredients necessary to produce Carisma&#8217;s product candidates in the quantities needed for its clinical trials or, if its product candidates are approved, in sufficient quantities for commercialization or to meet an increase in demand, as a result of capacity constraints or delays or disruptions in the market for the raw materials or active pharmaceutical ingredients, including shortages caused by the purchase of such raw materials or active pharmaceutical ingredients by its competitors or others. The failure of Carisma or its third-party manufacturers to obtain the raw materials or active pharmaceutical ingredients necessary to manufacture sufficient quantities of its product candidates, may have a material adverse effect on Carisma&#8217;s business. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma&#8217;s third-party manufacturers are subject to inspection and approval by regulatory authorities before Carisma can commence the manufacture and sale of any of its product candidates, and thereafter subject to ongoing inspection from time to time. Third-party manufacturers may not be able to comply with cGMP, regulations or similar regulatory requirements outside of the United States. Carisma&#8217;s failure, or the failure of its third-party manufacturers, to comply with applicable regulations could result in sanctions being imposed on Carisma, including clinical holds, fines, injunctions, civil penalties, delays, suspension or withdrawal of approvals, license revocation, seizures or recalls of product candidates or products, operating restrictions and criminal prosecutions, any of which could significantly and adversely affect supplies of Carisma&#8217;s products. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma&#8217;s product candidates and any products that it may develop may compete with other product candidates and products for access to manufacturing facilities. As a result, Carisma may not obtain access to these facilities on a priority basis or at all. There are a limited number of manufacturers that operate under cGMP regulations and that might be capable of manufacturing for Carisma. Any performance failure on the part of Carisma&#8217;s existing or future manufacturers could delay clinical development or marketing approval. Carisma does not currently have arrangements in place for redundant supply or a second source for bulk drug substance. If any of Carisma&#8217;s current contract manufacturers cannot perform as agreed, it may be required to replace such manufacturers. Although Carisma believes that there are several potential alternative manufacturers who could manufacture its product candidates, it may incur added costs and delays in identifying and qualifying any such replacement or be unable to reach agreement with an alternative manufacturer. In addition, the COVID-19 pandemic may impact Carisma&#8217;s ability to procure sufficient supplies for the development of its product candidates. The extent of this impact will depend on the severity and duration of the spread of the virus, and the actions undertaken to contain COVID-19 or treat its effects. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma&#8217;s current and anticipated future dependence upon others for the manufacture of its product candidates or products may adversely affect its future profit margins and its ability to commercialize any products that receive marketing approval on a timely and competitive basis. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Carisma expects to depend on collaborations with third parties for the research, development and commercialization of certain of its product candidates. If Carisma&#8217;s collaborations are not successful, it may not be able to capitalize on the market potential of these product candidates and its business could be adversely affected.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma anticipates seeking third-party collaborators for the research, development and commercialization of certain of its product candidates. For example, Carisma entered into a strategic collaboration with Moderna in January&#160;2022 focused on the development of </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;"> CAR-M therapeutics for up to twelve product candidates. In collaboration with Moderna, Carisma has established a myeloid tropic LNP/mRNA </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;"> CAR-M platform for oncology targets, which enables an off-the-shelf approach wherein the patient&#8217;s own myeloid cells are engineered directly within their body via the administration of a myeloid-tropic LNP encapsulating macrophage reprogramming mRNA CAR constructs, removing the requirement for </font><font style="font-style:italic;letter-spacing:0.2pt;">ex vivo</font><font style="letter-spacing:0.2pt;"> cell manufacturing entirely. As part of the collaboration, Carisma received a </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">78</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">$45.0&#160;million up-front cash payment from Moderna, in addition to future research funding, milestone payments and royalties. Concurrent with entering into the collaboration agreement, Moderna made an investment in Carisma in the form of a $35.0&#160;million convertible note. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma&#8217;s likely collaborators for any other collaboration arrangements include large and mid-size pharmaceutical companies and biotechnology companies. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Any such arrangements with third parties will likely limit Carisma&#8217;s control over the amount and timing of resources that its collaborators dedicate to the development or commercialization of its product candidates Carisma may seek to develop with them. Carisma&#8217;s ability to generate revenues from these arrangements will depend on its collaborators&#8217; abilities and efforts to successfully perform the functions assigned to them in these arrangements. Carisma cannot predict the success of any collaboration that it enters into. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Collaborations involving Carisma&#8217;s discovery programs or any product candidates it may develop, including its collaboration with Moderna, pose the following risks to Carisma: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">collaborators have significant discretion in determining the amount and timing of efforts and resources that they will apply to these collaborations; for example, Carisma&#8217;s collaboration with Moderna is managed by a joint steering committee, which is comprised of representatives from Carisma and Moderna, with Moderna having final decision-making authority, subject to specified limitations; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">collaborators may not perform their obligations as expected; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">collaborators may not pursue development of Carisma&#8217;s product candidates or may elect not to continue or renew development programs based on results of clinical trials or other studies, changes in the collaborators&#8217; strategic focus or available funding, or external factors, such as an acquisition or business combination, that divert resources or create competing priorities; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">collaborators may not pursue development and commercialization of any product candidates that achieve marketing approval or may elect not to continue or renew commercialization programs based on results of clinical trials or other studies, changes in the collaborators&#8217; strategic focus or available funding, or external factors, such as an acquisition or business combination, that may divert resources or create competing priorities; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">collaborators may delay clinical trials, provide insufficient funding for a clinical trial program, stop a clinical trial or abandon a product candidate, repeat or conduct new clinical trials or require a new formulation of a product candidate for clinical testing; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Carisma may not have access to, or may be restricted from disclosing, certain information regarding product candidates being developed or commercialized under a collaboration and, consequently, may have limited ability to inform its stockholders about the status of such product candidates on a discretionary basis; for example, data, results and know-how generated in the performance of the Moderna collaboration is deemed the confidential information of Moderna, which Carisma may not disclose except under limited circumstances; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">collaborators could independently develop, or develop with third parties, products that compete directly or indirectly with Carisma&#8217;s product candidates and products if the collaborators believe that the competitive products are more likely to be successfully developed or can be commercialized under terms that are more economically attractive than Carisma&#8217;s; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">product candidates discovered in collaboration with Carisma may be viewed by Carisma&#8217;s collaborators as competitive with their own product candidates or products, which may cause collaborators to cease to devote resources to the commercialization of Carisma&#8217;s product candidates; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">a collaborator may fail to comply with applicable regulatory requirements regarding the development, manufacture, distribution or marketing of a product candidate or product; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">a collaborator may seek to renegotiate or terminate their relationship with Carisma due to unsatisfactory clinical results, manufacturing issues, a change in business strategy, a change of control or other reasons; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">79</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">a collaborator with marketing and distribution rights to one or more of Carisma&#8217;s product candidates that achieve marketing approval may not commit sufficient resources to the marketing and distribution of such product or products; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">disagreements with collaborators, including disagreements over intellectual property or proprietary rights, contract interpretation or the preferred course of development, might cause delays or terminations of the research, development or commercialization of product candidates, might lead to additional responsibilities for Carisma with respect to product candidates, or might result in litigation or arbitration, any of which would be time-consuming and expensive; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Carisma may lose certain valuable rights under circumstances identified in its collaborations, including if it undergoes a change of control; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">collaborators may not properly obtain, maintain, enforce, defend or protect Carisma&#8217;s intellectual property or proprietary rights or may use its proprietary information in such a way as to potentially lead to disputes or legal proceedings that could jeopardize or invalidate its intellectual property or proprietary information or expose Carisma to potential litigation; for example, Moderna has the first right to prosecute, enforce or defend certain patent rights under its agreement with Carisma, and although Carisma may have the right to assume the prosecution, enforcement or defense of such patent rights if Moderna does not, Carisma&#8217;s ability to do so may be compromised by Moderna&#8217;s actions; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">disputes may arise with respect to the ownership of intellectual property developed pursuant to Carisma&#8217;s collaborations; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">collaborators may infringe, misappropriate or otherwise violate the intellectual property or proprietary rights of third parties, which may expose Carisma to litigation and potential liability; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">collaborations may be terminated, and, if terminated, Carisma could be required to raise additional capital to pursue further development or commercialization of the applicable product candidates; for example, Moderna has the right to terminate its agreement with Carisma for convenience in its entirety or with respect to a specific product or target on ninety days&#8217; prior notice, in connection with a material breach of the agreement by Carisma that remains uncured for a specified period of time or in the event of specified insolvency events involving Carisma; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">collaboration agreements may not lead to development or commercialization of product candidates in the most efficient manner, or at all. If a present or future collaborator of Carisma&#8217;s were to be involved in a business combination, the continued pursuit and emphasis on its product development or commercialization program under such collaboration could be delayed, diminished or terminated. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If any collaborations that Carisma enters into do not result in the successful development and commercialization of products or if one of Carisma&#8217;s collaborators terminates its agreement with it, Carisma may not receive any future research funding or milestone or royalty payments under the collaboration. If Carisma does not receive the funding it expects under these agreements, its development of its product candidates could be delayed and it may need additional resources to develop its product candidates. All of the risks relating to product development, marketing approval and commercialization described in this proxy statement/prospectus also apply to the activities of Carisma&#8217;s collaborators. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma may in the future decide to collaborate with biopharmaceutical companies for the development and potential commercialization of any product candidates it may develop. These relationships, or those like them, may require Carisma to incur non-recurring and other charges, increase Carisma&#8217;s near- and long-term expenditures, issue securities that dilute Carisma&#8217;s existing stockholders, or disrupt Carisma&#8217;s management and business. In addition, Carisma could face significant competition in seeking appropriate collaborators, and the negotiation process is time-consuming and complex. Carisma&#8217;s ability to reach a definitive collaboration agreement will depend, among other things, upon its assessment of the collaborator&#8217;s resources and expertise, the terms and conditions of the proposed collaboration, and the proposed collaborator&#8217;s evaluation of several factors. If Carisma licenses rights to any product candidates it or its collaborators may develop, Carisma may not be able to realize the benefit of such transactions if it is unable to successfully integrate them with its existing operations and company culture. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">80</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Carisma may seek to establish additional collaborations. If Carisma is not able to establish or maintain additional collaborations, on commercially reasonable terms, it may have to alter its development and commercialization plans and its business could be adversely affected.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">To realize the full potential of Carisma&#8217;s macrophage engineering platform and accelerate the development of additional macrophage engineering programs, Carisma plans to continue to selectively pursue collaborations with leading biopharmaceutical companies with particular experience, including development and commercial expertise and capabilities. Carisma faces significant competition in attracting appropriate collaborators, and a number of more established companies may also be pursuing strategies to license or acquire third-party intellectual property rights that it considers attractive. These established companies may have a competitive advantage over Carisma due to their size, financial resources and greater clinical development and commercialization capabilities. In addition, companies that perceive Carisma to be a competitor may be unwilling to assign or license rights to Carisma. Whether Carisma reaches a definitive agreement for a collaboration will depend, among other things, upon its assessment of the collaborator&#8217;s resources and expertise, the terms and conditions of the proposed collaboration and the proposed collaborator&#8217;s evaluation of a number of factors. Those factors may include the design or results of clinical trials, the likelihood of approval by the FDA or other regulatory authorities, the potential market for the subject product candidate, the costs and complexities of manufacturing and delivering such product candidate to patients, the potential of competing products, the existence of uncertainty with respect to Carisma&#8217;s ownership of technology, which can exist if there is a challenge to such ownership without regard to the merits of the challenge, the terms of any existing collaboration agreements, and industry and market conditions generally. The collaborator may also consider alternative product candidates or technologies for similar indications that may be available to collaborate on and whether such a collaboration could be more attractive than the one with Carisma for its product candidate. Carisma may also be restricted under future license agreements from entering into agreements on certain terms with potential collaborators. Collaborations are complex and time-consuming to negotiate, document and execute. In addition, there have been a significant number of recent business combinations among large biopharmaceutical companies that have resulted in a reduced number of potential future collaborators. Any collaboration Carisma may enter into may limit its ability to enter into future agreements on particular terms or covering similar target indications with other potential collaborators. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If Carisma is unable to reach agreements with suitable collaborators on a timely basis, on acceptable terms or at all, it may have to curtail the development of a product candidate, reduce or delay its development program or one or more of Carisma&#8217;s other development programs, delay its potential commercialization or reduce the scope of any sales or marketing activities, or increase its expenditures and undertake development or commercialization activities at its own expense. If Carisma elects to fund and undertake development or commercialization activities on its own, it may need to obtain additional expertise and additional capital, which may not be available to Carisma on acceptable terms or at all. If Carisma fails to enter into collaborations and does not have sufficient funds or expertise to undertake the necessary development and commercialization activities, it may not be able to further develop its product candidates or bring them to market and generate revenue from product sales, which could have an adverse effect on its business, prospects, financial condition and results of operations. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Carisma has a number of academic collaborations to supplement its internal discovery and product development program. If any such collaborator decides to discontinue or devote less resources to such research, Carisma&#8217;s discovery programs could be diminished.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma&#8217;s discovery engine is supplemented by academic collaborations to expand its platform, which Carisma relies upon to advance its development and commercialization plans for its product candidates. In August&#160;2020, Carisma entered into a scientific research and licensing agreement with Nathaniel R. Landau, Ph.D. and NYU Langone Health through which it obtained exclusive rights to develop their Vpx lentiviral vector globally for all indications. Carisma also has an ongoing discovery program in neurodegeneration being pursued through a sponsored research agreement with Dr.&#160;Saar Gill, Associate Professor of Medicine at the University of Pennsylvania and co-founder of Carisma, to develop CAR macrophages and microglia targeted against protein aggregates associated with neurodegenerative disease pathology. In addition, Carisma from time to time may enter into academic research collaborations to explore the development of new technologies and indications. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">81</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">While these academic institutions have contractual obligations to Carisma, they are independent entities and are not under Carisma&#8217;s control or the control of Carisma&#8217;s officers or directors. Carisma&#8217;s research and licensing agreements with academic collaborators generally provide academic collaborators with license maintenance fees, development and regulatory milestone payments, royalties on net sales of products and a portion of sublicense income that Carisma receives. Upon the scheduled expiration of any academic collaboration, Carisma may not be able to renew the related agreement or any renewal could be on terms less favorable to Carisma than those contained in the existing agreement. Furthermore, either Carisma or the academic institution generally may terminate the sponsored research agreement for convenience following a specified notice period. If any of these academic institutions decides to not renew or to terminate the related agreement or decides to devote fewer resources to such activities, Carisma&#8217;s discovery efforts would be diminished, while its royalty obligations, if any, would continue unmodified. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Any acquisitions or in-license transactions that Carisma completes could disrupt its business, cause dilution to its stockholders or reduce its financial resources.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma has licensed three patent families from the University of Pennsylvania and one patent family from New York University and may enter into transactions to in-license or acquire other businesses, intellectual property, technologies, product candidates or products. If Carisma determines to pursue a particular transaction, it may not be able to complete the transaction on favorable terms, or at all. Any in-licenses or acquisitions Carisma completes may not strengthen its competitive position, and these transactions may be viewed negatively by customers or investors. Carisma may decide to incur debt in connection with an in-license or acquisition or issue its common stock or other equity securities to the stockholders of the target company, which would reduce the&#160;percentage ownership of its existing stockholders. Carisma could incur losses resulting from undiscovered liabilities that are not covered by the indemnification it may obtain from the seller. In addition, Carisma may not be able to successfully integrate the acquired personnel, technologies and operations into its existing business in an effective, timely and nondisruptive manner. In-license and acquisition transactions may also divert management attention from day-to-day responsibilities, increase its expenses and reduce its cash available for operations and other uses. Carisma cannot predict the number, timing or size of additional future in-licenses or acquisitions or the effect that any such transactions might have on its operating results. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Risks Related to Carisma&#8217;s Intellectual Property</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If Carisma is unable to obtain, maintain and enforce patent protection for its technology and product candidates or if the scope of the patent protection obtained is not sufficiently broad, its competitors could develop and commercialize technology and products similar or identical to Carisma&#8217;s, and its ability to successfully develop and commercialize its technology and product candidates may be adversely affected and Carisma may not be able to compete effectively in its market.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma&#8217;s commercial success depends in part on its ability to obtain, maintain and enforce protection of the intellectual property it may own solely and jointly with others or may license from others, particularly patents, in the United States and other countries with respect to any proprietary technology and product candidates. Carisma seeks to protect its proprietary position by filing patent applications in the United States and abroad related to its technologies and product candidates that are important to its business and by in-licensing intellectual property related to such technologies and product candidates. If Carisma is unable to obtain, maintain or enforce patent protection with respect to any proprietary technology or product candidate, its business, financial condition, results of operations and prospects could be materially harmed. Any disclosure to or misappropriation by third parties of Carisma&#8217;s confidential proprietary information could enable competitors to quickly duplicate or surpass Carisma&#8217;s technological achievements, thus eroding Carisma&#8217;s competitive position in its market. Moreover, the patent applications Carisma owns, co-owns or licenses may fail to result in issued patents in the United States or in other foreign countries. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The patent prosecution process is expensive, time-consuming and complex, and Carisma may not be able to file, prosecute, maintain, defend or license all necessary or desirable patent applications at a reasonable cost or in a timely manner. It is also possible that Carisma will fail to identify patentable aspects of its research and development output before it is too late to obtain patent protection. Moreover, in some circumstances, Carisma does not have the right to control the preparation, filing and prosecution of patent </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">82</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">applications, or to maintain, enforce and defend the patents, covering technology that Carisma licenses from third parties. Therefore, these in-licensed patents and applications may not be prepared, filed, prosecuted, maintained, defended and enforced in a manner consistent with the best interests of its business. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The patent position of biopharmaceutical companies generally is highly uncertain, involves complex legal and factual questions and has in recent&#160;years been the subject of much litigation. In addition, the scope of patent protection outside of the United States is uncertain and laws of foreign countries may not protect Carisma&#8217;s rights to the same extent as the laws of the United States or vice versa. For example, European patent law restricts the patentability of methods of treatment of the human body more than United States law does. With respect to both owned and in-licensed patent rights, Carisma cannot predict whether the patent applications Carisma and its licensors are currently pursuing will issue as patents in any particular jurisdiction or whether the claims of any issued patents will provide sufficient protection from competitors. Further, Carisma may not be aware of all third-party intellectual property rights potentially relating to its product candidates. In addition, publications of discoveries in the scientific literature often lag behind the actual discoveries, and patent applications in the United States and other jurisdictions are typically not published until 18&#160;months after filing, or in some cases not published at all. Therefore, neither Carisma nor its licensors can know with certainty whether either Carisma or its licensors were the first to make the inventions claimed in the patents and patent applications Carisma owns or in-licenses now or in the future, or that either Carisma or its licensors were the first to file for patent protection of such inventions. As a result, the issuance, scope, validity, enforceability and commercial value of its patent rights are highly uncertain. Moreover, its owned or in-licensed pending and future patent applications may not result in patents being issued which protects its technology and product candidates, in whole or in part, or which effectively prevent others from commercializing competitive technologies and products. Changes in either the patent laws or interpretation of the patent laws in the United States and other countries may diminish the value of its patents and its ability to obtain, protect, maintain, defend and enforce its patent rights, narrow the scope of its patent protection and, more generally, could affect the value or narrow the scope of its patent rights. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Moreover, Carisma or its licensors may be subject to a third-party preissuance submission of prior art to the USPTO or become involved in opposition, derivation, revocation, reexamination, inter partes review, post-grant review or interference proceedings challenging its patent rights or the patent rights of others. An adverse determination in any such submission, proceeding or litigation could reduce the scope of, or invalidate, its patent rights, allow third parties to commercialize its technology or product candidates and compete directly with it, without payment to it, or result in its inability to manufacture or commercialize products without infringing third-party patent rights. If the breadth or strength of protection provided by its patents and patent applications is threatened, regardless of the outcome, it could dissuade companies from collaborating with it to license, develop or commercialize current or future product candidates. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma&#8217;s owned or licensed patent estate includes patent applications, many of which are at an early stage of prosecution. The coverage claimed in a patent application can be significantly reduced before the patent is issued, and its scope can be reinterpreted after issuance. Even if its owned or in-licensed patent applications issue as patents, they may not issue in a form that will provide it with any meaningful protection, prevent competitors from competing with it or otherwise provide it with any competitive advantage. The issuance of a patent is not conclusive as to its inventorship, scope, validity or enforceability, and its owned and in-licensed patents may be challenged in the courts or patent offices in the United States and abroad. Such challenges may result in loss of exclusivity or freedom to operate or in patent claims being narrowed, invalidated or held unenforceable, in whole or in part, which could limit its ability to stop others from using or commercializing similar or identical technology and products, or limit the duration of the patent protection of its technology and product candidates. Such proceedings also may result in substantial cost and require significant time from its management and employees, even if the eventual outcome is favorable to Carisma. Given the amount of time required for the development, testing and regulatory review of new product candidates, patents protecting such candidates might expire before or shortly after such candidates are commercialized. Furthermore, its competitors may be able to circumvent its owned or in-licensed patents by developing similar or alternative technologies or products in a non-infringing manner. As a result, its patent portfolio may not provide it with sufficient rights to exclude others from commercializing technology and products similar or identical to any of its technology and product candidates. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">83</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Patent terms may be inadequate to protect Carisma&#8217;s competitive position with respect to its current or future product candidates for an adequate amount of time.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11pt;">
          <font style="letter-spacing:0.2pt;">Patents have a limited lifespan. In the United States, if all maintenance fees are timely paid, the natural expiration of a patent is generally 20&#160;years from its earliest U.S. non-provisional filing date. Various extensions may be available, but there is no assurance that any such extensions will be obtained, and the life of a patent, and the protection it affords, is limited. Even if patents covering Carisma&#8217;s current or future product candidates are obtained, once the patent life has expired, it may be open to competition from competitive products, including generics or biosimilars. Given the amount of time required for the development, testing and regulatory review of new product candidates, patents protecting such candidates might expire before or shortly after such candidates are commercialized. As a result, its patent portfolio may not provide it with sufficient rights to exclude others from commercializing products similar or identical to Carisma&#8217;s. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11pt;">
          <font style="letter-spacing:0.2pt;">In the United States, patent term can also be adjusted due to delays that occur during examination of patent applications, which may extend the term of a patent beyond 20&#160;years. There is a risk that Carisma may take action that detracts from any accrued patent term adjustment. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11pt;">
          <font style="letter-spacing:0.2pt;">It is necessary to pay certain maintenance fees, also referred to as annuities or renewal fees in some countries, throughout the lifetime of a patent at regular intervals. Failure to pay these fees can cause a granted patent to prematurely expire, without an opportunity for revival. There is a risk that Carisma may be unable to maintain patent protection for certain patents in all markets due to finite availability of resources. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If Carisma is unable to obtain licenses from third parties on commercially reasonable terms or fail to comply with its obligations under such agreements, its business could be harmed.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">It may be necessary for it to use the patented or proprietary technology of third parties to commercialize its products, in which case Carisma would be required to obtain a license from these third parties. If Carisma is unable to license such technology, or if Carisma is forced to license such technology on unfavorable terms, its business could be materially harmed. If Carisma is unable to obtain a necessary license, Carisma may be unable to develop or commercialize the affected product candidate(s), which could materially harm its business and the third parties owning such intellectual property rights could seek either an injunction prohibiting its sales or an obligation on its part to pay royalties and/or other forms of compensation. Even if Carisma is able to obtain a license, it may be non-exclusive, thereby giving its competitors access to the same technologies licensed to it. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If Carisma is unable to obtain rights to required third-party intellectual property rights or maintain the existing intellectual property rights Carisma has, Carisma may be required to expend significant time and resources to redesign its technology, product candidates, or the methods for manufacturing them or to develop or license replacement technology, all of which may not be feasible on a technical or commercial basis. If Carisma is unable to do so, Carisma may be unable to develop or commercialize the affected technology and product candidates, which could harm its business, financial condition, results of operations and prospects significantly. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Additionally, if Carisma fails to comply with its obligations under any license agreements, its counterparties may have the right to terminate these agreements, in which event Carisma might not be able to develop, manufacture or market, or may be forced to cease developing, manufacturing or marketing, any product that is covered by these agreements or may face other penalties under such agreements. Such an occurrence could materially adversely affect the value of the product candidate being developed under any such agreement. Termination of these agreements or reduction or elimination of its rights under these agreements, or restrictions on its ability to freely assign or sublicense its rights under such agreements when it is in the interest of its business to do so, may result in it having to negotiate new or restated agreements with less favorable terms, cause it to lose its rights under these agreements, including its rights to important intellectual property or technology or impede, or delay or prohibit the further development or commercialization of one or more product candidates that rely on such agreements. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If Carisma does not obtain patent term extension for any product candidates it may develop, its business may be materially harmed.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In the United States, the term of a patent that covers an FDA-approved drug may, in certain cases, be eligible for a patent term extension under the Drug Price Competition and Patent Term Restoration Act of </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">84</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">1984, or the Hatch-Waxman Act, as compensation for the loss of a patent term during the FDA regulatory review process for a drug product subject to the provisions of the Hatch-Waxman Act. The Hatch-Waxman Act permits a patent term extension of up to five&#160;years, but patent extension cannot extend the remaining term of a patent beyond a total of 14&#160;years from the date of product approval. Only one patent among those eligible for an extension and only those claims covering the approved drug, a method for using it, or a method for manufacturing it may be extended. Similar provisions are available in Europe and certain other non-United States jurisdictions to extend the term of a patent that covers an approved drug. While, in the future, if and when its product candidates receive FDA approval, Carisma expects to apply for patent term extensions on patents covering those product candidates, there is no guarantee that the applicable authorities, including the FDA, will agree with its assessment of whether such extensions should be granted, and even if granted, the length of such extensions. Carisma may not be granted patent term extension either in the United States or in any foreign country because of, for example, failing to exercise due diligence during the testing phase or regulatory review process, failing to apply within applicable deadlines, failing to apply prior to expiration of relevant patents or otherwise failing to satisfy applicable requirements. Moreover, the term of extension, as well as the scope of patent protection during any such extension, afforded by the governmental authority could be less than requests. If Carisma is unable to obtain any patent term extension or the term of any such extension is less than it requests, its competitors may obtain approval of competing products following the expiration of its patent rights, and its business, financial condition, results of operations and prospects could be materially harmed. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Changes to patent laws in the United States and other jurisdictions could diminish the value of patents in general, thereby impairing its ability to protect its products.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Changes in either the patent laws or interpretation of patent laws in the United States, including patent reform legislation such as the Leahy-Smith America Invents Act, or the Leahy-Smith Act, could increase the uncertainties and costs surrounding the prosecution of its owned or in-licensed patent applications and the maintenance, enforcement or defense of its owned or in-licensed issued patents. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, the patent positions of companies in the development and commercialization of pharmaceuticals are particularly uncertain. Recent U.S. Supreme Court rulings have narrowed the scope of patent protection available in certain circumstances and wakened the rights of patent owners in certain situations. This combination of events has created uncertainty with respect to the validity and enforceability of patents once obtained. Depending on future actions by the U.S. Congress, the federal courts, and the USPTO, the laws and regulations governing patents could change in unpredictable ways that could have a material adverse effect on Carisma&#8217;s patent rights and its ability to protect, defend and enforce its patent rights in the future. Similarly, changes in patent law and regulations in other countries or jurisdictions, changes in the governmental bodies that enforce them or changes in how the relevant governmental authority enforces patent laws or regulations may weaken Carisma&#8217;s ability to obtain new patents or to enforce patents that Carisma owns or has licensed or that Carisma may obtain in the future. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The federal government retains certain rights in inventions created using its financial assistance under the Bayh-Dole Act. The federal government retains a &#8220;nonexclusive, nontransferable, irrevocable, paid-up license&#8221; for its own benefit. The Bayh-Dole Act also provides federal agencies with &#8220;march-in rights&#8221;. March-in rights allow the government, in specified circumstances, to require the contractor or successors in title to the patent to grant a &#8220;nonexclusive, partially exclusive, or exclusive license&#8221; to a &#8220;responsible applicant or applicants.&#8221; If the patent owner refuses to do so, the government may grant the license itself. Carisma collaborates with a number of universities with respect to certain of its research and development. Carisma cannot be sure that any co-developed intellectual property will be free from government rights pursuant to the Bayh-Dole Act. If, in the future, Carisma co-owns or in-licenses technology which is critical to its business that is developed in whole or in part with federal funds subject to the Bayh-Dole Act, its ability to enforce or otherwise exploit patents covering such technology may be adversely affected. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Although Carisma or its licensors are not currently involved in any litigation, Carisma may become involved in lawsuits to protect or enforce its patent, the patents of its licensors or other intellectual property rights, which could be expensive, time-consuming and unsuccessful.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Competitors and other third parties may infringe, misappropriate or otherwise violate Carisma&#8217;s or its licensor&#8217;s issued patents, the patents of its licensors or other intellectual property. It may be difficult to detect </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">85</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">infringers who do not advertise the components that are used in their products. Moreover, it may be difficult or impossible to obtain evidence of infringement in a competitor&#8217;s product. To counter infringement or misappropriation, Carisma or its licensors may need to file infringement, misappropriation or other intellectual property related claims, which can be expensive and time-consuming and can distract its management and scientific personnel. There can be no assurance that Carisma will have sufficient financial or other resources to file and pursue such infringement claims, which typically last for&#160;years before they are concluded. Any claims Carisma asserts against perceived infringers could provoke such parties to assert counterclaims against it, alleging that it infringes, misappropriates or otherwise violates their intellectual property. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, in a patent infringement proceeding, such parties could counterclaim that the patents Carisma or its licensors have asserted are invalid or unenforceable. In patent litigation in the United States, defendant counterclaims alleging invalidity or unenforceability are commonplace. Grounds for a validity challenge could be an alleged failure to meet any of several statutory requirements, including novelty, non-obviousness, enablement, or written description. Grounds for an unenforceability assertion could be an allegation that someone connected with prosecution of the patent withheld relevant information from the USPTO, or made a misleading statement, during prosecution. Third parties may institute such claims before administrative bodies in the United States or abroad, even outside the context of litigation. Such mechanisms include re-examination, post-grant review, inter partes review, interference proceedings, derivation proceedings, and equivalent proceedings in foreign jurisdictions, such as opposition proceedings. The outcome following legal assertions of invalidity and unenforceability is unpredictable. Similarly, if Carisma or its licensors assert trademark infringement claims, a court may determine that the marks Carisma or its licensors have asserted are invalid or unenforceable, or that the party against whom Carisma or its licensors have asserted trademark infringement has superior rights to the marks in question. In this case, Carisma could ultimately be forced to cease use of such trademarks, which could materially harm its business and negatively affect its position in the marketplace. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">An adverse result in any such proceeding could put one or more of its owned or in-licensed patents at risk of being invalidated, held unenforceable or interpreted narrowly, could put any of its owned or in-licensed patent applications at risk of not yielding an issued patent, and could limit its or its licensor&#8217;s ability to assert those patents against those parties, or other competitors, and curtail or preclude its ability to exclude third parties from developing and commercializing similar or competitive products. A court may also refuse to stop the third party from using the technology at issue in a proceeding on the grounds that its owned or in-licensed patents do not cover such technology. Even if Carisma establishes infringement, a court may not order the third party to stop using the technology at issue and instead award only monetary damages to Carisma, which may not be an adequate remedy. Furthermore, because of the substantial amount of discovery required in connection with intellectual property litigation, there is a risk that some of its confidential information or trade secrets could be compromised by disclosure during this type of litigation. There could also be public announcements of the results of hearings, motions, or other interim proceedings or developments. If securities analysts or investors perceive these results to be negative, it could have a material adverse effect on the price of its common stock. Any of the foregoing could allow such third parties to develop and commercialize competing technologies and products and have a material adverse impact on its business, financial condition, results of operations and prospects. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Interference or derivation proceedings provoked by third parties or brought by Carisma or declared by the USPTO may be necessary to determine the priority of inventions with respect to its patents or patent applications. An unfavorable outcome could require it to cease using the related technology or to attempt to license rights to it from the prevailing party. Carisma&#8217;s business could be harmed if the prevailing party does not offer it a license on commercially reasonable terms or at all, or if a non-exclusive license is offered and its competitors gain access to the same technology. Its defense of litigation or interference or derivation proceedings may fail and, even if successful, may result in substantial costs and distract its management, technical personnel and other employees. In addition, the uncertainties associated with litigation could have a material adverse effect on its ability to raise the funds necessary to continue its clinical trials, continue its research programs, license necessary technology from third parties, or enter into development partnerships that would help it bring its product candidates to market. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Any such litigation or proceedings could substantially increase Carisma&#8217;s operating losses and reduce the resources available for development activities or any future sales, marketing or distribution activities. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">86</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma may not have sufficient financial or other resources to conduct such litigation or proceedings adequately. Some of Carisma&#8217;s competitors may be able to sustain the costs of such litigation or proceedings more effectively than Carisma can because of their greater financial resources in one or more aspects, or for other reasons. Uncertainties resulting from the initiation and continuation of patent litigation or other proceedings could compromise Carisma&#8217;s ability to compete in the marketplace. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Carisma may need to license intellectual property from third parties, and such licenses may not be available or may not be available on commercially reasonable terms.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">A third party may hold intellectual property, including patent rights, that are important or necessary to the development of Carisma&#8217;s products. It may be necessary for it to use the patented or proprietary technology of a third party to commercialize its own technology or products, in which case it would be required to obtain a license from such third party. A license to such intellectual property may not be available or may not be available on commercially reasonable terms, which could have a material adverse effect on Carisma&#8217;s business and financial condition. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The licensing and acquisition of third-party intellectual property rights is a competitive practice, and companies that may be more established, or have greater resources than Carisma, may also be pursuing strategies to license or acquire third-party intellectual property rights that it may consider necessary or attractive in order to commercialize its product candidates. More established companies may have a competitive advantage over Carisma due to their larger size and cash resources or greater clinical development and commercialization capabilities. Carisma may not be able to successfully complete such negotiations and ultimately acquire the rights to the intellect al property surrounding the additional product candidates that it may seek to acquire. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Third parties may initiate legal proceedings alleging that Carisma is infringing, misappropriating or otherwise violating their intellectual property rights, the outcome of which would be uncertain and could have a material adverse effect on the success of its business.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma&#8217;s commercial success depends upon its ability and the ability of its collaborators to develop, manufacture, market and sell its product candidates and use its proprietary technologies without infringing, misappropriating or otherwise violating the intellectual property and proprietary rights of third parties. There is considerable patent and other intellectual property litigation in the biopharmaceutical industry. Carisma may become party to, or threatened with, adversarial proceedings or litigation regarding intellectual property rights with respect to its technology and product candidates, including interference proceedings, post grant review, </font><font style="font-style:italic;letter-spacing:0.2pt;">inter partes</font><font style="letter-spacing:0.2pt;"> review, and derivation proceedings before the USPTO and similar proceedings in foreign jurisdictions, such as opposition proceedings before the European Patent Office. Numerous U.S. and foreign issued patents and pending patent applications, which are owned by third parties, exist in the fields in which Carisma is pursuing development candidates. As the biopharmaceutical industry expands and more patents are issued, the risk increases that its technologies or product candidates that Carisma may identify may be subject to claims of infringement of the patent rights of third parties. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The legal threshold for initiating litigation or contested proceedings is low, so even lawsuits or proceedings with a low probability of success might be initiated and require significant resources to defend. Litigation and contested proceedings can also be expensive and time-consuming, and its adversaries in these proceedings may have the ability to dedicate substantially greater resources to prosecuting these legal actions than Carisma can. The risks of being involved in such litigation and proceedings may increase if and as its product candidates near commercialization and as Carisma gains the greater visibility associated with being a public company. Third parties may assert infringement claims against it based on existing patents or patents that may be granted in the future, regardless of merit. Even if Carisma diligently searches third-party patents for potential infringement by its products or product candidates, it may not successfully find patents its products or product candidates may infringe. Carisma may not be aware of all such intellectual property rights potentially relating to its technology and product candidates and their uses, or Carisma may incorrectly conclude that third-party intellectual property is invalid or that its activities and product candidates do not infringe such intellectual property. Thus, Carisma does not know with certainty that its technology and product candidates, or its development and commercialization thereof, do not and will not infringe, misappropriate or otherwise violate any third party&#8217;s intellectual property. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">87</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Third parties may assert that Carisma is employing its proprietary technology without authorization. There may be third-party patents or patent applications with claims to materials, formulations or methods, such as methods of manufacture or methods for treatment, related to the discovery, use or manufacture of the product candidates that Carisma may identify or related to its technologies. Because patent applications can take many&#160;years to issue, there may be currently pending patent applications which may later result in issued patents that the product candidates that Carisma may identify may infringe. In addition, third parties may obtain patents in the future and claim that use of its technologies infringe upon these patents. Moreover, as noted above, there may be existing patents that Carisma is not aware of or that Carisma has incorrectly concluded are invalid or not infringed by its activities. If any third-party patents were held by a court of competent jurisdiction to cover, for example, the manufacturing process of the product candidates that Carisma may identify, any molecules formed during the manufacturing process or any final product itself, the holders of any such patents may be able to block its ability to commercialize such product candidate unless Carisma obtained a license under the applicable patents, or until such patents expire. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Parties making claims against it may obtain injunctive or other equitable relief, which could effectively block its ability to further develop and commercialize the product candidates that Carisma may identify. Defense of these claims, regardless of their merit, would involve substantial litigation expense and would be a substantial diversion of employee resources from its business. In the event of a successful claim of infringement against us, Carisma may have to pay substantial damages, including treble damages and attorneys&#8217; fees for willful infringement, pay royalties, redesign its infringing products or obtain one or more licenses from third parties, which may be impossible or require substantial time and monetary expenditure. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma may choose to take a license or, if it is found to infringe, misappropriate or otherwise violate a third party&#8217;s intellectual property rights, it could also be required to obtain a license from such third party to continue developing, manufacturing and marketing its technology and product candidates. However, it may not be able to obtain any required license on commercially reasonable terms or at all. Even if it is able to obtain a license, it could be non-exclusive, thereby giving its competitors and other third parties access to the same technologies licensed to it and could require it to make substantial licensing and royalty payments. Carisma could be forced, including by court order, to cease developing, manufacturing and commercializing the infringing technology or product. In addition, Carisma could be found liable for significant monetary damages, including treble damages and attorneys&#8217; fees, if Carisma is found to have willfully infringed a patent or other intellectual property right, it could be forced to indemnify its customers or collaborators. A finding of infringement could prevent it from commercializing its product candidates or force it to cease some of its business operations, which could materially harm its business. In addition, Carisma may be forced to redesign its product candidates, seek new regulatory approvals and indemnify third parties pursuant to contractual agreements. Claims that Carisma has misappropriated the confidential information or trade secrets of third parties could have a similar material adverse effect on its business, financial condition, results of operations and prospects. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If its trademarks and trade names are not adequately protected, then Carisma may not be able to build name recognition in its markets of interest and its business may be adversely affected.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">While Carisma seeks to protect the trademarks and trade names it uses in the United States and in other countries, it may be unsuccessful in obtaining registrations or otherwise protecting these trademarks and trade names, which it needs to build name recognition in its markets of interest and among potential partners or customers. Carisma relies on both registration and common law protection for its trademarks. Its registered or unregistered trademarks or trade names may be challenged, infringed, diluted or declared generic, or determined to be infringing on other marks. At times, competitors may adopt trademarks and trade names similar to ours, or collaborators may fail to use Carisma&#8217;s trade names or trademarks, thereby impeding its ability to build brand identity and possibly leading to market confusion. In addition, there could be potential trademark infringement claims brought by owners of other registered trademarks or trademarks that incorporate variations of its registered or unregistered trademarks. If Carisma is unable to protect its rights to trademarks and trade names, Carisma may be prevented from using such marks and names unless Carisma enters into appropriate royalty, license or coexistence agreements, which may not be available or may not be available on commercially reasonable terms. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">During trademark registration proceedings, Carisma may receive rejections. Although Carisma would be given an opportunity to respond to those rejections, it may be unable to overcome such rejections. In </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">88</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">addition, in the USPTO and in comparable agencies in many foreign jurisdictions, third parties are given an opportunity to oppose pending trademark applications and to seek to cancel registered trademarks. Opposition or cancellation proceedings may be filed against its trademarks, and its trademarks may not survive such proceedings. Effective trademark protection may not be available or may not be sought in every country in which its products are made available. Any name Carisma proposes to use for its products in the United States must be approved by the FDA, regardless of whether Carisma has registered it, or applied to register it, as a trademark. The FDA typically conducts a review of proposed product names, including an evaluation of potential for confusion with other product names. If the FDA objects to any of its proposed product names, Carisma may be required to expend significant additional resources in an effort to identify a usable substitute name that would qualify under applicable trademark laws, not infringe the existing rights of third parties and be acceptable to the FDA. If Carisma is unable to establish name recognition based on its trademarks and trade names, Carisma may not be able to compete effectively and its business may be adversely affected. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma may license its trademarks and trade names to third parties, such as distributors and collaborators. Though these license agreements may provide guidelines for how our trademarks and trade names may be used, a breach of these agreements or misuse of or failure to use our trademarks and trade names by our licensees may jeopardize our rights in or diminish the goodwill associated with our trademarks, and trade names. Our efforts to enforce or protect our proprietary rights related to trademarks, trade names, trade secrets, know-how, domain names, copyrights or other intellectual property may be ineffective and could result in substantial costs and diversion of resources and could adversely affect Carisma&#8217;s business, financial condition, results of operations and prospects. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Intellectual property litigation or other legal proceedings relating to intellectual property could cause it to spend substantial resources and distract its personnel from their normal responsibilities.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Even if resolved in its favor, litigation or other legal proceedings relating to intellectual property claims may cause it to incur significant expenses and could distract its technical and management personnel from their normal responsibilities. In addition, there could be public announcements of the results of hearings, motions or other interim proceedings or developments and if securities analysts or investors perceive these results to be negative, it could have a substantial adverse effect on the price of its common stock. Such litigation or proceedings could substantially increase its operating losses and reduce the resources available for development activities or any future sales, marketing or distribution activities. Carisma may not have sufficient financial or other resources to conduct such litigation or proceedings adequately. Some of its competitors may be able to sustain the costs of such litigation or proceedings more effectively than Carisma can because of their greater financial resources and may also have an advantage in such proceedings due to their more mature and developed intellectual property portfolios. Uncertainties resulting from the initiation and continuation of intellectual property litigation or other proceedings could compromise its ability to compete in the marketplace. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Obtaining and maintaining patent protection depends on compliance with various procedural, document submission, fee payment and other requirements imposed by governmental patent agencies, and its patent protection could be reduced or eliminated for non-compliance with these requirements.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Periodic maintenance, renewal and annuity fees and various other government fees on any issued patent and pending patent application must be paid to the USPTO and foreign patent agencies in several stages or annually over the lifetime of its patents and patent applications. The USPTO and various foreign governmental patent agencies require compliance with a number of procedural, documentary, fee payment and other similar provisions during the patent application process. In certain circumstances, Carisma relies on its licensing partners to pay these fees to, or comply with the procedural and documentary rules of, the relevant patent agency. With respect to its patents, Carisma relies on an annuity service, outside firms and outside counsel to remind it of the due dates and to make payment after Carisma instructs them to do so. While an inadvertent lapse can in many cases be cured by payment of a late fee or by other means in accordance with the applicable rules, there are situations in which noncompliance can result in abandonment or lapse of the patent or patent application, resulting in partial or complete loss of patent rights in the relevant jurisdiction. Non-compliance events that could result in abandonment or lapse of a patent or patent application include failure to respond to official actions within prescribed time limits, non-payment of fees </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">89</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">and failure to properly legalize and submit formal documents. In such an event, potential competitors might be able to enter the market with similar or identical products or technology. If Carisma or its licensors fail to maintain the patents and patent applications covering its product candidates, it would have a material adverse effect on its business, financial condition, results of operations and prospects. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If Carisma fails to comply with its obligations in its current and future intellectual property licenses and funding arrangements with third parties, or otherwise experience disruptions to its business relationships with its licensors, Carisma could lose intellectual property rights that are important to its business.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma is party to a number license and research agreements. Some of these agreements provide Carisma with the intellectual property rights required for the development of its product candidates, including the license agreement with the University of Pennsylvania. These licenses and research agreements and similar agreements in the future may impose diligence, development and commercialization timelines, and milestone payment, royalty, insurance and other obligations on Carisma. If Carisma fails to comply with such obligations, the parties to these agreements may decide to terminate the agreements or require Carisma to grant them certain rights, in which Carisma may not be able to develop, manufacture, or market any products without the rights granted to it by these agreements and may face other penalties. Any such occurrences could adversely affect the value of any product candidate being developed, including CT-0508. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">For a variety of purposes, Carisma will likely enter into additional licensing and funding arrangements with third parties that may impose similar obligations on Carisma. Termination of these agreements or reduction or elimination of its rights under these agreements may result in it having to negotiate new or restated agreements with less favorable terms, or cause it to lose its rights under these agreements, including its rights to important intellectual property or technology, which would have a material adverse effect on its business, financial condition, results of operations and prospects. While Carisma still faces all of the risks described herein with respect to such agreements, Carisma cannot prevent third parties from also accessing those technologies. In addition, its licenses may place restrictions on its future business opportunities. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition to the above risks, intellectual property rights that Carisma licenses in the future may include sublicenses under intellectual property owned by third parties, in some cases through multiple tiers. The actions of its licensors may therefore affect its rights to use its sublicensed intellectual property, even if Carisma is in compliance with all of the obligations under its license agreements. Should its licensors or any of the upstream licensors fail to comply with their obligations under the agreements pursuant to which they obtain the rights that are sublicensed to Carisma, or should such agreements be terminated or amended, its ability to develop and commercialize its product candidates may be materially harmed. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Disputes may arise regarding intellectual property subject to a licensing agreement, including: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the scope of rights granted under the license agreement and other interpretation related issues; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the extent to which its technology and processes infringe on intellectual property of the licensor that is not subject to the licensing agreement; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the sublicensing of patent and other rights under its collaborative development relationships; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">its diligence obligations under the license agreement and what activities satisfy those diligence obligations; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the inventorship and ownership of inventions and know-how resulting from the joint creation or use of intellectual property by its licensors and it and its partners; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the payment obligations with respect to licensed technology. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, the agreements under which Carisma currently licenses intellectual property or technology from third parties are complex, and certain provisions in such agreements may be susceptible to multiple interpretations. The resolution of any contract interpretation disagreement that may arise could narrow what Carisma believes to be the scope of its rights to the relevant intellectual property or technology or increase what Carisma believes to be its financial or other obligations under the relevant agreement, either of which could have a material adverse effect on its business, financial condition, results of operations and prospects. Moreover, if disputes over intellectual property that Carisma has licensed prevent or impair its ability to maintain its current licensing arrangements on commercially acceptable terms, Carisma may be unable to </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">90</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">successfully develop and commercialize the affected technology and product candidates, which could have a material adverse effect on its business, financial conditions, results of operations and prospects. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Further, licensors could retain the right to prosecute and defend the intellectual property rights licensed to Carisma, in which case Carisma would depend on its licensors to control the prosecution, maintenance and enforcement of all of its licensed and sublicensed intellectual property, and even when it does have such rights, Carisma may require the cooperation of its licensors and upstream licensors, which may not be forthcoming. Licensors may determine not to pursue litigation against other companies or may pursue such litigation less aggressively than Carisma would. Its business could be adversely affected if Carisma or its licensors are unable to prosecute, maintain and enforce its licensed and sublicensed intellectual property effectively. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma&#8217;s current or future licensors may have relied on third-party consultants or collaborators or on funds from third parties such that its licensors are not the sole and exclusive owners of the patents and patent applications Carisma in-licenses. If other third parties have ownership rights to patents or patent applications Carisma in-licenses, they may be able to license such patents to its competitors, and its competitors could market competing products and technology. This could have a material adverse effect on its competitive position, business, financial conditions, results of operations and prospects. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In spite of its best efforts, its licensors might conclude that Carisma has materially breached its license agreements and might therefore terminate the license agreements, thereby removing its ability to develop and commercialize product candidates and technology covered by these license agreements. If these in-licenses are terminated, or if the underlying intellectual property fails to provide the intended exclusivity, competitors would have the freedom to seek regulatory approval of, and to market, products and technologies identical to its. This could have a material adverse effect on its competitive position, business, financial condition, results of operations and prospects. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Carisma may not be able to protect its intellectual property and proprietary rights throughout the world.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Filing, prosecuting and defending patents on product candidates in all countries throughout the world would be prohibitively expensive, and the laws of foreign countries may not protect its rights to the same extent as the laws of the United States. In addition, the laws of some foreign countries do not protect intellectual property rights to the same extent as federal and state laws in the United States, and even where such protection is nominally available, judicial and governmental enforcement of such intellectual property rights may be lacking. Consequently, Carisma may not be able to prevent third parties from practicing its inventions in all countries outside the United States, or from selling or importing products made using its inventions in and into the United States or other jurisdictions. Competitors may use its technologies in jurisdictions where Carisma has not obtained patent protection to develop their own products and, further, may export otherwise infringing products to territories where Carisma has patent protection or licenses but enforcement is not as strong as that in the United States. These products may compete with its products, and its patents or other intellectual property rights may not be effective or sufficient to prevent them from competing. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Many companies have encountered significant problems in protecting and defending intellectual property rights in foreign jurisdictions. The legal systems of certain countries, particularly certain developing countries, do not favor the enforcement of patents, trade secrets, and other intellectual property protection, particularly those relating to biotechnology products, which could make it difficult for it to stop the infringement of its patents or marketing of competing products in violation of its intellectual property and proprietary rights generally. In addition, certain jurisdictions do not protect to the same extent or at all inventions that constitute new methods of treatment. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Proceedings to enforce its intellectual property and proprietary rights in foreign jurisdictions could result in substantial costs and divert its efforts and attention from other aspects of its business, could put its patents at risk of being invalidated, held unenforceable or interpreted narrowly, could put its patent applications at risk of not issuing, and could provoke third parties to assert claims against Carisma. Carisma may not prevail in any lawsuits that Carisma initiates, and the damages or other remedies awarded, if any, may not be commercially meaningful. Accordingly, its efforts to enforce its intellectual property and </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">91</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">proprietary rights around the world may be inadequate to obtain a significant commercial advantage from the intellectual property that Carisma develops or licenses. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Many countries have compulsory licensing laws under which a patent owner may be compelled to grant licenses to third parties. In addition, many countries limit the enforceability of patents against government agencies or government contractors. In these countries, the patent owner may have limited remedies, which could materially diminish the value of such patent. If Carisma or any of its licensors are forced to grant a license to third parties with respect to any patents relevant to its business, its competitive position may be impaired, and its business, financial condition, results of operations and prospects may be adversely affected. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Carisma may be subject to claims challenging the inventorship or ownership of its patents and other intellectual property.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma or its licensors may be subject to claims that former employees, collaborators or other third parties have an interest in its owned or in-licensed patents, trade secrets or other intellectual property as an inventor or co-inventor. For example, Carisma or its licensors may have inventorship disputes arise from conflicting obligations of employees, consultants or others who are involved in developing its product candidates. Although it is Carisma&#8217;s policy to require its employees and contractors who may be involved in the conception or development of intellectual property to execute agreements assigning such intellectual property to us, Carisma may be unsuccessful in executing such an agreement with each party who, in fact, conceives or develops intellectual property that Carisma regards as its own, and Carisma cannot be certain that its agreements with such parties will be upheld in the face of a potential challenge, or that they will not be breached, for which Carisma may not have an adequate remedy. The assignment of intellectual property rights may not be self-executing or the assignment agreements may be breached, and litigation may be necessary to defend against these and other claims challenging inventorship or its or its licensors&#8217; ownership of its owned or in-licensed patents, trade secrets or other intellectual property. If Carisma or its licensors fail in defending any such claims, in addition to paying monetary damages, Carisma may lose valuable intellectual property rights, such as exclusive ownership of, or right to use, intellectual property that is important to its product candidates. Even if Carisma is successful in defending against such claims, litigation could result in substantial costs and be a distraction to management and other employees. Any of the foregoing could have a material adverse effect on its business, financial condition, results of operations and prospects. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Carisma may be subject to claims by third parties asserting that its employees, consultants or contractors have wrongfully used or disclosed confidential information of third parties, including of their current or former employers or claims asserting Carisma has misappropriated their intellectual property, or is claiming ownership of what Carisma regards as its own intellectual property.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Many of Carisma&#8217;s employees, consultants and contractors have been previously employed at universities or other biopharmaceutical companies, including its competitors or potential competitors. Although Carisma tries to ensure that its employees, consultants and contractors do not use the proprietary information or know-how of others in their work for Carisma, Carisma may be subject to claims that these individuals or Carisma have used or disclosed intellectual property, including trade secrets or other proprietary information, of any such individual&#8217;s current or former employer. Litigation may be necessary to defend against these claims. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If Carisma fails in prosecuting or defending any such claims, in addition to paying monetary damages, Carisma may lose valuable intellectual property rights or personnel, which could have a material adverse effect on its competitive business position and prospects. Such intellectual property rights could be awarded to a third party, and Carisma could be required to obtain a license from such third party to commercialize its technology or products, which license may not be available on commercially reasonable terms, or at all, or such license may be non-exclusive. Even if Carisma is successful in prosecuting or defending against such claims, litigation could result in substantial costs and be a distraction to its management and employees. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If Carisma is unable to protect the confidentiality of its trade secrets, its business and competitive position would be harmed.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition to seeking patents for some of its technology and product candidates, Carisma also relies on trade secrets and confidentiality agreements to protect its unpatented know-how, technology and other </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">92</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">proprietary information, to maintain its competitive position. Carisma seeks to protect its trade secrets and other proprietary technology, in part, by entering into non-disclosure and confidentiality agreements with parties who have access to them, such as its employees, corporate collaborators, outside scientific collaborators, contract research organizations, contract manufacturers, consultants, advisors and other third parties. Carisma may have also entered into confidentiality and invention or patent assignment agreements with its employees and consultants, but Carisma cannot guarantee that it has entered into such agreements with each party that may have or has had access to its trade secrets or proprietary technology. To the extent Carisma becomes involved in litigation that may require discovery of its trade secrets, know-how and other proprietary technology, Carisma will seek to secure protective orders from the court that bind the parties with access to the discovered information. Despite these efforts, any of these parties may breach the agreements and disclose its proprietary information, including its trade secrets, and Carisma may not be able to obtain adequate remedies for such breaches. Detecting the disclosure or misappropriation of a trade secret and enforcing a claim that a party illegally disclosed or misappropriated a trade secret is difficult, expensive and time-consuming, and the outcome is unpredictable. In addition, some courts inside and outside of the United States are less willing or unwilling to protect trade secrets. In addition, Carisma cannot be certain that proprietary technical information and related confidential documents that Carisma has shared with its collaborators and/or submitted to governmental agencies, including regulatory agencies for evaluation and supervision of pharmaceutical products, will be kept confidential. If any of its trade secrets were to be lawfully obtained or independently developed by a competitor or other third party, Carisma would have no right to prevent them, or those to whom they communicate it, from using that technology or information to compete with Carisma. If any of its trade secrets were to be disclosed to or independently developed by a competitor or other third party, its competitive position would be materially and adversely harmed. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Intellectual property rights do not necessarily address all potential threats to Carisma.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The degree of future protection afforded by Carisma&#8217;s intellectual property rights is uncertain because intellectual property rights have limitations and may not adequately protect its business or permit it to maintain its competitive advantage. For example: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">others may be able to make product candidates that are similar to Carisma&#8217;s but that are not covered by the claims of the patents that it owns or licenses; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.3pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Carisma, or its license partners or current or future collaborators, might not have been the first to make the inventions covered by the issued patent or pending patent applications that it licenses or may own in the future; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.3pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Carisma, or its license partners or current or future collaborators, might not have been the first to file patent applications covering its inventions; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.21pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.21pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">others may independently develop similar or alternative technologies or duplicate any of its technologies without infringing its owned or in-licensed intellectual property rights; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">it is possible that its owned or in-licensed pending patent applications or those Carisma may own or in-license in the future will not lead to issued patents; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.21pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.21pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">claims of issued patents that Carisma holds rights to may be held invalid or unenforceable, including as a result of legal challenges by its competitors; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">its competitors might conduct research, development, testing or commercialization activities in countries where Carisma does not have patent rights and then use the information learned from such activities to develop competitive products for sale in its major commercial markets; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Carisma cannot ensure that any of its patents, or any of its pending patent applications, if issued, or those of its licensors, will include claims having a scope sufficient to protect its product candidates; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.21pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.21pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Carisma cannot ensure that any patents issued to it or its licensors will provide a basis for an exclusive market for its commercially viable product candidates or will provide it with any competitive advantages; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the U.S. Supreme Court, other federal courts, Congress, the USPTO or similar foreign authorities may change the standards of patentability and any such changes could narrow or invalidate, or change the scope of, Carisma&#8217;s or its licensors&#8217; patents; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">93</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">patent terms may be inadequate to protect its competitive position on its product candidates for an adequate amount of time; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Carisma cannot ensure that its commercial activities or product candidates will not infringe upon the patents of others; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Carisma cannot ensure that it will be able to successfully commercialize its product candidates on a substantial scale, if approved, before the relevant patents that it owns or licenses expire; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Carisma may not develop additional proprietary technologies that are patentable; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the patents of others may harm its business; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Carisma may choose not to file a patent in order to maintain certain trade secrets or know-how, and a third party may subsequently file a patent covering such intellectual property. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Should any of these events occur, they could have a material adverse effect on its business, financial condition, results of operations and prospects. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Risks Related to Regulatory Approval and Other Legal Compliance Matters</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The regulatory approval process of the FDA is lengthy, time-consuming and inherently unpredictable, and if Carisma is ultimately unable to obtain marketing approval for its product candidates, its business will be substantially harmed.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The time required to obtain approval by the FDA is unpredictable but typically takes many&#160;years following the commencement of clinical trials and depends upon numerous factors, including the substantial discretion of the regulatory authorities. In addition, approval policies, regulations or the type and amount of clinical data necessary to gain approval may change during the course of a product candidate&#8217;s clinical development and may vary among jurisdictions. Carisma has not obtained marketing approval for any product candidate and it is possible that none of its existing product candidates, or any product candidates it may seek to develop in the future will ever obtain marketing approval. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma&#8217;s product candidates could fail to receive marketing approval for many reasons, including the following: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the FDA may disagree with the design or implementation of Carisma&#8217;s clinical trials; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Carisma may be unable to demonstrate to the satisfaction of the FDA that a product candidate is safe and effective for its proposed indication; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">results of clinical trials may not meet the level of statistical significance required by the FDA for approval; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Carisma may be unable to demonstrate that a product candidate&#8217;s clinical and other benefits outweigh its safety risks; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the FDA may disagree with Carisma&#8217;s interpretation of data from pre-clinical studies or clinical trials; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">data collected from clinical trials of Carisma&#8217;s product candidates may not be sufficient to support the submission of an NDA to the FDA or other submission or to obtain marketing approval in the United States; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the FDA may find deficiencies with or fail to approve the manufacturing processes or facilities of third-party manufacturers with which Carisma contracts for clinical and commercial supplies; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the approval policies or regulations of the FDA may significantly change in a manner rendering Carisma&#8217;s clinical data insufficient for approval. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">This lengthy approval process as well as the unpredictability of future clinical trial results may result in Carisma failing to obtain marketing approval to market any of its product candidates, which would significantly harm its business, results of operations and prospects. The FDA has substantial discretion in </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">94</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">the approval process and determining when or whether marketing approval will be obtained for any of Carisma&#8217;s product candidates. Even if Carisma believes the data collected from clinical trials of its product candidates are promising, such data may not be sufficient to support approval by the FDA. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, even if Carisma were to obtain approval, regulatory authorities may approve any of Carisma&#8217;s product candidates for fewer or more limited indications than it requests, may not approve the price it intends to charge for its products, may grant approval contingent on the performance of costly post-marketing clinical trials, or may approve a product candidate with a label that does not include the labeling claims necessary or desirable for the successful commercialization of that product candidate. Any of the foregoing scenarios could materially harm the commercial prospects for Carisma&#8217;s product candidates. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Even if Carisma completes the necessary pre-clinical studies and clinical trials, the marketing approval process is expensive, time-consuming and uncertain and may prevent Carisma from obtaining approvals for the commercialization of some or all of its product candidates. If Carisma is not able to obtain, or if there are delays in obtaining, required regulatory approvals, it will not be able to commercialize, or will be delayed in commercializing, its product candidates, and its ability to generate revenue will be materially impaired.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma&#8217;s product candidates and the activities associated with their development and commercialization, including their design, testing, manufacture, safety, efficacy, recordkeeping, labeling, storage, approval, advertising, promotion, sale and distribution, export and import are subject to comprehensive regulation by the FDA and other regulatory authorities in the United States and by the EMA and other regulatory authorities outside of the United States. Failure to obtain marketing approval for a product candidate will prevent Carisma from commercializing the product candidate. Carisma has not submitted an application for or received marketing approval for any of its product candidates in the United States or in any other jurisdiction. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma has only limited experience in filing and supporting the applications necessary to gain marketing approvals and expect to rely on third-party clinical research organizations or other third-party consultants or vendors to assist it in this process. Securing marketing approval requires the submission of extensive pre-clinical and clinical data and supporting information, including manufacturing information, to the various regulatory authorities for each therapeutic indication to establish the product candidate&#8217;s safety and efficacy. Carisma&#8217;s product candidates may not be effective, may be only moderately effective or may prove to have undesirable or unintended side effects, toxicities or other characteristics that may preclude Carisma obtaining marketing approval or prevent or limit commercial use. New cancer drugs frequently are indicated only for patient populations that have not responded to an existing therapy or have relapsed. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The process of obtaining marketing approvals, both in the United States and abroad, is expensive, may take many&#160;years if additional clinical trials are required, if approval is obtained at all, and can vary substantially based upon a variety of factors, including the type, complexity and novelty of the product candidates involved. Changes in marketing approval policies during the development period, changes in or the enactment of additional statutes or regulations, or changes in regulatory review for each submitted product application, may cause delays in the approval or rejection of an application. Regulatory authorities have substantial discretion in the approval process and may refuse to accept any application or may decide that Carisma&#8217;s data is insufficient for approval and require additional pre-clinical, clinical or other studies. In addition, varying interpretations of the data obtained from pre-clinical and clinical testing could delay, limit or prevent marketing approval of a product candidate. Any marketing approval Carisma ultimately obtain may be limited or subject to restrictions or post-approval commitments that render the approved product not commercially viable. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If Carisma experiences delays in obtaining approval or if it fails to obtain approval of its product candidates, the commercial prospects for its product candidates may be harmed and its ability to generate revenues will be materially impaired. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Failure to obtain marketing approval in foreign jurisdictions would prevent Carisma&#8217;s product candidates from being marketed in such jurisdictions, which, in turn, would materially impair Carisma&#8217;s ability to generate revenue. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In order to market and sell its products in the European Union and many other foreign jurisdictions, Carisma and its collaborators must obtain separate marketing approvals and comply with numerous and </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">95</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">varying regulatory requirements. The approval procedure varies among countries and can involve additional testing. The time required to obtain approval may differ substantially from that required to obtain FDA approval. The marketing approval process outside the United States generally includes all of the risks associated with obtaining FDA approval. In addition, in many countries outside the United States, it is required that the product be approved for reimbursement before the product can be approved for sale in that country. Carisma or these third parties may not obtain approvals from regulatory authorities outside the United States on a timely basis, if at all. Approval by the FDA does not ensure approval by regulatory authorities in other countries or jurisdictions, and approval by one regulatory authority outside the United States does not ensure approval by regulatory authorities in other countries or jurisdictions or by the FDA. The failure to obtain approval in one jurisdiction may negatively impact Carisma&#8217;s ability to obtain approval elsewhere. Carisma may not be able to file for marketing approvals and may not receive necessary approvals to commercialize its products in any jurisdiction, which would materially impair its ability to generate revenue. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Additionally, Carisma could face heightened risks with respect to seeking marketing approval in the United Kingdom as a result of the withdrawal of the United Kingdom from the European Union, commonly referred to as Brexit. The United Kingdom is no longer part of the European Single Market and European Union Customs Union. As of January&#160;1, 2021, the Medicines and Healthcare products Regulatory Agency, or the MHRA, became responsible for supervising medicines and medical devices in Great Britain, comprising England, Scotland and Wales under domestic law, whereas Northern Ireland will continue to be subject to European Union rules under the Northern Ireland Protocol. The MHRA will rely on the Human Medicines Regulations&#160;2012 (SI 2012/1916) (as amended), or the HMR, as the basis for regulating medicines. The HMR has been incorporated into the domestic law of the body of European Union law instruments governing medicinal products that pre-existed prior to the United Kingdom&#8217;s withdrawal from the European Union. Any delay in obtaining, or an inability to obtain, any marketing approvals, as a result of Brexit or otherwise, may force Carisma to restrict or delay efforts to seek regulatory approval in the United Kingdom for its product candidates, which could significantly and materially harm Carisma&#8217;s business. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma expects that it will be subject to additional risks in commercializing any of its product candidates that receive marketing approval outside the United States, including tariffs, trade barriers and regulatory requirements; economic weakness, including inflation, or political instability in particular foreign economies and markets; compliance with tax, employment, immigration and labor laws for employees living or traveling abroad; foreign currency fluctuations, which could result in increased operating expenses and reduced revenue, and other obligations incident to doing business in another country; and workforce uncertainty in countries where labor unrest is more common than in the United States. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Inadequate funding for the FDA, the SEC and other government agencies, including from government shutdowns, or other disruptions to these agencies&#8217; operations, could hinder their ability to hire and retain key leadership and other personnel, prevent new products and services from being developed or commercialized in a timely manner or otherwise prevent those agencies from performing normal business functions on which the operation of Carisma&#8217;s business may rely, which could negatively impact its business.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The ability of the FDA to review and approve new products can be affected by a variety of factors, including government budget and funding levels, ability to hire and retain key personnel and accept the payment of user fees, and statutory, regulatory and policy changes. Average review times at the agency have fluctuated in recent&#160;years as a result. Disruptions at the FDA and other agencies may also slow the time necessary for new product candidates to be reviewed and/or approved by necessary government agencies, which would adversely affect Carisma&#8217;s business. In addition, government funding of the SEC and other government agencies on which Carisma&#8217;s operations may rely, including those that fund research and development activities, is subject to the political process, which is inherently fluid and unpredictable. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Disruptions at the FDA and other agencies may also slow the time necessary for new product candidates to be reviewed and/or approved by necessary government agencies, which would adversely affect Carisma&#8217;s business. For example, over the last several&#160;years the U.S. government has shut down several times and certain regulatory agencies, such as the FDA and the SEC, have had to furlough critical FDA, SEC and other government employees and stop critical activities. If a prolonged government shutdown occurs, it could significantly impact the ability of the FDA to timely review and process Carisma&#8217;s regulatory submissions, </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">96</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">which could have a material adverse effect on Carisma&#8217;s business. Further, future government shutdowns could impact Carisma&#8217;s ability to access the public markets and obtain necessary capital in order to properly capitalize and continue Carisma&#8217;s operations. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Separately, in response to the COVID-19 pandemic, a number of companies announced in 2021 receipt of complete response letters due to the FDA&#8217;s inability to complete required inspections for their applications. Following a period of false starts and temporary suspensions due to the omicron variant, the FDA resumed domestic inspections in February&#160;2022 and indicated that it would conduct foreign inspections beginning in April&#160;2022 on a prioritized basis. However, the FDA may not be able to continue its current pace and review timelines could be extended, including where a pre-approval inspection or an inspection of clinical sites is required and due to the ongoing COVID-19 pandemic and travel restrictions, the FDA is unable to complete such required inspections during the review period. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If a prolonged government shutdown or other disruption occurs, it could significantly impact the ability of the FDA to timely review and process Carisma&#8217;s regulatory submissions, which could have a material adverse effect on its business. Future shutdowns or other disruptions could also affect other government agencies such as the SEC, which may also impact Carisma&#8217;s business by delaying review of its public filings, to the extent such review is necessary, and Carisma&#8217;s ability to access the public markets. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Regulatory requirements governing gene therapy products are periodically updated and may continue to change in the future.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The FDA has established the Office of Tissues and Advanced Therapies, or the OTAT, within the Center for Biologics Evaluation and Research, or the CBER, to consolidate the review of gene therapy and related products, and has established the Cellular, Tissue and Gene Therapies Advisory Committee to advise CBER in its review. Gene therapy clinical trials conducted at institutions that receive funding for recombinant DNA research from the U.S. National Institutes of Health, or the NIH, also are potentially subject to review by the Office of Biotechnology Activities&#8217; Recombinant DNA Advisory Committee, or the RAC; however, the NIH announced that the RAC will only publicly review clinical trials if the trials cannot be evaluated by standard oversight bodies and pose unusual risks. Although the FDA decides whether individual gene therapy protocols may proceed, the RAC public review process, if undertaken, can delay the initiation of a clinical trial, even if the FDA has reviewed the trial design and details and approved its initiation. Conversely, the FDA can put an IND on a clinical hold even if the RAC has provided a favorable review or an exemption from in-depth, public review. If Carisma were to engage an NIH-funded institution to conduct a clinical trial, that institution&#8217;s institutional biosafety committee, or IBC, as well as its IRB would need to review the proposed clinical trial to assess the safety of the trial. In addition, adverse developments in clinical trials of gene therapy products conducted by others may cause the FDA or other oversight bodies to change the requirements for approval of Carisma&#8217;s product candidates. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The FDA has issued various guidance documents regarding gene therapies, including final guidance documents released in January&#160;2020 relating to chemistry, manufacturing and controls information for gene therapy INDs, gene therapies for rare diseases and gene therapies for retinal disorders. Although the FDA has indicated that these and other guidance documents it previously issued are not legally binding, Carisma believes that its compliance with them is likely necessary to gain approval for any gene therapy product candidate that Carisma may develop. The guidance documents provide additional factors that the FDA will consider at each of the above stages of development and relate to, among other things, the proper pre-clinical assessment of gene therapies; the chemistry, manufacturing, and control information that should be included in an IND application; the proper design of tests to measure product potency in support of an IND or BLA application; and measures to observe delayed adverse effects in subjects who have been exposed to investigational gene therapies when the risk of such effects is high. Further, the FDA usually recommends that sponsors observe subjects for potential gene therapy-related delayed adverse events for a 15-year period, including a minimum of five&#160;years of annual examinations followed by 10&#160;years of annual queries, either in person or by questionnaire. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Further, for a gene therapy product, the FDA also will not approve the product if the manufacturer is not in compliance with good tissue practices, or GTP. These standards are found in FDA regulations and guidance that govern the methods used in, and the facilities and controls used for, the manufacture of human cells, tissues, and cellular and tissue based products, or HCT/Ps, which are human cells or tissue intended </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">97</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">for implantation, transplant, infusion, or transfer into a human recipient. The primary intent of the GTP requirements is to ensure that cell and tissue based products are manufactured in a manner designed to prevent the introduction, transmission, and spread of communicable disease. FDA regulations also require tissue establishments to register and list their HCT/Ps with the FDA and, when applicable, to evaluate donors through screening and testing. </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.12pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Finally, ethical, social and legal concerns about gene therapy, genetic testing and genetic research could result in additional regulations or prohibiting the processes that Carisma may use. Federal and state agencies, congressional committees and foreign governments have expressed their intentions to further regulate biotechnology. More restrictive regulations or claims that Carisma&#8217;s product candidates are unsafe or pose a hazard could prevent Carisma from commercializing any products. New government requirements may be established that could delay or prevent regulatory approval of Carisma&#8217;s product candidates under development. It is impossible to predict whether legislative changes will be enacted, regulations, policies or guidance changed, or interpretations by agencies or courts changed, or what the impact of such changes, if any, may be. </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.12pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As Carisma advances its product candidates through clinical development, it will be required to consult with these regulatory and advisory groups, and comply with applicable guidelines. These regulatory review committees and advisory groups and any new guidelines they promulgate may lengthen the regulatory review process, require Carisma to perform additional studies, increase Carisma&#8217;s development costs, lead to changes in regulatory positions and interpretations, delay or prevent approval and commercialization of Carisma&#8217;s product candidates or lead to significant post-approval limitations or restrictions. Delay or failure to obtain, or unexpected costs in obtaining, the regulatory approval necessary to bring a potential product to market could decrease Carisma&#8217;s ability to generate sufficient product revenue. </font>
        </div>
        <div style="margin-top:9.72pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Even if Carisma, or any collaborators, obtains marketing approvals for its product candidates, the terms of approvals and ongoing regulation of its products may limit how Carisma, or any collaborators, manufacture and market its products, which could materially impair Carisma&#8217;s ability to generate revenue.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.11pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Once marketing approval has been granted, an approved product and its manufacturer and marketer are subject to ongoing review and extensive regulation. Carisma, and any collaborators, must therefore comply with requirements concerning advertising and promotion for any of its product candidates for which Carisma or they obtain marketing approval. Promotional communications with respect to prescription drugs are subject to a variety of legal and regulatory restrictions and must be consistent with the information in the product&#8217;s approved labeling. Thus, Carisma, and any collaborators will not be able to promote any products developed for indications or uses for which they are not approved. </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.12pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, manufacturers of approved products and those manufacturers&#8217; facilities are required to comply with extensive FDA requirements, including ensuring that quality control and manufacturing procedures conform to cGMPs, which include requirements relating to quality control and quality assurance as well as the corresponding maintenance of records and documentation and reporting requirements. Carisma, its third-party manufacturers, any collaborators and their third-party manufacturers could be subject to periodic unannounced inspections by the FDA to monitor and ensure compliance with cGMPs. </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.12pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Accordingly, assuming Carisma, or any collaborators, receive marketing approval for one or more of their product candidates, Carisma, and any collaborators, and Carisma and any collaborators&#8217; respective third-party manufacturers will continue to expend time, money and effort in all areas of regulatory compliance, including manufacturing, production, product surveillance and quality control. </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.11pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If Carisma and such collaborators are not able to comply with post-approval regulatory requirements, Carisma and such collaborators could have the marketing approvals for their products withdrawn by regulatory authorities and Carisma or such collaborators&#8217;, ability to market any future products could be limited, which could adversely affect Carisma&#8217;s ability to achieve or sustain profitability. Further, the cost of compliance with post-approval regulations may have a negative effect on Carisma&#8217;s business, operating results, financial condition and prospects. </font>
        </div>
        <div style="margin-top:9.62pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Carisma may seek certain designations for its product candidates, including Breakthrough Therapy, Fast Track and Priority Review designations in the United States, but it might not receive such designations, and even if it does, such designations may not lead to a faster development or regulatory review or approval process.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.11pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma may seek certain designations for one or more of its product candidates that could expedite review and approval by the FDA. A Breakthrough Therapy product is defined as a product that is intended, </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">98</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">alone or in combination with one or more other products, to treat a serious condition, and preliminary clinical evidence indicates that the product may demonstrate substantial improvement over existing therapies on one or more clinically significant endpoints, such as substantial treatment effects observed early in clinical development. For products that have been designated as Breakthrough Therapies, interaction and communication between the FDA and the sponsor of the trial can help to identify the most efficient path for clinical development while minimizing the number of patients placed in ineffective control regimens. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The FDA may also designate a product for Fast Track review if it is intended, whether alone or in combination with one or more other products, for the treatment of a serious or life-threatening disease or condition, and it demonstrates the potential to address unmet medical needs for such a disease or condition. For Fast Track products, sponsors may have greater interactions with the FDA and the FDA may initiate review of sections of a Fast Track product&#8217;s application before the application is complete. This rolling review may be available if the FDA determines, after preliminary evaluation of clinical data submitted by the sponsor, that a Fast Track product may be effective. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma may also seek a priority review designation for one or more of its product candidates. If the FDA determines that a product candidate offers major advances in treatment or provides a treatment where no adequate therapy exists, the FDA may designate the product candidate for priority review. A priority review designation means that the goal for the FDA to review an application is six&#160;months, rather than the standard review period of ten&#160;months. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">These designations are within the discretion of the FDA. Accordingly, even if Carisma believes that one of its product candidates meets the criteria for these designations, the FDA may disagree and instead determine not to make such designation. Further, even if Carisma receives a designation, the receipt of such designation for a product candidate may not result in a faster development or regulatory review or approval process compared to products considered for approval under conventional FDA procedures and does not assure ultimate approval by the FDA, including the Fast Track designation Carisma received for CT-0508. In addition, even if one or more of Carisma&#8217;s product candidates qualifies for these designations, the FDA may later decide that the product candidates no longer meet the conditions for qualification or decide that the time period for FDA review or approval will not be shortened. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Carisma, or its collaborators, may seek approval from the FDA or comparable foreign regulatory authorities to use accelerated development pathways for its product candidates. If Carisma, or its collaborators, are not able to use such pathways, Carisma, or they, may be required to conduct additional clinical trials beyond those that are contemplated, which would increase the expense of obtaining, and delay the receipt of, necessary marketing approvals, if Carisma, or they, receive them at all. In addition, even if an accelerated approval pathway is available to Carisma, or its collaborators, it may not lead to expedited approval of Carisma&#8217;s product candidates, or approval at all.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Under the Federal Food, Drug, and Cosmetic Act and implementing regulations, the FDA may grant accelerated approval to a product candidate to treat a serious or life-threatening condition that provides meaningful therapeutic benefit over available therapies, upon a determination that the product has an effect on a surrogate endpoint or intermediate clinical endpoint that is reasonably likely to predict clinical benefit. The FDA considers a clinical benefit to be a positive therapeutic effect that is clinically meaningful in the context of a given disease, such as irreversible morbidity or mortality. For the purposes of accelerated approval, a surrogate endpoint is a marker, such as a laboratory measurement, radiographic image, physical sign, or other measure that is thought to predict clinical benefit, but is not itself a measure of clinical benefit. An intermediate clinical endpoint is a clinical endpoint that can be measured earlier than an effect on irreversible morbidity or mortality that is reasonably likely to predict an effect on irreversible morbidity or mortality or other clinical benefit measurement of a therapeutic effect that is considered reasonably likely to predict the clinical benefit of a drug. The accelerated approval pathway may be used in cases in which the advantage of a new drug over available therapy may not be a direct therapeutic advantage, but is a clinically important improvement from a patient and public health perspective. Prior to seeking such accelerated approval, Carisma, or its collaborators, will continue to seek feedback from the FDA or comparable foreign regulatory agencies and otherwise evaluate Carisma&#8217;s, or their, ability to seek and receive such accelerated approval. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">99</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">There can be no assurance that the FDA or foreign regulatory agencies will agree with Carisma&#8217;s, or its collaborators&#8217;, surrogate endpoints or intermediate clinical endpoints in any of Carisma&#8217;s, or their, clinical trials, or that Carisma, or its collaborators, will decide to pursue or submit any additional application for accelerated approval or any other form of expedited development, review or approval. Similarly, there can be no assurance that, after feedback from the FDA or comparable foreign regulatory agencies, Carisma, or its collaborators, will continue to pursue or apply for accelerated approval or any other form of expedited development, review or approval. Furthermore, for any submission of an application for accelerated approval or application under another expedited regulatory designation, there can be no assurance that such submission or application will be accepted for filing or that any expedited development, review or approval will be granted on a timely basis, or at all. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">A failure to obtain accelerated approval or any other form of expedited development, review or approval for Carisma&#8217;s product candidates, or withdrawal of a product candidate, would result in a longer time period until commercialization of such product candidate, could increase the cost of development of such product candidate and could harm Carisma&#8217;s competitive position in the marketplace. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Carisma may not be able to obtain orphan drug exclusivity for any product candidates it may develop, and even if it does, that exclusivity may not prevent the FDA or the EMA from approving other competing products.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Under the Orphan Drug Act, the FDA may designate a product as an orphan drug if it is a drug or biologic intended to treat a rare disease or condition. A similar regulatory scheme governs approval of orphan products by the EMA in the European Union. Generally, if a product candidate with an orphan drug designation subsequently receives the first marketing approval for the indication for which it has such designation, the product is entitled to a period of marketing exclusivity, which precludes the FDA or the EMA from approving another marketing application for the same product for the same therapeutic indication for that time period. The applicable period is seven&#160;years in the United States and ten&#160;years in the European Union. The exclusivity period in the European Union can be reduced to six&#160;years if a product no longer meets the criteria for orphan drug designation, in particular if the product is sufficiently profitable so that market exclusivity is no longer justified. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In order for the FDA to grant orphan drug exclusivity to one of Carisma&#8217;s products, the agency must find that the product is indicated for the treatment of a condition or disease with a patient population of fewer than 200,000 individuals annually in the United States. The FDA may conclude that the condition or disease for which Carisma seeks orphan drug exclusivity does not meet this standard. Even if Carisma obtains orphan drug exclusivity for a product, that exclusivity may not effectively protect the product from competition because different products can be approved for the same condition. In addition, even after an orphan drug is approved, the FDA and comparable foreign regulatory authorities such as the EMA can subsequently approve the same product for the same condition if the FDA or such other authorities conclude that the later product is clinically superior in that it is shown to be safer, more effective or makes a major contribution to patient care. Orphan drug exclusivity may also be lost if the FDA or EMA determines that the request for designation was materially defective or if the manufacturer is unable to assure sufficient quantity of the product to meet the needs of the patients with the rare disease or condition. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In 2017, the Congress passed the FDA Reauthorization Act of 2017, or the FDARA. The FDARA, among other things, codified the FDA&#8217;s pre-existing regulatory interpretation, to require that a drug sponsor demonstrate the clinical superiority of an orphan drug that is otherwise the same as a previously approved drug for the same rare disease in order to receive orphan drug exclusivity. Under omnibus legislation signed by former President Trump in December&#160;2020, the requirement for a product to show clinical superiority applies to drugs and biologics that received orphan drug designation before enactment of FDARA in 2017, but have not yet been approved or licensed by the FDA. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The FDA and Congress may further reevaluate the Orphan Drug Act and its regulations and policies. This may be particularly true in light of a decision from the Court of Appeals for the </font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">1</font><font style="letter-spacing:0.2pt;">1th Circuit in September&#160;2021 finding that, for the purpose of determining the scope of exclusivity, the term &#8220;same disease or condition&#8221; means the designated &#8220;rare disease or condition&#8221; and could not be interpreted by the FDA to mean the &#8220;indication or use.&#8221; Thus, the court concluded, orphan drug exclusivity applies to the entire designated disease or condition rather than the &#8220;indication or use.&#8221; Carisma does not know if, when, or how the FDA may change the orphan drug regulations and policies in the future, and it is uncertain how any </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">100</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">changes might affect Carisma&#8217;s business. Depending on what changes the FDA may make to its orphan drug regulations and policies, Carisma&#8217;s business could be adversely impacted. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If Carisma is unable to successfully develop companion diagnostics for its product candidates and secure clearance or approval of such devices by the FDA and other regulatory authorities, or Carisma experiences significant delays in doing so, Carisma may not realize the full commercial potential of its therapeutics.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma believes that its success will depend, in part, on its ability to develop companion diagnostics, which are assays or tests to identify an appropriate patient population for these product candidates. Carisma has little experience in the development of diagnostics and may not be successful in developing appropriate diagnostics to pair with any of its therapeutic product candidates that receive marketing approval. Companion diagnostics are subject to regulation by the FDA and similar regulatory authorities outside the United States as medical devices and require separate regulatory approval prior to commercialization. Given Carisma&#8217;s limited experience in developing diagnostics, it relies and expects to continue to rely in part or in whole on third parties for their design and manufacture. Carisma also may in the future depend on other third parties for the development of other companion diagnostics for its therapeutic product candidates. If Carisma or its collaborators are unable to successfully develop companion diagnostics for Carisma&#8217;s therapeutic product candidates, or experience delays in doing so: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the development of Carisma&#8217;s therapeutic product candidates may be adversely affected if Carisma is unable to appropriately select patients for enrollment in its clinical trials; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Carisma&#8217;s therapeutic product candidates may not receive marketing approval if safe and effective use of a therapeutic product candidate depends on an in vitro diagnostic; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Carisma may not realize the full commercial potential of any therapeutics that receive marketing approval if, among other reasons, Carisma is unable to appropriately select patients who are likely to benefit from therapy with its medicines. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As a result of any of these events, Carisma&#8217;s business would be harmed, possibly materially. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Any product candidate for which Carisma, or any collaborators, obtain marketing approval could be subject to post-marketing restrictions or withdrawal from the market and Carisma, or any collaborators, may be subject to substantial penalties if Carisma, or any collaborators, fail to comply with regulatory requirements or if Carisma, or any collaborators, experience unanticipated problems with its products when and if any of them are approved.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Any product candidate for which Carisma, or any collaborators, obtain marketing approval, as well as the manufacturing processes, post-approval clinical data, labeling, advertising and promotional activities for such product, will be subject to continual requirements of and review by the FDA, EMA and other regulatory authorities. These requirements include submissions of safety and other post-marketing information and reports, registration and listing requirements, cGMP requirements relating to manufacturing, quality control, quality assurance and corresponding maintenance of records and documents, requirements regarding the distribution of samples to physicians and recordkeeping. Even if marketing approval of a product candidate is granted, the approval may be subject to limitations on the indicated uses for which the product may be marketed or to the conditions of approval, including the requirement to implement a risk evaluation and mitigation strategy. New cancer drugs frequently are indicated only for patient populations that have not responded to an existing therapy or have relapsed. If any of Carisma&#8217;s product candidates receives marketing approval, the accompanying label may limit the approved use of its drug in this way, which could limit sales of the product. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The FDA may also impose requirements for costly post-marketing studies or clinical trials and surveillance to monitor the safety or efficacy of the product, including the adoption and implementation of risk evaluation and mitigation strategies. The FDA and other regulatory agencies, including the Department of Justice, or the DOJ, closely regulate and monitor the post-approval marketing and promotion of drugs to ensure they are marketed and distributed only for the approved indications and in accordance with the provisions of the approved labeling. The FDA, DOJ and other regulatory agencies impose stringent restrictions on manufacturers&#8217; communications regarding off-label use, and if Carisma does not market its products for their approved indications, it may be subject to enforcement action for off-label marketing by the </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">101</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">FDA and other federal and state enforcement agencies. Violations of the Federal Food, Drug, and Cosmetic Act and other statutes, including the False Claims Act, relating to the promotion and advertising of prescription drugs may lead to investigations and enforcement actions alleging violations of federal and state healthcare fraud and abuse laws, as well as state consumer protection laws. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, later discovery of previously unknown side effects or other problems with Carisma&#8217;s products or its manufacturers or manufacturing processes, or failure to comply with regulatory requirements, may yield various results, including: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">restrictions on such products, manufacturers or manufacturing processes; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">restrictions and warnings on the labeling or marketing of a product; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.91pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.91pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">restrictions on product distribution or use; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">requirements to conduct post-marketing studies or clinical trials; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">receipt of warning letters or untitled letters; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">withdrawal of the products from the market; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">refusal to approve pending applications or supplements to approved applications that Carisma submits; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">recall of products; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">fines, restitution or disgorgement of profits or revenues; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">suspension or withdrawal of marketing approvals; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">suspension of any ongoing clinical trials; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">damage to relationships with any potential collaborators; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">unfavorable press coverage and damage to Carisma&#8217;s reputation; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">refusal to permit the import or export of Carisma&#8217;s products; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">product seizure; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">injunctions or the imposition of civil or criminal penalties; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">litigation involving patients using Carisma&#8217;s products. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In addition, manufacturers of approved products and those manufacturers&#8217; facilities are required to comply with extensive FDA requirements, including ensuring that quality control and manufacturing procedures conform to cGMPs applicable to drug manufacturers or quality assurance standards applicable to medical device manufacturers, which include requirements relating to quality control and quality assurance as well as the corresponding maintenance of records and documentation and reporting requirements. Carisma, any contract manufacturers it may engage in the future, its collaborators and their contract manufacturers will also be subject to other regulatory requirements, including submissions of safety and other post-marketing information and reports, registration and listing requirements, requirements regarding the distribution of samples to clinicians, recordkeeping, and costly post-marketing studies or clinical trials and surveillance to monitor the safety or efficacy of the product such as the requirement to implement a risk evaluation and mitigation strategy. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Carisma&#8217;s relationships with healthcare providers, physicians and third-party payors will be subject to applicable anti-kickback, fraud and abuse and other healthcare laws and regulations, which could expose Carisma to civil, criminal and administrative sanctions, contractual damages, reputational harm and diminished future profits and earnings.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Healthcare providers, physicians and third-party payors will play a primary role in the recommendation and prescription of any drugs for which Carisma obtains marketing approval. Carisma&#8217;s future arrangements with third-party payors, healthcare providers and physicians may expose it to broadly applicable state and federal fraud and abuse and other healthcare laws and regulations that may constrain the business or financial </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">102</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">arrangements and relationships through which Carisma markets, sells and distributes any drugs for which it obtains marketing approval. These include the following: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Anti-Kickback Statute,</font><font style="letter-spacing:0.2pt;"> which prohibits, among other things, persons and entities from knowingly and willfully soliciting, offering, paying, or receiving remuneration, directly or indirectly, in cash or in kind, to induce or reward either the referral of an individual for, or the purchasing, ordering, leasing, arranging for, or recommending the purchasing, ordering, or leasing of, any good or service for which payment may be made, in whole or in part, under a federal healthcare program such as Medicare or Medicaid; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">False Claims Act &#8212;</font><font style="letter-spacing:0.2pt;"> the federal civil and criminal false claims laws, including the civil False Claims Act, and Civil Monetary Penalties Law, which prohibit individuals or entities from, among other things, knowingly presenting, or causing to be presented, to the federal government, false or fraudulent claims for payment or knowingly making, using or causing to made or used a false record or statement material to a false or fraudulent claim or to avoid, decrease or conceal an obligation to pay money to the federal government, or knowingly concealing or knowingly and improperly avoiding or decreasing an obligation to pay money to the federal government; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">HIPAA &#8212;</font><font style="letter-spacing:0.2pt;"> the federal Health Insurance Portability and Accountability Act of 1996, or HIPAA, which created additional federal criminal statutes that prohibit, among other things, executing a scheme to defraud any healthcare benefit program or making false statements relating to healthcare matters, and apply regardless of the payor (e.g., public or private); </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">HIPAA and HITECH &#8212;</font><font style="letter-spacing:0.2pt;"> HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act, or HITECH, and their implementing regulations, which impose obligations on HIPAA covered entities and their business associates, including mandatory contractual terms and required implementation of administrative, physical and technical safeguards to maintain the privacy and security of individually identifiable health information; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Transparency Requirements &#8212;</font><font style="letter-spacing:0.2pt;"> the federal physician transparency requirements known as the Physician Payments Sunshine Act, under the Patient Protection and Affordable Care Act, as amended by the Health Care Education Reconciliation Act, or the Affordable Care Act, which requires manufacturers of drugs, medical devices, biological and medical supplies covered by Medicare, Medicaid, or State Children&#8217;s Health Insurance Program to report annually to the Centers for Medicare &amp; Medicaid Services, or CMS, within the United States Department of Health and Human Services, information related to payments and other transfers of value made by that entity to physicians, other healthcare providers and teaching hospitals, as well as ownership and investment interests held by physicians and their immediate family members; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Analogous State, Local and Foreign Laws &#8212;</font><font style="letter-spacing:0.2pt;"> analogous state, local and foreign fraud and abuse laws and regulations, such as state anti-kickback and false claims laws, which may be broader than similar federal laws, can apply to claims involving healthcare items or services regardless of payor, and are enforced by many different federal and state agencies as well as through private actions. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Some state laws require pharmaceutical companies to comply with the pharmaceutical industry&#8217;s voluntary compliance guidelines and the relevant compliance guidance promulgated by the federal government and require drug manufacturers to report information related to payments and other transfers of value to physicians and other healthcare providers or marketing expenditures. State and foreign laws also govern the privacy and security of health information in some circumstances, many of which differ from each other in significant ways and often are not pre-empted by HIPAA, thus complicating compliance efforts. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Efforts to ensure that Carisma&#8217;s business arrangements with third parties will comply with applicable healthcare laws and regulations will involve substantial costs. It is possible that governmental authorities will conclude that Carisma&#8217;s business practices may not comply with current or future statutes, regulations or case law involving applicable fraud and abuse or other healthcare laws and regulations. If Carisma&#8217;s operations are found to be in violation of any of these laws or any other governmental regulations that may apply to Carisma, it may be subject to significant civil, criminal and/or administrative penalties, damages, fines, individual imprisonment, disgorgement, exclusion from government funded healthcare programs, such as Medicare and Medicaid, contractual damages, reputational harm, administrative burdens, diminished profits and future earnings, additional reporting obligations and oversight if Carisma becomes subject to a </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">103</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">corporate integrity agreement or similar agreement to resolve allegations of non-compliance with these laws and the curtailment or restructuring of its operations. If any of the physicians or other healthcare providers or entities with whom Carisma expects to do business is found to be not in compliance with applicable laws, they may be subject to criminal, civil or administrative sanctions, including exclusions from government funded healthcare programs. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The provision of benefits or advantages to physicians to induce or encourage the prescription, recommendation, endorsement, purchase, supply, order or use of medicinal products is also prohibited in the European Union. The provision of benefits or advantages to physicians is governed by the national anti-bribery laws of European Union Member States. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Compliance with global privacy and data security requirements could result in additional costs and liabilities to Carisma or inhibit its ability to collect and process data globally, and the failure to comply with such requirements could subject Carisma to significant fines and penalties, which may have a material adverse effect on its business, financial condition or results of operations.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The regulatory framework for the collection, use, safeguarding, sharing, transfer and other processing of information worldwide is rapidly evolving and is likely to remain uncertain for the foreseeable future. Globally, virtually every jurisdiction in which Carisma operates has established its own data security and privacy frameworks with which it must comply. For example, the collection, use, disclosure, transfer, or other processing of personal data regarding individuals in the European Union, including personal health data, is subject to the E.U. General Data Protection Regulation, or the GDPR, which took effect across all member states of the European Economic Area, or EEA, in May&#160;2018. The GDPR is wide-ranging in scope and imposes numerous requirements on companies that process personal data, including requirements relating to processing health and other sensitive data, obtaining consent of the individuals to whom the personal data relates, providing information to individuals regarding data processing activities, implementing safeguards to protect the security and confidentiality of personal data, providing notification of data breaches, and taking certain measures when engaging third-party processors. The GDPR increases Carisma&#8217;s obligations with respect to clinical trials conducted in the EEA by expanding the definition of personal data to include coded data and requiring changes to informed consent practices and more detailed notices for clinical trial subjects and investigators. In addition, the GDPR also imposes strict rules on the transfer of personal data to countries outside the European Union, including the United States and, as a result, increases the scrutiny that clinical trial sites located in the EEA should apply to transfers of personal data from such sites to countries that are considered to lack an adequate level of data protection, such as the United States. The GDPR also permits data protection authorities to require destruction of improperly gathered or used personal information and/or impose substantial fines for violations of the GDPR, which can be up to four&#160;percent of global revenues or 20.0&#160;million Euros, whichever is greater, and it also confers a private right of action on data subjects and consumer associations to lodge complaints with supervisory authorities, seek judicial remedies, and obtain compensation for damages resulting from violations of the GDPR. In addition, the GDPR provides that European Union member states may make their own further laws and regulations limiting the processing of personal data, including genetic, biometric or health data. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Similar actions are either in place or under way in the United States. There are a broad variety of data protection laws that are applicable to Carisma&#8217;s activities, and a wide range of enforcement agencies at both the state and federal levels that can review companies for privacy and data security concerns based on general consumer protection laws. The Federal Trade Commission and state Attorneys General all are aggressive in reviewing privacy and data security protections for consumers. New laws also are being considered at both the state and federal levels. For example, the California Consumer Privacy Act, or CCPA, which went into effect on January&#160;1, 2020, is creating similar risks and obligations as those created by the GDPR, though CCPA does exempt certain information collected as part of a clinical trial subject to the Federal Policy for the Protection of Human Subjects (the Common Rule). Many other states are considering similar legislation. A broad range of legislative measures also have been introduced at the federal level. Accordingly, failure to comply with federal and state laws (both those currently in effect and future legislation) regarding privacy and security of personal information could expose Carisma to fines and penalties under such laws. There also is the threat of consumer class actions related to these laws and the overall protection of personal data. Even if Carisma is not determined to have violated these laws, government investigations </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">104</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">into these issues typically require the expenditure of significant resources and generate negative publicity, which could harm Carisma&#8217;s reputation and business. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Given the breadth and depth of changes in data protection obligations, preparing for and complying with such requirements is rigorous and time intensive and requires significant resources and a review of Carisma&#8217;s technologies, systems and practices, as well as those of any third-party collaborators, service providers, contractors or consultants that process or transfer personal data. The GDPR and other changes in laws or regulations associated with the enhanced protection of certain types of sensitive data, such as healthcare data or other personal information from Carisma&#8217;s clinical trials, could require Carisma to change its business practices and put in place additional compliance mechanisms, may interrupt or delay its development, regulatory and commercialization activities and increase its cost of doing business, and could lead to government enforcement actions, private litigation and significant fines and penalties against Carisma and could have a material adverse effect on its business, financial condition or results of operations. Similarly, failure to comply with federal and state laws regarding privacy and security of personal information could expose Carisma to fines and penalties under such laws. Even if Carisma is not determined to have violated these laws, government investigations into these issues typically require the expenditure of significant resources and generate negative publicity, which could harm Carisma&#8217;s reputation and business. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Current and future legislation may increase the difficulty and cost for Carisma and any collaborators to obtain marketing approval of and commercialize product candidates and affect the prices Carisma, or any collaborators, may obtain.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In the United States and some foreign jurisdictions, there have been a number of legislative and regulatory changes and proposed changes regarding the healthcare system that could, among other things, prevent or delay marketing approval of Carisma&#8217;s product candidates, restrict or regulate post-approval activities, impact pricing and reimbursement and affect Carisma&#8217;s ability, or the ability of any collaborators, to profitably sell or commercialize any product candidates for which Carisma, or any collaborators, obtain marketing approval. The pharmaceutical industry has been a particular focus of these efforts and has been significantly affected by legislative initiatives. In particular, there have been and continue to be a number of initiatives at the U.S. federal and state levels that seek to reduce healthcare costs and improve the quality of healthcare. Current laws, as well as other healthcare reform measures that may be adopted in the future, may result in more rigorous coverage criteria and in additional downward pressure on the price that Carisma, or any collaborators, may receive for any FDA approved products. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In the United States, the Medicare Prescription Drug, Improvement, and Modernization Act of 2003, or the MMA, changed the way Medicare covers and pays for pharmaceutical products. The legislation expanded Medicare coverage for prescription drugs purchased through a pharmacy by the elderly and disabled and introduced a new reimbursement methodology based on average sales prices for physician-administered drugs. In addition, this statute provides authority for limiting the number of drugs that will be covered in any therapeutic class, subject to certain exceptions. Cost reduction initiatives and other provisions of this statute could decrease the coverage and price that Carisma receives for any approved products. While the MMA applies only to drug benefits for Medicare beneficiaries, private payors often follow Medicare coverage policy and payment limitations in setting their own reimbursement rates. Therefore, any reduction in reimbursement that results from the MMA may result in a similar reduction in payments from private payors. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In March&#160;2010, then-President Obama signed into law the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Affordability Reconciliation Act, or collectively the ACA. In addition, other legislative changes have been proposed and adopted since the ACA was enacted. In August&#160;2011, the Budget Control Act of 2011, among other things, created measures for spending reductions by Congress. A Joint Select Committee on Deficit Reduction, tasked with recommending a targeted deficit reduction of at least $1.2 trillion for the&#160;years 2013 through 2021, was unable to reach required goals, thereby triggering the legislation&#8217;s automatic reduction to several government programs. These changes included aggregate reductions to Medicare payments to providers of up to 2% per fiscal year, which went into effect in April&#160;2013 and will remain in effect through 2031 under the Coronavirus Aid, Relief, and Economic Security Act, or the CARES Act. The American Taxpayer Relief Act of 2012, among other things, reduced Medicare payments to several providers and increased the statute of limitations period for the government to </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">105</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">recover overpayments to providers from three to five&#160;years. Further, with passage of the Inflation Reduction Act in August&#160;2022, Congress extended the expansion of the Patient Protection and Affordable Care Act premium tax credits through 2025. Those subsidies were originally extended through 2022 under the American Rescue Plan&#160;Act of 2021. These laws may result in additional reductions in Medicare and other healthcare funding and otherwise affect the prices Carisma may obtain for any of its product candidates for which it may obtain regulatory approval or the frequency with which any such product candidate is prescribed or used. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Since enactment of the ACA, there have been and continue to be, numerous legal challenges and Congressional actions to repeal and replace provisions of the law. For example, with enactment of the Tax Cuts for Jobs Act, or TCJA, in 2017, Congress repealed the &#8220;individual mandate.&#8221; The repeal of this provision, which requires most Americans to carry a minimal level of health insurance, became effective in 2019. Further, on December&#160;14, 2018, a U.S. District Court judge in the Northern District of Texas ruled that the individual mandate portion of the ACA is an essential and inseverable feature of the ACA and therefore because the mandate was repealed as part of the TCJA, the remaining provisions of the ACA are invalid as well. The U.S. Supreme Court heard this case on November&#160;10, 2020 and on June&#160;17, 2021, dismissed this action after finding that the plaintiffs do not have standing to challenge the constitutionality of the ACA. Litigation and legislation over the ACA are likely to continue, with unpredictable and uncertain results. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Trump Administration also took executive actions to undermine or delay implementation of the ACA, including directing federal agencies with authorities and responsibilities under the ACA to waive, defer, grant exemptions from, or delay the implementation of any provision of the ACA that would impose a fiscal or regulatory burden on states, individuals, healthcare providers, health insurers, or manufacturers of pharmaceuticals or medical devices. On January&#160;28, 2021, however, President Biden rescinded those orders and issued a new Executive Order which directs federal agencies to reconsider rules and other policies that limit Americans&#8217; access to health care, and consider actions that will protect and strengthen that access. Under this Order, federal agencies are directed to re-examine: policies that undermine protections for people with pre-existing conditions, including complications related to COVID-19; demonstrations and waivers under Medicaid and the ACA that may reduce coverage or undermine the programs, including work requirements; policies that undermine the Health Insurance Marketplace or other markets for health insurance; policies that make it more difficult to enroll in Medicaid and the ACA; and policies that reduce affordability of coverage or financial assistance, including for dependents. This Executive Order also directs the U.S. Department of Health and Human Services to create a special enrollment period for the Health Insurance Marketplace in response to the COVID-19 pandemic. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma expects that these healthcare reforms, as well as other healthcare reform measures that may be adopted in the future, may result in additional reductions in Medicare and other healthcare funding, more rigorous coverage criteria, new payment methodologies and additional downward pressure on the price that Carisma receives for any approved product and/or the level of reimbursement physicians receive for administering any approved product it might bring to market. Reductions in reimbursement levels may negatively impact the prices Carisma receives or the frequency with which its products are prescribed or administered. Any reduction in reimbursement from Medicare or other government programs may result in a similar reduction in payments from private payors. Accordingly, such reforms, if enacted, could have an adverse effect on anticipated revenue from product candidates that Carisma may successfully develop and for which it may obtain marketing approval and may affect Carisma&#8217;s overall financial condition and ability to develop or commercialize product candidates. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The prices of prescription pharmaceuticals in the United States and foreign jurisdictions are subject to considerable legislative and executive actions and could impact the prices Carisma obtains for its drug products, if and when approved.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The prices of prescription pharmaceuticals have also been the subject of considerable discussion in the United States. There have been several recent U.S. congressional inquiries, as well as proposed and enacted state and federal legislation designed to, among other things, bring more transparency to pharmaceutical pricing, review the relationship between pricing and manufacturer patient programs, and reduce the costs of pharmaceuticals under Medicare and Medicaid. In 2020, President Trump issued several executive orders intended to lower the costs of prescription products and certain provisions in these orders have been incorporated into regulations. These regulations include an interim final rule implementing a most favored </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">106</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">nation model for prices that would tie Medicare Part&#160;B payments for certain physician-administered pharmaceuticals to the lowest price paid in other economically advanced countries, effective January&#160;1, 2021. That rule, however, has been subject to a nationwide preliminary injunction and, on December&#160;29, 2021, CMS issued a final rule to rescind it. With issuance of this rule, CMS stated that it will explore all options to incorporate value into payments for Medicare Part&#160;B pharmaceuticals and improve beneficiaries&#8217; access to evidence-based care. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, in October&#160;2020, HHS and the FDA published a final rule allowing states and other entities to develop a Section&#160;804 Importation Program, or SIP, to import certain prescription drugs from Canada into the United States. The final rule is currently the subject of ongoing litigation, but at least six states (Vermont, Colorado, Florida, Maine, New Mexico, and New Hampshire) have passed laws allowing for the importation of drugs from Canada with the intent of developing SIPs for review and approval by the FDA. Further, on November&#160;20, 2020, HHS finalized a regulation removing safe harbor protection for price reductions from pharmaceutical manufacturers to plan sponsors under Part&#160;D, either directly or through pharmacy benefit managers, unless the price reduction is required by law. The implementation of the rule has been delayed by the Biden administration from January&#160;1, 2022 to January&#160;1, 2023 in response to ongoing litigation. The rule also creates a new safe harbor for price reductions reflected at the point-of-sale, as well as a new safe harbor for certain fixed fee arrangements between pharmacy benefit managers and manufacturers, the implementation of which has been delayed until January&#160;1, 2026 by the Infrastructure Investment and Jobs Act. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">More recently, with passage of the Inflation Reduction Act in August&#160;2022, Congress authorized Medicare beginning in 2026 to negotiate lower prices for certain costly single-source drug and biologic products that do not have competing generics or biosimilars. This provision is limited in terms of the number of pharmaceuticals whose prices can be negotiated in any given year and it only applies to drug products that have been approved for at least 9&#160;years and biologics that have been licensed for 13&#160;years. Drugs and biologics that have been approved for a single rare disease or condition are categorically excluded from price negotiation. Further, the new legislation provides that if pharmaceutical companies raise prices in Medicare faster than the rate of inflation, they must pay rebates back to the government for the difference. The new law also caps Medicare out-of-pocket drug costs at an estimated $4,000 a year in 2024 and, thereafter beginning in 2025, at $2,000 a year. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">At the state level, individual states are increasingly aggressive in passing legislation and implementing regulations designed to control pharmaceutical and biological product pricing, including price or patient reimbursement constraints, discounts, restrictions on certain product access and marketing cost disclosure and transparency measures, and, in some cases, designed to encourage importation from other countries and bulk purchasing. In addition, health care organizations and individual hospitals are increasingly using bidding procedures to determine what pharmaceutical products and which suppliers will be included in their prescription drug and other health care programs. These measures could reduce the ultimate demand for Carisma&#8217;s products, once approved, or put pressure on its product pricing. Carisma expects that additional state and federal healthcare reform measures will be adopted in the future, any of which could limit the amounts that federal and state governments will pay for healthcare products and services, which could result in reduced demand for its product candidates or additional pricing pressures. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In other countries, particularly the countries of the European Union, the pricing of prescription pharmaceuticals is subject to governmental control. In these countries, pricing negotiations with governmental authorities can take considerable time after the receipt of marketing approval for a drug. To obtain reimbursement or pricing approval in some countries, Carisma, or its collaborators, may be required to conduct a clinical trial that compares the cost-effectiveness of its drug to other available therapies. If reimbursement of Carisma&#8217;s drugs is unavailable or limited in scope or amount, or if pricing is set at unsatisfactory levels, its business could be materially harmed. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Carisma is subject to anti-corruption laws, as well as export control laws, customs laws, sanctions laws and other laws governing its operations. If Carisma fails to comply with these laws, it could be subject to civil or criminal penalties, other remedial measures and legal expenses, which could adversely affect its business, results of operations and financial condition.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma&#8217;s operations are subject to anti-corruption laws, including the FCPA, the Bribery Act, and other anticorruption laws that apply in countries where Carisma does business and may do business in the </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">107</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">future. The FCPA, the Bribery Act, and these other laws generally prohibit Carisma, its officers and its employees and intermediaries from bribing, being bribed or making other prohibited payments to government officials or other persons to obtain or retain business or gain some other business advantage. Carisma may in the future operate in jurisdictions that pose a high risk of potential FCPA or Bribery Act violations, and it may participate in collaborations and relationships with third parties whose actions could potentially subject Carisma to liability under the FCPA, the Bribery Act, or local anti-corruption laws. In addition, Carisma cannot predict the nature, scope or effect of future regulatory requirements to which its international operations might be subject or the manner in which existing laws might be administered or interpreted. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma is also subject to other laws and regulations governing its international operations, including regulations administered by the governments of the United States, United Kingdom, and authorities in the European Union, including applicable export control regulations, economic sanctions on countries and persons, customs requirements and currency exchange regulations, which is collectively referred to as Trade Control Laws. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">There is no assurance that Carisma will be completely effective in ensuring its compliance with all applicable anti-corruption laws, including the FCPA, the Bribery Act, or other legal requirements, including Trade Control Laws. If Carisma is not in compliance with the FCPA, the Bribery Act, and other anti-corruption laws or Trade Control Laws, it may be subject to criminal and civil penalties, disgorgement and other sanctions and remedial measures, and legal expenses, which could have an adverse impact on its business, financial condition, results of operations and liquidity. The SEC also may suspend or bar issuers from trading securities on U.S. exchanges for violations of the FCPA&#8217;s accounting provisions. Likewise, any investigation of any potential violations of the FCPA, the Bribery Act, other anti-corruption laws or Trade Control Laws by the United States, the United Kingdom or other authorities could also have an adverse impact on Carisma&#8217;s reputation, business, results of operations and financial condition. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Carisma is subject to stringent privacy laws, information security laws, regulations, policies and contractual obligations related to data privacy and security and changes in such laws, regulations, policies, contractual obligations and failure to comply with such requirements could subject Carisma to significant fines and penalties, which may have a material adverse effect on Carisma&#8217;s business, financial condition or results of operations.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma is subject to data privacy and protection laws and regulations that apply to the collection, transmission, storage and use of personally-identifying information, which among other things, impose certain requirements relating to the privacy, security and transmission of personal information, including comprehensive regulatory systems in the United States, the European Union and the United Kingdom. The legislative and regulatory landscape for privacy and data protection continues to evolve in jurisdictions worldwide, and there has been an increasing focus on privacy and data protection issues with the potential to affect Carisma&#8217;s business. Failure to comply with any of these laws and regulations could result in an enforcement action against Carisma, including fines, imprisonment of company officials and public censure, claims for damages by affected individuals, damage to Carisma&#8217;s reputation and loss of goodwill, any of which could have a material adverse effect on Carisma&#8217;s business, financial condition, results of operations or prospects. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">There are numerous U.S. federal and state laws and regulations related to the privacy and security of personal information. In particular, regulations promulgated pursuant to HIPAA establish privacy and security standards that limit the use and disclosure of individually identifiable health information, or protected health information, and require the implementation of administrative, physical and technological safeguards to protect the privacy of protected health information and ensure the confidentiality, integrity and availability of electronic protected health information. Determining whether protected health information has been handled in compliance with applicable privacy standards and Carisma&#8217;s contractual obligations can be complex and may be subject to changing interpretation. These obligations may be applicable to some or all of Carisma&#8217;s business activities now or in the future. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If Carisma is unable to properly protect the privacy and security of protected health information, it could be found to have breached its contracts. Further, if Carisma fails to comply with applicable privacy laws, including applicable HIPAA privacy and security standards, it could face civil and criminal penalties. HHS enforcement activity can result in financial liability and reputational harm, and responses to such enforcement activity can consume significant internal resources. In addition, state attorneys general are </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">108</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">authorized to bring civil actions seeking either injunctions or damages in response to violations that threaten the privacy of state residents. Carisma cannot be sure how these regulations will be interpreted, enforced or applied to its operations. In addition to the risks associated with enforcement activities and potential contractual liabilities, Carisma&#8217;s ongoing efforts to comply with evolving laws and regulations at the federal and state level may be costly and require ongoing modifications to its policies, procedures and systems. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In 2018, California passed into law the California Consumer Privacy Act, or the CCPA, which took effect on January&#160;1, 2020 and imposed many requirements on businesses that process the personal information of California residents. Many of the CCPA&#8217;s requirements are similar to those found in the General Data Protection Regulation, or the GDPR, including requiring businesses to provide notice to data subjects regarding the information collected about them and how such information is used and shared, and providing data subjects the right to request access to such personal information and, in certain cases, request the erasure of such personal information. The CCPA also affords California residents the right to opt-out of &#8220;sales&#8221; of their personal information. The CCPA contains significant penalties for companies that violate its requirements. In November&#160;2020, California voters passed a ballot initiative for the California Privacy Rights Act, or the CPRA, which will significantly expand the CCPA to incorporate additional GDPR-like provisions including requiring that the use, retention, and sharing of personal information of California residents be reasonably necessary and proportionate to the purposes of collection or processing, granting additional protections for sensitive personal information, and requiring greater disclosures related to notice to residents regarding retention of information. Most CPRA provisions will take effect on January&#160;1, 2023, though the obligations will apply to any personal information collected after January&#160;1, 2022. These provisions may apply to some of Carisma&#8217;s business activities. In addition, other states, including Virginia and Colorado, already have passed state privacy laws. Other states will be considering these laws in the future. These laws may impact Carisma&#8217;s business activities, including Carisma&#8217;s identification of research subjects, relationships with business partners and ultimately the marketing and distribution of its products. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Similar to the laws in the United States, there are significant privacy and data security laws that apply in Europe and other countries. The collection, use, disclosure, transfer, or other processing of personal data, including personal health data, regarding individuals who are located in the European Economic Area, or EEA, and the processing of personal data that takes place in the EEA, is regulated by the GDPR, which went into effect in May&#160;2018 and which imposes obligations on companies that operate in Carisma&#8217;s industry with respect to the processing of personal data and the cross-border transfer of such data. The GDPR imposes onerous accountability obligations requiring data controllers and processors to maintain a record of their data processing and policies. If Carisma&#8217;s or its partners&#8217; or service providers&#8217; privacy or data security measures fail to comply with the GDPR requirements, Carisma may be subject to litigation, regulatory investigations, enforcement notices requiring it to change the way it uses personal data and/or fines of up to 20.0&#160;million Euros or up to 4% of the total worldwide annual turnover of the preceding financial year, whichever is higher, as well as compensation claims by affected individuals, negative publicity, reputational harm and a potential loss of business and goodwill. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The GDPR places restrictions on the cross-border transfer of personal data from the European Union to countries that have not been found by the European Commission to offer adequate data protection legislation, such as the United States. There are ongoing concerns about the ability of companies to transfer personal data from the European Union to other countries. In July&#160;2020, the Court of Justice of the European Union, or the CJEU invalidated the European Union-United States Privacy Shield, one of the mechanisms used to legitimize the transfer of personal data from the EEA to the United States. The CJEU decision also drew into question the long-term viability of an alternative means of data transfer, the standard contractual clauses, for transfers of personal data from the EEA to the United States. While Carisma is not self-certified under the Privacy Shield, this CJEU decision may lead to increased scrutiny on data transfers from the EEA to the United States, generally, and increase Carisma&#8217;s costs of compliance with data privacy legislation as well as its costs of negotiating appropriate privacy and security agreements with its vendors and business partners. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Following the withdrawal of the United Kingdom from the European Union, the UK Data Protection Act 2018 applies to the processing of personal data that takes place in the United Kingdom and includes parallel obligations to those set forth by GDPR. As with other issues related to Brexit, there are open </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">109</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">questions about how personal data will be protected in the United Kingdom and whether personal information can transfer from the European Union to the United Kingdom. Following the withdrawal of the United Kingdom from the European Union, the UK Data Protection Act 2018 applies to the processing of personal data that takes place in the United Kingdom and includes parallel obligations to those set forth by GDPR. While the Data Protection Act of 2018 in the United Kingdom that &#8220;implements&#8221; and complements the GDPR, has achieved Royal Assent on May&#160;23, 2018 and is now effective in the United Kingdom, it is still unclear whether transfer of data from the EEA to the United Kingdom will remain lawful under GDPR. The U.K. government has already determined that it considers all European Union and EEA member states to be adequate for the purposes of data protection, ensuring that data flows from the United Kingdom to the European Union/EEA remain unaffected. In addition, a recent decision from the EC appears to deem the United Kingdom as being &#8220;essentially adequate&#8221; for purposes of data transfer from the European Union to the United Kingdom, although this decision may be re-evaluated in the future. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Beyond GDPR, there are privacy and data security laws in a growing number of countries around the world. While many loosely follow GDPR as a model, other laws contain different or conflicting provisions. These laws will impact Carisma&#8217;s ability to conduct its business activities, including both its clinical trials and any eventual sale and distribution of commercial products, through increased compliance costs, costs associated with contracting and potential enforcement actions. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">While Carisma continues to address the implications of the recent changes to data privacy regulations, data privacy remains an evolving landscape at both the domestic and international level, with new regulations coming into effect and continued legal challenges, and Carisma&#8217;s efforts to comply with the evolving data protection rules may be unsuccessful. It is possible that these laws may be interpreted and applied in a manner that is inconsistent with Carisma&#8217;s practices. Carisma must devote significant resources to understanding and complying with this changing landscape. Failure to comply with laws regarding data protection would expose Carisma to risk of enforcement actions taken by data protection authorities in the EEA and elsewhere and carries with it the potential for significant penalties if Carisma is found to be non-compliant. Similarly, failure to comply with federal and state laws in the United States regarding privacy and security of personal information could expose Carisma to penalties under such laws. Any such failure to comply with data protection and privacy laws could result in government-imposed fines or orders requiring that Carisma change its practices, claims for damages or other liabilities, regulatory investigations and enforcement action, litigation and significant costs for remediation, any of which could adversely affect Carisma&#8217;s business. Even if Carisma is not determined to have violated these laws, government investigations into these issues typically require the expenditure of significant resources and generate negative publicity, which could harm Carisma&#8217;s business, financial condition, results of operations or prospects. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If Carisma employees, independent contractors, consultants, collaborators and vendors engage in misconduct or other improper activities, including non-compliance with regulatory standards and/or requirements and insider trading, Carisma could sustain significant liability and harm to its reputation.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma is exposed to the risk of fraud or other misconduct by its employees, independent contractors, consultants, collaborators and vendors. Misconduct by these partners could include intentional failures to comply with FDA regulations or similar regulations of comparable foreign regulatory authorities, provide accurate information to the FDA or comparable foreign regulatory authorities, comply with manufacturing standards, comply with federal and state healthcare fraud and abuse laws and regulations and similar laws and regulations established and enforced by comparable foreign regulatory authorities, report financial information or data accurately or disclose unauthorized activities to Carisma. Employee misconduct could also involve the improper use of information obtained in the course of clinical trials, which could result in regulatory sanctions and serious harm to Carisma&#8217;s reputation. This could include violations of HIPAA, other U.S. federal and state laws, and requirements of foreign jurisdictions, including the GDPR. Carisma is also exposed to risks in connection with any insider trading violations by employees or others affiliated with Carisma. It is not always possible to identify and deter employee or third-party misconduct, and the precautions that Carisma takes to detect and prevent these activities may not be effective in controlling unknown or unmanaged risks or losses or in protecting Carisma from governmental investigations or other actions or lawsuits stemming from a failure to be in compliance with such laws, standards, regulations, guidance or codes of conduct. If any such actions are instituted against Carisma, and Carisma is not </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">110</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">successful in defending itself or asserting its rights, those actions could have a significant impact on its business and results of operations, including the imposition of significant fines or other sanctions. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If Carisma or any third-party manufacturer it engages now or in the future fails to comply with environmental, health and safety laws and regulations, Carisma could become subject to fines or penalties or incur costs or liabilities that could significantly harm its business.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma and third-party manufacturers it engages now are, and any third-party manufacturer it may engage in the future will be, subject to numerous environmental, health and safety laws and regulations, including those governing laboratory procedures and the handling, use, storage, treatment and disposal of hazardous materials and wastes. From time to time and in the future, Carisma&#8217;s operations may involve the use of hazardous and flammable materials, including chemicals and biological materials, and may also produce hazardous waste products. Although Carisma contracts with third parties for the disposal of these materials and waste products, it cannot completely eliminate the risk of contamination or injury resulting from these materials. In the event of contamination or injury resulting from the use or disposal of Carisma&#8217;s hazardous materials, Carisma could be held liable for any resulting damages, and any liability could exceed its resources. Carisma also could incur significant costs associated with civil or criminal fines and penalties for failure to comply with such laws and regulations. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma maintains general liability insurance as well as workers&#8217; compensation insurance to cover costs and expenses it may incur due to injuries to its employees resulting from the use of hazardous materials, but this insurance may not provide adequate coverage against potential liabilities. Carisma does not maintain insurance for environmental liability or toxic tort claims that may be asserted against it. In addition, Carisma may incur substantial costs in order to comply with current or future environmental, health and safety laws and regulations. Current or future environmental laws and regulations may impair Carisma&#8217;s research, development or production efforts, which could adversely affect its business, financial condition, results of operations or prospects. In addition, failure to comply with these laws and regulations may result in substantial fines, penalties or other sanctions. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Risks Related to Employee Matters and Managing Growth</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Carisma&#8217;s future success depends on its ability to retain key executives and experienced scientists and to attract, retain and motivate qualified personnel.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma is highly dependent on the research and development, clinical, financial, operational and other business expertise of its executive officers, as well as the other principal members of its management, scientific and clinical teams. Although Carisma has entered into employment agreements with certain of its executive officers, each of them may terminate their employment with Carisma at any time. Carisma does not maintain &#8220;key person&#8221; insurance for any of its executives or other employees. Recruiting and retaining qualified scientific, clinical, manufacturing, accounting, legal and sales and marketing personnel will also be critical to Carisma&#8217;s success. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The loss of the services of Carisma&#8217;s executive officers or other key employees, including temporary loss due to illness, could impede the achievement of its discovery programs, development and commercialization objectives and seriously harm its ability to successfully implement its business strategy. Furthermore, replacing executive officers and key employees may be difficult and may take an extended period of time because of the limited number of individuals in Carisma&#8217;s industry with the breadth of skills and experience required to successfully develop, gain marketing approval of and commercialize products. Competition to hire from this limited pool is intense, and Carisma may be unable to hire, train, retain or motivate these key personnel on acceptable terms given the competition among numerous biopharmaceutical companies for similar personnel. Carisma also experiences competition for the hiring of scientific and clinical personnel from universities and research institutions. In addition, Carisma relies on consultants and advisors, including scientific and clinical advisors, to assist it in formulating its discovery, research and development and commercialization strategy. Carisma&#8217;s consultants and advisors may be employed by employers other than Carisma and may have commitments under consulting or advisory contracts with other entities that may limit their availability to Carisma. Failure to succeed in clinical trials may make it even more challenging to recruit and retain qualified scientific personnel. Carisma&#8217;s success as a public company </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">111</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">also depends on implementing and maintaining internal controls and the accuracy and timeliness of its financial reporting. If Carisma is unable to continue to attract and retain high quality personnel, its ability to pursue its growth strategy will be limited. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Carisma expects to expand its development and regulatory capabilities and potentially implement sales, marketing and distribution capabilities, and as a result, it may encounter difficulties in managing its growth, which could disrupt its operations.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma expects to experience significant growth in the number of its employees and the scope of its operations, particularly as it functions as a public company and in the areas of product development, clinical, regulatory affairs, manufacturing and quality control and, if any of its product candidates receives marketing approval, sales, marketing and distribution. To manage Carisma&#8217;s anticipated future growth, it must continue to implement and improve its managerial, operational and financial systems, expand its facilities and continue to recruit and train additional qualified personnel. Future growth will impose significant added responsibilities on members of management, including: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">identifying, recruiting, integrating, maintaining and motivating additional employees; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">managing its internal development efforts effectively, including the clinical and regulatory review process for CT-0508 and other product candidates Carisma is developing or may develop in the future, while complying with its contractual obligations to contractors and other third parties; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">improving its operational, financial and management controls, reporting systems and procedures. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma&#8217;s future financial performance and its ability to advance development of and, if approved, commercialize CT-0508 and any other product candidate Carisma is developing or may develop in the future will depend, in part, on Carisma&#8217;s ability to effectively manage any future growth. Due to Carisma&#8217;s limited financial resources and the limited experience of its management team in managing a company with such anticipated growth, Carisma may not be able to effectively manage the expansion of its operations or recruit and train additional qualified personnel. If Carisma does not effectively manage the expansion of its operations, Carisma could experience weaknesses in its infrastructure, operational mistakes, loss of business opportunities, loss of employees and reduced productivity among remaining employees. The expansion of Carisma&#8217;s operations also could lead to significant costs and may divert Carisma&#8217;s management and business development resources. Any inability to manage growth could delay the execution of Carisma&#8217;s business plans or disrupt its operations. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Many of the biopharmaceutical companies, and in particular cell therapy companies, that Carisma competes against for qualified personnel and consultants have greater financial and other resources, different risk profiles and a longer history in the industry than Carisma does. They also may provide more diverse opportunities and better chances for career advancement. Some of these characteristics may be more appealing to high-quality candidates than what Carisma has to offer. If Carisma is unable to continue to attract and retain high-quality personnel and consultants, the rate and success at which Carisma can develop product candidates and operate its business will be limited. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Carisma&#8217;s internal computer systems, or those of its collaborators, vendors, suppliers, contractors or consultants, may fail or suffer security breaches, which could result in a material disruption of Carisma&#8217;s product development programs.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma&#8217;s internal computer systems and those of any collaborators, vendors, suppliers, contractors or consultants are vulnerable to damage from computer viruses, unauthorized access, natural disasters, terrorism, war and telecommunication and electrical failures. Such systems are also vulnerable to service interruptions or to security breaches from inadvertent or intentional actions by Carisma&#8217;s employees, third-party vendors and/or business partners, or from cyber-attacks by malicious third parties. Cyber-attacks are increasing in their frequency, sophistication and intensity, and have become increasingly difficult to detect. Cyber-attacks could include the deployment of harmful malware, ransomware, denial-of-service attacks, unauthorized access to or deletion of files, social engineering and other means to affect service reliability and threaten the confidentiality, integrity and availability of information. Cyber-attacks also could include phishing attempts or email fraud to cause payments or information to be transmitted to an unintended recipient. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">112</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If Carisma experiences any material system failure, accident, cyber-attack or security that causes interruptions in its operations, it could result in a material disruption of Carisma&#8217;s development programs and its business operations, whether due to a loss of its trade secrets or other proprietary information or other similar disruptions. For example, the loss of clinical trial data from completed or future clinical trials could result in delays in Carisma&#8217;s marketing approval efforts and significantly increase its costs to recover or reproduce the data. To the extent that any disruption or security breach were to result in a loss of, or damage to, Carisma&#8217;s data or applications, or inappropriate disclosure of confidential or proprietary information, Carisma could incur liability, its competitive position could be harmed and the further development and commercialization of its product candidates could be delayed. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Carisma&#8217;s employees, independent contractors, including principal investigators, consultants and vendors and any third parties it may engage in connection with discovery programs, research, development, regulatory, manufacturing, quality assurance and other pharmaceutical functions and commercialization may engage in misconduct or other improper activities, including non-compliance with regulatory standards and requirements and insider trading, which could cause significant liability for Carisma and harm its reputation.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma is exposed to the risk of fraud or other misconduct by its employees, independent contractors, including principal investigators, consultants and vendors and any other third parties it engages. Misconduct by these parties could include intentional, reckless or negligent conduct or unauthorized activities that include failures to comply with FDA regulations or similar regulations of comparable foreign regulatory authorities, provide complete and accurate information to the FDA or comparable foreign regulatory authorities, comply with manufacturing standards, comply with federal and state data privacy, security, fraud and other healthcare fraud and abuse laws and regulations and similar laws and regulations established and enforced by comparable foreign regulatory authorities, report complete financial information or data accurately or disclose unauthorized activities to Carisma. Misconduct by employees and other third parties could also involve the improper use of information obtained in the course of clinical trials, which could result in regulatory sanctions and serious harm to Carisma&#8217;s reputation. This could include violations of HIPAA, other U.S. federal and state law, and requirements of non-U.S. jurisdictions, including the European Union Data Protection Directive. Carisma is also exposed to risks in connection with any insider trading violations by employees or others affiliated with Carisma. It is not always possible to identify and deter misconduct by employees and other third parties, and the precautions Carisma takes to detect and prevent this activity may not be effective in controlling unknown or unmanaged risks or losses or in protecting Carisma from governmental investigations or other actions or lawsuits stemming from a failure to be in compliance with such laws, standards, regulations, guidance or codes of conduct. Additionally, Carisma is subject to the risk that a person could allege such fraud or other misconduct, even if none occurred. If any such actions are instituted against Carisma, and it is not successful in defending itself or asserting its rights, those actions could have a significant impact on Carisma&#8217;s business and results of operations, including the imposition of significant civil, criminal and administrative penalties, damages, monetary fines, disgorgements, possible exclusion from participation in Medicare, Medicaid, other U.S. federal healthcare programs or healthcare programs in other jurisdictions, integrity oversight and reporting obligations to resolve allegations of non-compliance, individual imprisonment, other sanctions, contractual damages, reputational harm, diminished profits and future earnings, and curtailment of Carisma&#8217;s operations. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Risks Related to the Ownership of the Common Stock of the Combined Company</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The market price of the combined company&#8217;s common stock is expected to be volatile, and the market price of the combined company&#8217;s common stock may drop following the merger.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The market price of the combined company&#8217;s common stock following the merger could be subject to significant fluctuations. Some of the factors that may cause the market price of the combined company&#8217;s common stock to fluctuate include: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">results of clinical trials and pre-clinical studies of the combined company&#8217;s product candidates, or those of the combined company&#8217;s competitors or the combined company&#8217;s existing or future collaborators; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">failure to meet or exceed financial and development projections the combined company may provide to the public; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">113</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">failure to meet or exceed the financial and development projections of the investment community; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">if the combined company does not achieve the perceived benefits of the merger as rapidly or to the extent anticipated by financial or industry analysts; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">announcements of significant acquisitions, strategic collaborations, joint ventures or capital commitments by the combined company or its competitors; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">actions taken by regulatory agencies with respect to the combined company&#8217;s product candidates, clinical studies, manufacturing process or sales and marketing terms; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">disputes or other developments relating to proprietary rights, including patents, litigation matters, and the combined company&#8217;s ability to obtain patent protection for its technologies; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.09pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.09pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">additions or departures of qualified scientific and management personnel; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">significant lawsuits, including patent or stockholder litigation; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">if securities or industry analysts do not publish research or reports about the combined company&#8217;s business, or if they issue adverse or misleading opinions regarding its business and stock; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">changes in the market valuations of similar companies; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">general market or macroeconomic conditions or market conditions in the biopharmaceutical sector; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">sales of securities by the combined company or its stockholders in the future; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">if the combined company fails to raise an adequate amount of capital to fund its operations and continued development of its product candidates; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">trading volume of the combined company&#8217;s common stock; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">announcements by competitors of new commercial products, clinical progress or lack thereof, significant contracts, commercial relationships or capital commitments; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">adverse publicity relating to product candidates, including with respect to other products in such markets; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the introduction of technological innovations or new therapies that compete with the products and services of the combined company; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">period-to-period fluctuations in the combined company&#8217;s financial results. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Moreover, the stock markets in general have experienced substantial volatility that has often been unrelated to the operating performance of individual companies. These broad market fluctuations may also adversely affect the trading price of the combined company&#8217;s common stock. In addition, a recession, depression or other sustained adverse market event could materially and adversely affect the combined company&#8217;s business and the value of its common stock. In the past, following periods of volatility in the market price of a company&#8217;s securities, stockholders have often instituted class action securities litigation against such companies. Furthermore, market volatility may lead to increased shareholder activism if the combined company experiences a market valuation that activists believe is not reflective of its intrinsic value. Activist campaigns that contest or conflict with the combined company&#8217;s strategic direction or seek changes in the composition of its board of directors could have an adverse effect on the combined company&#8217;s operating results and financial condition. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The combined company will incur additional costs and increased demands upon management as a result of complying with the laws and regulations affecting public companies.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The combined company will incur significant legal, accounting and other expenses as a public company that Carisma did not incur as a private company, including costs associated with public company reporting obligations under the Exchange Act. The combined company&#8217;s management team will consist of the executive officers of Carisma prior to the merger, some of whom have not previously managed and operated a public company. These executive officers and other personnel will need to devote substantial time to gaining expertise related to public company reporting requirements and compliance with applicable laws and </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">114</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">regulations to ensure that the combined company complies with all of these requirements. Any changes the combined company makes to comply with these obligations may not be sufficient to allow it to satisfy its obligations as a public company on a timely basis, or at all. These reporting requirements, rules and regulations, coupled with the increase in potential litigation exposure associated with being a public company, could also make it more difficult for the combined company to attract and retain qualified persons to serve on the board of directors or on board committees or to serve as executive officers, or to obtain certain types of insurance, including directors&#8217; and officers&#8217; insurance, on acceptable terms. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Once the combined company is no longer a &#8220;smaller reporting company&#8221; or otherwise no longer qualifies for applicable exemptions, the combined company will be subject to additional laws and regulations affecting public companies that will increase the combined company&#8217;s costs and the demands on management and could harm the combined company&#8217;s operating results.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The combined company will be subject to the reporting requirements of the Exchange Act, which requires, among other things, that the combined company file with the SEC annual, quarterly and current reports with respect to the combined company&#8217;s business and financial condition as well as other disclosure and corporate governance requirements. However, as a &#8220;smaller reporting company,&#8221; as defined in Item&#160;10(f)(1) of Regulation&#160;S-K, the combined company may take advantage of certain exemptions from disclosure requirements, including not being required to comply with the auditor attestation requirements of Section&#160;404 of the Sarbanes-Oxley Act of 2022 and reduced disclosure obligations regarding executive compensation in the combined company&#8217;s periodic reports and proxy statements. Once the combined company no longer qualifies as a smaller reporting company or otherwise no longer qualifies for these exemptions, the combined company will be required to comply with these additional legal and regulatory requirements applicable to public companies and will incur significant legal, accounting and other expenses to do so. If the combined company is not able to comply with the requirements in a timely manner or at all, the combined company&#8217;s financial condition or the market price of the combined company&#8217;s common stock may be harmed. For example, if the combined company or its independent auditor identifies deficiencies in the combined company&#8217;s internal control over financial reporting that are deemed to be material weaknesses, then the combined company could face additional costs to remedy those deficiencies, the market price of the combined company&#8217;s stock could decline or the combined company could be subject to sanctions or investigations by the SEC or other regulatory authorities, which would require additional financial and management resources. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Provisions that will be in the combined company&#8217;s certificate of incorporation and bylaws and provisions under Delaware law could make an acquisition of the combined company, which may be beneficial to its stockholders, more difficult and may prevent attempts by its stockholders to replace or remove its management.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If the merger is completed, the Sesen Bio Bylaws and the Sesen Bio Certificate of Incorporation, as amended by the amendment thereto attached to this proxy statement/prospectus as </font><font style="font-style:italic;letter-spacing:0.2pt;">Annex G</font><font style="letter-spacing:0.2pt;">, assuming Proposal No. 2 is approved by Sesen Bio stockholders at the Sesen Bio special meeting, will become the combined company&#8217;s certificate of incorporation and bylaws. Provisions that will be included in the combined company&#8217;s certificate of incorporation and bylaws may discourage, delay or prevent a merger, acquisition or other change in control of the combined company that stockholders may consider favorable, including transactions in which its common stockholders might otherwise receive a premium price for their shares. These provisions could also limit the price that investors might be willing to pay in the future for shares of the combined company&#8217;s common stock, thereby depressing the market price of its common stock. In addition, because the combined company&#8217;s board of directors will be responsible for appointing the members of the combined company&#8217;s management team, these provisions may frustrate or prevent any attempts by the combined company&#8217;s stockholders to replace or remove its current management by making it more difficult for stockholders to replace members of the combined company&#8217;s board of directors. Among other things, these provisions: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">establish a classified board of directors such that only one of three classes of directors is elected each year; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">allow the authorized number of the combined company&#8217;s directors to be changed only by resolution of its board of directors; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">115</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">limit the manner in which stockholders can remove directors from the combined company&#8217;s board of directors; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">establish advance notice requirements for stockholder proposals that can be acted on at stockholder meetings and for nominations to the combined company&#8217;s board of directors; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">limit who may call stockholder meetings; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">prohibit actions by the combined company&#8217;s stockholders by written consent; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">require that stockholder actions be effected at a duly called stockholders meeting; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">authorize the combined company&#8217;s board of directors to issue preferred stock without stockholder approval, which could be used to institute a &#8220;poison pill&#8221; that would work to dilute the stock ownership of a potential hostile acquirer, effectively preventing acquisitions that have not been approved by the combined company&#8217;s board of directors; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">require the approval of the holders of at least 75% of the votes that all combined company stockholders would be entitled to cast to amend or repeal certain provisions of the combined company&#8217;s certificate of incorporation or bylaws. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Moreover, because the combined company is incorporated in Delaware, it is governed by the provisions of Section&#160;203 of the DGCL which prohibits a person who owns 15% or more of the combined company&#8217;s outstanding voting stock from merging or combining with the combined company for a period of three&#160;years after the date of the transaction in which the person acquired 15% or more of the combined company&#8217;s outstanding voting stock, unless the merger or combination is approved in a manner prescribed by the statute. For more information about provisions that will be included in the combined company&#8217;s certificate of incorporation and bylaws, see the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Comparison of Rights of Holders of Sesen Bio Stock and Carisma Stock</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tCORO">386</a> of this proxy statement/prospectus. </font>
          </div>

        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">An active trading market for the combined company&#8217;s common stock may not develop and its stockholders may not be able to resell their shares of common stock for a profit, if at all.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Prior to the merger, there had been no public market for shares of Carisma capital stock. An active trading market for the combined company&#8217;s shares of common stock may never develop or be sustained. If an active market for the combined company&#8217;s common stock does not develop or is not sustained, it may be difficult for its stockholders to sell their shares at an attractive price or at all. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">After completion of the merger, the combined company&#8217;s executive officers, directors and principal stockholders will have the ability to control or significantly influence all matters submitted to the combined company&#8217;s stockholders for approval.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Upon the completion of the merger, and giving effect to the issuance of the shares of common stock of Carisma prior to the closing of the merger pursuant to the Carisma pre-closing financing and the conversion of Carisma&#8217;s $35.0&#160;million outstanding convertible note, it is anticipated that the combined company&#8217;s executive officers, directors and principal stockholders will, in the aggregate, beneficially own approximately 56.94% of the combined company&#8217;s outstanding shares of common stock, subject to certain assumptions, including, but not limited to, Sesen Bio&#8217;s net cash as of closing being at least $75.0&#160;million. As a result, if these stockholders were to choose to act together, they would be able to control or significantly influence all matters submitted to the combined company&#8217;s stockholders for approval, as well as the combined company&#8217;s management and affairs. For example, these persons, if they choose to act together, would control or significantly influence the election of directors and approval of any merger, consolidation or sale of all or substantially all of the combined company&#8217;s assets. This concentration of voting power could delay or prevent an acquisition of the combined company on terms that other stockholders may desire. </font>
          </div>

        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If equity research analysts do not publish research or reports, or publish unfavorable research or reports, about the combined company, its business or its market, its stock price and trading volume could decline.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The trading market for the combined company&#8217;s common stock will be influenced by the research and reports that equity research analysts publish about it and its business. Equity research analysts may elect not </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">116</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:112pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">to provide research coverage of the combined company&#8217;s common stock after the completion of the merger, and such lack of research coverage may adversely affect the market price of its common stock. In the event it does have equity research analyst coverage, the combined company will not have any control over the analysts or the content and opinions included in their reports. The price of the combined company&#8217;s common stock could decline if one or more equity research analysts downgrade its stock or issue other unfavorable commentary or research. If one or more equity research analysts ceases coverage of the combined company or fails to publish reports on it regularly, demand for its common stock could decrease, which in turn could cause its stock price or trading volume to decline. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The combined company will have broad discretion in the use of the cash and cash equivalents of the combined company as well as the proceeds from the Carisma pre-closing financing and may invest or spend the proceeds in ways with which you do not agree and in ways that may not increase the value of your investment.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The combined company will have broad discretion over the use of the cash and cash equivalents of the combined company and the proceeds from the Carisma pre-closing financing. You may not agree with the combined company&#8217;s decisions, and its use of the proceeds may not yield any return on your investment. The combined company&#8217;s failure to apply these resources effectively could compromise its ability to pursue its growth strategy and the combined company might not be able to yield a significant return, if any, on its investment of these net proceeds. You will not have the opportunity to influence the combined company&#8217;s decisions on how to use its cash resources. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If Sesen Bio fails to consummate a strategic transaction with respect to Vicineum, the combined company will be responsible for unwinding related contractual relationships, which may adversely impact the business, financial condition and results of operations of the combined company following the merger.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On July 15, 2022, Sesen Bio made the strategic decision to voluntarily pause further development of Vicineum in the U.S. The decision was based on a thorough reassessment of Vicineum, which included the incremental development timeline and associated costs for an additional Phase 3 clinical trial, following Sesen Bio&#8217;s discussions with the FDA. If the merger is consummated, the combined company does not expect to pursue further development of Vicineum for the treatment of NMIBC. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="font-style:normal;letter-spacing:0.2pt;">Although Sesen Bio is seeking to consummate a strategic transaction with respect to Vicineum and has engaged a financial advisor for the potential sale of Vicineum, in the event that a transaction is delayed or does not occur, the combined company will be responsible for unwinding contractual relationships related to Vicineum, which could divert the attention of the management teams and employees of the combined company from day-to-day business, result in liability, impose additional costs and otherwise adversely affect the business and financial condition of the combined company. The combined company may also experience the same risks related to disagreements and disputes with certain licensees, licensors and other counterparties as discussed above in &#8220;</font><font style="letter-spacing:0.2pt;">Risk Factors&#8201;&#8212;&#8201;Risks Related to the Merger&#8201;&#8212;&#8201;In connection with Sesen Bio&#8217;s strategic decision to voluntarily pause further development of Vicineum in the United States, Sesen Bio may become involved in disagreements or disputes with its licensees, licensors and other counterparties relating to the development and/or commercialization of Vicineum, which may be time consuming, costly and could divert its efforts and attention from consummating the merger and harm Sesen Bio&#8217;s efforts to seek a partner to continue development of Vicineum</font><font style="font-style:normal;letter-spacing:0.2pt;">.&#8221; </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">117</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tCSCF">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CAUTIONARY STATEMENT CONCERNING FORWARD-LOOKING STATEMENTS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">This proxy statement/prospectus contains forward-looking statements (including within the meaning of Section&#160;21E of the Exchange Act and Section&#160;27A of the Securities Act) concerning, among other things, the following: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.3pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the expected benefits of, and potential value created by, the merger for the Sesen Bio stockholders and Carisma stockholders; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.3pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the likelihood of the satisfaction of certain conditions to the completion of the merger and whether and when the merger will be completed and the listing of the Sesen Bio common stock to be issued on the Nasdaq Capital Market; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.29pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.29pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the expected amount of the Sesen Bio net cash on the anticipated closing date or the merger, or the closing date, and Sesen Bio&#8217;s ability to control and correctly estimate its operating expenses and its expenses associated with the merger; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.3pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the expected number of Sesen Bio securities included in the fully diluted number of outstanding shares of Sesen Bio common stock for purposes of calculating the exchange ratio; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.3pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">any statements regarding the CVRs to be granted to Sesen Bio stockholders, pursuant to the Merger Agreement and the CVR Agreement; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.3pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">any statements regarding the special cash dividend that Sesen Bio may pay to Sesen Bio stockholders in connection with the completion of the merger; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.3pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">any statements of the plans, strategies and objectives of management for future operations, including the execution of integration plans and the anticipated timing of filings; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.3pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">any statements of plans to develop and commercialize additional products candidates, including planned pre-clinical, clinical, regulatory and manufacturing activities; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.3pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">any statements concerning the attraction and retention of highly qualified personnel; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.3pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">any statements concerning the ability to protect and enhance the combined company&#8217;s product candidates and intellectual property; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.3pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">any statements concerning developments and projections relating to the combined company&#8217;s competitors or industry; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.29pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.29pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">any statements concerning the combined company&#8217;s projected financial performance; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.3pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">any statements regarding expectations concerning Sesen Bio&#8217;s or Carisma&#8217;s relationships and actions with third parties; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.3pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">future regulatory, judicial and legislative changes in Sesen Bio&#8217;s or Carisma&#8217;s industry. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">These forward-looking statements should not be relied upon as predictions of future events as Sesen Bio and Carisma cannot assure you that the events or circumstances reflected in these statements will be achieved or will occur. You can identify forward-looking statements by the use of forward-looking terminology including &#8220;believes,&#8221; &#8220;expects,&#8221; &#8220;may,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;seeks,&#8221; &#8220;intends,&#8221; &#8220;plans,&#8221; &#8220;pro&#160;forma,&#8221; &#8220;estimates,&#8221; or &#8220;anticipates&#8221; or the negative of these words and phrases or other variations of these words and phrases or comparable terminology. All statements other than statements of historical fact are statements that could be deemed forward-looking statements. The events and circumstances reflected in forward-looking statements may not be achieved or occur and actual results could differ materially from those contained in any forward-looking statement as a result of various factors, including, without limitation: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.3pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio stockholders and Carisma stockholders may not realize a benefit from the merger commensurate with the ownership dilution they will experience in connection with the merger, including the Carisma pre-closing financing, and the conversion of the Carisma convertible note; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the merger consideration may have greater or lesser value at the closing of the merger than at the time the Merger Agreement is signed; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">118</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">failure to complete the merger may result in either party paying a termination fee or expenses to the other party and could harm the future business and operations of the applicable company; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">if the conditions to the merger are not met, including failure to obtain stockholder approval for the merger, or failure to comply with the listing standards of Nasdaq, the merger may not occur; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the timing of the consummation of the merger is uncertain as is the ability of each of Sesen Bio and Carisma to consummate the merger; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the merger may be completed even though material adverse changes may occur; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio may not be able to correctly estimate its operating expenses and its expenses associated with the merger and may have a significantly lower net cash on the anticipated closing date than currently estimated; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio may not be able to maintain its Nasdaq listing until the closing of the merger; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">as a result of any adjustments in the exchange ratio, Sesen Bio stockholders or Carisma stockholders may own less of the combined company after the closing of the merger than is currently anticipated; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">executive officers and directors of each company have interests in the merger that are different from yours, which may cause them to support or approve the merger without regard to your interests; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.71pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.71pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the market price of combined company&#8217;s common stock may decline following the merger; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">conditions to payment under the CVRs may not be met and the CVRs may never deliver any value to the Sesen Bio stockholders; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">restrictions in the Merger Agreement may prevent Sesen Bio and Carisma from entering into a business combination with another party at a favorable price; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">certain provisions of the Merger Agreement may discourage third parties from submitting alternative takeover proposals, including proposals that may be superior to the arrangements contemplated by the Merger Agreement; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the Carisma stockholders may receive consideration in the merger that is greater or less than the fair market value of the Carisma shares due to the lack of a public market for Carisma shares; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">if the merger does not qualify as a tax-free reorganization for U.S. federal income tax purposes, the receipt of Sesen Bio common stock pursuant to the merger could be fully taxable to all Carisma stockholders; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the combined company may never earn a profit; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the combined company will be subject to the uncertainties associated with the clinical development and regulatory approval of its product candidates including potential delays in the commencement, enrollment and completion of clinical trials and that the results of prior clinical trials may not be predictive of future results; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.71pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.71pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the combined company will be required to raise additional funds to finance its operations and remain a going concern and may be required to do so sooner than it expects; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the combined company may not be able to raise additional funds when necessary, and/or on acceptable terms; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the combined company&#8217;s small public float, low market capitalization, limited operating history, and lack of revenue may make it difficult and expensive for the combined company to raise additional funds; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the pro&#160;forma combined financial statements may not be an indication of the combined company&#8217;s financial condition or results of operations following the completion of the merger and the transactions contemplated thereby; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio and Carisma may not be able to protect their respective intellectual property rights; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">there may be changes in expected or existing competition for the combined company&#8217;s product candidates; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">119</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:16pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the merger will result in changes to the combined company&#8217;s board of directors that may affect the combined company&#8217;s business strategy and operations; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">both companies expect that the price of the combined company&#8217;s common stock may be volatile and may fluctuate substantially following the merger and the transactions contemplated thereby; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">if the combined company were to be delisted from Nasdaq, it could reduce the visibility, liquidity and price of its common stock; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">a significant portion of the combined company&#8217;s total outstanding shares of common stock may be sold into the public market at any point, which could cause the market price of the combined company&#8217;s common stock to drop significantly, even if the combined company is doing well; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">there may be adverse reactions or changes in business relationships resulting from announcement or completion of the merger; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the combined company will have broad discretion in the use of its cash reserves and may not use them effectively; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the combined company expects to continue to incur increased costs as a result of operating as a public company, and its management will be required to devote substantial time to compliance initiatives and corporate governance practices; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the combined company does not anticipate paying any cash dividends on its capital stock in the foreseeable future, other than the special cash dividend that Sesen Bio may pay to Sesen Bio stockholders in connection with the consummation of the merger; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">provisions in the combined company&#8217;s certificate of incorporation, its bylaws or Delaware law might discourage, delay or prevent a change in control of the company or changes in its management, which may depress the price of its common stock; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the COVID-19 pandemic may have an adverse effect on the business of Sesen Bio, Carisma and the combined company, the medical community and the global economy; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">securities analysts&#8217; published reports could cause a decline in the price of the combined company&#8217;s stock. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">The foregoing risks should not be construed as exhaustive and should be read in conjunction with statements that are included herein and elsewhere. Sesen Bio and Carisma can give no assurance that the conditions to the merger will be satisfied. For further discussion of the factors that may cause Sesen Bio, Carisma or the combined company&#8217;s actual results, performance or achievements to differ materially from any future results, performance or achievements expressed or implied in such forward-looking statements, or for a discussion of risks associated with the ability of Sesen Bio and Carisma to complete the merger and the effect of the merger on the business of Sesen Bio, Carisma and the combined company, see the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Risk Factors</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tRIFA">26</a> of this proxy statement/prospectus. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Additional factors that could cause actual results to differ materially from those expressed in the forward-looking statements are discussed in reports filed with the SEC by Sesen Bio. See the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Where You Can Find More Information</font><font style="letter-spacing:0.2pt;">&#8221; on page <a href="#tWYCF">404</a> of this proxy statement/prospectus. </font>
          </div>

        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If any of these risks or uncertainties materialize or any of these assumptions prove incorrect, the results of operations of Sesen Bio, Carisma or the combined company could differ materially from the forward-looking statements. All forward-looking statements in this proxy statement/prospectus are current only as of the date of this proxy statement/prospectus. Sesen Bio and Carisma do not undertake any obligation to publicly update any forward-looking statement to reflect events or circumstances after the date on which any statement is made, the occurrence of unanticipated events or any new information that becomes available in the future.</font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">120</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tTSMO">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">THE SPECIAL MEETING OF SESEN BIO STOCKHOLDERS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Date, Time and Place</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">The Sesen Bio special meeting will be held on &#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;, 2023, at &#8199;&#8199;&#8199;&#8199; commencing at &#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;, Eastern Time, which will be a virtual meeting held exclusively via live webcast. Sesen Bio is sending this proxy statement/prospectus to Sesen Bio stockholders in connection with the solicitation of proxies by the Sesen Bio board of directors for use at the Sesen Bio special meeting and any adjournments or postponements of the Sesen Bio special meeting. This proxy statement/prospectus is first being furnished to Sesen Bio stockholders on or about &#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199; &#8199;&#8199;, 2023. </font>
          </div>

        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Purposes of the Sesen Bio Special Meeting</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The purposes of the Sesen Bio special meeting are: </font>
        </div>

          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">1.</font>
            <br >
          </div>
          <div style=" margin-top:7.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
            <font style="letter-spacing:0.2pt;">to consider and vote upon a proposal to approve, for purposes of Nasdaq Listing Rule&#160;5635(a) and (b), the issuance of shares of Sesen Bio common stock to Carisma stockholders pursuant to the terms of the Original Merger Agreement, as amended by the Merger Agreement Amendment, copies of which are attached as </font><font style="font-style:italic;letter-spacing:0.2pt;">Annexes A-1 and A-2</font><font style="letter-spacing:0.2pt;">, respectively, to this proxy statement/</font>&#8203;<font style="letter-spacing:0.2pt;">prospectus, and the change of control of Sesen Bio resulting from the merger; </font></div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.71pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">2.</font>
          <br >
        </div>
        <div style=" margin-top:7.71pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:0.2pt;">to consider and vote upon a proposal to approve an amendment to the Sesen Bio Certificate of Incorporation, to (a) effect a reverse stock split of the issued and outstanding shares of Sesen Bio common stock at a ratio of 1-for-20, with the implementation and timing of the reverse stock split to be determined in the discretion of the Sesen Bio board of directors and as agreed to by Carisma at or prior to the closing of the merger, or in the sole discretion of the Sesen Bio board of directors if Proposal No. 1 is not approved, and (b) if and when the reverse stock split is effected, reduce the number of authorized shares of Sesen Bio common stock, in the form attached as </font><font style="font-style:italic;letter-spacing:0.2pt;">Annex G</font><font style="letter-spacing:0.2pt;"> to this proxy statement/prospectus; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">3.</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:0.2pt;">to consider and vote upon a proposal to approve an amendment and restatement of the 2014 Incentive Plan to, among other things, (a)&#160;increase the number of shares of Sesen Bio common stock reserved for issuance under the 2014 Incentive Plan, and (b)&#160;extend the term of the 2014 Incentive Plan to the tenth (10</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">th</font><font style="letter-spacing:0.2pt;">) anniversary of the closing of the merger; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">4.</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:0.2pt;">to consider and vote upon a proposal to approve an amendment to the 2014 ESPP to increase the number of shares of Sesen Bio common stock reserved for issuance under the 2014 ESPP to 6,568,655 shares of Sesen Bio common stock; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">5.</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:0.2pt;">to consider and vote upon a proposal to approve an adjournment of the Sesen Bio special meeting, if necessary, to solicit additional proxies if there are not sufficient votes in favor of Proposal Nos. 1 or 2; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">6.</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:0.2pt;">to transact such other business as may properly come before the Sesen Bio special meeting or any adjournment or postponement thereof. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Recommendation of the Sesen Bio Board of Directors</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">The Sesen Bio board of directors has determined and believes that it is fair to, advisable and in the best interests of Sesen Bio and Sesen Bio stockholders to approve, for purposes of Nasdaq Listing Rule&#160;5635(a) and (b), the issuance of shares of Sesen Bio common stock to Carisma stockholders pursuant to the terms of the Merger Agreement and has approved such proposal. The Sesen Bio board of directors unanimously recommends that Sesen Bio stockholders vote &#8220;FOR&#8221; Proposal No.&#160;1 to approve, for purposes of Nasdaq Listing Rule&#160;5635(a) and (b), the issuance of shares of Sesen Bio common stock to Carisma stockholders in connection with the merger pursuant to the terms of the Merger Agreement. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">The Sesen Bio board of directors has determined and believes that it is fair to, advisable and in the best interests of Sesen Bio and Sesen Bio stockholders to approve the amendment to the Sesen Bio Certificate of Incorporation to effect the reverse stock split and reduce the authorized shares of Sesen </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">121</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:30pt; width:426pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Bio common stock, as described in this proxy statement/prospectus and has approved the amendment to the Sesen Bio Certificate of Incorporation to effect the reverse stock split and has approved such proposal. The Sesen Bio board of directors unanimously recommends that Sesen Bio stockholders vote &#8220;FOR&#8221; Proposal No. 2 to approve the amendment to the Sesen Bio Certificate of Incorporation to effect the reverse stock split, as described in this proxy statement/prospectus. </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">The Sesen Bio board of directors has determined and believes that it is fair to, advisable and in the best interests of Sesen Bio and Sesen Bio stockholders to approve the amendment and restatement of the 2014 Incentive Plan, as described in this proxy statement/prospectus. The Sesen Bio board of directors unanimously recommends that Sesen Bio stockholders vote &#8220;FOR&#8221; Proposal No. 3 to approve the amendment and restatement of the 2014 Incentive Plan, as described in this proxy statement/prospectus. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">The Sesen Bio board of directors has determined and believes that it is fair to, advisable and in the best interests of Sesen Bio and Sesen Bio stockholders to approve the amendment to the 2014 ESPP, as described in this proxy statement/prospectus. The Sesen Bio board of directors unanimously recommends that Sesen Bio stockholders vote &#8220;FOR&#8221; Proposal No. 4 to approve the amendment to the 2014 ESPP, as described in this proxy statement/prospectus. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">The Sesen Bio board of directors has determined and believes that it is fair to, advisable, and in the best interests of Sesen Bio and Sesen Bio stockholders to approve the adjournment of the Sesen Bio special meeting, if necessary, to solicit additional proxies if there are not sufficient votes in favor of Proposal Nos. 1 or 2 and has approved such proposal. The Sesen Bio board of directors unanimously recommends that Sesen Bio stockholders vote &#8220;FOR&#8221; Proposal No. 5 to adjourn the Sesen Bio special meeting, if necessary, to solicit additional proxies if there are not sufficient votes in favor of Proposal Nos. 1 or 2. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Record Date and Voting Power</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Only holders of record of Sesen Bio common stock at the close of business on the record date, &#8199;&#8199;&#8199;&#8199;&#8199;&#8199;, 2023, are entitled to notice of, and to vote at, the Sesen Bio special meeting. There were &#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199; holders of record of Sesen Bio common stock at the close of business on the record date. At the close of business on the record date, &#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199; shares of Sesen Bio common stock were issued and outstanding. Each share of Sesen Bio common stock entitles the holder thereof to one vote on each matter submitted for stockholder approval. </font>
          </div>

        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Voting and Revocation of Proxies</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The proxy accompanying this proxy statement/prospectus is solicited on behalf of the Sesen Bio board of directors for use at the Sesen Bio special meeting. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If you are the &#8220;record holder&#8221; of your shares, meaning that you own your shares in your own name and not through a broker, bank or other nominee, you may vote in one of three ways prior to the Sesen Bio special meeting: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">You may vote over the internet.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;You may vote your shares by following the instructions in the enclosed proxy card. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">You may vote by telephone.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;You may vote your shares by following the instructions in the enclosed proxy card. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">You may vote by mail.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;You may vote by completing, dating and signing the enclosed proxy card and promptly mailing it in the postage-paid envelope provided. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">You may also vote during the Sesen Bio special meeting. To be admitted to the Sesen Bio special meeting and vote your shares, you must register in advance at www.&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199; and provide the control number as set forth on the proxy card. After completing your registration, you will receive further instructions via email, including a unique link to access the Sesen Bio special meeting. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">All proxies that are executed or are otherwise submitted over the internet or by telephone will be voted on the matters set forth in this proxy statement in accordance with the stockholders&#8217; instructions. However, </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">122</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11pt;">
          <font style="letter-spacing:0.2pt;">if no choice is specified on a proxy as to one or more of the proposals, the proxy will be voted in accordance with the Sesen Bio board of directors&#8217; recommendations on such proposals as set forth in this proxy statement/prospectus. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11pt;">
          <font style="letter-spacing:0.2pt;">After you have submitted a proxy, you may still change your vote and revoke your proxy by doing any one of the following things: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.41pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.41pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">submitting a new proxy via the internet or telephone by following the instructions on the enclosed proxy card; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.4pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">signing another proxy card and arranging for delivery of that proxy card by mail by 11:59&#160;p.m., Eastern Time, the day before the Sesen Bio special meeting; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.4pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">giving Sesen Bio&#8217;s Corporate Secretary a written notice before the Sesen Bio special meeting that you want to revoke your proxy; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.41pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.41pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">voting during the Sesen Bio special meeting. Your attendance at the Sesen Bio special meeting alone will not revoke a previously submitted proxy. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio will count your vote in accordance with the last instruction Sesen Bio receives from you prior to the closing of the polls, whether your instruction is received by internet, telephone, mail, or at the Sesen Bio special meeting. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Shares Held in &#8220;Street Name&#8221;</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11pt;">
          <font style="letter-spacing:0.2pt;">If the shares of Sesen Bio common stock you own are held in &#8220;street name&#8221; by a broker, bank or other nominee, then that broker, bank or other nominee, as the record holder of your shares of Sesen Bio common stock, is required to vote your shares of Sesen Bio common stock according to your instructions. In order to vote your shares of Sesen Bio common stock, change your vote or revoke your instructions, you will need to follow the directions your broker, bank or other nominee provides you. Many brokers, banks or other nominees also offer the option of providing for voting over the internet or by telephone, instructions for which, if available, would be provided by such broker, bank or other nominee on the voting instruction form that it delivers to you. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If you do not give instructions to your broker, bank or other nominee, such nominee can vote your shares of Sesen Bio common stock with respect to &#8220;discretionary&#8221; items but not with respect to &#8220;non-discretionary&#8221; items. Discretionary items are proposals considered routine under certain rules applicable to brokers and on which your broker may vote shares of Sesen Bio common stock held in &#8220;street name&#8221; in the absence of your voting instructions. On non-discretionary items for which you do not give your broker instructions, your shares of Sesen Bio common stock will be treated as broker non-votes. It is anticipated that Proposal Nos. 1, 3 and 4 will be non-discretionary. To make sure that your vote is counted, you should instruct your broker to vote your shares, following the procedures provided by the institution that holds your shares. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If your shares are held in &#8220;street name,&#8221; you are also invited to attend and vote your shares of Sesen Bio common stock at the Sesen Bio special meeting live via webcast. After completing your registration in advance at www.&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;, you will receive further instructions via email, including a unique link to access the Sesen Bio special meeting. As part of the registration process, you must enter the control number located on your voting instruction form. You will also need to provide the registered name on your account and the name of your broker, bank or other nominee as part of the registration process. You may be instructed to obtain a legal proxy from your broker, bank or nominee and to submit a copy in advance of the meeting. Further instructions will be provided to you as part of your registration process. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If your shares of Sesen Bio common stock are held in &#8220;street name,&#8221; you must follow the instructions provided by your broker, bank or other nominee to revoke your voting instructions, or, if you have obtained a legal proxy to vote your shares of Sesen Bio common stock at the Sesen Bio special meeting, by attending the Sesen Bio special meeting and voting. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Required Vote</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The presence, in person or represented by proxy, of Sesen Bio stockholders holding at least a majority in voting power of the shares of Sesen Bio common stock issued and outstanding and entitled to vote at the </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">123</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:176pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio special meeting is necessary to constitute a quorum at the Sesen Bio special meeting. Abstentions and broker non-votes will be treated as shares present for the purpose of determining the presence of a quorum for the transaction of business at the Sesen Bio special meeting. Approval of Proposal Nos. 1, 3, 4 and 5 requires the affirmative vote of a majority in voting power of the votes cast by the holders of all shares of Sesen Bio common stock present or represented by proxy at the Sesen Bio special meeting and entitled to vote on the matter. Approval of Proposal No. 2 requires the affirmative vote of the holders of a majority of the outstanding shares of Sesen Bio common stock entitled to vote on the record date for the Sesen Bio special meeting. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Votes will be counted by the inspector of election appointed for the Sesen Bio special meeting, who will separately count &#8220;FOR&#8221; and &#8220;AGAINST&#8221; votes, abstentions and broker non-votes. Abstentions will have the same effect as a vote &#8220;AGAINST&#8221; Proposal No. 2, but will have no effect on the outcome of Proposal Nos.&#160;1, 3, 4 and 5. Proposal Nos. 2 and 5 are matters on which Sesen Bio expects brokers, banks or other nominees to have discretionary authority to vote uninstructed shares and, therefore, broker non votes are not expected with respect to these proposals. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Proposal No. 1 is conditioned upon the approval of Proposal No. 2, and the merger cannot be consummated without the approval of Proposal Nos. 1 and 2. Proposal Nos. 3 and 4 are conditioned upon Proposal Nos. 1 and 2. Proposal No. 2 is not conditioned on the approval of any other proposal. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Solicitation of Proxies</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In addition to solicitation by mail, the directors, officers, employees and agents of Sesen Bio and Carisma may solicit proxies from Sesen Bio stockholders by personal interview, telephone or otherwise. Sesen Bio and Carisma will share equally the cost of printing and filing this proxy statement/prospectus and the proxy card. Sesen Bio also may be required to reimburse brokers, banks and other custodians, nominees and fiduciaries or their respective agents for reasonable expenses incurred in forwarding proxy materials to beneficial owners of Sesen Bio common stock. Sesen Bio has engaged MacKenzie Partners to assist in the solicitation of proxies and provide related advice and informational support. Sesen Bio will pay the fees of MacKenzie Partners, which Sesen Bio expects to be approximately $&#8199;&#8199;&#8199;&#8199;, plus reimbursement of out-of-pocket expenses. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Other Matters</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As of the date of this proxy statement/prospectus, the Sesen Bio board of directors does not know of any business to be presented at the Sesen Bio special meeting other than as set forth in the notice accompanying this proxy statement/prospectus. If any other matters should properly come before the Sesen Bio special meeting, it is intended that the shares of Sesen Bio common stock represented by proxies will be voted with respect to such matters in accordance with the judgment of the persons voting the proxies. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">124</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tTHME">&#8203;</a><a name="tBOTM">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">THE MERGER</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;font-style:italic;">
            <font style="letter-spacing:0.2pt;">This section and the section entitled &#8220;The Merger Agreement&#8221; in this proxy statement/prospectus describe the material aspects of the merger, including the Merger Agreement. While Sesen Bio and Carisma believe that this description covers the material terms of the merger and the Merger Agreement, it may not contain all of the information that is important to you. You should read carefully this entire proxy statement/prospectus for a more complete understanding of the merger and the Merger Agreement, including the Original Merger Agreement, as amended by the Merger Agreement Amendment, attached as Annexes A-1 and A-2, respectively, the opinion of SVB Securities attached as Annex B, and the other documents to which you are referred herein. See the section entitled &#8220;Where You Can Find More Information&#8221; on page <a href="#tWYCF">404</a> of this proxy statement/prospectus. </font>
          </div>

        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Background of the Merger</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In an effort to enhance stockholder value, the Sesen Bio board of directors, in consultation with members of the Sesen Bio management team, regularly reviews and discusses Sesen Bio&#8217;s near and long-term operating and strategic priorities. Among other things, these reviews and discussions focus on the opportunities and risks associated with Sesen Bio&#8217;s development programs, financial condition and its strategic relationships and potential long-term strategic options. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On April&#160;22, 2022, the Sesen Bio board of directors held a meeting at which members of Sesen Bio management, Michael O&#8217;Donnell, M.D., regulatory consultant to Sesen Bio, Neal D. Shore, M.D., FACS, clinical consultant to Sesen Bio, and a representative of Hogan Lovells, Sesen Bio&#8217;s outside legal counsel, were present. During the meeting, Dr.&#160;O&#8217;Donnell and Dr.&#160;Shore reviewed, among other things, the potential trial size scenarios for an additional Phase&#160;3 clinical trial for Vicineum, which the FDA previously confirmed would be required for a potential resubmission of a BLA. A discussion ensued regarding Sesen Bio&#8217;s cash runway and potential financing needs and the commercial viability of Vicineum if Sesen Bio conducted a successful clinical trial. Sesen Bio management discussed strategic alternatives for Sesen Bio, including conducting an additional Phase&#160;3 clinical trial for Vicineum, exploring a potential strategic transaction, and acquiring a new product. Monica Forbes, Sesen Bio&#8217;s Chief Financial Officer, discussed the estimated financial impacts of an additional Phase&#160;3 clinical trial for Vicineum, including the estimated time to achieve profitability and the need for additional financing to achieve profitability, with the estimated growth in Sesen Bio value barely outpacing the estimated dilution to existing stockholders. A discussion ensued regarding the process and timeline for conducting an additional Phase&#160;3 clinical trial for Vicineum, the financial impacts of the additional Phase&#160;3 clinical trial and whether other companies would be interested in a strategic acquisition of Vicineum. Following discussion, the Sesen Bio board of directors authorized and directed Sesen Bio management to continue planning for an additional Phase&#160;3 clinical trial for Vicineum and indicated that it would evaluate whether to conduct an additional Phase&#160;3 clinical trial in the third quarter of 2022 following an anticipated June&#160;2022 meeting with the FDA. Erin Clark, Sesen Bio&#8217;s Vice President of Corporate Strategy and Investor Relations, reviewed next steps for exploring a potential strategic alternative transaction, including the engagement of a financial advisor, and a possible timeline for a strategic alternative review process. Ms.&#160;Clark also discussed that Sesen Bio management would assess the feasibility of acquiring a new product and prepare a recommendation for the Sesen Bio board of directors to consider. Following further discussion, the Sesen Bio board of directors authorized Sesen Bio management to evaluate potential strategic alternatives, including (i)&#160;conducting an additional Phase&#160;3 clinical trial for Vicineum, (ii)&#160;exploring a potential strategic transaction, and (iii)&#160;acquiring a new product, in order to maximize value for Sesen Bio&#8217;s stockholders. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Following the April&#160;22, 2022 board meeting, Sesen Bio management thoroughly evaluated four highly-qualified financial advisors, including SVB Securities. Sesen Bio management provided a summary of its evaluation and made a recommendation to the Sesen Bio board of directors. On May&#160;2, 2022, the Sesen Bio board of directors authorized by unanimous written consent the engagement of SVB Securities to serve as Sesen Bio&#8217;s financial advisor in connection with a process to review potential strategic alternative transactions based on, among other factors, the qualifications, professional reputation and industry expertise of SVB Securities. This engagement was memorialized in an engagement letter, dated May&#160;6, 2022, between Sesen Bio and SVB Securities. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On May&#160;3, 2022, following the approval of the Sesen Bio board of directors to engage SVB Securities to serve as Sesen Bio&#8217;s financial advisor in connection with a process to review potential strategic alternative </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">125</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">transactions, Sesen Bio announced that it initiated a process to evaluate potential strategic alternatives with the goal of maximizing stockholder value. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On May&#160;9, 2022, the Sesen Bio board of directors held a meeting by videoconference at which members of Sesen Bio management and representatives of SVB Securities and Hogan Lovells were present. During the meeting, Dr.&#160;Rachelle Dillon, Ph.D., Sesen Bio&#8217;s Executive Director of Clinical Operations, provided a summary of Sesen Bio&#8217;s activities in planning for an additional Phase&#160;3 clinical trial for Vicineum. In addition, at the meeting, representatives of SVB Securities reviewed potential strategic alternative transactions for Sesen Bio. Representatives of SVB Securities and Ms.&#160;Clark reviewed the status of the identification of potential counterparties for a strategic transaction, the proposed timeline for a potential strategic transaction and estimated wind-down costs in the event of a strategic transaction. A discussion ensued regarding potential strategic alternatives for Sesen Bio. Sesen Bio management discussed with the Sesen Bio board of directors potential ways to monetize potential milestone payments remaining under a 2016 license agreement with Roche, pursuant to which Sesen Bio had granted Roche an exclusive, worldwide license to develop and commercialize all patent rights and know-how related to the legacy IL-6 program, or the Roche licensed intellectual property, and had received $42.5&#160;million in milestone payments to date. The Sesen Bio board of directors authorized Sesen Bio management to pursue a potential transaction with Roche related to the Roche licensed intellectual property. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On May&#160;11, 2022, Sesen Bio management updated the Sesen Bio board of directors on discussions with senior management at Roche, who requested a formal proposal for a potential transaction related to the Roche licensed intellectual property. Sesen Bio management provided proposed terms for a potential transaction with Roche for the Sesen Bio board of directors&#8217; review and consideration. Subsequently, Sesen Bio management engaged in negotiations with Roche for a potential transaction related to the Roche licensed intellectual property. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On May&#160;25, 2022, the Sesen Bio board of directors held a meeting by videoconference at which members of Sesen Bio management and representatives of Hogan Lovells were present. Members of Sesen Bio management provided an update on Sesen Bio&#8217;s activities in planning for an additional Phase&#160;3 clinical trial. Members of Sesen Bio management also provided an overview of the strategic alternative review process, including the proposed selection methodology and key evaluation criteria for identifying potential counterparties for a strategic transaction. A discussion ensued regarding strategic considerations for pursuing the additional Phase&#160;3 clinical trial or a strategic alternative transaction. Sesen Bio&#8217;s non-employee directors also met in executive session with a representative of Hogan Lovells to discuss a potential conflict of interest of a Sesen Bio director affiliated with a potential counterparty for a strategic transaction. All non-employee directors, including the director with a potential conflict of interest, agreed that the director would be recused from discussions of the strategic alternative review process until the potential conflict of interest no longer exists. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">During May&#160;2022, at the direction of Sesen Bio following approvals from the Sesen Bio board of directors at the meeting held on April&#160;22, 2022 and by unanimous written consent of the Sesen Bio board of directors on May&#160;2, 2022, SVB Securities contacted 130 companies to determine the level of interest in a potential strategic transaction with Sesen Bio. Of those companies, 62 expressed interest in the strategic alternative review process and, at the direction of Sesen Bio, SVB Securities requested that such companies submit non-binding indications of interest. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">From May&#160;18, 2022 to June&#160;7, 2022, 42 companies submitted non-binding indications of interest with respect to a potential strategic transaction with Sesen Bio based on publicly available information, including indications from Carisma and the companies referred to as Party A, Party B, Party C and Party D, as described below: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">The indication of interest from Carisma proposed a reverse merger transaction with an ascribed value of Sesen Bio of $110.0&#160;million (assuming closing net cash of $100.0&#160;million) and an ascribed value of Carisma of $196.0&#160;million, with an implied ownership interest in the combined company of approximately 30.0% for existing Sesen Bio stockholders. Carisma&#8217;s proposal also contemplated a concurrent financing of $30.0&#160;million committed by existing Carisma investors. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">The indication of interest from Party A, a privately held company, proposed a reverse merger transaction with an ascribed value of Sesen Bio of $150.0&#160;million (assuming closing net cash of </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">126</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:30pt; width:426pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">$100.0&#160;million) and an ascribed value of Party A of $249.0&#160;million, with an implied ownership interest in the combined company of approximately 40.0% for existing Sesen Bio stockholders. </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">The indication of interest from Party B, a privately held company, proposed a reverse merger transaction with an ascribed value of Sesen Bio of $100.0&#160;million (assuming closing net cash of $100.0&#160;million) and an ascribed value of Party B of $200.0&#160;million, with an implied ownership interest in the combined company of approximately 33.0% for existing Sesen Bio stockholders. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">The indication of interest from Party C, a privately held company, proposed a reverse merger transaction with an ascribed value of Sesen Bio of $130.0&#160;million (assuming closing net cash of $100.0&#160;million) and an ascribed value of Party C of $310.0&#160;million, with an implied ownership interest in the combined company of approximately 30.0% for existing Sesen Bio stockholders. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">The indication of interest from Party D, a privately held company, proposed a reverse merger transaction with an ascribed value of Sesen Bio of $106.0&#160;million (assuming closing net cash of $100.0&#160;million) and an ascribed value of Party D of $159.0&#160;million, with an implied ownership interest in the combined company of approximately 40.0% for existing Sesen Bio stockholders. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Also during this period, Sesen Bio entered into confidentiality agreements with 18 of the companies that submitted indications of interest. 17 of the 18 confidentiality agreements, including those of Carisma, Party A, Party B, Party C and Party D, contained standstill provisions that expired 24 months after their execution. The remaining confidentiality agreement contained a standstill provision that expires 12&#160;months after its execution. </font>
          </div>

        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">From May&#160;20, 2022 to June&#160;7, 2022, members of Sesen Bio management and representatives of SVB Securities analyzed the 42 indications of interest using the following key evaluation criteria discussed by the Sesen Bio board of directors at a meeting on May&#160;25, 2022: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">business assessment, including each company&#8217;s proof of concept data generated to date, clinical development stage, pipeline depth, magnitude of potential clinical impact, existing standard of care, potential competitors, commercial potential, intellectual property, platform technology or drug discovery capabilities, scientific personnel and manufacturing capabilities; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">management and board quality, including prior public company executive experience, and investor quality, including duration of investment; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">public company readiness, including analysis of existing potential public company infrastructure and existing audited financials and/or retention of an independent registered public accounting firm; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">ability/need to raise contingent financing with consideration given for any existing investor commitments; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">material inflection points, including meaningful clinical data readouts or regulatory submissions for programs in the relative near term; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">ability to reach inflection points with pro&#160;forma cash; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">current Sesen Bio stockholder ownership post-transaction. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Based on this analysis, members of Sesen Bio management identified 15 potential counterparties, including Carisma, Party A, Party B, Party C and Party D, to present to Sesen Bio management and/or the Sesen Bio board of directors. Since the company affiliated with the Sesen Bio director who had a potential conflict of interest was not one of the 15 potential counterparties identified, such director was able to resume full participation in discussions of the strategic alternative review process because the potential for a conflict of interest no longer existed. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On June&#160;15 and 16, 2022, the Sesen Bio board of directors held a meeting in person and by videoconference at which members of Sesen Bio management and representatives of Hogan Lovells and SVB Securities were present. Sesen Bio&#8217;s directors met in executive session with Ms.&#160;Clark and a representative of Hogan Lovells present. Dr.&#160;Thomas Cannell, Sesen Bio&#8217;s President and Chief Executive Officer, provided an update on recent changes in the NMIBC landscape and the strategic alternative review process. A discussion ensued regarding strategic considerations for an additional Phase&#160;3 clinical trial and a strategic </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">127</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">alternative transaction. Sesen Bio&#8217;s directors then met in executive session with a representative of Hogan Lovells present to further discuss, among other things, the potential alternatives for Sesen Bio, which included conducting an additional Phase&#160;3 clinical trial for Vicineum, exploring a potential strategic transaction, acquiring a new product, and liquidation. During this executive session, the Sesen Bio board of directors considered the cost, infrastructure needs, and time that would be involved in acquiring a new product and developing it for commercialization and determined not to pursue that strategic alternative at this time. Members of Sesen Bio management team and representatives of SVB Securities rejoined the meeting at which time Ms.&#160;Clark provided an update on the strategic alternative review process. Ms.&#160;Clark discussed the potential benefits of a reverse merger transaction for Sesen Bio stockholders, reviewed the proposed timeline and estimated wind-down costs in the event of a strategic transaction. Ms.&#160;Clark also discussed that Sesen Bio was exploring the potential sale of the Vicineum asset in the event the Sesen Bio board of directors determined to cease further development of Vicineum. A discussion ensued among the members of the Sesen Bio board of directors. Representatives of SVB Securities (i)&#160;reviewed the selection methodology and key evaluation criteria that members of Sesen Bio management, with the assistance of SVB Securities, used to analyze the 42 indications of interest received by Sesen Bio to identify 15 potential counterparties to present to the Sesen Bio board of directors and/or Sesen Bio management, (ii)&#160;provided perspectives on each of the 15 potential counterparties, (iii)&#160;discussed next steps in the strategic alternative review process, and (iv)&#160;reviewed the timeline for a potential strategic transaction. Members of Sesen Bio management and representatives of SVB Securities responded to questions regarding the key evaluation criteria. Following discussion, the Sesen Bio board of directors authorized SVB Securities to move forward with presentations, with the five potential counterparties meeting the most key evaluation criteria, including Party A, Party B and Party C, to present to the full Sesen Bio board of directors and the remaining ten potential counterparties identified based on the key evaluation criteria, including Carisma and Party D, to present first to Sesen Bio management and then, if warranting further consideration, to the full Sesen Bio board of directors. Dr.&#160;Dillon joined the meeting and provided an update on Sesen Bio&#8217;s activities in planning for an additional Phase&#160;3 clinical trial, including the projected timeline and next steps for evaluating whether to pursue an additional Phase&#160;3 clinical trial. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Over the course of June and July&#160;2022, ten potential counterparties presented to Sesen Bio management and five potential counterparties, including two (Carisma and Party D) that first presented to Sesen Bio management, presented to the full Sesen Bio board of directors about their respective businesses. Prior to the commencement of the presentations, two of the initial five potential counterparties that were identified to present to the Sesen Bio board of directors voluntarily withdrew from the process. At the direction of the Sesen Bio board of directors, SVB Securities informed the other potential counterparties that had submitted indications of interest that they were not advancing to the next stage of discussions based on determinations by the Sesen Bio board of directors, informed by the perspectives of Sesen Bio management and SVB Securities, that each such counterparty was not reasonably likely to provide the best opportunity to maximize value for Sesen Bio&#8217;s current stockholders based on most of the key evaluation criteria. Following these presentations, the Sesen Bio board of directors further evaluated its initial business assessment of the five potential counterparties that presented to the Sesen Bio board of directors and provided feedback to Sesen Bio management in advance of the July&#160;25, 2022 board meeting to facilitate robust discussions before selecting the lead counterparties. During this period, Sesen Bio management also engaged in discussions with Roche about the possibility of Roche purchasing the Roche licensed intellectual property. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On July&#160;13, 2022, the Sesen Bio board of directors held a meeting by videoconference at which members of Sesen Bio management and a representative of Hogan Lovells were present. Dr.&#160;Cannell provided an update on the negotiations of an asset purchase agreement between Sesen Bio and Roche, pursuant to which Roche would purchase the Roche licensed intellectual property for up to $70.0&#160;million, including a $40.0&#160;million payment to Sesen Bio upon execution of the agreement and an additional $30.0&#160;million payment to Sesen Bio upon the achievement by Roche of a specified milestone. A discussion ensued regarding, among other things, the associated proceeds having the potential to increase the range and attractiveness of strategic alternatives for Sesen Bio to consider and create the opportunity for a CVR that could provide enhanced value to Sesen Bio&#8217;s stockholders. Following discussion, the Sesen Bio board of directors unanimously approved and authorized Sesen Bio management to execute the Roche Asset Purchase Agreement. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">128</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On July&#160;15, 2022, the Sesen Bio board of directors held a meeting by videoconference at which members of Sesen Bio management and a representative of Hogan Lovells were present. Dr.&#160;Cannell provided an update on Sesen Bio&#8217;s July&#160;11, 2022 meeting with the FDA to discuss an additional Phase&#160;3 clinical trial for Vicineum, including the required design elements of an additional Phase&#160;3 clinical trial confirmed by the FDA. Dr.&#160;Cannell discussed that based on the agreed upon design elements and resulting trial size, estimated timing for enrollment and timing of sufficient data for BLA resubmission, a U.S. launch was projected between mid-2030 to mid-2033 with total trial cost estimated between $200.0&#160;million and $243.0&#160;million (assuming an approximately 1,000-patient trial). Ms.&#160;Forbes reviewed the estimated financial impact of an additional Phase&#160;3 clinical trial for Vicineum, including the estimated time to achieve profitability, the need for significant additional financing to achieve profitability, the anticipated negative return with dilution to existing stockholders outpacing the estimated growth in Sesen Bio&#8217;s value, and that the current cash runway was projected to run out before the first major inflection point of data disclosure was projected to occur. Ms.&#160;Forbes also reviewed the total estimated, risk-adjusted valuation of Sesen Bio, timing of first inflection point and cash runway in the case of an additional Phase&#160;3 clinical trial and in the case of a strategic alternative transaction. Members of management discussed the estimated impact of a potential liquidation, including that a meaningful amount of Sesen Bio&#8217;s current cash balance would need to be held back to cover current liabilities and future potential liabilities triggered by a liquidation strategy. Based on the FDA feedback on the requirements for an additional Phase&#160;3 clinical trial, the evolving competitive landscape and the resulting financial analysis for an additional Phase&#160;3 clinical trial, as well as the view that liquidation was not reasonably likely to create greater value for Sesen Bio stockholders than a strategic alternative transaction, Sesen Bio management recommended pausing further development of Vicineum in the U.S. and pursuing a strategic alternative transaction. Ms.&#160;Forbes also reviewed estimated wind-down costs in the event of a strategic transaction and possible next steps if the Sesen Bio board of directors were to approve pausing further development of Vicineum and pursue a strategic alternative transaction. Following discussion, the Sesen Bio board of directors unanimously approved pausing further development of Vicineum in the U.S., pursuing a strategic alternative transaction and implementing a restructuring plan to reduce operating expenses and to better align its workforce with the needs of its business following the decision to pause further development of Vicineum in the U.S. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On July&#160;18, 2022, Sesen Bio announced that it made the strategic decision to voluntarily pause further development of Vicineum in the U.S. based on discussions with the FDA and a thorough reassessment of Vicineum, which included the incremental development timeline and associated costs for an additional Phase&#160;3 clinical trial for Vicineum for the treatment of NMIBC. Sesen Bio also announced that it would turn its primary focus to the assessment of strategic alternatives and that it intended to seek a partner with larger infrastructure for the further development of Vicineum. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Also on July&#160;18, 2022, Sesen Bio announced that it had entered into the Roche Asset Purchase Agreement following execution of such agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On July&#160;25, 2022, the Sesen Bio board of directors held a meeting by videoconference at which members of Sesen Bio management and representatives of Hogan Lovells were present. Ms.&#160;Clark reviewed management&#8217;s proposed corporate strategy for 2022, including pursuing a potential strategic alternative transaction or, in the event a strategic alternative transaction is not completed, a liquidation and dissolution. Ms.&#160;Clark then reviewed the five remaining potential counterparties, Carisma, Party A, Party B, Party C and Party D, the presentations made by each potential counterparty and the due diligence conducted to date on each of the potential counterparties, including their respective business, management, board and investor quality, public company readiness, ability/need to raise contingent financing, material near-term inflection points, and ability to reach inflection points with pro&#160;forma cash. Following discussion, the Sesen Bio board of directors determined to prioritize discussions with Carisma, Party A and Party B based on the business assessment of each such counterparty after the presentations to the Sesen Bio board of directors, the terms of each such counterparty&#8217;s proposed indication of interest, and the results of due diligence conducted to date, and authorized and directed Sesen Bio management and SVB Securities to move forward with Carisma, Party A and Party B into a technical due diligence process, including a comprehensive business, regulatory, intellectual property, legal and financial analysis of all three potential counterparties. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">During the period from July&#160;25, 2022 through August&#160;19, 2022, members of Sesen Bio management and representatives of SVB Securities engaged in deep technical due diligence activities with each of Carisma, </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">129</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Party A and Party B, and, at the direction of the Sesen Bio board of directors, SVB Securities informed the other remaining counterparties that Sesen Bio was prioritizing discussions with other parties. On August&#160;4, 2022, at the direction of the Sesen Bio board of directors, Sesen Bio management terminated diligence activities and discussions with Party B based on the due diligence and business discussions conducted to date, particularly the potential regulatory risks related to Party B&#8217;s lead program that were discussed by the Sesen Bio board of directors in the July&#160;25, 2022 meeting. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On August&#160;11, 2022, the Sesen Bio board of directors held a meeting by videoconference at which members of Sesen Bio management and representatives of Hogan Lovells were present. Ms.&#160;Clark provided an update on the strategic alternative review process, including an overview of the due diligence process and possible timeline for the two remaining potential counterparties. A discussion ensued, including about the possibility that based on Sesen Bio&#8217;s estimated cash balance, Sesen Bio could issue a special cash dividend of up to $25.0 million in the aggregate to Sesen Bio stockholders to deliver additional value to Sesen Bio stockholders as a result of the payment received by Sesen Bio pursuant to the Roche APA and careful management of operating expenses. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">During the period from August&#160;11, 2022 through August&#160;18, 2022, members of Sesen Bio management and representatives of SVB Securities engaged in additional due diligence activities with each of Carisma and Party A. Also during this period, Sesen Bio management proposed to Carisma that Sesen Bio be permitted to issue a special cash dividend of up to $25.0 million to Sesen Bio stockholders.</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Based on the key evaluation criteria and the technical and other due diligence activities undertaken to date by Sesen Bio management on each of Carisma and Party A, the Sesen Bio board of directors and Sesen Bio management conducted an additional due diligence call with key opinion leaders about Carisma&#8217;s proprietary cell therapy platform on August&#160;19, 2022. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Later on August&#160;19, 2022, the Sesen Bio board of directors held a meeting by videoconference at which members of Sesen Bio management and representatives of Hogan Lovells were present. During the meeting, a representative of Hogan Lovells reviewed the fiduciary duties of the Sesen Bio board of directors in the context of considering a potential reverse merger transaction. Ms.&#160;Clark reviewed the key evaluation criteria that Sesen Bio management, with the assistance of SVB Securities, used to analyze the potential counterparties and the technical and other due diligence activities undertaken to date by Sesen Bio management and Sesen Bio&#8217;s consultants and advisors on each of Carisma and Party A. Based on the thorough assessment performed by Sesen Bio management and Sesen Bio&#8217;s consultants and advisors, including technical due diligence, and the belief that a transaction with Carisma would provide value to Sesen Bio stockholders with significant upside potential, Sesen Bio management proposed that Sesen Bio pursue a reverse merger transaction with Carisma. Following discussion, the Sesen Bio board of directors approved and authorized Sesen Bio management to enter into negotiations with Carisma. In determining to pursue a reverse merger transaction with Carisma, the Sesen Bio board of directors considered that, in its judgment, Carisma provided the best opportunity to maximize value for Sesen Bio&#8217;s current stockholders, including after considering the potential advantages of Carisma over Party A with respect to the potential breadth and application of Carisma&#8217;s scientific platform, the potential value inflection milestones during the anticipated cash runways for the two parties, and a comparison of the potential risks regarding regulatory approval of each. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On August&#160;19, 2022, Sesen Bio delivered a counterproposal to Carisma representing a $20&#160;million premium to Sesen Bio&#8217;s estimated cash balance at closing. Also on August&#160;19, 2022, representatives of Hogan Lovells delivered a first draft of the proposed merger agreement for the transaction to representatives of WilmerHale, Carisma&#8217;s outside legal counsel. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">During the period from August&#160;19, 2022 through September&#160;20, 2022, representatives of Sesen Bio, including Hogan Lovells, and representatives of Carisma, including WilmerHale, completed confirmatory due diligence on each other and negotiated the terms of the merger agreement, including the definition of net cash, the calculation of the exchange ratio, the representations and warranties and operating covenants of each party, the amount of the termination fees and the expense reimbursement cap, and the terms of the forms of CVR Agreement, support agreement, and lock-up agreement. In evaluating and negotiating the exchange ratio, Sesen Bio considered Carisma&#8217;s valuation based on its last financing round along with other factors that favored increasing the Sesen Bio valuation, including a decline in general market conditions </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">130</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">and limited opportunities available for privately-held biotechnology companies to access the capital markets for financing through an initial public offering. Also during this period, Carisma engaged in discussions with potential investors for an equity financing in Carisma that would close immediately prior to the closing of Sesen Bio&#8217;s transaction with Carisma. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On August&#160;23, 2022, Carisma delivered a revised proposal with a stated value for Sesen Bio of $140.0&#160;million, which represented a $15.0&#160;million premium to Sesen Bio&#8217;s estimated cash balance at closing, and agreeing to a $125.0&#160;million cash minimum and permitting Sesen Bio to issue a special cash dividend of excess cash and subject to the minimum net cash condition. On August&#160;24, 2022, Sesen Bio requested more information on Carisma&#8217;s revised proposal. On August 26, 2022, Sesen Bio and Carisma agreed to a $100.0 million cash minimum and to permit Sesen Bio to issue a special cash dividend of an aggregate amount of up to $25.0 million subject to the $100.0 million cash minimum. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On September&#160;14, 2022, the Sesen Bio board of directors held a meeting by videoconference at which members of Sesen Bio management and representatives of Hogan Lovells were present. Dr.&#160;Cannell and Ms.&#160;Clark provided an update on the negotiations with Carisma, the anticipated timing of Carisma&#8217;s pre-closing financing and the anticipated timeline for a potential transaction with Carisma. </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">On September&#160;20, 2022, the Sesen Bio board of directors held a meeting by videoconference at which members of Sesen Bio management and representatives of Hogan Lovells and SVB Securities were present. Sesen Bio&#8217;s directors met in executive session with representatives of Hogan Lovells to discuss, among other things, the potential benefits and risks of the proposed transaction with Carisma. Following the executive session, Ms.&#160;Clark reviewed the anticipated timeline and next steps for the proposed transaction with Carisma and the estimated wind-down costs if the proposed transaction with Carisma were completed. Representatives of SVB Securities reviewed SVB Securities&#8217; financial analysis of the proposed transaction with Carisma. Following discussion with the directors, SVB Securities then rendered to the Sesen Bio board of directors its oral opinion, which was subsequently confirmed by delivery of a written opinion dated September&#160;20, 2022, that, as of such date and based upon and subject to the assumptions made, and the qualifications and limitations upon the review undertaken by SVB Securities in preparing its opinion, the exchange ratio to be paid by Sesen Bio pursuant to the terms of the Original Merger Agreement was fair, from a financial point of view, to Sesen Bio. During the meeting, a representative from Hogan Lovells again reviewed the fiduciary duties of the Sesen Bio board of directors in connection with the proposed transaction with Carisma and reviewed the material terms of the Original Merger Agreement. The Sesen Bio board of directors discussed various considerations with respect to the proposed transaction with Carisma, as summarized in the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Sesen Bio Reasons for the Merger.</font><font style="letter-spacing:0.2pt;">&#8221; Following discussion, the Sesen Bio board of directors unanimously (i)&#160;determined that the merger and other transactions contemplated by the Original Merger Agreement are advisable and in the best interests of Sesen Bio and its stockholders, (ii)&#160;approved and declared advisable the Merger Agreement, the merger and the other transactions contemplated by the Merger Agreement, and (iii)&#160;resolved to recommend that the Sesen Bio stockholders approve the issuance of shares of Sesen Bio common stock to Carisma stockholders in the merger and the other proposals contemplated by the Original Merger Agreement. Later on September&#160;20, 2022, Sesen Bio and Carisma executed the Original Merger Agreement. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">On September&#160;21, 2022, Sesen Bio and Carisma issued a joint press release announcing the execution of the Original Merger Agreement. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Between September&#160;29, 2022 and November&#160;17, 2022, the Sesen Bio board of directors held three meetings by videoconference at which members of Sesen Bio management and representatives of Hogan Lovells were present. At each meeting, Ms.&#160;Clark provided an update on preparation for the Sesen Bio special meeting. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">On November&#160;18, 2022, Bradley L. Radoff and Michael Torok and their affiliates, collectively referred to as the Investor Group, filed a Schedule&#160;13D with the SEC disclosing their beneficial ownership of 5.7% of the outstanding shares of Sesen Bio common stock and their intent to vote against the merger and the transactions related thereto. On December&#160;1, 2022, the Investor Group amended the Schedule&#160;13D to disclose beneficial ownership of 7.4% of the outstanding shares of Sesen Bio common stock. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Between November&#160;18, 2022 and December&#160;17, 2022, representatives of SVB Securities and representatives of Sesen Bio engaged with the Investor Group regarding their views on the merger. During </font>
          </div>

      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">131</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">

          <div style="width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">this time, representatives of SVB Securities and representatives of Sesen Bio also engaged with other Sesen Bio stockholders regarding their views on the merger. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Between December&#160;13, 2022 and December&#160;17, 2022, members of Sesen Bio management and members of Carisma management discussed the Investor Group&#8217;s Schedule&#160;13D filings and opposition to the merger, engagement with the Investor Group and feedback received from the Investor Group on the amount of a potential special cash dividend to Sesen Bio stockholders. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">On December&#160;17, 2022, Sesen Bio entered into a confidentiality agreement with the Investor Group to facilitate the sharing of certain information with the Investor Group. The confidentiality agreement required Sesen Bio to notify the Investor Group, by the earlier of December&#160;29, 2022 or two business days following the Investor Group&#8217;s agreement to vote in favor of the merger, that the information shared with the Investor Group does not constitute material, non-public information as of such date. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Between December&#160;17, 2022 and December&#160;23, 2022, representatives of Sesen Bio and Carisma and their respective advisors engaged with the Investor Group and Olshan Frome Wolosky LLP, or Olshan, the Investor Group&#8217;s outside legal counsel, regarding the merger and the transactions related thereto. During such discussions, the Investor Group demanded, among other things, an approximate $100.0&#160;million special cash dividend to Sesen Bio stockholders and an expanded CVR to include Sesen Bio&#8217;s legacy assets, including Vicineum. During this time, representatives of Sesen Bio also engaged with other Sesen Bio stockholders regarding their views on the merger. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Between December&#160;20, 2022 and December&#160;21, 2022, members of Sesen Bio management and members of Carisma management discussed the status of engagement with the Investor Group, including the Investor Group&#8217;s demands for an approximate $100.0&#160;million special cash dividend to Sesen Bio stockholders and an expanded CVR to include Sesen Bio&#8217;s legacy assets, net cash for funding the combined company&#8217;s operations and Sesen Bio&#8217;s expected net cash as of immediately prior to the closing of the merger. Members of Sesen Bio management and members of Carisma management discussed that a $100.0 million special cash dividend to Sesen Bio stockholders would make the merger unfeasible (including that Carisma advised that such special cash dividend would be unacceptable) and potentially introduce significant risk to Sesen Bio. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">On December&#160;21, 2022, the Sesen Bio board of directors held a meeting by videoconference at which members of Sesen Bio management and representatives of Hogan Lovells were present. Ms.&#160;Clark provided an update on engagement with the Investor Group, including the demand for an approximate $100.0&#160;million special cash dividend to Sesen Bio stockholders instead of the potential special cash dividend to Sesen Bio stockholders of up to $25.0&#160;million as set forth in the Original Merger Agreement. Members of Sesen Bio management reviewed with the Sesen Bio board of directors the estimated wind-down costs for Sesen Bio through March&#160;1, 2023 and that estimated net cash at the closing of the merger based on such wind-down costs was approximately $145.0 million, or approximately $75.0 million after a $70.0 million special cash dividend to Sesen Bio stockholders in connection with the merger. Ms.&#160;Clark reviewed with the Sesen Bio board of directors that in the event the merger is not completed, a court-managed liquidation would likely provide greater value to Sesen Bio stockholders compared to other potential strategic alternatives available to Sesen Bio due to the additional time, costs and associated risks to pursue other potential strategic alternatives, such as starting a new strategic review process, in-licensing or acquiring a new asset in a new disease and/or therapeutic area. Ms.&#160;Clark also provided an update on the anticipated timeline for the Sesen Bio special meeting. A discussion ensued among the Sesen Bio directors and others in attendance regarding a court-managed liquidation process, the Investor Group&#8217;s opposition to the merger, stockholder feedback Sesen Bio had received to date regarding the merger, and the potential size of an increased special cash dividend and related considerations, including that a $100.0 million special cash dividend to Sesen Bio stockholders would make the merger unfeasible (including that Carisma advised that such special cash dividend would be unacceptable) and potentially introduce significant risk to Sesen Bio. Based on the estimated wind-down costs through March&#160;1, 2023 and estimated net cash at the closing of the merger, members of Sesen Bio management recommended that the Sesen Bio board of directors authorize an increase of the amount of the potential special cash dividend in connection with the merger up to $75.0 million. Following discussion and management&#8217;s recommendation, the Sesen Bio board of directors authorized an increase of the amount of the potential special cash dividend in connection with the merger up to $75.0&#160;million, subject to agreement with Carisma. </font>
          </div>

      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">132</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">

          <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">On December&#160;23, 2022, members of Carisma management advised members of Sesen Bio management that the Carisma board of directors had authorized a decrease to the minimum net cash requirement from $100.0&#160;million to $75.0&#160;million, which members of Carisma management advised that it believed was a sufficient amount to operate the combined company&#8217;s business as currently contemplated following the closing, with authorization for any excess cash above $75.0&#160;million to be part of a special cash dividend paid to Sesen Bio stockholders in connection with the merger, which was estimated to be approximately $70.0&#160;million. Members of Sesen Bio management and members of Carisma management discussed amending the CVR to also include potential proceeds from any sale of Sesen Bio&#8217;s legacy assets (including Vicineum). </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">On December&#160;23, 2022, representatives of Sesen Bio and Carisma and their respective advisors continued engaging with the Investor Group regarding the merger and the transactions related thereto. During such discussions, representatives of SVB Securities and representatives of Evercore Group L.L.C., or Evercore, Carisma&#8217;s financial advisor, communicated that Sesen Bio and Carisma had determined to significantly increase the amount of the special cash dividend by $45.0&#160;million to approximately $70.0&#160;million and amend the CVR Agreement to also include potential proceeds from any sale of Sesen Bio&#8217;s legacy assets (including Vicineum), which would increase the value paid to Sesen Bio stockholders upon completion of the merger. Representatives of SVB Securities and representatives of Evercore communicated that a special cash dividend of approximately $70.0&#160;million would leave the combined company with net cash of $75.0&#160;million to fund its operations, based on Sesen Bio&#8217;s expected net cash of approximately $145.0&#160;million as of immediately prior to the closing of the merger and prior to the issuance of the special cash dividend. In response, the Investor Group reiterated to representatives of SVB Securities and representatives of Evercore its demand for an approximate $100.0&#160;million special cash dividend to Sesen Bio stockholders and intent to vote against the merger. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">On December&#160;23, 2022, representatives of Hogan Lovells and representatives of WilmerHale negotiated the terms of the merger agreement amendment and form of CVR Agreement, which would increase the amount of the special cash dividend to be paid to Sesen Bio stockholders from up to $25.0&#160;million to the amount of cash available after Sesen Bio meets the $75.0&#160;million net cash minimum and amend the form of CVR Agreement to also include potential proceeds from any sale of Sesen Bio&#8217;s legacy assets (including Vicineum). </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">On December&#160;29, 2022, the Sesen Bio board of directors held a meeting by videoconference at which members of Sesen Bio management and representatives of Hogan Lovells and SVB Securities were present. Sesen Bio&#8217;s directors met in executive session with representatives of Hogan Lovells to review, among other things, the Sesen Bio board of directors&#8217; previous evaluation of strategic alternatives, including liquidation, that the Sesen Bio board of directors conducted before approving the merger. The Sesen Bio board of directors confirmed that it continues to believe such transaction maximizes stockholder value and is in the best interest of the Sesen Bio stockholders. Following the executive session, Ms.&#160;Clark provided an update on engagement with the Investor Group, including the Investor Group&#8217;s continued demand for an approximate $100.0 million special cash dividend to Sesen Bio stockholders, which the Sesen Bio board of directors agreed would make the merger unfeasible (including that Carisma advised that such special cash dividend would be unacceptable) and potentially introduce significant risk to Sesen Bio. Ms.&#160;Clark then reviewed the draft merger agreement amendment which would (i)&#160;reduce the minimum net cash of Sesen Bio required at the closing of the merger from $100.0&#160;million to $75.0&#160;million, (ii)&#160;increase the amount of the special cash dividend to be paid to Sesen Bio stockholders to the amount of cash available after Sesen Bio meets the $75.0&#160;million net cash minimum as of the closing of the merger, which was estimated to be approximately $70.0&#160;million, and (iii)&#160;amend the form of CVR Agreement to also include potential proceeds from any sale of Sesen Bio&#8217;s legacy assets (including Vicineum), in addition to any proceeds from the milestone payment under the Roche Asset Purchase Agreement, as part of the CVR. Representatives of SVB Securities reviewed SVB Securities&#8217; financial analysis of the proposed transaction with Carisma pursuant to the terms of the Merger Agreement. Following discussion with the Sesen Bio directors, SVB Securities then rendered to the Sesen Bio board of directors its oral opinion, which was subsequently confirmed by delivery of a written opinion dated December&#160;29, 2022, that, as of such date and based upon and subject to the various assumptions made, and the qualifications and limitations upon the review undertaken by SVB Securities in preparing its opinion, the exchange ratio to be paid by Sesen Bio pursuant to the terms of the Merger Agreement was fair, from a financial point of view, to Sesen Bio. Ms.&#160;Clark reviewed with the Sesen </font>
          </div>

      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">133</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tSBRF">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">

          <div style="width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Bio board of directors the prior discussions from December&#160;21, 2022 that in the event the merger is not completed, a court-managed liquidation would likely provide greater value to Sesen Bio stockholders compared to other potential strategic alternatives available to Sesen Bio. Ms.&#160;Clark reviewed that, if the Sesen Bio board of directors were to approve and recommend, and Sesen Bio stockholders were to approve, a liquidation of Sesen Bio, Sesen Bio would be required under Delaware corporate law to notify potential claimants and pay its outstanding obligations, as well as to make reasonable provision for contingent and unknown obligations, which may be sizeable, prior to making any distributions in liquidation to Sesen Bio stockholders. Ms.&#160;Clark noted that as a result of such requirement, a portion of Sesen Bio&#8217;s assets would need to be reserved pending the resolution of such obligations, the timing of any such resolution would be uncertain, and Sesen Bio may become subject to litigation or other claims related to a dissolution and liquidation of Sesen Bio. Representatives of Hogan Lovells reviewed with the Sesen Bio board of directors the Investor Group&#8217;s Schedule&#160;13D filings and opposition to the merger, engagement with the Investor Group to date and other matters related to the Investor Group, including potential responses and related considerations. A discussion ensued regarding engagement with the Investor Group, the terms of the Merger Agreement Amendment and the potential for a court-managed liquidation in the event the merger is not completed. Following discussion, the Sesen Bio board of directors unanimously (i)&#160;determined that the Merger Agreement Amendment and the transactions contemplated thereby are advisable and in the best interests of Sesen Bio and its stockholders, and (ii)&#160;approved and declared advisable the Merger Agreement Amendment and the transactions contemplated by the Merger Agreement. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Later on December&#160;29, 2022, Sesen Bio and Carisma executed the Merger Agreement Amendment and issued a joint press release announcing the execution of the Merger Agreement Amendment and providing an update on engagement with the Investor Group. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">On January&#160;3, 2023, the Investor Group issued a press release reiterating their intent to vote against the merger notwithstanding the increase to the amount of the expected special cash dividend in connection with the merger up to $70.0&#160;million. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">On January&#160;4, 2023, Sesen Bio issued a press release reiterating its confidence in the merger, detailing the terms of the Merger Agreement Amendment and correcting certain factual errors made by the Investor Group in its January&#160;3, 2023 press release. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">On January&#160;5, 2023, the Investor Group issued an open letter to the Sesen Bio board of directors regarding their intent to vote against the merger and further amended their Schedule&#160;13D to disclose beneficial ownership of 8.4% of the outstanding shares of Sesen Bio common stock. </font>
          </div>

        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Sesen Bio Reasons for the Merger</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">During the course of its evaluation of the Merger Agreement and the transactions contemplated by the Merger Agreement, the Sesen Bio board of directors held numerous meetings, consulted with Sesen Bio&#8217;s senior management, Sesen Bio&#8217;s consultants and advisors, outside legal counsel and financial advisor, and reviewed and assessed a significant amount of information. In reaching its decision to approve the Merger Agreement and the transactions contemplated by the Merger Agreement, the Sesen Bio board of directors considered a number of factors that it viewed as supporting its decision to approve the Merger Agreement, including: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the financial condition and prospects of Sesen Bio and the risks associated with continuing to operate Sesen Bio on a stand-alone basis, particularly in light of Sesen Bio&#8217;s July&#160;2022 decision to voluntarily pause further development of Vicineum for the treatment of NMIBC and reduce its workforce, which was based on a thorough reassessment of Vicineum following FDA feedback on the requirements for an additional Phase&#160;3 clinical trial, the evolving competitive landscape and the resulting financial analysis; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">that the Sesen Bio board of directors and its financial advisor undertook a comprehensive and thorough process of reviewing and analyzing potential strategic alternatives and merger partner candidates and Sesen Bio board of directors&#8217; view that no alternatives to the merger, including a liquidation and dissolution of Sesen Bio and the distribution of any available cash, were reasonably likely to create greater value to Sesen Bio stockholders; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">134</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the Sesen Bio board of directors&#8217; conclusion that the merger would provide existing Sesen Bio stockholders a significant opportunity to participate in the potential growth of the combined company following the merger, which will focus on Carisma&#8217;s product pipeline, while also potentially receiving certain cash payments following the closing of the merger on account of the CVR Agreement and the special cash dividend; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.89pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.89pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the Sesen Bio board of directors&#8217; belief, after a thorough review of strategic alternatives and discussions with Sesen Bio&#8217;s senior management, outside legal counsel and financial advisor, that the merger is more favorable to Sesen Bio stockholders than the potential value that might have resulted from other strategic alternatives available to Sesen Bio, including a liquidation and dissolution of Sesen Bio and the distribution of any available cash; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.89pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.89pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the Sesen Bio board of directors&#8217; belief, after thorough discussion with Sesen Bio management and Sesen Bio&#8217;s consultants and advisors, that a potential liquidation and dissolution was not reasonably likely to create greater value for Sesen Bio stockholders than a strategic alternative transaction based on, among other things, the need to hold back a meaningful amount of the Company&#8217;s current cash balance to cover current and potential future liabilities, including those triggered by a liquidation strategy; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.89pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.89pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the Sesen Bio board of directors&#8217; belief that, as a result of arm&#8217;s length negotiations with Carisma, Sesen Bio and its representatives negotiated the highest exchange ratio to which Carisma was willing to agree, and that the other terms of the Merger Agreement include the most favorable terms to Sesen Bio in the aggregate to which Carisma was willing to agree; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.89pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.89pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the Sesen Bio board of directors&#8217; positive view, based on the scientific, regulatory and technical due diligence conducted by Sesen Bio management and advisors, of the regulatory pathway for, and potential significant market opportunity of, Carisma&#8217;s product candidates, which will be the focus of the combined company; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.89pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6.89pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">the Sesen Bio board of directors&#8217; consideration of the expected cash balances of the combined company as of the closing of the merger resulting from the approximately $75.0 million of net cash expected to be held by Sesen Bio upon completion of the merger together with the cash Carisma currently holds and the $30.6&#160;million of expected gross proceeds from the Carisma pre-closing financing; </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.89pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.89pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the Sesen Bio board of directors&#8217; view, following a review with Sesen Bio&#8217;s management and advisors of Carisma&#8217;s current development and clinical trial plans, of the likelihood that the combined company would possess sufficient cash resources at the closing of the merger, or have access to sufficient resources, to fund continued development of Carisma&#8217;s product pipeline through upcoming value inflection points; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.99pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.99pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the prospects of and risks associated with the other strategic candidates that had made proposals for a strategic transaction with Sesen Bio based on the scientific, technical and other due diligence conducted by Sesen Bio&#8217;s management and advisors; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the Sesen Bio board of directors&#8217; view that the combined company will be led by an experienced senior management team from Carisma and a board of directors with representation from each of the current boards of directors of Carisma and Sesen Bio; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the current financial market conditions and historical market prices, volatility and trading information with respect to Sesen Bio common stock; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.99pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6.99pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">the opinion of SVB Securities, rendered orally to the Sesen Bio board of directors on December&#160;29, 2022 (and subsequently confirmed in writing as of December&#160;29, 2022) that, as of such date and based upon and subject to the various assumptions made, and the qualifications and limitations upon the review undertaken by SVB Securities in preparing its opinion, the exchange ratio was fair, from a financial point of view, to Sesen Bio, as more fully described below in the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Merger&#8201;&#8212;&#8201;Opinion of Sesen Bio&#8217;s Financial Advisor</font><font style="letter-spacing:0.2pt;">,&#8221; beginning on page <a href="#tOOSB">139</a> in this proxy statement/</font>&#8203;<font style="letter-spacing:0.2pt;">prospectus. </font></div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">135</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Sesen Bio board of directors also reviewed the terms of the Merger Agreement and related transaction documents, including those described below, and concluded that the terms of the Merger Agreement and related transaction documents, in the aggregate, were reasonable under the circumstances: </font>
        </div>

          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">the calculation of the exchange ratio, closing net cash and the estimated number of shares of Sesen Bio common stock to be issued in the merger, including that the valuation of Sesen Bio under the Merger Agreement would be reduced to the extent that Sesen Bio&#8217;s closing net cash is less than $75.0 million and increased to the extent Sesen Bio&#8217;s closing net cash exceeds $75.0 million, which would result in a decrease or increase, as applicable, in the ownership of the pre-merger Sesen Bio stockholders in the combined company; </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>


          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.3pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">the number and nature of the conditions to Sesen Bio&#8217;s and Carisma&#8217;s respective obligations to complete the merger and the likelihood that the merger will be completed on a timely basis, as more fully described below under the caption &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Merger Agreement&#8201;&#8212;&#8201;Conditions to the Completion of the Merger</font><font style="letter-spacing:0.2pt;">,&#8221; beginning on page <a href="#tCCM5">176</a> in this proxy statement/prospectus; </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>


          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.3pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">the respective rights of, and limitations on, Sesen Bio and Carisma under the Merger Agreement to consider and engage in discussions regarding unsolicited acquisition proposals under certain circumstances, and the limitations on the board of directors of each party to change its recommendation in favor of the merger, as more fully described below under the caption &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Merger Agreement&#8201;&#8212;&#8201;No Solicitation</font><font style="letter-spacing:0.2pt;">,&#8221; beginning on page <a href="#tNSON">179</a> in this proxy statement/prospectus; </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>


          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.3pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">the potential termination fee of $7.6&#160;million, in the case of the fee payable by Sesen Bio, or $5.49&#160;million, in the case of the fee payable by Carisma, and related reimbursement of certain transaction expenses of up to $1.75&#160;million, which could become payable by either Sesen Bio or Carisma to the other party if the Merger Agreement is terminated in certain circumstances, as more fully described below under the caption &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Merger Agreement&#8201;&#8212;&#8201;Termination Fee</font><font style="letter-spacing:0.2pt;">,&#8221; beginning on page <a href="#tTERFEE123">190</a> in this proxy statement/prospectus; </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>


          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.31pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.31pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">the lock-up agreements, pursuant to which certain stockholders of Carisma and Sesen Bio, respectively, have, subject to certain exceptions, agreed not to transfer their shares of the combined company common stock during the period of 180&#160;days following the completion of the merger, as more fully described below under the caption &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Agreements Related to the Merger&#8201;&#8212;&#8201;Lock-Up Agreements</font><font style="letter-spacing:0.2pt;">,&#8221; beginning on page <a href="#tLOAG">199</a> in this proxy statement/prospectus; </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>


          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.31pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.31pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">the support agreements, pursuant to which certain stockholders of Carisma and Sesen Bio, respectively, have agreed, solely in their capacities as stockholders, to vote their shares of Carisma common stock or Sesen Bio common stock, respectively, in favor of the proposals submitted to them in connection with the merger and against any alternative acquisition proposals, as more fully described below under the caption &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Agreements Related to the Merger&#8201;&#8212;&#8201;Support Agreements and Written Consents</font><font style="letter-spacing:0.2pt;">,&#8221; beginning on page <a href="#tSAAW">197</a> in this proxy statement/prospectus; and </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>


          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.31pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.31pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">the CVR Agreement, pursuant to which Sesen Bio stockholders of record as of a date agreed to by Sesen Bio and Carisma prior to the effective time will receive a CVR for each outstanding share of Sesen Bio common stock held by such Sesen Bio stockholders representing the contractual right to receive contingent cash payments upon the receipt of Sesen Bio of certain proceeds payable by Roche during a certain period following closing or of proceeds from any sale of Sesen Bio&#8217;s legacy assets, including Vicineum, as more fully described below under the caption &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Agreements Related to the Merger&#8201;&#8212;&#8201;CVR Agreement</font><font style="letter-spacing:0.2pt;">,&#8221; beginning on page <a href="#tCVAG">192</a> in this proxy statement/prospectus. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In the course of its deliberations, the Sesen Bio board of directors also considered a variety of risks and other countervailing factors related to entering into the merger, including: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the $7.6&#160;million termination fee payable by Sesen Bio and Sesen Bio&#8217;s expense reimbursement obligations upon the occurrence of certain events and the potential effect of such termination fee in deterring other potential acquirors from proposing an alternative acquisition that may be more advantageous to Sesen Bio stockholders; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the substantial expenses to be incurred by Sesen Bio in connection with the merger; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the prohibition on Sesen Bio to solicit alternative acquisition proposals during the pendency of the merger; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">136</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tCRFT">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the possible volatility of the trading price of Sesen Bio common stock resulting from the announcement, pendency or completion of the merger; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the risk that the merger might not be consummated in a timely manner or at all and the potential effect of the public announcement of the merger or the failure to complete the merger on the reputation of Sesen Bio; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the scientific, technical, regulatory and other risks and uncertainties associated with development and commercialization of Carisma&#8217;s product pipeline; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">the various other risks associated with the combined company and the proposed transaction, including those described in the sections entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Risk Factors</font><font style="letter-spacing:0.2pt;">&#8221; and &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Cautionary Statement Concerning Forward-Looking Statements</font><font style="letter-spacing:0.2pt;">&#8221; beginning on pages <a href="#tRIFA">26</a> and <a href="#tCSCF">118</a>, respectively, in this proxy statement/prospectus. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The foregoing information and factors considered by the Sesen Bio board of directors are not intended to be exhaustive but are believed to include all of the material factors considered by the Sesen Bio board of directors. In view of the wide variety of factors considered in connection with its evaluation of the merger and the complexity of these matters, the Sesen Bio board of directors did not find it useful to attempt, and did not attempt, to quantify, rank or otherwise assign relative weights to these factors. In considering the factors described above, individual members of the Sesen Bio board of directors may have given different weight to different factors. The Sesen Bio board of directors conducted an overall analysis of the factors described above, including thorough discussions with, and questioning of, Sesen Bio&#8217;s senior management team, outside legal counsel and financial advisor, and considered the factors overall to be favorable to, and to support, its determination. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Carisma Reasons for the Merger</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In the course of reaching its decision to approve the merger, the Carisma board of directors held numerous meetings, consulted with Carisma&#8217;s senior management, its financial advisors and legal counsel, and considered a wide variety of factors. Ultimately, the Carisma board of directors concluded that a merger with Sesen Bio, together with the additional financing committed from the Carisma pre-closing financing, was the best option to generate capital resources to support the advancement of Carisma&#8217;s pipeline and fund a combined organization. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Additional factors that the Carisma board of directors considered included the following: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the merger will provide current Carisma stockholders with greater liquidity by owning publicly-traded stock, and expanding both the access to capital for Carisma and the range of investors potentially available as a public company, compared to the investors Carisma could otherwise gain access to if it continued to operate as a privately-held company; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.71pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.71pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the potential benefits from increased public market awareness of Carisma and its pipeline; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the historical and current information concerning Carisma&#8217;s business, including its financial performance and condition, operations, management and pre-clinical and clinical data; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the competitive nature of the industry in which Carisma operates; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the Carisma board of directors&#8217; fiduciary duties to Carisma stockholders; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the Carisma board of directors&#8217; belief that no alternatives to the merger were reasonably likely to create greater value for Carisma stockholders, after reviewing the various financing and other strategic alternatives that were considered by the Carisma board of directors; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.71pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.71pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">the projected financial position, operations, management structure, operating plans, and anticipated cash burn rate of the combined company, including the ability to support the combined company&#8217;s current and planned clinical trials and operations), as further discussed in the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Carisma Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations &#8212; Liquidity and Capital Resources &#8212; Funding Requirements</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tFUNDRE1">335</a> of this proxy statement/</font>&#8203;<font style="letter-spacing:0.2pt;">prospectus; </font></div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the business, history, operations, financial resources, assets, technology and credibility of Sesen Bio; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">137</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the availability of appraisal rights under the DGCL to holders of Carisma&#8217;s capital stock who comply with the required procedures under the DGCL, which allow such holders to seek appraisal of the fair value of their shares of Carisma capital stock as determined by the Delaware Court of Chancery; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the terms and conditions of the Merger Agreement, including the following: </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="font-family:Times New Roman, Times, serif;">&#9702;</font>
          <br >
        </div>
        <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:50pt;">
          <font style="letter-spacing:0.2pt;">the determination that the expected relative&#160;percentage ownership of Sesen Bio stockholders and Carisma stockholders in the combined company was appropriate, based on the Carisma board of directors&#8217; judgment and assessment of the approximate valuations of Sesen Bio (including the value of the net cash Sesen Bio is expected to provide to the combined company) and Carisma;</font><font style="font-family:Times New Roman, Times, serif;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="font-family:Times New Roman, Times, serif;">&#9702;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:50pt;">
          <font style="letter-spacing:0.2pt;">the expectation that the merger will be treated as a reorganization for U.S. federal income tax purposes, with the result that in the merger Carisma stockholders will generally not recognize taxable gain or loss for U.S. federal income tax purposes;</font><font style="font-family:Times New Roman, Times, serif;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;font-family:Times New Roman, Times, serif;">&#9702;<br ></div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:50pt;font-family:Times New Roman, Times, serif;">
          <font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;">the limited number and nature of the conditions of the obligation of Sesen Bio to complete the merger;</font> </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;font-family:Times New Roman, Times, serif;">&#9702;<br ></div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:50pt;font-family:Times New Roman, Times, serif;">
          <font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;">the condition to Carisma&#8217;s obligation to complete the merger based on a minimum amount of net cash of Sesen Bio as of the closing of the merger;</font> </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;font-family:Times New Roman, Times, serif;">&#9702;<br ></div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:50pt;font-family:Times New Roman, Times, serif;">
          <font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;">the right of Carisma under the Merger Agreement to consider certain unsolicited acquisition proposals under certain circumstances should Carisma receive a superior proposal;</font> </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="font-family:Times New Roman, Times, serif;">&#9702;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:50pt;">
          <font style="letter-spacing:0.2pt;">the conclusion of the Carisma board of directors that the potential termination fees payable by Sesen Bio or Carisma to the other party, and the circumstances when such fee may be payable, were reasonable; and</font><font style="font-family:Times New Roman, Times, serif;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="font-family:Times New Roman, Times, serif;">&#9702;</font>
          <br >
        </div>
        <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:50pt;">
          <font style="letter-spacing:0.2pt;">the belief that the other terms of the Merger Agreement, including the parties&#8217; representations, warranties and covenants, and the conditions to their respective obligations, were reasonable in light of the entire transaction;</font><font style="font-family:Times New Roman, Times, serif;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the shares of Sesen Bio common stock issued to Carisma stockholders in connection with the merger will be registered on a Form&#160;S-4 registration statement and will become freely tradable for Carisma stockholders who are not affiliates of Carisma and who are not parties to lock-up agreements; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the ability to obtain a Nasdaq listing and the change of the combined company&#8217;s name to &#8220;Carisma Therapeutics Inc.&#8221; upon the closing of the merger; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the likelihood that the merger will be completed on a timely basis. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Carisma board of directors also considered a number of uncertainties and risks in its deliberations concerning the merger and the other transactions contemplated by the Merger Agreement, including the following: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the possibility that the merger might not be completed and the potential adverse effect of the public announcement of the merger on the reputation of Carisma and the ability of Carisma to obtain financing in the future in the event the merger is not completed; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the risk that future sales of common stock by existing Sesen Bio stockholders may cause the price of Sesen Bio common stock to fall, thus reducing the potential value of Sesen Bio common stock received by Carisma stockholders following the merger; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the exchange ratio used to establish the number of shares of Sesen Bio common stock to be issued to Carisma stockholders in the merger is fixed, except for adjustments including due to Sesen Bio&#8217;s net cash and the respective companies&#8217; outstanding capital stock at closing, and thus the relative&#160;percentage ownership of Sesen Bio stockholders and Carisma stockholders in the combined organization immediately following the completion of the merger is similarly fixed; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the termination fee payable by Carisma to Sesen Bio upon the occurrence of certain events, and the potential effect of such termination fee in deterring other potential acquirers from proposing an alternative transaction that may be more advantageous to Carisma stockholders; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">138</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tOOSB">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the potential reduction of Sesen Bio&#8217;s net cash prior to the closing of the merger; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the possibility that Sesen Bio could, under certain circumstances, consider unsolicited acquisition proposals if superior to the merger or change its recommendation to approve the merger upon certain events; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the risk that the merger might not be completed in a timely manner or at all, for a variety of reasons, such as the failure of Sesen Bio to obtain the required stockholder vote, and the potential adverse effect on the reputation of Sesen Bio and the ability of Sesen Bio to obtain financing in the future in the event the merger is not completed; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the costs involved in connection with completing the merger, the time and effort of Carisma senior management required to complete the merger, the related disruptions or potential disruptions to Carisma&#8217;s business operations and future prospects, including its relationships with its employees, suppliers and partners and others that do business or may do business in the future with Carisma, and related administrative challenges associated with combining the companies; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the additional expenses and obligations to which Carisma&#8217;s business will be subject following the merger that Carisma has not previously been subject to, and the operational changes to Carisma&#8217;s business, in each case that may result from being a public company; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the fact that the representations and warranties in the Merger Agreement do not survive the closing of the merger and the potential risk of liabilities that may arise post-closing; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">various other risks associated with the combined organization and the merger, including the risks described in the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Risk Factors</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tRIFA">26</a> of this proxy statement/</font>&#8203;<font style="letter-spacing:0.2pt;">prospectus. </font></div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The foregoing information is not intended to be exhaustive, but summarizes the material factors considered by the Carisma board of directors in its consideration of the Merger Agreement and the transactions contemplated. The Carisma board of directors concluded that the benefits, advantages and opportunities of a potential transaction outweighed the uncertainties and risks described above. After considering these and other factors, the Carisma board of directors unanimously approved the Merger Agreement, the merger and the other transactions contemplated by the Merger Agreement. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Opinion of Sesen Bio&#8217;s Financial Advisor</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Introduction</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Sesen Bio retained SVB Securities as its financial advisor in connection with the merger and the other transactions contemplated by the Merger Agreement. In connection with this engagement, the Sesen Bio board of directors requested that SVB Securities evaluate the fairness, from a financial point of view, to Sesen Bio of the exchange ratio proposed to be paid by Sesen Bio pursuant to the terms of the Merger Agreement. On December&#160;29, 2022, SVB Securities rendered to the Sesen Bio board of directors its oral opinion, which was subsequently confirmed by delivery of a written opinion dated December&#160;29, 2022, that, as of such date and based upon and subject to the various assumptions made, and the qualifications and limitations upon the review undertaken by SVB Securities in preparing its opinion, the exchange ratio proposed to be paid by Sesen Bio pursuant to the terms of the Merger Agreement was fair, from a financial point of view, to Sesen Bio. In providing its opinion, SVB Securities noted that the exchange ratio is subject to certain adjustments set forth in the Merger Agreement, and SVB Securities expressed no opinion as to any such adjustments. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">The full text of the written opinion of SVB Securities, dated December&#160;29, 2022, which describes the assumptions made and the qualifications and limitations upon the review undertaken by SVB Securities in preparing its opinion, is attached as </font><font style="font-style:italic;letter-spacing:0.2pt;">Annex B</font><font style="letter-spacing:0.2pt;"> to this proxy statement/prospectus and is incorporated herein by reference. The summary of the written opinion of SVB Securities set forth below is qualified in its entirety by the full text of the written opinion attached hereto as </font><font style="font-style:italic;letter-spacing:0.2pt;">Annex B</font><font style="letter-spacing:0.2pt;">. </font><font style="font-weight:bold;letter-spacing:-0.2pt;">SVB Securities&#8217; financial advisory services and opinion were provided for the information and assistance of the Sesen Bio board of directors (in their capacity as directors and not in any other capacity) in connection with and for purposes of the Sesen Bio board of directors&#8217; consideration of the merger and the opinion of SVB Securities addressed only the fairness, from </font>
          </div>

      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">139</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">a financial point of view, as of the date thereof, to Sesen Bio of the exchange ratio proposed to be paid by Sesen Bio pursuant to the terms of the Merger Agreement. The opinion of SVB Securities did not address any other term or aspect of the Merger Agreement or the merger and does not constitute a recommendation to any stockholder of Sesen Bio as to whether or how such holder should vote with respect to the merger or otherwise act with respect to the merger or any other matter.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The full text of the written opinion of SVB Securities should be read carefully in its entirety for a description of the assumptions made and the qualifications and limitations upon the review undertaken by SVB Securities in preparing its opinion.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In connection with rendering the opinion described above and performing its related financial analyses, SVB Securities reviewed, among other things: </font>
        </div>

          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">the Original Merger Agreement; </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>


          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">a draft of the Merger Agreement Amendment, dated December&#160;29, 2022; </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>


          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">a draft of the form of CVR Agreement to be entered into prior to the closing of the merger by Sesen Bio and a rights agent, dated December&#160;29, 2022; </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio&#8217;s Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2021, as filed by Sesen Bio with the SEC; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">Sesen Bio&#8217;s Quarterly Reports on Form 10-Q for the quarterly periods ended March&#160;31, 2022, June&#160;30, 2022 and September 30, 2022 (including any amendments thereto), as filed by Sesen Bio with the SEC; </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">certain Current Reports on Form 8-K (including any amendments thereto), as filed by Sesen Bio with, or furnished by Sesen Bio to, the SEC; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">certain internal information, primarily related to expense forecasts, relating to the business, operations, earnings, cash flow, assets, liabilities and prospects of Sesen Bio, as furnished to SVB Securities by the management of Sesen Bio; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">certain internal information relating to the business, operations, earnings, cash flow, assets, liabilities and prospects of Carisma, including the Financial Projections (as defined below), and furnished to, and approved for use by, SVB Securities by Sesen Bio for purposes of SVB Securities&#8217; analysis, as described in the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Merger&#8201;&#8212;&#8201;Certain Unaudited Financial Projections</font><font style="letter-spacing:0.2pt;">,&#8221; which are referred to in this summary of the opinion of SVB Securities as the &#8220;Financial Projections,&#8221; and which are collectively referred to in this summary of the opinion of SVB Securities as the &#8220;Internal Data&#8221;. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">SVB Securities also conducted discussions with members of the senior management of Sesen Bio and Carisma and their respective advisors and representatives regarding the Internal Data as well as the past and current business, operations, financial condition and prospects of each of Sesen Bio and Carisma. In addition, SVB Securities reviewed certain financial data for Carisma and compared that data to similar publicly available market, financial and other data for certain other companies, the securities of which are publicly traded, that SVB Securities believed to be comparable in certain respects to Carisma. SVB Securities also conducted such other financial studies and analyses and took into account such other information as SVB Securities deemed appropriate. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">SVB Securities assumed, without independent verification or any responsibility therefor, the accuracy and completeness of the financial, legal, regulatory, tax, accounting and other information supplied to, discussed with, or reviewed by SVB Securities for purposes of its opinion and, with Sesen Bio&#8217;s consent, SVB Securities relied upon such information as being complete and accurate. In that regard, SVB Securities was advised by Sesen Bio, and assumed, at Sesen Bio&#8217;s direction, that the Internal Data (including, without limitation, the Financial Projections) were reasonably prepared on bases reflecting the best currently available estimates and judgments of the management of Sesen Bio and Carisma as to the matters covered thereby and SVB Securities relied, at Sesen Bio&#8217;s direction, on the Internal Data for purposes of SVB Securities&#8217; analysis and its opinion. SVB Securities expressed no view or opinion as to the Internal Data (including, without limitation, the Financial Projections) or the assumptions on which they were based. The Sesen Bio </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">140</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">board of directors was aware that the management of Sesen Bio did not provide SVB Securities with, and SVB Securities did not otherwise have access to, financial forecasts regarding Sesen Bio&#8217;s business, other than the expense forecasts described above. Accordingly, SVB Securities did not perform a discounted cash flow analysis or any multiples-based analysis with respect to Sesen Bio. In addition, at Sesen Bio&#8217;s direction, SVB Securities did not make any independent evaluation or appraisal of any of the assets or liabilities (contingent, derivative, off-balance-sheet or otherwise) of Sesen Bio or Carisma, nor was SVB Securities furnished with any such evaluation or appraisal, and SVB Securities was not asked to conduct, and did not conduct, a physical inspection of the properties or assets of Sesen Bio or Carisma. Furthermore, at Sesen Bio&#8217;s direction, SVB Securities ascribed no value to the contingent value rights issuable pursuant to the CVR Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">SVB Securities assumed, at Sesen Bio&#8217;s direction, that the final executed Merger Agreement would not differ in any respect material to SVB Securities&#8217; analysis or its opinion from the last draft of the Merger Agreement reviewed by SVB Securities. SVB Securities also assumed, at Sesen Bio&#8217;s direction, that the representations and warranties made by Carisma and Sesen Bio and Merger Sub in the Merger Agreement and the related agreements were and would continue to be true and correct in all respects material to SVB Securities&#8217; analysis. Furthermore, SVB Securities assumed, at Sesen Bio&#8217;s direction, that the merger would be consummated on the terms set forth in the Merger Agreement and in accordance with all applicable laws and other relevant documents or requirements, without delay or the waiver, modification or amendment of any term, condition or agreement, the effect of which would be material to SVB Securities&#8217; analysis or SVB Securities&#8217; opinion and that, in the course of obtaining the necessary governmental, regulatory and other approvals, consents, releases and waivers for the merger, no delay, limitation, restriction, condition or other change would be imposed, the effect of which would be material to SVB Securities&#8217; analysis or SVB Securities&#8217; opinion. SVB Securities did not evaluate and did not express any opinion as to the solvency or fair value of Sesen Bio or Carisma, or their respective abilities to pay their obligations when they come due, or as to the impact of the merger on such matters, under any state, federal or other laws relating to bankruptcy, insolvency, or similar matters. SVB Securities is not a legal, regulatory, tax or accounting advisor, and SVB Securities expressed no opinion as to any legal, regulatory, tax or accounting matters. SVB Securities expressed no view or opinion as to the price or range of prices at which the shares of stock or other securities or instruments of Sesen Bio or any third party may trade at any time, including subsequent to the announcement or consummation of the merger. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The opinion of SVB Securities expressed no view as to, and did not address, Sesen Bio&#8217;s underlying business decision to proceed with or effect the merger, or the relative merits of the merger as compared to any alternative business strategies or transactions that might be available to Sesen Bio or in which Sesen Bio might engage. The opinion of SVB Securities was limited to and addressed only the fairness, from a financial point of view, as of the date of its opinion, to Sesen Bio of the exchange ratio proposed to be paid by Sesen Bio pursuant to the terms of the Merger Agreement. SVB Securities was not asked to, nor did it express any view on, and its opinion did not address, any other term or aspect of the Merger Agreement or the other transactions contemplated by the Merger Agreement, including, without limitation, the structure or form of the merger or the other transactions contemplated by the Merger Agreement, or any other agreements or arrangements contemplated by the Merger Agreement or entered into in connection with or otherwise contemplated by the merger or the other transactions contemplated by the Merger Agreement, including, without limitation, the fairness of the merger or any other term or aspect of the merger to, or any consideration to be received in connection therewith by, or the impact of the merger on, the holders of any class of securities, creditors or other constituencies of Sesen Bio or any other party. In addition, SVB Securities expressed no view or opinion as to the fairness (financial or otherwise) of the amount, nature or any other aspect of any compensation to be paid or payable to any of the officers, directors or employees of Sesen Bio or any other party, or class of such persons in connection with the merger or the other transactions contemplated by the Merger Agreement, whether relative to the exchange ratio to be paid by Sesen Bio pursuant to the terms of the Merger Agreement or otherwise. The opinion of SVB Securities was necessarily based on financial, economic, monetary, currency, market and other conditions and circumstances as in effect on, and the information made available to SVB Securities as of, the date of its written opinion, and SVB Securities does not have any obligation or responsibility to update, revise or reaffirm its opinion based on circumstances, developments or events occurring after the date of its opinion. SVB Securities&#8217; opinion does not constitute a recommendation to any stockholder of Sesen Bio as to </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">141</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">whether or how such stockholder should vote with respect to the merger or otherwise act with respect to the merger or the other transactions contemplated by the Merger Agreement or any other matter. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">SVB Securities&#8217; financial advisory services and its opinion were provided for the information and assistance of the Sesen Bio board of directors (in their capacity as directors and not in any other capacity) in connection with and for purposes of its consideration of the merger and the other transactions contemplated by the Merger Agreement. SVB Securities&#8217; opinion was authorized by the SVB Securities LLC Fairness Opinion Review Committee. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Summary of Financial Analyses</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">The following is a summary of the material financial analyses prepared by SVB Securities and reviewed with the Sesen Bio board of directors in connection its opinion, which was delivered orally to the Sesen Bio board of directors on December&#160;29, 2022 and subsequently confirmed in its written opinion, dated December&#160;29, 2022. For purposes of the analyses described below, SVB Securities was directed to rely upon the Internal Data, including the Financial Projections. The summary set forth below does not purport to be a complete description of the financial analyses performed or factors considered by, and underlying the opinion of, SVB Securities, nor does the order of the analyses described below represent the relative importance or weight given to those analyses by SVB Securities. The preparation of a fairness opinion is a complex analytical process involving various determinations as to the most appropriate and relevant methods of financial analysis and the application of those methods to the particular circumstances and, therefore, a fairness opinion is not readily susceptible to summary description. In arriving at its opinion, SVB Securities did not draw, in isolation, conclusions from or with regard to any factor or analysis that it considered. Accordingly, SVB Securities believes that its analyses must be considered as a whole and that selecting portions of such analyses and factors without considering all analyses and factors, could create a misleading or incomplete view of the processes underlying SVB Securities&#8217; financial analyses and its opinion. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">SVB Securities may have deemed various assumptions more or less probable than other assumptions, so the reference ranges resulting from any particular portion of the analyses summarized below should not be taken to be the view of SVB Securities as to the actual value of Carisma. Some of the summaries of the financial analyses set forth below include information presented in tabular format. In order to fully understand the financial analyses, the tables must be read together with the text of each summary, as the tables alone do not constitute a complete description of the financial analyses performed by SVB Securities. In its analyses, SVB Securities made numerous assumptions with respect to industry performance, general business and economic conditions and other matters, many of which are beyond the control of Sesen Bio or any other parties to the merger and the other transactions contemplated by the Merger Agreement. None of Sesen Bio, Carisma, Merger Sub, SVB Securities or any other person assumes responsibility if future results are materially different from those discussed. Any estimates contained in these analyses are not necessarily indicative of actual values or predictive of future results or values, which may be significantly more or less favorable than as set forth below. In addition, analyses relating to the value of Sesen Bio or Carisma do not purport to be appraisals or reflect the prices at which these companies may actually be sold. Accordingly, the assumptions and estimates used in, and the results derived from, the financial analyses are inherently subject to substantial uncertainty. Except as otherwise noted, the following quantitative information, to the extent that it is based on market data, is based on market data as it existed on or before December&#160;29, 2022 and is not necessarily indicative of current market conditions. </font>
          </div>

        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">SVB Securities&#8217; financial analyses and opinion were only one of many factors taken into consideration by the Sesen Bio board of directors in its evaluation of the merger, as described in the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Merger&#8201;&#8212;&#8201;Sesen Bio Reasons for the Merger</font><font style="letter-spacing:0.2pt;">.&#8221; Consequently, the analyses described below should not be viewed as determinative of the views of the Sesen Bio board of directors or management of Sesen Bio with respect to the exchange ratio or as to whether the Sesen Bio board of directors would have been willing to determine that a different exchange ratio was fair. The exchange ratio, as well as the type of consideration payable in the merger, was determined through arm&#8217;s-length negotiations between Sesen Bio and Carisma and was approved by the Sesen Bio board of directors. SVB Securities provided advice to Sesen Bio during these negotiations. However, SVB Securities did not recommend any specific exchange ratio or other financial terms to Sesen Bio or the Sesen Bio board of directors or that any specific exchange ratio or other financial terms constituted the only appropriate consideration for the merger. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">142</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">

          <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">In preparing its analysis, SVB Securities took into account that the exchange ratio contained in the Merger Agreement is calculated by attributing equity values of $90.0&#160;million and $196.0&#160;million to Sesen Bio and Carisma, respectively, subject to certain adjustments set forth in the Merger Agreement and before giving effect to the Carisma pre-closing financing. SVB Securities expressed no opinion as to any such adjustments. </font>
          </div>

        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Valuation Analysis&#8201;&#8212;&#8201;Discounted Cash Flow</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">A discounted cash flow analysis is a traditional valuation methodology used to derive a valuation of an asset or set of assets by calculating the &#8220;present value&#8221; of estimated future cash flows of the asset or set of assets. &#8220;Present value&#8221; refers to the current value of future cash flows or amounts and is obtained by discounting those future cash flows or amounts by a discount rate that takes into account assumptions and estimates of risk, the opportunity cost of capital, expected returns and other appropriate factors, and then adding the present value equivalent of the terminal value of the business at the end of the applicable projection period. SVB Securities performed a discounted cash flow analysis to calculate the estimated present value of the stand-alone, unlevered, after-tax free cash flows that Carisma was forecasted to generate from January&#160;1, 2023 through December&#160;31, 2041, which unlevered, after-tax free cash flows were derived from the Financial Projections on which SVB Securities relied. The time period of the Financial Projections was determined by Sesen Bio assuming U.S. approval and launch of CT-0508 in fiscal year 2027 with a 12-year exclusivity period (ending in fiscal year 2038), which Sesen Bio believes is consistent with current exclusivity for biological products, and includes a 3-year drop off period to account for the anticipated gradual decline in sales once generic competition is projected to enter the market in fiscal year 2039. Sesen Bio advised SVB Securities that it believed it was reasonable to forecast revenues through this projection period. SVB Securities estimated the net present value of unlevered, after-tax free flows after fiscal year 2041 by assuming an annual decline ranging from 10% to 30% of such cash flows in perpetuity, at the direction of Sesen Bio management, which range was determined by Sesen Bio management after taking into account (i)&#160;the uncertainty of the future regulatory pathway for generic cellular therapies, (ii) the potential for market entry of competing therapeutic products following the loss of exclusivity for CT-0508 and (iii) that revenue from the Moderna partnership is expected to begin declining after 2041. These cash flows were discounted to present value as of January&#160;1, 2023, using a discount rate ranging from 11% to 13%, derived from a weighted average cost of capital calculation for Carisma, which SVB Securities performed utilizing the capital asset pricing model with inputs that SVB Securities determined were relevant based on publicly available data and SVB Securities&#8217; professional judgment, including target capital structure, levered and unlevered betas for certain companies deemed by SVB Securities to be comparable to Carisma, size and equity market risk premiums and yields for U.S. treasury bonds, and adjusted for an estimated net cash balance of $9.0 million as of December&#160;31, 2022, as provided by management of Carisma. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">This analysis resulted in an implied equity value for Carisma of approximately $225.0 million to $335.0&#160;million and a corresponding implied exchange ratio of approximately 43.4142x to 64.3783x. The implied equity value for Carisma and corresponding exchange ratio derived from the discounted cash flow analysis performed by SVB Securities in connection with the opinion delivered by SVB Securities with respect to the Original Merger Agreement were approximately $210 million to $320 million and 26.4261x to 40.0919x, respectively. The differences are attributable to a revised estimated cash balance for Carisma as of December 31, 2022 as provided by management of Carisma of $9.0 million as compared to an estimated cash balance of ($6.0) million as provided by management of Carisma reflected in the discounted cash flow analysis performed by SVB Securities in connection with the opinion delivered by SVB Securities on September&#160;20, 2022, resulting in an increase in the implied value of Carisma of $15 million, and a reduction in the equity value attributed to Sesen Bio for purposes of the exchange ratio pursuant to the Merger Agreement Amendment from $140 million to $90 million which, together with the revised implied equity value for Carisma, results in an increase to the implied exchange ratio derived from SVB Securities&#8217; analysis. </font>
          </div>

        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Additional Factors Observed by SVB Securities&#8201;&#8212;&#8201;Carisma Valuation Analysis&#8201;&#8212;&#8201;Selected Public Companies </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As additional factors not part of its financial analysis but noted for reference purposes, SVB Securities reviewed publicly available information relating to the market capitalization of certain U.S.-listed publicly traded biopharmaceutical companies focused on cellular-based therapeutics whose lead products at the time of this analysis were (1)&#160;being developed for the treatment of oncology targets and (2)&#160;in early clinical </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">143</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">

          <div style="width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">development, selected based on SVB Securities&#8217; professional judgment and experience. These companies, which are referred to as the Selected Companies, were: </font>
          </div>


          <table style="width:456pt;height:80.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:154.22pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:-0.16pt;">Company</font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:73.77pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Lead Relevant</font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Program</font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:79.78pt;">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Indication</font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Equity</font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Value</font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">(in millions)</font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Enterprise</font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Value</font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">(in millions)</font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Adjusted</font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Equity</font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Value</font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">(in millions)</font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.25pt 0pt 1.5pt 0pt; width:154.22pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Arcellx, Inc. </font> </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; width:73.77pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">CART-ddBCMA</font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; width:79.78pt;">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:0.2pt;">Multiple Myeloma</font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.85pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">1,579 </td>
              <td style="padding:0pt;padding-left:5.85pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.85pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">1,298 </td>
              <td style="padding:0pt;padding-left:5.85pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.85pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">1,089 </td>
              <td style="padding:0pt;padding-left:5.85pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:154.22pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Celularity Inc. </font> </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:73.77pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">CYNK-001</font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:79.78pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">AML</font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.85pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">164 </td>
              <td style="padding:0pt;padding-left:5.85pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.85pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">161 </td>
              <td style="padding:0pt;padding-left:5.85pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.85pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">142 </td>
              <td style="padding:0pt;padding-left:5.85pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:154.22pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Adicet Bio, Inc. </font> </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:73.77pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">ADI-001</font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:79.78pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">NHL</font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.85pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">350 </td>
              <td style="padding:0pt;padding-left:5.85pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.85pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">67 </td>
              <td style="padding:0pt;padding-left:5.85pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.85pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">63</td>
              <td style="padding:0pt;padding-left:5.85pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
          </table>

        <div style="text-indent:20pt; margin-top:7.8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">SVB Securities noted that although such companies had certain financial and operating characteristics that could be considered similar to those of Carisma, none of the companies had the same management, make-up, technology, size or mix of businesses as Carisma and, accordingly, there were inherent limitations on the applicability of such companies to the valuation analysis of Carisma. In selecting the Selected Companies, based on its professional judgment and expertise, SVB Securities excluded numerous companies meeting the selection criteria described above. These companies were excluded because either (i) the company used technology that, in SVB Securities&#8217; judgment, differed significantly from Carisma&#8217;s autologous CAR-M immunotherapy technology, (ii) in SVB Securities&#8217; judgment, a substantial portion of the company&#8217;s market value was attributable to non-cell therapy assets or other platform technologies, or (iii) the company traded at a negative enterprise value. </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">SVB Securities calculated the aggregate enterprise value of each of the Selected Companies based upon the closing price of the common stock of each Selected Company on December 28, 2022 and the fully-diluted number of shares outstanding, using the treasury stock method. Using the 25</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">th</font><font style="letter-spacing:0.2pt;"> and 75</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">th</font><font style="letter-spacing:0.2pt;"> percentile of the Selected Companies, SVB Securities derived an enterprise value range for Carisma and then added Carisma&#8217;s estimated net cash for year ending December&#160;31, 2022 of $9.0 million to derive adjusted equity values for Carisma. SVB Securities then applied a 20% illiquidity discount to the derived adjusted equity values for Carisma. The results of this analysis are summarized as follows: </font>
          </div>


          <table style="width:416pt;height:56.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <tr style="line-height:9pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:350.67pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;text-align:center;" colspan="4">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Adjusted Equity </font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Value</font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">(in millions) </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.25pt 0pt 1.5pt 0pt; width:350.67pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">25</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">th</font><font style="letter-spacing:0.2pt;"> Percentile </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:16.665pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">105 </td>
              <td style="padding:0pt;padding-left:16.665pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:350.67pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">75</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">th</font><font style="letter-spacing:0.2pt;"> Percentile </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:16.665pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">615</td>
              <td style="padding:0pt;padding-left:16.665pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
          </table>


          <div style="text-indent:20pt; margin-top:7.8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">SVB Securities compared these adjusted equity valuations to the proposed Carisma valuation of $196.0&#160;million based on the proposed valuation and ownership ratio in the Merger Agreement and also compared the resulting implied exchange ratio range of approximately 19.6579x to 117.9667x to the exchange ratio. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">The foregoing analysis differs from the selected companies analysis performed by SVB Securities in connection with the opinion delivered by SVB Securities with respect to the Original Merger Agreement, which resulted in a range of adjusted equity values of approximately $205 million (25</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">th</font><font style="letter-spacing:0.2pt;"> percentile) to $715&#160;million (75</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">th</font><font style="letter-spacing:0.2pt;"> percentile) and a resulting implied exchange ratio range of approximately 25.8592x to 89.5943x. These differences are attributable to: (1) changes in closing stock prices between September 19, 2022 and December 28, 2022; (2) the exclusion of Lyell Immunopharma, Inc. and Nkarta, Inc. from SVB Securities&#8217; Selected Companies analysis in connection with its opinion with respect to the Merger Agreement Amendment because the companies traded at a negative enterprise value; (3) the revised estimated cash balance for Carisma as of December 31, 2022 of $9 million as provided by management of Carisma; and (4) the reduction in the equity value attributed to Sesen Bio for purposes of the exchange ratio pursuant to the Merger Agreement Amendment from $140 million to $90 million. </font>
          </div>

        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">General</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">SVB Securities is a full-service securities firm engaged in securities trading and brokerage activities as well as investment banking and financial advisory services. In the ordinary course of business, SVB Securities and its affiliates currently are providing and may in the future provide investment banking and commercial </font>
          </div>

      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">144</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tCUFP">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">

          <div style="width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">banking services to Sesen Bio, Carisma or their respective affiliates and would expect to receive customary fees for the rendering of such services. In the past two years, SVB Securities has not received any fees for investment banking services from Carisma. In the ordinary course of business, SVB Securities and its affiliates have in the past and may in the future hold positions, for their own account or the accounts of their customers, in equity, debt or other securities of Sesen Bio, Carisma or their respective affiliates. </font>
          </div>

        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Consistent with applicable legal and regulatory requirements, SVB Securities has adopted policies and procedures to establish and maintain the independence of its research department and personnel. As a result, SVB Securities&#8217; research analysts may hold views, make statements or investment recommendations and/or publish research reports with respect to Sesen Bio and the merger and other participants in the merger that differ from the views of SVB Securities&#8217; investment banking personnel. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Sesen Bio board of directors selected SVB Securities to act as Sesen Bio&#8217;s financial advisor in connection with the merger based on SVB Securities&#8217; qualifications, reputation, experience and expertise in the biopharmaceutical industry, its knowledge of and involvement in recent transactions in the biopharmaceutical industry and its relationship and familiarity with Sesen Bio and its business. SVB Securities is an internationally recognized investment banking firm that has substantial experience in transactions similar to the merger and the other transactions contemplated by the Merger Agreement. </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">In connection with SVB Securities&#8217; services as financial advisor to Sesen Bio, Sesen Bio has agreed to pay SVB Securities an aggregate fee of $2.5&#160;million, $750,000 of which became payable upon the rendering by SVB Securities of the opinion on September&#160;20, 2022 with respect to the Original Merger Agreement and the remainder of which is payable contingent upon consummation of the merger. Sesen Bio has agreed to pay SVB Securities a fee of $500,000 in connection with its opinion with respect to the Merger Agreement Amendment, which fee is not creditable against the $2.5 million fee described above. In addition, Sesen Bio has agreed to reimburse certain of SVB Securities&#8217; expenses arising, and to indemnify SVB Securities against certain liabilities that may arise, out of SVB Securities&#8217; engagement. The terms of the fee arrangement between SVB Securities and Sesen Bio, which are customary in transactions of this nature, were negotiated at arm&#8217;s length between SVB Securities and Sesen Bio, and the Sesen Bio board of directors was aware of the arrangement, including the fact that a significant portion of the fee payable to SVB Securities is contingent upon the completion of the merger. </font>
          </div>

        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Certain Unaudited Financial Projections</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">As a matter of course, Sesen Bio does not publicly disclose long-term projections of future financial results due to the inherent unpredictability and subjectivity of underlying assumptions and estimates. However, in connection with the Sesen Bio board of directors&#8217; evaluation of the merger, Carisma management provided to Sesen Bio management certain financial information relating to Carisma, and Sesen Bio management then, on the basis of various assumptions made by Sesen Bio management, prepared certain financial projections with respect to Carisma, such projections referred to herein as the Financial Projections. The Financial Projections were furnished to, and approved for use by, SVB Securities by Sesen Bio for purposes of SVB Securities&#8217; analyses, as described in the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Merger&#8201;&#8212;&#8201;Opinion of Sesen Bio&#8217;s Financial Advisor</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tOOSB">139</a> of this proxy statement/prospectus, and made available to the Sesen Bio board of directors. A summary of the Financial Projections is set forth below.</font>
          </div>

        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The inclusion of the Financial Projections should not be deemed an admission or representation by Sesen Bio, SVB Securities, Carisma or any of their respective officers, directors, affiliates, advisors, or other representatives with respect to such Financial Projections. The Financial Projections are not included to influence your views on the merger and are summarized in this proxy statement/prospectus solely to provide stockholders access to certain non-public information provided to and considered by the Sesen Bio board of directors in connection with its evaluation of the merger and provided to Sesen Bio&#8217;s financial advisor, SVB Securities, to assist with its financial analyses, as described in the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Merger&#8201;&#8212;&#8201;Opinion of Sesen Bio&#8217;s Financial Advisor</font><font style="letter-spacing:0.2pt;">&#8221;. The information from the Financial Projections should be evaluated, if at all, in conjunction with the historical financial statements and other information regarding Carisma in this proxy statement/prospectus. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Financial Projections were not prepared with a view toward public disclosure, nor were they prepared with a view toward compliance with published guidelines of the SEC, the guidelines established by </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">145</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">the American Institute of Certified Public Accountants for preparation and presentation of prospective financial information, or GAAP. Neither the independent registered public accounting firm of Sesen Bio nor Carisma nor any other independent accountant has audited, reviewed, compiled, examined or performed any procedures with respect to the accompanying unaudited prospective financial information for the purpose of its inclusion herein, and accordingly, neither the independent registered public accounting firm of Sesen Bio nor Carisma nor any other independent accountant expresses an opinion or provides any form of assurance with respect thereto for the purpose of this proxy statement/prospectus. The reports of Ernst &amp; Young LLP and KPMG LLP included in this proxy statement/prospectus relate to the consolidated financial statements of Sesen Bio and Carisma, respectively. The reports do not extend to the Financial Projections and should not be read to do so. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Financial Projections include unlevered free cash flow, total adjusted revenue and earnings before interest and taxes, which are &#8220;non-GAAP financial measures&#8221; and which are financial performance measures that are not calculated in accordance with GAAP. Non-GAAP financial measures should not be viewed as a substitute for GAAP financial measures and may be different from non-GAAP financial measures used by other companies. Furthermore, there are limitations inherent in non-GAAP financial measures because they exclude charges and credits that are required to be included in a GAAP presentation. Accordingly, non-GAAP financial measures should be considered together with, and not as an alternative to, financial measures prepared in accordance with GAAP. The SEC rules that would otherwise require a reconciliation of a non-GAAP financial measure to a GAAP financial measure do not apply to non-GAAP financial measures provided to a board of directors or a financial advisor in connection with a proposed business combination transaction such as the merger if the disclosure is included in a document such as this proxy statement/prospectus. In addition, reconciliations of non-GAAP financial measures to a GAAP financial measure were not provided to or relied upon by SVB Securities in connection with rendering its fairness opinion with respect to the merger, as further described in the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Merger&#8201;&#8212;&#8201;Opinion of Sesen Bio&#8217;s Financial Advisor</font><font style="letter-spacing:0.2pt;">&#8221;. Accordingly, Sesen Bio has not provided a reconciliation of the financial measures included in the Financial Projections to the relevant GAAP financial measures. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The financial projections prepared by Carisma and supplied to Sesen Bio were prepared solely for internal use as part of Carisma&#8217;s ongoing strategic planning processes and are subjective in many respects. As a result, the Financial Projections, are susceptible to multiple interpretations and periodic revisions based on actual experience and business developments. Although Carisma and Sesen Bio believe their respective assumptions to be reasonable, all financial projections are inherently uncertain, and Carisma and Sesen Bio expect that differences will exist between actual and projected results. Although presented with numerical specificity, the Financial Projections reflect numerous variables, estimates, and assumptions made by Carisma&#8217;s and Sesen Bio&#8217;s respective management at the time the initial financial projections were prepared by Carisma and prepared by Sesen Bio, and also reflect general business, economic, market, and financial conditions and other matters, all of which are difficult to predict and many of which are beyond Carisma&#8217;s and Sesen Bio&#8217;s control. In addition, the Financial Projections cover an extended period of time, and this information by its nature becomes subject to greater uncertainty with each successive year. Accordingly, there can be no assurance that the estimates and assumptions made in preparing the Financial Projections will prove accurate or that any of the Financial Projections will be realized. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Financial Projections included certain assumptions relating to, among others things, Carisma&#8217;s and Sesen Bio&#8217;s respective expectations, which may not prove to be accurate, relating to the business, earnings, cash flow, assets, liabilities and prospects of Carisma, industry metrics and the regulatory and commercial probability of success and revenue and expenses adjusted on the basis thereof. </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">The Financial Projections were prepared using the following material assumptions: (i) risk-adjusted sales of CT-0508 only for the treatment of breast cancer and gastric cancer</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">1</font><font style="letter-spacing:0.2pt;"> in the U.S., the E.U. Five (France, Germany, Italy, Spain and the United Kingdom) and Japan beginning with U.S. approval and launch </font>
          </div>

      </div>
      <div style="margin-left:69.66pt;width:456pt;">
        <div style="width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>

          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-top:9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">1</font>
            <br >
          </div>
          <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
            <font style="letter-spacing:0.2pt;">The Financial Projections include monotherapy only in breast cancer and gastric cancer as initial market opportunities, and does not include potential upside from expansion into other HER-2 positive solid tumors such as colon, bladder, and liver, or heme malignancy in mono or combo therapy with a checkpoint inhibitor, as well as non-oncology indications such as liver fibrosis, neurodegeneration, and autoimmune disorders.</font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

      </div>
      <div style="margin-top:1.99000000000001pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">146</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">in fiscal year 2027, E.U. Five approval and launch in fiscal year 2028, and Japan approval and launch in fiscal year 2029, with projected peak market share to be achieved five years post-launch in each region in the range of 0.6% to 50% depending on line of treatment and the anticipated competitive landscape (which includes the possibility of new competitive products); (ii) product exclusivity for a period of 12 years, which Sesen Bio believes is consistent with current exclusivity for biological products; (iii) a decline in sales after loss of exclusivity by 30% in the first year, 55% in the second year, and 75% in the third year; (iv) an estimated 75% market access; (v) an estimated 97% compliance/adherence to treatment; (vi) net annual price per patient of approximately $342,000 in the U.S. in fiscal year 2027, $262,000 in the E.U. Five in fiscal year 2028, and $267,000 in Japan in fiscal year 2029, each increasing 2% annually; (vii) costs associated with CT-0508 would include clinical development costs (including $50.0 million for a pivotal trial beginning in fiscal year 2024), technology transfer costs, cost of goods sold at approximately $75,000 per patient, other supporting research and development and general and administrative costs, as well as milestone and royalty obligations associated with the Penn License Agreement; and (viii) risk-adjusted estimated development, regulatory, and commercial milestone income and royalties on net sales of products that are commercialized and associated with Carisma&#8217;s strategic partnership with Moderna. The risk adjustment applied to projected cash flows associated with CT-0508 and the Moderna partnership was based upon phase success rates for CAR-T therapies from Phase 1 to approval, as reported in &#8220;Clinical Development Success Rates and Contributing Factors 2011-2020,&#8221; or the CDSR Report, a study of clinical drug development success rates published by Biotechnology Innovation Organization, Informa Pharma Intelligence and QLS Advisors LLC in February 2021. CAR-T is currently the closest analog against which to compare new CAR-M therapies.</font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">The Financial Projections are subject to many risks and uncertainties and you are urged to review the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Risk Factors</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tRIFA">26</a> of this proxy statement/prospectus for a description of risk factors relating to the merger and Carisma&#8217;s business. You should also read the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Cautionary Statement Concerning Forward-Looking Statements</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tCSCF">118</a> of this proxy statement/prospectus for additional information regarding the risks inherent in forward-looking information such as the Financial Projections. </font>
          </div>

        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The inclusion of the Financial Projections herein should not be regarded as an indication that Sesen Bio, SVB Securities, Carisma or any of their respective affiliates or representatives considered or consider the Financial Projections to be necessarily indicative of actual future events, and the Financial Projections should not be relied upon as such. The Financial Projections do not take into account any circumstances or events occurring after the date they were prepared. Sesen Bio and the combined company do not intend to, and disclaim any obligation to, update, correct, or otherwise revise the Financial Projections to reflect circumstances existing or arising after the date the Financial Projections were generated or to reflect the occurrence of future events, even in the event that any or all of the assumptions or other information underlying the Financial Projections are shown to be in error. Furthermore, the Financial Projections do not take into account the effect of any failure of the merger to be consummated and should not be viewed as accurate or continuing in that context. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">In light of the foregoing factors and the uncertainties inherent in financial projections, stockholders are cautioned not to place undue reliance, if any, on the Financial Projections.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following table, which is subject to the financial projection statements above, presents (in millions) a summary of the Financial Projections prepared by the management of Sesen Bio solely for use by SVB Securities in connection with the rendering of its fairness opinion and performing related financial analysis and made available to the Sesen Bio board of directors. The time period of the Financial Projections was determined by Sesen Bio assuming U.S. approval and launch of CT-0508 in fiscal year 2027 with a 12-year exclusivity period (ending in fiscal year 2038), which Sesen Bio believes is consistent with current exclusivity for biological products, and includes a 3-year drop off period to account for the anticipated gradual decline in sales once generic competition is projected to enter the market in fiscal year 2039. Sesen Bio management and the Sesen Bio board of directors believed the time period of the Financial Projections was reasonable, particularly for the use and preparation of financial forecasts in the biotechnology industry given the anticipated timing for the initiation of commercial sales and the anticipated period of patent term exclusivity for CT-0508.</font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">147</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tIOSB">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <table style="width:456pt;height:67pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:172.65pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="58">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Projected Financial Information for Carisma on a Risk-Adjusted Basis </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.25pt 0pt 2.5pt 0pt; width:172.65pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">($ in millions) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2023E </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2024E </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2025E </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2026E </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2027E </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2028E </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2029E </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2030E </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2031E </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2032E </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:172.65pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total Adjusted Revenue</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(1)</font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">6</td>
            <td style="padding:0pt;padding-left:3.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">12</td>
            <td style="padding:0pt;padding-left:3.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">15</td>
            <td style="padding:0pt;padding-left:3.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">38</td>
            <td style="padding:0pt;padding-left:3.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">73</td>
            <td style="padding:0pt;padding-left:3.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">104</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">130</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">151</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">159</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:172.65pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Earnings Before Interest and Taxes</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(2)</font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">($</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">82<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">($</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">8<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">($</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">3<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">($</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">7<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">10</td>
            <td style="padding:0pt;padding-left:3.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">38</td>
            <td style="padding:0pt;padding-left:3.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">62</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">85</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">100</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">110</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:172.65pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Unlevered Free Cash Flow</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(3)</font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">($</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">86<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">($</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">14<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">($</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">9<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">($</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">12<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">7</td>
            <td style="padding:0pt;padding-left:3.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">28</td>
            <td style="padding:0pt;padding-left:3.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">48</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">66</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">79</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">88</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <table style="width:456pt;height:79pt;margin-top:13pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:155.98pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="52">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Projected Financial Information for Carisma on a Risk-Adjusted Basis </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.25pt 0pt 2.5pt 0pt; width:155.98pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">($ in millions) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2033E </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2034E </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2035E </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2036E </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2037E </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2038E </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2039E </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2040E </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2041E </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:155.98pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total Adjusted Revenue</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(1)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">165</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">169</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">188</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">201</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">213</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">221</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">202</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">167</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">128</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:155.98pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Earnings Before Interest and Taxes</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">&#65279;(2)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">115</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">119</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">137</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">149</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">161</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">169</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">167</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">143</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">112</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.833pt 0pt; width:155.98pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Unlevered Free Cash Flow</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(3)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 0.833pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">92</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 0.833pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">95</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 0.833pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">108</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 0.833pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">118</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 0.833pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">126</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 0.833pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">132</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 0.833pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">134</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 0.833pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">116</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 0.833pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">93</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:12.8pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:8.3pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:8.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Equal to total risk-adjusted revenue. The risk adjustment applied to projected cash flows associated with CT-0508 (probability of success factor of 17%) and the Moderna partnership (cumulative probability of success factor of 6%) was based upon phase success rates for CAR-T therapies from Phase I to approval, as reported in the CDSR Report. CAR-T is currently the closest analog against which to compare new CAR-M therapies. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4.3pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(2)</font>
          <br >
        </div>
        <div style=" margin-top:4.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Earnings before interest and taxes is defined as total adjusted revenue less cost of goods sold, outbound milestones and royalties, research and development expense, sales and marketing expense, general and administrative expense and depreciation expense. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4.3pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(3)</font>
          <br >
        </div>
        <div style=" margin-top:4.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Unlevered free cash flow is defined as earnings before interest and taxes, less tax expense (if profitable), plus depreciation and amortization, less capital expenditures, and less change in net working capital. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Interests of Sesen Bio Directors and Executive Officers in the Merger</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In considering the recommendation of the Sesen Bio board of directors with respect to issuing shares of Sesen Bio common stock as contemplated by the Merger Agreement and the other matters to be acted upon by Sesen Bio stockholders at the Sesen Bio special meeting, Sesen Bio stockholders should be aware that certain members of the Sesen Bio board of directors and certain Sesen Bio executive officers have interests in the merger that may be different from, or in addition to, the interests of Sesen Bio stockholders. These interests may present them with actual or potential conflicts of interest, and these interests, to the extent material, are described below. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Each of the Sesen Bio board of directors and the Carisma board of directors were aware of these potential conflicts of interest and considered them, among other matters, in reaching their respective decisions to approve the Merger Agreement and the merger, and to recommend, as applicable, that Sesen Bio stockholders approve the proposals to be presented to Sesen Bio stockholders for consideration at the Sesen Bio special meeting as contemplated by this proxy statement/prospectus, and that Carisma stockholders sign and return the written consent as contemplated by this proxy statement/prospectus. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Ownership Interests</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">As of January&#160;4, 2023, Sesen Bio&#8217;s directors and current executive officers owned, in the aggregate, less than one&#160;percent of the shares of Sesen Bio common stock, which for purposes of this subsection excludes any Sesen Bio common stock issuable upon (i)&#160;exercise of Sesen Bio options held by such individual or (ii)&#160;vesting of Sesen Bio RSUs held by such individual. The affirmative vote of a majority in voting power of the votes cast by the holders of Sesen Bio common stock present or represented by proxy at the Sesen Bio special meeting and entitled to vote on the matter is required for approval of Proposal Nos. 1, 3, 4 and 5. The affirmative vote of the holders of a majority of the outstanding shares of Sesen Bio common stock on the record date for the Sesen Bio special meeting and entitled to vote on the matter is required for approval of Proposal No. 2. See the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Principal Stockholders of Sesen Bio</font><font style="letter-spacing:0.2pt;">&#8221; on page <a href="#tPSOS">395</a> of this proxy statement/prospectus for a description of the beneficial ownership of Sesen Bio&#8217;s directors and officers. </font>
          </div>

      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">148</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:29.6900000000001pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Effect of the Merger on Sesen Bio Options</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
            <font style="letter-spacing:0.2pt;">As of January&#160;4, 2023, Sesen Bio&#8217;s directors and current executive officers owned, in the aggregate, unvested Sesen Bio options covering 3,499,202 shares of Sesen Bio common stock and vested Sesen Bio options covering 8,215,261 shares of Sesen Bio common stock. </font>
          </div>

        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">All outstanding and unexercised Sesen Bio options granted pursuant to the 2014 Incentive Plan or the 2009 Incentive Plan or as an inducement grant under Nasdaq Listing Rule&#160;5635(c)(4) will remain in effect pursuant to their terms and will be unaffected by the merger. </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
            <font style="letter-spacing:0.2pt;">The following table presents certain information concerning the outstanding Sesen Bio options held by Sesen Bio&#8217;s directors and current executive officers as of January&#160;4, 2023. All of the Sesen Bio options in the table below were out-of-the-money as of January&#160;4, 2023, on which date the closing price per share of Sesen Bio common stock was $0.6340. The number of shares of Sesen Bio common stock underlying such Sesen Bio options will be adjusted appropriately to reflect the proposed reverse stock split. </font>
          </div>


          <table style="width:456pt;height:233.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:264.57pt;text-align:left;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Number of </font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Shares </font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Underlying </font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Vested </font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Options </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Weighted </font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Average </font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Exercise </font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Price of</font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Vested </font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Options </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Number of </font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Shares </font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Underlying </font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Unvested </font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Options </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Weighted </font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Average </font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Exercise </font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Price of </font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Unvested </font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Options </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:italic;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.25pt 0pt 1.5pt 0pt; width:264.57pt;text-align:left;">
                <font style="letter-spacing:-0.2pt;">Executive Officers</font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:264.57pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Thomas R. Cannell, D.V.M </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">4,346,875 </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">1.62 </td>
              <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">1,453,125 </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">2.46 </td>
              <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:264.57pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Monica Forbes </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">1,028,750 </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">1.64 </td>
              <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">531,250 </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">2.18 </td>
              <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:264.57pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Glen MacDonald, Ph.D </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">952,739 </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">1.68</td>
              <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">235,937 </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">2.34 </td>
              <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:264.57pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Minori Rosales, M.D., Ph.D </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">623,000 </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">0.73</td>
              <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:264.57pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Mark R. Sullivan </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">735,000 </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">1.45 </td>
              <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">285,000 </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">2.13 </td>
              <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:italic;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:264.57pt;text-align:left;">
                <font style="letter-spacing:-0.2pt;">Non-Employee Directors</font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:264.57pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Jay S. Duker, M.D </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">321,287 </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">2.29 </td>
              <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">32,500 </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">0.79</td>
              <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:264.57pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Carrie L. Bourdow </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">295,444 </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">1.40 </td>
              <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">39,056 </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">0.80</td>
              <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:264.57pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Peter K Honig, M.D., M.P.H </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">119,861 </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">3.03 </td>
              <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">130,139 </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">3.09</td>
              <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:264.57pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Michael A.S. Jewett, M.D., F.R.C.S.C., F.A.C.S </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">119,861 </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">3.03 </td>
              <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">130,139 </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">3.09 </td>
              <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:264.57pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Jason A. Keyes </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">295,444 </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">1.40 </td>
              <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">39,056 </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">0.80</td>
              <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
          </table>

        <div style="margin-top:13.19pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Effect of the Merger on Sesen Bio RSUs</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
            <font style="letter-spacing:0.2pt;">As of January 4, 2023, Sesen Bio&#8217;s directors and current executive officers owned, in the aggregate, unvested Sesen Bio RSUs covering 3,559,892 shares of Sesen Bio common stock. </font>
          </div>

        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">All outstanding Sesen Bio RSUs granted pursuant to the 2014 Incentive Plan or the 2009 Incentive Plan will remain in effect pursuant to their terms and will be unaffected by the merger. </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
            <font style="letter-spacing:0.2pt;">The following table presents certain information concerning the outstanding Sesen Bio RSUs held by Sesen Bio&#8217;s directors and current executive officers as of January 4, 2023. All of the Sesen Bio RSUs in the table below were unvested as of January 4, 2023 and the value of such RSUs was calculated based on the closing price per share of Sesen Bio common stock on January 4, 2023, which was $0.6340. The number of shares of Sesen Bio common stock underlying such Sesen Bio RSUs will be adjusted appropriately to reflect the proposed reverse stock split. </font>
          </div>

      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">149</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tTOESBEO123">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">

          <table style="width:416pt;height:224.5pt;margin-left:20pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:313.88pt;text-align:left;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Number of </font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Shares</font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Underlying</font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Unvested</font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">RSUs </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Value of</font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">RSUs </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:italic;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.25pt 0pt 1.5pt 0pt; width:313.88pt;text-align:left;">
                <font style="letter-spacing:-0.2pt;">Executive Officers</font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:313.88pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Thomas R. Cannell, D.V.M. </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">1,213,600</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">769,422 </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:313.88pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Monica Forbes </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">913,375</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">579,080 </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:313.88pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Glen MacDonald, Ph.D. </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">595,217</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">377,368 </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:313.88pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Minori Rosales, M.D., Ph.D. </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:313.88pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Mark R. Sullivan </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">637,700</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">404,302 </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:italic;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:313.88pt;text-align:left;">
                <font style="letter-spacing:-0.2pt;">Non-Employee Directors</font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:313.88pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Jay S. Duker, M.D. </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">40,000</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">25,360 </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:313.88pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Carrie L. Bourdow </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">40,000</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">25,360 </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:313.88pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Peter K Honig, M.D., M.P.H. </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">40,000</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">25,360 </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:313.88pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Michael A.S. Jewett, M.D., F.R.C.S.C., F.A.C.S. </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">40,000</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">25,360 </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:313.88pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Jason A. Keyes </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">40,000</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">25,360</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
          </table>

        <div style="margin-top:11.7pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Director Positions Following the Merger</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Thomas R. Cannell, D.V.M., Sesen Bio&#8217;s President and Chief Executive Officer and a member of the Sesen Bio board of directors, is expected to remain a member of the board of directors of the combined company and will receive compensation to be paid to directors of the combined company. For a description of Sesen Bio&#8217;s non-employee director compensation policy and the amounts paid to Sesen Bio&#8217;s non-employee directors in 2021, see the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Sesen Bio Executive Compensation&#8201;&#8212;&#8201;Director Compensation</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tDIRC">357</a> of this proxy statement/prospectus. Pursuant to the terms of the Merger Agreement, effective upon the effective time, all other then-current Sesen Bio directors will resign. Upon the resignation of such directors, all unvested Sesen Bio options and Sesen Bio RSUs held by such directors will be vested in full. All out-of-the money Sesen Bio options will be canceled for no consideration. </font>
          </div>

        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Termination of Existing Sesen Bio Executive Officers Following the Merger and Related Severance Payments</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Sesen Bio has entered into employment agreements with each of its executive officers providing that (i)&#160;upon the termination of each such executive officer&#8217;s employment without &#8220;cause&#8221; or (ii)&#160;if such executive officer terminates his or her employment with Sesen Bio for &#8220;good reason,&#8221; in each case within 12&#160;months (or 18&#160;months for Dr.&#160;Cannell) following a &#8220;change in control transaction,&#8221; as each such term is defined in the respective employment agreements, Sesen Bio is obligated to, among other things, (w)&#160;pay the executive officer an amount equal to his or her base salary for 12&#160;months (24&#160;months for Dr.&#160;Cannell), payable in accordance with Sesen Bio&#8217;s then-current payroll practices, (x)&#160;pay Dr.&#160;Cannell an amount equal to two times his target bonus payment for the year in which the termination of employment occurs, (y)&#160;continue, to the extent allowed by applicable law and the applicable plan documents, to provide the executive officer and certain of his or her dependents with group health and dental insurance for a period of up to 12&#160;months (24&#160;months for Dr.&#160;Cannell), and (z)&#160;accelerate in full the vesting of all outstanding equity awards held by such executive officer. For a description of the employment agreements of Sesen Bio&#8217;s named executive officers, see the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Sesen Bio Executive Compensation&#8201;&#8212;&#8201;Summary Compensation Table&#8201;&#8212;&#8201;Narrative to Summary Compensation Table</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tSBEC">349</a> of this proxy statement/</font>&#8203;<font style="letter-spacing:0.2pt;">prospectus. </font></div>

        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Pursuant to the terms of the Merger Agreement, effective immediately after the effective time, Sesen Bio will terminate the employment of all then-current Sesen Bio executive officers and each such termination will be deemed to be an involuntary termination without &#8220;cause&#8221; after a &#8220;change in control transaction.&#8221; Accordingly, all such executive officers will be entitled to the benefits afforded to each such executive officer in the event of his or her termination without &#8220;cause&#8221; within the period provided for under such executive officer&#8217;s employment agreement following a &#8220;change in control transaction.&#8221; Pursuant to the terms of the Merger Agreement, any severance payments or benefits payable to such executive officers pursuant to </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">150</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">their respective employment agreements will, to the maximum extent permitted by Section&#160;409A of the Code, be paid in a lump sum as soon as practicable following the effective time, provided that the executive officer consents to his or her severance being paid in a lump sum (to the extent such consent is required). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio&#8217;s obligation to pay the severance payments to Dr.&#160;Cannell, Ms.&#160;Forbes, Dr.&#160;MacDonald, Dr.&#160;Rosales and Mr.&#160;Sullivan pursuant to their respective employment agreements is contingent upon the executive&#8217;s execution and non-revocation of a release of claims in favor of Sesen Bio. In addition, Sesen Bio&#8217;s obligation to pay such severance payments is subject to the executive&#8217;s compliance with certain restrictive covenants, including non-competition and non-solicitation (of employees and customers) covenants, which run for one year following the executive&#8217;s termination of employment. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Taxation</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">To the extent that any severance or other compensation payment to Dr.&#160;Cannell, Ms.&#160;Forbes, Dr.&#160;Rosales and Mr.&#160;Sullivan pursuant to his or her employment agreement or any other agreement constitutes an &#8220;excess parachute payment&#8221; within the meaning of Sections&#160;280G and 4999 of the Code, then he or she will receive the full amount of such severance and other payments, or a reduced amount intended to avoid the application of Sections&#160;280G and 4999 of the Code, whichever provides the executive with the highest amount on an after-tax basis. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">2022 Retention Program</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Pursuant to a retention program that was approved by the Sesen Bio board of directors and the Sesen Bio compensation committee on August&#160;28, 2022, certain employees of Sesen Bio, including Ms.&#160;Forbes, Dr.&#160;MacDonald and Mr.&#160;Sullivan, received a cash bonus award, which vests in full upon the earlier of the completion of a potential strategic transaction and the employee&#8217;s termination of employment without cause, subject to the employee&#8217;s continued employment through that time. Pursuant to the retention program, Ms.&#160;Forbes was awarded a cash bonus of $199,894, Dr.&#160;MacDonald was awarded a cash bonus of CAD&#160;$121,153 and Mr.&#160;Sullivan was awarded a cash bonus of $191,013. The foregoing cash bonuses will vest and be paid in connection with the closing of the merger. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Golden Parachute Compensation</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">This section sets forth the information required by Item&#160;402(t) of Regulation&#160;S-K regarding the compensation that is based on or otherwise relates to the merger and that is payable or may become payable to Sesen Bio&#8217;s named executive officers. This compensation is referred to as &#8220;golden parachute&#8221; compensation by the applicable SEC disclosure rules. For purposes of calculating these amounts, Sesen Bio has assumed: </font>
        </div>

          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">the effective time occurred on January 4, 2023; </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">a price per share of Sesen Bio common stock of $0.40, which represents the average closing market price of Sesen Bio common stock over the first five business days following the public announcement on September&#160;21, 2022 of the entry into the Merger Agreement; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the employment of the named executive officer will be terminated on such date in a manner that entitles the named executive officer to receive the severance payments and benefits under the terms of the employment agreement with the named executive officer (as described above). The employment of the named executive officer is expected to be terminated effective immediately after the closing of the merger; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the named executive officer does not enter into a new agreement or otherwise becomes legally entitled to, prior to the effective time, additional compensation or benefits. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The amounts set forth in the table are estimates based on multiple assumptions that may or may not actually occur, including assumptions described below and elsewhere in this proxy statement/prospectus and in the footnotes to the table. Furthermore, the amounts set forth in the table do not reflect any reductions in payments or benefits that could result from the operation of Section&#160;280G of the Code modified cutback provision that is in the employment agreements of Dr.&#160;Cannell and Ms.&#160;Forbes, as described above. As a </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">151</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">result, the actual amounts, if any, that Sesen Bio&#8217;s named executive officers will receive, may materially differ from the amounts set forth in the table. </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;font-style:italic;">
            <font style="font-style:normal;letter-spacing:0.2pt;">For a narrative description of the terms and conditions applicable to the payments quantified in the table below, see the section entitled &#8220;</font><font style="letter-spacing:0.2pt;">The Merger&#8201;&#8212;&#8201;Interests of Sesen Bio Directors and Executive Officers in the Merger&#8201;&#8212;&#8201;Termination of Existing Sesen Bio Executive Officers Following the Merger and Related Severance Payments</font><font style="font-style:normal;letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tTOESBEO123">150</a> of this proxy statement/prospectus. </font>
          </div>


          <table style="width:456pt;height:80.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:228.35pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:-0.16pt;">Name </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Cash</font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">($)</font><font style=" position:relative; bottom:3.25pt;line-height:5pt;font-size:5pt;letter-spacing:-0.12pt;">(1)</font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Equity</font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">($)</font><font style=" position:relative; bottom:3.25pt;line-height:5pt;font-size:5pt;letter-spacing:-0.12pt;">(2)</font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Health </font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Benefits </font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Continuation </font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">($)</font><font style=" position:relative; bottom:3.25pt;line-height:5pt;font-size:5pt;letter-spacing:-0.12pt;">(3)</font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Total</font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">($) </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.25pt 0pt 1.5pt 0pt; width:228.35pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Thomas R. Cannell, D.V.M. </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">1,729,688</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">1,066,690 </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.35pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:5.35pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">2,796,378 </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:228.35pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Monica Forbes </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">599,681</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">577,850 </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.35pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">33,344</td>
              <td style="padding:0pt;padding-left:5.35pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">1,210,875 </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:228.35pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Glen MacDonald, Ph.D. </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">447,071 </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">332,462 </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.35pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">3,371 </td>
              <td style="padding:0pt;padding-left:5.35pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">782,904</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
          </table>

        <div style="margin-top:12.3pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>

          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">(1)</font>
            <br >
          </div>
          <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
            <font style="letter-spacing:0.2pt;">The amounts listed in this column represent (i)&#160;cash severance amounts payable to the named executive officer pursuant to his or her employment agreement equal to 12&#160;months (24&#160;months for Dr.&#160;Cannell) of base salary continuation ($1,153,125 for Dr.&#160;Cannell; $399,788 for Ms.&#160;Forbes; and $364,763 for Dr.&#160;MacDonald), which amounts are payable to the executive in installments over 12&#160;months (24&#160;months for Dr.&#160;Cannell) following the executive&#8217;s termination of employment; (ii)&#160;a cash severance amount payable to Dr.&#160;Cannell equal to two times his annual target bonus payment for calendar year 2022 ($576,563), payable in a lump sum following Dr.&#160;Cannell&#8217;s termination of employment, and (iii)&#160;a cash retention bonus payable to each of Ms.&#160;Forbes ($199,894) and Dr.&#160;MacDonald ($89,414) in a lump sum in connection with the closing of the merger. The cash severance payments payable to Dr.&#160;Cannell, Ms.&#160;Forbes and Dr.&#160;MacDonald pursuant to their respective employment agreements are a double-trigger benefit in that they will be paid only if the executive experiences a qualifying termination of employment within 12&#160;months (18&#160;months for Dr.&#160;Cannell) following the closing of the merger. The cash retention bonuses payable to Ms.&#160;Forbes and Dr.&#160;MacDonald are a single-trigger benefit in that they will be paid upon the consummation of the merger. The cash severance amounts and the cash retention amounts will be paid to Dr.&#160;MacDonald in Canadian dollars. For purposes of this table, such amounts in this column have been converted to U.S. dollars using the exchange rate between CAD and USD in effect on January 4, 2023 of 0.74. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>


          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; line-height:12pt; margin-top:3.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">(2)</font>
            <br >
          </div>
          <div style=" margin-top:3.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
            <font style="letter-spacing:0.2pt;">The amounts listed in this column represent (i)&#160;the value of the full acceleration of vesting of the unvested stock options held by the named executive officer ($581,250 for Dr.&#160;Cannell; $212,500 for Ms.&#160;Forbes; and $94,375 for Dr.&#160;MacDonald), and (ii)&#160;the value of the full acceleration of vesting of the unvested restricted stock&#160;units held by the named executive officer ($485,440 for Dr.&#160;Cannell; $365,350 for Ms.&#160;Forbes; and $238,087 for Dr.&#160;MacDonald). The acceleration of vesting of the named executive officers&#8217; unvested equity awards is a double-trigger benefit in that it will occur only if the executive experiences a qualifying termination of employment within 12&#160;months (18&#160;months for Dr.&#160;Cannell) following the closing of the merger. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

        <div style=" float:left; line-height:12pt; margin-top:3.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(3)</font>
          <br >
        </div>
        <div style=" margin-top:3.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">The amounts listed in this column represent the value of continued group health and dental insurance benefits to be provided to the named executive officer (and his or her eligible dependents) pursuant to their respective employment agreements for a period of up to 24&#160;months for Dr.&#160;Cannell and up to 12&#160;months for each of Ms.&#160;Forbes and Dr.&#160;MacDonald. This is a double-trigger benefit in that it will be provided only if the executive experiences a qualifying termination of employment within 12&#160;months (18&#160;months for Dr.&#160;Cannell) following the closing of the merger. As of the date of this proxy statement/</font>&#8203;<font style="letter-spacing:0.2pt;">prospectus, Dr.&#160;Cannell is not enrolled in Sesen Bio&#8217;s group health and dental insurance benefits and, therefore, would not receive any health benefit continuation payments in connection with his qualifying termination of employment. </font></div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Indemnification and Insurance</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Pursuant to the Merger Agreement, from the effective time through the sixth anniversary of the date on which the effective time occurs, each of Sesen Bio and the surviving corporation is required to indemnify and hold harmless each person who is or has served as a director or officer of Sesen Bio or Carisma </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">152</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tIOCD">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">against all claims, all claims, judgments, fines and reasonable fees, costs and expenses, including attorneys&#8217; fees and disbursements and investigation costs incurred in connection with any claim, action, suit, proceeding or investigation, whether civil, criminal, administrative or investigative, or any other actual, threatened or completed proceeding arising out of or pertaining to the fact that such person is or was a director or officer of Sesen Bio, to the fullest extent permitted under the DGCL for directors or officers of Delaware corporations. In addition, each such director and officer, or former director and officer, is entitled to advancement of expenses incurred in the defense of any such claim, action, suit, proceeding or investigation. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Pursuant to the Merger Agreement, the provisions of the Sesen Bio Certificate of Incorporation and the Sesen Bio Bylaws with respect to indemnification, advancement of expenses and exculpation of present and former directors and officers of Sesen Bio will not be amended, modified or repealed for a period of six&#160;years from the effective time in a manner that would adversely affect the rights thereunder of individuals who, at or prior to the effective time, were officers or directors of Sesen Bio, unless such modification is required by applicable law. The Carisma Certificate of Incorporation and Carisma Bylaws, as the surviving corporation in the merger, shall contain provisions no less favorable with respect to indemnification, advancement of expenses and exculpation of present and former directors and officers than those that are presently set forth in the Sesen Bio Certificate of Incorporation and Sesen Bio Bylaws. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The Merger Agreement also provides that Sesen Bio shall maintain directors&#8217; and officers&#8217; liability insurance policies commencing at the closing of the merger, on commercially available terms and conditions with coverage limits customary for U.S. public companies similarly situated to Sesen Bio. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Interests of Carisma Directors and Executive Officers in the Merger</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">In considering the recommendation of the Carisma board of directors with respect to approving the merger, stockholders should be aware that certain members of the Carisma board of directors and certain Carisma executive officers have interests in the merger that may be different from, or in addition to, the interests of Carisma stockholders. These interests may present them with actual or potential conflicts of interest, and these interests, to the extent material, are described below. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Each of the Sesen Bio board of directors and the Carisma board of directors were aware of these potential conflicts of interest and considered them, among other matters, in reaching their respective decisions to approve the Merger Agreement and the merger, and to recommend, as applicable, that Sesen Bio stockholders approve the proposals to be presented to Sesen Bio stockholders for consideration at the Sesen Bio special meeting as contemplated by this proxy statement/prospectus, and that Carisma stockholders sign and return the written consent as contemplated by this proxy statement/prospectus. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Ownership Interests</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
            <font style="letter-spacing:0.2pt;">As of January 4, 2023, Carisma&#8217;s directors and current executive officers owned, in the aggregate approximately 2.36% of the outstanding shares of Carisma capital stock, which for purposes of this subsection excludes any shares of Carisma common stock issuable upon exercise or settlement of Carisma options held by each such individual. See the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Principal Stockholders of Carisma</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page&#160;<a href="#tPSOC">397</a> of this proxy statement/prospectus for a description of the beneficial ownership of Carisma&#8217;s directors and officers.</font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
            <font style="letter-spacing:0.2pt;">Certain Carisma stockholders affiliated with Carisma directors also currently hold shares of Carisma capital stock. The table below sets forth the ownership of Carisma capital stock by affiliates of Carisma&#8217;s directors as of January 4, 2023. These Carisma stockholders have also agreed to purchase shares in the Carisma pre-closing financing, which is conditioned upon the satisfaction and waiver of the conditions to the merger as well as certain other conditions. See the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Related Party Transactions of Directors and Executive Officers of the Combined Company &#8212; Carisma Transactions &#8212; Carisma Pre-Closing Financing</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tCARPREC123">369</a> of this proxy statement/prospectus for a description of such relationships. </font>
          </div>

      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">153</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <table style="width:456pt;height:86.5pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:379.59pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Stockholder</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;text-align:center;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Number of</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Shares of </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Capital Stock Held</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:379.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">AbbVie Biotechnology Ltd</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(1)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">1,204,160</td>
            <td style="padding:0pt;padding-left:12pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:379.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">HealthCap VII L.P.</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(2)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">1,485,912</td>
            <td style="padding:0pt;padding-left:12pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:379.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">SymBiosis II, LLC</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(3)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">961,492</td>
            <td style="padding:0pt;padding-left:12pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:379.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Wellington Life Sciences V GmbH &amp; Co. KG</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(4)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">998,079</td>
            <td style="padding:0pt;padding-left:12pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:12.7pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:8.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:8.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Consists of (i)&#160;947,762 shares of Carisma common stock issuable upon conversion of the Carisma Series A preferred stock and (ii) 256,398 shares of Carisma common stock issuable upon conversion of the Carisma Series B preferred stock held by AbbVie Biotechnology Ltd. AbbVie Biotechnology Ltd. holds voting and investment control over the shares. The Board of Directors of AbbVie Biotechnology Ltd. consists of Lindsey Bristow, Jonathan C. Clipper, Stephen Muldoon and Arthur Price. Each of Ms. Bristow and each of Messrs. Clipper, Muldoon and Price may be deemed to share voting and investment power with respect to the shares held by AbbVie Biotechnology Ltd. and disclaim beneficial ownership of all shares held by AbbVie Biotechnology Ltd., except to the extent of their pecuniary interest therein, if any. Margarita Chavez is employed as a Managing Director of AbbVie Ventures and is a member of the Carisma board of directors. Ms. Chavez disclaims beneficial ownership of all shares held by AbbVie Biotechnology Ltd. except to the extent of her pecuniary interest therein, if any. The business address of AbbVie Biotechnology Ltd. is Thistle House, 4 Burnaby Street, Hamilton HM 11, Bermuda.</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(2)</font>
          <br >
        </div>
        <div style=" margin-top:4.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Consists of (i) 250,647 shares of Carisma common stock issuable upon conversion of the Carisma Series A preferred stock, (ii)&#160;937,501 shares of Carisma common stock issuable upon the conversion of the Carisma special voting preferred stock and (iii)&#160;297,764 shares of Carisma common stock issuable upon the conversion of the Carisma Series B special voting preferred stock held by HealthCap VII, L.P. HealthCap VII GP SA, a Swiss registered L.C.C., is the sole general partner of HealthCap VII, L.P. and has voting and investment control over the shares. HealthCap VII GP SA disclaims beneficial ownership of all shares held by HealthCap VII L.P., except to the extent of its pecuniary interest therein. Fabrice Bernhard is the General Manager of HealthCap VII GP SA. Dag Richter, Daniel Schafer and Frans Wuite are each Directors of HealthCap VII GP SA. Each of Messrs. Bernhard, Richter, Schafer and Wuite may be deemed to share voting and investment power with respect to the shares held by HealthCap VII L.P. and disclaim beneficial ownership of all shares held by HealthCap VII L.P., except to the extent of their pecuniary interest therein. Bj&#246;rn Odlander is a Managing Partner of HealthCap and is a member of the Carisma board of directors. Dr. Odlander disclaims beneficial ownership of all shares held by HealthCap VII L.P. except to the extent of his pecuniary interest therein, if any. The business address of HealthCap VII L.P. is c/o HealthCap VII GP SA, Avenue Villamont 23, CH 1005&#160;Lausanne Switzerland.</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(3)</font>
          <br >
        </div>
        <div style=" margin-top:4.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Consists of 961,492 shares of Carisma common stock issuable upon conversion of the Carisma Series B preferred stock held by SymBiosis II, LLC, which exercises voting and investment control of the shares. Chidozie Ugwumba is the Managing Partner of Symbiosis II, LLC and as such has sole voting and investment control over the shares. Mr. Ugwumba is also a member of the Carisma board of directors. The business address of Symbiosis II, LLC is 609 S.W. 8th Street, Suite 365, Bentonville, Arkansas&#160;72712.</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4.09pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(4)</font>
          <br >
        </div>
        <div style=" margin-top:4.09pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Consists of (i)&#160;798,072 shares of Carisma common stock issuable upon conversion of the Carisma Series A preferred stock and (ii)&#160;200,007 shares of Carisma common stock issuable upon conversion of the Carisma Series B preferred stock held by Wellington Life Sciences V GmbH &amp; Co. KG, or the Wellington Fund. The Wellington Fund is represented by Wellington Life Sciences Venture Capital Consulting GmbH, or the Wellington General Partner. The Wellington General Partner holds voting and investment control over the shares. Dr.&#160;Regina Hodits and Dr. Rainer Strohmenger, in their functions as managing directors of the Wellington General Partner, have individual signatory power as well as voting and/or investment control over the shares. Dr.&#160;Regina Hodits is a member of the Carisma board of directors. Dr.&#160;Regina Hodits disclaims beneficial ownership of all shares held by the Wellington Fund except to the extent of her pecuniary interest therein, if any. The business address of the Wellington Fund and the Wellington General Partner is Tuerkenstrasse 5, 80333 Munich, Germany.</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">154</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Effect of the Merger on Carisma Options</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <div style="text-indent:20pt; margin-top:7.12pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">As of January 4, 2023, Carisma&#8217;s directors and current executive officers owned, in the aggregate, unvested Carisma options covering 328,143 shares of Carisma common stock and vested Carisma options covering&#160;672,186 shares of Carisma common stock. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Under the terms of the Merger Agreement, each option to purchase shares of Carisma common stock that is outstanding and unexercised immediately prior to the effective time under the Carisma Plan and that, following assumption by Sesen Bio at the effective time, will be eligible to be registered on Form S-8, whether or not vested, will be converted into and become an option to purchase shares of Sesen Bio common stock. Sesen Bio will assume the Carisma Plan and each such outstanding Carisma option in accordance with the terms (as in effect as of the date of the Original Merger Agreement) of the Carisma Plan and the terms of the stock option agreement by which such Carisma option is evidenced. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">The following table presents certain information concerning the outstanding Carisma options held by Carisma directors and current executive officers as of January 4, 2023. The number of shares of Carisma common stock underlying such Carisma options and the exercise price of such Carisma options will be adjusted appropriately to reflect the exchange ratio. See the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Merger Agreement &#8212; Treatment of Carisma Options</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tTMAER7">174</a> of this proxy statement/prospectus for a more detailed description of the treatment of Carisma options in the merger. </font>
          </div>


          <table style="width:456pt;height:218.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:217.64pt;text-align:left;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Number of </font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Shares </font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Underlying </font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Vested Options </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Weighted </font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Average </font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Exercise </font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Price of </font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Vested Options </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Number of </font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Shares</font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Underlying</font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Unvested Options </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Weighted </font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Average </font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Exercise </font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Price of </font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Unvested </font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Options </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:italic;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.25pt 0pt 1.5pt 0pt; width:217.64pt;text-align:left;">
                <font style="letter-spacing:-0.2pt;">Executive Officers</font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:8.77pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:8.77pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:13.77pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:13.77pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:12.93pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:12.93pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:217.64pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Steven Kelly </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:8.77pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">445,814 </td>
              <td style="padding:0pt;padding-left:8.77pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:13.77pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">1.59 </td>
              <td style="padding:0pt;padding-left:13.77pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:12.93pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">102,657</td>
              <td style="padding:0pt;padding-left:12.93pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">2.77</td>
              <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:217.64pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Richard Morris </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:8.77pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">69,004 </td>
              <td style="padding:0pt;padding-left:8.77pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:13.77pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">2.77</td>
              <td style="padding:0pt;padding-left:13.77pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:12.93pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">105,322 </td>
              <td style="padding:0pt;padding-left:12.93pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">2.77</td>
              <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:217.64pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Michael Klichinsky, Pharm.D., Ph.D. </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:8.77pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">101,343 </td>
              <td style="padding:0pt;padding-left:8.77pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:13.77pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">1.38 </td>
              <td style="padding:0pt;padding-left:13.77pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:12.93pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">27,657 </td>
              <td style="padding:0pt;padding-left:12.93pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">2.77</td>
              <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:italic;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:217.64pt;text-align:left;">
                <font style="letter-spacing:-0.2pt;">Directors</font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:8.77pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:8.77pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:13.77pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:13.77pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:12.93pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:12.93pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:217.64pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Margarita Chavez </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:8.77pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:8.77pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:13.77pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:13.77pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:12.93pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:12.93pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:217.64pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Regina Hodits, Ph.D. </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:8.77pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:8.77pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:13.77pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:13.77pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:12.93pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:12.93pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:217.64pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Briggs Morrison, M.D. </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:8.77pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">29,700 </td>
              <td style="padding:0pt;padding-left:8.77pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:13.77pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">1.76</td>
              <td style="padding:0pt;padding-left:13.77pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:12.93pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">21,632 </td>
              <td style="padding:0pt;padding-left:12.93pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">1.86 </td>
              <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:217.64pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Bj&#246;rn Odlander, M.D., Ph.D. </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:8.77pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:8.77pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:13.77pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:13.77pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:12.93pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:12.93pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:217.64pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Chidozie Ugwumba </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:8.77pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:8.77pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:13.77pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:13.77pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:12.93pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:12.93pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:217.64pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Sanford Zweifach </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:8.77pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">26,325 </td>
              <td style="padding:0pt;padding-left:8.77pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:13.77pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">2.77</td>
              <td style="padding:0pt;padding-left:13.77pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:12.93pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">70,875 </td>
              <td style="padding:0pt;padding-left:12.93pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">2.77</td>
              <td style="padding:0pt;padding-left:4.295pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
          </table>

        <div style="margin-top:9.31pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Support Agreements</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <div style="text-indent:20pt; margin-top:7.12pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Each of Carisma&#8217;s executive officers and the majority of Carisma&#8217;s directors have also entered into a support agreement in connection with the merger, whereby such executive officers and directors have agreed to vote their shares in favor of adoption of the Merger Agreement and approval of the merger. For a more detailed discussion of the support agreements, see the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Agreements Related to the Merger&#8201;&#8212;&#8201;Support Agreements and Written Consents</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tSAAW">197</a> of this proxy statement/</font>&#8203;<font style="letter-spacing:0.2pt;">prospectus. </font></div>

        <div style="margin-top:11.32pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Management Following the Merger</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <div style="text-indent:20pt; margin-top:7.11pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">As described in the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Management Following the Merger</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tMFTM">342</a> of this proxy statement/prospectus, certain members of the Carisma board of directors and Carisma executive officers are expected to become the directors and executive officers of the combined company upon the closing of the merger. </font>
          </div>

        <div style="margin-top:11.22pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Indemnification and Insurance</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.11pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Pursuant to the Merger Agreement, from the effective time through the sixth anniversary of the date on which the effective time occurs, each of Sesen Bio and the surviving corporation in the merger is required </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">155</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tFOTM">&#8203;</a><a name="tETOT">&#8203;</a><a name="tMCAE">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">to indemnify and hold harmless each person who is or has served as a director or officer of Sesen Bio or Carisma against all claims, all claims, judgments, fines and reasonable fees, costs and expenses, including attorneys&#8217; fees and disbursements and investigation costs incurred in connection with any claim, action, suit, proceeding or investigation, whether civil, criminal, administrative or investigative, or any other actual, threatened or completed proceeding arising out of or pertaining to the fact that such person is or was a director or officer of Sesen Bio, to the fullest extent permitted under the DGCL for directors or officers of Delaware corporations. In addition, each such director and officer, or former director and officer, is entitled to advancement of expenses incurred in the defense of any such claim, action, suit, proceeding or investigation. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Pursuant to the Merger Agreement, the provisions of the Sesen Bio Certificate of Incorporation and the Sesen Bio Bylaws with respect to indemnification, advancement of expenses and exculpation of present and former directors and officers of Sesen Bio will not be amended, modified or repealed for a period of six&#160;years from the effective time in a manner that would adversely affect the rights thereunder of individuals who, at or prior to the effective time, were officers or directors of Sesen Bio, unless such modification is required by applicable law. The Carisma Certificate of Incorporation and the Carisma Bylaws, as the surviving corporation in the merger, shall contain provisions no less favorable with respect to indemnification, advancement of expenses and exculpation of present and former directors and officers than those that are presently set forth in the Sesen Bio Certificate of Incorporation and Sesen Bio Bylaws. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Merger Agreement also provides that Sesen Bio shall maintain directors&#8217; and officers&#8217; liability insurance policies commencing at the closing of the merger, on commercially available terms and conditions with coverage limits customary for U.S. public companies similarly situated to Sesen Bio. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Form of the Merger</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Merger Agreement provides that at the effective time, Merger Sub will be merged with and into Carisma, with Carisma surviving as a wholly-owned subsidiary of Sesen Bio. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">After completion of the merger, Sesen Bio will change its corporate name from &#8220;Sesen Bio, Inc.&#8221; to &#8220;Carisma Therapeutics Inc.&#8221; as contemplated by the Merger Agreement. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Effective Time of the Merger</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Merger Agreement requires the parties to consummate the merger as promptly as practicable (and in any event within two business days) after all of the conditions to the consummation of the merger contained in the Merger Agreement are satisfied or waived. The merger will become effective upon the filing of a certificate of merger with the Secretary of State of the State of Delaware or at such later time as is agreed by Sesen Bio and Carisma and specified in the certificate of merger. Neither Sesen Bio nor Carisma can predict the exact timing of the consummation of the merger. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Merger Consideration and Exchange Ratio</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Merger Consideration</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">At the effective time, upon the terms and subject to the conditions set forth in the Merger Agreement, each outstanding share of Carisma&#8217;s capital stock (including shares of Carisma capital stock sold in the Carisma pre-closing financing but excluding (i)&#160;shares of Carisma capital stock to be canceled pursuant to the Merger Agreement and (ii)&#160;Carisma common stock held by holders of Carisma common stock who have exercised and perfected appraisal rights or dissenters&#8217; rights) will be automatically converted solely into the right to receive a number of shares of Sesen Bio common stock and each outstanding Carisma option will become exercisable for shares of Sesen Bio common stock, in each case, equal to the exchange ratio described in more detail below. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">No fractional shares of Sesen Bio common stock will be issued in connection with the merger, and no certificates or scrip for any such fractional shares will be issued. Any fractional shares of Sesen Bio common stock resulting from the conversion of Carisma capital stock will receive cash (without interest and subject to applicable tax withholding) in an amount equal to such fractional part of a share of Sesen Bio common </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">156</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">stock multiplied by the last reported sale price of Sesen Bio common stock at 4:00&#160;p.m., Eastern Time, end of regular trading hours on Nasdaq on the last day prior to the effective time. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Exchange Ratio</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">The exchange ratio is calculated using a formula intended to allocate existing Sesen Bio and Carisma stockholders a&#160;percentage of the combined company. Based on Sesen Bio&#8217;s capitalization and Carisma&#8217;s capitalization as of December 29, 2022, the date the Merger Agreement Amendment was executed, the exchange ratio is estimated to be approximately 37.7924 shares of Sesen Bio common stock. This estimate is subject to adjustment prior to the closing of the merger for net cash at the cash determination time and aggregate proceeds from the sale of Carisma common stock in the Carisma pre-closing financing (and, as a result, Sesen Bio stockholders could own more, and Carisma stockholders (including, for this purpose, investors in the Carisma pre-closing financing) could own less, or vice versa, of the combined company). </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Based on the estimates set forth above, and certain other assumptions, Sesen Bio stockholders would own approximately 25.2% of the common stock of the combined company post-merger, and Carisma stockholders would own approximately 74.8% of the common stock of the combined company post-merger, of which the shares issued in the Carisma pre-closing financing and the shares issued upon the conversion of the Carisma convertible note are expected to represent approximately 8.4% and 11.3%, respectively, of the common stock of the combined company post-merger. For more information on the Carisma pre-closing financing, see the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Agreements Related to the Merger&#8201;&#8212;&#8201;Subscription Agreement</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tSUAG">198</a> of this proxy statement/prospectus. </font>
          </div>

        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The exchange ratio formula is the quotient obtained (rounded to four decimal places) by dividing the number of Carisma merger shares (defined below) by the Carisma outstanding shares (defined below), in which: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">&#8220;Aggregate valuation&#8221; means the sum of the (i)&#160;Carisma valuation plus (ii)&#160;the Sesen Bio valuation. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">&#8220;Carisma allocation&#160;percentage&#8221; means the quotient (expressed as a&#160;percentage with the&#160;percentage rounded to four decimal places) determined by dividing (i)&#160;the Carisma valuation by (ii)&#160;the aggregate valuation. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">&#8220;Carisma merger shares&#8221; means the product determined by multiplying (i)&#160;the post-closing Sesen Bio shares by (ii)&#160;the Carisma allocation&#160;percentage. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">&#8220;Carisma outstanding shares&#8221; means the total number of shares of Carisma capital stock outstanding immediately prior to the effective time expressed on a fully-diluted and as-converted to Carisma common stock basis and assuming, without limitation or duplication, (i)&#160;the exercise of all Carisma options outstanding as of immediately prior to the effective time, (ii)&#160;the closing of the Carisma pre-closing financing, and (iii)&#160;the issuance of shares of Carisma common stock issuable in respect of all other outstanding options, restricted stock awards, warrants or rights to receive such shares, whether conditional or unconditional and including any outstanding options, warrants or rights triggered by or associated with the consummation of the Merger. Carisma outstanding shares shall also include all shares of the Carisma issued in the Carisma pre-closing financing prior to the effective time and excludes any shares issued upon the conversion of the Carisma convertible note. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">&#8220;Carisma valuation&#8221; means (i)&#160;$196.0&#160;million, plus (ii)&#160;the amount of gross proceeds from the Carisma pre-closing financing prior to the effective time. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">&#8220;Sesen Bio allocation&#160;percentage&#8221; means the quotient (expressed as a&#160;percentage with the&#160;percentage rounded to four decimal places) determined by dividing (i)&#160;the Sesen Bio valuation by (ii)&#160;the aggregate valuation. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">&#8220;Sesen Bio outstanding shares&#8221; means the total number of shares of Sesen Bio common stock outstanding immediately prior to the effective time expressed on a fully-diluted and as converted to Sesen Bio common stock basis, assuming, without limitation or duplication, the issuance of shares of Sesen Bio common stock in respect of all Sesen Bio options, Sesen Bio RSUs, Sesen Bio warrants and other outstanding options, warrants or rights to receive such shares, in each case, outstanding as of immediately prior to the effective time. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">157</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tSBFN">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">

          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">&#8220;Sesen Bio valuation&#8221; means $140.0&#160;million, minus the amount by which net cash at the cash determination time is less than $125.0&#160;million, plus the amount by which net cash at the cash determination time is greater than $125.0&#160;million. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.89pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.89pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">&#8220;Post-closing Sesen Bio shares&#8221; mean the quotient determined by dividing (i)&#160;the Sesen Bio outstanding shares by (ii)&#160;the Sesen Bio allocation&#160;percentage. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Sesen Bio&#8217;s Final Net Cash</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Pursuant to the terms of the Merger Agreement, Sesen Bio&#8217;s &#8220;final net cash&#8221; means, as of the cash determination time (which is as of 8:00&#160;p.m. Eastern Time on the last business day prior to the anticipated closing date) the sum (without duplication) of the following: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">cash and cash equivalents, marketable securities and other short-term investments of Sesen Bio and its subsidiaries; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.99pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6.99pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">Sesen Bio&#8217;s accounts receivable (including any tax refund claims pending as of the date of the Original Merger Agreement), deposits and interest; and </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Seen Bio&#8217;s deposits, prepaid expenses and other prepaid assets which are reflected on the most recent balance sheet and do not constitute restricted cash of Sesen Bio and its subsidiaries; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.99pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.99pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">50% of the cost of settling any transaction litigation to the extent actually paid in cash by Sesen Bio prior to the closing date; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;font-style:italic;letter-spacing:0.2pt;">minus</font><font style="letter-spacing:0.2pt;">, the sum (without duplication) of the following: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">any unpaid transaction expenses of Sesen Bio or its subsidiaries; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">any unpaid indebtedness of Sesen Bio and/or its subsidiaries outstanding as of the closing date; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.99pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.99pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">any accounts payable, accrued expenses or short or long term liabilities that are or will become payable in cash, including any such accounts payable, accrued expenses or short or long term liabilities under any Sesen Bio contracts that were in effect prior to the effective time or associated with the termination of any Sesen Bio contracts which were in effect prior to the effective time, or the termination before, at or after the effective time, of all current or former employees of Sesen Bio and its subsidiaries (even if the applicable expenses or amounts are due and payable after the effective time); </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">any unpaid employer portion of payroll or employment taxes incurred in connection with the grant, exercise, conversion, settlement or cancellation of Sesen Bio RSUs, Sesen Bio options, equity compensation and other change in control or severance payments (including bonuses payable) due under the Merger Agreement or CVRs issued to holders of Sesen Bio RSUs or Sesen Bio options or otherwise as compensation (either incurred prior to or at the time of the Merger, and for the avoidance of doubt, not calculated as of the close of business on the business day prior to the closing date) in each case, incurred in connection with the merger by Sesen Bio at or prior to the effective time (even if payable after the effective time); </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">any pre-payment, termination, &#8220;end of term&#8221; or similar fee or charge payable to any lender in connection with the repayment of indebtedness by Sesen Bio at or prior to the effective time; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the amount of any cash dividend declared (or to be declared) but not yet paid as part of the pre-closing dividend; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.99pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.99pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">to the extent unpaid at closing, the cost and/or premium of the directors&#8217; and officer&#8217;s &#8220;tail policy&#8221;; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.99pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6.99pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">to the extent unpaid at closing, the cost of settling any legal proceeding or other dispute existing as of the date of the Original Merger Agreement, as well as the unpaid deductible amount under Sesen Bio&#8217;s insurance reasonably expected to be payable in connection with legal proceedings existing as of the date of the Original Merger Agreement. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">158</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tPFEC">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Each component of net cash, to the extent applicable, shall be determined in accordance with U.S. GAAP, applied on a basis consistent with the application of U.S. GAAP in the preparation of Sesen Bio&#8217;s most recent audited or reviewed financial statements. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Not more than ten nor less than five calendar days prior to the anticipated closing date, Sesen Bio will deliver to Carisma a schedule, or the net cash schedule, setting forth, in reasonable detail, Sesen Bio&#8217;s good faith estimated calculation of its net cash at the cash determination time, prepared and certified by Sesen Bio&#8217;s Chief Executive Officer and Chief Financial Officer (or if there is no chief financial officer at such time, the principal financial and accounting officer of Sesen Bio) together with the work papers and back-up materials used or useful in preparing the net cash schedule, as reasonably requested by Carisma. Within three business days after delivery of the net cash schedule (the last day of such period referred to as the response date), Carisma will have the right to dispute all or any part of the net cash schedule by delivering a written notice to that effect to Sesen Bio (referred to herein as a dispute notice). Any dispute notice will identify in reasonable detail to the extent then known, the nature and amounts of any proposed revisions to Sesen Bio&#8217;s net cash calculation. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If Carisma disputes the net cash schedule prior to 8:00&#160;pm Eastern Time on the response date, the parties will promptly, and in no event later than one calendar day after the response date, meet and attempt in good faith to resolve the disputed item(s) and negotiate an agreed-upon determination of net cash. If the parties are unable to negotiate an agreed-upon determination of net cash thereof within two calendar days after the delivery of a dispute notice (or such other period as Sesen Bio and Carisma may mutually agree upon in writing), then any remaining disagreements as to the calculation of net cash will be referred to Deloitte &amp; Touche LLP or another independent auditor of recognized national standing mutually agreed upon by Sesen Bio and Carisma. The determination of the amount of net cash made by such auditor shall be final and binding on Sesen Bio and Carisma. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio&#8217;s net cash balance is subject to numerous factors, some of which are outside of Sesen Bio&#8217;s control. The actual amount of net cash will depend significantly on the timing of the closing of the merger. In addition, the closing of the merger could be delayed if Sesen Bio and Carisma are not able to agree upon the amount of Sesen Bio&#8217;s net cash as of the cash determination time. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Procedures for Exchanging Carisma Stock Certificates</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Merger Agreement provides that, at the effective time, Sesen Bio will deposit with an exchange agent acceptable to Sesen Bio and Carisma evidence of book-entry shares representing the shares of Sesen Bio common stock issuable to Carisma stockholders and a sufficient amount of cash to make payments in lieu of fractional shares. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Merger Agreement provides that, promptly after the effective time, the exchange agent will mail to each record holder of Carisma capital stock immediately prior to the effective time a letter of transmittal and instructions for surrendering and exchanging Carisma stock certificates or transfer of book-entry shares held by such record holder in exchange for book-entry shares of Sesen Bio common stock. Upon surrender of a Carisma stock certificate or transfer of book-entry shares for exchange to the exchange agent, together with a duly signed letter of transmittal and such other documents as the exchange agent or Sesen Bio may reasonably require, the Carisma stock certificate or book-entry share surrendered will be cancelled and the holder of such Carisma stock certificate or book-entry share will be entitled to receive the following: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">book-entry shares representing the number of whole shares of Sesen Bio common stock that such holder has the right to receive pursuant to the provisions of the Merger Agreement, and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">cash in lieu of any fractional share of Sesen Bio common stock. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">From and after the effective time, until it is surrendered, each certificate or book-entry share that previously evidenced shares of Carisma capital stock will be deemed to represent only the right to receive shares of Sesen Bio common stock, and cash in lieu of any fractional share of Sesen Bio common stock. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If any Carisma stock certificate has been lost, stolen or destroyed, Sesen Bio may, in its discretion, and as a condition precedent to the delivery of any book-entry shares of Sesen Bio common stock, require the owner of such lost, stolen or destroyed certificate to provide an affidavit claiming such certificate has been </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">159</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tREAP">&#8203;</a><a name="tMUFI">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">lost, stolen or destroyed and, at Sesen Bio&#8217;s discretion, may also require such owner to indemnify Sesen Bio against any claim suffered by Sesen Bio related to the lost, stolen or destroyed certificate or any Sesen Bio common stock issued in exchange thereof as Sesen Bio may reasonably request. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio will not pay dividends or other distributions on any shares of Sesen Bio common stock to be issued in exchange for shares of Carisma capital stock represented by any unsurrendered Carisma stock certificate or book-entry share until such Carisma stock certificate is surrendered, or book-entry share transferred, as provided in the Merger Agreement. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Regulatory Approvals</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In the U.S., Sesen Bio must comply with applicable federal and state securities laws and the rules and regulations of Nasdaq in connection with the issuance of shares of Sesen Bio common stock and the filing of this proxy statement/prospectus with the SEC. Sesen Bio does not intend to seek any regulatory approval from antitrust authorities to consummate the transactions. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Material U.S. Federal Income Tax Consequences of the Merger</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following discussion is a summary of the material U.S. federal income tax consequences of the merger to Carisma U.S. holders (as defined below), but does not purport to be a complete analysis of all potential tax consequences that may be relevant to Carisma U.S. holders. The effects of other U.S. federal tax laws, such as estate and gift tax laws, and any applicable state, local or non-U.S. tax laws are not discussed. This discussion is based on the Code, Treasury Regulations promulgated thereunder, judicial decisions, and published rulings and administrative pronouncements of the IRS, in each case in effect as of the date hereof. These authorities may change or be subject to differing interpretations. Any such change or differing interpretation may be applied retroactively in a manner that could adversely affect a Carisma U.S. holder. Carisma has not sought and does not intend to seek any rulings from the IRS regarding the matters discussed below. There can be no assurance the IRS or a court will not take a position contrary to that discussed below regarding the tax consequences of the merger. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">This discussion is limited to Carisma U.S. holders that hold Carisma capital stock as a &#8220;capital asset&#8221; within the meaning of Section&#160;1221 of the Code (generally, property held for investment). This discussion does not address all U.S. federal income tax consequences that may be relevant to a Carisma U.S. holder&#8217;s particular circumstances, including the impact of the alternative minimum tax, the Medicare contribution tax on net investment income or the rules related to &#8220;qualified small business stock&#8221; within the meaning of Section&#160;1202 of the Code. In addition, it does not address consequences relevant to Carisma U.S. holders subject to special rules, including, without limitation: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">U.S. expatriates and former citizens or long-term residents of the U.S.; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">U.S. holders whose functional currency is not the U.S. dollar; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">persons holding Carisma capital stock as part of a hedge, straddle or other risk reduction strategy or as part of a conversion transaction or other integrated investment; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">banks, insurance companies and other financial institutions; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">real estate investment trusts or regulated investment companies; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">brokers, dealers or traders in securities; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">&#8220;controlled foreign corporations,&#8221; &#8220;passive foreign investment companies&#8221; and corporations that accumulate earnings to avoid U.S. federal income tax; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">S corporations, partnerships or other entities or arrangements treated as partnerships for U.S. federal income tax purposes (and investors therein); </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">tax-exempt organizations or governmental organizations; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">persons deemed to sell Carisma capital stock under the constructive sale provisions of the Code; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">persons who hold or received Carisma capital stock pursuant to the exercise of any employee stock option or otherwise as compensation; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">160</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tUSHCA">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">tax-qualified retirement plans. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11pt;">
          <font style="letter-spacing:0.2pt;">If an entity treated as a partnership for U.S. federal income tax purposes holds Carisma capital stock, the tax treatment of a partner in the partnership will depend on the status of the partner, the activities of the partnership and certain determinations made at the partner level. Accordingly, partnerships holding Carisma capital stock and the partners in such partnerships should consult their tax advisors regarding the U.S. federal income tax consequences to them. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11pt;">
          <font style="letter-spacing:0.2pt;">In addition, the following discussion does not address: (a)&#160;the tax consequences of transactions effectuated before, after or at the same time as the merger, whether or not they are in connection with the merger, including, without limitation, transactions in which shares of Carisma capital stock are acquired or disposed of other than in exchange for shares of Sesen Bio common stock in the merger, (b)&#160;the tax consequences to holders of convertible notes or options or warrants of Carisma, or (c)&#160;the tax consequences of the ownership of shares of Sesen Bio common stock following the merger. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">IT IS RECOMMENDED THAT HOLDERS CONSULT THEIR TAX ADVISORS WITH RESPECT TO THE APPLICATION OF THE U.S. FEDERAL INCOME TAX LAWS TO THEIR PARTICULAR SITUATIONS AS WELL AS ANY TAX CONSEQUENCES OF THE MERGER ARISING UNDER THE U.S. FEDERAL ESTATE OR GIFT TAX LAWS OR UNDER THE LAWS OF ANY STATE, LOCAL OR NON-U.S. TAXING JURISDICTION OR UNDER ANY APPLICABLE INCOME TAX TREATY.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11pt;">
          <font style="letter-spacing:0.2pt;">For purposes of this discussion, a &#8220;Carisma U.S. holder&#8221; is a beneficial owner of Carisma capital stock that, for U.S. federal income tax purposes, is or is treated as: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.41pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.41pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">an individual who is a citizen or resident of the U.S.; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.4pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">a corporation created or organized under the laws of the U.S., any state thereof, or the District of Columbia; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.31pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.31pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">an estate, the income of which is subject to U.S. federal income tax regardless of its source; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.3pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">a trust that (i)&#160;is subject to the primary supervision of a U.S. court and the control of one or more &#8220;United States persons&#8221; &#8203;(within the meaning of Section&#160;7701(a)(30) of the Code) over all of its substantial decisions or (ii)&#160;has a valid election in effect to be treated as a United States person for U.S. federal income tax purposes. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Tax Characterization of the Merger</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In the opinion of WilmerHale and Hogan Lovells, the merger will qualify as a &#8220;reorganization&#8221; within the meaning of Section&#160;368(a) of the Code and the material U.S. federal income tax consequences of the merger to Carisma U.S. holders are as described below under the heading &#8220;&#8212; </font><font style="font-style:italic;letter-spacing:0.2pt;">Tax Treatment of Carisma U.S.&#160;Holders in the Merger</font><font style="letter-spacing:0.2pt;">.&#8221; These opinions are based on facts and representations contained in representation letters provided to WilmerHale and Hogan Lovells by Sesen Bio, Merger Sub and Carisma and certain assumptions, including that the merger is completed in the manner set forth in the Merger Agreement and the registration statement on Form&#160;S-4 of which this proxy statement/prospectus forms a part. The accuracy of such facts, representations and assumptions, could affect the conclusions set forth in such opinions. The opinions will not be binding on the IRS or the courts.</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If the merger does not qualify as a tax-free &#8220;reorganization&#8221; within the meaning of Section&#160;368(a) of the Code (including if the IRS successfully challenges the qualification of the merger as such), then each Carisma U.S. holder generally would recognize gain or loss on the exchange of Carisma capital stock for Sesen Bio common stock in the merger equal to the difference between (x)&#160;the fair market value of the shares of Sesen Bio common stock received in exchange for the Carisma capital stock plus any cash received in lieu of a fractional share and (y)&#160;such Carisma U.S. holder&#8217;s adjusted tax basis in the shares of Carisma capital stock surrendered. The remainder of this discussion assumes that the merger will be treated as a tax-free &#8220;reorganization&#8221; within the meaning of Section&#160;368(a) of the Code in accordance with the opinions referred to above. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Tax Treatment of Carisma U.S. Holders in the Merger</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The material U.S. federal income tax consequences to a U.S. holder of Carisma capital stock as a result of the merger will be as follows: (i)&#160;except as described below with respect to the receipt of cash in lieu of a </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">161</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tMUFI1">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">fractional share of Sesen Bio common stock, a Carisma U.S. holder generally will not recognize gain or loss upon the exchange of the holder&#8217;s Carisma capital stock for Sesen Bio common stock, (ii)&#160;a Carisma U.S. holder generally will obtain an aggregate adjusted tax basis in the Sesen Bio common stock the holder receives in the merger equal to the holder&#8217;s adjusted tax basis in the Carisma capital stock exchanged therefor, reduced by the basis allocable to any fractional share of Sesen Bio common stock for which cash is received, and (iii)&#160;the holding period of the shares of Sesen Bio common stock received by a Carisma U.S. holder in the merger will include the holding period of the shares of Carisma capital stock surrendered in exchange therefor. Treasury Regulations provide detailed rules for allocating the tax basis and holding period of the shares of Carisma capital stock surrendered to the shares of Sesen Bio common stock received. Carisma U.S. holders of shares of Carisma capital stock acquired on different dates and at different prices should consult their tax advisors regarding the allocation of the tax basis and holding period of such shares. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Cash in Lieu of Fractional Share</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">A Carisma U.S. holder that receives cash in lieu of a fractional share of Sesen Bio common stock generally will be treated as having received such fractional share and then as having received such cash in redemption of the fractional share. A Carisma U.S. holder generally will recognize gain or loss equal to the difference between the amount of cash received in lieu of the fractional share of Sesen Bio common stock and the portion of the U.S. holder&#8217;s aggregate adjusted tax basis in the shares of Carisma capital stock allocable to the fractional share. Such gain or loss generally will be capital gain or loss and will be long-term capital gain or loss if the Carisma U.S. holder&#8217;s holding period for the Carisma capital stock surrendered in the merger exceeds one year at the effective time. Long-term capital gains of certain non-corporate holders of Carisma capital stock, including individuals, are generally taxed at preferential rates. The deductibility of capital losses is subject to limitations. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Reporting Requirements</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Each Carisma U.S. holder who receives shares of Sesen Bio common stock in the merger is required to retain permanent records pertaining to the merger and make such records available to any authorized IRS officers and employees. Such records should specifically include information regarding the amount, basis, and the fair market value of the Carisma capital stock exchanged and the amount of Sesen Bio common stock and cash received in exchange therefor. Carisma U.S. holders who owned immediately before the merger at least one&#160;percent (by vote or value) of the total outstanding stock of Carisma are required to attach a statement to their tax returns for the year in which the merger is consummated that contains the information listed in Treasury Regulation&#160;Section&#160;1.368-3(b). Such statement must include the Carisma U.S. holder&#8217;s tax basis in such holder&#8217;s Carisma capital stock surrendered in the merger, the fair market value of such stock, the date of the merger and the name and employer identification number of each of Carisma and Sesen Bio. Carisma U.S. holders are urged to consult with their tax advisors to comply with these rules. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Backup Withholding and Information Reporting</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">A Carisma U.S. holder may, under certain circumstances, be subject to information reporting and backup withholding on any payments of cash in lieu of fractional shares, unless such holder properly establishes an exemption or provides its correct tax identification number and otherwise complies with the applicable requirements of the backup withholding rules. Backup withholding is not an additional tax. Any amounts withheld under the backup withholding rules may be refunded or credited against a payee&#8217;s U.S.&#160;federal income tax liability, if any, so long as such payee furnishes the required information to the IRS in a timely manner. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The foregoing summary is of a general nature only and is not intended to be, and should not be construed to be, legal, business or tax advice to any particular Carisma stockholder. This summary does not take into account your particular circumstances and does not address consequences that may be particular to you. Therefore, you should consult your tax advisor regarding the particular consequences of the merger to you.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Material U.S. Federal Income Tax Consequences of the Special Cash Dividend</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following discussion is a summary of the material U.S. federal income tax consequences of receipt of the special cash dividend to Sesen Bio stockholders, but does not purport to be a complete analysis of all </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">162</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">potential tax consequences that may be relevant to a Sesen Bio stockholder. The effects of other U.S.&#160;federal tax laws, such as estate and gift tax laws, and any applicable state, local or non-U.S. tax laws are not discussed. This discussion is based on the Code, Treasury Regulations promulgated thereunder, judicial decisions, and published rulings and administrative pronouncements of the IRS, in each case in effect as of the date hereof. These authorities may change or be subject to differing interpretations. Any such change or differing interpretation may be applied retroactively in a manner that could adversely affect a Sesen Bio stockholder. Sesen Bio has not sought and does not intend to seek any rulings from the IRS regarding the matters discussed below. There can be no assurance the IRS or a court will not take a position contrary to that discussed below regarding the tax consequences of receipt of the special cash dividend. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">This discussion is limited to Sesen Bio stockholders that hold Sesen Bio common stock as a &#8220;capital asset&#8221; within the meaning of Section&#160;1221 of the Code (generally, property held for investment). This discussion does not address all U.S. federal income tax consequences that may be relevant to a Sesen Bio stockholder&#8217;s particular circumstances, including the impact of the alternative minimum tax, the Medicare contribution tax on net investment income or the rules related to &#8220;qualified small business stock&#8221; within the meaning of Section&#160;1202 of the Code . In addition, it does not address consequences relevant to Sesen Bio stockholders subject to special rules, including, without limitation: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">U.S. expatriates and former citizens or long-term residents of the U.S.; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio U.S. holders whose functional currency is not the U.S. dollar; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">persons holding Sesen Bio common stock as part of a hedge, straddle or other risk reduction strategy or as part of a conversion transaction or other integrated investment; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">banks, insurance companies and other financial institutions; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">real estate investment trusts or regulated investment companies; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">brokers, dealers or traders in securities; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">&#8220;controlled foreign corporations,&#8221; &#8220;passive foreign investment companies&#8221; and corporations that accumulate earnings to avoid U.S. federal income tax; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">S corporations, partnerships or other entities or arrangements treated as partnerships for U.S. federal income tax purposes (and investors therein); </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">tax-exempt organizations or governmental organizations; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">persons subject to special tax accounting rules as a result of any item of gross income with respect to Sesen Bio common stock being taken into account in an &#8220;applicable financial statement&#8221; &#8203;(as defined in the Code); </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">persons deemed to sell Sesen Bio common stock under the constructive sale provisions of the Code; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">persons who hold or received Sesen Bio common stock pursuant to the exercise of any employee stock option or otherwise as compensation; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">tax-qualified retirement plans. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If an entity treated as a partnership for U.S. federal income tax purposes holds Sesen Bio common stock, the tax treatment of a partner in the partnership will depend on the status of the partner, the activities of the partnership and certain determinations made at the partner level. Accordingly, partnerships holding Sesen Bio common stock and the partners in such partnerships should consult their tax advisors regarding the U.S. federal income tax consequences to them. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">For purposes of this discussion, a &#8220;Sesen Bio non-U.S. holder&#8221; means a beneficial owner of Sesen Bio common stock that is neither a Sesen Bio U.S. holder (which, for purposes of this discussion, has the same meaning as in &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Agreements Related to the Merger&#8201;&#8212;&#8201;CVR Agreement&#8201;&#8212;&#8201;Material U.S. Federal Income Tax Consequences of the Receipt of CVRs</font><font style="letter-spacing:0.2pt;">&#8221;) nor a partnership (or other entity treated as a partnership) for U.S. federal income tax purposes. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">IT IS RECOMMENDED THAT SESEN BIO STOCKHOLDERS CONSULT THEIR TAX ADVISORS WITH RESPECT TO THE APPLICATION OF THE U.S. FEDERAL INCOME TAX </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">163</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">LAWS TO THEIR PARTICULAR SITUATIONS AS WELL AS ANY TAX CONSEQUENCES OF THE SPECIAL CASH DIVIDEND ARISING UNDER THE U.S. FEDERAL ESTATE OR GIFT TAX LAWS OR UNDER THE LAWS OF ANY STATE, LOCAL OR NON-U.S. TAXING JURISDICTION OR UNDER ANY APPLICABLE INCOME TAX TREATY.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The discussion below assumes that the distribution of CVRs and the special cash dividend will be treated for U.S. federal income tax purposes as transactions that are separate and distinct from the proposed reverse stock split. However, it is possible that the IRS or a court could determine that the proposed reverse stock split and the receipt of CVRs or the special cash dividend constitute a single &#8220;recapitalization&#8221; for U.S. federal income tax purposes. If the proposed reverse stock split and the special cash dividend and the receipt of the CVRs are treated as a single &#8220;recapitalization&#8221; for U.S. federal income tax purposes, then a Sesen Bio stockholder generally should recognize gain (but not loss) equal to the lesser of (i)&#160;the amount of the special cash dividend received plus the fair market value of the CVRs received (assuming the receipt of CVRs is treated as a distribution of property as described in &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Agreements Related to the Merger&#8201;&#8212;&#8201;CVR Agreement&#8201;&#8212;&#8201;Material U.S. Federal Income Tax Consequences of the Receipt of CVRs</font><font style="letter-spacing:0.2pt;">&#8221;), and (ii)&#160;the excess (if any) of (A)&#160;the sum of (1)&#160;the amount of the special cash dividend received plus the fair market value of the CVRs and (2)&#160;the fair market value of the Sesen Bio shares received in the proposed reverse stock split over (B)&#160;the Sesen Bio stockholder&#8217;s adjusted tax basis in the Sesen Bio common stock surrendered in the proposed reverse stock split. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Consequences to Sesen Bio U.S. Holders</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The U.S. federal income tax consequences of a Sesen Bio U.S. holder&#8217;s receipt of a special cash dividend generally should be treated first as a taxable dividend to the extent of the Sesen Bio U.S. holder&#8217;s pro&#160;rata share of Sesen Bio&#8217;s current or accumulated earnings and profits (as determined for U.S. federal income tax purposes), then as a non-taxable return of capital to the extent of the Sesen Bio U.S. holder&#8217;s basis in its Sesen Bio common stock, and finally as capital gain from the sale or exchange of Sesen Bio common stock with respect to any remaining amount. Sesen Bio currently has negative accumulated earnings and profits and expects no or a small amount of current earnings and profits for the relevant taxable year. Thus, Sesen Bio expects most or all of the special cash dividend to be treated as other than a dividend for U.S. federal income tax purposes. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Consequences to Sesen Bio Non-U.S. Holders</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The U.S. federal income tax consequences of a Sesen Bio non-U.S. holder&#8217;s receipt of a special cash dividend generally should be treated first as a taxable dividend to the extent of the Sesen Bio non-U.S. holder&#8217;s pro&#160;rata share of Sesen Bio&#8217;s current or accumulated earnings and profits (as determined for U.S. federal income tax purposes), then as a non-taxable return of capital to the extent of the Sesen Bio non-U.S. holder&#8217;s basis in its Sesen Bio common stock, and finally as capital gain from the sale or exchange of Sesen Bio common stock with respect to any remaining amount. Sesen Bio currently has negative accumulated earnings and profits and expects no or a small amount of current earnings and profits for the relevant taxable year. Thus, Sesen Bio expects most or all of any special cash dividend to be treated as other than a dividend for U.S. federal income tax purposes. However, if Sesen Bio cannot determine at the time of the special cash dividend whether or not such special cash dividend will exceed current and accumulated earnings and profits, Sesen Bio or the applicable withholding agent is expected to withhold on the special cash dividend at the rate applicable to dividends, as described below. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Taxable Dividends. Dividend payments to a Sesen Bio non-U.S. holder will generally be subject to withholding at a 30% rate. If a Sesen Bio non-U.S. holder is eligible for a lower treaty rate, then withholding will be at the lower treaty rate only if such Sesen Bio non-U.S. holder provides a valid IRS Form W-8BEN or W-8BEN-E (or applicable successor form) certifying such Sesen Bio non-U.S. holder&#8217;s qualification for the reduced rate. If a Sesen Bio non-U.S. holder holds the stock through a financial institution or other intermediary, the Sesen Bio non-U.S. holder will be required to provide appropriate documentation to the intermediary, which then will be required to provide certification to the applicable withholding agent, either directly or through other intermediaries. Sesen Bio non-U.S. holders who do not timely provide the applicable withholding agent with the required certification, but who qualify for a reduced treaty rate, may obtain a refund of any excess amounts withheld by timely filing an appropriate claim for refund with the IRS. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">164</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tNALI">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Subject to the discussion below regarding backup withholding, if the special cash dividend is effectively connected with a Sesen Bio non-U.S. holder&#8217;s conduct of a trade or business within the U.S. (and, if required by an applicable income tax treaty, the Sesen Bio non-U.S. holder maintains a permanent establishment in the U.S. to which the special cash dividend is attributable), the Sesen Bio non-U.S. holder will be exempt from U.S. federal withholding tax and the special cash dividend generally will be subject to U.S. federal income tax on a net income basis in the same manner as if such Sesen Bio non-U.S. holder were a U.S. holder. To claim the exemption, the Sesen Bio non-U.S. holder must furnish to the applicable withholding agent a valid IRS Form W-8ECI (or applicable successor form), certifying that the special cash dividend is effectively connected with the Sesen Bio non-U.S. holder&#8217;s conduct of a trade or business within the United States. A Sesen Bio non-U.S. holder that is a corporation also may be subject to a branch profits tax at a rate of 30% (or such lower rate specified by an applicable income tax treaty) of all or a portion of its effectively connected earnings and profits for the taxable year. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Non-Dividend Distributions. To the extent that the distribution is treated as capital gain from the sale or exchange of Sesen Bio common stock, such gain generally will not be subject to U.S. federal income tax unless (i)&#160;such gain is effectively connected with the conduct by a Sesen Bio non-U.S. holder of a trade or business in the United States (and, if an income tax treaty applies, the gain is generally attributable to a U.S. permanent establishment maintained by such Sesen Bio non-U.S. holder), (ii)&#160;in the case of gain realized by a Sesen Bio non-U.S. holder that is an individual, such Sesen Bio non-U.S. holder is present in the United States for 183&#160;days or more in the taxable year of the sale and certain other conditions are met or (iii)&#160;Sesen Bio is or has been a United States real property holding corporation, or a USRPHC, for U.S. federal income tax purposes and, if the shares are &#8220;regularly traded on an established securities market,&#8221; such Sesen Bio non-U.S. holder owned, directly or indirectly, at any time during the five-year period ending on the date of the distribution, more than 5% of the shares of Sesen Bio common stock and such Sesen Bio non-U.S. holder is not eligible for any treaty exemption. The shares will be considered &#8220;regularly traded&#8221; if they are traded on an established securities market located in the United States and are regularly quoted by brokers or dealers making a market in the shares. Sesen Bio believes it is not, and has not been, a USRPHC for U.S. federal income tax purposes. In addition, although not free from doubt, Sesen Bio believes that Sesen Bio common shares currently should be considered to be regularly traded. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">A Sesen Bio non-U.S. holder should consult its tax advisor regarding its entitlement to benefits and the various rules under applicable tax treaties. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Information Reporting and Backup Withholding</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In general, the special cash dividend received by Sesen Bio U.S. holders will be reported to the IRS unless the holder is an exempt recipient. Backup withholding, currently at a rate of 24%, may apply unless the Sesen Bio U.S. holder (1)&#160;is an exempt recipient or (2)&#160;provides a certificate (generally on an IRS Form&#160;W-9) containing the Sesen Bio U.S. holder&#8217;s name, address, correct federal taxpayer identification number and statement that the Sesen Bio U.S. holder is a U.S. person and is not subject to backup withholding. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">A Sesen Bio non-U.S. holder will not be subject to backup withholding with respect to the special cash dividend, provided the Sesen Bio Non-U.S. holder certifies its non-U.S. status, such as by providing a valid IRS Form W-8BEN or W-8ECI or W-8BEN-E, or otherwise establishes an exemption. However, information returns will be filed with the IRS in connection with the special cash dividend, regardless of whether any tax was actually withheld. Copies of these information returns may also be made available under the provisions of a specific treaty or agreement to the tax authorities of the country in which the Sesen Bio non-U.S. holder resides or is established. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Backup withholding is not an additional tax. Any amounts withheld under the backup withholding rules may be allowed as a refund or credit against a Sesen Bio U.S. holder&#8217;s U.S. federal income tax liability, provided the required information is timely furnished to the IRS. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Nasdaq Listing</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio common stock currently is listed on Nasdaq under the symbol &#8220;SESN.&#8221; Sesen Bio has agreed to use commercially reasonable efforts to (i)&#160;maintain its existing listing on Nasdaq through the closing of the merger, (ii)&#160;prepare and submit a Nasdaq notification form for the listing of the shares of Sesen </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">165</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tAAT">&#8203;</a><a name="tARAD">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Bio common stock to be issued in connection with the merger, and to cause such shares to be approved for listing (subject to official notice of issuance), (iii)&#160;effect the proposed reverse stock split and (iv)&#160;file an initial listing application for the Sesen Bio common stock on Nasdaq and to cause such application to be approved prior to the effective time. In addition, under the Merger Agreement, each party&#8217;s obligation to complete the merger is subject to the satisfaction or waiver by each of the parties prior to the closing of the merger of various conditions, including that the existing shares of Sesen Bio common stock must have been continually listed on Nasdaq, and Sesen Bio must have caused the shares of Sesen Bio common stock to be issued in the merger to be approved for listing on Nasdaq as of the closing of the merger. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio has filed an initial listing application with Nasdaq pursuant to Nasdaq &#8220;business combination&#8221; rules. If such application is accepted, Sesen Bio anticipates that the shares of Sesen Bio common stock will be listed on Nasdaq following the closing of the merger under the trading symbol &#8220;CARM.&#8221; In order to meet the requirements for listing on Nasdaq, the post-merger combined company will be required to satisfy Nasdaq&#8217;s initial listing requirements, including the financial and liquidity requirements for the applicable Nasdaq market tier upon which the post-merger combined company&#8217;s shares will trade following the merger. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Anticipated Accounting Treatment</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">The merger is expected to be accounted for as a reverse recapitalization under U.S. GAAP because the primary assets of Sesen Bio are cash, cash equivalents and marketable securities. For financial reporting purposes, Carisma has been determined to be the accounting acquirer based upon the terms of the merger including: (i)&#160;Carisma stockholders and holders of securities convertible into Carisma common stock are expected to own approximately 74.8% of the combined company (based on estimates made at the time of the signing of the Merger Agreement), (ii)&#160;Carisma will hold the majority (six of seven) of board seats of the combined company and (iii)&#160;Carisma management will hold all key positions in the management of the combined company. Accordingly, the merger is expected to be treated as the equivalent of Carisma issuing stock to acquire the net assets of Sesen Bio. As a result of the merger, the net assets of Sesen Bio will be recorded at their acquisition-date fair value in the consolidated financial statements of Carisma and the reported operating results prior to the merger will be those of Carisma. See the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Unaudited Pro Forma Condensed Combined Financial Information</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tUPFC">372</a> of this proxy statement/</font>&#8203;<font style="letter-spacing:0.2pt;">prospectus for additional information. </font></div>

        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Appraisal Rights and Dissenters&#8217; Rights</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If the merger is completed, Carisma stockholders who do not deliver a written consent approving the merger are entitled to appraisal rights under Section&#160;262 of the DGCL, or Section&#160;262, provided that they comply with the conditions established by Section&#160;262. Holders of Sesen Bio common stock are not entitled to appraisal rights under Delaware law in connection with the merger. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The discussion below is not a complete summary regarding a Carisma stockholder&#8217;s appraisal rights under Delaware law and is qualified in its entirety by reference to the text of the relevant provisions of Delaware law, which is attached as </font><font style="font-style:italic;letter-spacing:0.2pt;">Annex H</font><font style="letter-spacing:0.2pt;"> to this proxy statement/prospectus. Carisma stockholders intending to exercise appraisal rights should carefully review </font><font style="font-style:italic;letter-spacing:0.2pt;">Annex H</font><font style="letter-spacing:0.2pt;">. Failure to follow precisely any of the statutory procedures set forth in </font><font style="font-style:italic;letter-spacing:0.2pt;">Annex H</font><font style="letter-spacing:0.2pt;"> may result in a termination or waiver of these rights. This summary does not constitute legal or other advice, nor does it constitute a recommendation that Carisma stockholders exercise their appraisal rights under Delaware law. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Under Section&#160;262, where a merger is adopted by stockholders by written consent in lieu of a meeting of stockholders pursuant to Section&#160;228 of the DGCL, either the constituent corporation before the effective date of the merger, or the surviving corporation within 10&#160;days after the effective date of the merger, must notify each stockholder of the constituent corporation entitled to appraisal rights of the approval of the merger, the effective date of the merger and that appraisal rights are available. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If the merger is completed, within 10&#160;days after the effective date Carisma will notify Carisma stockholders that the merger has been approved, the effective date and that appraisal rights are available to any Carisma stockholder who has not approved the merger. Carisma stockholders who desire to exercise their appraisal rights must deliver a written demand for appraisal to Carisma within 20&#160;days after the date of </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">166</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">mailing of that notice, and that Carisma stockholder must not have delivered a written consent approving the merger. A demand for appraisal must reasonably inform Carisma of the identity of the Carisma stockholder and that such Carisma stockholder intends thereby to demand appraisal of the shares of Carisma common stock held by such Carisma stockholder. Failure to deliver a written consent approving the merger will not in and of itself constitute a written demand for appraisal satisfying the requirements of Section&#160;262. All demands for appraisal should be addressed to CARISMA Therapeutics Inc., 3675 Market Street, Suite 200, Philadelphia, PA 19104, Attention: Corporate Secretary, Email: legal@carismatx.com, and should be executed by, or on behalf of, the record holder of shares of Carisma capital stock. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ALL DEMANDS MUST BE RECEIVED BY CARISMA WITHIN 20 DAYS AFTER THE DATE CARISMA MAILS A NOTICE TO CARISMA STOCKHOLDERS NOTIFYING THEM THAT THE MERGER HAS BEEN APPROVED, THE EFFECTIVE DATE OF THE MERGER AND THAT APPRAISAL RIGHTS ARE AVAILABLE TO ANY CARISMA STOCKHOLDER WHO HAS NOT APPROVED THE MERGER.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If you are a Carisma stockholder, and fail to deliver a written demand for appraisal within the time period specified above, you will be entitled to receive the merger consideration for your shares of Carisma capital stock as provided for in the Merger Agreement, but you will have no appraisal rights with respect to your shares of Carisma capital stock. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">To be effective, a demand for appraisal by a Carisma stockholder must be made by, or in the name of, the registered stockholder, fully and correctly, as the Carisma stockholder&#8217;s name appears on the Carisma stockholder&#8217;s stock certificate(s). Beneficial owners who do not also hold the shares of record may exercise appraisal rights directly, rather than relying on the record owner of their shares of Carisma capital stock to demand appraisal on their behalf. In order for a beneficial owner to assert appraisal rights with respect to any shares, such owner must maintain continuous beneficial ownership of such shares through the effective date of the merger and provide documentary evidence of such ownership, as more fully described in Section&#160;262(d)(3) of the DGCL. If shares of Carisma capital stock are owned of record or beneficially in a fiduciary capacity, such as by a trustee, guardian or custodian, execution of a demand for appraisal should be made by or for the fiduciary; and if the shares of Carisma capital stock are owned of record or beneficially by more than one person, as in a joint tenancy or tenancy in common, the demand should be executed by or for all joint owners. An authorized agent, including an authorized agent for two or more joint owners, may execute the demand for appraisal for a Carisma stockholder; however, the agent must identify the record/</font>&#8203;<font style="letter-spacing:0.2pt;">beneficial owner or owners and expressly disclose the fact that, in executing the demand, he or she is acting as agent for the record/beneficial owner. A record owner, such as a broker, who holds shares of Carisma capital stock as a custodian for others, may exercise the record owner&#8217;s right of appraisal with respect to the shares of Carisma capital stock held for one or more beneficial owners, while not exercising this right for other beneficial owners. In that case, the written demand should state the number of shares of Carisma capital stock as to which appraisal is sought. Where no number of shares of Carisma capital stock is expressly mentioned, the demand will be presumed to cover all shares of Carisma capital stock held in the name of the record owner. In addition, the Carisma stockholder must hold the shares of Carisma capital stock continuously through the effective time and on the date of making a demand. </font></div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If you hold your shares of Carisma capital stock in a brokerage account or in other custodian form and you do not wish to exercise appraisal rights directly as a beneficial owner, you should consult with your broker, bank or other custodian to determine the appropriate procedures for the making of a demand for appraisal by the custodian. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">At any time within 60&#160;days after the effective time, any Carisma stockholder who has demanded an appraisal, but has neither commenced an appraisal proceeding or joined an appraisal proceeding as a named party, has the right to withdraw such Carisma stockholder&#8217;s demand and accept the terms of the merger by delivering a written withdrawal to Carisma. If, following a demand for appraisal, you have withdrawn your demand for appraisal in accordance with Section&#160;262, you will have the right to receive the merger consideration for your shares of Carisma capital stock. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Within 120&#160;days after the effective time, any Carisma stockholder who has delivered a demand for appraisal in accordance with Section&#160;262 will, upon written request to the surviving corporation, be entitled to receive a written statement setting forth the aggregate number of shares of Carisma capital stock not </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">167</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">voted in favor of the Merger Agreement and with respect to which demands for appraisal rights have been received and the aggregate number of holders of these shares of Carisma capital stock. This written statement will be mailed to the requesting Carisma stockholder within 10&#160;days after the Carisma stockholder&#8217;s written request is received by the surviving corporation or within 10&#160;days after expiration of the period for delivery of demands for appraisal, whichever is later. Within 120&#160;days after the effective time, either the surviving corporation or any Carisma stockholder who has delivered a demand for appraisal in accordance with Section&#160;262 may file a petition in the Delaware Court of Chancery demanding a determination of the fair value of the shares of Carisma capital stock held by all such Carisma stockholders. Upon the filing of the petition by a Carisma stockholder, service of a copy of the petition must be made upon the surviving corporation. The surviving corporation has no obligation to file a petition in the Delaware Court of Chancery in the event there are dissenting Carisma stockholders, and Sesen Bio, which is expected to be the surviving corporation, has no present intent to file a petition in the Delaware Court of Chancery. Accordingly, the failure of a Carisma stockholder to file a petition within the period specified could nullify the Carisma stockholder&#8217;s previously written demand for appraisal. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If a petition for appraisal is duly filed by a Carisma stockholder and a copy of the petition is delivered to the surviving corporation, the surviving corporation will then be obligated, within 20&#160;days after receiving service of a copy of the petition, to provide the Delaware Court of Chancery with a duly verified list containing the names and addresses of all Carisma stockholders who have demanded an appraisal of their shares of Carisma capital stock and with whom agreements as to the value of their shares of Carisma capital stock have not been reached by the surviving corporation. After notice to dissenting Carisma stockholders who demanded appraisal of their shares of Carisma capital stock, the Delaware Court of Chancery is empowered to conduct a hearing upon the petition, and to determine those Carisma stockholders who have complied with Section&#160;262 and who have become entitled to the appraisal rights provided thereby. The Delaware Court of Chancery may require the Carisma stockholders who have demanded appraisal for their shares of Carisma capital stock to submit their stock certificates to the Register in Chancery for notation thereon of the pendency of the appraisal proceedings; and if any Carisma stockholder fails to comply with that direction, the Delaware Court of Chancery may dismiss the proceedings as to that Carisma stockholder. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">After determination of the Carisma stockholders entitled to appraisal of their shares of Carisma capital stock, the Delaware Court of Chancery will appraise the &#8220;fair value&#8221; of the shares of Carisma capital stock owned by those Carisma stockholders. This value will be exclusive of any element of value arising from the accomplishment or expectation of the merger, but may include a fair rate of interest, if any, upon the amount determined to be the fair value. When the value is determined, the Delaware Court of Chancery will direct the payment of the value, with interest thereon accrued during the pendency of the proceeding, if the Delaware Court of Chancery so determines, to the Carisma stockholders entitled to receive the same, upon surrender by the holders of the certificates representing those shares of Carisma capital stock. At any time before the entry of judgment in the proceedings, the surviving corporation may pay to each Carisma stockholder entitled to appraisal an amount in cash, in which case interest shall accrue thereafter only upon the sum of (i)&#160;the difference, if any, between the amount so paid and the fair value of the shares of Carisma capital stock subject to appraisal as determined by the Delaware Court of Chancery and (ii)&#160;interest theretofore accrued, unless paid at that time. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In determining fair value, and, if applicable, a fair rate of interest, the Delaware Court of Chancery is required to take into account all relevant factors. In </font><font style="font-style:italic;letter-spacing:0.2pt;">Weinberger v. UOP, Inc.</font><font style="letter-spacing:0.2pt;">, the Delaware Supreme Court discussed the factors that could be considered in determining fair value in an appraisal proceeding, stating that &#8220;proof of value by any techniques or methods which are generally considered acceptable in the financial community and otherwise admissible in court&#8221; should be considered, and that &#8220;fair price obviously requires consideration of all relevant factors involving the value of a company.&#8221; </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Section&#160;262 provides that fair value is to be &#8220;exclusive of any element of value arising from the accomplishment or expectation of the merger.&#8221; In </font><font style="font-style:italic;letter-spacing:0.2pt;">Cede &amp; Co. v. Technicolor, Inc.</font><font style="letter-spacing:0.2pt;">, the Delaware Supreme Court stated that this exclusion is a &#8220;narrow exclusion [that] does not encompass known elements of value,&#8221; but which rather applies only to the speculative elements of value arising from such accomplishment or expectation. In Weinberger, the Delaware Supreme Court construed Section&#160;262 to mean that &#8220;elements of future value, including the nature of the enterprise, which are known or susceptible of proof as of the date of the merger and not the product of speculation, may be considered.&#8221; </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">168</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tLRTM">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">You should be aware that the fair value of your shares of Carisma capital stock as determined under Section&#160;262 could be more than, the same as, or less than the value that you are entitled to receive under the terms of the Merger Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Costs of the appraisal proceeding may be imposed upon the surviving corporation and the Carisma stockholders participating in the appraisal proceeding by the Delaware Court of Chancery as the Court deems equitable in the circumstances. Upon the application of a Carisma stockholder, the Delaware Court of Chancery may order all or a portion of the expenses incurred by any Carisma stockholder in connection with the appraisal proceeding, including, without limitation, reasonable attorneys&#8217; fees and the fees and expenses of experts, to be charged pro&#160;rata against the value of all shares of Carisma capital stock entitled to appraisal. In the absence of such a determination of assessment, each party bears its own expenses. Any Carisma stockholder who had demanded appraisal rights will not, after the effective time, be entitled to vote shares of Carisma capital stock subject to that demand for any purpose or to receive payments of dividends or any other distribution with respect to those shares of Carisma capital stock, other than with respect to payment as of a record date prior to the effective time; however, if no petition for appraisal is filed within 120&#160;days after the effective time, or if the Carisma stockholder delivers a written withdrawal of his or her demand for appraisal and an acceptance of the terms of the merger within 60&#160;days after the effective time, then the right of that Carisma stockholder to appraisal will cease and that Carisma stockholder will be entitled to receive the merger consideration for shares of his or her Carisma capital stock pursuant to the Merger Agreement. Any withdrawal of a demand for appraisal made more than 60&#160;days after the effective time may only be made with the written approval of the surviving corporation. No appraisal proceeding in the Delaware Court of Chancery will be dismissed as to any stockholder without the approval of the court. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Failure to follow the steps required by Section&#160;262 for perfecting appraisal rights may result in the loss of appraisal rights. In view of the complexity of Section&#160;262, Carisma stockholders who may wish to dissent from the merger and pursue appraisal rights should consult their legal advisors. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Litigation Related to the Merger</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio received (a) one demand letter on October 21, 2022, attaching a draft complaint, sent on behalf of Thomas Budzinski, a purported stockholder of Sesen Bio (the &#8220;Budzinski Demand&#8221;), (b) one demand letter on October 21, 2022, sent on behalf of Derick Passmore, a purported stockholder of Sesen Bio (the &#8220;Passmore Demand&#8221;) and (c) one demand letter on November&#160;4, 2022, sent on behalf of Ryan McKinley, a purported stockholder of Sesen Bio (the &#8220;McKinley Demand&#8221; and together with the Budzinski Demand and the Passmore Demand, the &#8220;Demand Letters&#8221;). In addition, Sesen Bio received a books and records demand, dated November&#160;18, 2022 (the &#8220;Section 220 Demand&#8221;), on behalf of a purported stockholder of Sesen Bio seeking access to certain relevant books and records of Sesen Bio pursuant to Section 220 of the DGCL in connection with the merger and the securities and derivative litigations arising out of the CRL that Sesen Bio received from the FDA.</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Each of the Budzinski Demand, the Passmore Demand and the McKinley Demand alleges omissions of material information with respect to the merger from this proxy statement/prospectus, including information regarding the financial projections with respect to Carisma, the financial analyses performed by SVB Securities in support of its fairness opinion, and the background and process leading to the execution of the Merger Agreement, and demands that Sesen Bio promptly provide stockholders with additional disclosure. In addition, the Budzinski Demand includes a draft complaint, which asserts claims against Sesen Bio and the Sesen Bio board of directors under Section 14(a) of the Exchange Act and Rule&#160;14a-9 promulgated thereunder for allegedly false and misleading statements in this proxy statement/prospectus and under Section 20(a) of the Exchange Act for alleged &#8220;control person&#8221; liability with respect to such allegedly false and misleading statements. The Section 220 Demand states that the purpose of the demand is to, among other things, investigate purported questions of director independence and disinterestedness and the possibility of wrongdoing, mismanagement, and/or material non-disclosure related to the Sesen Bio board&#8217;s approval of the merger and the other transactions contemplated thereby and to determine whether suit should be brought in connection therewith.</font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Further, on November 28, 2022, a purported Sesen Bio stockholder filed a complaint in the U.S. District Court for the Southern District of New York against Sesen Bio and the Sesen Bio board of directors, captioned </font><font style="font-style:italic;letter-spacing:0.2pt;">Keller v. Sesen Bio, Inc., et al.</font><font style="letter-spacing:0.2pt;">, Case No.&#160;1:22-cv-10085 (S.D.N.Y.) (the &#8220;Original Keller </font>
          </div>

      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">169</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:396pt;margin-left:69.66pt;width:456pt;">

          <div style="width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Complaint&#8221;). The Original Keller Complaint made assertions similar to the Demand Letters and sought, among other relief, an order enjoining the merger and an award for plaintiffs&#8217; fees and costs. On December&#160;20, 2022, the purported stockholder voluntarily dismissed his complaint and on December&#160;21, 2022, filed a new complaint as a putative class action in the Court of Chancery for the State of Delaware, captioned </font><font style="font-style:italic;letter-spacing:0.2pt;">Keller v. Sesen Bio, Inc., et al.</font><font style="letter-spacing:0.2pt;">, Case No. 2022-1186 (Del. Ch. Dec. 21, 2022) (the &#8220;New Keller Complaint&#8221;). Along with the complaint, the purported stockholder filed motions for expedited proceedings and for a preliminary injunction to enjoin the Sesen Bio special meeting. The New Keller Complaint and associated filings contain substantially the same assertions as the Original Keller Complaint and the Demand Letters.</font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Sesen Bio believes that the claims asserted in the Demand Letters, the Section 220 Demand and the New Keller Complaint are without merit.</font>
          </div>

        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio stockholders and Carisma stockholders may serve additional demands and/or file additional lawsuits challenging the merger, which may name Sesen Bio, Carisma, members of the Sesen Bio board of directors, members of the Carisma board of directors and/or others as defendants. No assurance can be made as to the outcome of such additional demands, lawsuits, the Demand Letters, the Section 220 Demand or the Keller Complaint, including the amount of costs associated with defending, settling, or any other liabilities that may be incurred in connection with the litigation or settlement of, such claims. If any additional demands are served and/or any additional lawsuits filed, absent new or different allegations that are material, Sesen Bio will not necessarily announce such additional demands and/or complaints.</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">170</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:italic;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tTMA">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-style:normal;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-style:normal;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">THE MERGER AGREEMENT</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">The following is a summary of the material terms of the Merger Agreement. Copies of the Original Merger Agreement and the Merger Agreement Amendment are attached as Annexes A-1 and A-2, respectively, to this proxy statement/prospectus and are incorporated by reference into this proxy statement/prospectus. The Merger Agreement has been attached to this proxy statement/prospectus to provide you with information regarding its terms. It is not intended to provide any other factual information about Sesen Bio, Carisma or Merger Sub. The following description does not purport to be complete and is qualified in its entirety by reference to the Merger Agreement. You should refer to the full text of the Merger Agreement for details of the merger and the terms and conditions of the Merger Agreement.</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
          </div>

        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Merger Agreement contains representations and warranties that Sesen Bio and Merger Sub, on the one hand, and Carisma, on the other hand, have made to one another as of specific dates. These representations and warranties have been made for the benefit of the other parties to the Merger Agreement and may be intended not as statements of fact but rather as a way of allocating the risk to one of the parties if those statements prove to be incorrect. In addition, the assertions embodied in the representations and warranties are qualified by information in confidential disclosure schedules exchanged by the parties in connection with signing the Merger Agreement. While Sesen Bio and Carisma do not believe that these disclosure schedules contain information required to be publicly disclosed under the applicable securities laws, other than information that has already been so disclosed, the disclosure schedules do contain information that modifies, qualifies and creates exceptions to the representations and warranties set forth in the attached Merger Agreement. Accordingly, you should not rely on the representations and warranties as current characterizations of factual information about Sesen Bio and Carisma because they were made as of specific dates, may be intended merely as a risk allocation mechanism between Sesen Bio, Merger Sub and Carisma and are modified by the disclosure schedules. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:normal;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Structure</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;font-style:normal;">
          <font style="letter-spacing:0.2pt;">Merger Sub was formed as a wholly-owned subsidiary of Sesen Bio for the sole purpose of completing the merger transaction. Under the Merger Agreement at the effective time, Merger Sub will merge with and into Carisma, with Carisma surviving as the wholly-owned subsidiary of Sesen Bio. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:normal;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Completion and Effectiveness of the Merger</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;font-style:normal;">
            <font style="letter-spacing:0.2pt;">The consummation of the merger will take place as promptly as practicable, but in no event later than the second business day after all of the conditions to completion of the merger are satisfied or waived, including certain approvals by the stockholders of Sesen Bio and Carisma. Sesen Bio and Carisma are working to complete the merger and expect that the merger will be completed in the first quarter of 2023, after the Sesen Bio special meeting of stockholders. However, Sesen Bio and Carisma cannot predict the completion of the merger or the exact timing of the completion of the merger because it is subject to various conditions. </font>
          </div>

        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:normal;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Merger Consideration</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;font-style:normal;">
          <font style="letter-spacing:0.2pt;">At the effective time, upon the terms and subject to the conditions set forth in the Merger Agreement, each outstanding share of Carisma&#8217;s capital stock (including shares of Carisma capital stock sold in the Carisma pre-closing financing but excluding (i)&#160;shares of Carisma capital stock to be canceled pursuant to the Merger Agreement and (ii)&#160;Carisma common stock held by holders of Carisma common stock who have exercised and perfected appraisal rights or dissenters&#8217; rights) will be automatically converted solely into the right to receive a number of shares of Sesen Bio common stock and each outstanding Carisma option will become exercisable for shares of Sesen Bio common stock, in each case, equal to the exchange ratio described in more detail below. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;font-style:normal;">
          <font style="letter-spacing:0.2pt;">No fractional shares of Sesen Bio common stock will be issued in connection with the merger, and no certificates or scrip for any such fractional shares will be issued. Any fractional shares of Sesen Bio common stock resulting from the conversion of Carisma capital stock will receive cash (without interest and subject to applicable tax withholding) in an amount equal to such fractional part of a share of Sesen Bio common stock multiplied by the last reported sale price of Sesen Bio common stock at 4:00&#160;p.m., Eastern Time, end of regular trading hours on Nasdaq on the last day prior to the effective time. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-style:normal;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-style:normal;">
          <font style="letter-spacing:0.2pt;">171</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tTMAER">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Exchange Ratio</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">The exchange ratio is calculated using a formula intended to allocate existing Sesen Bio and Carisma stockholders a&#160;percentage of the combined company. Based on Sesen Bio&#8217;s capitalization and Carisma&#8217;s capitalization as of December 29, 2022, the date the Merger Agreement was executed, the exchange ratio is estimated to be approximately 37.7924 shares of Sesen Bio common stock. This estimate is subject to adjustment prior to the closing of the merger for net cash at the cash determination time and aggregate proceeds from the sale of Carisma common stock in the Carisma pre-closing financing (and, as a result, Sesen Bio stockholders could own more, and Carisma stockholders (including, for this purpose, investors in the Carisma pre-closing financing) could own less, or vice versa, of the combined company). </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Based on the estimates set forth above, and certain other assumptions, Sesen Bio stockholders would own approximately 25.2% of the common stock of the combined company post-merger, and Carisma stockholders would own approximately 74.8% of the common stock of the combined company post-merger, of which the shares issued in the Carisma pre-closing financing and the shares issued upon the conversion of the Carisma convertible note are expected to represent approximately 8.4% and 11.3%, respectively, of the common stock of the combined company post-merger. For more information on the Carisma pre-closing financing, see the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Agreements Related to the Merger&#8201;&#8212;&#8201;Subscription Agreement</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tSUAG">198</a> of this proxy statement/prospectus. </font>
          </div>

        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The exchange ratio formula is the quotient obtained (rounded to four decimal places) by dividing the number of Carisma merger shares (defined below) by the Carisma outstanding shares (defined below), in which: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">&#8220;Aggregate valuation&#8221; means the sum of the (i)&#160;Carisma valuation plus (ii)&#160;the Sesen Bio valuation. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">&#8220;Carisma allocation&#160;percentage&#8221; means the quotient (expressed as a&#160;percentage with the&#160;percentage rounded to four decimal places) determined by dividing (i)&#160;the Carisma valuation by (ii)&#160;the aggregate valuation. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">&#8220;Carisma merger shares&#8221; means the product determined by multiplying (i)&#160;the post-closing Sesen Bio shares by (ii)&#160;the Carisma allocation&#160;percentage. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">&#8220;Carisma outstanding shares&#8221; means the total number of shares of Carisma capital stock outstanding immediately prior to the effective time expressed on a fully-diluted and as-converted to Carisma common stock basis and assuming, without limitation or duplication, (i)&#160;the exercise of all Carisma options outstanding as of immediately prior to the effective time, (ii)&#160;the closing of the Carisma pre-closing financing, and (iii)&#160;the issuance of shares of Carisma common stock issuable in respect of all other outstanding options, restricted stock awards, warrants or rights to receive such shares, whether conditional or unconditional and including any outstanding options, warrants or rights triggered by or associated with the consummation of the Merger. Carisma outstanding shares shall also include all shares of the Carisma issued in the Carisma pre-closing financing prior to the effective time and excludes any shares issued upon the conversion of the Carisma convertible note. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">&#8220;Carisma valuation&#8221; means (i)&#160;$196.0&#160;million, plus (ii)&#160;the amount of gross proceeds from the Carisma pre-closing financing prior to the effective time. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">&#8220;Sesen Bio allocation&#160;percentage&#8221; means the quotient (expressed as a&#160;percentage with the&#160;percentage rounded to four decimal places) determined by dividing (i)&#160;the Sesen Bio valuation by (ii)&#160;the aggregate valuation. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">&#8220;Sesen Bio outstanding shares&#8221; means the total number of shares of Sesen Bio common stock outstanding immediately prior to the effective time expressed on a fully-diluted and as converted to Sesen Bio common stock basis, assuming, without limitation or duplication, the issuance of shares of Sesen Bio common stock in respect of all Sesen Bio options, Sesen Bio RSUs, Sesen Bio warrants and other outstanding options, warrants or rights to receive such shares, in each case, outstanding as of immediately prior to the effective time. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">&#8220;Sesen Bio valuation&#8221; means $140.0&#160;million, minus the amount by which net cash at the cash determination time is less than $125.0&#160;million, plus the amount by which net cash at the cash </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">172</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">

          <div style="margin-left:30pt; width:426pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">determination time is greater than $125.0&#160;million. However, and pursuant to the terms of the Merger Agreement Amendment, Sesen Bio expects to only have approximately $75.0 million of net cash at the cash determination time. </font>
          </div>

        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.71pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.71pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">&#8220;Post-closing Sesen Bio shares&#8221; mean the quotient determined by dividing (i)&#160;the Sesen Bio outstanding shares by (ii)&#160;the Sesen Bio allocation&#160;percentage. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Calculation of Sesen Bio&#8217;s Final Net Cash</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Pursuant to the terms of the Merger Agreement, Sesen Bio&#8217;s &#8220;final net cash&#8221; means, as of the cash determination time (which is as of 8:00&#160;p.m. Eastern Time on the last business day prior to the anticipated closing date) the sum (without duplication) of the following: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.71pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.71pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">cash and cash equivalents, marketable securities and other short-term investments of Sesen Bio and its subsidiaries; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">Sesen Bio&#8217;s accounts receivable (including any tax refund claims pending as of the date of the Original Merger Agreement), deposits and interest; and </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Seen Bio&#8217;s deposits, prepaid expenses and other prepaid assets which are reflected on the most recent balance sheet and do not constitute restricted cash of Sesen Bio and its subsidiaries; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.71pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.71pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">50% of the cost of settling any transaction litigation to the extent actually paid in cash by Sesen Bio prior to the closing date; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;font-style:italic;letter-spacing:0.2pt;">minus</font><font style="letter-spacing:0.2pt;">, the sum (without duplication) of the following: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">any unpaid transaction expenses of Sesen Bio or its subsidiaries; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">any unpaid indebtedness of Sesen Bio and/or its subsidiaries outstanding as of the closing date; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">any accounts payable, accrued expenses or short or long term liabilities that are or will become payable in cash, including any such accounts payable, accrued expenses or short or long term liabilities under any Sesen Bio contracts that were in effect prior to the effective time or associated with the termination of any Sesen Bio contracts which were in effect prior to the effective time or the termination before, at or after the effective time, of all current or former employees of Sesen Bio and its subsidiaries (even if the applicable expenses or amounts are due and payable after the effective time); </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">any unpaid employer portion of payroll or employment taxes incurred in connection with the grant, exercise, conversion, settlement or cancellation of Sesen Bio RSUs, Sesen Bio options, equity compensation and other change in control or severance payments (including bonuses payable) due under the Merger Agreement or CVRs issued to holders of Sesen Bio RSUs or Sesen Bio options or otherwise as compensation (either incurred prior to or at the time of the Merger, and for the avoidance of doubt, not calculated as of the close of business on the business day prior to the closing date) in each case, incurred in connection with the merger by Sesen Bio at or prior to the effective time (even if payable after the effective time); </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">any pre-payment, termination, &#8220;end of term&#8221; or similar fee or charge payable to any lender in connection with the repayment of indebtedness by Sesen Bio at or prior to the effective time; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the amount of any cash dividend declared (or to be declared) but not yet paid as part of the pre-closing dividend; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">to the extent unpaid at closing, the cost and/or premium of the directors&#8217; and officer&#8217;s &#8220;tail policy&#8221;; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">to the extent unpaid at closing, the cost of settling any legal proceeding or other dispute existing as of the date of the Original Merger Agreement, as well as the unpaid deductible amount under Sesen Bio&#8217;s insurance reasonably expected to be payable in connection with legal proceedings existing as of the date of the Original Merger Agreement. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Each component of net cash, to the extent applicable, shall be determined in accordance with U.S. GAAP, applied on a basis consistent with the application of U.S. GAAP in the preparation of Sesen Bio&#8217;s most recent audited or reviewed financial statements. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">173</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tTMAER7">&#8203;</a><a name="tTMAER9">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Not more than ten nor less than five calendar days prior to the anticipated closing date, Sesen Bio will deliver to Carisma the net cash schedule setting forth, in reasonable detail, Sesen Bio&#8217;s good faith estimated calculation of its net cash at the cash determination time, prepared and certified by Sesen Bio&#8217;s Chief Executive Officer and Chief Financial Officer (or if there is no chief financial officer at such time, the principal financial and accounting officer) together with the work papers and back-up materials used or useful in preparing the net cash schedule, as reasonably requested by Carisma. Within three business days after delivery of the net cash schedule (the last day of such period referred to as the response date), Carisma will have the right to dispute all or any part or parts of the net cash schedule by delivering a written notice to that effect to Sesen Bio (referred to herein as a dispute notice). Any dispute notice will identify in reasonable detail to the extent then known, the nature and amounts of any proposed revisions to Sesen Bio&#8217;s net cash calculation. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If Carisma disputes the net cash schedule prior to 8:00&#160;pm Eastern Time on the response date, the parties shall promptly, and in no event later than one calendar day after the response date, meet and attempt in good faith to resolve the disputed item(s) and negotiate an agreed-upon determination of net cash. If the parties are unable to negotiate an agreed-upon determination of net cash within two calendar days after the delivery of the dispute notice (or such other period as Sesen Bio and Carisma may mutually agree upon in writing), then any remaining disagreements as to the calculation of net cash will be referred to Deloitte &amp; Touche LLP or another independent auditor of recognized national standing mutually agreed upon by Sesen Bio and Carisma. The determination of the amount of net cash made by such auditor shall be final and binding on Sesen Bio and Carisma. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio&#8217;s net cash balance is subject to numerous factors, some of which are outside of Sesen Bio&#8217;s control. The actual amount of net cash will depend significantly on the timing of the closing of the merger. In addition, the closing of the merger could be delayed if Sesen Bio and Carisma are not able to agree upon the amount of Sesen Bio&#8217;s net cash as of the cash determination time. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Treatment of Sesen Bio Equity Awards and Warrants</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Sesen Bio Equity Awards</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">At the effective time, all outstanding and unexercised Sesen Bio options granted pursuant to the 2014 Incentive Plan or the 2009 Incentive Plan or as an inducement grant under Nasdaq Listing Rule 5635(c)(4) will remain in effect pursuant to their terms and will be unaffected by the merger. The number of shares of Sesen Bio common stock underlying the Sesen Bio options and the exercise prices for such Sesen Bio options will be appropriately adjusted to reflect the proposed reverse stock split, if approved and implemented.</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">At the effective time, all outstanding Sesen Bio RSUs granted pursuant to the 2014 Incentive Plan or the 2009 Incentive Plan will remain in effect pursuant to their terms and will be unaffected by the merger. The number of shares of Sesen Bio common stock underlying the Sesen Bio RSUs will be appropriately adjusted to reflect the proposed reverse stock split, if approved and implemented.</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Sesen Bio Warrants</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">At the effective time, all Sesen Bio warrants (other than certain Sesen Bio warrants that Sesen Bio may be required to repurchase at such warrant holder&#8217;s option as of a result of the merger) will remain in effect pursuant to their terms and will be unaffected by the merger. The number of shares of Sesen Bio common stock underlying such Sesen Bio warrants and the exercise prices for such Sesen Bio warrants will be appropriately adjusted to reflect the proposed reverse stock split, if approved.</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Treatment of Carisma Options</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Under the terms of the Merger Agreement, each Carisma option that is outstanding and unexercised immediately prior to the effective time under the Carisma Plan and that, following assumption by Sesen Bio at the effective time, will be eligible to be registered on Form S-8, whether or not vested, will be converted into and become an option to purchase Sesen Bio common stock. Sesen Bio will assume the Carisma Plan and each such Carisma option in accordance with the terms (as in effect as of the date of the Original Merger Agreement) of the Carisma Plan and the terms of the stock option agreement by which such Carisma option </font>
          </div>

      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">174</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">is evidenced (but with changes to such documents as Sesen Bio and Carisma mutually agree are appropriate to reflect the substitution of the Carisma options for an option to purchase shares of Sesen Bio common stock). All other Carisma options that are outstanding and unexercised as of immediately prior to the effective time shall be canceled immediately prior to the effective time. All rights with respect to Carisma common stock subject to Carisma options assumed by Sesen Bio shall thereupon be converted into rights with respect to Sesen Bio common stock. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Accordingly, from and after the effective time: (i)&#160;each Carisma option assumed by Sesen Bio may be exercised solely for shares of Sesen Bio common stock; (ii)&#160;the number of shares of Sesen Bio common stock subject to each Carisma option assumed by Sesen Bio shall be determined by multiplying (A)&#160;the number of shares of Carisma common stock that were subject to such Carisma option, as in effect immediately prior to the effective time, by (B)&#160;the exchange ratio, and rounding the resulting number down to the nearest whole number of shares of Sesen Bio common stock; (iii)&#160;the per share exercise price for the Sesen Bio common stock issuable upon the exercise of each Carisma option assumed by Sesen Bio shall be determined by dividing (A)&#160;the per share exercise price of Carisma common stock subject to such Carisma option, as in effect immediately prior to the effective time, by (B)&#160;the exchange ratio and rounding the resulting exercise price up to the nearest whole cent; and (iv)&#160;any restriction on the exercise of any Carisma option assumed by Sesen Bio shall continue in full force and effect and the term, exercisability, vesting schedule and other provisions of such Carisma option shall otherwise remain unchanged. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">However, to the extent provided under the terms of a Carisma option and the Carisma Plan, such Carisma option may be further adjusted as necessary to reflect Sesen Bio&#8217;s substitution of the Carisma options with options to purchase Sesen Bio common stock (such as by making any change in control or similar definition related to Sesen Bio and having any provision that provides for the adjustment of Carisma options upon the occurrence of certain corporate events related to corporate events that relate to Sesen Bio and/or Sesen Bio common stock); and (y)&#160;the Sesen Bio board of directors or a committee thereof shall succeed to the authority and responsibility of the Carisma board of directors or any committee thereof with respect to each Carisma option assumed by Sesen Bio. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Treatment of Carisma Convertible Note</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Under the terms of the Merger Agreement, as of immediately after the effective time, the Carisma convertible note shall convert into shares of Sesen Bio common stock in accordance with the convertible note conversion agreement, as amended or supplemented. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Directors and Officers of Sesen Bio Following the Merger</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Pursuant to the Merger Agreement, each of the current directors who will not continue as directors of Sesen Bio or the combined company following the consummation of the merger will resign effective as of the closing of the merger. Additionally, pursuant to the Merger Agreement, the employment and service of each officer of Sesen Bio will terminate. Effective as of the effective time, the Sesen Bio board of directors is expected to be comprised of seven directors, to serve in the class assigned to director. Pursuant to the terms of the Merger Agreement, one such director will be designated by Sesen Bio, and six such directors will be designated by Carisma. It is anticipated that Thomas R. Cannell will be the Sesen Bio designated director following the closing of the merger, and that all other current Sesen Bio directors will resign as of the closing of the merger. Carisma will appoint the remaining directors to the Sesen Bio board of directors to fill the resulting vacancies. It is anticipated that Sanford Zweifach, Regina Hodits, Briggs Morrison, Bj&#246;rn Odlander, Chidozie Ugwumba, and Steven Kelly will be appointed to the board of directors of the combined company by Carisma. Sanford Zweifach is expected to be appointed as chair of the board of directors of the combined company. It is anticipated that Sesen Bio&#8217;s executive officers upon the closing of the merger will be Steven Kelly, Richard Morris and Michael Klichinsky. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Amendments to the Sesen Bio Certificate of Incorporation</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Stockholders of record of Sesen Bio common stock on the record date will also be asked to approve Proposal No. 2, which include a series of alternative amendments to the Sesen Bio Certificate of Incorporation to effect the proposed reverse stock split in connection with consummation of the merger, which requires </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">175</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tCCM5">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">the affirmative vote of the holders of a majority of the outstanding shares of Sesen Bio common stock entitled to vote on the record date. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio has agreed to amend the Sesen Bio Certificate of Incorporation to change its name to &#8220;Carisma Therapeutics Inc.&#8221; </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Potentially Transferable Assets</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Sesen Bio is entitled, but under no obligation, to sell, transfer, license, assign or otherwise divest any of its non-cash assets existing as of the date of the Original Merger Agreement, in a transaction or series of transactions; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, that any such sale, transfer, license or other disposition, each, an asset disposition, must be expressly approved by the Sesen Bio board of directors. Pursuant to the Merger Agreement, Sesen Bio shall keep Carisma reasonably apprised of any developments related to an asset disposition. Without limiting the foregoing, Sesen Bio shall provide Carisma with notice of Sesen Bio&#8217;s intention to enter into any definitive written agreement providing for the consummation of an asset disposition or otherwise to consummate an asset disposition, at least ten business days prior to the execution or such definitive written agreement or to otherwise consummate an asset disposition. Sesen Bio shall not enter into a definitive written agreement or otherwise consummate an asset disposition that would result in a material continuing obligation without first obtaining the prior written consent of Carisma, such consent not to be unreasonably withheld, delayed or conditioned. </font>
          </div>

        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Conditions to the Completion of the Merger</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following contains a description of all material conditions to the completion of the merger. Each party&#8217;s obligation to effect the merger and otherwise consummate the other transactions contemplated by the Merger Agreement at the closing of the merger, is subject to the satisfaction or, the extent permitted by applicable law, the written waiver by each of the parties, at or prior to the closing of the merger, of various conditions, which include the following: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.91pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.91pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">no temporary restraining order, preliminary or permanent injunction or other order preventing the consummation of the transactions contemplated by the Merger Agreement shall have been issued by any court of competent jurisdiction or other governmental body of competent jurisdiction and remain in effect and there shall not be any law which has the effect of making the transactions contemplated by the Merger Agreement illegal; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Carisma shall have obtained the &#8220;required Carisma stockholder vote,&#8221; whereby the affirmative vote (or written consent) of (i)&#160;the holders of a majority of the Carisma capital stock, voting together as a single class, (ii)&#160;the holders of at least two-thirds of the Carisma Series&#160;A Preferred Stock, Carisma Special Voting Preferred Stock, Carisma Series&#160;B Preferred Stock and Carisma Series&#160;B Special Voting Preferred Stock, voting together as a single class, (iii)&#160;the holders of a majority of the Carisma Series&#160;A Preferred Stock and Carisma Special Voting Preferred Stock, voting together as a single class, and (iv)&#160;the holders of at least two-thirds of the Carisma Series&#160;B Preferred Stock and Carisma Series&#160;B Special Voting Preferred Stock, voting together as a single class, must have (x)&#160;adopted and approved the Merger Agreement and the transactions contemplated by the Merger Agreement, (y)&#160;acknowledged that the approval given thereby is irrevocable and that the Carisma stockholders are aware of their rights to demand appraisal for their respective shares and (z)&#160;acknowledged that by their approval of the merger they are not entitled to appraisal rights with respect to their shares in connection with the merger and thereby waive any rights to receive payment of the fair value of their capital stock under the DGCL; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio shall have obtained the &#8220;required Sesen Bio stockholder vote,&#8221; whereby the affirmative vote of (i)&#160;the holders of a majority of the outstanding shares of Sesen Bio common stock entitled to vote on the record date for the Sesen Bio special meeting must have approved Proposal No. 2 and (ii)&#160;the holders of a majority in voting power of the votes cast by the holders of all Sesen Bio common stock present or represented by proxy at the Sesen Bio special meeting and entitled to thereon must have approved Proposal No. 1; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">the existing shares of Sesen Bio common stock must have been continually listed on Nasdaq as of and from the date of the Original Merger Agreement through the closing date, the approval of the </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">176</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:30pt; width:426pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">listing of additional shares of Sesen Bio common stock on Nasdaq must have been obtained, and the shares of Sesen Bio common stock to be issued in the merger and the conversion pursuant to the Merger Agreement must have been approved for listing on Nasdaq; and </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.71pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.71pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the registration statement on Form S-4, of which this proxy statement/prospectus is a part, must have become effective in accordance with the Securities Act and must not be subject to any stop order or proceeding (or any proceeding threatened by the SEC) seeking a stop order with respect to such registration statement that has not been withdrawn. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, the obligation of Sesen Bio and Merger Sub to effect the merger and otherwise consummate the other transactions contemplated by the Merger Agreement at the closing of the merger is further subject to the satisfaction or written waiver by Sesen Bio of the following conditions: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the representations and warranties of Carisma regarding certain matters related to due organization, authority, vote required, non-contravention, and financial advisors in the Merger Agreement must be true and correct in all material respects on and as of the closing date with the same force and effect as if made on and as of such date, representations and warranties regarding the capitalization of Carisma and absence of a Carisma material adverse effect in the Merger Agreement must be true and correct in all respects, except for de minimis inaccuracies in the case of capitalization, on and as of the closing date with the same force and effect as if made on and as of such date, and the remaining representations and warranties of Carisma in the Merger Agreement shall be true and correct on and as of the closing date with the same force and effect as if made on and the closing date, except where the failure to be true and correct would not have a Carisma material adverse effect (in all cases, except to the extent such representations and warranties are specifically made as of a particular date, in which case as of such date); </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Carisma shall have performed or complied in all material respects with the agreements and covenants required to be performed or complied with by it under the Merger Agreement at or prior to the effective time; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio shall have received a certificate executed by the Chief Executive Officer or Chief Executive Officer of Carisma certifying that certain closing conditions have been duly satisfied and that the information set forth in an allocation certificate delivered by Carisma is true and accurate in all respects as of the closing date; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio shall have received (i)&#160;an original signed statement from Carisma that the Carisma common stock is not a &#8220;United States real property interest,&#8221; as defined in Section&#160;897(c) of the Code, conforming to the requirements of Treasury Regulations&#160;Section&#160;1.1445-2(c)(3) and 1.897-2(h), and (ii)&#160;an original signed notice to be delivered to the IRS by Sesen Bio in accordance with the provisions of Treasury Regulations&#160;Section&#160;1.897-2(h)(2), together with written authorization for Sesen Bio to deliver such notice to the IRS on behalf of Carisma following the closing of the merger, each dated as of the closing date, duly executed by an authorized officer of Carisma, and in form and substance reasonably acceptable to Sesen Bio; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">certain investor agreements between Carisma and its stockholders must have been terminated; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the Carisma lock-up agreements will continue to be in full force and effect as of immediately following the effective time. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, the obligation of Carisma to effect the merger and otherwise consummate the transactions to be consummated at the closing of the merger is further subject to the satisfaction or written waiver by Carisma of the following conditions: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the representations and warranties of Parent and Merger Sub regarding certain matters related to due organization, authority, vote required, non-contravention, and financial advisors in the Merger Agreement must be true and correct in all material respects on and as of the closing date with the same force and effect as if made on and as of such date, representations and warranties regarding the capitalization of Sesen Bio and Merger Sub and absence of a Sesen Bio material adverse effect in the Merger Agreement must be true and correct in all respects, except for de minimis inaccuracies in the case of capitalization, on and as of the closing date with the same force and effect as if made on and as of such date, and the remaining representations and warranties of Sesen Bio and Merger Sub in </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">177</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:30pt; width:426pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">the Merger Agreement shall be true and correct on and as of the closing date with the same force and effect as if made on and as of the closing date, except where the failure to be true and correct would not have a Sesen Bio material adverse effect (in all cases, except to the extent such representations and warranties are specifically made as of a particular date, in which case as of such date); </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio and Merger Sub shall have performed or complied in all material respects with the agreements and covenants required to be performed or complied with by each of them under the Merger Agreement at or prior to the effective time; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Carisma shall have received (i)&#160;a certificate by the Chief Executive Officer or Chief Financial Officer of Sesen Bio certifying that certain closing conditions have been duly satisfied, (ii)&#160;a copy of the CVR Agreement duly executed by Sesen Bio and the rights agent (as defined therein) and (iii)&#160;a written resignation, in form reasonably satisfactory to Carisma, dated as of the closing date and effective as of the closing, executed by each of the officers and directors, from their positions as such, of Sesen Bio who are not to continue as directors or officers (as applicable) of Sesen Bio after the closing of the merger, which such resignations not affecting such officer&#8217;s or director&#8217;s status as an employee (if applicable) including any characterization of their cessation from employment; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">The Sesen Bio lock-up agreements will continue to be in full force and effect as of immediately following the effective time; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">Sesen Bio&#8217;s final net cash shall have been determined to be greater than or equal to $75.0&#160;million. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Representations and Warranties</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Merger Agreement contains customary representations and warranties of Sesen Bio and Carisma for a transaction of this type relating to, among other things: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">corporate organization and power, and similar corporate matters; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">organizational documents; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">subsidiaries; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">authority to enter into the Merger Agreement and the related agreements; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">votes required for completion of the merger and approval of the proposals that will come before the Sesen Bio special meeting and that will be the subject of the Carisma stockholder written consent; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.09pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.09pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">except as otherwise specifically disclosed in the Merger Agreement, the fact that the consummation of the merger would not contravene the organizational documents, certain laws, governmental authorization or certain contracts of the parties; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">result in any encumbrance on the parties&#8217; assets or require the consent of any third party; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">capitalization; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">financial statements and with respect to Sesen Bio, documents filed with the SEC and the accuracy of information contained in those documents; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">material changes or events; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">liabilities; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">title to assets; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">ownership of real property and leasehold interests; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">intellectual property; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">privacy and data security; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the validity of material contracts to which the parties or their subsidiaries are a party and any violation, default or breach to such material contracts; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">regulatory compliance, permits and restrictions; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">178</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tNSON">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">legal proceedings and orders; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.89pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.89pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">tax matters; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">employee and labor matters and benefit plans; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.89pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.89pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">environmental matters; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">insurance; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.89pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.89pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">any brokerage or finder&#8217;s fee or other fee or commission in connection with the merger; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">certain transactions or relationships with affiliates; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.89pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.89pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">compliance with anti-bribery laws; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">with respect to Sesen Bio, the valid issuance in the merger of Sesen Bio common stock and the opinion of SVB Securities. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The representations and warranties are, in many respects, qualified by materiality and knowledge and will not survive the merger, but their accuracy forms the basis of one of the conditions to the obligations of Sesen Bio and Carisma to complete the merger. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Pre-Closing Dividend</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Prior to the effective time, Sesen Bio will declare a dividend to its common stockholders of record consisting of (a)&#160;one CVR for each outstanding share of Sesen Bio common stock held by such stockholder as of such date, representing the right to receive contingent payments upon the occurrence of certain events as well as proceeds from any sale of Sesen Bio&#8217;s non-cash assets, as set forth in, and subject to and in accordance with the terms and conditions of, the CVR Agreement, in the form attached hereto as </font><font style="font-style:italic;letter-spacing:0.2pt;">Annex F</font><font style="letter-spacing:0.2pt;">, and (b)&#160;cash in an amount expected to be approximately $70.0&#160;million in the aggregate, subject to Sesen Bio&#8217;s estimated net cash as of the closing of the merger being greater than or equal to $75.0 million and subject to the satisfaction of certain obligations of Sesen Bio under the Merger Agreement. The record date for the pre-closing dividend shall be a date agreed upon by Carisma and Sesen Bio prior to the day on which the effective time occurs and the payment date for which shall be three business days after the effective time; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, that the payment of such dividend may be conditioned upon the occurrence of the effective time. In connection with the pre-closing dividend, Sesen Bio shall cause the CVR Agreement to be duly authorized, executed and delivered by Sesen Bio and a rights agent selected by Sesen Bio with Carisma&#8217;s prior approval (such approval not to be unreasonably withheld, delayed or conditioned). For more information related to the CVRs, see the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Agreements Related to the Merger&#8201;&#8212;&#8201;CVR Agreement</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page&#160;<a href="#tCVAG">192</a> of this proxy statement/prospectus. </font>
          </div>

        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">No Solicitation</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Except as expressly permitted by the Merger Agreement, each of Sesen Bio and Carisma agreed that during the pre-closing period, except as described below, Sesen Bio and Carisma will not, nor will either party authorize any of the directors, officers, employees, agents, attorneys, accountants, investment bankers, advisors or representatives retained by it or any of its subsidiaries to, directly or indirectly: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.19pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">solicit, initiate or knowingly encourage, induce or facilitate the communication, making, submission or announcement of, any acquisition proposal or acquisition inquiry (each as defined below) or take any action that could reasonably be expected to lead to an acquisition proposal or acquisition inquiry; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">furnish any non-public information regarding the party and its subsidiaries to any person in connection with or in response to an acquisition proposal or acquisition inquiry; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">engage in discussions or negotiations with any person with respect to any acquisition proposal or acquisition inquiry; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.89pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.89pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">approve, endorse or recommend an acquisition proposal; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">179</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">execute or enter into any letter of intent or any contract contemplating or otherwise relating to any acquisition transaction, as defined below (other than a confidentiality agreement permitted under the Merger Agreement); or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">publicly propose to do any of the above. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">The Merger Agreement also provides that each of Carisma and Sesen Bio will immediately cease and cause to be terminated any existing discussions, negotiations and communications with any person that relate to any acquisition proposal or acquisition inquiry as of the date of the Original Merger Agreement and request the destruction or return of any non-public information of Sesen Bio or Carisma and their respective subsidiaries, as applicable, provided to such person. </font>
          </div>

        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">An &#8220;acquisition inquiry&#8221; means, with respect to a party, an inquiry, indication of interest or request for information (other than an inquiry, indication of interest or request for information made or submitted by Carisma or any of its affiliates, on the one hand, or Sesen Bio or any of its affiliates, on the other hand, to the other party) that could reasonably be expected to lead to an acquisition proposal, other than (i)&#160;with respect to Sesen Bio, solely with respect to an asset disposition and (ii)&#160;with respect to Carisma, solely with respect to the Carisma pre-closing financing. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">An &#8220;acquisition proposal&#8221; means, with respect to a party, any offer or proposal, whether written or oral (other than an offer or proposal made or submitted by or on behalf of Carisma or any of its affiliates, on the one hand, or by or on behalf of Sesen Bio or any of its affiliates, on the other hand, to the other party) contemplating or otherwise relating to any acquisition transaction with such party, other than (i)&#160;with respect to Sesen Bio, solely with respect to an asset disposition and (ii)&#160;with respect to Carisma, solely with respect to the Carisma pre-closing financing. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">An &#8220;acquisition transaction&#8221; means any transaction or series of related transactions (other than the asset disposition) involving: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">any merger, consolidation, amalgamation, share exchange, business combination, issuance of securities, acquisition of securities, reorganization, recapitalization, tender offer, exchange offer or other similar transaction: (A)&#160;in which a party is a constituent entity; (B)&#160;in which a person or &#8220;group&#8221; (as defined in the Exchange Act and the rules promulgated thereunder) of persons directly or indirectly acquires beneficial or record ownership of securities representing more than 15% of the outstanding securities of any class of voting securities of a party or any of its subsidiaries; or (C)&#160;in which a party or any of its subsidiaries issues securities representing more than 15% of the outstanding securities of any class of voting securities of such party or any of its subsidiaries; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, </font><font style="font-style:italic;letter-spacing:0.2pt;">however</font><font style="letter-spacing:0.2pt;">, that in the case of Carisma, to the extent the Carisma pre-closing financing is effected in accordance with the terms and conditions of the Merger Agreement, the Carisma pre-closing financing shall not constitute an acquisition transaction; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">any sale, lease, exchange, transfer, license, acquisition or disposition of any business or businesses or assets that constitute or account for 15% or more of the consolidated book value or the fair market value of the assets of Sesen Bio or Carisma and their respective subsidiaries, as applicable, taken as a whole. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Notwithstanding the foregoing, before obtaining the applicable approvals of the stockholders of Sesen Bio or Carisma required to consummate the merger, as applicable, each party may furnish non-public information regarding such party and its subsidiaries to, and enter into discussions or negotiations with, any person in response to a bona fide written unsolicited acquisition proposal by such person, which such party&#8217;s board of directors determines in good faith, after consultation with such party&#8217;s outside legal counsel and financial advisors, constitutes or is reasonably likely to result in a &#8220;superior offer,&#8221; &#8203;(as defined below) (and is not withdrawn) if: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">neither such party nor any of its representative has breached the no solicitation provisions of the Merger Agreement in any material respects; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">such party&#8217;s board of directors concludes in good faith, after consultation with such party&#8217;s outside legal counsel, that the failure to take such action is reasonably likely to be inconsistent with the fiduciary duties of such party&#8217;s board of directors under applicable law; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">180</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">at least two business days&#8217; prior to initially furnishing any such nonpublic information to, or entering into discussions with, such person, such party gives the other party written notice of the identity of such person and of that party&#8217;s intention to furnish non-public information to, or enter into discussions with, such person ; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">such party receives from the person an executed confidentiality agreement containing provisions (including nondisclosure provisions, use restrictions, non-solicitation provisions and no hire provisions) at least as favorable to such party as those contained in the confidentiality agreement between Sesen Bio and Carisma; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">at least two business days prior to furnishing any non-public information to such person, such party furnishes the same non-public information to the other party (to the extent such information has not been previously furnished). </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">A &#8220;superior offer&#8221; means an unsolicited bona fide written acquisition proposal (with all references to 15% in the definition of acquisition transaction being treated as references to 70% for these purposes) that: (a)&#160;was not obtained or made as a direct or indirect result of a breach of (or in violation of) the Merger Agreement; (b)&#160;is on terms and conditions that the Sesen Bio board of directors or the Carisma board of directors, as applicable, determines in good faith, based on such matters that it deems relevant (including the likelihood of consummation thereof, the financing terms thereof, any termination or break-up fees and conditions to consummation), as well as any written offer by the other party to the Merger Agreement to amend the terms of the Merger Agreement, and following consultation with its outside legal counsel and financial advisors, if any, are more favorable to Sesen Bio stockholders or Carisma stockholders, as applicable, than the terms of the transaction contemplated by the Merger Agreement; (c)&#160;is not subject to any financing conditions (and if financing is required, such financing is then fully committed to the person); and (d)&#160;is reasonably capable of being completed on the terms proposed without unreasonable delay. </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">The Merger Agreement also provides that each party will promptly advise the other in writing of such acquisition proposal or acquisition inquiry (including the identity of the person making or submitting such acquisition proposal or acquisition inquiry (subject to any confidentiality restrictions that may be in place between the applicable party and such person as of the date of the Original Merger Agreement), and a copy of the acquisition proposal or acquisition inquiry, or if the acquisition proposal or acquisition inquiry is not written, the terms thereof, and the material terms thereof). Each party shall keep the other party reasonably informed with respect to the status and terms of any such acquisition proposal or acquisition inquiry and any material modification or proposed material modification thereto. In addition to the foregoing, each party shall provide the other party with reasonable advance written notice of a meeting of the Sesen Bio board of directors or Carisma board of directors, as applicable, (or any committee thereof) at which such board of directors (or any committee thereof) is reasonably expected to consider an acquisition proposal or acquisition inquiry it has received. </font>
          </div>

        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Changes in Board Recommendation</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As described above, and subject to the provisions described below, (i)&#160;the Sesen Bio board of directors recommends that Sesen Bio stockholders vote &#8220;FOR&#8221; all of the proposals described in this proxy statement/</font>&#8203;<font style="letter-spacing:0.2pt;">prospectus and (ii)&#160;the Carisma board of directors recommends that Carisma stockholders execute the written consent to approve the merger, the Merger Agreement, and the transactions contemplated therein, substantially in accordance with the terms of the Merger Agreement and the other agreements contemplated by the Merger Agreement. </font></div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Under the Merger Agreement, subject to certain exceptions described below, Sesen Bio agreed that the Sesen Bio board of directors may not take any of the following actions, each of which are referred to in this proxy statement/prospectus as a Sesen Bio board of directors adverse recommendation change: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">withhold, amend, withdraw or modify (or publicly propose to withhold, amend, withdraw or modify) Sesen Bio board of directors&#8217; recommendation in favor of the proposals described in this proxy statement/prospectus in a manner adverse to Carisma; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">resolve, or have any committee of the Sesen Bio board of directors resolve, to withhold, amend, withdraw or modify the Sesen Bio board of directors&#8217; recommendation in favor of the proposals described in this proxy statement/prospectus in a manner adverse to Carisma; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">181</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">adopt, approve or recommend (or publicly propose to adopt, approve or recommend) any acquisition proposal shall be adopted or proposed. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">However, notwithstanding the foregoing, at any time prior to the approval of the proposals to be considered at the Sesen Bio special meeting by the required Sesen Bio stockholder vote, if Sesen Bio has received a bona fide written superior offer, the Sesen Bio board of directors may make a Sesen Bio board of directors adverse recommendation change if, but only if, following the receipt of and on account of such superior offer: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the Sesen Bio board of directors determines in good faith, based on the advice of its outside legal counsel, that the failure to withhold, amend, withdraw or modify the Sesen Bio board of directors recommendation would constitute a violation of the Sesen Bio board of directors&#8217; fiduciary duties under applicable law; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio has, and has caused its financial advisors and outside legal counsel to, during the required four business day notice period, or the required notice period, negotiate with Carisma in good faith to make such adjustments to the terms and conditions of the Merger Agreement so that such acquisition proposal ceases to constitute a superior offer; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">if after Carisma shall have delivered to Sesen Bio a written offer to alter the terms or conditions of the Merger Agreement during the required notice period, the Sesen Bio board of directors shall have determined in good faith, based on the advice of its outside legal counsel, that the failure to withhold, amend, withdraw or modify the Sesen Bio board of directors recommendation would constitute a violation of the Sesen Bio board of directors&#8217; fiduciary duties under applicable law (after taking into account such alterations of the terms and conditions of the Merger Agreement); </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, that (x)&#160;Carisma receives written notice from Sesen Bio confirming that the Sesen Bio board of directors has determined to change its recommendation during the required notice period, which notice shall include a description in reasonable detail of the reasons for such Sesen Bio board of directors adverse recommendation change, and written copies of any relevant transaction with any party making a potential superior offer, (y)&#160;during any required notice period, Carisma shall be entitled to deliver to Sesen Bio one or more counterproposals to such acquisition proposal and Sesen Bio will, and will cause its representatives to, negotiate with Carisma in good faith (to the extent Carisma desires to negotiate) to make such adjustments in the terms and conditions of the Merger Agreement so that the applicable acquisition proposal ceases to constitute a superior offer, and (z)&#160;in the event of any material amendment to any superior offer (including any revision in the amount, form or mix of consideration the Sesen Bio stockholders would receive as a result of such potential superior offer), Sesen Bio shall be required to provide Carisma with notice of such material amendment and the required notice period shall be extended, if applicable, to ensure that at least two business days remain in the required notice period following such notification during which the parties shall comply again with the requirements in this provision and the Sesen Bio board of directors shall not make a Sesen Bio board of directors adverse recommendation change prior to the end of such notice period so extended (it being understood that there may be multiple extensions). </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Under the Merger Agreement, subject to certain exceptions described below, Carisma agreed that the Carisma board of directors may not take any of the following actions, each of which are referred to in this proxy statement/prospectus as a Carisma board of directors adverse recommendation change: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">withdraw or modify (or publicly propose to withdraw or modify) the Carisma board of directors recommendation in a manner adverse to Sesen Bio; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.91pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.91pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">resolve or have any committee of the Carisma board of directors withdraw or modify the Carisma board of directors recommendation in a manner adverse to Sesen; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">adopt, approve or recommend (or publicly propose to adopt, approve or recommend) any acquisition proposal shall be adopted or proposed. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">However, notwithstanding the foregoing, at any time prior to the approval and adoption of the Merger Agreement by the required Carisma stockholder vote, if Carisma has received a bona fide written superior offer, the Carisma board of directors may make a Carisma board of directors adverse recommendation change if, but only if, following the receipt of and on account of such superior offer: </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">182</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the Carisma board of directors determines in good faith, based on the advice of its outside legal counsel, that the failure to withhold, amend, withdraw or modify the Carisma board of directors recommendation would constitute a violation of the Carisma board of directors&#8217; fiduciary duties under applicable law; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Carisma has, and has caused its financial advisors and outside legal counsel to, during the required notice period, negotiate with Sesen Bio in good faith to make such adjustments to the terms and conditions of the Merger Agreement so that such acquisition proposal ceases to constitute a superior offer; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">if after Sesen Bio shall have delivered to Carisma a written offer to alter the terms or conditions of the Merger Agreement during the required notice period, the Carisma board of directors shall have determined in good faith, based on the advice of its outside legal counsel, that the failure to withhold, amend, withdraw or modify the Carisma board of directors recommendation would constitute a violation of the Carisma board of directors&#8217; fiduciary duties under applicable law (after taking into account such alterations of the terms and conditions of the Merger Agreement); </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;"> that (x)&#160;Sesen Bio receives written notice from Carisma confirming that the Carisma board of directors has determined to change its recommendation at least four business days in advance of the Carisma board of directors adverse recommendation change, which notice shall include a description in reasonable detail of the reasons for such Carisma board of directors adverse recommendation change, and written copies of any relevant transaction agreements with any party making a potential superior offer, (y)&#160;during any required notice period, Sesen Bio shall be entitled to deliver to Carisma one or more counterproposals to such acquisition proposal and Carisma will, and cause its representatives to, negotiate with Sesen Bio in good faith (to the extent Sesen Bio desires to negotiate) to make such adjustments in the terms and conditions of the Merger Agreement so that the applicable acquisition proposal ceases to constitute a superior offer, and (z)&#160;in the event of any material amendment to any superior offer (including any revision in the amount, form or mix of consideration Carisma stockholders would receive as a result of such potential superior offer), Carisma shall be required to provide Sesen Bio with notice of such material amendment and the required notice period shall be extended, if applicable, to ensure that at least two business days remain in the notice period following such notification during which the parties shall comply again with the requirements in this provision and the Carisma board of directors shall not make a Carisma board of directors adverse recommendation change prior to the end of such notice period as so extended (it being understood that there may be multiple extensions). </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Meetings of Sesen Bio stockholders; Consent of Carisma stockholders</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio is obligated under the Merger Agreement to call, give notice of and hold the Sesen Bio special meeting for the purposes of considering the approval of, among the other items noted herein, the amendment of the Sesen Bio Certificate of Incorporation to effect the proposed reverse stock split, the issuance of shares of Sesen Bio common stock to Carisma stockholders in connection with the transactions contemplated under the Merger Agreement and change of control of Sesen Bio resulting therefrom, and the equity plan amendment proposals. Carisma is obligated under the Merger Agreement to obtain the written consent of its stockholders sufficient to adopt the Merger Agreement and approve the merger and related transactions and deliver to Sesen Bio such written consent within five business days following the registration statement on Form S-4, of which this proxy statement/prospectus is a part, being declared effective by the SEC. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Covenants; Conduct of Business Pending the Merger</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Except as expressly permitted by the Merger Agreement, as required by applicable law, in connection with any COVID-19 measures of COVID-19 response, or unless Carisma shall have otherwise consented in writing (which consent shall not be unreasonably withheld, delayed or conditioned), during the pre-closing period, Sesen Bio will and will cause its subsidiaries to, (i)&#160;use commercially reasonable efforts to conduct its business and operations in the ordinary course of business and (ii)&#160;conduct its business and operations in compliance in all material respects with all applicable laws, including timely making all filings required by the SEC, and the requirements of certain material contracts. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">183</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio has also agreed that, except as expressly permitted by the Merger Agreement, as required by applicable law, in connection with the asset disposition and the pre-closing dividend, in connection with any COVID-19 measures or COVID-19 response, or for certain limited exceptions with the prior written consent of Carisma (which consent shall not be unreasonably withheld, delayed or conditioned), at all times during the pre-closing period, it will not, nor shall it cause or permit its subsidiaries to, do any of the following: </font>
        </div>

          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">declare, accrue, set aside or pay any dividend or make any other distribution in respect of any shares of its capital stock or repurchase, redeem or otherwise reacquire any shares of its capital stock or other securities (except in connection with the payment of the exercise price and/or withholding taxes incurred upon the exercise of any Sesen Bio option or vesting of Sesen Bio RSUs in accordance with the terms of such award in effect on the date of the Original Merger Agreement); </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>


          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">sell, issue, grant, pledge, or otherwise dispose of or encumber or authorize the issuance of: any capital stock or other security of Sesen Bio (except for Sesen Bio common stock issued upon the valid exercise or settlement of outstanding Sesen Bio options, Sesen Bio warrants or the vesting of Sesen Bio RSUs, as applicable, in accordance with their terms as in effect as of the date of the Original Merger Agreement); any option, warrant or right to acquire any capital stock or any other security; or any other instrument convertible into or exchangeable for any capital stock or other security of Sesen Bio or any of its subsidiaries; </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">amend the organizational documents of Sesen Bio or any of its subsidiaries, or effect or be a party to any merger, consolidation, share exchange, business combination, recapitalization, reclassification of shares, stock split, reverse stock split, or similar transaction except, for the avoidance of doubt, the transactions contemplated under the Merger Agreement; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">form any subsidiary or acquire any equity interest, or other interest in any other entity, or enter into any joint venture with any other entity; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">(A) lend money to any person, (B)&#160;incur or guarantee any indebtedness for borrowed money, issue or sell any debt securities or options, warrants, call or other rights to acquire any debt securities, (C)&#160;guarantee any debt securities of others, or (D)&#160;make any capital expenditure or commitment in excess of $250,000; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">other than as required by applicable law or by the terms of a Sesen Bio employee plan as in effect on the date of the Original Merger Agreement and disclosed in certain sections of the confidential disclosure schedules, adopt, terminate, establish or enter into any Sesen Bio employee plan; cause or permit any Sesen Bio employee plan to be amended in any material respect; pay any bonus or make any profit-sharing or similar payment to, or increase the amount of the wages, salary, commissions, benefits or other compensation or remuneration payable to, any current or former employee, independent contractor, officer or director of Sesen Bio or any of its subsidiaries; or increase or otherwise modify the severance, retention or change of control benefits offered to any current or former employee, independent contractor, officer or director of Sesen Bio or any of its subsidiaries; </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">enter into any contract with a labor union, labor organization, or similar person except as otherwise required by applicable law; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">(A) hire or engage, or offer to hire, any director, officer, employee or consultant, or (B)&#160;enter into, amend or extend the term of any employment or consulting agreement with any current or former employee, independent contractor, officer or director of Sesen Bio or any of its subsidiaries; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">enter into any material transaction; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">acquire any material asset or sell, lease or otherwise irrevocably dispose of any of its material assets or properties, or grant any encumbrance with respect to such assets or properties; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">make, change or revoke any material tax election, file any material amended tax return, settle or compromise any income or other material tax liability, enter into any tax allocation, sharing, indemnification or other similar agreement or arrangement (other than customary commercial contracts entered into in the ordinary course of business the principal subject matter of which is not </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">184</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:30pt; width:426pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">taxes), request or consent to any extension or waiver of any limitation period with respect to any claim or assessment for any income or other material taxes (other than pursuant to an extension of time to file any tax return granted in the ordinary course of business of not more than six&#160;months), or change any material accounting method in respect of taxes; </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">(A) sell, assign, transfer, allow to lapse or expire, pledge, abandon, discontinue, fail to maintain or otherwise dispose of any right, title or interest of Sesen Bio or any of its subsidiaries in any material Sesen Bio intellectual property, or (B)&#160;license, sublicense or otherwise encumber (other than pursuant to a non-exclusive license granted to contract research organizations, including clinical trial sites and clinical trial services provides, or contract manufacturing organizations, in each case, (x)&#160;with whom Sesen Bio or any of its subsidiaries has previously entered into contracts prior to the effective time and (y)&#160;who are engaged to provide services directly related to clinical studies and manufacturing of any product candidate of Sesen Bio, </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;"> that the scope of any such non-exclusive license grant is limited to only the extent necessary for such persons to perform their obligations under the respective contracts) any right, title or interest of Sesen Bio or any of its subsidiaries in any material Sesen Bio intellectual property; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">enter into, amend or terminate certain material contracts (or any contract that would have been a material contract if in effect on or prior to the date of the Original Merger Agreement); </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">(A) materially change pricing or royalties or other payments set or charged by Sesen Bio or any of its subsidiaries to its customers or licensees or (B)&#160;agree to materially change pricing or royalties or other payments set or charged by persons who have licensed intellectual property rights to Sesen Bio or any of its subsidiaries; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">make any expenditures, incur any liabilities or discharge or satisfy any liabilities, in each case, other than those expenditures or liabilities that will not survive the closing of the merger, are discharged or satisfied prior to the closing of the merger, and/or are taken into account in the calculation of net cash; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">waive, settle or compromise any pending or threatened legal proceeding against Sesen Bio or any of its subsidiaries, other than waivers, settlements or agreements (A)&#160;for an amount not in excess of $75,000 individually or in the aggregate (excluding amounts to be paid under existing insurance policies or renewals thereof) and (B)&#160;that do not (1)&#160;impose any restriction on the operations or business of Sesen Bio or its subsidiaries (nor on Carisma or any of its subsidiaries, from and after the closing of the merger), (2)&#160;involve any equitable relief and (3)&#160;do not involve admission of any wrongdoing by Sesen Bio or any of its subsidiaries; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">agree, resolve, or commit to do any of the foregoing. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Notwithstanding the generality of the foregoing, nothing set forth above shall restrict (i)&#160;Sesen Bio or any of its subsidiaries from taking or not taking any action, including the establishment of any policy, procedure or protocol, in response to COVID-19 or any COVID-19 measures or otherwise take any COVID-19 response and (ii)&#160;Sesen Bio&#8217;s right to effectuate one or more asset dispositions or the pre-closing dividend, each on the on the terms and subject to the applicable limitations set forth in the Merger Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma has agreed that, except as expressly permitted by the Merger Agreement, as required by applicable law, in connection with any COVID-19 measures or COVID-19 response, or unless Sesen Bio shall have otherwise consented in writing (which consent shall not be unreasonably withheld, delayed or conditioned), during the pre-closing period, each of Carisma and its subsidiaries will (i)&#160;use commercially reasonable efforts to conduct its respective business and operations in the ordinary course of business and (ii)&#160;conduct its business and operations in compliance in all material respects with all applicable laws and the requirements of certain material contracts. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma has also agreed that, except (i)&#160;as expressly permitted in the Merger Agreement, as required by applicable law, in connection with any COVID-19 measures or COVID-19 response, or with the prior written consent of Sesen Bio (which consent shall not be unreasonably withheld, delayed or conditioned), at all times during the pre-closing period, it will not, nor will it cause or permit any of its subsidiaries to, do any of the following: </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">185</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">

          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">declare, accrue, set aside or pay any dividend or make any other distribution in respect of any shares of its capital stock or repurchase, redeem or otherwise reacquire any shares of capital stock or other securities (except in connection with the payment of the exercise price and/or withholding taxes incurred upon the exercise of any Carisma option in accordance with the terms of such award in effect on the date of the Original Merger Agreement); </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>


          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">except as contemplated by the Carisma pre-closing financing or the conversion of the Carisma convertible note, sell, issue, grant, pledge, or otherwise dispose of or encumber or authorize the issuance of: any capital stock or other security of Carisma or any of its subsidiaries (except for shares of outstanding Carisma common stock issued upon the valid exercise or settlement of Carisma options in accordance with their terms as in effect as of the date of the Original Merger Agreement); any option, warrant or right to acquire any capital stock or any other security, other than options grants to employees and service providers in the ordinary course of business; or any other instrument convertible into or exchangeable for any capital stock or any other security of Carisma or its subsidiaries; </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">amend the organizational documents of Carisma or its subsidiaries, or effect or be a party to any merger, consolidation, share exchange, business combination, recapitalization, reclassification of shares, stock split, reverse stock split, or similar transaction except, for the avoidance of doubt, the transactions contemplated under the Merger Agreement; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">form any subsidiary or acquire any equity interest, or other interest in any other entity or enter into a joint venture with any other entity; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">(A) lend money to any person (except for the advancement of reasonable expenses to employees, directors and consultants in the ordinary course of business), (B)&#160;incur or guarantee any indebtedness for borrowed money, other than in the ordinary course of business, (C)&#160;guarantee any debt securities of others or (D)&#160;except as contemplated by Carisma&#8217;s capital expenditure budget and operating budget made available to Sesen Bio, make any capital expenditure or commitment in excess of $350,000; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">acquire any material asset or sell, lease or otherwise irrevocably dispose of any of its material assets or properties, or grant any encumbrance with respect to such assets or properties, except in the ordinary course of business; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">sell, assign, license, sublicense, transfer, allow to lapse or expire, pledge abandon, discontinue, fail to maintain or otherwise dispose of any right, title or interest of Carisma or any of its subsidiaries in any material Carisma intellectual property rights (other than pursuant to a non-exclusive license in the ordinary course of business); </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">make, change or revoke any material tax election, file any material amended tax return, settle or compromise any income or other material tax liability, enter into any tax allocation, sharing, indemnification or other similar agreement or arrangement (other than customary commercial contracts entered into in the ordinary course of business the principal subject matter of which is not taxes), request or consent to any extension or waiver of any limitation period with respect to any claim or assessment for any income or other material taxes (other than pursuant to an extension of time to file any tax return granted in the ordinary course of business of not more than six&#160;months), or change any material accounting method in respect of taxes; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">enter into, materially amend or terminate any Carisma material contract (or any contract that would have been a Carisma material contract if in effect on or prior to the date of the Original Merger Agreement) other than in the ordinary course of business; </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">waive, settle or compromise any pending or threatened legal proceeding against Carisma or any of its subsidiaries, other than waivers, settlements or agreements (A)&#160;for an amount not in excess of $75,000 individually or in the aggregate (excluding amounts to be paid under existing insurance policies or renewals thereof) and (B)&#160;that do not (1)&#160;impose any material restriction on the operations or business of Carisma or its subsidiaries (nor, following the closing of the merger, on Sesen Bio or any of its subsidiaries), (2)&#160;involve any equitable relief and (3)&#160;involve admission of any wrongdoing by Carisma or any of its subsidiaries; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">186</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">agree, resolve or commit to do any of the foregoing. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Notwithstanding the generality of the foregoing, nothing set forth above shall restrict Carisma or any of its subsidiaries from taking or not taking any action, including the establishment of any policy, procedure or protocol, in response to COVID-19 or any COVID-19 measures or otherwise take any COVID-19 response. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Other Agreements</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Each of Sesen Bio and Carisma has agreed to use its commercially reasonable efforts to cause to be taken all actions necessary to consummate the merger and the other transactions contemplated by the Merger Agreement. In connection therewith, each party has agreed to: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">file or otherwise submit all applications and notices required to be filed in connection with the merger and the other transactions contemplated by the Merger Agreement; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">use reasonable best efforts to lift any injunction prohibiting, or any other legal bar to, the merger or the other transactions contemplated by the Merger Agreement; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.21pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.21pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">use commercially reasonable efforts to resolve the matters set forth on a schedule without any material continuing obligation; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">use commercially reasonable efforts to satisfy the conditions precedent to the consummation of the Merger Agreement. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Pursuant to the Merger Agreement, Sesen Bio and Carisma have further agreed that Sesen Bio will use its commercially reasonable efforts to: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">maintain its existing listing of its common stock on Nasdaq and to obtain approval for listing of the combined company on Nasdaq; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.11pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.11pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">if required by the rules and regulations of Nasdaq, to prepare and submit to Nasdaq a notification form for the listing of the shares of Sesen Bio common stock to be issued in connection with the merger; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.11pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.11pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">prepare and timely submit to Nasdaq a notification form of the proposed reverse stock split and to submit a copy of the amendment to Sesen Bio&#8217;s certificate of incorporation to effect the proposed reverse stock split, certified by the Secretary of State of the State of Delaware to Nasdaq on the date of closing; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">if required by Nasdaq Listing Rule&#160;5110, to file an initial listing application for Sesen Bio common stock on Nasdaq and to cause such listing application to be approved; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.11pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.11pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">in the event of receipt of a Nasdaq delisting determination, Sesen Bio will request a hearing to appeal the delisting determination and will pay the appropriate fee to Nasdaq to appeal the delisting determination. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Indemnification and Insurance for Directors and Officers</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Under the Merger Agreement, from the effective time through the sixth anniversary of the date on which the effective time occurs, each of Sesen Bio and the surviving corporation will, jointly and severally, indemnify and hold harmless each person who is now, or has been at any time prior to the date of the Original Merger Agreement, or who becomes prior to the effective time, a director, officer, fiduciary or agent of Sesen Bio or Carisma and their respective subsidiaries, respectively, the indemnified parties, against all claims, judgments, fines and reasonable fees, costs and expenses, including attorneys&#8217; fees and disbursements and investigation costs, incurred in connection with any claim, action, suit, proceeding or investigation, whether civil, criminal, administrative or investigative, or any other actual, threatened or completed proceeding arising out of or pertaining to the fact that the indemnified party is or was an indemnified party, whether asserted or claimed prior to, at or after the effective time, in each case, to the fullest extent permitted under applicable law. </font>
          </div>

        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Each indemnified party will also be entitled to advancement of expenses incurred in the defense of any such claim, action, suit, proceeding or investigation from each of Sesen Bio and the surviving corporation, </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">187</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tTMAER10">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">jointly and severally, upon receipt by Sesen Bio or the surviving corporation from the indemnified party of a request therefor; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, that any such person to whom expenses are advanced provides an undertaking to Sesen Bio, to the extent then required by the DGCL, to repay such advances if it is ultimately determined that such person is not entitled to indemnification </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Merger Agreement also provides that the provisions of Sesen Bio&#8217;s organizational documents with respect to indemnification, advancement of expenses and exculpation of present and former directors and officers of Sesen Bio that are presently set forth in the Sesen Bio Certificate of Incorporation and the Sesen Bio Bylaws shall not be amended, modified or repealed for a period of six&#160;years from the effective time in a manner that would adversely affect the rights thereunder of individuals who, at or prior to the effective time, were officers or directors of Sesen Bio, unless such modification is required by applicable law. The certificate of incorporation and bylaws of the surviving corporation shall contain, and Sesen Bio shall cause the certificate of incorporation and bylaws of the surviving corporation to so contain, provisions no less favorable with respect to indemnification, advancement of expenses and exculpation of present and former directors and officers as those presently set forth in the Carisma Certificate of Incorporation and the Carisma Bylaws. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">From and after the effective time, (i)&#160;the surviving corporation shall fulfill and honor, and Sesen Bio shall cause the surviving corporation to fulfill and honor, in all respects the obligations of Carisma to its indemnified parties as of immediately prior to the closing of the merger pursuant to any indemnification provisions under Carisma&#8217;s organizational documents and pursuant to any indemnification agreements between Carisma and such indemnified parties, with respect to claims arising out of matters occurring at or prior to the effective time and (ii)&#160;Sesen Bio shall fulfill and honor in all respects the obligations of Sesen Bio to its indemnified parties as of immediately prior to the closing of the merger pursuant to any indemnification provisions under Sesen Bio&#8217;s organizational documents and pursuant to any indemnification agreements between Sesen Bio and such indemnified parties, with respect to claims arising out of matters occurring at or prior to the effective time. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">From and after the effective time, Sesen Bio will maintain director and officers&#8217; liability insurance policies, with an effective date as of the date of closing, on commercially available terms and conditions and with coverage limits customary for U.S. public companies similarly situated to Sesen Bio. In addition, prior to the effective time, Sesen Bio will secure and purchase a six-year prepaid &#8220;tail policy&#8221; through Sesen Bio&#8217;s recognized broker of record for the non-cancellable extension on Sesen Bio&#8217;s existing directors&#8217; and officers&#8217; liability insurance policy with limits of liability no less than $20.0&#160;million, in each case. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Termination</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Merger Agreement may be terminated at any time prior to the effective time (whether before or after the required Carisma stockholder vote and the required Sesen Bio stockholder vote) have been obtained, unless otherwise specified below: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(a)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:0.2pt;">by mutual written consent of Sesen Bio and Carisma; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(b)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:0.2pt;">by either Sesen Bio or Carisma if the transactions contemplated by the Merger Agreement shall not have been consummated by January&#160;31, 2023 (subject to possible extension as provided in the Merger Agreement), or the end date</font><font style="font-style:italic;letter-spacing:0.2pt;">; provided</font><font style="letter-spacing:0.2pt;">, however, that this right to terminate the Merger Agreement will not be available to any party whose action or failure to act has been a principal cause of the failure of the transactions contemplated by the Merger Agreement to occur on or before the end date and such action or failure to act constitutes a breach of the Merger Agreement; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, further, however, that, in the event that a request for additional information has been made by any governmental body, or in the event that the SEC has not declared effective under the Securities Act the registration statement by the date which is 60&#160;days prior to the end date, then either Carisma or Sesen Bio shall be entitled to extend the end date to the date that is 60&#160;days after the date that the SEC has declared effective the registration statement under the Securities Act, but in any event no more than 60&#160;days after the original end date, by written notice to the other party; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(c)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:0.2pt;">by either Sesen Bio or Carisma if a court of competent jurisdiction or other governmental body has issued a final and non-appealable order, decree or ruling or has taken any other action, having </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">188</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:40pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">the effect of permanently restraining, enjoining or otherwise prohibiting the merger or any of the other transactions contemplated by the Merger Agreement; </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(d)</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:0.2pt;">by Sesen Bio if Carisma stockholder written consent evidencing the required Carisma stockholder vote has not been obtained within ten business days of the registration statement, of which this proxy statement/prospectus is a part, becoming effective; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided, however,</font><font style="letter-spacing:0.2pt;"> that once such vote has been obtained, Sesen Bio may not terminate the Merger Agreement pursuant to this provision; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(e)</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:0.2pt;">by either Sesen Bio or Carisma if the Sesen Bio special meeting shall have been held and completed and the Sesen Bio stockholders shall have taken a final vote and shall not have approved Proposal Nos. 1 and 2 at the Sesen Bio special meeting; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, however, that the right to terminate the Merger Agreement pursuant to this provision will not be available to Sesen Bio if Sesen Bio&#8217;s actions or failure to act has been a principal cause of the failure to obtain the required Sesen Bio stockholder vote and such action or failure to act constitutes a breach by Sesen Bio of the Merger Agreement; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(f)</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:0.2pt;">by Carisma, at any time prior to the required Sesen Bio stockholder vote being obtained, if any of the following circumstances shall occur, each of the following, a Sesen Bio triggering event: </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:50pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio has failed to include in the proxy statement/prospectus the Sesen Bio board of directors recommendation or has made a Sesen Bio adverse recommendation change; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:50pt;">
          <font style="letter-spacing:0.2pt;">the Sesen Bio board of directors, or any committee thereof, had publicly approved, endorsed or recommended any acquisition proposal; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:50pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio has entered into any letter of intent or similar document relating to any acquisition proposal (other than a confidentiality agreement permitted under the Merger Agreement); </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(g)</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:0.2pt;">by Sesen Bio, at any time prior to the required Carisma stockholder vote being obtained, if any of the following circumstances shall occur, each a Carisma triggering event: </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:50pt;">
          <font style="letter-spacing:0.2pt;">the Carisma board of directors has made a Carisma board of directors adverse recommendation change; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:50pt;">
          <font style="letter-spacing:0.2pt;">the Carisma board of directors, or any committee thereof, has publicly approved, endorsed or recommended any acquisition proposal; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:50pt;">
          <font style="letter-spacing:0.2pt;">Carisma has entered into any letter of intent or similar document relating to any acquisition proposal; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(h)</font>
          <br >
        </div>
        <div style=" margin-top:7.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:0.2pt;">by Carisma, upon a breach of any representation, warranty, covenant or agreement set forth in the Merger Agreement by Parent or Merger Sub or if any representation or warranty of Sesen Bio or Merger Sub has become inaccurate, in either case such that certain closing conditions would not be satisfied as of time of such breach or inaccuracy; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;"> that Carisma is not then in material breach of any representation, warranty covenant or agreement under the Merger Agreement; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, </font><font style="font-style:italic;letter-spacing:0.2pt;">further</font><font style="letter-spacing:0.2pt;">, that if such breach or inaccuracy is curable by the end date by Parent or Merger Sub, then the Merger Agreement will not terminate pursuant to this provision as a result of such particular breach or inaccuracy until the expiration of a 30-day period commencing upon delivery of written notice from Carisma to Sesen Bio or Merger Sub of such breach or inaccuracy and Carisma&#8217;s intention to terminate pursuant to this provision (it being understood that the Merger Agreement will not terminate pursuant to this provision as a result of such particular breach or inaccuracy if such breach by Sesen Bio or Merger Sub is cured prior to such termination becoming effective); or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(i)</font>
          <br >
        </div>
        <div style=" margin-top:7.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:0.2pt;">by Sesen Bio, upon a breach of any representation, warranty, covenant or agreement set forth in the Merger Agreement by Carisma or if any representation or warranty of Carisma has become inaccurate, in either case such that certain closing conditions would not be satisfied as of time of such breach or inaccuracy; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;"> that Sesen Bio is not then in material breach of any representation, warranty covenant or agreement under the Merger Agreement; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided, further</font><font style="letter-spacing:0.2pt;">, that if such breach or inaccuracy is curable by the end date by Carisma, then the Merger Agreement will not terminate pursuant to this provision as a result of a particular breach or inaccuracy until </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">189</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tTERFEE123">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:40pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">the expiration of a 30-day period commencing upon delivery of written notice from Sesen Bio to Carisma of such breach or inaccuracy and Sesen Bio&#8217;s intention to terminate pursuant to this provision (it being understood that the Merger Agreement will not terminate pursuant to this provision as a result of such particular breach or inaccuracy if such breach by Carisma is cured prior to such termination becoming effective). </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Termination Fee</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Fee payable by Sesen Bio</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio must pay Carisma a termination fee of $7.6&#160;million if: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(i)</font>
          <br >
        </div>
        <div style=" margin-top:7.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:0.2pt;">the Merger agreement is terminated by Sesen Bio or Carisma pursuant to clause (b)&#160;above (and the required Sesen Bio stockholder vote has not been obtained by Sesen Bio) or clause (e)&#160;above; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">(ii)</font>
            <br >
          </div>
          <div style=" margin-top:7.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
            <font style="letter-spacing:0.2pt;">at any time after the date of the Original Merger Agreement and prior to the Sesen Bio special meeting, an acquisition proposal with respect to Sesen Bio shall have been publicly announced or disclosed or otherwise communicated to Sesen Bio or the Sesen Bio board of directors (and shall not have been withdrawn); and </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(iii)</font>
          <br >
        </div>
        <div style=" margin-top:7.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:0.2pt;">within 12&#160;months after the date of such termination, Sesen Bio consummates any subsequent transaction that is an acquisition transaction; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(iv)</font>
          <br >
        </div>
        <div style=" margin-top:7.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:0.2pt;">the Merger Agreement is terminated by Carisma pursuant to clause (f)&#160;above. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If the Merger Agreement is terminated pursuant to clause (iv)&#160;above by Carisma, then Sesen Bio will pay the termination fee to Carisma within two business days of such termination. If the Merger Agreement is terminated by either Carisma or Sesen Bio pursuant to clause (e)&#160;above or by Carisma pursuant to clauses (f)&#160;or (h)&#160;above, then Sesen Bio shall reimburse Carisma for all reasonable out of pocket fees and expenses incurred by Carisma in connection with the Merger Agreement and the transactions contemplated thereby, up to a maximum of $1.75&#160;million. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Fee payable by Carisma</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma must pay Sesen Bio a termination fee of $5.49&#160;million if: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(i)</font>
          <br >
        </div>
        <div style=" margin-top:7.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:0.2pt;">the Merger agreement is terminated by Sesen Bio pursuant to clause (b)&#160;above (and the required Carisma stockholder vote has not been obtained by Carisma) or clause (d)&#160;above; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.91pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">(ii)</font>
            <br >
          </div>
          <div style=" margin-top:7.91pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
            <font style="letter-spacing:0.2pt;">at any time after the date of the Original Merger Agreement and before obtaining the required Carisma stockholder vote, an acquisition proposal with respect to Carisma shall have been publicly announced or disclosed or otherwise communicated to Carisma or the Carisma board of directors (and shall not have been withdrawn); and </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(iii)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:0.2pt;">within 12&#160;months after the date of such Merger Agreement termination, Carisma consummates any subsequent transaction that is an acquisition transaction; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(iv)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:0.2pt;">the Merger Agreement is terminated by Sesen Bio pursuant to clause (g)&#160;above. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If the Merger Agreement is terminated pursuant to clause (iv)&#160;above by Sesen Bio, then Carisma will pay the termination fee to Sesen Bio within two business days of such termination. If the Merger Agreement is terminated by Sesen Bio pursuant to clauses (d), (g), or (i)&#160;above, then Carisma shall reimburse Sesen Bio for all reasonable out of pocket fees and expenses incurred by Sesen Bio in connection with the Merger Agreement and the transactions contemplated thereby, up to a maximum of $1.75&#160;million. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Amendment</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Merger Agreement may be amended by the parties at any time if such amendment is in writing, is approved by the boards of directors of each party to the Merger Agreement and is signed by each party to the Merger Agreement; provided, however, that after any approval of the Merger Agreement by a party&#8217;s </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">190</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:440pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">stockholders, no amendment will be made which by law requires further approval by such stockholders without the further approval of such stockholders. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Fees and Expenses</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">The Merger Agreement provides all fees and expenses incurred in connection with the Merger Agreement and the transactions contemplated thereby shall be paid by the party incurring such expenses, except as described above in the section entitled &#8220;&#8212; </font><font style="font-style:italic;letter-spacing:0.2pt;">Termination Fee</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tTERFEE123">190</a> of this proxy statement/</font>&#8203;<font style="letter-spacing:0.2pt;">prospectus, and except that Sesen Bio and Carisma will share equally in any fees and expenses, other than attorneys&#8217; and accountants&#8217; fees and expenses, incurred in relation to the filings by the parties to the Merger Agreement under any filing requirement under antitrust or merger control laws applicable to the Merger Agreement and the transactions contemplated therein. Sesen Bio and Carisma shall also share equally all fees and expenses incurred in relation to (i)&#160;the printing and filing with the SEC of the registration statement on Form S-4, of which this proxy statement/prospectus is a part, and any amendments or supplements thereto and paid to a financial printer or the SEC and (ii)&#160;those filings with Nasdaq contemplated by the Merger Agreement. </font></div>

      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">191</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tARTT">&#8203;</a><a name="tCVAG">&#8203;</a><a name="tMFIT5">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">AGREEMENTS RELATED TO THE MERGER</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CVR Agreement</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Prior to the effective time, Sesen Bio will enter into the CVR Agreement with a rights agent. </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Pursuant to the Merger Agreement and the CVR Agreement, for each share of Sesen Bio common stock held after giving effect to the proposed reverse stock split if approved and implemented, Sesen Bio stockholders of record as of a date agreed to by Sesen Bio and Carisma prior to the effective time will receive one CVR. Each CVR will entitle such Sesen Bio stockholder to receive (i) a pro&#160;rata portion of the $30.0&#160;million milestone payment to be made by Roche to Sesen Bio upon Roche&#8217;s initiation of a Phase&#160;3 clinical trial with legacy IL-6 antagonist antibody technology previously owned by Sesen Bio for a certain indication if initiated prior to December&#160;31, 2026, pursuant to the Roche Asset Purchase Agreement, less certain permitted deductions and (ii) a pro rata portion of the proceeds from any sale of Sesen Bio&#8217;s non-cash assets existing as of the date of the Original Merger Agreement. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">The CVR Agreement also provides that neither Sesen Bio, nor its affiliates, may, without the prior written consent of holders of at least 33% of the then-outstanding CVRs: (i)&#160;amend, restate, supplement, terminate or otherwise modify the Roche Asset Purchase Agreement in a manner materially adversely affecting the holders&#8217; rights under the CVR Agreement; (ii)&#160;in the event that Roche fails to make the milestone payment at the time rightfully due and payable, take action with respect to, or unreasonably waive or fail to enforce, the right to receive the applicable payments which are rightfully due and payable under the Roche Asset Purchase Agreement, in a manner materially adversely affecting the holders&#8217; rights under the CVR Agreement; or (iii)&#160;agree to any of the foregoing. Further, during the period between signing the CVR Agreement and December 31, 2023, Sesen Bio agreed to use commercially reasonable efforts to effectuate a disposition of any and all assets, tangible and intangible related to Vicineum</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">TM</font><font style="letter-spacing:0.2pt;">, including the negotiation and execution of a sale agreement and completion of the transactions contemplated thereby. Further, Sesen Bio agreed not to take any actions for the primary purpose of frustrating the payment of CVR payments. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">The sole right of the holders of the CVRs is to receive cash from Sesen Bio, if any, through the rights agent in accordance with the CVR Agreement. The CVRs are not transferable, except in certain limited circumstances, will not be certificated or evidenced by any instrument and will not be registered with the SEC or listed for trading on any exchange. The CVRs will not have any voting or dividend rights, will not represent any equity or ownership interest in Sesen Bio or its subsidiaries, and interest will not accrue on any amounts payable on the CVRs. The CVR Agreement will be effective prior to the closing of the merger and will continue in effect until the earlier of (i) March&#160;31, 2027 for the Roche payments or December 31, 2023 for the payment of any proceeds from the sale of Sesen Bio&#8217;s legacy assets and (ii) the payment of all amounts payable thereunder, unless and until earlier terminated upon termination of the Merger Agreement. </font>
          </div>

        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The foregoing description of the CVR Agreement does not purport to be complete and is qualified in its entirety by the full text of the form of CVR Agreement, which is included in </font><font style="font-style:italic;letter-spacing:0.2pt;">Annex F</font><font style="letter-spacing:0.2pt;"> to this proxy statement/prospectus. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Material U.S. Federal Income Tax Consequences of the Receipt of CVRs</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following discussion is a summary of the material U.S. federal income tax consequences of the receipt of CVRs to Sesen Bio stockholders who receive CVRs with respect to Sesen Bio common stock, but this discussion does not purport to be a complete analysis of all potential tax consequences that may be relevant to a Sesen Bio stockholder. The effects of other U.S. federal tax laws, such as estate and gift tax laws, and any applicable state, local or non-U.S. tax laws are not discussed. This discussion is based on the Code, Treasury Regulations promulgated thereunder, judicial decisions, and published rulings and administrative pronouncements of the IRS, in each case in effect as of the date hereof. These authorities may change or be subject to differing interpretations. Any such change or differing interpretation may be applied retroactively in a manner that could adversely affect a Sesen Bio U.S. holder. Sesen Bio has not sought and does not intend to seek any opinions of counsel or rulings from the IRS regarding the matters discussed below. There can be no assurance the IRS or a court will not take a position contrary to that discussed below regarding the tax consequences of the receipt of CVRs. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">192</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tMUFI3">&#8203;</a><a name="tSBUH">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">This discussion is limited to Sesen Bio U.S. holders that hold Sesen Bio common stock as a &#8220;capital asset&#8221; within the meaning of Section&#160;1221 of the Code (generally, property held for investment). This discussion does not address all U.S. federal income tax consequences relevant to a Sesen Bio U.S. holder&#8217;s particular circumstances, including the impact of the alternative minimum tax or the Medicare contribution tax on net investment income or the rules related to &#8220;qualified small business stock&#8221; within the meaning of Section&#160;1202 of the Code. In addition, it does not address consequences relevant to Sesen Bio U.S. holders subject to special rules, including, without limitation: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">U.S. expatriates and former citizens or long-term residents of the U.S.; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio U.S. holders whose functional currency is not the U.S. dollar; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.91pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.91pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">persons holding Sesen Bio common stock as part of a hedge, straddle or other risk reduction strategy or as part of a conversion transaction or other integrated investment; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">banks, insurance companies, and other financial institutions; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">real estate investment trusts or regulated investment companies; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">brokers, dealers or traders in securities; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">&#8220;controlled foreign corporations,&#8221; &#8220;passive foreign investment companies,&#8221; and corporations that accumulate earnings to avoid U.S. federal income tax; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">S corporations, partnerships or other entities or arrangements treated as partnerships for U.S. federal income tax purposes (and investors therein); </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">tax-exempt organizations or governmental organizations; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">persons subject to special tax accounting rules as a result of any item of gross income with respect to Sesen Bio common stock being taken into account in an &#8220;applicable financial statement&#8221; &#8203;(as defined in the Code); </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">persons deemed to sell Sesen Bio common stock under the constructive sale provisions of the Code; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">persons who hold or received Sesen Bio common stock pursuant to the exercise of any employee stock option or otherwise as compensation; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">tax-qualified retirement plans. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If an entity treated as a partnership for U.S. federal income tax purposes holds Sesen Bio common stock, the tax treatment of a partner in the partnership will depend on the status of the partner, the activities of the partnership and certain determinations made at the partner level. Accordingly, partnerships holding Sesen Bio common stock and the partners in such partnerships should consult their tax advisors regarding the U.S. federal income tax consequences to them. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">IT IS RECOMMENDED THAT HOLDERS CONSULT THEIR TAX ADVISORS WITH RESPECT TO THE APPLICATION OF THE U.S. FEDERAL INCOME TAX LAWS TO THEIR PARTICULAR SITUATIONS AS WELL AS ANY TAX CONSEQUENCES OF THE RECEIPT OF CVRs ARISING UNDER THE U.S. FEDERAL ESTATE OR GIFT TAX LAWS OR UNDER THE LAWS OF ANY STATE, LOCAL OR NON-U.S. TAXING JURISDICTION OR UNDER ANY APPLICABLE INCOME TAX TREATY.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">For purposes of this discussion, a &#8220;Sesen Bio U.S. holder&#8221; is a beneficial owner of Sesen Bio common stock that, for U.S. federal income tax purposes, is or is treated as: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">an individual who is a citizen or resident of the U.S.; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">a corporation created or organized under the laws of the U.S., any state thereof, or the District of Columbia; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">an estate, the income of which is subject to U.S. federal income tax regardless of its source; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">a trust that (i)&#160;is subject to the primary supervision of a U.S. court and the control of one or more &#8220;United States persons&#8221; &#8203;(within the meaning of Section&#160;7701(a)(30) of the Code) over all of its </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">193</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tALTERT3">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:30pt; width:426pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">substantial decisions or (ii)&#160;has a valid election in effect to be treated as a United States person for U.S. federal income tax purposes. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">For purposes of this discussion, a &#8220;Sesen Bio non-U.S. holder&#8221; means a beneficial owner of Sesen Bio common stock that is neither a Sesen Bio U.S. holder nor a partnership (or other entity treated as a partnership) for U.S. federal income tax purposes. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Alternative Treatment of the Receipt of CVRs and the Proposed Reverse Stock Split as a Single Recapitalization </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio intends to report the proposed reverse stock split as a &#8220;recapitalization&#8221; within the meaning of Section&#160;368(a)(1)(E) of the Code that is separate from Sesen Bio&#8217;s distribution of the CVRs and the special cash dividend. Notwithstanding that Sesen Bio will report the receipt of CVRs, the receipt of the special cash dividend, and the proposed reverse stock split as separate transactions, it is possible that the IRS or a court could determine that the receipt of the CVRs or the special cash dividend, and the proposed reverse stock split constitute a single &#8220;recapitalization&#8221; for U.S. federal income tax purposes. In such case, the tax consequences of the receipt of CVRs and the proposed reverse stock split would differ from those described below and would depend in part on many of the same considerations described below, including whether the CVRs should be treated as property, equity or debt instruments or should be subject to the &#8220;open transaction&#8221; doctrine. In general, if the CVRs are treated as property and are not subject to the &#8220;open transaction&#8221; doctrine, and the receipt of the CVRs, the special cash dividend, and the proposed reverse stock split constitute a single &#8220;recapitalization&#8221; for U.S. federal income tax purposes, then a Sesen Bio stockholder should recognize gain (but not loss) equal to the lesser of (i)&#160;the fair market value of the CVRs received plus the amount of the special cash dividend, and (ii)&#160;the excess (if any) of (A)&#160;the sum of (1)&#160;the fair market value of the CVRs received plus the amount of the special cash dividend and (2)&#160;the fair market value of the Sesen Bio shares received in the proposed reverse stock split over (B)&#160;the Sesen Bio stockholder&#8217;s adjusted tax basis in the Sesen Bio common stock surrendered in the proposed reverse stock split. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Receipt of CVRs by Sesen Bio U.S. holders</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">This discussion assumes that the distribution of CVRs and the special cash dividend to Sesen Bio U.S. holders will be treated for U.S. federal income tax purposes as transactions that are separate and distinct from the proposed reverse stock split. If, contrary to that assumption, the distribution of CVRs to Sesen Bio U.S. holders were integrated for tax purposes with the proposed reverse stock split, this could affect the calculation of the extent to which the distribution constitutes a taxable dividend or capital gain. </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">There is substantial uncertainty as to the tax treatment of the CVRs. Specifically, there is no authority directly addressing whether contingent value rights with characteristics similar to the CVRs should be treated as a distribution of property with respect to Sesen Bio common stock, a distribution of equity, a &#8220;debt instrument&#8221; or an &#8220;open transaction&#8221; for U.S. federal income tax purposes. As a result, it is not possible to express a definitive conclusion as to the U.S. federal income tax treatment of receipt of the CVRs or receipt of any payments pursuant to the CVRs. Based on the specific characteristics of the CVRs, Sesen Bio intends to treat the issuance of the CVRs as a distribution of property with respect to its stock. No assurance can be given that the IRS would not assert, or that a court would not sustain, a position contrary to any description of the intended tax consequences summarized below. No opinion of counsel or ruling has been or will be sought from the IRS regarding the tax treatment of the CVRs. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Provided that the issuance of the CVRs is treated as a distribution of property with respect to Sesen Bio common stock, each Sesen Bio U.S. holder should be treated as receiving a distribution in an amount equal to the fair market value of the CVRs issued to such Sesen Bio U.S. holder on the date of the issuance. This distribution should be treated first as a taxable dividend to the extent of the Sesen Bio U.S. holder&#8217;s pro&#160;rata share of Sesen Bio&#8217;s current or accumulated earnings and profits (as determined for U.S. federal income tax purposes and after taking into account the special cash dividend as described in the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Merger&#8201;&#8212;&#8201;Material U.S. Federal Income Tax Consequences of the Special Cash Dividend</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tMUFI1">162</a> of this proxy statement/prospectus), then as a non-taxable return of capital to the extent of the Sesen Bio U.S. holder&#8217;s basis in its Sesen Bio common stock, and finally as capital gain from the sale or exchange of Sesen Bio common stock with respect to any remaining value. Sesen Bio currently has negative accumulated earnings and profits and expects no or a small amount of current earnings and profits for the relevant taxable year. Thus, Sesen Bio expects most or all of this distribution to be treated as other </font>
          </div>

      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">194</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">

          <div style="width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">than a dividend for U.S. federal income tax purposes. Sesen Bio U.S. holders will receive a Form 1099-DIV notifying them of the portion of the CVR value that is treated as a non-dividend distribution (or a dividend to the extent of Sesen Bio&#8217;s earnings and profits) for U.S. federal income tax purposes. Although Sesen Bio will estimate the value of the CVRs for purposes of reporting on Form 1099 to Sesen Bio U.S. holders, the value of the CVRs is uncertain and the IRS or a court could determine that the value of the CVRs at the time of issuance was higher. In such case the Sesen Bio U.S. holders could be treated as having additional income or gain upon receipt of the CVRs as described above. A Sesen Bio U.S. holder&#8217;s initial tax basis in such holder&#8217;s CVRs should equal the fair market value of such CVRs on the date of their issuance. The holding period of such CVRs should begin on the day after the date of issuance. Future payments received by a Sesen Bio U.S. holder with respect to a CVR would likely be treated as a non-taxable return of such Sesen Bio U.S. holder&#8217;s adjusted tax basis in the CVR to the extent thereof, and payments in excess of such amount would likely be treated as ordinary income. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">However, the treatment of the future payments, if any, pursuant to the CVRs is uncertain and alternative treatments are possible, although not expected. One such possible treatment is that the CVRs could be treated as one or more &#8220;debt instruments.&#8221; If that were to be the case, then the payments, if any, received with respect to the CVRs would likely be treated as payments in retirement of a &#8220;debt instrument,&#8221; except to the extent interest is imputed under complex rules under the Code. In such a case, a Sesen Bio U.S. holder would be required to include any such interest in income on an annual basis, whether or not currently paid. As discussed above, Sesen Bio does not intend to report the issuance of the CVRs as a distribution of a &#8220;debt instrument&#8221; for U.S. federal income tax purposes. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">It is also possible that the issuance of the CVRs could be treated as a distribution of equity for U.S. federal income tax purposes, in which case Sesen Bio U.S. holders should not recognize gain or loss as a result of the issuance of the CVRs. Each Sesen Bio U.S. holder&#8217;s tax basis in such holder&#8217;s Sesen Bio common stock would be allocated between such holder&#8217;s Sesen Bio common stock and such holder&#8217;s CVRs. The holding period of such CVRs should include the Sesen Bio U.S. holder&#8217;s holding period of such holder&#8217;s Sesen Bio common stock. The future payments, if any, on a CVR received by a Sesen Bio U.S. holder could be treated as dividends to the extent of the Sesen Bio U.S. holder&#8217;s pro&#160;rata share of Sesen Bio&#8217;s current or accumulated earnings and profits at the time of such payments (as determined for U.S. federal income tax purposes), then as a non-taxable return of capital to the extent of the Sesen Bio U.S. holder&#8217;s basis in the CVR, and finally as capital gain from the sale or exchange of the CVR with respect to any remaining amount. As discussed above, Sesen Bio does not intend to report the issuance of the CVRs as a distribution of equity for U.S. federal income tax purposes. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">It is also possible that the issuance of the CVRs could be treated as subject to the &#8220;open transaction&#8221; doctrine if the value of the CVRs at closing cannot be &#8220;reasonably ascertained.&#8221; If the receipt of CVRs were treated as an &#8220;open transaction&#8221; for U.S. federal income tax purposes, each Sesen Bio U.S. holder should not immediately take the CVRs into account in determining whether such holder must recognize income or gain, if any, on the receipt of the CVRs and such holder would not take any tax basis in the CVRs. Rather, the Sesen Bio U.S. holder&#8217;s U.S. federal income tax consequences would be determined in line with the discussion above based on whether the CVRs are treated as a distribution of property or of equity at the time the payments, if any, with respect to the CVRs is received or deemed received in accordance with the Sesen Bio U.S. holder&#8217;s regular method of accounting. As discussed above, Sesen Bio does not intend to report the issuance of the CVRs as an open transaction for U.S. federal income tax purposes. </font>
          </div>

        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The CVRs should generally be treated as capital assets for U.S. federal income tax purposes once issued. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Receipt of CVRs by Sesen Bio Non-U.S. Holders</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Provided that the issuance of the CVRs is treated as a distribution of property with respect to Sesen Bio common stock, each Sesen Bio non-U.S. holder should be treated as receiving a distribution in an amount equal to the fair market value of the CVRs issued to such Sesen Bio non-U.S. holder on the date of the issuance. This distribution should be treated first as a taxable dividend to the extent of the Sesen Bio non-U.S. holder&#8217;s pro&#160;rata share of Sesen Bio&#8217;s current or accumulated earnings and profits (as determined for U.S. federal income tax purposes and after taking into account the special cash dividend as described in the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Merger&#8212;Material U.S. Federal Income Tax Consequences of the Special Cash </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">195</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">

          <div style="width:456pt; line-height:11.5pt;">
            <font style="font-style:italic;letter-spacing:0.2pt;">Dividend</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tMUFI1">162</a> of this proxy statement/prospectus), then as a non-taxable return of capital to the extent of the Sesen Bio non-U.S. holder&#8217;s basis in its Sesen Bio common stock, and finally as capital gain from the sale or exchange of Sesen Bio common stock with respect to any remaining amount. Sesen Bio currently has negative accumulated earnings and profits and expects no or a small amount of current earnings and profits for the relevant taxable year. Thus, Sesen Bio expects most or all of the distribution of the CVRs to be treated as other than a dividend for U.S. federal income tax purposes. However, if Sesen Bio cannot determine at the time of the distribution of the CVRs whether or not the amount of such distribution will exceed current and accumulated earnings and profits, Sesen Bio or the applicable withholding agent may withhold (potentially by utilizing cash that otherwise would be distributed to such holder with respect to the special cash dividend or other property of such Sesen Bio non-U.S. holder held in an account with the applicable withholding agent) at the rate applicable to dividends, as described below. </font>
          </div>

        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Taxable Dividends. Dividend payments will generally be subject to withholding at a 30% rate. If a Sesen Bio non-U.S. holder is eligible for a lower treaty rate, withholding will be at such lower treaty rate only if such Sesen Bio non-U.S. holder provides a valid IRS Form W-8BEN or W-8BEN-E (or applicable successor form) certifying such Sesen Bio non-U.S. holder&#8217;s qualification for the reduced rate. If a Sesen Bio non-U.S. holder holds the stock through a financial institution or other intermediary, the Sesen Bio non-U.S. holder will be required to provide appropriate documentation to the intermediary, which then will be required to provide certification to the applicable withholding agent, either directly or through other intermediaries. Sesen Bio non-U.S. holders who do not timely provide the applicable withholding agent with the required certification, but who qualify for a reduced treaty rate, may obtain a refund of any excess amounts withheld by timely filing an appropriate claim for refund with the IRS. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Subject to the discussions below regarding backup withholding, if the issuance of the CVRs is effectively connected with a Sesen Bio non-U.S. holder&#8217;s conduct of a trade or business within the United States (and, if required by an applicable income tax treaty, the Sesen Bio non-U.S. holder maintains a permanent establishment in the United States to which the special cash dividend is attributable), the Sesen Bio non-U.S. holder will be exempt from U.S. federal withholding tax and the distribution of the CVRs generally will be subject to U.S. federal income tax on a net income basis in the same manner as if such Sesen Bio non-U.S. holder were a U.S. holder. To claim the exemption, the Sesen Bio non-U.S. holder must furnish to the applicable withholding agent a valid IRS Form W-8ECI (or applicable successor form), certifying that the distribution is effectively connected with the Sesen Bio non-U.S. holder&#8217;s conduct of a trade or business within the United States. A Sesen Bio non-U.S. holder that is a corporation also may be subject to a branch profits tax at a rate of 30% (or such lower rate specified by an applicable income tax treaty) of all or a portion of its effectively connected earnings and profits for the taxable year. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Any withholding required by Sesen Bio or other applicable withholding agents may be satisfied by Sesen Bio or such agent by withholding a portion of the issued CVRs, from the special cash dividend or from other property of the Sesen Bio non-U.S. holder held in an account with the applicable withholding agent. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Non-Dividend Distributions. To the extent that the issuance of the CVRs is treated as capital gain from the sale or exchange of Sesen Bio common stock, such gain generally will not be subject to U.S. federal income tax unless (i)&#160;such gain is effectively connected with the conduct by a Sesen Bio non-U.S. holder of a trade or business in the United States (and, if an income tax treaty applies, the gain is generally attributable to a U.S. permanent establishment maintained by such Sesen Bio non-U.S. holder), (ii)&#160;in the case of gain realized by a Sesen Bio non-U.S. holder that is an individual, such Sesen Bio non-U.S. holder is present in the United States for 183&#160;days or more in the taxable year of the sale and certain other conditions are met or (iii)&#160;Sesen Bio is or has been a USRPHC for U.S. federal income tax purposes and, if the shares are &#8220;regularly traded on an established securities market,&#8221; such Sesen Bio non-U.S. holder owned, directly or indirectly, at any time during the five-year period ending on the date of the distribution, more than 5% of the shares of Sesen Bio common stock and such Sesen Bio non-U.S. holder is not eligible for any treaty exemption. The shares will be considered &#8220;regularly traded&#8221; if they are traded on an established securities market located in the United States and are regularly quoted by brokers or dealers making a market in the shares. Sesen Bio believes it is not, and has not been, a USRPHC for U.S. federal income tax purposes. In addition, although not free from doubt, Sesen Bio believes that Sesen Bio common shares currently should be considered to be regularly traded. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">196</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tSAAW">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A Sesen Bio non-U.S. holder should consult its tax advisor regarding its entitlement to benefits and the various rules under applicable tax treaties. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Information Reporting and Backup Withholding</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In general, the issuance of the CVRs to Sesen Bio U.S. holders will be reported to the IRS unless the holder is an exempt recipient. Backup withholding, currently at a rate of 24%, may apply unless the Sesen Bio U.S. holder (1)&#160;is an exempt recipient or (2)&#160;provides a certificate (generally on an IRS Form W-9) containing the Sesen Bio U.S. holder&#8217;s name, address, correct federal taxpayer identification number and statement that the Sesen Bio U.S. holder is a U.S. person and is not subject to backup withholding. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A Sesen Bio non-U.S. holder will not be subject to backup withholding with respect to the issuance of the CVRs, provided the Sesen Bio non-U.S. holder certifies its non-U.S. status, such as by providing a valid IRS Form W-8BEN or W-8ECI or W-8BEN-E, or otherwise establishes an exemption. However, information returns will be filed with the IRS in connection with the issuance of the CVRs, regardless of whether any tax was actually withheld. Copies of these information returns may also be made available under the provisions of a specific treaty or agreement to the tax authorities of the country in which the Sesen Bio non-U.S. holder resides or is established. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Backup withholding is not an additional tax. Any amounts withheld under the backup withholding rules may be allowed as a refund or credit against a holder&#8217;s U.S. federal income tax liability, provided the required information is timely furnished to the IRS. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">PLEASE CONSULT YOUR TAX ADVISOR WITH RESPECT TO THE PROPER CHARACTERIZATION OF THE RECEIPT OF THE CVRs.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Support Agreements and Written Consents</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In order to induce Sesen Bio to enter into the Merger Agreement, certain stockholders of Carisma are parties to a support agreement with Sesen Bio and Carisma pursuant to which, among other things, each such stockholder has agreed, solely in his, her or its capacity as a stockholder of Carisma, to vote all of his, her or its shares of Carisma capital stock (subject to customary cutbacks in the event of certain triggering events) in favor of (i)&#160;adoption and approval of the Merger Agreement and the transactions contemplated thereby; (ii)&#160;adoption and approval of an amendment to the Carisma Certificate of Incorporation to increase the authorized shares of Carisma common stock; (iii)&#160;acknowledgement that the approval given thereby is irrevocable and that the stockholder is aware of the stockholder&#8217;s rights to demand appraisal for its shares pursuant to Section&#160;262 of the DGCL; and (iv)&#160;acknowledgement that by the stockholder&#8217;s approval of the merger, the stockholder is (a)&#160;waiving its appraisal rights under the DGCL with respect to its shares; and (b)&#160;waiving any notice that may have been or may be required relating to the merger or any other transactions contemplated thereby. Additionally, each such signatory has agreed, solely in his, her or its capacity as a Carisma stockholder, to vote against (subject to customary cutbacks in the event of certain triggering events) any such competing acquisition proposal and any action in furtherance of any competing acquisition proposal. These signatories have also granted an irrevocable proxy to Carisma and its designee to vote their respective shares of Carisma common stock in accordance with the support agreements. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In addition, in order to induce Carisma to enter into the Merger Agreement, certain stockholders of Sesen Bio are parties to a support agreement with Sesen Bio and Carisma pursuant to which, among other things, each such stockholder has agreed, solely in his or her capacity as a stockholder of Sesen Bio (if applicable), to vote all of his or her shares of Sesen Bio common stock in favor of (i)&#160;adoption and approval of the Merger Agreement and the transactions contemplated thereby; (ii)&#160;the issuance of shares of Sesen Bio common stock to Carisma stockholders in connection with the Merger Agreement and the transactions contemplated thereby; (iii)&#160;the change of control of Sesen Bio resulting from the Merger pursuant to Nasdaq rules; (iv)&#160;the approval of the equity plan amendment proposals; and (v)&#160;a waiver of any notice that may have been or may be required relating to the Merger or any other transactions contemplated thereby. Additionally, each such signatory has agreed, solely in his, her or its capacity as a Sesen Bio stockholder, to vote against any competing acquisition proposal and any action in furtherance of </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">197</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tSUAG">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">any such competing acquisition proposal. These signatories have also granted an irrevocable proxy to Sesen Bio and its designee to vote their respective shares of Sesen Bio common stock in accordance with the support agreements. </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">As of January 4, 2023, the Carisma stockholders who are party to a support agreement (including any affiliated entities) owned an aggregate of 97.23% of the outstanding shares of Carisma common stock. Following the effectiveness of the registration statement of which this proxy statement/prospectus is a part and pursuant to the Merger Agreement, these stockholders will execute a written consent providing for such adoption and approval. </font>
          </div>

        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Under these support agreements, subject to certain exceptions, such stockholders have also agreed not to sell or transfer the shares of Carisma capital stock subject to the support agreement held by them, or any voting rights with respect thereto, until the effective time. To the extent that any such sale or transfer is permitted pursuant to the exceptions included in the support agreement, each person to which any shares of Carisma capital stock subject to the support agreement are so sold or transferred shall be bound by the terms and provisions of the support agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The foregoing descriptions of the support agreements do not purport to be complete and are qualified in their entirety by the full text of the forms of support agreements, which are attached in </font><font style="font-style:italic;letter-spacing:0.2pt;">Annex C</font><font style="letter-spacing:0.2pt;"> and </font><font style="font-style:italic;letter-spacing:0.2pt;">Annex&#160;D</font><font style="letter-spacing:0.2pt;"> to this proxy statement/prospectus. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Subscription Agreement</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">On September&#160;20, 2022, immediately prior to the execution and delivery of the Original Merger Agreement, Carisma entered into a subscription agreement with certain investors named therein, pursuant to which the investors have agreed to purchase shares of Carisma common stock at an aggregate purchase price of approximately $30.6&#160;million. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">The shares of Carisma common stock issued in the Carisma pre-closing financing will be converted into shares of Sesen Bio common stock in the merger in accordance with the exchange ratio. The consummation of the transactions contemplated by the subscription agreement is conditioned on the satisfaction or waiver of the conditions set forth in the Merger Agreement. All shares of Sesen Bio common stock issued in exchange for shares of Carisma common stock issued in the Carisma pre-closing financing will be subject to restrictions on resale following the closing of the merger. On December 29, 2022, immediately prior to the execution and delivery of the Merger Agreement Amendment, Carisma entered into an amended and restated subscription agreement with the investors party to the original subscription agreement, pursuant to which the parties thereto clarified that shares of Carisma common stock issued in the pre-closing financing will not be registered under the Securities Act and will be subject to restrictions on resale and agreed, among other things, to enter into a registration rights agreement to provide for the registration of the resale of the shares of common stock purchased by such investors in connection with the Carisma pre-closing financing. </font>
          </div>

        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The subscription agreement contains customary representations and warranties of Carisma and also contains customary representations and warranties of the purchasers party thereto. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Each purchaser&#8217;s obligation to purchase shares of Carisma common stock from Carisma pursuant to the subscription agreement is subject to the satisfaction or waiver of certain conditions, including: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Carisma&#8217;s representations and warranties in the subscription agreement being true and correct in all material respects as of the closing date for the Carisma pre-closing financing, subject to certain exceptions; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Carisma having performed and complied in all material respects with all covenants, agreements, obligations and conditions required to be performed or complied with by it on or prior to the closing date; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Carisma having filed the charter amendment with the Secretary of State of the State of Delaware; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the delivery of a compliance certificate by the Chief Executive Officer or the Chief Financial Officer of Carisma; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">198</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tLOAG">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">

          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">the satisfaction or waiver of all conditions to the closing of the merger set forth in the Merger Agreement (other than the condition regarding the Carisma pre-closing financing and other than those conditions which, by their nature, are to be satisfied at the closing of the merger) and the closing of merger being set to occur substantially concurrently with the closing of the Carisma pre-closing financing; </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>


          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">all authorizations, approvals or permits, if any, required under applicable state securities laws having been obtained; and </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>


          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">the delivery of a fully executed registration rights agreement. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma&#8217;s obligation to sell shares of Carisma common stock to each purchaser pursuant to the subscription agreement is subject to the satisfaction or waiver of certain conditions, including: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the representations and warranties made by such purchaser being true and correct in all material respects as of the closing date of the Carisma pre-closing financing, subject to certain exceptions; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">such purchaser having performed and complied with all covenants, agreements, obligations and conditions required to be performed or complied with by it on or prior to the closing date; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the satisfaction or waiver of all conditions to the closing of the merger set forth in the Merger Agreement (other than the condition regarding the Carisma pre-closing financing and other than those conditions which, by their nature, are to be satisfied at the closing of the merger) and the closing of merger being set to occur substantially concurrently with the closing of the Carisma pre-closing financing. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The subscription agreement may not be changed, waived, amended or modified, except by an instrument in writing executed by Carisma and the purchasers then committed to purchase a majority of the shares to be sold in the Carisma pre-closing financing. The subscription agreement will terminate upon the earlier to occur of (i)&#160;such date and time that the Merger Agreement is terminated in accordance with its terms, (ii)&#160;upon the mutual written agreement of Carisma and the purchasers then committed to purchase a majority of the shares to be sold in the Carisma pre-closing financing (provided that Carisma and a purchaser may terminate the commitment of the applicable purchaser without the consent of any other party), and (iii)&#160;if the closing of the merger has not occurred on or before January&#160;31, 2023 (as such date may be extended in the event that a request for additional information is made by any governmental body or in the event that the SEC has not declared the registration statement effective under the Securities Act by the date which is 60&#160;days prior to the end date), other than as a result of a willful breach of a purchaser&#8217;s obligations under the subscription agreement. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Lock-Up Agreements</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As a condition to the closing of the merger, certain stockholders of each of Sesen Bio and Carisma and their affiliates, have entered into lock-up agreements, pursuant to which such parties have agreed not to, except in limited circumstances and among other restrictions, offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, make any short sale or otherwise transfer or dispose of or lend, directly or indirectly, any shares of Sesen Bio common stock or any securities convertible into, exercisable or exchangeable for or that represent the right to receive Sesen Bio common stock (including without limitation, Sesen Bio common stock or such other securities which may be deemed to be beneficially owned by the signatory in accordance with the rules and regulations of the SEC and securities of Sesen Bio which may be issued upon exercise of a Sesen Bio option, Sesen Bio RSU or Sesen Bio warrant), during the period commencing at the effective time and continuing until the date that is 180&#160;days after the effective time. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The foregoing description of the lock-up agreements do not purport to be complete and are qualified in their entirety by the full text of the form of lock-up agreement, which is attached in </font><font style="font-style:italic;letter-spacing:0.2pt;">Annex E</font><font style="letter-spacing:0.2pt;"> to this proxy statement/prospectus. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Certain directors and executive officers of both Sesen Bio and Carisma are party to a lock-up agreement. </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Certain Carisma stockholders party to Carisma support agreements are also party to lock-up agreements. Carisma stockholders who have executed lock-up agreements, as of January 4, 2023, beneficially </font>
          </div>

      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">199</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:464pt;margin-left:69.66pt;width:456pt;">

          <div style="width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">owned in the aggregate approximately 97.23% of the outstanding shares of Carisma capital stock on an as converted to Carisma common stock basis. </font>
          </div>

        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio has filed an initial listing application with Nasdaq pursuant to the Nasdaq Stock Market LLC &#8220;business combination&#8221; rules. If such application is accepted, Sesen Bio anticipates that Sesen Bio common stock will be listed on Nasdaq following the closing of the merger under the trading symbol &#8220;CARM.&#8221; In order to meet the requirements for listing on Nasdaq, the post-merger combined company will be required to satisfy Nasdaq&#8217;s initial listing requirements, including the financial and liquidity requirements for the applicable Nasdaq market tier upon which the post-merger combined company&#8217;s shares will trade following the merger. Certain Nasdaq market tiers and standards require companies seeking to list to demonstrate a minimum &#8220;Market Value of Unrestricted Publicly Held Shares&#8221; as of the effective time of the closing of a business combination. Per current Nasdaq Listing Rules, the &#8220;Market Value of Unrestricted Publicly Held Shares&#8221; may not include the value of any securities subject to resale restrictions, including the types of restrictions set forth in the Sesen Bio and Carisma lock-up agreements.</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">200</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tMBST">&#8203;</a><a name="tPN1A">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">MATTERS BEING SUBMITTED TO A VOTE OF SESEN BIO STOCKHOLDERS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Proposal No. 1: Approval, for purposes of Nasdaq Listing Rule&#160;5635(a) and (b), the issuance of shares of Sesen Bio common stock to Carisma stockholders pursuant to the terms of the Merger Agreement and the change of control of Sesen Bio resulting from the merger</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">At the Sesen Bio special meeting, Sesen Bio stockholders will be asked to consider and vote upon a proposal to approve, for purposes of Nasdaq Listing Rule&#160;5635(a) and (b), the issuance of shares of Sesen Bio common stock pursuant to the terms of the Merger Agreement and the change of control of Sesen Bio resulting from the merger. </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
            <font style="letter-spacing:0.2pt;">Immediately after the merger, pre-merger Sesen Bio stockholders are expected to own approximately 25.2% of the outstanding shares of capital stock of the combined company and pre-merger Carisma stockholders, after taking into account shares of Carisma common stock purchased in connection with the Carisma pre-closing financing and the conversion of the Carisma convertible note, are expected to own approximately 74.8% of the outstanding shares of capital stock of the combined company, subject to certain assumptions, including, Sesen Bio&#8217;s net cash as of closing being at least $75.0 million. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
            <font style="letter-spacing:0.2pt;">The terms of, reasons for and other aspects of the Merger Agreement, the merger and the issuance of Sesen Bio common stock in the merger are described in detail in the other sections in this proxy statement/</font>&#8203;<font style="letter-spacing:0.2pt;">prospectus. A copy of the Original Merger Agreement and the Merger Agreement Amendment are attached as </font><font style="font-style:italic;letter-spacing:0.2pt;">Annexes A-1</font><font style="letter-spacing:0.2pt;"> and </font><font style="font-style:italic;letter-spacing:0.2pt;">A-2</font><font style="letter-spacing:0.2pt;">, respectively, to this proxy statement/prospectus. </font></div>

        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Nasdaq Listing Rule&#160;5635(a) requires a company listed on Nasdaq to obtain stockholder approval prior to the issuance of common stock (or other securities convertible into or exercisable for common stock) in connection with the acquisition of the stock or assets of another company, if such securities are not issued in a public offering and (i)&#160;the common stock has, or will have upon issuance, voting power equal to or in excess of 20% of the voting power outstanding before the issuance of such securities, or (ii)&#160;the number of shares of common stock to be issued is or will be equal to or in excess of 20% of the number of shares of common stock outstanding before the issuance of such securities. The potential issuance of the shares of Sesen Bio common stock in the merger will exceed the 20% threshold under the Nasdaq Listing Rules. Accordingly, in order to ensure compliance with Nasdaq Listing Rule&#160;5635(a), Sesen Bio must obtain the approval of Sesen Bio stockholders for the issuance of these shares of Sesen Bio common stock in the merger. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Nasdaq Listing Rule&#160;5635(b) requires a company listed on Nasdaq to obtain stockholder approval prior to an issuance of securities that will result in a &#8220;change of control&#8221; of the company. Although Nasdaq has not adopted any rule as to what constitutes a &#8220;change of control&#8221; for purposes of Rule&#160;5635(b), Nasdaq has previously indicated that the acquisition of, or right to acquire, by a single investor or affiliated investor group, as little as 20% of the common stock (or securities convertible into or exercisable for common stock) or voting power of an issuer could constitute a change of control. In addition, the staff of Nasdaq has advised Sesen Bio that Nasdaq deems the merger to be a &#8220;change of control.&#8221; Accordingly, in order to ensure compliance with Nasdaq Listing Rule&#160;5635(b), Sesen Bio must obtain the approval of Sesen Bio stockholders for the potential change in control of Sesen Bio resulting from the merger. </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">The terms of, reasons for and other aspects of the Merger Agreement, the merger, the issuance of shares of Sesen Bio common stock pursuant to the terms of the Merger Agreement and the resulting change of control are described in detail in the other sections in this proxy statement/prospectus. A copy of the Original Merger Agreement and the Merger Agreement Amendment are attached as </font><font style="font-style:italic;letter-spacing:0.2pt;">Annexes A-1</font><font style="letter-spacing:0.2pt;"> and </font><font style="font-style:italic;letter-spacing:0.2pt;">A-2 to</font><font style="letter-spacing:0.2pt;"> this proxy statement/prospectus. </font>
          </div>

        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Vote Required</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The affirmative vote of a majority in voting power of the votes cast by the holders of Sesen Bio common stock present or represented by proxy at the Sesen Bio special meeting and entitled to vote on the matter is required for approval of Proposal No. 1. Abstentions will have no effect on Proposal No. 1. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">201</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:524pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-style:italic;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">Recommendation of Sesen Bio Board of Directors</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">THE SESEN BIO BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS THAT SESEN BIO STOCKHOLDERS VOTE &#8220;FOR&#8221; PROPOSAL NO. 1 TO APPROVE, FOR PURPOSES OF NASDAQ LISTING RULE 5635(a) and (b), THE ISSUANCE OF SHARES OF SESEN BIO COMMON STOCK PURSUANT TO THE TERMS OF THE MERGER AGREEMENT AND THE CHANGE OF CONTROL OF SESEN BIO RESULTING FROM THE MERGER. PROPOSAL NO. 1 IS CONDITIONED UPON THE APPROVAL OF PROPOSAL NO. 2, AND THE MERGER CANNOT BE CONSUMMATED WITHOUT THE APPROVAL OF PROPOSAL NOS. 1 AND 2. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">202</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tPN2A">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Proposal No. 2: Approval of an amendment to the Sesen Bio Certificate of Incorporation to effect the reverse stock split and reduce the number of authorized shares of Sesen Bio common stock</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">General</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">At the Sesen Bio special meeting, Sesen Bio stockholders will be asked to consider and vote upon a proposal to approve an amendment to the Sesen Bio Certificate of Incorporation to effect the proposed reverse stock split and reduce the authorized shares of Sesen Bio common stock. Upon the effectiveness of the amendment to the Sesen Bio Certificate of Incorporation effecting the reverse stock split, or the split effective time, the issued and outstanding shares of Sesen Bio common stock immediately prior to the split effective time will be reclassified into a smaller number of shares of Sesen Bio common stock, at a ratio of 1-for-20. If the merger is not consummated, then the implementation and timing of the reverse stock split would be in the Sesen Bio board of directors&#8217; sole discretion. If and when the reverse stock split is effected, the amendment to the Sesen Bio Certificate of Incorporation will also reduce the number of authorized shares of Sesen Bio common stock from 400,000,000 to 100,000,000. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Sesen Bio board of directors may determine to effect the reverse stock split, if it is approved by the Sesen Bio stockholders, even if Proposal No. 1 is not approved and the merger is not consummated. If the Sesen Bio stockholders approve Proposal No. 2, and the Sesen Bio board of directors decides to implement it, the reverse stock split will become effective on the date of the filing of the amendment to the Sesen Bio Certificate of Incorporation with the Secretary of State of the State of Delaware. The form of amendment to the Sesen Bio Certificate of Incorporation set forth in </font><font style="font-style:italic;letter-spacing:0.2pt;">Annex G</font><font style="letter-spacing:0.2pt;"> to this proxy statement/prospectus has been approved by the Sesen Bio board of directors. By approving the reverse stock split, Sesen Bio stockholders also will be approving the form of amendment to the Sesen Bio Certificate of Incorporation set forth in </font><font style="font-style:italic;letter-spacing:0.2pt;">Annex G</font><font style="letter-spacing:0.2pt;"> to this proxy statement/prospectus. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Purpose</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Sesen Bio board of directors approved Proposal No.&#160;2 approving the amendment to the Sesen Bio Certificate of Incorporation to effect the reverse stock split for the following reasons: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">The reverse stock split may be necessary to increase Sesen Bio&#8217;s stock price to meet Nasdaq&#8217;s $4.00 minimum bid price requirement upon the closing of the merger; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.09pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.09pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the Sesen Bio board of directors believes effecting the reverse stock split may be necessary to raise the per share trading price of Sesen Bio&#8217;s common stock to regain compliance with the Nasdaq Listing Rules to remain listed on the Nasdaq Capital Market; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the reverse stock split and the related amendment to the Sesen Bio Certificate of Incorporation will be required in order to make sufficient shares of Sesen Bio common stock available for issuance to Carisma stockholders pursuant to the Merger Agreement; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the Sesen Bio board of directors believes a higher stock price may help generate investor interest in Sesen Bio and help Sesen Bio attract and retain employees; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">if the reverse stock split successfully increases the per share price of Sesen Bio common stock, the Sesen Bio board of directors believes this increase may increase trading volume in Sesen Bio common stock and facilitate future financings by Sesen Bio. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Reasons for the Reverse Stock Split</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Requirements for Listing on Nasdaq</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio common stock is quoted on the Nasdaq Capital Market under the symbol &#8220;SESN,&#8221; and Sesen Bio is therefore subject to its continued listing requirements, including requirements with respect to the market value of publicly-held shares, market value of listed shares, minimum bid price per share and minimum stockholder&#8217;s equity, among others, and requirements relating to board and committee independence. If Sesen Bio fails to satisfy one or more of the requirements, Sesen Bio may be delisted from Nasdaq. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">203</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">

          <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Sesen Bio has filed an initial listing application with Nasdaq to seek listing of the combined company on the Nasdaq Capital Market upon the closing of the merger. According to Nasdaq Listing Rule&#160;5110, an issuer must apply for initial listing in connection with a transaction whereby the issuer combines with a non-Nasdaq entity, resulting in a change of control of the issuer and potentially allowing the non-Nasdaq entity to obtain a Nasdaq listing. Accordingly, the listing standards of Nasdaq will require Sesen Bio to have, among other things, a $4.00 per share minimum bid price upon the closing of the merger. As of January&#160;6, 2023 the closing price of Sesen Bio common stock was $0.6316 per share. If Sesen Bio stockholders do not approve Proposal No. 2, the merger will not be able to occur because continued listing on Nasdaq is a condition to the closing of the merger. </font>
          </div>

        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Requirements for Continued Listing on Nasdaq</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">To the extent the merger is not completed, the primary objective for the reverse stock split will be to raise the per share trading price of Sesen Bio&#8217;s common stock to regain compliance with the Nasdaq Listing Rules to remain listed on the Nasdaq Capital Market. The reverse stock split will have the immediate effect of increasing the bid price of the Sesen Bio common stock, which should help ensure a share price high enough to regain compliance with the $1.00 per share minimum bid price requirement. However, there can be no assurance that the trading price of Sesen Bio common stock would be maintained at such level or that Sesen Bio will be able to maintain the listing of Sesen Bio common stock on the Nasdaq Capital Market. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As previously disclosed, on January&#160;24, 2022, Sesen Bio received written notice from Nasdaq indicating that Sesen Bio was not in compliance with the $1.00 minimum bid price requirement for continued listing on the Nasdaq Global Market, as set forth in Nasdaq Listing Rule&#160;5450(a)(1). Sesen Bio was given until July&#160;25, 2022, to regain compliance with the minimum bid price requirement. In response, Sesen Bio submitted an application to transfer the listing of the Sesen Bio common stock from the Nasdaq Global Market to the Nasdaq Capital Market. On July&#160;26, 2022, Sesen Bio received approval from Nasdaq to transfer the listing of Sesen Bio common stock from the Nasdaq Global Market to the Nasdaq Capital Market. As a result, Sesen Bio has been granted a second 180-day grace period, or until January&#160;23, 2023, to regain compliance with the minimum bid price requirement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Sesen Bio common stock was transferred to the Nasdaq Capital Market effective at the opening of business on July&#160;28, 2022. The Nasdaq Capital Market operates in substantially the same manner as the Nasdaq Global Market, and requires that listed companies meet certain financial and liquidity requirements and comply with Nasdaq&#8217;s corporate governance requirements. To regain compliance with the minimum bid price requirement and qualify for continued listing on the Nasdaq Capital Market, the minimum bid price per share of the Sesen Bio common stock must be at least $1.00 for at least ten consecutive business days during the second 180-day grace period. If Sesen Bio does not regain compliance during this second grace period, its common stock would be subject to delisting by Nasdaq. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Potential Increased Investor Interest</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">To the extent the merger is not completed, another principal reason for the reverse stock split would be to generate investor interest in Sesen Bio common stock. On January&#160;6, 2023, Sesen Bio common stock closed at $0.6316 per share. An investment in Sesen Bio common stock may not appeal to brokerage firms that are reluctant to recommend lower priced securities to their clients. Investors may also be dissuaded from purchasing lower priced stocks because the brokerage commissions, as a&#160;percentage of the total transaction, tend to be higher for such stocks. Moreover, the analysts at many brokerage firms do not monitor the trading activity or otherwise provide coverage of lower priced stocks. Also, Sesen Bio believes that most investment funds are reluctant to invest in lower priced stocks. Accordingly, the Sesen Bio board of directors believes that a higher stock price may generate investor interest in Sesen Bio common stock. </font>
          </div>

        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Criteria to be Used for Determining Whether to Implement the Reverse Stock Split</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In determining whether to implement the reverse stock split following receipt of Sesen Bio stockholder approval of Proposal No. 2, Sesen Bio and/or Carisma (solely in connection with the merger) may consider, among other things, various factors, such as: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the historical trading prices and trading volume of Sesen Bio common stock; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">204</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio&#8217;s capitalization (including the number of shares of Sesen Bio common stock issued and outstanding); and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the then-prevailing trading price and trading volume of the Sesen Bio common stock and the anticipated or actual impact of the reverse stock split on the trading price and trading volume of Sesen Bio common stock; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the ability of Sesen Bio to continue its listing on the Nasdaq Capital Market; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.09pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.09pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">potential devaluation of Sesen Bio common stock as a result of the reverse stock split; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the anticipated impact of a particular ratio on Sesen Bio&#8217;s ability to reduce administrative and transactional costs; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">prevailing general market and economic conditions. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">In the event the Sesen Bio board of directors determines to implement the reverse stock split in connection with the merger, the total number of issued and outstanding shares of Sesen Bio common stock after the consummation of the transactions contemplated by the Merger Agreement, together with the total number of shares of Sesen Bio common stock then reserved for issuance or obligated to be issued by Sesen Bio pursuant to any agreement or arrangement or otherwise, including the Merger Agreement, will not exceed the total number of shares of Sesen Bio common stock then authorized under the Sesen Bio Certificate of Incorporation, as amended. Sesen Bio currently estimates that it will issue a maximum of 660,858,446 shares of Sesen Bio common stock (before giving effect to the reverse stock split) in connection with the transactions related to the merger (including to investors in the Carisma pre-closing financing and upon conversion of the Carisma convertible note). </font>
          </div>

        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Principal Effects of the Reverse Stock Split</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A reverse stock split refers to a reduction in the number of outstanding shares of a class of a corporation&#8217;s capital stock, which may be accomplished, as in this case, by reclassifying and combining all of the outstanding shares of Sesen Bio common stock into a proportionately smaller number of shares of Sesen Bio common stock. If the Sesen Bio board of directors decides to implement a 1-for-20 reverse stock split of Sesen Bio common stock, then a Sesen Bio stockholder holding 10,000 shares of Sesen Bio common stock before the reverse stock split would instead hold 500 shares of Sesen Bio common stock immediately after the reverse stock split. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If approved and implemented, the principal effects of the reverse stock split would include the following, all of which have been considered by the Sesen Bio board of directors in approving the reverse stock split: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">The number of outstanding shares of Sesen Bio common stock will be reduced and each Sesen Bio stockholder will own fewer shares of Sesen Bio common stock than they currently own. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">The number of shares of Sesen Bio common stock reserved and available for issuance under Sesen Bio&#8217;s equity-based compensation plans and the number of shares of Sesen Bio common stock issuable upon the exercise of outstanding Sesen Bio options and Sesen Bio warrants, or upon the conversion of outstanding Sesen Bio RSUs, will be reduced proportionately based on the ratio selected by the Sesen Bio board of directors, and the exercise price of all outstanding Sesen Bio options and Sesen Bio warrants will be increased proportionately. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Except for adjustments that may result from the treatment of fractional shares resulting from the reverse stock split, which are explained below under the section entitled &#8220;&#8212; </font><font style="font-style:italic;letter-spacing:0.2pt;">Fractional Shares</font><font style="letter-spacing:0.2pt;">,&#8221; each Sesen Bio stockholder will hold the same&#160;percentage of Sesen Bio common stock immediately following the reverse stock split as the stockholder held immediately prior to the reverse stock split. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">The voting rights, rights to dividends and distributions and other rights of Sesen Bio common stock will not be changed as a result of the reverse stock split. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">The reverse stock split will not affect the number of authorized shares of Sesen Bio preferred stock or the par value of Sesen Bio common stock or preferred stock. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">205</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">The number of authorized shares of Sesen Bio common stock will be reduced from 400,000,000 to 100,000,000. Authorized shares represent the number of shares of Sesen Bio common stock that Sesen Bio is permitted to issue under the Sesen Bio Certificate of Incorporation. Therefore, Proposal No. 2 would have the effect of reducing the number of shares of Sesen Bio common stock available for future issuance after giving effect to the merger. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The reverse stock split will not affect Sesen Bio continuing to be subject to the periodic reporting requirements of the Exchange Act. The reverse stock split is not intended as, and will not have the effect of, a &#8220;going private transaction&#8221; covered by Rule&#160;13e-3 under the Exchange Act. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The reverse stock split will be effected simultaneously for all outstanding shares of Sesen Bio common stock. The reverse stock split will affect all Sesen Bio stockholders uniformly and will not affect any Sesen Bio stockholder&#8217;s&#160;percentage interest in Sesen Bio, except for immaterial adjustments that may result from the treatment of fractional shares as described below. Shares of Sesen Bio common stock issued pursuant to the reverse stock split will remain fully paid and nonassessable. The reverse stock split does not affect the total proportionate ownership of Sesen Bio following the merger. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following table, which is for illustrative purposes only, illustrates the effects of a 1-for-20 reverse stock split (without giving effect to the treatment of fractional shares): </font>
        </div>

          <table style="width:456pt;height:65.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:185.65pt;text-align:left;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Shares Issued</font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">and</font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Outstanding</font><font style=" position:relative; bottom:3.25pt;line-height:5pt;font-size:5pt;letter-spacing:-0.12pt;">(1)</font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Shares Authorized</font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">and</font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Reserved for</font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Issuance</font><font style=" position:relative; bottom:3.25pt;line-height:5pt;font-size:5pt;letter-spacing:-0.12pt;">(1)(2)</font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Shares Authorized</font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">and</font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Unreserved for</font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Issuance</font><font style=" position:relative; bottom:3.25pt;line-height:5pt;font-size:5pt;letter-spacing:-0.12pt;">(1)</font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Total</font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Authorized </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.25pt 0pt 1.5pt 0pt; width:185.65pt;text-align:left;">
                <div style="white-space:nowrap;font-weight:bold;">
                  <font style="letter-spacing:-0.2pt;">As of January 4, 2023</font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">202,759,043</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:7.675pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">27,017,998</td>
              <td style="padding:0pt;padding-left:7.675pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.175pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">170,222,959</td>
              <td style="padding:0pt;padding-left:5.175pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">400,000,000</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:185.65pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">1-for-20 Reverse Split </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">10,137,952</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:7.675pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">1,350,899</td>
              <td style="padding:0pt;padding-left:7.675pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.175pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">8,511,147</td>
              <td style="padding:0pt;padding-left:5.175pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">100,000,000</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
          </table>

        <div style="margin-top:12.5pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">These estimates do not reflect the potential effects of the treatment of fractional shares that may result from the proposed reverse stock split. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">(2)</font>
            <br >
          </div>
          <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
            <font style="letter-spacing:0.2pt;">Includes outstanding 186,600 Sesen Bio warrants, 15,304,313 Sesen Bio options, 4,695,007 Sesen Bio RSUs, 4,532,078 shares of Sesen Bio common stock reserved for future issuance under the 2014 Incentive Plan and 2,300,000 shares of Sesen Bio common stock reserved for future issuance under the 2014 ESPP as of January 4, 2023. Does not include any shares of Sesen Bio common stock issuable upon the exercise or conversion of securities that may have been issued since January 4, 2023 or any shares of Sesen Bio common stock reserved or to be reserved in connection with the Carisma pre-closing financing and the conversion of the Carisma convertible note. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Certain Risks Associated with the Reverse Stock Split</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">There are risks associated with the reverse stock split, which have been considered by the Sesen Bio board of directors in recommending to Sesen Bio stockholders the reverse stock split for approval. </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">One of the effects of the reverse stock split will be to effectively increase the number of authorized shares of Sesen Bio common stock which are unissued relative to shares of Sesen Bio common stock which are issued. This could result in the Sesen Bio board of directors being able to issue more shares of Sesen Bio common stock without further stockholder approval. Therefore, the Sesen Bio board of directors has determined, if the reverse stock split is effected, to reduce the number of authorized shares of Sesen Bio common stock from 400,000,000 to 100,000,000. For example, before the reverse stock split, Sesen Bio estimates as of January 4, 2023, that Sesen Bio&#8217;s authorized but unallocated shares of Sesen Bio common stock immediately prior to the closing of the merger would be approximately 170,222,959 compared to issued and outstanding shares of Sesen Bio common stock of approximately 202,759,043. If Sesen Bio effects the reverse stock split using a 1-for-20 ratio, the authorized but unallocated shares of Sesen Bio common stock immediately prior to the closing of the merger would be approximately 88,511,149 compared to issued and outstanding shares of Sesen Bio common stock of approximately 10,137,952. Sesen Bio currently estimates that it will issue a maximum of 660,858,446 shares of Sesen Bio common stock (before giving effect to the reverse stock split) in connection with the transactions related to the merger (including to investors in the Carisma pre-closing financing and upon conversion of the Carisma convertible note). With respect to </font>
          </div>

      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">206</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">authorized but unallocated shares of Sesen Bio common stock available after the consummation of the merger, the combined company could use such shares that are available for issuance in future equity financing transactions, which could result in additional dilution to the stockholders of the combined company, or to oppose a hostile takeover attempt or delay or prevent future changes in control or changes in or removal of management, including transactions that are favored by a majority of such stockholders or in which such stockholders might otherwise receive a premium for their shares of the combined company&#8217;s common stock over then-current market prices or benefit in some other manner. Sesen Bio currently has no plans to issue shares of Sesen Bio common stock, other than in connection with the merger and to satisfy obligations under the Sesen Bio warrants, Sesen Bio options and Sesen Bio RSUs from time to time as such Sesen Bio warrants, Sesen Bio options and Sesen Bio RSUs are exercised, or vested and settled, for shares of Sesen Bio common stock. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio cannot predict whether the reverse stock split will increase the market price for Sesen Bio common stock. The history of similar stock split combinations for companies in like circumstances is varied. There is no assurance that: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the market price per share of Sesen Bio common stock after the reverse stock split will rise in proportion to the reduction in the number of shares of Sesen Bio common stock outstanding before the reverse stock split; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the reverse stock split will result in a per share price that will attract brokers and investors who do not trade in lower priced stocks or promote greater liquidity for Sesen Bio stockholders; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the bid price per share will exceed the $1.00 minimum bid price as required by Nasdaq for continued listing on the Nasdaq Capital Market; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">that Sesen Bio will otherwise meet the requirements of Nasdaq for initial listing on the Nasdaq Capital Market, including the $4.00 minimum bid price upon the closing of the merger. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The market price of Sesen Bio common stock will also be based on the performance of Sesen Bio and other factors, some of which are unrelated to the number of outstanding shares of Sesen Bio common stock. If the reverse stock split is effected and the market price of Sesen Bio common stock declines, the&#160;percentage decline as an absolute number and as a&#160;percentage of the overall market capitalization of Sesen Bio may be greater than would occur in the absence of a reverse stock split. Furthermore, the liquidity of Sesen Bio common stock could be adversely affected by the reduced number of shares of Sesen Bio common stock that would be outstanding after the reverse stock split. In addition, there can be no assurance that Sesen Bio common stock will not be delisted due to a failure to meet other listing requirements even if the market price per share of Sesen Bio common stock after reverse stock split is in excess of the minimum bid price requirement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Since the reverse stock split will decrease the number of shares of Sesen Bio common stock held by Sesen Bio stockholders, the reverse stock split may increase the number of Sesen Bio stockholders who hold less than a &#8220;round lot,&#8221; or 100 shares of Sesen Bio common stock. Typically, the transaction costs to stockholders selling &#8220;odd lots&#8221; are higher on a per share basis. Consequently, the reverse stock split could increase the transaction costs to existing Sesen Bio stockholders in the event they wish to sell all or a portion of their shares of Sesen Bio common stock. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Procedure for Effecting the Reverse Stock Split and Exchange of Stock Certificates</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If Sesen Bio stockholders approve the amendment to the Sesen Bio Certificate of Incorporation to effect the reverse stock split, and if the Sesen Bio board of directors still believes that a reverse stock split is in the best interests of Sesen Bio and Sesen Bio stockholders, Sesen Bio will file the amendment to the Sesen Bio Certificate of Incorporation with the Secretary of State of the State of Delaware at such time as the Sesen Bio board of directors has determined to be the appropriate split effective time. Beginning at the split effective time, each certificate representing pre-split shares of Sesen Bio common stock will be deemed for all corporate purposes to evidence ownership of post-split shares of Sesen Bio common stock. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The form of amendment to the Sesen Bio Certificate of Incorporation set forth in </font><font style="font-style:italic;letter-spacing:0.2pt;">Annex G</font><font style="letter-spacing:0.2pt;"> to this proxy statement/prospectus has been approved by the Sesen Bio board of directors. By approving the </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">207</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">reverse stock split, Sesen Bio stockholders also will be approving the form of amendment to the Sesen Bio Certificate of Incorporation set forth in </font><font style="font-style:italic;letter-spacing:0.2pt;">Annex G</font><font style="letter-spacing:0.2pt;"> to this proxy statement/prospectus. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As soon as practicable after the split effective time, Sesen Bio stockholders will be notified that the reverse stock split has been effected. Sesen Bio expects that the Sesen Bio transfer agent will act as exchange agent for purposes of implementing the exchange of stock certificates, if any. Holders of pre-split shares of Sesen Bio common stock holding all of their shares electronically in book-entry form with Sesen Bio&#8217;s transfer agent do not need to take any action to receive post-split shares. Holders of pre-split shares of Sesen Bio common stock held in certificated form will be asked to surrender to the exchange agent certificates representing pre-split shares of Sesen Bio common stock in exchange for certificates representing post-split shares of Sesen Bio common stock in accordance with the procedures to be set forth in a letter of transmittal to be sent by Sesen Bio. Upon receipt of the holder&#8217;s pre-split certificate(s) and the properly completed and executed letter of transmittal, the holder will be issued the appropriate number of shares of Sesen Bio common stock electronically in book-entry form under the Direct Registration System. No new shares in book-entry form will be reflected until the holder surrenders the holder&#8217;s outstanding pre-split certificate(s), together with the properly completed and executed letter of transmittal, to the exchange agent. Any pre-split shares of Sesen Bio common stock submitted for transfer, whether pursuant to a sale or other disposition, or otherwise, will automatically be exchanged for post-split shares of Sesen Bio common stock. </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Sesen Bio stockholders should not destroy any stock certificate(s) and should not submit any certificate(s) unless and until requested to do so.</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Fractional Shares</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">No fractional shares of Sesen Bio common stock will be issued in connection with the reverse stock split. Sesen Bio stockholders of record who otherwise would be entitled to receive a fractional share of Sesen Bio common stock because they hold a number of pre-split shares of Sesen Bio common stock not evenly divisible by the number of pre-split shares to be reclassified into one post-split share, will be entitled to a cash payment in lieu thereof at a price equal to the fraction to which the Sesen Bio stockholder would otherwise be entitled multiplied by the closing price of Sesen Bio common stock on Nasdaq on the date of the split effective time; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided, however</font><font style="letter-spacing:0.2pt;">, holders of certificated shares must first surrender to the exchange agent the certificates representing such pre-split shares of Sesen Bio common stock. The ownership of a fractional interest will not give the holder thereof any voting, dividend, or other rights except to receive payment therefor as described herein. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">By approving the amendment to the Sesen Bio Certificate of Incorporation to effect the reverse stock split, Sesen Bio stockholders will be approving the combination of 20 outstanding shares of Sesen Bio common stock into one share of Sesen Bio common stock. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio stockholders should be aware that, under the escheat laws of the various jurisdictions where Sesen Bio stockholders reside, where Sesen Bio is domiciled, and where the funds will be deposited, sums due for fractional interests that are not timely claimed after the split effective date of the reverse stock split may be required to be paid to the designated agent for each such jurisdiction, unless correspondence has been received by Sesen Bio or the exchange agent concerning ownership of such funds within the time permitted in such jurisdiction. Thereafter, Sesen Bio stockholders otherwise entitled to receive such funds will have to seek to obtain them directly from the state to which they were paid. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Accounting Consequences</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The par value per share of Sesen Bio common stock will remain unchanged at $0.001 per share after the reverse stock split. As a result, at the split effective time of the reverse stock split, the stated capital on Sesen Bio&#8217;s balance sheet attributable to Sesen Bio common stock will be reduced proportionately based on the ratio, from its present amount, and the additional paid-in capital account will be increased for the amount by which the stated capital is reduced. After the reverse stock split (and disregarding the impact of shares of Sesen Bio common stock issued in the merger), net income or loss per share, and other per share amounts will be increased because there will be fewer shares of Sesen Bio common stock outstanding. In future financial statements, net loss per share and other per share amounts for periods ending before the reverse stock split will be restated to give retroactive effect to the reverse stock split. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">208</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="MUIT6">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Potential Anti-Takeover Effect</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Although the increased proportion of unissued authorized shares of Sesen Bio common stock to issued shares of Sesen Bio common stock could, under certain circumstances, have an anti-takeover effect, for example, by permitting issuances that would dilute the stock ownership of a person seeking to effect a change in the composition of the Sesen Bio board of directors or contemplating a tender offer or other transaction for the combination of Sesen Bio with another company, the reverse stock split is not being proposed in response to any effort of which Sesen Bio is aware to accumulate shares of Sesen Bio common stock or obtain control of Sesen Bio, other than in connection with the merger, nor is it part of a plan by management to recommend a series of similar amendments to the Sesen Bio board of directors and Sesen Bio stockholders. Other than the proposals being submitted to Sesen Bio stockholders for their consideration at the Sesen Bio special meeting, the Sesen Bio board of directors does not currently contemplate recommending the adoption of any other actions that could be construed to affect the ability of third parties to take over or effect a change of control of Sesen Bio. For more information, see the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Description of Sesen Bio Capital Stock&#8201;&#8212;&#8201;Anti-Takeover Effect of Sesen Bio&#8217;s Certificate of Incorporation and Bylaw Provisions</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tANTIT">384</a> of this proxy statement/prospectus. </font>
          </div>

        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Material U.S. Federal Income Tax Consequences of the Reverse Stock Split</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following discussion is a summary of the material U.S. federal income tax consequences of the reverse stock split to Sesen Bio U.S. holders (which, for purposes of this discussion, has the same meaning as in &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Agreements Related to the Merger&#8201;&#8212;&#8201;CVR Agreement&#8201;&#8212;&#8201;Material U.S. Federal Income Tax Consequences of the Receipt of CVRs</font><font style="letter-spacing:0.2pt;">&#8221;), but does not purport to be a complete analysis of all potential tax consequences that may be relevant to Sesen Bio U.S. holders. The effects of other U.S. federal tax laws, such as estate and gift tax laws, and any applicable state, local or non-U.S. tax laws are not discussed. This discussion is based on the Code, Treasury Regulations promulgated thereunder, judicial decisions, and published rulings and administrative pronouncements of the IRS, in each case in effect as of the date hereof. These authorities may change or be subject to differing interpretations. Any such change or differing interpretation may be applied retroactively in a manner that could adversely affect a Sesen Bio U.S. holder. Sesen Bio has not sought and does not intend to seek any rulings from the IRS regarding the matters discussed below. There can be no assurance the IRS or a court will not take a position contrary to that discussed below regarding the tax consequences of the reverse stock split. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">This discussion is limited to Sesen Bio U.S. holders that hold Sesen Bio common stock as a &#8220;capital asset&#8221; within the meaning of Section&#160;1221 of the Code (generally, property held for investment). This discussion does not address all U.S. federal income tax consequences that may be relevant to a Sesen Bio U.S. holder&#8217;s particular circumstances, including the impact of the alternative minimum tax or the Medicare contribution tax on net investment income or the rules related to &#8220;qualified small business stock&#8221; within the meaning of Section&#160;1202 of the Code. In addition, it does not address consequences relevant to Sesen Bio U.S. holders subject to special rules, including, without limitation: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">U.S. expatriates and former citizens or long-term residents of the U.S.; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio U.S. holders whose functional currency is not the U.S. dollar; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">persons holding Sesen Bio common stock as part of a hedge, straddle or other risk reduction strategy or as part of a conversion transaction or other integrated investment; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">banks, insurance companies, and other financial institutions; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">real estate investment trusts or regulated investment companies; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">brokers, dealers or traders in securities; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">&#8220;controlled foreign corporations,&#8221; &#8220;passive foreign investment companies,&#8221; and corporations that accumulate earnings to avoid U.S. federal income tax; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">S corporations, partnerships or other entities or arrangements treated as partnerships for U.S. federal income tax purposes (and investors therein); </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">tax-exempt organizations or governmental organizations; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">209</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">persons subject to special tax accounting rules as a result of any item of gross income with respect to Sesen Bio common stock being taken into account in an &#8220;applicable financial statement&#8221; &#8203;(as defined in the Code); </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">persons deemed to sell Sesen Bio common stock under the constructive sale provisions of the Code; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">persons who hold or received Sesen Bio common stock pursuant to the exercise of any employee stock option or otherwise as compensation; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">tax-qualified retirement plans. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If an entity treated as a partnership for U.S. federal income tax purposes holds Sesen Bio common stock, the tax treatment of a partner in the partnership will depend on the status of the partner, the activities of the partnership and certain determinations made at the partner level. Accordingly, partnerships holding Sesen Bio common stock and the partners in such partnerships should consult their tax advisors regarding the U.S. federal income tax consequences to them. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">IT IS RECOMMENDED THAT SESEN BIO STOCKHOLDERS CONSULT THEIR TAX ADVISORS WITH RESPECT TO THE APPLICATION OF THE U.S. FEDERAL INCOME TAX LAWS TO THEIR PARTICULAR SITUATIONS AS WELL AS ANY TAX CONSEQUENCES OF THE REVERSE STOCK SPLIT ARISING UNDER THE U.S. FEDERAL ESTATE OR GIFT TAX LAWS OR UNDER THE LAWS OF ANY STATE, LOCAL OR NON-U.S. TAXING JURISDICTION OR UNDER ANY APPLICABLE INCOME TAX TREATY.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio intends to report the reverse stock split as a &#8220;recapitalization&#8221; within the meaning of Section&#160;368(a)(1)(E) of the Code. In general, and subject to the qualifications set forth below, if the reverse stock split qualifies as a &#8220;recapitalization&#8221; within the meaning of Section&#160;368(a)(1)(E) of the Code, a Sesen Bio U.S. holder should not recognize gain or loss upon the reverse stock split, except to the extent a Sesen Bio U.S. holder receives cash in lieu of a fractional share of Sesen Bio common stock. In addition, provided that the reverse stock split qualifies as a &#8220;recapitalization,&#8221; a Sesen Bio U.S. holder&#8217;s aggregate tax basis in the shares of Sesen Bio common stock received pursuant to the reverse stock split should equal the aggregate tax basis of the shares of Sesen Bio common stock surrendered excluding any portion of such basis that is allocated to any fractional share of Sesen Bio common stock, and such Sesen Bio U.S. holder&#8217;s holding period in the shares of Sesen Bio common stock received should include the holding period in the shares of Sesen Bio common stock surrendered. Treasury Regulations provide detailed rules for allocating the tax basis and holding period of the shares of Sesen Bio common stock surrendered, for the shares of Sesen Bio common stock received pursuant to the reverse stock split. Holders of shares of Sesen Bio common stock acquired on different dates and at different prices should consult their tax advisors regarding the allocation of the tax basis and holding period of such shares of Sesen Bio common stock. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">A Sesen Bio U.S. holder that receives cash in lieu of a fractional share of Sesen Bio common stock pursuant to the reverse stock split should recognize capital gain or loss in an amount equal to the difference between the amount of cash received and the Sesen Bio U.S. holder&#8217;s tax basis in the shares of Sesen Bio common stock surrendered that is allocated to such fractional share of Sesen Bio common stock. Such capital gain or loss should be long-term capital gain or loss if the Sesen Bio U.S. holder&#8217;s holding period for Sesen Bio common stock surrendered exceeded one year at the effective time of the reverse stock split. </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">This discussion assumes that the distribution of CVRs and the special cash dividend to Sesen Bio U.S. holders will be treated for U.S. federal income tax purposes as transactions that are separate and distinct from the reverse stock split. However, it is possible that the IRS or a court could determine that the reverse stock split and the receipt of CVRs or the special cash dividend constitute a single &#8220;recapitalization&#8221; for U.S. federal income tax purposes. For a discussion of such treatment with respect to the CVRs or the special cash dividend, see the sections entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Agreements Related to the Merger&#8201;&#8212;&#8201;CVR Agreement&#8201;&#8212;&#8201;Material U.S. Federal Income Tax Consequences of the Receipt of CVRs&#8201;&#8212;&#8201;Alternative Treatment of the Receipt of CVRs and the Proposed Reverse Stock Split as a Single Recapitalization</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tALTERT3">194</a> of this proxy statement/prospectus and &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Merger&#8201;&#8212;&#8201;Material U.S. Federal Income Tax Consequences of the Special Cash Dividend</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tMUFI1">162</a> of this proxy statement/prospectus. If the reverse stock split, the special cash dividend, and receipt of CVRs are treated as a single &#8220;recapitalization&#8221; for U.S. federal income tax purposes, then a Sesen Bio U.S. holder generally should recognize gain (but not loss) equal to </font>
          </div>

      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">210</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:316pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">the lesser of (i)&#160;the amount of the special cash dividend received plus the fair market value of the CVRs received (assuming the receipt of CVRs is treated as a distribution of property as described in &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Agreements Related to the Merger&#8201;&#8212;&#8201;CVR Agreement&#8201;&#8212;&#8201;Material U.S. Federal Income Tax Consequences of the Receipt of CVRs</font><font style="letter-spacing:0.2pt;">&#8221;), and (ii)&#160;the excess (if any) of (A)&#160;the sum of (1)&#160;the amount of the special cash dividend received plus the fair market value of the CVRs received and (2)&#160;the fair market value of the Sesen Bio shares received in the reverse stock split over (B)&#160;the Sesen Bio U.S. holder&#8217;s adjusted tax basis in the Sesen Bio common stock surrendered in the reverse stock split. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Reservation of Right to Abandon Reverse Stock Split</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Notwithstanding approval of this Proposal No.&#160;2 by Sesen Bio stockholders, the Sesen Bio board of directors may, in its sole discretion, abandon the proposed amendments and determine prior to the effectiveness of any filing with the Secretary of State of the State of Delaware not to effect the reverse stock split, as permitted under Section 242(c) of the Delaware General Corporation Law. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Vote Required</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The affirmative vote of the holders of a majority of the outstanding shares of Sesen Bio common stock on the record date for the Sesen Bio special meeting entitled to vote on the matter is required for approval of Proposal No. 2. Abstentions will have the same effect as votes &#8220;AGAINST&#8221; Proposal No. 2. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Recommendation of Sesen Bio Board of Directors</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">THE SESEN BIO BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS THAT SESEN BIO STOCKHOLDERS VOTE &#8220;FOR&#8221; PROPOSAL NO. 2 TO APPROVE AN AMENDMENT TO THE SESEN BIO CERTIFICATE OF INCORPORATION TO EFFECT THE REVERSE STOCK SPLIT. THE APPROVAL OF PROPOSAL NO. 2 IS REQUIRED TO CONSUMMATE THE MERGER. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">211</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tPN3A">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Proposal No. 3: Approval of an amendment and restatement of the 2014 Incentive Plan</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Why Sesen Bio is Requesting Sesen Bio Stockholder Approval of the Amendment and Restatement of the 2014 Incentive Plan</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio is asking the Sesen Bio stockholders to approve the amendment and restatement of the 2014 Incentive Plan, or the Amended and Restated Plan. The Sesen Bio board of directors believes that the combined company&#8217;s growth and success will depend, in large part, on its ability to maintain a competitive position by attracting, retaining and motivating key employees with experience and ability to advance the combined company&#8217;s clinical and business objectives, thereby creating value for all of the combined company&#8217;s stakeholders. Central to these objectives will be a stock-based compensation program. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The 2014 Incentive Plan was originally adopted by the Sesen Bio board of directors in December&#160;2013 and approved by the Sesen Bio stockholders in January&#160;2014. The 2014 Incentive Plan was amended by the Sesen Bio board of directors on April&#160;19, 2019 and approved by the Sesen Bio stockholders on June&#160;19, 2019 and was further amended by the Sesen Bio board of directors on March&#160;12, 2021 and approved by the Sesen Bio stockholders on May&#160;3, 2021. On &#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;, the Sesen Bio board of directors adopted, subject to stockholder approval, the amendment and restatement of the 2014 Incentive Plan. At the Sesen Bio special meeting, Sesen Bio stockholders will be asked to consider and vote upon a proposal to approve the amendment and restatement of the 2014 Incentive Plan to (i)&#160;increase the number of shares of Sesen Bio common stock reserved for future issuance under the 2014 Incentive Plan by a number of shares of Sesen Bio common stock equal to 12.79% of the fully diluted capitalization of Sesen Bio, determined as of immediately following the closing of the merger, minus the number of shares that remain available for the grant of awards under the 2014 Incentive Plan as of the closing of the merger, (ii)&#160;establish a maximum aggregate number of shares of Sesen Bio common stock that may be granted as incentive stock options, (iii)&#160;extend the term of the 2014 Incentive Plan to the tenth (10th) anniversary of the closing of the merger, and (iv)&#160;revise certain provisions in the 2014 Incentive Plan to address certain changes in law and accounting relating to (1)&#160;the Sesen Bio board of directors&#8217; ability to delegate authority to make awards under the Amended and Restated Plan, (2)&#160;the satisfaction of withholding taxes with shares of Sesen Bio common stock, and (3)&#160;the effect on awards outstanding under the Amended and Restated Plan of any clawback policy that Sesen Bio has in effect or may adopt after the effective date of the Amended and Restated Plan. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Amended and Restated Plan will be used, following the closing of the merger, to grant equity awards to the combined company&#8217;s projected employees, officers, non-employee directors, consultants and advisors. The number of shares remaining available for issuance under the 2014 Incentive Plan is insufficient to meet these needs and would thus impede the combined company&#8217;s ability to properly compensate, motivate, incentivize and retain key talent. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Sesen Bio board of directors determined the requested number of shares for the Amended and Restated Plan, in consultation with Carisma, based on projected annual equity awards to eligible participants, projected employee recognition and promotion awards and anticipated new-hire awards. If Sesen Bio stockholders approve the Amended and Restated Plan then, subject to adjustment in the event of stock splits and other similar events, including the proposed reverse stock split, awards may be made under the Amended and Restated Plan for up to the sum of: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">a number of shares of Sesen Bio common stock equal to 12.79% of the fully diluted capitalization of Sesen Bio, determined as of immediately following the closing of the merger, minus the number of shares of Sesen Bio common stock that remain available for the grant of awards under the 2014 Incentive Plan as of the closing of the merger; plus </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">25,313,283 shares of Sesen Bio common stock; plus</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the number of shares as is equal to the sum of (x)&#160;the number of shares of common stock reserved for issuance under the 2009 Incentive Plan, or the prior plan, that remained available for grant under the prior plan immediately prior to Sesen Bio&#8217;s initial public offering and (y)&#160;the number of shares of Sesen Bio common stock subject to (I)&#160;outstanding Sesen Bio awards granted under the prior plan and (II)&#160;stock options assumed by Sesen Bio in the merger, or, the awards described in the foregoing clauses (I)&#160;and (II)&#160;together, the Outstanding Awards, in each case which Outstanding Awards expire, </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">212</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:30pt; width:426pt; line-height:11pt;">
          <font style="letter-spacing:0.2pt;">terminate or are otherwise surrendered, canceled, forfeited or repurchased by Sesen Bio at their original issuance price pursuant to a contractual repurchase right. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11pt;">
          <font style="letter-spacing:0.2pt;">Up to 252,000,000 of the shares of Sesen Bio common stock available for issuance under the Amended and Restated Plan may be issued as incentive stock options under the Amended and Restated Plan, subject to adjustment under the terms of the Amended and Restated Plan, including in the event the proposed reverse stock split occurs. The Amended and Restated Plan will have a term of ten&#160;years following the closing of the merger. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11pt;">
          <font style="letter-spacing:0.2pt;">The proposed Amended and Restated Plan includes several features that are consistent with protecting the interests of Sesen Bio stockholders and sound corporate governance practices, as described below. If Sesen Bio stockholders do not approve the Amended and Restated Plan, the 2014 Incentive Plan will remain in effect pursuant to its terms. </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">The following table includes information regarding (i) all of Sesen Bio&#8217;s outstanding equity awards as of January 4, 2023 (under all of Sesen Bio&#8217;s equity-based compensation plans or arrangements under which shares of Sesen Bio common stock may be issued, including inducement grants made by Sesen Bio but excluding the 2014 ESPP) before giving effect to any equitable adjustments that may be made in connection with the distribution of the CVRs and any special cash dividend, including outstanding stock options granted under the Carisma equity incentive plan, which Sesen Bio will assume as part of the merger on an as-converted basis (assuming the merger was consummated as of January 4, 2023 at an assumed exchange ratio of 37.7924 shares of Sesen Bio common stock for each share of Carisma capital stock), (ii) shares available for future awards under the 2014 Incentive Plan as of January 4, 2023 and (iii)&#160;the number of shares of Sesen Bio common stock outstanding as of January 4, 2023 (including the number of shares of Sesen Bio common stock that will be issued in the merger (based on shares outstanding as of January 4, 2023 and taking into account the consummation of the Carisma pre-closing financing and the conversion of the Carisma convertible note and an assumed exchange ratio of 37.7924), prior to giving effect to the proposed reverse stock split): </font>
          </div>


          <table style="width:456pt;height:256pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:388.59pt;white-space:normal;text-align:left;">
                <div style="margin-left:10pt; text-indent:-10pt;">
                  <font style="letter-spacing:0.2pt;">Number of outstanding Sesen Bio options under Sesen Bio equity incentive plans and inducement grants </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">15,304,313</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.833pt 0pt; width:388.59pt;white-space:normal;text-align:left;">
                <div style="margin-left:10pt; text-indent:-10pt;">
                  <font style="letter-spacing:0.2pt;">Weighted average exercise price of outstanding Sesen Bio options under Sesen Bio equity incentive plans and inducement grants </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">1.82</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.833pt 0pt; width:388.59pt;white-space:normal;text-align:left;">
                <div style="margin-left:10pt; text-indent:-10pt;">
                  <font style="letter-spacing:0.2pt;">Weighted average remaining contractual term of outstanding Sesen Bio options under Sesen Bio equity incentive plans and inducement grants </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">7.175</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:388.59pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Number of outstanding Sesen Bio RSUs under Sesen Bio equity incentive plans </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">4,695,007</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.833pt 0pt; width:388.59pt;white-space:normal;text-align:left;">
                <div style="margin-left:10pt; text-indent:-10pt;">
                  <font style="letter-spacing:0.2pt;">Sesen Bio remaining shares of Sesen Bio common stock available under the 2014 Incentive Plan </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">4,532,078</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:388.59pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Estimated number of outstanding Carisma options under Carisma equity incentive plan </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">1,802,246</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:388.59pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Weighted average exercise price of Carisma options under Carisma equity incentive plan </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">1.92</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.833pt 0pt; width:388.59pt;white-space:normal;text-align:left;">
                <div style="margin-left:10pt; text-indent:-10pt;">
                  <font style="letter-spacing:0.2pt;">Weighted average remaining contractual term of outstanding Carisma options under Carisma equity incentive plan </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">7.666</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.833pt 0pt; width:388.59pt;text-align:left;">
                <div style="margin-left:10pt; text-indent:-10pt;">
                  <font style="letter-spacing:0.2pt;">Estimated number of shares requested for approval under the Amended and </font>
                  <br >
                  <font style="letter-spacing:0.2pt;">Restated Plan </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">79,902,694</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.833pt 0pt; width:388.59pt;text-align:left;">
                <div style="margin-left:10pt; text-indent:-10pt;">
                  <font style="letter-spacing:0.2pt;">Total number of shares of Sesen Bio common stock authorized for issuance under the 2014 </font>
                  <br >
                  <font style="letter-spacing:0.2pt;">Incentive Plan </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">25,313,283</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.833pt 0pt; width:388.59pt;text-align:left;">
                <div style="margin-left:10pt; text-indent:-10pt;">
                  <font style="letter-spacing:0.2pt;">Estimated number of shares of Sesen Bio common stock outstanding following the closing </font>
                  <br >
                  <font style="letter-spacing:0.2pt;">of the merger </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">656,865,489</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
          </table>


          <div style="text-indent:20pt; margin-top:7.51pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">As of January 4, 2023, there were no outstanding shares of restricted stock, no stock appreciation rights, or SARs, nor any other stock-based awards under the 2014 Incentive Plan. </font>
          </div>

        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio expects that the proposed share pool under the Amended and Restated Plan will allow the combined company to continue to grant market-competitive equity awards for approximately 3 years, but the actual duration of the share pool may vary based on changes in participation and the combined company&#8217;s stock price. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">213</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If the Amended and Restated Plan is not approved by Sesen Bio stockholders, the combined company will not be able to make long-term equity incentive awards that are sufficient to meet its needs. The inability to make competitive equity awards to retain talented employees in a highly competitive market could have an adverse impact on the combined company&#8217;s business and future prospects. Further, if the Amended and Restated Plan is not approved, the combined company could be forced to increase cash compensation, which will reduce the resources the combined company intends to allocate to meeting its clinical and business needs and objectives. Therefore, the approval of the Amended and Restated Plan is vital to the combined company&#8217;s future success. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Highlights of the Amended and Restated Plan</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Amended and Restated Plan includes several features that are consistent with protecting the interests of Sesen Bio stockholders and sound corporate governance practices. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">No Evergreen.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The Amended and Restated Plan does not include an &#8220;evergreen&#8221; or other provision that provides for automatic increases in the number of shares available for grant under the Amended and Restated Plan. Therefore, stockholders of the combined company will have a say in the combined company&#8217;s equity compensation programs because any increase to the maximum share reserve in the Amended and Restated Plan is subject to approval by the combined company&#8217;s stockholders. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Clawback Policy</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;In accepting an award granted under the Amended and Restated Plan, a participant agrees to be bound by any clawback policy that Sesen Bio has in effect or may adopt in the future. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">No Automatic Vesting of Awards on a Change in Control Event</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Amended and Restated Plan does not provide for the automatic vesting of awards in connection with a change in control event. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Limits on Liberal Share Recycling</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Amended and Restated Plan prohibits the re-granting of (i)&#160;Sesen Bio shares withheld or delivered to satisfy the exercise price of an award or to satisfy tax withholding obligations and (ii)&#160;Sesen Bio shares that were subject to a SAR and were not issued upon the net settlement or net exercise of such award. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">No Repricing of Awards</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Amended and Restated Plan prohibits the direct or indirect repricing of stock options or SARs without stockholder approval. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">No Discounted Options or SARs</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;All options and SARs must have an exercise or measurement price that is at least equal to the fair market value of the underlying Sesen Bio common stock on the date of grant. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Material Amendments Require Stockholder Approval</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Stockholder approval is required prior to an amendment of the Amended and Restated Plan that would (i)&#160;materially increase the number of Sesen Bio&#8217;s shares authorized (other than as provided under the Amended and Restated Plan with respect to certain corporate events or substitute awards), (ii)&#160;expand the types of awards that may be granted, or (iii)&#160;materially expand the class of participants eligible to participate in the Amended and Restated Plan. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Reasons Sesen Bio&#8217;s Stockholders Should Approve the Amended and Restated Plan</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Incentivizes, Retains and Motivates Talent</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;It is critical to the combined company&#8217;s success that it incentivizes, retains and motivates the best talent in what is a tremendously competitive labor market. The combined company&#8217;s equity-based compensation program will be a key component in its ability to pay market-competitive compensation to its employees and other service providers. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Aligns with a Pay-for-Performance Compensation Philosophy</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Sesen Bio believes that equity-based compensation is fundamentally performance-based. As the value of Sesen Bio common stock appreciates, its employees and other service providers receive greater compensation while Sesen Bio stockholders receive a greater return on their investment. Conversely, if the stock price does not appreciate following the grant of an equity award, then employees would not realize any compensation benefit in respect of stock options and would receive lower than intended compensation in respect of Sesen Bio RSUs. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Aligns Employee and Director Interests with Stockholder Interests</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Providing employees and non-employee directors with compensation in the form of equity directly aligns the interests of those employees and directors with the interests of the combined company&#8217;s stockholders. If the Amended and Restated Plan </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">214</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">is approved by Sesen Bio stockholders, the combined company will be able to continue fostering this alignment between its employees and non-employee directors and stockholders by granting meaningful equity-based incentives. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Consistent with Stockholder Interests and Sound Corporate Governance</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;As described under the heading above entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Highlights of the Amended and Restated Plan</font><font style="letter-spacing:0.2pt;">&#8221; and more thoroughly below, the Amended and Restated Plan purposefully includes features that are consistent with the interests of the stockholders of the combined company and sound corporate governance. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Description of the Amended and Restated Plan</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Types of Awards; Shares Available for Awards; Share Counting Rules</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Amended and Restated Plan provides for the grant of incentive stock options intended to qualify under Section&#160;422 of the Code, nonstatutory stock options, SARs, restricted stock, RSUs, and other stock-based awards, or collectively, the awards. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Subject to adjustment in the event of stock splits, stock dividends and other similar events, including the proposed reverse stock split, awards may be made under the Amended and Restated Plan for up to the sum of: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">a number of shares of Sesen Bio common stock equal to 12.79% of the fully diluted capitalization of Sesen Bio, determined as of immediately following the closing of the merger, minus the number of shares that remain available for the grant of awards under the 2014 Incentive Plan as of the closing of the merger; plus </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">25,313,283 shares of Sesen Bio common stock; plus</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the number of shares of Sesen Bio common stock as is equal to the sum of (x)&#160;the number of shares of Sesen Bio common stock reserved for issuance under the prior plan that remained available for grant under the prior plan immediately prior to Sesen Bio&#8217;s initial public offering and (y)&#160;the number of shares of Sesen Bio common stock subject to Outstanding Awards, which Outstanding Awards expire, terminate or are otherwise surrendered, canceled, forfeited or repurchased by Sesen Bio at their original issuance price pursuant to a contractual repurchase right. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Up to 252,000,000 of the shares of Sesen Bio common stock available for issuance under the Amended and Restated Plan may be issued as incentive stock options under the Amended and Restated Plan, subject to adjustment under the terms of the Amended and Restated Plan, including in the event the proposed reverse stock split occurs. Shares of Sesen Bio common stock issued under the Amended and Restated Plan may consist in whole or in part of authorized but unissued shares or treasury shares. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">For purposes of counting the number of shares available for the grant of awards under the Amended and Restated Plan, all shares of common stock covered by SARs will be counted against the number of shares available for the grant of awards. However, SARs that may be settled only in cash will not be so counted. In addition, if Sesen Bio grants a SAR in tandem with an option for the same number of shares of Sesen Bio common stock and provides that only one such award may be exercised, or the tandem SAR, only the shares covered by the option, and not the shares covered by the tandem SAR, will be so counted, and the expiration of one in connection with the other&#8217;s exercise will not restore shares to the Amended and Restated Plan. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Shares covered by awards under the Amended and Restated Plan that expire or are terminated, surrendered, or cancelled without having been fully exercised or are forfeited in whole or in part (including as the result of shares subject to such award being repurchased by Sesen Bio at the original issuance price pursuant to a contractual repurchase right) or that result in any shares not being issued (including as a result of a SAR that was settleable either in cash or in stock actually being settled in cash) will again be available for the grant of awards under the Amended and Restated Plan (subject, in the case of incentive stock options, to any limitations under the Code). In the case of the exercise of a SAR, the number of shares counted against the shares available for the grant of awards under the Amended and Restated Plan will be the full number of shares subject to the SAR multiplied by the&#160;percentage of the SAR actually exercised, </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">215</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">regardless of the number of shares actually used to settle the SAR upon exercise, and the shares covered by a tandem SAR will not again become available for grant upon the expiration or termination of the tandem SAR. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Shares of Sesen Bio common stock that are delivered (by actual delivery, attestation, or net exercise) to Sesen Bio by a participant to purchase shares of Sesen Bio common stock upon exercise of an award or to satisfy tax withholding obligations (including shares retained from the award creating the tax obligation) will not be added back to the number of shares available for the future grant of awards under the Amended and Restated Plan. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In connection with a merger or consolidation of an entity with Sesen Bio or Sesen Bio&#8217;s acquisition of property or stock of an entity, the Sesen Bio board of directors may grant awards under the Amended and Restated Plan in substitution for any options or other stock or stock-based awards granted by such entity or an affiliate thereof on such terms as the Sesen Bio board of directors determines appropriate in the circumstances, notwithstanding any limitation on awards contained in the Amended and Restated Plan. No such substitute awards shall count against the overall share limit, except as required by reason of Section&#160;422 and related provisions of the Code. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Descriptions of Awards</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Options</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;A participant who is awarded an option receives the right to purchase a specified number of shares of Sesen Bio common stock at a specified exercise price and subject to the other terms and conditions that are specified in connection with the award agreement. An option that is not intended to be an &#8220;incentive stock option&#8221; is a &#8220;nonstatutory stock option.&#8221; Options may not be granted at an exercise price that is less than 100% of the fair market value of Sesen Bio common stock on the date of grant. If the Sesen Bio board of directors approves the grant of an option with an exercise price to be determined on a future date, the exercise price may not be less than 100% of the fair market value of Sesen Bio common stock on that future date. Under present law, incentive stock options may not be granted at an exercise price less than 110% of the fair market value in the case of stock options granted to participants who hold more than 10% of the total combined voting power of all classes of Sesen Bio&#8217;s stock or any of Sesen Bio&#8217;s subsidiaries. Under the terms of the Amended and Restated Plan, options may not be granted for a term in excess of ten&#160;years (and, under present law, five&#160;years in the case of incentive stock options granted to participants who hold greater than 10% of the total combined voting power of all classes of Sesen Bio&#8217;s stock or any of Sesen Bio&#8217;s subsidiaries). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Amended and Restated Plan permits participants to pay the exercise price of options using one or more of the following manners of payment: (i)&#160;payment by cash or by check, (ii)&#160;except as may otherwise be provided in the applicable award agreement or approved by the Sesen Bio board of directors, in connection with a &#8220;cashless exercise&#8221; through a broker, (iii)&#160;to the extent provided in the applicable award agreement or approved by the Sesen Bio board of directors, and subject to certain conditions, by delivery to Sesen Bio (either by actual delivery or attestation) of shares of common stock owned by the participant valued at their fair market value, (iv)&#160;to the extent provided in an applicable nonstatutory stock option award agreement or approved by the Sesen Bio board of directors, by delivery of a notice of &#8220;net exercise&#8221; as a result of which Sesen Bio will retain a number of shares of Sesen Bio common stock otherwise issuable pursuant to the stock option equal to the aggregate exercise price for the portion of the option being exercised divided by the fair market value of Sesen Bio common stock on the date of exercise, (v)&#160;to the extent permitted by applicable law and provided for in the applicable award agreement or approved by the Sesen Bio board of directors, by any other lawful means as the Sesen Bio board of directors may determine, or (vi)&#160;by any combination of these forms of payment. </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">On January 6, 2023, the closing sale price of Sesen Bio common stock on Nasdaq was $0.6316 per share.</font>
          </div>

        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Stock Appreciation Rights</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;A participant who is awarded a SAR receives, upon exercise, a number of shares of Sesen Bio common stock, or cash (or a combination of shares of Sesen Bio common stock and cash) determined by reference to appreciation, from and after the date of grant, in the fair market value of a share of Sesen Bio common stock over the measurement price. The Amended and Restated Plan provides that the measurement price of a SAR may not be less than 100% of the fair market value of Sesen Bio </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">216</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">common stock on the date the SAR is granted (provided, however, that if the Sesen Bio board of directors approves the grant of a SAR effective as of a future date, the measurement price will not be less than 100% of the fair market value on such future date) and that SARs may not be granted with a term in excess of 10&#160;years. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Limitation on Repricing of Options or SARs.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;With respect to options and SARs, unless such action is approved by Sesen Bio stockholders or otherwise permitted under the terms of the Amended and Restated Plan in connection with certain changes in capitalization and reorganization events, Sesen Bio may not (1)&#160;amend any outstanding option or SAR granted under the Amended and Restated Plan to provide an exercise price or measurement price per share that is lower than the then-current exercise price or measurement price per share of such outstanding option or SAR, (2)&#160;cancel any outstanding option or SAR (whether or not granted under the Amended and Restated Plan) and grant in substitution for such awards new awards under the Amended and Restated Plan (other than certain substitute awards issued in connection with a merger or consolidation of an entity with Sesen Bio or an acquisition by Sesen Bio, described above) covering the same or a different number of shares of Sesen Bio common stock and having an exercise price or measurement price per share lower than the then-current exercise price or measurement price per share of the canceled option or SAR, (3)&#160;cancel in exchange for a cash payment any outstanding option or SAR with an exercise price or measurement price per share above the then-current fair market value of Sesen Bio common stock, or (4)&#160;take any other action under the Amended and Restated Plan that constitutes a &#8220;repricing&#8221; within the meaning of the rules of the Nasdaq Stock Market. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Restricted Stock Awards.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;A participant who is granted an award of restricted stock is entitled to acquire shares of Sesen Bio common stock, subject to Sesen Bio&#8217;s right to repurchase all or part of such shares at their issue price or other stated or formula price (or to require forfeiture of such shares if issued at no cost) in the event that the conditions specified in the applicable award are not satisfied prior to the end of the applicable restriction period established for such award. Unless otherwise provided in the applicable award agreement, any dividends (whether paid in cash, stock or property) declared and paid by Sesen Bio with respect to shares of restricted stock will be paid to the participant only if and when such shares become free from the restrictions on transferability and forfeitability that apply to such shares. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Restricted Stock Unit Awards.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;A participant who is granted an RSU award is entitled to receive shares of Sesen Bio common stock, or cash equal to the fair market value of such shares or a combination of cash and shares, to be delivered at the time such award vests or on a deferred basis pursuant to the terms and conditions established by the Sesen Bio board of directors. The Sesen Bio board of directors may provide that settlement of RSUs will be deferred, on a mandatory basis or at the election of the participant, in a manner that complies with Section&#160;409A of the Code. A participant has no voting rights with respect to any RSU. An RSU award agreement may provide the applicable participant with the right to receive an amount equal to any dividends or other distributions declared and paid on an equal number of outstanding shares of Sesen Bio common stock. Any such dividend equivalents may be settled in cash and/or shares of Sesen Bio common stock and may be subject to the same restrictions on transfer and forfeitability as the RSUs with respect to which such dividend equivalents are awarded, in each case to the extent provided in the applicable award agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Other Stock-Based Awards.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Under the Amended and Restated Plan, the Sesen Bio board of directors may grant other awards of shares of Sesen Bio common stock, and other awards that are valued in whole or in part by reference to, or are otherwise based on, shares of Sesen Bio common stock or other property, having such terms and conditions as the Sesen Bio board of directors may determine. Sesen Bio refers to these types of awards as other stock-based awards. Other stock-based awards may be available as a form of payment in settlement of other awards granted under the Amended and Restated Plan or as payment in lieu of compensation to which a participant is otherwise entitled. Other stock-based awards may be paid in shares of Sesen Bio common stock or in cash, as the Sesen Bio board of directors may determine. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Eligibility to Receive Awards</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">All employees, officers or directors of the combined company or an affiliate of the combined company, and consultants or advisors to the combined company or an affiliate of the combined company are eligible to participate in the Amended and Restated Plan. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">217</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">

          <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">As of January 4, 2023, following the closing of the merger, approximately 94 employees, 6 non-employee directors and 1 non-employee consultant of the combined company will be eligible to participate in the Amended and Restated Plan.</font>
          </div>

        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Transferability of Awards</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Awards may not be sold, assigned, transferred, pledged or otherwise encumbered by a participant, either voluntarily or by operation of law, except by will or the laws of descent and distribution or, other than in the case of an incentive stock option, pursuant to a qualified domestic relations order. During the life of the participant, awards are exercisable only by the participant. However, the Sesen Bio board of directors may permit or provide in an award for the gratuitous transfer of the award by the participant to or for the benefit of any immediate family member, family trust or other entity established for the benefit of the participant and/or an immediate family member thereof if Sesen Bio would be eligible to use a Form S-8 under the Securities Act for the registration of the sale of the common stock subject to such award to the proposed transferee. Further, Sesen Bio is not required to recognize any such permitted transfer until such time as the permitted transferee has, as a condition to the transfer, delivered to Sesen Bio a written instrument in form and substance satisfactory to Sesen Bio confirming that such transferee will be bound by all of the terms and conditions of the award. None of the restrictions described in this paragraph prohibit a transfer from the participant to Sesen Bio. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">No Rights as a Stockholder; Clawback</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Subject to the provisions of the applicable award, no participant or designated beneficiary will have any rights as a Sesen Bio stockholder with respect to any shares of Sesen Bio common stock to be distributed with respect to an award granted under the Amended and Restated Plan until becoming a record holder of such shares of Sesen Bio common stock. In accepting an award granted under the Amended and Restated Plan, a participant agrees to be bound by any clawback policy that Sesen Bio has in effect or may adopt in the future. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Effective Date</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The effective date of the 2014 Incentive Plan was February&#160;11, 2014, which was immediately prior to the closing of the initial public offering of Sesen Bio common stock on the Nasdaq Global Market. The Amended and Restated Plan will be effective as of the date of the closing of the merger. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Term.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The Amended and Restated Plan will terminate automatically on the tenth (10</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">th</font><font style="letter-spacing:0.2pt;">) anniversary of the closing of the merger (but any awards previously granted under the Amended and Restated Plan may extend beyond such date) unless it is earlier terminated by the Sesen Bio board of directors. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">New Plan Benefits</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Because the grant of awards under the Amended and Restated Plan is within the discretion of the Sesen Bio board of directors and the Sesen Bio compensation committee, Sesen Bio cannot determine the dollar value or number of shares of Sesen Bio common stock that will in the future be received by or allocated to any participant in the Amended and Restated Plan. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Administration</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Amended and Restated Plan will be administered by the Sesen Bio board of directors. The Sesen Bio board of directors has the authority to grant awards and to adopt, amend and repeal the administrative rules, guidelines and practices relating to the Amended and Restated Plan and to construe and interpret the terms of the Amended and Restated Plan and any award agreements entered into under the Amended and Restated Plan. The Sesen Bio board of directors may correct any defect, supply any omission or reconcile any inconsistency in the Amended and Restated Plan or any award under the Amended and Restated Plan in the manner and to the extent it deems expedient, and it is the sole and final judge of such expediency. All decisions by the Sesen Bio board of directors are made in its sole discretion and are final and binding on all persons having or claiming any interest in the Amended and Restated Plan or in any award under the Amended and Restated Plan. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Pursuant to the terms of the Amended and Restated Plan, the Sesen Bio board of directors may delegate any or all of its powers under the Amended and Restated Plan to one or more committees or </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">218</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">subcommittees of the Sesen Bio board of directors. The Sesen Bio board of directors has authorized the Sesen Bio compensation committee to administer certain aspects of the Amended and Restated Plan. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Subject to any requirements of applicable law, the Sesen Bio board of directors may, by resolution, delegate to one or more persons (including Sesen Bio&#8217;s officers) or bodies, which Sesen Bio refers to as &#8220;delegated persons,&#8221; the power to grant awards (subject to any limitations under the Amended and Restated Plan) to eligible service providers of Sesen Bio to exercise such other powers under the Amended and Restated Plan as the Sesen Bio board of directors may determine, provided that the Sesen Bio board of directors must fix (i)&#160;the maximum number of awards, and the maximum number of shares issuable upon exercise of those awards, that may be issued by the delegated persons, (ii)&#160;the time period during which those awards, and during which the shares issuable upon exercise of those awards, may be issued, and (iii)&#160;the minimum amount of consideration (if any) for which awards may be issued, and a minimum amount of consideration for the shares issuable upon exercise of those awards. Further, no delegated person will be authorized to grant awards to any &#8220;executive officer&#8221; &#8203;(as defined by Rule&#160;3b-7 under the Exchange Act) or to any &#8220;officer&#8221; of Sesen Bio (as defined by Rule&#160;16a-1 under the Exchange Act). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Subject to applicable limitations contained in the Amended and Restated Plan, the Sesen Bio board of directors, the Sesen Bio compensation committee, or any other committee or subcommittee of the Sesen Bio board of directors or delegated person to whom the Sesen Bio board of directors has delegated authority pursuant to the Amended and Restated Plan, as the case may be, selects the recipients of awards and determines (i)&#160;the number of shares of Sesen Bio common stock, cash or other consideration covered by awards and the terms and conditions of such awards, including the dates upon which such awards become exercisable or otherwise vest, (ii)&#160;the exercise or measurement price of awards, if any, and (iii)&#160;the duration of awards. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Except as otherwise provided in the Amended and Restated Plan, each award under the Amended and Restated Plan may be made alone or in addition or in relation to any other award. The terms of each award need not be identical, and the Sesen Bio board of directors need not treat participants uniformly. The Sesen Bio board of directors will determine the effect on an award of the disability, death, termination or other cessation of employment or service, authorized leave of absence or other change in the employment or other service status of a participant, and the extent to which, and the period during which, the participant (or the participant&#8217;s legal representative, conservator, guardian or designated beneficiary) may exercise rights or receive any benefits under an award. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Sesen Bio board of directors may at any time provide that any award will become immediately exercisable in whole or in part, free from some or all restrictions or conditions or otherwise realizable in whole or in part, as the case may be. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In the event of any stock split, reverse stock split, stock dividend, recapitalization, combination of shares, reclassification of shares, spin-off or other similar change in capitalization or event, or any dividend or distribution to holders of Sesen Bio common stock other than an ordinary cash dividend, Sesen Bio is required by the Amended and Restated Plan to make equitable adjustments (or make substitute awards, if applicable), in a manner determined by the board of directors, to: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the number and class of securities available under the Amended and Restated Plan and the number and class of securities available for issuance as incentive stock options under the Amended and Restated Plan; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the share counting rules under the Amended and Restated Plan; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the number and class of securities and exercise price per share of each outstanding Sesen Bio option; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the share and per-share provisions and measurement price of each outstanding SAR; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the number of shares and the repurchase price per share subject to each outstanding restricted stock award or Sesen Bio RSU award; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the share and per-share related provisions and purchase price, if any, of any outstanding other stock-based award. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">219</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In the event Sesen Bio effects a split of Sesen Bio common stock by means of a stock dividend and the exercise price of and the number of shares subject to an outstanding option are adjusted as of the date of the distribution of the dividend (rather than as of the record date for such dividend), then a participant who exercises an option between the record date and the distribution date for such stock dividend will be entitled to receive, on the distribution date, the stock dividend with respect to the shares of Sesen Bio common stock acquired upon such option exercise, notwithstanding the fact that such shares were not outstanding as of the close of business on the record date for such stock dividend. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio will indemnify and hold harmless each director, officer, employee or agent to whom any duty or power relating to the administration or interpretation of the Amended and Restated Plan has been or will be delegated against any cost or expense (including attorneys&#8217; fees) or liability (including any sum paid in settlement of a claim with the Sesen Bio board of director&#8217;s approval) arising out of any act or omission to act concerning the Amended and Restated Plan unless arising out of such person&#8217;s own fraud or bad faith. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Except as otherwise provided under the Amended and Restated Plan with respect to repricing outstanding stock options or SARs and with respect to actions requiring stockholder approval, the Sesen Bio board of directors may amend, modify or terminate any outstanding award, including but not limited to, substituting for the award another award of the same or a different type, changing the date of exercise or realization, and converting an incentive stock option to a nonstatutory stock option. The participant&#8217;s consent to any such action will be required unless the Sesen Bio board of directors determines that the action, taking into account any related action, does not materially and adversely affect the participant&#8217;s rights under the Amended and Restated Plan or the change is otherwise permitted under the terms of the Amended and Restated Plan in connection with certain corporate events. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Reorganization Events</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Amended and Restated Plan contains provisions addressing the consequences of any reorganization event. A reorganization event is defined under the Amended and Restated Plan as (a)&#160;any merger or consolidation of Sesen Bio with or into another entity as a result of which all of Sesen Bio common stock is converted into or exchanged for the right to receive cash, securities or other property, or is canceled, (b)&#160;any transfer or disposition of all of Sesen Bio common stock for cash, securities or other property pursuant to a share exchange or other transaction or (c)&#160;Sesen Bio&#8217;s liquidation or dissolution. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Provisions Applicable to Awards Other than Restricted Stock.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Under the Amended and Restated Plan, if a reorganization event occurs, the Sesen Bio board of directors may take any one or more of the following actions as to all or any (or any portion of) outstanding awards other than restricted stock on such terms as the Sesen Bio board of directors determines (except to the extent specifically provided otherwise in an applicable award agreement or another agreement between a participant and Sesen Bio): (1)&#160;provide that such awards will be assumed, or substantially equivalent awards will be substituted, by the acquiring or succeeding corporation (or an affiliate thereof), (2)&#160;upon written notice to a participant, provide that all of the participant&#8217;s unvested and/or exercised awards will terminate immediately prior to the consummation of the reorganization event unless exercised by the participant (to the extent then exercisable) within a specified period following the date of such notice, (3)&#160;provide that outstanding awards will become exercisable, realizable, or deliverable, or restrictions applicable to an award will lapse, in whole or in part prior to or upon such reorganization event, (4)&#160;in the event of a reorganization event under the terms of which holders of Sesen Bio common stock will receive upon consummation of the reorganization event a cash payment for each share surrendered in the reorganization event, which Sesen Bio refers to as the &#8220;Acquisition Price&#8221;, make or provide for a cash payment to participants with respect to each award held by a participant equal to (A)&#160;the number of shares of Sesen Bio common stock subject to the vested portion of the award (after giving effect to any acceleration of vesting that occurs upon or immediately prior to such reorganization event) multiplied by (B)&#160;the excess, if any, of (I)&#160;the Acquisition Price over (II)&#160;the exercise, measurement or purchase price of such award and any applicable tax withholdings, in exchange for the termination of such award, (5)&#160;provide that, in connection with Sesen Bio&#8217;s liquidation or dissolution, awards will convert into the right to receive liquidation proceeds (if applicable, net of the exercise, measurement or purchase price thereof and any applicable tax withholdings) and (6)&#160;any combination of the foregoing. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Sesen Bio board of directors is not obligated to treat all awards, all awards held by a participant, or all awards of the same type, identically. Certain RSU awards that are subject to Section&#160;409A of the </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">220</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Code will be settled in accordance with the terms of the applicable award agreement or as otherwise specified in the Amended and Restated Plan. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Provisions Applicable to Restricted Stock</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Upon the occurrence of a reorganization event other than Sesen Bio&#8217;s liquidation or dissolution, Sesen Bio&#8217;s repurchase and other rights with respect to outstanding restricted stock will inure to the benefit of Sesen Bio&#8217;s successor and will, unless the Sesen Bio board of directors determines otherwise, apply to the cash, securities or other property which Sesen Bio common stock is converted into or exchanged for pursuant to such reorganization event in the same manner and to the same extent as they applied to such restricted stock. However, the Sesen Bio board of directors may either provide for termination or deemed satisfaction of such repurchase or other rights under the instrument evidencing any restricted stock or any other agreement between a participant and Sesen Bio, either initially or by amendment. Upon the occurrence of a reorganization event involving Sesen Bio&#8217;s liquidation or dissolution, except to the extent specifically provided to the contrary in the instrument evidencing any award of restricted stock or any other agreement between the participant and Sesen Bio, all restrictions and conditions on all restricted stock then outstanding will automatically be deemed terminated or satisfied. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Provisions for Foreign Participants</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Sesen Bio board of directors may establish one or more sub-plans under the Amended and Restated Plan to satisfy applicable securities, tax or other laws of various jurisdictions. The Sesen Bio board of directors will establish such sub-plans by adopting supplements to the Amended and Restated Plan containing any limitations on the board of director&#8217;s discretion under the Amended and Restated Plan and any additional terms and conditions not otherwise inconsistent with the Amended and Restated Plan as the Sesen Bio board of directors deems necessary or desirable. All supplements adopted by the Sesen Bio board of directors will be deemed to be part of the Amended and Restated Plan, but each supplement will only apply to participants within the affected jurisdiction. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Withholding</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The participant must satisfy all applicable federal, state, and local or other income and employment tax withholding obligations before Sesen Bio will deliver stock certificates or otherwise recognize ownership of Sesen Bio common stock under an award. Sesen Bio may elect to satisfy the withholding obligations through additional withholding on salary or wages. If Sesen Bio elects not to or cannot withhold from other compensation, the participant must pay Sesen Bio the full amount, if any, required for withholding or have a broker tender to Sesen Bio cash equal to the withholding obligations. Payment of withholding obligations is due before Sesen Bio will issue any shares on exercise, vesting or release from forfeiture of an award or at the same time as payment of the exercise or purchase price, unless Sesen Bio determines otherwise. If provided for in an award or approved by the Sesen Bio board of directors, a participant may satisfy the tax obligations in whole or in part by delivery (either by actual delivery or attestation) of shares of Sesen Bio common stock, including shares retained from the award creating the tax obligation, valued at their fair market value. However, except as otherwise provided by the Sesen Bio board of directors, that the total tax withholding where stock is being used to satisfy such tax obligations cannot exceed Sesen Bio&#8217;s minimum statutory withholding obligations (based on minimum statutory withholding rates for federal and state tax purposes, including payroll taxes, that are applicable to such supplemental taxable income), except that, to the extent that Sesen Bio is able to retain shares of Sesen Bio common stock having a fair market value that exceeds the statutory minimum applicable withholding tax without financial accounting implications or Sesen Bio is withholding in a jurisdiction that does not have a statutory minimum withholding tax, Sesen Bio may retain such number of shares (up to the number of shares having a fair market value equal to the maximum individual statutory rate of tax) as Sesen Bio will determine to be necessary to satisfy the tax liability associated with any award. Shares used to satisfy tax withholding requirements cannot be subject to any repurchase, forfeiture, unfulfilled vesting or other similar requirements. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Amendment or Termination</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If Sesen Bio receives stockholder approval of the Amended and Restated Plan, no award may be granted under the Amended and Restated Plan after the tenth (10</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">th</font><font style="letter-spacing:0.2pt;">) anniversary of the closing of the merger, but awards previously granted may extend beyond that date. The Sesen Bio board of directors may </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">221</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">amend, suspend or terminate the Amended and Restated Plan or any portion of the Amended and Restated Plan at any time, except that (i)&#160;no amendment may be made to the plan to permit an option or SAR to be repriced without stockholder approval and (ii)&#160;no amendment that would require stockholder approval under the rules of the Nasdaq Stock Market may be made effective unless and until such amendment has been approved by Sesen Bio stockholders. If at any time the approval of Sesen Bio stockholders is required as to any other modification or amendment under Section&#160;422 of the Code or any successor provision with respect to incentive stock options, the Sesen Bio board of directors may not effect such modification or amendment without such approval. Unless otherwise specified in the amendment, any amendment to the Amended and Restated Plan adopted in accordance with the procedures described above will apply to, and be binding on the holders of, all awards outstanding under the Amended and Restated Plan at the time the amendment is adopted, provided that the Sesen Bio board of directors determines that such amendment, taking into account any related action, does not materially and adversely affect the rights of participants under the Amended and Restated Plan. No award will be made that is conditioned on stockholder approval of any amendment to the Amended and Restated Plan unless the award provides that (i)&#160;it will terminate or be forfeited if stockholder approval of such amendment is not obtained within no more than 12&#160;months from the date the award was granted and (ii)&#160;it may not be exercised or settled (or otherwise result in the issuance of shares of Sesen Bio common stock) prior to the receipt of such Sesen Bio stockholder approval. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Federal Income Tax Consequences</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following summarizes the federal income tax consequences of awards that may be granted under the Amended and Restated Plan. This summary is based on the federal tax laws in effect as of the date of this proxy statement/prospectus. In addition, this summary assumes that all awards are exempt from, or comply with, the rules under Section&#160;409A of the Code regarding nonqualified deferred compensation. Changes to these laws could alter the tax consequences described below. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Incentive Stock Options</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;An optionee who is granted an incentive stock option does not recognize taxable income at the time the option is granted or upon its exercise, although the exercise may subject the optionee to the alternative minimum tax. Upon a disposition of the shares more than two&#160;years after grant of the option and one year after exercise of the option, any gain or loss is treated as long-term capital gain or loss. If these holding periods are not satisfied, the optionee recognizes ordinary income at the time of disposition equal to the difference between the exercise price and the lower of (i)&#160;the fair market value of the shares at the date of the option exercise or (ii)&#160;the sale price of the shares. Any gain or loss recognized on such a premature disposition of the shares to the extent not recognized as taxable income as provided above, will be long-term or short-term capital gain or loss, depending on the holding period. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Nonstatutory Stock Options</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;An optionee does not recognize taxable income at the time the option is granted. Upon exercise, the optionee recognizes taxable income generally measured by the excess of the then fair market value of the shares over the exercise price. Any taxable income recognized in connection with an option exercise by an employee of the combined company is subject to tax withholding by Sesen Bio. Upon a disposition of such shares by the optionee, any difference between the sale price and the optionee&#8217;s exercise price, to the extent not recognized as taxable income as provided above, is treated as long-term or short-term capital gain or loss, depending on the holding period. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Stock Appreciation Rights</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;A holder of a SAR does not recognize taxable income at the time a SAR is granted. Upon exercise, the participant will recognize ordinary income in an amount equal to the amount of cash received and the fair market value of the shares received, and if granted to an employee, tax withholding is generally due. Any additional gain or loss recognized upon any later disposition of the shares would be capital gain or loss, depending on the holding period. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Restricted Stock</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;A participant will not have income upon the grant of restricted stock unless an election under Section&#160;83(b) of the Code is made within 30&#160;days of the date of grant. If a timely 83(b) election is made, then a participant will have ordinary income equal to the fair market value of the stock on the date of grant less the purchase price, if any. When the stock is sold, the participant will have capital gain or loss equal to the difference between the sales proceeds and the fair market value of the stock on the date of grant. If the participant does not make an 83(b) election, then when the stock vests the participant will have ordinary income equal to the fair market value of the stock on the vesting date less the purchase price, if any. When the stock is sold, the participant will have capital gain or loss equal to the sales proceeds </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">222</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:240pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">less the value of the stock on the vesting date. Any capital gain or loss will be long-term if the participant held the stock for more than one year, and otherwise will be short-term. If the participant is an employee, any ordinary income generally is subject to withholding of income and employment taxes. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Restricted Stock Units</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;A participant generally will recognize no income upon the grant of a restricted stock unit. Upon the settlement and/or payment of Sesen Bio RSUs, participants normally will recognize ordinary income in the year of receipt in an amount equal to the cash received and the fair market value of any nonrestricted shares received. If the participant is an employee, such ordinary income generally is subject to withholding taxes. Upon the sale of any shares received, any gain or loss, based on the difference between the sale price and the fair market value on the settlement date, will be taxed as short term or long term capital gain or loss, depending on the holding period. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Other Stock-Based Awards</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The tax consequences associated with any other stock-based award granted under the Amended and Restated Plan will vary depending on the specific terms of such award. Among the relevant factors are whether or not the award has a readily ascertainable fair market value, whether or not the award is subject to forfeiture provisions or restrictions on transfer, the nature of the property to be received by the participant under the award, and the participant&#8217;s holding period and tax basis for the award or underlying common stock. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Tax Consequences to Sesen Bio</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;There will be no tax consequences to Sesen Bio except that Sesen Bio will be entitled to a deduction when a participant has ordinary income, subject to the limitations of Section&#160;162(m) of the Code. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Vote Required</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The affirmative vote of a majority in voting power of the votes cast by the holders of Sesen Bio common stock present or represented by proxy at the Sesen Bio special meeting and entitled to vote on the matter is required for approval of Proposal No. 3. Abstentions will have no effect on Proposal No. 3. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Recommendation of Sesen Bio Board of Directors</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">THE SESEN BIO BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS THAT SESEN BIO STOCKHOLDERS VOTE &#8220;FOR&#8221; PROPOSAL NO. 3 TO APPROVE THE AMENDED AND RESTATED PLAN. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">223</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tPN4A">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Proposal No. 4: Approval of an amendment to the 2014 ESPP</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">At the Sesen Bio special meeting, Sesen Bio stockholders will be asked to consider and vote upon a proposal to approve an amendment to the 2014 ESPP to increase, subject to adjustment in the event of stock splits and other similar events, including the proposed reverse stock split, the number of shares of Sesen Bio common stock reserved for issuance under the 2014 ESPP to 6,568,655 shares of Sesen Bio common stock, referred to in Proposal No.&#160;4 as the ESPP Increase. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Overview</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">The 2014 ESPP was adopted by the Sesen Bio board of directors on December&#160;18, 2013 and approved by Sesen Bio stockholders on January&#160;14, 2014. The 2014 ESPP was amended on May&#160;3, 2021 to increase the number of shares of Sesen Bio common stock available for issuance under the 2014 ESPP. On November&#160;17, 2022, the Sesen Bio board of directors adopted, subject to stockholder approval and the closing of the merger, Amendment No. 2 to the 2014 ESPP to increase the number of shares of Sesen Bio common stock reserved for issuance under the 2014 ESPP. The 2014 ESPP, as amended by the ESPP Increase, will provide eligible employees with the opportunity to purchase, subject to adjustment in the event of stock splits and other similar events, including the proposed reverse stock split, up to an aggregate of 6,568,655 shares of Sesen Bio common stock. As of January 4, 2023, 2.3&#160;million shares of Sesen Bio common stock had been reserved for issuance under the 2014 ESPP. </font>
          </div>

        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio believes that the availability of an adequate reserve of shares of Sesen Bio common stock for issuance under the 2014 ESPP will benefit the combined company by providing employees with an opportunity to acquire shares of Sesen Bio common stock, and will enable the combined company to attract, retain and motivate key employees with experience and ability. Further, Sesen Bio believes it is in the best interest of the combined company to encourage stock ownership by its employees. Therefore, Sesen Bio considers approval of the ESPP Increase vital to the future success of the combined company. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Description of the 2014 ESPP</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">All of the combined company&#8217;s employees, including directors who are employees, and all employees of any of the combined company&#8217;s subsidiaries designated by the Sesen Bio board of directors from time to time, are eligible to participate in the 2014 ESPP provided that: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">such person is customarily employed by Sesen Bio or a designated subsidiary of Sesen Bio for more than 20 hours a week and for more than five&#160;months in a calendar year; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">such person has been employed by Sesen Bio or a designated subsidiary of Sesen Bio for at least six&#160;months prior to enrolling in the 2014 ESPP; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">such person was an employee of Sesen Bio or a designated subsidiary of Sesen Bio on the first day of the applicable plan period. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">No employee is eligible to receive an option to purchase Sesen Bio common stock that would result in the employee owning 5% or more of the total combined voting power or value of Sesen Bio&#8217;s capital stock or the capital stock of any of Sesen Bio&#8217;s subsidiaries immediately after the grant of such option. For purposes of determining stock ownership of an employee, certain attribution rules under the Code will apply, and all Sesen Bio capital stock which the employee has a contractual right to purchase will be treated as stock owned by the employee. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio has made, and it expects the combined company to continue to make one or more offerings to its eligible employees to purchase Sesen Bio common stock under the 2014 ESPP. Each offering consists of a six-month offering period during which payroll deductions are made and held for the purchase of Sesen Bio common stock at the end of the offering period. The Sesen Bio board of directors may, in its discretion, choose a different plan period of no more than 12&#160;months for offerings. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">With respect to any offering under the 2014 ESPP, an employee may authorize a payroll deduction in any dollar amount up to a maximum of 15% of the compensation such employee receives during the plan period (or during such shorter period during which payroll deductions are made). Compensation is defined under the 2014 ESPP to mean the amount of money reportable on the employee&#8217;s federal income tax </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">224</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">withholding statement, excluding overtime, shift premium, incentive or bonus awards, allowances and reimbursements for expenses such as relocation allowances for travel expenses, income or gains associated with the grant or vesting of restricted stock, income or gains on the exercise of stock options or SARs, and similar items, but including, in the case of salespersons, sales commissions to the extent determined by the Sesen Bio board of directors. The Sesen Bio board of directors may, in its discretion, designate a lower maximum contribution rate, and a minimum payroll deduction may be established from time to time by the Sesen Bio board of directors. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On the first day of each plan period, Sesen Bio will grant to each eligible employee who is then a participant in the 2014 ESPP an option to purchase up to a number of shares of Sesen Bio common stock determined by dividing (a)&#160;the product of $2,083 and the number of full&#160;months in the plan period by (b)&#160;the closing price of a share of Sesen Bio common stock on the first day of the plan period (as determined under the 2014 ESPP). No employee may be granted an option under the 2014 ESPP that permits his or her rights to purchase Sesen Bio common stock under the 2014 ESPP and any other employee stock purchase plans of Sesen Bio or a subsidiary of Sesen Bio to accrue at a rate that exceeds $25,000 of the fair market value of Sesen Bio common stock (determined on the date the option is granted) for each calendar year in which the option is outstanding at any time. Further, the Sesen Bio board of directors may, in its discretion, set a fixed maximum number of shares of Sesen Bio common stock that each eligible employee may purchase per plan period, so long as that number is not greater than the number of shares of Sesen Bio common stock determined by using the formula described above and is subject to $25,000 limitation described above. Each employee who continues to be a participant in the 2014 ESPP on the last business day of the plan period (referred to as the exercise date) is deemed to have exercised the option at the option price on such date and will be deemed to have purchased from Sesen Bio the number of whole shares of Sesen Bio common stock reserved for purposes of the 2014 ESPP that such employee&#8217;s accumulated payroll deductions on the exercise date will pay for, up to the maximum number determined as set forth above. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Under the terms of the 2014 ESPP, the option price will be determined by the Sesen Bio board of directors for each plan period and the option price will be at least 85% of the applicable closing price of Sesen Bio common stock (determined as provided under the 2014 ESPP). If the Sesen Bio board of directors does not make a determination of the option price, the option price will be 85% of the lesser of the closing price of Sesen Bio common stock (determined as provided under the 2014 ESPP) on either (a)&#160;the first business day of the plan period or (b)&#160;the exercise date. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Any balance remaining in an employee&#8217;s payroll deduction account at the end of a plan period will be automatically refunded to the employee, except that any balance that is less than the purchase price of one share of Sesen Bio common stock will be carried forward for the following offering, unless the employee elects not to participate in the following offering, in which case the balance in the employee&#8217;s account will be refunded. An employee may withdraw the balance accumulated in such employee&#8217;s account and withdraw from participation in an offering at any time prior to the close of business on the fifteenth business day prior to the end of the plan period. Any employee who so withdraws may not begin participating again during the remainder of the plan period but may participate in any subsequent offering in accordance with the terms and conditions established by the Sesen Bio board of directors. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If any employee&#8217;s employment ends before the last business day of a plan period, the employee&#8217;s account balance will be refunded to the employee (without any reductions for payroll deductions). In the event of the employee&#8217;s death before the last business day of a plan period, Sesen Bio will, upon notification of such death, pay the balance of the employee&#8217;s account to the executor or administrator of the employee&#8217;s estate, or if no executor or administrator has been appointed to Sesen Bio&#8217;s knowledge, to any other person Sesen Bio designate in its discretion. If, before the last business day of a plan period, a designated subsidiary in which an employee is employed ceases to be a subsidiary of Sesen Bio, or if the employee is transferred to a subsidiary that is not a designated subsidiary, the employee will be deemed to have terminated employment for purposes of the 2014 ESPP. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Options under the 2014 ESPP are not transferable by a participating employee other than by will or the laws of descent and distribution, and are exercisable during the employee&#8217;s lifetime only by the employee. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">All funds received or held by Sesen Bio under the 2014 ESPP may be combined with other corporate funds and may be used for any corporate purposes. Shares of Sesen Bio common stock may be issued upon </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">225</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">exercise of an option from authorized but unissued shares of Sesen Bio common stock, from shares held in Sesen Bio&#8217;s treasury, or from any other proper source. In the event the total number of shares of Sesen Bio common stock specified in elections to be purchased under any offering plus the number of shares of Sesen Bio common stock purchased under previous offerings under the 2014 ESPP exceeds the maximum number of shares of Sesen Bio common stock issuable under the 2014 ESPP, the Sesen Bio board of directors will allot the shares of Sesen Bio common stock then available on a pro-rata basis. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The 2014 ESPP will be administered by the Sesen Bio board of directors or by a committee appointed by the Sesen Bio board of directors. The Sesen Bio board of directors or such committee has the authority to make rules and regulations for the administration of the 2014 ESPP and its interpretation and decisions with regard thereto will be final and conclusive. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If the ESPP Increase is approved, up to 6,568,655 shares of Sesen Bio common stock will be available for issuance under the 2014 ESPP. Sesen Bio will be required to make equitable adjustments in the manner determined by the Sesen Bio board of directors to the number and class of securities available under the 2014 ESPP and the option price to reflect stock splits, reverse stock splits, stock dividends, recapitalizations, combinations of shares, reclassifications of shares, spin-offs and other similar changes in capitalization or any distribution to holders of Sesen Bio common stock other than an ordinary cash dividend. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Upon the occurrence of a reorganization event (as defined below), the Sesen Bio board of directors is authorized to take any one or more of the following actions as to outstanding options under the 2014 ESPP: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">provide that options will be assumed, or substantially equivalent options will be substituted, by the acquiring or succeeding corporation (or an affiliate thereof); </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">upon written notice to employees, provide that all outstanding options will be terminated immediately prior to the consummation of the reorganization event and that all such outstanding options will become exercisable to the extent of accumulated payroll deductions as of a date specified by the Sesen Bio board of directors in such notice, which date will not be less than 10&#160;days preceding the effective date of the reorganization event; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">upon written notice to employees, provide that all outstanding options will be cancelled as of a date prior to the effective date of the reorganization event and that all accumulated payroll deductions will be returned to participating employees on such date; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">upon the occurrence of a reorganization event in which holders of Sesen Bio common stock will receive a cash payment for each share surrendered in the reorganization event, or the acquisition price, change the last day of the plan period to be the date of the consummation of the reorganization event and make or provide for a cash payment to each employee equal to the acquisition price times the number of shares of Sesen Bio common stock that the employee&#8217;s accumulated payroll deductions as of immediately prior to the reorganization event could purchase at the option price, where the acquisition price is treated as the fair market value of the common stock and where the number of shares of Sesen Bio common stock that could be purchased is subject to the limitations set forth in the 2014 ESPP, minus the result of multiplying such number of shares of Sesen Bio common stock by the option price; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">provide that, in connection with a liquidation or dissolution of Sesen Bio, options will convert into the right to receive liquidation proceeds (net of the option price); and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">any combination of the foregoing. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">A &#8220;reorganization event&#8221; is defined under the 2014 ESPP as (i)&#160;any merger or consolidation of Sesen Bio with or into another entity as a result of which all of Sesen Bio common stock is converted into or exchanged for the right to receive cash, securities or other property or is cancelled, (ii)&#160;a transfer or disposition of all of Sesen Bio common stock for cash, securities or other property pursuant to a share exchange or other transaction, or (iii)&#160;Sesen Bio&#8217;s liquidation or dissolution. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In order to comply with the laws of any foreign jurisdiction, Sesen Bio may grant options to employees or employees of designated subsidiaries who are citizens or residents of such foreign jurisdiction with terms that are less favorable (but not more favorable) than the terms of options granted under the 2014 ESPP to employees who are residents of the United States. Sesen Bio&#8217;s employees or employees of Sesen Bio&#8217;s </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">226</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:12pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">designated subsidiaries who are citizens or residents of a foreign jurisdiction may be excluded from eligibility under the 2014 ESPP if the grant of an option under the 2014 ESPP to a citizen or resident of the foreign jurisdiction is prohibited under the laws of such jurisdiction or if compliance with the laws of the foreign jurisdiction would cause the 2014 ESPP to violate the terms of Section&#160;423 of the Code. Sesen Bio may add one or more appendices to the 2014 ESPP describing the operation of the 2014 ESPP in those foreign jurisdictions in which employees are excluded from participation or granted less favorable options. The Sesen Bio board of directors may from time to time establish one or more sub-plans under the 2014 ESPP with respect to one or more of Sesen Bio&#8217;s designated subsidiaries, provided such sub-plan complies with Section&#160;423 of the Code. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Sesen Bio board of directors may at any time, and from time to time, amend or suspend the 2014 ESPP or any portion of the 2014 ESPP. Sesen Bio is required under the 2014 ESPP to obtain stockholder approval for any amendment if such approval is required by Section&#160;423 of the Code. Further, the Sesen Bio board of directors may not make any amendment that would cause the 2014 ESPP to fail to comply with Section&#160;423 of the Code. The Sesen Bio board of directors may terminate the 2014 ESPP at any time. Upon termination, Sesen Bio will refund all amounts in the accounts of participating employees. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Federal Income Tax Consequences</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following generally summarizes the United States federal income tax consequences that will arise with respect to participation in the 2014 ESPP and with respect to the sale of Sesen Bio common stock acquired under the 2014 ESPP. This summary is based on the tax laws in effect as of the date of this proxy statement/prospectus. Changes to these laws could alter the tax consequences described below. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Tax Consequences to Participants</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;A participant will not have income upon enrolling in the 2014 ESPP or upon purchasing stock at the end of a plan period. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A participant may have both ordinary income and a capital gain or loss upon the sale of Sesen Bio common stock that was acquired under the 2014 ESPP. The amount of each type of income and loss will depend on when the participant sells the stock. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If the participant sells the Sesen Bio common stock more than two&#160;years after the commencement of the 2014 ESPP period during which the Sesen Bio common stock was purchased and more than one year after the date that the participant purchased the stock, at a profit (the sales proceeds exceed the purchase price), then the participant will have ordinary income equal to the lesser of: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">15% of the value of the Sesen Bio common stock on the day the plan period commenced; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the participant&#8217;s profit. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Any excess profit will be long-term capital gain. If the participant sells the Sesen Bio common stock at a loss (if sales proceeds are less than the purchase price) after satisfying these waiting periods, then the loss will be a long-term capital loss. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If the participant sells the Sesen Bio common stock prior to satisfying these waiting periods, then he or she will have engaged in a disqualifying disposition. Upon a disqualifying disposition, the participant will have ordinary income equal to the value of the Sesen Bio common stock on the day he or she purchased the stock less the purchase price. The participant also will have a capital gain or loss equal to the difference between the sales proceeds and the value of the Sesen Bio common stock on the day he or she purchased the Sesen Bio common stock. This capital gain or loss will be long-term if the participant has held the Sesen Bio common stock for more than one year and otherwise will be short-term. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Tax Consequences to Sesen Bio.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;There will be no tax consequences to Sesen Bio except that Sesen Bio will be entitled to a deduction when a participant has ordinary income upon a disqualifying disposition. Any such deduction will be subject to the limitations of Section&#160;162(m) of the Code. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">227</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:388pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">New Plan&#160;Benefits</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Participation in the 2014 ESPP is discretionary. The benefits received by any individual under the 2014 ESPP are dependent upon the individual&#8217;s decision to participate in the 2014 ESPP, the amount that the individual decides to contribute to the 2014 ESPP and the fair market value of Sesen Bio common stock on the exercise date. As a result, it is not possible to determine the benefits that will be received under the 2014 ESPP by Sesen Bio named executive officers, other executive officers and other employees if the ESPP Increase is approved by the Sesen Bio stockholders. Non-employee directors, consultants and advisors are not eligible to participate in the 2014 ESPP.</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Vote Required</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The affirmative vote of a majority in voting power of the votes cast by the holders of Sesen Bio common stock present or represented by proxy at the Sesen Bio special meeting and entitled to vote on the matter is required for approval of Proposal No. 4. Abstentions will have no effect on Proposal No. 4. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Recommendation of Sesen Bio Board of Directors</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">THE SESEN BIO BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS THAT SESEN BIO STOCKHOLDERS VOTE &#8220;FOR&#8221; PROPOSAL NO. 4 TO APPROVE AN AMENDMENT TO THE 2014 ESPP. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">228</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tPN5A">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:300pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Proposal No. 5: Approval of possible adjournment of the Sesen Bio special meeting</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">At the Sesen Bio special meeting, Sesen Bio stockholders will be asked to consider and vote upon a proposal to approve one or more adjournments of the Sesen Bio special meeting, if necessary or appropriate, to solicit additional proxies if there are not sufficient votes in favor of Proposal Nos. 1 and 2. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If the number of shares of Sesen Bio common stock present or represented by proxy at the Sesen Bio special meeting voting in favor of Proposal Nos. 1 or 2 is insufficient to approve such proposal at the time of the Sesen Bio special meeting, then Sesen Bio may move to adjourn the Sesen Bio special meeting in order to enable the Sesen Bio board of directors to solicit additional proxies in respect of such proposals. In that event, Sesen Bio stockholders will be asked to vote only upon the adjournment proposal, Proposal No. 5, and not on any other proposal. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio currently does not intend to propose adjournment at the Sesen Bio special meeting if there are sufficient votes to approve Proposal Nos. 1 and 2. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Vote Required</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The affirmative vote of a majority in voting power of the votes cast by the holders of Sesen Bio common stock present or represented by proxy at the Sesen Bio special meeting and entitled to vote on the matter is required for approval of Proposal No. 5. Abstentions will have no effect on Proposal No. 5. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Recommendation of Sesen Bio Board of Directors</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">THE SESEN BIO BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS THAT SESEN BIO STOCKHOLDERS VOTE &#8220;FOR&#8221; PROPOSAL NO. 5 TO APPROVE THE ADJOURNMENT OF THE SESEN BIO SPECIAL MEETING, IF NECESSARY OR APPROPRIATE, TO SOLICIT ADDITIONAL PROXIES IF THERE ARE NOT SUFFICIENT VOTES IN FAVOR OF PROPOSAL NOS. 1 OR 2.</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">229</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tSBB">&#8203;</a><a name="tOVE">&#8203;</a><a name="tCUST">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">SESEN BIO BUSINESS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Overview</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio is a late-stage clinical company that was previously focused on advancing targeted fusion protein therapeutics, or TFPTs, for the treatment of patients with cancer. Sesen Bio&#8217;s most advanced product candidate, Vicineum, also known as VB4-845, is a locally-administered targeted fusion protein composed of an anti-epithelial cell adhesion molecule, or EpCAM, antibody fragment tethered to a truncated form of Pseudomonas exotoxin A for the treatment of NMIBC. </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">On July&#160;15, 2022, Sesen Bio made the strategic decision to voluntarily pause further development of Vicineum in the U.S. The decision was based on a thorough reassessment of Vicineum, which included the incremental development timeline and associated costs for an additional Phase&#160;3 clinical trial, following Sesen Bio&#8217;s discussions with the FDA, which are further described below. Sesen Bio has turned its primary focus to consummating a strategic transaction with the goal of maximizing shareholder value. Additionally, Sesen Bio is seeking a partner for the further development of Vicineum and has engaged a financial advisor for the potential sale of Vicineum. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">On July&#160;15, 2022, Sesen Bio approved a restructuring plan to reduce operating expenses and better align its workforce with the needs of its business following the decision to pause further development of Vicineum in the U.S. The 2022 restructuring plan includes an incremental reduction in Sesen Bio&#8217;s workforce as well as additional cost-saving initiatives intended to preserve capital during the pendency of the merger and while Sesen Bio seeks a potential partner for the further development of Vicineum. The 2022 restructuring plan is expected to be substantially completed in connection with the closing of the merger, which is expected to occur in the first quarter of 2023.</font>
          </div>

        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Current Strategy</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The Merger</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">In May&#160;2022, Sesen Bio announced that it had commenced a process to explore and evaluate strategic alternatives to enhance stockholder value, and had engaged a financial advisor to assist Sesen Bio in this process. Sesen Bio then commenced an extensive process of evaluating strategic alternatives, including identifying and reviewing potential candidates for a strategic acquisition or other transaction as described in the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Merger&#8201;&#8212;&#8201;Background of the Merger</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tBOTM">125</a> of this proxy statement/prospectus. On September&#160;21, 2022, Sesen Bio announced that it had entered into the Original Merger Agreement, which was subsequently amended on December 29, 2022. Although Sesen Bio has entered into the Original Merger Agreement and the Merger Agreement Amendment and intends to consummate the merger, there is no assurance that it will be able to successfully consummate the merger on a timely basis, or at all. If, for any reason, the merger does not close, the Sesen Bio board of directors may elect to, among other things, attempt to complete another strategic transaction like the merger, attempt to sell or otherwise dispose of the various assets of Sesen Bio, resume its research and development activities and continue to operate the business of Sesen Bio or dissolve and liquidate its assets. </font>
          </div>

        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If the merger is not completed, the Sesen Bio board of directors may decide that it is in the best interests of the Sesen Bio stockholders to dissolve the company and liquidate its assets. In that event, the amount of cash available for distribution to the Sesen Bio stockholders would depend heavily on the timing of such decision and, ultimately, such liquidation, since the amount of cash available for distribution continues to decrease as Sesen Bio funds its operations and incurs fees and expenses related to the merger. In addition, if the Sesen Bio board of directors were to approve and recommend, and the Sesen Bio stockholders were to approve, a dissolution of Sesen Bio, it would be required under Delaware law to pay its outstanding obligations, as well as to make reasonable provision for contingent and unknown obligations, prior to making any distributions in liquidation to the Sesen Bio stockholders. As a result of this requirement, a portion of Sesen Bio&#8217;s assets may need to be reserved pending the resolution of such obligations. In addition, Sesen Bio may be subject to litigation or other claims related to a liquidation and dissolution of the company. If a liquidation and dissolution were pursued, the Sesen Bio board of directors, in consultation with its advisors, would need to evaluate these matters and make a determination about a reasonable </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">230</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tSBHP">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">amount to reserve. Accordingly, the Sesen Bio stockholders could lose all or a significant portion of their investment in the event of a liquidation and dissolution of Sesen Bio. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Sesen Bio&#8217;s Historical Pipeline Product Candidates</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">TFPT Platform</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio&#8217;s historical product candidates are based on its proprietary TFPT platform and are focused on addressing areas of unmet medical need in cancer. Sesen Bio&#8217;s novel TFPTs have been designed to overcome the efficacy and safety challenges of existing antibody-drug conjugates, or ADCs, and were being developed for both local and systemic-administration. Sesen Bio&#8217;s TFPTs are single protein therapeutics composed of targeting domains genetically fused via peptide linkers to cytotoxic protein payloads that are produced through its proprietary recombinant one-step, microbial manufacturing process. Sesen Bio&#8217;s TFPT platform uses protein binding antibody fragments, which include Fabs, single chain variable domains, and non-covalent scFv dimers, derived from the domains of antibodies that confer antigen recognition. Sesen Bio selects antibody fragments for its product candidates depending upon the target therapeutic indication. Sesen Bio targets tumor cell surface antigens that allow for rapid internalization into the targeted cancer cell and that also have limited expression in normal cells. For local administrations, Sesen Bio utilizes an immunogenic cytotoxic protein payload designed to both target cancer cells and promote a heightened local immune response against the tumor. For systemic-administrations, Sesen Bio uses deBouganin, a plant-derived, protein payload of reduced immunogenic potential that Sesen Bio believes can be repeatedly administered via infusion without the generation of an efficacy-limiting immune response against the payload. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Locally-administered TFPTs</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio utilizes its TFPTs with immunogenic cytotoxic protein payloads for tumors that can be targeted locally rather than systemically. Local administration allows for the TFPT to reach the tumor without being cleared by the immune system, which enables Sesen Bio to maximize the concentration of TFPTs directly to tumors. Sesen Bio&#8217;s locally-administered TFPT Vicineum, which has been its lead product candidate in development for the treatment of NMIBC, contains a targeting antibody binding domain that is designed to bind to EpCAM, a protein over-expressed in many cancers. This binding domain is genetically fused to a truncated form of exotoxin A, or ETA, which is an immunogenic cytotoxic protein payload that is produced by the bacterial species Pseudomonas. This product candidate is designed to bind to EpCAM on the surface of cancer cells. The TFPT-EpCAM complex is subsequently internalized into the cell and, once inside the cell, the TFPT is cleaved by a cellular enzyme to release the cytotoxic protein payload, thus enabling cancer cell killing. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio also believes that its TFPTs designed for local administration may not only directly kill cancer cells through targeted delivery of a cytotoxic protein payload, but also potentiate an anti-cancer therapeutic immune response. This immune response is believed to be triggered by the immunogenic cell death of the cancer cells due to the payload&#8217;s mechanism of action and the subsequent release of tumor antigens and the immunologically active setting created by the nature of the cytotoxic protein payloads. Sesen Bio believes that this immune response may also enhance the action of checkpoint inhibitors, that require a pre-existing immune response for maximum efficacy. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio&#8217;s most advanced locally-administered TFPT product candidate is Vicineum, in development for the treatment of NMIBC and recurrent, locally advanced or metastatic EpCAM-expressing SCCHN. This TFPT is not, however, suitable for systemic-administration over multiple doses because the body&#8217;s immune system would recognize and eliminate foreign proteins, such as ETA, prior to their reaching targeted cancer cells. Sesen Bio has deferred further development of Vicineum for the treatment of SCCHN in order to focus its efforts and resources on development and, if approved, the commercialization of Vicineum for the treatment of NMIBC. Sesen Bio had also been exploring collaborations for the development of Vicineum for the treatment of SCCHN. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Vicineum for the treatment of NMIBC</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio completed the follow-up stage of its single-arm, multi-center, open-label Phase&#160;3 clinical trial of Vicineum as a monotherapy in patients with BCG-unresponsive NMIBC, or the VISTA Trial in May&#160;2022. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">231</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The VISTA Trial completed enrollment in April&#160;2018 with a total of 133 patients. In December&#160;2020, Sesen Bio submitted its completed BLA for Vicineum for the treatment of BCG-unresponsive NMIBC to the FDA, which was accepted for filing by the FDA in February&#160;2021. The FDA granted Priority Review for the BLA and set a target Prescription Drug User Fee Act, or PDUFA, date for a decision on the BLA of August&#160;18, 2021. On August&#160;13, 2021, Sesen Bio received a CRL from the FDA indicating that the FDA had determined that it could not approve the BLA for Vicineum in its present form and provided recommendations specific to additional clinical/statistical data and analyses in addition to CMC issues pertaining to a recent pre-approval inspection and product quality. On August&#160;20, 2021, Sesen Bio withdrew its MAA to the EMA for Vysyneum for the treatment of BCG-unresponsive NMIBC in order to pause its plans to pursue regulatory approval of Vysyneum in the E.U. until there was more clarity from the FDA on next steps for Vicineum in the U.S. Vysyneum is the proprietary brand name that was conditionally approved by the EMA for oportuzumab monatox in the E.U. In October&#160;2021, the EMA issued its Withdrawal Assessment Report relating to its MAA for Vysyneum, as is consistent with the EMA&#8217;s standard practice when an MAA is withdrawn. The EMA Withdrawal Assessment Report reflects the initial assessment and corresponding questions from the EMA and identifies major objections in the areas of quality, good clinical practice, efficacy and safety. As a result of Sesen Bio&#8217;s decision on July&#160;15, 2022 to pause further development of Vicineum in the U.S., Sesen Bio no longer plans to pursue regulatory approval of Vysyneum for NMIBC in the E.U. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In October&#160;2021 and December&#160;2021, Sesen Bio participated in a CMC Type A meeting and a Clinical Type A meeting, respectively, with the FDA to discuss issues raised in the CRL and design elements of an additional Phase&#160;3 clinical trial for Vicineum, which the FDA confirmed would be required for a potential resubmission of a BLA. In March&#160;2022, Sesen Bio participated in a Type C meeting with the FDA. During the Type C meeting, the FDA agreed to a majority of Sesen Bio&#8217;s proposed protocol and statistical analysis plan design elements for an additional Phase&#160;3 clinical trial. On July&#160;11, 2022, Sesen Bio participated in a Type B meeting with the FDA to discuss outstanding items related to Sesen Bio&#8217;s proposed protocol and statistical analysis plan design elements for an additional Phase&#160;3 clinical trial. As discussed above, on July&#160;15, 2022, Sesen Bio made the strategic decision to voluntarily pause further development of Vicineum in the U.S. If the merger is consummated, the combined company does not expect to pursue further development of Vicineum. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Systemically-administered TFPTs</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio also utilizes its TFPTs with a de-immunized payload where systemic-administration is required. Sesen Bio&#8217;s systemically-administered TFPTs are built around deBouganin. Since the body&#8217;s immune system naturally recognizes and attempts to eliminate foreign proteins, Sesen Bio designed its systemically-administered TFPTs with a deBouganin payload to avoid inducing an immunogenic response. DeBouganin is constructed by mutating the immunogenic T-cell epitopes from bouganin so that they are not recognized as foreign by the immune system. However, Sesen Bio also believes that deBouganin may enhance the action of checkpoint inhibitors as a result of the promotion of a local tumor immune response following the death of cancer cells. Sesen Bio&#8217;s systemically-administered product candidate is VB6-845d for the treatment of multiple types of EpCAM-positive solid tumors. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Sale of EBI-031 Legacy Technology to Roche</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In June&#160;2016, Sesen Bio entered into a license agreement with Roche, or the Roche License Agreement, pursuant to which Sesen Bio granted Roche an exclusive, worldwide license, including the right to sublicense, to its patent rights and know-how related to its monoclonal antibody EBI-031 and all other IL-6 antagonist monoclonal antibody technology owned by Sesen Bio, or collectively, the Licensed Intellectual Property. Under the Roche License Agreement, Roche was required to continue developing, at its cost, EBI-031 and any other product made from the Licensed Intellectual Property that contains an IL-6 antagonist monoclonal antibody, or the Roche Licensed Product, and pursue ongoing patent prosecution, at its cost. At the time of the Roche License Agreement, EBI-031, which was derived using Sesen Bio&#8217;s previous AMP-Rx platform, was in pre-clinical development as an intravitreal injection for diabetic macular edema and uveitis. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On July&#160;15, 2022, Sesen Bio executed the Roche Asset Purchase Agreement pursuant to which Roche purchased all patent rights and know-how related to the monoclonal antibody EBI-031 and all other IL-6 antagonist monoclonal antibody technology owned by Sesen Bio for up to $70.0&#160;million. As a result of the </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">232</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tCOM">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Roche Asset Purchase Agreement, the Roche License Agreement was terminated resulting in no further diligence, milestone or royalty payment obligations under the Roche License Agreement. Pursuant to the Roche Asset Purchase Agreement, Roche made a $40.0&#160;million payment to Sesen Bio upon execution of the Roche Asset Purchase Agreement. The Roche Asset Purchase Agreement also provides that Roche will make an additional $30.0&#160;million payable to Sesen Bio upon Roche&#8217;s initiation of a Phase&#160;3 clinical trial with EBI-031 for a certain indication if initiated prior to December&#160;31, 2026. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Competition</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The pharmaceutical industry is highly competitive, subject to rapid and significant technological change and has a strong emphasis on developing proprietary products. While Sesen Bio believes that its next generation TFPT platform, knowledge, experience and scientific resources provide Sesen Bio with competitive advantages, Sesen Bio faces competition from both large and small pharmaceutical and biotechnology companies, academic institutions and other research organizations; specifically with companies, institutions and organizations that are actively researching and developing products that attach proprietary cell-killing payloads to antibodies for targeted delivery to cancer cells. Sesen Bio&#8217;s competitors include, but are not limited to: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">NMIBC: Merck &amp; Co., Inc. (Keytruda/pembrolizumab and BCG) (approved drugs), Endo Pharmaceuticals Inc. (Valstar/valrubicin) (approved drug), FerGene Inc. (Adstiladrin/nadofaragene firadenovec (rAd-IFN/Syn3)), Medical Enterprises Ltd. (Synergo RITE plus mitomycin C), Aadi, LLC (ABI-009), ImmunityBio (Anktiva/N-803 in combination with BCG), CG Oncology. (CG0070), Theralase Technologies Inc. (TLD-1433 photodynamic compound), Bristol-Myers Squibb (Opdivo/nivolumab with or without BCG or BMS-986205), F. Hoffmann-La Roche AG (Tecentriq/Atezolizumab), AstraZeneca (Imfinzi/durvalumab with or without BCG or External Beam Radiotherapy), Eli Lilly and Company (Gemcitabine) and Telormedix SA (Vesimune); Pfizer, Inc. (Sasanlimab) as well as the emerging use of generic intravesical chemotherapy agents, such as mytomycin-C, Gemcytabine and Gemcytobine + Docetaxel; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">SCCHN: Bristol-Myers Squibb Company (Opdivo/nivolumab) (approved drug), Eli Lilly and Company, and Merck (Erbitux, pembrolizumab) (approved drugs); </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Multiple types of solid tumors: Amgen Inc. (Panitumumab) (approved drug), Bayer AG and Onyx Pharmaceuticals (Sorafenib) (approved drug), Bristol-Myers Squibb Company, Eli Lilly and Company, and Merck (Erbitux) (approved drug), F. Hoffmann-La Roche AG (Bevacizumab) (approved drug), Genentech, Inc. (Bevacizumab, Erlotinib and Trastuzumab) (approved drugs), Pfizer, Inc. (Sunitinib) and Trion Research GmbH (Removab); and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">In addition to competition from alternative treatments, Sesen Bio may also face competition from products that are biosimilar to, and possibly interchangeable with, its product candidates. Biosimilar products are expected to become available over the coming&#160;years. Even if Sesen Bio&#8217;s product candidates achieve marketing approval, they may be priced at a significant premium over competitive biosimilar products if any have been approved by then and insurers or other third-party payors may encourage or even require the use of lower priced biosimilar products. Even if Sesen Bio treatments receive market authorization, they may not be listed on the formularies of payors (public or private insurers) or reimbursed. This may impact the uptake of the drug as a treatment option for patients and/or the price at which the drug can be sold at. Further, if the drug is reimbursed it may be at a narrower indication than the full scope of market authorization. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Many of Sesen Bio&#8217;s competitors have significantly greater financial resources and expertise in research and development, manufacturing, pre-clinical studies, conducting clinical trials, obtaining regulatory approval and marketing than Sesen Bio does. These competitors are also active in seeking patent protection and licensing arrangements in anticipation of collecting royalties for use of technology that they have developed. Moreover, specialized biologics, biopharmaceutical and biotechnology companies may prove to be significant competitors, particularly through collaborative arrangements with large and established companies. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio&#8217;s commercial opportunity could be substantially limited in the event that its competitors develop and commercialize products that are more effective, safer, less toxic, more convenient or cheaper </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">233</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tSAM">&#8203;</a><a name="tMAN">&#8203;</a><a name="tINPR">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">than its comparable products. In geographies that are critical to Sesen Bio&#8217;s commercial success, competitors may also obtain regulatory approvals before Sesen Bio, resulting in its competitors building a strong market position in advance of its product&#8217;s entry. Sesen Bio believes the factors determining the success of its programs will be the drug design, effectiveness against multi-drug resistance mechanisms, efficacy, safety, price and convenience of its product candidates. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Sales and Marketing</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio does not currently have the sales and marketing infrastructure in place that would be necessary to sell and market products. Sesen Bio has no current plans to build the infrastructure that would be needed to successfully market and sell any successful drug candidate on its own, and would therefore need to seek strategic alliances and partnership with third parties. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Manufacturing</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio previously leased a 31,100 square foot manufacturing, laboratory, warehouse and office facility in Winnipeg, Manitoba, with classified fermentation suite and post-production processing capabilities that were dedicated to producing its pre-clinical study and clinical trial batches of Vicineum. In September&#160;2017, Sesen Bio completed the manufacturing of all Vicineum necessary for its Phase&#160;3 VISTA Trial and for its Cooperative Research and Development Agreement, or CRADA, with the NCI. In conjunction with this achievement, Sesen Bio ended its manufacturing activities at its facility in Winnipeg and completed the technology transfer process to outsource future Vicineum clinical and commercial manufacturing to third-party manufacturers. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In October&#160;2018, Sesen Bio entered into a Master Bioprocessing Services Agreement with Fujifilm Diosynth Biotechnologies U.S.A., Inc., or the Fujifilm MSA, for the manufacturing process and technology transfer of Vicineum drug substance production. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In November&#160;2019, Sesen Bio entered into a Commercial Manufacturing and Supply Agreement with Baxter, or the Baxter CMSA, for the manufacturing process and technology transfer of Vicineum drug product production. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In June&#160;2021, Sesen Bio entered into a Global Supply Agreement with Qilu pursuant to which Qilu will be part of the manufacturing network for, if approved, global commercial supply of Vicineum drug substance and drug product. </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">In connection with Sesen Bio&#8217;s decision to voluntarily pause further development of Vicineum, Sesen Bio commenced the process to wind down its manufacturing operations by terminating the Fujifilm MSA and Baxter CMSA on July&#160;17, 2022 and July&#160;20, 2022, respectively. Sesen Bio requested that Fujifilm and Baxter cease all work under the respective agreements and refrain from incurring any additional costs or expenses. As a result of the termination, and in accordance with the terms of the Fujifilm MSA, Sesen Bio has the responsibility to pay Fujifilm for certain non-manufacturing stage services and current Good Manufacturing Practice batches of drug substance of Vicineum. In addition, Sesen Bio terminated its Global Supply Agreement with Qilu on December 23, 2022. </font>
          </div>

        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Intellectual Property</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio currently owns or exclusively licenses approximately 13 families of patents and applications, which generally relate to its TFPT-based product candidates and evolving its platform of targeting agents, cytotoxins (such as deBouganin) and linker technologies. As Sesen Bio&#8217;s product candidates evolve through clinical development, the company continues to monitor advancements and bolster patent coverage where possible. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio exclusively license two families under the Zurich License Agreement, which, among other things, include composition of matter claims directed to EpCAM antibody chimeras, EpCAM antibody chimera-cytotoxin conjugates, and their potential use in treating bladder and head and neck cancer. These families claim all or portions of Vicineum, as well as methods of treating bladder and head and neck cancer consist of issued patents in the U.S., Europe, Canada, China, Israel and Japan and also include pending applications in the U.S. The expiry dates of the patents in this family are April&#160;2024 and June&#160;2025, subject </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">234</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tSBOB">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">to any applicable patent term adjustment or extension that may be available on a jurisdictional basis. See the section entitled &#8220;Our Vicineum License Agreements&#8221; in Sesen Bio&#8217;s Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2021 for additional information. In addition to the Zurich portfolio, Sesen Bio owns two issued U.S. patents related to Vicineum. The expiry date of these patents is February&#160;2029, subject to any applicable patent term extension that may be available on a jurisdictional basis. In addition, Sesen Bio has patent families relating to treatment regimens using Vicineum that include issued patents in the U.S., Australia and Japan and patent applications in Canada and Europe. These patents will expire in 2036. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Additionally, Sesen Bio has a license agreement with Micromet AG, or Micromet, or the Micromet License Agreement, now part of Amgen, Inc., which grants Sesen Bio non-exclusive rights, with certain sublicense rights, for know-how and patents allowing exploitation of certain single chain antibody products. These patents (which are now expired) cover some key aspects of Vicineum. Under the terms of the License Agreement with Micromet, as of December 31, 2021, even though the patents have expired, Sesen Bio may be obligated to pay up to &euro;2.4 million in milestone payments for the first product candidate that achieves applicable regulatory and sales-based development milestones (approximately $2.7 million at exchange rates in effect on December 31, 2021). Sesen Bio is also required to pay up to a 3.5% royalty on the net sales for products covered by the agreement, which includes Vicineum. The royalty rate owed to Micromet in a particular country will be reduced to 1.5% if there are no valid claims covering the product in that country. The obligation to pay royalties in a particular country expires upon the later of the expiration date of the last valid claim covering the product and the tenth anniversary of the first commercial sale of the product in such country. Finally, Sesen Bio is required to pay to Micromet an annual license maintenance fee of &euro;50,000 (approximately $56,625 at exchange rates in effect as of December 31, 2021), which can be credited towards any royalty payment Sesen Bio owes to Micromet. Sesen Bio recorded an expense of &euro;0.7 million ($0.9 million) related to achievement of a development milestone in the three months ended December 31, 2020, due to the submission of its BLA for Vicineum with the FDA in December 2020. Sesen Bio recorded an expense of &euro;0.5 million ($0.6 million) related to the submission of the MAA to the EMA for Vysyneum in the first quarter of 2021. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio also has a license agreement with XOMA Ireland Limited, or XOMA, or the XOMA License Agreement, which grants Sesen Bio non-exclusive rights, with certain sublicense rights, to certain XOMA patent rights (which are now expired) and know-how related to certain expression technology, including plasmids, expression strains, plasmid maps and production systems. These patents and related know-how cover some key aspects of Vicineum. Under the terms of the License Agreement with XOMA, even though the patents have expired, Sesen Bio is required to pay up to $0.25 million in milestone payments for a product candidate that incorporates know-how under the license and achieves applicable clinical development milestones. Sesen Bio is also required to pay a 2.5% royalty on the net sales for products incorporating XOMA&#8217;s technology, which includes Vicineum. Sesen Bio has the right to reduce the amount of royalties owed to XOMA on a country-by-country basis by the amount of royalties paid to other third parties, provided that the royalty rate to XOMA may not be less than 1.75% of net sales. In addition, the foregoing royalty rates are reduced by 50% with respect to products that are not covered by a valid patent claim in the country of sale. The obligation to pay royalties in a particular country expires upon the later of the expiration date of the last valid claim covering the product and the tenth anniversary of the first commercial sale of the product in such country. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Sesen Bio&#8217;s OUS Business Development Partnering</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In connection with Sesen Bio&#8217;s decision to voluntarily pause further development of Vicineum, Sesen Bio has commenced the process to wind down its OUS business development partnerships in the Middle East and North Africa region, or MENA, and Turkey by providing notice of termination for its exclusive license agreements in these respective regions on July&#160;20, 2022. In connection with the termination of the exclusive license agreement with Sesen Bio&#8217;s partner in MENA, Sesen Bio was required to refund the $3.0&#160;million upfront payment paid to the company. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Greater China</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On July&#160;30, 2020, Sesen Bio and its wholly-owned subsidiary, Viventia Bio, Inc., entered into the Qilu License Agreement pursuant to which Sesen Bio granted Qilu an exclusive, sublicensable, royalty-bearing </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">235</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tGORE">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">license, under certain intellectual property owned or exclusively licensed by Sesen Bio, to develop, manufacture and commercialize Vicineum for the treatment of BCG-unresponsive NMIBC and other types of cancer in China, Hong Kong, Macau and Taiwan, or Greater China. Sesen Bio also granted Qilu a non-exclusive, sublicensable, royalty-bearing sublicense, under certain other intellectual property licensed by Sesen Bio to develop, manufacture and commercialize Vicineum in Greater China. Sesen Bio retains (i)&#160;development and commercialization rights in the rest of the world excluding Greater China and (ii)&#160;manufacturing rights with respect to Vicineum in the rest of the world excluding Greater China. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">During 2020, Sesen Bio received a total of $10.0&#160;million in net proceeds associated with the Qilu License Agreement. Sesen Bio is also entitled to receive up to an additional $23.0&#160;million upon the achievement of certain technology transfer, development and regulatory milestones, as well as a 12% royalty based upon annual net sales of Vicineum in Greater China. The royalties are payable upon the first commercial sale of Vicineum in a region and continuing until the latest of (i)&#160;twelve&#160;years after the first commercial sale of Vicineum in such region, (ii)&#160;the expiration of the last valid patent claim covering or claiming the composition of matter, method of treatment, or method of manufacture of Vicineum in such region, and (iii)&#160;the expiration of regulatory or data exclusivity for Vicineum in such region. The royalty rate is subject to reduction under certain circumstances, including when there is no valid claim of a licensed patent that covers Vicineum in a particular region or no data or regulatory exclusivity of Vicineum in a particular region. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The IND for Vicineum submitted by Qilu to the Center for Drug Evaluation of the China National Medical Products Administration was accepted for review in January&#160;2021 and approved in March&#160;2021, resulting in a $3.0&#160;million milestone payment from Qilu, the first milestone payment out of the $23.0&#160;million in potential milestone payments. Sesen Bio recorded $2.8&#160;million (net of value-added tax, or VAT) as license revenue during the three-month period ended March&#160;31, 2021. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In June&#160;2021, the Qilu License Agreement was recognized by Shandong Province, Bureau of Science and Technology as &#8220;Technology Transfer&#8221;. An agreement that is designated as a Technology Transfer shall be entitled to a tax incentive of VAT recovery. As such, Sesen Bio recorded $0.9&#160;million of revenue during the three&#160;months ended June&#160;30, 2021, for additional purchase price resulting from Qilu&#8217;s obligation to pay Sesen Bio an amount equal to its recovery of VAT. Sesen Bio will not be subject to VAT on future potential milestone payments to Qilu. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On July&#160;20, 2021 Sesen Bio and Qilu announced the enrollment of the first patient in China in a Phase&#160;3 clinical trial to assess the efficacy and safety of Vicineum in patients with BCG-unresponsive NMIBC. The open-label, single-arm, multi-center bridging trial will evaluate the efficacy and safety of Vicineum in approximately 53 patients with carcinoma in situ, or CIS, with or without papillary disease, high-grade Ta papillary disease or T1 papillary disease of any grade. Patients will be required to have failed previous treatment with BCG for inclusion in the trial. The primary endpoints are the complete response rate (for CIS patients) and the recurrence-free rate (for papillary patients) at six&#160;months, with the complete response rate and the recurrence-free rate at three&#160;months, safety and tolerability as the secondary endpoints. Based on the Qilu License Agreement, the trial is being run at the sole cost of Qilu. </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">On December 23, 2022, Sesen Bio terminated the Qilu License Agreement. In connection with the termination of the Qilu License Agreement, Sesen Bio will make a one-time aggregate payment to Qilu of $1,400,000, which consists of a $1,200,000 termination fee payable upon the termination of the Qilu License Agreement and a $200,000 payment payable upon Sesen Bio&#8217;s receipt of certain clinical data and chemistry, manufacturing, and controls data from Qilu. As a result of the termination of the Qilu License Agreement, all rights to Vicineum in China, Hong Kong, Macau and Taiwan have reverted to Sesen Bio. Sesen Bio currently retains all global rights to Vicineum. Sesen Bio is seeking a partner for the further development of Vicineum and has engaged a financial advisor for the potential sale of Vicineum. </font>
          </div>

        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Government Regulation</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As a clinical-stage biologics company, Sesen Bio is subject to extensive regulation by the FDA, and other national, supranational, state, provincial and local regulatory agencies. Sesen Bio is also subject to extensive regulation by similar governmental authorities in other countries in which it operates. In the United States, the Federal Food, Drug, and Cosmetic Act, or FDCA, and the Public Health Service Act, or PHSA and their implementing regulations set forth, among other things, requirements for the research, testing, </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">236</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">development, manufacture, quality control, safety, effectiveness, approval, post-approval monitoring and reporting, labeling, storage, record keeping, distribution, import, export, advertising and promotion of Sesen Bio&#8217;s product candidates. Although the discussion below focuses on regulation in the United States, Sesen Bio may seek marketing approval in other countries were it to resume development of Vicineum. Generally, Sesen Bio&#8217;s activities in other countries will be subject to regulation that is similar in nature and scope to that imposed in the United States, although there can be important differences. Additionally, some significant aspects of regulation in the E.U. are addressed in a centralized way through the European Commission following the opinion of the EMA, but country-specific regulation in the individual European Union Member States, or E.U. Member States, remains essential in many respects. The process of obtaining regulatory marketing approvals and the subsequent compliance with appropriate supranational, federal, state, provincial, local and non-U.S. statutes and regulations require the expenditure of substantial time and financial resources, and Sesen Bio may not be successful in any given jurisdiction were it to resume development of Vicineum. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">U.S. Government Regulation</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In the United States, drug products are regulated by the FDA under the FDCA and other laws, including, in the case of biologics, the PHSA. Drug products are also subject to other federal, state and local statutes and regulations. A failure to comply with any applicable requirements during the product development, approval, or post-approval periods may lead to administrative or judicial sanctions, including, among other things, the imposition by the FDA or an institutional review board, or IRB, of a hold on clinical trials, refusal to approve pending marketing applications or supplements, withdrawal of approval, warning letters, product recalls, product seizures, total or partial suspension of production or distribution, injunctions, fines, or administrative, civil and/or criminal investigation, penalties or prosecution. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Were Sesen Bio to resume development of Vicineum, the FDA would regulate Vicineum in the United States as a biologic. Biologics require the submission of a BLA and approval by the FDA prior to being marketed in the United States. Manufacturers of biologics may also be subject to state and local regulation. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The steps required before a biologic may be marketed in the United States generally include: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">completion of pre-clinical studies, animal studies and formulation studies, some in compliance with the FDA&#8217;s current Good Laboratory Practices, or GLP, regulations, and the Animal Welfare Act administered and enforced by the United States Department of Agriculture; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">submission to the FDA of an IND to support human clinical testing, which must become effective before human clinical trials may commence; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">approval by an IRB before each trial may be initiated at each clinical site; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">performance of adequate and well-controlled clinical trials under protocols submitted to the FDA and reviewed and approved by each IRB, conducted in accordance with federal regulations and current Good Clinical Practices, or GCP, to establish the safety, purity and potency of the biologic for each targeted indication; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">submission of a BLA to the FDA; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">satisfactory completion of an FDA Advisory Committee review, if applicable; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">satisfactory completion of an FDA inspection of the manufacturing facilities at which the biologic is produced to assess compliance with cGMP and to assure that the facilities, methods and controls are adequate; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">FDA review and approval of a BLA. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Pre-clinical Studies</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Pre-clinical studies include laboratory evaluation of product chemistry, formulation and toxicity, as well as animal studies to assess the characteristics and potential safety and efficacy of the product candidate. The conduct of the pre-clinical studies must comply with federal regulations and requirements, including, as applicable, GLP and the Animal Welfare Act. The results of the pre-clinical studies, together with </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">237</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">manufacturing information and analytical data, are submitted to the FDA as part of an IND. The FDA evaluates the IND to determine whether there is an adequate basis for starting the product candidate in initial clinical trials, and the IND must become effective before human clinical trials may be commenced. Additional pre-clinical studies may continue after the IND is submitted. A 30-day waiting period after the submission of each IND is required prior to the commencement of clinical testing in humans. If during this 30-day period the FDA does not raise any concerns or issues that must be addressed prior to the commencement of clinical trials or does not impose a clinical hold, the IND becomes effective 30&#160;days following the FDA&#8217;s receipt of the IND and the clinical trial proposed in the IND may begin. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Clinical Trials</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Clinical trials involve the administration of the product candidate to healthy volunteers or patients under the supervision of qualified investigators. Clinical trials are subject to extensive regulation and must be conducted in compliance with (i)&#160;federal regulations, (ii)&#160;GCP standards, which set safeguards to protect the rights and health of patients and establish standards for conducting, recording data from, and reporting results of clinical trials, and (iii)&#160;protocols detailing the objectives of the trial, the parameters to be used in monitoring safety, and the effectiveness criteria to be evaluated, if any. Non-U.S. studies conducted under an IND generally must meet the same requirements that apply to studies being conducted in the United States. The informed written consent of each study patient must be obtained before the patient may begin participation in the clinical trial. The study protocol, study plan, and informed consent forms for each clinical trial must be reviewed and approved by an IRB for each clinical site, and the study must be conducted under the auspices of an IRB for each trial site. Investigators and IRBs must also comply with FDA regulations and guidelines, including those regarding oversight of study patient informed consent, complying with the study protocol and investigational plan, adequately monitoring the clinical trial, and timely reporting of adverse events. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The clinical trial program for a product candidate is generally divided into three phases. Although the phases are usually conducted sequentially, they may overlap or be combined. The three phases are as follows: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Phase&#160;1.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Phase&#160;1 involves the initial introduction of a product candidate into humans. Phase&#160;1 clinical trials are typically conducted in healthy human subjects, but in some situations are conducted in patients with the target disease or condition. These clinical trials are generally designed to evaluate the safety, metabolism, pharmacokinetic, or PK, properties and pharmacologic actions of the product candidate in humans, the side effects associated with increasing doses and, if possible, to gain early evidence of effectiveness. During Phase&#160;1 clinical trials, sufficient information about the product candidate&#8217;s PK properties and pharmacological effects may be obtained to inform and support the design of Phase&#160;2 clinical trials. The total number of participants included in Phase&#160;1 clinical trials varies, but is generally in the range of 20 to 80; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Phase&#160;2.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Phase&#160;2 includes the controlled clinical trials conducted to obtain initial evidence of effectiveness of the product candidate for a particular indication(s) in patients with the target disease or condition, to determine dosage tolerance and optimal dosage, and to gather additional information on possible adverse side effects and safety risks associated with the product candidate. Phase&#160;2 clinical trials are typically well-controlled, closely monitored, and conducted in a limited patient population, usually involving no more than several hundred participants; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Phase&#160;3.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Phase&#160;3 clinical trials are clinical trials conducted in an expanded patient population at geographically dispersed clinical trial sites. They are performed after preliminary evidence suggesting effectiveness of the product candidate has been obtained and are intended to further evaluate dosage, clinical effectiveness and safety, to establish the overall benefit-risk relationship of the product candidate and to provide an adequate basis for regulatory approval. Phase&#160;3 clinical trials usually involve several hundred to several thousand participants. In most cases, the FDA requires two adequate and well controlled Phase&#160;3 clinical trials to demonstrate the efficacy of the product candidate, although a single Phase&#160;3 clinical trial with other confirmatory evidence may be sufficient in certain instances. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The decision to suspend or terminate development of a product candidate may be made by either a health authority body, such as the FDA, by an IRB, or by a company for various reasons and during any </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">238</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">phase of clinical trials. The FDA may order the temporary or permanent discontinuation of a clinical trial at any time or impose other sanctions if it believes that the clinical trial either is not being conducted in accordance with FDA requirements or presents an unacceptable risk to the clinical trial patients. In some cases, clinical trials are overseen by a data safety monitoring board, or DSMB, which is an independent group of qualified experts organized by the trial sponsor to evaluate at designated points in time whether or not a trial may move forward and/or should be modified. These decisions are based on unblinded access to data from the ongoing trial and generally involve determinations regarding the benefit-risk ratio for study patients and the scientific integrity and validity of the clinical trial. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In addition, there are requirements for the registration of certain clinical trials of product candidates on public registries, such as www.clinicaltrials.gov, and the submission of certain information pertaining to these trials, including clinical trial results, after trial completion. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Assuming successful completion of all required testing in accordance with all applicable regulatory requirements, a sponsor submits extensive information about the product candidate to the FDA in the form of a BLA to request marketing approval for the product candidate in specified indications. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Biologics License Applications</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In order to obtain approval to market a biologic in the United States, a marketing application must be submitted to the FDA that provides data establishing the safety and effectiveness of the product candidate for the proposed indication. The application includes all relevant data available from pertinent pre-clinical studies and clinical trials, including negative or ambiguous results as well as positive findings, together with detailed information relating to the product&#8217;s chemistry, manufacturing, controls and proposed labeling, among other things. Data can come from company-sponsored clinical trials intended to test the safety and effectiveness of a product candidate, or from a number of alternative sources, including studies initiated by investigators. To support marketing approval, the data submitted must be sufficient in quality and quantity to establish the safety and effectiveness of the product candidate to the satisfaction of the FDA. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Under the Prescription Drug User Fee Act, the fees payable to the FDA for reviewing an original BLA, as well as annual program fees for approved products, can be substantial, subject to certain limited deferrals, waivers and reductions that may be available. The FDA has 60&#160;days from receipt of a BLA to determine whether the application will be accepted for filing based on the agency&#8217;s threshold determination that it is sufficiently complete to permit substantive review. The FDA may refuse to accept for filing any BLA that it deems incomplete or not properly reviewable at the time of submission, in which case the BLA will have to be updated and resubmitted. The FDA&#8217;s PDUFA review goal is to review 90% of priority BLA applications within six&#160;months of filing and 90% of standard applications within 10&#160;months of filing, but the FDA can and frequently does extend this review timeline to consider certain later-submitted information or information intended to clarify or supplement information provided in the initial submission. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The FDA may not complete its review or approve a BLA within these established goal review times. The FDA reviews the BLA to determine, among other things, whether the proposed product is safe, pure, and potent for its intended use, and whether the product is being manufactured in compliance with cGMP. The FDA may also refer applications for novel product candidates which present difficult questions of safety or efficacy to an advisory committee, typically a panel that includes clinicians and other experts, for review, evaluation and a recommendation as to whether the application should be approved and under what conditions. The FDA is not bound by the recommendations of an advisory committee, but it considers such recommendations carefully when making decisions. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Before approving a BLA, the FDA will inspect the facilities at which the product candidate is manufactured or the facilities that are significantly involved in the product development and distribution process and will not approve the product candidate unless cGMP compliance is satisfactory. Additionally, before approving a BLA, the FDA will typically inspect one or more clinical sites to assure compliance with GCP. Under the Pediatric Research Equity Act, certain BLAs must include an assessment, generally based on clinical trial data, of the safety and effectiveness of the biological product in relevant pediatric populations. The FDA may waive or defer the requirement for a pediatric assessment, either at a company&#8217;s request or by its own initiative, including waivers for certain products not likely to be used in a substantial </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">239</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">number of pediatric patients. Products with orphan drug designation are exempt from these requirements for orphan-designated indications with no formal waiver process required. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">After the FDA evaluates the BLA and the manufacturing facilities, it issues either an approval letter or a CRL. A CRL generally outlines the deficiencies in the submission and may require substantial additional testing or information in order for the FDA to reconsider the application. On August&#160;13, 2021, Sesen Bio received a CRL from the FDA indicating that the FDA had determined that it could not approve the BLA for Vicineum in its present form and provided recommendations specific to additional clinical/statistical data and analyses in addition to CMC issues pertaining to a recent pre-approval inspection and product quality. If Sesen Bio were to resume development of Vicineum, it would be required to address these deficiencies to the FDA&#8217;s satisfaction in a resubmission of a BLA. The FDA&#8217;s PDUFA review goal is to review such resubmissions within two or six&#160;months of receipt, depending on the type of information included. Notwithstanding the submission of any requested additional information, the FDA ultimately may decide that the application does not satisfy the regulatory criteria for approval and deny approval of a resubmitted BLA. FDA approval of any application may include many delays or never be granted. An approval letter authorizes commercial marketing of the product candidate with specific prescribing information for specific indications. As a condition of BLA approval, the FDA may require a risk evaluation and mitigation strategy, or REMS, to help ensure that the benefits of the product outweigh the potential risks. REMS can include Medication Guides, communication plans for healthcare professionals, and also may include elements to assure safe use, or ETASU. ETASU can include, but are not limited to, special training or certification for prescribing or dispensing, dispensing only under certain circumstances, special monitoring, and the use of patient registries. The requirement for a REMS can materially affect the potential market and profitability of the biologic. Moreover, product approval may require substantial post-approval testing and surveillance to monitor the biologic&#8217;s safety, purity, or potency, which can be costly. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Changes to some of the conditions established in an approved application, including changes in indications, labeling, or manufacturing processes or facilities, require submission and FDA approval of a new BLA or a supplemental BLA before the change can be implemented. A supplemental BLA for a new indication typically requires clinical data similar to that in the original application, and the FDA generally uses the same procedures and actions in reviewing a supplemental BLA as it does in reviewing a new BLA. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Product approvals may be withdrawn if compliance with regulatory standards is not maintained or if safety or manufacturing problems occur following initial marketing. For example, quality control and manufacturing procedures must conform, on an ongoing basis, to cGMP requirements, and the FDA periodically inspects manufacturing facilities to assess compliance with cGMP. Accordingly, manufacturers must continue to spend time, money and effort to maintain cGMP compliance. In addition, new or modified government requirements, including from new legislation, may be established that could delay or prevent regulatory approval of Sesen Bio&#8217;s product candidates under development or affect its ability to maintain product approvals it has obtained. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Biosimilars and Market Exclusivity</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Under the Biologics Price Competition and Innovation Act of 2009, or BPCIA, the FDA can approve products that are biosimilar to (but not generic copies of) innovative biologics on the basis of less extensive data than is required by a full BLA. To be biosimilar, a biological product must be highly similar to an already-licensed FDA biological product, or reference product and can have no clinically meaningful differences in safety, purity and potency from the reference product. An interchangeable biosimilar product must meet additional standards for interchangeability and, if approved, may be substituted for the reference product. At this juncture, it is unclear whether any biosimilar product deemed &#8220;interchangeable&#8221; by the FDA, in fact, will be readily substituted by pharmacies, which are governed by state pharmacy law. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">After an innovator has marketed its product for four&#160;years, a manufacturer may file an application for approval of a &#8220;biosimilar&#8221; version of the innovator product. However, although an application for approval of a biosimilar may be filed four&#160;years after approval of the innovator product, qualified innovative biological products receive 12&#160;years of regulatory exclusivity, meaning that the FDA may not approve a biosimilar version until 12&#160;years after the innovative biological product was first approved by the FDA under the PHSA. The BPCIA also provides a mechanism for innovators to enforce the patents that protect </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">240</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">innovative biological products and for biosimilar applicants to challenge the patents. Such patent litigation may begin as early as four&#160;years after the innovative biological product is first approved by the FDA. Although the patents for the reference biologic may be challenged by the biosimilar applicant during that time period pursuant to the BPCIA statutory patent challenge framework, no biosimilar or interchangeable product will be licensed by the FDA until the end of the exclusivity period. The first biologic product candidate submitted under the abbreviated approval pathway that is determined to be interchangeable with the reference product has exclusivity against any other determinations of interchangeability to the reference product for the lesser of (i)&#160;one year after first commercial marketing of the interchangeable biosimilar product, (ii)&#160;18&#160;months after approval of the interchangeable biosimilar product if there is no legal challenge, (iii)&#160;18&#160;months after the resolution in the interchangeable biosimilar product applicant&#8217;s favor of a lawsuit challenging the reference product&#8217;s patents, and (iv)&#160;42&#160;months after approval of the interchangeable biosimilar product if a lawsuit is ongoing within the 42-month period. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The objectives of the BPCIA are conceptually similar to those of the Hatch-Waxman Act, which established abbreviated pathways for the approval of generic drugs. The FDA has published several guidance documents providing direction on developing and obtaining approval of biosimilar product candidates. The guidance documents to date explain, among other things, that the FDA will approve a biosimilar product if there are no clinically meaningful differences between the biological product and the reference product in terms of safety, purity and potency. A determination of biosimilarity may be based upon: (1)&#160;analytical studies showing that the biological product is highly similar to, with no clinically meaningful differences from, the reference product, (2)&#160;animal studies, including toxicity assessments, and/or (3)&#160;a clinical trial or trials (including assessment of immunogenicity and PKs) that are sufficient to demonstrate safety, purity and potency in one or more appropriate conditions of use for which the reference product is licensed and for which licensure is sought for the biological product. The FDA recommends that sponsors use a stepwise approach to developing the data and information needed to support biosimilarity. At each step, the sponsor should evaluate the extent of residual uncertainty of biosimilarity that remains and incorporate the FDA&#8217;s advice for additional studies to address remaining uncertainty. To meet the higher standard for interchangeability the sponsor must demonstrate, in addition to biosimilarity, that the proposed biological product can be expected to produce the same clinical result and, if administered more than once to any given patient, the safety risk and potential for diminished efficacy associated with switching between the proposed biological product and the reference product is not greater than continuing to use the reference product. A biological product that is determined to be interchangeable may be substituted for the reference product without the intervention of the prescribing healthcare provider. In March&#160;2015, the FDA approved the first biosimilar product under the BPCIA, and it has approved other biosimilar products since then. If Sesen Bio were to resume development of Vicineum and obtain approval by the FDA, the approval of a biosimilar to Vicineum could have a material impact on Sesen Bio. In particular, a biosimilar could be significantly less costly to bring to market and priced significantly lower than Vicineum, if approved by the FDA. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The &#8220;Purple Book,&#8221; first published by the FDA in September&#160;2014, lists biological products, including any biosimilar and interchangeable biological products licensed by the FDA under the PHSA. The lists include the date a biological product was licensed under Section&#160;351(a) of the PHSA and whether the FDA evaluated the biological product for reference product exclusivity under Section&#160;351(k)(7) of the PHSA. The Purple Book will also enable a user to see whether a biological product licensed under Section&#160;351(k) of the PHSA has been determined by the FDA to be biosimilar to or interchangeable with a reference biological product. Biosimilar and interchangeable biological products licensed under Section&#160;351(k) of the PHSA will be listed under the reference product to which biosimilarity or interchangeability was demonstrated. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Advertising and Promotion</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The FDA and other federal regulatory agencies closely regulate the marketing and promotion of biologics through standards and regulations for, among other things, direct-to-consumer advertising, communications regarding unapproved uses, industry-sponsored scientific and educational activities, and promotional activities involving the internet. A biologic cannot be promoted before it is approved. After approval, promotion of a biologic can include only those claims relating to safety and effectiveness that are consistent with the labeling approved by the FDA. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">241</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Healthcare providers are permitted, however, to prescribe products for unapproved uses (also known as &#8220;off-label&#8221; uses)&#8201;&#8212;&#8201;that is, uses not approved by the FDA and therefore not described in the product&#8217;s labeling&#8201;&#8212;&#8201;because the FDA does not regulate the practice of medicine. However, the FDA restricts manufacturers&#8217; communications regarding unapproved uses. Broadly speaking, a manufacturer may not promote a product for an unapproved use, but may engage in non-promotional, balanced communication regarding unapproved uses under specified conditions. Failure to comply with applicable FDA requirements and restrictions in this area may subject a company to adverse publicity and enforcement action by the FDA, the United States Department of Justice, or DOJ, or the Office of Inspector General of the United States Department of Health and Human Services, or HHS, as well as state authorities. Such enforcement action could subject a company to a range of penalties that could have a significant commercial impact, including civil and criminal fines and agreements that materially restrict the manner in which a company promotes or distributes products. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Post-approval Regulation</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">After regulatory approval of a product is obtained, a company is required to comply with a number of post-approval requirements. For example, as a condition of BLA approval, the FDA may require post-marketing testing, including Phase&#160;4 clinical trials, and surveillance to further assess and monitor the product&#8217;s safety and effectiveness after commercialization. Regulatory approval of oncology products often requires that patients in clinical trials be followed for long periods to determine the overall survival benefit of the product. In addition, as a holder of an approved BLA, a company would be required to report adverse reactions and production problems to the FDA, to provide updated safety and efficacy information, and to comply with requirements concerning advertising and promotional labeling for any of its products. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The manufacturing of Sesen Bio&#8217;s product candidates is required to comply with applicable FDA manufacturing requirements contained in the FDA&#8217;s cGMP regulations. Biologic manufacturers and other entities involved in the manufacture and distribution of approved biologics are also required to register their establishments and list any products they make with the FDA and to comply with related requirements in certain states. The FDA and certain state agencies periodically inspect manufacturing facilities to assess compliance with cGMP and other laws. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Discovery of problems with a product after approval may result in serious and extensive restrictions on a product or the manufacturer or holder of an approved BLA, as well as lead to potential market disruptions. These restrictions may include suspension of product manufacturing until the FDA is assured that quality standards can be met, continuing oversight of manufacturing by the FDA under a &#8220;consent decree,&#8221; which frequently includes the imposition of costs and continuing inspections over a period of many&#160;years, as well as possible withdrawal of the product from the market. Other potential consequences include interruption of production, issuance of warning letters or other enforcement letters, refusal to approve pending BLAs or supplements to approved BLAs, product seizure or detention, and injunctions or imposition of civil and/or criminal penalties. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, changes to the manufacturing process are strictly regulated, and, depending on the significance of the change, may require prior FDA approval before being implemented. FDA regulations also require investigation, correction, and reporting of any deviations from cGMP and impose reporting and documentation requirements upon a company and any third-party manufacturers that a company may decide to use. Accordingly, manufacturers must continue to expend time, money and effort in the area of production and quality control to maintain compliance with cGMP and other aspects of regulatory compliance. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Newly discovered or developed safety or effectiveness data may require changes to a product&#8217;s approved labeling, including the addition of new warnings and contraindications, and also may require the implementation of other risk management measures, such as additional post-market clinical trials to assess new safety risks or distribution-related or other restrictions under a REMS. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Patent Term Extension</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Were Sesen Bio to resume development of Vicineum, depending upon the timing, duration and specifics of the FDA approval, some of its U.S. patents may be eligible for limited patent term extension. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">242</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The provisions of the Hatch-Waxman Act permit a patent term extension of up to five&#160;years as compensation for patent term lost during product development and the FDA regulatory review process. However, patent term restoration cannot extend the remaining term of a patent beyond a total of 14&#160;years from the product&#8217;s approval date. The patent term restoration period is generally one-half the time between the effective date of an IND and the submission date of a BLA plus the time between the submission date of a BLA and the approval of that application. Only one patent applicable to an approved product is eligible for the extension and the application for the extension must be submitted prior to the expiration of the patent. The USPTO, in consultation with the FDA, reviews and approves the application for any patent term extension or restoration. In the future, were Sesen Bio to resume development of Vicineum, Sesen Bio may apply for patent term extension for one of its currently owned or licensed patents to add patent life beyond its current expiration date, depending on the expected length of the clinical trials and other factors involved in the filing of the relevant BLA. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Many other countries also provide for patent term extensions or similar extensions of patent protection for biologic products. For example, in Japan, it may be possible to extend the patent term for up to five&#160;years and in Europe, it may be possible to obtain a supplementary patent certificate that would effectively extend patent protection for up to five&#160;years. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">The Foreign Corrupt Practices Act</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The FCPA prohibits any United States individual or business from paying, offering, or authorizing payment or offering of anything of value, directly or indirectly, to any non-U.S. official, political party or candidate for the purpose of influencing any act or decision of the non-U.S. entity in order to assist the individual or business in obtaining or retaining business. The FCPA also obligates companies whose securities are listed in the United States to comply with accounting provisions requiring such companies to maintain books and records that accurately and fairly reflect all transactions of the corporation, including international subsidiaries, and to devise and maintain an adequate system of internal accounting controls for international operations. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">European Union and other International Government Regulation</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition to regulations in the United States, Sesen Bio will be subject to a variety of regulations in other jurisdictions governing, among other things, clinical trials and any commercial sales and distribution of its product candidates. Whether or not Sesen Bio obtains FDA approval for a product candidate, it must obtain the requisite approvals from regulatory authorities in countries outside of the United States prior to the commencement of clinical trials or marketing of a product in those countries should Sesen Bio resume development of Vicineum. Some countries outside of the United States have a similar process that requires the submission of a CTA much like the IND prior to the commencement of human clinical trials. In the E.U., for example, a CTA must be submitted to the competent authorities of the E.U. Member States where the clinical trial is conducted and to an independent ethics committee, much like the FDA and IRB, respectively. Once the CTA is approved in accordance with a country&#8217;s requirements, clinical trial development may proceed. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Marketing Authorization Application for Biologic Medicinal Products</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Should Sesen Bio resume development of Vicineum and seek regulatory approval under E.U. regulatory systems, it must submit a marketing authorization application. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In the E.U., a marketing authorization for a medicinal product can be obtained through a centralized, mutual recognition, decentralized procedure, or national procedure (single country). The centralized procedure is mandatory for certain medicinal products, including orphan medicinal products and certain biologic products and optional for certain other products, including medicinal products that are a significant therapeutic, scientific or technical innovation, or whose authorization would be in the interest of public or animal health. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In accordance with the centralized procedure, the applicant can submit a single application for marketing authorization to the EMA which will provide a positive opinion regarding the application if it meets certain quality, safety, and efficacy requirements. Based on the opinion of the EMA, the European </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">243</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Commission takes a final decision to grant a centralized marketing authorization which permits the marketing of a product in all 27 E.U. Member States and three of the four European Free Trade Association States&#8201;&#8212;&#8201;Iceland, Liechtenstein and Norway. Under the centralized procedure in the E.U., the maximum timeframe for the evaluation of a marketing authorization application is 210&#160;days (excluding clock stops, when additional written or oral information is to be provided by the applicant in response to questions asked by the EMA CHMP. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">For other countries outside of the E.U., such as the United Kingdom and countries in Eastern Europe, Latin America or Asia, the requirements governing the conduct of clinical trials, product licensing, pricing and reimbursement vary from country to country. Internationally, clinical trials are generally required to be conducted in accordance with GCPs, applicable regulatory requirements of each jurisdiction and the medical ethics principles that have their origin in the Declaration of Helsinki. If Sesen Bio fails to comply with applicable non-U.S. regulatory requirements, it may be subject to, among other things, fines, suspension or withdrawal of regulatory approvals, product recalls, seizure of products, operating restrictions and criminal prosecution. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Advertising, Promotion and Compliance</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In the E.U., the advertising and promotion of Sesen Bio&#8217;s products will also be subject to E.U. laws and E.U. Member States&#8217; national laws governing promotion of medicinal products, interactions with physicians, misleading and comparative advertising and unfair commercial practices. Other E.U. Member State national legislation may also apply to the advertising and promotion of medicinal products. These laws require that promotional materials and advertising in relation to medicinal products comply with the product&#8217;s Summary of Product Characteristics, or SmPC, as approved by the competent authorities. The SmPC is the document that provides information to physicians concerning the safe and effective use of the medicinal product. The SmPC forms an intrinsic and integral part of the marketing authorization granted for the medicinal product. Promotion of a medicinal product that does not comply with the SmPC is considered to constitute off-label promotion and is prohibited in the E.U. The applicable laws at the E.U. level and in the individual E.U. Member States also prohibit the direct-to-consumer advertising of prescription-only medicinal products. Violations of the rules governing the promotion of medicinal products in the E.U. could be penalized by administrative measures, fines and imprisonment. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">During all phases of development (pre- and post-marketing), failure to comply with applicable regulatory requirements may result in administrative or judicial sanctions. These penalties could include the imposition of a clinical hold on trials, refusal to approve pending applications, withdrawal of an approval, warning letters, product recalls, product seizures, total or partial suspension of production or distribution, product detention or refusal to permit the import or export of products, injunctions, fines, civil penalties or criminal prosecution. Any agency or judicial enforcement action could have a material adverse effect on Sesen Bio. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Orphan Drug Designation</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The FDA may grant Orphan Drug Designation to biologics intended to treat a rare disease or condition that affects fewer than 200,000 individuals in the United States or a disease or condition that affects more than 200,000 individuals in the United States but there is no reasonable expectation that the cost of developing and making the biologic would be recovered from sales in the United States. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In the United States, Orphan Drug Designation entitles a party to financial incentives, such as opportunities for grant funding towards clinical trial costs, tax credits for certain research and user fee waivers under certain circumstances. In addition, if a product receives the first FDA approval for the indication for which it has orphan designation, the product is entitled to seven&#160;years of market exclusivity, which means the FDA may not approve any other application for a biologic for the same indication for a period of seven&#160;years, except in limited circumstances, such as a showing of clinical superiority over the product with orphan exclusivity. The FDA can revoke a product&#8217;s orphan drug exclusivity under certain circumstances, including when the product sponsor is unable to assure the availability of sufficient quantities of the product to meet patient needs. Orphan drug exclusivity does not prevent the FDA from approving a different drug for the same disease or condition, or the same biologic for a different disease or condition. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">244</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In the E.U., medicinal products: (a)&#160;that are used to diagnose, treat or prevent life-threatening or chronically debilitating conditions that affect no more than five in 10,000 people in the E.U.; or (b)&#160;that are used to treat or prevent life-threatening, seriously debilitating or serious and chronic conditions and that, for economic reasons, would be unlikely to be developed without incentives; and (c)&#160;where no satisfactory method of diagnosis, prevention or treatment of the condition concerned exists, or, if such a method exists, the medicinal product would be of significant benefit to those affected by the condition, may be granted an orphan designation in the E.U. The application for orphan designation must be submitted to the EMA and approved by the European Commission before an application is made for marketing authorization for the product. Once designated, Orphan medicinal product designation also entitles a party to financial incentives such as reduction of fees or fee waivers. Moreover, ten&#160;years of market exclusivity is granted following marketing authorization, if the product continues to be designated as an orphan medicinal product upon grant of the marketing authorization. During this ten-year period, with a limited number of exceptions, neither the competent authorities of the E.U. Member States, the EMA, or the European Commission are permitted to accept applications or grant marketing authorization for other similar medicinal products with the same therapeutic indication. However, marketing authorization may be granted to a similar medicinal product with the same orphan indication during the ten-year period with the consent of the marketing authorization holder for the original orphan medicinal product or if the manufacturer of the original orphan medicinal product is unable to supply sufficient quantities. Marketing authorization may also be granted to a similar medicinal product with the same orphan indication if this latter product is demonstrated to be safer, more effective or otherwise clinically superior to the original orphan medicinal product. This period of market exclusivity may be reduced to six&#160;years, at the end of the fifth year, if the orphan designation criteria are no longer met, including where it can be demonstrated on the basis of available evidence that the product is sufficiently profitable not to justify maintenance of market exclusivity. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Orphan drug designation must be requested before submission of an application for marketing approval or marketing authorization. Orphan drug designation does not convey any advantage in, nor shorten the duration of the regulatory review and approval process. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Expedited Programs in the United States and Other Jurisdictions</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In the United States, a product may be granted Fast Track designation if it is intended for the treatment of a serious or life-threatening condition and demonstrates the potential to address unmet medical needs for such condition. With Fast Track designation, the sponsor may be eligible for more frequent opportunities to obtain the FDA&#8217;s feedback, and the FDA may initiate review of sections of a BLA before the application is complete. This Rolling Review is available if the applicant provides, and the FDA approves, a schedule for the remaining information. Even if a product receives Fast Track designation, the designation can be rescinded and provides no assurance that a product will be reviewed or approved more expeditiously than would otherwise have been the case, or that the product will be approved at all. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">FDA may designate a product candidate as a breakthrough therapy if it finds that the product candidate is intended, alone or in combination with one or more other product candidates or approved products, to treat a serious or life-threatening disease or condition, and preliminary clinical evidence indicates that the product candidate may demonstrate substantial improvement over existing therapies on one or more clinically significant endpoints. For product candidates designated as breakthrough therapies, more frequent interaction and communication between the FDA and the sponsor can help to identify the most efficient path for clinical development. Product candidates designated as breakthrough therapies by the FDA may also be eligible for Priority Review. The receipt of a breakthrough therapy designation for a product candidate may not result in a faster development process, review or approval compared to product candidates considered for approval under conventional FDA procedures and, in any event, does not assure ultimate approval by the FDA. In addition, even if a product candidate qualifies as a breakthrough therapy, the FDA may later decide that the product candidate no longer meets the conditions for designation. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Accelerated approval under FDA regulations allows a product designed to treat a serious or life-threatening disease or condition that provides a meaningful therapeutic advantage over available therapies to be approved on the basis of either an intermediate clinical endpoint or a surrogate endpoint that is reasonably likely to predict clinical benefit. Approvals of this kind typically include requirements for </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">245</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tEMP">&#8203;</a><a name="tCOIN">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">confirmatory clinical trials to be conducted with due diligence to validate the surrogate endpoint or otherwise confirm clinical benefit and for all promotional materials to be submitted to the FDA for review prior to dissemination. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The FDA may grant Priority Review designation to a product candidate, which sets the target date for FDA action on the application at six&#160;months from FDA filing, or eight&#160;months from the sponsor&#8217;s submission. Priority Review may be granted where a product is intended to treat a serious or life-threatening disease or condition and, if approved, has the potential to provide a safe and effective therapy where no satisfactory alternative therapy exists or a significant improvement in safety or efficacy compared to available therapy. If criteria are not met for Priority Review, the standard FDA review period is ten&#160;months from FDA filing or 12&#160;months from sponsor submission. Priority Review designation does not change the scientific/medical standard for approval or the quality of evidence necessary to support approval. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Under the Centralized Procedure in the E.U., the maximum timeframe for the evaluation of a marketing authorization application is 210&#160;days (excluding &#8220;clock stops,&#8221; when additional written or oral information is to be provided by the applicant in response to questions asked by the CHMP. Accelerated evaluation might be granted by CHMP in exceptional cases, when a medicinal product is expected to be of a major public health interest, which should be justified and assessed on a case-by-case basis. In this circumstance, EMA ensures that the opinion of CHMP is given within 150&#160;days. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Environmental and Safety Laws</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio is subject to a variety of federal, provincial and local regulations relating to the use, handling, storage and disposal of hazardous materials, including chemicals and radioactive and biological materials. Sesen Bio&#8217;s operations involve such hazardous materials and produce such hazardous waste products. Although Sesen Bio believes that its safety procedures for handling and disposing of these materials comply with the standards prescribed by federal, provincial and local regulations, the risk of accidental contamination or injury from these materials cannot be eliminated. Radioactive materials in Canada come under federal jurisdiction. Canada&#8217;s Nuclear Safety and Control Act 1997 c.9 contains a general prohibition against any activity, including possession of radioactive material, except in accordance with the terms and conditions set out in a federal license issued by the Canadian Nuclear Safety Commission. The Nuclear Substances and Radiation Devices Regulation does however, exempt licensing requirements for small quantities of radioactive substances that either meet concentrations set out in a schedule to the Regulation or, for radioactive substances not set out in the schedule, that meet certain regulatory criteria. Sesen Bio&#8217;s operations do not currently require a federal license issued by the Canadian Nuclear Safety Commission. Sesen Bio&#8217;s operations in Canada may be subject to license approvals, notification requirements and investigation and enforcement for air and water and waste matters. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Employees</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">As of January 4, 2023, Sesen Bio employed 17 individuals, all of whom are full-time employees. Sesen Bio has never had a work stoppage, and none of its employees are represented by a labor organization or covered by collective bargaining arrangements. Sesen Bio considers its relationship with its employees to be good. </font>
          </div>

        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Corporate Information</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio is a Delaware corporation formed in February&#160;2008. Sesen Bio&#8217;s principal executive offices are located in Cambridge, Massachusetts. Sesen Bio&#8217;s website address is www.sesenbio.com. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Acquisition of Viventia</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In September&#160;2016, Sesen Bio entered into a Share Purchase Agreement with Viventia Bio, Inc., a corporation incorporated under the laws of the Province of Ontario, Canada, the shareholders of Viventia named therein, collectively, the selling shareholders, and, solely in its capacity as seller representative, Clairmark Investments Ltd., a corporation incorporated under the laws of the Province of Ontario, Canada, or Clairmark, pursuant to which Sesen Bio agreed to and simultaneously completed the acquisition of all of the outstanding capital stock of Viventia from the Selling Shareholders, or the Viventia Acquisition. In </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">246</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tLEPR">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">connection with the closing of the Viventia Acquisition, Sesen Bio issued 4.0&#160;million shares of Sesen Bio common stock to the selling shareholders according to their pro&#160;rata share of Viventia&#8217;s then-outstanding shares of common stock, which represented approximately 19.9% of Sesen Bio voting power as of immediately prior to the issuance of such shares of common stock. Clairmark is an affiliate of Leslie L. Dan, who served on the Sesen Bio board of directors until his retirement in July&#160;2019. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In connection with the Viventia Acquisition, Sesen Bio is obligated to pay to the selling shareholders certain post-closing contingent cash payments upon the achievement of specified milestones and based upon net sales, in each case subject to the terms and conditions set forth in the Share Purchase Agreement, including: (i)&#160;a one-time milestone payment of $12.5&#160;million payable upon the first sale of Vicineum, in the United States; (ii)&#160;a one-time milestone payment of $7.0&#160;million payable upon the first sale of Vicineum in any one of certain specified European countries; (iii)&#160;a one-time milestone payment of $3.0&#160;million payable upon the first sale of Vicineum in Japan; and (iv)&#160;and quarterly earn-out payments equal to 2% of net sales of Vicineum during specified earn-out periods. Such earn-out payments are payable with respect to net sales in a country beginning on the date of the first sale in such country and ending on the earlier of (i)&#160;December&#160;31, 2033, and (ii)&#160;fifteen&#160;years after the date of such sale, subject to early termination in certain circumstances if a biosimilar product is on the market in the applicable country. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Under the Share Purchase Agreement, Sesen Bio, its affiliates, licensees and subcontractors are required to use commercially reasonable efforts, for the first seven&#160;years following the closing of the Viventia Acquisition, to achieve marketing authorizations throughout the world and, during the applicable earn-out period, to commercialize Vicineum in the United States, France, Germany, Italy, Spain, United Kingdom, Japan, China and Canada. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Additional Information</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio makes available free of charge annual reports on Form 10-K, quarterly reports on Form&#160;10-Q, current reports on Form 8-K and amendments to those reports, as soon as reasonably practicable after they are electronically filed or furnished to the SEC, on Sesen Bio&#8217;s website at www.sesenbio.com or by contacting Sesen Bio at (617) 444-8850. The SEC maintains an internet site that contains reports, proxy and information statements and other information regarding issuers that file electronically with the SEC at www.sec.gov. The inclusion of any website address in this proxy statement/prospectus is an inactive textual reference only, and information contained on or accessible through these websites is not a part of this proxy statement/prospectus. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Description of Property</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio&#8217;s corporate headquarters are currently located in Cambridge, Massachusetts and consists of approximately 150 square feet, where Sesen Bio occupies office space under a lease that was executed in October&#160;2016. The initial term of the lease expired in July&#160;2017, with the lease now continuing on a month-to-month basis unless terminated by either party with the requisite notice. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio also has office space in Philadelphia, Pennsylvania, where Sesen Bio occupies office space under a lease executed in December&#160;2017. The initial term of the lease expired in May&#160;2018, which now continues on a month-to-month basis unless terminated by either party with the requisite notice. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Legal Proceedings</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On August&#160;19, 2021, August&#160;31, 2021, and October&#160;7,2021, three substantially identical securities class action lawsuits captioned </font><font style="font-style:italic;letter-spacing:0.2pt;">Bibb v. Sesen Bio, Inc., et. al.</font><font style="letter-spacing:0.2pt;">, Case No. 1:21-cv-07025, </font><font style="font-style:italic;letter-spacing:0.2pt;">Cizek v. Sesen Bio, Inc., et.&#160;al.</font><font style="letter-spacing:0.2pt;">, Case No. 1:21-cv-07309 and </font><font style="font-style:italic;letter-spacing:0.2pt;">Markman v. Sesen Bio, Inc. et al.</font><font style="letter-spacing:0.2pt;">, Case No. 1:21-cv-08308 were filed against Sesen Bio and certain of its officers in the U.S. District Court for the Southern District of New York. The three complaints alleged violations of Sections&#160;10(b) and 20(a) of the Exchange Act and Rule&#160;10b-5 promulgated thereunder based on statements made by Sesen Bio concerning its BLA for Vicineum for the treatment of BCG-unresponsive NMIBC. The three complaints sought compensatory damages and costs and expenses, including attorneys&#8217; fees. On October&#160;29, 2021, the court consolidated the three cases under the caption </font><font style="font-style:italic;letter-spacing:0.2pt;">In re Sesen Bio, Inc. Securities Litigation</font><font style="letter-spacing:0.2pt;">, Master File No. 1:21-cv-07025-AKH, and appointed Ryan Bibb, Rodney Samaan, Lionel Dreshaj and Benjamin Dreshaj as the Lead Plaintiffs under the Private </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">247</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:128pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Securities Litigation Reform Act. On November&#160;1, 2021, two stockholders filed motions to reconsider asking the court to appoint a different lead plaintiff. On November&#160;24, 2021, defendants filed a motion to transfer venue to the U.S. District Court for the District of Massachusetts. That motion was fully briefed as of December&#160;13, 2021, but the court has not ruled on that motion. On December&#160;6, 2021, the Lead Plaintiffs filed the Amended Complaint. The Amended Complaint alleges the same violations of Sections&#160;10(b) and 20(a) of the Exchange Act and Rule&#160;10b-5 promulgated thereunder on the same theory as the prior complaints. The defendants moved to dismiss the Amended Complaint on March&#160;7, 2022, and that motion was fully briefed on May&#160;6, 2022. On June&#160;3, 2022, before the court ruled on the motion to dismiss, the parties requested that the court hold any decision on the motion to dismiss in abeyance to provide the parties with an opportunity to engage in mediation. On June&#160;30, 2022 and July&#160;6, 2022, Sesen Bio and the plaintiffs engaged in mediation sessions in an attempt to resolve the Securities Litigation and continued to discuss a potential settlement over the following weeks. On July&#160;19, 2022, the parties reached an agreement in principle to settle the Securities Litigation. Pursuant to that agreement, Sesen Bio and the individual defendants will pay or cause to be paid to members of the class who submit timely and valid proofs of claims. In exchange, the Lead Plaintiffs will dismiss the action and all class members who do not timely and validly opt-out of the settlement will provide broad customary releases to Sesen Bio and the individual defendants. On August&#160;3, 2022, the parties entered into a Stipulation and Agreement of Settlement to settle the Securities Litigation, which was filed with the court on August&#160;17, 2022. The Stipulation and Agreement of Settlement related to the Securities Litigation provides for a settlement payment of $21.0&#160;million to the class and the dismissal of all claims against Sesen Bio and the other defendants. The settlement payment is being funded by Sesen Bio and its insurance carriers. On September&#160;1, 2022, the U.S. District Court for the Southern District of New York issued an order denying the motions to appoint a different lead plaintiff. On September&#160;28, 2022, the court issued an order granting preliminary approval of the proposed settlement of the Securities Litigation. The court has set a final settlement approval hearing for January&#160;23, 2023 at 10:00&#160;a.m. Eastern Time. </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">On November 28, 2022, a purported Sesen Bio stockholder filed a complaint in the U.S. District Court for the Southern District of New York against Sesen Bio and the Sesen Bio board of directors, captioned </font><font style="font-style:italic;letter-spacing:0.2pt;">Keller v. Sesen Bio, Inc., et al.</font><font style="letter-spacing:0.2pt;">, Case No. 1:22-cv-10085 (S.D.N.Y.). The Original Keller Complaint asserts claims against Sesen Bio and the Sesen Bio board of directors under Section 14(a) of the Exchange Act and Rule&#160;14a-9 promulgated thereunder for allegedly false and misleading statements in this proxy statement/</font>&#8203;<font style="letter-spacing:0.2pt;">prospectus and under Section 20(a) of the Exchange Act for alleged &#8220;control person&#8221; liability with respect to such allegedly false and misleading statements and seeks, among other relief, an order enjoining the merger and an award for plaintiffs&#8217; fees and costs. On December 20, 2022, the purported stockholder voluntarily dismissed his complaint and on December&#160;21, 2022, filed a new complaint as a putative class action in the Court of Chancery for the State of Delaware, captioned </font><font style="font-style:italic;letter-spacing:0.2pt;">Keller v. Sesen Bio, Inc., et al.</font><font style="letter-spacing:0.2pt;">, Case No. 2022-1186 (Del. Ch. Dec. 21, 2022). Along with the complaint, the purported stockholder filed motions for expedited proceedings and for a preliminary injunction to enjoin the Sesen Bio special meeting. The New Keller Complaint and associated filings contain substantially the same assertions as the Original Keller Complaint and the Demand Letters. Sesen Bio believes that the claims asserted in the Demand Letters, the Section&#160;220 Demand and the New Keller Complaint are without merit. At this time, no assessment can be made as to the likely outcome or whether the outcome will be material to Sesen Bio.</font></div>

      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">248</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tCABU">&#8203;</a><a name="tOVE1">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CARISMA BUSINESS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Overview</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma is a clinical stage cell therapy company focused on utilizing Carisma&#8217;s proprietary macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. Carisma has created a comprehensive cell therapy platform to enable the therapeutic use of engineered macrophages and monocytes, which belong to a subgroup of white blood cells called myeloid cells. Macrophages and monocytes are part of the innate immune system and can detect and degrade harmful substances through a process referred to as phagocytosis, in which the harmful substance is engulfed and destroyed and in turn leads to the activation of a broad immune response. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">To harness the powerful immunologic functions of macrophages against cancer, Carisma has developed a proprietary Chimeric Antigen Receptor Macrophage, or CAR-M, platform technology. Chimeric antigen receptors, or CARs, are synthetically engineered receptors that are designed to bestow immune cells with the ability to target specific antigens on the surface of cancer cells. By introducing CARs into macrophage and monocyte cells, Carisma aims to redirect their potent innate immune functions against cancer. Carisma&#8217;s CAR-M platform technology incorporates proprietary tumor targeting constructs, vectors to deliver CARs to macrophages and monocytes and novel manufacturing processes. Carisma&#8217;s CAR-M therapeutics are designed to infiltrate the solid tumor microenvironment, kill cancer cells via targeted phagocytosis, and activate other immune cells, such as T-cells, to initiate a robust anti-tumor immune response. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma&#8217;s lead product candidate CT-0508, the first CAR-M to be evaluated in a human clinical trial, is an </font><font style="font-style:italic;letter-spacing:0.2pt;">ex vivo</font><font style="letter-spacing:0.2pt;"> autologous cell therapy product candidate, wherein immune cells from blood drawn from a patient are engineered outside of the body and reinfused into the same patient. CT-0508 is intended to treat solid tumors that overexpress HER2, a protein that is overexpressed on the surface of a variety of solid tumors, including breast cancer, gastric cancer, esophageal cancer, salivary gland cancer, and numerous others. Carisma has completed enrollment of the first group of patients in a Phase&#160;1 clinical trial of CT-0508, with nine patients having been successfully dosed. In November 2022, Carisma presented preliminary clinical results from the first group of patients. CT-0508 was successfully manufactured using macrophages obtained from heavily pre-treated, advanced solid tumor patients and has shown high CAR expression, viability, and purity. In addition, CT-0508 has been generally well-tolerated after infusion with no dose-limiting toxicities reported to date from the nine patients enrolled in the first group. While the results from this early clinical trial data are both preliminary and limited, Carisma believes the results indicate that CT-0508 can be detected within the tumor microenvironment, or TME, lead to remodeling and activation of the TME, and potentially induce anti-tumor adaptive immunity. Carisma anticipates providing multiple clinical data updates over the next 18&#160;months. In the combination setting, Carisma has observed the synergistic potential of CT-0508 with a PD1 blocking T-cell checkpoint inhibitor in pre-clinical models, enabling a combination trial with pembrolizumab. Carisma submitted a clinical protocol amendment to the FDA in September&#160;2022 to allow Carisma to treat patients with the co-administration of CT-0508 and pembrolizumab. The FDA has granted &#8220;Fast Track&#8221; status to CT-0508 for the treatment of patients with HER2 overexpressing solid tumors and Carisma plans to prioritize development for this indication. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Beyond CT-0508, Carisma has a broad pipeline of cell therapy assets in various stages of pre-clinical development. In addition to the development of </font><font style="font-style:italic;letter-spacing:0.2pt;">ex vivo</font><font style="letter-spacing:0.2pt;"> CAR-M cell therapies, Carisma is also developing </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;"> CAR-M gene therapies, wherein immune cells are directly engineered within the patient&#8217;s body. To advance its </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;"> CAR-M therapeutics, Carisma established a strategic collaboration with ModernaTX, Inc., or Moderna, focused on the development and potential commercialization of up to 12 product candidates, of which four have already been nominated. In collaboration with Moderna, Carisma has established an approach that uses Moderna&#8217;s myeloid cell specific lipid nanoparticle/mRNA, or LNP/mRNA, technology, together with Carisma&#8217;s CAR-M platform technology, to create novel </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;"> oncology gene therapies. Carisma believes this approach has the potential to enable a series of off-the-shelf product candidates to target a patient&#8217;s own myeloid cells against cancer cells directly within their body. As part of the agreement with Moderna, Carisma received a $45.0&#160;million up-front cash payment and an investment by Moderna in the form of a $35.0&#160;million convertible note, in addition to future research funding and the opportunity for milestone payments and royalties. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">249</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:125.43pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Through its robust internal discovery engine, Carisma is building upon its platform to enhance and expand the utility of macrophage cell and gene therapies, leading to the creation of multiple product candidates with the potential to treat cancer and other serious diseases. By replacing the targeting domain of the CAR, Carisma can reprogram the target antigen specificity of the CAR-M cell product and develop candidates against a range of cancer indications and therapeutic areas beyond oncology. As a result, Carisma believes the flexibility of its macrophage and monocyte cell engineering platform will allow Carisma to generate new product candidates suitable for clinical development in a cost-efficient manner to expand its pipeline. In addition to acting as a first line of defense in the innate immune system, macrophages are found in all tissues in the body where they serve key regulatory functions such as wound healing, termination of immune responses, and tissue regeneration. Using its macrophage and monocyte </font><font style="font-style:italic;letter-spacing:0.2pt;">ex vivo</font><font style="letter-spacing:0.2pt;"> and </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;"> engineering platform, Carisma is pursuing early research and development of multiple assets for the potential treatment of diseases beyond oncology, including liver fibrosis, neurodegeneration, and other immunologic and inflammatory diseases. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">By investing in early platform research and accessing key enabling technologies, Carisma is enhancing and expanding its platform capabilities and reinforcing its leadership position in the engineered macrophage field. Carisma has developed proprietary CAR-M platform enhancements directed toward key product parameters that are important for efficacy, safety, and patient access to its CAR-M therapies. Carisma plans to apply these technology enhancements to future CAR-M product candidates. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Carisma&#8217;s Pipeline Programs</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Using its proprietary CAR-M platform technology, Carisma is developing a broad pipeline of product candidates, with a strong initial focus in oncology. Carisma&#8217;s </font><font style="font-style:italic;letter-spacing:0.2pt;">ex vivo</font><font style="letter-spacing:0.2pt;"> autologous CAR-M product candidates are summarized in the table below. </font>
        </div>
        <div style="position:relative;margin-top:11.19pt; text-align:center; width:456pt;">
          <img src="tm2227887d8-tbl_pipelin4c.jpg" alt="[MISSING IMAGE: tm2227887d8-tbl_pipelin4c.jpg]" height="244" width="578" >
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">250</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma is also advancing discovery-stage candidates across a range of therapeutic areas, as summarized in the following table. </font>
        </div>
        <div style="position:relative;margin-top:9.8pt; text-align:center; width:456pt;">
          <img src="tm2227887d8-tbl_oncolog4c.jpg" alt="[MISSING IMAGE: tm2227887d8-tbl_oncolog4c.jpg]" height="347" width="578" >
        </div>
        <div style="text-indent:20pt; margin-top:12.6pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma&#8217;s lead product candidate, CT-0508, is an </font><font style="font-style:italic;letter-spacing:0.2pt;">ex vivo</font><font style="letter-spacing:0.2pt;"> autologous cell therapy product candidate intended to treat solid tumors that overexpress HER2, a protein that is overexpressed on the surface of a variety of solid tumors including breast cancer, gastric cancer, esophageal cancer, salivary gland cancer and numerous others. CT-0508 is produced by engineering a patient&#8217;s own monocyte-derived macrophages from blood drawn from the patient with a chimeric adenoviral vector, Ad5f35, containing an anti-HER2 CAR. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma has completed enrollment of the first group of patients in a Phase&#160;1 clinical trial, with nine patients successfully dosed. The second group is currently open for enrollment, with nine additional patients to be dosed. In November 2022, Carisma presented preliminary clinical results from the first group of patients. CT-0508 was successfully manufactured using macrophages obtained from heavily pre-treated, advanced solid tumor patients and has shown high CAR expression, viability, and purity. In addition, CT-0508 has been generally well-tolerated after infusion with no dose-limiting toxicities reported to date from the nine patients enrolled in the first group. While the results from this early clinical trial data are both preliminary and limited, Carisma believes the results indicate that CT-0508 can be detected within the TME, lead to remodeling and activation of the TME, and potentially induce anti-tumor adaptive immunity. Carisma anticipates providing multiple clinical data updates over the next 18&#160;months. In the combination setting, Carisma has observed the synergistic potential of CT-0508 with a PD1 blocking T-cell checkpoint inhibitor in pre-clinical models, enabling a combination trial with pembrolizumab. Carisma submitted a clinical protocol amendment to the FDA in September&#160;2022 to allow it to treat patients with the co-administration of CT-0508 and pembrolizumab. The FDA has granted &#8220;Fast Track&#8221; status to CT-0508 for the treatment of patients with HER2 overexpressing solid tumors and Carisma plans to prioritize development for this indication. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma is currently in the pre-clinical stage for another product candidate, CT-0525, which is also intended to treat solid tumors that overexpress HER2. By leveraging its discovery engine and preliminary clinical data from its Phase&#160;1 clinical trial of CT-0508, Carisma is building upon its CAR-M platform to generate next-generation therapeutics that may increase potential efficacy and patient access. Notably, Carisma has developed a novel approach to CAR-M therapy to accelerate the manufacturing process, increase the cell yield, and improve upon the potential anti-tumor effect by engineering patients&#8217; monocytes directly, without </font><font style="font-style:italic;letter-spacing:0.2pt;">ex vivo</font><font style="letter-spacing:0.2pt;"> differentiation into macrophages, as Carisma currently does for CT-0508. Carisma refers to </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">251</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tCATE">&#8203;</a><a name="tCAST">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">

          <div style="width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">this CAR-Monocyte approach as CAR-Mono. By increasing the cell yield, the CAR-Mono approach enables a larger potential dose, which may improve tumor control. The CAR-Mono approach reduces manufacturing time and leverages an automated, closed-system manufacturing process. CT-0525 is Carisma&#8217;s first CAR-Mono product candidate and is currently in the pre-clinical process development stage. Carisma expects to submit an IND to the FDA for CT-0525 in the third quarter of 2023 and initiate clinical development shortly thereafter. </font>
          </div>

        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma is also expanding its pipeline to include multiple tumor targets, encompassing diverse solid tumor indications with significant unmet medical needs, including the following product candidates: </font>
        </div>

          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">CT-1119:</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;CT-1119 is a mesothelin targeted CAR-M that Carisma plans to evaluate in patients with advanced mesothelin-positive solid tumors, including lung cancer, mesothelioma, pancreatic cancer, ovarian cancer, and others. Carisma has identified a lead construct for CT-1119 and expects to submit an IND to the FDA in 2025. In November 2022, Carisma presented preliminary and limited data demonstrating that CT-1119 can mediate phagocytosis, tumor cell killing, and pro-inflammatory cytokine release and control tumor growth in pre-clinical lung cancer models. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">CT-0729:</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;CT-0729 is a prostate-specific membrane antigen, or PSMA, targeted CAR-M that Carisma plans to evaluate in patients with advanced, PSMA positive metastatic castrate resistant prostate cancer. CT-0729 is in the discovery stage. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma&#8217;s current CAR-M cell therapy pipeline is informing the discovery and pre-clinical development of off-the-shelf engineered macrophage therapeutics. Carisma is developing </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;"> reprogrammed LNP/mRNA CAR-M therapies for cancer through its collaboration with Moderna. In addition, Carisma is establishing an </font><font style="font-style:italic;letter-spacing:0.2pt;">ex vivo</font><font style="letter-spacing:0.2pt;"> allogeneic, induced pluripotent stem cell, or iPSC, derived macrophage and monocyte platform with the potential to develop iPSC-derived CAR-M and other macrophage therapies for indications in oncology and beyond, including indications such as liver fibrosis, neurodegeneration and auto-immunity. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Carisma&#8217;s Team</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma was founded in 2016 by leading cell therapy experts from the University of Pennsylvania. Dr.&#160;Saar Gill is a co-inventor of the CAR-M technology and a co-founder of Carisma. He is an Associate Professor of Medicine in the Division of Hematology-Oncology at the University of Pennsylvania. Dr.&#160;Michael Klichinsky, Pharm.D., Ph.D., is a co-inventor of the CAR-M technology, a scientific co-founder of Carisma, and Carisma&#8217;s current Chief Scientific Officer. Dr.&#160;Carl June, a co-inventor of the CAR-M technology, is the Richard W. Vague Professor in Immunotherapy in the Department of Pathology and Laboratory Medicine at the University of Pennsylvania. He also is currently Director of the Center for Cellular Immunotherapies at the Perelman School of Medicine and Director of the Parker Institute for Cancer Immunotherapy at the University of Pennsylvania, and Scientific Advisor to Carisma. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma&#8217;s executive team has decades of experience in business operations, discovery, development, and manufacturing of advanced therapeutics for the treatment of serious diseases. Steven Kelly, Carisma&#8217;s Chief Executive Officer, brings over 35&#160;years of experience in the biopharmaceutical industry at all phases of the business across multiple therapeutic categories. Carisma&#8217;s Chief Technology and Development Officer, Dr.&#160;Daniel Cushing, Ph.D., brings over 30&#160;years of experience in the biopharmaceutical industry and is responsible for product development at Carisma. Richard Morris, Carisma&#8217;s Chief Financial Officer, has more than 25&#160;years of experience in building and growing successful biotechnology organizations, with a focus on capital fundraising (including initial public offerings), financial strategy and operations execution, and business development efforts. Carisma&#8217;s Chief Business Officer, Tom Wilton, has over 25&#160;years of biopharmaceutical industry experience, including corporate strategy, business development, research and development operations, and marketing. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Carisma&#8217;s Strategy</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma&#8217;s vision is to become a leading cell therapy company, developing and ultimately commercializing macrophage-based cell therapies that positively transform the treatment of cancer and other serious diseases. To achieve its vision, Carisma has developed its macrophage engineering platform, a pipeline of assets spanning numerous indications with unmet medical needs, a robust discovery engine, broad CAR-M </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">252</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">intellectual property, robust manufacturing capabilities, and a dedicated executive team with extensive experience in cell therapy and drug development, manufacturing and commercialization and leading scientific expertise in the field. The key components of Carisma&#8217;s strategy are: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Advance Carisma&#8217;s lead product candidate, CT-0508, through clinical development for the treatment of HER2 overexpressing solid tumors.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;CT-0508 is an </font><font style="font-style:italic;letter-spacing:0.2pt;">ex vivo</font><font style="letter-spacing:0.2pt;"> gene-modified autologous CAR-M cell therapy product candidate intended to treat solid tumors that overexpress HER2. Carisma has completed enrollment of the first group of patients in a Phase&#160;1 clinical trial, with nine patients successfully dosed. The second group is currently open for enrollment, with nine additional patients to be dosed. In November 2022, Carisma presented preliminary clinical results from the first group of patients. CT-0508 was successfully manufactured using macrophages obtained from heavily pre-treated, advanced solid tumor patients and has shown high CAR expression, viability, and purity. In addition, CT-0508 has been generally well-tolerated after infusion with no dose-limiting toxicities reported to date from the nine patients enrolled in the first group. While the results from this early clinical trial data are both preliminary and limited, Carisma believes the results indicate that CT-0508 can be detected within the TME, lead to remodeling and activation of the TME, and potentially induce anti-tumor adaptive immunity. Additionally, the FDA granted &#8220;Fast Track&#8221; status to CT-0508 for the treatment of patients with HER2 overexpressing solid tumors and Carisma plans to prioritize development for this indication. Carisma also plans to initiate multiple sub-studies to expand the utility of CT-0508, including combination therapy with a PD1 blocking T-cell checkpoint inhibitor in pre-clinical models, enabling a combination trial with pembrolizumab. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="font-weight:bold;letter-spacing:-0.2pt;">Invest in Carisma&#8217;s CAR-Mono platform technology to further extend its leadership position in macrophage and monocyte based cellular therapy.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;As part of its ongoing platform enhancement effort, Carisma has developed its CAR-Mono approach, which significantly reduces manufacturing time and leverages an automated, closed-system manufacturing process. Carisma is currently in the pre-clinical process development stage for CT-0525, Carisma&#8217;s first anti-HER2 CAR-Mono product candidate, and expects to submit an IND in the third quarter of 2023. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>


          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.91pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.91pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="font-weight:bold;letter-spacing:-0.2pt;">Advance Carisma&#8217;s pre-clinical CAR-M oncology pipeline candidates to clinical development stage.</font><font style="letter-spacing:0.2pt;"> Beyond its initial HER2 target, Carisma is expanding its pipeline into multiple tumor targets and constructs. CT-1119 is a mesothelin targeted CAR-M that Carisma plans to evaluate in patients with advanced mesothelin-positive solid tumors, with an IND expected to be submitted in 2025. In November 2022, Carisma presented preliminary and limited data demonstrating that CT-1119 can mediate phagocytosis, tumor cell killing, and pro-inflammatory cytokine release and control tumor growth in pre-clinical lung cancer models. Additionally, CT-0729 is a PSMA targeted CAR-M intended for use against metastatic castrate resistant prostate cancer and is currently in the discovery stage. Carisma is also developing product candidates targeting other cancer antigens. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Build next-generation technologies to expand the scope and capabilities of Carisma&#8217;s platform.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Beyond its CAR-M and CAR-Mono technologies, Carisma is pursuing multiple platform enhancements for its CAR constructs, editing technologies and therapeutic delivery vehicles. Further, Carisma is actively developing a gene edited iPSC-derived macrophage platform and leveraging delivery technologies for its mRNA-based </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;"> CAR-M platform for oncology. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Harness the potential of Carisma&#8217;s platform to develop novel product candidates to address therapeutic areas beyond oncology.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;While Carisma has initially been an oncology focused company, Carisma believes the breadth of the myeloid engineering platform enables significant opportunities outside of oncology. Based on early data related to Carisma&#8217;s novel therapeutic approach, Carisma believes its platform has significant potential across multiple therapeutic areas, including fibrosis, neurodegeneration, autoimmunity, and chronic inflammation, which are currently in the discovery stage. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Selectively enter into strategic partnerships and collaborations to maximize the potential of Carisma&#8217;s platform.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Given the breadth of opportunities enabled by Carisma&#8217;s platform, Carisma may opportunistically enter into strategic collaborations intended to advance and accelerate its development programs, expand into new therapeutic areas and enhance the capabilities of its platform. Carisma currently has a broad strategic collaboration with Moderna focused on the development of </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;"> CAR-M therapeutics for up to 12 oncology targets, of which four have already been nominated. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">253</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tBAC">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Background</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Cellular Immunotherapy</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Cellular immunotherapy is a type of immuno-oncology approach whereby human immune cells are utilized to recognize and destroy cancer cells in a targeted manner. To date, cellular immunotherapy has focused on the transfer of T-cells or natural killer, or NK, cells. For example, T-cells with intrinsic tumor reactivity, such as tumor infiltrating lymphocytes, have been utilized, as well as T-cells genetically engineered with tumor targeting T-cell receptors, or TCRs, or CARs, have been tested in a variety of hematologic malignancies and solid tumors. The only FDA approved genetically modified cellular immunotherapies for cancer are CAR T-cell therapies for B cell hematologic malignancies expressing CD19 or multiple myeloma expressing B-cell maturation antigen, or BCMA. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Despite the incredible promise shown by cell therapies for hematologic malignancies, the success has not been replicated in the solid tumor setting. There are numerous challenges impacting T and NK cell immunotherapy in patients with solid tumors, such as the inability of cells to appropriately access the tumor microenvironment, overcome immunosuppression in the tumor microenvironment and overcome target antigen heterogeneity. Importantly, there have been challenges in targeting solid tumors with CAR T-cells without inducing toxicities against normal tissues or inducing severe systemic cytokine release syndrome, or CRS. To date, no CAR therapies for the treatment of solid tumors have received marketing approval. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Macrophages and Monocytes and the Tumor Microenvironment</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Macrophages play a vital role in the innate immune system, the body&#8217;s first line of defense against foreign pathogens. Macrophages are highly plastic innate cells that mediate a multitude of protective and homeostatic functions, including elimination of pathogens through phagocytosis, clearance of cellular debris, induction or regulation of inflammation, antigen presentation, and tissue remodeling. Macrophages can arise from circulating bone marrow-derived monocytes or embryonic precursors and are found in all tissues in the human body. Depending on the environmental cues, macrophages can actively adopt distinct activation states, or phenotypes, to either initiate or terminate immune responses. While macrophage activation states are complex, they can be categorized into two general subsets: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Classically activated (M1):</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;M1 macrophages are pro-inflammatory and are associated with anti-tumoral functions. They initiate or enhance immune responses by recruiting T-cells, upregulating antigen processing machinery and co-stimulatory ligands, and secreting pro-inflammatory factors cytokines and chemokines, and ultimately promote T-cell responses. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Alternatively activated (M2):</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;M2 macrophages are immunosuppressive and are associated with pro-tumoral functions. They accelerate tumor invasion and metastasis and promote angiogenesis (or formation of new blood vessels) by secreting inhibitory cytokines and upregulating immunosuppressive cell surface molecules, and ultimately inhibit T-cell responses. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Macrophages are typically the most abundant immune cell in the TME of most cancers, where they generally adopt an M2 phenotype and are therefore associated with poor prognostic outcomes and increased intratumoral immunosuppression. For example, numerous studies have shown that patients with more M2 macrophages in their tumors have reduced responses to immune checkpoint inhibitors such as pembrolizumab. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Given the generally negative role of M2 macrophages in the TME, there have been numerous therapeutic approaches focused on inhibiting tumor associated macrophage, or TAM, infiltration or survival. Other approaches have sought to convert TAMs from an M2 to an M1 phenotype. While numerous studies have shown that TAM infiltration is typically associated with poor prognostic outcome, macrophages have been shown to have potent anti-tumor capabilities if appropriately activated and targeted. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The Opportunity for Engineered Macrophages in Treating Cancer</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma believes macrophage and monocyte cell therapies hold promise in addressing the limitations of other cell types and transforming the cell therapy treatment paradigm for solid tumors. The inherent biology of macrophages and monocytes offers several potential advantages that directly apply to current barriers for cell therapy efficacy in the solid tumor context. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">254</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Macrophages and monocytes are actively recruited into solid tumors, while other immune cells such as T-cells are often actively excluded. Macrophages are professional phagocytic cells capable of directly killing tumor cells through this unique mechanism. In addition to direct killing, macrophages can secrete pro-inflammatory factors that convert the immunosuppressive TME into an environment that promotes immunity. Importantly, macrophages and monocytes are professional antigen presenting cells, meaning they can directly present tumor-derived antigens to T-cells leading to anti-tumor T-cell responses, a phenomenon known as epitope spreading. Epitope spreading enables activity against tumor cells which either lack or lose expression of the initial antigen targeted by the CAR&#8201;&#8212;&#8201;a key challenge for cell therapies&#8201;&#8212;&#8201;and ultimately enables macrophages and monocytes to overcome target antigen heterogeneity within the patient&#8217;s cancer. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma believes an approach which harnesses the direct effector functions of macrophages or monocytes, optimizes their activation status toward an inflammatory M1 phenotype, and redirects phagocytosis with molecular specificity would represent a major advance in cancer immunotherapy. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Carisma&#8217;s Novel Platform</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">CAR-M have the potential to address the key challenges involved in treating solid tumors: </font>
        </div>
        <div style="position:relative;margin-top:11.19pt; text-align:center; width:456pt;">
          <img src="tm2227887d8-fc_problem4c.jpg" alt="[MISSING IMAGE: tm2227887d8-fc_problem4c.jpg]" height="367" width="597" >
        </div>
        <div style="text-indent:20pt; margin-top:14.69pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">CAR-M have the ability to infiltrate solid tumors, phagocytose and destroy tumor cells directly, and present tumor-derived antigens leading to activation of the adaptive immune system. CAR-M mount anti-tumor immunity in numerous ways. First, CAR-M leverage the natural tumor-homing ability of macrophages and monocytes, the naturally most abundant immune cells in the TME, to traffic to both primary tumors and metastases, enabling engineered macrophages to act as a &#8220;Trojan horse,&#8221; tricking the tumor into recruiting engineered, anti-tumor CAR-M as if they were normal monocytes or macrophages. Once within the tumor, CAR-M directly kill antigen-expressing tumor cells through phagocytosis and secretion of cytotoxic factors. CAR-M secrete inflammatory cytokines and chemokines that promote a pro-inflammatory environment and lead to the recruitment of T-cells and other leukocytes. Finally, CAR-M serve as professional antigen-presenting cells for T-cells, inducing epitope spreading, systemic anti-tumor immunity, and immune memory against tumor antigens, expanding anti-tumor immunity to target negative tumor cells and potentially preventing antigen negative relapse. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">255</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="position:relative;margin-top:8pt; text-align:center; width:456pt;">
          <img src="tm2227887d1-pht_tumor4c.jpg" alt="[MISSING IMAGE: tm2227887d1-pht_tumor4c.jpg]" height="245" width="608" >
        </div>
        <div style="text-indent:20pt; margin-top:12.8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Historically, macrophages have been challenging to genetically engineer due to their inherent resistance to most commonly used genetic manipulation methods. Furthermore, controlling the activation state of macrophages has been a long-standing challenge. Carisma believes that it has overcome these challenges with its proprietary platform that efficiently engineers macrophage-based cell therapies and enables control of their activation state. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma&#8217;s proprietary platform enables the therapeutic use of engineered macrophages and monocytes for the treatment of cancer and other serious diseases and disorders. In its first application, solid tumors that overexpress HER2, the CAR-M platform is designed to identify and eradicate HER2 overexpressing tumor cells. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Currently, CAR-M are an individualized therapy that begin with the isolation of monocytes, the pre-cursor cell to macrophages, from blood drawn from a patient through a process called apheresis. The cells are purified, cultured, differentiated, and engineered with a CAR which bestows the macrophage with the ability to identify and eradicate cancer cells. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">To enable its proprietary CAR-M therapy, Carisma had to overcome several key technical challenges, which are summarized by its platform capabilities: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Gene Delivery</font><font style="letter-spacing:0.2pt;">:&nbsp;&nbsp;&nbsp;Carisma has identified Ad5f35, a chimeric adenoviral vector, as a highly efficient vector for introducing genes such as CARs into primary human macrophages and monocytes. Carisma has further developed additional proprietary technologies for </font><font style="font-style:italic;letter-spacing:0.2pt;">ex vivo</font><font style="letter-spacing:0.2pt;"> and </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;"> macrophage engineering. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Activation State</font><font style="font-weight:bold;letter-spacing:-0.2pt;">:</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Carisma demonstrated that Ad5f35 transduction leads to M1 polarization of human macrophages and monocytes and renders them resistant to conversion to M2 by immunosuppressive environments. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Tumor targeting</font><font style="font-weight:bold;letter-spacing:-0.2pt;">:</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Carisma demonstrated that macrophage function can be harnessed against tumors in a targeted fashion via CARs. Carisma&#8217;s CARs enable antigen specific activation of macrophages and monocytes, antigen specific cancer cell phagocytosis and killing, and antigen specific release of pro-inflammatory cytokines and chemokines. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">T-cell activation</font><font style="font-weight:bold;letter-spacing:-0.2pt;">:</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;By appropriately engineering and polarizing CAR-M, Carisma has demonstrated that they are able to recruit and activate T-cells&#8201;&#8212;&#8201;a key aspect to solid tumor immunotherapy. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Cell manufacturing processes</font><font style="font-weight:bold;letter-spacing:-0.2pt;">:</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Carisma has developed manufacturing processes that enable the production of genetically engineered macrophages or monocytes for therapeutic use. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In the case of Carisma&#8217;s lead product, CT-0508, a chimeric adenoviral vector, or Ad5f35, is used to deliver an anti-HER2 CAR which enables the macrophages to detect, phagocytose, kill, release inflammatory mediators, and initiate an immune reaction in response to HER2 overexpressing tumor cells. The resulting CAR-M, which are adenovirally transduced and locked into a pro-inflammatory M1 phenotype during the </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">256</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">manufacturing process, are cryopreserved and shipped back to the patient for reinfusion. Reinfused CAR-M rapidly egress from peripheral blood and infiltrate tumor sites. Once in the tumor, CAR-M are activated by tumor-associated antigen engagement with the CAR, signaling via an intracellular signaling domain to phagocytose the tumor cell and release pro-inflammatory cytokines and chemokines that &#8220;warm up&#8221; the TME. They produce locally acting mediators that reprogram the TME, drawing in T-cells and NK cells, activating nearby antigen presenting cells, or APCs, such as dendritic cells, or DCs, and repolarizing immunosuppressive TAMs toward an M1 phenotype. In addition to direct phagocytosis of tumor cells, CAR-M present a patient&#8217;s unique array of tumor antigens to T-cells, leading to a broad adaptive immune response that has the potential to generate broad anti-tumor immunity. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Pre-clinical Data</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma evaluated its CAR-M platform in a variety of pre-clinical </font><font style="font-style:italic;letter-spacing:0.2pt;">in vitro</font><font style="letter-spacing:0.2pt;"> and </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;"> model systems and published its foundational data in Nature Biotechnology in March&#160;2020. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">First, Carisma found that Ad5f35 led to the efficient transduction of human macrophages and could be utilized to produce human CAR-M. CAR-M mediated potent antigen-specific phagocytosis and tumor killing in a targeted fashion. CAR-M took on an activated M1 phenotype, expressed pro-inflammatory cytokines and chemokines, converted bystander M2 macrophages toward an M1 phenotype, recruited T-cells, and increased antigen presentation to activate T-cells. Enhanced anti-tumor T-cell responses mediated by CAR-M were noted in humanized murine models and the findings are summarized below. </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Human CAR-M Anti-Tumoral Function </font><font style="font-style:italic;letter-spacing:-0.2pt;">In Vitro</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-top:10.2pt; text-align:center; width:456pt;">
          <img src="tm2227887d1-lc_human4c.jpg" alt="[MISSING IMAGE: tm2227887d1-lc_human4c.jpg]" height="159" width="599" >
        </div>
        <div style="margin-top:9.4pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">* SKOV3 = Human HER2+ ovarian cancer cell line </font>
          <br >
          <font style="letter-spacing:0.2pt;">* UTD = Untransduced </font>
          <br >
          <font style="letter-spacing:0.2pt;">* CAR = Anti-HER2 human CAR-M </font>
          <br >
          <font style="letter-spacing:0.2pt;">* Delta</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">Z</font><font style="letter-spacing:0.2pt;"> = CAR-M with a non-signaling control CAR </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">CAR-M were able to traffic to established tumors and co-localized with metastatic foci in the lung after intravenous administration without a pre-conditioning regimen. CAR-M treatment induced significant reduction in tumor burden and improved overall survival compared to mice treated with control macrophages in multiple mouse tumor models. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Transduction of macrophages with Ad5f35 led to the induction of a durable M1 phenotype. Despite the purported plasticity of macrophage phenotype, Ad5f35 transduced macrophages did not convert to M2 upon stimulation. CAR-M maintained a pro-inflammatory M1 state within the TME, while control macrophages were converted to M2. Additionally, CAR-M induced a pro-inflammatory signature in the surrounding TME. Given that solid tumors are rich in TAMs, Carisma evaluated the bidirectional interaction of CAR-M and M2 macrophages. While M2 macrophages failed to convert CAR-M from M1 to M2, CAR-M converted M2 macrophages to M1. Additionally, the presence of M2 macrophages did not impact the tumor killing capacity of CAR-M, highlighting their resistance to the immunosuppressive components of the TME. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Finally, CAR-M were shown to interact with cells of the adaptive immune system. CAR-M upregulated antigen presentation pathways and demonstrated heightened T-cell stimulation capacity as compared to </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">257</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">control macrophages. Notably, CAR-M were able to present antigens to T-cells following phagocytosis. In addition, CAR-M were able to directly recruit various subtypes of T-cells. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">To further its understanding of CAR-M, Carisma sought to model their function in fully immunocompetent mouse models which have an intact TME and immune system, enabling recapitulation of the complex immunological environment in human cancer patients. Toward that goal, Carisma developed a murine surrogate CAR-M to demonstrate the mechanism of action of CAR-M </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;"> in mice which have a fully intact immune system. First, Carisma validated comparability between human and murine CAR-M. Carisma demonstrated that the same vector utilized in its clinical pipeline, Ad5f35, could be used to engineer primary murine macrophages, and confirmed that T-cells were viable, expressed CAR, and were similarly polarized to an M1 phenotype. Functional studies showed CAR-M mediated tumor killing of target cancer cells and enhanced the </font><font style="font-style:italic;letter-spacing:0.2pt;">in vitro</font><font style="letter-spacing:0.2pt;"> function of T-cells. Furthermore, murine CAR-M released pro-inflammatory cytokines similarly to human CAR-M. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Pre-clinical immunocompetent solid tumor models were established via subcutaneous, or SC, injection and engraftment of the murine colorectal cancer cell line, or CT26, engineered to express human HER2. In this model, intratumoral, or IT, CAR-M monotherapy significantly reduced tumor growth and prolonged overall survival compared to untransduced macrophages (macrophages not expressing a CAR). By rechallenging complete responders several&#160;months post tumor clearance with the same tumor cells lacking HER2 expression, Carisma was able to demonstrate that CAR-M therapy leads to epitope spreading and immune memory which confers protection against antigen-negative relapse. </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:11.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CAR-M Control Tumor Progression, Improve Survival and Induce Long-Term Protection against Antigen-negative Relapse</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-top:9.6pt; text-align:center; width:456pt;">
          <img src="tm2227887d4-lc_contrl4c.jpg" alt="[MISSING IMAGE: tm2227887d4-lc_contrl4c.jpg]" height="249" width="593" >
        </div>
        <div style="margin-top:8.21pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">* UTD-M = Untransduced macrophage </font>
        </div>
        <div style="margin-top:10.1pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:7.6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(A)</font>
          <br >
        </div>
        <div style=" margin-top:7.6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">CT26-HER2+ tumors were implanted subcutaneously in immunocompetent syngeneic mice. After 15&#160;days, mice were treated with intratumoral CAR-M, UTD-M, or left untreated. CAR-M significantly reduced tumor progression. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.61pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(B)</font>
          <br >
        </div>
        <div style=" margin-top:3.61pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">CAR-M significantly increased long term survival compared to control groups. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(C)</font>
          <br >
        </div>
        <div style=" margin-top:3.6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Mice achieving complete responses, or CR, post CAR-M therapy were re-challenged with HER2-negative CT26-Wt tumors to model antigen negative relapse. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(D)</font>
          <br >
        </div>
        <div style=" margin-top:3.6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Na&#239;ve mice succumbed to disease within 35&#160;days, while 100% of the mice from the CAR-M treatment group survived, indicating long-term tumor protection against antigen negative relapse. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(E)</font>
          <br >
        </div>
        <div style=" margin-top:3.6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">T-cell depletion reversed CAR-M induced protection against antigen negative relapse, indicating that CAR-M treatment led to epitope spreading and anti-tumor T-cell memory. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Analysis of the tumor microenvironment of mice receiving CAR-M therapy demonstrated the ability of Carisma&#8217;s therapy to recruit additional immune cells, including T-cells, into the tumor. CAR-M led to </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">258</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:50.58pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">immune activation in the TME associated with T-cell expansion, activation, and modulation of the overall T-cell repertoire of tumor infiltrating lymphocytes&#8201;&#8212;&#8201;suggesting the induction of a broad anti-tumor immune response. </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CAR-M Reprogram the TME and Prime T-cells</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-top:11.19pt; text-align:center; width:456pt;">
          <img src="tm2227887d4-lc_reprogra4c.jpg" alt="[MISSING IMAGE: tm2227887d4-lc_reprogra4c.jpg]" height="397" width="547" >
        </div>
        <div style="margin-top:7.19pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:9.19pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(A)</font>
          <br >
        </div>
        <div style=" margin-top:9.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Immunohistochemistry assessment showed that CAR-M treatment increased tumor CD8+ T-cell infiltration in the CT26-HER2+ model indicating activation of the TME. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:5.19pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(B)</font>
          <br >
        </div>
        <div style=" margin-top:5.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Flow cytometric analysis showed increased tumor infiltration of T-cells, NK cells, activated CD86+ DCs and tumor associated antigen specific CD8 T-cells (gp70 Tet+) in CAR-M treated mice, suggesting epitope spreading. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Combined, these results demonstrate that CAR-M have the potential to overcome some of the key challenges cell therapies encounter in the solid tumor setting and represent a novel immunotherapeutic platform that can be broadly applied to diverse tumor antigen targets. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma is applying its CAR-M platform to a broad pipeline of product candidates, and Carisma intends to build a fully integrated immunotherapy company spanning autologous cell therapy, allogeneic cell therapy, and </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;"> macrophage gene therapy. Carisma currently owns all rights to its product candidates and programs outside of its Moderna collaboration, which is limited to direct </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;"> reprogrammed CAR-M in the field of oncology. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">259</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Macrophage and Monocyte Engineering Platform</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-top:9.9pt; text-align:center; width:456pt;">
          <img src="tm2227887d1-pht_macrop4clr.jpg" alt="[MISSING IMAGE: tm2227887d1-pht_macrop4clr.jpg]" height="332" width="608" >
        </div>
        <div style="margin-top:16.8pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Gene Delivery</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">At the core of Carisma&#8217;s platform are its proprietary viral and non-viral approaches for delivering different payloads into macrophages and monocytes and engineering them into a variety of phenotypes depending on the disease which they are intended to treat. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">For its initial solid tumor programs, Carisma&#8217;s adenoviral vector enables Carisma to generate an abundant supply of CAR-M cells and engineer the cells to be locked into an M1 phenotype. Carisma selected Ad5f35 after testing commonly utilized viral and non-viral approaches and demonstrating Ad5f35&#8217;s high efficiency in transducing primary human monocytes and macrophages. Ad5f35 can transduce macrophages with high efficiency, viability and reproducibility amongst donors. In addition to being highly efficient, transduction with Ad5f35 polarizes and locks macrophages into an M1 phenotype. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In addition to Ad5f35, Carisma&#8217;s platform includes two other proprietary methods for delivering genes into macrophages. The first is a modified lentiviral vector, or Vpx-LV, which carries viral protein X. Vpx-LV depletes SAMHD1 and permits lentiviral transduction of primary human monocytes, macrophages, and dendritic cells. Vpx-LV was developed by Dr.&#160;Nathaniel Landau at New York University, and Carisma holds a global exclusive license to develop this vector. Unlike Ad5f35, which induces a potent M1 phenotype upon transduction, Vpx-LV has minimal impact on macrophage phenotype and can be utilized as a flexible tool to generate M0, M1, or M2 polarized myeloid cell therapies with durable gene expression. Additionally, Carisma has developed a proprietary non-viral mRNA-based approach to transiently engineered macrophage and a companion method to induce a durable pro-inflammatory M1 phenotype. Carisma has successfully generated M1-primed non-viral CAR-M using a research manufacturing process consisting of mRNA transfection to deliver the CAR transgene followed by IFN&beta; priming to polarize the cells to an M1 anti-tumoral phenotype. Non-viral CAR-M demonstrated high viability, high CAR expression, M1 polarization and anti-tumoral function </font><font style="font-style:italic;letter-spacing:0.2pt;">ex vivo</font><font style="letter-spacing:0.2pt;"> similar to Ad5f35 engineered CAR-M. Additionally, in partnership with Moderna, Carisma is developing a myeloid tropic LNP/mRNA platform to program CAR-M directly </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Approach to Pipeline</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma&#8217;s proprietary technology and engineering capabilities enabled it to pioneer the CAR-M field and conduct the first in human CAR-M clinical trial, establishing its leading position in the engineered </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">260</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">macrophage space. Carisma&#8217;s goal is to advance </font><font style="font-style:italic;letter-spacing:0.2pt;">ex vivo</font><font style="letter-spacing:0.2pt;"> autologous cell therapies and off-the-shelf therapies including allogeneic cell therapies and direct </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;"> reprogramming approaches in oncology and other indications: </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Expansion: Building Upon the Learnings of Autologous Cell Therapy</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-top:10.2pt; text-align:center; width:456pt;">
          <img src="tm2227887d1-tbl_exvivo4c.jpg" alt="[MISSING IMAGE: tm2227887d1-tbl_exvivo4c.jpg]" height="255" width="608" >
        </div>
        <div style="text-indent:20pt; margin-top:13.39pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">While the first iteration of its platform is the CAR macrophage, Carisma has expanded its capabilities to include multiple myeloid cell types (monocytes, macrophages, and dendritic cells), multiple gene delivery modalities (Ad5f35, Vpx-LV, and mRNA), various phenotypes (M1, M2, and subtypes thereof), and a broad variety of payloads including CARs, immune ligands, secreted or tethered cytokines, transcription factors, and other genes that enhance efficacy. Importantly, Carisma has expanded its platform to enable </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;"> engineering of myeloid cells directly within the patient&#8217;s body. Additionally, Carisma has established a robust process to edit the genome of human myeloid cells by utilizing tools such as CRISPR/Cas9, enabling gene edited macrophages with inhibitory pathways such as SIRP&alpha; genetically removed from the cell product. Carisma&#8217;s engineered macrophage platform enables fine tuning the activation state of the engineered macrophage or monocyte. Finally, Carisma has established a novel Engineered Myeloid Microenvironment Converter, or EM-C, platform that utilizes proprietary synthetic cytokine switch receptors to generate engineered macrophages that respond to M2 cytokines with M1 responses (for oncology applications) or to generate engineered macrophages that respond to M1 cytokines with M2 responses, for auto-immune or chronic inflammatory diseases. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Carisma&#8217;s Pipeline of Product Candidates and Discovery Programs</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Using its proprietary CAR-M platform, Carisma is developing a broad pipeline of product candidates, with an initial focus in oncology. </font>
        </div>
        <div style="position:relative;margin-top:10.1pt; text-align:center; width:456pt;">
          <img src="tm2227887d4-tbl_pipelin4c.jpg" alt="[MISSING IMAGE: tm2227887d4-tbl_pipelin4c.jpg]" height="203" width="466" >
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">261</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">

          <div style="width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Lead Product Candidate: CT-0508</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">CT-0508 is a cell product comprised of autologous, peripheral blood monocyte-derived, pro inflammatory macrophages, transduced with a chimeric adenoviral vector, Ad5f35, containing an anti-HER2 CAR. The anti-HER2 CAR is a first-generation CAR composed of a fully human single-chain variable fragment, or scFv, derived from the monoclonal antibody trastuzumab, which is specific for human HER2. The anti-HER2 scFv is fused to a CAR backbone containing a cluster of differentiation CD8 hinge, CD8 transmembrane domain, and a CD3&#950; intracellular domain. The CAR is cloned into an adenoviral vector backbone and transduced into monocyte-derived macrophages. Based on the pre-clinical data generated to date, CT-0508 CAR-M are able to specifically recognize HER2 overexpressing tumor cells, which triggers both direct killing of tumor cells and phagocytosis. Additionally, CAR engagement by HER2 on tumor cells results in the secretion of a broad array of pro-inflammatory cytokines and chemokines, which contribute to the recruitment and activation of additional immune cells to the TME, including effector T-cells and other antigen presenting cells. CT-0508 CAR-M are antigen presenting cells, and after phagocytosing tumor cells they process tumor-derived antigens and present them to T-cells, leading to T-cell immunity against tumor antigens. This additional activation of the adaptive immune system amplifies anti-tumor immune response and can lead to long term immune memory not only against HER2, the primary target, but other tumor specific neoantigens as well. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">The Phase&#160;1 clinical trial of CT-0508 is currently ongoing. As of September&#160;1, 2022, five clinical sites were open for screening and enrollment: (i)&#160;the University of Pennsylvania Abramson Cancer Center, (ii)&#160;the University of North Carolina Lineberger Comprehensive Cancer Center, (iii)&#160;the City of Hope National Medical Center, (iv)&#160;the MD Anderson Cancer Center, and (v)&#160;the Sarah Cannon Cancer Research Institute. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">In November 2022, Carisma presented preliminary clinical results from the first group of patients. CT-0508 was successfully manufactured using macrophages obtained from heavily pre-treated, advanced solid tumor patients and has shown high CAR expression, viability, and purity. In addition, CT-0508 has been generally well-tolerated after infusion with no dose-limiting toxicities reported to date from the nine patients enrolled in the first group. While the results from this early clinical trial data are both preliminary and limited, Carisma believes the results indicate that CT-0508 can be detected within the TME, lead to remodeling and activation of the TME, and potentially induce anti-tumor adaptive immunity. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">The FDA has granted &#8220;Fast Track&#8221; status to CT-0508 for the treatment of patients with HER2 overexpressing solid tumors. The components of CT-0508 cells are shown below: </font>
          </div>


          <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Key Components of First-Generation CAR Construct</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>

        <div style="position:relative;margin-top:10.4pt; text-align:center; width:456pt;">
          <img src="tm2227887d1-pht_key4c.jpg" alt="[MISSING IMAGE: tm2227887d1-pht_key4c.jpg]" height="137" width="277" >
        </div>

          <div style="text-indent:20pt; margin-top:13.79pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Figure Legend: CT-0508 is an autologous monocyte derived macrophage cell product engineered with the adenoviral vector Ad5f35 to express an anti-HER2 CAR. The CAR is comprised of a single chain variable fragment derived from a humanized anti-HER2 antibody which provides specificity against the target antigen. The scFv is linked to a hinge domain derived from the human CD8 protein, which enables extension and flexibility from the cell membrane surface. The hinge is linked to a CD8 transmembrane, or TM, domain which spans the cell membrane, linking the extracellular portion of the CAR to the intracellular portion of the CAR, which is comprised of CD3&#950;. CD3&#950; signaling is activated when the CAR binds to the target antigen, leading to macrophage activation, phagocytosis, tumor cell killing, and release of pro-inflammatory factors such as cytokines and chemokines. </font>
          </div>

      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">262</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">

          <div style="width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">CT-0508 Therapy for HER2+ Solid Tumors</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">While therapies targeting solid tumors that overexpress HER2 have led to improved survival in breast and gastric or gastro-esophageal junction cancers, there remains an unmet need in patients with advanced HER2 positive, or HER2+, cancers and HER2 expressing cancers, including metastatic lung, ovarian, colon, bladder, and other cancers for which there are no HER2 targeted agents. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Approximately 20% of breast cancers overexpress HER2, a protein that is overexpressed on the surface of a variety of solid tumors. In addition to breast, gastric, and gastroesophageal junction cancers, HER2 is also overexpressed in a number of solid tumor indications including but not limited to bladder cancer, ovarian cancer, lung cancer and colon cancer. </font>
          </div>


          <table style="width:376pt;margin-left:40pt;margin-top:9.99999999999999pt;border-collapse: collapse;border-top:0.75pt solid #000000; border-left:0.75pt solid #000000; border-right:0.75pt solid #000000; font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:3.5pt 0pt 2.25pt 0pt; width:0pt;" colspan="5">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.2pt;">HER2 Positivity Frequencies Across Tumor Types </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
              <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:2.5pt 0pt 2.25pt 0pt; width:179.25pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.2pt;">Tumor type </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
              <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:2.5pt 0pt 2.25pt 0pt; width:179.25pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.2pt;">HER2 positivity (%) </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
              <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:2.5pt 0pt 2.25pt 0pt; width:179.25pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">Bladder cancer </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
              <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:2.5pt 0pt 2.25pt 0pt; width:179.25pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">8&#8201;&#8211;&#8201;70 </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
              <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:2.5pt 0pt 2.25pt 0pt; width:179.25pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">Breast cancer </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
              <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:2.5pt 0pt 2.25pt 0pt; width:179.25pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">11.0&#8201;&#8211;&#8201;25.0 </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
              <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:2.5pt 0pt 2.25pt 0pt; width:179.25pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">Cervical cancer </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
              <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:2.5pt 0pt 2.25pt 0pt; width:179.25pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">2.8&#8201;&#8211;&#8201;3.9 </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
              <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:2.5pt 0pt 2.25pt 0pt; width:179.25pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">Colorectal cancer </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
              <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:2.5pt 0pt 2.25pt 0pt; width:179.25pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">1.6&#8201;&#8211;&#8201;5.0 </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
              <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:2.5pt 0pt 2.25pt 0pt; width:179.25pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">Esophageal cancer </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
              <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:2.5pt 0pt 2.25pt 0pt; width:179.25pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">12.0&#8201;&#8211;&#8201;14.0 </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
              <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:2.5pt 0pt 2.25pt 0pt; width:179.25pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">Extrahepatic Cholangiocarcinoma </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
              <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:2.5pt 0pt 2.25pt 0pt; width:179.25pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">6.3&#8201;&#8211;&#8201;9.0 </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
              <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:2.5pt 0pt 2.25pt 0pt; width:179.25pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">Gallbladder cancer </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
              <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:2.5pt 0pt 2.25pt 0pt; width:179.25pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">9.8&#8201;&#8211;&#8201;12.8 </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
              <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:2.5pt 0pt 2.25pt 0pt; width:179.25pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">Gastric adenocarcinoma </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
              <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:2.5pt 0pt 2.25pt 0pt; width:179.25pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">7.0&#8201;&#8211;&#8201;34.0 </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
              <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:2.5pt 0pt 2.25pt 0pt; width:179.25pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">Ovarian cancer </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
              <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:2.5pt 0pt 2.25pt 0pt; width:179.25pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">26 </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
              <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:2.5pt 0pt 2.25pt 0pt; width:179.25pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">Salivary duct carcinoma </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
              <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:2.5pt 0pt 2.25pt 0pt; width:179.25pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">30&#8201;&#8211;&#8201;40 </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
              <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:2.5pt 0pt 2.25pt 0pt; width:179.25pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">Salivary mucoepidermoid carcinomas </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
              <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:2.5pt 0pt 2.25pt 0pt; width:179.25pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">17.6 </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
              <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:2.5pt 0pt 2.25pt 0pt; width:179.25pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">Testicular cancer </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
              <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:2.5pt 0pt 2.25pt 0pt; width:179.25pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">2.4 </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
              <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:2.5pt 0pt 2.25pt 0pt; width:179.25pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">Uterine cancer </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
              <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:2.5pt 0pt 2.25pt 0pt; width:179.25pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">3.0</font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
              <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            </tr>
          </table>


          <div style="margin-top:12.29pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">CT-0508 Clinical Study Design&#8201;&#8212;&#8201;Study 101</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">The ongoing Phase&#160;1 clinical trial of CT-0508 is a single-arm, open-label study of systemic intravenous administration of CT-0508. This study is intended to evaluate safety, tolerability, cell trafficking, cell-manufacturing feasibility, and preliminary evidence of efficacy in approximately 18 subjects with locally advanced or metastatic solid tumors overexpressing HER2 who have failed available therapies. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">A summary of the clinical trial design, dosing regimen, sample collection regimen, and primary and secondary objectives are shown below: </font>
          </div>

        <div style="position:relative;margin-top:10.2pt; text-align:center; width:456pt;">
          <img src="tm2227887d1-org_clinic4c.jpg" alt="[MISSING IMAGE: tm2227887d1-org_clinic4c.jpg]" height="232" width="579" >
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">263</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">

          <div style="text-indent:20pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Filgrastim, or recombinant G-CSF, is administered to patients five days prior to apheresis to mobilize monocytes into the peripheral blood, increasing the available circulating monocyte count prior to collection by apheresis. The CT-0508 cell product is then prepared, cryopreserved, and released following quality control testing. The first three participants in the study were hospitalized for eight days after the first infusion of CT-0508 (Day 1 to Day 8) as part of the pre-determined study design. There is no preparative chemotherapy prior to the cell product infusion. The first group of nine patients have been treated with an intra-participant dose escalation regimen consisting of: </font>
          </div>


          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Day 1:</font><font style="letter-spacing:0.2pt;"> Up to 0.5 &#215; 10</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">9</font><font style="letter-spacing:0.2pt;"> cells; </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>


          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Day 3:</font><font style="letter-spacing:0.2pt;"> Up to 1.5 &#215; 10</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">9</font><font style="letter-spacing:0.2pt;"> cells; and </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>


          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.09pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6.09pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Day 5:</font><font style="letter-spacing:0.2pt;"> Up to 3.0 &#215; 10</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">9</font><font style="letter-spacing:0.2pt;"> cells. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">AE reporting begins at the start of mobilization and continues until any toxicities resolve or are deemed irreversible. Participants are continually reassessed for evidence of acute and/or cumulative toxicity. Approximately nine participants in the second group of patients will receive up to 5.0 &#215; 10</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">9</font><font style="letter-spacing:0.2pt;"> total manufactured CT-0508 cells in a single infusion on Day 1. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">HER2 has several advantages as a target antigen for CAR-M. In addition to being expressed in a variety of solid tumor types with significant unmet medical needs, HER2 is not shed or internalized and is only expressed at low levels in non-tumor tissues. As HER2 expression is typically maintained over the course of disease, CT-0508 may be developed for treatment of metastatic disease, for example, in the liver and lung, as well as primary tumors. Additionally, HER2 is typically not lost after patients with metastatic cancer progress on available HER2 targeted therapies, rendering HER2 refractory patients potentially eligible for CT-0508 therapy. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Participants enrolled in Study 101 undergo one pre-treatment and two on-treatment biopsies to assess CT-0508 trafficking, impact on the TME, induction of anti-tumor T-cell immunity, and other biomarkers. Blood samples are also collected over a period of 52 weeks for evaluation of pharmacokinetics and biomarkers associated with safety and efficacy. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Based upon clinical data, Carisma may seek Regenerative Medicine Advanced Therapy, or RMAT, and PRIority MEdicine, or PRIME, designations for CT-0508, which provide an expedited developmental and approval pathway, in the United States and the European Union, respectively. </font>
          </div>


          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">CT-0508 Clinical Data&#8201;&#8212;&#8201;Study 101</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Enrollment of the first group of nine patients in the Phase&#160;1 clinical trial of CT-0508 has been completed and enrollment in the second group is currently ongoing. Carisma successfully generated CT-0508 product for all participants enrolled in the first group of the study with an average cell viability of 89%, an average purity of 85%, and an average CAR transduction of 81%. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Carisma has reported on the safety, clinical response, and correlative studies for the first nine patients dosed in the first group of the clinical trial. Of such patients, two had HER2 overexpression levels of 2+ by immunohistochemistry staining, or IHC, with additional fluorescent in-situ hybridization FISH confirmation; and seven had levels of HER2 3+ by IHC. HER2 grading was performed based on the ASCO/</font>&#8203;<font style="letter-spacing:0.2pt;">CAP guidelines. Patients in the trial had three median prior therapies with a range of two to 11. Patients had a median of two prior HER2 targeted therapies, with a range of zero to nine. </font></div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">CT-0508 was well tolerated with no dose-limiting toxicities. The majority (55.5%) of subjects with treatment-emergent adverse events, or TEAEs, by maximum severity were Grades 1 and 2. One subject experienced an unrelated Grade 4 TEAE (related to progression of disease of the patient&#8217;s cancer). For subjects with TEAEs considered related to CT-0508, the majority (66.6%) were Grades 1 and 2, and none were Grades 4 or 5 severity. With respect to TEAEs of special interest, six patients experienced CRS, and all of these were Grades 1 and 2. There were no episodes of immune cell therapy associated neurotoxic syndrome, or ICANS, reported. No patients had severe CRS. No AEs, or SAEs, led to CT-0508 dose modification or discontinuation. No major organ toxicity was observed. The majority of AEs, regardless of relatedness, were Grades 1 and 2. </font>
          </div>

      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">264</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:22.0599999999999pt;margin-left:69.66pt;width:456pt;">

          <table style="width:376pt;margin-left:40pt;margin-top:0pt;border-collapse: collapse;border-top:0.75pt solid #000000; border-left:0.75pt solid #000000; border-right:0.75pt solid #000000; font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:3.5pt 0pt 2.25pt 0pt; width:0pt;" colspan="5">
                <font style="letter-spacing:-0.2pt;">Overview of Subjects with Treatment-Emergent Adverse Events (Safety Population) </font>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
              <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:2.5pt 0pt 2.25pt 0pt; width:297.75pt;">
                <font style="letter-spacing:0.2pt;">Category </font>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
              <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:2.5pt 0pt 2.25pt 0pt; width:60.75pt;">
                <font style="letter-spacing:0.2pt;">n = 9 (%) </font>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
              <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:2.5pt 0pt 2.25pt 0pt; width:297.75pt;">
                <font style="letter-spacing:0.2pt;">Treatment-Emergent Adverse Event (TEAE) </font>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
              <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:2.5pt 0pt 2.25pt 0pt; width:60.75pt;">
                <font style="letter-spacing:0.2pt;">9 (100.0) </font>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
              <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:2.5pt 0pt 2.25pt 0pt; width:297.75pt;">
                <font style="letter-spacing:0.2pt;">TEAE, Related to CT-0508 </font>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
              <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:2.5pt 0pt 2.25pt 0pt; width:60.75pt;">
                <font style="letter-spacing:0.2pt;">8 (88.9) </font>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
              <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:2.5pt 0pt 2.25pt 0pt; width:297.75pt;">
                <font style="letter-spacing:0.2pt;">TEAE, Serious AE </font>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
              <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:2.5pt 0pt 2.25pt 0pt; width:60.75pt;">
                <font style="letter-spacing:0.2pt;">4 (44.4) </font>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
              <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:2.5pt 0pt 2.25pt 0pt; width:297.75pt;">
                <font style="letter-spacing:0.2pt;">TEAE, Serious AE Related to CT-0508 </font>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
              <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:2.5pt 0pt 2.25pt 0pt; width:60.75pt;">
                <font style="letter-spacing:0.2pt;">2 (22.2) </font>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
              <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:2.5pt 0pt 2.25pt 0pt; width:297.75pt;">
                <font style="letter-spacing:0.2pt;">TEAE, AEs of Special Interest</font>
              </td>
              <td style="padding:0pt; width:5.75pt;">&#8203;</td>
              <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
              <td style="padding:0pt; width:5.75pt;">&#8203;</td>
              <td style="padding:2.5pt 0pt 2.25pt 0pt; width:60.75pt;">
                <font style="letter-spacing:0.2pt;">7 (77.8)</font>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:3pt 0pt 2.25pt 0pt; width:297.75pt;">
                <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
                <div style=" float:left; margin-left:30pt; line-height:10pt; text-align:left; width:10pt;white-space:nowrap;font-family:Times New Roman, Times, serif;">&#9702;<br ></div>
                <div style=" line-height:10pt; text-align:left; margin-left:40pt;font-family:Times New Roman, Times, serif;">
                  <font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;">Grade 1</font>
                </div>
                <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
              </td>
              <td style="padding:0pt; width:5.75pt;">&#8203;</td>
              <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
              <td style="padding:0pt; width:5.75pt;">&#8203;</td>
              <td style="padding:3pt 0pt 2.25pt 0pt; width:60.75pt;white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">3 (33.3)</font>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:3pt 0pt 2.25pt 0pt; width:297.75pt;">
                <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
                <div style=" float:left; margin-left:30pt; line-height:10pt; text-align:left; width:10pt;white-space:nowrap;font-family:Times New Roman, Times, serif;">&#9702;<br ></div>
                <div style=" line-height:10pt; text-align:left; margin-left:40pt;font-family:Times New Roman, Times, serif;">
                  <font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;">Grade 2</font>
                </div>
                <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
              </td>
              <td style="padding:0pt; width:5.75pt;">&#8203;</td>
              <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
              <td style="padding:0pt; width:5.75pt;">&#8203;</td>
              <td style="padding:3pt 0pt 2.25pt 0pt; width:60.75pt;white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">4 (44.4)</font>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:3pt 0pt 2.25pt 0pt; width:297.75pt;">
                <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
                <div style=" float:left; margin-left:30pt; line-height:10pt; text-align:left; width:10pt;white-space:nowrap;font-family:Times New Roman, Times, serif;">&#9702;<br ></div>
                <div style=" line-height:10pt; text-align:left; margin-left:40pt;font-family:Times New Roman, Times, serif;">
                  <font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;">Grade 3</font>
                </div>
                <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
              </td>
              <td style="padding:0pt; width:5.75pt;">&#8203;</td>
              <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
              <td style="padding:0pt; width:5.75pt;">&#8203;</td>
              <td style="padding:3pt 0pt 2.25pt 0pt; width:60.75pt;white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">0 (0.0) </font>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:3pt 0pt 2.25pt 0pt; width:297.75pt;">
                <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
                <div style=" float:left; margin-left:30pt; line-height:10pt; text-align:left; width:10pt;white-space:nowrap;font-family:Times New Roman, Times, serif;">&#9702;<br ></div>
                <div style=" line-height:10pt; text-align:left; margin-left:40pt;font-family:Times New Roman, Times, serif;">
                  <font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;">Grade 4</font>
                </div>
                <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
              </td>
              <td style="padding:0pt; width:5.75pt;">&#8203;</td>
              <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
              <td style="padding:0pt; width:5.75pt;">&#8203;</td>
              <td style="padding:3pt 0pt 2.25pt 0pt; width:60.75pt;white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">0 (0.0) </font>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:3pt 0pt 2.25pt 0pt; width:297.75pt;">
                <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
                <div style=" float:left; margin-left:30pt; line-height:10pt; text-align:left; width:10pt;white-space:nowrap;font-family:Times New Roman, Times, serif;">&#9702;<br ></div>
                <div style=" line-height:10pt; text-align:left; margin-left:40pt;font-family:Times New Roman, Times, serif;">
                  <font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;">Grade 5 </font>
                </div>
                <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
              <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:3pt 0pt 2.25pt 0pt; width:60.75pt;white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">0 (0.0)</font>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
              <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:2.5pt 0pt 2.25pt 0pt; width:297.75pt;">
                <font style="letter-spacing:0.2pt;">Discontinued CT-0508 due to TEAE </font>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
              <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:2.5pt 0pt 2.25pt 0pt; width:60.75pt;">
                <font style="letter-spacing:0.2pt;">0 (0.0)</font>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #000000; width:3pt;">&#8203;</td>
              <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            </tr>
          </table>


          <div style="margin-top:13.19pt; text-align:center; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Summary of AEs by Preferred Term and by Severity</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>

        <div style="position:relative;margin-top:11.2pt; text-align:center; width:456pt;">
          <img src="tm2227887d4-bc_adverse4c.jpg" alt="[MISSING IMAGE: tm2227887d4-bc_adverse4c.jpg]" height="271" width="608" >
        </div>

          <div style="text-indent:20pt; margin-top:14.69pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">The best overall response was stable disease per RECIST 1.1 criteria. A best overall response of stable disease was observed in five out of nine patients. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
            <font style="letter-spacing:0.2pt;">Transient and low-grade fever was observed in seven out of nine patients post CT-0508 infusion. All fevers resolved within 48 hours. In concordance with clinical observations, a transient increase in serum&#160;IL-6, a pro-inflammatory cytokine, was observed. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
            <font style="letter-spacing:0.2pt;">Carisma evaluated the pharmacokinetics, or PK, of CT-0508 in the peripheral blood and the tumor. Similar peripheral blood PK was observed for all nine participants with CT-0508 detectable only on infusion days for four to eight hours post-infusion, consistent with rapid migration of CAR-M from the blood to tissues following infusion. CT-0508 was detected within the TME of eight out of nine evaluable patients assessed to date using RNAscope&#8482; technology as shown below. These data suggest that CT-0508 rapidly egresses from the peripheral blood and successfully traffic to the biopsied tumor mass. </font>
          </div>

      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">265</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:109.58pt;margin-left:69.66pt;width:456pt;">

          <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">CT-0508 Rapidly Migrates Out of the Blood and is Detected within the TME of 8/9 Participants Evaluated</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>

        <div style="position:relative;margin-top:11.19pt; text-align:center; width:456pt;">
          <img src="tm2227887d4-lc_rapidly4c.jpg" alt="[MISSING IMAGE: tm2227887d4-lc_rapidly4c.jpg]" height="170" width="578" >
        </div>

          <div style="text-indent:20pt; margin-top:14.69pt; width:456pt; line-height:12.5pt;">
            <font style="letter-spacing:0.2pt;">To evaluate the mechanism of action of CT-0508, single cell RNA sequencing, or scRNAseq, analysis was performed on fresh tumor biopsy to investigate changes within the TME following CT-0508 infusion. Analysis of screening (n=5), Day 8 post-infusion (n=5) and Week 4 post-infusion (n=3) biopsies revealed increases in CD8 T-cells, macrophages, and neutrophils on treatment consistent with inflammation and activation of an immune response. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
            <font style="letter-spacing:0.2pt;">These increases were also associated with reprogramming of the infiltrating macrophages toward an M1 phenotype by Week 4. </font>
          </div>


          <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12.5pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Single Cell RNAseq Analysis Demonstrates Remodeling of the Tumor Immune Landscape Following CT-0508 Infusion</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>

        <div style="position:relative;margin-top:11.19pt; text-align:center; width:456pt;">
          <img src="tm2227887d1-bc_single4clr.jpg" alt="[MISSING IMAGE: tm2227887d1-bc_single4clr.jpg]" height="181" width="608" >
        </div>

          <div style="text-indent:20pt; margin-top:14.69pt; width:456pt; line-height:12.5pt;">
            <font style="letter-spacing:0.2pt;">To evaluate whether CT-0508 was able to initiate anti-tumor adaptive immunity, TCR repertoire analysis was performed utilizing the Adaptive Biotechnologies&#8482; TCR sequencing platform. The analysis was performed on peripheral blood and tumor tissue. Peripheral blood TCR repertoire analysis revealed an expansion of T-cell clones in the blood of participants post CT-0508 infusion, indicative of the initiation of an adaptive immune response. </font>
          </div>

      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">266</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:53.11pt;margin-left:69.66pt;width:456pt;">

          <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Early Expansion of T-cells in the Periphery Following CT-0508 Infusion</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>

        <div style="position:relative;margin-top:11.19pt; text-align:center; width:456pt;">
          <img src="tm2227887d4-bc_mostpreva4c.jpg" alt="[MISSING IMAGE: tm2227887d4-bc_mostpreva4c.jpg]" height="293" width="581" >
        </div>

          <div style="text-indent:20pt; margin-top:14.69pt; width:456pt; line-height:12.5pt;">
            <font style="letter-spacing:0.2pt;">Based on scRNAseq analysis, the frequency of effector T-cells increased in all three participants with available screening and Week 4 biopsies (shown below). Furthermore, Carisma evaluated T-cell subtypes and found that Participant 1 demonstrated an increase in proliferating and effector memory CD8 T-cells, Participant 2 demonstrated an increase of all subsets except for activated CD8 T-cells, and Participant 4 demonstrated an increase in activated CD4, activated CD8 and effector memory CD8 T-cells. </font>
          </div>


          <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Frequency of effector T-cells in TME</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>

        <div style="position:relative;margin-top:11.19pt; text-align:center; width:456pt;">
          <img src="tm2227887d4-bc_frequen4c.jpg" alt="[MISSING IMAGE: tm2227887d4-bc_frequen4c.jpg]" height="228" width="437" >
        </div>

          <div style="text-indent:20pt; margin-top:14.69pt; width:456pt; line-height:12.5pt;">
            <font style="letter-spacing:0.2pt;">Differential gene expression analysis performed on biopsies collected at Week 4 post-CT-0508 infusion demonstrated an increased expression of genes associated with cytotoxic CD8 T-cell activation when compared to pre-treatment expression TME samples from six patients analyzed by RNA sequencing. </font>
          </div>

      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">267</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">

          <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Increased T-Cell Activation in the TME</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>

        <div style="position:relative;margin-top:9.2pt; text-align:center; width:456pt;">
          <img src="tm2227887d4-tbl_selct4c.jpg" alt="[MISSING IMAGE: tm2227887d4-tbl_selct4c.jpg]" height="174" width="571" >
        </div>

          <div style="text-indent:20pt; margin-top:12.6pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">TCR repertoire analysis of the TME revealed that newly expanded peripheral clones accumulated over time within the TME, suggesting that these clones are tumor reactive. Expanding T-cell clonotypes from patient 1, 2 and 4 at Week 4 post-infusion clustered with cells expressing high levels of CD8&alpha;, perforin, granzyme B, Ki67, IFN&#947;, and PD1 demonstrated their activated and/or proliferating CD8 cytotoxic T lymphocyte phenotype. </font>
          </div>


          <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Peripherally Expanded T-cell Clones Accumulate in the TME and Adopt a Cytotoxic Phenotype</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>

        <div style="position:relative;margin-top:9.2pt; text-align:center; width:456pt;">
          <img src="tm2227887d4-lc_pt4comp4c.jpg" alt="[MISSING IMAGE: tm2227887d4-lc_pt4comp4c.jpg]" height="168" width="608" >
        </div>

          <div style="text-indent:20pt; margin-top:12.61pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">While preliminary, the clinical data to date confirmed that CT-0508 is successfully manufactured from heavily pre-treated solid tumor patients, has been well tolerated, traffics to the tumor, activates the TME, and may initiate anti-tumor adaptive immunity. </font>
          </div>


          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Additional CT-0508 Studies</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>


          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">CT-0508 and Pembrolizumab combination sub study</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">This open-label sub study will assess the safety and feasibility of co-administering CT-0508 in combination with the PD-1 inhibitor, pembrolizumab. The target population for this sub study are subjects at least 18&#160;years of age who meet inclusion criteria per the main protocol and have HER2 over-expressing solid tumors and meet the sub study specific eligibility criteria. Carisma expects to report clinical data for this sub study in the second half of 2023. </font>
          </div>


          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">CT-0508 Intraperitoneal administration sub study</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">This sub study has been designed to assess the safety and feasibility of CT-0508 via regional administration into the peritoneal cavity. The target population for this sub study are subjects at least 18&#160;years of age who meet inclusion criteria per the main protocol, that have HER2 over-expressing gynecological cancers including but not limited to ovarian, fallopian tube, primary peritoneal, and endometrial cancers, who have disease spread mainly within the peritoneal cavity that meet the sub study specific eligibility criteria. Subjects will be enrolled at select clinical sites participating in Study 101 that have the capability to enroll and adequately treat subjects with intraperitoneal administration of CT-0508. Carisma expects to report clinical data for this sub study in the second half of 2023. </font>
          </div>

      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">268</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:5.95000000000005pt;margin-left:69.66pt;width:456pt;">

          <div style="width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">CT-0508 Biodistribution sub study</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
            <font style="letter-spacing:0.2pt;">This open-label sub study is designed to evaluate the whole body biodistribution of CT-0508 after intravenous administration using radiolabeled CT-0508 and longitudinal PET/CT imaging. This sub study includes </font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">89</font><font style="letter-spacing:0.2pt;">Zr-oxine radiolabeling a fraction of the CT-0508 cell product, followed by administration on Day&#160;1 and PET/CT imaging approximately on Day 1, 4, 8, 15, and 28 to assess trafficking and biodistribution of CT-0508. The target population for this sub study are subjects at least 18&#160;years of age that meet inclusion criteria per the main protocol. Subjects will be enrolled at specific sites in Study 101 that have the capability to perform </font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">89</font><font style="letter-spacing:0.2pt;">Zr-oxine labeling, administration, and routine PET/CT analysis. </font>
          </div>


          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Synergistic Potential of CAR-M Therapy with T-Cell Checkpoint Inhibitors</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
            <font style="letter-spacing:0.2pt;">Blocking the immune checkpoint molecule programmed cell death 1, or PD-1, has revolutionized cancer treatment for patients with a multitude of solid tumor indications. Pembrolizumab is a potent humanized immunoglobulin G4, or IgG4, monoclonal antibody, or mAb, with high specificity of binding to the PD-1 receptor, inhibiting its interaction with programmed cell death ligand 1, or PD-L1, and programmed cell death ligand 2, or PD-L2. While pembrolizumab is currently indicated for the treatment of patients across several solid tumor indications, the majority of patients have either primary or secondary resistance to immune checkpoint blockade and may benefit from combinatorial therapy that could overcome immune cell exclusion, poor antigen presentation, low T-cell infiltration, high TAM infiltration, a lack of productive co-stimulation, low mutational burden, IT immunosuppression, and a low frequency of tumor reactive T-cell clones. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
            <font style="letter-spacing:0.2pt;">Based on the data generated during pre-clinical development, CT-0508 cell product is able to specifically recognize, cancer cells through the binding of the CAR to HER2 expressed on the surface of these cells. This interaction triggers activation of the CAR-macrophages and results in direct anti-tumor effect by killing and phagocytosis of the tumor cells. In addition, CT-0508 recruits T-cells, activates the TME, and as professional antigen presenting cells, can process and present tumor associated antigen and/or neoantigens expressed by the tumor cells, leading to T-cell immunity against these specific antigens. However, this indirect anti-tumor effect involves the engagement of T-cells that may be actively suppressed, or exhausted, within the tumor micro-environment by a variety of factors including secreted immune-modulatory factors and inhibitory ligands expressed on both immune and tumor cells. Additionally, several studies have demonstrated that patients with low mutational burden, low MHC expression, defective antigen presentation, low CD8+&#160;T-cell infiltration, or minimal Th1 cytokine signatures tend to be unresponsive to PD-1 blockade. Therefore, based on the mechanism of action of CT-0508 and the limitations of PD-1 blockade, the combination of CAR-M therapy with PD-1 blockade therapy may be beneficial by enhancing antigen presentation (innate immunity) to initiate a robust anti-tumor T-cell response (adaptive immunity). </font>
          </div>


          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">CAR-M and PD-1 blockade combination therapy: Pre-clinical Development</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
            <font style="letter-spacing:0.2pt;">To model the combination of CT-0508 cell therapy with anti-PD-1 inhibitors, Carisma used a murine colorectal cancer cell line engineered to overexpress human HER2. Tumors were established in the flank of the immune competent mice and 14&#160;days post tumor inoculation, mice were randomized and received either murine CAR-M alone (IV), murine PD-1 blockade alone (IP) or a combination of both treatments. Using a regimen where CAR-M was injected first when the tumor was well established, followed by the anti-PD-1 inhibitor a few days later, neither murine CAR-M (Anti-HER2 muCAR-Mac) nor murine anti-PD1 monotherapy had a significant effect on tumor growth and overall survival. However, when co-administered the combination of both therapies resulted in significant tumor growth delay associated with prolonged survival of the mice (all mice in the combination group survived until the end of the study). All mice treated with the combination of Anti-HER2 muCAR-Mac and anti-PD1 mAb completely cleared their tumors (below). </font>
          </div>

      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">269</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:61.5599999999999pt;margin-left:69.66pt;width:456pt;">

          <div style="text-align:center; width:456pt; line-height:12.5pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Assessment of Tumor Burden and overall survival in a Syngeneic Mouse Model of Colon Carcinoma in response to treatment with IV CAR-M and Anti-PD-1 Therapy</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>

        <div style="position:relative;margin-top:11.19pt; text-align:center; width:456pt;">
          <img src="tm2227887d1-lc_asses4c.jpg" alt="[MISSING IMAGE: tm2227887d1-lc_asses4c.jpg]" height="489" width="608" >
        </div>
        <div style="margin-top:7.19pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>

          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-top:9.19pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">*</font>
            <br >
          </div>
          <div style=" margin-top:9.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
            <font style="letter-spacing:0.2pt;">Anti-HER2 muCAR-Mac are murine CAR-M and muUTD-Mac are untransduced murine CAR-M. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
            <font style="letter-spacing:0.2pt;">To determine the impact of Anti-HER2 muCAR-Mac and anti-PD-1 mAb combination therapy on tumor burden, tumor volumes were recorded during the treatment period (depicted in the left panel above) and mice were monitored for survival (depicted in the right panel above). </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
            <font style="letter-spacing:0.2pt;">In addition to the IV CAR-M alone and in combination with anti-PD-1 therapy study described above, Carisma has performed studies with IT administered murine CAR-M. In this study, anti-PD-1 therapy was administered four times, at 3-day intervals starting 14&#160;days post tumor inoculation (CAR-M therapy initiated on Day 15). IT murine CAR-M and anti-PD-1 therapy improved tumor control and significantly improved survival probability. Cumulative survival for all groups: 0% CR CTRL, 8.3% CR anti-PD-1, 38.9% CR CAR-M and 66.7% CR CAR-M and anti-PD-1: </font>
          </div>

      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">270</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">

          <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">IT CAR-M and Anti-PD-1 Combination Therapy Improves Survival in the CT26-HER2 Model</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>

        <div style="position:relative;margin-top:7.12pt; text-align:center; width:456pt;">
          <img src="tm2227887d1-lc_itcar4c.jpg" alt="[MISSING IMAGE: tm2227887d1-lc_itcar4c.jpg]" height="245" width="513" >
        </div>

          <div style="text-indent:20pt; margin-top:12pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Analysis of immune cell populations in the TME showed that macrophages were more abundant in the CAR-M samples while other myeloid cells and DCs showed the greatest infiltration in the combination group. A significant increase in total tumor infiltrating T-cells, and in particular helper T-cells, was noted in the combination therapy. </font>
          </div>


          <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Profound TME Modulation in Response to IT CAR-M and CAR-M +Anti-PD-1 Combination Therapy</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>

        <div style="position:relative;margin-top:7.12pt; text-align:center; width:456pt;">
          <img src="tm2227887d1-pht_profnd4clr.jpg" alt="[MISSING IMAGE: tm2227887d1-pht_profnd4clr.jpg]" height="441" width="579" >
        </div>

          <div style="text-indent:20pt; margin-top:12.01pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Analysis of the TCR repertoire demonstrated that IT administration of CAR-M in combination with a PD-1 blocking monoclonal antibody led to increased frequency of T-cells in the periphery and significantly modulated the TCR repertoire in the TME suggesting enhanced adaptive anti-tumor immunity. </font>
          </div>

      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">271</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:38.55pt;margin-left:69.66pt;width:456pt;">

          <div style="text-indent:20pt; width:456pt; line-height:12.5pt;">
            <font style="letter-spacing:0.2pt;">Based on these data, CAR-M and pembrolizumab represent a potentially synergistic immunotherapeutic combination regimen that combines CAR-M to infiltrate the TME, degrade the tumor via phagocytosis, and recruit and prime T-cells and pembrolizumab to prevent or reverse T-cell exhaustion. Patients with HER2 overexpressing tumors, such as metastatic breast cancer, gastric cancer, ovarian cancer, esophageal cancer, and others are generally poor responders to pembrolizumab. Carisma plans to evaluate CT-0508 in combination with pembrolizumab in an upcoming Phase&#160;1 clinical trial. </font>
          </div>


          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Additional Pipeline Candidates</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
            <font style="letter-spacing:0.2pt;">Carisma&#8217;s additional pipeline candidates are CAR-M therapies that incorporate all of the core elements of its macrophage cell engineering platform, along with certain new platform enhancements that Carisma is currently developing. The CT-1119 product candidate targets the mesothelin tumor associated antigen that is found on lung cancer, mesothelioma, pancreatic cancer, ovarian cancer, and numerous other solid tumors. The CT-0729 product candidate targets the PSMA tumor associated antigen that is found on prostate cancer. </font>
          </div>


          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">CT-1119 (Anti-Mesothelin CAR-M)</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
            <font style="letter-spacing:0.2pt;">Mesothelin is a well validated tumor associated antigen. Mesothelin has been shown to be aberrantly expressed on the surface of tumor cells and plays an important role in promoting cancer invasion and proliferation. Mesothelin has been demonstrated to be expressed at high levels in mesothelioma, lung cancer, ovarian cancer, pancreatic cancer, and other solid tumors with limited expression in normal tissue, though recent data suggests inflammation may induce expression. There are no approved anti-mesothelin agents and no approved cell therapies targeting any of the solid tumor types that overexpress mesothelin. Mesothelin positive solid tumors represent a significant unmet medical need. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
            <font style="letter-spacing:0.2pt;">While there are no mesothelin targeted approved agents, numerous clinical trials have been conducted targeting mesothelin and safety has been established with a variety of modalities including monoclonal antibodies, antibody drug conjugates, and CAR-T-cells. Targeting mesothelin enables a similar strategy to Carisma&#8217;s CT-0508 HER2 Phase&#160;1 trial in that it enables (i)&#160;a basket trial design that includes patients with diverse tumor types and (ii)&#160;separate arms for systemic and regional administration. There is a significant opportunity for regional administration of CT-1119, including intraperitoneal administration for mesothelin positive ovarian cancer with peritoneal metastasis and intrapleural administration for patients with malignant mesothelioma and lung tumors. There is also a significant opportunity for patients with mesothelin positive solid tumors with systemic metastasis. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
            <font style="letter-spacing:0.2pt;">To develop a mesothelin targeted CAR-M, Carisma has screened anti-mesothelin scFv&#8217;s using mRNA to identify humanized anti-mesothelin binders. Carisma obtained exclusive rights to a humanized anti-mesothelin scFv from the University of Pennsylvania. Carisma demonstrated that human CAR-M engineered with an Ad5f35 vector show high viability and efficiently express an anti-mesothelin (meso) CAR. Similar to CT-0508, CT-1119 adopts an M1 macrophage activation state. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
            <font style="letter-spacing:0.2pt;">CT-1119 effectively phagocytose mesothelin positive lung cancer (A549) and ovarian cancer (MesOV) cells as shown by two independent phagocytosis assays. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
            <font style="letter-spacing:0.2pt;">To evaluate the effector function of CT-1119, Carisma utilized mesothelin positive lung adenocarcinoma (A549) and ovarian cystadenocarcinoma (MesOV) cell lines. </font><font style="font-style:italic;letter-spacing:0.2pt;">In vitro</font><font style="letter-spacing:0.2pt;">, CT-1119 shows robust killing of lung cancer cells expressing mesothelin and CAR engagement induces the release of the pro-inflammatory cytokine TNF-&alpha; following stimulation with mesothelin expressing but not wild type (Wt) cell lines: </font>
          </div>

      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">272</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">

          <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">CT-1119 Kill and Produce Cytokine in Response to Biologically Relevant Targets</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>

        <div style="position:relative;margin-top:9.01pt; text-align:center; width:456pt;">
          <img src="tm2227887d1-bc_119ct4c.jpg" alt="[MISSING IMAGE: tm2227887d1-bc_119ct4c.jpg]" height="301" width="547" >
        </div>

          <div style="text-indent:20pt; margin-top:12.2pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">In order to evaluate the direct anti-tumor activity of CT-1119 in a relevant animal model, Carisma engrafted immunodeficient NSG-S mice with A549 lung adenocarcinoma cells expressing mesothelin by intravenous administration, which creates a lung metastasis model. CT1119 demonstrated the ability to reduce tumor progression and reduced the number of metastatic tumor nodules. </font>
          </div>

        <div style="position:relative;margin-top:9.4pt; text-align:center; width:456pt;">
          <img src="tm2227887d4-lc_ct1119a5494c.jpg" alt="[MISSING IMAGE: tm2227887d4-lc_ct1119a5494c.jpg]" height="304" width="361" >
        </div>

          <div style="text-indent:20pt; margin-top:12.21pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">These findings demonstrate that CT-1119, an autologous human anti-mesothelin CAR-M, can effectively phagocytose and kill target tumor cells as well as initiate pro-inflammatory cytokine production in response to mesothelin. Carisma believes that CAR-M is a feasible approach for the treatment of mesothelin expressing solid tumors and is advancing the development of this program toward a clinical trial. The IND is expected to be submitted in 2025. </font>
          </div>

        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CT-0729 (PSMA CAR-M)</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Prostate-specific membrane antigen, or PSMA, is highly specific to prostate cancer cells. </font><font style="font-style:italic;letter-spacing:0.2pt;">In vitro</font><font style="letter-spacing:0.2pt;"> studies have been conducted demonstrating that Carisma can: </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">273</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Express anti-PSMA CARs on human macrophages </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Mediate phagocytosis of PSMA overexpressing tumor cells </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Induce killing of PSMA overexpressing tumor cells </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Initiate cytokine release in a PSMA specific manner </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Generate M1 polarized anti-PSMA CAR-M </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">CT-0729 is in the discovery stage and a lead construct has not yet been nominated. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CAR-Mono: Pre-clinical Development</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Currently, the CAR-M platform requires differentiation of circulating monocytes into macrophage </font><font style="font-style:italic;letter-spacing:0.2pt;">ex vivo</font><font style="letter-spacing:0.2pt;"> prior to transduction with Ad5f35 to express the CAR. </font><font style="font-style:italic;letter-spacing:0.2pt;">Ex vivo</font><font style="letter-spacing:0.2pt;"> differentiation takes approximately one week and is associated with the loss of a fraction of cells during the differentiation process. Carisma hypothesized that monocytes could be directly engineered to express CARs, shortening the </font><font style="font-style:italic;letter-spacing:0.2pt;">ex vivo</font><font style="letter-spacing:0.2pt;"> manufacturing process from approximately eight days to approximately one to two days. By bypassing </font><font style="font-style:italic;letter-spacing:0.2pt;">ex vivo</font><font style="letter-spacing:0.2pt;"> differentiation, CAR monocytes will be administered to patients, wherein they will traffic to and enter tumor tissue, differentiating into macrophages </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;"> rather than </font><font style="font-style:italic;letter-spacing:0.2pt;">ex vivo.</font><font style="letter-spacing:0.2pt;"> CAR-Mono are a precursor to the CAR macrophage. Carisma further hypothesized that CAR-Mono may have improved tumor trafficking potential, given their smaller size and increased chemokine receptor expression. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">To determine the feasibility of generating CAR monocytes, or CAR-Mono, Carisma conducted </font><font style="font-style:italic;letter-spacing:0.2pt;">in vitro</font><font style="letter-spacing:0.2pt;"> time course studies to assess cell viability and CAR expression compared to untransduced monocytes. Following transduction with Ad5f35, CAR expression and cell viability were tracked </font><font style="font-style:italic;letter-spacing:0.2pt;">in vitro</font><font style="letter-spacing:0.2pt;"> for 28&#160;days. Viability was high (&gt;90%) and CAR expression was high (&gt;80%), and both stayed high for the entire 28&#160;days of culture. Durable CAR expression is critical to enable the cells to (a)&#160;retain CAR expression while trafficking to the tumor, (b)&#160;retain CAR expression during differentiation into CAR macrophages, and (c)&#160;to enable sustained anti-tumor activity. </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Carisma&#8217;s first CAR-Mono program is CT-0525, an autologous anti-HER2 CAR-Mono. CT-0525 is an advanced pre-clinical program, and Carisma plans to submit an IND for CT-0525 in the third quarter of 2023, followed by initiation of a Phase&#160;1 clinical trial. </font>
          </div>

        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The M1 phenotype of Carisma&#8217;s CAR-M platform is an important aspect of the mechanism of action. As monocytes are the precursors to macrophages, differentiation and cell morphology was evaluated after two days and seven days of culture. After seven days in culture, CAR-Mono showed a progressively increasing M1 phenotype (high CD80 and CD86 expression) and expressed CAR. Compared to untransduced monocytes cultured for two or seven days </font><font style="font-style:italic;letter-spacing:0.2pt;">in vitro</font><font style="letter-spacing:0.2pt;">, Ad5f35 transduced CAR-Mono upregulated M1 markers CD80 and CD86, confirming that Ad5f35 transduction similarly induces an M1 macrophage phenotype when added at the monocyte stage. Importantly, CAR-Mono-derived CAR-M had a similar morphology to CAR-M generated using the standard method&#8201;&#8212;&#8201;confirming morphologically that CAR-Mono differentiate into CAR-M. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">To confirm that CAR-Mono differentiate into CAR-M and take on an M1 phenotype </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;">, NSG-S mice were engrafted with NCI-H2444 (Non-Small Cell Lung Cancer). NSG-S mice are highly immunodeficient mice that express human Interleukin (IL)-3, human GM-CSF, and human stem cell factor. These animals support enhanced engraftment of myeloid cells compared to NOD/SCID Il2rg-/- (NSG) mice, they are ideal for studies investigating the adoptive transfer of myeloid cells. Untransduced control or CAR-Mono were intratumorally injected (N=3 donors) and tumors were harvested seven days post injection. Human immune cells were enriched using flow sorting and processed for scRNA sequencing. By comparing the gene expression of </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;"> and </font><font style="font-style:italic;letter-spacing:0.2pt;">in vitro</font><font style="letter-spacing:0.2pt;"> differentiated untransduced and CAR monocytes, Carisma&#8217;s data suggest that the monocytes have the potential to differentiate into macrophages and adopt an M1 like phenotype. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">CAR-M are able to directly kill tumor cells via phagocytosis and release of cytotoxic mediators such as TNF&alpha;. Carisma evaluated the direct tumor killing capacity of CAR-Mono at Day 2 (monocyte phase) and Day 7 (macrophage phase). AU565, a HER2+ breast cancer cell line, was utilized as the target tumor cell. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">274</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma&#8217;s data show that CAR-Mono mediated effective killing at Day 2 and that fully differentiated CAR-Mono-derived CAR-M (Day 7) also efficiently cleared tumor cells. When comparing CAR-Mono-derived CAR-M (Day 7) to CT-0508, Carisma found that CAR-Mono led to improved tumor killing and inflammatory cytokine production. </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CAR-Mono-derived CAR-M Show Robust Tumor Killing Activity</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-top:11.2pt; text-align:center; width:456pt;">
          <img src="tm2227887d1-lc_carmno4c.jpg" alt="[MISSING IMAGE: tm2227887d1-lc_carmno4c.jpg]" height="284" width="578" >
        </div>
        <div style="margin-top:18.69pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CAR-Mono-derived CAR-M Cocultures Show Robust Proinflammatory Cytokine Production</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-top:11.19pt; text-align:center; width:456pt;">
          <img src="tm2227887d1-bc_cyto4c.jpg" alt="[MISSING IMAGE: tm2227887d1-bc_cyto4c.jpg]" height="258" width="591" >
        </div>
        <div style="text-indent:20pt; margin-top:14.69pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma previously demonstrated that CT-0508 CAR-M are locked into an M1 phenotype by Ad5f35 transduction, and resist M2 conversion by immunosuppressive cytokines. Carisma evaluated whether CAR-Mono similarly resisted M2 environments by culturing the cells for seven days in the presence of M-CSF (differentiation factor) or M-CSF plus the immunosuppressive cytokines IL-10 and TGF-&beta; during differentiation. CAR-Mono showed resistance to polarization and continued to express CD86 (M1) and not CD163 (M2) as demonstrated by flow cytometry and bulk RNA sequencing of untransduced and CAR-Mono-derived CAR-M. Additionally, untransduced monocytes but not CAR-Mono significantly upregulated CD163 in response to IL-10 and TGF-&beta;. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">275</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CAR-Mono Are Protected Against M2 Polarization</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-top:10.6pt; text-align:center; width:456pt;">
          <img src="tm2227887d1-lc_polar4c.jpg" alt="[MISSING IMAGE: tm2227887d1-lc_polar4c.jpg]" height="219" width="578" >
        </div>
        <div style="text-indent:20pt; margin-top:13.99pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">An important element to Carisma&#8217;s cell therapies is the long-term expression of its engineered CAR payloads by human myeloid cells. To evaluate persistence </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;">, monocytes were engineered with a modified Ad5f35 vector that induces the co-expression of CAR and luciferase under a single promoter by using a ribosomal skip site. This approach enables the ability to track luciferase using bioluminescent imaging and infer not only the viable persistence but also the CAR expression of human monocytes in mice. Ad5f35 engineered CAR-Luciferase Mono was injected intravenously into NSG or NSG-S mice and imaged for 180&#160;days. While both NSG and NSG-S mice are immunodeficient, only NSG-S mice constitutively express human cytokines that promote myeloid cell survival (GM-CSF, IL3, and SCF). Carisma found that human CAR-Mono persisted for at least 180&#160;days </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;">, independent of cytokine support. </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CT-0525 Show Long Term Persistence </font><font style="font-style:italic;letter-spacing:-0.2pt;">In Vivo</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-top:10.5pt; text-align:center; width:456pt;">
          <img src="tm2227887d4-lc_persis4c.jpg" alt="[MISSING IMAGE: tm2227887d4-lc_persis4c.jpg]" height="327" width="576" >
        </div>
        <div style="text-indent:20pt; margin-top:14pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">To determine whether CAR-Mono are able to control tumor growth in xenograft models, Carisma utilized a SKOV3 HER2+ ovarian cancer intraperitoneal carcinomatosis model. Anti-HER2 CAR-Mono significantly suppressed tumor growth and prolonged survival up to 120&#160;days post treatment, while mice that received untransduced control monocytes or mice that were left untreated only survived for &lt;60&#160;days. Carisma is currently evaluating CAR-Mono in immunocompetent models. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">276</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:9.62pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CT-0525 Suppress Tumor Growth </font><font style="font-style:italic;letter-spacing:-0.2pt;">In Vivo</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-top:11.19pt; text-align:center; width:456pt;">
          <img src="tm2227887d4-lc_tumor4c.jpg" alt="[MISSING IMAGE: tm2227887d4-lc_tumor4c.jpg]" height="220" width="578" >
        </div>
        <div style="text-indent:20pt; margin-top:14.69pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">In summary, CAR-Mono were successfully generated with high efficiency and viability in a rapid, one-to-two day manufacturing process. CAR-Mono demonstrated stable CAR expression and viability </font><font style="font-style:italic;letter-spacing:0.2pt;">in vitro</font><font style="letter-spacing:0.2pt;">, and persisted for at least six&#160;months </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo.</font><font style="letter-spacing:0.2pt;"> CAR-Mono differentiated into CAR-M efficiently and adopted an M1 macrophage phenotype, and resisted conversion to M2 in immunosuppressive environments. CAR-Mono were able to kill tumors cells in the monocyte phase and the macrophage phase. CAR-Mono controlled tumor growth in a xenograft mouse model of cancer. Based on the pre-clinical data to date, Carisma believes that CAR-Mono represents a potentially promising approach for cancer immunotherapy, while meaningfully expanding Carisma&#8217;s proprietary platform. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Next Generation Constructs</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma&#8217;s discovery team is developing a next generation CAR-M platform utilizing enhanced CAR constructs to increase potency and functionality of the engineered cells. This includes optimization of each element of the CAR itself&#8201;&#8212;&#8201;the binder (which gives the CAR specificity to a target antigen), the hinge (which connects the binder to the transmembrane domain and gives the CAR length and flexibility), the transmembrane domain (which spans the cell membrane), and the intracellular signaling domains (which are responsible for activation of immune cell function). It is well accepted in the immunology field that T-cells require multiple signals for activation&#8201;&#8212;&#8201;signal 1 deriving from the TCR, and signal 2 deriving from co-stimulatory receptors such as CD28 or 4-1BB. Thus, all approved CAR-T products are second generation CARs, incorporating CD3&#950; as a primary signaling domain and either 4-1BB or CD28 as co-stimulatory domains. Third generation CARs, incorporating three signaling domains, have also been evaluated in T-cells. Unlike T-cells, macrophages do </font><font style="font-style:italic;letter-spacing:0.2pt;">not</font><font style="letter-spacing:0.2pt;"> require co-stimulation for activation and can be activated through a single signal, such as through an Fc receptor. However, multiple signaling pathways have the ability to enhance the macrophage response and may improve targeT-cell killing, cytokine/chemokine release, and macrophage activation. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Next Generation CAR-M Constructs</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma has been routinely developing and evaluating novel CAR-M constructs. Carisma&#8217;s well-established CAR-M assays enable a distinct opportunity to identify improved constructs in an efficient manner. Based on Carisma&#8217;s early findings, CD3&#950; is a potent activator of macrophage function and induces phagocytosis, cytokine release, chemokine release, killing, and activation of pro-inflammatory genes. Given this finding, Carisma has been evaluating the addition of other innate immune receptors such as Toll-like receptors, CD40, MyD88, Dectin-1, to CD3&#950; to improve upon CAR-M functionality. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">277</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="position:relative;margin-top:8pt; text-align:center; width:456pt;">
          <img src="tm2227887d4-fc_antibody4c.jpg" alt="[MISSING IMAGE: tm2227887d4-fc_antibody4c.jpg]" height="276" width="370" >
        </div>
        <div style="margin-top:13.52pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Next Generation Construct: Pre-clinical Development</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.12pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma&#8217;s preliminary data assessing tumor cell killing activity with CAR variants at a low &#8220;stress test&#8221; dose shows increased potency at low effector (macrophage) to target (tumor cell) ratios. CD40 is an activating receptor found on antigen presenting cells including macrophages that is activated after binding to CD40-Ligand, typically expressed on activated T-cells. CD40 signals through numerous second messengers leading to the activation of NF-&#1008;B and other transcription factors that induce a potent M1 phenotype and activate antigen presenting cells. MyD88 is expressed in macrophages and acts as an adaptor that plays a pivotal role in the signaling of Toll-like receptors. Carisma has found that addition of MyD88 and CD40 to CD3&#950; CAR-M, in a specific sequence with a specific hinge domain, leads to a significant improvement to macrophage anti-tumor activity. </font>
        </div>
        <div style="margin-top:11.02pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Addition of the MyD88/CD40 pathway significantly increases CAR-M potency</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-top:7.11pt; text-align:center; width:456pt;">
          <img src="tm2227887d1-lc_poten4c.jpg" alt="[MISSING IMAGE: tm2227887d1-lc_poten4c.jpg]" height="269" width="480" >
        </div>
        <div style="text-indent:20pt; margin-top:10.32pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Further testing of the M88-CD40-CD3&#950; CAR and other novel CAR-M are ongoing. Leading second/</font>&#8203;<font style="letter-spacing:0.2pt;">third generation CAR candidates may be incorporated into future autologous, allogeneic, or </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;"> LNP programs. </font></div>
        <div style="margin-top:10.92pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Novel Modalities</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.12pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma is applying learnings from its autologous CAR-M data, tools, and processes to establish off-the-shelf engineered macrophage therapeutics. To broaden the application of CAR myeloid cell therapy, Carisma </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">278</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">is actively seeking to develop a gene edited iPSC-derived macrophage platform. The goal is to establish a process to generate allogeneic, iPSC-derived M1, M2, or CAR myeloid cells. One approach is using allogeneic iPSC myeloid cells manufactured using the following summary process: </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">iPSC-Derived Myeloid Cells: Summary</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-top:7.12pt; text-align:center; width:456pt;">
          <img src="tm2227887d1-pht_ipsc4clr.jpg" alt="[MISSING IMAGE: tm2227887d1-pht_ipsc4clr.jpg]" height="412" width="547" >
        </div>
        <div style="text-indent:20pt; margin-top:11.31pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Initial </font><font style="font-style:italic;letter-spacing:0.2pt;">in vitro</font><font style="letter-spacing:0.2pt;"> studies show that iPSCs can be converted to monocytes or macrophages, skewed to an M1 or M2 phenotype with cytokine culture, and can be engineered with Carisma&#8217;s proprietary vectors to express tumor targeting CARs. In addition to offering an allogeneic, universal donor platform, iPSCs are expandable cells&#8201;&#8212;&#8201;unlike primary human monocytes or macrophages which are terminally differentiated. In the first 15&#160;days of the process, Carisma noted &gt;1,000x expansion. It took approximately 15&#160;days to generate iPSC-derived monocytes and approximately 20&#160;days to generate iPSC-derived macrophages. The process is currently being performed in a non-GMP research environment at research scale but has the potential to be developed into a commercial scale, GMP process in the future. The macrophages generated with this process express canonical macrophage markers, appear macrophage-like with Giemsa staining and microscopic evaluation, and importantly demonstrate cell-to-cell uniformity in morphology. </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">iCAR-M Production</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-top:7.12pt; text-align:center; width:456pt;">
          <img src="tm2227887d1-bc_icar4c.jpg" alt="[MISSING IMAGE: tm2227887d1-bc_icar4c.jpg]" height="180" width="516" >
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">279</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">iCAR-M Anti-Tumor Activity</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In order to confirm that iPSC-derived macrophages are effectively redirected against tumor associated antigens, Carisma introduced the anti-HER2 CAR into iPSC-derived macrophages using Ad5f35. Engineered iPSC-derived macrophages efficiently expressed CAR, upregulated M1 markers, and demonstrated an acceptable viability. To evaluate anti-tumor function, Carisma conducted an </font><font style="font-style:italic;letter-spacing:0.2pt;">in vitro</font><font style="letter-spacing:0.2pt;"> killing assay in which AU565 HER2+ breast cancer cells were cultured alone, together with iPSC-derived control macrophages, or iPSC-derived CAR-M. As shown below, while the control iPSC macrophages had minimal anti-tumor effect (orange), the iPSC-derived CAR-M cleared tumor cells over approximately 72 hours. </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">iPSC-Derived CAR-M Exert Potent Anti-Tumor Activity</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-top:10pt; text-align:center; width:456pt;">
          <img src="tm2227887d4-lc_ipscmacs4c.jpg" alt="[MISSING IMAGE: tm2227887d4-lc_ipscmacs4c.jpg]" height="315" width="502" >
        </div>
        <div style="text-indent:20pt; margin-top:13pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">While iCAR-M appear to be able to exert direct anti-tumor functionality, there are inherent complexities that will be critical to inform the ultimate allogeneic macrophage strategy. CAR-M exert anti-tumor immunity through tumor infiltration, phagocytosis, cytokine/chemokine release, TME activation, T-cell recruitment, and antigen presentation. To enable an allogeneic off-the-shelf iCAR-M program, the cells will inherently be either MHC mismatched or MHC-edited (for example, MHC-I and MHC-II may be deleted using CRISPR/</font>&#8203;<font style="letter-spacing:0.2pt;">Cas9 editing to generate universally accepted macrophages), and thus may have limited direct antigen presentation potential. However, iCAR-M are expected to maintain the other mechanisms of action, as summarized below. Future studies will evaluate whether allogeneic CAR-M are capable of inducing epitope spreading, as indirect mechanisms of antigen presentation have not been ruled out. </font></div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Importantly, the iPSC-derived myeloid cell platform, combined with Carisma&#8217;s gene engineering capabilities, has the potential to be produced in multiple ways. First, iPSC-derived myeloid cells can be expanded, qualified, and banked prior to being used as a master cell bank source for the production of engineered myeloid cell therapies. In this example, iPSC-derived myeloid cells would be engineered with Carisma&#8217;s proprietary methods (Ad5f35, Vpx-LV, modified mRNA, or other) after differentiation into the desired myeloid cell subtype. Alternatively, Carisma is optimizing methods to introduce the CAR (or other genetic payload) at the iPSC stage using targeted integration into desired genomic loci, isolating iPSC clones with integrated genes and additional potential genetic edits, and differentiating these cells into monocytes or macrophages, and skewing them to an M1 phenotype using Carisma&#8217;s proprietary polarization processes. For this approach, care must be taken to ensure that the CAR (or other payload) is not epigenetically downregulated or lost during the myeloid differentiation process. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">While the current focus of Carisma&#8217;s discovery efforts is to ultimately generate iCAR-M, the platform is expected to be readily adaptable to either develop (a)&#160;myeloid cells engineered with other anti-tumor </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">280</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:323.47pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">payloads, or (b)&#160;myeloid cells engineered with payloads designed to ameliorate disease outside of oncology. Notably, Carisma has early non-oncology programs in liver fibrosis, neurodegeneration, and auto-immunity/</font>&#8203;<font style="letter-spacing:0.2pt;">chronic inflammation which can be combined with the iPSC-derived myeloid cell platform. Currently, Carisma&#8217;s pipeline is focused on autologous approaches and direct </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;"> reprogramming, and the allogeneic iPSC-derived platform is at the pre-clinical discovery stage. </font></div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">LNP/mRNA Platform (Moderna Collaboration)</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">In collaboration with Moderna, Carisma is developing an mRNA based </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;"> CAR-M platform for oncology. This approach is highly differentiated in the cell therapy space&#8201;&#8212;&#8201;not only because it relies on myeloid cells as the engineered effectors, but also because it utilizes direct </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;"> reprogramming of a patients&#8217; own cells with a well-validated LNP/mRNA platform. By engineering a patients&#8217; own cells directly within their body, </font><font style="font-style:italic;letter-spacing:0.2pt;">ex vivo</font><font style="letter-spacing:0.2pt;"> autologous or allogeneic cell manufacturing is entirely bypassed&#8201;&#8212;&#8201;significantly increasing the commercial potential of the therapy. Importantly, while this approach enables an off-the-shelf therapy, the engineered cells are autologous, as it is the patients&#8217; own cells being engineered into CAR-M </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;">, or directly within their body. This strategic partnership enables Carisma to apply the learnings gleaned from autologous CAR-M development to expand its pipeline to up to 12 additional oncology candidates. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Studies with the myeloid tropic LNP have shown mRNA delivery is specific for myeloid cells (monocytes, macrophages, dendritic cells). Based on clinical data using other (non-CAR) payloads, Moderna has previously demonstrated that the LNP was well-tolerated after systemic administration and could furthermore be re-dosed. Preliminary data have demonstrated that the LNP is efficient in transfecting myeloid cells </font><font style="font-style:italic;letter-spacing:0.2pt;">in vitro</font><font style="letter-spacing:0.2pt;"> and </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;">. In addition, preliminary data confirms high CAR expression, viability, and CAR-M function, and availability of pre-clinical data is expected mid-2023. The platform summary for the </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;"> CAR-M approach is shown below: </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">281</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">Myeloid Tropic LNP/mRNA Platform (Moderna Collaboration)</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-top:11.19pt; text-align:center; width:456pt;">
          <img src="tm2227887d1-pht_myloid4clr.jpg" alt="[MISSING IMAGE: tm2227887d1-pht_myloid4clr.jpg]" height="658" width="456" >
        </div>
        <div style="margin-top:18.69pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">LNP/mRNA Pre-clinical Data (Moderna Collaboration): Pre-clinical Development</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">In vitro</font><font style="letter-spacing:0.2pt;"> pre-clinical studies with the myeloid tropic LNP/mRNA platform have shown efficient transfection. Carisma has optimized conditions for </font><font style="font-style:italic;letter-spacing:0.2pt;">ex vivo</font><font style="letter-spacing:0.2pt;"> LNP/mRNA delivery to human and murine monocytes/macrophages, as well as primary murine myeloid cells to establish various relevant murine tumor models. Carisma&#8217;s goal was to establish a platform with high viability (&gt;70%), high transfection efficiency (&gt;70%), and significantly increased CAR-M killing activity compared to untransfected control macrophages. Key data for the anti-HER2 CAR constructs CTX_001 and CTX_219 are shown in the figures below: </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">282</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">LNP Transfection is Well Tolerated by Human Macrophages</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-top:11.19pt; text-align:center; width:456pt;">
          <img src="tm2227887d4-lc_lnp4c.jpg" alt="[MISSING IMAGE: tm2227887d4-lc_lnp4c.jpg]" height="209" width="544" >
        </div>
        <div style="margin-top:18.69pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">LNP Engineering leads to Dose Dependent CAR Expression</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-top:11.2pt; text-align:center; width:456pt;">
          <img src="tm2227887d4-lc_2lnp4c.jpg" alt="[MISSING IMAGE: tm2227887d4-lc_2lnp4c.jpg]" height="200" width="544" >
        </div>
        <div style="text-indent:20pt; margin-top:14.69pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In addition to CAR expression and viability, Carisma has shown that one day post transfection, CTX001 and CTX219 mediate potent killing activity against target AU565 cells. </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">LNP Engineered CAR-M Display Effective Killing Function</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-top:11.19pt; text-align:center; width:456pt;">
          <img src="tm2227887d4-lc_3lnp4c.jpg" alt="[MISSING IMAGE: tm2227887d4-lc_3lnp4c.jpg]" height="223" width="533" >
        </div>
        <div style="text-indent:20pt; margin-top:14.69pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Statistical analysis was determined using Two-way ANOVA, * p&lt;0.5 **** p&lt;0.0001. The data were generated from N=3 donors (3 technical replicates per donor). </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">283</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">LNP Transfection is Well Tolerated by Human Monocytes</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-top:10.7pt; text-align:center; width:456pt;">
          <img src="tm2227887d4-lc_4lnp4c.jpg" alt="[MISSING IMAGE: tm2227887d4-lc_4lnp4c.jpg]" height="231" width="565" >
        </div>
        <div style="margin-top:17.39pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">LNP Engineering leads to Dose Dependent CAR Expression in Monocytes</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-top:10.7pt; text-align:center; width:456pt;">
          <img src="tm2227887d4-lc_5lnp4c.jpg" alt="[MISSING IMAGE: tm2227887d4-lc_5lnp4c.jpg]" height="215" width="559" >
        </div>
        <div style="text-indent:20pt; margin-top:13.4pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In addition to CAR expression and viability, Carisma has shown that monocytes engineered with LNP/mRNA encoding the CARs CTX001 and CTX219 mediate potent killing activity against target AU565 breast cancer cells. These findings demonstrate similarity between LNP engineered macrophage and monocyte effector function. </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">LNP Engineered CAR-Mono Display Effective Killing Function</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-top:10.8pt; text-align:center; width:456pt;">
          <img src="tm2227887d4-lc_6lnp4c.jpg" alt="[MISSING IMAGE: tm2227887d4-lc_6lnp4c.jpg]" height="229" width="533" >
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">284</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Statistical analysis was determined using Two-way ANOVA, * p&lt;0.5 **** p&lt;0.0001. The data were generated from N=3 donors (three technical replicates per donor). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">To model direct reprogramming of TAMs to CAR-M, Carisma generated tumor spheroids comprised of HER2+ breast cancer cells and human TAMs.&#160;Carisma confirmed that the macrophages embedded within these spheroids adopted an M2, TAM-like phenotype. Carisma added LNPs (containing CAR mRNA and an M1 polarizing gene) directly to the tumor spheroids and found that the reprogrammed TAMs mediated tumor spheroid shrinking over a 72-hour period. </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Directly Reprogramming Myeloid Cells </font><font style="font-style:italic;letter-spacing:-0.2pt;">within Tumors</font><font style="letter-spacing:-0.2pt;"> with LNP/mRNA</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-top:9.8pt; text-align:center; width:456pt;">
          <img src="tm2227887d1-pht_reprobw.jpg" alt="[MISSING IMAGE: tm2227887d1-pht_reprobw.jpg]" height="201" width="517" >
        </div>
        <div style="text-indent:20pt; margin-top:12.6pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The first four indications have been nominated by Moderna, spanning both solid tumors and hematologic malignancies. Pre-clinical platform optimization, as well as target discovery and CAR development, are ongoing in parallel. Early </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;"> proof of concept is expected in 2023. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">EM-C: A novel platform for regulation of inflammation</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Cytokines in tissue microenvironments regulate the balance between pro- and anti-inflammatory signaling. Dysregulated cytokine expression causes deleterious immunosuppression or inflammation, underpinning the pathophysiology of numerous diseases. As examples, anti-inflammatory cytokines in solid tumors suppress immune activation and safeguard the tumor, whereas pro-inflammatory cytokines in rheumatoid arthritis drive chronic inflammation. Rebalancing inflammation/immunosuppression by targeting aberrant cytokine signaling offers a generalizable approach to treating many diseases, but systemic cytokine blockade carries risks such as increased risk of serious infection. Cellular immunotherapies may offer a localized platform that could activate in response to cytokines then proportionately remodel the microenvironment&#8217;s inflammatory state as needed. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Macrophages are tissue infiltrating homeostatic regulators responsible for the initiation and resolution of inflammation. Carisma leveraged the ability of macrophages to regulate inflammation by generating macrophages that express genetically engineered, synthetic cytokine switch receptors (SR). Carisma termed this platform EM-C and evaluated its modular ability to convert immunosuppressive M2 signals into pro-inflammatory M1 responses for solid tumor microenvironment conversion, or vice versa for the conversion of pro-inflammatory M1 signals into immunosuppressive M2 responses for auto-immune or inflammatory diseases. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">EM-Cs were generated by expressing SRs in primary human macrophages. First, Carisma generated SRs that convert immunosuppressive signals into inflammatory signals&#8201;&#8212;&#8201;focusing on IL-10. To convert IL-10 (a cytokine well known to polarize macrophages toward an M2 phenotype) in the TME into a pro-inflammatory signal, an IL-10 SR was designed by fusing the extracellular domain of the IL-10 receptor to an engineered portion of the IFN&#955; receptor. The </font><font style="font-style:italic;letter-spacing:0.2pt;">in vitro</font><font style="letter-spacing:0.2pt;"> response of IL-10 EM-Cs to IL-10 was monitored by the expression of M1 and M2 markers. While control untransduced or CAR (a control irrelevant construct) expressing macrophages responded to IL-10 through the downregulation of M1 markers and upregulation of M2 markers, IL10-SR EM-Cs upregulated M1 markers and downregulated M2 markers. These data and others demonstrate that Carisma&#8217;s IL10-SR EM-Cs can induce an inflammatory response when exposed </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">285</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tMAD">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">to immunosuppressive conditions. Carisma has generated numerous additional EM-Cs that respond to other immunosuppressive factors, such as TGF&beta;. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Conversely, Carisma sought to develop EM-Cs that can convert inflammatory cytokines into anti-inflammatory responses. As myeloid cells are recruited to sites of inflammation. This approach would enable a myeloid cell therapy that accumulates at inflammatory sites and locally shuts down inflammation. This approach may have broad utility in autoimmunity, chronic inflammation, fibrosis, transplant, and graft versus host disease. Carisma generated EM-Cs targeting IFN-&#947; and demonstrated that while control untransduced or CAR (an irrelevant payload) macrophages respond to IFN-&#947; by upregulating M1 markers and downregulating M2 markers, IFN-&#947; SR EM-Cs responded to IFN-&#947; by downregulating M1 markers and upregulating M2 markers. These data demonstrate that Carisma&#8217;s proprietary EM-C platform can be broadly utilized to generate engineered macrophages with the ability to control the inflammatory nature of environments, and act as living converters, with broad potential applicability to oncology, autoimmunity, chronic inflammation, and other indications. This platform offers broad opportunity for strategic partnership. </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Macrophages Expressing Cytokine Switch Receptors Can Invert</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Pro- or Anti-Inflammatory Signals</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-top:10.2pt; text-align:center; width:456pt;">
          <img src="tm2227887d1-lc_macro4c.jpg" alt="[MISSING IMAGE: tm2227887d1-lc_macro4c.jpg]" height="267" width="570" >
        </div>
        <div style="margin-top:17.39pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Indications Beyond Oncology</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">While Carisma is an oncology focused company, the macrophage engineering platform Carisma has established offers broad opportunity to develop cell therapies for indications beyond oncology. Carisma has numerous early-stage research programs designed to produce development candidates for liver fibrosis, neurodegenerative disease, and autoimmunity/chronic inflammation. Carisma&#8217;s new product candidates will incorporate all the core elements of its macrophage cell engineering platform, plus certain indication specific modifications uniquely designed to address the pathology of each indication. While autologous cell therapy may be utilized for proof of concept, these indications have the potential to be combined with Carisma&#8217;s allogeneic or off-the-shelf therapeutic approaches. Indications beyond oncology offer opportunities for strategic partnerships to accelerate the development of these programs. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Manufacturing and Delivery</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma does not own or operate, and currently has no plans to establish, any manufacturing facilities. Carisma currently relies on and expects to continue to rely on third-party contract development manufacturing organizations, or CDMOs, for the manufacturing and release testing of viral vectors and cell drug products. Carisma also currently relies on third parties for patient leukapheresis material logistics as well as to package, label, store, and distribute the cell drug products. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">286</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tINPR1">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma has established and will continue to establish arrangements with contract manufacturers to supply clinical materials and manufacturing capabilities for Carisma&#8217;s clinical trials. Carisma currently obtains its supplies from these manufacturers on a purchase order basis and does not have long-term supply arrangements in place. Should any of these manufacturers become unavailable to Carisma for any reason, Carisma believes that there are several potential replacements, although Carisma may incur some delay in identifying and qualifying such replacements. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma also plans to continue to expand the scope and number of its collaborations to further develop its manufacturing capabilities and to minimize manufacturing risk. As Carisma scales to commercialization, it expects to increase its capacity with its current suppliers and evaluate other options to secure commercial scale capacity. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Manufacturing Process for CT-0508</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">A CDMO is used to produce cGMP lots of viral vector. The CT-0508 drug substance process begins by isolating the monocyte population from a single fresh patient leukopak mobilized by donor pretreatment with filgrastim. The resulting monocytes are cultured in the presence of a cytokine and other factors to induce differentiation into macrophages. The resulting macrophages are then transduced with the Ad5f35 vector encoding an anti-HER2 CAR. The resulting cells are then harvested as drug substance. Macrophages derived from a single leukopak from one patient comprise one batch of CT-0508. Final formulation is performed and transferred into freezing bags to generate drug product. The drug product is carefully frozen in a controlled process and then placed into secured storage and maintained at a temperature of &gt;-135&#8304; Celsius. Safety and specification tests are performed and if found acceptable the product is released and shipped to clinical trial sites. The current process from receipt of leukopak to drug product and cryopreservation is eight days. </font>
        </div>
        <div style="position:relative;margin-top:9.8pt; text-align:center; width:456pt;">
          <img src="tm2227887d4-fc_carm4c.jpg" alt="[MISSING IMAGE: tm2227887d4-fc_carm4c.jpg]" height="218" width="605" >
        </div>
        <div style="text-indent:20pt; margin-top:12.6pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma plans to continue to invest in process improvements to reduce the overall manufacturing process time and improve costs for the viral vector and cell drug product. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Intellectual Property</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma strives to protect and enhance its proprietary technology, inventions and improvements that Carisma believes are commercially important to the development of its business, including through seeking, maintaining and defending patent rights, whether developed internally or licensed from third parties. Carisma also intends to rely on trade secrets related to its proprietary technology platform and its know-how, continuing technological innovation and in-licensing opportunities to develop, strengthen and maintain its proprietary position in the fields of cancer and other indications including those related to neurodegeneration, liver fibrosis and autoimmune disease, which may be important for the development of Carisma&#8217;s business. Carisma additionally may rely on regulatory protection afforded through data exclusivity, market exclusivity and patent term extensions, where available. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma&#8217;s commercial success may depend, in part, on its ability to obtain and maintain patent and other proprietary protection for commercially important technology, inventions and know-how related to </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">287</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">its business, defend, and enforce its patents, preserve the confidentiality of its trade secrets and operate without infringing the valid enforceable patents and proprietary rights of third parties. Carisma&#8217;s ability to stop third parties from making, using, selling, offering to sell or importing its products may depend on the extent to which it has rights under valid and enforceable licenses, patents or trade secrets that cover these activities. With respect to both Carisma&#8217;s owned and licensed intellectual property, Carisma cannot be sure that patents will be granted with respect to any of its pending patent applications or with respect to any patent applications filed by Carisma in the future, nor can it be sure that any of its existing patents or any patents that may be granted to Carisma in the future will be commercially useful in protecting its commercial products and methods of manufacturing such products, as well as being held valid if challenged. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma currently controls over 15 granted patents and over 41 patent applications pending in several jurisdictions, including the United States, Europe, Australia, Brazil, Canada, China, Israel, Japan, Korea, Mexico, New Zealand, and Singapore. Intellectual property is a critical component of Carisma&#8217;s business plan for maximizing return on its investments. Carisma is actively developing intellectual property and will continue to maintain and defend United States and international patent rights for its products, technology, and development and improvement of its discovery platforms. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">To maintain its competitive position in the market, Carisma has spent considerable effort securing intellectual property rights, including several patent rights related to its proprietary CAR technology and myeloid cell engineering technology. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Exclusively Licensed Intellectual Property&#8201;&#8212;&#8201;UPenn</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma has exclusive rights to three patent families, and non-exclusive rights to related know-how by virtue of a license agreement with the University of Pennsylvania. These patent families are directed to, among other things, methods of efficiently expressing CARs in myeloid cells, including monocytes, macrophages, and dendritic cells and enhancing effector activity, as well as the modified cells and compositions including such modified cells for use in several indications including various oncology targets. The applications will have an expiration date of no earlier than 2036. This licensed patent portfolio includes:</font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">A patent family that includes eight issued U.S. patents and three pending U.S. patent applications relating to modified macrophages, monocytes and dendric cells comprising CARs. These U.S. patents are expected to expire in 2036, absent any term adjustments or extensions. Corresponding foreign applications have been filed and are pending in Australia, Brazil, Canada, China, Europe, Israel, India, Japan, Korea, Mexico, New Zealand, Russia, Singapore, Thailand and South Africa.</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">A patent family that includes one pending U.S. patent application relating to modified macrophages, monocytes and dendric cells in protein aggregate-associated disorders. Patent applications in this family are expected to expire in 2039, absent any term adjustments or extensions. Corresponding foreign applications have been filed and are pending in Australia, Canada, China, Europe, Israel, Japan, Korea, New Zealand, and Singapore.</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">A patent family that includes one pending U.S. patent application relating to activation of antigen presenting cells. Patent applications in this family are expected to expire in 2040, absent any term adjustments or extensions. A corresponding foreign application has been filed in Europe.</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Exclusively Licensed Intellectual Property&#8201;&#8212;&#8201;NYU</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma has exclusive rights to one patent family, and non-exclusive rights to related know-how by virtue of a license agreement with New York University, or NYU. The rights granted under the NYU license are to all indications for human use. This licensed patent portfolio includes: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">A patent family that includes one U.S. patent relating to a chimeric HIV-1 vector with an SIV minimal Vpx packaging domain and method of making virions with enhanced infectivity for macrophages and dendric cells. The U.S. patent is expected to expire in 2033, absent any term adjustments or extensions.</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">288</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Carisma Owned Intellectual Property</font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma currently owns four U.S. patent families. This owned patent portfolio includes:</font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">A patent family that includes one issued U.S. patent and two pending U.S. patent applications relating to macrophages, monocytes and dendric cells comprising novel CAR constructs. Patent applications in this family are expected to expire in 2041, absent any term adjustments or extensions.</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">A patent family that includes one pending Patent Cooperation Treaty, or PCT, application relating to mRNA transfection of macrophages, monocytes and dendric cells comprising CARs. Patent applications in this family are expected to expire in 2041, absent any term adjustments or extensions. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">A patent family that includes one pending PCT application relating to modified immune cells for fibrosis and inflammation. Patent applications in this family are expected to expire in 2041, absent any term adjustments or extensions.</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">A patent family that includes one pending PCT application relating to self-polarizing immune cells. Patent applications in this family are expected to expire in 2042, absent any term adjustments or extensions.</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma will also seek to generate additional intellectual property that covers enhancements to all aspects of the platform, including novel CARs, combinations, gene editing and manufacturing improvements. Where appropriate, Carisma will also look to in-license relevant technology from third parties. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Patent Term and Patent Term Extensions</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The term of individual patents depends upon the legal term for patents in the countries in which they are obtained. In most countries, including the United States, the patent term is 20&#160;years from the earliest filing date of a non-provisional patent application. In the United States, a patent&#8217;s term may be lengthened by patent term adjustment, which compensates a patentee for administrative delays by the USPTO in examining and granting a patent or may be shortened if a patent is terminally disclaimed over an earlier filed patent. The term of a patent that covers a drug, biological product or medical device approved pursuant to a pre-market approval may also be eligible for patent term extension, or PTE, when FDA approval is granted, provided statutory and regulatory requirements are met. The length of the PTE is related to the length of time the drug is under regulatory review while the patent is in force. The Drug Price Competition and Patent Term Restoration Act of 1984, or the Hatch-Waxman Act, permits a patent term extension of up to five&#160;years beyond the expiration date set for the patent. Patent extension cannot extend the remaining term of a patent beyond a total of 14&#160;years from the date of product approval, only one patent applicable to each regulatory review period may be granted an extension and only those claims regarding the approved drug are extended. Similar provisions are available in Europe and other foreign jurisdictions to extend the term of a patent that covers an approved drug. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Trademarks</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma&#8217;s trademark portfolio currently includes registered U.S. trademarks for Carisma in the United States, Europe, Great Britain and Japan. In order to supplement the protection of its brand, Carisma also has a registered internet domain name. Going forward, Carisma will consider additional trademarks to enhance its brand and support its products. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Trade Secrets</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma relies, in some circumstances, on trade secrets to protect its unpatented technology. However, trade secrets can be difficult to protect in certain circumstances. Carisma seeks to protect its trade secrets and proprietary technology and processes, including through confidentiality agreements with its employees, consultants, scientific advisors and contractors. Carisma also seeks to preserve the integrity and confidentiality of its data and trade secrets by maintaining physical security of its premises and physical and electronic security of its information technology systems. While Carisma has confidence in these individuals, organizations and systems, agreements or security measures may be breached. Carisma may not have adequate remedies for any breach and could lose its trade secrets through such a breach. In addition, Carisma&#8217;s trade secrets may otherwise become known or be independently discovered by competitors. To the extent </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">289</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">that its consultants, contractors or collaborators use intellectual property owned by others in their work for Carisma, disputes may arise as to the rights in related or resulting trade secrets, know-how and inventions. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Moderna Collaboration Agreement</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In January&#160;2022, Carisma entered into a Collaboration and License Agreement with Moderna providing for a broad strategic partnership to discover, develop and commercialize </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;"> engineered CAR-M therapeutics for up to 12 oncology programs. Carisma refers to this agreement as the Moderna Collaboration Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In collaboration with Moderna, Carisma has established an approach that uses Moderna&#8217;s LNP/</font>&#8203;<font style="letter-spacing:0.2pt;">mRNA technology, together with Carisma&#8217;s CAR-M platform technology, to create novel </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;"> oncology medications. </font></div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Under the Moderna Collaboration Agreement, the parties initiate research programs during a research term, focused on the discovery and research of products directed to biological targets. Either party may nominate a target for inclusion in a research program, subject to certain exclusions. Carisma refers to a target included in a research program pursuant to designated procedures as a research target. Moderna may replace research targets pursuant to designated procedures. The first four research targets have been nominated and all programs are currently in the discovery phase at Carisma. Moderna funds the cost of Carisma&#8217;s activities in accordance with an agreed research budget.</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Moderna has the right to designate up to 12 research targets as development targets during a specified development target nomination period upon payment of a development target designation milestone payment. Moderna can replace development targets with research targets during a specified period of time. If Moderna exercises its right to designate a development target, Moderna will have a worldwide, exclusive license under patents and know-how controlled by Carisma to develop and commercialize products directed to the applicable development target, subject to certain diligence obligations. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Commencing a specified time after the effective date of the Moderna Collaboration Agreement, Moderna will have the right to nominate targets relating to diseases outside the field of oncology for inclusion in research programs in specified circumstances. Such right is subject to the same exclusions as Moderna&#8217;s right to nominate other targets for inclusion in research programs. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">During the term of the Moderna Collaboration Agreement, Carisma and its affiliates are subject to various exclusivity obligations under which Carisma is not permitted to research, develop or commercialize particular products outside of the collaboration, including products for use as </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;"> therapies in the field of oncology, products directed to any target included in the collaboration, or products containing a polypeptide provided by Carisma to Moderna in connection with a research program that are directed to any development target. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Under the terms of the Moderna Collaboration Agreement, Carisma received a $45.0&#160;million up-front cash payment. Assuming Moderna develops and commercializes 12 products, each directed to a different development target, Carisma is also eligible to receive up to between $247.0 million and $253.0 million per product in development target designation, development, regulatory and commercial milestone payments. In addition, Carisma is eligible to receive mid to high single digit tiered royalties on net sales of any products that are commercialized under the agreement, which may be subject to reductions. Moderna has also agreed to cover the cost of certain milestone payments and royalties Carisma owes to a licensor under one of its intellectual property in-license agreements that Carisma is sublicensing to Moderna under the Moderna Collaboration Agreement, which royalties Moderna may deduct in part from any royalties owed to Carisma. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Unless earlier terminated, the Moderna Collaboration Agreement will expire upon the expiration of all royalty obligations thereunder. The royalty period for each product developed under the Moderna Collaboration Agreement will expire on a country-by-country basis upon the later of (1)&#160;the expiration of the last-to-expire valid patent claim of specified patents, (2)&#160;the expiration of regulatory-based exclusivity for such product in such country or (3)&#160;ten years after the first commercial sale with respect to such product in such country. Moderna has the right to terminate the Moderna Collaboration Agreement for convenience in its entirety or with respect to a specific product or target on ninety days&#8217; prior notice. Either Carisma or Moderna may terminate the Moderna Collaboration Agreement in its entirety if the other party is in material </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">290</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tUNPLA">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">breach and such breach is not cured within the specified cure period, except in the case of Moderna&#8217;s breach of its diligence obligations, termination by Carisma is limited to the applicable target and product. In addition, either Carisma or Moderna may terminate the Moderna Collaboration Agreement in the event of specified insolvency events involving the other party. As an alternative to termination in the event of Carisma&#8217;s uncured material breach of certain sections of the agreement, Moderna has the option to continue the collaboration under the agreement with reduced payment obligations. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">University of Pennsylvania License Agreement</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In November&#160;2017, Carisma entered into a license agreement with the Trustees of the University of Pennsylvania, or Penn, which was amended in February&#160;2018, January&#160;2019, March&#160;2020 and June&#160;2021. Carisma refers to this agreement as the Penn License Agreement. Pursuant to the Penn License Agreement, Penn granted Carisma (1)&#160;an exclusive, worldwide license, with specified rights to sublicense, under Penn&#8217;s interest in specified patents related to CAR macrophages, monocytes or dendritic cells, which Carisma refers to collectively as CAR-M, (2)&#160;an exclusive, worldwide license, with specified rights to sublicense, under Penn&#8217;s interest in specified patents related to CAR-M directed to mesothelin, and (3)&#160;a nonexclusive, worldwide license under Penn&#8217;s interest in specified know-how related to CAR-M, with limited rights to sublicense only in combination with specified products or patents. These licensed patents and know-how arose primarily from research conducted by Dr.&#160;Saar Gill and Dr.&#160;Michael Klichinsky at the University of Pennsylvania, co-founders of Carisma. The foregoing licenses are subject to rights retained by Penn for specified non-commercial uses and rights retained by the United States government. Under the Penn License agreement, Carisma is obligated to use commercially reasonable efforts to pursue development and commercialization of at least one CAR-M product in oncology and non-oncology fields. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma is responsible for paying Penn an annual license maintenance fee in the low tens of thousands of dollars, payable until Carisma&#8217;s first payment of a royalty. Carisma is required to pay Penn up to $10.9&#160;million per product in development and regulatory milestone payments, up to $30.0&#160;million per product in commercial milestone payments, and up to an additional $1.7&#160;million in development and regulatory milestone payments for the first CAR-M product directed to mesothelin. While the agreement remains in effect, Carisma is required to pay Penn low to mid-single digit&#160;percentage tiered royalties on annual net sales of licensed products, which may be subject to reductions. Penn is guaranteed a minimum royalty payment amount in the low hundreds of thousands of dollars for each year after the first commercial sale of a licensed product. Carisma must also pay Penn a&#160;percentage in the mid-single digits to low double digits of certain types of income Carisma receives from sublicensees. In addition, Carisma is required to pay Penn an annual alliance management fee in the low tens of thousands of dollars, ending after several&#160;years, unless Carisma provides funding to Penn for research and development activities that extend beyond a specified date, in which case Carisma will continue to owe the alliance management fee for each year in which Carisma continues to fund such activities. Carisma also paid Penn an upfront fee in the low hundreds of thousands of dollars for the license to the patents related to the mesothelin binder that is incorporated into the CAR design for Carisma&#8217;s mesothelin product candidate. Carisma is responsible for a pro&#160;rata share of costs relating to the prosecution and maintenance of the licensed patents. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The royalty period for each licensed product will expire on a product-by-product basis upon the later of (1) the expiration of the last-to-expire valid patent claim of the licensed patents covering such product in the country of sale or in the country of manufacture, or (2) the expiration of regulatory-based exclusivity for such product in the country of sale. The license agreement remains in effect until the later of (1)&#160;expiration or abandonment of the last licensed patent or (2)&#160;loss of regulatory exclusivity. Carisma may terminate the agreement for convenience upon thirty days&#8217; prior notice. Penn may terminate the agreement for Carisma&#8217;s material breach, subject to a specified cure period, except for certain breaches for which Penn may terminate immediately. Penn may also terminate if Carisma becomes the subject of a specified insolvency event. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">New York University License Agreement</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In July&#160;2020, Carisma entered into a license agreement with NYU. Carisma refers to this agreement as the NYU License Agreement. Pursuant to the NYU License Agreement, NYU granted Carisma (1)&#160;an exclusive, worldwide license, with specified rights to sublicense, under NYU&#8217;s interest in specified patents related to the Vpx-LV and (2)&#160;a nonexclusive, worldwide license, with specified rights to sublicense, under </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">291</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tCOM1">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">NYU&#8217;s interest in specified know-how related to the Vpx-LV, in each case to develop, manufacture, use and sell products developed using the Vpx-LV, which Carisma refers to as Licensed Products. The foregoing licenses are subject to rights retained by NYU to use, and to permit other non-commercial entities to use, the licensed patents and licensed know-how for educational and research purposes, as well as rights retained by the United States government. Under the NYU License Agreement, Carisma is obligated to use reasonable diligence to carry out a specified development plan and to obtain regulatory approval for Licensed Products in the U.S. and each of the other countries in which Carisma or its sublicensees intend to produce, use, and/or sell Licensed Products, as well as to begin the regular commercial production, use, and sale of the Licensed Products in good faith in accordance with the development plan and to continue diligently thereafter to commercialize the Licensed Products. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma is required to pay NYU an annual license maintenance fee in the mid tens of thousands of dollars; up to $1,685,000 per Licensed Product in development and regulatory milestone payments; and low single digit&#160;percentage tiered royalties on annual net sales of Licensed Products on a country-by-country basis until the later of (1)&#160;12&#160;years after first commercial sale of a Licensed Product in such country or (2)&#160;expiration of the last to expire licensed patent. Carisma must also pay NYU a&#160;percentage in the low single digits to low double digits of certain types of income Carisma receives from sublicensees or assignees of the agreement. Carisma is also responsible for all costs relating to the prosecution, maintenance, and defense of the licensed patents. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The NYU License Agreement remains in effect until the expiration of all royalty terms in all countries. Either party may terminate the NYU License Agreement for the other party&#8217;s uncured material breach or insolvency or bankruptcy. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Competition</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The biopharmaceutical industry, and in particular the cell therapy field, is characterized by intense investment and competition aimed at rapidly advancing new technologies, intense competition, and a strong emphasis on intellectual property and proprietary products. Carisma&#8217;s platform and therapeutic product candidates are expected to face substantial competition from multiple technologies, marketed products, and numerous other therapies being developed by other biopharmaceutical companies, academic research institutions, governmental agencies, and public and private research institutions. Many of Carisma&#8217;s potential competitors have substantially greater financial, technical, and other resources, such as larger research and development staff, established manufacturing capabilities and facilities, and experienced marketing organizations with well-established sales forces, and any product candidates that Carisma successfully develops and commercializes will compete with existing therapies and new therapies that may become available in the future. In addition, there is substantial patent infringement litigation in the biopharmaceutical industry, and, in the future, Carisma may bring or defend such litigation against its competitors. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The key competitive factors affecting the success of Carisma&#8217;s product candidates, if approved, are likely to be their efficacy, safety, convenience and price, the level of competition, and the availability of coverage and adequate reimbursement from third-party payors. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Unlike other cell therapy approaches, Carisma&#8217;s CAR-M platform is based on engineering macrophages and monocytes with proprietary vectors, constructs, and processes, enabling a differentiated platform from other cell therapy competitors that primarily focus on T or NK cells. While Carisma believes that its scientific expertise, novel technology, and intellectual property position offer competitive advantages, Carisma faces competition from multiple other cell therapy technologies and companies. Other companies developing engineered myeloid cell therapies include, among others, Myeloid Therapeutics, Shoreline Biosciences, Inceptor Bio, Thunder Bio, Resolution Therapeutics, CellOrigin, Sirpant Therapeutics, and others. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Due to the broad promise of cell therapies, and the potential of myeloid cell-based approaches to expand cell therapy efficacy into solid tumors, Carisma expects increasing competition from new and existing companies across several fronts, which include, among others: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Myeloid cell therapies:</font><font style="letter-spacing:0.2pt;"> Myeloid Therapeutics, Shoreline Biosciences, Inceptor Bio, Thunder Bio, CellOrigin, Deverra </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">292</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tGORE1">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Autologous T-cell therapies:</font><font style="letter-spacing:0.2pt;"> Adaptimmune Therapeutics, Autolus Therapeutics, Bluebird, Bristol Myers Squibb, Kite/Gilead, Novartis, Gracell, TCR2, Poseida, Vor, TMunity, among others </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Allogeneic T-cell therapies:</font><font style="letter-spacing:0.2pt;"> Allogene, Atara, Century, Cellectis, Celyad, CRISPR, Fate, Gracell, Kite/</font>&#8203;<font style="letter-spacing:0.2pt;">Gilead, Legend, Poseida, Precision Bio, Sana, Vor, among others </font></div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">NK and other cell therapies:</font><font style="letter-spacing:0.2pt;"> Artiva, Celularity, Century, Editas, Fate, Fortress, ImmunityBio, Nkarta, NKGen, Takeda, Adicet, Gamida Cell, among others </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Direct in vivo reprogrammed cell therapies:</font><font style="letter-spacing:0.2pt;"> Umoja, Ensoma, Interius, Tidal/Sanofi, BioNTech </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In addition to competition from other cell therapy companies, any products that Carisma develops may also face competition from other types of therapies. Other companies developing non-cell therapies, including gene therapies, include Gilead, ALX Oncology, Trillium, Five-Prime, Immune-Onc, Pionyr, Infinity, NextCure, OncoResponse, Curis, Faron, Apexigen, Pfizer, Dren, and multiple biotechnology and pharmaceutical companies developing other directly competitive technologies such as small molecules, immune agonists, antibodies, bi/tri specific antibodies, antibody drug conjugates, and other solid tumor therapeutics. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma also competes with third parties for retaining qualified scientific and management personnel and establishing clinical trial sites and patient registration for clinical trials, as well as in acquiring technologies complementary to, or necessary for, its programs. Carisma may pursue the in-license or acquisition of rights to complementary technologies and product candidates on an opportunistic basis. The acquisition and licensing of technologies and product candidates is a competitive area, and a number of more established companies also have similar strategies to in-license or acquire technologies and product candidates that Carisma may consider attractive. These established companies may have a competitive advantage over Carisma due to their size, cash resources and greater development and commercialization capabilities. In addition, companies that perceive Carisma to be a competitor may be unwilling to assign or license rights to Carisma. Carisma also may be unable to in-license or acquire the relevant technology or product candidate on terms that would allow it to make an appropriate return on its investment.</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma&#8217;s commercial opportunity could be reduced or eliminated if its competitors develop and commercialize products that are safer, more effective, have fewer or less severe side effects, are more convenient or are less expensive than any products that it may develop. Carisma&#8217;s competitors also may obtain FDA or other regulatory approval for their products more rapidly than it may obtain approval for Carisma&#8217;s, which could result in its competitors establishing a strong market position before it is able to enter the market. In addition, Carisma&#8217;s ability to compete may be affected in many cases by insurers or other third-party payors seeking to encourage the use of generic products. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Government Regulation</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Government authorities in the United States, at the federal, state and local level, and in other countries and jurisdictions, including the European Union, extensively regulate, among other things, the research, development, testing, manufacture, pricing, reimbursement, sales, quality control, approval, packaging, storage, recordkeeping, labeling, advertising, promotion, distribution, marketing, post-approval monitoring and reporting, and import and export of pharmaceutical products, including biological products. The processes for obtaining marketing approvals in the United States and in foreign countries and jurisdictions, along with subsequent compliance with applicable statutes and regulations and other regulatory authorities, require the expenditure of substantial time and financial resources. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Licensure and Regulation of Biologics in the United States</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In the United States, Carisma&#8217;s product candidates are regulated as biological products, or biologics, under the PHSA and the FDCA, and its implementing regulations and guidance. A company, institution, or organization which takes responsibility for the initiation and management of a clinical development program for such products, and for their regulatory approval, is typically referred to as a sponsor. The failure of a sponsor to comply with the applicable U.S. requirements at any time during the product development process, including pre-clinical testing, clinical testing, the approval process, or post-approval process, may </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">293</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">subject a sponsor to delays in the conduct of the study, regulatory review, and approval, and/or administrative or judicial sanctions. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">A sponsor seeking approval to market and distribute a new biologic in the United States generally must satisfactorily complete each of the following steps: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">pre-clinical laboratory tests, animal studies, and formulation studies all performed in accordance with the FDA&#8217;s GLP regulations and standards and other applicable regulations; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">completion of the manufacture, under cGMP conditions, of the drug substance and drug product that the sponsor intends to use in human clinical trials along with required analytical and stability testing; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.91pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.91pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">design of a clinical protocol and submission to the FDA of an IND application for human clinical testing, which must become effective before human clinical trials may begin; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">approval by an independent institutional review board, or IRB, representing each clinical site before each clinical trial may be initiated; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">performance of adequate and well-controlled human clinical trials to establish the safety, potency, and purity of the product candidate for each proposed indication, in accordance with current GCP; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">preparation and submission to the FDA of a BLA for a biologic product requesting marketing for one or more proposed indications, including submission of detailed information on the manufacture and composition of the product in clinical development and proposed labelling; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">review of the product by an FDA advisory committee, where appropriate or if applicable; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">satisfactory completion of one or more FDA inspections of the manufacturing facility or facilities, including those of third parties, at which the product, or components thereof, are produced to assess compliance with cGMP requirements and to assure that the facilities, methods, and controls are adequate to preserve the product&#8217;s identity, strength, quality, and purity; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">satisfactory completion of any FDA audits of the pre-clinical studies and clinical trial sites to assure compliance with GLP, as applicable, and GCP, and the integrity of clinical data in support of the BLA; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">payment of user PDUFA, securing FDA approval of the BLA and licensure of the new biologic product; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">compliance with any post-approval requirements, including the potential requirement to implement a or REMS and any post-approval studies or other post-marketing commitments required by the FDA. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Pre-clinical Studies</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Before testing any biologic product candidate in humans, the product candidate must undergo pre-clinical testing. Pre-clinical tests include laboratory evaluations of product chemistry, formulation and stability, as well as studies to evaluate the potential for efficacy and toxicity in animal studies. The conduct of the pre-clinical tests and formulation of the compounds for testing must comply with federal regulations and requirements, including GLP regulations and standards and the United States Department of Agriculture&#8217;s Animal Welfare Act, if applicable. The results of the pre-clinical tests, together with manufacturing information and analytical data, are submitted to the FDA as part of an IND application. </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Investigational New Drug Application</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">An IND is an exemption from the FDCA that allows an unapproved product candidate to be shipped in interstate commerce for use in an investigational clinical trial and a request for FDA authorization to administer such investigational product to humans. The IND automatically becomes effective 30&#160;days after receipt by the FDA, unless before that time the FDA raises concerns or questions about the product or conduct of the proposed clinical trial, including concerns that human research subjects will be exposed to unreasonable health risks. In that case, the IND sponsor and the FDA must resolve any outstanding FDA </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">294</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11pt;">
          <font style="letter-spacing:0.2pt;">concerns before the clinical trials can begin or recommence. As a result, submission of the IND may result in the FDA not allowing the trials to commence or allowing the trial to commence on the terms originally specified by the sponsor in the IND. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11pt;">
          <font style="letter-spacing:0.2pt;">If the FDA raises concerns or questions either during this initial 30-day period, or at any time during the IND process, it may choose to impose a partial or complete clinical hold. Clinical holds are imposed by the FDA whenever there is concern for patient safety and may be a result of new data, findings, or developments in clinical, pre-clinical, and/or chemistry, manufacturing, and controls. This order issued by the FDA would delay either a proposed clinical trial or cause suspension of an ongoing trial, until all outstanding concerns have been adequately addressed and the FDA has notified the company that investigations may proceed. This could cause significant delays or difficulties in completing Carisma&#8217;s planned clinical trial or future clinical trials in a timely manner. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11pt;">
          <font style="letter-spacing:0.2pt;">Following the issuance of a clinical hold or partial clinical hold, a clinical investigation may only resume once the FDA has notified the sponsor that the investigation may proceed. The FDA will base that determination on information provided by the sponsor correcting the deficiencies previously cited or otherwise satisfying the FDA that the investigation can proceed or recommence. Occasionally, clinical holds are imposed due to manufacturing issues that may present safety issues for the clinical study subjects. </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Expanded Access to an Investigational Drug for Treatment Use</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Expanded access, sometimes called &#8220;compassionate use,&#8221; is the use of investigational products outside of clinical trials to treat patients with serious or immediately life-threatening diseases or conditions when there are no comparable or satisfactory alternative treatment options. The rules and regulations related to expanded access are intended to improve access to investigational products for patients who may benefit from investigational therapies. FDA regulations allow access to investigational products under an IND by the company or the treating physician for treatment purposes on a case-by-case basis for: individual patients (single-patient IND applications for treatment in emergency settings and non-emergency settings); intermediate-size patient populations; and larger populations for use of the investigational product under a treatment protocol or treatment IND application. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">When considering an IND application for expanded access to an investigational product with the purpose of treating a patient or a group of patients, the sponsor and treating physicians or investigators will determine suitability when all of the following criteria apply: patient(s) have a serious or immediately life-threatening disease or condition, and there is no comparable or satisfactory alternative therapy to diagnose, monitor, or treat the disease or condition; the potential patient benefit justifies the potential risks of the treatment and the potential risks are not unreasonable in the context or condition to be treated; and the expanded use of the investigational drug for the requested treatment will not interfere initiation, conduct, or completion of clinical investigations that could support marketing approval of the product or otherwise compromise the potential development of the product. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">There is no obligation for a sponsor to make its drug products available for expanded access; however, as required by the 21st Century Cures Act, or Cures Act, passed in 2016, if a sponsor has a policy regarding how it evaluates and responds to expanded access requests, sponsors are required to make such policies publicly available upon the earlier of initiation of a Phase&#160;2 or Phase&#160;3 clinical trial, or 15&#160;days after the investigational drug or biologic receives designation as a breakthrough therapy, fast track product, or regenerative medicine advanced therapy. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition to and separate from expanded access, on May&#160;30, 2018, the Right to Try Act was signed into law. The law, among other things, provides a federal framework for certain patients to access certain investigational products that have completed a Phase&#160;1 clinical trial and that are undergoing investigation for FDA approval. Under certain circumstances, eligible patients can seek treatment without enrolling in clinical trials and without obtaining FDA permission under the FDA expanded access program. There is no obligation for a manufacturer to make its investigational products available to eligible patients as a result of the Right to Try Act. </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Human Clinical Trials in Support of a BLA</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Clinical trials involve the administration of the investigational product candidate to healthy volunteers or patients with the disease or condition to be treated under the supervision of a qualified principal </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">295</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">investigator in accordance with GCP requirements. Clinical trials are conducted under protocols detailing, among other things, the objectives of the trial, inclusion and exclusion criteria, the parameters to be used in monitoring safety, and the effectiveness criteria to be evaluated. A protocol for each clinical trial and any subsequent protocol amendments must be submitted to the FDA as part of the IND. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">A sponsor who wishes to conduct a clinical trial outside the United States may, but need not, obtain FDA authorization to conduct the clinical trial under an IND. When a foreign clinical trial is conducted under an IND, all FDA IND requirements must be met unless waived. When a foreign clinical trial is not conducted under an IND, the sponsor must ensure that the trial complies with certain regulatory requirements, including GCP requirements, of the FDA in order to use the trial as support for an IND or application for marketing approval. The GCP requirements encompass both ethical and data integrity standards for clinical trials. The FDA&#8217;s regulations are intended to help ensure the protection of human subjects enrolled in non-IND foreign clinical trials, as well as the quality and integrity of the resulting data. They further help ensure that non-IND foreign trials are conducted in a manner comparable to that required for clinical trials in the United States. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Further, each clinical trial must be reviewed and approved by an IRB either centrally or individually at each institution at which the clinical trial will be conducted. The IRB will consider, among other things, clinical trial design, patient informed consent, ethical factors, the safety of human subjects, and the possible liability of the institution. An IRB must operate in compliance with FDA regulations. The FDA, IRB, or the clinical trial sponsor may suspend or discontinue a clinical trial at any time for various reasons, including a finding that the clinical trial is not being conducted in accordance with FDA requirements or that the participants are being exposed to an unacceptable health risk. Clinical testing also must satisfy extensive GCP rules and the requirements for informed consent. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Additionally, some clinical trials are overseen by an independent group of qualified experts organized by the clinical trial sponsor, known as a data safety monitoring board, or DSMB. This group may recommend continuation of the trial as planned, changes in trial conduct, or cessation of the trial at designated check points based on certain available data from the trial to which only the DSMB has access. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Clinical trials typically are conducted in three sequential phases, but the phases may overlap or be combined. Additional studies may be required after approval. </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Phase&#160;1</font><font style="letter-spacing:0.2pt;"> clinical trials are initially conducted in a limited population to test the product candidate for safety, including adverse effects, dose tolerance, absorption, metabolism, distribution, excretion, and pharmacodynamics in healthy humans or, on occasion, in patients, such as cancer patients. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Phase&#160;2</font><font style="letter-spacing:0.2pt;"> clinical trials are generally conducted in a limited patient population to identify possible adverse effects and safety risks, evaluate the efficacy of the product candidate for specific targeted indications and determine dose tolerance and optimal dosage. Multiple Phase&#160;2 clinical trials may be conducted by the sponsor to obtain information prior to beginning larger and more costly Phase&#160;3 clinical trials. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Phase&#160;3</font><font style="letter-spacing:0.2pt;"> clinical trials proceed if the Phase&#160;2 clinical trials demonstrate that a dose range of the product candidate is potentially effective and has an acceptable safety profile. Phase&#160;3 clinical trials are undertaken within an expanded patient population to further evaluate dosage, provide substantial evidence of clinical efficacy, and further test for safety in an expanded and diverse patient population at multiple, geographically dispersed clinical trial sites. A well-controlled, statistically robust Phase&#160;3 trial may be designed to deliver the data that regulatory authorities will use to decide whether or not to approve, and, if approved, how to appropriately label a biologic; such Phase&#160;3 studies are referred to as &#8220;pivotal.&#8221; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In some cases, the FDA may approve a BLA for a product but require the sponsor to conduct additional clinical trials to further assess the product&#8217;s safety and effectiveness after approval. Such post-approval trials are typically referred to as Phase&#160;4 clinical trials. These studies are used to gain additional experience from the treatment of patients in the intended therapeutic indication and to document a clinical benefit in the case of biologics approved under accelerated approval regulations. If the FDA approves a product while a company has ongoing clinical trials that were not necessary for approval, a company may be able to use the data from these clinical trials to meet all or part of any Phase&#160;4 clinical trial requirement or to request a change </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">296</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">in the product labeling. The failure to exercise due diligence with regard to conducting Phase&#160;4 clinical trials could result in withdrawal of approval for products. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A clinical trial may combine the elements of more than one phase and the FDA often requires more than one Phase&#160;3 trial to support marketing approval of a product candidate. A company&#8217;s designation of a clinical trial as being of a particular phase is not necessarily indicative that the study will be sufficient to satisfy the FDA requirements of that phase because this determination cannot be made until the protocol and data have been submitted to and reviewed by the FDA. Generally, pivotal trials are Phase&#160;3 trials, but they may be Phase&#160;2 trials if the design provides a well-controlled and reliable assessment of clinical benefit, particularly in an area of unmet medical need. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Finally, sponsors of clinical trials are required to register and disclose certain clinical trial information on a public registry (clinicaltrials.gov) maintained by the U.S. National Institutes of Health, or NIH. In particular, information related to the product, patient population, phase of investigation, study sites and investigators and other aspects of the clinical trial is made public as part of the registration of the clinical trial. Both NIH and the FDA have recently signaled the government&#8217;s willingness to begin enforcing those requirements against non-compliant clinical trial sponsors. The failure to submit clinical trial information to clinicaltrials.gov, as required, is a prohibited act under the FDCA with violations subject to potential civil monetary penalties of up to $10,000 for each day the violation continues. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Special Regulations and Guidance Governing Gene Therapy Products</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The FDA has defined a gene therapy product as one that mediates its effects by transcription and/or translation of transferred genetic material and/or by integrating into the host genome and which is administered as nucleic acids, viruses, or genetically engineered microorganisms. The products may be used to modify cells </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;"> or transferred to cells </font><font style="font-style:italic;letter-spacing:0.2pt;">ex vivo</font><font style="letter-spacing:0.2pt;"> prior to administration to the recipient. Within the FDA, the Center for Biologics Evaluation and Research, or CBER, regulates gene therapy products. Within CBER, the review of gene therapy and related products is consolidated in the OTAT, and the FDA has established the Cellular, Tissue and Gene Therapies Advisory Committee to advise CBER on its reviews. CBER works closely with the Local Biosafety Board, a federal advisory committee, in reviewing proposed and ongoing gene therapy protocols and engaging in a public discussion of scientific, safety, ethical, and societal issues related to those protocols. The NIH and the Recombinant DNA Advisory Committee, or RAC, a federal advisory committee, also advise the FDA on gene therapy issues and other issues related to emerging technologies. The FDA and the NIH have published guidance documents with respect to the development and submission of gene therapy protocols. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The FDA has issued various guidance documents regarding gene therapies, including final guidance documents released in January&#160;2020 relating to chemistry, manufacturing and controls information for gene therapy INDs, gene therapies for rare diseases and gene therapies for retinal disorders, as well as draft guidance in January&#160;2021 for Human Gene Therapy for Neurodegenerative Diseases. Although the FDA has indicated that these and other guidance documents it previously issued are not legally binding, Carisma believes that its compliance with them is likely necessary to gain approval for any gene therapy product candidate Carisma may develop. The guidance documents provide additional factors that the FDA will consider at each of the above stages of development and relate to, among other things, the proper pre-clinical assessment of gene therapies; the chemistry, manufacturing, and control information that should be included in an IND application; the proper design of tests to measure product potency in support of an IND or BLA application; and measures to observe delayed adverse effects in subjects who have been exposed to investigational gene therapies when the risk of such effects is high. Further, the FDA usually recommends that sponsors observe subjects for potential gene therapy-related delayed adverse events for a 15-year period, including a minimum of five&#160;years of annual examinations followed by 10&#160;years of annual queries, either in person or by questionnaire. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Further, to facilitate adverse event reporting and dissemination of additional information about gene therapy trials, the FDA and the NIH established the Genetic Modification Clinical Research Information System, or GeMCRIS. Investigators and sponsors of human gene transfer trials can utilize this web-based system to report serious adverse events and to provide annual reports. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">297</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Finally, for a gene therapy product, the FDA also will not approve the product if the manufacturer is not in compliance with good tissue practices, or GTP. These standards are found in FDA regulations and guidance that govern the methods used in, and the facilities and controls used for, the manufacture of human cells, tissues, and cellular and tissue-based products, or HCT/Ps, which are human cells or tissue intended for implantation, transplant, infusion, or transfer into a human recipient. The primary intent of the GTP requirements is to ensure thatT-cell and tissue-based products are manufactured in a manner designed to prevent the introduction, transmission, and spread of communicable disease. FDA regulations also require tissue establishments to register and list their HCT/Ps with the FDA and, when applicable, to evaluate donors through screening and testing. </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Pediatric Studies</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Under the Pediatric Research Equity Act of 2003, or PREA, a BLA or supplement thereto must contain data that are adequate to assess the safety and effectiveness of the product for the claimed indications in all relevant pediatric subpopulations, and to support dosing and administration for each pediatric subpopulation for which the product is safe and effective. Sponsors must also submit pediatric study plans prior to the assessment data. Those plans must contain an outline of the proposed pediatric study or studies the sponsor plans to conduct, including study objectives and design, any deferral or waiver requests, and other information required by regulation. The sponsor, the FDA, and the FDA&#8217;s internal review committee must then review the information submitted, consult with each other, and agree upon a final plan. The FDA or the sponsor may request an amendment to the plan at any time. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The FDA may, on its own initiative or at the request of the sponsor, grant deferrals for submission of some or all pediatric data until after approval of the product for use in adults, or full or partial waivers from the pediatric data requirements. A deferral may be granted for several reasons, including a finding that the product or therapeutic candidate is ready for approval for use in adults before pediatric trials are completed. The FDA is required to send a PREA Non-Compliance letter to sponsors who have failed to submit their pediatric assessments under PREA, have failed to seek or obtain a deferral or deferral extension or have failed to request approval for a required pediatric formulation. Unless otherwise required by regulation, the pediatric data requirements do not apply to products with orphan designation, although FDA has recently taken steps to limit what it considers abuse of this statutory exemption in PREA. The FDA also maintains a list of diseases that are exempt from PREA requirements due to low prevalence of disease in the pediatric population. </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Compliance with cGMP Requirements</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In connection with its review of a BLA, the FDA typically will inspect the facility or facilities where the product is manufactured. The FDA will not approve an application unless it determines that the manufacturing processes and facilities are in full compliance with cGMP requirements and adequate to assure consistent production of the product within required specifications. The PHSA emphasizes the importance of manufacturing control for products like biologics whose attributes cannot be precisely defined. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Manufacturers and others involved in the manufacture and distribution of products must also register their establishments with the FDA and certain state agencies. Both domestic and foreign manufacturing establishments must register and provide additional information to the FDA upon their initial participation in the manufacturing process. Any product manufactured by or imported from a facility that has not registered, whether foreign or domestic, is deemed misbranded under the FDCA. Establishments may be subject to periodic unannounced inspections by government authorities to ensure compliance with cGMPs and other laws. Inspections must follow a &#8220;risk-based schedule&#8221; that may result in certain establishments being inspected more frequently. Manufacturers may also have to provide, on request, electronic or physical records regarding their establishments. Delaying, denying, limiting, or refusing inspection by the FDA may lead to a product being deemed to be adulterated. Changes to the manufacturing process, specifications or container closure system for an approved product are strictly regulated and often require prior FDA approval before being implemented. The FDA&#8217;s regulations also require, among other things, the investigation and correction of any deviations from cGMP and the imposition of reporting and documentation requirements upon the sponsor and any third-party manufacturers involved in producing the approved product. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">298</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Submission and Filing of a BLA</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The results of product candidate development, pre-clinical testing, and clinical trials, including negative or ambiguous results as well as positive findings, are submitted to the FDA as part of a BLA requesting license to market the product. The BLA must contain extensive manufacturing information and detailed information on the composition of the product and proposed labeling as well as payment of a user fee. Under federal law, the submission of most BLAs is subject to an application user fee, which for federal fiscal year 2022 is $3,117,218 for an application requiring clinical data. The sponsor of a licensed BLA is also subject to an annual program fee, which for federal fiscal year 2022 is $369,413. Certain exceptions and waivers are available for some of these fees, such as an exception from the application fee for products with orphan designation and a waiver for certain small businesses. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Following submission of a BLA, the FDA has 60&#160;days to conduct a preliminary review of the application and it must inform the sponsor within that period of time whether the BLA is sufficiently complete to permit substantive review. In the event that FDA determines that an application does not satisfy this standard, it will issue a Refuse to File, or RTF, determination to the sponsor. The FDA may request additional information and studies, and the application must be resubmitted with the additional information. The resubmitted application is also subject to review before the FDA accepts it for filing. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Once the submission has been accepted for filing, the FDA begins an in-depth review of the application. Under the goals and policies agreed to by the FDA under the PDUFA, the FDA has ten&#160;months in which to complete its initial review of a standard application and respond to the sponsor, and six&#160;months for a priority review of the application. The FDA does not always meet its PDUFA goal dates for standard and priority BLAs. The review process may often be significantly extended by FDA requests for additional information or clarification. The review process and the PDUFA goal date may be extended by three&#160;months if the FDA requests or if the sponsor otherwise provides additional information or clarification regarding information already provided in the submission within the last three&#160;months before the PDUFA goal date. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The FDA may also refer the application to an advisory committee for review, evaluation, and recommendation as to whether the application should be approved. In particular, the FDA may refer applications for novel biologic products or biologic products that present difficult questions of safety or efficacy to an advisory committee. Typically, an advisory committee is a panel of independent experts, including clinicians and other scientific experts, that reviews, evaluates, and provides a recommendation as to whether the application should be approved and under what conditions. The FDA is not bound by the recommendations of an advisory committee, but it considers such recommendations carefully when making decisions. </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">The FDA&#8217;s Decision on a BLA</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Under the PHSA, the FDA may approve a BLA if it determines that the product is safe, pure, and potent, and the facility where the product will be manufactured meets standards designed to ensure that it continues to be safe, pure, and potent. Specifically, the FDA must determine that the expected benefits of the proposed product outweigh its potential risks to patients. This &#8220;benefit-risk&#8221; assessment is informed by the extensive body of evidence about the proposed product in the BLA. On the basis of the FDA&#8217;s evaluation of the application and accompanying information, including the results of the inspection of the manufacturing facilities and any FDA audits of pre-clinical and clinical trial sites to assure compliance with GCPs, the FDA may issue a complete response letter, or CRL, or an approval letter. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If the application is not approved, the FDA will issue a CRL, which will contain the conditions that must be met in order to secure final approval of the application and will outline recommended actions the sponsor might take to obtain approval of the application. Sponsors that receive a CRL may submit to the FDA information that represents a complete response to the issues identified by the FDA, withdraw the application or request a hearing. The FDA will not approve an application until issues identified in the CRL have been addressed. If a CRL is issued, the sponsor will have one year to respond to the deficiencies identified by the FDA, at which time the FDA can deem the application withdrawn or, in its discretion, grant the sponsor an additional six-month extension to respond. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">An approval letter, on the other hand, authorizes commercial marketing of the product with specific prescribing information for specific indications. The FDA may limit the approved indication(s) for use of </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">299</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">the product. It may also require that contraindications, warnings, or precautions be included in the product labeling. In addition, the FDA may call for post-approval studies, including Phase&#160;4 clinical trials, to further assess the product&#8217;s efficacy and/or safety after approval. The agency may also require testing and surveillance programs to monitor the product after commercialization, or impose other conditions, including distribution restrictions or other risk management mechanisms, including REMS, to help ensure that the benefits of the product outweigh the potential risks. REMS can include medication guides, communication plans for healthcare professionals, and elements to assure safe use, or ETASU. ETASU can include, but are not limited to, special training or certification for prescribing or dispensing, dispensing only under certain circumstances, special monitoring, and the use of patent registries. The FDA may prevent or limit further marketing of a product based on the results of post-market studies or surveillance programs. After approval, many types of changes to the approved product, such as adding new indications, manufacturing changes and additional labeling claims, are subject to further testing requirements and FDA review and approval. </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Expedited Review Programs</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The FDA is authorized to expedite the review of applications in several ways. None of these expedited programs changes the standards for approval but each may help expedite the development or approval process governing product candidates. </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Fast Track designation.&nbsp;&nbsp;&nbsp;The sponsor of a product candidate may request the FDA to designate the product for a specific indication as a Fast Track product concurrent with or after the filing of the IND. Candidate products are eligible for Fast Track designation if </font><font style="font-style:italic;letter-spacing:0.2pt;">they</font><font style="letter-spacing:0.2pt;"> are intended to treat a serious or life-threatening condition and demonstrate the potential to address unmet medical needs for the condition. Fast Track designation applies to the combination of the product candidate and the specific indication for which it is being studied. In addition to other benefits, such as the ability to have greater interactions with the FDA, the FDA may initiate review of sections of a Fast Track application before the application is complete, a process known as rolling review. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Breakthrough therapy designation.&nbsp;&nbsp;&nbsp;To qualify for the breakthrough therapy program, product candidates must be intended to treat a serious or life-threatening disease or condition and preliminary clinical evidence must indicate that such product candidates may demonstrate substantial improvement on one or more clinically significant endpoints over existing therapies. The FDA will seek to ensure the sponsor of a breakthrough therapy product candidate receives intensive guidance on an efficient drug development program, intensive involvement of senior managers and experienced staff on a proactive, collaborative and cross-disciplinary review and rolling review. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Priority review.&nbsp;&nbsp;&nbsp;A product candidate is eligible for priority review if it treats a serious condition and, if approved, it would be a significant improvement in the safety or effectiveness of the treatment, diagnosis or prevention compared to marketed products. FDA aims to complete its review of priority review applications within six&#160;months as opposed to 10&#160;months for standard review. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Accelerated approval.&nbsp;&nbsp;&nbsp;Drug or biologic products studied for their safety and effectiveness in treating serious or life-threatening illnesses and that provide meaningful therapeutic benefit over existing treatments may receive accelerated approval. Accelerated approval means that a product candidate may be approved on the basis of adequate and well controlled clinical trials establishing that the product candidate has an effect on a surrogate endpoint that is reasonably likely to predict a clinical benefit, or on the basis of an effect on a clinical endpoint other than survival or irreversible morbidity or mortality or other clinical benefit, taking into account the severity, rarity and prevalence of the condition and the availability or lack of alternative treatments. As a condition of approval, the FDA may require that a sponsor of a drug or biologic product candidate receiving accelerated approval perform adequate and well controlled post-marketing clinical trials. In addition, the FDA currently requires as a condition for accelerated approval pre-approval of promotional materials. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Regenerative advanced therapy.&nbsp;&nbsp;&nbsp;With passage of the Cures Act, Congress authorized the FDA to accelerate review and approval of products designated as regenerative advanced therapies. A product is eligible for this designation if it is a regenerative medicine therapy that is intended to treat, modify, reverse or cure a serious or life-threatening disease or condition and preliminary clinical evidence indicates that the product candidate has the potential to address unmet medical needs for such disease or condition. The benefits of a regenerative advanced therapy designation include early </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">300</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:30pt; width:426pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">interactions with the FDA to expedite development and review, benefits available to breakthrough therapies, potential eligibility for priority review and accelerated approval based on surrogate or intermediate endpoints. </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Post-Approval Regulation</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If regulatory approval for marketing of a product or new indication for an existing product is obtained, the sponsor will be required to comply with all regular post-approval regulatory requirements as well as any post-approval requirements that the FDA have imposed as part of the approval process. The sponsor will be required to report certain adverse reactions and production problems to the FDA, provide updated safety and efficacy information and comply with requirements concerning advertising and promotional labeling requirements. Manufacturers and certain of their subcontractors are required to register their establishments with the FDA and certain state agencies and are subject to periodic unannounced inspections by the FDA and certain state agencies for compliance with ongoing regulatory requirements, including cGMP regulations, which impose certain procedural and documentation requirements upon manufacturers. Accordingly, the sponsor and its third-party manufacturers must continue to expend time, money, and effort in the areas of production and quality control to maintain compliance with cGMP regulations and other regulatory requirements. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">A product may also be subject to official lot release, meaning that the manufacturer is required to perform certain tests on each lot of the product before it is released for distribution. If the product is subject to official lot release, the manufacturer must submit samples of each lot, together with a release protocol showing a summary of the history of manufacture of the lot and the results of all of the manufacturer&#8217;s tests performed on the lot, to the FDA. The FDA may in addition perform certain confirmatory tests on lots of some products before releasing the lots for distribution. Finally, the FDA will conduct laboratory research related to the safety, purity, potency, and effectiveness of pharmaceutical products. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Once an approval is granted, the FDA may withdraw the approval if compliance with regulatory requirements and standards is not maintained or if problems occur after the product reaches the market. Later discovery of previously unknown problems with a product, including adverse events of unanticipated severity or frequency, or with manufacturing processes, or failure to comply with regulatory requirements, may result in revisions to the approved labeling to add new safety information; imposition of post-market studies or clinical trials to assess new safety risks; or imposition of distribution or other restrictions under a REMS program. Other potential consequences include, among other things: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">restrictions on the marketing or manufacturing of the product, complete withdrawal of the product from the market or product recalls; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">fines, warning letters or holds on post-approval clinical trials; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">refusal of the FDA to approve pending applications or supplements to approved applications, or suspension or revocation of product license approvals; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">product seizure or detention, or refusal to permit the import or export of products; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">injunctions or the imposition of civil or criminal penalties. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The FDA strictly regulates marketing, labeling, advertising and promotion of products that are placed on the market. Products may be promoted only for the approved indications and in accordance with the provisions of the approved label. The FDA and other agencies actively enforce the laws and regulations prohibiting the promotion of off-label uses, and a company that is found to have improperly promoted off-label uses may be subject to significant liability. If a company is found to have promoted off-label uses, it may become subject to adverse public relations and administrative and judicial enforcement by the FDA, the Department of Justice, or the Office of the Inspector General of the Department of Health and Human Services, as well as state authorities. This could subject a company to a range of penalties that could have a significant commercial impact, including civil and criminal fines and agreements that materially restrict the manner in which a company promotes or distributes drug products. In September&#160;2021, the FDA published final regulations which describe the types of evidence that the agency will consider in determining the intended use of a biologic product. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">301</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Orphan Drug Designation and Exclusivity</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Orphan drug designation in the United States is designed to encourage sponsors to develop products intended for rare diseases or conditions. In the United States, a rare disease or condition is statutorily defined as a condition that affects fewer than 200,000 individuals in the United States or that affects more than 200,000 individuals in the United States and for which there is no reasonable expectation that the cost of developing and making available the biologic for the disease or condition will be recovered from sales of the product in the United States. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Orphan drug designation qualifies a company for tax credits and market exclusivity for seven&#160;years following the date of the product&#8217;s marketing approval if granted by the FDA. An application for designation as an orphan product can be made any time prior to the filing of an application for approval to market the product. A product becomes an orphan when it receives orphan drug designation from the Office of Orphan Products Development at the FDA based on acceptable confidential requests made under the regulatory provisions. The product must then go through the review and approval process like any other product. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A sponsor may request orphan drug designation of a previously unapproved product or new orphan indication for an already marketed product. In addition, a sponsor of a product that is otherwise the same product as an already approved orphan drug may seek and obtain orphan drug designation for the subsequent product for the same rare disease or condition if it can present a plausible hypothesis that its product may be clinically superior to the first drug. More than one sponsor may receive orphan drug designation for the same product for the same rare disease or condition, but each sponsor seeking orphan drug designation must file a complete request for designation. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If a product with orphan designation receives the first FDA approval for the disease or condition for which it has such designation or for a select indication or use within the rare disease or condition for which it was designated, the product generally will receive orphan drug exclusivity. Orphan drug exclusivity means that the FDA may not approve another sponsor&#8217;s marketing application for the same product for the same indication for seven&#160;years, except in certain limited circumstances. If a product designated as an orphan drug ultimately receives marketing approval for an indication broader than what was designated in its orphan drug application, it may not be entitled to exclusivity. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The period of exclusivity begins on the date that the marketing application is approved by the FDA. Orphan drug exclusivity will not bar approval of another product under certain circumstances, including if a subsequent product with the same drug for the same condition is shown to be clinically superior to the approved product on the basis of greater efficacy or safety, or providing a major contribution to patient care, or if the company with orphan drug exclusivity is not able to meet market demand. Under Omnibus legislation enacted in December&#160;2020, the requirement for a product to show clinical superiority applies to drugs and biologics that received orphan drug designation before enactment of FDARA in 2017, but have not yet been approved or licensed by FDA. In addition, the FDA may approve a second application for the same product for a different use or a second application for a clinically superior version of the product for the same use. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The FDA and Congress may further reevaluate the Orphan Drug Act and its regulations and policies. This may be particularly true in light of a decision from the Court of Appeals for the 11</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">th</font><font style="letter-spacing:0.2pt;"> Circuit in September&#160;2021 finding that, for the purpose of determining the scope of exclusivity, the term &#8220;same disease or condition&#8221; means the designated &#8220;rare disease or condition&#8221; and could not be interpreted by the FDA to mean the &#8220;indication or use.&#8221; </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Pediatric Exclusivity</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Pediatric exclusivity is another type of non-patent exclusivity in the United States and for biologics, if granted, provides for the attachment of an additional six&#160;months of regulatory exclusivity to the term of any existing regulatory exclusivity, including orphan exclusivity. This six-month exclusivity may be granted if a BLA sponsor submits pediatric data that fairly respond to a written request from the FDA for such data. The data do not need to show the product to be effective in the pediatric population studied; rather, if the clinical trial is deemed to fairly respond to the FDA&#8217;s request, the additional protection is granted. If reports </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">302</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">of requested pediatric studies are submitted to and accepted by the FDA within the statutory time limits, whatever statutory or regulatory periods of exclusivity that cover the product are extended by six&#160;months. </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Biosimilars and Exclusivity</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The 2010 Patient Protection and Affordable Care Act, which was signed into law in March&#160;2010, included a subtitle called the BPCIA. The BPCIA established a regulatory scheme authorizing the FDA to approve biosimilars and interchangeable biosimilars. A biosimilar is a biological product that is highly similar to an existing FDA-licensed &#8220;reference product.&#8221; As of January&#160;1, 2021, the FDA has approved 29 biosimilar products for use in the United States. To date, the FDA has approved a number of biosimilars, and the first interchangeable biosimilar product was approved on July&#160;30, 2021, and a second product previously approved as a biosimilar was designated as interchangeable in October&#160;2021. The FDA has also issued numerous guidance documents outlining its approach to reviewing and licensing biosimilars and interchangeable biosimilars under the PHSA, including a draft guidance issued in November&#160;2020 that seeks to provide additional clarity to manufacturers of interchangeable biosimilars. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Under the BPCIA, a manufacturer may submit an application for licensure of a biologic product that is &#8220;biosimilar to&#8221; or &#8220;interchangeable with&#8221; a previously approved biological product or &#8220;reference product.&#8221; In order for the FDA to approve a biosimilar product, it must find that there are no clinically meaningful differences between the reference product and proposed biosimilar product in terms of safety, purity, and potency. For the FDA to approve a biosimilar product as interchangeable with a reference product, the agency must find that the biosimilar product can be expected to produce the same clinical results as the reference product, and (for products administered multiple times) that the biologic and the reference biologic may be switched after one has been previously administered without increasing safety risks or risks of diminished efficacy relative to exclusive use of the reference biologic. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Under the BPCIA, an application for a biosimilar product may not be submitted to the FDA until four&#160;years following the date of approval of the reference product. The FDA may not approve a biosimilar product until 12&#160;years from the date on which the reference product was approved. Even if a product is considered to be a reference product eligible for exclusivity, another company could market a competing version of that product if the FDA approves a full BLA for such product containing the sponsor&#8217;s own pre-clinical data and data from adequate and well-controlled clinical trials to demonstrate the safety, purity, and potency of their product. The BPCIA also created certain exclusivity periods for biosimilars approved as interchangeable products. There have been recent government proposals to reduce the 12-year reference product exclusivity period, but none has been enacted to date. At the same time, since passage of the BPCIA, many states have passed laws or amendments to laws, which address pharmacy practices involving biosimilar products. </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Federal and State Data Privacy and Security Laws</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Under HIPAA, the U.S. Department of Health and Human Services has issued regulations to protect the privacy and security of protected health information used or disclosed by covered entities including certain healthcare providers, health plans, and healthcare clearinghouses. HIPAA also regulates standardization of data content, codes, and formats used in healthcare transactions and standardization of identifiers for health plans and providers. HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act of 2009, or HITECH, and their regulations, including the omnibus final rule published on January&#160;25, 2013, also imposes certain obligations on the business associates of covered entities that obtain protected health information in providing services to or on behalf of covered entities. In addition to federal privacy regulations, there are a number of state laws governing confidentiality and security of health information that are applicable to Carisma&#8217;s business. In addition to possible federal civil and criminal penalties for HIPAA violations, state attorneys general are authorized to file civil actions for damages or injunctions in federal courts to enforce HIPAA and seek attorney&#8217;s fees and costs associated with pursuing federal civil actions. Accordingly, state attorneys general (along with private plaintiffs) have brought civil actions seeking injunctions and damages resulting from alleged violations of HIPAA&#8217;s privacy and security rules. New laws and regulations governing privacy and security may be adopted in the future as well. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">303</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Additionally, California recently enacted legislation that has been dubbed the first &#8220;GDPR-like&#8221; law in the United States, the CCPA. The CCPA creates new individual privacy rights for consumers (as that word is broadly defined in the law) and places increased privacy and security obligations on entities handling personal data of consumers or households. The CCPA went into effect on January&#160;1, 2020 and requires covered companies to provide new disclosures to California consumers, provide such consumers new ways to opt-out of certain sales of personal information, and allow for a new cause of action for data breaches. The CCPA could impact Carisma&#8217;s business activities depending on how it is interpreted and exemplifies the vulnerability of Carisma&#8217;s business to not only cyber threats but also the evolving regulatory environment related to personal data and protected health information. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Because of the breadth of these laws and the narrowness of the statutory exceptions and regulatory safe harbors available under such laws, it is possible that some of Carisma&#8217;s current or future business activities, including certain clinical research, sales, and marketing practices and the provision of certain items and services to Carisma&#8217;s customers, could be subject to challenge under one or more of such privacy and data security laws. The heightening compliance environment and the need to build and maintain robust and secure systems to comply with different privacy compliance and/or reporting requirements in multiple jurisdictions could increase the possibility that a healthcare company may fail to comply fully with one or more of these requirements. If Carisma&#8217;s operations are found to be in violation of any of the privacy or data security laws or regulations described above that are applicable to Carisma, or any other laws that apply to Carisma, Carisma may be subject to penalties, including potentially significant criminal, civil, and administrative penalties, damages, fines, imprisonment, contractual damages, reputational harm, diminished profits and future earnings, additional reporting requirements, and/or oversight if Carisma becomes subject to a consent decree or similar agreement to resolve allegations of non-compliance with these laws, and the curtailment or restructuring of Carisma&#8217;s operations, any of which could adversely affect Carisma&#8217;s ability to operate its business and its results of operations. To the extent that any of Carisma&#8217;s product candidates, once approved, are sold in a foreign country, Carisma may be subject to similar foreign laws. </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Patent Term Restoration and Extension</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In the United States, a patent claiming a new biologic product, its method of use or its method of manufacture may be eligible for a limited patent term extension under the Hatch-Waxman Act, which permits a patent extension of up to five&#160;years for patent term lost during product development and FDA regulatory review. Assuming grant of the patent for which the extension is sought, the restoration period for a patent covering a product is typically one-half the time between the effective date of the IND clearing clinical studies and the submission date of the BLA, plus the time between the submission date of the BLA and the ultimate approval date. Patent term restoration cannot be used to extend the remaining term of a patent past a total of 14&#160;years from the product&#8217;s approval date in the United States. Only one patent applicable to an approved product is eligible for the extension, and the application for the extension must be submitted prior to the expiration of the patent for which extension is sought. A patent that covers multiple products for which approval is sought can only be extended in connection with one of the approvals. The USPTO reviews and approves the application for any patent term extension in consultation with the FDA. </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">FDA Approval of Companion Diagnostics</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In August&#160;2014, the FDA issued final guidance clarifying the requirements that will apply to approval of therapeutic products and </font><font style="font-style:italic;letter-spacing:0.2pt;">in vitro</font><font style="letter-spacing:0.2pt;"> companion diagnostics. According to the guidance, for novel drugs, a companion diagnostic device and its corresponding therapeutic should be approved or cleared contemporaneously by the FDA for the use indicated in the therapeutic product&#8217;s labeling. Approval or clearance of the companion diagnostic device will ensure that the device has been adequately evaluated and has adequate performance characteristics in the intended population. In July&#160;2016, the FDA issued a draft guidance intended to assist sponsors of the drug therapeutic and </font><font style="font-style:italic;letter-spacing:0.2pt;">in vitro</font><font style="letter-spacing:0.2pt;"> companion diagnostic device on issues related to co-development of the products. The 2014 guidance also explains that a companion diagnostic device used to make treatment decisions in clinical trials of a biologic product candidate generally will be considered an investigational device, unless it is employed for an intended use for which the device is already approved or cleared. If used to make critical treatment decisions, such as patient selection, the diagnostic device generally will be considered a significant risk device under the FDA&#8217;s Investigational Device </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">304</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Exemption, or IDE, regulations. Thus, the sponsor of the diagnostic device will be required to comply with the IDE regulations. According to the guidance, if a diagnostic device and a product are to be studied together to support their respective approvals, both products can be studied in the same investigational study, if the study meets both the requirements of the IDE regulations and the IND regulations. The guidance provides that depending on the details of the study plan and subjects, a sponsor may seek to submit an IND alone, or both an IND and an IDE. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In April&#160;2020, the FDA issued additional guidance which describes considerations for the development and labeling of companion diagnostic devices to support the indicated uses of multiple biological oncology products, when appropriate. The 2020 guidance expands on the policy statement in the 2014 guidance by recommending that companion diagnostic developers consider a number of factors when determining whether their test could be developed, or the labeling for approved companion diagnostics could be revised through a supplement, to support a broader labeling claim such as use with a specific group of oncology therapeutic products (rather than listing an individual therapeutic product(s)). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Under the FDCA, </font><font style="font-style:italic;letter-spacing:0.2pt;">in vitro</font><font style="letter-spacing:0.2pt;"> diagnostics, including companion diagnostics, are regulated as medical devices. In the United States, the FDCA and its implementing regulations, and other federal and state statutes and regulations govern, among other things, medical device design and development, pre-clinical and clinical testing, premarket clearance or approval, registration and listing, manufacturing, labeling, storage, advertising and promotion, sales and distribution, export and import, and post market surveillance. Unless an exemption applies, diagnostic tests require marketing clearance or approval from the FDA prior to commercial distribution. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The FDA previously has required </font><font style="font-style:italic;letter-spacing:0.2pt;">in vitro</font><font style="letter-spacing:0.2pt;"> companion diagnostics intended to select the patients who will respond to the product candidate to obtain pre-market approval, or PMA, simultaneously with approval of the therapeutic product candidate. The PMA process, including the gathering of clinical and pre-clinical data and the submission to and review by the FDA, can take several&#160;years or longer. It involves a rigorous premarket review during which the sponsor must prepare and provide the FDA with reasonable assurance of the device&#8217;s safety and effectiveness and information about the device and its components regarding, among other things, device design, manufacturing and labeling. PMA applications are subject to an application fee. For federal fiscal year 2022, the standard fee is $374,858 and the small business fee is $93,714. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Coverage, Pricing, and Reimbursement</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Significant uncertainty exists as to the coverage and reimbursement status of any product candidates for which Carisma may seek regulatory approval by the FDA or other government authorities. In the United States and markets in other countries, patients who are prescribed treatments for their conditions and providers performing the prescribed services generally rely on third-party payors to reimburse all or part of the associated healthcare costs. Patients are unlikely to use any product candidates Carisma may develop unless coverage is provided and reimbursement is adequate to cover a significant portion of the cost of such product candidates. Even if any product candidates Carisma may develop are approved, sales of such product candidates will depend, in part, on the extent to which third-party payors, including government health programs in the United States such as Medicare and Medicaid, commercial health insurers, and managed care organizations, provide coverage, and establish adequate reimbursement levels for, such product candidates. The process for determining whether a payor will provide coverage for a product may be separate from the process for setting the price or reimbursement rate that the payor will pay for the product once coverage is approved. Third-party payors are increasingly challenging the prices charged, examining the medical necessity, and reviewing the cost-effectiveness of medical products and services and imposing controls to manage costs. Third-party payors may limit coverage to specific products on an approved list, also known as a formulary, which might not include all of the approved products for a particular indication. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In order to secure coverage and reimbursement for any product that might be approved for sale, a company may need to conduct expensive pharmacoeconomic studies in order to demonstrate the medical necessity and cost-effectiveness of the product, in addition to the costs required to obtain FDA or other comparable marketing approvals. Nonetheless, product candidates may not be considered medically necessary or cost effective. A decision by a third-party payor not to cover any product candidates Carisma may develop could reduce physician utilization of such product candidates once approved and have a material adverse effect on Carisma&#8217;s sales, results of operations and financial condition. Additionally, a payor&#8217;s decision </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">305</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">to provide coverage for a product does not imply that an adequate reimbursement rate will be approved. Further, one payor&#8217;s determination to provide coverage for a product does not assure that other payors will also provide coverage and reimbursement for the product, and the level of coverage and reimbursement can differ significantly from payor to payor. Third-party reimbursement and coverage may not be available to enable Carisma to maintain price levels sufficient to realize an appropriate return on Carisma&#8217;s investment in product development. In addition, any companion diagnostic tests require coverage and reimbursement separate and apart from the coverage and reimbursement for their companion pharmaceutical or biological products. Similar challenges to obtaining coverage and reimbursement, applicable to pharmaceutical or biological products, will apply to any companion diagnostics. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The containment of healthcare costs also has become a priority of federal, state and foreign governments and the prices of pharmaceuticals have been a focus in this effort. Governments have shown significant interest in implementing cost-containment programs, including price controls, restrictions on reimbursement, and requirements for substitution of generic products. Adoption of price controls and cost-containment measures, and adoption of more restrictive policies in jurisdictions with existing controls and measures, could further limit a company&#8217;s revenue generated from the sale of any approved products. Coverage policies and third-party reimbursement rates may change at any time. Even if favorable coverage and reimbursement status is attained for one or more products for which a company or its collaborators receive marketing approval, less favorable coverage policies and reimbursement rates may be implemented in the future. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Outside the United States, ensuring adequate coverage and payment for any product candidates Carisma may develop will face challenges. Pricing of prescription pharmaceuticals is subject to governmental control in many countries. Pricing negotiations with governmental authorities can extend well beyond the receipt of regulatory marketing approval for a product and may require Carisma to conduct a clinical trial that compares the cost effectiveness of any product candidates Carisma may develop to other available therapies. The conduct of such a clinical trial could be expensive and result in delays in Carisma&#8217;s commercialization efforts. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In the European Union, pricing and reimbursement schemes vary widely from country to country. Some countries provide that products may be marketed only after a reimbursement price has been agreed. Some countries may require the completion of additional studies that compare the cost-effectiveness of a particular product candidate to currently available therapies (so called health technology assessments) in order to obtain reimbursement or pricing approval. For example, the European Union provides options for its member states to restrict the range of products for which their national health insurance systems provide reimbursement and to control the prices of medicinal products for human use. European Union member states may approve a specific price for a product or it may instead adopt a system of direct or indirect controls on the profitability of the company placing the product on the market. Other member states allow companies to fix their own prices for products but monitor and control prescription volumes and issue guidance to physicians to limit prescriptions. Recently, many countries in the European Union have increased the amount of discounts required on pharmaceuticals and these efforts could continue as countries attempt to manage healthcare expenditures, especially in light of the severe fiscal and debt crises experienced by many countries in the European Union. The downward pressure on healthcare costs in general, particularly prescription products, has become intense. As a result, increasingly high barriers are being erected to the entry of new products. Political, economic, and regulatory developments may further complicate pricing negotiations, and pricing negotiations may continue after reimbursement has been obtained. Reference pricing used by various European Union member states, and parallel trade (arbitrage between low-priced and high-priced member states), can further reduce prices. There can be no assurance that any country that has price controls or reimbursement limitations for pharmaceutical products will allow favorable reimbursement and pricing arrangements for any of Carisma&#8217;s products, if approved in those countries. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Healthcare Law and Regulation</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Healthcare providers and third-party payors play a primary role in the recommendation and prescription of pharmaceutical products that are granted marketing approval. Arrangements with providers, consultants, third-party payors, and customers are subject to broadly applicable fraud and abuse, anti-kickback, false claims laws, reporting of payments to physicians and teaching physicians and patient privacy laws and </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">306</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">regulations and other healthcare laws and regulations that may constrain Carisma&#8217;s business and/or financial arrangements. Restrictions under applicable federal and state healthcare laws and regulations, include the following: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the U.S. federal Anti-Kickback Statute, which prohibits, among other things, persons and entities from knowingly and willfully soliciting, offering, paying, receiving, or providing remuneration, directly or indirectly, in cash or in kind, to induce or reward either the referral of an individual for, or the purchase, order or recommendation of, any good or service, for which payment may be made, in whole or in part, under a federal healthcare program such as Medicare and Medicaid; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the federal civil and criminal false claims laws, including the civil False Claims Act, and civil monetary penalties laws, which prohibit individuals or entities from, among other things, knowingly presenting, or causing to be presented, to the federal government, claims for payment that are false, fictitious, or fraudulent or knowingly making, using, or causing to made or used a false record or statement to avoid, decrease, or conceal an obligation to pay money to the federal government; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the Foreign Corrupt Practices Act, which prohibits companies and their intermediaries from making, or offering or promising to make improper payments to non-U.S. officials for the purpose of obtaining or retaining business or otherwise seeking favorable treatment; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the federal transparency requirements under the ACA, which require certain manufacturers of drugs, devices, biologics and medical supplies to report annually to the CMS within the U.S. Department of Health and Human Services, information related to payments and other transfers of value made by that entity to physicians, other healthcare providers, and teaching hospitals, as well as ownership and investment interests held by physicians and their immediate family members. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Some state laws require pharmaceutical companies to comply with the pharmaceutical industry&#8217;s voluntary compliance guidelines and the relevant compliance guidance promulgated by the federal government in addition to requiring pharmaceutical manufacturers to report information related to payments to physicians and other healthcare providers or marketing expenditures. In addition, certain state and local laws require drug manufacturers to register pharmaceutical sales representatives in the jurisdiction. State and foreign laws also govern the privacy and security of health information in some circumstances, many of which differ from each other in significant ways and often are not preempted by HIPAA, thus complicating compliance efforts. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If Carisma&#8217;s operations are found to be in violation of any of these laws or any other governmental regulations that may apply to Carisma, Carisma may be subject to significant civil, criminal, and administrative penalties, damages, fines, disgorgement, exclusion from government funded healthcare programs, such as Medicare and Medicaid, integrity oversight and reporting obligations, and the curtailment or restructuring of Carisma&#8217;s operations. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Healthcare Reform</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A primary trend in the U.S. healthcare industry and elsewhere is cost containment. There have been a number of federal and state proposals during the last few&#160;years regarding the pricing of pharmaceutical and biopharmaceutical products, limiting coverage and reimbursement for drugs and other medical products, government control and other changes to the healthcare system in the United States. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In March&#160;2010, the United States Congress enacted the ACA, which, among other things, includes changes to the coverage and payment for products under government healthcare programs. Other legislative changes have been proposed and adopted in the United States since the ACA was enacted. For example, in August&#160;2011, the Budget Control Act of 2011, among other things, created measures for spending reductions by Congress. A Joint Select Committee on Deficit Reduction, tasked with recommending a targeted deficit reduction of at least $1.2 trillion for the&#160;years 2012 through 2021, was unable to reach required goals, thereby triggering the legislation&#8217;s automatic reduction to several government programs. This includes aggregate reductions of Medicare payments to providers of up to 2% per fiscal year, which will remain in effect through 2031 pursuant to the Coronavirus Aid, Relief and Economic Security Act or CARES Act. The American Taxpayer Relief Act of 2012, which was enacted in January&#160;2013, among other things, further reduced Medicare payments to several providers, including hospitals, imaging centers, and cancer treatment centers, </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">307</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">and increased the statute of limitations period for the government to recover overpayments to providers from three to five&#160;years. Further, with passage of the Inflation Reduction Act in August&#160;2022, Congress extended the expansion of ACA premium tax credits through 2025. Those subsidies were originally extended through 2022 under the American Rescue Plan&#160;Act of 2021. These laws may result in additional reductions in Medicare and other healthcare funding and otherwise affect the prices Carisma may obtain for any of Carisma&#8217;s product candidates for which Carisma may obtain regulatory approval or the frequency with which any such product candidate is prescribed or used. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Since enactment of the ACA, there have been, and continue to be, numerous legal challenges and Congressional actions to repeal and replace provisions of the law. For example, with enactment of the Tax Cuts and Jobs Act of 2017, or the TCJA, which was signed by President Trump on December&#160;22, 2017, Congress repealed the &#8220;individual mandate.&#8221; The repeal of this provision, which requires most Americans to carry a minimal level of health insurance, became effective in 2019 Further, on December&#160;14, 2018, a U.S. District Court judge in the Northern District of Texas ruled that the individual mandate portion of the PPACA is an essential and inseverable feature of the ACA and therefore because the mandate was repealed as part of the Tax Act, the remaining provisions of the ACA are invalid as well. The U.S. Supreme Court heard this case on November&#160;10, 2020 and, on June&#160;17, 2021, dismissed this action after finding that the plaintiffs do not have standing to challenge the constitutionality of the ACA. Litigation and legislation over the ACA are likely to continue, with unpredictable and uncertain results. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Although the previous administration took executive actions to undermine or delay implementation of the ACA, those actions were rescinded with issuance of an Executive Order on January&#160;28, 2021, by President Biden which directs federal agencies to reconsider rules and other policies that limit Americans&#8217; access to health care, and consider actions that will protect and strengthen that access. Under this Executive Order, federal agencies are directed to re-examine: policies that undermine protections for people with pre-existing conditions, including complications related to COVID-19; demonstrations and waivers under Medicaid and the ACA that may reduce coverage or undermine the programs, including work requirements; policies that undermine the Health Insurance Marketplace or other markets for health insurance; policies that make it more difficult to enroll in Medicaid and the ACA; and policies that reduce affordability of coverage or financial assistance, including for dependents. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The prices of prescription pharmaceuticals have also been the subject of considerable discussion in the United States. There have been several recent U.S. congressional inquiries, as well as proposed and enacted state and federal legislation designed to, among other things, bring more transparency to pharmaceutical pricing, review the relationship between pricing and manufacturer patient programs, and reduce the costs of pharmaceuticals under Medicare and Medicaid. In 2020, President Trump issued several executive orders intended to lower the costs of prescription products and certain provisions in these orders have been incorporated into regulations. These regulations include an interim final rule implementing a most favored nation model for prices that would tie Medicare Part&#160;B payments for certain physician-administered pharmaceuticals to the lowest price paid in other economically advanced countries, effective January&#160;1, 2021. That rule, however, has been subject to a nationwide preliminary injunction and, on December&#160;29, 2021, CMS issued a final rule to rescind it. With issuance of this rule, CMS stated that it will explore all options to incorporate value into payments for Medicare Part&#160;B pharmaceuticals and improve beneficiaries&#8217; access to evidence-based care. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, in October&#160;2020, HHS and the FDA published a final rule allowing states and other entities to develop a Section&#160;804 Importation Program, or SIP, to import certain prescription products from Canada into the United States. The final rule is currently the subject of ongoing litigation, but at least six states (Vermont, Colorado, Florida, Maine, New Mexico, and New Hampshire) have passed laws allowing for the importation of products from Canada with the intent of developing SIPs for review and approval by the FDA. Further, on November&#160;20, 2020, HHS finalized a regulation removing safe harbor protection for price reductions from pharmaceutical manufacturers to plan sponsors under Part&#160;D, either directly or through pharmacy benefit managers, unless the price reduction is required by law. The implementation of the rule has been delayed by the Biden administration from January&#160;1, 2022 to January&#160;1, 2023 in response to ongoing litigation. The rule also creates a new safe harbor for price reductions reflected at the point-of-sale, as well as a new safe harbor for certain fixed fee arrangements between pharmacy benefit managers and manufacturers, the implementation of which has been delayed until January&#160;1, 2026, by the Infrastructure Investment and Jobs Act. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">308</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tEAHC">&#8203;</a><a name="tFAC">&#8203;</a><a name="tLEPR1">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">More recently, with passage of the Inflation Reduction Act in August&#160;2022, Congress authorized Medicare beginning in 2026 to negotiate lower prices for certain costly single-source drug and biologic products that do not have competing generics or biosimilars. This provision is limited in terms of the number of pharmaceuticals whose prices can be negotiated in any given year and it only applies to drug products that have been approved for at least 9&#160;years and biologics that have been licensed for 13&#160;years. Drugs and biologics that have been approved for a single rare disease or condition are categorically excluded from Medicare price negotiations. Further, the new legislation provides that if pharmaceutical companies raise prices in Medicare faster than the rate of inflation, they must pay rebates back to the government for the difference. The new law also caps Medicare out-of-pocket drug costs at an estimated $4,000 a year in 2024 and, thereafter beginning in 2025, at $2,000 a year. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On July&#160;9, 2021, President Biden signed Executive Order 14063, which focuses on, among other things, the price of pharmaceuticals. The Order directs HHS to create a plan within 45&#160;days to combat &#8220;excessive pricing of prescription pharmaceuticals and enhance domestic pharmaceutical supply chains, to reduce the prices paid by the federal government for such pharmaceuticals, and to address the recurrent problem of price gouging.&#8221; On September&#160;9, 2021, HHS released its plan to reduce pharmaceutical prices. The key features of that plan are to: (a)&#160;make pharmaceutical prices more affordable and equitable for all consumers and throughout the health care system by supporting pharmaceutical price negotiations with manufacturers; (b)&#160;improve and promote competition throughout the prescription pharmaceutical industry by supporting market changes that strengthen supply chains, promote biosimilars, and increase transparency; and (c)&#160;foster scientific innovation to promote better healthcare and improve health by supporting public and private research and making sure that market incentives promote discovery of valuable and accessible new treatments. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">At the state level, individual states are increasingly aggressive in passing legislation and implementing regulations designed to control pharmaceutical and biological product pricing, including price or patient reimbursement constraints, discounts, restrictions on certain product access and marketing cost disclosure and transparency measures, and, in some cases, designed to encourage importation from other countries and bulk purchasing. A number of states, for example, require pharmaceutical manufacturers and other entities in the supply chain, including health carriers, pharmacy benefit managers, wholesale distributors, to disclose information about pricing of pharmaceuticals. In addition, regional healthcare authorities and individual hospitals are increasingly using bidding procedures to determine what pharmaceutical products and which suppliers will be included in their prescription drug and other healthcare programs. These measures could reduce the ultimate demand for Carisma&#8217;s products, once approved, or put pressure on Carisma&#8217;s product pricing. Carisma expects that additional state and federal healthcare reform measures will be adopted in the future, any of which could limit the amounts that federal and state governments will pay for healthcare products and services, which could result in reduced demand for Carisma&#8217;s product candidates or additional pricing pressures. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Employees and Human Capital Resources</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">As of January 4, 2023, Carisma had 94 full-time employees, including a total of 33 employees with M.D. or Ph.D. degrees. Of these full-time employees, 85 are engaged in research and development activities. None of Carisma&#8217;s employees are represented by labor unions or covered by collective bargaining agreements. Carisma considers its relationship with its employees to be good. </font>
          </div>

        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma&#8217;s human capital objectives are focused on attracting, developing, and retaining talent. Cash compensation plans and equity grants are designed to attract, retain and to motivate employees, directors, and select consultants to achieve our corporate objectives. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Facilities</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma&#8217;s principal facilities consist of office and laboratory space in Philadelphia, Pennsylvania. Carisma occupies approximately 4,369 square feet of office space under a lease that is expected to expire in January&#160;2030 and approximately 3,600 square feet of laboratory space under a lease that expires in October&#160;2023. Carisma believes that its facilities are sufficient to meet its current needs. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Legal Proceedings</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma is currently not a party to any material legal proceedings.</font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">309</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tSBMD">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:11.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">SESEN BIO MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF</font>
          <br >
          <font style="letter-spacing:-0.2pt;">FINANCIAL CONDITION AND RESULTS OF OPERATIONS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;font-style:italic;">
            <font style="letter-spacing:0.2pt;">The following discussion and analysis should be read in conjunction with Sesen Bio&#8217;s financial statements and related notes included elsewhere in this proxy statement/prospectus. This discussion contains forward-looking statements based upon current expectations that involve risks and uncertainties. Sesen Bio&#8217;s actual results and the timing of selected events could differ materially from those anticipated in these forward-looking statements as a result of several factors, including those set out under the section entitled &#8220;Risk Factors&#8221; beginning on page <a href="#tRIFA">26</a> of this proxy statement/prospectus and elsewhere in this proxy statement/prospectus. See also the section entitled &#8220;Cautionary Statement Concerning Forward-Looking Statements&#8221; beginning on page&#160;<a href="#tCSCF">118</a> of this proxy statement/prospectus.</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
          </div>

        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Overview</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio is a late-stage clinical company that was previously focused on advancing TFPTs for the treatment of patients with cancer. Sesen Bio&#8217;s most advanced product candidate, Vicineum, also known as VB4-845, is a locally-administered targeted fusion protein composed of an EpCAM antibody fragment tethered to a truncated form of Pseudomonas exotoxin A for the treatment of NMIBC. </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">On July&#160;15, 2022, Sesen Bio made the strategic decision to voluntarily pause further development of Vicineum in the U.S. The decision was based on a thorough reassessment of Vicineum, which included the incremental development timeline and associated costs for an additional Phase&#160;3 clinical trial, following Sesen Bio&#8217;s discussions with the FDA, which are further described below. Sesen Bio no longer plans to pursue regulatory approval of Vicineum for NMIBC in the E.U. and has started to wind down certain of its manufacturing operations and business development partnerships. Sesen Bio has turned its primary focus to consummating a strategic transaction with the goal of maximizing shareholder value. Additionally, Sesen Bio is seeking a partner for the further development of Vicineum and has engaged a financial advisor for the potential sale of Vicineum. </font>
          </div>

        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Current Strategy</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The Merger</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">In May&#160;2022, Sesen Bio announced that it had commenced a process to explore and evaluate strategic alternatives to enhance stockholder value, and had engaged a financial advisor to assist Sesen Bio in this process. Sesen Bio then commenced an extensive process of evaluating strategic alternatives, including identifying and reviewing potential candidates for a strategic acquisition or other transaction as described in the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Merger&#8201;&#8212;&#8201;Background of the Merger</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tBOTM">125</a> of this proxy statement/prospectus. On September&#160;21, 2022, Sesen Bio announced that it had entered into the Merger Agreement. Although Sesen Bio has entered into the Merger Agreement and intends to consummate the merger, there is no assurance that it will be able to successfully consummate the merger on a timely basis, or at all. If, for any reason, the merger does not close, the Sesen Bio board of directors may elect to, among other things, attempt to complete another strategic transaction like the merger, attempt to sell or otherwise dispose of the various assets of Sesen Bio, resume its research and development activities and continue to operate the business of Sesen Bio or dissolve and liquidate its assets. </font>
          </div>

        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If the merger is not completed, the Sesen Bio board of directors may decide that it is in the best interests of the Sesen Bio stockholders to dissolve the company and liquidate its assets. In that event, the amount of cash available for distribution to the Sesen Bio stockholders would depend heavily on the timing of such decision and, ultimately, such liquidation, since the amount of cash available for distribution continues to decrease as Sesen Bio funds its operations and incurs fees and expenses related to the merger. In addition, if the Sesen Bio board of directors were to approve and recommend, and the Sesen Bio stockholders were to approve, a dissolution of Sesen Bio, it would be required under Delaware corporate law to pay its outstanding obligations, as well as to make reasonable provision for contingent and unknown obligations, prior to making any distributions in liquidation to the Sesen Bio stockholders. As a result of this requirement, a portion of Sesen Bio&#8217;s assets may need to be reserved pending the resolution of such obligations. In addition, Sesen Bio may be subject to litigation or other claims related to a liquidation and dissolution of the company. If a liquidation and dissolution were pursued, the Sesen Bio board of directors, </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">310</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">in consultation with its advisors, would need to evaluate these matters and make a determination about a reasonable amount to reserve. Accordingly, the Sesen Bio stockholders could lose all or a significant portion of their investment in the event of a liquidation and dissolution of Sesen Bio. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Other Recent Events</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">2022 Restructuring Plan</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">On July&#160;15, 2022, Sesen Bio approved the 2022 restructuring plan to reduce operating expenses and better align its workforce with the needs of its business following the decision to voluntarily pause further development of Vicineum in the United States. Execution of the 2022 restructuring plan is expected to be substantially completed in connection with the closing of the merger with Carisma, which is expected to occur in the first quarter of 2023. The 2022 restructuring plan includes an incremental reduction in Sesen Bio&#8217;s workforce as well as additional cost-saving initiatives intended to preserve capital during the pendency of the merger with Carisma and while Sesen Bio seeks a potential partner for the further development of Vicineum. Sesen Bio has also incurred one-time cash costs associated with the termination of certain contracts and all other activities under the 2022 restructuring plan. </font>
          </div>

        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Sale of Legacy Technology to Roche</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On July&#160;15, 2022, Sesen Bio executed the Roche Asset Purchase Agreement pursuant to which Roche purchased all patent rights and know-how related to the monoclonal antibody EBI-031 and all other IL-6 antagonist monoclonal antibody technology owned by Sesen Bio for up to $70&#160;million. As a result of the Roche Asset Purchase Agreement, the exclusive license agreement between Roche and Sesen Bio was terminated resulting in no further diligence, milestone or royalty payment obligations under such license agreement. Pursuant to the Roche Asset Purchase Agreement, Roche made a $40&#160;million payment to Sesen Bio upon execution of the Roche Asset Purchase Agreement. The Roche Asset Purchase Agreement also provides that Roche will make an additional $30&#160;million payable to Sesen Bio upon Roche&#8217;s initiation of a Phase&#160;3 clinical trial with EBI-031 for a defined indication if initiated prior to December&#160;31, 2026. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">2022 Retention Program</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On August&#160;28, 2022, the Sesen Bio board of directors and the Sesen Bio compensation committee approved a retention program for certain employees pursuant to which Sesen Bio will provide a cash incentive designed to retain such employees. Pursuant to this retention program, certain of Sesen Bio&#8217;s employees, including certain executive officers, will receive a cash bonus award, which vests in full upon the earlier of the completion of a strategic transaction and termination without cause, subject to continued employment through that time. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Components of Sesen Bio&#8217;s Results of Operations</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">License and Related Revenue</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">License revenue consists of revenue recognized pursuant to Sesen Bio&#8217;s OUS business development partnership agreements, including the Qilu License Agreement, and the Roche Asset Purchase Agreement, which is assessed under ASC Topic 606, Revenue. Sesen Bio has terminated all of its OUS business development partnership agreements. </font>
          </div>

        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Research and Development</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Research and development expenses consist primarily of costs incurred for the development of Vicineum for the treatment of NMIBC, which include: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">employee-related expenses, including salaries, benefits, travel and share-based compensation expense; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">expenses incurred under agreements with CROs and investigative sites that conduct Sesen Bio&#8217;s clinical trials; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">expenses associated with developing manufacturing capabilities; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">311</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">expenses associated with transferring manufacturing capabilities to CMOs for commercial-scale production; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">facilities, depreciation and other expenses, which include direct and allocated expenses for rent and maintenance of facilities, insurance and other supplies; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">expenses associated with regulatory activities; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">expenses associated with license milestone fees. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio expenses research and development costs as incurred. Sesen Bio recognizes external development costs based on an evaluation of the progress to completion of specific tasks using information and data provided to Sesen Bio by its vendors and its clinical sites. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio allocates direct research and development expenses, consisting principally of external costs, such as fees paid to investigators, consultants, central laboratories and CROs in connection with its clinical trials, costs related to manufacturing or purchasing clinical trial materials and technology transfer and license milestone fees, to specific product programs. Sesen Bio does not allocate employee and contractor-related costs, costs associated with its platform and facility expenses, including depreciation or other indirect costs, to specific product programs because these costs may be deployed across multiple product programs under research and development and, as such, are separately classified. The table below provides research and development expenses incurred for Vicineum for the treatment of NMIBC and other expenses by category. Sesen Bio expects to significantly reduce its research and development expenses during the pendency of the proposed merger with Carisma. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio did not allocate research and development expenses to any other specific product program during the periods presented (in thousands): </font>
        </div>
        <table style="width:456pt;height:183pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:284.84pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Three Months Ended</font>
                <br >
                <font style="letter-spacing:-0.16pt;">September&#160;30, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Nine Months Ended</font>
                <br >
                <font style="letter-spacing:-0.16pt;">September&#160;30, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:284.84pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:284.84pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Programs: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:284.84pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Vicineum for the treatment of NMIBC </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">813</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">2,989</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">29,705</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">10,888</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.25pt 0pt 2.5pt 0pt; width:284.84pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Total direct program expenses </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">813</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">2,989</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">29,705</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">10,888</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:284.84pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Personnel and other expenses: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:284.84pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Employee and contractor-related expenses </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">1,840</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">1,732</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">6,920</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">6,392</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:284.84pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Platform-related lab expenses </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">5</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">19</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">100</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">133</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:284.84pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Facility expenses </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">150</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">124</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">428</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">392</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:284.84pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Other expenses </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">123</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">103</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">483</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">468</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.25pt 0pt 2.5pt 0pt; width:284.84pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Total personnel and other expenses </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">2,118</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">1,978</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">7,931</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">7,385</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:284.84pt;text-align:left;">
              <div style="margin-left:30pt;">
                <font style="letter-spacing:-0.2pt;">Total Research and Development</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">2,931</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">4,967</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24pt; text-align:right; white-space:nowrap;">37,636</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">18,273</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">General and Administrative</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">General and administrative expenses consist primarily of salaries and related costs for personnel, including share-based compensation and benefits, in executive, operational, finance, legal, business development and human resource functions. Other general and administrative expenses include facility-related costs, professional fees for legal, estimated payments to settle litigation, insurance, investment banking fees, patent, consulting and accounting services, and pre-commercial United States market research. Sesen Bio expects its general and administrative expenses to increase due to increases in professional and advisory fees during the pendency of the proposed merger with Carisma. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Change in Fair Value of Contingent Consideration</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In connection with the Viventia Acquisition in September&#160;2016, Sesen Bio recorded contingent consideration pertaining to the amounts potentially payable to Viventia&#8217;s shareholders pursuant to the </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">312</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">terms of the Share Purchase Agreement among Sesen Bio, Viventia and the other signatories thereto and are based on regulatory approval in certain markets and future revenue levels. The fair value of contingent consideration is assessed at each balance sheet date and changes, if any, to the fair value are recognized in earnings (or loss) for the period. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Other Income, Net</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Other income, net consists primarily of interest income earned on cash and cash equivalents and, to a lesser extent, any gains or losses on foreign exchange. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Provision for Income Taxes</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Benefit for income taxes is driven by the intangible impairment charge, changing the value of deferred tax liabilities. Provision for income taxes consists of income taxes incurred to non-U.S. jurisdictions pursuant to Sesen Bio&#8217;s OUS business development partnership agreements, including the Qilu License Agreement, which was terminated on December 23, 2022. </font>
          </div>

        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Sesen Bio&#8217;s Results of Operations</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Comparison of the three&#160;months ended September&#160;30, 2022 and 2021</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:288.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:259.97pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Three Months Ended</font>
                <br >
                <font style="letter-spacing:-0.16pt;">September&#160;30, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Increase/(Decrease) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:259.97pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Dollars </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Percentage </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:259.97pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="22">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">(in thousands, except&#160;percentages) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:259.97pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Revenue: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.435pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.435pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:259.97pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">License and related revenue </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">40,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">40,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.435pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.435pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.25pt 0pt 2.5pt 0pt; width:259.97pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Total revenue </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">40,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">40,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.435pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.435pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:259.97pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Operating expenses: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.435pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.435pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:259.97pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Research and development </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">2,931</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">4,967</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">(2,036<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.435pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">(41<font style="position:absolute;">)%</font></td>
            <td style="padding:0pt;padding-left:4.435pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:259.97pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">General and administrative </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">8,141</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">8,699</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">(558<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.435pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">(6<font style="position:absolute;">)%</font></td>
            <td style="padding:0pt;padding-left:4.435pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:259.97pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Restructuring charge </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">10,947</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">5,522</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">5,425</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.435pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">98<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:4.435pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:259.97pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Intangibles impairment charge </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">31,700</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">(31,700<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.435pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">(100<font style="position:absolute;">)%</font></td>
            <td style="padding:0pt;padding-left:4.435pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:259.97pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Change in fair value of contingent consideration </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">(1,800<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">(114,000<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">112,200</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.435pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">(98<font style="position:absolute;">)%</font></td>
            <td style="padding:0pt;padding-left:4.435pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.25pt 0pt 2.5pt 0pt; width:259.97pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Total operating expenses </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">20,219</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">(63,112<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">83,331</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.435pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">(132<font style="position:absolute;">)%</font></td>
            <td style="padding:0pt;padding-left:4.435pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.25pt 0pt 2.5pt 0pt; width:259.97pt;text-align:left;">
              <div style="margin-left:30pt;">
                <font style="letter-spacing:0.2pt;">Income from Operations </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">19,781</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">63,112</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">(43,331<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.435pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">(69<font style="position:absolute;">)%</font></td>
            <td style="padding:0pt;padding-left:4.435pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:259.97pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Other income: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.435pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.435pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:259.97pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Other income, net </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">676</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">1</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">675</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.435pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">67,500<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:4.435pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.25pt 0pt 2.5pt 0pt; width:259.97pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">Income Before Taxes</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">20,457</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">63,113</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">(42,656<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.435pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">(68<font style="position:absolute;">)%</font></td>
            <td style="padding:0pt;padding-left:4.435pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.25pt 0pt 2.5pt 0pt; width:259.97pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Benefit from income taxes </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">8,561</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">(8,561<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.435pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">(100<font style="position:absolute;">)%</font></td>
            <td style="padding:0pt;padding-left:4.435pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:259.97pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">Net Income After Taxes</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24pt; text-align:right; white-space:nowrap;">20,457</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27pt; text-align:right; white-space:nowrap;">71,674</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">(51,217<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.435pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">(71<font style="position:absolute;">)%</font></td>
            <td style="padding:0pt;padding-left:4.435pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:17.3pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">License Revenue</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Revenue for the three&#160;months ended September&#160;30, 2022 was $40.0&#160;million, which was due to the execution of the Roche Asset Purchase Agreement for EBI-031 and all other IL-6 antagonist monoclonal antibody technology. Sesen Bio did not record any revenue for the three&#160;months ended September&#160;30, 2021. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Research and Development</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Research and development expenses were $2.9&#160;million for the three&#160;months ended September&#160;30, 2022, compared to $5.0&#160;million for the three&#160;months ended September&#160;30, 2021. The decrease of $2.0&#160;million was </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">313</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">primarily due to a decrease in costs associated with manufacturing ($1.9&#160;million) and a decrease in other R&amp;D related costs ($0.1&#160;million), driven by the strategic decision to voluntarily pause further development of Vicineum in the U.S. in the third quarter of 2022. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">General and Administrative</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">General and administrative expenses were $8.1&#160;million for the three&#160;months ended September&#160;30, 2022, compared to $8.7&#160;million for the three&#160;months ended September&#160;30, 2021. The decrease of $0.6&#160;million was primarily due to a decrease in marketing and commercialization expenses, which were incurred in the third quarter of 2021 in preparation for potential commercial launch of Vicineum but were discontinued as a result of the Complete Response Letter from the FDA received in August&#160;2021 ($2.3&#160;million) and a decrease in professional fees for accounting services ($0.4&#160;million). This was partially offset by an increase in legal expense ($1.3&#160;million), driven by legal fees associated with Sesen Bio&#8217;s assessment of strategic alternatives incurred in the third quarter of 2022 ($2.2&#160;million), partially offset by a decrease in legal fees associated with the internal review completed in February 2022 ($0.4&#160;million) and other legal expenses ($0.5&#160;million). Additionally, financial advisor fees increased due to financial advisor fees associated with Sesen Bio&#8217;s assessment of strategic alternatives incurred in the third quarter of 2022 ($0.8&#160;million). </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Restructuring Charge</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Restructuring charges were $10.9&#160;million for the three&#160;months ended September&#160;30, 2022 compared to $5.5&#160;million for the three&#160;months ended September&#160;30, 2021. The expense for the third quarter of 2022 consisted of severance and other employee-related costs ($6.9&#160;million) and termination of certain contracts and other associated costs ($4.0&#160;million) associated with the 2022 restructuring plan following the decision to voluntarily pause further development of Vicineum in the United States. The expense for the third quarter of 2021 consisted of severance and other employee-related costs ($2.8&#160;million) and termination of certain contracts ($2.7&#160;million) associated with the restructuring plan Sesen Bio approved on August&#160;30, 2021 to reduce operating expenses and better align its workforce with the needs of its business following the receipt of the CRL in August&#160;2021. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Intangibles impairment</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Intangibles impairment charge for the three&#160;months ended September&#160;30, 2022 was zero compared to $31.7&#160;million in the three&#160;months ended September&#160;30, 2021. In August&#160;2021, Sesen Bio received a CRL from the FDA regarding its BLA for Vicineum for the treatment of BCG-unresponsive NMIBC. As a result an impairment analysis was conducted, which concluded that the carrying value of its intangible asset of Vicineum U.S. rights was fully impaired as of September&#160;30, 2021. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Change in Fair Value of Contingent Consideration</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The non-cash change in fair value of contingent consideration was a gain of $1.8&#160;million for the three&#160;months ended September&#160;30, 2022, compared to a gain of $114.0&#160;million for the three&#160;months ended September&#160;30, 2021. The decrease in the fair value of contingent consideration of $1.8&#160;million for the three&#160;months ended September&#160;30, 2022 was due to Sesen Bio&#8217;s conclusion that it no longer expects to owe any future earnout payments related to the Greater China region since Qilu has informed Sesen Bio that it no longer intends to commercialize Vicineum in the Greater China region. Accordingly, Sesen Bio reduced its remaining $1.8&#160;million of contingent consideration liabilities to zero as of September&#160;30, 2022. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The change in fair value of contingent consideration was a gain of $114.0&#160;million for the three&#160;months ended September&#160;30, 2021. This was primarily driven by the receipt of a CRL from the FDA, in which the FDA determined that it cannot approve the BLA for Vicineum in its present form. Due to the inherent uncertainty in the path forward for Vicineum at the time, Sesen Bio reassessed the underlying assumptions used to develop the revenue projections upon which the fair value of contingent consideration was based. The most significant and impactful assumptions in Sesen Bio&#8217;s revenue projection models are timing of product launch and probabilities of clinical and regulatory success, or POS; Sesen Bio expected delays in the start of commercialization and estimated lower POS as a direct result of the CRL. Sesen Bio anticipated needing to conduct an additional clinical trial, which would lead to delays in the start of commercialization globally. Sesen Bio had assessed a range of commercialization timeline assumptions and applied a probability to each </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">314</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">outcome based on management&#8217;s best estimate. In addition, Sesen Bio assumed a lower POS in achieving certain clinical and regulatory milestones in the range of approximately 45% to 55% globally. The milestone payments constitute debt-like obligations, and the high-yield debt index rate applied to the milestones in order to determine the estimated fair value was 7.5% as of September&#160;30, 2021. The discount rate applied to the 2% earnout payment due on forecasted Vicineum revenues was derived from Sesen Bio&#8217;s estimated weighted-average cost of capital, or WACC, and this WACC-derived discount rate was 8.6% as of September&#160;30, 2021. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Benefit (Provision) from Income Taxes</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio did not record a benefit or loss for the three&#160;months ended September&#160;30, 2022. In the third quarter of 2021, Sesen Bio determined that the fair value of the Vicineum U.S. rights was zero, which resulted in an impairment charge of $31.7&#160;million. In connection with this impairment charge, in the third quarter of 2021, Sesen Bio reduced the associated deferred tax liability which resulted in an $8.6&#160;million income tax benefit. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Net income</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">For the three&#160;months ended September&#160;30, 2022, net income was $20.5&#160;million, compared to $71.7&#160;million for the three&#160;months ended September&#160;30, 2021. In the third quarter of 2022, Sesen Bio recorded revenue of $40.0&#160;million related to the execution of the Roche Asset Purchase Agreement and non-cash income of $1.8&#160;million related to changes in the fair value of contingent consideration, partially offset by operating expenses of $22.0&#160;million. In the third quarter of 2021, Sesen Bio recorded net non-cash income of $90.9&#160;million, which includes changes in the fair value of contingent consideration, income tax benefit and intangible impairment charge. Additionally, Sesen Bio recorded R&amp;D, G&amp;A and restructuring charges of $19.2&#160;million. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Comparison of the nine&#160;months ended September&#160;30, 2022 and 2021</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:273.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:266.64pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Nine Months Ended</font>
                <br >
                <font style="letter-spacing:-0.16pt;">September&#160;30, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Increase/(Decrease) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:266.64pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Dollars </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Percentage </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:266.64pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="22">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">(in thousands, except&#160;percentages) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:266.64pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Revenue: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.27pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.27pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:266.64pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">License and related revenue </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">40,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">6,544</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">33,456</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.27pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">511<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:5.27pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.25pt 0pt 2.5pt 0pt; width:266.64pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Total revenue </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">40,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">6,544</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">33,456</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.27pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">511<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:5.27pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:266.64pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Operating expenses: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.27pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.27pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:266.64pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Research and development </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">37,636</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">18,273</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">19,363</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.27pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">106<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:5.27pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:266.64pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">General and administrative </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">32,705</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">20,797</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">11,908</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.27pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">57<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:5.27pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:266.64pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Restructuring charge </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">10,947</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">5,522</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">5,425</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.27pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">98<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:5.27pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:266.64pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Intangibles impairment charge </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">27,764</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">31,700</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">(3,936<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.27pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">(12<font style="position:absolute;">)%</font></td>
            <td style="padding:0pt;padding-left:5.27pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:266.64pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Change in fair value of contingent consideration </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(52,000<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(52,240<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">240</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.27pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:5.27pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.25pt 0pt 2.5pt 0pt; width:266.64pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Total operating expenses </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">57,052</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">24,052</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">33,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.27pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">137<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:5.27pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.25pt 0pt 2.5pt 0pt; width:266.64pt;text-align:left;">
              <div style="margin-left:30pt;">
                <font style="letter-spacing:0.2pt;">Loss from Operations </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(17,052<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(17,508<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">456</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.27pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">(3<font style="position:absolute;">)%</font></td>
            <td style="padding:0pt;padding-left:5.27pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.25pt 0pt 2.5pt 0pt; width:266.64pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Other income (expense), net </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">867</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(45<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">912</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.27pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">(2,027<font style="position:absolute;">)%</font></td>
            <td style="padding:0pt;padding-left:5.27pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.25pt 0pt 2.5pt 0pt; width:266.64pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">Loss Before Taxes</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(16,185<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(17,553<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">1,368</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.27pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">(8<font style="position:absolute;">)%</font></td>
            <td style="padding:0pt;padding-left:5.27pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.25pt 0pt 2.5pt 0pt; width:266.64pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Benefit from income taxes </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">3,875</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">8,273</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">(4,398<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.27pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">(53<font style="position:absolute;">)%</font></td>
            <td style="padding:0pt;padding-left:5.27pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:266.64pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">Net Loss After Taxes</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(12,310<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(9,280<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">(3,030<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.27pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">33<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:5.27pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:16.81pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">License Revenue</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Revenue for the nine&#160;months ended September&#160;30, 2022 was $40.0&#160;million, which was due to the execution of the Roche Asset Purchase Agreement. Revenue for the nine&#160;months ended September&#160;30, 2021 </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">315</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">was $6.5&#160;million, which was due to achieving the IND milestone in China pursuant to the Qilu License Agreement, clinical supply revenue resulting from the delivery of drug product to Qilu and license revenue for additional purchase price due to the recovery of VAT by Qilu. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Research and Development</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Research and development expenses were $37.6&#160;million for the nine&#160;months ended September&#160;30, 2022, compared to $18.3&#160;million for the nine&#160;months ended September&#160;30, 2021. The increase of $19.4&#160;million was primarily due to the expense of prepaid balances related to consumables and manufacturing reservations as the balances were deemed to have no future value ($25.2&#160;million) in the second quarter of 2022. Additionally, employee-related compensation increased, primarily due to the retention programs implemented in the fourth quarter of 2021 and third quarter of 2022 ($2.6&#160;million). The increase was partially offset by decreased costs associated with manufacturing ($6.1&#160;million), clinical and manufacturing related consulting fees ($2.0&#160;million), and other individually immaterial R&amp;D costs ($0.3&#160;million), driven by the strategic decision to voluntarily pause further development of Vicineum in the U.S. in the third quarter of 2022. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">General and Administrative</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">General and administrative expenses were $32.7&#160;million for the nine&#160;months ended September&#160;30, 2022, compared to $20.8&#160;million for the nine&#160;months ended September&#160;30, 2021. The increase of $11.9&#160;million was primarily due to an increase in legal expense ($14.6&#160;million) driven by the preliminary settlements of the securities and derivative litigation net of expected insurance recovery ($8.2&#160;million) and legal fees associated with Sesen Bio&#8217;s assessment of strategic alternatives ($2.6&#160;million). Additionally, legal fees related to the internal review ($2.8&#160;million), securities litigation counseling ($0.9&#160;million) and other legal expenses ($0.1&#160;million) increased during the nine&#160;months ended September&#160;30, 2022. In addition, employee-related compensation increased, primarily driven by the retention programs implemented in the fourth quarter of 2021 and third quarter of 2022 ($1.3&#160;million). This was partially offset by decreases in marketing and commercial expenses ($4.0&#160;million), which were incurred during the first half of 2021 in preparation for potential commercial launch of Vicineum but were discontinued as a result of the CRL received in August&#160;2021. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Restructuring Charge</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Restructuring charges were $10.9&#160;million for the nine&#160;months ended September&#160;30, 2022 compared to $5.5&#160;million for the nine&#160;months ended September&#160;30, 2021. The expense for the nine&#160;months ended September&#160;30, 2022 consisted of severance and other employee-related costs ($6.9&#160;million) and termination of certain contracts and other associated costs ($4.0&#160;million) following the decision to pause further development of Vicineum in the U.S. The expense for the nine&#160;months ended September&#160;30, 2021 consisted of severance and other employee-related costs ($2.8&#160;million) and termination of certain contracts ($2.7&#160;million) following the receipt of the CRL in August&#160;2021. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Change in Fair Value of Contingent Consideration</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">The non-cash change in fair value of contingent consideration was a gain of $52.0&#160;million for the nine&#160;months ended September&#160;30, 2022, compared to a gain of $52.2&#160;million for the nine&#160;months ended September&#160;30, 2021. The decrease in the fair value of contingent consideration of $52.0&#160;million for the nine&#160;months ended September&#160;30, 2022 was driven by Sesen Bio&#8217;s strategic decision to voluntarily pause further development of Vicineum in the U.S. and its conclusion that Sesen Bio no longer expects to owe any future earnout payments related to the Greater China region since Qilu has informed Sesen Bio that it no longer intends to commercialize Vicineum in the Greater China region. The decision was based on a thorough reassessment of Vicineum following recent discussions with the FDA, which had implications for the size, timeline and costs for an additional Phase&#160;3 clinical trial for the treatment of NMIBC. Additionally, during the second quarter of 2022, Sesen Bio observed an evolution of the current market treatment paradigm in NMIBC, with substantial uptake of intravesical chemotherapy (monotherapy and combination therapy) during the ongoing BCG shortage. Sesen Bio continues to believe that Vicineum has benefits for patients and healthcare providers that can be maximized through a company with a larger infrastructure, and as such, is seeking a partner that can execute further development to realize the full potential of Vicineum. Sesen Bio </font>
          </div>

      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">316</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:55.9400000000001pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">expects that any partner who acquires Vicineum from Sesen Bio will be obligated to make any payments to the former shareholders of Viventia under the Share Purchase Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The change in fair value of contingent consideration was a gain of $52.2&#160;million for the nine&#160;months ended September&#160;30, 2021. This was primarily driven by the receipt of a CRL in August&#160;2021, in which the FDA determined that it could not approve the BLA for Vicineum in its present form. Due to the inherent uncertainty in the path forward for Vicineum at the time, Sesen Bio reassessed the underlying assumptions used to develop the revenue projections upon which the fair value of its contingent consideration is based. The most significant and impactful assumptions in Sesen Bio&#8217;s revenue projection models are timing of product launch and POS; Sesen Bio expected delays in the start of commercialization and estimate lower POS as a direct result of the CRL. Sesen Bio anticipated needing to conduct an additional clinical trial, which would lead to delays in the start of commercialization globally. Sesen Bio had assessed a range of commercialization timeline assumptions and applied a probability to each outcome based on management&#8217;s best estimate. In addition, Sesen Bio assumed a lower POS in achieving certain clinical and regulatory milestones in the range of approximately 45% to 55% globally. The milestone payments constitute debt-like obligations, and the high-yield debt index rate applied to the milestones in order to determine the estimated fair value was 7.5% as of September&#160;30, 2021. The discount rate applied to the 2% earnout payment due on forecasted Vicineum revenues was derived from Sesen Bio&#8217;s estimated WACC, and this WACC-derived discount rate was 8.6% as of September&#160;30, 2021. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Provision for Income Taxes</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">For the nine&#160;months ended September&#160;30, 2022, Sesen Bio recorded a benefit from income taxes of $3.9&#160;million. In the second quarter of 2022, Sesen Bio determined that the fair value of the Vicineum E.U. rights was zero, which resulted in an impairment charge of $14.7&#160;million. In connection with this impairment charge, in the second quarter of 2022, Sesen Bio reduced the associated deferred tax liability to zero, which resulted in a $4.0&#160;million income tax benefit, partially offset by $0.1&#160;million income tax paid to foreign jurisdictions pursuant to the Qilu License Agreement. Please refer to Note 8, &#8220;Intangible Assets and Goodwill,&#8221; in the Notes to Condensed Consolidated Financial Statements in Sesen Bio&#8217;s Quarterly Report on Form 10-Q for the quarter ended June&#160;30, 2022 for further information regarding the impairment charge. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">For the nine&#160;months ended September&#160;30, 2021, Sesen Bio recorded a benefit from income taxes of $8.3&#160;million. In the third quarter of 2021, Sesen Bio determined that the fair value of the Vicineum United States rights were zero, which resulted in an impairment charge of $31.7&#160;million. In connection with this impairment charge, in the third quarter of 2021, Sesen Bio reduced the associated deferred tax liability which resulted in an $8.6&#160;million income tax benefit. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Net Loss</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">For the nine&#160;months ended September&#160;30, 2022 net loss was $12.3&#160;million, compared to net loss of $9.3&#160;million, for the nine&#160;months ended September&#160;30, 2021. The increase of $3.0&#160;million was due to an increase in operating expense ($33.0&#160;million), primarily driven by the reduction of Sesen Bio&#8217;s prepaid balances related to consumables and manufacturing reservations in the second quarter of 2022 ($25.2&#160;million) and the preliminary settlements of the securities and derivative litigation net of expected insurance recovery ($8.2&#160;million). Additionally, the benefit from income taxes decreased ($4.4&#160;million) in 2022 compared to 2021. This was partially offset by increased revenue ($33.5&#160;million) primarily driven by the execution of the Roche Asset Purchase agreement. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">317</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Comparison of the Years Ended December&#160;31, 2021 and December&#160;31, 2020</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:261.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:263.19pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2pt 0pt; width:0pt;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Year ended December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2pt 0pt; width:0pt;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Increase/(Decrease) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:263.19pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.75pt 0pt 2pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.75pt 0pt 2pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.75pt 0pt 2pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Dollars </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.75pt 0pt 2pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Percentage </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:263.19pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt; width:0pt;text-align:center;" colspan="22">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">(in thousands, except&#160;percentages) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 1pt 0pt; width:263.19pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Revenue: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.125pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.125pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3pt 0pt 2pt 0pt; width:263.19pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">License and related revenue </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">26,544</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">11,236</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">15,308</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.125pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">136<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:9.125pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:2.75pt 0pt 2pt 0pt; width:263.19pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Total revenue </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">26,544</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">11,236</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">15,308</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.125pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">136<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:9.125pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 1pt 0pt; width:263.19pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Operating expenses: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.125pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.125pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 1pt 0pt; width:263.19pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Research and development </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">25,312</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">29,191</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">(3,879<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.125pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">(13<font style="position:absolute;">)%</font></td>
            <td style="padding:0pt;padding-left:9.125pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 1pt 0pt; width:263.19pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">General and administrative </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">29,393</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">14,302</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">15,091</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.125pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">106<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:9.125pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 1pt 0pt; width:263.19pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Restructuring charge </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">5,528</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">5,528</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.125pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:9.125pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 1pt 0pt; width:263.19pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Intangibles impairment charge </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">31,700</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">31,700</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.125pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:9.125pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3pt 0pt 2pt 0pt; width:263.19pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Change in fair value of contingent consideration </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(56,840<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(11,180<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">(45,660<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.125pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">408<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:9.125pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2.75pt 0pt 2pt 0pt; width:263.19pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Total operating expenses </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">35,093</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">32,313</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">2,780</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.125pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">9<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:9.125pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:2.75pt 0pt 2pt 0pt; width:263.19pt;text-align:left;">
              <div style="margin-left:30pt;">
                <font style="letter-spacing:0.2pt;">Loss from Operations </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(8,549<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(21,077<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">12,528</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.125pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">(59<font style="position:absolute;">)%</font></td>
            <td style="padding:0pt;padding-left:9.125pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 1pt 0pt; width:263.19pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Other (expense) income: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.125pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.125pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3pt 0pt 2pt 0pt; width:263.19pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Other (expense) income, net </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(60<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">125</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">(185<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.125pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">(148<font style="position:absolute;">)%</font></td>
            <td style="padding:0pt;padding-left:9.125pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2.75pt 0pt 2pt 0pt; width:263.19pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">Net Loss and Comprehensive Loss Before Taxes</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(8,609<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(20,952<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">12,343</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.125pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">(59<font style="position:absolute;">)%</font></td>
            <td style="padding:0pt;padding-left:9.125pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:2.75pt 0pt 2pt 0pt; width:263.19pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Benefit (provision) for income taxes </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">8,273</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(1,445<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">9,718</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.125pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">(673<font style="position:absolute;">)%</font></td>
            <td style="padding:0pt;padding-left:9.125pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 2.75pt 0pt; width:263.19pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">Net Loss and Comprehensive Loss After Taxes</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(336<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(22,397<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:3pt double #000000; min-width:24pt; text-align:right; white-space:nowrap;">22,061</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.125pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:3pt double #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">(98<font style="position:absolute;">)%</font></td>
            <td style="padding:0pt;padding-left:9.125pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:15.41pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">License Revenue</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.12pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Revenue for the year ended December&#160;31, 2021 was $26.5&#160;million, primarily due to the $20.0&#160;million milestone achieved pursuant to the Roche License Agreement upon initiating a Phase&#160;II clinical trial, $5.0&#160;million related to the Qilu License Agreement (achievement of the IND milestone, clinical supply revenue, and license revenue for additional purchase price due to the recovery of VAT), and $1.5&#160;million upfront milestone revenue achieved pursuant to the MENA License Agreement. Revenue for the year ended December&#160;31, 2020 was $11.2&#160;million, which was due to the recognition of revenue pursuant to the Qilu License Agreement. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Research and Development</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.12pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Research and development expenses were $25.3&#160;million for the year ended December&#160;31, 2021, compared to $29.2&#160;million for the year ended December&#160;31, 2020. The decrease of $3.9&#160;million was primarily due to lower costs associated with technology transfer and manufacturing ($7.4&#160;million). This was partially offset by increases in employee-related compensation driven by increased headcount as part of the commercial build and the retention program implemented after receipt of the CRL in August&#160;2021 ($2.1&#160;million), regulatory and clinical consulting fees ($1.0&#160;million) and certain other R&amp;D expense, none of which were individually material ($0.5&#160;million). </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">General and Administrative</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.12pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">General and administrative expenses were $29.4&#160;million for the year ended December&#160;31, 2021, compared to $14.3&#160;million for the year ended December&#160;31, 2020. The increase of $15.1&#160;million was primarily due to increases in employee-related compensation ($5.0&#160;million), legal costs ($4.8&#160;million), and marketing and commercial expenses ($4.1&#160;million) driven by preparation for the commercial launch of Vicineum prior to the issuance of the CRL in August&#160;2021. Additionally, increases in accounting services ($0.4&#160;million), insurance expenses ($0.4&#160;million), IT expenses ($0.3&#160;million) and others ($0.1&#160;million) contributed to the increase. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Restructuring Charge</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.11pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On August&#160;30, 2021, Sesen Bio approved a restructuring plan to reduce operating expenses and better align its workforce with the needs of its business following receipt of the CRL from the FDA regarding the </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">318</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">BLA for Vicineum for the treatment of BCG-unresponsive NMIBC, or the 2021 restructuring plan. The 2021 restructuring plan included a reduction in Sesen Bio&#8217;s workforce by 18 positions (or approximately 35% of its workforce) as well as additional cost-saving initiatives intended to preserve capital while it continued development of Vicineum. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Restructuring expenses were $5.5&#160;million for the year ended December&#160;31, 2021, compared to no restructuring expenses for the year ended December&#160;31, 2020. The increase was due to one-time costs associated with the 2021 restructuring plan implemented in response to the CRL for severance and other employee-related costs ($2.8&#160;million) and termination of certain contracts ($2.7&#160;million). </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Intangibles Impairment Charge</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio recorded an intangibles impairment charge of $31.7&#160;million during the year ended December&#160;31, 2021. Sesen Bio did not record any impairment charges during the year ended December&#160;31, 2020. In August&#160;2021, Sesen Bio received a CRL from the FDA regarding its BLA for Vicineum for the treatment of BCG-unresponsive NMIBC. The impairment charge of $31.7&#160;million for the year ended December&#160;31, 2021 relates to the full impairment of its U.S. in-process research and development asset due to expected delays in the start of commercialization and lower probabilities of success, combined with higher operating expenses expected to be incurred prior to commercialization, resulting in lower expected future cash flows estimated in the U.S. market at this time. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Change in Fair Value of Contingent Consideration</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The non-cash change in fair value of contingent consideration was income of $56.8&#160;million for the year ended December&#160;31, 2021, compared to income of $11.2&#160;million for the year ended December&#160;31, 2020. The decrease in the fair value of contingent consideration of $45.7&#160;million from the year ended December&#160;31, 2020 to the year ended December&#160;31, 2021, was driven by the receipt of a CRL from the FDA, regarding its BLA for Vicineum for the treatment of BCG-unresponsive NMIBC. Due to the inherent uncertainty in the path forward for Vicineum, Sesen Bio reassessed the underlying assumptions used to develop the revenue projections upon which the fair value of the contingent consideration is based. The most significant and impactful assumptions in Sesen Bio&#8217;s revenue projection models are timing of product launch and probabilities of clinical and regulatory success POS; Sesen Bio expects delays in the start of commercialization and estimate lower POS as a direct result of the CRL and its withdrawal of the MAA. Sesen Bio will need to conduct an additional clinical trial, which will lead to delays in the start of commercialization globally. Sesen Bio has assessed a range of commercialization timeline assumptions and applied a probability to each outcome based on management&#8217;s best estimate. In addition, Sesen Bio assumed a lower POS in achieving certain clinical and regulatory milestones in the range of approximately 45% to 55% globally. Sesen Bio participated in Type A Meetings with the FDA on October&#160;29, 2021 and December&#160;8, 2021 to discuss questions related to CMC and clinical issues raised in the CRL. Both meetings helped Sesen Bio determine the appropriate path forward for Vicineum. Any changes in these assumptions and estimates or other information obtained, may have a significant impact on the remeasurement of the contingent consideration liability in the future. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The change in fair value of contingent consideration was income of $11.2&#160;million for the year ended December&#160;31, 2020. This was primarily attributable to significantly higher discount rates as a result of financial market conditions as of the year ended December&#160;31, 2020, offset by changes to the competitive landscape. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Other (expense) income, net</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Other expense, net was $0.1&#160;million for the year ended December&#160;31, 2021, compared to other income of $0.1&#160;million for the year ended December&#160;31, 2020. The change of $0.2&#160;million was due primarily to lower interest income. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Provision for Income Taxes</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">For the twelve&#160;months ended December&#160;31, 2021, Sesen Bio recorded a benefit from income taxes of $8.3&#160;million. In the third quarter of 2021, Sesen Bio determined that the fair value of the Vicineum U.S. in-process research and development asset was zero, which resulted in an impairment charge of $31.7&#160;million. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">319</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In connection with this impairment charge, in the third quarter of 2021, Sesen Bio wrote-down the associated deferred tax liability by $8.6&#160;million as a benefit. See Note 8, &#8220;Intangibles and Goodwill,&#8221; to Sesen Bio&#8217;s audited annual consolidated financial statements for the fiscal year ended December&#160;31, 2021 for further information regarding the impairment charge. For the twelve&#160;months ended December&#160;31, 2020, Sesen Bio recorded a provision for income taxes of $1.4&#160;million. This provision consisted of income taxes paid to non-U.S. jurisdictions pursuant to Sesen Bio&#8217;s commercialization partnership agreements. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Liquidity and Capital Resources</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Overview</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As of September&#160;30, 2022, Sesen Bio had cash, cash equivalents and marketable securities of $184.9&#160;million, net working capital of $157.7&#160;million and an accumulated deficit of $328.6&#160;million. Sesen Bio incurred cash flows from operating activities of $22.2&#160;million for the nine&#160;months ended September&#160;30, 2022, compared to negative cash flows of $56.3&#160;million for the nine&#160;months ended September&#160;30, 2021. Sesen Bio believes that, based on its current operating plans and financial forecasts, its cash, cash equivalents and marketable securities of $184.9&#160;million as of September&#160;30, 2022, are sufficient to fund Sesen Bio&#8217;s current operating plan for at least twelve&#160;months from the date of Sesen Bio&#8217;s Form 10-Q filing on November&#160;7, 2022 for the fiscal quarter ended September&#160;30, 2022. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Following an extensive process of evaluating strategic alternatives, including identifying and reviewing potential candidates for a strategic transaction, on September&#160;20, 2022, Sesen Bio entered into the Merger Agreement with Carisma and Merger Sub, pursuant to which, among other things, and subject to the satisfaction or waiver of certain conditions set forth in the Merger Agreement, Merger Sub will merge with and into Carisma, with Carisma continuing as its wholly-owned subsidiary and the surviving corporation of the merger. The Sesen Bio board of directors unanimously approved the Merger Agreement and resolved to recommend that Sesen Bio stockholders approve the proposals described in the Merger Agreement. If the merger is completed, the business of Carisma will continue as the business of the combined company. </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">The merger is expected to close in the first quarter of 2023. Consummation of the merger is subject to certain closing conditions, including, among other things, (a)&#160;approval by Sesen Bio stockholders of the proposals described in the Merger Agreement, (b)&#160;approval by Carisma&#8217;s stockholders of, among other things, the adoption of the Merger Agreement, (c)&#160;Nasdaq&#8217;s approval of the listing of the shares of Sesen Bio common stock to be issued in connection with the merger, (d)&#160;the effectiveness of a registration statement on Form S-4 to register the shares of Sesen Bio common stock to be issued in connection with the merger, and (e)&#160;Sesen Bio having net cash as of closing of the merger greater than or equal to $75.0&#160;million. </font>
          </div>

        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Merger Agreement contains certain termination rights of each of Sesen Bio and Carisma. Upon termination of the Merger Agreement under specified circumstances, Sesen Bio may be required to pay Carisma a termination fee of $7.6&#160;million and/or reimburse Carisma&#8217;s expenses up to a maximum of $1.75&#160;million, and Carisma may be required to pay Sesen Bio a termination fee of $5.49&#160;million and/or reimburse Sesen Bio expenses up to a maximum of $1.75&#160;million. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio&#8217;s future operations are highly dependent on the success of the merger and there can be no assurances that the merger will be successfully consummated. In the event that Sesen Bio does not complete the merger with Carisma, Sesen Bio may continue to explore strategic alternatives, including, without limitation, another strategic transaction and/or pursue a liquidation and dissolution of Sesen Bio. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Since Sesen Bio&#8217;s inception, Sesen Bio has received no revenue from sales of its products, and Sesen Bio anticipates that operating losses will continue for the foreseeable future. Sesen Bio has financed its operations to date primarily through private placements of its common stock, preferred stock, common stock warrants and convertible bridge notes, venture debt borrowings, its IPO, follow-on public offerings, sales effected in ATM offerings, its OUS business development partnerships and license agreements, sale of assets, and, to a lesser extent, from a collaboration. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio has entered into an Open Market Sale Agreement with Jefferies LLC, or Jefferies, dated November&#160;29, 2019, as amended by Amendment No. 1 dated October&#160;30, 2020, Amendment No. 2 dated February&#160;17, 2021 and Amendment No. 3, dated June&#160;1, 2021, or as amended, the Sale Agreement, under </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">320</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">which Sesen Bio may issue and sell shares of Sesen Bio common stock from time to time through Jefferies, or the ATM Offering. In June and July&#160;2021, Sesen Bio filed prospectus supplements with the SEC in connection with the offer and sale of up to an aggregate of $200&#160;million of Sesen Bio common stock pursuant to the Sale Agreement of which $97.8&#160;million of common shares remain available for future issuance as of September&#160;30, 2022. Sales of common stock under the Sale Agreement are made by any method that is deemed to be an ATM offering as defined in Rule&#160;415(a)(4) of the Securities Act of 1933, including but not limited to sales made directly on or through the Nasdaq Stock Market or any other existing trading market for Sesen Bio common stock. Sesen Bio may sell shares of Sesen Bio common stock efficiently from time to time but have no obligation to sell any of Sesen Bio common stock and may at any time suspend offers under the Sale Agreement or terminate the Sale Agreement. Subject to the terms and conditions of the Sale Agreement, Jefferies will use its commercially reasonable efforts to sell Sesen Bio common stock from time to time, as the sales agent, based upon Sesen Bio&#8217;s instructions, which include a prohibition on sales below a minimum price set by Sesen Bio from time to time. Sesen Bio has provided Jefferies with customary indemnification rights, and Jefferies is entitled to a commission at a fixed rate equal to 3.0% of the gross proceeds for each sale of Sesen Bio common stock under the Sale Agreement. Sesen Bio did not sell any shares of common stock pursuant to the Sale Agreement during the nine&#160;months ended September&#160;30, 2022. Sesen Bio raised $175.0&#160;million of net proceeds from the sale of 56.9&#160;million shares of Sesen Bio common stock at a weighted-average price of $3.17 per share during the nine&#160;months ended September&#160;30, 2021, including $38.2&#160;million of net proceeds from the sale of 9.8&#160;million shares of Sesen Bio common stock at a weighted-average price of $4.01 per share during the three&#160;months ended September&#160;30, 2021. Share issue costs, including sales agent commissions, related to the ATM Offering totaled $1.2&#160;million and $5.4&#160;million for the three and nine&#160;months ended September&#160;30, 2021, respectively. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Funding Requirements</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio&#8217;s future funding requirements will depend on the outcome of the proposed merger with Carisma. </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Sesen Bio is subject to a number of risks similar to other clinical companies that have determined to focus primarily on pursuing a strategic transaction, including, but not limited to, those which are described under in the section entitled &#8220;Risk Factors&#8221; beginning on page <a href="#tRIFA">26</a> of the proxy statement/prospectus. </font>
          </div>

        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio will incur substantial expenses if and as Sesen Bio: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">addresses its ongoing securities litigation; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">maintains, expands and protects its intellectual property portfolio; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">reduces personnel and incur related severance and employee-related costs; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">winds down activities with its CMOs; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">terminates its property leases; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">explores, evaluates and pursues any strategic alternatives if the merger is not completed. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio&#8217;s future capital requirements will depend on many factors, including: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the outcome and the timing of the proposed merger with Carisma; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the outcome and timing of any pending or future litigation involving Sesen Bio or its business; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the costs and timing of maintaining and enforcing Sesen Bio&#8217;s intellectual property rights and defending any intellectual property-related claims; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio&#8217;s obligation to make milestone, royalty and other payments to third-party licensors under its licensing agreements. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Until such time, if ever, as Sesen Bio can generate substantial revenues, Sesen Bio expects to finance its cash needs through a combination of equity offerings, debt financings, or government or other third-party funding. To the extent that Sesen Bio raises additional capital through the sale of equity or convertible debt securities, the ownership interests of existing stockholders will be diluted, and the terms of these securities may include liquidation or other preferences that adversely affect the rights of existing Sesen Bio stockholders. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">321</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Debt financing, if available, may involve agreements that include liens or other restrictive covenants limiting Sesen Bio&#8217;s ability to take specific actions, such as incurring additional debt, making capital expenditures or declaring dividends. If Sesen Bio is unable to raise additional funds when needed, Sesen Bio may be required to delay, limit, reduce or terminate its assessment of strategic alternatives. If Sesen Bio does not successfully consummate the proposed merger with Carisma, the Sesen Bio board of directors may decide to explore other strategic alternatives, including, without limitation, another strategic transaction and/or a liquidation and dissolution of Sesen Bio. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Contractual and Other Obligations</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">For information related to Sesen Bio&#8217;s cash requirements from known contractual and other obligations, see the description of Contingent Consideration in Note 5 &#8220;Fair Value Measurement and Financial Instruments,&#8221; the information in Note 10 &#8220;Commitments and Contingencies&#8221;, Sesen Bio&#8217;s leases in Note&#160;11&#160;&#8220;Leases&#8221;, and the description of Sesen Bio&#8217;s license agreements in Note 17, &#8220;License Agreements&#8221; of &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Financial Statements&#8201;&#8212;&#8201;Notes to Condensed Consolidated Financial Statements</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tNTCC">F-48</a> of this proxy statement/prospectus.. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Cash Flows</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following table sets forth a summary of Sesen Bio&#8217;s cash flows for the nine&#160;months ended September&#160;30, 2022 and 2021 (in thousands): </font>
        </div>
        <table style="width:456pt;height:91.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:353.26pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Nine Months Ended</font>
                <br >
                <font style="letter-spacing:-0.16pt;">September&#160;30, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:353.26pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:353.26pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Net Cash Provided by (Used in) Operating Activities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">22,214</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">(56,278<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:353.26pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Net Cash Used in Investing Activities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(113,733<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">(4<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:353.26pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Net Cash Provided by Financing Activities </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">176,129</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:353.26pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.2pt;">Net (Decrease) Increase in Cash, Cash Equivalents and Restricted Cash</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27pt; text-align:right; white-space:nowrap;">(91,519<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">119,847</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:15.51pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Net Cash Used in Operating Activities</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Net cash provided by operating activities was $22.2&#160;million for the nine&#160;months ended September&#160;30, 2022 and consisted primarily of a net loss of $12.3&#160;million, adjusted for non-cash items including, a decrease in the fair value of contingent consideration ($52.0&#160;million), intangible impairment charge ($27.8&#160;million), share-based compensation ($5.9&#160;million), and a net increase in operating assets and liabilities ($52.9&#160;million). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Net cash used in operating activities was $56.3&#160;million for the nine&#160;months ended September&#160;30, 2021 and consisted primarily of a net loss of $9.3&#160;million, which includes $6.5&#160;million of revenue recognized pursuant to certain of Sesen Bio&#8217;s out-license agreements, adjusted for non-cash items, including share-based compensation ($3.4&#160;million), a decrease in the fair value of contingent consideration ($52.2&#160;million), increase in impairment charge ($31.7&#160;million), and a net decrease in operating assets and liabilities of ($29.9&#160;million). </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Net Cash Used in Investing activities</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Net cash used in investing activities was $113.7&#160;million for the nine&#160;months ended September&#160;30, 2022 and consisted of marketable security purchases. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Net cash used in investing activities consisted of de minimis purchases and sales or property and equipment during the nine&#160;months ended September&#160;30, 2021. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Net Cash Provided by Financing activities</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Net cash provided by financing activities was zero for the nine&#160;months ended September&#160;30, 2022. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Net cash provided by financing activities was $176.1&#160;million for the nine&#160;months ended September&#160;30, 2021 and consisted primarily of $175.0&#160;million net proceeds from the sale of common stock under the ATM Offering. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">322</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Critical Accounting Policies and Use of Estimates</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The preparation of Sesen Bio&#8217;s condensed consolidated financial statements in accordance with U.S.&#160;GAAP and the rules and regulations of the SEC require the use of estimates and assumptions, based on complex judgments considered reasonable, and affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of expenses during the reporting period. Sesen Bio&#8217;s critical accounting policies are those policies which involve a significant level of estimation uncertainty and have had or are reasonably likely to have a material impact on Sesen Bio&#8217;s financial condition or results of operations. Sesen Bio&#8217;s management has determined that Sesen Bio&#8217;s most critical accounting policies are those relating to the fair value of indefinite-lived intangible assets, goodwill; contingent consideration; revenue recognition; development and regulatory milestone payments and other costs; and research and development costs. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Fair Value of Indefinite-Lived Intangible Assets</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio&#8217;s intangible assets consist of indefinite-lived, acquired IPR&amp;D worldwide product rights to Vicineum as a result of the acquisition of Viventia in 2016. IPR&amp;D assets acquired in a business combination are considered indefinite-lived until the completion or abandonment of the associated research and development efforts. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Indefinite-lived intangible assets are quantitatively tested for impairment at least annually during the fourth quarter of the fiscal year, or more often if indicators of impairment are present. Impairment testing of indefinite-lived intangible assets requires management to estimate the future discounted cash flows of an asset using assumptions believed to be reasonable, but which are unpredictable and inherently uncertain. Actual future cash flows may differ from the estimates used in impairment testing. Sesen Bio recognizes an impairment loss when and to the extent that the estimated fair value of an intangible asset is less than its carrying value. In addition, on a quarterly basis, Sesen Bio performs a qualitative review of its business operations to determine whether events or changes in circumstances have occurred which could indicate that the carrying value of its intangible assets was not recoverable. If an impairment indicator is identified, an interim impairment assessment is performed. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">During the second quarter of 2022, Sesen Bio observed an evolution of the current market treatment paradigm in NMIBC, with substantial uptake of intravesical chemotherapy (monotherapy and combination therapy) during the ongoing BCG shortage. Sesen Bio has also experienced a sustained decline in share price and a resulting decrease in its market capitalization. On July&#160;15, 2022, Sesen Bio made the strategic decision to voluntarily pause further development of Vicineum in the United States. The decision was based on a thorough reassessment of Vicineum following recent discussions with the FDA, which had implications on the size, timeline and costs of an additional Phase&#160;3 clinical trial for the treatment of NMIBC. Sesen Bio management updated the discounted cash flow model using the market participant approach and considered preliminary terms of potential partnering deal to conclude the fair value of its intangible asset of Vicineum E.U. rights. Sesen Bio concluded that the carrying value of its intangible asset of Vicineum E.U. rights of $14.7&#160;million was fully impaired as of June&#160;30, 2022 and was reduced to zero in the second quarter of 2022. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Goodwill</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Goodwill on Sesen Bio&#8217;s condensed consolidated balance sheets is the result of its acquisition of Viventia in September&#160;2016 and represents the difference between the purchase price and the fair value of the identifiable tangible and intangible net assets acquired under the acquisition method of accounting. Goodwill is not amortized; rather than recording periodic amortization, goodwill is quantitatively tested for impairment at least annually during the fourth quarter of the fiscal year, or more often if indicators of impairment are present. Impairment testing of goodwill requires management to estimate the future discounted cash flows of a reporting unit using assumptions believed to be reasonable, but which are unpredictable and inherently uncertain. Actual future cash flows may differ from the estimates used in impairment testing. If the fair value of the equity of a reporting unit exceeds the reporting unit&#8217;s carrying value, including goodwill, then goodwill is considered not to be impaired. Sesen Bio recognizes a goodwill impairment when and to the extent that the fair value of the equity of a reporting unit is less than the reporting unit&#8217;s carrying value, including goodwill. Sesen Bio has only one reporting unit. In addition, on a quarterly basis, Sesen Bio performs a qualitative review of its business operations to determine whether events </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">323</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">or changes in circumstances have occurred which could have a material adverse effect on the estimated fair value of each reporting unit and thus indicate a potential impairment of the goodwill carrying value. If an impairment indicator is identified, an interim impairment assessment is performed. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">During the second quarter of 2022, Sesen Bio observed continued trends in its market capitalization as compared to the carrying value of its single reporting unit as well as changes in certain assumptions in the fair value of the business including market share, size, length and cost of a clinical trial, and time to potential market launch. Sesen Bio identified these changes as potential impairment indicators and performed a quantitative impairment analysis in advance of its typical annual assessment date of October&#160;1. Sesen Bio reassessed the underlying assumptions used to develop its revenue projections, which were then used as significant inputs to determine the fair value of equity. Sesen Bio updated its revenue forecast models based on further expected launch delays in both U.S. and OUS regions. Sesen Bio also recently observed an evolution of the current treatment paradigm in NMIBC, with substantial uptake of intravesical chemotherapy (monotherapy and combination therapy) during the ongoing BCG shortage resulting in lower projected peak market share for Vicineum. Sesen Bio also considered other factors including the preliminary valuations of strategic alternatives during the fair value assessment. As a result of the interim impairment test, Sesen Bio concluded that the carrying value of its goodwill of $13.1&#160;million was fully impaired as of June&#160;30, 2022. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Contingent Consideration</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Contingent consideration on Sesen Bio&#8217;s condensed consolidated balance sheets is the result of Sesen Bio&#8217;s acquisition of Viventia in September&#160;2016 and represents the discounted present value of future commercial launch milestones and net sales earnout payments due to the former shareholders of Viventia pursuant to the Share Purchase Agreement. Contingent consideration is measured at its estimated fair value on a recurring basis at each reporting period, with fluctuations in value resulting in a non-cash charge to earnings (or loss) during the period. The estimated fair value measurement is based on significant unobservable inputs (Level&#160;3 within the fair value hierarchy), including internally developed financial forecasts, probabilities of success and timing of certain milestone events and achievements, which are unpredictable and inherently uncertain. Actual future cash flows may differ from the assumptions used to estimate the fair value of contingent consideration. The valuation of contingent consideration requires the use of significant assumptions and judgments, which management believes are consistent with those that would be made by a market participant. Management reviews its assumptions and judgments on an ongoing basis as additional market and other data is obtained, and any future changes in the assumptions and judgments utilized by management may cause the estimated fair value of contingent consideration to fluctuate materially, resulting in earnings volatility. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The estimated fair value of Sesen Bio&#8217;s contingent consideration was determined using probabilities of successful achievement of regulatory milestones and commercial sales, the period in which these milestones and sales were expected to be achieved through 2033, the level of commercial sales of Vicineum forecasted for the U.S., Europe, Japan, China and other potential markets. Earnouts were determined using an earnout rate of 2% on all commercial net sales of Vicineum through December&#160;2033. The discount rate applied to the 2% earnout was derived from Sesen Bio&#8217;s estimated weighted-average cost of capital, which has fluctuated from 9.3% as of December&#160;31, 2021. Milestone payments constitute debt-like obligations, and therefore a high-yield debt index rate was applied to the milestones in order to determine the estimated fair value. This index rate was 8.0% as of December&#160;31, 2021. </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">On July&#160;15, 2022, Sesen Bio made the strategic decision to voluntarily pause further development of Vicineum in the United States. The decision was based on a thorough reassessment of Vicineum following recent discussions with the FDA, which had implications on the size, timeline and costs of an additional Phase&#160;3 clinical trial for the treatment of NMIBC. Sesen Bio continues to believe that Vicineum has benefits for patients and healthcare providers that can be maximized through a company with a larger infrastructure, and as such, Sesen Bio is seeking a partner for the further development of Vicineum. Accordingly, during the second quarter of 2022, Sesen Bio concluded that it was no longer expected to pay related milestone and earnout payments to the former shareholders of Viventia, with the exception of the potential 2% earnout payment related to the Greater China region since those territory rights had been out-licensed. Qilu held the exclusive license to develop Vicineum in the Greater China region, and accordingly, the $1.8&#160;million estimated earnout payment in the Greater China region remained as long-term contingent consideration as of June&#160;30, 2022. </font>
          </div>

      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">324</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:24pt;margin-left:69.66pt;width:456pt;">

          <div style="text-indent:20pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Qilu has informed Sesen Bio that it no longer intends to commercialize Vicineum in the Greater China region. Therefore, Sesen Bio terminated the Qilu License Agreement, upon which Sesen Bio regained the rights to develop, manufacture and commercialize Vicineum in Greater China. However, Sesen Bio does not plan to develop or commercialize Vicineum in that region or any other, as Sesen Bio is pursuing the merger with Carisma. Sesen Bio is also seeking to sell or out-license Vicineum and all the related obligations related to Vicineum. Sesen Bio expects that any partner who acquires or licenses Vicineum from Sesen Bio will be obligated to make any payments, including those related to sales in the Greater China region (if any), that become payable to the former shareholders of Viventia under the Share Purchase Agreement. If a sale or license of Vicineum has not occurred at the time the merger is completed, Carisma has indicated it may continue to seek a sale or license of Vicineum and has no plans to develop Vicineum. Accordingly, as of September&#160;30, 2022, Sesen Bio concluded that it no longer expects to owe any future earnout payments related to the Greater China region and reduced its remaining $1.8&#160;million of contingent consideration liabilities to zero as of September&#160;30, 2022. </font>
          </div>

        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Income Taxes</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and net operating loss and research and development credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the&#160;years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in operations in the period that includes the enactment date. A valuation allowance is recorded to the extent it is more likely than not that some portion or all of the deferred tax assets will not be realized. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Unrecognized income tax benefits represent income tax positions taken on income tax returns that have not been recognized in the financial statements. Sesen Bio recognizes the benefit of an income tax position only if it is more likely than not (greater than 50%) that the tax position will be sustained upon tax examination, based solely on the technical merits of the tax position. Otherwise, no benefit is recognized. The tax benefits recognized are measured based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement. Sesen Bio recognizes accrued interest and penalties related to uncertain tax positions as income tax expense in its condensed consolidated statements of operations. As of September&#160;30, 2022 and December&#160;31, 2021, Sesen Bio did not have any uncertain tax positions. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Research and Development Costs</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Research and development activities are expensed in the period incurred. Research and development expenses consist of both internal and external costs associated with all basic research activities, clinical development activities and technical efforts required to develop a product candidate. Internal research and development consist primarily of personnel costs, including salaries, benefits and share-based compensation, facilities leases, research-related overhead, pre-approval regulatory and clinical trial costs, manufacturing and other contracted services, license fees and other external costs. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In certain circumstances, Sesen Bio is required to make advance payments to vendors for goods or services that will be received in the future for use in research and development activities. In such circumstances, the advance payments are recorded as prepaid assets and expensed when the activity has been performed or when the goods have been received. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Recently Issued Accounting Standards</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Recently issued accounting standards are discussed in of &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Financial Statements&#8201;&#8212;&#8201;Notes to Condensed Consolidated Financial Statements</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tNTCC">F-48</a> of this proxy statement/prospectus.</font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">325</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tCMDA">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CARISMA MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF </font>
          <br >
          <font style="letter-spacing:-0.2pt;">FINANCIAL CONDITION AND RESULTS OF OPERATIONS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-style:italic;">
            <font style="letter-spacing:0.2pt;">The following discussion and analysis of Carisma&#8217;s financial condition and results of operations should be read in conjunction with Carisma&#8217;s consolidated financial statements and the related notes included elsewhere in this proxy statement/prospectus. Some of the information contained in this discussion and analysis or set forth elsewhere in this proxy statement/prospectus, including information with respect to Carisma&#8217;s plans and strategy for its business and related financing, includes forward-looking statements that involve risks and uncertainties. As a result of many factors, including those factors set out under the section entitled &#8220;Risk Factors&#8221; beginning on page <a href="#tRIFA">26</a> of this proxy statement/prospectus, Carisma&#8217;s actual results could differ materially from the results described in or implied by these forward-looking statements. See also the section entitled &#8220;Cautionary Statement Concerning Forward-Looking Statements&#8221; beginning on page <a href="#tCSCF">118</a> of this proxy statement/</font>&#8203;<font style="letter-spacing:0.2pt;">prospectus.</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font></div>

        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Overview</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma is a clinical stage cell therapy company focused on utilizing Carisma&#8217;s proprietary macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. Carisma has created a comprehensive cell therapy platform to enable the therapeutic use of engineered macrophages and monocytes, which belong to a subgroup of white blood cells called myeloid cells. Macrophages and monocytes are part of the innate immune system and can detect and degrade harmful substances through a process referred to as phagocytosis, in which the harmful substance is engulfed and destroyed and in turn leads to the activation of a broad immune response. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">To harness the powerful immunologic functions of macrophages against cancer, Carisma has developed a proprietary Chimeric Antigen Receptor Macrophage, or CAR-M, platform technology. Chimeric antigen receptors, or CARs, are synthetically engineered receptors that are designed to bestow immune cells with the ability to target specific antigens on the surface of cancer cells. By introducing CARs into macrophage and monocyte cells, Carisma aims to redirect their potent innate immune functions against cancer. Carisma&#8217;s CAR-M platform technology incorporates proprietary tumor targeting constructs, vectors to deliver CARs to macrophages and monocytes and novel manufacturing processes. Carisma&#8217;s CAR-M therapeutics are designed to infiltrate the solid tumor microenvironment, kill cancer cells via targeted phagocytosis, and activate other immune cells, such as T-cells, to initiate a robust anti-tumor immune response. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Beyond CT-0508, Carisma has a broad pipeline of cell therapy assets in various stages of pre-clinical development. In addition to the development of </font><font style="font-style:italic;letter-spacing:0.2pt;">ex vivo</font><font style="letter-spacing:0.2pt;"> CAR-M cell therapies, Carisma is also developing </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;"> CAR-M gene therapies, wherein immune cells are directly engineered within the patient&#8217;s body. To advance its </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;"> CAR-M therapeutics, Carisma established a strategic collaboration with Moderna focused on the development and potential commercialization of up to 12 product candidates, of which four have already been nominated. In collaboration with Moderna, Carisma has established an approach that uses Moderna&#8217;s LNP/mRNA technology, together with Carisma&#8217;s CAR-M platform technology, to create novel </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;"> oncology gene therapies. Carisma believes this approach has the potential to enable a series of off-the-shelf product candidates to target a patient&#8217;s own myeloid cells against cancer cells directly within their body. As part of the agreement with Moderna, Carisma received a $45.0&#160;million up-front cash payment and an investment by Moderna in the form of a $35.0&#160;million convertible note, in addition to future research funding and the opportunity for milestone payments and royalties. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Through its robust internal discovery engine, Carisma is building upon its platform to enhance and expand the utility of macrophage cell and gene therapies, leading to the creation of multiple product candidates with the potential to treat cancer and other serious diseases. By replacing the targeting domain of the CAR, Carisma can reprogram the target antigen specificity of the CAR-M cell product and develop candidates against a range of cancer indications and therapeutic areas beyond oncology. As a result, Carisma believes the flexibility of its macrophage and monocyte cell engineering platform will allow Carisma to generate new product candidates suitable for clinical development in a cost-efficient manner to expand its pipeline. In addition to acting as a first line of defense in the innate immune system, macrophages are found in all tissues in the body where they serve key regulatory functions such as wound healing, termination of immune responses and tissue regeneration. Using its macrophage and monocyte </font><font style="font-style:italic;letter-spacing:0.2pt;">ex vivo</font><font style="letter-spacing:0.2pt;"> and </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;"> engineering </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">326</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">platform, Carisma is pursuing early research and development of multiple assets for the potential treatment of diseases beyond oncology, including liver fibrosis, neurodegeneration, and other immunologic and inflammatory diseases. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">By investing in early platform research and accessing key enabling technologies, Carisma is enhancing and expanding its platform capabilities and reinforcing its leadership position in the engineered macrophage field. Carisma has developed proprietary CAR-M platform enhancements directed toward key product parameters that are important for efficacy, safety and patient access to its CAR-M therapies. Carisma plans to apply these technology enhancements to future CAR-M product candidates. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma was formed as Carma Therapeutics LLC, a Pennsylvania limited liability company, in April&#160;2016 and converted to a Delaware corporation in May&#160;2017. To date, Carisma has not yet commercialized any products or generated any revenue from product sales and has financed its operations primarily with proceeds from sales of Carisma&#8217;s preferred stock, proceeds from Carisma&#8217;s collaboration with Moderna, research tax credits and convertible debt financing. Carisma&#8217;s operations to date have been limited to organizing and staffing its company, business planning, capital raising, establishing and maintaining its intellectual property portfolio, building its pipeline of product candidates, conducting drug discovery activities, undertaking pre-clinical studies, manufacturing process development studies, conducting early-stage clinical trials, and providing general and administrative support for these operations. Carisma has devoted substantially all of its financial resources and efforts to pursuing discovery, research and development of its product candidates. Carisma only recently initiated clinical development of its lead product candidate, CT-0508, and is in the pre-clinical testing stages for its other product candidates. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma&#8217;s net losses were $40.8&#160;million for the year ended December&#160;31, 2021 and $28.3&#160;million for the year ended December&#160;31, 2020. As of September&#160;30, 2022, Carisma had $70.6&#160;million in cash, cash equivalents and marketable securities and an accumulated deficit of $141.5&#160;million. Carisma expects to devote substantial financial resources to its ongoing and planned activities, particularly as it conducts its ongoing clinical trial of CT-0508 and pursues related combination strategies, prepares for, initiates and conducts its planned clinical trials of CT-0525, CT-1119 and CT-0729 and advances its discovery programs and continues its product development efforts. In addition, if Carisma obtains marketing approval for CT-0508 or any other product candidate it is developing or develops in the future, it expects to incur significant commercialization expenses related to product manufacturing, sales, marketing and distribution. Furthermore, upon the closing of the merger, it expects to incur additional costs associated with operating as a public company. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Accordingly, Carisma will need to obtain substantial additional funding in connection with its continuing operations. If Carisma is unable to raise capital or obtain adequate funds when needed or on acceptable terms, it may be required to delay, limit, reduce or terminate its discovery and product development programs or any future commercialization efforts or grant rights to develop and market product candidates that it would otherwise prefer to develop and market itself. In addition, attempting to secure additional financing may divert the time and attention of Carisma management from day-to-day activities and distract from its discovery and product development efforts. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Because of the numerous risks and uncertainties associated with pharmaceutical product development, Carisma is unable to accurately predict the timing or amount of increased expenses or when, or if, it will be able to achieve or maintain profitability. Carisma may never succeed in these activities and, even if it does, may never generate revenues that are significant enough to achieve profitability. Even if Carisma does achieve profitability, it may not be able to sustain or increase profitability on a quarterly or annual basis. Carisma&#8217;s failure to become and remain profitable would depress the value of its company and could impair its ability to raise capital, expand its business, maintain its discovery and product development efforts, diversify its pipeline of product candidates or even continue its operations. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Moderna Collaboration and License Agreement</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In January&#160;2022, Carisma entered into the Moderna Collaboration Agreement, which provides for a broad strategic partnership with Moderna to discover, develop and commercialize </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;"> engineered CAR-M therapeutics for up to 12 oncology programs. Under the Moderna Collaboration Agreement, the parties initiate research programs during a research term, focused on the discovery and research of products directed </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">327</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">to biological targets. Either party may nominate a target for inclusion in a research program, subject to certain exclusions. Carisma refers to a target included in a research program pursuant to designated procedures as a research target. Moderna may replace research targets pursuant to designated procedures. The first four research targets have been nominated and all programs are currently in the discovery phase at Carisma. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In collaboration with Moderna, Carisma has established an approach that uses Moderna&#8217;s LNP/mRNA technology, together with Carisma&#8217;s CAR-M platform technology, to create novel </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;"> oncology gene therapies. Carisma believes this approach has the potential to enable a series of off-the-shelf product candidates to target a patient&#8217;s own myeloid cells against cancer cells directly within their body. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The collaboration is managed by a joint steering committee, or JSC, which is comprised of representatives from Carisma and Moderna. Decisions of the JSC are made by consensus, with each party having one vote. If the JSC is unable to agree, and the parties&#8217; executives are not able to resolve the dispute, then Moderna has final decision-making authority, subject to specified limitations. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Under the terms of the Moderna Collaboration Agreement, Carisma received a $45.0&#160;million up-front cash payment. Assuming Moderna develops and commercializes 12 products, each directed to a different Development Target, Carisma is also eligible to receive up to between $247.0&#160;million and $253.0&#160;million per product in development target designation, development, regulatory and commercial milestone payments. In addition, Carisma is eligible to receive mid to high single digit tiered royalties on net sales of any products that are commercialized under the agreement, which may be subject to reductions. Moderna has also agreed to cover the cost of certain milestone payments and royalties Carisma owes to a licensor under one of its intellectual property in-license agreements that Carisma is sublicensing to Moderna under the Moderna Collaboration Agreement, which royalties Moderna may deduct in part from any royalties owed to Carisma. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Impact of the COVID-19 Pandemic</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma is carefully monitoring the COVID-19 pandemic which continues to evolve worldwide. The continued spread of COVID-19 and the measures taken by governmental authorities, and any future epidemic disease outbreaks, could cause difficulties recruiting or retaining patients for Carisma&#8217;s clinical trials, disrupt the supply chain and the manufacture or shipment of pre-clinical materials, delay, limit or prevent Carisma&#8217;s employees and third parties from continuing research and development activities which could delay Carisma&#8217;s pre-clinical studies, and increase its development costs and/or have a material adverse effect on Carisma&#8217;s business, financial condition and results of operations. The effect of the COVID-19 pandemic on Carisma&#8217;s development timelines is difficult to assess or predict. The future impact of the COVID-19 pandemic on Carisma&#8217;s industry, the healthcare system and Carisma&#8217;s current and future operations and financial condition will depend on future developments, which are highly uncertain and cannot be predicted with confidence. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Financial Operations Overview</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Revenues</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">To date, Carisma has not generated any revenue from product sales and does not expect to generate any revenue from the sale of products for the foreseeable future. Carisma&#8217;s revenues to date have been generated from the Moderna Collaboration Agreement. Moderna reimburses Carisma for all costs incurred by it in connection with its research and development activities under the Moderna Collaboration Agreement plus a reasonable margin for the respective services performed. Carisma expects that its revenue for at least the next several&#160;years will be derived primarily from Moderna Collaboration Agreement, other current collaboration agreements and any additional collaborations that it may enter into in the future. To date, Carisma has not received any royalties under the Moderna Collaboration Agreement. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Research and development expense</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Research and development expenses consist primarily of costs incurred for Carisma&#8217;s research activities, including discovery efforts and the development of product candidates, and include: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">expenses incurred to conduct the necessary pre-clinical studies and clinical trials required to obtain regulatory approval; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">328</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">salaries, benefits and other related costs, including stock-based compensation expense, for personnel engaged in research and development functions; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">costs of funding research performed by third parties, including pursuant to agreements with CROs, as well as investigative sites and consultants that conduct Carisma&#8217;s pre-clinical studies and clinical trials; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">expenses incurred under agreements with CMOs, including manufacturing scale-up expenses and the cost of acquiring and manufacturing pre-clinical study and clinical trial materials; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">costs of outside consultants, including their fees, stock-based compensation and related travel expenses; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the costs of laboratory supplies and acquiring materials for pre-clinical studies; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">facility-related expenses, which include direct depreciation costs of equipment and expenses for rent and maintenance of facilities and other operating costs; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">third-party licensing fees. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Research and development activities are central to Carisma&#8217;s business model. Product candidates in later stages of clinical development will generally have higher development costs than those in earlier stages of clinical development, primarily due to the increased size and duration of later-stage clinical trials. Carisma expects its research and development expenses to increase significantly over the next several&#160;years as it increases personnel costs, including stock-based compensation, conducts ongoing and planned clinical trials for CT-0508, conducts research and development activities under the Moderna Collaboration Agreement and conducts other clinical and pre-clinical activities for other product candidates and prepares regulatory filings for any of its product candidates. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The successful development of Carisma&#8217;s current or future product candidates is highly uncertain. At this time, Carisma cannot reasonably estimate or know the nature, timing and costs of the efforts that will be necessary to complete the development of any product candidates. The success of CT-0508 and Carisma&#8217;s other product candidates will depend on several factors, including the following: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">successfully completing pre-clinical studies; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">successfully initiating future clinical trials; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">successfully enrolling patients in and completing clinical trials; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">scaling up manufacturing processes and capabilities to support clinical trials of CT-0508 and any other product candidate; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">applying for and receiving marketing approvals from applicable regulatory authorities; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">obtaining and maintaining intellectual property protection and regulatory exclusivity for CT-0508 and any other product candidates it is developing or may develop in the future; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">making arrangements with third-party manufacturers, or establishing commercial manufacturing capabilities, for both clinical and commercial supplies of its product candidates; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">establishing sales, marketing and distribution capabilities and launching commercial sales of its products, if and when approved, whether alone or in collaboration with others; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">acceptance of CT-0508 and any other product candidates, if and when approved, by patients, the medical community and third-party payors; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.91pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.91pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">effectively competing with other therapies; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">obtaining and maintaining coverage, adequate pricing and adequate reimbursement from third-party payors, including government payors; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">maintaining, enforcing, defending and protecting its rights in its intellectual property portfolio; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">not infringing, misappropriating or otherwise violating others&#8217; intellectual property or proprietary rights; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">329</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">maintaining a continued acceptable safety profile of its products following receipt of any marketing approvals. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">A change in the outcome of any of these variables with respect to the development, manufacture or commercialization activities of a product candidate could mean a significant change in the costs and timing associated with the development of that product candidate. For example, if Carisma is required to conduct additional clinical trials or other testing of its product candidates beyond those that it currently contemplates, if Carisma is unable to successfully complete clinical trials of its product candidates or other testing, if the results of these trials or tests are not positive or are only modestly positive, if there are safety concerns or if Carisma determines that the observed safety or efficacy profile would not be competitive in the marketplace, it could be required to expend significant additional financial resources and time on the completion of clinical development. Product commercialization will take several&#160;years, and Carisma expects to spend a significant amount in development costs. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">General and administrative expense</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">General and administrative expense consists primarily of personnel expenses, including salaries, benefits and stock-based compensation expense for employees in executive, finance, accounting, business development and human resource functions. General and administrative expense also includes corporate facility costs, including rent, utilities, depreciation and maintenance, and costs not otherwise included in research and development expense, legal fees related to intellectual property and corporate matters as well as fees for accounting and consulting services. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma expects that its general and administrative expense will increase in the future to support its continued research and development activities, potential commercialization efforts and increased costs of operating as a public company. These increases will likely include increased costs related to the hiring of additional personnel and fees to outside consultants, lawyers and accountants, among other expenses. Increased costs associated with being a public company will also include expenses related to services associated with maintaining compliance with the requirements of Nasdaq and the SEC, insurance and investor relations costs. If any of Carisma&#8217;s current or future product candidates obtains marketing approval, Carisma expects that it would incur significantly increased expenses associated with sales and marketing efforts. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Interest expense</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Interest expense consists of interest on the Carisma convertible note that was entered into concurrently with the Moderna Collaboration Agreement including non-cash interest expense associated with the amortization of the debt discount. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Change in fair value of derivative liability</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Change in fair value of the derivative liability for the redemption feature of the Carisma convertible note reflects the non-cash charge for changes in the fair value of the derivative liability that is subject to re-measurement at each balance sheet date until Carisma&#8217;s obligations under the Carisma convertible note are satisfied. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Income tax provision</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Since inception, Carisma has incurred significant net losses. As of December&#160;31, 2021, Carisma had net operating loss carryforwards, or NOLs, for federal and state income tax purposes of $76.4&#160;million. Carisma has provided a valuation allowance against the full amount of its deferred tax assets since, in the opinion of Carisma management, based upon its historical and anticipated future losses, it is more likely than not that the benefits will not be realized. As of September&#160;30, 2022, Carisma remained in a full valuation allowance position. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma&#8217;s utilization of its NOLs may be subject to a substantial annual limitation in the event of certain cumulative changes in the ownership interest of significant stockholders over a three-year period in excess of 50&#160;percent, as defined under Sections&#160;382 and 383 of the Code, respectively, as well as similar state </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">330</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">provisions. Carisma has recorded a valuation allowance on all of its deferred tax assets, including its deferred tax assets related to its NOLs. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Results of Operations</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:11.01pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Comparison of the Nine Months Ended September&#160;30, 2022 and 2021</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following table summarizes Carisma&#8217;s results of operations for the nine&#160;months ended September&#160;30, 2022 and 2021 (in thousands): </font>
        </div>
        <table style="width:416pt;height:159pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:288.25pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Nine Months Ended September&#160;30, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:288.25pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.25pt 0pt 2.5pt 0pt; width:288.25pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Collaboration revenues </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">6,103</td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:288.25pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Operating expenses: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:288.25pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Research and development </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">38,536</td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">24,597</td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:288.25pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">General and administrative </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">8,407</td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">3,852</td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.25pt 0pt 2.5pt 0pt; width:288.25pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Total operating expenses </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">46,943</td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">28,449</td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:288.25pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Operating loss </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(40,840<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(28,449<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:288.25pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Change in fair value of derivative liability </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(1,369<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:288.25pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Interest (expense) income, net </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(2,278<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">13</td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:288.25pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Net loss </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(44,487<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(28,436<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:16.5pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Collaboration Revenues</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Collaboration revenues were $6.1&#160;million for the nine&#160;months ended September&#160;30, 2022, which related to the research and development activities completed under the Moderna Collaboration Agreement that Carisma executed in January&#160;2022. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Research and Development Expenses</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma tracks outsourced development, outsourced personnel costs and other external research and development costs of its CT-0508 program. Carisma does not track its internal research and development costs on a program-by-program basis. The following table summarizes Carisma&#8217;s research and development expenses for the nine&#160;months ended September&#160;30, 2022 and 2021 (in thousands): </font>
        </div>
        <table style="width:416pt;height:97.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:288.25pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Nine Months Ended September&#160;30, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:288.25pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:288.25pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">CT-0508 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.585pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">8,044</td>
            <td style="padding:0pt;padding-left:9.585pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.585pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">7,965</td>
            <td style="padding:0pt;padding-left:9.585pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:288.25pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Personnel costs, including stock-based compensation </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.585pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">11,178</td>
            <td style="padding:0pt;padding-left:9.585pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.585pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">5,676</td>
            <td style="padding:0pt;padding-left:9.585pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:288.25pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Other clinical and pre-clinical development expenses </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.585pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">3,541</td>
            <td style="padding:0pt;padding-left:9.585pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.585pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">2,822</td>
            <td style="padding:0pt;padding-left:9.585pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:288.25pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Facilities and other expenses </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.585pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">15,773</td>
            <td style="padding:0pt;padding-left:9.585pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.585pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">8,134</td>
            <td style="padding:0pt;padding-left:9.585pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:288.25pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Total research and development expenses </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.585pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">38,536</td>
            <td style="padding:0pt;padding-left:9.585pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.585pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">24,597</td>
            <td style="padding:0pt;padding-left:9.585pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:12.5pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Research and development expenses for the nine&#160;months ended September&#160;30, 2022 were $38.5&#160;million, compared to $24.6&#160;million for the nine&#160;months ended September&#160;30, 2021. The increase of $13.9&#160;million was primarily attributable to a $7.6&#160;million increase in facilities and other expenses primarily due to the additional leases entered into during the nine&#160;months ended September&#160;30, 2022, a $5.5&#160;million increase in Carisma&#8217;s personnel costs attributable to an increase in its research and development employee headcount, and a $0.7&#160;million increase in the pre-clinical discovery work associated with the Moderna Collaboration Agreement. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">General and Administrative Expenses</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following table summarizes Carisma&#8217;s general and administrative expenses for the nine&#160;months ended September&#160;30, 2022 and 2021 (in thousands): </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">331</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <table style="width:416pt;height:97.5pt;margin-left:20pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:288.25pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Nine Months Ended September&#160;30, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:288.25pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:288.25pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Legal and professional fees </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.085pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">5,209</td>
            <td style="padding:0pt;padding-left:12.085pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.085pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1,016</td>
            <td style="padding:0pt;padding-left:12.085pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:288.25pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Personnel costs, including stock-based compensation </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.085pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">2,080</td>
            <td style="padding:0pt;padding-left:12.085pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.085pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1,958</td>
            <td style="padding:0pt;padding-left:12.085pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:288.25pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Facilities and supplies </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.085pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">471</td>
            <td style="padding:0pt;padding-left:12.085pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.085pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">586</td>
            <td style="padding:0pt;padding-left:12.085pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:288.25pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Other expenses </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.085pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">647</td>
            <td style="padding:0pt;padding-left:12.085pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.085pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">292</td>
            <td style="padding:0pt;padding-left:12.085pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:288.25pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Total general and administrative expenses </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.085pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">8,407</td>
            <td style="padding:0pt;padding-left:12.085pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.085pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">3,852</td>
            <td style="padding:0pt;padding-left:12.085pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:10.41pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">General and administrative expenses for the nine&#160;months ended September&#160;30, 2022 were $8.4&#160;million, compared to $3.9&#160;million for the nine&#160;months ended September&#160;30, 2021. The increase of $4.6&#160;million was primarily attributable to a $4.2&#160;million increase in legal and professional fees in support of Carisma&#8217;s patent portfolio, expanding infrastructure in preparation to operate as a public company and an increase legal fees incurred in connection with the merger, a $0.1&#160;million increase in personnel costs attributable to an increase in employee headcount and a $0.4&#160;million increase in other expenses attributable to the increase in travel and public relations in preparation to operate as a public company. </font>
        </div>
        <div style="margin-top:10.32pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Interest (Expense) Income, net</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.12pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma recognized $2.3&#160;million in interest (expense) income, net for the nine&#160;months ended September&#160;30, 2022, which was attributable primarily to the outstanding principal balance associated with the Carisma convertible note issued to Moderna in January&#160;2022 including non-cash interest expense associated with the amortization of the debt discount partially offset by interest income of $0.3&#160;million. </font>
        </div>
        <div style="margin-top:10.32pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Change in Fair Value of Derivative Liability</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.12pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma recognized a $1.4&#160;million non-cash charge for the increase in fair value of the derivative liability associated with the redemption feature of the Carisma convertible note with Moderna. The increase was attributable to the timing in which Carisma estimates a settlement event for the derivative to occur. </font>
        </div>
        <div style="margin-top:10.32pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Comparison of the Years Ended December&#160;31, 2021 and 2020</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:416pt;height:128.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:317.97pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Year Ended December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:317.97pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:317.97pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Operating expenses: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:317.97pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Research and development </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">34,387</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">23,292</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:317.97pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">General and administrative </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">6,407</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">5,086</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.25pt 0pt 2.5pt 0pt; width:317.97pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Total operating expenses </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">40,794</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">28,378</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:317.97pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Operating loss </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(40,794<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(28,378<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:317.97pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Interest income </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">10</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">29</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:317.97pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Net loss </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(40,784<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(28,349<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:13.33pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Research and Development Expenses</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.11pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following table summarizes Carisma&#8217;s research and development expenses for the year ended December&#160;31, 2021 and 2020 (in thousands): </font>
        </div>
        <table style="width:416pt;height:97.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:317.97pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Year Ended December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:317.97pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:317.97pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">CT-0508 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.15pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">10,570</td>
            <td style="padding:0pt;padding-left:2.15pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.15pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">7,225</td>
            <td style="padding:0pt;padding-left:2.15pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:317.97pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Personnel costs, including stock-based compensation </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.15pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">8,490</td>
            <td style="padding:0pt;padding-left:2.15pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.15pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">4,850</td>
            <td style="padding:0pt;padding-left:2.15pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:317.97pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Other clinical and pre-clinical development expenses </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.15pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">5,035</td>
            <td style="padding:0pt;padding-left:2.15pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.15pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">4,812</td>
            <td style="padding:0pt;padding-left:2.15pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:317.97pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Facilities and other expenses </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.15pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">10,292</td>
            <td style="padding:0pt;padding-left:2.15pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.15pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">6,405</td>
            <td style="padding:0pt;padding-left:2.15pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:317.97pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Total research and development expense </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.15pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">34,387</td>
            <td style="padding:0pt;padding-left:2.15pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.15pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">23,292</td>
            <td style="padding:0pt;padding-left:2.15pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">332</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:15.5pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Research and development expenses for the year ended December&#160;31, 2021 were $34.4&#160;million, compared to $23.3&#160;million for the year ended December&#160;31, 2021. The increase of $11.1&#160;million was primarily due to an increase in Carisma&#8217;s personnel costs of $3.6&#160;million attributable to an increase in Carisma&#8217;s research and development employee headcount and higher stock-based compensation and $3.9&#160;million increase attributable to an increase in facilities and supplies due to increased use of lab spaces and increased lab supplies as Carisma continued increasing its clinical and pre-clinical work. Carisma also had a $3.3&#160;million increase in its direct costs associated with CT-0508 as it initiated its Phase&#160;1 clinical trial in early 2021, and an increase in other clinical and pre-clinical development expenses of $0.2&#160;million as Carisma continues to further discover and develop earlier stage product candidates. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">General and Administrative Expense</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following table summarizes Carisma&#8217;s general and administrative expenses for the year ended December&#160;31, 2021 and 2020 (in thousands): </font>
        </div>
        <table style="width:416pt;height:97.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:317.97pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Year Ended December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:317.97pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:317.97pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Personnel costs, including stock-based compensation </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.65pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">2,446</td>
            <td style="padding:0pt;padding-left:4.65pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.65pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">2,479</td>
            <td style="padding:0pt;padding-left:4.65pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:317.97pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Legal and professional fees </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.65pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">2,321</td>
            <td style="padding:0pt;padding-left:4.65pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.65pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1,300</td>
            <td style="padding:0pt;padding-left:4.65pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:317.97pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Facilities and supplies </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.65pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">869</td>
            <td style="padding:0pt;padding-left:4.65pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.65pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">641</td>
            <td style="padding:0pt;padding-left:4.65pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:317.97pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Other expenses </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.65pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">771</td>
            <td style="padding:0pt;padding-left:4.65pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.65pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">666</td>
            <td style="padding:0pt;padding-left:4.65pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:317.97pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Total general and administrative expense </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.65pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">6,407</td>
            <td style="padding:0pt;padding-left:4.65pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.65pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">5,086</td>
            <td style="padding:0pt;padding-left:4.65pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:13pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">General and administrative expenses for the year ended December&#160;31, 2021 were $6.4&#160;million, compared to $5.1&#160;million for the year ended December&#160;31, 2020. The increase of $1.3&#160;million was primarily attributable to a $1.0&#160;million increase in legal and professional fees in support of Carisma&#8217;s patent portfolio and expanding infrastructure in preparation to operate as a public company as well as a $0.2&#160;million increase in facilities and supplies. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Liquidity and Capital Resources</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Sources of Liquidity</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As of September&#160;30, 2022, Carisma had $70.6&#160;million in cash, cash equivalents and marketable securities and an accumulated deficit of $141.5&#160;million. To date, Carisma has not yet commercialized any products or generated any revenue from product sales and has financed its operations primarily with proceeds from sales of Carisma&#8217;s preferred stock, proceeds from Carisma&#8217;s collaboration with Moderna, research tax credits and convertible debt financing. Since June&#160;2018, Carisma has sold convertible preferred stock, raising aggregate gross proceeds of $122.2&#160;million. In January&#160;2022, Carisma received $80.0&#160;million from Moderna comprised of an upfront non-refundable payment of $45.0&#160;million in connection with the Moderna Collaboration Agreement and $35.0&#160;million in connection with the Carisma convertible note. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Carisma Convertible Note</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If not earlier converted or repaid, the Carisma convertible note is payable on demand beginning in July&#160;2023 and accrues interest at an annual rate beginning at 0.33% through March&#160;2022 and then increases by 0.767% each month thereafter, capped at an annual rate of 8.0% in January&#160;2023. Upon the completion of a qualified financing event, the outstanding principal and accrued interest under the Carisma convertible note will automatically convert into shares of Carisma issued in connection with the qualified financing at a conversion price equal to the lesser of (a)&#160;90% of the purchase price paid by other investors in such qualified financing and (b)&#160;$21.06 per share on an as converted to common stock basis. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">333</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Cash Flows</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:8pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following table shows a summary of Carisma&#8217;s cash flows for the periods indicated (in thousands): </font>
        </div>
        <table style="width:456pt;height:97.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:230.22pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Nine Months Ended September&#160;30, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Year Ended December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:230.22pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:230.22pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Cash provided by (used in) </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:230.22pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Operating activities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">11,984</td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(28,207<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(37,328<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(27,012<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:230.22pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Investing activities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(46,369<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(1,526<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(1,871<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(440<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:230.22pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Financing activities </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">34,777</td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">15,962</td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">15,962</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">72,258</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:230.22pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Net change in cash and cash equivalents </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">392</td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(13,771<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:7.92pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(23,237<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">44,806</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:16pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Cash Flows from Operating Activities</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">During the nine&#160;months ended September&#160;30, 2022, Carisma provided $12.0&#160;million of net cash in operating activities. Cash provided by operating activities reflected Carisma&#8217;s net loss of $44.5&#160;million that was offset by $7.9&#160;million of non-cash charges related to depreciation and amortization expense, stock-based compensation, reductions in the operating right of use, or ROU, assets, amortization of the debt discount on the Carisma convertible note, change in fair value of the derivative liability, and non-cash interest on the finance liability from the failed sale-leaseback and the accretion on marketable securities and a $48.6&#160;million net change in Carisma&#8217;s operating assets and liabilities, which was primarily attributable to the upfront non-refundable payment received from Moderna pursuant to the Moderna Collaboration Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">During the nine&#160;months ended September&#160;30, 2021, Carisma used $28.2&#160;million of net cash in operating activities. Cash used in operating activities reflected Carisma&#8217;s net loss of $28.4&#160;million that was offset by $1.2&#160;million of non-cash charges related to depreciation and amortization expense, stock-based compensation and reductions in the operating ROU assets and a $1.0&#160;million net reduction in Carisma&#8217;s operating assets and liabilities attributable to the timing in which Carisma makes payments to its vendors for research and development activities. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">During the year ended December&#160;31, 2021, Carisma used $37.3&#160;million of net cash in operating activities. Cash used in operating activities reflected Carisma&#8217;s net loss of $40.8&#160;million that was offset by $2.0&#160;million of non-cash charges related to depreciation and amortization expense, stock-based compensation and reductions in the operating ROU assets and a $1.5&#160;million net change in Carisma&#8217;s operating assets and liabilities attributable to the timing in which Carisma pays its vendors for research and development activities. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">During the year ended December&#160;31, 2020, Carisma used $27.0&#160;million of net cash in operating activities. Cash used in operating activities reflected Carisma&#8217;s net loss of $28.3&#160;million that was offset by $1.8&#160;million of non-cash charges related to depreciation and amortization expense, stock-based compensation and reductions in the operating ROU assets and a $0.5&#160;million net change in Carisma&#8217;s operating assets and liabilities attributable to the timing in which Carisma pays its vendors for research and development activities. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Cash Flows from Investing Activities</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">During the nine&#160;months ended September&#160;30, 2022, Carisma used $46.4&#160;million of net cash in investing activities. Cash used in investing activities reflected purchases of marketable securities of $84.0&#160;million offset by $42.0&#160;million of proceeds from the sale of marketable securities. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">During the nine&#160;months ended September&#160;30, 2022 and 2021 and for the&#160;years ended December&#160;31, 2021 and 2020, Carisma used $4.3&#160;million, $1.5&#160;million, $1.9&#160;million and $0.4&#160;million, respectively, for the purchase of property and equipment. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Cash Flows from Financing Activities</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">During the nine&#160;months ended September&#160;30, 2022, Carisma received $34.8&#160;million of net cash from financing activities, primarily attributable to the $35.0&#160;million in proceeds from the Carisma convertible </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">334</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tFUNDRE1">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">note, partially offset by $0.8&#160;million in payments made on financing leases. Immediately prior to completion of the merger, the outstanding principal and unpaid interest of the Carisma convertible note will convert into shares of Carisma capital stock. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">During the nine&#160;months ended September&#160;30, 2021 and for the year ended December&#160;31, 2021, Carisma received $16.0&#160;million of net cash from financing activities, primarily attributable to the net proceeds from the sale of its Series&#160;B convertible preferred stock. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">During the year ended December&#160;31, 2020, Carisma received $72.3&#160;million of net cash from financing activities attributable from the sale of its Series&#160;A and Series&#160;B convertible preferred stock. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Funding Requirements</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma expects to devote substantial financial resources to its ongoing and planned activities, particularly as it conducts its ongoing clinical trial of CT-0508 and pursues related combination strategies, prepares for, initiates and conducts its planned clinical trials of CT-0525, CT-1119 and CT-0729 and advances its discovery programs and continues its product development efforts. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma expects its expenses to increase substantially in connection with its ongoing activities, particularly as it advances its pre-clinical activities and clinical trials. In addition, if Carisma obtains marketing approval for CT-0508 or any other product candidate it is developing or develops in the future, it expects to incur significant commercialization expenses related to product manufacturing, sales, marketing and distribution. Furthermore, upon the closing of the merger, it expects to incur additional costs associated with operating as a public company. Accordingly, Carisma will need to obtain substantial additional funding in connection with its continuing operations. If Carisma is unable to raise capital or obtain adequate funds when needed or on acceptable terms, it may be required to delay, limit, reduce or terminate its discovery and product development programs or any future commercialization efforts or grant rights to develop and market product candidates that it would otherwise prefer to develop and market itself. In addition, attempting to secure additional financing may divert the time and attention of Carisma management from day-to-day activities and distract from its discovery and product development efforts. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma&#8217;s future capital requirements will depend on many factors, including: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the progress, costs and results of its ongoing clinical trial of CT-0508 and other planned and future clinical trials; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the scope, progress, costs and results of pre-clinical testing and clinical trials of CT-0508 for additional combinations, targets and indications; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the number of and development requirements for additional indications for CT-0508 or for any other product candidates; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the success of its collaborations with Moderna or others; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">its ability to scale up its manufacturing processes and capabilities to support clinical trials of CT-0508 and other product candidates it is developing and develops in the future; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the costs, timing and outcome of regulatory review of CT-0508 and other product candidates it is developing and may develop in the future; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">potential changes in the regulatory environment and enforcement rules; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">its ability to establish and maintain strategic collaborations, licensing or other arrangements and the financial terms of such arrangements; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the payment of license fees and other costs of its technology license arrangements; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the costs and timing of future commercialization activities, including product manufacturing, sales, marketing and distribution, for CT-0508 and other product candidates it is developing and may develop in the future for which it may receive marketing approval; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">its ability to obtain and maintain acceptance of any approved products by patients, the medical community and third-party payors; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">335</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the amount and timing of revenue, if any, received from commercial sales of CT-0508 and any other product candidates it is developing or develops in the future for which it receives marketing approval; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">potential changes in pharmaceutical pricing and reimbursement infrastructure; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the availability of raw materials for use in production of its product candidates; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the costs and timing of preparing, filing and prosecuting patent applications, maintaining and enforcing its intellectual property and proprietary rights and defending any intellectual property- related claims; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the extent to which it in-licenses or acquires additional technologies or product candidates. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As of September&#160;30, 2022, Carisma had cash, cash equivalents and marketable securities of $70.6&#160;million. Immediately prior to the consummation of the merger, certain investors have agreed to purchase shares of Carisma common stock for an aggregate purchase price of approximately $30.6&#160;million. The closing of the Carisma pre-closing financing is conditioned upon the satisfaction or waiver of the conditions to the closing of the merger set forth in the Merger Agreement. Carisma believes that following consummation of the pre-closing financing and the merger, it will have cash, cash equivalents and marketable securities sufficient to sustain its operating expenses and capital expenditure requirements at least through the end of 2024. However, Carisma has based this estimate on assumptions that may prove to be wrong, and its operating plan may change as a result of many factors currently unknown to Carisma. In addition, changing circumstances could cause Carisma to consume capital significantly faster than it currently anticipates, and Carisma may need to spend more than currently expected because of circumstances beyond its control. As a result, Carisma could deplete its capital resources sooner than it currently expects. In addition, because the successful development of CT-0508, CT-0525, CT-1119, CT-0729 and any combination studies or other product candidates that it pursues is highly uncertain, at this time Carisma cannot reasonably estimate or know the nature, timing and costs of the efforts that will be necessary to complete the development of any product candidate. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma currently anticipates that it will use the expected cash balances of the combined company as of the closing of the merger resulting from the net cash expected to be provided by Sesen Bio upon completion of the merger, together with Carisma&#8217;s existing cash resources and the expected gross proceeds from the Carisma pre-closing financing, as follows:</font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">approximately $44.0 million to $55.0 million for the advancement of CT-0508 for treatment of solid tumors that overexpress HER2, including completion of its ongoing Phase 1 clinical trial and related combination studies;</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">approximately $28.0 million to $35.0 million for the advancement of CT-0525 for treatment of solid tumors that overexpress HER2, including submission of an IND to the FDA in the third quarter of 2023 and the initiation of clinical development shortly thereafter; and</font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>


          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">the remainder for preclinical studies for research stage programs, working capital and other general corporate purposes.</font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">This expected use of anticipated funds available to the combined company following the closing of the merger represents Carisma&#8217;s intentions based upon its current plans for the combined company and business conditions. The amounts and timing of the combined company&#8217;s actual expenditures may vary significantly depending on numerous factors, including the progress of the combined company&#8217;s development efforts, the status of and results from clinical trials and preclinical studies, the timing of regulatory submissions, as well as any collaborations that the combined company may enter into with third parties for its product candidates, and any unforeseen cash needs. As a result, the combined company&#8217;s management will retain broad discretion over the allocation of the anticipated funds available to the combined company following the closing of the merger. </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Based on Carisma&#8217;s planned use of the anticipated funds available to the combined company following the closing of the merger, Carisma estimates that such funds will be sufficient to enable the combined company to complete its ongoing Phase 1 clinical trial of CT-0508 and the related sub study evaluating the combination of CT-0508 and pembrolizumab, and initiate a Phase 1 clinical trial of CT-0525 following </font>
          </div>

      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">336</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">

          <div style="width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">submission of an IND to the FDA. Carisma has based these estimates on assumptions that may prove to be wrong, and the combined company could use its capital resources sooner than Carisma currently expects. </font>
          </div>

        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Identifying potential product candidates and conducting pre-clinical testing and clinical trials is a time-consuming, expensive and uncertain process that takes&#160;years to complete, and Carisma may never generate the necessary data or results required to obtain marketing approval and achieve product sales. In addition, Carisma&#8217;s product candidates, if approved, may not achieve commercial success. Carisma will not generate commercial revenues unless and until it can achieve sales of products, which it does not anticipate for a number of&#160;years, if at all. Accordingly, Carisma will need to obtain substantial additional financing to achieve its business objectives. Adequate additional financing may not be available to Carisma on acceptable terms, or at all, and may be impacted by the economic climate and market conditions. For example, market volatility resulting from the COVID-19 pandemic, any other future infectious diseases, epidemics or pandemics or general U.S. or global economic or market conditions could also adversely impact Carisma&#8217;s ability to access capital as and when needed. Alternatively, Carisma may seek additional capital due to favorable market conditions or strategic considerations, even if it believes it has sufficient funds for its current or future operating plans. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Until such time, if ever, as the combined company, operating as Carisma, can generate substantial revenues from product sales, Carisma expects to finance its cash needs through a combination of public and private equity offerings, debt financings, collaborations, strategic alliances and marketing, distribution or licensing arrangements. To the extent that Carisma raises additional capital through the sale of equity or convertible debt securities, your ownership interest will be diluted, and the terms of those securities may include liquidation or other preferences that adversely affect your rights as a holder of Carisma common stock. Debt financing and preferred equity financing, if available, would increase Carisma&#8217;s fixed payment obligations and may involve agreements that include covenants limiting or restricting Carisma&#8217;s operations and ability to take specific actions, such as incurring additional debt, making acquisitions, engaging in acquisition, merger or collaboration transactions, selling or licensing Carisma&#8217;s assets, making capital expenditures, redeeming its stock, making certain investments, declaring dividends or other operating restrictions that could adversely impact Carisma&#8217;s ability to conduct its business. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If Carisma raises funds through additional collaborations, strategic alliances or marketing, distribution or licensing arrangements with third parties, Carisma may have to relinquish valuable rights to its intellectual property, future revenue streams, discovery programs or product candidates, grant licenses on terms that may not be favorable to Carisma or grant rights to develop and market product candidates that Carisma would otherwise prefer to develop and market itself, any of which may have a material adverse effect on Carisma&#8217;s business, operating results and prospects. If Carisma is unable to raise capital or obtain adequate funds when needed or on acceptable terms, it may be required to delay, limit, reduce or terminate its discovery and product development programs or any future commercialization efforts or grant rights to develop and market product candidates that it would otherwise prefer to develop and market itself. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Contractual Obligations and Commitments</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following table summarizes Carisma&#8217;s contractual obligations and commitments at September&#160;30, 2022 (in thousands): </font>
        </div>
        <table style="width:456pt;height:93pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:216.91pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Total </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Less than</font>
                <br >
                <font style="letter-spacing:-0.16pt;">1 Year </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">1 to 3 Years </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">4 to 5 Years </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">More than</font>
                <br >
                <font style="letter-spacing:-0.16pt;">5 Years </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:216.91pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Contractual obligations: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.815pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.815pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.495pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.495pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:216.91pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Operating lease commitments</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(1)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">6,907</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">5,539</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.815pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">654</td>
            <td style="padding:0pt;padding-left:5.815pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">469</td>
            <td style="padding:0pt;padding-left:9.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.495pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">245</td>
            <td style="padding:0pt;padding-left:7.495pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:216.91pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Finance lease commitments </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">1,900</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">1,137</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.815pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">763</td>
            <td style="padding:0pt;padding-left:5.815pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:9.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.495pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.495pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:216.91pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Convertible promissory note</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(2)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">37,338</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">37,338</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.815pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:5.815pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.67pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:9.67pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.495pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.495pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:216.91pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total contractual obligations </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">46,145</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">44,014</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.815pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">1,417</td>
            <td style="padding:0pt;padding-left:5.815pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">469</td>
            <td style="padding:0pt;padding-left:9.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.495pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">245</td>
            <td style="padding:0pt;padding-left:7.495pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:5.3pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Reflects obligations pursuant to Carisma&#8217;s office and laboratory leases in Philadelphia, Pennsylvania. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(2)</font>
          <br >
        </div>
        <div style=" margin-top:3.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Reflects principal and interest payments pursuant to the Carisma convertible note issued to Moderna in January&#160;2022. The table above assumes cash settlement at the contractual maturity date in July&#160;31, </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">337</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">2023. Settlement may be through the conversion of outstanding principal and interest into shares of Carisma capital stock that may be issued in connection with a qualified or unqualified financing event and prior to maturity. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The commitment amounts in the table above are associated with contracts that are enforceable and legally binding and that specify all significant terms, including fixed or minimum services to be used, fixed, minimum or variable price provisions, and the approximate timing of the actions under the contracts. Carisma&#8217;s contracts with CMOs, CROs and other third parties for the manufacture of its product candidates and to support pre-clinical research studies and clinical testing are generally cancelable by Carisma upon prior notice and do not contain any minimum purchase commitments. Payments due upon cancellation consisting only of payments for services provided or expenses incurred, including noncancelable obligations of Carisma&#8217;s service providers, up to the date of cancellation are not included in the table above as the amount and timing of such payments are not known. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The table above does not include any potential milestone or royalty payments that Carisma may be required to make under license agreement with Penn and under licensing agreements with other third parties not considered material. Carisma excluded these milestone and royalty payments given that the timing and likelihood of any such payments cannot be reasonably estimated at this time. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">University of Pennsylvania License</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In November&#160;2017, Carisma entered into a license agreement with Penn for certain intellectual property licenses, which was amended in February&#160;2018, January&#160;2019, March&#160;2020 and June&#160;2021. Carisma is responsible for paying Penn an annual license maintenance fee in the low tens of thousands of dollars, payable until Carisma&#8217;s first payment of a royalty. Carisma is required to pay Penn up to $10.9&#160;million per product in development and regulatory milestone payments, up to $30.0&#160;million per product in commercial milestone payments, and up to an additional $1.7&#160;million in development and regulatory milestone payments for the first CAR-M product directed to mesothelin. While the license agreement remains in effect, Carisma is required to pay Penn low to mid-single digit&#160;percentage tiered royalties on annual net sales of licensed products, which may be subject to reductions. Penn is guaranteed a minimum royalty payment amount in the low hundreds of thousands of dollars for each year after the first commercial sale of a licensed product. Carisma must also pay Penn a&#160;percentage in the mid-single digits to low double digits of certain types of income Carisma receives from sublicensees. In addition, Carisma is required to pay Penn an annual alliance management fee in the low tens of thousands of dollars, ending after several&#160;years, unless Carisma provides funding to Penn for research and development activities that extend beyond a specified date, in which case Carisma will continue to owe the alliance management fee for each year in which Carisma continues to fund such activities. Carisma also paid Penn an upfront fee in the low hundreds of thousands of dollars for the license to the patents related to the mesothelin binder that is incorporated into the CAR design for Carisma&#8217;s mesothelin product candidate. Carisma is responsible for a pro&#160;rata share of costs relating to the prosecution and maintenance of the licensed patents. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Critical Accounting Policies</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma management&#8217;s discussion and analysis of its financial condition and results of operations are based on its consolidated financial statements, which have been prepared in accordance with U.S. GAAP. The preparation of the consolidated financial statements requires Carisma to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses and the disclosure of contingent assets and liabilities in its consolidated financial statements. On an ongoing basis, Carisma evaluates its estimates and judgments, including those related to accrued expenses, fair value of Carisma common stock and stock-based compensation. Carisma bases its estimates on historical experience, known trends and events, and various other factors that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">While Carisma&#8217;s significant accounting policies are described in more detail in Note 3 to its audited consolidated financial statements included elsewhere in this proxy statement/prospectus, Carisma believes </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">338</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">the following accounting policies are the most critical to the judgments and estimates used in the preparation of its consolidated financial statements. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Revenues from Contracts</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma accounts for its revenue in accordance with Accounting Standards Codification, or ASC, 606, </font><font style="font-style:italic;letter-spacing:0.2pt;">Revenue from Contracts with Customers</font><font style="letter-spacing:0.2pt;">, or ASC 606. Under ASC 606, an entity recognizes revenue when its customer obtains control of promised goods or services, in an amount that reflects the consideration that the entity expects to receive in exchange for those goods or services. To determine revenue recognition for arrangements that an entity determines are within the scope of ASC 606, the entity performs the following five steps at inception of the agreement or upon material modification of the agreement: (i)&#160;identifies the contract(s) with a customer; (ii)&#160;identifies the performance obligations in the contract; (iii)&#160;determines the transaction price, including variable consideration, if any; (iv)&#160;allocates the transaction price to the performance obligations in the contract; and (v)&#160;recognizes revenue when (or as) the entity satisfies a performance obligation. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma considers the pattern of satisfaction of the performance obligations under step (v)&#160;above to be a critical accounting estimate. More specifically, the determination of the level of achievement of research and development service performance obligations, whose pattern of satisfaction is measured using costs incurred to date as compared to total costs incurred and expected to be incurred in the future is driven by a critical accounting estimate. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In estimating the costs expected to be incurred in the future, Carisma management uses its most recent budget and long-range plan, adjusted for any pertinent information. While this is Carisma&#8217;s best estimate as of the reporting period, costs expected to be incurred in the future require management&#8217;s judgment as the scope and timing of research and development activities may change significantly over time. Carisma may adjust the scope of its research and development activities based on several factors, such as additional work needed to support advancement of product candidate or change in the number of patients in trials. Further, research and development services may no longer be within the scope of a collaboration agreement, as has been the case with certain of Carisma&#8217;s programs. The timing of when research and development costs are expected to be incurred may change as a result of external factors, such as delays caused by manufacturing or supply chain, or difficulty in enrolling patients; or internal factors, such as prioritization of programs. Carisma&#8217;s estimate of the scope and timing of research and development services performed relative to the actual scope and timing may have a significant impact on revenue recognition. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Research and Development Accruals</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Research and development expenses consist primarily of costs incurred in connection with the development of Carisma&#8217;s product candidates. Carisma expenses research and development costs as incurred. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma accrues expenses for pre-clinical studies and activities performed by third parties based upon estimates of the proportion of work completed over the term of the individual trial and patient enrollment rates in accordance with agreements with third parties. Carisma determines the estimates by reviewing contracts, vendor agreements and purchase orders, and through discussions with its internal clinical personnel and external service providers as to the progress or stage of completion of activities or services and the agreed-upon fee to be paid for such services. However, actual costs and timing of clinical trials are highly uncertain, subject to risks and may change depending upon a number of factors, including Carisma&#8217;s clinical development plan. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma makes estimates of its accrued expenses as of each balance sheet date in its consolidated financial statements based on facts and circumstances known at that time. If the actual timing of the performance of services or the level of effort varies from the estimate, Carisma will adjust the accrual accordingly. Non-refundable advance payments for goods and services, including fees for process development or manufacturing and distribution of pre-clinical supplies that will be used in future research and development activities, are deferred and recognized as expense in the period that the related goods are consumed or services are performed. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">339</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Milestone payments within Carisma&#8217;s licensing and collaboration arrangements are recognized when achievement of the milestone is deemed probable to occur. To the extent products are commercialized and future economic benefit has been established, commercial milestones that become probable are capitalized and amortized over the estimated remaining useful life of the intellectual property. In addition, Carisma accrues royalty expense and sublicense non-royalty payments, as applicable, for the amount it is obligated to pay, with adjustments as sales are made. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Stock-Based Compensation</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma measures compensation expense for all stock-based awards based on the estimated fair value of the award on the grant date. Carisma uses the Black-Scholes option pricing model to value its stock option awards. Carisma recognizes compensation expense on a straight-line basis over the requisite service period, which is generally the vesting period of the award. Carisma has not issued awards where vesting is subject to a market or performance condition. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Black-Scholes option pricing model requires the use of subjective assumptions that include the expected stock price volatility and the fair value of the underlying common stock on the date of grant. See Note 8 to Carisma&#8217;s audited consolidated financial statements and Note 8 to Carisma&#8217;s unaudited interim consolidated financial statements included elsewhere in this proxy statement/prospectus for information concerning certain of the specific assumptions Carisma used in applying the Black-Scholes option pricing model to determine the estimated fair value of its stock options granted during the&#160;years ended December&#160;31, 2021 and 2020 and for the nine&#160;months ended September&#160;30, 2022 and 2021. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Estimating the fair value of common stock</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma is required to estimate the fair value of Carisma common stock underlying its stock-based awards. Because Carisma common stock is not currently publicly traded, the fair value of Carisma common stock has been estimated on each grant date by the Carisma board of directors, with input from Carisma management, considering its most recently available third-party valuation of Carisma common stock. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Carisma board of directors considered various objective and subjective factors to estimate the estimated fair value of Carisma common stock, including: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the estimated value of all classes of securities outstanding; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the anticipated capital structure that will directly impact the value of the currently outstanding securities; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Carisma&#8217;s results of operations and financial position; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the status of Carisma&#8217;s research and development efforts; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the composition of, and changes to, Carisma&#8217;s management team and the Carisma board of directors; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the lack of liquidity of Carisma common stock as a private company; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Carisma&#8217;s stage of development and business strategy and the material risks related to its business and industry; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">external market conditions affecting the life sciences and biotechnology industry sectors; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the likelihood of achieving a liquidity event for the holders of Carisma common stock, such as an initial public offering, or a sale of the company, given the prevailing market conditions; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the market value and volatility of comparable companies. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In estimating the fair value of Carisma common stock, the Carisma board of directors considered the subjective factors discussed above in conjunction with the most recent valuations of Carisma common stock that were prepared by an independent third party. The independent valuation prepared as of February&#160;28, 2022 was utilized by the Carisma board of directors when estimating the fair value of Carisma common stock for the awards granted after such date and through September&#160;30, 2022. The independent valuation prepared as of April&#160;1, 2021 was utilized by the Carisma board of directors when estimating the fair value </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">340</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:200pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">of Carisma common stock for the awards granted after such date and through December&#160;31, 2021. These third-party valuations resulted in an estimated fair value of Carisma common stock of $2.68 and $2.77 per share as of February&#160;28, 2022 and April&#160;1, 2021, respectively. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Redemption feature</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The redemption feature of the Carisma convertible note with Moderna is marked-to-market each reporting period with the changes in fair value recorded to other expense in the consolidated statements of operations until the obligations under the Carisma convertible note are satisfied. The fair value of the redemption feature of the Carisma convertible note is estimated by using a discounted cash flow method in conjunction with assuming the probability of completing a qualified financing. During the nine&#160;months ended September&#160;30, 2022, the discount factor used was 12% and a 90% probability of completing a qualified financing prior to the maturity date of the Carisma convertible note was assumed. The estimated time of conversion ranged from three to twelve&#160;months. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Recent Accounting Pronouncements</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">See Note 3 to Carisma&#8217;s unaudited interim consolidated financial statements included elsewhere in this proxy statement/prospectus for a description of recent accounting pronouncements applicable to its consolidated financial statements. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Off-Balance Sheet Arrangements</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma does not have any relationships with unconsolidated entities or financial partnerships, including entities sometimes referred to as structured finance or special purpose entities that were established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes. Carisma does not engage in off-balance sheet financing arrangements. In addition, Carisma does not engage in trading activities involving non-exchange traded contracts. Carisma therefore believes that it is not materially exposed to any financing, liquidity, market or credit risk that could arise if it had engaged in these relationships. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Qualitative and Quantitative Disclosures About Market Risk</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma is exposed to market risks in the ordinary course of its business. These risks primarily include interest rate sensitivities. Carisma&#8217;s interest-earning assets consist of cash, cash equivalents and marketable securities. Interest income earned on these assets was de minimis for the&#160;years ended December&#160;31, 2021 and 2020 and for the nine&#160;months ended September&#160;30, 2022 and 2021.</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">341</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tMFTM">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">MANAGEMENT FOLLOWING THE MERGER</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:11.02pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Executive Officers and Directors</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The combined company&#8217;s board of directors will initially be fixed at seven members, consisting of six directors designated by Carisma and one director designated by Sesen Bio. The staggered structure of the current Sesen Bio board of directors will remain in place for the combined company&#8217;s board of directors following the completion of the merger. </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">The following table sets forth the name, age as of January 4, 2023 and position of each of the individuals who are expected to serve as executive officers and directors of the combined company. </font>
          </div>


          <table style="width:456pt;height:173.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:204pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:-0.16pt;">Name </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:24pt;">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Age </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:204pt;">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Position </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:italic;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.25pt 0pt 1.5pt 0pt; width:204pt;">
                <font style="letter-spacing:-0.2pt;">Executive Officers</font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:24pt;text-align:center;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:204pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:204pt;">
                <font style="letter-spacing:0.2pt;">Steven Kelly </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:24pt;text-align:center;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">57 </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:204pt;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">President and Chief Executive Officer, Director </font>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:204pt;">
                <font style="letter-spacing:0.2pt;">Richard Morris </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:24pt;text-align:center;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">49 </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:204pt;">
                <font style="letter-spacing:0.2pt;">Chief Financial Officer </font>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:204pt;">
                <font style="letter-spacing:0.2pt;">Michael Klichinsky, Pharm.D., Ph.D. </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:24pt;text-align:center;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">33 </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:204pt;">
                <font style="letter-spacing:0.2pt;">Chief Scientific Officer </font>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:italic;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:204pt;">
                <font style="letter-spacing:-0.2pt;">Non-Employee Directors</font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:24pt;text-align:center;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:204pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:204pt;">
                <font style="letter-spacing:0.2pt;">Sanford Zweifach </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:24pt;text-align:center;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">66 </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:204pt;">
                <font style="letter-spacing:0.2pt;">Director, Chair </font>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:204pt;">
                <font style="letter-spacing:0.2pt;">Thomas R. Cannell, D.V.M. </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:24pt;text-align:center;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">61 </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:204pt;">
                <font style="letter-spacing:0.2pt;">Director </font>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:204pt;">
                <font style="letter-spacing:0.2pt;">Regina Hodits, Ph.D. </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:24pt;text-align:center;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">53</font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:204pt;">
                <font style="letter-spacing:0.2pt;">Director </font>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:204pt;">
                <font style="letter-spacing:0.2pt;">Briggs Morrison, M.D. </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:24pt;text-align:center;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">63 </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:204pt;">
                <font style="letter-spacing:0.2pt;">Director </font>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:204pt;">
                <font style="letter-spacing:0.2pt;">Bj&#246;rn Odlander, M.D., Ph.D. </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:24pt;text-align:center;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">64 </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:204pt;">
                <font style="letter-spacing:0.2pt;">Director </font>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:204pt;">
                <font style="letter-spacing:0.2pt;">Chidozie Ugwumba </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:24pt;text-align:center;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">40 </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:204pt;">
                <font style="letter-spacing:0.2pt;">Director</font>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
          </table>

        <div style="margin-top:11.51pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Executive Officers</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Steven Kelly</font><font style="letter-spacing:0.2pt;"> has served as Carisma&#8217;s President and Chief Executive Officer and as a member of the Carisma board of directors since February&#160;2018. Prior to joining Carisma, Mr.&#160;Kelly served as Chief Executive Officer of Pinteon Therapeutics, a biotechnology company, from April&#160;2014 to July&#160;2015 and as the Chief Executive Officer of Theracrine, Inc., a biopharmaceutical company, from June&#160;2011 to August&#160;2012. Mr.&#160;Kelly currently serves on the board of directors of Artelo Biosciences, Inc. (Nasdaq: ARTL). Mr.&#160;Kelly received a B.S. from the University of Oregon and an M.B.A. from Cornell University. Carisma believes Mr.&#160;Kelly is qualified to serve as a member of the combined company&#8217;s board of directors because of his extensive knowledge of Carisma based on his current role as its President and Chief Executive Officer, as well as his significant biopharmaceutical industry and management experience. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Richard Morris</font><font style="letter-spacing:0.2pt;"> has served as Carisma&#8217;s Chief Financial Officer since June&#160;2021. Prior to joining Carisma, Mr.&#160;Morris served as Chief Financial Officer of Passage Bio, Inc., a genetic medicines company, from October&#160;2019 to May&#160;2021 and as Executive Vice President and Chief Financial Officer of Context Therapeutics, LLC, a biopharmaceutical company, or Context, from November&#160;2017 to July&#160;2019. Prior to Context, Mr. Morris served as Chief Financial Officer of Vitae Pharmaceuticals Incorporated, a biopharmaceutical company, from 2014 to October 2016, and held several senior financial roles over 12 years at ViroPharma Incorporated, a biopharmaceutical company, including Chief Accounting Officer and Vice President, Financial and Strategic Planning. Mr.&#160;Morris received a B.S. in Accounting from Saint Joseph&#8217;s University and has been a CPA since 1999. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Michael Klichinsky,</font><font style="letter-spacing:0.2pt;"> </font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Pharm.D., Ph.D.</font><font style="letter-spacing:0.2pt;"> has served as Carisma&#8217;s Chief Scientific Officer since April&#160;2022. He co-founded Carisma in 2016 and served as Vice President of Discovery of Carisma from October 2018 to April 2021 and as Senior Vice President of Research of Carisma from April 2021 to April&#160;2022. Dr.&#160;Klichinsky received a Doctor of Pharmacy from the University of Sciences in Philadelphia and a Ph.D. in Pharmacology from the University of Pennsylvania. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Non-Employee Directors</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Sanford Zweifach</font><font style="letter-spacing:0.2pt;"> has served as a member and Chair of the Carisma board of directors since November&#160;2021. Mr.&#160;Zweifach has served as the Founder and President of Pelican Consulting Group, a </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">342</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">biotechnology consulting firm, since December&#160;2019. Mr.&#160;Zweifach founded and served as Chief Executive Officer of Nuvelution Pharma, Inc., a pharmaceutical company, from June&#160;2015 to November&#160;2019. Mr.&#160;Zweifach currently serves on the boards of directors of Essa Pharma Inc. (Nasdaq: EPIX) and Compugen Ltd. (Nasdaq: CGEN). Mr.&#160;Zweifach received a B.A. in Biology from University of California San Diego and a M.S. in Human Physiology from University of California Davis. Carisma believes Mr.&#160;Zweifach is qualified to serve as Chair of the combined company&#8217;s board of directors because of his extensive experience in the biopharmaceutical industry and service on the boards of other public and private biopharmaceutical companies. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Thomas R. Cannell, </font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">D.V.M.</font><font style="letter-spacing:0.2pt;">, has served as Sesen Bio&#8217;s President and Chief Executive Officer and a member of the Sesen Bio board of directors since August&#160;2018. Prior to joining Sesen Bio, Dr.&#160;Cannell served as Orexigen Therapeutics, Inc.&#8217;s Chief Operating Officer &amp; President of Global Commercial Products from July&#160;2016 to July&#160;2018, and as its Chief Commercial Officer from March&#160;2015 to June&#160;2016. Prior to Orexigen, Dr.&#160;Cannell spent 27&#160;years with Merck &amp; Co., Inc., where he held senior leadership positions in global commercialization, consumer marketing, and sales operations and management for both development-stage programs and approved marketed products. Dr.&#160;Cannell received a D.V.M. from Washington State University. Carisma believes Dr.&#160;Cannell is qualified to serve as a member of the combined company&#8217;s board of directors because of his extensive industry experience and scientific background. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Regina Hodits</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">, Ph.D.,</font><font style="letter-spacing:0.2pt;"> has served as a member of the Carisma board of directors since June 2018. Dr.&#160;Hodits has served as a Managing Partner at Wellington Partners, a venture capital firm investing in companies mainly in areas of technology, life sciences and digital media, since 2010. Prior to that, Dr.&#160;Hodits served as Partner of Atlas Ventures from 2004 to 2010. She currently serves on the board of directors of Onward Medical. Dr.&#160;Hodits received a Master&#8217;s degree in Chemical Engineering and a Ph.D. in biochemistry from Technical University of Vienna, Austria. Carisma believes Dr.&#160;Hodits is qualified to serve as a member of the combined company&#8217;s board of directors because of her scientific background and training in biochemistry, extensive experience with biopharmaceutical companies and service on the boards of other biopharmaceutical companies. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Briggs Morrison</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">, M.D.,</font><font style="letter-spacing:0.2pt;"> has served as a member of the Carisma board of directors since July&#160;2020. Dr.&#160;Morrison has served as President, Head of Research and Development of Syndax Pharmaceuticals Inc., a biopharmaceutical company, since February 2022; he was previously Chief Executive Officer of Syndax Pharmaceuticals Inc. from June&#160;2015. Dr.&#160;Morrison currently serves on the boards of directors of Repare Therapeutics Inc. (Nasdaq: RPTX), Werewolf Therapeutics Inc. (Nasdaq: HOWL), Arvinas, Inc. (Nasdaq: ARVN) and Syndax Pharmaceuticals Inc. (Nasdaq: SNDX). Dr.&#160;Morrison received an M.D. from the University of Connecticut and a B.S. in Biology from Georgetown University. Carisma believes Dr.&#160;Morrison is qualified to serve as a member of the combined company&#8217;s board of directors due to his extensive executive leadership experience, medical background and training, and extensive service on the boards of other public and private biopharmaceutical companies. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Bj&#246;rn Odlander,</font><font style="letter-spacing:0.2pt;"> </font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">M.D., Ph.D.</font><font style="letter-spacing:0.2pt;"> has served as a member of the Carisma board of directors since February&#160;2022. Dr.&#160;Odlander is a co-founder of HealthCap, a family of venture capital funds investing globally in life sciences, where he has been a Managing Partner since 1996. Dr.&#160;Odlander received a M.D. and Ph.D. from Karolinska Institute. Dr.&#160;Odlander is qualified to serve as a member of the combined company&#8217;s board of directors with his medical background and training, industry background and extensive experience of investments in the life-science sector. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Chidozie Ugwumba</font><font style="letter-spacing:0.2pt;"> has served as a member of the Carisma board of directors since December 2020. Mr.&#160;Ugwumba has served as Managing Partner of SymBiosis, a venture capital firm focused on investments in biotherapeutics, since August&#160;2021. Prior to SymBiosis, Mr.&#160;Ugwumba served as a Managing Director and the Co-Head of the Direct and Impact Investment Group of WIT, LLC, an investment management entity affiliated with Walton Enterprises, from 2018 to 2021 and on the Private Credit and Infrastructure teams at Partners Group, a global private investment manager, from 2015 to 2018. Mr.&#160;Ugwumba currently serves on the board of directors of Clene, Inc. (Nasdaq: CLNN). Mr.&#160;Ugwumba received an M.B.A. from Cornell University and a B.A. in Political Science from Amherst College. Carisma believes Mr.&#160;Ugwumba is qualified to serve as a member of the combined company&#8217;s board of directors because of his significant experience and expertise in biopharmaceutical investments and his overall industry knowledge. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">343</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Director Independence</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Applicable Nasdaq Listing Rules require that the combined company&#8217;s board of directors be comprised of a majority of independent directors. Based upon information requested from and provided by each proposed director concerning his or her background, employment and affiliations, including family relationships, Carisma expects that the combined company&#8217;s board of directors will determine that each member of the combined company&#8217;s board of directors, except Mr.&#160;Kelly, Carisma&#8217;s current President and Chief Executive Officer, who will serve as President and Chief Executive Officer of the combined company, and Dr.&#160;Cannell, Sesen Bio&#8217;s current President and Chief Executive Officer, will qualify as an &#8220;independent director&#8221; as defined under applicable Nasdaq Listing Rules. In making such determination, the combined company&#8217;s board of directors will consider the current and prior relationships that each director has with Carisma and Sesen Bio and all other facts and circumstances that the company&#8217;s board of directors deems relevant in determining the independence of each director, including the interests of each director in the merger, any relevant related party transactions and the beneficial ownership of Carisma or Sesen Bio common stock by each director. See the sections entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Interests of Carisma Directors and Executive Officers in the Merger</font><font style="letter-spacing:0.2pt;">,&#8221; &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Related Party Transactions of Directors and Executive Officers of the Combined Company</font><font style="letter-spacing:0.2pt;">&#8221; and &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Principal Stockholders of Carisma</font><font style="letter-spacing:0.2pt;">&#8221; beginning on pages <a href="#tIOCD">153</a>, <a href="#tRPTO">368</a> and <a href="#tPSOC">397</a>, respectively, of this proxy statement/prospectus for additional information. </font>
          </div>

        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In addition, Nasdaq Listing Rules require that, subject to specified exceptions, each member of the combined company&#8217;s audit, compensation and nominating and corporate governance committees be independent under the Exchange Act. Audit committee members must also satisfy the independence criteria set forth in Rule&#160;10A-3 under the Exchange Act, and compensation committee members must also satisfy the independence criteria set forth in Rule&#160;10C-1 under the Exchange Act. Under applicable Nasdaq Listing Rules, a director will only qualify as an &#8220;independent director&#8221; if, in the opinion of the combined company&#8217;s board of directors, that person does not have a relationship that would interfere with the exercise of independent judgment in carrying out the responsibilities of a director. In order to be considered independent for purposes of Rule&#160;10A-3, a member of an audit committee of the combined company may not, other than in his or her capacity as a member of the audit committee, the combined company&#8217;s board of directors, or any other committee of the combined company&#8217;s board of directors, accept, directly or indirectly, any consulting, advisory or other compensatory fee from the combined company or any of its subsidiaries or otherwise be an affiliated person of the combined company or any of its subsidiaries. In order to be considered independent for purposes of Rule&#160;10C-1, the board of directors must consider, for each member of a compensation committee of the combined company, all factors specifically relevant to determining whether a director has a relationship to such company which is material to that director&#8217;s ability to be independent from management in connection with the duties of a compensation committee member, including, but not limited to: (1)&#160;the source of compensation of the director, including any consulting advisory or other compensatory fee paid by such company to the director; and (2)&#160;whether the director is affiliated with the company or any of its subsidiaries or affiliates. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">There are no family relationships among any of the proposed directors or officers of the combined company. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Composition of the Board of Directors</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Sesen Bio board of directors currently consists of six members divided into three staggered classes, with one class elected at each annual meeting to serve for a three-year term. The staggered structure of the current Sesen Bio board of directors will remain in place for the combined company&#8217;s board of directors following the completion of the merger. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Committees of the Board of Directors Following the Merger</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Sesen Bio board of directors has an established audit committee, compensation committee, nominating and corporate governance committee and science committee, each of which operate pursuant to a charter adopted by the Sesen Bio board of directors. After completion of the merger, the combined company&#8217;s board of directors will continue to have such standing committees. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">344</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Audit Committee</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The responsibilities of the Sesen Bio audit committee include: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">appointing, approving the compensation of, and assessing the independence of, Sesen Bio&#8217;s registered public accounting firm; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.41pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.41pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">overseeing the work of the independent registered public accounting firm, including through the receipt and consideration of reports and other communications from such firm; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.4pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">reviewing and discussing with management and the independent registered public accounting firm&#160;(x)&#160;the annual and quarterly financial statements and related disclosures (including any interim financial statements to be included in Sesen Bio&#8217;s periodic disclosures filed with the SEC); (y)&#160;earnings press releases; and (z)&#160;litigation or other legal matters that could have a significant impact on Sesen Bio&#8217;s financial results; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.4pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">monitoring internal control over financial reporting, disclosure controls and procedures and code of business conduct and ethics; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.4pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">overseeing Sesen Bio&#8217;s internal audit function; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.41pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.41pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">working with Sesen Bio&#8217;s Chief Compliance Officer to evaluate and define the goals of Sesen Bio&#8217;s ethics and compliance programs, evaluate the adequacy of Sesen Bio&#8217;s internal controls over compliance and develop proposals for improving Sesen Bio&#8217;s internal controls; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.4pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">overseeing Sesen Bio&#8217;s risk assessment and risk management policies; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.41pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.41pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">establishing policies and procedures for the receipt and retention of accounting-related complaints and concerns; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.4pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">meeting independently with Sesen Bio&#8217;s internal audit advisor, if applicable, and the independent registered public accounting firm and management; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.41pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.41pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">reviewing and approving or ratifying any related person transactions; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.4pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">preparing the audit committee report required by SEC rules; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.4pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">conducting a periodic self-assessment of the committee and its charter. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The audit committee of the combined company is expected to retain these duties and responsibilities following the completion of the merger. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In connection with the closing of the merger, the combined company&#8217;s board of directors is expected to select members of the audit committee. Sesen Bio and Carisma believe that, following the completion of the merger, the composition of the audit committee will meet the requirements for independence under current Nasdaq and SEC rules and regulations. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Compensation Committee</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The responsibilities of the Sesen Bio compensation committee include: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">reviewing and approving, or making recommendations to the Sesen Bio board of directors with respect to, the compensation of the chief executive officer and other executive officers, taking into consideration the executive officer&#8217;s performance as it relates to both legal compliance and compliance with Sesen Bio&#8217;s internal policies and procedures; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.4pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">reviewing and approving termination benefits and separation pay to executive officers, taking into consideration the circumstances surrounding the particular executive officer&#8217;s departure and performance as it relates to both legal compliance and compliance with Sesen Bio&#8217;s internal policies and procedures; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.4pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">overseeing an evaluation of Sesen Bio&#8217;s senior executives, including the establishment of corporate goals and objectives applicable to the chief executive officer and other executive officers; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.3pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">reviewing and approving, or making recommendations to the Sesen Bio board of directors with respect to, the terms of any binding offer letters, employment agreements, termination agreements or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">345</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:30pt; width:426pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">arrangements, change-in-control agreements, severance agreements, indemnification agreements or other material compensatory agreements with the chief executive officer or the other executive officers; </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">reviewing and making recommendations to the Sesen Bio board of directors with respect to incentive-compensation and equity-based plans that are subject to approval by the Sesen Bio board of directors; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">overseeing and administering Sesen Bio stock option, stock incentive, employee stock purchase and other equity-based plans; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">retaining the services, following the determination of independence under applicable Nasdaq Listing Rules and Exchange Act rules, of Sesen Bio&#8217;s compensation consultant, as well as overseeing and considering the recommendations of the compensation consultant; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">reviewing and making recommendations to the Sesen Bio board of directors with respect to director compensation; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">establishing, if deemed advisable by the Sesen Bio board of directors, and monitoring compliance with, stock ownership guidelines for the chief executive officer, directors and other executive officers; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">reviewing and discussing annually with management the compensation disclosure required by SEC rules; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">preparing the compensation committee report required by SEC rules; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">conducting a periodic self-assessment of the committee and its charter. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The compensation committee of the combined company is expected to retain these duties and responsibilities following completion of the merger. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In connection with the closing of the merger, the combined company&#8217;s board of directors is expected to select members of the compensation committee. Sesen Bio and Carisma believe that, following the completion of the merger, the composition of the compensation governance committee will meet the requirements for independence under current Nasdaq and SEC rules and regulations. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Nominating and Corporate Governance Committee</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The responsibilities of the Sesen Bio nominating and corporate governance committee include: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">identifying individuals qualified to become members of the Sesen Bio board of directors; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">recommending to the Sesen Bio board of directors the persons to be nominated for election as directors and to each of the board committees; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">reviewing and making recommendations to the Sesen Bio board of directors with respect to board leadership structure; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">reviewing and making recommendations to the Sesen Bio board of directors with respect to management succession planning; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">reviewing and making recommendations to the Sesen Bio board of directors with respect to the adequacy of the Sesen Bio Certificate of Incorporation and Sesen Bio Bylaws; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">developing and recommending corporate governance guidelines to the Sesen Bio board of directors; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">overseeing a periodic evaluation of the Sesen Bio board of directors; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">conducting a periodic self-assessment of the committee and its charter. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The nominating and corporate governance committee of the combined company is expected to retain these duties and responsibilities following completion of the merger. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In connection with the closing of the merger, the combined company&#8217;s board of directors is expected to select members of the nominating and corporate governance committee. Sesen Bio and Carisma believe that, following the completion of the merger, the composition of the nominating and corporate governance committee will meet the requirements for independence under current Nasdaq and SEC rules and regulations. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">346</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Science Committee</font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The responsibilities of the Sesen Bio science committee include:</font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">reviewing and advising on the overall strategy, direction and effectiveness of Sesen Bio&#8217;s research and development, or R&amp;D, initiatives, programs and related investments, and on Sesen Bio&#8217;s progress in achieving our long-term strategic R&amp;D goals and objectives, including preclinical studies and clinical trial design;</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">reviewing and advising on opportunities and risks associated with Sesen Bio&#8217;s R&amp;D initiatives, programs and related investments;</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">reviewing and advising on Sesen Bio&#8217;s significant medical affairs strategies and initiatives;</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">reviewing and advising on trends and innovation in research and development to enhance Sesen Bio&#8217;s R&amp;D capabilities; and</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">conducting a periodic self-assessment of the science committee and its charter. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The science committee of the combined company is expected to retain these duties and responsibilities following completion of the merger.</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In connection with the closing of the merger, the combined company&#8217;s board of directors is expected to select members of the science committee. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Compensation Committee Interlocks and Insider Participation</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In connection with the closing of the merger, the combined company&#8217;s board of directors is expected to select members of the compensation committee. None of the proposed executive officers of the combined company serve, or in the past year has served, as a member of the board of directors or compensation committee, or other committee serving an equivalent function, of any other entity that has one or more of its executive officers who is proposed to serve on the combined company&#8217;s board of directors or compensation committee following the completion of the merger. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Code of Business Conduct and Ethics</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The combined company will adopt a written code of business conduct and ethics, substantially in the form of Sesen Bio&#8217;s current Code of Business Conduct and Ethics, that applies to its directors, officers and employees, including the principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions, of the combined company. The combined company will post a current copy of the code on its website, www.carismatx.com. In addition, the combined company intends to post on its website all disclosures that are required by law or Nasdaq Listing Rules concerning any amendments to, or waivers from, any provision of the code of business conduct and ethics. The information contained on, or that can be accessed through, the website is not a part of this prospectus. The website address is included in this prospectus solely as an inactive textual reference. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Director Compensation</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Prior to the merger, Carisma did not have a formal policy to provide any cash or equity compensation to its non-employee directors for their service on the Carisma board of directors or committees of the Carisma board of directors. In connection with Mr.&#160;Zweifach&#8217;s election as a member and Chair of the Carisma board of directors in November&#160;2021, the Carisma board of directors authorized an annual cash retainer of $75,000 to be paid to Mr.&#160;Zweifach in equal quarterly installments and a grant to Mr.&#160;Zweifach of options to purchase 97,200 shares of Carisma common stock. In connection with Mr.&#160;Morrison&#8217;s election as a member of the Carisma board of directors in July&#160;2020, the Carisma board of directors authorized a grant to Mr.&#160;Morrison of options to purchase 33,332 shares of Carisma common stock. For additional information on compensation paid to directors of Carisma, see the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Carisma Executive Compensation&#8201;&#8212;&#8201;Carisma Director Compensation</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tCADCT">366</a> of this proxy statement/prospectus. </font>
          </div>

        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In connection with the closing of the merger and the transition of the board of directors, the combined company expects to evaluate Sesen Bio&#8217;s director compensation practices and finalize the combined company&#8217;s </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">347</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:568pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">non-employee director compensation program, pursuant to which non-employee directors will be eligible to receive compensation for service on the board of directors of the combined company and its committees. The board of directors of the combined company expects to review director compensation periodically to ensure that director compensation remains competitive such that the combined company is able to recruit and retain qualified directors. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">348</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tSBEC">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">SESEN BIO EXECUTIVE COMPENSATION</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio&#8217;s named executive officers for 2021 are Thomas R. Cannell, D.V.M., its President and Chief Executive Officer, Monica Forbes, its Chief Financial Officer, and Glen MacDonald, Ph.D., its Chief Technology Officer. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Summary Compensation Table</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following table sets forth information regarding compensation awarded to, earned by or paid to each of Sesen Bio&#8217;s named executive officers for the&#160;years ended December&#160;31, 2021 and 2020. </font>
        </div>
        <table style="width:456pt;height:148.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.667pt 0pt; width:140.88pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Name and Principal Position </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.25pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.667pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Year </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.25pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.667pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Salary</font>
                <br >
                <font style="letter-spacing:-0.16pt;">($) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.25pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.667pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Bonus</font>
                <br >
                <font style="letter-spacing:-0.16pt;">($)</font><font style=" position:relative; bottom:3.25pt;line-height:5pt;font-size:5pt;letter-spacing:-0.12pt;">(4)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.25pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.667pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Stock</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Awards</font>
                <br >
                <font style="letter-spacing:-0.16pt;">($)</font><font style=" position:relative; bottom:3.25pt;line-height:5pt;font-size:5pt;letter-spacing:-0.12pt;">(5)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.25pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.667pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Option</font>
                <br >
                <font style="letter-spacing:-0.16pt;">awards</font>
                <br >
                <font style="letter-spacing:-0.16pt;">($)</font><font style=" position:relative; bottom:3.25pt;line-height:5pt;font-size:5pt;letter-spacing:-0.12pt;">(6)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.25pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.667pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Non-equity</font>
                <br >
                <font style="letter-spacing:-0.16pt;">incentive</font>
                <br >
                <font style="letter-spacing:-0.16pt;">plan</font>
                <br >
                <font style="letter-spacing:-0.16pt;">compensation</font>
                <br >
                <font style="letter-spacing:-0.16pt;">($)</font><font style=" position:relative; bottom:3.25pt;line-height:5pt;font-size:5pt;letter-spacing:-0.12pt;">(7)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.25pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.667pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">All other</font>
                <br >
                <font style="letter-spacing:-0.16pt;">compensation</font>
                <br >
                <font style="letter-spacing:-0.16pt;">($)</font><font style=" position:relative; bottom:3.25pt;line-height:5pt;font-size:5pt;letter-spacing:-0.12pt;">(8)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.25pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.667pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Total</font>
                <br >
                <font style="letter-spacing:-0.16pt;">($) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:7.25pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 0.5pt 0pt; width:140.88pt;text-align:left;" rowspan="2">
              <div style="margin-left:10pt; text-indent:-10pt; text-align:justify; line-height:12pt; padding-bottom:0.666666666666667pt;">
                <font style="letter-spacing:0.2pt;">Thomas R. Cannell, D.V.M.</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">&#65279;(1)</font>
                <br >
                <font style="letter-spacing:0.2pt;">President and Chief Executive </font>
                <br >
                <font style="letter-spacing:0.2pt;">Officer </font>
              </div>
            </td>
            <td style="padding:0pt; width:2.25pt;" rowspan="2">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 1pt 0pt; line-height:12pt; min-width:15pt; text-align:right; white-space:nowrap;">2021</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 1pt 0pt; line-height:12pt; min-width:24.75pt; text-align:right; white-space:nowrap;">558,362</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 1pt 0pt; line-height:12pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 1pt 0pt; line-height:12pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 1pt 0pt; line-height:12pt; min-width:30.75pt; text-align:right; white-space:nowrap;">4,123,086</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.185pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 1pt 0pt; line-height:12pt; min-width:24.75pt; text-align:right; white-space:nowrap;">236,250</td>
            <td style="padding:0pt;padding-left:6.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.685pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 1pt 0pt; line-height:12pt; min-width:21pt; text-align:right; white-space:nowrap;">4,000</td>
            <td style="padding:0pt;padding-left:8.685pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 1pt 0pt; line-height:12pt; min-width:30.75pt; text-align:right; white-space:nowrap;">4,921,698</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;height:24pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.667pt 0pt 10.333pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.667pt 0pt 10.333pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">2020</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.667pt 0pt 10.333pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.667pt 0pt 10.333pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">532,917</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.667pt 0pt 10.333pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.667pt 0pt 10.333pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.667pt 0pt 10.333pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.667pt 0pt 10.333pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.667pt 0pt 10.333pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.667pt 0pt 10.333pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">817,449</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.185pt;width:0pt;">&#8203;</td>
            <td style="padding:1.667pt 0pt 10.333pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.667pt 0pt 10.333pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">348,140</td>
            <td style="padding:0pt;padding-left:6.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.685pt;width:0pt;">&#8203;</td>
            <td style="padding:1.667pt 0pt 10.333pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.667pt 0pt 10.333pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">4,000</td>
            <td style="padding:0pt;padding-left:8.685pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.667pt 0pt 10.333pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.667pt 0pt 10.333pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">1,702,506</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:7pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 0.5pt 0pt; width:140.88pt;white-space:normal;text-align:left;" rowspan="2">
              <div style="margin-left:10pt; text-indent:-10pt; text-align:justify; line-height:12pt; padding-bottom:0.666666666666667pt;">
                <font style="letter-spacing:0.2pt;">Monica Forbes</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">&#65279;(2)</font>
                <br >
                <font style="letter-spacing:0.2pt;">Chief Financial Officer and Treasurer </font>
              </div>
            </td>
            <td style="padding:0pt; width:2.25pt;" rowspan="2">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; line-height:12pt; min-width:15pt; text-align:right; white-space:nowrap;">2021</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; line-height:12pt; min-width:24.75pt; text-align:right; white-space:nowrap;">377,958</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; line-height:12pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; line-height:12pt; min-width:24.75pt; text-align:right; white-space:nowrap;">148,778</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; line-height:12pt; min-width:30.75pt; text-align:right; white-space:nowrap;">1,195,695</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.185pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; line-height:12pt; min-width:24.75pt; text-align:right; white-space:nowrap;">145,447</td>
            <td style="padding:0pt;padding-left:6.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.685pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; line-height:12pt; min-width:21pt; text-align:right; white-space:nowrap;">4,000</td>
            <td style="padding:0pt;padding-left:8.685pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; line-height:12pt; min-width:30.75pt; text-align:right; white-space:nowrap;">1,871,878</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;height:24pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.667pt 0pt 10.333pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.667pt 0pt 10.333pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">2020</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.667pt 0pt 10.333pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.667pt 0pt 10.333pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">360,500</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.667pt 0pt 10.333pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.667pt 0pt 10.333pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.667pt 0pt 10.333pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.667pt 0pt 10.333pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.667pt 0pt 10.333pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.667pt 0pt 10.333pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">259,329</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.185pt;width:0pt;">&#8203;</td>
            <td style="padding:1.667pt 0pt 10.333pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.667pt 0pt 10.333pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">174,500</td>
            <td style="padding:0pt;padding-left:6.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.685pt;width:0pt;">&#8203;</td>
            <td style="padding:1.667pt 0pt 10.333pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.667pt 0pt 10.333pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:8.685pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.667pt 0pt 10.333pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.667pt 0pt 10.333pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">795,329</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:7pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 0.5pt 0pt; width:140.88pt;text-align:left;" rowspan="2">
              <div style="margin-left:10pt; text-indent:-10pt; text-align:justify; line-height:12pt; padding-bottom:0pt;">
                <font style="letter-spacing:0.2pt;">Glen MacDonald, Ph.D.</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">&#65279;(3)</font>
                <br >
                <font style="letter-spacing:0.2pt;">Chief Technology Officer </font>
              </div>
            </td>
            <td style="padding:0pt; width:2.25pt;" rowspan="2">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; line-height:12pt; min-width:15pt; text-align:right; white-space:nowrap;">2021</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; line-height:12pt; min-width:24.75pt; text-align:right; white-space:nowrap;">362,156</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; line-height:12pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; line-height:12pt; min-width:24.75pt; text-align:right; white-space:nowrap;">143,262</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; line-height:12pt; min-width:30.75pt; text-align:right; white-space:nowrap;">618,463</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.185pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; line-height:12pt; min-width:24.75pt; text-align:right; white-space:nowrap;">135,625</td>
            <td style="padding:0pt;padding-left:6.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.685pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; line-height:12pt; min-width:21pt; text-align:right; white-space:nowrap;">14,486</td>
            <td style="padding:0pt;padding-left:8.685pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; line-height:12pt; min-width:30.75pt; text-align:right; white-space:nowrap;">1,273,992</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:18.5pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">2020</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">343,714</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">155,033</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.185pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">160,917</td>
            <td style="padding:0pt;padding-left:6.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.685pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">14,067</td>
            <td style="padding:0pt;padding-left:8.685pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">674,731</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:12.3pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:7.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:7.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Dr.&#160;Cannell&#8217;s base salary was increased from $535,600 to $562,500, effective March&#160;1, 2021. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.21pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(2)</font>
          <br >
        </div>
        <div style=" margin-top:3.21pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Ms.&#160;Forbes&#8217; base salary was increased from $362,600 to $380,750, effective March&#160;1, 2021. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(3)</font>
          <br >
        </div>
        <div style=" margin-top:3.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Dr.&#160;MacDonald&#8217;s base salary was increased from $353,961 to $368,180, effective March&#160;1, 2021. Dr.&#160;MacDonald&#8217;s base salary, non-equity incentive plan and all other compensation is paid by Sesen Bio in Canadian dollars and the above amounts for Dr.&#160;MacDonald&#8217;s base salary, non-equity incentive plan and all other compensation have been converted to U.S. dollars using the exchange rate between the Canadian and the U.S. dollar in effect at fiscal year-end. The exchange rates in effect on December&#160;31, 2021 and December&#160;31, 2020 were 0.7824, and 0.7849, respectively. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(4)</font>
          <br >
        </div>
        <div style=" margin-top:3.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">The amounts reported in the &#8220;Bonus&#8221; column reflect a $1,000 holiday bonus paid to all employees, other than Dr.&#160;Cannell, in December&#160;2020. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.21pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(5)</font>
          <br >
        </div>
        <div style=" margin-top:3.21pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">The amounts reported in the &#8220;Stock awards&#8221; column reflect the aggregate grant date fair value of performance-based restricted stock&#160;units awarded during the year computed in accordance with the provisions of Financial Accounting Standards Board Accounting Standard Codification, or ASC, Topic&#160;718. See Note 14 to Sesen Bio&#8217;s financial statements appearing at the end of Sesen Bio&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2021 regarding assumptions underlying the valuation of equity awards. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.11pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(6)</font>
          <br >
        </div>
        <div style=" margin-top:3.11pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">The amounts reported in the &#8220;Option awards&#8221; column reflect the aggregate grant date fair value of stock options awarded during the year computed in accordance with the provisions of Financial Accounting Standards Board Accounting Standard Codification, or ASC, Topic 718. See Note 14 to Sesen Bio financial statements appearing at the end of Sesen Bio&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2021 regarding assumptions underlying the valuation of equity awards. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.11pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(7)</font>
          <br >
        </div>
        <div style=" margin-top:3.11pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">The amounts reported in the &#8220;Non-equity incentive plan compensation&#8221; column reflect bonuses that were earned by Sesen Bio&#8217;s executive officers in the fiscal&#160;years ending December&#160;31, 2021 and 2020 based on the achievement of pre-established performance goals that were previously communicated to Sesen Bio&#8217;s executive officers. See &#8220;Bonus Compensation&#8221; below for additional information. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.11pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(8)</font>
          <br >
        </div>
        <div style=" margin-top:3.11pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">For Dr.&#160;Cannell, for the&#160;years 2021 and 2020, and for Ms.&#160;Forbes, for the year 2021, the amounts reported reflect discretionary 401(k) matching contributions contributed to Sesen Bio&#8217;s 401(k) retirement plan as approved by the Sesen Bio compensation committee. For Dr.&#160;MacDonald, the amounts reported in 2021 and 2020 reflect Company-paid pension contributions on behalf of Dr.&#160;MacDonald to the defined contribution pension plan that Sesen Bio maintain for all of its Canadian employees. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">349</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Narrative to Summary Compensation Table</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Employment Agreements with Named Executive Officers</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Thomas R. Cannell, D.V.M.</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On August&#160;7, 2018, Sesen Bio entered into an employment agreement with Dr.&#160;Cannell, which provides that his employment will continue until either Sesen Bio or Dr.&#160;Cannell provides notice of termination in accordance with the terms of the agreement. In addition, Sesen Bio entered into a non-competition, non-solicitation, confidentiality and assignment agreement with Dr.&#160;Cannell, which prohibits him from competing with Sesen Bio, soliciting Sesen Bio&#8217;s employees and customers and disclosing confidential information during the term of his employment and for one year following the conclusion of his service with Sesen Bio. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Pursuant to Dr.&#160;Cannell&#8217;s employment agreement, he is entitled to receive an annual base salary, which will be reviewed at least annually and will be subject to increase (but not decrease) from time to time, as determined by the Sesen Bio board of directors. In February&#160;2022, the Sesen Bio compensation committee approved an increase in Dr.&#160;Cannell&#8217;s annual base salary to $576,563, effective March&#160;1, 2022. In addition, pursuant to his employment agreement, Dr.&#160;Cannell is eligible to receive an annual cash bonus, which is based on the achievement of individual and corporate performance objectives, calculated as a&#160;percentage of his annual base salary, and which will be determined by the Sesen Bio board of directors, in its sole discretion. Dr.&#160;Cannell&#8217;s target annual bonus for 2020 and 2021 was 50% of his annual base salary. Dr.&#160;Cannell&#8217;s target annual bonus for 2022 is 50% of his annual base salary. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Monica Forbes</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On August&#160;26, 2019, Sesen Bio entered into an employment agreement with Ms.&#160;Forbes in connection with her appointment as Sesen Bio&#8217;s Chief Financial Officer and Treasurer. Ms.&#160;Forbes&#8217; employment agreement provides that her employment will continue until either Sesen Bio or Ms.&#160;Forbes provides notice of termination in accordance with the terms of the agreement. In addition, Sesen Bio entered into a non-competition, non-solicitation, confidentiality and assignment agreement with Ms.&#160;Forbes, which prohibits her from competing with Sesen Bio, soliciting Sesen Bio&#8217;s employees and customers and disclosing confidential information during the term of her employment and for one year following the conclusion of her service with Sesen Bio. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Pursuant to Ms.&#160;Forbes&#8217; employment agreement, she is entitled to receive an annual base salary, which will be reviewed at least annually and will be subject to increase (but not decrease) from time to time, as determined by the Sesen Bio board of directors. In February&#160;2022, the Sesen Bio compensation committee approved an increase in Ms.&#160;Forbes&#8217; annual base salary to $400,000, effective March&#160;1, 2022. In addition, pursuant to her employment agreement, Ms.&#160;Forbes is eligible to receive an annual cash bonus based on the achievement of individual and corporate performance objectives, calculated as a&#160;percentage of her annual base salary, and which will be determined by the Sesen Bio board of directors, in its sole discretion. Ms.&#160;Forbes&#8217; annual target bonus for (i)&#160;2020 was equal to 35% of her annual base salary, and (ii)&#160;2021 was equal to 40% of her annual base salary. Ms.&#160;Forbes&#8217; annual target bonus for 2022 is equal to 40% of her annual base salary. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Glen MacDonald, Ph.D.</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On September&#160;20, 2016, Sesen Bio entered into an employment agreement with Dr.&#160;MacDonald. Dr.&#160;MacDonald&#8217;s employment agreement provides that his employment will continue until either Sesen Bio or Dr.&#160;MacDonald provides notice of termination in accordance with the terms of the agreement. In addition, Sesen Bio entered into a non-competition, non-solicitation, confidentiality and assignment agreement with Dr.&#160;MacDonald, which prohibits him from competing with Sesen Bio, soliciting Sesen Bio&#8217;s employees and customers and disclosing confidential information during the term of his employment and for one year following the conclusion of his service with Sesen Bio. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Pursuant to Dr.&#160;MacDonald&#8217;s employment agreement, he is entitled to receive an annual base salary, which will be reviewed at least annually and will be subject to increase (but not decrease) from time to time, as determined by the Sesen Bio board of directors. In February&#160;2022, the Sesen Bio compensation </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">350</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">committee approved an increase in Dr.&#160;MacDonald&#8217;s annual base salary to $379,166, effective March&#160;1, 2022. In addition, pursuant to his employment agreement, Dr.&#160;MacDonald is eligible to receive an annual cash bonus based on the achievement of individual and corporate performance objectives, calculated as a&#160;percentage of his annual base salary, and which will be determined by the Sesen Bio board of directors, in its sole discretion. Dr.&#160;MacDonald&#8217;s annual target bonus for (i)&#160;2020 was equal to 35% of his annual base salary, and (ii)&#160;2021 is equal to 40% of his annual base salary. Dr.&#160;MacDonald&#8217;s annual target bonus for 2022 is equal to 40% of his annual base salary. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Equity Awards</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Although Sesen Bio does not have a formal policy with respect to the grant of equity incentive awards to its executive officers, or any formal equity ownership guidelines applicable to them, Sesen Bio believes that equity grants provide its executives with a strong link to its long-term performance, create an ownership culture and help to align the interests of its executives and Sesen Bio stockholders. In addition, Sesen Bio believes that equity grants with a time-based vesting feature promote executive retention by incentivizing its executive officers to remain in Sesen Bio&#8217;s employment during the vesting period. Accordingly, the Sesen Bio board of directors periodically reviews the equity incentive compensation of its executive officers and from time to time may grant equity incentive awards to them, including in the form of Sesen Bio options and Sesen Bio RSUs (both time-based RSUs and performance-based RSUs, or Sesen Bio PSUs). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On February&#160;18, 2022, Sesen Bio granted Dr.&#160;Cannell an award of 606,800 RSUs. Each Sesen Bio RSU represents a contingent right to receive one share of Sesen Bio common stock. The Sesen Bio RSU award vests annually in equal amounts over a four year period following the grant date, subject to Dr.&#160;Cannell&#8217;s continued service with Sesen Bio on the applicable vesting date. On February&#160;18, 2022, Sesen Bio also granted Dr.&#160;Cannell an award of 606,800 Sesen Bio PSUs. Each Sesen Bio PSU represents a contingent right to receive one share of Sesen Bio common stock upon the satisfaction of pre-determined performance criteria related to completing patient enrollment for the new clinical trial. Subject to continued employment, such Sesen Bio PSUs vest upon the determination by the Sesen Bio compensation committee of the level of achievement of a clinical trial milestone. On February&#160;19, 2021, Sesen Bio granted Dr.&#160;Cannell options to purchase 2,000,000 shares of Sesen Bio common stock at an exercise price of $3.17 per share. These options vest 6.25% every three&#160;months over four&#160;years commencing on January&#160;1, 2021, subject to Dr.&#160;Cannell&#8217;s continued service with Sesen Bio on the applicable vesting date. On February&#160;13, 2020, Sesen Bio granted Dr.&#160;Cannell options to purchase 1,450,000 shares of Sesen Bio common stock at an exercise price of $0.8911 per share. These options vest 6.25% every three&#160;months over four&#160;years, subject to Dr.&#160;Cannell&#8217;s continued service with Sesen Bio on the applicable vesting date. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On February&#160;18, 2022, Sesen Bio granted Ms.&#160;Forbes an award of 542,250 RSUs. Each Sesen Bio RSU represents a contingent right to receive one share of Sesen Bio common stock. The Sesen Bio RSU award vests annually in equal amounts over a four year period following the grant date, subject to Ms.&#160;Forbes&#8217;s continued service with Sesen Bio on the applicable vesting date. On February&#160;18, 2022, Sesen Bio also granted Ms.&#160;Forbes an award of 180,750 Sesen Bio PSUs. Each Sesen Bio PSU represents a contingent right to receive one share of Sesen Bio common stock upon the satisfaction of pre-determined performance criteria related to completing patient enrollment for the new clinical trial. Subject to continued employment, such Sesen Bio PSUs vest upon the determination by the Sesen Bio compensation committee of the level of achievement of a clinical trial milestone. On February&#160;19, 2021, Sesen Bio granted Ms.&#160;Forbes options to purchase 580,000 shares of Sesen Bio common stock at an exercise price of $3.17 per share. These options vest 6.25% every three&#160;months over four&#160;years commencing on January&#160;1, 2021, subject to Ms.&#160;Forbes&#8217; continued service with Sesen Bio on the applicable vesting date. On February&#160;13, 2020, Sesen Bio granted Ms.&#160;Forbes options to purchase 460,000 shares of Sesen Bio common stock at an exercise price of $0.8911 per share. These options vest 6.25% every three&#160;months over four&#160;years, subject to Ms.&#160;Forbes&#8217; continued service with Sesen Bio on the applicable vesting date. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On February&#160;18, 2022, Sesen Bio granted Dr.&#160;MacDonald an award of 308,925 RSUs. Each Sesen Bio RSU represents a contingent right to receive one share of Sesen Bio common stock. The Sesen Bio RSU award vests annually in equal amounts over a four year period following the grant date, subject to Dr.&#160;MacDonald&#8217;s continued service with Sesen Bio on the applicable vesting date. On February&#160;18, 2022, Sesen Bio also granted Dr.&#160;MacDonald an award of 102,975 Sesen Bio PSUs. Each Sesen Bio PSU represents </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">351</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">a contingent right to receive one share of Sesen Bio common stock upon the satisfaction of pre-determined performance criteria related to completing patient enrollment for the new clinical trial. Subject to continued employment, such Sesen Bio PSUs vest upon the determination by the Sesen Bio compensation committee of the level of achievement of a clinical trial milestone. On February&#160;19, 2021, Sesen Bio granted Dr.&#160;MacDonald options to purchase 300,000 shares of Sesen Bio common stock at an exercise price of $3.17 per share. These options vest 6.25% every three&#160;months over four&#160;years commencing on January&#160;1, 2021, subject to Dr.&#160;MacDonald&#8217;s continued service with Sesen Bio on the applicable vesting date. On February&#160;13, 2020, Sesen Bio granted Dr.&#160;MacDonald options to purchase 275,000 shares of Sesen Bio common stock at an exercise price of $0.8911 per share. These options vest 6.25% every three&#160;months over four&#160;years, subject to Dr.&#160;MacDonald&#8217;s continued service with Sesen Bio on the applicable vesting date. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In addition, on September&#160;9, 2021, the Sesen Bio board of directors and Sesen Bio compensation committee approved a retention program, or the 2021 retention program, for all current employees, except for the Chief Executive Officer, pursuant to which Sesen Bio has provided certain incentives designed to retain such employees. Pursuant to the 2021 retention program and effective as of October&#160;1, 2021, Sesen Bio&#8217;s executive officers, except for the Chief Executive Officer, were granted a Sesen Bio PSU award equal to the value of approximately fifty&#160;percent of the executive officer&#8217;s then-current base salary. Under the 2021 retention program, Ms.&#160;Forbes was granted an award of 190,375 Sesen Bio PSUs and Dr.&#160;MacDonald was granted an award of 183,317 Sesen Bio PSUs. Each Sesen Bio PSU represents a contingent right to receive one share of Sesen Bio common stock upon the satisfaction of pre-determined performance criteria. Subject to continued employment, such awards vest on September&#160;30, 2023 upon the determination by the Sesen Bio compensation committee of the level of achievement of certain key milestones consisting of a clinical trial milestone (weighted 50%), an employee retention milestone (weighted 30%) and a cash management milestone (weighted 20%). </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Bonus Compensation</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">With respect to the fiscal year ended December&#160;31, 2021, each of Sesen Bio&#8217;s named executive officers was eligible to receive a performance-based bonus based on the achievement of corporate objectives and individual objectives. Since Sesen Bio&#8217;s Chief Executive Officer is responsible for the overall performance of Sesen Bio&#8217;s business, his annual bonus was based solely on Sesen Bio&#8217;s overall performance in achieving corporate objectives. In November&#160;2020, the Sesen Bio compensation committee and the Sesen Bio board of directors reviewed a detailed set of overall corporate objectives for fiscal 2021 for use under the Sesen Bio annual bonus plan. These corporate objectives are initially prepared by management, reviewed (and revised, if determined appropriate) by the Sesen Bio compensation committee, and then presented to the full Sesen Bio board of directors for approval. The Sesen Bio compensation committee assigns weighting to the corporate objectives, but uses its judgment to determine a&#160;percentage that it believes fairly represents Sesen Bio&#8217;s achievement level for the year. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In February&#160;2022, the Sesen Bio compensation committee reviewed Sesen Bio&#8217;s 2021 corporate performance against Sesen Bio&#8217;s corporate objectives and noted that while Sesen Bio made substantial progress on Sesen Bio regulatory and financial goals during 2021, Sesen Bio had certain corporate setbacks as well. Further, the Sesen Bio compensation committee and the Sesen Bio board of directors determined to modify certain corporate objectives related to commercialization, which were determined to be no longer applicable in light of the CRL, as further described below. The weighting of the remaining corporate objectives was adjusted accordingly. Such objectives and outcomes included the following: </font>
        </div>
        <table style="width:456pt;height:100.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.5pt 0pt; width:144pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 Corporate Objective </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.5pt 0pt; width:192pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Outcome </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.5pt 0pt; width:48pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Weighting </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.5pt 0pt; width:36pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Score </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:normal;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:144pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Achieve FDA acceptance of the BLA for Vicineum for the treatment of BCG-unresponsive NMIBC after 1Q 2021 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:192pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Sesen Bio exceeded the target for this objective. The BLA for Vicineum was accepted with Priority Review during Q1 2021, which was earlier than the target. </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:48pt;white-space:nowrap;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">22% </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:36pt;white-space:nowrap;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">24 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:normal;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:7.167pt 0pt 0.5pt 0pt; width:144pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Receive FDA approval of the BLA in the second half of 2021 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:7.167pt 0pt 0.5pt 0pt; width:192pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Sesen Bio did not meet this objective. The FDA issued a Complete Response Letter regarding Sesen Bio&#8217;s BLA for Vicineum. </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:7.167pt 0pt 0.5pt 0pt; width:48pt;white-space:nowrap;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">22% </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:7.167pt 0pt 0.5pt 0pt; width:36pt;white-space:nowrap;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">0 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">352</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:202.74pt;margin-left:69.66pt;width:456pt;">
        <table style="width:456pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.5pt 0pt; width:144pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 Corporate Objective </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.5pt 0pt; width:192pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Outcome </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.5pt 0pt; width:48pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Weighting </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.5pt 0pt; width:36pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Score </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:normal;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0.917pt 0pt 0.5pt 0pt; width:144pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Submit the MAA for Vysyneum for the treatment of BCG-unresponsive NMIBC to the EMA after Q1 2021 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0.917pt 0pt 0.5pt 0pt; width:192pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Sesen Bio did not meet this objective. While Sesen Bio submitted the MAA earlier than its target date, Sesen Bio withdrew the MAA in order to pause its plans to pursue regulatory approval of Vysyneum in the E.U. until there is more clarity from the FDA on next steps for Vicineum in the U.S. </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0.917pt 0pt 0.5pt 0pt; width:48pt;white-space:nowrap;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">6% </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0.917pt 0pt 0.5pt 0pt; width:36pt;white-space:nowrap;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">0 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:normal;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:7.167pt 0pt 0.5pt 0pt; width:144pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Strengthen balance sheet and extend cash runway by finishing fiscal 2021 with $40.0&#160;million -$50.0&#160;million </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:7.167pt 0pt 0.5pt 0pt; width:192pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Sesen Bio exceeded the target for this objective by ending fiscal 2021 with a strong balance sheet of $163.0&#160;million in cash and cash equivalents. The strength of Sesen Bio&#8217;s balance sheet will be critical to supporting Sesen Bio&#8217;s business going forward, including future clinical development of Vicineum. </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:7.167pt 0pt 0.5pt 0pt; width:48pt;white-space:nowrap;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">50% </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:7.167pt 0pt 0.5pt 0pt; width:36pt;white-space:nowrap;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">60 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:8.5pt 0pt 0.5pt 0pt; width:144pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.2pt;">Total</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:192pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:8.5pt 0pt 0.5pt 0pt; width:48pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.2pt;">100%</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:8.5pt 0pt 0.5pt 0pt; width:36pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.2pt;">84</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:17.19pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">As a result, and as noted in the table below, the Sesen Bio compensation committee and the Sesen Bio board of directors approved 2021 performance cash bonus payments to Sesen Bio&#8217;s named executive officers based on an assessment of corporate performance during 2021. </font>
        </div>
        <table style="width:456pt;height:85pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:193.35pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="28">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Target </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt; width:193.35pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Name </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Annual</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Base Salary ($) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Annual</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Bonus (%)</font><font style=" position:relative; bottom:3.25pt;line-height:5pt;font-size:5pt;letter-spacing:-0.12pt;">(1)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Annual</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Bonus ($)</font><font style=" position:relative; bottom:3.25pt;line-height:5pt;font-size:5pt;letter-spacing:-0.12pt;">(1)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Company</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Scorecard</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Result </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Final</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Award </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:193.35pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Thomas R. Cannell, D.V.M. </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.305pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">562,500</td>
            <td style="padding:0pt;padding-left:9.305pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.865pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">50<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:15.865pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.509999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">281,250</td>
            <td style="padding:0pt;padding-left:0.509999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.58pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">84<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:11.58pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">236,250</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:193.35pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Monica Forbes </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.305pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">380,750</td>
            <td style="padding:0pt;padding-left:9.305pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.865pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">40<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:15.865pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.509999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">152,300</td>
            <td style="padding:0pt;padding-left:0.509999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.58pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">84<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:11.58pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">145,447</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:193.35pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Glen MacDonald. Ph.D.</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(2)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.305pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">364,583</td>
            <td style="padding:0pt;padding-left:9.305pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.865pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">40<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:15.865pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.509999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">145,833</td>
            <td style="padding:0pt;padding-left:0.509999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.58pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">84<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:11.58pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">135,625</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:13.69pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:9.19pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:9.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">2021 target annual bonus opportunity was a&#160;percentage of 2021 base salary. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:5.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(2)</font>
          <br >
        </div>
        <div style=" margin-top:5.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Dr.&#160;MacDonald&#8217;s annual base salary is paid by Sesen Bio in Canadian dollars and was $465,974 CAD as of December&#160;31, 2021. It has been converted to U.S. dollars using the exchange rate of 0.7824 in effect on December&#160;31, 2021. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">353</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Outstanding Equity Awards at December&#160;31, 2021</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following table sets forth information regarding all outstanding equity awards held by each of Sesen Bio&#8217;s named executive officers as of December&#160;31, 2021. </font>
        </div>
        <table style="width:456pt;height:376pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:130.11pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;" colspan="22">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Option Awards </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Stock Awards </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt; width:130.11pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Name </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Number of</font>
                <br >
                <font style="letter-spacing:-0.16pt;">securities</font>
                <br >
                <font style="letter-spacing:-0.16pt;">underlying</font>
                <br >
                <font style="letter-spacing:-0.16pt;">unexercised</font>
                <br >
                <font style="letter-spacing:-0.16pt;">options</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(#)</font>
                <br >
                <font style="letter-spacing:-0.16pt;">exercisable </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Number of</font>
                <br >
                <font style="letter-spacing:-0.16pt;">securities</font>
                <br >
                <font style="letter-spacing:-0.16pt;">underlying</font>
                <br >
                <font style="letter-spacing:-0.16pt;">unexercised</font>
                <br >
                <font style="letter-spacing:-0.16pt;">options</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(#)</font>
                <br >
                <font style="letter-spacing:-0.16pt;">unexercisable </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Option</font>
                <br >
                <font style="letter-spacing:-0.16pt;">exercise</font>
                <br >
                <font style="letter-spacing:-0.16pt;">price</font>
                <br >
                <font style="letter-spacing:-0.16pt;">($) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Option</font>
                <br >
                <font style="letter-spacing:-0.16pt;">expiration</font>
                <br >
                <font style="letter-spacing:-0.16pt;">date </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Equity</font>
                <br >
                <font style="letter-spacing:-0.16pt;">incentive plan</font>
                <br >
                <font style="letter-spacing:-0.16pt;">awards:</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Number of</font>
                <br >
                <font style="letter-spacing:-0.16pt;">unearned</font>
                <br >
                <font style="letter-spacing:-0.16pt;">shares, units</font>
                <br >
                <font style="letter-spacing:-0.16pt;">or other rights</font>
                <br >
                <font style="letter-spacing:-0.16pt;">that have not</font>
                <br >
                <font style="letter-spacing:-0.16pt;">vested</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(#) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Equity</font>
                <br >
                <font style="letter-spacing:-0.16pt;">incentive plan</font>
                <br >
                <font style="letter-spacing:-0.16pt;">awards:</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Market or</font>
                <br >
                <font style="letter-spacing:-0.16pt;">payout value</font>
                <br >
                <font style="letter-spacing:-0.16pt;">of unearned</font>
                <br >
                <font style="letter-spacing:-0.16pt;">shares, units</font>
                <br >
                <font style="letter-spacing:-0.16pt;">or other</font>
                <br >
                <font style="letter-spacing:-0.16pt;">rights that</font>
                <br >
                <font style="letter-spacing:-0.16pt;">have not</font>
                <br >
                <font style="letter-spacing:-0.16pt;">vested</font>
                <br >
                <font style="letter-spacing:-0.16pt;">($) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:7.25pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:130.11pt;text-align:left;" rowspan="4">
              <div style="white-space:nowrap; line-height:12pt; padding-bottom:0pt;">
                <font style="letter-spacing:0.2pt;">Thomas R. Cannell, D.V.M. </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;" rowspan="4">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; line-height:12pt; min-width:30.75pt; text-align:right; white-space:nowrap;">1,096,875</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; line-height:12pt; min-width:30.75pt; text-align:right; white-space:nowrap;">253,125<font style="position:absolute;"><font style=" position:relative; bottom:3.25pt;font-size:6.5pt;">(1)</font> </font></td>
            <td style="padding:0pt;padding-left:6.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; line-height:12pt; min-width:21pt; text-align:right; white-space:nowrap;">1.60</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; line-height:12pt; min-width:30.75pt; text-align:right; white-space:nowrap;">8/7/2028</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.3pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; line-height:12pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.065pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; line-height:12pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.065pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:15pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">687,500</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">312,500<font style="position:absolute;"><font style=" position:relative; bottom:3.25pt;font-size:6.5pt;">(2)</font> </font></td>
            <td style="padding:0pt;padding-left:6.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">0.8285</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">2/21/2029</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.3pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.065pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.065pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:15pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">634,375</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">815,625<font style="position:absolute;"><font style=" position:relative; bottom:3.25pt;font-size:6.5pt;">(3)</font> </font></td>
            <td style="padding:0pt;padding-left:6.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">0.8911</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">2/13/2030</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.3pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.065pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.065pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:15pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">375,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">1,625,000<font style="position:absolute;"><font style=" position:relative; bottom:3.25pt;font-size:6.5pt;">(8)</font> </font></td>
            <td style="padding:0pt;padding-left:6.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">3.17</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">2/19/2031</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.3pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.065pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.065pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:7pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:130.11pt;text-align:left;" rowspan="5">
              <div style="white-space:nowrap; line-height:12pt; padding-bottom:0pt;">
                <font style="letter-spacing:0.2pt;">Monica Forbes </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;" rowspan="5">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.3pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:24.75pt; text-align:right; white-space:nowrap;">190,375<font style="position:absolute;"><font style=" position:relative; bottom:3.25pt;font-size:6.5pt;">(9)</font> </font></td>
            <td style="padding:0pt;padding-left:7.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.065pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:24.75pt; text-align:right; white-space:nowrap;">155,156<font style="position:absolute;"><font style=" position:relative; bottom:3.25pt;font-size:6.5pt;">(10)</font> </font></td>
            <td style="padding:0pt;padding-left:6.065pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:15pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">135,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">105,000<font style="position:absolute;"><font style=" position:relative; bottom:3.25pt;font-size:6.5pt;">(4)</font> </font></td>
            <td style="padding:0pt;padding-left:6.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">1.16</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">8/1/2029</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.065pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.065pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:15pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">157,500</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">122,500<font style="position:absolute;"><font style=" position:relative; bottom:3.25pt;font-size:6.5pt;">(5)</font> </font></td>
            <td style="padding:0pt;padding-left:6.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">1.13</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">8/26/2029</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.3pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.065pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.065pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:15pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">201,250</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">258,750<font style="position:absolute;"><font style=" position:relative; bottom:3.25pt;font-size:6.5pt;">(3)</font> </font></td>
            <td style="padding:0pt;padding-left:6.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">0.8911</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">2/13/2030</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.3pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.065pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.065pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:15pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">108,750</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">471,250<font style="position:absolute;"><font style=" position:relative; bottom:3.25pt;font-size:6.5pt;">(8)</font> </font></td>
            <td style="padding:0pt;padding-left:6.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">3.17</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">2/19/2031</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.3pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.065pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.065pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:7pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:130.11pt;text-align:left;" rowspan="8">
              <div style="white-space:nowrap; line-height:12pt; padding-bottom:0pt;">
                <font style="letter-spacing:0.2pt;">Glen MacDonald, Ph.D. </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;" rowspan="8">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.3pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:24.75pt; text-align:right; white-space:nowrap;">183,317<font style="position:absolute;"><font style=" position:relative; bottom:3.25pt;font-size:6.5pt;">(9)</font> </font></td>
            <td style="padding:0pt;padding-left:7.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.065pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:24.75pt; text-align:right; white-space:nowrap;">149,403<font style="position:absolute;"><font style=" position:relative; bottom:3.25pt;font-size:6.5pt;">(10)</font> </font></td>
            <td style="padding:0pt;padding-left:6.065pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:15pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">100,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">3.37</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">9/20/2026</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.3pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.065pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.065pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:15pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">10,896</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">2.28</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">4/3/2027</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.3pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.065pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.065pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:15pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">102,780<font style="position:absolute;"><font style=" position:relative; bottom:3.25pt;font-size:6.5pt;">(6)</font> </font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">1.59</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">10/4/2027</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.3pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.065pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.065pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:15pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">131,250</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">18,750<font style="position:absolute;"><font style=" position:relative; bottom:3.25pt;font-size:6.5pt;">(7)</font> </font></td>
            <td style="padding:0pt;padding-left:6.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">1.50</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">4/9/2028</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.3pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.065pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.065pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:15pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">171,875</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">78,125<font style="position:absolute;"><font style=" position:relative; bottom:3.25pt;font-size:6.5pt;">(2)</font> </font></td>
            <td style="padding:0pt;padding-left:6.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">0.8285</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">2/21/2029</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.3pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.065pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.065pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:15pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">120,313</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">154,687<font style="position:absolute;"><font style=" position:relative; bottom:3.25pt;font-size:6.5pt;">(3)</font> </font></td>
            <td style="padding:0pt;padding-left:6.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">0.8911</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">2/13/2030</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.3pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.065pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.065pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:19pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">56,250</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">243,750<font style="position:absolute;"><font style=" position:relative; bottom:3.25pt;font-size:6.5pt;">(8)</font> </font></td>
            <td style="padding:0pt;padding-left:6.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">3.17</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">2/19/2031</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.3pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.065pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.065pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:12.3pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:7.21pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:7.21pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Option vests over four&#160;years, with 25% of the shares underlying the option vesting on August&#160;7, 2019, the first anniversary of the grant date, and 6.25% of the shares underlying the option vesting quarterly thereafter until the fourth anniversary of the grant date. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(2)</font>
          <br >
        </div>
        <div style=" margin-top:3.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Option vests over four&#160;years, with 6.25% of the shares underlying the option vesting at the end of each successive three-month period beginning on January&#160;1, 2019. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(3)</font>
          <br >
        </div>
        <div style=" margin-top:3.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Option vests over four&#160;years, with 6.25% of the shares underlying the option vesting at the end of each successive three-month period beginning on February&#160;13, 2020. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.11pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(4)</font>
          <br >
        </div>
        <div style=" margin-top:3.11pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Option vests over four&#160;years, with 25% of the shares underlying the option vesting on August&#160;1, 2020, the first anniversary of the grant date, and 6.25% of the shares underlying the option vesting quarterly thereafter until the fourth anniversary of the grant date. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(5)</font>
          <br >
        </div>
        <div style=" margin-top:3.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Option vests over four&#160;years, with 6.25% of the shares underlying the option vesting at the end of each successive three-month period beginning on August&#160;26, 2019. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(6)</font>
          <br >
        </div>
        <div style=" margin-top:3.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">On October&#160;4, 2017, Dr.&#160;MacDonald was granted an option to purchase 120,000 shares of common stock, with the option vesting in installments based on the achievement of certain strategic and clinical milestones. On January&#160;18, 2018, the Sesen Bio compensation committee determined that one of these performance milestones was met, resulting in vesting of the option with respect to 22,980 shares. On March&#160;14, 2018, the Sesen Bio compensation committee determined that one of these performance </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">354</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">milestones was met, resulting in vesting of the option with respect to 30,000 shares. On June&#160;12, 2018, the Sesen Bio compensation committee determined that one of these performance milestones was met, resulting in vesting of the option with respect to 24,900 shares. On July&#160;10, 2019, the Sesen Bio compensation committee determined that one of these performance milestones was met, effective May&#160;4, 2019, resulting in vesting of the option with respect to 24,900 shares. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:4.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(7)</font>
          <br >
        </div>
        <div style=" margin-top:4.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Option vests over four&#160;years, with 6.25% of the shares underlying the option vesting at the end of each successive three-month period beginning on August&#160;9, 2018. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(8)</font>
          <br >
        </div>
        <div style=" margin-top:4.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Option vests over four&#160;years, with 6.25% of the shares underlying the option vesting at the end of each successive three-month period beginning on January&#160;1, 2021. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(9)</font>
          <br >
        </div>
        <div style=" margin-top:4.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Performance-based restricted stock&#160;units granted on October&#160;1, 2021 pursuant to the 2021 retention program. Subject to continued employment, such awards vest on September&#160;30, 2023 upon the determination by the Sesen Bio compensation committee of the level of achievement of certain key milestones consisting of a clinical trial milestone, an employee retention milestone and cash management milestones, as described above under &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Narrative to Summary Compensation Table&#8201;&#8212;&#8201;Equity Awards</font><font style="letter-spacing:0.2pt;">&#8221; above. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(10)</font>
          <br >
        </div>
        <div style=" margin-top:4.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Based on the per share closing market price of the Sesen Bio common stock on December&#160;31, 2021 of $0.815. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Potential Payments to Named Executive Officers Upon Termination or Change in Control Transaction</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Pursuant to their respective employment agreements with Sesen Bio, upon execution and effectiveness of a release of claims, each of Dr.&#160;Cannell, Ms.&#160;Forbes and Dr.&#160;MacDonald will be entitled to severance payments if his or her employment is terminated under specified circumstances. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Dr.&#160;Cannell.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;If Sesen Bio terminates Dr.&#160;Cannell&#8217;s employment without cause, as defined in his employment agreement, or if Dr.&#160;Cannell terminates his employment with Sesen Bio for good reason, as defined in his employment agreement, absent a change in control transaction, as defined in his employment agreement, Sesen Bio is obligated to (i)&#160;pay Dr.&#160;Cannell&#8217;s base salary for a period of 12&#160;months, payable in accordance with Sesen Bio&#8217;s then-current payroll practices, (ii)&#160;pay Dr.&#160;Cannell an amount equal to his target bonus payment for the year in which the termination of employment occurs, prorated for the portion of the year in which he was employed, and (iii)&#160;continue, to the extent allowed by applicable law and the applicable plan documents, to provide Dr.&#160;Cannell and certain of his dependents with group health and dental insurance for a period up to 12&#160;months. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If Sesen Bio terminates Dr.&#160;Cannell&#8217;s employment without cause or if Dr.&#160;Cannell terminates his employment with Sesen Bio for good reason, in each case within 18&#160;months following a change in control transaction, as defined in his employment agreement, Sesen Bio is obligated to (i)&#160;pay Dr.&#160;Cannell an amount equal to his base salary for 24&#160;months, payable in accordance with Sesen Bio&#8217;s then-current payroll practices, (ii)&#160;pay Dr.&#160;Cannell an amount equal to two times his target bonus payment for the year in which the termination of employment occurs, (iii)&#160;accelerate in full the vesting of all of Dr.&#160;Cannell&#8217;s outstanding equity awards, and (iv)&#160;continue, to the extent allowed by applicable law and the applicable plan documents, to provide Dr.&#160;Cannell and certain of his dependents with group health and dental insurance for a period of up to 24&#160;months. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Ms.&#160;Forbes.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;If Sesen Bio terminates Ms.&#160;Forbes&#8217; employment without cause, as defined in her employment agreement, or if Ms.&#160;Forbes terminates her employment with Sesen Bio for good reason, as defined in her employment agreement, absent a change in control transaction, as defined in her employment agreement, Sesen Bio is obligated to (i)&#160;pay Ms.&#160;Forbes&#8217; base salary for a period of 12&#160;months, payable in accordance with Sesen Bio&#8217;s then-current payroll practices, and (ii)&#160;continue, to the extent allowed by applicable law and the applicable plan documents, to provide Ms.&#160;Forbes and certain of her dependents with group health and dental insurance for a period of up to 12&#160;months. In addition, if, prior to September&#160;30, 2023, Sesen Bio terminates Ms.&#160;Forbes&#8217; employment without cause, then each Sesen Bio PSU earned as of the time of such termination of employment based on the achievement of the applicable performance milestone, as determined by the Sesen Bio compensation committee in its sole discretion, will become vested as of the date of such termination of employment. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">355</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If Sesen Bio terminates Ms.&#160;Forbes employment without cause or if Ms.&#160;Forbes terminates her employment with Sesen Bio for good reason, in each case within 12&#160;months following a change in control transaction, as defined in her employment agreement, Sesen Bio is obligated to (i)&#160;pay Ms.&#160;Forbes&#8217; base salary for a period of 12&#160;months, payable in accordance with Sesen Bio&#8217;s then-current payroll practices, (ii)&#160;continue, to the extent allowed by applicable law and the applicable plan documents, to provide Ms.&#160;Forbes and certain of her dependents with group health and dental insurance for a period of 12&#160;months, and (iii)&#160;accelerate in full the vesting of all of Ms.&#160;Forbes&#8217; outstanding equity awards. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Dr.&#160;MacDonald.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;If Sesen Bio terminates Dr.&#160;MacDonald&#8217;s employment without cause, as defined in his employment agreement, or if Dr.&#160;MacDonald terminates his employment with Sesen Bio for good reason, as defined in his employment agreement, absent a change in control transaction, as defined in his employment agreement, Sesen Bio is obligated to (i)&#160;pay Dr.&#160;MacDonald&#8217;s base salary for a period of 12&#160;months, payable in accordance with Sesen Bio&#8217;s then-current payroll practices and (ii)&#160;continue, to the extent allowed by applicable law and the applicable plan documents, to provide Dr.&#160;MacDonald and certain of his dependents with group health and dental insurance for a period of up to 12&#160;months. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If Sesen Bio terminates Dr.&#160;MacDonald&#8217;s employment without cause or if Dr.&#160;MacDonald terminates his employment with Sesen Bio for good reason, in each case within 12&#160;months following a change in control transaction, as defined in his employment agreement, Sesen Bio is obligated to: (i)&#160;pay Dr.&#160;MacDonald&#8217;s base salary for a period of 12&#160;months, payable in accordance with Sesen Bio&#8217;s then-current payroll practices, (ii)&#160;continue, to the extent allowed by applicable law and the applicable plan documents, to provide Dr.&#160;MacDonald and certain of his dependents with group health and dental insurance for a period of 12&#160;months, and (iii)&#160;accelerate in full the vesting of all of Dr.&#160;MacDonald&#8217;s outstanding equity awards. In addition, if, prior to September&#160;30, 2023, Sesen Bio terminates Dr.&#160;MacDonald&#8217;s employment without cause, then each Sesen Bio PSU earned as of the time of such termination of employment based on the achievement of the applicable performance milestone, as determined by the Sesen Bio compensation committee in its sole discretion, will become vested as of the date of such termination of employment. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio&#8217;s obligation to pay the severance payments to Dr.&#160;Cannell, Ms.&#160;Forbes and Dr.&#160;MacDonald pursuant to their respective employment agreements, as described above, is contingent upon the executive&#8217;s execution and non-revocation of a release of claims in favor of Sesen Bio. In addition, Sesen Bio&#8217;s obligation to pay such severance payments is subject to such executive officer&#8217;s compliance with certain restrictive covenants, including non-competition and non-solicitation (of employees and customers) covenants, which run for one year following the executive&#8217;s termination of employment. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Taxation.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;To the extent that any severance or other compensation payment to Dr.&#160;Cannell or Ms.&#160;Forbes pursuant to his or her employment agreement or any other agreement constitutes an &#8220;excess parachute payment&#8221; within the meaning of Sections&#160;280G and 4999 of the Code, then he or she will receive the full amount of such severance and other payments, or a reduced amount intended to avoid the application of Sections&#160;280G and 4999 of the Code, whichever provides the executive with the highest amount on an after-tax basis. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">401(k) Plan</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio maintains a defined contribution 401(k) retirement plan for its employees in which substantially all of Sesen Bio&#8217;s full-time U.S. employees are eligible to participate, including its executive officers. Participants may contribute a&#160;percentage of their annual compensation to this plan, subject to statutory limitations. Sesen Bio made matching contributions of $64,153 to the plan for the year ended December&#160;31, 2021. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Limitation of Liability and Indemnification</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio&#8217;s Certificate of Incorporation limits the personal liability of directors for breach of fiduciary duty to the maximum extent permitted by the DGCL and provides that no director will have personal liability to Sesen Bio or to Sesen Bio stockholders for monetary damages for breach of fiduciary duty as a director. However, these provisions do not eliminate or limit the liability of any of Sesen Bio&#8217;s directors: </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">356</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tDIRC">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">for any breach of the director&#8217;s duty of loyalty to Sesen Bio or Sesen Bio stockholders; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:3.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:3.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">for acts or omissions not in good faith or that involve intentional misconduct or a knowing violation of law; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:3.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:3.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">for voting for or assenting to unlawful payments of dividends, stock repurchases or other distributions; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:3.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:3.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">for any transaction from which the director derived an improper personal benefit. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:7.12pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Any amendment to or repeal of these provisions will not eliminate or reduce the effect of these provisions in respect of any act, omission or claim that occurred or arose prior to such amendment or repeal. If the DGCL is amended to provide for further limitations on the personal liability of directors of corporations, then the personal liability of the Sesen Bio directors will be further limited to the greatest extent permitted by the DGCL. </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.61pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, the Sesen Bio Certificate of Incorporation provides that Sesen Bio must indemnify its directors and officers and Sesen Bio must advance expenses, including attorneys&#8217; fees, to its directors and officers in connection with legal proceedings, subject to very limited exceptions. </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.61pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio maintains a general liability insurance policy that covers specified liabilities of its directors and officers arising out of claims based on acts or omissions in their capacities as directors or officers. In addition, Sesen Bio has entered into indemnification agreements with all of its directors and executive officers. These indemnification agreements may require Sesen Bio, among other things, to indemnify each such director and executive officer for some expenses, including attorneys&#8217; fees, judgments, fines and settlement amounts incurred by him or her in any action or proceeding arising out of his or her service as one of its directors or executive officers. </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.52pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Some of Sesen Bio&#8217;s non-employee directors may, through their relationships with their employers, be insured or indemnified against specified liabilities incurred in their capacities as members of the Sesen Bio board of directors. </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.52pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, executive officers or persons controlling Sesen Bio, in the opinion of the SEC, such indemnification is against public policy as expressed in the Securities Act and is therefore unenforceable. </font>
        </div>
        <div style="margin-top:10.52pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Director Compensation</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.12pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio&#8217;s non-employee directors are compensated for their services on the Sesen Bio board of directors as follows: </font>
        </div>
        <table style="width:456pt;height:244pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:314.75pt;">
              <font style="letter-spacing:-0.2pt;">Compensation</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0.5pt 0.5pt 0pt; width:129.25pt;text-align:right;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:314.75pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Annual Board Cash Retainer </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0.5pt 0.5pt 0pt; width:129.25pt;text-align:right;">
              <div style="text-align:right;">
                <font style="letter-spacing:0.2pt;">$40,000</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:314.75pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Additional Retainer for Non-Executive Chair of the Board </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0.5pt 0.5pt 0pt; width:129.25pt;text-align:right;">
              <div style="text-align:right;">
                <font style="letter-spacing:0.2pt;">$30,000</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:314.75pt;">
              <font style="letter-spacing:0.2pt;">Additional Retainers for Committee Chairs </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0.5pt 0.5pt 0pt; width:129.25pt;text-align:right;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:normal;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:4pt 0pt 0.5pt 0pt; width:314.75pt;">
              <div style=" float:left; margin-left:10pt; line-height:10pt; text-align:left; width:10pt;white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">&#8226;</font>
                <br >
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Audit </font>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:4pt 0.5pt 0.5pt 0pt; width:129.25pt;white-space:nowrap;text-align:right;">
              <div style="text-align:right;">
                <font style="letter-spacing:0.2pt;">$15,000</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:normal;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:4pt 0pt 0.5pt 0pt; width:314.75pt;">
              <div style=" float:left; margin-left:10pt; line-height:10pt; text-align:left; width:10pt;white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">&#8226;</font>
                <br >
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Compensation </font>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:4pt 0.5pt 0.5pt 0pt; width:129.25pt;white-space:nowrap;text-align:right;">
              <div style="text-align:right;">
                <font style="letter-spacing:0.2pt;">$10,000</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:normal;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:4pt 0pt 0.5pt 0pt; width:314.75pt;">
              <div style=" float:left; margin-left:10pt; line-height:10pt; text-align:left; width:10pt;white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">&#8226;</font>
                <br >
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Nominating and Corporate Governance </font>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:4pt 0.5pt 0.5pt 0pt; width:129.25pt;white-space:nowrap;text-align:right;">
              <div style="text-align:right;">
                <font style="letter-spacing:0.2pt;">$8,000</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:normal;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:4pt 0pt 0.5pt 0pt; width:314.75pt;">
              <div style=" float:left; margin-left:10pt; line-height:10pt; text-align:left; width:10pt;white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">&#8226;</font>
                <br >
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Science </font>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:4pt 0.5pt 0.5pt 0pt; width:129.25pt;white-space:nowrap;text-align:right;">
              <div style="text-align:right;">
                <font style="letter-spacing:0.2pt;">$10,000</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:314.75pt;">
              <font style="letter-spacing:0.2pt;">Additional Retainers for Committee Members </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0.5pt 0.5pt 0pt; width:129.25pt;text-align:right;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:normal;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:4pt 0pt 0.5pt 0pt; width:314.75pt;">
              <div style=" float:left; margin-left:10pt; line-height:10pt; text-align:left; width:10pt;white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">&#8226;</font>
                <br >
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Audit </font>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:4pt 0.5pt 0.5pt 0pt; width:129.25pt;white-space:nowrap;text-align:right;">
              <div style="text-align:right;">
                <font style="letter-spacing:0.2pt;">$7,500</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:normal;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:4pt 0pt 0.5pt 0pt; width:314.75pt;">
              <div style=" float:left; margin-left:10pt; line-height:10pt; text-align:left; width:10pt;white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">&#8226;</font>
                <br >
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Compensation </font>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:4pt 0.5pt 0.5pt 0pt; width:129.25pt;white-space:nowrap;text-align:right;">
              <div style="text-align:right;">
                <font style="letter-spacing:0.2pt;">$5,000</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:normal;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:4pt 0pt 0.5pt 0pt; width:314.75pt;">
              <div style=" float:left; margin-left:10pt; line-height:10pt; text-align:left; width:10pt;white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">&#8226;</font>
                <br >
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Nominating and Corporate Governance </font>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:4pt 0.5pt 0.5pt 0pt; width:129.25pt;white-space:nowrap;text-align:right;">
              <div style="text-align:right;">
                <font style="letter-spacing:0.2pt;">$4,000</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:normal;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:4pt 0pt 0.5pt 0pt; width:314.75pt;">
              <div style=" float:left; margin-left:10pt; line-height:10pt; text-align:left; width:10pt;white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">&#8226;</font>
                <br >
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Science </font>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:4pt 0.5pt 0.5pt 0pt; width:129.25pt;white-space:nowrap;text-align:right;">
              <div style="text-align:right;">
                <font style="letter-spacing:0.2pt;">$5,000</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:314.75pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Annual Equity Award (non-employee directors) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0.5pt 0.5pt 0pt; width:129.25pt;text-align:right;">
              <div style="margin-left:10pt; text-indent:-10pt; text-align:right;">
                <font style="letter-spacing:0.2pt;">65,000 Sesen Bio options and </font>
                <br >
                <font style="letter-spacing:0.2pt;">40,000 Sesen Bio RSUs</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:314.75pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Initial Equity Award (non-employee directors) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0.5pt 0.5pt 0pt; width:129.25pt;text-align:right;">
              <div style="margin-left:10pt; text-indent:-10pt; text-align:right;">
                <font style="letter-spacing:0.2pt;">130,000 Sesen Bio options and </font>
                <br >
                <font style="letter-spacing:0.2pt;">80,000 Sesen Bio RSUs</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">357</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Sesen Bio compensation committee engages Radford, its independent compensation consultant, to provide advice on the competitiveness of Sesen Bio&#8217;s non-employee director compensation program and ensure that both cash and equity components of Sesen Bio&#8217;s non-employee director compensation program remain market competitive. In February&#160;2022, the Sesen Bio compensation committee and Sesen Bio board of directors, based on a market analysis prepared by Radford, approved annual board, chair and committee cash retainers, as well as a combination of options and Sesen Bio RSUs for both the initial and annual equity awards to non-employee directors. In its approvals, the Sesen Bio compensation committee and the Sesen Bio board of directors considered the time commitment and responsibilities of Sesen Bio&#8217;s directors as well as the size of the Sesen Bio board of directors. Consistent with the prior year, cash compensation aligns with the 50th&#160;percentile of the Radford market analysis and equity compensation aligns with the 75th&#160;percentile of the Radford market analysis. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Sesen Bio options granted to Sesen Bio&#8217;s non-employee directors will have an exercise price equal to the fair market value of the Sesen Bio common stock on the date of grant and will expire ten&#160;years after the date of grant. The initial stock options granted to Sesen Bio&#8217;s non-employee directors will, subject to the director&#8217;s continued service on the Sesen Bio board of directors, vest monthly in equal amounts over a three-year period following the grant date. The annual stock options granted to Sesen Bio&#8217;s non-employee directors will, subject to the director&#8217;s continued service on Sesen Bio board of directors, vest monthly in equal amounts over a one-year period following the grant date. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The initial restricted stock&#160;units granted to Sesen Bio&#8217;s non-employee directors will vest annually in equal amounts over a three-year period following the grant date. The annual restricted stock&#160;units granted to Sesen Bio&#8217;s non-employee directors will vest on the first anniversary of the grant date. Each restricted stock unit represents a contingent right to receive one share of Sesen Bio&#8217;s common stock and is subject to continued service with Sesen Bio on the applicable vesting date. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Each annual cash fee will be payable in arrears in four equal quarterly installments on the last day of each quarter, provided that the amount of each payment will be prorated for any portion of a quarter that a director is not serving on the Sesen Bio board of directors. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Each member of the Sesen Bio board of directors will also be entitled to reimbursement for reasonable travel and other expenses incurred in connection with attending meetings of the Sesen Bio board of directors and any committee on which he or she serves. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The table below shows all compensation to Sesen Bio&#8217;s non-employee directors during 2021. </font>
        </div>
        <table style="width:416pt;height:116.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:260.93pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Name </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Fees Earned or</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Paid in Cash ($) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Option</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Awards</font>
                <br >
                <font style="letter-spacing:-0.16pt;">($)</font><font style=" position:relative; bottom:3.25pt;line-height:5pt;font-size:5pt;letter-spacing:-0.12pt;">(1)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Total ($) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:260.93pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Jay S. Duker, M.D. </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.975pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">86,288</td>
            <td style="padding:0pt;padding-left:12.975pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">164,994</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">251,282</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:260.93pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Jane V. Henderson</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(2)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.975pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">56,435</td>
            <td style="padding:0pt;padding-left:12.975pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">164,994</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">221,429</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:260.93pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Jason A. Keyes </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.975pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">54,015</td>
            <td style="padding:0pt;padding-left:12.975pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">164,994</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">219,009</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:260.93pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Carrie L. Bourdow </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.975pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">50,916</td>
            <td style="padding:0pt;padding-left:12.975pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">164,994</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">215,910</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:260.93pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Peter K Honig, M.D.</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(3)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.975pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">21,298</td>
            <td style="padding:0pt;padding-left:12.975pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">449,516</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">470,814</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:260.93pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Michael A.S. Jewett, M.D.</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(4)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.975pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">20,258</td>
            <td style="padding:0pt;padding-left:12.975pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">449,516</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">469,774</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:12.5pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Immediately following the annual meeting of stockholders held on May&#160;3, 2021, Dr.&#160;Duker, Ms.&#160;Henderson, Mr.&#160;Keyes and Ms.&#160;Bourdow each received an option to purchase 92,500 shares of Sesen Bio common stock at an exercise price of $2.79 per share. These stock options vest over twelve&#160;months, with 1/12th of the shares underlying the option vesting at the end of each one-month period following May&#160;3, 2021. In connection with their appointment to the Sesen Bio board of directors, on July&#160;20, 2021, Dr.&#160;Honig and Dr.&#160;Jewett each received an option to purchase 185,000 shares of Sesen Bio common stock at an exercise price of $3.86 per share. These stock options vest monthly in equal amounts over a three-year period following the July&#160;20, 2021 grant date. The amounts reported in the &#8220;Option Awards&#8221; column reflect the aggregate grant date fair value of stock-based compensation awarded during the year computed in accordance with the provisions of Financial Accounting Standards </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">358</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:310.5pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Board ASC Topic 718. See Note 14 to Sesen Bio&#8217;s financial statements appearing at the end of Sesen Bio&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2021 regarding assumptions underlying the valuation of equity awards. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(2)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Ms.&#160;Henderson resigned from the Sesen Bio board of directors effective on November&#160;22, 2021. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(3)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Dr.&#160;Honig was appointed to the Sesen Bio board of directors on July&#160;20, 2021. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(4)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Dr.&#160;Jewett was appointed to the Sesen Bio board of directors on July&#160;20, 2021. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">During 2021, Sesen Bio did not provide any additional compensation to Dr.&#160;Cannell, its President and Chief Executive Officer, for his service as a director. Dr.&#160;Cannell&#8217;s compensation as a named executive officer is set forth above under &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Executive Compensation&#8201;&#8212;&#8201;Summary Compensation Table</font><font style="letter-spacing:0.2pt;">&#8221; above. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The table below shows all stock options held by each of Sesen Bio&#8217;s non-employee directors as of December&#160;31, 2021. </font>
        </div>
        <table style="width:416pt;height:116.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:356.1pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Name </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;text-align:center;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Stock Options</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Outstanding</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(#) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:356.1pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Jay S. Duker, M.D. </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.595pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">288,787</td>
            <td style="padding:0pt;padding-left:7.595pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:356.1pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Jane V. Henderson</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(1)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.595pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">309,849</td>
            <td style="padding:0pt;padding-left:7.595pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:356.1pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Peter K Honig, M.D. </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.595pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">185,000</td>
            <td style="padding:0pt;padding-left:7.595pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:356.1pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Michael A.S. Jewett, M.D. </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.595pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">185,000</td>
            <td style="padding:0pt;padding-left:7.595pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:356.1pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Jason A. Keyes </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.595pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">269,500</td>
            <td style="padding:0pt;padding-left:7.595pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:356.1pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Carrie L. Bourdow </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.595pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">269,500</td>
            <td style="padding:0pt;padding-left:7.595pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:12.5pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Ms.&#160;Henderson resigned from the Sesen Bio board of directors effective on November&#160;22, 2021.</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">359</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tCEC">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CARISMA EXECUTIVE COMPENSATION</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">This section describes the material elements of compensation awarded to, earned by or paid to each of Carisma&#8217;s named executive officers in 2021. Carisma&#8217;s &#8220;named executive officers&#8221; for 2021 are (i)&#160;Steven Kelly, Carisma&#8217;s President and Chief Executive Officer, (ii)&#160;Richard Morris, Carisma&#8217;s Chief Financial Officer, and (iii)&#160;Michael Klichinsky, Carisma&#8217;s Chief Scientific Officer. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Summary Compensation Table</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following table sets forth information regarding compensation awarded to, earned by, or paid to each of Carisma&#8217;s named executive officers for the&#160;years ended December&#160;31, 2021 and 2020. </font>
        </div>
        <table style="width:456pt;height:107.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:237.46pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Name and Principal Position </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Year </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Salary</font>
                <br >
                <font style="letter-spacing:-0.16pt;">($) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Bonus</font>
                <br >
                <font style="letter-spacing:-0.16pt;">($) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Option</font>
                <br >
                <font style="letter-spacing:-0.16pt;">awards</font><font style=" position:relative; bottom:3.25pt;line-height:5pt;font-size:5pt;letter-spacing:-0.12pt;">(1)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Total </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:7.25pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:237.46pt;text-align:left;" rowspan="2">
              <div style="margin-left:10pt; text-indent:-10pt; text-align:justify; line-height:12pt; padding-bottom:0pt;">
                <font style="letter-spacing:0.2pt;">Steven Kelly</font>
                <br >
                <font style="font-style:italic;letter-spacing:0.2pt;">President &amp; Chief Executive Officer</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;" rowspan="2">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; line-height:12pt; min-width:15pt; text-align:right; white-space:nowrap;">2021</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; line-height:12pt; min-width:24.75pt; text-align:right; white-space:nowrap;">416,148</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; line-height:12pt; min-width:24.75pt; text-align:right; white-space:nowrap;">158,080</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; line-height:12pt; min-width:24.75pt; text-align:right; white-space:nowrap;">482,883</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; line-height:12pt; min-width:30.75pt; text-align:right; white-space:nowrap;">1,057,111</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:15pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">2020</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">400,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">144,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">544,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:7pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:237.46pt;text-align:left;" rowspan="2">
              <div style="margin-left:10pt; text-indent:-10pt; text-align:justify; line-height:12pt; padding-bottom:0pt;">
                <font style="letter-spacing:0.2pt;">Richard Morris</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">&#65279;(2)</font>
                <br >
                <font style="font-style:italic;letter-spacing:0.2pt;">Chief Financial Officer</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;" rowspan="2">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:15pt; text-align:right; white-space:nowrap;">2021</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:24.75pt; text-align:right; white-space:nowrap;">227,500</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:24.75pt; text-align:right; white-space:nowrap;">73,255</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:24.75pt; text-align:right; white-space:nowrap;">606,630</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:30.75pt; text-align:right; white-space:nowrap;">907,385</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:15pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">2020</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:7pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:237.46pt;text-align:left;" rowspan="2">
              <div style="margin-left:10pt; text-indent:-10pt; text-align:justify; line-height:12pt; padding-bottom:0pt;">
                <font style="letter-spacing:0.2pt;">Michael Klichinsky, Pharm.D., Ph.D.</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">&#65279;(3)</font>
                <br >
                <font style="font-style:italic;letter-spacing:0.2pt;">Chief Scientific Officer</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;" rowspan="2">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:15pt; text-align:right; white-space:nowrap;">2021</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:24.75pt; text-align:right; white-space:nowrap;">300,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:24.75pt; text-align:right; white-space:nowrap;">87,750</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:24.75pt; text-align:right; white-space:nowrap;">163,430</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:30.75pt; text-align:right; white-space:nowrap;">551,180</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:19pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">2020</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">245,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">71,663</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">316,663</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:12.7pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:8.99pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:8.99pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">The amounts reported in the &#8220;Option awards&#8221; column reflect the grant date fair value of Carisma options awarded during the year computed in accordance with the provisions of Financial Accounting Standard Board, or FASB, Accounting Standards Codification, or ASC, Topic 718. See Note 3 to Carisma&#8217;s consolidated financial statements appearing at the end of this proxy/statement prospectus regarding assumptions underlying the valuation of option awards. These amounts reflect the accounting cost for these stock options and do not reflect the actual economic value that may be realized by the named executive officer upon the vesting of the stock options, the exercise of the stock options or the sale of the common stock underlying such stock options. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:5pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(2)</font>
          <br >
        </div>
        <div style=" margin-top:5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Mr.&#160;Morris was appointed as Carisma&#8217;s Chief Financial Officer on June&#160;1, 2021. His annual base salary for 2021 was $390,000. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4.99pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(3)</font>
          <br >
        </div>
        <div style=" margin-top:4.99pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Dr.&#160;Klichinsky was appointed as Carisma&#8217;s Chief Scientific Officer in April, 2022. Prior to that, he served as Senior Vice President of Research for Carisma. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Narrative Disclosure to Summary Compensation Table</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Base Compensation</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma uses base compensation or salaries to recognize the experience, skills, knowledge and responsibilities required of its executive officers. None of the Carisma named executive officers is currently party to an employment agreement or other agreement or arrangement that provides for automatic or scheduled increases in base compensation or salary. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">For the year ended December&#160;31, 2021, the annual base salaries for Mr.&#160;Kelly, Mr.&#160;Morris and Dr.&#160;Klichinsky were $416,000, $390,000 and $300,000, respectively. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Bonus Compensation</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Carisma board of directors may, in its discretion, award bonuses to the Carisma named executive officers from time to time. The Carisma named executive officers are eligible for annual performance-based bonuses up to a specified&#160;percentage of their base compensation or salary, subject to approval by the Carisma board of directors. Performance-based bonuses, which are calculated as a&#160;percentage of base compensation or salary, are designed to motivate Carisma&#8217;s executive officers to achieve annual goals based on Carisma&#8217;s strategic, financial and operating performance objectives. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">360</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">With respect to 2021 performance, the Carisma board of directors awarded performance-based bonuses of $158,080, $73,255 and $87,750, respectively, to Mr.&#160;Kelly, Mr.&#160;Morris and Dr.&#160;Klichinsky. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Equity Incentives</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Although Carisma does not have a formal policy with respect to the grant of equity incentive awards to its executive officers, or any formal equity ownership guidelines applicable to them, Carisma believes that equity grants provide its executives with a strong link to Carisma&#8217;s long-term performance, create an ownership culture and help to align the interests of Carisma executive officers and Carisma stockholders. Accordingly, Carisma uses stock options to compensate its executive officers in the form of initial grants in connection with the commencement of employment and also at various other times, if Carisma or they have performed as expected or better than expected. In addition, Carisma believes that equity grants with a time-based vesting feature promote executive retention because this feature incentivizes its executive officers to remain in Carisma&#8217;s employment during the vesting period. The option awards that Carisma has granted to its executive officers typically become exercisable as to 25% of the shares underlying the option on the first anniversary of the vesting commencement date and as to an additional 2.0833% of the original number of shares underlying the option monthly thereafter. Vesting rights cease upon termination of employment and exercise rights for previously vested stock options cease shortly after termination, though exercisability is extended in the case of death or disability. </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Carisma executive officers are eligible to participate in the Carisma Plan. All Carisma options have been granted pursuant to the Carisma Plan. For a description of the Carisma Plan, see the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">&#8212;&#8201;2017 Stock Incentive Plan</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tSTOIP">363</a> of this proxy statement/prospectus. </font>
          </div>

        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">None of the Carisma executive officers is currently party to an employment agreement that provides for the automatic award of stock options. Carisma granted stock option awards to each of the Carisma named executive officers during the year ended December&#160;31, 2021, as described in more detail in the &#8220;Outstanding Equity Awards at December&#160;31, 2021&#8221; table below. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Prior to the exercise of an option, the holder has no rights as a stockholder with respect to the shares subject to such option, including no voting rights and no right to receive dividends or dividend equivalents. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma has historically granted stock options with exercise prices that are equal to the fair market value of Carisma common stock on the date of grant as determined by the Carisma board of directors, based on a number of objective and subjective factors. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Outstanding Equity Awards at December&#160;31, 2021</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following table sets forth information regarding all outstanding equity awards held by each of Carisma&#8217;s named executive officers as of December&#160;31, 2021. </font>
        </div>
        <table style="width:456pt;height:163pt;margin-top:4pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:144.47pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="19">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Option Awards </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt; width:144.47pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Name </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Number of securities</font>
                <br >
                <font style="letter-spacing:-0.16pt;">underlying</font>
                <br >
                <font style="letter-spacing:-0.16pt;">unexercised options (#)</font>
                <br >
                <font style="letter-spacing:-0.16pt;">exercisable </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Number of securities</font>
                <br >
                <font style="letter-spacing:-0.16pt;">underlying</font>
                <br >
                <font style="letter-spacing:-0.16pt;">unexercised options (#)</font>
                <br >
                <font style="letter-spacing:-0.16pt;">unexercisable </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Option exercise</font>
                <br >
                <font style="letter-spacing:-0.16pt;">price ($) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt; width:58.95pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Option expiration</font>
                <br >
                <font style="letter-spacing:-0.16pt;">date </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:144.47pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Steven Kelly </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.935pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">315,743</td>
            <td style="padding:0pt;padding-left:21.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.935pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">13,728<font style="position:absolute;"><font style=" position:relative; bottom:3.25pt;font-size:6.5pt;">(1)</font> </font></td>
            <td style="padding:0pt;padding-left:21.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.855pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">1.18</td>
            <td style="padding:0pt;padding-left:16.855pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:58.95pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">9/18/2028 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:144.47pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.935pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:21.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.935pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">219,000<font style="position:absolute;"><font style=" position:relative; bottom:3.25pt;font-size:6.5pt;">(2)</font> </font></td>
            <td style="padding:0pt;padding-left:21.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.855pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">2.77</td>
            <td style="padding:0pt;padding-left:16.855pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:58.95pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">3/31/2031 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:9.5pt 0pt 1.5pt 0pt; width:144.47pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Richard Morris </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.935pt;width:0pt;">&#8203;</td>
            <td style="padding:9.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:9.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:21.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.935pt;width:0pt;">&#8203;</td>
            <td style="padding:9.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:9.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">174,326<font style="position:absolute;"><font style=" position:relative; bottom:3.25pt;font-size:6.5pt;">(3)</font> </font></td>
            <td style="padding:0pt;padding-left:21.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.855pt;width:0pt;">&#8203;</td>
            <td style="padding:9.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:9.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">2.77</td>
            <td style="padding:0pt;padding-left:16.855pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:9.5pt 0pt 1.5pt 0pt; width:58.95pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">5/31/2031 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:8.167pt 0pt 0.833pt 0pt; width:144.47pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Michael Klichinsky, Pharm.D., Ph.D. </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.935pt;width:0pt;">&#8203;</td>
            <td style="padding:8.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:8.167pt 0pt 0.833pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">30,000</td>
            <td style="padding:0pt;padding-left:21.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.935pt;width:0pt;">&#8203;</td>
            <td style="padding:8.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:8.167pt 0pt 0.833pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;<font style="position:absolute;"><font style=" position:relative; bottom:3.25pt;font-size:6.5pt;">(4)</font> </font></td>
            <td style="padding:0pt;padding-left:21.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.855pt;width:0pt;">&#8203;</td>
            <td style="padding:8.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:8.167pt 0pt 0.833pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">0.19</td>
            <td style="padding:0pt;padding-left:16.855pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:8.167pt 0pt 0.833pt 0pt; width:58.95pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">11/01/2027 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:144.47pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.935pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">31,666</td>
            <td style="padding:0pt;padding-left:21.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.935pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">8,334<font style="position:absolute;"><font style=" position:relative; bottom:3.25pt;font-size:6.5pt;">(5)</font> </font></td>
            <td style="padding:0pt;padding-left:21.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.855pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">1.18</td>
            <td style="padding:0pt;padding-left:16.855pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:58.95pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">10/21/2028 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:144.47pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.935pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:21.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.935pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">59,000<font style="position:absolute;"><font style=" position:relative; bottom:3.25pt;font-size:6.5pt;">(6)</font> </font></td>
            <td style="padding:0pt;padding-left:21.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.855pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">2.77</td>
            <td style="padding:0pt;padding-left:16.855pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:58.95pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">3/31/2031</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:12.3pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:7.5pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:7.5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">This Carisma option vests over four&#160;years, with 25% of the shares vested on February&#160;12, 2019 and 2.0833% of the original number of shares vested thereafter in equal monthly installments through February&#160;12, 2022, subject to continued service. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">361</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; line-height:12pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(2)</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">This Carisma option vests over four&#160;years, with 25% of the shares vested on April 1, 2022 and 2.0833% of the original number of shares vested thereafter in equal monthly installments through April 1, 2025, subject to continued service. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.71pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(3)</font>
          <br >
        </div>
        <div style=" margin-top:3.71pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">This Carisma option vests over four&#160;years, with 25% of the shares vested on June&#160;1, 2022 and 2.0833% of the original number of shares vesting thereafter in equal monthly installments through June&#160;1, 2025, subject to continued service. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(4)</font>
          <br >
        </div>
        <div style=" margin-top:3.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">This Carisma option is fully vested. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(5)</font>
          <br >
        </div>
        <div style=" margin-top:3.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">This Carisma option vests over four&#160;years, with 25% of the shares vested on October&#160;22, 2019 and 2.0833% of the original number of shares vesting thereafter in equal monthly installments through October&#160;22, 2022, subject to continued service. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(6)</font>
          <br >
        </div>
        <div style=" margin-top:3.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">This Carisma option vests over four&#160;years, with 25% of the shares vested on April 1, 2022 and 2.0833% of the original number of shares vested thereafter in equal monthly installments through April 1, 2025, subject to continued service. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Employment Agreements with Named Executive Officers</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Carisma has entered into written employment agreements with each of its executive officers. These agreements set forth the terms of the executive officer&#8217;s compensation, including base salary, annual discretionary bonus eligibility and severance benefits, among other matters. The employment agreements with the Carisma named executive officers are summarized below. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Agreement with Steven Kelly</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On February&#160;12, 2018, Carisma entered into an offer letter, or the Kelly Agreement, with Mr.&#160;Kelly in connection with his employment as Carisma&#8217;s President and Chief Executive Officer. Under the Kelly Agreement, Mr.&#160;Kelly is an at-will employee and his employment with Carisma can be terminated by Mr.&#160;Kelly or Carisma at any time and for any reason. Pursuant to the Kelly Agreement, Mr.&#160;Kelly&#8217;s annualized base salary may be adjusted from time to time in accordance with normal business practice and in the sole discretion of Carisma. He is eligible to receive an annual performance bonus of up to a specified&#160;percentage of his base salary for the applicable calendar year. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Under the Kelly Agreement, in the event of the termination of Mr.&#160;Kelly&#8217;s employment by Carisma without cause or by him for good reason, Mr.&#160;Kelly is entitled, subject to his execution of and compliance with a separation and release of claims agreement in Carisma&#8217;s favor and his continued compliance with certain restrictive covenants, to (i)&#160;continued payment of his base salary for a period of 12&#160;months following the date his release of claims becomes effective and (ii)&#160;payment of a pro-rated portion of his annual target discretionary bonus. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">After the date of the Kelly Agreement, the Carisma board of directors approved increases to Mr.&#160;Kelly&#8217;s annualized base salary to $400,000 for 2020 and $416,000 for 2021. The Carisma board of directors has authorized an annual performance bonus&#160;percentage of 40% for Mr.&#160;Kelly. In 2022, the Carisma board of directors authorized an increase in Mr.&#160;Kelly&#8217;s annualized base salary to $440,000. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Agreement with Richard Morris</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On March&#160;15, 2021, Carisma entered into an offer letter, or the Morris Agreement, with Mr.&#160;Morris in connection with his employment as Carisma&#8217;s Chief Financial Officer. Under the Morris Agreement, Mr.&#160;Morris is an at-will employee, and his employment with Carisma can be terminated by Mr.&#160;Morris or Carisma at any time and for any reason. Pursuant to the Morris Agreement, Mr.&#160;Morris&#8217;s annualized base salary may be adjusted from time to time in accordance with normal business practice and in the sole discretion of Carisma. He is eligible to receive an annual performance bonus of up to a specified&#160;percentage of his base salary for the applicable calendar year. The Morris Agreement also provided for an initial grant of options to purchase 174,326 shares of Carisma common stock, subject to the approval of the Carisma board of directors, or the Morris Grant. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Under the Morris Agreement, in the event of the termination of Mr.&#160;Morris&#8217; employment by Carisma without cause or by him for good reason, Mr.&#160;Morris is entitled, subject to his execution of and compliance </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">362</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tSTOIP">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">with a separation and release of claims agreement in Carisma&#8217;s favor and his continued compliance with certain restrictive covenants, to (i)&#160;continued payment of his base salary for a period of 12&#160;months following the date his release of claims becomes effective and (ii)&#160;payment of a pro-rated portion of his annual target discretionary bonus. In addition, in the event that Mr.&#160;Morris&#8217; employment is terminated by Carisma without cause or by Mr.&#160;Morris for good reason, within 12&#160;months following a change in control event (as defined in the Carisma Plan), then 100% of the unvested portion of the Morris Grant shall be accelerated and immediately vest and become exercisable. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In connection with the Morris Agreement, the Carisma board of directors approved an annualized base salary of $390,000 for 2021 and an annual performance bonus&#160;percentage of 35% for Mr.&#160;Morris. In 2022, the Carisma board of directors authorized an increase in Mr.&#160;Morris&#8217; annualized base salary to $400,000. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Agreement with Michael Klichinsky</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On October&#160;18, 2018, Carisma entered into an offer letter, or the Klichinsky Agreement, with Dr.&#160;Klichinsky in connection with his employment as Carisma&#8217;s Vice President of Discovery Research. Under the Klichinsky Agreement, Dr.&#160;Klichinsky is an at-will employee, and his employment with Carisma can be terminated by Dr.&#160;Klichinsky or Carisma at any time and for any reason. Pursuant to the Klichinsky Agreement, Dr.&#160;Klichinsky&#8217;s annualized base salary may be adjusted from time to time in accordance with normal business practice and in the sole discretion of Carisma. He is eligible to receive an annual performance bonus of up to a specified&#160;percentage of his base salary for the applicable calendar year. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Under the Klichinsky Agreement, in the event of the termination of Dr.&#160;Klichinsky&#8217;s employment by Carisma without cause or by him for good reason, Dr.&#160;Klichinsky is entitled, subject to his execution of and compliance with a separation and release of claims agreement in Carisma&#8217;s favor and his continued compliance with certain restrictive covenants, to (i)&#160;continued payment of his base salary for a period of 12&#160;months following the date his release of claims becomes effective and (ii)&#160;payment of a pro-rated portion of his annual target discretionary bonus. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">After the date of the Klichinsky Agreement, the Carisma board of directors approved increases to Dr.&#160;Klichinsky&#8217;s annualized base salary to $245,000 for 2020 and $300,000 for 2021. In 2022, Dr.&#160;Klichinsky was promoted to Chief Scientific Officer of Carisma, and the Carisma board of directors authorized an increase in his annualized base salary to $340,000 and an increase of his annual performance bonus&#160;percentage to 35%. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Employee Invention, Non-Disclosure, Non-Competition and Non-Solicitation Agreements</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Each of Carisma&#8217;s executive officers has entered into standard forms of agreements with respect to proprietary and confidential information, developments, non-competition, and non-solicitation. Under these agreements, each executive officer has agreed to protect Carisma&#8217;s confidential and proprietary information during and after the executive officer&#8217;s employment with Carisma, not to compete with Carisma during his or her employment and for a period generally lasting for one year after the termination of his or her employment, and not to solicit Carisma&#8217;s employees, consultants, clients or customers during his or her employment and for a period generally lasting for one year after the termination of his or her employment. In addition, under these agreements, each executive officer has agreed that Carisma owns all developments and inventions that are developed by such executive officer within the scope of and during the period of his or her employment with Carisma that are related to Carisma&#8217;s business or research and development conducted or planned to be conducted by Carisma at the time such development is created. Each executive officer has also agreed to provide Carisma with a non-exclusive, royalty-free, perpetual license to use any prior inventions that such executive officer incorporates into inventions assigned to Carisma under these agreements. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">2017 Stock Incentive Plan</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Carisma board of directors adopted, and the Carisma stockholders approved, the Carisma Plan in September&#160;2017. The Carisma Plan was amended on June 22, 2018, December&#160;21, 2020, November&#160;9, 2021 and April&#160;7, 2022 to increase the number of shares of Carisma common stock available for issuance under the Carisma Plan. At the effective time of the merger, Sesen Bio will assume the Carisma Plan and each </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">363</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma option in accordance with the terms of the Carisma Plan and the applicable stock option agreements evidencing by which such Carisma options but with such changes to such documents as Carisma and Sesen Bio mutually agree are appropriate to reflect the substitution of the Carisma option for a Sesen Bio option. The material terms of the Carisma Plan are summarized below. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Carisma Plan provides for the grant of incentive stock options, nonstatutory stock options, stock appreciation rights, restricted stock, restricted stock&#160;units and other stock-based awards. Carisma&#8217;s employees, officers, directors, as well as its consultants and advisors, are eligible to receive awards under the Carisma Plan. Incentive stock options, however, may only be granted to Carisma employees. </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Authorized Shares</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;As of January&#160;4, 2023, Carisma had reserved an aggregate of 2,664,018 shares of Carisma common stock for the issuance of awards under the Carisma Plan. As of January&#160;4, 2023, 1,802,246 stock options were issued and outstanding under the Carisma Plan to purchase shares of Carisma common stock at a weighted average exercise price of $1.92 per share and 748,753 shares of Carisma common stock remained available for the issuance of future awards under the Carisma Plan. </font>
          </div>

        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Plan&#160;Administration.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Pursuant to the terms of the Carisma Plan, the Carisma board of directors (or a committee delegated by the Carisma board of directors) administers the Carisma Plan and, subject to any limitations in the Carisma Plan, selects the recipients of awards and determines: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.3pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the number of shares of Carisma common stock covered by options and the dates upon which the options become exercisable; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.3pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the type of options to be granted; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.3pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the duration of options, which may not be in excess of ten&#160;years; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.3pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the exercise price of options, which must be at least equal to the fair market value of a share of Carisma common stock on the date of grant; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.3pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the number of shares of Carisma common stock subject to any stock appreciation rights, restricted stock awards, restricted stock&#160;units or other stock-based awards and the terms and conditions of such awards, including conditions for repurchase, issue price and repurchase price (though the measurement price of stock appreciation rights must be at least equal to the fair market value of a share of Carisma common stock on the date of grant and the duration of such awards may not be in excess of ten&#160;years). </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Transferability of Awards.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The Carisma Plan prohibits awards from being sold, assigned, transferred, pledged, hypothecated or otherwise encumbered by the person to whom such awards are granted, either voluntarily or by operation of law, and, during the life of a participant in the Carisma Plan, awards are exercisable only by the participant, except that certain awards may be transferred to family members through gifts or domestic relations orders or to an executor or guardian upon the death or disability of the participant. Carisma is not required to recognize any such permitted transfer until such time as a permitted transferee delivers to Carisma a written instrument, as a condition to such transfer, in form and substance satisfactory to Carisma confirming that such transferee shall be bound by all of the terms and conditions of the applicable award. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Effect of Certain Changes in Capitalization.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Upon the occurrence of any stock split, reverse stock split, stock dividend, recapitalization, combination of shares, reclassification of shares, spin-off or other similar change in capitalization or event, or any dividend or distribution to holders of Carisma common stock other than an ordinary cash dividend, under the terms of the Carisma Plan, Carisma is required to equitably adjust (or make substitute awards, if applicable), in the manner determined by the Carisma board of directors: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the number and class of securities available under the Carisma Plan; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the number and class of securities and exercise price per share of each outstanding option; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the share and per-share provisions and the measurement price of each outstanding stock appreciation right; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">364</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the number of shares subject to and the repurchase price per share subject to each outstanding award of restricted stock; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.51pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.51pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the share and per-share related provisions and the purchase price, if any, of each outstanding restricted stock unit award and each outstanding other stock-based award. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Effect of Certain Corporate Transactions.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Upon the occurrence of a merger or other reorganization event (as defined in the Carisma Plan), the Carisma board of directors may, on such terms as the Carisma board of directors determines (except to the extent specifically provided otherwise in an applicable award agreement or other agreement between the participant and Carisma), take any one or more of the following actions pursuant to the Carisma Plan as to all or any (or any portion of) outstanding awards, other than awards of restricted stock: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.5pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">provide that outstanding awards will be assumed, or substantially equivalent awards will be substituted, by the acquiring or succeeding corporation (or an affiliate thereof); </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.5pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">upon written notice to a participant, provide that all of the participant&#8217;s unexercised and/or unvested awards will terminate immediately prior to the consummation of the reorganization event unless exercised by the participant (to the extent then exercisable) within a specified period following the date of the notice; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.51pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.51pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">provide that outstanding awards will become exercisable, realizable or deliverable, or restrictions applicable to an award will lapse, in whole or in part, prior to or upon such reorganization event; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.4pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">in the event of a reorganization event pursuant to which holders of shares of Carisma common stock will receive a cash payment for each share surrendered in the reorganization event, make or provide for a cash payment to participants with respect to each award held by a participant equal to (1)&#160;the number of shares of Carisma common stock subject to the vested portion of the award (after giving effect to any acceleration of vesting that occurs upon or immediately prior to such reorganization event) multiplied by (2)&#160;the excess, if any, (A)&#160;of the cash payment for each share of Carisma common stock surrendered in the reorganization event, over (B)&#160;the exercise, measurement or purchase price of such award and any applicable tax withholdings, in exchange for the termination of such award; and/or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.41pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.41pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">provide that, in connection with Carisma&#8217;s liquidation or dissolution, awards will convert into the right to receive liquidation proceeds (if applicable, net of the exercise, measurement or purchase price thereof and any applicable tax withholdings). </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Carisma board of directors is not obligated under the Carisma Plan to treat all awards, all awards held by a participant, or all awards of the same type, identically. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In the case of certain restricted stock&#160;units, no assumption or substitution is permitted, and the restricted stock&#160;units will instead be settled in accordance with the terms of the applicable restricted stock unit agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Upon the occurrence of a reorganization event other than Carisma&#8217;s liquidation or dissolution, Carisma&#8217;s repurchase and other rights with respect to outstanding awards of restricted stock will continue for the benefit of the succeeding company and will, unless the Carisma board of directors determines otherwise, apply to the cash, securities, or other property which the Carisma common stock was converted into or exchanged for pursuant to the reorganization event in the same manner and to the same extent as they applied to the shares of Carisma common stock subject to the restricted stock award. However, the Carisma board of directors may provide for the termination or deemed satisfaction of such repurchase or other rights under the restricted stock award agreement or in any other agreement between a participant and Carisma, either initially or by amendment, or provide for forfeiture of such restricted stock if issued at no cost. Upon Carisma&#8217;s liquidation or dissolution, except to the extent specifically provided to the contrary in the restricted stock award agreement or any other agreement between the participant and Carisma, all restrictions and conditions on all restricted stock awards then outstanding will automatically be deemed terminated or satisfied. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Notwithstanding the provisions of the Carisma Plan described above related to reorganization events, except to the extent specifically provided to the contrary in the applicable award agreement or in any other agreement between a participant and Carisma: </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">365</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tCADCT">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">each stock option granted under the Carisma Plan will be immediately exercisable in full if, on or prior to the first anniversary of the date of the consummation of the change in control event (as defined in the Carisma Plan), the participant&#39;s employment with Carisma or the acquiring or succeeding corporation is terminated for good reason (as defined in the Carisma Plan) by the participant or is terminated without cause (as defined in the Carisma Plan) by Carisma or the acquiring or succeeding corporation; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:3.82pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:3.82pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">each award of restricted stock or restricted stock units will immediately become free from all conditions or restrictions if, on or prior to the first anniversary of the date of the consummation of the change in control event, the participant&#39;s employment with Carisma or the acquiring or succeeding corporation is terminated for good reason by the participant or is terminated without cause by Carisma or the acquiring or succeeding corporation. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:7.11pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Carisma board of directors may specify in an award agreement at the time of the grant the effect of a change in control event on any stock appreciation right or other stock-based award. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Acceleration.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;At any time, the Carisma board of directors may provide that any award under the Carisma Plan will become immediately exercisable in whole or in part, free of some or all restrictions or conditions, or otherwise realizable in whole or in part, as the case may be. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Amendment of Plan and Awards.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The Carisma board of directors may amend, suspend, or terminate the Carisma Plan or any portion thereof at any time, however if approval of the Carisma stockholders as to any modification or amendment is required under the Internal Revenue Code of 1986, as amended, with respect to incentive stock options, the Carisma board of directors may not effect such modification or amendment without such approval. The Carisma board of directors may amend, modify or terminate any outstanding award, however the participant&#8217;s consent to such action is required unless the Carisma board of directors determines that the action, taking into account any related action, does not materially and adversely affect the participant&#8217;s rights under the Carisma Plan or the change is otherwise permitted by the Carisma Plan. Furthermore, the Carisma board of directors may amend any outstanding award granted under the Carisma Plan to provide an exercise price per share that is lower than the then-current exercise price per share of such award or, without stockholder approval, cancel any outstanding award and grant in substitution therefor new awards under the Carisma Plan covering the same or a different number of shares of Carisma common stock and having an exercise price per share lower than the then-current exercise price per share of the cancelled award. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Termination</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;No award may be granted under the Carisma Plan on or after the date that is ten&#160;years following the earlier of (i)&#160;the date on which the Carisma Plan was adopted by the Carisma board of directors or (ii)&#160;the date the Carisma Plan was approved by the Carisma stockholders, but all awards previously granted may extend beyond such date. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Potential Payments to Named Executive Officers Upon Termination or Change in Control</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.11pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Carisma named executive officers are entitled to certain payments upon termination or a change in control as set forth above under the sections entitled &#8220;&#8212; </font><font style="font-style:italic;letter-spacing:0.2pt;">Employment Agreements with Named Executive Officers</font><font style="letter-spacing:0.2pt;">&#8221; and &#8220;&#8212;&#160;</font><font style="font-style:italic;letter-spacing:0.2pt;">2017 Stock Incentive Plan&#8201;&#8212;&#8201;Effect of Certain Corporate Transactions</font><font style="letter-spacing:0.2pt;">&#8221;. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Carisma Director Compensation</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.12pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The table below shows all compensation to non-employee directors of Carisma during the year ended December&#160;31, 2021. </font>
        </div>
        <table style="width:456pt;height:107.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:270.53pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Name </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Fees Earned or Paid</font>
                <br >
                <font style="letter-spacing:-0.16pt;">in Cash ($) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Option Awards</font>
                <br >
                <font style="letter-spacing:-0.16pt;">($)</font><font style=" position:relative; bottom:3.25pt;line-height:5pt;font-size:5pt;letter-spacing:-0.12pt;">(1)(2)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Total ($) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:270.53pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Margarita Chavez</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(3)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:22.155pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:22.155pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.52pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:8.52pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:270.53pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Regina Hodits, Ph.D. </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:22.155pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:22.155pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.52pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:8.52pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:270.53pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Briggs Morrison, M.D. </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:22.155pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:22.155pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.52pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">49,860<font style="position:absolute;"><font style=" position:relative; bottom:3.25pt;font-size:6.5pt;">(4)</font> </font></td>
            <td style="padding:0pt;padding-left:8.52pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">49,860</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:270.53pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Bj&#246;rn Odlander, M.D., Ph.D. </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:22.155pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:22.155pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.52pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:8.52pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:270.53pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Chidozie Ugwumba </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:22.155pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:22.155pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.52pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:8.52pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:270.53pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Sanford Zweifach </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:22.155pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">9,375<font style="position:absolute;"><font style=" position:relative; bottom:3.25pt;font-size:6.5pt;">(5)</font> </font></td>
            <td style="padding:0pt;padding-left:22.155pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.52pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">269,244<font style="position:absolute;"><font style=" position:relative; bottom:3.25pt;font-size:6.5pt;">(6)</font> </font></td>
            <td style="padding:0pt;padding-left:8.52pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">278,619</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">366</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:332pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">The amount reported in the &#8220;Option Awards&#8221; column reflects the aggregate grant date fair value of Carisma options awarded during the year computed in accordance with the provisions of ASC Topic&#160;718. See Note 3 to Carisma&#8217;s consolidated financial statements appearing at the end of this proxy statement/</font>&#8203;<font style="letter-spacing:0.2pt;">prospectus regarding assumptions underlying the valuation of option awards. This amount reflects the accounting cost for Carisma option and does not reflect the actual economic value that may be realized by the non-employee director upon the vesting of the stock option, the exercise of the stock option or the sale of the common stock underlying such stock option. </font></div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(2)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">As of December&#160;31, 2021, the aggregate number of shares of the Carisma common stock subject to outstanding option awards for each non-employee director was as follows: Mr.&#160;Morrison, 51,332 shares; and Mr.&#160;Zweifach, 97,200 shares. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(3)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Ms.&#160;Chavez is not expected to serve as a director of the combined company. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(4)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Represents an option to purchase 18,000 shares of Carisma common stock granted on June&#160;1, 2021, in respect of Mr.&#160;Morrison&#8217;s board services. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(5)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Represents fees paid to Mr.&#160;Zweifach in connection with his service as Chair of the Carisma board of directors for the year ended December&#160;31, 2021. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(6)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Represents an option to purchase 97,200 shares of Carisma common stock granted on November&#160;9, 2021, in respect of Mr.&#160;Zweifach&#8217;s board services. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">During the year ended December&#160;31, 2021, Carisma did not provide any additional compensation to Mr.&#160;Kelly, its President and Chief Executive Officer, for his service as a director. Mr.&#160;Kelly&#8217;s compensation as a named executive officer is set forth above under &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Carisma Executive Compensation&#8201;&#8212;&#8201;Summary Compensation Table</font><font style="letter-spacing:0.2pt;">&#8221;. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">367</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tRPTO">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:11.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">RELATED PARTY TRANSACTIONS OF DIRECTORS AND</font>
          <br >
          <font style="letter-spacing:-0.2pt;">EXECUTIVE OFFICERS OF THE COMBINED COMPANY</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">In addition to the compensation arrangements, including employment, termination of employment and change in control arrangements, with Sesen Bio&#8217;s and Carisma&#8217;s directors and executive officers, including those discussed in the sections entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Management Following the Merger</font><font style="letter-spacing:0.2pt;">,&#8221; &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Sesen Bio Executive Compensation</font><font style="letter-spacing:0.2pt;">&#8221; and &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Carisma Executive Compensation</font><font style="letter-spacing:0.2pt;">,&#8221; beginning on pages <a href="#tMFTM">342</a>, <a href="#tSBEC">349</a> and <a href="#tCEC">360</a>, respectively, of this proxy statement/prospectus, the following is a description of each transaction occurring since January&#160;1, 2019 and any currently proposed transactions in which: </font>
          </div>

        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">either Sesen Bio or Carisma was or is to be a participant; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.11pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.11pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the amounts involved exceeded or will exceed the lesser of $120,000 or 1% of the average of Sesen Bio&#8217;s or Carisma&#8217;s the total assets at year end for the last two completed fiscal&#160;years; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.11pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.11pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">any director, executive officer, holder of more than 5% of the voting securities of Sesen Bio, Carisma, or an affiliate or immediate family member of the foregoing persons, had or will have a direct or indirect material interest. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Sesen Bio Transactions</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Manufacturing and Office Lease</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio leases a manufacturing, laboratory, and office facility in Winnipeg, Manitoba, from an affiliate of Leslie Dan, a former director of Sesen Bio who retired from the Sesen Bio board of directors in July&#160;2019, under a two-year renewable lease through September&#160;2022 with a right to renew the lease for one subsequent three-year term. For the&#160;years ended December&#160;31, 2021, 2020 and 2019, Sesen Bio had a rent expense for this facility of $327,000, $301,000 and $320,000, respectively. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Protoden License</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio is party to an intellectual property license agreement under which Sesen Bio pays fees to Protoden Technologies Inc., or Protoden, a company owned by an affiliate of Mr.&#160;Dan. Pursuant to the agreement, Sesen Bio has an exclusive, perpetual, irrevocable and non-royalty bearing license, with the right to sublicense, under certain patents and technology to make, use and sell products that utilize such patents and technology. The annual fee is $100,000. Beginning on January&#160;1, 2025, the licenses granted to Sesen Bio will require no further payments to Protoden. Sesen Bio paid $100,000 under this license agreement to Protoden in each of the&#160;years ended December&#160;31, 2021, 2020 and 2019. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Carisma Transactions</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Private Placements of Securities</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Series&#160;A Convertible Preferred Stock Financing</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In June&#160;2018, November&#160;2018 and March&#160;2020, Carisma and CARISMA Therapeutics S.&#224; r.l., a soci&#233;t&#233; &#224; responsabilit&#233; limit&#233;e organized under the laws of Luxembourg and a subsidiary of Carisma, or Carisma Europe, as applicable, issued and sold an aggregate of 5,201,017 shares of the Carisma Series&#160;A preferred stock, $0.0001 par value per share and an aggregate of 937,501 Class&#160;B Shares, with a nominal value of one tenth of one eurocent (EUR 0.001), of Carisma Europe, or the Class&#160;B exchangeable shares, of which (i)&#160;4,701,925 shares of Series&#160;A preferred stock and all of the Class&#160;B exchangeable shares were sold at a price per share of $10.40 in cash, for an aggregate purchase price of $58,650,030.40 and (ii)&#160;499,092 shares of Carisma Series&#160;A preferred stock were sold at a price per share of $8.06 against payment by cancellation or conversion of indebtedness of Carisma to the applicable purchaser, including interest. Carisma also issued one share of Special Voting Preferred Stock of Carisma, $0.0001 par value per share, to the holder of the Class&#160;B exchangeable shares, which share shall be automatically cancelled at such time as all Class&#160;B exchangeable shares have been exchanged for capital stock of Carisma. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following table sets forth the aggregate number of shares of the Carisma Series&#160;A preferred stock and Class&#160;B exchangeable shares that were issued and sold to Carisma directors, executive officers and holders </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">368</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tCARPREC123">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">of more than 5% of Carisma voting securities and their affiliates in the transactions and the aggregate amount of consideration for such shares: </font>
        </div>
        <table style="width:456pt;height:122.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:224.95pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Purchaser</font><font style=" position:relative; bottom:3.25pt;line-height:5pt;font-size:5pt;letter-spacing:-0.12pt;">(1)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Shares of Series&#160;A</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Preferred Stock </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Shares of Class&#160;B</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Exchangeable Shares </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Aggregate</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Purchase Price </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:224.95pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">AbbVie Biotechnology Ltd </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.375pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">947,762</td>
            <td style="padding:0pt;padding-left:14.375pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.875pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:18.875pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:44.25pt; text-align:right; white-space:nowrap;">8,500,003.20</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:224.95pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">HealthCap VII L.P. </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.375pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">250,647</td>
            <td style="padding:0pt;padding-left:14.375pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.875pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">937,501</td>
            <td style="padding:0pt;padding-left:18.875pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:44.25pt; text-align:right; white-space:nowrap;">11,000,017.60</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:224.95pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Entities affiliated with IPG </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.375pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">947,186</td>
            <td style="padding:0pt;padding-left:14.375pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.875pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:18.875pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:44.25pt; text-align:right; white-space:nowrap;">8,500,003.20</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:224.95pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">MRL Ventures Fund, LLC </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.375pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">480,770</td>
            <td style="padding:0pt;padding-left:14.375pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.875pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:18.875pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:44.25pt; text-align:right; white-space:nowrap;">5,000,008.00</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:224.95pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">The Trustees of the University of Pennsylvania </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.375pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">309,594</td>
            <td style="padding:0pt;padding-left:14.375pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.875pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:18.875pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:44.25pt; text-align:right; white-space:nowrap;">2,750,009.60</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:224.95pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">TPG Biotechnology Partners V, L.P </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.375pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">673,076</td>
            <td style="padding:0pt;padding-left:14.375pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.875pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:18.875pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:44.25pt; text-align:right; white-space:nowrap;">6,999,990.40</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:224.95pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Wellington Life Sciences V GmbH &amp; Co. KG </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.375pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">798,072</td>
            <td style="padding:0pt;padding-left:14.375pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.875pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:18.875pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:44.25pt; text-align:right; white-space:nowrap;">8,299,948.80</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:12.3pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>

          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">(1)</font>
            <br >
          </div>
          <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
            <font style="letter-spacing:0.2pt;">See section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Principal Stockholders of Carisma</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tPSOC">397</a> of this proxy statement/</font>&#8203;<font style="letter-spacing:0.2pt;">prospectus for additional information about shares held by these entities. </font></div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Series&#160;B Convertible Preferred Stock Financing</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In December&#160;2020 and February&#160;2021, Carisma and Carisma Europe, as applicable, issued and sold an aggregate of 3,499,866 shares of the Carisma Series&#160;B preferred stock, $0.0001 par value per share and an aggregate of 297,764 Class&#160;B-1 Shares, with a nominal value of one tenth of one eurocent (EUR 0.001), of Carisma Europe, or the Class&#160;B-1 exchangeable shares, all of which were sold at a price per share of $15.60 in cash, for an aggregate purchase price of $59,243,028.00. Carisma also issued one share of Carisma Series&#160;B special voting preferred stock, $0.0001 par value per share, to the holder of the Class&#160;B-1 exchangeable shares, which share shall be automatically cancelled at such time as all Class&#160;B-1 exchangeable shares have been exchanged for capital stock of Carisma. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following table sets forth the aggregate number of shares of the Carisma Series&#160;B preferred stock and Class&#160;B-1 exchangeable shares that were issued and sold to Carisma directors, executive officers and holders of more than 5% of Carisma voting securities and their affiliates in the transactions and the aggregate amount of consideration for such shares: </font>
        </div>
        <table style="width:456pt;height:152.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:225.37pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Purchaser</font><font style=" position:relative; bottom:3.25pt;line-height:5pt;font-size:5pt;letter-spacing:-0.12pt;">(1)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Shares of Series&#160;B</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Preferred Stock </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Shares of Class&#160;B-1</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Exchangeable Shares </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Aggregate</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Purchase Price </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:225.37pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">AbbVie Biotechnology Ltd </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">256,398</td>
            <td style="padding:0pt;padding-left:14.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.875pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:18.875pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:44.25pt; text-align:right; white-space:nowrap;">3,999,808.80</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:225.37pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Briggs Morrison </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">6,410</td>
            <td style="padding:0pt;padding-left:14.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.875pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:18.875pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:44.25pt; text-align:right; white-space:nowrap;">99,996.00</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:225.37pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">HealthCap VII L.P. </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:14.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.875pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">297,764</td>
            <td style="padding:0pt;padding-left:18.875pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:44.25pt; text-align:right; white-space:nowrap;">4,645,118.40</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:225.37pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Entities affiliated with IPG </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">577,120</td>
            <td style="padding:0pt;padding-left:14.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.875pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:18.875pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:44.25pt; text-align:right; white-space:nowrap;">9,003,072.00</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:225.37pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">MRL Ventures Fund, LLC </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">134,609</td>
            <td style="padding:0pt;padding-left:14.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.875pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:18.875pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:44.25pt; text-align:right; white-space:nowrap;">2,099,900.40</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:225.37pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">SymBiosis II, LLC </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">961,492</td>
            <td style="padding:0pt;padding-left:14.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.875pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:18.875pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:44.25pt; text-align:right; white-space:nowrap;">14,999,275.20</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:225.37pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">The Trustees of the University of Pennsylvania </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">170,131</td>
            <td style="padding:0pt;padding-left:14.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.875pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:18.875pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:44.25pt; text-align:right; white-space:nowrap;">2,654,043.60</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:225.37pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">TPG Biotechnology Partners V, L.P </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">168,681</td>
            <td style="padding:0pt;padding-left:14.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.875pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:18.875pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:44.25pt; text-align:right; white-space:nowrap;">2,631,423.60</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:225.37pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Wellington Life Sciences V GmbH &amp; Co. KG </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">200,007</td>
            <td style="padding:0pt;padding-left:14.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.875pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:18.875pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:44.25pt; text-align:right; white-space:nowrap;">3,120,109.20</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:12.4pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>

          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-top:7.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">(1)</font>
            <br >
          </div>
          <div style=" margin-top:7.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
            <font style="letter-spacing:0.2pt;">See section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Principal Stockholders of Carisma</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tPSOC">397</a> of this proxy statement/</font>&#8203;<font style="letter-spacing:0.2pt;">prospectus for additional information about shares held by these entities. </font></div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Carisma Pre-Closing Financing</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">On September&#160;20, 2022, immediately prior to the execution and delivery of the Original Merger Agreement, Carisma entered into a subscription agreement with certain investors named therein in connection with the Carisma pre-closing financing. Pursuant to the Subscription Agreement, the investors agreed to purchase an aggregate of 1,964,101 shares of Carisma common stock, at a price of $15.60 per share, </font>
          </div>

      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">369</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">for aggregate gross proceeds of $30.6&#160;million. The closing of the Carisma pre-closing financing is conditioned upon the satisfaction or waiver of the conditions to the merger as well as certain other conditions. Seven of the investors or their affiliates are beneficial holders of more than 5% of Carisma&#8217;s capital stock, and the table below sets forth the number of shares of Carisma common stock expected to be purchased by such holders at the closing of the Carisma pre-closing financing: </font>
        </div>
        <table style="width:416pt;height:122.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:282.38pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Purchaser</font><font style=" position:relative; bottom:3.25pt;line-height:5pt;font-size:5pt;letter-spacing:-0.12pt;">(1)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Shares of</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Common Stock </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Aggregate</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Purchase Price </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:282.38pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">AbbVie Biotechnology Ltd </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.39pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">243,590</td>
            <td style="padding:0pt;padding-left:9.39pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:40.5pt; text-align:right; white-space:nowrap;">3,800,004.00</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:282.38pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">HealthCap VII L.P. </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.39pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">303,205</td>
            <td style="padding:0pt;padding-left:9.39pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:40.5pt; text-align:right; white-space:nowrap;">4,729,998.00</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:282.38pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">MRL Ventures Fund, LLC </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.39pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">160,256</td>
            <td style="padding:0pt;padding-left:9.39pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:40.5pt; text-align:right; white-space:nowrap;">2,499,993.60</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:282.38pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">SymBiosis II, LLC </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.39pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">205,128</td>
            <td style="padding:0pt;padding-left:9.39pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:40.5pt; text-align:right; white-space:nowrap;">3,199,996.80</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:282.38pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">The Trustees of the University of Pennsylvania </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.39pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">179,487</td>
            <td style="padding:0pt;padding-left:9.39pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:40.5pt; text-align:right; white-space:nowrap;">2,799,997.20</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:282.38pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">TPG Biotechnology Partners V, L.P </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.39pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">44,872</td>
            <td style="padding:0pt;padding-left:9.39pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:40.5pt; text-align:right; white-space:nowrap;">700,003.20</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:282.38pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Wellington Life Sciences V GmbH &amp; Co. KG </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.39pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">211,538</td>
            <td style="padding:0pt;padding-left:9.39pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:40.5pt; text-align:right; white-space:nowrap;">3,299,992.80</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:12.2pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>

          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-top:7.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">(1)</font>
            <br >
          </div>
          <div style=" margin-top:7.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
            <font style="letter-spacing:0.2pt;">See section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Principal Stockholders of Carisma</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tPSOC">397</a> of this proxy statement/</font>&#8203;<font style="letter-spacing:0.2pt;">prospectus for additional information about shares held by these entities. </font></div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Carisma has agreed to enter into a registration rights agreement with the investors party to the subscription agreement to provide for the registration of the resale of the shares of common stock purchased by such investors in connection with the Carisma pre-closing financing. The registration rights agreement will also provide these investors rights to require Carisma to register additional shares held by such investors under specified circumstances and to participate in future registrations of securities by Carisma under specified circumstances. </font>
          </div>

        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Other Agreements with Carisma Stockholders</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Investor Rights Agreement</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In December&#160;2020, Carisma and Carisma Europe entered into an amended and restated investor rights agreement, or the Investor Rights Agreement, with certain holders of Carisma common stock, the Series&#160;A preferred stock, Series&#160;B preferred stock, Class&#160;B exchangeable shares and Class&#160;B-1 exchangeable shares, including certain holders of 5% of Carisma&#8217;s capital stock, and including certain affiliates of Carisma&#8217;s directors and their affiliates. The Investor Rights Agreement provides such holders with certain registration rights, including the right to demand that Carisma file a registration statement or request that their shares be covered by a registration statement that Carisma is otherwise filing. The Investor Rights Agreement also provides certain major investors with certain information and observer rights. The Investor Rights Agreement is expected to be terminated in connection with the closing of the merger. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Voting Agreement</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In December&#160;2020, Carisma and Carisma Europe entered into an amended and restated voting agreement, or the Voting Agreement, with certain holders of Carisma common stock, Series&#160;A preferred stock, Series&#160;B preferred stock, Class&#160;B exchangeable shares and Class&#160;B-1 exchangeable shares, including certain holders of 5% of Carisma&#8217;s capital stock, and including certain of Carisma&#8217;s directors and their affiliates. Pursuant to the Voting Agreement, such holders party thereto agreed to vote their shares in favor of the election of certain directors and specified transactions approved by the requisite majority of the shares of voting capital stock held by such holders. The Voting Agreement is expected to be terminated in connection with the closing of the merger. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Right of First Refusal and Co-Sale Agreement</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In December&#160;2020, Carisma entered into an amended and restated right of first refusal and co-sale agreement, or the ROFR Agreement, with certain holders of Carisma common stock, the Series&#160;A preferred stock, Series&#160;B preferred stock, Class&#160;B exchangeable shares and Class&#160;B-1 exchangeable shares, including </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">370</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:140pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">certain holders of 5% of its capital stock, and including certain of Carisma&#8217;s directors and their affiliates. Pursuant to the ROFR Agreement, Carisma has a right of first refusal in respect of certain sales of securities by certain holders of its capital stock. To the extent Carisma does not exercise such right in full, certain holders of its capital stock are granted certain rights of first refusal and co-sale in respect of such sales. The ROFR Agreement is expected to be terminated in connection with the closing of the merger. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Share Exchange and Voting Agreement</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In December&#160;2020, Carisma and Carisma Europe entered into an amended and restated share exchange and voting agreement, or the Share Exchange Agreement, with certain holders of the Series&#160;A preferred stock, Series&#160;B preferred stock, Class&#160;B exchangeable shares and Class&#160;B-1 exchangeable shares, including certain holders of 5% of its capital stock, and including certain of Carisma&#8217;s directors and their affiliates. The Share Exchange Agreement provides for the exchange of the Class&#160;B exchangeable shares and Class&#160;B-1 exchangeable shares for shares of Series&#160;A preferred stock and Series&#160;B preferred stock, respectively, either voluntarily or automatically, upon certain circumstances as set forth therein. In connection with the closing of the merger, the Class&#160;B exchangeable shares and Class&#160;B-1 exchangeable shares will be exchanged into Carisma preferred stock, and the Share Exchange Agreement will terminate. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">License Agreements</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">In November&#160;2017, Carisma entered into the Penn License Agreement with Penn. Pursuant to the Penn License Agreement, Carisma is responsible for paying Penn an annual license maintenance fee in the low tens of thousands of dollars, payable until Carisma&#8217;s first payment of a royalty. Carisma is required to pay Penn up to $10.9&#160;million per product in development and regulatory milestone payments, up to $30.0&#160;million per product in commercial milestone payments, and up to an additional $1.7&#160;million in development and regulatory milestone payments for the first CAR-M product directed to mesothelin. Penn is a holder of 5% or more of the Carisma capital stock. For additional detail on the Penn License Agreement see the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Carisma Business&#8201;&#8212;&#8201;University of Pennsylvania License Agreement</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tUNPLA">291</a> of this proxy statement/prospectus. </font>
          </div>

        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Indemnification</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Carisma Certificate of Incorporation provides that Carisma will provide indemnification, and advancement of expenses to, directors and officers to the fullest extent permitted by applicable law. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Policies for Approval of Related Party Transactions</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Carisma does not have a written policy regarding the review and approval of related person transactions. Nevertheless, with respect to such transactions, it has been the practice of the Carisma board of directors to consider the nature of and business reasons for such transactions, how the terms of such transactions compared to those which might be obtained from unaffiliated third parties and whether such transactions were otherwise fair to and in the best interests of, or not contrary to, Carisma&#8217;s best interests.</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">371</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tUPFC">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">On September&#160;20, 2022, Sesen Bio, Merger Sub, and Carisma entered into the Original Merger Agreement (as amended by the Merger Agreement Amendment dated as of December&#160;29, 2022, the Merger Agreement) pursuant to which, among other things, and subject to the satisfaction or waiver of certain conditions set forth in the Merger Agreement, Merger Sub will merge with and into Carisma, with Carisma continuing as a wholly-owned subsidiary of Sesen Bio and the surviving corporation of the merger. At the effective time of the merger, Sesen Bio will change its name to &#8220;Carisma Therapeutics Inc.&#8221; </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Immediately prior to the execution and delivery of the Original Merger Agreement, Carisma entered into a subscription agreement in connection with the Carisma pre-closing financing, pursuant to which certain investors agreed to purchase shares of Carisma common stock at an aggregate purchase price of $30.6&#160;million. The closing of the Carisma pre-closing financing is conditioned upon the satisfaction or waiver of the conditions to the closing of the merger set forth in the Merger Agreement. The shares of Carisma common stock issued in the Carisma pre-closing financing will be converted into shares of Sesen Bio common stock in the merger in accordance with the exchange ratio. As of immediately after the effective time of the merger, the Carisma convertible note will automatically convert into a number of shares of Sesen Bio common stock calculated in accordance with the terms of the Carisma convertible note and based on the exchange ratio for the conversion of Carisma capital stock into Sesen Bio common stock. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Prior to the effective time, Sesen Bio will enter into the CVR Agreement with a rights agent pursuant to which Sesen Bio stockholders of record as of a date agreed to by Sesen Bio and Carisma prior to the effective time will receive one CVR for each outstanding share of Sesen Bio common stock held by such stockholders on such date. Each CVR will represent the contractual right to receive contingent cash payments upon the receipt by Sesen Bio of certain proceeds payable by Roche, if any, pursuant to the Roche Asset Purchase Agreement, upon the achievement by Roche of a specified milestone set forth in the Roche Asset Purchase Agreement as well as proceeds from any sale of Sesen Bio&#8217;s legacy assets, including Vicineum, subject to certain customary deductions, including for expenses and taxes. The CVRs will not have any voting or dividend rights, will not represent any equity or ownership interest in Sesen Bio or its subsidiaries, and interest will not accrue on any amounts payable on the CVRs. Prior to the effective time, Sesen Bio will declare a pre-closing dividend to its common stockholders of record consisting of (a)&#160;one CVR for each outstanding share of Sesen Bio common stock held by such stockholder as of such date, representing the right to receive contingent payments upon the occurrence of certain events set forth in, and subject to and in accordance with the terms and conditions of, the CVR Agreement and (b)&#160;a special cash dividend expected to be approximately $70.0&#160;million in the aggregate, subject to Sesen Bio&#8217;s estimated net cash as of the closing of the merger being greater than or equal to $75.0 million. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">At the effective time of the merger, each outstanding share of Carisma capital stock, including shares of Carisma common stock issued in connection with the Carisma pre-closing financing, will be converted into the right to receive a number of shares of Sesen Bio common stock equal to the exchange ratio. The exchange ratio was estimated at the time of the execution of the Merger Agreement Amendment on December&#160;29, 2022 to be 37.7924 shares of Sesen Bio common stock for each share of Carisma capital stock and is subject to adjustment prior to the closing for, among other things, Sesen Bio&#8217;s net cash at the cash determination time. Because Sesen Bio&#8217;s final net cash will not be determined until the closing, and because the number of shares of Sesen Bio common stock issuable to Carisma stockholders is determined based on, among other things, Sesen Bio&#8217;s final net cash, Sesen Bio stockholders cannot be certain of the exact number of shares that will be&#160;issued to Carisma stockholders when Sesen Bio stockholders vote on the proposals at the Sesen Bio special meeting. The exchange ratio referenced above is an estimate only and the final exchange ratio will be determined pursuant to a formula described in more detail in the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">The Merger Agreement&#8201;&#8212;&#8201;Merger Consideration</font><font style="letter-spacing:0.2pt;">&#8221; in this proxy statement/prospectus. </font>
          </div>

        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following selected unaudited pro&#160;forma condensed combined financial data gives effect to the (i)&#160;merger, (ii)&#160;the Carisma pre-closing financing, (iii)&#160;the automatic conversion of the Carisma convertible note, and (iv)&#160;the pre-closing dividend. Additionally, the unaudited pro&#160;forma condensed combined balance sheet reflects the proceeds received by Sesen Bio in connection with the Roche Asset Purchase Agreement in July&#160;2022. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">372</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:40pt;margin-left:69.66pt;width:456pt;">

          <div style="text-indent:20pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">The merger is accounted for as a reverse recapitalization under U.S. GAAP because the primary assets of Sesen Bio are cash, cash equivalents, and marketable securities. For financial reporting purposes, Carisma has been determined to be the accounting acquirer based upon the terms of the merger and other factors including: (i)&#160;Carisma stockholders and other persons holding securities that are convertible into Carisma common stock are expected to own approximately 74.8% of the fully diluted closing Sesen Bio common stock immediately following the effective time of the merger (based on estimates made at the time of the execution of the Merger Agreement), (ii)&#160;Carisma will hold the majority (six of seven) of board seats of the combined company, and (iii)&#160;Carisma&#8217;s management will hold all key positions in the management of the combined company. The &#8220;fully diluted closing Sesen Bio common stock&#8221; as used herein means (x)&#160;the number of outstanding shares of Sesen Bio common stock, which amount excludes the shares of Sesen Bio common stock available for issuance under the 2014 Incentive Plan and the 2009 Incentive Plan, as well as inducement grants made outside of the Sesen Bio stockholder-approved plans and out-of-the-money Sesen Bio options, </font><font style="font-style:italic;letter-spacing:0.2pt;">plus</font><font style="letter-spacing:0.2pt;"> (y)&#160;the number of outstanding shares of Carisma common stock, which amount includes the shares of Carisma common stock available for issuance under the Carisma Plan. </font>
          </div>

        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The unaudited pro&#160;forma condensed combined financial information was prepared in accordance with Article&#160;11 of Regulation&#160;S-X. The Sesen Bio and Carisma unaudited pro&#160;forma condensed combined balance sheet data assume that the merger took place on September&#160;30, 2022, and combines the Sesen Bio and Carisma historical balance sheets at September&#160;30, 2022. The Sesen Bio and Carisma unaudited pro&#160;forma condensed combined statements of operations data assume that the merger took place as of January&#160;1, 2021 and combines the historical results of Sesen Bio and Carisma for the nine&#160;months ended September&#160;30, 2022 and the year ended December&#160;31, 2021. The historical financial statements of Sesen Bio and Carisma, which are included in this proxy statement/prospectus, have been adjusted to give pro&#160;forma effect to events that are (i)&#160;directly attributable to the merger, (ii)&#160;factually supportable, and (iii)&#160;with respect to the statements of operations, expected to have a continuing impact on the combined results. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The unaudited pro&#160;forma condensed combined financial statements are based on the assumptions and adjustments that are described in the accompanying notes. The unaudited pro&#160;forma condensed combined financial statements and pro&#160;forma adjustments have been prepared based on preliminary estimates of fair value of assets acquired and liabilities assumed. A final determination of these estimated fair values will be based on the actual net tangible assets of Sesen Bio that exist as of the date of completion of the merger. Differences between these preliminary estimates and the final fair value of assets and liabilities acquired may occur and these differences could have a material impact on the accompanying unaudited pro&#160;forma condensed combined financial statements and the combined company&#8217;s future results of operations and financial position. The actual amounts recorded as of the completion of the merger may differ materially from the information presented in these unaudited pro&#160;forma condensed combined financial statements as a result of the amount of cash used by Sesen Bio&#8217;s operations between the signing of the Merger Agreement and the closing of the merger; the timing of the closing of the merger; and other changes in Sesen Bio&#8217;s assets and liabilities that occur prior to the completion of the merger. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The unaudited pro&#160;forma condensed combined financial statements do not give effect to the potential impact of current financial conditions, regulatory matters, operating efficiencies or other savings or expenses that may be associated with the merger. The unaudited pro&#160;forma condensed combined financial statements have been prepared for illustrative purposes only and are not necessarily indicative of the financial position or results of operations in future periods or the results that actually would have been realized had Sesen Bio and Carisma been a combined company during the specified period. The unaudited pro&#160;forma condensed combined financial statements, including the notes thereto, should be read in conjunction with the separate historical audited financial statements of Sesen Bio and Carisma for the year ended December&#160;31, 2021 and the unaudited condensed financial statements of Sesen Bio and Carisma for the nine&#160;months ended September&#160;30, 2022 included elsewhere in this proxy statement/prospectus. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">373</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">Unaudited Pro Forma Condensed Combined Balance Sheet </font>
          <br >
          <font style="letter-spacing:-0.2pt;">As of September&#160;30, 2022 </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(in thousands, except per share amounts)</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <table style="width:456pt;height:570.17pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:247.49pt;text-align:left;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.067pt 0pt;" colspan="4">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.16pt;">CARISMA </font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Therapeutics </font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Inc. </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.067pt 0pt;" colspan="4">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Sesen Bio, </font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Inc. </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.067pt 0pt;" colspan="4">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Transactions </font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Adjustments </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.067pt 0pt;" colspan="4">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Notes </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.067pt 0pt;" colspan="4">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Pro Forma </font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Combined </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:8.97pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
              <td style="padding:2.17pt 0pt 0.69pt 0pt; width:247.49pt;text-align:left;">
                <font style="letter-spacing:-0.18pt;">ASSETS</font>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:8.97pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
              <td style="padding:2.42pt 0pt 0.69pt 0pt; width:247.49pt;text-align:left;">
                <font style="letter-spacing:-0.18pt;">Current assets</font><font style="font-weight:normal;letter-spacing:0.18pt;">: </font>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:8.97pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
              <td style="padding:2.43pt 0pt 0.68pt 0pt; width:247.49pt;text-align:left;">
                <div style="margin-left:9pt;">
                  <font style="letter-spacing:0.18pt;">Cash and cash equivalents </font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
              <td style="padding:2.43pt 0pt 0.68pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:2.43pt 0pt 0.68pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">28,943</td>
              <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.43pt 0pt 0.68pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:2.43pt 0pt 0.68pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">71,107</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
              <td style="padding:2.43pt 0pt 0.68pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:2.43pt 0pt 0.68pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(62,793<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
              <td style="padding:2.43pt 0pt 0.68pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.43pt 0pt 0.68pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">A</td>
              <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.43pt 0pt 0.68pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:2.43pt 0pt 0.68pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">37,257 </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:8.97pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
              <td style="padding:2.43pt 0pt 0.68pt 0pt; width:247.49pt;text-align:left;">
                <div style="margin-left:9pt;">
                  <font style="letter-spacing:0.18pt;">Short-term marketable securities </font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
              <td style="padding:2.43pt 0pt 0.68pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.43pt 0pt 0.68pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">41,705</td>
              <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.43pt 0pt 0.68pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.43pt 0pt 0.68pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">106,427</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
              <td style="padding:2.43pt 0pt 0.68pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.43pt 0pt 0.68pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.43pt 0pt 0.68pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.43pt 0pt 0.68pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">148,132</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:8.97pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
              <td style="padding:2.43pt 0pt 0.68pt 0pt; width:247.49pt;text-align:left;">
                <div style="margin-left:9pt;">
                  <font style="letter-spacing:0.18pt;">Accounts receivable </font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
              <td style="padding:2.43pt 0pt 0.68pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.43pt 0pt 0.68pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.43pt 0pt 0.68pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.43pt 0pt 0.68pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
              <td style="padding:2.43pt 0pt 0.68pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.43pt 0pt 0.68pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.43pt 0pt 0.68pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.43pt 0pt 0.68pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:8.97pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
              <td style="padding:2.43pt 0pt 0.68pt 0pt; width:247.49pt;text-align:left;">
                <div style="margin-left:9pt;">
                  <font style="letter-spacing:0.18pt;">Other receivables </font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
              <td style="padding:2.43pt 0pt 0.68pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.43pt 0pt 0.68pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.43pt 0pt 0.68pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.43pt 0pt 0.68pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">14,297</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
              <td style="padding:2.43pt 0pt 0.68pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.43pt 0pt 0.68pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.43pt 0pt 0.68pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.43pt 0pt 0.68pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">14,297</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10.77pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
              <td style="border-bottom:1px solid #CCEEFF;padding:1.24pt 0pt 0.965pt 0pt; width:247.49pt;text-align:left;">
                <div style="margin-left:18pt; text-indent:-9pt; line-height:10.77pt; margin-bottom:-0.499999999999994pt;">
                  <font style="letter-spacing:0.18pt;">Prepaid expenses and other current </font>
                  <br >
                  <font style="letter-spacing:0.18pt;">assets </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.865pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:1.24pt 0pt 0.41pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:1.24pt 0pt 0.41pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">2,290</td>
              <td style="padding:0pt;padding-left:2.865pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:1.24pt 0pt 0.41pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:1.24pt 0pt 0.41pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">527</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.82pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:1.24pt 0pt 0.41pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:1.24pt 0pt 0.41pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:2.82pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:6pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:1.24pt 0pt 0.41pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:1.24pt 0pt 0.41pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">2,817</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:8.97pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
              <td style="padding:2.18pt 0pt 0.68pt 0pt; width:247.49pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:-0.18pt;">Total current assets</font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
              <td style="padding:2.18pt 0pt 0.68pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.18pt 0pt 0.68pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">72,938</td>
              <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.18pt 0pt 0.68pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.18pt 0pt 0.68pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">192,358</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
              <td style="padding:2.18pt 0pt 0.68pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.18pt 0pt 0.68pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(62,793<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.18pt 0pt 0.68pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.18pt 0pt 0.68pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">202,503</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:8.97pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
              <td style="padding:2.44pt 0pt 0.67pt 0pt; width:247.49pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.18pt;">Restricted cash </font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
              <td style="padding:2.44pt 0pt 0.67pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.44pt 0pt 0.67pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.44pt 0pt 0.67pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.44pt 0pt 0.67pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">30</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
              <td style="padding:2.44pt 0pt 0.67pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.44pt 0pt 0.67pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.44pt 0pt 0.67pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.44pt 0pt 0.67pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">30</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:8.97pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
              <td style="padding:2.44pt 0pt 0.67pt 0pt; width:247.49pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.18pt;">Marketable securities </font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
              <td style="padding:2.44pt 0pt 0.67pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.44pt 0pt 0.67pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.44pt 0pt 0.67pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.44pt 0pt 0.67pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">7,336</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
              <td style="padding:2.44pt 0pt 0.67pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.44pt 0pt 0.67pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.44pt 0pt 0.67pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.44pt 0pt 0.67pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">7,336</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:8.97pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
              <td style="padding:2.44pt 0pt 0.67pt 0pt; width:247.49pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.18pt;">Property and equipment, net </font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
              <td style="padding:2.44pt 0pt 0.67pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.44pt 0pt 0.67pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">8,677</td>
              <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.44pt 0pt 0.67pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.44pt 0pt 0.67pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
              <td style="padding:2.44pt 0pt 0.67pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.44pt 0pt 0.67pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.44pt 0pt 0.67pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.44pt 0pt 0.67pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">8,677</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
              <td style="border-bottom:1px solid #FFFFFF;padding:2.42pt 0pt 1.555pt 0pt; width:247.49pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.18pt;">Right of use assets&#8201;&#8211;&#8201;operating leases </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.865pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:2.42pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.42pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">6,121</td>
              <td style="padding:0pt;padding-left:2.865pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:2.42pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.42pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.82pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:2.42pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.42pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:2.82pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:6pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:2.42pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.42pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">6,121</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:9pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
              <td style="padding:2.18pt 0pt 2.305pt 0pt; width:247.49pt;text-align:left;">
                <div style="margin-left:18pt;">
                  <font style="letter-spacing:-0.18pt;">Total assets</font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
              <td style="padding:2.18pt 0pt 1.555pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:2.18pt 0pt 1.555pt 0pt;border-bottom:3pt double #000000; min-width:27pt; text-align:right; white-space:nowrap;">87,736</td>
              <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.18pt 0pt 1.555pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:2.18pt 0pt 1.555pt 0pt;border-bottom:3pt double #000000; min-width:27pt; text-align:right; white-space:nowrap;">199,724</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
              <td style="padding:2.18pt 0pt 1.555pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:2.18pt 0pt 1.555pt 0pt;border-bottom:3pt double #000000; min-width:27pt; text-align:right; white-space:nowrap;">(62,793<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.18pt 0pt 1.555pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:2.18pt 0pt 1.555pt 0pt;border-bottom:3pt double #000000; min-width:27pt; text-align:right; white-space:nowrap;">224,667</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10.77pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
              <td style="padding:2.25pt 0pt 0.5pt 0pt; width:247.49pt;white-space:normal;text-align:left;">
                <div style="margin-left:9pt; text-indent:-9pt;">
                  <font style="letter-spacing:-0.18pt;">LIABILITIES, CONVERTIBLE PREFERRED STOCK AND STOCKHOLERS&#8217; EQUITY (DEFICIT)</font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:8.96999999999997pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
              <td style="padding:2.45pt 0pt 0.66pt 0pt; width:247.49pt;text-align:left;">
                <font style="letter-spacing:-0.18pt;">Current liabilities</font><font style="font-weight:normal;letter-spacing:0.18pt;">: </font>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:8.96999999999997pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
              <td style="padding:2.45pt 0pt 0.66pt 0pt; width:247.49pt;text-align:left;">
                <div style="margin-left:9pt;">
                  <font style="letter-spacing:0.18pt;">Accounts payable </font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
              <td style="padding:2.45pt 0pt 0.66pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:2.45pt 0pt 0.66pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">4,084</td>
              <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.45pt 0pt 0.66pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:2.45pt 0pt 0.66pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">514</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
              <td style="padding:2.45pt 0pt 0.66pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:2.45pt 0pt 0.66pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.45pt 0pt 0.66pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:2.45pt 0pt 0.66pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">4,599</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:8.96999999999997pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
              <td style="padding:2.45pt 0pt 0.66pt 0pt; width:247.49pt;text-align:left;">
                <div style="margin-left:9pt;">
                  <font style="letter-spacing:0.18pt;">Accrued expenses </font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
              <td style="padding:2.45pt 0pt 0.66pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.45pt 0pt 0.66pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">8,997</td>
              <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.45pt 0pt 0.66pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.45pt 0pt 0.66pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">33,800</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
              <td style="padding:2.45pt 0pt 0.66pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.45pt 0pt 0.66pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(2,871<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
              <td style="padding:2.45pt 0pt 0.66pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.45pt 0pt 0.66pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">B</td>
              <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.45pt 0pt 0.66pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.45pt 0pt 0.66pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">39,926</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:8.96999999999997pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
              <td style="padding:2.45pt 0pt 0.66pt 0pt; width:247.49pt;text-align:left;">
                <div style="margin-left:9pt;">
                  <font style="letter-spacing:0.18pt;">Deferred revenues </font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
              <td style="padding:2.45pt 0pt 0.66pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.45pt 0pt 0.66pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">1,230</td>
              <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.45pt 0pt 0.66pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.45pt 0pt 0.66pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
              <td style="padding:2.45pt 0pt 0.66pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.45pt 0pt 0.66pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.45pt 0pt 0.66pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.45pt 0pt 0.66pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">1,230</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:8.96999999999997pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
              <td style="padding:2.46pt 0pt 0.65pt 0pt; width:247.49pt;text-align:left;">
                <div style="margin-left:9pt;">
                  <font style="letter-spacing:0.18pt;">Operating lease liabilities </font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
              <td style="padding:2.46pt 0pt 0.65pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.46pt 0pt 0.65pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">5,184</td>
              <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.46pt 0pt 0.65pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.46pt 0pt 0.65pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
              <td style="padding:2.46pt 0pt 0.65pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.46pt 0pt 0.65pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.46pt 0pt 0.65pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.46pt 0pt 0.65pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">5,184</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:8.96999999999997pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
              <td style="padding:2.46pt 0pt 0.65pt 0pt; width:247.49pt;text-align:left;">
                <div style="margin-left:9pt;">
                  <font style="letter-spacing:0.18pt;">Finance lease liabilities </font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
              <td style="padding:2.46pt 0pt 0.65pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.46pt 0pt 0.65pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">1,006</td>
              <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.46pt 0pt 0.65pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.46pt 0pt 0.65pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
              <td style="padding:2.46pt 0pt 0.65pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.46pt 0pt 0.65pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.46pt 0pt 0.65pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.46pt 0pt 0.65pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">1,006</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:8.96999999999997pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
              <td style="padding:2.46pt 0pt 0.65pt 0pt; width:247.49pt;text-align:left;">
                <div style="margin-left:9pt;">
                  <font style="letter-spacing:0.18pt;">Convertible promissory notes </font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
              <td style="padding:2.46pt 0pt 0.65pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.46pt 0pt 0.65pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">33,175</td>
              <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.46pt 0pt 0.65pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.46pt 0pt 0.65pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
              <td style="padding:2.46pt 0pt 0.65pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.46pt 0pt 0.65pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(33,175<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
              <td style="padding:2.46pt 0pt 0.65pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.46pt 0pt 0.65pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">C</td>
              <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.46pt 0pt 0.65pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.46pt 0pt 0.65pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
              <td style="border-bottom:1px solid #FFFFFF;padding:2.44pt 0pt 1.555pt 0pt; width:247.49pt;text-align:left;">
                <div style="margin-left:9pt;">
                  <font style="letter-spacing:0.18pt;">Other current liabilities </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.865pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:2.44pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.44pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">157</td>
              <td style="padding:0pt;padding-left:2.865pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:2.44pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.44pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">381</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.82pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:2.44pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.44pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:2.82pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:6pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:2.44pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.44pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">538</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:8.96999999999997pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
              <td style="padding:2.22pt 0pt 0.64pt 0pt; width:247.49pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:-0.18pt;">Total current liabilities</font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
              <td style="padding:2.22pt 0pt 0.64pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.22pt 0pt 0.64pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">53,834</td>
              <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.22pt 0pt 0.64pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.22pt 0pt 0.64pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">34,695</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
              <td style="padding:2.22pt 0pt 0.64pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.22pt 0pt 0.64pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(36,046<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.22pt 0pt 0.64pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.22pt 0pt 0.64pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">52,483</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:8.96999999999997pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
              <td style="padding:2.47pt 0pt 0.64pt 0pt; width:247.49pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.18pt;">Contingent consideration </font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
              <td style="padding:2.47pt 0pt 0.64pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.47pt 0pt 0.64pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.47pt 0pt 0.64pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.47pt 0pt 0.64pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
              <td style="padding:2.47pt 0pt 0.64pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.47pt 0pt 0.64pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.47pt 0pt 0.64pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.47pt 0pt 0.64pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:8.96999999999997pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
              <td style="padding:2.47pt 0pt 0.64pt 0pt; width:247.49pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.18pt;">Deferred revenues, noncurrent </font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
              <td style="padding:2.47pt 0pt 0.64pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.47pt 0pt 0.64pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">45,000</td>
              <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.47pt 0pt 0.64pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.47pt 0pt 0.64pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
              <td style="padding:2.47pt 0pt 0.64pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.47pt 0pt 0.64pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.47pt 0pt 0.64pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.47pt 0pt 0.64pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">45,000</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:8.96999999999997pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
              <td style="padding:2.47pt 0pt 0.64pt 0pt; width:247.49pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.18pt;">Derivative liability </font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
              <td style="padding:2.47pt 0pt 0.64pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.47pt 0pt 0.64pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">5,189</td>
              <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.47pt 0pt 0.64pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.47pt 0pt 0.64pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
              <td style="padding:2.47pt 0pt 0.64pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.47pt 0pt 0.64pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(5,189<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
              <td style="padding:2.47pt 0pt 0.64pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.47pt 0pt 0.64pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">C</td>
              <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.47pt 0pt 0.64pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.47pt 0pt 0.64pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:8.96999999999997pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
              <td style="padding:2.48pt 0pt 0.63pt 0pt; width:247.49pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.18pt;">Operating lease liabilities, noncurrent </font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
              <td style="padding:2.48pt 0pt 0.63pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.48pt 0pt 0.63pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">1,003</td>
              <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.48pt 0pt 0.63pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.48pt 0pt 0.63pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
              <td style="padding:2.48pt 0pt 0.63pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.48pt 0pt 0.63pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.48pt 0pt 0.63pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.48pt 0pt 0.63pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">1,003</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:8.96999999999997pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
              <td style="padding:2.48pt 0pt 0.63pt 0pt; width:247.49pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.18pt;">Finance lease liabilities, noncurrent </font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
              <td style="padding:2.48pt 0pt 0.63pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.48pt 0pt 0.63pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">703</td>
              <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.48pt 0pt 0.63pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.48pt 0pt 0.63pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
              <td style="padding:2.48pt 0pt 0.63pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.48pt 0pt 0.63pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.48pt 0pt 0.63pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.48pt 0pt 0.63pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">703</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:9pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
              <td style="border-bottom:1px solid #CCEEFF;padding:2.46pt 0pt 1.555pt 0pt; width:247.49pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.18pt;">Other noncurrent liabilities </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.865pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:2.46pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.46pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">307</td>
              <td style="padding:0pt;padding-left:2.865pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:2.46pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.46pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.82pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:2.46pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.46pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:2.82pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:6pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:2.46pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.46pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">307</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
              <td style="border-bottom:1px solid #FFFFFF;padding:2.21pt 0pt 1.555pt 0pt; width:247.49pt;text-align:left;">
                <div style="white-space:nowrap;font-weight:bold;">
                  <font style="letter-spacing:-0.18pt;">Total liabilities</font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.865pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:2.21pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">
                <div style="font-weight:bold;">&#8203;</div>
              </td>
              <td style="padding:2.21pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">
                <div style="font-weight:bold;">106,036</div>
              </td>
              <td style="padding:0pt;padding-left:2.865pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:2.21pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">
                <div style="font-weight:bold;">&#8203;</div>
              </td>
              <td style="padding:2.21pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">
                <div style="font-weight:bold;">34,695</div>
              </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.82pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:2.21pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">
                <div style="font-weight:bold;">&#8203;</div>
              </td>
              <td style="padding:2.21pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">
                <div style="font-weight:bold;">(41,235<font style="position:absolute;">)</font></div>
              </td>
              <td style="padding:0pt;padding-left:2.82pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:2.21pt 0pt 1.555pt 0pt;border-bottom:1px solid #FFFFFF; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.21pt 0pt 1.555pt 0pt;border-bottom:1px solid #FFFFFF; min-width:5.25pt; text-align:right; white-space:nowrap;">D</td>
              <td style="padding:0pt;padding-left:6pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:2.21pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">
                <div style="font-weight:bold;">&#8203;</div>
              </td>
              <td style="padding:2.21pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">
                <div style="font-weight:bold;">99,496</div>
              </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:9pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
              <td style="border-bottom:1px solid #CCEEFF;padding:2.22pt 0pt 1.555pt 0pt; width:247.49pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.18pt;">Convertible preferred stock </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.865pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:2.22pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.22pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">107,808</td>
              <td style="padding:0pt;padding-left:2.865pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:2.22pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.22pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.82pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:2.22pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.22pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">(107,808<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:2.82pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:6pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:2.22pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.22pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:8.96999999999997pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
              <td style="padding:2.24pt 0pt 0.62pt 0pt; width:247.49pt;text-align:left;">
                <font style="letter-spacing:-0.18pt;">Stockholders&#8217; equity (deficit):</font>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:8.96999999999997pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
              <td style="padding:2.49pt 0pt 0.62pt 0pt; width:247.49pt;text-align:left;">
                <div style="margin-left:9pt;">
                  <font style="letter-spacing:0.18pt;">Common stock </font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
              <td style="padding:2.49pt 0pt 0.62pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.49pt 0pt 0.62pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.49pt 0pt 0.62pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.49pt 0pt 0.62pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">202</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
              <td style="padding:2.49pt 0pt 0.62pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.49pt 0pt 0.62pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">596 </td>
              <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
              <td style="padding:2.49pt 0pt 0.62pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.49pt 0pt 0.62pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">E</td>
              <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.49pt 0pt 0.62pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.49pt 0pt 0.62pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">798 </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:8.96999999999997pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
              <td style="padding:2.49pt 0pt 0.62pt 0pt; width:247.49pt;text-align:left;">
                <div style="margin-left:9pt;">
                  <font style="letter-spacing:0.18pt;">Additional paid-in capital </font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
              <td style="padding:2.49pt 0pt 0.62pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.49pt 0pt 0.62pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">1,141</td>
              <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.49pt 0pt 0.62pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.49pt 0pt 0.62pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">493,629</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
              <td style="padding:2.49pt 0pt 0.62pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.49pt 0pt 0.62pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(225,920<font style="position:absolute;">) </font></td>
              <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
              <td style="padding:2.49pt 0pt 0.62pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.49pt 0pt 0.62pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">E</td>
              <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.49pt 0pt 0.62pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.49pt 0pt 0.62pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">268,850 </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:8.97000000000003pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
              <td style="padding:2.49pt 0pt 0.62pt 0pt; width:247.49pt;text-align:left;">
                <div style="margin-left:9pt;">
                  <font style="letter-spacing:0.18pt;">Accumulated other comprehensive income (loss) </font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
              <td style="padding:2.49pt 0pt 0.62pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.49pt 0pt 0.62pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(160<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.49pt 0pt 0.62pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.49pt 0pt 0.62pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(235<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
              <td style="padding:2.49pt 0pt 0.62pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.49pt 0pt 0.62pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">235</td>
              <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
              <td style="padding:2.49pt 0pt 0.62pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.49pt 0pt 0.62pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">E</td>
              <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.49pt 0pt 0.62pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.49pt 0pt 0.62pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(160<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
              <td style="border-bottom:1px solid #FFFFFF;padding:2.48pt 0pt 1.555pt 0pt; width:247.49pt;text-align:left;">
                <div style="margin-left:9pt;">
                  <font style="letter-spacing:0.18pt;">Accumulated deficit </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.865pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:2.48pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.48pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">(141,484<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:2.865pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:2.48pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.48pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">(328,567<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.82pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:2.48pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.48pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">325,734</td>
              <td style="padding:0pt;padding-left:2.82pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:2.48pt 0pt 1.555pt 0pt;border-bottom:1px solid #FFFFFF; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.48pt 0pt 1.555pt 0pt;border-bottom:1px solid #FFFFFF; min-width:5.25pt; text-align:right; white-space:nowrap;">E</td>
              <td style="padding:0pt;padding-left:6pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:2.48pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.48pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">(144,317<font style="position:absolute;">) </font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10.77pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
              <td style="padding:1.05pt 0pt 0.5pt 0pt; width:247.49pt;text-align:left;">
                <div style="margin-left:18pt; text-indent:-9pt; line-height:10.78pt;">
                  <font style="letter-spacing:0.18pt;">Total stockholders&#8217; equity (deficit) attributable to Carisma and </font>
                  <br >
                  <font style="letter-spacing:0.18pt;">Sesen Bio </font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
              <td style="padding:1.05pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:1.05pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(140,503<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:1.05pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:1.05pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">165,029</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
              <td style="padding:1.05pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:1.05pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">100,645 </td>
              <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:1.05pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:1.05pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">125,171 </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10.77pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
              <td style="border-bottom:1px solid #FFFFFF;padding:1.3pt 0pt 0.965pt 0pt; width:247.49pt;text-align:left;">
                <div style="margin-left:18pt; text-indent:-9pt; line-height:10.77pt; margin-bottom:-0.499999999999994pt;">
                  <font style="letter-spacing:0.18pt;">Equity attributable to noncontrolling </font>
                  <br >
                  <font style="letter-spacing:0.18pt;">interests </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.865pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:1.3pt 0pt 0.41pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:1.3pt 0pt 0.41pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">14,395</td>
              <td style="padding:0pt;padding-left:2.865pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:1.3pt 0pt 0.41pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:1.3pt 0pt 0.41pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.82pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:1.3pt 0pt 0.41pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:1.3pt 0pt 0.41pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">(14,395<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:2.82pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:1.3pt 0pt 0.965pt 0pt;border-bottom:1px solid #FFFFFF; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:1.3pt 0pt 0.965pt 0pt;border-bottom:1px solid #FFFFFF; min-width:5.25pt; text-align:right; white-space:nowrap;">F</td>
              <td style="padding:0pt;padding-left:6pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:1.3pt 0pt 0.41pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:1.3pt 0pt 0.41pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:9pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
              <td style="border-bottom:1px solid #CCEEFF;padding:2.23pt 0pt 1.555pt 0pt; width:247.49pt;text-align:left;">
                <div style="white-space:nowrap;font-weight:bold;">
                  <font style="letter-spacing:-0.18pt;">Total stockholders&#8217; equity (deficit)</font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.865pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:2.23pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">
                <div style="font-weight:bold;">&#8203;</div>
              </td>
              <td style="padding:2.23pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">
                <div style="font-weight:bold;">(126,108<font style="position:absolute;">)</font></div>
              </td>
              <td style="padding:0pt;padding-left:2.865pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:2.23pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">
                <div style="font-weight:bold;">&#8203;</div>
              </td>
              <td style="padding:2.23pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">
                <div style="font-weight:bold;">165,029</div>
              </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.82pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:2.23pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">
                <div style="font-weight:bold;">&#8203;</div>
              </td>
              <td style="padding:2.23pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">
                <div style="font-weight:bold;">86,250</div>
              </td>
              <td style="padding:0pt;padding-left:2.82pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:6pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:2.23pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">
                <div style="font-weight:bold;">&#8203;</div>
              </td>
              <td style="padding:2.23pt 0pt 1.555pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">
                <div style="font-weight:bold;">125,171</div>
              </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10.77pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
              <td style="padding:1.05pt 0pt 1.715pt 0pt; width:247.49pt;white-space:normal;text-align:left;">
                <div style="margin-left:9pt; text-indent:-9pt; line-height:10.77pt; margin-bottom:-0.499999999999994pt;">
                  <font style="letter-spacing:-0.18pt;">Total liabilities, convertible preferred stock and stockholders&#8217; equity (deficit)</font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
              <td style="padding:1.05pt 0pt 0.41pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:1.05pt 0pt 0.41pt 0pt;border-bottom:3pt double #000000; min-width:27pt; text-align:right; white-space:nowrap;">87,736</td>
              <td style="padding:0pt;padding-left:2.865pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:1.05pt 0pt 0.41pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:1.05pt 0pt 0.41pt 0pt;border-bottom:3pt double #000000; min-width:27pt; text-align:right; white-space:nowrap;">199,724</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
              <td style="padding:1.05pt 0pt 0.41pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:1.05pt 0pt 0.41pt 0pt;border-bottom:3pt double #000000; min-width:27pt; text-align:right; white-space:nowrap;">(62,793<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:2.82pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:6pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:1.05pt 0pt 0.41pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:1.05pt 0pt 0.41pt 0pt;border-bottom:3pt double #000000; min-width:27pt; text-align:right; white-space:nowrap;">224,667</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
          </table>

        <div style="margin-top:13pt; text-align:center; width:456pt; line-height:12pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">See accompanying notes to the unaudited pro&#160;forma condensed combined financial statements </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">374</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:218pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Unaudited Pro Forma Condensed Combined Statements of Operations </font>
          <br >
          <font style="letter-spacing:-0.2pt;">For the Nine Months Ended September&#160;30, 2022 </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(in thousands, except per share amounts)</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <table style="width:456pt;height:339pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:176.53pt;text-align:left;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.16pt;">CARISMA</font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Therapeutics </font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Inc. </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Sesen Bio, </font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Inc. </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Transaction </font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Adjustments </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Notes </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Other </font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Transaction </font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Adjustment </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Notes </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Pro Forma </font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Combined </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="border-bottom:1px solid #CCEEFF;padding:3.25pt 0pt 2.5pt 0pt; width:176.53pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Collaboration revenues </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:3.31pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">6,103</td>
              <td style="padding:0pt;padding-left:3.31pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">40,000</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.68pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:1.68pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.59pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.59pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.725pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(40,000<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:1.725pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:7.78pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:2.25pt; text-align:right; white-space:nowrap;">I</td>
              <td style="padding:0pt;padding-left:7.78pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">6,103</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.25pt 0pt 1.5pt 0pt; width:176.53pt;text-align:left;">
                <font style="letter-spacing:0.2pt;">Operating expenses: </font>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.59pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.59pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.725pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.725pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:7.78pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:2.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:7.78pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:176.53pt;text-align:left;">
                <div style="margin-left:10pt;">
                  <font style="letter-spacing:0.2pt;">Research and development </font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">38,536</td>
              <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">37,636</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.59pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.59pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.725pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:1.725pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:7.78pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:2.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:7.78pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">76,172</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:176.53pt;text-align:left;">
                <div style="margin-left:10pt;">
                  <font style="letter-spacing:0.2pt;">General administrative </font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">8,407</td>
              <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">32,705</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.59pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.59pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.725pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:1.725pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:7.78pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:2.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:7.78pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">41,112</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:176.53pt;text-align:left;">
                <div style="margin-left:10pt;">
                  <font style="letter-spacing:0.2pt;">Restructuring charge </font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">10,947</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.59pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.59pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.725pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:1.725pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:7.78pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:2.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:7.78pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">10,947</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:176.53pt;text-align:left;">
                <div style="margin-left:10pt;">
                  <font style="letter-spacing:0.2pt;">Intangibles impairment charge </font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">27,764</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.59pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.59pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.725pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:1.725pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:7.78pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:2.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:7.78pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">27,764</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="border-bottom:1px solid #CCEEFF;padding:2.167pt 0pt 1.833pt 0pt; width:176.53pt;white-space:normal;text-align:left;">
                <div style="margin-left:20pt; text-indent:-10pt;">
                  <font style="letter-spacing:0.2pt;">Change in fair value contingent consideration </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:3.31pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:3.31pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">(52,000<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.68pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:1.68pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.59pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.59pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.725pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:1.725pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:7.78pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:2.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:7.78pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">(52,000<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="border-bottom:1px solid #FFFFFF;padding:3.25pt 0pt 2.5pt 0pt; width:176.53pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Total operating expenses </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:3.31pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">46,943</td>
              <td style="padding:0pt;padding-left:3.31pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">57,052</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.68pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:1.68pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.59pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.59pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.725pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:1.725pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:7.78pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:2.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:7.78pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">103,995</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.25pt 0pt 1.5pt 0pt; width:176.53pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Loss from operations </font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(40,840<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">(17,052<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.59pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.59pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.725pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(40,000<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:1.725pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:7.78pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:2.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:7.78pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">(97,892<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:176.53pt;text-align:left;">
                <div style="margin-left:10pt;">
                  <font style="letter-spacing:0.2pt;">Non-operating income (expense): </font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.59pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.59pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.725pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.725pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:7.78pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:2.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:7.78pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:2.167pt 0pt 0.833pt 0pt; width:176.53pt;text-align:left;">
                <div style="margin-left:20pt; text-indent:-10pt;">
                  <font style="letter-spacing:0.2pt;">Change in fair value of derivative </font>
                  <br >
                  <font style="letter-spacing:0.2pt;">liability </font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(1,369<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">1,369</td>
              <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.59pt;width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">G</td>
              <td style="padding:0pt;padding-left:5.59pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.725pt;width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:1.725pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:7.78pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:2.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:7.78pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:176.53pt;text-align:left;">
                <div style="margin-left:10pt;">
                  <font style="letter-spacing:0.2pt;">Interest income (expense), net </font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(2,278<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">2,551</td>
              <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.59pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">G</td>
              <td style="padding:0pt;padding-left:5.59pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.725pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:1.725pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:7.78pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:2.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:7.78pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">273</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:176.53pt;text-align:left;">
                <div style="margin-left:10pt;">
                  <font style="letter-spacing:0.2pt;">Other income </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:3.31pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:3.31pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">867</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.68pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:1.68pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.59pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.59pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.725pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:1.725pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:7.78pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:2.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:7.78pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">867</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.25pt 0pt 1.5pt 0pt; width:176.53pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Loss before income taxes </font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(44,487<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">(16,185<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">3,920</td>
              <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.59pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.59pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.725pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(40,000<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:1.725pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:7.78pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:2.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:7.78pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">96,752</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:176.53pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Income tax expense </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:3.31pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:3.31pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">3,875</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.68pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:1.68pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.59pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.59pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.725pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.725pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:7.78pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:2.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:7.78pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">3,875</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.25pt 0pt 3.25pt 0pt; width:176.53pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Net Loss </font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(44,487<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">(12,310<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">3,920</td>
              <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.59pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.59pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.725pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(40,000<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:1.725pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:7.78pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:2.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:7.78pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">92,877</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:2.75pt 0pt 3.25pt 0pt; width:176.53pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Net loss per share, basic and diluted </font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
              <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(40.16<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">(0.06<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
              <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27.75pt; text-align:right; white-space:nowrap;"> </td>
              <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.59pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.59pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.725pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.725pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:7.78pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:2.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:7.78pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">(0.12<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:1.417pt 0pt 2.583pt 0pt; width:176.53pt;white-space:normal;text-align:left;">
                <div style="margin-left:10pt; text-indent:-10pt;">
                  <font style="letter-spacing:0.2pt;">Weighted average common shares outstanding, basic and diluted </font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
              <td style="padding:1.417pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:1.417pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">1,108</td>
              <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:1.417pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:1.417pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">199,801</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
              <td style="padding:1.417pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:1.417pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">596,215 </td>
              <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.59pt;width:0pt;">&#8203;</td>
              <td style="padding:1.417pt 0pt 1.833pt 0pt;padding-bottom:1.75pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:1.417pt 0pt 1.833pt 0pt;padding-bottom:1.75pt; min-width:5.25pt; text-align:right; white-space:nowrap;">H</td>
              <td style="padding:0pt;padding-left:5.59pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.725pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.725pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:7.78pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:2.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:7.78pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:1.417pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:1.417pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">797,124</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
          </table>

        <div style="margin-top:13pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">See accompanying notes to the unaudited pro&#160;forma condensed combined financial statements </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">375</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:245pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Unaudited Pro Forma Condensed Combined Statements of Operations </font>
          <br >
          <font style="letter-spacing:-0.2pt;">For the Year Ended December&#160;31, 2021 </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(in thousands, except per share amounts)</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <table style="width:456pt;height:312pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:176.53pt;text-align:left;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.16pt;">CARISMA </font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Therapeutics </font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Inc. </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Sesen Bio, </font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Inc. </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Transaction </font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Adjustments </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Notes </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Other </font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Transaction </font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Adjustment </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Notes </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Pro Forma </font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Combined </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="border-bottom:1px solid #CCEEFF;padding:3.25pt 0pt 2.5pt 0pt; width:176.53pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Collaboration revenues </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:3.31pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:3.31pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">26,544</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.68pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:1.68pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.59pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.59pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.725pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(20,000<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:1.725pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:7.515pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:3pt; text-align:right; white-space:nowrap;">J</td>
              <td style="padding:0pt;padding-left:7.515pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">6,544</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.25pt 0pt 1.5pt 0pt; width:176.53pt;text-align:left;">
                <font style="letter-spacing:0.2pt;">Operating Expenses: </font>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.59pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.59pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.725pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.725pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:7.515pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:7.515pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:176.53pt;text-align:left;">
                <div style="margin-left:10pt;">
                  <font style="letter-spacing:0.2pt;">Research and development </font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">34,387</td>
              <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">25,312</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.59pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.59pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.725pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:1.725pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:7.515pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:7.515pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">59,699</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:176.53pt;text-align:left;">
                <div style="margin-left:10pt;">
                  <font style="letter-spacing:0.2pt;">General and administrative </font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">6,407</td>
              <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">29,393</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.59pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.59pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.725pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:1.725pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:7.515pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:7.515pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">35,800</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:176.53pt;text-align:left;">
                <div style="margin-left:10pt;">
                  <font style="letter-spacing:0.2pt;">Restructuring charge </font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">5,528</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.59pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.59pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.725pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:1.725pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:7.515pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:7.515pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">5,528</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:176.53pt;text-align:left;">
                <div style="margin-left:10pt;">
                  <font style="letter-spacing:0.2pt;">Intangibles impairment charge </font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">31,700</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.59pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.59pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.725pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:1.725pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:7.515pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:7.515pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">31,700</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="border-bottom:1px solid #CCEEFF;padding:2.167pt 0pt 1.833pt 0pt; width:176.53pt;white-space:normal;text-align:left;">
                <div style="margin-left:20pt; text-indent:-10pt;">
                  <font style="letter-spacing:0.2pt;">Change in fair value of contingent consideration </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:3.31pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:3.31pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">(56,840<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.68pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:1.68pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.59pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.59pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.725pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:1.725pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:7.515pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:3pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:7.515pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">(56,840<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="border-bottom:1px solid #FFFFFF;padding:3.25pt 0pt 2.5pt 0pt; width:176.53pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Total operating expenses </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:3.31pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">40,794</td>
              <td style="padding:0pt;padding-left:3.31pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">35,093</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.68pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:1.68pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.59pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.59pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.725pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:1.725pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:7.515pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:3pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:7.515pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">75,887</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.25pt 0pt 1.5pt 0pt; width:176.53pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Loss from operations </font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(40,794<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">(8,549<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.59pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.59pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.725pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(20,000<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:1.725pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:7.515pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:7.515pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">(69,343<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:176.53pt;text-align:left;">
                <div style="margin-left:10pt;">
                  <font style="letter-spacing:0.2pt;">Non-operating income (expense): </font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.59pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.59pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.725pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.725pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:7.515pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:7.515pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:176.53pt;text-align:left;">
                <div style="margin-left:10pt;">
                  <font style="letter-spacing:0.2pt;">Interest income </font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">10</td>
              <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.59pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.59pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.725pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:1.725pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:7.515pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:7.515pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">10</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:176.53pt;text-align:left;">
                <div style="margin-left:10pt;">
                  <font style="letter-spacing:0.2pt;">Other income </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:3.31pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:3.31pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">(60<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.68pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:1.68pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.59pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.59pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.725pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:1.725pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:7.515pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:3pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:7.515pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">(60<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.25pt 0pt 1.5pt 0pt; width:176.53pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Loss before income taxes </font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(40,784<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">(8,609<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.59pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.59pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.725pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(20,000<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:1.725pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:7.515pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:7.515pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">(69,393<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:176.53pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Income tax expense </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:3.31pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:3.31pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">8,273</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.68pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:1.68pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.59pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.59pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.725pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:1.725pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:7.515pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:3pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:7.515pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">8,273</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.25pt 0pt 3.25pt 0pt; width:176.53pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Net Loss </font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(40,784<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">(336<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.59pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.59pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.725pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(20,000<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:1.725pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:7.515pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:3pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:7.515pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">(61,120<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:2.75pt 0pt 3.25pt 0pt; width:176.53pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Net loss per share, basic and diluted </font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
              <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(37.62<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">(0.00<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
              <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27.75pt; text-align:right; white-space:nowrap;"> </td>
              <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.59pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.59pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.725pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.725pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:7.515pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:3pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:7.515pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">(0.08<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:1.417pt 0pt 2.583pt 0pt; width:176.53pt;white-space:normal;text-align:left;">
                <div style="margin-left:10pt; text-indent:-10pt;">
                  <font style="letter-spacing:0.2pt;">Weighted average common shares outstanding, basic and diluted </font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
              <td style="padding:1.417pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:1.417pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">1,084</td>
              <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:1.417pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:1.417pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">182,323</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
              <td style="padding:1.417pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:1.417pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">607,511 </td>
              <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:5.59pt;width:0pt;">&#8203;</td>
              <td style="padding:1.417pt 0pt 1.833pt 0pt;padding-bottom:1.75pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:1.417pt 0pt 1.833pt 0pt;padding-bottom:1.75pt; min-width:5.25pt; text-align:right; white-space:nowrap;">H</td>
              <td style="padding:0pt;padding-left:5.59pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.725pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.725pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:7.515pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:3pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:7.515pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:1.417pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:1.417pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">790,918</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
          </table>

        <div style="margin-top:13pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">See accompanying notes to the unaudited pro&#160;forma condensed combined financial statements </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">376</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">NOTES TO UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:8.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">1.</font>
          <br >
        </div>
        <div style=" margin-top:8.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Description of Transactions</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Merger Transaction</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">On September&#160;20, 2022, Sesen Bio and Carisma entered into the Original Merger Agreement, as amended by the First Amendment thereto on December&#160;29, 2022, pursuant to which a wholly-owned subsidiary of Sesen Bio will merge with and into Carisma, with Carisma surviving as a wholly-owned subsidiary of Sesen Bio. After completion of the merger, Sesen Bio is expected to be renamed &#8220;Carisma Therapeutics Inc.&#8221; and to trade under the symbol &#8220;CARM.&#8221; As of October&#160;14, 2022, the Sesen Bio common stock is listed on the Nasdaq Capital Market under the symbol &#8220;SESN.&#8221; </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">At the effective time of the merger, each outstanding share of Carisma capital stock (including shares of Carisma common stock issued in connection with the Carisma pre-closing financing) will be converted into the right to receive shares of Sesen Bio common stock equal to the exchange ratio. Based on estimates made at the time of the Merger Agreement, the exchange ratio was initially estimated to be 37.7924 shares of Sesen Bio common stock for each share of Carisma capital stock and is subject to adjustment prior to the closing. Among other things, the exchange ratio will be adjusted to the extent that Sesen Bio&#8217;s net cash at closing is less than or greater than $75.0&#160;million and based on the amount of the Carisma pre-closing financing. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Sesen Bio currently estimates, assuming the closing of the merger occurred on December&#160;31, 2022, that (i)&#160;it would have approximately $75.0&#160;million in net cash immediately prior to closing, (ii)&#160;the Carisma pre-closing financing amount will be $30.6&#160;million, (iii)&#160;the outstanding shares of Sesen Bio common stock, Sesen Bio RSUs, Sesen Bio options and Sesen Bio warrants as of the closing will be equal to 222,944,963 and (iv)&#160;the outstanding shares of Carisma capital stock as of the closing on a fully diluted and as-converted basis will be equal to 14,855,514. Accordingly, it is currently estimated that the exchange ratio at closing will be 37.7924 and, based solely on such exchange ratio, at closing: (a)&#160;Carisma stockholders as of immediately prior to the merger (not including the shares of Carisma common stock issued in the Carisma pre-closing financing) are expected to own approximately 66.4% of the fully diluted closing Sesen Bio common stock, (b)&#160;the shares of Carisma common stock issued in the Carisma pre-closing financing to Carisma stockholders as of immediately prior to the merger are expected to represent approximately 8.4% of the fully diluted closing Sesen Bio common stock, (c)&#160;the Sesen Bio stockholders as of immediately prior to the merger (excluding for this purpose certain out-of-the-money Sesen Bio options) are expected to own approximately 25.2% of the fully diluted closing Sesen Bio common stock, (d)&#160;the shares of Sesen Bio common stock issued upon the conversion of the Carisma convertible note are expected to represent approximately 11.3% of the fully diluted closing Sesen Bio common stock, and (e)&#160;the shares of Carisma capital stock available for issuance under the Carisma Plan as of immediately prior to the merger are expected to represent approximately 10.7% of the fully diluted closing Sesen Bio common stock, in each case, subject to adjustment of the exchange ratio as set forth in the Merger Agreement and described herein. </font>
          </div>

        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Because Sesen Bio&#8217;s final net cash will not be determined until the closing, Sesen Bio stockholders cannot be certain of the exact number of shares that will be issued to Carisma stockholders when Sesen Bio stockholders vote on the proposals at the Sesen Bio special meeting. The exchange ratio referenced above is an estimate only and the final exchange ratio will be determined pursuant to a formula described in more detail in the Merger Agreement and in this proxy statement/prospectus. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As of the effective time of the merger, each Carisma option that is outstanding and unexercised immediately prior to the effective time granted under the Carisma Plan, or otherwise, whether or not vested, will be, along with the Carisma Plan, assumed by Sesen Bio and will become an option to purchase solely that number of shares of Sesen Bio common stock equal to the product obtained by multiplying (i)&#160;the number of shares of Carisma common stock by (ii)&#160;the exchange ratio, and rounding the resulting number down to the nearest whole number of shares of Sesen Bio common stock. The per share exercise price for Sesen Bio common stock issuable upon exercise of each Carisma option assumed shall be determined by dividing (a)&#160;the per share exercise price of Carisma common stock by (b)&#160;the exchange ratio and rounding the resulting exercise price up to the nearest whole cent. Any restriction on the exercise of any Carisma option </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">377</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">assumed will continue in full force and effect and the term, exercisability, vesting schedule and other provisions of such Carisma option shall otherwise remain unchanged. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Pre-Closing Financing</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As a condition of the Merger Agreement, certain investors have entered into the subscription agreement with Carisma pursuant to which such investors have agreed, subject to the terms and conditions of the subscription agreement, to purchase shares of Carisma common stock prior to closing for an aggregate purchase price of $30.6&#160;million. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Pre-Closing Dividend</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Prior to the effective time, Sesen Bio will declare a pre-closing dividend to its stockholders consisting of the right to receive contingent payments as discussed in greater detail in the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Agreements Related to the Merger&#8201;&#8212;&#8201;CVR Agreement</font><font style="letter-spacing:0.2pt;">&#8221; beginning on page <a href="#tCVAG">192</a> of this proxy statement/prospectus and a special cash dividend that is expected to be approximately $70.0&#160;million in the aggregate, subject to Sesen Bio&#8217;s estimated net cash as of the closing of the merger being greater than or equal to $75.0 million. </font>
          </div>

        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Conversion of Carisma Convertible Note</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Upon completion of the merger, Carisma&#8217;s $35.0&#160;million convertible note and accrued interest will convert into shares of Sesen Bio common stock. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Contingent Value Rights Agreement</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Prior to the effective time, Sesen Bio will enter into the CVR Agreement with a rights agent pursuant to which Sesen Bio stockholders will receive one CVR for each share of Sesen Bio common stock held. Each CVR will represent the contractual right to receive contingent cash payments upon the receipt by Sesen Bio of certain proceeds payable by Roche, if any, pursuant to the Roche Asset Purchase Agreement, upon the achievement by Roche of a specified milestone set forth in the Roche Asset Purchase Agreement as well as proceeds from any sale of Sesen Bio&#8217;s legacy assets, including Vicineum. The CVR will be recognized when the achievement of the milestone payment becomes probable. The CVRs will not have any voting or dividend rights and will not represent any equity or ownership interest in Sesen Bio. </font>
          </div>

        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Other Transaction</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Sesen Bio Sale of Legacy Technology to Roche</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On July&#160;15, 2022, Sesen Bio executed the Roche Asset Purchase Agreement pursuant to which Roche purchased all patent rights and know-how related to the monoclonal antibody EBI-031 and all other IL-6 antagonist monoclonal antibody technology owned by Sesen Bio. Sesen Bio received an upfront payment from Roche of $40.0&#160;million upon execution of the Roche Asset Purchase Agreement. In addition, Sesen Bio is eligible to receive an additional $30.0&#160;million payment from Roche upon Roche&#8217;s initiation of a Phase&#160;3 clinical trial with EBI-031 for a defined indication if initiated prior to December&#160;31, 2026 which will be paid to Sesen Bio stockholders through the CVR Agreement. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:8.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">2.</font>
          <br >
        </div>
        <div style=" margin-top:8.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Basis of Presentation</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The unaudited pro&#160;forma condensed combined financial statements were prepared in accordance with the regulations of the SEC. The unaudited pro&#160;forma condensed combined balance sheet as of September&#160;30, 2022 is presented as if the merger had been completed on September&#160;30, 2022. The unaudited pro&#160;forma condensed combined statements of operations for the nine&#160;months ended September&#160;30, 2022 and the year ended December&#160;31, 2021 assumes that the merger occurred on January&#160;1, 2021, and combines the historical results of Carisma and Sesen Bio. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Additionally, the unaudited pro&#160;forma condensed combined balance sheet and statements of operations data reflect the other transactions that will have occurred at or prior to the completion of the merger. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">378</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">

          <div style="text-indent:20pt; width:456pt; line-height:12.5pt;">
            <font style="letter-spacing:0.2pt;">For accounting purposes, Carisma is considered to be the acquiring company and the merger will be accounted for as a reverse recapitalization of Sesen Bio by Carisma because at the closing of the merger, the primary pre-combination assets of Sesen Bio will be cash, cash equivalents and marketable securities. The final exchange ratio will be determined based on a net cash calculation prior to the closing. Sesen Bio currently estimates that it will have approximately $75.0&#160;million in net cash immediately prior to the closing of the merger, assuming for this purpose that the closing of the merger occurred on December&#160;31, 2022. The exchange ratio will be adjusted dollar-for-dollar by the amount that the net cash amount is less than $75.0&#160;million. The pro&#160;forma financial statements reflect Sesen Bio management&#8217;s estimates of the fair value of Sesen Bio&#8217;s net assets that will be contributed to Carisma as part of the merger. However, the actual exchange ratio will vary based on the net cash calculation prior to the closing as described above and that difference could be material. A 10% decrease in Sesen Bio&#8217;s net cash would increase the exchange ratio by 9.1%. A 10% increase in Sesen Bio&#8217;s net cash could decrease the exchange ratio by 7.7%. As such, the estimated exchange ratio reflected in these unaudited pro&#160;forma condensed combined financial statements does not purport to represent what the actual exchange ratio will be when the merger is completed. </font>
          </div>

        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Under reverse recapitalization accounting, the assets and liabilities of Sesen Bio will be recorded, as of the completion of the merger, at their fair values which are expected to approximate book values because of the short-term nature of the instruments. No goodwill or intangible assets are expected to be recognized. The historical financial statements of Sesen Bio and Carisma, which are provided elsewhere in this proxy statement/prospectus, have been adjusted to give pro&#160;forma effect to events that are (i)&#160;directly attributable to the merger, (ii)&#160;factually supportable, and (iii)&#160;with respect to the statements of operations, expected to have a continuing impact on the combined results. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Pro&#160;forma adjustments related to the Carisma pre-closing financing for aggregate cash proceeds of $30.6&#160;million and reflect the conversion of the Carisma convertible note into shares of Sesen Bio common stock effective as of immediately after the effective time of the merger. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The unaudited pro&#160;forma condensed combined financial statements also give effect to the other transactions that are not directly attributable to the merger but are deemed relevant to the pro&#160;forma financial position and operations of the combined companies. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">To the extent there are significant changes to the business following completion of the merger, the assumptions and estimates set forth in the unaudited pro&#160;forma condensed combined financial statements could change significantly. Accordingly, the pro&#160;forma adjustments are subject to further adjustments as additional information becomes available and as additional analyses are conducted following the completion of the merger. There can be no assurances that these additional analyses will not result in material changes to the estimates of fair value. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:9.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">3.</font>
          <br >
        </div>
        <div style=" margin-top:9.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Pro Forma Adjustments</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The pro&#160;forma adjustments were based on the preliminary information available at the time of the preparation of the unaudited pro&#160;forma condensed combined financial information. The unaudited pro&#160;forma condensed combined financial information, including the notes thereto, are qualified in their entirety by reference to, and should be read in conjunction with, the separate historical audited financial statements of Sesen Bio and Carisma for the year ended December&#160;31, 2021 and the unaudited condensed financial statements of Sesen Bio and Carisma for the nine&#160;months ended September&#160;30, 2022 included elsewhere in this proxy statement/prospectus. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Merger Transaction Adjustments</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; line-height:12pt; margin-top:9.19pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">A</font>
            <br >
          </div>
          <div style=" margin-top:9.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
            <font style="letter-spacing:0.2pt;">Reflects (i)&#160;approximately $30.6&#160;million in proceeds from the Carisma pre-closing financing, (ii)&#160;payment of a $70.0&#160;million special cash dividend (iii)&#160;payment of total estimated unpaid transaction costs and (iv)&#160;payment of severance costs upon consummation of the merger. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">379</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:208pt;margin-left:69.66pt;width:456pt;">

          <table style="width:416pt;height:114pt;margin-left:20pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 2.167pt 0pt; width:265.26pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:-0.16pt;">(amounts in thousands) </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.16pt;">CARISMA </font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Therapeutics </font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Inc. </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Sesen Bio, </font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Inc. </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Total </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:1.917pt 0pt 0.833pt 0pt; width:265.26pt;white-space:normal;text-align:left;">
                <div style="margin-left:10pt; text-indent:-10pt;">
                  <font style="letter-spacing:0.2pt;">Proceeds from Carisma pre-closing financing, net of issuance costs </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.975pt;width:0pt;">&#8203;</td>
              <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">30,640</td>
              <td style="padding:0pt;padding-left:4.975pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">30,640</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:265.26pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Special cash dividend payment to Sesen Bio stockholders </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.975pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:4.975pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(70,000<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(70,000<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:265.26pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Payment of transaction costs </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.975pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">(7,333<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:4.975pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(7,700<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(15,033<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:265.26pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Payment of severance costs </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.975pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:4.975pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(8,400<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(8,400<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.25pt 0pt 3.25pt 0pt; width:265.26pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Pro&#160;forma adjustment </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.975pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">23,307</td>
              <td style="padding:0pt;padding-left:4.975pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(86,100<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(62,793<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
          </table>

        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:11pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">B</font>
          <br >
        </div>
        <div style=" margin-top:11pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Reflects payment of total estimated unpaid transaction costs as of September&#160;30, 2022 in connection with the merger and settlement of accrued interest upon conversion of the Carisma convertible note: </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <table style="width:416pt;height:72pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 2.167pt 0pt; width:271.71pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">(amounts in thousands) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">CARISMA </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Therapeutics </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Inc. </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Sesen Bio, </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Inc. </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Total </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:271.71pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Unpaid transaction costs as of September&#160;30, 2022 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.665pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">(290<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:9.665pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.775pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">(2,025<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:1.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">(2,315<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:271.71pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Accrued interest for Carisma convertible note </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.665pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">(556<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:9.665pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.775pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.775pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">(556<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:271.71pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.665pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">(846<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:9.665pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.775pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">(2,025<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:1.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">(2,871<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:11pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">C</font>
          <br >
        </div>
        <div style=" margin-top:11pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Settlement of the Carisma convertible note and related derivative liability through the issuance of Sesen Bio common stock upon completion of the merger. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">D</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Conversion of Carisma convertible preferred stock into common stock of the combined company upon completion of the merger. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">E</font>
            <br >
          </div>
          <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
            <font style="letter-spacing:0.2pt;">To record the (i)&#160;exchange ratio adjustment to Carisma&#8217;s common stock outstanding, (ii)&#160;conversion of Carisma convertible preferred stock into common stock, (iii)&#160;the elimination of Carisma&#8217;s noncontrolling interest upon conversion of Carisma convertible preferred stock, (iv)&#160;sale of Carisma common stock, net of issuance costs, in connection with Carisma pre-closing financing, (v)&#160;automatic conversion of the Carisma convertible note, (vi)&#160;elimination of Sesen Bio&#8217;s historical equity carrying value, (vii)&#160;issuance of common stock upon the acceleration of unvested Sesen Bio RSUs and PSUs upon closing of the merger, (viii)&#160;special cash dividend payment to Sesen Bio stockholders, (ix)&#160;post-combination stock-based compensation expense for Sesen Bio options and Sesen Bio RSUs and (x)&#160;payment of transaction and severance costs: </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">380</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:12pt;margin-left:27.16pt;width:541pt;">

          <table style="width:541pt;height:357pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <tr style="line-height:8pt;height:22.75pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:208.28pt;text-align:left;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;" colspan="10">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Common stock</font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;" rowspan="2">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;" colspan="4" rowspan="2">
                <div style="text-align:center; line-height:9pt; padding-bottom:0pt;">
                  <font style="letter-spacing:-0.16pt;">Additional</font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">paid-in</font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">capital</font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;" rowspan="2">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;" rowspan="2">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;" colspan="4" rowspan="2">
                <div style="text-align:center; line-height:9pt; padding-bottom:0pt;">
                  <font style="letter-spacing:-0.16pt;">Accumulated</font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">other</font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">comprehensive</font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">income</font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;" rowspan="2">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;" rowspan="2">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;" colspan="4" rowspan="2">
                <div style="text-align:center; line-height:9pt; padding-bottom:0pt;">
                  <font style="letter-spacing:-0.16pt;">Accumulated</font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">deficit</font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;" rowspan="2">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;" rowspan="2">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;" colspan="4" rowspan="2">
                <div style="text-align:center; line-height:9pt; padding-bottom:0pt;">
                  <font style="letter-spacing:-0.16pt;">Noncontrolling</font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">interests</font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;" rowspan="2">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;" rowspan="2">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;" colspan="4" rowspan="2">
                <div style="white-space:nowrap; text-align:center; line-height:9pt; padding-bottom:0pt;">
                  <font style="letter-spacing:-0.16pt;">Total </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;" rowspan="2">&#8203;</td>
            </tr>
            <tr style="line-height:8pt;height:13.5pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="border-bottom:1px solid #FFFFFF;padding:3.25pt 0pt 2.5pt 0pt; width:208.28pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:-0.16pt;">(amounts in thousands) </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">shares</font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">amount </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:1.917pt 0pt 0.5pt 0pt; width:208.28pt;white-space:normal;text-align:left;">
                <div style="margin-left:10pt; text-indent:-10pt;">
                  <font style="letter-spacing:0.2pt;">Adjustment to Carisma common stock outstanding in connection with the Exchange Ratio </font> </div>
              </td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:1.917pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:1.917pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">42,422</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.415pt;width:0pt;">&#8203;</td>
              <td style="padding:1.917pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:1.917pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">43 </td>
              <td style="padding:0pt;padding-left:2.415pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:1.917pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:1.917pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(43<font style="position:absolute;">) </font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:13.75pt;width:0pt;">&#8203;</td>
              <td style="padding:1.917pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:1.917pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">&#8212; </td>
              <td style="padding:0pt;padding-left:13.75pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.775pt;width:0pt;">&#8203;</td>
              <td style="padding:1.917pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:1.917pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212; </td>
              <td style="padding:0pt;padding-left:2.775pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.82pt;width:0pt;">&#8203;</td>
              <td style="padding:1.917pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:1.917pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212; </td>
              <td style="padding:0pt;padding-left:6.82pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:1.917pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:1.917pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212; </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:208.28pt;white-space:normal;text-align:left;">
                <div style="margin-left:10pt; text-indent:-10pt;">
                  <font style="letter-spacing:0.2pt;">Issuance of common stock upon conversion of Carisma convertible preferred shares </font> </div>
              </td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">341,209 </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.415pt;width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">341 </td>
              <td style="padding:0pt;padding-left:2.415pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">107,467</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:13.75pt;width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">&#8212; </td>
              <td style="padding:0pt;padding-left:13.75pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.775pt;width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212; </td>
              <td style="padding:0pt;padding-left:2.775pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.82pt;width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212; </td>
              <td style="padding:0pt;padding-left:6.82pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">107,808 </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:208.28pt;white-space:normal;text-align:left;">
                <div style="margin-left:10pt; text-indent:-10pt;">
                  <font style="letter-spacing:0.2pt;">Issuance of common stock upon conversion of Carisma noncontrolling interest </font> </div>
              </td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">34,301</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.415pt;width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">34 </td>
              <td style="padding:0pt;padding-left:2.415pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">14,361</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:13.75pt;width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">&#8212; </td>
              <td style="padding:0pt;padding-left:13.75pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.775pt;width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212; </td>
              <td style="padding:0pt;padding-left:2.775pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.82pt;width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(14,395<font style="position:absolute;">) </font></td>
              <td style="padding:0pt;padding-left:6.82pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212; </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:208.28pt;white-space:normal;text-align:left;">
                <div style="margin-left:10pt; text-indent:-10pt;">
                  <font style="letter-spacing:0.2pt;">Issuance of common stock upon completion of Pre-Closing Financing </font> </div>
              </td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">74,228</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.415pt;width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">75 </td>
              <td style="padding:0pt;padding-left:2.415pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">30,565</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:13.75pt;width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">&#8212; </td>
              <td style="padding:0pt;padding-left:13.75pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.775pt;width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212; </td>
              <td style="padding:0pt;padding-left:2.775pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.82pt;width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212; </td>
              <td style="padding:0pt;padding-left:6.82pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">30,640</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:208.28pt;text-align:left;">
                <div style="margin-left:10pt; text-indent:-10pt;">
                  <font style="letter-spacing:0.2pt;">Issuance of common stock upon settlement of </font>
                  <br >
                  <font style="letter-spacing:0.2pt;">Carisma convertible promissory note, accrued </font>
                  <br >
                  <font style="letter-spacing:0.2pt;">interest and related derivative liability </font> </div>
              </td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">98,068</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.415pt;width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">98 </td>
              <td style="padding:0pt;padding-left:2.415pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">40,647</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:13.75pt;width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">&#8212; </td>
              <td style="padding:0pt;padding-left:13.75pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.775pt;width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">(1,825<font style="position:absolute;">) </font></td>
              <td style="padding:0pt;padding-left:2.775pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.82pt;width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212; </td>
              <td style="padding:0pt;padding-left:6.82pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">38,920</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:208.28pt;white-space:normal;text-align:left;">
                <div style="margin-left:10pt; text-indent:-10pt;">
                  <font style="letter-spacing:0.2pt;">Elimination of Sesen Bio&#8217;s historical carrying values </font> </div>
              </td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212; </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.415pt;width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">&#8212; </td>
              <td style="padding:0pt;padding-left:2.415pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(328,802<font style="position:absolute;">) </font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:13.75pt;width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">235 </td>
              <td style="padding:0pt;padding-left:13.75pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.775pt;width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">328,567</td>
              <td style="padding:0pt;padding-left:2.775pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.82pt;width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212; </td>
              <td style="padding:0pt;padding-left:6.82pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212; </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:208.28pt;white-space:normal;text-align:left;">
                <div style="margin-left:10pt; text-indent:-10pt;">
                  <font style="letter-spacing:0.2pt;">Issuance of shares of common stock of the continuing company to Sesen Bio shareholders</font> </div>
              </td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">4,695</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.415pt;width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">5 </td>
              <td style="padding:0pt;padding-left:2.415pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(5<font style="position:absolute;">) </font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:13.75pt;width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">&#8212; </td>
              <td style="padding:0pt;padding-left:13.75pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.775pt;width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212; </td>
              <td style="padding:0pt;padding-left:2.775pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.82pt;width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212; </td>
              <td style="padding:0pt;padding-left:6.82pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212; </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:208.28pt;white-space:normal;text-align:left;">
                <div style="margin-left:10pt; text-indent:-10pt;">
                  <font style="letter-spacing:0.2pt;">Special dividend payment to Sesen Bio shareholders </font> </div>
              </td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212; </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.415pt;width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">&#8212; </td>
              <td style="padding:0pt;padding-left:2.415pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(70,000<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:13.75pt;width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">&#8212; </td>
              <td style="padding:0pt;padding-left:13.75pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.775pt;width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212; </td>
              <td style="padding:0pt;padding-left:2.775pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.82pt;width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212; </td>
              <td style="padding:0pt;padding-left:6.82pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">(70,000<font style="position:absolute;">) </font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:208.28pt;white-space:normal;text-align:left;">
                <div style="margin-left:10pt; text-indent:-10pt;">
                  <font style="letter-spacing:0.2pt;">Post-combination stock-based compensation costs </font> </div>
              </td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212; </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.415pt;width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">&#8212; </td>
              <td style="padding:0pt;padding-left:2.415pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">1,008</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:13.75pt;width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">&#8212; </td>
              <td style="padding:0pt;padding-left:13.75pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.775pt;width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">(1,008<font style="position:absolute;">) </font></td>
              <td style="padding:0pt;padding-left:2.775pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.82pt;width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212; </td>
              <td style="padding:0pt;padding-left:6.82pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212; </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="border-bottom:1px solid #FFFFFF;padding:2.167pt 0pt 0.5pt 0pt; width:208.28pt;white-space:normal;text-align:left;">
                <div style="margin-left:10pt; text-indent:-10pt;">
                  <font style="letter-spacing:0.2pt;">Payment of transaction costs and severance expenses </font> </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212; </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.415pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:14.25pt; text-align:right; white-space:nowrap;">&#8212; </td>
              <td style="padding:0pt;padding-left:2.415pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">(21,118<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:13.75pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:14.25pt; text-align:right; white-space:nowrap;">&#8212; </td>
              <td style="padding:0pt;padding-left:13.75pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.775pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212; </td>
              <td style="padding:0pt;padding-left:2.775pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.82pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212; </td>
              <td style="padding:0pt;padding-left:6.82pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">(21,118<font style="position:absolute;">) </font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.25pt 0pt 3.25pt 0pt; width:208.28pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Pro&#160;forma Adjustment </font> </div>
              </td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">594,923 </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.415pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:14.25pt; text-align:right; white-space:nowrap;">596 </td>
              <td style="padding:0pt;padding-left:2.415pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27pt; text-align:right; white-space:nowrap;">(225,920<font style="position:absolute;">) </font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:13.75pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:14.25pt; text-align:right; white-space:nowrap;">235 </td>
              <td style="padding:0pt;padding-left:13.75pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:2.775pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">325,734 </td>
              <td style="padding:0pt;padding-left:2.775pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.82pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(14,395<font style="position:absolute;">) </font></td>
              <td style="padding:0pt;padding-left:6.82pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt; width:4pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">86,250</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
          </table>

      </div>
      <div style="margin-top:12pt;margin-bottom:97.64pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; line-height:12pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">F</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Issuance of common stock upon conversion of Carisma noncontrolling interests. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:9.19pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">G</font>
          <br >
        </div>
        <div style=" margin-top:9.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Elimination of interest expense and change in fair value of derivative liability associated with the Carisma convertible note and related derivative, respectively, that were settled upon completion of the merger. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:9.19pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">H</font>
          <br >
        </div>
        <div style=" margin-top:9.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">The pro&#160;forma combined basic and diluted earnings per share have been adjusted to reflect the pro&#160;forma net loss for the nine&#160;months ended September&#160;30, 2022 and the year ended December&#160;31, 2021. In addition, the number of shares used in calculating the pro&#160;forma combined basic and diluted net income per share has been adjusted to reflect the estimated total number of shares of common stock of the combined company that would be outstanding as of the closing. The following table sets forth the calculation of the pro&#160;forma weighted average number of common shares outstanding&#8201;&#8212;&#8201;basic and diluted. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">381</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:353pt;margin-left:69.66pt;width:456pt;">

          <table style="width:416pt;height:180pt;margin-left:20pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 2.167pt 0pt; width:262.99pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:-0.16pt;">(amounts in thousands)</font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Nine&#160;months ended </font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">September&#160;30, 2022 </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Year ended </font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">December&#160;31, 2021 </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:1.917pt 0pt 0.833pt 0pt; width:262.99pt;white-space:normal;text-align:left;">
                <div style="margin-left:10pt; text-indent:-10pt;">
                  <font style="letter-spacing:0.2pt;">Effect of applying estimated exchange ratio to Carisma common stock </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:13.85pt;width:0pt;">&#8203;</td>
              <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">40,758 </td>
              <td style="padding:0pt;padding-left:13.85pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:12.94pt;width:0pt;">&#8203;</td>
              <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">39,886 </td>
              <td style="padding:0pt;padding-left:12.94pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:2.167pt 0pt 0.833pt 0pt; width:262.99pt;white-space:normal;text-align:left;">
                <div style="margin-left:10pt; text-indent:-10pt;">
                  <font style="letter-spacing:0.2pt;">Conversion of Carisma preferred stock and noncontrolling interest </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:13.85pt;width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">375,510 </td>
              <td style="padding:0pt;padding-left:13.85pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:12.94pt;width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">370,200 </td>
              <td style="padding:0pt;padding-left:12.94pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:2.167pt 0pt 0.833pt 0pt; width:262.99pt;white-space:normal;text-align:left;">
                <div style="margin-left:10pt; text-indent:-10pt;">
                  <font style="letter-spacing:0.2pt;">Issuance of common stock in connection with Carisma pre-closing financing </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:13.85pt;width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">74,228 </td>
              <td style="padding:0pt;padding-left:13.85pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:12.94pt;width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">74,228 </td>
              <td style="padding:0pt;padding-left:12.94pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:2.167pt 0pt 0.833pt 0pt; width:262.99pt;white-space:normal;text-align:left;">
                <div style="margin-left:10pt; text-indent:-10pt;">
                  <font style="letter-spacing:0.2pt;">Issuance of common stock upon settlement of Carisma convertible note, accrued interest and related derivative liability </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:13.85pt;width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">98,068 </td>
              <td style="padding:0pt;padding-left:13.85pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:12.94pt;width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">98,068 </td>
              <td style="padding:0pt;padding-left:12.94pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="border-bottom:1px solid #CCEEFF;padding:2.167pt 0pt 1.833pt 0pt; width:262.99pt;white-space:normal;text-align:left;">
                <div style="margin-left:10pt; text-indent:-10pt;">
                  <font style="letter-spacing:0.2pt;">Issuance of shares of common stock of the combined company to Sesen Bio stockholders </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:13.85pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">7,651</td>
              <td style="padding:0pt;padding-left:13.85pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:12.94pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">25,129 </td>
              <td style="padding:0pt;padding-left:12.94pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt 0pt 0.75pt 0pt; width:262.99pt;text-align:left;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:13.85pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">596,215 </td>
              <td style="padding:0pt;padding-left:13.85pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:12.94pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">607,511</td>
              <td style="padding:0pt;padding-left:12.94pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
          </table>

        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Other Transaction Adjustments</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">I</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Elimination of one time payments received in connection with the Roche Asset Purchase Agreement in July&#160;2022 of $40.0&#160;million. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">J</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Elimination of development milestone revenue received from Roche during the year ended December&#160;31, 2021 related to the assets sold to Roche in July&#160;2022.</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">382</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tDOSB">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">DESCRIPTION OF SESEN BIO CAPITAL STOCK</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;font-style:italic;">
            <font style="letter-spacing:0.2pt;">The following description of Sesen Bio&#8217;s capital stock is not complete and may not contain all the information you should consider before investing in Sesen Bio&#8217;s capital stock. This description is summarized from, and qualified in its entirety by reference to, the Sesen Bio Certificate of Incorporation and the Sesen Bio Bylaws, which have been publicly filed with the SEC. See the section entitled &#8220;Where You Can Find More Information&#8221; on page <a href="#tWYCF">404</a> of this proxy statement/prospectus. The following information does not give effect to the proposed reverse stock split described in Proposal No. 2 in this proxy statement/prospectus.</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
          </div>

        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">General</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Sesen Bio is authorized to issue up to 400,000,000 shares of common stock with a par value of $0.001 per share. As of January&#160;4, 2023, there were 202,759,043 shares of common stock outstanding and no shares of preferred stock outstanding. </font>
          </div>

        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Rights of Common Stock</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Voting Rights.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Holders of Sesen Bio common stock are entitled to one vote for each share held on all matters submitted to a vote of stockholders. When a quorum is present at any meeting, a plurality of the votes properly cast for election to any office shall elect to such office and a majority of the votes properly cast upon any question other than an election to an office shall decide the question, except when a larger vote is required by law, by the Sesen Bio Certificate of Incorporation or by the Sesen Bio Bylaws. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Sesen Bio Certificate of Incorporation and Sesen Bio Bylaws do not provide for cumulative voting rights. Because of this, the holders of a majority of the shares of Sesen Bio common stock entitled to vote in any election of directors can elect all of the directors standing for election, if they should so choose. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Dividends</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Subject to the preferences that may be applicable to any then outstanding preferred stock, the holders of outstanding Sesen Bio common stock are entitled to receive dividends, if any, as may be declared from time to time by the Sesen Bio board of directors out of legally available funds. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Liquidation Rights</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;In the event of Sesen Bio&#8217;s liquidation or dissolution, the holders of Sesen Bio common stock are entitled to receive proportionately all assets available for distribution to stockholders after the payment of all debts and other liabilities and subject to the prior rights of any holders of then outstanding preferred stock. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Other Rights.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The terms of Sesen Bio common stock do not include any preemptive, conversion or subscription rights, nor any redemption or sinking fund provisions. Sesen Bio common stock is not subject to future calls or assessments by Sesen Bio. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Preferred Stock</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Sesen Bio board of directors is authorized to issue up to 5,000,000 shares of preferred stock in one or more series, with such rights, preferences and privileges as shall be determined by the Sesen Bio board of directors. The rights, preferences and privileges of the holders of Sesen Bio common stock are subject to, and may be adversely affected by, the rights of shares of any series of preferred stock that Sesen Bio may classify and issue in the future. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Fully Paid and Nonassessable</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">All of Sesen Bio&#8217;s outstanding shares of common stock are fully paid and nonassessable. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Sesen Bio Options</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As of September&#160;30, 2022, there were 16,202,254 shares of Sesen Bio common stock issuable upon the exercise of outstanding Sesen Bio options, at a weighted-average exercise price of $1.83 per share. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Sesen Bio Restricted Stock Units</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As of September 30, 2022, there were 4,695,007 shares of Sesen Bio common stock issuable upon the vesting and settlement of outstanding Sesen Bio RSUs. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">383</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tANTIT">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Sesen Bio Warrants</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As of September 30, 2022, there were 198,535 shares of Sesen Bio common stock issuable upon the exercise of outstanding warrants, with a weighted-average exercise price of $3.57 per share. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Anti-Takeover Effect of Sesen Bio&#8217;s Certificate of Incorporation and Bylaw Provisions</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Sesen Bio Certificate of Incorporation and the Sesen Bio Bylaws contain provisions that could make it more difficult to complete an acquisition of Sesen Bio by means of a tender offer, a proxy contest or otherwise or the removal and replacement of its incumbent officers and directors. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Staggered Board; Removal of Directors.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The Sesen Bio Certificate of Incorporation and the Sesen Bio Bylaws divide the Sesen Bio board of directors into three classes with staggered three-year terms. In addition, The Sesen Bio Certificate of Incorporation and the Sesen Bio Bylaws provide that directors may be removed only for cause and only by the affirmative vote of the holders of 75% of Sesen Bio common stock present in person or by proxy and entitled to vote. Under the Sesen Bio Certificate of Incorporation and the Sesen Bio Bylaws, any vacancy on the Sesen Bio board of directors, including a vacancy resulting from an enlargement of the Sesen Bio board of directors, may be filled only by vote of a majority of Sesen Bio directors then in office. Furthermore, the Sesen Bio Certificate of Incorporation provides that the authorized number of directors may be changed only by the resolution of the Sesen Bio board of directors. The classification of the Sesen Bio board of directors and the limitations on the ability of Sesen Bio stockholders to remove directors, change the authorized number of directors and fill vacancies could make it more difficult for a third party to acquire, or discourage a third party from seeking to acquire, control of Sesen Bio. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Stockholder Action; Special Meeting of stockholders; Advance Notice Requirements for stockholder Proposals and Director Nominations</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Sesen Bio Certificate of Incorporation and the Sesen Bio Bylaws provide that any action required or permitted to be taken by Sesen Bio stockholders at an annual meeting or special meeting of stockholders may only be taken if it is properly brought before such meeting and may not be taken by written action in lieu of a meeting. The Sesen Bio Certificate of Incorporation and the Sesen Bio Bylaws also provide that, except as otherwise required by law, special meetings of the stockholders can only be called by the chairman of the Sesen Bio board of directors, the Sesen Bio chief executive officer or the Sesen Bio board of directors. In addition, the Sesen Bio Bylaws establish an advance notice procedure for stockholder proposals to be brought before an annual meeting of stockholders, including proposed nominations of candidates for election to the Sesen Bio board of directors. Stockholders at an annual meeting may only consider proposals or nominations specified in the notice of meeting or brought before the meeting by or at the direction of the Sesen Bio board of directors, or by a stockholder of record on the record date for the meeting who is entitled to vote at the meeting and who has delivered timely written notice in proper form to the Sesen Bio corporate secretary of the stockholder&#8217;s intention to bring such business before the meeting. These provisions could have the effect of delaying until the next stockholder meeting stockholder actions that are favored by the holders of a majority of Sesen Bio outstanding voting securities. These provisions also could discourage a third party from making a tender offer for Sesen Bio common stock because even if the third party acquired a majority of Sesen Bio&#8217;s outstanding voting stock, it would be able to take action as a stockholder, such as electing new directors or approving a merger, only at a duly called stockholders meeting and not by written consent. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Super-Majority Voting.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The DGCL provides generally that the affirmative vote of a majority of the shares entitled to vote on any matter is required to amend a corporation&#8217;s certificate of incorporation or bylaws unless a corporation&#8217;s certificate of incorporation or bylaws, as the case may be, requires a greater&#160;percentage. The Sesen Bio Bylaws may be amended or repealed by a majority vote of the Sesen Bio board of directors or the affirmative vote of the holders of at least 75% of the votes that all Sesen Bio stockholders would be entitled to cast in any annual election of directors. In addition, the affirmative vote of the holders of at least 75% of the votes that all Sesen Bio stockholders would be entitled to cast in any election of directors is required to amend or repeal or to adopt any provisions inconsistent with any of the provisions of the Sesen Bio Certificate of Incorporation described above. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Delaware Law.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Sesen Bio is subject to the provisions of Section&#160;203 of the DGCL. In general, Section&#160;203 prohibits a publicly held Delaware corporation from engaging in a &#8220;business combination&#8221; with </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">384</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:104pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">an &#8220;interested stockholder&#8221; for a three-year period following the time that this stockholder becomes an interested stockholder, unless the business combination is approved in a prescribed manner. Under Section&#160;203, a business combination between a corporation and an interested stockholder is prohibited unless it satisfies one of the following conditions: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">prior to the date of the transaction, the board of directors of the corporation approved either the business combination or the transaction which resulted in the stockholder becoming an interested stockholder; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the interested stockholder owned at least 85% of the voting stock of the corporation outstanding upon consummation of the transaction, excluding for purposes of determining the number of shares outstanding (1)&#160;shares owned by persons who are directors and also officers and (2)&#160;shares owned by employee stock plans in which employee participants do not have the right to determine confidentially whether shares held subject to the plan will be tendered in a tender or exchange offer; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">on or subsequent to the consummation of the transaction, the business combination is approved by the board of directors and authorized at an annual or special meeting of stockholders, and not by written consent, by the affirmative vote of at least 66-2/3% of the outstanding voting stock which is not owned by the interested stockholder. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Section&#160;203 defines a business combination to include: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">any merger or consolidation involving the corporation and the interested stockholder; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">any sale, transfer, lease, pledge or other disposition involving the interested stockholder of 10% or more of the assets of the corporation; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">subject to exceptions, any transaction that results in the issuance or transfer by the corporation of any stock of the corporation to the interested stockholder; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">subject to exceptions, any transaction involving the corporation that has the effect of increasing the proportionate share of the stock of any class or series of the corporation beneficially owned by the interested stockholder; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the receipt by the interested stockholder of the benefit of any loans, advances, guarantees, pledges or other financial benefits provided by or through the corporation. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In general, Section&#160;203 defines an interested stockholder as any entity or person beneficially owning 15% or more of the outstanding voting stock of the corporation and any entity or person affiliated with or controlling or controlled by the entity or person. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Listing</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio common stock is listed on the Nasdaq Capital Market under the symbol &#8220;SESN.&#8221; </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Transfer Agent and Registrar</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The transfer agent and registrar for Sesen Bio common stock is Computershare Trust Company, Inc. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">385</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tCORO">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">COMPARISON OF RIGHTS OF HOLDERS OF SESEN BIO STOCK AND CARISMA STOCK</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Both Sesen Bio and Carisma are incorporated under the laws of the State of Delaware and, accordingly, the rights of the stockholders of each are currently, and will continue to be, governed by the DGCL. If the merger is completed, Carisma stockholders will become stockholders of Sesen Bio, and their rights will be governed by the DGCL, the Sesen Bio Bylaws and the Sesen Bio Certificate of Incorporation, as amended by the amendment thereto attached to this proxy statement/prospectus as </font><font style="font-style:italic;letter-spacing:0.2pt;">Annex G</font><font style="letter-spacing:0.2pt;">, assuming Proposal No. 2 is approved by Sesen Bio stockholders at the Sesen Bio special meeting. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The table below summarizes the material differences between the current rights of Carisma stockholders under the Carisma Certificate of Incorporation and the Carisma Bylaws, and the rights of Sesen Bio stockholders, post-merger, under the Sesen Bio Certificate of Incorporation and Sesen Bio Bylaws, each as amended, as applicable, and as in effect immediately following the merger. </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">While Sesen Bio and Carisma believe that the summary tables cover the material differences between the rights of their respective stockholders prior to the merger and the rights of Sesen Bio stockholders following the merger, these summary tables may not contain all of the information that is important to you. These summaries are not intended to be a complete discussion of the respective rights of Sesen Bio stockholders and Carisma stockholders and are qualified in their entirety by reference to the DGCL and the various documents of Sesen Bio and Carisma that are referred to in the summaries. You should carefully read this entire proxy statement/prospectus and the other documents referred to in this proxy statement/</font>&#8203;<font style="letter-spacing:0.2pt;">prospectus for a more complete understanding of the differences between being a stockholder of Sesen Bio or Carisma before the merger and being a stockholder of Sesen Bio after the merger. Sesen Bio has filed copies of the Sesen Bio Certificate of Incorporation and Sesen Bio Bylaws with the SEC and will send copies of the documents referred to in this proxy statement/prospectus to you upon your request. Carisma will also send copies of its documents referred to in this proxy statement/prospectus to you upon your request. See the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Where You Can Find More Information</font><font style="letter-spacing:0.2pt;">&#8221; on page <a href="#tWYCF">404</a> of this proxy statement/prospectus. </font></div>

        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Current Carisma Rights Versus Post-Merger Sesen Bio Rights</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <table style="width:456pt;margin-bottom:5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:144pt;">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Provision </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:144pt;">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Carisma (Pre-Merger) </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:144pt;">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Sesen Bio (Post-Merger) </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 0.5pt 0pt; width:0pt;" colspan="7">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.2pt;">Elections; Voting; Procedural Matters</font>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Authorized Capital Stock </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;">
                <font style="letter-spacing:0.2pt;">The Carisma Certificate of Incorporation authorizes the issuance of up to 14,910,158 shares of common stock, par value $0.0001 per share, and 10,946,041 shares of preferred stock, par value of $0.0001 per share. </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;">
                <font style="letter-spacing:0.2pt;">The Sesen Bio Certificate of Incorporation authorizes the issuance of up to 400,000,000 shares of common stock, par value $0.001 per share, and 5,000,000 shares of preferred stock, par value $0.001 per share. </font>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Number of Directors </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;">
                <font style="letter-spacing:0.2pt;">The Carisma Certificate of Incorporation and the Carisma Bylaws provide that the number of directors that constitute the Carisma board of directors is established by the Carisma stockholders or the Carisma board of directors. </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;">
                <font style="letter-spacing:0.2pt;">The Sesen Bio Certificate of Incorporation and the Sesen Bio Bylaws provide that the number of directors that constitute the Sesen Bio board of directors is established by the Sesen Bio board of directors. </font>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;">
                <font style="letter-spacing:0.2pt;">Stockholder Nominations and Proposals </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;">
                <font style="letter-spacing:0.2pt;">The Carisma Bylaws do not contain advance notice requirements for stockholder proposals. </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;">
                <font style="letter-spacing:0.2pt;">The Sesen Bio Bylaws provide that in order for a stockholder to make a director nomination or propose business at an annual meeting of stockholders, the stockholder must give timely written notice to the Sesen Bio </font>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
          </table>

      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">386</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">

          <table style="width:456pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:144pt;">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Provision </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:144pt;">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Carisma (Pre-Merger) </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:144pt;">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Sesen Bio (Post-Merger) </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:144pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:144pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:1.917pt 0pt 0.5pt 0pt; width:144pt;white-space:normal;">
                <font style="letter-spacing:0.2pt;">Secretary, which must be received not less than 90&#160;days nor more than 120&#160;days prior to the first anniversary of the preceding year&#8217;s annual meeting (with certain adjustments if the date of the annual meeting is advanced by more than 20&#160;days, or delayed by more than 60&#160;days, from the first anniversary of the preceding year&#8217;s annual meeting). </font>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Quorum </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;">
                <font style="letter-spacing:0.2pt;">The Carisma Bylaws provide that the holders of a majority in voting power of the shares of the Carisma capital stock issued and outstanding and entitled to vote at the meeting, present in person, present by means of remote communication in a manner, if any, authorized by the Carisma board of directors in its sole discretion, or represented by proxy, shall constitute a quorum for the transaction of business. </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;">
                <font style="letter-spacing:0.2pt;">The Sesen Bio Bylaws provide that the holders of a majority in voting power of the shares of Sesen Bio capital stock issued and outstanding and entitled to vote at the meeting, present in person, present by means of remote communication in a manner, if any, authorized by the Sesen Bio in its sole discretion, or represented by proxy, shall constitute a quorum for the transaction of business. </font>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;">
                <font style="letter-spacing:0.2pt;">Structure of Board of Directors; Term of Directors; Election of Directors </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;">
                <div>
                  <font style="letter-spacing:0.2pt;">The Carisma Certificate of Incorporation and the Carisma Bylaws provide that the directors shall be elected at the annual meeting of stockholders. Each director holds office until the next annual meeting of stockholders or until a successor is elected and qualified, or until such director&#8217;s earlier death resignation or removal.</font>
                </div>
                <div style="margin-top:6pt;">
                  <font style="letter-spacing:0.2pt;">The holders of record of the Carisma Series&#160;B preferred stock and Series&#160;B Special Voting preferred stock, exclusively and as a separate class, shall be entitled to elect one director, and the holders of record of the Carisma Series&#160;A preferred stock and Special Voting preferred stock, exclusively and together as a single class, shall be entitled to elect three directors. The holders of record of Carisma capital stock, exclusively and voting together as a single class, shall be entitled to elect the balance of the total number of directors. </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;">
                <font style="letter-spacing:0.2pt;">The Sesen Bio Certificate of Incorporation and the Sesen Bio Bylaws provide for the division of the Sesen Bio board of directors into three staggered classes. Each director shall serve for a term ending on the date of the third annual meeting of stockholders following the annual meeting of stockholders at which such director was elected, provided, however, that the term of each director shall continue until the election and qualification of such director&#8217;s successor and be subject to such director&#8217;s earlier death, resignation or removal. </font>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
          </table>

      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">387</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">

          <table style="width:456pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:144pt;">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Provision </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:144pt;">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Carisma (Pre-Merger) </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:144pt;">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Sesen Bio (Post-Merger) </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:1.917pt 0pt 0.5pt 0pt; width:144pt;white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Removal of Directors </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:1.917pt 0pt 0.5pt 0pt; width:144pt;">
                <font style="letter-spacing:0.2pt;">The Carisma Certificate of Incorporation and the Carisma Bylaws provide for the removal of any one or more or all the directors, with or without cause, by the holders of a majority of the shares then entitled to vote at an election of directors, except that directors elected by the holders of a particular class or series of stock may be removed without cause only by the vote of the holders of a majority of the outstanding shares of such class or series. </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:1.917pt 0pt 0.5pt 0pt; width:144pt;">
                <font style="letter-spacing:0.2pt;">The Sesen Bio Certificate of Incorporation and the Sesen Bio Bylaws provide for the removal of any of its directors only for cause and requires the affirmative vote of the holders of at least seventy-five&#160;percent of the votes which all the stockholders would be entitled to cast in any annual election of directors or class of directors. </font>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Special Meetings </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;">
                <font style="letter-spacing:0.2pt;">The Carisma Bylaws provide that special meetings of stockholders may be called at any time by only the Carisma board of directors, the Chair of the Carisma board of directors, the Carisma Chief Executive Officer, or the Carisma President, and may not be called by any other person or persons. </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;">
                <font style="letter-spacing:0.2pt;">The Sesen Bio Certificate of Incorporation and the Sesen Bio Bylaws provide that a special meeting of stockholders may be called only by the Sesen Bio board of directors, the Chair of the Sesen Bio board of directors or the Sesen Bio Chief Executive Officer, and may not be called by any other person or persons. </font>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Cumulative Voting </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;">
                <font style="letter-spacing:0.2pt;">The Carisma Certificate of Incorporation provides that there shall be no cumulative voting. </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;">
                <font style="letter-spacing:0.2pt;">The Sesen Bio Certificate of Incorporation provides that there shall be no cumulative voting. </font>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Vacancies </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;">
                <font style="letter-spacing:0.2pt;">The Carisma Certificate of Incorporation and the Carisma Bylaws provide that, subject to the rights of holders of any series of Carisma preferred stock to elect directors, unless and until filled by the stockholders, any vacancy or newly-created directorship on the Carisma board of directors may be filled by vote of a majority of the directors then in office, although less than a quorum, or by a sole remaining director. A vacancy in any directorship filled by the holders of any class or series shall be filled only by vote or written consent in lieu of a meeting of the holders of such class or series or by any remaining director or directors elected by the holders of such class or series. A director elected to fill a vacancy shall be elected for the unexpired term of </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;">
                <font style="letter-spacing:0.2pt;">The Sesen Bio Certificate of Incorporation and the Sesen Bio Bylaws provide that any vacancy occurring on the Sesen Bio board of directors shall be filled only by vote of a majority of the directors then in office, although less than a quorum, or by a sole remaining director and shall not be filled by the stockholders. A director elected to fill a vacancy shall hold office until the next election of the class for which such director shall have been chosen, subject to the election and qualification of a successor and to such director&#8217;s earlier death, resignation or removal. </font>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
          </table>

      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">388</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:5.5pt;margin-left:69.66pt;width:456pt;">

          <table style="width:456pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:144pt;">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Provision </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:144pt;">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Carisma (Pre-Merger) </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:144pt;">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Sesen Bio (Post-Merger) </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:144pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:1.917pt 0pt 0.833pt 0pt; width:144pt;white-space:normal;">
                <font style="letter-spacing:0.2pt;">such director&#8217;s predecessor in office, and a director chosen to fill a position resulting from a newly-created directorship shall hold office until the next annual meeting of stockholders and until a successor is elected and qualified, or until such director&#8217;s earlier death, resignation or removal. </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:144pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.833pt 0pt; width:144pt;white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Voting Stock </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.833pt 0pt; width:144pt;">
                <div>
                  <font style="letter-spacing:0.2pt;">Under the Carisma Certificate of Incorporation and the Carisma Bylaws, each stockholder shall have one vote for each share of stock entitled to vote held of record by such stockholder.</font>
                </div>
                <div style="margin-top:6pt;">
                  <font style="letter-spacing:0.2pt;">Each holder of Carisma preferred stock shall be entitled to cast the number of votes equal to the number of whole shares of Carisma common stock into which such shares of preferred stock held by such holder are convertible as of the record date for determining stockholders entitled to vote on such matter; provided that each holder of the Carisma Special Voting preferred stock and Series&#160;B Special Voting preferred stock shall be entitled to cast the number of votes equal to the number of votes to which the holders of the Class&#160;B Exchangeable Shares and the Class&#160;B-1 Exchangeable Shares of CARISMA Therapeutics S.&#224; r.l., or Carisma Europe, respectively, would be entitled to cast if such exchangeable shares had, before the record date for such vote, been exchanged for shares of the applicable series of Carisma preferred stock pursuant to the terms of the Amended and Restated Share Exchange and Voting Agreement, dated December&#160;22, 2020, by and among Carisma, Carisma Europe and the holders of such exchangeable shares. </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.833pt 0pt; width:144pt;">
                <font style="letter-spacing:0.2pt;">Under the Sesen Bio Certificate of Incorporation and the Sesen Bio Bylaws, each stockholder shall at every meeting of the stockholders be entitled to one vote for each share of stock held by such stockholder. </font>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
          </table>

      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">389</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">

          <table style="width:456pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:144pt;">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Provision </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:144pt;">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Carisma (Pre-Merger) </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:144pt;">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Sesen Bio (Post-Merger) </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:1.917pt 0pt 0.5pt 0pt; width:144pt;">
                <font style="letter-spacing:0.2pt;">Stockholder Action by Written Consent </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:1.917pt 0pt 0.5pt 0pt; width:144pt;">
                <font style="letter-spacing:0.2pt;">Under the Carisma Certificate of Incorporation and the Carisma Bylaws, any action required or permitted to be taken at any annual or special meeting of stockholders may be taken without a meeting, without prior notice and without a vote, if a consent in writing, setting forth the action so taken, is signed by the holders of outstanding stock having not less than the minimum number of votes that would be necessary to authorize or take such action at a meeting at which all shares entitled to vote on such action were present and voted. </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:1.917pt 0pt 0.5pt 0pt; width:144pt;">
                <font style="letter-spacing:0.2pt;">The Sesen Bio Certificate of Incorporation and Sesen Bio Bylaws provide that stockholders may not take any action by written consent in lieu of a meeting. </font>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Notice of Stockholder Meeting </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;">
                <font style="letter-spacing:0.2pt;">Under the Carisma Bylaws, notice of each meeting of stockholders shall be given not less than 10 or more than 60&#160;days before the date of the meeting to each stockholder entitled to vote at such meeting. Without limiting the manner by which notice otherwise may be given to stockholders, any notice shall be effective if given by a form of electronic transmission consented to (in a manner consistent with the DGCL) by the stockholder to whom the notice is given. The notice of all meetings shall state the place, if any, date and time of the meeting and the means of remote communications, if any, by which stockholders and proxyholders may be deemed to be present in person and vote at such meeting. The notice of a special meeting shall state, in addition, the purpose or purposes for which the meeting is called. </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;">
                <font style="letter-spacing:0.2pt;">Under the Sesen Bio Bylaws, notice of each stockholder meeting must specify the place, date and time of the meeting and the means of remote communications, if any, by which stockholders and proxyholders may be deemed to be present in person and vote at such meeting, and, in the case of a special meeting, the purpose(s) for which the meeting is called. Notice shall be given not less than 10 nor more than 60&#160;days before the date of the meeting to each stockholder entitled to vote at such meeting. Without limiting the manner by which notice otherwise may be given to stockholders, any notice shall be effective if given by a form of electronic transmission consented to (in a manner consistent with the DGCL) by the stockholder to whom the notice is given. </font>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;">
                <font style="letter-spacing:0.2pt;">Conversion Rights and Protective Provisions </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;">
                <font style="letter-spacing:0.2pt;">The Carisma Certificate of Incorporation provides that holders of Carisma preferred stock have the right to convert such shares into shares of Carisma common stock at any time at a conversion rate in accordance with the terms of the Carisma Certificate of Incorporation. In addition, upon </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;">
                <font style="letter-spacing:0.2pt;">The Sesen Bio Certificate of Incorporation does not provide that stockholders have preemptive, conversion or other protective rights. </font>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
          </table>

      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">390</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">

          <table style="width:456pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:144pt;">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Provision </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:144pt;">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Carisma (Pre-Merger) </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:144pt;">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Sesen Bio (Post-Merger) </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:144pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:1.917pt 0pt 0.5pt 0pt; width:144pt;white-space:normal;">
                <font style="letter-spacing:0.2pt;">either (i)&#160;the closing of the sale of shares of Carisma common stock in a firm-commitment underwritten public offering in which the price is at least $46.80 per share and which results in at least $50&#160;million of proceeds or (ii)&#160;the date and time, or the occurrence of an event, specified by vote or written consent in accordance with the terms of the Carisma Certificate of Incorporation, all outstanding shares of Carisma preferred stock will be converted into shares of Carisma common stock. </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:144pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Right of First Refusal </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;">
                <font style="letter-spacing:0.2pt;">Pursuant to an Amended and Restated Right of First Refusal and Co-Sale Agreement, dated December&#160;22, 2020, or the ROFR Agreement, certain stockholders party to the ROFR Agreement, or a Key Holder, wishing to transfer any shares of Carisma capital stock must first provide Carisma with the right to purchase such shares. In such an event, if Carisma does not elect to exercise its right of first refusal in full, certain investors party to the ROFR Agreement, or the Investors, have a secondary right of first refusal to purchase all or any portion of the shares of Carisma common stock which are proposed for sale or transfer by the Key Holders. </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;">
                <font style="letter-spacing:0.2pt;">Sesen Bio does not have a right of first refusal in place. </font>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Right of Co-Sale </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;">
                <font style="letter-spacing:0.2pt;">Pursuant to the ROFR Agreement, each Investor has a right of co-sale with respect to any Carisma capital stock proposed to be transferred or sold by any Key Holder which is not earlier purchased by Carisma by exercise of its right of first refusal (as described above) or by any Investor by exercise of their secondary right of first refusal (as described above). </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;">
                <font style="letter-spacing:0.2pt;">Sesen Bio does not have a right of co-sale in place. </font>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Right of First Offer </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;">
                <font style="letter-spacing:0.2pt;">Pursuant to an Amended and Restated Investor Rights Agreement, dated December&#160;22, </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;">
                <font style="letter-spacing:0.2pt;">Sesen Bio does not have a right of first offer place. </font>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
          </table>

      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">391</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">

          <table style="width:456pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:144pt;">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Provision </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:144pt;">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Carisma (Pre-Merger) </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:144pt;">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Sesen Bio (Post-Merger) </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:144pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:1.917pt 0pt 0.5pt 0pt; width:144pt;white-space:normal;">
                <font style="letter-spacing:0.2pt;">2020, or the Investor Rights Agreement, if Carisma or Carisma Europe proposes to offer or sell certain new securities, Carisma and/or Carisma Europe, as applicable, must first offer such new securities to certain investors party to the Investor Rights Agreement. </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:144pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Forum Selection </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;">
                <font style="letter-spacing:0.2pt;">The Carisma Certificate of Incorporation provides that unless Carisma consents in writing to the selection of an alternative forum, the Court of Chancery in the State of Delaware shall be the sole and exclusive forum for any stockholder (including a beneficial owner) to bring (i)&#160;any derivative action or proceeding brought on behalf of Carisma, (ii)&#160;any action asserting a claim of breach of fiduciary duty owed by any director, officer or other employee of Carisma to Carisma or Carisma stockholders, (iii)&#160;any action asserting a claim against Carisma, its directors, officers or employees arising pursuant to any provision of the DGCL or the Carisma Certificate of Incorporation or the Carisma Bylaws or (iv)&#160;any action asserting a claim against Carisma, its directors, officers or employees governed by the internal affairs doctrine. </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;">
                <font style="letter-spacing:0.2pt;">The Sesen Bio Certificate of Incorporation and the Sesen Bio Bylaws do not provide for a specific forum. </font>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Registration Rights </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;">
                <font style="letter-spacing:0.2pt;">Under the Investor Rights Agreement, certain holders of Carisma capital stock that are party to the Investor Rights Agreement have certain registration rights, including the right to demand that Carisma file a registration statement, so called &#8220;demand&#8221; registration rights, or request that their shares be covered by a registration statement that Carisma is otherwise filing, so-called &#8220;piggyback&#8221; registration rights. </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;">
                <div>
                  <font style="letter-spacing:0.2pt;">The Sesen Bio Certificate of Incorporation and the Sesen Bio Bylaws do not provide registration rights to holders of Sesen Bio common stock. </font>
                </div>
                <div style="margin-top:6pt;">
                  <font style="letter-spacing:0.2pt;">In connection with the closing of the Carsima pre-closing financing, the combined company has agreed to enter into a registration rights agreement to provide for the registration of the resale of the shares of common stock purchased by the investors in connection with the Carisma pre-closing financing.</font>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
          </table>

      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">392</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">

          <table style="width:456pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.833pt 0pt; width:144pt;">
                <div style="white-space:nowrap; text-align:center; line-height:9pt;">
                  <font style="letter-spacing:-0.16pt;">Provision </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.833pt 0pt; width:144pt;">
                <div style="white-space:nowrap; text-align:center; line-height:9pt;">
                  <font style="letter-spacing:-0.16pt;">Carisma (Pre-Merger) </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.833pt 0pt; width:144pt;">
                <div style="white-space:nowrap; text-align:center; line-height:9pt;">
                  <font style="letter-spacing:-0.16pt;">Sesen Bio (Post-Merger) </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 0.5pt 0pt; width:0pt;" colspan="7">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.2pt;">Indemnification of Officers and Directors and Advancement of Expenses; Limitation on Personal Liability</font>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;">
                <font style="letter-spacing:0.2pt;">Indemnification; Advancement of Expenses </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;">
                <font style="letter-spacing:0.2pt;">The Carisma Certificate of Incorporation provides that Carisma shall provide indemnification of (and advancement of expenses to) directors, officers, and agents of Carisma (and any other persons to which the DGCL permits Carisma to provide indemnification), to the fullest extent permitted by applicable law through bylaw provisions, agreements with such agents or other persons, vote of stockholders or disinterested directors or otherwise, in excess of the indemnification and advancement otherwise permitted by Section&#160;145 of the DGCL. </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;">
                <div>
                  <font style="letter-spacing:0.2pt;">The Sesen Bio Certificate of Incorporation provides that Sesen Bio shall indemnify its directors and officers if such person acted in good faith and in a manner such person reasonably believed to be in or not opposed to the best interests of the Sesen Bio, and, with respect to any criminal action or proceeding, had no reasonable cause to believe such person&#8217;s conduct was unlawful.</font>
                </div>
                <div style="margin-top:6pt;">
                  <font style="letter-spacing:0.2pt;">The Sesen Bio Certificate of Incorporation provides that Sesen Bio will pay the expenses incurred by or on behalf of an indemnitee in defending an action, suit, proceeding or investigation or any appeal therefrom in advance of its final disposition, provided, however, that such payment of expenses in advance of the final disposition of the proceeding will be made only upon receipt of an undertaking by or on behalf of the indemnitee to repay all amounts so advanced in the event that it shall ultimately be determined by final judicial decision from which there is no further right to appeal that the indemnitee is not entitled to be indemnified. </font>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:0pt;" colspan="7">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.2pt;">Dividends</font>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;">
                <font style="letter-spacing:0.2pt;">Declaration and Payment of Dividends </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;">
                <font style="letter-spacing:0.2pt;">The Carisma Certificate of Incorporation states that the dividend rights of the holders of Carisma common stock are subject to and qualified by the rights, powers, and preferences of the holders of the Carisma preferred stock. Carisma shall not declare, pay or set aside dividends on shares of any other class or series of Carisma capital stock (other than dividends on shares of Carisma common stock payable in shares of Carisma common stock) unless (in addition to obtaining any of the consents required in the Carisma </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;">
                <font style="letter-spacing:0.2pt;">The Sesen Bio Certificate of Incorporation provides that holders of Sesen Bio common stock are entitled to receive dividends as may be lawfully declared from time to time by the Sesen Bio board of directors. </font>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
          </table>

      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">393</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">

          <table style="width:456pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:144pt;">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Provision </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:144pt;">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Carisma (Pre-Merger) </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:144pt;">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Sesen Bio (Post-Merger) </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:144pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:1.917pt 0pt 0.5pt 0pt; width:144pt;white-space:normal;">
                <font style="letter-spacing:0.2pt;">Certificate of Incorporation) the holders of the Carisma Series&#160;A and Series&#160;B preferred stock receive certain dividends as set forth in the Carisma Certificate of Incorporation. The Carisma Special Voting preferred stock and Series&#160;B Special Voting preferred stock shall not be entitled to receive any dividends. </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:144pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:0pt;" colspan="7">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.2pt;">Amendments to Certificate of Incorporation or Bylaws</font>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">General Provisions </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;">
                <div>
                  <font style="letter-spacing:0.2pt;">Provisions of the Carisma Certificate of Incorporation may be amended, altered or repealed in the manner prescribed by the DGCL and the Carisma Certificate of Incorporation. The Carisma Certificate of Incorporation provides that the affirmative vote of the holders of at least two-thirds of the voting power represented by the outstanding shares of the Carisma preferred stock, voting together as a single class are required to authorize amend, waive, alter or repeal any provision of the Carisma Certificate of Incorporation or the Carisma Bylaws, in a manner that adversely affects the powers, preferences or rights of the Carisma preferred stock.</font>
                </div>
                <div style="margin-top:6pt;">
                  <font style="letter-spacing:0.2pt;">The Carisma Certificate of Incorporation and the Carisma Bylaws provide that the Carisma Bylaws may be altered, amended or repealed, in whole or in part, or new bylaws may be adopted by the Carisma board of directors or by the affirmative vote of the holders of a majority of the shares of the Carisma capital stock issued and outstanding and entitled to vote at any annual meeting of stockholders, or at any special meeting of stockholders, provided notice of such alteration, amendment, repeal or adoption of new bylaws shall have been stated in the notice of such special meeting. </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:144pt;">
                <div>
                  <font style="letter-spacing:0.2pt;">Provisions of the Sesen Bio Certificate of Incorporation may be amended, altered or repealed in the manner prescribed by the DGCL and the Sesen Bio Certificate of Incorporation.</font>
                </div>
                <div style="margin-top:6pt;">
                  <font style="letter-spacing:0.2pt;">The Sesen Bio Certificate of Incorporation provides that the Sesen Bio board of directors has the power to amend, alter or repeal the Sesen Bio Bylaws by the affirmative vote of a majority of the directors present at any regular or special meeting of the Sesen Bio board of directors at which a quorum is present.</font>
                </div>
                <div style="margin-top:6pt;">
                  <font style="letter-spacing:0.2pt;">The Sesen Bio Certificate of Incorporation provides that the stockholders have the power to amend, alter or repeal the Sesen Bio Bylaws by the affirmative vote of the holders of at least seventy-five&#160;percent of the votes that all the stockholders would be entitled to cast in any annual election of directors or class of directors.</font>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
          </table>

      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">394</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a><a name="tPSOS">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">PRINCIPAL STOCKHOLDERS OF SESEN BIO</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Except where specifically noted, the following information and all of the information in this proxy statement/prospectus does not give effect to the proposed reverse stock split. The table below sets forth the beneficial ownership of Sesen Bio common stock as of January&#160;4, 2023 by the following individuals or entities: </font>
          </div>

        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">each of Sesen Bio&#8217;s directors; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.11pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.11pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">each of Sesen Bio&#8217;s named executive officers; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.01pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.01pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">all of Sesen Bio&#8217;s current directors and executive officers as a group; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">each person or entity known by Sesen Bio to own beneficially more than 5% of the outstanding shares of Sesen Bio common stock. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">The column entitled &#8220;Percentage&#8221; is based on a total of 202,759,043 shares of Sesen Bio common stock outstanding as of January&#160;4, 2023. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Beneficial ownership is determined in accordance with the rules and regulations of the SEC and includes voting or investment power with respect to Sesen Bio common stock. Shares of Sesen Bio common stock (i)&#160;subject to Sesen Bio options that are currently exercisable or exercisable within 60&#160;days after January&#160;4, 2023 and (ii)&#160;underlying Sesen Bio RSUs that are expected to vest and settle within 60&#160;days after January&#160;4, 2023 are considered outstanding and beneficially owned by the person holding such Sesen Bio option or Sesen Bio RSU, as applicable, for the purpose of calculating the&#160;percentage ownership of that person but not for the purpose of calculating the&#160;percentage ownership of any other person. Except as otherwise set forth below, the persons and entities in this table have sole voting and investment power with respect to all of the shares of Sesen Bio common stock beneficially owned by them, subject to applicable community property laws, where applicable. Except as otherwise set forth below, the address of each beneficial owner is c/o&#160;Sesen Bio, Inc., 245 First Street, Suite 1800, Cambridge, Massachusetts 02142. </font>
          </div>

        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Except as contemplated by the merger and the Carisma pre-closing financing, Sesen Bio does not know of any arrangements the operation of which may at a subsequent date result in a change in control of Sesen Bio. </font>
        </div>

          <table style="width:456pt;height:238pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:350.01pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Shares Beneficially Owned </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt; width:350.01pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:-0.16pt;">Name of Beneficial Owner </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Number of</font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Shares </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Percentage </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:italic;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.25pt 0pt 1.5pt 0pt; width:350.01pt;text-align:left;">
                <font style="letter-spacing:-0.2pt;">Directors and Named Executive Officers:</font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:11.935pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:11.935pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:350.01pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Jay S. Duker, M.D.</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(1)</font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">332,120 </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:11.935pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">*</td>
              <td style="padding:0pt;padding-left:11.935pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:350.01pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Peter K Honing, M.D.</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(2)</font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">140,972 </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:11.935pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">*</td>
              <td style="padding:0pt;padding-left:11.935pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:350.01pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Carrie L. Bourdow</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(3)</font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">312,833 </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:11.935pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">*</td>
              <td style="padding:0pt;padding-left:11.935pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:350.01pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Jason A. Keyes</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(4)</font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">312,833 </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:11.935pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">*</td>
              <td style="padding:0pt;padding-left:11.935pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:350.01pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Michael A.S. Jewett, M.D.</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(5)</font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">140,972 </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:11.935pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">*</td>
              <td style="padding:0pt;padding-left:11.935pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:350.01pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Thomas R. Cannell, D.V.M.</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(6)</font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">4,437,500 </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:11.935pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">2.2<font style="position:absolute;">%</font></td>
              <td style="padding:0pt;padding-left:11.935pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:350.01pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Monica Forbes</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(7)</font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">1,090,000 </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:11.935pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">*</td>
              <td style="padding:0pt;padding-left:11.935pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:350.01pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Glen MacDonald, Ph.D.</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(8)</font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">969,926 </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:11.935pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">*</td>
              <td style="padding:0pt;padding-left:11.935pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:350.01pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">All current executive officers and directors as a group (10 persons)</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(9)</font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">8,672,906 </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:11.935pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">4.3<font style="position:absolute;">%</font></td>
              <td style="padding:0pt;padding-left:11.935pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:italic;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:350.01pt;text-align:left;">
                <font style="letter-spacing:-0.2pt;">Greater than 5% stockholders:</font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:11.935pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:11.935pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:350.01pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">The Vanguard Group</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(10)</font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">12,366,756</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:11.935pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">6.1<font style="position:absolute;">%</font></td>
              <td style="padding:0pt;padding-left:11.935pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:2.167pt 0pt 1.5pt 0pt; width:350.01pt;white-space:normal;text-align:left;">
                <div style="margin-left:10pt; text-indent:-10pt;">
                  <font style="letter-spacing:0.2pt;">Bradley L. Radoff, The Radoff Family Foundation, JEC II Associates, LLC, The&#160;K. Peter Heiland 2008 Irrevocable Trust and Michael Torok</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">&#65279;(11)</font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">17,046,704</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:11.935pt;width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">8.4<font style="position:absolute;">%</font></td>
              <td style="padding:0pt;padding-left:11.935pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
          </table>

        <div style="margin-top:12.3pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>

          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-top:7.4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">*</font>
            <br >
          </div>
          <div style=" margin-top:7.4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
            <font style="letter-spacing:0.2pt;">Represents less than 1% of the issued and outstanding shares of Sesen Bio common stock as of January&#160;4, 2023. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>


          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; line-height:12pt; margin-top:3.41pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">(1)</font>
            <br >
          </div>
          <div style=" margin-top:3.41pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
            <font style="letter-spacing:0.2pt;">Consists of 332,120 shares of Sesen Bio common stock issuable upon the exercise of Sesen Bio options exercisable within 60&#160;days after January&#160;4, 2023. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">395</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:4pt;margin-left:69.66pt;width:456pt;">

          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; line-height:12pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">(2)</font>
            <br >
          </div>
          <div style=" line-height:12pt; text-align:left; margin-left:20pt;">
            <font style="letter-spacing:0.2pt;">Consists of 140,972 shares of Sesen Bio common stock issuable upon the exercise of Sesen Bio options exercisable within 60&#160;days after January&#160;4, 2023. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>


          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">(3)</font>
            <br >
          </div>
          <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
            <font style="letter-spacing:0.2pt;">Consists of 312,833 shares of Sesen Bio common stock issuable upon the exercise of Sesen Bio options exercisable within 60&#160;days after January&#160;4, 2023. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>


          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">(4)</font>
            <br >
          </div>
          <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
            <font style="letter-spacing:0.2pt;">Consists of 312,833 shares of Sesen Bio common stock issuable upon the exercise of Sesen Bio options exercisable within 60&#160;days after January&#160;4, 2023. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>


          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">(5)</font>
            <br >
          </div>
          <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
            <font style="letter-spacing:0.2pt;">Consists of 140,972 shares of Sesen Bio common stock issuable upon the exercise of Sesen Bio options exercisable within 60&#160;days after January&#160;4, 2023. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>


          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">(6)</font>
            <br >
          </div>
          <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
            <font style="letter-spacing:0.2pt;">Consists of 4,437,500 shares of Sesen Bio common stock issuable upon the exercise of Sesen Bio options exercisable within 60&#160;days after January&#160;4, 2023. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>


          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">(7)</font>
            <br >
          </div>
          <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
            <font style="letter-spacing:0.2pt;">Consists of 1,090,000 shares of Sesen Bio common stock issuable upon the exercise of Sesen Bio options exercisable within 60&#160;days after January&#160;4, 2023. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>


          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">(8)</font>
            <br >
          </div>
          <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
            <font style="letter-spacing:0.2pt;">Consists of 969,926 shares of Sesen Bio common stock issuable upon the exercise of Sesen Bio options exercisable within 60&#160;days after January&#160;4, 2023. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>


          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">(9)</font>
            <br >
          </div>
          <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
            <font style="letter-spacing:0.2pt;">Consists of 8,672,906 shares of Sesen Bio common stock issuable upon the exercise of Sesen Bio options exercisable within 60&#160;days after January&#160;4, 2023. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(10)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Holdings for The Vanguard Group are as of December&#160;31, 2021 and are based solely on information on Schedule&#160;13G filed on February&#160;10, 2022. As reported therein, The Vanguard Group reports sole voting power over 0 shares of Sesen Bio common stock, shared voting power over 343,061 shares of Sesen Bio common stock, sole dispositive power over 11,951,290 shares of Sesen Bio common stock and shared dispositive power over 415,466 shares of Sesen Bio common stock. The address of the principal business office of The Vanguard Group is 100 Vanguard Blvd., Malvern, PA 19355. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">(11)</font>
            <br >
          </div>
          <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
            <font style="letter-spacing:0.2pt;">Based solely on information provided on an amended Schedule 13D filed jointly on January&#160;5, 2023 by Bradley&#160;L. Radoff, The Radoff Family Foundation, JEC II Associates, LLC, the K. Peter Heiland 2008 Irrevocable Trust and Michael Torok. As reported therein, as of January&#160;3, 2023, Mr. Radoff reports sole voting power over 8,641,865 shares of Sesen Bio common stock, shared voting power over 0 shares of Sesen Bio common stock, sole dispositive power over 8,641,865 shares of Sesen Bio common stock and shared dispositive power over 0 shares of Sesen Bio common stock. As reported therein, as of January&#160;3, 2023, the Radoff Family Foundation reports sole voting power over 1,879,344, shared voting power over 0 shares of Sesen Bio common stock, sole dispositive power over 1,879,344 shares of Sesen Bio common stock and shared dispositive power over 0 shares of Sesen Bio common stock. As reported therein, as of January&#160;3, 2023, JEC II Associates,&#160;LLC reports sole voting power over 6,379,839 shares of Sesen Bio common stock, shared voting power over 0 shares of Sesen Bio common stock, sole dispositive power over 6,379,839 shares of Sesen Bio common stock and shared dispositive power over 0 shares of Sesen Bio common stock. As reported therein, as of November&#160;29, 2022, the K.&#160;Peter Heiland 2008 Irrevocable Trust reports sole voting power over 1,000,000 shares of Sesen Bio common stock, shared voting power over 0 shares of Sesen Bio common stock, sole dispositive power over 1,000,000 shares of Sesen Bio common stock and shared dispositive power over 0 shares of Sesen Bio common stock. As reported therein, as of January&#160;3, 2023, Mr. Torok reports sole voting power over 8,404,839 shares of Sesen Bio common stock, shared voting power over 0 shares of Sesen Bio common stock, sole dispositive power over 8,404,839 shares of Sesen Bio common stock and shared dispositive power over 0 shares of Sesen Bio common stock. The address of the principal business office of Mr. Radoff and the Radoff Family Foundation is 2727 Kirby Drive, Unit 29L, Houston, Texas 77098. The address of the principal business office of each of JEC II Associates, LLC, the K. Peter Heiland 2008 Irrevocable Trust and Mr. Torok is 68 Mazzeo Drive, Randolph, Massachusetts 02368. Mr. Radoff, the Radoff Family Foundation, JEC II Associates, LLC, the K. Peter Heiland 2008 Irrevocable Trust and Mr. Torok may be deemed to beneficially own as a group the 17,046,704 shares of Sesen Bio common stock owned in the aggregate by all of them, constituting approximately 8.4% of the outstanding shares of Sesen Bio common stock. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">396</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a><a name="tPSOC">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">PRINCIPAL STOCKHOLDERS OF CARISMA</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">The following table sets forth information with respect to the beneficial ownership of Carisma capital stock on an as converted basis as of January&#160;4, 2023 by: </font>
          </div>

        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.5pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">each of Carisma&#8217;s directors; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.51pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:4.51pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">each of Carisma&#8217;s named executive officers; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.51pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:4.51pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">all of Carisma&#8217;s directors and executive officers as a group; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.5pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:4.5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">each person or entity known by Carisma to beneficially own more than 5% of Carisma capital stock. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">The&#160;percentage of beneficial ownership prior to the merger and the Carisma pre-closing financing in the table below is based on 11,089,167 shares outstanding as of January&#160;4, 2023. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Carisma has determined beneficial ownership in accordance with the rules of the SEC. These rules generally attribute beneficial ownership of securities to persons who possess sole or shared voting power or investment power with respect to those securities. In addition, the rules require that Carisma includes shares of Carisma common stock issuable pursuant to the exercise of Carisma options that are either immediately exercisable or exercisable within 60&#160;days of January&#160;4, 2023. These shares of Carisma common stock are deemed to be outstanding and beneficially owned by the person holding those Carisma options for the purpose of calculating the&#160;percentage ownership of that person, but they are not treated as outstanding for the purpose of calculating the&#160;percentage ownership of any other person. Unless otherwise indicated, Carisma believes that the persons or entities identified in this table have sole voting and investment power with respect to all shares shown as beneficially owned by them, based on information provided to Carisma by such persons or entities, subject to applicable community property laws. </font>
          </div>

        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Except as otherwise set forth below, the address of each person or entity listed in the table is c/o&#160;CARISMA Therapeutics Inc., 3675 Market Street, Suite 200, Philadelphia, Pennsylvania 19104. </font>
        </div>

          <table style="width:456pt;height:310pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:355.01pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2pt 0pt; width:0pt;text-align:center;" colspan="10">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Shares Beneficially Owned </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="border-bottom:1px solid #000000;padding:2.083pt 0pt 1.667pt 0pt; width:355.01pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:-0.16pt;">Name of Beneficial Owner </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:2.083pt 0pt 1.667pt 0pt;" colspan="4">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Number of</font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Shares </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:2.083pt 0pt 1.667pt 0pt;" colspan="4">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Percentage </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:italic;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:2.75pt 0pt 1pt 0pt; width:355.01pt;text-align:left;">
                <font style="letter-spacing:-0.2pt;">Directors and Named Executive Officers:</font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3pt 0pt 1pt 0pt; width:355.01pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Margarita Chavez </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3pt 0pt 1pt 0pt; width:355.01pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Regina Hodits, Ph.D. </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3pt 0pt 1pt 0pt; width:355.01pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Steven Kelly</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(1)</font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">454,939 </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">3.94<font style="position:absolute;">%</font></td>
              <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3pt 0pt 1pt 0pt; width:355.01pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Michael Klichinsky, Pharm.D., PhD.</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(2)</font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">358,801</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">3.21<font style="position:absolute;">%</font></td>
              <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3pt 0pt 1pt 0pt; width:355.01pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Richard Morris</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(3)</font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">76,268 </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">*</td>
              <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3pt 0pt 1pt 0pt; width:355.01pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Briggs Morrison, M.D.</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(4)</font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">38,249 </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">*</td>
              <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3pt 0pt 1pt 0pt; width:355.01pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Bj&#246;rn Odlander, M.D., Ph.D. </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3pt 0pt 1pt 0pt; width:355.01pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Chidozie Ugwumba </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3pt 0pt 1pt 0pt; width:355.01pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Sanford Zweifach</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(5)</font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">30,375 </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">*</td>
              <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3pt 0pt 1pt 0pt; width:355.01pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">All current executive officers and directors as a group (9 persons)</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(6)</font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">958,632 </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">8.45<font style="position:absolute;">%</font></td>
              <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:italic;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3pt 0pt 1pt 0pt; width:355.01pt;text-align:left;">
                <font style="letter-spacing:-0.2pt;">Greater than 5% stockholders:</font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3pt 0pt 1pt 0pt; width:355.01pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">AbbVie Biotechnology Ltd</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(7)</font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">1,204,160</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">10.86<font style="position:absolute;">%</font></td>
              <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3pt 0pt 1pt 0pt; width:355.01pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">HealthCap VII L.P.</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(8)</font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">1,485,912</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">13.40<font style="position:absolute;">%</font></td>
              <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3pt 0pt 1pt 0pt; width:355.01pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Entities affiliated with IPG</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(9)</font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">1,524,306</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">13.75<font style="position:absolute;">%</font></td>
              <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3pt 0pt 1pt 0pt; width:355.01pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">MRL Ventures Fund, LLC</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(10)</font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">615,379</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">5.55<font style="position:absolute;">%</font></td>
              <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3pt 0pt 1pt 0pt; width:355.01pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">SymBiosis II, LLC</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(11)</font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">961,492</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">8.67<font style="position:absolute;">%</font></td>
              <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3pt 0pt 1pt 0pt; width:355.01pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">The Trustees of the University of Pennsylvania</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(12)</font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">969,725</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">8.74<font style="position:absolute;">%</font></td>
              <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3pt 0pt 1pt 0pt; width:355.01pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">TPG Biotechnology Partners V, L.P.</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(13)</font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">841,757</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">7.59<font style="position:absolute;">%</font></td>
              <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3pt 0pt 1pt 0pt; width:355.01pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Wellington Life Sciences V GmbH &amp; Co. KG</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(14)</font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">998,079</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3pt 0pt 1pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">9.00<font style="position:absolute;">%</font></td>
              <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
          </table>

        <div style="margin-top:12pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>

          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-top:7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">*</font>
            <br >
          </div>
          <div style=" margin-top:7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
            <font style="letter-spacing:0.2pt;">Represents less than 1% of the issued and outstanding shares of Carisma common stock as of January&#160;4, 2023. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">397</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">

          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; line-height:12pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">(1)</font>
            <br >
          </div>
          <div style=" line-height:12pt; text-align:left; margin-left:20pt;">
            <font style="letter-spacing:0.2pt;">Consists of 454,939 shares of Carisma common stock issuable upon the exercise of Carisma options exercisable within 60&#160;days after January&#160;4, 2023. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>


          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">(2)</font>
            <br >
          </div>
          <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
            <font style="letter-spacing:0.2pt;">Consists of (i)&#160;255,000 shares of Carisma common stock and (ii)&#160;103,801 shares of Carisma common stock issuable upon the exercise of Carisma options exercisable within 60&#160;days after January&#160;4, 2023. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>


          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">(3)</font>
            <br >
          </div>
          <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
            <font style="letter-spacing:0.2pt;">Consists of 76,268 shares of Carisma common stock issuable upon the exercise of Carisma options exercisable within 60&#160;days after January&#160;4, 2023. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>


          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">(4)</font>
            <br >
          </div>
          <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
            <font style="letter-spacing:0.2pt;">Consists of (i)&#160;6,410 shares of Carisma common stock issuable upon conversion of the Carisma Series&#160;B preferred stock and (ii)&#160;31,839 shares of Carisma common stock issuable upon the exercise of Carisma options exercisable within 60&#160;days after January&#160;4, 2023. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>


          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">(5)</font>
            <br >
          </div>
          <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
            <font style="letter-spacing:0.2pt;">Consists of 30,375 shares of Carisma common stock issuable upon the exercise of Carisma options exercisable within 60 days after January&#160;4, 2023. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>


          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">(6)</font>
            <br >
          </div>
          <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
            <font style="letter-spacing:0.2pt;">Consists of (i)&#160;255,000 shares of Carisma common stock, (ii)&#160;6,410 shares of Carisma common stock issuable upon conversion of the Carisma Series&#160;B preferred stock and (iii)&#160;697,222 shares of Carisma common stock issuable upon the exercise of Carisma options exercisable within 60&#160;days after January&#160;4, 2023. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(7)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Consists of (i)&#160;947,762 shares of Carisma common stock issuable upon conversion of the Carisma Series&#160;A preferred stock and (ii)&#160;256,398 shares of Carisma common stock issuable upon conversion of the Carisma Series&#160;B preferred stock held by AbbVie Biotechnology Ltd. AbbVie Biotechnology Ltd. holds voting and investment control over the shares. The Board of Directors of AbbVie Biotechnology Ltd. consists of Lindsey Bristow, Jonathan C. Clipper, Stephen Muldoon and Arthur Price. Each of Ms. Bristow and each of Messrs. Clipper, Muldoon and Price may be deemed to share voting and investment power with respect to the shares held by AbbVie Biotechnology Ltd. and disclaim beneficial ownership of all shares held by AbbVie Biotechnology Ltd., except to the extent of their pecuniary interest therein, if any. Margarita Chavez is employed as a Managing Director of AbbVie Ventures and is a member of the Carisma board of directors. Ms.&#160;Chavez disclaims beneficial ownership of all shares held by AbbVie Biotechnology Ltd. except to the extent of her pecuniary interest therein, if any. The business address of AbbVie Biotechnology Ltd. is Thistle House, 4 Burnaby Street, Hamilton&#160;HM&#160;11, Bermuda. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(8)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Consists of (i)&#160;250,647 shares of Carisma common stock issuable upon conversion of the Carisma Series&#160;A preferred stock, (ii)&#160;937,501 shares of Carisma common stock issuable upon the conversion of the Carisma special voting preferred stock and (iii)&#160;297,764 shares of Carisma common stock issuable upon the conversion of the Carisma Series&#160;B special voting preferred stock held by HealthCap VII, L.P. HealthCap VII GP SA, a Swiss registered L.C.C., is the sole general partner of HealthCap VII, L.P. and has voting and investment control over the shares. HealthCap VII GP SA disclaims beneficial ownership of all shares held by HealthCap VII L.P., except to the extent of its pecuniary interest therein. Fabrice Bernhard is the General Manager of HealthCap VII GP SA. Dag Richter, Daniel Schafer and Frans Wuite are each Directors of HealthCap VII GP SA. Each of Messrs. Bernhard, Richter, Schafer and Wuite may be deemed to share voting and investment power with respect to the shares held by HealthCap VII L.P. and disclaim beneficial ownership of all shares held by HealthCap VII L.P., except to the extent of their pecuniary interest therein. Bj&#246;rn Odlander is a Managing Partner of HealthCap and is a member of the Carisma board of directors. Dr.&#160;Odlander disclaims beneficial ownership of all shares held by HealthCap VII L.P. except to the extent of his pecuniary interest therein, if any. The business address of HealthCap VII L.P. is c/o&#160;HealthCap VII GP SA, Avenue Villamont 23, CH&#160;1005&#160;Lausanne Switzerland. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(9)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Consists of (i)&#160;(a)&#160;947,186 shares of Carisma common stock issuable upon conversion of the Carisma Series&#160;A preferred stock and (b)&#160;237,376 shares of Carisma common stock issuable upon conversion of the Carisma Series&#160;B preferred stock held by IPG Cayman LP, (ii)&#160;141,026 shares of Carisma common stock issuable upon conversion of the Carisma Series&#160;B preferred stock held by IPG USA SCO LP and (iii)&#160;198,718 shares of Carisma common stock issuable upon conversion of the Carisma Series&#160;B preferred stock held by CT SPV Investment LP., or collectively, the IPG entities. IP Group, Inc. has voting and investment control over the shares held by the IPG entities. The business address of the IPG entities is c/o&#160;IP Group, Inc., 1 Righter Parkway, Suite 260, Wilmington, Delaware 19803. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">398</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; line-height:12pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(10)</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Consists of (i)&#160;480,770 shares of Carisma common stock issuable upon conversion of the Carisma Series&#160;A preferred stock and (ii)&#160;134,609 shares of Carisma common stock issuable upon conversion of the Carisma Series&#160;B preferred stock held by MRL Ventures Fund, LLC. MRL Ventures Fund, LLC holds investment and voting control over the shares. Peter Dudek, Sunil Patel, Dean Li, Joe Miletich, Caroline Litchfield and George Adonna are members of the investment committee of MRL Ventures Fund, LLC. Each of Messrs. Dudek, Patel, Li, Miletich, Litchfield and Adonna may be deemed to share voting and investment power with respect to the shares held by MRL Ventures Fund, LLC and disclaim beneficial ownership of all shares held by MRL Ventures Fund, LLC, except to the extent of their pecuniary interest therein. The business address of MRL Ventures Fund, LLC is One Merck Drive, Whitehouse Station, New Jersey 08889. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(11)</font>
          <br >
        </div>
        <div style=" margin-top:3.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Consists of 961,492 shares of Carisma common stock issuable upon conversion of the Carisma Series&#160;B preferred stock held by SymBiosis II, LLC, which exercises voting and investment control of the shares. Chidozie Ugwumba is the Managing Partner of Symbiosis II, LLC and as such has sole voting and investment control over the shares. Mr.&#160;Ugwumba is also a member of the Carisma board of directors. The business address of Symbiosis II, LLC is 609 S.W. 8th Street, Suite 365, Bentonville, Arkansas 72712. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(12)</font>
          <br >
        </div>
        <div style=" margin-top:3.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Consists of (i)&#160;490,000 shares of Carisma common stock, (ii)&#160;309,594 shares of Carisma common stock issuable upon conversion of the Carisma Series&#160;A preferred stock and (iii)&#160;170,131 shares of Carisma common stock issuable upon conversion of the Carisma Series&#160;B preferred stock, held by The Trustees of the University of Pennsylvania. The Board of Trustees of the University of Pennsylvania has voting and dispositive power over the shares. The Board of Trustees of the University of Pennsylvania is comprised of more than three individuals who have authority over the voting and disposition of the share. A business address of The Trustees of the University of Pennsylvania is 2929 Walnut Street, Suite 300, Philadelphia, Pennsylvania 19104. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(13)</font>
          <br >
        </div>
        <div style=" margin-top:3.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Consists of (i)&#160;673,076 shares of Carisma common stock issuable upon conversion of the Carisma Series&#160;A preferred stock and (ii)&#160;168,681 shares of Carisma common stock issuable upon conversion of the Carisma Series&#160;B preferred stock held by TPG Biotechnology Partners V, L.P., a Delaware limited partnership. The general partner of TPG Biotechnology Partners V, L.P. is TPG Biotechnology GenPar&#160;V, L.P., a Delaware limited partnership, whose general partner is TPG Biotech GenPar V Advisors, LLC, a Delaware limited liability company, whose sole member is TPG Operating Group I, L.P., a Delaware limited partnership, whose general partner is TPG Holdings I-A, LLC, a Delaware limited liability company, whose managing member is TPG GPCo, LLC, a Delaware limited liability company, whose managing member is TPG Inc., a Delaware corporation, whose shares of Class&#160;B common&#160;stock (which represent a majority of the combined voting power of the common stock) are held by TPG Group Holdings (SBS), L.P., a Delaware limited partnership, whose general partner is TPG Group Holdings (SBS) Advisors, LLC, a Delaware limited liability company, whose managing member is TPG GP A, LLC, a Delaware limited liability company, which is owned by entities owned by David Bonderman, James G. Coulter and Jon Winkelried. Messrs. Bonderman, Coulter and Winkelried may therefore be deemed to share voting and investment power with respect to, and thus beneficially own the securities directly held by TPG Biotechnology Partners V, L.P. Messrs. Bonderman, Coulter and Winkelried disclaim beneficial ownership of the securities directly held by TPG Biotechnology Partners V, L.P. except to the extent of their pecuniary interest therein. The address of each of TPG GP A, LLC and Messrs. Bonderman, Coulter and Winkelried is 301 Commerce Street, Suite 3300, Fort Worth, Texas&#160;76102. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(14)</font>
          <br >
        </div>
        <div style=" margin-top:3.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Consists of (i)&#160;798,072 shares of Carisma common stock issuable upon conversion of the Carisma Series&#160;A preferred stock and (ii)&#160;200,007 shares of Carisma common stock issuable upon conversion of the Carisma Series&#160;B preferred stock held by Wellington Life Sciences V GmbH &amp; Co. KG, or the Wellington Fund. The Wellington Fund is represented by Wellington Life Sciences Venture Capital Consulting GmbH, or the Wellington General Partner. The Wellington General Partner holds voting and investment control over the shares. Dr. Regina Hodits and Dr. Rainer Strohmenger, in their functions as managing directors of the Wellington General Partner, have individual signatory power as well as voting and/or investment control over the shares. Dr. Regina Hodits is a member of the Carisma board of directors. Dr.&#160;Regina Hodits disclaims beneficial ownership of all shares held by the Wellington Fund except to the extent of her pecuniary interest therein, if any. The business address of the Wellington Fund and the Wellington General Partner is Tuerkenstrasse 5, 80333 Munich, Germany. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">399</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a><a name="tPSOT">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:100.73pt;margin-left:69.66pt;width:456pt;">

          <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">PRINCIPAL STOCKHOLDERS OF THE COMBINED COMPANY</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
            <font style="letter-spacing:0.2pt;">Except where specifically noted, the following information and all of the information in this proxy statement/prospectus does not give effect to the proposed reverse stock split. The table below sets forth certain information with respect to the beneficial ownership of the common stock of the combined company upon consummation of the merger based on beneficial ownership of Sesen Bio common stock and Carisma common stock as of January&#160;4, 2023 (assuming the closing of the merger occurred on January&#160;24, 2023) by: </font>
          </div>


          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.19pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:7.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">each director of the combined company; </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>


          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:7.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">each named executive officer of the combined company; </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>


          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.19pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:7.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">all of the combined company&#8217;s directors and executive officers as a group; and </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>


          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.19pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:7.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">each person or entity expected by Carisma and Sesen Bio to become the beneficial owner of more than 5% of the common stock of the combined company upon the consummation of the merger. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
            <font style="letter-spacing:0.2pt;">The table assumes effectiveness of the Carisma pre-closing financing, an exchange ratio of 37.7924, that the closing of the merger occurred on January&#160;4, 2023 and that the conversion of the Carisma convertible note occurred immediately after the effective time of the merger. Assuming a closing date of January&#160;4, 2023, immediately prior to the merger and after the closing of the Carisma pre-closing financing and conversion of the Carisma convertible note, Carisma is expected to have 15,689,808 shares of common stock outstanding and Sesen Bio is expected to have 202,759,043 shares of common stock outstanding. Upon the closing of the merger on the assumed date of January&#160;4, 2023, the 15,689,808 shares of Carisma common stock would be converted into the right to receive an aggregate of 591,720,707 shares of Sesen Bio common stock such that there would be a total of 794,479,750 shares of common stock of the combined company outstanding upon the closing of the merger. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
            <font style="letter-spacing:0.2pt;">Sesen Bio and Carisma have determined beneficial ownership in accordance with the rules of the SEC. These rules generally attribute beneficial ownership of securities to persons who possess sole or shared voting power or investment power with respect to those securities. In addition, the rules include (a)&#160;shares of Sesen Bio common stock (i)&#160;subject to Sesen Bio options that are currently exercisable or exercisable within 60&#160;days after January&#160;4, 2023 and (ii)&#160;underlying Sesen Bio RSUs that are expected to vest and settle within 60&#160;days after January&#160;4, 2023 and (b)&#160;shares of Carisma common stock issuable pursuant to the exercise of Carisma options that are either immediately exercisable or exercisable within 60&#160;days of January&#160;4, 2023. Such shares of Sesen Bio common stock or Carisma common stock are, in each case, deemed to be outstanding and beneficially owned by the person holding such Sesen Bio option, Sesen Bio RSU or Carisma option, as applicable, for the purpose of calculating the&#160;percentage ownership of that person, but they are not treated as outstanding for the purpose of calculating the&#160;percentage ownership of any other person. Except as otherwise set forth below, Sesen Bio and Carisma believe that the persons or entities identified in this table have sole voting and investment power with respect to all shares shown as beneficially owned by them, subject to applicable community property laws. Except as otherwise set forth below, the address of each person or entity listed in the table is c/o&#160;CARISMA Therapeutics Inc., 3675 Market Street, Suite 200, Philadelphia, Pennsylvania 19104. </font>
          </div>

      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">400</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">

          <table style="width:456pt;height:316pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:350.01pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Shares Beneficially Owned </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt; width:350.01pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:-0.16pt;">Name of Beneficial Owner </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Number of</font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Shares </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Percentage </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:italic;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.25pt 0pt 1.5pt 0pt; width:350.01pt;text-align:left;">
                <font style="letter-spacing:-0.2pt;">Directors and Named Executive Officers:</font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:350.01pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Thomas R. Cannell, D.V.M.</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(1)</font> </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">4,437,500</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">*</td>
              <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:350.01pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Regina Hodits, Ph.D </font> </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">*</td>
              <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:350.01pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Steven Kelly</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(2)</font> </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">17,193,237</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">2.12<font style="position:absolute;">%</font></td>
              <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:350.01pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Michael Klichinsky, Pharm.D., Ph.D.</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(3)</font> </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">13,559,964</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1.70<font style="position:absolute;">%</font></td>
              <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:350.01pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Richard Morris</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(4)</font> </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">2,882,335</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">*</td>
              <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:350.01pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Briggs Morrison, M.D.</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(5)</font> </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">1,445,515</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">*</td>
              <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:350.01pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Bj&#246;rn Odlander, M.D., Ph.D </font> </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">*</td>
              <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:350.01pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Chidozie Ugwumba </font> </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">*</td>
              <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:350.01pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Sanford Zweifach</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(6)</font> </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">1,147,944</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">*</td>
              <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:350.01pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">All current executive officers and directors as a group (9 persons)</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(7)</font> </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">40,666,495</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">5.05<font style="position:absolute;">%</font></td>
              <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:italic;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:350.01pt;text-align:left;">
                <font style="letter-spacing:-0.2pt;">Greater than 5% stockholders:</font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:350.01pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">AbbVie Biotechnology Ltd.</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(8)</font> </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">54,713,947</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">6.88<font style="position:absolute;">%</font></td>
              <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:350.01pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">HealthCap VII L.P.</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(9)</font> </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">67,615,025</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">8.50<font style="position:absolute;">%</font></td>
              <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:350.01pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Entities affiliated with IPG</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(10)</font> </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">57,607,182</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">7.24<font style="position:absolute;">%</font></td>
              <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:350.01pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Moderna Biotech Ventures, LLC.</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(11)</font> </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">99,641,170</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">12.52<font style="position:absolute;">%</font></td>
              <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:350.01pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">SymBiosis II, LLC</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(12)</font> </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">44,089,370</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">5.54<font style="position:absolute;">%</font></td>
              <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:350.01pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">The Trustees of the University of Pennsylvania</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(13)</font> </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">43,431,480</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">5.46<font style="position:absolute;">% </font></td>
              <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:350.01pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Wellington Life Sciences V GmbH &amp; Co. KG</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(14)</font> </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">45,714,330</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">5.75<font style="position:absolute;">%</font></td>
              <td style="padding:0pt;padding-left:6.935pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
          </table>

        <div style="margin-top:12.3pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>

          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">*</font>
            <br >
          </div>
          <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
            <font style="letter-spacing:0.2pt;">Represents less than 1% of the issued and outstanding shares of common stock of the combined company as of January&#160;4, 2023. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>


          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; line-height:12pt; margin-top:3.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">(1)</font>
            <br >
          </div>
          <div style=" margin-top:3.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
            <font style="letter-spacing:0.2pt;">Consists of 4,437,500 shares of common stock of the combined company issuable upon the exercise of options of the combined company exercisable within 60&#160;days after January&#160;4, 2023. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>


          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; line-height:12pt; margin-top:3.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">(2)</font>
            <br >
          </div>
          <div style=" margin-top:3.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
            <font style="letter-spacing:0.2pt;">Consists of 17,193,237 shares of common stock of the combined company issuable upon the exercise of options of the combined company exercisable within 60&#160;days after January&#160;4, 2023. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>


          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; line-height:12pt; margin-top:3.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">(3)</font>
            <br >
          </div>
          <div style=" margin-top:3.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
            <font style="letter-spacing:0.2pt;">Consists of (i)&#160;9,637,062 shares of common stock of the combined company and (ii)&#160;3,922,902 shares of common stock of the combined company issuable upon the exercise of options of the combined company exercisable within 60&#160;days after January&#160;4, 2023. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>


          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; line-height:12pt; margin-top:3.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">(4)</font>
            <br >
          </div>
          <div style=" margin-top:3.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
            <font style="letter-spacing:0.2pt;">Consists of 2,882,335 shares of common stock of the combined company issuable upon the exercise of options of the combined company exercisable within 60&#160;days after January&#160;4, 2023. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>


          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; line-height:12pt; margin-top:3.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">(5)</font>
            <br >
          </div>
          <div style=" margin-top:3.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
            <font style="letter-spacing:0.2pt;">Consists of (i)&#160;242,249 shares of common stock of the combined company and (ii)&#160;1,203,266 shares of common stock issuable upon the exercise of options of the combined company exercisable within 60&#160;days after January&#160;4, 2023. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>


          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; line-height:12pt; margin-top:3.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">(6)</font>
            <br >
          </div>
          <div style=" margin-top:3.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
            <font style="letter-spacing:0.2pt;">Consists of 1,147,944 shares of common stock of the combined company issuable upon the exercise of options of the combined company exercisable within 60&#160;days after January&#160;4, 2023. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>


          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; line-height:12pt; margin-top:3.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">(7)</font>
            <br >
          </div>
          <div style=" margin-top:3.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
            <font style="letter-spacing:0.2pt;">Consists of (i)&#160;9,879,311 shares of common stock of the combined company and (ii)&#160;30,787,183 shares of common stock of the combined company issuable upon the exercise of options of the combined company exercisable within 60&#160;days after January&#160;4, 2023. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>


          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; line-height:12pt; margin-top:3.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">(8)</font>
            <br >
          </div>
          <div style=" margin-top:3.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
            <font style="letter-spacing:0.2pt;">Consists of 54,713,947 shares of common stock of the combined company held by AbbVie Biotechnology Ltd. AbbVie Biotechnology Ltd. holds voting and investment control over the shares. The Board of Directors of AbbVie Biotechnology Ltd. consists of Lindsey Bristow, Jonathan C. Clipper, Stephen Muldoon and Arthur Price. Each of Ms.&#160;Bristow and each of Messrs. Clipper, Muldoon and Price may be deemed to share voting and investment power with respect to the shares held by AbbVie Biotechnology Ltd. and disclaim beneficial ownership of all shares held by AbbVie Biotechnology </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">401</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:8pt;margin-left:69.66pt;width:456pt;">

          <div style="margin-left:20pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Ltd., except to the extent of their pecuniary interest therein, if any. Margarita Chavez is employed as a Managing Director of AbbVie Ventures and is a member of the Carisma board of directors. Ms.&#160;Chavez disclaims beneficial ownership of all shares held by AbbVie Biotechnology Ltd. except to the extent of her pecuniary interest therein, if any. The business address of AbbVie Biotechnology Ltd. is Thistle House, 4 Burnaby Street, Hamilton HM 11, Bermuda. </font>
          </div>


          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">(9)</font>
            <br >
          </div>
          <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
            <font style="letter-spacing:0.2pt;">Consists of 67,615,025 shares of common stock of the combined company held by HealthCap VII, L.P. HealthCap VII GP SA, a Swiss registered L.C.C., is the sole general partner of HealthCap VII, L.P. and has voting and investment control over the shares. HealthCap VII GP SA disclaims beneficial ownership of all shares held by HealthCap VII L.P., except to the extent of their pecuniary interest therein. Fabrice Bernhard is the General Manager of HealthCap VII GP SA. Dag Richter, Daniel Schafer and Frans Wuite are each Directors of HealthCap VII GP SA. Each of Messrs. Bernhard, Richter, Schafer and Wuite may be deemed to share voting and investment power with respect to the shares held by HealthCap VII L.P. and disclaim beneficial ownership of all shares held by HealthCap&#160;VII L.P., except to the extent of their pecuniary interest therein. Bj&#246;rn Odlander is a Managing Partner of HealthCap and is a member of the Carisma board of directors. Dr.&#160;Odlander disclaims beneficial ownership of all shares held by HealthCap VII L.P. except to the extent of his pecuniary interest therein, if any. The business address of HealthCap VII L.P. is c/o&#160;HealthCap VII GP&#160;SA, Avenue Villamont 23, CH 1005 Lausanne Switzerland. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>


          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">(10)</font>
            <br >
          </div>
          <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
            <font style="letter-spacing:0.2pt;">Consists of (i)&#160;44,767,441 shares of common stock of the combined company held by IPG Cayman&#160;LP, (ii)&#160;5,329,711 shares of common stock of the combined company held by IPG USA SCO LP and (iii)&#160;7,510,030 shares of common stock of the combined company held by CT SPV Investment LP, or collectively, the IPG entities. IP Group, Inc. has voting and investment control over the shares held by the IPG entities. The business address of the IPG entities is c/o&#160;IP Group, Inc., 1 Righter Parkway, Suite&#160;260, Wilmington, Delaware 19803. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>


          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">(11)</font>
            <br >
          </div>
          <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
            <font style="letter-spacing:0.2pt;">Consists of 99,641,170 shares of common stock of the combined company held by ModernaTX, Inc. ModernaTX, Inc. is wholly owned by Moderna, Inc., a publicly-traded company. The business address of ModernaTX, Inc. is 200 Technology Square, Cambridge, MA 02139. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>


          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">(12)</font>
            <br >
          </div>
          <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
            <font style="letter-spacing:0.2pt;">Consists of 44,089,370 shares of common stock of the combined company held by SymBiosis II, LLC, which exercises voting and investment control of the shares. Chidozie Ugwumba is the Managing Partner of Symbiosis II, LLC and as such has sole voting and investment control over the shares. Mr.&#160;Ugwumba is also a member of the Carisma board of directors. The business address of Symbiosis&#160;II, LLC is 609 S.W. 8th Street, Suite 365, Bentonville, Arkansas 72712. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>


          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">(13)</font>
            <br >
          </div>
          <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
            <font style="letter-spacing:0.2pt;">Consists of 43,431,480 shares of common stock of the combined company held by The Trustees of the University of Pennsylvania. The Board of Trustees of the University of Pennsylvania has voting and dispositive power over the shares. The Board of Trustees of the University of Pennsylvania is comprised of more than three individuals who have authority over the voting and disposition of the share. A business address of The Trustees of the University of Pennsylvania is 2929 Walnut Street, Suite 300, Philadelphia, Pennsylvania 19104. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>


          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">(14)</font>
            <br >
          </div>
          <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
            <font style="letter-spacing:0.2pt;">Consists of 45,714,330 shares of common stock of the combined company held by Wellington Life Sciences V GmbH &amp; Co. KG, or the Wellington Fund. The Wellington Fund is represented by Wellington Life Sciences Venture Capital Consulting GmbH, or the Wellington General Partner. The Wellington General Partner holds voting and investment control over the shares. Dr.&#160;Regina Hodits and Dr.&#160;Rainer Strohmenger, in their functions as managing directors of the Wellington General Partner, have individual signatory power as well as voting and/or investment control over the shares. Dr.&#160;Regina Hodits is a member of the Carisma board of directors. Dr.&#160;Regina Hodits disclaims beneficial ownership of all shares held by the Wellington Fund except to the extent of her pecuniary interest therein, if any. The business address of the Wellington Fund and the Wellington General Partner is Tuerkenstrasse 5, 80333 Munich, Germany. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">402</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a><a name="tLEMA">&#8203;</a><a name="tEXP">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:376pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">LEGAL MATTERS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Hogan Lovells US LLP, Philadelphia, Pennsylvania, will pass on the validity of the Sesen Bio common stock offered by this proxy statement/prospectus. </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">EXPERTS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The consolidated financial statements of Sesen Bio, Inc. at December&#160;31, 2021 and 2020, and for each of the three&#160;years in the period ended December&#160;31, 2021, included in the Proxy Statement of Sesen Bio,&#160;Inc., which is referred to and made part of this Prospectus and Registration Statement, have been audited by Ernst &amp; Young LLP, independent registered public accounting firm, as set forth in their report appearing elsewhere herein, and are included in reliance upon such report given on the authority of such firm as experts in accounting and auditing. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The consolidated financial statements of CARISMA Therapeutics Inc. as of December&#160;31, 2021 and 2020, and for the&#160;years then ended, have been included herein and in the registration statement in reliance upon the report of KPMG LLP, independent registered public accounting firm, appearing elsewhere herein, and upon the authority of said firm as experts in accounting and auditing. The audit report covering the December&#160;31, 2021 consolidated financial statements contains an explanatory paragraph that states that CARISMA Therapeutics Inc.&#8217;s recurring losses and negative cash flows from operations raise substantial doubt about the entity&#8217;s ability to continue as a going concern. The consolidated financial statements do not include any adjustments that might result from the outcome of that uncertainty. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">403</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a><a name="tWYCF">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:117pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">WHERE YOU CAN FIND MORE INFORMATION</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio files annual, quarterly and current reports, proxy statements and other information with the SEC. Sesen Bio&#8217;s SEC filings are available to the public electronically at the SEC&#8217;s website at www.sec.gov. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio also makes available free of charge on or through its website at www.ir.sesenbio.com, its Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and amendments to those reports filed or furnished pursuant to Section&#160;13(a) or 15(d) of the Exchange Act as soon as reasonably practicable after Sesen Bio electronically files such material with or otherwise furnishes it to the SEC. The website addresses for the SEC and Sesen Bio are inactive textual references, and information on those websites are not part of this proxy statement/prospectus. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As of the date of this proxy statement/prospectus, Sesen Bio has filed with the SEC a registration statement on Form S-4, of which this proxy statement/prospectus is a part, under the Securities Act to register the shares of Sesen Bio common stock that Sesen Bio will issue to Carisma stockholders in the merger. This proxy statement/prospectus is a part of that registration statement and constitutes a prospectus of Sesen Bio, as well as a proxy statement of Sesen Bio for its special meeting. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio has supplied all information contained in this proxy statement/prospectus relating to Sesen Bio, and Carisma has supplied all information contained in this proxy statement/prospectus relating to Carisma. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If you would like to request documents from Sesen Bio or Carisma, please send a request in writing or by telephone to either Sesen Bio or Carisma at the following addresses: </font>
        </div>
        <table style="width:456pt;margin-bottom:5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; width:222pt;">
              <div style="text-align:center;">
                <font style="font-weight:bold;letter-spacing:-0.2pt;">Sesen Bio, Inc.</font>
                <br >
                <font style="letter-spacing:0.2pt;">245 First Street, Suite 1800</font>
                <br >
                <font style="letter-spacing:0.2pt;">Cambridge, Massachusetts 02142</font>
                <br >
                <font style="letter-spacing:0.2pt;">Telephone: (617) 444-8550</font>
                <br >
                <font style="letter-spacing:0.2pt;">Attn: Corporate Secretary</font>
                <br >
                <font style="letter-spacing:0.2pt;">Email: ir@sesenbio.com </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; width:222pt;">
              <div style="text-align:center;">
                <font style="font-weight:bold;letter-spacing:-0.2pt;">CARISMA Therapeutics Inc</font><font style="letter-spacing:0.2pt;">.</font>
                <br >
                <font style="letter-spacing:0.2pt;">3675 Market Street, Suite 200</font>
                <br >
                <font style="letter-spacing:0.2pt;">Philadelphia, PA 19104</font>
                <br >
                <font style="letter-spacing:0.2pt;">Telephone: (267) 491-6422</font>
                <br >
                <font style="letter-spacing:0.2pt;">Attn: Corporate Secretary</font>
                <br >
                <font style="letter-spacing:0.2pt;">Email: info@carismatx.com</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If you are a Sesen Bio stockholder and would like additional copies, without charge, of this proxy statement/prospectus or if you have questions about the merger, including the procedures for voting your shares, you should contact Sesen Bio&#8217;s proxy solicitor: </font>
        </div>
        <div style="position:relative;margin-top:10pt; text-align:center; width:456pt;">
          <img src="lg_mackenziepartners-bw.jpg" alt="[MISSING IMAGE: lg_mackenziepartners-bw.jpg]" height="57" width="192" >
        </div>
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">MacKenzie Partners, Inc. </font>
          <br >
          <font style="letter-spacing:0.2pt;">1407 Broadway, 27th Floor </font>
          <br >
          <font style="letter-spacing:0.2pt;">New York, New York 10018 </font>
          <br >
          <font style="letter-spacing:0.2pt;">(800) 322-2885</font>
          <br >
          <font style="letter-spacing:0.2pt;">proxy@mackenziepartners.com </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">404</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a><a name="tTRNO">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:560pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">TRADEMARK NOTICE</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">This proxy statement/prospectus contains trademarks, service marks and trade names of Sesen Bio, Inc. and CARISMA Therapeutics Inc., including their respective names and logos. Other trademarks, service marks and trade names referred to in this proxy statement/prospectus are the property of their respective owners. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">405</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a><a name="tOTMA">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">OTHER MATTERS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Section&#160;16(a) Beneficial Ownership Reporting Compliance</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Section&#160;16(a) of the Exchange Act requires Sesen Bio&#8217;s directors, certain officers and persons who own more than 10% of Sesen Bio common stock to file reports of ownership and reports of changes in ownership of Sesen Bio common stock and other equity securities of Sesen Bio with the SEC. Directors, certain officers and greater than 10% stockholders are required by SEC regulations to furnish Sesen Bio with copies of all Section&#160;16(a) forms they file. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">To Sesen Bio&#8217;s knowledge, based solely on a review of the copies of reports furnished to Sesen Bio and the written representations of Sesen Bio&#8217;s directors and officers, Sesen Bio believes that during the year ended December&#160;31, 2021, Sesen Bio&#8217;s officers, directors and greater than 10% stockholders complied with all Section&#160;16(a) filing requirements, except for the following: a Form 3 for Elly Ryu reporting her beneficial ownership upon being named a Section&#160;16 officer was filed late on May&#160;10, 2021 and a Form 4 for Jane Henderson reporting one transaction was filed late on May&#160;10, 2021. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Stockholder Proposals Pursuant to Rule&#160;14a-8</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Stockholders of Sesen Bio may submit proposals on matters appropriate for stockholder action at meetings of Sesen Bio stockholders in accordance with Rule&#160;14a-8 promulgated under the Exchange Act. For such proposals to be included in Sesen Bio&#8217;s proxy materials relating to the 2023 annual meeting of stockholders, all applicable requirements of Rule&#160;14a-8 must be satisfied and such proposals must have been received at Sesen Bio&#8217;s principal offices no later than December&#160;29, 2022, the date that is 120&#160;days prior to the first anniversary of the date of the proxy statement was released to stockholders in connection with the 2022 annual meeting of stockholders. If, however, the Sesen Bio 2023 annual meeting of stockholders is not held within 30&#160;days from the anniversary of the 2022 annual meeting of stockholders, then the deadline will be a reasonable time prior to the time Sesen Bio begins to print and send its proxy materials. All such proposals must comply with all applicable requirements of Rule&#160;14a-8 and, prior to consummation of the merger, should be sent to Sesen Bio&#8217;s executive offices, 245 First Street, Suite 1800 Cambridge, MA 02142, Attention: Corporate Secretary by the close of business on the required deadline. After the consummation of the merger, such proposals should be sent to the combined company&#8217;s Corporate Secretary at CARISMA Therapeutics Inc., 3675 Market Street, Suite 200, Philadelphia, PA 19104, Attention: Corporate Secretary, Email: legal@carismatx.com, by the close of business on the required deadline. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Nominations and Stockholder Proposals Under the Sesen Bio Bylaws</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Sesen Bio Bylaws also establish an advance notice procedure for nominations for election to the Sesen Bio board of directors and other matters that stockholders wish to present for action at an annual meeting of stockholders other than those to be included in the proxy statement. In general, notice must be received at Sesen Bio&#8217;s principal offices at 245 First Street, Suite 1800 Cambridge, MA 02142, Attention:&#160;Corporate Secretary, not less than 90 calendar days before nor more than 120 calendar days before the one year anniversary of the previous year&#8217;s annual meeting of stockholders. Therefore, to be presented at Sesen Bio&#8217;s 2023 annual meeting, such a proposal must be received no earlier than February&#160;22, 2023 and no later than March&#160;24, 2023. However, if the date of the annual meeting of stockholders is more than 20&#160;days earlier or more than 60&#160;days later than such anniversary date, notice must be received no earlier than 120 calendar days prior to such annual meeting of stockholders and no later than the close of business on the later of (A)&#160;90&#160;days prior to such annual meeting of stockholders and (B)&#160;10&#160;days following the day on which notice of the date of such annual meeting of stockholders was mailed or public announcement of the date of such annual meeting of stockholders was first made, whichever first occurs. If the stockholder fails to give notice by these dates, then the persons named as proxies in the proxies solicited by the Sesen Bio board of directors for the 2023 annual meeting of stockholders may exercise discretionary voting power regarding any such proposal. Stockholders are advised to review the Sesen Bio Bylaws which also specify requirements as to the form and content of a stockholder&#8217;s notice. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition to satisfying the foregoing advanced notice requirements under the Sesen Bio Bylaws, to comply with the universal proxy rules under the Exchange Act, shareholders who intend to solicit proxies in support of director nominees other than the Sesen Bio&#8217;s nominees must provide notice that sets forth the </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">406</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:120pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">information required by Rule&#160;14a-19 under the Exchange Act no later than April&#160;23, 2023. These requirements are separate from, and in addition to, the SEC&#8217;s requirements that a stockholder must meet in order to have a stockholder proposal included in the proxy statement. A copy of the full text of these bylaw provisions may be obtained from Sesen Bio&#8217;s website at www.ir.sesenbio.com/corporate-governance. Proposals or nominations not meeting these requirements will not be entertained at the 2023 Annual Meeting of stockholders. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Communications with the Sesen Bio Board of Directors</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Stockholders who wish to communicate with the Sesen Bio board of directors may do so by writing to Dr.&#160;Jay S. Duker, Chair of the Sesen Bio board of directors, Sesen Bio, Inc., 245 First Street, Suite 1800, Cambridge, MA 02142. Communications will be forwarded to other directors if they relate to substantive matters that the Chair of the Sesen Bio board of directors, in consultation with Sesen Bio&#8217;s legal counsel, considers appropriate for attention by the other directors. In general, communications relating to corporate governance and long-term corporate strategy are more likely to be forwarded than communications relating to ordinary business affairs, personal grievances or matters as to which Sesen Bio tends to receive repetitive or duplicative communications. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">&#8220;Householding&#8221;&#8201;&#8212;&#8201;Stockholders Sharing the Same Address</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The SEC has adopted rules that permit companies and intermediaries (such as brokers) to implement a delivery procedure called &#8220;householding.&#8221; Under this procedure, multiple stockholders who reside at the same address may receive a single copy of Sesen Bio&#8217;s proxy materials unless the affected stockholder has provided other instructions. This procedure reduces printing costs and postage fees, and helps protect the environment as well. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio expects that a number of brokers with account holders who are Sesen Bio stockholders will be &#8220;householding&#8221; Sesen Bio&#8217;s proxy materials. A single set of proxy materials will be delivered to multiple stockholders sharing an address unless contrary instructions have been received from one or more of the affected stockholders. Once you have received notice from your broker that it will be &#8220;householding&#8221; communications to your address, &#8220;householding&#8221; will continue until you are notified otherwise or until you revoke your consent. Sesen Bio stockholders may revoke their consent at any time by contacting your broker. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Upon written or oral request, Sesen Bio will undertake to promptly deliver a separate copy of proxy materials to any stockholder at a shared address to which a single copy of any of those documents was delivered. To receive a separate copy of proxy materials now or in the future, you may write to Sesen Bio at Sesen Bio, Inc., 245 First Street, Suite 1800 Cambridge, MA 02142, Attention: Corporate Secretary, or by calling (617) 444-8550. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Any stockholders who share the same address and currently receive multiple copies of Sesen Bio&#8217;s proxy materials who wish to receive only one copy in the future can contact their broker, bank or other holder of record to request information about &#8220;householding&#8221; or Sesen Bio&#8217;s Corporate Secretary at the address or telephone number listed above.</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">407</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a><a name="TOC4">&#8203;</a><a name="fISCF">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:318.5pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">INDEX TO SESEN BIO&#8217;S CONSOLIDATED FINANCIAL STATEMENTS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:272.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:424pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;text-align:center;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Page </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:424pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Audited Consolidated Financial Statements</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:424pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tROIR"><font style="letter-spacing:0.2pt;">Report of Independent Registered Public Accounting Firm (PCAOB ID: 42) </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tROIR">F-2</a></font> <a href="#tROIR"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:424pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tCBS"><font style="letter-spacing:0.2pt;">Consolidated Balance Sheets </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tCBS">F-5</a></font> <a href="#tCBS"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:424pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tCSOO"><font style="letter-spacing:0.2pt;">Consolidated Statements of Operations and Comprehensive Loss </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tCSOO">F-6</a></font> <a href="#tCSOO"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:424pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tCSOC"><font style="letter-spacing:0.2pt;">Consolidated Statements of Changes in Stockholders&#8217; Equity (Deficit) </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tCSOC">F-7</a></font> <a href="#tCSOC"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:424pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tCSOC1"><font style="letter-spacing:0.2pt;">Consolidated Statements of Cash Flows </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tCSOC1">F-8</a></font> <a href="#tCSOC1"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:424pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tNTCF"><font style="letter-spacing:0.2pt;">Notes to Consolidated Financial Statements </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tNTCF">F-9</a></font> <a href="#tNTCF"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:9.5pt 0pt 1.5pt 0pt; width:424pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Unaudited Condensed Consolidated Financial Statements</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:424pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tCCBS"><font style="letter-spacing:0.2pt;">Condensed Consolidated Balance Sheets as of September&#160;30, 2022 and December&#160;31, 2021 </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tCCBS">F-43</a></font> <a href="#tCCBS"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:424pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <a href="#tCCSO"><font style="letter-spacing:0.2pt;">Condensed Consolidated Statements of Operations for the Three and Nine Months Ended September&#160;30, 2022 and 2021 </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tCCSO">F-44</a></font> <a href="#tCCSO"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:424pt;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <a href="#tCCSO1"><font style="letter-spacing:0.2pt;">Condensed Consolidated Statements of Comprehensive Loss for the Three and Nine Months Ended </font>
                  <br >
                  <font style="letter-spacing:0.2pt;">September&#160;30, 2022 and 2021 </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tCCSO1">F-45</a></font> <a href="#tCCSO1"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:424pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <a href="#tCCSO2"><font style="letter-spacing:0.2pt;">Condensed Consolidated Statements of Changes in Stockholders&#8217; Equity for the Three and Nine Months Ended September&#160;30, 2022 and 2021 </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tCCSO2">F-46</a></font> <a href="#tCCSO2"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:424pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <a href="#tCCSO3"><font style="letter-spacing:0.2pt;">Condensed Consolidated Statements of Cash Flows for the Three and Nine Months Ended September&#160;30, 2022 and 2021 </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tCCSO3">F-47</a></font> <a href="#tCCSO3"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.833pt 0pt; width:424pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tNTCC"><font style="letter-spacing:0.2pt;">Notes to Condensed Consolidated Financial Statements </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.833pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tNTCC">F-48</a></font>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-1</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a><a name="tROIR">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:52pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Report of Independent Registered Public Accounting Firm</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">To the Shareholders and the Board of Directors of Sesen Bio, Inc. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Opinion on the Financial Statements</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We have audited the accompanying consolidated balance sheets of Sesen Bio, Inc. (the &#8220;Company&#8221;) as of December&#160;31, 2021 and 2020, the related consolidated statements of operations and comprehensive loss, stockholders&#8217; (deficit) equity, and cash flows for each of the three&#160;years in the period ended December&#160;31, 2021, and the related notes (collectively referred to as the &#8220;consolidated financial statements&#8221;). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at December&#160;31, 2021 and 2020, and the results of its operations and its cash flows for each of the three&#160;years in the period ended December&#160;31, 2021, in conformity with U.S. generally accepted accounting principles. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company&#8217;s internal control over financial reporting as of December&#160;31, 2021, based on criteria established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework), and our report dated February&#160;28, 2022 expressed an unqualified opinion thereon. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Basis for Opinion</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">These financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Critical Audit Matters</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The critical audit matters communicated below are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that: (1)&#160;relates to accounts or disclosures that are material to the financial statements and (2)&#160;involved our especially challenging, subjective or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing a separate opinion on the critical audit matters or on the accounts or disclosures to which they relate. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-2</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <table style="width:456pt;margin-bottom:5pt;margin-top:0pt;border-collapse: collapse;font-style:italic;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:italic;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:72pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:372pt;">
              <font style="letter-spacing:-0.2pt;">Fair Value of Contingent Consideration</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:72pt;">
              <div style="font-style:italic;">
                <font style="letter-spacing:0.2pt;">Description of the Matter</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:372pt;">
              <font style="letter-spacing:0.2pt;">As discussed in Notes 3 and 5 to the consolidated financial statements under the caption &#8220;Contingent Consideration,&#8221; the Company uses a discounted cash flow model to estimate the fair value of the contingent consideration liability each reporting period, which represents the present value of projected future cash flows associated with regulatory approval milestones and royalties on net sales due to the selling shareholders of Viventia Bio Inc. Fluctuations in the fair value of the liability result in a charge to earnings (or loss) during the period. As of December&#160;31, 2021, the Company estimated the fair value of the contingent consideration liability as $52.0&#160;million and recorded the change in fair value of $56.8&#160;million as operating income for the year ended December&#160;31, 2021. </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:72pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:372pt;white-space:normal;">
              <font style="letter-spacing:0.2pt;">Auditing the fair value of the contingent consideration liability required significant auditor judgment due to the high degree of subjectivity in evaluating certain assumptions used to estimate the fair value. In particular, the fair value measurement was sensitive to the significant assumptions underlying the projected commercial sales of Vicineum and probabilities of success and timing of certain milestone events and achievements. </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:8.167pt 0pt 0.5pt 0pt; width:72pt;">
              <div style="font-style:italic;">
                <font style="letter-spacing:0.2pt;">How We Addressed the Matter in Our Audit</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:8.167pt 0pt 0.5pt 0pt; width:372pt;">
              <font style="letter-spacing:0.2pt;">We obtained an understanding, evaluated the design and tested the operating effectiveness of controls over the development of the significant assumptions over the Company&#8217;s process to estimate the fair value of the contingent consideration liability. This included testing controls over management&#8217;s review of the significant estimation assumptions and methods used to develop the fair value estimate, the accuracy of the calculations included within the fair value model, and the underlying data used in the model. </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:72pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:372pt;white-space:normal;">
              <font style="letter-spacing:0.2pt;">To test the estimated fair value of the contingent consideration liability, our audit procedures included, among others, assessing the terms of the arrangement, evaluating the methodology used and testing the key inputs and significant assumptions discussed above. We evaluated the significant assumptions in light of observable industry and economic trends and standards, external data sources, probability of success benchmarks, and regulatory factors. Our procedures included evaluating the data sources used by management in determining its significant assumptions and included an evaluation of available information that either corroborated or contradicted management&#8217;s conclusions. In addition, we involved our valuation professionals to assess the methodology used to determine the fair value of the contingent consideration liability, which included performing corroborative fair value calculations. </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:italic;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:72pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:9.5pt 0pt 0.5pt 0pt; width:372pt;">
              <font style="letter-spacing:-0.2pt;">Impairment Evaluation of Goodwill and Indefinite-Lived Intangible Assets</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:72pt;">
              <div style="font-style:italic;">
                <font style="letter-spacing:0.2pt;">Description of the Matter</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:372pt;">
              <font style="letter-spacing:0.2pt;">As discussed in Notes 3 and 8 to the consolidated financial statements under the captions &#8220;Indefinite-Lived Intangible Assets&#8221; and &#8220;Goodwill,&#8221; the Company&#8217;s intangible assets consist of indefinite-lived, acquired in-process research and development (IPR&amp;D) worldwide product rights to Vicineum as a result of the acquisition of Viventia in 2016. Goodwill on the Company&#8217;s consolidated balance sheets is the result of the Company&#8217;s acquisition of Viventia in September&#160;2016 and represents the difference between the purchase price and the fair value of the identifiable tangible and intangible net assets acquired under the acquisition method of accounting. Indefinite-lived intangible assets are quantitatively tested for impairment at least annually during the fourth quarter of the fiscal year, or more often if indicators of impairment are present. Goodwill is quantitatively tested for impairment at least annually during the fourth quarter of the fiscal year, or more often if indicators of impairment are present. Impairment testing of IPR&amp;D requires management to estimate the future discounted cash flows of the underlying asset. Impairment testing of goodwill requires management to estimate the future discounted cash flows of the Company&#8217;s one reporting unit. </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-3</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:245pt;margin-left:69.66pt;width:456pt;">
        <table style="width:456pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:72pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:372pt;white-space:normal;">
              <font style="letter-spacing:0.2pt;">Auditing management&#8217;s impairment assessments required significant auditor judgment due to the high degree of subjectivity in evaluating certain assumptions used to estimate the fair value of the reporting unit for and the IPR&amp;D. In particular, the fair value estimates of goodwill and of IPR&amp;D were sensitive to the significant assumptions underlying the projected commercial sales of Vicineum. </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:8.167pt 0pt 0.833pt 0pt; width:72pt;">
              <div style="font-style:italic;">
                <font style="letter-spacing:0.2pt;">How We Addressed the Matter in Our Audit</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:8.167pt 0pt 0.833pt 0pt; width:372pt;">
              <font style="letter-spacing:0.2pt;">We obtained an understanding, evaluated the design and tested the operating effectiveness of controls over the development of the significant assumptions over the Company&#8217;s goodwill and indefinite-lived intangible asset impairment review processes. This included testing controls over management&#8217;s review of the quantitative impairment analyses of goodwill and IPR&amp;D, including the significant estimation assumptions and methods used, the accuracy of the calculations included within the valuation models, and the underlying data used in those models. </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:72pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:372pt;white-space:normal;">
              <font style="letter-spacing:0.2pt;">To test the impairment evaluations over goodwill and IPR&amp;D assets, our audit procedures included, among others, evaluating the methodology and valuation models used and testing the key inputs and significant assumptions discussed above. We evaluated the significant assumptions in light of observable industry and economic trends and standards, external data sources, probability of success benchmarks, and regulatory factors. Our procedures included evaluating the data sources used by management in determining its significant assumptions and included an evaluation of available information that either corroborated or contradicted management&#8217;s conclusions. In addition, we inspected the Company&#8217;s reconciliation of the fair value of the reporting unit to the market capitalization of the Company and assessed the results. We involved our valuation professionals to assess the methodology and valuation of the discounted cash flow models, including evaluating the reasonableness of certain significant assumptions.</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:20pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">/s/ Ernst &amp; Young LLP </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We have served as the Company&#8217;s auditor since 2010. </font> <br ><font style="letter-spacing:0.2pt;">Boston, Massachusetts </font> <br ><font style="letter-spacing:0.2pt;">February&#160;28, 2022</font></div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-4</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a><a name="tCBS">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">SESEN BIO, INC.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CONSOLIDATED BALANCE SHEETS </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(In thousands, except share and per share data)</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:581pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:359.93pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:359.93pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.25pt 0pt 1.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.25pt 0pt 1.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 0.5pt 0pt; width:359.93pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Assets</font>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:359.93pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Current assets: </font>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:359.93pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Cash and cash equivalents </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">162,636</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">52,389</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:359.93pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Accounts receivables </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">21,011</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:359.93pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Other receivables </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">3,482</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:359.93pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Prepaid expenses and other current assets </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">18,476</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">7,478</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:2.5pt 0pt 1.5pt 0pt; width:359.93pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Restricted Cash </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">3,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 0.5pt 0pt; width:359.93pt;text-align:left;">
              <div style="margin-left:30pt;">
                <font style="letter-spacing:0.2pt;">Total current assets </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">205,605</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">62,867</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:359.93pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Non-current assets: </font>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:359.93pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Restricted cash </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">20</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">20</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:359.93pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Property and equipment, net </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">43</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">123</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:359.93pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Intangible assets </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">14,700</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">46,400</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:359.93pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Goodwill </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">13,064</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">13,064</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:359.93pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Long term prepaid expenses </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">7,192</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:2.5pt 0pt 1.5pt 0pt; width:359.93pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Other assets </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">123</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">349</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 0.5pt 0pt; width:359.93pt;text-align:left;">
              <div style="margin-left:30pt;font-weight:normal;">
                <font style="letter-spacing:0.2pt;">Total non-current assets </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">35,142</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">59,956</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 2.25pt 0pt; width:359.93pt;text-align:left;">
              <div style="margin-left:40pt;font-weight:normal;">
                <font style="letter-spacing:0.2pt;">Total Assets </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">240,747</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">122,823</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.75pt 0pt 0.5pt 0pt; width:359.93pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Liabilities and Stockholders&#8217; Equity (Deficit)</font>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:359.93pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Current liabilities: </font>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:359.93pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Accounts payable </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">2,853</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">3,102</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:359.93pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Accrued expenses </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">8,255</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">3,973</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:359.93pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Deferred revenue </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">1,500</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:359.93pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Contingent consideration </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">8,985</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2.5pt 0pt 1.5pt 0pt; width:359.93pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Other current liabilities </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">460</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">489</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:2.25pt 0pt 1.5pt 0pt; width:359.93pt;text-align:left;">
              <div style="margin-left:30pt;">
                <font style="letter-spacing:0.2pt;">Total current liabilities </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">11,568</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">18,049</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 0.5pt 0pt; width:359.93pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Non-current liabilities: </font>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:359.93pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Contingent consideration, net of current portion </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">52,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">99,855</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:359.93pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Deferred tax liability </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">3,969</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">12,528</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:359.93pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Deferred revenue, net of current portion </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">1,500</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">1,500</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2.5pt 0pt 1.5pt 0pt; width:359.93pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Other non-current liabilities </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">118</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:2.25pt 0pt 1.5pt 0pt; width:359.93pt;text-align:left;">
              <div style="margin-left:30pt;">
                <font style="letter-spacing:0.2pt;">Total non-current liabilities </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">57,469</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">114,001</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 0.5pt 0pt; width:359.93pt;text-align:left;">
              <div style="margin-left:40pt;">
                <font style="letter-spacing:0.2pt;">Total Liabilities </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">69,037</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">132,050</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:359.93pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Stockholders&#8217; Equity (Deficit): </font>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0.5pt 0pt 0.5pt 0pt; width:359.93pt;text-align:left;">
              <div style="margin-left:20pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Preferred stock, $0.001 par value per share; 5,000,000 shares authorized at </font>
                <br >
                <font style="letter-spacing:0.2pt;">December&#160;31, 2021 and 2020; no shares issued and outstanding at December&#160;31, </font>
                <br >
                <font style="letter-spacing:0.2pt;">2021 and 2020 </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0.5pt 0pt 0.5pt 0pt; width:359.93pt;text-align:left;">
              <div style="margin-left:20pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Common stock, $0.001 par value per share; 400,000,000 and 200,000,000 shares </font>
                <br >
                <font style="letter-spacing:0.2pt;">authorized at December&#160;31, 2021 and 2020; 199,463,645 and 140,449,647 shares </font>
                <br >
                <font style="letter-spacing:0.2pt;">issued and outstanding at December&#160;31, 2021 and 2020, respectively </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">199</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">140</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:359.93pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Additional paid-in capital </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">487,768</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">306,554</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:2.5pt 0pt 1.5pt 0pt; width:359.93pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Accumulated deficit </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">(316,257<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">(315,921<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2.25pt 0pt 1.5pt 0pt; width:359.93pt;text-align:left;">
              <div style="margin-left:30pt;">
                <font style="letter-spacing:0.2pt;">Total Stockholders&#8217; Equity (Deficit) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">171,710</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">(9,227<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 2.25pt 0pt; width:359.93pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:normal;">
                <font style="letter-spacing:0.2pt;">Total Liabilities and Stockholders&#8217; Equity </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">240,747</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">122,823</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-left:10pt; margin-top:5pt; text-align:center; width:446pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;"> </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The accompanying notes are an integral part of these consolidated financial statements.</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-5</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a><a name="tCSOO">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:251pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">SESEN BIO, INC.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(In thousands, except per share data)</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:310pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:303.55pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="16">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Year ended December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:303.55pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2019 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:0pt;text-align:left;" colspan="13">
              <font style="letter-spacing:0.2pt;">Revenue: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:303.55pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">License and related revenue </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">26,544</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">11,236</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:303.55pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Total Revenue </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">26,544</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">11,236</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:303.55pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Operating expenses: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:303.55pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Research and development </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">25,312</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">29,191</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">24,663</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:303.55pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">General and administrative </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">29,393</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">14,302</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">12,208</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:303.55pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Restructuring charge </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">5,528</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:303.55pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Intangibles impairment charge </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">31,700</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:303.55pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Change in fair value of contingent consideration </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">(56,840<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">(11,180<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">71,620</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:303.55pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Total operating expenses </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">35,093</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">32,313</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">108,491</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:303.55pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Loss from Operations </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">(8,549<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">(21,077<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(108,491<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:303.55pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Other (expense) income, net </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">(60<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">125</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">991</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:303.55pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Loss Before Taxes </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">(8,609<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">(20,952<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(107,500<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:303.55pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Benefit (provision) from income taxes </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">8,273</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">(1,445<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.25pt 0pt 2.5pt 0pt; width:303.55pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Net Loss and Comprehensive Loss After Taxes </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">(336<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">(22,397<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">(107,500<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:303.55pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Deemed dividend on adjustment of exercise price of certain warrants </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">(147<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:303.55pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Net loss attributable to common stockholders&#8201;&#8211;&#8201;basic and diluted </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">(336<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">(22,544<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(107,500<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:303.55pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Net loss per common share&#8201;&#8211;&#8201;basic and diluted </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">(0.19<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">(1.18<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:303.55pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Weighted-average common shares outstanding&#8201;&#8211;&#8201;basic and diluted </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">182,323</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">118,221</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">90,929</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The accompanying notes are an integral part of these consolidated financial statements.</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-6</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a><a name="tCSOC">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:93pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">SESEN BIO, INC.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS&#8217; EQUITY (DEFICIT) </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(In thousands, except share data)</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:466pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;height:13.75pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:205.89pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Common Stock </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;" rowspan="2">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;" colspan="4" rowspan="2">
              <div style="text-align:center; line-height:9pt; padding-bottom:0pt;">
                <font style="letter-spacing:-0.16pt;">Additional</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Paid-in</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Capital </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;" rowspan="2">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;" rowspan="2">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;" colspan="4" rowspan="2">
              <div style="text-align:center; line-height:9pt; padding-bottom:0pt;">
                <font style="letter-spacing:-0.16pt;">Accumulated</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Deficit </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;" rowspan="2">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;" rowspan="2">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;" colspan="4" rowspan="2">
              <div style="text-align:center; line-height:9pt; padding-bottom:0pt;">
                <font style="letter-spacing:-0.16pt;">Stockholders&#8217;</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Equity (Deficit)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;" rowspan="2">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;height:13.5pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:205.89pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Shares </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Amount </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:205.89pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:bold;">
                <font style="letter-spacing:-0.2pt;">Balance at December&#160;31, 2018</font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:41.25pt; text-align:right; white-space:nowrap;">77,456,180</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">77</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">230,154</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(186,024<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.555pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">44,207</td>
            <td style="padding:0pt;padding-left:5.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:205.89pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Net loss </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:41.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(107,500<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.555pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(107,500<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:5.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:205.89pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Share-based compensation </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:41.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">1,237</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.555pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">1,237</td>
            <td style="padding:0pt;padding-left:5.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:205.89pt;white-space:normal;text-align:left;">
              <div style="margin-left:20pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Exercises of stock options and vesting of RSAs </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:41.25pt; text-align:right; white-space:nowrap;">89,812</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">98</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.555pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">98</td>
            <td style="padding:0pt;padding-left:5.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:205.89pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Sales of common stock under 2014 ESPP </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:41.25pt; text-align:right; white-space:nowrap;">10,283</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">8</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.555pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">8</td>
            <td style="padding:0pt;padding-left:5.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:205.89pt;white-space:normal;text-align:left;">
              <div style="margin-left:20pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Issuance of common stock and common stock warrants, net of issuance costs of $2.2&#160;million </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:41.25pt; text-align:right; white-space:nowrap;">20,410,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">21</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">27,812</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.555pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">27,833</td>
            <td style="padding:0pt;padding-left:5.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:205.89pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Exercises of common stock warrants </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:41.25pt; text-align:right; white-space:nowrap;">6,772,928</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">7</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">5,474</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.555pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">5,481</td>
            <td style="padding:0pt;padding-left:5.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2.167pt 0pt 1.833pt 0pt; width:205.89pt;white-space:normal;text-align:left;">
              <div style="margin-left:20pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Issuance of common stock under ATM Offering, net of issuance costs of $0.2&#160;million </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:41.25pt; text-align:right; white-space:nowrap;">2,062,206</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:14.25pt; text-align:right; white-space:nowrap;">2</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">1,934</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.555pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">1,936</td>
            <td style="padding:0pt;padding-left:5.555pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:205.89pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:bold;">
                <font style="letter-spacing:-0.2pt;">Balance at December&#160;31, 2019</font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:41.25pt; text-align:right; white-space:nowrap;">106,801,409</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">107</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">266,717</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(293,524<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.555pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(26,700<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:5.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:205.89pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Net loss </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:41.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(22,397<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.555pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(22,397<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:5.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:205.89pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Share-based compensation </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:41.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">1,757</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.555pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">1,757</td>
            <td style="padding:0pt;padding-left:5.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:205.89pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Exercises of stock options </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:41.25pt; text-align:right; white-space:nowrap;">12,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">13</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.555pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">13</td>
            <td style="padding:0pt;padding-left:5.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:205.89pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Sales of common stock under 2014 ESPP </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:41.25pt; text-align:right; white-space:nowrap;">28,186</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">11</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.555pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">11</td>
            <td style="padding:0pt;padding-left:5.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:205.89pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Exercises of common stock warrants </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:41.25pt; text-align:right; white-space:nowrap;">238,110</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">131</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.555pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">131</td>
            <td style="padding:0pt;padding-left:5.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:2.167pt 0pt 1.833pt 0pt; width:205.89pt;white-space:normal;text-align:left;">
              <div style="margin-left:20pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Issuance of common stock under ATM Offering, net of issuance costs of $1.2&#160;million </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:41.25pt; text-align:right; white-space:nowrap;">33,369,942</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:14.25pt; text-align:right; white-space:nowrap;">33</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">37,925</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.555pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">37,958</td>
            <td style="padding:0pt;padding-left:5.555pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:205.89pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:bold;">
                <font style="letter-spacing:-0.2pt;">Balance at December&#160;31, 2020</font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:41.25pt; text-align:right; white-space:nowrap;">140,449,647</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">140</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">306,554</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(315,921<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.555pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(9,227<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:5.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:205.89pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Net loss </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:41.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(336<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.555pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(336<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:5.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:205.89pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Share-based compensation </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:41.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">5,143</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.555pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">5,143</td>
            <td style="padding:0pt;padding-left:5.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:205.89pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Exercises of stock options </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:41.25pt; text-align:right; white-space:nowrap;">33,610</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">42</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.555pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">42</td>
            <td style="padding:0pt;padding-left:5.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:205.89pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Exercises of common stock warrants </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:41.25pt; text-align:right; white-space:nowrap;">2,048,059</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">2</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">1,124</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.555pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">1,126</td>
            <td style="padding:0pt;padding-left:5.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:2.167pt 0pt 1.833pt 0pt; width:205.89pt;white-space:normal;text-align:left;">
              <div style="margin-left:20pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Issuance of common stock under ATM Offering, net of issuance costs of $5.4&#160;million </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:41.25pt; text-align:right; white-space:nowrap;">56,932,329</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:14.25pt; text-align:right; white-space:nowrap;">57</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">174,905</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.555pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">174,962</td>
            <td style="padding:0pt;padding-left:5.555pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:205.89pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">Balance at December&#160;31, 2021</font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:41.25pt; text-align:right; white-space:nowrap;">199,463,645</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:14.25pt; text-align:right; white-space:nowrap;">199</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">487,768</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27pt; text-align:right; white-space:nowrap;">(316,257<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.555pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27pt; text-align:right; white-space:nowrap;">171,710</td>
            <td style="padding:0pt;padding-left:5.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The accompanying notes are an integral part of these consolidated financial statements.</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-7</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a><a name="tCSOC1">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">SESEN BIO, INC.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CONSOLIDATED STATEMENTS OF CASH FLOWS </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(In thousands)</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:582.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:317.22pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.5pt 0pt; width:0pt;text-align:center;" colspan="16">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Year ended December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:317.22pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.25pt 0pt 1.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.25pt 0pt 1.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.25pt 0pt 1.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2019 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 0.5pt 0pt; width:317.22pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Cash Flows from Operating Activities:</font>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:317.22pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Net loss </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">(336<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">(22,397<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(107,500<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:317.22pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Adjustments to reconcile net loss to net cash used in operating activities: </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:317.22pt;text-align:left;">
              <div style="margin-left:30pt;">
                <font style="letter-spacing:0.2pt;">Depreciation </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">85</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">122</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">219</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:317.22pt;text-align:left;">
              <div style="margin-left:30pt;">
                <font style="letter-spacing:0.2pt;">Share-based compensation </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">5,143</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">1,757</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">1,237</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:317.22pt;text-align:left;">
              <div style="margin-left:30pt;">
                <font style="letter-spacing:0.2pt;">Change in fair value of contingent consideration </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">(56,840<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">(11,180<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">71,620</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:317.22pt;text-align:left;">
              <div style="margin-left:30pt;">
                <font style="letter-spacing:0.2pt;">Intangibles impairment charge </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">31,700</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:317.22pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Changes in operating assets and liabilities: </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:317.22pt;text-align:left;">
              <div style="margin-left:30pt;">
                <font style="letter-spacing:0.2pt;">Accounts receivable (net) </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">(24,493<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:317.22pt;text-align:left;">
              <div style="margin-left:30pt;">
                <font style="letter-spacing:0.2pt;">Prepaid expenses and other assets </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">(17,964<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">(1,304<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(5,188<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:317.22pt;text-align:left;">
              <div style="margin-left:30pt;">
                <font style="letter-spacing:0.2pt;">Accounts payable </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">(249<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">1,200</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">535</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:317.22pt;text-align:left;">
              <div style="margin-left:30pt;">
                <font style="letter-spacing:0.2pt;">Accrued expenses and other liabilities </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">(4,424<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">(2,035<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">1,556</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:2.5pt 0pt 1.5pt 0pt; width:317.22pt;text-align:left;">
              <div style="margin-left:30pt;">
                <font style="letter-spacing:0.2pt;">Deferred revenue </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">(1,500<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">3,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 0.5pt 0pt; width:317.22pt;text-align:left;">
              <div style="margin-left:40pt;">
                <font style="letter-spacing:0.2pt;">Net cash used in operating activities </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">
              <div style="font-weight:bold;">&#8203;</div>
            </td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">(68,878<font style="position:absolute;">)</font></div>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">
              <div style="font-weight:bold;">&#8203;</div>
            </td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">(30,837<font style="position:absolute;">)</font></div>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">
              <div style="font-weight:bold;">&#8203;</div>
            </td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">(37,521<font style="position:absolute;">)</font></div>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:317.22pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Cash Flows from Investing Activities:</font>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2.5pt 0pt 1.5pt 0pt; width:317.22pt;text-align:left;">
              <div style="margin-left:30pt;">
                <font style="letter-spacing:0.2pt;">Purchases of equipment </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">(4<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">(8<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">(136<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:2.25pt 0pt 1.5pt 0pt; width:317.22pt;text-align:left;">
              <div style="margin-left:40pt;">
                <font style="letter-spacing:0.2pt;">Net cash used in investing activities </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">
              <div style="font-weight:bold;">&#8203;</div>
            </td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">(4<font style="position:absolute;">)</font></div>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">
              <div style="font-weight:bold;">&#8203;</div>
            </td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">(8<font style="position:absolute;">)</font></div>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">
              <div style="font-weight:bold;">&#8203;</div>
            </td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">(136<font style="position:absolute;">)</font></div>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 0.5pt 0pt; width:317.22pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Cash Flows from Financing Activities:</font>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0.5pt 0pt 0.5pt 0pt; width:317.22pt;white-space:normal;text-align:left;">
              <div style="margin-left:40pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Proceeds from issuance of common stock and common stock warrants, net of issuance costs </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">27,833</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:317.22pt;text-align:left;">
              <div style="margin-left:30pt;">
                <font style="letter-spacing:0.2pt;">Proceeds from exercises of common stock warrants </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">1,126</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">131</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">5,481</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0.5pt 0pt 0.5pt 0pt; width:317.22pt;text-align:left;">
              <div style="margin-left:40pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Proceeds from issuance of common stock under ATM Offering, net </font>
                <br >
                <font style="letter-spacing:0.2pt;">of issuance costs </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">174,962</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">37,958</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">1,936</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:317.22pt;text-align:left;">
              <div style="margin-left:30pt;">
                <font style="letter-spacing:0.2pt;">Proceeds from exercises of stock options </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">42</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">13</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">98</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:2.5pt 0pt 1.5pt 0pt; width:317.22pt;text-align:left;">
              <div style="margin-left:30pt;">
                <font style="letter-spacing:0.2pt;">Proceeds from sale of common stock pursuant to ESPP </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">11</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">8</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2.25pt 0pt 1.5pt 0pt; width:317.22pt;text-align:left;">
              <div style="margin-left:40pt;">
                <font style="letter-spacing:0.2pt;">Net cash provided by financing activities </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">
              <div style="font-weight:bold;">&#8203;</div>
            </td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">176,129</div>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">
              <div style="font-weight:bold;">&#8203;</div>
            </td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">38,113</div>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">
              <div style="font-weight:bold;">&#8203;</div>
            </td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">35,356</div>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 0.5pt 0pt; width:317.22pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Net increase (decrease) in cash, cash equivalents and restricted cash </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">107,247</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">7,268</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(2,301<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2.5pt 0pt 1.5pt 0pt; width:317.22pt;text-align:left;">
              <div style="margin-left:30pt;">
                <font style="letter-spacing:0.2pt;">Cash, cash equivalents and restricted cash&#8201;&#8211;&#8201;beginning of period </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">55,409</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">48,141</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">50,442</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 2.25pt 0pt; width:317.22pt;text-align:left;">
              <div style="margin-left:30pt;">
                <font style="letter-spacing:0.2pt;">Cash, cash equivalents and restricted cash&#8201;&#8211;&#8201;end of period </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">
              <div style="font-weight:bold;">$</div>
            </td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">162,656</div>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">
              <div style="font-weight:bold;">$</div>
            </td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:24pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">55,409</div>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">
              <div style="font-weight:bold;">$</div>
            </td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:27pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">48,141</div>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.75pt 0pt 0.5pt 0pt; width:317.22pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Reconciliation of cash, cash equivalents and restricted cash:</font>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:317.22pt;text-align:left;">
              <div style="margin-left:30pt;">
                <font style="letter-spacing:0.2pt;">Cash and cash equivalents </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">162,636</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">52,389</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">48,121</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:317.22pt;text-align:left;">
              <div style="margin-left:30pt;">
                <font style="letter-spacing:0.2pt;">Short term restricted cash </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">3,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:2.5pt 0pt 1.5pt 0pt; width:317.22pt;text-align:left;">
              <div style="margin-left:30pt;">
                <font style="letter-spacing:0.2pt;">Long term restricted cash </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">20</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">20</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">20</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 2.25pt 0pt; width:317.22pt;text-align:left;">
              <div style="margin-left:50pt;font-weight:normal;">
                <font style="letter-spacing:0.2pt;">Total cash, cash equivalents and restricted cash </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">162,656</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:24pt; text-align:right; white-space:nowrap;">55,409</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:27pt; text-align:right; white-space:nowrap;">48,141</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.75pt 0pt 0.5pt 0pt; width:317.22pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Supplemental cash flow disclosure: </font>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0.5pt 0pt 0.5pt 0pt; width:317.22pt;text-align:left;">
              <div style="margin-left:20pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Cash paid for amounts included in the measurement of lease </font>
                <br >
                <font style="letter-spacing:0.2pt;">liabilities </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:0.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">174</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:0.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">154</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:0.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">153</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:317.22pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Supplemental disclosure of non-cash operating activities: </font>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:317.22pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Right-of-use assets related to the adoption of ASC 842 </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">236</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:317.22pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Right-of-use assets obtained in exchange for lease obligations </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">290</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:317.22pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Supplemental disclosure of non-cash financing activities: </font>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.167pt 0pt 0.5pt 0pt; width:317.22pt;text-align:left;">
              <div style="margin-left:20pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Deemed Dividend on adjustment of exercise price on certain </font>
                <br >
                <font style="letter-spacing:0.2pt;">warrants </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.167pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.167pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">147</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.167pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.167pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The accompanying notes are an integral part of these consolidated financial statements.</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-8</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a><a name="tNTCF">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">SESEN BIO, INC.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">1.&nbsp;&nbsp;&nbsp;DESCRIPTION OF BUSINESS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio, Inc. (&#8220;Sesen&#8221; or the &#8220;Company&#8221;), a Delaware corporation formed in February&#160;2008, is a late-stage clinical company advancing targeted fusion protein therapeutics (&#8220;TFPTs&#8221;) for the treatment of patients with cancer. The Company&#8217;s most advanced product candidate, Vicineum</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">TM</font><font style="letter-spacing:0.2pt;">, also known as VB4-845, is a locally-administered targeted fusion protein composed of an anti-epithelial cell adhesion molecule (&#8220;EpCAM&#8221;) antibody fragment tethered to a truncated form of Pseudomonas exotoxin A for the treatment of non-muscle invasive CIS of the bladder in patients previously treated with bacillus Calmette-Gu&#233;rin (&#8220;BCG&#8221;). The Company has an ongoing single-arm, multi-center, open-label Phase&#160;3 VISTA clinical trial of Vicineum as a monotherapy in patients with BCG-unresponsive NMIBC (the &#8220;VISTA Trial&#8221;). The VISTA Trial completed enrollment in April&#160;2018 with a total of 133 patients. On December&#160;18, 2020, the Company submitted its completed Biologics License Application (the &#8220;BLA&#8221;) for Vicineum for the treatment of BCG-unresponsive NMIBC to the United States Food and Drug Administration (&#8220;FDA&#8221;). On February&#160;12, 2021, the FDA notified the Company that it has accepted for filing the BLA. The FDA also granted Priority Review for the BLA and set a target Prescription Drug User Fee Act (&#8220;PDUFA&#8221;) date for a decision on the BLA of August&#160;18, 2021. On July&#160;13, 2021, the Company participated in a productive Late-Cycle Meeting with the FDA regarding the BLA for Vicineum for the treatment of BCG-unresponsive NMIBC. In the meeting, the FDA confirmed that there was no Advisory Committee meeting planned at that time, and that no post-marketing requirements, including a confirmatory trial, had been identified at that time. Also in the meeting, the Company and the FDA discussed remaining questions related to manufacturing facilities inspection, product quality information requests and additional information related to chemistry, manufacturing and controls (&#8220;CMC&#8221;), and a timeline to submit additional supporting information was agreed upon. On August&#160;13, 2021, the Company received a complete response letter (&#8220;CRL&#8221;) from the FDA indicating that the FDA had determined that it could not approve the BLA for Vicineum in its present form and provided recommendations specific to additional clinical/statistical data and analyses in addition to CMC issues pertaining to a recent pre-approval inspection and product quality. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company participated in Type A Meetings with the FDA on October&#160;29, 2021 and December&#160;8, 2021 to discuss questions related to CMC and clinical issues raised in the CRL. Both meetings helped the Company determine the appropriate path forward for Vicineum. Any changes in these assumptions and estimates or other information obtained, may have a significant impact on the remeasurement of the contingent consideration liability in the future. The Company believes it has a clear understanding of what additional information regarding CMC is required for resubmission of a BLA. Additionally, although not an issue raised in the CRL, the FDA confirmed that Vicineum manufactured using the proposed commercial process is comparable to Vicineum used in prior clinical trials. The FDA also confirmed that the Company can utilize Vicineum manufactured during process validation for any future clinical trials needed to address issues raised in the CRL, and that these potential trials can proceed while addressing CMC issues. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Viventia Acquisition</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In September&#160;2016, the Company entered into a Share Purchase Agreement with Viventia Bio, Inc., a corporation incorporated under the laws of the Province of Ontario, Canada (&#8220;Viventia&#8221;), the shareholders of Viventia named therein (the &#8220;Selling Shareholders&#8221;) and, solely in its capacity as seller representative, Clairmark Investments Ltd., a corporation incorporated under the laws of the Province of Ontario, Canada (&#8220;Clairmark&#8221;) (the &#8220;Share Purchase Agreement&#8221;), pursuant to which the Company agreed to and simultaneously completed the acquisition of all of the outstanding capital stock of Viventia from the Selling Shareholders (the &#8220;Viventia Acquisition&#8221;). In connection with the closing of the Viventia Acquisition, the Company issued 4.0&#160;million shares of its common stock to the Selling Shareholders, which at that time represented approximately 19.9% of the voting power of the Company as of immediately prior to the issuance of such shares. Clairmark is an affiliate of Leslie L. Dan, a director of the Company until his retirement in July&#160;2019. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, under the Share Purchase Agreement, the Company is obligated to pay to the Selling Shareholders certain post-closing contingent cash payments upon the achievement of specified milestones </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-9</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">and based upon net sales, in each case subject to the terms and conditions set forth in the Share Purchase Agreement, including: (i)&#160;a one-time milestone payment of $12.5&#160;million payable upon the first sale of Vicineum (the &#8220;Purchased Product&#8221;), in the United States; (ii)&#160;a one-time milestone payment of $7.0&#160;million payable upon the first sale of the Purchased Product in any one of certain specified European countries; (iii)&#160;a one-time milestone payment of $3.0&#160;million payable upon the first sale of the Purchased Product in Japan; and (iv)&#160;quarterly earn-out payments equal to 2% of net sales of the Purchased Product during specified earn-out periods. Such earn-out payments are payable with respect to net sales in a country beginning on the date of the first sale in such country and ending on the earlier of (i)&#160;December&#160;31, 2033, and (ii)&#160;fifteen&#160;years after the date of such sale, subject to early termination in certain circumstances if a biosimilar product is on the market in the applicable country. Under the Share Purchase Agreement, the Company, its affiliates, licensees and subcontractors are required to use commercially reasonable efforts, for the first seven&#160;years following the closing of the Viventia Acquisition, to achieve marketing authorizations throughout the world and, during the applicable earn-out period, to commercialize the Purchased Product in the United States, France, Germany, Italy, Spain, United Kingdom, Japan, China and Canada. Certain of these payments are payable to individuals or affiliates of individuals that became employees or members of the Company&#8217;s board of directors. However, as of December&#160;31, 2021, none of these individuals are active employees or members of the Company&#8217;s board of directors. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Liquidity and Capital Resources</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As of December&#160;31, 2021, the Company had cash and cash equivalents of $162.6&#160;million and an accumulated deficit of $316.3&#160;million. The Company incurred negative cash flows from operating activities of $68.9&#160;million, $30.8&#160;million and $37.5&#160;million for the&#160;years ended December&#160;31, 2021, 2020 and 2019, respectively. Since the Company&#8217;s inception, it has received no revenue from sales of its products, and the Company anticipates that operating losses will continue for the foreseeable future as it seeks to address the issues raised in the CRL it received for a BLA for Vicineum for the treatment of BCG unresponsive NMIBC and the concerns identified in the EMA Withdrawal Assessment Report, complete the follow-up stage of the ongoing Phase&#160;3 VISTA Trial of Vicineum for the treatment of BCG-unresponsive NMIBC, complete any additional clinical trials for Vicineum for the treatment of non-muscle invasive CIS of the bladder in patients previously treated with adequate or less than adequate BCG, and seek marketing approval from the FDA and the European Commission and, if approved, commercialize Vicineum. The Company has financed its operations to date primarily through private placements of its common stock, preferred stock, common stock warrants and convertible bridge notes, venture debt borrowings, its initial public offering (&#8220;IPO&#8221;), follow-on public offerings, sales effected in &#8220;at-the-market&#8221; &#8203;(&#8220;ATM&#8221;) offerings, commercialization partnership and out-license agreements. See &#8220;Note 12. Stockholders&#8217; Equity&#8221; below for information regarding the Company&#8217;s recently completed equity financings. Management believes that the Company&#8217;s cash and cash equivalents as of December&#160;31, 2021 will be sufficient to fund the Company&#8217;s current operating plan for at least the next twelve&#160;months from the date these consolidated financial statements were issued. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Funding Requirements</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company&#8217;s future success is dependent on its ability to develop, and if approved, commercialize its product candidates, including Vicineum for the treatment of non-muscle invasive CIS of the bladder in patients previously treated with adequate or less than adequate BCG, and ultimately upon its ability to attain profitable operations. In order to commercialize its product candidates, including Vicineum for the treatment of non-muscle invasive CIS of the bladder in patients previously treated with adequate or less than adequate BCG, the Company needs to complete clinical development and comply with comprehensive regulatory requirements. The Company is subject to a number of risks similar to other late-stage clinical companies, including, but not limited to, successful discovery and development of its product candidates, raising additional capital, development and commercialization by its competitors of new technological innovations, protection of proprietary technology and market acceptance of its products. The successful discovery, development and, if approved, commercialization of product candidates, including Vicineum for the treatment of non-muscle invasive CIS of the bladder in patients previously treated with adequate or less than adequate BCG, requires substantial working capital, and the Company expects to seek additional funds through equity or debt financings or through additional outside of United States (&#8220;OUS&#8221;) business development partnerships, collaborations, licensing transactions or other sources. The Company may be unable to obtain equity or debt financings or enter into additional OUS business development partnerships, </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-10</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">collaborations or licensing transactions at favorable terms, or at all, and, if necessary, may be required to implement cost reduction strategies. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company will incur substantial expenses if and as it: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.71pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.71pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">addresses the issues identified in the CRL it received from the FDA for its BLA for Vicineum for the treatment of BCG-unresponsive NMIBC and the concerns identified in the European Medicines Agency&#8217;s (&#8220;EMA&#8221;) Withdrawal Assessment Report, which the Company expects will include the completion of an additional Phase&#160;3 clinical trial; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">seeks marketing approvals for Vicineum for the treatment of non-muscle invasive CIS of the bladder in patients previously treated with adequate or less than adequate BCG; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.71pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.71pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">establishes and implement sales, marketing and distribution capabilities and scale up and validate external manufacturing capabilities to commercialize Vicineum for the treatment of non-muscle invasive CIS of the bladder in patients previously treated with adequate or less than adequate BCG, if approved; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">maintains, expands and protects its intellectual property portfolio; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">hires additional clinical, regulatory, quality control, scientific and management personnel; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.71pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.71pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">expands its operational, financial and management systems and personnel; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">conducts research and pre-clinical and clinical development of Vicineum for the treatment of non-muscle invasive CIS of the bladder in patients previously treated with adequate or less than adequate BCG, and its other product candidates; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">seeks to discover and develop additional product candidates; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">in-licenses or acquires the rights to other products, product candidates or technologies. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company&#8217;s future capital requirements will depend on many factors, including: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the scope, initiation, progress, timing, costs and results of laboratory testing and clinical trials for Vicineum for the treatment of non-muscle invasive CIS of the bladder in patients previously treated with adequate or less than adequate BCG and its other product candidates; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the ongoing COVID-19 pandemic and its impact on the Company&#8217;s business; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the Company&#8217;s ability to establish additional OUS business development partnerships, collaborations or licensing arrangements on favorable terms, if at all, particularly manufacturing, marketing and distribution arrangements for its product candidates; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the costs and timing of the implementation of commercial-scale manufacturing activities, including those associated with the manufacturing process and technology transfer to third-party manufacturers to facilitate such commercial-scale manufacturing of Vicineum; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the costs and timing of establishing and implementing sales, marketing and distribution capabilities for Vicineum for the treatment of non-muscle invasive CIS of the bladder in patients previously treated with adequate or less than adequate BCG, if approved; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the costs and timing of preparing, filing and prosecuting patent applications, maintaining and enforcing its intellectual property rights and defending any intellectual property-related claims; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the Company&#8217;s obligation to make milestone, royalty and other payments to third-party licensors under its licensing agreements; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the extent to which the Company in-licenses or acquires rights to other products, product candidates or technologies; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the outcome, timing and cost of regulatory review by the FDA, EMA and comparable non-US regulatory authorities for Vicineum for the treatment of non-muscle invasive CIS of the bladder in patients previously treated with adequate or less than adequate BCG, including the potential for the FDA, EMA or comparable non-US regulatory authorities to require that the Company perform more studies or clinical trials than those that it currently expects to perform; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-11</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the Company&#8217;s ability to achieve certain future regulatory, development and commercialization milestones under its out-license and OUS business development partnership agreements </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the effect of competing technological and market developments; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.71pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.71pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the revenue, if any, received from commercial sales of Vicineum for the treatment of non-muscle invasive CIS of the bladder in patients previously treated with adequate or less than adequate BCG, if approved. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Until such time, if ever, as the Company can generate substantial product revenues from commercial sales, the Company expects to finance its cash needs through a combination of equity offerings, debt financings, government or other third-party funding, strategic collaborations, OUS business development partnership agreements, partnerships, alliances, and licensing arrangements. The Company does not have any committed external source of funds other than the amounts payable under the license agreement with F.&#160;Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc. (collectively, &#8220;Roche&#8221;) and the license agreement with Qilu Pharmaceutical, Co., Ltd. (&#8220;Qilu&#8221;). To the extent the Company raises additional capital through the sale of equity or convertible debt securities, the ownership interests of existing stockholders will be diluted, and the terms of these securities may include liquidation or other preferences that adversely affect the rights of existing stockholders. Debt financing, if available, may involve agreements that include liens or other restrictive covenants limiting the Company&#8217;s ability to take specific actions, such as incurring additional debt, making capital expenditures or declaring dividends. If the Company raises additional funds through government or other third-party funding, strategic OUS business development partnerships, collaborations, alliances or licensing arrangements, the Company may have to relinquish valuable rights to its technologies, future revenue streams, research programs or product candidates or grant licenses on terms that may not be favorable to the Company. If the Company is unable to raise additional funds when needed, the Company may be required to delay, limit, reduce or terminate its product development or future commercialization efforts or grant rights to develop and market products or product candidates that the Company would otherwise prefer to develop and market itself. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The COVID-19 pandemic has negatively impacted the global economy, disrupted business operations and created significant volatility and disruption to financial markets. Significant uncertainty remains as to the potential impact of the COVID-19 pandemic on the Company&#8217;s operations, and on the global economy as a whole. The extent and duration of the pandemic could continue to disrupt global markets and may affect the Company&#8217;s ability to raise additional capital in the future. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">2.&nbsp;&nbsp;&nbsp;BASIS OF PRESENTATION</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The accompanying financial statements have been prepared in accordance with United States generally accepted accounting principles (&#8220;GAAP&#8221;). Any reference in these notes to applicable guidance is meant to refer to GAAP as found in the ASC and Accounting Standards Updates (&#8220;ASUs&#8221;), promulgated by the Financial Accounting Standards Board (&#8220;FASB&#8221;). </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Use of Estimates</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The preparation of financial statements in accordance with GAAP and the rules and regulations of the SEC requires the use of estimates and assumptions, based on judgments considered reasonable, which affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company bases its estimates and assumptions on historical experience, known trends and events and various other factors that management believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Although management believes its estimates and assumptions are reasonable when made, they are based upon information available at the time they are made. Management evaluates the estimates and assumptions on an ongoing basis and, if necessary, makes adjustments. Due to the risks and uncertainties involved in the Company&#8217;s business and evolving market conditions, and given the subjective element of the estimates and assumptions made, actual results may differ from estimated results. The most significant estimates and judgments impact the fair value of intangible assets, goodwill and contingent consideration; income taxes (including the valuation allowance for deferred tax assets); research and development expenses; and going concern considerations. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-12</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Principles of Consolidation</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company&#8217;s consolidated financial statements include the accounts of the Company, its wholly owned subsidiary Viventia and its indirect subsidiaries, Viventia Bio USA Inc. and Viventia Biotech (EU) Limited. All intercompany transactions and balances have been eliminated in consolidation. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Foreign Currency Translation</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The functional currency of the Company and each of its subsidiaries is the US dollar. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">3.&nbsp;&nbsp;&nbsp;SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Cash, Cash Equivalents, Restricted Cash and Concentration of Credit Risk</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company&#8217;s cash is held on deposit in demand accounts at a large financial institution in amounts in excess of the Federal Deposit Insurance Corporation (&#8220;FDIC&#8221;) insurance coverage limit of $250,000 per depositor, per FDIC-insured bank, per ownership category. Restricted cash represents cash held by the Company&#8217;s primary commercial bank to collateralize a letter of credit issued related to a license agreement and the credit limit on the Company&#8217;s corporate credit card, and are classified as short term and long term, respectively. The Company considers all highly liquid investments purchased with an original maturity of three&#160;months or less to be cash equivalents. Financial instruments that potentially subject the Company to credit risk principally consists of cash equivalents and accounts receivable. As of December&#160;31, 2021 and 2020, the Company limited its credit risk associated with cash equivalents by placing investments in highly-rated money market funds. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Property and Equipment</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Property and equipment are recorded at cost. Maintenance and repairs are charged to expense as incurred, and costs of improvements and renewals are capitalized. Depreciation is recognized using the straight-line method over the estimated useful lives of the relative assets. The Company uses an estimated useful life of five&#160;years for lab equipment, four&#160;years for furniture and fixtures, three&#160;years for computer equipment and software and the lesser of five&#160;years or the remaining lease term for leasehold improvements. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Indefinite-Lived Intangible Assets</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company&#8217;s intangible assets consist of indefinite-lived, acquired in-process research and development (&#8220;IPR&amp;D&#8221;) worldwide product rights to Vicineum as a result of the acquisition of Viventia in 2016. IPR&amp;D assets acquired in a business combination are considered indefinite-lived until the completion or abandonment of the associated research and development efforts. Amortization over the estimated useful life will commence at the time of Vicineum&#8217;s commercial launch in the respective markets, if approved. If regulatory approval to market Vicineum for the treatment of BCG-unresponsive NMIBC is not obtained, the Company will immediately expense the related capitalized cost. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Indefinite-lived intangible assets are quantitatively tested for impairment at least annually during the fourth quarter of the fiscal year, or more often if indicators of impairment are present. Impairment testing of indefinite-lived intangible assets requires management to estimate the future discounted cash flows of an asset using assumptions believed to be reasonable, but which are unpredictable and inherently uncertain. Actual future cash flows may differ from the estimates used in impairment testing. The Company recognizes an impairment loss when and to the extent that the estimated fair value of an intangible asset is less than its carrying value. In addition, on a quarterly basis, the Company performs a qualitative review of its business operations to determine whether events or changes in circumstances have occurred which could indicate that the carrying value of its intangible assets was not recoverable. If an impairment indicator is identified, an interim impairment assessment is performed. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In August&#160;2021, the Company received a CRL from the FDA regarding its BLA for Vicineum for the treatment of NMIBC, its lead product candidate. In the CRL, the FDA determined that it could not approve the BLA for Vicineum in its present form and provided recommendations specific to additional clinical/</font>&#8203;<font style="letter-spacing:0.2pt;">statistical data and analyses in addition to CMC issues pertaining to a recent pre-approval inspection and </font></div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-13</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">product quality. Given the inherent uncertainty in the development plans for Vicineum (and Vysyneum in the EMA) as a result of the CRL and the withdrawal of the Company&#8217;s marketing authorization application (&#8220;MAA&#8221;), an interim impairment analysis was conducted in the third quarter of 2021, which concluded that the carrying value of the Company&#8217;s intangible asset of Vicineum US rights was fully impaired as of September&#160;30, 2021. The $31.7&#160;million of impairment charges were due to delays in the expected start of commercialization and lower probabilities of success, combined with higher operating expenses expected to be incurred prior to commercialization, resulting in lower expected future cash flows estimated in the US market. However, while similar delays in timelines and reduced probabilities of success also affected the estimated fair value of the Company&#8217;s intangible asset of Vicineum EU rights, this asset was not impaired as of September&#160;30, 2021. At that time, management assessed that the carrying value of the Vicineum EU rights is not at significant risk of impairment in the future within the current range of commercialization timelines and probability of clinical and regulatory success (&#8220;POS&#8221;) assumptions. This is primarily due to the fact that the Company expects the Vicineum sales outside of the US to be two to three times the expected sales volume in the US, based on management&#8217;s reassessment of the total addressable global market for high-risk NMIBC during the quarter ended June&#160;30, 2019, wherein management determined that both the global market size and the estimated potential Vicineum commercial sales within the global market were likely higher than the Company&#8217;s previous estimate. In addition, the EU asset is burdened with significantly less expense than the US asset, as the Company&#8217;s strategic operating plan is to sublicense Vicineum to business development partners in all regions outside the US, including the EU, with it earning a potential combination of upfront, milestone, and royalty payments, and the business development partner bearing the majority of regulatory and commercialization costs. The Company participated in Type A Meetings with the FDA on October&#160;29, 2021 and December&#160;8, 2021 to discuss questions related to CMC and clinical issues raised in the CRL. Both meetings helped the Company determine the appropriate path forward for Vicineum. Based upon the outcome of these meetings, the Company plans to conduct an additional Phase&#160;3 clinical trial. Also, during the Clinical Type A Meeting, the Company aligned with FDA to include patients with less than adequate BCG into its new clinical trial. The Company performed the annual impairment test, which incorporated the impact of the CRL and the subsequent Type A Meetings in the fourth quarter of 2021 and concluded that the carrying value of the Company&#8217;s intangible asset of Vicineum EU rights was not impaired as of December&#160;31, 2021. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company did not recognize any impairment charges during the year ended December&#160;31, 2020. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Goodwill</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Goodwill on the Company&#8217;s consolidated balance sheets is the result of the Company&#8217;s acquisition of Viventia in September&#160;2016 and represents the difference between the purchase price and the fair value of the identifiable tangible and intangible net assets acquired under the acquisition method of accounting. Goodwill is not amortized; rather than recording periodic amortization, goodwill is quantitatively tested for impairment at least annually during the fourth quarter of the fiscal year, or more often if indicators of impairment are present. Impairment testing of goodwill requires management to estimate the future discounted cash flows of a reporting unit using assumptions believed to be reasonable, but which are unpredictable and inherently uncertain. Actual future cash flows may differ from the estimates used in impairment testing. If the fair value of the equity of a reporting unit exceeds the reporting unit&#8217;s carrying value, including goodwill, then goodwill is considered not to be impaired. The Company recognizes a goodwill impairment when and to the extent that the fair value of the equity of a reporting unit is less than the reporting unit&#8217;s carrying value, including goodwill. The Company has only one reporting unit. In addition, on a quarterly basis, the Company performs a qualitative review of its business operations to determine whether events or changes in circumstances have occurred which could have a material adverse effect on the estimated fair value of each reporting unit and thus indicate a potential impairment of the goodwill carrying value. If an impairment indicator is identified, an interim impairment assessment is performed. Given the inherent uncertainty in the development plans for Vicineum as a result of the CRL and the Company&#8217;s withdrawal of its MAA, an impairment analysis was conducted in the third quarter of 2021. While an impairment was recognized in one of the Company&#8217;s intangible assets, Vicineum US Rights, the Company concluded that the carrying value of its goodwill of $13.1&#160;million was not impaired as of September&#160;30, 2021. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-14</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In October and December&#160;2021, we participated in a CMC Type A Meeting and a Clinical Type A Meeting, respectively, with the FDA to discuss issues raised in the CRL and to discuss design elements of an additional Phase&#160;3 clinical trial for Vicineum, which the FDA confirmed will be required for a potential resubmission of a BLA. Following these Type A Meetings, we believe we have greater clarity of the requirements for potential resubmission of a BLA. We have a Type C Meeting scheduled with the FDA for March&#160;28, 2022, in which we expect to discuss the study protocol for the additional Phase&#160;3 clinical trial that we plan to conduct for potential resubmission of our a BLA for Vicineum for the treatment of non-muscle invasive CIS of the bladder in patients previously treated with adequate or less than adequate BCG. The Company performed the annual impairment test, which incorporated the impact of the CRL and the subsequent Type A Meetings in the fourth quarter of 2021 and concluded that there was no goodwill impairment as of December&#160;31, 2021. Management believes the Company has sufficient future cash flows from additional geographic regions outside the US to support the value of its goodwill. The Company projects future cash flows based on various timeline assumptions and applies a probability to each outcome based on management&#8217;s best estimate. In addition, probabilities of success in achieving certain clinical and regulatory success can also have a material effect on the estimated fair value of the equity of its reporting unit as of the impairment assessment date. The Company will continue to evaluate timelines for commercialization and probability of success of development of Vicineum for the treatment of non-muscle invasive CIS of the bladder in patients previously treated with adequate or less than adequate BCG. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Based on the annual testing and quarterly reviews performed, the Company concluded that there was no goodwill impairment during the year ended December&#160;31, 2020. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Contingent Consideration</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company uses a discounted cash flow model to estimate the fair value of the contingent consideration liability each reporting period, which represents the present value of projected future cash flows associated with regulatory approval milestones and royalties on net sales due to the selling shareholders of Viventia Bio Inc. as a result of the Viventia Acquisition in September&#160;2016. See &#8220;Note 1. Description of Business&#8221; for additional information. Contingent consideration is measured at its estimated fair value on a recurring basis at each reporting period, with fluctuations in value resulting in a non-cash charge to earnings (or loss) during the period. The estimated fair value measurement is based on significant unobservable inputs (Level&#160;3 within the fair value hierarchy), including internally developed financial forecasts, probabilities of success and timing of certain milestone events and achievements, which are inherently uncertain. Actual future cash flows may differ from the assumptions used to estimate the fair value of contingent consideration. The valuation of contingent consideration requires the use of significant assumptions and judgments, which management believes are consistent with those that would be made by a market participant. Management reviews its assumptions and judgments on an ongoing basis as additional market and other data is obtained, and any future changes in the assumptions and judgments utilized by management may cause the estimated fair value of contingent consideration to fluctuate materially, resulting in earnings volatility. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In October and December&#160;2021, we participated in a CMC Type A Meeting and a Clinical Type A Meeting, respectively, with the FDA to discuss issues raised in the CRL and to discuss design elements of an additional Phase&#160;3 clinical trial for Vicineum, which the FDA confirmed will be required for a potential resubmission of a BLA. Following these Type A Meetings, we believe we have greater clarity of the requirements for potential resubmission of a BLA. We have a Type C Meeting scheduled with the FDA for March&#160;28, 2022, in which we expect to discuss the study protocol for the additional Phase&#160;3 clinical trial that we plan to conduct for potential resubmission of our a BLA for Vicineum for the treatment of non-muscle invasive CIS of the bladder in patients previously treated with adequate or less than adequate BCG. The Company reassessed the underlying assumptions used to develop the revenue projections upon which the fair value of its contingent consideration is based. The most significant and impactful assumptions in the Company&#8217;s revenue projection models are timing of product launch and probabilities of clinical and regulatory success (&#8220;POS&#8221;); the Company expects delays in the start of commercialization and estimates lower POS as a direct result of the CRL. The Company plans to conduct an additional clinical trial, which will lead to delays in the start of commercialization globally. The Company has assessed a range of commercialization timeline assumptions and applied a probability to each outcome based on management&#8217;s best estimate. In addition, the Company now assumes a lower POS in achieving certain clinical and regulatory milestones in </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-15</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">the range of approximately 45% to 55% globally. Any changes in these assumptions and estimates, or other information obtained, may have a significant impact on the remeasurement of the contingent consideration liability in the future. The fair value of the Company&#8217;s contingent consideration is determined based on the present value of projected future cash flows associated with sales-based milestones and earnouts on net sales and is heavily dependent on discount rates to estimate the fair value at each reporting period. Earnouts are determined using an earnout rate of 2% on all commercial net sales of Vicineum through December&#160;2033. The discount rate applied to the 2% earnout is derived from the Company&#8217;s estimated weighted-average cost of capital (&#8220;WACC&#8221;), which has fluctuated from 8.8% as of December&#160;31, 2020, to 7.8% as of March&#160;31, 2021, 6.8% as of June&#160;30, 2021, 8.6% as of September&#160;30, 2021, and 9.3% as of December&#160;31, 2021. Milestone payments constitute debt-like obligations, and therefore a high-yield debt index rate is applied to the milestones in order to determine the estimated fair value. This index rate changed from 8.4% as of December&#160;31, 2020, to 7.4% as of March&#160;31, 2021, 6.6% as of June&#160;30, 2021, 7.5% as of September&#160;30, 2021, and 8.0% as of December&#160;31, 2021. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Leases</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Effective January&#160;1, 2019, the Company adopted ASC Topic 842, </font><font style="font-style:italic;letter-spacing:0.2pt;">Leases</font><font style="letter-spacing:0.2pt;"> (&#8220;ASC 842&#8221;) using the optional transition method outlined in ASU No. 2018-11, </font><font style="font-style:italic;letter-spacing:0.2pt;">Leases (Topic 842), Targeted Improvements</font><font style="letter-spacing:0.2pt;">. The adoption of ASC 842 represents a change in accounting principle that aims to increase transparency and comparability among organizations by requiring the recognition of right-of-use assets and lease liabilities on the balance sheet for both operating and finance leases. In addition, the standard requires enhanced disclosures that meet the objective of enabling financial statement users to assess the amount, timing and uncertainty of cash flows arising from leases. The reported results for the year ended December&#160;31, 2021, 2020 and 2019 reflect the application of ASC 842 guidance, while the reported results for priors were prepared in accordance with the previous ASC Topic 840, </font><font style="font-style:italic;letter-spacing:0.2pt;">Leases</font><font style="letter-spacing:0.2pt;"> (&#8220;ASC 840&#8221;) guidance. The adoption of ASC 842 resulted in the recognition of operating lease right-of-use assets and corresponding lease liabilities of $0.2&#160;million on the Company&#8217;s consolidated balance sheet as of January&#160;1, 2019. The adoption of this guidance did not have a material impact on the Company&#8217;s financial condition, results of operations or cash flows; however, the adoption did result in significant changes to the Company&#8217;s financial statement disclosures. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As part of the adoption of ASC 842, the Company utilized certain practical expedients outlined in the guidance. These practical expedients include: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.51pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.51pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Accounting policy election to use the short-term lease exception by asset class; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.3pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Election of the practical expedient package during transition, which includes: </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:7.01pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8212;</font>
          <br >
        </div>
        <div style=" margin-top:7.01pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <font style="letter-spacing:0.2pt;">An entity need not reassess whether any expired or existing contracts are or contain leases; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:7.4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8212;</font>
          <br >
        </div>
        <div style=" margin-top:7.4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <font style="letter-spacing:0.2pt;">An entity need not reassess the classification for any expired or existing leases. As a result, all leases that were classified as operating leases in accordance with ASC 840 are classified as operating leases under ASC 842, and all leases that were classified as capital leases in accordance with ASC 840 are classified as finance leases under ASC 842; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:7.41pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8212;</font>
          <br >
        </div>
        <div style=" margin-top:7.41pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <font style="letter-spacing:0.2pt;">An entity need not reassess initial direct costs for any existing leases. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company&#8217;s lease portfolio as of the adoption date and as of December&#160;31, 2021 includes: a property lease for manufacturing, laboratory, warehouse and office space in Winnipeg, Manitoba, a property lease for its headquarters in Cambridge, MA, and a property lease for office space in Philadelphia, PA. The Company determines if an arrangement is a lease at the inception of the contract and has made a policy election to not separate out non-lease components from lease components, for all classes of underlying assets. The asset components of the Company&#8217;s operating leases are recorded as operating lease right-of-use assets and reported within other assets on the Company&#8217;s consolidated balance sheet. The short-term and long-term liability components are recorded in other current liabilities and other liabilities, respectively, on the Company&#8217;s consolidated balance sheet. As of December&#160;31, 2021, the Company did not have any finance leases. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Right-of-use assets and operating lease liabilities are recognized based on the present value of lease payments over the lease term at the commencement date. Existing leases in the Company&#8217;s lease portfolio as </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-16</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">of the adoption date were valued as of January&#160;1, 2019. The Company uses an incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments, if an implicit rate of return is not provided with the lease contract. Operating lease right-of-use assets are adjusted for incentives received. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Operating lease costs are recognized on a straight-line basis over the lease term, in accordance with ASC 842, and also include variable operating costs incurred during the period. Lease costs also include amounts related to short-term leases. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Research and Development Costs</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Research and development activities are expensed in the period incurred. Research and development expenses consist of both internal and external costs associated with all basic research activities, clinical development activities and technical efforts required to develop a product candidate. Internal research and development consist primarily of personnel costs, including salaries, benefits and share-based compensation, facilities leases, research-related overhead, pre-approval regulatory and clinical trial costs, manufacturing and other contracted services, license fees and other external costs. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">In certain circumstances, the Company is required to make advance payments to vendors for goods or services that will be received in the future for use in research and development activities. In such circumstances, the advance payments are recorded as prepaid assets and expensed when the activity has been performed or when the goods have been received. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Share-Based Compensation</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The Company recognizes the grant-date fair value of share-based awards granted as compensation as expense on a straight-line basis over the requisite service period, which is generally the vesting period of the award. To date, the Company has not issued awards where vesting is subject to market conditions. From time to time, the Company has granted to its executives&#8217; stock option awards which contain both performance-based and service-based vesting criteria. Performance milestone events are specific to the Company&#8217;s corporate goals, including certain clinical development objectives related to the new clinical trial, regulatory and financial objectives. Share-based compensation expense associated with performance-based vesting criteria is recognized using the accelerated attribution method if the performance condition is considered probable of achievement in management&#8217;s judgment. The fair value of stock options is estimated at the time of grant using the Black-Scholes option pricing model, which requires the use of inputs and assumptions such as the fair value of the underlying stock, exercise price of the option, expected term, risk-free interest rate, expected volatility and dividend yield. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The fair value of each grant of options during the&#160;years ended December&#160;31, 2021, 2020 and 2019 was determined using the following methods and assumptions: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.5pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Expected Term.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Due to the lack of historical exercise data and given the plain vanilla nature of the options granted by the Company, the expected term is determined using the &#8220;simplified&#8221; method, as prescribed in SEC Staff Accounting Bulletin (&#8220;SAB&#8221;) No. 107 (&#8220;SAB 107&#8221;), whereby the expected life equals the arithmetic average of the vesting term (generally four&#160;years) and the original contractual term (ten&#160;years) of the option, taking into consideration multiple vesting tranches. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.5pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Risk-Free Interest Rate.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The risk-free rate is based on the interest rate payable on United States Treasury securities in effect at the time of grant for a period that is commensurate with the assumed expected term. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.5pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Expected Volatility.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The expected volatility is based on historical volatilities of a representative group of publicly traded biopharmaceutical companies, including the Company&#8217;s own volatility, which were commensurate with the assumed expected term, as prescribed in SAB 107. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.5pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Dividend Yield.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The dividend yield is 0% because the Company has never declared or paid, and for the foreseeable future does not expect to declare or pay, a dividend on its common stock. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-17</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Income Taxes</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and net operating loss (&#8220;NOL&#8221;) and research and development credit (&#8220;R&amp;D credit&#8221;) carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the&#160;years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in operations in the period that includes the enactment date. A valuation allowance is recorded to the extent it is more likely than not that some portion or all of the deferred tax assets will not be realized. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Unrecognized income tax benefits represent income tax positions taken on income tax returns that have not been recognized in the financial statements. The Company recognizes the benefit of an income tax position only if it is more likely than not (greater than 50%) that the tax position will be sustained upon tax examination, based solely on the technical merits of the tax position. Otherwise, no benefit is recognized. The tax benefits recognized are measured based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement. The Company recognizes accrued interest and penalties related to uncertain tax positions as income tax expense in its consolidated statements of operations. As of December&#160;31, 2021 and 2020, the Company did not have any uncertain tax positions. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Revenue Recognition</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company records revenue from out-license agreements and OUS business development partnership agreements, including the License Agreement with Roche and its OUS partnerships. Under each of these agreements, the Company granted the counterparty an exclusive license to develop and commercialize the underlying licensed product. These agreements contain up-front license fees, development and regulatory milestone payments, sales-based milestone payments, and sales-based royalty payments. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company determines whether the out-license agreements and OUS business development partnership agreements are in scope of ASC 606, which it adopted as of January&#160;1, 2018. Under ASC 606, in determining the appropriate amount of revenue to be recognized as the Company fulfills its obligations under these agreements, management performs the following steps: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.5pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">1)</font>
          <br >
        </div>
        <div style=" margin-top:7.5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:0.2pt;">Identification of the contract; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.5pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">2)</font>
          <br >
        </div>
        <div style=" margin-top:7.5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:0.2pt;">Determination of whether the promised goods or services are performance obligations including whether they are distinct in the context of the contract; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.51pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">3)</font>
          <br >
        </div>
        <div style=" margin-top:7.51pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:0.2pt;">Measurement of the transaction price, including the constraint on variable consideration; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.5pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">4)</font>
          <br >
        </div>
        <div style=" margin-top:7.5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:0.2pt;">Allocation of the transaction price to the performance obligations; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">5)</font>
          <br >
        </div>
        <div style=" margin-top:7.4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:0.2pt;">Recognition of revenue when or as the Company satisfies each performance obligation. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Development and Regulatory Milestones and Other Payments</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">At the inception of an arrangement that includes development milestone payments, management evaluates whether the development milestones are considered probable of being reached and estimate the amount to be included in the transaction price using the most likely amount method. If it is probable that a significant revenue reversal would not occur, the associated development milestone value is included in the transaction price. Development milestone payments that are not within the Company&#8217;s control or the licensee&#8217;s control, such as regulatory approvals, are not considered probable of being achieved until those approvals are received. For payments pursuant to sales milestones and royalty payments, the Company will not recognize revenue until the subsequent sale of a licensed product occurs. For arrangements with one than one performance obligations, the milestones are generally allocated entirely to the license performance obligation, as (1)&#160;the terms of milestone and royalty payments relate specifically to the license and (2)&#160;allocating milestones and royalties to the license performance obligation is consistent with the overall allocation objective, because management&#8217;s estimate of milestones and royalties approximates the standalone selling price of the license. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-18</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In December&#160;2021, a $20&#160;million milestone was achieved due to Roche initiating a Phase&#160;II clinical trial. The Company invoiced Roche $20&#160;million with payment terms of 30&#160;days following the achievement of the corresponding milestone event, pursuant to the Roche License Agreement. Management evaluated the transaction under ASC 606 and determined it is probable that a significant revenue reversal will not occur in future periods, which was not the case in the previous quarter. Accordingly, the Company recorded $20&#160;million as license revenue and accounts receivables in the fourth quarter of 2021. In January&#160;2022, the payment of $20&#160;million was received. </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.71pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company recognized $26.5&#160;million of license revenue related to the Roche, Qilu and MENA License Agreements during the year ended December&#160;31, 2021 and $11.2&#160;million of license revenue related to the Qilu License Agreement during the year ended December&#160;31, 2020. </font>
        </div>
        <div style="margin-top:10.71pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">4.&nbsp;&nbsp;&nbsp;RECENT ACCOUNTING PRONOUNCEMENTS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:9.63pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Adopted in 2021</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.12pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In December&#160;2019, the FASB issued ASU No. 2019-12, </font><font style="font-style:italic;letter-spacing:0.2pt;">Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes</font><font style="letter-spacing:0.2pt;"> (&#8220;ASU 2019-12&#8221;). ASU 2019-12 simplifies the accounting for income taxes by removing certain exceptions to the general principles in Topic 740. The amendments in ASU 2019-12 also improve consistent application of and simplify GAAP for other areas of Topic 740 by clarifying and amending existing guidance. ASU 2019-12 is effective for fiscal&#160;years, and interim periods within those fiscal&#160;years, beginning after December&#160;15, 2020. Early adoption is permitted. The method with which the amendments in this ASU are to be applied varies depending on the nature of the tax item impacted by amendment. The Company adopted this guidance effective January&#160;1, 2021, and it did not have a material impact on its financial position, results of operations or cash flows. </font>
        </div>
        <div style="margin-top:10.72pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">5.&nbsp;&nbsp;&nbsp;FAIR VALUE MEASUREMENT AND FINANCIAL INSTRUMENTS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.11pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The carrying values of cash and cash equivalents, restricted cash, prepaid expenses and other current assets, and accounts payable on the Company&#8217;s consolidated balance sheets approximated their fair values as of December&#160;31, 2021 and 2020 due to their short-term nature. </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.61pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Certain of the Company&#8217;s financial instruments are measured at fair value using a three-level hierarchy that prioritizes the inputs used to measure fair value. This fair value hierarchy prioritizes the use of observable inputs and minimizes the use of unobservable inputs. The three levels of inputs used to measure fair value are as follows: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.62pt; margin-bottom:0pt; text-align:left; width:41pt;white-space:nowrap;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Level&#160;1</font><font style="letter-spacing:0.2pt;">:</font>
          <br >
        </div>
        <div style=" margin-top:5.62pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:61pt;">
          <font style="letter-spacing:0.2pt;">Inputs are quoted prices for identical instruments in active markets, </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.61pt; margin-bottom:0pt; text-align:left; width:41pt;white-space:nowrap;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Level&#160;2</font><font style="letter-spacing:0.2pt;">:</font>
          <br >
        </div>
        <div style=" margin-top:5.61pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:61pt;">
          <font style="letter-spacing:0.2pt;">Inputs are quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; or model-derived valuations whose inputs are observable or whose significant value drivers are observable. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.62pt; margin-bottom:0pt; text-align:left; width:41pt;white-space:nowrap;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Level&#160;3</font><font style="letter-spacing:0.2pt;">:</font>
          <br >
        </div>
        <div style=" margin-top:5.62pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:61pt;">
          <font style="letter-spacing:0.2pt;">Inputs are unobservable and reflect the Company&#8217;s own assumptions, based on the best information available, including the Company&#8217;s own data. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:7.52pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following tables set forth the carrying amounts and fair values of the Company&#8217;s financial instruments measured at fair value on a recurring basis as of December&#160;31, 2021 and 2020 (in thousands): </font>
        </div>
        <table style="width:456pt;height:146.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:214.14pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="28">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">December&#160;31, 2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:214.14pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt; width:0pt;" colspan="16">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Fair Value Measurement Based on </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:214.14pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Carrying </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Amount </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Fair Value </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Quoted </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Prices in </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Active</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Markets</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(Level&#160;1) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Significant </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Other </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Observable</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Inputs</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(Level&#160;2) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Significant </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Unobservable</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Inputs</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(Level&#160;3) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:214.14pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Assets:</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.125pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.125pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.065pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.065pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:214.14pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Money market funds (cash equivalents) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">16,382</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">16,382</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">16,382</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.125pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">&nbsp;&nbsp;&nbsp;&#8212;</td>
            <td style="padding:0pt;padding-left:6.125pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.065pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.065pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:214.14pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Liabilities:</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.125pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.125pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.065pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.065pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:214.14pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Contingent consideration&#8201;&#8211;&#8201;short term </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.125pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.125pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.065pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.065pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:214.14pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Contingent consideration&#8201;&#8211;&#8201;long term </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">52,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">52,000</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.125pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.125pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.065pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">52,000</td>
            <td style="padding:0pt;padding-left:6.065pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-19</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <table style="width:456pt;height:158.5pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:214.14pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="28">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">December&#160;31, 2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:214.14pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt; width:0pt;" colspan="16">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Fair Value Measurement Based on </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:214.14pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Carrying </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Amount </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Fair Value </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Quoted </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Prices in </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Active</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Markets</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(Level&#160;1) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Significant </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Other </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Observable</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Inputs</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(Level&#160;2) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Significant </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Unobservable</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Inputs</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(Level&#160;3) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:214.14pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Assets:</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.125pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.125pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.065pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.065pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:214.14pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Money market funds (cash equivalents) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">16,374</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">16,374</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">16,374</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.125pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">&nbsp;&nbsp;&nbsp;&#8212;</td>
            <td style="padding:0pt;padding-left:6.125pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.065pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.065pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:214.14pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Liabilities:</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.125pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.125pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.065pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.065pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:214.14pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Contingent consideration, current portion </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">8,985</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">8,985</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.125pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.125pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.065pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">8,985</td>
            <td style="padding:0pt;padding-left:6.065pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 1.5pt 0pt; width:214.14pt;white-space:normal;text-align:left;">
              <div style="margin-left:20pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Contingent consideration, net of current portion </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">99,855</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">99,855</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.125pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.125pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.065pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">99,855</td>
            <td style="padding:0pt;padding-left:6.065pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:7.8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company evaluates transfers between fair value levels at the end of each reporting period. There were no transfers of assets or liabilities between fair value levels during the year ended December&#160;31, 2021. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Contingent Consideration</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The estimated fair value of the Company&#8217;s contingent consideration was determined using probabilities of successful achievement of regulatory milestones and commercial sales, the period in which these milestones and sales are expected to be achieved ranging from 2025 to 2033, the level of commercial sales of Vicineum forecasted for the US, Europe, Japan, China and other potential markets and discount rates ranging from 8.0% to 9.3% as of December&#160;31, 2021 and 8.4% to 8.8% as of December&#160;31, 2020. There have been no changes to the valuation methods utilized during the year ended December&#160;31, 2021. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following table sets forth a summary by quarter of the change in the fair value of the Company&#8217;s contingent consideration liability, measured on a recurring basis at each reporting period, for the year ended December&#160;31, 2021 (in thousands): </font>
        </div>
        <table style="width:416pt;height:164pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; width:362.96pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:bold;">
                <font style="letter-spacing:-0.2pt;">Balance at December&#160;31, 2020</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:0pt 0pt 1pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">108,840</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:362.96pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Change in fair value included in loss </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">48,160</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:362.96pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Balance at March&#160;31, 2021 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">157,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:362.96pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Change in fair value included in loss </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">13,600</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:362.96pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Balance at June&#160;30, 2021 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">170,600</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:362.96pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Change in fair value included in loss </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">(114,000<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:362.96pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Balance at September&#160;30, 2021 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">56,600</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:362.96pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Change in fair value included in loss </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">(4,600<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:362.96pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">Balance at December&#160;31, 2021</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27pt; text-align:right; white-space:nowrap;">52,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.5pt 0pt; width:362.96pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Balance at December&#160;31, 2021, current portion </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:362.96pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Balance at December&#160;31, 2021, net of current portion </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">52,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:7.9pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following table sets forth a summary of the change in the fair value of the Company&#8217;s total contingent consideration liability, measured on a recurring basis at each reporting period, for the year ended December&#160;31, 2021. </font>
        </div>
        <table style="width:416pt;height:55.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; width:366.29pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:bold;">
                <font style="letter-spacing:-0.2pt;">Balance at December&#160;31, 2020</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:0pt 0pt 1pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">108,840</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:366.29pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Change in fair value of contingent consideration&#8201;&#8211;&#8201;short term </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">(8,985<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:366.29pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Change in fair value of contingent consideration&#8201;&#8211;&#8201;long term </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">(47,855<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:366.29pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">Balance at December&#160;31, 2021</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">52,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:12.9pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The fair value of the Company&#8217;s contingent consideration is determined based on the present value of projected future cash flows associated with sales-based milestones and earnouts on net sales and is heavily </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-20</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">dependent on discount rates to estimate the fair value at each reporting period. Earnouts are determined using an earnout rate of 2% on all commercial net sales of Vicineum through December&#160;2033. The discount rate applied to the 2% earnout is derived from the Company&#8217;s WACC, which has fluctuated from 8.8% as of December&#160;31, 2020, to 7.8% as of March&#160;31, 2021, 6.8% as of June&#160;30, 2021, 8.6% as of September&#160;30, 2021, and 9.3% as of December&#160;31, 2021. Milestone payments constitute debt-like obligations, and therefore a high-yield debt index rate is applied to the milestones in order to determine the estimated fair value. This index rate changed from 8.4% as of December&#160;31, 2020, to 7.4% as of March&#160;31, 2021, 6.6% as of June&#160;30, 2021, 7.5% as of September&#160;30, 2021, and 8.0% as of December&#160;31, 2021. The decrease in the fair value of contingent consideration of $56.8&#160;million for the year ended December&#160;31, 2021 was driven by the receipt of the CRL from the FDA, in which the FDA determined that it could not approve the BLA for Vicineum in its present form, and the Company&#8217;s withdrawal of its MAA with EMA. In October and December&#160;2021, we participated in a CMC Type A Meeting and a Clinical Type A Meeting, respectively, with the FDA to discuss issues raised in the CRL and to discuss design elements of an additional Phase&#160;3 clinical trial for Vicineum, which the FDA confirmed will be required for a potential resubmission of a BLA. Following these Type A Meetings, we believe we have greater clarity of the requirements for potential resubmission of a BLA. We have a Type C Meeting scheduled with the FDA for March&#160;28, 2022, in which we expect to discuss the study protocol for the additional Phase&#160;3 clinical trial that we plan to conduct for potential resubmission of our a BLA for Vicineum for the treatment of non-muscle invasive CIS of the bladder in patients previously treated with adequate or less than adequate BCG. Incorporating the impact of the CRL and the subsequent Type A Meetings in the fourth quarter of 2021, the Company reassessed the underlying assumptions used to develop the revenue projections upon which the fair value of its contingent consideration is based. The most significant and impactful assumptions in the Company&#8217;s revenue projection models are timing of commercial product launch and probabilities of clinical and regulatory success; the Company expects delays in the start of commercialization and estimates lower POS as a direct result of the CRL and the Company&#8217;s withdrawal of its MAA. The Company plans to conduct an additional Phase&#160;3 clinical trial in order to resubmit a BLA for Vicineum for the treatment of non-muscle invasive CIS of the bladder in patients previously treated with adequate or less than adequate BCG, which will lead to delays in the start of commercialization globally. The Company has assessed a commercialization timeline assumption and applied a probability to each outcome based on management&#8217;s best estimate. In addition, the Company now assumes a lower POS in achieving certain clinical and regulatory milestones in the range of approximately 45% to 55% globally. Any changes in these assumptions and estimates as a result of these meetings, or other information obtained, may have a significant impact on the remeasurement of the contingent consideration liability in the future. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">6.&nbsp;&nbsp;&nbsp;RECEIVABLES</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The accounts receivable balance as of December&#160;31, 2021 is $21.0&#160;million, comprised primarily of a $20&#160;million milestone achieved in December&#160;2021 due to Roche initiating a Phase&#160;II clinical trial. The Company invoiced Roche $20&#160;million with payment terms of 30&#160;days following the achievement of the corresponding milestone event, pursuant to the Roche License Agreement. In January&#160;2022 the payment of $20&#160;million was received. Additionally, in June&#160;2021, the Qilu License Agreement was recognized by Shandong Province, Bureau of Science and Technology as a &#8220;Technology Transfer&#8221;. As such, the Company recorded $0.9&#160;million of revenue and accounts receivable for the additional purchase price resulting from Qilu&#8217;s obligation to pay Sesen an amount equal to its recovery of VAT. The Company will not be subject to VAT on future potential milestone payments from Qilu. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The other receivable balance as of December&#160;31, 2021 is $3.5&#160;million. The Company recorded $3.4&#160;million to other receivables in the fourth quarter of 2021 for German VAT recovery related to drug substance sent to Baxter. The Company received a payment for $1.8&#160;million in January&#160;2022 and expects to collect the remaining balance. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The accounts receivable and other receivable balances as of December&#160;31, 2020 were de minims. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-21</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">7.&nbsp;&nbsp;&nbsp;PROPERTY AND EQUIPMENT</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following table sets forth the composition of property and equipment, net as of December&#160;31, 2021 and 2020 (in thousands): </font>
        </div>
        <table style="width:416pt;height:143pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:336.59pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:336.59pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:336.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Lab equipment </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">569</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">570</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:336.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Furniture and fixtures </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">16</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">16</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:336.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Computer equipment </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">99</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">97</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:336.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Software </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">32</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">28</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:336.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Leasehold improvements </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">293</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">293</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:336.59pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Property and equipment, gross </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1,009</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1,004</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:336.59pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Less: accumulated depreciation </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">(966<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">(881<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:336.59pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:-0.2pt;">Total Property and Equipment, Net</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">43</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">123</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:12.71pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Depreciation expense was $0.1&#160;million, $0.1&#160;million and $0.2&#160;million for the&#160;years ended December&#160;31, 2021, 2020 and 2019, respectively. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">8.&nbsp;&nbsp;&nbsp;INTANGIBLES AND GOODWILL</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Intangibles</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Intangible assets on the Company&#8217;s consolidated balance sheet are the result of the Viventia Acquisition in September&#160;2016. The following table sets forth the composition of intangible assets as of December&#160;31, 2021 and 2020 (in thousands): </font>
        </div>
        <table style="width:416pt;height:82.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:326.59pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:326.59pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:326.59pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">IPR&amp;D intangible assets: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:326.59pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Vicineum United States rights </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">31,700</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:326.59pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Vicineum European Union rights </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">14,700</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">14,700</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:326.59pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:-0.2pt;">Total Intangibles</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24pt; text-align:right; white-space:nowrap;">14,700</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">46,400</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:12.81pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The fair value of the acquired intangible assets for the US and EU rights of Vicineum is determined using a risk-adjusted discounted cash flow approach, which includes probability adjustments for projected revenues and operating expenses based on the success rates assigned to each stage of development for each geographical region; as well as discount rates applied to the projected cash flows. In August&#160;2021, the Company received a CRL from the FDA regarding its BLA for Vicineum for the treatment of NMIBC, the Company&#8217;s lead product candidate. In the CRL, the FDA determined that it could not approve the BLA for Vicineum in its present form and provided recommendations specific to additional clinical/statistical data and analyses in addition to CMC issues pertaining to a recent pre-approval inspection and product quality. Given the inherent uncertainty in the development plans for Vicineum as a result of the CRL and the Company&#8217;s withdrawal of its MAA, an impairment analysis was conducted in the third quarter of 2021, which concluded that the carrying value of the Company&#8217;s intangible asset of Vicineum United States rights was fully impaired as of September&#160;30, 2021. The $31.7&#160;million of impairment charges as of September&#160;30, 2021 are due to delays in the expected start of commercialization and lower probabilities of success, combined with higher operating expenses expected to be incurred prior to commercialization, resulting in lower expected future cash flows estimated in the US market. At this time, management has assessed that the carrying value of the Vicineum EU rights is not at significant risk of impairment in the future within the current range of commercialization timelines and POS assumptions. This is primarily due to the fact that the Company expects the Vicineum sales outside of the US to be two to three times the expected sales volume in the US, based on management&#8217;s reassessment of the total addressable global market for high-risk NMIBC during the quarter ended June&#160;30, 2019, wherein management determined that both the global market size </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-22</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">and the estimated potential Vicineum commercial sales within the global market were likely higher than the Company&#8217;s previous estimate. In addition, the EU asset is burdened with significantly less expense than the US asset, as the Company&#8217;s strategic operating plan is to sublicense Vicineum to business development partners in all regions outside the US, including the EU, with it earning a potential combination of upfront, milestone, and royalty payments, and the business development partner bearing the majority of regulatory and commercialization costs. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In October and December&#160;2021, we participated in a CMC Type A Meeting and a Clinical Type A Meeting, respectively, with the FDA to discuss issues raised in the CRL and to discuss design elements of an additional Phase&#160;3 clinical trial for Vicineum, which the FDA confirmed will be required for a potential resubmission of a BLA. Following these Type A Meetings, we believe we have greater clarity of the requirements for potential resubmission of a BLA. We have a Type C Meeting scheduled with the FDA for March&#160;28, 2022, in which we expect to discuss the study protocol for the additional Phase&#160;3 clinical trial that we plan to conduct for potential resubmission of our a BLA for Vicineum for the treatment of non-muscle invasive CIS of the bladder in patients previously treated with adequate or less than adequate BCG. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company performed the annual impairment test, which incorporated the impact of the CRL and the subsequent Type A Meetings in the fourth quarter of 2021 and concluded that the carrying value of the Company&#8217;s intangible asset of Vicineum EU rights was not impaired as of December&#160;31, 2021. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company did not recognize any impairment charges during the year ended December&#160;31, 2020. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Goodwill</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Goodwill on the Company&#8217;s consolidated balance sheet is the result of the Viventia Acquisition in September&#160;2016. Goodwill had a carrying value of $13.1&#160;million as of December&#160;31, 2021 and 2020. Given the inherent uncertainty in the development plans for Vicineum as a result of the CRL and the Company&#8217;s withdrawal of its MAA, a quantitative impairment analysis was conducted during the third quarter of 2021, in advance of the Company&#8217;s typical annual assessment date of October&#160;1. While an impairment was recognized in one of its intangible assets, Vicineum US Rights, the Company concluded that the carrying value of its goodwill of $13.1&#160;million was not impaired as of September&#160;30, 2021, with the fair value of equity of the reporting unit exceeding the estimated carrying value of the reporting unit by approximately 45%. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In October and December&#160;2021, we participated in a CMC Type A Meeting and a Clinical Type A Meeting, respectively, with the FDA to discuss issues raised in the CRL and to discuss design elements of an additional Phase&#160;3 clinical trial for Vicineum, which the FDA confirmed will be required for a potential resubmission of a BLA. Following these Type A Meetings, we believe we have greater clarity of the requirements for potential resubmission of a BLA. We have a Type C Meeting scheduled with the FDA for March&#160;28, 2022, in which we expect to discuss the study protocol for the additional Phase&#160;3 clinical trial that we plan to conduct for potential resubmission of our a BLA for Vicineum for the treatment of non-muscle invasive CIS of the bladder in patients previously treated with adequate or less than adequate BCG. The Company performed the annual impairment test, which incorporated the impact of the CRL and the subsequent Type A Meetings in the fourth quarter of 2021 and concluded that there was no goodwill impairment as of December&#160;31, 2021. The Company believes it has sufficient future cash flows from additional geographic regions outside the US to support the value of its goodwill. The Company projects future cash flows based on various timeline assumptions and applies a probability to each outcome based on management&#8217;s best estimate. In addition, probabilities of success in achieving certain clinical and regulatory success in the Company&#8217;s current development profile (ranging from 45% to 55% globally) also have a material effect on the estimated fair value of its reporting unit as of the impairment assessment date. The Company will continue to evaluate its timelines for commercialization and probability of success of development of Vicineum for the treatment of non-muscle invasive CIS of the bladder in patients previously treated with adequate or less than adequate BCG. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Based on the annual testing and quarterly reviews performed, the Company concluded that there was no goodwill impairment during the year ended December&#160;31, 2020. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-23</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">9.&nbsp;&nbsp;&nbsp;ACCRUED EXPENSES</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following table sets forth the composition of accrued expenses as of December&#160;31, 2021 and 2020 (in thousands): </font>
        </div>
        <table style="width:416pt;height:112.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:336.59pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:336.59pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:336.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Research and development </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">1,841</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1,372</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:336.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Payroll-related expenses </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">2,967</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1,892</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:336.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Restructuring charge related </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">1,497</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:336.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Professional fees </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">1,941</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">684</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:336.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Other </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">9</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">25</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:336.59pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.2pt;">Total Accrued Expenses</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">8,255</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">3,973</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:16.71pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">10.&nbsp;&nbsp;&nbsp;COMMITMENTS AND CONTINGENCIES</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Legal Proceedings</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">From time to time, the Company may become subject to legal proceedings, claims, and litigation arising in the ordinary course of business. When the Company becomes aware of a claim or potential claim, it assesses the likelihood of any loss or exposure. In accordance with authoritative guidance, the Company records loss contingencies in its financial statements only for matters in which losses are probable and can be reasonably estimated. Where a range of loss can be reasonably estimated with no best estimate in the range, the Company records the minimum estimated liability. If the loss is not probable or the amount of the loss cannot be reasonably estimated, the Company discloses the nature of the specific claim if the likelihood of a potential loss is reasonably possible, and the amount involved is material. The Company continuously assesses the potential liability related to the Company&#8217;s pending litigation and revises its estimates when additional information becomes available. The Company is not currently a party to any material legal proceedings, other than as described below. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On August&#160;19, 2021, August&#160;31, 2021, and October&#160;7, 2021, three substantially identical securities class action lawsuits captioned Bibb v. Sesen Bio, Inc., et. al., Case No. 1:21-cv-07025, Cizek v. Sesen Bio, Inc., et. al., Case No. 1:21-cv-07309, and Markman v. Sesen Bio, Inc. et al., Case No. 1:21-cv-08308 were filed against the Company and certain of its officers in the US District Court for the Southern District of New York. The three complaints allege violations of Sections&#160;10(b) and 20(a) of the Exchange Act and Rule&#160;10b-5 promulgated thereunder based on statements made by the Company concerning its BLA for Vicineum for the treatment of BCG-unresponsive NMIBC. The three complaints seek compensatory damages and costs and expenses, including attorneys&#8217; fees. On October&#160;29, 2021, the court consolidated the three cases under the caption In re Sesen Bio, Inc. Securities Litigation, Master File No. 1:21-cv-07025-AKH (the &#8220;Securities Litigation&#8221;), and appointed Ryan Bibb, Rodney Samaan, Lionel Dreshaj and Benjamin Dreshaj (&#8220;Lead Plaintiffs&#8221;) collectively as the lead plaintiffs under the Private Securities Litigation Reform Act. On November&#160;1, 2021, two stockholders filed motions to reconsider asking the court to appoint a different lead plaintiff. The court has not ruled on those motions at this time. On November&#160;24, 2021, defendants filed a motion to transfer venue to the US District Court for the District of Massachusetts. That motion was fully briefed as of December&#160;13, 2021, but the court has not yet ruled on that motion. On December&#160;6, 2021, the Lead Plaintiffs filed an amended class action complaint (the &#8220;Amended Complaint&#8221;). The Amended Complaint alleges the same violations of Sections&#160;10(b) and 20(a) of the Exchange Act and Rule&#160;10b-5 promulgated thereunder on the same theory as the prior complaints. Defendants&#8217; response to the Amended Complaint is due to be filed on March&#160;7, 2022. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On September&#160;20, 2021 and September&#160;24, 2021, two substantially similar derivative lawsuits captioned Myers v. Sesen Bio, Inc., et. al., Case No. 1:21-cv-11538 and D&#8217;Arcy v. Sesen Bio, Inc., et. al., Case No. 1:21-cv-11577 were filed against the Company&#8217;s board of directors and certain of its officers in the US District Court for the District of Massachusetts, with the Company named as a nominal defendant. On January&#160;12, 2022, a third derivative complaint captioned Tang v. Sesen Bio, Inc., et al., was filed in Superior Court in Massachusetts against the Company&#8217;s board of directors and certain of its officers in the US District </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-24</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Court for the District of Massachusetts, with the Company named as nominal defendant, but no defendant has yet been served. The three derivative complaints allege breach of fiduciary duties, waste of corporate assets, and violations of federal securities laws based on statements made by the Company concerning its BLA for Vicineum for the treatment of BCG-unresponsive NMIBC. The D&#8217;Arcy complaint further alleges unjust enrichment, abuse of control, gross mismanagement and aiding and abetting thereof. The three derivative complaints seek unspecified damages, restitution and disgorgement of profits, benefits and compensation obtained by the defendants and costs and expenses, including attorneys&#8217; fees. On October&#160;18, 2021, the court consolidated the two federal cases under the caption In re Sesen Bio, Inc. Derivative Litigation, Lead Case No. 1:21-cv-11538 (the &#8220;Federal Derivative Litigation&#8221;). On December&#160;22, 2021, the court entered a joint stipulation among the parties to stay the Federal Derivative Litigation until after a ruling on any motion to dismiss filed by defendants in the Securities Litigation. Defendants intend to seek a similar stay of the state court derivative litigation in the event any defendant is served. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company believes that these lawsuits are without merit and intends to vigorously defend against them. The lawsuits are in the early stages and, at this time, no assessment can be made as to the likely outcome or whether the outcome will be material to the Company. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Executive Employment Agreements</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company has entered into employment agreements and offer letters with certain of its key executives, providing for separation payments and benefits in certain circumstances, as defined in the agreements. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">11.&nbsp;&nbsp;&nbsp;LEASES</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company accounts for operating leases under ASC Topic 842, </font><font style="font-style:italic;letter-spacing:0.2pt;">Leases.</font><font style="letter-spacing:0.2pt;"> The Company&#8217;s lease portfolio includes an operating lease for its 31,100 square foot facility in Winnipeg, Manitoba which consists of manufacturing, laboratory, warehouse and office space. In September&#160;2020, the Company entered into an extension of this lease for an additional two&#160;years, through September&#160;2022, with a right to extend the lease for one subsequent three-year term. The minimum monthly rent under this lease is CAD $18,100 (approximately $14,300 at exchange rates in effect on December&#160;31, 2021). In addition to rent expense, the Company expects to incur CAD $18,200 per month related to operating expenses (approximately $14,300 at exchange rates in effect on December&#160;31, 2021). Operating lease cost under this lease, including the related operating costs, were $0.3&#160;million and $0.3&#160;million for the year ended December&#160;31, 2021 and $0.3&#160;million and $0.3&#160;million for the year ended December&#160;31, 2020, respectively. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The asset component of the Company&#8217;s operating leases is recorded as operating lease right-of-use assets and reported within other assets on the Company&#8217;s consolidated balance sheets. The short-term lease liability is recorded in other current liabilities and the long-term lease liability is recorded in other liabilities on the Company&#8217;s consolidated balance sheets. Operating lease cost is recognized on a straight-line basis over the term of the lease. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, the Company has short-term property leases for modular office space for 1) its corporate headquarters in Cambridge, MA and 2) office space in Philadelphia, PA. The short-term leases renew every three&#160;months to six&#160;months and currently extend through June&#160;2022 and May&#160;2022, respectively. The minimum monthly rent for these office spaces is $2,100 and $18,400, respectively, which is subject to change if and as the Company adds space to or deducts space from the leases. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The components of lease cost for the&#160;years ended December&#160;31, 2021 and 2020 is as follows (in thousands): </font>
        </div>
        <table style="width:416pt;height:78pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:264.81pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Year Ended </font>
                <br >
                <font style="letter-spacing:-0.16pt;">December&#160;31, 2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Year Ended </font>
                <br >
                <font style="letter-spacing:-0.16pt;">December&#160;31, 2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:264.81pt;text-align:left;">
              <font style=" text-decoration:underline #000000 solid;letter-spacing:-0.2pt;">Lease Cost:</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.795pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.795pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.795pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.795pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:264.81pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Operating lease (including related operating costs) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.795pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">327</td>
            <td style="padding:0pt;padding-left:21.795pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.795pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">301</td>
            <td style="padding:0pt;padding-left:21.795pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:264.81pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Short term property leases </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.795pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:14.25pt; text-align:right; white-space:nowrap;">262</td>
            <td style="padding:0pt;padding-left:21.795pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.795pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">261</td>
            <td style="padding:0pt;padding-left:21.795pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:264.81pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Total lease costs </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.795pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">
              <div style="font-weight:bold;">$</div>
            </td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">589</div>
            </td>
            <td style="padding:0pt;padding-left:21.795pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.795pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">
              <div style="font-weight:bold;">$</div>
            </td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">562</div>
            </td>
            <td style="padding:0pt;padding-left:21.795pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-25</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <table style="width:416pt;height:62.5pt;margin-left:20pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:264.81pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Year Ended </font>
                <br >
                <font style="letter-spacing:-0.16pt;">December&#160;31, 2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Year Ended </font>
                <br >
                <font style="letter-spacing:-0.16pt;">December&#160;31, 2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:264.81pt;">
              <font style=" text-decoration:underline #000000 solid;letter-spacing:-0.2pt;">Supplemental Information:</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td colspan="6">&#8203;</td>
            <td colspan="6">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:264.81pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Weighted-average remaining lease term (years) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:22.94pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">0.75</td>
            <td style="padding:0pt;padding-left:22.94pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:22.94pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">1.75</td>
            <td style="padding:0pt;padding-left:22.94pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:264.81pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Weighted-average discount rate&#8201;&#8211;&#8201;operating leases </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:22.94pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">12<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:22.94pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:22.94pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">12<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:22.94pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:8.1pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following table sets forth the Company&#8217;s future minimum lease payments under non-cancelable leases as of December&#160;31, 2021 (in thousands): </font>
        </div>
        <table style="width:416pt;height:78pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:340.41pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;text-align:center;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Year Ended </font>
                <br >
                <font style="letter-spacing:-0.16pt;">December&#160;31, 2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:340.41pt;">
              <font style=" text-decoration:underline #000000 solid;letter-spacing:-0.2pt;">Minimum Lease Payments:</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td colspan="6">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:340.41pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total future minimum lease payments (2022) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.795pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">129</td>
            <td style="padding:0pt;padding-left:21.795pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:340.41pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Less: Amounts representing present value adjustment </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.795pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">(5<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:21.795pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:340.41pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Operating lease liabilities, net of current portion </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.795pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">
              <div style="font-weight:bold;">$</div>
            </td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">124</div>
            </td>
            <td style="padding:0pt;padding-left:21.795pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:17.1pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">12.&nbsp;&nbsp;&nbsp;STOCKHOLDERS&#8217; EQUITY DEFICIT</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Equity Financings</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">ATM Offering</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In November&#160;2019, the Company entered into an Open Market Sale Agreement </font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">SM</font><font style="letter-spacing:0.2pt;"> (the &#8220;Sale Agreement&#8221;) with Jefferies LLC (&#8220;Jefferies&#8221;), under which the Company may issue and sell shares of its common stock, par value $0.001 per share, from time to time (the &#8220;ATM Offering&#8221;) for an aggregate sales price of up to $35&#160;million through Jefferies. In October&#160;2020 and February&#160;2021, the Company entered into Amendments No. 1 and No. 2 to the Sale Agreement, respectively. Amendments No. 1 and No. 2 modified the Sale Agreement to reflect that the Company may issue and sell shares of its common stock from time to time for an aggregate sales price of up to an additional $50.0&#160;million and $34.5&#160;million, respectively. In June&#160;2021, the Company entered into Amendment No. 3 to the Sale Agreement, which modified the Sale Agreement to remove the maximum dollar amount of shares of common stock that may be sold pursuant to the Sale Agreement. In June and July&#160;2021, the Company filed prospectus supplements with the SEC in connection with the offer and sale of up to an aggregate of $200&#160;million of common stock pursuant to the Sale Agreement. Sales are made by any method that is deemed to be an ATM offering as defined in Rule&#160;415(a)(4) of the Securities Act of 1933, as amended, including but not limited to sales made directly on or through the Nasdaq Global Market or any other existing trading market for the Company&#8217;s common stock. The Company may sell shares of its common stock efficiently from time to time but has no obligation to sell any of its common stock and may at any time suspend offers under the Sale Agreement or terminate the Sale Agreement. Subject to the terms and conditions of the Sale Agreement, Jefferies will use its commercially reasonable efforts to sell common stock from time to time, as the sales agent, based upon the Company&#8217;s instructions, which include a prohibition on sales below a minimum price set by the Company from time to time. The Company has provided Jefferies with customary indemnification rights, and Jefferies is entitled to a commission at a fixed rate equal to 3.0% of the gross proceeds for each sale of common stock under the Sale Agreement. The Company raised $175.0&#160;million of net proceeds from the sale of 56.9&#160;million shares of common stock at a weighted-average price of $3.17 per share during the year ended December&#160;31, 2021, compared to $38.0&#160;million of net proceeds from the sale of 33.4&#160;million shares of common stock at a weighted-average price of $1.17 per share during the year ended December&#160;31, 2020. Share issuance costs, including sales agent commissions, related to the ATM Offering totaled $5.4&#160;million and $1.2&#160;million during the year ended December&#160;31, 2021 and 2020, respectively. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">June&#160;2019 Financing</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In June&#160;2019, the Company raised $27.8&#160;million of net proceeds from the sale of 20.4&#160;million shares of common stock and accompanying warrants to purchase an additional 20.4&#160;million shares of common stock in an underwritten public offering (the &#8220;June&#160;2019 Financing&#8221;). The combined purchase price for each </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-26</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11pt;">
          <font style="letter-spacing:0.2pt;">share of common stock and accompanying warrant was $1.47. Subject to certain ownership limitations, the warrants issued in the June&#160;2019 Financing were exercisable immediately upon issuance at an exercise price of $1.47 per share, subject to adjustments as provided under the terms of such warrants, and had a one-year term that expired on June&#160;21, 2020. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Preferred Stock</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11pt;">
          <font style="letter-spacing:0.2pt;">Pursuant to its Amended and Restated Certificate of Incorporation (the &#8220;Certificate of Incorporation&#8221;), the Company is authorized to issue 5.0&#160;million shares of &#8220;blank check&#8221; preferred stock, $0.001 par value per share, which enables its board of directors, from time to time, to create one or more series of preferred stock. Each series of preferred stock issued shall have the rights, preferences, privileges and restrictions as designated by the board of directors. The issuance of any series of preferred stock could affect, among other things, the dividend, voting and liquidation rights of the Company&#8217;s common stock. The Company had no preferred stock issued and outstanding as of December&#160;31, 2021 and 2020. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Common Stock</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11pt;">
          <font style="letter-spacing:0.2pt;">Following approval by the Company&#8217;s stockholders on May&#160;3, 2021, an amendment became effective to the Certificate of Incorporation that increased the number of authorized shares of common stock from 200&#160;million to 400&#160;million, of which 199&#160;million and 140&#160;million shares were issued and outstanding as of December&#160;31, 2021 and 2020, respectively. In addition, the Company had reserved for issuance the following amounts of shares of its common stock for the purposes described below as of December&#160;31, 2021 and 2020 (in thousands): </font>
        </div>
        <table style="width:456pt;height:142.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:366.59pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:366.59pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:366.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Shares of common stock issued </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">199,464</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">140,450</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:366.59pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Shares of common stock reserved for issuance for: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:366.59pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Warrants </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">199</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">2,247</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:366.59pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Stock options </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">15,703</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">10,147</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:366.59pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">RSUs </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">3,041</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:366.59pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Shares available for grant under 2014 Stock Incentive Plan </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">8,933</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">4,863</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:366.59pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Shares available for sale under 2014 Employee Stock Purchase Plan </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">2,300</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:366.59pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:-0.2pt;">Total shares of common stock issued and reserved for issuance</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">229,640</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">157,707</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:12.4pt; width:456pt; line-height:11pt;">
          <font style="letter-spacing:0.2pt;">The voting, dividend and liquidation rights of holders of shares of common stock are subject to and qualified by the rights, powers and preferences of holders of shares of preferred stock. Each share of common stock entitles the holder to one vote on all matters submitted to a vote of the Company&#8217;s stockholders; provided, however, that, except as otherwise required by law, holders of common stock shall not be entitled to vote on any amendment to the Company&#8217;s Certificate of Incorporation that relates solely to the terms of one or more outstanding series of preferred stock if the holders of such affected series are entitled, either separately or together as a class with the holders of one or more such series, to vote thereon. There shall be no cumulative voting. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Dividends may be declared and paid on the common stock from funds lawfully available thereof as and when determined by the board of directors and subject to any preferential dividend or other rights of any then-outstanding preferred stock. The Company has never declared or paid, and for the foreseeable future does not expect to declare or pay, dividends on its common stock. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Upon the dissolution or liquidation of the Company, whether voluntary or involuntary, holders of common stock will be entitled to receive all assets of the Company available for distribution to its stockholders, subject to any preferential or other rights of any then-outstanding preferred stock. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Warrants</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;font-style:italic;">
          <font style="font-style:normal;letter-spacing:0.2pt;">All of the Company&#8217;s outstanding warrants are non-tradeable and equity-classified because they meet the derivative scope exception under ASC Topic 815-40, </font><font style="letter-spacing:0.2pt;">Derivatives and Hedging&#8201;&#8212;&#8201;Contracts in Entity&#8217;s </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-27</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Own Equity</font><font style="letter-spacing:0.2pt;"> (&#8220;ASC 815-40&#8221;)</font><font style="font-style:italic;letter-spacing:0.2pt;">.</font><font style="letter-spacing:0.2pt;"> The following table sets forth the Company&#8217;s warrant activity for the year ended December&#160;31, 2021 (in thousands): </font>
        </div>
        <table style="width:456pt;height:108pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:114.65pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Issued </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Exercise</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Price </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:41.92pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Expiration </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">December&#160;31, </font>
                <br >
                <font style="letter-spacing:-0.16pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:20.74pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Issued </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">(Exercised) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:37.92pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">(Cancelled) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">December&#160;31, </font>
                <br >
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:114.65pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Jun-2019 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.209999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1.47</td>
            <td style="padding:0pt;padding-left:0.209999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:41.92pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Jun-2020 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.44pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:11.44pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:20.74pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">&#8212;</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.705pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:5.705pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:37.92pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">&#8212;</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:15.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:114.65pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Mar-2018 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.209999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">0.55<font style="position:absolute;">*</font></td>
            <td style="padding:0pt;padding-left:0.209999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:41.92pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Mar-2023 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.44pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">1,705</td>
            <td style="padding:0pt;padding-left:11.44pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:20.74pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">&#8212;</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.705pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">(1,573<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:5.705pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:37.92pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">&#8212;</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">132</td>
            <td style="padding:0pt;padding-left:15.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:114.65pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Nov-2017 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.209999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">0.55<font style="position:absolute;">*</font></td>
            <td style="padding:0pt;padding-left:0.209999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:41.92pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Nov-2022 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.44pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">487</td>
            <td style="padding:0pt;padding-left:11.44pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:20.74pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">&#8212;</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.705pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">(475<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:5.705pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:37.92pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">&#8212;</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">12</td>
            <td style="padding:0pt;padding-left:15.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:114.65pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">May-2015 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.209999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">11.83</td>
            <td style="padding:0pt;padding-left:0.209999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:41.92pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Nov-2024 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.44pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">28</td>
            <td style="padding:0pt;padding-left:11.44pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:20.74pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">&#8212;</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.705pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:5.705pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:37.92pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">&#8212;</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">28</td>
            <td style="padding:0pt;padding-left:15.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:114.65pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Nov-2014 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.209999999999999pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:17.25pt; text-align:right; white-space:nowrap;">11.04</td>
            <td style="padding:0pt;padding-left:0.209999999999999pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:41.92pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Nov-2024 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.44pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">27</td>
            <td style="padding:0pt;padding-left:11.44pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.5pt 0pt 2.5pt 0pt; width:20.74pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">&#8212;</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.705pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:5.705pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.5pt 0pt 2.5pt 0pt; width:37.92pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">&#8212;</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.295pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">27</td>
            <td style="padding:0pt;padding-left:15.295pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 0.75pt 0pt; width:114.65pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.209999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.209999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.75pt 0pt; width:41.92pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.44pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">2,247</td>
            <td style="padding:0pt;padding-left:11.44pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="border-bottom:3pt double #000000;padding:3.25pt 0pt 2.5pt 0pt; width:20.74pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.2pt;">&#8212;</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.705pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">(2,048<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:5.705pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="border-bottom:3pt double #000000;padding:3.25pt 0pt 2.5pt 0pt; width:37.92pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.2pt;">&#8212;</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">199</td>
            <td style="padding:0pt;padding-left:15.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:5.2pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:7.71pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">*</font>
          <br >
        </div>
        <div style=" margin-top:7.71pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Exercise price shown (i)&#160;reflects modification described below and (ii)&#160;subject to further adjustment based on down round provision added by amendment described below. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">During the year ended December&#160;31, 2021, the Company received proceeds of $1.1&#160;million from the exercises of 1.6&#160;million 2018 Warrants and 0.5&#160;million 2017 Warrants. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Warrant Modifications</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In October&#160;2019, the Company entered into transactions with holders of its outstanding 2018 Warrants and 2017 Warrants to purchase the Company&#8217;s common stock. At such time, the 2018 Warrants and 2017 Warrants utilized the same form of warrant, which contained a prohibition on variable rate transactions (as defined therein). Warrant holders agreed to waive such prohibition in exchange for certain concessions from the Company. Management evaluated the warrants after modifications and determined that they continued to be equity-classified under the derivative scope exception of ASC 815-40. The warrants were revalued immediately before and immediately after the modifications to calculate the $1.1&#160;million incremental value of the modified warrants. The Company considers this incremental value to be akin to an offering cost since the modifications were directly related to enabling the ATM Offering and would not have otherwise been incurred. Therefore, in the fourth quarter of 2019, management initially capitalized the $1.1&#160;million to deferred financing cost asset, with an offsetting credit to additional paid-in capital, and then reclassified the deferred financing cost asset to reduce the ATM Offering proceeds within equity as proceeds were received from sales of common stock under the ATM Offering. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">2018 Warrants</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In October&#160;2019, the Company entered into transactions with the holders of its outstanding 2018 Warrants pursuant to which such holders either (i)&#160;exercised their warrants pursuant to a Warrant Exercise Agreement (the &#8220;2018 Warrant Exercise Agreements&#8221;) or (ii)&#160;amended their warrants pursuant to a Warrant Amendment Agreement (the &#8220;2018 Warrant Amendment Agreements&#8221;). As consideration for those holders executing the 2018 Warrant Exercise Agreements, the Company reduced the exercise price of the warrants from $1.20 to $0.60 per share of the Company&#8217;s common stock, resulting in proceeds of $2.0&#160;million from the exercise of 3.4&#160;million warrants. Pursuant to the 2018 Warrant Amendment Agreements, the prohibition on certain variable rate transactions included in the 2018 Warrants was amended to exclude ATM offerings and the exercise price of the warrants was reduced from $1.20 to the lesser of (a)&#160;$0.95 per share of common stock and (b)&#160;the exercise price as determined from time to time pursuant to the anti-dilution provisions in the 2018 Warrant Amendment Agreements. During the second quarter of 2020, the anti-dilution provision was triggered to lower the exercise price of the warrants to $0.55; as such, the Company recognized a deemed dividend of approximately $0.1&#160;million which reduced the income available to common stockholders. As the Company has an accumulated deficit balance, there is no overall impact to additional paid-in capital, as the deemed dividend is recorded as offsetting debit and credit entries to additional paid-in capital. Therefore, the amounts were not presented on the Statement of Stockholders&#8217; (Deficit) Equity. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In connection with the 2018 Warrant Exercise Agreements and 2018 Warrant Amendment Agreements, the Company entered into an amendment to the Securities Purchase Agreement dated March&#160;21, 2018 related </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-28</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">to the March&#160;2018 Financing, by and among the Company and each purchaser identified on the signature pages thereto, with certain holders representing greater than 50.1% of the securities issued based on initial subscription amounts, pursuant to which the prohibition on variable rate transactions, including ATM offerings, was deleted in its entirety. </font>
        </div>
        <div style="margin-top:9.92pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">2017 Warrants</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.12pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In October&#160;2019, the Company entered into transactions with the holders of its outstanding 2017 Warrants pursuant to which such holders either (i)&#160;exercised their warrants pursuant to a Warrant Exercise Agreement (the &#8220;2017 Warrant Exercise Agreements&#8221;) or (ii)&#160;amended their warrants pursuant to a Warrant Amendment Agreement (the &#8220;2017 Warrant Amendment Agreements&#8221;). As consideration for those holders executing the 2017 Warrant Exercise Agreements, the Company reduced the exercise price of the warrants from $0.80 to $0.55 per share of the Company&#8217;s common stock. Pursuant to the 2017 Warrant Amendment Agreements, the prohibition on certain variable rate transactions, including ATM offerings, included in the 2017 Warrants was deleted in its entirety and the exercise price of the warrants was reduced from $0.80 to the lesser of (a)&#160;$0.55 per share of common stock and (b)&#160;the exercise price as determined from time to time pursuant to the anti-dilution provisions in the 2017 Warrant Amendment Agreements. As of December&#160;31, 2021, there has been no adjustment to the exercise price of these warrants. </font>
        </div>
        <div style="margin-top:9.92pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">13.&nbsp;&nbsp;&nbsp;EARNINGS (LOSS) PER SHARE</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.12pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">A net loss cannot be diluted. Therefore, when the Company is in a net loss position, basic and diluted loss per common share are the same. If the Company achieves profitability, the denominator of a diluted earnings per common share calculation includes both the weighted-average number of shares outstanding and the number of common stock equivalents, if the inclusion of such common stock equivalents would be dilutive. Dilutive common stock equivalents potentially include warrants, stock options and non-vested restricted stock awards and&#160;units using the treasury stock method, along with the effect, if any, from outstanding convertible securities. The majority of the Company&#8217;s outstanding warrants to purchase common stock have participation rights to any dividends that may be declared in the future and are therefore considered to be participating securities. Participating securities have the effect of diluting both basic and diluted earnings per share during periods of income. During periods of loss, no loss is allocated to the participating securities since the holders have no contractual obligation to share in the losses of the Company. </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.12pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Additionally, an entity that presents earnings per share shall recognize the value of the effect of an anti-dilution provision in an equity-classified freestanding financial instrument in the period the anti-dilution provision is triggered. That effect shall be treated as a deemed dividend and as a reduction of income available to common stockholders in basic earnings per share. The deemed dividend is added back to income available to common stockholders when applying the treasury stock method for diluted earnings per share. </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.12pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">For periods with net income, diluted net earnings per share is calculated by either (i)&#160;adjusting the weighted-average shares outstanding for the dilutive effect of common stock equivalents outstanding for the period as determined using the treasury stock method or (ii)&#160;the two-class method considering common stock equivalents, whichever is more dilutive. The two-class method is an earnings allocation formula that treats a participating security as having rights to earnings that otherwise would have been available to common stockholders. </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.12pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The two-class method was not applied for the twelve&#160;months ended December&#160;31, 2021, 2020 and 2019 as the Company&#8217;s participating securities do not have any obligation to absorb net losses. </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.12pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">For purposes of the diluted net loss per share calculation, common stock equivalents are excluded from the calculation if their effect would be anti-dilutive. </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.12pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following potentially dilutive securities outstanding as of December&#160;31, 2021, 2020 and 2019 have been excluded from the denominator of the diluted loss per share of common stock outstanding calculation (in thousands): </font>
        </div>
        <table style="width:416pt;height:59.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:296.88pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.5pt 0pt; width:0pt;text-align:center;" colspan="16">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:296.88pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.25pt 0pt 1.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.25pt 0pt 1.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.25pt 0pt 1.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2019 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 0.5pt 0pt; width:296.88pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Warrants </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">199</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">2,247</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">22,895</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2.5pt 0pt 0.5pt 0pt; width:296.88pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Stock options </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">15,703</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">10,147</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">6,236</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 2.25pt 0pt; width:296.88pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.2pt;">Total</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:24pt; text-align:right; white-space:nowrap;">15,902</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:24pt; text-align:right; white-space:nowrap;">12,394</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">29,131</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-29</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">14.&nbsp;&nbsp;&nbsp;SHARE-BASED COMPENSATION</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following table sets forth the amount of share-based compensation expense recognized by the Company by line item on its Consolidated Statements of Operations and Comprehensive Loss for the&#160;years ended December&#160;31, 2021, 2020 and 2019 (in thousands): </font>
        </div>
        <table style="width:416pt;height:67.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:296.88pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="16">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Year ended December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:296.88pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2019 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:296.88pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Research and development </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">973</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">350</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">188</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:296.88pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">General and administrative </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">4,170</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">1,407</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">1,049</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:296.88pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.2pt;">Total Share Based Compensation</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">5,143</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">1,757</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">1,237</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:16.8pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">2014 Stock Incentive Plan</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company&#8217;s 2014 Stock Incentive Plan, as amended (the &#8220;2014 Plan&#8221;), was adopted by its board of directors in December&#160;2013 and subsequently approved by its stockholders in January&#160;2014. The 2014 Plan became effective immediately prior to the closing of the Company&#8217;s IPO in February&#160;2014 and provides for the grant of incentive and non-qualified stock options, restricted stock awards and restricted stock&#160;units, stock appreciation rights and other stock-based awards, with amounts and terms of grants determined by the Company&#8217;s board of directors at the time of grant, to the Company&#8217;s employees, officers, directors, consultants and advisors. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">At the Annual Meeting of the Company&#8217;s stockholders in June&#160;2019, the Company&#8217;s stockholders approved an amendment to the 2014 Plan that (i)&#160;increased by 7.9&#160;million the number of shares of common stock reserved for issuance under the 2014 Plan and (ii)&#160;eliminated the &#8220;evergreen&#8221; or automatic replenishment provision of the 2014 Plan, pursuant to which the number of shares of common stock authorized for issuance under the 2014 Plan was automatically increased on an annual basis. At the Annual Meeting of the Company&#8217;s stockholders in May&#160;2021, the Company&#8217;s stockholders approved an amendment to the 2014 Plan that increased by 12&#160;million the number of shares of common stock reserved for issuance under the 2014 Plan. There were approximately 8.9&#160;million shares of common stock available for issuance under the 2014 Plan as of December&#160;31, 2021. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Stock options outstanding under the 2014 Plan generally vest over a four-year period at the rate of 25% of the grant vesting on the first anniversary of the date of grant and 6.25% of the grant vesting at the end of each successive three-month period thereafter. Stock options granted under the 2014 Plan are exercisable for a period of ten&#160;years from the date of grant. There were approximately 12.8&#160;million stock options outstanding under the 2014 Plan as of December&#160;31, 2021. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On September&#160;9, 2021, the Board of Directors and the Compensation Committee of the Company approved a retention program for all current employees, except for the Chief Executive Officer, pursuant to which the Company will provide certain incentives designed to retain such employees (the &#8220;Retention Program&#8221;). Pursuant to the Retention Program and effective as of October&#160;1, 2021, the Company&#8217;s non-executive employees received a combination of a cash bonus award and a one-time restricted stock unit (&#8220;RSU&#8221;) award which vests in full on September&#160;30, 2022, subject to continued employment through September&#160;30, 2022. Each RSU represents a contingent right to receive one share of the Company&#8217;s common stock. The Company recorded an expense of $0.5&#160;million for retention-related RSUs for the year ended December&#160;31, 2021. Additionally, the Company expensed $0.6&#160;million in relation to the cash bonus portion of the retention program. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Also pursuant to the Retention Program and effective as of October&#160;1, 2021, the Company&#8217;s executive officers, except for the Chief Executive Officer, were granted a one-time performance-based restricted stock unit (&#8220;PSU&#8221;) award equal to the value of approximately fifty&#160;percent of current base salary. Each PSU represents a contingent right to receive one share of the Company&#8217;s common stock upon the satisfaction of pre-determined performance criteria. Subject to continued employment, such awards vest on September&#160;30, 2023 upon the determination by the Compensation Committee of the level of achievement of certain key milestones consisting of a clinical trial milestone, an employee retention milestone and cash management milestones. As none of the retention milestones were met in the year ended December&#160;31, 2021 and </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-30</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:141.39pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">achievement was deemed not probable, the Company did not record expenses for retention-related PSUs. As of December&#160;31, 2021, the unrecognized compensation expense for the retention-related PSUs, granted on October&#160;1, 2021, was $0.4&#160;million. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A summary of the status of restricted stock&#160;units is presented below: </font>
        </div>
        <table style="width:416pt;height:87pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:349.03pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;text-align:center;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Restricted Stock </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Units</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(in thousands) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:349.03pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Unvested at December&#160;31, 2020 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.13pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:16.13pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:349.03pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Granted RSU </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.13pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">2,482</td>
            <td style="padding:0pt;padding-left:16.13pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:349.03pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Granted PSU </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.13pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">559</td>
            <td style="padding:0pt;padding-left:16.13pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:349.03pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Unvested at December&#160;31, 2021 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.13pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">
              <div style="font-weight:bold;">&#8203;</div>
            </td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">3,041</div>
            </td>
            <td style="padding:0pt;padding-left:16.13pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:14.19pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The weighted average remaining contractual life of unvested RSUs and PSUs as of December&#160;31, 2021 is 9.75&#160;years. The Company did not grant restricted stock&#160;units during the&#160;years ended December&#160;31, 2020 and 2019. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">2009 Stock Incentive Plan</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The Company maintains a 2009 Stock Incentive Plan, as amended and restated (the &#8220;2009 Plan&#8221;), which provided for the grant of incentive and non-qualified stock options and restricted stock awards and restricted stock&#160;units, with amounts and terms of grants determined by the Company&#8217;s board of directors at the time of grant, to its employees, officers, directors, consultants and advisors. Upon the closing of its IPO in February&#160;2014, the Company ceased granting awards under the 2009 Plan and all shares (i)&#160;available for issuance under the 2009 Plan at such time and (ii)&#160;subject to outstanding awards under the 2009 Plan that expire, terminate or are otherwise surrendered, canceled, forfeited or repurchased without having been fully exercised or resulting in any common stock being issued were carried over to the 2014 Plan. Stock options granted under the 2009 Plan are exercisable for a period of ten&#160;years from the date of grant. There were approximately 0.1&#160;million fully vested stock options outstanding under the 2009 Plan as of December&#160;31, 2021. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Out-of-Plan&#160;Inducement Grants</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">From time to time, the Company has granted equity awards to its newly hired employees, including executives, in accordance with the Nasdaq Stock Market LLC (&#8220;Nasdaq&#8221;) employment inducement grant exemption (Nasdaq Listing Rule&#160;5635(c)(4)). Such grants are made outside of the 2014 Plan and act as an inducement material to the employee&#8217;s acceptance of employment with the Company. There were approximately 2.8&#160;million stock options outstanding which were granted as employment inducement awards outside of the 2014 Plan as of December&#160;31, 2021. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-31</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Stock Options</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The following table sets forth a summary of the Company&#8217;s total stock option activity, including awards granted under the 2014 Plan and 2009 Plan and inducement grants made outside of stockholder approved plans, for the&#160;years ended December&#160;31, 2021, 2020 and 2019: </font>
        </div>
        <table style="width:456pt;height:268pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:241.76pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Number of </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Shares under </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Option</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(in thousands) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Weighted-</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Average</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Exercise </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Price </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Weighted-</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Average </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Remaining</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Contractual</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Life</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(in&#160;years) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Aggregate</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Intrinsic</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Value</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(in thousands) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:241.76pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Outstanding at December&#160;31, 2018 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">3,942</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.625pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">2.12</td>
            <td style="padding:0pt;padding-left:5.625pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">9.14</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">57</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:241.76pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Granted </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">3,986</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.625pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">1.02</td>
            <td style="padding:0pt;padding-left:5.625pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:241.76pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Exercised </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">(90<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.625pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">1.10</td>
            <td style="padding:0pt;padding-left:5.625pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:241.76pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Canceled or forfeited </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">(1,602<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.625pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:13.5pt; text-align:right; white-space:nowrap;">1.78</td>
            <td style="padding:0pt;padding-left:5.625pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.25pt 0pt 2.5pt 0pt; width:241.76pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Outstanding at December&#160;31, 2019 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">6,236</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.625pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:13.5pt; text-align:right; white-space:nowrap;">1.52</td>
            <td style="padding:0pt;padding-left:5.625pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:13.5pt; text-align:right; white-space:nowrap;">8.83</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:17.25pt; text-align:right; white-space:nowrap;">358</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:241.76pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Granted </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">4,044</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.625pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">0.87</td>
            <td style="padding:0pt;padding-left:5.625pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:241.76pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Exercised </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">(12<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.625pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">1.13</td>
            <td style="padding:0pt;padding-left:5.625pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:241.76pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Canceled or forfeited </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">(121<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.625pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:13.5pt; text-align:right; white-space:nowrap;">1.04</td>
            <td style="padding:0pt;padding-left:5.625pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.25pt 0pt 2.5pt 0pt; width:241.76pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Outstanding at December&#160;31, 2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">10,147</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.625pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:13.5pt; text-align:right; white-space:nowrap;">1.26</td>
            <td style="padding:0pt;padding-left:5.625pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:13.5pt; text-align:right; white-space:nowrap;">8.50</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:17.25pt; text-align:right; white-space:nowrap;">3,160</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:241.76pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Granted </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">8,273</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.625pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">3.32</td>
            <td style="padding:0pt;padding-left:5.625pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:241.76pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Exercised </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">(34<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.625pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">1.23</td>
            <td style="padding:0pt;padding-left:5.625pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:241.76pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Canceled or forfeited </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">(2,683<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.625pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:13.5pt; text-align:right; white-space:nowrap;">3.70</td>
            <td style="padding:0pt;padding-left:5.625pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:241.76pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Outstanding at December&#160;31, 2021 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">15,703</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.625pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:13.5pt; text-align:right; white-space:nowrap;">1.93</td>
            <td style="padding:0pt;padding-left:5.625pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:13.5pt; text-align:right; white-space:nowrap;">8.03</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:17.25pt; text-align:right; white-space:nowrap;">82</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 3.25pt 0pt; width:241.76pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Exercisable at December&#160;31, 2021 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">7,562</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.625pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:13.5pt; text-align:right; white-space:nowrap;">1.65</td>
            <td style="padding:0pt;padding-left:5.625pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:13.5pt; text-align:right; white-space:nowrap;">7.41</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:17.25pt; text-align:right; white-space:nowrap;">59</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:14.19pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The Company recognized share-based compensation expense of $5.1&#160;million for the year ended 2021. The stock option related expenses were $4.6&#160;million, $1.8&#160;million and $1.2&#160;million for the&#160;years ended December&#160;31, 2021, 2020 and 2019, respectively. The RSU related expense was $0.5&#160;million for the year ended December&#160;31, 2021. The Company did not record RSU related expenses for the&#160;years ended December&#160;31, 2020 and 2019. As of December&#160;31, 2021, there was $10.4&#160;million of total unrecognized compensation cost related to non-vested stock options which the Company expects to recognize over a weighted-average period of 2.7&#160;years. The weighted-average grant-date fair value of stock options granted during the year ended December&#160;31, 2021, 2020 and 2019 were $2.16, $0.56 and $1.02, respectively. The total intrinsic value of stock options exercised for the&#160;years ended December&#160;31, 2021, 2020 and 2019 was de minimis. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">For the&#160;years ended December&#160;31, 2021, 2020 and 2019, the grant-date fair value of stock options was determined using the following weighted-average inputs and assumptions in the Black-Scholes option pricing model: </font>
        </div>
        <table style="width:456pt;height:112pt;margin-top:9.99999999999994pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:351.88pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="16">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Year ended December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:351.88pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2019 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:351.88pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Fair market value </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">3.32</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">0.87</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">1.02</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:351.88pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Grant exercise price </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">3.32</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">0.87</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">1.02</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:351.88pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Expected term (in&#160;years) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">6.0</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">6.1</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">6.0</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:351.88pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Risk-free interest rate </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">0.9<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">1.3<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">2.1<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:351.88pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Expected volatility </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">74.6<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">71.5<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">78.1<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:351.88pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Dividend yield </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-32</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:0.330000000000041pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">15.&nbsp;&nbsp;&nbsp;EMPLOYEE BENEFIT PLANS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">2014 Employee Stock Purchase Plan</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The Company&#8217;s 2014 Employee Stock Purchase Plan (&#8220;2014 ESPP&#8221;) was adopted by its board of directors in December&#160;2013 and subsequently approved by its stockholders in January&#160;2014. The 2014 ESPP became effective immediately prior to the closing of the Company&#8217;s IPO in February&#160;2014 and established an initial reserve of 0.2&#160;million shares of the Company&#8217;s common stock for issuance to participating employees. At the Annual Meeting of the Company&#8217;s stockholders in May&#160;2021, the Company&#8217;s stockholders approved an amendment to the 2014 ESPP that increased by 2.3&#160;million the number of shares of common stock reserved for issuance under the 2014 ESPP. The purpose of the 2014 ESPP is to enhance employee interest in the success and progress of the Company by encouraging employee ownership of common stock of the Company. The 2014 ESPP provides employees with the opportunity to purchase shares of common stock at a 15% discount to the market price through payroll deductions or lump sum cash investments. The Company estimates the number of shares to be issued at the end of an offering period and recognizes expense over the requisite service period. Shares of the common stock issued and sold pursuant to the 2014 ESPP are shown on the consolidated statements of changes in stockholders&#8217; equity (deficit). As of December&#160;31, 2021, there were 2.3&#160;million shares of common stock available for sale under the 2014 ESPP. The Company sold a de minimis number of shares under the ESPP for the&#160;years ended December&#160;31, 2021, 2020 and 2019, respectively. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Defined Contribution Plans</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">United States&#8201;&#8212;&#8201;401(k) Plan</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The Company maintains a 401(k) defined contribution retirement plan which covers all of its US employees. Employees are eligible to participate on the first of the month following their date of hire. Under the 401(k) plan, participating employees may defer up to 100% of their pre-tax salary, subject to certain statutory limitations. Employee contributions vest immediately. The plan allows for a discretionary match per participating employee up to a maximum of $4,000 per year. The Company contributed a de minimis amount for each of the three&#160;years ended December&#160;31, 2021, 2020 and 2019, respectively. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Canada&#8201;&#8212;&#8201;Defined Contribution Plan</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The Company maintains a defined contribution plan for its Canadian employees. Participants may contribute a&#160;percentage of their annual compensation to this plan, subject to statutory limitations. The Company contributes up to the first 4% of eligible compensation for its Canadian-based employees to the retirement plan. The Company contributed a de minimis amount for each of the three&#160;years ended December&#160;31, 2021, 2020 and 2019, respectively. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">16.&nbsp;&nbsp;&nbsp;INCOME TAXES</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The following table sets forth the components of the Company&#8217;s loss before income taxes by country (in thousands): </font>
        </div>
        <table style="width:456pt;height:82.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:306.89pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="16">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Year Ended December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:306.89pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2019 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:306.89pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Country </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:306.89pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">United States </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(32,757<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(35,529<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(27,468<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:306.89pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Canada </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">24,148</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">14,577</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">(80,032<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:306.89pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:-0.2pt;">Total Loss Before Income Taxes</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(8,609<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(20,952<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27pt; text-align:right; white-space:nowrap;">(107,500<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-33</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company&#8217;s tax benefit (provision) is comprised of the following components (in thousands): </font>
        </div>
        <table style="width:456pt;height:165pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:336.26pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.5pt 0pt; width:0pt;text-align:center;" colspan="16">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Year Ended December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:336.26pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.25pt 0pt 1.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.25pt 0pt 1.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.25pt 0pt 1.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2019 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 0.5pt 0pt; width:336.26pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Current Tax Provision </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:336.26pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Federal </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">&nbsp;&nbsp;&nbsp;&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:336.26pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">State </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2.5pt 0pt 1.5pt 0pt; width:336.26pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Foreign </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">(286<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">(1,445<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:15pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:2.25pt 0pt 1.5pt 0pt; width:336.26pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Total current (provision) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">(286<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">(1,445<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:15pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 0.5pt 0pt; width:336.26pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Deferred tax provision </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:336.26pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Federal </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:336.26pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">State </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:2.5pt 0pt 1.5pt 0pt; width:336.26pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Foreign </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">8,559</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:15pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2.25pt 0pt 1.5pt 0pt; width:336.26pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Total deferred benefit (provision) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">8,559</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:15pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 2.25pt 0pt; width:336.26pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:normal;">
                <font style="letter-spacing:0.2pt;">Total Tax Benefit (Provision) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">8,273</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">(1,445<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:15pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:13pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company did not record current or deferred income tax or benefit for the year ended December&#160;31, 2019. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following table sets forth a reconciliation of the statutory United States federal income tax rate to the Company&#8217;s effective income tax rate: </font>
        </div>
        <table style="width:456pt;height:163.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:355.22pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.5pt 0pt; width:0pt;text-align:center;" colspan="16">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Year ended December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:355.22pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.25pt 0pt 1.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.25pt 0pt 1.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.25pt 0pt 1.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2019 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 0.5pt 0pt; width:355.22pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">United States federal statutory income tax rate </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">21.0<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:15.75pt; text-align:right; white-space:nowrap;">21.0<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:15.75pt; text-align:right; white-space:nowrap;">21.0<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:355.22pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Impact of foreign rate differential </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">(15.9<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:15.75pt; text-align:right; white-space:nowrap;">(4.2<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:15.75pt; text-align:right; white-space:nowrap;">4.4</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:355.22pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">State taxes, net of federal benefit </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">2.3</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:15.75pt; text-align:right; white-space:nowrap;">2.0</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:15.75pt; text-align:right; white-space:nowrap;">0.6</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:355.22pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Stock option cancellations </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">(1.1<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:15.75pt; text-align:right; white-space:nowrap;">(0.2<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:15.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:355.22pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Contingent consideration </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">178.2</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:15.75pt; text-align:right; white-space:nowrap;">14.4</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:15.75pt; text-align:right; white-space:nowrap;">(18.0<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:355.22pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">General business credits and other credits </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">2.4</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:15.75pt; text-align:right; white-space:nowrap;">6.6</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:15.75pt; text-align:right; white-space:nowrap;">0.4</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:355.22pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Permanent differences </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">(1.4<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:15.75pt; text-align:right; white-space:nowrap;">0.2</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:15.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:355.22pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Other </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">(13.8<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:15.75pt; text-align:right; white-space:nowrap;">(2.1<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:15.75pt; text-align:right; white-space:nowrap;">(0.5<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:355.22pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Foreign taxes </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">(3.3<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:15.75pt; text-align:right; white-space:nowrap;">(6.9<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:15.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2.5pt 0pt 1.5pt 0pt; width:355.22pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Change in valuation allowance </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">(72.3<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:15.75pt; text-align:right; white-space:nowrap;">(37.7<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:15.75pt; text-align:right; white-space:nowrap;">(7.9<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 2.25pt 0pt; width:355.22pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.2pt;">Effective Income Tax Rate</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">96.1<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:15.75pt; text-align:right; white-space:nowrap;">(6.9<font style="position:absolute;">)%</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:15.75pt; text-align:right; white-space:nowrap;">&#8212;<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:13pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following table sets forth the tax effects of temporary differences that gave rise to significant portions of the Company&#8217;s deferred tax assets and liabilities (in thousands): </font>
        </div>
        <table style="width:456pt;height:178.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:311.89pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.5pt 0pt; width:0pt;text-align:center;" colspan="16">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:311.89pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.25pt 0pt 1.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.25pt 0pt 1.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.25pt 0pt 1.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2019 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 0.5pt 0pt; width:311.89pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Deferred tax assets: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:311.89pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">NOL carryforwards </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">63,381</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">57,935</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">50,727</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:311.89pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">R&amp;D credit carryforwards </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">4,316</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">3,787</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">4,385</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:311.89pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Accruals and other </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">4,058</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">3,811</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">2,464</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:311.89pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Capitalized start-up costs </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">53</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">70</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">91</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2.5pt 0pt 0.5pt 0pt; width:311.89pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Other </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">41</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">28</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">57</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:2.25pt 0pt 0.5pt 0pt; width:311.89pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Gross deferred tax assets </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">71,849</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">65,631</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">57,724</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 0.5pt 0pt; width:311.89pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Deferred tax liabilities: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:2.5pt 0pt 0.5pt 0pt; width:311.89pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">IPR&amp;D </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:23.25pt; text-align:right; white-space:nowrap;">(3,969<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:23.25pt; text-align:right; white-space:nowrap;">(12,528<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(12,528<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2.25pt 0pt 0.5pt 0pt; width:311.89pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Gross deferred tax liabilities </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(3,969<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(12,528<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(12,528<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:2.25pt 0pt 0.5pt 0pt; width:311.89pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Valuation allowance </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(71,849<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(65,631<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(57,724<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 2.25pt 0pt; width:311.89pt;text-align:left;">
              <div style="margin-left:30pt;">
                <font style="letter-spacing:-0.2pt;">Net Deferred Tax Liability</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(3,969<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(12,528<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(12,528<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-34</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In assessing the realizability of the Company&#8217;s deferred tax assets, management considers all relevant positive and negative evidence in determining whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The realization of deferred tax assets is dependent on several factors, including the generation of sufficient taxable income prior to the expiration of the NOL and R&amp;D credit carryforwards. The Company has generated NOLs since its inception, and management believes that it is more likely than not that the Company&#8217;s deferred tax assets will not be realized. As a result, valuation allowances of $71.8&#160;million, $65.6&#160;million and $57.7&#160;million have been established as of December&#160;31, 2021, 2020 and 2019, respectively. The $6.2&#160;million increase in the valuation allowance was attributable to the NOL for the year ended December&#160;31, 2021. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The net deferred tax liability of $4.0&#160;million primarily relates to the potential future impairments or amortization associated with IPR&amp;D intangible assets, which is not deductible for tax purposes and cannot be considered as a source of income to realize deferred tax assets. As a result, the Company recorded the deferred tax liability with an offset to goodwill. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following table summarizes the Company&#8217;s NOL and R&amp;D and other credit carryforwards in the United States and Canada as of December&#160;31, 2021 (in millions): </font>
        </div>
        <table style="width:456pt;height:179.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:322.77pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Amount </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:41.34pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Expiration </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Beginning in </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:28.18pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Through </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:322.77pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">United States: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:41.34pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:28.18pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:322.77pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Federal NOL carryforwards&#8201;&#8211;&#8201;indefinite </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">101.1</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:41.34pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">None </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:28.18pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">None </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:322.77pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Federal NOL carryforwards </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">118.9</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:41.34pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">2030 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:28.18pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">2038 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:322.77pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">State NOL carryforwards </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">138.4</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:41.34pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">2030 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:28.18pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">2040 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:322.77pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Federal R&amp;D credit carryforwards </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">2.5</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:41.34pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">2027 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:28.18pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">2040 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:322.77pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">State R&amp;D credit carryforwards </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">0.8</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:41.34pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">2027 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:28.18pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">2040 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:322.77pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Canada: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:41.34pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:28.18pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:322.77pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Federal non-capital loss carryforwards </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">31.2</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:41.34pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">2035 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:28.18pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">2040 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:322.77pt;white-space:normal;text-align:left;">
              <div style="margin-left:30pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Federal scientific research and experimental development expense carryforwards </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">5.1</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:41.34pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">2032 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:28.18pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">2040 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.833pt 0pt; width:322.77pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Federal and provincial investment tax credit carryforwards </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 0.833pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1.2</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.833pt 0pt; width:41.34pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">2032 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.833pt 0pt; width:28.18pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">2040</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:7.9pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Under the Tax Reform Act of 1986 (the &#8220;Act&#8217;), NOL and R&amp;D credit carryforwards are subject to review and possible adjustment by the Internal Revenue Service, and there are similar provisions in certain state and non-US tax laws. NOL and R&amp;D credit carryforwards may become subject to an annual limitation in the event of certain cumulative changes in the ownership interests of significant shareholders over a three-year period in excess of 50&#160;percent, as defined in Sections&#160;382 and 383 of the Internal Revenue Code, respectively. This could limit the amount of tax attributes that can be utilized to offset future taxable income or tax liabilities. The amount of the annual limitation is determined based on the value of the Company immediately prior to the ownership change. Subsequent ownership changes may further affect the limitation in future&#160;years. Management completed a Section&#160;382 study through March&#160;31, 2016 and determined that it is more likely than not that the Company&#8217;s NOL carryforwards are subject to a material limitation. Accordingly, the Company reduced its NOL carryforward by $0.8&#160;million. The Company has continued to raise additional equity capital since March&#160;2016 but has not done any additional analysis to determine whether or not ownership changes, as defined in the Act, have occurred, which would result in additional limitations. There could be additional ownership changes in the future that could further limit the amount of NOL carryforwards that the Company can utilize. The Company has not yet conducted a study of its R&amp;D credit carryforwards. Such a study may result in an adjustment to the Company&#8217;s R&amp;D credit carryforwards; however, until a study is completed and any adjustment is known, no amount is being presented as an uncertain tax position. A full valuation allowance has been provided against the Company&#8217;s R&amp;D credit carryforwards, and, if an adjustment is required, it would be offset by an adjustment to the valuation allowance. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We assess the impact of various tax reform proposals and modifications to existing tax treaties in all jurisdictions where we have operations to determine the potential effect on our business and any assumptions </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-35</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">we have made about our future taxable income. We cannot predict whether any specific proposals will be enacted, the terms of any such proposals or what effect, if any, such proposals would have on our business if they were to be enacted. Beginning in 2022, the Tax Cuts and Jobs Act of 2017 eliminates the currently available option to deduct research and development expenditures and requires taxpayers to amortize them over five&#160;years. The U.S. Congress is considering legislation that would defer the amortization requirement to future periods, however, we have no assurance that the provision will be repealed or otherwise modified. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As of December&#160;31, 2021, the Company had no accrued interest or penalties related to uncertain tax positions and no amounts have been recognized in the Company&#8217;s consolidated statements of operations. Due to NOL and R&amp;D credit carryforwards that remain unutilized, income tax returns filed in the United States, certain states within the United States and Canadian tax jurisdictions from the Company&#8217;s inception through 2020 remain subject to examination by the taxing jurisdictions. There are currently no audits in process in any of the Company&#8217;s tax filing jurisdictions. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">17.&nbsp;&nbsp;&nbsp;LICENSE AGREEMENTS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">In-License Agreements</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">License Agreement with Zurich</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company has a license agreement with the University of Zurich (&#8220;Zurich&#8221;) which grants the Company exclusive license rights, with the right to sublicense, to make, have made, use and sell under certain patents primarily directed to the Company&#8217;s targeting agent, including an EpCAM chimera and related immunoconjugates and methods of use and manufacture of the same (the &#8220;Zurich License Agreement&#8221;). These patents cover some key aspects of Vicineum. Upon the Company&#8217;s receipt of the CRL regarding the BLA for Vicineum for the treatment of BCG-unresponsive NMIBC, the Company became obligated to pay $0.5&#160;million in a milestone payment to Zurich. The Company is also obligated to pay up to a 4% royalty on the net product sales for products covered by or manufactured using a method covered by a valid claim in the Zurich patent rights. Royalties owed to Zurich will be reduced if the total royalty rate owed by the Company to Zurich and any other third party is 10% or greater, provided that the royalty rate to Zurich may not be less than 2% of net sales. The obligation to pay royalties in a particular country expires upon the expiration or termination of the last of the Zurich patent rights that covers the manufacture, use or sale of a product. There is no obligation to pay royalties in a country if there is no valid claim that covers the product or a method of manufacturing the product. The Company recorded an expense of $0.5&#160;million and $0.3&#160;million related to achievement of a development milestone, (the submission of the Company&#8217;s BLA with the FDA in December&#160;2020), in the year ended December&#160;31, 2021 and 2020, respectively, and a regulatory milestone, (the Company&#8217;s receipt of the CRL from the FDA in August&#160;2021), in the twelve&#160;months ended December&#160;31, 2021, respectively. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">License Agreement with Micromet</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company has a License Agreement with Micromet AG (&#8220;Micromet&#8221;), now part of Amgen, Inc., which grants it nonexclusive rights, with certain sublicense rights, for know-how and patents allowing exploitation of certain single chain antibody products (the &#8220;Micromet License Agreement&#8221;). These patents cover some key aspects of Vicineum. Under the terms of the Micromet License Agreement, as of December&#160;31, 2021, the Company may be obligated to pay up to &euro;2.4&#160;million in milestone payments for the first product candidate that achieves applicable regulatory and sales-based development milestones (approximately $2.7&#160;million at exchange rates in effect on December&#160;31, 2021). The Company is also required to pay up to a 3.5% royalty on the net sales for products covered by the agreement, which includes Vicineum. The royalty rate owed to Micromet in a particular country will be reduced to 1.5% if there are no valid claims covering the product in that country. The obligation to pay royalties in a particular country expires upon the later of the expiration date of the last valid claim covering the product and the tenth anniversary of the first commercial sale of the product in such country. Finally, the Company is required to pay to Micromet an annual license maintenance fee of &euro;50,000 (approximately $56,625 at exchange rates in effect as of December&#160;31, 2021), which can be credited towards any royalty payment the Company owes to Micromet. The Company recorded an expense of &euro;0.7&#160;million ($0.9&#160;million) related to achievement of a development milestone in the three&#160;months ended December&#160;31, 2020, due to the submission of the Company&#8217;s BLA </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-36</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">for Vicineum with the FDA in December&#160;2020. The Company recorded an expense of &euro;0.5&#160;million ($0.6&#160;million) related to the submission of the MAA to the EMA for Vysyneum&#8482; in the first quarter of 2021. Vysyneum is the proprietary brand name that was conditionally approved by the EMA for oportuzumab monatox in the European Union. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">License Agreement with XOMA</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company has a license agreement with XOMA Ireland Limited (&#8220;XOMA&#8221;) which grants it non-exclusive rights to certain XOMA patent rights and know-how related to certain expression technology, including plasmids, expression strains, plasmid maps and production systems (the &#8220;XOMA License Agreement&#8221;). These patents and related know-how cover some key aspects of Vicineum. Under the terms of the XOMA License Agreement, the Company is required to pay up to $0.25&#160;million in milestone payments for a product candidate that incorporates know-how under the license and achieves applicable clinical development milestones. Based on current clinical status, the Company anticipates that these milestones may be triggered by Vicineum&#8217;s clinical development pathway. The Company is also required to pay a 2.5% royalty on the net sales for products incorporating XOMA&#8217;s technology, which includes Vicineum. The Company has the right to reduce the amount of royalties owed to XOMA on a country-by-country basis by the amount of royalties paid to other third parties, provided that the royalty rate to XOMA may not be less than 1.75% of net sales. In addition, the foregoing royalty rates are reduced by 50% with respect to products that are not covered by a valid patent claim in the country of sale. The obligation to pay royalties in a particular country expires upon the later of the expiration date of the last valid claim covering the product and the tenth anniversary of the first commercial sale of the product in such country. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Out-License Agreements</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Roche License Agreement</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In June&#160;2016, the Company entered into the license agreement with Roche (the &#8220;Roche License Agreement&#8221;), pursuant to which the Company granted Roche an exclusive, worldwide license, including the right to sublicense, to its patent rights and know-how related to the Company&#8217;s monoclonal antibody EBI-031 and all other IL-6 anti-IL-6 antagonist monoclonal antibody technology owned by the Company (collectively, the &#8220;Roche Licensed Intellectual Property&#8221;). Under the Roche License Agreement, Roche is required to continue developing, at its cost, EBI-031 and any other product made from the Roche Licensed Intellectual Property that contains an IL-6 antagonist anti-IL monoclonal antibody (&#8220;Roche Licensed Product&#8221;) and pursue ongoing patent prosecution, at its cost. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Financial Terms</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company received from Roche an upfront license fee of $7.5&#160;million in August&#160;2016 upon the effectiveness of the Roche License Agreement following approval by the Company&#8217;s stockholders, and Roche agreed to pay up to an additional $262.5&#160;million upon the achievement of specified regulatory, development and commercialization milestones with respect to up to two unrelated indications. Specifically, an aggregate amount of up to $197.5&#160;million is payable to the Company for the achievement of specified milestones with respect to the first indication, consisting of (i)&#160;$72.5&#160;million in development milestones, the next of which is $30&#160;million for initiation of the first Phase&#160;III clinical trial, (ii)&#160;$50&#160;million in regulatory milestones and (iii)&#160;$75&#160;million in commercialization milestones. Additional amounts of up to $65&#160;million are payable upon the achievement of specified development and regulatory milestones in a second indication. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In September&#160;2016, Roche paid the Company the first development milestone of $22.5&#160;million as a result of the Investigational New Drug application for EBI-031 becoming effective on or before September&#160;15, 2016. In December&#160;2021, a $20&#160;million milestone was achieved due to Roche initiating a Phase&#160;II clinical trial. Management evaluated the milestone under ASC 606 and determined it is probable that a significant revenue reversal will not occur in future periods, which was not the case in the previous quarter. Accordingly, the Company invoiced Roche $20&#160;million with payment terms of 30&#160;days following the achievement of the corresponding milestone event, pursuant to the Roche License Agreement and $20&#160;million was recorded as license revenue and accounts receivables in the fourth quarter of 2021. In January&#160;2022, the payment of $20&#160;million was received. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-37</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, the Company is entitled to receive royalty payments in accordance with a tiered royalty rate scale, with rates ranging from 7.5% to 15% of net sales of potential future products containing EBI-031 and up to 50% of these rates for net sales of potential future products containing other IL-6 compounds, with each of the royalties subject to reduction under certain circumstances and to the buy-out options of Roche. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Buy-Out Options</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Roche License Agreement provides for two &#8220;option periods&#8221; during which Roche may elect to make a one-time payment to the Company and, in turn, terminate its diligence, milestone and royalty payment obligations under the Roche License Agreement. Specifically, (i)&#160;Roche may exercise a buy-out option following the first dosing (&#8220;Initiation&#8221;) in the first Phase&#160;2 study for a Roche Licensed Product until the day before Initiation of the first Phase&#160;3 study for a Roche Licensed Product, in which case Roche is required to pay the Company $135&#160;million within 30&#160;days after Roche&#8217;s exercise of such buy-out option and receipt of an invoice from the Company, or (ii)&#160;Roche may exercise a buy-out option following the day after Initiation of the first Phase&#160;3 study for a Roche Licensed Product until the day before the acceptance for review by the FDA or other regulatory authority of a BLA or similar application for marketing approval for a Roche Licensed Product in either the United States or in the EU, in which case Roche is required to pay the Company, within 30&#160;days after Roche&#8217;s exercise of such buy-out option and receipt of an invoice from the Company, $265&#160;million, which amount would be reduced to $220&#160;million if none of the Company&#8217;s patent rights containing a composition of matter claim covering any compound or Roche Licensed Product has issued in the EU. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Termination</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Either the Company or Roche may each terminate the Roche License Agreement if the other party breaches any of its material obligations under the agreement and does not cure such breach within a specified cure period. Roche may terminate the Roche License Agreement following effectiveness by providing advance written notice to the Company or by providing written notice if the Company is debarred, disqualified, suspended, excluded, or otherwise declared ineligible from certain federal or state agencies or programs. The Company may terminate the Roche License Agreement if, prior to the first filing of a BLA for a Roche Licensed Product, there is a period of twelve&#160;months where Roche is not conducting sufficient development activities with respect to the products made from the Roche Licensed Intellectual Property. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">OUS Business Development Partnership Agreements</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Qilu License Agreement</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On July&#160;30, 2020, the Company and its a wholly-owned subsidiary, Viventia Bio, Inc., entered into an exclusive license agreement with Qilu (the &#8220;Qilu License Agreement&#8221;) pursuant to which the Company granted Qilu an exclusive, sublicensable, royalty-bearing license, under certain intellectual property owned or exclusively licensed by the Company, to develop, manufacture and commercialize Vicineum (the &#8220;Qilu Licensed Product&#8221;) for the treatment of NMIBC and other types of cancer (the &#8220;Field&#8221;) in China, Hong Kong, Macau and Taiwan (&#8220;Greater China&#8221;). The Company also granted Qilu a non-exclusive, sublicensable, royalty-bearing sublicense, under certain other intellectual property licensed by the Company to develop, manufacture and commercialize the Qilu Licensed Product in Greater China. The Company retains (i)&#160;development, and commercialization rights in the rest of the world excluding Greater China, the Middle East and North Africa region (&#8220;MENA&#8221;) and Turkey and (ii)&#160;manufacturing rights with respect to Vicineum in the rest of the world excluding China. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In consideration for the rights granted by the Company, Qilu agreed to pay to the Company a one-time upfront cash payment of $12&#160;million, and milestone payments totaling up to $23&#160;million upon the achievement of certain technology transfer, development and regulatory milestones. All payments were to be inclusive of value-added tax (&#8220;VAT&#8221;), which can be withheld by Qilu upon payment, and for which future recovery of such taxes may be available. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Qilu also agreed to pay the Company a 12% royalty based upon annual net sales of Qilu Licensed Products in Greater China. The royalties are payable on a Qilu Licensed Product-by-Licensed Product and </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-38</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">region-by-region basis commencing on the first commercial sale of a Licensed Product in a region and continuing until the latest of (i)&#160;twelve&#160;years after the first commercial sale of such Qilu Licensed Product in such region, (ii)&#160;the expiration of the last valid patent claim covering or claiming the composition of matter, method of treatment, or method of manufacture of such Qilu Licensed Product in such region, and (iii)&#160;the expiration of regulatory or data exclusivity for such Qilu Licensed Product in such region (collectively, the &#8220;Royalty Terms&#8221;). The royalty rate is subject to reduction under certain circumstances, including when there is no valid claim of a licensed patent that covers a Qilu Licensed Product in a particular region or no data or regulatory exclusivity of a Qilu Licensed Product in a particular region. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Qilu is responsible for all costs related to developing, obtaining regulatory approval of and commercializing the Qilu Licensed Products in the Field in Greater China. Qilu is required to use commercially reasonable efforts to develop, seek regulatory approval for, and commercialize at least one Qilu Licensed Product in the Field in Greater China. A joint development committee was established between the Company and Qilu to coordinate and review the development, manufacturing and commercialization plans with respect to the Qilu Licensed Products in Greater China. The Company and Qilu also executed the terms and conditions of a supply agreement and related quality agreement pursuant to which the Company will manufacture or have manufactured and supply Qilu with all quantities of the Qilu Licensed Product necessary for Qilu to develop and commercialize the Qilu Licensed Product in the Field in Greater China until the Company has completed manufacturing technology transfer to Qilu and approval of a Qilu manufactured product by the National Medical Products Administration in China (&#8220;NMPA&#8221;) for the Qilu Licensed Product has been obtained. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Qilu License Agreement will expire on a Qilu Licensed Product-by-Licensed Product and region-by-region basis on the date of the expiration of all applicable Royalty Terms. Either party may terminate the Qilu License Agreement for the other party&#8217;s material breach following a cure period or upon certain insolvency events. Qilu has the right to receive a refund of all amounts paid to the Company in the event the Qilu License Agreement is terminated under certain circumstances. The Qilu License Agreement includes customary representations and warranties, covenants and indemnification obligations for a transaction of this nature. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Qilu License Agreement is subject to the provisions of Accounting Standards Codification 606, Revenue from Contracts with Customers (&#8220;ASC 606&#8221;), which was adopted effective January&#160;1, 2018. In 2020, the initial transaction price was estimated to be $11.2&#160;million and was based on the up-front fixed consideration of $12&#160;million less amounts withheld for VAT. The Company concluded that its agreements under the Qilu License Agreement represented one bundled performance obligation that had been achieved as of September&#160;30, 2020. As such, $11.2&#160;million of the total $11.2&#160;million transaction price was considered earned and the Company recorded $11.2&#160;million of revenue during the three-month period ended September&#160;30, 2020. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Investigational New Drug application for Vicineum submitted by Qilu to the Center for Drug Evaluation of the NMPA was accepted for review in January&#160;2021 and approved in March&#160;2021, resulting in a $3&#160;million milestone payment from Qilu, the first milestone payment out of the $23&#160;million in potential milestone payments. The Company recorded $2.8&#160;million (net of VAT) as license revenue during the three-month period ended March&#160;31, 2021. The Company received the payment in 2021. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In June&#160;2021, the Qilu License Agreement was recognized by Shandong Province, Bureau of Science and Technology as a &#8220;Technology Transfer&#8221;. An agreement that is designated as a Technology Transfer shall be entitled to a tax incentive of VAT recovery. As such, the Company recorded $0.9&#160;million of revenue during the three&#160;months ended June&#160;30, 2021 for additional purchase price resulting from Qilu&#8217;s obligation to pay Sesen an amount equal to its recovery of VAT. The Company will not be subject to VAT on future potential milestone payments from Qilu. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">MENA License Agreement</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On November&#160;30, 2020, the Company entered into a license agreement with a third party pursuant to which the Company granted an exclusive, sublicensable, royalty-bearing license, under certain intellectual property owned or exclusively licensed by the Company, to commercialize Vicineum in the MENA region, (&#8220;MENA License Agreement&#8221;). The Company retains development and commercialization rights in the rest </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-39</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">of the world excluding Greater China, Turkey and MENA. In consideration for the rights granted by the Company, the counterparty to the MENA License Agreement agreed to pay to the Company an upfront payment of $3&#160;million, which would be subject to certain tax withholdings. In addition, the counterparty agreed to pay to the Company milestone payments upon the achievement of certain sales-based milestones as well as a royalty based upon annual net sales in the MENA region for the term of the MENA License Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The MENA License Agreement is subject to the provisions of ASC 606. The initial transaction price was estimated by management as $1.5&#160;million as of December&#160;31, 2020 and was based on 50% of the upfront payment, or the amount not subject to a refund if certain regulatory approvals in MENA are not obtained. The remaining upfront payment ($1.5&#160;million) is subject to a refund if certain regulatory approvals in MENA are not obtained and recorded as long-term deferred revenue as of December&#160;31, 2021. The Company also concluded that its agreements under the MENA License Agreement represented two distinct performance obligations, the first of which is a bundled performance obligation related to the delivery of the license, associated know-how and certain documentation. The second performance obligation relates to the delivery of manufactured product. The first performance obligation (delivery of the license, associated know-how and certain documentation) was achieved during the quarter ended March&#160;31, 2021; as such, revenue of $1.5&#160;million has been recognized. Additional variable consideration, determined to be allocated entirely to the bundled license performance obligation, to be paid to the Company based upon future sales levels will be recognized as revenue when the underlying sales of the licensed product occurs. In addition, variable consideration related to any future delivery of product will be recognized in future periods as the product is delivered. As of December&#160;31, 2021, none of these additional amounts were reasonably certain to be achieved due to the nature and timing of the underlying activities. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">EIP License Agreement</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On August&#160;5, 2021, the Company entered into an exclusive license agreement with E&#304;P Eczac&#305;ba&#351;&#305; &#304;la&#231; Pazarlama A.&#350;., (&#8220;EIP&#8221;) pursuant to which it granted EIP an exclusive license to register and commercialize Vicineum for the treatment of BCG-unresponsive NMIBC in Turkey and Northern Cyprus (the &#8220;EIP License Agreement). Under the terms of the License Agreement, the Company is entitled to receive an upfront payment of $1.5&#160;million. The Company is in the process of amending the license agreement to defer payment of the upfront payment to coincide with the potential FDA approval of Vicineum. The Company is eligible to receive additional regulatory and commercial milestone payments of $2.0&#160;million and is also entitled to receive a 30% royalty on net sales in Turkey and Northern Cyprus. The EIP License Agreement is subject to the provisions of ASC 606 and as of December&#160;31, 2021, none of these amounts have been received by the Company. No initial transaction price was estimated by management as of December&#160;31, 2021, as the upfront payment is subject to a refund if certain regulatory approvals in the US are not obtained. The Company also concluded that its promises under the EIP License Agreement represented two distinct performance obligations, the first of which is a bundled performance obligation related to the delivery of the license and associated know-how. The second performance obligation relates to the delivery of manufactured product. Additional variable consideration, determined to be allocated entirely to the bundled license performance obligation, to be paid to the Company based upon future regulatory milestones will be recognized as achievement of those milestones. In addition, variable consideration related to any future delivery of product will be recognized in future periods as the product is delivered. As of December&#160;31, 2021, none of these additional amounts were reasonably certain to be achieved due to the nature and timing of the underlying activities. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">18.&nbsp;&nbsp;&nbsp;RELATED-PARTY TRANSACTIONS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company leases its facility in Winnipeg, Manitoba from an affiliate of Leslie L. Dan, a director of the Company until his retirement in July&#160;2019. For each of the&#160;years ended December&#160;31, 2021, 2020 and 2019, the Company paid $0.3&#160;million of rent, which includes the related operating expenses. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company pays fees under an intellectual property license agreement to Protoden Technologies Inc. (&#8220;Protoden&#8221;), a company owned by Clairmark, an affiliate of Mr.&#160;Dan. Pursuant to the agreement, the Company has an exclusive, perpetual, irrevocable and non-royalty bearing license, with the right to sublicense, to certain patents and technology to make, use and sell products that utilize such patents and technology. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-40</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The annual fee is $0.1&#160;million. Upon expiration of the term on December&#160;31, 2024, the licenses granted to the Company will require no further payments to Protoden. For each of the&#160;years ended December&#160;31, 2021, 2020 and 2019, the Company paid $0.1&#160;million under this license agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Due to his retirement in July&#160;2019, Mr.&#160;Dan was not deemed a related party during the twelve-month period ended December&#160;31, 2020 and 2021; as such, only payments made through the nine month period ended September&#160;30, 2019 are considered payments to a related party. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">19.&nbsp;&nbsp;&nbsp;RESTRUCTURING AND RELATED ACTIVITIES</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On August&#160;30, 2021, the Company approved a restructuring plan to reduce operating expenses and better align its workforce with the needs of its business following receipt of the CRL from the FDA regarding the BLA for Vicineum for the treatment of BCG-unresponsive NMIBC (the &#8220;Restructuring Plan&#8221;). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Restructuring Plan included a reduction in the Company&#8217;s workforce by 18 positions (or approximately 35% of the Company&#8217;s workforce as of the date of the Restructuring Plan), as well as additional cost-saving initiatives intended to preserve capital while the Company continues development of Vicineum. The following is a summary of accrued restructuring costs related to the Restructuring Plan: </font>
        </div>
        <table style="width:416pt;height:122pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:357.69pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;text-align:center;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">December&#160;31,</font>
                <br >
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:357.69pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;text-align:center;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">(in thousands) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:357.69pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Severance and benefits costs </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.635pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">2,792</td>
            <td style="padding:0pt;padding-left:7.635pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:357.69pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Contract termination costs </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.635pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">2,736</td>
            <td style="padding:0pt;padding-left:7.635pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:357.69pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Other restructuring costs </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.635pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.635pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:357.69pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Total restructuring costs </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.635pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">5,528</td>
            <td style="padding:0pt;padding-left:7.635pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:357.69pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Cash payments </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.635pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">(4,031<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:7.635pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:357.69pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Balance at December&#160;31, 2021 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.635pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">1,497</td>
            <td style="padding:0pt;padding-left:7.635pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:8.19pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Restructuring costs related to the Restructuring Plan were recorded in operating expenses in the Company&#8217;s Consolidated Statements of Operations and Comprehensive Loss in the year ended December&#160;31, 2021. The Company expects that substantially all of the accrued restructuring costs as of December&#160;31, 2021 will be paid in cash by the end of September&#160;2022. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">20.&nbsp;&nbsp;&nbsp;SUBSEQUENT EVENTS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On January&#160;7, 2022, the FDA granted the Company&#8217;s request for a Type C Meeting (&#8220;Type C Meeting&#8221;) to discuss the study protocol for an additional Phase&#160;3 clinical trial that the Company plans to conduct for potential resubmission of a BLA for Vicineum&#8482; for the treatment of BCG-unresponsive NMIBC. The Type C Meeting has been scheduled for March&#160;28, 2022. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On January&#160;24, 2022, the Company received written notice (the &#8220;Notice&#8221;) from Nasdaq indicating that the Company is not in compliance with the $1.00 minimum bid price requirement for continued listing on The Nasdaq Global Market, as set forth in Nasdaq Listing Rule&#160;5450(a)(1). The Notice has no effect at this time on the listing of the Company&#8217;s common stock (the &#8220;Common Stock&#8221;), which continues to trade on The Nasdaq Global Market under the symbol &#8220;SESN&#8221;. In accordance with Nasdaq Listing Rule&#160;5810(c)(3)(A), the Company has a period of 180 calendar days, or until July&#160;25, 2022, to regain compliance with the minimum bid price requirement. To regain compliance, the closing bid price of the Company&#8217;s Common Stock must meet or exceed $1.00 per share for a minimum of ten consecutive business days during this 180-day period. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If the Company is not in compliance by July&#160;25, 2022, the Company may qualify for a second 180 calendar day compliance period. If the Company does not qualify for, or fail to regain, compliance during the second compliance period, then Nasdaq will notify the Company of its determination to delist the Company&#8217;s common stock, at which point the Company would have an opportunity to appeal the delisting determination to a Nasdaq hearings panel. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-41</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:452pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company intends to actively monitor the closing bid price of the Company&#8217;s common stock and may, if appropriate, consider implementing available options to regain compliance with the minimum bid price requirement under the Nasdaq Listing Rules. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As previously announced, the Company&#8217;s Board of Directors (the &#8220;Board&#8221;) initiated an independent internal review conducted by outside counsel with the assistance of subject matter experts focusing on the conduct of, and data generated from, the clinical trials of Vicineum for the treatment of BCG-unresponsive NMIBC, and the overall safety of Vicineum (the &#8220;Review&#8221;). The Review took place over the course of five&#160;months, involved full cooperation from the Company&#8217;s management team, a review of more than 600,000 documents, and 39 interviews of current and former employees and consultants. It is now complete. As a result of the Review, the Board continues to fully support the Company&#8217;s current management team and believes no changes or amendments relating to the Company&#8217;s prior disclosures to the SEC or the FDA relating to Vicineum, the Phase&#160;3 VISTA trial for Vicineum for the treatment of BCG-unresponsive NMIBC, or the BLA for Vicineum are warranted. The Company intends to work cooperatively with the FDA in preparing for an additional Phase&#160;3 clinical trial for Vicineum.</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-42</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a><a name="tCCBS">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">SESEN BIO, INC. </font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CONDENSED CONSOLIDATED BALANCE SHEETS</font>
          <br >
          <font style="letter-spacing:-0.2pt;">(Unaudited; In thousands, except share and per share data)</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:577.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">September&#160;30, </font>
                <br >
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">December&#160;31,</font>
                <br >
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Assets</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Current assets: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Cash and cash equivalents </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">71,107</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">162,636</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Short term marketable securities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">106,427</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Accounts receivables </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">21,011</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Other receivables </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">14,297</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">3,482</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:2.5pt 0pt 1.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Prepaid expenses and other current assets </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">527</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">18,476</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2.25pt 0pt 1.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:30pt;">
                <font style="letter-spacing:0.2pt;">Total current assets </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">192,358</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">205,605</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Non-current assets: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Restricted cash </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">30</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">20</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Marketable securities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">7,336</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Property and equipment, net </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">43</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Intangible assets </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">14,700</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Goodwill </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">13,064</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Long term prepaid expenses </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">7,192</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2.5pt 0pt 1.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Other assets </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">123</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:30pt;">
                <font style="letter-spacing:0.2pt;">Total non-current assets </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">7,366</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">35,142</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 2.25pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:40pt;font-weight:normal;">
                <font style="letter-spacing:0.2pt;">Total Assets </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">199,724</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">240,747</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.75pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Liabilities and Stockholders&#8217; Equity</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Current liabilities: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Accounts payable </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">514</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">2,853</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Accrued expenses </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">33,800</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">8,255</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:2.5pt 0pt 1.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Other current liabilities </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">381</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">460</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2.25pt 0pt 1.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:30pt;">
                <font style="letter-spacing:0.2pt;">Total current liabilities </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">34,695</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">11,568</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Non-current liabilities: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Contingent consideration </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">52,000</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Deferred tax liability </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">3,969</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2.5pt 0pt 1.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Deferred revenue </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">1,500</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:2.25pt 0pt 1.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:30pt;">
                <font style="letter-spacing:0.2pt;">Total non-current liabilities </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">57,469</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:40pt;">
                <font style="letter-spacing:0.2pt;">Total Liabilities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">34,695</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">69,037</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Stockholders&#8217; Equity: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0.5pt 0pt 0.5pt 0pt; width:338.99pt;white-space:normal;text-align:left;">
              <div style="margin-left:20pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Preferred stock, $0.001 par value per share; 5,000,000 shares authorized at September&#160;30, 2022 and December&#160;31, 2021; no shares issued and outstanding at September&#160;30, 2022 and December&#160;31, 2021 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0.5pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:20pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Common stock, $0.001 par value per share; 400,000,000 shares authorized at </font>
                <br >
                <font style="letter-spacing:0.2pt;">September&#160;30, 2022 and December&#160;31, 2021; 202,757,012 and 199,463,645 </font>
                <br >
                <font style="letter-spacing:0.2pt;">shares issued and outstanding at September&#160;30, 2022 and December&#160;31, </font>
                <br >
                <font style="letter-spacing:0.2pt;">2021, respectively </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">202</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">199</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Additional paid-in capital </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">493,629</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">487,768</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Other comprehensive loss </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">(235<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2.5pt 0pt 1.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Accumulated deficit </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">(328,567<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">(316,257<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:30pt;">
                <font style="letter-spacing:0.2pt;">Total Stockholders&#8217; Equity </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">165,029</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">171,710</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 2.25pt 0pt; width:338.99pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:normal;">
                <font style="letter-spacing:0.2pt;">Total Liabilities and Stockholders&#8217; Equity </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">199,724</td>
            <td style="padding:0pt;padding-left:3.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">240,747</td>
            <td style="padding:0pt;padding-left:2.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-left:10pt; margin-top:5pt; text-align:center; width:446pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;"> </font>
        </div>
      </div>
      <div style="margin-top:15.5pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The accompanying notes are an integral part of these condensed consolidated financial statements. </font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-43</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a><a name="tCCSO">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:187.5pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">SESEN BIO, INC. </font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CONDENSED CONSOLIDATED STATEMENTS OF INCOME (OPERATIONS)</font>
          <br >
          <font style="letter-spacing:-0.2pt;">(Unaudited; In thousands, except per share data)</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:373.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:253.84pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Three Months Ended</font>
                <br >
                <font style="letter-spacing:-0.16pt;">September&#160;30, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Nine Months Ended</font>
                <br >
                <font style="letter-spacing:-0.16pt;">September&#160;30, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:253.84pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:253.84pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Revenue: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:253.84pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">License and related revenue </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">40,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">40,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">6,544</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:253.84pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Total revenue </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">40,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">40,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">6,544</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:253.84pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Operating expenses: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:253.84pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Research and development </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">2,931</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">4,967</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">37,636</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">18,273</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:253.84pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">General and administrative </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">8,141</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">8,699</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">32,705</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">20,797</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:253.84pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Restructuring charge </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">10,947</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">5,522</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">10,947</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">5,522</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:253.84pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Intangibles impairment charge </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">31,700</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">27,764</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">31,700</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:253.84pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Change in fair value of contingent consideration </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">(1,800<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">(114,000<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">(52,000<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">(52,240<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:253.84pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Total operating expenses </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">20,219</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(63,112<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">57,052</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">24,052</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:253.84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Income (loss) from Operations </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">19,781</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">63,112</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">(17,052<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">(17,508<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:253.84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Other income (expense), net </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">676</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">1</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">867</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">(45<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:253.84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Income (loss) Before Taxes </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">20,457</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">63,113</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">(16,185<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">(17,553<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:253.84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Benefit from income taxes </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">8,561</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">3,875</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">8,273</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.25pt 0pt 2.5pt 0pt; width:253.84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Net Income (loss) After Taxes </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">20,457</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">71,674</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">(12,310<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">(9,280<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.917pt 0pt 0.833pt 0pt; width:253.84pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Net income (loss) attributable to common stockholders&#8201;&#8211;&#8201; basic </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">20,442</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">71,622</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">(12,310<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">(9,280<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:253.84pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Net income (loss) attributable to common stockholders&#8201;&#8211;&#8201; diluted </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">20,442</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">71,623</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">(12,310<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">(9,280<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:253.84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Net income (loss) per common share&#8201;&#8211;&#8201;basic </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">0.10</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">0.36</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">(0.06<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">(0.05<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:253.84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Weighted-average common shares outstanding&#8201;&#8211;&#8201;basic </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">200,464</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">196,778</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">199,801</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">176,547</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:253.84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Net income (loss) per common share&#8201;&#8211;&#8201;diluted </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">0.10</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">0.36</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">(0.06<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">(0.05<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:253.84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Weighted-average common shares outstanding&#8201;&#8211;&#8201;diluted </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">200,947</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">201,017</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">199,801</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">176,547</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The accompanying notes are an integral part of these condensed consolidated financial statements. </font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-44</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a><a name="tCCSO1">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:484.5pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">SESEN BIO, INC. </font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</font>
          <br >
          <font style="letter-spacing:-0.2pt;">(Unaudited; In thousands, except per share data)</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:76.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:275.51pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Three Months Ended</font>
                <br >
                <font style="letter-spacing:-0.16pt;">September&#160;30, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Nine Months Ended</font>
                <br >
                <font style="letter-spacing:-0.16pt;">September&#160;30, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:275.51pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:275.51pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Net income (loss) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">20,457</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">71,674</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(12,310<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">(9,280<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:275.51pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Unrealized (gain) loss on marketable securities </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">(46<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">235</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:275.51pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total comprehensive income (loss) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">20,503</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">71,674</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(12,545<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">(9,280<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-left:10pt; text-align:center; width:446pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;"> </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The accompanying notes are an integral part of these condensed consolidated financial statements. </font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-45</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a><a name="tCCSO2">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">SESEN BIO, INC. </font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:11.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS&#8217; EQUITY</font>
          <br >
          <font style="letter-spacing:-0.2pt;">(Unaudited; In thousands, except share data)</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:230pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;height:31.75pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:154.89pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Common Stock </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;" rowspan="2">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;" colspan="4" rowspan="2">
              <div style="text-align:center; line-height:9pt; padding-bottom:0pt;">
                <font style="letter-spacing:-0.16pt;">Additional</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Paid-in</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Capital </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;" rowspan="2">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;" rowspan="2">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;" colspan="4" rowspan="2">
              <div style="text-align:center; line-height:9.00000000000001pt; padding-bottom:0pt;">
                <font style="letter-spacing:-0.16pt;">Accumulated </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Other </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Comprehensive </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Loss </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Investments </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;" rowspan="2">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;" rowspan="2">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;" colspan="4" rowspan="2">
              <div style="text-align:center; line-height:9pt; padding-bottom:0pt;">
                <font style="letter-spacing:-0.16pt;">Accumulated</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Deficit </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;" rowspan="2">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;" rowspan="2">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;" colspan="4" rowspan="2">
              <div style="text-align:center; line-height:9pt; padding-bottom:0pt;">
                <font style="letter-spacing:-0.16pt;">Stockholders&#8217;</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Equity </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;" rowspan="2">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;height:13.5pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:154.89pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Shares </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Amount </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:154.89pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:bold;">
                <font style="letter-spacing:-0.2pt;">Balance at December&#160;31, 2021</font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:41.25pt; text-align:right; white-space:nowrap;">199,463,645</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">199</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">487,768</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.21pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:13.21pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(316,257<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">171,710</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:154.89pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Net loss </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:41.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.21pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:13.21pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(807<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">(807<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:154.89pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Share-based compensation </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:41.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:14.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">1,894</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.21pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:13.21pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">1,894</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:154.89pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:bold;">
                <font style="letter-spacing:-0.2pt;">Balance at March&#160;31, 2022</font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:41.25pt; text-align:right; white-space:nowrap;">199,463,645</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:14.25pt; text-align:right; white-space:nowrap;">199</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">489,662</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.21pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:13.21pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27pt; text-align:right; white-space:nowrap;">(317,064<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">172,797</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 1.5pt 0pt; width:154.89pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Net loss </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.5pt 0pt; min-width:41.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.21pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:13.21pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(31,960<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">(31,960<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:154.89pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Share-based compensation </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:41.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">1,802</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.21pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:13.21pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">1,802</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:154.89pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Unrealized loss of investments </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:41.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:14.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.21pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">(281<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:13.21pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">(281<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:154.89pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:bold;">
                <font style="letter-spacing:-0.2pt;">Balance at June&#160;30, 2022</font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:41.25pt; text-align:right; white-space:nowrap;">199,463,645</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:14.25pt; text-align:right; white-space:nowrap;">199</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">491,464</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.21pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">(281<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:13.21pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27pt; text-align:right; white-space:nowrap;">(349,024<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">142,358</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 1.5pt 0pt; width:154.89pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Net income </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.5pt 0pt; min-width:41.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.21pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:13.21pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">20,457</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">20,457</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:154.89pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Share-based compensation </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:41.25pt; text-align:right; white-space:nowrap;">3,293,367</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">3</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">2,165</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.21pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:13.21pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">2,168</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:154.89pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Unrealized gain of investments </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:41.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:14.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.21pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">46</td>
            <td style="padding:0pt;padding-left:13.21pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">46</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:154.89pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">Balance at September&#160;30, 2022</font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:41.25pt; text-align:right; white-space:nowrap;">202,757,012</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:14.25pt; text-align:right; white-space:nowrap;">202</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">493,629</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.21pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">(235<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:13.21pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27pt; text-align:right; white-space:nowrap;">(328,567<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">165,029</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <table style="width:456pt;height:359pt;margin-top:15pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;height:13.75pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:192.64pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Common Stock </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;" rowspan="2">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;" colspan="4" rowspan="2">
              <div style="text-align:center; line-height:9pt; padding-bottom:0pt;">
                <font style="letter-spacing:-0.16pt;">Additional</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Paid-in</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Capital </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;" rowspan="2">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;" rowspan="2">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;" colspan="4" rowspan="2">
              <div style="text-align:center; line-height:9pt; padding-bottom:0pt;">
                <font style="letter-spacing:-0.16pt;">Accumulated</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Deficit </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;" rowspan="2">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;" rowspan="2">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;" colspan="4" rowspan="2">
              <div style="text-align:center; line-height:9pt; padding-bottom:0pt;">
                <font style="letter-spacing:-0.16pt;">Stockholders&#8217;</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Equity </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;" rowspan="2">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;height:13.5pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:192.64pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Shares </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Amount </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:192.64pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:bold;">
                <font style="letter-spacing:-0.2pt;">Balance at December&#160;31, 2020</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:41.25pt; text-align:right; white-space:nowrap;">140,449,647</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">140</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">306,554</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(315,921<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">(9,227<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:192.64pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Net loss </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:41.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(55,512<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">(55,512<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:192.64pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Share-based compensation </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:41.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">958</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">958</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:192.64pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Exercises of stock options </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:41.25pt; text-align:right; white-space:nowrap;">30,610</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">39</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">39</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:192.64pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Exercises of common stock warrants </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:41.25pt; text-align:right; white-space:nowrap;">852,840</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">1</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">468</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">469</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2.167pt 0pt 0.5pt 0pt; width:192.64pt;white-space:normal;text-align:left;">
              <div style="margin-left:20pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Issuance of common stock under ATM Offering, net of issuance costs of $2.2&#160;million </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:41.25pt; text-align:right; white-space:nowrap;">30,645,702</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:14.25pt; text-align:right; white-space:nowrap;">31</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">72,512</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">72,543</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:192.64pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:bold;">
                <font style="letter-spacing:-0.2pt;">Balance at March&#160;31, 2021</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:41.25pt; text-align:right; white-space:nowrap;">171,978,799</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:14.25pt; text-align:right; white-space:nowrap;">172</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">380,531</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27pt; text-align:right; white-space:nowrap;">(371,433<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">9,270</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 0.5pt 0pt; width:192.64pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Net loss </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">
              <div style="font-weight:bold;">&#8203;</div>
            </td>
            <td style="padding:2.75pt 0pt 0.5pt 0pt; min-width:41.25pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">&#8212;</div>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(25,442<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">(25,442<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:192.64pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Share-based compensation </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">
              <div style="font-weight:bold;">&#8203;</div>
            </td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:41.25pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">&#8212;</div>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">1,260</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">1,260</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2.167pt 0pt 0.5pt 0pt; width:192.64pt;white-space:normal;text-align:left;">
              <div style="margin-left:20pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Issuance of common stock under ATM Offering, net of issuance costs of $2.0&#160;million </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:41.25pt; text-align:right; white-space:nowrap;">16,482,152</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:14.25pt; text-align:right; white-space:nowrap;">16</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">64,245</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">64,261</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:192.64pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:bold;">
                <font style="letter-spacing:-0.2pt;">Balance at June&#160;30, 2021</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:41.25pt; text-align:right; white-space:nowrap;">188,460,951</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:14.25pt; text-align:right; white-space:nowrap;">188</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">446,036</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27pt; text-align:right; white-space:nowrap;">(396,875<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">49,349</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 0.5pt 0pt; width:192.64pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Net income </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.5pt 0pt; min-width:41.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">71,674</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">71,674</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:192.64pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Share-based compensation </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:41.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">1,168</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">1,168</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:192.64pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Exercises of stock options </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:41.25pt; text-align:right; white-space:nowrap;">3,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">3</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">3</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:192.64pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Exercises of common stock warrants </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:41.25pt; text-align:right; white-space:nowrap;">1,195,219</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">1</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">656</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">657</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2.167pt 0pt 0.5pt 0pt; width:192.64pt;white-space:normal;text-align:left;">
              <div style="margin-left:20pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Issuance of common stock under ATM Offering, net of issuance costs of $1.2&#160;million </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:41.25pt; text-align:right; white-space:nowrap;">9,804,475</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:14.25pt; text-align:right; white-space:nowrap;">10</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">38,147</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">38,157</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:192.64pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">Balance at September&#160;30, 2021</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:41.25pt; text-align:right; white-space:nowrap;">199,463,645</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:14.25pt; text-align:right; white-space:nowrap;">199</td>
            <td style="padding:0pt;padding-left:3.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">486,010</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27pt; text-align:right; white-space:nowrap;">(325,201<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:1.11pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">161,008</td>
            <td style="padding:0pt;padding-left:3.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The accompanying notes are an integral part of these condensed consolidated financial statements. </font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-46</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a><a name="tCCSO3">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:33pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">SESEN BIO, INC. </font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</font>
          <br >
          <font style="letter-spacing:-0.2pt;">(Unaudited; In thousands)</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:528pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:353.26pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Nine Months Ended</font>
                <br >
                <font style="letter-spacing:-0.16pt;">September&#160;30, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:353.26pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:353.26pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Cash Flows from Operating Activities:</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:353.26pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Net loss </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(12,310<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">(9,280<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:353.26pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Adjustments to reconcile net loss to net cash used in operating activities: </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:353.26pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Depreciation </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">13</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">74</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:353.26pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Share-based compensation </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">5,864</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">3,386</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:353.26pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Change in fair value of contingent consideration </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(52,000<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">(52,240<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:353.26pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Intangibles impairment charge </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">27,764</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">31,700</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:353.26pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Changes in operating assets and liabilities: </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:353.26pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Accounts receivable (net) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">21,012</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">(1,107<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:353.26pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Other receivables </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(10,816<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:353.26pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Prepaid expenses and other current assets </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">17,949</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">(23,665<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:353.26pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Long term prepaid expenses </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">7,192</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:353.26pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Unrealized loss on marketable securities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(235<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:353.26pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Other assets </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">123</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:353.26pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Accounts payable </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(2,339<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">807</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:353.26pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Accrued expenses and other liabilities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">21,497</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">(4,453<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:353.26pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Deferred revenue </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">(1,500<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">(1,500<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:353.26pt;text-align:left;">
              <div style="margin-left:30pt;">
                <font style="letter-spacing:0.2pt;">Net cash provided by (used in) operating activities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">
              <div style="font-weight:bold;">&#8203;</div>
            </td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">22,214</div>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">
              <div style="font-weight:bold;">&#8203;</div>
            </td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">(56,278<font style="position:absolute;">)</font></div>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:353.26pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Cash Flows from Investing Activities:</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:353.26pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Purchase of marketable securities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(113,763<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:353.26pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Disposal (purchase) of equipment </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">30</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">(4<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.25pt 0pt 2.5pt 0pt; width:353.26pt;text-align:left;">
              <div style="margin-left:30pt;">
                <font style="letter-spacing:0.2pt;">Net cash used in investing activities </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">
              <div style="font-weight:bold;">&#8203;</div>
            </td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">(113,733<font style="position:absolute;">)</font></div>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">
              <div style="font-weight:bold;">&#8203;</div>
            </td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">(4<font style="position:absolute;">)</font></div>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:353.26pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Cash Flows from Financing Activities:</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:353.26pt;text-align:left;">
              <div style="margin-left:30pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Proceeds from issuance of common stock under ATM Offering, net of</font>
                <br >
                <font style="letter-spacing:0.2pt;">issuance costs </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">174,961</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:353.26pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Proceeds from exercises of stock options </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">42</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:353.26pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Proceeds from exercises of common stock warrants </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">1,126</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.25pt 0pt 2.5pt 0pt; width:353.26pt;text-align:left;">
              <div style="margin-left:40pt;">
                <font style="letter-spacing:0.2pt;">Net cash provided by financing activities </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">
              <div style="font-weight:bold;">&#8203;</div>
            </td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">&#8212;</div>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">
              <div style="font-weight:bold;">&#8203;</div>
            </td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">176,129</div>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:353.26pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Net (decrease) increase in cash, cash equivalents and restricted cash </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(91,519<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">119,847</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:353.26pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Cash, cash equivalents and restricted cash&#8201;&#8211;&#8201;beginning of period </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">162,656</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">55,409</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:353.26pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Cash, cash equivalents and restricted cash&#8201;&#8211;&#8201;end of period </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">
              <div style="font-weight:bold;">$</div>
            </td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">71,137</div>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">
              <div style="font-weight:bold;">$</div>
            </td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">175,256</div>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 1.5pt 0pt; width:353.26pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Supplemental cash flow disclosure: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:353.26pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Cash paid for amounts included in the measurement of lease liabilities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">127</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">131</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The accompanying notes are an integral part of these condensed consolidated financial statements. </font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-47</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a><a name="tNTCC">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">SESEN BIO, INC. </font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:11.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</font>
          <br >
          <font style="letter-spacing:-0.2pt;">(Unaudited)</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">1.&nbsp;&nbsp;&nbsp;DESCRIPTION OF BUSINESS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio, Inc. (&#8220;Sesen Bio&#8221; or the &#8220;Company&#8221;), a Delaware corporation formed in February&#160;2008, is a late-stage clinical company focused on advancing targeted fusion protein therapeutics for the treatment of patients with cancer. The Company&#8217;s most advanced product candidate, Vicineum</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">TM</font><font style="letter-spacing:0.2pt;">, also known as VB4-845, is a locally-administered targeted fusion protein composed of an anti-epithelial cell adhesion molecule (&#8220;EpCAM&#8221;) antibody fragment tethered to a truncated form of Pseudomonas exotoxin A for the treatment of non-muscle invasive bladder cancer (&#8220;NMIBC&#8221;). On July&#160;15, 2022, the Company made the strategic decision to voluntarily pause further development of Vicineum in the United States. The decision was based on a thorough reassessment of Vicineum following recent discussions with the United States Food and Drug Administration (&#8220;FDA&#8221;), which had implications on the size, timeline and costs of an additional Phase&#160;3 clinical trial, which the FDA previously confirmed would be required for a potential resubmission of a biologics license application (&#8220;BLA&#8221;) for Vicineum for the treatment of NMIBC. The Company continues to believe that Vicineum has benefits for patients and healthcare providers that can be maximized through a company with a larger infrastructure, and as such, intends to seek a partner that can execute further development to realize the full potential of Vicineum. As a result of this decision, the Company has&#160;turned its primary focus to the careful assessment of potential strategic alternatives with the goal of maximizing shareholder value. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Anticipated Merger with CARISMA Therapeutics Inc.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Following an extensive process of evaluating strategic alternatives, including identifying and reviewing potential candidates for a strategic transaction, on September&#160;20, 2022, Sesen Bio, Seahawk Merger Sub, Inc., a Delaware corporation and wholly-owned subsidiary of Sesen Bio (&#8220;Merger Sub&#8221;), and CARISMA Therapeutics Inc., a Delaware corporation (&#8220;Carisma&#8221;), entered into an Agreement and Plan of Merger and Reorganization (the &#8220;Merger Agreement&#8221;), pursuant to which, among other things, and subject to the satisfaction or waiver of certain conditions set forth in the Merger Agreement, Merger Sub will merge with and into Carisma, with Carisma continuing as a wholly-owned subsidiary of Sesen Bio and the surviving corporation of the merger (the &#8220;Merger&#8221;). Sesen Bio&#8217;s board of directors unanimously approved the&#160;Merger Agreement and resolved to recommend that Sesen Bio&#8217;s stockholders approve the proposals described in the Merger Agreement. If the Merger is completed, the business of Carisma will continue as the business of the combined company. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio&#8217;s future operations are highly dependent on the success of the Merger and there can be no assurances that the Merger will be successfully consummated. In the event that Sesen Bio does not complete the Merger with Carisma, Sesen Bio may continue to review and evaluate a strategic alternatives, including, without limitation, another strategic transaction and/or pursue a liquidation and dissolution of Sesen Bio. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Viventia Acquisition</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In September&#160;2016, the Company entered into a Share Purchase Agreement with Viventia Bio, Inc., a corporation incorporated under the laws of the Province of Ontario, Canada (&#8220;Viventia&#8221;), the shareholders of Viventia named therein (the &#8220;Selling Shareholders&#8221;) and, solely in its capacity as seller representative, Clairmark Investments Ltd., a corporation incorporated under the laws of the Province of Ontario, Canada (the &#8220;Share Purchase Agreement&#8221;), pursuant to which the Company agreed to and simultaneously&#160;completed the acquisition of all of the outstanding capital stock of Viventia from the Selling Shareholders (the &#8220;Viventia Acquisition&#8221;). In connection with the closing of the Viventia Acquisition, the Company issued 4.0&#160;million shares of its common stock to the Selling Shareholders, which at that time represented approximately 19.9% of the voting power of the Company as of immediately prior to the issuance of such shares. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, under the Share Purchase Agreement, the Company is obligated to pay to the Selling Shareholders certain post-closing contingent cash payments upon the achievement of specified milestones and based upon net sales, in each case subject to the terms and conditions set forth in the Share Purchase </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-48</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Agreement, including: (i)&#160;a one-time milestone payment of $12.5&#160;million payable upon the first sale of Vicineum (the &#8220;Purchased Product&#8221;), in the United States; (ii)&#160;a one-time milestone payment of $7.0&#160;million payable upon the first sale of the Purchased Product in any one of certain specified European countries; (iii)&#160;a one-time milestone payment of $3.0&#160;million payable upon the first sale of the Purchased Product in Japan; and (iv)&#160;quarterly earn-out payments equal to 2% of net sales of the Purchased Product during specified earn-out periods. Such earn-out payments are payable with respect to net sales in a country beginning on the date of the first sale in such country and ending on the earlier of (i)&#160;December&#160;31, 2033, and (ii)&#160;fifteen&#160;years after the date of such sale, subject to early termination in certain circumstances if a biosimilar product is on the market in the applicable country. Under the Share Purchase Agreement, the Company, its affiliates, licensees and subcontractors are required to use commercially reasonable efforts, for the first seven&#160;years following the closing of the Viventia Acquisition, to achieve marketing authorizations throughout the world and, during the applicable earn-out period, to commercialize the Purchased Product in the United States, France, Germany, Italy, Spain, United Kingdom, Japan, China and Canada. Certain of these payments are payable to individuals or affiliates of individuals that became employees or members of the Company&#8217;s board of directors. However, as of September&#160;30, 2022, none of these individuals are active employees of the Company or members of the Company&#8217;s board of directors. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">2.&nbsp;&nbsp;&nbsp;BASIS OF PRESENTATION</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The accompanying financial statements have been prepared in accordance with United States generally accepted accounting principles (&#8220;GAAP&#8221;). Any reference in these notes to applicable guidance is meant to refer to GAAP as found in the Accounting Standards Codification (&#8220;ASC&#8221;) and Accounting Standards Updates (&#8220;ASUs&#8221;), promulgated by the Financial Accounting Standards Board (&#8220;FASB&#8221;). </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Interim Financial Statements</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The accompanying unaudited interim condensed consolidated financial statements have been prepared from the books and records of the Company in accordance with GAAP for interim financial information and Rule&#160;10-01 of Regulation&#160;S-X promulgated by the United States Securities and Exchange Commission (&#8220;SEC&#8221;), which permit reduced disclosures for interim periods. All adjustments, consisting only of normal recurring adjustments, which are, in the opinion of management, necessary for a fair presentation of the accompanying condensed consolidated balance sheets and statements of operations and comprehensive (loss) income, stockholders&#8217; equity (deficit) and cash flows have been made. Although these interim financial statements do not include all of the information and footnotes required for complete annual financial statements, management believes the disclosures are adequate to make the information presented not misleading. These unaudited interim results of operations and cash flows for the nine&#160;months ended September&#160;30, 2022 are not necessarily indicative of the results that may be expected for the full year. These unaudited interim condensed consolidated financial statements and footnotes should be read in conjunction with the Company&#8217;s audited annual consolidated financial statements and footnotes included in its Annual Report on Form 10-K, as filed with the SEC on February&#160;28, 2022, wherein a more complete discussion of significant accounting policies and certain other information can be found. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Use of Estimates</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The preparation of financial statements in accordance with GAAP and the rules and regulations of the SEC requires the use of estimates and assumptions, based on judgments considered reasonable, which affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company bases its estimates and assumptions on historical experience, known trends and events and various other factors that management believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Although management believes its estimates and assumptions are reasonable when made, they are based upon information available at the time they are made. Management evaluates the estimates and assumptions on an ongoing basis and, if necessary, makes adjustments. Due to the risks and uncertainties involved in the Company&#8217;s business and evolving market conditions, and given the subjective element of the estimates and assumptions made, actual results may differ from estimated results. The most </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-49</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">significant estimates and judgments impact the fair value of intangible assets; goodwill and contingent consideration; income taxes (including the valuation allowance for deferred tax assets); and research and development expenses. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Principles of Consolidation</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company&#8217;s condensed consolidated financial statements include the accounts of the Company, its wholly owned subsidiaries Viventia and Seahawk Merger Sub, Inc. and its indirect subsidiary, Viventia Bio USA Inc. All intercompany transactions and balances have been eliminated in consolidation. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Foreign Currency Translation</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The functional currency of the Company and each of its subsidiaries is the US dollar. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">3.&nbsp;&nbsp;&nbsp;SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company&#8217;s complete summary of significant accounting policies can be found in &#8220;Item&#160;15.&#160;Exhibits and Financial Statement Schedules&#8201;&#8212;&#8201;Note 3. Summary of Significant Accounting Policies&#8221; in the audited annual consolidated financial statements included in its Annual Report on Form 10-K for the year ended December&#160;31, 2021. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">4.&nbsp;&nbsp;&nbsp;RECENT ACCOUNTING PRONOUNCEMENTS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Adopted in 2022</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In August&#160;2020, the FASB issued ASU No. 2020-06, </font><font style="font-style:italic;letter-spacing:0.2pt;">Debt&#8201;&#8212;&#8201;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#8201;&#8212;&#8201;Contracts in Entity&#8217;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity</font><font style="letter-spacing:0.2pt;"> (&#8220;ASU 2020-06&#8221;). ASU&#160;2020-06 simplifies the complexity associated with applying US GAAP for certain financial instruments with characteristics of both liability and equity. More specifically, the amendments focus on the guidance for convertible instruments and derivative scope exception for contracts in an entity&#8217;s own equity. The ASU&#160;also amends the diluted earnings per share (&#8220;EPS&#8221;) guidance, including the requirement to use the if-converted method for all convertible instruments. ASU 2020-06 is effective for public companies for fiscal&#160;years, and interim periods within those fiscal&#160;years, beginning after December&#160;15, 2021, and should be applied on a full or modified retrospective basis. The Company adopted this guidance on a modified retrospective basis effective January&#160;1, 2022 and it did not have an impact on the Company&#8217;s financial position, results of operations including per-share amounts, or cash flows. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="font-style:normal;letter-spacing:0.2pt;">In May&#160;2021, the FASB issued ASU No. 2021-04, </font><font style="letter-spacing:0.2pt;">Earnings Per Share (Topic 260), Debt&#8201;&#8212;&#8201;Modifications and Extinguishments (Subtopic 470-50), Compensation&#8201;&#8212;&#8201;Stock Compensation (Topic 718), and Derivatives and Hedging&#8201;&#8212;&#8201;Contracts in Entity&#8217;s Own Equity (Subtopic 815-40): Issuer&#8217;s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options</font><font style="font-style:normal;letter-spacing:0.2pt;"> (&#8220;ASU 2021-04&#8221;)</font><font style="letter-spacing:0.2pt;">.</font><font style="font-style:normal;letter-spacing:0.2pt;"> ASU&#160;2021-04 clarifies and reduces diversity in an issuer&#8217;s accounting for modifications or exchanges of freestanding equity-classified written call options (for example, warrants) that remain equity classified after modification or exchange. ASU 2021-04 is effective for public companies for fiscal&#160;years, and interim&#160;periods within those fiscal&#160;years, beginning after December&#160;15, 2021, and should be applied on a prospective basis. The Company adopted this guidance effective January&#160;1, 2022 and it did not have an impact on the Company&#8217;s financial position, results of operations including per-share amounts, or cash flows. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Other recent accounting pronouncements issued, but not yet effective, are not expected to be applicable to the Company or have a material effect on the consolidated financial statements upon future adoption. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">5.&nbsp;&nbsp;&nbsp;FAIR VALUE MEASUREMENT AND FINANCIAL INSTRUMENTS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The carrying values of cash and cash equivalents, restricted cash, prepaid expenses and other current assets, and accounts payable on the Company&#8217;s condensed consolidated balance sheets approximated their fair values as of September&#160;30, 2022 and December&#160;31, 2021 due to their short-term nature. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-50</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Certain of the Company&#8217;s financial instruments are measured at fair value using a three-level hierarchy that prioritizes the inputs used to measure fair value. This fair value hierarchy prioritizes the use of observable inputs and minimizes the use of unobservable inputs. The three levels of inputs used to measure fair value are as follows: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.9pt; margin-bottom:0pt; text-align:left; width:41pt;white-space:nowrap;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Level&#160;1</font><font style="letter-spacing:0.2pt;">:</font>
          <br >
        </div>
        <div style=" margin-top:7.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:61pt;">
          <font style="letter-spacing:0.2pt;">Inputs are quoted prices for identical instruments in active markets. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.9pt; margin-bottom:0pt; text-align:left; width:41pt;white-space:nowrap;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Level&#160;2</font><font style="letter-spacing:0.2pt;">:</font>
          <br >
        </div>
        <div style=" margin-top:7.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:61pt;">
          <font style="letter-spacing:0.2pt;">Inputs are quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; or model-derived valuations whose inputs are observable or whose significant value drivers are observable. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.9pt; margin-bottom:0pt; text-align:left; width:41pt;white-space:nowrap;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Level&#160;3</font><font style="letter-spacing:0.2pt;">:</font>
          <br >
        </div>
        <div style=" margin-top:7.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:61pt;">
          <font style="letter-spacing:0.2pt;">Inputs are unobservable and reflect the Company&#8217;s own assumptions, based on the best information available, including the Company&#8217;s own data. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following tables set forth the carrying amounts and fair values of the Company&#8217;s financial instruments measured at fair value on a recurring basis as of September&#160;30, 2022 and December&#160;31, 2021 (in thousands): </font>
        </div>
        <table style="width:456pt;height:161.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:205.34pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="28">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">September&#160;30, 2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;height:5pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:205.34pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;" rowspan="2">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4" rowspan="2">
              <div style="text-align:center; line-height:9pt; padding-bottom:0.333333333333333pt;">
                <font style="letter-spacing:-0.16pt;">Carrying</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Amount </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;" rowspan="2">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;" rowspan="2">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4" rowspan="2">
              <div style="white-space:nowrap; text-align:center; line-height:9pt; padding-bottom:0.333333333333333pt;">
                <font style="letter-spacing:-0.16pt;">Fair Value </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;" rowspan="2">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt; width:0pt;" colspan="16">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Fair Value Measurement Based on </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;height:49.5pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:205.34pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Quoted</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Prices in</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Active</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Markets</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(Level&#160;1) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Significant</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Other</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Observable</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Inputs</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(Level&#160;2) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Significant</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Unobservable</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Inputs</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(Level&#160;3) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:205.34pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Assets:</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.42pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.42pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:205.34pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Marketable securities: </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.42pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.42pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:205.34pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Money market funds (cash equivalents) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">11,450</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">11,450</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">11,450</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.42pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:12.42pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:205.34pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Marketable securities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">113,763</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">113,763</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">113,763</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.42pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:12.42pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:205.34pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Liabilities:</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.42pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.42pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:205.34pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Contingent consideration </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.42pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8199;&#8212;</td>
            <td style="padding:0pt;padding-left:12.42pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <table style="width:456pt;height:131.5pt;margin-top:13pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:214.14pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="28">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">December&#160;31, 2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:214.14pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt; width:0pt;" colspan="16">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Fair Value Measurement Based on </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:214.14pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Carrying</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Amount </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Fair Value </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Quoted</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Prices in</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Active</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Markets</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(Level&#160;1) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Significant</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Other</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Observable</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Inputs</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(Level&#160;2) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Significant</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Unobservable</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Inputs</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(Level&#160;3) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:214.14pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Assets:</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.625pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.625pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.065pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.065pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:214.14pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Money market funds (cash equivalents) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">16,382</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">16,382</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">16,382</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.625pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:8.625pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.065pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.065pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:214.14pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Liabilities:</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.625pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.625pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.065pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.065pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:214.14pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Contingent consideration </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">52,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">52,000</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.625pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8199;&#8212;</td>
            <td style="padding:0pt;padding-left:8.625pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.065pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">52,000</td>
            <td style="padding:0pt;padding-left:6.065pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:7.9pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company evaluates transfers between fair value levels at the end of each reporting period. There were no asset or liability transfers between fair value levels during the nine&#160;months ended September&#160;30, 2022 and the year ended December&#160;31, 2021. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Contingent Consideration</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On September&#160;20, 2016, the Company acquired Viventia through the issuance of shares of common stock plus contingent consideration, pursuant to the terms of a Share Purchase Agreement. The Company recorded the acquired assets and liabilities based on their estimated fair values as of the acquisition date and finalized its purchase accounting for the Viventia Acquisition during the third quarter of 2017. The contingent consideration relates to amounts potentially payable to the former shareholders of Viventia under the Share Purchase Agreement. Contingent consideration is measured at its estimated fair value at each reporting period, with fluctuations in value resulting in a non-cash charge to earnings (or loss) during </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-51</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">the period. The estimated fair value measurement is based on significant inputs, including internally developed financial forecasts, probabilities of success, and the timing of certain milestone events and achievements, which are not observable in the market, representing a Level&#160;3 measurement within the fair value hierarchy. The valuation of contingent consideration requires the use of significant assumptions and judgments, which management believes are consistent with those that would be made by a market participant. Management reviews its assumptions and judgments on an ongoing basis as additional market and other data is obtained, and any future changes in the assumptions and judgments utilized by management may cause the estimated fair value of contingent consideration to fluctuate materially, resulting in earnings volatility. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On July&#160;15, 2022, the Company made the strategic decision to voluntarily pause further development of Vicineum in the United States. The decision was based on a thorough reassessment of Vicineum following recent discussions with the FDA, which had implications on the size, timeline and costs of an additional Phase&#160;3 clinical trial for the treatment of NMIBC. The Company continues to believe that Vicineum has benefits for patients and healthcare providers that can be maximized through a company with a larger infrastructure, and as such intends to seek a partner for the further development of Vicineum. Additionally, during the second quarter of 2022, the Company observed an evolution of the current market treatment paradigm in NMIBC, with substantial uptake of intravesical chemotherapy (monotherapy and combination therapy) during the bacillus Calmette-Gu&#233;rin (&#8220;BCG&#8221;) shortage. Accordingly, during the second quarter of 2022, the Company concluded that it no longer expected to pay related milestone and earnout payments to the former shareholders of Viventia, with the exception of the potential 2% earnout payment related to the Greater China region since those territory rights had been out-licensed pursuant to the exclusive license agreement with Qilu Pharmaceutical Co., Ltd. (&#8220;Qilu&#8221;) (the &#8220;Qilu License Agreement&#8221;) (as further&#160;described in Note 17. &#8220;License Agreements&#8221; below). As of June&#160;30, 2022, Qilu held the exclusive license to develop Vicineum in the Greater China region, and accordingly, the $1.8&#160;million estimated earnout payment in the Greater China region remained as long-term contingent consideration as of June&#160;30, 2022. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company and Qilu are in the process of negotiating a termination of the Qilu License Agreement. Upon the termination of the Qilu License Agreement, the Company will regain the rights to develop, manufacture and commercialize Vicineum in Greater China. However, the Company does not plan to develop or commercialize Vicineum in that region or any other, as it is pursuing the Merger with Carisma. The Company is also seeking to sell or out-license Vicineum and all the related obligations related to Vicineum. The Company expects that any partner who acquires or licenses Vicineum from the Company will be obligated to make any payments, including those related to sales in the Greater China region (if any), that become payable to the former shareholders of Viventia under the Share Purchase Agreement. If a sale or license of Vicineum has not occurred at the time the Merger is completed, Carisma has indicated it may continue to seek a sale or license of Vicineum and has no plans to develop Vicineum. Accordingly, as of September&#160;30, 2022, the Company concluded that it no longer expects to owe any future earnout payments related to the Greater China region and reduced its remaining $1.8&#160;million of contingent consideration liabilities to zero as of September&#160;30, 2022. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The contingent consideration balance as of December&#160;31, 2021 was $52.0&#160;million which was based upon projected world-wide net sales. The estimated fair value of the Company&#8217;s contingent consideration was determined using probabilities of successful achievement of regulatory milestones and commercial sales, the period in which these milestones and sales are expected to be achieved through 2033, the level of commercial sales of Vicineum forecasted for the US, Europe, Japan, China and other potential markets and discount rates ranging from 8.0% to 9.3% as of December&#160;31, 2021. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following table sets forth a summary of the change in the fair value of the Company&#8217;s contingent consideration liability, measured on a recurring basis at each reporting period (in thousands). </font>
        </div>
        <table style="width:416pt;height:40.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; width:367.96pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:bold;">
                <font style="letter-spacing:-0.2pt;">Balance at December&#160;31, 2021</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:0pt 0pt 1pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">52,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:367.96pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Change in fair value of contingent consideration </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(52,000<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:367.96pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">Balance at September&#160;30, 2022</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:12.9pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The fair value of the Company&#8217;s contingent consideration was determined based on the present value of projected future cash flows associated with sales-based milestones and earnouts on net sales and is heavily </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-52</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">dependent on discount rates to estimate the fair value at each reporting period. Earnouts were determined using an earnout rate of 2% on all commercial net sales of Vicineum through December&#160;2033. The discount rate applied to the 2% earnout was derived from the Company&#8217;s weighted-average cost of capital, which was 9.3% as of December&#160;31, 2021. As of December&#160;31, 2021, the balance also reflected potential milestone payments which constitute debt-like obligations, and therefore a high-yield debt index rate was applied to the milestones in order to determine the estimated fair value. This index rate was 8.0% as of December&#160;31, 2021. The decrease in the fair value of contingent consideration of $52.0&#160;million for the nine&#160;months ended September&#160;30, 2022 was driven by the Company&#8217;s decision to voluntarily pause further development of Vicineum in the United States and seek a partner to acquire or license the asset and assume all associated liabilities. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">6.&nbsp;&nbsp;&nbsp;RECEIVABLES</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The accounts receivable balance as of December&#160;31, 2021 was $21.0&#160;million, comprised primarily of a $20&#160;million milestone achieved in December&#160;2021 due to F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc. (collectively, &#8220;Roche&#8221;) initiating a Phase&#160;II clinical trial in the fourth quarter of 2021. In January&#160;2022 the payment of $20&#160;million was received. Additionally, in June&#160;2021, the Qilu License Agreement was recognized by Shandong Province, Bureau of Science and Technology as a &#8220;Technology Transfer&#8221;. As such, the Company recorded $0.9&#160;million of revenue and accounts receivable for the additional purchase price resulting from Qilu&#8217;s obligation to pay the Company an amount equal to its recovery of value-added tax (&#8220;VAT&#8221;). The accounts receivable balance as of September&#160;30, 2022 was zero. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The other receivables balance as of September&#160;30, 2022 was $14.3&#160;million compared to $3.5&#160;million as of December&#160;31, 2021. The increase of $10.8&#160;million was primarily driven by expected insurance recovery of $13.4&#160;million related to the preliminary settlements of the Securities Litigation and Derivative Litigation (as defined in Note 10. &#8220;Commitments and Contingencies&#8221; below). This amount was partially offset by the receipt of $2.4&#160;million for German VAT recovery in the first half of 2022, related to drug substance sent to Baxter in 2020 and 2019 and other individually immaterial changes of $0.2&#160;million. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">7.&nbsp;&nbsp;&nbsp;PREPAID EXPENSES</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The prepaid expenses balance as of September&#160;30, 2022 was $0.5&#160;million compared to $25.7&#160;million as of December&#160;31, 2021. In light of the Company&#8217;s decision to voluntarily pause further development of Vicineum in the United States, the Company evaluated prepaid balances and determined that the prepayments for the manufacturing of Vicineum, including consumables, had no future economic benefit or value. Pursuant to ASC Topic 730, </font><font style="font-style:italic;letter-spacing:0.2pt;">Certain Nonrefundable Advance Payment</font><font style="letter-spacing:0.2pt;">, the Company expensed $25.2&#160;million of prepayments during the second quarter of 2022. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">8.&nbsp;&nbsp;&nbsp;INTANGIBLE ASSETS AND GOODWILL</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Intangibles</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Intangible assets on the Company&#8217;s condensed consolidated balance sheets are the result of the Viventia Acquisition in September&#160;2016. The following table sets forth the composition of intangible assets as of September&#160;30, 2022 and December&#160;31, 2021 (in thousands): </font>
        </div>
        <table style="width:416pt;height:63pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:298.99pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">September&#160;30, </font>
                <br >
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">December&#160;31,</font>
                <br >
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:298.99pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">IPR&amp;D intangible assets: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.705pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.705pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:298.99pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Vicineum European Union rights </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.705pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">
              <div style="font-weight:bold;">$</div>
            </td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">&#8212;</div>
            </td>
            <td style="padding:0pt;padding-left:13.705pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">
              <div style="font-weight:bold;">$</div>
            </td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">14,700</div>
            </td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:298.99pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">Total Intangibles</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.705pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:14.25pt; text-align:right; white-space:nowrap;">&#8199;&#8212;</td>
            <td style="padding:0pt;padding-left:13.705pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24pt; text-align:right; white-space:nowrap;">14,700</td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:13.1pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The fair value of the acquired intangible assets for the European Union (&#8220;EU&#8221;) rights of Vicineum is determined using a risk-adjusted discounted cash flow approach, which includes probability adjustments for projected revenues and operating expenses based on the success rates assigned to each stage of development for each geographical region; as well as discount rates applied to the projected cash flows. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-53</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">During the second quarter of 2022, the Company observed an evolution of the current market treatment paradigm in NMIBC, with substantial uptake of intravesical chemotherapy (monotherapy and combination therapy) during the ongoing BCG shortage. On July&#160;15, 2022, the Company made the strategic decision to voluntarily pause further development of Vicineum in the United States. The decision was based on a thorough reassessment of Vicineum following recent discussions with the FDA, which had implications on the size, timeline and costs of an additional Phase&#160;3 clinical trial for the treatment of NMIBC. Management updated the discounted cash flow model using the market participant approach and considered preliminary terms of a potential partnering deal to conclude the fair value of the Company&#8217;s intangible asset of Vicineum EU rights. The Company concluded that the carrying value of the Company&#8217;s intangible asset of Vicineum EU rights of $14.7&#160;million was fully impaired and was reduced to zero in the second quarter of 2022. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Goodwill</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Goodwill on the Company&#8217;s condensed consolidated balance sheets is the result of the Viventia Acquisition in September&#160;2016. During the second quarter of 2022, the Company observed continued trends in the Company&#8217;s market capitalization as compared to the carrying value of its single reporting unit as well as changes in certain assumptions in the fair value of the business including market share, size, length and cost of a clinical trial, and time to potential market launch. The Company identified these changes as potential impairment indicators and performed a quantitative impairment analysis, in advance of the Company&#8217;s typical annual assessment date of October&#160;1 and concluded that the carrying value of its goodwill of $13.1&#160;million was fully impaired and was reduced to zero in the second quarter of 2022. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following table sets forth a summary of the change in goodwill as of September&#160;30, 2022 and December&#160;31, 2021 (in thousands). </font>
        </div>
        <table style="width:416pt;height:40.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; width:367.96pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:bold;">
                <font style="letter-spacing:-0.2pt;">Balance at December&#160;31, 2021</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:0pt 0pt 1pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">13,064</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:367.96pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Impairment loss </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(13,064<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:367.96pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">Balance at September&#160;30, 2022</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:16.9pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">9.&nbsp;&nbsp;&nbsp;ACCRUED EXPENSES</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following table sets forth the composition of accrued expenses as of September&#160;30, 2022 and December&#160;31, 2021 (in thousands): </font>
        </div>
        <table style="width:416pt;height:123pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:298.99pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">September&#160;30,</font>
                <br >
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">December&#160;31,</font>
                <br >
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:298.99pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Research and development </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.35pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">1,242</td>
            <td style="padding:0pt;padding-left:7.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.94pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1,841</td>
            <td style="padding:0pt;padding-left:8.94pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:298.99pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Payroll-related expenses </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.35pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">2,043</td>
            <td style="padding:0pt;padding-left:7.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.94pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">2,967</td>
            <td style="padding:0pt;padding-left:8.94pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:298.99pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Restructuring charge related </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.35pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">6,365</td>
            <td style="padding:0pt;padding-left:7.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.94pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1,497</td>
            <td style="padding:0pt;padding-left:8.94pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:298.99pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Professional fees </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.35pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">381</td>
            <td style="padding:0pt;padding-left:7.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.94pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">597</td>
            <td style="padding:0pt;padding-left:8.94pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:298.99pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Legal expenses, including preliminary litigation settlement </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.35pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">23,720</td>
            <td style="padding:0pt;padding-left:7.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.94pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1,344</td>
            <td style="padding:0pt;padding-left:8.94pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:298.99pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Other </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.35pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">49</td>
            <td style="padding:0pt;padding-left:7.35pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.94pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">9</td>
            <td style="padding:0pt;padding-left:8.94pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:298.99pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.2pt;">Total Accrued Expenses</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.35pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24pt; text-align:right; white-space:nowrap;">33,800</td>
            <td style="padding:0pt;padding-left:7.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.94pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">8,255</td>
            <td style="padding:0pt;padding-left:8.94pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:16.9pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">10.&nbsp;&nbsp;&nbsp;COMMITMENTS AND CONTINGENCIES</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Legal Proceedings</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">From time to time, the Company may become subject to legal proceedings, claims, and litigation arising in the ordinary course of business. When the Company becomes aware of a claim or potential claim, it assesses the likelihood of any loss or exposure. In accordance with authoritative guidance, the Company records loss contingencies in its financial statements only for matters in which losses are probable and can be reasonably estimated. Where a range of loss can be reasonably estimated with no best estimate in the range, the Company records the minimum estimated liability. If the loss is not probable or the amount of </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-54</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">the loss cannot be reasonably estimated, the Company discloses the nature of the specific claim if the likelihood of a potential loss is reasonably possible, and the amount involved is material. The Company continuously assesses the potential liability related to the Company&#8217;s pending litigation and revises its estimates when additional information becomes available. The Company is not currently a party to any material legal proceedings, other than as described below. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On August&#160;19, 2021, August&#160;31, 2021, and October&#160;7, 2021, three substantially identical securities class action lawsuits captioned Bibb v. Sesen Bio, Inc., et. al., Case No. 1:21-cv-07025, Cizek v. Sesen Bio, Inc., et. al., Case No. 1:21-cv-07309, and Markman v. Sesen Bio, Inc. et al., Case No. 1:21-cv-08308 were filed against the Company and certain of its officers in the US District Court for the Southern District of New York. The three complaints alleged violations of Sections&#160;10(b) and 20(a) of the Exchange Act and Rule&#160;10b-5 promulgated thereunder based on statements made by the Company concerning its BLA for Vicineum for the treatment of BCG-unresponsive NMIBC. The three complaints sought compensatory damages and costs and expenses, including attorneys&#8217; fees. On October&#160;29, 2021, the court consolidated the three cases under the caption In re Sesen Bio, Inc. Securities Litigation, Master File No. 1:21-cv-07025-AKH (the &#8220;Securities Litigation&#8221;), and appointed Ryan Bibb, Rodney Samaan, Lionel Dreshaj and Benjamin Dreshaj (collectively, the &#8220;Lead Plaintiffs&#8221;) collectively as the lead plaintiffs under the Private Securities Litigation Reform Act. On November&#160;1, 2021, two stockholders filed motions to reconsider asking the court to appoint a different lead plaintiff. On November&#160;24, 2021, defendants filed a motion to transfer venue to the US District Court for the District of Massachusetts. That motion was fully briefed as of December&#160;13, 2021, but the court has not ruled on that motion. On December&#160;6, 2021, the Lead Plaintiffs filed an amended class action complaint (the &#8220;Amended Complaint&#8221;). The Amended Complaint alleges the same violations of Sections&#160;10(b) and 20(a) of the Exchange Act and Rule&#160;10b-5 promulgated thereunder on the same theory as the prior complaints. The defendants moved to dismiss the Amended Complaint on March&#160;7, 2022, and that motion was fully briefed on May&#160;6, 2022. On June&#160;3, 2022, before the court ruled on the motion to dismiss, the parties requested that the court hold any decision on the motion to dismiss in abeyance to provide the parties with an opportunity to engage in mediation. On June&#160;30, 2022 and July&#160;6, 2022, the Company and the plaintiffs engaged in mediation sessions in an attempt to resolve the Securities Litigation and continued to discuss a potential settlement over the following weeks. On July&#160;19, 2022, the parties reached an agreement in principle to settle the Securities Litigation. Pursuant to that agreement, the Company and the individual defendants will pay or cause to be paid to members of the class who submit timely and valid proofs of claims. In exchange, the Lead Plaintiffs will dismiss the action and all class members who do not timely and validly opt-out of the settlement will provide broad customary releases to the Company and the individual defendants. On August&#160;3, 2022, the parties entered into a Stipulation and Agreement of Settlement to settle the Securities Litigation, which was filed with the court on August&#160;17, 2022. The Stipulation and Agreement of Settlement related to the Securities Litigation provides for a settlement payment of $21.0&#160;million to the class and the dismissal of all claims against the Company and the other defendants. The settlement payment is being funded by the Company and its insurance carriers. On September&#160;1, 2022, the US District Court for the Southern District of New York issued an order denying the motions to appoint a different lead plaintiff. On September&#160;28, 2022, the court issued an order granting preliminary approval of the proposed settlement of the Securities Litigation. The court has set a final settlement approval hearing for January&#160;23, 2023 at 10:00&#160;a.m. local time. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On September&#160;20, 2021 and September&#160;24, 2021, two substantially similar derivative lawsuits captioned&#160;Myers v. Sesen Bio, Inc., et. al., Case No. 1:21-cv-11538 and D&#8217;Arcy v. Sesen Bio, Inc., et. al., Case No. 1:21-cv-11577 were filed against the Company&#8217;s board of directors and certain of its officers in the US District Court for the District of Massachusetts, with the Company named as nominal defendant. On January&#160;12, 2022, a third derivative complaint captioned Tang v. Sesen Bio, Inc., et al., was filed in Superior Court in Massachusetts against the Company&#8217;s board of directors and certain of its officers (the &#8220;State Derivative Litigation&#8221;). The three derivative complaints allege breach of fiduciary duties, waste of corporate assets, and violations of federal securities laws based on statements made by the Company concerning its BLA for Vicineum for the treatment of BCG-unresponsive NMIBC. The D&#8217;Arcy complaint further alleges unjust enrichment, abuse of control, gross mismanagement and aiding and abetting thereof. The three derivative complaints seek unspecified damages, restitution and disgorgement of profits, benefits and compensation obtained by the defendants and costs and expenses, including attorneys&#8217; fees. On October&#160;18, 2021, the court consolidated the two federal court cases under the caption In re Sesen Bio, Inc. Derivative Litigation, Lead Case No. 1:21-cv-11538 (the &#8220;Federal Derivative Litigation&#8221;). On December&#160;22, 2021, the </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-55</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">court entered a joint stipulation among the parties to stay the Federal Derivative Litigation until after a ruling on any motion to dismiss filed by defendants in the Securities Litigation. On May&#160;1, 2022, the plaintiffs filed a verified consolidated shareholder derivative complaint in the Federal Derivative Litigation. On May&#160;18, 2022, the court entered a joint stipulation among the parties to stay the State Derivative Litigation until after a ruling on any motion to dismiss filed by defendants in the Securities Litigation. On July&#160;6, 2022, the Company and the plaintiffs to the Federal Derivative Litigation and the State Derivative Litigation engaged in mediation in an attempt to resolve the litigation, with settlement discussions continuing over the following days. On July&#160;19, 2002, the parties reached an agreement in principle to settle the Federal Derivative Litigation, the State Derivative Litigation and other potential related derivative claims (collectively, the &#8220;Derivative Litigation&#8221;). Pursuant to that agreement, the individual defendants will cause the Company to adopt certain enhancements to its corporate governance policies and procedures. In exchange, plaintiffs will dismiss the Derivative Litigation and, on behalf of the Company, provide broad customary releases to the individual defendants. On August&#160;22, 2002, the parties entered into a Stipulation of Settlement to settle the Derivative Litigation, which was filed with the court on August&#160;30, 2022. The Stipulation of Settlement related to the Derivative Litigation confirms that the Company previously adopted certain corporate governance enhancements in response to, among other things, the filing of the Derivative Litigation, and that, subject to final court approval, the Company will adopt additional corporate governance enhancements. The Stipulation of Settlement also provides for a $0.6&#160;million payment for plaintiffs&#8217; attorneys fees due to the benefits the corporate governance enhancements are intended to provide to the Company. The payment of plaintiffs&#8217; attorneys fees is being funded by the Company. On September&#160;2, 2022, the court issued an order granting preliminary approval of the Stipulation of Settlement related to the Derivative Litigation. The court has set a final settlement approval hearing for November&#160;8, 2022 at 2:00&#160;p.m. local time. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">During the second quarter of 2022, the Company deemed the settlements of the Securities Litigation and the Derivative Litigation probable and amounts reasonably estimable and recorded $21.6&#160;million to litigation related liability. During the third quarter of 2022, the Company paid $0.6&#160;million to be held in escrow for the plaintiffs&#8217; attorneys fees and $21.0&#160;million remains as a litigation related liability as of September&#160;30, 2022. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company, its board of directors and the individual defendants continue to deny all allegations of any wrongdoing but are seeking to settle the Securities Litigation and the Derivative Litigation to avoid the uncertainty, risk, expense and distraction of protracted litigation. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Subsequent to September&#160;30, 2022, on October&#160;21, 2022, the Company received two separate letters and on November&#160;4, 2022, the Company received one letter from purported stockholders demanding that the Company amend the Registration Statement filed with the SEC on October&#160;14, 2022 (the &#8220;Registration Statement&#8221;) to provide additional disclosures that such stockholders allege were improperly omitted from the Registration Statement, including information regarding the financial projections for Carisma, the financial analyses performed by the Company&#8217;s financial advisor in support of its fairness opinion, and the background and process leading to the execution of the Merger Agreement. The Company believes that these demands are without merit and intends to vigorously defend against them. See discussion in Note 19. &#8220;Subsequent Events.&#8221; </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Executive Employment Agreements</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company has entered into employment agreements or offer letters with certain of its key executives, providing for separation payments and benefits in certain circumstances, as defined in the agreements. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Termination Fees associated with the Anticipated Merger with Carisma</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Merger Agreement contains certain termination rights of each of the Company and Carisma. Upon termination of the Merger Agreement under specified circumstances, the Company may be required to pay Carisma a termination fee of $7.6&#160;million and/or reimburse Carisma&#8217;s expenses up to a maximum of $1.75&#160;million, and Carisma may be required to pay the Company a termination fee of $5.49&#160;million and/or reimburse the Company expenses up to a maximum of $1.75&#160;million. At this time, no assessment can be made as to the likely outcome or whether the outcome will be material to the Company </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-56</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">11.&nbsp;&nbsp;&nbsp;LEASES</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">During the third quarter of 2022, the Company entered into a Lease Termination Agreement (the &#8220;Lease Termination Agreement&#8221;) pursuant to which the Company terminated its operating lease agreement for its 31,000 square foot facility in Winnipeg, Manitoba which consists of manufacturing, laboratory, warehouse, and office space and agreed to end the lease by September&#160;30, 2022. As part of the execution of the Lease Termination Agreement, the Company paid the landlord the all-inclusive sum of CAD $1.2&#160;million (USD $0.9&#160;million). Operating lease costs under this lease, including the related operating costs, were $81,000 and $245,000 for the three and nine&#160;months ended September&#160;30, 2022, respectively, and $79,000 and $245,000 for the three and nine&#160;months ended September&#160;30, 2021, respectively. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The right of use asset total was zero as of September&#160;30, 2022 and $123,300 as of December&#160;31, 2021. As of December&#160;31, 2021, the asset component of the Company&#8217;s operating leases was recorded as operating lease right-of-use assets and reported within other assets on the Company&#8217;s condensed consolidated&#160;balance sheets. The short-term lease liability was zero as of September&#160;30, 2022 and $123,300 as of December&#160;31, 2021. As of December&#160;31, 2021, the short-term lease liability was recorded in other current liabilities on the Company&#8217;s condensed consolidated balance sheets. There was no long-term operating lease liability as of September&#160;30, 2022 or December&#160;31, 2021. Operating lease cost is recognized on a straight-line basis over the term of the lease. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In addition, the Company has short-term property leases for modular office space for 1) its corporate headquarters in Cambridge, MA and 2) office space in Philadelphia, PA. The Company intends to terminate both leases in connection with the closing of the anticipated Merger with Carisma. The short-term lease in Philadelphia is renewed on a month-to-month basis. The short-term lease in Cambridge ends in June&#160;2023. The minimum monthly rent for these office spaces is $2,500 and $17,200, respectively, which is subject to change if and as the Company adds space to or deducts space from the leases. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">12.&nbsp;&nbsp;&nbsp;STOCKHOLDERS&#8217; EQUITY</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Equity Financings</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">ATM Offering</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company has entered into an Open Market Sale Agreement </font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">SM</font><font style="letter-spacing:0.2pt;"> with Jefferies LLC (&#8220;Jefferies&#8221;), dated November&#160;29, 2019, as amended by Amendment No. 1 dated October&#160;30, 2020, Amendment No. 2 dated February&#160;17, 2021 and Amendment No. 3, dated June&#160;1, 2021 (as amended, the &#8220;Sale Agreement&#8221;), under which the Company may issue and sell shares of its common stock, par value $0.001 per share, from time to time through Jefferies (the &#8220;ATM Offering&#8221;). In June and July&#160;2021, the Company filed prospectus supplements with the SEC in connection with the offer and sale of up to an aggregate of $200&#160;million of common stock pursuant to the Sale Agreement of which $97.8&#160;million of common stock remain available for future issuance as of September&#160;30, 2022. Sales of common stock under the Sale Agreement are made by any method that is deemed to be an ATM offering as defined in Rule&#160;415(a)(4) of the Securities Act of 1933, as amended, including but not limited to sales made directly on or through the Nasdaq Stock Market or any other existing trading market for the Company&#8217;s common stock. The Company may sell shares of its common stock efficiently from time to time but has no obligation to sell any of its common stock and may at any time suspend offers under the Sale Agreement or terminate the Sale Agreement. Subject to the terms and conditions of the Sale Agreement, Jefferies will use its commercially reasonable efforts to sell common stock from time to time, as the sales agent, based upon the Company&#8217;s instructions, which include a prohibition on sales below a minimum price set by the Company from time to time. The Company has provided Jefferies with customary indemnification rights, and Jefferies is entitled to a commission at a fixed rate equal to 3.0% of the gross proceeds for each sale of common stock under the Sale Agreement. The Company did not sell any shares of common stock pursuant to the Sale Agreement during the nine&#160;months ended September&#160;30, 2022. The Company raised $175.0&#160;million of net proceeds from the sale of 56.9&#160;million shares of common stock at a weighted-average price of $3.17 per share during the nine&#160;months ended September&#160;30, 2021. The Company raised $38.2&#160;million of net proceeds from the sale of 9.8&#160;million shares of common stock at a weighted-average price of $4.01 per share during the three&#160;months ended September&#160;30, </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-57</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">2021. Share issuance costs, including sales agent commissions, related to the ATM Offering totaled $1.2&#160;million and $5.4&#160;million during the three and nine&#160;months ended September&#160;30, 2021, respectively. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Preferred Stock</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Pursuant to its Amended and Restated Certificate of Incorporation (the &#8220;Certificate of Incorporation&#8221;), the Company is authorized to issue 5.0&#160;million shares of &#8220;blank check&#8221; preferred stock, $0.001 par value per share, which enables its board of directors, from time to time, to create one or more series of preferred stock. Each series of preferred stock issued shall have the rights, preferences, privileges and restrictions as designated by the board of directors. The issuance of any series of preferred stock could affect, among other things, the dividend, voting and liquidation rights of the Company&#8217;s common stock. The Company had no preferred stock issued and outstanding as of September&#160;30, 2022 and 2021. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Common Stock</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Following approval by the Company&#8217;s stockholders on May&#160;3, 2021, an amendment became effective to the Certificate of Incorporation that increased the number of authorized shares of common stock from 200&#160;million to 400&#160;million, of which approximately 203&#160;million and 199&#160;million shares were issued and outstanding as of September&#160;30, 2022 and December&#160;31, 2021, respectively. In addition, the Company had reserved for issuance the following amounts of shares of its common stock for the purposes described below as of September&#160;30, 2022 and December&#160;31, 2021 (in thousands): </font>
        </div>
        <table style="width:456pt;height:138pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">September&#160;30, </font>
                <br >
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">December&#160;31,</font>
                <br >
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Shares of common stock issued </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.35pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">202,757</td>
            <td style="padding:0pt;padding-left:7.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">199,464</td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:338.99pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Shares of common stock reserved for issuance for: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Warrants </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.35pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">199</td>
            <td style="padding:0pt;padding-left:7.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">199</td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Stock options </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.35pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">16,202</td>
            <td style="padding:0pt;padding-left:7.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">15,703</td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Restricted stock&#160;units </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.35pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">4,695</td>
            <td style="padding:0pt;padding-left:7.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">3,041</td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Shares available for grant under 2014 Stock Incentive Plan </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.35pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">3,725</td>
            <td style="padding:0pt;padding-left:7.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">8,933</td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Shares available for sale under 2014 Employee Stock Purchase Plan </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.35pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">2,300</td>
            <td style="padding:0pt;padding-left:7.35pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">2,300</td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:-0.2pt;">Total shares of common stock issued and reserved for issuance</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.35pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">229,878</td>
            <td style="padding:0pt;padding-left:7.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">229,640</td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:12.01pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The voting, dividend and liquidation rights of holders of shares of common stock are subject to and qualified by the rights, powers and preferences of holders of shares of preferred stock. Each share of common stock entitles the holder to one vote on all matters submitted to a vote of the Company&#8217;s stockholders; provided, however, that, except as otherwise required by law, holders of common stock shall not be entitled to vote on any amendment to the Company&#8217;s Certificate of Incorporation that relates solely to the terms of one or more outstanding series of preferred stock if the holders of such affected series are entitled, either separately or together as a class with the holders of one or more such series, to vote thereon. There shall be no cumulative voting. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Dividends may be declared and paid on the common stock from funds lawfully available thereof as and when determined by the board of directors and subject to any preferential dividend or other rights of any then-outstanding preferred stock. The Company has never declared or paid, and for the foreseeable future does not expect to declare or pay, dividends on its common stock, other than the CVR (as further described in Note 17. &#8220;License Agreements&#8221; below) and any special cash dividend that the Company may pay to its stockholders in connection with the consummation of the Merger. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Upon the dissolution or liquidation of the Company, whether voluntary or involuntary, holders of common stock will be entitled to receive all assets of the Company available for distribution to its stockholders, subject to any preferential or other rights of any then-outstanding preferred stock. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Warrants</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;font-style:italic;">
          <font style="font-style:normal;letter-spacing:0.2pt;">All of the Company&#8217;s outstanding warrants are non-tradeable and equity-classified because they meet the derivative scope exception under ASC Topic 815-40, </font><font style="letter-spacing:0.2pt;">Derivatives and Hedging&#8201;&#8212;&#8201;Contracts in Entity&#8217;s </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-58</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:42.72pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Own Equity</font><font style="letter-spacing:0.2pt;">. The following table sets forth the Company&#8217;s warrant activity for the three&#160;months ended September&#160;30, 2022 (in thousands): </font>
        </div>
        <table style="width:456pt;height:93pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:112.83pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Issued </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Exercise</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Price </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Expiration </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">December&#160;31, </font>
                <br >
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Issued </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">(Exercised) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">(Cancelled) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">September&#160;30, </font>
                <br >
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:112.83pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Mar-2018 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.209999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">0.55<font style="position:absolute;">*</font></td>
            <td style="padding:0pt;padding-left:0.209999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:30pt; text-align:right; white-space:nowrap;">Mar-2023</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">132</td>
            <td style="padding:0pt;padding-left:15.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.37pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:5.37pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.725pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:13.725pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.96pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:13.96pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.205pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">132</td>
            <td style="padding:0pt;padding-left:16.205pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:112.83pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Nov-2017 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.209999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">0.55<font style="position:absolute;">*</font></td>
            <td style="padding:0pt;padding-left:0.209999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30pt; text-align:right; white-space:nowrap;">Nov-2022</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">12</td>
            <td style="padding:0pt;padding-left:15.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.37pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:5.37pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.725pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:13.725pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.96pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:13.96pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.205pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">12</td>
            <td style="padding:0pt;padding-left:16.205pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:112.83pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">May-2015 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.209999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">11.83</td>
            <td style="padding:0pt;padding-left:0.209999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30pt; text-align:right; white-space:nowrap;">Nov-2024</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">28</td>
            <td style="padding:0pt;padding-left:15.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.37pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:5.37pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.725pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:13.725pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.96pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:13.96pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.205pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">28</td>
            <td style="padding:0pt;padding-left:16.205pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:112.83pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Nov-2014 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.209999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:17.25pt; text-align:right; white-space:nowrap;">11.04</td>
            <td style="padding:0pt;padding-left:0.209999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:30pt; text-align:right; white-space:nowrap;">Nov-2024</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.295pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:14.25pt; text-align:right; white-space:nowrap;">27</td>
            <td style="padding:0pt;padding-left:15.295pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.37pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:5.37pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.725pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:13.725pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.96pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:13.96pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.205pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">27</td>
            <td style="padding:0pt;padding-left:16.205pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 0.75pt 0pt; width:112.83pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.209999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.209999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:30pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:14.25pt; text-align:right; white-space:nowrap;">199</td>
            <td style="padding:0pt;padding-left:15.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.37pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:5.37pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.725pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:13.725pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.96pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:13.96pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.205pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">199</td>
            <td style="padding:0pt;padding-left:16.205pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:6.69pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:9.19pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">*</font>
          <br >
        </div>
        <div style=" margin-top:9.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Exercise price shown (i)&#160;reflects modification and (ii)&#160;is subject to further adjustment based on down round provision added by amendment described in &#8220;Item&#160;15. Exhibits and Financial Statement Schedules&#8201;&#8212;&#8201;Note 12. Stockholders&#8217; Equity (Deficit)&#8221; in the audited annual consolidated financial statements included in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2021. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">13.&nbsp;&nbsp;&nbsp;EARNINGS (LOSS) PER SHARE</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">A net loss cannot be diluted. Therefore, when the Company is in a net loss position, basic and diluted loss per common share are the same. If the Company achieves profitability, the denominator of a diluted earnings per common share calculation includes both the weighted-average number of shares outstanding and the number of common stock equivalents, if the inclusion of such common stock equivalents would be dilutive. Dilutive common stock equivalents potentially include warrants, stock options and unvested restricted stock awards and&#160;units using the treasury stock method, along with the effect, if any, from outstanding convertible securities. The majority of the Company&#8217;s outstanding warrants to purchase common stock have participation rights to any dividends that may be declared in the future and are therefore considered to be participating securities. Participating securities have the effect of diluting both basic and diluted earnings per share during periods of income. During periods of loss, no loss is allocated to the participating securities since the holders have no contractual obligation to share in the losses of the Company. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Additionally, an entity that presents earnings per share shall recognize the value of the effect of an anti-dilution provision in an equity-classified freestanding financial instrument in the period the anti-dilution provision is triggered. That effect shall be treated as a deemed dividend and as a reduction of income available to common stockholders in basic earnings per share. The deemed dividend is added back to income available to common stockholders when applying the treasury stock method for diluted earnings per share. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">For periods with net income, diluted net earnings per share is calculated by either (i)&#160;adjusting the weighted-average shares outstanding for the dilutive effect of common stock equivalents outstanding for the period as determined using the treasury stock method or (ii)&#160;the two-class method considering common stock equivalents, whichever is more dilutive. The two-class method is an earnings allocation formula that treats a participating security as having rights to earnings that otherwise would have been available to common stockholders. Accordingly, the Company applied the two-class method to calculate basic and diluted net earnings per share of common stock for the three&#160;months ended September&#160;30, 2022 and September&#160;30, 2021. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">For purposes of the diluted net loss per share calculation, common stock equivalents are excluded from the calculation if their effect would be anti-dilutive. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-59</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:51.3099999999999pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following table illustrates the determination of earnings (loss) per share for each period presented: </font>
        </div>
        <table style="width:456pt;height:402.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:273.17pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Three Months Ended</font>
                <br >
                <font style="letter-spacing:-0.16pt;">September&#160;30, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Nine Months Ended</font>
                <br >
                <font style="letter-spacing:-0.16pt;">September&#160;30, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:273.17pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:273.17pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="22">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">(in thousands, except per share amounts) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:273.17pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Basic Earnings (Loss) Per Share:</font>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:273.17pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Numerator: </font>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:273.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Net income (loss) </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">20,457</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">71,674</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">(12,310<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">(9,280<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:273.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Less: Income attributable to participating securities&#8201;&#8211;&#8201;basic </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">(15<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">(52<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.917pt 0pt 2.583pt 0pt; width:273.17pt;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Net income (loss) attributable to common stockholders&#8201;&#8211;&#8201;</font>
                <br >
                <font style="letter-spacing:0.2pt;">basic </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">20,442</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">71,622</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">(12,310<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">(9,280<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 1.5pt 0pt; width:273.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Denominator: </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:273.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Weighted average common shares outstanding&#8201;&#8211;&#8201;basic </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">200,464</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">196,778</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">199,801</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">176,547</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.917pt 0pt 2.583pt 0pt; width:273.17pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Net income (loss) per share applicable to common stockholders&#8201;&#8211;&#8201;basic </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">0.10</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">0.36</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">(0.06<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">(0.05<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 1.5pt 0pt; width:273.17pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Dilutive Earnings (Loss) Per Share:</font>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:273.17pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Numerator: </font>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:273.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Net income (loss) </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">20,457</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">71,674</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">(12,310<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">(9,280<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:273.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Less: Income attributable to participating securities&#8201;&#8211;&#8201;diluted </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">(15<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">(51<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.917pt 0pt 2.583pt 0pt; width:273.17pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Net income (loss) attributable to common stockholders&#8201;&#8211;&#8201; diluted </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">20,442</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">71,623</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">(12,310<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">(9,280<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 1.5pt 0pt; width:273.17pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Denominator: </font>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:273.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Weighted average shares outstanding </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">200,464</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">196,778</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">199,801</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">176,547</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:273.17pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Dilutive impact from: </font>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:273.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Stock options and employee stock purchase plan </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">20</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">4,239</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:273.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Restricted stock&#160;units &amp; performance based stock&#160;units </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">463</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:273.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Weighted average common shares outstanding&#8201;&#8211;&#8201;diluted </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">200,947</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">201,017</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">199,801</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">176,547</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.417pt 0pt 2.5pt 0pt; width:273.17pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Net income (loss) per share applicable to common stockholders&#8201;&#8211;&#8201;diluted </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.417pt 0pt 2.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.417pt 0pt 2.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">0.10</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.417pt 0pt 2.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.417pt 0pt 2.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">0.36</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.417pt 0pt 2.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.417pt 0pt 2.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">(0.06<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.417pt 0pt 2.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.417pt 0pt 2.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">(0.05<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:9.19pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The following potentially dilutive securities outstanding as of September&#160;30, 2022 and 2021 have been excluded from the denominator of the diluted loss per share of common stock outstanding calculation (in thousands): </font>
        </div>
        <table style="width:456pt;height:93pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:294.84pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Three Months Ended</font>
                <br >
                <font style="letter-spacing:-0.16pt;">September&#160;30, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Nine Months Ended</font>
                <br >
                <font style="letter-spacing:-0.16pt;">September&#160;30, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:294.84pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:294.84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Warrants </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">55</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">55</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">199</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">199</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:294.84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Stock options </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">16,182</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">11,273</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">16,202</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">15,511</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 3.25pt 0pt; width:294.84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">RSUs and PSUs </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24pt; text-align:right; white-space:nowrap;">4,232</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">
              <div style="font-weight:bold;">&#8203;</div>
            </td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">&#8212;</div>
            </td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24pt; text-align:right; white-space:nowrap;">4,695</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">
              <div style="font-weight:bold;">&#8203;</div>
            </td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">&#8212;</div>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 3.25pt 0pt; width:294.84pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Total</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24pt; text-align:right; white-space:nowrap;">20,469</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24pt; text-align:right; white-space:nowrap;">11,328</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24pt; text-align:right; white-space:nowrap;">21,096</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">15,710</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-60</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">14.&nbsp;&nbsp;&nbsp;SHARE-BASED COMPENSATION</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following table sets forth the amount of share-based compensation expense recognized by the Company by line item on its Condensed Consolidated Statements of Operations for the three and nine&#160;months ended September&#160;30, 2022 and 2021 (in thousands): </font>
        </div>
        <table style="width:456pt;height:76.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:294.84pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Three Months Ended</font>
                <br >
                <font style="letter-spacing:-0.16pt;">September&#160;30, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Nine Months Ended</font>
                <br >
                <font style="letter-spacing:-0.16pt;">September&#160;30, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:294.84pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:294.84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Research and development </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">863</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">152</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">1,838</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">536</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:294.84pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">General and administrative </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">1,305</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">1,016</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">4,026</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">2,849</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:294.84pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.2pt;">Total Share Based Compensation</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">2,168</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">1,168</td>
            <td style="padding:0pt;padding-left:0.584999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">5,864</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">3,385</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:16.9pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">2014 Stock Incentive Plan</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company&#8217;s 2014 Stock Incentive Plan, as amended (the &#8220;2014 Plan&#8221;), was adopted by its board of directors in December&#160;2013 and subsequently approved by its stockholders in January&#160;2014. The 2014 Plan became effective immediately prior to the closing of the Company&#8217;s IPO in February&#160;2014 and provides for the grant of incentive and non-qualified stock options, restricted stock awards, restricted stock&#160;units (&#8220;RSU&#8221;), stock appreciation rights and other stock-based awards, with amounts and terms of grants determined by the Company&#8217;s board of directors at the time of grant, to the Company&#8217;s employees, officers, directors, consultants and advisors. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">At the Annual Meeting of the Company&#8217;s stockholders in June&#160;2019, the Company&#8217;s stockholders approved an amendment to the 2014 Plan that (i)&#160;increased by 7.9&#160;million the number of shares of common stock reserved for issuance under the 2014 Plan and (ii)&#160;eliminated the &#8220;evergreen&#8221; or automatic replenishment provision of the 2014 Plan, pursuant to which the number of shares of common stock authorized for issuance under the 2014 Plan was automatically increased on an annual basis. At the Annual Meeting of the Company&#8217;s stockholders in May&#160;2021, the Company&#8217;s stockholders approved an amendment to the 2014 Plan that increased by 12&#160;million the number of shares of common stock reserved for issuance under the 2014 Plan. There were approximately 3.7&#160;million shares of common stock available for issuance under the 2014 Plan as of September&#160;30, 2022. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Stock options outstanding under the 2014 Plan generally vest over a four-year period at the rate of 25% of the grant vesting on the first anniversary of the date of grant and 6.25% of the grant vesting at the end of each successive three-month period thereafter. Stock options granted under the 2014 Plan are exercisable for a period of ten&#160;years from the date of grant. There were approximately 13.0&#160;million stock options outstanding under the 2014 Plan as of September&#160;30, 2022. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On September&#160;9, 2021, the Company&#8217;s board of directors and the compensation committee of the board of directors (the &#8220;Compensation Committee&#8221;) approved a retention program for all then-current employees, except for the Chief Executive Officer, pursuant to which the Company will provide certain incentives designed to retain such employees (the &#8220;2021 Retention Program&#8221;). Pursuant to the 2021 Retention Program and effective as of October&#160;1, 2021, the Company&#8217;s non-executive employees received a combination of a cash bonus award and a one-time RSU award which vested in full on September&#160;30, 2022, subject to continued employment through September&#160;30, 2022. Each RSU represents a contingent right to receive one share of the Company&#8217;s common stock. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Also pursuant to the 2021 Retention Program and effective as of October&#160;1, 2021, the Company&#8217;s executive officers, except for the Chief Executive Officer, were granted a one-time performance-based restricted stock unit (&#8220;PSU&#8221;) award equal to the value of approximately fifty&#160;percent of then-current base salary. The fair value of PSUs at the grant date was $0.4&#160;million. Each PSU represents a contingent right to receive one share of the Company&#8217;s common stock upon the satisfaction of pre-determined performance criteria. Subject to continued employment, such awards vest on September&#160;30, 2023 upon the determination by the Compensation Committee of the level of achievement of certain key milestones consisting of a clinical trial milestone, an employee retention milestone and cash management milestones. As of September&#160;30, 2022, achievement was deemed probable for only the cash management milestone, representing $87,000, </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-61</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">20% of the PSU awards. Therefore, $11,000 and $44,000 have been expensed during the three and nine&#160;months ended September&#160;30, 2022, respectively and $43,000 remains measured but unrecognized. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">2009 Stock Incentive Plan</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The Company maintains a 2009 Stock Incentive Plan, as amended and restated (the &#8220;2009 Plan&#8221;), which provided for the grant of incentive and non-qualified stock options and restricted stock awards and restricted stock&#160;units, with amounts and terms of grants determined by the Company&#8217;s board of directors at the time of grant, to its employees, officers, directors, consultants and advisors. Upon the closing of its IPO in February&#160;2014, the Company ceased granting awards under the 2009 Plan and all shares (i)&#160;available for issuance under the 2009 Plan at such time and (ii)&#160;subject to outstanding awards under the 2009 Plan that expire, terminate or are otherwise surrendered, canceled, forfeited or repurchased without having been fully exercised or resulting in any common stock being issued were carried over to the 2014 Plan. Stock options granted under the 2009 Plan are exercisable for a period of ten&#160;years from the date of grant. There were approximately 0.1&#160;million fully vested stock options outstanding under the 2009 Plan as of September&#160;30, 2022. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Out-of-Plan&#160;Inducement Grants</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">From time to time, the Company has granted equity awards to its newly hired employees, including executives, in accordance with Nasdaq employment inducement grant exemption (Nasdaq Listing Rule&#160;5635(c)(4)). Such grants are made outside of the 2014 Plan and act as an inducement material to the employee&#8217;s acceptance of employment with the Company. There were approximately 3.1&#160;million stock options outstanding which were granted as employment inducement awards outside of the 2014 Plan as of September&#160;30, 2022. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Stock Options</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The following table sets forth a summary of the Company&#8217;s total stock option activity, including&#160;awards granted under the 2014 Plan and the 2009 Plan and inducement grants made outside of stockholder approved plans, for the nine&#160;months ended September&#160;30, 2022: </font>
        </div>
        <table style="width:456pt;height:146pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:228pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Number of</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Shares under</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Option</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(in thousands) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Weighted-</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Average</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Exercise Price </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Weighted-</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Average</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Remaining</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Contractual</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Life</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(in&#160;years) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Aggregate</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Intrinsic</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Value</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(in thousands) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:228pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Outstanding at December&#160;31, 2021 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">15,703</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.505pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">1.93</td>
            <td style="padding:0pt;padding-left:12.505pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">8.03</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.59pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:12pt; text-align:right; white-space:nowrap;">82</td>
            <td style="padding:0pt;padding-left:11.59pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:228pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Granted </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">1,510</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.505pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">0.72</td>
            <td style="padding:0pt;padding-left:12.505pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.59pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:12pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.59pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:228pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Exercised </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.505pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:12.505pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.59pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:12pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.59pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:228pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Canceled or forfeited </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">(1,011<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.505pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:13.5pt; text-align:right; white-space:nowrap;">2.10</td>
            <td style="padding:0pt;padding-left:12.505pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.59pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:12pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.59pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:228pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Outstanding at September&#160;30, 2022 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">16,202</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.505pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:13.5pt; text-align:right; white-space:nowrap;">1.81</td>
            <td style="padding:0pt;padding-left:12.505pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:13.5pt; text-align:right; white-space:nowrap;">7.41</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.59pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:12pt; text-align:right; white-space:nowrap;">DM</td>
            <td style="padding:0pt;padding-left:11.59pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 3.25pt 0pt; width:228pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Exercisable at September&#160;30, 2022 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">10,494</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.505pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:13.5pt; text-align:right; white-space:nowrap;">1.72</td>
            <td style="padding:0pt;padding-left:12.505pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:13.5pt; text-align:right; white-space:nowrap;">6.94</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.59pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:12pt; text-align:right; white-space:nowrap;">DM</td>
            <td style="padding:0pt;padding-left:11.59pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:14.19pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The Company recognized share-based compensation expense, related to stock options, of $1.0&#160;million and $3.5&#160;million for the three and nine&#160;months ended September&#160;30, 2022, respectively and $1.2&#160;million and $3.4&#160;million for the three and nine&#160;months ended September&#160;30, 2021, respectively. As of September&#160;30,&#160;2022, there was $6.4&#160;million of total unrecognized compensation cost related to unvested stock options which the Company expects to recognize over a weighted-average period of 2.09&#160;years. The weighted-average grant-date fair value of stock options granted during the nine&#160;months ended September&#160;30, 2022 and 2021 were $0.46 and $2.20, respectively. No stock options were exercised during the nine&#160;months ended September&#160;30, 2022. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-62</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11pt;">
          <font style="letter-spacing:0.2pt;">For the nine&#160;months ended September&#160;30, 2022 and 2021, the grant-date fair value of stock options was determined using the following weighted-average inputs and assumptions in the Black-Scholes option pricing model: </font>
        </div>
        <table style="width:416pt;height:107.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:297.17pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">September&#160;30,</font>
                <br >
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">September&#160;30,</font>
                <br >
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:297.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Fair market value </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.35pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">0.72</td>
            <td style="padding:0pt;padding-left:12.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.35pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">3.40</td>
            <td style="padding:0pt;padding-left:12.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:297.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Grant exercise price </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.35pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">0.72</td>
            <td style="padding:0pt;padding-left:12.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.35pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">3.40</td>
            <td style="padding:0pt;padding-left:12.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:297.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Expected term (in&#160;years) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.35pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">6.0</td>
            <td style="padding:0pt;padding-left:12.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.35pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">6.03</td>
            <td style="padding:0pt;padding-left:12.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:297.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Risk-free interest rate </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.35pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">2.1<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:12.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.35pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">0.9<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:12.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:297.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Expected volatility </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.35pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">71.8<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:12.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.35pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">74.6<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:12.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:297.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Dividend yield </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.35pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:12.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.35pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:12.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:11.4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Restricted Stock Units and Performance Stock Units</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11pt;">
          <font style="letter-spacing:0.2pt;">The following table sets forth a summary of the Company&#8217;s RSU and PSU activity for the nine&#160;months ended September&#160;30, 2022: </font>
        </div>
        <table style="width:416pt;height:117pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:284.34pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Restricted Stock </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Units</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(in thousands) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Weighted</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Average Grant</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Date Fair Value </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:284.34pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Unvested at December&#160;31, 2021 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.465pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">3,041</td>
            <td style="padding:0pt;padding-left:14.465pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.99pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">0.80</td>
            <td style="padding:0pt;padding-left:14.99pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:284.34pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Granted RSU </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.465pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">4,160</td>
            <td style="padding:0pt;padding-left:14.465pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.99pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">0.68</td>
            <td style="padding:0pt;padding-left:14.99pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:284.34pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Cancelled RSU </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.465pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">(217<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:14.465pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.99pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">0.75</td>
            <td style="padding:0pt;padding-left:14.99pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:284.34pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Released RSU </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.465pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">(3,293<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:14.465pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.99pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">0.76</td>
            <td style="padding:0pt;padding-left:14.99pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:284.34pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Granted PSU </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.465pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">1,004</td>
            <td style="padding:0pt;padding-left:14.465pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.99pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:13.5pt; text-align:right; white-space:nowrap;">0.67</td>
            <td style="padding:0pt;padding-left:14.99pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:284.34pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Unvested at September&#160;30, 2022 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.465pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">
              <div style="font-weight:bold;">&#8203;</div>
            </td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">4,695</div>
            </td>
            <td style="padding:0pt;padding-left:14.465pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.99pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:13.5pt; text-align:right; white-space:nowrap;">0.68</td>
            <td style="padding:0pt;padding-left:14.99pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:12.4pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company did not grant any RSUs or PSUs during the nine&#160;months ended September&#160;30, 2021. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11pt;">
          <font style="letter-spacing:0.2pt;">The share-based compensation expense related to RSUs and PSUs for the three and nine&#160;months ended September&#160;30, 2022 was $1.2&#160;million and $2.4&#160;million, respectively. There was no shared-based compensation expense related to RSUs and PSUs for the three and nine&#160;months ended September&#160;30, 2021. As of September&#160;30, 2022, there was $1.8&#160;million of total unrecognized compensation cost related to unvested RSUs and PSUs. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">15.&nbsp;&nbsp;&nbsp;EMPLOYEE BENEFIT PLANS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">2014 Employee Stock Purchase Plan</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company&#8217;s 2014 Employee Stock Purchase Plan (&#8220;2014 ESPP&#8221;) was adopted by its board of directors in December&#160;2013 and subsequently approved by its stockholders in January&#160;2014. The 2014 ESPP became effective immediately prior to the closing of the Company&#8217;s IPO in February&#160;2014 and established an initial reserve of 0.2&#160;million shares of the Company&#8217;s common stock for issuance to participating employees. At the Annual Meeting of the Company&#8217;s stockholders in May&#160;2021, the Company&#8217;s stockholders approved an amendment to the 2014 ESPP that increased by 2.3&#160;million the number of shares of common stock reserved for issuance under the 2014 ESPP. The purpose of the 2014 ESPP is to enhance employee interest in the success and progress of the Company by encouraging employee ownership of common stock of the Company. The 2014 ESPP provides employees with the opportunity to purchase shares of common stock at a 15% discount to the market price through payroll deductions or lump sum cash investments. The Company estimates the number of shares to be issued at the end of an offering period and recognizes expense over the requisite service period. Shares of the common stock issued and sold pursuant to the 2014 ESPP are shown on the condensed consolidated statements of changes in stockholders&#8217; equity (deficit). As of September&#160;30, 2022, there were 2.3&#160;million shares of common stock available for sale under the 2014 ESPP. The Company did not sell any shares under the ESPP during the nine&#160;months ended September&#160;30, 2022 and 2021. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-63</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Defined Contribution Plans</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">United States&#8201;&#8212;&#8201;401(k) Plan</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company maintains a 401(k) defined contribution retirement plan which covers all of its US employees. Employees are eligible to participate on the first of the month following their date of hire. Under the 401(k) plan, participating employees may defer up to 100% of their pre-tax salary, subject to certain statutory limitations. Employee contributions vest immediately. The plan allows for a discretionary match per participating employee up to a maximum of $4,000 per year. The expenses incurred for the periods presented were de minimis amount for each of the nine&#160;months ended September&#160;30, 2022 and 2021, respectively. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Canada&#8201;&#8212;&#8201;Defined Contribution Plan</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company maintains a defined contribution plan for its Canadian employees. Participants may contribute a&#160;percentage of their annual compensation to this plan, subject to statutory limitations. The Company contributes up to the first 4% of eligible compensation for its Canadian-based employees to the retirement plan. The expenses incurred for the periods presented were de minimis amount for each of the nine&#160;months ended September&#160;30, 2022 and 2021, respectively. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">16.&nbsp;&nbsp;&nbsp;INCOME TAXES</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following table sets forth the components of the Company&#8217;s loss before income taxes by country (in thousands): </font>
        </div>
        <table style="width:456pt;height:91.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:359.93pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Nine Months Ended</font>
                <br >
                <font style="letter-spacing:-0.16pt;">September&#160;30, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:359.93pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:359.93pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Country: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:359.93pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">United States </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(32,083<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(38,864<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:359.93pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Canada </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">15,898</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">21,311</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:359.93pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:-0.2pt;">Total loss before income taxes</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(16,185<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(17,553<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-left:20pt; margin-top:13pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company&#8217;s tax benefit (provision) is comprised of the following components (in thousands): </font>
        </div>
        <table style="width:456pt;height:106.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:376.59pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Nine Months Ended</font>
                <br >
                <font style="letter-spacing:-0.16pt;">September&#160;30, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:376.59pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:376.59pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Current tax benefit (provision) </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:376.59pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Federal </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">8,559</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:376.59pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">State </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:376.59pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Foreign </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">3,875</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">(286<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:376.59pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:-0.2pt;">Total current benefit</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">3,875</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">8,273</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-left:20pt; margin-top:13pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company&#8217;s deferred tax liability is comprised of the following: </font>
        </div>
        <table style="width:456pt;height:63pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">September&#160;30,</font>
                <br >
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">December&#160;31, </font>
                <br >
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:338.99pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Deferred tax liabilities </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.705pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.705pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">IPR&amp;D </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.705pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:14.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:13.705pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.275pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">(3,969<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:7.275pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:-0.2pt;">Total deferred tax liabilities</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.705pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:14.25pt; text-align:right; white-space:nowrap;">&#8199;&#8212;</td>
            <td style="padding:0pt;padding-left:13.705pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.275pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">(3,969<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:7.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:13pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">For the nine&#160;months ended September&#160;30, 2022, the Company recorded a benefit from income taxes of $3.9&#160;million. In the second quarter of 2022, the Company determined that the fair value of the Vicineum EU rights was zero, which resulted in an impairment charge of $14.7&#160;million. In connection with this </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-64</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">impairment charge, the Company reversed the associated deferred tax liability by $4.0&#160;million as an income tax benefit, partially offset by $0.1&#160;million income tax paid to foreign jurisdictions pursuant to the Qilu License Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">During the nine&#160;months ended September&#160;30, 2021, the Company recorded a benefit from income&#160;taxes of $8.3&#160;million. In the third quarter of 2021, the Company determined that the fair value of the Vicineum US rights was zero, which resulted in an impairment charge of $31.7&#160;million. In connection with this impairment charge, in the third quarter of 2021, the Company wrote-down the associated deferred tax liability by $8.6&#160;million as a benefit. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">17.&nbsp;&nbsp;&nbsp;LICENSE AGREEMENTS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">In-License Agreements</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">License Agreement with Zurich</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company has a license agreement with the University of Zurich (&#8220;Zurich&#8221;) which grants the Company exclusive license rights, with the right to sublicense, to make, have made, use and sell under certain patents primarily directed to the Company&#8217;s targeting agent, including an EpCAM chimera and related immunoconjugates and methods of use and manufacture of the same (the &#8220;Zurich License Agreement&#8221;). These patents cover some key aspects of Vicineum. The Company&#8217;s receipt of the Complete Response Letter (&#8220;CRL&#8221;) regarding the BLA for Vicineum for the treatment of BCG-unresponsive NMIBC triggered a $0.5&#160;million milestone payment to Zurich. Under the Zurich License Agreement, as of September&#160;30, 2022, the Company is also obligated to pay up to a 4% royalty on the net product sales for products covered by or manufactured using a method covered by a valid claim in the Zurich patent rights, which includes Vicineum. Royalties owed to Zurich will be reduced if the total royalty rate owed by the Company to Zurich and any other third party is 10% or greater, provided that the royalty rate to Zurich&#160;may not be less than 2% of net sales. The obligation to pay royalties in a particular country expires upon the expiration or termination of the last of the Zurich patent rights that covers the manufacture, use or sale of a product. There is no obligation to pay royalties in a country if there is no valid claim that covers the product or a method of manufacturing the product. The Company recorded an expense of $0.3&#160;million and $0.5&#160;million related to meeting a development milestone, the submission of the Company&#8217;s BLA with the FDA in December&#160;2020, in the fourth quarter of 2020, and a regulatory milestone, the Company&#8217;s receipt of the CRL from the FDA in August&#160;2021, in the third quarter of 2021, respectively. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">License Agreement with Micromet</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company has a License Agreement with Micromet AG (&#8220;Micromet&#8221;), now part of Amgen, Inc., which grants it nonexclusive rights, with certain sublicense rights, for know-how and patents allowing exploitation of certain single chain antibody products (the &#8220;Micromet License Agreement&#8221;). These patents cover some key aspects of Vicineum. Under the terms of the Micromet License Agreement, as of September&#160;30, 2022, the Company may be obligated to pay up to &euro;2.4&#160;million in milestone payments for the first product candidate that achieves applicable regulatory and sales-based development milestones (approximately $2.4&#160;million at exchange rates in effect on September&#160;30, 2022). The Company is also&#160;required to pay up to a 3.5% royalty on the net sales for products covered by the agreement, which includes Vicineum. The royalty rate owed to Micromet in a particular country will be reduced to 1.5% if there are no valid claims covering the product in that country. The obligation to pay royalties in a particular country expires upon the later of the expiration date of the last valid claim covering the product and the tenth anniversary of the first commercial sale of the product in such country. Finally, the Company is required to pay to&#160;Micromet an annual license maintenance fee of &euro;50,000 (approximately $48,987 at exchange rates in effect as of September&#160;30, 2022), that can be credited towards any royalty payment the Company owes to Micromet. The Company recorded an expense of &euro;0.7&#160;million ($0.9&#160;million) related to achievement of a development milestone in the three&#160;months ended December&#160;31, 2020, due to the submission of the Company&#8217;s BLA for Vicineum with the FDA in December&#160;2020. The Company recorded an expense of &euro;0.5&#160;million ($0.6&#160;million) related to the submission of marketing authorization application (the &#8220;MAA&#8221;) to the European Medicines Agency (the &#8220;EMA&#8221;) for Vysyneum&#8482; in the first quarter of 2021. Vysyneum is the proprietary brand name that was conditionally approved by the EMA for oportuzumab monatox in the EU. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-65</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">License Agreement with XOMA</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company has a license agreement with XOMA Ireland Limited (&#8220;XOMA&#8221;) which grants it non-exclusive rights to certain XOMA patent rights and know-how related to certain expression technology, including plasmids, expression strains, plasmid maps and production systems (the &#8220;XOMA License Agreement&#8221;). These patents and related know-how cover some key aspects of Vicineum. Under the terms of the XOMA License Agreement, the Company is required to pay up to $0.25&#160;million in milestone payments for a product candidate that incorporates know-how under the license and achieves applicable clinical development milestones. The Company is also required to pay a 2.5% royalty on the net sales for products incorporating XOMA&#8217;s technology, which includes Vicineum. The Company has the right to reduce the amount of royalties owed to XOMA on a country-by-country basis by the amount of royalties paid to other third parties, provided that the royalty rate to XOMA may not be less than 1.75% of net sales. In addition, the foregoing royalty rates are reduced by 50% with respect to products that are not covered by a valid patent claim in the country of sale. The obligation to pay royalties in a particular country expires upon the later of the expiration date of the last valid claim covering the product and the tenth anniversary of the first commercial sale of the product in such country. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Out-License Agreements</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Roche License Agreement</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In June&#160;2016, the Company entered into the license agreement with Roche (the &#8220;Roche License Agreement&#8221;), pursuant to which the Company granted Roche an exclusive, worldwide license, including the&#160;right to sublicense, to its patent rights and know-how related to the Company&#8217;s monoclonal antibody EBI-031 and all other IL-6 antagonist monoclonal antibody technology owned by the Company (collectively, the &#8220;Roche Licensed Intellectual Property&#8221;). Under the Roche License Agreement, Roche was required to continue developing, at its cost, EBI-031 and any other product made from the Roche Licensed Intellectual Property that contains an IL-6 antagonist monoclonal antibody and pursue ongoing patent prosecution, at its cost. For additional information regarding the Roche License Agreement, see Note 17. &#8220;License Agreements&#8221; in the Notes to Condensed Consolidated Financial Statements in the Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended June&#160;30, 2022. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On July&#160;15, 2022, the Company entered into an asset purchase agreement with Roche (the &#8220;Roche Asset Purchase Agreement&#8221;) pursuant to which Roche purchased all patent rights and know-how related to the monoclonal antibody EBI-031 and all other IL-6 antagonist monoclonal antibody technology owned by the Company for up to $70&#160;million. As a result of the Roche Asset Purchase Agreement, the Roche License Agreement was terminated resulting in no further diligence, milestone or royalty payment obligations under the Roche License Agreement. Pursuant to the Roche Asset Purchase Agreement, Roche made a $40&#160;million payment to the Company upon execution of the Roche Asset Purchase Agreement, which was recorded as license revenue in the third quarter of 2022. The Roche Asset Purchase Agreement also provides that Roche will make an additional $30&#160;million payment to the Company upon Roche&#8217;s initiation of a Phase&#160;3 clinical trial with EBI-031 for a defined indication if initiated prior to December&#160;31, 2026. Pursuant to ASC 606, the variable consideration of $30&#160;million is constrained. Therefore, the amount was not recorded as revenue during the third quarter of 2022. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Additionally, at or prior to the effective time of the Merger, the Company will enter into a Contingent Value Rights Agreement (the &#8220;CVR Agreement&#8221;) with a rights agent (&#8220;Rights Agent&#8221;) pursuant to which the Company intends to declare a dividend payable to the Company&#8217;s stockholders of record as of a date agreed to by the Company and Carisma prior to the effective time of the Merger with respect to the receipt of one contingent value right (each, a &#8220;CVR&#8221;) for each outstanding share of the Company&#8217;s common stock held by such stockholders on such date. Each CVR will represent the contractual right to receive contingent cash payments upon the receipt by the Company of certain proceeds payable by Roche, if any, pursuant to the Roche Asset Purchase Agreement, upon the achievement by Roche of a specified milestone set forth in the Roche Asset Purchase Agreement, subject to certain customary deductions, including for expenses and taxes. The contingent payments under the CVR Agreement, if they become due, will be payable to the Rights Agent for subsequent distribution to the holders of the CVRs. In the event that no such proceeds are </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-66</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">received, holders of the CVRs will not receive any payment pursuant to the CVR Agreement. There can be no assurance that any cash payment will be made or that any holders of CVRs will receive any amounts with respect thereto. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">OUS Business Development Partnership Agreements</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Qilu License Agreement</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On July&#160;30, 2020, the Company and its wholly-owned subsidiary, Viventia Bio, Inc., entered into the Qilu License Agreement pursuant to which the Company granted Qilu an exclusive, sublicensable, royalty-bearing license, under certain intellectual property owned or exclusively licensed by the Company, to develop, manufacture and commercialize Vicineum (the &#8220;Qilu Licensed Product&#8221;) for the treatment of NMIBC and other types of cancer (the &#8220;Field&#8221;) in China, Hong Kong, Macau and Taiwan (&#8220;Greater China&#8221;). The Company also granted Qilu a non-exclusive, sublicensable, royalty-bearing sublicense, under certain other intellectual property licensed by the Company to develop, manufacture and commercialize the Qilu Licensed Product in Greater China. The Company retains (i)&#160;development, and commercialization rights in the rest of the world, excluding Greater China and (ii)&#160;manufacturing rights with respect to Vicineum in the rest of the world, excluding China. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In consideration for the rights granted by the Company, Qilu agreed to pay to the Company a one-time upfront cash payment of $12&#160;million, and milestone payments totaling up to $23&#160;million upon the achievement of certain technology transfer, development and regulatory milestones. All payments were to be inclusive of VAT, which can be withheld by Qilu upon payment, and for which future recovery of such taxes may be available. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Qilu also agreed to pay the Company a 12% royalty based upon annual net sales of Qilu Licensed Products in Greater China. The royalties are payable on a Qilu Licensed Product-by-Licensed Product and region-by-region basis commencing on the first commercial sale of a Qilu Licensed Product in a region and continuing until the latest of (i)&#160;twelve&#160;years after the first commercial sale of such Qilu Licensed Product in such region, (ii)&#160;the expiration of the last valid patent claim covering or claiming the composition of matter, method of treatment, or method of manufacture of such Qilu Licensed Product in such region, and (iii)&#160;the expiration of regulatory or data exclusivity for such Qilu Licensed Product in such region (collectively, the &#8220;Royalty Terms&#8221;). The royalty rate is subject to reduction under certain circumstances, including when there is no valid claim of a licensed patent that covers a Qilu Licensed Product in a particular region or no data or regulatory exclusivity of a Qilu Licensed Product in a particular region. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Qilu is responsible for all costs related to developing, obtaining regulatory approval of and commercializing the Qilu Licensed Products in the Field in Greater China. Qilu is required to use commercially reasonable efforts to develop, seek regulatory approval for, and commercialize at least one Qilu Licensed Product in the Field in Greater China. A joint development committee was established between the Company and Qilu to coordinate and review the development, manufacturing and commercialization plans with respect to the Qilu Licensed Products in Greater China. The Company and Qilu also executed the terms and conditions of a supply agreement and related quality agreement pursuant to which the Company will manufacture or have manufactured and supply Qilu with all quantities of the Qilu Licensed Product necessary for Qilu to develop and commercialize the Qilu Licensed Product in the Field in Greater China until the Company has completed manufacturing technology transfer to Qilu and approval of a Qilu manufactured product by the National Medical Products Administration in China (&#8220;NMPA&#8221;) for the Qilu Licensed Product has been obtained. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Qilu License Agreement will expire on a Qilu Licensed Product-by-Licensed Product and region-by-region basis on the date of the expiration of all applicable Royalty Terms. Either party may terminate the Qilu License Agreement for the other party&#8217;s material breach following a cure period or upon certain insolvency events. Qilu has the right to receive a refund of all amounts paid to the Company in the event the Qilu License Agreement is terminated under certain circumstances. The Qilu License Agreement includes customary representations and warranties, covenants and indemnification obligations for a transaction of this nature. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-67</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Qilu License Agreement is subject to the provisions of ASC Topic 606, </font><font style="font-style:italic;letter-spacing:0.2pt;">Revenue</font><font style="letter-spacing:0.2pt;">. In 2020, the initial transaction price was estimated to be $11.2&#160;million and was based on the up-front fixed consideration of $12&#160;million less amounts withheld for VAT. The Company concluded that its agreements under the Qilu License Agreement represented one bundled performance obligation that had been achieved as of September&#160;30, 2020. As such, $11.2&#160;million of the total $11.2&#160;million transaction price was considered earned and the Company recorded $11.2&#160;million of revenue during the three-month period ended September&#160;30, 2020. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Investigational New Drug application for Vicineum submitted by Qilu to the Center for Drug Evaluation of the NMPA was accepted for review in January&#160;2021 and approved in March&#160;2021, resulting in a $3&#160;million milestone payment from Qilu, the first milestone payment out of the $23&#160;million in potential milestone payments. The Company recorded $2.8&#160;million (net of VAT) as license revenue during the three-month period ended March&#160;31, 2021. The Company received the payment in 2021. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In June&#160;2021, the Qilu License Agreement was recognized by Shandong Province, Bureau of Science and Technology as a &#8220;Technology Transfer&#8221;. An agreement that is designated as a Technology Transfer shall be entitled to a tax incentive of VAT recovery. As such, the Company recorded $0.9&#160;million of revenue during the three&#160;months ended June&#160;30, 2021 for additional purchase price resulting from Qilu&#8217;s obligation to pay Sesen Bio an amount equal to its recovery of VAT. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">MENA License Agreement</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On November&#160;30, 2020, the Company entered into a license agreement with a third party pursuant to which the Company granted an exclusive, sublicensable, royalty-bearing license, under certain intellectual property owned or exclusively licensed by the Company, to commercialize Vicineum in the Middle East and North Africa region (&#8220;MENA&#8221;) (the &#8220;MENA License Agreement&#8221;). In consideration for the rights granted by the Company, the counterparty to the MENA License Agreement agreed to pay to the Company an upfront payment of $3&#160;million, which would be subject to certain tax withholdings. In addition, the counterparty agreed to pay to the Company milestone payments upon the achievement of certain sales-based milestones as well as a royalty based upon annual net sales in the MENA region for the term of the MENA License Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On July&#160;20, 2022, the Company provided notice of termination of the MENA License Agreement as a result of the Company&#8217;s strategic decision to voluntarily pause further development of Vicineum in the US. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">EIP License Agreement</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On August&#160;5, 2021, the Company entered into an exclusive license agreement with E&#304;P Eczac&#305;ba&#351;&#305; &#304;la&#231; Pazarlama A.&#350;., (&#8220;EIP&#8221;) pursuant to which it granted EIP an exclusive license to register and commercialize Vicineum for the treatment of BCG-unresponsive NMIBC in Turkey and Northern Cyprus (the &#8220;EIP License Agreement&#8221;). Under the terms of the EIP License Agreement, the Company was entitled to receive an upfront payment of $1.5&#160;million. The Company and EIP have amended the license agreement to defer EIP&#8217;s payment of the upfront payment to coincide with the potential FDA approval of Vicineum. The Company would be eligible to receive additional regulatory and commercial milestone payments of $2.0&#160;million and also to receive a 30% royalty on net sales in Turkey and Northern Cyprus. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On July&#160;20, 2022, the Company provided notice of termination of the EIP License Agreement as a result of the Company&#8217;s strategic decision to voluntarily pause further development of Vicineum in the US. The EIP License Agreement was terminated on October&#160;20, 2022. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">18.&nbsp;&nbsp;&nbsp;RESTRUCTURING AND RELATED ACTIVITIES</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On July&#160;15, 2022, the Company approved a restructuring plan to reduce operating expenses and better align its workforce with the needs of its business following the decision to voluntarily pause further development of Vicineum in the US (the &#8220;2022 Restructuring Plan&#8221;). Execution of the 2022 Restructuring Plan is expected to be substantially completed in connection with the closing of the Merger with Carisma, which is expected to occur approximately two to three&#160;months from the date of this Form 10-Q filing, November&#160;7, 2022. The 2022 Restructuring Plan includes an incremental reduction in the Company&#8217;s </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-68</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC4">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:228.5pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">workforce as well as additional cost-saving initiatives intended to preserve capital during the pendency of the Merger with Carisma and while the Company seeks a potential partner for the further development of Vicineum. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company also incurred one-time cash costs associated with the termination of certain contracts and all other activities under the 2022 Restructuring Plan. The following is a summary of accrued restructuring costs related to the 2022 Restructuring Plan, (in thousands): </font>
        </div>
        <table style="width:456pt;height:84.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:363.36pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;text-align:center;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2022 Restructuring Plan </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:363.36pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Severance and benefits costs </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:23.965pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">6,944</td>
            <td style="padding:0pt;padding-left:23.965pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:363.36pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Contract termination and other associated costs </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:23.965pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">4,003</td>
            <td style="padding:0pt;padding-left:23.965pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:363.36pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Total restructurings costs </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:23.965pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">10,947</td>
            <td style="padding:0pt;padding-left:23.965pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:363.36pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Cash payments </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:23.965pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">(4,582<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:23.965pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:363.36pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:bold;">
                <font style="letter-spacing:-0.2pt;">Balance at September&#160;30, 2022</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:23.965pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">6,365</td>
            <td style="padding:0pt;padding-left:23.965pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:13pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Restructuring costs related to the Restructuring Plan were recorded in operating expenses in the Company&#8217;s Condensed Consolidated Statements of Income (Operations) and Comprehensive Income (Loss) in the three&#160;months ended September&#160;30, 2022. The Company expects that substantially all of the accrued restructuring costs as of September&#160;30, 2022 will be paid in cash in connection with the closing of the Merger with Carisma, which is expected to occur approximately two to three&#160;months from the date of this Form 10-Q filing, November&#160;7, 2022. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">19.&nbsp;&nbsp;&nbsp;SUBSEQUENT EVENTS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On October&#160;21, 2022, the Company received two separate letters and on November&#160;4, 2022, the Company received one letter from purported stockholders demanding that the Company amend the Registration Statement filed with the SEC on October&#160;14, 2022 to provide additional disclosures that such stockholders allege were improperly omitted from the Registration Statement, including information regarding the financial projections for Carisma, the financial analyses performed by the Company&#8217;s financial advisor in support of its fairness opinion, and the background and process leading to the execution of the Merger Agreement. The Company believes that these demands are without merit and intends to vigorously defend against them. At this time, no assessment can be made as to the likely outcome or whether the outcome will be material to the Company.</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-69</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a><a name="TOC5">&#8203;</a><a name="fISCS">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:351.5pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">INDEX TO CARISMA&#8217;S CONSOLIDATED FINANCIAL STATEMENTS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:239.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:424pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;text-align:center;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Page </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:424pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Audited Consolidated Financial Statements</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:424pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tROIR1"><font style="letter-spacing:0.2pt;">Report of Independent Registered Public Accounting Firm </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tROIR1">F-71</a></font> <a href="#tROIR1"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:424pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tCBS1"><font style="letter-spacing:0.2pt;">Consolidated Balance Sheets, December&#160;31, 2021 and 2020 </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tCBS1">F-72</a></font> <a href="#tCBS1"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:424pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tCSOO1"><font style="letter-spacing:0.2pt;">Consolidated Statements of Operations, Years Ended December&#160;31, 2021 and 2020 </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tCSOO1">F-73</a></font> <a href="#tCSOO1"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:424pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <a href="#tCSOC2"><font style="letter-spacing:0.2pt;">Consolidated Statements of Convertible Preferred Stock and Stockholders&#8217; Deficit, Years ended December&#160;31, 2021 and 2020 </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tCSOC2">F-74</a></font> <a href="#tCSOC2"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:424pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tCSOC3"><font style="letter-spacing:0.2pt;">Consolidated Statements of Cash Flows, Years ended December&#160;31, 2021 and 2020 </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tCSOC3">F-75</a></font> <a href="#tCSOC3"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:424pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tNTTC"><font style="letter-spacing:0.2pt;">Notes to Consolidated Financial Statements </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tNTTC">F-76</a></font> <a href="#tNTTC"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:424pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Unaudited Interim Consolidated Financial Statements</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:424pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tUCBS"><font style="letter-spacing:0.2pt;">Consolidated Balance Sheets, September&#160;30, 2022 and December&#160;31, 2021 </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tUCBS">F-89</a></font> <a href="#tUCBS"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:424pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <a href="#tUCSO"><font style="letter-spacing:0.2pt;">Consolidated Statements of Operations and Comprehensive Loss, Nine Months Ended September&#160;30, 2022 and 2021 </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tUCSO">F-90</a></font> <a href="#tUCSO"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:424pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <a href="#tUCSO1"><font style="letter-spacing:0.2pt;">Consolidated Statements of Convertible Preferred Stock and Stockholders&#8217; Deficit, Nine Months Ended September&#160;30, 2022 and 2021 </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tUCSO1">F-91</a></font> <a href="#tUCSO1"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:424pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tUCSO2"><font style="letter-spacing:0.2pt;">Consolidated Statements of Cash Flows, Nine Months Ended September&#160;30, 2022 and 2021 </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tUCSO2">F-92</a></font> <a href="#tUCSO2"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:424pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tNTTI"><font style="letter-spacing:0.2pt;">Notes to Interim Consolidated Financial Statements </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tNTTI">F-93</a></font>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-70</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC5">TABLE OF CONTENTS</a><a name="tROIR1">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Report of Independent Registered Public Accounting Firm</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">To the Stockholders and Board of Directors</font> <br ><font style="letter-spacing:0.2pt;">CARISMA Therapeutics Inc.: </font></div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Opinion on the Consolidated Financial Statements </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We have audited the accompanying consolidated balance sheets of CARISMA Therapeutics Inc. and subsidiary (the Company) as of December&#160;31, 2021 and 2020, the related consolidated statements of operations, convertible preferred stock and stockholders&#8217; deficit, and cash flows for the&#160;years then ended, and the related notes (collectively, the consolidated financial statements). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December&#160;31, 2021 and 2020, and the results of its operations and its cash flows for the&#160;years then ended, in conformity with U.S. generally accepted accounting principles. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Going Concern </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 2 to the consolidated financial statements, the Company has incurred losses and negative cash flows from operations since inception that raise substantial doubt about its ability to continue as a going concern. Management&#8217;s plans in regard to these matters are also described in Note 2. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Basis for Opinion </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">These consolidated financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on these consolidated financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We conducted our audits in accordance with the standards of the PCAOB and in accordance with auditing standards generally accepted in the United States of America. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Critical Audit Matters </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Critical audit matters are matters arising from the current period audit of the consolidated financial statements that were communicated or required to be communicated to the audit committee and that: (1)&#160;relate to accounts or disclosures that are material to the consolidated financial statements and (2)&#160;involved our especially challenging, subjective, or complex judgments. We determined that there are no critical audit matters. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">/s/ KPMG LLP </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We have served as the Company&#8217;s auditor since 2018. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Philadelphia, Pennsylvania</font> <br ><font style="letter-spacing:0.2pt;">October 14, 2022</font></div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-71</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC5">TABLE OF CONTENTS</a><a name="tCBS1">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:6.00999999999999pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CARISMA THERAPEUTICS INC.</font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Consolidated Balance Sheets </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(in thousands, except share and per share data)</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:569pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:358.26pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:358.26pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:358.26pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Assets</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:358.26pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Current assets: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:358.26pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Cash and cash equivalents </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">28,551</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">51,788</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:358.26pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Prepaid expenses and other assets </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">1,235</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">1,277</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:358.26pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Total current assets </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">29,786</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">53,065</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:358.26pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Property and equipment, net </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">3,084</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">1,774</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:358.26pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Right of use assets&#8201;&#8211;&#8201;operating leases </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">2,579</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">3,413</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:358.26pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Other assets </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">211</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:358.26pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Total assets </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">35,449</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">58,463</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 1.5pt 0pt; width:358.26pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Liabilities, Convertible Preferred Stock and Stockholders&#8217; Deficit</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:358.26pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Current liabilities: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:358.26pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Accounts payable </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">2,322</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">3,293</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:358.26pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Accrued expenses </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">4,471</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">1,573</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:358.26pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Operating lease liabilities </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">898</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">813</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:358.26pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Total current liabilities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">7,691</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">5,679</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:358.26pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Operating lease liabilities </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">1,734</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">2,632</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.25pt 0pt 2.5pt 0pt; width:358.26pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Total liabilities </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">9,425</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">8,311</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:358.26pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Commitments and Contingencies (Note 6) </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:358.26pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Convertible preferred stock, $0.0001 par value: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:358.26pt;text-align:left;">
              <div style="margin-left:20pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Series&#160;A convertible preferred stock, 6,138,518 shares authorized; 5,201,017 shares </font>
                <br >
                <font style="letter-spacing:0.2pt;">issued and outstanding (liquidation value of $54,091 at December&#160;31, 2021) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">53,577</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">53,577</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:358.26pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Special voting preferred stock, 1 share authorized, issued and outstanding </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:358.26pt;white-space:normal;text-align:left;">
              <div style="margin-left:20pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Series&#160;B convertible preferred stock, 4,807,541 shares authorized, 3,499,866 and 2,453,170 shares issued and outstanding as of December&#160;31, 2021 and 2020, respectively (liquidation value of $54,598 at December&#160;31, 2021) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">54,231</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">38,054</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:2.167pt 0pt 1.833pt 0pt; width:358.26pt;text-align:left;">
              <div style="margin-left:20pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Series&#160;B special voting preferred stock, 1 share authorized, issued and </font>
                <br >
                <font style="letter-spacing:0.2pt;">outstanding </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.25pt 0pt 2.5pt 0pt; width:358.26pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Total convertible preferred stock </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">107,808</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">91,631</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:358.26pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Stockholders&#8217; deficit: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:358.26pt;text-align:left;">
              <div style="margin-left:20pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Common stock $0.0001 par value, 14,230,158 shares authorized, 1,084,082 shares </font>
                <br >
                <font style="letter-spacing:0.2pt;">issued and outstanding </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:358.26pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Additional paid-in capital </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">818</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">339</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:358.26pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Accumulated deficit </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">(96,997<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(56,213<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:358.26pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Total CARISMA Therapeutics Inc. stockholders&#8217; deficit </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">(96,179<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(55,874<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:358.26pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Noncontrolling interests </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">14,395</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">14,395</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.25pt 0pt 2.5pt 0pt; width:358.26pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Total stockholders&#8217; deficit </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">(81,784<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(41,479<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:358.26pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Total liabilities, convertible preferred stock and stockholders&#8217; deficit </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">35,449</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">58,463</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">See accompanying notes to consolidated financial statements </font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-72</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC5">TABLE OF CONTENTS</a><a name="tCSOO1">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:381.5pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CARISMA THERAPEUTICS INC.</font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Consolidated Statements of Operations </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(in thousands, except share and per share data)</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:177.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:341.17pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Year Ended December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:341.17pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:341.17pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Operating expenses: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:341.17pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Research and development </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">34,387</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">23,292</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:341.17pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">General and administrative </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">6,407</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">5,086</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.25pt 0pt 2.5pt 0pt; width:341.17pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Total operating expenses </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">40,794</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">28,378</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:341.17pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Operating loss </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">(40,794<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">(28,378<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:341.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Interest income </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">10</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">29</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:341.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Net loss </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">(40,784<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">(28,349<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 1.5pt 0pt; width:341.17pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Share information: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 3.25pt 0pt; width:341.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Net loss per share of common stock, basic and diluted </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">(37.62<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">(26.66<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 3.25pt 0pt; width:341.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Weighted-average shares of common stock outstanding, basic and diluted </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">1,084,082</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">1,063,309</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">See accompanying notes to consolidated financial statements </font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-73</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="min-height:579.31pt;page-break-after:always; width:775.7pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC5">TABLE OF CONTENTS</a><a name="tCSOC2">&#8203;</a>
      </div>
      <div style="margin-top:61.66pt;margin-left:46.86pt;width:680pt;">
        <div style="width:680pt; line-height:12pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:115.5pt;margin-left:46.86pt;width:680pt;">
        <div style="margin-top:12pt; text-align:center; width:680pt; line-height:12pt;font-weight:bold;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">CARISMA THERAPEUTICS INC.</font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:680pt; line-height:12pt;font-weight:bold;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">Consolidated Statements of Convertible Preferred Stock and Stockholders&#8217; Deficit </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(in thousands, except share and per share data)</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:680pt;height:253.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:152.33pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;" colspan="46">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Convertible preferred stock </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;" colspan="34">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Stockholders&#8217; deficit </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;height:23pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:152.33pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt; width:0pt;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Series&#160;A </font>
                <br >
                <font style="letter-spacing:-0.16pt;">convertible </font>
                <br >
                <font style="letter-spacing:-0.16pt;">preferred stock </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt; width:0pt;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Special voting </font>
                <br >
                <font style="letter-spacing:-0.16pt;">preferred stock </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt; width:0pt;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Series&#160;B </font>
                <br >
                <font style="letter-spacing:-0.16pt;">convertible </font>
                <br >
                <font style="letter-spacing:-0.16pt;">preferred stock </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt; width:0pt;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Series&#160;B </font>
                <br >
                <font style="letter-spacing:-0.16pt;">special voting </font>
                <br >
                <font style="letter-spacing:-0.16pt;">preferred stock </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt; width:0pt;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Common stock </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;" rowspan="2">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4" rowspan="2">
              <div style="text-align:center; line-height:9pt; padding-bottom:0pt;">
                <font style="letter-spacing:-0.16pt;">Additional </font>
                <br >
                <font style="letter-spacing:-0.16pt;">paid-in </font>
                <br >
                <font style="letter-spacing:-0.16pt;">capital </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;" rowspan="2">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;" rowspan="2">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4" rowspan="2">
              <div style="text-align:center; line-height:9pt; padding-bottom:0pt;">
                <font style="letter-spacing:-0.16pt;">Accumulated </font>
                <br >
                <font style="letter-spacing:-0.16pt;">deficit </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;" rowspan="2">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;" rowspan="2">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4" rowspan="2">
              <div style="text-align:center; line-height:9pt; padding-bottom:0pt;">
                <font style="letter-spacing:-0.16pt;">Noncontrolling </font>
                <br >
                <font style="letter-spacing:-0.16pt;">interests </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;" rowspan="2">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;" rowspan="2">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4" rowspan="2">
              <div style="white-space:nowrap; text-align:center; line-height:9pt; padding-bottom:0pt;">
                <font style="letter-spacing:-0.16pt;">Total </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;" rowspan="2">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;height:13.5pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:152.33pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Shares </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Amount </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Shares </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Amount </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Shares </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Amount </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Shares </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Amount </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Shares </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Amount </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:152.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.18pt;">Balance, January&#160;1, 2020 </font>
              </div>
            </td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:29.25pt; text-align:right; white-space:nowrap;">2,910,151</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">29,752</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.66pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:6.75pt; text-align:right; white-space:nowrap;">1</td>
            <td style="padding:0pt;padding-left:6.66pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&nbsp;&nbsp;&nbsp;&#8212;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:29.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.66pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:6.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.66pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&nbsp;&nbsp;&nbsp;&#8212;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt; width:4.75pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:29.25pt; text-align:right; white-space:nowrap;">1,042,187</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&nbsp;&nbsp;&nbsp;&#8212;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.455pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">157</td>
            <td style="padding:0pt;padding-left:8.455pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.415pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:22.5pt; text-align:right; white-space:nowrap;">(27,864<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:5.415pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.12pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">4,250</td>
            <td style="padding:0pt;padding-left:10.12pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:22.5pt; text-align:right; white-space:nowrap;">(23,457<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:152.33pt;white-space:normal;text-align:left;">
              <div style="margin-left:9pt; text-indent:-9pt;">
                <font style="letter-spacing:0.18pt;">Issuance of Series&#160;A convertible preferred stock at $10.40 per share </font>
              </div>
            </td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:29.25pt; text-align:right; white-space:nowrap;">2,290,866</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">23,825</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.66pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.66pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:29.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.66pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.66pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt; width:4.75pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:29.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.455pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:8.455pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.415pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:22.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:5.415pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.12pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">5,500</td>
            <td style="padding:0pt;padding-left:10.12pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:22.5pt; text-align:right; white-space:nowrap;">5,500</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:152.33pt;white-space:normal;text-align:left;">
              <div style="margin-left:9pt; text-indent:-9pt;">
                <font style="letter-spacing:0.18pt;">Issuance of Series&#160;B convertible preferred stock at $15.60 per share, net of issuance costs of $215 </font>
              </div>
            </td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:29.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.66pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.66pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:29.25pt; text-align:right; white-space:nowrap;">2,453,170</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">38,054</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.66pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6.75pt; text-align:right; white-space:nowrap;">1</td>
            <td style="padding:0pt;padding-left:6.66pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt; width:4.75pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:29.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.455pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:8.455pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.415pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:22.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:5.415pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.12pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">4,645</td>
            <td style="padding:0pt;padding-left:10.12pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:22.5pt; text-align:right; white-space:nowrap;">4,645</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:152.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.18pt;">Exercise of stock options </font>
              </div>
            </td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:29.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.66pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.66pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:29.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.66pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.66pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt; width:4.75pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:29.25pt; text-align:right; white-space:nowrap;">41,895</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.455pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">19</td>
            <td style="padding:0pt;padding-left:8.455pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.415pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:22.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:5.415pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.12pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:10.12pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:22.5pt; text-align:right; white-space:nowrap;">19</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:152.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.18pt;">Stock-based compensation </font>
              </div>
            </td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:29.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.66pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.66pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:29.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.66pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.66pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt; width:4.75pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:29.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.455pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">163</td>
            <td style="padding:0pt;padding-left:8.455pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.415pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:22.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:5.415pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.12pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:10.12pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:22.5pt; text-align:right; white-space:nowrap;">163</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:152.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.18pt;">Net loss </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:29.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.66pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.66pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:29.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.66pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.66pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4.75pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:29.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.455pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:8.455pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.415pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:22.5pt; text-align:right; white-space:nowrap;">(28,349<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:5.415pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.12pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:10.12pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:22.5pt; text-align:right; white-space:nowrap;">(28,349<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:152.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.18pt;">Balance, December&#160;31, 2020 </font>
              </div>
            </td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:29.25pt; text-align:right; white-space:nowrap;">5,201,017</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">53,577</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.66pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:6.75pt; text-align:right; white-space:nowrap;">1</td>
            <td style="padding:0pt;padding-left:6.66pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:29.25pt; text-align:right; white-space:nowrap;">2,453,170</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">38,054</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.66pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:6.75pt; text-align:right; white-space:nowrap;">1</td>
            <td style="padding:0pt;padding-left:6.66pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt; width:4.75pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:29.25pt; text-align:right; white-space:nowrap;">1,084,082</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.455pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">339</td>
            <td style="padding:0pt;padding-left:8.455pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.415pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:22.5pt; text-align:right; white-space:nowrap;">(56,213<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:5.415pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.12pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">14,395</td>
            <td style="padding:0pt;padding-left:10.12pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:22.5pt; text-align:right; white-space:nowrap;">(41,479<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:152.33pt;white-space:normal;text-align:left;">
              <div style="margin-left:9pt; text-indent:-9pt;">
                <font style="letter-spacing:0.18pt;">Issuance of Series&#160;B convertible preferred stock at $15.60 per share, net of issuance costs of $151 </font>
              </div>
            </td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:29.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.66pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.66pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:29.25pt; text-align:right; white-space:nowrap;">1,046,696</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">16,177</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.66pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.66pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt; width:4.75pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:29.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.455pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:8.455pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.415pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:22.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:5.415pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.12pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:10.12pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:22.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:152.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.18pt;">Stock-based compensation </font>
              </div>
            </td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:29.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.66pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.66pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:29.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.66pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.66pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt; width:4.75pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:29.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.455pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">479</td>
            <td style="padding:0pt;padding-left:8.455pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.415pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:22.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:5.415pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.12pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:10.12pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:22.5pt; text-align:right; white-space:nowrap;">479</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:152.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.18pt;">Net loss </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:29.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.66pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.66pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:29.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.66pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.66pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4.75pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:29.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.455pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:8.455pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.415pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:22.5pt; text-align:right; white-space:nowrap;">(40,784<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:5.415pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.12pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:10.12pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:22.5pt; text-align:right; white-space:nowrap;">(40,784<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:152.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.18pt;">Balance, December&#160;31, 2021 </font>
              </div>
            </td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:29.25pt; text-align:right; white-space:nowrap;">5,201,017</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">53,577</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.66pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6.75pt; text-align:right; white-space:nowrap;">1</td>
            <td style="padding:0pt;padding-left:6.66pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:29.25pt; text-align:right; white-space:nowrap;">3,499,866</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">54,231</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.66pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6.75pt; text-align:right; white-space:nowrap;">1</td>
            <td style="padding:0pt;padding-left:6.66pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt; width:4.75pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:29.25pt; text-align:right; white-space:nowrap;">1,084,082</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.04pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.455pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">818</td>
            <td style="padding:0pt;padding-left:8.455pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.415pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:22.5pt; text-align:right; white-space:nowrap;">(96,997<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:5.415pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.12pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">14,395</td>
            <td style="padding:0pt;padding-left:10.12pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:22.5pt; text-align:right; white-space:nowrap;">(81,784<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:1.99999999999997pt;height:12pt;margin-left:46.86pt;width:680pt;">
        <div style="text-align:center; width:680pt; line-height:12pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">See accompanying notes to consolidated financial statements</font>
          <br >
        </div>
      </div>
      <div style="margin-top:49.64pt;margin-left:168.89pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">F-74</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC5">TABLE OF CONTENTS</a><a name="tCSOC3">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:83.5pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CARISMA THERAPEUTICS INC.</font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Consolidated Statement of Cash Flows </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(in thousands)</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:475.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:357.97pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Year Ended December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:357.97pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:357.97pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Cash flows from operating activities: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:357.97pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Net loss </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(40,784<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(28,349<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:357.97pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Adjustment to reconcile net loss to net cash used in operating activities: </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:357.97pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Depreciation and amortization expense </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">682</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">448</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:357.97pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Stock-based compensation expense </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">479</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">163</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:357.97pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Reduction in the operating right of use assets </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">834</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">1,179</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:357.97pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Changes in operating assets and liabilities: </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:357.97pt;text-align:left;">
              <div style="margin-left:30pt;">
                <font style="letter-spacing:0.2pt;">Prepaid expenses and other assets </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">253</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(936<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:357.97pt;text-align:left;">
              <div style="margin-left:30pt;">
                <font style="letter-spacing:0.2pt;">Accounts payable </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(974<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">1,282</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:357.97pt;text-align:left;">
              <div style="margin-left:30pt;">
                <font style="letter-spacing:0.2pt;">Accrued expenses </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">2,995</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">353</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:357.97pt;text-align:left;">
              <div style="margin-left:30pt;">
                <font style="letter-spacing:0.2pt;">Operating lease liabilities </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(813<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(1,152<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.25pt 0pt 2.5pt 0pt; width:357.97pt;text-align:left;">
              <div style="margin-left:40pt;">
                <font style="letter-spacing:0.2pt;">Net cash used in operating activities </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(37,328<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(27,012<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:357.97pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Cash flows from investing activities: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:357.97pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Purchases of property and equipment </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(1,871<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(440<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.25pt 0pt 2.5pt 0pt; width:357.97pt;text-align:left;">
              <div style="margin-left:40pt;">
                <font style="letter-spacing:0.2pt;">Net cash used in investing activities </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(1,871<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(440<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:357.97pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Cash flows from financing activities: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:357.97pt;text-align:left;">
              <div style="margin-left:20pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Proceeds from the sale of Series&#160;A convertible preferred stock and noncontrolling </font>
                <br >
                <font style="letter-spacing:0.2pt;">interests </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">29,325</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:357.97pt;text-align:left;">
              <div style="margin-left:20pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Proceeds from the sale of Series&#160;B convertible preferred stock and noncontrolling </font>
                <br >
                <font style="letter-spacing:0.2pt;">interests </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">16,328</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">42,914</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:357.97pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Proceeds from the exercise of stock options </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">19</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:357.97pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Payment of Series&#160;B offering costs </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(366<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.25pt 0pt 2.5pt 0pt; width:357.97pt;text-align:left;">
              <div style="margin-left:40pt;">
                <font style="letter-spacing:0.2pt;">Net cash provided by financing activities </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">15,962</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">72,258</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:357.97pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Net (decrease) increase in cash and cash equivalents </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(23,237<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">44,806</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:357.97pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Cash and cash equivalents at beginning of the year </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">51,788</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">6,982</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:357.97pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Cash and cash equivalents at end of the year </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">28,551</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">51,788</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 1.5pt 0pt; width:357.97pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Supplemental disclosures of non-cash financing and investing activities: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 3.25pt 0pt; width:357.97pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Series&#160;B issuance costs in accounts payable </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">118</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 3.25pt 0pt; width:357.97pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Series&#160;B issuance costs in accrued expenses </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">97</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 3.25pt 0pt; width:357.97pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Property and equipment in accounts payable </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">121</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.484999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">See accompanying notes to the consolidated financial statements</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-75</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC5">TABLE OF CONTENTS</a><a name="tNTTC">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CARISMA THERAPEUTICS INC.</font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Notes to the Consolidated Financial Statements</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:10.42pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">(1)&nbsp;&nbsp;&nbsp;Background</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.42pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">CARISMA Therapeutics Inc., a Delaware Corporation (the Company), is a clinical-stage biopharmaceutical company focused on utilizing the Company&#8217;s proprietary macrophage and monocyte cell engineering platform to develop transformative therapies to treat cancer and other serious disorders. Cell therapy enables the utilization of reprogrammed living cells to perform complex functions such as clearance of tumor cells or resolution of inflammation. The Company&#8217;s initial focus is its proprietary Chimeric Antigen Receptor Macrophage (CAR-M) platform, which redirects macrophages against specific tumor associate antigens and enables targeted anti-tumor immunity by utilizing genetically modifying myeloid cells (macrophages and monocytes) to express chimeric antigen receptors, or CARs, enabling the innate immune cells to recognize specific tumor associated antigens on the surface of tumor cells. The Company&#8217;s clinical lead product candidate CT-0508 is an ex vivo gene-modified autologous CAR-M cell therapy product intended to treat solid tumors that overexpress HER2. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company received an investigational new drug application, or IND, clearance for CT-0508 for the treatment of HER2-overexpressing solid tumors in July&#160;2020 and dosed the first patient in March&#160;2021. The Food and Drug Administration, or FDA, granted CT-0508 Fast Track Status in September&#160;2021. As of September&#160;1, 2022, enrollment in group 1 of the first in human study has been completed with 9 patients successfully dosed with CT-0508, and group 2 is currently open for enrollment with an additional 9 patients to be dosed in the study. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">(2)&nbsp;&nbsp;&nbsp;Development-Stage Risks and Liquidity</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.41pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company has incurred losses and negative cash flows from operations since inception and has an accumulated deficit of $97.0&#160;million as of December&#160;31, 2021. The Company anticipates incurring additional losses until such time, if ever, that it can generate significant sales from its product candidates currently in development. Management believes that cash and cash equivalents of $28.6&#160;million as of December&#160;31, 2021 and the $80.0&#160;million of cash proceeds received in January&#160;2022 from ModernaTX, Inc. (Moderna) related to the Collaboration and License Agreement and the Convertible Promissory Note (Note 11) are sufficient to sustain planned operations into the second quarter of 2023. As a result, the Company has concluded that there is substantial doubt about its ability to continue as a going concern within one year after the date that the financial statements are issued. The accompanying consolidated financial statements have been prepared on a going-concern basis, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. The consolidated financial statements do not include any adjustments related to the recoverability and classification of recorded asset amounts or the amounts and classification of liability that might result from the outcome of this uncertainty. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Management is currently evaluating different strategies to obtain the required funding for future operations. These strategies may include but are not limited to private placements of equity and/or debt, licensing and/or marketing arrangements, and public offerings of equity and/or debt securities. There is no assurance that such financing will be available when needed. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company is subject to those risks associated with any specialty biotechnology company that has substantial expenditures for research and development. There can be no assurance that the Company&#8217;s research and development projects will be successful, that products developed will obtain necessary regulatory approval, or that any approved product will be commercially viable. In addition, the Company operates in an environment of rapid technological change and is largely dependent on the services of its employees and consultants. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">(3)&nbsp;&nbsp;&nbsp;Summary of Significant Accounting Policies</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:10.32pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Principles of Consolidation</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.31pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company has a majority owned subsidiary in Luxembourg. The functional currency of the majority owned subsidiary is the US dollar. The consolidated financial statements include the accounts of the Company and its majority owned subsidiary. All intercompany transactions have been eliminated in consolidation. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-76</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC5">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Use of Estimates</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The preparation of consolidated financial statements in conformity with U.S. generally accepted accounting principles (GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from such estimates. Estimates and assumptions are periodically reviewed, and the effects of revisions are reflected in the consolidated financial statements in the period they are determined to be necessary. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Significant areas that require management&#8217;s estimates include the fair value of the Company&#8217;s common stock and stock-based compensation assumptions, the estimated useful lives of property and equipment and accrued research and development expenses. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Fair Value of Financial Instruments</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Management believes that the carrying amounts of the Company&#8217;s financial instruments, including cash equivalents and accounts payable, approximate fair value due to the short-term nature of those instruments. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Fair Value Measurements</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible. The Company determines fair value based on assumptions that market participants would use in pricing an asset or liability in the principal or most advantageous market. When considering market participant assumptions in fair value measurements, the following fair value hierarchy distinguishes between observable and unobservable inputs, which are categorized in one of the following levels: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Level&#160;1 Inputs:&nbsp;&nbsp;&nbsp;Unadjusted quoted prices in active markets for identical assets or liabilities accessible to the reporting entity at the measurement date. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.11pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.11pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Level&#160;2 Inputs:&nbsp;&nbsp;&nbsp;Other than quoted prices included in Level&#160;1 inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the asset or liability. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Level&#160;3 Inputs:&nbsp;&nbsp;&nbsp;Unobservable inputs for the asset or liability used to measure fair value to the extent that observable inputs are not available, thereby allowing for situations in which there is little, if any, market activity for the asset or liability at the measurement date. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Cash equivalents of $5.2&#160;million and $0.2&#160;million are classified as Level&#160;1 assets as of December&#160;31, 2021 and 2020, respectively. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Concentration of credit risk</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents. The Company maintains deposits in federally insured financial institutions in excess of federally insured limits. The Company has not experienced any losses in such accounts and believes it is not exposed to significant risk on its cash and cash equivalents. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Segment information</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Operating segments are defined as components of an enterprise about which separate discrete information is available for evaluation by the chief operating decision maker, or decision-making group, in deciding how to allocate resources and in assessing performance. The Company views its operations and manages its business in one segment. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Cash and Cash Equivalents</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company considers all highly-liquid investments that have maturities of three&#160;months or less when acquired to be cash equivalents. As of December&#160;31, 2021 and 2020, cash equivalents consisted of investments in a money market account. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-77</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC5">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Property and Equipment</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Property and equipment are carried at cost less accumulated depreciation and amortization. Depreciation and amortization are calculated using the straight-line method over the estimated useful lives of the assets ranging from two to five&#160;years. Leasehold improvements are amortized over the shorter of the life of the lease or the estimated useful life of the assets. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Long-lived Assets</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Long-lived assets, such as property and equipment, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. When events indicate a triggering event occurred, the recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated undiscounted future cash flows, then an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the asset. Considerable management judgment is necessary to estimate discounted future cash flows. Accordingly, actual results could vary significantly from such estimates. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company did not recognize any impairment of long-lived assets during the&#160;years ended December&#160;31, 2021, or 2020. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Leases</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In February&#160;2016, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2016-02, </font><font style="font-style:italic;letter-spacing:0.2pt;">Leases (ASC 842)</font><font style="letter-spacing:0.2pt;">, which requires lessees to recognize most leases on-balance sheet and disclose key information about leasing arrangements. The Company adopted ASC 842 effective as of January&#160;1, 2019 using the modified retrospective approach. The Company determines whether an arrangement is or contains a lease, its classification, and its term at the lease commencement date. Leases with a term greater than one year will be recognized on the balance sheet as right-of-use (ROU) assets, current lease liabilities, and if applicable, long-term lease liabilities. The Company includes renewal options to extend the lease term where it is reasonably certain that it will exercise these options. Lease liabilities and the corresponding ROU assets are recorded based on the present values of lease payments over the lease term. The interest rate implicit in lease contracts is typically not readily determinable. As such, the Company utilizes the appropriate incremental borrowing rates, which are the rates that would be incurred to borrow on a collateralized basis, over similar terms, amounts equal to the lease payments in a similar economic environment. Payments for non-lease components or that are variable in nature that do not depend on a rate or index are not included in the lease liability and are typically expensed as incurred. If significant events, changes in circumstances, or other events indicate that the lease term or other inputs have changed, the Company would reassess lease classification, remeasure the lease liability using revised inputs as of the reassessment date, and adjust the ROU assets. Lease expense is recognized on a straight-line basis over the expected lease term for operating classified leases. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company has elected the &#8220;package of 3&#8221; practical expedients permitted under the transition guidance, which eliminated the requirements to reassess prior conclusions about lease identification, lease classification, and initial direct costs. In addition, the Company elected the practical expedient of hindsight in determining the lease term upon adoption of ASC 842. The Company also adopted an accounting policy which provides that leases with an initial term of 12&#160;months or less and without a purchase option that the Company is reasonably certain of exercising will not be included within the lease right-of-use assets and lease liabilities on its consolidated balance sheet. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Noncontrolling Interest</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">To the extent that ownership interests in the Company&#8217;s subsidiary are held by entities other than the Company, management reports these as noncontrolling interests on the consolidated balance sheet. At December&#160;31, 2021 and 2020, an investor had outstanding Class&#160;B and Class&#160;B-1 shares in the Company&#8217;s Luxembourg subsidiary related to the sale of the Company&#8217;s Series&#160;A and Series&#160;B convertible preferred stock. The shares are nonvoting shares at the subsidiary entity level and presented as noncontrolling interests in the accompanying consolidated balance sheet. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-78</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC5">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Earnings or losses are attributed to noncontrolling interests under the hypothetical liquidation at book value (HLBV) method. The HLBV method is a point in time calculation that utilizes inputs to determine the amount that the Company and noncontrolling interest holders would receive upon a hypothetical liquidation at each balance sheet date based on the liquidation provisions of the respective articles of incorporation. Holders of the noncontrolling interests do not share in earnings or losses of the Luxembourg subsidiary. In addition and upon a liquidation event, as described in the Company&#8217;s articles of incorporation, holders of noncontrolling interests will automatically convert into the Company&#8217;s preferred securities for purposes of liquidation. As a result, no earnings or losses at the Company&#8217;s subsidiaries are allocated to noncontrolling interests. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Research and Development Costs</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Research and development costs are charged to expense as incurred. Up-front and milestone payments made to third parties who perform research and development services on the Company&#8217;s behalf are expensed as services are rendered. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Stock-Based Compensation</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The Company measures stock-based awards, including stock options, at their grant-date fair value and records compensation expense over the requisite service period, which is the vesting period of the awards. The Company accounts for forfeitures as they occur. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Estimating the fair value of stock options requires the use of subjective assumptions, including the fair value of the Company&#8217;s common stock, the expected term of the option and expected stock price volatility. The Company uses the Black-Scholes option-pricing model to value its stock option awards. The assumptions used in calculating the fair value of stock options represent management&#8217;s best estimates and involve inherent uncertainties and the application of management&#8217;s judgment. As a result, if factors change and management uses different assumptions, stock-based compensation expense could be materially different for future awards. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The expected term of stock options for employees is estimated using the &#8220;simplified method,&#8221; as the Company has limited historical information to develop reasonable expectations about future exercise patterns and post-vesting employment termination behavior for its stock option grants. The simplified method is the midpoint between the vesting date and the contractual term of the option. The contractual term is used as the expected term for stock options granted to nonemployees. For stock price volatility, the Company uses comparable public companies as a basis for the expected volatility to calculate the fair value of option grants. The risk-free rate is based on the U.S. Treasury yield curve commensurate with the expected term of the option. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Net Loss per Share Attributable to Common Stockholders</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Basic net loss per share of common stock is computed by dividing net loss by the weighted-average number of shares of common stock outstanding during each period. Diluted net loss per share of common stock includes the effect, if any, from the potential exercise or conversion of securities, such as convertible preferred stock and stock options, which would result in the issuance of incremental shares of common stock. For diluted net loss per share, the weighted-average number of shares of common stock is the same for basic net loss per share due to the fact that when a net loss exists, potentially dilutive securities are not included in the calculation as their impact is anti-dilutive. The Company&#8217;s convertible preferred stock entitles the holder to participate in dividends and earnings of the Company, and, if the Company were to recognize net income, it would have to use the two-class method to calculate earnings per share. The two-class method is not applicable during periods with a net loss, as the holders of the convertible preferred stock have no obligation to fund losses. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-79</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC5">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:79.0700000000001pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The following potentially dilutive securities have been excluded from the computation of diluted weighted-average shares of common stock outstanding, as they would be anti-dilutive: </font>
        </div>
        <table style="width:416pt;height:112.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:306.17pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:306.17pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:306.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Series&#160;A Convertible Preferred Stock </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">5,201,017</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">5,201,017</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:306.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Series&#160;B Convertible Preferred Stock </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">3,499,866</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">2,453,170</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:306.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Class&#160;B exchangeable shares </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">937,501</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">937,501</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:306.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Class&#160;B-1 exchangeable shares </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">297,764</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">297,764</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:306.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Stock options </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">1,869,438</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">965,912</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 0.75pt 0pt; width:306.17pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">11,805,586</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">9,855,364</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:18.19pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Accounting guidance not yet adopted</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">In August&#160;2020, the FASB issued ASU No. 2020-06, </font><font style="font-style:italic;letter-spacing:0.2pt;">Debt&#8201;&#8212;&#8201;Debt with Conversion and Other Options</font><font style="letter-spacing:0.2pt;"> (Subtopic 470-20) </font><font style="font-style:italic;letter-spacing:0.2pt;">and Derivatives and Hedging&#8201;&#8212;&#8201;Contracts in Entity&#8217;s Own Equity</font><font style="letter-spacing:0.2pt;"> (Subtopic 815-40)</font><font style="font-style:italic;letter-spacing:0.2pt;">: Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity</font><font style="letter-spacing:0.2pt;"> (ASU 2020-06), which simplifies the accounting for convertible instruments by reducing the number of accounting models available for convertible debt instruments. This guidance also eliminates the treasury stock method to calculate diluted earnings per share for convertible instruments and requires the use of the if converted method. This standard is effective for the Company on January&#160;1, 2022, including interim periods within those fiscal&#160;years. Adoption is either a modified retrospective method or a fully retrospective method of transition. The Company does not expect the adoption of this standard to have a material impact on the consolidated financial statements. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">(4)&nbsp;&nbsp;&nbsp;Property and Equipment, net</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Property and equipment, net consisted of the following (in thousands): </font>
        </div>
        <table style="width:416pt;height:143pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:333.26pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:333.26pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:333.26pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Computer software </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">214</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">108</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:333.26pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Lab equipment </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">3,694</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1,821</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:333.26pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Office furniture </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">267</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">267</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:333.26pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Leasehold improvements </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">317</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">317</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:333.26pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Construction in progress </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">13</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:333.26pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">4,505</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">2,513</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:333.26pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Less: accumulated depreciation and amortization </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">(1,421<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">(739<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 0.75pt 0pt; width:333.26pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">3,084</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">1,774</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:14.2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Depreciation and amortization expense was $0.7&#160;million and $0.4&#160;million for the&#160;years ended December&#160;31, 2021, and 2020, respectively. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-80</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC5">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">(5)&nbsp;&nbsp;&nbsp;Accrued Expenses</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Accrued expenses consisted of the following (in thousands): </font>
        </div>
        <table style="width:416pt;height:97.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:336.59pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:336.59pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:336.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Compensation and related expenses </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1,563</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">985</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:336.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Research and development </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">2,352</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">361</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:336.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Professional fees </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">323</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">191</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:336.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Other </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">233</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">36</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 0.75pt 0pt; width:336.59pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">4,471</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">1,573</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:18.2pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">(6)&nbsp;&nbsp;&nbsp;Commitments and Contingencies</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Leases</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The Company has operating leases for its lab and office space. In April&#160;2019, the Company entered into a lease agreement for its headquarters in Philadelphia, Pennsylvania, which commenced in October&#160;2019 and has a termination date of September&#160;2029. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">In October&#160;2018, the Company entered into a lease agreement for lab and office space in Philadelphia, Pennsylvania. This lease agreement commenced the same month and initially had a month-to-month lease term. As of January&#160;2019, upon adoption of ASC 842, the Company was reasonably certain the lease would be renewed for approximately five&#160;years based on certain economic factors at that time. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The Company&#8217;s operating lease ROU assets and the related lease liabilities are initially measured at the present value of future lease payments over the lease term. The Company is responsible for payment of certain real estate taxes, insurance and other expenses on certain of its leases. These amounts are generally considered to be variable and are not included in the measurement of the ROU assets and lease liability. The Company accounts for non-lease components, such as maintenance, separately from lease components. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The elements of the lease costs were as follows (in thousands): </font>
        </div>
        <table style="width:416pt;height:37pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:317.97pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Year Ended December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:317.97pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:317.97pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Operating lease cost </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.65pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">1,129</td>
            <td style="padding:0pt;padding-left:4.65pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.65pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">1,129</td>
            <td style="padding:0pt;padding-left:4.65pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-left:20pt; margin-top:14.19pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Lease term and discount rate information related to leases was as follows: </font>
        </div>
        <table style="width:416pt;height:82pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:358.41pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:358.41pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:358.41pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Weighted-average remaining lease term (in&#160;years) </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.045pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.045pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.045pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.045pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:358.41pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Operating leases </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.045pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">4.4</td>
            <td style="padding:0pt;padding-left:2.045pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.045pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">4.9</td>
            <td style="padding:0pt;padding-left:2.045pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:358.41pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Weighted-average discount rate </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.045pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.045pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.045pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.045pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:358.41pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Operating leases </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.045pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">9.8<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:2.045pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.045pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">9.6<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:2.045pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-left:20pt; margin-top:9.19pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Supplemental cash flow information (in thousands): </font>
        </div>
        <table style="width:416pt;height:52pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:317.97pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Year Ended December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:317.97pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:317.97pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Cash paid for amounts included in the measurement of lease liabilities:</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.65pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.65pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.65pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.65pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:317.97pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Operating cash used in operating leases </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.65pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1,108</td>
            <td style="padding:0pt;padding-left:4.65pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.65pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1,103</td>
            <td style="padding:0pt;padding-left:4.65pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-81</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC5">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Future maturities of lease liabilities were as follows as of December&#160;31, 2021 (in thousands): </font>
        </div>
        <table style="width:416pt;height:168.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:370.17pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;text-align:center;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Operating </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Leases </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:370.17pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Fiscal year ending:</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.06pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.06pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:370.17pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.06pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1,114</td>
            <td style="padding:0pt;padding-left:3.06pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:370.17pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">2023 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.06pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">892</td>
            <td style="padding:0pt;padding-left:3.06pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:370.17pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">2024 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.06pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">213</td>
            <td style="padding:0pt;padding-left:3.06pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:370.17pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">2025 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.06pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">219</td>
            <td style="padding:0pt;padding-left:3.06pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:370.17pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">2026 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.06pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">226</td>
            <td style="padding:0pt;padding-left:3.06pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:370.17pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Thereafter </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.06pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">657</td>
            <td style="padding:0pt;padding-left:3.06pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:370.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total future minimum payments </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.06pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">3,321</td>
            <td style="padding:0pt;padding-left:3.06pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:370.17pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Less imputed interest </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.06pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">(689<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.06pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:370.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Present value of lease liabilities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.06pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">2,632</td>
            <td style="padding:0pt;padding-left:3.06pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:16.9pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Licensing and Sponsored Research Agreements</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In November&#160;2017, the Company entered into a license agreement (Penn License Agreement) with The Trustees of the University of Pennsylvania (Penn) for certain intellectual property licenses. The Penn License Agreement specifies the Company will provide $5.5&#160;million of sponsored research as part of the research and development plan within the first three&#160;years of the agreement. The Company is required to make annual payments of $10,000 through 2021 and $25,000 in annual payments thereafter. Penn is eligible to receive up to $10.9&#160;million per product in development upon the achievement of certain clinical, regulatory and commercial milestone events. There are additional milestone payments required to be paid of up to $30.0&#160;million per product in commercial milestones, and up to an additional $1.7&#160;million in development and regulatory milestone payments for the first CAR-M product directed to mesothelin. Additionally, the Company is obligated to pay Penn single-digit royalties based on its net sales. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Contingencies</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Liabilities for loss contingencies, arising from claims, assessments, litigation, fines, penalties, and other sources are recorded when it is probable that a liability has been incurred and the amount of the assessment and/or remediation can be reasonably estimated. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">(7)&nbsp;&nbsp;&nbsp;Convertible Preferred Stock, Noncontrolling Interests and Common Stock</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In March&#160;2020, the Company sold 2,290,866 shares of its Series&#160;A convertible preferred stock (Series&#160;A) and 528,847 shares of Class&#160;B exchangeable shares issued by the Luxembourg subsidiary at an original issuance price of $10.40 per share. One special voting preferred stock share was also issued to the investor in the Luxembourg subsidiary. In December&#160;2020, the Company sold 2,453,170 shares of its Series&#160;B convertible preferred stock (Series&#160;B) and 297,764 shares of Class&#160;B-1 exchangeable shares issued by the Luxembourg subsidiary at an original issuance price of $15.60 per share. One Series&#160;B special voting preferred stock share was also issued to the investor in the Luxembourg subsidiary. The proceeds received associated with Luxembourg subsidiary securities are presented as noncontrolling interests in the Company&#8217;s consolidated financial statements. As of December&#160;31, 2021 and 2020, there were 937,501 and 297,764 Class&#160;B and Class&#160;B-1 exchangeable shares outstanding, respectively. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In February&#160;2021, the Company sold an additional 1,046,696 shares of Series&#160;B at an original issuance price of $15.60 per share. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Class&#160;B and Class&#160;B-1 exchangeable shares (the Exchangeable Shares) are exchangeable into shares of Series&#160;A and Series&#160;B, respectively, on a one for one basis, at the option of the holder, or automatically upon an initial public offering or liquidation event. The Class&#160;B and Class&#160;B-1 exchangeable shares participate as Series&#160;A and Series&#160;B preferred shareholders, respectively, as it pertains to all rights and preferences held by the Company&#8217;s preferred shareholders. In addition, the Class&#160;B and Class&#160;B-1 exchangeable share investor </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-82</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC5">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">holds a share of special voting preferred stock and Series&#160;B special voting preferred stock that provides the investor with additional control relating voting matters for the Series&#160;A and Series&#160;B preferred shareholders, respectively. The following is a summary of the rights, preferences, and terms of the Series&#160;A and Series&#160;B (collectively, Convertible Preferred Stock): </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Dividends</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The holders of the Convertible Preferred Stock are entitled to receive dividends payable when, as and if declared by the Board of Directors of the Company, with the holders of common stock, paid out of any assets or on the common stock of the Company, on an as-converted or as exchangeable to common stock basis. No dividends on common stock were declared or paid from inception through December&#160;31, 2021. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Voting</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The holders of Convertible Preferred Stock, Special voting preferred stock and Series&#160;B special voting preferred stock are entitled to vote on any matter presented to the stockholders of the Company. Each holder of outstanding shares of Convertible Preferred Stock is entitled to the number of votes equal to the number of shares of common stock into which the shares of Convertible Preferred Stock are convertible or exchangeable. Holders of Series&#160;A and the holder of Special voting preferred stock, exclusively and together as a single class, are entitled to elect three directors of the corporation and Series&#160;B holders and the holder of Series&#160;B special voting preferred stock, exclusively and as a separate class, are entitled to elect one director of the corporation. The holders of record of common stock and Convertible Preferred Stock, together as a separate class, are entitled to elect the balance of the total directors of the corporation and on an as converted or exchangeable basis. As of December&#160;31, 2021, the Company had 7 directors. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Liquidation Preference</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In the event of any voluntary or involuntary liquidations, dissolution or winding up of the Company, the holders of Series&#160;B shall be entitled to be paid out of the consideration payable to stockholders before any payment shall be made to the holders of Series&#160;A or common stock, an amount equal to the greater of (i)&#160;Series&#160;B original issue price, plus any dividend declared but unpaid, or (ii)&#160;such amount per share as would have been payable had all shares of Series&#160;B been converted into common stock immediately prior to liquidation, dissolution or winding up. The holders of Series&#160;A shall be entitled to be paid out of the consideration payable to stockholders after any payment to the Series&#160;B but before any payment shall be made to the holders common stock, an amount equal to the greater of (i)&#160;Series&#160;A original issue price, plus any dividend declared but unpaid, or (ii)&#160;such amount per share as would have been payable had all shares of Series&#160;A been converted into common stock immediately prior to liquidation, dissolution or winding up. If exchanged as of December&#160;31, 2021, the Class&#160;B and Class&#160;B-1 exchangeable shares have a liquidation value of $9.8&#160;million and $4.6&#160;million, respectively. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Conversion</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Convertible Preferred Stock is convertible into common stock based on the original issuance price of the security. The Convertible Preferred Stock automatically converts to common stock upon (1)&#160;an initial public offering totaling at least $50.0&#160;million in proceeds, or (2)&#160;the date and time, or the occurrence of an event, specified by vote or written consent of (i)&#160;the holders of a majority of the voting power represented by&#160;the outstanding shares of Series&#160;A, voting together as a single class and (ii)&#160;the holders of at least two-thirds&#160;(2/3) of the voting power represented by the outstanding shares of Series&#160;B, voting together as a single class (the time of such closing or the date and time specified or the time of the event specified in such vote or written consent). </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Redemption</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Convertible Preferred Stock is subject to redemption under certain deemed liquidation events not solely within the control of the Company, as defined, and as such is considered contingently redeemable for accounting purposes. Accordingly, the Convertible Preferred Stock is classified outside of permanent stockholders&#8217; deficit. An adjustment of the carrying amount of the Convertible Preferred Stock is not </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-83</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC5">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">necessary until it is probable that the securities will become redeemable. At December&#160;31, 2021, the Company has determined that redemption of the Convertible Preferred Stock is not probable. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Common Stock</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The holders of the common stock are entitled to one vote for each share of common stock held at all meetings of stockholders. Unless required by law, there shall be no cumulative voting. In the event of any voluntary or involuntary liquidation, dissolution or winding up of the Company, after the payment of all preferential amounts required to be paid to the holders of shares of Convertible Preferred Stock, the remaining funds and assets available for distribution to the stockholders of the Company will be distributed among the holders of shares of common stock, pro&#160;rata based on the number of shares of common stock held by each such holder. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">(8)&nbsp;&nbsp;&nbsp;Stock-based Compensation</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">In August&#160;2017, the Company adopted the 2017 Stock Incentive Plan (the Plan) as amended that authorized the Company to grant up to 1,739,936 shares of common stock. In 2021, the Company amended the Plan and increased the total number of shares authorized under the Plan to 1,984,018. As of December&#160;31, 2021, there were 24,242 shares available to be granted. The Company&#8217;s stock options vest based on the terms in the awards agreements and generally vest over four&#160;years. The Company recorded stock-based compensation expense in the following expense categories in its accompanying consolidated statements of operations: </font>
        </div>
        <table style="width:416pt;height:67.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:317.97pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Year Ended December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:317.97pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:317.97pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Research and development </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.505pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">185</td>
            <td style="padding:0pt;padding-left:8.505pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.505pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">67</td>
            <td style="padding:0pt;padding-left:8.505pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:317.97pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">General and administrative </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.505pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">294</td>
            <td style="padding:0pt;padding-left:8.505pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.505pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">96</td>
            <td style="padding:0pt;padding-left:8.505pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 0.75pt 0pt; width:317.97pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.505pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">479</td>
            <td style="padding:0pt;padding-left:8.505pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.505pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">163</td>
            <td style="padding:0pt;padding-left:8.505pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-left:20pt; margin-top:14.19pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following is a summary of stock option activity under the Plan: </font>
        </div>
        <table style="width:456pt;height:199.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:236.73pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Options </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Weighted</font>
                <br >
                <font style="letter-spacing:-0.16pt;">average</font>
                <br >
                <font style="letter-spacing:-0.16pt;">exercise price </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Weighted</font>
                <br >
                <font style="letter-spacing:-0.16pt;">average </font>
                <br >
                <font style="letter-spacing:-0.16pt;">remaining</font>
                <br >
                <font style="letter-spacing:-0.16pt;">contractual</font>
                <br >
                <font style="letter-spacing:-0.16pt;">term (years) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Aggregate </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Intrinsic</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Value</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(in thousands) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:236.73pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Outstanding as of January&#160;1, 2020 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">912,321</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.775pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">1.06</td>
            <td style="padding:0pt;padding-left:10.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.785pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.785pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:236.73pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Granted </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">134,997</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.775pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">1.28</td>
            <td style="padding:0pt;padding-left:10.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.785pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.785pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:236.73pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Exercised </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">(41,895<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.775pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">0.47</td>
            <td style="padding:0pt;padding-left:10.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.785pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.785pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">34</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:236.73pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Forfeited </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">(16,386<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.775pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">1.23</td>
            <td style="padding:0pt;padding-left:10.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.785pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.785pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:236.73pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Expired </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">(23,125<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.775pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:13.5pt; text-align:right; white-space:nowrap;">1.18</td>
            <td style="padding:0pt;padding-left:10.775pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.785pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:9.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.785pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10.0000000000001pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:236.73pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Outstanding as of December&#160;31, 2020 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">965,912</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.775pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">1.11</td>
            <td style="padding:0pt;padding-left:10.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.785pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.785pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:236.73pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Granted </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">903,526</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.775pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:13.5pt; text-align:right; white-space:nowrap;">2.63</td>
            <td style="padding:0pt;padding-left:10.775pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.785pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:9.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.785pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:236.73pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Outstanding as of December&#160;31, 2021 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">1,869,438</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.775pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:13.5pt; text-align:right; white-space:nowrap;">1.85</td>
            <td style="padding:0pt;padding-left:10.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.785pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:9.75pt; text-align:right; white-space:nowrap;">8.2</td>
            <td style="padding:0pt;padding-left:13.785pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1,693</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 3.25pt 0pt; width:236.73pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Exercisable as of December&#160;31, 2021 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">828,821</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.775pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:13.5pt; text-align:right; white-space:nowrap;">1.24</td>
            <td style="padding:0pt;padding-left:10.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.785pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:9.75pt; text-align:right; white-space:nowrap;">7.2</td>
            <td style="padding:0pt;padding-left:13.785pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1,270</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 3.25pt 0pt; width:236.73pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Vested and expected to vest </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">1,869,438</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.775pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:13.5pt; text-align:right; white-space:nowrap;">1.85</td>
            <td style="padding:0pt;padding-left:10.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.785pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:9.75pt; text-align:right; white-space:nowrap;">8.2</td>
            <td style="padding:0pt;padding-left:13.785pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1,693</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:14.19pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The weighted-average grant-date per share fair values of options granted in 2021 and 2020 were $1.43 and $0.66, respectively. The fair values in 2021 and 2020 were estimated using the Black-Scholes option-pricing model based on the following assumptions: </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-84</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC5">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <table style="width:456pt;height:97pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:307.43pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Year Ended December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:307.43pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt; width:62.28pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt; width:62.28pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:right;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:307.43pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Risk-free interest rate </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0.5pt 1.5pt 0pt; width:62.28pt;">
              <div style="text-align:right;">
                <font style="letter-spacing:0.2pt;">0.89%&#8201;&#8211;&#8201;1.26%</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0.5pt 1.5pt 0pt; width:62.28pt;">
              <div style="text-align:right;">
                <font style="letter-spacing:0.2pt;">0.4%&#8201;&#8211;&#8201;1.8%</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:right;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:307.43pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Expected term </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0.5pt 1.5pt 0pt; width:62.28pt;">
              <div style="text-align:right;">
                <font style="letter-spacing:0.2pt;">6&#160;years</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0.5pt 1.5pt 0pt; width:62.28pt;">
              <div style="text-align:right;">
                <font style="letter-spacing:0.2pt;">6&#160;years</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:right;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:307.43pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Expected volatility </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0.5pt 1.5pt 0pt; width:62.28pt;">
              <div style="text-align:right;">
                <font style="letter-spacing:0.2pt;">53.3%&#8201;&#8211;&#8201;54.2%</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0.5pt 1.5pt 0pt; width:62.28pt;">
              <div style="text-align:right;">
                <font style="letter-spacing:0.2pt;">54.1%&#8201;&#8211;&#8201;55.5%</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:right;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:307.43pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Expected dividend yield </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0.5pt 1.5pt 0pt; width:62.28pt;">
              <div style="text-align:right;">
                <font style="letter-spacing:0.2pt;">&#8212;</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0.5pt 1.5pt 0pt; width:62.28pt;">
              <div style="text-align:right;">
                <font style="letter-spacing:0.2pt;">&#8212;</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:right;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:307.43pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Estimated fair value of the Company&#8217;s common stock per share </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0.5pt 1.5pt 0pt; width:62.28pt;">
              <div style="text-align:right;">
                <font style="letter-spacing:0.2pt;">$2.77</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0.5pt 1.5pt 0pt; width:62.28pt;">
              <div style="text-align:right;">
                <font style="letter-spacing:0.2pt;">$1.28</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:7.9pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company recorded stock-based compensation expense of $0.5&#160;million and $0.2&#160;million for the&#160;years ended December&#160;31, 2021, and 2020, respectively. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Future compensation cost for awards not vested as of December&#160;31, 2021, was $1.2&#160;million and will be expensed over a weighted-average period of 3&#160;years. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">(9)&nbsp;&nbsp;&nbsp;Income Taxes</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company has incurred losses since inception and has not recorded current or deferred income taxes. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">A reconciliation of income tax benefit at the statutory federal income tax rate and income taxes as reflected in the consolidated financial statements is as follows: </font>
        </div>
        <table style="width:416pt;height:127.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:317.97pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Year Ended December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:317.97pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:317.97pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Federal tax benefit at statutory rate </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.985pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:15.75pt; text-align:right; white-space:nowrap;">(21.0<font style="position:absolute;">)%</font></td>
            <td style="padding:0pt;padding-left:7.985pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.985pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:15.75pt; text-align:right; white-space:nowrap;">(21.0<font style="position:absolute;">)%</font></td>
            <td style="padding:0pt;padding-left:7.985pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:317.97pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">State tax, net of federal benefit </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.985pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:15.75pt; text-align:right; white-space:nowrap;">(12.6<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:7.985pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.985pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:15.75pt; text-align:right; white-space:nowrap;">(12.6<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:7.985pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:317.97pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Permanent differences </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.985pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:15.75pt; text-align:right; white-space:nowrap;">0.2</td>
            <td style="padding:0pt;padding-left:7.985pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.985pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:15.75pt; text-align:right; white-space:nowrap;">0.1</td>
            <td style="padding:0pt;padding-left:7.985pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:317.97pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Research and development </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.985pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:15.75pt; text-align:right; white-space:nowrap;">(4.3<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:7.985pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.985pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:15.75pt; text-align:right; white-space:nowrap;">(4.3<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:7.985pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:317.97pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Change in valuation allowance </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.985pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:15.75pt; text-align:right; white-space:nowrap;">37.1</td>
            <td style="padding:0pt;padding-left:7.985pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.985pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:15.75pt; text-align:right; white-space:nowrap;">40.3</td>
            <td style="padding:0pt;padding-left:7.985pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:317.97pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Return to provision </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.985pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:15.75pt; text-align:right; white-space:nowrap;">0.6</td>
            <td style="padding:0pt;padding-left:7.985pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.985pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:15.75pt; text-align:right; white-space:nowrap;">(2.5<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:7.985pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:317.97pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total provision </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.985pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:15.75pt; text-align:right; white-space:nowrap;">&#8212;<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:7.985pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.985pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:15.75pt; text-align:right; white-space:nowrap;">&#8212;<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:7.985pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:12.9pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Deferred tax assets and liabilities are determined based on the differences between the financial statement carrying amounts and tax bases of assets and liabilities using enacted tax rates in effect for&#160;years in which differences are expected to reverse. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Significant components of the Company&#8217;s deferred tax assets for federal income taxes consisted of the following (in thousands): </font>
        </div>
        <table style="width:416pt;height:173.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:319.93pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:319.93pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:319.93pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Deferred tax assets</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:319.93pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Net operating losses </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">25,507</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">14,474</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:319.93pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Research and development credits </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">3,862</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">2,166</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:319.93pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Start-up costs </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">6,133</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">3,732</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:319.93pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Equity compensation </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">65</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">34</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:319.93pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Change in valuation allowance </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(35,374<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(20,299<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.25pt 0pt 2.5pt 0pt; width:319.93pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Deferred tax assets, net of valuation allowance </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">193</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">107</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:319.93pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Deferred tax liabilities</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:319.93pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Depreciation </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(193<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(107<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:319.93pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Net deferred tax assets and liabilities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-85</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC5">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As of December&#160;31, 2021, the Company has net operating loss (NOL) carryforwards for federal income tax purposes of $76.4&#160;million, which are available to offset future federal taxable income. The pre-2018 federal NOL carryforwards of $1.1&#160;million will begin to expire in 2037, if not utilized. The post-2017 federal NOL carryforwards of $75.3&#160;million carry forward indefinitely. The Company also has NOLs for state and local income tax purposes of $76.4&#160;million and $71.2&#160;million, respectively that are available to offset future taxable income. The state NOL carryforwards will begin to expire in 2037 while the local NOLs expire after three&#160;years with $4.1&#160;million expiring in 2021. As of December&#160;31, 2021, the Company also had federal research and development tax credit carryforwards of $3.9&#160;million that will begin to expire in 2038, unless previously utilized. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In assessing the need for a valuation allowance, management must determine that there will be sufficient taxable income to allow for the realization of deferred tax assets. Based upon the historical and anticipated future losses, management has determined that the deferred tax assets do not meet the more-likely-than-not threshold for realizability. Accordingly, a full valuation allowance has been recorded against all of the Company&#8217;s net deferred tax assets as of December&#160;31, 2021. The valuation allowance increased by $15.1&#160;million and $11.4&#160;million during the&#160;years ended December&#160;31, 2021 and December&#160;31, 2020, respectively. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The NOL and tax credit carryforwards are subject to review and possible adjustment by the Internal Revenue Service and state tax authorities. NOL and tax credit carryforwards may become subject to an annual limitation in the event of certain cumulative changes in the ownership interest of significant stockholders over a three-year period in excess of 50&#160;percent, as defined under Sections&#160;382 and 383 of the Internal Revenue Code, respectively, as well as similar state provisions. This could limit the amount of tax attributes that can be utilized annually to offset future taxable income or tax liabilities. The amount of the annual limitation is determined based on the value of the Company immediately prior to the ownership change. Subsequent ownership changes may further affect the limitation in future&#160;years. The Company has not done an analysis to determine whether or not ownership changes have occurred since inception. Certain state NOLs may also be limited, including Pennsylvania, which limits NOL utilization as a&#160;percentage of apportioned taxable income. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company will recognize interest and penalties related to uncertain tax positions as a component of income tax expense/(benefit). As of December&#160;31, 2021, the Company had no accrued interest or penalties related to uncertain tax positions and no amounts have been recognized in the Company&#8217;s consolidated financial statements. Tax&#160;years from 2018 and after remain subject to examination by all of the taxing jurisdictions. The NOL and credit carryforwards remain subject to review until utilized. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">(10)&nbsp;&nbsp;&nbsp;Related Party Transactions</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company has outstanding licensing and scientific research agreements with Penn, a significant shareholder (Note 6). The Company recognized $0.8&#160;million of research and development expense for each of the&#160;years ended December&#160;31, 2021 and 2020 related to the Penn License Agreement. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">(11)&nbsp;&nbsp;&nbsp;Subsequent Events</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company has evaluated subsequent events from the balance sheet date through October&#160;14, 2022, the issuance date of these consolidated financial statements and has not identified any requiring disclosure except as noted below. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Moderna Collaboration and License Agreement</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In January&#160;2022, the Company entered into a Collaboration and License Agreement with ModernaTX, Inc. (Moderna License Agreement), to develop and commercialize </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;"> engineered chimeric antigen receptor monocyte (CAR-M) therapeutics for different forms of cancer. The Moderna License Agreement allows Moderna to develop and commercialize product candidates for up to twelve research targets. The Company will be responsible for discovering and optimizing development candidates, and Moderna will be responsible for the clinical development thereafter. Pursuant to the Moderna License Agreement, the Company and Moderna will form a joint steering committee, or JSC, that will be responsible for the coordination and oversight of all research activities to which the Company is responsible for providing. The </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-86</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC5">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">JSC will be comprised of three representatives each from the Company and Moderna and with Moderna having final decision-making authority, subject to customary exclusions. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">During the research term of the Moderna License Agreement, the Company has granted Moderna an exclusive worldwide royalty free license to the Company&#8217;s intellectual property associated with the product candidates that permits Moderna to conduct its research and development activities. Upon Moderna&#8217;s election of a development target (and payment of a related development target designation milestone) for commencement of pre-clinical development of a product candidate, the Company will grant Moderna an exclusive worldwide, sublicensable royalty bearing license to develop, manufacture and commercialize the product candidate. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Upon execution of the Moderna License Agreement, Moderna made an upfront non-refundable payment of $45.0&#160;million to the Company. Moderna also will reimburse the Company for all costs incurred by the Company in connection with its research and development activities under the Moderna License Agreement plus a reasonable margin for the respective services performed (with a minimum commitment to reimburse $10.0&#160;million in research and development costs over the first three&#160;years from execution of the Moderna License Agreement). In addition, assuming Moderna develops and commercializes 12 products, each directed to a different development target, the Company is eligible to receive up to between $247.0&#160;million and $253.0 million per product in development target designation, development, regulatory and commercial milestone payments. The Company is also eligible to receive tiered mid-to-high single digit royalties of net product sales, subject to adjustment. In addition, Moderna will repay the Company for certain development, regulatory and commercial milestone payments and certain royalty payments pursuant to the Company&#8217;s license agreement with the University of Pennsylvania. The Moderna License Agreement terminates on a product-by-product basis upon the latest of expiration of the applicable product patents, expiration of regulatory exclusivity and the tenth anniversary of first commercial sale, unless terminated earlier by the Company or Moderna. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Moderna Convertible Promissory Note</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Concurrent with entering into the Moderna License Agreement, the Company issued and sold to Moderna a convertible promissory note in the aggregate principal amount of $35.0&#160;million (the Note). If not earlier converted or repaid, the Note is payable on demand beginning in July&#160;2023. The Note accrues interest at an annual rate beginning at 0.33% through March&#160;2022 and then increasing by 0.767% each month thereafter capping at an annual rate of 8.0% in January&#160;2023. Upon the completion of a qualified financing event, the outstanding principal and accrued interest under the Note will automatically convert into shares of the Company issued in connection with the qualified financing at a conversion price equal to the lesser of (a)&#160;90% of the purchase price paid by other investors in such qualified financing and (b)&#160;$21.06 per share on an as converted to common stock basis. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Office and Laboratory Space</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In January&#160;2022, the Company amended its October&#160;2018 lease to add additional lab and office spaces. The lease for the additional spaces commenced in April&#160;2022 and has a term of 18&#160;months. The total future minimum lease payments for these spaces are $3.6&#160;million. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In February&#160;2022, the Company entered into another agreement to lease additional office and laboratory space in Philadelphia, Pennsylvania. This lease commenced in March&#160;2022 and has a term of 18&#160;months with an option for the Company to renew the lease for two additional terms of six&#160;months each at the end of lease term. The total future minimum lease payments for the lease are $3.3&#160;million. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Merger with Seahawk Merger Sub, Inc.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On September&#160;20, 2022, the Company entered into an Agreement and Plan of Merger and Reorganization (the Merger Agreement) with Seahawk Merger Sub, Inc. (Merger Sub), a Delaware corporation and wholly-owned subsidiary of Sesen Bio, Inc. (Sesen Bio). The Merger Agreement provides for the merger of the Company with Merger Sub, with the Company as the surviving entity and the Company continuing as a wholly-owned subsidiary of Sesen Bio (the Merger). Subject to the terms and conditions of the Merger Agreement, at the closing of the Merger, (a)&#160;each then outstanding share of the Company&#8217;s </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-87</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC5">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:444pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">common stock and preferred stock (collectively, the Company&#8217;s capital stock) (including shares of the Company&#8217;s common stock issued in connection with the pre-closing financing transaction described below) will be converted into the right to receive a number of shares of Sesen Bio common stock, and (b)&#160;each then outstanding stock option to purchase the Company&#8217;s common stock will be assumed by Sesen Bio, subject to adjustment as set forth in the Merger Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Following the Merger, the shareholders of the Company are expected to hold 58.3% of the combined company, and the shareholders of Sesen Bio are expected to hold 41.7% of the combined company. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Concurrently with the execution and delivery of the Merger Agreement, certain parties entered into agreements with the Company to purchase prior to the consummation of the Merger shares of the Company&#8217;s common stock for an aggregate purchase price of $30.6&#160;million (Pre-Closing Financing). Shares of the Company&#8217;s common stock issued pursuant to the Pre-Closing Financing transaction will be converted into shares of Sesen Bio common stock in the Merger. Upon completion of the merger, the outstanding principal and unpaid interest associated with the Notes will automatically convert into the shares of Sesen Bio common stock.</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-88</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC5">TABLE OF CONTENTS</a><a name="tUCBS">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">CARISMA THERAPEUTICS INC. </font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">Unaudited Consolidated Balance Sheets </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(in thousands, except share and per share data)</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:592pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">September&#160;30, </font>
                <br >
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">December&#160;31, </font>
                <br >
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <font style="letter-spacing:-0.16pt;">Assets</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <font style="letter-spacing:0.16pt;">Current assets: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Cash and cash equivalents </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">28,943</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">28,551</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Marketable securities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">41,705</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Prepaid expenses and other assets </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21.75pt; text-align:right; white-space:nowrap;">2,290</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">1,235</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:24pt;">
                <font style="letter-spacing:0.16pt;">Total current assets </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">72,938</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">29,786</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.16pt;">Property and equipment, net </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">8,677</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">3,084</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.16pt;">Right of use assets&#8201;&#8211;&#8201;operating leases </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21.75pt; text-align:right; white-space:nowrap;">6,121</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">2,579</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:24pt;">
                <font style="letter-spacing:0.16pt;">Total assets </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21.75pt; text-align:right; white-space:nowrap;">87,736</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">35,449</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:2.75pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <font style="letter-spacing:-0.16pt;">Liabilities, Convertible Preferred Stock and Stockholders&#8217; Deficit</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <font style="letter-spacing:0.16pt;">Current liabilities: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Accounts payable </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">4,085</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">2,322</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Accrued expenses </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">8,997</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">4,471</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Deferred revenue </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">1,230</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Operating lease liabilities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">5,184</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">898</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Finance lease liabilities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">1,006</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Convertible promissory note </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">33,175</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Other current liabilities </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21.75pt; text-align:right; white-space:nowrap;">157</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:24pt;">
                <font style="letter-spacing:0.16pt;">Total current liabilities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">53,834</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">7,691</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.16pt;">Deferred revenues </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">45,000</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.16pt;">Derivative liability </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">5,189</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.16pt;">Operating lease liabilities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">1,003</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">1,734</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.16pt;">Finance lease liabilities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">703</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.16pt;">Other long-term liabilities </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21.75pt; text-align:right; white-space:nowrap;">307</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.25pt 0pt 2.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:16pt;">
                <font style="letter-spacing:0.16pt;">Total liabilities </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21.75pt; text-align:right; white-space:nowrap;">106,036</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">9,425</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <font style="letter-spacing:0.16pt;">Commitments (Note 6) </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:9.5pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <font style="letter-spacing:0.16pt;">Convertible preferred stock, $0.0001 par value: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:338.99pt;white-space:normal;text-align:left;">
              <div style="margin-left:16pt; text-indent:-8pt;">
                <font style="letter-spacing:0.16pt;">Series&#160;A convertible preferred stock, 6,138,518 shares authorized; 5,201,017 shares issued and outstanding (liquidation value of $54,091 at September&#160;30, 2022) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">53,577</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">53,577</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Special voting preferred stock, 1 share authorized, issued and outstanding </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:338.99pt;white-space:normal;text-align:left;">
              <div style="margin-left:16pt; text-indent:-8pt;">
                <font style="letter-spacing:0.16pt;">Series&#160;B convertible preferred stock, 4,807,541 shares authorized, 3,499,866 shares issued and outstanding (liquidation value of $54,598 at September&#160;30, 2022) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">54,231</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">54,231</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Series&#160;B special voting preferred stock, 1 share authorized, issued and outstanding </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.25pt 0pt 2.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:24pt;">
                <font style="letter-spacing:0.16pt;">Total convertible preferred stock </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21.75pt; text-align:right; white-space:nowrap;">107,808</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">107,808</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <font style="letter-spacing:0.16pt;">Stockholders&#8217; deficit: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:338.99pt;white-space:normal;text-align:left;">
              <div style="margin-left:16pt; text-indent:-8pt;">
                <font style="letter-spacing:0.16pt;">Common stock $0.0001 par value, 14,910,158 shares authorized, 1,153,019 and 1,084,082 shares issued and outstanding as of September&#160;30, 2022 and December&#160;31, 2021, respectively </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Additional paid-in capital </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">1,141</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">818</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Accumulated other comprehensive loss </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">(160<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Accumulated deficit </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21.75pt; text-align:right; white-space:nowrap;">(141,484<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">(96,997<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:24pt;">
                <font style="letter-spacing:0.16pt;">Total CARISMA Therapeutics Inc. stockholders&#8217; deficit </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">(140,503<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">(96,179<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Noncontrolling interests </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21.75pt; text-align:right; white-space:nowrap;">14,395</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">14,395</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:24pt;">
                <font style="letter-spacing:0.16pt;">Total stockholders&#8217; deficit </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21.75pt; text-align:right; white-space:nowrap;">(126,108<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">(81,784<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:2.75pt 0pt 3.25pt 0pt; width:338.99pt;text-align:left;">
              <div style="margin-left:24pt;">
                <font style="letter-spacing:0.16pt;">Total liabilities, convertible preferred stock and stockholders&#8217; deficit </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21.75pt; text-align:right; white-space:nowrap;">87,736</td>
            <td style="padding:0pt;padding-left:7.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">35,449</td>
            <td style="padding:0pt;padding-left:7.71pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">See accompanying notes to the unaudited interim consolidated financial statements </font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">F-89</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC5">TABLE OF CONTENTS</a><a name="tUCSO">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:273.5pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CARISMA THERAPEUTICS INC. </font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Unaudited Consolidated Statements of Operations and Comprehensive Loss</font>
          <br >
          <font style="letter-spacing:-0.2pt;">(in thousands, except share and per share data)</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:285.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:341.17pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Nine Months Ended </font>
                <br >
                <font style="letter-spacing:-0.16pt;">September&#160;30, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:341.17pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.25pt 0pt 2.5pt 0pt; width:341.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Collaboration revenues </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">6,103</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:341.17pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Operating expenses: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:341.17pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Research and development </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">38,536</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">24,597</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:341.17pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">General and administrative </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">8,407</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">3,852</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.25pt 0pt 2.5pt 0pt; width:341.17pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Total operating expenses </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">46,943</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">28,449</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:341.17pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Operating loss </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">(40,840<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">(28,449<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:341.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Change in fair value of derivative liability </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">(1,369<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:341.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Interest (expense) income, net </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">(2,278<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">13</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:341.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Net loss </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">(44,487<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">(28,436<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:8.75pt 0pt 1.5pt 0pt; width:341.17pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Share information: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 3.25pt 0pt; width:341.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Net loss per share of common stock, basic and diluted </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">(40.16<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">(26.23<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 3.25pt 0pt; width:341.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Weighted-average shares of common stock outstanding, basic and diluted </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">1,107,792</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">1,084,082</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 1.5pt 0pt; width:341.17pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Comprehensive loss </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:341.17pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Net loss </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">(44,487<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">(28,436<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:341.17pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Unrealized loss on marketable securities </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">(160<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:341.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Comprehensive loss </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">(44,647<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">(28,436<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-left:10pt; margin-top:5pt; text-align:center; width:446pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;"> </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">See accompanying notes to the unaudited interim consolidated financial statements </font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-90</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:6.5pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC5">TABLE OF CONTENTS</a><a name="tUCSO1">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:12pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">CARISMA THERAPEUTICS INC. </font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">Unaudited Consolidated Statements of Convertible Preferred Equity and Stockholders&#8217; Deficit </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(in thousands, except per share and share data)</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
      </div>
      <div style="margin-top:12pt;margin-bottom:350.06pt;margin-left:27.16pt;width:541pt;">
        <table style="width:541pt;height:227.44pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:6.2pt;">
          <tr style="line-height:6.2pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:6.2pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:85.75pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 3.07pt 0pt; width:0pt;" colspan="46">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.124pt;">Convertible preferred stock </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.25pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.25pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 3.07pt 0pt; width:0pt;" colspan="40">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.124pt;">Stockholders&#8217; deficit </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:6.97pt;height:18.27pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:6.2pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:85.75pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.727pt 0pt 2.813pt 0pt; width:0pt;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.124pt;">Series&#160;A</font>
                <br >
                <font style="letter-spacing:-0.124pt;">convertible</font>
                <br >
                <font style="letter-spacing:-0.124pt;">preferred stock </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.727pt 0pt 2.813pt 0pt; width:0pt;" colspan="10">
              <div style="text-align:center; line-height:6.96pt;">
                <font style="letter-spacing:-0.124pt;">Special voting</font>
                <br >
                <font style="letter-spacing:-0.124pt;">preferred stock </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.727pt 0pt 2.813pt 0pt; width:0pt;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.124pt;">Series&#160;B</font>
                <br >
                <font style="letter-spacing:-0.124pt;">convertible</font>
                <br >
                <font style="letter-spacing:-0.124pt;">preferred stock </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.727pt 0pt 2.813pt 0pt; width:0pt;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.124pt;">Series&#160;B</font>
                <br >
                <font style="letter-spacing:-0.124pt;">special voting</font>
                <br >
                <font style="letter-spacing:-0.124pt;">preferred stock </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.25pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.25pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.727pt 0pt 2.813pt 0pt; width:0pt;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.124pt;">Common stock </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;" rowspan="2">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.727pt 0pt 2.813pt 0pt;" colspan="4" rowspan="2">
              <div style="text-align:center; line-height:6.97pt; padding-bottom:0pt;">
                <font style="letter-spacing:-0.124pt;">Additional </font>
                <br >
                <font style="letter-spacing:-0.124pt;">paid-in </font>
                <br >
                <font style="letter-spacing:-0.124pt;">capital </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;" rowspan="2">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;" rowspan="2">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.727pt 0pt 2.813pt 0pt;" colspan="4" rowspan="2">
              <div style="text-align:center; line-height:6.97pt; padding-bottom:0pt;">
                <font style="letter-spacing:-0.124pt;">Accumulated</font>
                <br >
                <font style="letter-spacing:-0.124pt;">other </font>
                <br >
                <font style="letter-spacing:-0.124pt;">comprehensive</font>
                <br >
                <font style="letter-spacing:-0.124pt;">loss </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;" rowspan="2">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;" rowspan="2">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.727pt 0pt 2.813pt 0pt;" colspan="4" rowspan="2">
              <div style="text-align:center; line-height:6.97pt; padding-bottom:0pt;">
                <font style="letter-spacing:-0.124pt;">Accumulated</font>
                <br >
                <font style="letter-spacing:-0.124pt;">deficit </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;" rowspan="2">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;" rowspan="2">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.727pt 0pt 2.813pt 0pt;" colspan="4" rowspan="2">
              <div style="text-align:center; line-height:6.97pt; padding-bottom:0pt;">
                <font style="letter-spacing:-0.124pt;">Noncontrolling</font>
                <br >
                <font style="letter-spacing:-0.124pt;">interests </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;" rowspan="2">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;" rowspan="2">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.727pt 0pt 2.813pt 0pt;" colspan="4" rowspan="2">
              <div style="white-space:nowrap; text-align:center; line-height:6.97pt; padding-bottom:0pt;">
                <font style="letter-spacing:-0.124pt;">Total </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;" rowspan="2">&#8203;</td>
          </tr>
          <tr style="line-height:6.2pt;height:12.84pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:6.2pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:85.75pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.24pt 0pt 3.07pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.124pt;">Shares </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.24pt 0pt 3.07pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.124pt;">Amount </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.24pt 0pt 3.07pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.124pt;">Shares </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.24pt 0pt 3.07pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.124pt;">Amount </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.24pt 0pt 3.07pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.124pt;">Shares </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.24pt 0pt 3.07pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.124pt;">Amount </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.24pt 0pt 3.07pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.124pt;">Shares </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.24pt 0pt 3.07pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.124pt;">Amount </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.25pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.25pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.24pt 0pt 3.07pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.124pt;">Shares </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.24pt 0pt 3.07pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.124pt;">Amount </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
          </tr>
          <tr style="line-height:6.5pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:6.5pt;">
            <td style="padding:3.24pt 0pt 2.01pt 0pt; width:85.75pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.13pt;">Balance, January&#160;1, 2022 </font>
              </div>
            </td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.01pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.01pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">5,201,017</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.24pt 0pt 2.01pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">53,577</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.4pt;width:0pt;">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.01pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.01pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">1</td>
            <td style="padding:0pt;padding-left:5.4pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.24pt 0pt 2.01pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&nbsp;&nbsp;&nbsp;&#8212;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.01pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.01pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">3,499,866</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.24pt 0pt 2.01pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">54,231</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.4pt;width:0pt;">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.01pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.01pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">1</td>
            <td style="padding:0pt;padding-left:5.4pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.24pt 0pt 2.01pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&nbsp;&nbsp;&nbsp;&#8212;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.01pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.01pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">1,084,082</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.24pt 0pt 2.01pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&nbsp;&nbsp;&nbsp;&#8212;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.52pt;width:0pt;">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.24pt 0pt 2.01pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">818</td>
            <td style="padding:0pt;padding-left:4.52pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.82pt;width:0pt;">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.24pt 0pt 2.01pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:10.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.42pt;width:0pt;">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.24pt 0pt 2.01pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">(96,997<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.42pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.615pt;width:0pt;">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.24pt 0pt 2.01pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">14,395</td>
            <td style="padding:0pt;padding-left:8.615pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.24pt 0pt 2.01pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">(81,784<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:6.5pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:6.5pt;">
            <td style="padding:3.49pt 0pt 2.01pt 0pt; width:85.75pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.13pt;">Exercise of stock options </font>
              </div>
            </td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.4pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:5.4pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.4pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:5.4pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">68,937</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.52pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">88</td>
            <td style="padding:0pt;padding-left:4.52pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.82pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:10.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.42pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.42pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.615pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:8.615pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">88</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:6.5pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:6.5pt;">
            <td style="padding:3.49pt 0pt 2.01pt 0pt; width:85.75pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.13pt;">Stock-based compensation </font>
              </div>
            </td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.4pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:5.4pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.4pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:5.4pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.52pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">235</td>
            <td style="padding:0pt;padding-left:4.52pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.82pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:10.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.42pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.42pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.615pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:8.615pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">235</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:6.5pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:6.5pt;">
            <td style="padding:3.49pt 0pt 2.01pt 0pt; width:85.75pt;text-align:left;">
              <div style="margin-left:6.5pt; text-indent:-6.5pt;">
                <font style="letter-spacing:0.13pt;">Unrealized loss on marketable </font>
                <br >
                <font style="letter-spacing:0.13pt;">securities </font>
              </div>
            </td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.4pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:5.4pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.4pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:5.4pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.52pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.52pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.82pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">(160<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:10.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.42pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.42pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.615pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:8.615pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">(160<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:6.5pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:6.5pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.49pt 0pt 2.75pt 0pt; width:85.75pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.13pt;">Net loss </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:16.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.4pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:5.4pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:16.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.4pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:5.4pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2.25pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.52pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.52pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.82pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:10.82pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.42pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">(44,487<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.42pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.615pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:16.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:8.615pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">(44,487<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:6.5pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:6.5pt;">
            <td style="padding:3.24pt 0pt 3.5pt 0pt; width:85.75pt;text-align:left;">
              <div style="margin-left:6.5pt; text-indent:-6.5pt;">
                <font style="letter-spacing:0.13pt;">Balance at September&#160;30, </font>
                <br >
                <font style="letter-spacing:0.13pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:24pt; text-align:right; white-space:nowrap;">5,201,017</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:16.5pt; text-align:right; white-space:nowrap;">53,577</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.4pt;width:0pt;">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:5.25pt; text-align:right; white-space:nowrap;">1</td>
            <td style="padding:0pt;padding-left:5.4pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:24pt; text-align:right; white-space:nowrap;">3,499,866</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:16.5pt; text-align:right; white-space:nowrap;">54,231</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.4pt;width:0pt;">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:5.25pt; text-align:right; white-space:nowrap;">1</td>
            <td style="padding:0pt;padding-left:5.4pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:24pt; text-align:right; white-space:nowrap;">1,153,019</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.52pt;width:0pt;">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">1,141</td>
            <td style="padding:0pt;padding-left:4.52pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.82pt;width:0pt;">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:10.5pt; text-align:right; white-space:nowrap;">(160<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:10.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.42pt;width:0pt;">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">(141,484<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.42pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.615pt;width:0pt;">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:16.5pt; text-align:right; white-space:nowrap;">14,395</td>
            <td style="padding:0pt;padding-left:8.615pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">(126,108<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:6.5pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:6.5pt;">
            <td style="padding:8.74pt 0pt 2.01pt 0pt; width:85.75pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.13pt;">Balance, January&#160;1, 2021 </font>
              </div>
            </td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:8.74pt 0pt 2.01pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:8.74pt 0pt 2.01pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">5,201,017</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:8.74pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:8.74pt 0pt 2.01pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">53,577</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.4pt;width:0pt;">&#8203;</td>
            <td style="padding:8.74pt 0pt 2.01pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:8.74pt 0pt 2.01pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">1</td>
            <td style="padding:0pt;padding-left:5.4pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:8.74pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:8.74pt 0pt 2.01pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:8.74pt 0pt 2.01pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:8.74pt 0pt 2.01pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">2,453,170</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:8.74pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:8.74pt 0pt 2.01pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">38,054</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.4pt;width:0pt;">&#8203;</td>
            <td style="padding:8.74pt 0pt 2.01pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:8.74pt 0pt 2.01pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">1</td>
            <td style="padding:0pt;padding-left:5.4pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:8.74pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:8.74pt 0pt 2.01pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:8.74pt 0pt 2.01pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:8.74pt 0pt 2.01pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">1,084,082</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:8.74pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:8.74pt 0pt 2.01pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.52pt;width:0pt;">&#8203;</td>
            <td style="padding:8.74pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:8.74pt 0pt 2.01pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">339</td>
            <td style="padding:0pt;padding-left:4.52pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.82pt;width:0pt;">&#8203;</td>
            <td style="padding:8.74pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:8.74pt 0pt 2.01pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:10.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.42pt;width:0pt;">&#8203;</td>
            <td style="padding:8.74pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:8.74pt 0pt 2.01pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">(56,213<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.42pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.615pt;width:0pt;">&#8203;</td>
            <td style="padding:8.74pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:8.74pt 0pt 2.01pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">14,395</td>
            <td style="padding:0pt;padding-left:8.615pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:8.74pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:8.74pt 0pt 2.01pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">(41,479<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:6.5pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:6.5pt;">
            <td style="padding:3.49pt 0pt 2.01pt 0pt; width:85.75pt;text-align:left;">
              <div style="margin-left:6.5pt; text-indent:-6.5pt;">
                <font style="letter-spacing:0.13pt;">Sale of Series&#160;B convertible </font>
                <br >
                <font style="letter-spacing:0.13pt;">preferred stock at $15.60 per </font>
                <br >
                <font style="letter-spacing:0.13pt;">share, net of issuance costs </font>
                <br >
                <font style="letter-spacing:0.13pt;">of $151 </font>
              </div>
            </td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.4pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:5.4pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">1,046,696</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">16,177</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.4pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:5.4pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.52pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.52pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.82pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:10.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.42pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.42pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.615pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:8.615pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:6.5pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:6.5pt;">
            <td style="padding:3.49pt 0pt 2.01pt 0pt; width:85.75pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.13pt;">Stock-based compensation </font>
              </div>
            </td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.4pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:5.4pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.4pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:5.4pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.52pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">361</td>
            <td style="padding:0pt;padding-left:4.52pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.82pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:10.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.42pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.42pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.615pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:8.615pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.01pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">361</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:6.5pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:6.5pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.49pt 0pt 2.75pt 0pt; width:85.75pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.13pt;">Net loss </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:16.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.4pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:5.4pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:16.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.4pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:5.4pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.25pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.52pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.52pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.82pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:10.82pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.42pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">(28,436<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.42pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.615pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:16.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:8.615pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.49pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">(28,436<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:6.5pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:6.5pt;">
            <td style="padding:3.24pt 0pt 3.5pt 0pt; width:85.75pt;text-align:left;">
              <div style="margin-left:6.5pt; text-indent:-6.5pt;">
                <font style="letter-spacing:0.13pt;">Balance at September&#160;30, </font>
                <br >
                <font style="letter-spacing:0.13pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:24pt; text-align:right; white-space:nowrap;">5,201,017</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:16.5pt; text-align:right; white-space:nowrap;">53,577</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.4pt;width:0pt;">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:5.25pt; text-align:right; white-space:nowrap;">1</td>
            <td style="padding:0pt;padding-left:5.4pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:24pt; text-align:right; white-space:nowrap;">3,499,866</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:16.5pt; text-align:right; white-space:nowrap;">54,231</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.4pt;width:0pt;">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:5.25pt; text-align:right; white-space:nowrap;">1</td>
            <td style="padding:0pt;padding-left:5.4pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt; width:2.25pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:24pt; text-align:right; white-space:nowrap;">1,084,082</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.17pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.52pt;width:0pt;">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">700</td>
            <td style="padding:0pt;padding-left:4.52pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.82pt;width:0pt;">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:10.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.42pt;width:0pt;">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">(84,649<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.42pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.615pt;width:0pt;">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:16.5pt; text-align:right; white-space:nowrap;">14,395</td>
            <td style="padding:0pt;padding-left:8.615pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt; width:2.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.24pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">(69,554<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">See accompanying notes to the unaudited interim consolidated financial statements </font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">F-91</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.7pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC5">TABLE OF CONTENTS</a><a name="tUCSO2">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">CARISMA THERAPEUTICS INC.</font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">Unaudited Consolidated Statements of Cash Flows</font>
          <br >
          <font style="letter-spacing:-0.2pt;">(in thousands)</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:572.38pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:362.1pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.467pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Nine Months Ended </font>
                <br >
                <font style="letter-spacing:-0.16pt;">September&#160;30, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:362.1pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.55pt 0pt 1.8pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.55pt 0pt 1.8pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9.7pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.7pt;">
            <td style="padding:2.55pt 0pt 0.5pt 0pt; width:362.1pt;text-align:left;">
              <font style="letter-spacing:0.194pt;">Cash flows from operating activities: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9.7pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.7pt;">
            <td style="padding:2.8pt 0pt 0.5pt 0pt; width:362.1pt;text-align:left;">
              <div style="margin-left:9.7pt;">
                <font style="letter-spacing:0.194pt;">Net loss </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.8pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.8pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(44,487<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.8pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.8pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(28,436<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9.7pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.7pt;">
            <td style="padding:2.8pt 0pt 0.5pt 0pt; width:362.1pt;text-align:left;">
              <div style="margin-left:9.7pt;">
                <font style="letter-spacing:0.194pt;">Adjustment to reconcile net loss to net cash provided by (used in) operating activities: </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9.69999999999999pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.7pt;">
            <td style="padding:2.8pt 0pt 0.5pt 0pt; width:362.1pt;text-align:left;">
              <div style="margin-left:19.4pt;">
                <font style="letter-spacing:0.194pt;">Depreciation and amortization expense </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.8pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.8pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">1,188</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.8pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.8pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">475</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9.69999999999999pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.7pt;">
            <td style="padding:2.8pt 0pt 0.5pt 0pt; width:362.1pt;text-align:left;">
              <div style="margin-left:19.4pt;">
                <font style="letter-spacing:0.194pt;">Stock-based compensation expense </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.8pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.8pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">235</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.8pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.8pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">361</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9.69999999999999pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.7pt;">
            <td style="padding:2.8pt 0pt 0.5pt 0pt; width:362.1pt;text-align:left;">
              <div style="margin-left:19.4pt;">
                <font style="letter-spacing:0.194pt;">Reduction in the operating right of use assets </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.8pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.8pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">2,895</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.8pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.8pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">408</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9.69999999999999pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.7pt;">
            <td style="padding:2.8pt 0pt 0.5pt 0pt; width:362.1pt;text-align:left;">
              <div style="margin-left:19.4pt;">
                <font style="letter-spacing:0.194pt;">Amortization of debt discount </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.8pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.8pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">1,995</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.8pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.8pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9.69999999999999pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.7pt;">
            <td style="padding:2.79pt 0pt 0.5pt 0pt; width:362.1pt;text-align:left;">
              <div style="margin-left:19.4pt;">
                <font style="letter-spacing:0.194pt;">Change in fair value of derivative liability </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.79pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.79pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">1,369</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.79pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.79pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9.69999999999999pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.7pt;">
            <td style="padding:2.79pt 0pt 0.5pt 0pt; width:362.1pt;text-align:left;">
              <div style="margin-left:19.4pt;">
                <font style="letter-spacing:0.194pt;">Non-cash interest expense </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.79pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.79pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">176</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.79pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.79pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9.69999999999999pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.7pt;">
            <td style="padding:2.79pt 0pt 0.5pt 0pt; width:362.1pt;text-align:left;">
              <div style="margin-left:19.4pt;">
                <font style="letter-spacing:0.194pt;">Changes in operating assets and liabilities: </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9.69999999999999pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.7pt;">
            <td style="padding:2.79pt 0pt 0.5pt 0pt; width:362.1pt;text-align:left;">
              <div style="margin-left:29.1pt;">
                <font style="letter-spacing:0.194pt;">Prepaid expenses and other assets </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.79pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.79pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(1,055<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.79pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.79pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(81<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9.69999999999999pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.7pt;">
            <td style="padding:2.79pt 0pt 0.5pt 0pt; width:362.1pt;text-align:left;">
              <div style="margin-left:29.1pt;">
                <font style="letter-spacing:0.194pt;">Accounts payable </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.79pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.79pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">1,794</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.79pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.79pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(952<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9.69999999999999pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.7pt;">
            <td style="padding:2.79pt 0pt 0.5pt 0pt; width:362.1pt;text-align:left;">
              <div style="margin-left:29.1pt;">
                <font style="letter-spacing:0.194pt;">Accrued expenses </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.79pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.79pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">4,526</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.79pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.79pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">414</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9.69999999999999pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.7pt;">
            <td style="padding:2.79pt 0pt 0.5pt 0pt; width:362.1pt;text-align:left;">
              <div style="margin-left:29.1pt;">
                <font style="letter-spacing:0.194pt;">Deferred revenues </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.79pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.79pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">46,230</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.79pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.79pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9.7pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.7pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:2.79pt 0pt 1.45pt 0pt; width:362.1pt;text-align:left;">
              <div style="margin-left:29.1pt;">
                <font style="letter-spacing:0.194pt;">Operating lease liabilities </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.79pt 0pt 1.45pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.79pt 0pt 1.45pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(2,882<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.79pt 0pt 1.45pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.79pt 0pt 1.45pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(396<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9.7pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.7pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2.54pt 0pt 1.45pt 0pt; width:362.1pt;text-align:left;">
              <div style="margin-left:38.8pt;">
                <font style="letter-spacing:0.194pt;">Net cash provided by (used in) operating activities </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.54pt 0pt 1.45pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.54pt 0pt 1.45pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">11,984</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.54pt 0pt 1.45pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.54pt 0pt 1.45pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(28,207<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9.69999999999999pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.7pt;">
            <td style="padding:2.54pt 0pt 0.5pt 0pt; width:362.1pt;text-align:left;">
              <font style="letter-spacing:0.194pt;">Cash flows from investing activities: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9.69999999999999pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.7pt;">
            <td style="padding:2.79pt 0pt 0.5pt 0pt; width:362.1pt;text-align:left;">
              <div style="margin-left:9.7pt;">
                <font style="letter-spacing:0.194pt;">Purchase of marketable securities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.79pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.79pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(84,028<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.79pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.79pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9.69999999999999pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.7pt;">
            <td style="padding:2.79pt 0pt 0.5pt 0pt; width:362.1pt;text-align:left;">
              <div style="margin-left:9.7pt;">
                <font style="letter-spacing:0.194pt;">Proceeds from the sale of marketable securities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.79pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.79pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">42,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.79pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.79pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9.7pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.7pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2.79pt 0pt 1.45pt 0pt; width:362.1pt;text-align:left;">
              <div style="margin-left:9.7pt;">
                <font style="letter-spacing:0.194pt;">Purchases of property and equipment </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.79pt 0pt 1.45pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.79pt 0pt 1.45pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(4,341<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.79pt 0pt 1.45pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.79pt 0pt 1.45pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(1,526<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9.7pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.7pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:2.54pt 0pt 1.45pt 0pt; width:362.1pt;text-align:left;">
              <div style="margin-left:38.8pt;">
                <font style="letter-spacing:0.194pt;">Net cash used in investing activities </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.54pt 0pt 1.45pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.54pt 0pt 1.45pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(46,369<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.54pt 0pt 1.45pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.54pt 0pt 1.45pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(1,526<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9.69999999999999pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.7pt;">
            <td style="padding:2.54pt 0pt 0.5pt 0pt; width:362.1pt;text-align:left;">
              <font style="letter-spacing:0.194pt;">Cash flows from financing activities: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9.69999999999999pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.7pt;">
            <td style="padding:2.79pt 0pt 0.5pt 0pt; width:362.1pt;text-align:left;">
              <div style="margin-left:9.7pt;">
                <font style="letter-spacing:0.194pt;">Proceeds from the exercise of stock options </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.79pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.79pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">88</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.79pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.79pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9.69999999999999pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.7pt;">
            <td style="padding:2.79pt 0pt 0.5pt 0pt; width:362.1pt;text-align:left;">
              <div style="margin-left:9.7pt;">
                <font style="letter-spacing:0.194pt;">Payment of principal related to the finance lease liabilities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.79pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.79pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(766<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.79pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.79pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9.69999999999999pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.7pt;">
            <td style="padding:2.79pt 0pt 0.5pt 0pt; width:362.1pt;text-align:left;">
              <div style="margin-left:9.7pt;">
                <font style="letter-spacing:0.194pt;">Proceeds from failed sale-leaseback arrangement </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.79pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.79pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">505</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.79pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.79pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9.69999999999999pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.7pt;">
            <td style="padding:2.78pt 0pt 0.5pt 0pt; width:362.1pt;text-align:left;">
              <div style="margin-left:9.7pt;">
                <font style="letter-spacing:0.194pt;">Payment of finance liability from failed sale-leaseback arrangement </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.78pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.78pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(50<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.78pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.78pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9.69999999999999pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.7pt;">
            <td style="padding:2.78pt 0pt 0.5pt 0pt; width:362.1pt;text-align:left;">
              <div style="margin-left:9.7pt;">
                <font style="letter-spacing:0.194pt;">Proceeds from the sale of Series&#160;B convertible preferred stock </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.78pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.78pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.78pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.78pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">16,328</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9.69999999999999pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.7pt;">
            <td style="padding:2.78pt 0pt 0.5pt 0pt; width:362.1pt;text-align:left;">
              <div style="margin-left:9.7pt;">
                <font style="letter-spacing:0.194pt;">Payment of Series&#160;B issuance costs </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.78pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.78pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.78pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.78pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(366<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9.7pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.7pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:2.78pt 0pt 1.45pt 0pt; width:362.1pt;text-align:left;">
              <div style="margin-left:9.7pt;">
                <font style="letter-spacing:0.194pt;">Proceeds from issuance of convertible promissory note </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.78pt 0pt 1.45pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.78pt 0pt 1.45pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">35,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.78pt 0pt 1.45pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.78pt 0pt 1.45pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9.7pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.7pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2.53pt 0pt 1.45pt 0pt; width:362.1pt;text-align:left;">
              <div style="margin-left:38.8pt;">
                <font style="letter-spacing:0.194pt;">Net cash provided by financing activities </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.53pt 0pt 1.45pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.53pt 0pt 1.45pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">34,777</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.53pt 0pt 1.45pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.53pt 0pt 1.45pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">15,962</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9.69999999999999pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.7pt;">
            <td style="padding:2.53pt 0pt 0.5pt 0pt; width:362.1pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.194pt;">Net increase (decrease) in cash and cash equivalents </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.53pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.53pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">392</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.53pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.53pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(13,771<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9.7pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.7pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2.78pt 0pt 1.45pt 0pt; width:362.1pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.194pt;">Cash and cash equivalents at beginning of the period </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.78pt 0pt 1.45pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.78pt 0pt 1.45pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">28,551</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.78pt 0pt 1.45pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.78pt 0pt 1.45pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">51,788</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9.7pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.7pt;">
            <td style="padding:2.53pt 0pt 2.2pt 0pt; width:362.1pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.194pt;">Cash and cash equivalents at end of the period </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.53pt 0pt 1.45pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.53pt 0pt 1.45pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">28,943</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.53pt 0pt 1.45pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.53pt 0pt 1.45pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">38,017</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9.70000000000005pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.7pt;">
            <td style="padding:2.03pt 0pt 0.5pt 0pt; width:362.1pt;text-align:left;">
              <font style="letter-spacing:0.194pt;">Supplemental disclosures of cash flow information: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9.7pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.7pt;">
            <td style="padding:2.78pt 0pt 2.2pt 0pt; width:362.1pt;text-align:left;">
              <div style="margin-left:9.7pt;">
                <font style="letter-spacing:0.194pt;">Cash paid for interest </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.78pt 0pt 1.45pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.78pt 0pt 1.45pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(50<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.78pt 0pt 1.45pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.78pt 0pt 1.45pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9.70000000000005pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.7pt;">
            <td style="padding:2.03pt 0pt 0.5pt 0pt; width:362.1pt;text-align:left;">
              <font style="letter-spacing:0.194pt;">Supplemental disclosures of non-cash financing and investing activities: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9.7pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.7pt;">
            <td style="padding:2.78pt 0pt 2.2pt 0pt; width:362.1pt;text-align:left;">
              <div style="margin-left:9.7pt;">
                <font style="letter-spacing:0.194pt;">Property and equipment in accounts payable </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.78pt 0pt 1.45pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.78pt 0pt 1.45pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">90</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.78pt 0pt 1.45pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.78pt 0pt 1.45pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">212</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9.7pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.7pt;">
            <td style="padding:2.03pt 0pt 2.2pt 0pt; width:362.1pt;text-align:left;">
              <div style="margin-left:9.7pt;">
                <font style="letter-spacing:0.194pt;">Unrealized loss on marketable securities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.03pt 0pt 1.45pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.03pt 0pt 1.45pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(160<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.03pt 0pt 1.45pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.03pt 0pt 1.45pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9.7pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.7pt;">
            <td style="padding:2.03pt 0pt 2.2pt 0pt; width:362.1pt;text-align:left;">
              <div style="margin-left:9.7pt;">
                <font style="letter-spacing:0.194pt;">Allocation of debt proceeds to derivative liability </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.03pt 0pt 1.45pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.03pt 0pt 1.45pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">3,820</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.03pt 0pt 1.45pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.03pt 0pt 1.45pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10.7pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.7pt;">
            <td style="padding:1.646pt 0pt 2.254pt 0pt; width:362.1pt;text-align:left;">
              <div style="margin-left:19.4pt; text-indent:-9.7pt; line-height:10.6999999999999pt; margin-bottom:-0.499999999999978pt;">
                <font style="letter-spacing:0.194pt;">Operating lease right of use assets obtained in exchange for operating lease </font>
                <br >
                <font style="letter-spacing:0.194pt;">liabilities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.144pt 0pt 1.756pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.144pt 0pt 1.756pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">6,437</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.144pt 0pt 1.756pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.144pt 0pt 1.756pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9.7pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9.7pt;">
            <td style="padding:2.03pt 0pt 2.2pt 0pt; width:362.1pt;text-align:left;">
              <div style="margin-left:9.7pt;">
                <font style="letter-spacing:0.194pt;">Operating lease right of use assets obtained in exchange for finance lease liabilities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.03pt 0pt 1.45pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.03pt 0pt 1.45pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">2,471</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.03pt 0pt 1.45pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.03pt 0pt 1.45pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:20.62pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">See accompanying notes to the unaudited interim consolidated financial statements</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">F-92</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC5">TABLE OF CONTENTS</a><a name="tNTTI">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CARISMA THERAPEUTICS INC.</font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Notes to the Interim Consolidated Financial Statements</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">(1)&nbsp;&nbsp;&nbsp;Background</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">CARISMA Therapeutics Inc., a Delaware Corporation (the Company), is a clinical-stage biopharmaceutical company focused on utilizing the Company&#8217;s proprietary macrophage and monocyte cell engineering platform to develop transformative therapies to treat cancer and other serious disorders. Cell therapy enables the utilization of reprogrammed living cells to perform complex functions such as clearance of tumor cells or resolution of inflammation. The Company&#8217;s initial focus is its proprietary Chimeric Antigen Receptor Macrophage (CAR-M) platform, which redirects macrophages against specific tumor associate antigens and enables targeted anti-tumor immunity by utilizing genetically modifying myeloid cells (macrophages and monocytes) to express chimeric antigen receptors, or CARs, enabling the innate immune cells to recognize specific tumor associated antigens on the surface of tumor cells. The Company&#8217;s clinical lead product candidate CT-0508 is an ex vivo gene-modified autologous CAR-M cell therapy product intended to treat solid tumors that overexpress HER2. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company received an investigational new drug application, or IND, clearance for CT-0508 for the treatment of HER2-overexpressing solid tumors in July&#160;2020 and dosed the first patient in March&#160;2021. The Food and Drug Administration, or FDA, granted CT-0508 Fast Track Status in September&#160;2021. As of September&#160;1, 2022, enrollment in group 1 of the first in human study has been completed with 9 patients successfully dosed with CT-0508, and group 2 is currently open for enrollment with an additional 9 patients to be dosed in the study. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On September&#160;20, 2022, the Company entered into an Agreement and Plan of Merger and Reorganization (the Merger Agreement) with Seahawk Merger Sub, Inc. (Merger Sub), a Delaware corporation and wholly-owned subsidiary of Sesen Bio, Inc. (Sesen Bio). The Merger Agreement provides for the merger of the Company with Merger Sub, with the Company as the surviving entity and the Company continuing as a wholly-owned subsidiary of Sesen Bio (the Merger). Subject to the terms and conditions of the Merger Agreement, at the closing of the Merger, (a)&#160;each then outstanding share of the Company&#8217;s common stock and preferred stock (collectively, the Company&#8217;s capital stock) (including shares of the Company&#8217;s common stock issued in connection with the pre-closing financing transaction described below) will be converted into the right to receive a number of shares of Sesen Bio common stock, and (b)&#160;each then outstanding stock option to purchase the Company&#8217;s common stock will be assumed by Sesen Bio, subject to adjustment as set forth in the Merger Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Following the Merger, the shareholders of the Company are expected to hold 58.3% of the combined company, and the shareholders of Sesen Bio are expected to hold 41.7% of the combined company. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Concurrently with the execution and delivery of the Merger Agreement, certain parties entered into agreements with the Company to purchase prior to the consummation of the Merger shares of the Company&#8217;s common stock for an aggregate purchase price of $30.6&#160;million (Pre-Closing Financing). Shares of the Company&#8217;s common stock issued pursuant to the Pre-Closing Financing transaction will be converted into shares of Sesen Bio common stock in the Merger. Upon completion of the Merger, the outstanding principal and unpaid interest associated with the $35.0&#160;million convertible promissory note will automatically convert into the shares of Sesen Bio common stock. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">(2)&nbsp;&nbsp;&nbsp;Development-Stage Risks and Liquidity</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company has incurred losses since inception and has an accumulated deficit of $141.5&#160;million as of September&#160;30, 2022. The Company anticipates incurring additional losses until such time, if ever, that it can generate significant sales from its product candidates currently in development. Management believes that cash, cash equivalents and marketable securities of $70.6&#160;million as of September&#160;30, 2022 are sufficient to sustain planned operations into the third quarter of 2023. As a result, the Company has concluded that there is substantial doubt about its ability to continue as a going concern within one year after the date that the unaudited interim consolidated financial statements are issued. The accompanying unaudited interim consolidated financial statements have been prepared on a going-concern basis, which contemplates the </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-93</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC5">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">realization of assets and satisfaction of liabilities in the normal course of business. The unaudited interim consolidated financial statements do not include any adjustments related to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might result from the outcome of this uncertainty. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Management is currently evaluating different strategies to obtain the required funding for future operations. These strategies may include but are not limited to private placements of equity and/or debt, licensing and/or marketing arrangements, and public offerings of equity and/or debt securities. There is no assurance that such financing will be available when needed. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company is subject to those risks associated with any specialty biotechnology company that has substantial expenditures for research and development. There can be no assurance that the Company&#8217;s research and development projects will be successful, that products developed will obtain necessary regulatory approval, or that any approved product will be commercially viable. In addition, the Company operates in an environment of rapid technological change and is largely dependent on the services of its employees and consultants. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">(3)&nbsp;&nbsp;&nbsp;Summary of Significant Accounting Policies</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The summary of significant accounting policies included in the Company&#8217;s annual consolidated financial statements that can be found elsewhere in this registration statement, have not materially changed, except as set forth below. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Interim Financial Statements</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The accompanying unaudited interim consolidated financial statements have been prepared in conformity with U.S. generally accepted accounting principles (U.S. GAAP) for interim financial information. Any reference in these notes to applicable guidance is meant to refer to U.S. GAAP as found in the Accounting Standards Codification (ASC) and Accounting Standards Updates (ASU) of the Financial Accounting Standards Board (FASB). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In the opinion of management, the accompanying interim consolidated financial statements include all normal and recurring adjustments (which consist primarily of accruals, estimates and assumptions that impact the consolidated financial statements) considered necessary to present fairly the Company&#8217;s financial position as of September&#160;30, 2022 and its results of operations for the nine&#160;months ended September&#160;30, 2022 and 2021. Operating results for the nine&#160;months ended September&#160;30, 2022 are not necessarily indicative of the results that may be expected for the year ending December&#160;31, 2022. The interim consolidated financial statements, presented herein, do not contain the required disclosures under U.S. GAAP for annual financial statements. The accompanying unaudited interim consolidated financial statements should be read in conjunction with the annual audited consolidated financial statements and related notes as of and for the year ended December&#160;31, 2021. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Use of Estimates</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The preparation of unaudited interim consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the unaudited interim consolidated financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates. Estimates and assumptions are periodically reviewed and the effects of revisions are reflected in the unaudited interim consolidated financial statements in the period they are determined to be necessary. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Significant areas that require management&#8217;s estimates include the fair value of the Company&#8217;s common stock, the derivative liability, stock-based compensation assumptions, the estimated useful lives of property and equipment and accrued research and development expenses. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Fair Value of Financial Instruments</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Management believes that the carrying amounts of the Company&#8217;s financial instruments, including cash equivalents and accounts payable approximate fair value due to the short-term nature of those </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-94</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC5">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">instruments. Due to the related-party relationship of the Convertible Promissory Note (Note 5), it is impractical to determine the fair value of the debt. The derivative liability is recorded at its estimated fair value. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Marketable Securities</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company&#8217;s marketable securities consist of investments in U.S. Treasuries that are classified as available-for-sale. The securities are carried at fair value with the unrealized gains and losses included in accumulated other comprehensive loss, a component of stockholders&#8217; deficit. Realized gains and losses and declines in value determined to be other than temporary are included in the Company&#8217;s statements of operations. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Fair Value Measurements</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible. The Company determines fair value based on assumptions that market participants would use in pricing an asset or liability in the principal or most advantageous market. When considering market participant assumptions in fair value measurements, the following fair value hierarchy distinguishes between observable and unobservable inputs, which are categorized in one of the following levels: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Level&#160;1 Inputs:&nbsp;&nbsp;&nbsp;Unadjusted quoted prices in active markets for identical assets or liabilities accessible to the reporting entity at the measurement date. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Level&#160;2 Inputs:&nbsp;&nbsp;&nbsp;Other than quoted prices included in Level&#160;1 inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the asset or liability. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Level&#160;3 Inputs:&nbsp;&nbsp;&nbsp;Unobservable inputs for the asset or liability used to measure fair value to the extent that observable inputs are not available, thereby allowing for situations in which there is little, if any, market activity for the asset or liability at the measurement date. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following fair value hierarchy table presents information about the Company&#8217;s assets and liabilities measured at fair value on a recurring basis: </font>
        </div>
        <table style="width:456pt;height:172pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:329.19pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;text-align:center;" colspan="16">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Fair value measurement at </font>
                <br >
                <font style="letter-spacing:-0.16pt;">reporting date using </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.25pt 0pt 2.5pt 0pt; width:329.19pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">(in thousands) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">(Level&#160;1) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">(Level&#160;2) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">(Level&#160;3) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:329.19pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">September&#160;30, 2022:</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.025pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.025pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:329.19pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Assets: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.025pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.025pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:329.19pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Cash equivalents&#8201;&#8211;&#8201;money markets accounts </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">575</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.025pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.025pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:329.19pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Marketable securities&#8201;&#8211;&#8201;U.S. Treasuries </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">41,705</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.025pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.025pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:329.19pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Liabilities: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.025pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.025pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:329.19pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Derivative liability&#8201;&#8211;&#8201;redemption feature on convertible promissory note </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.025pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212; </td>
            <td style="padding:0pt;padding-left:7.025pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">5,189</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:9.5pt 0pt 1.5pt 0pt; width:329.19pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">December&#160;31, 2021:</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.025pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.025pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:329.19pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Assets: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.025pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.025pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:329.19pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Cash equivalents&#8201;&#8211;&#8201;money markets accounts </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">5,182</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.025pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212; </td>
            <td style="padding:0pt;padding-left:7.025pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.67pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-left:20pt; margin-top:7.8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following is a summary of the Company&#8217;s marketable securities as of September&#160;30, 2022. </font>
        </div>
        <table style="width:456pt;height:56.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:317.06pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Amortized </font>
                <br >
                <font style="letter-spacing:-0.16pt;">costs </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Gross </font>
                <br >
                <font style="letter-spacing:-0.16pt;">unrealized </font>
                <br >
                <font style="letter-spacing:-0.16pt;">loss </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Fair Value </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:317.06pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Available-for-sale marketable securities </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.06pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.06pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.215pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.215pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:317.06pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">U.S. Treasury securities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.06pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">41,865</td>
            <td style="padding:0pt;padding-left:1.06pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.215pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">(160<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:5.215pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">41,705</td>
            <td style="padding:0pt;padding-left:0.824999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:7.8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company evaluated a redemption feature within the convertible promissory note issued in January&#160;2022 and determined bifurcation of the redemption feature was required. The redemption feature is </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-95</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC5">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">classified as a liability on the accompanying consolidated balance sheet and is marked-to-market each reporting period with the changes in fair value recorded in the accompanying statements of operations until it is triggered, terminated, reclassified or otherwise settled. The fair value of the derivative was determined based on an income approach that identified the cash flows using a &#8220;with-and-without&#8221; valuation methodology. The inputs used to determine the estimated fair value of the derivative instrument were based primarily on the probability of an underlying event triggering the embedded derivative occurring and the timing of such event. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">During the nine&#160;months ended September&#160;30, 2022, the discount factor used was 12% and a 90% probability of completing a qualified financing prior to the maturity date of the convertible promissory note was assumed. The estimated time of conversion ranged from three to twelve&#160;months. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The table presented below is a summary of the changes in fair value of the Company&#8217;s derivative liability (Level&#160;3 measurement): </font>
        </div>
        <table style="width:416pt;height:78pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 2.167pt 0pt; width:345.03pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">(in thousands) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;text-align:center;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Fair value of </font>
                <br >
                <font style="letter-spacing:-0.16pt;">derivative liability </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:345.03pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Balance at January&#160;1, 2022 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.63pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:15.63pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:345.03pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Balance at issuance </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.63pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">3,820</td>
            <td style="padding:0pt;padding-left:15.63pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:345.03pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Change in fair value </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.63pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">1,369</td>
            <td style="padding:0pt;padding-left:15.63pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:345.03pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Balance at September&#160;30, 2022 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.63pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">5,189</td>
            <td style="padding:0pt;padding-left:15.63pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:13.2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">During the nine&#160;months ended September&#160;30, 2022 and 2021, there were no transfers between Level&#160;1, Level&#160;2 and Level&#160;3. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Revenue Recognition</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company recognizes revenue in accordance with ASC Topic 606, </font><font style="font-style:italic;letter-spacing:0.2pt;">Revenue from Contracts with Customers</font><font style="letter-spacing:0.2pt;"> (ASC 606). This standard applies to all contracts with customers, except for contracts that are within the scope of other standards. Under ASC 606, an entity recognizes revenue when its customer obtains control of promised goods or services, in an amount that reflects the consideration which the entity expects to receive in exchange for those goods or services. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company enters into collaboration and licensing agreements with strategic partners, which are within the scope of ASC 606, under which it may exclusively license rights to research, develop, manufacture, and commercialize its product candidates to third parties. The terms of these arrangements typically include payment to the Company of one or more of the following: (1)&#160;non-refundable, upfront license fees; (2)&#160;reimbursement of certain costs; (3)&#160;customer option fees for additional goods or services; (4)&#160;development milestone payments, (5)&#160;regulatory and commercial milestone payments; and (6)&#160;royalties on net sales of licensed products. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In determining the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its agreements, the Company performs the following steps: (i)&#160;identification of the promised goods or services in the contract; (ii)&#160;determination of whether the promised goods or services are performance obligations including whether they are distinct in the context of the contract; (iii)&#160;measurement of the transaction price, including the constraint on variable consideration; (iv)&#160;allocation of the transaction price to the performance obligations; and (v)&#160;recognition of revenue when (or as) the Company satisfies each performance obligation. As part of the accounting for these arrangements, the Company must use its judgment to determine: (a)&#160;the number of performance obligations based on the determination under step (i)&#160;above; (b)&#160;the transaction price under step (iii)&#160;above; (c)&#160;the stand-alone selling price for each performance obligation identified in the contract for the allocation of transaction price in step (iv)&#160;above; and (d)&#160;the contract term and pattern of satisfaction of the performance obligations under step (v)&#160;above. The Company uses judgment to determine whether milestones or other variable consideration, except for royalties, should be included in the transaction price as described further below. The transaction price is allocated to each performance obligation on a relative stand-alone selling price basis, for which the Company recognizes revenue as or when the performance obligations under the contract are satisfied. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-96</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC5">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Amounts due to the Company for satisfying the revenue recognition criteria or that are contractually due based upon the terms of the collaboration agreements are recorded as accounts receivable in the Company&#8217;s consolidated balance sheet. Contract liabilities consist of amounts received prior to satisfying the revenue recognition criteria, which are recorded as deferred revenue in the Company&#8217;s consolidated balance sheet. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following table summarizes the changes in deferred revenue (in thousands): </font>
        </div>
        <table style="width:416pt;height:78pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:338.59pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;text-align:center;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Nine&#160;months ended </font>
                <br >
                <font style="letter-spacing:-0.16pt;">September&#160;30, 2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:338.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Balance at the beginning of the period </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.35pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:16.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:338.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Deferral of revenue </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.35pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">52,333</td>
            <td style="padding:0pt;padding-left:16.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:338.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Recognition of unearned revenue </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.35pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">(6,103<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:16.35pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:338.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Balance at the end of the period </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.35pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">46,230</td>
            <td style="padding:0pt;padding-left:16.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-left:20pt; margin-top:12.1pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">There was no deferred revenue as of December&#160;31, 2021. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The current portion of deferred revenue represents advanced payments received from ModernaTX, Inc. (Moderna) for costs expected to be incurred by the Company within the next twelve&#160;months. The noncurrent portion of deferred revenue represents the $45.0&#160;million upfront, non-refundable and non- creditable payment allocated to customer option right which is not expected to be recognized within the next 12&#160;months. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Upfront license fees</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If the license to the Company&#8217;s intellectual property is determined to be distinct from the other promises or performance obligations identified in the arrangement, the Company recognizes revenue from non-refundable, upfront fees allocated to the license when the license is transferred to the customer and the customer is able to use and benefit from the license. In assessing whether a promise or performance obligation is distinct from the other promises, the Company considers factors such as the research, manufacturing, and commercialization capabilities of the customer; the retention of any key rights by the Company; and the availability of the associated expertise in the general marketplace. In addition, the Company considers whether the customer can benefit from a promise for its intended purpose without the receipt of the remaining promises, whether the value of the promise is dependent on the unsatisfied promise, whether there are other vendors that could provide the remaining promise and whether it is separately identifiable from the remaining promise. For licenses that are combined with other promises, the Company exercises judgment to assess the nature of the combined performance obligation to determine whether the combined performance obligation is satisfied over time or at a point in time and, if over time, the appropriate method of measuring progress for purposes of recognizing revenue. The Company evaluates the measure of progress each reporting period and, if necessary, adjusts the measure of performance and related revenue recognition. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Customer options</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company evaluates the customer options for material rights or options to acquire additional goods or services for free or at a discount. If the customer options are determined to represent a material right, the material right is recognized as a separate performance obligation at the outset of the arrangement. The Company allocates the transaction price to material rights based on the relative standalone selling price, which is determined based on the identified discount and the probability that the customer will exercise the option. Amounts allocated to a material right are not recognized as revenue until, at the earliest, the option is exercised. If an option is not exercised and the research and development target is terminated, the Company will accelerate and recognize all remaining revenue related to the material right performance obligation. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Research and development services</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The promises under the Company&#8217;s collaboration agreements may include research and development services to be performed by the Company for or on behalf of the customer. Payments or reimbursements </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-97</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC5">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:23pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">resulting from the Company&#8217;s research and development efforts are recognized as the services are performed and presented on a gross basis because the Company is the principal for such efforts. Reimbursements from and payments to the customer that are the result of a collaborative relationship with the customer, instead of a customer relationship, such as co-development activities, are recorded as a reduction to research and development expense. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Milestone payments</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">At the inception of each arrangement that includes development milestone payments, the Company evaluates whether the milestones are considered probable of being achieved and estimates the amount to be included in the transaction price using the most likely amount method. If it is probable that a significant revenue reversal would not occur, the associated milestone value is included in the transaction price. Milestone payments that are not within the control of the Company or the licensee, such as regulatory approvals, are not considered probable of being achieved until those approvals are received. The Company evaluates factors such as the scientific, clinical, regulatory, commercial and other risks that must be overcome to achieve the particular milestone in making this assessment. There is considerable judgment involved in determining whether it is probable that a significant revenue reversal would not occur. At the end of each subsequent reporting period, the Company reevaluates the probability of achievement of all milestones subject to constraint and, if necessary, adjusts its estimate of the overall transaction price. Any such adjustments are recorded on a cumulative catch-up basis, which would affect revenues and earnings in the period of adjustment. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Net Loss per Share Attributable to Common Shareholders</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following potentially dilutive securities have been excluded from the computation of diluted weighted-average shares of common stock outstanding, as they would be anti-dilutive: </font>
        </div>
        <table style="width:456pt;height:114pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:302.99pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">September&#160;30, 2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">December&#160;31, 2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:302.99pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Series&#160;A convertible preferred stock </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">5,201,017</td>
            <td style="padding:0pt;padding-left:10pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.09pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">5,201,017</td>
            <td style="padding:0pt;padding-left:9.09pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:302.99pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Series&#160;B convertible preferred stock </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">3,499,866</td>
            <td style="padding:0pt;padding-left:10pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.09pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">3,499,866</td>
            <td style="padding:0pt;padding-left:9.09pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:302.99pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Class&#160;B exchangeable shares </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">937,501</td>
            <td style="padding:0pt;padding-left:10pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.09pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">937,501</td>
            <td style="padding:0pt;padding-left:9.09pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:302.99pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Class&#160;B-1 exchangeable shares </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">297,764</td>
            <td style="padding:0pt;padding-left:10pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.09pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">297,764</td>
            <td style="padding:0pt;padding-left:9.09pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:302.99pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Stock options to purchase common stock </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">1,804,246</td>
            <td style="padding:0pt;padding-left:10pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.09pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">1,869,438</td>
            <td style="padding:0pt;padding-left:9.09pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:302.99pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Conversion of convertible promissory note </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">1,688,301</td>
            <td style="padding:0pt;padding-left:10pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.09pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:9.09pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 0.75pt 0pt; width:302.99pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">13,428,695</td>
            <td style="padding:0pt;padding-left:10pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.09pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">11,805,586</td>
            <td style="padding:0pt;padding-left:9.09pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:13pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The above table assumes outstanding principal and interest converted into shares of the Company&#8217;s common stock at $21.06 per share. Conversion of the promissory note and related interest may vary depending on the terms and conditions to upon conversion of the promissory note. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Recent Accounting Pronouncements</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In August&#160;2020, the FASB issued ASU No. 2020-06, </font><font style="font-style:italic;letter-spacing:0.2pt;">Debt&#8201;&#8212;&#8201;Debt with Conversion and Other Options</font><font style="letter-spacing:0.2pt;"> (Subtopic 470-20) </font><font style="font-style:italic;letter-spacing:0.2pt;">and Derivatives and Hedging&#8201;&#8212;&#8201;Contracts in Entity&#8217;s Own Equity</font><font style="letter-spacing:0.2pt;"> (Subtopic 815-40)</font><font style="font-style:italic;letter-spacing:0.2pt;">: Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity</font><font style="letter-spacing:0.2pt;"> (ASU 2020-06), which simplifies the accounting for convertible instruments by reducing the number of accounting models available for convertible debt instruments. This guidance also eliminates the treasury stock method to calculate diluted earnings per share for convertible instruments and requires the use of the if converted method. The Company adopted the ASU effective January&#160;1, 2022 using the modified retrospective method of adoption. The Company applied this ASU to the convertible promissory note entered into in January&#160;2022 (see Note&#160;5). </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-98</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC5">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">(4)&nbsp;&nbsp;&nbsp;Property and Equipment, net</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:7.12pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Property and equipment, net consisted of the following (in thousands): </font>
        </div>
        <table style="width:416pt;height:129.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:262.99pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">September&#160;30, 2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">December&#160;31, 2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:262.99pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Computer software </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.35pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">917</td>
            <td style="padding:0pt;padding-left:16.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.275pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">214</td>
            <td style="padding:0pt;padding-left:16.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:262.99pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Lab equipment</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(1)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.35pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">9,749</td>
            <td style="padding:0pt;padding-left:16.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.275pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">3,694</td>
            <td style="padding:0pt;padding-left:16.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:262.99pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Office furniture </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.35pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">267</td>
            <td style="padding:0pt;padding-left:16.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.275pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">267</td>
            <td style="padding:0pt;padding-left:16.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:262.99pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Leasehold improvements </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.35pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">340</td>
            <td style="padding:0pt;padding-left:16.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.275pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">317</td>
            <td style="padding:0pt;padding-left:16.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:262.99pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Construction in progress </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.35pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">13</td>
            <td style="padding:0pt;padding-left:16.35pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.275pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">13</td>
            <td style="padding:0pt;padding-left:16.275pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:262.99pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.35pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">11,286</td>
            <td style="padding:0pt;padding-left:16.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.275pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">4,505</td>
            <td style="padding:0pt;padding-left:16.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:262.99pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Less: accumulated depreciation and amortization </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.35pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">(2,609<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:16.35pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.275pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">(1,421<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:16.275pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 0.75pt 0pt; width:262.99pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.35pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">8,677</td>
            <td style="padding:0pt;padding-left:16.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.275pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">3,084</td>
            <td style="padding:0pt;padding-left:16.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:5pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:6.61pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:6.61pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Lab equipment includes finance lease right of use (ROU) assets of $2.2&#160;million and are recorded net of accumulated amortization of $83,000 as of September&#160;30, 2022. There were no financial lease ROU assets as of December&#160;31, 2021. Lab equipment includes $0.6&#160;million resulting from a failed sale-leaseback (see Note&#160;6) and is recorded net of accumulated depreciation of $62,000 as of September&#160;30, 2022. There were no assets from failed sale-leasebacks as of December&#160;31, 2021.</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:7.12pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Depreciation and amortization expense was $1.2&#160;million and $0.5&#160;million for the nine&#160;months ended September&#160;30, 2022 and 2021, respectively. </font>
        </div>
        <div style="margin-top:10.02pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">(5)&nbsp;&nbsp;&nbsp;Convertible Promissory Note</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.12pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In January&#160;2022, concurrent with entering into the Moderna Collaboration and License Agreement (Note 8), the Company issued and sold to Moderna a convertible promissory note in the aggregate principal amount of $35.0&#160;million (the Note). If not earlier converted or repaid, the Note is payable on demand beginning in July&#160;2023. The Note accrues interest at an annual rate beginning at 0.33% through March&#160;2022 and then increasing by 0.767% each month thereafter capping at an annual rate of 8.0% in January&#160;2023. Upon the completion of a qualified financing event, the outstanding principal and accrued interest under the Note will automatically convert into shares of the Company issued in connection with the qualified financing at a conversion price equal to the lesser of (a)&#160;90% of the purchase price paid by other investors in such qualified financing and (b)&#160;$21.06 per share on an as converted to common stock basis. </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.22pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Since the Note is convertible into either (i)&#160;a variable number of shares of stock or (ii)&#160;a fixed conversion price, the Company evaluated the conversion provisions as a redemption feature and as a conversion feature, with the redemption feature evaluated as an embedded derivative and bifurcated from the proceeds of the Note due to the substantial premium paid upon redemption. Upon bifurcating the redemption feature, the Company recorded a debt discount of $3.8&#160;million which represents the initial fair value of the derivative liability that will be recognized as interest expense over the term of the Note. For the nine&#160;months ended September&#160;30, 2022, the Company recognized a change in fair value related to the redemption feature of $1.4&#160;million, which was included in the change in fair value of derivative liability on the consolidated statement of operations. For the nine&#160;months ended September&#160;30, 2022, the Company recognized interest expense of $2.6&#160;million of which $2.0&#160;million was related to the amortization of the debt discount. </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.12pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following table summarizes the carrying value of the Note at September&#160;30, 2022 (in thousands): </font>
        </div>
        <table style="width:416pt;height:40.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; width:371.29pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Principal amount of the Note </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:0pt 0pt 1pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">35,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:371.29pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Unamortized debt discount </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">(1,825<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:371.29pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Carrying value of the Note </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">33,175</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:12.92pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">(6)&nbsp;&nbsp;&nbsp;Commitments</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:9.63pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Leases</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.11pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In January&#160;2022, the Company amended its October&#160;2018 lease to add additional lab and office spaces. The lease for the additional spaces commenced in April&#160;2022 and has a term of 18&#160;months. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-99</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC5">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In February&#160;2022, the Company entered into another agreement to lease additional office and laboratory space in Philadelphia, Pennsylvania. This lease commenced in March&#160;2022 and has a term of 18&#160;months with an option for the Company to renew the lease for two additional terms of six&#160;months each at the end of lease term. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In June&#160;2022, the Company entered into a purchase and sale agreement under which the Company sold lab equipment for a purchase price of $0.5&#160;million. Concurrent with the sale of the equipment, the Company entered into a three-year lease agreement, whereby the Company will lease back the equipment at an annual rental rate of $0.2&#160;million. The Company was considered to have continuing involvement, and thus, accounted for the transaction as a failed sale-leaseback, with the equipment remaining on the balance sheet and the sale proceeds recorded as a finance liability. No gain or loss was recorded on the failed sale-leaseback. The Company continues to carry the lab equipment as property and equipment, net on the accompanying consolidated balance sheet. The ongoing lease payments are recorded as reductions to the finance liability and interest expense. As of September&#160;30, 2022, the Company had a $0.5&#160;million financing liability recorded in other liabilities and other noncurrent liabilities on the unaudited consolidated balance sheet. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company also has obligations under an arrangement for the use of certain lab equipment that are classified as finance leases that commenced in May&#160;2022 and have an end date of April&#160;2025. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The elements of the lease costs were as follows (in thousands): </font>
        </div>
        <table style="width:416pt;height:122pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:341.25pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Nine&#160;months ended </font>
                <br >
                <font style="letter-spacing:-0.16pt;">September&#160;30, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:341.25pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:341.25pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Operating lease cost </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.76pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">3,331</td>
            <td style="padding:0pt;padding-left:0.76pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.76pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">847</td>
            <td style="padding:0pt;padding-left:0.76pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:341.25pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Finance lease cost: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.76pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.76pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.76pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.76pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:341.25pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Amortization of lease assets </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.76pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">264</td>
            <td style="padding:0pt;padding-left:0.76pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.76pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.76pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:341.25pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Interest on lease liabilities </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.76pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">50</td>
            <td style="padding:0pt;padding-left:0.76pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.76pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.76pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.25pt 0pt 2.5pt 0pt; width:341.25pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total finance lease cost </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.76pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">314</td>
            <td style="padding:0pt;padding-left:0.76pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.76pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.76pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:341.25pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total lease cost </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.76pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">3,645</td>
            <td style="padding:0pt;padding-left:0.76pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.76pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">847</td>
            <td style="padding:0pt;padding-left:0.76pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-left:20pt; margin-top:13pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Lease term and discount rate information related to leases was as follows: </font>
        </div>
        <table style="width:416pt;height:98.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:338.59pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;text-align:center;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">September&#160;30, 2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:338.59pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Weighted-average remaining lease term (in&#160;years) </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:26.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:26.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:338.59pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Operating leases </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:26.35pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">2.0</td>
            <td style="padding:0pt;padding-left:26.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:338.59pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Finance leases </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:26.35pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">2.4</td>
            <td style="padding:0pt;padding-left:26.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:338.59pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Weighted-average discount rate </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:26.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:26.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:338.59pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Operating leases </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:26.35pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">9.3<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:26.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:338.59pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Finance leases </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:26.35pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">9.0<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:26.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Supplemental cash flow information (in thousands): </font>
        </div>
        <table style="width:416pt;height:91pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:341.25pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Nine&#160;months ended </font>
                <br >
                <font style="letter-spacing:-0.16pt;">September&#160;30, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:341.25pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:341.25pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Cash paid for amounts included in the measurement of lease liabilities:</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.76pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.76pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.76pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.76pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:341.25pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Operating cash used in operating leases </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.76pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">3,319</td>
            <td style="padding:0pt;padding-left:0.76pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.76pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">830</td>
            <td style="padding:0pt;padding-left:0.76pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:341.25pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Operating cash used for finance leases </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.76pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">50</td>
            <td style="padding:0pt;padding-left:0.76pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.76pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.76pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:341.25pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Financing cash used in finance leases </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.76pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">766</td>
            <td style="padding:0pt;padding-left:0.76pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.76pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.76pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-100</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC5">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Future maturities of lease liabilities were as follows as of September&#160;30, 2022 (in thousands): </font>
        </div>
        <table style="width:416pt;height:174.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:289.51pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Finance leases </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Operating leases </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:289.51pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Fiscal year ending:</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.815pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.815pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.725pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.725pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:289.51pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">2022 (remaining three&#160;months) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.815pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">110</td>
            <td style="padding:0pt;padding-left:9.815pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.725pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1,430</td>
            <td style="padding:0pt;padding-left:13.725pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:289.51pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">2023 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.815pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1,137</td>
            <td style="padding:0pt;padding-left:9.815pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.725pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">4,161</td>
            <td style="padding:0pt;padding-left:13.725pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:289.51pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">2024 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.815pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">437</td>
            <td style="padding:0pt;padding-left:9.815pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.725pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">213</td>
            <td style="padding:0pt;padding-left:13.725pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:289.51pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">2025 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.815pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">216</td>
            <td style="padding:0pt;padding-left:9.815pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.725pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">219</td>
            <td style="padding:0pt;padding-left:13.725pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:289.51pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">2026 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.815pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:9.815pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.725pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">226</td>
            <td style="padding:0pt;padding-left:13.725pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:289.51pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">2027 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.815pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:9.815pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.725pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">233</td>
            <td style="padding:0pt;padding-left:13.725pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:289.51pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Thereafter </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.815pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:9.815pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.725pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">425</td>
            <td style="padding:0pt;padding-left:13.725pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:289.51pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total future minimum payments </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.815pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1,900</td>
            <td style="padding:0pt;padding-left:9.815pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.725pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">6,907</td>
            <td style="padding:0pt;padding-left:13.725pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:289.51pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Less imputed interest </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.815pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">(191<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:9.815pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.725pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">(720<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:13.725pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:289.51pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Present value of lease liabilities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.815pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">1,709</td>
            <td style="padding:0pt;padding-left:9.815pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.725pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">6,187</td>
            <td style="padding:0pt;padding-left:13.725pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:16.8pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">(7)&nbsp;&nbsp;&nbsp;Stock-based Compensation</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In August&#160;2017, the Company adopted the 2017 Stock Incentive Plan (the Plan) as amended that authorized the Company to grant up to 1,739,936 shares of common stock. In 2022, the Company amended the Plan and increased the total number of shares authorized under the Plan to 2,664,018. As of September&#160;30, 2022, there were 631,560 shares available to be granted. The Company&#8217;s stock options vest based on the terms in the awards agreements and generally vest over four&#160;years. The Company recorded stock-based compensation expense in the following expense categories in its accompanying statements of operations: </font>
        </div>
        <table style="width:416pt;height:76.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:337.66pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Nine Months Ended </font>
                <br >
                <font style="letter-spacing:-0.16pt;">September&#160;30, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:337.66pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:337.66pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Research and development </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.585pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">122</td>
            <td style="padding:0pt;padding-left:3.585pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.585pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">135</td>
            <td style="padding:0pt;padding-left:3.585pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:337.66pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">General and administrative </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.585pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">113</td>
            <td style="padding:0pt;padding-left:3.585pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.585pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">226</td>
            <td style="padding:0pt;padding-left:3.585pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 0.75pt 0pt; width:337.66pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.585pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">235</td>
            <td style="padding:0pt;padding-left:3.585pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.585pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">361</td>
            <td style="padding:0pt;padding-left:3.585pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-left:20pt; margin-top:12.8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following is a summary of stock option activity under the Plan: </font>
        </div>
        <table style="width:456pt;height:169pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:236.73pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Options </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Weighted </font>
                <br >
                <font style="letter-spacing:-0.16pt;">average </font>
                <br >
                <font style="letter-spacing:-0.16pt;">exercise price </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Weighted </font>
                <br >
                <font style="letter-spacing:-0.16pt;">average </font>
                <br >
                <font style="letter-spacing:-0.16pt;">remaining </font>
                <br >
                <font style="letter-spacing:-0.16pt;">contractual </font>
                <br >
                <font style="letter-spacing:-0.16pt;">term (years) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Aggregate </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Intrinsic </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Value </font>
                <br >
                <font style="letter-spacing:-0.16pt;">(in thousands) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:236.73pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Outstanding as of January&#160;1, 2022 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">1,869,438</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.775pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">1.85</td>
            <td style="padding:0pt;padding-left:10.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.785pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.785pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:236.73pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Granted </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">107,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.775pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">2.67</td>
            <td style="padding:0pt;padding-left:10.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.785pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.785pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:236.73pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Exercised </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">(68,937<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.775pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">1.28</td>
            <td style="padding:0pt;padding-left:10.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.785pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.785pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">97</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:236.73pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Forfeited </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">(101,844<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.775pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">1.78</td>
            <td style="padding:0pt;padding-left:10.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.785pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.785pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:236.73pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Expired </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">(1,411<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.775pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:13.5pt; text-align:right; white-space:nowrap;">1.89</td>
            <td style="padding:0pt;padding-left:10.775pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.785pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:9.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.785pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #CCEEFF; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:236.73pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Outstanding as of September&#160;30, 2022 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">1,804,246</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.775pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:13.5pt; text-align:right; white-space:nowrap;">1.92</td>
            <td style="padding:0pt;padding-left:10.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.785pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:9.75pt; text-align:right; white-space:nowrap;">7.6</td>
            <td style="padding:0pt;padding-left:13.785pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1,441</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:4pt 0pt 3.25pt 0pt; width:236.73pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Exercisable as of September&#160;30, 2022 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:4pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:4pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">1,039,047</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.775pt;width:0pt;">&#8203;</td>
            <td style="padding:4pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:4pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:13.5pt; text-align:right; white-space:nowrap;">1.51</td>
            <td style="padding:0pt;padding-left:10.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.785pt;width:0pt;">&#8203;</td>
            <td style="padding:4pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:4pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:9.75pt; text-align:right; white-space:nowrap;">6.9</td>
            <td style="padding:0pt;padding-left:13.785pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:4pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:4pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1,243</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:4pt 0pt 2.25pt 0pt; width:236.73pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Vested and expected to vest at September&#160;30, 2022 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:4pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:4pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">1,804,246</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.775pt;width:0pt;">&#8203;</td>
            <td style="padding:4pt 0pt 1.5pt 0pt;padding-bottom:1.75pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:4pt 0pt 1.5pt 0pt;padding-bottom:1.75pt; min-width:13.5pt; text-align:right; white-space:nowrap;">1.92</td>
            <td style="padding:0pt;padding-left:10.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.785pt;width:0pt;">&#8203;</td>
            <td style="padding:4pt 0pt 1.5pt 0pt;padding-bottom:1.75pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:4pt 0pt 1.5pt 0pt;padding-bottom:1.75pt; min-width:9.75pt; text-align:right; white-space:nowrap;">7.6</td>
            <td style="padding:0pt;padding-left:13.785pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:4pt 0pt 1.5pt 0pt;padding-bottom:1.75pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:4pt 0pt 1.5pt 0pt;padding-bottom:1.75pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1,441</td>
            <td style="padding:0pt;padding-left:9.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:12.8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The weighted-average grant-date per share fair values of options granted during the nine&#160;months ended September&#160;30, 2022 and 2021 was $1.46 and $1.44, respectively. The fair values during the nine&#160;months ended September&#160;30, 2022 and 2021 were estimated using the Black-Scholes option-pricing model based on the following assumptions: </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-101</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC5">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <table style="width:456pt;height:97pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:287.43pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Nine Months Ended September&#160;30, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:287.43pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt; width:72.28pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt; width:72.28pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:right;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:287.43pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Risk-free interest rate </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0.5pt 1.5pt 0pt; width:72.28pt;">
              <div style="text-align:right;">
                <font style="letter-spacing:0.2pt;">2.40%&#8201;&#8211;&#8201;3.05%</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0.5pt 1.5pt 0pt; width:72.28pt;">
              <div style="text-align:right;">
                <font style="letter-spacing:0.2pt;">0.98%&#8201;&#8211;&#8201;1.19%</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:right;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:287.43pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Expected term </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0.5pt 1.5pt 0pt; width:72.28pt;">
              <div style="text-align:right;">
                <font style="letter-spacing:0.2pt;">6&#160;years</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0.5pt 1.5pt 0pt; width:72.28pt;">
              <div style="text-align:right;">
                <font style="letter-spacing:0.2pt;">6&#160;years</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:right;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:287.43pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Expected volatility </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0.5pt 1.5pt 0pt; width:72.28pt;">
              <div style="text-align:right;">
                <font style="letter-spacing:0.2pt;">54.54%&#8201;&#8211;&#8201;56.50%</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0.5pt 1.5pt 0pt; width:72.28pt;">
              <div style="text-align:right;">
                <font style="letter-spacing:0.2pt;">53.27%&#8201;&#8211;&#8201;54.22%</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:right;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:287.43pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Expected dividend yield </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0.5pt 1.5pt 0pt; width:72.28pt;">
              <div style="text-align:right;">
                <font style="letter-spacing:0.2pt;">&#8212;</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0.5pt 1.5pt 0pt; width:72.28pt;">
              <div style="text-align:right;">
                <font style="letter-spacing:0.2pt;">&#8212;</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:right;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:287.43pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Estimated fair value of the Company&#8217;s common stock per share </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0.5pt 1.5pt 0pt; width:72.28pt;">
              <div style="text-align:right;">
                <font style="letter-spacing:0.2pt;">$2.68</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0.5pt 1.5pt 0pt; width:72.28pt;">
              <div style="text-align:right;">
                <font style="letter-spacing:0.2pt;">$2.77</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:7.3pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Future compensation cost for awards not vested as of September&#160;30, 2022 was $0.9&#160;million and will be expensed over a weighted-average period of 2.5&#160;years. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">(8)&nbsp;&nbsp;&nbsp;Moderna Collaboration and License Agreement</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In January&#160;2022, the Company entered into a Collaboration and License Agreement with Moderna (Moderna License Agreement), to develop and commercialize </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;"> engineered chimeric antigen receptor monocyte (CAR-M) therapeutics for different forms of cancer. The Moderna License Agreement allows Moderna to develop and commercialize product candidates for up to twelve research targets. The Company is responsible for discovering and optimizing development candidates, and Moderna is responsible for the clinical development thereafter. Pursuant to the Moderna License Agreement, the Company and Moderna formed a joint steering committee, or JSC, that is responsible for the coordination and oversight of all research activities to which the Company is responsible for providing. The JSC is comprised of three representatives each from the Company and Moderna and with Moderna having final decision-making authority, subject to customary exclusions. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">During the research term of the Moderna License Agreement, the Company has granted Moderna an exclusive worldwide royalty free license to the Company&#8217;s intellectual property associated with the product candidates that permits Moderna to conduct its research and development activities. Upon Moderna&#8217;s election of a development target (and payment of a related development target designation milestone) for commencement of pre-clinical development of a product candidate, the Company will grant Moderna an exclusive worldwide, sublicensable royalty bearing license to develop, manufacture and commercialize the product candidate. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Upon execution of the Moderna License Agreement, Moderna made an upfront non-refundable payment of $45.0&#160;million to the Company. Moderna also will reimburse the Company for all costs incurred by the Company in connection with its research and development activities under the Moderna License Agreement plus a reasonable margin for the respective services performed (with a minimum commitment to reimburse $10.0&#160;million in research and development costs over the first three&#160;years from execution of the Moderna License Agreement). In addition, assuming Moderna develops and commercializes 12 products, each directed to a different development target, the Company is eligible to receive up to between $247.0&#160;million and $253.0&#160;million per product in development target designation, development, regulatory and commercial milestone payments. The Company is also eligible to receive tiered mid-to-high single digit royalties of net product sales, subject to adjustment. In addition, Moderna will repay the Company for certain development, regulatory and commercial milestone payments and certain royalty payments pursuant to the Company&#8217;s license agreement with the University of Pennsylvania. The Moderna License Agreement terminates on a product-by-product basis upon the latest of expiration of the applicable product patents, expiration of regulatory exclusivity and the tenth anniversary of first commercial sale, unless terminated earlier by the Company or Moderna. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">At commencement, the Company identified several potential performance obligations within the Moderna License Agreement, including research and development services on research targets, option rights held by Moderna, a non-exclusive royalty-free license to use the Company&#8217;s intellectual property to conduct research and development activities and participation on the JSC. The Company determined that there were two performance obligations comprised of (1)&#160;research and development services and (2)&#160;option rights. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">For the research and development services, the stand-alone selling price was determined considering the expected passthrough costs and cost of the research and development services and a reasonable margin </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-102</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC5">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:155pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">for the respective services. The material rights from the option rights were valued based on the estimated discount at which the option is priced and the Company&#8217;s estimated probability of the options&#8217; exercise as of the time of the amendment. The transaction price allocated to research and development services is recognized as collaboration revenues as the research and development services are provided, using an input method, in proportion to costs incurred to date for each research development target as compared to total costs incurred and expected to be incurred in the future to satisfy the underlying obligation related to the research and development target. The transfer of control occurs over this period and, in management&#8217;s judgment, is the best measure of progress towards satisfying the performance obligation. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The transaction price allocated to the options rights, which are considered material rights, will be recognized in the period that Moderna elects to exercise or elects to not exercise its option right to license and commercialize the underlying research and development target. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company included the $45.0&#160;million upfront payment and $73.9&#160;million of variable consideration for expected research and development services to be performed during the five year contract term, inclusive of passthrough costs, in the transaction price as of the outset of the arrangement. During the nine&#160;months ended September&#160;30, 2022, the Company recognized $6.1&#160;million of research and development services as collaboration revenues as the Company is the principal in providing such services. The following table summarizes the allocation of the total transaction price to the identified performance obligations under the arrangement, and the amount of the transaction price unsatisfied as of September&#160;30, 2022 (in thousands): </font>
        </div>
        <table style="width:416pt;height:78pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:276.51pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Transaction price </font>
                <br >
                <font style="letter-spacing:-0.16pt;">allocated </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Transaction price </font>
                <br >
                <font style="letter-spacing:-0.16pt;">unsatisfied </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:276.51pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Performance obligations: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:276.51pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Research and development services </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">73,937</td>
            <td style="padding:0pt;padding-left:10.015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">67,834</td>
            <td style="padding:0pt;padding-left:10.015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:276.51pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Option rights </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.015pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">45,000</td>
            <td style="padding:0pt;padding-left:10.015pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.015pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">45,000</td>
            <td style="padding:0pt;padding-left:10.015pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:276.51pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Total performance obligations </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">118,937</td>
            <td style="padding:0pt;padding-left:10.015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">112,834</td>
            <td style="padding:0pt;padding-left:10.015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">(9)&nbsp;&nbsp;&nbsp;Related Party Transactions</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company has outstanding licensing and scientific research agreements with the University of Pennsylvania, a significant shareholder. The Company recognized $1.4&#160;million and $1.0&#160;million of research and development expense for the nine&#160;months ended September&#160;30, 2022 and 2021, respectively, related to the license agreement. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">(10)&nbsp;&nbsp;&nbsp;Subsequent Events</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company has evaluated subsequent events from the balance sheet date through November&#160;21, 2022, the issuance date of these unaudited interim consolidated financial statements and has not identified any requiring disclosure except as noted below.</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-103</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a><a name="tAAPM">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;height:660pt;margin-left:69.66pt;width:456pt;">

          <div style="text-align:right; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">ANNEX A-1</font>&#8203;</div>

        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">AGREEMENT AND PLAN OF MERGER</font>
          <br >
          <font style="letter-spacing:-0.2pt;">AND REORGANIZATION</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">among:</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">SESEN BIO, INC.,</font>
          <br >
          <font style="letter-spacing:-0.2pt;">a Delaware corporation;</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">SEAHAWK MERGER SUB, INC.,</font>
          <br >
          <font style="letter-spacing:-0.2pt;">a Delaware corporation; and</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CARISMA THERAPEUTICS INC.,</font>
          <br >
          <font style="letter-spacing:-0.2pt;">a Delaware corporation</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Dated as of September&#160;20, 2022</font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a><a name="TOC6">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">TABLE OF CONTENTS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:620.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:414.63pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;text-align:center;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Page </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; line-height:10pt; text-align:left; width:51pt;white-space:nowrap;font-weight:bold;">
                <a href="#tS1OT"><font style="letter-spacing:-0.2pt;">Section&#160;1.</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:51pt;font-weight:bold;">
                <a href="#tS1OT"><font style="letter-spacing:-0.2pt;">DESCRIPTION OF TRANSACTION</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#tS1OT">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tS1OT">A-1-2</a></font> <a href="#tS1OT"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t1MUT"><font style="letter-spacing:0.2pt;">1.1</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t1MUT"><font style="font-weight:bold;letter-spacing:-0.2pt;">The Merger</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t1MUT">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t1MUT">A-1-2</a></font> <a href="#t1MUT"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t1OTM"><font style="letter-spacing:0.2pt;">1.2</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t1OTM"><font style="font-weight:bold;letter-spacing:-0.2pt;">Effects of the Merger</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t1OTM">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t1OTM">A-1-2</a></font> <a href="#t1OTM"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t1ETU"><font style="letter-spacing:0.2pt;">1.3</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t1ETU"><font style="font-weight:bold;letter-spacing:-0.2pt;">Closing; Effective Time</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t1ETU">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t1ETU">A-1-2</a></font> <a href="#t1ETU"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t1OIA"><font style="letter-spacing:0.2pt;">1.4</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t1OIA"><font style="font-weight:bold;letter-spacing:-0.2pt;">Certificate of Incorporation and Bylaws; Directors and Officers</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t1OIA">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t1OIA">A-1-2</a></font> <a href="#t1OIA"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t1OS"><font style="letter-spacing:0.2pt;">1.5</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t1OS"><font style="font-weight:bold;letter-spacing:-0.2pt;">Conversion of Shares</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t1OS">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t1OS">A-1-3</a></font> <a href="#t1OS"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t1OTC"><font style="letter-spacing:0.2pt;">1.6</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t1OTC"><font style="font-weight:bold;letter-spacing:-0.2pt;">Closing of the Company&#8217;s Transfer Books</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t1OTC">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t1OTC">A-1-4</a></font> <a href="#t1OTC"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t1OC"><font style="letter-spacing:0.2pt;">1.7</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t1OC"><font style="font-weight:bold;letter-spacing:-0.2pt;">Surrender of Certificates</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t1OC">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t1OC">A-1-4</a></font> <a href="#t1OC"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t18RI"><font style="letter-spacing:0.2pt;">1.8</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t18RI"><font style="font-weight:bold;letter-spacing:-0.2pt;">Appraisal Rights</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t18RI">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t18RI">A-1-5</a></font> <a href="#t18RI"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t1AIA"><font style="letter-spacing:0.2pt;">1.9</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t1AIA"><font style="font-weight:bold;letter-spacing:-0.2pt;">Further Action</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t1AIA">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t1AIA">A-1-5</a></font> <a href="#t1AIA"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t1TPA"><font style="letter-spacing:0.2pt;">1.10</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t1TPA"><font style="font-weight:bold;letter-spacing:-0.2pt;">Withholding</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t1TPA">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t1TPA">A-1-6</a></font> <a href="#t1TPA"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t1ONC"><font style="letter-spacing:0.2pt;">1.11</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t1ONC"><font style="font-weight:bold;letter-spacing:-0.2pt;">Calculation of Net Cash</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t1ONC">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t1ONC">A-1-6</a></font> <a href="#t1ONC"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:9.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; line-height:10pt; text-align:left; width:51pt;white-space:nowrap;font-weight:bold;">
                <a href="#tS2AW"><font style="letter-spacing:-0.2pt;">Section&#160;2.</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:51pt;font-weight:bold;">
                <a href="#tS2AW"><font style="letter-spacing:-0.2pt;">REPRESENTATIONS AND WARRANTIES OF THE COMPANY</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#tS2AW">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:9.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:9.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tS2AW">A-1-7</a></font> <a href="#tS2AW"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t2OS"><font style="letter-spacing:0.2pt;">2.1</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t2OS"><font style="font-weight:bold;letter-spacing:-0.2pt;">Due Organization; Subsidiaries</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t2OS">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t2OS">A-1-7</a></font> <a href="#t2OS"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t2DTC"><font style="letter-spacing:0.2pt;">2.2</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t2DTC"><font style="font-weight:bold;letter-spacing:-0.2pt;">Organizational Documents</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t2DTC">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t2DTC">A-1-8</a></font> <a href="#t2DTC"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t2BNO"><font style="letter-spacing:0.2pt;">2.3</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t2BNO"><font style="font-weight:bold;letter-spacing:-0.2pt;">Authority; Binding Nature of Agreement</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t2BNO">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t2BNO">A-1-8</a></font> <a href="#t2BNO"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t2RTA"><font style="letter-spacing:0.2pt;">2.4</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t2RTA"><font style="font-weight:bold;letter-spacing:-0.2pt;">Vote Required</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t2RTA">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t2RTA">A-1-8</a></font> <a href="#t2RTA"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t2CST"><font style="letter-spacing:0.2pt;">2.5</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t2CST"><font style="font-weight:bold;letter-spacing:-0.2pt;">Non-Contravention; Consents</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t2CST">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t2CST">A-1-8</a></font> <a href="#t2CST"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t26C"><font style="letter-spacing:0.2pt;">2.6</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t26C"><font style="font-weight:bold;letter-spacing:-0.2pt;">Capitalization</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t26C">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t26C">A-1-9</a></font> <a href="#t26C"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t27ST"><font style="letter-spacing:0.2pt;">2.7</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t27ST"><font style="font-weight:bold;letter-spacing:-0.2pt;">Financial Statements</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t27ST">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t27ST">A-1-10</a></font> <a href="#t27ST"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t2OCA"><font style="letter-spacing:0.2pt;">2.8</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t2OCA"><font style="font-weight:bold;letter-spacing:-0.2pt;">Absence of Changes</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t2OCA">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t2OCA">A-1-11</a></font> <a href="#t2OCA"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t2OUL"><font style="letter-spacing:0.2pt;">2.9</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t2OUL"><font style="font-weight:bold;letter-spacing:-0.2pt;">Absence of Undisclosed Liabilities</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t2OUL">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t2OUL">A-1-11</a></font> <a href="#t2OUL"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t2TAE"><font style="letter-spacing:0.2pt;">2.10</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t2TAE"><font style="font-weight:bold;letter-spacing:-0.2pt;">Title to Assets</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t2TAE">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t2TAE">A-1-11</a></font> <a href="#t2TAE"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t2PLN"><font style="letter-spacing:0.2pt;">2.11</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t2PLN"><font style="font-weight:bold;letter-spacing:-0.2pt;">Real Property; Leasehold</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t2PLN">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t2PLN">A-1-12</a></font> <a href="#t2PLN"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t21PR"><font style="letter-spacing:0.2pt;">2.12</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t21PR"><font style="font-weight:bold;letter-spacing:-0.2pt;">Intellectual Property</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t21PR">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t21PR">A-1-12</a></font> <a href="#t21PR"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t2CAC"><font style="letter-spacing:0.2pt;">2.13</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t2CAC"><font style="font-weight:bold;letter-spacing:-0.2pt;">Agreements, Contracts and Commitments</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t2CAC">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t2CAC">A-1-14</a></font> <a href="#t2CAC"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t2PR"><font style="letter-spacing:0.2pt;">2.14</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t2PR"><font style="font-weight:bold;letter-spacing:-0.2pt;">Compliance; Permits; Restrictions</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t2PR">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t2PR">A-1-15</a></font> <a href="#t2PR"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t2PO"><font style="letter-spacing:0.2pt;">2.15</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t2PO"><font style="font-weight:bold;letter-spacing:-0.2pt;">Legal Proceedings; Orders</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t2PO">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t2PO">A-1-17</a></font> <a href="#t2PO"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t21MA"><font style="letter-spacing:0.2pt;">2.16</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t21MA"><font style="font-weight:bold;letter-spacing:-0.2pt;">Tax Matters</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t21MA">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t21MA">A-1-18</a></font> <a href="#t21MA"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t2ALM"><font style="letter-spacing:0.2pt;">2.17</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t2ALM"><font style="font-weight:bold;letter-spacing:-0.2pt;">Employee and Labor Matters; Benefit Plans</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t2ALM">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t2ALM">A-1-19</a></font> <a href="#t2ALM"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t2MSJ"><font style="letter-spacing:0.2pt;">2.18</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t2MSJ"><font style="font-weight:bold;letter-spacing:-0.2pt;">Environmental Matters</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t2MSJ">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t2MSJ">A-1-22</a></font> <a href="#t2MSJ"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t2TCH"><font style="letter-spacing:0.2pt;">2.19</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t2TCH"><font style="font-weight:bold;letter-spacing:-0.2pt;">Insurance</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t2TCH">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t2TCH">A-1-22</a></font> <a href="#t2TCH"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t2FAN"><font style="letter-spacing:0.2pt;">2.20</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t2FAN"><font style="font-weight:bold;letter-spacing:-0.2pt;">No Financial Advisors</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t2FAN">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t2FAN">A-1-23</a></font> <a href="#t2FAN"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t2WAS"><font style="letter-spacing:0.2pt;">2.21</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t2WAS"><font style="font-weight:bold;letter-spacing:-0.2pt;">Transactions with Affiliates</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t2WAS">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t2WAS">A-1-23</a></font> <a href="#t2WAS"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t2NOT"><font style="letter-spacing:0.2pt;">2.22</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t2NOT"><font style="font-weight:bold;letter-spacing:-0.2pt;">Anti-Bribery</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t2NOT">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t2NOT">A-1-23</a></font> <a href="#t2NOT"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t2OOR"><font style="letter-spacing:0.2pt;">2.23</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t2OOR"><font style="font-weight:bold;letter-spacing:-0.2pt;">Disclaimer of Other Representations or Warranties</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t2OOR">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t2OOR">A-1-23</a></font> <a href="#t2OOR"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:9.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; line-height:10pt; text-align:left; width:51pt;white-space:nowrap;font-weight:bold;">
                <a href="#tS3AW"><font style="letter-spacing:-0.2pt;">Section&#160;3.</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:51pt;font-weight:bold;">
                <a href="#tS3AW"><font style="letter-spacing:-0.2pt;">REPRESENTATIONS AND WARRANTIES OF PARENT AND MERGER SUB</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#tS3AW">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:9.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:9.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tS3AW">A-1-23</a></font> <a href="#tS3AW"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t3OS"><font style="letter-spacing:0.2pt;">3.1</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t3OS"><font style="font-weight:bold;letter-spacing:-0.2pt;">Due Organization; Subsidiaries</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t3OS">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t3OS">A-1-23</a></font> <a href="#t3OS"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t3DPH"><font style="letter-spacing:0.2pt;">3.2</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t3DPH"><font style="font-weight:bold;letter-spacing:-0.2pt;">Organizational Documents</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t3DPH">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t3DPH">A-1-24</a></font> <a href="#t3DPH"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t3BNO"><font style="letter-spacing:0.2pt;">3.3</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t3BNO"><font style="font-weight:bold;letter-spacing:-0.2pt;">Authority; Binding Nature of Agreement</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t3BNO">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t3BNO">A-1-24</a></font> <a href="#t3BNO"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-ii</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <table style="width:456pt;height:647.5pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:414.63pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;text-align:center;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Page </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t3RAT"><font style="letter-spacing:0.2pt;">3.4</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t3RAT"><font style="font-weight:bold;letter-spacing:-0.2pt;">Vote Required</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t3RAT">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t3RAT">A-1-25</a></font> <a href="#t3RAT"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t3CST"><font style="letter-spacing:0.2pt;">3.5</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t3CST"><font style="font-weight:bold;letter-spacing:-0.2pt;">Non-Contravention; Consents</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t3CST">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t3CST">A-1-25</a></font> <a href="#t3CST"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t36C"><font style="letter-spacing:0.2pt;">3.6</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t36C"><font style="font-weight:bold;letter-spacing:-0.2pt;">Capitalization</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t36C">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t36C">A-1-26</a></font> <a href="#t36C"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t3FFS"><font style="letter-spacing:0.2pt;">3.7</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t3FFS"><font style="font-weight:bold;letter-spacing:-0.2pt;">SEC Filings; Financial Statements</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t3FFS">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t3FFS">A-1-27</a></font> <a href="#t3FFS"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t3OCA"><font style="letter-spacing:0.2pt;">3.8</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t3OCA"><font style="font-weight:bold;letter-spacing:-0.2pt;">Absence of Changes</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t3OCA">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t3OCA">A-1-29</a></font> <a href="#t3OCA"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t3OUL"><font style="letter-spacing:0.2pt;">3.9</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t3OUL"><font style="font-weight:bold;letter-spacing:-0.2pt;">Absence of Undisclosed Liabilities</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t3OUL">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t3OUL">A-1-29</a></font> <a href="#t3OUL"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t3TAE"><font style="letter-spacing:0.2pt;">3.10</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t3TAE"><font style="font-weight:bold;letter-spacing:-0.2pt;">Title to Assets</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t3TAE">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t3TAE">A-1-29</a></font> <a href="#t3TAE"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t3PLN"><font style="letter-spacing:0.2pt;">3.11</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t3PLN"><font style="font-weight:bold;letter-spacing:-0.2pt;">Real Property; Leasehold</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t3PLN">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t3PLN">A-1-29</a></font> <a href="#t3PLN"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t31PR"><font style="letter-spacing:0.2pt;">3.12</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t31PR"><font style="font-weight:bold;letter-spacing:-0.2pt;">Intellectual Property</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t31PR">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t31PR">A-1-29</a></font> <a href="#t31PR"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t3CAC"><font style="letter-spacing:0.2pt;">3.13</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t3CAC"><font style="font-weight:bold;letter-spacing:-0.2pt;">Agreements, Contracts and Commitments</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t3CAC">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t3CAC">A-1-31</a></font> <a href="#t3CAC"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t31PE"><font style="letter-spacing:0.2pt;">3.14</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t31PE"><font style="font-weight:bold;letter-spacing:-0.2pt;">Compliance; Permits</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t31PE">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t31PE">A-1-33</a></font> <a href="#t31PE"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t3PO"><font style="letter-spacing:0.2pt;">3.15</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t3PO"><font style="font-weight:bold;letter-spacing:-0.2pt;">Legal Proceedings; Orders</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t3PO">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t3PO">A-1-35</a></font> <a href="#t3PO"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t31MA"><font style="letter-spacing:0.2pt;">3.16</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t31MA"><font style="font-weight:bold;letter-spacing:-0.2pt;">Tax Matters</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t31MA">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t31MA">A-1-35</a></font> <a href="#t31MA"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t3ALM"><font style="letter-spacing:0.2pt;">3.17</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t3ALM"><font style="font-weight:bold;letter-spacing:-0.2pt;">Employee and Labor Matters; Benefit Plans</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t3ALM">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t3ALM">A-1-36</a></font> <a href="#t3ALM"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t3MSJ"><font style="letter-spacing:0.2pt;">3.18</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t3MSJ"><font style="font-weight:bold;letter-spacing:-0.2pt;">Environmental Matters</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t3MSJ">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t3MSJ">A-1-39</a></font> <a href="#t3MSJ"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t3PHM"><font style="letter-spacing:0.2pt;">3.19</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t3PHM"><font style="font-weight:bold;letter-spacing:-0.2pt;">Insurance</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t3PHM">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t3PHM">A-1-39</a></font> <a href="#t3PHM"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t3FAO"><font style="letter-spacing:0.2pt;">3.20</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t3FAO"><font style="font-weight:bold;letter-spacing:-0.2pt;">No Financial Advisors</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t3FAO">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t3FAO">A-1-40</a></font> <a href="#t3FAO"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t3WAE"><font style="letter-spacing:0.2pt;">3.21</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t3WAE"><font style="font-weight:bold;letter-spacing:-0.2pt;">Transactions with Affiliates</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t3WAE">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t3WAE">A-1-40</a></font> <a href="#t3WAE"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t3NPN"><font style="letter-spacing:0.2pt;">3.22</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t3NPN"><font style="font-weight:bold;letter-spacing:-0.2pt;">Anti-Bribery</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t3NPN">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t3NPN">A-1-40</a></font> <a href="#t3NPN"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t3ITP"><font style="letter-spacing:0.2pt;">3.23</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t3ITP"><font style="font-weight:bold;letter-spacing:-0.2pt;">Valid Issuance</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t3ITP">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t3ITP">A-1-40</a></font> <a href="#t3ITP"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t3OFA"><font style="letter-spacing:0.2pt;">3.24</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t3OFA"><font style="font-weight:bold;letter-spacing:-0.2pt;">Opinion of Financial Advisor</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t3OFA">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t3OFA">A-1-40</a></font> <a href="#t3OFA"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t3OOR"><font style="letter-spacing:0.2pt;">3.25</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t3OOR"><font style="font-weight:bold;letter-spacing:-0.2pt;">Disclaimer of Other Representations or Warranties</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t3OOR">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t3OOR">A-1-40</a></font> <a href="#t3OOR"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:9.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; line-height:10pt; text-align:left; width:51pt;white-space:nowrap;font-weight:bold;">
                <a href="#tS4CO"><font style="letter-spacing:-0.2pt;">Section&#160;4.</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:51pt;font-weight:bold;">
                <a href="#tS4CO"><font style="letter-spacing:-0.2pt;">CERTAIN COVENANTS OF THE PARTIES</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#tS4CO">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:9.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:9.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tS4CO">A-1-40</a></font> <a href="#tS4CO"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t4OPB"><font style="letter-spacing:0.2pt;">4.1</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t4OPB"><font style="font-weight:bold;letter-spacing:-0.2pt;">Operation of Parent&#8217;s Business</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t4OPB">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t4OPB">A-1-40</a></font> <a href="#t4OPB"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t4OTC"><font style="letter-spacing:0.2pt;">4.2</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t4OTC"><font style="font-weight:bold;letter-spacing:-0.2pt;">Operation of the Company&#8217;s Business</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t4OTC">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t4OTC">A-1-43</a></font> <a href="#t4OTC"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t4AI"><font style="letter-spacing:0.2pt;">4.3</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t4AI"><font style="font-weight:bold;letter-spacing:-0.2pt;">Access and Investigation</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t4AI">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t4AI">A-1-44</a></font> <a href="#t4AI"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t44NO"><font style="letter-spacing:0.2pt;">4.4</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t44NO"><font style="font-weight:bold;letter-spacing:-0.2pt;">Parent Non-Solicitation</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t44NO">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t44NO">A-1-45</a></font> <a href="#t44NO"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t45NO"><font style="letter-spacing:0.2pt;">4.5</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t45NO"><font style="font-weight:bold;letter-spacing:-0.2pt;">Company Non-Solicitation</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t45NO">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t45NO">A-1-46</a></font> <a href="#t45NO"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t4OCM"><font style="letter-spacing:0.2pt;">4.6</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t4OCM"><font style="font-weight:bold;letter-spacing:-0.2pt;">Notification of Certain Matters</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t4OCM">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t4OCM">A-1-47</a></font> <a href="#t4OCM"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t4TA"><font style="letter-spacing:0.2pt;">4.7</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t4TA"><font style="font-weight:bold;letter-spacing:-0.2pt;">Potentially Transferable Assets</font><font style="letter-spacing:0.2pt;">. </font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t4TA">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t4TA">A-1-48</a></font> <a href="#t4TA"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:9.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; line-height:10pt; text-align:left; width:51pt;white-space:nowrap;font-weight:bold;">
                <a href="#tS5AO"><font style="letter-spacing:-0.2pt;">Section&#160;5.</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:51pt;font-weight:bold;">
                <a href="#tS5AO"><font style="letter-spacing:-0.2pt;">ADDITIONAL AGREEMENTS OF THE PARTIES.</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#tS5AO">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:9.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:9.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tS5AO">A-1-48</a></font> <a href="#tS5AO"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t5SPS"><font style="letter-spacing:0.2pt;">5.1</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t5SPS"><font style="font-weight:bold;letter-spacing:-0.2pt;">Registration Statement; Proxy Statement/Prospectus</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t5SPS">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t5SPS">A-1-48</a></font> <a href="#t5SPS"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t52MA"><font style="letter-spacing:0.2pt;">5.2</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t52MA"><font style="font-weight:bold;letter-spacing:-0.2pt;">Regulatory Matters</font><font style="letter-spacing:0.2pt;">. </font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t52MA">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t52MA">A-1-49</a></font> <a href="#t52MA"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t5SM"><font style="letter-spacing:0.2pt;">5.3</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t5SM"><font style="font-weight:bold;letter-spacing:-0.2pt;">Company Stockholder Matters</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t5SM">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t5SM">A-1-50</a></font> <a href="#t5SM"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t5SM1"><font style="letter-spacing:0.2pt;">5.4</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t5SM1"><font style="font-weight:bold;letter-spacing:-0.2pt;">Parent Stockholders&#8217; Meeting</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t5SM1">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t5SM1">A-1-51</a></font> <a href="#t5SM1"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:12pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t5OCC"><font style="letter-spacing:0.2pt;">5.5</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:12pt; text-align:left; margin-left:80pt;">
                <a href="#t5OCC"><font style="font-weight:bold;letter-spacing:-0.2pt;">Company Options, Company Convertible Note, Parent Warrants, and Parent Equity Awards</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t5OCC">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t5OCC">A-1-53</a></font> <a href="#t5OCC"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t5OOA"><font style="letter-spacing:0.2pt;">5.6</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t5OOA"><font style="font-weight:bold;letter-spacing:-0.2pt;">Indemnification of Officers and Directors</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t5OOA">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t5OOA">A-1-54</a></font> <a href="#t5OOA"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t5AIA"><font style="letter-spacing:0.2pt;">5.7</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t5AIA"><font style="font-weight:bold;letter-spacing:-0.2pt;">Additional Agreements</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t5AIA">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t5AIA">A-1-56</a></font> <a href="#t5AIA"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t5TIP"><font style="letter-spacing:0.2pt;">5.8</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t5TIP"><font style="font-weight:bold;letter-spacing:-0.2pt;">Disclosure</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t5TIP">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t5TIP">A-1-56</a></font> <a href="#t5TIP"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t5DTP"><font style="letter-spacing:0.2pt;">5.9</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t5DTP"><font style="font-weight:bold;letter-spacing:-0.2pt;">Listing</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t5DTP">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t5DTP">A-1-56</a></font> <a href="#t5DTP"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t51MA"><font style="letter-spacing:0.2pt;">5.10</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t51MA"><font style="font-weight:bold;letter-spacing:-0.2pt;">Tax Matters</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t51MA">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t51MA">A-1-56</a></font> <a href="#t51MA"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-iii</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <table style="width:456pt;height:647.5pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:414.63pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;text-align:center;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Page </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t5PSB"><font style="letter-spacing:0.2pt;">5.11</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t5PSB"><font style="font-weight:bold;letter-spacing:-0.2pt;">Legends</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t5PSB">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t5PSB">A-1-57</a></font> <a href="#t5PSB"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t5AOP"><font style="letter-spacing:0.2pt;">5.12</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t5AOP"><font style="font-weight:bold;letter-spacing:-0.2pt;">Directors and Officers</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t5AOP">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t5AOP">A-1-57</a></font> <a href="#t5AOP"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t5OCA"><font style="letter-spacing:0.2pt;">5.13</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t5OCA"><font style="font-weight:bold;letter-spacing:-0.2pt;">Termination of Certain Agreements and Rights</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t5OCA">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t5OCA">A-1-57</a></font> <a href="#t5OCA"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t51MP"><font style="letter-spacing:0.2pt;">5.14</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t51MP"><font style="font-weight:bold;letter-spacing:-0.2pt;">Section&#160;16 Matters</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t51MP">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t51MP">A-1-57</a></font> <a href="#t51MP"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t5EPS"><font style="letter-spacing:0.2pt;">5.15</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t5EPS"><font style="font-weight:bold;letter-spacing:-0.2pt;">Cooperation</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t5EPS">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t5EPS">A-1-58</a></font> <a href="#t5EPS"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t51CE"><font style="letter-spacing:0.2pt;">5.16</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t51CE"><font style="font-weight:bold;letter-spacing:-0.2pt;">Allocation Certificates</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t51CE">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t51CE">A-1-58</a></font> <a href="#t51CE"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t5FST"><font style="letter-spacing:0.2pt;">5.17</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t5FST"><font style="font-weight:bold;letter-spacing:-0.2pt;">Company Financial Statements</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t5FST">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t5FST">A-1-58</a></font> <a href="#t5FST"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t5SIA"><font style="letter-spacing:0.2pt;">5.18</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t5SIA"><font style="font-weight:bold;letter-spacing:-0.2pt;">Takeover Statutes</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t5SIA">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t5SIA">A-1-58</a></font> <a href="#t5SIA"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t5LEP"><font style="letter-spacing:0.2pt;">5.19</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t5LEP"><font style="font-weight:bold;letter-spacing:-0.2pt;">Stockholder Litigation</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t5LEP">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t5LEP">A-1-58</a></font> <a href="#t5LEP"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t52BE"><font style="letter-spacing:0.2pt;">5.20</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t52BE"><font style="font-weight:bold;letter-spacing:-0.2pt;">Employee Benefits</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t52BE">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t52BE">A-1-59</a></font> <a href="#t52BE"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t5DPT"><font style="letter-spacing:0.2pt;">5.21</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t5DPT"><font style="font-weight:bold;letter-spacing:-0.2pt;">Pre-Closing Dividend</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t5DPT">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t5DPT">A-1-59</a></font> <a href="#t5DPT"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t5RSP"><font style="letter-spacing:0.2pt;">5.22</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t5RSP"><font style="font-weight:bold;letter-spacing:-0.2pt;">Nasdaq Reverse Split</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t5RSP">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t5RSP">A-1-59</a></font> <a href="#t5RSP"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t5SDF"><font style="letter-spacing:0.2pt;">5.23</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t5SDF"><font style="font-weight:bold;letter-spacing:-0.2pt;">Parent SEC Documents</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t5SDF">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t5SDF">A-1-59</a></font> <a href="#t5SDF"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t5OMS"><font style="letter-spacing:0.2pt;">5.24</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t5OMS"><font style="font-weight:bold;letter-spacing:-0.2pt;">Obligations of Merger Sub</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t5OMS">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t5OMS">A-1-60</a></font> <a href="#t5OMS"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:9.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; line-height:10pt; text-align:left; width:51pt;white-space:nowrap;font-weight:bold;">
                <a href="#tS6PT"><font style="letter-spacing:-0.2pt;">Section&#160;6.</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:51pt;font-weight:bold;">
                <a href="#tS6PT"><font style="letter-spacing:-0.2pt;">CONDITIONS PRECEDENT TO OBLIGATIONS OF EACH PARTY</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#tS6PT">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:9.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:9.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tS6PT">A-1-60</a></font> <a href="#tS6PT"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t6RNT"><font style="letter-spacing:0.2pt;">6.1</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t6RNT"><font style="font-weight:bold;letter-spacing:-0.2pt;">No Restraints</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t6RNT">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t6RNT">A-1-60</a></font> <a href="#t6RNT"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t6AIP"><font style="letter-spacing:0.2pt;">6.2</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t6AIP"><font style="font-weight:bold;letter-spacing:-0.2pt;">Stockholder Approval</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t6AIP">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t6AIP">A-1-60</a></font> <a href="#t6AIP"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t6TES"><font style="letter-spacing:0.2pt;">6.3</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t6TES"><font style="font-weight:bold;letter-spacing:-0.2pt;">Listing</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t6TES">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t6TES">A-1-60</a></font> <a href="#t6TES"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t6ORS"><font style="letter-spacing:0.2pt;">6.4</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t6ORS"><font style="font-weight:bold;letter-spacing:-0.2pt;">Effectiveness of Registration Statement</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t6ORS">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t6ORS">A-1-60</a></font> <a href="#t6ORS"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:8.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; line-height:12pt; text-align:left; width:51pt;white-space:nowrap;font-weight:bold;">
                <a href="#tS7CP"><font style="letter-spacing:-0.2pt;">Section&#160;7.</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:12pt; text-align:left; margin-left:51pt;font-weight:bold;">
                <a href="#tS7CP"><font style="letter-spacing:-0.2pt;">ADDITIONAL CONDITIONS PRECEDENT TO OBLIGATIONS OF PARENT AND MERGER SUB</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#tS7CP">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:8.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:8.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tS7CP">A-1-60</a></font> <a href="#tS7CP"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t7ORT"><font style="letter-spacing:0.2pt;">7.1</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t7ORT"><font style="font-weight:bold;letter-spacing:-0.2pt;">Accuracy of Representations</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t7ORT">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t7ORT">A-1-60</a></font> <a href="#t7ORT"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t7OCT"><font style="letter-spacing:0.2pt;">7.2</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t7OCT"><font style="font-weight:bold;letter-spacing:-0.2pt;">Performance of Covenants</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t7OCT">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t7OCT">A-1-61</a></font> <a href="#t7OCT"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t7CPS"><font style="letter-spacing:0.2pt;">7.3</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t7CPS"><font style="font-weight:bold;letter-spacing:-0.2pt;">Closing Certificate</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t7CPS">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t7CPS">A-1-61</a></font> <a href="#t7CPS"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t7CPS1"><font style="letter-spacing:0.2pt;">7.4</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t7CPS1"><font style="font-weight:bold;letter-spacing:-0.2pt;">FIRPTA Certificate</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t7CPS1">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t7CPS1">A-1-61</a></font> <a href="#t7CPS1"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t7OIA"><font style="letter-spacing:0.2pt;">7.5</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t7OIA"><font style="font-weight:bold;letter-spacing:-0.2pt;">Termination of Investor Agreements</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t7OIA">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t7OIA">A-1-61</a></font> <a href="#t7OIA"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t7LAT"><font style="letter-spacing:0.2pt;">7.6</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t7LAT"><font style="font-weight:bold;letter-spacing:-0.2pt;">Company Lock-Up Agreements</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t7LAT">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t7LAT">A-1-61</a></font> <a href="#t7LAT"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:8.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; line-height:12pt; text-align:left; width:51pt;white-space:nowrap;font-weight:bold;">
                <a href="#tS8CP"><font style="letter-spacing:-0.2pt;">Section&#160;8.</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:12pt; text-align:left; margin-left:51pt;font-weight:bold;">
                <a href="#tS8CP"><font style="letter-spacing:-0.2pt;">ADDITIONAL CONDITIONS PRECEDENT TO OBLIGATION OF THE COMPANY</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#tS8CP">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:8.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:8.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tS8CP">A-1-61</a></font> <a href="#tS8CP"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t8ORT"><font style="letter-spacing:0.2pt;">8.1</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t8ORT"><font style="font-weight:bold;letter-spacing:-0.2pt;">Accuracy of Representations</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t8ORT">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t8ORT">A-1-61</a></font> <a href="#t8ORT"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t8OCP"><font style="letter-spacing:0.2pt;">8.2</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t8OCP"><font style="font-weight:bold;letter-spacing:-0.2pt;">Performance of Covenants</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t8OCP">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t8OCP">A-1-62</a></font> <a href="#t8OCP"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t8TCS"><font style="letter-spacing:0.2pt;">8.3</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t8TCS"><font style="font-weight:bold;letter-spacing:-0.2pt;">Documents</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t8TCS">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t8TCS">A-1-62</a></font> <a href="#t8TCS"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t8LAT"><font style="letter-spacing:0.2pt;">8.4</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t8LAT"><font style="font-weight:bold;letter-spacing:-0.2pt;">Parent Lock-Up Agreements</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t8LAT">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t8LAT">A-1-62</a></font> <a href="#t8LAT"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t8PFN"><font style="letter-spacing:0.2pt;">8.5</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t8PFN"><font style="font-weight:bold;letter-spacing:-0.2pt;">Minimum Parent Final Net Cash</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t8PFN">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t8PFN">A-1-62</a></font> <a href="#t8PFN"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:9.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; line-height:10pt; text-align:left; width:51pt;white-space:nowrap;font-weight:bold;">
                <a href="#tSE9T"><font style="letter-spacing:-0.2pt;">Section&#160;9.</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:51pt;font-weight:bold;">
                <a href="#tSE9T"><font style="letter-spacing:-0.2pt;">TERMINATION</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#tSE9T">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:9.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:9.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tSE9T">A-1-62</a></font> <a href="#tSE9T"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t9TAM"><font style="letter-spacing:0.2pt;">9.1</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t9TAM"><font style="font-weight:bold;letter-spacing:-0.2pt;">Termination</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t9TAM">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t9TAM">A-1-62</a></font> <a href="#t9TAM"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t9OTI"><font style="letter-spacing:0.2pt;">9.2</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t9OTI"><font style="font-weight:bold;letter-spacing:-0.2pt;">Effect of Termination</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t9OTI">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t9OTI">A-1-63</a></font> <a href="#t9OTI"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t9TF"><font style="letter-spacing:0.2pt;">9.3</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t9TF"><font style="font-weight:bold;letter-spacing:-0.2pt;">Expenses; Termination Fees</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t9TF">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t9TF">A-1-64</a></font> <a href="#t9TF"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:9.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; line-height:10pt; text-align:left; width:51pt;white-space:nowrap;font-weight:bold;">
                <a href="#tS1P"><font style="letter-spacing:-0.2pt;">Section&#160;10.</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:51pt;font-weight:bold;">
                <a href="#tS1P"><font style="letter-spacing:-0.2pt;">MISCELLANEOUS PROVISIONS</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#tS1P">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:9.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:9.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tS1P">A-1-65</a></font> <a href="#tS1P"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t1ORA"><font style="letter-spacing:0.2pt;">10.1</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t1ORA"><font style="font-weight:bold;letter-spacing:-0.2pt;">Non-Survival of Representations and Warranties</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t1ORA">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t1ORA">A-1-65</a></font> <a href="#t1ORA"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t1TAM"><font style="letter-spacing:0.2pt;">10.2</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t1TAM"><font style="font-weight:bold;letter-spacing:-0.2pt;">Amendment</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t1TAM">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t1TAM">A-1-65</a></font> <a href="#t1TAM"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-iv</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:214.5pt;margin-left:69.66pt;width:456pt;">
        <table style="width:456pt;height:143.5pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:414.63pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;text-align:center;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Page </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t103"><font style="letter-spacing:0.2pt;">10.3</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t103"><font style="font-weight:bold;letter-spacing:-0.2pt;">Waiver</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t103">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t103">A-1-65</a></font> <a href="#t103"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t1ACE"><font style="letter-spacing:0.2pt;">10.4</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t1ACE"><font style="font-weight:bold;letter-spacing:-0.2pt;">Entire Agreement; Counterparts; Exchanges by Electronic Transmission</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t1ACE">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t1ACE">A-1-65</a></font> <a href="#t1ACE"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t1LJW"><font style="letter-spacing:0.2pt;">10.5</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t1LJW"><font style="font-weight:bold;letter-spacing:-0.2pt;">Applicable Law; Jurisdiction; Waiver of Jury Trial</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t1LJW">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t1LJW">A-1-66</a></font> <a href="#t1LJW"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t1TAS"><font style="letter-spacing:0.2pt;">10.6</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t1TAS"><font style="font-weight:bold;letter-spacing:-0.2pt;">Assignability</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t1TAS">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t1TAS">A-1-66</a></font> <a href="#t1TAS"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t1ANA"><font style="letter-spacing:0.2pt;">10.7</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t1ANA"><font style="font-weight:bold;letter-spacing:-0.2pt;">Notices</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t1ANA">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t1ANA">A-1-66</a></font> <a href="#t1ANA"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t1ATO"><font style="letter-spacing:0.2pt;">10.8</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t1ATO"><font style="font-weight:bold;letter-spacing:-0.2pt;">Severability</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t1ATO">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t1ATO">A-1-67</a></font> <a href="#t1ATO"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t1RSP"><font style="letter-spacing:0.2pt;">10.9</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t1RSP"><font style="font-weight:bold;letter-spacing:-0.2pt;">Other Remedies; Specific Performance</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t1RSP">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t1RSP">A-1-67</a></font> <a href="#t1RSP"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t1TPB"><font style="letter-spacing:0.2pt;">10.10</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t1TPB"><font style="font-weight:bold;letter-spacing:-0.2pt;">No Third Party Beneficiaries</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t1TPB">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t1TPB">A-1-68</a></font> <a href="#t1TPB"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:414.63pt;white-space:normal;text-align:left;">
              <div style=" float:left; margin-left:50pt; line-height:10pt; text-align:left; width:30pt;white-space:nowrap;">
                <a href="#t101"><font style="letter-spacing:0.2pt;">10.11</font>
                  <br >
                </a>
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:80pt;">
                <a href="#t101"><font style="font-weight:bold;letter-spacing:-0.2pt;">Construction</font></a>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">
                <a href="#t101">&#8203;</a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#t101">A-1-68</a></font>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:16pt; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Schedules</font><font style="letter-spacing:0.2pt;">: </font> <br ><font style="letter-spacing:0.2pt;">Company Disclosure Schedule </font> <br ><font style="letter-spacing:0.2pt;">Parent Disclosure Schedule </font> <br ><font style="letter-spacing:0.2pt;">Schedule&#160;5.7&#8201;&#8211;&#8201;Additional Agreements </font> <br ><font style="letter-spacing:0.2pt;">Schedule&#160;5.12&#8201;&#8211;&#8201;Post-Closing Directors and Officers of Parent and the Surviving Corporation </font><br ><font style="letter-spacing:0.2pt;">Schedule&#160;N </font></div>
        <table style="width:456pt;height:160pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; width:60pt;">
              <font style="letter-spacing:-0.2pt;">Exhibits</font><font style="font-weight:normal;letter-spacing:0.2pt;">: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:384pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:60pt;">
              <font style="letter-spacing:0.2pt;">Exhibit&#160;A </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:384pt;">
              <font style="letter-spacing:0.2pt;">Definitions </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:60pt;">
              <font style="letter-spacing:0.2pt;">Exhibit&#160;B-1 </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:384pt;">
              <font style="letter-spacing:0.2pt;">Form of Company Stockholder Support Agreement </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:60pt;">
              <font style="letter-spacing:0.2pt;">Exhibit&#160;B-2 </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:384pt;">
              <font style="letter-spacing:0.2pt;">Form of Parent Stockholder Support Agreement </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:60pt;">
              <font style="letter-spacing:0.2pt;">Exhibit&#160;C-1 </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:384pt;">
              <font style="letter-spacing:0.2pt;">Form of Company Lock-Up Agreement </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:60pt;">
              <font style="letter-spacing:0.2pt;">Exhibit&#160;C-2 </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:384pt;">
              <font style="letter-spacing:0.2pt;">Form of Parent Lock-Up Agreement </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:60pt;">
              <font style="letter-spacing:0.2pt;">Exhibit&#160;D </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:384pt;">
              <font style="letter-spacing:0.2pt;">Form of Contingent Value Right Agreement </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:60pt;">
              <font style="letter-spacing:0.2pt;">Exhibit&#160;E </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:384pt;">
              <font style="letter-spacing:0.2pt;">Net Cash Illustrative Calculations </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:60pt;">
              <font style="letter-spacing:0.2pt;">Exhibit&#160;F </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:384pt;">
              <font style="letter-spacing:0.2pt;">Form of Certificate of Merger </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:60pt;">
              <font style="letter-spacing:0.2pt;">Exhibit&#160;G </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:384pt;">
              <font style="letter-spacing:0.2pt;">Form of Company Stockholder Written Consent </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:60pt;">
              <font style="letter-spacing:0.2pt;">Exhibit&#160;H </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:384pt;">
              <font style="letter-spacing:0.2pt;">Exchange Ratio Calculation</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-v</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">AGREEMENT AND PLAN OF MERGER AND REORGANIZATION</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">THIS AGREEMENT AND PLAN OF MERGER AND REORGANIZATION</font><font style="letter-spacing:0.2pt;"> (this &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Agreement</font><font style="letter-spacing:0.2pt;">&#8221;) is made and entered into as of September&#160;20, 2022, by and among </font><font style="font-weight:bold;letter-spacing:-0.2pt;">SESEN BIO, INC.</font><font style="letter-spacing:0.2pt;">, a Delaware corporation (&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent</font><font style="letter-spacing:0.2pt;">&#8221;), </font><font style="font-weight:bold;letter-spacing:-0.2pt;">SEAHAWK MERGER SUB, INC.</font><font style="letter-spacing:0.2pt;">, a Delaware corporation and wholly-owned subsidiary of Parent (&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Merger Sub</font><font style="letter-spacing:0.2pt;">&#8221;), and </font><font style="font-weight:bold;letter-spacing:-0.2pt;">CARISMA THERAPEUTICS INC.</font><font style="letter-spacing:0.2pt;">, a Delaware corporation (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company</font><font style="letter-spacing:0.2pt;">&#8221;). Certain capitalized terms used in this Agreement are defined in </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Exhibit&#160;A</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">RECITALS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">A.&nbsp;&nbsp;&nbsp;Parent and the Company intend to effect a merger of Merger Sub with and into the Company (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Merger</font><font style="letter-spacing:0.2pt;">&#8221;) in accordance with this Agreement and the DGCL. Upon consummation of the Merger, Merger Sub will cease to exist and the Company will become a wholly-owned subsidiary of Parent. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">B.&nbsp;&nbsp;&nbsp;The Parties intend that the Merger qualify as a &#8220;reorganization&#8221; within the meaning of Section&#160;368(a) of the Code, and by executing this Agreement, the Parties intend to adopt this Agreement as a plan of reorganization within the meaning of Treasury Regulations&#160;Sections&#160;1.368-2(g) and 1.368-3. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">C.&nbsp;&nbsp;&nbsp;The Parent Board has (i)&#160;determined that the Contemplated Transactions, including the Merger, are fair to, advisable and in the best interests of Parent and its stockholders, (ii)&#160;approved and declared advisable this Agreement and the Contemplated Transactions, including the issuance of shares of Parent Common Stock to the stockholders of the Company pursuant to the terms of this Agreement, and (iii)&#160;determined to recommend, upon the terms and subject to the conditions set forth in this Agreement, that the stockholders of Parent vote to approve the Parent Stockholder Matters. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">D.&nbsp;&nbsp;&nbsp;The Merger Sub Board has (i)&#160;determined that the Contemplated Transactions are fair to, advisable, and in the best interests of Merger Sub and its sole stockholder, (ii)&#160;approved and declared advisable this Agreement and the Contemplated Transactions and (iii)&#160;determined to recommend, upon the terms and subject to the conditions set forth in this Agreement, that the stockholder of Merger Sub votes to adopt this Agreement and thereby approve the Contemplated Transactions. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">E.&nbsp;&nbsp;&nbsp;Parent, as the sole stockholder of Merger Sub, has adopted this Agreement and thereby approved the Contemplated Transactions. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">F.&nbsp;&nbsp;&nbsp;The Company Board has (i)&#160;determined that the Contemplated Transactions are fair to, advisable and in the best interests of the Company and its stockholders, (ii)&#160;approved and declared advisable this Agreement and the Contemplated Transactions and (iii)&#160;determined to recommend, upon the terms and subject to the conditions set forth in this Agreement, that the stockholders of the Company vote to approve the Company Stockholder Matters. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">G.&nbsp;&nbsp;&nbsp;Concurrently with the execution and delivery of this Agreement and as a condition and inducement to Parent&#8217;s willingness to enter into this Agreement, the officers, directors and stockholders of the Company listed in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;A</font><font style="letter-spacing:0.2pt;"> of the Company Disclosure Schedule (solely in their capacity as stockholders of the Company) (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company Signatories</font><font style="letter-spacing:0.2pt;">&#8221;) are executing (a)&#160;support agreements in favor of Parent in substantially the form attached hereto as </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Exhibit&#160;B-1</font><font style="letter-spacing:0.2pt;"> (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company Stockholder Support Agreement</font><font style="letter-spacing:0.2pt;">&#8221;), pursuant to which the Company Signatories have, subject to the terms and conditions set forth therein, agreed to vote all of their shares of Company Common Stock in favor of the Company Stockholder Matters and against any proposals that compete with the Contemplated Transactions, and (b)&#160;lock-up agreements in substantially the form attached hereto as </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Exhibit&#160;C-1</font><font style="letter-spacing:0.2pt;"> (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company Lock-Up Agreement</font><font style="letter-spacing:0.2pt;">&#8221;). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">H.&nbsp;&nbsp;&nbsp;Concurrently with the execution and delivery of this Agreement and as a condition and inducement to the Company&#8217;s willingness to enter into this Agreement, the officers and directors of Parent listed in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;A</font><font style="letter-spacing:0.2pt;"> of the Parent Disclosure Schedule (solely in their capacity as stockholders of Parent) (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent Signatories</font><font style="letter-spacing:0.2pt;">&#8221;) are executing (a)&#160;support agreements in favor of the Company in substantially the form attached hereto as </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Exhibit&#160;B-2</font><font style="letter-spacing:0.2pt;"> (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent Stockholder Support Agreement</font><font style="letter-spacing:0.2pt;">&#8221;), pursuant to which the Parent Signatories have, subject to the terms and conditions set forth therein, agreed to vote all of their shares of capital stock of Parent in favor of the Parent Stockholder Matters and against any proposals that compete with the Contemplated Transactions, and (b)&#160;lock-up agreements in substantially the form attached hereto as </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Exhibit&#160;C-2</font><font style="letter-spacing:0.2pt;"> (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent Lock-Up Agreement</font><font style="letter-spacing:0.2pt;">&#8221;). </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-1</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="tS1OT">&#8203;</a><a name="t1MUT">&#8203;</a><a name="t1OTM">&#8203;</a><a name="t1ETU">&#8203;</a><a name="t1OIA">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">I.&nbsp;&nbsp;&nbsp;It is expected that promptly after the Registration Statement is declared effective under the Securities Act (and in any event no later than five Business Days), the holders of shares of Company Capital Stock sufficient to adopt and approve the Company Stockholder Matters as required under the DGCL and the Company&#8217;s certificate of incorporation and bylaws will execute and deliver the Company Stockholder Written Consent evidencing the Required Company Stockholder Vote. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">J.&nbsp;&nbsp;&nbsp;In connection with the execution and delivery of this Agreement, the Company has entered into one or more Subscription Agreements with certain investors, pursuant to which such investors have agreed to purchase immediately prior to the Effective Time certain shares of the Company in connection with the Pre-Closing Financing. </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">AGREEMENT</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Parties, intending to be legally bound, agree as follows: </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Section&#160;1.&nbsp;&nbsp;&nbsp;DESCRIPTION OF TRANSACTION</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">1.1&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">The Merger</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Upon the terms and subject to the conditions set forth in this Agreement and in accordance with the DGCL, at the Effective Time, Merger Sub shall be merged with and into the Company, and the separate existence of Merger Sub shall cease. Following the Effective Time, the Company will continue as the surviving corporation in the Merger (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Surviving Corporation</font><font style="letter-spacing:0.2pt;">&#8221;). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">1.2&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Effects of the Merger</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Merger shall have the effects set forth in this Agreement, the Certificate of Merger and the applicable provisions of the DGCL. As a result of the Merger, the Company will become a wholly-owned subsidiary of Parent. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">1.3&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Closing; Effective Time</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Unless this Agreement is earlier terminated pursuant to the provisions of </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;9.1</font><font style="letter-spacing:0.2pt;">, and subject to the satisfaction or waiver of the conditions set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;6</font><font style="letter-spacing:0.2pt;">, </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7</font><font style="letter-spacing:0.2pt;"> and </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;8</font><font style="letter-spacing:0.2pt;">, the consummation of the Merger (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Closing</font><font style="letter-spacing:0.2pt;">&#8221;) shall take place remotely as promptly as practicable (but in no event later than the second Business Day following the satisfaction or waiver (to the extent permitted by applicable Law) of the last to be satisfied or waived of the conditions set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;6</font><font style="letter-spacing:0.2pt;">, </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7</font><font style="letter-spacing:0.2pt;"> and </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;8</font><font style="letter-spacing:0.2pt;">, other than those conditions that by their nature are to be satisfied at the Closing, but subject to the satisfaction or waiver of each of such conditions), or at such other time, date and place as Parent and the Company may mutually agree in writing. The date on which the Closing actually takes place is referred to as the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Closing Date</font><font style="letter-spacing:0.2pt;">&#8221;. At the Closing, the Parties shall cause the Merger to be consummated by executing and filing with the Secretary of State of the State of Delaware a certificate of merger with respect to the Merger, in the form attached hereto as </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Exhibit&#160;F</font><font style="letter-spacing:0.2pt;"> (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Certificate of Merger</font><font style="letter-spacing:0.2pt;">&#8221;). The Merger shall become effective at the time of such filing of the Certificate of Merger with the Secretary of State of the State of Delaware or at such later time as may be specified in the Certificate of Merger with the consent of Parent and the Company (the time as of which the Merger becomes effective being referred to as the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Effective Time</font><font style="letter-spacing:0.2pt;">&#8221;). </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">1.4&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Certificate of Incorporation and Bylaws; Directors and Officers</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;At the Effective Time: </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;the certificate of incorporation of the Surviving Corporation shall be amended and restated in the Merger to read as set forth on Exhibit&#160;A to the Certificate of Merger, until thereafter amended as provided by the DGCL and such certificate of incorporation; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;the certificate of incorporation of Parent shall be identical to the certificate of incorporation of Parent immediately prior to the Effective Time (which shall reflect the Nasdaq Reverse Split, if approved), until thereafter amended as provided by the DGCL and such certificate of incorporation; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, </font><font style="font-style:italic;letter-spacing:0.2pt;">however</font><font style="letter-spacing:0.2pt;">, that at the Effective Time Parent shall file an amendment to its certificate of incorporation, to change the name of Parent to &#8220;CARISMA Therapeutics Inc.&#8221;; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;the bylaws of the Surviving Corporation shall be amended and restated in their entirety to read identically to the bylaws of Merger Sub as in effect immediately prior to the Effective Time (except that the name of the Surviving Corporation in such bylaws shall reflect the name identified on Exhibit&#160;A to the Certificate of Merger), until thereafter amended as provided by the DGCL and such bylaws; </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-2</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="t1OS">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; text-indent:20pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;the directors and officers of Parent, each to hold office in accordance with the certificate of incorporation and bylaws of Parent, shall be as set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.12</font><font style="letter-spacing:0.2pt;">; and </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(e)&nbsp;&nbsp;&nbsp;the directors and officers of the Surviving Corporation, each to hold office in accordance with the certificate of incorporation and bylaws of the Surviving Corporation, shall be the directors and officers of Parent as set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.12</font><font style="letter-spacing:0.2pt;"> or such other persons as shall be mutually agreed upon by Parent and the Company. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">1.5&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Conversion of Shares</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;At the Effective Time, by virtue of the Merger and without any further action on the part of Parent, Merger Sub, the Company or any stockholder of the Company or Parent: </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(i)&nbsp;&nbsp;&nbsp;any shares of Company Capital Stock held as treasury stock or held or owned by the Company, Merger Sub or any Subsidiary of the Company immediately prior to the Effective Time shall be canceled and retired and shall cease to exist, and no consideration shall be delivered in exchange therefor; and </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(ii)&nbsp;&nbsp;&nbsp;subject to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;1.5(c)</font><font style="letter-spacing:0.2pt;"> and </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;1.8</font><font style="letter-spacing:0.2pt;">, each share of Company Capital Stock outstanding immediately prior to the Effective Time (including any shares of Company Capital Stock issued pursuant to the Pre-Closing Financing, and excluding shares to be canceled pursuant to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;1.5(a)(i)</font><font style="letter-spacing:0.2pt;"> and Dissenting Shares) shall be automatically converted solely into the right to receive a number of shares of Parent Common Stock equal to the Exchange Ratio (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Merger Consideration</font><font style="letter-spacing:0.2pt;">&#8221;). </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;If any shares of Company Capital Stock outstanding immediately prior to the Effective Time are unvested or are subject to a repurchase option or a risk of forfeiture under any applicable restricted stock purchase agreement or other similar agreement with the Company, then the shares of Parent Common Stock issued in exchange for such shares of Company Capital Stock will to the same extent be unvested and subject to the same repurchase option or risk of forfeiture, and such shares of Parent Common Stock shall accordingly be marked with appropriate legends. The Company shall take all actions that may be necessary to ensure that, from and after the Effective Time, Parent is entitled to exercise any such repurchase option or other right set forth in any such restricted stock purchase agreement or other agreement in accordance with its terms. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;No fractional shares of Parent Common Stock shall be issued in connection with the Merger or the Conversion, and no certificates or scrip for any such fractional shares shall be issued. Notwithstanding any other provision of this Agreement, any holder of Company Capital Stock or the Company Convertible Note, as applicable, converted in connection with the Merger or the Conversion, as applicable, who would otherwise have been entitled to receive a fraction of a share of Parent Common Stock (after taking into account all Company Stock Certificates delivered or Book-Entry Shares transferred by such holder and the aggregate number of shares of Company Capital Stock represented thereby, as applicable) shall receive, in lieu thereof, cash (without interest and subject to applicable Tax withholding) in an amount equal to such fractional part of a share of Parent Common Stock multiplied by the last reported sale price of Parent Common Stock at the 4:00&#160;p.m., Eastern Time, end of regular trading hours on Nasdaq on the last trading day prior to the Effective Time. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;All Company Options outstanding immediately prior to the Effective Time under the Company Plan shall be treated in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.5(a)</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(e)&nbsp;&nbsp;&nbsp;The Company Convertible Note shall be treated in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.5(c)</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(f)&nbsp;&nbsp;&nbsp;All Parent Warrants outstanding immediately prior to the Effective Time shall be treated in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.5(e)</font><font style="letter-spacing:0.2pt;"> and Parent RSUs and Parent Options outstanding immediately prior to the Effective Time shall be treated in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.5(f)</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(g)&nbsp;&nbsp;&nbsp;Each share of common stock, $0.0001 par value per share, of Merger Sub issued and outstanding immediately prior to the Effective Time shall be converted into and exchanged for one validly issued, fully paid and nonassessable share of common stock, $0.0001 par value per share, of the </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-3</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="t1OTC">&#8203;</a><a name="t1OC">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Surviving Corporation. Each stock certificate of Merger Sub, if any, evidencing ownership of any such shares shall, as of the Effective Time, evidence ownership of such shares of common stock of the Surviving Corporation. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(h)&nbsp;&nbsp;&nbsp;If, between the date of this Agreement and the Effective Time, any outstanding shares of Company Capital Stock or Parent Common Stock shall have been changed into, or exchanged for, a different number of shares or a different class, by reason of any stock dividend, subdivision, reclassification, recapitalization, split (including the Nasdaq Reverse Split), combination or exchange of shares or other like change, the Exchange Ratio shall, to the extent necessary, be equitably adjusted to reflect such change to provide the holders of Company Capital Stock, Company Options, Parent Common Stock, Parent Options, Parent RSUs and Parent Warrants with the same economic effect as contemplated by this Agreement prior to such stock dividend, subdivision, reclassification, recapitalization, split (including the Nasdaq Reverse Split), combination or exchange of shares or other like change; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided, however</font><font style="letter-spacing:0.2pt;">, that nothing herein will be construed to permit the Company or Parent to take any action with respect to Company Capital Stock or Parent Common Stock, respectively, that is prohibited by the terms of this Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">1.6&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Closing of the Company&#8217;s Transfer Books</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;At the Effective Time: (a)&#160;all shares of Company Capital Stock outstanding immediately prior to the Effective Time (including any shares of Company Capital Stock issued pursuant to the Pre-Closing Financing) shall be treated in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;1.5(a)</font><font style="letter-spacing:0.2pt;">, and all holders of (i)&#160;certificates representing shares of Company Capital Stock and (ii)&#160;book-entry shares representing shares of Company Capital Stock (&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Book-Entry Shares</font><font style="letter-spacing:0.2pt;">&#8221;), in each case, that were outstanding immediately prior to the Effective Time shall cease to have any rights as stockholders of the Company; and (b)&#160;the stock transfer books of the Company shall be closed with respect to all shares of Company Capital Stock outstanding immediately prior to the Effective Time. No further transfer of any such shares of Company Capital Stock shall be made on such stock transfer books after the Effective Time. If, after the Effective Time, a valid certificate previously representing any shares of Company Capital Stock outstanding immediately prior to the Effective Time (a &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company Stock Certificate</font><font style="letter-spacing:0.2pt;">&#8221;) is presented to the Exchange Agent or to the Surviving Corporation, such Company Stock Certificate shall be canceled and shall be exchanged as provided in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Sections&#160;1.5</font><font style="letter-spacing:0.2pt;"> and </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">1.7</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">1.7&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Surrender of Certificates</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;Prior to the Closing Date, Parent and the Company shall agree upon and select a reputable bank, transfer agent or trust company to act as exchange agent in the Merger (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Exchange Agent</font><font style="letter-spacing:0.2pt;">&#8221;). At the Effective Time, Parent shall deposit with the Exchange Agent: (i)&#160;evidence of book-entry shares representing the Parent Common Stock issuable pursuant to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;1.5(a)</font><font style="letter-spacing:0.2pt;"> in exchange for shares of Company Capital Stock and conversion of the Company Convertible Note; and (ii)&#160;cash sufficient to make payments in lieu of fractional shares in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;1.5(c)</font><font style="letter-spacing:0.2pt;">. The Parent Common Stock and cash amounts so deposited with the Exchange Agent, together with any dividends or distributions received by the Exchange Agent with respect to such shares, are referred to collectively as the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Exchange Fund.</font><font style="letter-spacing:0.2pt;">&#8221; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;Promptly after the Effective Time, the Parties shall cause the Exchange Agent to mail to the Persons who were record holders of shares of Company Capital Stock that were converted into the right to receive the Merger Consideration: (i)&#160;a letter of transmittal in customary form and containing such provisions as Parent may reasonably specify (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">LoT</font><font style="letter-spacing:0.2pt;">&#8221;) (including a provision confirming that delivery of Company Stock Certificates or transfer of Book-Entry Shares to the Exchange Agent shall be effected, and risk of loss and title thereto shall pass, only upon proper delivery of such Company Stock Certificates or transfer of the Book-Entry Shares to the Exchange Agent); and (ii)&#160;instructions for effecting the surrender of Company Stock Certificates or transfer of Book-Entry Shares in exchange for shares of Parent Common Stock. Upon surrender of a Company Stock Certificate or transfer of Book-Entry Share to the Exchange Agent for exchange, together with a duly executed LoT and such other documents as may be reasonably required by the Exchange Agent or Parent: (A)&#160;the holder of such Company Stock Certificate or Book-Entry Share shall be entitled to receive in exchange therefor book-entry shares representing the Merger Consideration (in a number of whole shares of Parent Common Stock) that such holder has the right to receive pursuant to the provisions of </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;1.5(a)</font><font style="letter-spacing:0.2pt;"> (and cash in lieu of any fractional share of Parent Common Stock pursuant to the provisions of </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;1.5(c)</font><font style="letter-spacing:0.2pt;">); </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-4</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="t18RI">&#8203;</a><a name="t1AIA">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">and (B)&#160;the Company Stock Certificate or Book-Entry Share so surrendered or transferred, as the case may be, shall be canceled. Until surrendered or transferred as contemplated by this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;1.7(b)</font><font style="letter-spacing:0.2pt;">, each Company Stock Certificate or Book-Entry Share shall be deemed, from and after the Effective Time, to represent only the right to receive book-entry shares of Parent Common Stock representing the Merger Consideration (and cash in lieu of any fractional share of Parent Common Stock). If any Company Stock Certificate shall have been lost, stolen or destroyed, Parent may, in its discretion and as a condition precedent to the delivery of any shares of Parent Common Stock, require the owner of such lost, stolen or destroyed Company Stock Certificate to provide an applicable affidavit with respect to such Company Stock Certificate. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;No dividends or other distributions declared or made with respect to Parent Common Stock with a record date on or after the Effective Time shall be paid to the holder of any unsurrendered Company Stock Certificate or Book-Entry Shares with respect to the shares of Parent Common Stock that such holder has the right to receive in the Merger until such holder surrenders such Company Stock Certificate or transfers such Book-Entry Share or provides an affidavit of loss or destruction in lieu thereof in accordance with this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;1.7</font><font style="letter-spacing:0.2pt;"> (at which time (or, if later, on the applicable payment date) such holder shall be entitled, subject to the effect of applicable abandoned property, escheat or similar Laws, to receive all such dividends and distributions, without interest). </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;Any portion of the Exchange Fund that remains unclaimed by holders of shares of Company Common Stock as of the first anniversary of the Closing Date shall be delivered to Parent upon demand, and any holders of Company Stock Certificates or Book-Entry Shares who have not theretofore surrendered their Company Stock Certificates or transferred their Book-Entry Shares in accordance with this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;1.7</font><font style="letter-spacing:0.2pt;"> shall thereafter look only to Parent for satisfaction of their claims for Parent Common Stock, cash in lieu of fractional shares of Parent Common Stock and any dividends or distributions with respect to shares of Parent Common Stock. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(e)&nbsp;&nbsp;&nbsp;No Party shall be liable to any holder of shares of any Company Capital Stock or to any other Person with respect to any shares of Parent Common Stock (or dividends or distributions with respect thereto) or for any cash amounts delivered to any public official pursuant to any applicable abandoned property Law, escheat Law or similar Law. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">1.8&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Appraisal Rights</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;Notwithstanding any provision of this Agreement to the contrary, shares of Company Capital Stock that are outstanding immediately prior to the Effective Time and which are held by stockholders who have exercised and perfected appraisal rights for such shares of Company Capital Stock in accordance with the DGCL (collectively, the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Dissenting Shares</font><font style="letter-spacing:0.2pt;">&#8221;) shall not be converted into or represent the right to receive the Merger Consideration described in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;1.5</font><font style="letter-spacing:0.2pt;"> attributable to such Dissenting Shares. Such stockholders shall be entitled to receive payment of the appraised value of such shares of Company Capital Stock held by them in accordance with the DGCL, unless and until such stockholders fail to perfect or effectively withdraw or otherwise lose their appraisal rights under the DGCL. All Dissenting Shares held by stockholders who shall have failed to perfect or who effectively shall have withdrawn or lost their right to appraisal of such shares of Company Capital Stock under the DGCL (whether occurring before, at or after the Effective Time) shall thereupon be deemed to be converted into and to have become exchangeable for, as of the Effective Time, the right to receive the Merger Consideration, without interest, attributable to such Dissenting Shares upon their surrender in the manner provided in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Sections&#160;1.5</font><font style="letter-spacing:0.2pt;"> and </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">1.7</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;The Company shall give Parent prompt written notice of any demands by dissenting stockholders received by the Company, withdrawals of such demands and any other instruments served on the Company and any material correspondence received by the Company in connection with such demands. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">1.9&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Further Action</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;If, at any time after the Effective Time, any further action is determined by the Surviving Corporation to be necessary or desirable to carry out the purposes of this Agreement or to vest the Surviving Corporation with full right, title and possession of and to all rights and property of the Company, then the officers and directors of the Surviving Corporation shall be fully authorized, and shall </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-5</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="t1TPA">&#8203;</a><a name="t1ONC">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">use their and its commercially reasonable efforts (in the name of the Company, in the name of Merger Sub, in the name of the Surviving Corporation and otherwise) to take such action. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">1.10&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Withholding</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Parties and the Exchange Agent and their respective agents shall be entitled to deduct and withhold from any amounts otherwise payable pursuant to this Agreement such amounts as such Party or the Exchange Agent is required to deduct and withhold under the Code or any other Tax Law with respect to the making of such payment and shall be entitled to request any reasonably appropriate Tax forms, including an IRS Form W-9 or the appropriate IRS Form W-8, as applicable, from any recipient of payments hereunder. The payor shall provide commercially reasonable notice to the payee upon becoming aware of any such withholding obligation (other than any withholding on amounts treated as compensation), and the Parties shall cooperate with each other and with such payee to the extent reasonable to obtain reduction of or relief from such withholding. To the extent that amounts are so deducted and withheld and paid to the appropriate taxing authority, such deducted and withheld amounts shall be treated for all purposes of this Agreement as having been paid to the Person in respect of whom such deduction and withholding was made. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">1.11&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Calculation of Net Cash</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;Not more than ten nor less than five calendar days prior to the anticipated date for Closing (as mutually agreed in good faith by Parent and the Company) (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Anticipated Closing Date</font><font style="letter-spacing:0.2pt;">&#8221;), Parent will deliver to the Company a schedule (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Net Cash Schedule</font><font style="letter-spacing:0.2pt;">&#8221;) setting forth, in reasonable detail, Parent&#8217;s good faith estimated calculation of Net Cash (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Net Cash Calculation</font><font style="letter-spacing:0.2pt;">&#8221; and the date of delivery of such schedule, the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Delivery Date</font><font style="letter-spacing:0.2pt;">&#8221;) as of 8:00&#160;p.m. Eastern Time on the last Business Day prior to the Anticipated Closing Date (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Cash Determination Time</font><font style="letter-spacing:0.2pt;">&#8221;), prepared and certified by Parent&#8217;s chief executive officer and chief financial officer (or if there is no chief financial officer at such time, the principal financial and accounting officer of Parent). Subject to the terms of the Confidentiality Agreement, Parent shall make available to the Company, its accountants and/or counsel, the work papers and back-up materials used or useful in preparing the Net Cash Schedule, as reasonably requested by the Company. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;Within three Business Days following the Delivery Date (the last day of such period, the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Response Date</font><font style="letter-spacing:0.2pt;">&#8221;), the Company will have the right to dispute all or any part or parts of the Net Cash Calculation by delivering a written notice to that effect (a &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Dispute Notice</font><font style="letter-spacing:0.2pt;">&#8221;) to Parent. Any Dispute Notice shall identify in reasonable detail to the extent then known the nature and amounts of any proposed revisions to the Net Cash Calculation. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;If (i)&#160;the Company notifies Parent in writing on or prior to the Response Date that it has no objections to the Net Cash Calculation or (ii)&#160;the Company has failed to deliver a Dispute Notice as provided in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;1.11(b)</font><font style="letter-spacing:0.2pt;"> prior to 8:00&#160;p.m. Eastern Time on the Response Date, then the Net Cash Calculation as set forth in the Net Cash Schedule shall be deemed to have been finally determined for purposes of this Agreement and to represent the Net Cash at the Cash Determination Time (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Final Net Cash</font><font style="letter-spacing:0.2pt;">&#8221;) for purposes of this Agreement. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;If the Company delivers a Dispute Notice prior to 8:00&#160;p.m. Eastern Time on the Response Date, then Representatives of Parent and the Company shall promptly, and in no event later than one calendar day after the Response Date, meet and attempt in good faith to resolve the disputed item(s) and negotiate an agreed-upon determination of the Net Cash, which agreed-upon Net Cash shall be deemed to have been finally determined for purposes of this Agreement and to represent the Final Net Cash for purposes of this Agreement. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(e)&nbsp;&nbsp;&nbsp;If Representatives of Parent and the Company are unable to negotiate an agreed-upon determination of Final Net Cash pursuant to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;1.11(d)</font><font style="letter-spacing:0.2pt;"> within two calendar days after delivery of the Dispute Notice (or such other period as Parent and the Company may mutually agree upon in writing), then any remaining disagreements as to the calculation of Net Cash shall be referred to Deloitte &amp; Touche LLP or another independent auditor of recognized national standing mutually agreed upon by Parent and the Company (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Accounting Firm</font><font style="letter-spacing:0.2pt;">&#8221;). Parent shall promptly deliver to the Accounting Firm all work papers and back-up materials used in preparing the Net Cash Schedule, and Parent and the Company shall use commercially reasonable efforts to cause the Accounting Firm to make its </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-6</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="tS2AW">&#8203;</a><a name="t2OS">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">determination within five calendar days of accepting its selection. The Company and Parent shall be afforded the opportunity to present to the Accounting Firm any material related to the unresolved disputes and to discuss the issues with the Accounting Firm; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, </font><font style="font-style:italic;letter-spacing:0.2pt;">however</font><font style="letter-spacing:0.2pt;">, that no such presentation or discussion shall occur without the presence of a Representative of each of the Company and Parent. The determination of the Accounting Firm shall be limited to the disagreements submitted to the Accounting Firm. The determination of the amount of Net Cash made by the Accounting Firm shall be made in writing delivered to each of the Company and Parent, shall be final and binding on the Company and Parent and shall be deemed to have been finally determined for purposes of this Agreement and to represent the Final Net Cash for purposes of this Agreement, absent fraud or manifest error. The Parties shall delay the Closing until the resolution of the matters described in this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;1.11(e)</font><font style="letter-spacing:0.2pt;">. The fees and expenses of the Accounting Firm shall be allocated between Parent and the Company in the same proportion that the disputed amount of the Net Cash that was unsuccessfully disputed by such Party (as finally determined by the Accounting Firm) bears to the total disputed amount of the Net Cash and such portion of the costs and expenses of the Accounting Firm borne by Parent and any other fees, costs or expenses incurred by Parent following the Delivery Date in connection with the procedures set forth in this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;1.11(e)</font><font style="letter-spacing:0.2pt;"> shall be deducted from the final determination of the amount of Net Cash. If this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;1.11(e)</font><font style="letter-spacing:0.2pt;"> applies as to the determination of the Final Net Cash described in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;1.11(e)</font><font style="letter-spacing:0.2pt;">, upon resolution of the matter in accordance with this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;1.11(e)</font><font style="letter-spacing:0.2pt;">, the Parties shall not be required to determine the Net Cash again even though the Closing Date may occur later than the Anticipated Closing Date, except that either Party may require a re-determination of Final Net Cash if the Closing Date is more than ten calendar days after the Anticipated Closing Date. </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Section&#160;2.&nbsp;&nbsp;&nbsp;REPRESENTATIONS AND WARRANTIES OF THE COMPANY</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Subject to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;10.11(m)</font><font style="letter-spacing:0.2pt;">, except as set forth in the written disclosure schedule delivered by the Company to Parent (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company Disclosure Schedule</font><font style="letter-spacing:0.2pt;">&#8221;), the Company represents and warrants to Parent and Merger Sub as follows: </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">2.1&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Due Organization; Subsidiaries</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;The Company is a corporation duly incorporated, validly existing and in good standing under the Laws of the State of Delaware and has all necessary corporate power and authority: (i)&#160;to conduct its business in the manner in which its business is currently being conducted; (ii)&#160;to own or lease and use its property and assets in the manner in which its property and assets are currently owned or leased and used; and (iii)&#160;to perform its obligations under all material Contracts by which it is bound. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;The Company is duly licensed and qualified to do business, and is in good standing (to the extent applicable in such jurisdiction), under the Laws of all jurisdictions where the nature of its business requires such licensing or qualification other than in jurisdictions where the failure to be so qualified would not have a Company Material Adverse Effect. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;The Company has no Subsidiaries, except for the Entities identified in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.1(c)</font><font style="letter-spacing:0.2pt;"> of the Company Disclosure Schedule; and neither the Company nor any of the Company&#8217;s Subsidiaries owns any capital stock of, or any equity, ownership or profit sharing interest of any nature in, or controls, directly or indirectly, any other Entity other than the Entities identified in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.1(c)</font><font style="letter-spacing:0.2pt;"> of the Company Disclosure Schedule. Each of the Company&#8217;s Subsidiaries is a corporation or other legal Entity duly incorporated or otherwise organized, validly existing and, if applicable, in good standing under the Laws of the jurisdiction of its incorporation or organization, as applicable, and has all necessary corporate or similar power and authority to conduct its business in the manner in which its business is currently being conducted and to own or lease and use its property and assets in the manner in which its property and assets are currently owned or leased and used, except where the failure to have such power or authority would not have a Company Material Adverse Effect. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;Neither the Company nor any of its Subsidiaries is or has otherwise been a party to, or a member of, any partnership, joint venture or similar business Entity. Neither the Company nor any of its Subsidiaries has agreed or is obligated to make, or is bound by any Contract under which it may become obligated to make, any future investment in or capital contribution to any other Entity. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-7</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="t2DTC">&#8203;</a><a name="t2BNO">&#8203;</a><a name="t2RTA">&#8203;</a><a name="t2CST">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Neither the Company nor any of its Subsidiaries has, at any time, been a general partner of, or has otherwise been liable for, any of the debts or other obligations of, any general partnership, limited partnership or other Entity. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">2.2&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Organizational Documents</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Company has made available to Parent accurate and complete copies of the Organizational Documents of the Company and each of its Subsidiaries&#8217; in effect as of the date of this Agreement. Neither the Company nor any of its Subsidiaries is in material breach or violation of its respective Organizational Documents. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">2.3&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Authority; Binding Nature of Agreement</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;The Company has all necessary corporate power and authority to enter into and to perform its obligations under this Agreement and, subject to receipt of the Required Company Stockholder Vote, to consummate the Contemplated Transactions. The Company Board (at a meeting or meetings duly called and held and at which all members were present) has unanimously (i)&#160;determined that the Contemplated Transactions are fair to, advisable and in the best interests of, the Company and its stockholders, (ii)&#160;authorized, approved and declared advisable this Agreement and the Contemplated Transactions and (iii)&#160;determined to recommend, upon the terms and subject to the conditions set forth in this Agreement, that the stockholders of the Company vote to approve the Company Stockholder Matters. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;This Agreement has been duly executed and delivered by the Company and, assuming the due authorization, execution and delivery by Parent and Merger Sub, constitutes the valid and binding obligation of the Company, enforceable against the Company in accordance with its terms, subject to the Enforceability Exceptions. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">2.4&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Vote Required</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The affirmative vote (or written consent) of (i)&#160;the holders of a majority of the Company Capital Stock, voting together as a single class, (ii)&#160;the holders of at least two-thirds of the Company Series&#160;A Preferred Stock, Company Special Voting Preferred Stock, Company Series&#160;B Preferred Stock and Company Series&#160;B Special Voting Preferred Stock, voting together as a single class, (iii)&#160;the holders of a majority of the Company Series&#160;A Preferred Stock and Company Special Voting Preferred Stock, voting together as a single class, and (iv)&#160;the holders of at least two-thirds of the Company Series&#160;B Preferred Stock and Company Series&#160;B Special Voting Preferred Stock, voting together as a single class, in the form attached hereto as </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Exhibit&#160;G</font><font style="letter-spacing:0.2pt;"> (collectively, the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company Stockholder Written Consent</font><font style="letter-spacing:0.2pt;">&#8221; and such vote thereon, the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Required Company Stockholder Vote</font><font style="letter-spacing:0.2pt;">&#8221;), is the only vote (or written consent) of the holders of any class or series of Company Capital Stock necessary to adopt and approve the Company Stockholder Matters. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">2.5&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Non-Contravention; Consents</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Subject to obtaining the Required Company Stockholder Vote, the filing of the Certificate of Merger with the Secretary of State of the State of Delaware required by the DGCL and clearance of the Merger under any applicable Antitrust Laws, neither (x)&#160;the execution, delivery or performance of this Agreement by the Company, nor (y)&#160;the consummation by the Company of the Contemplated Transactions, will directly or indirectly (with or without notice or lapse of time): </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;contravene, conflict with or result in a violation of any of the provisions of the Company&#8217;s Organizational Documents; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;contravene, conflict with or result in a material violation of, or, to the Knowledge of the Company, give any Governmental Body or other Person the right to successfully challenge the Contemplated Transactions or to successfully exercise any material remedy or obtain any material relief under, any Law or any order, writ, injunction, judgment or decree to which the Company or its Subsidiaries, or any of the assets owned or used by the Company or its Subsidiaries, is subject, except as would not reasonably be expected to be material to the Company and its Subsidiaries, taken as a whole; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;contravene, conflict with or result in a material violation of any of the terms or requirements of, or give any Governmental Body the right to revoke, withdraw, suspend, cancel, terminate or modify, any Governmental Authorization that is held by the Company or its Subsidiaries, except as would not reasonably be expected to be material to the Company and its Subsidiaries, taken as a whole; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;contravene, conflict with or result in a violation or breach of, or result in a default under, any provision of any Company Material Contract, or give any Person the right to: (i)&#160;declare a default or </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-8</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="t26C">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">exercise any remedy under any Company Material Contract; (ii)&#160;any material payment, rebate, chargeback, penalty or change in delivery schedule under any Company Material Contract; (iii)&#160;accelerate the maturity or performance of any Company Material Contract; or (iv)&#160;cancel, terminate or modify any term of any Company Material Contract, except in each case under this clause (d), as would not reasonably be expected to be material to the Company and its Subsidiaries, taken as a whole; or </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(e)&nbsp;&nbsp;&nbsp;result in the imposition or creation of any material Encumbrance upon or with respect to any material asset owned or used by the Company or its Subsidiaries (except for Permitted Encumbrances). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Except for (i)&#160;any Consent set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.5</font><font style="letter-spacing:0.2pt;"> of the Company Disclosure Schedule, (ii)&#160;the Required Company Stockholder Vote, (iii)&#160;the filing of the Certificate of Merger with the Secretary of State of the State of Delaware pursuant to the DGCL and the clearance of the Merger under any applicable Antitrust Laws, and (iv)&#160;such consents, waivers, approvals, orders, authorizations, registrations, declarations and filings as may be required under applicable federal and state securities Laws or, if not given or obtained, as would not reasonably be expected to be material to the Company and its Subsidiaries, taken as a whole, or would not reasonably be expected to prevent or materially delay beyond the End Date the ability of the Company to consummate the Contemplated Transactions, neither the Company nor any of its Subsidiaries is or will be required to make any filing with or give any notice to, or to obtain any Consent from, any Person in connection with (A)&#160;the execution, delivery or performance by the Company of this Agreement, or (B)&#160;the consummation by the Company of the Contemplated Transactions. None of the Company nor any of its &#8220;affiliates&#8221; or &#8220;associates&#8221; directly or indirectly &#8220;owns,&#8221; beneficially or otherwise, and at all times during the three-year period prior to the date of this Agreement, none of its &#8220;affiliates&#8221; or &#8220;associates&#8221; directly or indirectly has &#8220;owned,&#8221; beneficially or otherwise, any of the outstanding Parent Common Stock, as those terms are defined in Section&#160;203 of the DGCL. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">2.6&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Capitalization</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;The authorized Company Capital Stock as of the date of this Agreement consists of (i)&#160;14,910,158 shares of Company Common Stock, par value $0.0001 per share, of which 1,085,436 shares have been issued and are outstanding as of the date of this Agreement, and (ii)&#160;10,946,061 shares of Company Preferred Stock, par value $0.0001 per share, of which (a)&#160;6,138,518 shares have been designated as Company Series&#160;A Preferred Stock, of which 5,201,017 shares are issued and outstanding as of the date of this Agreement, (b)&#160;1 share has been designated as Company Special Voting Preferred Stock, of which 1 share is issued and outstanding as of the date of this Agreement, (c)&#160;4,807,541 shares have been designated as Company Series&#160;B Preferred Stock, of which 3,499,866 shares are issued and outstanding as of the date of this Agreement and (d)&#160;1 share has been designated as Company Series&#160;B Special Voting Preferred Stock, of which 1 share is issued and outstanding as of the date of this Agreement. As of the date of this Agreement, the Company does not hold any shares of its capital stock in treasury. </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.6(a)</font><font style="letter-spacing:0.2pt;"> of the Company Disclosure Schedule lists, as of the date of this Agreement (x)&#160;each record holder of issued and outstanding Company Capital Stock and the number and type of shares of Company Capital Stock held by such holder and (y)(A) the holder of the issued and outstanding convertible promissory note into Company Capital Stock (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company Convertible Note</font><font style="letter-spacing:0.2pt;">&#8221;), (B)&#160;the date the Company Convertible Note was issued, (C)&#160;the type of securities subject to the Company Convertible Note, (D)&#160;the underlying principal amount and accrued interest of the Company Convertible Note, and (E)&#160;the maturity date of the Company Convertible Note. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;All of the outstanding shares of Company Capital Stock have been duly authorized and validly issued, and are fully paid and nonassessable. None of the outstanding shares of Company Capital Stock are entitled or subject to any preemptive right, right of participation, right of maintenance or any similar right and none of the outstanding shares of Company Capital Stock are subject to any right of first refusal in favor of the Company, in each case under any Company Contract. Except as contemplated herein, there is no Company Contract relating to the voting or registration of, or restricting any Person from purchasing, selling, pledging or otherwise disposing of (or granting any option or similar right with respect to), any shares of Company Capital Stock. The Company is not under any obligation, nor is it bound by any Contract pursuant to which it may become obligated, to repurchase, redeem or otherwise acquire any outstanding shares of Company Capital Stock or other </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-9</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="t27ST">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">securities. None of the outstanding shares of Company Capital Stock held by current or former Company employees or other service providers are subject to any repurchase or forfeiture rights held by the Company. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;Except for the Company Plan (and awards granted thereunder), the Company does not have any stock option plan or any other plan, program, agreement or arrangement providing for any equity-based compensation for any Person. As of the date of this Agreement, the Company has reserved 2,664,018 shares of Company Common Stock for issuance under the Company Plan, of which 45,436 shares have been issued and are currently outstanding, 1,900,829 shares have been reserved for issuance upon the exercise of Company Options previously granted and are currently outstanding under the Company Plan, and 717,753 shares of Company Common Stock remain available for future issuance pursuant to the Company Plan. Only shares of Company Common Stock are subject to Company Options. </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.6(c)</font><font style="letter-spacing:0.2pt;"> of the Company Disclosure Schedule sets forth the following information with respect to each Company Option outstanding as of the date of this Agreement: (i)&#160;the name of the optionee; (ii)&#160;the number of shares of Company Common Stock subject to such Company Option at the time of grant; (iii)&#160;the number of shares of Company Common Stock subject to such Company Option as of the date of this Agreement; (iv)&#160;the exercise price of such Company Option; (v)&#160;the date on which such Company Option was granted; (vi)&#160;the applicable vesting schedule, including the number of vested and unvested shares as of the date of this Agreement and any acceleration provisions; (vii)&#160;the date on which such Company Option expires; and (viii)&#160;whether such Company Option is intended to constitute an &#8220;incentive stock option&#8221; &#8203;(as defined in the Code) or a non-qualified stock option. The Company has made available to Parent accurate and complete copies of the Company Plan and all forms of stock option and other award agreements evidencing outstanding options granted thereunder. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;Except for the Company Convertible Note and the Company Options set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.6(c)</font><font style="letter-spacing:0.2pt;"> of the Company Disclosure Schedule, there is no: (i)&#160;outstanding subscription, option, call, warrant or right (whether or not currently exercisable) to acquire any shares of the capital stock or other securities of the Company or any of its Subsidiaries; or (ii)&#160;outstanding security, instrument or obligation that is or may become convertible into or exchangeable for any shares of the capital stock or other securities of the Company or any of its Subsidiaries. There are no outstanding or authorized stock appreciation, phantom stock, profit participation or other similar rights with respect to the Company or any of its Subsidiaries. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(e)&nbsp;&nbsp;&nbsp;All outstanding shares of Company Capital Stock, Company Options, the Company Convertible Note, and other securities of the Company have been issued and granted in material compliance with (i)&#160;the Organizational Documents of the Company in effect as of the relevant time and all applicable securities Laws and other applicable Law, and (ii)&#160;all requirements set forth in applicable Contracts. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">2.7&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Financial Statements</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;The Company has made available to Parent true and complete copies of (i)&#160;the Company&#8217;s audited consolidated balance sheets at December&#160;31, 2021 and 2020, together with related audited consolidated statements of income, stockholders&#8217; equity and cash flows, and notes thereto, for the fiscal&#160;years then ended and (ii)&#160;the Company Unaudited Interim Balance Sheet, together with the unaudited consolidated statements of income, stockholders&#8217; equity and cash flows of the Company for the six-month period ended on the date of the Company Unaudited Interim Balance Sheet (collectively, the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company Financial Statements</font><font style="letter-spacing:0.2pt;">&#8221;). The Company Financial Statements were prepared in accordance with GAAP (except that the unaudited financial statements may not contain footnotes and are subject to normal and recurring year-end adjustments that are not reasonably expected to be material) and fairly present, in all material respects, the financial position and operating results of the Company and its consolidated Subsidiaries as of the dates and for the periods indicated therein. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;Each of the Company and its Subsidiaries maintains a system of internal accounting controls designed to provide reasonable assurance that: (i)&#160;transactions are executed in accordance with management&#8217;s general or specific authorizations; (ii)&#160;transactions are recorded as necessary to permit preparation of the financial statements of the Company and its Subsidiaries in accordance with GAAP </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-10</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="t2OCA">&#8203;</a><a name="t2OUL">&#8203;</a><a name="t2TAE">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">and to maintain accountability of the Company&#8217;s and its Subsidiaries&#8217; assets; (iii)&#160;access to the Company&#8217;s and its Subsidiaries&#8217; assets is permitted only in accordance with management&#8217;s general or specific authorization; (iv)&#160;the recorded accountability for the Company&#8217;s and its Subsidiaries&#8217; assets is compared with the existing assets at regular intervals and appropriate action is taken with respect to any differences; and (v)&#160;accounts, notes and other receivables are recorded accurately, and proper and adequate procedures are implemented to effect the collection thereof on a current and timely basis. The Company and each of its Subsidiaries maintains internal control over financial reporting that provides reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with GAAP. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.7(c)</font><font style="letter-spacing:0.2pt;"> of the Company Disclosure Schedule lists, and the Company has made available to Parent accurate and complete copies of the documentation creating or governing, all securitization transactions and &#8220;off-balance sheet arrangements&#8221; &#8203;(as discussed in Item&#160;303 of Regulation&#160;S-K under the Exchange Act) effected by the Company or any of its Subsidiaries since January&#160;1, 2019. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;As of the date of this Agreement, there have been no formal internal investigations regarding financial reporting or accounting policies and practices discussed with, reviewed by or initiated at the direction of the chief executive officer, chief financial officer or general counsel of the Company, the Company Board or any committee thereof. As of the date of this Agreement, the Company nor its independent auditors have identified (i)&#160;any significant deficiency or material weakness in the design or operation of the system of internal accounting controls utilized by the Company and its Subsidiaries, (ii)&#160;any fraud, whether or not material, that involves the Company, any of its Subsidiaries, the Company&#8217;s management or other employees who have a role in the preparation of financial statements or the internal accounting controls utilized by the Company and its Subsidiaries or (iii)&#160;any claim or allegation regarding any of the foregoing. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(e)&nbsp;&nbsp;&nbsp;The Company Financial Statements will be suitable for inclusion in the Registration Statement and prepared in accordance with GAAP as applied on a consistent basis during the periods involved (except in each case as described in the notes thereto) and on that basis will present fairly, in all material respects, the financial position and the results of operations, changes in stockholders&#8217; equity, and cash flows of the Company as of the dates of and for the periods referred to in the Company Financial Statements. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">2.8&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Absence of Changes</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;(a)&#160;Between the date of the Company Unaudited Interim Balance Sheet and the date of this Agreement, (i)&#160;the Company has conducted its business only in the Ordinary Course of Business (except for the execution and performance of this Agreement and the discussions, negotiations and transactions related thereto) and (ii)&#160;the Company has not taken any action that would have required the consent of Parent pursuant to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;4.2(b)</font><font style="letter-spacing:0.2pt;"> had such action taken place after the execution and delivery of this Agreement; and (b)&#160;since the date of the Company Unaudited Interim Balance Sheet, there has not been any Company Material Adverse Effect. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">2.9&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Absence of Undisclosed Liabilities</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Neither the Company nor any of its Subsidiaries has any liability, indebtedness, obligation or expense of any kind, whether accrued, absolute, contingent, matured or unmatured (whether or not required to be reflected in the financial statements in accordance with GAAP) (each a &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Liability</font><font style="letter-spacing:0.2pt;">&#8221;), except for: (a)&#160;Liabilities disclosed, reflected or reserved against in the Company Unaudited Interim Balance Sheet; (b)&#160;Liabilities that have been incurred by the Company or its Subsidiaries since the date of the Company Unaudited Interim Balance Sheet in the Ordinary Course of Business; (c)&#160;Liabilities for performance of obligations of the Company or any of its Subsidiaries under Company Contracts (other than those arising as a result of a breach or default thereunder or as a result of failure to comply with applicable Law); (d)&#160;Liabilities for payment of fees and expenses incurred in connection with the Contemplated Transactions; (e)&#160;Liabilities which would not, individually or in the aggregate, reasonably be expected to be material to the Company and its Subsidiaries, taken as a whole; and (f)&#160;Liabilities described in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.9</font><font style="letter-spacing:0.2pt;"> of the Company Disclosure Schedule. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">2.10&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Title to Assets</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Each of the Company and its Subsidiaries owns, and has good and valid title to, or, in the case of leased properties and assets, valid leasehold interests in, all tangible properties or tangible assets and equipment used or held for use in its business or operations or purported to be owned by it, in </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-11</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="t2PLN">&#8203;</a><a name="t21PR">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">each case that are material to the Company and its Subsidiaries, taken as a whole, including: (a)&#160;all such tangible assets reflected on the Company Unaudited Interim Balance Sheet; and (b)&#160;all other such tangible assets reflected in the books and records of the Company or any of its Subsidiaries as being owned by the Company or such Subsidiary. All of such assets are owned or, in the case of leased assets, leased by the Company or any of its Subsidiaries free and clear of any Encumbrances, other than Permitted Encumbrances. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">2.11&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Real Property; Leasehold</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Neither the Company nor any of its Subsidiaries owns or has ever owned any real property. The Company has made available to Parent (a)&#160;an accurate and complete list of all real properties with respect to which the Company directly or indirectly holds a valid leasehold interest as well as any other real estate that is in the possession of, or occupied or leased by the Company or any of its Subsidiaries, and (b)&#160;copies of all leases under which any such real property is possessed, occupied or leased (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company Real Estate Leases</font><font style="letter-spacing:0.2pt;">&#8221;), each of which is in full force and effect, with no existing material default by the Company or any Subsidiary thereunder. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">2.12&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Intellectual Property</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.12(a)(1)</font><font style="letter-spacing:0.2pt;"> of the Company Disclosure Schedule identifies, as of the date of this Agreement, each item of material Company IP that is owned or purported to be owned by or assigned to the Company or its Subsidiaries and that is the subject of a registration or application in any jurisdiction (&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company Registered IP</font><font style="letter-spacing:0.2pt;">&#8221;), including, with respect to each such patent and patent application: (i)&#160;the name of the applicant/registrant; (ii)&#160;the jurisdiction of application/registration; (iii)&#160;the application or registration number; and (iv)&#160;any other co-owners. </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.12(a)(2)</font><font style="letter-spacing:0.2pt;"> of the Company Disclosure Schedule identifies, as of the date of this Agreement, each license agreement under which the Company or its Subsidiaries exclusively license material Company IP from a third party. To the Knowledge of the Company, each of the patents and patent applications included in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.12(a)(1)</font><font style="letter-spacing:0.2pt;"> of the Company Disclosure Schedule properly identifies by name each and every inventor of the inventions claimed therein as determined in accordance with applicable Laws of the United States. To the Knowledge of the Company, as of the date of this Agreement, no cancellation, interference, opposition, reissue, reexamination or other proceeding of any nature (other than office actions or similar communications issued by any Governmental Body in the ordinary course of prosecution of any pending applications for registration) is pending or threatened in writing, in which the scope, validity, enforceability or ownership of any Company IP, other than such items with pending applications, is being or has been contested or challenged. To the Knowledge of the Company, each item of issued Company Registered IP is valid, enforceable and subsisting. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;Except as would not have a Company Material Adverse Effect, the Company and its Subsidiaries collectively exclusively own, are the sole assignees of, or have exclusively licensed all material Company IP, free and clear of all Encumbrances other than Permitted Encumbrances (other than as disclosed in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.12(b)</font><font style="letter-spacing:0.2pt;"> of the Company Disclosure Schedule). The Company IP and the Intellectual Property Rights licensed to the Company pursuant to a valid, enforceable written agreement constitute all Intellectual Property Rights used in, material to and otherwise necessary for the operation of the Company&#8217;s business as currently conducted. Each Company Associate involved in the creation or development of any material Company IP, pursuant to such Company Associate&#8217;s activities on behalf of the Company or its Subsidiaries, has signed a valid and enforceable written agreement containing an assignment of such Company Associate&#8217;s rights in such Company IP to the Company or its applicable Subsidiary. Each Company Associate who has or has had access to the Company&#8217;s trade secrets or confidential information has signed a valid and enforceable written agreement containing confidentiality provisions protecting the Company IP, trade secrets and confidential information. The Company and its Subsidiaries have taken commercially reasonable steps to protect and preserve the confidentiality of its trade secrets and confidential information. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;To the Knowledge of the Company, no funding, facilities or personnel of any Governmental Body or any university, college, research institute or other educational institution has been used to create material Company IP that is owned or purported to be owned by or assigned to the Company or its Subsidiaries, except for any such funding or use of facilities or personnel that does not result in such Governmental Body or institution obtaining ownership rights or a license to such Company IP (excluding confirmatory licenses to inventions made with government funding and for which the Company, its </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-12</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Subsidiaries or either of their licensors has duly retained title under the Bayh-Dole Act) or the right to receive royalties for the practice of such Company IP. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.12(d)</font><font style="letter-spacing:0.2pt;"> of the Company Disclosure Schedule sets forth, as of the date of this Agreement, each license agreement pursuant to which the Company (i)&#160;is granted a license under any material Intellectual Property Right owned by any third party that is used by the Company or its Subsidiaries in its business as currently conducted (each a &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company In-bound License</font><font style="letter-spacing:0.2pt;">&#8221;) or (ii)&#160;grants to any third party a license under any material Company IP or material Intellectual Property Right licensed to the Company or its Subsidiaries under a Company In-bound License (each a &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company Out-bound License</font><font style="letter-spacing:0.2pt;">&#8221;) (</font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, that, Company In-bound Licenses shall not include, when entered into in the Ordinary Course of Business, material transfer agreements, clinical trial agreements, agreements with Company Associates, services agreements, commercially available Software-as-a-Service offerings or off-the-shelf software licenses; and Company Out-bound Licenses shall not include, when entered into in the Ordinary Course of Business, material transfer agreements, clinical trial agreements, services agreements, or non-exclusive outbound licenses). All Company In-bound Licenses and Company Out-bound Licenses are in full force and effect and are valid, enforceable and binding obligations of the Company or the applicable Subsidiary and, to the Knowledge of Company, each other party to such Company In-bound Licenses or Company Out-bound Licenses. Neither the Company or any of its Subsidiaries, nor to the Knowledge of the Company, any other party to such Company In-bound Licenses or Company Out-bound Licenses, is in material breach under any Company In-bound Licenses or Company Out-bound Licenses. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(e)&nbsp;&nbsp;&nbsp;To the Knowledge of the Company: (i)&#160;the operation of the businesses of the Company and its Subsidiaries as currently conducted does not infringe, misappropriate or otherwise violate any Intellectual Property Rights of any other Person; and (ii)&#160;no other Person is infringing, misappropriating or otherwise violating any Company IP. As of the date of this Agreement, no Legal Proceeding is pending (or, to the Knowledge of the Company, is threatened in writing) (A)&#160;against the Company or its Subsidiaries alleging that the operation of the businesses of the Company or its Subsidiaries infringes or constitutes the misappropriation or other violation of any Intellectual Property Rights of another Person or (B)&#160;by the Company or its Subsidiaries alleging that another Person has infringed, misappropriated or otherwise violated any of the Company IP or any Intellectual Property Rights exclusively licensed to the Company or its Subsidiaries. Between January&#160;1, 2019 and the date of this Agreement, neither the Company nor its Subsidiaries has received any written notice or other written communication alleging that the operation of the business of the Company or its Subsidiaries infringes or constitutes the misappropriation or other violation of any Intellectual Property Right of another Person. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(f)&nbsp;&nbsp;&nbsp;None of the Company IP that is owned or purported to be owned by or assigned to the Company or its Subsidiaries and, to the Knowledge of the Company, no material Intellectual Property Rights exclusively licensed to the Company or its Subsidiaries is subject to any pending or outstanding injunction, directive, order, judgment or other disposition of dispute that adversely and materially restricts the use, transfer, registration or licensing by the Company or its Subsidiaries of any such Company IP that is owned or purported to be owned by or assigned to the Company or its Subsidiaries or material Intellectual Property Rights exclusively licensed to the Company or its Subsidiaries. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(g)&nbsp;&nbsp;&nbsp;To the Knowledge of the Company, the Company, its Subsidiaries and the operation of the Company&#8217;s and its Subsidiaries&#8217; business are in substantial compliance with all Laws pertaining to data privacy and data security of any personally identifiable information or sensitive business information (collectively, &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Sensitive Data</font><font style="letter-spacing:0.2pt;">&#8221;). Between January&#160;1, 2019 and the date of this Agreement, there have been (i)&#160;no losses or thefts of data or security breaches relating to Sensitive Data used in the business of the Company or its Subsidiaries, (ii)&#160;no material violations of any security policy of the Company regarding any such Sensitive Data used in the business of the Company or its Subsidiaries and (iii)&#160;no unauthorized access, unauthorized use or unintended or improper disclosure of any Sensitive Data used in the business of the Company or its Subsidiaries, except in each case as would not reasonably be expected to be material to the Company and its Subsidiaries, taken as a whole. The Company has taken commercially reasonable steps and implemented reasonable disaster recovery and security plans and procedures to protect the information technology systems used in, material to and necessary for </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-13</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="t2CAC">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">operation of the Company&#8217;s business as currently conducted from unauthorized use or access. To the Knowledge of the Company, as of the date of this Agreement, there have been no material malfunctions or unauthorized intrusions or breaches of the information technology systems used in, material to and necessary for the operation of the Company&#8217;s business as currently conducted. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">2.13&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Agreements, Contracts and Commitments</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.13(a)</font><font style="letter-spacing:0.2pt;"> of the Company Disclosure Schedule lists the following Company Contracts in effect as of the date of this Agreement and under which the Company or any of its Subsidiaries has any remaining material rights or obligations (each, a &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company Material Contract</font><font style="letter-spacing:0.2pt;">&#8221; and collectively, the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company Material Contracts</font><font style="letter-spacing:0.2pt;">&#8221;): </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(i)&nbsp;&nbsp;&nbsp;each Company Contract relating to any agreement of indemnification or guaranty not entered into in the Ordinary Course of Business; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(ii)&nbsp;&nbsp;&nbsp;each Company Contract containing (A)&#160;any covenant limiting the freedom of the Company, its Subsidiaries or the Surviving Corporation to engage in any line of business or compete with any Person, (B)&#160;any most-favored pricing arrangement, (C)&#160;any exclusivity provision, or (D)&#160;any non-solicitation provision, in each case, except for restrictions that would not materially affect the ability of the Company and its Subsidiaries to conduct its business; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(iii)&nbsp;&nbsp;&nbsp;each Company Contract relating to capital expenditures and requiring payments after the date of this Agreement in excess of $250,000 pursuant to its express terms and not cancelable without penalty; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(iv)&nbsp;&nbsp;&nbsp;each Company Contract relating to the disposition or acquisition of material assets or any ownership interest in any Entity, in each case, involving payments in excess of $250,000, other than Company Contracts in which the applicable acquisition or disposition has been consummated and there are no material ongoing liabilities or obligations; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(v)&nbsp;&nbsp;&nbsp;each Company Contract relating to any mortgages, indentures, loans, notes or credit agreements, security agreements or other agreements or instruments relating to the borrowing of money or extension of credit in excess of $250,000 or creating any material Encumbrances with respect to any assets of the Company or any of its Subsidiaries or any loans or debt obligations with officers or directors of the Company; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(vi)&nbsp;&nbsp;&nbsp;each Company Contract requiring payment by or to the Company or its Subsidiaries after the date of this Agreement in excess of $250,000 pursuant to its express terms and constituting: (A)&#160;an exclusive distribution agreement; (B)&#160;an agreement involving provision of material services or products with respect to any pre-clinical or clinical development activities of the Company or its Subsidiaries; (C)&#160;a dealer, distributor, joint marketing, alliance, joint venture, cooperation, development or similar agreement currently in force under which the Company or its Subsidiaries has continuing obligations to develop or market any product, technology or service, or an agreement pursuant to which the Company or its Subsidiaries has continuing obligations to develop any Intellectual Property Rights that will not be owned, in whole or in part, by the Company or its Subsidiaries; or (D)&#160;a Contract to license any patent, trademark registration, service mark registration, trade name or copyright registration to or from any third party relating to the manufacture or production of any product, service or technology of the Company or its Subsidiaries or any Contract to sell, distribute or commercialize any products or service of the Company or its Subsidiaries, in each case under clauses (A)&#160;through (D), except for Company Contracts that are entered into in the Ordinary Course of Business; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(vii)&nbsp;&nbsp;&nbsp;each Company Contract with any financial advisor, broker, finder, investment banker or other similar Person, providing advisory services to the Company in connection with the Contemplated Transactions; </font>
        </div>
        <div style="margin-left:60pt; margin-top:8pt; width:396pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(viii)&nbsp;&nbsp;&nbsp;each Company Real Estate Lease; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(ix)&nbsp;&nbsp;&nbsp;each Company Contract that would be a material contract as defined in Item&#160;601(b)(10) of Regulation&#160;S-K as promulgated under the Securities Act if the Company were subject to such regulation; </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-14</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="t2PR">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:40pt; text-indent:20pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(x)&nbsp;&nbsp;&nbsp;each Company Out-bound License and Company In-bound License, and each Company Contract containing a covenant not to sue or otherwise enforce any Intellectual Property Rights; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(xi)&nbsp;&nbsp;&nbsp;each Company Contract containing any royalty, dividend or similar arrangement based on the revenues or profits of the Company or any of its Subsidiaries; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(xii)&nbsp;&nbsp;&nbsp;each (A)&#160;Company Contract, offer letter, employment agreement or other agreement with any employee that requires payment of base salary and target annual cash bonus in excess of $150,000 in any calendar year that (1)&#160;provides for employment by the Company or any of its Subsidiaries and is not immediately terminable at will by the Company without advance notice, severance, or other similar cost or liability (other than for accrued compensation, vacation or other amounts due upon any termination) or (2)&#160;provides for retention payments, change of control payments, severance, accelerated vesting or any payment or benefit that may or will become due as a result of the Merger (whether alone or in connection with any other event) and (B)&#160;each Company Contract, independent contractor agreement, or other agreement with any individual consultant or service provider requiring payment of fees in excess of $150,000 in any calendar year that (1)&#160;is not immediately terminable at will by the Company without more than 30&#160;days&#8217; prior notice, severance, or other cost or liability or (2)&#160;provides for retention payments, change of control payments, severance, accelerated vesting or any payment or benefit that may or will become due as a result of the Merger (whether alone or in connection with any other event); </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(xiii)&nbsp;&nbsp;&nbsp;each Company Contract under which a third party would be entitled to receive a license or have any other rights in, any material Company IP; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(xiv)&nbsp;&nbsp;&nbsp;each Company Contract entered into in settlement of any Legal Proceeding or other dispute; and </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(xv)&nbsp;&nbsp;&nbsp;any other Company Contract that is not terminable at will (with no penalty or payment) by the Company or its Subsidiaries, as applicable, and (A)&#160;which involves payment or receipt by the Company or its Subsidiaries after the date of this Agreement under any such agreement, Contract or commitment of more than $250,000 in the aggregate, or obligations after the date of this Agreement in excess of $250,000 in the aggregate, or (B)&#160;that is material to the business or operations of the Company and its Subsidiaries, taken as a whole. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;The Company has made available to Parent accurate and complete copies of all Company Material Contracts, including all amendments thereto, in each case in effect on the date of this Agreement. There are no Company Material Contracts that are not in written form. Neither the Company nor any of its Subsidiaries has, nor to the Company&#8217;s Knowledge, as of the date of this Agreement, has any other party to a Company Material Contract, breached, violated or defaulted under, or as of the date of this Agreement received notice that it breached, violated or defaulted under, any of the terms or conditions of any Company Material Contract in such manner as would permit any other party to cancel or terminate any such Company Material Contract, or would permit any other party to seek damages which would have a Company Material Adverse Effect. As to the Company and its Subsidiaries, as of the date of this Agreement, each Company Material Contract is valid, binding, enforceable and in full force and effect, subject to the Enforceability Exceptions. As of the date of this Agreement, no Person is renegotiating, or has a right pursuant to the terms of any Company Material Contract to change, any material amount paid or payable to the Company under any Company Material Contract or any other material term or provision of any Company Material Contract, and, as of the date of the Agreement, no Person has indicated in writing to the Company that it desires to renegotiate, modify, not renew or cancel any Company Material Contract. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">2.14&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Compliance; Permits; Restrictions</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;The Company and each of its Subsidiaries is, and since January&#160;1, 2019 has been, in compliance in all material respects with all applicable Laws, including the Federal Food, Drug and Cosmetic Act and regulations issued thereunder by the United States Food and Drug Administration (&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">FDA</font><font style="letter-spacing:0.2pt;">&#8221;) (collectively, the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">FDCA</font><font style="letter-spacing:0.2pt;">&#8221;), the Public Health Service Act and its implementing regulations (&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">PHSA</font><font style="letter-spacing:0.2pt;">&#8221;) and any other similar Law administered or promulgated by the FDA or other comparable Governmental Body responsible for regulation of the research, development, pre-clinical and clinical </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-15</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">testing, manufacturing, storage, supply, approval, sale, marketing, distribution and importation or exportation of drug and biological products (each, a &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Drug Regulatory Agency</font><font style="letter-spacing:0.2pt;">&#8221;), except for any noncompliance, either individually or in the aggregate, which would not be material to the Company and its Subsidiaries, taken as a whole. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;As of the date of this Agreement, no investigation, claim, suit, proceeding, audit or other action by any Governmental Body is pending or, to the Knowledge of the Company, threatened against the Company or any of its Subsidiaries. There is no judgment, injunction, order or decree binding upon the Company or any of its Subsidiaries which (i)&#160;has or would reasonably be expected to have the effect of prohibiting or materially impairing any business practice of the Company or any of its Subsidiaries, any acquisition of material property by the Company or any of its Subsidiaries or the conduct of business by the Company or any of its Subsidiaries as currently conducted, (ii)&#160;is reasonably likely to have an adverse effect on the Company&#8217;s ability to comply with or perform any covenant or obligation under this Agreement, or (iii)&#160;is reasonably likely to have the effect of preventing, delaying, making illegal or otherwise interfering with the Contemplated Transactions. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;The Company and its Subsidiaries hold all required Governmental Authorizations to develop, test manufacture, store, label, package, distribute, import and export the respective current products or product candidates that are material to the operation of the business of the Company and its Subsidiaries as currently conducted (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company Permits</font><font style="letter-spacing:0.2pt;">&#8221;). </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.14(c)</font><font style="letter-spacing:0.2pt;"> of the Company Disclosure Schedule identifies each Company Permit. Each such Company Permit is valid and in full force and effect, and each of the Company and its Subsidiaries is in material compliance with the terms of the Company Permits. As of the date of this Agreement, no Legal Proceeding is pending or, to the Knowledge of the Company, threatened, which seeks to revoke, limit, suspend, or materially modify any Company Permit. The rights and benefits of each Company Permit will be available to the Surviving Corporation or its Subsidiaries, as applicable, immediately after the Effective Time on terms substantially identical to those enjoyed by the Company and its Subsidiaries as of the date of this Agreement and immediately prior to the Effective Time. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;As of the date of this Agreement, there has not been and is not now any Form FDA-483 observation, civil, criminal or administrative action, suit, demand, claim, complaint, hearing, investigation, demand letter, warning letter, untitled letter, or proceeding pending or in effect against the Company or its Subsidiaries or any of their respective officers and employees, and the Company has no liability for failure to comply with the FDCA, PHSA, or other similar Laws. There is no act, omission, event, or circumstance of which the Company has Knowledge that would reasonably be expected to give rise to or form the basis for any civil, criminal or administrative action, suit, demand, claim, complaint, hearing, investigation, demand letter, warning letter, untitled letter, proceeding or request for information or any liability (whether actual or contingent) for failure to comply with the FDCA, PHSA or other similar Laws. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(e)&nbsp;&nbsp;&nbsp;All clinical, pre-clinical and other studies and tests conducted by or on behalf of, or sponsored by, the Company or its Subsidiaries, or of their respective current products or product candidates, were and, if still pending, are being conducted in all material respects with applicable regulations of any applicable Drug Regulatory Agency and other applicable Law, including the Good Clinical Practice (&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">GCP</font><font style="letter-spacing:0.2pt;">&#8221;) regulations under 21 C.F.R. Parts 50, 54, 56 and 312 and Good Laboratory Practice (&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">GLP</font><font style="letter-spacing:0.2pt;">&#8221;) regulations under 21 C.F.R. Part&#160;58. No preclinical study or clinical trial conducted by or on behalf of the Company or any of its Subsidiaries has been terminated or suspended prior to completion for safety or non-compliance reasons. Between January&#160;1, 2019 and the date of this Agreement, neither the Company nor any of its Subsidiaries has received any written notices, correspondence, or other written communications from any Drug Regulatory Agency requiring, or to the Knowledge of the Company, threatening to initiate, the termination or suspension of any clinical studies conducted by or on behalf of, or sponsored by, the Company or any of its Subsidiaries or of their respective current products or product candidates. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(f)&nbsp;&nbsp;&nbsp;As of the date of this Agreement, neither the Company nor any of its Subsidiaries is the subject of any pending or, to the Knowledge of the Company, threatened investigation in respect of its business or products or product candidates pursuant to the FDA&#8217;s &#8220;Fraud, Untrue Statements of Material Facts, Bribery, and Illegal Gratuities&#8221; Final Policy set forth in 56 Fed. Reg. 46191 (September&#160;10, </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-16</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="t2PO">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">1991). To the Knowledge of the Company, neither the Company nor any of its Subsidiaries has committed any acts, made any statement, or failed to make any statement, in each case in respect of its business or products that would violate the FDA&#8217;s &#8220;Fraud, Untrue Statements of Material Facts, Bribery, and Illegal Gratuities&#8221; Final Policy. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(g)&nbsp;&nbsp;&nbsp;Neither the Company nor its Subsidiaries, nor any of their respective officers, directors, employees or, to the Knowledge of the Company, agents has been, is, or is in anticipation of being (based on a conviction by the courts or a finding of fault by a regulatory authority): (a)&#160;debarred pursuant to the Generic Drug Enforcement Act of 1992 (21 U.S.C. &#167;&#160;335a), as amended from time to time; (b)&#160;disqualified from participating in clinical trials pursuant to 21 C.F.R. &#167;312.70, as amended from time to time; (c)&#160;disqualified as a testing facility under 21 C.F.R. Part&#160;58, Subpart K, as amended from time to time; (d)&#160;excluded, debarred or suspended from or otherwise ineligible to participate in a &#8220;Federal Health Care Program&#8221; as that term is defined in 42 U.S.C. 1320a-7b(f), including under 42 U.S.C. &#167;&#160;1320a-7 or relevant regulations in 42 C.F.R. Part&#160;1001; (e)&#160;assessed or threatened with assessment of civil money penalties pursuant to 42 C.F.R. Part&#160;1003; or (f)&#160;included on the HHS/OIG List of Excluded Individuals/Entities, the General Services Administration&#8217;s System for Award Management, or the FDA Debarment List or the FDA Disqualified/Restricted List. Neither the Company nor its Subsidiaries, nor any of their respective officers, directors, employees or, to the Knowledge of the Company, agents has engaged in any activities that are prohibited, or are cause for civil penalties, or grounds for mandatory or permissive exclusion, debarment, or suspension pursuant to any of these authorities. Neither the Company nor its Subsidiaries are using, or have ever used, in any capacity any Person that has ever been, or to the Knowledge of Company, is the subject of a proceeding that could lead to the Persons becoming debarred, excluded, disqualified, restricted or suspended pursuant to any of these authorities. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(h)&nbsp;&nbsp;&nbsp;The Company and its Subsidiaries have materially complied with all applicable Laws relating to patient, medical or individual health information, including the Health Insurance Portability and Accountability Act of 1996 and its implementing regulations promulgated thereunder, all as amended from time to time (collectively &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">HIPAA</font><font style="letter-spacing:0.2pt;">&#8221;), including the standards for the privacy of Individually Identifiable Health Information at 45 C.F.R. Parts 160 and 164, Subparts A and E, the standards for the protection of Electronic Protected Health Information set forth at 45 C.F.R. Part&#160;160 and 45 C.F.R. Part&#160;164, Subpart A and Subpart C, the standards for transactions and code sets used in electronic transactions at 45 C.F.R. Part&#160;160, Subpart A and Part&#160;162, and the standards for Breach Notification for Unsecured Protected Health Information at 45 C.F.R. Part&#160;164, Subpart D, all as amended from time to time. The Company and its Subsidiaries have entered into, where required, and are in compliance in all material respects with the terms of all Business Associate (as defined in HIPAA) agreements (&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Business Associate Agreements</font><font style="letter-spacing:0.2pt;">&#8221;) to which the Company or any Subsidiary is a party or otherwise bound. The Company and its Subsidiaries where required, have (i)&#160;created and maintained written policies and procedures to protect the privacy of Protected Health Information in its possession or control, (ii)&#160;provided training to all employees and agents, and (iii)&#160;implemented security procedures, including physical, technical and administrative safeguards, to protect all Protected Health Information stored or transmitted in electronic form. As of the date of this Agreement, neither the Company nor any of its Subsidiaries has received written notice from the Office for Civil Rights for the U.S. Department of Health and Human Services or any other Governmental Body alleging a failure to comply with HIPAA or any other federal or state law or regulation applicable to the protection of individually identifiable health information or personally identifiable information. To the Knowledge of the Company, as of the date of this Agreement, there has been no Breach of Unsecured Protected Health Information, unpermitted disclosure of Personal Health Information, or breach of personally identifiable information with respect to information maintained or transmitted to the Company or any of its Subsidiaries that would require notice to a Governmental Body. All capitalized terms in this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.14(h)</font><font style="letter-spacing:0.2pt;"> not otherwise defined in this Agreement shall have the meanings set forth under HIPAA. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">2.15&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Legal Proceedings; Orders</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;As of the date of this Agreement, there is no material pending Legal Proceeding and, to the Knowledge of the Company, no Person has threatened in writing to commence any Legal Proceeding: (i)&#160;that involves (A)&#160;the Company, (B)&#160;any of its Subsidiaries, (C)&#160;any Company Associate (in his or her </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-17</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="t21MA">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">capacity as such) or (D)&#160;any of the material assets owned or used by the Company or any of its Subsidiaries; or (ii)&#160;that challenges, or that would have the effect of preventing, delaying beyond the End Date, or making illegal, the Contemplated Transactions. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;There is no order, writ, injunction, judgment or decree to which the Company or any of its Subsidiaries is a party or any of the material assets owned or used by the Company or any of its Subsidiaries is subject. To the Knowledge of the Company, no officer or other Key Employee of the Company or any of its Subsidiaries is subject to any order, writ, injunction, judgment or decree that prohibits such officer or employee from engaging in or continuing any conduct, activity or practice relating to the business of the Company or any of its Subsidiaries or to any material assets owned or used by the Company or any of its Subsidiaries. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">2.16&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Tax Matters</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;The Company and each of its Subsidiaries has timely filed all income Tax Returns and other material Tax Returns that they were required to file under applicable Law. All such Tax Returns are correct and complete in all material respects and have been prepared in material compliance with all applicable Law. No written claim has ever been made by any Governmental Body in any jurisdiction where the Company or any of its Subsidiaries does not file a particular Tax Return or pay a particular Tax that the Company or such Subsidiary is subject to taxation by that jurisdiction. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;All income and other material Taxes due and owing by the Company or any of its Subsidiaries (whether or not shown on any Tax Return) have been fully paid. The unpaid Taxes of the Company and its Subsidiaries did not, as of the date of the Company Unaudited Interim Balance Sheet, materially exceed the reserve for Tax liability (excluding any reserve for deferred Taxes established to reflect timing differences between book and Tax items) set forth on the face of the Company Unaudited Interim Balance Sheet. Since the date of the Company Unaudited Interim Balance Sheet, neither the Company nor any of its Subsidiaries has incurred any material Liability for Taxes outside the Ordinary Course of Business. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;All Taxes that the Company or any of its Subsidiaries are or were required by Law to withhold or collect from payments to employees, independent contractors, stockholders, lenders, customers or other third parties have been duly and timely withheld or collected in all material respects and, have been timely paid to the proper Governmental Body or properly set aside in accounts for this purpose. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;There are no Encumbrances for material Taxes (other than Permitted Encumbrances) upon any of the assets of the Company or any of its Subsidiaries. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(e)&nbsp;&nbsp;&nbsp;No deficiencies for income or other material Taxes with respect to the Company or any of its Subsidiaries have been claimed, proposed or assessed by any Governmental Body in writing other than any deficiency that has been resolved. There are no pending or ongoing, and to the Knowledge of the Company, threatened audits, assessments or other actions for or relating to any liability in respect of a material amount of Taxes of the Company or any of its Subsidiaries. Neither the Company nor any of its Subsidiaries (or any of their predecessors) has waived any statute of limitations in respect of any income or other material Taxes or agreed to any extension of time with respect to any income or other material Tax assessment or deficiency, which waiver is still in effect. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(f)&nbsp;&nbsp;&nbsp;Neither the Company nor any of its Subsidiaries has, since January&#160;1, 2019, distributed stock of another Person, or had its stock distributed by another Person, in a transaction that was purported or intended to be governed in whole or in part by Section&#160;355 of the Code or Section&#160;361 of the Code (or any similar provisions of state, local or foreign Law). </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(g)&nbsp;&nbsp;&nbsp;Neither the Company nor any of its Subsidiaries has participated in or been a party to a transaction that, as of the date of this Agreement, constitutes a &#8220;listed transaction&#8221; that is required to be reported to the IRS pursuant to Section&#160;6011 of the Code and applicable Treasury Regulations thereunder. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-18</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="t2ALM">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; text-indent:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(h)&nbsp;&nbsp;&nbsp;Neither the Company nor any of its Subsidiaries has taken or agreed to take any action or knows of any fact or circumstance that would reasonably be expected to prevent the Merger from qualifying for the Intended Tax Treatment. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(i)&nbsp;&nbsp;&nbsp;Neither the Company nor any of its Subsidiaries is a party to any Tax allocation agreement, Tax sharing agreement, Tax indemnity agreement, or similar agreement or arrangement, other than customary commercial Contracts entered into in the Ordinary Course of Business the principal subject matter of which is not Taxes. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(j)&nbsp;&nbsp;&nbsp;Neither the Company nor any of its Subsidiaries will be required to include any material item of income in, or exclude any material item of deduction from, taxable income for any Tax period (or portion thereof) ending after the Closing Date as a result of any: (i)&#160;change in method of accounting for Tax purposes filed on or prior to the Closing Date; (ii)&#160;use of an improper method of accounting for a Tax period ending on or prior to the Closing Date; (iii)&#160;&#8220;closing agreement&#8221; as described in Section&#160;7121 of the Code (or any similar provision of state, local or foreign Law) executed on or prior to the Closing Date; (iv)&#160;intercompany transaction or excess loss account described in Treasury Regulations under Section&#160;1502 of the Code (or any similar provision of state, local or foreign Law) as a result of a transaction on or prior to the Closing Date; (v)&#160;installment sale or open transaction disposition made on or prior to the Closing Date; or (vi)&#160;prepaid amount received outside of the Ordinary Course of Business on or prior to the Closing Date. The Company has not made any election under Section&#160;965(h) of the Code. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(k)&nbsp;&nbsp;&nbsp;Neither the Company nor any of its Subsidiaries has ever been (i)&#160;a member of a consolidated, combined or unitary Tax group (other than such a group the common parent of which is the Company) or (ii)&#160;a party to any joint venture, partnership, or other arrangement that is treated as a partnership for U.S. federal income Tax purposes. Neither the Company nor any of its Subsidiaries has any Liability for any Taxes of any Person (other than the Company and any of its Subsidiaries) under Treasury Regulations&#160;Section&#160;1.1502-6 (or any similar provision of state, local, or foreign Law), or as a transferee or successor. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(l)&nbsp;&nbsp;&nbsp;Neither the Company nor any of its Subsidiaries (i)&#160;is a &#8220;controlled foreign corporation&#8221; as defined in Section&#160;957 of the Code; (ii)&#160;is a &#8220;passive foreign investment company&#8221; within the meaning of Section&#160;1297 of the Code; (iii)&#160;has ever had a permanent establishment (within the meaning of an applicable Tax treaty) or otherwise had an office or fixed place of business in a country other than the country in which it is organized; or (iv)&#160;is or was a &#8220;surrogate foreign corporation&#8221; within the meaning of Section&#160;7874(a)(2)(B) or is treated as a U.S. corporation under Section&#160;7874(b) of the Code. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">2.17&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Employee and Labor Matters; Benefit Plans</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.17(a)</font><font style="letter-spacing:0.2pt;"> of the Company Disclosure Schedule is a list as of the date of this Agreement of all Company Benefit Plans, including each Company Benefit Plan that provides for retirement, change in control, stay or retention, deferred compensation, incentive compensation, severance or retiree medical or life insurance benefits. &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company Benefit Plan</font><font style="letter-spacing:0.2pt;">&#8221; means each (i)&#160;&#8220;employee benefit plan&#8221; as defined in Section&#160;3(3) of ERISA (whether or not ERISA governs such plan) and (ii)&#160;other pension, retirement, deferred compensation, excess benefit, profit sharing, bonus, incentive, equity or equity-based (other than individual Company Options made pursuant to the Company&#8217;s standard forms, in which case only representative standard forms of such stock option agreements shall be scheduled), phantom equity, employment (other than individual employment agreements made pursuant to the Company&#8217;s standard forms, in which case only representative standard forms of such employment agreements shall be scheduled), offer letter (other than individual offer letters made pursuant to the Company&#8217;s standard forms, in which case only representative standard forms of such offers shall be scheduled), consulting, severance, change-of-control, retention, health, life, disability, group insurance, paid-time off, holiday, welfare and fringe benefit plan, program, agreement, Contract, or arrangement (whether written or unwritten, qualified or nonqualified, funded or unfunded and including any that have been frozen or terminated but only if the Company has continuing liabilities with respect thereto), in any case, maintained, contributed to, or required to be contributed to, by the Company or any of its Subsidiaries or Company ERISA Affiliates for the benefit of any current or former employee, director, officer or independent contractor of the Company or any of its Subsidiaries or under which </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-19</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">the Company or any of its Subsidiaries has any Liability (including as the result of its being treated as a single employer under Code Section&#160;414 with any other person). </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;As applicable with respect to each Company Benefit Plan, the Company has made available to Parent, true and complete copies of (i)&#160;each Company Benefit Plan, including all amendments thereto, and in the case of an unwritten Company Benefit Plan, a written description thereof, (ii)&#160;all current trust documents, investment management Contracts, custodial agreements, administrative services agreements and insurance and annuity Contracts relating thereto, (iii)&#160;the current summary plan description and each summary of material modifications thereto, (iv)&#160;the most recently filed annual reports with any Governmental Body (e.g., Form 5500 and all schedules thereto), (v)&#160;the most recent IRS determination, opinion or advisory letter, (vi)&#160;the most recent summary annual reports, nondiscrimination testing reports, actuarial reports, financial statements and trustee reports, (vii)&#160;all material records, notices and filings concerning IRS or Department of Labor or other Governmental Body audits or investigations, and (viii)&#160;any written reports constituting a valuation of the Company Common Stock for purposes of Section&#160;409A of the Code, whether prepared internally by the Company or by an outside, third-party valuation firm. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;Each Company Benefit Plan has been maintained, operated and administered in compliance in all material respects with its terms and any related documents or agreements and the applicable provisions of ERISA, the Code and all other Laws. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;The Company Benefit Plans that are &#8220;employee pension benefit plans&#8221; within the meaning of Section&#160;3(2) of ERISA and which are intended to meet the qualification requirements of Section&#160;401(a) of the Code have received determination, opinion, or advisory letters from the IRS to the effect that such plans are qualified under Section&#160;401(a) of the Code and the related trusts are exempt from federal income Taxes under Section&#160;501(a) of the Code, respectively, and to the Knowledge of the Company, nothing has occurred that would reasonably be expected to adversely affect the qualification of such Company Benefit Plan or the tax exempt status of the related trust. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(e)&nbsp;&nbsp;&nbsp;Since January&#160;1, 2016, neither the Company nor any of its Subsidiaries maintained, contributed to, been required to contribute to, or had any liability with respect to, (i)&#160;any &#8220;employee pension benefit plan&#8221; &#8203;(within the meaning of Section&#160;3(2) of ERISA) that is subject to Title IV or Section&#160;302 of ERISA or Section&#160;412 of the Code, (ii)&#160;any &#8220;multiemployer plan&#8221; &#8203;(within the meaning of Section&#160;3(37) of ERISA), (iii)&#160;any &#8220;multiple employer plan&#8221; &#8203;(within the meaning of Section&#160;413 of the Code) or (iv)&#160;any &#8220;multiple employer welfare arrangement&#8221; &#8203;(within the meaning of Section&#160;3(40) of ERISA). No Company Benefit Plan is sponsored by a professional employer organization. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(f)&nbsp;&nbsp;&nbsp;As of the date of this Agreement, there are no (i)&#160;pending audits or investigations by any Governmental Body involving any Company Benefit Plan, and (ii)&#160;pending or, to the Knowledge of the Company, threatened claims (except for individual claims for benefits payable in the normal operation of the Company Benefit Plans), suits or proceedings involving any Company Benefit Plan, any fiduciary thereof or service provider thereto. All contributions and premium payments required to have been made under any of the Company Benefit Plans or by applicable Law (without regard to any waivers granted under Section&#160;412 of the Code), have been timely made in all material respects and neither the Company nor any Company ERISA Affiliate has any material liability for any unpaid contributions with respect to any Company Benefit Plan. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(g)&nbsp;&nbsp;&nbsp;Neither the Company, any of its Subsidiaries nor any Company ERISA Affiliates, nor to the Knowledge of the Company, any fiduciary, trustee or administrator of any Company Benefit Plan, has engaged in, or in connection with the Contemplated Transactions will engage in, any transaction with respect to any Company Benefit Plan which would subject any such Company Benefit Plan, the Company or any of its Subsidiaries or Parent to a material Tax, material penalty or material liability for a &#8220;prohibited transaction&#8221; under Section&#160;406 of ERISA or Section&#160;4975 of the Code. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(h)&nbsp;&nbsp;&nbsp;No Company Benefit Plan provides death, medical, dental, vision, life insurance or other welfare benefits beyond termination of service or retirement other than coverage mandated by Law and fully paid by the participant (except in connection with severance), and neither the Company nor any of its Subsidiaries or Company ERISA Affiliates has made a written or oral representation promising the same. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-20</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; text-indent:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(i)&nbsp;&nbsp;&nbsp;Neither the execution of this Agreement nor the consummation of the Contemplated Transactions will either alone or in connection with any other event(s) (i)&#160;result in any payment becoming due to any current or former employee, director, officer, or independent contractor of the Company or any of its Subsidiaries, (ii)&#160;increase any amount of compensation or benefits otherwise payable under any Company Benefit Plan, (iii)&#160;result in the acceleration of the time of payment, funding or vesting of any benefits under any Company Benefit Plan, (iv)&#160;require any contribution or payment to fund any obligation under any Company Benefit Plan or (v)&#160;limit the right to merge, amend or terminate any Company Benefit Plan that is subject to ERISA. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(j)&nbsp;&nbsp;&nbsp;Neither the execution of this Agreement nor the consummation of the Contemplated Transactions (either alone or when combined with the occurrence of any other event, including without limitation, a termination of employment) will result in the receipt or retention by any Person who is a &#8220;disqualified individual&#8221; &#8203;(within the meaning of Code Section&#160;280G) with respect to the Company and its Subsidiaries of any payment or benefit under any Company Benefit Plan that is or could reasonably be expected to be characterized as a &#8220;parachute payment&#8221; &#8203;(within the meaning of Code Section&#160;280G). </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(k)&nbsp;&nbsp;&nbsp;The exercise price of each Company Option granted to a U.S. taxpayer is not and never has been less than the fair market value of one share of Company Common Stock, as determined by the Company Board, as of the grant date of such Company Option. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(l)&nbsp;&nbsp;&nbsp;Each Company Benefit Plan providing for deferred compensation that constitutes a &#8220;nonqualified deferred compensation plan&#8221; &#8203;(as defined in Section&#160;409A(d)(1) of the Code and the regulations promulgated thereunder) is, and has been, established, administered and maintained in material compliance with the requirements of Section&#160;409A of the Code and the regulations promulgated thereunder in all material respects. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(m)&nbsp;&nbsp;&nbsp;No current or former employee, officer, director or independent contractor of the Company or any of its Subsidiaries has any &#8220;gross up&#8221; agreements with the Company or any of its Subsidiaries or other assurance of reimbursement by the Company or any of its Subsidiaries for any Taxes imposed under Code Section&#160;409A or Code Section&#160;4999. </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(n)&nbsp;&nbsp;&nbsp;No Company Benefit Plan is maintained outside of the United States. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(o)&nbsp;&nbsp;&nbsp;Neither the Company nor any of its Subsidiaries has ever been a party to, bound by, or has a duty to bargain under, any collective bargaining agreement or other Contract with a labor union, labor organization, or similar Person representing any of its employees, and there is no labor union, labor organization, or similar Person representing or, to the Knowledge of the Company, purporting to represent or seeking to represent any employees of the Company or its Subsidiaries, including through the filing of a petition for representation election. There is not and has not been in the past three&#160;years, nor is there or has there been in the past three&#160;years any threat of, any strike, slowdown, work stoppage, lockout, union election petition, demand for recognition, or any similar activity or dispute, or, to the Knowledge of the Company, any union organizing activity, against the Company or any of its Subsidiaries. No event has occurred, and no condition or circumstance exists, that might directly or indirectly be likely to give rise to or provide a basis for the commencement of any such strike, slowdown, work stoppage, lockout, union election petition, demand for recognition, any similar activity or dispute, or, to the Knowledge of the Company, any union organizing activity. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(p)&nbsp;&nbsp;&nbsp;The Company and each of its Subsidiaries is, and since January&#160;1, 2019 has been, in material compliance with all applicable Laws respecting labor, employment, employment practices, and terms and conditions of employment, including worker classification, discrimination, harassment and retaliation, equal employment opportunities, fair employment practices, meal and rest periods, immigration, employee safety and health, payment of wages (including overtime wages), unemployment and workers&#8217; compensation, leaves of absence, and hours of work. Except as would not be reasonably likely to result in a material liability to the Company or any of its Subsidiaries, with respect to employees of the Company and its Subsidiaries, each of the Company and its Subsidiaries, since January&#160;1, 2019: (i)&#160;has withheld and reported all amounts required by Law or by agreement to be withheld and reported with respect to wages, salaries and other payments, benefits, or compensation to employees; </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-21</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="t2MSJ">&#8203;</a><a name="t2TCH">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">(ii)&#160;is not liable for any arrears of wages (including overtime wages), severance pay or any Taxes or any penalty for failure to comply with any of the foregoing; and (iii)&#160;is not liable for any payment to any trust or other fund governed by or maintained by or on behalf of any Governmental Body, with respect to unemployment compensation benefits, disability, social security or other benefits or obligations for employees (other than routine payments to be made in the Ordinary Course of Business). As of the date of this Agreement, there are no Legal Proceedings, claims, or charges pending or, to the Knowledge of the Company, threatened or reasonably anticipated against the Company or its Subsidiaries relating to any employee, applicant for employment, consultant or employment agreement or otherwise relating to labor, employment, employment practices, or terms and conditions of employment. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(q)&nbsp;&nbsp;&nbsp;Except as would not be reasonably likely to result in a material liability to the Company or any of its Subsidiaries, the Company and each of its Subsidiaries has accurately classified each individual service provider as an employee, independent contractor, or otherwise under all applicable Laws and, for each individual classified as an employee, the Company and each of its Subsidiaries has accurately classified him or her as exempt or non-exempt under all applicable Laws. Neither the Company nor any of its Subsidiaries has any material liability with respect to any misclassification of: (a)&#160;any Person as an independent contractor rather than as an employee; (b)&#160;any employee leased from another employer; or (c)&#160;any employee currently or formerly classified as exempt under all applicable Laws. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(r)&nbsp;&nbsp;&nbsp;Within the preceding five&#160;years, the Company has not implemented any &#8220;plant closing&#8221; or &#8220;mass layoff&#8221; of employees that would reasonably be expected to require notification under the WARN Act or any similar state, local or foreign Law, and no such &#8220;plant closing&#8221; or &#8220;mass layoff&#8221; will be implemented before the Closing Date without advance notification to and approval of Parent. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">2.18&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Environmental Matters</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Since January&#160;1, 2019, the Company and each of its Subsidiaries have complied with all applicable Environmental Laws, which compliance includes the possession by the Company of all permits and other Governmental Authorizations required under applicable Environmental Laws and compliance with the terms and conditions thereof, except for any failure to be in such compliance that would not have a Company Material Adverse Effect. Neither the Company nor any of its Subsidiaries has received between January&#160;1, 2019 and the date of this Agreement any written notice, whether from a Governmental Body or other Person, that alleges that the Company or any of its Subsidiaries is not in compliance with any Environmental Law and, to the Knowledge of the Company, there are no circumstances that would reasonably be expected to prevent or interfere with the Company&#8217;s or any of its Subsidiaries&#8217; compliance in any material respects with any Environmental Law, except where such failure to comply would not have a Company Material Adverse Effect. To the Knowledge of the Company, (i)&#160;no current or prior owner of any property leased or controlled by the Company or any of its Subsidiaries has received, between January&#160;1, 2019 and the date of this Agreement, any written notice relating to property owned or leased at any time by the Company or any of its Subsidiaries, whether from a Governmental Body or other Person, that alleges that such current or prior owner or the Company or any of its Subsidiaries is not in compliance with or violated any Environmental Law relating to such property and (ii)&#160;neither the Company nor any of its Subsidiaries has any material liability under any Environmental Law. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">2.19&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Insurance</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Company has made available to Parent accurate and complete copies of all material insurance policies and all material self-insurance programs and arrangements relating to the business, assets, liabilities and operations of the Company and each of its Subsidiaries. Each of such insurance policies is in full force and effect and the Company and each of its Subsidiaries are in compliance in all material respects with the terms thereof. Other than customary end of policy notifications from insurance carriers, between January&#160;1, 2019 and the date of this Agreement, neither the Company nor any of its Subsidiaries has received any written notice regarding any actual or possible: (a)&#160;cancellation or invalidation of any insurance policy; or (b)&#160;refusal or denial of any coverage, reservation of rights or rejection of any material claim under any insurance policy. The Company and each of its Subsidiaries has provided timely written notice to the appropriate insurance carrier(s) of each Legal Proceeding that is currently pending against the Company or any of its Subsidiaries for which the Company or such Subsidiary has insurance coverage, and no such carrier has issued a denial of coverage or a reservation of rights with respect to any such Legal Proceeding, or informed the Company or any of its Subsidiaries of its intent to do so. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-22</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="t2FAN">&#8203;</a><a name="t2WAS">&#8203;</a><a name="t2NOT">&#8203;</a><a name="t2OOR">&#8203;</a><a name="tS3AW">&#8203;</a><a name="t3OS">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">2.20&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">No Financial Advisors</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;No broker, finder or investment banker is entitled to any brokerage fee, finder&#8217;s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Contemplated Transactions based upon arrangements made by or on behalf of the Company or any of its Subsidiaries. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">2.21&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Transactions with Affiliates</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.21</font><font style="letter-spacing:0.2pt;"> of the Company Disclosure Schedule describes any material transactions or relationships, between January&#160;1, 2019 and the date of this Agreement, between, on one hand, the Company or any of its Subsidiaries and, on the other hand, any (A)&#160;executive officer or director of the Company or, to the Knowledge of the Company, any of its Subsidiaries or any of such executive officer&#8217;s or director&#8217;s immediate family members, (B)&#160;owner of more than 5% of the voting power of the outstanding Company Capital Stock or (C)&#160;to the Knowledge of the Company, any &#8220;related person&#8221; &#8203;(within the meaning of Item&#160;404 of Regulation&#160;S-K under the Securities Act) of any such officer, director or owner (other than the Company or its Subsidiaries) in the case of each of (A), (B)&#160;or (C)&#160;that is of the type that would be required to be disclosed under Item&#160;404 of Regulation&#160;S-K under the Securities Act. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">2.22&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Anti-Bribery</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;None of the Company or any of its Subsidiaries or any of their respective directors, officers, employees or, to the Company&#8217;s Knowledge, agents or any other Person acting on their behalf has, directly or indirectly, made any bribes, rebates, payoffs, influence payments, kickbacks, illegal payments, illegal political contributions, or other payments, in the form of cash, gifts, or otherwise, or taken any other action, in violation of the Foreign Corrupt Practices Act of 1977, or any other applicable anti-bribery or anti-corruption Law (collectively, the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Anti-Bribery Laws</font><font style="letter-spacing:0.2pt;">&#8221;). To the Knowledge of the Company, neither the Company nor any of its Subsidiaries has been the subject of any investigation or inquiry by any Governmental Body with respect to potential violations of Anti-Bribery Laws. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">2.23&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Disclaimer of Other Representations or Warranties</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Company acknowledges and agrees that, except for the representations and warranties contained in this Agreement, neither Parent nor any of its Subsidiaries nor any other person on behalf of Parent or its Subsidiaries make any express or implied representation or warranty with respect to Parent or its Subsidiaries or with respect to any other information provided by the Company, any of the Company&#8217;s Subsidiaries or stockholder or any of their respective Affiliates in connection with the Contemplated Transactions, and (subject to the express representation and warranties of Parent set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3</font><font style="letter-spacing:0.2pt;"> (in each case qualified and limited by the Parent Disclosure Schedule)), neither the Company, its Subsidiaries nor any of their respective Representatives or stockholders, has relied on such information including the accuracy or completeness thereof. </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Section&#160;3.&nbsp;&nbsp;&nbsp;REPRESENTATIONS AND WARRANTIES OF PARENT AND MERGER SUB</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Subject to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;10.11(m)</font><font style="letter-spacing:0.2pt;">, except (a)&#160;as set forth in the written disclosure schedule delivered by Parent to the Company (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent Disclosure Schedule</font><font style="letter-spacing:0.2pt;">&#8221;) or (b)&#160;as disclosed in the Parent SEC Documents filed with the SEC prior to the date hereof and publicly available on the SEC&#8217;s Electronic Data Gathering Analysis and Retrieval system (but (i)&#160;without giving effect to any amendment thereof filed with, or furnished to the SEC on or after the date hereof and (ii)&#160;excluding any disclosures contained under the heading &#8220;Risk Factors&#8221; and any disclosure of risks included in any &#8220;forward-looking statements&#8221; disclaimer or in any other section to the extent they are forward-looking statements or cautionary, predictive or forward-looking in nature), it being understood and agreed that any matter disclosed in the Parent SEC Documents (x)&#160;shall not be deemed disclosed for purposes of </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.1</font><font style="letter-spacing:0.2pt;">, </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.2</font><font style="letter-spacing:0.2pt;">, </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.3</font><font style="letter-spacing:0.2pt;">, </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.4</font><font style="letter-spacing:0.2pt;">, </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.5</font><font style="letter-spacing:0.2pt;"> and </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.6</font><font style="letter-spacing:0.2pt;"> and (y)&#160;shall be deemed to be disclosed in a section of the Parent Disclosure Schedule only to the extent to which its relevance is readily apparent from a reading of such Parent SEC Documents, Parent and Merger Sub represent and warrant to the Company as follows: </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">3.1&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Due Organization; Subsidiaries</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;Parent is a corporation duly incorporated, validly existing and in good standing under the Laws of the State of Delaware, and has all necessary corporate power and authority: (i)&#160;to conduct its business in the manner in which its business is currently being conducted; (ii)&#160;to own or lease and use its property and assets in the manner in which its property and assets are currently owned or leased and used; and (iii)&#160;to perform its obligations under all material Contracts by which it is bound. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;Parent is duly licensed and qualified to do business, and is in good standing (to the extent applicable in such jurisdiction), under the Laws of all jurisdictions where the nature of its business </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-23</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="t3DPH">&#8203;</a><a name="t3BNO">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">requires such licensing or qualification other than in jurisdictions where the failure to be so qualified would not have a Parent Material Adverse Effect. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;Other than Merger Sub, Parent has no Subsidiaries, except for the Entities identified in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.1(c)</font><font style="letter-spacing:0.2pt;"> of the Parent Disclosure Schedule; and neither Parent nor any of Parent&#8217;s Subsidiaries owns any capital stock of, or any equity, ownership or profit sharing interest of any nature in, or controls, directly or indirectly, any other Entity other than the Entities identified in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.1(c)</font><font style="letter-spacing:0.2pt;"> of the Parent Disclosure Schedule. Each of Parent&#8217;s Subsidiaries identified in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.1(c)</font><font style="letter-spacing:0.2pt;"> of the Parent Disclosure Schedule is a corporation or other legal Entity duly incorporated or otherwise organized, validly existing and, if applicable, in good standing under the Laws of the jurisdiction of its incorporation or organization, as applicable, and has all necessary corporate or similar power and authority to conduct its business in the manner in which its business is currently being conducted and to own or lease and use its property and assets in the manner in which its property and assets are currently owned or leased and used, except where the failure to have such power or authority would not have a Parent Material Adverse Effect. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;Merger Sub is a corporation duly incorporated, validly existing and in good standing under the Laws of the State of Delaware. Merger Sub was formed solely for the purpose of engaging in the Contemplated Transactions. All of the issued and outstanding capital stock of Merger Sub, which consists of 100 shares of common stock, $0.0001 par value, is validly issued, fully paid and non-assessable and is owned, beneficially and of record, by Parent, free and clear of any Encumbrances with respect thereto. Except for obligations and liabilities incurred in connection with its incorporation and the Contemplated Transactions, Merger Sub has not, and will not have, incurred, directly or indirectly, any obligations or liabilities or engaged in any business activities or conducted any operations of any type or kind whatsoever or entered into any agreements or arrangements with any Person. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(e)&nbsp;&nbsp;&nbsp;Neither Parent nor any of its Subsidiaries is or has otherwise been a party to, or a member of, any partnership, joint venture or similar business Entity. Neither Parent nor any of its Subsidiaries has agreed or is obligated to make, or is bound by any Contract under which it may become obligated to make, any future investment in or capital contribution to any other Entity. Neither Parent nor any of its Subsidiaries has, at any time, been a general partner of, or has otherwise been liable for, any of the debts or other obligations of, any general partnership, limited partnership or other Entity. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">3.2&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Organizational Documents</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Parent has made available to the Company accurate and complete copies of Parent&#8217;s and each of its Subsidiaries Organizational Documents in effect as of the date of this Agreement. Neither Parent nor any of its Subsidiaries is in material breach or violation of its respective Organizational Documents. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">3.3&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Authority; Binding Nature of Agreement</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;Parent and each of its Subsidiaries has all necessary corporate power and authority to enter into and to perform its obligations under this Agreement and to consummate the Contemplated Transactions. The Parent Board (at a meeting or meetings duly called and held and at which all members were present) has unanimously: (i)&#160;determined that the Contemplated Transactions are fair to, advisable and in the best interests of Parent and its stockholders; (ii)&#160;authorized, approved and declared advisable this Agreement and the Contemplated Transactions, including the issuance of shares of Parent Common Stock to the stockholders of the Company pursuant to the terms of this Agreement; and (iii)&#160;determined to recommend, upon the terms and subject to the conditions set forth in this Agreement, that the stockholders of Parent vote to approve the Parent Stockholder Matters. The Merger Sub Board (by unanimous written consent) has: (A)&#160;determined that the Contemplated Transactions are fair to, advisable, and in the best interests of Merger Sub and its sole stockholder; (B)&#160;authorized, approved and declared advisable this Agreement and the Contemplated Transactions; and (C)&#160;determined to recommend, upon the terms and subject to the conditions set forth in this Agreement, that the stockholder of Merger Sub vote to adopt this Agreement and thereby approve the Contemplated Transactions. Parent, in its capacity as the sole stockholder of Merger Sub, has by written consent duly approved votes adopting this Agreement and approving the Contemplated Transactions. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;This Agreement has been duly executed and delivered by each of Parent and Merger Sub and, assuming the due authorization, execution and delivery by the Company, constitutes the valid and </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-24</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="t3RAT">&#8203;</a><a name="t3CST">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">binding obligation of Parent and Merger Sub, enforceable against each of Parent and Merger Sub in accordance with its terms, subject to the Enforceability Exceptions. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">3.4&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Vote Required</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;(a)&#160;The affirmative vote of the holders of a majority of the outstanding shares of Parent Common Stock entitled to vote on the record date for the Parent Stockholders&#8217; Meeting is the only vote of the holders of any class or series of Parent&#8217;s capital stock necessary to approve the Nasdaq Reverse Split and (b)&#160;the affirmative vote of a majority in voting power of the votes cast by the holders of all shares of Parent Common Stock present or represented by proxy at the Parent Stockholders&#8217; Meeting and entitled to vote thereon is the only vote of the holders of any class or series of Parent&#8217;s capital stock necessary to approve all other Parent Stockholder Matters (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Required Parent Stockholder Vote</font><font style="letter-spacing:0.2pt;">&#8221;). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">3.5&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Non-Contravention; Consents</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Subject to obtaining the Required Parent Stockholder Vote, the filing of the Certificate of Merger with the Secretary of State of the State of Delaware required by the DGCL and clearance of the Merger under any applicable Antitrust Laws, neither (x)&#160;the execution, delivery or performance of this Agreement by Parent or Merger Sub, nor (y)&#160;the consummation by Parent and Merger Sub of the Contemplated Transactions, will directly or indirectly (with or without notice or lapse of time): </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;contravene, conflict with or result in a violation of any of the provisions of the Organizational Documents of Parent or Merger Sub; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;contravene, conflict with or result in a material violation of, or, to the Knowledge of Parent, give any Governmental Body or other Person the right to successfully challenge the Contemplated Transactions or to successfully exercise any material remedy or obtain any material relief under, any Law or any order, writ, injunction, judgment or decree to which Parent or its Subsidiaries, or any of the assets owned or used by Parent or its Subsidiaries, is subject, except as would not reasonably be expected to be material to Parent and its Subsidiaries, taken as a whole; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;contravene, conflict with or result in a material violation of any of the terms or requirements of, or give any Governmental Body the right to revoke, withdraw, suspend, cancel, terminate or modify, any Governmental Authorization that is held by Parent or its Subsidiaries, except as would not reasonably be expected to be material to Parent and its Subsidiaries, taken as a whole; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;contravene, conflict with or result in a violation or breach of, or result in a default under, any provision of any Parent Material Contract, or give any Person the right to: (i)&#160;declare a default or exercise any remedy under any Parent Material Contract; (ii)&#160;any material payment or payments, rebate, chargeback, penalty or change in delivery schedule under any Parent Material Contract; (iii)&#160;accelerate the maturity or performance of any Parent Material Contract; or (iv)&#160;cancel, terminate or modify any term of any Parent Material Contract, except in the case under this clause (d)&#160;as would not reasonably be expected to be material to Parent and its Subsidiaries, taken as a whole; or </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(e)&nbsp;&nbsp;&nbsp;result in the imposition or creation of any material Encumbrance upon or with respect to any material asset owned or used by Parent or its Subsidiaries (except for Permitted Encumbrances). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Except for (i)&#160;any Consent set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.5</font><font style="letter-spacing:0.2pt;"> of the Parent Disclosure Schedule, (ii)&#160;the Required Parent Stockholder Vote, (iii)&#160;the filing of the Certificate of Merger with the Secretary of State of the State of Delaware pursuant to the DGCL and the clearance of the Merger under any applicable Antitrust Laws; and (iv)&#160;such consents, waivers, approvals, orders, authorizations, registrations, declarations and filings as may be required under applicable federal and state securities Laws or, if not given or obtained, as would not reasonably be expected to be material to Parent and its Subsidiaries, taken as a whole, or would not reasonably be expected to prevent or materially delay beyond the End Date the ability of Parent or the Merger Sub to consummate the Contemplated Transactions, neither Parent nor any of its Subsidiaries is or will be required to make any filing with or give any notice to, or to obtain any Consent from, any Person in connection with (A)&#160;the execution, delivery or performance by Parent and the Merger Sub of this Agreement, or (B)&#160;the consummation of the Contemplated Transactions. Assuming the accuracy of the representations and warranties of the Company in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.5</font><font style="letter-spacing:0.2pt;">, the Parent Board and the Merger Sub Board have taken and will take all actions necessary to ensure that the restrictions applicable to business combinations contained in Section&#160;203 of the DGCL are, and will be, inapplicable to the execution, delivery and performance of this Agreement and the Parent Stockholder Support Agreements, and to the </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-25</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="t36C">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">consummation of the Contemplated Transactions. No other state Takeover Statute or similar Law applies or purports to apply to the Merger, this Agreement, the Parent Stockholder Support Agreements or any of the Contemplated Transactions. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">3.6&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Capitalization</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;The authorized capital stock of Parent as of the date of this Agreement consists of (i)&#160;400,000,000 shares of Parent Common Stock, par value $0.001 per share, of which 201,701,853 shares have been issued and are outstanding as of the date of this Agreement, and (ii)&#160;5,000,000 shares of preferred stock of Parent, par value $0.001 per share, of which no shares have been issued and are outstanding as of the date of this Agreement. As of the date of this Agreement, Parent does not hold any shares of its capital stock in its treasury. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;All of the outstanding shares of Parent Common Stock have been duly authorized and validly issued, and are fully paid and nonassessable. None of the outstanding shares of Parent Common Stock are entitled or subject to any preemptive right, right of participation, right of maintenance or any similar right and none of the outstanding shares of Parent Common Stock are subject to any right of first refusal in favor of Parent, in each case under any Parent Contract. Except as contemplated herein, there is no Parent Contract relating to the voting or registration of, or restricting any Person from purchasing, selling, pledging or otherwise disposing of (or granting any option or similar right with respect to), any shares of Parent Common Stock. Parent is not under any obligation, nor is it bound by any Contract pursuant to which it may become obligated, to repurchase, redeem or otherwise acquire any outstanding shares of Parent Common Stock or other securities. There are outstanding Parent Warrants to purchase 198,535 shares of Parent Common Stock. </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.6(b)</font><font style="letter-spacing:0.2pt;"> of the Parent Disclosure Schedule accurately and completely lists all repurchase or forfeiture rights held by Parent with respect to shares of Parent Common Stock (including shares issued pursuant to the exercise of stock options) and specifies which of those repurchase rights are currently exercisable and, to the Knowledge of Parent, whether the holder of such shares of Parent Common Stock timely filed an election with the IRS under Section&#160;83(b) of the Code with respect to such shares. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;Except for the Parent Stock Plans (and awards granted thereunder) and as set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.6(c)</font><font style="letter-spacing:0.2pt;"> of the Parent Disclosure Schedule, Parent does not have any stock option plan or any other plan, program, agreement or arrangement providing for any equity-based compensation for any Person. As of the date of this Agreement, 13,133,660 shares of Parent Common Stock have been reserved for issuance upon the exercise of Parent Options granted under the Parent Stock Plan that are outstanding as of the date of this Agreement, 3,068,594 shares of Parent Common Stock have been reserved for issuance upon the exercise of Parent Options granted outside of the Parent Stock Plans that are outstanding as of the date of this Agreement, 5,750,166 shares of Parent Common Stock have been reserved for issuance upon the settlement of Parent RSUs granted under the Parent Stock Plans that are outstanding as of the date of this Agreement, 0 shares of Parent Common Stock have been reserved for issuance upon the settlement of Parent RSUs granted outside of the Parent Stock Plans that are outstanding as of the date of this Agreement, 2,300,000 shares of Parent Common Stock have been reserved for issuance under the Parent ESPP, and 3,724,762 shares remain available for future issuance pursuant to the Parent Stock Plans. </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.6(c)</font><font style="letter-spacing:0.2pt;"> of the Parent Disclosure Schedule sets forth the following information with respect to each Parent Option and Parent RSU outstanding as of the date of this Agreement: (i)&#160;the name of the holder; (ii)&#160;the number of shares of Parent Common Stock subject to such Parent Option or Parent RSU at the time of grant; (iii)&#160;the number of shares of Parent Common Stock subject to such Parent Option or Parent RSU as of the date of this Agreement; (iv)&#160;the exercise price of such Parent Option; (v)&#160;the date on which such Parent Option or Parent RSU was granted; (vi)&#160;the applicable vesting schedule, including the number of vested and unvested shares as of the date of this Agreement and any acceleration provisions; (vii)&#160;the date on which such Parent Option expires; and (viii)&#160;whether such Parent Option is intended to constitute an &#8220;incentive stock option&#8221; &#8203;(as defined in the Code) or a non-qualified stock option. Parent has made available to the Company accurate and complete copies of the Parent Stock Plans and all forms of the stock option and other award agreements evidencing outstanding awards granted thereunder. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;Except for the Parent Warrants, the Parent Options and the Parent RSUs, there is no: (i)&#160;outstanding subscription, option, call, warrant or right (whether or not currently exercisable) to </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-26</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="t3FFS">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">acquire any shares of the capital stock or other securities of Parent or any of its Subsidiaries; or (ii)&#160;outstanding security, instrument or obligation that is or may become convertible into or exchangeable for any shares of the capital stock or other securities of Parent or any of its Subsidiaries. There are no outstanding or authorized stock appreciation, phantom stock, profit participation or other similar rights with respect to Parent or any of its Subsidiaries. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(e)&nbsp;&nbsp;&nbsp;All outstanding shares of Parent Common Stock, Parent Options, Parent Warrants, Parent RSUs and other securities of Parent have been issued and granted in material compliance with (i)&#160;the Organizational Documents of Parent in effect as of the relevant time and all applicable securities Laws and other applicable Law, and (ii)&#160;all requirements set forth in applicable Contracts. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">3.7&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">SEC Filings; Financial Statements</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;Parent has filed or furnished, as applicable, on a timely basis all forms, statements, certifications, reports and other documents required to be filed or furnished by Parent with the SEC under the Exchange Act or the Securities Act since January&#160;1, 2019 (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent SEC Documents</font><font style="letter-spacing:0.2pt;">&#8221;). As of the time it was filed with the SEC (or, if amended or superseded by a filing prior to the date of this Agreement, then on the date of such filing), each of the Parent SEC Documents complied in all material respects with the applicable requirements of the Securities Act or the Exchange Act (as the case may be) and, as of the time they were filed, or if amended or superseded by a filing prior to the date of this Agreement, on the date of the last such amendment or superseding filing prior to the date of this Agreement, none of the Parent SEC Documents contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading. The certifications and statements required by (i)&#160;Rule&#160;13a-14 or Rule&#160;15d-14(a) under the Exchange Act and (ii)&#160;18 U.S.C. &#167;1350 (Section&#160;906 of the Sarbanes-Oxley Act) relating to the Parent SEC Documents (collectively, the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Certifications</font><font style="letter-spacing:0.2pt;">&#8221;) are accurate and complete and comply as to form and content with all applicable Laws. Parent meets the registration requirements for the use of Form S-3 under the Securities Act. As used in this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.7</font><font style="letter-spacing:0.2pt;">, the term &#8220;file&#8221; and variations thereof shall be broadly construed to include any manner in which a document or information is filed, furnished, supplied or otherwise made available to the SEC. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;The financial statements (including any related notes) contained or incorporated by reference in the Parent SEC Documents: (i)&#160;complied as to form in all material respects with the published rules and regulations of the SEC applicable thereto; (ii)&#160;were prepared in accordance with GAAP (except as may be indicated in the notes to such financial statements or, in the case of unaudited financial statements, except as permitted by Form 10-Q of the SEC, and except that the unaudited financial statements may not contain footnotes and are subject to normal and recurring year-end adjustments) applied on a consistent basis unless otherwise noted therein throughout the periods indicated; and (iii)&#160;fairly present, in all material respects, the financial position of Parent as of the respective dates thereof and the results of operations and cash flows of Parent for the periods covered thereby. Other than as expressly disclosed in the Parent SEC Documents filed prior to the date hereof or have been permitted or required by any regulatory authority, there has been no material change in Parent&#8217;s accounting methods or principles that would be required to be disclosed in Parent&#8217;s financial statements in accordance with GAAP. The interactive data in eXtensible Business Reporting Language included or incorporated by reference in the Parent SEC Documents fairly presents the information called for in all material respects and has been prepared in accordance with the SEC&#8217;s rules and guidelines applicable thereto. The books of accounts and other financial records of Parent and each of its Subsidiaries are true and complete in all material respects. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;Parent&#8217;s independent registered accounting firm has at all times since its first date of service to Parent been: (i)&#160;a registered public accounting firm (as defined in Section&#160;2(a)(12) of the Sarbanes-Oxley Act); (ii)&#160;to the Knowledge of Parent, &#8220;independent&#8221; with respect to Parent within the meaning of Regulation&#160;S-X under the Exchange Act; and (iii)&#160;to the Knowledge of Parent, in compliance with subsections (g)&#160;through (l)&#160;of Section&#160;10A of the Exchange Act and the rules and regulations promulgated by the SEC and the Public Company Accounting Oversight Board thereunder. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-27</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; text-indent:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;Except as set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.7(d)</font><font style="letter-spacing:0.2pt;"> of the Parent Disclosure Schedule, Parent has not received any comment letter from the SEC or the staff thereof or any correspondence from officials of Nasdaq or the staff thereof relating to the delisting or maintenance of listing of the Parent Common Stock on Nasdaq that has not been resolved, and Parent has made available to Company all such comments or correspondence (written or oral) with the Company. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(e)&nbsp;&nbsp;&nbsp;Between January&#160;1, 2019 and the date of this Agreement, there have been no formal investigations regarding financial reporting or accounting policies and practices discussed with, reviewed by or initiated at the direction of the chief executive officer, chief financial officer, principal accounting officer or general counsel of Parent, the Parent Board or any committee thereof, other than ordinary course audits or reviews of accounting policies and practices or internal controls required by the Sarbanes-Oxley Act. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(f)&nbsp;&nbsp;&nbsp;Parent is in compliance in all material respects with the applicable provisions of the Sarbanes-Oxley Act and the applicable listing and other rules and regulations of Nasdaq and, except as set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.7(f)</font><font style="letter-spacing:0.2pt;"> of the Parent Disclosure Schedule, has not received any notice from Nasdaq asserting any noncompliance with such rules and regulations. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(g)&nbsp;&nbsp;&nbsp;Parent maintains a system of internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) that is sufficient to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with GAAP, including policies and procedures sufficient to provide reasonable assurance (i)&#160;that Parent maintains records that in reasonable detail accurately and fairly reflect Parent&#8217;s transactions and dispositions of assets, (ii)&#160;that transactions are recorded as necessary to permit preparation of financial statements in accordance with GAAP, (iii)&#160;that receipts and expenditures are made only in accordance with authorizations of management and the Parent Board, (iv)&#160;regarding prevention or timely detection of the unauthorized acquisition, use or disposition of Parent&#8217;s assets that could have a material effect on Parent&#8217;s financial statements, and (v)&#160;interactive data in eXtensible Business Reporting Language included or incorporated by reference in the Parent SEC Documents fairly presents the SEC&#8217;s rules and guidelines applicable thereto. Parent has evaluated the effectiveness of Parent&#8217;s internal control over financial reporting and, to the extent required by applicable Law, presented in any applicable Parent SEC Document that is a report on Form 10-K or Form 10-Q (or any amendment thereto) its conclusions about the effectiveness of the internal control over financial reporting as of the end of the period covered by such report or amendment based on such evaluation. Parent has disclosed to Parent&#8217;s auditors and audit committee (and made available to the Company a summary of the significant aspects of such disclosure) (A)&#160;all significant deficiencies and material weaknesses, if any, in the design or operation of internal control over financial reporting that are reasonably likely to adversely affect Parent&#8217;s ability to record, process, summarize and report financial information and (B)&#160;any fraud, whether or not material, that involves management or other employees who have a significant role in Parent&#8217;s or its Subsidiaries&#8217; internal control over financial reporting. Parent has not identified any material weaknesses in the design or operation of Parent&#8217;s internal control over financial reporting. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(h)&nbsp;&nbsp;&nbsp;Parent maintains &#8220;disclosure controls and procedures&#8221; &#8203;(as defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act) that are reasonably designed to ensure that all information (both financial and non-financial) required to be disclosed by Parent in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods required by the SEC, and that all such information is accumulated and communicated to Parent&#8217;s management as appropriate to allow timely decisions regarding required disclosure and to make the Certifications. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(i)&nbsp;&nbsp;&nbsp;Between January&#160;1, 2019 and the date of this Agreement, (i)&#160;Parent has not received or otherwise had or obtained knowledge of any material complaint, allegation, assertion or claim, whether written or oral, regarding the accounting or auditing practices, procedures, methodologies or methods of Parent&#8217;s internal accounting controls relating to periods after January&#160;1, 2019, including any material complaint, allegation, assertion or claim that Parent has engaged in questionable accounting or auditing practices (except for any of the foregoing after the date of this Agreement which have no reasonable basis), and (ii)&#160;no attorney representing Parent, whether or not employed by Parent, has </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-28</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="t3OCA">&#8203;</a><a name="t3OUL">&#8203;</a><a name="t3TAE">&#8203;</a><a name="t3PLN">&#8203;</a><a name="t31PR">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">reported evidence of a material violation of securities Laws, breach of fiduciary duty or similar violation, relating to periods after January&#160;1, 2019, by Parent or agents to the Parent Board or any committee thereof or, to the Knowledge of Parent, to any director or officer of Parent. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">3.8&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Absence of Changes</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;(a)&#160;Between the date of the Parent Balance Sheet and the date of this Agreement, (i)&#160;Parent has conducted its business only in the Ordinary Course of Business (except for the execution and performance of this Agreement and the discussions, negotiations and transactions related thereto) and (ii)&#160;Parent has not taken any action that would have required the consent of the Company pursuant to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;4.1(b)</font><font style="letter-spacing:0.2pt;"> had such action taken place after the execution and delivery of this Agreement; and (b)&#160;since the date of the Parent Balance Sheet, there has not been any Parent Material Adverse Effect. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">3.9&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Absence of Undisclosed Liabilities</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Neither Parent nor any of its Subsidiaries has any Liability, except for: (a)&#160;Liabilities disclosed, reflected or reserved against in the Parent Balance Sheet; (b)&#160;Liabilities that have been incurred by Parent or its Subsidiaries since the date of the Parent Balance Sheet in the Ordinary Course of Business; (c)&#160;Liabilities for performance of obligations of Parent or any of its Subsidiaries under Parent Contracts (other than those arising as a result of a breach or default thereunder or as a result of failure to comply with applicable Law); (d)&#160;Liabilities for payment of fees and expenses incurred in connection with the Contemplated Transactions; (e)&#160;Liabilities which would not, individually or in the aggregate, reasonably be expected to be material to Parent and its Subsidiaries, taken as a whole; and (f)&#160;Liabilities described in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.9</font><font style="letter-spacing:0.2pt;"> of the Parent Disclosure Schedule. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">3.10&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Title to Assets</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Each of Parent and its Subsidiaries owns, and has good and valid title to, or, in the case of leased properties and assets, valid leasehold interests in, all tangible properties or tangible assets and equipment used or held for use in its business or operations or purported to be owned by it, in each case, that are material to Parent and its Subsidiaries, taken as a whole, including: (a)&#160;all such tangible assets reflected on the Parent Balance Sheet; and (b)&#160;all other such tangible assets reflected in the books and records of Parent or any of its Subsidiaries as being owned by Parent or such Subsidiary. All of such assets are owned or, in the case of leased assets, leased by Parent or any of its Subsidiaries free and clear of any Encumbrances, other than Permitted Encumbrances. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">3.11&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Real Property; Leasehold</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Neither Parent nor any of its Subsidiaries owns or has ever owned any real property. Parent has made available to the Company (a)&#160;an accurate and complete list of all real properties with respect to which Parent directly or indirectly holds a valid leasehold interest as well as any other real estate that is in the possession of, or occupied or leased by Parent or any of its Subsidiaries, and (b)&#160;copies of all leases under which any such real property is possessed, occupied or leased (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent Real Estate Leases</font><font style="letter-spacing:0.2pt;">&#8221;), each of which is in full force and effect, with no existing material default by Parent or any Subsidiary thereunder. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">3.12&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Intellectual Property</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.12(a)(1)</font><font style="letter-spacing:0.2pt;"> of the Parent Disclosure Schedule identifies, as of the date of this Agreement, each item of material Parent IP that is owned or purported to be owned by or assigned to Parent or its Subsidiaries and that is the subject of a registration or application in any jurisdiction (&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent Registered IP</font><font style="letter-spacing:0.2pt;">&#8221;), including, with respect to each such patent and patent application: (i)&#160;the name of the applicant/registrant; (ii)&#160;the jurisdiction of application/registration; (iii)&#160;the application or registration number; and (iv)&#160;any other co-owners. </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.12(a)(2)</font><font style="letter-spacing:0.2pt;"> of the Parent Disclosure Schedule identifies, as of the date of this Agreement, each license agreement under which Parent or its Subsidiaries exclusively licenses material Parent IP from a third party. To the Knowledge of Parent, each of the patents and patent applications included in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.12(a)(1)</font><font style="letter-spacing:0.2pt;"> of the Parent Disclosure Schedule properly identifies by name each and every inventor of the inventions claimed therein as determined in accordance with applicable Laws of the United States. To the Knowledge of Parent, as of the date of this Agreement, no cancellation, interference, opposition, reissue, reexamination or other proceeding of any nature (other than office actions or similar communications issued by any Governmental Body in the ordinary course of prosecution of any pending applications for registration) is pending or threatened in writing, in which the scope, validity, enforceability or ownership of any Parent IP, other than such items with pending applications, is being or has been contested or challenged. To the Knowledge of Parent, each item of issued Parent Registered IP is valid and enforceable and subsisting. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-29</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; text-indent:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;Except as would not have a Parent Material Adverse Effect, Parent and its Subsidiaries collectively exclusively own, are the sole assignees of, or have exclusively licensed all material Parent IP, free and clear of all Encumbrances other than Permitted Encumbrances (other than as disclosed in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.12(b)</font><font style="letter-spacing:0.2pt;"> of the Parent Disclosure Schedule). The Parent IP and the Intellectual Property Rights licensed to Parent pursuant to a valid, enforceable written agreement constitute all Intellectual Property Rights used in, material to and otherwise necessary for the operation of Parent&#8217;s business as currently conducted. Each Parent Associate involved in the creation or development of any material Parent IP, pursuant to such Parent Associate&#8217;s activities on behalf of Parent or its Subsidiaries, has signed a valid and enforceable written agreement containing an assignment of such Parent Associate&#8217;s rights in such Parent IP to Parent or its applicable Subsidiary. Each Parent Associate who has or has had access to Parent&#8217;s trade secrets or confidential information has signed a valid and enforceable written agreement containing confidentiality provisions protecting the Parent IP, trade secrets and confidential information. Parent and its Subsidiaries have taken commercially reasonable steps to protect and preserve the confidentiality of its trade secrets and confidential information. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;To the Knowledge of Parent, no funding, facilities or personnel of any Governmental Body or any university, college, research institute or other educational institution has been used to create material Parent IP that is owned or purported to be owned by or assigned to Parent or its Subsidiaries, except for any such funding or use of facilities or personnel that does not result in such Governmental Body or institution obtaining ownership rights or a license to such Parent IP (excluding confirmatory licenses to inventions made with government funding and for which Parent, its Subsidiaries or either of their licensor has duly retained title under the Bayh-Dole Act) or the right to receive royalties for the practice of such Parent IP. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.12(d)</font><font style="letter-spacing:0.2pt;"> of the Parent Disclosure Schedule sets forth, as of the date of this Agreement, each license agreement pursuant to which Parent (i)&#160;is granted a license under any material Intellectual Property Right owned by any third party that is used by Parent or its Subsidiaries in its business as currently conducted (each a &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent In-bound License</font><font style="letter-spacing:0.2pt;">&#8221;) or (ii)&#160;grants to any third party a license under any material Parent IP or material Intellectual Property Right licensed to Parent or its Subsidiaries under a Parent In-bound License (each a &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent Out-bound License</font><font style="letter-spacing:0.2pt;">&#8221;) (</font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, that, Parent In-bound Licenses shall not include, when entered into in the Ordinary Course of Business, material transfer agreements, clinical trial agreements, agreements with Parent Associates, services agreements, commercially available Software-as-a-Service offerings or off-the-shelf software licenses; and Parent Out-bound Licenses shall not include, when entered into in the Ordinary Course of Business, material transfer agreements, clinical trial agreements, services agreements, or non-exclusive outbound licenses). All Parent In-bound Licenses and Parent Out-bound Licenses are in full force and effect and are valid, enforceable and binding obligations of Parent or the applicable Subsidiary and, to the Knowledge of Parent, each other party to such Parent In-bound Licenses or Parent Out-bound Licenses. Neither Parent or any of its Subsidiaries, nor to the Knowledge of Parent, any other party to such Parent In-bound Licenses or Parent Out-bound Licenses, is in material breach under any Parent In-bound Licenses or Parent Out-bound Licenses. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(e)&nbsp;&nbsp;&nbsp;To the Knowledge of Parent: (i)&#160;the operation of the businesses of Parent and its Subsidiaries as currently conducted does not infringe, misappropriate or otherwise violate any Intellectual Property Rights of any other Person; and (ii)&#160;no other Person is infringing, misappropriating or otherwise violating any Parent IP. As of the date of this Agreement, no Legal Proceeding is pending (or, to the Knowledge of Parent, is threatened in writing) (A)&#160;against Parent or its Subsidiaries alleging that the operation of the businesses of Parent or its Subsidiaries infringes or constitutes the misappropriation or other violation of any Intellectual Property Rights of another Person or (B)&#160;by Parent or its Subsidiaries alleging that another Person has infringed, misappropriated or otherwise violated any of the Parent IP or any Intellectual Property Rights exclusively licensed to Parent or its Subsidiaries. Between January&#160;1, 2019 and the date of this Agreement, neither Parent nor its Subsidiaries has received any written notice or other written communication alleging that the operation of the business of Parent or its Subsidiaries infringes or constitutes the misappropriation or other violation of any Intellectual Property Right of another Person. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(f)&nbsp;&nbsp;&nbsp;None of the Parent IP that is owned or purported to be owned by or assigned to Parent or its Subsidiaries and, to the Knowledge of Parent, no material Intellectual Property Rights exclusively </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-30</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="t3CAC">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">licensed to Parent or its Subsidiaries is subject to any pending or outstanding injunction, directive, order, judgment or other disposition of dispute that adversely and materially restricts the use, transfer, registration or licensing by Parent or its Subsidiaries of any such Parent IP that is owned or purported to be owned by or assigned to Parent or its Subsidiaries or material Intellectual Property Rights exclusively licensed to Parent or its Subsidiaries. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(g)&nbsp;&nbsp;&nbsp;To the Knowledge of Parent, Parent, its Subsidiaries and the operation of Parent&#8217;s and its Subsidiaries&#8217; business are in substantial compliance with all Laws pertaining to data privacy and data security of Sensitive Data. Between January&#160;1, 2019 and the date of this Agreement, there have been (i)&#160;no losses or thefts of data or security breaches relating to Sensitive Data used in the business of Parent, (ii)&#160;no material violations of any security policy of Parent regarding any such Sensitive Data used in the business of Parent or its Subsidiaries, (iii)&#160;no unauthorized access, unauthorized use or unintended or improper disclosure of any Sensitive Data used in the business of Parent or its Subsidiaries, except in each case as would not reasonably be expected to be material to the Company and its Subsidiaries, taken as a whole. Parent has taken commercially reasonable steps and implemented reasonable disaster recovery and security plans and procedures to protect the information technology systems used in, material to and necessary for operation of Parent&#8217;s business as currently conducted from unauthorized use or access. To the Knowledge of Parent, as of the date of this Agreement, there have been no material malfunctions or unauthorized intrusions or breaches of the information technology systems used in, material to and necessary for the operation of Parent&#8217;s business as currently conducted. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">3.13&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Agreements, Contracts and Commitments</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.13(a)</font><font style="letter-spacing:0.2pt;"> of the Parent Disclosure Schedule lists the following Parent Contracts in effect as of the date of this Agreement and under which Parent or any of its Subsidiaries has any remaining material rights or obligations (each, a &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent Material Contract</font><font style="letter-spacing:0.2pt;">&#8221; and collectively, the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent Material Contracts</font><font style="letter-spacing:0.2pt;">&#8221;): </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(i)&nbsp;&nbsp;&nbsp;a material Contract as defined in Item&#160;601(b)(10) of Regulation&#160;S-K as promulgated under the Securities Act; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(ii)&nbsp;&nbsp;&nbsp;each Parent Contract relating to any agreement of indemnification or guaranty not entered into in the Ordinary Course of Business; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(iii)&nbsp;&nbsp;&nbsp;each Parent Contract containing (A)&#160;any covenant limiting the freedom of Parent or its Subsidiaries to engage in any line of business or compete with any Person, (B)&#160;any most-favored pricing arrangement, (C)&#160;any exclusivity provision, or (D)&#160;any non-solicitation provision, in each case, except for restrictions that would not materially affect the ability of Parent and its Subsidiaries to conduct its business; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(iv)&nbsp;&nbsp;&nbsp;each Parent Contract relating to capital expenditures and requiring payments after the date of this Agreement in excess of $250,000 pursuant to its express terms and not cancelable without penalty; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(v)&nbsp;&nbsp;&nbsp;each Parent Contract relating to the disposition or acquisition of material assets or any ownership interest in any Entity, in each case, involving payments in excess of $250,000, other than Parent Contracts in which the applicable acquisition or disposition has been consummated and there are no material ongoing liabilities or obligations; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(vi)&nbsp;&nbsp;&nbsp;each Parent Contract relating to any mortgages, indentures, loans, notes or credit agreements, security agreements or other agreements or instruments relating to the borrowing of money or extension of credit in excess of $250,000 or creating any material Encumbrances with respect to any assets of Parent or any of its Subsidiaries or any loans or debt obligations with officers or directors of Parent; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(vii)&nbsp;&nbsp;&nbsp;each Parent Contract requiring payment by or to Parent or its Subsidiaries after the date of this Agreement in excess of $250,000 pursuant to its express terms and constituting: (A)&#160;an exclusive distribution agreement; (B)&#160;an agreement involving provision of material services </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-31</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:40pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">or products with respect to any pre-clinical or clinical development activities of Parent or its Subsidiaries; (C)&#160;a dealer, distributor, joint marketing, alliance, joint venture, cooperation, development or similar agreement currently in force under which Parent or its Subsidiaries has continuing obligations to develop or market any product, technology or service, or an agreement pursuant to which Parent or its Subsidiaries has continuing obligations to develop any Intellectual Property Rights that will not be owned, in whole or in part, by Parent or its Subsidiaries; or (D)&#160;a Parent Contract to license any patent, trademark registration, service mark registration, trade name or copyright registration to or from any third party to the manufacture or produce any product, service or technology of Parent or its Subsidiaries or any Parent Contract to sell, distribute or commercialize any products or service of Parent or its Subsidiaries, in each case under clauses (A)&#160;through (D), except for Parent Contracts that are entered into in the Ordinary Course of Business; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(viii)&nbsp;&nbsp;&nbsp;each Parent Contract with any financial advisor, broker, finder, investment banker or other similar Person, providing advisory services to Parent in connection with the Contemplated Transactions; </font>
        </div>
        <div style="margin-left:60pt; margin-top:8pt; width:396pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(ix)&nbsp;&nbsp;&nbsp;each Parent Real Estate Lease; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(x)&nbsp;&nbsp;&nbsp;each Parent Out-bound License and Parent In-bound License, and each Parent Contract containing a covenant not to sue or otherwise enforce any Intellectual Property Rights; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(xi)&nbsp;&nbsp;&nbsp;each Parent Contract containing any royalty, dividend or similar arrangement based on the revenues or profits of Parent or any of its Subsidiaries; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(xii)&nbsp;&nbsp;&nbsp;each (A)&#160;Parent Contract, offer letter, employment agreement or other agreement with any employee that requires payment of base salary and target annual cash bonus in excess of $150,000 in any calendar year that (1)&#160;provides for employment by Parent or any of its Subsidiaries and is not immediately terminable at will by Parent without advance notice, severance, or other similar cost or liability (other than for accrued compensation, vacation, or other amounts due upon any termination), or (2)&#160;provides for or otherwise relates to any retention payments, change of control payments, severance, accelerated vesting or any payment or benefit that may or will become due as a result of the Merger (whether alone or in connection with any other event), and (B)&#160;Parent Contract, independent contractor agreement, or other agreement with any individual consultant or service provider requiring payment of fees in excess of $150,000 in any calendar year that (1)&#160;is not immediately terminable at will by the Company without more than 30&#160;days&#8217; prior notice, severance, or other similar cost or liability (other than for any accrued but unpaid fees) or (2)&#160;provides for retention payments, change of control payments, severance, accelerated vesting or any payment or benefit that may or will become due as a result of the Merger (whether alone or in connection with any other event); </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(xiii)&nbsp;&nbsp;&nbsp;each Parent Contract under which a third party would be entitled to receive a license or have any other rights in any material Parent IP; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(xiv)&nbsp;&nbsp;&nbsp;each Parent Contract entered into in settlement of any Legal Proceeding or other dispute; and </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(xv)&nbsp;&nbsp;&nbsp;any other Parent Contract that is not terminable at will (with no penalty or payment) by Parent or any of its Subsidiaries, as applicable and (A)&#160;which involves payment or receipt by Parent or its Subsidiaries after the date of this Agreement under any such agreement, Contract or commitment of more than $250,000 in the aggregate, or obligations after the date of this Agreement in excess of $250,000 in the aggregate, or (B)&#160;that is material to the business or operations of Parent and its Subsidiaries, taken as a whole. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;Parent has made available to the Company accurate and complete copies of all Parent Material Contracts, including all amendments thereto, in each case in effect on the date of this Agreement. There are no Parent Material Contracts that are not in written form. Neither Parent nor any of its Subsidiaries has, nor, to Parent&#8217;s Knowledge, as of the date of this Agreement, has any other party to a Parent Material Contract, breached, violated or defaulted under, or as of the date of this </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-32</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="t31PE">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Agreement received notice that it breached, violated or defaulted under, any of the terms or conditions of any Parent Material Contract in such manner as would permit any other party to cancel or terminate any such Parent Material Contract, or would permit any other party to seek damages which would have a Parent Material Adverse Effect. As to Parent and its Subsidiaries, as of the date of this Agreement, each Parent Material Contract is valid, binding, enforceable and in full force and effect, subject to the Enforceability Exceptions. As of the date of this Agreement, no Person is renegotiating, or has a right pursuant to the terms of any Parent Material Contract to change, any material amount paid or payable to Parent under any Parent Material Contract or any other material term or provision of any Parent Material Contract, and, as of the date of this Agreement, no Person has indicated in writing to Parent that it desires to renegotiate, modify, not renew or cancel any Parent Material Contract. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">3.14&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Compliance; Permits</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;Parent and each of its Subsidiaries is, and since January&#160;1, 2019 has been, in compliance in all material respects with all applicable Laws, including the FDCA, PHSA and any other similar Law administered or promulgated by the FDA or other Drug Regulatory Agency, except for any noncompliance, either individually or in the aggregate, which would not be material to Parent and its Subsidiaries, taken as a whole. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;As of the date of this Agreement, no investigation, claim, suit, proceeding, audit or other action by any Governmental Body is pending or, to the Knowledge of Parent, threatened against Parent or any of its Subsidiaries. There is no judgment, injunction, order or decree binding upon Parent or any of its Subsidiaries which (i)&#160;has or would reasonably be expected to have the effect of prohibiting or materially impairing any business practice of Parent or any of its Subsidiaries, any acquisition of material property by Parent or any of its Subsidiaries or the conduct of business by Parent or any of its Subsidiaries as currently conducted, (ii)&#160;is reasonably likely to have an adverse effect on Parent&#8217;s ability to comply with or perform any covenant or obligation under this Agreement, or (iii)&#160;is reasonably likely to have the effect of preventing, delaying, making illegal or otherwise interfering with the Contemplated Transactions. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;Parent and its Subsidiaries hold all required Governmental Authorizations to develop, test, manufacture, store, label, package, distribute, import and export the respective current products or product candidates that are material to the operation of the business of Parent and its Subsidiaries as currently conducted (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent Permits</font><font style="letter-spacing:0.2pt;">&#8221;). </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.14(c)</font><font style="letter-spacing:0.2pt;"> of the Parent Disclosure Schedule identifies each Parent Permit. Each such Parent Permit is valid and in full force and effect, and each of Parent and its Subsidiaries is in material compliance with the terms of the Parent Permits. As of the date of this Agreement, no Legal Proceeding is pending or, to the Knowledge of Parent, threatened, which seeks to revoke, limit, suspend, or materially modify any Parent Permit. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;As of the date of this Agreement, there has not been and is not now any Form FDA-483 observation, civil, criminal or administrative action, suit, demand, claim, complaint, hearing, investigation, demand letter, warning letter, untitled letter, or proceeding pending or in effect against Parent or its Subsidiaries or any of their respective officers and employees, and Parent has no liability for failure to comply with the FDCA, PHSA, or other similar Laws. There is no act, omission, event, or circumstance of which Parent has Knowledge that would reasonably be expected to give rise to or form the basis for any civil, criminal or administrative action, suit, demand, claim, complaint, hearing, investigation, demand letter, warning letter, untitled letter, proceeding or request for information or any liability (whether actual or contingent) for failure to comply with the FDCA, PHSA or other similar Laws. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(e)&nbsp;&nbsp;&nbsp;All clinical, pre-clinical and other studies and tests conducted by or on behalf of, or sponsored by, Parent or its Subsidiaries, or of their respective current products or product candidates, were and, if still pending, are being conducted in all material respects with applicable regulations of any applicable Drug Regulatory Agency and other applicable Law, including the GCP regulations under 21 C.F.R. Parts 50, 54, 56 and 312 and GLP regulations under 21 C.F.R. Part&#160;58. No preclinical study or clinical trial conducted by or on behalf of Parent or any of its Subsidiaries has been terminated or suspended prior to completion for safety or non-compliance reasons. Between January&#160;1, 2019 and the date of this Agreement, neither Parent nor any of its Subsidiaries has received any written notices, correspondence, </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-33</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">or other written communications from any Drug Regulatory Agency requiring, or to the Knowledge of Parent, threatening to initiate, the termination or suspension of any clinical studies conducted by or on behalf of, or sponsored by, Parent any of its Subsidiaries or of their respective current products or product candidates. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(f)&nbsp;&nbsp;&nbsp;As of the date of this Agreement, neither Parent nor any of its Subsidiaries is the subject of any pending or, to the Knowledge of Parent, threatened investigation in respect of its business or products or product candidates pursuant to the FDA&#8217;s &#8220;Fraud, Untrue Statements of Material Facts, Bribery, and Illegal Gratuities&#8221; Final Policy set forth in 56 Fed. Reg. 46191 (September&#160;10, 1991). To the Knowledge of Parent, neither Parent nor any of its Subsidiaries has committed any acts, made any statement, or failed to make any statement, in each case in respect of its business or products that would violate the FDA&#8217;s &#8220;Fraud, Untrue Statements of Material Facts, Bribery, and Illegal Gratuities&#8221; Final Policy. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(g)&nbsp;&nbsp;&nbsp;Neither Parent nor its Subsidiaries, nor any of their respective officers, directors, or employees has been, is, or is in anticipation of being (based on a conviction by the courts or a finding of fault by a regulatory authority): (a)&#160;debarred pursuant to the Generic Drug Enforcement Act of 1992 (21 U.S.C. &#167;&#160;335a), as amended from time to time; (b)&#160;disqualified from participating in clinical trials pursuant to 21 C.F.R. &#167;312.70, as amended from time to time; (c)&#160;disqualified as a testing facility under 21 C.F.R. Part&#160;58, Subpart K, as amended from time to time; (d)&#160;excluded, debarred or suspended from or otherwise ineligible to participate in a &#8220;Federal Health Care Program&#8221; as that term is defined in 42 U.S.C. 1320a-7b(f), including under 42 U.S.C. &#167;&#160;1320a-7 or relevant regulations in 42 C.F.R. Part&#160;1001; (e)&#160;assessed or threatened with assessment of civil money penalties pursuant to 42 C.F.R. Part&#160;1003; or (f)&#160;included on the HHS/OIG List of Excluded Individuals/Entities, the General Services Administration&#8217;s System for Award Management, or the FDA Debarment List or the FDA Disqualified/</font>&#8203;<font style="letter-spacing:0.2pt;">Restricted List. Neither Parent nor its Subsidiaries, nor any of their respective officers, directors or employees has engaged in any activities that are prohibited, or are cause for civil penalties, or grounds for mandatory or permissive exclusion, debarment, or suspension pursuant to any of these authorities. Neither Parent nor its Subsidiaries are using, or have ever used, in any capacity any Person that has ever been, or to the Knowledge of Parent, is the subject of a proceeding that could lead to the Persons becoming debarred, excluded, disqualified, restricted or suspended pursuant to any of these authorities. </font></div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(h)&nbsp;&nbsp;&nbsp;Parent and its Subsidiaries have materially complied with all applicable Laws relating to patient, medical or individual health information, including HIPAA and the standards for the privacy of Individually Identifiable Health Information at 45 C.F.R. Parts 160 and 164, Subparts A and E, the standards for the protection of Electronic Protected Health Information set forth at 45 C.F.R. Part&#160;160 and 45 C.F.R. Part&#160;164, Subpart A and Subpart C, the standards for transactions and code sets used in electronic transactions at 45 C.F.R. Part&#160;160, Subpart A and Part&#160;162, and the standards for Breach Notification for Unsecured Protected Health Information at 45 C.F.R. Part&#160;164, Subpart D, all as amended from time to time. Parent and its Subsidiaries have entered into, where required, and are in compliance in all material respects with the terms of all Business Associate Agreements to which Parent or any Subsidiary is a party or otherwise bound. Parent and its Subsidiaries where required, have (i)&#160;created and maintained written policies and procedures to protect the privacy of Protected Health Information in its possession or control, (ii)&#160;provided training to all employees and agents, and (iii)&#160;implemented security procedures, including physical, technical and administrative safeguards, to protect all Protected Health Information stored or transmitted in electronic form. As of the date of this Agreement, neither Parent nor any of its Subsidiaries has received written notice from the Office for Civil Rights for the U.S. Department of Health and Human Services or any other Governmental Body alleging a failure to comply with HIPAA or any other federal or state law or regulation applicable to the protection of individually identifiable health information or personally identifiable information. To the Knowledge of Parent, as of the date of this Agreement, there has been no Breach of Unsecured Protected Health Information, unpermitted disclosure of Personal Health Information, or breach of personally identifiable information with respect to information maintained or transmitted to Parent or any of its Subsidiaries that would require notice to a Governmental Body. All capitalized terms in this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.14(h)</font><font style="letter-spacing:0.2pt;"> not otherwise defined in this Agreement shall have the meanings set forth under HIPAA. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-34</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="t3PO">&#8203;</a><a name="t31MA">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">3.15&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Legal Proceedings; Orders</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;As of the date of this Agreement, there is no material pending Legal Proceeding and, to the Knowledge of Parent, no Person has threatened in writing to commence any Legal Proceeding: (i)&#160;that involves (A)&#160;Parent, (B)&#160;any of its Subsidiaries, (C)&#160;any Parent Associate (in his or her capacity as such) or (D)&#160;any of the material assets owned or used by Parent or any of its Subsidiaries; or (ii)&#160;that challenges, or that would have the effect of preventing, delaying beyond the End Date, or making illegal, the Contemplated Transactions. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;There is no order, writ, injunction, judgment or decree to which Parent or any of its Subsidiaries is a party or any of the material assets owned or used by Parent or any of its Subsidiaries is subject. To the Knowledge of Parent, no officer or Key Employee of Parent or any of its Subsidiaries is subject to any order, writ, injunction, judgment or decree that prohibits such officer or employee from engaging in or continuing any conduct, activity or practice relating to the business of Parent or any of its Subsidiaries or to any material assets owned or used by Parent or any of its Subsidiaries. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">3.16&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Tax Matters</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;Parent and each of its Subsidiaries have timely filed all income Tax Returns and other material Tax Returns that they were required to file under applicable Law. All such Tax Returns are correct and complete in all material respects and have been prepared in material compliance with all applicable Law. No written claim has ever been made by any Governmental Body in any jurisdiction where Parent or its any of its Subsidiaries does not file a particular Tax Return or pay a particular Tax that Parent or such Subsidiary is subject to taxation by that jurisdiction. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;All income and other material Taxes due and owing by Parent or any of its Subsidiaries (whether or not shown on any Tax Return) have been fully paid. The unpaid Taxes of Parent and its Subsidiaries did not, as of the date of the Parent Balance Sheet, materially exceed the reserve for Tax liability (excluding any reserve for deferred Taxes established to reflect timing differences between book and Tax items) set forth on the face of the Parent Balance Sheet. Since the Parent Balance Sheet Date, neither Parent nor any of its Subsidiaries has incurred any material Liability for Taxes outside the Ordinary Course of Business. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;All Taxes that Parent or any of its Subsidiaries are or were required by Law to withhold or collect from payments to employees, independent contractors, stockholders, lenders, customers or other third parties have been duly and timely withheld or collected in all material respects and, have been timely paid to the proper Governmental Body or properly set aside in accounts for this purpose. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;There are no Encumbrances for material Taxes (other than Permitted Encumbrances) upon any of the assets of Parent or any of its Subsidiaries. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(e)&nbsp;&nbsp;&nbsp;No deficiencies for income or other material Taxes with respect to Parent or any of its Subsidiaries have been claimed, proposed or assessed by any Governmental Body in writing other than any deficiency that has been resolved. There are no pending or ongoing, and to the Knowledge of Parent, threatened audits, assessments or other actions for or relating to any liability in respect of a material amount of Taxes of Parent or any of its Subsidiaries. Neither Parent nor any of its Subsidiaries (or any of their predecessors) has waived any statute of limitations in respect of any income or other material Taxes or agreed to any extension of time with respect to any income or other material Tax assessment or deficiency which waiver is still in effect. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(f)&nbsp;&nbsp;&nbsp;Neither Parent nor any of its Subsidiaries has, since January&#160;1, 2019, distributed stock of another Person, or had its stock distributed by another Person, in a transaction that was purported or intended to be governed in whole or in part by Section&#160;355 of the Code or Section&#160;361 of the Code (or any similar provisions of state, local or foreign Law). </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(g)&nbsp;&nbsp;&nbsp;Neither Parent nor any of its Subsidiaries has participated in or been a party to a transaction that, as of the date of this Agreement, constitutes a &#8220;listed transaction&#8221; that is required to be reported to the IRS pursuant to Section&#160;6011 of the Code and applicable Treasury Regulations thereunder. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-35</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="t3ALM">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; text-indent:20pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(h)&nbsp;&nbsp;&nbsp;Neither Parent nor any of its Subsidiaries has taken or agreed to take any action or knows of any fact or circumstance that would reasonably be expected to prevent the Merger from qualifying for the Intended Tax Treatment. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(i)&nbsp;&nbsp;&nbsp;Neither Parent nor any of its Subsidiaries is a party to any Tax allocation agreement, Tax sharing agreement, Tax indemnity agreement, or similar agreement or arrangement, other than customary commercial Contracts entered into in the Ordinary Course of Business the principal subject matter of which is not Taxes. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(j)&nbsp;&nbsp;&nbsp;Neither Parent nor any of its Subsidiaries will be required to include any material item of income in, or exclude any material item of deduction from, taxable income for any Tax period (or portion thereof) ending after the Closing Date as a result of any: (i)&#160;change in method of accounting for Tax purposes filed on or prior to the Closing Date; (ii)&#160;use of an improper method of accounting for a Tax period ending on or prior to the Closing Date; (iii)&#160;&#8220;closing agreement&#8221; as described in Section&#160;7121 of the Code (or any similar provision of state, local or foreign Law) executed on or prior to the Closing Date; (iv)&#160;intercompany transaction or excess loss account described in Treasury Regulations under Section&#160;1502 of the Code (or any similar provision of state, local or foreign Law) as a result of a transaction on or prior to the Closing Date; (v)&#160;installment sale or open transaction disposition made on or prior to the Closing Date; or (vi)&#160;prepaid amount received outside of the Ordinary Course of Business on or prior to the Closing Date. Parent has not made any election under Section&#160;965(h) of the Code. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(k)&nbsp;&nbsp;&nbsp;Neither Parent nor any of its Subsidiaries has ever been (i)&#160;a member of a consolidated, combined or unitary Tax group (other than such a group the common parent of which is Parent) or (ii)&#160;a party to any joint venture, partnership, or other arrangement that is treated as a partnership for U.S. federal income Tax purposes. Neither Parent nor its Subsidiaries has any Liability for any Taxes of any Person (other than Parent and any of its Subsidiaries) under Treasury Regulations&#160;Section&#160;1.1502-6 (or any similar provision of state, local, or foreign Law), or as a transferee or successor. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(l)&nbsp;&nbsp;&nbsp;Neither Parent nor any of its Subsidiaries (i)&#160;is a &#8220;controlled foreign corporation&#8221; as defined in Section&#160;957 of the Code; (ii)&#160;is a &#8220;passive foreign investment company&#8221; within the meaning of Section&#160;1297 of the Code; (iii)&#160;has ever had a permanent establishment (within the meaning of an applicable Tax treaty) or otherwise had an office or fixed place of business in a country other than the country in which it is organized; or (iv)&#160;is or was a &#8220;surrogate foreign corporation&#8221; within the meaning of Section&#160;7874(a)(2)(B) or is treated as a U.S. corporation under Section&#160;7874(b) of the Code. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">3.17&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Employee and Labor Matters; Benefit Plans</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.17(a)</font><font style="letter-spacing:0.2pt;"> of the Parent Disclosure Schedule is a list as of the date of this Agreement of all Parent Benefit Plans, including each Parent Benefit Plan that provides for retirement, change in control, stay or retention, deferred compensation, incentive compensation, severance or retiree medical or life insurance benefits. &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent Benefit Plan</font><font style="letter-spacing:0.2pt;">&#8221; means each (i)&#160;&#8220;employee benefit plan&#8221; as defined in Section&#160;3(3) of ERISA (whether or not ERISA governs such plan) and (ii)&#160;other pension, retirement, deferred compensation, excess benefit, profit sharing, bonus, incentive, equity or equity-based (other than individual Parent Options or Parent RSUs made pursuant to Parent&#8217;s standard forms, in which case only representative standard forms of such stock option agreements and other award agreements shall be scheduled), phantom equity, employment (other than individual employment agreements made pursuant to Parent&#8217;s standard forms, in which case only representative standard forms of such employment agreements shall be scheduled), offer letter (other than individual offer letters made pursuant to Parent&#8217;s standard forms, in which case only representative standard forms of such offers shall be scheduled), consulting, severance, change-of-control, retention, health, life, disability, group insurance, paid-time off, holiday, welfare and fringe benefit plan, program, agreement, Contract, or arrangement (whether written or unwritten, qualified or nonqualified, funded or unfunded and including any that have been frozen or terminated but only if Parent has continuing liabilities with respect thereto), in any case, maintained, contributed to, or required to be contributed to, by Parent, any of its Subsidiaries or Parent ERISA Affiliates for the benefit of any current or former employee, director, officer or independent contractor of Parent or any of its Subsidiaries or under which Parent or </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-36</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">any of its Subsidiaries has any Liability (including as the result of its being treated as a single employer under Code Section&#160;414 with any other person). </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;As applicable with respect to each Parent Benefit Plan, Parent has made available to the Company, true and complete copies of (i)&#160;each Parent Benefit Plan, including all amendments thereto, and in the case of an unwritten Parent Benefit Plan, a written description thereof, (ii)&#160;all current trust documents, investment management Contracts, custodial agreements, administrative services agreements and insurance and annuity Contracts relating thereto, (iii)&#160;the current summary plan description and each summary of material modifications thereto, (iv)&#160;the most recently filed annual reports with any Governmental Body (e.g., Form 5500 and all schedules thereto), (v)&#160;the most recent IRS determination, opinion or advisory letter, (vi)&#160;the most recent summary annual reports, nondiscrimination testing reports, actuarial reports, financial statements and trustee reports, and (vii)&#160;all material records, notices and filings concerning IRS or Department of Labor or other Governmental Body audits or investigations. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;Each Parent Benefit Plan has been maintained, operated and administered in compliance in all material respects with its terms and any related documents or agreements and the applicable provisions of ERISA, the Code and all other Laws, including applicable pension Laws and, if applicable, the Income Tax Act (Canada) and the regulations thereunder. All filings and reports as to each Parent Plan required to have been submitted to the Internal Revenue Service, the Canada Revenue Agency, a Canadian Governmental Entity or to the Department of Labor, in each case to the extent applicable, have been timely submitted. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;The Parent Benefit Plans that are &#8220;employee pension benefit plans&#8221; within the meaning of Section&#160;3(2) of ERISA and which are intended to meet the qualification requirements of Section&#160;401(a) of the Code have received determination, opinion or advisory letters from the IRS to the effect that such plans are qualified under Section&#160;401(a) of the Code and the related trusts are exempt from federal income Taxes under Section&#160;501(a) of the Code, respectively, and to the Knowledge of Parent, nothing has occurred that would reasonably be expected to adversely affect the qualification of such Parent Benefit Plan or the tax exempt status of the related trust. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(e)&nbsp;&nbsp;&nbsp;Since January&#160;1, 2016, neither Parent nor any of its Subsidiaries nor any Parent ERISA Affiliate has maintained, contributed to, been required to contribute to, or had any liability with respect to, (i)&#160;any &#8220;employee pension benefit plan&#8221; &#8203;(within the meaning of Section&#160;3(2) of ERISA) that is subject to Title IV or Section&#160;302 of ERISA or Section&#160;412 of the Code, (ii)&#160;any &#8220;multiemployer plan&#8221; &#8203;(within the meaning of Section&#160;3(37) of ERISA), or (iii)&#160;any &#8220;multiple employer plan&#8221; &#8203;(within the meaning of Section&#160;413 of the Code). No Parent Benefit Plan is a self-funded group health plan that is a &#8220;multiple employer welfare arrangement&#8221; &#8203;(within the meaning of Section&#160;3(40) of ERISA). No Parent Benefit Plan is sponsored by a professional employer organization. Except as set forth on </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.17(e)</font><font style="letter-spacing:0.2pt;"> of the Parent Disclosure Schedule, Parent has not maintained any Parent Benefit Plans outside the United States that are defined-benefit type plans. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(f)&nbsp;&nbsp;&nbsp;As of the date of this Agreement, there are no (i)&#160;pending audits or investigations by any Governmental Body involving any Parent Benefit Plan, and (ii)&#160;pending or, to the Knowledge of Parent, threatened claims (except for individual claims for benefits payable in the normal operation of the Parent Benefit Plans), suits or proceedings involving any Parent Benefit Plan, any fiduciary thereof or service provider thereto. All contributions and premium payments required to have been made under any of the Parent Benefit Plans or by applicable Law (without regard to any waivers granted under Section&#160;412 of the Code), have been timely made in all material respects and neither Parent nor any Parent ERISA Affiliate has any material liability for any unpaid contributions with respect to any Parent Benefit Plan. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(g)&nbsp;&nbsp;&nbsp;Neither Parent, any of its Subsidiaries nor any Parent ERISA Affiliates, nor to the Knowledge of Parent, any fiduciary, trustee or administrator of any Parent Benefit Plan, has engaged in, or in connection with the Contemplated Transactions will engage in, any transaction with respect to any Parent Benefit Plan which would subject any such Parent Benefit Plan, Parent or any of its Subsidiaries or Parent to a material Tax, material penalty or material liability for a &#8220;prohibited transaction&#8221; under Section&#160;406 of ERISA or Section&#160;4975 of the Code. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-37</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; text-indent:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(h)&nbsp;&nbsp;&nbsp;No Parent Benefit Plan provides death, medical, dental, vision, life insurance or other welfare benefits beyond termination of service or retirement other than coverage mandated by Law and fully paid by the participant (except in connection with severance), and neither Parent, any of its Subsidiaries nor any Parent ERISA Affiliates has made a written or oral representation promising the same. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(i)&nbsp;&nbsp;&nbsp;Neither the execution of this Agreement nor the consummation of the Contemplated Transactions will either alone or in connection with any other event(s) (i)&#160;result in any payment becoming due to any current or former employee, director, officer, or independent contractor of Parent or any of its Subsidiaries, (ii)&#160;increase any amount of compensation or benefits otherwise payable under any Parent Benefit Plan, (iii)&#160;result in the acceleration of the time of payment, funding or vesting of any benefits under any Parent Benefit Plan, (iv)&#160;require any contribution or payment to fund any obligation under any Parent Benefit Plan or (v)&#160;limit the right to merge, amend or terminate any Parent Benefit Plan that is subject to ERISA. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(j)&nbsp;&nbsp;&nbsp;Neither the execution of this Agreement nor the consummation of the Contemplated Transactions (either alone or when combined with the occurrence of any other event, including without limitation, a termination of employment) will result in the receipt or retention by any Person who is a &#8220;disqualified individual&#8221; &#8203;(within the meaning of Code Section&#160;280G) with respect to Parent and its Subsidiaries of any payment or benefit under any Parent Benefit Plan that is or could reasonably be expected to be characterized as a &#8220;parachute payment&#8221; &#8203;(within the meaning of Code Section&#160;280G). </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(k)&nbsp;&nbsp;&nbsp;The exercise price of each Parent Option granted to a U.S. taxpayer is not and never has been less than the fair market value, as determined by the Parent Board, of one share of Parent Common Stock as of the grant date of such Parent Option. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(l)&nbsp;&nbsp;&nbsp;Each Parent Benefit Plan providing for deferred compensation that constitutes a &#8220;nonqualified deferred compensation plan&#8221; &#8203;(as defined in Section&#160;409A(d)(1) of the Code and the regulations promulgated thereunder) is, and has been, established, administered and maintained in material compliance with the requirements of Section&#160;409A of the Code and the regulations promulgated thereunder in all material respects. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(m)&nbsp;&nbsp;&nbsp;No current or former employee, officer, director or independent contractor of Parent or any of its Subsidiaries has any &#8220;gross up&#8221; agreements with Parent or any of its Subsidiaries or other assurance of reimbursement by Parent or any of its Subsidiaries for any Taxes imposed under Code Section&#160;409A or Code Section&#160;4999. </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(n)&nbsp;&nbsp;&nbsp;No Parent Benefit Plan is maintained outside of the United States. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(o)&nbsp;&nbsp;&nbsp;Parent has made available to the Company a true and correct list, as of the date of this Agreement, containing an anonymized list of all full-time, part-time or temporary employees and independent contractors (and indication as such), and, as applicable: (i)&#160;the annual dollar amount of all compensation (including wages, salary or fees, commissions, director&#8217;s fees, fringe benefits, bonuses, profit sharing payments, and other payments or benefits of any type) payable to each person; (ii), dates of employment or service; (iii)&#160;title; (iv)&#160;any eligibility to receive severance, retention payment, change of control payment, or other similar compensation; (v)&#160;visa status, if applicable; (vi)&#160;if any employee is an on approved leave, and the expected date of return, if known; and (vii)&#160;with respect to employees, a designation of whether they are classified as exempt or non-exempt for purposes of the Fair Labor Standards Act and any similar state or foreign law. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(p)&nbsp;&nbsp;&nbsp;Neither Parent nor any of its Subsidiaries is and has never been a party to, bound by, or has a duty to bargain under, any collective bargaining agreement or other Contract with a labor union, labor organization, or similar Person representing any of its employees, and there is no labor union, labor organization, or similar Person representing or, to the Knowledge of Parent, purporting to represent or seeking to represent any employees of Parent or its Subsidiaries, including through the filing of a petition for representation election. There is not and has not been in the past three&#160;years, nor is there or has there been in the past three&#160;years any threat of, any strike, slowdown, work stoppage, lockout, union election petition, demand for recognition, or any similar activity or dispute, or, to the Knowledge of Parent, any union organizing activity, against Parent or any of its Subsidiaries. No event has occurred, and no condition or circumstance exists, that might directly or indirectly be likely to give rise </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-38</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="t3MSJ">&#8203;</a><a name="t3PHM">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">to or provide a basis for the commencement of any such strike, slowdown, work stoppage, lockout, union election petition, demand for recognition, any similar activity or dispute, or, to the Knowledge of Parent, any union organizing activity. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(q)&nbsp;&nbsp;&nbsp;Parent and each of its Subsidiaries is, and since January&#160;1, 2019 has been, in material compliance with all applicable Laws respecting labor, employment, employment practices, and terms and conditions of employment, including worker classification, discrimination, harassment and retaliation, equal employment opportunities, fair employment practices, meal and rest periods, immigration, employee safety and health, payment of wages (including overtime wages), unemployment and workers&#8217; compensation, leaves of absence, and hours of work. Except as would not be reasonably likely to result in a material liability to Parent or any of its Subsidiaries, with respect to employees of Parent and its Subsidiaries, each of Parent and its Subsidiaries, since January&#160;1, 2019: (i)&#160;has withheld and reported all amounts required by Law or by agreement to be withheld and reported with respect to wages, salaries and other payments, benefits, or compensation to employees; (ii)&#160;is not liable for any arrears of wages (including overtime wages), severance pay or any Taxes or any penalty for failure to comply with any of the foregoing; and (iii)&#160;is not liable for any payment to any trust or other fund governed by or maintained by or on behalf of any Governmental Body, with respect to unemployment compensation benefits, disability, social security or other benefits or obligations for employees (other than routine payments to be made in the Ordinary Course of Business). As of the date of this Agreement, there are no Legal Proceedings, claims or charges pending or, to the Knowledge of Parent, threatened or reasonably anticipated against Parent or its Subsidiaries relating to any employee, applicant for employment, consultant, or employment agreement or otherwise relating to labor, employment, employment practices, or terms and conditions of employment. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(r)&nbsp;&nbsp;&nbsp;Except as would not be reasonably likely to result in a material liability to Parent or any of its Subsidiaries, Parent and each of its Subsidiaries has accurately classified each individual service provider as an employee, independent contractor, or otherwise under all applicable Laws and, for each individual classified as an employee, Parent and each of its Subsidiaries has accurately classified him or her as exempt or non-exempt under all applicable Laws. Neither Parent nor any of its Subsidiaries has any material liability with respect to any misclassification of: (a)&#160;any Person as an independent contractor rather than as an employee; (b)&#160;any employee leased from another employer; or (c)&#160;any employee currently or formerly classified as exempt under all applicable Laws. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(s)&nbsp;&nbsp;&nbsp;Within the preceding five&#160;years, Parent has not implemented any &#8220;plant closing&#8221; or &#8220;mass layoff&#8221; of employees that would reasonably be expected to require notification under the WARN Act or any similar state, local or foreign Law. No &#8220;plant closing&#8221; or &#8220;mass layoff&#8221; will be implemented before the Closing Date without advance notification to and approval of the Company. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">3.18&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Environmental Matters</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Since January&#160;1, 2019, Parent and each of its Subsidiaries have complied with all applicable Environmental Laws, which compliance includes the possession by Parent of all permits and other Governmental Authorizations required under applicable Environmental Laws and compliance with the terms and conditions thereof, except for any failure to be in such compliance that would not have a Parent Material Adverse Effect. Neither Parent nor any of its Subsidiaries have received between January&#160;1, 2019 and the date of this Agreement any written notice, whether from a Governmental Body or other Person, that alleges that Parent or any of its Subsidiaries is not in compliance with any Environmental Law and, to the Knowledge of Parent, there are no circumstances that would reasonably be expected to prevent or interfere with Parent&#8217;s or any of its Subsidiaries&#8217; compliance in any material respects with any Environmental Law, except where such failure to comply would not have a Parent Material Adverse Effect. To the Knowledge of Parent, (i)&#160;no current or prior owner of any property leased or controlled by Parent or any of its Subsidiaries has received, between January&#160;1, 2019 and the date of this Agreement, any written notice relating to property owned or leased at any time by Parent or any of its Subsidiaries, whether from a Governmental Body or other Person, that alleges that current or prior owners or Parent or any of its Subsidiaries is not in compliance with or violated any Environmental Law relating to such property and (ii)&#160;neither Parent nor any of its Subsidiaries has any material liability under any Environmental Law. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">3.19&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Insurance</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Parent has made available to the Company accurate and complete copies of all material insurance policies and all material self-insurance programs and arrangements relating to the </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-39</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="t3FAO">&#8203;</a><a name="t3WAE">&#8203;</a><a name="t3NPN">&#8203;</a><a name="t3ITP">&#8203;</a><a name="t3OFA">&#8203;</a><a name="t3OOR">&#8203;</a><a name="tS4CO">&#8203;</a><a name="t4OPB">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">business, assets, liabilities and operations of Parent and each of its Subsidiaries. Each of such insurance policies is in full force and effect and Parent and each of its Subsidiaries are in compliance in all material respects with the terms thereof. Other than customary end of policy notifications from insurance carriers, between January&#160;1, 2019 and the date of this Agreement, neither Parent nor any of its Subsidiaries has received any written notice regarding any actual or possible: (a)&#160;cancellation or invalidation of any insurance policy; or (b)&#160;refusal or denial of any coverage, reservation of rights or rejection of any material claim under any insurance policy. Parent and each of its Subsidiaries have provided timely written notice to the appropriate insurance carrier(s) of each Legal Proceeding that is currently pending against Parent or any of its Subsidiaries for which Parent or such Subsidiaries has insurance coverage, and no such carrier has issued a denial of coverage or a reservation of rights with respect to any such Legal Proceeding, or informed Parent or any of its Subsidiaries of its intent to do so. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">3.20&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">No Financial Advisors</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Other than SVB Securities LLC, no broker, finder or investment banker is entitled to any brokerage fee, finder&#8217;s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Contemplated Transactions based upon arrangements made by or on behalf of Parent or any of its Subsidiaries. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">3.21&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Transactions with Affiliates</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Except as set forth in the Parent SEC Documents filed prior to the date of this Agreement, since December&#160;31, 2021, no event has occurred that would be required to be reported by Parent pursuant to Item&#160;404 of Regulation&#160;S-K. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">3.22&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Anti-Bribery</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Neither Parent nor any of its Subsidiaries or any of their respective directors, officers, employees or, to Parent&#8217;s Knowledge, agents or any other Person acting on their behalf has, directly or indirectly, made any bribes, rebates, payoffs, influence payments, kickbacks, illegal payments, illegal political contributions, or other payments, in the form of cash, gifts, or otherwise, or taken any other action, in violation of Anti-Bribery Laws. To the Knowledge of Parent, neither Parent nor any of its Subsidiaries is or has been the subject of any investigation or inquiry by any Governmental Body with respect to potential violations of Anti-Bribery Laws. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">3.23&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Valid Issuance</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Parent Common Stock to be issued in the Merger will, when issued in accordance with the provisions of this Agreement, be validly issued, fully paid and nonassessable. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">3.24&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Opinion of Financial Advisor</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Parent Board has received an opinion of SVB Securities LLC to the effect that, as of the date of this Agreement and subject to the assumptions, qualifications, limitations and other matters set forth therein, the Exchange Ratio is fair, from a financial point of view, to Parent. It is agreed and understood that such opinion is for the benefit of the Parent Board and may not be relied upon by the Company or any other party. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">3.25&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Disclaimer of Other Representations or Warranties</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Parent hereby acknowledges and agrees that, except for the representations and warranties contained in this Agreement, neither the Company nor any of its Subsidiaries nor any other person on behalf of the Company or any of its Subsidiaries makes any express or implied representation or warranty with respect to the Company or any of its Subsidiaries or with respect to any other information provided to Parent, Merger Sub or stockholders or any of their respective Affiliates in connection with the Contemplated Transactions, and (subject to the express representations and warranties of the Company set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2</font><font style="letter-spacing:0.2pt;"> (in each case as qualified and limited by the Company Disclosure Schedule)) neither Parent, its Subsidiaries nor any of their respective Representatives or stockholders, has relied on any such information (including the accuracy or completeness thereof). </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Section&#160;4.&nbsp;&nbsp;&nbsp;CERTAIN COVENANTS OF THE PARTIES</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">4.1&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Operation of Parent&#8217;s Business</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;Except as expressly permitted by this Agreement, as required by applicable Law, in connection with any COVID-19 Measures or COVID-19 Response or unless the Company shall otherwise consent in writing (which consent shall not be unreasonably withheld, delayed or conditioned), during the period commencing on the date of this Agreement and continuing until the earlier to occur of the termination of this Agreement pursuant to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;9</font><font style="letter-spacing:0.2pt;"> and the Effective Time (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Pre-Closing Period</font><font style="letter-spacing:0.2pt;">&#8221;), Parent shall, and shall cause each of its Subsidiaries to, (x)&#160;use commercially reasonable efforts to </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-40</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">conduct its business and operations in the Ordinary Course of Business and (y)&#160;conduct its business and operations in compliance in all material respects with all applicable Laws, including timely making all filings required by the SEC, and the requirements of all Contracts that constitute Parent Material Contracts. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;Except (i)&#160;as expressly permitted by this Agreement, (ii)&#160;as set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;4.1(b)</font><font style="letter-spacing:0.2pt;"> of the Parent Disclosure Schedule, (iii)&#160;as required by applicable Law, (iv)&#160;in connection with an Asset Disposition, on the terms and subject to the limitations set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;4.7</font><font style="letter-spacing:0.2pt;">, (v)&#160;in connection with the Pre-Closing Dividend in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.21</font><font style="letter-spacing:0.2pt;">, (vi)&#160;in connection with any COVID-19 Measures or COVID-19 Response, or (vii)&#160;with the prior written consent of the Company (which consent shall not be unreasonably withheld, delayed or conditioned), at all times during the Pre-Closing Period, Parent shall not, nor shall it cause or permit any of its Subsidiaries to, do any of the following: </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(i)&nbsp;&nbsp;&nbsp;declare, accrue, set aside or pay any dividend or make any other distribution in respect of any shares of its capital stock or repurchase, redeem or otherwise reacquire any shares of its capital stock or other securities (except in connection with the payment of the exercise price and/or withholding Taxes incurred upon the exercise of any Parent Option or vesting of Parent RSUs in accordance with the terms of such award in effect on the date of this Agreement); </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(ii)&nbsp;&nbsp;&nbsp;sell, issue, grant, pledge or otherwise dispose of or encumber or authorize the issuance of: (A)&#160;any capital stock or other security of Parent (except for Parent Common Stock issued upon the valid exercise or settlement of outstanding Parent Options, Parent Warrants or the vesting of Parent RSUs, as applicable, in accordance with their terms as in effect as of the date of this Agreement); (B)&#160;any option, warrant or right to acquire any capital stock or any other security; or (C)&#160;any other instrument convertible into or exchangeable for any capital stock or other security of Parent or any of its Subsidiaries; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(iii)&nbsp;&nbsp;&nbsp;amend any of its or any of its Subsidiaries&#8217; Organizational Documents, or effect or be a party to any merger, consolidation, share exchange, business combination, recapitalization, reclassification of shares, stock split, reverse stock split or similar transaction except, for the avoidance of doubt, the Contemplated Transactions; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(iv)&nbsp;&nbsp;&nbsp;form any Subsidiary or acquire any equity interest or other interest in any other Entity, or enter into a joint venture with any other Entity; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(v)&nbsp;&nbsp;&nbsp;(A) lend money to any Person, (B)&#160;incur or guarantee any indebtedness for borrowed money, issue or sell any debt securities or options, warrants, calls or other rights to acquire any debt securities, (C)&#160;guarantee any debt securities of others, or (D)&#160;make any capital expenditure or commitment in excess of $250,000; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(vi)&nbsp;&nbsp;&nbsp;other than as required by applicable Law or by the terms of any Parent Benefit Plan as in effect on the date of this Agreement and disclosed in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.17(a)</font><font style="letter-spacing:0.2pt;"> of the Parent Disclosure Schedule: (A)&#160;adopt, terminate, establish or enter into any Parent Benefit Plan; (B)&#160;cause or permit any Parent Benefit Plan to be amended in any material respect; (C)&#160;pay any bonus or make any profit-sharing or similar payment to, or increase the amount of the wages, salary, commissions, benefits or other compensation or remuneration payable to, any Parent Associate; or (D)&#160;increase or otherwise modify the severance, retention or change of control benefits offered to any current or former or new Parent Associate; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(vii)&nbsp;&nbsp;&nbsp;enter into any Contract with a labor union, labor organization, or similar Person, except as otherwise required by applicable Law; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(viii)&nbsp;&nbsp;&nbsp;(A) hire or engage, or offer to hire, any director, officer, employee or consultant, or (B)&#160;enter into, amend or extend the term of any employment or consulting agreement with any Parent Associate; </font>
        </div>
        <div style="margin-left:60pt; margin-top:8pt; width:396pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(ix)&nbsp;&nbsp;&nbsp;enter into any material transaction; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(x)&nbsp;&nbsp;&nbsp;acquire any material asset or sell, lease or otherwise irrevocably dispose of any of its material assets or properties, or grant any Encumbrance with respect to such assets or properties; </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-41</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:40pt; text-indent:20pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(xi)&nbsp;&nbsp;&nbsp;make, change or revoke any material Tax election, file any material amended Tax Return, settle or compromise any income or other material Tax liability, enter into any Tax allocation, sharing, indemnification or other similar agreement or arrangement (other than customary commercial Contracts entered into in the Ordinary Course of Business the principal subject matter of which is not Taxes), request or consent to any extension or waiver of any limitation period with respect to any claim or assessment for any income or other material Taxes (other than pursuant to an extension of time to file any Tax Return granted in the Ordinary Course of Business of not more than six&#160;months), or change any material accounting method in respect of Taxes; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(xii)&nbsp;&nbsp;&nbsp;(A) sell, assign, transfer, allow to lapse or expire, pledge, abandon, discontinue, fail to maintain or otherwise dispose of any right, title or interest of Parent or any of its Subsidiaries in any material Parent IP, or (B)&#160;license, sublicense or otherwise encumber (other than pursuant to a non-exclusive license granted to contract research organizations, including clinical trial sites and clinical trial services provides, or contract manufacturing organizations, in each case, (x)&#160;with whom Parent or any of its Subsidiaries has previously entered into Contracts prior to the Effective Time and (y)&#160;who are engaged to provide services directly related to clinical studies and manufacturing of any product candidate of Parent, provided that the scope of any such non-exclusive license grant is limited to only the extent necessary for such Persons to perform their obligations under the respective Contracts) any right, title or interest of Parent or any of its Subsidiaries in any material Parent IP; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(xiii)&nbsp;&nbsp;&nbsp;enter into, amend or terminate any Parent Material Contract (or any Contract that would have been a Parent Material Contract if in effect on or prior to the date of this Agreement); </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(xiv)&nbsp;&nbsp;&nbsp;(A) materially change pricing or royalties or other payments set or charged by Parent or any of its Subsidiaries to its customers or licensees or (B)&#160;agree to materially change pricing or royalties or other payments set or charged by persons who have licensed Intellectual Property Rights to Parent or any of its Subsidiaries; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(xv)&nbsp;&nbsp;&nbsp;make any expenditures, incur any Liabilities or discharge or satisfy any Liabilities, in each case, other than those expenditures or Liabilities that (A)&#160;will not survive the Closing, (B)&#160;are discharged or satisfied prior to the Closing, and/or (C)&#160;are taken into account in the calculation of Net Cash; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(xvi)&nbsp;&nbsp;&nbsp;waive, settle or compromise any pending or threatened Legal Proceeding against Parent or any of its Subsidiaries, other than waivers, settlements or agreements (A)&#160;for an amount not in excess of $75,000 individually or in the aggregate (excluding amounts to be paid under existing insurance policies or renewals thereof) and (B)&#160;that do not (1)&#160;impose any restriction on the operations or business of Parent or its Subsidiaries (nor on the Company or any of its Subsidiaries, from and after the Closing), (2)&#160;involve any equitable relief and (3)&#160;do not involve admission of any wrongdoing by Parent or any of its Subsidiaries; or </font>
        </div>
        <div style="margin-left:60pt; margin-top:8pt; width:396pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(xvii)&nbsp;&nbsp;&nbsp;agree, resolve or commit to do any of the foregoing. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Notwithstanding anything to the contrary contained herein, nothing herein shall prevent Parent or any of its Subsidiaries from taking or not taking any action, including the establishment of any policy, procedure or protocol, in response to COVID-19 or any COVID-19 Measures or otherwise take any COVID-19 Response and (a)&#160;no such actions or failure to take such actions or COVID-19 Responses shall be deemed to violate or breach this Agreement in any way, (b)&#160;all such actions or failures to take such actions or COVID-19 Responses shall be deemed to constitute an action taken in the Ordinary Course of Business and (c)&#160;no such actions or failures to take such actions or COVID-19 Responses shall serve as a basis for the Company to terminate this Agreement or assert that any of the conditions to the Closing contained herein have not been satisfied. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Notwithstanding the generality of the foregoing, nothing set forth in this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;4.1</font><font style="letter-spacing:0.2pt;"> shall restrict Parent&#8217;s right to effectuate one or more Asset Dispositions, on the terms and subject to the limitations set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;4.7</font><font style="letter-spacing:0.2pt;">, or the Pre-Closing Dividend, on the terms and subject to the limitations set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.21</font><font style="letter-spacing:0.2pt;">, it being understood that </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;4.7</font><font style="letter-spacing:0.2pt;"> and </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.21</font><font style="letter-spacing:0.2pt;"> contains the parties&#8217; entire agreement </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-42</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="t4OTC">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">pertaining to Parent&#8217;s rights and obligations in connection with the preparation for, and negotiation and execution of, one or more Asset Dispositions prior to the Closing and the Pre-Closing Dividend. Nothing contained in this Agreement shall give the Company, directly or indirectly, the right to control or direct the operations of Parent prior to the Effective Time. Prior to the Effective Time, Parent shall exercise, consistent with the terms and conditions of this Agreement, complete unilateral control and supervision over its business operations. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">4.2&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Operation of the Company&#8217;s Business</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;Except as set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;4.2(a)</font><font style="letter-spacing:0.2pt;"> of the Company Disclosure Schedule, as expressly permitted by this Agreement, as required by applicable Law, in connection with any COVID-19 Measures or COVID-19 Response or unless Parent shall otherwise consent in writing (which consent shall not be unreasonably withheld, delayed or conditioned), during the Pre-Closing Period, each of the Company and its Subsidiaries shall (i)&#160;use commercially reasonable efforts to conduct its respective business and operations in the Ordinary Course of Business and (ii)&#160;conduct its business and operations in compliance in all material respects with all applicable Laws and the requirements of all Contracts that constitute Company Material Contracts. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;Except (i)&#160;as expressly permitted by this Agreement, (ii)&#160;as set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;4.2(b)</font><font style="letter-spacing:0.2pt;"> of the Company Disclosure Schedule, (iii)&#160;as required by applicable Law, (iv)&#160;in connection with any COVID-19 Measures or COVID-19 Response, or (v)&#160;with the prior written consent of Parent (which consent shall not be unreasonably withheld, delayed or conditioned), at all times during the Pre-Closing Period, the Company shall not, nor shall it cause or permit any of its Subsidiaries to, do any of the following: </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(i)&nbsp;&nbsp;&nbsp;declare, accrue, set aside or pay any dividend or make any other distribution in respect of any shares of its capital stock or repurchase, redeem or otherwise reacquire any shares of its capital stock or other securities (except in connection with the payment of the exercise price and/or withholding Taxes incurred upon the exercise of any Company Option in accordance with the terms of such award in effect on the date of this Agreement); </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(ii)&nbsp;&nbsp;&nbsp;except as contemplated by the Company Pre-Closing Financing or the Conversion in accordance with the Convertible Note Conversion Agreement, sell, issue, grant, pledge or otherwise dispose of or encumber or authorize the issuance of: (A)&#160;any capital stock or other security of the Company or any of its Subsidiaries (except for shares of outstanding Company Common Stock issued upon the valid exercise or settlement of Company Options in accordance with their terms as in effect as of the date of this Agreement); (B)&#160;any option, warrant or right to acquire any capital stock or any other security, other than options grants to employees and service providers in the Ordinary Course of Business; or (C)&#160;any other instrument convertible into or exchangeable for any capital stock or other security of the Company or any of its Subsidiaries; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(iii)&nbsp;&nbsp;&nbsp;amend any of its or its Subsidiaries&#8217; Organizational Documents, or effect or be a party to any merger, consolidation, share exchange, business combination, recapitalization, reclassification of shares, stock split, reverse stock split or similar transaction except, for the avoidance of doubt, the Contemplated Transactions; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(iv)&nbsp;&nbsp;&nbsp;form any Subsidiary or acquire any equity interest or other interest in any other Entity, or enter into a joint venture with any other Entity; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(v)&nbsp;&nbsp;&nbsp;(A) lend money to any Person (except for the advancement of reasonable expenses to employees, directors and consultants in the Ordinary Course of Business), (B)&#160;incur or guarantee any indebtedness for borrowed money, other than in the Ordinary Course of Business, (C)&#160;guarantee any debt securities of others or (D)&#160;except as contemplated by the Company&#8217;s capital expenditure budget and operating budget made available to Parent, make any capital expenditure or commitment in excess of $350,000; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(vi)&nbsp;&nbsp;&nbsp;acquire any material asset or sell, lease or otherwise irrevocably dispose of any of its material assets or properties, or grant any Encumbrance with respect to such assets or properties, except in the Ordinary Course of Business; </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-43</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="t4AI">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:40pt; text-indent:20pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(vii)&nbsp;&nbsp;&nbsp;sell, assign, license, sublicense, transfer, allow to lapse or expire, pledge, abandon, discontinue, fail to maintain or otherwise dispose of any right, title or interest of the Company or any of its Subsidiaries in any material Company IP (other than pursuant to a non-exclusive license in the Ordinary Course of Business); </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(viii)&nbsp;&nbsp;&nbsp;make, change or revoke any material Tax election file any material amended Tax Return, settle or compromise any income or other material Tax liability, enter into any Tax allocation, sharing, indemnification or other similar agreement or arrangement (other than customary commercial Contracts entered into in the Ordinary Course of Business the principal subject matter of which is not Taxes), request or consent to any extension or waiver of any limitation period with respect to any claim or assessment for any income or other material Taxes (other than pursuant to an extension of time to file any Tax Return granted in the Ordinary Course of Business of not more than six&#160;months), or change any material accounting method in respect of Taxes; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(ix)&nbsp;&nbsp;&nbsp;enter into, materially amend or terminate any Company Material Contract (or any Contract that would have been a Company Material Contract if in effect on or prior to the date of this Agreement) other than in the Ordinary Course of Business; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(x)&nbsp;&nbsp;&nbsp;waive, settle or compromise any pending or threatened Legal Proceeding against the Company or any of its Subsidiaries, other than waivers, settlements or agreements (A)&#160;for an amount not in excess of $75,000 individually or in the aggregate (excluding amounts to be paid under existing insurance policies or renewals thereof) and (B)&#160;that do not (1)&#160;impose any material restriction on the operations or business of the Company or its Subsidiaries (nor, following the Closing, on Parent or any of its Subsidiaries), (2)&#160;involve any equitable relief and (3)&#160;involve admission of any wrongdoing by the Company or any of its Subsidiaries; or </font>
        </div>
        <div style="margin-left:60pt; margin-top:8pt; width:396pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(xi)&nbsp;&nbsp;&nbsp;agree, resolve or commit to do any of the foregoing. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Notwithstanding anything to the contrary contained herein, nothing herein shall prevent the Company or any of its Subsidiaries from taking or not taking any action, including the establishment of any policy, procedure or protocol, in response to COVID-19 or any COVID-19 Measures or otherwise take any COVID-19 Response and (a)&#160;no such actions or failure to take such actions or COVID-19 Responses shall be deemed to violate or breach this Agreement in any way, (b)&#160;all such actions or failures to take such actions or COVID-19 Responses shall be deemed to constitute an action taken in the Ordinary Course of Business and (c)&#160;no such actions or failures to take such actions or COVID-19 Responses shall serve as a basis for Parent to terminate this Agreement or assert that any of the conditions to the Closing contained herein have not been satisfied. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;Nothing contained in this Agreement shall give Parent, directly or indirectly, the right to control or direct the operations of the Company prior to the Effective Time. Prior to the Effective Time, the Company shall exercise, consistent with the terms and conditions of this Agreement, complete unilateral control and supervision over its business operations. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">4.3&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Access and Investigation</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;Subject to the terms of the Confidentiality Agreement, which the Parties agree will continue in full force following the date of this Agreement, during the Pre-Closing Period, upon reasonable notice, Parent, on the one hand, and the Company, on the other hand, shall and shall use commercially reasonable efforts to cause such Party&#8217;s Representatives to: (i)&#160;provide the other Party and such other Party&#8217;s Representatives with reasonable access, upon reasonable notice and during normal business hours to such Party&#8217;s Representatives, personnel, property and assets and to all existing books, records, Tax Returns, work papers and other documents and information relating to such Party and its Subsidiaries; (ii)&#160;provide the other Party and such other Party&#8217;s Representatives with such copies of the existing books, records, Tax Returns, work papers, product data, and other documents and information relating to such Party and its Subsidiaries, and with such additional financial, operating and other data and information regarding such Party and its Subsidiaries as the other Party may reasonably request; (iii)&#160;permit the other Party&#8217;s officers and other employees to meet, upon reasonable notice and during normal business hours, with the principal financial officer and other officers and managers of such </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-44</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="t44NO">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Party responsible for such Party&#8217;s financial statements and the internal controls of such Party to discuss such matters as the other Party may deem necessary or appropriate; and (iv)&#160;make available to the other Party copies of unaudited financial statements and any material notice, report or other document filed with or sent to or received from any Governmental Body in connection with the Contemplated Transactions. Any investigation conducted by either Parent or the Company pursuant to this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;4.3(a)</font><font style="letter-spacing:0.2pt;"> shall be conducted in such manner as not to interfere unreasonably with the conduct of the business of the other Party and to comply with applicable COVID-19 Measures and COVID-19 Responses. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;Notwithstanding the foregoing, any Party may restrict the foregoing access to the extent that any Law applicable to such Party requires such Party to restrict or prohibit access to any such properties or information or if access would jeopardize protections afforded the Party under the attorney-client privilege or the attorney work product doctrine, violate applicable Law or breach such Party&#8217;s confidentiality obligations to a third party in effect as of the date of this Agreement; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, </font><font style="font-style:italic;letter-spacing:0.2pt;">however</font><font style="letter-spacing:0.2pt;">, that such Party shall use commercially reasonable efforts to allow for such access in a manner that does not violate any such applicable Law or jeopardize protections afforded the Party under the attorney-client privilege or the attorney work product doctrine, including by entering into such effective and appropriate joint-defense agreements or other protective arrangements as may be reasonably required by the other Party in order that all such information may be provided to the other Party without causing such violation or waiver. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">4.4&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Parent Non-Solicitation</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;Except as expressly permitted by this Agreement, Parent agrees that, during the Pre-Closing Period, neither it nor any of its Subsidiaries shall, nor shall it or any of its Subsidiaries authorize any of its Representatives to (and shall use reasonable best efforts to cause such Representative not to), directly or indirectly: (i)&#160;solicit, initiate or knowingly encourage, induce or facilitate the communication, making, submission or announcement of any Acquisition Proposal or Acquisition Inquiry or take any action that could reasonably be expected to lead to an Acquisition Proposal or Acquisition Inquiry; (ii)&#160;furnish any non-public information regarding Parent to any Person in connection with or in response to an Acquisition Proposal or Acquisition Inquiry; (iii)&#160;engage in discussions (other than to inform any Person of the existence of the provisions contained in this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;4.4</font><font style="letter-spacing:0.2pt;">) or negotiations with any Person with respect to any Acquisition Proposal or Acquisition Inquiry; (iv)&#160;approve, endorse or recommend any Acquisition Proposal (subject to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.4</font><font style="letter-spacing:0.2pt;">); (v)&#160;execute or enter into any letter of intent or any Contract contemplating or otherwise relating to any Acquisition Transaction (other than a confidentiality agreement permitted under this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;4.4(a)</font><font style="letter-spacing:0.2pt;">); or (vi)&#160;publicly propose to do any of the foregoing; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, </font><font style="font-style:italic;letter-spacing:0.2pt;">however</font><font style="letter-spacing:0.2pt;">, that, notwithstanding anything contained in this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;4.4</font><font style="letter-spacing:0.2pt;"> and subject to compliance with this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;4.4</font><font style="letter-spacing:0.2pt;">, prior to obtaining the Required Parent Stockholder Vote, Parent may furnish non-public information regarding Parent to, and enter into discussions or negotiations with, any Person in response to a </font><font style="font-style:italic;letter-spacing:0.2pt;">bona fide</font><font style="letter-spacing:0.2pt;"> written unsolicited Acquisition Proposal by such Person, which the Parent Board determines in good faith, after consultation with Parent&#8217;s outside legal counsel and financial advisers, constitutes, or is reasonably likely to result in, a Superior Offer (and is not withdrawn) if: (A)&#160;neither Parent nor any of its Representatives shall have breached this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;4.4</font><font style="letter-spacing:0.2pt;"> in any material respect; (B)&#160;the Parent Board concludes in good faith, after consultation with Parent&#8217;s outside legal counsel, that the failure to take such action is reasonably likely to be inconsistent with the fiduciary duties of the Parent Board under applicable Law; (C)&#160;at least two Business Days prior to initially furnishing any such nonpublic information to, or entering into discussions with, such Person, Parent gives the Company written notice of the identity of such Person and of Parent&#8217;s intention to furnish nonpublic information to, or enter into discussions with, such Person; (D)&#160;Parent receives from such Person an executed confidentiality agreement containing provisions (including nondisclosure provisions, use restrictions, non-solicitation provisions and no hire provisions) at least as favorable to Parent as those contained in the Confidentiality Agreement; and (E)&#160;at least two Business Days prior to furnishing any such nonpublic information to such Person, Parent furnishes such nonpublic information to the Company (to the extent such information has not been previously furnished by Parent to the Company). Without limiting the generality of the foregoing, Parent acknowledges and agrees that, in the event any Representative of Parent (whether or not such Representative is purporting to act on behalf of Parent) takes any action that, if taken by Parent, would constitute a breach of this </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-45</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="t45NO">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;4.4</font><font style="letter-spacing:0.2pt;">, the taking of such action by such Representative shall be deemed to constitute a breach of this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;4.4</font><font style="letter-spacing:0.2pt;"> by Parent for purposes of this Agreement. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;If Parent or any Representative of Parent receives an Acquisition Proposal or Acquisition Inquiry at any time during the Pre-Closing Period, then Parent shall promptly (and in no event later than twenty-four hours after Parent becomes aware of such Acquisition Proposal or Acquisition Inquiry) advise the Company in writing of such Acquisition Proposal or Acquisition Inquiry (including the identity of the Person making or submitting such Acquisition Proposal or Acquisition Inquiry (subject to any confidentiality restrictions that may be in place between Parent and such Person as of the date of this Agreement), and a copy of the Acquisition Proposal or Acquisition Inquiry, or if the Acquisition Proposal or Acquisition Inquiry is not written, the terms thereof, and the material terms thereof). Parent shall keep the Company reasonably informed with respect to the status and terms of any such Acquisition Proposal or Acquisition Inquiry and any material modification or proposed material modification thereto. In addition to the foregoing, Parent shall provide the Company with reasonable advance (and in any event not less than 24 hours) written notice of a meeting of the Parent Board (or any committee thereof) at which the Parent Board (or any committee thereof) is reasonably expected to consider an Acquisition Proposal or Acquisition Inquiry it has received. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;Parent shall immediately cease and cause to be terminated any existing discussions, negotiations and communications with any Person that relate to any Acquisition Proposal or Acquisition Inquiry as of the date of this Agreement and request the destruction or return of any nonpublic information of Parent provided to such Person. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">4.5&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Company Non-Solicitation</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;Except as expressly permitted by this Agreement, the Company agrees that, during the Pre-Closing Period, neither it nor any of its Subsidiaries shall, nor shall it or any of its Subsidiaries authorize any of its Representatives to (and shall use reasonable best efforts to cause each such Representative not to), directly or indirectly: (i)&#160;solicit, initiate or knowingly encourage, induce or facilitate the communication, making, submission or announcement of any Acquisition Proposal or Acquisition Inquiry or take any action that could reasonably be expected to lead to an Acquisition Proposal or Acquisition Inquiry; (ii)&#160;furnish any non-public information regarding the Company or any of its Subsidiaries to any Person in connection with or in response to an Acquisition Proposal or Acquisition Inquiry; (iii)&#160;engage in discussions (other than to inform any Person of the existence of the provisions contained in this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;4.5</font><font style="letter-spacing:0.2pt;">) or negotiations with any Person with respect to any Acquisition Proposal or Acquisition Inquiry; (iv)&#160;approve, endorse or recommend any Acquisition Proposal (subject to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.3</font><font style="letter-spacing:0.2pt;">); (v)&#160;execute or enter into any letter of intent or any Contract contemplating or otherwise relating to any Acquisition Transaction (other than a confidentiality agreement permitted under this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;4.5(a)</font><font style="letter-spacing:0.2pt;">); or (vi)&#160;publicly propose to do any of the foregoing; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, </font><font style="font-style:italic;letter-spacing:0.2pt;">however</font><font style="letter-spacing:0.2pt;">, that, notwithstanding anything contained in this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;4.5</font><font style="letter-spacing:0.2pt;"> and subject to compliance with this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;4.5</font><font style="letter-spacing:0.2pt;">, prior to obtaining the Required Company Stockholder Vote, the Company may furnish non-public information regarding the Company to, and enter into discussions or negotiations with, any Person in response to a </font><font style="font-style:italic;letter-spacing:0.2pt;">bona fide</font><font style="letter-spacing:0.2pt;"> written unsolicited Acquisition Proposal by such Person, which the Company Board determines in good faith, after consultation with the Company&#8217;s outside legal counsel and financial advisers, constitutes, or is reasonably likely to result in, a Superior Offer (and is not withdrawn) if: (A)&#160;neither the Company nor any of its Representatives shall have breached this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;4.5</font><font style="letter-spacing:0.2pt;"> in any material respect; (B)&#160;the Company Board concludes in good faith, after consultation with the Company&#8217;s outside legal counsel, that the failure to take such action is reasonably likely to be inconsistent with the fiduciary duties of the Company Board under applicable Law; (C)&#160;at least two Business Days prior to initially furnishing any such nonpublic information to, or entering into discussions with, such Person, the Company gives Parent written notice of the identity of such Person and of the Company&#8217;s intention to furnish nonpublic information to, or enter into discussions with, such Person; (D)&#160;the Company receives from such Person an executed confidentiality agreement containing provisions (including nondisclosure provisions, use restrictions, non-solicitation provisions and no hire provisions), at least as favorable to the Company as those contained in the Confidentiality Agreement; and (E)&#160;at least two Business Days prior to furnishing any such nonpublic information to such Person, the Company furnishes such nonpublic information to Parent (to the extent such information has not been previously </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-46</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="t4OCM">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">furnished by the Company to Parent). Without limiting the generality of the foregoing, the Company acknowledges and agrees that, in the event any Representative of the Company (whether or not such Representative is purporting to act on behalf of the Company) takes any action that, if taken by the Company, would constitute a breach of this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;4.5</font><font style="letter-spacing:0.2pt;">, the taking of such action by such Representative shall be deemed to constitute a breach of this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;4.5</font><font style="letter-spacing:0.2pt;"> by the Company for purposes of this Agreement. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;If the Company or any Representative of the Company receives an Acquisition Proposal or Acquisition Inquiry at any time during the Pre-Closing Period, then the Company shall promptly (and in no event later than twenty-four hours after the Company becomes aware of such Acquisition Proposal or Acquisition Inquiry) advise Parent in writing of such Acquisition Proposal or Acquisition Inquiry (including the identity of the Person making or submitting such Acquisition Proposal or Acquisition Inquiry (subject to any confidentiality restrictions that may be in place between the Company and such Person as of the date of this Agreement), and a copy of the Acquisition Proposal or Acquisition Inquiry, or if the Acquisition Proposal or Acquisition Inquiry is not written, the terms thereof, and the material terms thereof). The Company shall keep Parent reasonably informed with respect to the status and terms of any such Acquisition Proposal or Acquisition Inquiry and any material modification or proposed material modification thereto. In addition to the foregoing, the Company shall provide Parent with reasonable advance (and in any event not less than 24 hours) written notice of a meeting of the Company Board (or any committee thereof) at which the Company Board (or any committee thereof) is reasonably expected to consider an Acquisition Proposal or Acquisition Inquiry it has received. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;The Company shall immediately cease and cause to be terminated any existing discussions, negotiations and communications with any Person that relate to any Acquisition Proposal or Acquisition Inquiry as of the date of this Agreement and request the destruction or return of any nonpublic information of the Company or any of its Subsidiaries provided to such Person. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">4.6&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Notification of Certain Matters</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;During the Pre-Closing Period, the Company shall promptly notify Parent (and, if in writing, furnish copies of) if any of the following occurs: (i)&#160;any notice or other communication is received from any Person alleging that the Consent of such Person is or may be required in connection with any of the Contemplated Transactions; (ii)&#160;any Legal Proceeding against or involving or otherwise affecting the Company or its Subsidiaries is commenced, or, to the Knowledge of the Company, threatened against the Company or its Subsidiaries or, to the Knowledge of the Company, any director, officer or Key Employee of the Company or its Subsidiaries; (iii)&#160;the Company becomes aware of any inaccuracy in any representation or warranty made by it in this Agreement; or (iv)&#160;the failure of the Company to comply with any covenant or obligation of the Company; in the case of (iii)&#160;and (iv)&#160;that will or could reasonably be expected to result in the failure by the Company to satisfy any of the conditions set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;6</font><font style="letter-spacing:0.2pt;"> or </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7</font><font style="letter-spacing:0.2pt;">. No notification given to Parent pursuant to this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;4.6(a)</font><font style="letter-spacing:0.2pt;"> shall change, limit or otherwise affect any of the representations, warranties, covenants or obligations of the Company or any of its Subsidiaries contained in this Agreement or the Company Disclosure Schedule for purposes of </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;6</font><font style="letter-spacing:0.2pt;"> or </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7</font><font style="letter-spacing:0.2pt;">, as applicable. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;During the Pre-Closing Period, Parent shall promptly notify the Company (and, if in writing, furnish copies of) if any of the following occurs: (i)&#160;any notice or other communication is received from any Person alleging that the Consent of such Person is or may be required in connection with any of the Contemplated Transactions; (ii)&#160;any Legal Proceeding against or involving or otherwise affecting Parent or its Subsidiaries is commenced, or, to the Knowledge of Parent, threatened against Parent or its Subsidiaries or, to the Knowledge of Parent, any director, officer or Key Employee of Parent or its Subsidiaries; (iii)&#160;Parent becomes aware of any inaccuracy in any representation or warranty made by it in this Agreement; or (iv)&#160;the failure of Parent to comply with any covenant or obligation of Parent or Merger Sub; in the case of (iii)&#160;and (iv)&#160;that will or could reasonably be expected to result in the failure by Parent to satisfy any of the conditions set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;6</font><font style="letter-spacing:0.2pt;"> or </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;8</font><font style="letter-spacing:0.2pt;">. No notification given to the Company pursuant to this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;4.6(b)</font><font style="letter-spacing:0.2pt;"> shall change, limit or otherwise affect any of the representations, warranties, covenants or obligations of Parent contained in this Agreement or the Parent Disclosure Schedule for purposes of </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;6</font><font style="letter-spacing:0.2pt;"> or </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;8</font><font style="letter-spacing:0.2pt;">, as applicable. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-47</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="t4TA">&#8203;</a><a name="tS5AO">&#8203;</a><a name="t5SPS">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">4.7&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Potentially Transferable Assets</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;Parent shall be entitled, but under no obligation, to sell, transfer, license, assign or otherwise divest Potentially Transferable Assets in a transaction or series of transactions; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, that any such sale, transfer, license or other disposition must be expressly approved by the Parent Board (each, an &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Asset Disposition</font><font style="letter-spacing:0.2pt;">&#8221; and collectively, the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Asset Dispositions</font><font style="letter-spacing:0.2pt;">&#8221;). </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;Parent shall keep the Company reasonably apprised of any developments related to the Asset Dispositions and any transactions undertaken pursuant to this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;4.7</font><font style="letter-spacing:0.2pt;">. Without limiting the foregoing, Parent shall provide the Company with notice of Parent&#8217;s intention to enter into any definitive written agreement (each, a &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Sale Agreement</font><font style="letter-spacing:0.2pt;">&#8221;) providing for the consummation of an Asset Disposition (such notice to include copies of the proposed execution form of such agreement) or otherwise to consummate an Asset Disposition, at least ten Business Days prior to the execution of such Sale Agreement or to otherwise consummate an Asset Disposition. Parent shall not enter into a Sale Agreement or otherwise consummate an Asset Disposition that would result in a Material Continuing Obligation without first obtaining the prior written consent of the Company, such consent not to be unreasonably withheld, delayed or conditioned (it being understood that if the Company does not notify Parent by the tenth Business Day following receipt of the applicable notice from Parent that the Company has not consented to the entry into such Sale Agreement, then the Company shall be deemed to have given its consent). </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Section&#160;5.&nbsp;&nbsp;&nbsp;ADDITIONAL AGREEMENTS OF THE PARTIES.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">5.1&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Registration Statement; Proxy Statement/Prospectus</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;As promptly as practicable after the date of this Agreement (but in no event later than 30&#160;days following the date of this Agreement), Parent shall, in cooperation with the Company, prepare and cause to be filed with the SEC, the Registration Statement, in which the Proxy Statement/</font>&#8203;<font style="letter-spacing:0.2pt;">Prospectus will be included, in connection with the registration under the Securities Act of the shares of Parent Common Stock to be issued by virtue of the Merger or the Conversion. Each of Parent and the Company shall use their commercially reasonable efforts to cause the Registration Statement to become effective as promptly as practicable, and shall take all or any action required under any applicable federal, state, securities and other Laws in connection with the issuance of shares of Parent Common Stock pursuant to the Merger or the Conversion. Each of the Parties shall furnish all information concerning itself and their Affiliates, as applicable, to the other Parties as the other Parties may reasonably request in connection with such actions and the preparation of the Registration Statement and the Proxy Statement/Prospectus. </font></div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;Parent covenants and agrees that the Registration Statement (and the letter to stockholders, notice of meeting and form of proxy included therewith), will comply with applicable U.S. federal securities laws and the DGCL in all material respects, and will not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements made therein, in light of the circumstances in which they were made, not misleading. The Company covenants and agrees that the information supplied, or to be supplied, by or on behalf of the Company or any of its Subsidiaries to Parent for inclusion in the Registration Statement (including the Company Financial Statements) will not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make such information, in light of the circumstances in which they were made, not misleading. Notwithstanding the foregoing, Parent makes no covenant, representation or warranty with respect to statements made in the Registration Statement (and the letter to stockholders, notice of meeting and form of proxy included therewith), if any, based on information furnished in writing by the Company or any of its Subsidiaries or any of their representations specifically for inclusion therein. The Company and its legal counsel shall be given reasonable opportunity to review and comment on the Registration Statement, including all amendments and supplements thereto, prior to the filing thereof with the SEC, and on the response to any comments of the SEC on the Registration Statement, prior to the filing thereof with the SEC. The Registration Statement (and the letter to stockholders, notice of meeting and form of proxy included therewith), including any amendments thereto, shall be subject to the Company&#8217;s advance review and reasonable approval. Each of the Parties shall use commercially reasonable efforts to cause the </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-48</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="t52MA">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Registration Statement, including the Proxy Statement/Prospectus, to comply with the applicable rules and regulations promulgated by the SEC, to respond promptly to any comments of the SEC or its staff and to have the Registration Statement declared effective under the Securities Act as promptly as practicable after it is filed with the SEC. Each of the Parties shall use commercially reasonable efforts to cause the Proxy Statement/Prospectus to be mailed to holders of Parent Common Stock as promptly as practicable after the Registration Statement is declared effective under the Securities Act. If Parent, Merger Sub or the Company become aware of any event or information that, pursuant to the Securities Act or the Exchange Act, should be disclosed in an amendment or supplement to the Registration Statement or Proxy Statement/Prospectus, as the case may be, then such Party, as the case may be, shall promptly inform the other Parties thereof and shall cooperate with such other Parties in filing such amendment or supplement with the SEC and, if appropriate, in mailing such amendment or supplement to Parent&#8217;s stockholders. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;The Company will use commercially reasonable efforts to cause to be delivered to Parent a consent letter of the Company&#8217;s independent accounting firm, dated no more than two Business Days before the date on which the Registration Statement becomes effective, that is customary in scope and substance for consent letters delivered by independent public accountants in connection with registration statements similar to the Registration Statement. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">5.2&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Regulatory Matters</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;Subject to the terms and conditions of this Agreement, the Company and Parent shall use their respective reasonable best efforts to take, or cause to be taken, all actions and to do, or cause to be done, all things necessary or desirable under applicable Laws to consummate the Merger as promptly as practicable, including in connection with (i)&#160;preparing and filing as promptly as practicable with any Governmental Body documentation to effect all necessary or desirable filings, notices, petitions, statements, registrations, submissions of information, applications and other documents and (ii)&#160;obtaining and maintaining all approvals, consents, registrations, permits, authorizations and other confirmations required to be obtained from any Governmental Body that are necessary or desirable to consummate the Merger as promptly as practicable. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;In furtherance and not in limitation of the foregoing, each of the Company and, solely to the extent required under applicable Law as mutually determined by Parent and the Company, Parent shall make, with respect to the Merger: (i)&#160;no later than 10 Business Days after the date hereof, a Notification and Report Form pursuant to the HSR Act, as applicable; and (ii)&#160;as promptly as practicable after the date hereof, all filings required pursuant to applicable Antitrust Laws as described in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.2(b)</font><font style="letter-spacing:0.2pt;"> of the Company Disclosure Schedule. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;Each of the Company and Parent shall (i)&#160;respond as promptly as practicable to any inquiries or requests received from any Governmental Body, including in connection with any Antitrust Laws applicable to the Contemplated Transactions, (ii)&#160;supply as promptly as practicable any additional information and documentary material that may be requested by a Governmental Body, including pursuant to the HSR Act, as applicable, (iii)&#160;if any request for additional information and documents, including a &#8220;second request&#8221; under the HSR Act, as applicable, is received from any Governmental Body, then substantially comply with any such request at the earliest practicable date, (iv)&#160;not extend any waiting period or agree to refile under the HSR Act, as applicable, or any other Antitrust Law except with the prior consent of the other Party, and (v)&#160;take all other actions necessary or desirable to cause the expiration or termination of the applicable waiting periods under the HSR Act, as applicable, and any other Antitrust Laws, and obtain all other required consents, authorizations, orders and approvals from Governmental Bodies, as promptly as practicable. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;If any objections are asserted with respect to the Contemplated Transactions by any Governmental Body, including under the HSR Act, as applicable, or any other applicable Law (including applicable Antitrust Laws), or if any action is instituted or threatened by any Governmental Body or any private party challenging the transaction as violative of the HSR Act, as applicable, or any other applicable Law (including applicable Antitrust Laws), the Parties shall, and shall cause their respective Affiliates to, take any and all actions to resolve such objections as promptly as practicable and in any event prior to the End Date. The Company and Parent shall oppose, fully and vigorously, </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-49</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="t5SM">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(A)&#160;any administrative or judicial action or proceeding that is initiated or threatened to be initiated challenging this Agreement or the consummation of the Contemplated Transactions and (B)&#160;any request for, the entry of, and seek to have vacated or terminated, any order that could restrain, prevent or delay the consummation of the transaction, including in the case of either (A)&#160;or (B)&#160;by defending through litigation any action asserted by any Person in any court or before any Governmental Body as may be required (x)&#160;by the applicable Governmental Body in order to resolve such objections as such Governmental Body may have to such transactions under the HSR Act, as applicable, or any other applicable Law (including any other applicable Antitrust Law) or (y)&#160;by any domestic or foreign court or other tribunal, in any action challenging the transaction as violative of the HSR Act, as applicable, or any other applicable Law (including other applicable Antitrust Law), in order to avoid the entry of, or to effect the dissolution, vacating, lifting, altering or reversal of, any order that has the effect of restricting, preventing or prohibiting the consummation of the transaction. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(e)&nbsp;&nbsp;&nbsp;Subject to applicable Law relating to the sharing of information, each Party shall (i)&#160;furnish the other Party with copies of all documents (except documents or portions thereof for which confidential treatment has been requested or given, which the Party may limit to sharing only with the external legal counsel of the other Party) and correspondence (A)&#160;prepared by or on behalf of such Party for any Governmental Body and affording the other Party the opportunity to comment and participate in responding, where appropriate; or (B)&#160;received by or on behalf of such Party from any Governmental Body, in each case in connection with the consents, authorizations, orders or approvals contemplated by this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.2</font><font style="letter-spacing:0.2pt;"> and (ii)&#160;use reasonable best efforts to consult with and keep the other Party informed as to the status of such matters. Further, no Party shall, nor shall it permit any of its Representatives to, meet or engage in substantive conversations with any Governmental Body or representative of such Governmental Body in connection with obtaining any such consent, authorization, order and approval unless it consults with the other Party in advance and, to the extent not precluded by applicable Law, offers the other Party the opportunity to participate in such meeting or conversation. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">5.3&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Company Stockholder Matters</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;Promptly after the Registration Statement shall have been declared effective under the Securities Act, the Company shall prepare, with the cooperation of Parent, and cause to be mailed to its stockholders an information statement, which shall include a copy of the Proxy Statement/Prospectus, and the Company Stockholder Written Consent, in order to solicit the approval of the Company&#8217;s stockholders, including the Company&#8217;s stockholders sufficient for the Required Company Stockholder Vote in lieu of a meeting pursuant to Section&#160;228 of the DGCL, for purposes of (i)&#160;adopting and approving this Agreement and the Contemplated Transactions, (ii)&#160;acknowledging that the approval given thereby is irrevocable and that such stockholder is aware of its rights to demand appraisal for its shares pursuant to Section&#160;262 of the DGCL, a true and correct copy of which will be attached thereto, and that such stockholder has received and read a copy of Section&#160;262 of the DGCL and (iii)&#160;acknowledging that by its approval of the Merger it is not entitled to appraisal rights with respect to its shares in connection with the Merger and thereby waives any rights to receive payment of the fair value of its capital stock under the DGCL (collectively, the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company Stockholder Matters</font><font style="letter-spacing:0.2pt;">&#8221;). Promptly following receipt of the duly executed Company Stockholder Written Consent from the stockholders representing the Required Company Stockholder Vote, the Company shall deliver a copy of the duly executed Company Stockholder Written Consent to Parent. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;The Company agrees that, subject to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.3(c)</font><font style="letter-spacing:0.2pt;">: (i)&#160;the Company Board shall recommend that the Company&#8217;s stockholders vote to approve the Company Stockholder Matters and shall use its reasonable best efforts to solicit such approval from each of the Company stockholders necessary to deliver the Company Stockholder Written Consent evidencing the Required Company Stockholder Vote within the time set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.3(a)</font><font style="letter-spacing:0.2pt;"> (the recommendation of the Company Board that the Company&#8217;s stockholders vote to adopt and approve this Agreement being referred to as the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company Board Recommendation</font><font style="letter-spacing:0.2pt;">&#8221;); and (ii)&#160;the Company Board Recommendation shall not be withdrawn or modified (and the Company Board shall not publicly propose to withdraw or modify the Company Board Recommendation) in a manner adverse to Parent, and no resolution by the Company Board or any committee thereof to withdraw or modify the Company Board Recommendation in a manner adverse to Parent or to adopt, approve or recommend (or publicly propose to adopt, approve or recommend) </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-50</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="t5SM1">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">any Acquisition Proposal shall be adopted or proposed (the actions set forth in the foregoing clause (ii), collectively, a &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company Board Adverse Recommendation Change</font><font style="letter-spacing:0.2pt;">&#8221;). </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;Notwithstanding anything to the contrary contained in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.3(b)</font><font style="letter-spacing:0.2pt;"> and subject to compliance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;4.5</font><font style="letter-spacing:0.2pt;">, if at any time prior to the approval and adoption of this Agreement by the Required Company Stockholder Vote, the Company receives a bona fide written Superior Offer, the Company Board may make a Company Board Adverse Recommendation Change, if, but only if, following the receipt of and on account of such Superior Offer, (i)&#160;the Company Board determines in good faith, based on the advice of its outside legal counsel, that the failure to withhold, amend, withdraw or modify the Company Board Recommendation would constitute a violation of the Company Board&#8217;s fiduciary duties under applicable Law; (ii)&#160;the Company has, and has caused its financial advisors and outside legal counsel to, during the Notice Period (as defined below), negotiate with Parent in good faith to make such adjustments to the terms and conditions of this Agreement so that such Acquisition Proposal ceases to constitute a Superior Offer and (iii)&#160;if after Parent shall have delivered to the Company a written offer to alter the terms or conditions of this Agreement during the Notice Period, the Company Board shall have determined in good faith, based on the advice of its outside legal counsel, that the failure to withhold, amend, withdraw or modify the Company Board Recommendation would constitute a violation of the Company Board&#8217;s fiduciary duties under applicable Law (after taking into account such alterations of the terms and conditions of this Agreement); </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;"> that (x)&#160;Parent receives written notice from the Company confirming that the Company Board has determined to change its recommendation at least four Business Days in advance of the Company Board Adverse Recommendation Change (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Notice Period</font><font style="letter-spacing:0.2pt;">&#8221;), which notice shall include a description in reasonable detail of the reasons for such Company Board Adverse Recommendation Change, and written copies of any relevant transaction agreements with any party making a potential Superior Offer, (y)&#160;during any Notice Period, Parent shall be entitled to deliver to the Company one or more counterproposals to such Acquisition Proposal and the Company will, and cause its Representatives to, negotiate with Parent in good faith (to the extent Parent desires to negotiate) to make such adjustments in the terms and conditions of this Agreement so that the applicable Acquisition Proposal ceases to constitute a Superior Offer, and (z)&#160;in the event of any material amendment to any Superior Offer (including any revision in the amount, form or mix of consideration the Company&#8217;s stockholders would receive as a result of such potential Superior Offer), the Company shall be required to provide Parent with notice of such material amendment and the Notice Period shall be extended, if applicable, to ensure that at least two Business Days remain in the Notice Period following such notification during which the parties shall comply again with the requirements of this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.3(c)</font><font style="letter-spacing:0.2pt;"> and the Company Board shall not make a Company Board Adverse Recommendation Change prior to the end of such Notice Period as so extended (it being understood that there may be multiple extensions). </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;The Company&#8217;s obligation to solicit the consent of its stockholders to sign the Company Stockholder Written Consent in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.3(a)</font><font style="letter-spacing:0.2pt;"> and </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.3(b)</font><font style="letter-spacing:0.2pt;"> shall not be limited or otherwise affected by the commencement, disclosure, announcement or submission of any Superior Offer or other Acquisition Proposal or by any withdrawal or modification of the Company Board Recommendation. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">5.4&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Parent Stockholders&#8217; Meeting</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;Promptly after the Registration Statement has been declared effective by the SEC under the Securities Act, Parent shall take all action necessary under applicable Law to call, give notice of and hold a meeting of the holders of Parent Common Stock for the purpose of seeking approval of this Agreement and the Contemplated Transactions, including: </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(i)&nbsp;&nbsp;&nbsp;the amendment of Parent&#8217;s certificate of incorporation to effect the Nasdaq Reverse Split; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(ii)&nbsp;&nbsp;&nbsp;the issuance of shares of Parent Common Stock to the Company&#8217;s stockholders in connection with the Contemplated Transactions pursuant to the terms of this Agreement; </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-51</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:40pt; text-indent:20pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(iii)&nbsp;&nbsp;&nbsp;the change of control of Parent resulting from the Merger pursuant to Nasdaq rules (the matters contemplated by </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Sections&#160;5.4(a)(i)</font><font style="letter-spacing:0.2pt;"> through </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">5.4(a)(iii)</font><font style="letter-spacing:0.2pt;"> are referred to as the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent Stockholder Matters,</font><font style="letter-spacing:0.2pt;">&#8221; and such meeting, the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent Stockholders&#8217; Meeting</font><font style="letter-spacing:0.2pt;">&#8221;); and </font>
        </div>
        <div style="margin-left:60pt; margin-top:8pt; width:396pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(iv)&nbsp;&nbsp;&nbsp;the approval of the Equity Plan&#160;Amendments. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;The Parent Stockholders&#8217; Meeting shall be held as promptly as practicable after the Registration Statement is declared effective under the Securities Act, and in any event no later than 45&#160;days after the effective date of the Registration Statement. Parent shall take reasonable measures to ensure that all proxies solicited in connection with the Parent Stockholders&#8217; Meeting are solicited in compliance with all applicable Law. Notwithstanding anything to the contrary contained herein, if on the date of the Parent Stockholders&#8217; Meeting, or a date preceding the date on which the Parent Stockholders&#8217; Meeting is scheduled, Parent reasonably believes that (i)&#160;it will not receive proxies sufficient to obtain the Required Parent Stockholder Vote, whether or not a quorum would be present or (ii)&#160;it will not have sufficient shares of Parent Common Stock represented (whether in person or by proxy) to constitute a quorum necessary to conduct the business of the Parent Stockholders&#8217; Meeting, Parent may (and at the Company&#8217;s request, Parent shall) postpone or adjourn, or make one or more successive postponements or adjournments of, the Parent Stockholders&#8217; Meeting as long as the date of the Parent Stockholders&#8217; Meeting is not postponed or adjourned more than an aggregate of 30 calendar days in connection with any postponements or adjournments in reliance on the preceding sentence. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;Parent agrees that, subject to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.4(d)</font><font style="letter-spacing:0.2pt;">: (i)&#160;the Parent Board shall recommend that the holders of Parent Common Stock vote to approve the Parent Stockholder Matters and shall use its reasonable best efforts to solicit such approval within the timeframe set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.4(b)</font><font style="letter-spacing:0.2pt;">; (ii)&#160;the Proxy Statement/Prospectus shall include a statement to the effect that the Parent Board recommends that the holders of Parent Common Stock vote to approve the Parent Stockholder Matters (the recommendation of the Parent Board with respect to the Parent Stockholder Matters being referred to as the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent Board Recommendation</font><font style="letter-spacing:0.2pt;">&#8221;); and (iii)&#160;the Parent Board Recommendation shall not be withheld, amended, withdrawn or modified (and the Parent Board shall not publicly propose to withhold, amend, withdraw or modify the Parent Board Recommendation) in a manner adverse to the Company, and no resolution by the Parent Board or any committee thereof to withdraw of modify the Parent Board Recommendation in a manner adverse to the Company or to adopt, approve or recommend (or publicly propose to adopt, approve or recommend) any Acquisition Proposal shall be adopted or proposed (the actions set forth in the foregoing clause (iii), collectively, a &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent Board Adverse Recommendation Change</font><font style="letter-spacing:0.2pt;">&#8221;). </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;Notwithstanding anything to the contrary contained in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.4(c)</font><font style="letter-spacing:0.2pt;"> and subject to compliance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;4.4</font><font style="letter-spacing:0.2pt;">, if at any time prior to the approval of Parent Stockholder Matters by the Required Parent Stockholder Vote, Parent receives a bona fide written Superior Offer, the Parent Board may make a Parent Board Adverse Recommendation Change, if, but only if, following the receipt of and on account of such Superior Offer, (i)&#160;the Parent Board determines in good faith, based on the advice of its outside legal counsel, that the failure to withhold, amend, withdraw or modify the Parent Board Recommendation would constitute a violation of the Parent Board&#8217;s fiduciary duties under applicable Law; (ii)&#160;Parent has, and has caused its financial advisors and outside legal counsel to, during the Notice Period, negotiate with the Company in good faith to make such adjustments to the terms and conditions of this Agreement so that such Acquisition Proposal ceases to constitute a Superior Offer and (iii)&#160;if after the Company shall have delivered to Parent a written offer to alter the terms or conditions of this Agreement during the Notice Period, the Parent Board shall have determined in good faith, based on the advice of its outside legal counsel, that the failure to withhold, amend, withdraw or modify the Parent Board Recommendation would constitute a violation of the Parent Board&#8217;s fiduciary duties under applicable Law (after taking into account such alterations of the terms and conditions of this Agreement); </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, that (x)&#160;the Company receives written notice from Parent confirming that the Parent Board has determined to change its recommendation during the Notice Period, which notice shall include a description in reasonable detail of the reasons for such Parent Board Adverse Recommendation Change, and written copies of any relevant transaction with any party making a potential Superior Offer, (y)&#160;during any Notice Period, the Company shall be entitled to deliver to Parent one or more counterproposals to such Acquisition Proposal and Parent will, and will cause </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-52</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="t5OCC">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">its Representatives to, negotiate with the Company in good faith (to the extent the Company desires to negotiate) to make such adjustments in the terms and conditions of this Agreement so that the applicable Acquisition Proposal ceases to constitute a Superior Offer, and (z)&#160;in the event of any material amendment to any Superior Offer (including any revision in the amount, form or mix of consideration the Parent&#8217;s stockholders would receive as a result of such potential Superior Offer), Parent shall be required to provide the Company with notice of such material amendment and the Notice Period shall be extended, if applicable, to ensure that at least two Business Days remain in the Notice Period following such notification during which the parties shall comply again with the requirements of this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.4(d)</font><font style="letter-spacing:0.2pt;"> and the Parent Board shall not make a Parent Board Adverse Recommendation Change prior to the end of such Notice Period so extended (it being understood that there may be multiple extensions). </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(e)&nbsp;&nbsp;&nbsp;Parent&#8217;s obligation to solicit the consent of its stockholders to approve the Parent Stockholder Matters shall not be limited or otherwise affected by the commencement, disclosure, announcement or submission of any Superior Offer or other Acquisition Proposal or by any withdrawal or modification of the Parent Board Recommendation. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(f)&nbsp;&nbsp;&nbsp;Nothing contained in this Agreement shall prohibit Parent or the Parent Board from (i)&#160;complying with Rules 14d-9 and 14e-2(a) under the Exchange Act, (ii)&#160;issuing a &#8220;stop, look and listen&#8221; communication or similar communication of the type contemplated by Rule&#160;14d-9(f) under the Exchange Act or (iii)&#160;otherwise making any disclosure to Parent&#8217;s stockholders if, in the case of the foregoing clause (iii), the Parent Board determines in good faith, after consultation with its outside legal counsel, that failure to make such disclosure would be inconsistent with applicable Law, including its fiduciary duties under applicable Law; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, that in no event shall Parent or the Parent Board make a Parent Board Adverse Recommendation Change except in accordance with the provisions of </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.4(d)</font><font style="letter-spacing:0.2pt;"> above. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">5.5</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Company Options, Company Convertible Note, Parent Warrants, and Parent Equity Awards</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;Subject to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.5(d)</font><font style="letter-spacing:0.2pt;">, at the Effective Time, each Company Option that is outstanding and unexercised immediately prior to the Effective Time under the Company Plan and that, following assumption by Parent at the Effective Time, will be eligible to be registered on Form S-8, whether or not vested, shall be converted into and become an option to purchase Parent Common Stock, and Parent shall assume the Company Plan and each such Company Option in accordance with the terms (as in effect as of the date of this Agreement) of the Company Plan and the terms of the stock option agreement by which such Company Option is evidenced (but with changes to such documents as Parent and the Company mutually agree are appropriate to reflect the substitution of the Company Options for an option to purchase shares of Parent Common Stock). All other Company Options that are outstanding and unexercised as of immediately prior to the Effective Time shall be canceled immediately prior to the Effective Time. All rights with respect to Company Common Stock subject to Company Options assumed by Parent shall thereupon be converted into rights with respect to Parent Common Stock. Accordingly, from and after the Effective Time: (i)&#160;each Company Option assumed by Parent may be exercised solely for shares of Parent Common Stock; (ii)&#160;the number of shares of Parent Common Stock subject to each Company Option assumed by Parent shall be determined by multiplying (A)&#160;the number of shares of Company Common Stock that were subject to such Company Option, as in effect immediately prior to the Effective Time, by (B)&#160;the Exchange Ratio, and rounding the resulting number down to the nearest whole number of shares of Parent Common Stock; (iii)&#160;the per share exercise price for the Parent Common Stock issuable upon the exercise of each Company Option assumed by Parent shall be determined by dividing (A)&#160;the per share exercise price of Company Common Stock subject to such Company Option, as in effect immediately prior to the Effective Time, by (B)&#160;the Exchange Ratio and rounding the resulting exercise price up to the nearest whole cent; and (iv)&#160;any restriction on the exercise of any Company Option assumed by Parent shall continue in full force and effect and the term, exercisability, vesting schedule and other provisions of such Company Option shall otherwise remain unchanged; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided, however</font><font style="letter-spacing:0.2pt;">, that: (x)&#160;to the extent provided under the terms of a Company Option and the Company Plan, such Company Option may be further adjusted as necessary to reflect Parent&#8217;s substitution of the Company Options with options to purchase Parent Common Stock (such as by making any change in control or similar definition relate to Parent and having any provision that </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-53</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="t5OOA">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">provides for the adjustment of Company Options upon the occurrence of certain corporate events relate to corporate events that relate to Parent and/or Parent Common Stock); and (y)&#160;the Parent Board or a committee thereof shall succeed to the authority and responsibility of the Company Board or any committee thereof with respect to each Company Option assumed by Parent. Notwithstanding anything to the contrary in this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.5(a)</font><font style="letter-spacing:0.2pt;">, the conversion of each Company Option (regardless of whether such option qualifies as an &#8220;incentive stock option&#8221; within the meaning of Section&#160;422 of the Code) into an option to purchase shares of Parent Common Stock shall be made in a manner consistent with Treasury Regulation&#160;Section&#160;1.424-1, such that the conversion of a Company Option shall not constitute a &#8220;modification&#8221; of such Company Option for purposes of Section&#160;409A or Section&#160;424 of the Code. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;Parent shall file with the SEC, promptly after the Effective Time, a registration statement on Form S-8 (or any successor or alternative form), relating to the shares of Parent Common Stock issuable with respect to Company Options assumed by Parent in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.5(a)</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;Subject to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.5(d)</font><font style="letter-spacing:0.2pt;">, as of immediately after the Effective Time, the Company Convertible Note shall convert into shares of Parent Common Stock in accordance with the Convertible Note Conversion Agreement, as amended or supplemented. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;Prior to the Effective Time, the Company shall take all actions that may be necessary (under the Company Plan and otherwise) to effectuate the provisions of </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.5(a)</font><font style="letter-spacing:0.2pt;"> and </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.5(c)</font><font style="letter-spacing:0.2pt;"> and to ensure that, from and after the Effective Time, holders of Company Options and the Company Convertible Note have no rights with respect thereto other than those specifically provided in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.5</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(e)&nbsp;&nbsp;&nbsp;Prior to the Closing, Parent shall notify the holders of the Parent Warrants of the Contemplated Transactions in accordance with the terms of the applicable Parent Warrants and, at the Effective Time, each Parent Warrant that is outstanding and unexercised immediately prior to the Effective Time, shall survive the Closing and remain outstanding in accordance with its terms. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(f)&nbsp;&nbsp;&nbsp;Prior to the Effective Time, the Parent Board shall have the right, in its sole discretion, to adopt appropriate resolutions and take all other actions necessary and appropriate to provide that each Parent RSU and/or each Parent Option, to the extent unvested immediately prior to the Effective Time, be accelerated in full effective as of immediately prior to the Effective Time. At the Effective Time, each Parent RSU and/or each Parent Option that is outstanding and unexercised immediately prior to the Effective Time, whether or not vested, shall survive the Closing and remain outstanding in accordance with its terms. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">5.6&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Indemnification of Officers and Directors</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;From the Effective Time through the sixth anniversary of the date on which the Effective Time occurs, each of Parent and the Surviving Corporation shall, jointly and severally, indemnify and hold harmless each person who is now, or has been at any time prior to the date hereof, or who becomes prior to the Effective Time, a director, officer, fiduciary or agent of Parent or the Company and their respective Subsidiaries, respectively (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">D&amp;O Indemnified Parties</font><font style="letter-spacing:0.2pt;">&#8221;), against all claims, judgments, fines and reasonable fees, costs and expenses, including attorneys&#8217; fees and disbursements and investigation costs, incurred in connection with any claim, action, suit, proceeding or investigation, whether civil, criminal, administrative or investigative, or any other actual, threatened or completed proceeding arising out of or pertaining to the fact that the D&amp;O Indemnified Party is or was a director, officer, fiduciary or agent of Parent or of the Company or their respective Subsidiaries, whether asserted or claimed prior to, at or after the Effective Time, in each case, to the fullest extent permitted under applicable Law. Each D&amp;O Indemnified Party will be entitled to advancement of expenses incurred in the defense of any such claim, action, suit, proceeding or investigation from each of Parent and the Surviving Corporation, jointly and severally, upon receipt by Parent or the Surviving Corporation from the D&amp;O Indemnified Party of a request therefor; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, that any such person to whom expenses are advanced provides an undertaking to Parent, to the extent then required by the DGCL, to repay such advances if it is ultimately determined that such person is not entitled to indemnification. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-54</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; text-indent:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;The provisions of Parent&#8217;s Organizational Documents with respect to indemnification, advancement of expenses and exculpation of present and former directors and officers of Parent that are presently set forth in the certificate of incorporation and bylaws of Parent shall not be amended, modified or repealed for a period of six&#160;years from the Effective Time in a manner that would adversely affect the rights thereunder of individuals who, at or prior to the Effective Time, were officers or directors of Parent, unless such modification is required by applicable Law. The certificate of incorporation and bylaws of the Surviving Corporation shall contain, and Parent shall cause the certificate of incorporation and bylaws of the Surviving Corporation to so contain, provisions no less favorable with respect to indemnification, advancement of expenses and exculpation of present and former directors and officers as those presently set forth in the certificate of incorporation and bylaws of the Company. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;From and after the Effective Time, (i)&#160;the Surviving Corporation shall fulfill and honor, and Parent shall cause the Surviving Corporation to fulfill and honor, in all respects the obligations of the Company to its D&amp;O Indemnified Parties as of immediately prior to the Closing pursuant to any indemnification provisions under the Company&#8217;s Organizational Documents and pursuant to any indemnification agreements between the Company and such D&amp;O Indemnified Parties, with respect to claims arising out of matters occurring at or prior to the Effective Time and (ii)&#160;Parent shall fulfill and honor in all respects the obligations of Parent to its D&amp;O Indemnified Parties as of immediately prior to the Closing pursuant to any indemnification provisions under Parent&#8217;s Organizational Documents and pursuant to any indemnification agreements between Parent and such D&amp;O Indemnified Parties, with respect to claims arising out of matters occurring at or prior to the Effective Time. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;From and after the Effective Time, Parent shall maintain directors&#8217; and officers&#8217; liability insurance policies, with an effective date as of the Closing Date, on commercially available terms and conditions and with coverage limits customary for U.S. public companies similarly situated to Parent. In addition, prior to the Effective Time, Parent shall purchase a six-year prepaid &#8220;tail policy&#8221; through Parent&#8217;s recognized broker of record for the non-cancellable extension of the directors&#8217; and officers&#8217; liability coverage of Parent&#8217;s existing directors&#8217; and officers&#8217; insurance policies for a claims reporting or discovery period of at least six&#160;years from and after the Effective Time with respect to any claim related to any period of time at or prior to the Effective Time with terms, conditions, and retentions that are no less favorable than the coverage provided under Parent&#8217;s existing policies as of the date of this Agreement and with limits of liability no less than $20,000,000, in each case with respect to any actual or alleged error, misstatement, misleading statement, act, omission, neglect, breach of duty or any matter claimed against a director or officer of Parent by reason of him or her serving in such capacity that existed or occurred at or prior to the Effective Time (including in connection with this Agreement or the Contemplated Transactions) (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">D&amp;O Tail Policy</font><font style="letter-spacing:0.2pt;">&#8221;). For clarity, the cost of any such D&amp;O Tail Policy, to the extent unpaid as of the Effective Time, shall reduce the amount of Net Cash. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(e)&nbsp;&nbsp;&nbsp;From and after the Effective Time, Parent shall pay all expenses, including reasonable attorneys&#8217; fees, that are incurred by the persons referred to in this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.6</font><font style="letter-spacing:0.2pt;"> in connection with their successful enforcement of the rights provided to such persons in this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.6</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(f)&nbsp;&nbsp;&nbsp;The provisions of this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.6</font><font style="letter-spacing:0.2pt;"> are intended to be in addition to the rights otherwise available to the current and former officers and directors of Parent and the Company by Law, charter, statute, bylaw or agreement, and shall operate for the benefit of, and shall be enforceable by, each of the D&amp;O Indemnified Parties, their heirs and their Representatives. The obligations set forth in this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.6</font><font style="letter-spacing:0.2pt;"> shall not be terminated, amended or otherwise modified in any manner that adversely affects any D&amp;O Indemnified Party (and their heirs and Representatives) without the prior written consent of such affected D&amp;O Indemnified Party (or their heirs and Representatives), </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(g)&nbsp;&nbsp;&nbsp;In the event Parent or the Surviving Corporation or any of their respective successors or assigns (i)&#160;consolidates with or merges into any other Person and shall not be the continuing or surviving corporation or entity of such consolidation or merger, or (ii)&#160;transfers all or substantially all of its properties and assets to any Person, then, and in each such case, proper provision shall be made so that the successors and assigns of Parent or the Surviving Corporation, as the case may be, shall succeed to the obligations set forth in this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.6</font><font style="letter-spacing:0.2pt;">. Parent shall cause the Surviving Corporation to perform all of the obligations of the Surviving Corporation under this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.6</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-55</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="t5AIA">&#8203;</a><a name="t5TIP">&#8203;</a><a name="t5DTP">&#8203;</a><a name="t51MA">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">5.7&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Additional Agreements</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;In addition to each Party&#8217;s obligations in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.2</font><font style="letter-spacing:0.2pt;">, the Parties shall use commercially reasonable efforts to cause to be taken all actions necessary to consummate the Contemplated Transactions. Without limiting the generality of the foregoing, each Party: (a)&#160;shall make all filings and other submissions (if any) and give all notices (if any) required to be made and given by such Party in connection with the Contemplated Transactions; (b)&#160;shall use commercially reasonable efforts to obtain each Consent (if any) reasonably required to be obtained by such Party in connection with the Contemplated Transactions pursuant to any applicable Law or any Contracts set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Schedule&#160;5.7</font><font style="letter-spacing:0.2pt;">; (c)&#160;shall use reasonable best efforts to lift any injunction prohibiting, or any other legal bar to, the Contemplated Transactions; (d)&#160;in the case of Parent, commercially reasonable efforts to resolve the matters set forth on </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Schedule&#160;N</font><font style="letter-spacing:0.2pt;">, either without any Material Continuing Obligation, except for obligations which would reduce Net Cash pursuant to the definition thereof; and (e)&#160;shall use commercially reasonable efforts to satisfy the conditions precedent to the consummation of this Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">5.8&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Disclosure</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The initial press release relating to this Agreement shall be a joint press release issued by, and mutually acceptable to, the Company and Parent and thereafter Parent and the Company shall obtain the consent of the other before issuing any further press release(s) or otherwise making any public statement or making any announcement to Parent Associates or Company Associates (to the extent not previously issued or made in accordance with this Agreement) with respect to the Contemplated Transactions and shall not issue any such press release, public statement or announcement to Parent Associates or Company Associates without the other Party&#8217;s prior written consent (which shall not be unreasonably withheld, conditioned or delayed). Notwithstanding the foregoing: (a)&#160;each Party may, without such consultation or consent, make any public statement in response to questions from the press, analysts, investors or those attending industry conferences, make internal announcements to employees and make disclosures in Parent SEC Documents, so long as such statements are consistent with previous press releases, public disclosures or public statements made jointly by the Parties (or individually, if approved by the other Party); (b)&#160;a Party may, without the prior consent of the other Party hereto but subject to giving advance notice to the other Party, issue any such press release or make any such public announcement or statement such Party has determined in good faith, upon the advice of outside legal counsel, is required by applicable Law; and (c)&#160;a Party need not consult with the any other Party in connection with such portion of any press release, public statement or filing to be issued or made pursuant to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.4(e)</font><font style="letter-spacing:0.2pt;"> or with respect to any Acquisition Proposal, Parent Board Adverse Recommendation Change or Company Board Adverse Recommendation Change, as applicable, or with respect to Parent only, pursuant to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.4(f)</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">5.9&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Listing</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;During the Pre-Closing Period, Parent shall use its commercially reasonable efforts: (a)&#160;to maintain its existing listing on Nasdaq and to obtain approval of the listing of the combined corporation on Nasdaq; (b)&#160;to the extent required by the rules and regulations of Nasdaq, to prepare and submit to Nasdaq a notification form for the listing of the shares of Parent Common Stock to be issued in connection with the Contemplated Transactions; (c)&#160;to prepare and timely submit to Nasdaq a notification form of the Nasdaq Reverse Split and to submit a copy of the amendment to Parent&#8217;s certificate of incorporation to effect the Nasdaq Reverse Split certified by the Secretary of State of the State of Delaware to Nasdaq on the Closing Date; (d)&#160;to the extent required by Nasdaq Listing Rule&#160;5110, to file an initial listing application for the Parent Common Stock on Nasdaq (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Nasdaq Listing Application</font><font style="letter-spacing:0.2pt;">&#8221;) and to cause such Nasdaq Listing Application to be approved; and (e)&#160;in the event of receipt of a Nasdaq delisting determination, Parent will request a hearing to appeal the delisting determination and will pay the appropriate fee to Nasdaq to appeal the delisting determination. Prior to the Effective Time, each Party will promptly inform the other Party of all verbal or written communications between Nasdaq and such Party or its Representatives. The Parties will use commercially reasonable efforts to coordinate with respect to compliance with Nasdaq rules and regulations. The Company will cooperate with Parent as reasonably requested by Parent with respect to the Nasdaq Listing Application and promptly furnish to Parent all information concerning the Company and its stockholders that may be required or reasonably requested in connection with any action contemplated by this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.9</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">5.10&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Tax Matters</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;For U.S. federal income Tax purposes, (i)&#160;the Parties intend that (A)&#160;the Merger qualify as a &#8220;reorganization&#8221; within the meaning of Section&#160;368(a) of the Code, and (B)&#160;the Nasdaq Reverse Split qualify as a &#8220;recapitalization&#8221; within the meaning of Section&#160;368(a)(1)(e) of the Code (collectively, the </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-56</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="t5PSB">&#8203;</a><a name="t5AOP">&#8203;</a><a name="t5OCA">&#8203;</a><a name="t51MP">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Intended Tax Treatment</font><font style="letter-spacing:0.2pt;">&#8221;), and (ii)&#160;this Agreement is intended to be, and is hereby adopted as, a &#8220;plan of reorganization&#8221; for purposes of Section&#160;354 and 361 of the Code and Treasury Regulations&#160;Section&#160;1.368-2(g) and 1.368-3(a), to which Parent, Merger Sub and the Company are parties under Section&#160;368(b) of the Code. The Parties shall treat and shall not take any tax reporting position inconsistent with the Intended Tax Treatment, unless otherwise required pursuant to a &#8220;determination&#8221; within the meaning of Section&#160;1313(a) of the Code. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;The Parties acknowledge and agree that each has relied upon the advice of its own tax advisors in connection with the Merger and the Contemplated Transactions and that none of the Company, on the one hand, and Parent and Merger Sub, on the other hand, makes any representation or warranty as to the Intended Tax Treatment, other than the representations and warranties contained in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Sections&#160;2.16(h)</font><font style="letter-spacing:0.2pt;"> and </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">3.16(h)</font><font style="letter-spacing:0.2pt;">, respectively. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;The Parties shall use their respective commercially reasonable efforts to cause the Merger to qualify, and will not take any action or cause or permit any action to be taken which action would reasonably be expected to prevent the Merger from qualifying, for the Intended Tax Treatment. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;Parent shall prepare and file, or cause to be prepared and filed, any IRS Forms 8937 that are required to be filed in connection with the Contemplated Transactions. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(e)&nbsp;&nbsp;&nbsp;In the event that the SEC requests or requires a tax opinion in connection with the Contemplated Transactions, each of Parent and the Company shall use its commercially reasonable efforts to deliver a &#8220;Tax Representation Letter,&#8221; signed by an officer of Parent and/or the Company, as applicable, containing customary representations of Parent and Merger Sub or Company, as applicable, in each case, as shall be reasonably necessary or appropriate to enable legal counsel to provide an opinion relating to the Contemplated Transactions. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">5.11&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Legends</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Parent shall be entitled to place appropriate legends on the book entries evidencing any shares of Parent Common Stock to be received in the Merger by equityholders of the Company who may be considered &#8220;affiliates&#8221; of Parent for purposes of Rules 144 and 145 under the Securities Act reflecting the restrictions set forth in Rules 144 and 145 and to issue appropriate stop transfer instructions to the transfer agent for Parent Common Stock. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">5.12&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Directors and Officers</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Parent shall cause, effective as of the Effective Time, the Parent Board to be composed of seven members, to serve in the respective director class set forth opposite such member&#8217;s name on </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Schedule&#160;5.12</font><font style="letter-spacing:0.2pt;">, which shall consist of (a)&#160;one such member designated by Parent as set forth on </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Schedule&#160;5.12</font><font style="letter-spacing:0.2pt;"> under the heading &#8220;Directors&#8221; &#8203;(the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent Designee</font><font style="letter-spacing:0.2pt;">&#8221;), and (b)&#160;six such members designated by the Company as set forth on </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Schedule&#160;5.12</font><font style="letter-spacing:0.2pt;"> under the heading &#8220;Directors&#8221; &#8203;(the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company Designees</font><font style="letter-spacing:0.2pt;">&#8221;). Furthermore, the Parties shall take all necessary action so that the Persons listed in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Schedule&#160;5.12</font><font style="letter-spacing:0.2pt;"> under the headings &#8220;Officers&#8221; or &#8220;Directors&#8221;, as applicable, are elected or appointed, as applicable, to the positions of officers or directors of Parent and the Surviving Corporation, as set forth therein, to serve in such positions effective as of the Effective Time until the earlier of their resignation or removal or until their respective successors are duly elected or appointed and qualified, as the case may be. If any Person named in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Schedule&#160;5.12</font><font style="letter-spacing:0.2pt;"> as a director is unable or unwilling to serve as a director of Parent after the Effective Time, as set forth therein, the Party appointing such Person shall designate a successor. Other than with respect to the Parent Designee, prior to the Closing, Parent shall deliver to the Company written resignations, in a form reasonably satisfactory to the Company, of each pre-Closing member of the Parent Board. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">5.13&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Termination of Certain Agreements and Rights</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Company shall cause the Investor Agreements (excluding the Company Stockholder Support Agreements and the Company Lock-Up Agreements) to be terminated, contingent upon, and to take effect as of immediately prior to, the Effective Time, without any liability being imposed on the part of Parent or the Surviving Corporation. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">5.14&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Section&#160;16 Matters</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Prior to the Effective Time, Parent shall take all such steps as may be required to cause any acquisitions of Parent Common Stock (including derivative securities with respect to Parent Common Stock) in connection with the Contemplated Transactions, by each individual who is or is reasonably expected to become, subject to the reporting requirements of Section&#160;16(a) of the Exchange Act with respect to Parent, to be exempt under Rule&#160;16b-3 under the Exchange Act. At least 30 calendar days prior to the Closing Date, the Company shall furnish the following information to Parent for each </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-57</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="t5EPS">&#8203;</a><a name="t51CE">&#8203;</a><a name="t5FST">&#8203;</a><a name="t5SIA">&#8203;</a><a name="t5LEP">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">individual who, immediately after the Effective Time, will become subject to the reporting requirements of Section&#160;16(a) of the Exchange Act with respect to Parent: (a)&#160;the number of shares of Company Capital Stock owned by such individual and expected to be exchanged for shares of Parent Common Stock pursuant to the Merger; and (b)&#160;the number of other derivative securities (if any) with respect to Company Capital Stock owned by such individual and expected to be converted into shares of Parent Common Stock, restricted stock awards to acquire Parent Common Stock or derivative securities with respect to Parent Common Stock in connection with the Merger. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">5.15&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Cooperation</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Each Party shall cooperate reasonably with the other Party and shall provide the other Party with such assistance as may be reasonably requested for the purpose of facilitating the performance by each Party of its respective obligations under this Agreement and to enable the combined entity to continue to meet its obligations following the Effective Time. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">5.16&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Allocation Certificates</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;The Company will prepare and deliver to Parent at least two Business Days prior to the Closing Date a certificate signed by the Chief Executive Officer or Chief Financial Officer of the Company setting forth, as of immediately prior to the Effective Time, after giving effect to the Pre-Closing Financing: (i)&#160;each holder of Company Capital Stock and Company Options; (ii)&#160;such holder&#8217;s name and address; (iii)&#160;the number and type of Company Capital Stock held and/or underlying the Company Options as of immediately prior to the Effective Time for each such holder and the per share exercise price of each Company Option; and (iv)&#160;the number of shares of Parent Common Stock to be issued to such holder, or to underlie any Parent Option to be issued to such holder, pursuant to this Agreement in respect of the Company Capital Stock or Company Options held by such holder as of immediately prior to the Effective Time (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Allocation Certificate</font><font style="letter-spacing:0.2pt;">&#8221;). </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;Parent will prepare and deliver to the Company at least two Business Days prior to the Closing Date a certificate signed by the Chief Executive Officer or Chief Financial Officer of Parent, setting forth (as of immediately prior to the Effective Time), the number of Parent Outstanding Shares and each component thereof (broken down by outstanding shares of Parent Common Stock, Parent Options, Parent RSUs and Parent Warrants). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">5.17&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Company Financial Statements</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Company will furnish to Parent Company Financial Statements required to be included in the Registration Statement prior to the initial filing of such Registration Statement and in no event later than 15 calendar days after the date hereof; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;"> that, for clarity, the final, signed audit opinion with respect to such Company Financial Statements shall not be provided until the date of filing of the Registration Statement. The Company shall also furnish to Parent unaudited interim financial statements for each interim period completed prior to Closing required to be included in the Registration Statement prior to the initial filing of such Registration Statement and in no event later than 15 calendar days after the date hereof. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">5.18&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Takeover Statutes</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;If any Takeover Statute is or may become applicable to the Contemplated Transactions, each of the Company, the Company Board, Parent and the Parent Board, as applicable, shall grant such approvals and take such actions as are necessary so that the Contemplated Transactions may be consummated as promptly as practicable on the terms contemplated by this Agreement and otherwise act to eliminate or minimize the effects of such statute or regulation on the Contemplated Transactions. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">5.19&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Stockholder Litigation</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Each Party shall give the other Party the opportunity to participate in the settlement or defense of any stockholder litigation brought or threatened against such Party or any of its directors and officers relating to or challenging this Agreement or the consummation of the Contemplated Transactions (each, a &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Transaction Litigation</font><font style="letter-spacing:0.2pt;">&#8221;), and no such settlement shall be agreed to without the prior written consent of the other Party, which consent shall not be unreasonably withheld, conditioned or delayed. Without limiting in any way the Parties&#8217; obligations under </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.19</font><font style="letter-spacing:0.2pt;">, each of Parent and the Company will cooperate, and cause its Subsidiaries to cooperate, and shall use its reasonable best efforts to cause its Representatives to cooperate, in the defense against any Transaction Litigation. All costs and expenses, including attorney&#8217;s fees and settlement costs, incurred in connection with any Transaction Litigation shall be treated in accordance with the definition of Net Cash. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-58</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="t52BE">&#8203;</a><a name="t5DPT">&#8203;</a><a name="t5RSP">&#8203;</a><a name="t5SDF">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">5.20&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Employee Benefits</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;Immediately following the Effective Time, the employment and service, as applicable, of each employee, independent contractor or officer of Parent, subject to the exceptions listed in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.20(a)</font><font style="letter-spacing:0.2pt;"> of the Parent Disclosure Schedule (each, a &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Terminated Parent Associate</font><font style="letter-spacing:0.2pt;">&#8221;) who remains employed or engaged immediately prior to the Effective Time shall automatically terminate. Each such termination shall be deemed to be an involuntary termination without &#8220;cause&#8221; after a &#8220;change in control transaction&#8221; or a &#8220;covered termination&#8221;, as applicable, and Parent shall comply with the terms of any employment, severance, retention, change of control, or similar Contract or Parent Benefit Plan specified in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.17(a)</font><font style="letter-spacing:0.2pt;"> of the Parent Disclosure Schedule; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, </font><font style="font-style:italic;letter-spacing:0.2pt;">however</font><font style="letter-spacing:0.2pt;">, that any Terminated Parent Associate who is an employee of Parent as of the Effective Time and is terminated in accordance with the immediately preceding sentence and is not otherwise party to such Contract or subject to such a Parent Benefit Plan, shall be paid severance by Parent equal to two weeks of base salary plus one week of base salary for each full or partial year of employment with Parent, but no less than a minimum of 12 weeks of base salary, subject to such releases of claims against Parent and the Company and their agents, representatives, and other customary releases as the Company shall require. Notwithstanding the forgoing, any severance pay or severance benefits payable, including payments to cover COBRA, to Terminated Parent Associates pursuant to any employment, severance, retention, change of control, or similar Contract or Parent Benefit Plan specified in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.17(a)</font><font style="letter-spacing:0.2pt;"> of the Parent Disclosure Schedule as a result of the Effective Time, to the maximum extent permitted by Code Section&#160;409A, be paid in lump sum as soon as practicable following the Effective Time, </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;"> that the Terminated Parent Associate consents to the lump sum severance payment (to the extent required). From time to time after the date hereof, Parent may update </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.20(a)</font><font style="letter-spacing:0.2pt;"> of the Parent Disclosure Schedule upon the prior written consent of the Company. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;Each Person, other than any Person who has previously entered into a Contract with Parent providing for the payment of severance benefits and/or is a Terminated Parent Associate, who is an employee of Parent as of the Effective Time and who is terminated by Parent following the Effective Time shall be entitled to severance benefits to be paid by Parent pursuant to Parent&#8217;s current severance practice, but in no event shall such severance benefits be less than two weeks of base salary plus one week of base salary for each full or partial year of employment with Parent, but no less than a minimum of 12 weeks of base salary, subject to such releases of claims against Parent and the Company and their agents, representatives, and other customary releasees as the Company shall require. For the avoidance of doubt, all such payments under this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.20(b)</font><font style="letter-spacing:0.2pt;"> shall not be included in the calculation of Parent Transaction Expenses nor in the calculation of Net Cash. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">5.21&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Pre-Closing Dividend</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Prior to the Effective Time, Parent may (a)&#160;declare a dividend (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Pre-Closing Dividend</font><font style="letter-spacing:0.2pt;">&#8221;) to its common stockholders of record consisting of (i)&#160;the right to receive one contingent value right (each, a &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">CVR</font><font style="letter-spacing:0.2pt;">&#8221;) for each outstanding share of Parent Common Stock held by such stockholder as of such date, each representing the right to receive contingent payments upon the occurrence of certain events set forth in, and subject to and in accordance with the terms and conditions of, the Contingent Value Rights Agreement in the form attached hereto as </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Exhibit&#160;D</font><font style="letter-spacing:0.2pt;"> (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">CVR Agreement</font><font style="letter-spacing:0.2pt;">&#8221;) and (ii)&#160;cash in an amount not to exceed $25,000,000 in the aggregate subject to satisfaction of Parent&#8217;s obligation set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;8.5</font><font style="letter-spacing:0.2pt;"> and (b)&#160;make any necessary equitable adjustment required under the Parent Stock Plans. The record date for the Pre-Closing Dividend shall be a date agreed by Parent and the Company prior to the Effective Time and the payment date for which shall be three Business Days after the Effective Time; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, that the payment of such dividend may be conditioned upon the occurrence of the Effective Time. In connection with the Pre-Closing Dividend, Parent shall cause the CVR Agreement to be duly authorized, executed and delivered by Parent and a rights agent selected by Parent with the Company&#8217;s prior approval (such approval not to be unreasonably withheld, delayed or conditioned). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">5.22&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Nasdaq Reverse Split</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Parent shall submit to Parent&#8217;s stockholders at the Parent Stockholders Meeting a proposal to approve and adopt an amendment to Parent&#8217;s certificate of incorporation to authorize the Parent Board to effect the Nasdaq Reverse Split, and shall take such other actions as shall be reasonably necessary to effectuate the Nasdaq Reverse Split. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">5.23&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Parent SEC Documents</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;From the date of this Agreement until the Effective Time, Parent shall use commercially reasonable efforts to timely file with the SEC all Parent SEC Documents. As of its filing </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-59</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="t5OMS">&#8203;</a><a name="tS6PT">&#8203;</a><a name="t6RNT">&#8203;</a><a name="t6AIP">&#8203;</a><a name="t6TES">&#8203;</a><a name="t6ORS">&#8203;</a><a name="tS7CP">&#8203;</a><a name="t7ORT">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">date, or if amended after the date of this Agreement, as of the date of the last such amendment, each Parent SEC Document filed by Parent with the SEC shall comply in all material respects with the applicable requirements of the Exchange Act and the Securities Act. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">5.24&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Obligations of Merger Sub</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Parent will take all actions necessary to cause Merger Sub to perform its obligations under this Agreement and to consummate the Merger on the terms and conditions set forth in this Agreement. </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Section&#160;6.&nbsp;&nbsp;&nbsp;CONDITIONS PRECEDENT TO OBLIGATIONS OF EACH PARTY</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The obligations of each Party to effect the Merger and otherwise consummate the Contemplated Transactions to be consummated at the Closing are subject to the satisfaction or, to the extent permitted by applicable Law, the written waiver by each of the Parties, at or prior to the Closing, of each of the following conditions: </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">6.1&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">No Restraints</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;No temporary restraining order, preliminary or permanent injunction or other order preventing the consummation of the Contemplated Transactions shall have been issued by any court of competent jurisdiction or other Governmental Body of competent jurisdiction and remain in effect and there shall not be any Law which has the effect of making the consummation of the Contemplated Transactions illegal. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">6.2&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Stockholder Approval</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;(i)&#160;Parent shall have obtained the Required Parent Stockholder Vote and (ii)&#160;the Company shall have obtained the Required Company Stockholder Vote. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">6.3&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Listing</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The existing shares of Parent Common Stock shall have been continually listed on Nasdaq as of and from the date of this Agreement through the Closing Date, the approval of the listing of additional shares of Parent Common Stock on Nasdaq shall have been obtained and the shares of Parent Common Stock to be issued in the Merger and the Conversion pursuant to this Agreement shall have been approved for listing on Nasdaq. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">6.4&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Effectiveness of Registration Statement</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Registration Statement shall have become effective in accordance with the provisions of the Securities Act, and shall not be subject to any stop order or proceeding (or threatened proceeding by the SEC) seeking a stop order with respect to the Registration Statement that has not been withdrawn. </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:11.8pt; margin-bottom:0pt; text-align:left; width:60pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Section&#160;7.</font>
          <br >
        </div>
        <div style=" margin-top:11.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:80pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADDITIONAL CONDITIONS PRECEDENT TO OBLIGATIONS OF PARENT AND MERGER SUB</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The obligations of Parent and Merger Sub to effect the Merger and otherwise consummate the transactions to be consummated at the Closing are subject to the satisfaction or the written waiver by Parent, at or prior to the Closing, of each of the following conditions: </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">7.1&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Accuracy of Representations</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Company Fundamental Representations shall be true and correct in all material respects on and as of the Closing Date with the same force and effect as if made on and as of such date (except to the extent such representations and warranties are specifically made as of a particular date, in which case such representations and warranties shall be true and correct in all material respects as of such date). The Company Capitalization Representations shall be true and correct in all respects on and as of the Closing Date with the same force and effect as if made on and as of such date, except, in each case, (x)&#160;for such inaccuracies which are </font><font style="font-style:italic;letter-spacing:0.2pt;">de minimis</font><font style="letter-spacing:0.2pt;">, individually or in the aggregate, or (y)&#160;for those representations and warranties which address matters only as of a particular date (which representations and warranties shall have been true and correct, subject to the qualifications as set forth in the preceding clause (x), as of such particular date). The representations and warranties of the Company set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.8(b)</font><font style="letter-spacing:0.2pt;"> shall be true and correct in all respects on and as of the Closing Date with the same force and effect as if made on and as of such date. The representations and warranties of the Company contained in this Agreement (other than the Company Fundamental Representations, the Company Capitalization Representations and the representations and warranties of the Company set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.8(b)</font><font style="letter-spacing:0.2pt;">) shall be true and correct on and as of the Closing Date with the same force and effect as if made on the Closing Date, except (a)&#160;in each case, or in the aggregate, where the failure to be true and correct would not have a Company Material Adverse Effect (without giving effect to any references therein to any </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-60</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="t7OCT">&#8203;</a><a name="t7CPS">&#8203;</a><a name="t7CPS1">&#8203;</a><a name="t7OIA">&#8203;</a><a name="t7LAT">&#8203;</a><a name="tS8CP">&#8203;</a><a name="t8ORT">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Company Material Adverse Effect or other materiality qualifications), or (b)&#160;for those representations and warranties which address matters only as of a particular date (which representations shall have been true and correct, subject to the qualifications as set forth in the preceding clause (a), as of such particular date) (it being understood that, for purposes of determining the accuracy of such representations and warranties, any update of or modification to the Company Disclosure Schedule made or purported to have been made after the date of this Agreement shall be disregarded). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">7.2&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Performance of Covenants</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Company shall have performed or complied in all material respects with the agreements and covenants required to be performed or complied with by it under this Agreement at or prior to the Effective Time. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">7.3&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Closing Certificate</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Parent shall have received a certificate executed by the Chief Executive Officer or Chief Financial Officer of the Company certifying (i)&#160;that the conditions set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Sections&#160;7.1</font><font style="letter-spacing:0.2pt;">, </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">7.2</font><font style="letter-spacing:0.2pt;"> and </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">7.5</font><font style="letter-spacing:0.2pt;"> have been duly satisfied and (ii)&#160;that the information set forth in the Allocation Certificate delivered by the Company in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.16</font><font style="letter-spacing:0.2pt;"> is true and accurate in all respects as of the Closing Date. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">7.4&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">FIRPTA Certificate</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Parent shall have received (i)&#160;an original signed statement from the Company that the Company Common Stock is not a &#8220;United States real property interest,&#8221; as defined in Section&#160;897(c) of the Code, conforming to the requirements of Treasury Regulations&#160;Section&#160;1.1445-2(c)(3) and 1.897-2(h), and (ii)&#160;an original signed notice to be delivered to the IRS by Parent in accordance with the provisions of Treasury Regulations&#160;Section&#160;1.897-2(h)(2), together with written authorization for Parent to deliver such notice to the IRS on behalf of the Company following the Closing, each dated as of the Closing Date, duly executed by an authorized officer of the Company, and in form and substance reasonably acceptable to Parent. If Parent does not receive the certification and notice described above on or before the Closing Date, Parent&#8217;s sole remedy shall be to withhold from the payments to be made pursuant to this Agreement any required withholding Tax under Section&#160;1445 of the Code. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">7.5&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Termination of Investor Agreements</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Investor Agreements shall have been terminated. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">7.6&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Company Lock-Up Agreements</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Company Lock-Up Agreement will continue to be in full force and effect as of immediately following the Effective Time. </font>
        </div>
        <div style="text-indent:20pt; margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Section&#160;8.&nbsp;&nbsp;&nbsp;ADDITIONAL CONDITIONS PRECEDENT TO OBLIGATION OF THE COMPANY</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The obligations of the Company to effect the Merger and otherwise consummate the transactions to be consummated at the Closing are subject to the satisfaction or the written waiver by the Company, at or prior to the Closing, of each of the following conditions: </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">8.1&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Accuracy of Representations</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Parent Fundamental Representations shall be true and correct in all material respects on and as of the Closing Date with the same force and effect as if made on and as of such date (except to the extent such representations and warranties are specifically made as of a particular date, in which case such representations and warranties shall be true and correct in all material respects as of such date). The Parent Capitalization Representations shall be true and correct in all respects on and as of the Closing Date with the same force and effect as if made on and as of such date, except, in each case, (x)&#160;for such inaccuracies which are </font><font style="font-style:italic;letter-spacing:0.2pt;">de minimis</font><font style="letter-spacing:0.2pt;">, individually or in the aggregate, or (y)&#160;for those representations and warranties which address matters only as of a particular date (which representations and warranties shall have been true and correct, subject to the qualifications set forth in the preceding clause (x), as of such particular date). The representations and warranties of Parent and Merger Sub set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.8(b)</font><font style="letter-spacing:0.2pt;"> shall be true and correct in all respects as of the Closing Date with the same force and effect as if made on and as of such date. The representations and warranties of Parent and Merger Sub contained in this Agreement (other than the Parent Fundamental Representations, the Parent Capitalization Representations or the representations and warranties of Parent and Merger Sub set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.8(b)</font><font style="letter-spacing:0.2pt;">) shall be true and correct on and as of the Closing Date with the same force and effect as if made on the Closing Date except (a)&#160;in each case, or in the aggregate, where the failure to be true and correct would not have a Parent Material Adverse Effect (without giving effect to any references therein to any Parent Material Adverse Effect or other materiality qualifications), or (b)&#160;for those representations and warranties which address matters only as of a particular date (which representations shall have been true and correct, subject to the qualifications as set </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-61</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="t8OCP">&#8203;</a><a name="t8TCS">&#8203;</a><a name="t8LAT">&#8203;</a><a name="t8PFN">&#8203;</a><a name="tSE9T">&#8203;</a><a name="t9TAM">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">forth in the preceding clause (a), as of such particular date) (it being understood that, for purposes of determining the accuracy of such representations and warranties, any update of or modification to the Parent Disclosure Schedule made or purported to have been made after the date of this Agreement shall be disregarded). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">8.2&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Performance of Covenants</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Parent and Merger Sub shall have performed or complied in all material respects with their agreements and covenants required to be performed or complied with by each of them under this Agreement at or prior to the Effective Time. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">8.3&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Documents</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Company shall have received the following documents, each of which shall be in full force and effect: </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;a certificate executed by the Chief Executive Officer of Parent confirming that the conditions set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Sections&#160;8.1</font><font style="letter-spacing:0.2pt;">, </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">8.2</font><font style="letter-spacing:0.2pt;">, and </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">8.5</font><font style="letter-spacing:0.2pt;"> have been duly satisfied; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;a copy of the CVR Agreement, duly executed by Parent and the Rights Agent (as defined therein); and </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;a written resignation, in a form reasonably satisfactory to the Company, dated as of the Closing Date and effective as of the Closing, executed by each of the officers and directors, from their positions as such, of Parent who are not to continue as officers or directors (as applicable) of Parent after the Closing pursuant to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.12</font><font style="letter-spacing:0.2pt;">, such resignation not effecting such officer&#8217;s or directors&#8217; status as an employee (if applicable), including any characterization of their cessation from employment. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">8.4&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Parent Lock-Up Agreements</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Parent Lock-Up Agreements will continue to be in full force and effect as of immediately following the Effective Time. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">8.5&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Minimum Parent Final Net Cash</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Final Net Cash shall have been determined in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;1.11</font><font style="letter-spacing:0.2pt;"> to be greater than or equal to $100,000,000. </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Section&#160;9.&nbsp;&nbsp;&nbsp;TERMINATION</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">9.1&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Termination</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;This Agreement may be terminated prior to the Effective Time (whether before or after adoption of this Agreement by the Company&#8217;s stockholders and whether before or after approval of the Parent Stockholder Matters by Parent&#8217;s stockholders, unless otherwise specified below): </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;by mutual written consent of Parent and the Company; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;by either Parent or the Company if the Contemplated Transactions shall not have been consummated by January&#160;31, 2023 (subject to possible extension as provided in this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;9.1(b)</font><font style="letter-spacing:0.2pt;">, the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">End Date</font><font style="letter-spacing:0.2pt;">&#8221;); </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, </font><font style="font-style:italic;letter-spacing:0.2pt;">however</font><font style="letter-spacing:0.2pt;">, that the right to terminate this Agreement pursuant to this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;9.1(b)</font><font style="letter-spacing:0.2pt;"> shall not be available to the Company, on the one hand, or to Parent, on the other hand, if such Party&#8217;s action or failure to act has been a principal cause of the failure of the Contemplated Transactions to occur on or before the End Date and such action or failure to act constitutes a breach of this Agreement; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, </font><font style="font-style:italic;letter-spacing:0.2pt;">further</font><font style="letter-spacing:0.2pt;">, </font><font style="font-style:italic;letter-spacing:0.2pt;">however</font><font style="letter-spacing:0.2pt;">, that, in the event that a request for additional information has been made by any Governmental Body, or in the event that the SEC has not declared effective under the Securities Act the Registration Statement by the date which is 60&#160;days prior to the End Date, then either the Company or Parent shall be entitled to extend the End Date to the date that is 60&#160;days after the date that the SEC has declared effective the Registration Statement under the Securities Act, but in any event no more than 60&#160;days after the original End Date, by written notice to the other Party; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;by either Parent or the Company if a court of competent jurisdiction or other Governmental Body shall have issued a final and nonappealable order, decree or ruling, or shall have taken any other action, having the effect of permanently restraining, enjoining or otherwise prohibiting the Contemplated Transactions; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;by Parent if the Company Stockholder Written Consent evidencing the Required Company Stockholder Vote shall not have been obtained within ten Business Days of the Registration Statement becoming effective in accordance with the provisions of the Securities Act; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, </font><font style="font-style:italic;letter-spacing:0.2pt;">however</font><font style="letter-spacing:0.2pt;">, that </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-62</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="t9OTI">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">once the Company Stockholder Written Consent evidencing the Required Company Stockholder Vote has been obtained, Parent may not terminate this Agreement pursuant to this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;9.1(d)</font><font style="letter-spacing:0.2pt;">; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(e)&nbsp;&nbsp;&nbsp;by either Parent or the Company if (i)&#160;the Parent Stockholders&#8217; Meeting (including, if applicable, following adjournments or postponements thereof as permitted or required pursuant to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.4(b)</font><font style="letter-spacing:0.2pt;">) shall have been held and completed and Parent&#8217;s stockholders shall have taken a final vote on the Parent Stockholder Matters and (ii)&#160;the Parent Stockholder Matters shall not have been approved at the Parent Stockholders&#8217; Meeting (or at any adjournment or postponement thereof) by the Required Parent Stockholder Vote; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, </font><font style="font-style:italic;letter-spacing:0.2pt;">however</font><font style="letter-spacing:0.2pt;">, that the right to terminate this Agreement pursuant to this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;9.1(e)</font><font style="letter-spacing:0.2pt;"> shall not be available to Parent if Parent&#8217;s actions or failure to act has been a principal cause of the failure of Parent to obtain the Required Parent Stockholder Vote and such action or failure to act constitutes a breach by Parent of this Agreement; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(f)&nbsp;&nbsp;&nbsp;by the Company (at any time prior to the approval of the Parent Stockholder Matters by the Required Parent Stockholder Vote) if a Parent Triggering Event shall have occurred; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(g)&nbsp;&nbsp;&nbsp;by Parent (at any time prior to the Required Company Stockholder Vote being obtained) if a Company Triggering Event shall have occurred; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(h)&nbsp;&nbsp;&nbsp;by the Company, upon a breach of any representation, warranty, covenant or agreement set forth in this Agreement by Parent or Merger Sub or if any representation or warranty of Parent or Merger Sub shall have become inaccurate, in either case, such that the conditions set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;8.1</font><font style="letter-spacing:0.2pt;"> or </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;8.2</font><font style="letter-spacing:0.2pt;"> would not be satisfied as of the time of such breach or as of the time such representation or warranty shall have become inaccurate; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, that the Company is not then in material breach of any representation, warranty, covenant or agreement under this Agreement; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, </font><font style="font-style:italic;letter-spacing:0.2pt;">further</font><font style="letter-spacing:0.2pt;">, that if such inaccuracy in Parent&#8217;s or Merger Sub&#8217;s representations and warranties or breach by Parent or Merger Sub is curable by the End Date by Parent or Merger Sub, then this Agreement shall not terminate pursuant to this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;9.1(h)</font><font style="letter-spacing:0.2pt;"> as a result of such particular breach or inaccuracy until the expiration of a 30-day period commencing upon delivery of written notice from the Company to Parent or Merger Sub of such breach or inaccuracy and its intention to terminate pursuant to this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;9.1(h)</font><font style="letter-spacing:0.2pt;"> (it being understood that this Agreement shall not terminate pursuant to this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;9.1(h)</font><font style="letter-spacing:0.2pt;"> as a result of such particular breach or inaccuracy if such breach by Parent or Merger Sub is cured prior to such termination becoming effective); or </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(i)&nbsp;&nbsp;&nbsp;by Parent, upon a breach of any representation, warranty, covenant or agreement set forth in this Agreement by the Company or if any representation or warranty of the Company shall have become inaccurate, in either case, such that the conditions set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.1</font><font style="letter-spacing:0.2pt;"> or </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.2</font><font style="letter-spacing:0.2pt;"> would not be satisfied as of the time of such breach or as of the time such representation or warranty shall have become inaccurate; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, that Parent is not then in material breach of any representation, warranty, covenant or agreement under this Agreement; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, </font><font style="font-style:italic;letter-spacing:0.2pt;">further</font><font style="letter-spacing:0.2pt;">, that if such inaccuracy in the Company&#8217;s representations and warranties or breach by the Company is curable by the End Date by the Company then this Agreement shall not terminate pursuant to this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;9.1(i)</font><font style="letter-spacing:0.2pt;"> as a result of such particular breach or inaccuracy until the expiration of a 30-day period commencing upon delivery of written notice from Parent to the Company of such breach or inaccuracy and its intention to terminate pursuant to this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;9.1(i)</font><font style="letter-spacing:0.2pt;"> (it being understood that this Agreement shall not terminate pursuant to this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;9.1(i)</font><font style="letter-spacing:0.2pt;"> as a result of such particular breach or inaccuracy if such breach by the Company is cured prior to such termination becoming effective). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Party desiring to terminate this Agreement pursuant to this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;9.1</font><font style="letter-spacing:0.2pt;"> (other than pursuant to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;9.1(a)</font><font style="letter-spacing:0.2pt;">) shall give notice of such termination to the other Party specifying the provisions hereof pursuant to which such termination is made and the basis therefore described in reasonable detail. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">9.2&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Effect of Termination</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;In the event of the termination of this Agreement as provided in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;9.1</font><font style="letter-spacing:0.2pt;">, this Agreement shall be of no further force or effect; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, </font><font style="font-style:italic;letter-spacing:0.2pt;">however</font><font style="letter-spacing:0.2pt;">, that (a)&#160;this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;9.2</font><font style="letter-spacing:0.2pt;">, </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;9.3</font><font style="letter-spacing:0.2pt;">, </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;10</font><font style="letter-spacing:0.2pt;"> and the definitions of the defined terms in such Sections shall survive the termination of this Agreement and shall remain in full force and effect, and (b)&#160;the termination of this Agreement and the provisions of </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;9.3</font><font style="letter-spacing:0.2pt;"> shall not relieve any Party of any liability for fraud or for any willful and material breach of any covenant or other obligation contained in this Agreement. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-63</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="t9TF">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">9.3&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Expenses; Termination Fees</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;Except as set forth in this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;9.3</font><font style="letter-spacing:0.2pt;">, whether or not the Merger is consummated, (i)&#160;all Parent Transaction Expenses shall be paid by Parent (or on behalf of Parent) at or prior to the Closing and (ii)&#160;all Company Transaction Expenses shall be paid by the Company at or prior to the Closing; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, </font><font style="font-style:italic;letter-spacing:0.2pt;">however</font><font style="letter-spacing:0.2pt;">, that Parent and the Company shall share equally all fees and expenses, other than attorneys&#8217; and accountants&#8217; fees and expenses, incurred in relation to the filings by the Parties under any filing requirement under any Antitrust Law, to the extent applicable to this Agreement and the transactions contemplated hereby; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, </font><font style="font-style:italic;letter-spacing:0.2pt;">further</font><font style="letter-spacing:0.2pt;">, </font><font style="font-style:italic;letter-spacing:0.2pt;">however</font><font style="letter-spacing:0.2pt;">, that Parent and the Company shall also share equally all fees and expenses incurred in relation to the printing and filing with the SEC of the Registration Statement (including any financial statements and exhibits) and any amendments or supplements thereto and paid to a financial printer or the SEC and the filings with Nasdaq pursuant to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Sections&#160;5.9(b)</font><font style="letter-spacing:0.2pt;"> and </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">(d)</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;If (i)&#160;this Agreement is terminated by Parent or the Company pursuant to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;9.1(b)</font><font style="letter-spacing:0.2pt;"> (and the Required Parent Stockholder Vote has not been obtained by Parent) or </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;9.1(e)</font><font style="letter-spacing:0.2pt;">, (ii)&#160;at any time after the date of this Agreement and prior to the Parent Stockholder Meeting, an Acquisition Proposal with respect to Parent shall have been publicly announced or disclosed or otherwise communicated to Parent or the Parent Board (and shall not have been withdrawn), and (iii)&#160;within 12&#160;months after the date of such termination, Parent consummates any Subsequent Transaction, then Parent shall pay to the Company, upon consummation of a Subsequent Transaction, a nonrefundable fee in an amount equal to $7,600,000 (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company Termination Fee</font><font style="letter-spacing:0.2pt;">&#8221;). If this Agreement is terminated by the Company pursuant to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;9.1(f)</font><font style="letter-spacing:0.2pt;">, then Parent shall pay to the Company the Company Termination Fee within two Business Days of such termination. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;If (i)&#160;this Agreement is terminated by Parent pursuant to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;9.1(b)</font><font style="letter-spacing:0.2pt;"> (and the Required Company Stockholder Vote has not been obtained by the Company) or </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;9.1(d)</font><font style="letter-spacing:0.2pt;">, (ii)&#160;at any time after the date of this Agreement and before obtaining the Required Company Stockholder Vote, an Acquisition Proposal with respect to the Company shall have been publicly announced or disclosed or otherwise communicated to the Company or the Company Board (and shall not have been withdrawn), and (iii)&#160;within 12&#160;months after the date of such termination, the Company consummates any Subsequent Transaction, then the Company shall pay to Parent, upon consummation of a Subsequent Transaction, a nonrefundable fee in an amount equal to $5,490,000 (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent Termination Fee</font><font style="letter-spacing:0.2pt;">&#8221;). If this Agreement is terminated by Parent pursuant to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;9.1(g)</font><font style="letter-spacing:0.2pt;">, then the Company shall pay to Parent the Parent Termination Fee within two Business Days of such termination. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;If this Agreement is terminated by either the Company or Parent pursuant to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;9.1(e)</font><font style="letter-spacing:0.2pt;"> or by the Company pursuant to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;9.1(f)</font><font style="letter-spacing:0.2pt;"> or </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;9.1(h)</font><font style="letter-spacing:0.2pt;">, then Parent shall reimburse the Company for all reasonable out of pocket fees and expenses incurred by the Company in connection with this Agreement and the Contemplated Transactions, up to a maximum of $1,750,000, by wire transfer of same day funds within five Business Days following the date on which the Company submits to Parent true and correct copies of reasonable documentation supporting such expenses. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(e)&nbsp;&nbsp;&nbsp;If this Agreement is terminated by Parent pursuant to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;9.1(d)</font><font style="letter-spacing:0.2pt;">, </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;9.1(g)</font><font style="letter-spacing:0.2pt;"> or </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;9.1(i)</font><font style="letter-spacing:0.2pt;">, then the Company shall reimburse Parent for all reasonable out of pocket fees and expenses incurred by Parent in connection with this Agreement and the Contemplated Transactions, up to a maximum of $1,750,000, by wire transfer of same day funds within five Business Days following the date on which Parent submits to the Company true and correct copies of reasonable documentation supporting such expenses. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(f)&nbsp;&nbsp;&nbsp;If a Party fails to pay when due any amount payable by it under this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;9.3</font><font style="letter-spacing:0.2pt;">, then (i)&#160;such Party shall reimburse the other Party for reasonable costs and expenses (including reasonable fees and disbursements of counsel) incurred in connection with the collection of such overdue amount and the enforcement by the other Party of its rights under this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;9.3</font><font style="letter-spacing:0.2pt;"> and (ii)&#160;such Party shall pay to the other Party interest on such overdue amount (for the period commencing as of the date such overdue amount was originally required to be paid and ending on the date such overdue amount is actually paid to the other Party in full) at a rate per annum equal to the &#8220;prime rate&#8221; &#8203;(as published in </font><font style="font-style:italic;letter-spacing:0.2pt;">The Wall Street Journal</font><font style="letter-spacing:0.2pt;"> or any successor thereto) in effect on the date such overdue amount was originally required to be paid. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-64</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="tS1P">&#8203;</a><a name="t1ORA">&#8203;</a><a name="t1TAM">&#8203;</a><a name="t103">&#8203;</a><a name="t1ACE">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; text-indent:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(g)&nbsp;&nbsp;&nbsp;The Parties agree that, subject to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;9.2</font><font style="letter-spacing:0.2pt;">, (i)&#160;payment of the fees and expenses in this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;9.3</font><font style="letter-spacing:0.2pt;"> shall, in the circumstances in which they are owed in accordance with the terms of this Agreement, constitute the sole and exclusive remedy of each Party following the termination of this Agreement under the circumstances described in this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;9.3</font><font style="letter-spacing:0.2pt;">, it being understood that in no event shall either Parent or the Company be required to pay the individual amounts payable pursuant to this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;9.3</font><font style="letter-spacing:0.2pt;"> on more than one occasion and (ii)&#160;following the termination of this Agreement under the circumstances described in this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;9.3</font><font style="letter-spacing:0.2pt;"> and the payment of the fees and expenses set forth in this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;9.3</font><font style="letter-spacing:0.2pt;"> by a Party, (A)&#160;such Party shall have no further liability to the other Party in connection with or arising out of this Agreement or the termination thereof, any breach of this Agreement by the other Party giving rise to such termination, or the failure of the Contemplated Transactions to be consummated, (B)&#160;no other Party or their respective Affiliates shall be entitled to bring or maintain any other claim, action or proceeding against such Party or seek to obtain any recovery, judgment or damages of any kind against such Party (or any partner, member, stockholder, director, officer, employee, Subsidiary, Affiliate, agent or other Representative of such Party) in connection with or arising out of this Agreement or the termination thereof, any breach by any such Party giving rise to such termination or the failure of the Contemplated Transactions to be consummated and (C)&#160;all other Parties and their respective Affiliates shall be precluded from any other remedy against such Party and its Affiliates, at law or in equity or otherwise, in connection with or arising out of this Agreement or the termination thereof, any breach by such Party giving rise to such termination or the failure of the Contemplated Transactions to be consummated. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(h)&nbsp;&nbsp;&nbsp;Each of the Parties acknowledges that (i)&#160;the agreements contained in this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;9.3</font><font style="letter-spacing:0.2pt;"> are an integral part of the Contemplated Transactions, (ii)&#160;without these agreements, the Parties would not enter into this Agreement and (iii)&#160;any amount payable pursuant to this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;9.3</font><font style="letter-spacing:0.2pt;"> is not a penalty, but rather is liquidated damages in a reasonable amount that will compensate the Party in the circumstances in which such amount is payable. </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Section&#160;10.&nbsp;&nbsp;&nbsp;MISCELLANEOUS PROVISIONS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">10.1&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Non-Survival of Representations and Warranties</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The representations and warranties of the Company, Parent and Merger Sub contained in this Agreement or any certificate or instrument delivered pursuant to this Agreement shall terminate at the Effective Time, and only the covenants that by their terms survive the Effective Time and this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;10</font><font style="letter-spacing:0.2pt;"> shall survive the Effective Time. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">10.2&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Amendment</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;This Agreement may be amended with the approval of the respective boards of directors of the Company, Merger Sub and Parent at any time (whether before or after the adoption and approval of this Agreement by the Company&#8217;s stockholders or before or after obtaining the Required Parent Stockholder Vote); </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, </font><font style="font-style:italic;letter-spacing:0.2pt;">however</font><font style="letter-spacing:0.2pt;">, that after any such approval of this Agreement by a Party&#8217;s stockholders, no amendment shall be made which by Law requires further approval of such stockholders without the further approval of such stockholders. This Agreement may not be amended except by an instrument in writing signed on behalf of each of the Company, Merger Sub and Parent. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">10.3&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Waiver</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;No failure on the part of any Party to exercise any power, right, privilege or remedy under this Agreement, and no delay on the part of any Party in exercising any power, right, privilege or remedy under this Agreement, shall operate as a waiver of such power, right, privilege or remedy; and no single or partial exercise of any such power, right, privilege or remedy shall preclude any other or further exercise thereof or of any other power, right, privilege or remedy. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;Any provisions hereof may be waived (or the time for performance extended) by the waiving Party solely on such Party&#8217;s own behalf, without the consent of any other Party. No Party shall be deemed to have waived any claim arising out of this Agreement, or any power, right, privilege or remedy under this Agreement, unless the waiver of such claim, power, right, privilege or remedy is expressly set forth in a written instrument duly executed and delivered on behalf of such Party and any such waiver shall not be applicable or have any effect except in the specific instance in which it is given. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">10.4&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Entire Agreement; Counterparts; Exchanges by Electronic Transmission</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;This Agreement and the other agreements referred to in this Agreement constitute the entire agreement and supersede all prior </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-65</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="t1LJW">&#8203;</a><a name="t1TAS">&#8203;</a><a name="t1ANA">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:24pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">agreements and understandings, both written and oral, among or between any of the Parties with respect to the subject matter hereof and thereof; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, </font><font style="font-style:italic;letter-spacing:0.2pt;">however</font><font style="letter-spacing:0.2pt;">, that the Confidentiality Agreement shall not be superseded and shall remain in full force and effect in accordance with its terms. This Agreement may be executed in several counterparts, each of which shall be deemed an original and all of which shall constitute one and the same instrument. The exchange of a fully executed Agreement (in counterparts or otherwise) by all Parties by electronic transmission in PDF format shall be sufficient to bind the Parties to the terms and conditions of this Agreement. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">10.5&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Applicable Law; Jurisdiction; Waiver of Jury Trial</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;This Agreement shall be governed by, and construed in accordance with, the Laws of the State of Delaware, regardless of the Laws that might otherwise govern under applicable principles of conflicts of laws. In any action or proceeding between any of the Parties arising out of or relating to this Agreement or any of the Contemplated Transactions, each of the Parties: (i)&#160;irrevocably and unconditionally consents and submits to the exclusive jurisdiction and venue of the Court of Chancery of the State of Delaware, New Castle County, or, to the extent such court does not have subject matter jurisdiction, the United States District Court for the District of Delaware or, to the extent that neither of the foregoing courts has jurisdiction, the Superior Court of the State of Delaware; (ii)&#160;agrees that all claims in respect of such action or proceeding shall be heard and determined exclusively in accordance with clause (i)&#160;of this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;10.5</font><font style="letter-spacing:0.2pt;">; (iii)&#160;waives any objection to laying venue in any such action or proceeding in such courts; (iv)&#160;waives any objection that such courts are an inconvenient forum or do not have jurisdiction over any Party; and (v)&#160;agrees that service of process upon such Party in any such action or proceeding shall be effective if notice is given in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;10.7</font><font style="letter-spacing:0.2pt;"> of this Agreement. Nothing in this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;10.5</font><font style="letter-spacing:0.2pt;">, however, shall affect the right of any Person to serve legal process in any other manner permitted by law. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;EACH PARTY HEREBY WAIVES, TO THE FULLEST EXTENT PERMITTED BY LAW, ANY RIGHT TO TRIAL BY JURY OF ANY CLAIM, DEMAND, ACTION, OR CAUSE OF ACTION (i)&#160;ARISING UNDER THIS AGREEMENT OR (ii)&#160;IN ANY WAY CONNECTED WITH OR RELATED OR INCIDENTAL TO THE DEALINGS OF THE PARTIES HERETO IN RESPECT OF THIS AGREEMENT OR ANY OF THE CONTEMPLATED TRANSACTIONS, IN EACH CASE WHETHER NOW EXISTING OR HEREAFTER ARISING, AND WHETHER IN CONTRACT, TORT, EQUITY, OR OTHERWISE. EACH PARTY HEREBY AGREES AND CONSENTS THAT ANY SUCH CLAIM, DEMAND, ACTION, OR CAUSE OF ACTION SHALL BE DECIDED BY COURT TRIAL WITHOUT A JURY AND THAT THE PARTIES TO THIS AGREEMENT MAY FILE AN ORIGINAL COUNTERPART OF A COPY OF THIS AGREEMENT WITH ANY COURT AS WRITTEN EVIDENCE OF THE CONSENT OF THE PARTIES HERETO TO THE WAIVER OF THEIR RIGHT TO TRIAL BY JURY. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">10.6&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Assignability</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;This Agreement shall be binding upon, and shall be enforceable by and inure solely to the benefit of, the Parties and their respective successors and permitted assigns; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, </font><font style="font-style:italic;letter-spacing:0.2pt;">however</font><font style="letter-spacing:0.2pt;">, that neither this Agreement nor any of a Party&#8217;s rights or obligations hereunder may be assigned or delegated by such Party without the prior written consent of the other Party, and any attempted assignment or delegation of this Agreement or any of such rights or obligations by such Party without the other Party&#8217;s prior written consent shall be void and of no effect. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">10.7&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Notices</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;All notices and other communications hereunder shall be in writing and shall be deemed to have been duly delivered and received hereunder (a)&#160;one Business Day after being sent for next Business Day delivery, fees prepaid, via a reputable international overnight courier service, (b)&#160;upon delivery in the case of delivery by hand, or (c)&#160;on the date delivered in the place of delivery if sent by email (with a written or electronic confirmation of delivery) prior to 5:00&#160;p.m. New York time, otherwise on the next succeeding Business Day, in each case to the intended recipient as set forth below: </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-66</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="t1ATO">&#8203;</a><a name="t1RSP">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">if to Parent or Merger Sub: </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">245 First Street, Suite 1800</font> <br ><font style="letter-spacing:0.2pt;">Cambridge, MA</font> <br ><font style="letter-spacing:0.2pt;">Attention: Chief Executive Officer</font> <br ><font style="letter-spacing:0.2pt;">Email: *****@*****.com </font></div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">with a copy to (which shall not constitute notice): </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Hogan Lovells US LLP</font> <br ><font style="letter-spacing:0.2pt;">1735 Market St, 23</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">rd</font><font style="letter-spacing:0.2pt;"> Floor</font> <br ><font style="letter-spacing:0.2pt;">Philadelphia, PA 19103</font> <br ><font style="letter-spacing:0.2pt;">Attention: Steve Abrams; Jessica A. Bisignano</font> <br ><font style="letter-spacing:0.2pt;">Email: *****@*****.com; *****@*****.com </font></div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">if to the Company: </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">3675 Market Street, Suite 200</font> <br ><font style="letter-spacing:0.2pt;">Philadelphia, Pennsylvania 19104</font> <br ><font style="letter-spacing:0.2pt;">Attention: President and Chief Executive Officer</font> <br ><font style="letter-spacing:0.2pt;">Email: *****@*****.com </font></div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">with a copy to (which shall not constitute notice): </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Wilmer Cutler Pickering Hale and Dorr LLP</font> <br ><font style="letter-spacing:0.2pt;">7 World Trade Center</font> <br ><font style="letter-spacing:0.2pt;">250 Greenwich Street</font> <br ><font style="letter-spacing:0.2pt;">New York, NY 10007</font> <br ><font style="letter-spacing:0.2pt;">Attention: Brian A. Johnson; Hal Leibowitz; Christopher Barnstable-Brown</font><br ><font style="letter-spacing:0.2pt;">Email: *****@*****.com; *****@*****.com; *****@*****.com </font></div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">10.8&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Severability</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Any term or provision of this Agreement that is invalid or unenforceable in any situation in any jurisdiction shall not affect the validity or enforceability of the remaining terms and provisions of this Agreement or the validity or enforceability of the offending term or provision in any other situation or in any other jurisdiction. If a final judgment of a court of competent jurisdiction declares that any term or provision of this Agreement is invalid or unenforceable, the Parties agree that the court making such determination shall have the power to limit such term or provision, to delete specific words or phrases or to replace such term or provision with a term or provision that is valid and enforceable and that comes closest to expressing the intention of the invalid or unenforceable term or provision, and this Agreement shall be valid and enforceable as so modified. In the event such court does not exercise the power granted to it in the prior sentence, the Parties agree to replace such invalid or unenforceable term or provision with a valid and enforceable term or provision that will achieve, to the extent possible, the economic, business and other purposes of such invalid or unenforceable term or provision. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">10.9&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Other Remedies; Specific Performance</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Except as otherwise provided herein, any and all remedies herein expressly conferred upon a Party will be deemed cumulative with and not exclusive of any other remedy conferred hereby, or by law or equity upon such Party, and the exercise by a Party of any one remedy will not preclude the exercise of any other remedy. The Parties agree that irreparable damage for which monetary damages, even if available, would not be an adequate remedy, would occur in the event that any Party does not perform the provisions of this Agreement (including failing to take such actions as are required of it hereunder to consummate the Contemplated Transactions) in accordance with its specified terms or otherwise breaches such provisions. Accordingly, the Parties acknowledge and agree that the Parties shall be entitled to an injunction, specific performance and other equitable relief to prevent breaches of this Agreement and to enforce specifically the terms and provisions hereof, in addition to any other remedy to which they are entitled at law or in equity. Each of the Parties agrees that it will not oppose the granting of an injunction, specific performance or other equitable relief on the basis that any other Party has an adequate remedy at law or that any award of specific performance or other equitable relief is not an appropriate remedy for any reason at law or in equity. Any Party seeking an injunction or injunctions to </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-67</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a><a name="t1TPB">&#8203;</a><a name="t101">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">prevent breaches of this Agreement shall not be required to provide any bond or other security in connection with any such order or injunction. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">10.10&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">No Third Party Beneficiaries</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Nothing in this Agreement, express or implied, is intended to or shall confer upon any Person (other than the Parties and the D&amp;O Indemnified Parties to the extent of their respective rights pursuant to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.6</font><font style="letter-spacing:0.2pt;">) any right, benefit or remedy of any nature whatsoever under or by reason of this Agreement. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">10.11&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Construction</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;References to &#8220;cash,&#8221; &#8220;dollars&#8221; or &#8220;$&#8221; are to U.S. dollars. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;For purposes of this Agreement, whenever the context requires: (i)&#160;the singular number shall include the plural, and vice versa; the masculine gender shall include the feminine and neuter genders; (ii)&#160;the feminine gender shall include the masculine and neuter genders; and (iii)&#160;the neuter gender shall include masculine and feminine genders. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;The Parties have participated jointly in the negotiating and drafting of this Agreement and agree that any rule of construction to the effect that ambiguities are to be resolved against the drafting Party shall not be applied in the construction or interpretation of this Agreement, and no presumption or burden of proof shall arise favoring or disfavoring any Party by virtue of the authorship of any provision of this Agreement. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;As used in this Agreement, the words &#8220;include&#8221; and &#8220;including,&#8221; and variations thereof, shall not be deemed to be terms of limitation, but rather shall be deemed to be followed by the words &#8220;without limitation.&#8221; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(e)&nbsp;&nbsp;&nbsp;As used in this Agreement, the words &#8220;hereof&#8221;, &#8220;hereto&#8221;, &#8220;hereby&#8221;, &#8220;herein&#8221; and &#8220;hereunder&#8221; and variations thereof refer to this Agreement as a whole and not to any particular provision of this Agreement. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(f)&nbsp;&nbsp;&nbsp;As used in this Agreement, the words &#8220;date hereof&#8221; refers to the date set forth in the initial caption of this Agreement. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(g)&nbsp;&nbsp;&nbsp;As used in this Agreement, the word &#8220;extent&#8221; in the phrase &#8220;to the extent&#8221; means the degree to which a subject or other thing extended, and such phrase does not simply mean &#8220;if&#8221;. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(h)&nbsp;&nbsp;&nbsp;Except as otherwise indicated, all references in this Agreement to an &#8220;Article,&#8221; &#8220;Section,&#8221; &#8220;Recital,&#8221; &#8220;preamble,&#8221; &#8220;Annex,&#8221; &#8220;Exhibit&#8221; and &#8220;Schedule&#8221; are intended to refer to an Article, Section, Recital or preamble of, or an Annex, Exhibit or Schedule to, this Agreement, respectively. </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(i)&nbsp;&nbsp;&nbsp;Any reference to a Person is also to its permitted successors and assigns. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(j)&nbsp;&nbsp;&nbsp;Any reference to legislation or to any provision of any legislation shall include any modification, amendment, re-enactment thereof, any legislative provision substituted therefore and all rules, regulations, and statutory instruments issued or related to such legislations. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(k)&nbsp;&nbsp;&nbsp;Any reference to a communication by a regulatory agency include a communication by the staff of such regulatory agency. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(l)&nbsp;&nbsp;&nbsp;The bold-faced headings and table of contents contained in this Agreement are for convenience of reference only, shall not be deemed to be a part of this Agreement and shall not be referred to in connection with the construction or interpretation of this Agreement. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(m)&nbsp;&nbsp;&nbsp;The Parties agree that each of the Company Disclosure Schedule and the Parent Disclosure Schedule shall be arranged in sections and subsections corresponding to the numbered and lettered sections and subsections contained in this Agreement. The disclosures in any section or subsection of the Company Disclosure Schedule or the Parent Disclosure Schedule shall only qualify other sections and subsections in this Agreement to the extent it is reasonably apparent from a reading of the disclosure that such disclosure is applicable to such other sections and subsections. The inclusion of any information in the Company Disclosure Schedule or the Parent Disclosure Schedule shall not be </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-68</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:436pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">deemed to be an admission or acknowledgment, in and of itself, that such information is required by the terms hereof to be disclosed, is material, has resulted in or would result in a Company Material Adverse Effect or a Parent Material Adverse Effect or is outside the Ordinary Course of Business. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(n)&nbsp;&nbsp;&nbsp;Each of &#8220;delivered&#8221; or &#8220;made available&#8221; means, with respect to any documentation, that prior to 11:59&#160;p.m. (New York time) on the date that is one Business Days prior to the date of this Agreement (i)&#160;a copy of such material has been posted to and made available by a Party to the other Party and its Representatives in the electronic data room maintained by such disclosing Party or (ii)&#160;such material is disclosed in the Parent SEC Documents filed with the SEC prior to the date hereof and publicly made available on the SEC&#8217;s Electronic Data Gathering Analysis and Retrieval system. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(o)&nbsp;&nbsp;&nbsp;Whenever the last day for the exercise of any privilege or the discharge of any duty hereunder shall fall upon a Saturday, Sunday, or any date on which banks in New York, New York are authorized or obligated by Law to be closed, the Party having such privilege or duty may exercise such privilege or discharge such duty on the next succeeding day which is a regular Business Day. </font>
        </div>
        <div style="margin-top:8pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(</font><font style="font-style:italic;letter-spacing:0.2pt;">Remainder of page intentionally left blank</font><font style="letter-spacing:0.2pt;">) </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-69</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;height:660pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">IN WITNESS WHEREOF</font><font style="letter-spacing:0.2pt;">, the Parties have caused this Agreement to be executed as of the date first above written. </font>
        </div>
        <div style="margin-left:220pt; margin-top:8pt; width:236pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">SESEN BIO, INC.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:220pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">By:</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:240pt;">
          <font style="letter-spacing:0.2pt;">/s/ Thomas R. Cannell, D.V.M.</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:240pt; margin-top:2.5pt; width:216pt;">
          <div style="margin-left: 0pt; width: 216pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-left:240pt; margin-top:2pt; width:216pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Name:&nbsp;&nbsp;&nbsp;Thomas R. Cannell, D.V.M. </font>
          <br >
          <font style="letter-spacing:0.2pt;">Title:&nbsp;&nbsp;&nbsp;&#8199;&#8201;President &amp; Chief Executive Officer </font>
        </div>
        <div style="margin-left:220pt; margin-top:36pt; width:236pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">SEAHAWK MERGER SUB, INC.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:220pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">By:</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:240pt;">
          <font style="letter-spacing:0.2pt;">/s/ Mark Sullivan</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:240pt; margin-top:2.5pt; width:216pt;">
          <div style="margin-left: 0pt; width: 216pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-left:240pt; margin-top:2pt; width:216pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Name:&nbsp;&nbsp;&nbsp;Mark Sullivan </font>
          <br >
          <font style="letter-spacing:0.2pt;">Title:&nbsp;&nbsp;&nbsp;&#8199;&#8201;President, Secretary &amp; Treasurer </font>
        </div>
        <div style="margin-left:220pt; margin-top:36pt; width:236pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CARISMA THERAPEUTICS INC.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:220pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">By:</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:240pt;">
          <font style="letter-spacing:0.2pt;">/s/ Steven Kelly</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:240pt; margin-top:2.5pt; width:216pt;">
          <div style="margin-left: 0pt; width: 216pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-left:240pt; margin-top:2pt; width:216pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Name:&nbsp;&nbsp;&nbsp;Steven Kelly </font>
          <br >
          <font style="letter-spacing:0.2pt;">Title:&nbsp;&nbsp;&nbsp;&#8199;&#8201;Chief Executive Officer </font>
        </div>
        <div style="margin-top:144pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">[</font><font style="font-style:italic;letter-spacing:0.2pt;">Signature Page to Agreement and Plan of Merger and Reorganization</font><font style="letter-spacing:0.2pt;">]</font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">EXHIBIT A</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CERTAIN DEFINITIONS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;For purposes of this Agreement (including this </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Exhibit&#160;A</font><font style="letter-spacing:0.2pt;">): </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Acquisition Inquiry</font><font style="letter-spacing:0.2pt;">&#8221; means, with respect to a Party, an inquiry, indication of interest or request for information (other than an inquiry, indication of interest or request for information made or submitted by the Company or any of its Affiliates, on the one hand, or Parent or any of its Affiliates, on the other hand, to the other Party) that could reasonably be expected to lead to an Acquisition Proposal, other than (i)&#160;with respect to Parent, solely with respect to the Asset Dispositions and (ii)&#160;with respect to the Company, solely with respect to the Pre-Closing Financing. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Acquisition Proposal</font><font style="letter-spacing:0.2pt;">&#8221; means, with respect to a Party, any offer or proposal, whether written or oral (other than an offer or proposal made or submitted by or on behalf of the Company or any of its Affiliates, on the one hand, or by or on behalf of Parent or any of its Affiliates, on the other hand, to the other Party) contemplating or otherwise relating to any Acquisition Transaction with such Party, other than (i)&#160;with respect to Parent, solely with respect to an Asset Disposition and (ii)&#160;with respect to the Company, solely with respect to the Pre-Closing Financing. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Acquisition Transaction</font><font style="letter-spacing:0.2pt;">&#8221; means any transaction or series of related transactions (other than the Asset Dispositions) involving: </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(i)&nbsp;&nbsp;&nbsp;any merger, consolidation, amalgamation, share exchange, business combination, issuance of securities, acquisition of securities, reorganization, recapitalization, tender offer, exchange offer or other similar transaction: (A)&#160;in which a Party is a constituent Entity; (B)&#160;in which a Person or &#8220;group&#8221; &#8203;(as defined in the Exchange Act and the rules promulgated thereunder) of Persons directly or indirectly acquires beneficial or record ownership of securities representing more than 15% of the outstanding securities of any class of voting securities of a Party or any of its Subsidiaries; or (C)&#160;in which a Party or any of its Subsidiaries issues securities representing more than 15% of the outstanding securities of any class of voting securities of such Party or any of its Subsidiaries; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, </font><font style="font-style:italic;letter-spacing:0.2pt;">however</font><font style="letter-spacing:0.2pt;">, that in the case of the Company, to the extent the Pre-Closing Financing is effected in accordance with the terms and conditions of this Agreement, the Pre-Closing Financing shall not constitute an Acquisition Transaction; or </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(ii)&nbsp;&nbsp;&nbsp;any sale, lease, exchange, transfer, license, acquisition or disposition of any business or businesses or assets that constitute or account for 15% or more of the consolidated book value or the fair market value of the assets of a Party and its Subsidiaries, taken as a whole. </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Affiliate</font><font style="letter-spacing:0.2pt;">&#8221; shall have the meaning given to such term in Rule&#160;145 under the Securities Act. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Antitrust Laws</font><font style="letter-spacing:0.2pt;">&#8221; shall mean the Sherman Act, as amended, the Clayton Act, as amended, the HSR Act, the Federal Trade Commission Act, as amended, all applicable foreign anti-trust laws and all other applicable Laws issued by a Governmental Body that are designed or intended to prohibit, restrict or regulate actions having the purpose or effect of monopolization or restraint of trade or lessening of competition. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Business Day</font><font style="letter-spacing:0.2pt;">&#8221; means any day other than a Saturday, Sunday or other day on which banks in New York, New York are authorized or obligated by Law to be closed. </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Code</font><font style="letter-spacing:0.2pt;">&#8221; means the Internal Revenue Code of 1986, as amended. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company Associate</font><font style="letter-spacing:0.2pt;">&#8221; means any current or former employee, independent contractor, officer or director of the Company or its Subsidiaries. </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company Board</font><font style="letter-spacing:0.2pt;">&#8221; means the board of directors of the Company. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company Capital Stock</font><font style="letter-spacing:0.2pt;">&#8221; means the Company Common Stock and the Company Preferred Stock. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-71</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; text-indent:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company Capitalization Representations</font><font style="letter-spacing:0.2pt;">&#8221; means the representations and warranties of the Company set forth in the first sentence of </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Sections&#160;2.6(a)</font><font style="letter-spacing:0.2pt;"> and in Section </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">2.6(d)</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company Common Stock</font><font style="letter-spacing:0.2pt;">&#8221; means the common stock, $0.0001 par value per share, of the Company. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company Contract</font><font style="letter-spacing:0.2pt;">&#8221; means any Contract: (a)&#160;to which the Company or any of its Subsidiaries is a Party; (b)&#160;by which the Company or any of its Subsidiaries or any Company IP or any other asset of the Company or its Subsidiaries is or may become bound or under which the Company or any of its Subsidiaries has, or may become subject to, any obligation; or (c)&#160;under which the Company or any of its Subsidiaries has or may acquire any right or interest. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company Convertible Note</font><font style="letter-spacing:0.2pt;">&#8221; means the outstanding note convertible described in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.6(a)</font><font style="letter-spacing:0.2pt;"> of the Company Disclosure Schedule. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company ERISA Affiliate</font><font style="letter-spacing:0.2pt;">&#8221; means any corporation or trade or business (whether or not incorporated) which is (or at any relevant time was) treated with the Company or any of its Subsidiaries as a single employer within the meaning of Section&#160;414 of the Code. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company Fundamental Representations</font><font style="letter-spacing:0.2pt;">&#8221; means the representations and warranties of the Company set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Sections&#160;2.1(a)</font><font style="letter-spacing:0.2pt;"> and </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">2.1(b)</font><font style="letter-spacing:0.2pt;"> (Due Organization; Subsidiaries), </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">2.3</font><font style="letter-spacing:0.2pt;"> (Authority; Binding Nature of Agreement), </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">2.4</font><font style="letter-spacing:0.2pt;"> (Vote Required), </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">2.5(a)</font><font style="letter-spacing:0.2pt;"> (Non-Contravention) and </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">2.20</font><font style="letter-spacing:0.2pt;"> (No Financial Advisors). </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company IP</font><font style="letter-spacing:0.2pt;">&#8221; means all Intellectual Property Rights that are owned or purported to be owned by, assigned to, or exclusively licensed by, the Company or its Subsidiaries that are necessary for or used in the operation of the business of the Company or its Subsidiaries. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company Material Adverse Effect</font><font style="letter-spacing:0.2pt;">&#8221; means any Effect that, considered together with all other Effects that have occurred prior to the date of determination of the occurrence of a Company Material Adverse Effect, has or would reasonably be expected to have a material adverse effect on the business, financial condition, assets, liabilities or results of operations of the Company and its Subsidiaries, taken as a whole; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided, however</font><font style="letter-spacing:0.2pt;">, that Effects arising or resulting from the following shall not be taken into account in determining whether there has been a Company Material Adverse Effect: (a)&#160;the announcement of this Agreement or the pendency of the Contemplated Transactions; (b)&#160;general business, economic or political conditions or conditions generally affecting the industry in which the Company and its Subsidiaries operate; (c)&#160;hurricane, flood, tornado, earthquake or other natural disaster, changes in weather conditions, epidemic, plague, pandemic (including COVID-19) or any other outbreak of illness or other public health event or any other force majeure event, whether or not cause by any Person, or any national or international calamity or crises, or any law, regulation, statute, directive, pronouncement or guideline issued by a Governmental Body, the World Health Organization or industry group providing for business closures, &#8220;sheltering-in-place,&#8221; curfews or other restrictions that relate to, or arise out of, an epidemic, pandemic or disease outbreak (including COVID-19) or any change in such law, regulation, statute, directive, pronouncement or guideline or interpretation thereof or any worsening of such conditions; (d)&#160;any COVID-19 Measures or COVID-19 Responses; (e)&#160;any acts, threats or escalations of war, armed hostilities or terrorism anywhere in the world or any governmental or other response or reaction to any of the foregoing; (f)&#160;any change in, or any compliance with or action taken for the purpose of complying with, any Law or GAAP (or interpretations of any Law or GAAP); (g)&#160;with respect to any product or product candidate of the Company or any of its Subsidiaries, the request of the FDA to refile, amend, or temporarily delay making any regulatory application or filing related to such product or product candidate or the protocol for any clinical trial relating to such product or product candidate (provided that this clause (g)&#160;shall not apply in the event of repeated or continued adverse decisions with respect to the Company&#8217;s product or product candidates by the FDA); or (h)&#160;resulting from the taking of any action, or the failure to take any action, by the Company that is expressly required to be taken by this Agreement; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, </font><font style="font-style:italic;letter-spacing:0.2pt;">however</font><font style="letter-spacing:0.2pt;">, that, in the case of clauses (b), (c), (d), (e)&#160;and (f), solely to the extent the impact on the Company and its Subsidiaries, taken as a whole, is disproportionately adverse compared to the impact on similarly situated companies operating in the industries in which the Company and its Subsidiaries operate, the incrementally disproportionate impact </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-72</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">or impacts shall be taken into account in determining whether there has been, or would reasonably be expected to be, a Company Material Adverse Effect. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company Options</font><font style="letter-spacing:0.2pt;">&#8221; means options or other rights to purchase shares of Company Common Stock issued by the Company. </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company Plan</font><font style="letter-spacing:0.2pt;">&#8221; means the 2017 Stock Incentive Plan, as amended from time to time. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company Preferred Stock</font><font style="letter-spacing:0.2pt;">&#8221; means, collectively, the Company Series&#160;A Preferred Stock, Company Special Voting Preferred Stock, Company Series&#160;B Preferred Stock and the Company Series&#160;B Special Voting Preferred Stock. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company Series&#160;A Preferred Stock</font><font style="letter-spacing:0.2pt;">&#8221; means the Series&#160;A Preferred Stock, $0.0001 par value per share, of the Company. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company Series&#160;B Preferred Stock</font><font style="letter-spacing:0.2pt;">&#8221; means the Series&#160;B Preferred Stock, $0.0001 par value per share, of the Company. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company Series&#160;B Special Voting Preferred Stock</font><font style="letter-spacing:0.2pt;">&#8221; means the Series&#160;B Special Voting Preferred Stock, $0.0001 par value per share, of the Company. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company Special Voting Preferred Stock</font><font style="letter-spacing:0.2pt;">&#8221; means the Special Voting Preferred Stock, $0.0001 par value per share, of the Company. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company Transaction Expenses</font><font style="letter-spacing:0.2pt;">&#8221; means, as of the applicable time of determination and without duplication, the sum of (a)&#160;the cash cost of any accrued and unpaid retention payments or other bonuses, as well as any change of control payments or severance, termination or similar payments that are due or become due to any current or former employee, director or independent contractor of the Company or any of its Subsidiaries at or prior to the Effective Time or otherwise in connection with the Merger or the Contemplated Transactions, and (b)&#160;subject to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;9.3</font><font style="letter-spacing:0.2pt;">, all costs, fees and expenses incurred by the Company or its Subsidiaries at or prior to the Effective Time in connection with the negotiation, preparation and execution of this Agreement or any agreements, documents, certificate, opinions or other items contemplated hereby and the consummation of the Merger or the Contemplated Transactions and that are unpaid as of the Effective Time, including brokerage fees and commissions, finder&#8217;s fees, legal fees or financial advisory fees payable or otherwise incurred by such person at or prior to the Effective Time. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company Triggering Event</font><font style="letter-spacing:0.2pt;">&#8221; shall be deemed to have occurred if: (a)&#160;the Company shall have made a Company Board Adverse Recommendation Change; (b)&#160;the Company Board or any committee thereof shall have publicly approved, endorsed or recommended any Acquisition Proposal; or (c)&#160;the Company shall have entered into any letter of intent or similar document relating to any Acquisition Proposal. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company Unaudited Interim Balance Sheet</font><font style="letter-spacing:0.2pt;">&#8221; means the unaudited consolidated balance sheet of the Company and its consolidated Subsidiaries for the period ended June&#160;30, 2022 provided to Parent prior to the date hereof. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Confidentiality Agreement</font><font style="letter-spacing:0.2pt;">&#8221; means that certain Confidentiality Agreement, dated as of June&#160;25, 2022, between the Company and Parent. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Consent</font><font style="letter-spacing:0.2pt;">&#8221; means any approval, consent, ratification, permission, waiver or authorization (including any Governmental Authorization). </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Contemplated Transactions</font><font style="letter-spacing:0.2pt;">&#8221; means the Merger, the Nasdaq Reverse Split, and the other transactions and actions contemplated by this Agreement, including the CVR Agreement. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Contract</font><font style="letter-spacing:0.2pt;">&#8221; means, with respect to any Person, any written or oral agreement, contract, subcontract, lease (whether for real or personal property), mortgage, license, sublicense or other legally binding commitment or undertaking of any nature to which such Person is a party or by which such Person or any of its assets are bound or affected under applicable Law. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-73</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; text-indent:20pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Conversion</font><font style="letter-spacing:0.2pt;">&#8221; means the conversion of the Company Convertible Note for shares of Parent Common Stock pursuant to the Convertible Note Conversion Agreement. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Convertible Note Conversion Agreement</font><font style="letter-spacing:0.2pt;">&#8221; means that certain Conversion Agreement, dated as of September&#160;20, 2022, by and between the Company and the holder of the Company Convertible Note. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">COVID-19</font><font style="letter-spacing:0.2pt;">&#8221; means SARS-CoV-2 or the COVID-19 virus, and any evolutions or mutations thereof and any related or associated epidemics, pandemics or disease outbreaks. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">COVID-19 Measures</font><font style="letter-spacing:0.2pt;">&#8221; means any quarantine, &#8220;shelter in place,&#8221; &#8220;stay at home,&#8221; workforce reduction, social distancing, shut down, closure, sequester or any other law, regulation, rule, order, directive, guideline or recommendation of any Governmental Body or industry group in connection with or in response to COVID-19, including the Coronavirus Aid, Relief, and Economic Security Act. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">COVID-19 Responses</font><font style="letter-spacing:0.2pt;">&#8221; means any action or inaction, including the establishment of any policy, procedure or protocol, by a Party or any of its Subsidiaries that such Party or any of its Subsidiaries determines in its reasonable discretion is necessary, advisable or prudent in connection with (a)&#160;mitigating the adverse effects of COVID-19 or applicable COVID-19 Measures, (b)&#160;ensuring compliance by such Party or any of its Subsidiaries with COVID-19 Measures applicable to any of them and/or (c)&#160;in respect of COVID-19, protecting the health and safety of employees or other persons with whom such Party or any of its Subsidiaries and their personnel come into contact with during the course of business operations. </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">DGCL</font><font style="letter-spacing:0.2pt;">&#8221; means the General Corporation Law of the State of Delaware. </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Effect</font><font style="letter-spacing:0.2pt;">&#8221; means any effect, change, event, circumstance, or development. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Encumbrance</font><font style="letter-spacing:0.2pt;">&#8221; means any lien, pledge, hypothecation, charge, mortgage, security interest, exclusive license, easement, adverse title or similar restriction or encumbrance of any nature. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Enforceability Exceptions</font><font style="letter-spacing:0.2pt;">&#8221; means the (a)&#160;Laws of general application relating to bankruptcy, insolvency and the relief of debtors; and (b)&#160;rules of law governing specific performance, injunctive relief and other equitable remedies. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Entity</font><font style="letter-spacing:0.2pt;">&#8221; means any corporation (including any non-profit corporation), partnership (including any general partnership, limited partnership or limited liability partnership), joint venture, estate, trust, company (including any company limited by shares, limited liability company or joint stock company), firm, society or other enterprise, association, organization or entity, and each of its successors. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Environmental Law</font><font style="letter-spacing:0.2pt;">&#8221; means any federal, state, local or foreign Law relating to pollution or protection of human health or the environment (including ambient air, surface water, ground water, land surface or subsurface strata), including any Law or regulation relating to emissions, discharges, releases or threatened releases of Hazardous Materials, or otherwise relating to the manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling of Hazardous Materials. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Equity Plan&#160;Amendments</font><font style="letter-spacing:0.2pt;">&#8221; means (a)&#160;an amendment to the Sesen Bio, Inc. 2014 Stock Incentive Plan to provide for (i)&#160;such number of shares of common stock of Parent as mutually agreed by Parent and the Company (such agreement not to be unreasonably withheld, conditioned or delayed), not to exceed 9.5% on a fully diluted basis to be available for grant or issuance thereunder, as calculated to be as of immediately following the Closing, (ii)&#160;an extension of the term of the Sesen Bio, Inc. 2014 Incentive Plan up to, in the Company&#8217;s discretion, the 10th anniversary of the effectiveness of the Equity Plan&#160;Amendments and (iii)&#160;any other amendments deemed necessary and advisable by the Company, and (b)&#160;an amendment to the Parent ESPP to provide for such number of shares of common stock of Parent equal to one&#160;percent (1.0%) on a fully diluted basis to be available for purchase thereunder, as calculated to be as of immediately following the Closing. </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">ERISA</font><font style="letter-spacing:0.2pt;">&#8221; means the Employee Retirement Income Security Act of 1974, as amended. </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Exchange Act</font><font style="letter-spacing:0.2pt;">&#8221; means the Securities Exchange Act of 1934, as amended. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-74</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; text-indent:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Exchange Ratio</font><font style="letter-spacing:0.2pt;">&#8221; means, subject to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;1.5(h)</font><font style="letter-spacing:0.2pt;">, the following ratio (rounded to four decimal places): the quotient obtained by dividing (a)&#160;the Company Merger Shares by (b)&#160;the Company Outstanding Shares, in which: </font>
        </div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:50pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Aggregate Valuation</font><font style="letter-spacing:0.2pt;">&#8221; means the sum of (i)&#160;the Company Valuation, plus (ii)&#160;the Parent Valuation. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:50pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company Allocation Percentage</font><font style="letter-spacing:0.2pt;">&#8221; means the quotient (expressed as a&#160;percentage with the&#160;percentage rounded to four decimal places) determined by dividing (i)&#160;the Company Valuation by (ii)&#160;the Aggregate Valuation. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:50pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company Merger Shares</font><font style="letter-spacing:0.2pt;">&#8221; means the product of (i)&#160;the Post-Closing Parent Shares multiplied by (ii)&#160;the Company Allocation Percentage. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:50pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company Outstanding Shares</font><font style="letter-spacing:0.2pt;">&#8221; means the total number of shares of Company Capital Stock outstanding immediately prior to the Effective Time expressed on a fully-diluted and as-converted to Company Common Stock basis and assuming, without limitation or duplication, (i)&#160;the exercise of all Company Options outstanding as of immediately prior to the Effective Time, (ii)&#160;the closing of the Pre-Closing Financing, and (iii)&#160;the issuance of shares of Company Common Stock issuable in respect of all other outstanding options, restricted stock awards, warrants or rights to receive such shares, whether conditional or unconditional and including any outstanding options, warrants or rights triggered by or associated with the consummation of the Merger. Company Outstanding Shares shall also include all shares of the Company issued in the Pre-Closing Financing prior to the Effective Time and excludes any shares to be issued upon the conversion of the Company Convertible Note. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:50pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company Valuation</font><font style="letter-spacing:0.2pt;">&#8221; means (i)&#160;$196,000,000, plus (ii)&#160;the amount of gross proceeds from the Pre-Closing Financing prior to the Effective Time. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:50pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent Allocation Percentage</font><font style="letter-spacing:0.2pt;">&#8221; means the quotient (expressed as a&#160;percentage, with the&#160;percentage rounded to four decimal places) determined by dividing (i)&#160;the Parent Valuation by (ii)&#160;the Aggregate Valuation. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:50pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent Outstanding Shares</font><font style="letter-spacing:0.2pt;">&#8221; means the total number of shares of Parent Common Stock outstanding immediately prior to the Effective Time expressed on a fully-diluted and as converted to Parent Common Stock basis, assuming, without limitation or duplication, the issuance of shares of Parent Common Stock in respect of all Parent Options, Parent RSUs, Parent Warrants and other outstanding options, warrants or rights to receive such shares, in each case, outstanding as of immediately prior to the Effective Time. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:50pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent Valuation</font><font style="letter-spacing:0.2pt;">&#8221; means $140,000,000, minus the amount by which Final Net Cash as determined in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;1.11</font><font style="letter-spacing:0.2pt;"> is less than $125,000,000 (if any), and plus the amount by which Final Net Cash as determined in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;1.11</font><font style="letter-spacing:0.2pt;"> is greater than $125,000,000. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:50pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Post-Closing Parent Shares</font><font style="letter-spacing:0.2pt;">&#8221; means the quotient determined by dividing (i)&#160;the Parent Outstanding Shares by (ii)&#160;the Parent Allocation Percentage. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">An example of the calculation of the Exchange Ratio and its components is set forth on </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Exhibit&#160;H</font><font style="letter-spacing:0.2pt;"> for illustrative purposes only. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">GAAP</font><font style="letter-spacing:0.2pt;">&#8221; means generally accepted accounting principles and practices in effect from time to time within the United States applied consistently throughout the period involved. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Governmental Authorization</font><font style="letter-spacing:0.2pt;">&#8221; means any: (a)&#160;permit, license, certificate, certification, franchise, permission, approval, exemption, variance, exception, order, clearance, registration, qualification or authorization issued, granted, given or otherwise made available by or under the authority of any Governmental Body or pursuant to any Law; or (b)&#160;right under any Contract with any Governmental Body. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Governmental Body</font><font style="letter-spacing:0.2pt;">&#8221; means any: (a)&#160;nation, state, commonwealth, province, territory, county, municipality, district or other jurisdiction of any nature; (b)&#160;federal, state, local, municipal, foreign or </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-75</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">other government; (c)&#160;governmental or quasi-governmental authority of any nature (including any governmental division, department, agency, commission, bureau, instrumentality, official, ministry, fund, foundation, center, organization, unit, body or Entity and any court or other tribunal, and for the avoidance of doubt, any taxing authority); or (d)&#160;self-regulatory organization (including Nasdaq). </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Hazardous Materials</font><font style="letter-spacing:0.2pt;">&#8221; means any pollutant, chemical, substance and any toxic, infectious, carcinogenic, reactive, corrosive, ignitable or flammable chemical, or chemical compound, or hazardous substance, material or waste, whether solid, liquid or gas, that is subject to regulation, control or remediation under any Environmental Law, including without limitation, crude oil or any fraction thereof, and petroleum products or by-products. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">HSR Act</font><font style="letter-spacing:0.2pt;">&#8221; means the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, and the rules and regulations promulgated thereunder. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Intellectual Property Rights</font><font style="letter-spacing:0.2pt;">&#8221; means and includes all intellectual property or other proprietary rights under the laws of any jurisdiction in the world, including, without limitation: (a)&#160;rights associated with works of authorship, including exclusive exploitation rights, copyrights, moral rights, software, databases, and mask works; (b)&#160;trademarks, service marks, trade dress, logos, trade names and other source identifiers, domain names and URLs and similar rights and any and all goodwill associated therewith; (c)&#160;rights associated with trade secrets, know how, inventions, invention disclosures, methods, processes, protocols, specifications, techniques and other forms of technology; (d)&#160;patents and industrial property rights; and (e)&#160;other similar proprietary rights in intellectual property of every kind and nature; (f)&#160;rights of privacy and publicity; and (g)&#160;all registrations, renewals, extensions, statutory invention registrations, provisionals, continuations, continuations-in-part, provisionals, divisions, or reissues of, and applications for, any of the rights referred to in clauses &#8220;(a)&#8221; through &#8220;(f)&#8221; above (whether or not in tangible form and including all tangible embodiments of any of the foregoing, such as samples, studies and summaries), along with all rights to prosecute and perfect the same through administrative prosecution, registration, recordation or other administrative proceeding, and all causes of action and rights to sue or seek other remedies arising from or relating to the foregoing, including for past, present or future infringement of any of the foregoing. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Investor Agreements</font><font style="letter-spacing:0.2pt;">&#8221; means each stockholders agreement, voting agreement, registration rights agreement, co-sale agreement or other similar Contract between the Company and any holders of Company Common Stock, including any such Contract granting any Person investor rights, rights of first refusal, rights of first offer, registration rights, director designation rights or similar rights. </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">IRS</font><font style="letter-spacing:0.2pt;">&#8221; means the United States Internal Revenue Service. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Key Employee</font><font style="letter-spacing:0.2pt;">&#8221; means, with respect to the Company or Parent, an executive officer of such Party or any employee of such Party that reports directly to the board of directors of such Party or to the chief executive officer or chief accounting officer of such party. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Knowledge</font><font style="letter-spacing:0.2pt;">&#8221; means, with respect to the Company or the Parent, that an individual identified on Schedule&#160;A of the Company Disclosure Schedule or Schedule&#160;A of the Parent Disclosure Schedule, as applicable, was actually aware on the date of this Agreement of the relevant fact. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Law</font><font style="letter-spacing:0.2pt;">&#8221; means any federal, state, national, foreign, material local or municipal or other law, statute, constitution, principle of common law, resolution, ordinance, code, edict, decree, rule, regulation, ruling or requirement issued, enacted, adopted, promulgated, implemented or otherwise put into effect by or under the authority of any Governmental Body (including under the authority of Nasdaq or the Financial Industry Regulatory Authority). </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Legal Proceeding</font><font style="letter-spacing:0.2pt;">&#8221; means any action, suit, litigation, arbitration, proceeding (including any civil, criminal, administrative, investigative or appellate proceeding), hearing, inquiry, audit, examination or investigation commenced, brought, conducted or heard by or before, or otherwise involving, any court or other Governmental Body or any arbitrator or arbitration panel. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Material Continuing Obligation</font><font style="letter-spacing:0.2pt;">&#8221; shall mean (a)&#160;any non-competition obligation affecting any of the assets or business of the Company as they exist as of the date of this Agreement, or (b)&#160;any Liability </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-76</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">or other obligation which would require Parent, Company or any of their respective Subsidiaries, to, after the Effective Time, make any cash payment or expenditure in excess of $250,000, which would not be offset by the receipt of a future payment or contingent consideration. </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Merger Sub Board</font><font style="letter-spacing:0.2pt;">&#8221; means the board of directors of Merger Sub. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Nasdaq</font><font style="letter-spacing:0.2pt;">&#8221; means the Nasdaq Stock Market, LLC, including the Nasdaq Capital Market or such other Nasdaq market on which shares of Parent Common Stock are then listed. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Nasdaq Reverse Split</font><font style="letter-spacing:0.2pt;">&#8221; means a reverse stock split of all outstanding shares of Parent Common Stock at a reverse stock split ratio as mutually agreed to by Parent and the Company that is effected by Parent for the purpose of maintaining compliance with Nasdaq listing standards. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Net Cash</font><font style="letter-spacing:0.2pt;">&#8221; means, as of any applicable time of determination and without duplication, (A)&#160;the sum of (i)&#160;cash and cash equivalents, marketable securities and other short-term investments of Parent and its Subsidiaries, (ii)&#160;accounts receivable (including any Tax refund claims pending as of the date of this Agreement), deposits and interest, (iii)&#160;deposits, prepaid expenses and other prepaid assets which are reflected on the most recent balance sheet and do not constitute restricted cash of Parent and its Subsidiaries, and (iv)&#160;50% of the cost of settling any Transaction Litigation to the extent actually paid in cash by Parent prior to the Closing Date, minus (B)&#160;the sum of (1)&#160;any unpaid Parent Transaction Expenses, (2)&#160;any unpaid indebtedness of Parent and/or its Subsidiaries outstanding as of the Closing Date, (3)&#160;any accounts payable, accrued expenses or short or long term liabilities that are or will become payable in cash, including any such accounts payable, accrued expenses or short or long term liabilities under any Parent Contracts which were in effect prior to the Effective Time or associated with the termination of any Parent Contracts which were in effect prior to the Effective Time, or the termination before, at or after the Effective Time, of all current or former employees of Parent and its Subsidiaries (even if the applicable expenses or amounts are due and payable after the Effective Time) pursuant to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.20(a)</font><font style="letter-spacing:0.2pt;"> (including, for clarity, any amounts in respect of the matters set forth on </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Schedule&#160;N</font><font style="letter-spacing:0.2pt;"> if reasonably estimable by Parent in good faith), (4)&#160;any unpaid employer portion of payroll or employment Taxes incurred in connection with the grant, exercise, conversion, settlement or cancellation of Parent RSUs, Parent Options, equity compensation and other change in control or severance payments (including bonuses payable) to be paid pursuant to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.20(a)</font><font style="letter-spacing:0.2pt;"> or CVRs issued to holders of Parent RSUs or Parent Options or otherwise as compensation (either incurred prior to or at the time of the Merger, and for the avoidance of doubt, not calculated as of the close of business on the Business Day prior to the Closing Date) in each case with respect to this clause (4), incurred in connection with the Merger by Parent at or prior to the Effective Time (even if payable after the Effective Time), (5)&#160;any pre-payment, termination, &#8220;end of term&#8221; or similar fee or charge payable to any lender in connection with the repayment of indebtedness by Parent at or prior to the Effective Time, (6)&#160;the amount of any cash dividend declared (or to be declared) but not yet paid as part of the Pre-Closing Dividend, (7)&#160;to the extent unpaid at Closing, the cost and/or premium of the D&amp;O Tail Policy, and (8)&#160;to the extent unpaid at Closing, (A)&#160;the cost of settling any Legal Proceeding or other dispute existing as of the date of this Agreement, as well as the unpaid deductible amount under the Parent&#8217;s insurance reasonably expected to be payable in connection with Legal Proceedings existing as of the date of this Agreement, and (B)&#160;if reasonably estimable by Parent in good faith as of the Closing Date, 50% of the cost of settling any Transaction Litigation. Each component of Net Cash, to the extent applicable, shall be determined in accordance with GAAP, applied on a basis consistent with the application of GAAP in the preparation of Parent&#8217;s most recent audited or reviewed financial statements. Net Cash shall be calculated excluding the effects of any payments or liabilities (including attorney&#8217;s fees and settlement costs) in respect of Dissenting Shares or any Transaction Litigation (other than as set forth in clause (8)(B)) and any payments which become due and payable after the Effective Time, if any, under that certain Share Purchase Agreement, dated September&#160;20, 2016, by and among Eleven Biotherapeutics, Inc., Viventia Bio Inc. and the other parties thereto. Net Cash shall be increased as necessary to account for any payments made by Parent to cover expenses or fees that are required to be shared pursuant to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;9.3(a)</font><font style="letter-spacing:0.2pt;">. A sample calculation of Net Cash and its components is set forth on </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Exhibit&#160;E</font><font style="letter-spacing:0.2pt;"> for illustrative purposes only. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Ordinary Course of Business</font><font style="letter-spacing:0.2pt;">&#8221; means, in the case of each of the Company and Parent, such actions taken in the ordinary course of its normal operations and consistent in all material respects </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-77</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">with its past practices, taking into account any acts or omissions that have been or may be taken to comply with COVID-19 Measures or in good faith response to the COVID-19 pandemic, or otherwise to the extent necessary to avoid, mitigate or remediate a material adverse effect on the Company, Parent or any of their respective Subsidiaries or their respective businesses as may result from the COVID-19 pandemic, and subject to any reasonable changes required to address any then current facts and circumstances (including requirements to comply with applicable Law and guidelines and to reasonably preserve the health and safety of current employees and other service providers of the Company, Parent or any of their respective Subsidiaries); </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, that any actions taken or not taken by the Company, Parent and any of their respective Subsidiaries reasonably and in good faith to respond to any other extraordinary event that was not reasonably foreseeable as of the date of this Agreement and occurring after the date of this Agreement that is outside of the control of the Company, Parent or their respective Affiliates, as applicable, shall be deemed to have been taken or not taken, as applicable, in the &#8220;Ordinary Court of Business.&#8221; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Organizational Documents</font><font style="letter-spacing:0.2pt;">&#8221; means, with respect to any Person (other than an individual), (a)&#160;the certificate or articles of association or incorporation or organization or limited partnership or limited liability company, and any joint venture, limited liability company, operating or partnership agreement and other similar documents adopted or filed in connection with the creation, formation or organization of such Person and (b)&#160;all bylaws, regulations and similar documents or agreements relating to the organization or governance of such Person, in each case, as amended or supplemented. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent Associate</font><font style="letter-spacing:0.2pt;">&#8221; means any current or former employee, independent contractor, officer or director of Parent or any of its Subsidiaries. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent Balance Sheet</font><font style="letter-spacing:0.2pt;">&#8221; means the unaudited balance sheet of Parent as of June&#160;30, 2022 (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent Balance Sheet Date</font><font style="letter-spacing:0.2pt;">&#8221;), included in Parent&#8217;s Report on Form 10-Q for the quarterly period ended June&#160;30, 2022, as filed with the SEC. </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent Board</font><font style="letter-spacing:0.2pt;">&#8221; means the board of directors of Parent. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent Capitalization Representations</font><font style="letter-spacing:0.2pt;">&#8221; means the representations and warranties of Parent and Merger Sub set forth in the first sentence of </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Sections&#160;3.6(a)</font><font style="letter-spacing:0.2pt;"> and </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">3.6(d)</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent Common Stock</font><font style="letter-spacing:0.2pt;">&#8221; means the common stock, $0.001 par value per share, of Parent. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent Contract</font><font style="letter-spacing:0.2pt;">&#8221; means any Contract: (a)&#160;to which Parent or any of its Subsidiaries is a party; (b)&#160;by which Parent, any of its Subsidiaries or any Parent IP or any other asset of Parent or any of its Subsidiaries is or may become bound or under which Parent or any of its Subsidiaries has, or may become subject to, any obligation; or (c)&#160;under which Parent or any of its Subsidiaries has or may acquire any right or interest. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent ERISA Affiliate</font><font style="letter-spacing:0.2pt;">&#8221; means any corporation or trade or business (whether or not incorporated) which is (or at any relevant time was) treated with Parent or any of its Subsidiaries as a single employer within the meaning of Section&#160;414 of the Code. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent ESPP</font><font style="letter-spacing:0.2pt;">&#8221; means the Sesen Bio, Inc. 2014 Employee Stock Purchase Plan, as amended from time to time. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent Fundamental Representations</font><font style="letter-spacing:0.2pt;">&#8221; means the representations and warranties of Parent and Merger Sub set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Sections&#160;3.1</font><font style="letter-spacing:0.2pt;"> (Due Organization; Subsidiaries), </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">3.3</font><font style="letter-spacing:0.2pt;"> (Authority; Binding Nature of Agreement), </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">3.4</font><font style="letter-spacing:0.2pt;"> (Vote Required), </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">3.5(a)</font><font style="letter-spacing:0.2pt;"> (Non-Contravention) and </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">3.20</font><font style="letter-spacing:0.2pt;"> (No Financial Advisors). </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent IP</font><font style="letter-spacing:0.2pt;">&#8221; means all Intellectual Property Rights that are owned or purported to be owned by, assigned to, or exclusively licensed by, Parent or its Subsidiaries that are necessary for or used in the operation of the business of Parent and its Subsidiaries as presently conducted. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent Material Adverse Effect</font><font style="letter-spacing:0.2pt;">&#8221; means any Effect that, considered together with all other Effects that have occurred prior to the date of determination of the occurrence of a Parent Material Adverse Effect, has or would reasonably be expected to have a material adverse effect on the business, financial condition, assets, liabilities or results of operations of Parent and its Subsidiaries, taken as a whole; </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-78</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, </font><font style="font-style:italic;letter-spacing:0.2pt;">however</font><font style="letter-spacing:0.2pt;">, that Effects arising or resulting from the following shall not be taken into account in determining whether there has been a Parent Material Adverse Effect: (a)&#160;the announcement of this Agreement or the pendency of the Contemplated Transactions; (b)&#160;general business, economic or political conditions or conditions generally affecting the industry in which Parent and its Subsidiaries operate; (c)&#160;hurricane, flood, tornado, earthquake or other natural disaster, changes in weather conditions, epidemic, plague, pandemic (including COVID-19) or any other outbreak of illness or other public health event or any other force majeure event, whether or not caused by any Person, or an national or international calamity or crises, or any law, regulation, statute, directive, pronouncement or guideline issued by a Governmental Body, the World Health Organization or industry group providing for business closures, &#8220;sheltering-in-place,&#8221; curfews or other restrictions that relate to, or arise out of, an epidemic, pandemic or disease outbreak (including COVID-19) or any change in such law, regulation, statute, directive, pronouncement or guideline or interpretation thereof or any worsening of such conditions; (d)&#160;any COVID-19 Measures or COVID-19 Responses; (e)&#160;any acts, threats or escalations of war, armed hostilities or terrorism anywhere in the world or any governmental or other response or reaction to any of the foregoing; (f)&#160;changes in the trading price or trading volume of Parent Common Stock (it being understood, however, that any Effect causing or contributing to any change in stock price or trading volume of Parent Common Stock may be taken into account in determining whether a Parent Material Adverse Effect has occurred, unless such Effects are otherwise excepted from this definition), or the suspension of trading in or delisting of Parent&#8217;s securities on Nasdaq; (g)&#160;any change in, or any compliance with or action taken for the purpose of complying with, any Law or GAAP (or interpretations of any Law or GAAP); (h)&#160;with respect to any product or product candidate of Parent or any of its Subsidiaries, the request of the FDA to refile, amend, or temporarily delay making any regulatory application or filing related to such product or product candidate or the protocol for any clinical trial relating to such product or product candidate (provided that this clause (h)&#160;shall not apply in the event of repeated or continued adverse decisions with respect to Parent&#8217;s product or product candidates by the FDA); or (i)&#160;resulting from the taking of any action or the failure to take any action, by Parent that is expressly required to be taken by this Agreement; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, </font><font style="font-style:italic;letter-spacing:0.2pt;">however</font><font style="letter-spacing:0.2pt;">, that, in the case of clauses (b), (c), (d), (e), and (h), solely to the extent the impact on Parent and its Subsidiaries, taken as a whole, is disproportionately adverse compared to the impact on similarly situated companies operating in the industries in which Parent and its Subsidiaries operate, the incrementally disproportionate impact or impacts shall be taken into account in determining whether there has been, or would reasonably be expected to be, a Parent Material Adverse Effect. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent Options</font><font style="letter-spacing:0.2pt;">&#8221; means options or other rights to purchase shares of Parent Common Stock issued by Parent other than Parent Warrants. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent RSUs</font><font style="letter-spacing:0.2pt;">&#8221; means restricted stock&#160;units issued by Parent, whether time-based or performance based vesting. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent Stock Plans</font><font style="letter-spacing:0.2pt;">&#8221; means the Sesen Bio, Inc. 2014 Stock Incentive Plan and the Sesen Bio, Inc. 2009 Stock Incentive Plan, in each case, as amended from time to time. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent Transaction Expenses</font><font style="letter-spacing:0.2pt;">&#8221; means as of the applicable time of determination and without duplication, the sum of (a)&#160;the cash cost of any accrued and unpaid retention payments or other bonuses, as well as any change of control payments or severance, termination or similar payments that are due or become due to any current or former employee, director or independent contractor of Parent or any of its Subsidiaries at or prior to the Effective Time otherwise in connection with the Merger or the Contemplated Transactions (and, for the avoidance of doubt, shall exclude any payments under arrangements entered into by Parent after the Effective Time), and (b)&#160;subject to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;9.3</font><font style="letter-spacing:0.2pt;">, all costs, fees and expenses incurred by Parent or its Subsidiaries at or prior to the Effective Time in connection with the negotiation, preparation and execution of this Agreement or any agreements, documents, certificate, opinions or other items contemplated hereby and the consummation of the Merger or the Contemplated Transactions and that are unpaid as of the Effective Time, including brokerage fees and commissions, finder&#8217;s fees, legal fees or financial advisory fees payable or otherwise incurred by such person at or prior to the Effective Time. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent Triggering Event</font><font style="letter-spacing:0.2pt;">&#8221; shall be deemed to have occurred if: (a)&#160;Parent shall have failed to include in the Proxy Statement/Prospectus the Parent Board Recommendation or shall have made a </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-79</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Parent Board Adverse Recommendation Change; (b)&#160;the Parent Board or any committee thereof shall have publicly approved, endorsed or recommended any Acquisition Proposal; or (c)&#160;Parent shall have entered into any letter of intent or similar document relating to any Acquisition Proposal (other than a confidentiality agreement permitted pursuant to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;4.4</font><font style="letter-spacing:0.2pt;">). </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent Warrants</font><font style="letter-spacing:0.2pt;">&#8221; means the warrants to purchase capital stock of Parent listed in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;B</font><font style="letter-spacing:0.2pt;"> of the Parent Disclosure Schedule. </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Party</font><font style="letter-spacing:0.2pt;">&#8221; or &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parties</font><font style="letter-spacing:0.2pt;">&#8221; means the Company, Merger Sub and Parent. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Permitted Encumbrance</font><font style="letter-spacing:0.2pt;">&#8221; means: (a)&#160;any liens for current Taxes not yet due and payable or for Taxes that are being contested in good faith and, in each case, for which adequate reserves have been made on the Company Unaudited Interim Balance Sheet or the Parent Balance Sheet, as applicable; (b)&#160;minor liens that have arisen in the Ordinary Course of Business and that do not (in any case or in the aggregate) materially detract from the value of the assets or properties subject thereto or materially impair the use thereof or the operations of the Company or any of its Subsidiaries or Parent, as applicable; (c)&#160;statutory liens to secure obligations to landlords, lessors or renters under leases or rental agreements; (d)&#160;deposits or pledges made in connection with, or to secure payment of, workers&#8217; compensation, unemployment insurance or similar programs mandated by Law in the Ordinary Course of Business; (e)&#160;non-exclusive licenses of Intellectual Property Rights granted by the Company or any of its Subsidiaries or Parent or any of its Subsidiaries, as applicable, in the Ordinary Course of Business and that do not (in any case or in the aggregate) materially detract from the value of the Intellectual Property Rights subject thereto; and (f)&#160;statutory liens in favor of carriers, warehousemen, mechanics and materialmen, to secure claims for labor, materials or supplies. </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Person</font><font style="letter-spacing:0.2pt;">&#8221; means any individual, Entity or Governmental Body. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Potentially Transferable Assets</font><font style="letter-spacing:0.2pt;">&#8221; means the non-cash assets of Parent existing as of the date of this Agreement. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Pre-Closing Financing</font><font style="letter-spacing:0.2pt;">&#8221; means an acquisition of capital stock of the Company to be consummated immediately prior to the Closing pursuant to the Subscription Agreements. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Proxy Statement/Prospectus</font><font style="letter-spacing:0.2pt;">&#8221; means the proxy statement/prospectus, which shall be included in the Registration Statement, to be sent to Parent&#8217;s stockholders in connection with the Parent Stockholders&#8217; Meeting. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Registration Statement</font><font style="letter-spacing:0.2pt;">&#8221; means the registration statement on Form S-4 (or any other applicable form under the Securities Act to register Parent Common Stock) to be filed with the SEC by Parent registering the public offering and sale of Parent Common Stock to holders of Company Capital Stock and the Company Convertible Note in the Merger or the Conversion, as applicable, as may be amended prior to the time it is declared effective by the SEC. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Representatives</font><font style="letter-spacing:0.2pt;">&#8221; means directors, officers, employees, agents, attorneys, accountants, investment bankers, advisors and representatives. </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Sarbanes-Oxley Act</font><font style="letter-spacing:0.2pt;">&#8221; means the Sarbanes-Oxley Act of 2002. </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">SEC</font><font style="letter-spacing:0.2pt;">&#8221; means the United States Securities and Exchange Commission. </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Securities Act</font><font style="letter-spacing:0.2pt;">&#8221; means the Securities Act of 1933, as amended. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Subscription Agreement</font><font style="letter-spacing:0.2pt;">&#8221; means any stock purchase agreement, as well as related investment agreements, entered into among the Company and the Person(s) named therein, pursuant to which such Persons have agreed to purchase immediately prior to the Effective Time the number of shares of capital stock of the Company set forth therein in connection with the Pre-Closing Financing. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Subsequent Transaction</font><font style="letter-spacing:0.2pt;">&#8221; means any Acquisition Transaction (with all references to 15% in the definition of Acquisition Transaction being treated as references to 50% for these purposes). </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-80</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; text-indent:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Subsidiary</font><font style="letter-spacing:0.2pt;">&#8221; means, with respect to a Person, another entity of which such Person directly or indirectly owns or purports to own, beneficially or of record, (a)&#160;an amount of voting securities or other interests that is sufficient to enable such Person to elect at least a majority of the members of such entity&#8217;s board of directors or other governing body, or (b)&#160;at least 50% of the outstanding equity, voting, beneficial or financial interests in such Entity. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Superior Offer</font><font style="letter-spacing:0.2pt;">&#8221; means an unsolicited bona fide written Acquisition Proposal (with all references to 15% in the definition of Acquisition Transaction being treated as references to 70% for these purposes) that: (a)&#160;was not obtained or made as a direct or indirect result of a breach of (or in violation of) this Agreement; (b)&#160;is on terms and conditions that the Parent Board or the Company Board, as applicable, determines in good faith, based on such matters that it deems relevant (including the likelihood of consummation thereof, the financing terms thereof, any termination or break-up fees and conditions to consummation), as well as any written offer by the other Party this Agreement to amend the terms of this Agreement, and following consultation with its outside legal counsel and financial advisors, if any, are more favorable to Parent&#8217;s stockholders or the Company&#8217;s stockholders, as applicable, than the terms of the Contemplated Transactions; (c)&#160;is not subject to any financing conditions (and if financing is required, such financing is then fully committed to the third party); and (d)&#160;is reasonably capable of being completed on the terms proposed without unreasonable delay. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Takeover Statute</font><font style="letter-spacing:0.2pt;">&#8221; means any &#8220;fair price,&#8221; &#8220;moratorium,&#8221; &#8220;control share acquisition&#8221; or other similar anti-takeover Law. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Tax</font><font style="letter-spacing:0.2pt;">&#8221; means any federal, state, local, foreign or other tax, including any income, capital gain, gross receipts, capital stock, profits, transfer, estimated, registration, stamp, premium, escheat, unclaimed property, customs duty, ad valorem, occupancy, occupation, alternative, add-on, windfall profits, value added, severance, property, business, production, sales, use, license, excise, franchise, employment, payroll, social security, disability, unemployment, workers&#8217; compensation, national health insurance, withholding or other taxes, duties, fees, assessments or governmental charges in the nature of a tax, surtaxes or deficiencies thereof of any kind whatsoever, however denominated, and including any fine, penalty, addition to tax or interest imposed by a Governmental Body with respect thereto. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Tax Return</font><font style="letter-spacing:0.2pt;">&#8221; means any return (including any information return), report, statement, declaration, estimate, schedule, notice, notification, form, election, certificate or other document, and any amendment or supplement to any of the foregoing, filed with or submitted to, or required to be filed with or submitted to, any Governmental Body in connection with the determination, assessment, collection or payment of any Tax or in connection with the administration, implementation or enforcement of or compliance with any Law relating to any Tax. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Treasury Regulations</font><font style="letter-spacing:0.2pt;">&#8221; means the United States Treasury regulations promulgated under the Code. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">WARN Act</font><font style="letter-spacing:0.2pt;">&#8221; means the Worker Adjustment and Retraining Notification Act of 1988, as amended, or any similar state or local plant closing mass layoff statute, rule or regulation. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;Each of the following terms is defined in the Section set forth opposite such term: </font>
        </div>
        <table style="width:416pt;height:143.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Term </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:41pt;text-align:center;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Section </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Accounting Firm </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">1.11(e) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <font style="letter-spacing:0.2pt;">Agreement </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">Preamble </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Allocation Certificate </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">5.16(a) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Anti-Bribery Laws </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">2.22 </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Anticipated Closing Date </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">1.11(a) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Asset Disposition </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">4.7(a) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Asset Dispositions </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">4.7(a) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Book-Entry Shares </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">1.6 </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Business Associate Agreements </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">2.14(h) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-81</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <table style="width:416pt;height:653.5pt;margin-left:20pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Term </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:41pt;text-align:center;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Section </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Cash Determination Time </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">1.11(a) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Certificate of Merger </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">1.3 </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <font style="letter-spacing:0.2pt;">Certifications </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">3.7(a) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <font style="letter-spacing:0.2pt;">Closing </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">1.3 </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Closing Date </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">1.3 </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <font style="letter-spacing:0.2pt;">Company </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">Preamble </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Company Benefit Plan </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">2.17(a) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Company Board Adverse Recommendation Change </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">5.3(b) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Company Board Recommendation </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">5.3(b) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Company Convertible Note </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">2.6(a)</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Company Designees </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">5.12 </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Company Disclosure Schedule </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">Section&#160;2 </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Company Financial Statements </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">2.7(a) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Company In-bound License </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">2.12(d) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Company Lock-Up Agreement </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">Recitals </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Company Material Contract </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">2.13(a) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Company Material Contracts </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">2.13(a) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Company Out-bound License </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">2.12(d) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Company Permits </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">2.14(c) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Company Real Estate Leases </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">2.11 </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Company Registered IP </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">2.12(a) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Company Signatories </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">Recitals </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Company Stock Certificate </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">1.6 </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Company Stockholder Matters </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">5.3(a) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Company Stockholder Support Agreement </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">Recitals </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Company Stockholder Written Consent </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">2.4 </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Company Termination Fee </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">9.3(b) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <font style="letter-spacing:0.2pt;">CVR </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">5.21 </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">CVR Agreement </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">5.21 </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">D&amp;O Indemnified Parties </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">5.6(a) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">D&amp;O Tail Policy </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">5.6(d) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Delivery Date </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">1.11(a) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Dispute Notice </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">1.11(b) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Dissenting Shares </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">1.8(a) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Drug Regulatory Agency </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">2.14(a) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Effective Time </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">1.3 </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">End Date </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">9.1(b) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Exchange Agent </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">1.7(a) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Exchange Fund </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">1.7(a) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <font style="letter-spacing:0.2pt;">FDA </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">2.14(a) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <font style="letter-spacing:0.2pt;">FDCA </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">2.14(a) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Final Net Cash </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">1.11(c) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <font style="letter-spacing:0.2pt;">GCP </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">2.14(e) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-82</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <table style="width:416pt;height:653.5pt;margin-left:20pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Term </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:41pt;text-align:center;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Section </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:363pt;">
              <font style="letter-spacing:0.2pt;">GLP </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">2.14(e) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <font style="letter-spacing:0.2pt;">HIPAA </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">2.14(h) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Intended Tax Treatment </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">5.10(a) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <font style="letter-spacing:0.2pt;">Liability </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">2.9 </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <font style="letter-spacing:0.2pt;">LoT </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">1.7(b) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <font style="letter-spacing:0.2pt;">Merger </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">Recitals </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Merger Consideration </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">1.5(a)(ii) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Merger Sub </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">Preamble </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Nasdaq Listing Application </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">5.9 </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Net Cash Calculation </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">1.11(a) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Net Cash Schedule </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">1.11(a) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Notice Period </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">5.3(c) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <font style="letter-spacing:0.2pt;">Parent </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">Preamble </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Parent Benefit Plan </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">3.17(a) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Parent Board Adverse Recommendation Change </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">5.4(c) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Parent Board Recommendation </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">5.4(c) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Parent Designees </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">5.12 </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Parent Disclosure Schedule </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">Section&#160;3 </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Parent In-bound License </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">3.12(d) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Parent Lock-Up Agreement </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">Recitals </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Parent Material Contract </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">3.13(a) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Parent Material Contracts </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">3.13(a) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Parent Out-bound License </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">3.12(d) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Parent Permits </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">3.14(c) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Parent Real Estate Leases </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">3.11 </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Parent Registered IP </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">3.12(a) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Parent SEC Documents </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">3.7(a) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Parent Signatories </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">Recitals </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Parent Stockholder Matters </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">5.4(a)(iii) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Parent Stockholder Support Agreement </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">Recitals </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Parent Stockholders&#8217; Meeting </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">5.4(a)(iii) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Parent Termination Fee </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">9.3(c) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <font style="letter-spacing:0.2pt;">PHSA </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">2.14(a) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Pre-Closing Dividend </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">5.21 </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Pre-Closing Period </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">4.1(a) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Required Company Stockholder Vote </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">2.4 </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Required Parent Stockholder Vote </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">3.4 </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Response Date </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">1.11(b) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Sale Agreement </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">4.7(b) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Sensitive Data </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">2.12(g) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Surviving Corporation </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">1.1 </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Terminated Parent Associate </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">5.20(a) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:363pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Transaction Litigation </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:41pt;">
              <font style="letter-spacing:0.2pt;">5.19</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1-83</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;height:660pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">EXHIBIT B-1</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">Form of Company Stockholder Support Agreement </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;height:660pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">EXHIBIT B-2</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">Form of Parent Stockholder Support Agreement </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;height:660pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">EXHIBIT C-1</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">Form of Company Lock-Up Agreement </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;height:660pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">EXHIBIT C-2</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">Form of Parent Lock-Up Agreement </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;height:660pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">EXHIBIT D</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">Form of CVR Agreement </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;height:660pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">EXHIBIT E</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">Net Cash Illustrative Calculations </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;height:660pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">EXHIBIT F</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">Form of Certificate of Merger </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;height:660pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">EXHIBIT G</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">Form of Company Stockholder Written Consent </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;height:660pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">EXHIBIT H</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">Exchange Ratio Calculation </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;height:660pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">Schedule&#160;5.7</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">Additional Agreements</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:8pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">None. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;height:660pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">Schedule&#160;5.12</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">Post-Closing Directors and Officers of Parent and the Surviving Corporation </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC6">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;height:660pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">Schedule&#160;N</font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a><a name="tFAAP">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">

          <div style="margin-left:20pt; text-align:right; width:436pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">ANNEX A-2</font>&#8203;</div>


          <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">FIRST AMENDMENT TO </font>
            <br >
            <font style="letter-spacing:-0.2pt;">AGREEMENT AND PLAN OF MERGER AND REORGANIZATION</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="font-weight:bold;letter-spacing:-0.2pt;">THIS FIRST AMENDMENT TO AGREEMENT AND PLAN OF MERGER AND REORGANIZATION</font><font style="letter-spacing:0.2pt;"> (this &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">First Amendment</font><font style="letter-spacing:0.2pt;">&#8221;) is made and entered into and made as of December&#160;29, 2022, by and among </font><font style="font-weight:bold;letter-spacing:-0.2pt;">SESEN BIO, INC.</font><font style="letter-spacing:0.2pt;">, a Delaware corporation (&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent</font><font style="letter-spacing:0.2pt;">&#8221;), </font><font style="font-weight:bold;letter-spacing:-0.2pt;">SEAHAWK MERGER SUB, INC.</font><font style="letter-spacing:0.2pt;">, a Delaware corporation and wholly-owned subsidiary of Parent (&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Merger Sub</font><font style="letter-spacing:0.2pt;">&#8221;), and </font><font style="font-weight:bold;letter-spacing:-0.2pt;">CARISMA THERAPEUTICS INC.</font><font style="letter-spacing:0.2pt;">, a Delaware corporation (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company</font><font style="letter-spacing:0.2pt;">&#8221;). Parent, Merger Sub and the Company are sometimes individually referred to herein as a &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Party</font><font style="letter-spacing:0.2pt;">&#8221; or collectively referred to herein as the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parties</font><font style="letter-spacing:0.2pt;">&#8221;. Unless otherwise defined herein, capitalized terms shall have the meanings set forth in the Merger Agreement. </font>
          </div>


          <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">RECITALS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">A.&nbsp;&nbsp;&nbsp;The Parties previously entered into that certain Agreement and Plan of Merger and Reorganization dated as of September&#160;20, 2022 (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Merger Agreement</font><font style="letter-spacing:0.2pt;">&#8221;). </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">B.&nbsp;&nbsp;&nbsp;Section&#160;10.2 of the Merger Agreement provides that the Merger Agreement may be amended with the approval of the respective boards of directors of the Company, Merger Sub and Parent at any time. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">C.&nbsp;&nbsp;&nbsp;The Parties desire to amend the Merger Agreement pursuant to the terms and conditions of this First Amendment and the respective boards of directors of the Company, Merger Sub and Parent have each approved this First Amendment to be effective as of the date hereof. </font>
          </div>


          <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">AGREEMENT</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>


          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">The Parties, intending to be legally bound, agree as follows: </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">1.&nbsp;&nbsp;&nbsp;AMENDMENT TO SECTION 3.24 &#8220;Opinion of Financial Advisor&#8221;. Section&#160;3.24 &#8220;Opinion of Financial Advisor&#8221; of the Merger Agreement is hereby deleted in its entirety and replaced with the following: </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Opinion of Financial Advisor</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Parent Board has received an opinion of SVB Securities LLC to the effect that, as of the date of this First Amendment and subject to the assumptions, qualifications, limitations and other matters set forth therein, the Exchange Ratio is fair, from a financial point of view, to Parent. It is agreed and understood that such opinion is for the benefit of the Parent Board and may not be relied upon by the Company or any other party. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">2.&nbsp;&nbsp;&nbsp;AMENDMENT TO SECTION 5.21 &#8220;Pre-Closing Dividend&#8221;. Section&#160;5.21 &#8220;Pre-Closing Dividend&#8221; of the Merger Agreement is hereby deleted in its entirety and replaced with the following: </font>
          </div>


          <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#8220;5.21&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Pre-Closing Dividend</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Prior to the Effective Time, Parent shall (a)&#160;declare a dividend (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Pre-Closing Dividend</font><font style="letter-spacing:0.2pt;">&#8221;) to its common stockholders of record consisting of (i)&#160;the right to receive one contingent value right (each, a &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">CVR</font><font style="letter-spacing:0.2pt;">&#8221;) for each outstanding share of Parent Common Stock held by such stockholder as of such date, each representing the right to receive contingent payments upon the occurrence of certain events set forth in, and subject to and in accordance with the terms and conditions of, the Contingent Value Rights Agreement in the form attached hereto as </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Exhibit&#160;D</font><font style="letter-spacing:0.2pt;"> (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">CVR Agreement</font><font style="letter-spacing:0.2pt;">&#8221;) and (ii)&#160;cash equal to or greater than $70,000,000 in the aggregate, subject to satisfaction of Parent&#8217;s obligation set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;8.5</font><font style="letter-spacing:0.2pt;"> (and, for clarity, such cash dividend shall be reduced by any excess amount necessary to cause Parent to satisfy its obligation set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;8.5</font><font style="letter-spacing:0.2pt;">) and (b)&#160;make any necessary equitable adjustment required under the Parent Stock Plans. The record date for the Pre-Closing Dividend shall be a date agreed by Parent and the Company prior to the Effective Time and the payment date for which shall be three Business Days after the Effective Time; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, that the payment of such dividend may be conditioned upon the occurrence of the Effective Time. In connection with the Pre-Closing Dividend, Parent shall cause the CVR Agreement to be duly authorized, executed and delivered by Parent and a rights agent selected by Parent with the Company&#8217;s prior approval (such approval not to be unreasonably withheld, delayed or conditioned).&#8221; </font>
          </div>

      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-2-1</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:156pt;margin-left:69.66pt;width:456pt;">

          <div style="text-indent:20pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">3.&nbsp;&nbsp;&nbsp;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">AMENDMENT TO EXHIBIT D &#8220;Form of Contingent Value Right Agreement&#8221;.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Exhibit&#160;D to the Merger Agreement shall be deleted in its entirety and replaced with the form attached hereto. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">4.&nbsp;&nbsp;&nbsp;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">AMENDMENT TO SECTION 8.5 &#8220;Minimum Parent Final Net Cash&#8221;.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Section&#160;8.5 &#8220;Minimum Parent Final Net Cash&#8221; of the Merger Agreement is hereby deleted in its entirety and replaced with the following: </font>
          </div>


          <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#8220;8.5&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-weight:bold;letter-spacing:-0.2pt;">Minimum Parent Final Net Cash</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Final Net Cash shall have been determined in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;1.11</font><font style="letter-spacing:0.2pt;"> to be greater than or equal to $75,000,000.&#8221; </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">5.&nbsp;&nbsp;&nbsp;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">APPLICABLE LAW.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;This First Amendment shall be governed by, and construed in accordance with, the Laws of the State of Delaware, regardless of the Laws that might otherwise govern under applicable principles of conflicts of laws. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">6.&nbsp;&nbsp;&nbsp;HEADINGS.&nbsp;&nbsp;&nbsp;The bold-faced headings contained in this First Amendment are for convenience of reference only, shall not be deemed to be a part of this First Amendment and shall not be referred to in connection with the construction or interpretation of this First Amendment. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">7.&nbsp;&nbsp;&nbsp;ASSIGNABILITY.&nbsp;&nbsp;&nbsp;This First Amendment shall be binding upon, and shall be enforceable by and inure solely to the benefit of, the Parties and their respective successors and permitted assigns; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, </font><font style="font-style:italic;letter-spacing:0.2pt;">however</font><font style="letter-spacing:0.2pt;">, that neither this First Amendment nor any of a Party&#8217;s rights or obligations hereunder may be assigned or delegated by such Party without the prior written consent of the other Party, and any attempted assignment or delegation of this First Amendment or any of such rights or obligations by such Party without the other Party&#8217;s prior written consent shall be void and of no effect. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">8.&nbsp;&nbsp;&nbsp;CONSTRUCTION.&nbsp;&nbsp;&nbsp;The terms of this First Amendment amend and modify the Merger Agreement as if fully set forth in the Merger Agreement. Upon the effectiveness of this First Amendment, all references in the Merger Agreement to &#8220;the Agreement&#8221; or &#8220;this Agreement,&#8221; as applicable, shall refer to the Merger Agreement, as modified by this First Amendment. If there is any conflict between the terms, conditions and obligations of this First Amendment and the Merger Agreement, this First Amendment&#8217;s terms, conditions and obligations shall control. All other provisions of the Merger Agreement not specifically modified by this First Amendment are expressly preserved. This First Amendment may be executed in several counterparts, each of which shall be deemed an original and all of which shall constitute one and the same instrument. The exchange of a fully executed First Amendment (in counterparts or otherwise) by all Parties by electronic transmission in PDF format shall be sufficient to bind the Parties to the terms and conditions of this First Amendment. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">9.&nbsp;&nbsp;&nbsp;AUTHORITY.&nbsp;&nbsp;&nbsp;By their execution of this First Amendment, the undersigned Parties hereby confirm that they are duly authorized to execute this First Amendment and any necessary requisite approval has been obtained with respect to this First Amendment and all matters set forth herein. </font>
          </div>


          <div style="margin-top:8pt; text-align:center; width:456pt; line-height:12pt;font-style:italic;">
            <font style="letter-spacing:0.2pt;">(Remainder of page intentionally left blank)</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
          </div>

      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-2-2</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;height:660pt;margin-left:69.66pt;width:456pt;">

          <div style="text-indent:20pt; width:456pt; line-height:12pt;">
            <font style="font-weight:bold;letter-spacing:-0.2pt;">IN WITNESS WHEREOF</font><font style="letter-spacing:0.2pt;">, the Parties have caused this First Amendment to be executed as of the date first above written. </font>
          </div>


          <table style="width:456pt;height:233pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:208.81pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 1.833pt 0pt; width:0pt;" colspan="4">
                <font style="letter-spacing:-0.2pt;">SESEN BIO, INC. </font>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:208.81pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:15.167pt 0pt 0.5pt 0pt; width:14.38pt;">
                <font style="letter-spacing:0.2pt;">By:</font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:15.167pt 0pt 0.5pt 0pt; width:208.81pt;white-space:normal;">
                <div>
                  <font style="letter-spacing:0.2pt;">/s/ Thomas Cannell</font>
                </div>
                <div style="margin-top:2.5pt; text-align:justify;">
                  <div style="margin-left: 0pt; width: 208.81pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:208.81pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:14.38pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3pt 0pt 0.5pt 0pt; width:208.81pt;white-space:normal;">
                <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
                <div style=" float:left; line-height:10pt; text-align:left; width:36pt;white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Name:</font>
                  <br >
                </div>
                <div style=" line-height:10pt; text-align:left; margin-left:36pt;">
                  <font style="letter-spacing:0.2pt;">Thomas Cannell </font>
                </div>
                <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:208.81pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:14.38pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.5pt 0pt 0.5pt 0pt; width:208.81pt;white-space:normal;">
                <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
                <div style=" float:left; line-height:10pt; text-align:left; width:36pt;white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Title:</font>
                  <br >
                </div>
                <div style=" line-height:10pt; text-align:left; margin-left:36pt;">
                  <font style="letter-spacing:0.2pt;">President and Chief Executive Officer </font>
                </div>
                <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:208.81pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:18.5pt 0pt 1.833pt 0pt; width:0pt;" colspan="4">
                <font style="letter-spacing:-0.2pt;">SEAHAWK MERGER SUB, INC. </font>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:208.81pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:15.167pt 0pt 0.5pt 0pt; width:14.38pt;">
                <font style="letter-spacing:0.2pt;">By:</font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:15.167pt 0pt 0.5pt 0pt; width:208.81pt;white-space:normal;">
                <div>
                  <font style="letter-spacing:0.2pt;">/s/ Mark Sullivan</font>
                </div>
                <div style="margin-top:2.5pt; text-align:justify;">
                  <div style="margin-left: 0pt; width: 208.81pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:208.81pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:14.38pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3pt 0pt 0.5pt 0pt; width:208.81pt;white-space:normal;">
                <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
                <div style=" float:left; line-height:10pt; text-align:left; width:36pt;white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Name:</font>
                  <br >
                </div>
                <div style=" line-height:10pt; text-align:left; margin-left:36pt;">
                  <font style="letter-spacing:0.2pt;">Mark Sullivan </font>
                </div>
                <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:208.81pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:14.38pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.5pt 0pt 0.5pt 0pt; width:208.81pt;white-space:normal;">
                <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
                <div style=" float:left; line-height:10pt; text-align:left; width:36pt;white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Title:</font>
                  <br >
                </div>
                <div style=" line-height:10pt; text-align:left; margin-left:36pt;">
                  <font style="letter-spacing:0.2pt;">President, Secretary &amp; Treasurer </font>
                </div>
                <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:208.81pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:18.5pt 0pt 1.833pt 0pt; width:0pt;" colspan="4">
                <font style="letter-spacing:-0.2pt;">CARISMA THERAPEUTICS INC. </font>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:208.81pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:15.167pt 0pt 0.5pt 0pt; width:14.38pt;">
                <font style="letter-spacing:0.2pt;">By:</font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:15.167pt 0pt 0.5pt 0pt; width:208.81pt;white-space:normal;">
                <div>
                  <font style="letter-spacing:0.2pt;">/s/ Steven Kelly</font>
                </div>
                <div style="margin-top:2.5pt; text-align:justify;">
                  <div style="margin-left: 0pt; width: 208.81pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:208.81pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:14.38pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3pt 0pt 0.5pt 0pt; width:208.81pt;white-space:normal;">
                <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
                <div style=" float:left; line-height:10pt; text-align:left; width:36pt;white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Name:</font>
                  <br >
                </div>
                <div style=" line-height:10pt; text-align:left; margin-left:36pt;">
                  <font style="letter-spacing:0.2pt;">Steven Kelly </font>
                </div>
                <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:208.81pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:14.38pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.5pt 0pt 0.5pt 0pt; width:208.81pt;white-space:normal;">
                <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
                <div style=" float:left; line-height:10pt; text-align:left; width:36pt;white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Title:</font>
                  <br >
                </div>
                <div style=" line-height:10pt; text-align:left; margin-left:36pt;">
                  <font style="letter-spacing:0.2pt;">Chief Executive Officer</font>
                </div>
                <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
          </table>


          <div style="margin-top:8pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">[</font><font style="font-style:italic;letter-spacing:0.2pt;">Signature Page to First Amendment to Agreement and Plan of Merger and Reorganization</font><font style="letter-spacing:0.2pt;">] </font>
          </div>

      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;height:660pt;margin-left:69.66pt;width:456pt;">

          <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <font style="letter-spacing:-0.2pt;">EXHIBIT D</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>


          <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <font style="letter-spacing:-0.2pt;">Form of CVR Agreement </font>
          </div>

      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">

          <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">CONTINGENT VALUE RIGHTS AGREEMENT</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">THIS CONTINGENT VALUE RIGHTS AGREEMENT, dated as of [&#8226;], 2023 (this &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Agreement</font><font style="letter-spacing:0.2pt;">&#8221;), is entered into by and among Sesen Bio, Inc., a Delaware corporation (&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent</font><font style="letter-spacing:0.2pt;">&#8221;), and Computershare Inc. (&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Computershare</font><font style="letter-spacing:0.2pt;">&#8221;) and its affiliate, Computershare Trust Company, N.A., together, as the Rights Agent. </font>
          </div>


          <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">RECITALS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">WHEREAS, Parent, Seahawk Merger Sub, Inc., a Delaware corporation (&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Merger Sub</font><font style="letter-spacing:0.2pt;">&#8221;), and CARISMA Therapeutics Inc., a Delaware corporation (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company</font><font style="letter-spacing:0.2pt;">&#8221;), have entered into an Agreement and Plan of Merger and Reorganization, dated as of September&#160;20, 2022 (as it may be amended or supplemented from time to time pursuant to the terms thereof, the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Merger Agreement</font><font style="letter-spacing:0.2pt;">&#8221;), pursuant to which Merger Sub will merge with and into the Company, with the Company surviving the Merger as a subsidiary of Parent; and </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">WHEREAS, pursuant to the Merger Agreement, Parent has agreed to provide to the holders of record of Parent&#8217;s common stock, par value $0.001 per share (&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent Common Stock</font><font style="letter-spacing:0.2pt;">&#8221;), immediately prior to the Effective Time, the right to receive certain contingent cash payments, on the terms and subject to the conditions hereinafter described. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">NOW, THEREFORE, in consideration of the foregoing and the consummation of the transactions referred to above, Parent and the Rights Agent agree, for the proportionate benefit of all Holders (as hereinafter defined), as follows: </font>
          </div>


          <div style="margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">1.&nbsp;&nbsp;&nbsp;DEFINITIONS; CERTAIN RULES OF CONSTRUCTION </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">1.1</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Definitions</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Capitalized terms used but not otherwise defined herein will have the meanings ascribed to them in the Merger Agreement, unless expressly set forth otherwise herein. As used in this Agreement, the following terms will have the following meanings: </font>
          </div>


          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Acquiror</font><font style="letter-spacing:0.2pt;">&#8221; has the meaning set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.3(a)</font><font style="letter-spacing:0.2pt;">. </font>
          </div>


          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Acquisition</font><font style="letter-spacing:0.2pt;">&#8221; has the meaning set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.3(a)</font><font style="letter-spacing:0.2pt;">. </font>
          </div>


          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Acting Holders</font><font style="letter-spacing:0.2pt;">&#8221; has the meaning set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.3(d)</font><font style="letter-spacing:0.2pt;"> </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Affiliate</font><font style="letter-spacing:0.2pt;">&#8221; of a Person means any other Person that directly or indirectly, through one or more intermediaries, controls, is controlled by, or is under common control with, such Person. The term &#8220;control&#8221; (including the terms &#8220;controlled by&#8221; and &#8220;under common control with&#8221;) means the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of a Person, whether through the ownership of voting securities, by contract or otherwise. </font>
          </div>


          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Agreement</font><font style="letter-spacing:0.2pt;">&#8221; has the meaning set forth in the Preamble. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Asset Disposition Proceeds</font><font style="letter-spacing:0.2pt;">&#8221; means, without duplication, any and all consideration of any kind that is paid to Parent, or is received by, Parent or any of its Affiliates during the period specified in clause (b)&#160;of the definition of CVR Term in respect of an Asset Disposition, if any. The value of any securities (whether debt or equity) or other non-cash property constituting Asset Disposition Proceeds shall be determined as follows: (A)&#160;the value of securities for which there is an established public market shall be equal to the volume weighted average of their closing market prices for the five (5)&#160;trading days ending the day prior to the date of payment to, or receipt by, Parent or its relevant Affiliate, and (B)&#160;the value of securities that have no established public market and the value of consideration that consists of other non-cash property, shall be the fair market value thereof as of the date of payment to, or receipt by, Parent or its relevant Affiliate. </font>
          </div>


          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Assignee</font><font style="letter-spacing:0.2pt;">&#8221; has the meaning set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.3(a)</font><font style="letter-spacing:0.2pt;">. </font>
          </div>


          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Board of Directors</font><font style="letter-spacing:0.2pt;">&#8221; means the board of directors of Parent. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Board Resolution</font><font style="letter-spacing:0.2pt;">&#8221; means a copy of the resolution(s) certified by the secretary or an assistant secretary (or other comparable officer) of Parent that have been duly adopted by the Board of Directors and are in full force and effect on the date of such approval, and delivered to the Rights Agent. </font>
          </div>

      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-2-5</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">

          <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Business Day</font><font style="letter-spacing:0.2pt;">&#8221; means any day other than a Saturday, Sunday or other day on which banks in New York, New York are authorized or obligated by Law to be closed. </font>
          </div>


          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company</font><font style="letter-spacing:0.2pt;">&#8221; has the meaning set forth in the Recitals. </font>
          </div>


          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Computershare</font><font style="letter-spacing:0.2pt;">&#8221; has the meaning set forth in the Preamble. </font>
          </div>


          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">CVR Payment</font><font style="letter-spacing:0.2pt;">&#8221; has the meaning set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.4(a)</font><font style="letter-spacing:0.2pt;">. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">CVR Payment Amount</font><font style="letter-spacing:0.2pt;">&#8221; means, with respect to each Holder, an amount equal to (a)&#160;(i)&#160;the applicable Total Payment Amount, less (ii)&#160;applicable accrued and documented Permitted Deductions, as calculated in accordance with GAAP, divided by (b)&#160;the total number of CVRs and then multiplied by the total number of CVRs held by such Holder as reflected on the CVR Register (rounded down to the nearest whole cent). </font>
          </div>


          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">CVR Register</font><font style="letter-spacing:0.2pt;">&#8221; has the meaning set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.3(b)</font><font style="letter-spacing:0.2pt;">. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">CVR Sale Assets</font><font style="letter-spacing:0.2pt;">&#8221; means any and all assets, tangible and intangible, including, without limitation, patents, patent applications, know-how, trade secrets and other intellectual property rights, data, documentation, agreements and licenses, inventory related to Vicineum</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">TM</font><font style="letter-spacing:0.2pt;">, also known as VB4-845, which Parent or any of its subsidiaries owned or had rights to, as of immediately prior to the Effective Time. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">CVR Term</font><font style="letter-spacing:0.2pt;">&#8221; means (a)&#160;with respect to any Roche Payment Amount, the period beginning on the date hereof and ending on the earlier of (i)&#160;the CVR Payment being delivered to each Holder in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.4</font><font style="letter-spacing:0.2pt;"> of this Agreement, and (ii)&#160;March&#160;31, 2027, and (b)&#160;with respect to any Disposition or Asset Disposition or otherwise in respect of Asset Disposition Proceeds, the period beginning on the date hereof and ending on December&#160;31, 2023. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">CVRs</font><font style="letter-spacing:0.2pt;">&#8221; means the rights of Holders to receive contingent cash payments pursuant to the Merger Agreement and this Agreement. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Disposition</font><font style="letter-spacing:0.2pt;">&#8221; means the sale, license, transfer, disposition or other monetizing event of any CVR Sale Assets, in each case (i)&#160;during the period set forth in clause (b)&#160;of the definition of CVR Term and (ii)&#160;in a transaction identified by Parent&#8217;s financial advisor who was engaged as of the Effective Time for the purpose of identifying and proposing a potential Disposition transaction to Parent. </font>
          </div>


          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">DTC</font><font style="letter-spacing:0.2pt;">&#8221; means The Depository Trust Company or any successor thereto. </font>
          </div>


          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Funds</font><font style="letter-spacing:0.2pt;">&#8221; has the meaning set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.9</font><font style="letter-spacing:0.2pt;">. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Holder</font><font style="letter-spacing:0.2pt;">&#8221; means a Person in whose name a CVR is registered in the CVR Register at the applicable time. </font>
          </div>


          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Merger Agreement</font><font style="letter-spacing:0.2pt;">&#8221; has the meaning set forth in the Recitals. </font>
          </div>


          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Merger Sub</font><font style="letter-spacing:0.2pt;">&#8221; has the meaning set forth in the Recitals. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Officer&#8217;s Certificate</font><font style="letter-spacing:0.2pt;">&#8221; means a certificate signed by the chief executive officer, president, chief financial officer, any vice president, the controller, the treasurer or the secretary, in each case of Parent, in his or her capacity as such an officer, and delivered to the Rights Agent. </font>
          </div>


          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent</font><font style="letter-spacing:0.2pt;">&#8221; has the meaning set forth in the Preamble. </font>
          </div>


          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent Common Stock</font><font style="letter-spacing:0.2pt;">&#8221; has the meaning set forth in the Recitals. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Permitted Deductions</font><font style="letter-spacing:0.2pt;">&#8221; means the following costs or expenses, without duplication (as approved by the Board of Directors, including, if applicable, the Parent Designee (as defined in the Merger Agreement)): </font>
          </div>


          <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;any applicable Tax (including any unreimbursed applicable value added or sales tax) imposed on the Total Payment Amount and payable by Parent or any of its Affiliates to any tax authority and, without duplication, any income or other similar Taxes payable by Parent or any of its Affiliates that would not have been incurred by Parent or any of its Affiliates but for the Total Payment Amount; provided that, for purposes of calculating income Taxes incurred by Parent and its Affiliates in respect </font>
          </div>

      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-2-6</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">

          <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">of the Total Payment Amount, any such income Taxes shall be computed after reduction for any net operating loss carryforwards or other Tax attributes (including Tax credits) of Parent or its subsidiaries (owned prior to the Merger) as of the Closing Date that are available to the maximum extent permitted by law to offset such gain after taking into account any limits on the usability of such attributes, including under Section&#160;382 of the Code, in each case, as reasonably determined by a nationally recognized tax advisor (and for the sake of clarity such income taxes shall be calculated without taking into account any net operating losses or other Tax attributes generated by Parent or its subsidiaries after the Closing Date or any Tax attributes of the Company, whether generated before or after the Closing Date), assuming for this purpose that (i)&#160;the only item of gross income of Parent and its subsidiaries is the Total Payment Amount (for the avoidance of doubt, assuming that the Total Payment Amount is taxable in the hands of Parent or its subsidiaries no later than the taxable year that includes the corresponding CVR Payment), and (ii)&#160;the net operating loss carryforwards or other Tax attributes (including Tax credits) of Parent or its subsidiaries shall only include any net operating loss carryforwards or other Tax attributes (including Tax credits) of Parent or its subsidiaries (owned prior to the Merger) existing as of immediately prior to the Merger for U.S. federal income tax purposes and applicable state and local income tax purposes; </font>
          </div>


          <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;any reasonable and documented out-of-pocket expenses incurred by Parent or any of its Affiliates in respect of its performance of this Agreement following the Effective Time, losses incurred and paid by Parent or any of its Affiliates following the Effective Time arising out of any Legal Proceeding relating to or in connection with (i)&#160;an Asset Disposition, (ii)&#160;Parent&#8217;s, Roche&#8217;s or any of their respective Affiliates&#8217; obligations under the Roche Agreement or (iii)&#160;otherwise with respect to the Total Payment Amount; and </font>
          </div>


          <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;any Liabilities that were ascertainable prior to or at the Effective Time which Parent reasonably and in good faith determines should have been, but were not, deducted from &#8220;Net Cash&#8221; &#8203;(as defined in the Merger Agreement), in connection with the Closing of the Merger, to the extent that deduction of such Liabilities would have resulted in a change in the Exchange Ratio under the Merger Agreement were such amounts properly deducted; </font>
          </div>


          <div style="margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">provided that no Permitted Deductions shall be deducted to the extent they were otherwise deducted from the calculation of Net Cash (as defined in the Merger Agreement). </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Permitted Transfer</font><font style="letter-spacing:0.2pt;">&#8221; means a transfer of CVRs: (a)&#160;on death of a Holder by will or intestacy; (b)&#160;by instrument to an inter vivos or testamentary trust in which the CVRs are to be passed to beneficiaries upon the death of the trustee; (c)&#160;pursuant to a court order; (d)&#160;made by operation of law (including a consolidation or merger) or without consideration in connection with the dissolution, liquidation or termination of any corporation, limited liability company, partnership or other entity; (e)&#160;in the case of CVRs held in book-entry or other similar nominee form, from a nominee to a beneficial owner (through an intermediary if applicable) or from a nominee to another nominee for the same beneficial owner, to the extent allowable by DTC; (f)&#160;a transfer from a participant&#8217;s account in a tax-qualified employee benefit plan to the participant or to such participant&#8217;s account in a different tax-qualified employee benefit plan or to a tax-qualified individual retirement account for the benefit of such participant; (g)&#160;to Parent or its Affiliates for any or no consideration; or (h)&#160;as provided in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.6</font><font style="letter-spacing:0.2pt;">. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Person</font><font style="letter-spacing:0.2pt;">&#8221; means any natural person, corporation, limited liability company, trust, unincorporated association, partnership, joint venture or other entity. </font>
          </div>


          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Record Time</font><font style="letter-spacing:0.2pt;">&#8221; has the meaning set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.3(e)</font><font style="letter-spacing:0.2pt;">. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Rights Agent</font><font style="letter-spacing:0.2pt;">&#8221; means the Rights Agent named in the Preamble, until a successor Rights Agent will have become such pursuant to the applicable provisions of this Agreement, and thereafter &#8220;Rights Agent&#8221; will mean such successor Rights Agent. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Roche</font><font style="letter-spacing:0.2pt;">&#8221; means the collective reference to F. Hoffman-La Roche Ltd and Hoffmann La Roche Inc. or its successors or any of its or their respective Affiliates; provided, that neither Chugai Pharmaceutical Co., Ltd, a Japanese corporation (&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Chugai</font><font style="letter-spacing:0.2pt;">&#8221;) nor its subsidiaries (if any) shall be deemed as Affiliates of Roche unless Roche provides written notice to Parent of its desire to include Chugai or its respective subsidiaries (as applicable) as Affiliate(s) of Roche. </font>
          </div>

      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-2-7</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">

          <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">RocheAgreement</font><font style="letter-spacing:0.2pt;">&#8221; means that certain Asset Purchase Agreement, dated as of July&#160;15, 2022, by and among F. Hoffman-La Roche Ltd, Hoffmann La Roche Inc. and Parent. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Roche Payment Amount</font><font style="letter-spacing:0.2pt;">&#8221; means the thirty million dollar ($30,000,000) milestone payment to be made by Roche to Parent upon the initiation of a phase III clinical study in diabetic macular disorder with the compound known as &#8220;EBI-031&#8221; during the CVR Term, as set forth in Section&#160;11.1 of the Roche Agreement. </font>
          </div>


          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Third Party</font><font style="letter-spacing:0.2pt;">&#8221; means any Person other than Parent, Rights Agent or their respective Affiliates. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Total Payment Amount</font><font style="letter-spacing:0.2pt;">&#8221; means, as of any applicable time of determination, any Asset Disposition Proceeds plus any Roche Payment Amounts. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">1.2</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Rules of Construction</font><font style="letter-spacing:0.2pt;">. Except as otherwise explicitly specified to the contrary, (a)&#160;whenever the context requires, the singular number shall include the plural, and vice versa; (b)&#160;the masculine gender shall include the feminine gender and neuter genders, the feminine gender shall include the masculine and neuter genders, and the neuter genders shall include masculine and feminine genders; (c)&#160;the word &#8220;extent&#8221; in the phrase &#8220;to the extent&#8221; means the degree to which a subject or other thing extends, and does not simply mean &#8220;if&#8221;; (d)&#160;the word &#8220;including&#8221; &#8203;(in its various forms) means &#8220;including without limitation&#8221;; (e)&#160;references to a &#8220;Section&#8221; means a Section of this Agreement unless another agreement is specified; (f)&#160;references to a particular statute or regulation include all rules and regulations thereunder and any predecessor or successor statute, rules or regulation, in each case as amended or otherwise modified from time to time; (g)&#160;words in the singular or plural form include the plural and singular form, respectively; (h)&#160;references to a particular Person include such Person&#8217;s successors and assigns to the extent not prohibited by this Agreement; (i)&#160;the word &#8220;or&#8221; shall not be exclusive (i.e., &#8220;or&#8221; shall be deemed to mean &#8220;and/or&#8221;) unless the subject of the conjunction are mutually exclusive; and (j)&#160;all references to dollars or &#8220;$&#8221; refer to United States dollars. For clarity, the parties agree that the phrase &#8220;materially adverse&#8221; when used in this Agreement with respect to the Holders includes any amendment or other action, as applicable, that does or would be reasonably expected to reduce, eliminate, or materially delay the Roche Payment Amount. </font>
          </div>


          <div style="margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">2.&nbsp;&nbsp;&nbsp;CONTINGENT VALUE RIGHTS </font>
          </div>


          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">2.1</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">CVRs; Appointment of Rights Agent.</font><font style="letter-spacing:0.2pt;"> </font>
          </div>


          <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;Each Holder is entitled to one CVR in the form of a dividend for each share of Parent Common Stock held by such Holder as of the Record Time. The CVRs represent the rights of Holders to receive contingent cash payments pursuant to the Merger Agreement and this Agreement. The initial Holders will be the holders of Parent Common Stock as of immediately prior to the Effective Time, and a list of the initial Holders shall be furnished to the Rights Agent by or on behalf of Parent in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;4.1</font><font style="letter-spacing:0.2pt;"> hereof. </font>
          </div>


          <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;Parent hereby appoints the Rights Agent to act as rights agent for Parent as contemplated hereby in accordance with the express terms and conditions set forth in this Agreement (and no implied terms or conditions), and the Rights Agent hereby accepts such appointment. </font>
          </div>


          <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;Parent intends to treat the issuance of the CVRs as a distribution of property by Parent to the holders of Parent Common Stock for U.S. federal income tax purposes. Consistent with such intended tax treatment, Parent will timely send Forms 1099-DIV to all Holders notifying them of the portion of the CVR value that is a nondividend distribution (or a dividend to the extent of Parent&#8217;s earnings and profits) for U.S. federal income tax purposes, and take all necessary steps to file its tax returns and any information statements consistent with such tax treatment. Parent will determine, in consultation with and with the consent of the Parent Designee, the fair market value of the CVRs in connection with the issuance and Parent will utilize such fair market value for purposes of all tax reporting (including on Forms 1099-DIV) with respect to the CVR. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">2.2</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Nontransferable</font><font style="letter-spacing:0.2pt;">. The CVRs shall not be sold, assigned, transferred, pledged, encumbered or in any other manner transferred or disposed of, in whole or in part, other than through a Permitted Transfer. Any attempted sale, assignment, transfer, pledge, encumbrance, transfer or disposition, in whole or in part, that is not a Permitted Transfer will be void </font><font style="font-style:italic;letter-spacing:0.2pt;">ab initio</font><font style="letter-spacing:0.2pt;"> and of no effect. </font>
          </div>


          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">2.3</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">No Certificate; Registration; Registration of Transfer; Change of Address</font><font style="letter-spacing:0.2pt;">. </font>
          </div>

      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-2-8</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">

          <div style="margin-left:40pt; width:416pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;The CVRs will not be evidenced by a certificate or other instrument. </font>
          </div>


          <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;The Rights Agent will create and keep a register (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">CVR Register</font><font style="letter-spacing:0.2pt;">&#8221;) for the purpose of identifying the Holders and registering CVRs and transfers of CVRs as permitted herein. The CVR Register will be created, and CVRs will be distributed, pursuant to written instructions to the Rights Agent from Parent. The CVR Register will initially show one position for Cede &amp; Co. representing all the CVRs provided to the holders of shares of Parent Common Stock held as of immediately prior to the Effective Time. The Rights Agent will have no responsibility whatsoever directly to the street name holders or DTC participants with respect to transfers of CVRs unless and until such CVRs are transferred into the name of such street name holders or DTC participants in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.2</font><font style="letter-spacing:0.2pt;"> of this Agreement. With respect to any payments to be made under </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.4(a)</font><font style="letter-spacing:0.2pt;"> below, the Rights Agent will accomplish the payment to any former street name holders of shares of Parent Common Stock by sending one lump-sum payment to DTC. The Rights Agent will have no responsibilities whatsoever with regard to the distribution of payments by DTC to such street name holders. </font>
          </div>


          <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;Subject to the restrictions on transferability set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.2</font><font style="letter-spacing:0.2pt;">, every request made to transfer a CVR must be in writing and accompanied by a written instrument of transfer and other reasonably requested documentation in form reasonably satisfactory to the Rights Agent, duly executed by the Holder thereof or the Holder&#8217;s attorney duly authorized in writing, personal representative or survivor and setting forth in reasonable detail the circumstances relating to the transfer. Upon receipt of such written notice, the Rights Agent will, subject to its reasonable determination that the transfer instrument is in proper form, notify Parent that it has received such written notice. Upon receipt of such notice from the Rights Agent, Parent shall determine whether the transfer otherwise complies with the other terms and conditions of this Agreement (including the provisions of </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.2</font><font style="letter-spacing:0.2pt;">), and if it determines that it does so comply, Parent shall instruct the Rights Agent in writing to register the transfer of the CVRs in the CVR Register and notify Parent of the same. No service charge shall be made for any registration of transfer of a CVR; however Parent and the Rights Agent may require payment of a sum sufficient to cover any stamp or other tax or governmental charge that is imposed in connection with any such registration of transfer. The Rights Agent shall have no duty or obligation to take any action under any section of this Agreement that requires the payment by a Holder of applicable taxes or charges unless and until the Rights Agent is satisfied that all such taxes or charges have been paid or will be paid. All duly transferred CVRs registered in the CVR Register will be the valid obligations of Parent and will entitle the transferee to the same benefits and rights under this Agreement as those held immediately prior to the transfer by the transferor. No transfer of a CVR will be valid until registered in the CVR Register. </font>
          </div>


          <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;A Holder may make a written request to the Rights Agent to change such Holder&#8217;s address of record in the CVR Register. The written request must be duly executed by the Holder. Upon receipt of such written request, the Rights Agent is hereby authorized to promptly record the change of address in the CVR Register. </font>
          </div>


          <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">(e)&nbsp;&nbsp;&nbsp;Parent will provide written instructions to the Rights Agent for the distribution of CVRs to holders of Parent Common Stock as of immediately prior to the Effective Time (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Record Time</font><font style="letter-spacing:0.2pt;">&#8221;). Subject to the terms and conditions of this Agreement and Parent&#8217;s prompt confirmation of the Effective Time, the Rights Agent shall effect the distribution of the CVRs, less any applicable tax withholding, to each holder of Parent Common Stock as of the Record Time by the mailing of a statement of holding reflecting such CVRs. </font>
          </div>


          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">2.4</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Payment Procedures</font><font style="letter-spacing:0.2pt;">. </font>
          </div>


          <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;Within thirty (30) days after the receipt of any portion of the Total Payment Amount, Parent shall (i)&#160;deliver to the Rights Agent a certificate certifying to and specifying in reasonable detail (A)&#160;the amount of the applicable Total Payment Amount received by Parent or its Affiliates, (B)&#160;a calculation of the CVR Payment Amount and CVR Payment, and (C)&#160;the Permitted Deductions reflected in such CVR Payment Amount, (ii)&#160;deliver to the Rights Agent an amount equal to the aggregate CVR Payment Amount in immediately available funds (each, a &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">CVR Payment</font><font style="letter-spacing:0.2pt;">&#8221;) and (iii)&#160;instruct the Rights Agent to deliver the CVR Payment to the Holders. The Rights Agent will promptly, and in any event </font>
          </div>

      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-2-9</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">

          <div style="margin-left:20pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">within ten (10) Business Days after receipt of each applicable CVR Payment, pay to each Holder, by check mailed to the address of each Holder as reflected in the CVR Register as of the close of business on the date of the receipt of the CVR Payment statement, such Holder&#8217;s CVR Payment Amount less any applicable tax withholding. Until such certificate, CVR Payment and instructions are received by the Rights Agent, the Rights Agent may presume conclusively for all purposes that such portion of the Total Payment Amount has not been received. </font>
          </div>


          <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;All payments by Parent to the Rights Agent under this Agreement shall be made in U.S. dollars. </font>
          </div>


          <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;Parent shall be entitled to deduct or withhold, or cause the Rights Agent to deduct or withhold from any CVR Payment Amount otherwise payable or otherwise deliverable pursuant to this Agreement, in each case directly or through an authorized payroll agent, such amounts as are reasonably determined to be required to be deducted or withheld therefrom under the Code or any other provision of any applicable federal, state, local or non-U.S. Tax Law as may be determined by Parent. To the extent such amounts are so deducted or withheld and paid over or deposited with the relevant Tax authority, such amounts shall be treated for all purposes under this Agreement as having been paid to the Holder(s) to whom such amounts would otherwise have been paid or delivered. Prior to making any such Tax withholdings or causing any such Tax withholdings to be made with respect to any Holder, Parent shall instruct the Rights Agent, to the extent practicable, to provide notice to the Holder of such potential withholding and a reasonable opportunity for the Holder to provide any necessary Tax forms (including an IRS Form W-9 or an applicable IRS Form W-8) in order to avoid or reduce such withholding amounts; provided, that the time period for payment of a CVR Payment Amount by the Rights Agent set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.4(a)</font><font style="letter-spacing:0.2pt;"> shall be extended by a period equal to any delay caused by the Holder providing such forms; provided, further, that in no event shall such period be extended for more than ten (10) Business Days, unless otherwise requested by the Holder for the purpose of delivering such forms and agreed to by the Rights Agent. </font>
          </div>


          <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;Any portion of any CVR Payment that remains undistributed to any Holder six (6)&#160;months after such CVR Payment is received by the Rights Agent from Parent, provided, that the Rights Agent has fully complied with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.4(a)</font><font style="letter-spacing:0.2pt;">, will be delivered by the Rights Agent to Parent, upon demand, and such Holder will thereafter look only to Parent for payment of its share of such returned CVR Payment, without interest. </font>
          </div>


          <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">(e)&nbsp;&nbsp;&nbsp;Neither Parent nor the Rights Agent will be liable to any person in respect of any CVR Payment Amount delivered to a public official pursuant to any applicable abandoned property, escheat or similar Law. If, despite Parent&#8217;s and/or the Rights Agent&#8217;s commercially reasonable efforts to deliver a CVR Payment Amount to the applicable Holder, such CVR Payment Amount has not been paid immediately prior to the date on which such CVR Payment Amount would otherwise escheat to or become the property of any Governmental Body, any such CVR Payment Amount will, to the extent permitted by applicable Law, become the property of Parent, free and clear of all claims or interest of any person previously entitled thereto. In addition to and not in limitation of any other indemnity obligation herein, Parent agrees to indemnify and hold harmless the Rights Agent with respect to any liability, penalty, cost or expense the Rights Agent may incur or be subject to in connection with transferring such property to Parent and such indemnification obligation shall survive the termination of this Agreement, the resignation, replacement or removal of the Rights Agent, and the payment, termination and the expiration of the CVRs. </font>
          </div>


          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">2.5</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">No Voting, Dividends or Interest; No Equity or Ownership Interest in Parent</font><font style="letter-spacing:0.2pt;">. </font>
          </div>


          <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;The CVRs will not have any voting or dividend rights, and interest will not accrue on any amounts payable on the CVRs to any Holder. </font>
          </div>


          <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;The CVRs will not represent any equity or ownership interest in Parent or in any constituent company to the Merger. The sole right of the Holders to receive property hereunder is the right to receive the CVR Payment in accordance with the terms hereof. It is hereby acknowledged and agreed that a CVR shall not constitute a security of Parent or any constituent company to the Merger. </font>
          </div>

      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-2-10</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">

          <div style="margin-left:20pt; text-indent:20pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;Each Holder acknowledges and agrees that such Holder will not challenge or contest any action, inaction, determination or decision of Parent or the Rights Agent, except via written action of the Acting Holders, and will not threaten, bring, commence, institute, maintain, prosecute or voluntarily aid any action, which challenges the validity of or seeks to enjoin the operation of any provision of this Agreement. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">2.6</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Ability to Abandon CVR</font><font style="letter-spacing:0.2pt;">. A Holder may at any time, at such Holder&#8217;s option, abandon all of such Holder&#8217;s remaining rights in a CVR by transferring such CVR to Parent without consideration therefor, and such rights will be cancelled, with the Rights Agent being promptly notified in writing by Parent of such transfer and cancellation. Nothing in this Agreement is intended to prohibit Parent from offering to acquire CVRs, in a private transaction or otherwise, for consideration in its sole discretion. </font>
          </div>


          <div style="margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">3.&nbsp;&nbsp;&nbsp;THE RIGHTS AGENT </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">3.1</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Certain Duties and Responsibilities</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Rights Agent will be authorized and protected and will not have any liability for or in respect of any actions taken, suffered or omitted to be taken by it in connection with its acceptance and administration of this Agreement and the exercise and performance of its duties hereunder, except to the extent of its own willful misconduct, bad faith or gross negligence (each as determined by a final non-appealable judgment of a court of competent jurisdiction). </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">3.2</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Certain Rights of the Rights Agent</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Rights Agent undertakes to perform such duties and only such duties as are specifically set forth in this Agreement, and no implied duties, covenants or obligations will be read into this Agreement against the Rights Agent. The Rights Agent shall not assume any obligations or relationship of agency or trust with any Holder. In addition: </font>
          </div>


          <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;the Rights Agent may rely and will be protected by Parent in acting or refraining from acting upon any resolution, certificate, statement, instrument, opinion, report, notice, request, direction, consent, order or other paper or document believed by it in the absence of bad faith to be genuine and to have been signed or presented by the proper party or parties; </font>
          </div>


          <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;whenever the Rights Agent will deem it desirable that a matter be proved or established prior to taking, suffering or omitting any action hereunder, the Rights Agent may request and rely upon an Officer&#8217;s Certificate with respect to such matter, which certificate shall be full authorization and protection to the Rights Agent, and the Rights Agent shall, in the absence of gross negligence, bad faith or willful or intentional misconduct (each as determined by a final non appealable judgment of a court of competent jurisdiction) on its part, incur no liability and be held harmless by Parent for or in respect of any action taken, suffered or omitted to be taken by it in the absence of bad faith under the provisions of this Agreement in reliance upon such certificate; </font>
          </div>


          <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;in the event the Rights Agent believes any ambiguity or uncertainty exists hereunder or in any notice, instruction, direction, request or other communication, paper or document received by the Rights Agent hereunder, the Rights Agent, may, in its sole discretion, refrain from taking any action, and shall be fully protected and shall not be liable in any way to Parent, any Holder or any other person or entity for refraining from taking such action, unless the Rights Agent receives written instructions from the Parent which eliminates such ambiguity or uncertainty to the satisfaction of the Rights Agent; </font>
          </div>


          <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;the Rights Agent may engage and consult with counsel of its selection (who may be legal counsel for the Rights Agent or the Parent or an employee of the Rights Agent) and the written advice of such counsel or any opinion of counsel will be full and complete authorization and protection to the Rights Agent and the Rights Agent shall be held harmless by Parent and shall incur no liability for or in respect of any action taken, suffered or omitted by it hereunder in the absence of bad faith and in reliance thereon; </font>
          </div>


          <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">(e)&nbsp;&nbsp;&nbsp;the permissive rights of the Rights Agent to do things enumerated in this Agreement will not be construed as a duty; </font>
          </div>


          <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">(f)&nbsp;&nbsp;&nbsp;the Rights Agent will not be required to give any note or surety in respect of the execution of such powers or otherwise in respect of the premises; </font>
          </div>

      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-2-11</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">

          <div style="margin-left:20pt; text-indent:20pt; width:436pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">(g)&nbsp;&nbsp;&nbsp;the Rights Agent shall not be liable for or by reason of, and shall be held harmless by Parent with respect to any of the statements of fact or recitals contained in this Agreement or be required to verify the same, but all such statements and recitals are and shall be deemed to have been made by the Parent only and the Rights Agent will have no liability and shall be held harmless by Parent in respect of the validity of this Agreement or the execution and delivery hereof (except the due execution and delivery hereof by the Rights Agent), nor shall the Rights Agent be responsible for any breach by Parent of any covenant or condition contained in this Agreement; </font>
          </div>


          <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">(h)&nbsp;&nbsp;&nbsp;Parent agrees to indemnify the Rights Agent for, and hold the Rights Agent harmless against, any loss, liability, damage, judgment, fine, penalty, settlement, claim, demands, suits, cost or expense (including without limitation, the reasonable and documented fees and expenses of legal counsel) for any action taken, suffered or omitted to be taken by the Rights Agent or arising out of or in connection with the Rights Agent&#8217;s duties under this Agreement, including the reasonable and documented out-of-pocket costs and expenses of defending the Rights Agent against any claims, charges, demands, suits or loss arising therefrom, directly or indirectly, or enforcement of its rights hereunder, unless such loss has been determined by a final non-appealable judgment of a court of competent jurisdiction to be a result of the Rights Agent&#8217;s gross negligence, bad faith or willful or intentional misconduct; </font>
          </div>


          <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">(i)&nbsp;&nbsp;&nbsp;anything to the contrary notwithstanding, (i)&#160;any liability of the Rights Agent under this Agreement will be limited to the aggregate amount of the annual fees (but not reimbursed expenses) paid by Parent to the Rights Agent under this Agreement during the twelve&#160;months immediately preceding the event for which recovery is sought, and (ii)&#160;in no event shall the Rights Agent be liable for any special, punitive, indirect, consequential or incidental loss or damage of any kind whatsoever (including but not limited to lost profits) arising out of any action taken, suffered or omitted to be taken by it, even if the Rights Agent has been advised of the likelihood of such loss or damage and regardless of the form of action; </font>
          </div>


          <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">(j)&nbsp;&nbsp;&nbsp;Parent agrees (i)&#160;to pay the fees and expenses of the Rights Agent in connection with the Rights Agent&#8217;s duties under this Agreement as agreed upon in writing by the Rights Agent and Parent on or prior to the date hereof, and (ii)&#160;to reimburse the Rights Agent for all taxes and governmental charges, reasonable and documented out-of-pocket expenses and other charges of any kind and nature incurred by the Rights Agent in the preparation, delivery, amendment and execution of this Agreement and the exercise and performance of its duties hereunder (other than taxes imposed on or measured by the Rights Agent&#8217;s net income and franchise or similar taxes imposed on it (in lieu of net income taxes)). The Rights Agent will also be entitled to reimbursement from Parent for all reasonable and documented out-of-pocket expenses paid or incurred by it in connection with the administration by the Rights Agent of its duties hereunder. </font>
          </div>


          <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">(k)&nbsp;&nbsp;&nbsp;the Rights Agent shall not be deemed to have knowledge of any event of which it was supposed to receive notice thereof hereunder, and the Rights Agent shall be fully protected and shall incur no liability for failing to take action in connection therewith, unless and until it has received such notice in writing from the Parent and all notices or other instruments required by this Agreement to be delivered to the Rights Agent must, in order to be effective, be received by the Rights Agent as specified herein, and in the absence of such notice so delivered the Rights Agent may conclusively assume no such event or condition exists; </font>
          </div>


          <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">(l)&nbsp;&nbsp;&nbsp;the Rights Agent and any shareholder, affiliate, director, officer or employee of the Rights Agent may buy, sell or deal in any securities of the Parent or become peculiarly interested in any transaction in which the Parent may be interested, or contract with or lend money to the Parent or otherwise act as fully and freely as though it were not the Rights Agent under this Agreement. Nothing herein shall preclude the Rights Agent from acting in any other capacity for the Parent or for any other Person; </font>
          </div>


          <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">(m)&nbsp;&nbsp;&nbsp;the Rights Agent may execute and exercise any of the rights or powers hereby vested in it or perform any duty hereunder either itself or by or through its attorneys or agents, and the Rights Agent shall not be liable, answerable or accountable for any act, omission, default, neglect or misconduct of any such attorneys or agents or for any loss to the Parent, any Holder or any other person or entity </font>
          </div>

      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-2-12</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">

          <div style="margin-left:20pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">resulting from any such act, omission, default, neglect or misconduct, absent gross negligence, bad faith or willful misconduct (each as determined by a final non-appealable judgment of a court of competent jurisdiction) in the selection and continued employment thereof; </font>
          </div>


          <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">(n)&nbsp;&nbsp;&nbsp;no provision of this Agreement shall require the Rights Agent to expend or risk its own funds or otherwise incur any financial liability in the performance of any of its duties hereunder or in the exercise of its rights if there shall be reasonable grounds for believing that repayment of such funds or adequate indemnification against such risk or liability is not reasonably assured to it; </font>
          </div>


          <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">(o)&nbsp;&nbsp;&nbsp;the Rights Agent shall not have any duty or responsibility in the case of the receipt of any written demand from any Holder with respect to any action or default by the Parent or its Affiliates, including, without limiting the generality of the foregoing, any duty or responsibility to initiate or attempt to initiate any proceedings at law or otherwise or to make any demand upon the Parent; </font>
          </div>


          <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">(p)&nbsp;&nbsp;&nbsp;the Rights Agent shall neither be responsible for, nor chargeable with, knowledge of, nor have any requirements to comply with, the terms and conditions of any other agreement, instrument or document, including, without limitation, the Merger Agreement, nor shall the Rights Agent be required to determine if any person or entity has complied with any such agreements, instruments or documents, nor shall any additional obligations of the Rights Agent be inferred from the terms of such agreements, instruments or documents even though reference thereto may be made in this Agreement. In the event of any conflict between the terms and provisions of this Agreement and those of any other agreement, instrument or document, including but not limited to the Merger Agreement, the terms and conditions of this Agreement shall control as they relate to the Rights Agent; and </font>
          </div>


          <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">(q)&nbsp;&nbsp;&nbsp;The provisions of </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.1</font><font style="letter-spacing:0.2pt;"> and this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.2</font><font style="letter-spacing:0.2pt;"> shall survive the termination of this Agreement, the resignation, replacement or removal of the Rights Agent, and the payment, termination and the expiration of the CVRs. </font>
          </div>


          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">3.3</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Resignation and Removal; Appointment of Successor</font><font style="letter-spacing:0.2pt;">. </font>
          </div>


          <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;The Rights Agent may resign at any time by giving written notice thereof to Parent specifying a date when such resignation will take effect, which notice will be sent at least thirty (30) days prior to the date so specified, and such resignation will become effective on the earlier of (i)&#160;the date so specified and (ii)&#160;the appointment of a successor Rights Agent. Parent has the right to remove the Rights Agent at any time by a Board Resolution specifying a date when such removal will take effect (or, if earlier, the appointment of the successor Rights Agent). Notice of such removal will be given by Parent to the Rights Agent, which notice will be sent at least thirty (30) days prior to the date so specified. Notwithstanding anything to the contrary contained herein, such replacement or removal of the Rights Agent shall not affect any of the provisions of this Agreement that expressly survive the termination of this Agreement, or the resignation, replacement or removal of the Rights Agent. </font>
          </div>


          <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;If the Rights Agent provides notice of its intent to resign, is removed or becomes incapable of acting, Parent, by a Board Resolution, will as soon as is reasonably possible appoint a qualified successor Rights Agent, who shall be a stock transfer agent or national reputation or the corporate trust department of a commercial bank. The successor Rights Agent so appointed will, forthwith upon its acceptance of such appointment in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.4</font><font style="letter-spacing:0.2pt;">, become the successor Rights Agent. Notwithstanding the foregoing, if Parent shall fail to make such appointment within a period of thirty (30) days after giving notice of such removal or after it has been notified in writing of such resignation or incapacity by the resigning or incapacitated Rights Agent, then the incumbent Rights Agent may apply to any court of competent jurisdiction for the appointment of a new Rights Agent. </font>
          </div>


          <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;Parent will give notice to each Holder of each resignation and each removal of a Rights Agent and each appointment of a successor Rights Agent by delivering a written notice of such event to the Holders as their names and addresses appear in the CVR Register in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.1</font><font style="letter-spacing:0.2pt;">. Each notice will include the name and address of the successor Rights Agent. If Parent fails to send such notice within ten (10) Business Days after acceptance of appointment by a successor Rights Agent, the successor Rights Agent will cause the notice to be mailed at the expense of Parent. Failure to give </font>
          </div>

      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-2-13</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">

          <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">any notice provided for in this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.3</font><font style="letter-spacing:0.2pt;">, however, and any defect therein, shall not affect the legality or validity of the resignation or removal of the Rights Agent or the appointment of the successor Rights Agent, as the case may be. </font>
          </div>


          <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;Notwithstanding anything to the contrary in this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.3</font><font style="letter-spacing:0.2pt;">, unless consented to in writing by, at the applicable time of determination, Holders of at least 33% of the then outstanding CVRs, as set forth in the CVR Register (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Acting Holders</font><font style="letter-spacing:0.2pt;">&#8221;), Parent will not appoint as a successor Rights Agent any Person that is not a stock transfer agent of national reputation or the corporate trust department of a commercial bank. </font>
          </div>


          <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">(e)&nbsp;&nbsp;&nbsp;The Rights Agent will reasonably cooperate with Parent and any successor Rights Agent in connection with the transition of the duties and responsibilities of the Rights Agent to the successor Rights Agent, including the transfer of all relevant data, including the CVR Register, to the successor Rights Agent, but such predecessor Rights Agent shall not be required to make any additional expenditure or assume any additional liability in connection with the foregoing. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">3.4</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Acceptance of Appointment by Successor</font><font style="letter-spacing:0.2pt;">. Every successor Rights Agent appointed hereunder will, at or prior to such appointment, execute, acknowledge and deliver to Parent and to the retiring Rights Agent an instrument accepting such appointment and a counterpart of this Agreement, and thereupon such successor Rights Agent, without any further act, deed or conveyance, will become vested with all the rights, powers, trusts and duties of the retiring Rights Agent. On request of Parent or the successor Rights Agent, the retiring Rights Agent will execute and deliver an instrument transferring to the successor Rights Agent all the rights (except such rights of the predecessor Rights Agent which survive pursuant to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.3</font><font style="letter-spacing:0.2pt;"> of this Agreement), powers and trusts of the retiring Rights Agent. </font>
          </div>


          <div style="margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">4.&nbsp;&nbsp;&nbsp;COVENANTS </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">4.1</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">List of Holders</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Parent will furnish or cause to be furnished to the Rights Agent in such form as Parent receives from Parent&#8217;s transfer agent (or other agent performing similar services for Parent), the names and addresses of the Holders within ten (10) Business Days of the Effective Time. Until such initial list of Holders is furnished to the Rights Agent, the Rights Agent shall have no duties, responsibilities or obligations with respect to such Holders. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">4.2</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Payment of CVR Payment Amounts</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;If a CVR Payment is due under </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.4(a)</font><font style="letter-spacing:0.2pt;">, Parent will deposit the CVR Payment with the Rights Agent for payment to the Holders in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.4(a)</font><font style="letter-spacing:0.2pt;">. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">4.3</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Roche Agreements</font><font style="letter-spacing:0.2pt;">. Without the prior written consent of the Acting Holders, neither Parent nor any of its Affiliates shall (a)&#160;amend, restate, supplement, terminate or otherwise modify the Roche Agreement in a manner materially adversely affecting the Holders&#8217; rights under this Agreement, (b)&#160;in the event that Roche fails to make a payment of a Roche Payment at the time rightfully due and payable, take action with respect to, or unreasonably waive or fail to enforce, the right to receive the applicable payments which are rightfully due and payable under the Roche Agreement, in a manner materially adversely affecting the Holders&#8217; rights under this Agreement or (c)&#160;agree to any of the foregoing. Without limiting the foregoing, Parent and its Affiliates shall pursue their rights under the Roche Agreement in good faith, and not take any action (or fail to take any action) with the intention of avoiding, reducing or materially delaying any payment to the Holders hereunder. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">4.4</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Records</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Parent shall, and shall cause its Affiliates to, keep true, complete and accurate records in sufficient detail to enable the Holders and their consultants or professional advisors to confirm (a)&#160;whether the Roche Payment Amount or the Asset Disposition Proceeds have been received by Parent or its successors or Affiliates and (b)&#160;the applicable CVR Payment Amount payable to each Holder hereunder in accordance with the terms specified in this Agreement. </font>
          </div>


          <div style="margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">5.&nbsp;&nbsp;&nbsp;DISPOSITION </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">5.1</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;During the period specified in clause (b)&#160;of the definition of &#8220;CVR Term&#8221;, Parent will, and will cause its subsidiaries to, use commercially reasonable efforts to effectuate a Disposition, including the negotiation and execution of a Sale Agreement and completion of the transactions contemplated thereby. Further, Parent will not take any actions for the primary purpose of frustrating the payment of CVR Payments. </font>
          </div>

      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-2-14</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">

          <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
            <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">5.2</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The Holders acknowledge and agree that, except as expressly set forth in the foregoing Section&#160;5.1, (a)&#160;Parent has a fiduciary obligation to operate its business in the best interests of its stockholders, and any potential obligation to pay any potential Asset Disposition Proceeds or any other amounts will not create any express or implied obligation to operate its business in any particular manner in order to maximize any such CVR Payments, (b)&#160;the Holders are not relying on any representation of Parent or any other Person with regard to any Disposition or other action involving CVR Sale Assets following the Closing, and neither Parent nor any other Person has provided, or can provide, any assurance to the Holders that any potential Asset Disposition Proceeds or any other amounts will in fact be earned and paid, and (c)&#160;none of Parent or any of its Subsidiaries, officers or directors shall have any obligation or liability whatsoever to any Person relating to or in connection with any action, or failure to act, with respect to the sale of CVR Sale Assets. </font>
          </div>


          <div style="margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">6.&nbsp;&nbsp;&nbsp;AMENDMENTS </font>
          </div>


          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">6.1</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Amendments without Consent of Holders</font><font style="letter-spacing:0.2pt;">. </font>
          </div>


          <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;Without the consent of any Holders, Parent, when authorized by a Board Resolution, at any time and from time to time, and the Rights Agent may enter into one or more amendments hereto, solely to evidence any successor to or permitted Assignee of Parent and the assumption by any such successor or permitted Assignee of the covenants of Parent herein as provided in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.3</font><font style="letter-spacing:0.2pt;">. </font>
          </div>


          <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;Without the consent of any Holders, Parent, when authorized by a Board Resolution, may, with the consent of the Rights Agent, which consent shall not be unreasonably withheld, conditioned or delayed, at any time and from time to time, enter into one or more amendments hereto, solely for any of the following purposes: </font>
          </div>


          <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">(i)&nbsp;&nbsp;&nbsp;to evidence the succession of another Person as a successor Rights Agent in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3</font><font style="letter-spacing:0.2pt;"> and the assumption by any successor of the covenants and obligations of the Rights Agent herein; </font>
          </div>


          <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">(ii)&nbsp;&nbsp;&nbsp;to add to the covenants of Parent such further covenants, restrictions, conditions or provisions as Parent shall consider to be for the protection of the Holders; provided, that, in each case, such provisions do not adversely affect the interests of the Holders; </font>
          </div>


          <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">(iii)&nbsp;&nbsp;&nbsp;to cure any ambiguity, to correct or supplement any provision herein that may be defective or inconsistent with any other provision herein, or to make any other provisions with respect to matters or questions arising under this Agreement; provided, that, in each case, such provisions do not adversely affect the interests of the Holders; </font>
          </div>


          <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">(iv)&nbsp;&nbsp;&nbsp;as may be necessary or appropriate to ensure that the CVRs are not subject to registration under the Securities Act or the Exchange Act or any applicable state securities or &#8220;blue sky&#8221; laws; provided, that, in each case, such provisions do not adversely affect the interests of the Holders; </font>
          </div>


          <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">(v)&nbsp;&nbsp;&nbsp;to cancel any CVRs (A)&#160;in the event that any Holder has abandoned its rights in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.6</font><font style="letter-spacing:0.2pt;">, or (B)&#160;following a transfer of such CVRs to Parent or its Affiliates in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.2</font><font style="letter-spacing:0.2pt;"> or </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.3</font><font style="letter-spacing:0.2pt;">; </font>
          </div>


          <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">(vi)&nbsp;&nbsp;&nbsp;any other amendments hereto for the purpose of adding, eliminating or changing any provisions of this Agreement, unless such addition, elimination or change is adverse to the interests of the Holders; or </font>
          </div>


          <div style="text-indent:60pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">(vii)&nbsp;&nbsp;&nbsp;as may be necessary or appropriate to ensure that Parent complies with applicable Law. </font>
          </div>


          <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;Promptly after the execution by Parent and the Rights Agent of any amendment pursuant to the provisions of this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;6.1</font><font style="letter-spacing:0.2pt;">, Parent will transmit a notice thereof in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.1</font><font style="letter-spacing:0.2pt;"> to the Holders at their addresses as they appear on the CVR Register, setting forth in general terms the substance of such amendment. </font>
          </div>


          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">6.2</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Amendments with Consent of Holders</font><font style="letter-spacing:0.2pt;">. </font>
          </div>


          <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;Subject to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;6.1</font><font style="letter-spacing:0.2pt;"> (which amendments pursuant to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;6.1</font><font style="letter-spacing:0.2pt;"> may be made without the consent of the Holders), with the consent of the Acting Holders, whether evidenced in writing or taken </font>
          </div>

      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-2-15</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">

          <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">at a meeting of such Holders, Parent, when authorized by a Board Resolution, and the Rights Agent may enter into one or more amendments hereto for the purpose of adding, eliminating or changing any provisions of this Agreement, even if such addition, elimination or change is materially adverse to the interest of the Holders. </font>
          </div>


          <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;Promptly after the execution by Parent, and the Rights Agent of any amendment pursuant to the provisions of this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;6.2</font><font style="letter-spacing:0.2pt;">, Parent will transmit (or cause the Rights Agent to transmit) a notice thereof in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.1</font><font style="letter-spacing:0.2pt;"> to the Holders at their addresses as they appear on the CVR Register, setting forth in general terms the substance of such amendment. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">6.3</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Execution of Amendments</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;In executing any amendment permitted by this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;6</font><font style="letter-spacing:0.2pt;">, the Rights Agent will be entitled to receive, and will be fully protected in relying upon, an opinion of counsel selected by Parent stating that the execution of such amendment is authorized or permitted by this Agreement. Notwithstanding anything contained herein, the Rights Agent may, but is not obligated to, enter into any such amendment that affects the Rights Agent&#8217;s own rights, privileges, covenants or duties under this Agreement or otherwise. No supplement or amendment to this Agreement shall be effective unless duly executed by the Rights Agent. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">6.4</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Effect of Amendments</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Upon the execution of any amendment under this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;6</font><font style="letter-spacing:0.2pt;">, this Agreement will be modified in accordance therewith, such amendment will form a part of this Agreement for all purposes and every Holder will be bound thereby. </font>
          </div>


          <div style="margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">7.&nbsp;&nbsp;&nbsp;OTHER PROVISIONS OF GENERAL APPLICATION </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">7.1</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Notices to Rights Agent and Parent</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Any notice or other communication required or permitted hereunder shall be in writing and shall be deemed given when delivered and received hereunder (a)&#160;one Business Day after being sent for next Business Day delivery, fee prepared, via a reputable international overnight courier service, (b)&#160;upon delivery in the case of delivery by hand, or (c)&#160;on the date delivered in the place of delivery if sent by email (with a written or electronic confirmation of delivery) prior to 5:00&#160;p.m. New York time, otherwise on the next succeeding Business Day, in each case to the intended recipient as set forth below: </font>
          </div>


          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">If to the Rights Agent, to it at: </font>
          </div>


          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Computershare Inc. and Computershare Trust Company, N.A. </font> <br ><font style="letter-spacing:0.2pt;">150 Royall Street, 2nd Floor </font> <br ><font style="letter-spacing:0.2pt;">Canton, MA 02021 </font> <br ><font style="letter-spacing:0.2pt;">Attention: Relationship Manager </font></div>


          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">If to Parent, to it at: </font>
          </div>


          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Sesen Bio, Inc. </font>
          </div>


          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:0pt; margin-bottom:0pt; text-align:left; width:60pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">Telephone:</font>
            <br >
          </div>
          <div style=" margin-top:0pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:80pt;">
            <font style="letter-spacing:0.2pt;">[&#8226;] </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>


          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:0pt; margin-bottom:0pt; text-align:left; width:60pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">Email:</font>
            <br >
          </div>
          <div style=" margin-top:0pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:80pt;">
            <font style="letter-spacing:0.2pt;">[&#8226;] </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>


          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:0pt; margin-bottom:0pt; text-align:left; width:60pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">Attention:</font>
            <br >
          </div>
          <div style=" margin-top:0pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:80pt;">
            <font style="letter-spacing:0.2pt;">[&#8226;] </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>


          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">with a copy to: </font>
          </div>


          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">[&#8226;] </font>
          </div>


          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:0pt; margin-bottom:0pt; text-align:left; width:60pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">Telephone:</font>
            <br >
          </div>
          <div style=" margin-top:0pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:80pt;">
            <font style="letter-spacing:0.2pt;">[&#8226;] </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>


          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:0pt; margin-bottom:0pt; text-align:left; width:60pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">Email:</font>
            <br >
          </div>
          <div style=" margin-top:0pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:80pt;">
            <font style="letter-spacing:0.2pt;">[&#8226;] </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>


          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:0pt; margin-bottom:0pt; text-align:left; width:60pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">Attention:</font>
            <br >
          </div>
          <div style=" margin-top:0pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:80pt;">
            <font style="letter-spacing:0.2pt;">[&#8226;] </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">The Rights Agent or Parent may specify a different address, email address by giving notice to each other in accordance with this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.1</font><font style="letter-spacing:0.2pt;"> and to the Holders in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.2</font><font style="letter-spacing:0.2pt;">. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">7.2</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Notice to Holders</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Where this Agreement provides for notice to Holders, such notice will be sufficiently given (unless otherwise herein expressly provided) if in writing and mailed, first-class postage prepaid or, if applicable, transmitted through the facilities of DTC in accordance with DTC&#8217;s procedures, to each Holder affected by such event, at the Holder&#8217;s address as it appears in the CVR Register, not later </font>
          </div>

      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-2-16</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">

          <div style="width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">than the latest date, and not earlier than the earliest date, if any, prescribed for the giving of such notice. In any case where notice to Holders is given by mail, neither the failure to mail such notice, nor any defect in any notice so mailed, to any particular Holder will affect the sufficiency of such notice with respect to other Holders. </font>
          </div>


          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">7.3</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Parent Successors and Assigns</font><font style="letter-spacing:0.2pt;">. </font>
          </div>


          <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;Parent may not assign this Agreement without the prior written consent of the Acting Holders. Notwithstanding the foregoing (i)&#160;Parent may assign, in its sole discretion and without the consent of any other party, any or all of its rights, interests and obligations hereunder to one or more direct or indirect wholly-owned subsidiaries of Parent for so long as they remain wholly-owned subsidiaries of Parent (each, an &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Assignee</font><font style="letter-spacing:0.2pt;">&#8221;) and the Assignee agrees to assume and be bound by all of the terms of this Agreement; provided, however, that in connection with any assignment to an Assignee, Parent shall, and shall agree to, remain liable for the performance by such Assignee of all obligations of Parent hereunder, with such Assignee substituted for Parent under this Agreement, and (ii)&#160;Parent may assign this Agreement in its entirety without the consent of any other party to its successor in interest in connection with the sale of all or substantially all of its assets or of its stock, or in connection with a merger, acquisition or similar transaction (such successor in interest, the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Acquiror</font><font style="letter-spacing:0.2pt;">&#8221;, and such transaction, the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Acquisition</font><font style="letter-spacing:0.2pt;">&#8221;). This Agreement will be binding upon, inure to the benefit of and be enforceable by Parent&#8217;s successors, acquirers and each Assignee. Each reference to &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent</font><font style="letter-spacing:0.2pt;">&#8221; in this Agreement shall be deemed to include Parent&#8217;s successors, acquirers and all Assignees. Each of Parent&#8217;s successors, acquirers and assigns shall expressly assume by an instrument supplemental hereto, executed and delivered to the Rights Agent, the due and punctual payment of the CVR Payments and the due and punctual performance and observance of all of the covenants and obligations of this Agreement to be performed or observed by Parent. Notwithstanding anything to the contrary contained herein, no assignment pursuant to this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.3</font><font style="letter-spacing:0.2pt;"> shall relieve Parent of its obligations and liabilities to the Rights Agent hereunder, unless specifically agreed to in writing by the Rights Agent. </font>
          </div>


          <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;Any Person into which the Rights Agent or any successor Rights Agent may be merged or with which it may be consolidated, or any Person resulting from any merger or consolidation to which the Rights Agent or any successor Rights Agent shall be a party, or any Person succeeding to the stock transfer or other shareholder services business of the Rights Agent or any successor Rights Agent, shall be the successor to the Rights Agent under this Agreement without the execution or filing of any paper or any further act on the part of any of the parties hereto; provided, that such Person would be eligible for appointment as a successor Rights Agent under the provisions of this Agreement. The purchase of all or substantially all of the Rights Agent&#8217;s assets employed in the performance of transfer agent activities shall be deemed a merger or consolidation for purposes of this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.3(b)</font><font style="letter-spacing:0.2pt;">. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">7.4</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Benefits of Agreement; Action by Acting Holders</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The holders shall be intended third-party beneficiaries hereof and shall be entitled to, solely by action by the written consent of the Acting Holders, specifically enforce the terms hereof; </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;"> that under no circumstances shall the rights of Holders as third-party beneficiaries pursuant to this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.4</font><font style="letter-spacing:0.2pt;"> be enforceable by such Holders or any other Person acting for or on their behalf other than through the action of the Acting Holders, which Acting Holders shall have the sole power and authority to act on behalf of the Holders in enforcing any of their rights hereunder. Nothing in this Agreement, express or implied, will give to any Person (other than the Rights Agent, Parent, Parent&#8217;s successors and permitted assignees, and the Holders and their respective successors and permitted assignees) any benefit or any legal or equitable right, remedy or claim under this Agreement or under any covenant or provision herein contained, all such covenants and provisions being for the sole benefit of the Rights Agent, Parent, Parent&#8217;s successors and permitted Assignees, and the Holders and their respective successors and permitted assignees. The rights of Holders are limited to those expressly provided in this Agreement and the Merger Agreement. Except for the rights of the Rights Agent set forth herein, the Acting Holders will have the sole right, on behalf of all Holders, by virtue of or under any provision of this Agreement, to institute any action or proceeding at law or in equity with respect to this Agreement, and no individual Holder or other group of Holders will be entitled to exercise such rights. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">7.5</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Governing Law</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;This Agreement, the CVRs and all claims and causes of action based upon, arising out of or in connection herewith shall be governed by, and construed in accordance with, the Laws of the State of Delaware, without regard to Laws that may be applicable under conflicts of laws principles </font>
          </div>

      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-2-17</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">

          <div style="width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">(whether of the State of Delaware or any other jurisdiction) that would cause the application of the Laws of any jurisdiction other than the State of Delaware. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">In any Legal Proceeding between any of the parties arising out of our relating to this Agreement, each of the parties hereby (i)&#160;irrevocably and unconditionally consent and submits, for itself and its property, to the exclusive jurisdiction and venue of the Court of Chancery of the State of Delaware, New Castle County, or, if such court does not have jurisdiction, the United States District Court for the District of Delaware or, to the extent that neither of the foregoing courts has jurisdiction, the Superior Court of the State of Delaware, (ii)&#160;agrees that any claim in respect of any such Legal Proceeding shall be heard and determined exclusively in accordance with clause (i)&#160;of this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.5</font><font style="letter-spacing:0.2pt;">, (iii)&#160;waives, to the fullest extent it may legally and effectively do so, any objection which it may now or hereafter have to the laying of venue of any such Legal Proceeding in any such court, (iv)&#160;waives, to the fullest extent permitted by Law, any objection that such courts are an inconvenient forum or do not have jurisdiction over any party, and (v)&#160;agrees that service of process upon such party in any such Legal Proceeding shall be effective if notice is given in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.1</font><font style="letter-spacing:0.2pt;"> of this Agreement. Nothing in this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.5</font><font style="letter-spacing:0.2pt;">, however, shall affect the right of any Person to serve legal process in any manner permitted by Law. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">7.6</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Severability</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Any term or provision of this Agreement that is invalid or unenforceable in any situation in any jurisdiction shall not affect the validity or enforceability of the remaining terms and provisions of this Agreement or the validity or enforceability of the offending term or provision in any other situation or in any other jurisdiction. If any term or other provision of this Agreement is determined by a final judgement of a court of competent jurisdiction to be invalid or unenforceable, the parties agree that the court making such determination shall have the power to limit such term or provisions, to delete specific words or phrases or to replace such term or provision with a term or provision that is valid and enforceable and that comes closest to expressing the intention of the invalid or unenforceable term or provision, and this Agreement shall be valid and enforceable as so modified. Notwithstanding anything to the contrary herein, if any such excluded provision shall affect the rights, immunities, liabilities, duties or obligations of the Rights Agent, the Rights Agent shall be entitled to resign immediately upon written notice to Parent. In the event such court does not exercise the power granted to it in the prior sentence, the parties agree to replace such invalid or unenforceable term or provision with a valid and enforceable term or provision that will achieve, to the extent possible, the economic, business or other purposes of such invalid or unenforceable term or provision. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">7.7</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Counterparts and Signature</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;This Agreement may be signed in any number of counterparts, including by electronic transmission, each of which shall be an original, with the same effect as if the signatures thereto and hereto were upon the same instrument. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">7.8</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Termination</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;This Agreement will expire and be of no force or effect, the parties hereto will have no liability hereunder (other than with respect to monies due and owing by Parent to the Rights Agent or any other rights of the Rights Agent which expressly survive the termination of this Agreement), and no additional payments will be required to be made, upon the later of (i)&#160;the conclusion of the CVR Term, and (ii)&#160;the payment of the full amount of all CVR Payments made to Parent on or prior to the end of the applicable CVR Term to the Rights Agent and the payment of the full amount of all CVR Payment Amounts to the Holders by the mailing by the Rights Agent of each applicable CVR Payment Amount to each Holder at the address reflected in the CVR Register; provided that, for clarity, the term &#8220;CVR Term&#8221; as used in this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.8</font><font style="letter-spacing:0.2pt;"> shall be deemed to mean clause (a)&#160;of such definition with respect to any Roche Payment Amount, and shall be deemed to mean clause (b)&#160;of such definition with respect to any Asset Disposition Proceeds. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">7.9</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Funds</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;All funds received by the Rights Agent under this Agreement that are to be distributed or applied by Computershare in the performance of services hereunder (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Funds</font><font style="letter-spacing:0.2pt;">&#8221;) shall be held by Computershare as agent for Parent and deposited in one or more bank accounts to be maintained by Computershare in its name as agent for Parent. Until paid pursuant to the terms of this Agreement, Computershare will hold the Funds through such accounts in: deposit accounts of commercial banks with Tier 1 capital exceeding $1&#160;billion or with an average rating above investment grade by S&amp;P (LT Local Issuer Credit Rating), Moody&#8217;s (Long Term Rating) and Fitch Ratings, Inc. (LT Issuer Default Rating) (each as reported by Bloomberg Finance L.P.). The Rights Agent shall have no responsibility or liability for any diminution of the Funds that may result from any deposit made by the Rights Agent in accordance with this </font>
          </div>

      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-2-18</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:256pt;margin-left:69.66pt;width:456pt;">

          <div style="width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">paragraph, including any losses resulting from a default by any bank, financial institution or other Third Party. The Rights Agent may from time to time receive interest, dividends or other earnings in connection with such deposits. The Rights Agent shall not be obligated to pay such interest, dividends or earnings to Parent, any Holder or any other party. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">7.10</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Entire Agreement</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;As between Parent and the Holders, this Agreement and the Merger Agreement (including the schedules, annexes and exhibits thereto, the documents and instruments referred to therein and the documents delivered pursuant thereto) constitute the entire agreement of Parent and the Holders and supersede all prior agreements and undertakings, both written and oral, among Parent and the Holders, or any of them, with respect to the subject matter hereof and, except as otherwise expressly provided herein or therein, are not intended to confer upon any other Person any rights or remedies hereunder or thereunder. As between Parent and the Rights Agent, this Agreement (including the documents and instruments referred to herein (other than the Merger Agreement) and the documents delivered pursuant thereto) contains the entire understanding of the parties with reference to the transactions and matters contemplated hereby and thereby and supersedes all prior agreements, written or oral, among the parties with respect thereto. If and to the extent that any provision of this Agreement is inconsistent or conflicts with the Merger Agreement, this Agreement will govern and control. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">7.11</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Waiver of Jury Trial</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;EACH PARTY HEREBY WAIVES, TO THE FULLEST EXTENT PERMITTED BY LAW, ANY RIGHT TO TRIAL BY JURY OF ANY CLAIM, DEMAND, ACTION, OR CAUSE OF ACTION (i)&#160;ARISING UNDER THIS AGREEMENT OR (ii)&#160;IN ANY WAY CONNECTED WITH OR RELATED OR INCIDENTAL TO THE DEALINGS OF THE PARTIES HERETO IN RESPECT OF THIS AGREEMENT OR ANY OF THE TRANSACTIONS CONTEMPLATED HEREBY, IN EACH CASE WHETHER NOW EXISTING OR HEREAFTER ARISING, AND WHETHER IN CONTRACT, TORT, EQUITY, OR OTHERWISE. EACH PARTY HEREBY AGREES AND CONSENTS THAT ANY SUCH CLAIM, DEMAND, ACTION, OR CAUSE OF ACTION SHALL BE DECIDED BY COURT TRIAL WITHOUT A JURY AND THAT THE PARTIES TO THIS AGREEMENT MAY FILE AN ORIGINAL COUNTERPART OF A COPY OF THIS AGREEMENT WITH ANY COURT AS WRITTEN EVIDENCE OF THE CONSENT OF THE PARTIES HERETO TO THE WAIVER OF THEIR RIGHT TO TRIAL BY JURY. </font>
          </div>


          <div style="margin-top:8pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">[</font><font style="font-style:italic;letter-spacing:0.2pt;">Remainder of page intentionally left blank</font><font style="letter-spacing:0.2pt;">] </font>
          </div>

      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-2-19</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;height:660pt;margin-left:69.66pt;width:456pt;">

          <div style="text-indent:20pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">IN WITNESS WHEREOF, each of the parties has caused this Agreement to be executed on its behalf by its duly authorized officers as of the day and year first above written. </font>
          </div>


          <table style="width:456pt;height:207pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 1.5pt 0pt; width:0pt;" colspan="4">
                <font style="letter-spacing:0.2pt;">SESEN BIO, INC. </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:204pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:11.5pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:15.5pt 0pt 0.5pt 0pt; width:24pt;">
                <font style="letter-spacing:0.2pt;">By: </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:15.5pt 0pt 0.5pt 0pt; width:204pt;white-space:normal;">
                <div>
                  <font style="letter-spacing:0.2pt;">&#8199;</font>
                  <br >
                </div>
                <div style="margin-top:2.5pt; text-align:justify;">
                  <div style="margin-left: 0pt; width: 204pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:204pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:11.5pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2pt 0pt 1.5pt 0pt; width:24pt;">
                <font style="letter-spacing:0.2pt;">Name: </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2pt 0pt 1.5pt 0pt; width:204pt;white-space:normal;">
                <div>
                  <font style="letter-spacing:0.2pt;">&#8199;</font>
                  <br >
                </div>
                <div style="margin-top:2.5pt; text-align:justify;">
                  <div style="margin-left: 0pt; width: 204pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:204pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:11.5pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:4pt 0pt 1.5pt 0pt; width:24pt;">
                <font style="letter-spacing:0.2pt;">Title: </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:4pt 0pt 1.5pt 0pt; width:204pt;white-space:normal;">
                <div>
                  <font style="letter-spacing:0.2pt;">&#8199;</font>
                  <br >
                </div>
                <div style="margin-top:2.5pt; text-align:justify;">
                  <div style="margin-left: 0pt; width: 204pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:204pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:15.667pt 0pt 1.5pt 0pt; width:0pt;" colspan="4">
                <font style="letter-spacing:0.2pt;">COMPUTERSHARE INC. and </font>
                <br >
                <font style="letter-spacing:0.2pt;">COMPUTERSHARE TRUST</font>
                <br >
                <font style="letter-spacing:0.2pt;">COMPANY, N.A., jointly as RIGHTS </font>
                <br >
                <font style="letter-spacing:0.2pt;">AGENT </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td colspan="3">&#8203;</td>
            </tr>
            <tr style="line-height:11.5pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:15.5pt 0pt 0.5pt 0pt; width:24pt;">
                <font style="letter-spacing:0.2pt;">By: </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:15.5pt 0pt 0.5pt 0pt; width:204pt;white-space:normal;">
                <div>
                  <font style="letter-spacing:0.2pt;">&#8199;</font>
                  <br >
                </div>
                <div style="margin-top:2.5pt; text-align:justify;">
                  <div style="margin-left: 0pt; width: 204pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:204pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:11.5pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2pt 0pt 1.5pt 0pt; width:24pt;">
                <font style="letter-spacing:0.2pt;">Name: </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2pt 0pt 1.5pt 0pt; width:204pt;white-space:normal;">
                <div>
                  <font style="letter-spacing:0.2pt;">&#8199;</font>
                  <br >
                </div>
                <div style="margin-top:2.5pt; text-align:justify;">
                  <div style="margin-left: 0pt; width: 204pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:204pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:11.5pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:4pt 0pt 1.5pt 0pt; width:24pt;">
                <font style="letter-spacing:0.2pt;">Title: </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:4pt 0pt 1.5pt 0pt; width:204pt;white-space:normal;">
                <div>
                  <font style="letter-spacing:0.2pt;">&#8199;</font>
                  <br >
                </div>
                <div style="margin-top:2.5pt; text-align:justify;">
                  <div style="margin-left: 0pt; width: 204pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:204pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
          </table>

        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;"> </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;min-height:690.02pt;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a><a name="tANNB">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">

          <div style="text-align:right; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">ANNEX B</font>&#8203;</div>

        <div style="position:relative;margin-top:8.71pt; width:456pt;">
          <img src="lg_svbsecurities-4c.jpg" alt="[MISSING IMAGE: lg_svbsecurities-4c.jpg]" height="51" width="224" >
        </div>

          <div style="margin-top:14.81pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">December&#160;29</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">th</font><font style="letter-spacing:0.2pt;">, 2022 </font>
          </div>


          <div style="margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">The Board of Directors </font> <br ><font style="letter-spacing:0.2pt;">Sesen Bio, Inc. </font> <br ><font style="letter-spacing:0.2pt;">245 First Street, Suite 1800 </font> <br ><font style="letter-spacing:0.2pt;">Cambridge, MA 02142 </font></div>


          <div style="margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Ladies and Gentlemen: </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">You have requested our opinion as to the fairness, from a financial point of view, to Sesen Bio, Inc., a Delaware corporation (&#8220;Parent&#8221;), of the Exchange Ratio (as defined below) proposed to be paid by Parent pursuant to the terms of the Agreement and Plan of Merger and Reorganization (the &#8220;Original Merger Agreement&#8221;) dated as of September&#160;20, 2022 by and among Parent, Sesen Merger Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of Parent (&#8220;Merger Sub&#8221;), and CARISMA Therapeutics Inc., a Delaware corporation (the &#8220;Company&#8221;), as proposed to be amended by the First Amendment to Agreement and Plan of Merger and Reorganization (the &#8220;First Amendment to Merger Agreement&#8221;) to be entered into by and among Parent, Merger Sub and the Company (the Original Merger Agreement, as proposed to be amended by the First Amendment to Merger Agreement, the &#8220;Amended Merger Agreement&#8221;). The Amended Merger Agreement provides for the acquisition by Parent of the Company through the merger of Merger Sub with and into the Company (the &#8220;Merger&#8221;), with the Company continuing as the surviving entity of the Merger and as a wholly-owned subsidiary of Parent. Capitalized terms used but not defined herein have the meanings set forth in the Amended Merger Agreement. At the effective time of the Merger (the &#8220;Effective Time&#8221;), after giving effect to the Nasdaq Reverse Split, if any, and the declaration of the Pre-Closing Dividend, by virtue of the Merger and without any further action on the part of Parent, Merger Sub, the Company or any stockholder of the Company or Parent, among other things, each share of Company Capital Stock outstanding immediately prior to the Effective Time (excluding Excluded Shares (as defined below)) shall be converted solely into the right to receive a number of shares of the common stock, $0.001 par value per share, of Parent (the &#8220;Parent Common Stock&#8221;) equal to the Exchange Ratio. As used herein, (i)&#160;the &#8220;Exchange Ratio&#8221; is the number of shares of Parent Common Stock to be received by holders of Company Capital Stock, other than Excluded Shares, in the Merger, which is derived from the agreed relative valuations of the Company and Parent as set forth in the Amended Merger Agreement; and (ii)&#160;&#8220;Excluded Shares&#8221; means (a)&#160;any shares of Company Capital Stock held as treasury stock or held or owned by the Company, Merger Sub or any Subsidiary of the Company immediately prior to the Effective Time (which shares shall be canceled and retired and shall cease to exist, and no consideration shall be delivered in exchange therefor); and (b)&#160;any shares of Company Capital Stock that are outstanding immediately prior to the Effective Time and which are held by stockholders who have exercised and perfected appraisal rights for such shares of Company Capital Stock in accordance with the General Corporation Law of the State of Delaware. The Exchange Ratio is subject to certain adjustments set forth in the Amended Merger Agreement; we express no opinion as to any such adjustments. The Merger and the other transactions summarized above are collectively referred to herein as the &#8220;Transaction.&#8221; The terms and conditions of the Transaction are more fully set forth in the Amended Merger Agreement. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">We have been engaged by Parent to act as its financial advisor in connection with the Transaction and we will receive a fee from Parent for providing such services, a portion of which was payable upon delivery of our opinion in connection with the Original Merger Agreement, another portion of which is payable upon delivery of this opinion in connection with the Amended Merger Agreement, and the remaining (and principal) portion of which is contingent upon consummation of the Transaction. In addition, Parent has agreed to reimburse certain of our expenses arising, and indemnify us against certain liabilities that may arise, out of our engagement.</font>
          </div>

        <div style="position:relative;margin-top:12.21pt; width:456pt;">
          <img src="ft_svbsecurities-4c.jpg" alt="[MISSING IMAGE: ft_svbsecurities-4c.jpg]" height="42" width="594" >
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">B-1</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">

          <div style="text-indent:20pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">SVB Securities LLC is a full-service securities firm engaged in securities trading and brokerage activities as well as investment banking and financial advisory services. In the ordinary course of business, we and our affiliates have in the past provided, currently are providing and may in the future provide investment banking and commercial banking services to Parent, the Company or their respective affiliates and have received and would expect to receive customary fees for the rendering of such services. In the ordinary course of our business, we or our affiliates have in the past and may in the future hold positions, for our own account or the accounts of our customers, in equity, debt or other securities of Parent, the Company or their respective affiliates. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Consistent with applicable legal and regulatory requirements, we have adopted policies and procedures to establish and maintain the independence of our research department and personnel. As a result, our research analysts may hold views, make statements or investment recommendations and/or publish research reports with respect to Parent, the Company and the Transaction and other participants in the Transaction that differ from the views of our investment banking personnel. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">In connection with this opinion, we have reviewed, among other things: (i)&#160;the Original Merger Agreement; (ii)&#160;a draft of the First Amendment to Merger Agreement, dated December&#160;29</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">th</font><font style="letter-spacing:0.2pt;">, 2022; (iii)&#160;a draft of the form of Contingent Value Rights Agreement to be entered into at the closing of the Transaction by Parent and a rights agent (the &#8220;CVR Agreement&#8221;), dated December&#160;29</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">th</font><font style="letter-spacing:0.2pt;">, 2022; (iv)&#160;Parent&#8217;s Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2021, as filed by Parent with the Securities and Exchange Commission (the &#8220;SEC&#8221;); (v)&#160;Parent&#8217;s Quarterly Reports on Form 10-Q for the quarterly periods ended March&#160;31, 2022, June&#160;30, 2022, and September&#160;30, 2022 (including any amendments thereto), as filed by Parent with the SEC; (vi)&#160;certain Current Reports on Form 8-K (including any amendments thereto), as filed by Parent with, or furnished by Parent to, the SEC; (vii)&#160;certain internal information, primarily related to expense forecasts, relating to the business, operations, earnings, cash flow, assets, liabilities and prospects of Parent, as furnished to us by the management of Parent; and (viii)&#160;certain internal information relating to the business, operations, earnings, cash flow, assets, liabilities and prospects of the Company, including certain financial forecasts, analyses and projections relating to the Company prepared by management of the Company, as modified by management of Parent and furnished to, and approved for use by, us by Parent for purposes of our analysis (the &#8220;Company Forecast&#8221;) (collectively, the &#8220;Internal Data&#8221;). We have also conducted discussions with members of the senior management of Parent and the Company and their respective advisors and representatives regarding such Internal Data as well as the past and current business, operations, financial condition and prospects of each of Parent and the Company. In addition, we reviewed certain financial data for the Company and compared that data to similar publicly available market, financial and other data for certain other companies, the securities of which are publicly traded, that we believe to be comparable in certain respects to the Company. We also conducted such other financial studies and analyses and took into account such other information as we deemed appropriate. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">We have assumed, without independent verification or any responsibility therefor, the accuracy and completeness of the financial, legal, regulatory, tax, accounting and other information supplied to, discussed with, or reviewed by us for purposes of this opinion and have, with your consent, relied upon such&#160;information as being complete and accurate. In that regard, we have been advised by Parent, and have assumed, at your direction, that the Internal Data (including, without limitation, the Company Forecast) has been reasonably prepared on bases reflecting the best currently available estimates and judgments of the management of Parent and the Company as to the matters covered thereby and we have relied, at your direction, on the Internal Data for purposes of our analysis and this opinion. We express no view or opinion as to the Internal Data (including, without limitation, the Company Forecast) or the assumptions on which it is based. As you are aware, Parent&#8217;s management did not provide us with, and we did not otherwise have access to, financial forecasts regarding Parent&#8217;s business, other than the expense forecasts described above. Accordingly, we did not perform a discounted cash flow analysis or any multiples-based analysis with respect to Parent. In addition, at your direction, we have not made any independent evaluation or appraisal of any of the assets or liabilities (contingent, derivative, off-balance-sheet or otherwise) of Parent or the Company, nor have we been furnished with any such evaluation or appraisal, and we have not been asked to conduct, and did not conduct, a physical inspection of the properties or assets of Parent or the Company. Furthermore, at your direction, we have ascribed no value to the contingent value rights issuable pursuant to the CVR Agreement. </font>
          </div>

      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">B-2</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">

          <div style="text-indent:20pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">We have assumed, at your direction, that the final executed First Amendment to Merger Agreement will not differ in any respect material to our analysis or this opinion from the last draft of the First Amendment to Merger Agreement reviewed by us. We have also assumed, at your direction, that the representations and warranties made by the Company and Parent and Merger Sub in the Amended Merger Agreement and the related agreements are and will continue to be true and correct in all respects material to our analysis. Furthermore, we have assumed, at your direction, that the Transaction will be consummated on the terms set forth in the Amended Merger Agreement and in accordance with all applicable laws and other relevant documents or requirements, without delay or the waiver, modification or amendment of any term, condition or agreement, the effect of which would be material to our analysis or this opinion and that, in the course of obtaining the necessary governmental, regulatory and other approvals, consents, releases and waivers for the Transaction, no delay, limitation, restriction, condition or other change will be imposed, the effect of which would be material to our analysis or this opinion. We have not evaluated and do not express any opinion as to the solvency or fair value of Parent or the Company, or their respective abilities to pay their obligations when they come due, or as to the impact of the Transaction on such matters, under any state, federal or other laws relating to bankruptcy, insolvency, or similar matters. We are not legal, regulatory, tax or accounting advisors, and we express no opinion as to any legal, regulatory, tax or accounting matters. We express no view or opinion as to the price or range of prices at which the shares of stock or other securities or instruments of Parent or any third party may trade at any time, including subsequent to the announcement or consummation of the Transaction. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">We express no view as to, and our opinion does not address, Parent&#8217;s underlying business decision to proceed with or effect the Transaction, or the relative merits of the Transaction as compared to any alternative business strategies or transactions that might be available to Parent or in which Parent might engage. This opinion is limited to and addresses only the fairness, from a financial point of view, as of the date hereof, to Parent of the Exchange Ratio proposed to be paid by Parent pursuant to the terms of the Amended Merger Agreement. We have not been asked to, nor do we express any view on, and our opinion does not address, any other term or aspect of the Amended Merger Agreement or the Transaction, including, without limitation, the structure or form of the Transaction, or any other agreements or arrangements contemplated by the Amended Merger Agreement or entered into in connection with or otherwise contemplated by the Transaction, including, without limitation, the fairness of the Transaction or any other term or aspect of the Transaction to, or any consideration to be received in connection therewith by, or the impact of the Transaction on, the holders of any class of securities, creditors or other constituencies of Parent or any other party. In addition, we express no view or opinion as to the fairness (financial or otherwise) of the amount, nature or any other aspect of any compensation to be paid or payable to any of the officers, directors or employees of Parent or any other party, or class of such persons in connection with the Transaction, whether relative to the Exchange Ratio to be paid by Parent pursuant to the terms of the Amended Merger Agreement or otherwise. Our opinion is necessarily based on financial, economic, monetary, currency, market and other conditions and circumstances as in effect on, and the information made available to us as of, the date hereof, and we do not have any obligation or responsibility to update, revise or reaffirm this opinion based on circumstances, developments or events occurring after the date hereof. Our opinion does not constitute a recommendation to any stockholder of Parent as to whether or how such stockholder should vote with respect to the Merger or otherwise act with respect to the Transaction or any other matter. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Our financial advisory services and the opinion expressed herein are provided for the information and assistance of the Board of Directors of Parent (in their capacity as directors and not in any other capacity) in connection with and for purposes of its consideration of the Transaction. This opinion has been authorized by our Fairness Opinion Review Committee. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Based upon and subject to the foregoing, including the various assumptions, qualifications and limitations set forth herein, it is our opinion that, as of the date hereof, the Exchange Ratio proposed to be paid by Parent pursuant to the terms of the Amended Merger Agreement is fair, from a financial point of view, to Parent. </font>
          </div>


          <div style="margin-left:240pt; margin-top:8pt; width:216pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Very truly yours, </font>
          </div>


          <div style="margin-left:240pt; margin-top:12pt; width:216pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">/s/ SVB SECURITIES LLC </font>
          </div>

      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">B-3</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a><a name="tANNC">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; text-align:right; width:436pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ANNEX C</font>&#8203;</div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">FORM OF COMPANY STOCKHOLDER SUPPORT AGREEMENT</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">This STOCKHOLDER SUPPORT AGREEMENT (this &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Support Agreement</font><font style="letter-spacing:0.2pt;">&#8221;) is entered into as of [&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;], 2022, among CARISMA Therapeutics Inc., a Delaware corporation (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company</font><font style="letter-spacing:0.2pt;">&#8221;), Sesen Bio, Inc., a Delaware corporation (&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent</font><font style="letter-spacing:0.2pt;">&#8221;), and the undersigned stockholder (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Stockholder</font><font style="letter-spacing:0.2pt;">&#8221;) of the Company. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">WHEREAS, as of the date hereof, the Stockholder is the sole record owner of and has the sole power to vote (or to direct the voting of) the number of shares of common stock, par value $0.0001 per share, of the Company (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Common Stock</font><font style="letter-spacing:0.2pt;">&#8221;), and/or the number of shares of preferred stock, $0.0001 par value per share of the Company (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Preferred Stock</font><font style="letter-spacing:0.2pt;">&#8221;), set forth opposite the Stockholder&#8217;s name on </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Schedule&#160;I</font><font style="letter-spacing:0.2pt;"> hereto (such Common Stock and Preferred Stock, together with any other shares of the Company that are hereafter issued to or otherwise acquired or owned by, including upon exercise of options or securities convertible into or exercisable or exchangeable for Common Stock (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Shares</font><font style="letter-spacing:0.2pt;">&#8221;), the voting power of which is acquired by such Stockholder during the Voting Period (as defined below), are collectively referred to herein as the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Subject Shares</font><font style="letter-spacing:0.2pt;">&#8221;); </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">WHEREAS, the Company, Parent, and Seahawk Merger Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of Parent (&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Merger Sub</font><font style="letter-spacing:0.2pt;">&#8221;), are concurrently entering into an Agreement and Plan of Merger and Reorganization, dated on or about the date hereof (as amended from time to time, the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Merger Agreement</font><font style="letter-spacing:0.2pt;">&#8221;), pursuant to which Merger Sub shall be merged with and into the Company, with the Company continuing as the surviving corporation and as a wholly-owned subsidiary of Parent (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Merger</font><font style="letter-spacing:0.2pt;">&#8221;); </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">WHEREAS, the adoption of the Merger Agreement and the transactions contemplated thereby requires the written consent or affirmative vote of (i)&#160;the holders of a majority of the capital stock of the Company, voting together as a single class, (ii)&#160;the holders of a majority of the Series&#160;A Preferred Stock, $0.0001 par value per share, of the Company (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Series&#160;A Preferred Stock</font><font style="letter-spacing:0.2pt;">&#8221;), and the Special Voting Preferred Stock, $0.0001 par value per share, of the Company (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Special Voting Preferred Stock</font><font style="letter-spacing:0.2pt;">&#8221;), voting together as a single class, (iii)&#160;the holders of at least two-thirds of the Series&#160;B Preferred Stock, $0.0001 par value per share, of the Company (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Series&#160;B Preferred Stock</font><font style="letter-spacing:0.2pt;">&#8221;), and the Series&#160;B Special Voting Preferred Stock, $0.0001 par value per share, of the Company (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Series&#160;B Special Voting Preferred Stock</font><font style="letter-spacing:0.2pt;">&#8221;), voting together as a single class, and (iv)&#160;the holders of at least two-thirds of the Series&#160;A Preferred Stock, Special Voting Preferred Stock, Series&#160;B Preferred Stock and Series&#160;B Special Voting Preferred Stock, voting together as a single class; and </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">WHEREAS, as a condition and inducement to Parent&#8217;s willingness to enter into the Merger Agreement and consummate the transactions contemplated thereby, Parent and the Company have required the Stockholder to, as an inducement and in consideration therefor, and the Stockholder (in the Stockholder&#8217;s capacity as holder of the Subject Shares) has agreed to, enter into this Support Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">NOW, THEREFORE, in consideration of the foregoing and the respective representations, warranties, covenants and agreements set forth herein, the parties agree as follows: </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ARTICLE I</font>
          <br >
          <font style="letter-spacing:-0.2pt;">DEFINITIONS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">SECTION 1.1&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Capitalized Terms</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;For purposes of this Support Agreement, capitalized terms used and not defined herein shall have the respective meanings ascribed to them in the Merger Agreement. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Expiration Time</font><font style="letter-spacing:0.2pt;">&#8221; shall mean the earliest to occur of (i)&#160;the Effective Time, (ii)&#160;any amendment to the Merger Agreement that reduces the amount, or changes the form of any consideration payable to the Stockholder in the transaction, (iii)&#160;the date and time of the valid termination of the Merger Agreement in accordance with its terms and (iv)&#160;the End Date (as defined in the Merger Agreement in effect on the date hereof) provided that the Effective Time has not occurred on or before such date. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">C-1</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; text-indent:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Voting Period</font><font style="letter-spacing:0.2pt;">&#8221; shall mean such period of time between the date hereof and the Expiration Time. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Recommendation Change Requirement</font><font style="letter-spacing:0.2pt;">&#8221; shall mean, with respect to the Stockholder, 35% of the Subject Shares held by such Stockholder. </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:11.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ARTICLE II</font>
          <br >
          <font style="letter-spacing:-0.2pt;">VOTING AGREEMENT AND IRREVOCABLE PROXY</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">SECTION 2.1&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Agreement to Vote.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The Stockholder hereby agrees that, during the Voting Period, and at any duly called meeting of the stockholders of the Company (or any adjournment or postponement thereof), or in any other circumstances (including action by written consent of stockholders in lieu of a meeting) upon which a vote, adoption or other approval or consent with respect to the adoption of the Merger Agreement or the approval of the Merger and any of the transactions contemplated thereby is sought, the Stockholder: </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;if no Company Board Adverse Recommendation Change has occurred in accordance with Section&#160;5.3(c) of the Merger Agreement, shall, if a meeting is held, appear at the meeting, in person or by proxy, and shall provide a written consent (a &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Written Consent</font><font style="letter-spacing:0.2pt;">&#8221;) or vote (or cause to be voted), in person or by proxy, all of the Subject Shares, in each case (i)&#160;in favor of (A)&#160;any proposal to adopt and approve or reapprove the Merger Agreement and the transactions contemplated thereby, including (1)&#160;adoption and approval of the Merger Agreement and the Contemplated Transactions, (2)&#160;adoption and approval of an amendment of the Company&#8217;s certificate of incorporation to increase the authorized shares of the Common Stock, (3)&#160;acknowledgment that the approval given thereby is irrevocable and that the Stockholder is aware of the Stockholder&#8217;s rights to demand appraisal for its shares pursuant to Section&#160;262 of the DGCL, a true and correct copy of which will be attached thereto, and that the Stockholder has received and read a copy of Section&#160;262 of the DGCL, (4)&#160;acknowledgment that by the Stockholder&#8217;s approval of the Merger the Stockholder is (A)&#160;waiving its appraisal rights with respect to the Subject Shares in connection with the Merger and thereby waives any rights to receive payment of the fair value of the Stockholder&#8217;s capital stock under the DGCL, and (B)&#160;waiving any notice that may have been or may be required relating to the Merger or any of the other Contemplated Transactions (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Stockholder Approval Matters</font><font style="letter-spacing:0.2pt;">&#8221;), and (ii)&#160;against any Acquisition Proposal and any action in furtherance of any such Acquisition Proposal; and </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;if a Company Board Adverse Recommendation Change has occurred in accordance with Section&#160;5.3(c) of the Merger Agreement, shall, if a meeting is held, appear at the meeting, in person or by proxy, and shall provide a Written Consent or vote (or caused to be voted), in person or by proxy, at least the Recommendation Change Requirement (rounded up to the nearest whole number of Subject Shares) of Subject Shares held by such Stockholder, in each case (i)&#160;in favor of the Stockholder Approval Matters, and (ii)&#160;against any proposals that compete with the Contemplated Transactions, including any Acquisition Proposal and any action in furtherance of any such Acquisition Proposal. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">SECTION 2.2&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Grant of Irrevocable Proxy.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;In the event and to the extent that the Stockholder fails to vote the Subject Shares in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.1</font><font style="letter-spacing:0.2pt;"> at any applicable meeting of the stockholders of the Company or pursuant to any applicable meeting of the stockholders of the Company or pursuant to any applicable written consent of the stockholders of the Company, the Stockholder hereby appoints the Company and any designee of the Company, and each of them individually, as the Stockholder&#8217;s proxy, with full power of substitution and re-substitution, to vote, including by executing written consents, during the Voting Period with respect to any and all of the Subject Shares solely on the matters and in the manner specified in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.1</font><font style="letter-spacing:0.2pt;">; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, that, for the avoidance of doubt, if a Company Board Adverse Recommendation Change in accordance with Section&#160;5.3(c) of the Merger Agreement has occurred the Stockholder shall only be deemed to have granted a proxy to the extent of the Recommendation Change Requirement. The Stockholder shall take all further action or execute such other instruments as may be necessary to effectuate the intent of any such proxy. The Stockholder affirms that the irrevocable proxy given by it hereby with respect to the Merger Agreement and the Contemplated Transactions is given to the Company by the Stockholder to secure the performance of the obligations of the Stockholder under </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.1</font><font style="letter-spacing:0.2pt;"> of this Support Agreement. It is agreed that the Company (and its designees) will use the irrevocable proxy that is granted by the Stockholder hereby only in accordance with applicable Laws and that, </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">C-2</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">to the extent the Company (and its designees) uses such irrevocable proxy, it will only vote (or sign written consents in respect of) the Subject Shares subject to such irrevocable proxy with respect to the matters specified in, and in accordance with the provisions of, </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.1</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">SECTION 2.3&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Nature of Irrevocable Proxy.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The proxy granted pursuant to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.2</font><font style="letter-spacing:0.2pt;"> to the Company by the Stockholder shall be irrevocable during the term of this Support Agreement, shall be deemed to be coupled with an interest sufficient in law to support an irrevocable proxy and shall revoke any and all prior proxies or powers of attorney granted by the Stockholder and no subsequent proxy or power of attorney shall be given or written consent executed (and if given or executed, shall not be effective) by the Stockholder with respect thereto. The proxy that may be granted hereunder shall terminate automatically, without any further action on the part of the Company, Stockholder or any other Person, upon the Expiration Time, but shall survive the death or incapacity of the Stockholder and any obligation of the Stockholder under this Support Agreement shall be binding upon the heirs, personal representatives and successors of the Stockholder. </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:11.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ARTICLE III</font>
          <br >
          <font style="letter-spacing:-0.2pt;">COVENANTS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">SECTION 3.1&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Subject Shares.</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;The Stockholder agrees that (i)&#160;from the date hereof until the Expiration Time, it shall not, and shall not commit or agree to, without the prior written consent of Parent and the Company, directly or indirectly, whether by merger, consolidation or otherwise, offer for sale, sell (including short sales), transfer, tender, pledge, encumber, assign or otherwise dispose of (including by gift or by operation of law) (any of the foregoing, a &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Transfer</font><font style="letter-spacing:0.2pt;">&#8221;), or enter into any contract, option, derivative, hedging or other agreement or arrangement or understanding (including any profit-sharing arrangement) with respect to, or consent to or permit, a Transfer of, any or all of the Subject Shares or any interest therein; and (ii)&#160;during the Voting Period, it shall not, and shall not commit or agree to, without the prior written consent of Parent and the Company, (A)&#160;grant any proxies or powers of attorney with respect to any or all of the Subject Shares or agree to vote (or sign written consents in respect of) the Subject Shares on any matter or divest itself of any voting rights in the Subject Shares that would conflict with the terms of this Support Agreement, or (B)&#160;take any action that would have the effect of preventing or disabling the Stockholder from performing its obligations under this Support Agreement. Notwithstanding the foregoing, the Stockholder may, at any time, Transfer its Subject Shares (1)&#160;by will or other testamentary document or by intestacy, (2)&#160;to any investment fund or other entity controlled or managed by the Stockholder or the investment adviser or general partner of the Stockholder, (3)&#160;to another corporation, partnership, limited liability company, trust or other business entity that is a direct or indirect Affiliate of the Stockholder, including any investment funds or other entities that controls or manages, or is under common control or management with, or is controlled or managed by, the Stockholder, (4)&#160;to any member of the Stockholder&#8217;s immediate family, (5)&#160;to any trust for the direct or indirect benefit of the Stockholder or the immediate family of the Stockholder or otherwise for estate planning purposes, (6)&#160;to stockholders, current or former partners (general or limited), members or managers of the Stockholder, as applicable, or to the estates of any of the foregoing, or (7)&#160;to the extent required by applicable Law; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, that the case of clauses (1)-(6), such permitted transferee shall have executed and delivered to Parent and the Company a support agreement substantially identical to this Support Agreement. The Stockholder agrees that any Transfer of Subject Shares not permitted hereby shall be null and void and that any such prohibited Transfer shall be enjoined. If any voluntary or involuntary Transfer of any Subject Shares covered hereby shall occur (including a sale by the Stockholder&#8217;s trustee in bankruptcy, or a sale to a purchaser at any creditor&#8217;s or court sale), the permitted transferee (which term, as used herein, shall include any and all transferees and subsequent transferees of the initial transferee) shall take and hold such Subject Shares subject to all of the restrictions, liabilities and rights under this Support Agreement, which shall continue in full force and effect. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;In the event of a stock dividend or distribution, or any change in the Subject Shares by reason of any stock dividend or distribution, split-up, recapitalization, combination, conversion, exchange of shares or the like, the term &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Subject Shares</font><font style="letter-spacing:0.2pt;">&#8221; shall be deemed to refer to and include the Subject Shares as well as all such stock dividends and distributions and any securities into which or for </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">C-3</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">which any or all of the Subject Shares may be changed or exchanged or which are received in such transaction. The Stockholder further agrees that, in the event the Stockholder purchases or otherwise acquires beneficial or record ownership of or an interest in, or acquires the right to vote or share in the voting of, any additional Shares, in each case after the execution of this Support Agreement and prior to the Expiration Time, the Stockholder shall deliver promptly to the Company and Parent written notice of such event, which notice shall state the number of additional Shares so acquired; provided, that no such notice shall be required with respect to any additional Shares acquired in connection with the Pre-Closing Financing. The Stockholder agrees that any such additional Shares shall constitute Subject Shares for all purposes of this Support Agreement and shall be subject to the terms of this Support Agreement, including all covenants, agreements, obligations, representations and warranties set forth herein as if those additional Shares were owned by the Stockholder on the date of this Support Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">SECTION 3.2&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Stockholder&#8217;s Capacity.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;All agreements and understandings made herein shall be made solely in the Stockholder&#8217;s capacity as a holder of the Subject Shares and not in any other capacity, including not in the Stockholder&#8217;s capacity as a director or officer of the Company. Notwithstanding anything herein to the contrary, nothing herein shall in any way restrict a director of the Company (including any director who is an Affiliate of the Stockholder) in the taking of any actions (or failure to act) solely in his or her capacity as a director of the Company, or in the exercise of his or her fiduciary duties as a director of the Company, or prevent or be construed to create any obligation on the part of any director of the Company from taking any action in his or her capacity as such director, and no action taken solely in any such capacity as a director of the Company shall be deemed to constitute a breach of this Support Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">SECTION 3.3&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Other Offers.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Except to the extent the Company is permitted to take such action pursuant to the Merger Agreement, the Stockholder (in the Stockholder&#8217;s capacity as such) shall not, and shall direct its Representatives not to, take any of the following actions: (a)&#160;solicit, initiate, knowingly encourage or knowingly facilitate an Acquisition Proposal; (b)&#160;furnish any non-public information regarding the Company to any Person in connection with or in response to an Acquisition Proposal (except as required by applicable Law, pursuant to applicable rules and regulations of any applicable national securities exchange or pursuant to a request by a Governmental Body); (c)&#160;engage in, enter into, continue or otherwise participate in any discussions or negotiations with any Person with respect to, or otherwise knowingly cooperate in any way with any Person (or any Representative thereof) with respect to, any Acquisition Proposal; (d)&#160;approve, endorse or recommend or publicly propose to approve, endorse or recommend, any Acquisition Proposal; or (e)&#160;enter into any letter of intent or any Contract contemplating or otherwise relating to any Acquisition Transaction or publicly proposing to approve, endorse or recommend, any Acquisition Transaction; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, </font><font style="font-style:italic;letter-spacing:0.2pt;">however</font><font style="letter-spacing:0.2pt;">, that none of the foregoing restrictions shall apply to the Stockholder&#8217;s and its Representatives&#8217; interactions with Parent, Merger Sub, the Company and their respective subsidiaries and Representatives; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, </font><font style="font-style:italic;letter-spacing:0.2pt;">further</font><font style="letter-spacing:0.2pt;">, that nothing in this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.3</font><font style="letter-spacing:0.2pt;"> shall prevent the Stockholder from referring a Person to this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.3</font><font style="letter-spacing:0.2pt;"> or to the Merger Agreement. Without limiting the foregoing, it is understood that any violation of the foregoing restrictions by any Representatives of the Stockholder shall be deemed to be a breach of this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.3</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">SECTION 3.4&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Communications.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;During the Voting Period, the Stockholder shall not, and shall direct its Representatives not to, make any press release, public announcement or other broad-based public communication that disparages this Support Agreement or the Merger Agreement or the Merger, without the prior written consent of Parent and the Company, except as may be required by applicable Law, including applicable rules and regulations of any national securities exchange applicable to Stockholder, in which circumstance such announcing party shall consult with the Company and Parent to the extent legally permissible prior to any such disclosure; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, that the foregoing shall not: (x)&#160;limit or affect any actions taken by the Stockholder (or any affiliated officer or director of Stockholder) that would be permitted to be taken by Stockholder pursuant to the Merger Agreement or (y)&#160;prohibit the Stockholder or its Representatives from communicating truthfully with any Governmental Body or from cooperating with any such Governmental Body, or testifying truthfully pursuant to subpoena, as required by valid legal process, in which circumstance such announcing party shall consult with the Company and Parent to the extent legally permissible prior to any such disclosure. The Stockholder hereby: (a)&#160;consents to and authorizes the publication and disclosure in all documents and schedules filed the with SEC, and any press release or other disclosure document that Parent or the Company reasonably determines to be necessary in connection </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">C-4</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">with the Merger or any Contemplated Transaction of (i)&#160;the Stockholder&#8217;s identity, (ii)&#160;the Stockholder&#8217;s ownership of the Subject Shares, (iii)&#160;this Support Agreement and (iv)&#160;the nature of the Stockholder&#8217;s commitments, arrangements and understandings under this Support Agreement; and (b)&#160;agrees as promptly as practicable to notify Parent, Merger Sub and the Company of any required corrections with respect to any written information supplied by the Stockholder specifically for use in any such disclosure document. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">SECTION 3.5&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Voting Trusts.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Except for this Agreement and the Amended and Restated Voting Agreement of the Company, dated as of December&#160;22, 2020 (the &#8220;Voting Agreement&#8221;), the Stockholder agrees that it will not, nor will it permit any entity under its control to, deposit any of its Subject Shares in a voting trust or subject any of its Subject Shares to any arrangement with respect to the voting of such Subject Shares, in each case to the extent that such action would restrict the Stockholder from performing its obligations under this Support Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">SECTION 3.6&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Waiver of Appraisal Rights.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The Stockholder hereby irrevocably and unconditionally waives, and agrees not to assert, exercise or perfect (or attempt to exercise, assert or perfect) any rights of appraisal or rights to dissent from the Merger or quasi-appraisal rights that it may at any time have under applicable Laws, including Section&#160;262 of the DGCL. The Stockholder agrees not to commence, join in, facilitate, assist or encourage, and agrees to take all actions necessary to opt out of any class in any class action with respect to, any claim, derivative or otherwise, against Parent, Merger Sub, the Company or any of their respective successors, directors or officers, (a)&#160;challenging the validity, binding nature or enforceability of, or seeking to enjoin the operation of, this Support Agreement or the Merger Agreement, or (b)&#160;alleging a breach of any fiduciary duty of any Person in connection with the evaluation, negotiation, entry into or consummation of transactions contemplated by the Merger Agreement; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided, however</font><font style="letter-spacing:0.2pt;">, that (i)&#160;the Stockholder may defend against, contest or settle any action, claim, suit or cause of action brought against the Stockholder that relates solely to the Stockholder&#8217;s capacity as a director, officer or securityholder of the Company and (ii)&#160;the foregoing shall not limit or restrict in any manner the Stockholder from enforcing the Stockholder&#8217;s rights under this Support Agreement and the other agreements entered into by the Stockholder in connection herewith, or otherwise in connection with the Merger, including the Stockholder&#8217;s right to receive the Merger Consideration pursuant to the terms of the Merger Agreement. </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:11.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ARTICLE IV</font>
          <br >
          <font style="letter-spacing:-0.2pt;">REPRESENTATIONS AND WARRANTIES OF STOCKHOLDER</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Stockholder hereby represents and warrants to Parent and the Company as follows: </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">SECTION 4.1&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Due Authorization, etc.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The Stockholder is a natural person, corporation, limited partnership or limited liability company. If the Stockholder is a corporation, limited partnership or limited liability company, the Stockholder is an entity duly organized, validly existing and in good standing under the laws of the jurisdiction in which it is incorporated, organized or constituted. The Stockholder has all necessary power and authority to execute and deliver this Support Agreement, perform the Stockholder&#8217;s obligations hereunder and to consummate the transactions contemplated hereby. The execution and delivery by the Stockholder of this Support Agreement, the performance by the Stockholder&#8217;s of its obligations hereunder and the consummation by the Stockholder of the transactions contemplated hereby have been duly authorized by all necessary action on the part of the Stockholder and no other proceedings on the part of the Stockholder are necessary to authorize this Support Agreement, or to consummate the transactions contemplated hereby. This Support Agreement has been duly executed and delivered by the Stockholder and (assuming the due authorization, execution and delivery by Parent and the Company) constitutes a valid and binding obligation of the Stockholder, enforceable against the Stockholder in accordance with its terms, except to the extent enforcement is limited by bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium and similar Laws of general applicability relating to or affecting creditors&#8217; rights and by general equitable principles. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">SECTION 4.2&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Ownership of Shares.</font><font style="letter-spacing:0.2pt;"> </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Schedule&#160;I</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;hereto sets forth opposite the Stockholder&#8217;s name the Shares over which the Stockholder has record ownership as of the date hereof. As of the date hereof, the Stockholder is the lawful record owner of the Shares denoted as being owned by the Stockholder on </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Schedule&#160;I</font><font style="letter-spacing:0.2pt;"> hereto, has the power to vote or cause to be voted such Shares and has the power to dispose of, or cause to be disposed, such Shares (other than, if the Stockholder is a partnership or a limited liability company, the rights and interest of Persons that own partnership interests or&#160;units in the Stockholder under </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">C-5</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">the partnership agreement or operating agreement governing the Stockholder and applicable partnership or limited liability company law, or if the Stockholder is a married individual and resides in a state with community property laws, the community property interest of his or her spouse to the extent applicable under such community property laws, which spouse hereby consents to this Support Agreement by executing the spousal consent attached hereto as </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Exhibit&#160;A</font><font style="letter-spacing:0.2pt;">). The Stockholder has, and will at all times up until the Expiration Time have, good and valid title to the Shares denoted as being owned by the Stockholder on </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Schedule&#160;I</font><font style="letter-spacing:0.2pt;"> hereto, free and clear of any and all pledges, mortgages, liens, charges, proxies, voting agreements, encumbrances, adverse claims, options, security interests and demands of any nature or kind whatsoever, other than (a)&#160;those created by this Support Agreement, (b)&#160;those created by the Voting Agreement, (c)&#160;those created by the Amended and Restated Investors&#8217; Rights Agreement of the Company, dated as of December&#160;22, 2020, (d)&#160;those existing under applicable securities laws and (e)&#160;those that would not prevent or materially delay the Stockholder&#8217;s ability to perform its obligations under this Support Agreement. Without limiting the generality of the foregoing, no Person has any contractual or other right or obligation to purchase or otherwise acquire any of the Shares denoted as being owned by the Stockholder on Schedule&#160;I hereto, and no such Shares are subject to any proxy, voting trust or other agreement or arrangement with respect to the voting of such Shares except as provided hereunder and in the Voting Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">SECTION 4.3&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">No Conflicts.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;(a)&#160;No filing with any Governmental Body, and no authorization, consent or approval of any other Person, is necessary for the execution of this Support Agreement by the Stockholder and (b)&#160;none of the execution and delivery of this Support Agreement by the Stockholder, the performance of the Stockholder&#8217;s obligations hereunder, the consummation by the Stockholder of the transactions contemplated hereby or compliance by the Stockholder with any of the provisions hereof shall (i)&#160;conflict with or result in any breach of the organizational documents of the Stockholder, (ii)&#160;result in, or give rise to, a violation or breach of or a default under any of the terms of any material Contract, understanding, agreement or other instrument or obligation to which the Stockholder is a party or by which the Stockholder or any of the Subject Shares or its assets may be bound or (iii)&#160;violate any applicable order, writ, injunction, decree, judgment, statute, rule or regulation, in each case except for any of the foregoing as would not reasonably be expected to prevent or materially delay the Stockholder&#8217;s ability to perform its obligations under this Support Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">SECTION 4.4&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Finder&#8217;s Fees.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;No investment banker, broker, finder or other intermediary is entitled, whether directly or indirectly, to a fee, commission or other benefit from Parent, Merger Sub or the Company in respect of this Support Agreement based upon any Contract made by or on behalf of the Stockholder. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">SECTION 4.5&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Reliance.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The Stockholder has had the opportunity to review the Merger Agreement and this Support Agreement with counsel of the Stockholder&#8217;s own choosing. The Stockholder has had an opportunity to review with its own tax advisors the tax consequences of the Merger and the Contemplated Transactions. The Stockholder understands that it must rely solely on its advisors and not on any statements or representations made by Parent, the Company or any of their respective Representatives with respect to the tax consequences of the Merger and the Contemplated Transactions. The Stockholder understands that such Stockholder (and not Parent, the Company or the Surviving Corporation) shall be responsible for such Stockholder&#8217;s tax liability that may arise as a result of the Merger or the Contemplated Transactions. The Stockholder understands and acknowledges that Parent and the Company are entering into the Merger Agreement in reliance upon the Stockholder&#8217;s execution, delivery and performance of this Support Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">SECTION 4.6&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">No Litigation.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;As of the date of this Support Agreement, there is no Legal Proceeding pending or, to the knowledge of the Stockholder, threatened against the Stockholder that would reasonably be expected to prevent or materially delay the ability of the Stockholder to perform its obligations hereunder or consummate the transactions contemplated hereby. </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:11.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ARTICLE V</font>
          <br >
          <font style="letter-spacing:-0.2pt;">TERMINATION</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">SECTION 5.1&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Termination.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;This Support Agreement shall automatically terminate, and none of Parent, the Company or the Stockholder shall have any rights or obligations hereunder and this Support Agreement shall become null and void and have no effect upon the earliest to occur of: (a)&#160;the Effective Time; (b)&#160;the valid termination of the Merger Agreement in accordance with its terms; (c)&#160;any amendment to the Merger Agreement that reduces the amount, or changes the form of any consideration payable to the </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">C-6</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Stockholder in the Contemplated Transactions; (d)&#160;the time this Support Agreement is terminated upon the written agreement of the Stockholder, the Company and Parent; and (e)&#160;the End Date (as defined in the Merger Agreement in effect on the date hereof) provided that the Effective Time has not occurred on or before such date. The parties acknowledge that upon termination of this Support Agreement as permitted under and in accordance with the terms of this Support Agreement, no party to this Support Agreement shall have the right to recover any claim with respect to any losses suffered by such party in connection with such termination, and no party shall have any further obligations or liabilities under this Support Agreement, subject to the following sentence. Notwithstanding anything to the contrary herein, (i)&#160;nothing set forth in this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.1</font><font style="letter-spacing:0.2pt;"> shall relieve any party from liability for any willful breach of this Support Agreement prior to termination hereof, and (ii)&#160;the provisions of this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Article&#160;V</font><font style="letter-spacing:0.2pt;"> and of </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Article&#160;VI</font><font style="letter-spacing:0.2pt;"> (other than </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;6.1</font><font style="letter-spacing:0.2pt;">) shall survive the termination of this Support Agreement. </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ARTICLE VI</font>
          <br >
          <font style="letter-spacing:-0.2pt;">MISCELLANEOUS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">SECTION 6.1&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Further Actions.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Subject to the terms and conditions set forth in this Support Agreement, the Stockholder agrees to take any and all actions and to do all things reasonably necessary to effectuate this Support Agreement. If the Stockholder is a married individual, his or her spouse shall deliver the spousal consent attached hereto as Exhibit&#160;A unless such Stockholder can demonstrate to Parent&#8217;s and the Company&#8217;s reasonable satisfaction that his or her spouse does not have any community property interests in the Subject Shares. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">SECTION 6.2&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Fees and Expenses.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Except as otherwise specifically provided herein, each party shall bear its own fees and expenses in connection with this Support Agreement and the transactions contemplated hereby. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">SECTION 6.3&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Amendments, Waivers, etc.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;This Support Agreement may not be amended except by an instrument in writing signed by all the parties hereto and specifically referencing this Support Agreement. No failure on the part of any party to exercise any power, right privilege or remedy under this Support Agreement, and no delay on the part of any party in exercising any power, right, privilege or remedy under this Support Agreement, shall operate as a waiver of such power, right, privilege or remedy, and no single or partial exercise of any such power, right, privilege or remedy shall preclude any other or further exercise thereof or of any other power, right, privilege or remedy. No party shall be deemed to have waived any claim arising out of this Support Agreement, or any power, right, privilege or remedy under this Support Agreement, unless the waiver of such claim, power, right, privilege or remedy is expressly set forth in a written instrument duly executed and delivered on behalf of such party and any such waiver shall not be applicable or have any effect except in the specific instance in which it is given. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">SECTION 6.4&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Notices.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;All notices and other communications hereunder shall be in writing and shall be deemed to have been duly delivered and received hereunder (a)&#160;one Business Day after being sent for next Business Day delivery, fees prepaid, via a reputable international overnight courier service, (b)&#160;upon delivery in the case of delivery by hand, or (c)&#160;on the date delivered in the place of delivery if sent by email (with a written or electronic confirmation of delivery) prior to 5:00&#160;p.m. New York time, otherwise on the next succeeding Business Day, in each case to the intended recipient as set forth below: </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If to the Company, to </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">[&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;]</font> <br ><font style="letter-spacing:0.2pt;">[&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;]</font> <br ><font style="letter-spacing:0.2pt;">[&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;]</font> <br ><font style="letter-spacing:0.2pt;">Attn: [&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;]</font> <br ><font style="letter-spacing:0.2pt;">Email: [&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;] </font></div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">with a copy to (which shall not constitute notice): </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">[&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;]</font> <br ><font style="letter-spacing:0.2pt;">[&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;]</font></div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">C-7</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:40pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">[&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;]</font> <br ><font style="letter-spacing:0.2pt;">Attn: [&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;]</font> <br ><font style="letter-spacing:0.2pt;">Email: [&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;] </font></div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If to Parent, to </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">[&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;]</font> <br ><font style="letter-spacing:0.2pt;">[&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;]</font> <br ><font style="letter-spacing:0.2pt;">[&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;]</font> <br ><font style="letter-spacing:0.2pt;">Attn: [&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;]</font> <br ><font style="letter-spacing:0.2pt;">Email: [&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;] </font></div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">with a copy to (which shall not constitute notice): </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">[&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;]</font> <br ><font style="letter-spacing:0.2pt;">[&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;]</font> <br ><font style="letter-spacing:0.2pt;">[&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;]</font> <br ><font style="letter-spacing:0.2pt;">Attn: [&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;]</font> <br ><font style="letter-spacing:0.2pt;">Email: [&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;] </font></div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If to the Stockholder, to the address or electronic mail address set forth on the signature pages hereto or to such other Person or address as any party shall specify by written notice so given. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">SECTION 6.5&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Interpretation; Construction.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Headings of the Articles and Sections of this Support Agreement are for convenience of the parties only, and shall be given no substantive or interpretive effect whatsoever. Except as otherwise indicated, all references in this Support Agreement to &#8220;Exhibits&#8221;, &#8220;Sections&#8221; or &#8220;Schedules&#8221; are intended to refer to Sections of this Support Agreement and the Exhibits or Schedules to this Support Agreement. Any rule of construction to the effect that ambiguities are to be resolved against the drafting party shall not be applied in the construction or interpretation of this Support Agreement. As used in this Support Agreement, the words &#8220;include&#8221; and &#8220;including,&#8221; and variations thereof, shall not be deemed to be terms of limitation, but rather shall be deemed to be followed by the words &#8220;without limitation.&#8221; For purposes of this Support Agreement, whenever the context requires: the singular number shall include the plural, and vice versa; the masculine gender shall include the feminine and neuter genders; the feminine gender shall include the masculine and neuter genders; and the neuter gender shall include masculine and feminine genders. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">SECTION 6.6&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Severability.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Any term or provision of this Support Agreement that is invalid or unenforceable in any situation in any jurisdiction shall not affect the validity or enforceability of the remaining terms and provisions of this Support Agreement or the validity or enforceability of the offending term or provision in any other situation or in any other jurisdiction. If a final judgment of a court of competent jurisdiction declares that any term or provision of this Support Agreement is invalid or unenforceable, the parties agree that the court making such determination shall have the power to limit such term or provision, to delete specific words or phrases or to replace such term or provision with a term or provision that is valid and enforceable and that comes closest to expressing the intention of the invalid or unenforceable term or provision, and this Support Agreement shall be valid and enforceable as so modified. In the event such court does not exercise the power granted to it in the prior sentence, the parties agree to replace such invalid or unenforceable term or provision with a valid and enforceable term or provision that will achieve, to the extent possible, the economic, business and other purposes of such invalid or unenforceable term or provision. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">SECTION 6.7&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Entire Agreement; Assignment.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;This Support Agreement constitutes the entire agreement, and supersedes all other prior agreements and understandings, both written and oral, between the parties, or any of them, with respect to the subject matter hereof; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, </font><font style="font-style:italic;letter-spacing:0.2pt;">however</font><font style="letter-spacing:0.2pt;">, that, as between the Company and Parent, to the extent of any conflict between the Merger Agreement and this Support Agreement, the terms of the Merger Agreement shall control and supersede any such conflicting terms. This Support Agreement will be binding upon, inure to the benefit of and be enforceable by the parties hereto and their respective successors and permitted assigns, and, in the case of Stockholder, such Persons to which record or beneficial ownership of the Stockholder&#8217;s Subject shares shall pass; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided, however</font><font style="letter-spacing:0.2pt;">, that neither this Support Agreement nor any of the rights, interests or obligations hereunder shall be assigned or </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">C-8</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">delegated by any of the parties hereto (whether by operation of law or otherwise) without the prior written consent of the other parties, except that, without consent, each of Parent and the Company may assign all or any of its rights and obligations hereunder to any of its Affiliates that assume the rights and obligations of such party under the Merger Agreement, and any attempted assignment or delegation of this Support Agreement or any of the rights, interests or obligations by any of the parties without the other parties prior written consent shall be void and of no effect. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">SECTION 6.8&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Governing Law.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;THIS SUPPORT AGREEMENT AND ALL QUESTIONS RELATING TO THE INTERPRETATION OR ENFORCEMENT OF THIS SUPPORT AGREEMENT SHALL BE DEEMED TO BE MADE IN AND IN ALL RESPECTS SHALL BE INTERPRETED, CONSTRUED AND GOVERNED BY AND IN ACCORDANCE WITH THE LAW OF THE STATE OF DELAWARE WITHOUT REGARD TO THE CONFLICTS OF LAW PRINCIPLES THEREOF TO THE EXTENT THAT SUCH PRINCIPLES WOULD DIRECT A MATTER TO ANOTHER JURISDICTION. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">SECTION 6.9&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Specific Performance.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The parties hereto acknowledge that any breach of this Support Agreement would give rise to irreparable harm for which monetary damages, even if applicable, would not be an adequate remedy, and would occur in the event that any party does not perform the provisions of this Support Agreement (including failing to take such actions as are required of it hereunder to consummate the transactions contemplated hereby) in accordance with its specified terms or otherwise breaches such provisions. Accordingly, the parties shall be entitled to a decree of specific performance, an injunction or other equitable relief to prevent breaches or threatened breaches of any of the provisions of this Support Agreement and to enforce specifically the terms and provisions hereof, in addition to any other remedy to which they are entitled at law or in equity. Each of the parties agrees that it will not oppose the granting of specific performance, an injunction or other equitable relief on the basis that any other party has an adequate remedy at law or that any award of specific performance or other equitable relief is not an appropriate remedy for any reason at law or in equity. Any party seeking an injunction or injunctions to prevent breaches of this Support Agreement shall not be required to provide any bond or other security in connection with any such order or injunction. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">SECTION 6.10&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Submission to Jurisdiction.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The parties hereby (a)&#160;irrevocably and unconditionally submit to the exclusive personal jurisdiction and venue of the Court of Chancery of the State of Delaware, New Castle County, or, if the Chancery Court declines jurisdiction, the United States District Court for the District of Delaware or, to the extent that neither of the foregoing courts has jurisdiction, the Superior Court of the State of Delaware, (b)&#160;agree that all claims in respect of such action or proceeding shall be heard and determined exclusively in accordance with clause (a)&#160;of this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;6.10</font><font style="letter-spacing:0.2pt;">, (c)&#160;waive any objection to laying venue in any such action or proceeding in such courts, (d)&#160;waive any objection that such courts are an inconvenient forum or do not have jurisdiction over any party, and (e)&#160;agree that service of process upon such party in any such action or proceeding shall be effective if notice is given in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;6.4</font><font style="letter-spacing:0.2pt;"> of this Support Agreement. Nothing in this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;6.10</font><font style="letter-spacing:0.2pt;">, however, shall affect the right of any person to serve legal process in any other manner permitted by Law. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">SECTION 6.11&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Waiver of Jury Trial.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;EACH PARTY HEREBY WAIVES, TO THE FULLEST EXTENT PERMITTED BY LAW, ANY RIGHT TO TRIAL BY JURY OF ANY CLAIM, DEMAND, ACTION, OR CAUSE OF ACTION (i)&#160;ARISING UNDER THIS SUPPORT AGREEMENT OR (ii)&#160;IN ANY WAY CONNECTED WITH OR RELATED OR INCIDENTAL TO THE DEALINGS OF THE PARTIES HERETO IN RESPECT OF THIS SUPPORT AGREEMENT OR ANY OF THE TRANSACTIONS CONTEMPLATED HEREBY, IN EACH CASE WHETHER NOW EXISTING OR HEREAFTER ARISING, AND WHETHER IN CONTRACT, TORT, EQUITY, OR OTHERWISE. EACH PARTY HEREBY AGREES AND CONSENTS THAT ANY SUCH CLAIM, DEMAND, ACTION, OR CAUSE OF ACTION SHALL BE DECIDED BY COURT TRIAL WITHOUT A JURY AND THAT THE PARTIES TO THIS SUPPORT AGREEMENT MAY FILE AN ORIGINAL COUNTERPART OF A COPY OF THIS SUPPORT AGREEMENT WITH ANY COURT AS WRITTEN EVIDENCE OF THE CONSENT OF THE PARTIES HERETO TO THE WAIVER OF THEIR RIGHT TO TRIAL BY JURY. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">C-9</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:548pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">SECTION 6.12&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Counterparts</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;This Support Agreement may be executed in two or more counterparts (including by facsimile transmission or other means of electronic transmission, such as by electronic mail in &#8220;pdf&#8221; form), each of which shall be an original, with the same effect as if the signatures thereto and hereto were upon the same instrument, and shall become effective when one or more counterparts have been signed by each of the parties and delivered (by facsimile or otherwise) to the other parties. </font>
        </div>
        <div style="margin-top:8pt; text-align:center; width:456pt; line-height:12pt;font-style:italic;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">(Signature Page Follows)</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">C-10</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;height:660pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">IN WITNESS WHEREOF, the Company, Parent and the Stockholder have caused this Support Agreement to be duly executed as of the day and year first above written. </font>
        </div>
        <div style="margin-left:220pt; margin-top:12pt; width:236pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CARISMA THERAPEUTICS INC.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:220pt; margin-top:12pt; width:236pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">By:</font>
        </div>
        <div style="margin-left:240pt; margin-top:3.5pt; width:216pt;">
          <div style="margin-left: 0pt; width: 216pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-left:240pt; margin-top:2pt; width:216pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Name: </font>
          <br >
          <font style="letter-spacing:0.2pt;">Title: </font>
        </div>
        <div style="margin-left:220pt; margin-top:24pt; width:236pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">SESEN BIO, INC.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:220pt; margin-top:8pt; width:236pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">By:</font>
        </div>
        <div style="margin-left:240pt; margin-top:3.5pt; width:216pt;">
          <div style="margin-left: 0pt; width: 216pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-left:240pt; margin-top:2pt; width:216pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Name: </font>
          <br >
          <font style="letter-spacing:0.2pt;">Title: </font>
        </div>
        <div style="margin-left:220pt; margin-top:24pt; width:236pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">STOCKHOLDER</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:220pt; margin-top:8pt; width:236pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">By:</font>
        </div>
        <div style="margin-left:240pt; margin-top:3.5pt; width:216pt;">
          <div style="margin-left: 0pt; width: 216pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-left:240pt; margin-top:2pt; width:216pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Name: </font>
          <br >
          <font style="letter-spacing:0.2pt;">Title: </font>
        </div>
        <div style="margin-left:240pt; margin-top:24pt; width:216pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Address: </font>
        </div>
        <div style="margin-left:240pt; margin-top:36pt; width:216pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Electronic Mail Address: </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">[</font><font style="font-style:italic;letter-spacing:0.2pt;">Signature Page to Stockholder Support Agreement</font><font style="letter-spacing:0.2pt;">]</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:-0.2pt;">Exhibit&#160;A</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:-0.2pt;">Form of Spousal Consent</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">I acknowledge that I have read the Stockholder Support Agreement (to which this consent is attached) and that I know and understand, and have been fully advised by my attorney with respect to, its contents. As the spouse of the Stockholder, I hereby agree: (i)&#160;that all shares of capital stock, all options, all warrants and all additional securities of the Company held by the Stockholder, and all other rights with respect to the capital stock of the Company held by the Stockholder, and my interest in such shares, options, warrants, additional securities and other rights, if any, are subject to the provisions of the Stockholder Support Agreement and the Merger Agreement (as defined in the Stockholder Support Agreement), which I consent to; and (ii)&#160;that I will take no action at any time to hinder the operation of the Stockholder Support Agreement or the Merger Agreement. </font>
        </div>
        <div style="margin-left:220pt; margin-top:12pt; width:236pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">SIGNATURE OF SPOUSE:</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:220pt; margin-top:26.5pt; width:236pt;">
          <div style="margin-left: 0pt; width: 236pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <table style="border-collapse:collapse;width:236pt;margin-top:19.5pt;margin-left:220pt;white-space:nowrap;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="vertical-align:baseline;">
            <td style="width:287.38pt;">
              <font style="letter-spacing:0.2pt;">Printed Name:&#8199;</font>
            </td>
            <td style="padding-left:0pt;text-align:right;max-width:168.62pt;">
              <div style="margin-left: 0pt; width: 168.62pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
            </td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-weight:normal;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;height:660pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:-0.2pt;">Schedule&#160;I</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.2pt;">Ownership of Shares</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:32.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:144pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Name and Address of </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Stockholder </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:144pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Number of Shares of </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Common Stock </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:144pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Number of Shares of </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Preferred Stock </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.167pt 0pt; width:144pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.2pt;">[&#8226;]</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.167pt 0pt; width:144pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.2pt;">[&#8226;]</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.167pt 0pt; width:144pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.2pt;">[&#8226;]</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-weight:normal;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a><a name="tANND">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:right; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ANNEX D</font>&#8203;</div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">FORM OF PARENT STOCKHOLDER SUPPORT AGREEMENT</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">This STOCKHOLDER SUPPORT AGREEMENT (this &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Support Agreement</font><font style="letter-spacing:0.2pt;">&#8221;) is entered into as of [&#8199;&#8199;&#8199;], 2022, among CARISMA Therapeutics Inc., a Delaware corporation (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company</font><font style="letter-spacing:0.2pt;">&#8221;), Sesen Bio, Inc., a Delaware corporation (&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent</font><font style="letter-spacing:0.2pt;">&#8221;), and the undersigned stockholder (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Stockholder</font><font style="letter-spacing:0.2pt;">&#8221;) of Parent. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">WHEREAS, as of the date hereof, the Stockholder is the sole record owner of and has the sole power to vote (or to direct the voting of) the number of shares of common stock, par value $0.001 per share, of Parent (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Common Stock</font><font style="letter-spacing:0.2pt;">&#8221;), set forth opposite the Stockholder&#8217;s name on </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Schedule&#160;I</font><font style="letter-spacing:0.2pt;"> hereto (such Common Stock, together with any other shares of Parent that are hereafter issued to or otherwise acquired or owned by, including upon exercise of options or securities convertible into or exercisable or exchangeable for Common Stock (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Shares</font><font style="letter-spacing:0.2pt;">&#8221;), the voting power of which is acquired by such Stockholder during the Voting Period (as defined below), are collectively referred to herein as the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Subject Shares</font><font style="letter-spacing:0.2pt;">&#8221;); </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">WHEREAS, the Company, Parent, and Seahawk Merger Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of Parent (&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Merger Sub</font><font style="letter-spacing:0.2pt;">&#8221;), are concurrently entering into an Agreement and Plan of Merger and Reorganization, dated on or about the date hereof (as amended from time to time, the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Merger Agreement</font><font style="letter-spacing:0.2pt;">&#8221;), pursuant to which Merger Sub shall be merged with and into the Company, with the Company continuing as the surviving corporation and as a wholly-owned subsidiary of Parent (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Merger</font><font style="letter-spacing:0.2pt;">&#8221;); </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">WHEREAS, the adoption of the Merger Agreement and the transactions contemplated thereby requires the written consent or affirmative vote of (i)&#160;the holders of a majority of the outstanding shares of Common Stock entitled to vote on the record date for the Parent Stockholders&#8217; Meeting and (ii)&#160;the holders of a majority in voting power of the votes cast by the holders of all shares of Common Stock present or represented by proxy at the Parent Stockholders&#8217; Meeting and entitled to vote thereon; and </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">WHEREAS, as a condition and inducement to the Company&#8217;s willingness to enter into the Merger Agreement and consummate the transactions contemplated thereby, Parent and the Company have required the Stockholder to, as an inducement and in consideration therefor, and the Stockholder (in the Stockholder&#8217;s capacity as holder of the Subject Shares) has agreed to, enter into this Support Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">NOW, THEREFORE, in consideration of the foregoing and the respective representations, warranties, covenants and agreements set forth herein, the parties agree as follows: </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:11.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ARTICLE I</font>
          <br >
          <font style="letter-spacing:-0.2pt;">DEFINITIONS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">SECTION 1.1&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Capitalized Terms</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;For purposes of this Support Agreement, capitalized terms used and not defined herein shall have the respective meanings ascribed to them in the Merger Agreement. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Expiration Time</font><font style="letter-spacing:0.2pt;">&#8221; shall mean the earliest to occur of (i)&#160;the Effective Time, (ii)&#160;any amendment to the Merger Agreement that reduces the amount, or changes the form of any consideration payable to the Stockholder in the transaction or otherwise materially and adversely affects the Stockholder and (iii)&#160;the date and time of the valid termination of the Merger Agreement in accordance with its terms. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Voting Period</font><font style="letter-spacing:0.2pt;">&#8221; shall mean such period of time between the date hereof and the Expiration Time. </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:11.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ARTICLE II</font>
          <br >
          <font style="letter-spacing:-0.2pt;">VOTING AGREEMENT AND IRREVOCABLE PROXY</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">SECTION 2.1&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Agreement to Vote.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The Stockholder hereby agrees that, during the Voting Period, and at any duly called meeting of the stockholders of Parent (or any adjournment or postponement thereof), or in any other circumstances (including action by written consent of stockholders in lieu of a meeting) upon which a vote, adoption or other approval or consent with respect to the adoption of the Merger Agreement or the approval of the Merger and any of the transactions contemplated thereby is sought, the </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">D-1</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Stockholder, if a meeting is held, appear at the meeting, in person or by proxy, and shall provide a written consent (a &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Written Consent</font><font style="letter-spacing:0.2pt;">&#8221;) or vote (or cause to be voted), in person or by proxy, all of the Subject Shares, in each case (i)&#160;in favor of (A)&#160;any proposal to adopt and approve or reapprove the Merger Agreement and the transactions contemplated thereby, including (1)&#160;adoption and approval of the Merger Agreement and the Contemplated Transactions, (2)&#160;the issuance of shares of Common Stock to the Company&#8217;s stockholders in connection with the Contemplated Transactions pursuant to the terms of the Merger Agreement, (3)&#160;the change of control of Parent resulting from the Merger pursuant to Nasdaq rules, (4)&#160;the approval of the Equity Plan&#160;Amendments, and (B)&#160;waiving any notice that may have been or may be required relating to the Merger or any of the other Contemplated Transactions (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Stockholder Approval Matters</font><font style="letter-spacing:0.2pt;">&#8221;), and (ii)&#160;against any Acquisition Proposal and any action in furtherance of any such Acquisition Proposal. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">SECTION 2.2&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Grant of Irrevocable Proxy.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;In the event and to the extent that the Stockholder fails to vote the Subject Shares in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.1</font><font style="letter-spacing:0.2pt;"> at any applicable meeting of the stockholders of Parent or pursuant to any applicable meeting of the stockholders of Parent or pursuant to any applicable written consent of the stockholders of Parent, the Stockholder hereby appoints Parent and any designee of Parent, and each of them individually, as the Stockholder&#8217;s proxy, with full power of substitution and re-substitution, to vote, including by executing written consents, during the Voting Period with respect to any and all of the Subject Shares on the matters and in the manner specified in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.1</font><font style="letter-spacing:0.2pt;">. The Stockholder shall take all further action or execute such other instruments as may be necessary to effectuate the intent of any such proxy. The Stockholder affirms that the irrevocable proxy given by it hereby with respect to the Merger Agreement and the Contemplated Transactions is given to Parent by the Stockholder to secure the performance of the obligations of the Stockholder under this Support Agreement. It is agreed that Parent (and its designees) will use the irrevocable proxy that is granted by the Stockholder hereby only in accordance with applicable Laws and that, to the extent Parent (and its designees) uses such irrevocable proxy, it will only vote (or sign written consents in respect of) the Subject Shares subject to such irrevocable proxy with respect to the matters specified in, and in accordance with the provisions of, </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.1</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">SECTION 2.3&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Nature of Irrevocable Proxy.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The proxy granted pursuant to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.2</font><font style="letter-spacing:0.2pt;"> to Parent by the Stockholder shall be irrevocable during the term of this Support Agreement, shall be deemed to be coupled with an interest sufficient in law to support an irrevocable proxy and shall revoke any and all prior proxies or powers of attorney granted by the Stockholder and no subsequent proxy or power of attorney shall be given or written consent executed (and if given or executed, shall not be effective) by the Stockholder with respect thereto. The proxy that may be granted hereunder shall terminate upon the termination of this Support Agreement, but shall survive the death or incapacity of the Stockholder and any obligation of the Stockholder under this Support Agreement shall be binding upon the heirs, personal representatives and successors of the Stockholder. </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ARTICLE III</font>
          <br >
          <font style="letter-spacing:-0.2pt;">COVENANTS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">SECTION 3.1&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Subject Shares.</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;The Stockholder agrees that (i)&#160;from the date hereof until the Expiration Time, it shall not, and shall not commit or agree to, without the prior written consent of Parent and the Company, directly or indirectly, whether by merger, consolidation or otherwise, offer for sale, sell (including short sales), transfer, tender, pledge, encumber, assign or otherwise dispose of (including by gift or by operation of law) (collectively, a &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Transfer</font><font style="letter-spacing:0.2pt;">&#8221;), or enter into any contract, option, derivative, hedging or other agreement or arrangement or understanding (including any profit-sharing arrangement) with respect to, or consent to or permit, a Transfer of, any or all of the Subject Shares or any interest therein; and (ii)&#160;during the Voting Period, it shall not, and shall not commit or agree to, without the prior written consent of Parent and the Company, (A)&#160;grant any proxies or powers of attorney with respect to any or all of the Subject Shares or agree to vote (or sign written consents in respect of) the Subject Shares on any matter or divest itself of any voting rights in the Subject Shares that would conflict with the terms of this Support Agreement, or (B)&#160;take any action that would have the effect of preventing or disabling the Stockholder from performing its obligations under this Support Agreement. Notwithstanding the foregoing, the Stockholder may, at any time, Transfer its Subject Shares (1)&#160;by will or other testamentary document or by intestacy, (2)&#160;to any investment fund or other entity controlled or managed by the </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">D-2</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Stockholder or the investment adviser or general partner of the Stockholder,, (3)&#160;to any member of the Stockholder&#8217;s immediate family, (4)&#160;to any trust for the direct or indirect benefit of the Stockholder or the immediate family of the Stockholder or otherwise for estate planning purposes or (5)&#160;to the extent required by applicable Law; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, that the case of clauses (1)-(4), such permitted transferee shall have executed and delivered to Parent and the Company a support agreement substantially identical to this Support Agreement. The Stockholder agrees that any Transfer of Subject Shares not permitted hereby shall be null and void and that any such prohibited Transfer shall be enjoined. If any voluntary or involuntary Transfer of any Subject Shares covered hereby shall occur (including a sale by the Stockholder&#8217;s trustee in bankruptcy, or a sale to a purchaser at any creditor&#8217;s or court sale), the permitted transferee (which term, as used herein, shall include any and all transferees and subsequent transferees of the initial transferee) shall take and hold such Subject Shares subject to all of the restrictions, liabilities and rights under this Support Agreement, which shall continue in full force and effect. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;In the event of a stock dividend or distribution, or any change in the Subject Shares by reason of any stock dividend or distribution, split-up, recapitalization, combination, conversion, exchange of shares or the like, the term &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Subject Shares</font><font style="letter-spacing:0.2pt;">&#8221; shall be deemed to refer to and include the Subject Shares as well as all such stock dividends and distributions and any securities into which or for which any or all of the Subject Shares may be changed or exchanged or which are received in such transaction. The Stockholder further agrees that, in the event the Stockholder purchases or otherwise acquires beneficial or record ownership of or an interest in, or acquires the right to vote or share in the voting of, any additional Shares, in each case after the execution of this Support Agreement and prior to the Expiration Time, the Stockholder shall deliver promptly to the Company and Parent written notice of such event, which notice shall state the number of additional Shares so acquired. The Stockholder agrees that any such additional Shares shall constitute Subject Shares for all purposes of this Support Agreement and shall be subject to the terms of this Support Agreement, including all covenants, agreements, obligations, representations and warranties set forth herein as if those additional Shares were owned by the Stockholder on the date of this Support Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">SECTION 3.2&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Stockholder&#8217;s Capacity.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;All agreements and understandings made herein shall be made solely in the Stockholder&#8217;s capacity as a holder of the Subject Shares and not in any other capacity, including not in the Stockholder&#8217;s capacity as a director or officer of Parent. Notwithstanding anything herein to the contrary, nothing herein shall in any way restrict a director of Parent (including any director who is an Affiliate of the Stockholder) in the taking of any actions (or failure to act) solely in his or her capacity as a director of Parent, or in the exercise of his or her fiduciary duties as a director of Parent, or prevent or be construed to create any obligation on the part of any director of Parent from taking any action in his or her capacity as such director, and no action taken solely in any such capacity as a director of Parent shall be deemed to constitute a breach of this Support Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">SECTION 3.3&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Other Offers.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Except to the extent Parent is permitted to take such action pursuant to the Merger Agreement, the Stockholder (in the Stockholder&#8217;s capacity as such) shall not, and shall instruct and cause its Representatives not to, take any of the following actions: (a)&#160;solicit, initiate, knowingly encourage or knowingly facilitate an Acquisition Proposal; (b)&#160;furnish any non-public information regarding Parent to any Person in connection with or in response to an Acquisition Proposal (except as required by applicable Law or pursuant to a request by a Governmental Body); (c)&#160;engage in, enter into, continue or otherwise participate in any discussions or negotiations with any Person with respect to, or otherwise knowingly cooperate in any way with any Person (or any representative thereof) with respect to, any Acquisition Proposal; (d)&#160;approve, endorse or recommend or publicly propose to approve, endorse or recommend, any Acquisition Proposal; or (e)&#160;enter into any letter of intent or any Contract contemplating or otherwise relating to any Acquisition Transaction or publicly proposing to approve, endorse or recommend, any Acquisition Transaction; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, </font><font style="font-style:italic;letter-spacing:0.2pt;">however</font><font style="letter-spacing:0.2pt;">, that none of the foregoing restrictions shall apply to the Stockholder&#8217;s and its Representatives&#8217; interactions with Parent, Merger Sub, the Company and their respective subsidiaries and Representatives; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, </font><font style="font-style:italic;letter-spacing:0.2pt;">further</font><font style="letter-spacing:0.2pt;">, that nothing in this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.3</font><font style="letter-spacing:0.2pt;"> shall prevent the Stockholder from referring a Person to this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.3</font><font style="letter-spacing:0.2pt;"> or to the Merger Agreement. Without limiting the foregoing, it is understood that any violation of the foregoing restrictions by any Representatives of the Stockholder shall be deemed to be a breach of this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.3</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">SECTION 3.4&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Communications.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;During the Voting Period, the Stockholder shall not, and shall use its reasonable best efforts to cause its Representatives, if any, not to, directly or indirectly, make any press </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">D-3</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">release, public announcement or other public communication that criticizes or disparages this Support Agreement or the Merger Agreement or any of the transactions contemplated hereby and thereby, without the prior written consent of Parent and the Company, except as may be required by applicable Law in which circumstance such announcing party shall consult with the Company and Parent to the extent legally permissible prior to any such disclosure; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, that the foregoing shall not limit or affect any actions taken by the Stockholder (or any affiliated officer or director of Stockholder) that would be permitted to be taken by Stockholder pursuant to the Merger Agreement. The Stockholder hereby: (a)&#160;consents to and authorizes the publication and disclosure in all documents and schedules filed the with SEC, and any press release or other disclosure document that Parent or the Company reasonably determines to be necessary in connection with the Merger or any Contemplated Transaction of (i)&#160;the Stockholder&#8217;s identity, (ii)&#160;the Stockholder&#8217;s ownership of the Subject Shares, (iii)&#160;this Support Agreement and (iv)&#160;the nature of the Stockholder&#8217;s commitments, arrangements and understandings under this Support Agreement; and (b)&#160;agrees as promptly as practicable to notify Parent, Merger Sub and the Company of any required corrections with respect to any written information supplied by the Stockholder specifically for use in any such disclosure document. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">SECTION 3.5&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Voting Trusts.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Except for this Agreement, the Stockholder agrees that it will not, nor will it permit any entity under its control to, deposit any of its Subject Shares in a voting trust or subject any of its Subject Shares to any arrangement with respect to the voting of such Subject Shares that would restrict the Stockholder from performing its obligations under this Support Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">SECTION 3.6&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Waiver of Appraisal Rights.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The Stockholder hereby irrevocably and unconditionally waives, and agrees not to assert, exercise or perfect (or attempt to exercise, assert or perfect) any rights of appraisal or rights to dissent from the Merger or quasi-appraisal rights that it may at any time have under applicable Laws, including Section&#160;262 of the DGCL. The Stockholder agrees not to commence, join in, facilitate, assist or encourage, and agrees to take all actions necessary to opt out of any class in any class action with respect to, any claim, derivative or otherwise, against Parent, Merger Sub, the Company or any of their respective successors, directors or officers, (a)&#160;challenging the validity, binding nature or enforceability of, or seeking to enjoin the operation of, this Support Agreement or the Merger Agreement, or (b)&#160;alleging a breach of any fiduciary duty of any Person in connection with the evaluation, negotiation, entry into or consummation of the Merger Agreement; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided, however</font><font style="letter-spacing:0.2pt;">, that (i)&#160;the Stockholder may defend against, contest or settle any action, claim, suit or cause of action brought against the Stockholder that relates solely to the Stockholder&#8217;s capacity as a director, officer or securityholder of Parent and (ii)&#160;the foregoing shall not limit or restrict in any manner the Stockholder from enforcing the Stockholder&#8217;s rights under this Support Agreement and the other agreements entered into by the Stockholder in connection herewith, or otherwise in connection with the Merger, including the Stockholder&#8217;s right to receive the Merger Consideration pursuant to the terms of the Merger Agreement. </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ARTICLE IV</font>
          <br >
          <font style="letter-spacing:-0.2pt;">REPRESENTATIONS AND WARRANTIES OF STOCKHOLDER</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Stockholder hereby represents and warrants to Parent and the Company as follows: </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">SECTION 4.1&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Due Authorization, etc.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The Stockholder is a natural person, corporation, limited partnership or limited liability company. If the Stockholder is a corporation, limited partnership or limited liability company, Stockholder is an entity duly organized, validly existing and in good standing under the laws of the jurisdiction in which it is incorporated, organized or constituted. The Stockholder has all necessary power and authority to execute and deliver this Support Agreement, perform the Stockholder&#8217;s obligations hereunder and to consummate the transactions contemplated hereby. The execution and delivery by the Stockholder of this Support Agreement, the performance by the Stockholder&#8217;s of its obligations hereunder and the consummation by the Stockholder of the transactions contemplated hereby have been duly authorized by all necessary action on the part of the Stockholder and no other proceedings on the part of the Stockholder are necessary to authorize this Support Agreement, or to consummate the transactions contemplated hereby. This Support Agreement has been duly executed and delivered by the Stockholder and (assuming the due authorization, execution and delivery by Parent and the Company) constitutes a valid and binding obligation of the Stockholder, enforceable against the Stockholder in accordance with its terms, </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">D-4</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">except to the extent enforcement is limited by bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium and similar Laws of general applicability relating to or affecting creditors&#8217; rights and by general equitable principles. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">SECTION 4.2&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Ownership of Shares.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Schedule&#160;I</font><font style="letter-spacing:0.2pt;"> hereto sets forth opposite the Stockholder&#8217;s name the Shares over which the Stockholder has record ownership as of the date hereof. As of the date hereof, the Stockholder is the lawful record owner of the Shares denoted as being owned by the Stockholder on </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Schedule&#160;I</font><font style="letter-spacing:0.2pt;"> hereto, has the power to vote or cause to be voted such Shares and has the power to dispose of, or cause to be disposed, such Shares (other than, if the Stockholder is a partnership or a limited liability company, the rights and interest of Persons that own partnership interests or&#160;units in the Stockholder under the partnership agreement or operating agreement governing the Stockholder and applicable partnership or limited liability company law, or if the Stockholder is a married individual and resides in a state with community property laws, the community property interest of his or her spouse to the extent applicable under such community property laws, which spouse hereby consents to this Support Agreement by executing the spousal consent attached hereto as </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Exhibit&#160;A</font><font style="letter-spacing:0.2pt;">). The Stockholder has, and will at all times up until the Expiration Time have, good and valid title to the Shares denoted as being owned by the Stockholder on </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Schedule&#160;I</font><font style="letter-spacing:0.2pt;"> hereto, free and clear of any and all pledges, mortgages, liens, charges, proxies, voting agreements encumbrances, adverse claims, options, security interests and demands of any nature or kind whatsoever, other than (a)&#160;those created by this Support Agreement, (b)&#160;those existing under applicable securities laws and (c)&#160;those that would not adversely affect the Stockholder&#8217;s ability to perform its obligations under this Support Agreement. Without limiting the generality of the foregoing, no Person has any contractual or other right or obligation to purchase or otherwise acquire any of the Shares, and no Shares are subject to any proxy, voting trust or other agreement or arrangement with respect to the voting of the Shares except as provided hereunder. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">SECTION 4.3&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">No Conflicts.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;(a)&#160;No filing with any Governmental Body, and no authorization, consent or approval of any other Person, is necessary for the execution of this Support Agreement by the Stockholder and (b)&#160;none of the execution and delivery of this Support Agreement by the Stockholder, the performance of the Stockholder&#8217;s obligations hereunder, the consummation by the Stockholder of the transactions contemplated hereby or compliance by the Stockholder with any of the provisions hereof shall (i)&#160;conflict with or result in any breach of the organizational documents of the Stockholder, (ii)&#160;result in, or give rise to, a violation or breach of or a default under any of the terms of any material Contract, understanding, agreement or other instrument or obligation to which the Stockholder is a party or by which the Stockholder or any of the Subject Shares or its assets may be bound or (iii)&#160;violate any applicable order, writ, injunction, decree, judgment, statute, rule or regulation, except for any of the foregoing as would not reasonably be expected to impair the Stockholder&#8217;s ability to perform its obligations under this Support Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">SECTION 4.4&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Finder&#8217;s Fees.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;No investment banker, broker, finder or other intermediary is entitled, whether directly or indirectly, to a fee, commission or other benefit from Parent, Merger Sub or the Company in respect of this Support Agreement based upon any Contract made by or on behalf of the Stockholder. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">SECTION 4.5&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Reliance.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The Stockholder has had the opportunity to review the Merger Agreement and this Support Agreement with counsel of the Stockholder&#8217;s own choosing. The Stockholder has had an opportunity to review with its own tax advisors the tax consequences of the Merger and the Contemplated Transactions. The Stockholder understands that it must rely solely on its advisors and not on any statements or representations made by Parent, the Company or any of their respective Representatives with respect to the tax consequences of the Merger and the Contemplated Transactions. The Stockholder understands that such Stockholder (and not Parent, the Company or the Surviving Corporation) shall be responsible for such Stockholder&#8217;s tax liability that may arise as a result of the Merger or the Contemplated Transactions. The Stockholder understands and acknowledges that Parent and the Company are entering into the Merger Agreement in reliance upon the Stockholder&#8217;s execution, delivery and performance of this Support Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">SECTION 4.6&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">No Litigation.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;As of the date of this Support Agreement, there is no Legal Proceeding pending or, to the knowledge of the Stockholder, threatened against the Stockholder that would reasonably be expected to impair the ability of the Stockholder to perform its obligations hereunder or consummate the transactions contemplated hereby. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">D-5</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:11.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ARTICLE V</font>
          <br >
          <font style="letter-spacing:-0.2pt;">TERMINATION</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">SECTION 5.1&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Termination.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;This Support Agreement shall automatically terminate, and none of Parent, the Company or the Stockholder shall have any rights or obligations hereunder and this Support Agreement shall become null and void and have no effect upon the earliest to occur of: (a)&#160;the Effective Time; (b)&#160;the valid termination of the Merger Agreement in accordance with its terms; (c)&#160;any amendment to the Merger Agreement that reduces the amount, or changes the form of any consideration payable to the Stockholder in the Contemplated Transactions or otherwise materially and adversely affects the Stockholder; and (d)&#160;the time this Support Agreement is terminated upon the written agreement of the Stockholder, the Company and Parent. The parties acknowledge that upon termination of this Support Agreement as permitted under and in accordance with the terms of this Support Agreement, no party to this Support Agreement shall have the right to recover any claim with respect to any losses suffered by such party in connection with such termination, and no party shall have any further obligations or liabilities under this Support Agreement, subject to the following sentence. Notwithstanding anything to the contrary herein, (i)&#160;nothing set forth in this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;5.1</font><font style="letter-spacing:0.2pt;"> shall relieve any party from liability for any willful breach of this Support Agreement prior to termination hereof, and (ii)&#160;the provisions of this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Article&#160;V</font><font style="letter-spacing:0.2pt;"> and of </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Article&#160;VI</font><font style="letter-spacing:0.2pt;"> shall survive the termination of this Support Agreement. </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:11.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ARTICLE VI</font>
          <br >
          <font style="letter-spacing:-0.2pt;">MISCELLANEOUS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">SECTION 6.1&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Further Actions.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Subject to the terms and conditions set forth in this Support Agreement, the Stockholder agrees to take any all actions and to do all things reasonably necessary to effectuate this Support Agreement. If the Stockholder is a married individual, his or her spouse shall deliver the spousal consent attached hereto as Exhibit&#160;A unless such Stockholder can demonstrate to Parent&#8217;s and the Company&#8217;s reasonable satisfaction that his or her spouse does not have any community property interests in the Subject Shares. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">SECTION 6.2&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Fees and Expenses.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Except as otherwise specifically provided herein, each party shall bear its own fees and expenses in connection with this Support Agreement and the transactions contemplated hereby. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">SECTION 6.3&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Amendments, Waivers, etc.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;This Support Agreement may not be amended except by an instrument in writing signed by all the parties hereto and specifically referencing this Support Agreement. No failure on the part of any party to exercise any power, right privilege or remedy under this Support Agreement, and no delay on the part of any party in exercising any power, right, privilege or remedy under this Support Agreement, shall operate as a waiver of such power, right, privilege or remedy, and no single or partial exercise of any such power, right, privilege or remedy shall preclude any other or further exercise thereof or of any other power, right, privilege or remedy. No party shall be deemed to have waived any claim arising out of this Support Agreement, or any power, right, privilege or remedy under this Support Agreement, unless the waiver of such claim, power, right, privilege or remedy is expressly set forth in a written instrument duly executed and delivered on behalf of such party and any such waiver shall not be applicable or have any effect except in the specific instance in which it is given. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">SECTION 6.4&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Notices.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;All notices and other communications hereunder shall be in writing and shall be deemed to have been duly delivered and received hereunder (a)&#160;one Business Day after being sent for next Business Day delivery, fees prepaid, via a reputable international overnight courier service, (b)&#160;upon delivery in the case of delivery by hand, or (c)&#160;on the date delivered in the place of delivery if sent by email (with a written or electronic confirmation of delivery) prior to 5:00&#160;p.m. New York time, otherwise on the next succeeding Business Day, in each case to the intended recipient as set forth below: </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If to the Company, to </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">[&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;]</font> <br ><font style="letter-spacing:0.2pt;">[&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;]</font> <br ><font style="letter-spacing:0.2pt;">[&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;]</font> <br ><font style="letter-spacing:0.2pt;">Attn: [&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;]</font> <br ><font style="letter-spacing:0.2pt;">Email: [&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;] </font></div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">D-6</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">with a copy to (which shall not constitute notice): </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">[&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;]</font> <br ><font style="letter-spacing:0.2pt;">[&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;]</font> <br ><font style="letter-spacing:0.2pt;">[&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;]</font> <br ><font style="letter-spacing:0.2pt;">Attn: [&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;]</font> <br ><font style="letter-spacing:0.2pt;">Email: [&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;] </font></div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If to Parent, to </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">[&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;]</font> <br ><font style="letter-spacing:0.2pt;">[&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;]</font> <br ><font style="letter-spacing:0.2pt;">[&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;]</font> <br ><font style="letter-spacing:0.2pt;">Attn: [&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;]</font> <br ><font style="letter-spacing:0.2pt;">Email: [&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;] </font></div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">with a copy to (which shall not constitute notice): </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">[&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;]</font> <br ><font style="letter-spacing:0.2pt;">[&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;]</font> <br ><font style="letter-spacing:0.2pt;">[&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;]</font> <br ><font style="letter-spacing:0.2pt;">Attn: [&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;]</font> <br ><font style="letter-spacing:0.2pt;">Email: [&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;] </font></div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If to the Stockholder, to the address or electronic mail address set forth on the signature pages hereto or to such other Person or address as any party shall specify by written notice so given. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">SECTION 6.5&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Interpretation; Construction.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Headings of the Articles and Sections of this Support Agreement are for convenience of the parties only, and shall be given no substantive or interpretive effect whatsoever. Except as otherwise indicated, all references in this Support Agreement to &#8220;Exhibits&#8221;, &#8220;Sections&#8221; or &#8220;Schedules&#8221; are intended to refer to Sections of this Support Agreement and the Exhibits or Schedules to this Support Agreement. Any rule of construction to the effect that ambiguities are to be resolved against the drafting party shall not be applied in the construction or interpretation of this Support Agreement. As used in this Support Agreement, the words &#8220;include&#8221; and &#8220;including,&#8221; and variations thereof, shall not be deemed to be terms of limitation, but rather shall be deemed to be followed by the words &#8220;without limitation.&#8221; For purposes of this Support Agreement, whenever the context requires: the singular number shall include the plural, and vice versa; the masculine gender shall include the feminine and neuter genders; the feminine gender shall include the masculine and neuter genders; and the neuter gender shall include masculine and feminine genders. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">SECTION 6.6&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Severability.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Any term of provision of this Support Agreement that is invalid or unenforceable in any situation in any jurisdiction shall not affect the validity or enforceability of the remaining terms and provisions of this Support Agreement or the validity or enforceability of the offending term or provision in any other situation or in any other jurisdiction. If a final judgment of a court of competent jurisdiction declares that any term or provision of this Support Agreement is invalid or unenforceable, the parties agree that the court making such determination shall have the power to limit such term or provision, to delete specific words or phrases or to replace such term or provision with a term or provision that is valid and enforceable and that comes closest to expressing the intention of the invalid or unenforceable term or provision, and this Support Agreement shall be valid and enforceable as so modified. In the event such court does not exercise the power granted to it in the prior sentence, the parties agree to replace such invalid or unenforceable term or provision with a valid and enforceable term or provision that will achieve, to the extent possible, the economic, business and other purposes of such invalid or unenforceable term or provision. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">SECTION 6.7&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Entire Agreement; Assignment.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;This Support Agreement constitutes the entire agreement, and supersedes all other prior agreements and understandings, both written and oral, between the parties, or any of them, with respect to the subject matter hereof; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, </font><font style="font-style:italic;letter-spacing:0.2pt;">however</font><font style="letter-spacing:0.2pt;">, that, as between the Company and Parent, to the extent of any conflict between the Merger Agreement and this Support Agreement, the terms of the Merger Agreement shall control and supersede any such conflicting terms. This </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">D-7</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Support Agreement will be binding upon, inure to the benefit of and be enforceable by the parties hereto and their respective successors and permitted assigns, and, in the case of Stockholder, such Persons to which record or beneficial ownership of the Stockholder&#8217;s Subject shares shall pass; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided, however</font><font style="letter-spacing:0.2pt;">, that neither this Support Agreement nor any of the rights, interests or obligations hereunder shall be assigned or delegated by any of the parties hereto (whether by operation of law or otherwise) without the prior written consent of the other parties, except that, without consent, each of Parent and the Company may assign all or any of its rights and obligations hereunder to any of its Affiliates that assume the rights and obligations of such party under the Merger Agreement, and any attempted assignment or delegation of this Support Agreement or any of the rights, interests or obligations by any of the parties without the other parties prior written consent shall be void and of no effect. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">SECTION 6.8&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Governing Law.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;THIS SUPPORT AGREEMENT AND ALL QUESTIONS RELATING TO THE INTERPRETATION OR ENFORCEMENT OF THIS SUPPORT AGREEMENT SHALL BE DEEMED TO BE MADE IN AND IN ALL RESPECTS SHALL BE INTERPRETED, CONSTRUED AND GOVERNED BY AND IN ACCORDANCE WITH THE LAW OF THE STATE OF DELAWARE WITHOUT REGARD TO THE CONFLICTS OF LAW PRINCIPLES THEREOF TO THE EXTENT THAT SUCH PRINCIPLES WOULD DIRECT A MATTER TO ANOTHER JURISDICTION. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">SECTION 6.9&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Specific Performance.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The parties hereto acknowledge that any breach of this Support Agreement would give rise to irreparable harm for which monetary damages, even if applicable, would not be an adequate remedy, would occur in the event that any party does not perform the provisions of this Support Agreement (including failing to take such actions as are required of it hereunder to consummate the transactions contemplated hereby) in accordance with its specified terms or otherwise breaches such provisions. Accordingly, the parties shall be entitled to a decree of specific performance, an injunction or other equitable relief to prevent breaches or threatened breaches of any of the provisions of this Support Agreement and to enforce specifically the terms and provisions hereof, in addition to any other remedy to which they are entitled at law or in equity. Each of the parties agrees that it will not oppose the granting of specific performance, an injunction or other equitable relief on the basis that any other party has an adequate remedy at law or that any award of specific performance or other equitable relief is not an appropriate remedy for any reason at law or in equity. Any party seeking an injunction or injunctions to prevent breaches of this Support Agreement shall not be required to provide any bond or other security in connection with any such order or injunction. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">SECTION 6.10&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Submission to Jurisdiction.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The parties hereby (a)&#160;irrevocably and unconditionally submit to the exclusive personal jurisdiction and venue of the Court of Chancery of the State of Delaware, New Castle County, or, if the Chancery Court declines jurisdiction, the United States District Court for the District of Delaware or, to the extent that neither of the foregoing courts has jurisdiction, the Superior Court of the State of Delaware, (b)&#160;agree that all claims in respect of such action or proceeding shall be heard and determined exclusively in accordance with clause (a)&#160;of this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;6.10</font><font style="letter-spacing:0.2pt;">, (c)&#160;waive any objection to laying venue in any such action or proceeding in such courts, (d)&#160;waive any objection that such courts are an inconvenient forum or do not have jurisdiction over any party, and (e)&#160;agree that service of process upon such party in any such action or proceeding shall be effective if notice is given in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;6.4</font><font style="letter-spacing:0.2pt;"> of this Support Agreement. Nothing in this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;6.10</font><font style="letter-spacing:0.2pt;">, however, shall affect the right of any person to serve legal process in any other manner permitted by Law. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">SECTION 6.11&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Waiver of Jury Trial.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;EACH PARTY HEREBY WAIVES, TO THE FULLEST EXTENT PERMITTED BY LAW, ANY RIGHT TO TRIAL BY JURY OF ANY CLAIM, DEMAND, ACTION, OR CAUSE OF ACTION (i)&#160;ARISING UNDER THIS SUPPORT AGREEMENT OR (ii)&#160;IN ANY WAY CONNECTED WITH OR RELATED OR INCIDENTAL TO THE DEALINGS OF THE PARTIES HERETO IN RESPECT OF THIS SUPPORT AGREEMENT OR ANY OF THE TRANSACTIONS CONTEMPLATED HEREBY, IN EACH CASE WHETHER NOW EXISTING OR HEREAFTER ARISING, AND WHETHER IN CONTRACT, TORT, EQUITY, OR OTHERWISE. EACH PARTY HEREBY AGREES AND CONSENTS THAT ANY SUCH CLAIM, DEMAND, ACTION, OR CAUSE OF ACTION SHALL BE DECIDED BY COURT TRIAL WITHOUT A JURY AND THAT THE PARTIES TO THIS SUPPORT AGREEMENT MAY FILE AN ORIGINAL COUNTERPART OF A COPY OF THIS SUPPORT AGREEMENT WITH ANY COURT AS </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">D-8</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:516pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">WRITTEN EVIDENCE OF THE CONSENT OF THE PARTIES HERETO TO THE WAIVER OF THEIR RIGHT TO TRIAL BY JURY. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">SECTION 6.12&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Counterparts</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;This Support Agreement may be executed in two or more counterparts (including by facsimile transmission or other means of electronic transmission, such as by electronic mail in &#8220;pdf&#8221; form), each of which shall be an original, with the same effect as if the signatures thereto and hereto were upon the same instrument, and shall become effective when one or more counterparts have been signed by each of the parties and delivered (by facsimile or otherwise) to the other parties. </font>
        </div>
        <div style="margin-top:8pt; text-align:center; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">(Signature Page Follows)</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">D-9</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">IN WITNESS WHEREOF, the Company, Parent and the Stockholder have caused this Support Agreement to be duly executed as of the day and year first above written. </font>
        </div>
        <table style="width:456pt;height:361pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:202pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1.5pt 0pt; width:0pt;" colspan="7">
              <font style="letter-spacing:-0.2pt;">CARISMA THERAPEUTICS INC. </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:11.5pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:202pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:27.5pt 0pt 0.5pt 0pt; width:24pt;">
              <font style="letter-spacing:0.2pt;">By: </font>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:27.5pt 0pt 0.5pt 0pt; width:0pt;white-space:normal;" colspan="4">
              <div>
                <font style="letter-spacing:0.2pt;">&#8199;</font>
              </div>
              <div style="margin-top:2.5pt; text-align:justify;">
                <div style="margin-left: 0pt; width: 216pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:202pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:24pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:5pt 0pt 0.5pt 0pt; width:48pt;">
              <font style="letter-spacing:0.2pt;">Name: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:156pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:202pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:24pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:1.5pt 0pt 0.5pt 0pt; width:48pt;">
              <font style="letter-spacing:0.2pt;">Title:</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:156pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:40pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:202pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:29.5pt 0pt 1.5pt 0pt; width:0pt;" colspan="7">
              <font style="letter-spacing:-0.2pt;">SESEN BIO, INC. </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:11.5pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:202pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:27.5pt 0pt 0.5pt 0pt; width:24pt;">
              <font style="letter-spacing:0.2pt;">By: </font>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:27.5pt 0pt 0.5pt 0pt; width:0pt;white-space:normal;" colspan="4">
              <div>
                <font style="letter-spacing:0.2pt;">&#8199;</font>
              </div>
              <div style="margin-top:2.5pt; text-align:justify;">
                <div style="margin-left: 0pt; width: 216pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:202pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:24pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:5pt 0pt 0.5pt 0pt; width:48pt;">
              <font style="letter-spacing:0.2pt;">Name: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:156pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:202pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:24pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:1.5pt 0pt 0.5pt 0pt; width:48pt;">
              <font style="letter-spacing:0.2pt;">Title:</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:156pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:40pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:202pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:29.5pt 0pt 1.5pt 0pt; width:0pt;" colspan="7">
              <font style="letter-spacing:-0.2pt;">STOCKHOLDER </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:11.5pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:202pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:27.5pt 0pt 0.5pt 0pt; width:24pt;">
              <font style="letter-spacing:0.2pt;">By: </font>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:27.5pt 0pt 0.5pt 0pt; width:0pt;white-space:normal;" colspan="4">
              <div>
                <font style="letter-spacing:0.2pt;">&#8199;</font>
              </div>
              <div style="margin-top:2.5pt; text-align:justify;">
                <div style="margin-left: 0pt; width: 216pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:202pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:24pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:5pt 0pt 0.5pt 0pt; width:48pt;">
              <font style="letter-spacing:0.2pt;">Name: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:156pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:202pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:24pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:1.5pt 0pt 0.5pt 0pt; width:48pt;">
              <font style="letter-spacing:0.2pt;">Title:</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:156pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:202pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:24pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:17.5pt 0pt 0.5pt 0pt; width:48pt;">
              <font style="letter-spacing:0.2pt;">Address:</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:156pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:39pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:202pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:24pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:28.5pt 0pt 0.5pt 0pt; width:0pt;" colspan="4">
              <font style="letter-spacing:0.2pt;">Electronic Mail Address:</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:255.56pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">[</font><font style="font-style:italic;letter-spacing:0.2pt;">Signature Page to Stockholder Support Agreement</font><font style="letter-spacing:0.2pt;">] </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;height:660pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:-0.2pt;">Exhibit&#160;A</font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:-0.2pt;">Form of Spousal Consent</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">I acknowledge that I have read the Stockholder Support Agreement (to which this consent is attached) and that I know and understand, and have been fully advised by my attorney with respect to, its contents. As the spouse of the Stockholder, I hereby agree: (i)&#160;that all shares of capital stock, all options, all warrants and all additional securities of Parent held by the Stockholder, and all other rights with respect to the capital stock of Parent held by the Stockholder, and my interest in such shares, options, warrants, additional securities and other rights, if any, are subject to the provisions of the Stockholder Support Agreement and the Merger Agreement (as defined in the Stockholder Support Agreement), which I consent to; and (ii)&#160;that I&#160;will take no action at any time to hinder the operation of the Stockholder Support Agreement or the Merger Agreement. </font>
        </div>
        <table style="width:459pt;height:83pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:216pt;">&#8203;</td>
            <td style="padding:0pt; width:1.5pt;">&#8203;</td>
            <td style="padding:0pt; width:1.5pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; width:0pt;" colspan="4">
              <font style="letter-spacing:-0.2pt;">SIGNATURE OF SPOUSE: </font>
            </td>
            <td style="padding:0pt; width:1.5pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:216pt;">&#8203;</td>
            <td style="padding:0pt; width:1.5pt;">&#8203;</td>
            <td style="padding:0pt; width:1.5pt;">&#8203;</td>
            <td style="padding:17.167pt 0pt 14.833pt 0pt; width:0pt;white-space:normal;" colspan="4">
              <div>
                <font style="letter-spacing:0.2pt;">&#8199;</font>
              </div>
              <div style="margin-top:2.5pt; text-align:justify;">
                <div style="margin-left: 0pt; width: 237pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
              </div>
            </td>
            <td style="padding:0pt; width:1.5pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:216pt;">&#8203;</td>
            <td style="padding:0pt; width:1.5pt;">&#8203;</td>
            <td style="padding:0pt; width:1.5pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 14.833pt 0pt; width:63pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Printed Name: </font>
              </div>
            </td>
            <td style="padding:0pt; width:1.5pt;">&#8203;</td>
            <td style="padding:0pt; width:1.5pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 14.833pt 0pt; width:171pt;white-space:normal;">
              <div>
                <font style="letter-spacing:0.2pt;">&#8199;</font>
              </div>
              <div style="margin-top:2.5pt; text-align:justify;">
                <div style="margin-left: 0pt; width: 171pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
              </div>
            </td>
            <td style="padding:0pt; width:1.5pt;">&#8203;</td>
            <td style="padding:0pt; width:1.5pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;height:660pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:-0.2pt;">Schedule&#160;I</font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">Ownership of Shares</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:32.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:222pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Name and Address of </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Stockholder </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:222pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Number of Shares of </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Common Stock </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.167pt 0pt; width:222pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.2pt;">[&#8226;]</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.167pt 0pt; width:222pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.2pt;">[&#8226;]</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a><a name="tANNE">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; text-align:right; width:436pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ANNEX E</font>&#8203;</div>
        <div style="margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio, Inc.</font> <br ><font style="letter-spacing:0.2pt;">245 First Cambridge Street, Suite 1800 </font> <br ><font style="letter-spacing:0.2pt;">Cambridge, MA 02142 </font></div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Lock-Up Agreement</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:8pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199; &#8199;&#8199; &#8199;&#8199;&#8199;&#8199;, 2022 </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">This Lock-Up Agreement (this &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Lock-Up Agreement</font><font style="letter-spacing:0.2pt;">&#8221;) is executed in connection with the Agreement and Plan of Merger and Reorganization (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Merger Agreement</font><font style="letter-spacing:0.2pt;">&#8221;) by and among Sesen Bio, Inc. (&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent</font><font style="letter-spacing:0.2pt;">&#8221;), Seahawk Merger Sub, Inc. (&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Merger Sub</font><font style="letter-spacing:0.2pt;">&#8221;), and CARISMA Therapeutics Inc. (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company</font><font style="letter-spacing:0.2pt;">&#8221;), dated as of &#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199; &#8199;&#8199; &#8199;&#8199;&#8199;&#8199;, 2022. Capitalized terms used herein but not defined shall have the meanings ascribed to such terms in the Merger Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In connection with, and as an inducement to, each of the parties entering into the Merger Agreement and to consummate the transactions contemplated thereby and for other good and valuable consideration the receipt and sufficiency of which is hereby acknowledged, the undersigned, by executing this Lock-Up Agreement, irrevocably agrees that, without the prior written consent of Parent, during the period commencing at the Effective Time and continuing until the end of the Lock-Up Period (as hereinafter defined), the undersigned will not: (i)&#160;offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, make any short sale or otherwise transfer or dispose of or lend, directly or indirectly, any shares of Parent Common Stock or any securities convertible into, exercisable or exchangeable for or that represent the right to receive Parent Common Stock (including without limitation, Parent Common Stock which may be deemed to be beneficially owned by the undersigned in accordance with the rules and regulations of the SEC and securities of Parent which may be issued upon exercise of a stock option, restricted stock unit or warrant) whether now owned or hereafter acquired (collectively, the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent Securities</font><font style="letter-spacing:0.2pt;">&#8221;); (ii)&#160;enter into any swap or other agreement that transfers, in whole or in part, any of the economic consequences of ownership of the Parent Securities, whether any such transaction described in clause (i)&#160;or this clause (ii)&#160;is to be settled by delivery of Parent Common Stock or such other securities, in cash or otherwise; (iii)&#160;make any demand for or exercise any right with respect to, the registration of any Parent Common Stock or any security convertible into or exercisable or exchangeable for Parent Common Stock (other than such rights set forth in the Merger Agreement); (iv)&#160;except for any voting agreement entered into as of the date hereof by the undersigned with Parent and the Company, grant any proxies or powers of attorney with respect to any Parent Securities, deposit any Parent Securities into a voting trust or enter into a voting agreement or similar arrangement or commitment with respect to any Parent Securities; or (v)&#160;publicly disclose the intention to do any of the foregoing (each of the foregoing restrictions, the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Lock-Up Restrictions</font><font style="letter-spacing:0.2pt;">&#8221;). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Notwithstanding the terms of the foregoing paragraph, the Lock-Up Restrictions shall automatically terminate and cease to be effective on the date that is one-hundred and eighty (180) days after the Effective Time. The period during which the Lock-Up Restrictions apply to the Parent Securities shall be deemed the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Lock-Up Period</font><font style="letter-spacing:0.2pt;">&#8221; with respect thereto. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The undersigned agrees that the Lock-Up Restrictions preclude the undersigned from engaging in any hedging or other transaction with respect to any then-subject Parent Securities which is designed to or which reasonably could be expected to lead to or result in a sale or disposition of such Parent Securities even if such Parent Securities would be disposed of by someone other than the undersigned. Such prohibited hedging or other transactions would include without limitation any short sale or any purchase, sale or grant of any right (including without limitation any put or call option) with respect to such Parent Securities or with respect to any security that includes, relates to, or derives any significant part of its value from such Parent Securities. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Notwithstanding the foregoing, the undersigned may transfer any of the Parent Securities: (i)&#160;if the undersigned is a natural person, (1)&#160;to any person related to the undersigned (or to an ultimate beneficial owner of the undersigned) by blood or adoption who is an immediate family member of the undersigned, or a family member by marriage or domestic partnership (a &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Family Member</font><font style="letter-spacing:0.2pt;">&#8221;), (2)&#160;as a </font><font style="font-style:italic;letter-spacing:0.2pt;">bona fide</font><font style="letter-spacing:0.2pt;"> gift or </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">E-1</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">charitable contribution, (3)&#160;to any trust for the direct or indirect benefit of the undersigned or any Family Member of the undersigned, (4)&#160;to the undersigned&#8217;s estate, following the death of the undersigned, by will, intestacy or other operation of law, (5)&#160;by operation of law pursuant to a qualified domestic order or in connection with a divorce settlement, or (6)&#160;to any partnership, corporation, limited liability company, investment fund or other entity which is controlled by the undersigned and/or by any Family Member of the undersigned; (ii)&#160;if the undersigned is a corporation, partnership, limited liability company, trust or other business entity, (1)&#160;to another corporation, partnership, limited liability company, trust or other business entity that controls, is controlled by or is under common control with the undersigned, or to direct or indirect affiliates (as defined in Rule&#160;405 promulgated under the Securities Act of 1933, as amended) of the undersigned, including any investment funds or other entities that controls or manages, or is under common control or management with, or is controlled or managed by, the undersigned, (2)&#160;to current or former partners (general or limited), members or managers, limited liability company members or stockholders of the undersigned or holders of similar equity interests in the undersigned (including upon the liquidation and dissolution of the undersigned pursuant to a plan of liquidation approved by the undersigned&#8217;s stockholders) or to the estates of any of the foregoing, (3)&#160;as a </font><font style="font-style:italic;letter-spacing:0.2pt;">bona fide</font><font style="letter-spacing:0.2pt;"> gift, donation or charitable contribution or otherwise to a trust or entity for the direct or indirect benefit of an immediate family member of a beneficial owner (as defined in Rule&#160;405 promulgated under the Securities Act of 1933, as amended) of the undersigned&#8217;s Parent Securities or (4)&#160;transfers of dispositions not involving a change in beneficial ownership; (iii)&#160;if the undersigned is a trust, to any grantors or beneficiaries of such trust; (iv)&#160;to a nominee or custodian of a person or entity to whom a disposition or transfer would be permissible under above clauses (i)&#160;through (iii); (v)&#160;to Parent in a transaction exempt from Section&#160;16(b) of the Securities Exchange Act of 1934, as amended (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Exchange Act</font><font style="letter-spacing:0.2pt;">&#8221;) upon a vesting event of the Parent Securities or upon the exercise of options or warrants to purchase Parent Common Stock, including on a &#8220;cashless&#8221; or &#8220;net exercise&#8221; basis or to cover tax withholding obligations of the undersigned in connection with such vesting or exercise (but for the avoidance of doubt, excluding all manners of exercise that would involve a sale in the open market of any securities relating to such options or warrants, whether to cover the applicable aggregate exercise price, withholding tax obligations or otherwise); (vi)&#160;to Parent in connection with the termination of employment or other termination of a service provider and pursuant to agreements in effect as of the Effective Time whereby Parent has the option to repurchase such shares or securities; (vii)&#160;acquired by the undersigned in open market transactions or in a public offering by Parent after the Effective Time; (viii)&#160;pursuant to a bona fide third party tender offer, merger, consolidation or other similar transaction made to all holders of Parent&#8217;s capital stock involving a change of control of Parent, </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, that in the event that such tender offer, merger, consolidation or other such transaction is not completed, the Parent Securities shall remain subject to the restrictions contained in this Lock-Up Agreement; or (ix)&#160;pursuant to an order of a court or regulatory agency; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, that in the case of clauses (i)-(iv), that (A)&#160;such transfer shall not involve a disposition for value and (B)&#160;the transferee shall have executed and delivered a Lock-Up Agreement with terms and in a form substantially identical to this Lock-Up Agreement with respect to the Parent Securities so transferred. For purposes of this Agreement, &#8220;change of control&#8221; shall mean the transfer (whether by tender offer, merger, consolidation or other similar transaction), in one transaction or a series of related transactions, to a person or group of affiliated persons, of shares of capital stock if, after such transfer, such person or group of affiliated persons would hold a majority of the outstanding voting securities of Parent (or the surviving entity). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In addition, the foregoing restrictions shall not apply to (i)&#160;the exercise of stock options granted pursuant to equity incentive plans existing immediately following the Effective Time, including the &#8220;net&#8221; or cashless exercise of such options in accordance with their terms and any related transfers of Parent Common Stock to Parent for purposes of paying the exercise price of such options or for paying taxes (including estimated taxes and withholding taxes) due as a result of such exercise; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, that the restrictions set forth in this Lock-Up Agreement shall apply to any of the Parent Securities issued upon such exercise; or (ii)&#160;the establishment of any contract, instruction or plan (a &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Plan</font><font style="letter-spacing:0.2pt;">&#8221;) that satisfies the requirements of Rule&#160;10b5-1 under the Securities Exchange Act of 1934, as amended (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Exchange Act</font><font style="letter-spacing:0.2pt;">&#8221;); </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, that such Plan does not provide for the transfer of Parent Common Stock or any securities convertible into or exercisable or exchangeable for Parent Common Stock during the Lock-Up Period; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided, further</font><font style="letter-spacing:0.2pt;">, that with respect to each of clauses (i)&#160;and (ii)&#160;above, no filing by any party under Section&#160;16 of the Exchange Act or other public announcement shall be made voluntarily reporting a reduction in beneficial ownership of shares of Parent Common Stock or any securities convertible into or exercisable or </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">E-2</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">exchangeable for Parent Common Stock in connection with such transfer or disposition during the Lock-Up Period (other than any exit filings) and if any filings under Section&#160;16(a) of the Exchange Act, or other public filing, report or announcement reporting a reduction in beneficial ownership of shares of Parent Common Stock in connection with such transfer or distribution, shall be legally required during the Lock-Up Period, such filing, report or announcement shall clearly indicate in the footnotes therein, in reasonable detail, a description of the circumstances of the transfer and that the shares remain subject to the Lock-Up Agreement, including a statement to the effect that no transfer of Parent Common Stock may be made under such Plan during the Lock-Up Period. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Any attempted transfer in violation of this Lock-Up Agreement will be of no effect and null and void, regardless of whether the purported transferee has any actual or constructive knowledge of the transfer restrictions set forth in this Lock-Up Agreement, and will not be recorded on the share register of Parent. In furtherance of the foregoing, the undersigned hereby agrees and consents to the entry of &#8220;stop transfer&#8221; instructions with Parent&#8217;s transfer agent and registrar relating to the transfer of the undersigned&#8217;s shares of Parent Common Stock in violation of this Lock-Up Agreement and further agrees that Parent and its transfer agent and registrar are hereby authorized to decline to make any transfer of shares of Parent Common Stock if such transfer would constitute a violation or breach of this Lock-Up Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Parent may cause the legend set forth below, or a legend substantially equivalent thereto, to be placed upon any certificate(s) or other documents, ledgers or instruments evidencing the undersigned&#8217;s ownership of Parent Common Stock: </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">THE SHARES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO AND MAY ONLY BE TRANSFERRED IN COMPLIANCE WITH A LOCK-UP AGREEMENT, A COPY OF WHICH IS ON FILE AT THE PRINCIPAL OFFICE OF THE COMPANY. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Upon the release of any Parent Common Stock from this Lock-Up Agreement, Parent will cooperate with the undersigned to facilitate the timely preparation and delivery of certificates or the establishment of book entry positions at the Parent&#8217;s transfer agent representing the Parent Common Stock without the restrictive legend above and the withdrawal of any stop transfer instructions at the Parent&#8217;s transfer agent. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The undersigned hereby represents and warrants that the undersigned has full power and authority to enter into this Lock-Up Agreement and that upon request, the undersigned will execute any additional documents reasonably necessary to ensure the validity or enforcement of this Lock-Up Agreement. All authority herein conferred or agreed to be conferred and any obligations of the undersigned shall be binding upon the successors, assigns, heirs or personal representatives of the undersigned. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In the event that during the Lock-Up Period any holder of Parent Securities that is subject to a substantially similar agreement entered into by such holder (such agreement, a &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Similar Agreement</font><font style="letter-spacing:0.2pt;">&#8221;), other than the undersigned, is permitted by Parent or otherwise granted a release to sell or otherwise transfer or dispose of shares of Parent Common Stock for value other than as permitted by this or a substantially similar agreement entered into by such holder (whether in one or multiple releases), the same&#160;percentage of shares of Parent Common Stock held by the undersigned on the date of such release or waiver as the&#160;percentage of the total number of outstanding shares of Parent Common Stock held by such holder on the date of such release or waiver that are subject to such release or waiver shall be immediately and fully released on the same terms from any remaining restrictions set forth herein (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Pro-Rata Release</font><font style="letter-spacing:0.2pt;">&#8221;). Parent will notify the undersigned of any Pro-Rata Release within ten business days of such release. Upon the release of any Parent Securities from this Lock-Up Agreement, Parent will promptly cooperate with the undersigned to facilitate the timely preparation and delivery of evidence of book-entry shares representing the Parent Securities without the restrictive legend above or the withdrawal of any stop transfer instructions. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">This Lock-Up Agreement shall terminate automatically, and the undersigned shall automatically be released from all restrictions and obligations under this Lock-Up Agreement upon the earlier of (i)&#160;the expiration of the Lock-Up Period, (ii)&#160;if the Merger Agreement is terminated prior to the Effective Time pursuant to its terms, upon the date of such termination and (iii)&#160;the End Date (as defined in the Merger Agreement in effect on the date hereof) provided that the Effective Time has not occurred on or before such date. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">E-3</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:456pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">This Lock-Up Agreement and any claim, controversy or dispute arising under or related to this Lock-Up Agreement shall be governed by, and construed in accordance with, the laws of the State of Delaware, without regard to the conflict of laws principles thereof. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">This Lock-Up Agreement, and any certificates, documents, instruments and writings that are delivered pursuant hereto, constitutes the entire agreement and understanding of Parent, the Company and the undersigned in respect of the subject matter hereof and supersedes all prior understandings, agreements or representations by or among Parent, the Company and the undersigned, written or oral, to the extent they relate in any way to the subject matter hereof. This Lock-Up Agreement may be executed in counterparts, each of which shall be deemed an original and all of which shall constitute one and the same instrument. The exchange of a fully executed Agreement (in counterparts or otherwise) by the undersigned by facsimile or electronic transmission in &#8220;.pdf&#8221; format shall be sufficient to bind the undersigned to the terms and conditions of this Lock-Up Agreement. </font>
        </div>
        <div style="margin-top:8pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(</font><font style="font-style:italic;letter-spacing:0.2pt;">Signature Page Follows</font><font style="letter-spacing:0.2pt;">) </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">E-4</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The undersigned understands that Parent, Merger Sub and the Company are relying on this Lock-Up Agreement in entering into the Merger Agreement and proceeding toward consummation of the transactions contemplated thereby. The undersigned further understands that this Lock-Up Agreement is irrevocable and shall be binding upon the undersigned and the heirs, personal representatives, successors and assigns of the undersigned. </font>
        </div>
        <table style="width:456pt;height:149pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:216pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; width:228pt;">
              <font style="letter-spacing:0.2pt;">Very truly yours, </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:216pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:20.167pt 0pt 0.5pt 0pt; width:228pt;white-space:normal;">
              <div style="text-align:justify;">
                <div style="margin-left: 0pt; width: 228pt; margin-top: 17.5pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
              </div>
              <div style="margin-top:2pt; text-align:center;">
                <font style="letter-spacing:0.2pt;">Printed Name of Holder </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:216pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:20.667pt 0pt 0.5pt 0pt; width:228pt;white-space:normal;">
              <div style="text-align:justify;">
                <div style="overflow:hidden;">
                  <div style="float:left;">
                    <font style="letter-spacing:0.2pt;">By:&#8199;</font>
                  </div>
                  <div style="overflow:hidden;line-height:10pt;border-bottom:0.5pt #000000 solid;">&#160;</div>
                </div>
              </div>
              <div style="margin-top:1.5pt; text-align:center;">
                <font style="letter-spacing:0.2pt;">Signature </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:216pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:20.167pt 0pt 0.5pt 0pt; width:228pt;white-space:normal;">
              <div style="text-align:justify;">
                <div style="margin-left: 0pt; width: 228pt; margin-top: 17.5pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
              </div>
              <div style="margin-top:2pt; text-align:center;">
                <font style="letter-spacing:0.2pt;">Printed Name of Person Signing</font>
                <br >
                <font style="letter-spacing:0.2pt;">(and indicate capacity of person signing if signing</font>
                <br >
                <font style="letter-spacing:0.2pt;">as custodian, trustee, or on behalf of an entity)</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:431.88pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">[</font><font style="font-style:italic;letter-spacing:0.2pt;">Lock-Up Agreement Signature Page]</font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a><a name="tANNF">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">

          <div style="margin-left:20pt; text-align:right; width:436pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">ANNEX F</font>&#8203;</div>


          <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">CONTINGENT VALUE RIGHTS AGREEMENT</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">THIS CONTINGENT VALUE RIGHTS AGREEMENT, dated as of [&#8226;], 2023 (this &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Agreement</font><font style="letter-spacing:0.2pt;">&#8221;), is entered into by and among Sesen Bio, Inc., a Delaware corporation (&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent</font><font style="letter-spacing:0.2pt;">&#8221;), and Computershare Inc. (&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Computershare</font><font style="letter-spacing:0.2pt;">&#8221;) and its affiliate, Computershare Trust Company, N.A., together, as the Rights Agent. </font>
          </div>


          <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">RECITALS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">WHEREAS, Parent, Seahawk Merger Sub, Inc., a Delaware corporation (&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Merger Sub</font><font style="letter-spacing:0.2pt;">&#8221;), and CARISMA Therapeutics Inc., a Delaware corporation (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company</font><font style="letter-spacing:0.2pt;">&#8221;), have entered into an Agreement and Plan of Merger and Reorganization, dated as of September&#160;20, 2022 (as it may be amended or supplemented from time to time pursuant to the terms thereof, the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Merger Agreement</font><font style="letter-spacing:0.2pt;">&#8221;), pursuant to which Merger Sub will merge with and into the Company, with the Company surviving the Merger as a subsidiary of Parent; and </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">WHEREAS, pursuant to the Merger Agreement, Parent has agreed to provide to the holders of record of Parent&#8217;s common stock, par value $0.001 per share (&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent Common Stock</font><font style="letter-spacing:0.2pt;">&#8221;), immediately prior to the Effective Time, the right to receive certain contingent cash payments, on the terms and subject to the conditions hereinafter described. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">NOW, THEREFORE, in consideration of the foregoing and the consummation of the transactions referred to above, Parent and the Rights Agent agree, for the proportionate benefit of all Holders (as hereinafter defined), as follows: </font>
          </div>


          <div style="margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">1.&nbsp;&nbsp;&nbsp;DEFINITIONS; CERTAIN RULES OF CONSTRUCTION </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">1.1</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Definitions.&nbsp;&nbsp;&nbsp;Capitalized terms used but not otherwise defined herein will have the meanings ascribed to them in the Merger Agreement, unless expressly set forth otherwise herein. As used in this Agreement, the following terms will have the following meanings: </font>
          </div>


          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Acquiror</font><font style="letter-spacing:0.2pt;">&#8221; has the meaning set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.3(a)</font><font style="letter-spacing:0.2pt;">. </font>
          </div>


          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Acquisition</font><font style="letter-spacing:0.2pt;">&#8221; has the meaning set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.3(a)</font><font style="letter-spacing:0.2pt;">. </font>
          </div>


          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Acting Holders</font><font style="letter-spacing:0.2pt;">&#8221; has the meaning set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.3(d)</font><font style="letter-spacing:0.2pt;"> </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Affiliate</font><font style="letter-spacing:0.2pt;">&#8221; of a Person means any other Person that directly or indirectly, through one or more intermediaries, controls, is controlled by, or is under common control with, such Person. The term &#8220;control&#8221; (including the terms &#8220;controlled by&#8221; and &#8220;under common control with&#8221;) means the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of a Person, whether through the ownership of voting securities, by contract or otherwise. </font>
          </div>


          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Agreement</font><font style="letter-spacing:0.2pt;">&#8221; has the meaning set forth in the Preamble. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Asset Disposition Proceeds</font><font style="letter-spacing:0.2pt;">&#8221; means, without duplication, any and all consideration of any kind that is paid to Parent, or is received by, Parent or any of its Affiliates during the period specified in clause (b)&#160;of the definition of CVR Term in respect of an Asset Disposition, if any. The value of any securities (whether debt or equity) or other non-cash property constituting Asset Disposition Proceeds shall be determined as follows: (A)&#160;the value of securities for which there is an established public market shall be equal to the volume weighted average of their closing market prices for the five (5)&#160;trading days ending the day prior to the date of payment to, or receipt by, Parent or its relevant Affiliate, and (B)&#160;the value of securities that have no established public market and the value of consideration that consists of other non-cash property, shall be the fair market value thereof as of the date of payment to, or receipt by, Parent or its relevant Affiliate. </font>
          </div>


          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Assignee</font><font style="letter-spacing:0.2pt;">&#8221; has the meaning set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.3(a)</font><font style="letter-spacing:0.2pt;">. </font>
          </div>


          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Board of Directors</font><font style="letter-spacing:0.2pt;">&#8221; means the board of directors of Parent. </font>
          </div>

      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-1</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">

          <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Board Resolution</font><font style="letter-spacing:0.2pt;">&#8221; means a copy of the resolution(s) certified by the secretary or an assistant secretary (or other comparable officer) of Parent that have been duly adopted by the Board of Directors and are in full force and effect on the date of such approval, and delivered to the Rights Agent. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Business Day</font><font style="letter-spacing:0.2pt;">&#8221; means any day other than a Saturday, Sunday or other day on which banks in New York, New York are authorized or obligated by Law to be closed. </font>
          </div>


          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company</font><font style="letter-spacing:0.2pt;">&#8221; has the meaning set forth in the Recitals. </font>
          </div>


          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Computershare</font><font style="letter-spacing:0.2pt;">&#8221; has the meaning set forth in the Preamble. </font>
          </div>


          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">CVR Payment</font><font style="letter-spacing:0.2pt;">&#8221; has the meaning set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.4(a)</font><font style="letter-spacing:0.2pt;">. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">CVR Payment Amount</font><font style="letter-spacing:0.2pt;">&#8221; means, with respect to each Holder, an amount equal to (a)&#160;(i)&#160;the applicable Total Payment Amount, less (ii)&#160;applicable accrued and documented Permitted Deductions, as calculated in accordance with GAAP, divided by (b)&#160;the total number of CVRs and then multiplied by the total number of CVRs held by such Holder as reflected on the CVR Register (rounded down to the nearest whole cent). </font>
          </div>


          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">CVR Register</font><font style="letter-spacing:0.2pt;">&#8221; has the meaning set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.3(b)</font><font style="letter-spacing:0.2pt;">. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">CVR Sale Assets</font><font style="letter-spacing:0.2pt;">&#8221; means any and all assets, tangible and intangible, including, without limitation, patents, patent applications, know-how, trade secrets and other intellectual property rights, data, documentation, agreements and licenses, inventory related to Vicineum</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">TM</font><font style="letter-spacing:0.2pt;">, also known as VB4-845, which Parent or any of its subsidiaries owned or had rights to, as of immediately prior to the Effective Time. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">CVR Term</font><font style="letter-spacing:0.2pt;">&#8221; means (a)&#160;with respect to any Roche Payment Amount, the period beginning on the date hereof and ending on the earlier of (i)&#160;the CVR Payment being delivered to each Holder in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.4</font><font style="letter-spacing:0.2pt;"> of this Agreement, and (ii)&#160;March&#160;31, 2027, and (b)&#160;with respect to any Disposition or Asset Disposition or otherwise in respect of Asset Disposition Proceeds, the period beginning on the date hereof and ending on December&#160;31, 2023. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">CVRs</font><font style="letter-spacing:0.2pt;">&#8221; means the rights of Holders to receive contingent cash payments pursuant to the Merger Agreement and this Agreement. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Disposition</font><font style="letter-spacing:0.2pt;">&#8221; means the sale, license, transfer, disposition or other monetizing event of any CVR Sale Assets, in each case (i)&#160;during the period set forth in clause (b)&#160;of the definition of CVR Term and (ii)&#160;in a transaction identified by Parent&#8217;s financial advisor who was engaged as of the Effective Time for the purpose of identifying and proposing a potential Disposition transaction to Parent. </font>
          </div>


          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">DTC</font><font style="letter-spacing:0.2pt;">&#8221; means The Depository Trust Company or any successor thereto. </font>
          </div>


          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Funds</font><font style="letter-spacing:0.2pt;">&#8221; has the meaning set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.9</font><font style="letter-spacing:0.2pt;">. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Holder</font><font style="letter-spacing:0.2pt;">&#8221; means a Person in whose name a CVR is registered in the CVR Register at the applicable time. </font>
          </div>


          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Merger Agreement</font><font style="letter-spacing:0.2pt;">&#8221; has the meaning set forth in the Recitals. </font>
          </div>


          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Merger Sub</font><font style="letter-spacing:0.2pt;">&#8221; has the meaning set forth in the Recitals. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Officer&#8217;s Certificate</font><font style="letter-spacing:0.2pt;">&#8221; means a certificate signed by the chief executive officer, president, chief financial officer, any vice president, the controller, the treasurer or the secretary, in each case of Parent, in his or her capacity as such an officer, and delivered to the Rights Agent. </font>
          </div>


          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent</font><font style="letter-spacing:0.2pt;">&#8221; has the meaning set forth in the Preamble. </font>
          </div>


          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent Common Stock</font><font style="letter-spacing:0.2pt;">&#8221; has the meaning set forth in the Recitals. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Permitted Deductions</font><font style="letter-spacing:0.2pt;">&#8221; means the following costs or expenses, without duplication (as approved by the Board of Directors, including, if applicable, the Parent Designee (as defined in the Merger Agreement)): </font>
          </div>


          <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;any applicable Tax (including any unreimbursed applicable value added or sales tax) imposed on the Total Payment Amount and payable by Parent or any of its Affiliates to any tax authority and, </font>
          </div>

      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-2</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">

          <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">without duplication, any income or other similar Taxes payable by Parent or any of its Affiliates that would not have been incurred by Parent or any of its Affiliates but for the Total Payment Amount; provided that, for purposes of calculating income Taxes incurred by Parent and its Affiliates in respect of the Total Payment Amount, any such income Taxes shall be computed after reduction for any net operating loss carryforwards or other Tax attributes (including Tax credits) of Parent or its subsidiaries (owned prior to the Merger) as of the Closing Date that are available to the maximum extent permitted by law to offset such gain after taking into account any limits on the usability of such attributes, including under Section&#160;382 of the Code, in each case, as reasonably determined by a nationally recognized tax advisor (and for the sake of clarity such income taxes shall be calculated without taking into account any net operating losses or other Tax attributes generated by Parent or its subsidiaries after the Closing Date or any Tax attributes of the Company, whether generated before or after the Closing Date), assuming for this purpose that (i)&#160;the only item of gross income of Parent and its subsidiaries is the Total Payment Amount (for the avoidance of doubt, assuming that the Total Payment Amount is taxable in the hands of Parent or its subsidiaries no later than the taxable year that includes the corresponding CVR Payment), and (ii)&#160;the net operating loss carryforwards or other Tax attributes (including Tax credits) of Parent or its subsidiaries shall only include any net operating loss carryforwards or other Tax attributes (including Tax credits) of Parent or its subsidiaries (owned prior to the Merger) existing as of immediately prior to the Merger for U.S. federal income tax purposes and applicable state and local income tax purposes; </font>
          </div>


          <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;any reasonable and documented out-of-pocket expenses incurred by Parent or any of its Affiliates in respect of its performance of this Agreement following the Effective Time, losses incurred and paid by Parent or any of its Affiliates following the Effective Time arising out of any Legal Proceeding relating to or in connection with (i)&#160;an Asset Disposition, (ii)&#160;Parent&#8217;s, Roche&#8217;s or any of their respective Affiliates&#8217; obligations under the Roche Agreement or (iii)&#160;otherwise with respect to the Total Payment Amount; and </font>
          </div>


          <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;any Liabilities that were ascertainable prior to or at the Effective Time which Parent reasonably and in good faith determines should have been, but were not, deducted from &#8220;Net Cash&#8221; &#8203;(as defined in the Merger Agreement), in connection with the Closing of the Merger, to the extent that deduction of such Liabilities would have resulted in a change in the Exchange Ratio under the Merger Agreement were such amounts properly deducted; </font>
          </div>


          <div style="margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">provided that no Permitted Deductions shall be deducted to the extent they were otherwise deducted from the calculation of Net Cash (as defined in the Merger Agreement). </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Permitted Transfer</font><font style="letter-spacing:0.2pt;">&#8221; means a transfer of CVRs: (a)&#160;on death of a Holder by will or intestacy; (b)&#160;by instrument to an inter vivos or testamentary trust in which the CVRs are to be passed to beneficiaries upon the death of the trustee; (c)&#160;pursuant to a court order; (d)&#160;made by operation of law (including a consolidation or merger) or without consideration in connection with the dissolution, liquidation or termination of any corporation, limited liability company, partnership or other entity; (e)&#160;in the case of CVRs held in book-entry or other similar nominee form, from a nominee to a beneficial owner (through an intermediary if applicable) or from a nominee to another nominee for the same beneficial owner, to the extent allowable by DTC; (f)&#160;a transfer from a participant&#8217;s account in a tax-qualified employee benefit plan to the participant or to such participant&#8217;s account in a different tax-qualified employee benefit plan or to a tax-qualified individual retirement account for the benefit of such participant; (g)&#160;to Parent or its Affiliates for any or no consideration; or (h)&#160;as provided in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.6</font><font style="letter-spacing:0.2pt;">. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Person</font><font style="letter-spacing:0.2pt;">&#8221; means any natural person, corporation, limited liability company, trust, unincorporated association, partnership, joint venture or other entity. </font>
          </div>


          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Record Time</font><font style="letter-spacing:0.2pt;">&#8221; has the meaning set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.3(e)</font><font style="letter-spacing:0.2pt;">. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Rights Agent</font><font style="letter-spacing:0.2pt;">&#8221; means the Rights Agent named in the Preamble, until a successor Rights Agent will have become such pursuant to the applicable provisions of this Agreement, and thereafter &#8220;Rights Agent&#8221; will mean such successor Rights Agent. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Roche</font><font style="letter-spacing:0.2pt;">&#8221; means the collective reference to F. Hoffman-La Roche Ltd and Hoffmann La Roche Inc. or its successors or any of its or their respective Affiliates; provided, that neither Chugai Pharmaceutical Co., </font>
          </div>

      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-3</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">

          <div style="width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Ltd, a Japanese corporation (&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Chugai</font><font style="letter-spacing:0.2pt;">&#8221;) nor its subsidiaries (if any) shall be deemed as Affiliates of Roche unless Roche provides written notice to Parent of its desire to include Chugai or its respective subsidiaries (as applicable) as Affiliate(s) of Roche. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">RocheAgreement</font><font style="letter-spacing:0.2pt;">&#8221; means that certain Asset Purchase Agreement, dated as of July&#160;15, 2022, by and among F. Hoffman-La Roche Ltd, Hoffmann La Roche Inc. and Parent. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Roche Payment Amount</font><font style="letter-spacing:0.2pt;">&#8221; means the thirty million dollar ($30,000,000) milestone payment to be made by Roche to Parent upon the initiation of a phase III clinical study in diabetic macular disorder with the compound known as &#8220;EBI-031&#8221; during the CVR Term, as set forth in Section&#160;11.1 of the Roche Agreement. </font>
          </div>


          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Third Party</font><font style="letter-spacing:0.2pt;">&#8221; means any Person other than Parent, Rights Agent or their respective Affiliates. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Total Payment Amount</font><font style="letter-spacing:0.2pt;">&#8221; means, as of any applicable time of determination, any Asset Disposition Proceeds plus any Roche Payment Amounts. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">1.2</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Rules of Construction. Except as otherwise explicitly specified to the contrary, (a)&#160;whenever the context requires, the singular number shall include the plural, and vice versa; (b)&#160;the masculine gender shall include the feminine gender and neuter genders, the feminine gender shall include the masculine and neuter genders, and the neuter genders shall include masculine and feminine genders; (c)&#160;the word &#8220;extent&#8221; in the phrase &#8220;to the extent&#8221; means the degree to which a subject or other thing extends, and does not simply mean &#8220;if&#8221;; (d)&#160;the word &#8220;including&#8221; &#8203;(in its various forms) means &#8220;including without limitation&#8221;; (e)&#160;references to a &#8220;Section&#8221; means a Section of this Agreement unless another agreement is specified; (f)&#160;references to a particular statute or regulation include all rules and regulations thereunder and any predecessor or successor statute, rules or regulation, in each case as amended or otherwise modified from time to time; (g)&#160;words in the singular or plural form include the plural and singular form, respectively; (h)&#160;references to a particular Person include such Person&#8217;s successors and assigns to the extent not prohibited by this Agreement; (i)&#160;the word &#8220;or&#8221; shall not be exclusive (i.e., &#8220;or&#8221; shall be deemed to mean &#8220;and/or&#8221;) unless the subject of the conjunction are mutually exclusive; and (j)&#160;all references to dollars or &#8220;$&#8221; refer to United States dollars. For clarity, the parties agree that the phrase &#8220;materially adverse&#8221; when used in this Agreement with respect to the Holders includes any amendment or other action, as applicable, that does or would be reasonably expected to reduce, eliminate, or materially delay the Roche Payment Amount. </font>
          </div>


          <div style="margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">2.&nbsp;&nbsp;&nbsp;CONTINGENT VALUE RIGHTS </font>
          </div>


          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">2.1</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;CVRs; Appointment of Rights Agent. </font>
          </div>


          <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;Each Holder is entitled to one CVR in the form of a dividend for each share of Parent Common Stock held by such Holder as of the Record Time. The CVRs represent the rights of Holders to receive contingent cash payments pursuant to the Merger Agreement and this Agreement. The initial Holders will be the holders of Parent Common Stock as of immediately prior to the Effective Time, and a list of the initial Holders shall be furnished to the Rights Agent by or on behalf of Parent in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;4.1</font><font style="letter-spacing:0.2pt;"> hereof. </font>
          </div>


          <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;Parent hereby appoints the Rights Agent to act as rights agent for Parent as contemplated hereby in accordance with the express terms and conditions set forth in this Agreement (and no implied terms or conditions), and the Rights Agent hereby accepts such appointment. </font>
          </div>


          <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;Parent intends to treat the issuance of the CVRs as a distribution of property by Parent to the holders of Parent Common Stock for U.S. federal income tax purposes. Consistent with such intended tax treatment, Parent will timely send Forms 1099-DIV to all Holders notifying them of the portion of the CVR value that is a nondividend distribution (or a dividend to the extent of Parent&#8217;s earnings and profits) for U.S. federal income tax purposes, and take all necessary steps to file its tax returns and any information statements consistent with such tax treatment. Parent will determine, in consultation with and with the consent of the Parent Designee, the fair market value of the CVRs in connection with the issuance and Parent will utilize such fair market value for purposes of all tax reporting (including on Forms 1099-DIV) with respect to the CVR. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">2.2</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Nontransferable.&nbsp;&nbsp;&nbsp;The CVRs shall not be sold, assigned, transferred, pledged, encumbered or in any other manner transferred or disposed of, in whole or in part, other than through a Permitted Transfer. </font>
          </div>

      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-4</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">

          <div style="width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Any attempted sale, assignment, transfer, pledge, encumbrance, transfer or disposition, in whole or in part, that is not a Permitted Transfer will be void </font><font style="font-style:italic;letter-spacing:0.2pt;">ab initio</font><font style="letter-spacing:0.2pt;"> and of no effect. </font>
          </div>


          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">2.3</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;No Certificate; Registration; Registration of Transfer; Change of Address. </font>
          </div>


          <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;The CVRs will not be evidenced by a certificate or other instrument. </font>
          </div>


          <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;The Rights Agent will create and keep a register (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">CVR Register</font><font style="letter-spacing:0.2pt;">&#8221;) for the purpose of identifying the Holders and registering CVRs and transfers of CVRs as permitted herein. The CVR Register will be created, and CVRs will be distributed, pursuant to written instructions to the Rights Agent from Parent. The CVR Register will initially show one position for Cede &amp; Co. representing all the CVRs provided to the holders of shares of Parent Common Stock held as of immediately prior to the Effective Time. The Rights Agent will have no responsibility whatsoever directly to the street name holders or DTC participants with respect to transfers of CVRs unless and until such CVRs are transferred into the name of such street name holders or DTC participants in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.2</font><font style="letter-spacing:0.2pt;"> of this Agreement. With respect to any payments to be made under </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.4(a)</font><font style="letter-spacing:0.2pt;"> below, the Rights Agent will accomplish the payment to any former street name holders of shares of Parent Common Stock by sending one lump-sum payment to DTC. The Rights Agent will have no responsibilities whatsoever with regard to the distribution of payments by DTC to such street name holders. </font>
          </div>


          <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;Subject to the restrictions on transferability set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.2</font><font style="letter-spacing:0.2pt;">, every request made to transfer a CVR must be in writing and accompanied by a written instrument of transfer and other reasonably requested documentation in form reasonably satisfactory to the Rights Agent, duly executed by the Holder thereof or the Holder&#8217;s attorney duly authorized in writing, personal representative or survivor and setting forth in reasonable detail the circumstances relating to the transfer. Upon receipt of such written notice, the Rights Agent will, subject to its reasonable determination that the transfer instrument is in proper form, notify Parent that it has received such written notice. Upon receipt of such notice from the Rights Agent, Parent shall determine whether the transfer otherwise complies with the other terms and conditions of this Agreement (including the provisions of </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.2</font><font style="letter-spacing:0.2pt;">), and if it determines that it does so comply, Parent shall instruct the Rights Agent in writing to register the transfer of the CVRs in the CVR Register and notify Parent of the same. No service charge shall be made for any registration of transfer of a CVR; however Parent and the Rights Agent may require payment of a sum sufficient to cover any stamp or other tax or governmental charge that is imposed in connection with any such registration of transfer. The Rights Agent shall have no duty or obligation to take any action under any section of this Agreement that requires the payment by a Holder of applicable taxes or charges unless and until the Rights Agent is satisfied that all such taxes or charges have been paid or will be paid. All duly transferred CVRs registered in the CVR Register will be the valid obligations of Parent and will entitle the transferee to the same benefits and rights under this Agreement as those held immediately prior to the transfer by the transferor. No transfer of a CVR will be valid until registered in the CVR Register. </font>
          </div>


          <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;A Holder may make a written request to the Rights Agent to change such Holder&#8217;s address of record in the CVR Register. The written request must be duly executed by the Holder. Upon receipt of such written request, the Rights Agent is hereby authorized to promptly record the change of address in the CVR Register. </font>
          </div>


          <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">(e)&nbsp;&nbsp;&nbsp;Parent will provide written instructions to the Rights Agent for the distribution of CVRs to holders of Parent Common Stock as of immediately prior to the Effective Time (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Record Time</font><font style="letter-spacing:0.2pt;">&#8221;). Subject to the terms and conditions of this Agreement and Parent&#8217;s prompt confirmation of the Effective Time, the Rights Agent shall effect the distribution of the CVRs, less any applicable tax withholding, to each holder of Parent Common Stock as of the Record Time by the mailing of a statement of holding reflecting such CVRs. </font>
          </div>


          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">2.4</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Payment Procedures. </font>
          </div>


          <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;Within thirty (30) days after the receipt of any portion of the Total Payment Amount, Parent shall (i)&#160;deliver to the Rights Agent a certificate certifying to and specifying in reasonable detail (A)&#160;the amount of the applicable Total Payment Amount received by Parent or its Affiliates, (B)&#160;a calculation </font>
          </div>

      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-5</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">

          <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">of the CVR Payment Amount and CVR Payment, and (C)&#160;the Permitted Deductions reflected in such CVR Payment Amount, (ii)&#160;deliver to the Rights Agent an amount equal to the aggregate CVR Payment Amount in immediately available funds (each, a &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">CVR Payment</font><font style="letter-spacing:0.2pt;">&#8221;) and (iii)&#160;instruct the Rights Agent to deliver the CVR Payment to the Holders. The Rights Agent will promptly, and in any event within ten (10) Business Days after receipt of each applicable CVR Payment, pay to each Holder, by check mailed to the address of each Holder as reflected in the CVR Register as of the close of business on the date of the receipt of the CVR Payment statement, such Holder&#8217;s CVR Payment Amount less any applicable tax withholding. Until such certificate, CVR Payment and instructions are received by the Rights Agent, the Rights Agent may presume conclusively for all purposes that such portion of the Total Payment Amount has not been received. </font>
          </div>


          <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;All payments by Parent to the Rights Agent under this Agreement shall be made in U.S. dollars. </font>
          </div>


          <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;Parent shall be entitled to deduct or withhold, or cause the Rights Agent to deduct or withhold from any CVR Payment Amount otherwise payable or otherwise deliverable pursuant to this Agreement, in each case directly or through an authorized payroll agent, such amounts as are reasonably determined to be required to be deducted or withheld therefrom under the Code or any other provision of any applicable federal, state, local or non-U.S. Tax Law as may be determined by Parent. To the extent such amounts are so deducted or withheld and paid over or deposited with the relevant Tax authority, such amounts shall be treated for all purposes under this Agreement as having been paid to the Holder(s) to whom such amounts would otherwise have been paid or delivered. Prior to making any such Tax withholdings or causing any such Tax withholdings to be made with respect to any Holder, Parent shall instruct the Rights Agent, to the extent practicable, to provide notice to the Holder of such potential withholding and a reasonable opportunity for the Holder to provide any necessary Tax forms (including an IRS Form W-9 or an applicable IRS Form W-8) in order to avoid or reduce such withholding amounts; provided, that the time period for payment of a CVR Payment Amount by the Rights Agent set forth in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.4(a)</font><font style="letter-spacing:0.2pt;"> shall be extended by a period equal to any delay caused by the Holder providing such forms; provided, further, that in no event shall such period be extended for more than ten (10) Business Days, unless otherwise requested by the Holder for the purpose of delivering such forms and agreed to by the Rights Agent. </font>
          </div>


          <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;Any portion of any CVR Payment that remains undistributed to any Holder six (6)&#160;months after such CVR Payment is received by the Rights Agent from Parent, provided, that the Rights Agent has fully complied with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.4(a)</font><font style="letter-spacing:0.2pt;">, will be delivered by the Rights Agent to Parent, upon demand, and such Holder will thereafter look only to Parent for payment of its share of such returned CVR Payment, without interest. </font>
          </div>


          <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">(e)&nbsp;&nbsp;&nbsp;Neither Parent nor the Rights Agent will be liable to any person in respect of any CVR Payment Amount delivered to a public official pursuant to any applicable abandoned property, escheat or similar Law. If, despite Parent&#8217;s and/or the Rights Agent&#8217;s commercially reasonable efforts to deliver a CVR Payment Amount to the applicable Holder, such CVR Payment Amount has not been paid immediately prior to the date on which such CVR Payment Amount would otherwise escheat to or become the property of any Governmental Body, any such CVR Payment Amount will, to the extent permitted by applicable Law, become the property of Parent, free and clear of all claims or interest of any person previously entitled thereto. In addition to and not in limitation of any other indemnity obligation herein, Parent agrees to indemnify and hold harmless the Rights Agent with respect to any liability, penalty, cost or expense the Rights Agent may incur or be subject to in connection with transferring such property to Parent and such indemnification obligation shall survive the termination of this Agreement, the resignation, replacement or removal of the Rights Agent, and the payment, termination and the expiration of the CVRs. </font>
          </div>


          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">2.5</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;No Voting, Dividends or Interest; No Equity or Ownership Interest in Parent. </font>
          </div>


          <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;The CVRs will not have any voting or dividend rights, and interest will not accrue on any amounts payable on the CVRs to any Holder. </font>
          </div>


          <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;The CVRs will not represent any equity or ownership interest in Parent or in any constituent company to the Merger. The sole right of the Holders to receive property hereunder is the right to receive </font>
          </div>

      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-6</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">

          <div style="margin-left:20pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">the CVR Payment in accordance with the terms hereof. It is hereby acknowledged and agreed that a CVR shall not constitute a security of Parent or any constituent company to the Merger. </font>
          </div>


          <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;Each Holder acknowledges and agrees that such Holder will not challenge or contest any action, inaction, determination or decision of Parent or the Rights Agent, except via written action of the Acting Holders, and will not threaten, bring, commence, institute, maintain, prosecute or voluntarily aid any action, which challenges the validity of or seeks to enjoin the operation of any provision of this Agreement. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">2.6</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Ability to Abandon CVR. A Holder may at any time, at such Holder&#8217;s option, abandon all of such Holder&#8217;s remaining rights in a CVR by transferring such CVR to Parent without consideration therefor, and such rights will be cancelled, with the Rights Agent being promptly notified in writing by Parent of such transfer and cancellation. Nothing in this Agreement is intended to prohibit Parent from offering to acquire CVRs, in a private transaction or otherwise, for consideration in its sole discretion. </font>
          </div>


          <div style="margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">3.&nbsp;&nbsp;&nbsp;THE RIGHTS AGENT </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">3.1</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Certain Duties and Responsibilities.&nbsp;&nbsp;&nbsp;The Rights Agent will be authorized and protected and will not have any liability for or in respect of any actions taken, suffered or omitted to be taken by it in connection with its acceptance and administration of this Agreement and the exercise and performance of its duties hereunder, except to the extent of its own willful misconduct, bad faith or gross negligence (each as determined by a final non-appealable judgment of a court of competent jurisdiction). </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">3.2</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Certain Rights of the Rights Agent.&nbsp;&nbsp;&nbsp;The Rights Agent undertakes to perform such duties and only such duties as are specifically set forth in this Agreement, and no implied duties, covenants or obligations will be read into this Agreement against the Rights Agent. The Rights Agent shall not assume any obligations or relationship of agency or trust with any Holder. In addition: </font>
          </div>


          <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;the Rights Agent may rely and will be protected by Parent in acting or refraining from acting upon any resolution, certificate, statement, instrument, opinion, report, notice, request, direction, consent, order or other paper or document believed by it in the absence of bad faith to be genuine and to have been signed or presented by the proper party or parties; </font>
          </div>


          <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;whenever the Rights Agent will deem it desirable that a matter be proved or established prior to taking, suffering or omitting any action hereunder, the Rights Agent may request and rely upon an Officer&#8217;s Certificate with respect to such matter, which certificate shall be full authorization and protection to the Rights Agent, and the Rights Agent shall, in the absence of gross negligence, bad faith or willful or intentional misconduct (each as determined by a final non appealable judgment of a court of competent jurisdiction) on its part, incur no liability and be held harmless by Parent for or in respect of any action taken, suffered or omitted to be taken by it in the absence of bad faith under the provisions of this Agreement in reliance upon such certificate; </font>
          </div>


          <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;in the event the Rights Agent believes any ambiguity or uncertainty exists hereunder or in any notice, instruction, direction, request or other communication, paper or document received by the Rights Agent hereunder, the Rights Agent, may, in its sole discretion, refrain from taking any action, and shall be fully protected and shall not be liable in any way to Parent, any Holder or any other person or entity for refraining from taking such action, unless the Rights Agent receives written instructions from the Parent which eliminates such ambiguity or uncertainty to the satisfaction of the Rights Agent; </font>
          </div>


          <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;the Rights Agent may engage and consult with counsel of its selection (who may be legal counsel for the Rights Agent or the Parent or an employee of the Rights Agent) and the written advice of such counsel or any opinion of counsel will be full and complete authorization and protection to the Rights Agent and the Rights Agent shall be held harmless by Parent and shall incur no liability for or in respect of any action taken, suffered or omitted by it hereunder in the absence of bad faith and in reliance thereon; </font>
          </div>


          <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">(e)&nbsp;&nbsp;&nbsp;the permissive rights of the Rights Agent to do things enumerated in this Agreement will not be construed as a duty; </font>
          </div>

      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-7</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">

          <div style="margin-left:20pt; text-indent:20pt; width:436pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">(f)&nbsp;&nbsp;&nbsp;the Rights Agent will not be required to give any note or surety in respect of the execution of such powers or otherwise in respect of the premises; </font>
          </div>


          <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">(g)&nbsp;&nbsp;&nbsp;the Rights Agent shall not be liable for or by reason of, and shall be held harmless by Parent with respect to any of the statements of fact or recitals contained in this Agreement or be required to verify the same, but all such statements and recitals are and shall be deemed to have been made by the Parent only and the Rights Agent will have no liability and shall be held harmless by Parent in respect of the validity of this Agreement or the execution and delivery hereof (except the due execution and delivery hereof by the Rights Agent), nor shall the Rights Agent be responsible for any breach by Parent of any covenant or condition contained in this Agreement; </font>
          </div>


          <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">(h)&nbsp;&nbsp;&nbsp;Parent agrees to indemnify the Rights Agent for, and hold the Rights Agent harmless against, any loss, liability, damage, judgment, fine, penalty, settlement, claim, demands, suits, cost or expense (including without limitation, the reasonable and documented fees and expenses of legal counsel) for any action taken, suffered or omitted to be taken by the Rights Agent or arising out of or in connection with the Rights Agent&#8217;s duties under this Agreement, including the reasonable and documented out-of-pocket costs and expenses of defending the Rights Agent against any claims, charges, demands, suits or loss arising therefrom, directly or indirectly, or enforcement of its rights hereunder, unless such loss has been determined by a final non-appealable judgment of a court of competent jurisdiction to be a result of the Rights Agent&#8217;s gross negligence, bad faith or willful or intentional misconduct; </font>
          </div>


          <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">(i)&nbsp;&nbsp;&nbsp;anything to the contrary notwithstanding, (i)&#160;any liability of the Rights Agent under this Agreement will be limited to the aggregate amount of the annual fees (but not reimbursed expenses) paid by Parent to the Rights Agent under this Agreement during the twelve&#160;months immediately preceding the event for which recovery is sought, and (ii)&#160;in no event shall the Rights Agent be liable for any special, punitive, indirect, consequential or incidental loss or damage of any kind whatsoever (including but not limited to lost profits) arising out of any action taken, suffered or omitted to be taken by it, even if the Rights Agent has been advised of the likelihood of such loss or damage and regardless of the form of action; </font>
          </div>


          <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">(j)&nbsp;&nbsp;&nbsp;Parent agrees (i)&#160;to pay the fees and expenses of the Rights Agent in connection with the Rights Agent&#8217;s duties under this Agreement as agreed upon in writing by the Rights Agent and Parent on or prior to the date hereof, and (ii)&#160;to reimburse the Rights Agent for all taxes and governmental charges, reasonable and documented out-of-pocket expenses and other charges of any kind and nature incurred by the Rights Agent in the preparation, delivery, amendment and execution of this Agreement and the exercise and performance of its duties hereunder (other than taxes imposed on or measured by the Rights Agent&#8217;s net income and franchise or similar taxes imposed on it (in lieu of net income taxes)). The Rights Agent will also be entitled to reimbursement from Parent for all reasonable and documented out-of-pocket expenses paid or incurred by it in connection with the administration by the Rights Agent of its duties hereunder. </font>
          </div>


          <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">(k)&nbsp;&nbsp;&nbsp;the Rights Agent shall not be deemed to have knowledge of any event of which it was supposed to receive notice thereof hereunder, and the Rights Agent shall be fully protected and shall incur no liability for failing to take action in connection therewith, unless and until it has received such notice in writing from the Parent and all notices or other instruments required by this Agreement to be delivered to the Rights Agent must, in order to be effective, be received by the Rights Agent as specified herein, and in the absence of such notice so delivered the Rights Agent may conclusively assume no such event or condition exists; </font>
          </div>


          <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">(l)&nbsp;&nbsp;&nbsp;the Rights Agent and any shareholder, affiliate, director, officer or employee of the Rights Agent may buy, sell or deal in any securities of the Parent or become peculiarly interested in any transaction in which the Parent may be interested, or contract with or lend money to the Parent or otherwise act as fully and freely as though it were not the Rights Agent under this Agreement. Nothing herein shall preclude the Rights Agent from acting in any other capacity for the Parent or for any other Person; </font>
          </div>


          <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">(m)&nbsp;&nbsp;&nbsp;the Rights Agent may execute and exercise any of the rights or powers hereby vested in it or perform any duty hereunder either itself or by or through its attorneys or agents, and the Rights Agent </font>
          </div>

      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-8</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">

          <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">shall not be liable, answerable or accountable for any act, omission, default, neglect or misconduct of any such attorneys or agents or for any loss to the Parent, any Holder or any other person or entity resulting from any such act, omission, default, neglect or misconduct, absent gross negligence, bad faith or willful misconduct (each as determined by a final non-appealable judgment of a court of competent jurisdiction) in the selection and continued employment thereof; </font>
          </div>


          <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">(n)&nbsp;&nbsp;&nbsp;no provision of this Agreement shall require the Rights Agent to expend or risk its own funds or otherwise incur any financial liability in the performance of any of its duties hereunder or in the exercise of its rights if there shall be reasonable grounds for believing that repayment of such funds or adequate indemnification against such risk or liability is not reasonably assured to it; </font>
          </div>


          <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">(o)&nbsp;&nbsp;&nbsp;the Rights Agent shall not have any duty or responsibility in the case of the receipt of any written demand from any Holder with respect to any action or default by the Parent or its Affiliates, including, without limiting the generality of the foregoing, any duty or responsibility to initiate or attempt to initiate any proceedings at law or otherwise or to make any demand upon the Parent; </font>
          </div>


          <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">(p)&nbsp;&nbsp;&nbsp;the Rights Agent shall neither be responsible for, nor chargeable with, knowledge of, nor have any requirements to comply with, the terms and conditions of any other agreement, instrument or document, including, without limitation, the Merger Agreement, nor shall the Rights Agent be required to determine if any person or entity has complied with any such agreements, instruments or documents, nor shall any additional obligations of the Rights Agent be inferred from the terms of such agreements, instruments or documents even though reference thereto may be made in this Agreement. In the event of any conflict between the terms and provisions of this Agreement and those of any other agreement, instrument or document, including but not limited to the Merger Agreement, the terms and conditions of this Agreement shall control as they relate to the Rights Agent; and </font>
          </div>


          <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">(q)&nbsp;&nbsp;&nbsp;The provisions of </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.1</font><font style="letter-spacing:0.2pt;"> and this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.2</font><font style="letter-spacing:0.2pt;"> shall survive the termination of this Agreement, the resignation, replacement or removal of the Rights Agent, and the payment, termination and the expiration of the CVRs. </font>
          </div>


          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">3.3</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Resignation and Removal; Appointment of Successor. </font>
          </div>


          <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;The Rights Agent may resign at any time by giving written notice thereof to Parent specifying a date when such resignation will take effect, which notice will be sent at least thirty (30) days prior to the date so specified, and such resignation will become effective on the earlier of (i)&#160;the date so specified and (ii)&#160;the appointment of a successor Rights Agent. Parent has the right to remove the Rights Agent at any time by a Board Resolution specifying a date when such removal will take effect (or, if earlier, the appointment of the successor Rights Agent). Notice of such removal will be given by Parent to the Rights Agent, which notice will be sent at least thirty (30) days prior to the date so specified. Notwithstanding anything to the contrary contained herein, such replacement or removal of the Rights Agent shall not affect any of the provisions of this Agreement that expressly survive the termination of this Agreement, or the resignation, replacement or removal of the Rights Agent. </font>
          </div>


          <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;If the Rights Agent provides notice of its intent to resign, is removed or becomes incapable of acting, Parent, by a Board Resolution, will as soon as is reasonably possible appoint a qualified successor Rights Agent, who shall be a stock transfer agent or national reputation or the corporate trust department of a commercial bank. The successor Rights Agent so appointed will, forthwith upon its acceptance of such appointment in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.4</font><font style="letter-spacing:0.2pt;">, become the successor Rights Agent. Notwithstanding the foregoing, if Parent shall fail to make such appointment within a period of thirty (30) days after giving notice of such removal or after it has been notified in writing of such resignation or incapacity by the resigning or incapacitated Rights Agent, then the incumbent Rights Agent may apply to any court of competent jurisdiction for the appointment of a new Rights Agent. </font>
          </div>


          <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;Parent will give notice to each Holder of each resignation and each removal of a Rights Agent and each appointment of a successor Rights Agent by delivering a written notice of such event to the Holders as their names and addresses appear in the CVR Register in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.1</font><font style="letter-spacing:0.2pt;">. Each notice will include the name and address of the successor Rights Agent. If Parent fails to send such notice within ten (10) Business Days after acceptance of appointment by a successor Rights Agent, the successor Rights Agent will cause the notice to be mailed at the expense of Parent. Failure to give </font>
          </div>

      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-9</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">

          <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">any notice provided for in this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.3</font><font style="letter-spacing:0.2pt;">, however, and any defect therein, shall not affect the legality or validity of the resignation or removal of the Rights Agent or the appointment of the successor Rights Agent, as the case may be. </font>
          </div>


          <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;Notwithstanding anything to the contrary in this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.3</font><font style="letter-spacing:0.2pt;">, unless consented to in writing by, at the applicable time of determination, Holders of at least 33% of the then outstanding CVRs, as set forth in the CVR Register (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Acting Holders</font><font style="letter-spacing:0.2pt;">&#8221;), Parent will not appoint as a successor Rights Agent any Person that is not a stock transfer agent of national reputation or the corporate trust department of a commercial bank. </font>
          </div>


          <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">(e)&nbsp;&nbsp;&nbsp;The Rights Agent will reasonably cooperate with Parent and any successor Rights Agent in connection with the transition of the duties and responsibilities of the Rights Agent to the successor Rights Agent, including the transfer of all relevant data, including the CVR Register, to the successor Rights Agent, but such predecessor Rights Agent shall not be required to make any additional expenditure or assume any additional liability in connection with the foregoing. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">3.4</font><font style="letter-spacing:0.2pt;"> Acceptance of Appointment by Successor. Every successor Rights Agent appointed hereunder will, at or prior to such appointment, execute, acknowledge and deliver to Parent and to the retiring Rights Agent an instrument accepting such appointment and a counterpart of this Agreement, and thereupon such successor Rights Agent, without any further act, deed or conveyance, will become vested with all the rights, powers, trusts and duties of the retiring Rights Agent. On request of Parent or the successor Rights Agent, the retiring Rights Agent will execute and deliver an instrument transferring to the successor Rights Agent all the rights (except such rights of the predecessor Rights Agent which survive pursuant to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3.3</font><font style="letter-spacing:0.2pt;"> of this Agreement), powers and trusts of the retiring Rights Agent. </font>
          </div>


          <div style="margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">4.&nbsp;&nbsp;&nbsp;COVENANTS </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">4.1</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;List of Holders.&nbsp;&nbsp;&nbsp;Parent will furnish or cause to be furnished to the Rights Agent in such form as Parent receives from Parent&#8217;s transfer agent (or other agent performing similar services for Parent), the names and addresses of the Holders within ten (10) Business Days of the Effective Time. Until such initial list of Holders is furnished to the Rights Agent, the Rights Agent shall have no duties, responsibilities or obligations with respect to such Holders. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">4.2</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Payment of CVR Payment Amounts. If a CVR Payment is due under </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.4(a)</font><font style="letter-spacing:0.2pt;">, Parent will deposit the CVR Payment with the Rights Agent for payment to the Holders in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.4(a)</font><font style="letter-spacing:0.2pt;">. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">4.3</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Roche Agreements.&nbsp;&nbsp;&nbsp;Without the prior written consent of the Acting Holders, neither Parent nor any of its Affiliates shall (a)&#160;amend, restate, supplement, terminate or otherwise modify the Roche Agreement in a manner materially adversely affecting the Holders&#8217; rights under this Agreement, (b)&#160;in the event that Roche fails to make a payment of a Roche Payment at the time rightfully due and payable, take action with respect to, or unreasonably waive or fail to enforce, the right to receive the applicable payments which are rightfully due and payable under the Roche Agreement, in a manner materially adversely affecting the Holders&#8217; rights under this Agreement or (c)&#160;agree to any of the foregoing. Without limiting the foregoing, Parent and its Affiliates shall pursue their rights under the Roche Agreement in good faith, and not take any action (or fail to take any action) with the intention of avoiding, reducing or materially delaying any payment to the Holders hereunder. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">4.4</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Records. Parent shall, and shall cause its Affiliates to, keep true, complete and accurate records in sufficient detail to enable the Holders and their consultants or professional advisors to confirm (a)&#160;whether the Roche Payment Amount or the Asset Disposition Proceeds have been received by Parent or its successors or Affiliates and (b)&#160;the applicable CVR Payment Amount payable to each Holder hereunder in accordance with the terms specified in this Agreement. </font>
          </div>


          <div style="margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">5.&nbsp;&nbsp;&nbsp;DISPOSITION </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">5.1</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;During the period specified in clause (b)&#160;of the definition of &#8220;CVR Term&#8221;, Parent will, and will cause its subsidiaries to, use commercially reasonable efforts to effectuate a Disposition, including the negotiation and execution of a Sale Agreement and completion of the transactions contemplated thereby. Further, Parent will not take any actions for the primary purpose of frustrating the payment of CVR Payments. </font>
          </div>

      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-10</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">

          <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
            <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">5.2</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The Holders acknowledge and agree that, except as expressly set forth in the foregoing Section&#160;5.1, (a)&#160;Parent has a fiduciary obligation to operate its business in the best interests of its stockholders, and any potential obligation to pay any potential Asset Disposition Proceeds or any other amounts will not create any express or implied obligation to operate its business in any particular manner in order to maximize any such CVR Payments, (b)&#160;the Holders are not relying on any representation of Parent or any other Person with regard to any Disposition or other action involving CVR Sale Assets following the Closing, and neither Parent nor any other Person has provided, or can provide, any assurance to the Holders that any potential Asset Disposition Proceeds or any other amounts will in fact be earned and paid, and (c)&#160;none of Parent or any of its Subsidiaries, officers or directors shall have any obligation or liability whatsoever to any Person relating to or in connection with any action, or failure to act, with respect to the sale of CVR Sale Assets. </font>
          </div>


          <div style="margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">6.&nbsp;&nbsp;&nbsp;AMENDMENTS </font>
          </div>


          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">6.1</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Amendments without Consent of Holders. </font>
          </div>


          <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;Without the consent of any Holders, Parent, when authorized by a Board Resolution, at any time and from time to time, and the Rights Agent may enter into one or more amendments hereto, solely to evidence any successor to or permitted Assignee of Parent and the assumption by any such successor or permitted Assignee of the covenants of Parent herein as provided in </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.3</font><font style="letter-spacing:0.2pt;">. </font>
          </div>


          <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;Without the consent of any Holders, Parent, when authorized by a Board Resolution, may, with the consent of the Rights Agent, which consent shall not be unreasonably withheld, conditioned or delayed, at any time and from time to time, enter into one or more amendments hereto, solely for any of the following purposes: </font>
          </div>


          <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">(i)&nbsp;&nbsp;&nbsp;to evidence the succession of another Person as a successor Rights Agent in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;3</font><font style="letter-spacing:0.2pt;"> and the assumption by any successor of the covenants and obligations of the Rights Agent herein; </font>
          </div>


          <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">(ii)&nbsp;&nbsp;&nbsp;to add to the covenants of Parent such further covenants, restrictions, conditions or provisions as Parent shall consider to be for the protection of the Holders; provided, that, in each case, such provisions do not adversely affect the interests of the Holders; </font>
          </div>


          <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">(iii)&nbsp;&nbsp;&nbsp;to cure any ambiguity, to correct or supplement any provision herein that may be defective or inconsistent with any other provision herein, or to make any other provisions with respect to matters or questions arising under this Agreement; provided, that, in each case, such provisions do not adversely affect the interests of the Holders; </font>
          </div>


          <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">(iv)&nbsp;&nbsp;&nbsp;as may be necessary or appropriate to ensure that the CVRs are not subject to registration under the Securities Act or the Exchange Act or any applicable state securities or &#8220;blue sky&#8221; laws; provided, that, in each case, such provisions do not adversely affect the interests of the Holders; </font>
          </div>


          <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">(v)&nbsp;&nbsp;&nbsp;to cancel any CVRs (A)&#160;in the event that any Holder has abandoned its rights in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.6</font><font style="letter-spacing:0.2pt;">, or (B)&#160;following a transfer of such CVRs to Parent or its Affiliates in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.2</font><font style="letter-spacing:0.2pt;"> or </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;2.3</font><font style="letter-spacing:0.2pt;">; </font>
          </div>


          <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">(vi)&nbsp;&nbsp;&nbsp;any other amendments hereto for the purpose of adding, eliminating or changing any provisions of this Agreement, unless such addition, elimination or change is adverse to the interests of the Holders; or </font>
          </div>


          <div style="text-indent:60pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">(vii)&nbsp;&nbsp;&nbsp;as may be necessary or appropriate to ensure that Parent complies with applicable Law. </font>
          </div>


          <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;Promptly after the execution by Parent and the Rights Agent of any amendment pursuant to the provisions of this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;6.1</font><font style="letter-spacing:0.2pt;">, Parent will transmit a notice thereof in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.1</font><font style="letter-spacing:0.2pt;"> to the Holders at their addresses as they appear on the CVR Register, setting forth in general terms the substance of such amendment. </font>
          </div>


          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">6.2</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Amendments with Consent of Holders. </font>
          </div>


          <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;Subject to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;6.1</font><font style="letter-spacing:0.2pt;"> (which amendments pursuant to </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;6.1</font><font style="letter-spacing:0.2pt;"> may be made without the consent of the Holders), with the consent of the Acting Holders, whether evidenced in writing or taken </font>
          </div>

      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-11</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">

          <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">at a meeting of such Holders, Parent, when authorized by a Board Resolution, and the Rights Agent may enter into one or more amendments hereto for the purpose of adding, eliminating or changing any provisions of this Agreement, even if such addition, elimination or change is materially adverse to the interest of the Holders. </font>
          </div>


          <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;Promptly after the execution by Parent, and the Rights Agent of any amendment pursuant to the provisions of this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;6.2</font><font style="letter-spacing:0.2pt;">, Parent will transmit (or cause the Rights Agent to transmit) a notice thereof in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.1</font><font style="letter-spacing:0.2pt;"> to the Holders at their addresses as they appear on the CVR Register, setting forth in general terms the substance of such amendment. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">6.3</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Execution of Amendments.&nbsp;&nbsp;&nbsp;In executing any amendment permitted by this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;6</font><font style="letter-spacing:0.2pt;">, the Rights Agent will be entitled to receive, and will be fully protected in relying upon, an opinion of counsel selected by Parent stating that the execution of such amendment is authorized or permitted by this Agreement. Notwithstanding anything contained herein, the Rights Agent may, but is not obligated to, enter into any such amendment that affects the Rights Agent&#8217;s own rights, privileges, covenants or duties under this Agreement or otherwise. No supplement or amendment to this Agreement shall be effective unless duly executed by the Rights Agent. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">6.4</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Effect of Amendments.&nbsp;&nbsp;&nbsp;Upon the execution of any amendment under this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;6</font><font style="letter-spacing:0.2pt;">, this Agreement will be modified in accordance therewith, such amendment will form a part of this Agreement for all purposes and every Holder will be bound thereby. </font>
          </div>


          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">7.&nbsp;&nbsp;&nbsp;OTHER PROVISIONS OF GENERAL APPLICATION </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">7.1</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Notices to Rights Agent and Parent.&nbsp;&nbsp;&nbsp;Any notice or other communication required or permitted hereunder shall be in writing and shall be deemed given when delivered and received hereunder (a)&#160;one Business Day after being sent for next Business Day delivery, fee prepared, via a reputable international overnight courier service, (b)&#160;upon delivery in the case of delivery by hand, or (c)&#160;on the date delivered in the place of delivery if sent by email (with a written or electronic confirmation of delivery) prior to 5:00&#160;p.m. New York time, otherwise on the next succeeding Business Day, in each case to the intended recipient as set forth below: </font>
          </div>


          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">If to the Rights Agent, to it at: </font>
          </div>


          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Computershare Inc. and Computershare Trust Company, N.A. </font> <br ><font style="letter-spacing:0.2pt;">150 Royall Street, 2nd Floor </font> <br ><font style="letter-spacing:0.2pt;">Canton, MA 02021 </font> <br ><font style="letter-spacing:0.2pt;">Attention: Relationship Manager </font></div>


          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">If to Parent, to it at: </font>
          </div>


          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Sesen Bio, Inc. </font>
          </div>


          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:0pt; margin-bottom:0pt; text-align:left; width:60pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">Telephone:</font>
            <br >
          </div>
          <div style=" margin-top:0pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:80pt;">
            <font style="letter-spacing:0.2pt;">[&#8226;] </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>


          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:0pt; margin-bottom:0pt; text-align:left; width:60pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">Email:</font>
            <br >
          </div>
          <div style=" margin-top:0pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:80pt;">
            <font style="letter-spacing:0.2pt;">[&#8226;] </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>


          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:0pt; margin-bottom:0pt; text-align:left; width:60pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">Attention:</font>
            <br >
          </div>
          <div style=" margin-top:0pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:80pt;">
            <font style="letter-spacing:0.2pt;">[&#8226;] </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>


          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">with a copy to: </font>
          </div>


          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">[&#8226;] </font>
          </div>


          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:0pt; margin-bottom:0pt; text-align:left; width:60pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">Telephone:</font>
            <br >
          </div>
          <div style=" margin-top:0pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:80pt;">
            <font style="letter-spacing:0.2pt;">[&#8226;] </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>


          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:0pt; margin-bottom:0pt; text-align:left; width:60pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">Email:</font>
            <br >
          </div>
          <div style=" margin-top:0pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:80pt;">
            <font style="letter-spacing:0.2pt;">[&#8226;] </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>


          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:0pt; margin-bottom:0pt; text-align:left; width:60pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">Attention:</font>
            <br >
          </div>
          <div style=" margin-top:0pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:80pt;">
            <font style="letter-spacing:0.2pt;">[&#8226;] </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">The Rights Agent or Parent may specify a different address, email address by giving notice to each other in accordance with this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.1</font><font style="letter-spacing:0.2pt;"> and to the Holders in accordance with </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.2</font><font style="letter-spacing:0.2pt;">. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">7.2</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Notice to Holders.&nbsp;&nbsp;&nbsp;Where this Agreement provides for notice to Holders, such notice will be sufficiently given (unless otherwise herein expressly provided) if in writing and mailed, first-class postage prepaid or, if applicable, transmitted through the facilities of DTC in accordance with DTC&#8217;s procedures, to each Holder affected by such event, at the Holder&#8217;s address as it appears in the CVR Register, not later </font>
          </div>

      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-12</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">

          <div style="width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">than the latest date, and not earlier than the earliest date, if any, prescribed for the giving of such notice. In any case where notice to Holders is given by mail, neither the failure to mail such notice, nor any defect in any notice so mailed, to any particular Holder will affect the sufficiency of such notice with respect to other Holders. </font>
          </div>


          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">7.3</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Parent Successors and Assigns. </font>
          </div>


          <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;Parent may not assign this Agreement without the prior written consent of the Acting Holders. Notwithstanding the foregoing (i)&#160;Parent may assign, in its sole discretion and without the consent of any other party, any or all of its rights, interests and obligations hereunder to one or more direct or indirect wholly-owned subsidiaries of Parent for so long as they remain wholly-owned subsidiaries of Parent (each, an &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Assignee</font><font style="letter-spacing:0.2pt;">&#8221;) and the Assignee agrees to assume and be bound by all of the terms of this Agreement; provided, however, that in connection with any assignment to an Assignee, Parent shall, and shall agree to, remain liable for the performance by such Assignee of all obligations of Parent hereunder, with such Assignee substituted for Parent under this Agreement, and (ii)&#160;Parent may assign this Agreement in its entirety without the consent of any other party to its successor in interest in connection with the sale of all or substantially all of its assets or of its stock, or in connection with a merger, acquisition or similar transaction (such successor in interest, the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Acquiror</font><font style="letter-spacing:0.2pt;">&#8221;, and such transaction, the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Acquisition</font><font style="letter-spacing:0.2pt;">&#8221;). This Agreement will be binding upon, inure to the benefit of and be enforceable by Parent&#8217;s successors, acquirers and each Assignee. Each reference to &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Parent</font><font style="letter-spacing:0.2pt;">&#8221; in this Agreement shall be deemed to include Parent&#8217;s successors, acquirers and all Assignees. Each of Parent&#8217;s successors, acquirers and assigns shall expressly assume by an instrument supplemental hereto, executed and delivered to the Rights Agent, the due and punctual payment of the CVR Payments and the due and punctual performance and observance of all of the covenants and obligations of this Agreement to be performed or observed by Parent. Notwithstanding anything to the contrary contained herein, no assignment pursuant to this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.3</font><font style="letter-spacing:0.2pt;"> shall relieve Parent of its obligations and liabilities to the Rights Agent hereunder, unless specifically agreed to in writing by the Rights Agent. </font>
          </div>


          <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;Any Person into which the Rights Agent or any successor Rights Agent may be merged or with which it may be consolidated, or any Person resulting from any merger or consolidation to which the Rights Agent or any successor Rights Agent shall be a party, or any Person succeeding to the stock transfer or other shareholder services business of the Rights Agent or any successor Rights Agent, shall be the successor to the Rights Agent under this Agreement without the execution or filing of any paper or any further act on the part of any of the parties hereto; provided, that such Person would be eligible for appointment as a successor Rights Agent under the provisions of this Agreement. The purchase of all or substantially all of the Rights Agent&#8217;s assets employed in the performance of transfer agent activities shall be deemed a merger or consolidation for purposes of this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.3(b)</font><font style="letter-spacing:0.2pt;">. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">7.4</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Benefits of Agreement;&nbsp;&nbsp;&nbsp;Action by Acting Holders. The holders shall be intended third-party beneficiaries hereof and shall be entitled to, solely by action by the written consent of the Acting Holders, specifically enforce the terms hereof; </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;"> that under no circumstances shall the rights of Holders as third-party beneficiaries pursuant to this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.4</font><font style="letter-spacing:0.2pt;"> be enforceable by such Holders or any other Person acting for or on their behalf other than through the action of the Acting Holders, which Acting Holders shall have the sole power and authority to act on behalf of the Holders in enforcing any of their rights hereunder. Nothing in this Agreement, express or implied, will give to any Person (other than the Rights Agent, Parent, Parent&#8217;s successors and permitted assignees, and the Holders and their respective successors and permitted assignees) any benefit or any legal or equitable right, remedy or claim under this Agreement or under any covenant or provision herein contained, all such covenants and provisions being for the sole benefit of the Rights Agent, Parent, Parent&#8217;s successors and permitted Assignees, and the Holders and their respective successors and permitted assignees. The rights of Holders are limited to those expressly provided in this Agreement and the Merger Agreement. Except for the rights of the Rights Agent set forth herein, the Acting Holders will have the sole right, on behalf of all Holders, by virtue of or under any provision of this Agreement, to institute any action or proceeding at law or in equity with respect to this Agreement, and no individual Holder or other group of Holders will be entitled to exercise such rights. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">7.5</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Governing Law.&nbsp;&nbsp;&nbsp;This Agreement, the CVRs and all claims and causes of action based upon, arising out of or in connection herewith shall be governed by, and construed in accordance with, the Laws of the State of Delaware, without regard to Laws that may be applicable under conflicts of laws principles </font>
          </div>

      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-13</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">

          <div style="width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">(whether of the State of Delaware or any other jurisdiction) that would cause the application of the Laws of any jurisdiction other than the State of Delaware. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">In any Legal Proceeding between any of the parties arising out of our relating to this Agreement, each of the parties hereby (i)&#160;irrevocably and unconditionally consent and submits, for itself and its property, to the exclusive jurisdiction and venue of the Court of Chancery of the State of Delaware, New Castle County, or, if such court does not have jurisdiction, the United States District Court for the District of Delaware or, to the extent that neither of the foregoing courts has jurisdiction, the Superior Court of the State of Delaware, (ii)&#160;agrees that any claim in respect of any such Legal Proceeding shall be heard and determined exclusively in accordance with clause (i)&#160;of this Section&#160;7.5, (iii)&#160;waives, to the fullest extent it may legally and effectively do so, any objection which it may now or hereafter have to the laying of venue of any such Legal Proceeding in any such court, (iv)&#160;waives, to the fullest extent permitted by Law, any objection that such courts are an inconvenient forum or do not have jurisdiction over any party, and (v)&#160;agrees that service of process upon such party in any such Legal Proceeding shall be effective if notice is given in accordance with Section&#160;7.1 of this Agreement. Nothing in this Section&#160;7.5, however, shall affect the right of any Person to serve legal process in any manner permitted by Law. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">7.6</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Severability.&nbsp;&nbsp;&nbsp;Any term or provision of this Agreement that is invalid or unenforceable in any situation in any jurisdiction shall not affect the validity or enforceability of the remaining terms and provisions of this Agreement or the validity or enforceability of the offending term or provision in any other situation or in any other jurisdiction. If any term or other provision of this Agreement is determined by a final judgement of a court of competent jurisdiction to be invalid or unenforceable, the parties agree that the court making such determination shall have the power to limit such term or provisions, to delete specific words or phrases or to replace such term or provision with a term or provision that is valid and enforceable and that comes closest to expressing the intention of the invalid or unenforceable term or provision, and this Agreement shall be valid and enforceable as so modified. Notwithstanding anything to the contrary herein, if any such excluded provision shall affect the rights, immunities, liabilities, duties or obligations of the Rights Agent, the Rights Agent shall be entitled to resign immediately upon written notice to Parent. In the event such court does not exercise the power granted to it in the prior sentence, the parties agree to replace such invalid or unenforceable term or provision with a valid and enforceable term or provision that will achieve, to the extent possible, the economic, business or other purposes of such invalid or unenforceable term or provision. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">7.7</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Counterparts and Signature.&nbsp;&nbsp;&nbsp;This Agreement may be signed in any number of counterparts, including by electronic transmission, each of which shall be an original, with the same effect as if the signatures thereto and hereto were upon the same instrument. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">7.8</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Termination.&nbsp;&nbsp;&nbsp;This Agreement will expire and be of no force or effect, the parties hereto will have no liability hereunder (other than with respect to monies due and owing by Parent to the Rights Agent or any other rights of the Rights Agent which expressly survive the termination of this Agreement), and no additional payments will be required to be made, upon the later of (i)&#160;the conclusion of the CVR Term, and (ii)&#160;the payment of the full amount of all CVR Payments made to Parent on or prior to the end of the applicable CVR Term to the Rights Agent and the payment of the full amount of all CVR Payment Amounts to the Holders by the mailing by the Rights Agent of each applicable CVR Payment Amount to each Holder at the address reflected in the CVR Register; provided that, for clarity, the term &#8220;CVR Term&#8221; as used in this </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Section&#160;7.8</font><font style="letter-spacing:0.2pt;"> shall be deemed to mean clause (a)&#160;of such definition with respect to any Roche Payment Amount, and shall be deemed to mean clause (b)&#160;of such definition with respect to any Asset Disposition Proceeds. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">7.9</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Funds.&nbsp;&nbsp;&nbsp;All funds received by the Rights Agent under this Agreement that are to be distributed or applied by Computershare in the performance of services hereunder (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Funds</font><font style="letter-spacing:0.2pt;">&#8221;) shall be held by Computershare as agent for Parent and deposited in one or more bank accounts to be maintained by Computershare in its name as agent for Parent. Until paid pursuant to the terms of this Agreement, Computershare will hold the Funds through such accounts in: deposit accounts of commercial banks with Tier 1 capital exceeding $1&#160;billion or with an average rating above investment grade by S&amp;P (LT Local Issuer Credit Rating), Moody&#8217;s (Long Term Rating) and Fitch Ratings, Inc. (LT Issuer Default Rating) (each as reported by Bloomberg Finance L.P.). The Rights Agent shall have no responsibility or liability for any diminution of the Funds that may result from any deposit made by the Rights Agent in accordance with this </font>
          </div>

      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-14</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:256pt;margin-left:69.66pt;width:456pt;">

          <div style="width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">paragraph, including any losses resulting from a default by any bank, financial institution or other Third Party. The Rights Agent may from time to time receive interest, dividends or other earnings in connection with such deposits. The Rights Agent shall not be obligated to pay such interest, dividends or earnings to Parent, any Holder or any other party. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">7.10</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Entire Agreement.&nbsp;&nbsp;&nbsp;As between Parent and the Holders, this Agreement and the Merger Agreement (including the schedules, annexes and exhibits thereto, the documents and instruments referred to therein and the documents delivered pursuant thereto) constitute the entire agreement of Parent and the Holders and supersede all prior agreements and undertakings, both written and oral, among Parent and the Holders, or any of them, with respect to the subject matter hereof and, except as otherwise expressly provided herein or therein, are not intended to confer upon any other Person any rights or remedies hereunder or thereunder. As between Parent and the Rights Agent, this Agreement (including the documents and instruments referred to herein (other than the Merger Agreement) and the documents delivered pursuant thereto) contains the entire understanding of the parties with reference to the transactions and matters contemplated hereby and thereby and supersedes all prior agreements, written or oral, among the parties with respect thereto. If and to the extent that any provision of this Agreement is inconsistent or conflicts with the Merger Agreement, this Agreement will govern and control. </font>
          </div>


          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">7.11</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Waiver of Jury Trial.&nbsp;&nbsp;&nbsp;EACH PARTY HEREBY WAIVES, TO THE FULLEST EXTENT PERMITTED BY LAW, ANY RIGHT TO TRIAL BY JURY OF ANY CLAIM, DEMAND, ACTION, OR CAUSE OF ACTION (i)&#160;ARISING UNDER THIS AGREEMENT OR (ii)&#160;IN ANY WAY CONNECTED WITH OR RELATED OR INCIDENTAL TO THE DEALINGS OF THE PARTIES HERETO IN RESPECT OF THIS AGREEMENT OR ANY OF THE TRANSACTIONS CONTEMPLATED HEREBY, IN EACH CASE WHETHER NOW EXISTING OR HEREAFTER ARISING, AND WHETHER IN CONTRACT, TORT, EQUITY, OR OTHERWISE. EACH PARTY HEREBY AGREES AND CONSENTS THAT ANY SUCH CLAIM, DEMAND, ACTION, OR CAUSE OF ACTION SHALL BE DECIDED BY COURT TRIAL WITHOUT A JURY AND THAT THE PARTIES TO THIS AGREEMENT MAY FILE AN ORIGINAL COUNTERPART OF A COPY OF THIS AGREEMENT WITH ANY COURT AS WRITTEN EVIDENCE OF THE CONSENT OF THE PARTIES HERETO TO THE WAIVER OF THEIR RIGHT TO TRIAL BY JURY.</font>
          </div>


          <div style="margin-top:8pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">[</font><font style="font-style:italic;letter-spacing:0.2pt;">Remainder of page intentionally left blank</font><font style="letter-spacing:0.2pt;">] </font>
          </div>

      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-15</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;height:660pt;margin-left:69.66pt;width:456pt;">

          <div style="text-indent:20pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">IN WITNESS WHEREOF, each of the parties has caused this Agreement to be executed on its behalf by its duly authorized officers as of the day and year first above written. </font>
          </div>


          <table style="width:468pt;height:183pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 1.5pt 0pt; width:0pt;" colspan="4">
                <font style="letter-spacing:0.2pt;">SESEN BIO, INC.</font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:204pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:11.5pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:15.5pt 0pt 0.5pt 0pt; width:24pt;">
                <font style="letter-spacing:0.2pt;">By:</font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:15.5pt 0pt 0.5pt 0pt; width:204pt;white-space:normal;">
                <div>
                  <font style="letter-spacing:0.2pt;">&#8199;</font>
                  <br >
                </div>
                <div style="margin-top:2.5pt; text-align:justify;">
                  <div style="margin-left: 0pt; width: 204pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:204pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td colspan="3">&#8203;</td>
            </tr>
            <tr style="line-height:11.5pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2pt 0pt 1.5pt 0pt; width:24pt;">
                <font style="letter-spacing:0.2pt;">Name: </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2pt 0pt 1.5pt 0pt; width:204pt;white-space:normal;">
                <div>
                  <font style="letter-spacing:0.2pt;">&#8199;</font>
                  <br >
                </div>
                <div style="margin-top:2.5pt; text-align:justify;">
                  <div style="margin-left: 0pt; width: 204pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:204pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td colspan="3">&#8203;</td>
            </tr>
            <tr style="line-height:11.5pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:4pt 0pt 1.5pt 0pt; width:24pt;">
                <font style="letter-spacing:0.2pt;">Title:</font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:4pt 0pt 1.5pt 0pt; width:204pt;white-space:normal;">
                <div>
                  <font style="letter-spacing:0.2pt;">&#8199;</font>
                  <br >
                </div>
                <div style="margin-top:2.5pt; text-align:justify;">
                  <div style="margin-left: 0pt; width: 204pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:204pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td colspan="3">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:15.667pt 0pt 1.5pt 0pt; width:0pt;" colspan="4">
                <font style="letter-spacing:0.2pt;">COMPUTERSHARE INC. and COMPUTERSHARE TRUSTCOMPANY, N.A., jointly as RIGHTS AGENT</font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:204pt;white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td colspan="3">&#8203;</td>
            </tr>
            <tr style="line-height:11.5pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:15.5pt 0pt 0.5pt 0pt; width:24pt;">
                <font style="letter-spacing:0.2pt;">By:</font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:15.5pt 0pt 0.5pt 0pt; width:204pt;white-space:normal;">
                <div>
                  <font style="letter-spacing:0.2pt;">&#8199;</font>
                  <br >
                </div>
                <div style="margin-top:2.5pt; text-align:justify;">
                  <div style="margin-left: 0pt; width: 204pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:204pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td colspan="3">&#8203;</td>
            </tr>
            <tr style="line-height:11.5pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2pt 0pt 1.5pt 0pt; width:24pt;">
                <font style="letter-spacing:0.2pt;">Name: </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2pt 0pt 1.5pt 0pt; width:204pt;white-space:normal;">
                <div>
                  <font style="letter-spacing:0.2pt;">&#8199;</font>
                  <br >
                </div>
                <div style="margin-top:2.5pt; text-align:justify;">
                  <div style="margin-left: 0pt; width: 204pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:204pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td colspan="3">&#8203;</td>
            </tr>
            <tr style="line-height:11.5pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:4pt 0pt 1.5pt 0pt; width:24pt;">
                <font style="letter-spacing:0.2pt;">Title:</font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:4pt 0pt 1.5pt 0pt; width:204pt;white-space:normal;">
                <div>
                  <font style="letter-spacing:0.2pt;">&#8199;</font>
                  <br >
                </div>
                <div style="margin-top:2.5pt; text-align:justify;">
                  <div style="margin-left: 0pt; width: 204pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; width:204pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td colspan="3">&#8203;</td>
            </tr>
          </table>

        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;"> </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a><a name="AnnexG">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:58pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; text-align:right; width:436pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ANNEX G</font>&#8203;</div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">FORM OF CERTIFICATE OF AMENDMENT </font>
          <br >
          <font style="letter-spacing:-0.2pt;">TO THE RESTATED CERTIFICATE OF INCORPORATION OF </font>
          <br >
          <font style="letter-spacing:-0.2pt;">SESEN BIO, INC.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio, Inc., a corporation organized and existing under the laws of the State of Delaware (the &#8220;Corporation&#8221;) hereby certifies as follows: </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">FIRST:</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;That the Board of Directors of the Corporation adopted resolutions setting forth the proposed amendment to the Restated Certificate of Incorporation of the Corporation, declaring said amendment to be advisable and in the best interests of the Corporation and its stockholders in accordance with Section&#160;242 of the Delaware General Corporation Law (the &#8220;DGCL&#8221;). The resolution setting forth the proposed amendment is as follows: </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">RESOLVED</font><font style="letter-spacing:0.2pt;">, the first paragraph of Article&#160;FOURTH shall be amended and restated to read in its entirety as follows: </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The total number of shares of all classes of stock which the Corporation shall have authority to issue is 105,000,000 shares, consisting of (i)&#160;100,000,000 shares of Common Stock, $0.001 par value per share (&#8220;Common Stock&#8221;), and (ii)&#160;5,000,000 shares of Preferred Stock, $0.001 par value per share (&#8220;Preferred Stock&#8221;). </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Upon the filing and effectiveness (the &#8220;Effective Time&#8221;) of this Certificate of Amendment to the Restated Certificate of Incorporation with the Secretary of State of the State of Delaware, every 20&#160;shares of Common Stock issued and outstanding immediately prior to the Effective Time shall, automatically and without any action on the part of the Corporation or the respective holder thereof, be combined into one validly issued, fully paid and non-assessable share of Common Stock (the &#8220;Reverse Stock Split&#8221;). No fractional shares of Common Stock shall be issued as a result of the Reverse Stock Split and, in lieu thereof, the Corporation shall pay cash equal to such fraction multiplied by the fair market value per share of Common Stock immediately prior to the Effective Time, as determined by the Board of Directors of the Corporation. The Reverse Stock Split shall occur whether or not the certificates representing such shares of Common Stock are surrendered to the Corporation or its transfer agent.&#8221; </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">SECOND:</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The Certificate of Amendment to the Restated Certificate of Incorporation has been duly adopted in accordance with the provisions of Section&#160;242 of the DGCL. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">THIRD:</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;That except as amended hereby, the provisions of the Restated Certificate of Incorporation shall remain in full force and effect. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">FOURTH:</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;This Certificate of Amendment shall be effective as of </font><font style=" white-space:pre; text-decoration:underline #000000 solid;letter-spacing:0.2pt;">&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199; &#8199;&#8199;</font><font style="letter-spacing:0.2pt;">, </font><font style=" white-space:pre; text-decoration:underline #000000 solid;letter-spacing:0.2pt;">&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199; &#8199;&#8199;</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">IN WITNESS WHEREOF, I have signed this Certificate this </font><font style=" white-space:pre; text-decoration:underline #000000 solid;letter-spacing:0.2pt;">&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199; &#8199;&#8199;</font><font style="letter-spacing:0.2pt;"> day of </font><font style=" white-space:pre; text-decoration:underline #000000 solid;letter-spacing:0.2pt;">&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199; &#8199;&#8199;</font><font style="letter-spacing:0.2pt;">, </font><font style=" white-space:pre; text-decoration:underline #000000 solid;letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:220pt; margin-top:8pt; width:236pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">SESEN BIO, INC.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:220pt; margin-top:8pt; width:236pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;</font>
        </div>
        <div style="margin-left:220pt; margin-top:2.5pt; width:236pt;">
          <div style="margin-left: 0pt; width: 236pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-left:220pt; margin-top:2pt; width:236pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Thomas R. Cannell, D.V.M. </font>
          <br >
          <font style="letter-spacing:0.2pt;">President and Chief Executive Officer</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">G-1</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a><a name="tANNH">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; text-align:right; width:436pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ANNEX H</font>&#8203;</div>
        <div style="margin-top:8pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Section&#160;262 of the Delaware General Corporation Law </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#167;&#160;262. Appraisal rights </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a) Any stockholder of a corporation of this State who holds shares of stock on the date of the making of a demand pursuant to subsection (d)&#160;of this section with respect to such shares, who continuously holds such shares through the effective date of the merger, consolidation, or conversion, who has otherwise complied with subsection (d)&#160;of this section and who has neither voted in favor of the merger, consolidation or conversion nor consented thereto in writing pursuant to &#167;&#160;228 of this title shall be entitled to an appraisal by the Court of Chancery of the fair value of the stockholder&#8217;s shares of stock under the circumstances described in subsections (b)&#160;and (c)&#160;of this section. As used in this section, the word &#8220;stockholder&#8221; means a holder of record of stock in a corporation; the words &#8220;stock&#8221; and &#8220;share&#8221; mean and include what is ordinarily meant by those words; the words &#8220;depository receipt&#8221; mean a receipt or other instrument issued by a depository representing an interest in 1 or more shares, or fractions thereof, solely of stock of a corporation, which stock is deposited with the depository; the words &#8220;beneficial owner&#8221; mean a person who is the beneficial owner of shares of stock held either in voting trust or by a nominee on behalf of such person; and the word &#8220;person&#8221; means any individual, corporation, partnership, unincorporated association or other entity. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b) Appraisal rights shall be available for the shares of any class or series of stock of a constituent or converting corporation in a merger, consolidation or conversion to be effected pursuant to &#167;&#160;251 (other than a merger effected pursuant to &#167;&#160;251(g) of this title), &#167;&#160;252, &#167;&#160;254, &#167;&#160;255, &#167;&#160;256, &#167;&#160;257, &#167;&#160;258, &#167;&#160;263, &#167;&#160;264 or &#167;&#160;266 of this title (other than, in each case and solely with respect to a domesticated corporation, a merger, consolidation or conversion authorized pursuant to and in accordance with the provisions of &#167;&#160;388 of this title): </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(1) Provided, however, that no appraisal rights under this section shall be available for the shares of any class or series of stock, which stock, or depository receipts in respect thereof, at the record date fixed to determine the stockholders entitled to receive notice of the meeting of stockholders, or at the record date fixed to determine the stockholders entitled to consent pursuant to &#167;&#160;228 of this title, to act upon the agreement of merger or consolidation or the resolution providing for conversion (or, in the case of a merger pursuant to &#167;&#160;251(h) of this title, as of immediately prior to the execution of the agreement of merger), were either: (i)&#160;listed on a national securities exchange or (ii)&#160;held of record by more than 2,000 holders; and further provided that no appraisal rights shall be available for any shares of stock of the constituent corporation surviving a merger if the merger did not require for its approval the vote of the stockholders of the surviving corporation as provided in &#167;&#160;251(f) of this title. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(2) Notwithstanding paragraph (b)(1) of this section, appraisal rights under this section shall be available for the shares of any class or series of stock of a constituent or converting corporation if the holders thereof are required by the terms of an agreement of merger or consolidation, or by the terms of a resolution providing for conversion, pursuant to &#167;&#8201;251, &#167;&#8201;252, &#167;&#8201;254, &#167;&#8201;255, &#167;&#8201;256, &#167;&#8201;257, &#167;&#8201;258, &#167;&#8201;263, &#167;&#8201;264 or &#167;&#8201;266 of this title to accept for such stock anything except: </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">a. Shares of stock of the corporation surviving or resulting from such merger or consolidation, or of the converted entity if such entity is a corporation as a result of the conversion, or depository receipts in respect thereof; </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">b. Shares of stock of any other corporation, or depository receipts in respect thereof, which shares of stock (or depository receipts in respect thereof) or depository receipts at the effective date of the merger, consolidation or conversion will be either listed on a national securities exchange or held of record by more than 2,000 holders; </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">c. Cash in lieu of fractional shares or fractional depository receipts described in the foregoing paragraphs (b)(2)a. and b. of this section; or </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">d. Any combination of the shares of stock, depository receipts and cash in lieu of fractional shares or fractional depository receipts described in the foregoing paragraphs (b)(2)a., b. and c. of this section. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">H-1</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(3) In the event all of the stock of a subsidiary Delaware corporation party to a merger effected under &#167;&#160;253 or &#167;&#160;267 of this title is not owned by the parent immediately prior to the merger, appraisal rights shall be available for the shares of the subsidiary Delaware corporation. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(4) [Repealed.] </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(c) Any corporation may provide in its certificate of incorporation that appraisal rights under this section shall be available for the shares of any class or series of its stock as a result of an amendment to its certificate of incorporation, any merger or consolidation in which the corporation is a constituent corporation, the sale of all or substantially all of the assets of the corporation or a conversion effected pursuant to &#167;&#160;266 of this title. If the certificate of incorporation contains such a provision, the provisions of this section, including those set forth in subsections (d), (e), and (g)&#160;of this section, shall apply as nearly as is practicable. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(d) Appraisal rights shall be perfected as follows: </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(1) If a proposed merger, consolidation or conversion for which appraisal rights are provided under this section is to be submitted for approval at a meeting of stockholders, the corporation, not less than 20&#160;days prior to the meeting, shall notify each of its stockholders who was such on the record date for notice of such meeting (or such members who received notice in accordance with &#167;&#160;255(c) of this title) with respect to shares for which appraisal rights are available pursuant to subsection (b)&#160;or (c)&#160;of this section that appraisal rights are available for any or all of the shares of the constituent corporations or the converting corporation, and shall include in such notice either a copy of this section (and, if 1 of the constituent corporations or the converting corporation is a nonstock corporation, a copy of &#167;&#160;114 of this title) or information directing the stockholders to a publicly available electronic resource at which this section (and, &#167;&#160;114 of this title, if applicable) may be accessed without subscription or cost. Each stockholder electing to demand the appraisal of such stockholder&#8217;s shares shall deliver to the corporation, before the taking of the vote on the merger, consolidation or conversion, a written demand for appraisal of such stockholder&#8217;s shares; provided that a demand may be delivered to the corporation by electronic transmission if directed to an information processing system (if any) expressly designated for that purpose in such notice. Such demand will be sufficient if it reasonably informs the corporation of the identity of the stockholder and that the stockholder intends thereby to demand the appraisal of such stockholder&#8217;s shares. A proxy or vote against the merger, consolidation or conversion shall not constitute such a demand. A stockholder electing to take such action must do so by a separate written demand as herein provided. Within 10&#160;days after the effective date of such merger, consolidation or conversion, the surviving, resulting or converted entity shall notify each stockholder of each constituent or converting corporation who has complied with this subsection and has not voted in favor of or consented to the merger, consolidation or conversion, and any beneficial owner who has demanded appraisal under paragraph (d)(3) of this section, of the date that the merger, consolidation or conversion has become effective; or </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(2) If the merger, consolidation or conversion was approved pursuant to &#167;&#160;228, &#167;&#160;251(h), &#167;&#160;253, or &#167;&#160;267 of this title, then either a constituent or converting corporation before the effective date of the merger, consolidation or conversion, or the surviving, resulting or converted entity within 10&#160;days after such effective date, shall notify each stockholder of any class or series of stock of such constituent or converting corporation who is entitled to appraisal rights of the approval of the merger, consolidation or conversion and that appraisal rights are available for any or all shares of such class or series of stock of such constituent or converting corporation, and shall include in such notice either a copy of this section (and, if 1 of the constituent corporations or the converting corporation is a nonstock corporation, a copy of &#167;&#160;114 of this title) or information directing the stockholders to a publicly available electronic resource at which this section (and &#167;&#160;114 of this title, if applicable) may be accessed without subscription or cost. Such notice may, and, if given on or after the effective date of the merger, consolidation or conversion, shall, also notify such stockholders of the effective date of the merger, consolidation or conversion. Any stockholder entitled to appraisal rights may, within 20&#160;days after the date of giving such notice or, in the case of a merger approved pursuant to &#167;&#160;251(h) of this title, within the later of the consummation of the offer contemplated by &#167;&#160;251(h) of this title and 20&#160;days after the date of giving such notice, demand in writing from the surviving or resulting entity the appraisal of such holder&#8217;s shares; provided that a demand may be delivered to such entity by electronic transmission if directed to an information processing system (if any) expressly designated for that purpose in such notice. Such </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">H-2</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">demand will be sufficient if it reasonably informs such entity of the identity of the stockholder and that the stockholder intends thereby to demand the appraisal of such holder&#8217;s shares. If such notice did not notify stockholders of the effective date of the merger, consolidation or conversion, either (i)&#160;each such constituent corporation or the converting corporation shall send a second notice before the effective date of the merger, consolidation or conversion notifying each of the holders of any class or series of stock of such constituent or converting corporation that are entitled to appraisal rights of the effective date of the merger, consolidation or conversion or (ii)&#160;the surviving, resulting or converted entity shall send such a second notice to all such holders on or within 10&#160;days after such effective date; provided, however, that if such second notice is sent more than 20&#160;days following the sending of the first notice or, in the case of a merger approved pursuant to &#167;&#160;251(h) of this title, later than the later of the consummation of the offer contemplated by &#167;&#160;251(h) of this title and 20&#160;days following the sending of the first notice, such second notice need only be sent to each stockholder who is entitled to appraisal rights and who has demanded appraisal of such holder&#8217;s shares in accordance with this subsection and any beneficial owner who has demanded appraisal under paragraph (d)(3) of this section. An affidavit of the secretary or assistant secretary or of the transfer agent of the corporation or entity that is required to give either notice that such notice has been given shall, in the absence of fraud, be prima facie evidence of the facts stated therein. For purposes of determining the stockholders entitled to receive either notice, each constituent corporation or the converting corporation may fix, in advance, a record date that shall be not more than 10&#160;days prior to the date the notice is given, provided, that if the notice is given on or after the effective date of the merger, consolidation or conversion, the record date shall be such effective date. If no record date is fixed and the notice is given prior to the effective date, the record date shall be the close of business on the day next preceding the day on which the notice is given. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(3) Notwithstanding subsection (a)&#160;of this section (but subject to this paragraph (d)(3)), a beneficial owner may, in such person&#8217;s name, demand in writing an appraisal of such beneficial owner&#8217;s shares in accordance with either paragraph (d)(1) or (2)&#160;of this section, as applicable; provided that (i)&#160;such beneficial owner continuously owns such shares through the effective date of the merger, consolidation or conversion and otherwise satisfies the requirements applicable to a stockholder under the first sentence of subsection (a)&#160;of this section and (ii)&#160;the demand made by such beneficial owner reasonably identifies the holder of record of the shares for which the demand is made, is accompanied by documentary evidence of such beneficial owner&#8217;s beneficial ownership of stock and a statement that such documentary evidence is a true and correct copy of what it purports to be, and provides an address at which such beneficial owner consents to receive notices given by the surviving, resulting or converted entity hereunder and to be set forth on the verified list required by subsection (f)&#160;of this section. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(e) Within 120&#160;days after the effective date of the merger, consolidation or conversion, the surviving, resulting or converted entity, or any person who has complied with subsections (a)&#160;and (d)&#160;of this section hereof and who is otherwise entitled to appraisal rights, may commence an appraisal proceeding by filing a petition in the Court of Chancery demanding a determination of the value of the stock of all such stockholders. Notwithstanding the foregoing, at any time within 60&#160;days after the effective date of the merger, consolidation or conversion, any person entitled to appraisal rights who has not commenced an appraisal proceeding or joined that proceeding as a named party shall have the right to withdraw such person&#8217;s demand for appraisal and to accept the terms offered upon the merger, consolidation or conversion. Within 120&#160;days after the effective date of the merger, consolidation or conversion, any person who has complied with the requirements of subsections (a)&#160;and (d)&#160;of this section hereof, upon request given in writing (or by electronic transmission directed to an information processing system (if any) expressly designated for that purpose in the notice of appraisal), shall be entitled to receive from the surviving, resulting or converted entity a statement setting forth the aggregate number of shares not voted in favor of the merger, consolidation or conversion (or, in the case of a merger approved pursuant to &#167;&#160;251(h) of this title, the aggregate number of shares (other than any excluded stock (as defined in &#167;&#160;251(h)(6)d. of this title)) that were the subject of, and were not tendered into, and accepted for purchase or exchange in, the offer referred to in &#167;&#160;251(h)(2) of this title)), and, in either case, with respect to which demands for appraisal have been received and the aggregate number of stockholders or beneficial owners holding or owning such shares (provided that, where a beneficial owner makes a demand pursuant to paragraph (d)(3) of this section, the record holder of such shares shall not be considered a separate stockholder holding such shares for purposes of such aggregate number). Such statement shall be given to the person within 10&#160;days after such person&#8217;s request </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">H-3</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">for such a statement is received by the surviving, resulting or converted entity or within 10&#160;days after expiration of the period for delivery of demands for appraisal under subsection (d)&#160;of this section hereof, whichever is later. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(f) Upon the filing of any such petition by any person other than the surviving, resulting or converted entity, service of a copy thereof shall be made upon such entity, which shall within 20&#160;days after such service file in the office of the Register in Chancery in which the petition was filed a duly verified list containing the names and addresses of all persons who have demanded appraisal for their shares and with whom agreements as to the value of their shares have not been reached by such entity. If the petition shall be filed by the surviving, resulting or converted entity, the petition shall be accompanied by such a duly verified list. The Register in Chancery, if so ordered by the Court, shall give notice of the time and place fixed for the hearing of such petition by registered or certified mail to the surviving, resulting or converted entity and to the persons shown on the list at the addresses therein stated. The forms of the notices by mail and by publication shall be approved by the Court, and the costs thereof shall be borne by the surviving, resulting or converted entity. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(g) At the hearing on such petition, the Court shall determine the persons who have complied with this section and who have become entitled to appraisal rights. The Court may require the persons who have demanded an appraisal for their shares and who hold stock represented by certificates to submit their certificates of stock to the Register in Chancery for notation thereon of the pendency of the appraisal proceedings; and if any person fails to comply with such direction, the Court may dismiss the proceedings as to such person. If immediately before the merger, consolidation or conversion the shares of the class or series of stock of the constituent or converting corporation as to which appraisal rights are available were listed on a national securities exchange, the Court shall dismiss the proceedings as to all holders of such shares who are otherwise entitled to appraisal rights unless (1)&#160;the total number of shares entitled to appraisal exceeds 1% of the outstanding shares of the class or series eligible for appraisal, (2)&#160;the value of the consideration provided in the merger, consolidation or conversion for such total number of shares exceeds $1&#160;million, or (3)&#160;the merger was approved pursuant to &#167;&#160;253 or &#167;&#160;267 of this title. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(h) After the Court determines the persons entitled to an appraisal, the appraisal proceeding shall be conducted in accordance with the rules of the Court of Chancery, including any rules specifically governing appraisal proceedings. Through such proceeding the Court shall determine the fair value of the shares exclusive of any element of value arising from the accomplishment or expectation of the merger, consolidation or conversion, together with interest, if any, to be paid upon the amount determined to be the fair value. In determining such fair value, the Court shall take into account all relevant factors. Unless the Court in its discretion determines otherwise for good cause shown, and except as provided in this subsection, interest from the effective date of the merger, consolidation or conversion through the date of payment of the judgment shall be compounded quarterly and shall accrue at 5% over the Federal Reserve discount rate (including any surcharge) as established from time to time during the period between the effective date of the merger, consolidation or conversion and the date of payment of the judgment. At any time before the entry of judgment in the proceedings, the surviving, resulting or converted entity may pay to each person entitled to appraisal an amount in cash, in which case interest shall accrue thereafter as provided herein only upon the sum of (1)&#160;the difference, if any, between the amount so paid and the fair value of the shares as determined by the Court, and (2)&#160;interest theretofore accrued, unless paid at that time. Upon application by the surviving, resulting or converted entity or by any person entitled to participate in the appraisal proceeding, the Court may, in its discretion, proceed to trial upon the appraisal prior to the final determination of the persons entitled to an appraisal. Any person whose name appears on the list filed by the surviving, resulting or converted entity pursuant to subsection (f)&#160;of this section may participate fully in all proceedings until it is finally determined that such person is not entitled to appraisal rights under this section. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(i) The Court shall direct the payment of the fair value of the shares, together with interest, if any, by the surviving, resulting or converted entity to the persons entitled thereto. Payment shall be so made to each such person upon such terms and conditions as the Court may order. The Court&#8217;s decree may be enforced as other decrees in the Court of Chancery may be enforced, whether such surviving, resulting or converted entity be an entity of this State or of any state. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(j) The costs of the proceeding may be determined by the Court and taxed upon the parties as the Court deems equitable in the circumstances. Upon application of a person whose name appears on the list filed by </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">H-4</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:264pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">the surviving, resulting or converted entity pursuant to subsection (f)&#160;of this section who participated in the proceeding and incurred expenses in connection therewith, the Court may order all or a portion of such expenses, including, without limitation, reasonable attorney&#8217;s fees and the fees and expenses of experts, to be charged pro&#160;rata against the value of all the shares entitled to an appraisal not dismissed pursuant to subsection (k)&#160;of this section or subject to such an award pursuant to a reservation of jurisdiction under subsection (k)&#160;of this section. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(k) From and after the effective date of the merger, consolidation or conversion, no person who has demanded appraisal rights with respect to some or all of such person&#8217;s shares as provided in subsection (d)&#160;of this section shall be entitled to vote such shares for any purpose or to receive payment of dividends or other distributions on such shares (except dividends or other distributions payable to stockholders of record at a date which is prior to the effective date of the merger, consolidation or conversion); provided, however, that if no petition for an appraisal is filed within the time provided in subsection (e)&#160;of this section, or if a person who has made a demand for an appraisal in accordance with this section shall deliver to the surviving, resulting or converted entity a written withdrawal of such person&#8217;s demand for an appraisal in respect of some or all of such person&#8217;s shares in accordance with subsection (e)&#160;of this section, then the right of such person to an appraisal of the shares subject to the withdrawal shall cease. Notwithstanding the foregoing, no appraisal proceeding in the Court of Chancery shall be dismissed as to any person without the approval of the Court, and such approval may be conditioned upon such terms as the Court deems just, including without limitation, a reservation of jurisdiction for any application to the Court made under subsection (j)&#160;of this section; provided, however that this provision shall not affect the right of any person who has not commenced an appraisal proceeding or joined that proceeding as a named party to withdraw such person&#8217;s demand for appraisal and to accept the terms offered upon the merger, consolidation or conversion within 60&#160;days after the effective date of the merger, consolidation or conversion, as set forth in subsection (e)&#160;of this section. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(l) The shares or other equity interests of the surviving, resulting or converted entity to which the shares of stock subject to appraisal under this section would have otherwise converted but for an appraisal demand made in accordance with this section shall have the status of authorized but not outstanding shares of stock or other equity interests of the surviving, resulting or converted entity, unless and until the person that has demanded appraisal is no longer entitled to appraisal pursuant to this section.</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">H-5</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a><a name="tAnnexI">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; text-align:right; width:436pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ANNEX I</font>&#8203;</div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:11.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">SESEN BIO, INC.</font>
          <br >
          <font style="letter-spacing:-0.2pt;">AMENDED AND RESTATED 2014 STOCK INCENTIVE PLAN</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.71pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">1.</font>
          <br >
        </div>
        <div style=" margin-top:7.71pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Purpose</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The purpose of this Amended and Restated 2014 Stock Incentive Plan (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Plan</font><font style="letter-spacing:0.2pt;">&#8221;) of Sesen Bio, Inc., a Delaware corporation (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company</font><font style="letter-spacing:0.2pt;">&#8221;), is to advance the interests of the Company&#8217;s stockholders by enhancing the Company&#8217;s ability to attract, retain and motivate persons who are expected to make important contributions to the Company and by providing such persons with equity ownership opportunities and performance-based incentives that are intended to better align the interests of such persons with those of the Company&#8217;s stockholders. The Plan amends and restates the 2014 Stock Incentive Plan (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Original Plan</font><font style="letter-spacing:0.2pt;">&#8221;) that was originally adopted by the board of directors of the Company (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Board</font><font style="letter-spacing:0.2pt;">&#8221;) in December&#160;2013 and approved by the Company&#8217;s stockholders in January&#160;2014, was amended by the Board on April&#160;19, 2019 and approved by the Company&#8217;s stockholders on June&#160;19, 2019 and was amended by the Board on March&#160;12, 2021 and approved by the Company&#8217;s stockholders on May&#160;3, 2021. Except where the context otherwise requires, the term &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company</font><font style="letter-spacing:0.2pt;">&#8221; shall include any of the Company&#8217;s present or future parent or subsidiary corporations as defined in Sections&#160;424(e) or (f)&#160;of the Internal Revenue Code of 1986, as amended, and any regulations thereunder (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Code</font><font style="letter-spacing:0.2pt;">&#8221;) and any other business venture (including, without limitation, joint venture or limited liability company) in which the Company has a controlling interest, as determined by the Board. </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">2.</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Eligibility</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">All of the Company&#8217;s employees, officers and directors, as well as consultants and advisors to the Company (as such terms consultants and advisors are defined and interpreted for purposes of Form S-8 under the Securities Act of 1933, as amended (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Securities Act</font><font style="letter-spacing:0.2pt;">&#8221;) (or any successor form)) are eligible to be granted Awards under the Plan. Each person who is granted an Award under the Plan is deemed a &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Participant</font><font style="font-style:italic;letter-spacing:0.2pt;">.</font><font style="letter-spacing:0.2pt;">&#8221; &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Award</font><font style="letter-spacing:0.2pt;">&#8221; means Options (as defined in Section&#160;5), SARs (as defined in Section&#160;6), Restricted Stock (as defined in Section&#160;7), Restricted Stock Units (as defined in Section&#160;7) and Other Stock-Based Awards (as defined in Section&#160;8). </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">3.</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Administration and Delegation</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Administration by Board of Directors</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Plan will be administered by the Board. The Board shall have authority to grant Awards and to adopt, amend and repeal such administrative rules, guidelines and practices relating to the Plan as it shall deem advisable. The Board may construe and interpret the terms of the Plan and any Award agreements entered into under the Plan. The Board may correct any defect, supply any omission or reconcile any inconsistency in the Plan or any Award in the manner and to the extent it shall deem expedient and it shall be the sole and final judge of such expediency. All decisions by the Board shall be made in the Board&#8217;s sole discretion and shall be final and binding on all persons having or claiming any interest in the Plan or in any Award. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Appointment of Committees</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;To the extent permitted by applicable law, the Board may delegate any or all of its powers under the Plan to one or more committees or subcommittees of the Board (each, a &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Committee</font><font style="letter-spacing:0.2pt;">&#8221;). All references in the Plan to the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Board</font><font style="letter-spacing:0.2pt;">&#8221; shall mean the Board or a Committee of the Board or the Delegated Persons referred to in Section&#160;3(c) to the extent that the Board&#8217;s powers or authority under the Plan have been delegated to such Committee or such Delegated Persons. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Delegation to Delegated Persons</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Subject to any requirements of applicable law (including as applicable Sections&#160;152(b) and 157(c) of the General Corporation Law of the State of Delaware), the Board may, by resolution, delegate to one or more persons (including officers of the Company) or bodies (such persons or bodies, the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Delegated Persons</font><font style="letter-spacing:0.2pt;">&#8221;) the power to grant Awards (subject to any limitations under the Plan) to eligible service providers of the Company and to exercise such other powers under the Plan as the Board may determine, provided that the Board shall fix: (i)&#160;the maximum number of Awards, and the maximum number of shares issuable upon exercise thereof, that may be issued by such Delegated Persons, (ii)&#160;the time period during which such Awards, and during which the </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">I-1</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">shares issuable upon exercise thereof, may be issued, and (iii)&#160;the minimum amount of consideration (if any) for which such Awards may be issued, and a minimum amount of consideration for the shares issuable upon exercise thereof; and provided further, that no Delegated Person shall be authorized to grant Awards to itself; and provided further, that no Delegated Person shall be authorized to grant Awards to any &#8220;executive officer&#8221; of the Company (as defined by Rule&#160;3b-7 under the Securities Exchange Act of 1934, as amended (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Exchange Act</font><font style="letter-spacing:0.2pt;">&#8221;)) or to any &#8220;officer&#8221; of the Company (as defined by Rule&#160;16a-1(f) under the Exchange Act). </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">4.&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Stock Available for Awards</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Number of Shares; Share Counting</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(1)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Authorized Number of Shares</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Subject to adjustment under Section&#160;9, Awards may be made under the Plan for up to such number of shares of common stock, $0.001 par value per share, of the Company (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Common Stock</font><font style="letter-spacing:0.2pt;">&#8221;) as is equal to the sum of: </font>
        </div>
        <div style="margin-left:60pt; text-indent:20pt; margin-top:8pt; width:396pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(i)&nbsp;&nbsp;&nbsp;an aggregate number of shares of Common Stock equal to 12.79% of the fully-diluted capitalization of the Company as of immediately following the closing of the transactions contemplated by the Agreement and Plan of Merger and Reorganization between the Company, Seahawk Merger Sub Inc. and Carisma Therapeutics Inc. (as it may be amended from time to time, the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Merger Agreement</font><font style="letter-spacing:0.2pt;">&#8221;) minus the number of shares of Common Stock that remain available for the grant of Awards as of the closing of the transactions contemplated by the Merger Agreement; plus </font>
        </div>
        <div style="margin-left:80pt; margin-top:8pt; width:376pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(ii)&nbsp;&nbsp;&nbsp;25,313,283 shares of Common Stock; plus</font>
        </div>
        <div style="margin-left:60pt; text-indent:20pt; margin-top:8pt; width:396pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(iii)&nbsp;&nbsp;&nbsp;such additional number of shares of Common Stock as is equal to the sum of (x)&#160;the number of shares of Common Stock reserved for issuance under the Company&#8217;s 2009 Stock Incentive Plan (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Prior Plan</font><font style="letter-spacing:0.2pt;">&#8221;) that remained available for grant under the Prior Plan immediately prior to the closing of the Company&#8217;s initial public offering and (y)&#160;the number of shares of Common Stock (I)&#160;that were subject to awards granted under the Prior Plan and (II)&#160;that are subject to stock options assumed by the Company pursuant to the Merger Agreement, as of the closing of the transactions contemplated by the Merger Agreement (the awards described in the foregoing clauses (I)&#160;and (II)&#160;together, the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Outstanding Awards</font><font style="letter-spacing:0.2pt;">&#8221;) in each case which Outstanding Awards expire, terminate or are otherwise surrendered, canceled, forfeited or repurchased by the Company at their original issuance price pursuant to a contractual repurchase right (subject, however, in the case of Incentive Stock Options to any limitations of the Code). </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Subject to adjustment under Section&#160;9, up to 252,000,000 of the shares of Common Stock available for issuance under the Plan may be issued as Incentive Stock Options (as defined in Section&#160;5(b)) under the Plan. Shares issued under the Plan may consist in whole or in part of authorized but unissued shares or treasury shares. </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(2)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Share Counting</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;For purposes of counting the number of shares available for the grant of Awards under the Plan: </font>
        </div>
        <div style="margin-left:60pt; text-indent:20pt; margin-top:8pt; width:396pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(i)&nbsp;&nbsp;&nbsp;all shares of Common Stock covered by SARs shall be counted against the number of shares available for the grant of Awards under the Plan; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, </font><font style="font-style:italic;letter-spacing:0.2pt;">however</font><font style="letter-spacing:0.2pt;">, that (i)&#160;SARs that may be settled only in cash shall not be so counted and (ii)&#160;if the Company grants an SAR in tandem with an Option for the same number of shares of Common Stock and provides that only one such Award may be exercised (a &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Tandem SAR</font><font style="letter-spacing:0.2pt;">&#8221;), only the shares covered by the Option, and not the shares covered by the Tandem SAR, shall be so counted, and the expiration of one in connection with the other&#8217;s exercise will not restore shares to the Plan; </font>
        </div>
        <div style="margin-left:60pt; text-indent:20pt; margin-top:8pt; width:396pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(ii)&nbsp;&nbsp;&nbsp;if any Award (i)&#160;expires or is terminated, surrendered or canceled without having been fully exercised or is forfeited in whole or in part (including as the result of shares of Common Stock subject to such Award being repurchased by the Company at the original issuance price pursuant to a contractual repurchase right) or (ii)&#160;results in any Common Stock </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">I-2</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:60pt; width:396pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">not being issued (including as a result of an SAR that was settleable either in cash or in stock actually being settled in cash), the unused Common Stock covered by such Award shall again be available for the grant of Awards; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, </font><font style="font-style:italic;letter-spacing:0.2pt;">however</font><font style="letter-spacing:0.2pt;">, that (1)&#160;in the case of Incentive Stock Options, the foregoing shall be subject to any limitations under the Code, (2)&#160;in the case of the exercise of an SAR, the number of shares counted against the shares available under the Plan shall be the full number of shares subject to the SAR multiplied by the&#160;percentage of the SAR actually exercised, regardless of the number of shares actually used to settle such SAR upon exercise and (3)&#160;the shares covered by a Tandem SAR shall not again become available for grant upon the expiration or termination of such Tandem SAR; and </font>
        </div>
        <div style="margin-left:60pt; text-indent:20pt; margin-top:8pt; width:396pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(iii)&nbsp;&nbsp;&nbsp;shares of Common Stock delivered (either by actual delivery, attestation, or net exercise) to the Company by a Participant to (i)&#160;purchase shares of Common Stock upon the exercise of an Award or (ii)&#160;satisfy tax withholding obligations (including shares retained from the Award creating the tax obligation) shall not be added back to the number of shares available for the future grant of Awards. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Substitute Awards</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;In connection with a merger or consolidation of an entity with the Company or the acquisition by the Company of property or stock of an entity, the Board may grant Awards in substitution for any options or other stock or stock-based awards granted by such entity or an affiliate thereof. Substitute Awards may be granted on such terms as the Board deems appropriate in the circumstances, notwithstanding any limitations on Awards contained in the Plan. Substitute Awards shall not count against the overall share limit set forth in Section&#160;4(a), except as may be required by reason of Section&#160;422 and related provisions of the Code. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">5.&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Stock Options</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">General</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Board may grant options to purchase Common Stock (each, an &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Option</font><font style="letter-spacing:0.2pt;">&#8221;) and determine the number of shares of Common Stock to be covered by each Option, the exercise price of each Option and the conditions and limitations applicable to the exercise of each Option, including conditions relating to applicable federal or state securities laws, as it considers necessary or advisable. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Incentive Stock Options</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;An Option that the Board intends to be an &#8220;incentive stock option&#8221; as defined in Section&#160;422 of the Code (an &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Incentive Stock Option</font><font style="letter-spacing:0.2pt;">&#8221;) shall only be granted to employees of Sesen Bio, Inc., any of Sesen Bio, Inc.&#8217;s present or future parent or subsidiary corporations as defined in Sections&#160;424(e) or (f)&#160;of the Code, and any other entities the employees of which are eligible to receive Incentive Stock Options under the Code, and shall be subject to and shall be construed consistently with the requirements of Section&#160;422 of the Code. An Option that is not intended to be an Incentive Stock Option shall be designated a &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Nonstatutory Stock Option.</font><font style="letter-spacing:0.2pt;">&#8221; The Company shall have no liability to a Participant, or any other party, if an Option (or any part thereof) that is intended to be an Incentive Stock Option is not an Incentive Stock Option or if the Company converts an Incentive Stock Option to a Nonstatutory Stock Option. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Exercise Price</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Board shall establish the exercise price of each Option and specify the exercise price in the applicable Option agreement. The exercise price shall be not less than 100% of the fair market value per share of Common Stock, as determined by (or in a manner approved by) the Board (&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Fair Market Value</font><font style="letter-spacing:0.2pt;">&#8221;), on the date the Option is granted; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;"> that if the Board approves the grant of an Option with an exercise price to be determined on a future date, the exercise price shall be not less than 100% of the Fair Market Value on such future date. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Duration of Options</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Each Option shall be exercisable at such times and subject to such terms and conditions as the Board may specify in the applicable option agreement; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, </font><font style="font-style:italic;letter-spacing:0.2pt;">however</font><font style="letter-spacing:0.2pt;">, that no Option will be granted with a term in excess of 10&#160;years. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(e)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Exercise of Options</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Options may be exercised by delivery to the Company of a notice of exercise in a form (which may be electronic) approved by the Company, together with payment in full (in a manner specified in Section&#160;5(f)) of the exercise price for the number of shares for which the Option is exercised. Shares of Common Stock subject to the Option will be delivered by the Company as soon as practicable following exercise. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">I-3</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; text-indent:20pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(f)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Payment Upon Exercise</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Common Stock purchased upon the exercise of an Option granted under the Plan shall be paid for as follows: </font>
        </div>
        <div style="margin-left:60pt; margin-top:8pt; width:396pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(1)&nbsp;&nbsp;&nbsp;in cash or by check, payable to the order of the Company; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(2)&nbsp;&nbsp;&nbsp;except as may otherwise be provided in the applicable Option agreement or approved by the Board, in its sole discretion, by (i)&#160;delivery of an irrevocable and unconditional undertaking by a creditworthy broker to deliver promptly to the Company sufficient funds to pay the exercise price and any required tax withholding or (ii)&#160;delivery by the Participant to the Company of a copy of irrevocable and unconditional instructions to a creditworthy broker to deliver promptly to the Company cash or a check sufficient to pay the exercise price and any required tax withholding; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(3)&nbsp;&nbsp;&nbsp;to the extent provided for in the applicable Option agreement or approved by the Board, in its sole discretion, by delivery (either by actual delivery or attestation) of shares of Common Stock owned by the Participant valued at their Fair Market Value, </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;"> (i)&#160;such method of payment is then permitted under applicable law, (ii)&#160;such Common Stock, if acquired directly from the Company, was owned by the Participant for such minimum period of time, if any, as may be established by the Board in its discretion and (iii)&#160;such Common Stock is not subject to any repurchase, forfeiture, unfulfilled vesting or other similar requirements; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(4)&nbsp;&nbsp;&nbsp;to the extent provided for in the applicable Nonstatutory Stock Option agreement or approved by the Board in its sole discretion, by delivery of a notice of &#8220;net exercise&#8221; to the Company, as a result of which the Participant would receive (i)&#160;the number of shares underlying the portion of the Option being exercised, less (ii)&#160;such number of shares as is equal to (A)&#160;the aggregate exercise price for the portion of the Option being exercised divided by (B)&#160;the Fair Market Value on the date of exercise; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(5)&nbsp;&nbsp;&nbsp;to the extent permitted by applicable law and provided for in the applicable Option agreement or approved by the Board, in its sole discretion, by payment of such other lawful consideration as the Board may determine; or </font>
        </div>
        <div style="margin-left:60pt; margin-top:8pt; width:396pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(6)&nbsp;&nbsp;&nbsp;by any combination of the above permitted forms of payment. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(g)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Limitation on Repricing</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Unless such action is approved by the Company&#8217;s stockholders, the Company may not (except as provided for under Section&#160;9): (1)&#160;amend any outstanding Option granted under the Plan to provide an exercise price per share that is lower than the then-current exercise price per share of such outstanding Option, (2)&#160;cancel any outstanding option (whether or not granted under the Plan) and grant in substitution therefor new Awards under the Plan (other than Awards granted pursuant to Section&#160;4(b)) covering the same or a different number of shares of Common Stock and having an exercise price per share lower than the then-current exercise price per share of the cancelled option, (3)&#160;cancel in exchange for a cash payment any outstanding Option with an exercise price per share above the then-current Fair Market Value, or (4)&#160;take any other action under the Plan that constitutes a &#8220;repricing&#8221; within the meaning of the rules of the Nasdaq Stock Market (&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Nasdaq</font><font style="letter-spacing:0.2pt;">&#8221;). </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">6.&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Stock Appreciation Rights</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">General</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Board may grant Awards consisting of stock appreciation rights (&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">SARs</font><font style="letter-spacing:0.2pt;">&#8221;) entitling the holder, upon exercise, to receive an amount of Common Stock or cash or a combination thereof (such form to be determined by the Board) determined by reference to appreciation, from and after the date of grant, in the Fair Market Value of a share of Common Stock over the measurement price established pursuant to Section&#160;6(b). The date as of which such appreciation is determined shall be the exercise date. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Measurement Price</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Board shall establish the measurement price of each SAR and specify it in the applicable SAR agreement. The measurement price shall not be less than 100% of the Fair Market Value on the date the SAR is granted; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;"> that if the Board approves the grant of an SAR effective as of a future date, the measurement price shall be not less than 100% of the Fair Market Value on such future date. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">I-4</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; text-indent:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Duration of SARs</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Each SAR shall be exercisable at such times and subject to such terms and conditions as the Board may specify in the applicable SAR agreement; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, </font><font style="font-style:italic;letter-spacing:0.2pt;">however</font><font style="letter-spacing:0.2pt;">, that no SAR will be granted with a term in excess of 10&#160;years. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Exercise of SARs</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;SARs may be exercised by delivery to the Company of a notice of exercise in a form (which may be electronic) approved by the Company, together with any other documents required by the Board. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(e)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Limitation on Repricing</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Unless such action is approved by the Company&#8217;s stockholders, the Company may not (except as provided for under Section&#160;9): (1)&#160;amend any outstanding SAR granted under the Plan to provide a measurement price per share that is lower than the then-current measurement price per share of such outstanding SAR, (2)&#160;cancel any outstanding SAR (whether or not granted under the Plan) and grant in substitution therefor new Awards under the Plan (other than Awards granted pursuant to Section&#160;4(b)) covering the same or a different number of shares of Common Stock and having an exercise or measurement price per share lower than the then-current measurement price per share of the cancelled SAR, (3)&#160;cancel in exchange for a cash payment any outstanding SAR with a measurement price per share above the then-current Fair Market Value, or (4)&#160;take any other action under the Plan that constitutes a &#8220;repricing&#8221; within the meaning of the rules of Nasdaq. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">7.&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Restricted Stock; Restricted Stock Units</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">General</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Board may grant Awards entitling recipients to acquire shares of Common Stock (&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Restricted Stock</font><font style="letter-spacing:0.2pt;">&#8221;), subject to the right of the Company to repurchase all or part of such shares at their issue price or other stated or formula price (or to require forfeiture of such shares if issued at no cost) from the recipient in the event that conditions specified by the Board in the applicable Award are not satisfied prior to the end of the applicable restriction period or periods established by the Board for such Award. The Board may also grant Awards entitling the recipient to receive shares of Common Stock or cash to be delivered at the time such Award vests (&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Restricted Stock Units</font><font style="letter-spacing:0.2pt;">&#8221;) (Restricted Stock and Restricted Stock Units are each referred to herein as a &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Restricted Stock Award</font><font style="letter-spacing:0.2pt;">&#8221;). </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Terms and Conditions for All Restricted Stock Awards</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Board shall determine the terms and conditions of a Restricted Stock Award, including the conditions for vesting and repurchase (or forfeiture) and the issue price, if any. </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Additional Provisions Relating to Restricted Stock</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(1)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Dividends</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Unless otherwise provided in the applicable Award agreement, any dividends (whether paid in cash, stock or property) declared and paid by the Company with respect to shares of Restricted Stock (&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Accrued Dividends</font><font style="letter-spacing:0.2pt;">&#8221;) shall be paid to the Participant only if and when such shares become free from the restrictions on transferability and forfeitability that apply to such shares. Each payment of Accrued Dividends will be made no later than the end of the calendar year in which the dividends are paid to stockholders of that class of stock or, if later, the 15th day of the third month following the lapsing of the restrictions on transferability and the forfeitability provisions applicable to the underlying shares of Restricted Stock. </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(2)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Stock Certificates</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Company may require that any stock certificates issued in respect of shares of Restricted Stock, as well as dividends or distributions paid on such Restricted Stock, shall be deposited in escrow by the Participant, together with a stock power endorsed in blank, with the Company (or its designee). At the expiration of the applicable restriction periods, the Company (or such designee) shall deliver the certificates no longer subject to such restrictions to the Participant or if the Participant has died, to his or her Designated Beneficiary. &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Designated Beneficiary</font><font style="letter-spacing:0.2pt;">&#8221; means (i)&#160;the beneficiary designated, in a manner determined by the Board, by a Participant to receive amounts due or exercise rights of the Participant in the event of the Participant&#8217;s death or (ii)&#160;in the absence of an effective designation by a Participant, the Participant&#8217;s estate. </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Additional Provisions Relating to Restricted Stock Units</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(1)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Settlement</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Upon the vesting of and/or lapsing of any other restrictions (i.e., settlement) with respect to each Restricted Stock Unit, the Participant shall be entitled to receive from the </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">I-5</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:40pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Company such number of shares of Common Stock or (if so provided in the applicable Award agreement) an amount of cash equal to the Fair Market Value of such number of shares of Common Stock as set forth in the applicable Award agreement. The Board may, in its discretion, provide that settlement of Restricted Stock Units shall be deferred, on a mandatory basis or at the election of the Participant in a manner that complies with Section&#160;409A of the Code. </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(2)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Voting Rights</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;A Participant shall have no voting rights with respect to any Restricted Stock Units. </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(3)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Dividend Equivalents</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Award agreement for Restricted Stock Units may provide Participants with the right to receive an amount equal to any dividends or other distributions declared and paid on an equal number of outstanding shares of Common Stock (&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Dividend Equivalents</font><font style="letter-spacing:0.2pt;">&#8221;). Dividend Equivalents may be paid currently or credited to an account for the Participants, may be settled in cash and/or shares of Common Stock and may be subject to the same restrictions on transfer and forfeitability as the Restricted Stock Units with respect to which paid, in each case to the extent provided in the applicable Award agreement. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">8.&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Other Stock-Based Awards</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">General</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Other Awards of shares of Common Stock, and other Awards that are valued in whole or in part by reference to, or are otherwise based on, shares of Common Stock or other property, may be granted hereunder to Participants (&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Other Stock-Based-Awards</font><font style="letter-spacing:0.2pt;">&#8221;). Such Other Stock-Based Awards shall also be available as a form of payment in the settlement of other Awards granted under the Plan or as payment in lieu of compensation to which a Participant is otherwise entitled. Other Stock-Based Awards may be paid in shares of Common Stock or cash, as the Board shall determine. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Terms and Conditions</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Subject to the provisions of the Plan, the Board shall determine the terms and conditions of each Other Stock-Based Award, including any purchase price applicable thereto. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">9.&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Adjustments for Changes in Common Stock and Certain Other Events</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Changes in Capitalization</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;In the event of any stock split, reverse stock split, stock dividend, recapitalization, combination of shares, reclassification of shares, spin-off or other similar change in capitalization or event, or any dividend or distribution to holders of Common Stock other than an ordinary cash dividend, (i)&#160;the number and class of securities available under the Plan and the number and class of securities available for issuance as Incentive Stock Options under the Plan, (ii)&#160;the share counting rules set forth in Section&#160;4(a), (iii)&#160;the number and class of securities and exercise price per share of each outstanding Option, (iv)&#160;the share and per-share provisions and the measurement price of each outstanding SAR, (v)&#160;the number of shares subject to and the repurchase price per share subject to each outstanding Restricted Stock Award and (vi)&#160;the share and per-share-related provisions and the purchase price, if any, of each outstanding Other Stock-Based Award, shall be equitably adjusted by the Company (or substituted Awards may be made, if applicable) in the manner determined by the Board. Without limiting the generality of the foregoing, in the event the Company effects a split of the Common Stock by means of a stock dividend and the exercise price of and the number of shares subject to an outstanding Option are adjusted as of the date of the distribution of the dividend (rather than as of the record date for such dividend), then an optionee who exercises an Option between the record date and the distribution date for such stock dividend shall be entitled to receive, on the distribution date, the stock dividend with respect to the shares of Common Stock acquired upon such Option exercise, notwithstanding the fact that such shares were not outstanding as of the close of business on the record date for such stock dividend. </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Reorganization Events</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(1)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Definition</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;A &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Reorganization Event</font><font style="letter-spacing:0.2pt;">&#8221; shall mean: (a)&#160;any merger or consolidation of the Company with or into another entity as a result of which all of the Common Stock of the Company is converted into or exchanged for the right to receive cash, securities or other property or is cancelled, (b)&#160;any transfer or disposition of all of the Common Stock of the Company for cash, securities or other property pursuant to a share exchange or other transaction or (c)&#160;any liquidation or dissolution of the Company. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">I-6</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:60pt; width:396pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(2)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Consequences of a Reorganization Event on Awards Other than Restricted Stock</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:60pt; text-indent:20pt; margin-top:8pt; width:396pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(i)&nbsp;&nbsp;&nbsp;In connection with a Reorganization Event, the Board may take any one or more of the following actions as to all or any (or any portion of) outstanding Awards other than Restricted Stock on such terms as the Board determines (except to the extent specifically provided otherwise in an applicable Award agreement or another agreement between the Company and the Participant): (i)&#160;provide that such Awards shall be assumed, or substantially equivalent Awards shall be substituted, by the acquiring or succeeding corporation (or an affiliate thereof), (ii)&#160;upon written notice to a Participant, provide that all of the Participant&#8217;s unvested and/or unexercised Awards will terminate immediately prior to the consummation of such Reorganization Event unless exercised by the Participant (to the extent then exercisable) within a specified period following the date of such notice, (iii)&#160;provide that outstanding Awards shall become exercisable, realizable, or deliverable, or restrictions applicable to an Award shall lapse, in whole or in part prior to or upon such Reorganization Event, (iv)&#160;in the event of a Reorganization Event under the terms of which holders of Common Stock will receive upon consummation thereof a cash payment for each share surrendered in the Reorganization Event (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Acquisition Price</font><font style="letter-spacing:0.2pt;">&#8221;), make or provide for a cash payment to Participants with respect to each Award held by a Participant equal to (A)&#160;the number of shares of Common Stock subject to the vested portion of the Award (after giving effect to any acceleration of vesting that occurs upon or immediately prior to such Reorganization Event) multiplied by (B)&#160;the excess, if any, of (I)&#160;the Acquisition Price over (II)&#160;the exercise, measurement or purchase price of such Award and any applicable tax withholdings, in exchange for the termination of such Award, (v)&#160;provide that, in connection with a liquidation or dissolution of the Company, Awards shall convert into the right to receive liquidation proceeds (if applicable, net of the exercise, measurement or purchase price thereof and any applicable tax withholdings) and (vi)&#160;any combination of the foregoing. In taking any of the actions permitted under this Section&#160;9(b)(2), the Board shall not be obligated by the Plan to treat all Awards, all Awards held by a Participant, or all Awards of the same type, identically. </font>
        </div>
        <div style="margin-left:60pt; text-indent:20pt; margin-top:8pt; width:396pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(ii)&nbsp;&nbsp;&nbsp;Notwithstanding the terms of Section&#160;9(b)(2)(i), in the case of outstanding Restricted Stock Units that are subject to Section&#160;409A of the Code: (i)&#160;if the applicable Restricted Stock Unit agreement provides that the Restricted Stock Units shall be settled upon a &#8220;change in control event&#8221; within the meaning of Treasury Regulation&#160;Section&#160;1.409A-3(i)(5)(i), and the Reorganization Event constitutes such a &#8220;change in control event&#8221;, then no assumption or substitution shall be permitted pursuant to Section&#160;9(b)(2)(i)(i) and the Restricted Stock Units shall instead be settled in accordance with the terms of the applicable Restricted Stock Unit agreement; and (ii)&#160;the Board may only undertake the actions set forth in clauses (iii), (iv)&#160;or (v)&#160;of Section&#160;9(b)(2)(i) if the Reorganization Event constitutes a &#8220;change in control event&#8221; as defined under Treasury Regulation&#160;Section&#160;1.409A-3(i)(5)(i) and such action is permitted or required by Section&#160;409A of the Code; if the Reorganization Event is not a &#8220;change in control event&#8221; as so defined or such action is not permitted or required by Section&#160;409A of the Code, and the acquiring or succeeding corporation does not assume or substitute the Restricted Stock Units pursuant to clause (i)&#160;of Section&#160;9(b)(2)(i), then the unvested Restricted Stock Units shall terminate immediately prior to the consummation of the Reorganization Event without any payment in exchange therefor. </font>
        </div>
        <div style="margin-left:60pt; text-indent:20pt; margin-top:8pt; width:396pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(iii)&nbsp;&nbsp;&nbsp;For purposes of Section&#160;9(b)(2)(i)(i), an Award (other than Restricted Stock) shall be considered assumed if, following consummation of the Reorganization Event, such Award confers the right to purchase or receive pursuant to the terms of such Award, for each share of Common Stock subject to the Award immediately prior to the consummation of the Reorganization Event, the consideration (whether cash, securities or other property) received as a result of the Reorganization Event by holders of Common Stock for each share of Common Stock held immediately prior to the consummation of the Reorganization Event (and if holders were offered a choice of consideration, the type of consideration chosen by the holders of a majority of the outstanding shares of Common Stock); </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, </font><font style="font-style:italic;letter-spacing:0.2pt;">however</font><font style="letter-spacing:0.2pt;">, that if the consideration received as a result of the Reorganization Event is not solely common stock of the acquiring or succeeding corporation (or an affiliate thereof), the Company may, with </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">I-7</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:60pt; width:396pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">the consent of the acquiring or succeeding corporation, provide for the consideration to be received upon the exercise or settlement of the Award to consist solely of such number of shares of common stock of the acquiring or succeeding corporation (or an affiliate thereof) that the Board determined to be equivalent in value (as of the date of such determination or another date specified by the Board) to the per share consideration received by holders of outstanding shares of Common Stock as a result of the Reorganization Event. </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(3)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Consequences of a Reorganization Event on Restricted Stock</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Upon the occurrence of a Reorganization Event other than a liquidation or dissolution of the Company, the repurchase and other rights of the Company with respect to outstanding Restricted Stock shall inure to the benefit of the Company&#8217;s successor and shall, unless the Board determines otherwise, apply to the cash, securities or other property which the Common Stock was converted into or exchanged for pursuant to such Reorganization Event in the same manner and to the same extent as they applied to such Restricted Stock; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, </font><font style="font-style:italic;letter-spacing:0.2pt;">however</font><font style="letter-spacing:0.2pt;">, that the Board may provide for termination or deemed satisfaction of such repurchase or other rights under the instrument evidencing any Restricted Stock or any other agreement between a Participant and the Company, either initially or by amendment. Upon the occurrence of a Reorganization Event involving the liquidation or dissolution of the Company, except to the extent specifically provided to the contrary in the instrument evidencing any Restricted Stock or any other agreement between a Participant and the Company, all restrictions and conditions on all Restricted Stock then outstanding shall automatically be deemed terminated or satisfied. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">10.&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">General Provisions Applicable to Awards</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Transferability of Awards</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Awards shall not be sold, assigned, transferred, pledged or otherwise encumbered by the person to whom they are granted, either voluntarily or by operation of law, except by will or the laws of descent and distribution or, other than in the case of an Incentive Stock Option, pursuant to a qualified domestic relations order, and, during the life of the Participant, shall be exercisable only by the Participant; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, </font><font style="font-style:italic;letter-spacing:0.2pt;">however</font><font style="letter-spacing:0.2pt;">, that the Board may permit or provide in an Award for the gratuitous transfer of the Award by the Participant to or for the benefit of any immediate family member, family trust or other entity established for the benefit of the Participant and/or an immediate family member thereof if the Company would be eligible to use a Form S-8 under the Securities Act for the registration of the sale of the Common Stock subject to such Award to such proposed transferee; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided further</font><font style="letter-spacing:0.2pt;">, that the Company shall not be required to recognize any such permitted transfer until such time as such permitted transferee shall, as a condition to such transfer, deliver to the Company a written instrument in form and substance satisfactory to the Company confirming that such transferee shall be bound by all of the terms and conditions of the Award. References to a Participant, to the extent relevant in the context, shall include references to authorized transferees. For the avoidance of doubt, nothing contained in this Section&#160;10(a) shall be deemed to restrict a transfer to the Company. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Documentation</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Each Award shall be evidenced in such form (written, electronic or otherwise) as the Board shall determine. Each Award may contain terms and conditions in addition to those set forth in the Plan. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Board Discretion</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Except as otherwise provided by the Plan, each Award may be made alone or in addition or in relation to any other Award. The terms of each Award need not be identical, and the Board need not treat Participants uniformly. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Termination of Status</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Board shall determine the effect on an Award of the disability, death, termination or other cessation of employment, authorized leave of absence or other change in the employment or other status of a Participant and the extent to which, and the period during which, the Participant, or the Participant&#8217;s legal representative, conservator, guardian or Designated Beneficiary, may exercise rights under the Award. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(e)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Withholding</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Participant must satisfy all applicable federal, state, and local or other income and employment tax withholding obligations before the Company will deliver stock certificates or otherwise recognize ownership of Common Stock under an Award. The Company may decide to </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">I-8</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">satisfy the withholding obligations through additional withholding on salary or wages. If the Company elects not to or cannot withhold from other compensation, the Participant must pay the Company the full amount, if any, required for withholding or have a broker tender to the Company cash equal to the withholding obligations. Payment of withholding obligations is due before the Company will issue any shares on exercise, vesting or release from forfeiture of an Award or at the same time as payment of the exercise or purchase price unless the Company determines otherwise. If provided for in an Award or approved by the Board in its sole discretion, a Participant may satisfy such tax obligations in whole or in part by delivery (either by actual delivery or attestation) of shares of Common Stock, including shares retained from the Award creating the tax obligation, valued at their Fair Market Value; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, </font><font style="font-style:italic;letter-spacing:0.2pt;">however</font><font style="letter-spacing:0.2pt;">, except as otherwise provided by the Board, that the total tax withholding where stock is being used to satisfy such tax obligations cannot exceed the Company&#8217;s minimum statutory withholding obligations (based on minimum statutory withholding rates for federal and state tax purposes, including payroll taxes, that are applicable to such supplemental taxable income), except that, to the extent that the Company is able to retain shares of Common Stock having a fair market value (determined or approved by the Company) that exceeds the statutory minimum applicable withholding tax without financial accounting implications or the Company is withholding in a jurisdiction that does not have a statutory minimum withholding tax, the Company may retain such number of shares of Common Stock (up to the number of shares having a fair market value equal to the maximum individual statutory rate of tax (determined or approved by, the Company)) as the Company shall determine to be necessary to satisfy the tax liability associated with any Award. Shares used to satisfy tax withholding requirements cannot be subject to any repurchase, forfeiture, unfulfilled vesting or other similar requirements. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(f)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Amendment of Award</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Except as otherwise provided in Sections&#160;5(g) and 6(e) with respect to repricings and Section&#160;11(d) with respect to actions requiring stockholder approval, the Board may amend, modify or terminate any outstanding Award, including but not limited to, substituting therefor another Award of the same or a different type, changing the date of exercise or realization, and converting an Incentive Stock Option to a Nonstatutory Stock Option. The Participant&#8217;s consent to such action shall be required unless (i)&#160;the Board determines that the action, taking into account any related action, does not materially and adversely affect the Participant&#8217;s rights under the Plan or (ii)&#160;the change is permitted under Section&#160;9. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(g)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Conditions on Delivery of Stock</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Company will not be obligated to deliver any shares of Common Stock pursuant to the Plan or to remove restrictions from shares previously issued or delivered under the Plan until (i)&#160;all conditions of the Award have been met or removed to the satisfaction of the Company, (ii)&#160;in the opinion of the Company&#8217;s counsel, all other legal matters in connection with the issuance and delivery of such shares have been satisfied, including any applicable securities laws and regulations and any applicable stock exchange or stock market rules and regulations, and (iii)&#160;the Participant has executed and delivered to the Company such representations or agreements as the Company may consider appropriate to satisfy the requirements of any applicable laws, rules or regulations. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(h)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Acceleration</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Board may at any time provide that any Award shall become immediately exercisable in whole or in part, free of some or all restrictions or conditions, or otherwise realizable in whole or in part, as the case may be. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">11.&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Miscellaneous</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">No Right To Employment or Other Status</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;No person shall have any claim or right to be granted an Award by virtue of the adoption of the Plan, and the grant of an Award shall not be construed as giving a Participant the right to continued employment or any other relationship with the Company. The Company expressly reserves the right at any time to dismiss or otherwise terminate its relationship with a Participant free from any liability or claim under the Plan, except as expressly provided in the applicable Award. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">No Rights As Stockholder; Clawback</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp; Subject to the provisions of the applicable Award, no Participant or Designated Beneficiary shall have any rights as a stockholder with respect to any shares of Common Stock to be distributed with respect to an Award until becoming the record holder </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">I-9</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">of such shares. In accepting an Award made under the Plan on and after the Closing Date (as defined in Section&#160;11(c)), the Participant agrees to be bound by any clawback policy that the Company has in effect or may adopt in the future. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Effective Date and Term of Plan</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Original Plan became effective immediately prior to the closing of the Company&#8217;s initial public stock offering of its Common Stock on a U.S.-based stock exchange whereby the Company&#8217;s shares of Common Stock are offered for sale to the public. The Plan shall become effective on the closing of the transactions contemplated by the Merger Agreement (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Closing Date</font><font style="letter-spacing:0.2pt;">&#8221;). No Awards shall be granted under the Plan after the expiration of 10&#160;years from the Closing Date, but Awards previously granted may extend beyond that date. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Amendment of Plan</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Board may amend, suspend or terminate the Plan or any portion thereof at any time provided that (i)&#160;to the extent required by Section&#160;162(m) of the Code, no Award granted to a Participant that is intended to comply with Section&#160;162(m) of the Code after the date of such amendment shall become exercisable, realizable or vested, as applicable to such Award, unless and until the Company&#8217;s stockholders approve such amendment in the manner required by Section&#160;162(m) of the Code; and (ii)&#160;no amendment that would require stockholder approval under the rules of the Nasdaq Stock Market may be made effective unless and until the Company&#8217;s stockholders approve such amendment. In addition, if at any time the approval of the Company&#8217;s stockholders is required as to any other modification or amendment under Section&#160;422 of the Code or any successor provision with respect to Incentive Stock Options, the Board may not effect such modification or amendment without such approval. Unless otherwise specified in the amendment, any amendment to the Plan adopted in accordance with this Section&#160;11(d) shall apply to, and be binding on the holders of, all Awards outstanding under the Plan at the time the amendment is adopted, provided the Board determines that such amendment, taking into account any related action, does not materially and adversely affect the rights of Participants under the Plan. No Award shall be made that is conditioned upon stockholder approval of any amendment to the Plan unless the Award provides that (i)&#160;it will terminate or be forfeited if stockholder approval of such amendment is not obtained within no more than 12&#160;months from the date of grant and (2)&#160;it may not be exercised or settled (or otherwise result in the issuance of Common Stock) prior to such stockholder approval. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(e)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Authorization of Sub-Plans (including Grants to non-U.S. Employees)</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Board may from time to time establish one or more sub-plans under the Plan for purposes of satisfying applicable securities, tax or other laws of various jurisdictions. The Board shall establish such sub-plans by adopting supplements to the Plan containing (i)&#160;such limitations on the Board&#8217;s discretion under the Plan as the Board deems necessary or desirable or (ii)&#160;such additional terms and conditions not otherwise inconsistent with the Plan as the Board shall deem necessary or desirable. All supplements adopted by the Board shall be deemed to be part of the Plan, but each supplement shall apply only to Participants within the affected jurisdiction and the Company shall not be required to provide copies of any supplement to Participants in any jurisdiction which is not the subject of such supplement. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;font-size:9.8pt;">
          <font style="font-size:10pt;letter-spacing:0.2pt;">(f)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;font-size:10pt;letter-spacing:0.2pt;">Compliance with Section&#160;409A of the Code</font><font style="font-size:10pt;letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;</font><font style="font-size:10pt;letter-spacing:0.196pt;">Except as provided in individual Award agreements initially or by amendment, if and to the extent (i)&#160;any portion of any payment, compensation or other benefit provided to a Participant pursuant to the Plan in connection with his or her employment termination constitutes &#8220;nonqualified deferred compensation&#8221; within the meaning of Section&#160;409A of the Code and (ii)&#160;the Participant is a specified employee as defined in Section&#160;409A(a)(2)(B)(i) of the Code, in each case as determined by the Company in accordance with its procedures, by which determinations the Participant (through accepting the Award) agrees that he or she is bound, such portion of the payment, compensation or other benefit shall not be paid before the day that is six&#160;months plus one day after the date of &#8220;separation from service&#8221; &#8203;(as determined under Section&#160;409A of the Code) (the &#8220;</font><font style="font-style:italic;font-weight:bold;font-size:10pt;letter-spacing:-0.196pt;">New Payment Date</font><font style="font-size:10pt;letter-spacing:0.196pt;">&#8221;), except as Section&#160;409A of the Code may then permit. The aggregate of any payments that otherwise would have been paid to the Participant during the period between the date of separation from service and the New Payment Date shall be paid to the Participant in a lump sum on such New Payment Date, and any remaining payments will be paid on their original schedule.</font><font style="font-size:10pt;">&#8203;<font style="letter-spacing:0.2pt;"> </font></font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company makes no representations or warranty and shall have no liability to the Participant or any other person if any provisions of or payments, compensation or other benefits under the Plan are </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">I-10</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:408pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">determined to constitute nonqualified deferred compensation subject to Section&#160;409A of the Code but do not to satisfy the conditions of that section. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(g)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Limitations on Liability</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Notwithstanding any other provisions of the Plan, no individual acting as a director, officer, employee, or agent of the Company will be liable to any Participant, former Participant, spouse, beneficiary, or any other person for any claim, loss, liability, or expense incurred in connection with the Plan, nor will such individual be personally liable with respect to the Plan because of any contract or other instrument he or she executes in his or her capacity as a director, officer, employee, or agent of the Company. The Company will indemnify and hold harmless each director, officer, employee, or agent of the Company to whom any duty or power relating to the administration or interpretation of the Plan has been or will be delegated, against any cost or expense (including attorneys&#8217; fees) or liability (including any sum paid in settlement of a claim with the Board&#8217;s approval) arising out of any act or omission to act concerning the Plan unless arising out of such person&#8217;s own fraud or bad faith. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(h)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Governing Law</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The provisions of the Plan and all Awards made hereunder shall be governed by and interpreted in accordance with the laws of the State of Delaware, excluding choice-of-law principles of the law of such state that would require the application of the laws of a jurisdiction other than the State of Delaware.</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">I-11</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a><a name="tAnnexJ">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:180pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; text-align:right; width:436pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ANNEX J</font>&#8203;</div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">AMENDMENT NO. 2</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">TO</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">SESEN BIO, INC.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">2014 EMPLOYEE STOCK PURCHASE PLAN</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Sesen Bio, Inc. 2014 Employee Stock Purchase Plan, as amended (the &#8220;Plan&#8221;), is hereby amended as follows: </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">1.&nbsp;&nbsp;&nbsp;The second sentence of the first paragraph of the Plan shall be deleted in its entirety and replaced with the following: </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;Subject to adjustment under Section&#160;15 hereof, the number of shares of Common Stock that have been approved for this purpose is 6,568,655 shares of Common Stock.&#8221; </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">2.&nbsp;&nbsp;&nbsp;The following sentence shall be added to the end of Section&#160;26 of the Plan: </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;The first amendment to the Plan took effect on May&#160;3, 2021. The second amendment to the Plan shall take effect as of the effective time of the merger contemplated by the Agreement and Plan of Merger and Reorganization, dated as of September&#160;20, 2022, by and between the Company, Seahawk Merger Sub Inc. and Carisma Therapeutics Inc., subject to approval by the shareholders of the Company as required by Section&#160;423 of the Code, which approval must occur within twelve&#160;months of the second amendment of the Plan by the Board.&#8221; </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Except as set forth above, the remainder of the Plan remains in full force and effect. For the avoidance of doubt and for purposes of the Plan, the &#8220;Board&#8221; shall mean the Board of Directors of the Company. </font>
        </div>
        <div style="margin-left:220pt; margin-top:24pt; width:236pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Adopted by the Board of Directors on </font>
        </div>
        <div style="margin-left:220pt; margin-top:8pt; width:236pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">[&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199; &#8199;&#8199;&#8201; &#8199;&#8199;&#8199;&#8199;] </font>
        </div>
        <div style="margin-left:220pt; margin-top:24pt; width:236pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Approved by the Stockholders on </font>
        </div>
        <div style="margin-left:220pt; margin-top:8pt; width:236pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">[&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199; &#8199;&#8199;&#8201; &#8199;&#8199;&#8199;&#8199;]</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">J-1</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">PART II</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">INFORMATION NOT REQUIRED IN</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">PROXY STATEMENT/PROSPECTUS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Item&#160;20&#8201;&#8212;&#8201;Indemnification of Directors and Officers</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Delaware General Corporation Law</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Section&#160;145(a) of the DGCL empowers a corporation to indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative (other than an action by or in the right of the corporation) by reason of the fact that the person is or was a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise, against expenses (including attorneys&#8217; fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by the person in connection with such action, suit or proceeding if the person acted in good faith and in a manner the person reasonably believed to be in or not opposed to the best interests of the corporation, and, with respect to any criminal action or proceeding, had no reasonable cause to believe the person&#8217;s conduct was unlawful. The termination of any action, suit or proceeding by judgment, order, settlement, conviction or upon a plea of nolo contendere or its equivalent, shall not, of itself, create a presumption that the person did not act in good faith and in a manner which the person reasonably believed to be in or not opposed to the best interests of the corporation, and, with respect to any criminal action or proceeding, had reasonable cause to believe that the person&#8217;s conduct was unlawful. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Section&#160;145(b) of the DGCL empowers a corporation to indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action or suit by or in the right of the corporation to procure a judgment in its favor by reason of the fact that the person is or was a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise against expenses (including attorneys&#8217; fees) actually and reasonably incurred by the person in connection with the defense or settlement of such action or suit if the person acted in good faith and in a manner the person reasonably believed to be in or not opposed to the best interests of the corporation and except that no indemnification shall be made in respect of any claim, issue or matter as to which the person shall have been adjudged to be liable to the corporation unless and only to the extent that the Delaware Court of Chancery or the court in which such action or suit was brought shall determine upon application that, despite the adjudication of liability but in view of all the circumstances of the case, the person is fairly and reasonably entitled to indemnity for such expenses which the Delaware Court of Chancery or such other court shall deem proper. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Section&#160;145(c) of the DGCL provides that to the extent that a present or former director or officer of a corporation has been successful on the merits or otherwise in defense of any action, suit or proceeding referred to in subsections (a)&#160;and (b)&#160;of Section&#160;145, or in defense of any claim, issue or matter therein, such person shall be indemnified against expenses (including attorneys&#8217; fees) actually and reasonably incurred by such person in connection therewith. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Section&#160;145(d) of the DGCL states that any indemnification under subsections (a)&#160;and (b)&#160;of Section&#160;145 (unless ordered by a court) shall be made by the corporation only as authorized in the specific case upon a determination that indemnification of the present or former director, officer, employee or agent is proper in the circumstances because the person has met the applicable standard of conduct set forth in subsections (a)&#160;and (b)&#160;of Section&#160;145. Such determination shall be made with respect to a person who is a director or officer at the time of such determination (i)&#160;by a majority vote of the directors who are not parties to such action, suit or proceeding, even though less than a quorum, (ii)&#160;by a committee of such directors designated by majority vote of such directors, even though less than a quorum, (iii)&#160;if there are no such directors, or if such directors so direct, by independent legal counsel in a written opinion or (iv)&#160;by the stockholders. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">II-1</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11pt;">
          <font style="letter-spacing:0.2pt;">Section&#160;145(f) of the DGCL states that the indemnification and advancement of expenses provided by, or granted pursuant to, the other subsections of Section&#160;145 shall not be deemed exclusive of any other rights to which those seeking indemnification or advancement of expenses may be entitled under any bylaw, agreement, vote of stockholders or disinterested directors or otherwise, both as to action in such person&#8217;s official capacity and as to action in another capacity while holding such office. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11pt;">
          <font style="letter-spacing:0.2pt;">Section&#160;145(g) of the DGCL provides that a corporation shall have the power to purchase and maintain insurance on behalf of any person who is or was a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise, against any liability asserted against such person and incurred by such person in any such capacity or arising out of such person&#8217;s status as such, whether or not the corporation would have the power to indemnify such person against such liability under the provisions of Section&#160;145. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11pt;">
          <font style="letter-spacing:0.2pt;">Section&#160;145(j) of the DGCL states that the indemnification and advancement of expenses provided by, or granted pursuant to, Section&#160;145 shall, unless otherwise provided when authorized or ratified, continue as to a person who has ceased to be a director, officer, employee or agent and shall inure to the benefit of the heirs, executors and administrators of such a person. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11pt;">
          <font style="letter-spacing:0.2pt;">Section&#160;102(b)(7) of the DGCL provides that a corporation&#8217;s certificate of incorporation may contain a provision eliminating or limiting the personal liability of a director or officer to the corporation or its stockholders for monetary damages for breach of fiduciary duty as a director or officer, provided that such provision shall not eliminate or limit the liability of (i)&#160;a director or officer for any breach of the director&#8217;s or officer&#8217;s duty of loyalty to the corporation or its stockholders, (ii)&#160;a director or officer for acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law, (iii)&#160;a director under Section&#160;174 of the DGCL, (iv)&#160;a director or officer for any transaction from which the director or officer derived an improper personal benefit, or (v)&#160;an officer in any action by or in the right of the corporation. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Certificate of Incorporation</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio has adopted provisions in the Sesen Bio Certificate of Incorporation that provide for indemnification of Sesen Bio&#8217;s officers and directors to the maximum extent permitted under the DGCL. As authorized by the DGCL, the Sesen Bio Certificate of Incorporation limits the liability of Sesen Bio&#8217;s directors for monetary damages. The effect of this provision is to eliminate Sesen Bio&#8217;s rights and those of Sesen Bio&#8217;s stockholders to recover monetary damages against a director for breach of the fiduciary duty of care as a director except in certain limited situations. This provision does not limit or eliminate Sesen Bio&#8217;s rights or that of any stockholder to seek non-monetary relief such as an injunction or rescission in the event of a breach of a director&#8217;s duty of care. These provisions will not alter the liability of the Sesen Bio board of directors under federal securities laws. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Insurance Policy</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio maintains a general liability insurance policy that covers certain liabilities of Sesen Bio directors and officers arising out of claims based on acts or omissions in their capacities as directors or officers. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Indemnification Agreemen</font><font style="letter-spacing:0.2pt;">t </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sesen Bio has entered into indemnification agreements with its directors and executive officers. In general, these agreements provide that Sesen Bio will indemnify the director or executive officer to the fullest extent permitted by law for claims arising in his or her capacity as a director or officer of Sesen Bio or in connection with their service at Sesen Bio&#8217;s request for another corporation or entity. The indemnification agreements also provide for procedures that will apply in the event that a director or executive officer makes a claim for indemnification and establish certain presumptions that are favorable to the director or executive officer. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Merger Agreement</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Further, pursuant to the terms of the Merger Agreement, the provisions of the Sesen Bio Certificate of Incorporation and the Sesen Bio Bylaws with respect to indemnification, advancement of expenses and </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">II-2</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">exculpation of present and former directors and officers of Sesen Bio, shall not be amended, modified or repealed for a period of six&#160;years from the effective time in a manner that would adversely affect the rights thereunder of individuals who, at or prior to the effective time, were officers or directors of Sesen Bio. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Item&#160;21&#8201;&#8212;&#8201;Exhibits and Financial Statement Schedules</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">(a) Exhibit&#160;Index</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">A list of exhibits filed with this registration statement on Form S-4 is set forth on the Exhibit&#160;Index and is incorporated herein by reference. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">(b) Financial Statements</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The financial statements filed with this registration statement on Form S-4 are set forth on the Financial Statement Index and are incorporated herein by reference. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Item&#160;22&#8201;&#8212;&#8201;Undertakings</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(a)</font>
          <br >
        </div>
        <div style=" margin-top:7.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:0.2pt;">The undersigned registrant hereby undertakes: </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:7.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:7.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <font style="letter-spacing:0.2pt;">To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement: </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:60pt; line-height:12pt; margin-top:7.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(i)</font>
          <br >
        </div>
        <div style=" margin-top:7.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:80pt;">
          <font style="letter-spacing:0.2pt;">To include any prospectus required by Section&#160;10(a)(3) of the Securities Act of 1933; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:60pt; line-height:12pt; margin-top:7.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(ii)</font>
          <br >
        </div>
        <div style=" margin-top:7.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:80pt;">
          <font style="letter-spacing:0.2pt;">To reflect in the prospectus any facts or events arising after the effective date of this registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in this registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule&#160;424(b) if, in the aggregate, the changes in volume and price represent no more than 20% change in the maximum aggregate offering price set forth in the &#8220;Calculation of Registration Fee&#8221; table in the effective registration statement; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:60pt; line-height:12pt; margin-top:7.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(iii)</font>
          <br >
        </div>
        <div style=" margin-top:7.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:80pt;">
          <font style="letter-spacing:0.2pt;">To include any material information with respect to the plan of distribution not previously disclosed in this registration statement or any material change to such information in this registration statement. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:7.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(2)</font>
          <br >
        </div>
        <div style=" margin-top:7.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <font style="letter-spacing:0.2pt;">That, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(3)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <font style="letter-spacing:0.2pt;">To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(4)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <font style="letter-spacing:0.2pt;">That, for the purpose of determining liability under the Securities Act of 1933 to any purchaser: if the registrant is subject to Rule&#160;430C, each prospectus filed pursuant to Rule&#160;424(b) as part of a registration statement relating to an offering, other than registration statements relying on Rule&#160;430B or other than prospectuses filed in reliance on Rule&#160;430A, shall be deemed to be part of and included in the registration statement as of the date it is first used after effectiveness. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such first use, supersede or modify any statement that was made in the registration statement </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">II-3</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:60pt; width:396pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">or prospectus that was part of the registration statement or made in any such document immediately prior to such date of first use. </font>
        </div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:7.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(5)</font>
          <br >
        </div>
        <div style=" margin-top:7.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <font style="letter-spacing:0.2pt;">That, for the purpose of determining liability of the registrant under the Securities Act of 1933 to any purchaser in the initial distribution of the securities, the undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser: </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:60pt; line-height:12pt; margin-top:7.71pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(i)</font>
          <br >
        </div>
        <div style=" margin-top:7.71pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:80pt;">
          <font style="letter-spacing:0.2pt;">Any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule&#160;424; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:60pt; line-height:12pt; margin-top:7.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(ii)</font>
          <br >
        </div>
        <div style=" margin-top:7.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:80pt;">
          <font style="letter-spacing:0.2pt;">Any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned registrant; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:60pt; line-height:12pt; margin-top:7.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(iii)</font>
          <br >
        </div>
        <div style=" margin-top:7.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:80pt;">
          <font style="letter-spacing:0.2pt;">The portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant or its securities provided by or on behalf of the undersigned registrant; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:60pt; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(iv)</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:80pt;">
          <font style="letter-spacing:0.2pt;">Any other communication that is an offer in the offering made by the undersigned registrant to the purchaser. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(b)</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:0.2pt;">The undersigned registrant hereby undertakes as follows: that prior to any public reoffering of the securities registered hereunder through use of a prospectus which is a part of this registration statement, by any person or party who is deemed to be an underwriter within the meaning of Rule&#160;145(c), the issuer undertakes that such reoffering prospectus will contain the information called for by the applicable registration form with respect to reofferings by persons who may be deemed underwriters, in addition to the information called for by the other items of the applicable form. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.81pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(c)</font>
          <br >
        </div>
        <div style=" margin-top:7.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:0.2pt;">The undersigned registrant hereby undertakes as follows: that every prospectus (i)&#160;that is filed pursuant to paragraph (b)&#160;immediately preceding, or (ii)&#160;that purports to meet the requirements of Section&#160;10(a)(3) of the Securities Act of 1933 and is used in connection with an offering of securities subject to Rule&#160;415, will be filed as a part of an amendment to the registration statement and will not be used until such amendment is effective, and that, for purposes of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(d)</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:0.2pt;">The undersigned registrant hereby undertakes to respond to requests for information that is incorporated by reference into this proxy statement/prospectus pursuant to Item&#160;4, 10(b), 11, or 13 of Form S-4, within one business day of receipt of such request, and to send the incorporated documents by first class mail or other equally prompt means. This includes information contained in documents filed subsequent to the effective date of the registration statement through the date of responding to the request. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(e)</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:0.2pt;">The undersigned registrant hereby undertakes that, for purposes of determining any liability under the Securities Act of 1933, each filing of the registrant&#8217;s annual report pursuant to Section&#160;13(a) or 15(d) of the Securities Exchange Act of 1934 (and, where applicable, each filing of an employee benefit plan&#8217;s annual report pursuant to Section&#160;15(d) of the Securities Exchange Act of 1934) that is incorporated by reference in the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(f)</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:0.2pt;">The undersigned registrant hereby undertakes to supply by means of a post-effective amendment all information concerning a transaction, and the company being acquired involved therein, that was not the subject of and included in the registration statement when it became effective. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(g)</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:0.2pt;">Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">II-4</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:496pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:40pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act of 1933 and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act of 1933 and will be governed by the final adjudication of such issue.</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">II-5</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;letter-spacing:0.2pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">INDEX TO EXHIBITS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <table style="width:456pt;height:633.5pt;margin-top:6pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.667pt 0pt; width:42.39pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.16pt;">EXHIBIT</font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">NUMBER </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.667pt 0pt; width:401.61pt;">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">DESCRIPTION OF DOCUMENT </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;letter-spacing:0.2pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.417pt 0pt 0.5pt 0pt; width:42.39pt;">
                <font style="margin-left:10pt;letter-spacing:0.2pt;">2.1* </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.417pt 0pt 0.5pt 0pt; width:401.61pt;white-space:normal;">
                <a href="#tAAPM">Agreement and Plan of Merger, dated as of September&#160;20, 2022, by and among Sesen Bio, Inc., Seahawk Merger Sub, Inc. and Carisma (included as Annex A-1 to the proxy statement/&#8203;prospectus forming a part of this Registration Statement).</a>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;letter-spacing:0.2pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 0.5pt 0pt; width:42.39pt;">
                <font style="margin-left:10pt;letter-spacing:0.2pt;">2.2*</font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 0.5pt 0pt; width:401.61pt;white-space:normal;">
                <a href="#tFAAP">First Amendment to Agreement and Plan of Merger and Reorganization, dated as of December&#160;29, 2022, by and among Sesen Bio,&#160;Inc., Seahawk Merger Sub,&#160;Inc., and Carisma (included as Annex&#160;A-2 to the proxy statement/ prospectus forming a part of this Registration Statement).</a>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 0.5pt 0pt; width:42.39pt;">
                <font style="margin-left:10pt;letter-spacing:0.2pt;">2.3</font><font style="letter-spacing:0.2pt;">* </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 0.5pt 0pt; width:401.61pt;white-space:normal;">
                <a href="#tANNC">Form of Carisma Support Agreement, by and between the Sesen Bio, Inc., Carisma and certain stockholders of Carisma (included as Annex C to the proxy statement/prospectus forming a part of this Registration Statement).</a>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 0.5pt 0pt; width:42.39pt;">
                <font style="margin-left:10pt;letter-spacing:0.2pt;">2.4</font><font style="letter-spacing:0.2pt;">* </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 0.5pt 0pt; width:401.61pt;white-space:normal;">
                <a href="#tANND">Form of Sesen Bio Support Agreement, by and between the Sesen Bio, Inc., Carisma and certain stockholders of Sesen Bio, Inc. (included as Annex D to the proxy statement/&#8203;prospectus forming a part of this Registration Statement).</a>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 0.5pt 0pt; width:42.39pt;">
                <font style="margin-left:10pt;letter-spacing:0.2pt;">2.5</font><font style="letter-spacing:0.2pt;">* </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 0.5pt 0pt; width:401.61pt;white-space:normal;">
                <a href="#tANNE">Form of Lock-Up Agreement, by and between Sesen Bio, Inc., Carisma and certain stockholders of Sesen Bio, Inc. and Carisma (included as Annex E to the proxy statement/&#8203;prospectus forming a part of this Registration Statement).</a>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 0.5pt 0pt; width:42.39pt;">
                <font style="margin-left:10pt;letter-spacing:0.2pt;">2.6</font><font style="letter-spacing:0.2pt;">* </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 0.5pt 0pt; width:401.61pt;white-space:normal;">
                <a href="#tANNF">Form of Contingent Value Rights Agreement by and among Sesen Bio, Inc. and the Rights Agent (included as Annex F to the proxy statement/prospectus forming a part of this Registration Statement).</a>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 0.5pt 0pt; width:42.39pt;">
                <font style="margin-left:10pt;letter-spacing:0.2pt;">2.7</font><font style="letter-spacing:0.2pt;">&#8224; </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 0.5pt 0pt; width:401.61pt;white-space:normal;">
                <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1485003/000119312516715368/d261598dex21.htm">Share Purchase Agreement, effective as of September&#160;20, 2016, by and between Eleven Biotherapeutics, Inc., Viventia Bio Inc. and Clairmark Investments Ltd., as representative of the selling shareholders (incorporated by reference to Exhibit&#160;2.1 to the Registrant&#8217;s Current Report on Form 8-K filed on September&#160;21, 2016).</a>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 0.5pt 0pt; width:42.39pt;">
                <font style="margin-left:10pt;letter-spacing:0.2pt;">3.1 </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 0.5pt 0pt; width:401.61pt;white-space:normal;">
                <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1485003/000119312514056904/d679756dex31.htm">Restated Certificate of Incorporation of Sesen Bio, Inc. (incorporated by reference to Exhibit&#160;3.1 to the Registrant&#8217;s Current Report on Form 8-K, filed on February&#160;18, 2014).</a>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;letter-spacing:0.2pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 0.5pt 0pt; width:42.39pt;">
                <font style="margin-left:10pt;letter-spacing:0.2pt;">3.2 </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 0.5pt 0pt; width:401.61pt;white-space:normal;">
                <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1485003/000148500318000071/exhibit31-ebioxcertificate.htm">Certificate of Amendment of Certificate of Incorporation of Sesen Bio, Inc. (incorporated by reference to Exhibit&#160;3.1 to the Registrant&#8217;s Current Report on Form 8-K, filed on May&#160;17, 2018).</a>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;letter-spacing:0.2pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 0.5pt 0pt; width:42.39pt;">
                <font style="margin-left:10pt;letter-spacing:0.2pt;">3.3 </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 0.5pt 0pt; width:401.61pt;white-space:normal;">
                <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1485003/000148500321000103/ex33-certificateofamendm.htm">Certificate of Amendment of Certificate of Incorporation of Sesen Bio, Inc. (incorporated by reference to Exhibit&#160;3.3 to the Registrant&#8217;s Quarterly Report on Form 10-Q, filed on May&#160;10, 2021).</a>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 0.5pt 0pt; width:42.39pt;">
                <font style="margin-left:10pt;letter-spacing:0.2pt;">3.4 </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 0.5pt 0pt; width:401.61pt;white-space:normal;">
                <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1485003/000148500318000071/exhibit32-elevenbiotherape.htm">Amended and Restated By-Laws of Sesen Bio, Inc. (incorporated by reference to Exhibit&#160;3.2 to the Registrant&#8217;s Current Report on Form 8-K, filed on May&#160;17, 2018).</a>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;letter-spacing:0.2pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 0.5pt 0pt; width:42.39pt;">
                <font style="margin-left:10pt;letter-spacing:0.2pt;">4.1 </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 0.5pt 0pt; width:401.61pt;white-space:normal;">
                <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1485003/000119312514018644/d613481dex41.htm">Specimen Certificate for Sesen Bio, Inc.&#8217;s Common Stock, par value $.001 per share (incorporated by reference to Exhibit&#160;4.1 to the Registrant&#8217;s Registration Statement on Form&#160;S-1/A (File No. 333-193131), filed on January&#160;23, 2014).</a>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;letter-spacing:0.2pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 0.5pt 0pt; width:42.39pt;">
                <font style="margin-left:10pt;letter-spacing:0.2pt;">4.2 </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 0.5pt 0pt; width:401.61pt;white-space:normal;">
                <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1485003/000119312514448885/d704357dex1023.htm">Eleven Biotherapeutics, Inc. Form of Warrant issued to Silicon Valley Bank and Life Science Loans, LLC dated November&#160;25, 2014 (incorporated by reference to Exhibit&#160;10.23 to the Registrant&#8217;s Registration Statement on Form S-1 (File No. 333-201176), filed on December&#160;19, 2014).</a>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 0.5pt 0pt; width:42.39pt;">
                <font style="margin-left:10pt;letter-spacing:0.2pt;">4.3 </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 0.5pt 0pt; width:401.61pt;white-space:normal;">
                <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1485003/000148500317000132/ex41ebiopre-fundedwarrant1.htm">Form of Common Warrant (incorporated by reference to Exhibit&#160;4.1 to the Registrant&#8217;s Current Report on Form 8-K, filed on November&#160;3, 2017).</a>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 0.5pt 0pt; width:42.39pt;">
                <font style="margin-left:10pt;letter-spacing:0.2pt;">4.4 </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 0.5pt 0pt; width:401.61pt;white-space:normal;">
                <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1485003/000148500318000027/exhibit41.htm">Form of Warrant (incorporated by reference to Exhibit&#160;4.1 to the Registrant&#8217;s Current Report on Form 8-K, filed on March&#160;23, 2018).</a>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 0.5pt 0pt; width:42.39pt;">
                <font style="margin-left:10pt;letter-spacing:0.2pt;">4.5 </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 0.5pt 0pt; width:401.61pt;white-space:normal;">
                <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1485003/000148500319000082/sesn-2017warrantamendmenta.htm">Form of 2017 Warrant Amendment Agreement (incorporated by reference to Exhibit&#160;4.2 to the Registrant&#8217;s Current Report on Form 8-K, filed on October&#160;29, 2019).</a>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
          </table>

      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">II-6</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;letter-spacing:0.2pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:0.5pt;margin-left:69.66pt;width:456pt;">

          <table style="width:456pt;height:625.5pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.667pt 0pt; width:42.39pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.16pt;">EXHIBIT</font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">NUMBER </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.667pt 0pt; width:401.61pt;">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">DESCRIPTION OF DOCUMENT </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.417pt 0pt 1.333pt 0pt; width:42.39pt;">
                <font style="margin-left:10pt;letter-spacing:0.2pt;">4.6 </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.417pt 0pt 1.333pt 0pt; width:401.61pt;white-space:normal;">
                <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1485003/000148500319000082/sesn-2018warrantamendmenta.htm">Form of 2018 Warrant Amendment Agreement (incorporated by reference to Exhibit&#160;4.4 to the Registrant&#8217;s Current Report on Form 8-K, filed on October&#160;29, 2019).</a>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;letter-spacing:0.2pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 1.333pt 0pt; width:42.39pt;">
                <font style="margin-left:10pt;letter-spacing:0.2pt;">5.1^ </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 1.333pt 0pt; width:401.61pt;white-space:normal;">
                <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1485003/000110465922120867/sesn-20220930xex5d1.htm">Opinion of Hogan Lovells US LLP as to the validity of shares of common stock to be issued to CARISMA Therapeutics Inc. </a>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:4pt 0pt 2pt 0pt; width:42.39pt;">
                <font style="margin-left:10pt;letter-spacing:0.2pt;">8.1</font><font style="letter-spacing:0.2pt;">^</font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:4pt 0pt 2pt 0pt; width:401.61pt;">
                <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1485003/000110465922127022/tm2227887d10_ex8-1.htm">Opinion of Wilmer Cutler Pickering Hale and Dorr LLP as to certain tax matters. </a>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:4pt 0pt 2pt 0pt; width:42.39pt;">
                <font style="margin-left:10pt;letter-spacing:0.2pt;">8.2</font><font style="letter-spacing:0.2pt;">^</font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:4pt 0pt 2pt 0pt; width:401.61pt;">
                <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1485003/000110465922127022/tm2227887d10_ex8-2.htm">Opinion of Hogan Lovells US LLP as to certain tax matters. </a>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;letter-spacing:0.2pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 1.333pt 0pt; width:42.39pt;">
                <font style="margin-left:5pt;letter-spacing:0.2pt;">10.1+ </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 1.333pt 0pt; width:401.61pt;white-space:normal;">
                <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1485003/000119312513487942/d613481dex101.htm">Eleven Biotherapeutics, Inc. Amended and Restated 2009 Stock Incentive Plan (incorporated by reference to Exhibit&#160;10.1 to the Registrant&#8217;s Registration Statement on Form S-1 (File No.&#160;333-193131), filed on December&#160;30, 2013).</a>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;letter-spacing:0.2pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 1.333pt 0pt; width:42.39pt;">
                <font style="margin-left:5pt;letter-spacing:0.2pt;">10.2+ </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 1.333pt 0pt; width:401.61pt;white-space:normal;">
                <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1485003/000119312513487942/d613481dex102.htm">Form of Incentive Stock Option Agreement under the Eleven Biotherapeutics, Inc. Amended and Restated 2009 Stock Incentive Plan (incorporated by reference to Exhibit&#160;10.2 to the Registrant&#8217;s Registration Statement on Form S-1 (File No. 333-193131), filed on December&#160;30, 2013).</a>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;letter-spacing:0.2pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 1.333pt 0pt; width:42.39pt;">
                <font style="margin-left:5pt;letter-spacing:0.2pt;">10.3+ </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 1.333pt 0pt; width:401.61pt;white-space:normal;">
                <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1485003/000119312513487942/d613481dex103.htm">Form of Non-Statutory Stock Option Agreement under the Eleven Biotherapeutics, Inc. Amended and Restated 2009 Stock Incentive Plan (incorporated by reference to Exhibit&#160;10.3 to the Registrant&#8217;s Registration Statement on Form S-1 (File No. 333-193131), filed on December&#160;30, 2013).</a>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 1.333pt 0pt; width:42.39pt;">
                <font style="margin-left:5pt;letter-spacing:0.2pt;">10.4+ </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 1.333pt 0pt; width:401.61pt;white-space:normal;">
                <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1485003/000148500319000045/sesenbio-2014stockincentiv.htm">Sesen Bio, Inc. 2014 Stock Incentive Plan, as amended (incorporated by reference to Exhibit&#160;10.1 to the Registrant&#8217;s Current Report on Form 8-K, filed on June&#160;25, 2019).</a>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;letter-spacing:0.2pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 1.333pt 0pt; width:42.39pt;">
                <font style="margin-left:5pt;letter-spacing:0.2pt;">10.5+ </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 1.333pt 0pt; width:401.61pt;white-space:normal;">
                <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1485003/000119312514018644/d613481dex106.htm">Form of Incentive Stock Option Agreement under the Sesen Bio Inc. 2014 Stock Incentive Plan (incorporated by reference to Exhibit&#160;10.6 to the Registrant&#8217;s Registration Statement on Form&#160;S-1/A (File No. 333-193131), filed on January&#160;23, 2014).</a>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;letter-spacing:0.2pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 1.333pt 0pt; width:42.39pt;">
                <font style="margin-left:5pt;letter-spacing:0.2pt;">10.6+ </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 1.333pt 0pt; width:401.61pt;white-space:normal;">
                <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1485003/000119312514018644/d613481dex107.htm">Form of Non-Statutory Stock Option Agreement under the Sesen Bio, Inc. 2014 Stock Incentive Plan (incorporated by reference to Exhibit&#160;10.7 to the Registrant&#8217;s Registration Statement on Form S-1/A (File No. 333-193131), filed on January&#160;23, 2014).</a>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;letter-spacing:0.2pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 1.333pt 0pt; width:42.39pt;">
                <font style="margin-left:5pt;letter-spacing:0.2pt;">10.7+ </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 1.333pt 0pt; width:401.61pt;white-space:normal;">
                <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1485003/000119312515239156/d34817dex101.htm">Form of Restricted Stock Unit Agreement under the Sesen Bio, Inc. 2014 Stock Incentive Plan (incorporated by reference to Exhibit&#160;10.1 to the Registrant&#8217;s Current Report on Form 8-K, filed on June&#160;29, 2015).</a>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;letter-spacing:0.2pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 1.333pt 0pt; width:42.39pt;">
                <font style="margin-left:5pt;letter-spacing:0.2pt;">10.8+ </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 1.333pt 0pt; width:401.61pt;white-space:normal;">
                <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1485003/000148500322000033/exhibit108_formindemnifica.htm">Form of Indemnification Agreement by and between Sesen Bio, Inc. and Each of its Directors and Executive Officers (incorporated by reference to Exhibit&#160;10.8 to the Registrant&#8217;s Annual Report on Form 10-K, filed on February&#160;28, 2022).</a>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;letter-spacing:0.2pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 1.333pt 0pt; width:42.39pt;">
                <font style="margin-left:5pt;letter-spacing:0.2pt;">10.9+ </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 1.333pt 0pt; width:401.61pt;white-space:normal;">
                <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1485003/000119312514018644/d613481dex1013.htm">Eleven Biotherapeutics, Inc. 2014 Employee Stock Purchase Plan (incorporated by reference to Exhibit&#160;10.13 to the Registrant&#8217;s Registration Statement on Form S-1/A (Reg. No. 333-193131), filed on January&#160;23, 2014).</a>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;letter-spacing:0.2pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 1.333pt 0pt; width:42.39pt;">
                <font style="margin-left:5pt;letter-spacing:0.2pt;">10.10&#9826; </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 1.333pt 0pt; width:401.61pt;white-space:normal;">
                <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1485003/000148500318000120/sesnexhibit101micrometli.htm">Non-Exclusive Product License Agreement, effective as of October&#160;18, 2005, by and between Micromet AG and Viventia Biotech Inc. (incorporated by reference to Exhibit&#160;10.1 to the Registrant&#8217;s Quarterly Report on Form 10-Q, filed on November&#160;9, 2018).</a>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;letter-spacing:0.2pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 1.333pt 0pt; width:42.39pt;">
                <font style="margin-left:5pt;letter-spacing:0.2pt;">10.11&#9826; </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 1.333pt 0pt; width:401.61pt;white-space:normal;">
                <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1485003/000148500318000120/sesnexhibit102xomanonexc.htm">Non-Exclusive License Agreement, effective as of November&#160;30, 2001, by and between XOMA Ireland Limited and Viventia Biotech Inc. (incorporated by reference to Exhibit&#160;10.2 to the Registrant&#8217;s Quarterly Report on Form 10-Q, filed on November&#160;9, 2018).</a>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;letter-spacing:0.2pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 1.333pt 0pt; width:42.39pt;">
                <font style="margin-left:5pt;letter-spacing:0.2pt;">10.12+ </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 1.333pt 0pt; width:401.61pt;white-space:normal;">
                <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1485003/000148500318000105/exhibit101-tcannellemploym.htm">Employment Agreement, dated August&#160;7, 2018, by and between Sesen Bio, Inc. and Thomas R. Cannell, D.V.M. (incorporated by reference to Exhibit&#160;10.1 to the Registrant&#8217;s Current Report on Form 8-K, filed on August&#160;13, 2018).</a>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 1.333pt 0pt; width:42.39pt;">
                <font style="margin-left:5pt;letter-spacing:0.2pt;">10.13 </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 1.333pt 0pt; width:401.61pt;white-space:normal;">
                <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1485003/000148500318000027/exhibit101.htm">Form of Securities Purchase Agreement (incorporated by reference to Exhibit&#160;10.1 to the Registrant&#8217;s Current Report on Form 8-K, filed on March&#160;23, 2018).</a>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
          </table>

      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">II-7</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;letter-spacing:0.2pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:4.5pt;margin-left:69.66pt;width:456pt;">

          <table style="width:456pt;height:621.5pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.667pt 0pt; width:42.39pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.16pt;">EXHIBIT</font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">NUMBER </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.667pt 0pt; width:401.61pt;">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">DESCRIPTION OF DOCUMENT </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;letter-spacing:0.2pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.417pt 0pt 1.333pt 0pt; width:42.39pt;">
                <font style="margin-left:5pt;letter-spacing:0.2pt;">10.14 </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.417pt 0pt 1.333pt 0pt; width:401.61pt;white-space:normal;">
                <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1485003/000148500319000082/sesn-spaamendment.htm">Amendment to Securities Purchase Agreement, dated October&#160;28, 2019, by and among Sesen Bio, Inc. and the undersigned parties thereto (incorporated by reference to Exhibit&#160;10.1 to the Registrant&#8217;s Current Report on Form 8-K, filed on October&#160;29, 2019).</a>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;letter-spacing:0.2pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 1.333pt 0pt; width:42.39pt;">
                <font style="margin-left:5pt;letter-spacing:0.2pt;">10.15 </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 1.333pt 0pt; width:401.61pt;white-space:normal;">
                <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1485003/000148500319000015/ex1032sesn-tomcannellstock.htm">Stock Option Award Agreement, dated August&#160;7, 2018, by and between Sesen Bio, Inc. and Thomas R. Cannell, D.V.M (incorporated by reference to Exhibit&#160;10.32 to the Registrant&#8217;s Annual Report on Form 10-K, filed on March&#160;1, 2019).</a>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;letter-spacing:0.2pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 1.333pt 0pt; width:42.39pt;">
                <font style="margin-left:5pt;letter-spacing:0.2pt;">10.16+ </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 1.333pt 0pt; width:401.61pt;white-space:normal;">
                <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1485003/000148500319000029/glenmacdonaldebioemploym.htm">Employment Agreement, dated September&#160;20, 2016, by and between Eleven Biotherapeutics, Inc. and Glen Macdonald, as amended on February&#160;21, 2017 (incorporated by reference to Exhibit&#160;10.1 to the Registrant&#8217;s Quarterly Report on Form 10-Q, filed on May&#160;10, 2019).</a>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;letter-spacing:0.2pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 1.333pt 0pt; width:42.39pt;">
                <font style="margin-left:5pt;letter-spacing:0.2pt;">10.17+ </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 1.333pt 0pt; width:401.61pt;white-space:normal;">
                <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1485003/000148500319000070/sesenbio-monicaforbesemplo.htm">Employment Agreement, dated August&#160;26, 2019, by and between Monica Forbes and Sesen Bio, Inc. (incorporated by reference to Exhibit&#160;10.1 to the Registrant&#8217;s Current Report on Form&#160;8-K, filed on August&#160;26, 2019).</a>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;letter-spacing:0.2pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 1.333pt 0pt; width:42.39pt;">
                <font style="margin-left:5pt;letter-spacing:0.2pt;">10.18+ </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 1.333pt 0pt; width:401.61pt;white-space:normal;">
                <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1485003/000148500319000090/sesn-09302019x10qex101.htm">Employment Agreement, dated July&#160;26, 2019, by and between Mark R. Sullivan and Sesen Bio, Inc. (incorporated by reference to Exhibit&#160;10.1 to the Registrant&#8217;s Quarterly Report on Form&#160;10-Q, filed on November&#160;12, 2019).</a>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;letter-spacing:0.2pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 1.333pt 0pt; width:42.39pt;">
                <font style="margin-left:5pt;letter-spacing:0.2pt;">10.19+ </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 1.333pt 0pt; width:401.61pt;white-space:normal;">
                <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1485003/000148500319000090/sesn-09302019x10qex103.htm">Stock Option Award Agreement, dated August&#160;1, 2019, by and between Sesen Bio, Inc. and Monica Forbes (incorporated by reference to Exhibit&#160;10.3 to the Registrant&#8217;s Quarterly Report on Form 10-Q, filed on November&#160;12, 2019).</a>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;letter-spacing:0.2pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 1.333pt 0pt; width:42.39pt;">
                <font style="margin-left:5pt;letter-spacing:0.2pt;">10.20 </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 1.333pt 0pt; width:401.61pt;white-space:normal;">
                <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1485003/000148500319000096/sesn-atmsalesagencyagreeme.htm">Open Market Sale Agreement</a><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;"><a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1485003/000148500319000096/sesn-atmsalesagencyagreeme.htm">SM</a></font><a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1485003/000148500319000096/sesn-atmsalesagencyagreeme.htm">, dated November&#160;2019, by and between Sesen Bio, Inc. and Jefferies LLC (incorporated by reference to Exhibit&#160;10.1 to the Registrant&#8217;s Current Report on Form 8-K, filed on November&#160;29, 2019).</a>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;letter-spacing:0.2pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 1.333pt 0pt; width:42.39pt;">
                <font style="margin-left:5pt;letter-spacing:0.2pt;">10.21 </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 1.333pt 0pt; width:401.61pt;white-space:normal;">
                <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1485003/000148500320000110/exhibit11-amendmentno1to.htm">Amendment No. 1 to the Open Market Sale Agreement</a><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;"><a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1485003/000148500320000110/exhibit11-amendmentno1to.htm">SM</a></font><a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1485003/000148500320000110/exhibit11-amendmentno1to.htm">, dated October&#160;30, 2020, by and between Sesen Bio, Inc. and Jefferies LLC (incorporated by reference to Exhibit&#160;1.1 to the Registrant&#8217;s Current Report on Form 8-K, filed on October&#160;30, 2020).</a>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;letter-spacing:0.2pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 1.333pt 0pt; width:42.39pt;">
                <font style="margin-left:5pt;letter-spacing:0.2pt;">10.22&#9826; </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 1.333pt 0pt; width:401.61pt;white-space:normal;">
                <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1485003/000148500320000118/sesn-ex101qilulicensea.htm">Exclusive License Agreement, dated July&#160;30, 2020, by and among Sesen Bio, Inc., Viventia Bio, Inc. and Qilu Pharmaceutical Co., Ltd. (incorporated by reference to Exhibit&#160;10.1 to the Registrant&#8217;s Quarterly Report on Form 10-Q, filed on November&#160;9, 2020).</a>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;letter-spacing:0.2pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 1.333pt 0pt; width:42.39pt;">
                <font style="margin-left:5pt;letter-spacing:0.2pt;">10.23 </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 1.333pt 0pt; width:401.61pt;white-space:normal;">
                <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1485003/000148500321000024/sesenatm-amendmentno2toa.htm">Amendment No. 2 to the Open Market Sale Agreement</a><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;"><a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1485003/000148500321000024/sesenatm-amendmentno2toa.htm">SM</a></font><a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1485003/000148500321000024/sesenatm-amendmentno2toa.htm">, dated February&#160;17, 2021, by and between Sesen Bio, Inc. and Jefferies LLC (incorporated by reference to Exhibit&#160;1.1 to the Registrant&#8217;s Current Report on Form 8-K, filed on February&#160;17, 2021).</a>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 1.333pt 0pt; width:42.39pt;">
                <font style="margin-left:5pt;letter-spacing:0.2pt;">10.24+ </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 1.333pt 0pt; width:401.61pt;white-space:normal;">
                <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1485003/000148500321000088/exhibit101-amendmentno2t.htm">Amendment No. 2 to the Sesen Bio, Inc. 2014 Stock Incentive Plan (incorporated by reference to Exhibit&#160;10.1 to the Registrant&#8217;s Current Report on Form 8-K, filed on May&#160;3, 2021).</a>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;letter-spacing:0.2pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 1.333pt 0pt; width:42.39pt;">
                <font style="margin-left:5pt;letter-spacing:0.2pt;">10.25+ </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 1.333pt 0pt; width:401.61pt;white-space:normal;">
                <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1485003/000148500321000088/exhibit102-amendmentno1t.htm">Amendment No. 1 to the Sesen Bio, Inc. 2014 Employee Stock Purchase Plan (incorporated by reference to Exhibit&#160;10.2 to the Registrant&#8217;s Current Report on Form 8-K, filed on May&#160;3, 2021).</a>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;letter-spacing:0.2pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 1.333pt 0pt; width:42.39pt;">
                <font style="margin-left:5pt;letter-spacing:0.2pt;">10.26 </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 1.333pt 0pt; width:401.61pt;white-space:normal;">
                <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1485003/000148500321000114/sesn-amendmentno3toatmsa.htm">Amendment No. 3 to the Open Market Sale Agreement</a><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;"><a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1485003/000148500321000114/sesn-amendmentno3toatmsa.htm">SM</a></font><a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1485003/000148500321000114/sesn-amendmentno3toatmsa.htm">, dated June&#160;1, 2021, by and between Sesen Bio, Inc. and Jefferies LLC (incorporated by reference to Exhibit&#160;1.1 to the Registrant&#8217;s Current Report on Form 8-K, filed on June&#160;1, 2021).</a>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 1.333pt 0pt; width:42.39pt;">
                <font style="margin-left:5pt;letter-spacing:0.2pt;">10.27+ </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 1.333pt 0pt; width:401.61pt;white-space:normal;">
                <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1485003/000148500322000033/exhibit1030-rsuandcashrete.htm">Form of RSU Award Agreement for Retention Awards (incorporated by reference to Exhibit&#160;10.30 to the Registrant&#8217;s Annual Report on Form 10-K, filed on February&#160;28, 2022).</a>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 1.333pt 0pt; width:42.39pt;">
                <font style="margin-left:5pt;letter-spacing:0.2pt;">10.28+ </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 1.333pt 0pt; width:401.61pt;white-space:normal;">
                <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1485003/000148500322000033/exhibit1031-performancexba.htm">Form of PSU Award Agreement for Retention Awards (incorporated by reference to Exhibit&#160;10.31 to the Registrant&#8217;s Annual Report on Form 10-K, filed on February&#160;28, 2022).</a>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;letter-spacing:0.2pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 1.333pt 0pt; width:42.39pt;">
                <font style="margin-left:5pt;letter-spacing:0.2pt;">10.29&#9826; </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 1.333pt 0pt; width:401.61pt;white-space:normal;">
                <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1485003/000148500322000063/sesn-ex101xzurichlicenseag.htm">License Agreement, effective January&#160;13, 2003, as amended and restated on October&#160;14, 2015, by and between The University of Zurich and Viventia Bio, Inc. (incorporated by reference to Exhibit&#160;10.1 to the Registrant&#8217;s Quarterly Report on Form 10-Q, filed on May&#160;9, 2022).</a>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
          </table>

      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">II-8</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">

          <table style="width:456pt;height:645.5pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.667pt 0pt; width:42.39pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.16pt;">EXHIBIT</font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">NUMBER </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.667pt 0pt; width:401.61pt;">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">DESCRIPTION OF DOCUMENT </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;letter-spacing:0.2pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.417pt 0pt 0.5pt 0pt; width:42.39pt;">
                <font style="margin-left:5pt;letter-spacing:0.2pt;">10.30&#9826; </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.417pt 0pt 0.5pt 0pt; width:401.61pt;white-space:normal;">
                <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1485003/000148500322000092/ex101-sesenrocheassetpur.htm">Asset Purchase Agreement, dated as of July&#160;15, 2022 by and among Sesen Bio, Inc., F.&#160;Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc. (incorporated by reference to Exhibit&#160;10.1 to the Registrant&#8217;s Current Report on Form 8-K, filed on July&#160;18, 2022).</a>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;letter-spacing:0.2pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 0.5pt 0pt; width:42.39pt;">
                <font style="margin-left:5pt;letter-spacing:0.2pt;">10.31+ </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 0.5pt 0pt; width:401.61pt;white-space:normal;">
                <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1485003/000148500322000121/sesenbio_minorirosales-e.htm">Employment Agreement, dated January 5, 2022, by and between Sesen Bio, Inc. and Minori Rosales (incorporated by reference to Exhibit 10.1 to the Registrant&#8217;s Quarterly Report on Form 10-Q/A, filed on August 25, 2022).</a>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;letter-spacing:0.2pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 0.5pt 0pt; width:42.39pt;">
                <font style="margin-left:5pt;letter-spacing:0.2pt;">10.32^&#9826; </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 0.5pt 0pt; width:401.61pt;white-space:normal;">
                <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1485003/000110465922120867/sesn-20220930xex10d32.htm">Collaboration and License Agreement, dated January&#160;7, 2022, by and between Carisma and Moderna Therapeutics Inc. </a>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;letter-spacing:0.2pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 0.5pt 0pt; width:42.39pt;">
                <font style="margin-left:5pt;letter-spacing:0.2pt;">10.33&#9826; </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 0.5pt 0pt; width:401.61pt;white-space:normal;">
                <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1485003/000110465922108912/sesn-20211231xex10d33.htm">License Agreement, dated as of November&#160;10, 2017, by and between Carisma and the Trustees of the University of Pennsylvania, as amended (incorporated by reference to Exhibit 10.33 to the Registrant&#8217;s Registration Statement on Form S-4 (File No. 333-267891), filed on October 14, 2022).</a>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;letter-spacing:0.2pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 0.5pt 0pt; width:42.39pt;">
                <font style="margin-left:5pt;letter-spacing:0.2pt;">10.34&#9826; </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 0.5pt 0pt; width:401.61pt;white-space:normal;">
                <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1485003/000110465922108912/sesn-20211231xex10d34.htm">License Agreement, dated as of July&#160;24, 2020, by and between Carisma and New York University (incorporated by reference to Exhibit 10.34 to the Registrant&#8217;s Registration Statement on Form S-4 (File No. 333-267891), filed on October 14, 2022).</a>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 0.5pt 0pt; width:42.39pt;">
                <font style="margin-left:5pt;letter-spacing:0.2pt;">10.35</font><font style="letter-spacing:0.2pt;">*</font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 0.5pt 0pt; width:401.61pt;white-space:normal;">
                <div style="letter-spacing:0.2pt;">
                  <a style="-sec-extract:exhibit" href="tm2227887d12_ex10-35.htm">Amended and Restated Subscription Agreement, dated as of December&#160;29, 2022, by and between Carisma and each of the purchasers listed on the signature pages thereto, severally and not jointly.</a>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:4pt 0pt 2pt 0pt; width:42.39pt;">
                <font style="margin-left:5pt;letter-spacing:0.2pt;">10.36^+ </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:4pt 0pt 2pt 0pt; width:401.61pt;">
                <div style="letter-spacing:0.2pt;">
                  <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1485003/000110465922120867/sesn-20220930xex10d36.htm">Offer Letter, dated as of February 12, 2018, by and between Carisma and Steven Kelly.</a>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:4pt 0pt 2pt 0pt; width:42.39pt;">
                <font style="margin-left:5pt;letter-spacing:0.2pt;">10.37^+ </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:4pt 0pt 2pt 0pt; width:401.61pt;">
                <div style="letter-spacing:0.2pt;">
                  <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1485003/000110465922120867/sesn-20220930xex10d37.htm">Offer Letter, dated as of October 18, 2018, by and between Carisma and Michael Klichinsky.</a>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:4pt 0pt 2pt 0pt; width:42.39pt;">
                <font style="margin-left:5pt;letter-spacing:0.2pt;">10.38^+ </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:4pt 0pt 2pt 0pt; width:401.61pt;">
                <div style="letter-spacing:0.2pt;">
                  <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1485003/000110465922120867/sesn-20220930xex10d38.htm">Offer Letter, dated as of March 15, 2021, by and between Carisma and Richard Morris.</a>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:4pt 0pt 2pt 0pt; width:42.39pt;">
                <font style="margin-left:5pt;letter-spacing:0.2pt;">10.39^+ </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:4pt 0pt 2pt 0pt; width:401.61pt;">
                <div style="letter-spacing:0.2pt;">
                  <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1485003/000110465922120867/sesn-20220930xex10d39.htm">Carisma 2017 Stock Incentive Plan, as amended.</a>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:4pt 0pt 2pt 0pt; width:42.39pt;">
                <font style="margin-left:5pt;letter-spacing:0.2pt;">21.1^ </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:4pt 0pt 2pt 0pt; width:401.61pt;">
                <div style="letter-spacing:0.2pt;">
                  <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1485003/000110465922108912/sesn-20211231xex21d1.htm">Subsidiaries of Sesen Bio, Inc.</a>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:4pt 0pt 2pt 0pt; width:42.39pt;">
                <font style="margin-left:5pt;letter-spacing:0.2pt;">23.1* </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:4pt 0pt 2pt 0pt; width:401.61pt;">
                <div style="letter-spacing:0.2pt;">
                  <a style="-sec-extract:exhibit" href="tm2227887d12_ex23-1.htm">Consent of KPMG LLP.</a>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:4pt 0pt 2pt 0pt; width:42.39pt;">
                <font style="margin-left:5pt;letter-spacing:0.2pt;">23.2^ </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:4pt 0pt 2pt 0pt; width:401.61pt;">
                <div style="letter-spacing:0.2pt;">
                  <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1485003/000110465922120867/sesn-20220930xex5d1.htm">Consent of Hogan Lovells US LLP (contained in Exhibit&#160;5.1). </a>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:4pt 0pt 2pt 0pt; width:42.39pt;">
                <font style="margin-left:5pt;letter-spacing:0.2pt;">23.3* </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:4pt 0pt 2pt 0pt; width:401.61pt;">
                <div style="letter-spacing:0.2pt;">
                  <a style="-sec-extract:exhibit" href="tm2227887d12_ex23-3.htm">Consent of Ernst &amp; Young, LLP.</a>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:4pt 0pt 2pt 0pt; width:42.39pt;">
                <font style="margin-left:5pt;letter-spacing:0.2pt;">23.4</font><font style="letter-spacing:0.2pt;">^</font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:4pt 0pt 2pt 0pt; width:401.61pt;">
                <div style="letter-spacing:0.2pt;">
                  <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1485003/000110465922127022/tm2227887d10_ex8-1.htm">Consent of Wilmer Cutler Pickering Hale and Dorr LLP (contained in Exhibit 8.1).</a>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:4pt 0pt 2pt 0pt; width:42.39pt;">
                <font style="margin-left:5pt;letter-spacing:0.2pt;">23.5</font><font style="letter-spacing:0.2pt;">^</font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:4pt 0pt 2pt 0pt; width:401.61pt;">
                <div style="letter-spacing:0.2pt;">
                  <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1485003/000110465922127022/tm2227887d10_ex8-2.htm">Consent of Hogan Lovells US LLP (contained in Exhibit 8.2). </a>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:4pt 0pt 2pt 0pt; width:42.39pt;">
                <font style="margin-left:5pt;letter-spacing:0.2pt;">24.1^ </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:4pt 0pt 2pt 0pt; width:401.61pt;">
                <div style="letter-spacing:0.2pt;">
                  <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1485003/000110465922108912/sesn-20211231xs4.htm#Signature">Power of Attorney.</a>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:4pt 0pt 2pt 0pt; width:42.39pt;">
                <font style="margin-left:5pt;letter-spacing:0.2pt;">99.1** </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:4pt 0pt 2pt 0pt; width:401.61pt;">
                <font style="letter-spacing:0.2pt;">Form of Proxy Card for Special Meeting of Stockholders of Registrant. </font>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;letter-spacing:0.2pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 0.5pt 0pt; width:42.39pt;">
                <font style="margin-left:5pt;letter-spacing:0.2pt;">99.2* </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 0.5pt 0pt; width:401.61pt;white-space:normal;">
                <a href="#AnnexG">Proposed Certificate of Amendment to the Restated Certificate of Incorporation of Registrant for the Sesen Bio, Inc. Reverse Stock Split (included as Annex G to the proxy statement/&#8203;prospectus forming a part of this Registration Statement).</a>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 0.5pt 0pt; width:42.39pt;">
                <font style="margin-left:5pt;letter-spacing:0.2pt;">99.3* </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.667pt 0pt 0.5pt 0pt; width:401.61pt;white-space:normal;">
                <div style="letter-spacing:0.2pt;">
                  <a href="#tANNB">Opinion of SVB Securities LLC, financial advisor to Sesen Bio, Inc. (included as Annex B to the proxy statement/prospectus forming part of this Registration Statement).</a>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:4pt 0pt 2pt 0pt; width:42.39pt;">
                <font style="margin-left:5pt;letter-spacing:0.2pt;">99.4* </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:4pt 0pt 2pt 0pt; width:401.61pt;">
                <div style="letter-spacing:0.2pt;">
                  <a style="-sec-extract:exhibit" href="tm2227887d12_ex99-4.htm">Consent of SVB Securities LLC, financial advisor to Sesen Bio, Inc.</a>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:4pt 0pt 2pt 0pt; width:42.39pt;">
                <font style="margin-left:5pt;letter-spacing:0.2pt;">99.5^ </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:4pt 0pt 2pt 0pt; width:401.61pt;">
                <div style="letter-spacing:0.2pt;">
                  <a style="-sec-extract:exhibit" href="http://www.sec.gov/Archives/edgar/data/1485003/000110465922108912/sesn-20211231xex99d5.htm">Consent of Sanford Zweifach to be named as a Director.</a>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:4pt 0pt 2pt 0pt; width:42.39pt;">
                <font style="margin-left:5pt;letter-spacing:0.2pt;">99.6^ </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:4pt 0pt 2pt 0pt; width:401.61pt;">
                <div style="letter-spacing:0.2pt;">
                  <a style="-sec-extract:exhibit" href="http://www.sec.gov/Archives/edgar/data/1485003/000110465922108912/sesn-20211231xex99d6.htm">Consent of Regina Hodits, Ph.D. to be named as a Director.</a>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:4pt 0pt 2pt 0pt; width:42.39pt;">
                <font style="margin-left:5pt;letter-spacing:0.2pt;">99.7^ </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:4pt 0pt 2pt 0pt; width:401.61pt;">
                <div style="letter-spacing:0.2pt;">
                  <a style="-sec-extract:exhibit" href="http://www.sec.gov/Archives/edgar/data/1485003/000110465922108912/sesn-20211231xex99d7.htm">Consent of Steven Kelly to be named as a Director. </a>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:4pt 0pt 2pt 0pt; width:42.39pt;">
                <font style="margin-left:5pt;letter-spacing:0.2pt;">99.8^ </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:4pt 0pt 2pt 0pt; width:401.61pt;">
                <div style="letter-spacing:0.2pt;">
                  <a style="-sec-extract:exhibit" href="http://www.sec.gov/Archives/edgar/data/1485003/000110465922108912/sesn-20211231xex99d8.htm">Consent of Briggs Morrison, M.D. to be named as a Director.</a>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;letter-spacing:0.2pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:4pt 0pt 2pt 0pt; width:42.39pt;">
                <font style="margin-left:5pt;letter-spacing:0.2pt;">99.9^ </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:4pt 0pt 2pt 0pt; width:401.61pt;">
                <a style="-sec-extract:exhibit" href="http://www.sec.gov/Archives/edgar/data/1485003/000110465922108912/sesn-20211231xex99d9.htm">Consent of Bj&#246;rn Odlander to be named as a Director.</a>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:4pt 0pt 2pt 0pt; width:42.39pt;">
                <font style="margin-left:5pt;letter-spacing:0.2pt;">99.10^ </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:4pt 0pt 2pt 0pt; width:401.61pt;">
                <div style="letter-spacing:0.2pt;">
                  <a style="-sec-extract:exhibit" href="http://www.sec.gov/Archives/edgar/data/1485003/000110465922108912/sesn-20211231xex99d10.htm">Consent of Chidozie Ugwumba to be named as a Director.</a>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:4pt 0pt 2pt 0pt; width:42.39pt;">
                <font style="letter-spacing:0.2pt;">101.INS </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:4pt 0pt 2pt 0pt; width:401.61pt;">
                <font style="letter-spacing:0.2pt;">XBRL Instance Document. </font>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
          </table>

      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">II-9</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:389.5pt;margin-left:69.66pt;width:456pt;">

          <table style="width:456pt;height:115.5pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0.167pt 0pt 2.667pt 0pt; width:42.39pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.16pt;">EXHIBIT</font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">NUMBER </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0.167pt 0pt 2.667pt 0pt; width:401.61pt;">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">DESCRIPTION OF DOCUMENT </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:3.75pt 0pt 2pt 0pt; width:42.39pt;">
                <font style="letter-spacing:0.2pt;">101.SCH </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.75pt 0pt 2pt 0pt; width:401.61pt;">
                <font style="letter-spacing:0.2pt;">XBRL Taxonomy Extension Schema Document. </font>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:4pt 0pt 2pt 0pt; width:42.39pt;">
                <font style="letter-spacing:0.2pt;">101.CAL </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:4pt 0pt 2pt 0pt; width:401.61pt;">
                <font style="letter-spacing:0.2pt;">XBRL Taxonomy Extension Calculation Linkbase Document. </font>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:4pt 0pt 2pt 0pt; width:42.39pt;">
                <font style="letter-spacing:0.2pt;">101.DEF </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:4pt 0pt 2pt 0pt; width:401.61pt;">
                <font style="letter-spacing:0.2pt;">XBRL Taxonomy Extension Definition Linkbase Document. </font>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:4pt 0pt 2pt 0pt; width:42.39pt;">
                <font style="letter-spacing:0.2pt;">101.LAB </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:4pt 0pt 2pt 0pt; width:401.61pt;">
                <font style="letter-spacing:0.2pt;">XBRL Taxonomy Extension Label Linkbase Document. </font>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:4pt 0pt 2pt 0pt; width:42.39pt;">
                <font style="letter-spacing:0.2pt;">101.PRE </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:4pt 0pt 2pt 0pt; width:401.61pt;">
                <font style="letter-spacing:0.2pt;">XBRL Taxonomy Extension Presentation Linkbase Document. </font>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:4pt 0pt 2pt 0pt; width:42.39pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:0.2pt;">107^ </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:4pt 0pt 2pt 0pt; width:401.61pt;text-align:left;">
                <div style="letter-spacing:0.2pt;">
                  <a style="-sec-extract:exhibit" href="http://www.sec.gov/Archives/edgar/data/1485003/000110465922108912/sesn-20211231xexfilingfees.htm">Filing Fee Table.</a>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
          </table>

        <div style="margin-top:12.5pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">*</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Filed herewith. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">**</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">To be filed by amendment. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">^</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Previously filed. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">+</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Indicates management contract or compensatory plan. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8224;</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Certain schedules and exhibits have been omitted pursuant to Item&#160;601 of Regulation&#160;S-K. A copy of any omitted schedule and/or exhibit will be furnished to the SEC upon request. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#9826;</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Portions of this exhibit have been omitted pursuant to Item 601(b)(10)(iv) of Regulation S-K.</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">II-10</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style=" width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:30.5pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">SIGNATURES</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Pursuant to the requirements of the Securities Act of 1933, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized in the town of Cambridge, Commonwealth of Massachusetts, on January&#160;9, 2023. </font>
          </div>

        <div style="margin-left:240pt; margin-top:8pt; width:216pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">SESEN BIO, INC.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:240pt; line-height:12pt; margin-top:18pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">By:</font>
          <br >
        </div>
        <div style=" margin-top:18pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:260pt;">
          <font style="letter-spacing:0.2pt;">/s/ Thomas R. Cannell, D.V.M.</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="white-space:nowrap; margin-left:260pt; margin-top:2.5pt; width:196pt;">
          <div style="margin-left: 0pt; width: 196pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-left:260pt; margin-top:2pt; margin-bottom:0pt; text-align:left; width:33pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">Name:</font>
          <br >
        </div>
        <div style=" margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:293pt;">
          <font style="letter-spacing:0.2pt;">Thomas R. Cannell, D.V.M. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:260pt; line-height:12pt; margin-top:0pt; margin-bottom:0pt; text-align:left; width:33pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">Title:</font>
          <br >
        </div>
        <div style=" margin-top:0pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:293pt;">
          <font style="letter-spacing:0.2pt;">President and Chief Executive Officer </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed below by the following persons in the capacities and on the dates indicated. </font>
        </div>

          <table style="width:456pt;height:333.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <tr style="line-height:8pt;min-height:9.25pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:182.93pt;">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Signature </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:182.93pt;">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Title </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:66.15pt;">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Date </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;min-height:52.25pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:19.917pt 0pt 0.5pt 0pt; width:182.93pt;">
                <div>
                  <font style="letter-spacing:0.2pt;">/s/ Thomas R. Cannell, D.V.M.</font>
                </div>
                <div style="margin-top:2.5pt; text-align:justify;">
                  <div style="margin-left: 0pt; width: 182.93pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
                </div>
                <div style="margin-top:2pt;">
                  <font style="letter-spacing:0.2pt;">Thomas R. Cannell, D.V.M. </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:19.917pt 0pt 0.5pt 0pt; width:182.93pt;">
                <font style="letter-spacing:0.2pt;">Director, President and Chief Executive Officer (Principal Executive Officer) </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:19.917pt 0pt 0.5pt 0pt; width:66.15pt;white-space:nowrap;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">January&#160;9, 2023</font>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;min-height:39pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:7.167pt 0pt 0.5pt 0pt; width:182.93pt;">
                <div>
                  <font style="letter-spacing:0.2pt;">*</font>
                </div>
                <div style="margin-top:2.5pt; text-align:justify;">
                  <div style="margin-left: 0pt; width: 182.93pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
                </div>
                <div style="margin-top:2pt;">
                  <font style="letter-spacing:0.2pt;">Monica Forbes </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:7.167pt 0pt 0.5pt 0pt; width:182.93pt;">
                <font style="letter-spacing:0.2pt;">Chief Financial Officer (Principal Financial Officer) </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:7.167pt 0pt 0.5pt 0pt; width:66.15pt;white-space:nowrap;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">January&#160;9, 2023</font>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;min-height:39pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:7.167pt 0pt 0.5pt 0pt; width:182.93pt;">
                <div>
                  <font style="letter-spacing:0.2pt;">*</font>
                </div>
                <div style="margin-top:2.5pt; text-align:justify;">
                  <div style="margin-left: 0pt; width: 182.93pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
                </div>
                <div style="margin-top:2pt;">
                  <font style="letter-spacing:0.2pt;">Elly Ryu </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:7.167pt 0pt 0.5pt 0pt; width:182.93pt;">
                <font style="letter-spacing:0.2pt;">Corporate Controller (Principal Accounting Officer) </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:7.167pt 0pt 0.5pt 0pt; width:66.15pt;white-space:nowrap;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">January&#160;9, 2023</font>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;min-height:39pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:7.167pt 0pt 0.5pt 0pt; width:182.93pt;white-space:normal;">
                <div>
                  <font style="letter-spacing:0.2pt;">*</font>
                </div>
                <div style="margin-top:2.5pt; text-align:justify;">
                  <div style="margin-left: 0pt; width: 182.93pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
                </div>
                <div style="margin-top:2pt;">
                  <font style="letter-spacing:0.2pt;">Jay S. Duker, M.D. </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:7.167pt 0pt 0.5pt 0pt; width:182.93pt;">
                <font style="letter-spacing:0.2pt;">Chair of the Board of Directors </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:7.167pt 0pt 0.5pt 0pt; width:66.15pt;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">January&#160;9, 2023</font>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;min-height:39pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:7.167pt 0pt 0.5pt 0pt; width:182.93pt;white-space:normal;">
                <div>
                  <font style="letter-spacing:0.2pt;">*</font>
                </div>
                <div style="margin-top:2.5pt; text-align:justify;">
                  <div style="margin-left: 0pt; width: 182.93pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
                </div>
                <div style="margin-top:2pt;">
                  <font style="letter-spacing:0.2pt;">Carrie L. Bourdow </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:7.167pt 0pt 0.5pt 0pt; width:182.93pt;">
                <font style="letter-spacing:0.2pt;">Director </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:7.167pt 0pt 0.5pt 0pt; width:66.15pt;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">January&#160;9, 2023</font>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;min-height:39pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:7.167pt 0pt 0.5pt 0pt; width:182.93pt;white-space:normal;">
                <div>
                  <font style="letter-spacing:0.2pt;">*</font>
                </div>
                <div style="margin-top:2.5pt; text-align:justify;">
                  <div style="margin-left: 0pt; width: 182.93pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
                </div>
                <div style="margin-top:2pt;">
                  <font style="letter-spacing:0.2pt;">Peter K. Honig, M.D. </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:7.167pt 0pt 0.5pt 0pt; width:182.93pt;">
                <font style="letter-spacing:0.2pt;">Director </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:7.167pt 0pt 0.5pt 0pt; width:66.15pt;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">January&#160;9, 2023</font>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;min-height:44pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:12.167pt 0pt 0.5pt 0pt; width:182.93pt;white-space:normal;">
                <div>
                  <font style="letter-spacing:0.2pt;">*</font>
                </div>
                <div style="margin-top:2.5pt; text-align:justify;">
                  <div style="margin-left: 0pt; width: 182.93pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
                </div>
                <div style="margin-top:2pt;">
                  <font style="letter-spacing:0.2pt;">Michael A.S. Jewett, M.D. </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:12.167pt 0pt 0.5pt 0pt; width:182.93pt;">
                <font style="letter-spacing:0.2pt;">Director </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:12.167pt 0pt 0.5pt 0pt; width:66.15pt;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">January&#160;9, 2023</font>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;min-height:38pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:7.167pt 0pt 0.5pt 0pt; width:182.93pt;white-space:normal;">
                <div>
                  <font style="letter-spacing:0.2pt;">*</font>
                </div>
                <div style="margin-top:2.5pt; text-align:justify;">
                  <div style="margin-left: 0pt; width: 182.93pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
                </div>
                <div style="margin-top:2pt;">
                  <font style="letter-spacing:0.2pt;">Jason A. Keyes </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:7.167pt 0pt 0.5pt 0pt; width:182.93pt;">
                <font style="letter-spacing:0.2pt;">Director </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:7.167pt 0pt 0.5pt 0pt; width:66.15pt;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">January&#160;9, 2023</font>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
          </table>

        <div style="margin-top:12.5pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">*</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Thomas R. Cannell, by signing his name hereto, signs this registration statement on behalf of the officers and directors of the registrant above in front of whose name an asterisk appears pursuant to powers of attorney duly executed by such officers and directors and filed with the SEC.</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">By: /s/ Thomas R. Cannell, D.V.M.</font>
        </div>
        <div style="margin-top:1.5pt; width:456pt;">
          <div style="margin-left: 0pt; width: 192pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Attorney-in-fact</font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">II-11</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.35
<SEQUENCE>2
<FILENAME>tm2227887d12_ex10-35.htm
<DESCRIPTION>EXHIBIT 10.35
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>EXHIBIT&nbsp;10.35</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>AMENDED AND RESTATED SUBSCRIPTION AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>THIS AMENDED AND RESTATED SUBSCRIPTION AGREEMENT
</B>(this &ldquo;<B><I>Agreement</I></B>&rdquo;) is made as of December&nbsp;29, 2022 (the &ldquo;<B><I>Effective Date</I></B>&rdquo;)
by and among CARISMA Therapeutics Inc., a Delaware corporation (the &ldquo;<B><I>Company</I></B>&rdquo;), and each of the purchasers
listed on <U>Schedule I</U> hereto, severally and not jointly (each a &ldquo;<B><I>Purchaser</I></B>&rdquo; and together the &ldquo;<B><I>Purchasers</I></B>&rdquo;).
Certain terms used and not otherwise defined in the text of this Agreement are defined in <U>Section&nbsp;7</U> hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>RECITALS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>WHEREAS, </B>the Company and the Purchasers
are party to that certain Subscription Agreement, dated as of September&nbsp;20, 2022 (the &ldquo;<B><I>Original Agreement</I></B>&rdquo;),
and the parties hereto desire to amend and restate the Original Agreement in its entirety and to accept the rights and obligations created
pursuant to this Agreement in lieu of the rights and obligations created pursuant to the Original Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>WHEREAS</B>, the Company is party to that certain
Agreement and Plan of Merger and Reorganization by and among the Company, Sesen Bio,&nbsp;Inc. (&ldquo;<B><I>Sesen Bio</I></B>&rdquo;),
and Seahawk Merger Sub,&nbsp;Inc. (&ldquo;<B><I>Merger Sub</I></B>&rdquo;), dated as of September&nbsp;20, 2022, as amended by Amendment
No.&nbsp;1 (the &ldquo;<B><I>Amendment</I></B>&rdquo;), dated as of December&nbsp;29, 2022 (the &ldquo;<B><I>Merger Agreement</I></B>&rdquo;),
pursuant to which Merger Sub will merge with and into the Company (the &ldquo;<B><I>Merger</I></B>&rdquo;) and, upon consummation of
the Merger, Merger Sub will cease to exist and the Company will become a wholly-owned subsidiary of Sesen Bio;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>WHEREAS</B>, the Company desires to sell to
the Purchasers, and the Purchasers desire to purchase from the Company,&nbsp;up to $30,639,975.60 in the aggregate of shares of the Company&rsquo;s
common stock, par value $0.0001 per share (the &ldquo;<B><I>Common Stock</I></B>&rdquo;), at a per share purchase price equal to the
Purchase Price, in accordance with the terms and provisions of this Agreement, immediately prior to, but subject to, the subsequent closing
of the Merger;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>WHEREAS</B>, it is understood and agreed that,
upon the closing of the Merger, the Common Stock purchased pursuant to this Agreement shall be exchanged for shares of Sesen Bio&rsquo;s
common stock, par value $0.001 per share (&ldquo;<B><I>Sesen Bio Common Stock</I></B>&rdquo;); and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>WHEREAS</B>, the Company and the Purchasers
are executing and delivering this Agreement in reliance upon the exemption from registration available under Section&nbsp;4(a)(2)&nbsp;of
the Securities Act;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>NOW, THEREFORE</B>, in consideration of the
foregoing and the mutual representations, warranties and covenants, and subject to the conditions, herein contained, and intending to
be legally bound hereby, the parties hereto hereby agree that the Original Agreement shall be amended and restated in its entirety by
this Agreement and further agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">SECTION&nbsp;1.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Authorization
of Securities</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">1.01&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Company has authorized the sale and issuance of shares of Common Stock on the terms and subject to the conditions set forth in this Agreement.
The shares of Common Stock sold hereunder at the Closing (as defined below) shall be referred to as the &ldquo;<B><I>Securities</I></B>.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">SECTION&nbsp;2.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Sale
and Purchase of the Securities</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">2.01&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Upon
the terms and subject to the conditions herein contained, the Company agrees to sell to each Purchaser, and each Purchaser agrees, severally
and not jointly, to purchase from the Company, at a closing to take place remotely via exchange of executed documents (the &ldquo;<B><I>Closing</I></B>&rdquo;
and the date of the Closing, the &ldquo;<B><I>Closing Date</I></B>&rdquo;) to occur immediately prior to the Effective Time (as such
term is defined in the Merger Agreement), that number of Securities (the &ldquo;<B><I>Closing Shares</I></B>&rdquo;) set forth opposite
such Purchaser&rsquo;s name on <U>Schedule I</U> for the aggregate Purchase Price set forth under the heading &ldquo;Subscription Amount&rdquo;
(the &ldquo;<B><I>Subscription Amount</I></B>&rdquo;). The Company&rsquo;s agreements hereunder with each of the Purchasers are separate
agreements, and the sales of the Securities to each of the Purchasers are separate sales.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">2.02&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;At
least two Business Days prior to the Closing, each Purchaser will pay the Subscription Amount set forth opposite such Purchaser&rsquo;s
name on <U>Schedule I</U> by wire transfer of U.S. dollars in immediately available funds in accordance with wire instructions to be
provided by the Company to the Purchasers at least five Business Days prior to the Closing (the &ldquo;<B><I>Wire Instructions Notice</I></B>&rdquo;)
specifying (i)&nbsp;the anticipated Closing Date and (ii)&nbsp;the wire instructions for delivery of the Subscription Amount to the Company.
The Subscription Amount of each Purchaser shall be paid into an escrow fund or trust account designated by the Company in writing (the
 &ldquo;<B><I>Escrow Account</I></B>&rdquo;) to be released to the Company only upon satisfaction (or, if applicable, waiver) of each
of the closing conditions set forth in <U>Section&nbsp;6</U> below. On the Closing Date, the Company will issue, against payment of the
aggregate Purchase Price, the Closing Shares. In the event the Closing does not occur within ten Business Days of the Closing Date specified
in the Wire Instructions Notice, unless otherwise agreed by the Company and such Purchaser, the Company shall, or shall cause the escrow
agent for the Escrow Account to, promptly (but not later than two Business Days thereafter) return the aggregate Purchase Price to each
Purchaser by wire transfer of U.S. dollars in immediately available funds to the account specified by such Purchaser. Notwithstanding
such return of the aggregate Purchase Price to Purchasers, (i)&nbsp;a failure to close on the anticipated Closing Date shall not, by
itself, be deemed to be a failure of any of the conditions to Closing set forth in <U>Section&nbsp;6</U> to be satisfied or waived on
or prior to the Closing Date, and (ii)&nbsp;unless and until this Agreement is terminated in accordance with <U>Section&nbsp;8.12</U>
hereof, the Purchasers shall remain obligated (A)&nbsp;to redeliver funds to the Company following the Company&rsquo;s delivery to the
Purchasers of a new Wire Instructions Notice and (B)&nbsp;to consummate the Closing upon satisfaction of the conditions set forth in
<U>Section&nbsp;6</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">SECTION&nbsp;3.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Representations
and Warranties of the Purchasers</U>. Each Purchaser, severally and not jointly, represents and warrants to the Company that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">3.01&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Validity</U>.
The execution, delivery and performance of this Agreement and the consummation by the Purchaser of the transactions contemplated hereby
have been duly authorized by all necessary corporate, partnership, limited liability or similar actions, as applicable, on the part of
such Purchaser. This Agreement has been duly executed and delivered by the Purchaser and, assuming that this Agreement constitutes the
valid and binding obligation of the Company, constitutes a valid and binding obligation of the Purchaser, enforceable against it in accordance
with its terms, except as limited by applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance, and any other
laws of general application affecting enforcement of creditors&rsquo; rights generally, and as limited by laws relating to the availability
of specific performance, injunctive relief, or other equitable remedies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">3.02&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Disclosure
and Offering Documents</U>. No disclosure or offering document has been provided to the Purchaser in connection with the offer and sale
of the Securities by any of Evercore Group L.L.C., BofA Securities,&nbsp;Inc. or their respective affiliates (together, the &ldquo;<B><I>Placement
Agents</I></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">3.03&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Investment
Decision</U>. (i)&nbsp;The Purchaser has conducted its own investigation of the Company and the Securities and the Purchaser has not
relied on any statements or other information provided by the Placement Agents concerning the Company or the Securities or the offer
and sale of the Securities, (ii)&nbsp;the Purchaser has had access to, and an adequate opportunity to review, financial and other information
as the Purchaser deems necessary to make its decision to purchase the Securities, (iii)&nbsp;the Purchaser has been offered the opportunity
to ask questions of the Company and received answers thereto, including on the financial information, as the Purchaser deems necessary
in connection with its decision to purchase the Securities; and (iv)&nbsp;the Purchaser has made its own assessment and has satisfied
itself concerning the relevant tax and other economic considerations relevant to the Purchaser&rsquo;s investment in the Securities.
The Purchaser is relying solely on the Purchaser&rsquo;s own determination as to tax consequences or the advice of its own tax advisors
and not on any statements or representations of the Company or any of its agents and understands that the Purchaser (and not the Company)
shall be responsible for the Purchaser&rsquo;s own tax liability that may arise as a result of the transactions contemplated by this
Agreement. It is acknowledged that the Purchaser is relying on the Company&rsquo;s representations, warranties and covenants contained
in this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">3.04&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Projections
and Assumptions</U>. The Purchaser acknowledges that certain information provided to the Purchaser was based on projections, and such
projections were prepared based on assumptions and estimates that are inherently uncertain and are subject to a wide variety of significant
business, economic and competitive risks and uncertainties that could cause actual results to differ materially from those contained
in the projections. The Purchaser acknowledges that such information and projections were prepared without the participation of the Placement
Agents and that the Placement Agents do not assume responsibility for independent verification of, or the accuracy or completeness of,
such information or projections. It is acknowledged that the Purchaser is relying on the Company&rsquo;s representations, warranties
and covenants contained in this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">3.05&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Liability
and Release</U>. The Purchaser agrees that none of the Placement Agents shall be liable to the Purchaser (including in contract, tort,
under federal or state securities laws or otherwise) for any action heretofore or hereafter taken or omitted to be taken by any of them
in connection with the transactions contemplated herein. On behalf of the Purchaser and its affiliates, the Purchaser releases the Placement
Agents in respect of any losses, claims, damages, obligations, penalties, judgments, awards, liabilities, costs, expenses or disbursements
related to the transactions contemplated herein. The Purchaser agrees not to commence any litigation or bring any claim against any of
the Placement Agents in any court or any other forum which relates to, may arise out of, or is in connection with, the transactions contemplated
herein. This undertaking is given freely and after obtaining independent legal advice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">3.06&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Information
Supplied</U>. The Purchaser acknowledges that the Placement Agents and their respective directors, officers, employees, representatives
and controlling persons have made no independent investigation with respect to the Company or the Securities or the accuracy, completeness
or adequacy of any information supplied to the Purchaser by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">3.07&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Placement
Agents Not Financial Advisors or Fiduciaries</U>. In connection with the issue and purchase of the Securities, the Placement Agents have
not acted as the Purchaser&rsquo;s financial advisors or fiduciaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">3.08&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Accredited
Investor</U>. The Purchaser is (i)&nbsp;a qualified institutional buyer (as defined in Rule&nbsp;144A of the Securities Act) or (ii)&nbsp;an
institutional &ldquo;accredited investor&rdquo; (as described in Rule&nbsp;501(a)(1), (2), (3)&nbsp;or (7)&nbsp;under the Securities
Act). Accordingly, the Purchaser understands that this financing meets the exemptions from filing under FINRA Rule&nbsp;5123(b)(1)(C)&nbsp;or
(J).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">3.09&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>FINRA</U>.
The Purchaser (i)&nbsp;is an institutional account as defined in FINRA Rule&nbsp;4512(c), (ii)&nbsp;is a sophisticated investor, experienced
in investing in private equity transactions and capable of evaluating investment risks independently, both in general and with regard
to all transactions and investment strategies involving a security or securities and (iii)&nbsp;has exercised independent judgment in
evaluating its participation in the purchase of the Securities. Accordingly, the Purchaser understands that this financing meets (A)&nbsp;the
exemptions from filing under FINRA Rule&nbsp;5123(b)(1)(A)&nbsp;and (B)&nbsp;the institutional customer exemption under FINRA Rule&nbsp;2111(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">3.10&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Acquisition
for Own Account</U>. The Purchaser is aware that the sale to it is being made in reliance on a private placement exemption from registration
under the Securities Act and is acquiring the Securities for the Purchaser&rsquo;s own account or for an account over which it exercises
sole discretion for another qualified institutional buyer or institutional accredited investor. The Purchaser is acquiring the Securities
for investment and not with a view towards distribution in a manner which would violate the Securities Act or any applicable state or
other securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">3.11&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Ability
to Protect Its Own Interests and Bear Economic Risks</U>. The Purchaser is able to fend for itself in the transactions contemplated herein;
has such knowledge and experience in financial and business matters as to be capable of evaluating the merits and risks of the Purchaser&rsquo;s
prospective investment in the Securities; and has the ability to bear the economic risks of its prospective investment and can afford
the complete loss of such investment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">3.12&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Restricted
Securities</U>. The Purchaser understands and agrees that the Securities have not been registered under the Securities Act or any other
applicable securities laws, are being offered for resale in transactions not requiring registration under the Securities Act, and until
so registered, may not be offered, sold or otherwise transferred except in compliance with the registration requirements of the Securities
Act or any other applicable securities laws, pursuant to any exemption therefrom or in a transaction not subject thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">3.13&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>No
General Solicitation</U>. The Purchaser has not been solicited to purchase the Securities by any form of general solicitation or general
advertising.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">3.14&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Brokers</U>.
There is no broker, investment banker, financial advisor, finder or other person which has been retained by or is authorized to act on
behalf of the Purchaser who is entitled to any fee or commission for which the Company will be liable in connection with the execution
of this Agreement and the consummation of the transactions contemplated hereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">3.15&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Residency</U>.
Such Purchaser&rsquo;s residence (if an individual) or offices in which its investment decision with respect to the Securities was made
(if an entity) are located at the address immediately below such Purchaser&rsquo;s name on the Schedule of Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">3.16.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Legends</U>.
Each Purchaser understands and agrees that any certificates, instruments, or book entries representing the Securities and any Sesen Bio
Common Stock received in the Merger in exchange for the Securities may be notated with one or all of the following legends:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;THESE
SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 AND HAVE BEEN ACQUIRED FOR INVESTMENT AND NOT WITH A VIEW TO, OR
IN CONNECTION WITH, THE SALE OR DISTRIBUTION THEREOF. THEY MAY&nbsp;NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE
OF A REGISTRATION STATEMENT IN EFFECT WITH RESPECT TO THE SECURITIES UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL (WHICH COUNSEL
SHALL BE REASONABLY SATISFACTORY TO THE COMPANY) THAT SUCH REGISTRATION IS NOT REQUIRED.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Any
legend required by the applicable laws of any state or other jurisdiction to the extent such laws are applicable to the Securities represented
by the certificate, instrument, or book entry so legended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">SECTION&nbsp;4.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Representations
and Warranties by the Company</U>. The Company represents and warrants to the Purchasers that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">4.01&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>No
Material Adverse Change in Business</U>. Since June&nbsp;30, 2022, (i)&nbsp;there has not occurred any Company Material Adverse Effect
(as defined in the Merger Agreement) (for purposes herein, a &ldquo;<B><I>Material Adverse Effect</I></B>&rdquo;), and (ii)&nbsp;there
has been no dividend or distribution of any kind declared, paid or made by the Company on any class or series of its capital stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">4.02&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Organization
and Good Standing of the Company</U>. The Company has been duly incorporated and is validly existing as a corporation in good standing
under the laws of the State of Delaware and has corporate power and authority to own, lease and operate its properties and to conduct
its business as currently conducted and to enter into and perform its obligations under this Agreement and the Merger Agreement. The
Company is duly qualified as a foreign corporation to transact business and is in good standing in each other jurisdiction in which the
failure to so qualify would result in a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">4.03&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Organization
and Good Standing of Subsidiaries</U>. Each subsidiary of the Company has been duly incorporated or organized and is validly existing
in good standing under the laws of the jurisdiction of its incorporation or organization, has corporate or similar power and authority
to own, lease and operate its properties and to conduct its business as currently conducted and is duly qualified to transact business
and is in good standing in each jurisdiction in which the failure to so qualify would result in a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">4.04&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Capitalization</U>.
The Company hereby represents and warrants to the Purchasers that the Company Capitalization Representations (as defined in, and included
in Section&nbsp;2.6 of, the Merger Agreement), which are hereby incorporated by reference in all respects, are true and correct.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">4.05&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Validity;
Valid Issuance of Securities</U>. This Agreement, the performance by the Company of its obligations hereunder and the issuance and sale
of the Securities have been duly authorized by requisite corporate action, and the Agreement has been duly executed and delivered by
the Company and constitutes a valid and binding obligation of the Company, enforceable against it in accordance with its terms, except
as limited by applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance, and any other laws of general application
affecting enforcement of creditors&rsquo; rights generally, and as limited by laws relating to the availability of specific performance,
injunctive relief, or other equitable remedies. Notwithstanding the foregoing or anything else to the contrary in this Agreement, it
is understood and agreed that (i)&nbsp;as of the date hereof, the Company has not yet solicited or obtained the Company Stockholder Written
Consent (as defined in, and contemplated by, the Merger Agreement), (ii)&nbsp;the Company Stockholder Written Consent will approve, among
other matters in connection with the Merger, an amendment to the Company&rsquo;s certificate of incorporation to increase the authorized
shares of Common Stock sufficient to accommodate the issuance and sale of all Securities under this Agreement (the &ldquo;<B><I>Charter
Amendment</I></B>&rdquo;) and (iii)&nbsp;obtaining the Company Stockholder Written Consent is a condition to the closing of the Merger.
When issued, sold and delivered in accordance with the terms and for the consideration set forth in this Agreement, the Securities will
be validly issued, fully paid and nonassessable and free and clear of any liens, encumbrances or other restrictions, other than restrictions
on transfer under applicable state and federal securities or such restrictions as the Purchaser has agreed to in writing with the Company,
and will not have been issued in violation of or subject to any preemptive or similar rights created under the Company&rsquo;s certificate
of incorporation or bylaws or the Delaware General Corporation Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">4.06&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Absence
of Violations, Defaults and Conflicts</U>. Neither the Company nor any of its subsidiaries is (i)&nbsp;in violation of its certificate
of incorporation, bylaws or similar organizational document, (ii)&nbsp;in default in the performance or observance of any obligation,
agreement, covenant or condition contained in any contract, indenture, mortgage, deed of trust, loan or credit agreement, note, lease
or other agreement or instrument to which the Company or any of its subsidiaries is a party or by which it or any of them may be bound
or to which any of the properties or assets of the Company or any subsidiary is subject (collectively, &ldquo;<B><I>Agreements and Instruments</I></B>&rdquo;),
except for any such defaults that would not, singly or in the aggregate, result in a Material Adverse Effect, or (iii)&nbsp;in violation
of any law, statute, rule, regulation, judgment, order, writ or decree of any arbitrator, court, governmental body, regulatory body,
administrative agency or other authority, body or agency having jurisdiction over the Company or any of its subsidiaries or any of their
respective properties, assets or operations (each, a &ldquo;<B><I>Governmental Entity</I></B>&rdquo;), except for any such violations
that would not, singly or in the aggregate, result in a Material Adverse Effect. The execution, delivery and the performance of this
Agreement and the consummation of the transactions contemplated herein (including the issuance and sale of the Securities) and compliance
by the Company with its obligations hereunder do not and will not, whether with or without the giving of notice or passage of time or
both, (A)&nbsp;conflict with or constitute a breach of, or default under, or result in the creation or imposition of any lien, charge
or encumbrance upon any properties or assets of the Company or any subsidiary pursuant to, the Agreements and Instruments, (B)&nbsp;result
in any violation of the provisions of the certificate of incorporation, bylaws or similar organizational document of the Company or any
of its subsidiaries or (C)&nbsp;result in any violation of any applicable law, statute, rule, regulation, judgment, order, writ or decree
of any Governmental Entity, except in the case of clauses (A)&nbsp;and (C)&nbsp;for such violations as would not, singly or in the aggregate,
have or reasonably be expected to have a Material Adverse Effect, or materially affect the validity of the Securities or the legal authority
of the Company to perform its obligations hereunder and timely comply in all material respects with the terms of this Agreement or the
Merger Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">4.07&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Absence
of Proceedings</U>. There is no action, suit, proceeding, inquiry or investigation before or brought by any Governmental Entity now pending
or, to the knowledge of the Company, threatened, against the Company or any of its subsidiaries, which would have or reasonably be expected
to have a Material Adverse Effect or materially affect the validity of the Securities or the legal authority of the Company to perform
its obligations hereunder and timely comply in all material respects with the terms of this Agreement or the Merger Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">4.08&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Possession
of Licenses and Permits</U>. The Company and its subsidiaries possess such permits, licenses, approvals, consents and other authorizations
(collectively, &ldquo;<B><I>Governmental Licenses</I></B>&rdquo;) issued by the appropriate Governmental Entities necessary to conduct
the business now operated by them, except where the failure so to possess would not, singly or in the aggregate, have or reasonably be
expected to have a Material Adverse Effect. The Company and its subsidiaries are in compliance with the terms and conditions of all Governmental
Licenses, except where the failure so to comply would not, singly or in the aggregate, have or reasonably be expected to have a Material
Adverse Effect. All of the Governmental Licenses are valid and in full force and effect, except when the invalidity of such Governmental
Licenses or the failure of such Governmental Licenses to be in full force and effect would not, singly or in the aggregate, have or reasonably
be expected to have a Material Adverse Effect. Neither the Company nor any of its subsidiaries has received any notice of proceedings
relating to the revocation or material modification of any Governmental Licenses which, singly or in the aggregate, if the subject of
an unfavorable decision, ruling or finding, would have or reasonably be expected to have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">4.09&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Title
to Property</U>. The Company and its subsidiaries do not own any real property. The Company and its subsidiaries own, and have title
to, or in the case of leased properties and assets, valid leasehold interests in all tangible properties or tangible assets and equipment
used or held for use in its business or operations or purported to be owned by them, in each case that are material to the Company and
its subsidiaries, taken as a whole. All of such assets are owned or, in the case of leased assets, leased by the Company or any of its
subsidiaries free and clear of all mortgages, pledges, liens, security interests, claims, restrictions or encumbrances of any kind, other
than Permitted Encumbrances (as defined in the Merger Agreement).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">4.10&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Intellectual
Property</U>. Except as would not, singly or in the aggregate, have or reasonably be expected to have a Material Adverse Effect:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Company owns or possesses or believes it can acquire on commercially reasonable terms sufficient legal rights to all Company Intellectual
Property without any known conflict with, or infringement of, the rights of others. &ldquo;<B><I>Company Intellectual Property</I></B>&rdquo;
means patents, patent applications, registered and unregistered trademarks, trademark applications, registered and unregistered service
marks, service mark applications, tradenames, copyrights, trade secrets, domain names, mask works, information and proprietary rights
and processes, similar or other intellectual property rights, subject matter of any of the foregoing, tangible embodiments or any of
the foregoing, licenses in, or and under any of the foregoing, and any and all such cases as are owned or controlled by the Company and
necessary to the conduct of its business as now conducted and as presently proposed to be conducted (the &ldquo;<B><I>Company Business</I></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;To
the Company&rsquo;s knowledge, the operation of the Company Business has not, does not, and will not conflict with, infringe, violate,
interfere with, or misappropriate any right (including any proprietary or intellectual property right), title, or interest of any person.
The Company has not received any written communications alleging that the Company has violated or, by conducting the Company Business
would violate any of the patents, trademarks, service marks, trade names, copyrights or trade secrets or other proprietary rights of
any other person or entity. To the Company&rsquo;s knowledge, there is and has been no unauthorized use, unauthorized disclosure, infringement,
violation, or misappropriation of any Company Intellectual Property by any person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;There
is no action, suit, proceeding or investigation pending or, to the Company&rsquo;s knowledge, currently threatened in writing against
the Company that any of the Company Intellectual Property is invalid or contesting the ownership or right of the Company to exploit any
of the Company Intellectual Property, nor is there a basis for any such claim.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">4.11&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Payment
of Taxes</U>. All United States federal income tax returns of the Company and its subsidiaries required by law to be filed have been
filed and all taxes shown by such returns or otherwise assessed, which are due and payable, have been paid, except assessments against
which appeals have been or will be promptly taken and as to which adequate reserves have been provided. No assessment in connection with
United States federal tax returns has been made against the Company. The Company and its subsidiaries have filed all other tax returns
that are required to have been filed by them through the date hereof or have timely requested extensions thereof pursuant to applicable
foreign state, local or other law except insofar as the failure to file such returns would not have or reasonably be expected to have
a Material Adverse Effect, and has paid all taxes due pursuant to such returns or all taxes due and payable pursuant to any assessment
received by the Company and its subsidiaries, except for such taxes, if any, as are being contested in good faith and as to which adequate
reserves have been established by the Company or its subsidiaries and except where the failure to pay such taxes would not have or reasonably
be expected to have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">4.12&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Insurance</U>.
The Company and the subsidiaries carry or are entitled to the benefits of insurance, with what the Company reasonably believes to be
financially sound and reputable insurers, in such amounts and covering such risks as is adequate for the conduct of their respective
businesses and the value of their respective properties and assets, and all such insurance is in full force and effect. The Company has
no reason to believe that it or any of the subsidiaries will not be able (i)&nbsp;to renew its existing insurance coverage as and when
such policies expire or (ii)&nbsp;to obtain comparable coverage from similar institutions as may be necessary or appropriate to conduct
its business as now conducted and at a cost that would not have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">4.13&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Investment
Company Act</U>. The Company is not required, and upon the issuance and sale of the Securities will not be required, to register as an
 &ldquo;investment company&rdquo; under the Investment Company Act of 1940, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">4.14&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Regulatory
Matters.</U>&nbsp;Except as would not, singly or in the aggregate, have or reasonably be expected to have a Material Adverse Effect:
(i)&nbsp;neither the Company nor any of its subsidiaries has received any Form&nbsp;FDA-483 observation, notice of adverse finding, warning
letter or other correspondence or written notice from the U.S. Food and Drug Administration (&ldquo;<B><I>FDA</I></B>&rdquo;) or any
other Governmental Entity alleging or asserting noncompliance with any Applicable Laws (as defined in clause (ii)&nbsp;below) or Authorizations
(as defined in clause (iii)&nbsp;below); (ii)&nbsp;the Company and each of its subsidiaries is and has been in compliance with statutes,
laws, ordinances, rules&nbsp;and regulations applicable to the Company and its subsidiaries for the ownership, testing, development,
manufacture, packaging, processing, use, distribution, marketing, labeling, promotion, sale, offer for sale, storage, import, export
or disposal of any product manufactured or distributed by the Company, including the Federal Food, Drug, and Cosmetic Act, the Public
Health Service Act and its implementing regulations and any other similar laws administered or promulgated by the FDA or other comparable
Governmental Entities and the regulations promulgated pursuant to such laws (collectively, &ldquo;<B><I>Applicable Laws</I></B>&rdquo;);
(iii)&nbsp;the Company and each of its subsidiaries possesses all licenses, certificates, approvals, clearances, authorizations, permits
and supplements or amendments thereto required by any such Applicable Laws and/or to carry on its businesses as now conducted (&ldquo;<B><I>Authorizations</I></B>&rdquo;)
and such Authorizations are valid and in full force and effect and the Company is not in violation of any term of any such Authorizations;
(iv)&nbsp;neither the Company nor any of its subsidiaries has received notice of any ongoing claim, action, suit, proceeding, hearing,
enforcement, investigation, arbitration or other action from any Governmental Entity or third party alleging that any product, operation
or activity is in violation of any Applicable Laws or Authorizations or has any knowledge that any such Governmental Entity or third
party is considering any such claim, litigation, arbitration, action, suit, investigation or proceeding, nor, to the Company&rsquo;s
knowledge, has there been any noncompliance with or violation of any Applicable Laws by the Company or any of its subsidiaries that could
reasonably be expected to require the issuance of any such communication or result in an investigation, corrective action, or enforcement
action by FDA or similar Governmental Entity; and (v)&nbsp;neither the Company nor any of its subsidiaries has received notice that any
Governmental Entity has taken, is taking or intends to take action to limit, suspend, modify or revoke any Authorizations or has any
knowledge that any such Governmental Entity is threatening or is considering such action.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">4.15&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Private
Placement</U>. None of the Company, its subsidiaries or any person acting on its or their behalf, has, directly or indirectly, made any
offers or sales of any security or solicited any offers to buy any security under any circumstances that would require registration under
the Securities Act of the Securities being sold pursuant to this Agreement. Assuming the accuracy of the representations and warranties
of the Purchasers contained in <U>Section&nbsp;3</U> hereof, the issuance of the Securities is exempt from registration under the Securities
Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">4.16&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>No
General Solicitation</U>. Neither the Company nor, to the Company&rsquo;s knowledge, any person acting on behalf of the Company has offered
or sold any of the Securities by any form of general solicitation or general advertising.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">4.17&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Brokers</U>.
There is no broker, investment banker, financial advisor, finder or other person, other than the Placement Agents, which has been retained
by or is authorized to act on behalf of the Company that is entitled to any fee or commission in connection with the execution of this
Agreement and the consummation of the transactions contemplated hereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">SECTION&nbsp;5.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Covenants</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">5.01&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Commercially
Reasonable Efforts</U>. Each party shall use its commercially reasonable efforts to satisfy the conditions precedent to the consummation
of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">5.02&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Disclosure
of Transactions and Other Material Information</U>. The Company shall or shall cause Sesen Bio to, by the fourth (4th) Business Day immediately
following the date of this Agreement, issue one or more press releases and/or file with the Commission a Current Report on Form&nbsp;8-K
(collectively, the &ldquo;<B><I>Disclosure Document</I></B>&rdquo;) disclosing all material terms of the transactions contemplated hereby
that have not previously been publicly disclosed and any other material nonpublic information that the Company, Sesen Bio or their respective
officers, directors, employees, agents or any other person acting at the direction of the Company or Sesen Bio has provided to the Purchasers
in connection with the transactions contemplated by this Agreement prior to the filing of the Disclosure Document. The Company shall
not, and shall cause its officers, directors, employees and agents and Sesen Bio not to, publicly disclose the name of any Purchaser
or any affiliate or investment adviser of any Purchaser, or include the name of any Purchaser or any affiliate or investment adviser
of any Purchaser without the prior written consent (including by e-mail) of such Purchaser (i)&nbsp;in any press release or marketing
materials, or (ii)&nbsp;in any filing with the Commission or any regulatory agency or trading market, except (A)&nbsp;as required by
the federal securities laws, rules&nbsp;or regulations, (B)&nbsp;to the extent such disclosure is required by other laws, rules&nbsp;or
regulations, at the request of the staff of the Commission or regulatory agency or under regulations of any national securities exchange
on which Sesen Bio&rsquo;s securities are listed for trading or (C)&nbsp;to the extent such announcements or other communications contain
only information previously disclosed in a public statement, press release, or other communications previously approved in accordance
with this <U>Section&nbsp;5.02</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">5.03&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Expenses</U>.
The Company and each Purchaser is liable for, and will pay, its own expenses incurred in connection with the negotiation, preparation,
execution and delivery of this Agreement and the transactions contemplated hereby, including, without limitation, attorneys&rsquo; and
consultants&rsquo; fees and expenses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">SECTION&nbsp;6.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Conditions
of Closing</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">6.01&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Conditions
of the Purchasers&rsquo; Obligations at the Closing</U>. The obligations of each Purchaser under <U>Section&nbsp;2</U> hereof are subject
to the fulfillment, at or prior to the Closing, of all of the following conditions, any of which may be waived in whole or in part by
the Purchaser Majority.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Representations
and Warranties</U>. The representations and warranties of the Company contained in this Agreement shall be true and correct in all material
respects on and as of the Closing Date with the same effect as though such representations and warranties had been made on and as of
the Closing Date (except to the extent such representations and warranties are specifically made as of a particular date, in which case
such representations and warranties shall be true and correct in all material respects as of such date).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Performance</U>.
The Company shall have performed and complied in all material respects with all covenants, agreements, obligations and conditions contained
in this Agreement that are required to be performed or complied with by it on or prior to the Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Charter
Amendment</U>. The Company shall have filed the Charter Amendment with the Secretary of State of the State of Delaware.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Compliance
Certificate</U>. The Chief Executive Officer or the Chief Financial Officer of the Company shall have delivered to the Purchasers at
the Closing Date a certificate certifying that the conditions specified in <U>Sections 6.01(a)</U>, <U>6.01(b)</U>, <U>6.01(c)</U>&nbsp;and
<U>6.01(e)</U>&nbsp;of this Agreement have been fulfilled.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">(e)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Merger</U>.
All conditions to the closing of the Merger set forth in the Merger Agreement shall have been satisfied or waived (other than the Closing
hereunder and other than those conditions which, by their nature, are to be satisfied at the closing of the transactions contemplated
by the Merger Agreement), and the closing of the Merger shall be set to occur substantially concurrently with the Closing hereunder.
The Company shall not have amended, modified, or waived any provision under the Merger Agreement (other than as set forth in the Amendment)
in a manner that would reasonably be expected to materially and adversely affect the benefits that Purchaser would reasonably expect
to receive under this Agreement without having received Purchaser&rsquo;s prior written consent (which consent shall not be unreasonably
withheld, conditioned or delayed).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">(f)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Qualifications</U>.
All authorizations, approvals or permits, if any, of any state that are required in connection with the lawful issuance and sale of the
Securities pursuant to this Agreement shall be obtained and effective as of such Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">(g)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Registration
Rights Agreement</U>. The Company shall have delivered to the Purchasers at the Closing Date the fully executed Registration Rights Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">6.02&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Conditions
of the Company&rsquo;s Obligations</U>. The obligations of the Company under <U>Section&nbsp;2</U> hereof are subject to the fulfillment,
at or prior to the Closing, of all of the following conditions, any of which may be waived in whole or in part by the Company in its
absolute discretion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Representations
and Warranties</U>. The representations and warranties of such Purchaser contained in this Agreement shall be true and correct in all
material respects on and as of the Closing Date with the same effect as though such representations and warranties had been made on and
as of the Closing Date (except to the extent such representations and warranties are specifically made as of a particular date, in which
case such representations and warranties shall be true and correct in all material respects as of such date).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Performance</U>.
Such Purchaser shall have performed and complied in all material respects with all covenants, agreements, obligations and conditions
contained in this Agreement that are required to be performed or complied with by it on or prior to the Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Merger</U>.
All conditions to the closing of the Merger set forth in the Merger Agreement shall have been satisfied or waived (other than the Closing
hereunder and other than those conditions which, by their nature, are to be satisfied at the closing of the transactions contemplated
by the Merger Agreement), and the closing of the Merger shall be set to occur substantially concurrently with the Closing hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">SECTION&nbsp;7.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Definitions</U>.&nbsp;Unless
the context otherwise requires, the terms defined in this <U>Section&nbsp;7</U> shall have the meanings specified for all purposes of
this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Business Day</I></B>&rdquo; means
any day other than Saturday, Sunday or other day on which commercial banks in the New York, New York are authorized or obligated by law
to be closed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Commission</I></B>&rdquo; means the
U.S. Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>FINRA</I></B>&rdquo; means the Financial
Industry Regulatory Authority.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Purchase Price</I></B>&rdquo; means
$15.60 per share of Common Stock, which, for the avoidance of doubt, does not give effect to the exchange ratio for each such share of
Common Stock into shares of Sesen Bio Common Stock in connection with the Merger.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Purchaser Majority</I></B>&rdquo;
means Purchasers, other than any Purchaser that has defaulted in its obligation to pay its Subscription Amount pursuant to Section&nbsp;2.02,
then committed to purchasing a majority of the Closing Shares to be purchased hereunder at the Closing by (or, if after the Closing,
then holding a majority of the Closing Shares held by) all Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Registration Rights Agreement</I></B>&rdquo;
means the Registration Rights Agreement, in substantially the form attached hereto as <U>Exhibit&nbsp;A</U>, to be entered into at the
Closing among the Company and each Purchaser.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Securities Act</I></B>&rdquo; means
the Securities Act of 1933, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">SECTION&nbsp;8.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Miscellaneous</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">8.01&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Waivers
and Amendments</U>.&nbsp;Neither this Agreement, nor any provision hereof, may be changed, waived, amended or modified orally or by course
of dealing, except by an instrument in writing executed by the Company and the Purchaser Majority, <I>provided</I> that, (i)&nbsp;if
any, change, waiver, amendment, modification disproportionately and adversely impacts a Purchaser (or group of Purchasers), the consent
of such disproportionately impacted Purchaser (or group of Purchasers) shall be required and (ii)&nbsp;any change to the Purchase Price
shall require the consent of each Purchaser.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">8.02&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Notices</U>.
All notices and other communications hereunder shall be in writing and shall be deemed to have been duly delivered and received hereunder
(i)&nbsp;one Business Day after being sent for next Business Day delivery, fees prepaid, via a reputable international overnight courier
service, (ii)&nbsp;upon delivery in the case of delivery by hand, or (iii)&nbsp;on the date delivered in the place of delivery if sent
by email (with a written or electronic confirmation of delivery) prior to 5:00 p.m.&nbsp;New York time, otherwise on the next succeeding
Business Day, in each case to the intended recipient as set forth below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">if to the Company:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">CARISMA Therapeutics Inc.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">3675 Market St., Ste. 200&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Philadelphia, PA 19104&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Attention:&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Steven
Kelly, President and Chief Executive Officer</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.75in">Richard Morris, Chief Financial Officer&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Email:&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Steven.Kelly@carismatx.com</U>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.75in"><U>Richard.Morris@carismatx.com</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">with a copy to (which shall not constitute notice):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">Wilmer Cutler Pickering Hale and Dorr
LLP&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">7 World Trade Center&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">250 Greenwich Street&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">New York, NY 10007&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">Attention: Brian A. Johnson; Hal Leibowitz;
Christopher Barnstable-Brown&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">Email: <U>Brian.Johnson@wilmerhale.com</U>; <U>Hal.Leibowitz@wilmerhale.com</U>;
<U>Chris.Barnstable-Brown@wilmerhale.com</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">or at such other address as the Company or each Purchaser may specify
by written notice to the other parties hereto in accordance with this <U>Section&nbsp;8.02</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">8.03&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Cumulative
Remedies</U>. None of the rights, powers or remedies conferred upon the Purchasers on the one hand or the Company on the other hand shall
be mutually exclusive, and each such right, power or remedy shall be cumulative and in addition to every other right, power or remedy,
whether conferred by this Agreement or now or hereafter available at law, in equity, by statute or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">8.04&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Successors
and Assigns</U>. All the terms and provisions of this Agreement shall be binding upon and inure to the benefit of and be enforceable
by the respective parties hereto, the successors and permitted assigns of each Purchaser and the successors of the Company, whether so
expressed or not. None of the Purchasers may assign its rights or obligations hereof without the prior written consent of the Company,
except that a Purchaser may, without the prior consent of the Company, assign its rights to purchase the Securities hereunder to any
of its affiliates or to any other investment funds or accounts managed or advised by the investment manager who acts on behalf of Purchaser
(<I>provided</I> each such assignee agrees to be bound by the terms of this Agreement and makes the same representations and warranties
set forth in <U>Section&nbsp;3</U> hereof). The Company may not assign its rights or obligations hereof without the consent of the Purchasers.
This Agreement shall not inure to the benefit of or be enforceable by any other person; <I>provided, however</I>, that that the Placement
Agents shall be third-party beneficiaries to the representations and warranties made by the Company and the Purchasers in this Agreement.
Notwithstanding anything to the contrary herein, each party hereto agrees that Sesen Bio is a third-party beneficiary of the Purchasers&rsquo;
agreement to purchase the Securities under this Agreement and, subject to the satisfaction (or waiver) of the conditions herein, Sesen
Bio may directly enforce the obligations of the Purchasers to pay the aggregate Purchase Price and acquire the Securities under this
Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">8.05&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Headings
and Captions</U>. The headings and captions of the various Sections and paragraphs of this Agreement have been inserted for convenience
of reference only and shall in no way modify or affect the meaning or construction of any of the terms or provisions hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">8.06&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Governing
Law; Jurisdiction</U>. This Agreement shall be governed by, and construed in accordance with, the laws of the State of Delaware, regardless
of the laws that might otherwise govern under applicable principles of conflicts of laws. IN ANY ACTION OR PROCEEDING BETWEEN ANY OF
THE PARTIES ARISING OUT OF OR RELATING TO THIS AGREEMENT OR ANY OF THE CONTEMPLATED TRANSACTIONS, EACH OF THE PARTIES: (A)&nbsp;IRREVOCABLY
AND UNCONDITIONALLY CONSENTS AND SUBMITS TO THE EXCLUSIVE JURISDICTION AND VENUE OF THE COURT OF CHANCERY OF THE STATE OF DELAWARE OR,
TO THE EXTENT SUCH COURT DOES NOT HAVE SUBJECT MATTER JURISDICTION, THE SUPERIOR COURT OF THE STATE OF DELAWARE OR THE UNITED STATES
DISTRICT COURT FOR THE DISTRICT OF DELAWARE, (B)&nbsp;AGREES THAT ALL CLAIMS IN RESPECT OF SUCH ACTION OR PROCEEDING SHALL BE HEARD AND
DETERMINED EXCLUSIVELY IN ACCORDANCE WITH CLAUSE (A)&nbsp;OF THIS <U>SECTION&nbsp;8.06</U>, (C)&nbsp;WAIVES ANY OBJECTION TO LAYING VENUE
IN ANY SUCH ACTION OR PROCEEDING IN SUCH COURTS, (D)&nbsp;WAIVES ANY OBJECTION THAT SUCH COURTS ARE AN INCONVENIENT FORUM OR DO NOT HAVE
JURISDICTION OVER ANY PARTY, (E)&nbsp;AGREES THAT SERVICE OF PROCESS UPON SUCH PARTY IN ANY SUCH ACTION OR PROCEEDING SHALL BE EFFECTIVE
IF NOTICE IS GIVEN IN ACCORDANCE WITH <U>SECTION&nbsp;8.02</U> OF THIS AGREEMENT AND (F)&nbsp;IRREVOCABLY WAIVES THE RIGHT TO TRIAL BY
JURY.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">8.07&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Survival</U>.
The representations and warranties of the Company and the Purchasers contained in <U>Sections 3</U> and <U>4</U>, and the agreements
and covenants set forth in <U>Sections 5</U> and <U>8</U> shall survive the Closing in accordance with their respective terms. Each Purchaser
shall be responsible only for its own representations, warranties, agreements and covenants hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">8.08&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Counterparts;
Effectiveness</U>. This Agreement may be executed in any number of counterparts and by different parties hereto in separate counterparts,
with the same effect as if all parties had signed the same document. All such counterparts (including counterparts delivered by facsimile
or other electronic format, including .pdf) shall be deemed an original, shall be construed together and shall constitute one and the
same instrument. This Agreement shall become effective when each party hereto shall have received counterparts hereof signed by all of
the other parties hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">8.09&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Entire
Agreement</U>. This Agreement, together with the Registration Rights Agreement, contains the entire agreement among the parties hereto
with respect to the subject matter hereof and, except as set forth below, this agreement supersedes and replaces all other prior agreements,
written or oral, among the parties hereto with respect to the subject matter hereof. Notwithstanding the foregoing or anything to the
contrary in this Agreement, this Agreement shall not supersede any confidentiality or other non-disclosure agreements that may be in
place between the Company and any Purchaser.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">8.10&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Severability</U>.
If any provision of this Agreement shall be invalid, illegal or unenforceable, the validity, legality or enforceability of the remaining
provisions of this Agreement shall not in any way be affected or impaired thereby and shall continue in full force and effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">8.11&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Independent
Nature of Purchasers&rsquo; Obligations and Rights</U>. The obligations of each Purchaser under this Agreement are several and not joint
with the obligations of any other Purchaser, and no Purchaser shall be responsible in any way for the performance of the obligations
of any other Purchaser under this Agreement. Nothing contained herein, and no action taken by any Purchaser pursuant hereto or thereto,
shall be deemed to constitute the Purchasers as, and the Company acknowledges that the Purchasers do not so constitute, a partnership,
an association, a joint venture or any other kind of entity, or create a presumption that the Purchasers are in any way acting in concert
or as a group, and the Company will not assert any such claim with respect to such obligations or the transactions contemplated by this
Agreement and the Company acknowledges that the Purchasers are not acting in concert or as a group with respect to such obligations or
the transactions contemplated by this Agreement. The Company acknowledges and each Purchaser confirms that it has independently participated
in the negotiation of the transaction contemplated hereby with the advice of its own counsel and advisors. Each Purchaser shall be entitled
to independently protect and enforce its rights, including, without limitation, the rights arising out of this Agreement, and it shall
not be necessary for any other Purchaser to be joined as an additional party in any proceeding for such purpose. The Company has elected
to provide all Purchasers with the same terms for the convenience of the Company and not because it was required or requested to do so
by any Purchaser.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">8.12&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Termination</U>.
This Agreement shall terminate and be void and of no further force and effect, and all obligations of the parties hereunder shall terminate
without any further liability on the part of any party in respect thereof, upon the earlier to occur of (i)&nbsp;such date and time that
the Merger Agreement is terminated in accordance with its terms, (ii)&nbsp;upon the mutual written agreement of the Company and the Purchaser
Majority (provided that the Company and a Purchaser may terminate the commitment of the applicable Purchaser without the consent of any
other party), or (iii)&nbsp;if the Closing has not occurred on or before the End Date (as such term is defined in the Merger Agreement),
other than as a result of a Willful Breach of a Purchaser&rsquo;s obligations hereunder; <I>provided, however</I>, that nothing herein
shall relieve any party to this Agreement of any liability for common law fraud or for any Willful Breach of any representation, warranty,
covenant, obligation or other provision contained in this Agreement. &ldquo;<B><I>Willful Breach&rdquo;</I></B> means a deliberate act
or deliberate failure to act, taken with the actual knowledge that such act or failure to act would result in or constitute a material
breach of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">8.13&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Waivers</U>.
Each Purchaser that is an existing holder of capital stock of the Company, for itself and on behalf of all other applicable holders of
capital stock of the Company, hereby waives (i)&nbsp;any and all rights of first refusal, preemptive or participation rights or applicable
anti-dilution provisions or similar rights under the Company&rsquo;s certificate of incorporation or bylaws, the Delaware General Corporation
Law or any contractual agreement or arrangement between such Purchaser and the Company applicable to, or triggered by, this Agreement
or the issuance or sale of the Securities and (ii)&nbsp;any related prior notice requirements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">8.14&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Construction</U>.
The words&nbsp;<I>&ldquo;include,&rdquo; &ldquo;includes,&rdquo;</I>&nbsp;and&nbsp;<I>&ldquo;including&rdquo;</I>&nbsp;will be deemed
to be followed by &ldquo;without limitation.&rdquo; Pronouns in masculine, feminine, and neuter genders will be construed to include
any other gender, and words in the singular form will be construed to include the plural and vice versa, unless the context otherwise
requires. The words &ldquo;<I>this Agreement</I>,&rdquo; &ldquo;<I>herein</I>,&rdquo; &ldquo;<I>hereof</I>,&rdquo; &ldquo;<I>hereby</I>,&rdquo;
 &ldquo;<I>hereunder</I>,&rdquo; and words of similar import refer to this Agreement as a whole and not to any particular subdivision
unless expressly so limited. The parties hereto intend that each representation, warranty, and covenant contained herein will have independent
significance. If any party hereto has breached any representation, warranty, or covenant contained herein in any respect, the fact that
there exists another representation, warranty or covenant relating to the same subject matter (regardless of the relative levels of specificity)
which such party hereto has not breached will not detract from or mitigate the fact that such party hereto is in breach of the first
representation, warranty, or covenant. All references in this Agreement to numbers of shares, per share amounts and purchase prices shall
be appropriately adjusted to reflect any stock split, stock dividend, stock combination, recapitalization or the like occurring after
the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">IN WITNESS WHEREOF, the parties hereto have caused
this Amended and Restated Subscription Agreement to be duly executed as of the Effective Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="text-transform: uppercase"><B>CARISMA THERAPEUTICS</B></FONT><B>&nbsp;INC.</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 5%">By:</TD>
    <TD STYLE="width: 45%; border-bottom: black 1pt solid">/s/ Steven Kelly</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Name:</TD>
    <TD>Steven Kelly</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD>Chief Executive Officer</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">[<I>Signature Page&nbsp;to
Amended and Restated Subscription Agreement</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">IN WITNESS WHEREOF, the parties hereto have caused
this Amended and Restated Subscription Agreement to be duly executed as of the Effective Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><B>4BIO VENTURES FUN II LP</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">represented by its general partner</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">4BIO Ventures II GP Limited,</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Itself represented by its Director</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 5%">By:</TD>
    <TD STYLE="width: 45%; border-bottom: black 1pt solid">/s/ Andrew Kozlov</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Name:</TD>
    <TD>Andrew Kozlov</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD>Director</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<I>Signature Page&nbsp;to Amended and Restated
Subscription Agreement</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">IN WITNESS WHEREOF, the parties hereto have caused
this Amended and Restated Subscription Agreement to be duly executed as of the Effective Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><B>ABBVIE TECHNOLOGY LTD.</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 5%">By:</TD>
    <TD STYLE="width: 45%; border-bottom: black 1pt solid">/s/ Arthur C. Price</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Name:</TD>
    <TD>Arthur C. Price</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD>Director</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">IN WITNESS WHEREOF, the parties hereto have caused
this Amended and Restated Subscription Agreement to be duly executed as of the Effective Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><B>AGENT CAPITAL FUND I LP</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 5%">By:</TD>
    <TD STYLE="width: 45%; border-bottom: black 1pt solid">/s/ Geeta Vemuri</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Name:</TD>
    <TD>Dr.&nbsp;Geeta Vemuri</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD>Managing Member</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">IN WITNESS WHEREOF, the parties hereto have caused
this Amended and Restated Subscription Agreement to be duly executed as of the Effective Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><B>AJU LIFE SCIENCE 3.0 VENTURE FUND</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 5%">By:</TD>
    <TD STYLE="width: 45%; border-bottom: black 1pt solid">/s/ Ji-won Kim</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Name:</TD>
    <TD>Ji-won Kim</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD>Chief Executive Officer</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">IN WITNESS WHEREOF, the parties hereto have caused
this Amended and Restated Subscription Agreement to be duly executed as of the Effective Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><B>b-to-v Partners S.a.r.l</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 5%">By:</TD>
    <TD STYLE="width: 45%; border-bottom: black 1pt solid">/s/ Florian Schweitzer</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Name:</TD>
    <TD>Florian Schweitzer</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD>Managing Director</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid">/s/ Christian Schuetz</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Name:</TD>
    <TD>Dr.&nbsp;Christian Schuetz</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD>Managing Director</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">IN WITNESS WHEREOF, the parties hereto have caused
this Amended and Restated Subscription Agreement to be duly executed as of the Effective Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><B>HEALTHCAP VII LP</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 5%">By:</TD>
    <TD STYLE="width: 45%; border-bottom: black 1pt solid">/s/ Dag Richter</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Name:</TD>
    <TD>Dag Richter</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD>Director</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid">/s/ Fabrice Bernhard</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Name:</TD>
    <TD>Fabrice Bernhard</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD>General Manager</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">IN WITNESS WHEREOF, the parties hereto have caused
this Amended and Restated Subscription Agreement to be duly executed as of the Effective Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><B>LIVZON INTERNATIONAL VENTURES I</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 5%">By:</TD>
    <TD STYLE="width: 45%; border-bottom: black 1pt solid">/s/ Yanggang Tang</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Name:</TD>
    <TD>Yanggang Tang</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD>Director</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">IN WITNESS WHEREOF, the parties hereto have caused
this Amended and Restated Subscription Agreement to be duly executed as of the Effective Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><B>MRL VENTURES FUND, LLC</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 5%">By:</TD>
    <TD STYLE="width: 45%; border-bottom: black 1pt solid">/s/ Peter Dudek</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Name:</TD>
    <TD>Peter Dudek</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD>Partner</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">IN WITNESS WHEREOF, the parties hereto have caused
this Amended and Restated Subscription Agreement to be duly executed as of the Effective Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Pictet Thematic Private Equity, SICAV-RAIF-Pictet</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Thematic Private Equity &ndash; Health Fund I</B></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 5%">By:</TD>
    <TD STYLE="width: 45%; border-bottom: black 1pt solid">/s/ Christope Vasselin</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Name:</TD>
    <TD>Christope Vasselin</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD>Assistant Vice President</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid">/s/ Christope Dorrer</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Name:</TD>
    <TD>Christope Dorrer</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD>Officer</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">IN WITNESS WHEREOF, the parties hereto have caused
this Amended and Restated Subscription Agreement to be duly executed as of the Effective Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><B>SYMBIOSIS II, LLC</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 5%">By:</TD>
    <TD STYLE="width: 45%; border-bottom: black 1pt solid">/s/ Chidozie Ugwumba</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Name:</TD>
    <TD>Chidozie Ugwumba</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD>Managing Partner</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">IN WITNESS WHEREOF, the parties hereto have caused
this Amended and Restated Subscription Agreement to be duly executed as of the Effective Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><B>THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 5%">By:</TD>
    <TD STYLE="width: 45%; border-bottom: black 1pt solid">/s/ John S. Swartley</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Name:</TD>
    <TD>John S. Swartley</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Associate Vice Provost for Research and Managing Director
for the Penn Center for Innovation</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">IN WITNESS WHEREOF, the parties hereto have caused
this Amended and Restated Subscription Agreement to be duly executed as of the Effective Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><B>TPG BIOTECHNOLOGY PARTNERS V, L.P.</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 5%">By:</TD>
    <TD STYLE="width: 45%; border-bottom: black 1pt solid">/s/ Ken Murphy</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Name:</TD>
    <TD>Ken Murphy</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD>Chief Operating Officer</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">IN WITNESS WHEREOF, the parties hereto have caused
this Amended and Restated Subscription Agreement to be duly executed as of the Effective Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>WELLINGTON PARTNERS LIFE SCIENCES V GMBH&nbsp;&amp; CO. KG</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">c/o Wellington Partners Life Science Venture Capital Management
    GmbH</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 5%">By:</TD>
    <TD STYLE="width: 45%; border-bottom: black 1pt solid">/s/ Regina Hodits</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Name:</TD>
    <TD>Dr.&nbsp;Regina Hodits</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD>Managing Partner</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in"><U>Schedule I</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">SCHEDULE OF PURCHASERS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 27 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT&nbsp;A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>Form&nbsp;of Registration Rights Agreement</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(To be attached.)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 28; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>tm2227887d12_ex23-1.htm
<DESCRIPTION>EXHIBIT 23.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>EXHIBIT 23.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Consent of Independent Registered Public Accounting
Firm</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">We consent to the use of our report dated October
14, 2022, with respect to the consolidated financial statements of CARISMA Therapeutics Inc., included herein and to the reference to
our firm under the heading &#8220;Experts&#8221; in the prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">/s/ KPMG LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Philadelphia, Pennsylvania</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">January 9, 2023</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.3
<SEQUENCE>4
<FILENAME>tm2227887d12_ex23-3.htm
<DESCRIPTION>EXHIBIT 23.3
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0pt">&nbsp;</P>

<P STYLE="text-align: right; margin: 0pt"><B>EXHIBIT 23.3</B></P>

<P STYLE="margin: 0pt">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>Consent of Independent Registered Public Accounting Firm</B></P>

<P STYLE="margin: 0pt">&nbsp;</P>

<P STYLE="margin: 0pt">We consent to the reference to our firm under the caption &ldquo;Experts&rdquo; and to the use of our report
dated&nbsp;February 28, 2022, included in the Proxy Statement of Sesen Bio, Inc. that is made part of Amendment No. 3 to the
Registration Statement (Form S-4) and Prospectus of Sesen Bio, Inc. for the registration of shares of its common
stock.&NegativeThickSpace;</P>

<P STYLE="margin: 0pt">&nbsp;</P>

<P STYLE="margin: 0pt">/s/ Ernst &amp; Young LLP&NegativeThickSpace;</P>

<P STYLE="margin: 0pt">&nbsp;</P>

<P STYLE="margin: 0pt">Boston, Massachusetts</P>

<P STYLE="margin: 0pt">January 9, 2023</P>

<P STYLE="margin: 0pt">&nbsp;</P>

<P STYLE="margin: 0pt"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.4
<SEQUENCE>5
<FILENAME>tm2227887d12_ex99-4.htm
<DESCRIPTION>EXHIBIT 99.4
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>EXHIBIT 99.4</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CONSENT OF SVB SECURITIES LLC</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We hereby consent to the use of our opinion letter dated December
29, 2022 to the Board of Directors of Sesen Bio, Inc., included as Annex B to the proxy statement/prospectus which forms a part of Amendment
No. 3 to the Registration Statement on Form S-4 of Sesen Bio, Inc. to be filed on the date hereof, and to the references to such opinion
in such proxy statement/prospectus under the captions: &#8220;Prospectus Summary &#8211; Opinion of Sesen Bio&#8217;s Financial Advisor,&#8221;
 &#8220;The Merger &#8211; Background of the Merger,&#8221; &#8220;The Merger &#8211; Sesen Bio Reasons for the Merger&#8221; and &#8220;The
Merger &#8211; Opinion of Sesen Bio&#8217;s Financial Advisor&#8221;. In giving such consent, we do not admit that we come within the
category of persons whose consent is required under Section 7 of the Securities Act of 1933, as amended, or the rules and regulations
of the Securities and Exchange Commission thereunder, nor do we thereby admit that we are experts with respect to any part of such Registration
Statement within the meaning of the term &#8220;expert&#8221; as used in the Securities Act of 1933, as amended, or the rules and regulations
of the Securities and Exchange Commission thereunder. Additionally, such consent does not cover any future amendments to the Registration
Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">/s/ SVB SECURITIES LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">New York, New York</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">January 9, 2023</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>lg_sesenbio-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 lg_sesenbio-4c.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ L@$H P$1  (1 0,1 ?_$ -<  0 " P$  P$!
M       )"@<("P8"! 4# 0$!  $% 0$!              <" P0%!@@!"1
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MVQ?-%$7+5RB< $IR&*8H_0.84T,5Q$Z"=K7PO%'-< 00<P0<".]9#FM<TM<
M6G@5;8\;W,"0Y4:DD&=V5;FVQK)Q'P]Q<MTTVR=EC))%R>NV\K1(B:+5U)%8
M.$'B20>D#ML94A4DUTT2>7O,#:L>VM4:^SK^S+D%T8./013K97B!4%I./2:&
MI:2>.U.R%I,#'^9?B.SF/Z%(MG!+6)A$PB81,(F$3")A$PB81,(F$3")A$PB
M81,(F$3")A$PB81,(F$3"*%[EY2E:CNB=>D2$D;<46UI8' OU#+.R_*RZ8G
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M>CWW[-U2"]^3'("[ZIP=ZVDJKFN@LV76;.$E$'#=51!=%4HD5162.*:J2A#
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M_P!IQ#A2C"ZH8(]GK)[&NW#"1:.F#YHJ=!TR>MU6KMLNF/0Z+ANN1-9%4@_
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MS*MP_J*$8M!.8$_445.)EEE3&\K[KW3>;IU#[U/[%HRHBCK@QO,\WNPZG<:
M#  +C+V\DO)>MV#!D.0_I/$K;;.76&F$3")A$PB81,(F$3")A$PB81,(F$3"
M)A$PB81,(F$3")A$PB81,(F$3")A$PBQU>=3:ZV0EV7.IQ<PN4GII2(IG9S"
M! _>D0EV!VTDFF4?CV>KZ8B'Q*.;73M;U7275L)WQMK[N;3WM-6^FE5RNX]D
M;4W8SIU^RAGD H)*%LH'(2L+9 .SJIS!6K-N\?&C[?'2<,^=VP8.9;+L92#>
M.H65BG3%R02*M3(OH0[D2&*/TG5.(= $.@AUSLK+S/W#9R-F8V#QV$%K@'M<
M"..#Z>H!13-_\=-G"Y%UIUWJ5M(UU1TR1N#:9=/5%U>MQ46.U_;XZU0DW%@X
M^["6;&.<ZS>F[D%:8AVBYSF.!&=GK<:1RG'I (%(D[B9!8 ^)ES#DDV/_P B
MM=GA%MKL+0VE#);#I<1VM>XX\RV1@[%*^WMB[2T5S9+R&6]F9D^9S7>DQL9'
M$X][:=BP\;P=<B[.8T79[3HUE$H+BD5Z2PW)ZZ!+H<@/(=!O0VYR_ A>A5E6
MIA*8 $/I*%YGG1H=F?&M([TS$9=,8!['5D/P!RDNYU'2[F$0RQ.<P# 4 IW&
MN'H7["_MWI>-0:/XCD) 6*4],3NH.PTR3A(5NX QC%*G,QDO-/I)$"]H?79-
M_B B)3 /:%7_ /0@FK')8/B9\]D@<XCZKFM#3_6=WA:.WCTZ.8OE9(^*N J/
MAP%?6.VJSEK7P>O4WK,^UMV1[>%;B0KB#UK7%3/7*!>XH(,[#9!0:10D*!>A
MC13H/I#L#Z<YS4?.1KFN_9MFXS'Y4S\*\RUE2[\,=ZWC]=:UO3;QTH,*Y#T#
M^D*:/1?';4''"K#4M25!E7&;D4%9B3,91_8K&\;D,1-[8)UV*C^15(*AQ33$
MQ6[?U#%032(/;D1:UKVJ[@N?O6J2F1XKTC)K >#6C <*G,T%22M)<7,UT_KF
M=4\.0[@LVYIU83")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB8
M1,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3"**WGYYDN#7CI]2
MO;FV&ZMNW3-2.V>B]4-65OV:5!=NFX:.K$U5DHNO45B[1<)*(GFY!@J[1.*C
M1)P!#].FT+:.M;@_*6<89:5_./JUGHP)<?J@TXD*ASVMSS59_;7O!-IO))5+
M17#/7]<B$53%1?[:V18KI)2* &()%U8BG1%":PRIB=P"D#Y^ #T'U!^@9&M?
M*>V#:WMY(Y_)C T#TN+J^H*V9CP"P17?=V\[VSPY[;QVXD3<>*Z!DVM=A-QU
M=X1L4RHNDCOI/;UP0476() 34!N4J8E,(D/W !<V3RJT0C\E<737=IC=\ C;
M\:^>,[D%*3Q?]VWQ?OTBP@.5.A=@<>UG)@05O-(F";GHS8_<G_#9B-:P=4O<
M2S,03CZ;&.G%BB4H?6 PB7FM2\K-2@:9-,GCG ^2X>&[T&KFGTEJJ$PXBBM#
M:2WQIKDEKN&VSH79=/VQKF>]0D;;*3--9F,%VW*F+R+??+G%Q$S<<*I2NV#M
M-!ZT4'L62(?ZN1K>6-YIUP;6^C?%<-S:X4/>.8/ BH/ JZ""*C)9:S%7U,(M
M5.5W-WBOPBI'W]Y/;GJ&K8ERDZ/!1,F[4D+E;EFA2BLSIE'ATI"V6IRD8Y"J
M?)-%4V_>!ECID^L&STO1M3UF;P--A?*X9D8-;]9QHUOI./!?"X-Q*J^\@_=\
MZMA7\C$<7^)EPOK5%==NRNNYKO&Z^9K@B)DROD*14XV[R+QBZ.'>D"\M'N/2
M$!433.(IDDJP\J+E[0_4KIC#Q;&TN]'4XM'J:0K1F' */N0]W7SZ4E&RT5Q]
MX@,H0AD?G(^0K6YY.47*5P<S@&TPVW5$M&AE6@E(03L5_34 3B!RB"8;UOE5
MH8:0Z>[+^8,8'J\,_&J?&=R"V@TS[P6THOVC3D-PR@)"+5.F5]8-,[*D8=^Q
M3ZE]55I3KO#3C>5.(=PE3/.L@ >@"?\ #FMO/*>(M)L+QP=P$C 0?ZS2*?@E
M?1-S"LQ\$_+CP:\B"!8[0&U2L]E)LW#^1TALEHWI6WH]HT(*SMVVKBK^0C+8
MP9-^U1R[@'\NS:E.4%U4SCVA'.M[5UK0#U7T5;>M!(SVHSZ: M)X!P:3P"NM
M>UV6:DNSG54F$7T9.3C82-D)F9D&,1#Q#%W)RLK)NT&$;&1K!!1T^D)!\Z42
M:LF+)JD91550Q4TTRB8P@ ".5-:Y[@Q@)>30 8DDY #FBK3\R?=(\%>.\Y+4
MK0M<MO+^X1!UF[F7I$JPH^F_GD#F259-]H3,?.2,YT.7J5Y#P,I%K)CW).C_
M $9(FD>6FMW[!-?.9:1'@X%TE.?0" .YSFGF%:=*T98J%*[>[SYHOW2A]<<9
M.+]49"Y[DF]V#:^P'1&G<YZ(*/(*_P"M$E'/:=$/5! A>J9Q]/\ *%!/L8?*
MG1VC_P!Q<W+C]'H;\;7_ !JCQG<@O4:V]W[R>C'C4VW^)&AKK'E^7!ZCK:U;
M!U>\4Z&4^:.U<V=[MY!#U""3TRG24[!*/4QNX.VU<>5&FN!^Z74['?3:U_Q>
M&@F/$*>WA7[D+QW\M92)I5OLLYQ:V=++HLF->WC]FL*7,2"Y^Q-M!;5BG+FH
MI]YC%(0)H8-9=4P$124-TZ\/K'E[K^E-,T36W-L,28ZEP':P^U^#U=I5QLK3
MV%3^%,4Y2G(8IR'*!B'*(&*8I@ZE,4P=0,4P#U 0^G.%5Q?+")A%#9SI\[GC
MXX'2TS1;GL:1V[N:%.JUD=/:.9,;E8H*1(5<GR5SL3J3B*)3G35TF4CID[E
MF$"* H5BH7IUZ[1-DZ]KC1/#&(K-V4DA+01]$4+G=A Z3\Y4.D:WO5=;:_O
M]POI%9/1O#;6M7B4U3E;N]K[$M%[D7J  ($76CJA&ZY;1BIQZ"*173L"A\/4
M-].=_:^4]HUO_O;N1S_H,:T>MQ?7U!6C,> 6"Z[[NOGPV>E4MG'OB#-1H'0$
M[2NUS<]7>F2*L4SDA9"2W1;T"G60ZE3,+803.(&$IP#L'-D\JM#(_)7%VUW:
M8W? (V_&GC.Y!2<<:/=S<=KE)1T#RHXX[ TB+I5)JM>]:V%GM^HM3G-^4DYJ
M =1-*N,-&)$Z]R<>C/NNH!VD-U'MYS4?*K4(6E^F7$<U/DO'AN[@:N:3W](5
M0F'$*TCH3D3HWE'KJ+VUQ[VC3]MZ\ESG;MK+3I5*1;MGZ22*SF'F69@2DZ]/
MLDG"8N(]^@V?-^\OJI$ZAD:7VGWNFW!M;^)\5P.#A3#F.!'(@D'@5=!!Q"S/
MF&OJ815B-\>Z5XB\?]X[ET-:N._)&5L^DMK;$U'8Y2"3U>K"24]K:WS%-F'\
M.H^OK)ZI%/)"&44;F6125%$Q1.0INI0DBQ\M-5O[*&^BN+<1S1,D /74![0X
M T;G0XJT90#2A6Z?C+\WG'ORA[1V#J?4FK-P:]L&O*"38;]UL="FEC9*'&Q1
M5:6;QZM8M$\L5\@]F4#"54B93)B(@81#IFGW'LR_VU;1W5U+%)'))T#HZJ@T
M)QJ!A@54UX>:!;3\[O)KP_\ '13F]EY(['*RL4PV4<4[4M.;M[-MN\E24]-5
M2O5+YY@DTC$S%,4\G*NHV((H7TC.@6.FF?6:)MS5MP3>'I\=8Q[SW8,;WNH<
M>QH+N-*+ZYS6YJJ-O'W?^V'DJ^;<:^(FO*Y!HBLG&36\;A9+K*R)104!!X^K
M%"6H+.&$KDQ!.V3EW_<F00!<!. IR?9>5%J&@ZC=R.?Q$;0T#N+NJO?TCN5H
MS'@%AJE>[QYNL)--78O&OBM:H<%T3+,*4TVW09,[8O=ZZ2<M.[+V4U274ZAV
M*"R.4G0>I#]?AF3>5.C.;2WN+IK^;NAP]08SXU\\9W(*?[Q_^Y(X1\T+' ZO
MV0SF.)VY[(Z:1L#7=E3D=.ZVM$T^4(@S@:MMQFR@V0S#IP;TD49N,@OFUCIH
MMA774*EG"Z[Y>:SH\;KFW(NK-HJ2P$/:!Q<S'#ZI=3,T&*N-E:[ X%6'<X%7
M%"3YWO)A*>-[B"$EK-RQ3Y%;XE9/7.F%GB23LM2*UC2.[OM/[.<)G:2:E#C7
MS5-FBL!T/MF38G727;$71/V6R=N-W#JW3<U_9\ #Y/I8^RRO#J(->/2'4(-"
MK<CND89KEW6BT66[6*;M]RL$U:[799-Y-6*RV.3>S4].R\@L=P^E)>6D5G#Z
M1?O%SB=5950ZAS"(B(CGI2.*.&-L4+0V)HH !0 #( # !8JF'X8^ CR.\VZ3
M![0I&NJMJ?5EI:HR%4V#OJRO*+&6B+<)^LUF8&N1$#;-@OX!\@)%&LB6&!@]
M24*HW65((F#DM8WSM_1IG6TTCI;EIHYL0ZBT\B26M!'$=51Q 5;8W.QX+>#8
M7M-/(U58!28IFQ^+NT)%NU]5:J0=ZO=;GW;OM$PM8=Q<];0=7<$$0[04>23#
MXB'4H!U$--;^:.WY9.B:.YB;7WBUI'IZ7EWJ!51A=V*OAR'XR;_XF[%?ZGY'
M:GN&HK]'D^8^Q+9'>@E)L!5.@28K<TT4=P%K@%ETCD3D(QT[8JG(8I%3"4P!
MWEAJ5CJEN+K3Y62P'BTY'D1FT]A /8K9!!H5O;X;^6?-7C+S'U]'<-:Q9MP3
M6SIAE6[OQSCU7*E<VW5TSBXDPERB;[.JLC68Y-9ZULZOI$@2IJ*N3FCS/&Z^
MDW=I>CZEI$CM7<V)D8JV4YL=PIQ<"<"SY60]JA%3"X.]E=7MJJJLV;K+MCLU
MU4$E5FBIT556JJB93*-E%&ZBK=0Z!Q$HF(8Q!$.I1$.@YY?( -!B%EJ&/S,>
M7JA>+S3K)K",XR]<H-J1DH33>N7:PGBXAJV$63K9VPTVRZ+YO2H1Z?L;MDS)
MN)Q\F9J@=)--XZ:=?M#:D^Y;LEY+--B(\1_$_09PZCQ.31B:X T/>&#M7,EY
M <A]U\I]IV3=7('8UBVALRUK@K+6:QN2**)MDSJ&9P\-'-4FT17:[%E5,1G&
MQZ#9@S2'L11(7X9Z-L+"STRU;9V$;8K9N0'QDYDGB223Q*Q2234YK8/AOXU>
M:W/:3<-N,FB[-=:_'.ODYO8DH=C4-8P+@GIF7:R%]M#F+KR\JW15*H:.9K.I
M,R8]Q&Y@S U?<6CZ&VNI3M9(1@P5<\]S14T[30=J^M:YV2FW@_:/^0>0@3OY
MC=W$>OSJB0J-(!2W[:DR$.*8"1"6EV&G#-V:OK=2G%LF^(4O0P&,(]H<:_S4
MT%K^ED-TYG/I8/4#)\=%<\%W8HWN9?@K\CO"&MS&P-CZ>9[!U57TEW,[M+2$
MX&Q*M!L6Q3J.):P116,1?JW!-T2^HK(R,*T8)%$ .L4WU0Z'2-Z[?UF006\Q
MCNG9,D'0XGD#4M)[ XGL5#HW-[E$Y5[19:38H2WTVP354M=:DV<U7;+7)-["
MST%+QZQ'#&4B):.6;OHY^S7(!TEDE"*$, " @.=3)%'-&Z*9H=$X4((J"#F"
M#@0J%T=/ !YH7G/ZE/\ C?R-E6"?+355>3E6=D C2-1WOKU@9LQ7MB3% $&K
M?8%;772).M6Z9$7*2R;]L0"B[2:>?=];0&A3#4-/!_9<KJ4S\)YQZ:_-/R2<
MO=/ G)C?U8'-64\CM75S^?<T>5JZ[2W79O'KIFS2,%I74+J/9[Z<Q+@6GZ5M
MJ)D9S!ZI(KI 5VXI>LU%$43LS&(B[L":ZBR:H,F*H3KY<[7AMK-NO7C0Z\E!
M\*OR&9=0^D_GF&T I5P6/*^IZ1DJK.M=9;"W)>JSK'5-+LFPM@W&31AZO3ZE
M$O)N?FI%?J)4&4>Q256.5-,IE%5! $T4B&44,4A3&"3KBYM[2!US=/;' P5<
MYQH .]6@"< K%>H?:F^2S84)'3M\L/'/1WSK9-=Q6+QL*QV.Y1YED3J)H.6F
MM*1=*D*J:@%*J!9H>SN^'>("7. N_,_;MN\L@;<34.;6@-/X;FN_%5P1..=%
MACDW[:GR?\<Z_(VV$HM#Y(UN*27>2!^.]ID[-:6<>EWB18*!<*W1KK.O#% H
M&:PC*66*8WP Q"F.&7IOF)MO4)!$][[>0Y>*T!M?K-+FCO<6KX8G#M4!;QF[
MCG;J/D&KEB_8N5V;UD\05;.V;MLJ9!RU=-ERD6;N6ZQ#$.0Y0,0P" @ AG<@
MAP#FD%I&!5M7P/:M<KN<&S*K>]"[&J5IV)Q#U?!D)KC>-F=B0^L;6FLT(UTO
M"RDNZ*\NM9=1)E7+=DS*Y-5P1334,BT=M$20EYFZ7HMM*R^MWMCU:5WMQCY;
M?[P@>Z:X$FG7VD$K(B+C@<E<<R)%>5%+SS>X NDK<[OPHX*WI>KTZKNGE6W;
MR#ITBX:6>V6-FJ\C[#KO6,^S43/"T^'7+Z$C-LS@[E7:9T6:R3!,ZLC->R-B
MPMA9K.MLZIG#JCB<,&C,/>.+CF&G!HQ(+L&V))/DM5,TI5W2Y2$*JX<N%0*0
MA0.LNNNL?H4I2AW**JJJ&Z  =1,(_CR7L .Q6%.#Q:]NWY0>4L%&VYMJ. T/
M39E!%S$6/D;9'.O5G[9= CE)R2D1,+;=GM6BJ"I#)K.()%%8#@*9C]#]O%ZG
MO[;6F/,1E=/,,Q$.NG]8EK/4[O5P1O*W/N?M*?(= P@R=4V[Q3O<D@U66<UQ
MI<MEU^3<N"$2,BSA'D[JIO!NSKG%0O>]=1R9>THB/UA[-1#YIZ ]_3+%=,;7
M/I81Z:/KZ@5]\%W8H%N6/"#E3P=NS:@\HM,VG5<S)D<KU^0D2L9>I6MJT4*F
MY=5*[5YY+5.R$;>H05R-'BJS;U2 N1,Q@ >XTO6M,UJ$SZ;,V5@S J'-^LTT
M</2,>"MEI;@5[?@-Y".1GCHW5'[?T':5V[-VO&M-CZUE%U5J%M:K,G@.%:Y;
M8GZZ0+@D=8K&30*22BSK'.V5("BI%+&N:#I^X+,VE\W$5Z'CWF.YM/Q@X.XC
M)?6N+34+JM<+N7NI>=7'#7/);3+]5:J7R,$9"#?G1^WZ1;8X0:VFBV=!$QDT
M)VLRI3HJ&)U1=)>FY;F4;+HJ'\QZQI-UHFH2:=>#\JPX$9.:?=<.PCU9'$%9
M;7!PJ%M/FL7U<B3RSL6D?Y..>Z#) C=%3EAN]\=-,! IG<G?9F2?KCU$?KNG
MSM14W_C''/5>UG%VV[$G/[K&/4T ? L-_O'O6>/#?Y!X?QL;/Y6;]>-B3UJD
M.&]RHFGZ0].^"$N&YI_<NC%:@E.ILUFW=#UJ'92TP^_+-UU(Q@Z0;JD<+I]V
M#N[07[BMK6Q!Z8A=M=(X4JV,1R=5.TDM:,Q4@D4"^L=TDGL6C5GL/*;R#<D9
M:QR#;8_([D=N2=4=J,8"'D[5:)EPFB!46,/!P[9<(JMUR*;E20;H)(Q\7'-P
M* )()?5W4<>F:#IPC;X=OI\+<R0UH[23F2<R<7$\253BX\RI<Z![8GRP7:N$
ML$KKG5.M5UXX\BVK=_V]726-?\F15LQ.VIB-SCH^1>$/]5)VZ;^B8!*N*)@$
MN<K/YD;7AD\-LDL@K2K8S3O]KI)'<#V55?A/6A7,GQ-<^>!L<-FY%Z#G(/7I
MGR$>WVG4Y6"O^N5'#HZB3).0L51D94*NN_61.1NA-)1KI80^HD(&*)MYI&Z=
M#UQWAZ?.UUQ2O0X%K^V@<!U4XEM1VJES'-S4<F= J5?T]LEY8[3OVN2? ;D-
M:'-AV5JVJ#8] 76=?*.INXZNA!;LIO74L]=]5I.=UPFN@O&*&55<.8(ZJ8E(
MG%^HK!GF/M:*QD&N6#0VWE=25H&#7G$/ X!^(/ .I\[#(B?7V3FHU?=XV^:>
M\W>-=!7%U]W:UQ6:6^**=3JQ":O&V]EPL^+='Y<O8Z,QU[&^L;U3]Y 2#L)V
M]3]%Y4Q,&C7$XIXCKKI/.C6,(^%Q^%4S>\.Y5]?'U4=:7_G3P_I&XRQZNK;9
MR2TS7[TUEUTFL/(UZ4OT$T>Q,TY6*9)O"RY50:O#F%,I6RQQ%1/_ ,X7N]>E
MN8-%NYK2OWEMO(6TS!#30CM&8[>:MMH7"N55V($$$&J"+9LBDW;-TDT&[=!,
MB*""") 321123 J:22290*4I0 "@'0/AGDTDDU.:S%_7/B+1;R%< =(>1;CQ
M:-';?A6"4N=A(O-6[,2BV;NVZFO)T4CQMHK3Y4A7:;-9VS03EF!%4DI:/*=N
MJ)>I%$]WH.NWNW[]M[:$]%1ULK[+V\6D>OI/R3B%2YH<*%8B\8'BBX[^,+5?
MW=UTS+<]RVR,8I[=WM/L&R=JN;U($7*\+")%]7[HZ\8R).]E#H*'_>)JO%G;
MHHN!RMR;HO\ <EUXEP>BT83X<8/LM',_.>1FX]P &"^-8&C#-217*WUS7U0M
M=]N$JV@JC2*W.6^TS;P1*TAZY6HMU,S<JZ,4#&!M'QC)58X@ B!2#G/0Q23R
MM@A'5*]P:T<R30#TE5Y8KD"\^^8EYYY<LMP<FKPH\0&]V1PG2ZXZ6(H2CZTA
MCFC:!2FQ4#"T*:"KB*)7:B(%*\D3N'1@]1<XCZOT+28=#TN'38:>PWVC\YYQ
M<[TG+D*#@L-SNHU4@'@L\4RGDMY(OW^R4)%EQ=T7]C6+<3YHJZCW%VDY)=<U
M6U)"2C51!TR=VC[/<.)-TW,"K&);*]JB+ERS..AWKN<;=T\-MZ'4YZB,9]('
MO/(^C4  YN(S *JC9U'')=.S7FNZ)J6D5C6NL:C7J%0*7$MH*J4^JQ;2%K\!
M$,RB"#&-C6*2+9ND!C"8P@7N44,8YQ,<QC#YPN+B>ZF=<7+W/G>:N<XU)/,D
MK* I@,E[++*+X*I)+I*(K)D616(=)5)4A5$E4E"B11-1,X"4Y#E$0$! 0$!P
M"0:C-%SBO<I>+RE<+-[4SD?H6ML:KHCDL^GF\O285N#6"UKN2&30E)J/@V9>
MUO%5:_13PTE',$.J+)TRD4DBH-"M$"^@O+O<LVL63]/OG%U]; 4<<WQG $\W
M-.!)S!:34U*QI6=)J,BH'.)/)*\\0.2FF.2FNG2Z%GU%>X:TD:(N#-DK#!I+
M"SME/D%2?7^Q[I57;V)>@40,+5XIVB4W0P=OJNG0ZMITVG7 _)RL+>X_)<.U
MKJ.':%;!(-0NQ7KR]5S:- HVS*<\^T:CL6GUF]5:0_)_PZN6Z%96"#>?D55D
MOX3&2"1_JG.7ZWP,(?'/)=Q!);3OMI126-Y:X<BTD'X0LT8XKC4\A+=,[ WY
MN^^6-P9W8;MM_95NGG9S'.9S,V2YS4S*.#'4$QSF6?/3F$3"(B(_'/7-A$R"
MQA@CPC9$QH[@T ? L(YJV)[/NF:QEMP<U+Q.,(-UMRG432\1KEV]^64G(RF6
M^8V8.T',&BJ4RZ2"\C7:T@\<)=!3*JFD8>U<0-%_FQ-<MM+.%A<+5[Y"_D7-
M#.BOH+R!Z>"O0TJ>:OA9"*OIA% KY!_;]\4.??)?6G)"9E)74TLA, ;D7$4*
M,;-E.0%=8L>D*#F2%RBC4;HW=MDFCN;2:NG+V*.9,X%<(-ET^XT'?>J:%ITF
MGL E93\D7'\T2<</E-XAM0 [L)"MNC#C532ZEU'K+1&N:GJ/3E'KNN-:T:*2
MAJK3JK'(QD-$,4SG64%-%(!4<OGSM91P[=KF5=/7:JBZZBBRBBAN/NKJYOKA
M]U=O=)</-7.<:DG^@9 9 8#!5@ "@R4/'N"N>\SP7X#V4-=3BL%N[D-+&TMK
M239*'3E:S'RL:Z?;$O,>JF9-5H\KU014:LG21RK,Y>49+D ?3'IUFP]#9K6N
M-^\-ZK*W'B/' D&C&GO=B1Q:"%1([I;AF5RYL]*K%70"]N7X9J-JO4U%Y]\E
M*8PLV[=H1C.W:$JEG8-Y".U%KJ0*D\K&P$HUXBJV_2/>F79(LG@]ZD5$+-@1
M%%TNZ*2"O,#=\]U=/T+3GEME$>F5P-#(\9MK\QIP(^4X&M0 LB-E!U'-6X\B
MM7DPBUMY:<3]*<UM$W?CYOFJ,[-2KG&.4&[L6[4;!3+"#9=*%O-*DW"#@\';
MJTZ6]=HY(42F^LBL15LJLBIL=*U2\T>]9?V+BV9A]#AQ:X<6G(CTBA *^$!P
MH5R.^7O&FZ<.N36ZN,E_52=V;3MYDZJK*MT3MVEBA^U&3JMK8ME3'6;1]NJL
M@RDVZ:@^HFB[*4_U@'/5&DZC#JVFPZE!A',P.IR.3FGM:X$'N6&1TFA5C[VG
MO,B3UQRHV-PRL<T<*+R(J4G>:)%.7?\ !V>Y-:1WVB_"*9J=")KVK6#:1.^4
M(;U%?L!F42F G<2/?-'2&W&F1ZO&/R]N\-<?^V\T%?JOI3ZQ5V)U#T\UT&,@
MA9"Y%WES_:?<]/[TNX?YWR.>JMJ_PW8_Z:/^R%AO]\]ZT @H.8L\W#UNNQCZ
M;L%AE8^#@H:,;*O)*7F)9VBPC(R/:(%.LZ?/WK@B229 $QU#@4 $1S>O>R-A
MDD(;&T$DG( 8DGL"I75=\/\ XL=9^-#CE7H4\%!2_)>^P4=*[_VDFW;O)1[/
MO"(/UM>UN9,4SAOKRE.0*U:HHBDE(.$#2"J95E^U/S%NS<USN+4'/ZG#3HW$
M1,X4RZR/GNS/('I& 66Q@:.U2YYRJK7F[C3JIL.J6.B7NN0MOIEOA9&N6FK6
M..:R\#8(&7:J,I.(EXQZFLT?,'S18R:J2A3%,4P@(9<AFEMY6SP.+)F$%K@:
M$$8@@C(A%R<_+[PA:>/[GKN70=;0>)ZQ7<QNQ],JOE5G"QM7WQ!23A8L7;E1
M5V_-3I5-] '<JF%1TK$G6-\3YZBVIK)UW0X;Z2GWG%DE/GMP)[.H4=3AU46(
M]O2ZG!8P\9V]Y+C3S^XC;FCWAF3>K[SHC"R* N9L"U&N$NC2M@,S+%.F4A7M
M)L3]+J?JF G 3E,4! <G<=BW4="N[-PJ70.(^LT=3?4X!?&FC@5;]]V)P<M^
MS]4:;YM:\A'DX;0K:9UUNAI'H"Z>1^M+5)M96HW0R28 J2%J-N.\:R!B^J)
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MPZ=QH]J6(]1A6TG)'+U@)9T$HV$YP;JR2#=P[)"N[]H3;:F;+&\2:=*XAA)
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M?SK?>]X>[[V?R>WEVHH\_'[_ ,2VY^S0_P"-G_9^_P#$O]X#^ES_ .-_C_\
M29O]=]V+_P C[O\ ]UE_]/L5+?1Z%)?G.*I,(F$3")A$PB81,(F$3")A$PB8
#1?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>lg_carismatherapeutics-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 lg_carismatherapeutics-4c.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ H )8 P$1  (1 0,1 ?_$ /@  0 " P$  P$
M       )"@8'" 4! P0" 0$  04! 0$             ! ,%!@<( @$)$
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MPI^%8W">OEW.-WB![)J/1$JP*<!<-H-AL"OO%DP-\XK=\_O=F00.8O@!C-E
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MWR")K29": 4QK6E*<:_=Q6R9KBWM[=UW/(QEJQA>Y[G -:T"I<7$T#0,22:
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MJR1]#@0)):5' *5^'](;MN)K.'JMA>6]U?VR1UIC9T%-KQ;Z0D%Q ZB+>MR
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M,8KATZ)YPN#6\LEE?Z0HKOYMO!&/*Q=3[JJ=+MY])CL^T7&,E9JA,MTW1-$
MD+9M5JVL;%9<Q4Q5^%TAPFI3XMH18@F0ZVKEZD4>DSI3CG)3(6-&(J>]0)+J
M:3G1O8%(#$:XU]7V*,7!4:H0L8W+T(1T36H6.8H$XXZ46C-BB@D7ZQ2@&50
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MP 4,R2.]9Q/PKW+=I?3]_8#%WG5FN[C&_.X86BE5N>:$$X !C)H2D:Z33,(
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M<MZQC?3/JF(.*KUL6_W\]66T46Q^D3'OGT2G[6TX*)>A&2=S[X@D\ \I;I\
M'-XZ4\ZGL,LGJ3[-*VO\UF#/B :/@7!.[8&;6]X1DNG -8[5+26G?<9'S#P)
MDEPY @<%:.S1Z[V7Y'KYI&M'+]^Y09LF3=9V\>.EDF[5HU;)G6<.7+A8Y$D&
MZ"1!,<YA I2@(B/ 9] <XAK02XF@ XDG@!XKR][(F&25P;&T$DDT  %223P
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M8N%5T%T$8QFU6 BCGS")]07B78VB:;I$S[Z;_>BPTE?Z#&NXC*WG6E#ZY()
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M?E$?JY&NO4'BIEE]:?!>=Z!$K#JZ+W="H"F$\QVLQD9(OS/.-&252BVT2H8
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MU,2"#=/[&W0DI*'5<)IE^:0BH '@&<YZ]I[-*U>>PC-8F/\ 1[<K@' 'O <
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MR<V:-W-6I]O*PT(*Z)>;TTI'-??I#;^KV#(2B<'CR_U-LU$@"("<'"TL1+I
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MU2&\#% ?#)(>P\"%#,<C<""%_%Q[J.VK7\>ZD[EOG4D"V9IG453=W^L'?J=
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M!W7F-+:J_(]8M))HZ8/VZ+QD];K-'C1PF19LZ:N4S(N&ZZ*A3)JHKHG$IRF
M0,41 ?#/K26N#VDAP-0>PA>9&,EC=%* Z-P((.((.!![B.*B:7]'GMX5OGTD
M):+\A3U)/XB;7B;V/%F5$5A7-"I6)1H:=3A>!\KCJ%Z"(\ Y _V3,\;U$UH6
M8MW-B-SE \S&N&(-.%5SP?=JV.=8-_YUX-++\WLN9OEY0XN\O/E\W)4TIFS!
MH S*6")C(^%C&$-$LVT=%1+)K&QD>R2(@S8Q[%NFU9LVJ"8%30;-6Z14R$*
M 4I0 /#,#<YSW%[B2XDDD\R>*Z%ABBMXFP0M#(6-#6M H  *  =@% %Z&?%4
M7%7>[VB1G=MKJ/@T)=&MWNGO'4O1[ [26<1R:SY!)&4A9A! #+?"9HC1#S%4
MBG605024*4Y2G24R+;6X)-OWAERE]K( U[>!H*T<W\IM32N&)\5K'JGTWMNH
M^A,L?-%OJEN\O@D(S $TS,>*@Y'T%:8M<UKJ.REKH9*=Z0?<I+VAK&7*6H53
MJQ'9 D[(SG%I]T=B0W*JD+#-V39=VZ4*'V,CH[(GCR8P<=([)N>HNC10F2T9
M-)<4P:0&@'O=4\.. *Y@TWW:=[7-ZV#5)[.VT_-Z4K'&5Q;SRLHW$C 9G- .
M)X*QKK#7U=U3K^HZXJ:"B%=IL&Q@HHJYP4<JH,T@*=V\5 I"KOGRXG674  !
M190QN YXS3EW=2WMR^[G-9I'%Q\3V=PX!=M:+I%GH&DV^BZ>,ME;0MC8.=&B
ME212I)Q<:8DDK.\CJYJL9ZJ+A2]=ZT%3HT/->LJ9KFDII"(<&DYR6EII @<
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M?0,[E_?Q3^^_HOX;YG2#SWN_B_%'JX$XQOT)!N"HD\>GWOCJ\.KCQRG[+)7
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M=0 H:K5VTW!0I! .HQ$Y8*.0YP'V )B@/'MP+1U/2(7PW[1@UII\2D][:/2
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M&Y&AHY*A(\R/+SQ*V_GI>%A6P]<43;%1EJ'LFJ0ETI\XD5&4K\^R2?Q[GRS
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M+7+7MI4T[*K;V0%D*B+]97\G"B?C@B/N2M^9_P!.S36)B./LSOTV+G#WG?\
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M=Z=]BD]&[;WEV275VJ*]-L$C<]8N'0G+\4K;T[=1\1F!T2B<KN.=,I$I0$0
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MHMF-7,)CII7JB3B[-^.6D>J1A0BH];C@K<[W:-:;LUE]'.UV\072&WJ/*+'
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M%A>U9]W777RTEWM;Q6VM?9TE61.:Y@8(I,AJUSQ4U=49CRX*?C-5+KY?D?\
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M:[!N]NV-$NZM,V%]#)1;. K\XD:.EE&Z*3UV=$SR/660.]?J,&C(IQ5$YQ*
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M:33,-6\$PB\4:Y &G@M)H6+&RA&%A0GQ8-1F0ARN57A8LLGY7OI8X':QU?)
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M\D:+,='#P/-]H:)<M:9_)\HMKCZGG8<<_(=V-]PO7SHGM#MPVHW$65\@6KS
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M5PTCW*SMJ5-.2<+$;F(LN81,7@1 >!]F6K5=Q:KK4;(M0>US(W$BC6MQ( Y
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7A$PB81,(F$3")A$PB81,(F$3")A%_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>lg_mackenziepartners-bw.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 lg_mackenziepartners-bw.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ 6 $B P$1  (1 0,1 ?_$ ($   $% 0$! 0$
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M3.WH=AQ3&FIT:F0%J*3U6B+D0NSDY.X1JJFM2Z$&8P7X.,9"()9??  AHX=
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MV LQV6.[P?)[-M>3:W7!B?VK*3,FDHW.3JT$#*3D-[ UB"B;&Y/@")"1@8P
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M*AI_>&4!C,B>X^&2Q:MJ 6QB1!97)2VX?8XM<-FVM>K87;";[",T],F.,3F
M$,HL6<@P'._\ZMQ9?^ >_P#_ +K-=?\ U5= \%:^W5QO6C$;NG3-2&[[1%Z!
MK=#9<Z=)'75 HBSF]YL*$U?'8W'BT6S#D:[S"1RV?(@)$?B4#ZI2I4::4G2G
M&!"SSBQYE-1.7>,6L^ZT)+2B#U33\R-$TKVZV*&QF>%-<F;S5D<F;<WPB?6*
MS+8B\*T"Y"6=]\"HM8W'!.3E &F,/"V'H*O-LN6[6'3W<+6'1>?L-P3+8/;,
MR-8K-@J^*QF0-C8EET^%73"Z3AP?9M%SX\SJWM&X'"5 (4D$HFE8:8('Q!",
M*N=F_;<XT-6MA;EUOE=9;ASN64=8DGJ^6RFL:]I1W@;A*X:Y',DF)C;G)]A8
M@^+T;4^)%",1I[:E\SDX\@P(OP&(&+_YU;BR_P# /?\ _P!UFNO_ *JN@FKN
MQ[,^B.A#_2$-O&H]N54ZN[7JNMD"H1"()3+Q(JQBEGA<C(W$;5"\WY'&IDL8
MDII-&L;FY4[$)R\EC^R()I>1!&)_]PKCWB3+&I-+M1^3.)QB8ITZR*262T#2
MK*P25"J2)W A='W9?LP2C>T9K>K*4!,2".P,DP(P]PB#G(72<</*YIIRH028
M3;4^</3FNKER;&RQJ\G,?,B-C08Q^ O.CBU[8A*G%"I99&2UJLHEZ!8M1&F)
M3R<FA/(.*+"OS93V4-,JRN9VUJU3JO8WD>V"852Q$^PK32NE5B1]E6-2S")W
M1G2].,T4B.;SAA (Z.M[XA":+XC%)1N!!P#9Z;>S34FQ6X,+T2O?2#;W4'9.
MPI$1%([#Y_$#9%^-?%:9:YI")TSF-4.L>&(36-,%8:N.CIS>B3_,>K/3HR!J
ML@3AT"Z"$W(_MJTZ*Z+;0[7.:A"2LIZI9&\PY.Y9)^D[V:[E%QBJ8\H">, !
MDR*R7QJ0CQCR%X'Y\0#SV#D,</036B2<@6^VONO+FXNBXZ];D0'6C*!*1B=6
M^OTRI7.+LG2A<8 T(5C#7K0\N@SCNQ?R$=S!A#G(L!IW\??LD\:N\.S,5T=H
M>,WO6<I6,\B9ZJ=;1A-:1.K)@"NV_(TD2A+A%K<F;\2X.<6:U"UH3KFI 6>D
M1#*$(M4(A,:!$W006Y$.0[7OC%UV-V9V4%,CH'_.HA73<T5\S-3_ #)]E$Q/
M5Y2)&9I>G^,-RH+6S-2]T6>2TLP+>WGB* <;@!)@/?5>Q< LW7"!;3.0':GJ
MOGE7,%Q8'=HX_ G>&062,2:3-SC8>!2!S88B<4PK"E"HL]?GZ6!^!^2S # $
M*%=AO:PXTJOL/%.Z]ME\[UVHJ7',S4SZNUV!]B[H_D?9R8U-4JE3K&CY8'XD
MV3 *XTWOZ,XL6!%F#Q@>0A':P/:Y-U[6,SKMSQ!<A^L];R5P)21J:6!#Q1Q9
M(2A(3%2C+,TV;&JM87-P*$'&0)T[T;@PCN;DP';PR!(FE>Y-)[]ZXP':;7E;
M*E]56*%Z QGS*(/,+?2ET;>E\;D+>I;'<@!2L30_-:E(-4@/6MQQQ \$*3<!
MSG 2IZ!= W-P6G$*-J6S[JL%P"U02HJ]F5FS-S$(L.$$5@D=<90_J\9.&45Y
M$-36:+&!"#C.<8QWQT +?J>5K+MR]].1?ETM]N$>]/TFDD/AZA65]M"EL&^Y
M6HLRQ"H^KR666C.KN$-30SD@+" );7(?B"$(.V.@/JZ#%OYR=S,[V<HFUUW-
MCD%R@#9/E%15&8G4@5MHZOIX&(%''AI-"''BAFZAG52/(,Y%X'O!F,9[8QC
M%I:"<\?%)P\\2= T374X?MG=I$D!6618]5UI#IG'DA]ZV>K'*Y"QS6UIG%F>
M"H&F%JG,J/#7-(WM3AO8RS2TBC(RLG *&ZU5N_S,;$[%;X6HE+A57K71ULG8
MC:F>('QAUQH*OX\B+;6J,H)"H)7*I"HBD9:$;#&HHSY=)*[G$IDQ1)IIAAV
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MIIQ(:PQ=V:Q-<]NIE5;-V26:6 A2.0742@?(P0N38#@U*Y,=4I(XUJ2C<Y-
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M_P!Q;<S-Y\B,,U9C[D%5#--*U2MCJ0G5!4)1V_<Z-AGDU/",D."<B0PI-%D
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MFO'4_4$#:=#OZ+TRSWI=$ ,=D3LX1&[[V:&Y4@KZ4*D&<HU3U6E?M9!I)Y.
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MH.3KVAN6J.6C$:)IBFF?1.<K6>!V$IBCA VJY;K5L=Q1YEF]40EY)M6'.D4
M\+H))6Q0Z)D,:3.:5Y6G-@A$J$!P3 /[U%DUXS35?7&7[,QA'"MB)11]7O\
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C*@+>PS-:UGR-G0A/6G#P4G4EEX&://;N(6<@Y70+H%T'_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>tm2227887d8-tbl_pipelin4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2227887d8-tbl_pipelin4c.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@!@@.2 P$1  (1 0,1 ?_$ 1L  0 !! ,! 0$
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M9"J8E&76)A5N3"UKE/IFXE>'5(R3C?!EFAT6#MC#O?9!KO:^)G$NWO9.6M)
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MZJ86]A/4!"?)5C^MR?Z#'"R>^/NIA;V$]0$)\E6/ZW)_H,<+)[X^ZF%O83U
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ML^$&HLU@Z^][Y6WS5J.MJ^XK^;CF<+A[1'93:U-3Y_L5[;RS0+9:\MDACB5
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M:V\%EQDODV\JGI=5OEE/_P 6L=]U?&*\XN+RCN33!9<9+Y-O*IZ75;Y93_\
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M[DTP67&2^3;RJ>EU6^64_P#Q:QWW5\8KSBXO*.Y-,%EQDODV\JGI=5OEE/\
M\6L=]U?&*\XN+RCN33!9<9+Y-O*IZ75;Y93_ /%K'?=7QBO.+B\H[DTP67&2
M^3;RJ>EU6^64_P#Q:QWW5\8KSBXO*.Y-,%EQDODV\JGI=5OEE/\ \6L=]U?&
M*\XN+RCN33!9<9+Y-O*J_P"OFCC0>O<P6=8=Z-<?TW:$E40.FX ^O G?2U+I
M.2>CD%[1Q$!N$DV?L9@3Q&A,"7K0-A$(0=6Z?FX8.9Q6SI:Z<<KVBE#NMA<:
MUIN=G2MJUCR<O//9;EL5-&")CC6HW'3-%*5W:UIH64?4[YO'VX>9_P#%MH_^
M59FEPNU/$9?Y>;ZLMW@=D_[1F/T>'ZRGJ=\WC[</,_\ BVT?_*LQPNU/$9?Y
M>;ZLG [)_P!HS'Z/#]93U.^;Q]N'F?\ Q;:/_E68X7:GB,O\O-]63@=D_P"T
M9C]'A^LIZG?-X^W#S/\ XMM'_P JS'"[4\1E_EYOJR<#LG_:,Q^CP_64]3OF
M\?;AYG_Q;:/_ )5F.%VIXC+_ "\WU9.!V3_M&8_1X?K*>IWS>/MP\S_XMM'_
M ,JS'"[4\1E_EYOJR<#LG_:,Q^CP_64]3OF\?;AYG_Q;:/\ Y5F.%VIXC+_+
MS?5DX'9/^T9C]'A^LIZG?-X^W#S/_BVT?_*LQPNU/$9?Y>;ZLG [)_VC,?H\
M/UE/4[YO'VX>9_\ %MH_^59CA=J>(R_R\WU9.!V3_M&8_1X?K*JD42\WJO6I
M$)-Q\S FK52=(4(SC=2.BPF*#0$@$9L/*H8M T(>NN]:WOI\3>4=/M2UI<8,
MOH!7Y>;ZNKFP;*.<&BXS&I-/W>'ZRBV)>;U0+5:$ZX^9@C42I0D-$7QNI'98
MC$YHR1B+V+E4 6P;$#?3>]:WT^)K#9]J7-#A!E]"*_+S?5T=!LHUQ:;C,:@T
M_=X?K*I?4[YO'VX>9_\ %MH_^59E>%VIXC+_ "\WU96\#LG_ &C,?H\/UE/4
M[YO'VX>9_P#%MH_^59CA=J>(R_R\WU9.!V3_ +1F/T>'ZRGJ=\WC[</,_P#B
MVT?_ "K,<+M3Q&7^7F^K)P.R?]HS'Z/#]93U.^;Q]N'F?_%MH_\ E68X7:GB
M,O\ +S?5DX'9/^T9C]'A^LIZG?-X^W#S/_BVT?\ RK,<+M3Q&7^7F^K)P.R?
M]HS'Z/#]93U.^;Q]N'F?_%MH_P#E68X7:GB,O\O-]63@=D_[1F/T>'ZRGJ=\
MWC[</,_^+;1_\JS'"[4\1E_EYOJR<#LG_:,Q^CP_64]3OF\?;AYG_P 6VC_Y
M5F.%VIXC+_+S?5DX'9/^T9C]'A^LIZG?-X^W#S/_ (MM'_RK,<+M3Q&7^7F^
MK)P.R?\ :,Q^CP_65R#C'F\BPDBW<7,[>CB]F!Z<;J0ZZ#HTTGH+KRKUTWVB
MM][KW.F.&VIXC+_+S?5E7@=E!_VC,?H\/UE<?J=\WC[</,_^+;1_\JS'"[4\
M1E_EYOJRIP.R?]HS'Z/#]93U.^;Q]N'F?_%MH_\ E68X7:GB,O\ +S?5DX'9
M/^T9C]'A^LIZG?-X^W#S/_BVT?\ RK,<+M3Q&7^7F^K)P.R?]HS'Z/#]93U.
M^;Q]N'F?_%MH_P#E68X7:GB,O\O-]63@=D_[1F/T>'ZRGJ=\WC[</,_^+;1_
M\JS'"[4\1E_EYOJR<#LG_:,Q^CP_64]3OF\?;AYG_P 6VC_Y5F.%VIXC+_+S
M?5DX'9/^T9C]'A^LIZG?-X^W#S/_ (MM'_RK,<+M3Q&7^7F^K)P.R?\ :,Q^
MCP_64]3OF\?;AYG_ ,6VC_Y5F.%VIXC+_+S?5DX'9/\ M&8_1X?K*>IWS>/M
MP\S_ .+;1_\ *LQPNU/$9?Y>;ZLG [)_VC,?H\/UE?AU9.'!$,GHZOL[DPZO
MPH\U@6D3VBJM8&@IFW.(@(\]*KCW(J2K#W,*X*<("ADEE;*&8+9FA " =8Y,
M^-Q%SR&S;%B-,$TCC7 [<= T4I736M::$?'L^+>7F4UXZ7 *XX8VBF-FHMG<
M:UIHI2E=/9UR]+JM\LI_^+6.^ZOG6Q7G%Q>4=R:Y&"RXR7R;>53TNJWRRG_X
MM8[[J^,5YQ<7E'<FF"RXR7R;>53TNJWRRG_XM8[[J^,5YQ<7E'<FF"RXR7R;
M>53TNJWRRG_XM8[[J^,5YQ<7E'<FF"RXR7R;>53TNJWRRG_XM8[[J^,5YQ<7
ME'<FF"RXR7R;>53TNJWRRG_XM8[[J^,5YQ<7E'<FF"RXR7R;>53TNJWRRG_X
MM8[[J^,5YQ<7E'<FF"RXR7R;>53TNJWRRG_XM8[[J^,5YQ<7E'<FF"RXR7R;
M>53TNJWRRG_XM8[[J^,5YQ<7E'<FF"RXR7R;>53TNJWRRG_XM8[[J^,5YQ<7
ME'<FF"RXR7R;>53TNJWRRG_XM8[[J^,5YQ<7E'<FF"RXR7R;>53TNJWRRG_X
MM8[[J^,5YQ<7E'<FF"RXR7R;>53TNJWRRG_XM8[[J^,5YQ<7E'<FF"RXR7R;
M>53TNJWRRG_XM8[[J^,5YQ<7E'<FF"RXR7R;>53TNJWRRG_XM8[[J^,5YQ<7
ME'<FF"RXR7R;>53TNJWRRG_XM8[[J^,5YQ<7E'<FF"RXR7R;>54]%FZK]2:.
M;!,)\(?IZT=D(JWCP0[%Z8)^SH0M6J/8=;WW]]-]/C;S%.Z[X%_>1^"?TW=C
MQ:RP,LN&9227PA_R;>SXQ>F?GD1>QUY%O(#]_N\OPR6C]_+]GN')^B;;Q$?Q
M0O!6T/3MW\X?\8K$F=%<9,(MJJ9^TL/U7=/\L'.!>_O#E+K+]UC^"%E?-5;2
M81,(F$3")A$PB81,(K1>_MGA7^DOWV%/R]O@._)VU0ZPKNRQ53")A$PB81,(
MF$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(H.3_ &MR
M'ZANW[049<SPQ[85#J54R_N.T_4Q!^U2LH[PC[:JI+*(F$3")A$PB81,(F$3
M"*])1^X=<?<8N_*'/,UX?E)?&#XC%L3_ "</BSYQZLO-A:Z81,(F$3")A$PB
M81,(JLG_ #57_P W_P IO+3K"J-15)ERHF$3")A$PB81,(F$3"*:CGVPL/U:
M:_V\1F.7Y)WP3VEDB^5;\(=M)']L+]]6G3]O'XB^2;\$=I)?E7?"/;4+F18T
MPB81,(F$3")A$PB815:C_$H/]$'^WEN6C6?;_,%<=0]K\Y5)ERM3")A$PB81
M,(F$3")A%>D7_<.Q_N,0_E#@>:\WRD7C#\1ZV(/DYO%CSC%9>;"UTPB81,(F
M$3")A$PB81,(F$3")A$PB81,(I^*?;1&_J^S_9%-F*?Y!_P#VEE@^79\,=M>
MH;GCM>T5Y%O(#]_N\OPR6C]_+]GN')^B;;Q$?Q0O!6T/3MW\X?\ &*Q)G17&
M3"+:JF?M+#]5W3_+!S@7O[PY2ZR_=8_@A97S56TF$3")A$PB81,(F$3"*T7O
M[9X5_I+]]A3\O;X#OR=M4.L*[LL54PB81,(F$3")A$PB81,(F$3")A$PB81,
M(F$3")A$PB81,(F$3")A$PB81,(F$3"*#D_VMR'ZANW[049<SPQ[85#J54R_
MN.T_4Q!^U2LH[PC[:JI+*(F$3")A$PB81,(F$3"*])1^X=<?<8N_*'/,UX?E
M)?&#XC%L3_)P^+/G'JR\V%KIA$PB81,(F$3")A$PBJR?\U5_\W_RF\M.L*HU
M%4F7*B81,(F$3")A$PB81,(IJ.?;"P_5IK_;Q&8Y?DG?!/:62+Y5OPAVTD?V
MPOWU:=/V\?B+Y)OP1VDE^5=\(]M0N9%C3")A$PB81,(F$3")A%5J/\2@_P!$
M'^WEN6C6?;_,%<=0]K\Y5)ERM3")A$PB81,(F$3")A%>D7_<.Q_N,0_E#@>:
M\WRD7C#\1ZV(/DYO%CSC%9>;"UTPB81,(F$3")A$PB81,(F$3")A$PB81,(I
M^*?;1&_J^S_9%-F*?Y!_P#VEE@^79\,=M>H;GCM>T5Y%O(#]_N\OPR6C]_+]
MGN')^B;;Q$?Q0O!6T/3MW\X?\8K$F=%<9,(MJJ9^TL/U7=/\L'.!>_O#E+K+
M]UC^"%E?-5;281,(F$3")A$PB81,(K1>_MGA7^DOWV%/R]O@._)VU0ZPKNRQ
M53")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB
M81,(H.3_ &MR'ZANW[049<SPQ[85#J54R_N.T_4Q!^U2LH[PC[:JI+*(F$3"
M)A$PB81,(F$3"*])1^X=<?<8N_*'/,UX?E)?&#XC%L3_ "</BSYQZLO-A:Z8
M1,(F$3")A$PB81,(JLG_ #57_P W_P IO+3K"J-15)ERHF$3")A$PB81,(F$
M3"*:CGVPL/U::_V\1F.7Y)WP3VEDB^5;\(=M)']L+]]6G3]O'XB^2;\$=I)?
ME7?"/;4+F18TPB81,(F$3")A$PB815:C_$H/]$'^WEN6C6?;_,%<=0]K\Y5)
MERM3")A$PB81,(F$3")A%>D7_<.Q_N,0_E#@>:\WRD7C#\1ZV(/DYO%CSC%9
M>;"UTPB81,(F$3")A$PB81,(F$3")A$PB81,(I^*?;1&_J^S_9%-F*?Y!_P#
MVEE@^79\,=M>H;GCM>T5Y%O(#]_N\OPR6C]_+]GN')^B;;Q$?Q0O!6T/3MW\
MX?\ &*Q)G17&3"+:JF?M+#]5W3_+!S@7O[PY2ZR_=8_@A97S56TF$3")A$PB
M81,(F$3"*T7O[9X5_I+]]A3\O;X#OR=M4.L*[LL54PB81,(F$3")A$PB81,(
MF$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3"*#D_VMR'ZANW[049<
MSPQ[85#J54R_N.T_4Q!^U2LH[PC[:JI+*(F$3")A$PB81,(F$3"*])1^X=<?
M<8N_*'/,UX?E)?&#XC%L3_)P^+/G'JR\V%KIA$PB81,(F$3")A$PBJR?\U5_
M\W_RF\M.L*HU%4F7*B81,(F$3")A$PB81,(IJ.?;"P_5IK_;Q&8Y?DG?!/:6
M2+Y5OPAVTD?VPOWU:=/V\?B+Y)OP1VDE^5=\(]M0N9%C3")A$PB81,(F$3")
MA%5J/\2@_P!$'^WEN6C6?;_,%<=0]K\Y5)ERM3")A$PB81,(F$3")A%>D7_<
M.Q_N,0_E#@>:\WRD7C#\1ZV(/DYO%CSC%<M!Q1DG=Z4M!Y*F,61R96S7,4?T
MA2@](:J9)%,&9H=4Q2M,,I2E,/0K# A,+$$8-[ZAWK>M;S#F<TEMEUQ<0FDL
M<$CFG70M:2-'MA9LK@CNLSM[:85ADGC:X:JASP#I&K05]&$F\SY1<7\XK341
M31UWD_#JZ&"RD1#<DEK^-3#[/K.%/9[W"W&7(7+T[":8Z,^G%-I0H":;O2Q-
MH(@HQ[SY5#MWF4VRMQ.7M9GUNZ,U+6]]'(\4>&D4U'":#1WI_2"^MS; 99!M
M;;P!CG[/W#)!0.=WDD;#5A<#76,0J=/?#]$KJ!HWS:5]WQ6L-LIFE5)00FU5
M\F:J0AEJ623"Y[>CE$!F)W]'5S(:U+4CH-$O*VFV-:J;RMG;#\WV!@&*=9CM
M=EF6W<EI(RXE,(:9GQQXV0AW@F0U!%1IT!VCV5 <MV.S3,[..\C?;1"<N$+)
M9,#YBSPA&*$&AT:2T5]A1--^;@Y+7W&R'^L6R+OJU)=(*+F\.$\+TDSJN5]A
MP-.>;'9SF713+#4A3</9C@0>KUH?^#T#9H#2R\E_M9E&62\%>%[6FWX9CJ L
MD;HT1FNEYKH:0.S6E"<>7[(YQFD(ELFL<X7' O94A\3M.F04T,%/"!/8I6H&
M?85YM2-.?$GE?=[[?E.J9W1LY#!8Z6UVDU(ZZVHC3L1ZK1.KBZL*9T<'V6$I
MS6^(IR_%R'E28$9(C@FDCUS+C:V9F>6671VUP+:YCQNK&2_OAWM "0 W0Z4Z
M2P:Z4*ZMML?"_(K[,I;JW-U;2X&TD C[T]]4EH)<[2V(: \ZJU"U=\W]QP:>
M4G*:O*UEHC$]:(-ND]MQR"K-;B6VLH,A,?),)4Z$#+/:B';1!+;I4 01D&K@
M#"(.]:WKL;3YL_)LFENX--V:,B%*UD>:-H-VFEU-VBXNRN41YWG<5G/HLQ5\
MIK2D;!B=4[E=#:[A*SESMX>0*$\D**:^+0=AHWEW"JHEE#*'UW<ER= JG!S=
M%E[*]/+@8Z.X%*)^-*7+ F>&,1%.0">FQ%[ 'G;-Y[<W&4W+\YZ1L9)&S4 %
M<%7 @"@H6Z!JKAKNKI;3;/VMMF]LS).C;^.)T&(DT+Z-()-3H=1QUT#J;E%'
M6;YJCD15<,N"6O<WX_/*^A'*.I[:@,3M0#[84(8Y8M3)H],I$P%L9*=DC#HD
M4Z7%[6*4Z[:  S_%NR 72ZSVTRJ]N(((X[IK;D.X)[HZ,>6COF-=72X'1H!%
M=%59>[$9M8V]Q/)):N=:EO"L;+BD8''O7N;AT-(TZ2'8:G"MX1>:DK>NN3?$
M.M$J^ \D6NX: 43":U\+D 7"7Q]G &">R);.(PZ0R,.;LV4EXHV(RF%ST2J
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M0E(G)5V=%!$:I)3!Y66[<Q2LOKG,XI8;6VF+6_LW T!#1&ZI^7+C4LT81KT
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MOLQGUU;/O(+=SK6/A,3L3 &\%7'6KAX-/RZA52<N\WCS-@=0J;VEE%2!GK)
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MAL98)[.[:]\YP\$&L<XET;@:N<_%6@ T]G6))<9EDUKF68[2B^BG@O;1T<<
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MD+2.$>YPC<6C%A:30$:12FC<TA;FT&V.:7S[K+8GPMRV29P/!L:TR,#SAQ.
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M$:'&'FKC0CPB36A!X6U$4#8KV\BS:.:*ZO#)';Q/+PYKC6LHQ#@S&*-%0?!
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M>6?$N=;9 7W)KM:D;N4P1ZO(FC:"I"..L3DZ=MI>B5A?9/!L\6_!J=C0QS:
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M(/K*M/63UBT_#>6_XP_[J4PGO3F4EZ[WQ/I8?3?:]]T_!^)_!<WEW\*Y&?\
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MC;2PI]!XH@$$L1"(&]Z%L6^WO>^NM=-:K_!F3?WC-]$'UE6^MK;ZE?X:R_\
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ME<AM:*1JK;\?>1B *F3)K6:)/6#)#F*OFLJ 2%ZB;NOFT5KV+[97MUG)+*@
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M_9_OLWHM2C%TK%<?UW[+Y.\Z,2B=XK$<N_O^^W_Y6=*!1.\\(JPW#]=Z&_\
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M5V!<V#]1I=./<@;DB5":G]+R&U,(:T2LS9A]<0II]I*++43XSML14*7=+-I
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MEP'[-E&UE)!)) T$E?.<TV8S1F2&+A67!M<LGMHF,B<U[P]L0:3^T?5U(@"
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M3XV-:_O"T5P&KMS$":E9+X8^;>:^)\TB3^!+Q8&BK6MW.M(K(JFX>5U4MV6
M0K,9$:&;7?<Q;K*)%()<FC;)M.M P%QY \N"Y6N6E&:$F2)-3/-J'YQ ^.MY
MBEE#W-DN7R1,UDMBBHUH;B-1CQEH#6M(TEVUD>R[,GG9)2SPQ1%C71VS(Y7U
MH Z66KG%V$4.# '$ES@=#6]I.1)2Y,(F$3")A%K/S3]YQRS_ (,]\?DME6=7
M(NG+/YW#YQJY>>="7GS67S;EU_\ ]#/DC^_%'/N1>=)R-]\)>_X9;/\ OV?,
M].97T9;^(C^*%YOS'I"X\?)\<K#.;RTTPB]%W^K3_P U_%?PS6]]EF_/,?6G
M^+7^(C[17I#JP_"K?'R=L+O\SYROH:81,(F$3")A$PB81,(M >2GOV/-N?=E
MRB_-ODV2/*^@<T\7!Y]JCN:=.Y7\.?S+EO\ 9'%(DPB81,(F$3")A$PB81,(
MF$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3"+6?FG[SCEG_!GOC\E
MLJSJY%TY9_.X?.-7+SSH2\^:R^;<M'Z&_>1I_P#!?7_WHL^8,TZ3N/'R?'*S
M97T;;^(C^(%F,G];^QS3;K6XY7"E^=!Z ?D!QNK&[4KC0_$]'67;B#6KS1?/
M%_J?)PU5.I7PV]_]G\K*G6C?!5V).]K^^^7C=13Z7YW?HY3=50I<OYT/H9:5
M<-:Y,M5RMYI,<1.\J"LTITC+<T 6G9Q8P$[2B86H:CQ08@A":5Z8".[6P[WK
M1G:UW];UHBN'")A$PB81,(F$3")A$PBM]S&XA?(T!+I3XB8<ZZ<]E%C$GT +
M:8))XT/0=A*#XSK78Z[UU%W-817!A$PB81,(F$3")A$PB811CV)4!F=QH?"[
M6A;%XD>B B&?M4%*;M/X$ ="$,WPNM=G6M;WO>$7,V[/$W(!*?">,B1)=J/"
MAV$WP^R"]F^$"+6MA,\)UZZWK6];PBK<(F$3")A$PB81,(F$3"*WF(QQ&JDV
ME^E.BBY"(MK\8+&6#;=Z3,P];2[$$.C4WCHS_FM===OM:Z]=;UHBN'")A$PB
M81,(F$3")A$PBT!Y*>_8\VY]V7*+\V^39(\KZ!S3Q<'GVJ.YIT[E?PY_,N6_
MV1Q2),(F$3")A$PB81,(F$3")A$PB81,(F$3"+6?FG[SCEG_  9[X_);*LZN
M1=.6?SN'SC5R\\Z$O/FLOFW+K_\ Z&?)']^*.?<B\Z3D;[X2]_PRV?\ ?L^9
MZ<ROHRW\1'\4+S?F/2%QX^3XY6&<WEIIA%Z+O]6G_FOXK^&:WOLLWYYCZT_Q
M:_Q$?:*](=6'X5;X^3MA=_F?.5]#3")A$PB81,(F$3")A%H#R4]^QYMS[LN4
M7YM\FR1Y7T#FGBX//M4=S3IW*_AS^9<M_LCBD281,(F$3")A$PB81,(F$3")
MA$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A%K/S3]YQRS_@SWQ^2V59
MU<BZ<L_G</G&KEYYT)>?-9?-N6C]#?O(T_\ @OK_ .]%GS!FG2=QX^3XY6;*
M^C;?Q$?Q LQD_K?V.:;=:W'*X4OSH/0#\@.-U8W:E<:'XGHZR[<0:U>:+YXO
M]3Y.&JIU*^&WO_L_E94ZT;X*NQ)WM?WWR\;J*?2_.[]'*;JJ%+E_.A]#+2KA
MK7)EJN5O-+DI6.\J1G;!LAI<T"5'H(-!$$E0PM3@9HP7_&"VI5CWK?Q-=-?$
MPBN'")A$PB81,(F$3")A$PBM]S<5*5\C2 K8-)W0YU KT(&A"V%(VF*B>P+O
M@WHT.NOQ]=S"*X,(F$3")A$PB81,(F$3"*,>U1R%F=UR?8='HVQ>J)V(/:#H
MY.E-.+V(.^X(.A@UUU\7"+F;3S%3<@4F[ULU0B2GF;#KLZV8:068/>M?$UVA
M;[F$5;A$PB81,(F$3")A$PB816\Q.2E>JDQ*C8-@:Y")M2=@&@[TFTS,R[6A
M[U\^/PZXSN_&Z:^)A%<.$3")A$PB81,(F$3")A%H#R4]^QYMS[LN47YM\FR1
MY7T#FGBX//M4=S3IW*_AS^9<M_LCBD281,(F$3")A$PB81,(F$3")A$PB81,
M(F$6L_-/WG'+/^#/?'Y+95G5R+IRS^=P^<:N7GG0EY\UE\VY=?\ _0SY(_OQ
M1S[D7G2<C??"7O\ AEL_[]GS/3F5]&6_B(_BA>;\QZ0N/'R?'*PSF\M-,(O1
M=_JT_P#-?Q7\,UO?99OSS'UI_BU_B(^T5Z0ZL/PJWQ\G;"[_ #/G*^AIA$PB
M81,(F$3")A$PBT!Y*>_8\VY]V7*+\V^39(\KZ!S3Q<'GVJ.YIT[E?PY_,N6V
M=SSXZJJ>MBT$S8)[45O6D[GQ#,'8]"=SH?%W60E-@=E[T/0EXV[16NSO6_F^
MYG&L;87E[#:$X1+*QE>QB<&U_)5=B^N39V,UV!B,43WT[.%I=3\M%I'0%,W"
M=$N,?(-XYB68Z3V:-D*F=YLLQ7-[_2=IMEBPWTQ<(' *N 8P,54C:I$[)-QA
MQ8S"UQ)"70''3QLXW1G?S&^LA-=Y:RRB%O&7-B+01+&6.H'ODTF2K0>$:_02
M>]P4"X&6V-Z8;3,GWTIN) QTH<08I ]M2QD>@1T<1P;F:0!WV.IKCZ#U1,DG
M/V>4ZHY0<J7>OJ]XR<=+Q9V)XM@"PMPF4SNGD9%I&E?C=1XHQTCCBR58U$B1
M;V .M:.WH74W?39N+R [.1WHM+-MS+=S1$B.E&MB@<VG?:' R.-?:["UK>SG
M;M')8F[O'6T5I#* 9*U<Z69KJ][I:1&T4]OLJZK>Y0P3D;/^+M*<7>4L3>(C
M;MLSQIN"R>-%E5W.).QQ^M*6F=FHH,@E;,;,F^$.<QD3:V;4J/ :7C9TZHI,
M,D9VCR\-EE-QEEM=W^;6CVS0PL,;)V/8TE\K8R\M.$O#6EU!6F(@FM*'->YM
M;YI<VEAE-XQT,TSQ(^!['N 9$YX8'#$&%S@VII7""!2M5J@Y2[F_;T+K2IJ^
M>+\GY-/\K^8]57';U4SBHZBL67PFBU#_ !RCTTVF<J8/4LTNTB+E;<%R&WLY
MVW=Q81GB*3A/&81V&PY!93RWERVVC,]G;211R,DD8UTM'2X6M.(AN%V&KAA:
M^E32AX[YL_O8(K.V=<R""\N8Y9(WQQO<V*HBQ.<,(+L3<5&]\YE:"NCF9;HL
M7DTP6H?2_(SD-5<6XO<$ZQMJ%+GG=>K;%EU]RV0\G61[6<@3CXP_L,Z30%UX
MVE-*UJ0"3M+@H5.1FC#="1G$4DL;;*I(1?6MM--=YA)&X#&&-A:V @0]\"S&
M)\0<:N #10=\#6._N<VCF-C=7,,5IE\<C2<!>Z9SIP3-WI#\!@#2T4:27FI[
MTC%5G\S>0TH=)+<$>G=NQIDA]6<&[!:%U;-L./XN4$KNB-Q2>7(V\PMR%@/G
M$C2J8K)BG$\UD+>MLD46(E9/I2L$:K,W+3(\MA8VRECA?(^:Z80\NYQ-P3G,
MB-MA.!O?-PC%AQR!P.-M&K3N\\S.9S[V*29D;(;5X+ WF\)E:U\HN<3<;N]<
M''!BPQEKA@=5R^CS/F"^GIA$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3"
M)A$PB81,(M5^<SHVLW"[EDM=5J9O2;XY7.@TI5F@))VM=J\D#4V)=&#WH/AE
MSDM)(*#WQFF!#KN[UG9V=BDFSZRCB:7/-U%H&O0\$^X 2H_M7?V65[,W]_F,
MK(+*.TE+GO(:UH+"!4G0-) ]LKJ9IGF3Q39JBJYH=N0E2MSHUUW"6YQ0*YJR
MD*D2Y%&6M*K2*21JM#*4)E!0@##O6MA$'>MYU\QV1VGDS">1EA=%CIGD$1NH
M07$@C1NJ"Y=US=5$=A!&_:+* ]L+ 0;F.H(: 1X6XLJ%<WN(.NG7DE3FOG>_
M.F/Z;S5;L?M57H^[\F[N+:=UT]4O^8LH^DQ_K*<3\Y>'8=![7)>F==[OSQBU
M\;_Z7_:Q_!^U5>C[OR;NXK#UT=4U/Q%E'TF/]93J/G9PU!T[?)NE@]W7?GS#
MK_\ >\K_  ?M33H^[\F[N(.N?JFK^(LH^DQ_K*ZTG/?A6$1>Q<HJ1#T[_6P(
M_KIW?[:S*MV/VI_N^[\F[N*IZZ.J:GXBRCZ3'^LKP0><#X0E[^;Y548#YKK\
MU8<>UW.G]M9@['[4_P!WW?DW=Q!UT=4U/Q%E'TF/]97*F\X9P9#K7:Y84.'N
M_%L:.Z^+_IN/X/VIKT?=^3=W$]='5-7\191])C_64TF\XEP4"'>A<M:%UW?B
MV1'-?)6X_@_:FO1]WY-W<5?71U3?YBRCZ3'^LI0'G%^"&@ZZ\N*"UW/;)C?T
M[EIV/VJ_N^[\F[N*X=='5+7\191])C_67[_[QC@?_M<4%^,F-_3N6_P=M5_=
M]WY-W<5?73U2_P"8\G^DQ?K*+1><CX-GKGA.IY64(G3(5:8EO4;LB/=%Y!K:
MB5''AV);V=Z)6'F%?,]SJ7\?KC^#MJO[ON_)N[B>NGJE_P QY1])C_64I_WC
M' __ &N*"_&3&_IW'\';5?W?=^3=W$]=/5+_ )BRCZ3'^LG_ 'C' _\ VN*"
M_&3&_IW'\';5?W?=^3=W$]=/5+_F+*/I,?ZR?]XQP/\ ]KB@OQDQOZ=Q_!VU
M7]WW?DW=Q/73U2_YBRCZ3'^LG_>,<#_]KB@OQDQOZ=Q_!VU7]WW?DW=Q/73U
M2_YBRCZ3'^LG_>,<#_\ :XH+\9,;^G<?P=M5_=]WY-W<3UT]4O\ F+*/I,?Z
MR?\ >,<#_P#:XH+\9,;^G<?P=M5_=]WY-W<3UT]4O^8LH^DQ_K)_WC' _P#V
MN*"_&3&_IW'\';5?W?=^3=W$]=/5+_F+*/I,?ZR?]XQP/_VN*"_&3&_IW'\'
M;5?W?=^3=W$]=/5+_F+*/I,?ZR?]XQP/_P!KB@OQDQOZ=Q_!VU7]WW?DW=Q/
M73U2_P"8LH^DQ_K*,5^<CX-DN#2F(Y6T(>D6&+ KE6K(CV](@D)!G)Q"V%;V
M=>'/#H'S7Q^YW<?P=M5_=]WY-W<3UT]4O^8\H^DQ_K*3_P"\8X'_ .UQ07XR
M8W].X_@[:K^[[OR;NXGKIZI?\Q91])C_ %EDZJN6'&>\G]5%:>O>K+*DR)M-
M>54?ATS9'MX*:2#R$RARVW(U9BH2).H5% ,,T'80",!H6]=K772O\@SO*XA/
MF-K/# 74#GL<T5UTJ12N@^XN[L_UA;#;5WCLOV:S;+[Z^8PO,<,S'O# 0"["
MTUP@D FE 2*ZPM@LY"F*81,(F$3")A$PBCW98)N:G-P  )@T+>L6 +%O>@F"
M2IC#P@%O7=T$6P=-],(N5 H$K0HE8@Z )4D3J! #O>PA$<2 S8=;WW=Z#L73
M"*KPB81,(F$3")A$PB81,(H1H=3')2_D#* 5IG>Q-10@"%O9Q>FIJ</"CZ]P
M(^VX"#TUW.@=813>$3")A$PB81,(F$3")A%H#R4]^QYMS[LN47YM\FR1Y7T#
MFGBX//M4=S3IW*_AS^9<M_LCBD281,(F$3")A$PB81,(F$3")A$PB81,(F$6
ML_-/WG'+/^#/?'Y+95G5R+IRS^=P^<:N7GG0EY\UE\VY=?\ _0SY(_OQ1S[D
M7G2<C??"7O\ AEL_[]GS/3F5]&6_B(_BA>;\QZ0N/'R?'*PSF\M-,(O1=_JT
M_P#-?Q7\,UO?99OSS'UI_BU_B(^T5Z0ZL/PJWQ\G;"[_ #/G*^AIA$PB81,(
MF$3")A$PBT!Y*>_8\VY]V7*+\V^39(\KZ!S3Q<'GVJ.YIT[E?PY_,N6^RM(E
M7I5*%<F3K4*U.<D6(U9):E*K2J2Q$J$RE.<$9)Z<\D>P# /6PB#O>MZWK>1U
MKBTAS20X&H(W%(2 X%K@"TC2%HI"O-]5M#G>J$ZFU[[FM34%(4<JHKCS-I;$
M'*H:L?6-.:DA:ML.;( S6K,T]<)3M@CB25RB0HV78"C$Q0#2"#"I!/M)=3LF
M(AMX[RY:6RS-:X22 Z75J\QMQ_IF.-A=I!-":QZ#9NU@?"#-<26=L[%%"]S3
M'&1H;2C!([ / $DCPW00*@$;.(:;B+=>4IY!IS'C<\E]40&FW8DQ:0)@#$:X
ME]DS:/F)&_2,*DEX&\VFYZ4'"4# 82$@(2P; (0^4Z^F=E[,M.'F[)GRC1IQ
M/:QIJ:ZJ1MH*:ZZ5UFV,+<P?F0Q<X?"R(Z=&%CGO%!3761U37530H2]*!B=]
M-T)+>WZ;0F45E-B+$K6Q:V?B8Y.8-+01V10Y:O9UZUN>6A8B>X=+G1J<$#BA
M7-ZU"N, :0+>BQ R9?F,V7.D,;8Y(98\#V/&)CVXFN (!!!#FM<"T@@@4*QY
MAEL.8MC$CI(YHI,;'L.%['87-)!(((+7.:X.!!!-1J6%">!52,L8KIF@,SN>
MKY17!MEGIK7@M@B3V=,3[JD9<TN-18SS(6B1,TV5V1-B2WE8>L;Q'(7$L!K:
M-#H.@ZWCM#>/EE?<QP30RX/V;V?LV\$W#%@#2TMP,[T .H6Z'XEH#9VRCABC
MMI)X9HL?[1C_ -H[A78I,9(<'E[^^)+:AVEN%0,I\V]QY?6*.Q>/.-K5C&VR
MG">/<K9JUL1R8BK8I4MV>GT^!6BO<4ST\R #@\RIY4J'A.I12(TY\<1[<.JP
M[8LL.U&91R.FD$,LIGX9I>P'@Y: 8XP* 4#6@-(+*,;WO>A8Y=E\LDC;#$9H
M8A!P+@QY'"15)P2$U)J7.)<"'DO=WW?%3E@>;_HJP7V4+#EUC1.%V.WPMJN.
MGH/+_4_5%SMM>L35%(DAGL>TV*G0A*WQ!A0LZ@#(O9M.;2B)2+O&2"P@S';;
M1YA;1L:!$^>(N,4CVUDB+R7.+'5II<2X8@["XES:$K+<[.9?<R/),K()0T2Q
ML=2.4, :T/%*Z&@-. MQ- :ZH"W?S@+O)A$PB81,(F$3")A$PB81,(F$3")A
M$PB81,(F$3")A$PB81,(M*O.*^\IY _<BA^^=AR3;'?B:S\;_P 5R^7==/\
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M,;<3&0X+$L2R)F(9V]>#9.M(7?01A4;K%D5OP'/+2436LEG</'"1ECFNAIB
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MHTUJZ^X]1NKZ[M&NH5+9XT$6I8=]V@OE93DP^K"*R_D+.Y;8LH70U<&-@:4
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M\B\B6S6Q :?=K2FE*O:W/7A6PY#KYG'\37<CY3=PV\]O*Z-W!/:_@V&)N"/
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MOIF7?6U;"OASSR4=>QP[F6N[O?S5Q<9/B]/C75O-MG69L2W7>_ZF?DEP+O\
ME7Z]KCP<D ]N]R_ZTK+<N$W/(9Z5*/B1*25"T1P4A1EQ\:>T>(@O9YV@=+GW
MK>RRM;%O^UFZSK6V&::F\/D9^24>N/Y/^OR84;DT8_[[8?6E!*?-_P#G S_G
M>(\EUW==^X^-?Q/0N7>;3>MW81NN[=Y&?DUR9/Y,/Y@7ZLHB^FV/UE7957FJ
M.8UIV"Q1>VJ[6\>ZN-,&LF]@*)[5$ND8F9,,KPL=@S/!)I,3RI4^Z,V64N7%
M%H6\H)A^_#&A*3F\G:#KHV=M\L><@D=<9D=#6EDC *_I.+FMT#= .(Z *5Q-
MFW5Q_([UEYAM5 WK"@CR[9AAQRO;/;3/>&GY-C(I93C?J!>T1M%7.Q4$<GU*
MUI6D$IV"1FLZSC+9#X/#VPIIC\?:2MEI4:4O8C#####!&*5J]:I,&>J5'C,4
MJU)@SCAC-&,>_*]]?7>97<E]?2.DNI'5<XZR?S :@!H H   OULR+(LHV9RB
M#(<A@CMLIMHPR.-@HUK1_67$U<YSB7/<2YQ+B2KYS5763")A$PB81,(J!U+2
M'-CB4O,V2A-0+"UANA=G920:<P*@S0NR+L[ 3O>^O3?3IWL(N5" @M$C+2CV
M8F E3@3F;WUV,@)0-$CWOH'KL1>M;Z]-8156$3")A$PB81,(F$3")A%#-)#:
M2H?1-Y^SCE#R(]U#L?;\7<O2QK*V0'78#V->(E$#Z?-=T?7KW>FB*9PB81,(
MF$3")A$PB81,(M >2GOV/-N?=ERB_-ODV2/*^@<T\7!Y]JCN:=.Y7\.?S+EO
M]D<4B3")A$PB81,(L%\FKP0<:Z!MB]7"/JY876D.<I$DBJ%<2UJ),\ T6D88
M\%V4$*R&<IZ?%2=,8L&2<%(6:([99F@=@70RK+W9KF4.7M<&&5X;B(KA&LFF
M[05-*BNJH7/S6_;E>739@YI>(F%P:#3$=0;7<J:"M#370KJ[D'++E/2?(?DV
M=>:>E&E=#>*O#UP@,,*NZ0LM!FR.V^0=_0MTGJIPDT1*DR*2IO%PMA[6V-3D
M^2D,91E-Y03W!.E2RR/)\HO\MM!EYG<V2\N0]W!-,V&.&%P91KL);^D'.<UD
M>-Q<:-),2DSG-[#,[LYAP#7,L[8L;PI$.*2:9I?5S<0=^B6M:Y\G!M#15P M
MO?G!N1UMZK)FKYKKZ./\8\XM5/&^R78H%HQ"-6=7TTHTFZ&LUHCUK5*W65$4
MCDF>PD+/#(RQ'#;"3T"Q6VN'A-9?X;RNSX5]R971ORR2=@_9N=&]LO!&ICD+
M'$4J-.C$0YK7-HL7\29G>\%';"-LC,SC@>?VC6R,=%PHHV2,/;6M#4:<(+7.
M:Y9KK/SD<FFW+"KJ.51BJ72$W+9EZ5E''6MY/8<X<X6HIV'65-6MZEME)*])
MH"0N$T::L6^,QYFD)KLPG+"BS/&_%EHR=&ZV7BM\GES /F$\$44C@]K&!W".
M8TAK,?#-#3(*/<S"\ D8:MKOVFU$MQG$.7ED)MYY98VECGO+>":]P+GAG N+
MA&:L:\N82 <5'4[<<ABF:81,(F$3")A%K/S3]YQRS_@SWQ^2V59U<BZ<L_G<
M/G&KEYYT)>?-9?-N77__ $,^2/[\4<^Y%YTG(WWPE[_AEL_[]GS/3F5]&6_B
M(_BA>;\QZ0N/'R?'*[IK!@O& F64#7G/2_>1-E@IKS9<4MA9%?9 AE?19JDC
MG!*O?J!XX\;$[C'G!K(&DJQ7XLZ&G)353X] $J$<,>C0Z@EM<9L8;FYV=MK:
M+A\U=&'8'/<6A\@FGGHX'3)I;IHQNBFI3BY@RL36]MG]Q<RB#*VR%N-K&@EC
M#%##4$?)Z':*N=IKK76AYP+C[6G':_TC'2;I*W6D[.J&EK]J$R>;1[G**!77
M7#!.FMGEVT"9&CV]LRIS/3#$ H';+* +8="V+62K9O,KO,\M,E^&-OXII89,
M%<!?$\L);6IH: J,;0Y=:Y;F CL2\V,L,4L>.F(,E8'@.I05%2%]P']6G_FO
MXK^&:WOLLWY\"ZT_Q:_Q$?:*^Y]6'X5;X^3MA=_F?.5]#3")A$PB81,(F$3"
M)A%H#R4]^QYMS[LN47YM\FR1Y7T#FGBX//M4=S3IW*_AS^9<MZWMX;X\S.[^
M['Z2M3&V+WAS4[UO>D[>V)35JP_>M=W>BDQ A?J9'%(EU$P>K)$]5##)\OXV
MG5U92G3#=LZY&O$RB7JD;MJ9"GM2=N47;8@_/<T>'IP;3EC<VM3B2W(S"3@$
M+AED:,)%E)TTKHU45M%EVN.4]R&JV.=6-&']% )-6LYLR1,3C6Q<0:ZY9(Q$
M#)NVG1B>J9:X+9^E FT4UKU![:0%4J5D+"0(2>J4="T:AK5:JV)%=7+A@B4W
M=GV=5LSO4(XC1+D-,D#75C@N]3\X>4<T(8JWCI;C, #7DS)\A*P"A0NV(].%
M-X),2$2@)Z8 W1[=%2I5PR*=VZSV->%X-,CB")#7TBXS\?'2#'L:M^U-'\TV
M/O\ *HZR.NGM&*,'J7CD7XFA4$DJ5"IQ1I]*?")DP"3*4% /;_I_4J[JNU3<
M=^2R9ID4.DT"CL=GG(JR:-K@*^'JGPQ%&JFC,@.L6P'Q=ZI$7IP\H9;6+\V-
M#8G F)\84E'JS#B"QE%J-IIUTJE58,[O*1DA](IP]MDN_P!7RY[;FDEEC(TF
M1Y#.X/QXX](+0VI5LR1>YD-SC';8LIA9'#1!W@#ES0:(!16SM$EU &YNC\ZI
M592;W.^T<OJ.JJ[EM<MJAOBL#D5W11/4JD;36C&L;33Y&J,D8;%3>+R.PI0B
M6D,#5I":<65H]6H$,E*(2BFBE37V%72I:.<DI$Y,U%OKD8PIT%H.=[6@\B*0
M*0&H>-T 03-SASLA),7"V%Z4)GF%:6K3-[3'"5J?!E%^&)T50MUCL=M*K!"N
M\^51,262A^G=;Q'2'B&;R<G*1+62US,KLTM.M<(W%&PQPEI 79;)RVIR O.6
MAT!-IK&6E*$,>U ;J-K3V:)4JZK Y*W*U*6QQ8#-#%%GJEH#-X^V56K<84IM
M.>2"%L$OB+Q9C],&(2-0D<)LF1("&)*XGH5G3:H2L?A41- T;J57,7.+*9;4
ML^XV&4QDZ%R'E=4?'5# %3"H<GF1,#>L@]43!41) O*7TA70N6O\E?4Z<I$8
M$:=O/\8&:$XOQ=04H==*I[*V<X^N*M:*\D?AS5#"R\AK&;HN:9VQ:\44$L+Y
M*""C!]!&%([(>'PGO:T#9>P:ZZ#K>[3N>T@6PV454PB81,(F$3")A$PB81,(
MF$3")A$PB81,(F$6L_-/WG'+/^#/?'Y+95G5R+IRS^=P^<:N7GG0EY\UE\VY
M:/T-^\C3_P""^O\ [T6?,&:=)W'CY/CE9LKZ-M_$1_$"S&3^M_8YIMUK<<KA
M2_.@] /R XW5C=J5QH?B>CK+MQ!K5YHOGB_U/DX:JG4KX;>_^S^5E3K1O@J[
M$G>U_??+QNHI]+\[OT<INJH4N7\Z'T,M*N&M<F6JY0S<W$HW*0+"U03S'9>C
M5'D:T'6T0T[.W-X"1;",0M[-*2!-^:T'?0?>Z=W9%,X1,(F$3")A$PB81,(F
M$4,N;B53JQ+AJM$FMAK@,A/O0=[5[5H1IC AWL81:\" 7;[FA=[N]._A%,X1
M,(F$3")A$PB81,(F$5 ZI0+FQQ1&G:3EK$"Q*8HWK6]$ 4)S"AG;T(00[T4$
M?:[N]:[G?PBY4) 4R)&F 9HX"=*G( ;KIT-"44 L)FNFQ:Z#T'KW-[UW<(JK
M")A$PB81,(F$3")A$PBAFEN)0*'TTI5I2)T>1.)X-:!KQ0[;8UHMI1=D8M[W
MHM$$SN]G?0SO=.F]D4SA$PB81,(F$3")A$PB81: \E/?L>;<^[+E%^;?)LD>
M5] YIXN#S[5'<TZ=ROX<_F7+?[(XI$F$3")A$PB81658]=0FW8#,JNLF.H9;
M +!C3Q$)A&G+PX43U'GY"<W.B TU*<G6)A')3Q: <0:4H(,[)A0P&!"+6>UN
MI[*Y9=VKBRYC>'-<-8<#4'L?D.@ZCH6"ZMH+VV?:730^VD86N:=1:10CL_E&
MD:QI6E7_ '9_'H];*G]XDM]R:<2M)3A([)E%X3E^L*/+Z!EK],:E?(E)UZXU
M7'W6*N4A/+WX'7BR\G8MK"5!RA8:I[O\59D&LC8RW9;L,O>-B8&.$S0V0.:!
M1P<&C7I!\$@!H'!_A7+2Y\CW7#[AXB[]TKR]IA<71EKB:@M+CJT$>$"2XF;:
M_-VT*SMTA(2O5QGOTDO:#\EED\=K6DC]/2+J@46;X4VS%-)7LQP4C XQ9!XB
MJ;5 3VG28T92=*G+T4$NQ^TN8O<TEL C;;O@#!&T,X)[BXMPBFIQJ'"CJBI)
MTUR,V9RYC7 .G,C[ADY>9'%_"L:&AV(UUM%"TU;30 -%/W O-WT#6]@U+8<:
M=+@VIH64SZ44M$7FVI:_5W6?LG1V91>9L$8A+LK5,I;$XM$Y6%DZ4 4+$  E
M%I%!!(-E"7.TV8W5M-;2B"EPQC97"-H?)P;FN:7.&FH+!6E =)()TI;[,Y=:
MW,-S$9ZV[WNB:9'%C.$:YK@UA)%"'FE:D: "!H6]F1Y2%,(F$3")A$PBUGYI
M^\XY9_P9[X_);*LZN1=.6?SN'SC5R\\Z$O/FLOFW+K__ *&?)']^*.?<B\Z3
MD;[X2]_PRV?]^SYGIS*^C+?Q$?Q0O-^8](7'CY/CE?1+1),-)XY\;"?.-B\V
MB&Q 5!&]\0RN4NKX%=1%$F#5G5*3=@*-V"-@J :<98HQJ0;V>%F&;L6NQH0<
M^9Y@9SFET=F/M7FW#NYSS?@>"X;1PG!<+WW"<9@T8J+Z38" 9;:C:7[,YSP+
M>;\/PO"\%_R?"\%WO!^\QZ<-5TH^<7*Y&%\P;;'RFW$1VLH41H\"BMO$!5*J
MKT439 52?3IC5K3<95 JX+; L.P?X8* ( JM:6:4:U.]F#EAR2'[(Q\S =X=
M>$QXCPG"UT\)CQ8]RNKO:*#[2#,AG,WVK@YW5O@4X/!A'!\'31P>##@]C7IJ
MON _JT_\U_%?PS6]]EF_/@76G^+7^(C[17W/JP_"K?'R=L+O\SYROH:81,(F
M$3")A$PB81,(M >2GOV/-N?=ERB_-ODV2/*^@<T\7!Y]JCN:=.Y7\.?S+EO.
M_L+1*6%[C#^B+<V&1M#DPO;:<(T!+@T.Z,YO<D1HR1E'!+5HU RQ; ((M:%W
M-ZWW<CFK2I$I "9,6F C+3D%HRR IBTH"BPI@)@EZ*"G 0$.B@D!*UV= UKL
MZ#W.G3"+!K'QAH6.(Y4WM-:LI2&9Q=Q@S^D5J'9U(,@COK07.!M13JXK0QR"
MK0A#HQF;O%&S>@!UX#H$/2[$Y*!9#=JW@S\;)#WB,MKB;+RXT1)S%0##!/::
M'K37&-(U_P#A->%0M"U0:861W"MB.,[01>$'VJ5**SRN/-+DSDNR"Z_9M3,M
M[62?;MLQP&4?*5NU';E2QI&M$RKI2E)5#)2N1R8Q<B3;\"G-*)UH&F(TIN)1
M2CY2M7R*'HX&Z1)(*,MKVHDS4E0+'5F7LTD6+W-S62)E?V=>@D+,_+5CVM$<
ML2JBE!H5AX!CV XP(E3K2BHDM TRB86V+I*ZC:>/M,9DD.0-92084Q4;F;VR
M269-ANM&]M4&82".(EKL:=L9SDI3A,4C-%L6]JE4H%3E<>:;)GRVT280C*GC
MD^$29QD!3D^%FKWY*C2-R9T6H@.FFQ4J3H$!!(-C(%H!9)8=:UH >C$:4W%6
MBC8[QAH6)I')"P5LRH$[M#I-7BK6U#LK.+@,P.0'R"$MRE<XJ5+/$U9K6GV6
MW)!D)$NB0Z(+*UKIC$52@5_.M8P![U)-.L4:%H9A&X_#I, T@6BWB)Q54^K8
M]&U98!@+VR-2J3N(RDP=!)ZKC^H=Z,%K:I5:*S''CA23O,CY^YP!L6RA1)H]
M-1JE"QX&W%S2*K&E>PS-+'=N7J<12Y"H8TO5T)2%KCBR]EFFC+&, F(ZE2@5
M.3QTJECD"Z=PN&QV.6,,^6O3/*%*-R>D+5-)GMV-?IP.,FO2)K5REW/>U(5S
M@#:=S6)#AIA*M$"[&F(ZCJ5:+(E?P=GKB'LL-8QJU")I+5&'N+D84>[/CRZK
MU3S(I*]*""4Q*E]D\@<%3@N- 66 U6I,'H =;T'0FIJBO+*(F$3")A$PB81,
M(F$3")A$PB81,(F$3")A$PBUGYI^\XY9_P &>^/R6RK.KD73EG\[A\XU<O/.
MA+SYK+YMRT?H;]Y&G_P7U_\ >BSY@S3I.X\?)\<K-E?1MOXB/X@68R?UO['-
M-NM;CE<*7YT'H!^0'&ZL;M2N-#\3T=9=N(-:O-%\\7^I\G#54ZE?#;W_ -G\
MK*G6C?!5V).]K^^^7C=13Z7YW?HY3=50I<OYT/H9:5<-:Y,M5R@VQJ.0NDD7
M&&%C+>G%$L( #M=LHM*RMK8,)W:#H/;$<B$+79WO79WKXO76$4YA$PB81,(F
M$3")A$PB810;@UG+'B/N(#"PE-!KD8> ?:\(;I:WF)"]%= [#U ,?7?7>NYW
ML(IS")A$PB81,(F$3")A$PBCG=&-Q:71O*$ !BYN6HRQF=>P :E,:2 0^SH0
MNP$0^N^FM[Z81<S>G$D0(D@Q!$-*D3)QB#U[(A$D@+$(/76M]G>P]SKA%5X1
M,(F$3")A$PB81,(F$4&S-1S:ID)QIA9@7A\$ZD:+[74HG;2TM_@S>T'6O">$
M;Q"[G779%KN]>N$4YA$PB81,(F$3")A$PB81: \E/?L>;<^[+E%^;?)LD>5]
M YIXN#S[5'<TZ=ROX<_F7+?[(XI$F$3")A$PB81,(F$3")A$PB81,(F$3")A
M%K/S3]YQRS_@SWQ^2V59U<BZ<L_G</G&KEYYT)>?-9?-N77_ /T,^2/[\4<^
MY%YTG(WWPE[_ (9;/^_9\STYE?1EOXB/XH7F_,>D+CQ\GQRNS1]M;S;7,=@J
M.P>4]C\E>/-[UI3M8TU9#35U8Q.TX)<#13<510:(2N%N2^3Q]P@LP?(@QHR7
M).X)S6PE8$(B-;+\(+<4CL]J<CDFMLHBM;G+I9Y)6&21T;XS*XO<UP#7![0X
MDM(.(C7IHI3)=[,YU'#<9K+=6U_%"R-X8QLC9!&T-:YI+@6.+0 X$80=6ZM5
M?.,6>OM/D2B7E51-*6K^'TQ1E;T;!+'Z&3XJA(/6$<9ZDDLO6%EE)'![G$2
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MGQF:7LA(YH"'AL0.A*%Z;5C*\HRG!*4K+2.S.XDIW!I<TX#M /3'E@.(-T(
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MKXV;3.IZ-_@YD?HW_7KDS?SG7,'A[,-_)F?_ /SU J?/#7$EZ^$X:PS?3O\
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MK-+0 X$[&;"WL[RYS*WNHI;^&"V9'!)&USI VI8UKW]\[AG2&CX:4?H<7%I
M^AK/FJ^E)A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(M*O.
M*^\IY _<BA^^=AR3;'?B:S\;_P 5R^7==/\ [6YS\V'G8U>AGSNO[[Y>\ZHW
M%K.U_D5&=WM>C_=S*%J2:U%F?.[_ %/E9E;J6L]4)G]W,S=7Y%K.W5&&=[_<
MS*W65KN48;W]?WVLSMU+4<J$S]=^KF5NM:CU'']_7H;^5F9NLK4FUJ+-[V;
MUK5?NJQWK_C/1WFU#K"C=_J6)'OO"_9_*SK0*#YGNK$KM^NSK0ZPH'?ZC[2Q
M8\?K_1%\K.O H%FFZL3O/?'Z/RA9V[?\Z^?YEN^TL4//>,]'Y6=J'6%\^S;6
ML0O7SV_[WY>=R%?-\PU_E6*7U,G6IU:1604I2J2S"%"<\ 3"3B3 ]@PLPL6M
MA& 8=]-ZWG18T.&%PJT@_G7!<]\3Q)&2V1I!!&@@@ZPNX;S:OG)E5>K8QQBY
M)R(]9"5RA#&Z7M]]5C.4QA2>,"-FK*QG-2,1AS(:,0$[&]'"WM-O8$:L7@_
MG%^;^M'JO,)DVCV>9^STNFB:/RE[!_6YN[K&FH=^G_\ *?\ S5B]9;]6G61/
M2X%([*\>=>H-@G<=S4(Y#X.ACC@H8_I%SSLOTG3"*WW-<L3O<:1D;Z)7 YU
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M*TB;S%9>RN@M!ZC&#IOKK?<[V$4YA$PB81,(F$3")A$PB811SNL&W-+HX%!
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MQ*OJ,5I7C5:\OD<!<&%)7;SI0:@E32[J$C?*F[:%-+8&:]*]110M-3-NWEL
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M(7/&GN<:TVIC OICQX%'M4L\,0#,S.<OYY%=QW;(\O@N;IT\/?5G$DTC@6M
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M@>D@;3'Y.]695U5OSE D9S"-E0MK<YI&Z/&.9)!FQ-P2RB52J.;47%I<.M^
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MBB*!2F$Q:95?Q>]6T\66%!I!93)N;SK3)6B5&2V,%E5<ZHG),N@$N)TM-6*
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MPB81,(F$3"+6?FG[SCEG_!GOC\ELJSJY%TY9_.X?.-7+SSH2\^:R^;<NO_\
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MAW,I!O6N[VJMN37R:]RIV$VK.JT/E(OUU8>O[JC:>^SAH]NWN_JZXQ><^X-
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M.T AE>%!FS5"NH52@W6BC1;$./C%TWU1;_P'QCK-ZL1F+7[09 RE^!62,?\
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M:VFF#N#+C&YKRT8G-!C>ZC@T%U' 5:"030A;@9Q5VTPB81,(M9^:?O..6?\
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M?OG8<DVQWXFL_&_\5R^7==/_ +6YS\V'G8U>1OSVO[WY>==OYEIOU%11_?\
MU19F;K6B_45$'?.[_5^1F=BU'ZU$'][_ ,;-ABTY-:B#OE_*UFPU:$BB5'?U
M^KFPQ:,NH*WW#_%#]#-J/6N=<_)E8:DO>,_5^5G6MM:^?YKK<L#/_P"O_5SO
M0:POE^;;JP;(N\9Z&_D9(+74%\LSG65@J1=\ST19([;4%\JSKP7+ DD^>WZ(
M_P#A;R1VZ^19KX7Y5BE/&)58<MCE85[%5D\L.>K1LT5AC< L1SL<(O8EJIQ.
M/Z)&J-M2/0SW%>IV!*D2@$,P6M:Z;KF^<Y?D.729CF3VLMF-J:[OL4W2=0 !
M))  )("VMB-B=H]O]I;?9S9>"2?,YY &X?T=TN)T!H: 7%Q(:UH+G$-!(^PS
M@OQPE/%+C9!J9F5BN5D/[$%8O6+3S33(_%MNHRU/J$@(5A078J!Q86MDM^EI
MAB@6A#'K1!0BDB?PWM9G=OM#GDV:6L#+>&0Z&C6ZGZ;])&-V[31J%7&KC^]_
M5#L+F/5SL%9;)YK?RYC>V[.^D>:M874_8PU =P,9T,Q:22X@,:6QLV]R.+Z8
MF$3")A$PB810#D%RV]1S:7P_B 3G3TT\&+>B>QMN,TD\8#UUH6O&NG9[_06$
M4_A$PB81,(F$3")A$PB811KSI7MG=M(/">/;;5VD?@=]D[QO:4W2?P0NNNAG
MANG9W\?"+E;M'Z;T&E7;\9TB2Z4>$WU,\/X 'AO";[O4?A.O7^WA%6X1,(F$
M3")A$PB81,(F$4 R!<M*I)MP\/X$3^(35X87:#Z6^D[/K7BVNN^R1X]H_N=S
MYOM;^+A%/X1,(F$3")A$PB81,(F$6@/)3W['FW/NRY1?FWR;)'E?0.:>+@\^
MU1W-.G<K^'/YERW^R.*1)A$PB818@OZ46W"Z8L>3T-61-QW*TQE:;6U:JY&P
M1)OE,M/V6D:4SK(9,]1UF;F9">H\;6[,6IC#$I!A9(O#C+UO=RZ&SGOHHLQE
MX"Q+QC?A+BUNLT:T.))U#0=)!.BJTLQFO8+&67+HN'OFL.!A<&ASMRI<6@ :
MSI&@$#31=0T,X_<C'.N$UC/W&:ZP\GH#RDH7E-8;]<MH\8U<DY5.L?2RJ%3"
M%UP=6%Q32%53%ZMKU^4%Q&/NZQE:4G;2$^-'G'.B\4TGS++&71M8[JW^R9+2
M:W8(HY\-N#A<US^$B:Z1TCP.$>T.<=)H &-4*@RW,W6O.I+2?[6CNX;AYED@
M+K@C$US6<'(YL;8V$\&QQ:T:!4DO<KHF,=Y]Q6)\A;+J#CS-FFR^:O**/R"6
M1R*61QQ%;'&[CO!Z$K"E2I @73FT$%./-\R\NK=GH2T3S(&1B$[@4F[6#0[2
M*<,$NSLTUM:WMS&ZUL+0AKG,GX.>9\TDM"&1F40MX2AJUCGX:##BQ#-/%M'#
M#<W=E;2"[O[L%S6O@X2"%D,<6(%\@B,SN#J*.>QF*IQ8<)LBW/-Y6[<O'>"F
M5(7+>,1M*4!R&@E=<1[>9:EN]U?+/M!KF33(;5?;3CMTNL-U;EM-KZI2ZDBY
MR<U#7M_<58A)U*Y=VMBRVELK',Y.>X+L3W,+WW$9DB CC+2V,1NB#N#C(!P!
MK0[ UND-:L%[LU>WV61FSQVA@MIF,MY!'*3)(' R&1LI;PD@)&,N<6XW.T%S
MEVA\;XI/J^@U'0"R8>)^F<2X]QICE=TID4!:&]*_-.V- ?5P6ILE#O*@J  +
M\9\.D*4,9VD&S!*M'C*+%$\TFMKFXN+FU?A@?<N+8JO)H:GA*EH;[%#1XK2E
M*E2S*X;FVM[>VNF8IV6S0Z6C *B@X.@<7>S458::ZD!:06/Q5N^2W5=LG20
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MK#.;RTTPB]%W^K3_ ,U_%?PS6]]EF_/,?6G^+7^(C[17I#JP_"K?'R=L+O\
M,^<KZ&F$3")A$PB81,(F$3"+0'DI[]CS;GW9<HOS;Y-DCROH'-/%P>?:H[FG
M3N5_#G\RY;KS9O=G:&RUJ8%'BCZYQA^;V57X79'BSLM:E:9M4>&UUV3X%88
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MXW>]EG;UX/A?RLWU[W^!X[:Z][7^T1F82Y+_ 'E9_P"OY!:[[C;!W^RV??\
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M$6@B6,L=0/?)I,E6@\(U^@D][@H%P,ML;TPVF9/OI3<2!CI0X@Q2![:EC(]
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MX M(TA:*0KS?5;0YWJA.IM>^YK4U!2%'*J*X\S:6Q!RJ&K'UC3FI(6K;#FR
M,UJS-/7"4[8(XDE<HD*-EV HQ,4 T@@PJ03[274[)B(;>.\N6ELLS6N$D@.E
MU:O,;<?Z9CC87:030FL>@V;M8'P@S7$EG;.Q10O<TQQD:&THP2.P#P!)(\-T
M$"H!&SB&FXBW7E*>0:<QXW/)?5$!IMV),6D"8 Q&N)?9,VCYB1OTC"I)>!O-
MIN>E!PE P&$A("$L&P"$/E.OIG9>S+3AYNR9\HT:<3VL::FNJD;:"FNNE=9M
MC"W,'YD,7.'PLB.G1A8Y[Q04UUD=4UU4T*$O2@8G?3="2WM^FT)E%938BQ*U
ML6MGXF.3F#2T$=D4.6KV=>M;GEH6(GN'2YT:G! XH5S>M0KC &D"WHL0,F7Y
MC-ESI#&V.2&6/ ]CQB8]N)K@" 000YK7 M(((%"L>89;#F+8Q(Z2.:*3&Q[#
MA>QV%S202"""USFN#@0034:E8+1PRIIDKBIJP0^JX3!4MUM_(=*O7R(3K))W
M;Z:4R&>N4RLI\<T:M5*'*26!)E+XNV'Q;M.&BO ^!(* 3K8?GE])=37;L'"3
M0&&@;1K(\+6!K ",(:QH8->BM:DU6NS([&.UAM&X^#AG$U2ZKGR8G/+I"1WQ
M<]Q>=6FE* 45H79P8BUU7HT\B-7KR2JFQ&*MA52T&U%.XM'6=NB*E_,DKN2A
M0/T!E)R)PD3KI.)Q4$G &L+0)"S.H$Y>M9[#:":PR]V6<WM9K9TO"'A&.<2Z
MF$5(>VH:*X01HJZFLK!?[/PW^8-S/G%U#<MBX,<&]K0&UQ&@+'4+C3$0=-&@
MZ@IJ><):SLJ5!D,PFUS.C([-]<H[(K4=AJ-5G<:JJE12Z&O%D1C;<(1[@6K3
M$B<RVA0T(G\I.6G="%B8.B<QV^?75K#P4$< D!>6/P?M(Q(*.#'5U4KAQ!Q9
M4EA:=*R7.0VEU-PD\DYC<&![,?>2\'I:7MIKK3%A+0^@#PX:%N+G$7;3")A$
MPB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81:5><5]Y3R!^Y%#]\[
M#DFV._$UGXW_ (KE\NZZ?_:W.?FP\[&KK5=X7H_^3G88N?-J5MJ^\+T=?*S=
M9NKDS*V57SV_0W_PM9N1ZES)E;2SXOH?19NQKD3:_P BPM-_G3?0%\G>=BS\
M(+YYM'J=[2U F?\ QO[+Y.3&P7G_ &F\%RU"FW_'?LO^#DXL-Q>=MJ_DW>WW
M5I[*D[JX/4<9XLBD3I/W62LZ>N&R%B5@G*J<EK '1XV''-X@+T3\B7 "<4I*
M$#Q;L;,&((-"WG=S&;+8,KFDS<L^SQ&['CIAPTTUKHI36OFVR=EM3?[76EOL
M8)SM$;EG \#BQA^(82W#WU0ZA%""" 0014?:5QE07FV4162'DH[1QZNY-&4I
M<^<(L0$EL-=-#,\7 >,D6D*Q[(;O @<E",LA H< G#2E 3B+#GA//'Y6_-9W
MY*U[<K,AX,/-33M@5KA!JX-IB-:K^@C82':VWV3L(=NI()MJVV[1<.A%&%^Y
MNX2\-H)',HQTF(L 919VSDJ7*$;42-,YR)2G6 4*'!P1'KTP1E"$WGDLS<C*
M(," 6QEB.2)RSM:'K6]Z,UO7<WK>$4WA$PB81,(F$3")A$PB810B]&D/=V%6
M>L 0J0FN(D240R@C7"4(#"#P@ ,6C![3DBV/?8UOIK77?<PBF\(F$3")A$PB
M81,(F$3"*/=B"%34YI51X4J92WK"%"D0@ "G(.3&%FGB$9O180DEBV+>Q;UK
M73N]S"+E0%%$(41!)NCR24B<HHX.PB"<462 !9NA WL.]&!UK?76^G=PBJ\(
MF$3")A$PB81,(F$3"*$:$2-(I?S$JP"LQ>]B6KBP#*'M"LVU-27:,>BQ"$6/
M29*4;V1]!=#=;Z=-ZPBF\(F$3")A$PB81,(F$3"+0'DI[]CS;GW9<HOS;Y-D
MCROH'-/%P>?:H[FG3N5_#G\RY;_9'%(DPB81,(F$3")A$PB81,(F$3")A$PB
M81,(M9^:?O..6?\ !GOC\ELJSJY%TY9_.X?.-7+SSH2\^:R^;<NO_P#H9\D?
MWXHY]R+SI.1OOA+W_#+9_P!^SYGIS*^C+?Q$?Q0O-^8](7'CY/CE89S>6FF$
M7HN_U:?^:_BOX9K>^RS?GF/K3_%K_$1]HKTAU8?A5OCY.V%W^9\Y7T-,(F$3
M")A$PB81,(F$6@/)3W['FW/NRY1?FWR;)'E?0.:>+@\^U1W-.G<K^'/YERWL
M>79"P,[J^NAWB[8RMJYV<3^SL7@$+:E-6*SNR'NB\&G)$+IKN[Z9'%(EUF2A
M]DLN2\:TDNC]O3MQN F>\EK$@M52I5'GYEBJ6)M$:A$"&N)G%>A;HG##[9:2
MC"2%Q.W1W:C%PBCC!JAYDH!75HT*WVU<&JRLY3#9^Q1I/)J_99M,H$ZUS0UN
MWP^^K6:QN$I@.EJLA<]99;93_7J:Q4>P:"B;G!<%,6AV8M*3:<%A9:HK7^NB
MJK'?"O&JQLFL*R4V_34ILJQJ1IU?3LGD[B8_5'(7=Y42*QI77<Y2RB6)CF&;
MU$0>H1C9UNVPH]H-4=DI0<N*+;M30A47'';9E-W._"1I;)"[M<+8V:HIM93T
MB>'%J,?[!.HHZYU+,_J N 5*N,P^()$/IRE6;/(5+ILU"'O8T9W94 K_ $W5
M6M5(4O>PK&Y2PNQ 26?:9+D)N6O8M"':.6&QP1O@L<;8Q+ZED:!0]L[="W>6
M2YKK>3R *E$>I4^EDB\6'\RDUL BC::*A4!TK;&ZRETZM.G:,.?'J/PN91RU
MK'GHXX].D:>98S5BIK:/H:]*D3(K0/36W/SQ:I*]?I&>2>J1-!J;9FB#CP#M
M&@%VZJ^PL93E^AW$^!W.Y5A+G-\=%SG#H?"Z=5NSU/DT%M^3M ]MFV]J *1S
MA$SO;,Z(I Z-1.C"BFUK4K4A 1GJ-F5'?$534M>(]/7)HXSWS5\1E%MV0^I;
MJ@%101W>C9!$;>F;/<314I[ZZ-!]E.,*6,;R6JD<J,2F*5;2B(VVCV2<20$L
MW*D=\#HU*FY17]7;FWQ^YU#LQUWR!HJ/4U'UKG=;';%F/]I.,T99VVJFVO28
ME7$.MJ]DTA1!D3<H5%OZ8)8DYS4K0$[,&-8 D=6X:ZOZ:%55W)NT%\NE?&EU
MKF0RYJC,:F,2MV6%!(ET'4.S$7R'I.EO2.41EV1L+XJ;G:/3^4*DR5:060H-
M:0&]DPOL=JC10&O]-"%8_DEA2^Q'_EM=B25R"/0F$<19LNJ0EL?')*S)F!<N
MDZROK:)0)E@6Y7*Y1(:@>GA$KV4(\,86M)0M "H-"?6@%!NU5/97:RUJ%*ML
M;E:U-M$L5($:A6C%H6MI%)R<LP]-O0^@];(-%L/=[O<[N8U<J_")A$PB81,(
MF$3")A$PB81,(F$3")A$PB81,(M+/.*EJ!\(^1QR=&M7>E]?'O*HEO1J5ZHM
ML8W1L>'=;I,D+-/$0W-2$Y0<+0>A9)0ABZ!#O>I)L>YK=IK,O(:#-2I( J00
M-)T:20![*^:=<=O<W75EG$%G%+-<&UJ&1L<][L+V..%C07.( )H = *U93\Z
MZB>4"1S:8'R<<FUQ3)US>X(.*G(!6A7(E9 #TBQ&K3U^8G4I5)!@1EF $( P
M"T+6]ZWK>2_[*,;RR2ZR]KP2"#=VX((U@CA-!&ZOFKMMX)6!\>4[2N814$9-
MF1!!U$'FVD%4)_,VNC=;[%9<IQ==ZZ?_ )3.0O\ :_\ 9YF=EC&/^UY=]+M^
M46A)M;BU91M+_@V9?5E$'<NX0;OJ757*H6M]>G3B9R%^+O6]?_V\S9;:PC7>
M9=]+M^46C)M.]VK)]I?\'S+ZLHD_E1%3^O@JCY6CZZ^)Q+Y#;^/_ .SS^WFT
MR&V&N\R_Z5;\HN=)G]PXZ,FVDU?W/F/U98YDU]I'70](:4Y8G;'U[/\ ^4WD
M&'KUWW/GJ]UG1MG6,9JZ]R_Z5!RBA^=7&;W@/ 9)M&:__:<P';MUK[(Y?)W7
MPGB/'[ED=VNO3IQ4OP/?^)\U -9([7,\FB\._L!_WF']=?),[V;VRO0[F^0;
M0FO_ -LOAVX%KU*&.XW@)I;%QAY7.:X_?@D*0WC9<;.2I5&]"TY)SH]0Y TM
MI)AHM:&>I.*()#U&,00ZWO)/;[4;-6[<4F86.@5T3Q$Z.P XD^T-*^09SU3]
M:&:O$%KLYGN)[@ 76%TT"II4N=$ !ITDD #22 NZ3S>WF_47'1/NY[B+:I-R
M5E+:),:<F$!PC].QY>#0CH)!3Q:V ]R.+WH#R\AUHQ>9K9).PI _X;X%M[M]
M=;571L[4NCR2,]ZW49"/TWCL>];N:SWU W]#/Y=OY=LHZH,K;F^:MCN-N[EG
M[630YMNUPTPPG==N22CPM+&=Y4O[62_G0^AGS8KT^-:Y,M5RA&UJ,0N<B7C-
M 8!Z<$2PHL(1:$0%*S-S8(!F]]P0A&(MBUT^(+6$4WA$PB81,(F$3")A$PB8
M10B]K,6.["XA-  #0:XF&%BT+8SM+4!B0&@;UW [ (?7?7XF$4WA$PB81,(F
M$3")A$PB811[LC$XM3FW@&$L:YO6(P&"UO82Q*DQA 1BUKN["'8^N^F$7*@3
MB2(4200M#$E2)TXAAUO01")) 7L6M;[NM"V'KA%5X1,(F$3")A$PB81,(F$4
M(T-1C:I?SQF@-T\/8G4H( BULDO;4U-_@A]>X(?;;Q"ZZ[G06L(IO")A$PB8
M1,(F$3")A$PBT!Y*>_8\VY]V7*+\V^39(\KZ!S3Q<'GVJ.YIT[E?PY_,N6_V
M1Q2),(F$3")A$PB81,(F$3")A$PB81,(F$3"+6?FG[SCEG_!GOC\ELJSJY%T
MY9_.X?.-7+SSH2\^:R^;<NO_ /H9\D?WXHY]R+SI.1OOA+W_  RV?]^SYGIS
M*^C+?Q$?Q0O-^8](7'CY/CE89S>6FF$7HN_U:?\ FOXK^&:WOLLWYYCZT_Q:
M_P 1'VBO2'5A^%6^/D[87?YGSE?0TPB81,(F$3")A$PB81: \E/?L>;<^[+E
M%^;?)LD>5] YIXN#S[5'<TZ=ROX<_F7+>I\9D,B9'B/NA8C6Q]:W!F<2@#V6
M,Q"YI#D2LL!FNZ6(:<\6M;UW=;WUR.*1+'%9U:BAK3!%KWXL\6)%JIBU5N<L
M2FKR$KDV1\E,:J&B9C#]-S<4ZO"?:H?8)\-KJ H1HP%%]*DU]JJ*5L>JH=:B
M)F2RHAY)61IW]/HQ(8O)Y'"I9&7G:%8UFKF*4Q)T9GU!XXV.!Z942$_Q98F-
M&2H+-*%L&P)&I%;\8H&L(H<Q+D;2\NCW'IDLL)+)91,)?*I,NFJZ%N]=FR%^
M?9 ^.#A(5*>$OJIL2%+1GI4"4P($I1.BRNPJ2J44 V\5:$9X<B@+3 ]-D3;X
MY8L43-B"3S)(9Z26PI;U5@%*',B0ENRQ?(!-9)>UIQYBY*FT(A.<20886.N)
MQ-=U*!9:=8/%7HV%FKV<@0J[?2I+"@I#E3:5'WDF-OT/+4(R&T](0,@,9DR]
M%XN8$:;9*@6ME]=!V&E2JJ LBIH9:B9C+E!#TF<8NYF/,7DL4D\BA,NC;B>C
M/;E9K-*8FYL[VD3N+>I&0K3>&$E6%;T$\HS00] )&I%$16A*JAI\76LD;/\
M3.(/,JDS2\.LADS^\*99-VT+-*9A(7-\>'!9*Y>[,VA(]NCF-6N(1F&)R#2B
M3#"Q,1*44ROJ*O'.8E3Y='O#RLEYCDA X^FSX42)ZB;#+8S'G YI)<RV90>W
M,DX<B=>$3B"9LTHPS0C4J09"II3<17$.&QLR9)K!VV!#,$L96PTMY+4K21FQ
MM>ZM[V:V+$92D#<X!(=&T!J8T\DPY'LP\) RPJE(3:5T4W$5FSVCJNLXN9E3
MF,B?"[ A;-7LL#M]DC;Z8Q!@>GF1-;2GVT/" 30(IX?E)QBE%M.K4=2P'&F
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9V?\ N9Y\J^G?OW]/^\KZI]!_<?Z?]V7_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>tm2227887d8-tbl_oncolog4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2227887d8-tbl_oncolog4c.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@") .2 P$1  (1 0,1 ?_$ 0H  0 " @,! 0$!
M       %" 8'! D+ P(* 0$!  $% 0$!              4! @,$!@@'"1
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M?77<F/N][7\]H>;N0=Q6G%,Z5/.S:;N^ZXQWNK_,\QN7O1G_ /RNY,>1G_\
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M,GHY\@O7(\F/;';O\_H>*LI[DM.)BZ5/'6<]V77'2=,GHY\@O7(\F/;';O\
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MN,]_V-W_ +LO_P"$<!K5#J4'2_ZG5/Z68'YUM1?)^T=^D>>@U!9*+%5 1 1
M1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M1 1 11LU_P 'EO\ EC_^BJBK>B'MHN+6/ZMU[_D<3_0&XJ_HS[95!J4X+55
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MR?M'?I'GKMAJ"R46*J B B B B B B B BXSW_8W?^[+_P#A' :U0ZE!TO\
MJ=4_I9@?G6U%\G[1WZ1YZ#4%DHL54!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!
M$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!%&S7_!Y;_EC_\ HJHJWHA[
M:+BUC^K=>_Y'$_T!N*OZ,^V50:E."U50$0$0$0$0$0$0$0$0$0$7(<_QA?\
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MY1,=EU.7C&\DGC'5OT&W_P"Z57?P4!AO.J1<6[E$QV74Y>,;R2>,=6_0;?\
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M%CF)GA9:2]"+A7I_O46G/\0@HMC'UM<=]E/H_=%#8Y^/_<&>#MY15%_L\?\
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MLJM/MJ;5^#4.T,__ )@SP=O*)XPV>_ES_"7<FGHR<,/656GVU-J_!J':&?\
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M=^D>>@U!9*+%5 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
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M%Z>?_I8\@],O9ON+R0>0'U^]Y?;DVC]7,\/;F3^2;;K$?P0O!NT/EV[[X?\
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MW_NR_P#X1Q>-:QG4H.E_U.J?TLP/SK:B^3]H[](\]!J"R46*J B B B B B
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M4U)TX<@RS),S,5W=6-M#9WET8V!\T[G%K6AI; U@T$.JYSY'4!-!0#1P-?\
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M\RD?G>5Y,W)[]]E;<#/89AP#7XWN=(VKFDO#B6U)%1A IH'-KTH#Z$OG* B
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MSJ.XMZ"B;0U@V:$)VI(EK.[NG:HJXCI)5NJHDT5ZI$\&+CK:<VV5_/97><V
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M)K,J9<%PC80YQ.$-#7#"V-NLEHKN"BS9EEF3Y>Z\S;,+>2]<_-GVX:99 6M
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M]NXU!F>-- TG?2&A<=6D[[^>X?45\J0$7+9?QQ_]T?\ ]!<"UVK\(YZN;K_
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M\*H*'<(D)FL=J,VM(+LYB^5][%9\*R*:!L1Q T+F.CHU\-2->^.FA%"5BO\
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MEYV*A->P=7@R3LTZ[KYZ=L=T]+\:NHH3XT+39S)+*"6W@MV\#. 'AQ<\N %
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M@WFXXOD"YCR1T$=-7<,*;!XN[Y46BE%\/FAL=.$,'PSS_G(Y&1^49=)()GQ
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M?&^>V83%'P;0,31@&IA:TAKF@Z0' @%+;:C/[1DL<%U(!-(9'$AKCPAUO#G
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M,HYX+2\U?I#@XAWY322T[H4K%M7M!#/+<LN7<+,QK7U:PAP8*,WI:6@M'0N
M#AN%?Y$^Z#<Q(>Z678"6ZY:3M%UKE9JMU7M%:HURB;G#TQ$R%5\V%7MM7FZM
M:9:!2-GP:1?LG$BGG.<X7ZV<Y!^R^0R6[+4V[1#&]SF87/86%_187-<'-#MU
MK2&^PD>U6T$=P^Z%RYTTC&M?B:QX>&=#C:YI:XMW'.!=[*XE>Y\<O*QLN_;=
MCMUSKJ];2:Q3'8+RQPE0N$#:V5?[E;:RE(MM=FZ.=O5R])8HA(TA8PIC%:]E
M@QL9NEV9R.:TBL7V[1;0DE@:7-<TNZ(A[7!^^_*WV^_*JK8MJ,^AO);]ERXW
M,X D+@Q[7!O0@L<TLWOY.]WOY-%7C96R[[N*]6/9>S[3*W2]VUZ20L5FFE2+
M2$DY1:MV+?M.R3200;LV#1)N@BD1-%NW2(DF4I"%+B4M+2VL+9EI9L;';,%&
MM&H;O^DDDDZ234Z5$WEY=9A<OO+U[I+J0U<XZSHI_H   &@  #0I"3V]L>9U
M=6-+2=H=N]84RR35OK%2.UC2,XFQV)%-":E$7B3(DHLJ^12*4Q%5U$B]'QI2
MBUEC:1WC\P8P"\D8&N=4U+6ZA2M-'M*]]_=R63,N>\FRC>7M;04#G:S6E=/L
ME:V&VM- 13[;^J\Q_P _K?SNM8Q']NW]!W/:LH_8._3;SG* &58D!%LF,V]L
M>&U=9]+1EH=M-87.R0MOL]2(UC3LY:QUU%1"%E%GBK(\HBJQ15,4I$ETTC=/
MQQ3#4?8VDEXS,'L!O(V%K75-0UVL4K33[2W&7]W'9/RYCR+*1X>YM!0N;J-:
M5T>P4UQM[8^H_-YZ'5H=5CT3M;VC4-[\%:QKKS0ZXNG@/FGJ[GQDR>^#-9;Q
M:AUU6_9.2=GCJ*%Z<]*[L;2^X+MM@?P,K965)WLC*X7:"-(J=!J/82TO[NPX
M7M1Y9PT+HGT .*-],3=(.@T&D4/,*VO1.:')W6;O4[RC[9EX)31\!;JKK) D
M15WT? 5F^/,2-O@'<7*03V,L\1.ORE66;RR+Y+"I"&+@N2$SC2N<@R>\;.VX
M@:X7+FNDTN!<Y@HUP((+2!H!:05O6NT6<V;H'6T[FFV8YL>AI#6O-7M(+2'!
MQTD.#A^)92\]T%YC/[?0[VYWG8\VC62=N:T=^C$5)HW@HB]&8YM%93B&E>0A
MGU-D"Q;8A(1TW7B&J2":;=LD0A2XP-V8R%L$ML+9G S8<8JXXBRN%U2ZH>*G
M?@AQJ225F=M5M ZXBNC<OX>'$&&C1A#Z8FT#:%AH-X06@   !<.6YZ\N)G9U
M'W YW1-,[UK6*D8.B.(&"I]8K58A9K!RSD3&4"MUV)U^2-GRFQB00-%F3?X(
M3PC"G9DZMS-FLCCLY+ 6[3;3.!?B+G.<1J)>YQ?5OY)Q:-RE5;)M1GTE[%F!
MN'"YA:6LPM8UK0>B 8UH91WY0P[[16M M6;PY$[EY(6&(M&YKJXN$I7X)O6:
M\BG#UZLP5=@&JRSA&)K]5J$1 5>#9877,<Q&C-'KFSTFZ>C'1NY=E5AE,3H<
MOC$;'.Q.TN<7..ZYSBYQ/MDK2S+-LPS>5LV8R&1[&X6Z&M:UHW&M8&M:/: 5
MA(KW33G/!Z]C]40_("=CM>1-.;:_C:LTJ^OTH]E3F<*2O-8% Y:EX61JA#)X
M0*;M.UZN.GK=;NB+?LCLY)=&]DM6FZ=)C+BY]2XG$7=%2M=*E6;9;2Q6@L8[
MIPM&QA@:&LH& 80WH:TIH5$1TBYE 1<ME_''_P!T?_T%P+7:OPCGJYNO\!YR
MX@N5J BV3KC;VQ]1^;ST.K0ZK'HG:WM&H;WX*UC77FAUQ=/ ?-/5W/C)D]\&
M:RWBU#KJM^R<D[/'44+TYZ=2[L;2^X+MM@?P,K965)WLC*X7:"-(J=!J/86Y
M:7]W8<+VH\LX:%T3Z '%&^F)ND'0:#2*'F%1NM]C7745YK.RM<SSBKWBG21)
M>M6!JW8NG$5))IJ)$=)-Y)J]8JG*FL;'0JD<O=\@7W=I;WUL^TNVA]O(*.::
MBHYFBA_TJRSN[FPN67EHXLN8S5KA0T/-T@C\86PX3D_ONMPSBOU_9<["Q;K<
M4;R 42C$8MFY+N.(QGQ9>VTDA'DDF<JRZ>DA$5B-L9[O9=(U),GRR:02RPM<
M\0&'34_JCK92M"#[(K[*VX\ZS2&,Q13.:PW GT4'ZT:GUI4$>P:>PMMWCW13
MFCL4Q#6C>]@4[&X5[8+-.!@J73D8N]U=R[>15QAF].K4"A"68SE\J9X]:%1<
M263Y\+.OCHQC2MME=G[3]C;-_9N8:E[JL=0%AQ.=5N@4!J&_DT6]<[6[17?[
M>Z?^T;(,+6,H]M2'C UM':34BA=^558]M;G3RNW22J)7_<,LY2I-R;;'K:-6
M@:?KE%EL5F?KL]@N4=<5VII2]Z:'Z<I3#S#B13R8W56QUL].6RV<R7+\9M8&
M@R1\&[$YTE8SK9^L<ZC#NM%&^PL5]M-GF8X!=7#B(Y.$;A:R.D@U2?JVMJ\;
MCS5WLJ*WMS-Y,<EH*&K&ZMH/+?78*95LC*%;URFU*,<6==FK'KVJ;9TJNUQ&
MR6M9BNHD:3D<.GYDU3ERKT'-TWY;D&491(Z;+X1'*YN$G$]QPUKA!>YV%M=.
M%M&ZM"LS/:'.,XB;#F,QDB:[$!A8T8J4Q$,:W$ZFC$ZKM>E2&CN<?*WC=3IS
M7^E-R3U(I\_(K3#N$1BZQ-HL9IRPS&.9NM.+-!33VGS;IAG"2KR)59.5"E+U
MCYZI>BS,=G<ES:=MUF%NV2=HH#5PJ*UH["0'"NXZH]A79;M+GF3V[K7+KAT=
MN\U(HTT-*$MQ-)82-%6D'V55M\^?2CYY)R;QU(R4BZ</I"0?.%G;Y\^=K'<.
MWCQVX.HNZ=.EU#'44.8QSG-G.<YSG.1,M:UC0Q@ 8!0 :  -0 YBA7.<]Q>\
MDO)J2=)).LD[I*X@N5JR6F?UPJGTR07ST:C#/^P?^@><LUO\HC_3;SPO3S_]
M+'D'IE[-]Q>2#R ^OWO+[<FT?JYGA[<R?R3;=8C^"%X-VA\NW??#_A%:D$BH
M9 1?DWD9\K/P@.I5;T0]M7>I?]3JG]+,#\ZVHYF3]H[](\]=L-062BQ50$0$
M0$0$0$0$0$0$7&>_[&[_ -V7_P#". UJAU*#I?\ 4ZI_2S _.MJ+Y/VCOTCS
MT&H+)18JH"("("("("("("("("("("("("("("("("("("("("("("("("("
M("("("("("("("("("*-FO\ @\M_RQ__ $545;T0]M%Q:Q_5NO?\CB?Z W%7
M]&?;*H-2G!:JH"("("("("("("("("("+D.?XPO_ &#7^BHB@53K_ N.*JB
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M4QU<XZ>E,O=[G[8]J93,YN5VS0T$<!'N_P"J/87B'.LK?/F]U,'@!T[]%/\
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MR?:#JUK[Y_2)^CO\R/LBZ"_M'=/.*'VIY#U*Y]ZSIT^R?:#JUK[Y_2)^CO\
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MFB/#YN0:2#+);!<\H=C!LI5-X553S#])%,^.$LDQT9QG&#=W'1CIL/K1R+A
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M=R@TN;L1DH!L9\PGCSN"S@N[AO:S3 R"80R2-CDX<.DE@AF$A#HXXY"U\;)
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M!$!%ZQWN<OY/;@A[#3B_Z2-''CG:?TES'OZ?LKUZWV9]&\O[Q@[$Q7+$&IQ
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MSC2KB: 5H *-:&L: -#6@>RLA&LMI 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
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M=IADDX(0QSX5-D_A&%<YQTE+T=7X/P"*9!$!$!$!$!$!%5_C1_Q'DO[*"_\
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MQ4/"4F7MU382*$;-/H**KL<WS@V"H/48YJF\3<)MTBEU1F%Q@P'"3OJ.+07
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MBBW.B0S:<@I)3*QCE+E",E6CYP0F2)J9RL=%#."8SC&,FSCISC'=!%-@B B
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MHYL^2=F(<[B;G7Z62',IC#60E7;QJ7.3%+DIRMUBXR7R"Y[F,Y!%-@B B B
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MNN0IVZ+HKSJ(];/8YR<Y>G/1CK?M] (IL$0$0$0$0$0$57^-'_$>2_LH+_\
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MZZI 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
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M\K ^P!?#7;JR]AWV?+ JK>A65-N^-Y6/ABAU*A4TAWQ?D?B"AU*JFD>^_?\
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MFQ]]M$U-/$GRT5#%L]O+$H=FU=K&>(YP8A2FR8E8\MQ-#Y9 UI$>X2:R8L(
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MR*T)\:J=8Z:)\MWF\-K=,LF1RRW4D9>T,#34 TUEP YM3HINUH%![$^H;/\
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M_=IJ*1FWT37VY.R2;GZ[7'2L0I%#&4SN63]H,P?$W+A=3R6@_5B-KGF(%U=
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MG[O&K:#EUU2 B B B B B B B B B B B B B B B B B B B B B B B B
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M$0$0$4(R?NEYN<8*E)AK'I1)VIL$,4YS/$71W'7/DV2GP4R1>CHQCH!%-@B
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M-VV\N'W+9:L#N"B#6.;1I>!5S\6G"* -TZ5U!CM5QR]8[W.7\GMP0]AIQ?\
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MXD=& 2:E[*5 H#S=9HWFD+&[-[8-#V-D>PQ,D) %&L?6A-2.9T(J[F J=?\
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M9R4V-6]C0S9AL_:KBVOYN\LZ(]O392'3;-X=L1E#MFKA!P9-NX;2+LUQ0&#
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M+AL[6"C6L&%QQ X&AO,&@@#1K'-4A#:/CMGV[GFKG/(<T87#&XNYIWP+CIT
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M"("("*K_ !H_XCR7]E!?_J6H(ZS:G]EE7])A[),OC_JE^5;6_P#6%Y^[V:M
M.37V! 1 1 10SR34;3,+&%2(9.42E#J*YSG!TLL$FZA,$QCN9[3*V<9Z?(Z
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M+ZGL)Z#Y-_2K3]WC5M!RZZI 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
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M-_>S#V[.^'_++,SU#^M*3H,O@=[5_EQ_YM?O^\AIQMT^$6E\A_VM.O"?[/\
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M4>$Q],I%MSAX?%-CK<E--X[GP;W!?Z6,_P [%QV/VIIY/N^+=[BL^VCU3?\
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M-3;A<^<ESV3YQ*.EG[7'5*3HPU=G.GCR<_&]W.?)!%- B B B B B B B B
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M=X5=NDHHKQIC),Y:%;I.2MC9QC/7QX24YLXZ?]'N BF@1 1 1 1 1 1 1 1
M1 1 10KUJS5FH1TL[PD[:I2I6;3.28R[*X2;%<FQC.>OGP8I"YST?Z7=!%-
MB B B B B B B B B B BA9UJS=MV1'KO#--*:@W2*ALDQVKQK*-7#-ICKYQ
MC.7CE,J>.CN])NYW0130(@(@(@(@(@(@(@(@(@(@(JS\T_4<<L_8S[X]*VU"
M5R+RY9]]P]D:HO//(EYWK+V-RZ__ /!G'1_7BYSZD7G2<C?5";W^W+L_ZMIP
M>G,K\F6_6(_@A>;\Q\H7'7Y/AE:9&\M- 1 1>L=[G+^3VX(>PTXO^DC1QXYV
MG])<Q[^G[*]>M]F?1O+^\8.Q,5RQ!J<70KNWFIOSS66!O#S;V;TCLJ_\I- Q
M#QCJ".I>OV#?7&J]\*,I"C;8LNSXS;5UV9!6[4W1*.V%3<50^<OD&:V$T6DD
MM]#L,BR[@6E[0V_BCMYB#(7/..2&H?&V,QM86R;T&02="7"I<T?.[_/LQX9P
M8XNL)9+B$$1AK!@CFH62.D$CGAT>^(C,?1!IH \SFG-O[B8V-'6-$O4?5;!O
M/;_&37)-DWN)=WQA1(IA[F?3-U3A*Q7'T_"QTC>;G(T=1NR2=+Y;%.\=OU4'
M9V_@ZUE]963H^VKB,OBMX)WX&$,+R;YT0Q. )#&A]305T-:"*U&2QO;YLHM+
M>0,DN)H&8W@O# +%LIPM) +W%E!4TTN<0:4.60O*SE1L64V;K6%VUI77-DXR
MTC>ULM^VIK5SN3I&_'>I]K6K7<6XCJ\_V,P+1:;6F-2.6_'8R;Y=C./T4VCE
MD@3LEL,F49/:LBNGPSRQ7<D36QB0!\(DC:\U(8<;G%WZFK0"P$D..D9F9QF]
MT^6UCF@BEM(Y7.D,9+)C'(Y@HTO&!K0W]=1Q(>0 6C0=64CW0GF!?58F_1%#
M*I3J9(\2:M=()&DZUB]?6EUN_5F@M@7^7L6T[OR%J=PUW87RF[#HTI@SKLBT
M5,U8=L>3-)&09[=QLUDEL'6SY/U[Q<.:<4A>T123,8&QLA<U[1P5927M(JZF
M##5VI;[2YU<$7#(_U$9MVN&!@8[A8X7O+I'3-<QQX6D0#' T;7'CHW/%^:/*
MO6^K:!R7NDQK[952V'1^8$FGHNJ:TD:S)1C_ (]ZJW'MBB+P=Z\U\_+2\W:$
M=.GC9-!9AEL<TL4S5-(S7K.=<9%D]U=RY5 V2*:*2V'"N>' B:2*-]680 &\
M+B:0:[W2371L'/<XM;2/-9W12PRQW)X)K"T@PQR2,H_$22[@\+@13?:*4TQ%
M=Y7\I'%EU[3=S5AE,Q-ROG$RUPMCMM,UWK5]'NKQR,I=(L*%+JNLN26W96TZ
M\6B["B[K<P_ZG@CE@LD_7D_"$2)7RY/E BDGL7EKV1W#2UKGO!P0/>W$Z2",
M-?5M'M&L$%H90ULBSC-S+%!?,#F226[@YS6,(QS-8["UD\A<RA!8XZB"'%]1
M2X?%C<>ZMFKZNVIL3<&FRT?D'#[+>U;0J=6-6=@TF5JL\=:$KE7LIK1)N[W/
M4VKL'S6](/&2)T)9'MFI&***K0\)F]E86@FL[6"?MBV<P.FQ8F.#AI<YN$!@
M<X@Q$$U::'$2"IO*+Z_NS#>7,\':]RV0MAPX7M+3H:UV(EY:T$2@@4<*C" 6
MKL-'-+I5AFQOK>WSZ3+1\Y'PSVORF/KC>>%@NODLG6W<XJL_N<OY/;@A[#3B
M_P"DC1Q*[3^DN8]_3]E>HK9GT;R_O&#L3%KZ<X9RFQ=D*SNULU"?HLUR8OW(
M"SPC">MS64?>+]$0G'K1L6@JSCX@V,P=19N'\HAAVDW;R62&0RZZZBF(6M!H
MUT4U33IYJV3<= .-<UAA&<:M7Z=>UZ7GWZNZ]27M-*(B]X5J3JSNNI)SVP'E
M2V',&GZXX*R6;^'LWC=\S;G8JG03,11-6NM*4U+1U'XN[PUA$T6[4N)U@UL6
MO=SW^[T[CKF_W!?5U$U!L36410)34M$V;(TQS+0S^/L,/FU-SEKJ4,B]D7L4
M@V09F0>)*@ZTH5<#6Y.0?2ZGMH)4$KBU6MN?S 5RRO74/J*ALJR\12)#VY37
MD;+[6NTU:FZ"T@5ZA!1S5N].5HJ;P OC2FA5%=U83R+HVTKHNPC877FGM\Z@
MG*S,5[8.D-ORB548.9Q21BY"LWJ(L^==;)P]/&(MW31Q&KM6^"]ND[;KX60[
M)4*>T4-?P*M5$XZ<L-*';3%*<:EV+;;)I)#4)I&_;$OV([0YH_<&Z-CUM&H.
M):CVZ?VS1:O5ML1M>RA(+0<E*-Z1%Y6.EARJ9E6H.M4H0M<K^YMWQ'6CO549
M=:@6$95/;T+6YB0>V-63+)%XJ:RX<:"/*LVL*U3)%I:BKL[FS$;N,';NI0V&
MGA9G"ZY*XA_V]NJIAW%<W3^N-ON=VV?=NXZMJJD?_P .T;4VN:;K>VSMW=5Y
MDPM-NLM^5G[#+T+7[59M,N%(#$>@T:Y3;ILE2F^.^/5M)%*!7 &M2M$1&A^4
M=7EM>6R%@--2UGJ5_P":E@<-IW95M9P!9OD5L=O;M<[04.QU@_D9=.D5)[,0
M;FO=5HN=-XWPE)D3*KDM:A4H5#US@K?(W6$EK^8EZ!*N9O7'"S24W*JOIU?$
MKJ_2]T+>>11W)%*NB<D_M26N%KPT1)U6KK+ED=T9OA,R2;%I_&F%9<]X[;TI
M>\Y?DE38356R;C,7W>+QQ2;/?;-1XQ*LW^G<>]?:VLC.U(:ZN2C.U4NI\?DV
M;QCB-,V["S2AVSDZGQKI44HE#6JSOC7Q>M>H;\]O%YFZK9)%764A%-'\ E(-
M5F^R-P[]W#R&Y(NV<<]CTD8NESEMN->;PB)'*KCP:&-ER0F>RP!-=2 4-5=X
M6JY 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 158YS^HEYB>Q
M8Y!^E+;A.[+^DV7=_P!OV5BX'UK_ .%NTO\ 0,P_=)EAU<_J;5/I<@_G8U'5
M/^4/_3=SRN)M_)T'6&?!"BI'R?W<_%&]$HZZU%:VLO\ L3GY#(E[7HA[:Y'-
MOD[U0;:7D._^\'>91K"\M[=ZI/PKK>ND);=@WN U1K*"S;=F7)50L) E4,DQ
MCHU$Q4Y&V6M^4JA8.H0A3]9RZ/CI4-T(HE.L<I1W=QGV7[.94_,\Q>&PL&CF
MN=N-:-TG<'. )'FFP]7>TGK.VRAV6V9A=+>S.WQU-C8.BD>ZA#&-&ESCJT
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M\3158)2I469L%RH\P[2;$4,GG*I3%PUPEC)N@A^GK8Z>CX)%- B B B B B
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M:F3?.O"[OET][*XG_*^3'M\N=WXR0>=><_-/!+3D$\U,F^=>%W?+I[V5Q/\
ME?)CV^7.[\9(/.O.?FG@EIR">:F3?.O"[OET][*XG_*^3'M\N=WXR0>=><_-
M/!+3D$\U,F^=>%W?+I[V5Q/^5\F/;Y<[OQD@\Z\Y^:>"6G()YJ9-\Z\+N^73
MWLKB?\KY,>WRYW?C)!YUYS\T\$M.03S4R;YUX7=\NGO97$_Y7R8]OESN_&2#
MSKSGYIX):<@GFIDWSKPN[Y=/>RN)_P KY,>WRYW?C)!YUYS\T\$M.03S4R;Y
MUX7=\NGO97$_Y7R8]OESN_&2#SKSGYIX):<@GFIDWSKPN[Y=1C;W+_BRE)RC
MI7^\@9J[3CRM$T^=?.HCA,S=-<KC+A8O(PBBY3F4+DF#'/U,8ST=7I[KSKSG
MYIX):<@GFID_SKPN[Y=2?O97$_Y7R8]OESN_&2#SKSGYIX):<@GFIDWSKPN[
MY=/>RN)_RODQ[?+G=^,D'G7G/S3P2TY!/-3)OG7A=WRZ>]E<3_E?)CV^7.[\
M9(/.O.?FG@EIR">:F3?.O"[OET][*XG_ "ODQ[?+G=^,D'G7G/S3P2TY!/-3
M)OG7A=WRZ>]E<3_E?)CV^7.[\9(/.O.?FG@EIR">:F3?.O"[OET][*XG_*^3
M'M\N=WXR0>=><_-/!+3D$\U,F^=>%W?+I[V5Q/\ E?)CV^7.[\9(/.O.?FG@
MEIR">:F3?.O"[OET][*XG_*^3'M\N=WXR0>=><_-/!+3D$\U,F^=>%W?+I[V
M5Q/^5\F/;Y<[OQD@\Z\Y^:>"6G()YJ9-\Z\+N^73WLKB?\KY,>WRYW?C)!YU
MYS\T\$M.03S4R;YUX7=\NGO97$_Y7R8]OESN_&2#SKSGYIX):<@GFIDWSKPN
M[Y=1CGW+_BRK)Q;I+^\@5JT3D"NTU.=?.H[A0SA- K?+=8W(PZB!2&3-D^"G
M)U\9QT];H[CSKSGYIX):<@GFID_SKPN[Y=2?O97$_P"5\F/;Y<[OQD@\Z\Y^
M:>"6G()YJ9-\Z\+N^73WLKB?\KY,>WRYW?C)!YUYS\T\$M.03S4R;YUX7=\N
MGO97$_Y7R8]OESN_&2#SKSGYIX):<@GFIDWSKPN[Y=/>RN)_RODQ[?+G=^,D
M'G7G/S3P2TY!/-3)OG7A=WRZ>]E<3_E?)CV^7.[\9(/.O.?FG@EIR">:F3?.
MO"[OET][*XG_ "ODQ[?+G=^,D'G7G/S3P2TY!/-3)OG7A=WRZ>]E<3_E?)CV
M^7.[\9(/.O.?FG@EIR">:F3?.O"[OET][*XG_*^3'M\N=WXR0>=><_-/!+3D
M$\U,F^=>%W?+I[V5Q/\ E?)CV^7.[\9(/.O.?FG@EIR">:F3?.O"[OET][*X
MG_*^3'M\N=WXR0>=><_-/!+3D$\U,F^=>%W?+I[V5Q/^5\F/;Y<[OQD@\Z\Y
M^:>"6G()YJ9-\Z\+N^749*^Y?\67:+4C3^\@F=*3BW2N7/.OG4N0S5H_0<.T
MTRJ\C%L$<*-TS%3/C&#$/G!L&+G&,X>=><_-/!+3D$\U,G^=>%W?+J3][*XG
M_*^3'M\N=WXR0>=><_-/!+3D$\U,F^=>%W?+I[V5Q/\ E?)CV^7.[\9(/.O.
M?FG@EIR">:F3?.O"[OET][*XG_*^3'M\N=WXR0>=><_-/!+3D$\U,F^=>%W?
M+I[V5Q/^5\F/;Y<[OQD@\Z\Y^:>"6G()YJ9-\Z\+N^73WLKB?\KY,>WRYW?C
M)!YUYS\T\$M.03S4R;YUX7=\NGO97$_Y7R8]OESN_&2#SKSGYIX):<@GFIDW
MSKPN[Y=/>RN)_P KY,>WRYW?C)!YUYS\T\$M.03S4R;YUX7=\NGO97$_Y7R8
M]OESN_&2#SKSGYIX):<@GFIDWSKPN[Y=/>RN)_RODQ[?+G=^,D'G7G/S3P2T
MY!/-3)OG7A=WRZ>]E<3_ )7R8]OESN_&2#SKSGYIX):<@GFIDWSKPN[Y=/>R
MN)_RODQ[?+G=^,D'G7G/S3P2TY!/-3)OG7A=WRZK_P LO<Y^+]7XK\E[-$$Y
M%8EJ[Q^W+.QGC3FWS8GXSQC$:YL<@R\8P,_R$DX*;8^$MR]LT>MG#1RGTIK)
M*)F,7,EDVT^;39O:Q/[5P.N8@:6MJ#0O:#0B$$'F$$$:P:J.SC9C*8<INI6=
MLXVVTI%;JZ(J&.(J#,01[!!!U$44+_@SB_Z\5GU(O.DY&^J$WO\ ;EV?]6TX
M/3F5^3+?K$?P0O-^8^4+CK\GPRL@TIQ5WWR-K.UK/H[7DMLU/2L-"V;8,!53
MM9&Y1]6FW,DS+9(FGIKXL5GB8EW'8)(&C6[M5D5PDJJ0J.3J$QW^<9=E<L,6
M82MB,[BUA=H:7"APEW0M)!T8B*T(&G0LUCE.89E%-+81F40-#GANEP::C$&Z
MW 4TX0:5!.C2J]F*8AC$.4Q#D-DIBFQDIBF+GH,4Q<]&<&QG'1G&1)*.7Y!4
M7K'>YR_D]N"'L-.+_I(T<>.=I_27,>_I^RO7K?9GT;R_O&#L3%<L0:G$!$!$
M!$!$!$!$!$!%AFQOK>WSZ3+1\Y'PSVORF/KC>>%@NODLG6W<XJL_N<OY/;@A
M[#3B_P"DC1Q*[3^DN8]_3]E>HK9GT;R_O&#L3%<L0:G$!$!$!$!$!$!$!$!$
M!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!%IGD;ZG
MK?'VF=H?41.#>RSRE;]?C^&%HYGY-N.L2?!*ZP>)GJ7>.'V@].>EY7AGSWRY
M>=]S=D<L&1>1+/O6+L;58M/R"_N_%$4I0ZE*->^QY7^M@7G4K%.(^1_E^V 5
MOY2R5E\#R_BX%3K'M*K-:RMIW^/*P*A';JR]AWV?+ JK>A65-N^-Y6/ABAU*
MA4TAWQ?D?B"AU*JFD>^_?^$*N5=Q<P8U<-2 JJ$@8U>+;/D7!T3F<SD[))Y1
M,<Q<(2<J[?-R'R=-/.%B(KXP?&,9Q@V,]&<X[H(IL$0$0$0$0$0$0$0$0$0$
M0$4(RC5VTW.21SI90DTHDB!"&/E4F6"+E-;MBY3*0N#&6QU>J8W3CIZ>@$4V
M"("("("("("("("("("("*$>QJ[F;@Y(ATL(1B4L1<AS'PJ?+]%LFCV)<)F(
M;!3(YZW6,7HQT='2"*;!$!$!$!$!$!$!$!$!$!$!%"3T:O*-F*+<Z)#-IR"D
ME,K&.4N4(R5:/G!"9(FIG*QT4,X)C.,8R;..G.,=T$4V"("("("("("("("(
M"("("*L_-/U''+/V,^^/2MM0E<B\N6??</9&J+SSR)>=ZR]C<NO_ /P9QT?U
MXN<^I%YTG(WU0F]_MR[/^K:<'IS*_)EOUB/X(7F_,?*%QU^3X95T/<S;!%:R
MN>V>0T;H7>F_]K\<*";<&O(;6-UG-;ZVH475$9>4O.TM]72H+,[FG2Z>R9LS
M(Q#%TU2G<K+M'*G9&Z,P6U<;[N"'+'7-O;6=U)P;S(T/>\NH&1PM=5N)Q)WQ
M!+* @54YLO(RUGFS%MO<7%W;1\(P,<6,8&U+I)7-H["T ;T$8ZD'0M_^ZAVS
MW4VPZYJ,OSOT11-6:XV/LY6^4J=J&J-+5I62MY(">60BU[MKX\M=733->MKI
M5-I.2*RK[LL+J&<+MC*DC=DH=D8KI[-GKB2:ZBBP.#I)74;4:<#Z-KB:-+&B
ME:: :*1VJFVKDMF/S^WCBMI9<;2V.)M74.C$RKM3CH<XUUZ2*KI*'>KAEZQW
MN<OY/;@A[#3B_P"DC1QXYVG])<Q[^G[*]>M]F?1O+^\8.Q,5RQ!J<0$733JW
MF1L/=UYEFL3RTU/KO$QO[:6N*!JG/$[8>P)AW3ZAN.T:XHLB\V8SV;#5IP[V
M!7J^VF,.BMB-62,B3"N,=DH4O<7>1VUA;M<^SFEPVT;WR=L,8 YT37O C,9=
MO'$MI6I+=&L+A[3.[F_N'!EY#%BN9&,C[7>\X6RN8PE^,-J]H#JTH [3J*[!
M-'<HJ+R!EI^&HU?O+=W2"2,9LH\_$P[%KK/8L19)"M2NG+<Y9V"22-M"-5BE
MWKAG&YD62$69J\4=E0D8P[SF\PRFXRUC7W#HRV2A90DXV%H<)6U _5FH +L)
M+JMI5K\/29?FUOF3W,MVR QU#Z@#@WAQ:8G4)_6"A)#<0#:.)HYF*/M?+77%
M0GKQ4W\+=GMNINZ=0Z)8U>,C8):9OMOW56Z?;*M)49%S9&C=Y5HN$L[U>6>/
MU8XS!"LS*YDC-FB:SBZ')KJ:..9KHQ"^"24N)-&-B<YK@_>FCB6@- Q5,D8K
M5Q MFSFUADDA<V0S,GCB#0!5[I6M<TLWVEH#B7$X:!CS2@!.F:9[H#K%WJRQ
M;"FFFP)@C+5.L-_5%HUIU7AIK9M#Y.;3VE2>.%'UM#-MC6%C/W^POJ2TA$RN
M9!BB]=2<:[5,T+(&1:[T^SEV+MMM&8VUFDA<<3B(WP1QNG>\X 0QH<7: 2 U
MX&+#4Z$&TEH;-US()'4ACF:,+09&3R2-@8P8W O<6AFD@$N83AQ4&74OF[6+
MM>Z9!M=2[8BM8;.V+<-1:PW[*$U]G6][V/1XRY2LO$Q47&7V2V.SKLFCKR<2
MB)YW!H0\LO&F[!?*+J.7>X9\@E@MY)'30F[BB;))",>-C'EH!)+ PN&-F)@>
M7-#M(J'!N>#/XI[B.,0S"TEE='',<&![V!Q( #R\-.!X:\L#7%N@T+2Z[0@5
M/("+#-C?6]OGTF6CYR/AGM?E,?7&\\+!=?)9.MNYQ59_<Y?R>W!#V&G%_P!)
M&CB5VG])<Q[^G[*]16S/HWE_>,'8F+?]#VK7MAVG=51A6<RUDM$[,BM56Y>4
M;L4&,C89C3>I=WMGE<4:2+U=W#$JFY(MNHHZ29KXD4'2>$3(D277C;BSEMH8
M)I"TMN(C(VE:AHEDBH[0*'%$XZ*C"1IK4"1M[R*YFGAC#@ZWE$;JTH7&*.6K
M=)J,,K1IH<0.BE"?E5=PT2S5.3MZT] UQC78=U8;<VF+GK^0/2X!JM-$Q.6J
M7I]MM-5BH==K7G;DKG,B=$J""G:&(HBLFG6:RN(IA"&N<YSL+:->,1T:&AS6
MN)WP%,-:D4T$50WMO+"9BYK&M;B=5S#A&G2XM<YH&@FN*E :ZC3Y--[Z/?["
ME]1L=RZI>[6K\2:?GM8M-B5!QL*$@B()N3S4O2T9@]DC8DC98BF7*S8B."&P
M;K=&<9%3E]^VV;>N@F%FXT$F!V GF!U,)/L U5!F.7NN7639X3>-;4QXVXP.
M:6UQ >R1183:.5NBX31V\^057OU9V]0N/%/V+;=D>@U:J??Y1@IJ^G.[S9JB
MEXOL24,UNV()J7*3!^]99Z[A'*ITDSX4QGBR?,),PM\MEC?#<7+V-9PK7,!X
M1V!KM+:X:[H!U&E3H6";.,OCR^XS*&1D]O;,>Y_!.:\C@VXW-T.ICIN$C6*T
M&E0U<Y&W9]E5:^<2]_Z6B\3-"@&<YL^[\-BQ4K*[ V)5-=1[&/5H/+&^N<O8
MYS:RR"C=5))R_;-%&D6G(2Z[",>9)<L@;HM[RVG?A>2(V7-0&,<\DX[=F@X:
M5U D%Y:P.>W'%FEP[3<6=S S$P R/MJ$O>U@ P7#](Q5H:$@$,#GEK'?O3/,
MSC=O.(DWM/VQ0VE@KD%-6B[:[G;W0T-CZ[K4%*/HQ[8M@U*+M,N]J4%GP'+@
MCMWDC?P55-0QR];HQ2^R/-,O>&SPR&-S@UKPQ^![B 0UCBT!QTTH--:A+'/,
MKS!A=!-&)&M+GL+V8V-!(+GM#B6C16IT4HIUSRYXHLXV#F7G)WCTUB+/;96@
MUJ5<[IUNA&V&]02Z+6;I<&^5LI6LM;89TX33=1S<RCQNH<I5$RY-C&<8R;.'
M/=&VTN2]C ]PX)]6L.IQ&'0T[CCH.X5D.=9.UK7NN[8,>\L:>%91SQK:#BTN
M&ZT:1NA96_WUI6/V&]TZIMK6*FYV-=<VL^FR[$I+?:BE?;1YY0TN6C/Y]G/(
MQ1V).UP\6129E3_A#JE3QDV,+<NOW6POA#+VB78>%P.X.M:4Q@$5KN U]BJS
M.S&P;<FQ,T7;P;BX+&SA*4K7 2#2FZ='LT41'\D='K2^L:A.;4UI3MF;>JD+
M<*'J2R[/UGC9-BBIMAE\CFO0$%<)Q"Y)-^S52,\@7$K&+'04,W=+I8PH;([*
M[\,EFCAE?:0/+7R-C?@:0:;XEHP[FAX:X5%0#H5C<TL"^*"2:)EW.P.9&Z1F
M-P(KO0''%NZ6%S30T)&E;Q$>I! 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 15CYLOGD9PSY<24>Y69OX_C'OM\Q>-SF2<-7C355K7;
M.4%2YP9-9!9,IBFQW<&QC(F]FF,DVCR^.0 QNO8 0=1!E:"#[:XCUF75S8^K
M?:"]LWNBO(<DOGL>TT<Q[+65S7-(TAS7 $'<(77K2^$5'AJ'2V$-N'DW#QC&
MIUQE'149O.T,XV,8-8AF@SCX]FD7"35BR;D*FBF7'533+@N.Y@=]/?PRW4CY
M;*P<]TCB28&$DDFI)W23I*^*VNRUVS+X#'GFT36\"R@&83 #>C0!N ;@W%]W
M?$B%0S_![UY3X[N?)WS;,_LC-'-9.UV.7\0Q:T^0YDP;W/MH_P#\A,L0F.,S
M:/;+*MM]<I"G(7.2YSO:UYQ^SY'3@2$+<ND(#K&PIUABY^_L<ZMXG/CS[:'$
M/G\Q_P"]57O%(MT!AQXMY"\F$^I@^"94W39U,XZ,=S/QQNC.<?MCJ<OR?(K@
M@26%EQ3?<7P[:G:[;K*0\V>T&> BNN\E/_>MT<->94D:R1?'#D-.D<7I4V66
MIMK/L)-&FVF*!>E&M60Y<)M(_:L>W+T=&.HE.)E[1+&'/734X3;W8!^5@YYD
MS"<J=IDC&G@3S1_Y?P/T=7W3_+S_ )BH-K)6; [;SM;M;&,-O.XAHO&C4Q^H
M"Y T5T";<I)H?VZM._QY6!\G"]A.W5E[#OL^6!56]"LJ;=\;RL?#%#J5"II#
MOB_(_$%#J55-(]]^_P#"%7*NXN8,:N&I 55"0+!U'-GR3LQ#G<3<Z_2R0YE,
M8:R$J[>-2YR8I<E.5NL7&2^07/<QG((IL$0$0$0$0$0$0$0$0$0$0$4(R8.D
M)N<?JF)EK()1)&I<',8Y#,T71''7)DN"DP8RI>CHSGI!%-@B B B B B B B
M B B B BA'K!TO-P;](Q,-8]*6(Z+DYBG.9XBU(WZA,%R4^"F2-T].<= (IL
M$0$0$0$0$0$0$0$0$0$0$4)/,'4BV8I-#$(=O-P3]7)SF3QEK'RK1XZ+C)2F
MR8YFZ)L8+Y!L]S.< BFP1 1 1 1 1 1 1 1 1 1 15GYI^HXY9^QGWQZ5MJ$
MKD7ERS[[A[(U1>>>1+SO67L;EU__ .#..C^O%SGU(O.DY&^J$WO]N79_U;3@
M].97Y,M^L1_!"\WYCY0N.OR?#*O1[G;=]96K6W*[A#L:]W;4#GF&RTJ:C;9I
M=!MVTR1=NTE:+38F] NFOM?H.+S.T;8T?:W!'*L<DY,P>Q[1PJW613/@O/[3
M6]W#=6>?VL<<XL3+CC<]L=6RM:W&U[]X'L+13%2H) ()4_LY/:S6UWD5S(^$
MWHBPR-8Z2CHG..!S&;XM>'&M*T(!((5E/=(=EL=7Z'M_&:Z;ZN/)[D=O/D/K
MCD9MJY3?'NZ<=J'KR'U9I^9U'2XJFT^]5FBOY>W6^%EF_C"981#=@>/C$VY^
MT<8,L:*V7M'7>8LS6"W9:97;VSX(VB9LSWF202.+G,<\!K2#1I<3B<3H&A2>
MTMTVUR]^5S7#[K,I[EDTCC"Z%C!'&8VAK7M:2YP(JX- HT#7I70Z/H:X%>L=
M[G+^3VX(>PTXO^DC1QXYVG])<Q[^G[*]>M]F?1O+^\8.Q,5RQ!J<7R7*J=%8
MB"I45S)*%16,GVQ4E3$SA-4R63D[4J9\XSDO6QUNCHZ<"HI73J5#6FC6J%Z)
MXH;^T+1:!K&O<OG,S1-<U-O5(6(E]#4'P]\FPAUF,?)3DXUEDI%_('E#$?O5
M"Y2.\6[3'63[3K%Z',,XRW,;B2[DL@VXE?B)$SZ"IJ0!2@%- Y@IKHN=R_)\
MRRZWCM(KTNMXF80#"RIH* DUJ372>;[%5F-%X/Z8JD#L^B6J,:[JU=N)S3K;
ML77F\8&O;-@K=N"!,<]KW%8&=DCG<0_M.QG,=#/)!N5DE'M9*'3<LD6QE#EQ
M@N,_OII(KB$F"[@#FL?$71EL9Z&,%IJ&LJX U+BUQ#B:+/;Y!8PQRV\P$]I.
M6N>R4-D#I!T4A#@07/HTN%*!S06@56*RG +6/HTN]P4V7<ZZ;1W'K&D-<:RI
M\! P^M]76)O VND0^X*I78Y!BV:W"MZSM:]9C6R6$&+.&471(3^'SDF9FT=W
MVB+*=HE)N>%?(XDOD;5KC&YQKO7/:)''22ZAW%B?LY:=OF]@<8@+;@F1M: R
M-U',$C6BE'-C<8VC0 VHW5RT>!>LFVSN+M_;S]A2A>+6KJ[K6MZ^*FPQ6[@;
M7\.[AM4V.X]5(JCUWK$LW*/(ML0I6Z<H\3>=&%FC?):':*Z-I=VQ:WA+N9SW
M/TXFXS61K>8)*-#CKP@MU.*J-G;07=I<ASN#M(6L:S1A=@!$;G<TQU<6C5B(
M=K:%QM2\*'NNK+J=.P[IGK]J/CC)626XYZG=4^ @BTJ2GX"QTV.E;U<&;AW)
M[,E:)1KA*P\"IE"*20;/SKO$GS\B#Q*M[GS;J*8Q0-CO;H-$TF(G$ 6N(8TT
M# ][6N?I=4BC2UM6FEGD+K:6'A9W265J7&&/"!A)#F@O<*F0L8YS6:&T!)<'
M.HX7P'/+H4!%AFQOK>WSZ3+1\Y'PSVORF/KC>>%@NODLG6W<XJL_N<OY/;@A
M[#3B_P"DC1Q*[3^DN8]_3]E>HK9GT;R_O&#L3%AE'SOO4/(GE1X-QKN%^U[O
MCD9K_95<VA7=B:9C(6'K"?%CB_I.=6FJW:;_  EWPZKUGU+*K*I(1RIW#7"9
MF^%3'P49[CQ=>Y99UNF1W-O:O8Z-S)22[MB>44<UA9OFR-&EPH:UHL%OXQLL
MSO*6KY+:XNF/;(U\0 ;VO!$:M<\.T.C<= TBE*JHY."^^<P7'BHM(N$C*QL"
M!<:=YLLUI^*64-I^B<AGW(37I(LK5T9"P8LL1*6RER#=/#HY6-\.KT(E:JG$
MR=H,NX2YF)<98W<+:FA_:/A$+Z_FX2(Y0=&F&FFH4-YOYCP=M" T0R-X.ZTC
M]FR8S,IS<0,D3AIT35T4*A:WP;Y"QNV<1,XUV'.5*N<DN2'(6%OQ]MZ8::P=
MI;:+N%_7#Q=.9ZI0WOG9\@TV0VKD\VDI@D*>.*\63E%F_@T<7)+G^6OL\<9B
M;,^U@A+.#EX0<'P8=5QDX'@P6%["UN+%A!8#5RQQ;/YDR\P2"5T+;J>8/X2+
M@_UG"%M&B/A>$(>&/#G8<.(XR*-5PK%QPO6?<I[3Q2K56AF&V)+@#/:&851@
M\A(V'-LY_P <W&NV\1XX260@4FJEH,1#+S*N&V$\=ID_9XZPA(\TM_.]F<2O
M<;,9D)BX@D\&)L=::^ATTU[FM3<N5W'F@_)XF-%X<M,(:" .$,."E=71:*ZM
MW4I;:'#R @-8-ZSHB(MKF8E.27![8UD;W;<>R[\3%3T'R_T]MRVOHU?;=[M2
M,.M%4:O3#G*##+=:34221R594K<I;+3.Y)+LRY@6!@M;IC<$3&;Z:VDC:#P;
M&UJ\M%34-TG0*J^[R2..T$67M>7FZM7NQ2O?O8;F.1Q'"/=2C&N-!0NT#2:*
M@['AUR=LVA:SHY[Q\I.K9/3D+S:L++8<7L:D2>-R2_(G4/(?6M4H<8PAT$I6
M&/9YC<,3/VIU,J-&2$G66>$5'^.JNVZ-V=Y3%F+\P;<R3,G=:@L+'C@A#)"]
MSR3H.$1N9&&U):]U<.H\XW),UERYE@ZVCA? VZ<'A[#PIFCF8U@ TC$9&OD+
MJ .C;3%K%G]I<?MMU.R3LMKGCMKS=D'M#A5KGBB6J2]LJ%+A]0S5$>;37>.Y
MAE.13AK(:FOL=LB-:318/#V323J+$B<:[)E(S>(M,RLYHFLNKF6"2&_?<8@U
MSC('B.E"#HD86.+<=&_K'5<W366N\MO(97/M;:*=DM@RWPES6B,L,E:@BAC>
M'M#L%7?JVT8[131E=X9<FJ#MZML*G$/5ZRQ/5GVQ+O8+SK&]:=VD>N\4H_0[
MW8<?1;O4W&\]0<G)5U$I1F'M:DF5><0ICJOW;G+APRS(2YYE5S9/=,X"4X@Q
MC62,ECQ7!E#"]KN"D@%<5'M+P[0UHH'*/BR+-;:]:V$'@AA+W%['Q28;<0EX
M8]O"QSDC#5C@PMTN)J6KY1'$'D]5+1QI5I]%5KTK7M<<%:_M*P&V!J>ZZ1L!
M>/.(#S;1NX-2;"JD];6>PJ&@SD#4>QZY>H.#/UF:R[QGX.=0U7YUE,T5UPTF
M)CI;LQC!(V5O#5P&.1C@TL?4<*R8$4#@&NK1&9+FT,UJ8(\+VQ6@D=CC=$>!
MIB$D;VEP>S?<$^$@U+27-I5=Y(X!=^@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(JL<Y_42\Q/8L<@_2EMPG=E_2;+N_[?LK%P/K7_
M ,+=I?Z!F'[I,L.KG]3:I]+D'\[&HZI_RA_Z;N>5Q-OY.@ZPSX(45(^3^[GX
MHWHE'76HK6UE_P!B<_(9$O:]$/;7(YM\G>J#;2\AW_W@[S*-87EO;O5)^%=7
M6^4H92+?&G3Y18H*HN2.4U%47C1ZBJ0T>ZBUVW0\1ET7G4RU,A_#]OU<)])L
MXQGZ=8MMWVKFW6'M<M.*NJFZO'VT,N90YY%)E!>,R$@X/!7%BKHI3V?=7]$O
M!5UR(><>*6OR;1*GL/.%\1JC\AD+F[I&"M_,J\V6T+CP1EL)PTZV7Z:6<FP7
MLLN,%>&<D+XUVO;D#,_G;LV7'+,7L8<53B$?-CU4W*UP[W"5^WWJ8E]8<_JZ
ML)/6>UC-J"P5I7A3%1O!FX! I<'3C TTPF2DID O*P[[/ECF"OJS>A65-N^-
MY6/ABAU*A4TAWQ?D?B"AU*JFD>^_?^$*N5=Q<P8U<-2 JJ$@6;QBV?)OC==1
M:;G7B.>URKT,WLJ[=,B];/>]5LJ7'5\@OD? !%-@B B B B B B B B B B
MBA&3-XC-SCQ8W2S>I1)61>UR;JF:HN2.OX+R$NL=0OR7[@(IL$0$0$0$0$0$
M0$0$0$0$0$4(]9O%IN#>(FZ&;)*6*]+VN2]8SI%L1K_!>0KU3IF^1_=!%-@B
M B B B B B B B B B BA)YF\?-F*;(W541FX)XM_"Y2Z6;*6:.GI>G'?=9L
MD;'5_P [R/@@BFP1 1 1 1 1 1 1 1 1 1 15GYI^HXY9^QGWQZ5MJ$KD7ER
MS[[A[(U1>>>1+SO67L;EU_\ ^#..C^O%SGU(O.DY&^J$WO\ ;EV?]6TX/3F5
M^3+?K$?P0O-^8^4+CK\GPRNR3W+"X23*@<RM9:8WA0^./,K;%3U!&<?-IWFX
M,=6J.ZC 6^?D-VZPINWI),C77UVOS)S JL5,.62S[,69!-=/.>N7EMKX&NN;
M&[OK>2ZR.%\AFC8TR4<6@12.C'1M8<==! Q5(*Z?929S;>]M;*>.VSJ9D8AD
M<X1[T.)E8V0] YXP4T@G#0$+;7.N<VY2^!L%I#G'R7I7)'E<?DI WG3L,RW%
M$<B=GZ5TZCKVU1VS#WK;45(V56.A-C6&0KQF$"YEG':FC<.TR8PD;L]/9Z.R
MGVB=F&06DEKD_:I9*3$88Y9<;3'@C(;4L:'U>&BF+"=:W,^DO(,@;8Y[=,N<
MW[:#HP)!,^*/ X/QR NH'DLHPN/0U&K1T-CZ&N 7K'>YR_D]N"'L-.+_ *2-
M''CG:?TES'OZ?LKUZWV9]&\O[Q@[$Q;RWQL?.H-+[2V>FZJS-U1J-8['&JW=
M_-QE3/,1\8X5AFD\\K,%9[*2/?RW8H&)&QK^05RIA-LW66,1,T?EUKV[?0VA
M#R))&M.$ NH3I(#BUM0*G?. &LD#2I#,;KM*QFNZL!CC<X8R0VH&BI:'.H30
M;UI/,!.A=:.FN>N]9G=\?I+8L#7)A22V'Q[CFMQ7XY;UXK2+BE;SH_,&:6(W
MU%O&^W&])R%=L'%HA&\N\59HR#:452/&-5VN<FZJ^V=R]E@;^V<YM(ICAX>*
MX&*)]L/VD3&LHYMQI:*D%H.,@KE;':+,'WXL+IK7$RPC%P$MN<,K+D_LY7N?
M5IM]#C0$.(P A8_MOFOO&I[DFKXU4JV=/\?:M[H]+7?6L9'V TYLZ-XLU745
MC@LIRY; :/8VE8]D,W;*'9+MF^5G72@<RB64<EGD.7S6+;<X^W;E]D&/)%(S
M<.D:=%*EN]J=()H-.@UQWN?7\-\ZX;@[2MF7I>P UD%NV-PTUH';Z@T$"IT:
MJ9%MG?/*.F7[3FE]PVK5SBP7O9?%?9<+:^.L?L'7C.,J3SE%K+76Q=3W1K8]
M@WIU<8>79W-JFUF$G$4UL#,K])>':E3P53%9Y=E,]O/?63)A''%<,+9BQY+A
M;R/9(W"QF$@M-6T<6'"0\U62\S'-H+F"POGPF626W>'0A[ &\/&Q\;L3WEP.
M(4=5H>,0+!33P+/[H'OW66IZ9R=NU8TY9=/[S@]WOM3ZLJT;=*WM'7S[7&E]
MQ[TI2FS]BRUMLE9ML39*SIQRQL*K&L5_-7DWZ)"9DTRF,:Z+9O+KN\?E-N^=
ME[;NB$DCBUT;P^6*)W!L#6N:6NE!961_"-!Z!6S;29C:6<>;3L@?8W#93'&T
M.;(PLBDE9PCRYS7!S8B'T8S@W$4QA9+9.4W,W6FY\<9;LOQ>M&SKY':"4UGL
MFK47:56HM7>[>G-X-[0OL+7<OMFU6&?8TV*T9()Q165BB<V-^Z;$.I%]=0B.
M*+*,CNK'QK!VVRTC,W",<^-SW",18<#Q&T N,HQ58[  =#]W++F^>6M]XIG-
MH^[D$/!O:R1K&F0RXL;#(YQ#1$<-'MQDC2S33;FB.5FV;5R67XN;/B]</[+1
MHKDJTOM_U[&66"KMJG]01_ 6X4F7IM;L%GM;VJ14O3.::C::C'<G-+LIN%,F
MB_42*?*FGF&3V<.5>-K0RB*0P%C'EI<T2&[:X.<&M#B'6M6N#6@L=4MKJW<N
MSB\FS4Y1=B(RQB</>P.#7&,6;FEK2YQ:"VZHYI<XA[:!U%6ZF^Z%;_L-CXWV
M.U5_6VNM*[9K/'AQ*VIYJ7<=\JEAMNY;$>#L5;]''7]QF:YQQG8'QC&EK[&[
MUEY'V=V[23S,1R;@JR,I/LWEL<5U%"Z66^A?-1HDB8YK8FU:[@GM#IP:.QF*
M0&, G XBABX-I<REEM99FQ16$S(:N,<KVETKJ.;PK'%L!%6X!*PMD) QMK4=
MT@X5=TL,V-];V^?29:/G(^&>U^4Q]<;SPL%U\EDZV[G%5G]SE_)[<$/8:<7_
M $D:.)7:?TES'OZ?LKU%;,^C>7]XP=B8KEB#4X@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(JO\ -YLX><+>
M7K1H@LZ=.N+^_FS9LV2.NX<.%]46Q)%!!%(IE%EEE#8*4I<9,8V<8QCI$YLR
MYK-I,O>\@-%] 23H  E9I*X7UH0S7/JSVBM[=CI+B3(K]K6M!<YSG6LH:UK1
M4EQ)   J3H"H-5.=_&UY2JBJQF=K2#=6LP*K=Y'<:.3,@P=H*1;0Z+IC(,]0
M+LGS-PGG!TED5#I*DS@Q#9+G&<_0)<GNV7,@>^U:0]U0;FV!&DZ"#+4'F@Z0
MOB5MM[D)L(&MBS8D0L&C*LT(Z$:B+.A'L@D'<7X><UM!K9_@U]QF[N?_ /5_
MD]C]G]G3V!L1Y=,W7+:>$VW*K4N-M,H?7#!F_P#^*S3^#6%3?+S2SULNFU)N
M14YR9P4N.,?)@O3^Z?41<8$C!:EA!=-: =\V_*KG<PVFLIX7-BMLW+C]%YF.
M?:*HU^W34YK#GQ77-T.\GP?J8QQTY HY-TX[F,>$ZR1QC.?V^@==EUS90$<+
M<V@_]>$\YY7P/:RQSC,P\6.6YN^M:?\ V^]'PK<+>/#[AX]F;)#<B]^UY1C+
M,UTY;3NHYE$AC48AL=9E?;ZS-DZ*^RG2)L'9,3=9*NIFZ<]:0R8S;@-OO6"^
M^:[(,DDIEXT2R-/[4[K6GJ?-/Y>H;SH_O7^7C_+E!D%Q'ZQ=N[<':1]'VMM(
M*]JM.ELLK3_Q!T%K#^PT%WZZ@A[@&G?X\K ^0!>T7;JR]AWV?+ JK>A65-N^
M-Y6/ABAU*A4TAWQ?D?B"AU*JFD>^_?\ A"KE7<7,&-7#4@*JA(%&10;/BR9E
MC+'G)U9MVSC#@V(Y>5=JQI2&PHKV:)61B8(GTXRF7H+T%Z.C!%-@B B B B
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M<PW92JB_2X1_AU1WN=W,%Q+*+6YRMUI01QDQ'AN#:T1L)>8*AP8!IQ;VF@Z
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M=M%DW#9PBIC!DUD%T3'262.7/3@Q<YQG'D"A!:<+@0X*H<' .:06G=7(%%5
M1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 158YS^HEYB
M>Q8Y!^E+;A.[+^DV7=_V_96+@?6O_A;M+_0,P_=)EAU<_J;5/I<@_G8U'5/^
M4/\ TW<\KB;?R=!UAGP0HJ1\G]W/Q1O1*.NM16MK+_L3GY#(E[7HA[:Y'-OD
M[U0;:7D._P#O!WF4:PO+>W>J3\*J5I/DG,<+KVZQX/(3O'"URZCZ[T=@FH[?
M:REGZO:/MA:\8$Z3&BEU#95F85+&"JXZSEJ7"V#IJ-L]@(]J;'QA8 ,SN)N@
MZA*T?D/]D?DNW-1WO0Q7J1_S%W'JEVB&S6T3GR["74NENMUK(XZ981^:3IDB
M&A_1-I)H?_172;76[S7H.XTZ<C;+5K)&-)B!GH=TD]C)6,>IX6;.V;E$QB*)
M*$-Y9<].,XQG&<8\Q3V\]I.^UNF.CN(W%KFN%""-8(7ZLY?F67YSE\6:Y5-'
M<9=<1A\<C"',>QPJ'-(U@_Z-1TK9[#OL^6,)6^WH5E3;OC>5CX8H=2H5-(=\
M7Y'X@H=2JII'OOW_ (0JY5W%S!C5PU("JH2!6D5VSXTF58JQ)R=1;=LWPW-F
M.0E7:4:8A<)I=HB9D4F2*=&<J%Z#=)NGIR138(@(@(@(@(@(@(@(@(@(@(H1
MDM(GFYQ%P57$<@E$YC3';X32,=5%SE]V+C"9<N,X4*3K8R8W4ST8[G2"*;!$
M!$!$!$!$!$!$!$!$!$!%"/5I$DW!HMRJYCETI;,D8C?"B13I(MLL>V<93-EO
MG*AC]7&#%Z^>G'=Z 138(@(@(@(@(@(@(@(@(@(@(H2>6D4&S$T858RQYR"1
M<]BWPX-B.7E6B4D8Y<IJ]FB5D8^3J=&,IEZ3=)>CIP138(@(@(@(@(@(@(@(
M@(@(@(JS\T_4<<L_8S[X]*VU"5R+RY9]]P]D:HO//(EYWK+V-RZ__P#!G'1_
M7BYSZD7G2<C?5";W^W+L_P"K:<'IS*_)EOUB/X(7F_,?*%QU^3X95]/<Y&];
MUUK+EKRTV#<N1*6NN/++2,+)Z=XY;>G='S>X;AN*SVV$I2%\V+ X=/Z_KFJX
MK,@=VN@T6>8>/FI$#%RH<BW.[3F6ZN[+)K9EMVU<F4B6>,2B-L36EV!AH'/=
MB;0$@4!KJT=#LT(K:UO,WN7W/:UL(@8X9#$9'2.<&XWC2&-PFI )J13V=I\Q
MKE1.6_"I7E1JB3Y5ZSA=9<C*3J&_<?-[\F;QR9U=(3-UU[>[#4-AZMNEX;Q$
MTG<(9G69%K+LG310R32524;J(IY4(OIY'!<9-GWB>\%G+)+:ND9-# R"0!KV
M-<R1K*C"2YI:0=;2"":4V\YFM\WR/QM:&[B9%<MC?#+.Z=A+F/+7QN=0X@&N
M#@1J<*$;O2D.\7#KUCO<Y?R>W!#V&G%_TD:./'.T_I+F/?T_97KUOLSZ-Y?W
MC!V)BN6(-3BI/>>>6DZM)W2L1IKM)V*N>BG782;?:OV?#Z@M6UM3U&U6VRZH
MBMU.Z=C7#RX,6M+DTE4$'ZV,.8YVU)D[ULJV+/6^SU_,V.5_!B)W!N($D9D;
M'(YK6R&+%C#3B;0D#0YIZ$@J!N-H;"%\D3>$,K.$:"8Y!&Z2-KG.C$N' 7#"
M[0"=+7#H@0L<IW/2G+Q%MF-CUZ6KOBRS:2I5*K]&A+AM.Z[%N&X>.E-W^2MU
M>ETZLR-DE).&C9V2Z^&[95)*,B%Y!R=N@FME++/L[.'LCM7-=5DKG%Y;&UC8
MYG0XG.<X- )#=9Z)P:*DBN*#:* L>^Z:6T?$UH8'2.>Z6%LV%K6M+B0"[4.A
M:7&@!IDTW[H+QBA*S6K6>Q; EV%@B;Q8G\96-);GM%LU_6]7V'-1V98=M4F!
MH;^WZIC-?VLIHV5\?LF"S=XFJ3"9NP7RGACV;S625\.&-KFN8T%TL36O=(W$
MP1N+PV0O;OFX"0133I%<LFTF4QQ,FQ2.:X/<0V*5SF-C=AD=(P,+HPQV]=C
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M"("("("*$9/'BTW.,UB]#-DE$F9&[+)>L9TBY.Z_A?(5ZITR_(_N@BFP1 1
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M1@=B<YQ#23J;A!(%14!3&T^9W5[%:Q8QVF(6/,;(VQQLF<#C :UK02 -;JD
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M=KUCO<Y?R>W!#V&G%_TD:./'.T_I+F/?T_97KUOLSZ-Y?WC!V)BN6(-3B B
MB B B B B B BPS8WUO;Y])EH^<CX9[7Y3'UQO/"P77R63K;N<56?W.7\GMP
M0]AIQ?\ 21HXE=I_27,>_I^RO45LSZ-Y?WC!V)BN6(-3B B B B B B B B
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MQ@[$Q7+$&IQ 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M1 1 1 1 1 1 1 1 1 1 1:3Y+.&[/CEO]V[71:M6ND]JN'+EPJ1!NW;H46>5
M67765,5-%%%,N3&,;."E+C.<YZ!OY4US\TMF,!+C<1@ :227C0%&YS-#;9/=
MW%P]L=O';2N<YQ#6M:UCBYSG&@#0 2230#25TY<7=[Z/B.-O'V*EMR:JBY2-
MT?J6/D8V1V'463^/?LJ% MGC%ZS<S"3AJ[:.$S)JI*%*=,Y<E-C&<9P)K.\D
MSJ3.;N2.SNG,==2D$12$$%[J$$-T@[BX_)=OMA(\FM(WYUE+9&VT0(-Y;@@A
MC001PF@C="W\GR)X_8Z.G>FG,>3_ /U-I7[?_P!;$9XASSN*[XF3I5)GU@;!
M4\MY1X9;\HI)MR+X^%-CIWMIO'<^#L^DX_SL?LS@O.0YY3Y%=\3)TJQ_:!L'
M_.\H\,M^44RCR/X\X\G?.F,>7M&CX_9_^N ,ASSN*[XF3I53[0-@\7EO*/#+
M?E%8.%?,I-DRDHUXUD(Z0;(/F#]BX2=LGS)VF1=J\9ND#J(.6KE!0ITU"&,0
MY#8SC.<9$9(Q\;S'("U[30@BA!&@@@ZB-T+JK::&XB;<6[VO@>T.:YI#FN:X
M5#FD5!!!!!!H1I"S1IW^/*P*!97;JR]AWV?+ JK>A65-N^-Y6/ABAU*A4TAW
MQ?D?B"AU*JFD>^_?^$*N5=Q<P8U<-2 JJ&A)+QFW>+>#D;^#3,U&]4ANMA3Q
M;)NF7A&<]4G0=QV'7SCN]&<^3GR013((@(@(@(@(@(@(@(@(@(@(H9G)>$S,
MS'>#D3\6I19_",&Z3N/#DG*G0<O5QU<(]CT8[N>GI^ "*9!$!$!$!$!$!$!$
M!$!$!$!%#/)+P:9AH[P<BGC)*4/X1DW0=OX"DV4Z"%ZN>MA;MNC/=QT='P01
M3((@(@(@(@(@(@(@(@(@(@(H:;DO%C=FMX.1QX3,PL;U3FZN$_&4FU9>$8SU
M3])V_;]?&.YTYQY./)!%,@B B B B B B B B B B BK/S3]1QRS]C/OCTK;
M4)7(O+EGWW#V1JB\\\B7G>LO8W+K_P#\&<=']>+G/J1>=)R-]4)O?[<NS_JV
MG!Z<ROR9;]8C^"%YOS'RA<=?D^&5A-2V%?J H^6HEXN%*5DR()R2M2LLU7%)
M!-J94S9-\>'>LS.R-S+GRGA3)L$R<W1T=.1L36UM<T%Q&R0#5B:'4]JH-%AA
MN;BW)-O(]A.O"XMK[="%(6O;&T[W'(Q%XV7?[E$MGJ<DWB[7<K%88Y"110<-
M4GZ+*7DGC9)ZDV>+)E5*7!RD5.7&>@QL9LAL[2W=CMXHV/(I5K6M-.94 :-
M5\MW=W#<$\LCV UHYQ(KS:$G3I6OQLK67K'>YR_D]N"'L-.+_I(T<>.=I_27
M,>_I^RO7K?9GT;R_O&#L3%:6NW*KVQU:F-<FF4N[H]F5IMM0:&.8\%:$(:%L
M*T*^P<A,$>IPMC8N<X+UL=FY)W>G.<8B)8)H0QTK2ULC,3:[K:EM1[%6D?@4
MO%/#,7MB<'&-^%U-QU :'V:.!_"L"A>0>E+'KO&VH'956F-;^:GS$&M\<_\
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MENM-GSF350SE,RV2=P'7MX\ /FE($0C%7.-(P:B/7T .D-Z&NXC;*S8260Q
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M4E2UU1.)JO(:L\LK!J:Y<4VUTNY:5(\M-BW)[S/GZ[JG-@L.T6NJY*;V5%[
MDJZT=IU=1T1"+C);$F5##.17;=ML27DUS<7@RQ]FV\9>86XQ;L:+4.DHV/A
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M5ZZ9I34(U6:85=NDI4S-WG!,Y:%;I-C.2XSG'7QX24Y<9Z/]'N@BF@1 1 1
M1 1 1 1 1 1 1 10LZZ9M&[([UIAXFK-0;5%,V"9[)XZE&K=F[QU\9QC+-RH
M53'1W>DO<[H(IH$0$0$0$0$0$0$0$0$0$0$59^:?J..6?L9]\>E;:A*Y%Y<L
M^^X>R-47GGD2\[UE[&Y=?_\ @SCH_KQ<Y]2+SI.1OJA-[_;EV?\ 5M.#TYE?
MDRWZQ'\$+S?F/E"XZ_)\,K3(WEIH"("+UCO<Y?R>W!#V&G%_TD:./'.T_I+F
M/?T_97KUOLSZ-Y?WC!V)BN6(-3B B B B B B B B BPS8WUO;Y])EH^<CX9
M[7Y3'UQO/"P77R63K;N<56?W.7\GMP0]AIQ?])&CB5VG])<Q[^G[*]16S/HW
ME_>,'8F*Y8@U.("("("("("("("("("("("("("("("("("("("("("("("(
M"("("("("("("("("("("("+3/(WU/6^/M,[0^HB<&]EGE*WZ_'\,+1S/R;<
M=8D^"5U@\3/4N\</M!Z<]+RO#/GOER\[[F[(Y8,B\B6?>L78VJQ:?D%_=^*(
MI2AU*4:]]CRO]; O.I6*<1\C_+]L K?REDK+X'E_%P*G6/:56:UE;3O\>5@5
M".W5E[#OL^6!56]"LJ;=\;RL?#%#J5"II#OB_(_$%#J55-(]]^_\(5<J[BY@
MQJX:D!54+!.&+EN].P:Y:IIS4VW7)G!<=J^;RCI%^ZQU3'Z<.G9#J8\C/QW=
MQCR 130(@(@(@(@(@(@(@(@(@(@(H5DX8J34VW0;92?-THK+]SG!>AT59)R9
MH7&<&R;/@Y"&QGIQCOO@@BF@1 1 1 1 1 1 1 1 1 1 10KUPQ3FH1NNVRJ^
M<)2N6#G&"]#4J*38SLN<Y-@V/""'+C'1C/>_ !%- B B B B B B B B B B
M BA9UPQ;-V1G[;+I-2:@VZ!"X+GLGSB4:HL'.>L8G<:NSD4SY.>@O<QGR 13
M0(@(@(@(@(@(@(@(@(@(@(JS\T_4<<L_8S[X]*VU"5R+RY9]]P]D:HO//(EY
MWK+V-RZ__P#!G'1_7BYSZD7G*;W\9>CAN7QSX+XX]%78?C7P+K^!>,O-=+^'
M>"=I_">"^%=;L^MW>IT=/='I[+L'B^#@ZX.!92NNF$4JO-=]PW;TV/#CX9]?
M;Q&JU2-Q:OZSV/\ 2@)^L]C_ $H"I^L]A?WI</?T@#^Z3Q;]!GWO3T'_ .[G
MI'T*?-KZ)GFR]#;T,ZSYA?-;X!_Y'S3>9?P7P_L?X+PKK]3XWH'G?._LX\<W
M?;WC+MWMJ7A,.##CX1V/#73AQ5I7<7WW)?M&\36G:/BWM+M:+@\6/%@P-P8J
M:,6&E:;JL7^LE?FSOOKB,^ZWZ5^+4G]Z'T7\8GZR5^;.^^N'W6_2OQ:?>A]%
M_&)^LE?FSOOKA]UOTK\6GWH?1?QB?K)7YL[[ZX?=;]*_%I]Z'T7\8GZR5^;.
M^^N'W6_2OQ:?>A]%_&)^LE?FSOOKA]UOTK\6GWH?1?QB?K)7YL[[ZX?=;]*_
M%I]Z'T7\8GZR5^;.^^N'W6_2OQ:?>A]%_&)^LE?FSOOKA]UOTK\6GWH?1?QB
MQRX_I&_F1M/CGWMCQ/YG)OQKX%Z*GAOBWQ8Z\.\$[3^#\*\%Z_9];N=?HZ>X
M,L'V8<,S@_&F/$*5X.E:Z*K%/]IW OX3Q7P>$UIPE:4TK2_#W]( _ND\6_09
M][T]!_\ NYZ1]"GS:^B9YLO0V]#.L^87S6^ ?^1\TWF7\%\/['^"\*Z_4^-Z
M!O9W]G'CF[[>\9=N]M2\)AP8<?".QX:Z<.*M*[BT<E^T;Q-:=H^+>TNUHN#Q
M8\6# W!BIHQ8:5INJQ?ZR5^;.^^N(S[K?I7XM2?WH?1?QB?K)7YL[[ZX?=;]
M*_%I]Z'T7\8GZR5^;.^^N'W6_2OQ:?>A]%_&)^LE?FSOOKA]UOTK\6GWH?1?
MQB?K)7YL[[ZX?=;]*_%I]Z'T7\8GZR5^;.^^N'W6_2OQ:?>A]%_&)^LE?FSO
MOKA]UOTK\6GWH?1?QB?K)7YL[[ZX?=;]*_%I]Z'T7\8GZR5^;.^^N'W6_2OQ
M:?>A]%_&)^LE?FSOOKA]UOTK\6GWH?1?QB?K)7YL[[ZX?=;]*_%I]Z'T7\8G
MZR5^;.^^N'W6_2OQ:?>A]%_&)^LE?FSOOKA]UOTK\6GWH?1?QB?K)7YL[[ZX
M?=;]*_%I]Z'T7\8GZR5^;.^^N'W6_2OQ:?>A]%_&)^LE?FSOOKA]UOTK\6GW
MH?1?QB?K)7YL[[ZX?=;]*_%I]Z'T7\8GZR5^;.^^N'W6_2OQ:?>A]%_&)^LE
M?FSOOKA]UOTK\6GWH?1?QB?K)7YL[[ZX?=;]*_%I]Z'T7\8GZR5^;.^^N'W6
M_2OQ:?>A]%_&)^LE?FSOOKA]UOTK\6GWH?1?QB?K)7YL[[ZX?=;]*_%I]Z'T
M7\8GZR5^;.^^N'W6_2OQ:?>A]%_&)^LE?FSOOKA]UOTK\6GWH?1?QB?K)7YL
M[[ZX?=;]*_%I]Z'T7\8GZR5^;.^^N'W6_2OQ:?>A]%_&)^LE?FSOOKA]UOTK
M\6GWH?1?QB?K)7YL[[ZX?=;]*_%I]Z'T7\8GZR5^;.^^N'W6_2OQ:?>A]%_&
M)^LE?FSOOKA]UOTK\6GWH?1?QB?K)7YL[[ZX?=;]*_%I]Z'T7\8GZR5^;.^^
MN'W6_2OQ:?>A]%_&)^LE?FSOOKA]UOTK\6GWH?1?QB?K)7YL[[ZX?=;]*_%I
M]Z'T7\8GZR5^;.^^N'W6_2OQ:?>A]%_&+7.X?TB7T)-I>;/WN'S'^AS=_-7X
ME]%+QSYFO,S)^/?%/;_P'C/Q7VO8=?XSM>KT]P;5E]F7;L/ >-.'X5F&O!TQ
M8A2OL5UK6O?M,[3FX?Q9P/!.Q4QUPX36GLTU*DNA/?LO00T[Z'_]QWS"^A5K
MOS&>:+T0?'WF3\R,1YF_'?@O_E_&_B?L?">S^,[;K=7N= R9I]FOC.Y[;\9]
MM</)CP\'AQXSBPUTTK6GL+%E?VD>++?M7Q9VKP$>#%PF+!@&'%316E*^RMOD
M]_DZ,=7^X'\'HZ?1(&C]UWTK\6MX_:A]%4_]1<Y#W^SIQV?O?_3T=SK>B3_I
M8_8^#TBX_9?3_P!U^+5OWG?1?QBDTO?]?\WWOK_WO1+_ &_V 'V7_2OQ:M^\
MZO\ [77_ -133;](#[G9>]Y^3_G>B;\0#]E^CRK\6JM^TZNCQ7\8IUO^D)=;
M'9^]U]/<[[T3_B"H^R_Z5^+0_:=N^*_C%D+3](CZ?X'WN+I_]OT4O)_< _9?
MN^-?BU4?:?31XJI_ZBG$?TC+K9ZGO;73T=WK>BIY'2!^R^G_ +K\6J?>=]%_
M&*22_2/.DO5][5\C_.]%7R.CX/0*?=?3_P!U^+5?O.^B_C%))_I(O6^-][1Z
M>[Y/HK='_P#8#]E^[XU^+3[SZ?\ M7QBY/ZR3^;.^^P+?NN^E?BU</M0I_[5
M\8GZR3^;.^^P'W7?2OQ:K]Z'T5\8HN*_2-^Q=>*O>R^Q\9RGA/4]%SH\9^'K
M^-.GMOCNOX=VG6Z/C>GO>YT!]UOTK\6J?>A]%?&*3_62OS9WWUP^ZWZ5^+3[
MT/HOXQ/UDK\V=]]</NM^E?BT^]#Z+^,3]9*_-G??7#[K?I7XM/O0^B_C$_62
MOS9WWUP^ZWZ5^+3[T/HOXQ/UDK\V=]]</NM^E?BT^]#Z+^,3]9*_-G??7#[K
M?I7XM/O0^B_C$_62OS9WWUP^ZWZ5^+3[T/HOXQ/UDK\V=]]</NM^E?BT^]#Z
M+^,3]9*_-G??7#[K?I7XM/O0^B_C$_62OS9WWUP^ZWZ5^+3[T/HOXQ/UDK\V
M=]]</NM^E?BT^]#Z+^,48V_2-_&<IX-[V9XS[./\9]'HN=?L^S7\ Z_6_@OX
MOK]'5[O[/P ^ZWZ5^+3[T/HOXQ2?ZR5^;.^^N'W6_2OQ:?>A]%_&)^LE?FSO
MOKA]UOTK\6GWH?1?QB?K)7YL[[ZX?=;]*_%I]Z'T7\8GZR5^;.^^N'W6_2OQ
M:?>A]%_&)^LE?FSOOKA]UOTK\6GWH?1?QB?K)7YL[[ZX?=;]*_%I]Z'T7\8G
MZR5^;.^^N'W6_2OQ:?>A]%_&)^LE?FSOOKA]UOTK\6GWH?1?QB?K)7YL[[ZX
M?=;]*_%I]Z'T7\8GZR5^;.^^N'W6_2OQ:?>A]%_&)^LE?FSOOKA]UOTK\6GW
MH?1?QBC'/Z1OXSB_"?>S/&?9R'BSI]%SK]GV:'A_4ZO\%_%]3IZW=_8^"'W6
M_2OQ:?>A]%_&*3_62OS9WWUP^ZWZ5^+3[T/HOXQ/UDK\V=]]</NM^E?BT^]#
MZ+^,3]9*_-G??7#[K?I7XM/O0^B_C$_62OS9WWUP^ZWZ5^+3[T/HOXQ/UDK\
MV=]]</NM^E?BT^]#Z+^,3]9*_-G??7#[K?I7XM/O0^B_C$_62OS9WWUP^ZWZ
M5^+3[T/HOXQ/UDK\V=]]</NM^E?BT^]#Z+^,3]9*_-G??7#[K?I7XM/O0^B_
MC$_62OS9WWUP^ZWZ5^+3[T/HOXQ/UDK\V=]]</NM^E?BT^]#Z+^,49*_I&_8
MM?&OO9G8^,XOP7K^BYT>,_#T/%?1V7=Z_AW9]'3\;T]]W.D/NM^E?BT^]#Z+
M^,4G^LE?FSOOKA]UOTK\6GWH?1?QB?K)7YL[[ZX?=;]*_%I]Z'T7\8GZR5^;
M.^^N'W6_2OQ:?>A]%_&)^LE?FSOOKA]UOTK\6GWH?1?QB?K)7YL[[ZX?=;]*
M_%I]Z'T7\8GZR5^;.^^N'W6_2OQ:?>A]%_&)^LE?FSOOKA]UOTK\6GWH?1?Q
MB?K)7YL[[ZX?=;]*_%I]Z'T7\8GZR5^;.^^N'W6_2OQ:?>A]%_&)^LE?FSOO
MKA]UOTK\6GWH?1?QB?K)7YL[[ZX?=;]*_%I]Z'T7\8M+\D?TA/\ N[;[]$SW
MNOT-_06VEZ(/F7]$_P TOF(\PT[YJ_,[X7_Y3Q[XA\(\$[7^#\(ZG6[G2-[*
M_LU\9VW:GC/MKAX\&+@\./&,.*FFE:5]A:.9_:3XMN.VO%G:O 28\./%AP'%
23V:5I[*N9_@SB"^O%._4B__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>tm2227887d8-fc_problem4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2227887d8-fc_problem4c.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@")@." P$1  (1 0,1 ?_$ -\  0 !! (# 0
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M*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*5N+_DTYX/\
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M%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2O&/\
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M#6#BUS20"*WYKO;=W;=;?+<-@_\ ?EN(9'M>8W"5&N:_2USV$M8QS3H(P<'
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MM;F*[!,@69EZ+<R\R&X>*E.4Y20O.<XQZ>V;Q;;K+=16[9&NM+AT+]0 !<T
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MM<'7I(5LB.E4L2@^,8P2WASU>>O^[RWW>&WOY-[B?%?27SG.U-+0\Z&@O:H
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MG4T*26AJC XAVK"M0=%]W="]0?CVZE4#86N>G_<'%=[I[V'W)J*^16N]QVR
MUQZ@Q$;"UG'33QI%2=GTM+=B)H@#(,HAMMO[6U*\>UN&P;CO?,U[<VTM]8ZK
M"'NI&%\32_\ <D(34G[3 5;B<Z\;;]^V_9>6[.WN8K*]TWTO>QO#)'!F';8"
MNE?V7$([ 95/[[M_6P'8CY>[E/\ </3&Y:?V$^->R-=;;:QL/5T25*0<\_3F
MJ)H,>G5TN'"KFT:)'Q+T:[5F@!99:!,&K#1DK/->WLKIVV;)!'8SP3VVZM[]
MNB0H1JUS:G ET;R0[O"2W'2'85L7%[:MW+>IY+V">&YVMW<.UQA0=.B'2T@-
MD8 6]V '8:M.-0CLQJ_IE\B':Q7R"7'OSH/2O738NO=>SF[-2$W=4#VVUG9M
M>:=K=%F=;:TTY)UJ5>NJY&9JS/T9X6"Q%H((6VA[T,I)V-IN]]Y8V?[-0;=<
MS[I%*\12:%MI&OE<\/?*'#0@<5!0X!4Q3!NMIL?,N[_:.?<;>#;)8V&6/4EP
MQS(VL+&1EIU*6A"%&)1<%Z7NGVK--[I[F:?USL"^5K6'7^;VHT9<+EN.XUBC
M1L9J6N%&6:8 LMLDY*#K<=9+!58=<:/E#[:'I8MIMA*LK0C/=;W>7UAL4]U;
M1OFW)L*-;$USR9'(T%K0"XM#CJ.&#02:X?9;2ROM\AMKF1L6W.F5SI'-8!&U
M7$.<2&AQ:-(QQ<0E?03V5[M?'[\AFE?D*T_5+QMG75^L*XWMCIN3[0VO3-/T
MYC8?7JOU?6,5KCK\/'F0,E 3NU=11_W6#$2CI;Y/E3WK0\TM#GYMM6P<R\LW
M^V7LT<,MLU;>46[972Z)G.D+YE!!$<AU%S4 RR(3]&W3?>7.9+'<K*&2:*X<
MEQ$9W1-CUPAK R%""#)&-(:Y2<\QCO%J_P"2'J78^Z&G^N>^-R:CE-(TC4'5
MO?'7?>:=DU)=/TGV4USJEN#V%1IJ_??3M8KL9=*JLP$P(TAI LIA;66TFG-N
MM<_=\K;S%L,^Z;=!,-PDGN(9HM#M4L#Y%8\,34XL<A! Q;BNEI!]ZTYGV>7?
M(=LW">$V$<,$L,NMNF*=D:/87KI:'-4$$X.P34X$="?03;&K*;W&^1ZSV_9=
M JM:O/4[OK7*58;)<J[!P=PL-P.:748&K2TG(B@6"9M*,>8X41QY\['VLI7S
M]%YCL[R?8]KA@BD?+'>V;GM:UQ+6M':+@ K0W]HE .-?GO+MY:0;WN<LTL;(
MI+.[:TN<T!Q<>R&DE"7?L@*3PJ:=$.U&H>N/Q^U"?M]GJ,G;-:_+QUSWR=J-
M-BKZMES6LJ-0 EV*V5ZE$R+,X8#'O#+9'D,,?1M226T+<PK[.8.8=GO=TYD?
M' QXAEV2>$2:7=V)'O.EKGH@)S+54M7"L_+^[V6V<N,DF>PS1;S#*8]0UEC&
M#4X-52!D"B:DQK>#5G7?H@)VA[%=D>QVUOC[[%],]^;/NF[(O;=O[.7:L=A:
M+ W8FY6A[7L3H:EGQMQFMC%S=E'$E0I 7W5C!./M80XO(G/ O-SYB=M%KM6U
MP[E:[[;0MB,;8&.A>6:6ZS,X%H8 TEI!S(!PQKWK3;>7V[M<[IN<VVW.R7$K
MI1(Z=S9F!VIV@1-(<7JX!P(R!(Z*X.NFR:#8/C3ZMZ[U=>?A_E+32=M]I)6R
M:_\ DGLVJS9>EU>T[0,,HQE)JEW/>GJX3/1367"W'F&LE"H%5Y7C&,\;I:W,
M7-5Y=7<>]B&2&W#7V+9 '.;& \/<P(Y#DAP*U&V75O)RO:6UI)LIFCFG+F7K
MHR6M=(2PM:XJU1GAB$K'G6_N@S\>6C.ZUDB=F=3+)MC_ *_-.7H[3W7C8%,D
M=.;4U'=*]*F[1IVFJU%EH3)ZEAH2U.Q Z@PR0:^6,RG/E8B/.UNFQ'F;<;")
M\5ZRR]6RL$LS'"6.1I C=*XY2$MU%2"\$\'5K;9O@Y;V^^E9+9NO/6,;S'"]
MICDC<"9&Q-&<8#M(0$,('[M:W_.9L'J5<A>B,/TTV!3[?J&IZ!M7W16J[:H>
M?G-7@6Z].W"(U_=(D"1/EJ?.5X*7R)B.E/0>RV/Z7<N+2I:O4^[ZVWJ!VXOW
MV)[+U]RU7.:0)"UFDO82 '!Q"ZFX%<*\SGZYV><;>S9)&/LF6SD:UP)C#GZ@
MQP!):0"FEV(3&LT: ^0#KGUF^/[XSZGLS4G53M9#!;R[,+WWJK9=4U]M;;NI
M*3*["#*B+93(.=?DC==SDP$>LX51H*!YYL!IE+C:?X]O0W+EO=-VYDW::TFO
M+-YMX.YD8Y\<<CPPJUQ"!X!"%"K%)0Y'>V[F+;-JY<VN&ZAL[Q@N)^^C>UDD
MD;2\(YH*EA(*A0CT 49C;35.TZE'=A_EZS-=R/C^[!S/82C=:I[KQ=^VFRM)
MJZ^[,IX=DFBXJBWJH(,C*^%.ZGIX;<:; HC12(^1"%*4*TT0PXYXUY9S.VS9
M.[L=RMH[:2<3,MV2]]&XM"O8Y"XB1QU!^H@M)"D@@>Q9W<+=RWGO+W;KE]S'
M 877#XNY>T.)#'M4 &-HTEFD$$ H 0:U,J6W-?\ 7SO'7K/V$O\ \:](U]V.
MZD[UZGRML^,ERJ3VMM..7,4S$/M+9=2UJTXH.UES=B8"6=G"GWX@;&<XPT%G
M//9FLKG<N7W1;9'NLES:WL-P&W^H/ETHL<;GYM :2F0<>EU>/#>6VV[^V7<I
M-KCMKJSEMRZQTED>I4D>UF3E< N9:.AM=;^_NF76_K%UPM$[:.Z6E>P'9*T;
M!K,?IO7?4?9<5M37(6NPL'N6Z][FF5UH0N!E"AUI8B(M+P9XSKJ5NMOH=?2'
MU.V[[NF[;HR.&PGMMJ9&XRON8S&\O*:61#401Q<Y"#P(0:N8W'8]LVK;'R2W
MT%SNCY&B)EN\2,# NI\ITA#P:U01Q!4Z>^OY3++ =AMC]FY[4.U/@&MFKKO1
MX\2!VC>;]H^5[I%-QFIJW#S9$;? S)265>(R=BBPZRXR\XZP$P"RCQE&$X_.
M>4(I-LM;2.]AYD9=QR$F-C)1:XR.(5A &@@@R*,27&OT+FV6/<KJZDLIN77V
MDD8 D>^(W.$;04>"3J!!#$R :*TNW=\ENL^N>J?C"-U+I/IMV2W-JCI3J)\?
M9]^7)[)N>@-G5Z4F_IJL1$4[8$1&5RR50UEN58#DQT2(1SR'\>G*6O'O;?RI
M=[I>;LV]N+ZUL9K^3^6Q&-FC<!VE<PES7#LDM.D@)TUX=_S3:[99[4ZS@L;J
M^AL8_P"8]7NAD!/91KP&N:>T X:@2O16FWQC;_AG>QG>K;?8#:53@+/N?I#W
M1</M=^LE=J"+SMO9XL=,?=,8Y)DQ($A;+?.E$+%CA$Y?(<RI++6?'C'N\V;:
M\;9MUEML+W0P;A:HUC7.T1QJ%**0UH17' <37B<J[BP[GN%YN,S&RSV%RKGN
M:W7)(A0*@+G%4:,3P%2;K+C7/;OXS)_H>/O'4>B.P.L>W&>SU% WG<P];:[W
M95+#K#&N)BOQUYEDHK\;L*JDX4^PR8ZE1(;B6V4J3DAX7#NWI6R\UMYB-O-<
M;;+9=P\Q-+WQ.;)K#BP8ECLB1D<3P!R[5Z-O/*SN7Q<0V^XQ7G?L$K@QDK71
MZ" \X![<P#F,!Q([(.I&T^O72FY?%]TYN_9S0=YN&NNT6]NS6_\ :50V; 26
MB-&L6W2-RUY4=:9W#(OQM/D9:261@B40T^VV!*XR.KUY=8==Y?>K/<]^@W??
M+>TN8X);2&"&-T9$TNF5KW/[H*X 9-48MQX$#I]FN]MV*?:=DGNK>2:*[EGF
MD:\&*+5$YC6=X4:2<W8X.PX@G63;'<_6W;;XZ^U>O=?(ZG=+=Y439\5:=HT#
M4%4U%HRM]\='Q]G-/KC,&:\.)8K+LG6$PQB37#!RK^9=G&7&&272T##^M9[%
M=;+S/9W-SZ;?[?)$6QOD=)*ZTE+0'*,6M9(.SJ+1I.9 :I\J\WRUWGEJ\MK;
MT.QOXY0Z1D;8XFW<0<2U#Y3GQGM:0XZAB 2Y!K?\2'9&K]8];_('?SK[3JC?
MX[26K+'J2$LMLA:Y,7N[T/<]>N0M?IX,F:,=8YA*8K#BQ@FWWTL^591Z?//3
MYTVN;=KK;;9L<C[8W$C9"UI<&,?$6DN("-&.90+7F<G;I%M5KN-RZ1C+D01N
MC#G!I>YDH<C02KCAD%*5W:]D.SO3*'K/;OKUH+L'I*2H.P>A/<_=L5(L;7UV
M!$6SL1W-[#15P1J84I=C9BG[]2JI5PQ6H=+F3 (Y:?6A&/=SC@MKVG?9);+<
M]RMK@7,6XVL1'=O);#:PEO>>2NA[G$EV1=XJ[O<]UV-D5[MNW7,!MY-NN90>
M\8 Z:YF#N[\I-;6M TYAOCJ(U3N!\6FFK_HKX^)K9NS+G0ZMU:D.D-]VOKR\
M:8,Z,V(KL\'5+=N?;DU/E'O6'!K6QE,/%3XTF.'!K#<QZ<H8><7GFV3F^^MK
MCF6.**.X?>"Z9&]DHNV]P7-BC#4TIH4!A:2]1Q(%8(=ZY2L;FWY<DEE?;LM#
M:OD8^(VKN_#72R$JJZT)>' -3J)KK=NNK=,]QNJ?5;J["=UNHVF=L_'U>^S.
MG;ZYNW:PE&U5M6@WC;R;'7-VZ0V "+8:K>@3@8[.2! RGBCL9P\UX;]CZGJ8
M+N^V/>+S=Y+"]GLMRC@E9W4>N2-[(]+HI6'2YA!.!( &1Q5.8GM+'>]HM-IC
MOK."\VV2>-_>R:(Y&/DU-EB>%:\$#$ DG,8(LMZM;<Z=]-;1\M06A=I:XWKK
MR/ZY4^NZ=_ZL1*3*PG9.\1MKB2;C&1VN)7%;9V- JFG#%A!,,O$$@CM%J\I7
MC/,&\66^;[#LKMQAEM[DW3G2^CZP8&%ITDO&K04122 "2*S;3>;+LDN\-V^:
M*XMA;-;'Z1I(G>'#4 PZ=854 !) !K9..^1;KV%MOXH^[U?LNG=2=>=66;9V
MOMZ=%M81^NJB5UNVSL6@VBAV[>E3U)2HN-O-PUG:(^?Q-,R:@I)P%87T:'\F
M&*'QY;^6-S=9;SR_(R>;<YF1OBNY"]W?QL>U[872.)8V1I&DM5JKJ32U:]1O
M,VVMO-HWZ-T$.VPO>R6UC#&]Q(]CF.E;&T![F.!U!R.1-*ZG)6 .GN@=5_&7
MV?FN^6R^[?4W;NFM/5/;\GJ"O:FW3";"VYV=G-@T&TT2GU7.LX;ZJ<KRUKMR
M7YYZ1_\ 3Q![",.*6/ATMGT=[W*\YLVEO+MIM][!?3OC$CI(BR. ,>U[G=X<
M'>2C W%P.&*-/G;+MUIRKNKN8;J_LYK&!DAC$<H?).7L<QK= Q'E*\NP:1C@
MKAP;)^1K5/73K%\6OX TETY[/[CU=UX=D<V79KTIL.V=?K_"W\V0@X@^NTO8
M$&U7I5DA+4FT+*,MF)=0AYO*/"58FTY7O-SW;=_2;B^M+&:Z33&C&S,+ "0Y
MS#J'[*M*)@:BZYFL]LVK:?1H+*[O8K9=3U>Z%X>2 6M>$/[2."\15EB/DC15
MOC';N=QANG_9KLCMCY&=Q[-V+K#LIK^@[AD8J.N^N 94O9\3J4V2",J()EC:
M7'B23(C0+3+BPV?2GPC&1_*QFYL[B!U[:;7#M<4;)('OB!+'D",R $.(;VBT
ME5[1JC.9^ZY5[^=ME=;I-N<CWQSL9(0',![P1D@M!=@' (G9%;K&=E.G3G?W
M6?R![,VKHIZI]4OB_P!%62 U9INY:PS)S'92QQEKK .GM2:[79L@XF=9#V ]
M]R*PE_\ "ZV(]1C33>4N)\%NU;Y]FYN6[2&X[Z\W>5IDE;(@@:6N,LC]*I)I
M U8=XKM))PKW7;ILGVBBYCNIK?N;/:8G".-T:F=P<T1QLU(K%)TX]VC=0 QK
M7/97;WH]<==?'7VWU7;]C2EQ^.OM75:3>]?=G[IJ:1[4;:T'+W&/VV+=(2/J
M!T0%=8S64_@J+BG HUA82RE+,\I:P0[ZEILG,$%UNFRWC(FP;G9N<Q]NV06\
M<P:8RTEP):9 CG*XJG9S0>9=;SL,]MMF\VCY3/MEXUKV3NC-Q)"7"34 T@.#
M"K6HT(O:R4Y6U9UWZ("=H>Q79'L=M;X^^Q?3/?FS[INR+VW;^SEVK'86BP-V
M)N5H>U[$Z&I9\;<9K8Q<W91Q)4*0%]U8P3C[6$.+R)S3O-SYB=M%KM6UP[E:
M[[;0MB,;8&.A>6:6ZS,X%H8 TEI!S(!PQK;M-MY?;NUSNFYS;;<[)<2NE$CI
MW-F8':G:!$TAQ>K@' C($CHK@ZZ;)H-@^-/JWKO5UY^'^4M-)VWVDE;)K_Y)
M[-JLV7I=7M.T##*,92:I=SWIZN$ST4UEPMQYAK)0J!5>5XQC/&Z6MS%S5>75
MW'O8ADAMPU]BV0!SFQ@/#W,".0Y(<"M1MEU;R<KVEM:2;*9HYIRYEZZ,EK72
M$L+6N*M49X8A*^<7L-""T[M#L<:SR&BK4!G9C]HGE=5I:(F^O[@%ID&+A(UW
M31D$X)"LTR#%F5Q@(@[B&@,#?2X7CV?5S]1VR0S[1$8A<,=W6D>D B96C2'2
M@J=1342<U7C7YGN48@W:42FW>WO=1]'(,*..HMB(PTA=( R1.%?21VAVGJ@W
MY _EKZV[6V[4=/5SOWH+K;^@#L!;52*-6 NU37VK;IK2,L<]%1Y;U:UW<8G+
M@)4G].X,'D+.%87G*<*_+-HL[QO+>R[K9P/GEVVYG[Z%J=X=3Y&R%H)&I[3B
M&JI6OT[=KNS=S'O&UWDS((MQMX.YF<O=C2R-S X@=ECA@7(@2NMZJ]#.EE*V
M=TTTWLSO+H>_[+O^[Y&R=DIW7NZ*5(=2-3]<JS&,SS\,3N.58K4:_MR_C0KH
M;'LR?M-OO-B9'P\D=XOJ9N8M^GM+Z^M-ON(K2.W#8 ^)PN9)W%%[H:CW;%!*
MM5 7*BAO,0\O;'!=V-C=7]O)=23ETY9*TV\<+0J=X=([QZ($=F0$5"[L0[*]
MVOC]^0S2OR%:?JEXVSKJ_6%<;VQTW)]H;7IFGZ<QL/KU7ZOK&*UQU^'CS(&2
M@)W:NHH_[K!B)1TM\GRI[UH>:6ASF=JV#F7EF_VR]FCAEMFK;RBW;*Z71,YT
MA?,H((CD.HN:@&61"=+NF^\N<R6.Y64,DT5PY+B(SNB;'KA#6!D*$$&2,:0U
MRDYYC'/AGR0]9$]QJ#I5R1Z=U;\3=--/U+3GR.0-/TW=ME=;.P'Z*LA#IN^W
M)QFSQ3=/C)'U1)XKRPGH13V/<=8;R\XWYK>5MV]1R7Z7S]%](Z6R+I6,GA[Q
M>Q&-)U$=H$*'I@"4!]%W,^U>NX[$FR9KL8VQWH;$Y\$W=IVI#J&D'LD%"U<2
M I'0SUIO_4G6NV==5?<FO)NR]G:OV]H)TGVSBNR\$?H@(""WO5#YJW$QX\(?
M7[;6ON*.D'LSB9U(931"3?<]M/V_HNZVV]7=G+-8RM9M+[)X%N8")B3"X!JJ
M'-<I T:%":46OSW:[G9K6\BBOHG.W5EZPFX$X,0 E:2Y$(<U >WK0KJRKZ%]
MC]Z.J)=;['[K&WWJ$_?6MNQO8KISJ@<79=*./O76[M'VOTMM69VM .,S3Q$I
M0:=2#;.(--">Y'LC9)94ZEO*<\_-+7E_>6RVM@;:<;=+:PW,G\MP#)[>WEC$
M9PP>YXC):>T2A1:_2+K?]G=%=7PN(3N$5U-;1]MI+X)[B*0R#'%C6F0!PP 4
M+6CG9"_T.ST7_P#&-=EP]OJUXU'L_:O3:M:SL=6L478ZO>]@)VD=/Q)=-GH8
MHN'FUUV!C3CB'!B58P(A6/#F,Y3SW]JMKF&XY7M9&/CO88;ITC7-+7,9W8!U
M H1J) "C.O!W.XMY;?F:Z8]DEG+-;-8YK@YKW]X2-)"@Z0"2ARKY<.?KM?DU
M.*4XI3BE.*5N+_DTYX/]]7K?V%;.?.7_ /A7.XW_ -V=+_Y2Z_YY?W??\.L?
M^QWRCZ]CGW_F%]__ %&_)LKJ>YV5<C3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4
MXI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3B
ME.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI7C'^W_
M -^?_KXJ!^FO/%33BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*
M4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3
MBE.*4XI62MD;AV5MY%"3LFV'6Y6L-=U_4U&?DV ,&0>NZF](O5FK8.%$',D@
M8+$J\T*HM9#S(^4,)7AEIIM&I:V-K9=YZ*P,[Z5TCT5"]R:G(J E J("<<R3
M6U=7MU>]WZ4\O[J(1L5%#&KI:J*0%**I PR K&O-NM6G%*<4IQ2G%*R1G;^R
M/T1(T,FU&M:C3L-S:[E)8'CQXXO82ZZU4V[/(E,!MRDF:'76\BBH(?=8$0\]
MEA#:GWE.:OH5KZ;ZQT#TWNN[UXKHU:M(Q0 NQ*!2@54";7IMUZ'ZOUGT/O.\
MTX)KTZ=1P4D-P"E I1%-8WYM5JTXI3BE.*4XI6XO^33G@_WU>M_85LY\Y?\
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M>3'<E[F1@]N5P[L -:%(4C400%(-0O=OS<E:-U_L79=@T&-*UW67R9;;Z(6
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M"2]F=,77K&CZJ)E4A8]@@%@A:&W/",;,OW@6\<>Y[AMKWQ;I/NT5Q TM.,;
M6G61V1J;@]NK$.("C&M>+D"XDDVS;]R8R7;(=IEMYW!PPD>0X: >T=+L6.TX
M%H)0X5JE _%)WIKO1/O'U\MT+!;?V=LOL9HBQ:ZEC-@5@!G;&MM/S%:CESLM
M*RDEARNE2%3KC?J:E,XD%*SGU^Z[E2E^]-S[RM-S3M>[V[GV]C!9SMD C<>Z
MDF#CI  [0#W9M[/0@KP8N0^:8>5MTVBX:VXOI[R!T9,C1WL<1:-1)/9)8W)W
M:Z5-=H_Q^Z7MVF]J6;*?BHU3T>KEGIKX\YM"A=I*IN&0G#(J3 (A:B748>F0
M9J!2\DD$?6?4>AA0^$J0K+F,XX7FW<[?<K!G_P#GKC=)F2=F*2U="&@@ZGAY
M>X*$ 1,5ZJ[GE+;;C;K]_P#_ (&#:X7Q]J6.Z9,7$$:6%@8TH5)5<$ZZOV^]
M'=K--]T)7N[U+UO0NP+&SM'0>E=QZ*N6RFM16#,E4+([,4S8='ODI 6*OH8&
MCBE!R$<4VSY0U[C7O./8R+BVG=-AW+EIO+',$TMH8+ITT,[(^]:CVH^-\8<U
MV)"M<%S0H!VLN[;9OVW<R.YFV"&*[$]JV&:!\G=.5CE9(QY:YN11S2F2A2>S
MK!VNZC_()V0Z04VM;OA-?=A]Y/=U*GV"GM%1-EIE"U]3='1+UB>1H6/V$;#0
M:K$.!'&X#?E342)^<GK2A9;0R''/<V#F#E'9N9Y)]L=-9[6-L?;MG+7R2/G.
MG^>8PYVE2%#&Z6]D8-+D'A[]R_S=O/+$<.YMAO-T.Y-N'0!S(XV0#5_($A#=
M2 H7.U.[6;@U3Q57JCM\OK#WDT7KWXNM5])9/>_7B?KL-,4GM+2MJ(V;?@PI
MB(I=4F@1JO5VJZ,"/;I-]N1(*P.WE:FU)\N84F9]_P!N;OFU[K>;Y<;FRTO&
MN(?:OB[N,D%[VDN=J)T-&D!>/"D&P[B[8]TVNTV.#;'W5FYH++IDO>2 $,80
M&MT@:W'42@RXUF/6[GR&63K"=U%V/T0K&LX%CJ);](@[<%[<ZZO+AUIB-&R5
M*J*E:_C:5%D",W&QC#,KRJ54U&()RXXZZAK.5>;>CE"'>QS!9;K)/*=P9,8C
M:2,1IG#W_P PO*Z&DGR%<B  FO0LCS?-L9Y>O-J9!$-O?")1=QO5P@+&?RPP
M)K< /*1JJ24J1_']*_(#IS7O6SJ]MWHG6J?KG6=!@-<VC>X7;;7MI*&%J=8>
M&$L3.J8>DJDBE3,D$RSD-J7<R-@C*\NN);SZL/-K.4MRO+W?-OW5\EY/*Z1L
M!M)&A7N4M[TO0("2I9BB(%K/RE)S;MUG9;'N&U,CLX(FQNG%W&X@,:@=W08I
M4@! _!54I6V'R(Z<OW8/I+V/TOJZ+&FM@[%UT;7JI%&2<?##'2KQ\>^VP]*2
MI L<$C+0ZL^MYQ",>/U>>#R?N5IM',UEN=\XMM(9@YY )("'@%)\5>_S?MUW
MN_+-[MMBT.NYH2UH) !*CB4 \=:?]N.B5N[*1GQET:TZXKU\UQHJYPA78ZMS
ML[$LQS%7$U2)63&4,+D17[$C$^-A'M@9=6K"<+Q^;]O.AY?YJM]E?O=U!,^*
M]NHG"W<UI7492X<#I[)_:3HKGN8.5KC>F;):SPLEL[65IN&N<$TB(-/$:NU^
MZM8)I/2?M9T@UW\A'7SIQJ2I6C6^YZQ^*>J.P&++KZGWNFVR\J:I]LUSL*PS
MLE'6RTLZMB)TN:JTI).&X2P!D91'O%)9;]6ZYFV'F>\VC=^8[B1E[;/TW4>F
M1['L9VV21M:"QO>EH9*UNG%VK2C5/DVW+._<L6>[[1R[;QOL[F/5:R:HV2,>
M_L.CD<XA[NZ#B^)SM6#=.I7((YKGXH>RO4#8O1+;>FMYS'8%[KQ9&=6W35D]
M#:WUS7JWU[VD'.YW.;49X8>%DK8]#662^]0 )=U\DDQ?OI<;>POW,]YS]LO,
M5GNNW[E:MM!>,[UDK3)(YUQ$6]R'M)(8K1H<Y@  P0A$Q6?(6]<O7FU;AMMT
MZ[-F_NGQ.$<;6V\H=WQ8X:2]''4UKR23BH*KGOX]?BQUAJ:,E-I=C>O5 5V8
MCNR>UMG4V_JD!;!/QU?.O)$]KF4&DH26(C6"1 W,.(96GW6%?8XG&?LYY/-_
M/=]N#VV.S7DWJ1UE%$^-"UI<&!L@1P5">.1X5ZO*/(MC8,=?;Q9P^NA>RRLD
M4.<&EY=&06DA0.&8XTZA_%CK"*VEVTW9VHZ]4"?VO;?D+WSOG0]YD) 6>FP]
M1SUBK5MU?*,.PDLXS#DCV1N1,2$6A)8[R\Y=1C"DXXYAY[OI+#;]LV&\F981
M[/!!.P M:96M<R4=H8C3I&H8$9&G+W(MC'?;AN>^V<3[^3=YYX'DASA$YS7Q
M'LG ZM1TG$',5B6^?&SV/O=A[BWNOYI]/V*W\A>C^\?4H^US;$C4+?-:6K3D
M8+'7=FO*E):OQLLU*G#^E\93B'\M+4W[?E6-^TYTV:UAVZUF[R2S]3SV5V&-
M1[&S.4EFI XA&G HBA5K0N^3-YNIMQNH>[CO/6\%[:E[E8\PM0!^E2T%7#$*
MJ%$K:.L1WR9[[L^T9;>5(UWUJTXWUTV!KFO]?JIL2H;CFMN;BM,4<#'7R9V'
M^#H=VEU.)8>R@4%@H9_W7$?4^^WA:D^'._DG:8((]KEFO=Q],CD=</C?"(H6
MD$QMCUG6\\7$$)Y*&O<@9SMNL\\FZ10V6W>AR1M@;(R9TLS@0'F30-#!P:""
MOE**T;T'\6>Y>FVG>D^^^M6N8:&[F:B-*B.U^N47B$:"[$ZOV3-,HV/4I&XR
M$S^%,S51%CP3J[G)+<<*Z-E?H<(;:PKJ-VY[VWF3<=SVG>IG.Y;N #:R:"MO
M+&W^6\, U:7DN;)@7$%, 37+[5R+N7+FW;9NVRPM;S);DBZCUM2XBD/\QA>7
M:%8 UT>(:"%Q(%7SLQ\?':;9S?R=KJ=&BB5=G.P_2C8FHFB[I40G)JL:;37\
M[!)D<O3&&H(F'R"[A#)2FUE93_$8<QG&<XMDYNV*Q.Q^D2N'H-G>QRHQYTNF
MU=VF':!48A4XI63>N4=]OAO9MXFGTZ\LY(E>P*V'3WA./91#@<^"U=(;XG=@
MZV^4F.VU0F!W^B]NJ_82P3-2'LL9%O:CV+V#UM(TK94)5*VZZU(I@[?*1\<:
M*H!M8P"7?8]MI R5NXY.?K2]Y%.WW9(YICDMVA^DGO8[>0/C<]V6I@+FG5BY
M%4ER#)%R#=V7/+=PM #RO(RX<6!P'=27$99(UC<]+R&N&D(U40!N.%;MTR^0
M>/ZMUCH+GK"-MD/2_P"-J]UU[F:Z[BC]?:U"05C1+HI]LVCJ./,%OUBL-(8/
M;]^*;:.C"GF4)];N,.D/^G:\R<HOWU_-GIQMW7.AUQ9R6?I#G.:FMD4I!C:U
MZ%'$M< 3@,&CS;GESFYFQLY4]!%PVVUMM[R.[%NUK7+H?+$")'.8N+4<TD#/
M$GZ&NM^OK3J7KQH755YG1[3=M9Z7U=KZXV84R1D1;'::91X*N6"=&D)AD:6.
M'EY:->(0\4VV2ZES"G$I7E6,?D&\W<&X;Q=W]JPQVL]S+(QI !:U[W.:T@*
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M#'D:@#I\%"]@.DD:O#7O"6& LP.).MSD18(W+KC&)"$D@I8'+[/I]UG!8#Q
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M&4Y_)R"Q[0"X$ Y89T#V.)#2"1GCE7K%VRJS@!DI"66OS$9'*>3(2,7,QT@
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M,)_-5G%Q#(Z,R =AJ>W53-&V01D]MR^U4B L]:E)22@XRPP<C-0V<8EX@"6
M,E(K.5>C&)*/'(<+!SE?V?QJ$_;]G*%CPT.((:<BF!JX>PDM!!<,PM>8>S5N
MQ*/17[!"3JXHG(4FF'E0)-4:9C*\9$/2$0_D,G&6U?Q;GI5^;G[/LX<Q[$U
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MOO80RZ0"YA*\9RC.4YQY\XSC%I8G1/+'<"G55(I6RL#QQ"I4K3)QJH[[W3(
MJB<"*/S)I+8S'?0H:R\LSZW#GTWTB64Y7ESU>C"<>?/CE$*Z4[59%":E[-6$
MF^T8(-4B9=*F)'HE'X19Y-BAV T30JO03$**=,0PF4&5]C@^5>ZC/ZJ<<L(Y
M"4#7*BY'+I\%4,D8"ES45,QGT57S-HK-<8%*L-B@H$4YY X1,S+Q\6P80XGU
MH8%>.(8;(>6G[<)1G*LX_P!G(:Q[RC 2>H+5G/8S%Q '6:&VBM1I;($C8H(
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MJU)YV;*3"JDX76A0X9<A"PA;:,,A(2VP.VG"/S4X5FK9X^\#M3?_ #$] 32
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MKQ:L1EY<I8FG96O,#4.F:^VE(5N>.LKDEE3]?O\  V)M4=8X9#+&)./:]?\
MZ-"7E89=PKF1\C!)*Q6]YWBXES5"=+2,CP/3AC5&QO,<3P'=WW9& :Y"O0X'
M CB.C&K_ &74EAC*CK@=NE;,<E!M<6"NMMR5%UQMV+?!G;7+SK.O+C3PFX$*
MEK$'($P+(0Q4>,*-CZ1QS&!D9S1D[3(\ZF:=8.;FY #4#BO%057/C5GP/;&P
M:7KH(R:[,DZ2,$X(00!EPK=*W-W8_K]+#N4N,D[](:P2+)4,4QY,.Y/G5YH>
M:KPI+,J&05'C$//--H2<TLAM&$8?3E?N8T&=V+D=HB(/\KBBX'+]'BKT']X;
M4]D&0L\G@J8C\C6BKVO]@2,?N+,91[G]W6#K-:ZC!-NZEKVLF3[&'*Q"PJ_'
MU:N/'RJGFA"U8$7)O+<?_CDB^6VW%K]'O8@8]3FJ)@3VB[#'%3AX4\=>:8I2
MV32UR&$@=D-Q48(,? OBK.^SM-2/WULN(UE21XN(F]"5:#0%"##UV)LQL#?9
M$LVI.R#*10OO24J/N I6^O&4,E8]:TMYSG&O#.-+'3.5PE)QQ(5N?B./BK9F
MMSJ>V%J Q 88 H<EZQAXZD>I8D<G>EDN%>T_8-6U,W4E<@,.3-7 J29>>C+1
M+.D(Q$1CSS#3P$:ZPQAUST.OM,X]&%#H8<72=Q%L&.D#WZR<"J!!Q/Y>-:O
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MZ@AHFD6]O4@,?V ,BH>Y"S8D"<I,SI\R%/C(64=24!4L2+I3T**:R/EMT7)
M[*4I:<S#I)8XY'.<WOR6*0BY.7$<>E.E#4MCCDDC:UKNX&O JF;4PZ.A?"*B
M-4A04R^OVQ:Q<V.SP>XA2=EV@B"MK+CE0Q<#B+F3+V\@-%</U]*T;.6H@9!"
MV%*=%0RVEQ*O3D>XZ7$EOH?=]D*,TP09Z@<_'5&-&IJ!WIG>=HH<EQ4Y(1EX
MJBNFJI9&=@Z\,G9N7#W /;S7-DL :(O UC(&;S*NV'%TVU+[!:J<Q0IAO"<
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M\QS2TZ79UZC7!PU-RK3:@;4K^K=216H9VN3\YM>GQ1-,3K/%=F'#;Y,,/$C
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M40MUYC]HX HO$E/#4R=SHTQ,/<EX50[1D?V1B0J+D%XU0ZNC)Q >O8]<3(#
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MK/Y%M<']WW^+N_\ =;SY9U=J7.$KO*M,[/0M8B#Y^Q2L?!PD6QDF1E90MD$
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ML?'1XI!QYYQ#0@0(0C2WRC#"GUML#"C,-J6XXM24(0G.<YQC',8!)08DUD)
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M!K^[R]K3#@MIN8F+!-0H]G@5NK)2TIU,,AG!R&V4?JRUFK0Z:("361I #=0
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M/L5)+1)VL6#WG?5;"O<;B"W8'KMXP.=,7"Z_U6?.:\;MT_&UKP]%KEH*'F9
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M\QE!#3;JE-+;<PA:=:V=HCE<@*,&>(\MM;-RW7+$U2%><L#Y+N-:Z3M[D8>
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MTY]Y?WU?!/\ 85]_O2S_ +WOEO\ [R>F?_'&B<^4>=?\+L7]'+\N^OJ_D?\
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M4^A+1:GDX0RGW?5ZL>$8_P!F.2"XD(JC*H(: 51#G^NN1!$$[,D#-OQ+M@9
M;26.AT-<RU%J=]QI)#259-0 IY[U)PK&&\J7YQ]N>$=I7'2OBHK=28:D\:5R
M@P\1%B+ C(N.C@7%.K<"!!&$$<6_CP\M8P[3;*U/8QX5G*?*L?J\@N<2I))H
M&M 0  5Z"PD,#'KB0HB,#BG$O)<C!0!!X]:2//OI6$RT@927_5GUXRG\[S]O
MGDESB=1)U4#6@:0!IJI!CP(L5H&,"$C@F,9PR&",R(*SA2LJ5AH<=#;3>%*5
MG.?&,><YY!))4XFI  "# 5!H"BU>J6"R3"G1RIF]74RVBKE41V3 95ZG5VN&
MQ]=<RRV4EA</3T/N)3E;F<9<RK/HQC"<CI'O:&_LM:F'0I./C-8F1,8XN_:<
MY<>E ,/$*G;00;&"4LB#,I,><(,PTPTW@HAY"&W7R<(3C#[SK:$I4I7E2L8Q
MC.?&.8U)SK*@&50FU:XKMGJ::<VPBO1"+!4[$AJ $!!2@RI7"#N8K:&$C9%2
MT;(03;;^<(]66UJ\9PKPK&1DKF/[S-R$8]8(_36.2%KV=WDU0<.H@_HJ7C1,
M4$$N-#C(\2.<P_AR/&#&8"7@K*U%86*TVAA6"5.*RYY3^?E6?/GSS&7.)4DK
M5PT ( $JC^[:W%A@QN (.. ^\!LQ@'TH @?WJV]DT3((OMML_>"'V/>;]M/N
M86CU)^W'GDJ\DE22E$8T 8 +[=,QM;G%HEE 0<PXMC(+<ED4"06H88W+R@T&
M9;>5E@>19RK+>%>E#R//C"L<*]O94BH1CNT@-5CD1%/2#$L]&1[LJ,TI@:3<
M"&7(#LK]7K98-4UDEII7KSY2E6,9\YY&IR:5.FITM74@U5X3$Q"))<NF,CDS
M#S&&')1(0R9)T9'I3AE9N&\%+81X3CTY5E./LXU.32ITTTM74@U54NBBONBO
MOC#O/A.K>#>=9;<=$>=8=%==%<6G*QW7!GUMJ4C.,Y;6I.?LSG'"D5*"J F!
M@36%!F0L06,Z:N46*3'!/L.2.594N14PZRIM9N5.9SE[./7Y5^K]O)#G J"5
MJ"UIP("9UR.PL.0(7'OQ,8\!(.J?/"= %<$-?6IM:WBQEM99)=4MI.<J6E6<
MY3C/^S'&IP*@E132TA$"&O>1B8J890/+1L?*#MNH?;8D0QS66WV_/MO(:);=
M0EU'G/A6,><>?LY <YN+20:%K78. (JL6TTXTMAQMMQEQM33C*T)6TMI:<H4
MVMM6,H4VI&?&<9QXSC[.14]7"J(&(B8Q3ZXV,CH]96!TDK!"&$40D-G XB7U
M#M-Y>P*/C"&\*\^A&/2GQC[.27..9)J UHR % 8B)BUENQL9'1SA[WU!S@(0
MPBS2/SOX\M8[3:B7OS\_G+]2OMS]O!<XYDE*!K1D %KA9@($=J298A(AAF9]
MW[X:9C0VFI7WT+;>^\FT,I2=[S;JDJ]W"O4E6<9^S.>3J<4Q.&7532T*@&.?
M77ALB ^N:4T_#_>6%OP3"FW0OKL.#L_>),,UE*OJ/6P.S[ZQ\?:E"/7E.,8\
M\(Y.*9_KHK5X+E^JJHB,C2U$+*CP25E@KC"U$",/**C7,N9<CR%.-JR^"O+J
MO+2O+>?5GSC[<\@$C(G.I(!S RKT<B(EULUEV,CG&9-I#,DTX$,MN09:9P,V
MT:A364EM-CIPVE+F%8PC'IQ]GV<:G88G"HTMQP&-"(B),-#DBXR.*D8[U_=Y
MY 0SYH/N8\.?1E.M*?&]S'^]Z%)\_P"W@.(" E#0M:2I 457K0AQ"VW$)<;<
M2I"T+3A2%H5C*5(6E6,I4E2<^,XS]F<<BIJS8K5<2R&.FOPF!X]DL<!C$4!A
MD$<]"FSF VL,>@9DU"U)>2C"4N8SG"L9\\MK>JJ5/75=#,D"#JJJS$1.6RV<
MQD=EF0$; /:R$-[9H+3+@S09:/:])(C8[JFTMKPI&$*RG&/&<XY&IW2<*G2W
MH&->"H:(.=!?-BHTQZ,7AR->*!%(=CW,>G&' 7'6EK$7CT8^UO*<_9C\G <X
M* 2AH6M.) 45ZGPD+*N(=E(B+DG6QR16W#P!#'&Q34>V8,A9#3BDCEMX]+J,
M?FN)^Q6,XY(<YN1(H6M.8!JL*%%.&?#-&',$):6R2*4RV0,0RYCTK:?8=2MI
MUI:<^,I5C.,XY )!49U) (0Y5P+BHMQLMIR- 6T>2@TYI88ZFS3&DC):++0I
MO*226TALX2XO"E8PTCQG\U/AJ/2<*C2#P&-5_(JU.*4XI3BE.*5^6'_DTY]Y
M?WU?!/\ 85]_O2S_ +WOEO\ [R>F?_'&B<^4>=?\+L7]'+\N^OJ_D?\ S.^_
MUD7R#*[/^?G=?H].*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI
M3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.
M*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE=5OQ'?\#.P7]_'N7_ ,Y)
MGG=_>!_E+3_:K/Y%M<']WW^+N_\ =;SY9U=J7.$KO*UF[-QU@D8G5C,!:B:N
MZ[NO7 KA T7&RGK?)FD8CRELR3;K2_NHQM+Z6\XRVZK&,+QG&,<W+,M#GZFZ
MOY;N/5^FM.[#R&:7:?YC>"\:PW29+8=0?59H^\)S5)WM_LNBE:_76H9<<_%6
M?<%RC391^?6TJR(GQ9)W+["F26@\,MH:6,M65NJSR"*0:"WMB!IU*>#1@F2>
MWUU@B,K#K#NP9W#2@XN.*YK[757!7MP[^G["!<AX^3;IAFV7Z*]!21FCH>B#
M0C%X=IY(23I*X";9_'XPC"WVVUHQ@H_"6&X_VEH7DZ"V:PQJ.\T:E[9*HO1I
MT_F&*U#+BY<\2(>[UZ4[ ":DXG5J_.>%; [A,'C]C=<I MYL84&_7\PDA[.<
M,L#C:(VF\\\[E.,JPVTVC*E>/M\8YK0 F*4#,M'_ /-M;,Y FB)R#G?_ ,'5
MA+5NV]H2.S=5@ST[;YNL;4B;9(X59:/1*55W6X^ S9(D_6HD>>[LMR+;8]MM
MQ<XEW"F'VU*4EY>$XV)H(1"\M#0]A&1).:=K]E?!6"&>8S,#BXL>"<0 ,E&G
M]I/#4&U'>=A:NTQU\LJ+B+?(*WTR9AV-:"P40SB'9J>L[;;H\Z!EHQC\1EFQ
MY-/;!F,&/%,^\:KVD#Y2A',D\<4UQ*S3I<UP.I3BK@,1EQ4(F7&L4$DL-O$_
M5J:YI&E!@C2<#GP0KT\*R4-L#:E6$UG/R>SX^^L[>HMQFEP[59K<='U*1B-:
M2FP )NHDQ K4D;6Q"X]$<]B5>/4XHIA7N)6KTYQ&*%Y>UK"WNW *IQ5VE"O'
MC@F1K,)9F!CB\.$C2<A@C=2A.'#%<ZIR;KMANI:F8_25<INX[-K:]BR$5KS6
ME D[3'Q"(*M./15;S9&0Z9#52/F["TV\7-Y*.>4\TAMY./<RD(X.\?V&B-AT
MJYSD53B4Q)09#"H,DX8P:W&1XU=EK2408!<$4YG&H96KML.[G];=BREF+<D
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MXI3BE.*4XI3BE.*4XI3BE?EA_P"33GWE_?5\$_V%??[TL_[WOEO_ +R>F?\
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M!MQ,QQ>UQ#CGXLO8HZW@>T-<T%HR\>?LU22VA-+3A@!TMJ^DFD1D6'" X<@
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M=LYT8TH8,N6CF2"$!+>P0Y'/.YQA9<6Z^GUK%>RX.M7VJ1G.<\O'/-$"(W$
M]'Y9]=4D@AE(,C02.FJ2<TMJ6RSX5HGM=U*5G@$!-CR)<*&XZIN,PA,6@MOV
M\,2"(O#:?I<$(=P-Z<>WZ?&.2VXG8W0U[@T]?Y>.H=;P/=K<QI<.KHRJ0LT.
MGCR3$PS  -R8MDD[@.:E"_>:LTS"/5N4F4Y]SQ]8;!$+&7GQXRTK./&,_;RG
M>2$:5*(GB!5/9JW=Q@ZD"JOC(0GV*CD#I34M6D9.7KFO:M"24P)( &EQL6P(
M[]#++RY*!A^UA*8P21<SZGFQL,H=5C&58SG&,XNZXG> U[G$#KZ*JVW@82YK
M6@GJZ?S5D6/ $BP HR/82,!'"# !#(RK*!Q V4#C,(RM2EY2TRVE./.<Y\8^
MW/,1)<23F:R@!H &0JKY%33BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI7Y8?\
MDTY]Y?WU?!/]A7W^]+/^][Y;_P"\GIG_ ,<:)SY1YU_PNQ?T<OR[Z^K^1_\
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M">?F5ML\]_?/W#;+=[]B9=D*0H;&'@AKE/!CFJJYUW=QN<5G:-L[^9C=W=;
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MM&^FW5L-O72T]X[49CVW!SF@D#LZLT(&5=?=Z[5=@+UU;N-Q<V)W=J;ER_\
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MVLX6C*O'/6D<%WS-MUI<LV::!SY"1:1C2>P<)06@'$*T$'(FO:N'RVVQ7MQ
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MW,>X^D65U'H9-8Q-CC+0<6M)\M7%54AR(""B5MC9++N;JW?J=%=R.>\$C N
M'90!$0$*I!Q6MD]*:N8TGJ;7^HP[G>=A1^NJS&U*+M^RI"%E[U+P\,U])$?B
M26K\!6(R4/CXQ#0N"<!-/OML)6^IU]3KSGF7UV;Z\DO',CC=*\N+6 A@)ST@
MEQ )Q14"X($ ]"TMQ:6S+8/>]L;0T.<07$#)2  2!@J8\5.-91YJ5L4XI3BE
M.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI75A\2'_  ,[ ?W[
MNY/_ #CF>=9SA_K[?^@MODQ7-\L?Z.?^MG^4-=I_.3KI*P+V2ZUZG[7:N/U+
MN&'/DJX_*Q-DAY."ESJ[:Z?;Z\^HNNW.FV2,<:/@+/!$K4H<AO.4Y0M;3J'&
M7'&U^AMFYWFT78O+)P$J%I! +7-/E-<TX%IXCQA" :TK^PMMRMS;70)C4$$$
M@M<,G-(Q!' ^(X85IU6OBFTO"1.]'+!NWM5M'9V_=0&Z#L>_=L[7AKUNBIZ>
ME%*7+T/7L])T=-;K</+J6I1&5Q)3[CBE.>YAU2EY]J7FV^D?;B."TBM;>82M
MBCC+(G2#)[P':G$<.T!P1*\N/ENU8V;7-<R7$T7=F1[PZ0,.;6DM0 \>R3QS
MJ2VSXKNGD_JG5&L:S0!-2R>E9S5-GH&Y-45[75:WA'6/3[H#U<G)"_&T295-
MR<J['X7*NEBO*.==6[GTO92XG%#S9O4=W-=2R&9D[9&OCD+W1%LBZ@&!X0!>
MRA"9985DDY<VM]M%;QL[IT)86O8&B0%B(2[25)3%1CGG4D9^.3KRYI?MQH:=
M5=+;0^YF\-K]@]F-V23KQ$K6MA[:77RCB=<EQ]6C1X,*G2U8".@L',R9(I;.
M%$/E(_,YC/,NY>G6>X1Z&7%E!'"S2"CF1JFM7%2X.(>A:",@*N-BL?1+JR?K
M=#=S/E>I"AST\E $TD M52#F36?8;KW4@M,0^FK#-VC8:(;6?Z*T;-OOX6E]
MLGP*(0F 'DY.S@U:*CBK*."3E7UF $9>(QEYY#KJW5K\Y^XS.O77L;61ZI>\
MT,U",%50-+B=*\%P& 0)6ZVQB%H+21SGI'HUN0O(1%)0!4XIGB5-:7TWXB>K
M=)OO6+9 $SMB2LO5'3$[HW7JYF?II <]5ID38(@TO>A@Z"#F6M%<SLV5>C2
MU1X[#ZVUK8<]&,9]N?G'=I[>ZMG-A$5W.)7H'*' L*,5Y1KM#=0*DCB*\J+E
MG;H9K>X:9#);1&-JEN(.K%W9"D:RB(!T5LWJ#J%1-'=1@>F^O[GLR/H<5K^[
M:\B+V_+UES:D2#>2+&6=/ 30]0%JS5EB"K,\X \J&4PTMIK+C+OI5Z_+O=YN
M+_>#O5PR(W!D:\L1W=DLT@ C5JTG2%&I<\17H6NV0V>V#:H7R"$,<T.4:QJ7
M$'2BA<.RF6!K7>;^(SI1*]8X#K''Z[9J(U9AZ4!#[UJ$)KV&[(BS-(FHFP#7
M5.TLT0E6+?.R<5E4B_@' [S93[3;#+2D(;])G..^,W5VZNDUESG$Q.+S"C@1
MI[O7Y(!P"J$!))K1?RSM+MO;MS8](:&@2-#1*K2#JUZ?*)&)1,2$ INKXJ]&
M[FNM^O(^V>SVFCMS1H,;O^"T1MYO7E-W^@.,:A7R]I5)-8E80P^7AT*&.<BV
MHKZIEY["\9]YW*ECS;?V4$=N8;6=L!)A,L>MT*E?Y;M0( .(U:D0= I=\N6=
MW*^82W$1E $@C?I;)@G;:A"D8%$4+TFM@]M=+M*;8ZBR?27(D]KS1QU*JVOP
M M='1P%@KU:ITG!RL.Q#REFB+6(X9E^ 9P00:*8\3ZW5N*4\O+O/.L]\OK/>
M!OJMDOQ(YY+P2"YP(*AI;AB4 ( PX85O7.U6ESMAVE#'9E@:-* @-((0D'HS
M(*^&KCL/J7KG9>S.J^U)V:NPEAZB2-LE-;!Q,E!,0TV1<::+1Y-%X',K9YTD
MRQ$B)<8P 1&*21G*EY6CPWBMMO%S:VMW:1MC,=X&AY(*C2[4-*. &)Q4.PJ9
M]M@N+BVN7EX?:DEJ$(=3=)U8%<.@C&H KX_-"K[O?]?67;I^F;-4'KCD#][P
MV=;.RH=5+H0=_<@%5Q4[F^B4,YV%:+Q*8'1'N*1@?"U*7G8^T6X>HOL]V/0=
M>I4.M"[7H54T:QJ32J\:P>I++UOZZ[?I>E$4:5TZ=2(NK3V55$X53TWXYNJU
M?N&^=@777L/OBZ=A]FS.R[C9-\U?7VP96"3)QPD3'T&D$+I49FOZ^J\<+[,<
M*K!!J$+S[Y;^4MY1,_,N[20V]O!(ZW@MH@QK8G/8"A4O=VBKW'%QP'0!C2+8
MMNCEFGE8)I9Y"]QD#7$*$#6]D(T#(8GI)JRL_'%IIOHC(_'F1?-RR.DS8TF%
M%L4C8J<3M"%@WM@(V,+#1=BS0DP"@(F71@43ZJ))<:CL89]:O0A:;GF:]]?C
MF,1P"^!5 UW=DZ-"D:U4C$HX8XU0;%:C9CL9?*;0A%);K U:D!TH@. 4'#"I
M)VEZ(:^[5P^C(^>VGO34\OUXL"K1K>ZZ1MM7J5T!F<UY%:P43,3U'MS:5HCD
M9RE0K(J\.*SGU>G/IYCVG?[G:7W#HXK>9ERW2]LK7.:0NK(.;QZ2:R;CLT&Y
M-A#Y)HGP.5KHW!KE1,RUW#H2IQUHZP&];_QK]7V8[3]BOQG^&_;_ .I?9,#L
M/\'_ (=^_O7^"ON.D4W[H_$'W[C[R]WZGZCZ$7T^W[:O7K[INK=S[M+6TMM&
MK_P,+-2IY2N<J)V<D4YK6:PV\V&M;BYGUI_Y7!VE%\E&M15QS5!5XWYU?H/8
MNP]?[+=I>X19W7#===WQ1VJM(0H0DK;ZR%(  1UK;EJ_./'5MUF2<R\R&X"4
MI6$^DA.,9QFFW[K<;;'<10-86W,#HG:@2C7$$EJ$([# E1U5:]V^&^?!),7
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M(4:-&$Y0PA2"D/*(>?VY>;=QEN)IQ' UDMBZT# TAD<+DP8 Y0X)@7%PQR1
M->/ERRCACB+Y7/CNQ<EY<"Y\H7%YTX@\0 #UJI,8@?AUZIU@2XAP,YMZ,:NO
M;JD=R#\CV&E87'7K7<S9)RI4"']>O5)'U/%F6P_"07</2OH?S_\ 2.%>59RR
M<Z;O*6.D;"2RS=;#!V+'AH<\]O\ \A#1C@W#R:QLY7VV,/##* ^Z;.<6X.:2
M6M'9\@*<,_\ JJ\;%^+2AV+86U+WJ/LCVKZN!;[F2['O"BZ V1#5NEWRS2;.
M1IRWBQT_4[(14+C865KP>?&O,Y(5G"O;PK&<YI;<V7$5M%;WEK:7;K=NF)\S
M"YS&C)JAS=31P#E2K3\NPR3R36MQ<VXF*R-C> UQ.;D+3I<>)&=99JOQW==:
M#:>EMDU^):Z2)T1B=T1&FJE!R\:Y69=.^JFQ4[](;#^^(.5L5AEB$MN2#) L
MA'KS)$.NO^^A6&DZ<W,FY7$5]%<%DCMP,1D<0=0[IVI@8A#0.!!![( "9UM1
M['8PR6DD <P68D$;00A[P(XN4$D\5!&))*UD72O4;6_7_<'8';FLYN[P[/9*
MQ15VONK')*!>U1'; !"^CE;]3X-NM,6" M%QPI3LRO[U>&/>RE664^RQAK6O
MMXN=QLK>SNFQN-JTM9(A[PL)4,<=2%K?V>R"!QQ*Y[3;(+*ZGNK<O N'!SF*
M- =Q<T(H+OVL4/1@$UQWW\4W7#L6=V[DKY9-N"'=RYCKC/[!)KM@IH3E)E^L
M4&Y6Z&;JY4E09?,*]-0I+[$QF4^^/J$$.?3?2>4^GT]OYMW/;6V;;=L);9-F
M#-0<=0G.IXD1X5"A;ITH@5:T+WENPOC=.F=*MV8BY"WLF((W0K2BA0Y=2K@E
M6N^?$=UFOS.V!"[-N& CMO5?J]3IF,K5@I(@-?@NI*(IG6 U41(Z\E70LG,0
M[+<MDM9N"$>?I\"Y\9Q:WYQW2W,)#87.A?.X%P<I-PNO4CPJ*=*(G%:K-RSM
M\PD!=*ULK86D MP$*:$5IS3M*J\$J3[\^,+26]-DWG:<=M#LGH&R[=AHZO;R
M&ZY[==UU7=YPT5'XA@@]G5XR"LD;*.(@?4 HD- !;@CKB%.YRXM2L6W\U7UA
M;1VCHK6XBA<3%WT>LQ$E26$%I&.*%0J885DO>7K2\G?<-DN())0!)W3](D "
M=L(0<,%"%..-9-C^A.@X"\=+;I3QK/26.A]>VS6=(TRN2<8FHEQ>Y*(!0+5F
M]MR\'+V.P'LQH&"QR6)(%]R2>=?+45[F4\U7<P;A)!?03%LAW!T;I7.!U+&\
MO;H0AH"E""TC2  E;#=FLF36DL0<P6;7B-H(TH]H:=2@DE JJ"JDK42,^-7K
M7)O=N(R5'N4EK3NF9$V#;^E'YJ)9U<!?HM([KFSM?@@UX2U5"_3$J(U('%MR
MSK)![+3N6<>PPEK,WF?<VBS<PL%U8@B.5#WA8?V'DDM<P# #2H"A<2N([!8.
M-TUVLV]V07QJ-&H?MMP5KB<2=6)0I@*QYKOXM*'7-AZKO.V.R/:OL[%Z$F1+
M'H[7>^]D0UCHE!LT4S@:O6\F,@JG72[=<:L,G"(X^2?>R/Y4KVU+5A2=FYYL
MN);:6WL[6TM7W#=,KXF%KWM.;5+G:6N_:#0%K!!R[#'/'-<W%S<-A*QMD>"U
MI&3D#1J<.!)PJQ?_ 'IBHQ%WW%=-;]U?D TNWO'<NPM\76FZBW7K^HTC&P=F
M2_WM9#XR'_0T>4VSA+3 K.222B<""LH<><RCU9R?:^9\$,%S8[=.8(&1-=)$
M]SM# C03W@ZR4 "DH!5?LU$R:66"[O8N^E=(YK)&M;J>5) [L^#$DH!C6R(_
M132[^S]P[3MI]WV+)[XT#4^N&SJ]>Y2"EJO8J%5 "8[ZX@<*LQ<TJT6%@QU4
MB4LY;+CB\K9985XSCRSO]\+6&TA$<3+>X=,PL!#@]Q5,7$:0G9"+TDUO#9[0
MW$MS*7R.F@$3PX@@M 3@ 5/$KX *Q]K'XR>NVK.E%_Z%Q<ILFPZ4V*U=4RTC
M:INLG7R-?NK[)JSH67C:=$03!M;DQ&"HM;\83AHAA"GL/XQE.=FZYIW*[WR/
MF!XB;?1:4#0X,.G!""XE'!0Y'!0<$K#;\OV-MM+]F:9'6DFI22-0U<00T!04
M(4'$8K7F6^,[0$OT.D?CT<L.TQ=/32P2YRZC3]6<W!.S(VUX[<AEBF+0?2C:
M[(STW;HU"3'W(?/K#5EIM+><-K09S1N+.8!S'IB-ZU4:CN[ [LQ@!H<' !IP
M&K/'&CN7[)VS'8]4@M3FY1K)UAZDEJ$EPQ[.59<A.F&FHO:_<';,HW8;B5W?
M@=6UC==)MI4*?0LP&I]=RVL(B+K$6# QDR"-/5J9?^]/K9"04Z1G"F,C)QZ,
MZ<F]WK[.RLV:6"P=(Z)S5#UD>'DN))!1P&E ,,UK99M5JVYNKEVIYO&L$C7(
M6HQI8  @.(.*DXY)6NQGQ4:1?T3HS2PNU^Q,=-=7YN<F>N.^0;[7X_>NH!IY
MS.2:E VV(I<7%2M'2'AL'[NDHXSU1K#0V7?;99]OTF\VWXW"XOC#;%ETT":(
ML)BD3]HM+B0Y<5:X=HDIB:T3RY:&SAM!).'VY)BDU 2,7]D.#0"W@A!P "X"
MKC1_C U)!0O8A[8NV=][VVMV;TM:>O=_WMM>XP<UL>OZDMD)(0IU.UDV-51*
MA2XD=9^3VVONLM#DDA+SV'48]KE9^:KR1]L+:&WM[2UG;,R*-I##(T@AS^UJ
M<<$\H=G )G5H>7K9C)S/+--<W$1B=(]P+@QP0M9AI:..1QQ*Y54W/XLNLMY>
MZ+R4L3L,6S?'XUJ,'3=QBYBK#66U06F%50BJUK:I+M,)!LD&3(4\<HEL >)=
M00^3D1P5)#B<U@YLW2W%^U@C,6X]X9&D.TM,NK4Z/M*THX@*78 *"@J9>7=O
MF-FYVL266C0X$*0S2@?V<0K02@;B2B+4&OGPZ]4]DQ$]#6N<V\:-8^[U\[X2
M3J+#2D$JV3LL.,!N6NFEKUZXVG3<NQ#"^N/4E4QG+*?,IG'G&=BWYTW>U>U\
M+806V#+08.\AA):_R_\ R!3CY./D5AFY6VVX:YDAE(=>.N#BWRW)J;Y/D%!A
MY6'E5<]E?$QH;9,5>P%;4[$TB3O/= +O?^+*!<:)"6RH[PBZW+UN)12Y0W64
MNW$56);F%%C-NM$R;1K+3F#O2G*%4M>;]PM7QN[FVD;'8FTTO:\M=$7!QU /
M"N*(<FH3V:M<<M6=PUX[R=CGW?I&IKF@MD (&DEA0!5&97C5?(_&!5[5J#=6
MD-I=O^\VZJ1O"LP-8FVMN;@HUN.J3,!:XJW,2U#RO4H<=#S9IL.T.2Z4,<VX
M)E2$MH7G#B8;S5+#>P7]I96$$\#BX=W&YH<K2U'_ ,PD@ J$(QJSN7HY+66T
MN+J\EAF: =;VNTH0Y6]A <$*@X5DRY_';U\NO:;K]W#*_&,+N7KO6G:E!&5^
M2@ X2]PJ8*4K\2WLL JL'F31=>!FS/HR "8Q['O^AY3S+3#36I!S)N,&TW.R
MC0ZRN7:B""2PJ"=!U !2 H(<,,$)).>78[*7<8-T.H7<#=(0A'!"!KP*H"4(
M(ZU  &7O^F"@_P#5W_UH?>]P_2C_ -.'_3!]P_7POX!_ /Z3?TK?>_W7^'_Q
M%^,/Q%_$_4?>OT7T7YGTGN_QW-/UK<>IO4FEGHGI/?JAUZ]'=HJII3%-*KQ3
M"MKU?#ZS];*[TCN.Z11ITZ]:HBZEXJB<.-;'\\RM^G%*<4IQ2G%*<4IQ2G%*
M_+1_R:<^J_[ZOG?^PK[]>F7_ 'O_ "V_WD],_P#CE1.?/.[?\?V;^ED^6?7[
MC;_\CW?^IC^1979SSFJ]>NL?Y>]R;<T/T?NVP='WL[6NQFK[IZN1-QCHV(ER
MHH6V[-K-<EE(CIT(^-)P]&R+B%)6WY\9_-4G/A6.IY-LK/<-^CMK^,2VW=R.
M+22%TL<X8@@YBN?YGNKFSVA\UF\QSZV . !34\ X%1D:Z&NU_P G?=>/Z8=<
M%:PW/(TSL5JFA;LL?<N6!@*D?,.E:P[*Z\ZH5])XLE &Q,?FQ7&W.2"U,"CI
M\9:3A*<K4VW^@;1RML;M[N?2H _;9I(FVP)<!VX'W!1""=+6IB3Q\)XW<N8=
MV;M4'H\I9?1LD,Y :O8E;"%4(%<Y< .'BWIWAWZ[/ZVV/\BM I-W#(LP_;+I
MAU=ZRE6B"A)*N:8/[!TDTRP6A<:W&-N61 :X\@MIF148U@SVO6A;&%L.>#8<
MO;5=6NVW$\9$7H=S//I)#I1"X -5>RJ@*$P7CC7L7F];C!/?0PO'>>DP0Q*
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M@Y>?ARG VEM//NO%H&PM[VU/YDG3XS411"<HW#2W% 23CP \./LUE2,N7UE
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M)N6@R=74=;$ZQ!26 AAXB$38@Y:'(*)P8^MPR+C(Y@):LXSDC*,O9RE2LHQ
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M>N=JRMT9BI@>DOTB'@V$6MT%$3>H\Y-KN;)CTVRW%@NQXCL>T0Y@S*\BMJQ
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M/UKT!*D:NPM+"B;/)6*&O%/,JP43(DUVT58F/L,J%/RK,! D5\1IXH683+6
MAL%.&W_4P4XA)&&<*3G,ZQQ6J^C2$@-+7 G,'##$KT88UD2D78.\QYQH\+9Z
MZ5%R;D1)PMNA'X*8"-0*(<G"F'%O#%BOA'M.-OC//L+POQA?J2I*9!6L4D9C
M(!(((S!44OE[A-=P'W_.(D26WI.*A(V,APE2,Q,SDX:U'1$1%AI6VEXTXMY*
M4^M;;2,>5+6E*<JP)0+2.-TKM+4R7'( 9FK#"[<K4S^#V7(^SP<E=+'.U./A
MK' %Q$J#.UR!F;)*"2C#^<M--)BH-Y;;[+CX[V<HPA:O5]C4*LZ%S=6((: 5
M!7 D#]-6V6WC38P92AA;+/RKEUL% CJS7H1V2L4S8JLEYV?1&@X=99S'1@HZ
MWG2WG61T-IQY7A2D)5&H>W4BW>>@-T@J3@ <JQT?V18;N5.&B:Q<YN"L=(V(
M>16(RER;VP1+C2K;48(B+,BR'Q6HMF,%/D?J<OJ2TXXVUAIU65M)=C7CXJRB
MU[#B2T.#FXK@A!/N5L#6+A 7"IQ-V@S,OUV9BFYD,M]AX1Q(:V\N+^I%(0@@
M5\;T*2ZVM.%MK3E.<><<N""%X5K/8YCS&[R@4K&$!V%I,V6EHN)NU4CS*S-7
M&"G[?5C(2%LM:KS YDO)PCRW'S%I%C2VBO:(8'?<&7A:$*QC/BH>#TUF=;2-
M&!:2H! *D$]-2;76UX;96"/NV ND!EN,B9T/\6ULF%:F(*<P0J+EX@O#A018
MQ.!E9RWEU)+6/'N-(]2?,ARU26%T69:<2,"J$<#6.MO2FYZW8JH[4[]2HZOW
MB^5^D@1$OK,^:D('[RA) HJ3(FF=AQ#4SY-AW%H9P()Z4/I1[F<M^IRKM0.!
MP)K+"('-.MKBYK25#D7Q:2GLUFA@\JGTU^7V'98HURNQ,C+6>SAPSU=B< QZ
M"3B3T0RY6P/@L!QS?YZ?JGU*RC*L?[V$XMD,:P('OTQ@XE %7V\*QF#V(I+P
M<L;,0U]J*8Z*CYL$:TTR5 .L\7+RH<%$O5<,9)S\H9)34D*(T%G#9_OELI4P
MGU\C6*RFVD4!I:Y2F!&'''Q<<JL<]OQ+@<>-"PD_5[2WL;3M?F:WL"NOQ,IB
MJ;'V!&U5R;C6FS' SAB1E&-LD,/O8'*9REY"58]&1=[*BK-M\5<06:7$$%<6
MA4_-XJ1&_6@8I_-DB9FP6.2VQN*CU:MT6#<DIB1A];6^P1F35"OFLL?_ $=!
MQC*RW5/(]QUS'MHSE6$8:NG-30VZGLD!H8TDD\7 ?IK/E>G0;/!1-AC4FH F
M@!I$1N1 +BSVV"FDNH;-CCV6# BF\*]*VW$)6A6,XSCE@5"UK.:6.+3F#4"O
MFW(>AR3,.NM7FVRJH9^Q&@TFM/3BXF!8><&^\Y-Y9 0C3;Y##B&64..%.Y:7
MZ6LXQYY!<F'&LL<+I!J5H"IB4QJVD[XHS<C5HT!NPSF;94H*_A'P\*\_%1U$
MGGUCL6^>DB7!!8>$"5A"B5.JPZTVYA?H4E+F41J%2+>1"2@TDC$XJ. Z37+4
M=W5:X347##PUV@TV00H^FR]IJDA PMT##&^N>=KQ9?\ &Y=S&?\ JT#EMB$N
MBX4ZAM2$+RD' E,:A\#V-+E:4S0J1X?S5=+SM>#HTI&5Y4-;;;9Y:/.F1JS2
M(%V?F&H.->&&-FSF\/"B 1K19C3*%//(6^\O"&DN*QG&))3#C41PND:7*UK
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M.:U7'1ZB:XN[V5DB7&D(*G,8<]^6,B'( W);BDLBL-#..*=]M"E8:AUU)M9
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ME%XO.H)]J+UM63HL+[IUW>XZX3BY"<,8S+2DG.-A8;&'RTR*+EI/E2\K6YB
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MMVNTS55CSC!W8QN-'KDA(Q[3(9B2UJ>?]["VVVD(==:AXJOW$A1H:[O%(3P
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M(YLX1H2%?>DO4MC"2!1E>UE2LI\P7M 6LC+29TG=D(2TGV/UX5,]I;;K>K*
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M:QJG;?XN?V W9@G'YV"6JX+%."KCHC,@#..(LF/O3+KN?+^%^Q[Z7E+9D!V
MX U5TL)UR:CK>Q$3(X<>C#"I7J?5-OJ]VJ,W/18K(4+7^QP;[Z30"G!CMB[Z
MC;O5O9;9><=RH^J,O.+6C'AG.<M.92M7IS+6D''K_/6.:9CXW-:<26?PL0^W
M6((UZ6Z]'ZN?G&:6Y85Z;GZ?(5VU7>+HXT:W'W;[_1,15KEAB:W* Y^\T(E
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M'J6KU><8\8SR"%3PUEB>UFO5Q80/#A6)J/JBW0,)U@",BA!G]9V2YR=P0R:
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MI"'2_8[*\J9GI>0 A"UGE-(2S]5EWQ^:XG*P:01XZF69CV/:"JEB8(H:#P&
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MVV''1_O)J+<<((0AEU*T>]A'A*L*QY\^<<C X58"1@U . Z<15T$LU;/ECH
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M$5J7CW"8)K#:GLN3+"",NQ;>&497Y?PC'IQG/ZF.2HJ-#T!0H<L,_!5O=O\
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MHE_$/(QIV*\? 0A4Z0//LLEJ) ??'$6AM&4>OUX^W&,8SG$:@J5<0OT&0A
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M,_[>9 5K2<TL.DYX>V%KKLH=2V'G86GY<[7%BJSL%LV>E;D%':T@86 K6;%
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M>,_;D8,%XUIW4A=)H7L !!PR"UALFH+MU\B(&S1,I(UF0[6[2?E0GTR+<>;
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M1_R:<^J_[ZOG?^PK[]>F7_>_\MO]Y/3/_CE1.?/.[?\ ']F_I9/EGU^XV_\
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M.#QR'6VTN(!8<7E2&<9]M.<YSC&,\5*DX$X52.5ZO/($8>@X9UN.;); 9<C
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MA*<I\9<5CQCSGC#Q5(+BY03J]NO*8^NR4=F*0%"GQ(+^!,QJ1@2HX0F/<3G
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M:<834.<N-9WPQ&-8P-01<2'#)5!P13@E7X;<MN>JG7^0Q-Q[DM?="6^^V9*
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M<^>=V_X_LW]+)\L^OW&W_P"1[O\ U,?R+*[.><U7KU8[)6:]<84ZN6J%C;!
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M*DX"1C"A!'V\X<%C'098EOZ1O*14X=SG#>%>,X!K1D*R.N)WC2YQ(_+W,ZF
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M/IWW"S67D*4TG*<H%SD)"8"H9! ',C>7$O<0""$ #M/055/$*G\WN6S1L1V
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M79@]YXIYHEV3L<9(.,*9;9;^B]G\U2O4M5@5QX5KS1B(AH75I!/A.*>PGCK
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MI4WL\JK14?LNW+C%(I%?G8*<-CRR\)9>*9<=1'LI\Y:5ZT93*D##I-1W<3Y
M'YB-B!0U>R.)!'NUM+3-A@S>K8?8DG(1DH.J!7(S1U)C;/+1SAL;EX6;1"0K
MT3^+W<C2(CS6 W \GM.(RTM&7$Y\W!P6M22(MF,0!&."IXE.7C5*K0+G!WBE
MSTY753/T+8<P%ZINLV>I'8)'C\N+RF+M<1"2N6<)>3Z7L,^TO/G"59RE6,%!
M&%06.C>&N1<,B#^8FM.(#:,Y0]8U*8A8:O24[ ]--/6D.1F4RSA1YIAHL5F+
MDGQY1AM45]N7L90TDC#Z\JRXI/A',8*#_P"HK==$V25S7$AIG<,*E]JV3V&K
M.=R"*FM4%D:=H4;MHT]--LS3,_%2D?:3FZ*-&YNBUQJAE4D_&9=1+ZW4N,8^
ME;SEQ29)>%RP"U1D5L_04>CW:<QAECEUC#PXU8K_ '"^2L[/,T0BKU$AKL7H
MV'+,*CK&>_/HL&N==SH&+%]WVJ(;-$$,/PP0RRD=!(0[2/"7<+>6)/#I%6C9
M&&CO%<.Z<>&".(PP-2@#8FP3+4Q1J$Q0:L_:-K;ZBY*=E8&P3J0AZ(3#O#S3
M<0U;(I,C-2BSU)(1D@<;*U)<0E&$9:<*50)F:H8XPSO)-1 8S!0,UPRRJNKF
MW-K7T77%4@GZ/6[Q/";=D+99)&"F)VMMC:?V"SKDAJO5U%CA#W"+/+EM$>'C
M\_1"X<QX=7E*DR'.* 9^Y1T,,9<]VHQC2@5#VAJQ*'+P8UE;4ESNVQ=2)LDE
MBJQ=[(.V-!-K "E#*B-+U2ZVJHQ)2@7)=N6/C,YA&72$),8<?\K]M3/J3A$M
M)+5XUAF9'%-I"F/LGK0@'HZ^BM2-2E;GL#O71R,N-81:)OK=>94FQ6*$L$\R
MB&=M.IB!GY&,5:A2)ZV.E.-M/F++89RAYUU+7G&&ET;J*)FE;DP@;WJM.@2C
M $#%'=6 ZJEC_9/9UC%H<;58!,?/2VLP-@6DZ%UO:=IB)-.L$[61(F-AXFR5
MHB(BR#JP6ZX2440ZVTXTVA#B\+<Q.LE$Z/#5!:PMU%Y5H>@5P;P!S0KGT5M;
M2[=/V'6,7<9ZNOU>QD5\H^1KY[!;&0Y()!+;F/IRL,&H!,=&]YE+GI=^G=1Z
ML^K[>7!4+QK3D8ULI8TJU<ZUFB]_;3K=-U_LW8(]'G*YLK6EDN0M;IT5,1$G
M69*L:OE-GM-*EY*?G6Y@&=BX(EEY"AF%@%NLMX6_A*EN4U. !.1%;9MH7/=%
M'J#F. 4IBKM/0$1?&*NE@ON](",  L4YKDHO9VNKO,5LRM5VQ1:J)8JY5TV9
M0KCKMO-?M,4[$Y>0T:VJ->:,0TOVU(7Z<2KAT8BH;';N*M#D8X J1B"4Z,,>
M&.%0.)W3N*/@M=4>&:1*3L7INA76PV.)U3<]BXE5VK$NU68<B-C[K'$P_B)@
ML?>,F\60X68I:QQVTX4A-0YR =715S! 7.D=@TO( +@,D4Y8YX#HXU/"MN[P
ML3S[%?C:;K\F#T+6=NS\9=*W8IR6Q9)&6O<>;44-C6*MX#A2\5)*FS%M*)81
MGSEEW+N,,6U..6&"U00V[?*+G R%H0@888Y'''*L>778E_,)VO="EU21ICG4
M*B;"&H,J!92 TN6%-X(4(20':H]E9+\P 0DTEED=PF.2&QCVW!U/.U).)X::
MR1QQ@,8-0?WQ"X<$ZNC+K7IJ:;>[!7>E6BVKKTC7)&#HLG7@C*Q&:WV);R#V
MCF8DB;5;=FQ[T31M='BHE/2,*O![N,X;6[YR\EI,N<0<,A5(;:-[&Z@0YP..
MIHZ41N;LNJLT:;==<LO89+CCCB6=YOM,X6M2\--?HEU*Y[;>%9SA#?N.*5XQ
MXQY5G/ZN<\LW,^'] K7G\B/_ /I__P"SJPM-]@KO'[(!# DJY-5-_<,#JXB$
M@M;[$D00(Z9M =05+RNZ"7HVD,6P64+4IR)&$)0TIA0N75.I4[FNHKU+^6-;
M#;:,Q*00_07*7-X!4TYIU^.L@5VZ;EN;Q5T@)+6,90TWZT45BKV.+G&IUJ-K
M=KEJ.NT$6H:?P(Y.DS\9[K,/]W--/C+0Q@I#R\/XD%QQ")6-T<#/Y;@\R:05
M")B%1$R3BOBK"VO+=MAJIZSRY^#;E?YL3LM(U*4DXRS^^T;73FU1T08X]<5K
M)3-3V'VGG<J3AH'(S;:4K9<=>J"Y!TXUFD9#K?Y38QH7+CXN ]M:F%SWT[<*
M7:Y:KPU=FZ9$Z<I]TG6IUB4>7^*[W-BK@JN_D&6B'6DQ$'&EOGM83[N'7Q?S
MV\86AR2Y0>A*HRW[MX#R1(7D!.@#$\<RB>.N.!V!M"F3>X['892MS]+BNRM<
MJDVPF*L+<C6ZI8*=08M4C%%$6<\0*-A'[#$$/M8%6CRU)/\ C&"6\#%(4G):
M.CBD:QK00\Q$C+$@GJXH?:Z,=B=2W:4V'7)2V&,1S$*?;[6'2E -D(=.IL'+
MOP,5+R*WRB$/%S9$8^8VMK#37TC[.,(]6%+7<%0M:TT8B<&!=6D+X2%3Q5@6
M%V[N*1@-<;*>(UXFH;?G@JY7ZHFOSN9NGXMC<BBDS,G8,6C#%I?&+88S+@MA
M1WAI3F&7DY;\YIJ<@."&MAT, <Z+M:V!25"%,PB8=14U)^H4))@:>CYZ<>B#
MINYR<E8CI2-&F&39'WB%#^]/D3,Y..R$Q]6R_G+S.1F/94VC#.%(6MR6>2IS
M-5O7 S:6KI:$X>T@%8\J.S=I3L#1:YKUG6]-09IZR;&,(D:]9)P0,J#MRH<>
M%B8Y-N"=0)*>^GW7GR'ECX]:TI<SE*,0"4 "95D?%"USGRZG=L#,#,*N57&+
MWEM@>)@+98&J(]%['Z^7S<M3@8R)FVR:G(TZ'J$U'Q4U,D3RL6<*5 M[2B,M
M#1RVGF\H;SZ<>XXU.12F(6H=!"I8W4K9 TE1BI(P"89==<HNP.Q4A*#0*)K4
MX1MBU*WM\&0Q3[.4-6V1'QQ2*8H)5R:<L"I B2&_^EE/">PAM[. EY6WA!7Y
M89+0QVP&I'H'Z<QCUY8>#VZF-3WA8K($1(.1D&(S_P!,.N=X#M8:.6MJQ7-J
M[OG1A#RI!*'H,1%;'PTE*&W\94YE3JO4G")#B?86L;[=K2BG_P KF>()[>-0
M@W<FZ)R.L<I57]<0PM*T+K;<DJB8K=BEWYN7M<-;Y@^L"_36V.1%P[Z*LO#9
M6??(&^Q.4O>YZVHU..(3 +600P-(#]1+I'-P(" )CEGC5MM78K:1]AGA->58
ME0=/A*?(%@MZTM=_18YBT5")NKD059H*?@@Z< /&S;##;^1)!Y3V''%-I;2E
M*Q>5PX=569;0AH,IQ<3^T @!(R(*Y=5;JPA[\K#1$H3'%1!,E& 'D1)R?0=%
MOF"M$.QQB<I1E)03CF6G,>,>%IS]G,E:#AI<0"H!JY\5%.*5U8?$A_P,[ ?W
M[NY/_..9YUG.'^OM_P"@MODQ7-\L?Z.?^MG^4-=I_.3KI*<4IQ2G%*<4IQ2G
M%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4
MIQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G
M%*<4IQ2G%*_+1_R:<^J_[ZOG?^PK[]>F7_>_\MO]Y/3/_CE1.?/.[?\ ']F_
MI9/EGU^XV_\ R/=_ZF/Y%E=G/.:KUZCMIJT-<HC,%/CN%1N92OS/LM$/BK^O
MK$_&6:'=]X=;;OI'F(=AQ2?/I<2G*58RE6<9$+@:LQ[F.U-S0CV0A]HU!;MH
M_7>P)=V=GX^:9E#8IN FB*[;K74L66O-./.H@K.S6)F)9L$6E9"_2V4ES*4K
MRE.<)SG&8+0<:R1W$L;=+2$!4* 4/2%&%8%W#UHG[U+38-8&I454[-4X>H/$
M8LFP:H; 1L3'KB@_JZ;5',U#9F8-ES+\5B46'D-W"6E9>8;0G%',).&5;$%T
MV-H+]1>'+D"OC.+5XHJUFNW]?-87D@HJPQ<P\[)5=BGS3<=:K+" V&%"8*9B
MT6&*AI4")FRH;)SK@;Q+#C@[JL*3G&4-^BQ:#G6!ES+&$:1@5& *'J7$+57-
M:*UU.YD'B@)@.0/L,1:TS4)9[%7YV-GX.HA40&0AIJ%D@9*+5^%0$".H9<2V
M^E2LN)4I6<\:0:AMQ*U$1 "$(!"$KB#UXU0M=>M8#5N8JH4?/ QDU:HR]%$"
MW*V-SK-SB1XL8:T!654RNPBSCJ(=A3Q"2?<?=2IQ><K6I66D(E3Z3*7!Y(4!
M,@B'@B(F-50V@]8BV=NU-Q$HHIBPJN+$,[:;.[3V+FXI;CMP9I3DNJJ-V9UY
MQ3N2\">Y[^<O8\._G\:0JT-S*6:%"(BH%3H5%3QUXN6MR<:RO='UW'U[!5\)
MN3TDW<#Y94.DC8\A)FVV3<^D#E"WUI(F7WV \);96K&&?<91GUI$8$#C1DH[
MULDI*-3+/LY?FSJ>TFIQM$I]7I</C/W95H&+@0UKQC#K[,8&R)@E_P 95ZB2
ME-9<=5G.<J<7G.<YSGSR0$"5BD>9'F1V9*U9(K5M,AI>-G(^/(:D8F;O]A">
M5(&NH;E-FR>9BWOJ:<>4VX@\_/J;0K&4,8_-;PG'V<:0JU8S/<TM)P( ][E2
M,U;3(=JE,@1Y#3>OINPV&KX5(&NY"E+0'8@)EY[+CRLF((&M1N$H=]2&\N8R
MG&,H3X:1[%#,]VHD^4 #XD]P4@M6TRN-:_9B8\AAO6$)(5ZG87(&OY BY,,$
M QE_+SR\GK<&CFL86]ZUIRG.<9QG.> T!.JCIGNU*?+*FHV;H'69\?6HYR,F
M1&ZFNQXARH>VVF DDA6Z25*V:'-DX.7CCI&$FC<X4^(^XME6$I3A.,8\<C2*
MN+F4$E1VD50#ED<>(J0U'5-(HST$_6HMT!=;JA%*ATY-+?:%KI4NU..A8:>=
M6VM7WBRE27,XRM*<>G&<)^SDAH&55?-)(NLYE?&B5$C.N>JRXRKQC<;/Q*:A
M5VJ1%2%<NEOK$R]3FLX5FL2\O7IN,/FX9QSRK+)2W<)6I2D^G*UY5&D5<74P
M)*@ZBN(!"](!&!K*(=1K(%59HXD)'M5%B#_#3=>RPER,^X?HLQRHMP=WUX?%
M="SEM>%^K+B<Y]6<YSG/+($3A6$O>7]X2=:JO76+0^M^I!@YD R#EK$)-P::
MNXU;;A;[4J+K#9PLH/7ZX1/3AY-;C1)(%@AK *V'&WQVG,+];3>4UTMK,;J9
M000""N  QZ2@Q\=5D=H'6T<#+AY!GI5^>/J$A+S5DN%JL]B-70Y\2RU(-4]8
M)>2DV8N&E@D+;%;<0PK'JPI*O4KRTBH-S*2#@ %0  #$(< .-<\KHK7DL*PP
MH2>BRP[/;[?'3E=MMGK5CC)N^RS\S;7(^>@96/DV ILPA7NB^YD;*,(QA&/;
M1E+2*@7$H/ A $(!" (,#T5D"JU6 I,!'UBL1Z8R$C$D8##P068O"S"R#S2"
M#3R"CS3#3RG7WWWW7'GGG%+6I2E9SFP  05C>]TCB]Y5QJ]$CM%C$"/IRI@I
MAT=Y.%93E33[:FW$X4G.%)SE"L_;C[<<54%"M8H=T9KAZ&9@7(@O,8/KROZM
M:9Q+26%XIE8*0;#Q^7L$^[D@<AO&5$9S[SF/L4K..5TC+J2LWI$NK4N.HN\9
MSJ13&M:C/.7YR2 ?>7LRH!T:WY0<8S]?7 !K*(,(QAIY. '4,6T[&7F?0YGW
M,9SGRA/B4!7KJK97MTH?(<H\.'N"K%,:3H$V%8 BPI8?\26"L6HTZ*L4Y#RH
MMAIT-"0-=EHB5BSQ#X<N/C*\*C"AW&_4I*E*\J4K.6D59L\C2"$P!&0.!))!
MZ<ZN<5JJF0TV%8@0"DRP$S<I\<EV2.?\2E]R%FSD.-NOJ;=P=D!K*4JQE+6<
M9]&$^<\:0,:J9GN;I.1 'L95B/96B3#HNH!:W @DHK$U?)G(TS=+_19A!FP)
MAR?FBH78=%R;9(L<B3+*P5'J8?#,9?0G/M*&86FI;AA6>*X +C*N( P (P"!
M0</'F/'63]+:Z5JG6E<HJR!"7HIR=.*7'H*1'-&6.QR]G-#C<'.OG*CH\N96
MP.I]>7ELMI4O\[.>6:-(2L,\O?2F3I3V@!^BO%(TS1=>E1!=9%EVEU^$G:U!
M-R5BG)MF'KUADH"5.A(]N7/,^FC&C*T)D=K&?2,E"DM^G"U8R#0,J23R2@AZ
M8D$X *0N.'A-64WKUK R.K4>W'S\0NI19T%"RU;N5LJ]@;@9,O)TC!F3E>F8
MR2DX@LK/K4.0XZVE6<Y3A.<YSF- JPN902<"I4@@$+TH1G61 *E#UZFMTNJQ
MXD-#1\&["0T>UEW H;'TK@["5.+R^0Y^<OU..+RXZXK.5*RI6<YS*($%8B]S
MGZWE7$J:P]J'KI3]>UBGCS,?F:M$/KZ-J$M]98K+8ZF*43!@ 7154@;"4J*A
M0;0<,XLG(X0JR4+SA:$X6M&8:P =:5GFNGR/=I*,+ER .>"D9IX:D]7T)K*H
MDO%1L3+&.9@SZO'MV*V6NT#5^KR>&L'UVKBV&:DAZU$DI80E;826<J0A*<YR
ME*<8!H%5?<2O"$C-<  IZ2@Q/AJTN=;-7.1M?CL,W$=5:A"*M&RP&QK[&6%=
M0)+<,53Y*P1MB$EY:KL..92.$2\ZR*U^8SAM/G'&@==3Z5,I/9Q*II"+THF?
M74UC]4T2(^K3%0B(U@N@1&L5"!DE,B,TR"=G7HR+&'P]E#"QUV,OR_C^/7Z\
M>I6?3CQ.D>U6,S2',J=1=XRGN"HY,:!UK-LM#& 3*!TZX9U,2,%9[ "))T45
M@U@")EPQ9%H23=C?O(A8Q#R%$,NO*6E>,Y^R-(]I*NVXE;DGE:LAGTBJ.T=<
M=57"0L1\W&V%;=J?Q(SL,#>+G%5D^>0.P*S9GJO&SHL JQ#LBM>V5D?*TN-)
M=_\ FIPO@M!SJ6W4S  TC#(H%3H5%2LI0-5AJV59C8EAQDFWV'-IGG'"'G_J
MYI4)"U]1+:'%*0,C,77Q4>VWA+?J1E7CRI6<V 2L+GN< #DT(/ I/Z:Q8_UQ
MU4_+YF%1UA2XU;&+U&Q:+O<DUJ#N#,\U97+% U7,YFN1,F7--Y=>6R*G"\..
M(\80ZXE5=#:S"ZF#=*C),@I"(A**<*NKNB=;/6O\7KBY;ZO\0MW%<(BTV=%,
M<N33OU#=N=I")=-5<L>",8=R5D3UY?Q[V?+WES,Z0JU7TB71H4(B*@5.A45/
M'596=,T6HR<=*PHLNV]#2ENEH4<VQ3DF!#/WG(J[(-$@R)Y0\=&&OB8=2*UA
M+#3RW%H2E3B\J!H&-'SR/!#DQ !P&*952Q^BM9Q58N]0CX!0D%L.?.LMI&:/
M.2Z;)GNB.N88*]_ZD$(?Z%I+ [*D,L(3Z4)3C.?+2$(X&AN)7/:\GM-""HWL
MC3*Y> VD-06H\6>W&']SV_\ %,_97*J,T;#-UPRVQM:%Q(1^+:!%"C^U[38?
MU:AFTND(PG"\06YIF:O%/I<PR+I9B$ 7-47H]GP5F6KUV,J%:K]4A6LL1%:A
M8R!C&LYQE38$2$R (E:L83A3GL,)]2O'YRO.>6 0)6![B]Y>[RB5K'4)H;65
M?L@MGC(:203&R<A-P<.39[,=4*U-2Z2DRDM6J89+OU:"D#<&O>71A&U-^ZOV
M_1A2O-0T K61UQ*YN@D(0A*!2!P)S-9 J=6AJ378NK5X=P2&AV%C@#ND/%.-
M-./ND*2H@A;CSN<NO*SY4K.?M\<L @05C>]TCB]WE&HO7M24>KJCE0T:0/F*
MJ$A10O<D3B/;K<I*IFC!%>\^OW'7)!&%X>5Y=3C\W&<8^SD!H'L5=TTCUU<7
M+XT2N%>G*$Y$5F#7%DYCJAKR<U;!-?><AA8U,L47 0\K'N.X(]PDA\"LAI20
MYE3R,MY4E6,J5G+2,NI*=_(I<N+G!Q\(4_I-7H?7M6&D0I5D)Y)L?25:]%<R
M:4I**LM\0E02F\NY0M[+H+>?>SC+OV>/5]N>$'M54RO(0Y%VKQU!)3KKJJ7#
MK8!</+MBUBC@ZV$:C[9:8A$I1XQC#,?6K,W%2X;=HBA%X]U+)Z2$9=RK*L*P
MM>%1I;[59!<S-)((4NU9 X](PP\52<+4M'CP9Z.%C2$"V6AU[6LNC,B<M1%1
MJT?.Q<, A:W\K8?'#LA:5/HSAYS+F,J5G*4YQ.D9=55,TA().3BX>$HOYA4;
ML/7C5EF?01(Q,T.IR BZM+M0EPMU;%M-=A6%#1D1;PX";C1;0((PO*$_6(=7
MEO/HRK*/S>06 U9MS,W(C-<0"A/$*,/%69QAAPAAPQ&&AA!&&AA1F&TM,#CL
M-I:989:1A*&VFFT82E.,8QC&/&.6K 225.=<_%*<4KJP^)#_ (&=@/[]W<G_
M )QS/.LYP_U]O_06WR8KF^6/]'/_ %L_RAKM/YR==)3BE.*4XI3BE.*4XI3B
ME.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4
MXI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3B
ME.*4XI7Y:/\ DTY]5_WU?._]A7WZ],O^]_Y;?[R>F?\ QRHG/GG=O^/[-_2R
M?+/K]QM_^1[O_4Q_(LKLYYS5>O6/=F7IR@5QB4#AUV&;EY^OU.M02341C<I8
M;/*CQ,8P7*.,%-QD>RX_EXE_+3N6V&EY2A:_2A4$H*R11]XY"4: 23U"L+73
ML!<=9PXH^P:'6H&W3-GQ7:V6F]$DZYEA,0CDV;8W; W5,VR/#ADMY'?%7!J(
M=)RWAG*VUK<9J7$#'.L[+9DI6-Q+ %.':&*(BICX:AHF^9/8I6KWXMW, 2-L
M;8E3M@]=F3I*M3_W9H:[VV+.B90J+@BI6%49](0VD@1AX8T92%H]36%JC4J)
M^6%9#;B(/7$:00HQ'; QSQ\>59;JEIMJ>K=1N@3F)VZ*T95[)]5,R.6%R$X[
M1H^1*DCY!T&5RX0LA:WU96P[AYS'I5_O9SBP)T+Q2L+V,]+=&<(^\(PZ%K M
M9VYO-J0 E6ZQ$V8ACJ]K785BAI78!,;"M.??VS%%3$<2/42?J+A=H:,$7EG(
M8X@RVE-.$J2RVMZ@<[^&MAT-NB*1_-<T%,<F]>0*\?%4SNO;4&&D(>.K<16G
M72:15K](_CBV2-64L*V!N2$77(-,-4[=@R?6$WZW7B5" L>I"?<7E2O;L7UC
MCLRX$N)341@%RXE2,/9-3>O[UGKM/#C4N@LFUP77E'V389&<LV(*>&C+V-8E
MQT%%P;L,0 _8A'ZZ]AW!<@&'G"%8R^C\W.0<N6251UNV-O;=VM1:$"C!,57+
M'H)J UCMB]*2-@CI.&UV<5'ZQN6R@PM>[48O3\8JFCQI1=1N9HE9#BXB:*;E
M482Z$[(,I6R[CPKPG.8#_!E61]GI (+DUAN+45>(QR\*5<)O?5M$J,Z9>M?8
MJH=HTI?]ET5=7O[Y,ZZ-4ZPS,R==FY-%8!_!]LS'2C+XI0>)(9E6%^%J<9QA
MR=13$<*AMNPO C<I$@:5&&)11CB/"E6BZ]NA*A.S4+&P<#)"4@2&_$;,W<)*
M-MDV8?7XRP/QU+C!JA+1TL;'@2C6,NR)T8V45E32,X\9<Y!>A2I99ZVAQ)!<
MJ( @Q3''\P*5+5=D77=NC:\%@JR-&$&UD09=ENN*G=9Z/LT/'RS=LJ%9FX(>
M%LL!&KD/IGF&);[S6\._[8RE-X;7.OM)PJGHO\GO22N.04!#D2"H/B3KK:KE
MZU*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<
M4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*ZL/B0
M_P"!G8#^_=W)_P"<<SSK.</]?;_T%M\F*YOEC_1S_P!;/\H:[3^<G724XI3B
ME.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4
MXI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3B
ME.*4XI3BE.*4XI3BE.*5^6C_ )-.?5?]]7SO_85]^O3+_O?^6W^\GIG_ ,<J
M)SYYW;_C^S?TLGRSZ_<;?_D>[_U,?R+*[.><U7KU#+[1XK85>77Y4F2C_;D(
MF:BYB%(;$FH*=@9$>6A9J))>8*8:.CSQ4+3AQIUIQ/J0XA:%*3F"%"5>.0Q.
MU!#@0AR(.8K%;_7UL]&)66VCLF1V$-.AV&(V-DJLA2\"5'Q,C!CQ\17P:T/2
MF($J+E2&S@UQJTGY>4MY658;RW&GK*UF])3LM8T1HA;BAQ7$JJ]&.%7D320:
M<U@F:O%XM<Q7;/9K8Y-620CRB9*3M-&FJ&8*@,2,!B82$"BYI;@H4>.,RTZW
MC.<*RIS*VGK-5,YQ#6M#2 $'40?&<,S4XK]$BH#7$)K)L@TR$A:3&T1!3ZVD
M2!45&P3-?20\XRTAA!KXC/J5E",(PO/G"<8^SD@($K&Z0NE,O[1<OMK6/ZCH
MJ/JX9PQ-NLEC>-U9#ZBP=*L0(Y+-7KYUM*AEI1#Q$:*Y(!"6U8WNJ;S[K8S:
MG,*=RXM<!J>PE97W!>00T!'EV"YE%S\%41/7X5C,2_4=C[!H$@+2*UKV>/JI
M%;]=JKE5%>$B'I$>=KDT*!8@FBGL,202!R64NJ3C.4X1A+3T$C"I%R<0]K7#
M42%7 G/(C#J-21O2]:]N\BDR-A/"O^M:SJZ:0=*NE2'W!60+=&M&HFGTN2K\
MW(#7$C)!+SKBU.(0O'A7J]4Z1[(JG?O[)  +7EP\)3AT85BN5ZWE@0$L8'?+
MK=[%%:IV-KRH0TVFDQ4.B.ML$,*/%L!P-<K,>*8N0B15+.=7AQY7GWUY3A/H
MJ689J4K,+H%P!:UK2\$D*N!ZR>G*KC ]<!R:<J(NESN\Z:9J28U=&"S!=<?;
MU["W"!"C;*)7W(J%$Q*2&%B-MH-D79!_+ [;?N*3Z\K:,$/14.NB'K&UH&L.
MXXD'!<?:"5(Y?00Q<I-'5[9.R:(%;AXAF[0U0DH,,2QOPL4'"#2C!A]?DIFK
MS)<3'#C%%1)(;I#+*/.<+3Z^3IZ"156W)  <QKBU4)7!<>E"/"M>UIT#&VZ=
M=-EKY?7ZL5/05F-H1)<!+0:YBN_=*@7(Z9G*_)W. "(=AF'"1P),=#J_5G'H
MPM6,BU3F4J&7)8U UNM"%Q5#U H<^(K-4:$:&J2R9,%RV#)-\T-!0T</B)"=
M:80U#BYCPQ%$"#+:6M+A&7B59=SA3BDX3A-JP$@H@3#\C5SXJ*<4IQ2G%*<4
MIQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G
M%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2NK#XD/^!G8#^_=W)_YQS/
M.LYP_P!?;_T%M\F*YOEC_1S_ -;/\H:[3^<G724XI3BE.*4XI3BE.*4XI3BE
M.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4X
MI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE
M.*5^6C_DTY]5_P!]7SO_ &%??KTR_P"]_P"6W^\GIG_QRHG/GG=O^/[-_2R?
M+/K]QM_^1[O_ %,?R+*[.><U7KTXI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4X
MI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE
M.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*5U8?$A_P #
M.P']^[N3_P XYGG6<X?Z^W_H+;Y,5S?+'^CG_K9_E#7:?SDZZ2G%*<4IQ2G%
M*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4I
MQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%
M*<4IQ2G%*<4IQ2ORT?\ )ISZK_OJ^=_["OOYZ7M^ON_\MWV^/'9/3/\ L\__
M /.5$_\ ;CGS)S/N3K'8MD8&!VJTE.:?_N_JKZ2Y>V-FZ[]O4CI"S1=Q# *O
M\AAZ179Y[/[K^#^SSBOM _S0]]^JNP^QT7GW>]'PJ>S^Z_@_L\?:!_FA[[]5
M/L=%Y]WO1\*GL_NOX/[/'V@?YH>^_53['1>?=[T?"I[/[K^#^SQ]H'^:'OOU
M4^QT7GW>]'PJ>S^Z_@_L\?:!_FA[[]5/L=%Y]WO1\*GL_NOX/[/'V@?YH>^_
M53['1>?=[T?"I[/[K^#^SQ]H'^:'OOU4^QT7GW>]'PJ>S^Z_@_L\?:!_FA[[
M]5/L=%Y]WO1\*GL_NOX/[/'V@?YH>^_53['1>?=[T?"I[/[K^#^SQ]H'^:'O
MOU4^QT7GW>]'PJ>S^Z_@_L\?:!_FA[[]5/L=%Y]WO1\*GL_NOX/[/'V@?YH>
M^_53['1>?=[T?"I[/[K^#^SQ]H'^:'OOU4^QT7GW>]'PJ>S^Z_@_L\?:!_FA
M[[]5/L=%Y]WO1\*GL_NOX/[/'V@?YH>^_53['1>?=[T?"I[/[K^#^SQ]H'^:
M'OOU4^QT7GW>]'PJ>S^Z_@_L\?:!_FA[[]5/L=%Y]WO1\*GL_NOX/[/'V@?Y
MH>^_53['1>?=[T?"I[/[K^#^SQ]H'^:'OOU4^QT7GW>]'PJ>S^Z_@_L\?:!_
MFA[[]5/L=%Y]WO1\*GL_NOX/[/'V@?YH>^_53['1>?=[T?"I[/[K^#^SQ]H'
M^:'OOU4^QT7GW>]'PJ>S^Z_@_L\?:!_FA[[]5/L=%Y]WO1\*GL_NOX/[/'V@
M?YH>^_53['1>?=[T?"I[/[K^#^SQ]H'^:'OOU4^QT7GW>]'PJ>S^Z_@_L\?:
M!_FA[[]5/L=%Y]WO1\*GL_NOX/[/'V@?YH>^_53['1>?=[T?"I[/[K^#^SQ]
MH'^:'OOU4^QT7GW>]'PJ>S^Z_@_L\?:!_FA[[]5/L=%Y]WO1\*GL_NOX/[/'
MV@?YH>^_53['1>?=[T?"I[/[K^#^SQ]H'^:'OOU4^QT7GW>]'PJ>S^Z_@_L\
M?:!_FA[[]5/L=%Y]WO1\*GL_NOX/[/'V@?YH>^_53['1>?=[T?"I[/[K^#^S
MQ]H'^:'OOU4^QT7GW>]'PJ>S^Z_@_L\?:!_FA[[]5/L=%Y]WO1\*GL_NOX/[
M/'V@?YH>^_53['1>?=[T?"I[/[K^#^SQ]H'^:'OOU4^QT7GW>]'PJ>S^Z_@_
ML\?:!_FA[[]5/L=%Y]WO1\*GL_NOX/[/'V@?YH>^_53['1>?=[T?"I[/[K^#
M^SQ]H'^:'OOU4^QT7GW>]'PJ>S^Z_@_L\?:!_FA[[]5/L=%Y]WO1\*GL_NOX
M/[/'V@?YH>^_53['1>?=[T?"I[/[K^#^SQ]H'^:'OOU4^QT7GW>]'PJ>S^Z_
M@_L\?:!_FA[[]5/L=%Y]WO1\*GL_NOX/[/'V@?YH>^_53['1>?=[T?"I[/[K
M^#^SQ]H'^:'OOU4^QT7GW>]'PJ>S^Z_@_L\?:!_FA[[]5/L=%Y]WO1\*GL_N
MOX/[/'V@?YH>^_53['1>?=[T?"I[/[K^#^SQ]H'^:'OOU4^QT7GW>]'PJ>S^
MZ_@_L\?:!_FA[[]5/L=%Y]WO1\*GL_NOX/[/'V@?YH>^_53['1>?=[T?"I[/
M[K^#^SQ]H'^:'OOU4^QT7GW>]'PJ>S^Z_@_L\?:!_FA[[]5/L=%Y]WO1\*GL
M_NOX/[/'V@?YH>^_53['1>?=[T?"I[/[K^#^SQ]H'^:'OOU4^QT7GW>]'PJZ
MK_B/:\Z,[ _G>/'?#N5C]3\FY)G_ -O.SYXWET&Y6K1&"NVVKL^F(%,JX_DK
MEF.\V^YD,Q;IW&Z;Y(/DRD+GQKM0]G]U_!_9YQGV@?YH>^_578?8Z+S[O>CX
M5/9_=?P?V>/M _S0]]^JGV.B\^[WH^%3V?W7\']GC[0/\T/??JI]CHO/N]Z/
MA4]G]U_!_9X^T#_-#WWZJ?8Z+S[O>CX5/9_=?P?V>/M _P T/??JI]CHO/N]
MZ/A4]G]U_!_9X^T#_-#WWZJ?8Z+S[O>CX5/9_=?P?V>/M _S0]]^JGV.B\^[
MWH^%3V?W7\']GC[0/\T/??JI]CHO/N]Z/A4]G]U_!_9X^T#_ #0]]^JGV.B\
M^[WH^%3V?W7\']GC[0/\T/??JI]CHO/N]Z/A4]G]U_!_9X^T#_-#WWZJ?8Z+
MS[O>CX5/9_=?P?V>/M _S0]]^JGV.B\^[WH^%3V?W7\']GC[0/\ -#WWZJ?8
MZ+S[O>CX5/9_=?P?V>/M _S0]]^JGV.B\^[WH^%3V?W7\']GC[0/\T/??JI]
MCHO/N]Z/A4]G]U_!_9X^T#_-#WWZJ?8Z+S[O>CX5/9_=?P?V>/M _P T/??J
MI]CHO/N]Z/A4]G]U_!_9X^T#_-#WWZJ?8Z+S[O>CX5/9_=?P?V>/M _S0]]^
MJGV.B\^[WH^%3V?W7\']GC[0/\T/??JI]CHO/N]Z/A4]G]U_!_9X^T#_ #0]
M]^JGV.B\^[WH^%3V?W7\']GC[0/\T/??JI]CHO/N]Z/A4]G]U_!_9X^T#_-#
MWWZJ?8Z+S[O>CX5/9_=?P?V>/M _S0]]^JGV.B\^[WH^%3V?W7\']GC[0/\
M-#WWZJ?8Z+S[O>CX5/9_=?P?V>/M _S0]]^JGV.B\^[WH^%3V?W7\']GC[0/
M\T/??JI]CHO/N]Z/A4]G]U_!_9X^T#_-#WWZJ?8Z+S[O>CX5/9_=?P?V>/M
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M; ;G'>LA$K'"2%\3B@E+6OU,**2UQ!0*@5!G3JQOGM/V$ W3&TSO!\>^^+3
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M J"J@!*T"WA\P&Q1:1\M&R^N5HTGLG7_ $[_ .@[_IUN,9'%6FO6+_J#EXF
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M'51BQ-,Q)-=O89$@\6=G('J&!RYEYQ.$H\\C;.1=DN-JVRY?8[K=2WL0=))
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MHGDCG);#%B-#7EX<'.1$&3=79Q,YZW:[VZ"QMH(&\V2[A+9.!+C!')  Z67
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MN8-+#;1RL[2YR:BY6ID@5:SQV1Z97O=&M?C^I,#::E%']1NU?5/?=U+EU3&
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M0W6(^GW%PUUL^*,D3.)#7EVI4&8 1>)K9=R;S'9[DW<-M.U2CT"WMW"Y9*\
MPM +F!NE%.1)5,P*V:ENDV\-O[8^.W:^_7.M.%=6H'N55MXZZU/7;G%:NN%:
M[#ZZ5JZDP&MJM;69M]$/'5849$Z-*EM-+<6_@9*FE(:3XD?,VU[=M^\;?M(O
M4OWV;H))7,,K'6\G>O=(YFG$N)T%H7+5CC7MR<L[IN-_L]_NWH7_ *++QL\<
M37B)[;B/NF-C:_5@&@:PX@9Z<,*L'QC_ !ES?QX;2[D2;-_B[IJW>4[J;.G8
MY9$\7<J=2]:(V<Q'UFY$RX^12G(6)NP,<$\,2_AX>/RM:6/4EK&;G?G:+G"Q
MVUAA=%?6K9>^/9#'OD[I7, Q&HL<YP("%W'.L/)/),O*%]N+Q*V2QNGQ=R.T
M7L9'WJ->3@=(>UK2"5#5PRK9CH=U;M_5&E;UK-RL-;L9>U.U>\-]PY%9S)Y'
MCJYM&6C#XB&DOO4"/<Q-Q[0*L$X:2XQZLX]#B\><\\3FK?;??[FUGMF/8V"P
M@@.I,71 @D(3V2N"H>D5[?*NQ7&PVUU!<O8]T]_-.-*X-E((!4#M!,4PZ#6*
M.Q74OLG'=I@>Z72:]Z?@MK3FJQM+[@U=V!"N2]3[/J<1,O3E6L7W[063[76;
MG5R"%--.L#/,D#MMMJ]"/J$D^AL_,&ROV(\M<S17#[!LYFAEMRSO8GENES=,
MB,<QV9!((*G$HFAO&P;TS?1S)RS+;LOW0"&:*X#^ZE8#J:[5&KVO:J! 00@P
MQU:B[:^*?L;V%Z_]X#MT;=U%*=Q>Z"-$P*Y2L1]QB="Z@UUHW9E.ND/0*=]<
M#)7:3&D0Z^^X2:6)AX@[+&5(3X??>Z#;^?=FVC=]K;MMO<-Y<VWOW(XL,\TD
M\;V&1Z$,!!<$:"@:N.0'/;AR'O.[[3N;MRN+=W,6Y=PU6AX@AC@D8\1L4%Y!
M#22XA2Y,,R>\*J:XUY1'#7:/0Z9379)##<B[5*O!UUP]L93JAFS5Q (:BD#J
M>7E&%Y5A&5J\>/.>?F%Q>7ET +J620-RUN<Y%S124K]/@L[2U)-K%'&79Z6M
M:J=* +4SYK5LTXI3BE.*4XI75;\1W_ SL%_?Q[E_\Y)GG=_>!_E+3_:K/Y%M
M<']WW^+N_P#=;SY9U=J7.$KO*Z^_D0Z@7+O'KG6.AA[C$5#2QFY*;<>QS"RI
M<6V7;65-(7+(H=/=  + &-F9Y(Y"RBEM8$<"9=1[F4J;5UW)_,5MRO>3[J8W
M2;F+9[+? %C)7X=X]2"0UJA JZB"F=<CS?R]<\SV<&U"1L>VFY8^XQ(>^-F.
MAB @$N0J41 0N5:CI^'&!K6Y=DF4_:=YL6@NS76F\Z"[.06XMC6W8VU#I=_+
M!6KMBT"T3X$JT[-T@D9#++4F_@<,?"LM-NY<4C'0'[QII]M@;<01,W:QO63V
MSH8V1Q 92QR-:1V7YDM"DYD(M<_^'44.Y3.MYY7[3>V3X+ELTCY)2<XI(W.!
M[3#@ XH!D"J5-=7]-_D.9L77&@[H[C4-[KCU<GJU-0Q6C:SL?6F\NP(=&A%P
M-2JN]I9=R,KC-56(O&)<*/62Q,-I4DI#CJT$L:U]S'R@8;V[VW;91O-\QP(G
M=')!;E[M3W0#0':U\ASD+/V2 "T[-CRYS>)K.TW+<8O4UB]K@8&R1SW 8W2Q
MLYUENE/+#5#QY0)((VCOO5NWVSO]H/MN'8:V-2]3:-VGJV:K169/\424Q?)(
M,V.D(M+0#D3F-#;&SA_W26W?.<>E"L<\*TWVWM^4KOE]S'FYN+J*4.":0(P0
M0<54K@@2O=NMCN+CFRTY@:]@MK>UEB+2NHEY!!&"($Q4K6+ZQT#)-OWR<%;1
MFZU-ZV[]II49%1,0W(OSM5AH/4TEKN6?G&SP@04R[<@>DP!0C[N$9:2K*VUX
MQXWI^; VTV1MBU[;W:=9)*:7%THD&E"2B!'*!GQ%:,'*;G7>]NOG,=9;MH
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M[QM^TB]2_?9N@DE<PRL=;R=Z]TCF:<2XG06A<M6.->Q)RSNFXW^SW^[>A?\
MHLO&SQQ->(GMN(^Z8V-K]6 :!K#B!GIPPK3_ $G\%0NNM??(IHNP[;05J?M6
M9I1_0,_%N3TCL;3B-&S%\L6OE6=4KD)F573#YZ(#92'(XS(QL>ZVI8?O)2CH
MMS^]-UY=[/ND-NE_8";OVG2(YN_$;9-**FL->2K>RYP*.3'G=L^ZUMG:;QM<
MUPMA?F'N'#49(>X,CH]2HN@N8 CNTUI"M7#.-HZ<_(MVK9U3J#N]MOJJYUQU
MW?J1L"^O:$A-G-;6[%E:W.1*5ZOWP.W@Q=+H<%.3 K!LLF%4\I3Z/ V&$81A
M/EP<Q\G;";C<>6+>_P#7,T3XX^_=%W5N) CG1EA+Y'-!(9K3#REQ7U)^7.<-
M^$&W<SW%AZFAE9))W#9.]N#&5:V0/ 8QKB 7Z%Q\E E0?8'Q]]]JJCO1IOK5
ML[JIGK3WVV1MS9EY,W+&;3:W#J^8["P M:W"S3!JA'R%5LS)D4VI$;]X%#)&
M6AM?I3GW,*V[3F[E2?U5N6]07_KO:88HV"$Q=S*VW<70ZR\A[4/E:05Q'0FM
M=\I<UP#=-NV6>P]2[K-+(\S"7OHC<-#9M&@%KE'DZB$PZZS;LKIGW$UT#U_@
M^I6U=(;#U?JOK'4>LMTZX=Q(NXDZ4MS5#CHJ.KVWX\:AQEDD!-A$!Q+0I3+S
M#@OT;>4(7ZGG5<\NRYDY<O'7<O,%O=0WT]\^Y9<6A8)F=X270GO"T&-22""J
MXD8"O2O>6^8K-MI%L$]K-8P6++9]O=AYA?H #90&!Q$A  ((1,!F:V'^.;J)
M/=+.N>-4VRRUBQ6VP[%OVU+./0(@JO:PJ<Q?Y9,B]2M70!W@N'H=<88;:#:<
M0UE2\N.>TUAS#:?'YQYABYEWGT^W9(RW9#'$WO"'2O$837*X8&1V9./ *46O
M8Y.Y>EY:V?T"X>Q]P^:25W=@MB89"NB)IQ#&Y 8<2@5*T@COBNVLQ;6)N0O>
ML38K'S%;.^1<R.<39'_J]2WN& BQM?NLOU_Z9Z\M?2K^H;7G,8I"O&"%?;CG
M3OY[L#;F)D4XD^SD6W@]G"6-Q/>>5Y&.'[757,,Y$OQ<"5\L!C^T4FX$=K&)
MX $?DIKPQ_9_ZJP?I;X1]HZCB* .O;E$L,Q1?DBZP=F19(YVUNJQU>ZK0=UA
M->ZQ'<>A%.HOPK%].PAG.,1:?5E62U+<7GGJ;E]YUCN$DQ]'E9'+LMS;$#3_
M *FZ<QTDN?\ XSW;<?*_Z4 KR]M^[.^V^.(>D1/DBWFVN03K_P!-:M>V./R?
M_(.\=AY/_5C7"=\'^R9T7KT',;6U^*)1^T.WM@[S!BOQ1D;:O7K9.\=9[MC]
M:(R_!->[.PTWK=M:4$I;!;+)R][COM(3F6?>?91.O'1V\Q=+8PQP$Z5BN(X)
M(3)Y7DN;(<NT@1 M'_=C>RMLVR3PAL5]-).!J26WDGCF$?D^4'1\>RI52E9<
M)^*[L+6M?"3FL=K:BCNPNL_D1W!W<T^1;(^W2FJYBN[0]D-_6^Q4@1PEDC22
M(Q&/J2XU@I3.6\H'7A3OU#/GMY[VB:\,5];W!VB?9X;*8,+!*'18]Y&I+3CD
M'$*JG)#OGD3=X+02V-Q;MW>'>)KV$O#S$6RX=W(@#@4S+04R!Q42M/QX=K-M
MPW?_ &/V/OV@ .P?</KS&==J=7],L[#7IS759K\/-!@24M/7.+;NL[(3,C(L
MOD^D#&!/:<PU[J74-L8/MAL.WR;39[-%=G:-NO#</=-W??2.<6D@-8=#0T @
M=K%0J(IV/LAOVX1[M>;S+:#=]QLQ;L;#WG<QM:' $N>-;B203V<,450!%KK\
M.,F?V+^/OLE1+O3ZS:NN45U^B.RL*O$^U#[?)T#7X&OUBXUI(D>M+MM#B!CH
MQMR2:8]R-4*G"V<MNI=S6WWC,9LV[[+=12/@O'3FV=V5A$[G.<QRGR"=+B&D
M]K5@5"8+G[N7NWC:-YM98V3V;;<7([23&!K6M>U!Y8 <U7 =G3B$*VS6'0/Y
M!= 6'<V-5#?&+=ZWLCL3M;>T'/;\U?NRW[-A5;#LOWP##.3U<,KH P\,,,SE
MMIEM?LDJ=4EY>%)\9+[FSE'=H;;T\[Y%-#9Q0.;!+"R)W=M0G2X.)7'$G$)A
M6.QY3YNVF:Y] &R2PS7DL[73Q3/D'>.4#4TM 0 8#(KC7:]VGU/NC='7JRT3
M3>ZC] [N(&@)6J[-K+1+D9'V:"D 9,J*D@E9</?I]E0,\"2G&5OLL$8=]#V6
M\LN\%L5_MNV[NRZW*V%WM@+@Z)R*6N! (.6MJAPX$A,%4=[OMAN6Y;0^UVZY
M-IN9#2V1JH'-()!&>AR%IX@%<40Z+=8.D'9F/[GX[H=H/^D:AVF#TW.ZDC:?
MTWKM[B8[8Q-GFHN9D[MMV?OD5"2<L:!F/RV&"EHI",X8<^H3EC.'NHWSF?9'
M\M_9K8_6$L#KELI?>.83&&M+0R)L9< "N+E'$:<<.7V/EC>V<R?:3?/5\4[;
M9T099M>!(7.!+Y7/#22$P:AX%<,=GM1]5K7KSO7V[[5R4[6#*GV'HVA*M6H$
M#$E^)X4S4];.A)PB>R_'LQOTTF\^VH;Z<AY64(_C,(SC&.>)N&_07G*VW["Q
MCQ<6<L[G.*:2)7!S0W%<$*J!U5[>W[%<6?-.X;\][#;WD4#6M"ZFF)I:[5@B
M'@A/7779V8^.;OQOJ)W/U_G-M]3]M]==K;)D[94-P]@ZC?K3VNZ^T^>E(^6>
MH^L6(V+51C&JK]W_ $T86Y) /+;((6K+/NMM,=ALG./*>TR6V[Q6]_;[S;PA
MCX;=\;;6X>T$:Y23K&M5< UPP Q0D\?O?)W->ZQW.TRW%A<;//,7LFN&2/NK
M=CB#HB0:#I1&G4TH3DH WY[/]/K5N<_HC^$+?&#1W4KL?K/;UE+NQ4H7/6ZK
MT&M2< ^($7'1Q39=LDU%MNJ<)^G8<7ZU*6G.<8SR>Q\Q0;:S=?2(W%^X64D+
M0P -8Y[@Y2"0C B8*<L*ZS?.79]R?M7H\C0S;[R.5Q>27/;&TM0$ J\JN*#/
M&M>>VO23M+?>\D+V_P"O;O3FP"C=48WK;)TCMK3]B7>(:(9V]9-GFVJ%AZ1B
M.;'DD-F!"#$N&Y4AI9B%,9PXVYCV.7^9]BM.5W<N[N-Q8XWYN0^T?&P_^%L0
M:XO7#!Q(TYZ2N!%>1O\ RSOMUS0WF':/5SVBP%N673)'C_RNE+FAB8XM .K+
M4$Q!JT77X^.P78BV].;'V+DNKM>C-$U7O7KK9]-Z]UJ_UJDS-%[8:18U)7!Z
M'7;;F7<;DHIQXLF8268*PXES&6,*5E6.9+;F[:-GM]QAV=M\]]U)8R1/N'1N
M>U]K-WKB]S$P. 8@)PQK%<\H[OO%QMTV\.L6,M8[Z.5ENV1K"RZA[INAKUQ&
M)>I QPK"G4CX@-R=?I'I19[GMC7]SN.@]\[OV_N*<'=M)!5NC;UIBFZ3U[ U
M(V2@1BBLU:LT,'ZC!_TC:5+=RWEQ:E*7Z?,'WA[=N[-S@MK>:*VN[2&&%O91
MA9,^:1SP'(-3GN32O!4&7F\O_=YN.TOVR>YN(9+FTNYI9G=HEX?"R&-K"6@G
M2V-JZDXHO'Z">?D=?K=.*4XI3BE.*4XI3BE?EA_Y-.?>7]]7P3_85]_O2S_O
M>^6_^\GIG_QQHG/E'G7_  NQ?T<OR[Z^K^1_\SOO]9%\@RNS_GYW7Z/6F?R#
M=JY#I)U"VYV>BZ6'L(_67X"]BGGS;]=$E_QGLZEZ^=]V9'C9=X/[O9MBBD^!
MW/<4QA&?3A65)Z3E'86<S\PV^QR2F%D_>=L-U$:(GR9*%70F?%:YOF[?G\L\
MO7&]QQB9\'=]@NT@ZY61YH436N7!*U:T_P#(5OI?;'3753LWUSUIKR5["UO9
MDSK&X:8[$0>ZP@Y'4]=7;+)'WN!&K,!)5N-D81"L GJ7Z'C$X8;;>\ON">[N
M/*&U#8+G?MDO)YH[-\8E9-;NA)$KM#3&XN<'$.\IO 8DC .\+;N;MU]?VVP[
MW9P0OO&2&)\-PV8 Q-UN#VZ6EH+?)=Q. !Q+<5=:/D>[M=I8>OWO7W4OKP-K
M6<V%-TO!\_VR9AKJV+6;H74)H]FE%Z\2:^9[@#K@H^',?59]&$J\*QGF_O7)
MO+.Q2/M;O<+PWK86O1MJK%<P/:-8D1,0">%:&R<Y<S;[&RZM-OLQ9.F<Q772
M/1KRQQT&-5P*#C7/MSY1>P ?93L'I;KIUPUCM87J]*UB(N5"M6[VZ7V/W$_,
M0L?/RY>B=6-5V6)F8V'"/]+3SF"_K?2E;:?4\EA,;?R-M+MEL]SWF]GMS?-<
M62-@UV\*.+0)Y=00N(R":>.2U;<.>-V;O5WMNSV<$[;%S0^-TVBXF5H<3!%I
M*@ X''5PS2MD;Y\AF=?]B[GI^7U#/IK%)^-&Q?(9*&O$OA;(QFMWHRKFZA=H
MCT?E@2?Q'A*6IQ9N7&S_ /T^6O&/<YXMKRAZ7LT>XQW#._EWMNW@9Q]I@<)>
M\7%JG]WR<5X5[-WS?Z)O$FW26[^XBV5VX$Y2=EY:8M"8.0=/E8)QK!_3?Y&N
MSG9*R:KD)OK/K&3T[O:GV&RU786@=V?I<>TA-Q\!FQ5ZC]G8\6N")H,Q8TK3
M'^[Y9R)*(6PXQZTOI']3F/DW8]EAG9%>SMW&UD:U\<\/==^TNTN?;$N/>!OE
M)BK<0<E\OESG'>]YF@?+90.VZZC<YLD$W>]RX-U-9<@-'=EWDK@CL",TC\!W
M^^1:8[/RG4Y[HUHL;9M=U? [GL24=J"G8@/7<[:_PBT>')YU<A@V7;D4+S])
MC"5>G&,^KQGF:;E+DZ/8V[^-TNC9/G="W_U0ID:S6A'>X!.-8HN;.<)-\=L!
MVNU%ZR!LSO\ VB@C<[0H/=8E>%9?[*?*) =>>\>D.I3NNGK+4+L]08O<FXAY
MI8\7I.P[GE['7-.0\X&B-(!;79)> 2^6X:6"@>.*;>1ES.?1SSMEY&EWCE>Z
MY@$P9<1=X882,9FPAKIBTJO9#D&D.5P(*5Z&]<\1;1S1:[ 8==O*8Q--JPA=
M,7-A#@B=HM4ZBU&D$+7/M?Y0ZAI/Y)]:]"]C5$2$K>V-=UF7JNX5V#*4,;*N
M4U8(JJ4F9@7HYH86.L+U=6&,8@QQU4D6.UEG#:ENHBPY&N-SY+GYKLY"Z:WF
M<'0Z?_S8UI>\.526ZE(1-()54!M?\\6^V<YP\JWD8;#<0M+9M7_Z/+@UA:B
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M\*Y=UO.QFMS2&^[^CKRJK;B![]#7 N]S]/57/%;GU=-VQ5'BKI$&V;!,B"T
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M+!S ,-/Y]PCZK#R7O2C#*DYRM.-L3GM5H)<7(.C'QY^*LKI6L<CB T-4]/\
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M3NG=H(7!V(.!0;,M=.^Y]>[6Q6WZS=*S(6VM_#= ]2(_?]O(CYZ.L';6O[<
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MBE.*4XI3BE.*5U6_$=_P,[!?W\>Y?_.29YW?W@?Y2T_VJS^1;7!_=]_B[O\
MW6\^6=7:ESA*[RL1;IJUBLU6B"*D*))62GW>EWN+A3C$QHL^JJSHIYL(N36A
MUN-?D8SWT,/K0IMLCV\N8]'JSC/;O8QY#\&.:0O0HSK!<,>]@,:%[7 ITH<O
M8K$DS5MG;0E;Q:I>@/Z_PWH?8.KJI7YNR5>7FY^=OKT3(E'%/5F5F(**BP7*
MP(PSE9>77%$.*6E"4)\YVOAA#6-=J_F-<2 0 &KT@$G$\*P%DTSG/<W3_+<T
M D$DE.@D 8#C5)>M/728A4 0T0'E;?3S:VGFV4GQPS;=TLPE 9@(A'J>;0D-
MW,"5CW\?^G:PC'J5CU)\S'/&URN/_P"[7>(:E/MU$D$C@C1_^#F^,H@]JK+=
MM!6JZ/VR+D 7FX"T;$T/)EOQL^/&2"JO3ZK'PMR='+')06&0.XTZVC",I>=3
MGRWY\XSRT=RR,-<#VFL?PXDJ*K);/D5I'9+F9'@ AJU3NE=I*BM6#_=1TMC2
M)%SHX#%(V*5J:7O% G0:ZU6K7&RM9,CFX6PQ+$"R+(QI*F!"G,D.-*2A;.,2
MVXA5^('>(<6Z@'!5"',%5!SRJKK>9&!">[48.TDM*(5&1"8C+.MA=*T.3J-!
MDHN:CB*[+V2>LD\>)F[3U^E US+N&!WI"W6%Y\R3G<@CM.$N-^!\$Y5EO&<?
MG*U;B022 M*M  R#<NH<*VK>)S(BUP1Q).9<<>L\:Q!2M;;52#HG75AIU9K]
M>T3,1D@1?HZQ#'XM[-7JLW6(?-;K[(;4G%F6;[U2_+*.4SAK'O(;^H]S"L9Y
M)85DE8XET@R3)2"5/4F">U6".*9(XG- ;&?*7- 0$'6N*]>=56H]8W^#F-)J
MM-8%BV-4U?=51-/1-1,HR>Y9YC79M;G8E SOUK0LN'%GHRAUILACV<X=2G#B
M/4GFB<V305+W,.1&0<H/@45,,,K71ZP@8'C,',M0^-#6-L:!V5"(HD\S"V*8
M>BZW>JI-UFD[BE]53D?]Z[*GKE 2XL[ R04;-1A@4GALT1]Y"V5)9<;PM2%(
MYE])B=J:H"D$$M#A@T A",.HUB]&F&EP!* @@.+3Y1(*C ]8K,FJ]1V*FVG5
MLB=# @1];U/M&%F$#V62M/W;;+WL:EW%L-J8L;J[#-..#AG^\8O'HRXG*<>E
M"VT\UYIV2,> 227M(P3 -(R& X85G@@?&]A(  8X'%<2X',XGCC4YVK7+<Y9
M]:;#IT$%;CM?FVAHVIE2PT$3)1UMA41+LA"RIS3L<Q,Q#HZ,I01EI#PKQ",.
M(5E.%8X7LT/BD.D.3%%R*XCH/YTK+,Q^MDL8#BTG#+,)@>D?F6M?;1J?;4U:
M(;9I=*R*4=#6>"EJ#J?;\[JR:@VY"T+L<-+2%JAS(J*N$G)9>=^_/.66\D^T
MZQA[+:LKVF3P-880[ $$.<T.!P0A"I'5[=:KX)W/$Q:A0@AKBTC%05&!Z_:J
MC)Z^7]BH3D+'P$>.1*:3'K2 FK>9/MMVX_;4[?96/78+23B9DLM#3.5K,(]+
M;CN581X3Z4XD741D#B2@D7),-( P&'#*H]%E$9:!B8TS7'42<3CQSK9[>M9L
M5MUK(Q-4CV):?&LFO+(#%D'L1:))--V+5+@: B0)QD84@P""=;94YX;]U2?5
ME*?.<:=L]C)0YY1J."^%I'Z:V[ECI(2U@5RM/L.!_16O\?7'+-VE=#!*!Q48
MP"M[ROM8',%/?KNY&:_*:VAX67<BWW0&B285+,EZ/6I2RHG#RL92XTK.R7:+
M-3_Y"2QIZ6+J)"]>'CK6#2^\0)H #W#H>FD ^+'Q5'],UN_7*G:L@55&#AZ5
M4MO6C8Z[ZQ/#NE2+<+>[P^/#AUA(+<@)/R,H;],:^X]D7('NN)<6X][#=[A\
M<<CW:B9',#=*=+1BO0F77X%JL#)9&,;I C;(7*O03@G2N?!/"E<>L>OE^JLI
MKRLSD#.R$7KRR8E<W:2WO>)6G'B0WWBY 2<#J?[T2-'V$MU]G!([[38#'J(]
MM;B5I3A-=1/#WM(#G!$T ''-7)E[>51#:RL+&.!(:<]93#(AO3[6=3#2FK]J
MTN]0JG8<NET6)BIX"<KCVPQK[27GBT#XC6M21DG$O7"D0[DB.DIX8@YEAME"
M6,,N*2ES%+B:&2,XZI"0ATZ3_P#;%"?%UUDMX9HY!AIC *C5J'_UP4#Q]597
MV#"; C]I4K8U'JT=<VPJ/=Z%+1)ME'JZXY=EFZ1/1D[DPH&025',/U-;)3;3
M:B4(>PMMMW.,HY@B=$8712.+5<' HN0(3VZS2ME$S9HVAW9+2%3,@@^U6%*W
MJ3:=;A]7CO5@.3*#T7MG5EJ0%/Q0^8":N,Y6IZ)DT)+(PU)Q;BZ^IE6&'5NM
MY=PK./"<^=A\\+W/.I!WC7# X@ @^#.M=D$S Q0I[MS3B,"2"/%A7)!Z2V&%
M$-"$1(J'TW3J',Y3B5CEX^[]2C4%J\.^I)&4^J-7 D^VG_>)]&/:PKU)\G7$
M1<H.&F49?O:D_/4BWE#43]J(Y_NHOYJO=(@]O3]KLTYM'5IT7/7,"<JH=L$N
MU1D8?6-()')Q'P];A195^2(+,(;:(DBT)0\<9E'JP@<=E#=9'0-8&PO!:T@H
MA5QZ24]@<!UFK1MG<\NF8CW A5"-'0!^<\3U"L<4KKE?EC5>H6B#G8IBHU>P
MP2[L=OB\7*MX/.HDW1X^7UWKDN2P-"K>'F5Y<:-:&;"$6XPSASRE6,LEU&ID
M802YP*: #Y0*.=QRX*IQK#':2HUCP0&@A=9(R(5K>&?'(85E.DT_;+U[TB5:
MM?5NKP>HJ3;J<;,1-I!F?O<N1A:S%!F0<>V$"7&5LK$!A;;3V,DX4KTN-MI9
M2X]ADD@[N0,<2Y[@4(1,3GTG'\N&>..?O(R]H#6-(4%5P PZ!A5;OK5ETO1M
M_?K<<.8W/==+IKR,R[(!"9>M,S8(P\ )>"7VLLLNC#+SEY7AI.<>,JQG/(MI
MHXPW6<I0[Q 5-S#)+JT#.(M\9-93&J$J/N\NY-A#LUE>I(>H#OM.C(4F5!MT
MS*J"2$A6'VQV8\QM25^C#?V^G&?.,XYA+VFW[O\ ;UD^) *S!A%QWB=C0![9
MJ*30&PM?;)MMSI]">V37MBQM;5,1<38Z[ 6&O6>K!E1"#4IM9\1$R,%,PRQ$
M*PV6E\9X1:L-.8=^R[3%+$V.1VAS"44$@@X\%Q!7AQJCA+%*Z2-NMC@% (!!
M&'% A%1^;H.U]HQU#@-COX@8EZVS>P;?FF3C 9M::@WTEZMHD?,,-,&2TC%2
MQ(\@7)MCH;R5%>$9QA;><V;+#"7.BQ=I#0HS7RG)PPP Z#5'13S!K9<&ZBXH
M<D\EJ\4.)/541MFA[A'5[=-%J;DQ<*MM*L0\TT3<+./(RK.Q I(6)GAC"Y-Q
MD@@.Q5,0!2'%8RAI<<XE2O+J,9R,N6%\<CT:]CB,!AIS&705]FJ/MGALD;%<
MQX!Q..K(^R$]BI[ :(KVJMLQ-VU31:Q%0%GAR*K?8V- BH\F%^E0[(P-KKSS
M^&WF&726\@RH RTI+0Z.3[:G!E>YB=<OF@,<SB7 JW/'I!_.#PQ'&LC;9D,X
MD@:T-(1W5T$?F(XX'A4BV/ 74'85&VA3:T)>5URLW6FRE4?FPH&00-;Y"H2C
M-@KY\HW]U)-"?J?TY+;SC*G1B<^A6<H]"JQ.C,3H9#I4@JBY+@4QXU>5D@E;
M-&-2 @A4S0J/8K EFU#M<RRP.PWJAG)9]',J\S1-/;BLFH4U8MJ[V>UPC_WU
M&E10-L;+!LOM3#JD-95(,9)&9RA>6^;+)X0PQ:L Y07-#EP .&*98=6!K6?!
M,7B73B6H0UQ:F)(QP7/'KQ%>CG7Z]A5^6B(Z#C6,EZFTI7611;.5+"MV2L;I
MN%_MP#,M92LS1@P$;/H6V25Z?J,Y]*/MQZ$O2HRX.)/EO.28%@:,!APX5'HL
MH:0 /_&P9KB'EQQ./&MD=XUNRV6G12:E%LSDU7=A:RNS4*[(C1*I86E7R LQ
M\>/(&X^B&+)"C5I;4]E+?J_5S_LSJ6[V,D.LHTM<%S16D5MW+'OC&@*X/:4R
M5"#6*6]57-ZIR JH(<.4DNU==VZX(N0BU.(JH>TZS9RSB"6"7!W#AH",<_BL
M+4ZKV\-IQG.4XYG[Z/6"N A+>.>DC\]8>YD+$3$S!W#+4#^:L;U_K[?(FP@5
MN1@)Z;K\?M-=V;N#^^;P+2%PC=[=O$>3G4HLDAA%U!?RWX9PS]W*/;^I4_GS
ME&<K[J-S"\$!Q8B: JZ4\KH]M,$K"VUE:[002W6JZRB*OD]/M+C60936FT -
M7V2'K4<*B?D>P-YV ^,))5T.<.ITSLZP6B/*K,Y-1LY"0=M=CB G6'R6L.BX
M2I*5LO80M&(2PF8.>>R(@WBBAH&("$C/P^"LIAF$):P=HREW!4+B<"5 .580
MEZ#LVGAGS$[75%R5L["]?IVJQEQV#FYER3L,I("XFP6GZ%:P3DE (SA;0;@8
M>'V\,^^EE6<[#9(9"&M.#8G@HU,^('ZU/%*US%-&"YP[3I6$*Y<N!/ZD'!:G
M.SH:?A*9M;=5R#@J#=BK9KFX:VJ+\Z),/NV/586$P<04> VT-+6?8;.3HU0@
M7O9Q'NM-X<5E+F48X7-=(RWC5T>EP<43!V9Z@W J>-99FN;&^XD ;)J:6A>+
M<AUEV(0<*V'UG%'ZMJ&JJ&> 3+S$[B7>M\X.ZSE(MMD ):[VB:/9RMPAT.6L
MKQ+274YRAMU]E"E>5HQG5F<)GOD!1H1!U8 #Q"MF%IAC9$<7%5/7B2?&:NE_
MJ,M8;WI";"#8*BZ3=['.V!QYX=&0PS=8WBNQQ++#RL.%.XG9@5.,-X4M'GW/
MLPG.<1$]K8Y&G-S0![X'\P-6EC<^6-P\EKB3[TC\YK$\?J:W"QM:8^Z0VGP.
MV-YVP?Z#8_'BGS5HV$=&2F5H=\/%N1<Z'C+&,Y?0E7HRG'HSC&8SL)..!@#?
M& W#V0:P-@>  F4Y=XB78^W6)ZUIW>A-HU>7;HV4;:IUZDY>S&B;&A,4_+4M
M7+G!YE=<ZYA(6#CH<$8FP)?PL[&99E#BFT^_ZWEYSOGM@QXC([30!V2N!!1S
MB2N7##P5@;;W)>PR ]EQ)[03$$*UH 3/CCX:F<;1=SM:OBM-.ZUHS E+UG:*
M2S?GIX(]=B5C7\K4X$FDQ2&A)"M3%E-)8=DWY%3;3#.2&L8?RZEQ&,R6_?&X
MUN5SP=*9=H$J>('!.JLK8YQ"("QJ-80JY]D@(.!/%>O.IN;3=@TZ=U7>*M3X
MVYOUK4S^L;!5,S\=7I&)60Y5Y)B7K\B>TY#D#H+@5C&LY<94IKV7&LN>WEO.
M,212-?&]Q:"_4"BKG@>/'"LACE8YDC&AR,TD*B99<.&-8>8K6P=:WS0>!ZA7
M[7<7HSM7=I6H1L\Q%1\)B^WK7UB(AZ=,RH#06'*_FQ(&]3R1FR&$D93E.5H1
MG.7Q2QRJXMC6, HJH'!2!TI^:M<,EAEB[(=(DA14346E >I?SUE/56H;=4[W
M3[-/@Q*&VZCO8R::BS6B8VM6C;&W:ML "MP:'FAC'@8N*:,&R2AE#:UM+S^9
MAY*.89IV/C<QJ^4Q.L-:6J?:K-# ]DK7N3R7KU%S@Y!X M8K$U'O*$A];PH4
M2=B/B-=/5PUFG[#A*!*QEG?M4Q($+L]H&A9*R2%/7%D!+89ARTNLD,OY4RO+
MB%)S&>V<Y[B0I>N+2X$(,@H"YYCQUA[BY:UK0, Q,'!I53F45$3(]-0D8N8Z
M]1@,#81Z"39);K'3*;/0]RNT;6&:ZJCFWT#$I'R,B(_'6VK33D^XHP"+<(E&
M'&6<N#8P4UGF0AMTXN;JT"8D$!573[!"8$X=>%8QJM6Z7:=9A ()1$7CQ!7$
M#'JQJ_0^F=BLP>I+A%0%QG4E];M/T>4K]9W-9=,SM;L5/AS"4?>CD4;'B2\$
M6JP+0ZVY[I0)#"U--JP\M.:NGBU/8XM'\UQ4L#P03P7(X>.K-MY=+)&AQ_DM
M"!Y800.*9C'Q5=K-H?9L1'U@&@UA<3-@ZPKM68LM(VJ7%184Y%NS968+8=>O
MD=9 -BT*'/EO<"=6&[(Y9<?:4A.%-Y15ES$XDRE6EY*%JE"F+2$TN*8XIE5G
MVTS0!$$<& *'(%"X.#EU <,%SK?B.0:W'@MR;[),DV&,B0)';RR.0:AA"2WV
M&<YSEIEU_"E)3G_=3G&.>:44IE7IA4"YU6<BIIQ2ORP_\FG/O+^^KX)_L*^_
MWI9_WO?+?_>3TS_XXT3GRCSK_A=B_HY?EWU]7\C_ .9WW^LB^0979_S\[K]'
MJ#;(O(NMZ9,7(R+D)IF)5%M)BHI83<@<1+S$?"!CC.2100#:E%R*/*G76T)3
MC.<YYDBC,L@C! 7B>H+6*6011F0@E.'A*58JQ?[=*&DHMNH[3KB%$CBCW[+9
MK3K$^*:R-EK.1WD5>[SL@QE;*EN>ZME+"$MY]:TYRGS9\3&CL/:]RY .7VP*
MJR61Q_F1EC4S):GM$UDQTX%AQIE\P5EY]D@AAITAEMQX<1+:BWVD+7A3C(R7
MD9<5C&4HPO'G./..8D.=9E S-6B,MM5FP7Y2&LU>EXT8I(),C&34:>".:I;3
M20WRQ271VBE./(3AM2L+RI:<>/.<<DL>THX$'P54/8X:FD$>&O>-M-9F0")2
M(L<%*Q@C2WRI&-EX\X 9A&'5+>(+%(='9:0EA><J4K&,80K\F>"Q[2C@0?!0
M/8X*T@CPU=E%"H%4<LD=(21\E*,4\VD5(J6_>42HC*L-8'PUCU97Y]/I^WSX
MY"%4XU90B\*L(UUIQD$1:!+;62JT'EQ)=B&GHI^"%4TI"'4D2[12H]C+:W$X
M5A3F/&58QG]7'+&.0.T%IU]"%?8JHDC+=8<-'2N'LUR-6^IOQ#%@9M%=>@2<
MD8&FVIN-<B",BLDD%88DD$Y#=R,.$\XYZ5Y]"&EJSXPE6<-#P[20=70F--;-
M.I1IZ5PHNWU-$"FU+M%=16%)2M-C7-QJ8%2%N^PA:9C).(_*5/\ YF,^YXRO
M[/U>-#]6A#KZ$Q]BFMFG6HT=*X>S7DZW5.+AF+')V>O1U>*]CZ6=.FHT2&)^
MJQE0WL2A!+8+WU"4YRCTKSZ\8^SSP&/<[0T$NZ$QH7L#=9(#>E<*Y3K/6XQH
M-^2L,''L2.!\Q[QTL (T=@QUE@3(;A!#:"<%/$MH;]&5>M3B<)\Y5CS 8\X
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M<D%%!9)>]661\%'O,,9?=PC/I1ZO4KQGQC[.&M<\HP$GJQHYS6!7$ ==4^+
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MF1C98)J5L!V &G7BQRU#Y8#=SY>2A2G$X_43G/V<LV%Y<6D:7!I..& JCIF
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MHEW(BU)0AQ6<IQ_[,\/AD;(8@-3AT8U+)F.C$I.EIZ<*E,U;:K6Q1#K%9J_
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M:TU\BP*"V/#RAPP]/UU6H(N47685E_"I$KUM88(<;9RI"?5B>^:U[ 2Q07'
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M*2O$8#I5,>KKK-+"6.?W+!I,0"<#B? N'!<<JP<S0M@'$;$("I=S^[9VBZO
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M)U)6HVM*[^(AJQ'5S54N!:X_LW=;P?MS,7&-0RJO7]S6_P#$:\6=!>9')4K
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M'U3V+B9M"7EY:<8D7(V(4MJ(A1Q"!74X82UE*GWUVADA:QO:&G21BXX$KAI
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MJ\2I6(S1@HO[6GQHM9"YBK+3BE1FTVV'IP<8?-+(0/+6:KU(/(["B%*F+?/
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M$[*Q\>.)(V8X62GBVL*P[*' Q0$&(25G*LX4ZQ$Q8["?&,?Q;2?]OV\L7.(
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MA>,W:YPTB<M-UVM))!3#LJ<L_)7+P51S6]KN&N%KV=0 (7'M(,\O*3.HK)@
M',;S TK&V*#UNW;M!D3L8S2[J8.FBJC[+^*"8+7B2ZQ:)&HJDTLNF!!+%08*
MT5E&'&%Y2YD!([LW!!ETO3$9X(KL0O03D4XU1P!$@MP1%J8N!RQ5&X%.D#/'
MA5_@*7E^C6*%@Y2:EZ'.[NZ[ "B5G5UMTU4Q657^':O$A2@).XSL^D8F-*91
M(E#LQPC+XN5M*=7EUQ%'2)('. $HC?FX//DE%0 >#,XU9L?\LM:28C(S)I8/
M*Q3$GPG 85?=@428JT5NNG:YB9"MZ[$VIJ26EX2#K=AL<6/3I*IQ[UX?B:?
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MP1@),]\]E2V?IG24^CT+4I/NL^YLRM ,TBMT.<TMQ&(+E5*U8G$MAC1VMK7
MJ#@=)"+Q\7N4UUHNF&.]8AIJGF$B77KW,R6U1I)Z<6):;'%1.IGZ\S>AWR?8
MDR((FP27W>P8G/TF4X2TE.!V\-I;F0=\6NQ;*-.6 .I4\*!4S\=(K:,F$.;@
MZ(ZL\2 U-7@4HN7BJQUN*K28C5/_ % 5FU6+78NE!H2H"&5ZXVJ,C+S'VZQ,
M3 \C&PH4B:)9RJFW#MQ1!",.Y;&>PRYA>,^;/<_4_P!%+1+WBG$!0@3/@JKX
M14-:Q&>D@F+NT&!.*E<N*(E9$U?K^3L=MTX/M>"G)15<TA)3(85N4<2]%30>
MR(YRF$3^'5Y:<N\)5GFVU*?RLEEU3_V^K*E<Q32M;'(82 LB8=&G%.HG]%98
M8B]\?? E(UQX'5@O6!^FLO;AI,5?=JZ3@[+#NSM25'[4=G(Q[!:H,Q:(JLYC
M1YUEE2!2Q_J<9<:9(\H4ZWA6,9RGF""1T<,CF%'JU.GCE6>>-LLT;7A6(Y>C
M(9UKYK>A-5!/7.ZQE9GW[>Y:=RURPG.$3!,\?38:F;834JH<5)D/>S!A+KL0
MS&,O>EAA;;66_"G%97M2RZ^]C)&C2TC)%):I\.)6M2*+N^ZD:#K5X.:H Y!X
M, E8YU&P0WLG7$O#5TV"(EJ_L./ON:I1-HQET1-G4F6F&('8&S=C$QT=<[RU
M,QRE"IP(TELUC+F7&VUL(7EG3N7M<00"W2KFD(H"M:W()GCEXZQ0*)FN:""0
MY4:Y514<YV97+#/Q5[ZWAUQM:V;4X*$M9D1-:?DVK!>J!KG9%'V1&2H),8.P
M#>Z/:)%%3N6RY%N6,<?(BCE2)+01*,8PAYM:XE<KV/<6Z@_ .<TM3J(Q#<!F
M$"BIB:C7L:':2PJ6M<'+AF#@79Y%2AK.W6B>BJ3&['01#P<10HMVJ'L7>HU+
M9=(ITM*2[YL(1'#Z]NC#ZH2> P*&[)/1.7@W,FMY?6AQO*4Z]VUTA8A)E*X$
MM)"8^4,QFBXX85LVCA&'J (@F(#@"N'DG(Y*F&.-9=[.DN,ZN<&S!%3D?)V>
ML 36$8M3T3%PWWHV8;*VD"E#%667JK> TLFACX3@E#^$.+0UE:L8+,?SE5"
M4R4GH"X ]!K/>'^2B*"0N:(O%,2.D5J)KB-D6<'Q<;#X$K8_970MBKX%>U_;
MM?U)N*,'9;EIFM52UF24J!$/'1KGU!*E-MD/-+>PA"%I\[TK@4<3V^Z>"K@X
MKP!(P6M&$$*T#L]ZPA&EH3I .*5>XB&@&8?4?Z:ZQ.R^I&8?<[&8QRMV2P0
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M$^P*BO8Z'4U+[+BX&G."V6D5NMQ>M##Z/M6^W=^*K52BI .>U?/P[\;2M?1
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M<"N"#(H,">I*SM@$A#9@7 0\5&*E%"G$#K)%7'45:AG-EZ:G[O 'E6:Y]3:
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M7K"Y?9F:5%BVJSS$Z*\W!+&(*>R6XET530V/=1ZI+N]6=S#::QI"@X+@@&0
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M\->=D:_E:DC<E0UK$2-;UTBV:.F[!#05=L=EBD5P\&>9O1L?4(.6AY*<$>)
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M7,TZV^TV\RM+K+S:'6G$9PI#C;B<+0M"L?8I*TYQG&?]N.13/$95R<5-4AP
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M4??K'69"3I_71,D^Q/8<=@Z%-["M,#L:V0L 0E[WFZ17$*?:(;9<Q$K-??\
MS<NYSS+ .\@C:6AP#G\,W!H+03UGV4 K#.>[GE<'$$MCXY DAQ ZA["K6;M,
MS *=I7RJ4C8DULW7,=3JA-.R<Q<2-A)K5UE)*P,%0H%P-,D#2FY6"#&,<#62
M^D-6$J1[27L(SKW#3W+7R-#)2XA -*@)BGAP7CXJV;=P[YS(WE\0:#B=2$K@
MO@Q3A6&ML;"D:GO.9EW]@2<I#P%AUV"BCU?:#M.M=:;+&@G"HC&HK'&)K6W8
MRYN2*W,&"K=.1A]8[#C;HF,)V((@^W#0T!Q#L2U0<\=0Q:B99<3G6O/*67)<
M7$M!;@'(1EAI.#EZ<^C*K\B2M=UN5;J)M[NT3#R^_P#L) RF:[8CH62)KE7A
M3C86!8E1%I.C@0B&$>VH9;3S2,9PTMM6?5BJ,CC+PUI<(F$*%Q)Q*5=7R2!A
M<X-,KP4*8 8!:CD99BWWZ72=D[;M]3UW%6WLI )O!%[?J<Y9)O6NS&:[0JY9
M]@LD1QZGAZ@L\K*5OM9DW O+GN^TI/+%@&J2%C72EL932H <U7$-\*>!:H'D
MEL<SW-B#I!JU(26N1H+O IZTJ(0UYNC]*UI>*Y/2M]N$=J'O255+#*X3)RTX
MJO[.J8=7.<'4TA!CS<;'#9:&2WA*L-I:2CQX3S(Z./O'QO ;&7PJ!D%:5K&)
M).[9(TET@9,AZ4<$J8:3M]]3<!LUS8%,VFB6UU+6(NE![ZNVRY"6+:,@T15@
M>,L>M(N)U>Z@@MT=X7+H@[_OY0V%[@^<HQW$<?=]MKF(\!= :F:C!RN\./AQ
MK);R2]YV7M>K"4UERY8XM ;X,/!A4FW9L6P+.HM?N*#M9RI<1<[&;7Q>P$?J
MJKFAQ1$)'@&R>U8^*'L)98>3G'414<PI/MJ4\3ZDMM)S2WB:CGQ]MH("Z-1Q
M7]E4\9\57N)7*UCU8Y"4UZ1@G[6?B'CJ-ZID+7N)O1D)8MD7P2.E-.[AF9TF
MHV^7@9"P'U+:50J,"2=/",Q4XX3'A'95DG"12WUHRE_'H=?97>8,@[QS6-42
M- 4 HK23AB/SCVJI"7W'=M<]R&-Q*%%1P QP/YCT\:C3<J=)N=;;Y9;_ &,:
MS/Z WL*&:[9ONI$U/U@FF)BL*&1].Q(34VT0IPU*$^Z<H%A:L9]C&>70-[V-
MC1H[UG!4!5?$.'0O755),,CW'7W;^**0B>,\>E.JN.R7U\BHVN7O>ZK;KVQ5
MCKUKJR:M$ N[M8_%<S.4!^0D[(Y%)?:_2'*R5S1]W.,/))^G]"?;2T\\EW)L
M0$C6QQM<PRN#L%0!V2_LA,:/E[#G22.:]L32W%%);FG[17"K3?-@;"+G[)B3
MVE T)JIZ^UO-4]ZR[HM^M22V)2BQDO)6X.IUVC6<7:CK]O=,$>'+49ZEBH'2
M(G+F%O6CCB#0C"XN<X%&!W%$4D:<$."=*U2664O*O#0UK2%>6\ 50 ZL5&*]
M"=,YOQM^+A>Q5W-V1=XBPZGI>OK)68RIV*8@JD'9OT:Q5DFWWH%\8%R9AYB5
M1E+@,H/EO#*E?Q#3RUJQCB$0=%&&-+'N<"H!*:B!CP('$>S664REDLA>X/8U
MI"$@+I!.'$'H/L5M+V7CL2G7G=HN2I /T:NNQR78PIP,EQ<57SY1 :W6OSW
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MQ\_##;>(UE=ES@Q<T[.7N'C[)&DTK<V;*_'9&S%F./8%6PEE+:,D)RJT#63
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MID1%2+X9,A&1YQ,>[[X!!@0Q+X+V?3G+P;K[2W!G<Y3C\Y&4Y^S',8<X! 2
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M"RO!GL%0\[<-<UPB1+])6'/O)D6Y/K1Z,I:]QIORC./5A6(6[2]C5*.C+O&
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MT5"*%7A'D9ML2GA8<3CSAQ25YS_OYYD$\@+2$5H('C5?SFL9@C(<,4<03XD
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M0-7/H<!,$90IP]IK!+B6G'%-XP74<4;FB(D@L:<DS *YG//JRK-:R2R,<90
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MA$N+6@HL5EY#:<(7E;F4-Q':L=H#GD/>2 $X@IB5R/@-3)=2-U.:P%C "2O
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M&-D2& _S?"590C*:.NG.![+1(X(78J1[*!>*#&LC+5K7#M.,;2H;@@/L*4X
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M!GPH+;$.>]SGARJ4X A$   Q]FLB5&E@4YVW/ E%E*N-QD[H=@O+/@4^4"C
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M?<E<@(PB&#,EI' 9)[WKD+%*P<#%1X88JW""BRV66DXQC&5.+0A>.&%TQ(&
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MQ([04(@).'54>F,+&N:'%SE08 ]DH54H,>NLOZZV!!;-JXMJKZ2V172Y*,,
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M_?5\$_V%?:%KB]=TZ;WL^4%/6KK_ *;W5&2G876[]K>NF\975\A5C0](4X.
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M].'RV_V#NM7^,,O^J+CU3]WWUQ=_0S\Y3UO]X?U/:?3!\W7P>_AR'_G]4O\
MLZ]K_P"P[U_N?_I'_P"Y7_R?_9_\S]SSZM[U_FW_ .NZ6?"KY.[IGG&?Z'H?
%[/DU_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>tm2227887d1-pht_tumor4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2227887d1-pht_tumor4c.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ N '( P$1  (1 0,1 ?_$ .T  0 !! ,! 0$
M       &!0<("0$$"@,""P$!  $$ P$!              4$!@<( @,) 0H0
M  $%  ( ! $%#@($!@T-  0! @,%!@ '$1(3"!0A%1:7"3$BU)6UU59V%S=7
MUU@902-187$R@9%")+<8\*'1X6)TM"8V=S@Y"K'!\3,T)36V)T>'QT@1  (!
M P," @(*# H(! ,'!0$" Q$$!0 2!B$3,0<B%$%1TB.35)0550AAT3*24].5
MU587&!EQ0K(S<[-T-18V\(&1L5(DU FA<G4WP6*T\<)#-"5V.(*B8V0F_]H
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MWXE=_ R>YT_6#P'Z<P_RRV_&:?MVZ0_C)U5]8>1_._'S!G?B5W\#)[G3]8/
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MIIQII_V?]SC31/\ L_X^-?=;7/:+_P"[Y^T(_P#$^N?_ "LWF'N:?^Y/&_\
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M0K;&$EE;WRO-AF/\/QX\7C7<YA];CR)+6IMXEMEL.QZ,=PESZQ),;[9&P]6
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ME%H=*!9U^Z9"WJP48Z@GR\/B4\TJCLG9P2]8YGI6D3]#*(Y$^#\4L6PM.?\
MJ4T>0E_YKYN*1E6AKZP2'$AZ4#KO:+K6,B$/_'UG_D&7^KM\^6=QQZT!Q/\
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MY?\ ']CI'\S^?/V@(OHEOE(_Z?3]W9<?I>GY+/YQT_L76G]3@'U.D?S/X_:
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M_P!BZS_J< ^IXC^9W/G[0$7T2WRD?B-/W=ES^EZ?DL_G'3^Q?:>/C_UFZ_\
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M5R2>:%\K)%\'L]9[EJ&*JM3X#5'82.\HMY JHYIN*=5INI3:-QZ^(%1T\#M
M%(QG<T;:N1F7DK3"71FV$I;&QG(-7BS,%+ TJU8X)"L<"WP6.160*^2-R3(W
MR^/"-T9?0I0_;U4WN)NH)E>[[J*"% ^X)W+T"EB:J>O0>T?1K74]=: 2Q4QU
MKH\U"LY L,T]U7Q#0RF0E-5\%1)86=@@MH/",]T21??HD:.^]=&KE[: T;I4
M>S]KVM0R"56D@C2<I0U"FO0BE7 4!E-0#44]CJ#K(4#L$RFH81 X(AHA6_#6
MDC9[(Y4KW212EB>H]?3@:H9C63PN\L+GN=&J)]ZQW.@:02RU8@U'V& %&\/$
M$=#X@]0:ZZHKF:.U]2L*1AEHWC1D9B6C%6/H,"0P^Y8$AEI76=?LH]V'7W7+
MFNT?6@FHMR=%#\'NK=(@KVCKY'!@Q1PLLE(KA7ND:1-'+$^*95F\LDGE:B-L
MCF_&[[DT9N;.Z>WA6(@P4Z.RU_X>I# +T-105"@DZS_Y"^:^!\L[KYNY#B8<
MAD'NU*9 L-\4;!!0=ST%*DR$LNUJL0SE #K<+0ZNT]R^LP\X%9)5]9=>7<.U
MT5G 8A]?H]K53R/Q^9J;6&*$2VCS\Z,/L98/5&;.UD*.54CE=A>XLX>)V5P)
M'WY>ZC,4:D49(F'OLC*22N\51 :,02WM@;UX[-7?F_G,<]I"8N'8JY6[GD#;
MXY[N)B;6WBD "RB!J3SLFZ,.%CJ?1<YE<L/6?M.--.--4"]T]+FD$?>%/KQ2
MWR1ML)0S7U8SV+"U$LK2(>0"I;*LR>1Q,D37^#O*J^5?"KM;*YO=PME#NH^Y
M!7<?'[E2=STIUV@D=*^.HS(YC'XC8V1<Q0R$C>5<QJ13^<D"E(JUZ&1E!ZT)
MH=0RWWC0-[UO4#FUQF9WM;KQH#()H)FNO::"IM:MXQL;WQ3#DUK3V*UJKYI$
M8J+\G@LC;XHRXJ\N'5UO;1X2001Z#ED:JGJ"&V&OM5U;U_R<6O)\1812128C
M*0W2JRD&LT*Q21E7!(*M&)@0/%MM/"AQ]]POO1PG3_7&BV&9FK]E:5&O#Q5>
M-"4R6CMKMM97Z&Z@&M@")&2LJ:,UJ2O9XI&7(R-R>'F5+AXUP2^S&4BL\ANM
MK=X&F8D>FJ;F125(KZ3J:#V5!(]C6+?-3ZP7'N"\3N\Y@.WD\E#D$LXT5@8I
M9^W'/*JRH2*10N S#HLK*A_C4L?TK[_O;R#UYH-IO]TROWU]?GV]OFU ,EMK
M.18!1:0/-PQCI$37I60PMC]21GP[E=ZRQ-1%Y-\BX#G9<G!88R(-BTC"1N6
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M.0.>F@]-8_)YOB58LCFM155[46XIO+WED:M)%;=Z%17=&Z-4?_*M0Y]OHM:
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MS_RCIQO_ "[8?V*#^J74QY1:FM.--1[3_P#X:-^L.1__ #92\@.2_P!W1_\
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MLTL8)J=K,M?X:$5U&WV&Q&3(;)6MO<,HH#)&CD#[!933_5KQ&_:A^X'(=/\
MNI[.Z^JZ^XSSL_OB?AZT:OKQ$5AK"[81T$D3HVBT,TD3I!/49XR1JB^"HB^O
MLEA,P7X_833NSSF)"S'K4BJT%6\>@+'_ (J].G3R]YWY?M^LKD,./MXXL<MU
M.(T'O>T.8W)HB ,/?:HH\$()-22<![OW*U)XM2T,YM=,%&1\*]4$C1XA9<T\
M-3#%,^4+XN @_P#R7S1^E)(KDEAD\5;RXQE(F H::QS!PN^[S&1#(HZ$4:@V
MCJW05V&A)"]0.H(K76+'=?N$-#&T-._1E% E7%>*D]+ 9'<V8ZQL(G:.2K1S
M[1\$*.;*41% YZ)Y6LE9X3OC<AE$[916H>E::R)Q'@YNKB&][*]WM.Q[A!C#
M5(7<.JK4THBEJ4J65O0$^]L/?8M;HK*IDIB-94&U+K(,$FY/"J*MX,I<TIA%
M<Y&5Q!1;FQ-G<V1LSVO\BL<UZ*OW#Y%68QCJIZ_P:B^=\,ECLXKMV6.X2;8?
M14E]P6BAJ[@HZ[005%*@UJ-9@&Z]VX)$UD>2/"JH:F2PMPT?3D_,/P,EG&%Z
M\]>2/)]$+)M<PAS7N@BB<L,WA%X*U;F$BN*@=/\ 3_PUBA[#YNW67?5IBP"D
M!AOW!":!A03)NV5H2?24;NAU>W,6[3#3*JJ0EL!\4)B)3'AS&59)=AIA2IYI
MIF+%,,8)2O\ +)(DK723/'<YL;H8X^8ZF@U!W"%+<22^*U%6! ("J:4]OTO#
MH:>E2HU+)-7?!WY-2?"1!5U+2)# 72CR2F-A+<R$FN$D5D;H)@60J*USWJUK
M6O\ 321ZHO:D@5ZGV-4,UBDEJ$# NY!\.G4"H)(]CP]JOMCKKU9_9]2YY_MN
MREC3:D6_;8!5]I:Q+=@VAN<LS:@$NVI;.,"P-$IU&M)2)(1U\L[1Y&.G\9G/
M5-8O,E[B3D\O>A,5"0OH%0ZAB%9:@%O1 !857<"%]$#7K)]6.#&VOE19>HWJ
MW99$>4=Y9&@E:-&EB<*S"*DA=D1@L@C93+60MJ^76??>/[@U^YS_ %Y"?HLW
MU]./4778XGPCL4?KI55Y>4S=@TE\]^;2BHDAQ$,?P<#I8F-ED>]4;!YCC-_@
M;&VN<J5BN[I2Z0&O>6+V)9%I1%<]$4G>:$E0 *Y(XIYBX/F^:R..XRLMUB\8
MXBEOEV^J/<GJ]O ^ZLSPK0S.B]I"RJ'9B0M\>6YJ_P#3C35H.Y 6#Y@S5 2Z
M,+1T0DS:PS+U9UZ60R;[YU9;4 <!;+JA(E:U9XY89&Q(GJ)X>#D=/\?F+7BV
M,HA:SE8;A(P0"G\97)&QP/ A@3X>U2Q.>VPCP\F:M3=QY:V0]MK:-YG8'_\
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M@. 2K#JK#H1X'55Y5:HM.--0[L3]W^Z_4[3_ )$.Y6XW^\;?^G3^4-0O)/\
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MY5;YI96^FQ%Q[YC<FP*1OPS*)<1OL24SQJCE7(Z(T3LGHT](LK!EJ0JD-TW
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MUD[C'XFQS^3E81K<"&&WD+1LOK+LXBAAE+&-Y>\PB1=[21Q1[4U?=A#56OK
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M,:Y'R?#.=X2>+$<R1Z-5&HDJI\CO!/N(ORHG+3%HUW=BPB3==S2*B -M%6(
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MP9$LP=A6'5[LZMG9V%C+5G02QJ:V8,F)S2)60JD*MC5T:)&YK=B418X^V@H
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MB#0M9".,-!&UD;&(C6,:B(B(G/>&VMK>SMX[2T1([6)%1$4!555 "JJB@"J
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MU]K[/^W4VEE/-<"+'.7GM(Q+$8&** &!*R*%ZLO0.P8#:*58[2>.K<W%HP)
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ME"D]6!-&!%>HW4(ZFAZZM=G>K+(:VNV:4CX:HD$>Y"W^<RQ'G>D"B11'T 4
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M4*16O\5AT\!6K(IJ>,\:CGP]_)=6-VV0QZ[KN)HG  [H3TRZN/1H&97;P&X
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MM%960K8(XIIX8VN\CF?+YUYFWR<SMG;W4O&Y;62:]O9HS'(G41A%?>7J1M0
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MH8L<L2F&1&^<=SFQ1*UL\<]F9[M"ZCK<I#.89 H<-0&E>XL@(2%Q0@,X:H)
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MZF3T[G%>+E]/PENODW*N,8.UBGN6D6Z-QL[(VB5X^Y3N[-VY(RBEHW;;O!
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MA-,P/;Q["-)WQBO>1A6=G9'"]O>UZILJ@GJ\$=ER_=$Y$C95>Q8 ?$6%=4-
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MIHS!N0CN %7J_41L=@6-E8$U#U0!=MWM!RO=^K]G.6,KNQ8:F+56$MWF,L(
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M$[+3>M".HH/'Q'3V=:Y^C/LWK_3Z3H+W:7G:E_U?[EL1'O:?N2MJ*VHTN5[
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M(.[).)4D#;B654D8D58-+M<':QZD:\YW8/V5W?-/I=%-TA?BR9"AV<&;S;=
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M(=FEJ1Z *J1UZ5I>MOQ_BEWQ*_SZYE+?.V?JBQ8^6&1I;QIF87#0RI[U&EL
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MHK9AQ+&SF"@,B:]6PR,:QT:KXHJ.^^Y8\OE7Y>+#/LQ%L!+&RL$6A(H1Z'I
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M2QO7TFLYU/G9Y(.Q(B'WD1[O2W #K4&OBQ)W^PP)!'6NNE^374MKZM+&C?\
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4M)E55D0LS&-@  #4DGH .I.O_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>tm2227887d1-lc_human4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2227887d1-lc_human4c.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ C@'/ P$1  (1 0,1 ?_$ ,P  0 " @,! 0$
M       ("08'! 4* @,! 0$  00# 0$             !0,$!@<! @@)"A
M 00" @ % 08!!P@&"P$ !0(#! 8!!P ($1(3% D5(>069I87,5$B(W>W.'A!
M)"6U)K8W"M$R0ABX.6%QD:$S-=5VJ-A9&1$  @$# P(# @P"!P4&!@,  0(#
M !$$$@4&(1,Q(@=!%%'A,I+B(V.3%646"&%Q@;%"LW4V.)$S=+4)\%)B<B1V
MH<&"-"47LE-S_]H # ,!  (1 Q$ /P#W\<4IQ2G%*<4IQ2G%*<4IQ2G%*<4I
MQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%
M*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4I
MQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*KW[S:KW
M=L6=K.?KBL7G95)!5G;PRQZRUSV.L76"QN[2LS-"QIG:4[8-<,UZ7/JVMF M
MDC3!_N)3C<@_%(,CI[X]IM&2\?S,#%65<IXXIV>,K(\"SKVUU]V,(P8!GNA!
ML.B%2RAC6-\@P\_*:)L5))<=4D#1I.T#=QM':D+J5)5+."+GJX8*Q45#2[]9
M?D6NAGLV0?L"P@7LR3K0H2&$;OL)-W2@;2^[M0U^A$Q$..6U\Q A;(T0)M1H
M_FND8!,I/F-1IGMY"D8CSF/NW&($Q%"ZI,0,23$H[IEBD9P39[E)C&J:U*J
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MCT=N.VCMH5U!Y"3*%1%D!4IHTH" -+WTZC5BV7D,&UY&W"35W)+ZNXX;24C
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MY2(!&UE/G9@J]&!!ZGP(-;"1G.4(RK'@K*4Y5C^3.<8SG'_MY''QZ>%9(+D
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MI/N7'XC]AC?,^.GZ:_,-S^_^C3]O_P [;!_4GW+C\1^PQOF?'3]-?F&Y_?\
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M^I/N7'XC]AC?,^.GZ:_,-S^_^C3]O_SML']2?<N/Q'[#&^9\=/TU^8;G]_\
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M@=3#K?\ D3:WCT OTKPSNOK_ ,ZW/U-RM_</E<*QMP$L."Y)0)"0-0(U"S@
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MBE.*4XI6G=H!]U%+#I^1JBUU6N5H/L9@EN<?8(&91&V:V2",1GJ_6)60YE$
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M"?+; 2:(YR*&:,.ID53T#%+Z@I)L"18T;$RDQES7BD&&[%5D*D(6'4J&MI+
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M8<KM"@RQNPK)!B:EO&*Q8TGP;U4JSH^UN6L@%DW:,U]:FRFFXS)%N-A<#/\
M1^"W/->^F6'RM-M>;D3Y6.ZY#@8\NA]:F-+2=PJ91YBP #A;KX=3?'OW?;_Z
M*S\KAV_TJAV;=()MJQW;<\/WB P3#)R0^,,9)5Q&/:2-FD>!I+3?*\JVM*YM
M2O%U.*4XI3BE0B^1=%ID]/\ ; NEZXO6U;099K0\%4-<OVF':I!C%K"S@\Z-
M.I @Q;QD$>7A,.2Y8U,27#BX6^W.'9;]_'4K)J1HHI8]0=08EJV7NL>?T6WK
MB^3E&"X:):KZ>$:V)U.36MU^0$O-ACH8L\E4UA"F'7"<=F2ZZ[(92[Q2H[]>
MJ!^ ?E-[_?[:[ NGXTZ@?'O?_P#;^R?B/\)_B/L5\JO^Q5*_S.']!U^!]G_H
MT;_2^U]5S^D5YOL4J34#I/U5&;@);X@Z3J#.SBH1FNS2_@4=!Y%QVAK+*(M$
M>(N4 ?,0@0Q_G<<6U+RI*E9<\SCF51R[3MRY1S!$OO!%K];6Z?V;Z1X#J!>L
M#B],. P<C?ED6UXXWV2(1L_F*: % M 6]W4^1?.L0?H3JN3?(R/5C092;:"D
MG7L5DQ<94N8:.##EI"GT/S;R#VA(^A'@YR 8J;*MEUZ/8DM"GX32#KDF>E.)
M<V8Z_(UGE;P#!A-=#BJ^!&P0P($-@A@H<9%9@C10D9%:A#AH^%'0W'AP8,-A
M#333:4H;;1A*<8QC&.*5V7%*<4IQ2G%*C!LWM=KC5>ZZ/HH\]B9=[_3S%RK]
M?"2OK5Q(0@\J1$5%%T03&G64H\0S$D.1G&VL1U,0)SJW$-PGU8RO:N([GNVQ
M9&_XXTX&/,L;NPTQ@L ;M*Q"*!<!@3>[Q@ EU%1>5NN-BYJ8,G6>1"P ZL0/
M@47)OUM[+!CX*:K4J/7;:7<;K0\([>Z#(!H(#M,=,@-"4C88B4XN#7;])@VB
MWV?89'8T:206"K+YZEA1H^?"BI2TF:MI],B-(&[/S.2[3PKE FX;N*O))M**
M^7+"PZO"#'''"L) UN(LF5W1FZ]L%2K++C<.W96\;9HW?'(5<HD1*X\ ]F9G
M+];+JC4 @?VK&X*WCMJRM"%J;6TI2$J4TYE&5MY5C&<MKRTMQO*T9SX9\JE)
M\?X9SC[>:&(L;#K6<5]\XI3BE.*5H'LAN?\ 8W73UKQ5;);'2$]NO1(=9CX=
MD0I9&%/>9)3GU9PW!'QL0\X]3.,^9];3>,>+F,XU5ZR\_7TXX+D[][MF9,TE
MX(QC+=XWEC?3*S=="1E;EK&QMTK9/I5P%O4;EB;",W"P8TB:=GR6TJZQL@,:
M =7=M0\MQ90S'HM5@4.R290<;.(XC+D%4RYRLSH;$E2DSI2);D]$A>79&9CD
MM&5>HO.5I5XYY^8+DF\\NXYR#,W0/(-YS8'/O#C5,ZY199)TE^4DLA60B9&5
MPQ9@>MC[9Y%LD'O$T&&K+%C,J#MN5%XP45=/R=*I86'0D5G4@BW+:6E+>5X0
MTG*W,N8\RO+G/FSCS8\<)2G&/+_'.>:=Q\6 9&C+:2,'5X*&;5I)0=6 LSZ5
M8W\JDM9B IQN'!DQ7#$V!;H+=!?P_I^'P%1MW(0CK%K2V24.*YPI")J(F'IT
M5"%(3'99SE2,.85C'CA/\W^=_)_'GL+]L/J;S[AW)8]JVWE>_<=X=D,ARGV^
M7(</VU;0QQ89X%E96;2NN1=*DD$_(;MOGIKQ?DD WS=N)[)RG=\-![O!N!@2
M-@Y#2CWB;'R#"E_,0$*NP :U]0D5L;8URZT=;?"7IAX'>S.O$@X.TAC(&)/(
M3)XS"E8+S1@Y<@,=C^HEY<>8K+DCT',X=R\GU.?JB](-@S-]V39L/=M^S-ZF
MAQX9)FS8VAR)"45M<D+2.NJYTO:1G# E@;]?B]^X;U"3T]Q]^W7:^&X7&9L\
MSP02[:\,N-#J)4HD\6.K(%MW8U,:JZ@A"ND$>=JYE%&QZWK>[,AM#T5:<MY]
M&%,.6 \E$6"TYB*I6#N0A-STT>7$A"'9&,X\/)A2?4"DL=#"SA5)L.G6_0?R
MM7S,*R1SJ<,B1)Y'"^:[,J=2>OF (-QJ%A:P]E:LLA*O?@^H AK1 D6D%/0-
MV@;!BI*5,:*<'F%(@Q,,Q,Q1IS,9E&'%NHS)QEO*EY<SX)J$$V'L%2&WKD--
M/EOI1%34J.;K(6NHZ>%T!+'QL#\!-:2)[-L#PVV5:M-F9Z5ELBX5L #I,.Q)
M$R5>Q*RIC\5/IIFOSX.5H=0G"DQG$^9M.5Y\!L;BU3T6R8T&5C;CE-%&ZQ%V
MB=PT9<78*HO?2%(!OXGP\*[<32RM9:KE>BDY\2P'YDZ8:D/.25*B-LMKD,#?
M9KEJB3<+CLNN.*RN.K+^'/([C*_'G86!L?&K+(W6'.:;+T#W6-5TVT]3X$W"
M@^)Z=/#^ KG?@>$T8LS\"W!"X.LL$G%PY3I*+*6Q#&2'93*F(^)JXQ%E#"F?
M!/F\S6$*SA>?#.>C*"UP>EZY&Y2QPP1RP2Q22Z;FRD=6 # DC4I.AC<_*N/
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MLWXI3BE8R>NE.JJLIL]LK-<4D=,+J2>/"PZDB1V48(%,X(2H^<#H.74^L_\
M_":\V/,K'CCEUCX.;E]<6&64:@OD1F\Q\%Z ]3[!XGV52DFAB_WKJO2_4@=!
MXGK[!\->>/N?\PY:Y]6@&V^D9DSKAZ/V,@:UL5AV(,URY;"L0/43ELGPJWK:
M9-N\J959R,"WIIB4D=Z&)#$)"7'I$M,+/=TPN*^DFZJGJ9&NZ^\8@:+'PI22
MIE!*322%H  -#(%77\H2_)$?<T-ZE^MFU<3XW#O6WEW,F<L.E3"92#%)*&$;
M,28CI0,_2VM0 22!N"I?'_O^\=X>WFU=D.6:BZ=['=8B&H?Q?+M.K[AL T[8
M:OJ$ 4KMI&!X.8H9$E%?(KFMA68,.-F(B(/FXCXCR%Z_W3E/,N0;:>(Y[QX_
M"(BTD&/&D7U<C*5(+V:9O]Y,3KD8DNWG;RD67Z.]1N3<XWR+?W?!]/MRVAX(
MK-B2S:Y8L:-XY=*EP#]>7",%4^2*8KVWJSGK-U)UMUMTGK#340>%NR=62[$4
M!6T]6!F#*#-CMDZV2S$3,I9:0+((ER6&TNM2,KPB&QX*QAM"40^W[;!@8D>*
M '[9)#$"]R=5_;8_T^P5L[@_I[LG"N,8/&HTBRA@-(R2R1+KUR2M*7%]95KE
M1<->R+U\H E3R1K/:<4IQ2G%*<4IQ2G%*<4J,0??I@Q9=?@7JC&K:;B*A%GU
M'[%6&Y:6I4>E/I0)8;L2,$?<9MBD,H:R],4IE/FBI\^,<U;A>H.;F[GMV ^&
MN,,V%9#W9H UF&,;1@3#7?W@A0NJ0E1>(7K<F?Z7X&!M&Z;G'GOF';YWB'8@
MR"MU;+%Y6,![>GW8%RVB(!S:8Z:^-=;N(GU5D5/KE7JQ S.AL-5I^Q,0C;D(
MA7ZY9'B(@4VS*B21\&-9,+4][A.92_3;0WAUW.$<<;YUE;B<7$R,;%Q,F>10
M(3,%E*M##,7CC 961%F!U:QK.E54,QTN4^FV#M"9F7A969F8>/&[&=<<M"'2
M?(@$<LA*LKNT!&CMGMC6[,40%I$G:^"M N2$L@<:>#S/2]T++PHY"!(RRZA]
MG+T64VZRXIE]M*T9SCQ2M.%8\,XQGFV<?)R,289&*[QSKX,I*D7Z&Q'7J.A_
MA6C=RVS;=XPWV[=L>'*P)+:HY461&L0PNK J;, 1<=" 1U%8D)U%JT B2D'K
MRFA\RV'8LIT971<&0_&?1EMUAR3&C-R%-+;SG&4^;P\,\NYMXW;(MW\F=[&X
MN[&Q_@">E0V#PGAVV!_PW:MNQRZE6,>/$A*L+$$J@-B/9>J=_D^U%HV%3:35
M=?#ZS"WF0MT$55:>"B8(VB:&L22[61<87'?_ -'!Y!TJC+3:VD)>>7X-YQX+
MYN;TJS-^S\S+S=U>?].Q8SM).]Q&KJ!I.INC/8$6!) L+7(%>./W0<0X)M^U
M[3M/%(,-.?2[E#%!B0V[TF/,SAT$:'R1*\G=&I0NH7O8->@_M%I/8W4^Y6_7
M4Z8+F')(,?.+R*IE#HPBT<#Q<LBW69H\<Y*D1'X[GG>=4OT'$.I0M<?R^7:F
MPYT?)-M_%=J#>[N74!@ PTFU^A( -UL6MT=;VZV\W\K]/LO@_(!QOE,L<TT(
MAD!0LR#N:6 \RABR^;4$N"8VMTLQB9$G&H+0^\RHB@UM%M)D3' CXO.#8;"E
MX3B:+E,,-8'.249\6TMN^*<84K/E;\Z)S"V#<Y474R-,QL-+6/@/*;@>;V].
MEJA-VR=J7(.WXL<WN,B@VF3P<DD/&0PT@@6!)_\ #;K6IP?8&T6(^3D%)C^
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MA6NMJY)O.R9;9FVS,I8DNA\T<@/BLJ&ZNI'0W%_@(K:NX\?VK=L9<;.A5M(
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M-V4/A$\0"4)['GB$&89%E3C?BKR^?&/'/-9F+)2&*;)BDA,T2R*KBS:6O8D
MFW4$>/LJ<WO:I=AWK,V+(DAERL+(>&1HFUQET-FT-8:E^ V%Q[*B+MOXT=(;
M7M?82_JO.]Z5>NR%8KU5NE@J&USL1 T=7" *?&8"#)N)L10V<BOM17QTWW@Y
MJ$XZS$8BX4G*-C;/ZH[]M&)MNW>[[?/M^V2O)$DF.AU,X<$LPL=0UE@ZZ7+
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M>O(?>=DOOO>DA/JO/2'UN+4KQ4I:U*SGQSG/.CRRR6[C,U@ +DFP   %_
M #V  54BQX(-781$U,6.D 7))8DV'4EB22>I))/4FN5SI5:G%*<4IQ2G%*<4
MIQ2G%*T-V.T"![(ZWDZZL%FM54CKG9(L$*U)@2(,[+P<Q72E<O5)LD Y0-JZ
MYM-<L$X<8K5D&$A$Z-)]3#34UB',BJ5ENH-6 =,ZZI^O 4XP>_"U3IE8)W6U
MR(Q.^[ F4FE5R@PKGL6Q1X<)RU7@I7ZI!;FD7D8<>]!"<82VA"$J5V5]V)6=
M=C8DDX1@X,GGB@NBU'ZL&@6?9-M&UD];D46@#C!$:FR7(B"K,Z0Q!87EW+$5
MYY7E99=<0I5+8'6NPODUWM7MKW"W!Q'6+4;FO2\8%7H"R5B$[9D!*S9]M]?M
M>[9&,:9NK=3@21M7D7279P-B7%N;,L6,BUFS4N ;94J](= CBQ\$9$]QF*.A
MQH$;,N9,(RO;Q&41V?<D"+\HA.D>FWCSO/NN/.J\5+4I6<YRI6HNPVVY>C-1
MV7:$.KIMRZ].J$60.DEY=>""QUGNM=J9:Z7"R0:_:YE9U]KH6=>L%C)MC)ZQ
MH$9+DX8=]+R94JL_J[U@NN^^P5F[M[NO[UGK<6]6F+UP4# )H!;8>HQUGGVK
M2%XMAN@V< %L('68FYF*S67'ZW%-F1KA(A-,%P9^% B*5<SQ2G%*<4IQ2G%*
M<4IQ2J(^YN\^ZW;7L<'Z&]"V%4?1ID+#(=I/D% &BS0O4P@%=[#6ME:FTCL?
M6EFG-I[&QWP'TJ2&D. +  E+R\EQ##CD\:I5I/43J7I'HYU[U[UCZ\5N96-5
MZWADF@\,H8GV T2*GS)"RVFRGC))UQ^<<M%F+RY\KTTL1&G9&6HK$>,AEAM2
MHU_)5\EFHOCJU'(L=@0W?-UV@63<T]HH+,:<N5^F#6E.DBK8IE:B?X7K,)IZ
M<0>9;4Y[.'(6CP;8D/1U*AY\<O1?L5L \_W=^1S:]DVMMO9DRO7BCZ2(50KK
MFAZMFTB^R;!I;9^=8DB\]W6^U &O( D9'%C8U?>@CY$Z-9VCQQ^844I5UVSM
MH:[TO0[)L_;%VJ^NM>U"&U/LMSN9T96JT%C2)D8=$62-&94(;"]Z2FLQF?5=
M1ZDAY#:?%2DXRI7ERUIL#L;_ ,P;M>V24(MFA?BZUW8&ZS("RA1R/*[!8$7]
M4D^+-*D31U1V!(V#KT.@45$$81X)48YR6AR*T9@0)QA2O5+4Z?5:&$:K=+KP
M>K &2!PL@0#@1QL'):SG"5GLI9R/&;;0Z4L-E,2R$Z0OS/2YTIY]U2W7%JRI
M62<4IQ2G%*<4IQ2G%*Z]H2*CDYQM@8/9,DX8X<2+M0HS9,@/#ND7Q,&=/0WB
M5+ABWC$M<9IQ:D,*E/91A.7%^92NPXI3BE8FJA49=I_'"Z74U77'M?"X*K@=
M5IQ[$<5$0O\ :#,/);_,Q)V=%:_IOZ./,?;3X(=<2I2M+]A=B]@]>M!IVC=%
MB]WQ\ SY6S"Y-[8I)M$X;:=<#@E?K"IHN>*(%+""L!R3E4UZ#&AMBLO9==7A
M$.4I6HJ#V8[76JR4T7:.A-RUZ!-78)5+=83&ZM?%G*@)*UTL=F7B,*"#I2;%
M60,H3@=*Q[F',S-EQTLLNH6M;2E39*5X <<A.F@8<PZ-D1I8YTH,A$'($J$4
M%G(<F$N6P\J+(B&@D*8TM&4J;E0V'4YPXTVI*E=QQ2G%*QVQU"IW"/'B6ZKU
MVTQ(BIZXL6QA!IN/&65#$JZ45'9)QI3;*B5?,S(#^4XQEZ'+>97XMNK2I2LB
MXI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI6$
M[(V!6]4T.U['M[LYFM4T+,.E_I0V::+O18:/-[,,#&-2"ITU.=REF' B-/3)
MLEQ###;CSB$*4JG6C$K[\K=KCW<UK&Q=7],::E#26EMY"&JE,[&&SECGT$O=
MQ&M]G8CV2NT_7UPHH1QARS4>:7:/P#D1V(1'S [3LQ2KO&6DL--,HRXI#+:&
MD9>>=D.Y2VG"$Y=??6X^^YG&/YRUJ4M6?MSG.<^/%*_3BE.*4XI3BE.*4XI3
MBE.*4XI5;'R9]9.XW:[5FO\ 5W4OM&+ZO0".R K._3^01Z3<;#IF7(BMVB#K
MZQ@3,!0FR-C6I,;,"8PN$4CSU^:3">C,.J4J174/J#H[H]I,!H?05<E!JH*>
MR7/'CL]1V][(NLH:,&&]D;,M;S3,NW7ZR1@\9,R<ZE&/2CLL,-LQ6&&&E*U3
MW_\ D*T=\>^G26Q]FS_KER(1R8[5FI1*#K]EVA?6Z;>;E6*-&E5VLV[-1<O#
M&NR<$:4*1F1CQ)I,7#N7W$-J4J$7QR]/>T>UHE>[C?*A/@VGL7+NPS<.A=19
M!N5R1U#R8JR1-NIS4X59BBBH&U/L#IK5/*/&!]2(BFY;$F07D3)V5*N@OVP*
M5JVH'+]L2SAZ=3:W#5/.6([,;A#1T;"DMX4\\O[5..NK2AMM&%..N*PA"5*S
MC&5*\_>JKYV$^9G;ECL!&M6K1'QQ:_)!J,4UG9[!0C9_>5B@" ^U"KVP ]51
M%O\ J?;(%^\46:!<"V53^M+132\,BMTPY*&PE*] &MZ#6]4Z]HNL*;";'5'7
M5/K=&K$!J- AMPP%4#PP0B.F**ACAD?TH$%O&41X[#*<X\$-H3X)PI6:<4IQ
M2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*
M<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*K*[7]!#_ &NW94R%\VO:
MBW66>R 7LW2RMC;0J$5M=$;.% 0BHURA'0E&.P;O=IP@L6*FHV;*+S7?8Q2$
MD.8EBXRE6-UVN@ZD%'UVMC(H<*+9RQ!'PT90TTE;BWWW5J5E3LB5+DNK>?><
M4MY]]Q;CBE+6I65*[KBE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI5&?3'XA;;K/
MMYNCO+W:WU![9;_LM^(/Z8F1JEFM5/7-#&*]I3B[H4J^8E0K\T-Q]D(=):!A
ME+]&,F2U$$_2U*O,XI5?7?WX\-<?(<#TY3=M7W8H#7>MME1+I=-<U0Y*@T_=
M%91F&].I%Y&L2HF6GO>BHK@P[&6@Q7U9D/#'8TQYN7'4J;],I=/US5*]0]?U
M6NT>D5(3# U:H5(,.KM9K@0<RF/ $ P8F/$&"AL-A&$-,L-(;0G'AC&.*5DW
M%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4
MIQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G
M%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4
MIQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G
M%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4
MIQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G
$%*__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>tm2227887d4-lc_contrl4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2227887d4-lc_contrl4c.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@!> -Z P$1  (1 0,1 ?_$ 0<  0 " P$! 0$!
M       ("08'"@4$ @,! 0$  04! 0$             !0$#! 8'" ()$
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M;U@'ZP!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
MP!@# & , 8 P!@# & , 8 P!@'*/Y!_*3?\ 3GDLO+EHCR0\G>/RHJUI:AIW
M"EG0G.RJX'&QY'9"64&2U"TN3;+(VI1!COU*F-&$W1@=@6 T'T]-^H%O?A\Z
M\N#N3A.NNAKL10D<M?9=:L4;YM7#8]QV#V[$J]L:1PF,V]&HE)C3Y)#VV>M[
M'I4%O6B^, 7J;H!11I9)8%GN , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
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M]95VTF +);V9$:),1O1AA82@FZ(+ L'P!@# & , 8 P!@# & , 8 P!@# &
M, 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P
M!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# &
M , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
MP!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
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M+M9]]]G\SX_XR/O;?)!^LSBOY"U:_P!:N/%-6]61^TQ]$/<EVL^^^S^9\?\
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M , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
MP!@# & , 8 P!@# & , J4[O8+_EO1M'L%+4/0<Z=4M5V5)859?2E-V;=D$9
M;-;'R,MY42B;E')I'*\YRGB6&/#A) R)[3GJIHF9_LVC-2[$8M1@; X"KEP2
MOG04_G]:1MGL:*7)-*&CE\QZD7/F5VZ=J.+,U=/NI]/:B"8B;W19#;?6RF)L
M3X>F.(<&MC,=F0PIM?S?F@+*\ 8 P"@#^[>_V$[A_'_[:_IA7X!?_@# & ,
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MVE7TESV=4/SY& , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
M8 P!@# & , 8 P!@# & , 8 P!@# & , 8!5%Y?V=D>.?*C#+F>J7N"HNG:U
M4SA)?E7RR]Z$#'U,8L)H*'<-#0E.9(K=BIK\YHB4:(LU*E97\UND"PX*)G4:
M$!GWB^:*F9J"EZ6G(_R!&XP9<#^H7(>*N7Y+R95AK\*%U^6J5O\ 7,I7N+@]
M6 -O*2@5/8!Z)4MQ:%+H.A(Q[V!8_@# & 4 ?W;W^PG</X__ &U_3"OP"_\
MP!@# & , 8 P!@# & ?D8P%@$88((  "(8QC%H(  #K8A"$(6]:"$.M>N][^
MC6L Q]CE\3DXU)<:E$=D(T82QJP,;VVNPTH#MC"2)2% I4;(";LL6@[%Z:%L
M._3[F\ TC6;LU+.A>G&I(YMZIS9_X%OK=N3K4QZ]K^L(0O4(/K%&48)0A^>3
MAV83\4(?B@UL0?77TX!Z'4G\1,Z__MG]V,>P"0& , 8 P!@# & , 8 P!@#
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M=IW9G:QK_:#H.J:-9S)3C8EEX]RPKLK:BYJ#FEQ."G%RINXE7>;KR6.=C &
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MQ&W%N$:>'*O@HF]FVGG(8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
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M:-UK>I8T!J9'<U$K664\J&O9I?S2G8'4A@# & , 8 P!@# & , 8 P!@# &
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M %Y?[.,GSO/.?Z)^2_YW_#('1]-]O]2_^W^YLMSSD!L(P!@# & , 8 P!@#
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MT_25[WQ=L 7UO$:.7.D=&E%+8](W:=3=":4A0P^+IFKT_P#I%_>5R-(B&=L
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M94;J2J8XL9F]\G,L.4)V1M6R)U2L;(G4FI4RHX)CD[+BB"_0&_49FO7TU].
M:+\<-_4UT=Q9SW.J-L*/V7$6>KX) '-^C9QYZ!%,X3#(^SRN/'#4$)QZ<&-S
M+V2?K0=AT/7T;WKZ< G!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
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MM?7+KJ]D:[(Q6W<Z5+FC7<YWLK%S;W72LW(I2X(PV.*ENCY/=9:+G+"=& ,
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M%+A[!DW(44KWG:"6+2/U'(H9&29K*'R0VFWV'8H6Z1L3PJO%RKY5'(\V:A(
M+4B;ZQ),6-ZDU\:AE99MIBES-4J9+@Z-E\=N_HAM31GAMXZ.BL5.LB>LD39[
M&=%ENI@*OX.7TX(V9K0IF!%\)B6%:+0&D:",H)FAX!%:,7ET'5;HL16!/)U3
M#1'@^/:22AKN'H-1=AUFQ:Z>T><HE+K@K^:22&QY% JRCD&7RN*3%!IS4&[5
M/*8Q4B;4Y38O>@.@&(3>%V$S D<!E\7G$>-4'I"WZ(/[3)68Q4E%H*I,!T95
M:U"-0F$+6C :'[@;W].M8!E& , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
M8 P!@# & , 8 P!@# *\N]8G?\G:H2Z597;E*F*MW85DM\XIZ\8!475-36,W
M,\DB@)943'T#7,LY8LIM<:\F3RUNC7.W5G:1(UQX3 *]&!T2!X?B]MB@+KIJ
MUK!HVT[FN5_<+^D+3T5/+\1PI'9BSH"+UO5<:>69[#4D8B-#&ABM;-47; ;@
M*3[+E[2;* 8->6OW@%E. , 8!0!_=O?["=P_C_\ ;7],*_ +_P# & , 8 P!
M@# (_P#2_P#%U'/Q@.3?]J>FL \.R9-'H9T-6LMEKVUQN,1OFOJ1[?W][6IV
MUH9FAMGW**I>XN*]4,I.D1I$Y0AC&,6@A#K/F<X6X.<VE!*K;W)&/EY>+I^+
M<SLZY"SAV8.<YS:C&$8JLI2D]B26UME$_ ]GV%Y#?+)?O3UE\VW[!>4*NA:%
M1X_IW/JRE$?JVR'!A.1UG8EJ+'YS 4T:FCV>0)9&D6RM&C93?B#T6J:]C,CX
MV;.=?M:BI.5N,'PKHJWY[R:;/_8:!CZ+HO.^MZ3VC6LB61IV-B7/%;+H[<;M
MV23R-C_?%!.VXM-1:BTU*!TR.SJ@8VIS>W4_Y5L9V]:ZN*GX1Q_RZ!O3&*UA
M_P %.6<H.^"G)$+VE@$,7IZ!UO?IK)(Z.<E?CM['J+SL=L6&="02YHY%XELC
M[XM)6MB,C8V/=VW'9KJ^,]:R^2,S<[2!M*A<%0Q%8I2HCE'S6E(PZ4%;+6FD
MINE\O\V:5RMR7GV-)5WW:ZE/J)W7'AC8PJ)R5F2DVYWI>#-M1:5*)."E*%S-
M/OYVI6I9'#[&65QJ-:N=SHXE3=%;5O[^^BZY,YH30P!@# (!V?U/S=3/2\E<
M;/O*KH=]D: ^%(&QUFK &1(EPIR4X)V@,8)7'2%6^KD:@L:9"2F,5J=&@^&6
M+WA]<//S\32\.YGY\U;Q+4>*4GN2^1M;>Y)5;>Q&R<H<H<R<^\RX?*'*.)<S
MN8\^\K5BS"G%.;V[Y-1C%).4ISE&$(IRDTDV5]=%<ZV;YV:Q<JKM#=@<M>.9
M[=F%_1[:4T<;>E>AED7>4[[&Y&B#*X_,6&MH 2Y(2E*;:A"I/6!"$>@* ' ,
M1Z?HVJ\Q<R:C;U2Q!8?*L*\,;D:WLJJ:4Z575VU7BCMJVDZ23\'TQVH=G_8G
MV'<DY?(&K9<N9_C"Y3MJ_=P;ZCI>@]7<A<GCJXX2\>S)\/59"45&W&4X*=BY
M!]?8EXY/'I2_C#YH;.5Z$D]H2ZO6F82R;)WBWGJ*/\R&ZS%4G6.:<YPAD*@#
M()O(-3AT0 +<$P(=[]Y@]_3K?#R&3OP!@# & , 8 P!@# & , 8 P!@# & ,
M 8 P!@# & , YXWJ<>/3H'J!FBW2'@P"VWI<4NBC+)[*ZAHOQ-226Z5OI;<Q
M,<CGZ@/5]AW*_H4S82F++VC:7=P&E*++3)S?: O .@2/1Y@B+ QQ2*,;/&(M
M&&=LCT:C4>;$3*P1Y@941#:S,;&S-I"9N:6=I;DQ:=,F3EEDD$EA  (0AUK0
M'L8!6!YK?T1_D:_% O#]Q+I@$_ZF_BKK3^3^&_N<;< V!@# & , 8 P!@# &
M , HQXUZHYOH:Z/(Y'+HN^M*O?GCNFSGMJ:)M+&J/KW!HVTQ]#IQ2)EZ@DPY
M'M8D-*]X=;#[RQ:^[K-<P,W$QLC+AD7(0D\F32;2V41YQY YTY3Y:U_FS$Y@
MU'#P\FYS)D3C&]=C"4H\,%Q)2:JJIJO=3+9:@Z.H;H#[0_P(V[ +4^R7U3]I
M_L-)6V0_4/U]]9_4OUI]7GG?)_6GU*K^![_3XGRYGI_B[R;L9>-E5\7N1GPT
MK1UI7=7Y3.W:%S7RUS/UON=SL7-ZCAZSJ;D9\''Q<'%PMTXN"5*[^%]PW3F0
M; , JZX=_MB^5?\ &+I__9\A6=4YZ_L;RG_)N1^%W2"TOVRU#^&A]SB6BYRL
MG1@# & , 8 P!@# & >>N:6IS,0FN38WN!K6L+<6PQ<B3*S&YP*"()2Y"-06
M8)(L+"/>@FE["/6M[]-_3@']C4*(\9QAZ-*<-2EVA4#-3E&#/1;V8+:,X0P;
MV:EWLT>_AB]0>HM_1].\ ^%RCS \$Z3N[&SNJ?2,YNT0Y-B)<3IO4'H5*A#H
MI40:#2,]2UIC!E>GL$-.4+>M[+!O0']&=C98\B"VL#.UL;>$PPX*!G;TC8B"
M:;O6S30I41)!&C#-Z]1"]OKO_#@'J8 P!@# & , 8 P!@# & , 8 P!@# &
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M3E*4FW*4FZN4FZMMMU;>UO:S^V5+8P!@# & , 8 P!@# & , 8 P!@# & ,
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M , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
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M1])E8>AZ?@7_ !C&C-74FMLY-;>\VT3_ ,YZ2XP!@# & , 8 P!@# & , 8
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MQKD#^?"$_MI@#\];XC_UC7('\^$)_;3 'YZWQ'_K&N0/Y\(3^VF /SUOB/\
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M+4$#%HT %(7D)[PFL_\ "GVFWW!4-@2ZT'^-^2+E>5S[F^F)N[T&UR#E>V[
MY_4VE)E3A)9FX4W7]A%L)3JC)=W=U$C$!>G^<5!0B4& 6"UIY.X\AKF (M\0
M>355M'"8JEVJ0\0V@J1*=IV) 3L]&I!^P4)3M@]Q9FOH&#>MZ^[@&;?G18[^
M SY/_P AFTL ?G18[^ SY/\ \AFTL ?G18[^ SY/_P AFTL ?G18[^ SY/\
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M0/R::8_>5@#\WMP+^ ]R!^333'[RL _(_'SP&6 1AG$/'P  "(8QCYKI<(
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MA$'KL,%^UC\;%XD\SF6.",RRIW6T2,)8(TQFC"BTZ[>'=<<F;FA$X.:M*C-
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M6[)YC#*M0+H68;"O<VMSEM>H(9][;4BMQ-()$8$KXI@%A. , 8 P!@# & ,
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M?-FR2+(+&L>Y(M?"ZY8S!K0DD^K]EDS)9$.0+T#(!IW#R34Q0OJC8B2=E@6
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M)G[-08F:VXH AB^D>P^N_NX!FF , 8 P!@# & , 8 P!@# & , 8 P!@# &
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M'F'A*-]@2M@80Z>:^-)9S7-<,?-$]FDPM"AE=F15BBEDU4[R0RTD/%CQW-_
MA(84TO[M,(&]/%8,1[6V*7Y&W+%S\,GX;=MH/)=Q@?UM;S>5C#:I<KSK6@K3
MN>F=7 UU1';98%[.R5NYDF<W1+H>0SJ12]:0M:X!#&11,2(:6XNVR6T^5I%A
M)RI(E3_-# N5@LN;; A$.GC+LD3/-HK'I<TB3NK$^IQ-LD:$;RAV0^1=T?(R
M\D[2K0>U6W+5B!0'T,3GFE" 8(#*L 8 P!@# & , 8 P!@# & , 8 P!@# &
M , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
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ME[ N2P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
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MS,C(S(4K8T,S0V)2D3:U-3:B*(1-S:W(B $D$$@ 424 ( !T'6M8!Z6 , 8
MP!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
M& , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
M P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
M & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
M8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@
M# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
M 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!
M@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# &
M, 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P
M!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# &
M , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
MP!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
M& , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
M P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
M & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
M8!RE5ER-2'E+L'RO]!=Y7/>#1+^7>V^B^::6!%^B;,I>)\64ESLP,@X#;<0B
M,-ED7C.I)-&U:?+G%ZD*1R;UP?9["M:)4&G@=&/)JUC<.9:'51F_%'4T?%5<
M,)9^C%K@R.SA=#>E9$B5-8;JYQT(&=>\20LG1ZPTK6MF*A&;,_RFQX!(3 &
M, 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@&A^IE:I!S
M%T:N0J5")<BH>WE:-8D.,3*DBI-7TA.3J4R@D0#B%!!P-# ,&]""+6MZWK>L
M XY(YSLW<9>(#@[RUT!>O4+#V(,GAF62B*O?1]M3ZN^HSKVL^L8'9=,R:IYE
M*)#'%C3)HY-'!R)3M2$"I(8W:-3Z (L)I0'<G@# & , 8 P!@# & , 8 P!@
M# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# .$J24'=72O?GE0
M=&OQ]=9]WLD"[8>X4RS&J?*BAXNBU:("ZQKMY#7)-;R*THAMX,+-=!..G%*F
M$G]J[1'N]Q0M: [BX*S%1R$0Z/$(%S42PQ6/,Q+6YO!DA<FTIK:$:$M X/YQ
MZDU\7(P$:+-6",,$I,#LS8A;%Z[ RK & , 8 P!@# & , 8 P!@# & , 8 P
M!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & 5;=/>&+QT=@7 \7I>-$KG
M2Q)@VL+-9RZ&6I;E6L]R,\6 $F-M]PQBM)Q%(]8P69, *<H]R3'*A) %IC#1
MIRBB@ 64Q.*1J!Q6-0>&,37%X?#8^S12)QEC1DMS+'8U'6Y,T,3$T-Z8($Z%
MK:&M&4G3DEAT HHL(0ZUK6L R# & , 8 P!@# & , 8 P!@# & , 8 P!@#
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M.K0ZMZH&C4RYM<D!QZ-<C4%BT(LTH8@##OUUO>L ]3 & , 8 P!@# & , 8
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MN:(HAF-V22HT4[&F'A+;C-IU!8]!.V#?L,"+[@M;V![& , 8 P!@# & , 8
MP!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
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M2'#;9]<:E[-IS^4^-[/C?*)_B>GK\,/W,UI<O<YYZ\=L<P7+-F[X4;?BMN7
MGM4>)W$Y4W5HJ]P_23L+^,/\7FWV-\LV^=^R+%UWG!:+BK,U&>OY>-+-R.JC
MUN3+'M84K=EW95D[<).,:T3H;L^\D\BGZVJ4_DFUS_6%E?<GSQ[Y;GK.UZ8=
M7_6*^*A_D;A?XFS_ ,1'WDGD4_6U2G\DVN?ZPL>Y/GCWRW/6=KTP?K%?%0_R
M-PO\39_XB/O)/(I^MJE/Y)M<_P!86/<GSQ[Y;GK.UZ8/UBOBH?Y&X7^)L_\
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MCLC'B;=$NA*M$NX8UV?6W97**/%)NBW*NVB[W<,MRT6Q@# & , 8 P!@# &
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MUM5*9 I \O!ZY>,MN/-0;:P)F_P,+_\ SPW!_$?_  ,?^-1/_P __P#/#_\
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MYCZO$L**5B2?#V< )GNUH#+L J \_'Z&WR$_R ._^G6' +?\ 8 P!@# & ,
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M;SV0\W:KSQR+B\QZTK2U"]<O1DK<7&%+=V<(T3E)[HJNW>3YR3.F# & , 8
MP!@# & , 8 P!@# & , 8 P!@# & , 8!XLCDD=AT??);+GYEBL5C+2X/TDD
MTC=$+''X^Q-*4U<ZO3X\N9Z5N:6EL1$#.4*3S"R22@"&,6@ZWO .7N@.X.OY
MU<J8[D?K+FBZ*TL*03=55/(7372587[TQ9"6&FNK],&R!R3GRLZ[,YU9R8HP
M.*QI6V+-+'";L!9(BDI8B]; ZGL 8!4!YM_[(E5_C_\ CA_VUZ3P"W_ & ,
M8 P!@# & , CMU/S1".N*:?:0L)]FL:C+\ZQEY/>J^=&AFE:)=%'Y!(VLQM<
M7MADK>F]7!N+T9O:08_9Z^P0!>@M8N;B6\['>/=<E!M.L:)['5;T_*-5YSY1
MT[GG0+O+NJ7,BSAW9VYN=B487$[<XW(\,IPN17A15?!;INH]I4S>'.LWX_NW
MA1[A_;'>5FHK1Z]KNM)C$;KZ0=YG#'2++TCL[+4BE@:V2,E+OFS6L!1A:H:A
M,80,81%;WO6]0F1BW,#(QI6\C)FIWXQ:G<;36U[J+YIQ'F/E74>1.8>6\C Y
MAYES+>9KMC'NVLO/E=M2MR4I-.$86TZN*34G*+3:<2^_-E/3!7)"?TJ5[_B:
MTK_2=8&:-B?I$S/Y+L?=;AZSYB_T4\L_^8&K?U=@EC>;R>3!@# & , 8 P!@
M# (]VQR=S/>\B12ZYJ+K"SI0W,J:.('Z:Q%H?W5(PHUSDYI6A.L7ISCBV].X
M/"HX!6M^T)B@8O3U%O,6_A8>3/K,BW"<TJ5:3=.Y\UFKZWR3RAS)EQSM?TW#
MS,R%M6XSNVHSDH)RDHIR3?"I2DTN[)OI-;IO';PHC4IUB3DJA4ZI*>4I3*"J
MXC@#2%!!@323BAA1:V PHP.A!WKZ=;UEE:5IJ=58M5_<HB(=E?9O;FIPT/3%
M.+335BW5-;GN))6A748N"M+$J6;)U2N&6C!9;74N2H5AK>M4QB;,#A&GY.C7
MD>AZ%4<U.9H2S@?LRA[T+7TZR0-_-7515]X1R5?::X^AOX6"F:)JH7%&",UH
MCJAB4I5[BRN*^<6:VI9=,4<WM<_[/D$$N+87&F- F/6 1LR?YPT6 13D'BKY
MMLZN:3JV_H[%[PBU*<>(N26,<N@;"-[2:2H:_0_PM0I^5F.SE6\\)U "34I[
M8/2E&>8$PM3[B0^X#94#YIZ*K*?HIC%NAJA<4CY7-$0"U4<QYA>U3Q+1TLDD
M+4ID$,703HNN8G6ZJ8-<C.WM)]0.R!M5A",@H2?6DF@)VX P!@# & , 8 P!
M@'GKW5L:B]&.2]&A +0M@^:4%$;,]GI[M%!,&$1HM>[7T!UO?KO7_+GS*48^
M>:1]1C*7G4V8R&Q8@)2%-IUV$0M:W\8Q$O*2ZWL6@^@U1B8! /3U]=[V+0=:
M^G>\M]?;K3;\IGWU-RE:?-1F %"<TLHTL\DPHX(1DF , (!H!A]X!%CUO81A
M$#Z=;UZ^NOIR[54KT,MT=:=)_;*E!O6M_1O7KK_DW@$.[!Y2YC N7365QU8T
M?:!]86@_;6]R1&@.E,TE#?'& PAN:E @I5#A)G].2$  @0%C.^(86$/O'DS9
MU_5L>U&S;N^!'=6,6Z+<JM-T^;WS9,?FO7<>S&Q;NIP@J+BC%NBZ*M5?D[^^
M;EJJB*QI@+L* , VU6_:1:>7):YN3LX.'U> X"70CW)4ITE+!\P/>RTX22M[
MWZ[#]&O3$S=1S-0DI9<^+AK38DE7R$OEO:1^I:SJ.K./CT^*,*\*244JTKL2
M5=RVNK-OY@D6, 8 P!@'S*EB1"5L]:J3HR [UH1RHXM.5K>_N:V8:( -;WZ?
M\N4;4=K=$52;V)59B1]B1!.8$L3KLW8A^SWID:Y23KT]?V?QB$QA0BM^GT"U
MO>MZ^G7KK+3OVUW?E%Q6;CZ#*4CB@7I@+$:Q,I2F:]0GDG%C+^[Z;#L01;T$
M81?1L._38=_1O7KEQ2BUQ)^"6W%I\+WD.>L>-FKJA\JJ2*;(E5</=0F/*^).
M\22MICHA?7>7U;*"I$A<%I8U+4\,Q-;B3I#4PB][VX#TH^.C^81*_HIN(Q?F
MU)XF2-KO(.Z.A7"1P]9&7^/SQ9+I[]<1T4>0,Z.1HB2G2SW*/ C$I;6E2%8F
MVC"-1IR4[7GKPEH@I!6I5VE3<Y(757(HMY&NJ6FP+C;(3&IBJB+6[M$Z6JX!
M$+Y@+,NG*PF<HY61(DPHH\.:,E>X'GF%)BQ%D*3%:8\JFXKO-U4*L:Y[;!%L
M-?D"Z<3<^QU)$>EH<5('B\')EF-:43)E=<VM!YLX2%>&*;9DTD=6U'\)I5/)
MD@*V8K<1N!^A!35*,_K9-:<>78=8J-_\IL_F?V@99")(PO4P?I:AKBOK!?8=
M/F9.D96YY0")C[="0(&$U8OWM.YK3" .FU"X(T9E 97+C^ K@_A!;IIUZR2E
MA:N;%,*<)E<</4R]U:89-@7K)8)*8+9%E+%+XI+BC+<"9P<3M!6F.?V18E@E
MI0VQ;[:E=N\D92G(M/V]9(^BJ(NU-'8U'[&DKNPMU/01NA3.U-%D516ZN-;8
M-HY Z0IS=@54[HS&R0',RA4!GE;DB&20/Y,MI%&;0@/C,CE?]%I>B$5VV8[.
M3=:LGM%JAKJL4E1=N438,Y;I:R$IV9U:1&-SM''YB2:),T)$$R*(C1IC/B'%
M["I9]@H, _@H5)DA0CU:@A*2#T]YR@TLDH/J+0=>XPP00!]1;UKZ=_=WE&TE
M5NB*I-[%O,24V%$4IFBQ.VCM_$T7[DB1:L*_^/H],G-)$5_X01;UEMW[:Z:E
MQ6;CVT,E0NC<Y)=+$*U.I3;]?4THT @E["'0A -UZ^I)@ [U[@CUH0?\.M9]
MJ49+B3V%MQ<71K:?=K>M_3K>MZ_Y=?3GT4/]P!@''YS/T0N-[3H6.KI6?$WB
MQ)MSV[/D:C?F1Z/L=MG@'RNZV;XM-Y53B_QTUU%[BE5A5^A9U[H4[R!K,?3S
MM_-JT^Q;^&!V!X P"H#S\?H;?(3_ " ._P#IUAP"W_ & , 8 P!@# & , 8!
MBL[_ /$B9?\ DK(?]$+,^+O[W+]R_*,+4O:Z_P#P,_J657>"[]&_47_E5;7]
M)4DR%Y<]J8?NI?5,XQ\7#]$V!_#9/X1<+>\G3N@P!@# & , 8 P!@# & , 8
M P!@# & , 8 P!@# & :+Z;<Y$S<]7*Z1%*L7R5%7<G.96] *K +'%=IM."4
MW)Q7@^QBG_B.'NV3_P#:1P1L^]#_ .DF@+]V\ Y_?&:9;D:[)8HL;7@ZIK@Q
M/:R4^$I&'PLMI,<1FH7Q\2118X<?WW.NF%A;6^$D^[29N4%F*" C<=ED:-,"
M!T[8 P"H#S;_ -D2J_Q__'#_ +:])X!;_@# & , 8 P!@# & , JN\DG\9WC
M2_'\K#]S\HR%U;]^Q/OF/E,XOVM>V_*/]Y\?ZBX6HY-':"N2$_I4KW_$UI7^
MDZP,T;$_2)F?R78^ZW#UGS%_HIY9_P#,#5OZNP2QO-Y/)@P!@# & , 8 P!@
M# & , 8 P!@# & , 8 P!@# & :YM&>IJ\BYKN,(3%RQ2!K:"1ZWLL;BH*.-
M 8?H(@#VF2$$#-,UK>MB"#VZWK8M;S'R;RL6^+YYNB\DOX]EWKG#\ZMK\@J#
MNP?2DZLQY:XT";B:O^CG-;FV.AL<8#$9:1.+2M5(@+6I*I/,4*!;TG+---*_
MQ2R@A+U[<2;==E6WT_MF5%)=Q)$PH&EDZ*%QE%-%)*R5IF5$G?E9)VE 5+@2
M2$L\_9X24X#CC/36S!! $.S-[WKZ/3*Q;25?/%71UIN-&UM Y]&UTH)GTC=
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M$J<1NFB'+2, P.LG & 5 >;?^R)5?X__ (X?]M>D\ M_P!@# & , 8 P!@#
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MXXQ<HW+-V+4FEQ+P%<3H]E55TVTH;:;Z=O%&Y">WAPA3PF V#3@C[6Z.292
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MU\8YLWL1NBE$4!UTX P"H#S;_P!D2J_Q_P#QP_[:])X!;_@# & , 8 P!@#
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MOT_;B\V87&-O^HO+Y?7\BVU.J8:59]2S> /L9FT5<O@F;^$N:G!$N3C]!E'
M'K0M <GWC&@O/T*\C-=#KX=>NLV/DW;,:.Y:9^A^[+$Z%\?"&.ODC1R2<=!-
MUX=:VS7<E)Z#=&]*4\G.4 B(E,F?6M<T*7 !(U!@'7G@'([$?)SU:\)>R$\K
MZZ9V>-:[+Y<C**_83OFZ0U;P;R[?/:_05+K8N^'R_FV%E5]T1"X-7+8WR1%:
MXYVG;RE[8[^J0:I0CV!]G775G8=\>.OQI2&QN=$\I@-RW!XO['M3K9)9<$AZ
M5+/C^T:_*9R4W/P&PN2N*>RF1D9'T"]K,(9TX9-H!!024@@X!UK8 P!@# &
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MB,FA4;41==-(TRL[7'E<N7M<X,,D.]N#35+686T/\)5GG?("%HLH\*5LT/\
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M>P&%&!%K?IO />P"H#S\?H;?(3_( [_Z=8< M_P!@# & , 8 P!@# & , 8
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M980@ #OWQP    =!   >UJ3"$(0AUK00AUKTUK7T:U@%P. , 8 P!@# & ,
M8 P!@%5W0WZ5?QV_R5];_N,9,A<KVZQ?W%WRD<7YI_33RK]Y:G]R@6HY-':!
M@# & 5>>6[^S5 ?QH>=?W>ILY]VE>T-G^4,;[HCV;\1?]+^J?W,UW\"D6AYT
M$\9# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
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M"DY&_IUOVC&$>];]=:WK+4[L8.F]ER%J4]JV(P,ZWC-&;TGCX!%:W^Q$<Z;
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M(608>!*XF@=(6 , J \V_P#9$JO\?_QP_P"VO2> 6_X P!@# & , 8 P!@#
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M_=R'IGFCG?I!K9%$:;>@:+J2[FZ.*U0%RJ/H;7@$?GB1D4K2R4Y:Q0U)WX)
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M\@F7U2L?%WUFL0_/_5:)+]>.KK]1QMC^M57U<SM_RK2W?-'?+)BOBF>X"1>
M, 8!B\OA$+L)F'')]$(O.(\:H(5F,,O8&F2LQBI*+8DJD;6])%J$:A,(6]EC
MV#W WOZ-ZP")4)\;W$%<O]!2>#\[PV-O/,$1:X-1RAN62<*>%QIB/F*R/I#F
MTU^-;)8NC;C8D@5MBY[)<E[<N?'!2F.*/6*## )NX P!@# & , 8 P!@# &
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M , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
MP#5=VTQ7_0]532E;41R1RKFPVLMCF33%+ L&KW9Z8OGDBU8Q&3*K91#)JD8W
MP"3Y1U1IW$E,[M9RAO6@4(52E.:!GD>C['$F!CBL8:6]@C499VR/QYB:4I*%
MJ96-F1$-S2TMB).$!"-O;D"8LDDH = ++!H.M:UK6 >Q@# & , 8 P!@# &
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M,Z-A8D!KFZJ5KHXF)&M 46(]2<<H.V'WF#$/>Q; RS & , 8 P!@# & , 8
0P!@# & , 8 P!@# & ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>tm2227887d4-lc_reprogra4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2227887d4-lc_reprogra4c.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@"'@+L P$1  (1 0,1 ?_$ .$  0 " P$! 0$! 0
M       ("04&!P0* P(!"P$!  (# 0$!              ,$ @4& 0<($  !
M! (" 0," @0)!0L) @\$ @,%!@$'  @)$A,4$146%R&7&%@B(]76F*C860HD
MYE=H&3&U5I9WM]<X>#F903(SU"4FY[AIV31VB;DUE38W44)#52>G>3H1  $#
M @0"!0<*! 0% 08' 0$  @,1!"$Q$@5!$U%A(A0&<8'1,I-4%9&AP4*2TB-3
MHP>Q4N)D\&(S".'Q<B06@J)#-"4U%\)$M'4V=K88_]H # ,!  (1 Q$ /P#[
M^.$5>_?_ ,EW73QO0.KIW?HFPYC.W+-+UVKPVM(&#L,XR+6P Y"SVJ4#GK35
M&45FN(E FREC.DF>Z<SAL9S&5J1TOAOPKNGBB2:/;3$WDL#G%Y+1VB0UH(:[
MM.H:5H,#4A<UXC\5;9X7CADW$2NYSRUH8 X]D N<07-[+:BM*G$4!4_0#PI4
M *4C"QSXZ2$&/CSA'4/BFA&,H($+&?;RIMX<EAQ*T+3G*5)SC./T<YQS7,<6
M/!#@:$'@0ND:YKVA[2"TBH/2"O7S%>IPB<(G")PB<(G")PB<(G")PB<(G")P
MB<(G")PB<(G")PB^47R$]@_.'UG[O]7M%:][:=1&]>=_^RFYM>=?Q9/KA(2<
MMIND5E\2R5$'8\H_*H<MLH#4["$$20&E&7RQW'?IA*\8X16CZ.\BM8UG5^WN
MD.VNTF]F=IO&-HL+>7>.[:PU/*5#79M2L^OI_>U:D=70A1SSTP8SJ4<=M\-"
MDK^X,K3]?JO&>$6NW7SJ]'Z<YUTC XWL=L6X]LNMP/:3K_K?4/7Z\;0V1L;7
M<B[*)$BX>F4]F3E\7+XT&84^&XA#(8(CQ)+[+#3CB2+E%!_Q(7C7V2O0<A63
M>Q.=?[[V%7=-C[GE>O%\A]*:IWA;#C H#2FX=FR##-:K6RCF@\G*# =E6&(E
MQ$B\^V!G)&"+IF^_//T+Z[[IV7I^W_M!6B&T-:J]1^RN_M7Z OFQ.M_6BWV<
MID&+KFZMJ5X0@2O2WS26QW60QI%31>5"Y_RIE]ELBW'L?YKNDG67L;2>J=K,
MVY?-T[+H>LME:]K^F]7RVRP+E3]KW%FH5F6@IR%*Q&/CL(R_+%N+<;:;B!'7
M6UNNY98=(N(?X@GO!VZZ*=6.N-OZ2OT]K>&\N[^H.L\</=:H/<(J2 V9KK<\
MH)&#QI+B,#R!ENJ$2E!"<+6AOW$X3GUYX14:=^?\1UW'J703QP[WZ@&ZL3MK
M;?52R]A^XDA/4<:RPM?33=MZPZI%/5."(-6S#1<_V2FK /AIQQ2Q&@V6<.NJ
MPOZD5^4!Y(Q:-WA['T7?/8BCU[16@?'AKWMI>*(_J6:BYB@?/S5RK1L(O:@Q
M!@]LCY$>1>8#K@0;A^2'VT,I=<]+:B+HW5/S5=-^V\KL^MU2+W[JNXZTT2OM
M$/2>P&EK#J>U;/ZV^PX\-O+4,;+ODHO6N9#^)2,8TXTM_)3*D-Y0K*TD7)-9
M_P"(B\;&TM*;M[%Q-IW% Z4T/ ZXD;1L&VZ9M4/"V6R[5G;%6ZAK'7"6L&G7
MO91$M67T$1X3*FQDY4M;^$#FJ%(NW:"\SO2G=\'V&.LQNW^K=KZJZ[SN+>VJ
M.W>GK=HS;%)T\L%)X6T,4R7'D2;#4Y-#B&A_M;AAJR'QFLCI6:%@DBP75WS;
M]+>U<W=:M6P-_P"J;;6-%R_9^K5?L#HZV:EEMU=<H9A9!&Z='YF_>CM@T@IK
M"%BK:(9,*:7EUL=3+)#C)%S[0W^((\??8G9_6O6U&SV&B@NVDE-5;2&V;YH&
M[4K25NV- D$"2&JX[9<TVS#3%^9+;:8='C<'B"EEL"DDL%.>S@BZZ%YGNDDA
MUWIO9(::V0JL7OMF/T=@*)G7YN-NK[/DS1L*WJPN@?-R<+.84"HI6,N9PD)2
M'O\ S58X11[*\M=*Z[;C\Q5J[.[J;L_7[Q^V3IA&)HM T9- WG3K78Y,E66!
M96RKDLC[B<N-PD8Y]MT1 ^(85AU+GK]>.$712O/!T99Z^U+L0'']BYN(VMN^
M?T'U\U?!:#N$GO3LO;H"'KUA5.:*U6Q_[>ME$E8&T!%!RY/P&'/?;97ALEUE
MATBS/^W,Z$L=-]L=V96?VM7-?:!V5#Z<WYK2T:HL=<W]I;:<W88RM!T?86J)
M?XDI%RR9"79];C+Q(?TPZA+RGAR&FB+P4KSL=%+H?VLBG$[^HLMU&T2?V@ND
M+M/1%TUM8-@== ?@?3=&H:W;68VPVRBR*9J-6&^4+&O&-2@CK32FG?7@BY/&
M?XCKQYR\[2JZ!7>X)$CM_6L/L;KPTSU%W 2]V><EEQP;E$Z[QPD,1,[0NT/.
MGKC#,"#)AT'ADH;/<0RISA%U./\ /%T E>I4-VYCIO;IT59-\E]5JYH4#4=B
MDNT4]V:":!+)T/%:9C5ER).P6HR5$*4W\K *6BV$*)P^^RRLB]SWG4Z!1_46
MW]S+#8]J5#7NL=V1O77<M!N.J+'6=WZ4W-)$,LXI&T-82WQI2!,";(0X^0RX
M4&G'N(2\MY@AIHBY-=?\0#U79TMWXN6N-:]CB]R=&]*M[E.T3MO16P]1738M
M6LZPXK7>P(2"FX<FW1NFI*>GHM^:GS8P9V!KQF98@3XB/5DBVGHMYG-<]B>N
M_0*Y[CHNT*3N?NW,2&MXJ*AM*WN#USC:=8J%2MUOD8&1L9LF6-IQYJXL-05@
M?+,&D\,NX0\XMI:N$78/+QWVV/T3T'JM.@:75]@]INV'8_5/4+K'6[T^<S01
M]M;@-/'BK/?OM9(4J_4Z^+&.^XT*ZVZ\:^*WE2&EN+21<8ZT5[SMZ1[2:LK?
M:?8W6/NWU/VC7[(YMK8NN:1!]?M@=7[G&1:C*\-7:^_+A.;9H\],/H"2OXA4
MHIA#I+WV]3#;,B15.=?N[WGR[+=>NW/=O2&Z>E$[KWJMOOLC2!^N&R='V..L
M.Q:SUZ6Q/R42Q>JE-@J&DYJJFX8"^KX>7CVL)=(80YEU!%O':7SH]D;Q1O'1
M>>N=QZ\='--=Q>J&U^P]P[.=LJ_(W76\5N74\/.IE>I]4EOO54K6+0[:ZR^*
M@@K*I*5&.$< %P4GX)9%?EXM^SNY.YG0#K'V>[ :N;TYMS<%#+L=LHHT?+Q4
M<TD:TV"#K]L@XR>?*EX^M[(J\4%9(QE]XA;<?+,I]Y[&,.K(J +IO+_$%4SR
M.Z<\<97=;I(;=MQ]=+AV+C-D,=695NK0T+3[#-U\FN'13DQ]V?E#'H1;B'6\
M^TE*\8S^G&>$7TX77<T#U5ZO';M[<;(K,1&Z8U+&6;?&S8Z)/ K1,U P(+=O
MFZY6A&CICV;#9,.8BHH=L@UYPE@5E#CRD)410>ZO>:GI-V?8W;Z2MP==Y;0&
MEQ>RE_K/:O5$[I*R*ZW&QN9<7?M:C99V0_$NK'XY3+J9$5:U906*KV_24/EP
MBUSK=YM.HG<&PV366I!=YZWV;*Z3MV]-$C]A=&W#4D-V(U?7 35N;0T;*V)I
M4;?J>,\RV]G&7!3'A?<=;'6V.6H<BJCZI^9#NMMS2W^'NO%QG->/SWD<["=N
MM<=F'(^@  "RE9TWMNV4ZE-4\9LI2:D8Q"P[*2'FLN9(<QE><8SGA%=/Y ^U
MUOZY[R\<5"K.W:WK6/[-=LX;3]JKT[JJ3V(;M*%-'CW'*97YX T5C6DH_DC.
M<3!"7FD>K&/3^CA%%ZW_ .(W\<-'D[HS.N=DL53578JP=9-T[4C^N6P)+4.E
M-A04HU"#%[,V,&,[7(>!M$J@MJ(P,Z9*&XCBG,!)9;2XLBZ1KOSP=%-A([.H
M6-V&UU*=5] F]JK=6]OZ$NFLK7?>MHF([+6Z]35FU-@S=KHLIB;CU!O$,1Y!
M2)$9Q#.6W/7@BY?&?XCKQYR\[2JZ!7>X)$CM_6L/L;KPTSU%W 2]V><EEQP;
ME$Z[QPD,1,[0NT/.GKC#,"#)AT'ADH;/<0RISA%VO6OG&Z'[3U;UWVK7YO:0
M$?V2[DPO06LU*Q:TDX>^T;M)-O1R&M<[6KCA;OX->!'F0B"B?>)898+:5ZLY
MRI*2+H6R?+STVU3_ +0#\736P&?]FA^2?[4/P*(<;]J_: ^1^7?X,]!2?Q?\
MGXROE^S[?Q?T>KZ\(M=ZM^9WI?VU[ O];:$K=-&OANE4]B=?2F\M-6W3=.W+
MI7#HK1&R-13UV:CEW"HLX)4ZU(888$/%%))!<*&&>>01<VTYY]?'_N[<>N=6
M5<G?<'4MW;(F-/=?>R]ZT)>ZAU6[ [3A)1Z%)H>I-T28J8F>L!$L.L9A!+ 3
M;I.$LX7[SK*'"*OK7?\ B(Z[HOL/Y.J'W=B-O6'6757NB5J*GW30W6JW7*FZ
M)TF;.&U*L6GL/L"OM?8(9FP6UGX$>IU]Z7DB65MC!.J].%$4\-K>4O7^@?('
MNBJ[>[+TN&ZH:E\9@'<J7HX>HY^2L0J9'=%)H\1M",VY%/&CVF/L@UH8B(ZK
M"!K-+/D&'6U*_0G)%L>F_.5U2WA$[U;KNJ^W-&V/I#KL;VI;TUN7KA>==;*V
MMHQ#./L^PM10>69S-UKME-<;9CUCY^49A2G6!WFFG5H(HQ]'_P#$)Z;VGXS8
MCOEW"JMJTW/D;:G=2MTFAZLV#,1NS[U9MF[$CM/ZZZV_<%'R&[[,[K^MB,S1
M8#C8@\X)(X>2"VRIEDBG'IKS*](]LZH[/[3L$_L[KR3TNB1)[M)J7LUJBW:?
MWAIJ&F(U^5JTA8]92HALR>FYB,>F(:C,G$&D.-#I;P0^RTLBXU3?-7H3LWHW
MN@_U]B-T:D[&==>H%][0UC6/:'2\SJFV6&@XUU.6/6^Y:M69TDIBZZLEIAJ/
M^A;+V$N-&C96E+93"UD4>_%?Y]=1]IJ7T:T]V&#W!7NS_:JB65,!M62Z]6_7
M'6';NVM?_="MB4'4NQ91D>$L4Y3V!$"FY!;=BFI+*!$F**?8:=(I45?SP] +
M?V-B^O<1-[CQ%63>975^E]F3-+W(7J+>^R(;V0W=(T_?*Q\U^9O#T@E3(_T:
M1'&?P7ARG1G6'W2+GNS_ /$3^.[4UGW+7K*UV6/CNN'8ZP]9.Q6P*OUQO]CU
M?HN[5ZW.4/\ $&R]@QP[E;A:;8;8,2%#N-O$2DJZ(]\8%S",9R1?H?YQ^K>Y
M*1W5I&D[#MW2V[=$](MT=OM9VOL%UQO-4J]]U%4*5-G5[L;JJJV1$5-;:U<'
M+(#/8'4U'%3H.59$0XVDAQ@BT^&\\/7'3>A^JC.VRM[=K.P&T^G52[<;&8ZD
M=8+A:GZYI@L)3$[V!OU+%,:8U-K7,J*]EULHQY^-:RA3Z$-.LN.$6F]L/\0)
MKW4G8+Q<4/1FL[YN72/?BKV#;]DVE ZCV?8K$/JQF,DHZJ5G4E/C HTFP;43
M=0EKMP1.'2*A"L-.%!9S)CDBD77ML_XB3Q[ZBV_N_1\H%V1MUXZVVK9E7WFK
M7NAK%::]K1&J(:4G++9K-8VCA8L2JDAP,A@ G"U.%N /XPTG",*413Y;\AG6
M4_=_4?K[7;-.6W87=?3]BW[I1%9KIDC!*T]7ZB'<T7VY32ECCU2#L,69AJ+4
M]A:S#$*8PG"_3A1%-_A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A%\A?<>
M [%^17R#]P4:&ZP5SM#J#K%HRU]%(LFT;>K6IHF@;DV;$$';+V96GK&(\N=O
MM)DW#(;(Z,9892&,\M2<N-8S]JV.3:_#'AJQ^(W;[2^N[AMV=,;I"^*,TCC=
MI.#'BCJYFI' KXMOD>Y^)_$E[\.M&7=E:6[K0:I&QADKQ621NK-[#5M,A0$Y
MA7!>$C>5CVWT,HU"V(,1&;@ZGV6S=2=L0ASB5R$38]*O#0T(*9CW''%D-4<B
M*9?=SE6'#62/HI7ISSB?'NWQ67B*2YM2#97C&W$9&1;+B2/_ %ZB.HA=MX"W
M"6]\.QVUR"+VS>ZWD!S#HL!7_P!&D'K!5N7.+79IPB<(G")PB<(G")PB<(G"
M)PB<(G")PB<(G")PB<(G")PBIC\D73G??8OO+X?-W:IJ\;.:[ZB]BMJ;"WG+
M&V: A"JU5K34JA$PQL=%2QXDC9'B#8A]*F0&WW6\)QE2<8SC.2*M+N-T.\ET
M;W9\T5LZT]9M=[VT_P"6?I)4M+PVS['V#I>IT:2MM#ZRNZ'D(*:ILP++6RXS
MEJ;?-(AUC#B0Z#'0T'R @_R7V2+HO2'QD=O=+=S?$=N/8FOX&+HG4OQ)_LI;
MJE1[U398JL[O^98%YKT9&Q\P3(6 '+$BC'W(!M\+Z+SCW?\ =X11(@O#AWS
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ME;CO^R^X?KR>A.X;U[_^A'Z4_)/M[^^]_5KUC_*W'?\ 9?</UY/0G<-Z]_\
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MLX:0\E%B6YC!>87!PK32<"TCJ./G6-=1!&2Z99J>.5.P=^?#F74H8B6V&96
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MK)DNUF6KLF#^)E5$0^).D6)HA+8S.!!F%M+:PKU^K+#S?K@<^"+1;PFLCSK
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M:VN=:@$GATT7BBP3,'X@I0+\'14!.1;4$2B6)C8RTR:JLQ9DS\[)"R,;8)!
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M&NU 5H,3,FX0U/RS\3 !R83$>Q]&/B884I#CKZ_X&*3[&>0MDUA[X\A0#RY
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M!00_ENQ\YR\R\))S6FES$D!$Q,3-.,Y!LY,?(BO!3(PJ'CK#*2C. Y.=-_\
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M.5A+0;LR6F7JZ0>DH0$5(=7A"0HXC*1<QWIEVI8EB,EH^7@:R8*.X&VL=T;
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M$NIP..S#:VL<MW#/+J+2P@NDK6HR%7<!P'#@O9G:FBH:)*9"GT+60;E'R3+
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MC8Y@-22LU1 R38B,+D#(Z/<JC0$O]N'KQA\X2.L8F/ )E2(!EA,4MS+F'/\
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MPN-O>63@R-&+>./SJ['$R<4% 1F:XK!650\1AP(61G-A#4N1K!8H$[5IJI%
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MY^VYAAB@F(O$@<4VYAPYYO)(K:^;VJZ%K8/EN(GBSA)#"[LATA(#6MZ26ZB
M0,CBMSNEO+=WG-A>UTSV Z0:@ 9D^>BD#83B("J%7H\J'IT@T:$XV\=6FX2$
MHDP:(."(]>'JW-3-<1: 6VG!Y#(Y2R77W@F\O-XQG'-]<6NWS6A=A9VP8'N$
MAH=3NF@(QX4)XK2V]Q-;W1A##)+6E *G'HZL,5H=I;H%LF-=ZND[T1*E6,9<
M]7=?O /NREECJ8.T@E68AR:4?,2)DU*DG!>D,*$-:>6OV24@)QS126&U=[B;
M?2\RK0Z,-<:4.1(IA578;R^;;330P@-8_2]V1KT>;BN4;/[$043:W:+2#"V+
M;6+5682?)L%+D,?*J\W6PPS8R5N,S#S%.@(N$];# F,945.NBJ$%8+>=;,5%
MO>\-BOHXXGF,Q@1Z"SL$#LDEU:GIK3'-7=NV5SXS>31A]>UV7XUSRIAY*K?=
MD6JK5R:CH&OU%RU8T_%5;7=<M,/7HK9%QAC;FP1;8B-N]6?BW;A$H!KU5),6
M6,E["?='PVA#B5.\S^(;=M,XMVMYCOJ.A&IXZ:5T\*\<E[%87NYQOF>\0AWK
M!YTC#'K73Z#)C6>7LT->#(IGVZ>U<(O3X$(<3<&V)%34#-V?&1)%DY,.**+#
M/8"<CHZPQOS<>\\XEYG#N\E.NP8QE.=/B.9@:8C'/%:EXC,NJ,N+6G22W'T8
M+JOCUV#L6?[*5BM;)-U]"V63N)%M%K>OK:5;JB-7 :7/"L 0X1+#)E*D#'R%
ME89=(.0:TAY>5(^C/JTT%@^.PNY+F)CI8M #FN%&ZC7(T)K2F P4FZ21AD;(
M#)0M.K4*5RI3%?3-S1K3)PB<(G")PB<(G")PB<(G"+QR(SQL><&.:1&D%ADC
M,2(B6%%1[S[*VFC1DDM/C*(%6O#B,.(6C*DX]2<X^N.$7RV]&*/N*I=N.IFC
M:QV:[K[U@.J>\^Q-4[IWBZ:T[16;K3MW=-7ZY;RH(EF@M[;@V)?#*3*2\A>8
M.0MU/+/D:$_>P&#*HS$9SZ9,BL_[B:YV+<^\72*7I6HNP9U?J5DCK+L/L+K[
M8F1Z!KRO05D><'U<7JPK;5+BC/S9*D5?C.PN0TT^/4HQ$>.(608R[&D7#M;:
M@[P6;O=O/=$'$[*T/&;,U;LZ2K&SMT2$+L_5L+$7S3_1T3KOJR1ZZU/?03#]
MZT/LVA[->GA0<P8R'RSW1YXI-A<>)(L;XWJSO.I^5/RXP_8C;5#W7LE&E/&$
M^5>=<:<D=%5DB(?A^Y"HJ-:H$IM?<Y8YD<UA27BLS;B2<YPK#+7T^F2*^+A$
MX1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A%'KM:^:+U\V87'R68<L
M2)CRVI),4Y-*%P+/Q+[JTQC) KQ2U,MJ3CT*RM&5>I*'%)PA5JR<673"T FM
M/EP^E21-8^0-D]7T8JB!42&Q.6R'-%/BJH<-8K,,5"34K89$55M-#L-ECL1C
MQ 0X%8M%N R?'!-86T^&<L=60_TCXZ"PVJ\M99M$G,8) 6-=C0XDG"G"H"MW
M%S'/&'$-#@=.&'RY]"]90/VN7;E)V,8#;C$Q0<"/,+S6G*^P_*P5=&9F:T6:
M_+R0TM!P[#[ 0;KY+#6'$+^7EQII?2"[M;K5%;R.U2-IIIGTT=@!CADM<&D$
MUR)6>CXE.SG),#)I\RV0DR+C+! 2UAJ#YH%A@78"QB4YE0  M?,K,E!_<&<9
M4I]XD9I]*66R&EN:S>K61MO'82UCDD%"2:Z ,M1 QJ*'STS"LVAY5P)10N'3
MDL)4 QXNKUW$1^,K#:(LAH&9E)*@P,Q9')9*?O'W*SR\(\V/'R2Z\D5>%F2+
M2F7FF_5CW$8]<C[8MB;;S3#DT#0X9UI2M?G4;G.,I<W%^JH'75?S"!0#"+W*
M6^\3$J'.6:8*U/53)^2L&8FIB5R$CIJ%EYR)FB2)@=%W=.^(X;+M9.998;5A
MHEA_/*MO:2[=4-<U]K(X N=B<>@X4^16IYHKYS>PX31MQI@/.,5T(/,P;5HY
MR?B)IC\.+N$9;2:>[7Q(ZL0[I1:&&A07+(L:(D7:$0@H=P,I9X:',?5A3I3B
M'<IHQ:2FW87.UN;IU&O3JI0#J46MLC0\!HDR-!_%9J\ 0J2]:A*GX1#U6&D+
MO*N24+.R,JIM$/F/BI^,3%,EGS9%)DA$JDF<2+1?L.-J?=^B\((GV\2Q/N6.
M!,,CM%0X C3C05&!-<5"\=K%<4F8R-MQF?O#HQY@4R#-XLJXB5<'6U(S<O%S
MSLX3_D,E%QY3J1' %9&<&B'@FVU.-//.L,;JWGE@@;VW&LA92H- #0<.'$\5
M5<<3B<UKC5[Q-0$NS(6B4CV0IF84!#OAQ\H]*N2R%H8:&*'>?<=$AY!\6+")
M0\H7 CS^''B%.+RQDVW<;AK=-6:=-!Q Q^7!3-QC+SF N@, V2K"QL%)FS$I
M]SHKZ3H^?)K%4B(^& F7GR)7(DH2"^HJEP'T^I"EJ?/">8RZZZWAW&:4[V7E
MN]S&::&E>O\ P%BQ[G&F7D6*4''5":GZ2U7Y1H^U'3\?KZ5DWJR$%#1+<8]]
MNN@8$U,Y'LADRS[?JE A7L-Y6I"\JSAUK.<<7>=,Q>-#0 \'I&5.C#RK)TFE
MN@>L5HA#-S?U//P,:B2'O$V'/5J!^T)^;BF3& IL0[8<8EE^S $6Z,>0IZ*4
M0-_E2<,KPAO.%J3'?P65[.6-E?$V@R& P'4I+:1UIIGF:Q[!6C2.OCBO-6<4
M[$K P5L-L84- 5BFQ4^?9B'4VB\SU3CU0@'XKCXDQ*$/SLP6X9(X#RTS\]C#
M#V5I4RI>3;.2VL3'9T?<N%-68%12O#$9KQSM;B\"@)K3HJO;#I9 3;ST!1U%
MC3) 5BO#FOVL/(8E=E,/SN#8.TN/DSQ;9,JPV&(P*T/DK#K.',)2PI=MVAHB
M(<TRM;V^FM.'0L'-#A1V2RUH.LE68"K5BEP$PL87)V2#E#8V(.F)@P6/5+ R
MV9AR<AGPC,Y)6R2M212EM&>AM;J&7750MCANI'R-$@D:!F1I.?"GTH!04"\)
MUALE$+I9$RV2E^R2<!&L1D?)'$B6'!Q#T6S7V O8*<K%<#,4*<42_E))BG\I
M9P<A2D*\=);/B+(3I=6A PQ&-5/&T2!S79 56>J\E"BM@U.<+@\53XD^T;3%
MUMR2!G&9TZ<E(XBPP2X6+L14@3 Y!D"U)>D 4.*>]"EB*2[F*2+<[VSGE=%1
MVLZ2'4JWA7/%1.,<;F,BJ7$ FN./5DI#=(S:[)]FJKFNRI8QT!);!B+0,U69
M&OJL>,P>P1(+)_W8A27($$&$2_'-,8]QE.6U8:9'>;QSG]SNC+MY<ZV+ YK6
MAY<"0 YI\]:4\ZN2PN8PN,FKJ5]7.25-.$4-^\@ 9^G(O)ZV4! ["K,F4DEI
MMY@AD$69>6&XC*'2D*.QCV6W6&W'&'7$NJQ[*'<XW.QRF&\+VMU.Y9 %:<1U
M%-.O!5" /4NO0C)CKKA! IH!4/+-R(DFT\^U%8ETL*&IQP>,3D6@T?!ONCNC
MX"PUEQ"L*4I72.%Y(6R2BN> ^KEQXU\@R63G&-S0.OZ%KDF^WF,LY;M/A21E
M1XLF_-RN9:0A%S$F&\W%MI?)BZY&AMS!(:GGR'AT-B#&.X1AU2_2N.6)]C'#
M()8P9)2&L)H7'H)QH.NA\BML)N7F)W9:&UKG\V'\5AGC#$P\,-'?#'B4L2D.
M\;(X1)!E6,F/)GOER<!(GEG$.MR!A(27E",EL"X:5E*$,?7FW&IKWNO1"9-7
MJ"3+JU:<?+I5>5CJ:8W4(XTS^=>E-A(GIW#PLZY-EEBV5ZKJJC(1E@'E\&"H
M&D7_ +,P=,!^P0XVMHI8KN4M(6E*FF7\M)RDC%K%^,S1"/6QK4?,H7M:6$!V
M/D7^E,7#$U",&K!EC(V0%L)HA;,S)%%R![#1KF#H\MU]_ Y11B, ,E$Y94.P
MCTH;]I"<R1-MN72-NF%P\_E7A,FMKFFAI19<Z-F;)<V*>#; 6RJ5%BIA6A6P
MHYL$L>2^<]&MQ,>EMMN>$K^,M8',(%P.IM*\HPO'U35M7V\-J+J%F#GN#FUK
M4MI0UIUG"B2!Y>6N-:=2Q@V$@0^<VEJ%'2@Q,5D@B4E,'"LNS9RU%DI*>J\1
M6FT2=:+^8ZTVMR0^,ZUA2UJQE<D;9Y+@EM&14J#GCT<$/+CBU%W;Z*?\?H6;
M(MD-.P]>B9*NSC\G&P@65FUEX^OX?*B')@?&28&7?%CI"-D 0F$.?-9<2/DQ
M.'EMN-Y3F)[)8)H99I:-Y[L*5KCTU%/D7L;V2M'+%33$9+!PX%MMRA=0D1*D
M$+D; S9<V)U"HI42>S"J]\9Q]Z6&8GTGB>^RK*RUH=]MO"\H0AM&VN9["V+[
M^04B(P QIZ5$QC]6 6R&(S50+C7KK*P,=8(Z0C+-$2=J3(/.R,Q&NRS@7X:A
M7I3 (Z'$Q\<'ZTJ2X<AK./;SA*4\UD<S;EW.MF/<UPI@,<<5(]I:*R8,KY<5
M^TY8'I,X:T2<;$'KC"S3)?,;#&,Q@S=4<88EI)]G!XZLEV.4B2 4-O*PQZ%X
M5ZU9RA;V/(+2;;2Z.0XAQ&?FK]*RUM> &<%E9N_PY$=>,4MF.A27AW2UAQD;
M(6R*9AFK'B'F4SBJW@=B DY!)#JABD?'%"]62%.OY=)6JL;2^DGC;I#H-5-1
M-/FI]*Q#H6$ZZZB%HE?>D-@PU9#E*XJ:G9N,!JYUOKLH])K9)KZXN8JLL[&8
MDF(:*?9B,O8<9)<$?] BTC?1U"V<[&=K;&5[&2BE34:<.O&JS9R>5H(J>!KE
MT8?\5^85=EPF+35#T2$/6\5^%$=ITR,-#Q=HL$=$E2460$7.R0(L(;E=?<R^
ML3#S#J&/XWWDH2KE*;<H8V":$-$IR<&4T]>:F8R0O#GXN.96..J> "'H1$5(
M%0%DEB38AR-<%)-!L@0S);M7"EHXQ\9O \29*N(2 UE6<+]G#.!<_15JVG=<
M117!G:VYB!!#A36"0: USJ!A0\<<%"^D;3&T5).?0ND1-2D"!ZS2W7:X[3:?
M3IUV1L\%(B3=X'G2Y>4B(" +S6TK<76'("=+-<=];1#:FTLJSA:\N\TUQN=[
M#>NN+F%_<:TU'"G_ $BAU@\344ZZHZ.!]H6.E+;FHH--=7GJ*?.M!G=5R,2?
M;Q@AX=TYVN+K$.2*5:SE-DR%A!;D#+,FW/G#&%C,C'*<EEYPE;9C64J]'KRG
M=VE^YQ9 ]Y#0=5*9M.6*\ETO(+1I[('37K4F/'(*\CL0U+)0\%"S.HI]B"!.
MGI(F2)5#DT(>?E$0CJ2 VH-^Q.E*"-41E\IEY'J2O*<O.:OQ//(;%\+^46FX
MU-TTU!IU4!PX#/KX+TLT@4RHKX>< O$X1?(UL*N#;1OUVD1[G,LR]:6O5LG'
MU^8-B1XNOQ!,=:HN2898;B5O.2=5C4A%%.5TMQ0<A@5M;C*F%.=):[5$V^?+
M/-*VX<-<K6G4V5S15IJ?K8"C1@3@N@%\([6.-L(Y#W!K3CJ!)H"1T KP ]@;
M/N:; D]0P0OY?Z;F/PZU8;'7X >V.79R)K->=^#72(UM0(57@YTC.6WP@BI!
MQ]M36/;^N'(-F.W;C-*^=CF0QZ];'$MDUBG+(IP/%2WMI=6,+6S2-=<2D%H%
M" WC4\"O\9A1MR?*>N=DV+1HOY</ 15/C9TB,-L&(>?%JP\C*B@Q;-K@&;+)
M5+&78+!K."8LA>,9PM6,(L1,W*6".8MY< DQ;J)%!EGCCBH)XH+4/Y0$DKFT
M!KB*YK4IJ];+U%:[;JG6M?C99K9<H)<P).3JM9B:[ 6"(CX\:W2DJJ";M@U@
M312EAE%Q98\"9E8B,B*EEDH8QK+V=UAO>D1&<S@$M-=+ <-0(XX*_:6T-S8!
M]R\1,A;0$9N(-=)!X8KHP6M[!>]YZKDK'%55\#5M<)"7@PC-GGXJ4DYV=]^T
M*/BIN!K@D]-GL%(;0X 44 Z4KU)'2TG#W0OVF#0VXU.ECB.IC#@&R'_WE1B3
MPH<%JANH:76Q;I9(<"!EY%@-AVDV-H(TAN0*NP&*E1@3<UV=MU?AI2%^;:E"
MP44N:@8T6+<F HT_*LJB4G"LGA,MN/MI<4E5R1\%WX>EO+RW?$]YT.81@&G
MD'.O0H;<2Q;SIL9HY&QFK7 XN(R%,ES!>J6]HV>&G=>R</%ZFO<+N9W9/Y>2
M2:R[LF=:!KL*F&?D7<)E(NAQ4D \[C(#PX4BU]"<LD92-@;0W&S[??BTN;1P
MBV^W.DZ\-1)K0=)P-%LF[I>V$4MM>%KMPE=5I;CV<<Z>4+I=(&DX42UPR'0(
M8O7UMOE,C8_8U3SFMS8SD>7/5\ANY0#SN6:W"%3:(Q>$JP0VT,EIQAY]I*>=
M+;2QN?/!96TO/CC!C?E&2*UK0XC+/):B>T!,4]XXZB7$](RX+BJ]3V.3D:_<
M-KP55A3XIJ/7)PE)L%^A#I*R KN(=(M$<^1,'0D]6R(.QKCUQIXZU!-)4^C"
M5+PH?G(-MW;<=UAN=TN8XIYF.QB<101CLBE*5Z2MS\2LX; P;>QKPPBNIO\
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M-<3.-5MF/CFD1[(JFL,9;PM24J3GE.]V<.F?MMY,)G3OUF/U:-KBX!N#7 D
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MZ'58AA[\P.9"->W-]0G$N) +A4Y]HD4ZJ*:33HCY6,N-:Y9FGS46M2\7K^6
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ME;>9R^"-[QS-<Y.$8QK_ ,LU$V"8-YKFN#.L+]=@VLDHFI,1XJ)R:JD'(78
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M\A;;S,#;O@ *4\JC@:(G/?$>S3(YGR+7[T%+V6JV;WYXH>ZD!@04;=*R(F<
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M#G)$6EEW(V:Y:!:,- 64 U\*TPRU(71DZ6ZM76N!#WN[69N 93,1TS($S8!
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M+[:5N-I]:<_1M'K'W+9RQSP8R>QY.'S+P-<YNIQ[2T.GW"6K_P!U"KLN)7X
MJ\H>'K0_XZD)&%);K+LH?!QTG%1[T>8$_@%@GU?&< ]MYQIQ*LHS[FZO+%ER
M&MN"7R",.#N.=,A@JK7%K@X9KV[FV,J[T>-CI8-V/F1K399>.@8J>BVK!67(
M\"3+;40XQ-!1\M5VG%8RJ21G#8WN?3+6%MX^M:QLY;"[=>#3RQ$0&])JT_P"
MS?*YXH13%<WM \CBZ:PKU69'E:LV/*U.ZV)A_P!94O2)#7NP,R)L#68Y4JB3
MC1+3$QXWNR+Z8LHJ1PV/]2WTMO07UU?QQ]Y#:Q2S!I;T"F84UHVV=S.>[2]D
M9<T]=<EV5Z*F(>M5D:9<DPY)EN+P+!M&N^R3(OE/@*KU@*FXZ8'P*4,YEXXD
M3T80VV]A7U0_R"&2UF=+% QSNLU&DT&2PJY^ES\^/7Y?,N)7^^SDS::Y8QG:
M[(0ITTF..KF9\L1$1%@N).AR(P@R$DX609)]F-?5AMT!X@4U13+:VL(;5NX+
M*:+:S:V4+S(ZNJ3"H:?6\U%@'1M=S#V7--6CA48CYPO\,54(J&)J5!JD1$'V
M^&/C6+/.66PSLE'!R;T/:S*[)$#E7.<0/+6<U<AE/IRQA@O"\)1E2&EUMOV"
M.)QW%Y+98SF,3CA2APQR*2;C=RX/=V#P7]BXDX>KFR!PUC/L#J84Z!: -BBQ
MOD/'M1 (,#."#$(^ZDI.PO*6 V3?D-K^.PVT]E*M[*]MS.*N$3:>L?H"J@!Y
M)JLE:03X:*BYRO1LK#J)K$,$DHZ8*EH,R.^/$2),Q"O,XG'PH,6/84AU#P[1
M#*C<J2V\_G*VX+5CKR=T4T@>&ZM) P-<*%9->8G88K+3UN?L9I4_#5,:4@XV
MS>HEDV/C,E%BM1YM?1#!RV1)^3D(XB7;E74*]YR/^1EEIHA*O6PF&&SBMX>X
MW#S&0,*?-_C->/E+Y>;A5=QZ40X!G:ZM&$2 ALK#*L<L,=!CO"1+D=*TN_"0
M\*^P._&0;+K-5E@,LC M&M"?;W$O)PZMI;&OWQ]Q'LCM,<G(FTU+P#IH]I%'
M''$BGG7K7ZG45^?/G2D3A%&+M4T<Y3:2L'T?1K:58P?ET=\EC$87'3\<?AY+
M'\)I+K!N4)<5C*6W%)5],_3&.7]O>(Y7..6@_.0LF9JH&\2D!89EE^4B[,4&
M.>(V+&5]1 \6]9Q26C[$F=D2B2LMX!R[GVTI,<4TRPPIO&5)PVOIXGW5L1;0
MZ>:X DDX4.5,,\ZJ7L?7JN5R"CXVO5TVN?98RQ5T".?K3\V>EJ&GT+L5=E6W
M63AO3)0#EHC?E,-DL)(9.!]]"EH<1E6(]PM(9H>R]O>&FKB:_0"K%K,R*1VJ
MO)(\_P BPY5J*V3L3;%CB)LF7@*Z-#5 ^,BZR-^)JO9" 1'#V1#9@QF,M8UU
MB;$":&E(2XAG*5#D^_\ I4UJ]GO)0V2TCO(1)).YH#P:-(-,3I.'6K-Y':1B
M.X,#G,TC)QJ?-5;5,P%L+A8)IL@)^EU2KN$24H,N-^\QER)-AA(4S,$1"CS'
MV-+AMB0IIIX1D<9KT-MX:<]2-M87,C-+;H![W'M:B17R$8JO)RPPD UHO7\?
M*JU,"M&2KF+/$C_--$)2P-)JB(9^?+S.QQ)9T8,5)1ONI%($)]Q"D94XEI>?
MJO9,N8WR@PD,:UV+:<.-''$^15WU:-(H21YO^:V=VRNV0/7D7+01<T26).3;
M4\S.1\N5!+*CALPL/,,MMQP#OXE9:+1[N&$M-L)=<;<9SAM7*5S);]]Y,)>\
MSD:B1V0UM:BM<*UP'4C+>1]N7U8TL.5<37HPQR6L6*KR+!7WIQ^7(%*4;(R"
M!["67)K'/AU9DFLF19@T7$N-D.- ?':<'*85]$(3E.4Y5>@OXW%UFS3IC]2O
M <%"8Y W66FB_HF?B:W*5VN57,R?+6IXU@P>&$GLKK$, R?)2)YT?8P9!CVH
ME(C2L9-(948HKT82K#"<8H3WW+<QKWMYDKJ"M=-?+3+S*S%$Z2+F-H:9CB/,
ML#F;G7Q9/,8-/3%1&L)4&:?(2S8KT."76IFNP\A"BB0Y4H<BQGI$"RPRXRX.
M\2V8\0KZ/CIN7#KR%\'(<UY+NW0U%/D5> 6\T4SIJ\O3V*9U6;N$?)L&HR)&
MP#BWXF$<;Q)F$O3C*64&I%?22@M\SY"A(/+7SBU9>??4YE/H1[?+$!M'L>UH
MTS#M8?S#Z,2HCSGN#GN)B ICT+V$QSDR8;5GQB3J)2XLIB1<AH1;60I$*;G'
MIV/23+/$**RQ)HC8Y/K<89P^O!:EX&3[F*<T\5C"+J0M=,XXU];#*@\YJIX8
M^;(8(R ",*Y89K)ADS Y\L$7#?;HZST^+D9TJ69A9XS#K@,U7I6M$PU0?G !
M,QL1&A20_P :3+>=?60AG&4D^XBNZY;=SLAN(RYIH<21GU51C.7&3_[P$CJ7
M''K#?FI"D0D_+RD:\))O"3A,9*E)(L,.>S)CQ@$4T+*H9AY'TA,G8D"<K(CV
MVGFT8;4KWFME>[:WEZ[,#2,VN)P\F:D@G )Y]3Y%T-_<\B\WB*F0CBID))]9
MC8\W+3E;E":PW@L\Z5)*E!KG$E)R+G#B33EXD1QL+<]U+SK;L0L.7&RX9(#
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M,-C[.5,U^.*DGI%YY 8:77V,NN)R^EQ&9N+"RNQ-MY%O-,PM-6_B2$5JPU[
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M;K[:.ZG#[ENB9F9&%?-E\RJ\WL_AG\/AY%JD1*Z7&/BW[/:HN .L[X[TM\%
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M+=;:0Z_%,)<:7DC'H=T[=NM;K?'7 ?,UIQ,;L6./73Y%<=>/%@+4YU6512K
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M00X@$BO 'J4HE>UC2P:-1H0O-?I^BQE?M%YLTG:HVJU.T2$++/VNG"/LQ^9
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M+*A@(YMMO[ $Q%KEQSG<CP6$*<$"()$9=*7G*6E9?;S@EAU.L(H9N2W N<,
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M&N0\06BJUMI3-=K*"8\,=Y-?@&5J0$%A7QA4YSAI"<9X156=5/\ ODO+U_R
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M@(JN1.6$M"38T."[ 6R%470D6,>8"AH\D5DHAY]CX3ZL)]67<.9ZL[=9"&.
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MS^%C^ O/_D_1R_MAD%]&8L'U/\#7YEX<10JA[X$>+^$C1Q172W"7ZT,L"<E
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MU.9;RM]6*XC%M%_W .AV(KGCTGB5'4$UX578^JE@^\=A-:BG10.7T2=WE0K
MMV!S*RKB*%;85XM3,2XW[2"UCEO/H=3A]I][*&6&Q?X+.OW>U+-IFF8^K.Q4
M?^MN2S;VI XYJZKG *=.$44.YF ?R7*6>^@1MF<&>:.606/D!]$1-^@]O[=C
M[B^X(G*E^TQG#KF,9QCZ_IQFW9O+)30$@M(-.C!30-U2CJQ52-]=,)BY,R<D
MIYP4C"@PSFJJ$K!L5\1E,5+-1.)"-+&D*Q(X>&<>'<22IM+;:L>Y[2<]#M]V
MV.5H8 Z$&A!X%V7\#56+F(.<9G$TZEJE<L-?^\R<+ EE.V6FC6!B5B)(B5AA
MHQ$_7HE4*"+)XC)=+9DC#R YK*6_<;]I7N.*]Q+B>97)-_=EI(:R)Y[3<C3@
M>-/E7K8Q%&#4Z4K#^R\/Q+*:6634J6K(D-*%$%L7J-LT_+&KDI#/S1_@2*5L
MR3>6FV D$,O(]IU.'$^EOR?;H;>Z;=374.EXJ!4TQX#!91W,+HG0:':B<\*+
M<E'DVB?&^;-3"7QXL(2.EK%!/R$0B8BVR@Y4\Q]7V*'$FI7&$L!FH2V4EG'I
MPTA+J%9UUQ$(+1O.@9%.?5=J!QZE,VH&BM8OK ="TVB/;$9^3,3!-+^]15\L
M\9;?PX@%-.L,7\^P@UQ<6'?7!3*U-585\!:QPC'PF<9]I)9*%+3F2,;BR&W@
MW)XB<RI!%2YP/1AETJ:>2TYKWVH>UCZ8&G 4X$K,R,7)U> 0G!%;"M5FL,)7
M3FAXHB4P%#R*5E/*GW"V9/%84PXZ\ZX>VX:*\M_'\-3./?3LVW]HVZU3OE=&
MUM""W,GH5 VTD[7-93,9D#^*T]<-1F,6Z*BQJR+*(P#.2,B'8%GP<Y8&1D*/
M%LZRPY#W2G X8;"LA?1MO"\+&;:R\I*\[+GFW;-:.?H,SL*"M*]:PN/P@(7T
M#P/+_!9JP/U>O0<?*@$U\W$(X&NR%0>);Z,24R?,5V/;9CUEC0($F@9[+A0>
M4M.Y]]QO"FTLHPJ\R&=UT]\S3%5Q(+O^%5&:!@Y?;-,AF%S21K\$3*5",=J"
MS<BV2&V ",? +-7'F8.3(1=BR6=,U\QH .!^B4N-B+>RTUE:7,K0WERU+;07
MNIUT6RW#!4/=@0>! "PMYGVTCN7_ *#LZY_X\ZSD<4+&IPQ)P=C!CX^1>6$3
M&2:)0%IL0<V,5(.@FG/GA2A+F5H(<23[64E-X6W]$HRJIRYM3.[N8^;00^E:
M$U%",.'6LM!8\\=6*]Q,LBVV<PR%GLCUV.8FY,<^R1(N,24H0+&*_"K9EI 6
MK[F_-99<](H2?XKUO-9>5CZ*L2VT=G9F20.YO5]"P;([6-(^5?A+#8'FW6E$
M1%IKA[$?%8?"F8\.535TBQR9,6MQ:CSBYADZ&,4TRW]<O/E///Y5AY?U68(6
MVS!6LI=7S<%/*Z0OK4##@N?$8D;$Y3&:[)U.>D"#8V/ARC655K%:D&[0PDS*
MBX:KGRK"H*$4XH8<01$;(&C.?QC*6E./5]PFG%J_NT;=0>0>DXXE+81F?7/J
MH/\ '2NDRCUB/,(.D9VN&SN*[B.?<==1'X GV*N0*@8P>9)AJK)2TW96OBIP
MMIYH9&5MI<%<:QEO%TEO#&UD5O*Z-N9:!3YR%@ ]SM)<!CF<ESTJI+>5?YV^
M7=#,)&7:3(C8$NKC0:V1WA1W!P(Q88T*R2/'V9) :Y <4I;V'%Y>)RRZX]RM
M8W=S!"YKF:G.EP)(%&XX&O'++H4UR62.')-0UN/613)=]AX!FJU*)M#=SF U
M"NM"3N1'C1F9UL4DZNG!2[,@+&M@*5!")6VYEQDB14EA]/LKPE]4\D\US)RG
M0L$HRD+A5E<](%2:JO&T@ME-:="C\DJ'B5C5](Q]HB=@RLW<!(= X\@=&C0+
MY<JT-%K C*OD67D(-AUD=$@^:Z^0/E.4N_IY+#+;VM&/G?)<.J07M(Q'#CAT
M*U)#/>/,L+!I  S R\ZG1X\!*8)V*M+<&38US,34KW1RVIT&<AQLBTF]M0*V
MH^'D?DQPY0#D:VHDH9U'W1DL8O.%Y6M7.<W"2>[LC=G"+FT/6XUQ'4<>OJ4-
MPTQAC'>MI!/5ADKP^<\JR<(OF2N%K;A;[+PU$J0,K) 6.T(AF&8:1D?4%F/L
MC4R.2V?*',R&6'H,D(K*U",%$O..,.DMNX0KK -KGMHX+ISFF9PC=_TO.DX^
M0Y\%<AANH>TT!Q&(%<^A<)$8J=^PWM&JXC9^P .O.P[@&PRS*'4")@D9]C"I
M"GVP,F9;/?4PRD*40XV(^\4I"FV59RF^]TERR)D-Q$Q]O5@)QUM.51AB.FI4
MX=-!A>1U8[&@-*=&-%E96/+$$4JOLEQT$W%REPOUA?L,XB<K@;0RI*+#KH88
ML5#R$@=.A/"%-?4L%\89+S*,.86ERSSKMKX[2W-O,23JJ*:<J=.>/1DJW(A+
M73SM<QF&@UK4\>'#!9>Y:L"V.92J58[2\=$V^5BY4YAMJ1>=JMC8B&+!!F"3
M>+6!:H60DY=DPT)UIQE+:FVTH1ZU+]NAN]I'N6WW##;L9?6Y8X/C=BX5R&&%
M,^.:SM+L[>[FN_TI!0&F17Y1UDK8(MDL,+;(E<U 6VP5*8UN"95HX*UD/1%/
M54V"F;W-6S \G7@2RB TA.C-S.'GLMK=P(C+-&66[?=<R*Y$D,= 8W8.R&;\
M03PKI5PV\+FZ&L(DDQUUJ#UZ>'RKG<Z%FN35%B5%UJ7NU?A[$?#&S8(5FL<-
MKBSRC0 3\-,.CQ<=$ED6]$4$23]K)%1#NX%&POU(4+;AL]L&Y1P,E(G:9II<
M.UID!JUKJX$ X.H?(ES=WS[)TI;2V,@8P@YN. [/#R56TSVD6H:.B:[ ,("K
M43<C+D@"J62ULPR10I2-M4W"3;\5;(":=KR'Y%ET]WW"7'SWVVOX]6$#IUU_
M86'='NU&!G-;JF+NV(\=6-!JQIV<*]."EMKR8.+9@9*1.H *G5A3S=:Q UW)
MM%XN!;S5O!V-1S:S[I]8_$M0I$H&^\_F)KA,GB:$_%34U+1><-OC,&F,Y=RV
M48VRX0AK="PV^:[A#)9F\F('M5(>UP[#FG"E=))&-,%7D=N$%H97L81,<@<1
MIZ<,/66DS8,)=;";8SLA%=;R H^4J[-PE(J<-J%K@#B95V5A"'T&'?>)WWSF
MBUO$E*><>1DA.5H?]4W<[*0NOKXQRF(GEU;0APZ37$?(L([B4-;:V_-;.[.C
ML*'S+*5O9Y$\:Q "RNJ8(I5>DK%K^JL05Y0,7JV3EJS'P3TVF0D:N Y92"(0
MDV5?8$2L<PYAI;K65?1VC'+<[G(Z!TK'74I);&&EHH3@-53_  5B:%D# UT;
MA,/6>7!VH\32@I7HJNN.;".C:Q#6&+PS(3K*A*3'5L@VGQ@<S3GC\OQ4/)2,
M8J1,@Y9T@9D@Y3N5N)04ASVUY9:4C"/;H+BZFN9+?_YQ' 6F,NP^U3YJ*N:_
MAVH?6R:<74R'32OTK_8^/H,*[)6]BK5UBXSC\U R0EGBQ(P4ANON10Y(=9*>
MA5D$ EY%RW'#N/MD$(&4^XX.I.58K;7807$,T\<$3)VDC$5H[H^8X]2MR[C=
M=BT$@?::@*TH:4/6N:-;5$M]")!<!(T\0!$[-LS&KY^),K\I>J;4%C1"YV%6
M_,UD*6BU1DV"Z\,J+EAC0,92A+:7&RV=9;[FV[;%:[G2%H>YS@T8NY5*8\/6
MZU:FLS;@W%B!)-J:T'(-U5K48UR7[ZK^V637CUCI[3\C(G1,A-8&K\IC,!)A
ME1#,:D>%>*2HBK9<C326S"A&&Y058KOQG6E(;'5U.Y3,WV)K[30V"@H6BDGD
MU=7D6MY<FU3N9+V)JU-<1CQ_X+$1PONW:NGUHEZ!B:PC7L0RTEU 5.$BC9K\
M69D/BO3D3#V4J,9;?RHDA[)TJ*E"5F);)2RFU;V]K9V43+IKGW;^RP:N8X@9
M%Y %"0*N&8."I3N?*\R,=0N<3ETFOSKSWR;?MWL,3X<$N$.N(5?J.1*9:K)A
MMB%LA1L/=KO:S8T4%J="$BBA4F/2+P7N89P,K#Q;:TP,BALH1;;@&LBFE+FZ
M7:(SA@'"AIB,^FBLQ/==2&>R[4T,>EP/#$8UXYY+J.+!7S[#-LJ1>X= <97U
M0UK=H%/KLU-,1D7&Q2"H"V3,?.QKD=][.>'(7.>^A0@G\0T8XD@GE9]WN3+E
MUBV-L+W,.E^H2-(J,C1N/'S+(001L$D[M<NNKF#"@H:FN/&@RXJ4?2X*\RO8
M'2-B*.KT#F+D[K!251K)CJJK9Z>-6_AO2X-5N,?"6<,ZH3PD/@>8!<-4CYI
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M9MZPCRQ[,M:+F_&_8B<%B2IL8>80$4$^22Y\0=C*UX]/J3<M6MCMFOD#2^0
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M:8 +V-L[VFY=A$[@<_/P^=7A\XI$X111[E#E%::=:%&"+RFR19#C1YZHQC.
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M H2>&5*\5J55A==2N_9.Y/F1:+Q;Z-79J\TT6>NAH]3B91:ZN&?'40B-F*;
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M1+R-=J;9]<-MQT(T$B6?8=>%<(9RVQ]!T-IQKSLS=PCCGW0O[X& &A &!)X
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M4ZMDN873)]$4X[ZO<4RTCZJ4M"WGMX-QVMI)H\DN/U:&E</K'&F?6JXD)H"
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M4XP.WG!0.<$/O(2EO&'FLJ7G"<*QE7)82\2@L-'8GS %Q^8$_P#%2PFCB3D
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M8T&&DXY89Y+)SFM.DBCAF>E9C)-I_&0E=C#RBYQ^,?(RJ>>@&",0L"T/(O\
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MI?=8?R@MEU[+ZWN<L]V=>11,GK$V29S@:4[))(KT&A6R?:-M;@FHD,;!4 U
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M6_>UM<['Q.\3]5[)9T1N=_6E&[(Z,!/ U)OF(0 Z4?*U7!11P$@[72&VTOF
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MUP[K<_ER?9/H3O5K^9']H>E;9M#Q:=!=N?[1G\5;-MK?^U#_ "(_:4^T[:I
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M9V/LOZD^!_WE][7^E/V-_P#6J[F?KR_S7X^.?V=C[+^I/@?]Y?>U_I3]C?\
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M.)).9)XDJ<  4& "[_S%>K'RTA]IBI.5^%(27VV/-D/MT2-\R5D/AC.$?"C
M_6W\J0*]OVV6_4GUN*PGZX^OUX15I['[4:QW%67:7MSQR=Q-ITY\P21>J>Q^
MH5?N]9>D %J<!.=@;-89.+<,"6O*F7<M96WG.<ISCZ\(JJ0-<]*<=\[):%>+
MOLD]3$: K$^QH%?3'6CNM1+?*62PTTN[_E*IK[&(ER"K3#8YJ,X6J066M6,J
MSC..:;X6L6^*'>*Q)-W]T'*T:ARZ8"M*:JT PU4KC2J^ZS?[@/%L_P"P4/\
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M1.$3A$X1.$3A%\\?^(1U]I>P:CTE==SU_O:N#@9+9&O7KYTXKO5VR4BFUW;
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M',8Y7,BF#!J&B1P +A*.W&U4_=L;#8X+<'1\:B^5[N]N@%6X'K#LN]04WU$
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M-3[?M'4W9&P+JK0.[MA675-&O9-^UV=1(J\0NPJYKW;.*QM#53Y;C\*\;7)
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M3$A1XEP2R]AD5J!="&=CVA(>7(?4\VIATS'TJQW;P]^Y7CZYWC]R+E^W6=Q
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MQ&Z^OT/=->:RHVHM?ST-J>RMP0!](H^NK!9JI'5<E"LN"+8*SEUM?U4E.?\
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MU]]UMAAAM;SSSRTMM,M-IRMQUUQ>4H;;;0G.5*SG&,8Q]<\(J?O,00.9K+H
M6(^R4*5Y>?%X0,2.ZA\<@=_M'2W67V'FE*;>9>;5A25)SE*DYQG&?IPBN%X1
M.$7S3=#]$#;0ZT]M'?'WMCMQUH?E+[<:N'JW?@77BPZSF;DFLAQOHD9V1ZXV
MO:L2$Q'$? /'%GUR$:2TA3CKJ\YROFMI;&_;YV[6'Q2EY ,F/:H.KAED2.-5
M^:/VGM[&Z\ ;[;?M=#?;9NCKR9L;[\A^F?0T-H0QS0(QV"TLD>QV,AD*EHKJ
M1Y/Z9U-T[4=4=W?A[]JK-,K5HJ=CK>DF=$0-!@1S8P.,I,Q$]97-NG6""C X
M9L@F7F#6)!#4BKV_4\*EJ[+#N[MOCCBE8+\$:G<",</5..5<,:'I7;[KLW[N
MS?M]8;=M>YV<?CV.5AN;@M'+?&.95K?P'C4*Q:G")NO0^E-0!N: 08V"&W(/
M-$'H$'0<^PWEIA\Q+*$DO,M9SG+33KV%*2G_ /AQGZ<VXK3'-?78Q((VB4@R
MZ14C $TQ('15>OGJS3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$4
M$N^?0+6/D!HU HVS+GLJFAZ]V-5]@QSU$LCC,9*K@;% SQD59Z%.HF-8W5)R
M(!MD1^?A)?,5EUY8R$X?);?(L]T Z5TSQ]=7-==6J#:I"Z5K7D>.*-99:DZM
MH4K+%?;(T20/DXC45)H=<D) \T%9#TF:*;89-QW)$Q)RLDLF1)(IG\(G")PB
M<(OS>9:(:=8?:;?8?;6R\R\A+C3S3B<H<:=;7A2'&W$*SA2<XSC.,_3/"+"N
M56L.AC1[M<@7  HTJ&#!<AX]88D.<D9)L4,,H?++$:8D-G#K"4X:<PTCU)SZ
M4_0B]2(.%;,^X-P\6@_YC\C\Y$>(DS[@4"S&$G?)2SA[YA$:,V.MWU>M;#:6
M\YRE.,8(O'FIU50:(Y59KZH]MR2>;!S#1V0VW9D<P28=0-D;V4N2HL@0T2K"
M?J^V^XE?JPM6,D7[9K==5[.%0$+G \LW/L8S%@Y]B=:9^,U-,_5C^+EFQ_XM
M)*?H]A'\'"OI^CA%Z&(:'&/?E1HJ-'E"DK05), BM'DH=^/[J7S&VDD/)<^(
MUZL*5G&?:1]?_-Q]"+],1D;B25,XCP<3"@4QBI; @_W)4:@A9:(]1WM_*R"@
MIQ3F&O7[>'%95]/KG.>$6-.J=5E '(J3K-?D8QV0?EG8XZ&CBP'94IY\@J3<
M#(&<'7($D%.N./93EQ:W%*SG.59SDBR3L9&D#BAOQX+P@3P) 0KH@[@XA$8\
MT1&OBL+;RT.]'OL(6PI&,*:6A.4YQG&,\(OQCH.%B%+5$P\7%J<'&$<5'1X@
M2G!0G"G0QEY&9:RH<1TY]32,_P %M3R\IQC*U?4BR#S+1#3K#[3;[#[:V7F7
MD)<:>:<3E#C3K:\*0XVXA6<*3G&<9QGZ9X18T. @HYP-Z/A8D!V.C<PT>Z''
M!BN PZG67U10:V&4*&C<O#-KRPC*6O4VG/I^J<?0B\N*G54A$QJ:S7TQYD>%
M$E@8AH[ 145&Y?S'1A(N!O8?CP,E.Y994G+;7N*].,>K/U(O8;!PLD]@B1AX
ML\A+;#*7S8\0IY+0IXTJ,UAU]EQ>&QY,-DEM/U^B'VD.8^BTIS@B]00(4<.@
M./#% $;4ZML4(=H4=M;[SA#ZD,,(0TE3S[JEKSC'U4M6<Y_3G.>$7JX1.$3A
M$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$5+G8:H4VP>6WK
M9;$XI9DU ZLK%3N(=JN4A32RQ@+?L&^:^:J2:];;3+7.V56W%CRJ8(^FP,*0
MP0EYRSDNLXBQB*Z/A%&+?O;;4W6NS:UKNT%ST>-L=,J:NU!BQ*JI0Z]$W?4^
ML'+7?9"1FHPP&!)V7O2HPB,QXTD4V1-))>8:CA3S1"*AOJIY7?&I5/)5Y7ME
M67O+UD@]?[7_ &%?RTN,GMNIB5Z\_@70EB@+E^&)-V02-+_AF:(;%-]E2OCO
MKPA7TSGA%:%_MK?$?_>-=0/UX4G^5.$7#^R7F4Z"V'1^PX?K-Y2NC5"WH;$C
M)UY;+AMV@R]=BI-F6CB#OG EXG0U.'0C)0P[KP1C(Y+S;KC+J$*0JO=MN76[
MVV;@VYIV2<0,?(>%>!7.^+;?Q)=>';J#PA/#;>)','(EE:',:X.:34%KQBP.
M:TEC@UQ#BT@47!;-W;\.O82#Z>V[MEY,>IMMWSU?=KMU<LFO>PU.J]2GMHML
MTZ1M1I,2Q@!HZ /L]-$(:2T-&NI2WG#21FW7&.57[>VZ; ^^.JYAH:M- 785
MPIE4#H\V2YF\_;ZW\4V^PWWC>1T_B79C'+S('&.)]Q2)TA+0UH+'21-<*-C.
M& 8'%JG5_MK?$?\ WC74#]>%)_E3FR7TA/\ ;6^(_P#O&NH'Z\*3_*G")_MK
M?$?_ 'C74#]>%)_E3A$_VUOB/_O&NH'Z\*3_ "IPB?[:WQ'_ -XUU _7A2?Y
M4X1/]M;XC_[QKJ!^O"D_RIPB?[:WQ'_WC74#]>%)_E3A$_VUOB/_ +QKJ!^O
M"D_RIPB?[:WQ'_WC74#]>%)_E3A$_P!M;XC_ .\:Z@?KPI/\J<(G^VM\1_\
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M)PB<(G")PB<(G")PBH9W;MSI9</,_IK45TL>\(;MEKRMZM%IL7!4W45KUW*
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M3A$X1.$7SBZQ\!TO $1$9L+MW<#:;79B-IU;C]3P4S0+)6^M=*Z_]B>OFO\
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M5:&OB,/+9SU_@??-B\/;^S<O$6W1[GMHC>TPOI34X4:^C@YKBTX4<"!4N':
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M0[[KSBFU\Y"P\*^&O#6U7EMI VF<N?-SG:F!M*$$NH UHRKCQ+B:%?I7Q?\
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M53=>WY\GMCD>U&(A8$>7I%9BHKN1: <0,64D<EB.AU//+=8D')0BU+QL=8M
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MOP)&&-&(#,'8+$+8=&*%):;?&)&?;4T^.0PZE;3S#S2\I6A6,I4G.<9Q]."
M10Y+%[&2,,<@#F.!!!%00<""#F#Q"Y_JW3^K-(5A5+U!K^I:UJ:Y60G%UZFP
M@,#$N2\HIO)\BX& RRTLHA+#;?KSC.4LM-MI^C;:$IBA@AMV<N!K6,K6@%!4
MK5[-L6S>';/X?L5K!:6)>Y^B)@8W4[UG4: *F@%>@ #  #H_)5MDX1.$7&=J
M]>=*;P(A2MM:XKM[(KK)H\([.,D.KC69)8SAS8WLD,82DE8;65?7Z_I1CA%Q
MD;QY=)@GI D/K9K,0B7,1(2Q T40P])R#4>#$MG2#K1B%FF-Q<8,,EUS*EX'
M':;QGT-HQ@BEU#0\97H>*@(4-F.AH.-!AXF/'QE(X$9&"M! !L85E2L,BBL(
M0G&<YSZ4XX19+A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.
M$3A$X1.$3A$X1.$3A$X15,'V#1E/\K5;UQ =.]ES&V;Y0\[.L79N";V#(Z;H
M<C*4+9<"?:K)!C,':?IUWFJ]K@"IKL+BP+5*XGA@,X=!SZGB*V?A%0KO#:GE
M&WYHWN%HJA]+Z9LS&QB.PO7\&P;!V!9>G[.L*O;(6X4.!-@&K[K[9S'9R/BH
M0P"5_$\"]"5Z96:M@1_"F7L#D6UZFWCYDM7ZKUIK/_9,Z G/R[U_3:+][_VH
M4%&?>/PC7(V ^Z?;?V/Y#[?]P^W^]['R'_:]?I]Q?T]62+H'[5?F2_NA= ?^
M*?!?V-.$4=NW/;GS,Q'6#?D^UXVM1:.9J^J;I;I3;=0\DU?NUJH5?J4(79;+
M8*W5%]4:OF<G!J_%$I%91(A.9>6G+;S:\)5B"YCEEMWQP/T2D4#N@K1>)MOW
M3==@N]NV6Z-CNLT);%.!4QN/U@*@Y5%0:MKJ&("_SJ+VX\S4MU?T'//>-S4F
M\V;1JJFV^*VY</)+7:1:[[7K?#"V:LSUCJC75"S?8YIZO2HJ"65R)SN'4*RX
M^XYE2\K6.6*W9'._7*!0NZ2GAG;]TVG8+3;M[NS?;K#"&RSD4,CA]8C$Y4%3
MBZFIV)*D5^U7YDO[H70'_BGP7]C3DZWJ?M5^9+^Z%T!_XI\%_8TX1?F[VE\Q
MKV$8>\0'7QW#;C;S>'?*97W,(>:5A;3J,*Z9Y]+C:\?5*L?IQG]..>AQ;ZI(
MJ*)FN0.^2'RIL]@H_K*OQ':4_-*2TW+[V%$QY/8?,+F@0EVA-?GD+F/V-_91
M*)L5@&2D;T^I365+^OT3].>(NQ_M5^9+^Z%T!_XI\%_8TX1/VJ_,E_="Z _\
M4^"_L:<(G[5?F2_NA= ?^*?!?V-.$6KW?NUY>=?4NWWZQ^(G1#5>I%7G[?/.
MB>4B$**;AJU$ES4HL85'35*R2$ A+RAO&<96KZ8Q_N\(M7TCY"?+!V#TOJ'?
M>N?$9I G7N[]7T#;U$)EO*!"Q4J13=E52)N=7?DXQWILMV.D'82:84\PI65,
MN9RC.<YQPBZA^U7YDO[H70'_ (I\%_8TX1/VJ_,E_="Z _\ %/@O[&G"*T/5
MTW?[)KJE3^U:)%ZPV3,5N*D+QKN$NC6QHBEV8D5MV6KD;?&:_5&K<'%%J4TB
M03&@X)2GUX9;^OIP1;YPB<(O'(QX4M'G14D.V9'R89,>>(]C.6B@C&5C%#NX
MQG&<MOL.*2KZ9Q^C/"*HKQK=7=\]9]S=OX6]16XH[1Q]V,QH5>TNSFVM\P3]
M9<VKN"6@U:OB-D=J=_FP<2_K&3K)%B,EZ]19Y^W$2+*6I6-:#+;(I&=A^L>Y
M]K]D=*[8H&X'M;5BA56Z0DC(Q\L>JV4N6FJO>(=F=HU&DZ_8]7WPJU'VF+7)
M(LS6 P4U<):1I#+N6F"*,M)\7_937-WW+L>F^7#M_#7/L#<*W?=NS/Y"^/.0
M_%MLJ&M*5I^NROVZ5Z@'14#]OUUKN'CO8C& AG?A^^ZVLIU]YPBZA^Q+W>_O
ME.W_ /1M\:O]BSA$_8E[O?WRG;_^C;XU?[%G"*.&I^KGE>L6\NU53V?Y1>T]
M.TSKZX:LC>LU_ Z\>--^3V]5+!IRHV;94U.#8ZE2>0B*CMF2E81A.0XWUCA(
M5Z'OK[ZR*1_[$O=[^^4[?_T;?&K_ &+.$3]B7N]_?*=O_P"C;XU?[%G")^Q+
MW>_OE.W_ /1M\:O]BSA%PCLOU3\I-%TU9;/UX\J7:O:>VP9B@C5ZCS/7;QIB
M1TI%3&Q*I"W<UXA746 PARNT*1DY-K'RV_4\&E/I<^OM+(N[_L2]WO[Y3M__
M $;?&K_8LX1/V)>[W]\IV_\ Z-OC5_L6<(G[$O=[^^4[?_T;?&K_ &+.$3]B
M7N]_?*=O_P"C;XU?[%G"*.&L^KGE>G>PG9RF;$\HO:>JZ(H?Y+_LY[)"Z\>-
M-Z6VM^**0?*[=^]"XZE2&0_P-<66 !OJ#'^XTYG/\?\ ^DP12/\ V)>[W]\I
MV_\ Z-OC5_L6<(G[$O=[^^4[?_T;?&K_ &+.$4H.MVDMWZ<_&?YR=RMP=M_Q
M'^'?PY^:^MNM6O?R_P#M'WW[Q]A_9XTKI_[O^*_N@OROO'W'X_VUGXGL>X3[
MQ%)_A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X15T;A\=U2W/VT@>Q]FV!(*I>(
M^B+O^D'JI#'1E]LFKM>]GM7T>15=W"VINOU_\)]L;&F7BVAWLR) 4:MDD-M!
M[,@1<7_V _AM_N]M ?\ Z(G?Y>X1<OKGAU\ EQ,I\=4>JG3"TR&PX^^2U !K
MEH!G#+S%:KG8NK;/DZ>+&70I^S1^N+-.!1T\\$E]N'/,8'+RRZZVA1%NQW@K
M\)<7+P5?D^BO6:.GK0J21680Y)XDO8EPP?W"73!1I%F;-EU10'\>3@=#F6&?
MX:_2G]/"+A1O^&_\;#_;NL[>%ZI: 'ZYQG6^\:WG-#_8++G[QNN<V=KVSU7;
MGR\37Q4_ANBUZ9AO;RO#F?NOJQC.,9S@B[J=X*_"7%R\%7Y/HKUFCIZT*DD5
MF$.2>)+V)<,']PETP4:19FS9=44!_'DX'0YEAG^&OTI_3PB\-T\'W@XUO5YB
M[[$Z2]6*%2Z\.@N?M]T)(JU7@Q72&1&R9B?G+2#$Q@[A1#;25O.H3EQQ*<9^
MJL8R1)OP?>#BLSE-K-DZ2]6*_9-C3$E7M>UZ;)(BIR]S\-6IJZ3$'38D^TCG
MVB8BJ=6I&6)&!;?>8C(\DI:4L,.K211H)Z(?X7,*U5*BF5?Q@B7:_P#V'\"4
MXGL!K5BU77\52*H>L?A*O.[31+V/\1RZ,B@?#9>^83C+37K7_!X1<MZ+^'+P
M7;)N/;F+KT5X_NY1DGV-LFRZ+4]-;'KNQYCKII&:I6NJE6]36>.I]^F"XE,5
M>ZC8#DNOH0VMV44WA65H4G!%(*5\9W^&Q@OQ1][T_P"/"&_ ^T(O2-U^Z[:I
MT?\ A#=$W\O[+J*T?+V,S^']H2_P'_BP!?LRQ'LN>VPKT*^A%(__ & _AM_N
M]M ?_HB=_E[A%QF5\2G^'H@MO0G7R;ZW=&H??=EC<S-<TA*WF%C]O6"(PP03
MF5A-:EWIFYRL;@8-USWV G&O0TM7J^B59P1<XW;X</ [9=+=M8"@Z<Z-:TNV
MH]=7FL; V45=8E(?5>\3=!DS:M:]PN?CC*=<*K6"QYKT3'PU9#9]W&,HSZN$
M7EZ=^'[P(;4Z\TDFEZGZ(=L9'5=#IE+W-NO3U]@]C5>2V+6Z7$8N-@GIJH7N
M8CH,R>+9>E%L%.-.ML$86I.$_IX1;A3?&'_AO-BE:C!U]I;Q\7L[?X]X+T.'
M3=J5.SE;L%UBY*L[))U&/";$.>V0/KUZ"-1.+AL&IB5!OX*RUEISTD4A_P#8
M#^&W^[VT!_\ HB=_E[A%8GU[ZXZ.ZHZMA=)]=-:UO4FJ:X9,R$'1JFR0/"1I
MMBE2IR;(&:*)*>2Y)2QSK[GU7GZK<S]/IC]'"+MG")PB<(G")PB<(G")PB<(
MG")PB<(G")PB<(G")PB<(G")PB<(G"*DN[N:E.\MW6N\2N_NL5_VEB2V1HNN
MZ6ITBZYV!U=)B:1[+;'E)JPBU?><$\BLEZ^KXP,LQ::S:A&9CV'H\*+>):."
M(KM.$3A$X15E=O-N=Y=>[+M<?ULU7+;%A&]-5BZZ]9>JD/*466V#4:KW E]C
MTRWV%J2C+%%O6>>C]2 A"H?'),^:]B-<QE,DXR11WE]Y>61;F_H:2Z\:>O4;
M"/;1B*A"2>G;K&4^\4^DCR='AYH1]6ZY\R<9W))COVI,"M!9HT"VW"-?**.8
MD^$6M2_:'RTQ!5>BJ/TUH$/!5"EU!Q^IQ-"N.:]8; 1U&W%:RZM!6DJ[0R('
M7\1OB%I\<)A,,'+AMR"H@IE#P[Q3I%*?JSNCOWL?L&!!]CM.U_5NIH[1$U*$
MDU"IV)-<M6RC(_K%)UZQM72YRWXDB7#)2Q;%C&J:_$1\C LP7O2)4I\L!Y@B
ML[X10,WI;.U3&_([6VM(NZ ZTV'$: '@MD56JT:8CM?D1M]W:[VDE9Z>ML?-
MQL!,-ZQ>I+E>:E@#!3Y!#C0+!#N#6N$4):%(^1FJ[?U!*30FV=RVTK2.J"+$
M)L#6/7.BZXDCK)>NR1&^ZE>-V4+2=9M&OY*FP%7UZ36HZ.*=9)D#4J+!D4/$
M$"$78>GU_P#)/8^WFVX/L[37J]UF!3V@;UF<N!IC'RBX;L144Z10J=@HR/ES
M04Z7L)P8#[V$9F!XM1A*/E84XX16V<(N0[_DMK0^C]M2NBX@6>W)':]M9FLH
M8QJ/(:DKJ/#%NP B!)>7KT.<4[()1A@<R0CPR'_0V^4.TI;R"*I#>&X/)+&T
MP)CK_JW=VWJ7#:AW@W:[1O#4^B*WM?8MRV0!L.FZ#9_+2(54HSWM37B!B96;
M;:K0 TK5)CZFQS;S?U61?U8;=Y7=.=88"#H.H8^[[0UAN"5R7&Q4CJN3=L6E
M-=RTQ)06EZVFM:/T?0)B#V/KB&"&BKA%5>I/Q#TD/&/0[<@(4^LBM+ZJD;G*
MZY::=[%%.';S_ <*UM,]V&BJZY(W-AG+$Q(J@H(<2'B/N#[7O8'&:;9:POZ)
M2G&/IPBD!PB<(G")PBQ\LT4_%2; *&W#7H\UH-MX\V*:<*<&<0.AV4C6W9&-
M;4[G&%$#I4^SC^&C&58QCA%6IT+ZC;AU':+;V%[%V>+L^]=O4N+JEV0XS(%V
M&MA4BQR492X5-P#O$Y!VZN9UW'0N4(D1#Y^/DVC'7YV47(%.\(K.^$3A%'_L
MCJ:U;>HU?BZ+9:_5;I2]H:PVK5Y&V0,C9*N3*ZWN47:$P\]%0\Y7)9<?-"A.
MC9=',;<&<<2[Z7<(RTLBJ;G/$/OM NH6*1WQVU5\Z=US)T2N1P5QWY"TR.-"
MZ#ZOZ<ZYMM-U[7=ZQ]/UU-4*\0]ROJ<Q@V%R1UK4*:X1EI1*R+KCWCD[/B7Z
M2EH3R%[]3K@GL3J3905$E]A;MDY,32^N+27,S&D,7$S<!DMD&[4HI%4E#_\
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MZOZ_BPZ#0XZCNG/ 3$^<\3+D"*82WAAUS)%#2\^"SNS:MC;:M%ADM97M=_[
MM=F9JS?> *8W>=WZO["6H;7.R,T,5<K$U J\=>NS>Q"BAL%EJB"(2,CD.K]3
M;N2+[(^$5(8G3_L=1NX.U)0?JWU"WYJ#='=V@]S7.T&X+0X;N34T/4-6Z[J"
M*!6=8D:\</?V]KJ;UO[>OY]BTMPL?&R3:R6AG6'FGB*N"/\ $;Y)(G4_?+%C
MMNCK]=/)KTN[,06Y:36(I6NEZP[2V_;]ZW)I<"S; D+O:8C=,3$ ]A[K4<6&
M/A:QB-AH>%%4(2.RT\T13[T3XW.U6@)WN/6]>;\2,+MO9NO+C"]B=EUZN[;V
M;OK2$7K"9K?[->QJRU(:_JVK9[5MF..8C;A"1WIE(>58=?$4:P1E1%!#QV^%
M?M)U:[*] =G7R*UZU1NI,#K*"'$A[JS*R581<?'AV+J':LR/&P*RP:JW]U-R
M H8:'_01$QB9%2\Y6IMLB^L_A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A
M$X1.$3A$X1.$3A$X1.$5+.>QVW-=^72I=4[6]U\LFOMHULZ[5:= U%6:[OR&
M58*;V2NT7#DSCO8(&W34/%1NHWXTVU@4*2@U,C!1I+PTM($$((KIN$3A$X1.
M$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$
MX1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$
M3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X
M1.$3A$X1.$3A$X1.$3A$X1.$3A$X154524\EH/DODXB\5_3\ET*DJ_L_-.L<
M8G7TEMF&!S6-2R-7S)&.6RBWZ.A\WX>5"<;%KM@996ZALUU]#H$D 16K\(G"
M)PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<
M(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")
MPB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(
1G")PB<(G")PB<(G")PB__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>tm2227887d1-pht_macrop4clr.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2227887d1-pht_macrop4clr.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@!] .2 P$1  (1 0,1 ?_$ 0D  0 !! ,! 0
M       &!0<("0,$"@$" 0$  00# 0$             !0,$!@<! @@)"A
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M(0 2!% \N.3WLYO(@-[$FP(4 >;>/[+R?@7H1B^IG%(Y,CCN][5N.!O.*"S
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M,;D,;:51OVBO5NNS6_3%;UC-,67U)*/VN,B;,NKA74T_JS7EN?JF.^;"M/\
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M=EBU)L>SUNPWR03W;%-=2%8NYVTSTM:+1:3U..:132->J)*RB[YN9%R;H3;
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M=7:UAE5'$-K^DQ#E5JX8K.8NJ0,>X69.TQ2=LU5FC!%11HZ3'I43,(D.7P,
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M.#'$QQ.8VO.58N+@<D>+%71"Z E1V!*];#L+FYMV%["P %7O(L+'Q-SEQ\=
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MXW;+XQN>!N$DIRV99<O1%.\;Y495+NC#X;J+!5]E9+=Y5]N51V[V.Q54M4W
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M/=?>S=)B]W&S&UAL?2E\VKK/7+R4?&K]?K+;;=9I56>MH580:-GIHZ)=<*D
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M3)D 0Y \PVEQT,4;)$H20,?-=&",MB16X:3^I?W$0'<Y-ZPN@:<U53X3<R-
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M2$G.X>HG*MXV1=BS,@'!154MH42.J?=61P+D=!J(LS@?&6)-Z!+1QF)3;7W
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M.FY!9@LFFW7(/()'$ACG(=,M7)X9A-+B-LNZ8N;A964L%U5HY4=B.I@DL[*
M0;K[;=.A-IM_K/OD6-N\/,.+[IM&];5MDF=H9DR,6:%%)"IFP!HEE9E=0C _
M=)!8@J/NG^[_ 'WM[^;J:9=EEXA=;[#-79!OLAQM;7#V-BZG83-E26I:"240
MGG31K&N/F#-RI$<F*'3T@8>,[[YQ#8=D.5C2;WCON>+K4PB"<,TB7O&&(T E
MAIU$Z?&]JZ<,]7.?<Q.VYL7"LV#C.X^2XS#N&&Z)!,%83F(:96 1M10*'Z:;
M!NE6F0^I7=Y*(VO<:[VB; M.M=+VVVU>^WJ!V#3%B11:6N)IN2+7'R#"9<HM
MXH2.S@F4R::)A$RI0(<Q99_33#AR,3 R=XQXMTSH8Y(HGAE ;S1\(+KJ4$GX
M1[3V'A6)I^)3>LG$W?>MNX?N.5Q;9,O(@RLJ++QB4&,?VL@@8+(0J6<@= +W
M?H2*SM?ZD,MKJ@5;=,'VW7*[:)N,%3I6%V>-XIU=3_%+@W 4ZQ(5=09:<:3$
M3(E4:.3%*HV!=(W2H)  XVVT>G*;EN4VQY.YP8^_PRR*T'E2.=,?76)!9"I7
MXAU!((Z5>\O_ !'9/&^/8O-=NXUFY_!<R'':/,^9QX?VF0+"!H3KD62-]4;F
MQ4.O0E?BJ=6KOME-8:YA;-N'M^OE'V1?[\%!U#I.+L-4N]OV2\6CX5PUEV$A
M!.@BHZ'_ !&9(T6%03KI*^F!4E#KI)FL,3@\>Z[C)C[+N$$^U8^/YV3E-')%
M' -3 JP<:F;2NI0/O=1?ITR#=O7')XMQN#<^8\?SL'DVX9_RFW[:D^/DY&:Y
M2-E=&B.B.,N_EL6NRG2=!UJ#R4;O@LR6UJ1J#N*[>;IV[6+:*CEKK6:E;)6;
MO3+-+(ID53KZ]CKAR-HJ?=>H1-)L8%!.L<A#BF91/K9_"<8[3/O'&]RQ]RQL
M2QG54>*1%/36$?JR ]V%K"Y%Z;#ZV;HO*\'AWJ-QW-XYN6ZEAA2//!DX\SJ+
M^4983^SF/0*A!)8J#I+*#!)'ZAFQ%IC>!:3VB7V_TW0.P;U0;S=8#85-1(@M
M0GCDDK(-ZY(MV\VYZXM KPJ*!5^"'Z.L3 /$@GI[@)!@'/WC&QLW<<:*6*-X
M9>OF@:5+BZ ACI-R.HZ>%\>F_$-R&7.WX;'Q#/W#8^.[CE8F5DQ9F.#?%9O,
M=(&42-\ #A0#T-M1(-2&R_44@GB&A(?2&I[AN78W<12GE]IM(),5FDDB8.,!
M^G+$LUCG'JL4SE&#R&D$121%=$YV"OZXH&0%>VQO3O*C;<)M^RX<+;-MG$4L
MNEY=3M8IY:(+E65D:YL;,/A)# 2FZ?B&VZ6+8,7@^TYF]\DY'AME8N*)(<;1
M"@;S#--,WEJRM'*H"EE8QL0X!4ME%V^;CN6XH*PO+UI#8.C;!6)T8!_!7DT.
MZ:RCHK5)VJ]JDQ%.SA/PJ)%R$%Y\NBW45$2HG5Z#B7&.0;1A[/DI'@9V/GXT
MD>H/%J%A<BSJP!1NE])-P+$@7M6S^ \OWCE^WSS[[L>X;%N.-/Y3Q9.AE<Z0
MQ:"1#^UC ('F:54FX4M9K9 Y UGE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4
MIBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4
MIBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4
MIBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE<#
MH>&ZP_U@A_SOA_ASO&+R >^J<QM$Q]U6_L:HI0KT0\U ;H /V+ND$3^/VIG$
M,F<5;Y">XWK&MS?1@R$=R /M8#\U6\:DX I?/@ 'G\GO#[<D9FN+>)-8[$M@
M![JDK)/P#P'D1X#W\#Y>'W9:2&PJ3@7I?QO4K:)#P4H ''Y/8'CEDQN;U+PI
MTKSO?78>%BK]VE2"@]""#+:_4H8@^GR#_7P\=7' F /'W@ <_;F_?1)1/M^[
MQ+U-X/S35-8#>1DQL1XD_P"+6TCZ7,VTL_:-4YMD ?*.K1=B)" &Z5!:S[EH
MJ8HF H& %T#!R <<@(>8#FJO4>%\3E4V._WQ''?ZUO\ F-_KJ9WAUR,XRKT4
MHO\ B@5L1X*4!'CPX$1\_( S B2>]1@ ':O$KW\479+7ZFVWX!E3+$[F-H7>
MLNZ&Q;Q;I8UK93=?KL>R=PIR)"DZ:_.)JI*J%,)4%$C@H).@W'A_U=XMN>[^
MH4D$,$C239,+1V4_$"(Q<>T:A;W=17Z)_P ,'*.(3?@WV'=<G<<2/;]EVW(7
M-=I%48S0SSNZS FZMH*LJD7=64H&U"_I8[QM(ZKW]7]HZ3V_;7=!J]_K-(O$
M#<$'3!DM'VN@2LL@Z/'_ (HF9A)K,V)(_P!=F(^HX:N3E3$I@ Y/87)N/8?*
MMFDV;-+K%(0=2]U*FZD7Z'W@BUO?8CX:^AGK'R'T%]2,/U'XW#CY69C))$\$
MVKRYH9D,<B%D(9200R./N2*I*NNI#3_IT=E=:[/=1O$HRPV&TV3:2D'9[)+3
M[1O$"W9,F+DE;A6,"W.M^%),6,HJJL"RR[DSEPH!C@0J::<5P'@6W<#PY\;;
MY))I<B4/([6%RHL %'0 7/B22;D] !F7XG/Q+\@_$KR/"W?=]OQ=JVS;8)(\
M?'A=I3>=D::269U4R.Y1 -,<:*D:@+J+N^?3E(>!,7P$!Y_J^?AXYL53<7KR
MS(GB*C;U+@>0#P$OB/' <\^ <<Y<Q-XFHR=/LJ*.TPY, AR _D^_[O/+M2;@
M^%0\B]2M3Z-.8\8Q4-YF;(_>(E*4H^7M'C+"4:967V&LBQ6+8T;'Q0?FJ<)C
MR0@^\A1_. 9$MT8_34^INH/NK'/3_P#IE[LO]IVO/]P>K,JR?NX_\$_G-6\'
M[Z;_ $@_Q$J1=RS-Y)=NF_(R-9NY&2DM*[3CXZ.8-EGCY^^>4><;-&3)HW(H
MNZ=NG"I4TTR%,<YS !0$1R3XY)'%R+ EE8+$N; 2Q-@ )5)))Z  =23X5B_J
M-CSY?I[OV+BH\F3+LV:B(H+,S-C2JJJHN2S$@  7)-A7GMB>V;9T!JCLFG]I
MN.XO9/;[-VA-+<&@DQL@DUG+-IR5&!DV]+C(@9-"J$0]1P]361%T0/5*DNF9
MRF)?0<W+-IGW??8-J&VXW(8XB,?,^"\ZE%#AI&8KYA'PJ00.Q*FU?/C ],>5
M;;Q#@N;REN1;EZ>2Y &X;4/-'R4@DD\F08Z1Z_( N\JLNK[VF1?,6I;N:CP;
M/O>[J[%L?7G>DO4)][K0M#F>V"%L#!C*#'Z]@VTR6;DT6J3.39,Q!%)J5(Y_
M25!<IND><M=CW">3@FTXVV96R+FQ+/YJYK*2NJ5BFD=2I-V+7M>XO>U2?-=C
MVN'URY7N'*MLYF^T9#80QI-FBE5)-.-'YGF.%"R*OPA+%@IUCI=KY&3<';-,
MVCM-[Q=6ZKW?L[6=6U-.ZBO5&NK!Q,;_ *K792;F9-C;GD68 =.I=-VZ4*YY
M#@6Q2)G,F5?U4\8QYL/>\;=^';EE8&)NLN8F1%)$0N)(ZHH,0;LJV *^QM5@
M>U;,W+"W7A6Z<2]9>*[5OFY\6Q-GEP,K$G4R;K!#))(Z3LAZM(&8A^H^$!20
M'U+>NR]R]][G]3]ST'4.W#:U6UHWT!>FT-=K]$.*W9K->GE?E4?V6K]"(V?O
MYM!9JLGT+H.#"58AB&)R=(!@8N,X'%]UVR?-W+#FW,Y\>J.)M<:1!E/F/+=0
MOQ7NI';K?O;.=P]2M^]3N)\GP-GXWNN+QE-@R5CR<N,PSS931./(BQ;.\@TL
MMG5OO7!'5:P@[/ZWK&!L7;PPG*']1V(V-%R>OFDH,HSGV&BHZU-UXU%X+YB\
M11*SUVUD@-U)J%*)&1>!XXXS8'-<C=)\?<WQ\GC;[8XE90I0Y31FY%BO>8KX
MB]V]]:']&MLXGM^Y\<AS=N]1(>4Q28B.9$E7;4G&A6U*P&G$5Q8@@6C%K"K@
M=KW9#9MUP/<U'["VEW+Z;JMC[B-ELGFN:M(I4JKWNM/G+-T>:>1UCJSX\NVF
MFZQFQURB=JX;HE()3 !N8[E?.<;9LK:Y-LQ=KS<V+;8")W4RO%(H(T@JX"E#
MU (OJ[]*R7TP]#MSYIM_*,?D6Z\EV?9\KD6:K8<#_+0Y4+LI\QEEA8N) =!9
M?V;*+6/6^2GU&-,$K78K7-/:>ID[*Q],MVJXBOUNN1DI8Y5*#@WQR'=+(,4'
MC]V=-(HJNG!RF$QS&44-R(CF,>G6]^?SN3>=[G1))HIV=W8(NIE[=2 /8H^@
M"MD?B)X4-M]"\;A_#,*>7%PLW 2*&%'FD$<3]6(4,S&WQ.YZDDLQN2:K??-K
M/9K6V=J'=+K>E26S#]M=AEGERUO$H@ZL,I4K8Q@FTK+UR.$2JO)J$1B%.E(@
M**>LJBJ!#$0/E#@FY;7)@[MQ3<IDQEW1$$4[&R+)&S%5<V("/J%VZ64,+_%U
MO/73C/)X]XXEZI\;PI-SDXSE2-DX: &9\?(2-9)(5/5I8@ALHNQ9E8"R-5H;
ME?+GW_[B[;JY0]*;9UOK32NW:YN[8&RMJU9:F*D>4U3U6-1K;=1P[^?>RQUC
MI*&(H8Y#BFJ)"IHG,,M@X&+Z>[/N>5N&;B9.YYN))BQ0P2>9TDZ-)(0+ *!<
M#I?J.[5BF][WO/X@N8<;V_8-EW?;.-;'N\.YY>7GP'&8-CGX,>!26UO(25)!
M)7HU@$-\5KMVU=Q<Y4/J W[7UMWG4G27=3MAXIJ&$6F*W7-PZXD9DRTY,1#!
M*-(^GI*2AWHE;K('=-'K9L* )*&,'.6X7)^,X^9QW;]PBV^9?X3CCYAPLCXT
MX6RACJTJ X)96 *L0;@"M2;SZ9^I6?LWJ'OW'<S?L.7^UF>W\/B+PP[AAO*3
M+(BA-<CM$QT,C.DB)Y81KBKS[^IV@%M6]J\'9>TCN1<:T@M0QZE;VUJIL_+M
M+4$^LHU4=4ZRP@-4'#N72D&Z[M\O)- 1*_4]1DF<RBXIP?',SD7\6W:?&W?;
M!N<V61)CY%F@RE!OYB-U4*.@15;JH(8] #G7J#L_IY+Q3BF#N7$>2OQF':$\
MC/P XSMOE)4G&FC #L^M6>5YD"B4ZH@=4FG*/Z8Q=Y$KNWR7]QN-QIY.W1Z6
M@S]P'J#M8U<(@_\ Q126.Y(1V$<<!:>D7@&Q5@5! "EZ@S&_4X["<K#.W##&
M]F$_-_*_N-=QIT^%[Z[]S;2&-Q6S/PR+SM=KW=>0MO+<.&:HVG^+=,_R K:S
M)< Z#\&G]'5K\L!>E;2,U=7J"F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2
MF*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2
MF*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2OR8Q2AR8P%#WF$
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M<I?VI/\ \F3_ ,$,B7^^?I-9"GW!] K'33_^F7NR_P!IVO/]P>K,J2?NX_\
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M^[G9#9@??720:D(]U0:71]:,?)^T&ZB@!QYG0_7%#[^M,./MR5B;3*K?WPJ
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M[>*15]"V>4N>MT/Q=Y'6B<?%>SLQ)OIA\O..)D"1L*DQD49,5$#M2,FA6P)
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M5 H>($3 0%98W\E(G("8?>/D'M$,KQ1/,VA!<_D'TFK/)RH<2/S)C8> \3]
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M:+'6%3H(543?+(@90@>FHN=7I^$H9+\D^7VK!Q>/1.&:,&21AXNU_L^\1;N
MJ^^L&]*VSN6;_NGJ3G1-#!E:<;%C/Z,$84WO;K?2MV'PL[/IN *RU] P@/ "
M/AXATB/A[>0]V8?KC]O2MZ!&/A7X%(@@  0O(!["EX'][&I/;770/8*IAW,8
M$@6+,^9DE3H"Y)&_-I)OCM"B &=%9B8KD[<IAX$X%$@&X#GD<J6D,8E"L8KV
MU6-K^R]K?1UZU:F7#^:^3:2,9I74(]0UE?UM-]6GP)M8'I>N51N;Q$H 8 *
MB4>#"/O#GSSD.>A\*[-#[*ZX"H@H11,QT%B#R0Z9S$,3@/XIB" @ ^W*@TR
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M8EN.W[GB'ILV.3:]XQYBCI_SNOU?76ZN-<MX9O*M&_.\Y50V9,ESBR=[="=
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MR8(,T8F-*OS,F/CG*C^9\B7)58-6.S2L=,:SZ"M>APBQ0( B(B(CX_"8O'@
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MH/[=V&9CX%FU0,:13>+ FNFZ23ZE&J#10YW*JO)1*4@]1@$/B'@!'([(X_N
MW/\ A^.C2N6LMA>X)[D]K6/?V=;5DV!ZB\;DXO\ VHW7)BQ,5$)DUFQ# $E0
MI)8FX(MU(/?L36G;N=[]X;;]<G:NV8_L[0FSD'#%FHU3?62??-05_#S.5UB&
M:Q)TG10X215(8AAZ5#'(82YMOC'#H]AE7<,A_-W(K;H?@4'[PM^DWA<]!X '
MK7B#U7]=LCU0Q).,[?B_*\7\P,H=5>:5E)T,[$D1*ILUHV#=P2RDBM;+V]/5
MUHX8>2?KD<KO#2*R"X@\8$BVKA^LN<[UVA\FXYKR35!195-%-9V4WB @(YS\
M( L!7GN#%F#2-.S1R(%8-<BYU!0 W4DW8-<=0%-B#8U&F# Y6\VM'V%]8R)(
M+FD(1[ZHOPB5FZ2CEX\CYYD:(=D9O5DO3^53<"(EX]0X*E HDWTG^7T5=L%T
M+(RJCV[J+#I^LP(U$WM8F]_B]E^L>@*J1R;".,:K03LC=1N> =MV3R+FEA.<
MJ,E'+.8JOG:HBZ.!4F: <',IZB9SD(8_!!_1[UW7=(_/^9S3\QD(3T?4RM8=
M!>]Q<GN2=(%@0.AH*H2!GZL,A 5!R_<K?*NHV>4KL +X4I*/$'-335E$9"0E
M'$KZ:RB8%(X3.4QA4.8$S!T)"FY_,?IN;"KZ*.;)B,D,L_EQK?[Q(0'2F@ZO
MAM8A+ @%0.AZVN':X]\J^:I*.8Y-RR3*W6.=_(N/75.U;.9-9)=@QC3JMFKQ
MR"0 L5,YA3.82B/PC40EE!M4%_LT$KQHS&-^M](\.@^\#8VZ7M>UQV-3W6O<
M/N;3T>#.G7ZTQM._&&\@^B8^3DVS-:38JG(X?+BNV!D=B I)%5(F9$>HIO5
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M@ >!3#Q]H!X9=I.>TES[ZBI<&QUX_8?H_P!'L^@_;731=&24],Q3I*%_224
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M'I,D>L,"K= ZC[P6_?5[1[ZRO41Z1-X<!S^3\_GF,*P\>U;9="IZU3U$^ Y
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M_P"+<Y^8R/\ ./\ UC_33Y;&_P W'_5']%??Z,?;G_J+U-_F#6?\6X^8R/\
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MK,I87\T:P1,<R<R4O+-7(-U0B[).M&1'*#M8S%!01:'103/Z92GZ#B"G32+
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M*8I5$D3\K 3V$*'YS<C^]E[CBR7]M1V4UY-/L%1"S.1:PKP2CTJ."E:)B'F
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M1-HX3Y2ZBB)05.7]'I*&2X&5Y$<+$@R%B2?I;H/HM6)\WV:+=-FSL(J- QR
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M6,$GH@K?U'K/7-<:K.EW2CY&ZL8@'9%%UGJ#=JT7_"';0R(G=*L@/(IN4SF
M551Z!X^ QLV+CKIC&J][5\_]PNN?Y>/I\LQ.WCT+=74WZDZ4"V'4Z@ +$WEU
M@D*Q(&L#V=;SQ'LBT*G)NHI5JDFHL0J*YW"8'=HH"*"BB1Q](A0,D<WJE#DX
MA4-[=>PJ,PXLJ-X4Q&BT#I9K'H#V-[]+6M87/<B]ZSY^GWL>M:OV_0=BVZTS
M%,U_4#++.GL% A.620!1@*9HA>-9@^=-H:2.\%-X*17"AR=?I)]728(CDV+G
M;CQZ?:L**.:610 K,$ L;ZO %E_1\>PO:LJ],-PV3C/J=@\FWG)RL6+&9R\L
M"&0R*05$13JPCDN/,^%F(!L+V-;S;O\ 5-H=CD75,[7]>7S=M]<)=# QJI8(
M>$;N%OA36&$.P3NDV5N<P"H0C1FW$H")G:90$P:KVOTURDC^>Y+E08. OWAJ
M!<V\ 3^S4GWLWN4]J]G;U^(+;,S(.T^GFW9N[[PP^$^6R1J3V)2PG>W<C1&E
MKDRJ 2+_ ';S3^ZUR^'9'<ILMLDXEHQ9&,TE58"KM*[6/G3HJHNIVP,&SJ2D
M)AHBF)"-DGCE-N8PB=ZY_0"-Y-G\/$7\)XKAL$1P6RY))#)(1W"IJTJA)[E0
M2!;2H)K+>%;3ZD-+_'O4#<5\Z6,A<"&*%88M78R2*K,\B@6"K(RJ3=I9+ 5E
M:H843D6#P%(Y%2B'L%,Y3^'V_#F(1VL4/8BM@L2C!QW4@_8;U=CGD $/(?$/
MN$1Z?SEXR(]U9?>_6J['#RAQ_).8/S\#_#EED#X[^ZI'%-X[>PUW\H5<TQ2F
M*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F
M*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F
M*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F
M*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*5%UO%94?'Q.;W_
M ,H?9DDG1!]%1$ANY/OJWMR 3.HH 'R(Z-^4#M0_>R3P?NO](_GK&][ZS0CW
M-^=:H:0")@#^+X@'D'W?;Y9<R"X ^VK!.]6 W9L/;&K7T1:JM66MNHH$^7L4
M:1NX,_:JE*LJ=T#UFBX=,2F(0 (H9%= 1Y X%'I$<@V#;=GW9'P\N8P9VJZ-
MTL1[+$@'WBX;V7K5WJ-ROF_"Y\?>]CPDS^.@:<B,*VM3U.H.@9DZ#HQ1T[A@
MO2_#KWO9T%;" VG;0;7DV1,XKQ5X2)$IB"8<+J-9ANJ]AU4@-ST]:Z2_AR9,
MOEG.Y\%Y'AG7!#\S >S17;Z+J;,+_01[&-6_$OQ%^F'(AY&=F':MS4'5%F 1
M]NA*S*SPD>R\BOXLBUH[VN[@GM\N,DYGF]I:(6R:/"RR#M-ZI/IINWI(B41?
M+ =RJ208IE7( '](Y.D3"8. -O?;(I5VS'71Y,I@34A%M'PBZV\+&X/2][VK
MYP\PR<3)Y;N>0<H9T SIO*F1@YF4.PBE#]6(=-+*+Z2-))/0-BA;3JDCY)LI
M^TSHCA1XJ[:,YM-V\2:/2*) T2*Z9L3$2,X3#H4$R:8%!4GJE#RE%%O9;W#O
M6*0MYDHD06TVZOU]HN;$"_7V=;=?=AK?9#6^FZ'(W:RNVZL*WB9B.59#(LYB
M2:-S2!CHP<2ZB?5@4E499TN82N'!WAU^D! H<B:WRLB'&C,LWW?RF_@*SO9,
M'?.0[FNU;9TRVE1NEPM[ F1R;N056P(L--S<W%:G!VUM#>T=(Q5<FWM7IL:J
M@S!<S]9FX> ^<F1AS3SY%9$\E(N19](%$! YBF .D0Z1QJ7/ERBD(!#M<J "
M+V_G^GOX7KU/LG!]@V&27<L_RCDJNIW8 JA%BWEK^B+]@!T%A[*Q^-H.\2ME
M<Q\J+@ABOPCVRSUH_<.)B>69/9*,@(Y,J?"DY9U&Q6S+K,@@N_<H("J!W")3
MQF[Y6!LN$VX[NXBP8S=V:P5$6QDE<L541Q+>21]5D12Q[$5DD7(=M&C&VMEG
MR9(R\:QFY*!UC+V )TQEM3@ L$61E4^6]LD;=V\Z)K3:IZSCMH:[BMC5F'KD
MSL&>M\R2FNY&1O\ $HV'Y2/)<T8BKI1='A'4*1LV)(E=+G-*E72*L=$@:E],
MN6\GW?+W#FN6">*961DXV!C+ KF*'"G./'E%E$EYLJ:/(>1=+QF P(C* S-=
M[GSO?-GB5<;9-QF8P:_,C1,B$R?I1'RVEFU%BZ%VA5 ZQE&:,EEL%:K96ZQ6
MI+7%5;1LXZF94DC8K!$/W2L8@FRKSF!"*C7\"\393\>T"T3C<S@GK,G[)PW4
M+PH94$O3,F]X$^UC&Q<.$MDZFDTI)"%4Q-$$9%92^D22KU"JZLC$:S(%N<;-
M?<\Y=XRX#CRK]R)E"MUDU*S(P^!V*1G3\+HVI>H5"V*4DP [LH',I(OC'557
M=>HL8SA0PB)2$7<%*LH <_$81#K.8<U_FP2R3M+,_F9)/5NO7M87/6P]_B?:
M:R^#<<[.D+-TCL J].@  '0$@= .GZ(^NLSNU&GJ_M"XV')5QSZ=.8/C)-/1
M.*JJBL<M\DZ0("!R@NJL<$R@)B@*?J'Y "@;+B'#S8YL?SH],!:[!KA[="K6
M/=6-P.][7[=:P?U#W"7&P!ML+JN1FWC!+6*@VNQ!*DA1?J/'IWK8?KG8*C5^
MUKB*1).-6IPV&5*FW9@G$2SI-Y*M$F[A1,%W[CY%1  *=,AA!H!_$0(1?.-*
MJ.G2W0?R]M>8-_V0-BOG3'RYAG-#&2&/FK&P5V[6C4%1XD:Y+#X5)6X,=+E>
MLIUA+?"?T_EVCT$RAS(%4*(M542BFF7K9F 43& B;<JAB_H]90YMUZ=0*Q"6
M,QA)(E"Z@QM<DZ>ND@]NGW;7!]UJWS?3>T1)HZ]L;6T=E.P=OW]2QHKP]CO4
MV.I]5Q%4=PT8HV0*]GW[1*=D5G8JNU!:1T@HJBY3$."\=6M.9[R8\J-(-X3#
MQ!&-:1+YLQ?4P)TJ.@ LMF9;$&XKTAZ-<+CRL'(FW#A^3NF\F<>7/DR?*8J0
ME%(%Y6!9[DM\$<K%64W\*]%VKJ#"TFGQB##6=$U;,/&**L_7:$5DYBVC_I 5
M&P3S: KKB>!+VKJM4S"83 ')>#&TKGYD^9DLTN1-DQACI:0FY'MTEG"D^P$U
M[8V+:,3:-LCBQL##V_(*#S(L<*45OU1((XC(!^L4'CT\3+W).0$>?+XO'[O'
MQ\1\1SHA]O>KJ=;B]4%V7E-0 \^@_ ?\D1+]@>.5P0"+=ZCY!=3;O:KH-A$6
M[<1_C((F_P"<F4?X<BS]XCWUE49O&I/BH_-5?C/[6I_9A_X.6>3]X5)8GW3]
M-5/+:KNF*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4
MQ2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4
MQ2F*4Q2F*5^% 4%-0$3$*J)#@D90HG3*H)1Z#'(4Z9CD W'( 8HB'M#.K:M)
MT6UVZ7[7\+]JX-[=.]8\W^3[G*XW7DZ5#:HOS9#U%#PBA+%5)TZ!"G,!6KEY
M/2D2Z7X .0.9#D?(!\LUCR7*]7-LC;+X[!LNYQ*2?)(GQIBOL5VFDB9OIT^Z
M_:H3-DY! #)AIC3@?H_&C?42S*?M6L0]9_4_UU8YJ3KNPJA-4M_"R",;*2,:
MJ-AB6BRR2:I%5DB-F4F5OTG$!,BFX$!(8./ .=2[#^*78V;'BYGM\VV'(N5D
MC<9$0"N4;794D4J1ULK]+$5B&T^IFUYT\V+E12128\GEN1\0#:5:]K!M-F[@
M'J"/"ME%<L]?M\-'V&L2[&<A)5 CF/DXY<KAJZ1.'(&(H3GI,4?A,4W!B& 2
MF ! 0STUMFZ[;O6#%N>TS1Y&!,NI)$.I6!]A'V$'J#<$ @UL7'R(,J%<C&=7
MA87!!N"*KN2%5J8I7&LLDW3.LNH1)),HG444,!2$(4!$QCF$0 I2E#D1'R#'
MN'>N"0!<]JTK]VGUPNV/MYE9.F:W92G<-?XQPNQ?-J8_:1=$B7R)E$E&TA?'
M;9\W?.&ZQ0*H2,:R!2& 2G.0P"&9[L?I[N^[J)\@C&Q6[%P2Y^A!UM[";7KS
MMSS\3'I_PZ=]NP'?=-V1BK+ 1Y:,#8AY3\-P?! _L)%=GM.[KOJ1]YE10W'5
MM:]K.B-*23F>0@I'8!=D;0NTY^S\H_A9$[""K-OUZU2192\:NV44>JL3F51,
M8B1D^D3==]VGB/'Y6PY)LW*S44%A'Y<:"ZAA\3))W!!Z7M>U2OIYSSU!]1]I
M3D^%B;7@\9F+^4TC2SRR:'*,0L<D:@!E9?B*FX)L18G$E7ZP_>[3H*W[1GNU
M/7VV-'Z]O3G7MWO&MG-MJ#FNSC*-AI99:682,SLA6&BW3&?;"@[<)_)BJ)DC
M+%.  -QLW&N-[[CP"++EQ-PR,=94CD*R75]5A<)%<W4@CZ^Q%:CV'\2O/<S8
M<OEN;QZ#(XUA;E/ARRXTCJ4: @EW5C*54JR_$1H#&Q8=JV,]F'U8NV+O'DVU
M,B)"6UEM=PW%5#6^P2L6;N942*!G*51G6;A:'LJJ)1Z@;E.C(&2*93Y8$RF,
M$3O_  O>>/KY\RB7"_SB7([7N1W MUOU'OK=7ISZ[<$]2)1M^VS-C;X03\O/
M97:W?RV^[);V A^A.FP)J]&[>^?4^I)!U78H7-_M3/K3>Q\ X;$B8QR4PD%K
M*3JGJH).B&*/6D@FX43$.#@4?#/*/J+^(OA7!,IMIQ=>Y[XEPT<)41QL/T9)
MC<!O:J*Y'9@#6<[MS+:]LD./'>?)7N%(TJ?8S=KCV $CQK%NV]^O<+ 2NF2/
M=44^GPN\MA4VD4YQ/-YV6D!:6^Z5>H%L2K9.?KRIX]@:T)."]2*/S9"#Z8](
M@;,(V?UJ]5M\W[:]ODVC;MJV[=]38[Y(GE<Q);5)H2:$D$.NC4$##X@2.M8M
MN//MWV^7;Q/BQ1P[EF1X\18,Q!D=$#D:T.D:[]AJ\.G6L2/J-?42^J7]-55C
MMF^:;[+MT]KLK8BUF/GJ?.[:U]LUO,KQ\O.,8B<BYN7M\:T=2$/!.S)KM&[Y
MJ4R ^J=(3)D/[]].N#8O-A/M\F8Z[SCXKY#D1".+RX](;2IDF8MJ=; R+T^B
M]9QF;GE;3%$=Q,<KS3K&IC1D%V!/56DD-@ ;G5U]E3#Z?G_Q$/9OWKS4+KNZ
MIRO;)N*;<MF,-5=C2<=(4NV2#@$BHL:ILAH@PC5)!TLIT)-)-M%N%CB!$"K&
M'.=_],M_V: Y^+;,V\"Y,8(=1[6CZDBW4E2;#J0*D(-P@F(4_"Q^RO0"0Y5"
M@<@@8H^("'D(>_-<U?U^L4IBE6@W3O75^@*:[O&TK4RK,,@8R#1-7J<2LW(
MF94D5 12(&>2\DJ4O()HE-TEY.<2$*8Y9[CO&-\Y9N*[7L4#S9)M<CHB+>VN
M1C\**/:>_8 D@&!Y%R;9>*[>VY[Y,L6.+@#N[L!?2B]V;W#H.Y(%S6H&6^K_
M &R_[#JFM] :C@$Y"[VN*IU5D]JS2Y5)>8FWI6,:FK#5URR0C"*K* 8XC(K]
M"93&$ X\/0N/^'S;=FV:;>N9[E*(<>%I)%Q4'PJHN;-(&+G_ .]K<UYUR/Q
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M'\]8_O"_M(F]S#\JU'T0#W>(>/Y_^++F4G58=@*CDM;WU66I2G*/64#";D!
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MAPNJ8B2*"*1!,<YA I2@(B(!F0@%C8=2:OY98X(FFF94A12S,Q "@"Y))L
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MJZ^-JQC\*&W2P<(W[#W7'=%DY+G$I-&5UQ.D-B4<"Z.OM%F!\0:U![@T=IV
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MA95TL?#4 0IO]-K^VO;$W<(ND4G#=0BR"Q"JHK)'*HFJF<H&(HFH03$.0Y1
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M<-@?'="0Q5#*$+X,_$G!O:\PBR,ULAMEDQD\B]_)1_B$B)8E=?0,Y:SD$7^
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M9@I:;<)3=DEE%4GQ7,DV?*IJ-'H @8%G+XB94N!%-81,'%QMVUQX 9P%$C>
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M6)7:C]/?LEDT0A]\;IAD4556B,CKJB2K<WS4>*XE5:6VQL52@1![\N'7'M%
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M"[>?22W! 0[9Q(.@[:JFBQ:D*+ATNFP:514")ID*!EG'R[01 I"B8YO  Y$
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M7]8C\G>J6"A?)#?HH"3])Z#^<_54V\1\ \Q\OO\ 9EC4[WJ3HD]-),@^92%
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M$[!],/1"+"EAY/RY <U662'&-K(P (>?VN&LRQCHI +ZF%AZ%"E H<  !]P
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ML\B1LT3)D+XRCS%'F+;6H.M=8+/O0[H54G7TV[\JF)#$'MY@1 X"!@'B%@1
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MCY\$ :\<=/9_14YA[RQ819MNO37:W]8?SU<-NY,CPHF8IB' HCP/40Y1XX,
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M(U83/9D< /\ !U /:K'=O7>5W*[YDJK/Q7<5VKPEFG+J6(GNV&Y56:KEDKL
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M?]:;_P"13_UA^F/^Y[W_ *G%_P#&4_\ DA_LM_U8]SO^9VJO_;/G'_#/?_\
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M;&DF15UG3+9QK6WPJO4>=E+FD2M,LW;'N66T):*WJ^!T[/.'M+@]F0%\J%8
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M8DT6 11=2:0.V,/7TG1>!1"1>M%'!! Z15"<B&!<N]3^(<*80[QD7S2+^5&
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MK@'_ ))M7_=8/\BG]#7M(_[,6@?^J&@_X@SC^-[U_OF3_K7_ ,JN?^'7 /\
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M0@%Z# )3%$2G Q1*8IB#TG*)3 !BF*8/$! !#-/9BE)C<6/L^BO1<^,TMBK
M@^SQ]EOIJF; M\!1:?9;K8W/R4!5(.3GIAV4I3G2CXQDL\< BB)R"X=*II="
M*0#U*JF*0O)C%*-A-EP8&/)GY1"XL*%F/L !-A_?'LH\3TZ7N,JX?Q?=N4[_
M (/%MDC\W>,_*C@A2]KR2,%74?T4!-W;LB!G-E5B--VR/JU]TETDD&^CT:_J
M>BQ:"#2(^<@XRUV^4;M$4T$W=@?3"$E#-5G I]9F[)N!4>H2>LMQUCH[E'XF
M-^BF^4V$1XN''95U(KR,  +L7+*";7TJ !VN>Y^DW!?_ +'3Z#<:PWR/5%LS
MD'*YW9Y=$\N)AQ,[%BN/'"8YF"WL'FD)>VKRX[Z!E[V2?5HMMEV#7--]U,;"
M%>W26:0=1VK763>$9DG9%8K6.B[E"%6^20;RSP2H(/VGI$2653(JW!/K7)L'
MTO\ Q!GD>;'LO)1&)Y6"1SJ-(U&P E4=!J/0,H !M<6-QH'\3/\ ]CUXYL7%
M,SU&]!I<HX^W0//E;7D.T[F&/XY)<.8C66BCN[P3%BR(Q24OIB?T*$9%'C@O
M(\^(>/("'CQXCS^YGJ/7[*^3 @]U4&YR(5>HVBS"S4=_LY79N>%FE_;'00T8
MZD?ETQ\1 Z_RW0'GXCEKFY1Q<.7)MJ\N)FM[=*DV^NU3.P;*-[WW!V;6(OF\
MR&'6>H3S9%34?<NJY^BO!G%R\[MVV6/95ZDU9JW7J;?V:>E'0F$SJ1E51<K"
MD4YE/0:MP."*"8<%11(5,H%*4H!\E/47DVXYV[3Y^6[/DR2,S$FYN2>GT#L
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M=^PZ55$8\A.#*&$Y@]@>!?N'VC^YEL^03T7H*O$Q57JW6J@4I2@!2@!0#R
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M.V1%:A]7W2F5-R_;HV78]WKDI6:Y7(?U03D7S49Q&-5L$DFV$PH,V?JJ*J@
M&$A>I0F&\#]#N2[ON<<?RLL&(''F22(455N+GX@-1 [*.I]PN:V!ZF_B)]$?
M1'8,C>=RWK;MQWY(F./M^'D1Y&1D2VO&C>2T@@C+6URRZ552;!VLC>OG4^I*
MUI/5M$U33TERUN@UN.KD89WZ9GSQ-@D!5Y)^9$B:1Y"3=&4<.#%*!3+*F$
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M+-%&AD8]3\7F,ZM;N1<W)J1])-LW9/6*/E_("PW[D_$=QW:9#?3&N3DS) B
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M:%W90NY:E6:_<+/7PV@>%KIU#*3.LX]UL!\_I4/=9F0K-.I6Q]@.6*4%&32
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MLD7EB0]WDBE5"W58%%96]E'TE=?=L]L9;8V1:S;JVO$F%2L/%H((&GTE90H
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M_$-Z9[,_(=\V)LK9(E+2RX$T.;Y*@%F>6+'9ITB4 EYC%Y*#[\B]"=@AD4U
M$Z8@8/T1XX'@0\0\/8)1'V<?;FPPP)^*O*[)8=*ZIT ]OO$>>1\_M\0$> \N
M<JII!N.]4&!(L:H[A'CCR$/$ X]WM$/R9= ^RK"2,>-1EZB &-X!P(>'A^^'
M[N74;7Z>%1<R=2*BSI,0$X<\" &#P]_2(E'[.!R[0V-1,J]"/&KE,EA6:-'
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MCP(&\CME[GB;;2=U6W0[VKWF$6<E<'>1B\%7)Q%[<]E0E;CJXI/2B\]*6%.
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M//D5AY,:E6#Z;,=(.D-=36X)HHJHB0RX%*J)2B<A#=9"'$H=12'$B0J%*;D
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M,H*8B<2CD0GJ%B86W[%N9<9&[8V5E29,=B"%G+@]2MM15R5(O8V[5F,OX?\
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MSSMD/%)D220+HA9V*K^JI)('U#I7T4VZ')QMO@Q\V3SLQ(4623]=PH#O[M3
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M*B-ZIL;L"J3M.F'4PSB[#'+QCYU7IN3KDV@@XZ>M2,FX==M(QKH.GP514(<
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M]Q!'@:_2_P"A'--G]3/0/C7)>/Z"(]K@Q9XU/6#)Q(U@FB<=U(9 ZWM>-XW
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MY_N#U9E>7]W'_@G\YJUQ_P!]-_I!_B)58[I2$/VR]Q(&*!O_ %%;<\P ?_Z
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M^]OG=8"[XNOKKON<U-J!D];F;*KTO5E,24?SHH*AZB"<O/V-=0"< 8BWK$.
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MH;U2@CFY,@A%F;%C,I'?5JD O_?%0MN_2Q/LK(MLWY]-NB7I(0A4R^T")EX
M/$?'P //S$<F'?2"S=_YZPV*.]HT%E'3ZJE!" F0I"^ %  #\F1Q)8W/<U+J
MH4!1V%?K.*YK'#3_ /IE[L?]IVO?]P>K,KR_NX_\$_G-6N/^^F_T@_Q$J\5]
MIT;L.D7"@S2SQ"%N]5L50F%8Y9-O()Q=FB'<*_48KK(.D47:;1Z<4C'34*50
M $2F .![X.7-M^=#GP6\^"5)%N+C4C!A<>(N!?J*MM[VG%W_ &7,V+.+C"S<
M67'D*$!@DT;1OI)! ;2QL2" ? U96.[5]=Q?;4IVK-G]H-K=6H2U),_6D8X]
ML_!YER\=.E0DRPZ<;\^51\<"'%D)   ^ 1#)B7D^Y2\F'*W$/\4$RRVTGR]2
M@ ?#JO;H.FJL+QO2[C6)Z9GTHB;*_LN<)\7474S^5(6)_:%-.L:C8Z+#ITJ&
M;+[%M&;5UGJK6UC;6=FII*NU^MZOV'7I\8/9=4:UR*BXAFY96-FS!JJZ70AF
MZJI%6BC47*1%B(D4(0Q;[:^<[_M&Z9>YXK1-\]([SPNFJ"0NS,=49/@78 A@
M0#:]JAN3>AW!>5\8VGC6YKE(^QX\,.#EPS>5FXZPQI&K+,JV+,L:E@R%"XUA
M0P!')V_=D.H>W>RV*^0,IL&_;*M,::%F-E[8MRMRNJT,=5JX/%(R'R4:S;M5
M5V*)CF*W!=3T2%,H)"%*#D7-]YY)C1X&0N/C[7$^M8($\N+78C402Q+68VN>
MES8"YKMZ>^BG$/3K<<C?<"7<=QY+DQ>5)FY^0<G),5U/EA]**J$HM]* G2H)
M(%JAZ?TZ="$[>6/;69S>%:9#W8^PJ_8C3L8G>Z[:5'HO#/X6=;UY%FSX(HH@
M "T./H*F#GK IRW;>HO(CR)N3W@&X/!Y+J$/EO'ITE60L;W[GKU;K[:AD_#K
MZ>IZ>1^FG^W'8H<[YN*4RI\S%/JU:XY1$%7Q6WEGX2>YL1<<_9]K-YM.?V_-
MREQLELM>CC=O]H2FY2)5AY^DK@R"1=R#-E ,ES6&5%ERX6(J1N85#@5 @" %
MC%Y?NL>TQ[+ (8L.'/&6FE2&64:M(!)/[-=1LOA8=:R;_A)Q>3E>3S+,DS,G
M>,S9/X5/YLB&.7&(4.658U_:R:;NP(6Y-D'2U,@^R/3E<CNVZ+AU+2Q:=KDC
M,R^O2)2<;S*25@1*G,/;B88032Z[];J7.9O\GRLH80X+P4*L_-=[R9-SEG,3
M/NJJLUU[*M](CZ_"%!TCOT]_6K3"]%.%;=#QK'PAE1P\5DEDPP)%^)Y@/,:?
M]G>0L1J^$I\1/A8"";:^G-I':>P+#LMA9MNZAM%U3Z+\KI>^C26%\,83^LXM
M$<I#R[5VX=E/PX,D" .#]2JH'6.=0U_M'J)ONT[=%M<D>'F8L'[KYF$2M%[
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M5'K@I\M)SB+)1&O1KPR)B*D9OIU9LDJ<! 2)G,/LR)Y!O)V#8<S=@ Q@QW<
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M!K\N7*MCR^(<JW/BF>0V;MFX9&(Y'8OCRO$Q^@E21U[5<-)R/ <&\/'V^/\
M4'*Y4BHE)?MJ$;;+/26J-F1M5.N2TR&OKFQKBC<XD<%GG=;DD(<R!BC\"Q9%
M1/I$/$#<9%[O%/)M.4F)_P!J;'D"?X90A?RVK,N!9VU87.-ES-]"G9(MVQ'R
M PNI@7(C:4,#TMY8:]^EJ\%^M ;,N&DFF+5ZT.NU?-'9?2<MW:!^A=!RBJ(J
MIK)KE$IBF^(I@\0 >0SY$<W@SER9$L_F!^MP;WN0?9U]OV5^IGEK29/^TX3!
M\:0!D93=65A=64CH05(((Z$=C:I9L)Q$F:JF1!(@>B8 _0\0X$0+XAR \C[
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M387!\#]EQ8UZ$V'='WO9<7>),7)PI,F!)#!D*$GBUJ&T2J"P5UO9EO<'HP#
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MODY/YN9DOF9TCSYDKL[NY)+.Q+,QN26+$DDL6)))\:DZ+15;]$ *4 \##X%
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M#Q$)Y98L"!*4NMR">QR2@H;:O=GW;TGN9=Z7V)HW4^D-87*N0C/;D*C6=B[
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M3019*ZCT?VU5Q,R?!?X.J$]5/8^_W'W_ &U==B^;R+5-TV/U)J!P)1XZTC@
M=::@ (])RB.0LD;Q.4?N/R_167X\\63$)HC=3]H]Q]]5=FY] _2;^UG$.0\N
MD1XY-^8/'+:6/6+C[PJ]@F\MK'[IJO@(& ! >0$.0$/=EB00;'O4D""+CM7W
M%<TQ2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*5!;MK'7.RV*<9L:A4R
M_P 8@H=5"-NM6@[5'H*'_34293S&0;$4,'@(@4!X#+3+P,+<(Q%G0Q31@] Z
M*X'U,"*R+CG+N5\/RFSN);GN.UYK"QDQ,F;&<@=@7A=&(]UZ[M/H5)U[$%K]
M#J%7I< 0YE$X.I5Z(K<0FH<  RA(V&9LF93F H (@3D0 /=G;$P\7 B\G"CC
MAA!OI10@O[;* /R5;;_R/D'*LX[IR?.S-QW)A8S94\N1*1[#),SN0/ 7M5>5
MCT3CR7E,?<'B7\P^62"SN._6L=;&C8W'2NF>.6 1Z#$.'LYY*/[H<957(4]^
ME4&Q9!]VQK@,Q<>U(3<>7!BC_"&=_.C]M4SCRCPKZ5BX'R3Z?[(2AX_D$<>=
M'[:Y&/*?"N<D:J(_K#$*'ASQR8?M]@!G1LA1]T7KNN(Y^^0!7=28H)^(@*AO
M>;R_( >&46G=NW05<)C1K[S7=RC5Q3%*8I42NUSB*#7W-FG4IE:-:KLVZJ<#
M7IVT28G?.4VB HP];CI657("RQ>LQ$3%3)R8XE* B'95+G2._P!E=)'6-2[7
MTCV G\U6;#NJU8( /R&UO+Q_]1VX_P#\!QYRK\M+_>_UA_35#YR &QU?U6_H
MJC]N\V2UWSN3N3&+L<? VC8]-=0*]EK%AJCJ2:Q>G->P#URA&V6-BI$4$I6*
M72ZQ2Z1%,>!$.!Q,-*HI^\ ?SFNN*P>25P#I+@BX(_1 \?HK*G*%7E,4IBE,
M4IBE,4IBE,4IG%AW\:4SFE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4I
MBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4KR _5)WO>=E]TFQ=
M?R,Y*%H&K9=M5JS4R/%TX-%ZPC&IY>>6CB*?*N9E])O%P^9.450;@FF @0O
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M(F0. #W!F0HBPQB->P_D:P6227(E::0W=CU_F'T#M7=0;]  8P%$P_8(_D
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M%PS_ !FQR<\O4U&K12+=K&2:K(1J#8[LH*)K@H1,>H! NQ-ZF9\:&%!C@>7
MZDM)+J(/07">6K:@S]W!9C8_<L:YI]M92L7+>#5?PY6\4WBV[J7N\ZK!D?\
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MKT(/Z+V&JXL+FU<3*'N#V;E4*P98LZQDOQANVLJSEA'^@]0;J>H)&4:8DA#
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MS49'Y)9Y*/DWBA&QVJ8ATIG^8 B2O2/9C92:M,'9C*9<S)FA7RY%4HQN6)+
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M)3^FW!8#K$6!,R)2@'00_@7QX\\R&&/3CA 0& ZWZ5@.5D&3,:0J[J[GJH!
M'87Z@VM;L#]559)/P H  >'[GVY19B.@[U>(HM;PKD?PL?.QKZ&EFJ3V,E&C
MAB_:*D R2[1TD=%=(X"'Z*B9Q_?RG#-+C3+D0G3,C!E/L([$5SDX&+N>)+MV
M<@EPIXV21#U#(P(8'Z0:\U'=7K^@UW;T_!U":2<-*5+ I%R7RL85\FY3,8LO
M7GD@[0*5=)CU+-U%TQ8'_5&Z5#CU<>E>/9V?G[/!EYZ%<B1 3?J"/!@.XN+&
MQO\ 1:OE!ZG[/QWC//-RV'CDHGVJ&70.A!5_TXF9?A=HSJ0,0HZ'[Q%8A;,V
M$S;O(]JR.X.\GFXI3L*C+%Z:\W:(G;_M*O**.7$4Y)"2ADE!2.Y.NH5,R9C$
M*)A"86^FP'4>-O"L+@PUR&ERI"4@"]!>1M<@'1%/Q W[ZC>QL#8DFK&P4 \M
M,\T4L$^B]H\)8W4R^K4-*O7+B5?H-HU[ L"-HYR9).O-7D@($(X*U(Y;)HB4
M@EX%7FS$?R_E_+K4JN=!M^.3%"!N,L6E)&2/2H8GS&^(7$K6!!%BG6W:OKRR
M66@O*I'VV*0H*]C?R,5&MQ2:V0L3$LG$LUKS=RLN)7C=B2'*U!WUJ)_*'<IE
M7Y3/ZN=;7Z'[P_E_+WU=+ML.X'(FPG\V*&,,VJZ:F(3SK#J->IF\L6NZIJ6V
MK0+:M]+PL]<Y&[H/H)-!<6TZ^=1[AN5S+1B9E'+YK%,4EI9%-S:'2#9L]?M1
M=("AU="[CT3@Y#MTMU-2LG(\S%VY-DG25DC!10RD!)"-"!FL&81EF9(WZAP3
MIU&]?=W;2[?M5LXEIMJY2LG:FS=S-Q]0K;F*9U]&6;+G-%RSM  ":C6;99=9
M!FF98Z1RIJJK)&.N<REKE9V'BW6:1%MX7Z_95_PSBG,N2Q39&P8I^7=S&9G#
M!BK*"RAF.EKW#,UB0; -TTUKOO7=SI:UR$?!.!=%,+YT#F5A8V'>QKH%WQ%E
M%$6<X]D#R"PA_=(JG48&46#GD!Z52Q3\CP$E^#44!^]T[7Z$>T5NKC_HURW!
MQI,UY(EF,?PQEYPP)6VEF32JV[$VDM<E1X5EO3]O:^N5$AD8JVL+D[BOGTT4
MGS9LQL-?:LJ[+KI20-7$M*'^69"Q08E,#HIE$'7HJK] B&2N-F8^6@:%K^-O
MZ?Y=:U/R'B7(M@WB<94$F.DA0ZD+20R$R)\*LB('=AJ=D"*%*?=!(O.W%D3=
MIR$<8L).2)),6SAG8V#>4F585$Y6KV-7>//1ER,A6> P,J#LATW8@J!?2.45
M+B]SI-@*A,?'E@*Y-IT0QW!0E$62S%"M[J6.G6 P&N[6OWJ7M+ $&]%DTCI9
MJ1-NT-%.7"I6Z;F.G(]65/'EF%V:R\FHS<.7**X+.!5,H"IE X4(97D*HZ#I
M_+ZZC\C'?)B&7*T3>8T@<=[,C :M MH#7#1]@5/2NA4=@1IY2S*W TC*0ROS
M+UC^(L3OX]-O*-6LF:0<)0I5)9)J!W8I*^J@F?Y@1ZSF,;@0T_I#M[K_ /)7
M;/V[(6&(X#1^>_1R&T:6#%0A+#XFZ7!'@;"_6KA5U&M/]A5M).9<0Y75D@HA
MS9$B+-7L4Q?R+54)!L#ILFJHL@P6]05"J )BE%,ABE$#!3G+1 NH!LKD#VM;
M^<V!_E>SV^.7,6*&<F*-IHU+65@JZ@&8@,O06+J!<7MV/;W'QL:E%Q$3'HN%
MG3>/BV#!%VX'J5<HLFQ&J2RJG4('47(F!Q'D>HPCQY9Y4DE\R5W;HS,3;V7/
M7I[ >E_MKZ]PXHQL2&",EHXXE4,>Y"BP)-SU(%_S=J_"J8\CS]@_E_=RI&0#
MUJDXJ5U14?EG;03<^BX^83#^2DY >0#W!ZZ9S?\ *RSS%M(&'8C\M3&T/>%X
MB?NM<?0?[H/VU-&ANARD//'(] _<;PX_/EA*+QFIN%BLH/OJ1Y'U*TQ2F*4Q
M2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q
M2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q
M2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*5:#<[\[:LMFA#"7\1DD4E  >.I%
MN0[D2C[1#U4R9-;%'JS"Y'W4/Y>G\]8=S:=H]J6%3;S) #]"W;\X%:ZNYO83
MC5F@MJ7EDLHWDXFJ.FD*Y2,4JS2P6)=O6*^]2$0X_P#1\S,H+B'F()B 9LGC
MFWKNN^XN"XO$\P+>]4^-A]:J1U_6]U><O4?D+<4X'NN_PDKE08C"(^R64B&)
MAT/W9)%?_F^R]>>[M8[BXKMHOKO9RNK(+:%U;E8HU-W:Y=VW85<R[LYK)+-&
MS=LNHXLTC&\-F;TRI08"HHIT*B;C-\\NXU+RC;EVSYM\7;^OF"-1=[+9%)N
M(U))9 #KM;H+&O /I+ZDXOIGO[<HEVJ'==^&@8[3R%5@NQ\YU4 WG=#HCD+
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MO_+^5JB(L+&S/*?;V?S9(V8BQ31IN753T1^@5A\7Q=5 NOQ0=FJ6,LLW"/E
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M<^/'N_<#S\<T .IZ5]!'6QMXBN[75/2E>CD>'+55,>/+J1.DL3G_ ))3_P#
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M#&'R_P#M2ESX_:&#;P[4L>U2B-[M4QX*^9.$QX\5'$<DN0!X\Q%A((GXY_\
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M>\XV."9DQUFZ?JP2QS/]02-B?&W;K7F#'S_X?O9Z9_/_ "]E?,8'L1^7^?\
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M%<GC=Q7)%)-%?\,6K]@;MD:XS!T[12,GT%09+*('!-98AR!G*][FWT_T^/\
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M0LJD;Q?IV5FD06J7=FL[]VC*1LF[2<1ZJ:ZR45\J"9(V2;HM6+E=>83*X%-
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M9-<CGSGC362TK._0_"!?HJ@>%ZOXY >/+VA_W0^_(R/M62S]JZL<7F9C1#Q
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MF>YY.;-U*QD@1)<DGRX$TPQCP^%1T]O>I-7='R\H5-=R1?T3@ @L?^X&@@/
M\D.J15VY(/L,1/CCQR\FW+'A)#L"_L'4_P OK%89C0;YN:A\#'\K'/Z<G0$>
MT>)]MP&J[$;H6*1  <G8@8 #GTFJSX?#C_I'BA?'_P#-_DRPDWL?]6A^O^1J
M3AXENTO_ &K-"CV(I/Y25_-7=7I&LH812E++$,%B_I)N9"OL% $/,!063]0/
M#[.<Z?Q#.D-TCN/H-#Q7:4.F?-D,OLUH#]EB:I9X333CE,EU@N1\!]:3KXEY
M$?#Q.BF7CW<#XYW&7N2]3#70\:V9^D>9.I]Y_P#V1_-75/J&G3OA 3E=E#&Y
M,)&BK;J  \Q]6(=+&YYX_B"&=QNDJ']O$Z_1?^<"NG]FLK5IVW<8Y'O;2UC_
M (K-]EJM]8=$RL<!U6A%CID#GK;",BW('(B(F#H0?I%*'F8Q!  \?'+N#=,6
M4VU6;V'H?Y?75ME8G(-M!?,@$T('5XOB_)W'UJ!4+@9W96IY LO59Z6@CIJ$
M,JZB7:AHYUT&#I3D6!P,V=(G\ $CI$2CSQXCR&4-TV;9M]A.-NV/%-&1^D.H
M!\5868'V$$&LEX1ZE\FXCG#/X=N67M^6#<JC61_:)(FO%*I[$,K>P@5GQIWO
MLCI%1K!;A8IQ#E0Z;=*YPK94T0)S"!05G8DAEG,<!OXRS4%DP,/BDD0!.&B>
M5^B\^.K9O%',J=_EY"-?T1.2 ]O8]CX:R38_03TJ_&A@;A+%LGJI"N'E-95S
MX$9H";@:LB :GBOXO#YBW_ZI$U,-NVHMK$B?PQ$TJ5W7'X-GD)-LGA'2#$'8
M$4:NV;Y ZB"T,N0_6(IF,0@&Z@$2B8#:(DBEQY6Q\A629&*LK AE8="K ]00
M>A!Z@U[LQLK%W#&CSL"2.;#E0/'(C!T=&%U='6ZNK"Q5E)4CL:V=4^RDL$?^
MM$"R+0$B/2!^BH)RB!'2/_S)8Q# (> %. AY<"-(BU5P;_34PQ7-,4JR>Q=:
MJ2ZJT] D3"0$ACOF'@3Y\2%#A9N/'2#T0+P(#P"GAX@8/BG=KW48X&/D7\GP
M/ZOT^[\U8/R7C+9K'/P+?,VNR_K^\'];W'O[CWQK=M/%RQ?M?,%&[MF[0 0$
M# )%$'+=8H@)3 /28AP\0'@0S*T:X$D9Z=P01^2WC6L)8F75!.I!L0RL.X[$
M$'H1X$'OV-8SV7LV[8[<_4E)?3M42?+&%196#"2K*2QQ$1,=5E77\6Q,<YA$
M3&]/J'GD1YS)<7E_)L.+RH<R70.VJSG[6!(M[JUIN?H_Z8;MD?,YNS8OGGN8
M]<()]ZPLB_DJX.O-&:AU4)CZ\US5:LZ.F*2DDPCB*S*B(@(&36G'XNY=1,W/
MB45^D>1Y#QR.S]ZW?=.F?DRRI>^DM\/V"P_(*R/8.%<0XKUX[MN)B2VMK1+R
MD>PR.6DM[M5JM#WK;K?Z,T-.V&",LA:;/(MZ%4Y!$OPQ4S,L9!ZZEO4Y ".(
MB"C7:S<?'AX" "'2(Y+\,V:/>M]C@GM\M$IE<?K*I T_0S,H)M;23:YZ5B?K
M/S3)X+P*?=<$D;IE2KBP-^I+(&8R=?&.)'=>OW]'@:U*_3&TE_/7W:T?\39_
M/5G6I7&S;*"Q#+(G/ *I$K;=<Q@,0QW5K<M#])Q_6)(J>8 .;0]4-\&Q\1F6
M VR<HB%+=#9A\9 []$##W$BO)_X7N$?VV]7,-\M->W[8#F3:NMS%;R0?:6F9
M#UZ$!JSW^MWM-B[LNB=+-'157,(27V58FW6!BM@EUDJS5/4$HB8JAD8^7$Q1
MX,"9B#QP8.<#]#MJF6#/WMA9&*0H?;I_:2?5UCMWN0?96^/QR\J@DS-CX7 P
M,T2R9DP]@<B*$'V$A)^_4 @_I5KJ[:/V&_:IN-XZABP-_= )@0RH)]9/4$@'
MX#KX$?,>,V/RLYWR=L']Y;W]Z\Y>D8V$[H#OW7%#?%;J0+@]#] (IW+!1/VL
M<A11.,7R;Y8#@0%>CU#='J= F)U<>? CXYSQ(Y_R8^?_ 'OY/RUU]7EXZN\/
M_ +C&L;7]ES8GWV/@3^:KY?2&VDQH/> -5D7!4([;E0LE)8F.8A&X6)BZ9VV
M"%4YA H"X:P#MHD <B99V0H (F#C'_6':9,_B RXP2^),DIMW"-\#GZ+NA-O
M9<]!6>?@YY5!L'JV-HRF"P;O@RXZWL 9D*SQF_M(ADC \2XMU(JZ/UI]&A3]
MQTO=D0P*C%;1@C0MA<(D$$OVRJ)$D$EW(@0"D7E*TNV*3QY/\B<?$0YR,]$]
M\^;V>?8IVO)BMJ0?^[D/4#_!<'ZFMXUE7XU^#_PCF.!SC#2V+ND'E3$6 ^8@
M L3[WA*@#N?+;WUG+]&_N*?;*TI-:9LTHH]L6EGS)"OF7$!75UO-IJ?@+0QS
M*"HO^SLFS=LR\% B++Y1,/$!',$]8^-IM>^1[SC+IQLX,6MV$R6UGV?&"K?X
M6KPK>_X-_4;(Y/P:?ANZ2M+N>R.JQ%NYPY;^2M[W/DNLD=^EH_*'@:W*YIZO
M8M,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4JDR91_5&X\/B+S]O@(9=8
MQ[BK++'8U%9M'UXB03#GJ^64.3CSZT0]<O'M\TLOHFTRJWOJ)S4,F)(H[Z#^
M3K_-5N$.# F(#^D #S]GGDN_1@/?6+Q]1]55MJ7@Q@Y]W'/EX<_OY:M5]!]Z
ML,^^FK:T>ZAEY>SP44O;#$(TJ\J?U6DF5=L;YQTW3=-B\+I@P(M^K<"5$3=(
M"<@\#F9<"R=TCWE(L61QA=3(HL01]#>_Q%S[JT%^)+9>(Y/ LC/WC&@;?@ N
M+*;K(&7XF4,HZC0&^%[(>@+#I7G2?:W+*V]2<4CU"1:,2!1=NWKKYM9-HY,L
MUCD2+ DP10<%<*&.LD14Q2$$ICD$_5GH%G4$6M<_77S.@>5<1X@'$2DE58 7
M!\2UKGW =/::B\RZ@JPZ4M$L0&*#MFNU"0B)PT^Y9LT4W: R;)C I.^IXF5X
M8%%$C>J4AS /P%SFX8>-O>"*J)!ER.N#%HUZU/0KU+>#,6 4>/Q$+]==I2NU
MZ)KDK-V-[$RL)+1C5W95GT"\D:],L1310BIEY7$F+T49@[$Z2:JR#,A%DB#^
MB9(PAUNI-NIZ^T7_ #]OK_)5U')G23(F*1%.I^%EO8>)&JUP!UT_D-[BL.-B
M,ZE&RH3$1-5(C&3FTU6L1(.A:I3,L9O%R$<O$O91PDYD8\D0@0 (T:.S'1$
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MJ8V61=0(JMC@M&NT8\3K..4Q*F@O(NF<:\;C\0@ * OR4/U90Y$,1W'!W?#
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M^Y^7(\G3I#BPJ"W6X_:9,A2) +V'Q$WTAO(OXDN/[]SC)P>-3>9!Q8Y./!
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M_P >"OIQ^!\/_P"G+UU!ZH>+=/I_@_)+_P U7I^E:@4VE-A#T@83;7=\A_&
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MB B/Q!QEC(@=;'O4U#(8WN.U2$ABG*!BCR4P<@.6!!!L>]2BD,+CM6.6G_\
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MBE,4IBE<*Z15DS$, "/ B4?<;CP$,[HQ1KUTD02+I-1LY3$,8A@X$H\#^3)
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MDQ<3(DCR"PB*HQ$A07<)8'5I NUNUNM1NX<\X7M,N9#N>ZX$$VWB,Y*O,BF
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M./DQ4;>BJY20 AC"DH!<=W-L'-X'.<3)W/(VU-RQCDON%_,6,D*1 >HM<KJ
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M<(Q!95,LCZ=5A<K8D=+V)%1K878'VB[2NJVPKMI:NREL>N0>2L@V<S$,A-O
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M*L#6R^A:WJ>MXG\)J[ 6Y5.DSQ^X,5Q)2*I"](*O7700#<!^BF0I$4^1Z"%
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M4".CP-U@Q9@;W@V0#]X@9QJ<]V8_6:Y$$ [1I?\ P1_17;*0A X(4I"\<=)
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MH4XKHIJ%5*)3&* "!@$/,,IF.18Q*RL(F[-8V/ML>Q]]JN5R<9\AL5)(SE(
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M'.<QC&,(B(B(Y<\R!&T(" %&2G0=K>7)8 5DWJ)J&Q1IV5<N, #L (IK >P
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MWDV[AJ\52Q =\&Q6RKM9-9ZZ^1 '4+UO3\M>DOL^/PSH_/-_DSI]Q<P_,9.
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MOWKIX\7^-=T\?.E53FX*7J/P4I2@ !AN[;IF;UN$NYY[!LN5KL0+#H   /
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MC>Q!T2K>2WB#T938][]K&M"96)'N?H#N>?+&YV'>O4]IX20R^=BS21PZP.C
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ME417]R3DX\B/ >/0X-[?Y8_UP<7L#ZQH/1@.GT#^>H+/Q_*;SE'[-CU]Q/\
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M?L:;=+R0S"96DBN6 8I_A1B*KF],6HJ)%.HFDF.Q]YWO$V3EV3F;QOBC:%A
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M'B""01X_76 Z.YIWMS[<.[WL10.Y4V;#;E/IK04(Z4.:3G-==P<D\".4BD^
M<'.G73/Y %D_!)U--"< 8Q><_.R0<BY-L_/3;^%OA_,Y;#[JS8BBX8^%Y-*V
M-M0C8];FVA5YIG^G'IQS#T(C+?VHAWL[?M,1/[23#W>1S&4%KD+!YLNI0=+9
M$:DZB#6^;MXT]#Z$TOKG4L(D@5K2ZO&Q;I=!(B02,R*7S4_+JE(4H"M+33A=
MP81Y'E3SS0_(-WGW[>LG=\@_M)Y2WT+V5?\ FK8?57N_T^XCA\$X7MO$L)5$
M>#BI&Q MKDM>5_I>0LY^FKT9#UF-,4IBE,4K'?N\#GM/[G0$ $![>]S\@/'
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MYG!>8;K_ &739TPH9@ZX^1'([3*RHS*9 ?OWM<AF(7L;]Q/\RVCUS](>*_\
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M4HW&'@YNY9D>V[=#)-G3-I1$!+,Q\ !]I/0  DD 52FR(,:%LG)=4@079CV
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M[D:M&U/9D?).&D%/,K37):!F)"O6.M62.3<(LIN#FHQ9)RS>H(NE"ASUICU
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MLD%2Q9&6P!O8:2&O:X/:MF;!Z-/#ROFVY\HDQ<OCW+5QT\E0X=4CBEC?7J0
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M3>-[D\S*?HH LD:"^F.-?!5N?$DDEF)8DF0P<3$VO&&+A@A+W8DW+-XLQ]I
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MQ@=M1EA'7&Q:=6)2ENT+;4V7XU,TZVUQ_:+:U.9[  H[CW[1PB0_RRB*B '
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DF*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2O_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>tm2227887d1-tbl_exvivo4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2227887d1-tbl_exvivo4c.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ OP'( P$1  (1 0,1 ?_$ -8  0 !!0$! 0$
M       &! 4'" D# @$* 0$   <! 0               @,$!08'" $)$
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MS0,ITH'#3JRS/#?)BP9?'(T!(1QDUV%R+CZJS6,H*:>N5H"5>V6+B,\F-9%
M9HXUFE([ICW217B)'<6\$57*)D3:H=[Y6QME]ER8FNK0=M(L[J '4(S8GH<3
M.M_34Z25D3@K!A5_Y$[V=SYX^5=MR8B)(\_V+'EP(978PR-/''O'PYTC E*6
MAD42H),>>[RQF,UKW5>0V>;;,X]*C/>"?4ZS4#C?D2.?-&"<%8^0X-\F*Y)D
MI=-FQ2D21<<%,A%DVS5=L4S::.*8AYAQR3+Y:Y>PX,DM'JCGBFS86!.M,.\
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MKSA*/>%.*KL!0<M4,LVGD39I)L3.RBY$VX*C0KKE@ .4T+8YR$31K5!V@<S
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MOQ4]=J[_ #:O]*Y_AZ>P9/O1[H_'3Z0;7[]OT6_%5;'V:(DW)6C-P=1<Q3G
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ML64,25M>P4@W%QQL+GA7Y7OS!^.5G6HIXE_?%X&\1V#W2MU_ZYM9Z)1I7DC
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MZ;N3AYB(>@0%F<C&/7T<\0.!DES"!@+8<K&]EE[+M(Y!8$,C:E((OXB".L,
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MGT5W?PX?\YA_]^GUM\G>]WK^B;U\WT]YK%?^AEGX>.0?LOT^BN[^'#_G,/\
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M[UN95TBP6DDP [20:*K,'Q=C)JB7H(:X;YRAA9^$NZ;1(N1@.MU=#<@#IL;
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M:K*:4K&&6+NE2:LY=@Z3:/'23DJ3E0W0#%HW1%:0DQ'_  E9-_(/^$YRCV@
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MF*+))=RIV=Z[<%1[U=4VYE53&.81,81'2>Y9\^YY\^Y99OD3R-(QZKL23;P
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M+27(1"^6"-I=+8LH9@YL+HE?.HRA2M2$^G(4ZH"@*U^/W=-+VJC6YGY#B%/
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MZR-'OI%TA#0R#)1Z!0,Y5?.EU_)\'-QXA-D02QPDBS,C*#J!*V) 'I $CCQ
M)'146#S!L&YY38.VYV'D9J!]4<<T<CCLV59"45BPT,Z*]QZ+.H-BPOH)<#(?
M_P! L^>C05*S-*M"J@.V_?AB_''I05.@1#NC3I51+OV["7?8>S6^\+5]7.W=
MK;7H/N=O-I_Y+7\]?/+?#'_^3',OLMQ!VRW\OR?@]I>W5VVHB_BKL]']?@&/
M>@4%/!MN\ F_0!^Y)U@7?<>GJ\G]VM&RV[1K=&H_AKO/&U>S1ZK:M"WMX;"J
MS4%3J:4II2FE*:4K0CG89<*'(@CN(^K:_9V"4$S2[('(@!O-W\/OO\O8']VM
MB=WVGY075^U_^4V^_7-_VBC)]&Y>SZ?93[G:IJ_Y:O-'MCVF_ESXEG*O95*:
MN%(H,5(VE!FJZ7KB4Q.LHBY6)(BJ*P=[7"NWDAT].SGPHH(B!EDAU9^8XL:;
MO&R(MQE6*,[@-(+1J)FUKV&+\("/]6VC&&FT@,H92&%95R!N&X[;]F3:\SEV
M)WG785$LB).[8<95AF[B!"0P^34[;/8O>!QCE'5D<"HO'$2Q1>*/+TJQ6.%G
M+AD:EUVXQ,BODV82LZE@R),5^2BY9&YV6P1LJZBH@)5NC)D034!2IJJ)*E-9
M(SNHMS3;YMJRGS3BX<+21R]NBX<9>6V+%$K,L*W;+*XV)I8F71E11QE7PR12
M\O2[OM'->U#8VW+<<XZ\9\.:3=\A%QVFW&7)(27+D71MJON&X"5%6 2[5D3R
MAH]XC6LNY%3G$K7FE%.8C)"RB_@7S"1?9]F*Y#57&DFVQO#OH!_C>)R+231E
MC+XF3<QX.#,8U^[<ME59(AGJB*>&Q[?GR1QRQP3-%(2$(1B&(O<*;$,1I-P+
MVL? :Z"GYDY=Q<B?$R<_"CR\95:9&GB5XE<H%:12P,88R(%+ !BZ6/I"]LQ%
M7K%&B_=VO)[-U/MY;&$)68ISFQS/DB*<AD^PY5-$/(PUHD8M:PS&$F#%<[@P
M.'4BP9'Z5U6I#',;;\]5U''F"68W[-K>BPC8WMT+(0A\#D*?2-J\CYEY<DD[
M*/<,)I=2+I$\1-Y(6R8Q8/>\F.K3H.EH5:5;H"U1>/J$C:Y^Q-7N3$#4%2S2
M]F(NCR+GD++)RMN@,@$KI'3FGY%]$K5=O(V&"7KATVL*Z,B1,'#0ZD>R=*QO
MMFY1\),:=6X],;#U39NE?R;'5X+&]JEP<U\K9(+8^Y[?(@T<5R(F_6@&/H<_
MK RF/WX(*WN*B]L@+XPJZ4/3,J0#I*3HU?L$7-N>0+][/,<P/ZC Q9+,UEIK
M)<<V5J<O.RK-ZLJJG,%5<N6XM&6\BNN'HVK<]1'LV1J4D$=F_#3JN#Z/ C0U
MQU:6OZIJ \W\IZ%D^5-N[-U5E/M,-F5^ST,IUV*OVT6DBX;M8[7UK>.?FPB@
M$7@ Q1*$@6SWHS<2]CDK,(&)\6*8E\\$0=>%Z_DZ^[^7;6U.Y_5VNXC_ *?9
M17\%];6\]M7FO7(GVT.S&)RR1;VH9>9I]]I[&/5;Q:NSOX]/BK<3 XJ#37G7
MOTA87H)=@!]'X"+$=MNT0[T3>7MUA',-O;EMT]D/PM6\^[G5\A2:NCVI[>31
M'_QO6?X;[P1^:K]D;6.S?JS6R\#]Z'D/X*ESGZH?G!JW2>K62P^OYJM^I-5E
M-*5QYYPF3"WUT7O;&!?41DNL#&3\*5Y! L"@% 5!3!EWVX!_AW_NUQ=WZE?E
MK',_[K\HC7X-.J*]^NVG5T=5=[?9P5_D'+&/^^?)A[/J.HK-:U^%]>GIZ[5V
M=UVU7SXKX*F0@J&(0A3*G!14Q2@45#@0B0'4$  3G!),I=QW'I* >0 UX%52
M2  2;GQFP%SX>  \@%1%F8 ,20HL/$+DV'@%R3Y23UU';A*6*%K<I)U.K^NE
MB:))'C*QZ;8USTLJ=R@DJCZ:DDU6+#N6RAU>I0H@;N^D.TP:MN\Y6Y86V2Y6
MT8GMVY(!H@[58>T)8 CM7!5+*2UR.-K=)J[;!A;3N&[P8>^9OR=M3L1)D=B\
M_9 *2#V,9#O=@%LIX:K] -:M\)\MY?R_B6/L65*YT*'=V<D=?O3%8-ZW'8WR
MVPZS#U6KD;&! >JS:,18=ZH39]W/?!N)S&'5/<=SASCSERA'N7-F-9B\X3+[
M2#_4%<O(C*=A"B=EV"HL6HCX73KZ22=T?:*Y%Y#Y"YYEVGDG+NH3',F%V61_
MI0^%C2A_:9Y).W]I:1IM(/P.OL^ 4 ;DZW37/]-*5R!SX*(<\FGA1V$V/*Z$
MB"8GV%V$'>S "X?HB?P8-1_LV GRZXU[P]'U^KV/3\FPZ[7];LLKI_R]G_RU
MWIW8ZS]F5^WZMUG[.]O5[;#Z/%K[3SZNJNI-6[P:S7!5#97T%$=X ;; IZ/;
M]8!L(AV&W\G9KK#:-7R5BZ_7]GCOY="WKB[>M/RQEZ/4]IEMY-;6J_:N-6VJ
MAK]8/S!_:+J./UO-4B?U!Y:K]3JI::4J'S-_IU>ME+HLU/,X^VY$]8_4J#6!
M<7=A]48U*8LG@A31.@'HF,7(LIWAR>:;S=Q[-5L&W9N3AS[A!&S8>-H[5Q:R
M=HVE+\;^DPL+7JQY_,NQ;7O6!R[GY,<6][IV_LL1OJF]FC$L^BP(^#C(9M1'
M \+FIAJBJ^5S]@.=&#)"!IT[9(+U6A[_ (.=9AR L[K]G71A)=2PX.I<11D3
M.:+&-\E.[!8\U),4'[0W0)VB8]T*;HIT8M)^_7EZGZ/,?CE*JPI(,;9;5[;#
M-3QWJIB&_6<KP)><R/3TJP]=Q%6>-&<RXL&%)]B=BY43'KBMS?1"D<WEC2XJ
M3T?E9QRR)=HW%5+N+&8G+!#LIV'9IUV:90DR2<J++):;%F_D(EI&N)M6FRZ4
MLLUW[XB1E@.'?MW2:*Q'&EQ6#+1S2A(>4OL6^PZS?7:N<BZ=A"OQ:UE:==MH
M\_(3L4KEEU+J5)8T SAR5&Z)IQ)TW0KN88C<':8R1#)>Z>OQ4O4DGN;&$E(R
M7/68P)T\%*6R(R!%6V#L=*<U.,:87S?FXDI.1+VF3$VLVGUL)OV3EB#+TDV5
M4466;&52(V<-)I<5-WO++C\X<OX+P]NG57$A L&+)AA^_2S>ZKRDM8H2N.ZC
MT591K<HI:9H[Y)%^S%=DB1J5P94C4R2YO+&EQ5*\YT<<HX2>D+-9(Y-?&LUE
M9BI(X^O,>>3J==H#_)\X>+9O8!"1?R,538IXLN@FB84WC-=@(A((J-2M)I<5
M*XOE=B:8F6]:8)9'5M'IPL#-5@V(\F)3],<.'-;;QC^^QBE6*XI4',EN,6X:
M/I(&[55DZ,ZZP;-7JK98TO63,;Y8H^6HYQ+4247F(UJSJ[MR[/&R#!-N:WU.
M&O$/'KE?MVRJ$N%6L;!VY:'*5PT(\2!8I#&Z="+5[61]>4II2FE*:4II2H1,
M?>+C]S]@EJNA_5C[NNL>SOWI_-^ 5QTY[5V;K\FQOU>3$)JD7"!O<$H.Y0*Z
M(]CY9DOWA2[IE+;81NGN'D\OE#;6[.[S)@R8FV[)/P$\#Q/Y+%2/_P!-V-<+
M_:1VO<-LRX^9=K'^OV_.AS(3^<'21#?J_P!3$@OU=/2+5U9;,<3<F\7U*T24
M#%6ZH7&O1]A@SR*!!?Q[:9;-72[=%ZW.1]$OR&3!L^225((F3.@J!B]1!TWE
MINW+^=E;6)9L?)0O%(8W:,]:ZE92&!L=4;J0RDAT(8 CM7;7Y/[S.7-LYFEQ
M,3<-HR(H<J 9$4<P75HDT.CAEZ5$>1"UTD >&960LAGM.H=,Q]%!"TFLPU8C
M-RG4;0[%%IXE4H" +O5B%\0^<[#MWBQU%!#Y=4>7G9N>XDS9I9I + NQ8@>5
MB?/X3Q/&K[LW+^Q\NX[8FPX>-AXS,6*PQI&"3?B0@%SQX7Z!P%APJR.,08M=
MF.=S0*HJ=5>'<JG-#,@.LO7JZ^J,&JL<J0&6/$U>3<1[<3"/=-%C)EV*.VJE
M=ZW9!9<F8 !@/2/ .XD>W@U2*'/A8 ]-6R7D?D^<EI=LPF8M$Q/9)<M# ^-"
M3PXF/'D>%+WTQL4' VJHCL58SB!5&+H-0CN_2A4%@95^,; HC6XX\37$3%2;
M$**5?BU3-V)?(T1,)4N@!$-0R[ONLUNVR9FL6(N['B[:G/3^6W%_?'B;U,Q>
M3.4L(L</;<&+4L0.F&-;B!#' ."]$,9*0C_I*2$T@U506.*'6&ZC6O5*"AVR
MK*,CE4&$>@W248PT4X@HIJ<A"@4R3"&=*-4@']% XD_1[-0Y&Y[AEL'R9I'8
M,S7))XLP=CYV 8^/C4_;N5>6]HB,.V86-!$T<:$(@4%(HVAC4@=21,T:^!#I
MZ*M*M2Q;CE.6R&:O5JLA6X:U2TI92L6[92*A7IT[%;G)G?3U-FCM:+*Z==(@
M4QTQ./:)A&:,S=MS*;;VDLO:O&JI<G4P]",6ZR VE?$;50OLG)W*J3<T'%Q,
M08D&1))/H53'$Y$^2VK\E6,8DDM8$@L>)-^&G%XDIF;,N1,L/V2S93(MPE7Z
M+9<1.>/;7*Q'G21H'$PB4]:K;=JV./E @!L/:.M^\V&'8]DQMGC8$8T*@D=9
MB31J_P [EF\M?/'N@7,Y\Y[W3G3)C96W3.D<*>E%RIS,([_^! L:'KMT5W,
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M6G&D1+EBXZXO+"X2F;C4'22"*;0[@K0R3A4B8'$A;_\ +,%F=HY5A07+'38
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M<]RK%RAD3M)@Y;G3%C2RL2T<C'T4QLAR75R0L&094D.F0&/ML @8 ,40,4P
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MS@U;I/5K)8?7\U6_4FJRFE*Q/F&C)7:J.FX-2O'+1!W_ ,02]7CX]VB*,DP
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M21:>95C4,@EM-N(F%4:1!-'CENCU,0,HHJ0OT3J=61(B?PVY=C,89F (IB
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M ?(3CFW^8 56ORU]IK&C&2_+,+KQ)1<C 9U\H&XB_DC9S?PU8V'+W*&)9MG
M9=HU^QB]<*%2:ISL?*M(Y^;8@B6+8V1N6(F$BEWZU(]ZY,4 $H!U%'51)R7M
M.\P-D;-D8^5&!QT,I8?XBAU+Y'5:MV/WX<W<E;@FV\\;=N6T9#&RB9)%1^C]
M6DZ]G*/"T,LA'$ 7%=#<4<DJED-DV45?1Y>_$J2<HR4.# 7 @ ^'?MU_^5#N
MMC!YJWF]NXB4!#?6N\<KYFVR$!6X?DGIMX01P8>3[]=/\F=ZNR<SP(SR1#5P
M$BGT-7O74^E$WB;AUW'"ME/+VAV@.L6K:U?NE*ND-]X(_-5^R-J5-^K-5N!^
M]#R'\%2YS]4/S@U;I/5K)8?7\U6_4FJRFE*:4JP6*S0]68&D)AT""8B)4$2
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M#7$WZ2#9%S'(C)J.'Y4T?+5[>L?H?F$.)%.86#'L8QG*J61E5*LURJP+!2\
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M'28?68V_\)B7M^SD9CP6N5.X7FU>ZSO*S>[C>Y.SY:WV99,-V/HIF$".-;\
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M1\]\C<W]W_-Z<^<AR&#F2'42 NJ/)B8@R*T=QVL<NE>V@N&UA98V694>MV\
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M[X#K%^&H#I!]8=/2;<O=]G=%C<PX+Y6*@5>+(P!^"<\2K6XB)R 0PXQO8CH
M:'\?.>D[B@[/$/+)":Z(<B<? YD(T=2[AQ')B"+(N06K%)9X_P"[(7H+/,DU
MR+E*!GB::A5G*E;S)W>X^\!MZY.*7?B^-<* W2>Q)L!X>R8@C\@D646/NR^T
MAN/);1\C]]*Y&F !(=T"M(2@X)[:J L]AP&9$KAP 9T5@\K=:*G<JC?(9M8J
M1:*];X!V&[::K,Q'SD6OV 82IOHUPY;&.4#!N7JZB_* :T[F8.;M\YQL^*2'
M(7I5U*,/,P!KM39=^V3F/ 7=.7\S%SMM?U9<>5)HSY'C9EOX1>XZZDNJ6KM6
M&\M\@<.8-C1D<G7V"K:ITQ48P9G R%JF3;#TI0=4C"/+!+G,(;;H-SD)ON<Q
M2[B%[V;ES>]_E[+:L>247XO;3&O^.1K(OG8$]5S6"<[=YG(O=YB>U<W;ECXC
MD72&^O(E\46/&&FD/^!"!TL0.-<7\U9\RGSAGTZ96(A_0L#1,FU?+Q<B5NI*
MV%TR<$<1TU?'+-59J55H<I56, S<+)%7Z5G*JQDR"VWEL7+NT<A8YSLMUR.8
M70@,M]* BS+$#8\>AYF -O14"YU<%<_=Y/./VA=R&P[1!+MO=Q#,KF-])DF9
M"&27,925NO!HL.)V4/9Y7<JIBZ+\<L&QN,X"/<'8J-5D$3A&MG1 !Z4[DHE>
M3$D/201DY H](%$"]TD/3L =)2:RYGW^7=<AE#74GTB.CAT*OYH^^>/C/4G=
M9W>8G*6VQR&,I(JG0K#T[MZTLG1\(_1:PTKPL. 7:36)5M^KI#?>"/S5?LC:
ME3?JS5;@?O0\A_!4N<_5#\X-6Z3U:R6'U_-5OU)JLII2J"4C6<Q'NXN02!9F
M]1.@NF/8(E-Y#$-V]"B9P Q3>4I@ 0\FHXI7AD$L9LZFXJGRL:',QWQ<@:H7
M6Q'W=8Z1X#7'OD[QJN=9N,9D_&$D_KV0*Z]+,P,["F3;.Y!5DF9(CUF94AFB
MLH#(XM7[!P4[:0:'%(Y3%,'>[MY0YMPLC"?:=V59-ME72Z-Q"@\;'KTW])''
MI(PN+?D\-]\O<_OF'O47.7)LLF+S5B2"6*6(A6<H+!TOZ)DT'LYH7!CGC)1@
M;^GL%@'\Q.B6E-K3N0/@</9&:=+%S-2AE8_&UC>)#W2BS6;D#=--D%3E$5(^
M7.B"9QZ$7+GY+/S#W;9^,3G<MZLW;&XA%L9T'38J/UJ^!XP;CBRK68]W'VGN
M7]T"[#WG"/8N:8_0:62Z8,[#@2LK_NKD^M#DE0I]&.67JZ/LWK.1:MWT>[;/
MF3M(B[5XS72<M7*"@=2:S=P@8Z*R1R]H&*(@(:UDZ/$YCD!60&Q!%B#X"#Q%
M=2P3P94*Y&,Z28[@%64AE8'H(87!!ZB#:JG4-3:U0SIS.P;@I!\PE;,WM]]0
M35*SQK27#6<M2KPH?1I30(+#'U!F)NTSF56:DZ2F[H%5 !,V7[!R1O\ O[++
M%$8-N)XSR@I';\VXU2'\V,,?#8<1IGO#[]^[WN\CDQ<O+7.YD4$+@XC++D%N
MH2V.C&7PR9#1BP.@.UD/+5E"Y>YIY2C<G95:N&%59=XTH- B5G!X>+CEC$.X
M90G?D;JOW4F"!3R\XLDF9P4@(H D@F4J.TLC,V7D;:7VC9B&S&XS3,!J9NHO
M:X 6_P '$"=-]378W;E/:]CYW[^^<(N<^>$:+8X[KAX<9;LDC)!*0Z@I=I+
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M/(>!(K1K+O":M78[MVV9-I!5<A@%RBHWBIXQ>G8$W*BB1X>7$I2@ '<D 0
M    [<_V7GS*P $9BH'4;LGF_*7R*:YYYW^S_M/,#/-%&DKL/6!6.;R,2#%+
MU<7'B  K4I+A_F+'HG:8YR5ENB,A,?NXZJS%_J; H',7K*"U&LS".5 P (B!
M$"AN =G;N&8GG79=R]/<\7#R'\,BPR'W)8RWWZTJG<;SSRP3#RMNV][=!<V3
M'ES,9./3QQ,A$/A-D'0/*/%YQ0SK>DQBK[E?,%RC% $BL599W)]TCU4! 2G3
M5:6VTKQR9%"J&*/6F8O;V@.XAJ).<.7]O/;;?AX4$H_*1((C?RQQAOOU+G[F
M.\7F-/8^9-ZWS/Q#P,<\VX92$=8*Y.04 -R.((X]!O6Q6)^!\#6CM'+^,;H&
M;B0Z3B<\)(+("'28#1\%'E2BFPE,&Y16^F2'R".L9WCO"R,H%(W)OU)<7\KG
MTCYN!K:/)?V<MMVEDFR854K8AI=+D?X(4M&OB+>DIZ#70.JTR"I[06\0V^F5
M*4'3]P)5'SL2^3O5@*4"I@/:"9 *0![=M]Q'7&9G9&:^J8^B.@#H'W>$\:Z8
MV?8=NV.'LL)/3(])SQ=O*?!XA8>*]2S5'5YII2FE*:4II2FE*:4II2OA1,BI
M#I*D(HFH0R:B:A0.10AP$IR'(8!*8ABCL(#V"&O02#<<"*\95=2C@%"+$'B"
M#T@BM8LI\8J;?VJI$F+#I.8ZI8N1(KX1%4X;&4BY!L(2,.H;R#W8B78=@Z2]
MFLKVCFO.VYP69K^^7IM^<#P;S_?-:CYP[H]BYEA94CBL;GLW!T@GKC=?3B/^
M$D=0L.%: 3G ZR567<S5$E;M3));ZR3K"ST[U4A!,8A1FZ=)0DL5NGU")>_,
MH8O;OV[ZV-C]X6+EPB#<$@GB'Y+VM^A*K+?R6KFG<?LX[IL^<^X<N3;A@9;=
M,F.7UD=7PN+)%)8=6LDBK:OQ[Y121#L)//F?'\>Y^C7:N\BYQD47!0'J3(M'
MN[>+9<!4*4>DPB #VAN(!J:O,G*<1[2+;MN60=!$.*I'G$=Q5+)W8][^6IQL
MOF3F63%?@5;.W9PW@!1LG2W&W U+\>_E])E?FDYQG)R;MTJ59\^G!+ )/%3"
M43*R:?>O;*^4'I#<3+&[ V-OV:HMR[QR8^RQV1$ X!/3M_AZ$'N>2KWRQ]F5
M%R3E[@DLTSF[O+\"&/AD%WG<^5ST6/571C'6#ZG0&[/NFC1RY9%#PB*#-)G%
M1QOTA,R8)AT&6 W;WJFYA'S@ H[ZUEN>_P"9N+&Y8*W22;LWE/@\0^_74O*W
M=]LO+42=FB/+'ZH"A8T/YB#A?\XW-^( -9JU8JSVFE*ND-]X(_-5^R-J5-^K
M-5N!^]#R'\%2YS]4/S@U;I/5K)8?7\U6_4FJRFE*:4JV2T/&SK%6-EFB3UFM
MMU)*@/FG ! JJ1RB51%8FX])RB!@W[!U,AFEQY!+"Q5Q]WG'BJER\/&SX#C9
M:!X6ZC^$'I!'41QK2;,'"ZJ7X5W2+)N_6.F*::_>IQ=@22$HD!#TB5,6$HB0
M!'I*[)T% ?((]HYYLG/6=MMD+%5OT>LGET]*GQJ;FM"\]=PVP<U:I6B628BP
M8$1S =%M=M$@'4)5(%^CKK2@>#F2\?NECXUO>3* 0RBIRHU-Y;ZL055NH%#J
MRF/K#$M'"JY3"!S @ F 1WWW$-9^.\3;-Q0#=<?%R3;ID$<G1^;,C$6ZN-<\
M/]FKF3ER9GY1W3==L4DD#';)QN)O<F3"GB4D]9T GCTWKY6XF<@[87T9;\T9
MKL48<!*I'2]MS!;&:B2@;+%4C[#;Q8 53I* B8IBB':/D !]'/'+N'\+A8.#
M%+X5CQHSXN*1WJ!^X7O'WD>R;[S#OV5AGI27)W/)4@](*3Y6CCP!N"/#T6.>
M\1_E]5JKF:KO89L0J)@4*>=(Q5;)FZ@W49UJ+(FR$X;=@.S&, AN!O)K&M[[
MRLS-!5)#Q]Y>_GD;C^C[E;/Y&^S#R_L)22;'4E3<=L$*@^%,>,!+_P#F7/6#
MT5T6J%$@*8V[N,;]X\.F";B2< 4SM8H;"*9!*4I&S<! -DR  =@=74(;ZUCF
M;AD9S7E/H \%'0/QGQFNI-GV#;]ECTXJWF(L7/K'Q#J \0\]SQJ::HJO=-*4
MTI50U^L'Y@_M%U''ZWFJ1/Z@\M5^IU4M-*5K_P"\MCK\.<@/A.Y3^QK61_1;
M<_VNW?U# ^,UK/ZV>5OX7F;^W.8?FNGO+8Z_#G(#X3N4_L:T^BVY_M=N_J&!
M\9I];/*W\+S-_;G,/S73WEL=?ASD!\)W*?V-:?1;<_VNW?U# ^,T^MGE;^%Y
MF_MSF'YKI[RV.OPYR ^$[E/[&M/HMN?[7;OZA@?&:?6SRM_"\S?VYS#\UT]Y
M;'7X<Y ?"=RG]C6GT6W/]KMW]0P/C-/K9Y6_A>9O[<YA^:Z>\MCK\.<@/A.Y
M3^QK3Z+;G^UV[^H8'QFGUL\K?PO,W]N<P_-=/>6QU^'.0'PG<I_8UI]%MS_:
M[=_4,#XS3ZV>5OX7F;^W.8?FNGO+8Z_#G(#X3N4_L:T^BVY_M=N_J&!\9I];
M/*W\+S-_;G,/S73WEL=?ASD!\)W*?V-:?1;<_P!KMW]0P/C-/K9Y6_A>9O[<
MYA^:Z>\MCK\.<@/A.Y3^QK3Z+;G^UV[^H8'QFGUL\K?PO,W]N<P_-=/>6QU^
M'.0'PG<I_8UI]%MS_:[=_4,#XS3ZV>5OX7F;^W.8?FNGO+8Z_#G(#X3N4_L:
MT^BVY_M=N_J&!\9I];/*W\+S-_;G,/S73WEL=?ASD!\)W*?V-:?1;<_VNW?U
M# ^,T^MGE;^%YF_MSF'YKI[RV.OPYR ^$[E/[&M/HMN?[7;OZA@?&:?6SRM_
M"\S?VYS#\UT]Y;'7X<Y ?"=RG]C6GT6W/]KMW]0P/C-/K9Y6_A>9O[<YA^:Z
M>\MCK\.<@/A.Y3^QK3Z+;G^UV[^H8'QFGUL\K?PO,W]N<P_-=0^5Y'8]._7,
M6O9Y ![K8#\5^3R9NQ%,.TBF("G#R?*&JR+EC<A&!VNW?S^#X?\ ^IJQ9O>I
MRPV2S#%YDMPZ>7M_'4.H[9>K?[QF/_P]G?X6N3?LBU,^C.Y?M-O_ )_!^,U2
M_6ERS_"\Q_V_O_S;3WC,?_A[._PM<F_9%I]&=R_:;?\ S^#\9I]:7+/\+S'_
M &_O_P VT]XS'_X>SO\ "UR;]D6GT9W+]IM_\_@_&:?6ERS_  O,?]O[_P#-
MM/>,Q_\ A[._PM<F_9%I]&=R_:;?_/X/QFGUI<L_PO,?]O[_ /-M/>,Q_P#A
M[._PM<F_9%I]&=R_:;?_ #^#\9I]:7+/\+S'_;^__-M/>,Q_^'L[_"UR;]D6
MGT9W+]IM_P#/X/QFGUI<L_PO,?\ ;^__ #;3WC,?_A[._P +7)OV1:?1G<OV
MFW_S^#\9I]:7+/\ "\Q_V_O_ ,VT]XS'_P"'L[_"UR;]D6GT9W+]IM_\_@_&
M:?6ERS_"\Q_V_O\ \VT]XS'_ .'L[_"UR;]D6GT9W+]IM_\ /X/QFGUI<L_P
MO,?]O[_\VT]XS'_X>SO\+7)OV1:?1G<OVFW_ ,_@_&:?6ERS_"\Q_P!O[_\
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MI^UVW^H[?\9I];?*O\)S/_;?,7S73WD\=_AW/OPI<H_8[I]%-T_:[;_4=O\
MC-/K;Y5_A.9_[;YB^:Z>\GCO\.Y]^%+E'['=/HING[7;?ZCM_P 9I];?*O\
M"<S_ -M\Q?-=/>3QW^'<^_"ERC]CNGT4W3]KMO\ 4=O^,T^MOE7^$YG_ +;Y
MB^:Z]VW)3'8'$1KF?OT!\G%#E*;Y2_(7#@CJ-.5=S!_6[;T?_P"1V_XS4F;O
M:Y5*_NG,W3__ ,WS#\UU6^\MCK\.<@/A.Y3^QK4WZ+;G^UV[^H8'QFJ;ZV>5
MOX7F;^W.8?FNGO+8Z_#G(#X3N4_L:T^BVY_M=N_J&!\9I];/*W\+S-_;G,/S
$77__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>tm2227887d4-tbl_pipelin4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2227887d4-tbl_pipelin4c.jpg
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M  ( .$))300E       0_.$?B<BWR7@O-&(T!UAWZ__N  Y!9&]B90!DP
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M(95YU6;\,I-C_BV/[[O9*+\['(^"%Q,5X
M                                  %CL7[ZK?OI[)Q9?FAIY'Q67PK;
M@
M
M                    #Z@XO_1JS? :7_<M/+7^*>MV*\T/D52]#OP'LGDJ
M*@A8   $M/W[3_CL]D)YF']4,P-=U                   4ET_B^H_$,J\
MZK-^&4FQ_P 6Q_?=[)1?G8Y'P0N)BO
M                                L=B_?5;]]/9.++\T-/(^*R^%;<
M
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ML<CX(7$Q7@
M           6.Q?OJM^^GLG%E^:&GD?%9?"MN
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M6L953HU$3U$1#8XR<:559'Q6<EG7:
M                             ?4'%_Z-6;X#2_[EIY:_Q3UNQ7FA\BJ7
MH=^ ]D\E14$+    EI^_:?\ '9[(3S,/ZH9@:[J                   I+
MI_%]1^(95YU6;\,I-C_BV/[[O9*+\['(^"%Q,5X
M                                        %CL7[ZK?OI[)Q9?FAIY'
MQ67PK;@
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M;K[O'%!OC4[J8M#*^@D=3M\3JT2*26!M'%331NY5D1NO([E7CIP7[AE7A_\
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M.7F5K:9TM!'1:@
M             ?4'%_Z-6;X#2_[EIY:_Q3UNQ7FA\BJ7H=^ ]D\E14$+
MEI^_:?\ '9[(3S,/ZH9@:[J                   I+I_%]1^(95YU6;\,I
M-C_BV/[[O9*+\['(^"%Q,5X
M                        %CL7[ZK?OI[)Q9?FAIY'Q67PK;@
M
M
M          #Z@XO_ $:LWP&E_P!RT\M?XIZW8KS0^15+T._ >R>2HJ"%@
M2T_?M/\ CL]D)YF']4,P-=U                   4ET_B^H_$,J\ZK-^&4
MFQ_Q;']]WLE%^=CD?!"XF*\
M                        "QV+]]5OWT]DXLOS0T\CXK+X5MP
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MO^Y:>6O\4];L5YH?(JEZ'?@/9/)45!"P   ):?OVG_'9[(3S,/ZH9@:[J
M                I+I_%]1^(95YU6;\,I-C_BV/[[O9*+\['(^"%Q,5X
M                                                          %C
ML7[ZK?OI[)Q9?FAIY'Q67PK;@
M
M                                            #Z@XO_1JS? :7_<M
M/+7^*>MV*\T/D52]#OP'LGDJ*@A8   $M/W[3_CL]D)YF']4,P-=U
M            4ET_B^H_$,J\ZK-^&4FQ_P 6Q_?=[)1?G8Y'P0N)BO
M                                                        L=B_
M?5;]]/9.++\T-/(^*R^%;<
M
M                                          ?4'%_Z-6;X#2_[EIY:
M_P 4];L5YH?(JEZ'?@/9/)45!"P   ):?OVG_'9[(3S,/ZH9@:[J
M           I+I_%]1^(95YU6;\,I-C_ (MC^^[V2B_.QR/@A<3%>
M                                                      !8[%^^
MJW[Z>R<67YH:>1\5E\*VX
M
M                                         ^H.+_T:LWP&E_W+3RU_
MBGK=BO-#Y%4O0[\![)Y*BH(6   !+3]^T_X[/9">9A_5#,#7=0
M        %)=/XOJ/Q#*O.JS?AE)L?\6Q_?=[)1?G8Y'P0N)BO
M                                                   L=B_?5;]]
M/9.++\T-/(^*R^%;<
M
M                                     ?4'%_Z-6;X#2_[EIY:_Q3UN
MQ7FA\BJ7H=^ ]D\E14$+    EI^_:?\ '9[(3S,/ZH9@:[J
M      I+I_%]1^(95YU6;\,I-C_BV/[[O9*+\['(^"%Q,5X
M                                                %CL7[ZK?OI[)
MQ9?FAIY'Q67PK;@
M
M                                  #Z@XO_ $:LWP&E_P!RT\M?XIZW
M8KS0^15+T._ >R>2HJ"%@   2T_?M/\ CL]D)YF']4,P-=U
M      4ET_B^H_$,J\ZK-^&4FQ_Q;']]WLE%^=CD?!"XF*\
M                                                "QV+]]5OWT]D
MXLOS0T\CXK+X5MP
M
M                                  !]0<7_ *-6;X#2_P"Y:>6O\4];
ML5YH?(JEZ'?@/9/)45!"P   ):?OVG_'9[(3S,/ZH9@:[J
M     I+I_%]1^(95YU6;\,I-C_BV/[[O9*+\['(^"%Q,5X
M                                               %CL7[ZK?OI[)Q
M9?FAIY'Q67PK;@
M                                                           !
ME^VF!U&Y&508M35K*":>*69*F1BRM1(6\RIRHJ+Q*<[-W==99ETUYP>[D[>7
MC;/)9,=NSDG18V3T=;&U6QSPOX<S4754T<CFJGJH,G-C,KC!F4FDX+M?=I:N
MQ[86?<Q]SCFI;O+'"RWMB<V2-9$EXJ]7*BZ=5ZG=,*Y\6S)IAS,[96%=;%KD
MV5    95DFWF3XE8K-?[_3MI*:_=8ZWP.>CIUCB:QW.]K=4:CDD3E15U^XA3
M3-K>9B.A9;+FL8RQ4N5@ #=F']FW)<OP1F:TUQBIY*F&HGH+4^%[I9DAYD8G
M,CD1.L5O@\.A44T<SBZTOJX-FN1-JXXM**BHJHJ:*G!44WFL\  97%MWE#\(
MGW"EIFP8Q'(V&"IE<B.J)'2]2J1,3551KD7F<NB<%3I*=[77U.E9NYU=;H76
MR[8_+&W%VW"^6Z:G^2Y7Q?)#VZU$O5I'Q:O.G!>L_:]PPMG87BF'.RKE8UUL
M6OS94@&P+UMC\C[<6G<+Y;IJCY4E9%\D,;I41=8DG%R\Z\$ZO]KW36KG8WFF
M',NME85UL6OS94@  !EEPVZRBTX319]<J=M-8;C4QTEOYWIUTRRQRRI(UB:Z
M,TB7B[375-$5"F,VLWU8YX63ES%<98F7*P !L:V[2U=QVJN.Z3;G''26Z587
M6Y8G+(]4ECBU1_-HG^LUZ#6G/B,R*8+XRL::V+OO%_Z-6;X#2_[EIY^_Q3UN
MC7FA\BJ7H=^ ]D\E14$+    EI^_:?\ '9[(3S,/ZH9@:[J
M      I+I_%]1^(95YU6;\,I-C_BV/[[O9*+\['(^"%Q,5X
M                                                %CL7[ZK?OI[)
MQ9?FAIY'Q67PK;@
M
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M9RYBNLPLO5  "DNG\7U'XAE7G59OPRDV/^+8_ON]DHOSL<CX(7$Q7@
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M[7RSS>-2K#\C^+:<NE7)2Z]?UW'UG-_J_N?=,XS_ /VZF#'=?HUL6L3:4@
M    (XHI9Y600L62:5R,CC:FKG.<NB(B>JJD#H*@[+<D-+0QYAFMMQW(+FB>
M(V:1K)I9)'?]VCGSP\SD541>K:_CT:]WGSQO/JUF8AMQP^F6IMPMOK]MKD+\
M?OS6.D5B3TM5"JNAG@<JHCV*J(J<6JBHJ:HJ&WE9L9E<847I-)PEB9<K
M!T!B'9JH,DPJU9G<<UALM-<X^LZJHHFJR-RO<U&]:^KC157E_:H<[,XR:WFL
M5QP]M#;KP^,8XH[WV5[K'9ZJ[87D]'E/BK5<M+!&D,DBM35S(U9+.U7Z=#5<
MFHKQL8X6C GAYPY)Q83MEM$NXMBRB\K>/DQ<:A;,M.M-XQU_-'-)R\W6Q\FG
M5:=#NDOSL_=S$88XJ\O*UXGE:R-I0        ;GP?L_5&18O3YEE>34.(8_7
M.Y;?-6HU[Y=55&KI)+ UJ.T=RZOYETUTTT4T<SBM6VK6-:6S3(QC&9P8SNGM
M)?=K:VD97U$-QM%Q:Y]NN=-JC).335KFKKRN1%1=-531>"KQTMR<^,V.3G89
MF5-&OC94@  !N?LN>EV@^"5G^Z4T>-\-L\/\2<FX=5MKV@\DOK5<^URWBMIK
MO3MX]9225"\RHFJ:N8J(]GW4TZ%4C=;S)B.G!.OJYDMR]J)]MFV?MM3:.K6V
M55UI:JF? B)&]E3#42\[=/V_-S?A-/@\=[..A?G_  *BBR;-<_VOQRLV9OU-
M0Y%:X8J2^6J=M,]ZK'$V-4_XB*3EY7-YF+P1S7=.J:&,TKEYDQF1R3S)UIM6
M)K+7&^,V?6_%[7B^5YVR_P"27>6%:S$Z2WT:+&]/#:[KX&,D3PE:UB<GAJO#
M@AM<-J3:;5KA$=.*K-UHC"9Y99CCU9CO9@PNTPY!&M5EV45,,MXAA=S/AIHU
M\-41-45M.UZHB?LY'+HNG11>+<3><.:&<895>7GEK'M%[84]@N4.X.+HV;#\
MD5LZN@XQ0U,[>LU;IPZN9/#9]W5."<IM<)G:T:EN>%.?EX?JCF;%WGPVY9]M
M-AV28[44LMKQVT2U]<]\O*KH6TD+EZO1%17)U+FJU51=>!K</F13,M$],KLZ
MNM6)AR(=ESP#HOLH8O3NO=YW"NJI%;,=IGQ0SOU1K9IV.65^J)I^YPHY'?CH
M<WCK\D4CI;G#UY9DKNUC<YJZ:HCQ&TRM615AFG1[IE8U=&*YVOKD1$$<#&'Q
M23Q/N9+O0VGW;V4L6Z=OA:RYVE=;A#&O-U<<KD@J6?MM&2M8]NO0S5>Z5</_
M .K-FD]+/-_7366O?7T"[6?!;=_-C3/AO&OV_>QS?#K[=!;_ .QQ=?A3?YW@
M$_-1[=!_\/MI7S#L7J]R^R_;\1QNIIEO,%5(D[*A[F,C<RXRU'*]6M<J*L;V
MN3@5YEXR^(FT\WY,JUULK"/;E67"J=])V6\[I9=.M@N%5$_1=4YF>*-71?P&
M>9./$516,,N>U58A2T&].PE+MU:J^GH\RQ^9)8Z.I>K4D2*1ZM?HW5W(Z.56
MJY&KH_I[A&9,Y.=KS'))7_V9>'2P[+ME,9VUVXFN6<W5R;A5$KDM%LM\['0O
M:JM:U'M?"KG-:B/>]Z*U.AJ+KTW9?$6S+X5C]*NV5%:\O.R+/_[*6%?#*?\
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MO3X9V8LGQQMRI[I<:.9J7:6C=UD$58^JIGNA:[1->1KF([[NO1T$1?7SXG#
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ME=<[73<OB[XZ=K9)&\K$8Q$2)W6,>QC=>+51>E)IF7RLR*6G&)1:M;TUHC#
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M(X-'1131.;&U$:Q='N1W+HB\.'3K?PF9:9FMIQP5Y](B(F'/QT6H
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MY V:.H;5RMIFLC35GK=(T54<OK]55/6FGP>$VM,_%H7\1S1AS.:#J-(
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MQ6XR8J2Z?Q?4?B&5>=5F_#*38_XMC^^[V2B_.QR/@A<3%>
M                       ,WVNSBVX)D;KC>K+!?[-50.I:V@J&1R>"YS7)
M)'UK7-YVJWNIQ153AKJ49V7-ZX1.$K<N^K/*VW;]S^SGC60R9QCN+7;Z1HLD
MU'2/2*&DAGF:J.5K$J'LC3PE1-&N1NO@MX)IISDY]JZLS&#8C,RXG&(Y6B<Q
MRBNS3)[GE-Q:UE7<YEF=$Q55L;41&L8BKQ5&M:UJ?>-_+I%*Q6.AJWMK3BL9
M8P                    L=B_?5;]]/9.++\T-/(^*R^%;<
M    &7W_ '2W"RFW+:;_ )%65MM=ISTKGHR-_*J*G.C$;SZ*FOA:\2FN32LX
MQ"RV9:8PF6(%RL
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M_P!RT\M?XIZW8KS0^15+T._ >R>2HJ"%@   2T_?M/\ CL]D)YF']4,P-=U
M                  4ET_B^H_$,J\ZK-^&4FQ_Q;']]WLE%^=CD?!"XF*\
M
M"QV+]]5OWT]DXLOS0T\CXK+X5MP
M
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MK=BO-#Y%4O0[\![)Y*BH(6   !+3]^T_X[/9">9A_5#,#7=0
M      %)=/XOJ/Q#*O.JS?AE)L?\6Q_?=[)1?G8Y'P0N)BO
M                                                 L=B_?5;]]/9
M.++\T-/(^*R^%;<
M
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M\7U'XAE7G59OPRDV/^+8_ON]DHOSL<CX(7$Q7@
M                                       6.Q?OJM^^GLG%E^:&GD?%
M9?"MN
M
M                         /J#B_\ 1JS? :7_ '+3RU_BGK=BO-#Y%4O0
M[\![)Y*BH(6   !+3]^T_P".SV0GF8?U0S UW4                  !273
M^+ZC\0RKSJLWX92;'_%L?WW>R47YV.1\$+B8KP
M                                       +'8OWU6_?3V3BR_-#3R/B
MLOA6W
M
M                         'U!Q?\ HU9O@-+_ +EIY:_Q3UNQ7FA\BJ7H
M=^ ]D\E14$+    EI^_:?\=GLA/,P_JAF!KNH                  "DNG\
M7U'XAE7G59OPRDV/^+8_ON]DHOSL<CX(7$Q7@
M                                      6.Q?OJM^^GLG%E^:&GD?%9
M?"MN
M
M                        /J#B_P#1JS? :7_<M/+7^*>MV*\T/D52]#OP
M'LGDJ*@A8   $M/W[3_CL]D)YF']4,P-=U                   4ET_B^H
M_$,J\ZK-^&4FQ_Q;']]WLE%^=CD?!"XF*\
M                                   "QV+]]5OWT]DXLOS0T\CXK+X5
MMP
M
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MZF-=D;T&6/X17_&Y"WC_ !I[%7 ^#':WB:#?
M                                      X;[-OI#W'^$?\ 53G9^H>'
M1R/I_P =_;2Z<:<5V$Y@E"8G2@$Q 0F-"4U@$Q.D"8T(34)$U"$IK>A"4(T
MC3I($UO02AZA,(36=PD3F])A+)8ZG^DE/^*G^!Q,"_@
M !8\G_>D/_B?]E21>H_]6S[R?X"!$                  **[_Q;4_B?XP)
M=B_BJG_S_9N N(                   6'&_P#SGX[?\80OP2
M        #C;'O[<UU_A'\TM.W?Y2/;I<6GS<^W0[).([0
M                 -9]H7T*YI\W/]FTVN$\6O6U>*\*W4QKLC>@RQ_"*_XW
M(6\?XT]BK@?!CM?-U#T[SD/0D   ,EVZ](6)_/-N^-1E6=\%NJ6>7\=>N'UM
M/'/7                   UGVA?0KFGS<_V;3:X3Q:];5XKPK=3&NR-Z#+'
M\(K_ (W(6\?XT]BK@?!CM;Q-!O@
M                            <-]FWTA[C_"/^JG.S]0\.CD?3_CO[:73
MC3BNPG,$H3$Z4 F("$QH2FL F)T@3&A":A(FH0E-;T(2A&@$:=) FMZ"4/4)
MA":SN$B<WI,)9+?+/1-NT4+X%=5JG@3=Q$T7[I,"Y@
M!;KO/1P0,=60K-&K]&M33@NB\>*H!<&JBM:J<$T31 /0
M !3UKXHZ25\[.LA:W5[/50"&W202T44E-'U4"\W*Q>YHY47^^!5
M          !;;3/13]?XG"L/*Y$DUTXKQ^ZH%R                   #C;
M'O[<UU_A'\TM.W?Y2/;I<6GS<^W0[).([0
M      -9]H7T*YI\W/\ 9M-KA/%KUM7BO"MU,:[(WH,L?PBO^-R%O'^-/8JX
M'P8[7S=0].\Y#T)   #)=NO2%B?SS;OC495G?!;JEGE_'7KA];3QSUP
M             -9]H7T*YI\W/]FTVN$\6O6U>*\*W4QKLC>@RQ_"*_XW(6\?
MXT]BK@?!CM;Q-!O@$N*>&=JN@D;*UJJURL<CD1R=*+IW1@)@
M                                              !PWV;?2'N/\(_Z
MJ<[/U#PZ.1]/^._MI=.-.*["<P2A,3I0"8@(3&A*:P"8G2!,:$)J$B:A"4UO
M0A*$: 1ITD":WH)0]0F$)K.X2)S>DPEDLM2QZY%3O1J\J-35VG#H<3 OH
M                67)6/?2PHQJN5).A$U_8J2+Q'_JV_>3_  $"(
M           4=U176ZH:U%559P1.*@2[(US+7 UR*UR<^J+P7U[@+@
M             %CQUCV>-\[5;J]NFJ:>J$+X$@                  XVQ[
M^W-=?X1_-+3MW^4CVZ7%I\W/MT.R3B.T
M    #6?:%]"N:?-S_9M-KA/%KUM7BO"MU,:[(WH,L?PBO^-R%O'^-/8JX'P8
M[7S=0].\Y#T)   #)=NO2%B?SS;OC495G?!;JEGE_'7KA];3QSUP
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MOHY,.3FY_=@BN[UZ[J>7'EY^9V2<1V0
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M[E?HEOW9[O\ R>?9TN7GM/Y(_P#6QYRNS[=QZ);]V>[_ ,GGV=;EY[3^2/\
MULGSE=D]$M^[/=_Y'V=;GY[3^2/_ %L>;KLGHEOW9[O_ ">+V=[DG]=9_)'_
M *T3YN-E'HMOW9[O_) O9[N:?UTG\D?^M#S<;*/1K?NSW?\ DENV N3?ZYS^
M2O\ UHGS4;+&?H]H_P#EGN_\DI=A;DG]<9_)7_K1,<3798S](M^[/=^:!VQ-
MR;_7"=?X,_\ 62?,UV4>DW_<GN_\DMVQUS3^M\_D[_UDGS%=E$_2K_N3W?\
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M4LYV/:O%%[K7(O%'(O!44\MF9=J3,6?6.'XBF?2+TG&)7A.A"ML/0
M*>OG?34<T\>G.QNK=>*:@06RIDJZ&*HETZQ_-KR\$X.5/\0%6
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M=KYNH>G><AZ$@  !DNW7I"Q/YYMWQJ,JSO@MU2SR_CKUP^MIXYZX
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M       4UPADJ**:&)-9'MT:G1Q @M5/+2T$,$R:2,YN9$77I<J]S[X%8
M                %JLM#447C'C#4;UCD5FBHO!-?4^^!=0
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MYN?[-IM<)XM>MJ\5X5NIC79&]!EC^$5_QN0MX_QI[%7 ^#':WB:#?
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MDZ5 KP                   LN/SS3>-==(Z3E>B-YW*[3IZ-0+T
M            '&V/?VYKK_"/YI:=N_RD>W2XM/FY]NAV2<1V@   H8[+9HKM
M-?HK=3,OE1$VFGN;88VU<D#%16QOF1O.K$5-4:JZ&6M.&&/(QU8QQPY4%#8+
M%;'5S[;:Z2C?=)7U-S=3P10K53R:\\DRL:G6/=KQ<_55$VF<,9YB*Q'-'.I&
M85AL=JI[$S';8VQTDR5=);&T5.E)%4-<KDECA1G(UZ*Y5YD3753+>7QQQG%C
MNZX881@@R7",/S)L#<KL5#>4I55:9:ZGCG='S>NY%>BJB+IQ1.D4S+4^&9@O
MEUO\48JJSXQC6/25$M@LU#:I:ML+*I]#30TSI6TS59"DBQ-:KDC:JM8B^M3@
MA%KVMSS,IK2M>:,$V\V*QY'1+;<AME)=K<YS9'4=?!'50*]GK7*R5KFZIW%T
M(K::SC$X)M6+1A,8L<^J':?S#QW^2*']"6^8S-J>^5>XR]F.Z%ZO>(XMDELB
MLU_LM%<K3 K5IZ.JIXY88E8G*U8VN:J-T3@G+IPX%=<RU9QB<)9VI6T83&,(
M:3#L2H+$_%Z.Q4$.-RHK9K0VEB2CD1VG-SQ<O([71->9.),YEIG6QG$C+K$8
M81@L_P!4.T_F'CO\D4/Z$S\QF;4]\L-QE[,=T+Q5X=B5=8F8O66*WS8W$B-A
MM#Z6%:.-&ZZ<D/+R-TU73E1-#",RT3K8SBSG+K,881@8YA^*8?3RTN*V6BLT
M$[N>=E#!'!UCDZ%>K$17*G<U%\RU_BG$IEUI\,8*NUV*QV/QKY%ME);?'IG5
M=;XG!'3]?42>NEDZMK>=[NZYW%3&UIMSSBFM8CF@JK#8ZZYT=ZK;925-YMR/
M2WW&:".2IITD31Z12N:KV<R+HO*J:B+3$81/))-8F<<.5<%1%31>*+TH8LED
MI,-Q"@M%18*''[;2V*J>Z2JM<%'!'22O<B(YSX6L1CE5&MU56]Q"R<RTSC,S
MBPC+K$81$8+;8]KMN,:KVW6P8I:K=<F:]75T]'#',S7IY'HW5O\ FF5L_,M&
M$VF885R:5G&(ADM=04-SI):"Y4T590SMY)Z6HC;+%(WIT<QZ*BI]]"J)F)QA
M;,1,82QFS;6[;8[<&7:QXG:;?<XU58JNGHH62QJO2K'(W5O3^QT+;9^9:,)M
M."JN32LXQ$,JF@AJ89*>HC;-3RM5DL4C4>QS7)HJ.:NJ*BIW"F)P7,5MNU>V
MEGN;;S:L1M%'=&.ZR*KAH8&21OUUYF*C/ 7[K="Z<_,F,)M.'6IC)I$XQ6,6
M7%*X   -9]H7T*YI\W/]FTVN$\6O6U>*\*W4QKLC>@RQ_"*_XW(6\?XT]BK@
M?!CM?-U#T[SD/0D   ,EVZ](6)_/-N^-1E6=\%NJ6>7\=>N'UM/'/7
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M7].B\=95_9.[G0G=5?,\;QDYGZ:\SZC]%^BQPM=YF<N9/_:WTG0ARGJGH
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MJ!<0                   XVQ[^W-=?X1_-+3MW^4CVZ7%I\W/MT.R3B.T
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MNEM25M%4ZN1T;:AO+(G!414<B=#M?5Z0*\
M+?;+':;,^MDM=(REDN-0^LK7,UUEJ).+I':JO%0+@   %37@O0!B*;6[=MK?
ME!,:H/&>?K=>I3DY]==>3UG3W.4#+D33@G0!(K:.GN%)/05;5?2U,;H9F(YS
M%<QZ:.3F8J*FJ+W% @MMMH+10T]LME.REH*5B1T]/$G*QC4[B)_A7N@50
M                   #AOLV^D/<?X1_U4YV?J'AT<CZ?\=_;2Z<:<5V$Y@E
M"8G2@$Q 0F-"4U@$Q.D"8T(34)$U"$IK>A"4(T C3I($UO02AZA,(36=PD3F
M])A+)8ZG^DE/^*G^!Q,"_@                  !8\G_>D/_B?]E21>H_\
M5L^\G^ @1                  "BN_\6U/XG^,"78OXJI_\_P!FX"X@
M              !8<;_\Y^.W_&$+\$@                  XVQ[^W-=?X1
M_-+3MW^4CVZ7%I\W/MT.R3B.T            !C&-8'9,5ON2Y#;'3K7Y54Q
M5ES29[7QI+"US6]6B-16IHY==54MOFS:(B?Z55,N*S,Q_4R<J6@
M       !K/M"^A7-/FY_LVFUPGBUZVKQ7A6ZF-=D;T&6/X17_&Y"WC_&GL5<
M#X,=KYNH>G><AZ$@  !DNW7I"Q/YYMWQJ,JSO@MU2SR_CKUP^MIXYZX
M             &L^T+Z%<T^;G^S:;7">+7K:O%>%;J8UV1O098_A%?\ &Y"W
MC_&GL5<#X,=K>)H-\
M                  #AOLV^D/<?X1_U4YV?J'AT<CZ?\=_;2Z<:<5V$Y@E"
M8G2@$Q 0F-"4U@$Q.D"8T(34)$U"$IK>A"4(T C3I($UO02AZA,(36=PD3F]
M)A+);Y;C+'=HJ!&-6*1$57+KS="KZOW"8%S                   "WW>X2
M6Z!DL36O5[^54=KIIHJ]P"O:O,UKO51% ]                  %/6SNI:2
M6H8B*Z-NJ(O0!#;JI]91Q5,B(U[^;5&]'!RIW?O 50
M 6VTW&6X=?UC&MZIR-3EUXZZ^K]X"Y                   !QMCW]N:Z_P
MC^:6G;O\I'MTN+3YN?;H=DG$=H                                &L
M^T+Z%<T^;G^S:;7">+7K:O%>%;J8UV1O098_A%?\;D+>/\:>Q5P/@QVOFZAZ
M=YR'H2   &2[=>D+$_GFW?&HRK.^"W5+/+^.O7#ZVGCGK@
M    :S[0OH5S3YN?[-IM<)XM>MJ\5X5NIC79&]!EC^$5_P ;D+>/\:>Q5P/@
MQVMXF@WP
M         .&^S;Z0]Q_A'_53G9^H>'1R/I_QW]M+IQIQ783F"4)B=* 3$!"8
MT)36 3$Z0)C0A-0D34(2FMZ$)0C0"-.D@36]!*'J$PA-9W"1.;TF$LEKGHJE
M][AK&LUIV-1'/U3@NB]S77NDP+N                   %JOM'4UE/''3,Y
MWM?S*FJ)PT5.ZJ 7-B*C&HO2B(B@1                  "EN,4D]#/#$G-
M(]NC6ZHFJ_A @M,$M-;X8)V\LK>;F;JB]+E5.*:IT*!6@
M   !:;)15-'XSXPSDZQR*SBBZHFOJ*H%V                   #C;'O[<U
MU_A'\TM.W?Y2/;I<6GS<^W0[).([0
M -9]H7T*YI\W/]FTVN$\6O6U>*\*W4QKLC>@RQ_"*_XW(6\?XT]BK@?!CM?-
MU#T[SD/0D   ,EVZ](6)_/-N^-1E6=\%NJ6>7\=>N'UM/'/7
M       UGVA?0KFGS<_V;3:X3Q:];5XKPK=3&NR-Z#+'\(K_ (W(6\?XT]BK
M@?!CM;Q-!O@
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M>H\:Z^1TG*Y$;S+KHG$"\@                  !QMCW]N:Z_PC^:6G;O\
M*1[=+BT^;GVZ'9)Q':                                !K/M"^A7-/
MFY_LVFUPGBUZVKQ7A6ZF-=D;T&6/X17_ !N0MX_QI[%7 ^#':^;J'IWG(>A(
M   9+MUZ0L3^>;=\:C*L[X+=4L\OXZ]</K:>.>N                  !K/
MM"^A7-/FY_LVFUPGBUZVKQ7A6ZF-=D;T&6/X17_&Y"WC_&GL5<#X,=K>)H-\
M
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MWW^GE<9P.I^JG-H>J^B_7=__ .K.G]?1.G\W0C'*Y.)R'L40
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M<G5M3GQZ\76IQW7
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M                   .-L>_MS77^$?S2T[=_E(]NEQ:?-S[=#LDXCM
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M1.75-8^N<_D71535FA;?B<R\83/(JIP^72<8CE9\:[8
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MC%$O==^W?W>A.'3Y;C.,G-G"/A?5OH_T>O"5UK<N9/V>Z&Z$1$Z.Z<YZ1Z
M          %+<HWS4$\<;5=(YNC6ITJH$NSPR06Z&*9JLD;S<S5Z4U>J@5P
M                  6>PTM13>-=?&L?.Y%;KW4X@7@
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MQ6]&O5_B<<G5+*KD3E1.?P4U75>.G0IGN[:NMT<S#7C6U>E>C!F
M     UGVA?0KFGS<_P!FTVN$\6O6U>*\*W4QKLC>@RQ_"*_XW(6\?XT]BK@?
M!CM?-U#T[SD/0D   ,EVZ](6)_/-N^-1E6=\%NJ6>7\=>N'UM/'/7
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M,5/R.9(^-$:C7*C]%\%.CCQU-;C,JN7?".3D;/"9DWIC.EMTTFX
M  #6?:%]"N:?-S_9M-KA/%KUM7BO"MU,:[(WH,L?PBO^-R%O'^-/8JX'P8[7
MS=0].\Y#T)   #)=NO2%B?SS;OC495G?!;JEGE_'7KA];3QSUP
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M@C>QO)S450WK*9SDZ.;1'(NGJ 9F
M     X;[-OI#W'^$?]5.=GZAX='(^G_'?VTNG&G%=A.8)0F)TH!,0$)C0E-8
M!,3I F-"$U"1-0A*:WH0E"- (TZ2!-;T$H>H3"$UG<)$YO282R6.I_I)3_BI
M_@<3 OX                   6/)_WI#_XG_94D7J/_ %;/O)_@($0
M             HKO_%M3^)_C EV+^*J?_/\ 9N N(
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MHL:_>T]0"LVU>VKW&W/N$"\](^MH*1LB="S4<4K)4_S570#:A
M                          <-]FWTA[C_  C_ *J<[/U#PZ.1]/\ CO[:
M73C3BNPG,$H3$Z4 F("$QH2FL F)T@3&A":A(FH0E-;T(2A&@$:=) FMZ"4/
M4)A":SN$B<WI,)9+?*RW+=HGR2.2O1$Y(TUY531?N:?WR8%S
M       "WW=E ^!B7"1T<7/X*MUUYM%]1% KVZ<K>7UNB:?> ]
M        %/6I ZDE2I<K8%;^Z.3I1/P(H$-N;3-HXFT;E?3)S<CG:ZKX2Z]*
M)W0*H                   +;:66]G7^(2.DU<G6\VO!>.G2B 7(
M            .-L>_MS77^$?S2T[=_E(]NEQ:?-S[=#LDXCM
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M<YU1<:UVO-45<NBR2+KJO'31/N(A R8
M       !PWV;?2'N/\(_ZJ<[/U#PZ.1]/^._MI=.-.*["<P2A,3I0"8@(3&A
M*:P"8G2!,:$)J$B:A"4UO0A*$: 1ITD":WH)0]0F$)K.X2)S>DPEDL=3_22G
M_%3_  .)@7\                   +'D_[TA_\ $_[*DB]1_P"K9]Y/\! B
M                  %%=_XMJ?Q/\8$NQ?Q53_Y_LW 7$
M    +#C?_G/QV_XPA?@D                  '&V/?VYKK_  C^:6G;O\I'
MMTN+3YN?;H=DG$=H                                &L^T+Z%<T^;G
M^S:;7">+7K:O%>%;J8UV1O098_A%?\;D+>/\:>Q5P/@QVOFZAZ=YR'H2   &
M2[=>D+$_GFW?&HRK.^"W5+/+^.O7#ZVGCGK@                  :S[0OH
M5S3YN?[-IM<)XM>MJ\5X5NIC79&]!EC^$5_QN0MX_P :>Q5P/@QVMXF@WP
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MSD/0D   ,EVZ](6)_/-N^-1E6=\%NJ6>7\=>N'UM/'/7
M   UGVA?0KFGS<_V;3:X3Q:];5XKPK=3&NR-Z#+'\(K_ (W(6\?XT]BK@?!C
MM;Q-!O@
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M<AZ$@  !DNW7I"Q/YYMWQJ,JSO@MU2SR_CKUP^MIXYZX
M  &L^T+Z%<T^;G^S:;7">+7K:O%>%;J8UV1O098_A%?\;D+>/\:>Q5P/@QVM
MXF@WP
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MV/;N1Z1F_OV^W_)Y]G*Y^>T_DC_UL>:C8]NY'I.;^_;[?\GGV<[EY[3^2/\
MUHGS,;'MW(])S?W[?;_D\7LZ7)/Z[3^1O_6R?,QL>W<CTK-_>M]O^26[L]7)
MO1FLZ_P1_P"M#S,;'MW(]*S?WK?;_DE.V!N3?ZYSK_!7_K1/F(V/;N1Z7F_O
M6^W_ "27[#W-O]<9U_@S_P!9,HSXV5=OIF;,83FV^W_))=L=<V_UOG7^#/\
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M$\6O6U>*\*W4QKLC>@RQ_"*_XW(6\?XT]BK@?!CM;Q-!O@
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M&VLLR[VM\5=5EY2N
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MHY>E[4<W17>$OA<5;RD<12LTKF5C#6Z$Y%[1>U+3CATMUFBW0
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MZ+PXHH%P:B(UJ)Q31-% ]                  %/6LBDI)63OZN%S='O]1
M(;='!%111TTG6P)S<KU[NKE5?[X%4                   %MM,%%!U_B<R
MS<SD6373@O'[B 7(                   .-L>_MS77^$?S2T[=_E(]NEQ:
M?-S[=#LDXCM                                 UGVA?0KFGS<_V;3:
MX3Q:];5XKPK=3&NR-Z#+'\(K_C<A;Q_C3V*N!\&.U\W4/3O.0]"0   R7;KT
MA8G\\V[XU&59WP6ZI9Y?QUZX?6T\<]<   &F.U3:[G>-EKS06BBGKZZ2HH59
M2TL3YY7(VJC551D:*JZ(FJ\#>X&T1FQ,^]I<;$SE3$+90=I6V4M#34TFW>=+
M)#%'&Y6V5FBJQJ(NFM2GJ&4\',S\5>]C'%Q$?#;N0[C[E7_-=O:&Q8%BUVAR
M#.Y)K0D-ZH'1);Z)7+!45%6B=;&QKFJO5\SN+=7?L=%G)R:TO,VF,*\O)//U
M&;G3>F%8G&W)RQS+'MMA=TVKO5ZV(OE/5W3;[+Z.6HM634=,^-8ZBII_%ZJ"
MHEB:J1N<C?W-SG>#HW]MX.>=F1FQ&;'):O0KRLN<N9RYY:VZ6RL'V&P7;Z_,
MR.P/N+KBR*2!J5=;)41<DJ:.\!W#7U#6S>*OF5PG!LY?#4I.,8M*W';3*I=V
MF[1-MTR[0U>0)G4M6D;O%4B6%7242N1O*C%G:K$CYM=%1VG=-Z,ZNZWF/Z\-
M7\VE.3;>:F'Z,=;\FT:RUW-W:HM]X;13K:&X4ZF=7I$_Q9)_E&5W5K+IR\_*
MNO+KKH:D6CRTQTZW^C:F)\Q$]&K_ *M793MME<VZ\^TU';YEVFRJ^TV:U]8R
M-WBT3(XY%K*1ST:K&];+&WE9JBM\#AHIMTSJ[O>8_KK&K^$M6^5;>:F'Z9G6
M_%G.=ONVV&]U-NJZR5MYPN[V+Y NDMK@6JJ*":*=LS)%C;Q2-R,8G!43I_9(
MU%U\K#-R=3'"T3CR]*_,QR\W7PQB8PZD.,55UW8WNM>X]OLM=:,'Q2UU-#35
MUV@=235]96\S7)%$_CU;&N]=ZK>/3H+Q&5DS29B;6GHZ"DSFYL7B,(K'2Z!.
M<Z   UGVA?0KFGS<_P!FTVN$\6O6U>*\*W4QKLC>@RQ_"*_XW(6\?XT]BK@?
M!CM;Q-!OM<;C[1TN<7*W919[S58MG5H8Z&@R&@:DC_%WZJL,T3E:V6/5RN1J
MJG=[BJ;63GZD368UJST-;-R->8M$X6CI8_0;%WJ[9):\CW7SFJSE;%*E39[7
MXC3VF@CJ6^MEEA@<]LCFKQ3H^[JG LGB8BLQEUU<??BKCAIFT3>VMAV,^W(P
MN+<3";OADU8Z@BNT;(G5C(TE='U<K)=48KFZZ\FG2:^3F;N\6T-C-R]Y2:Z5
M]M- EJM5#:VO65M%3Q4R2*G*KDA8C.;3CIKH5VG&9E96,(P4V38Y:LNQ^Y8S
M>XEFM5T@?2U3$71W)(FG,U>.CFKX35[BIJ32\TM%HYX8WI%HF)YI:DH]@K_5
M.L%IS3<"KR3!\:GBJ;;CSZ"&E=(ZEX4[:JI9(YT[8TX:.:FIN3Q58QFM<+3T
MXM2.&F<(M;&(Z%]RK:.[5F:3[@8!EDN'Y+<:>.DO;O$HKG2UL<#4;$Y\,SXT
M1[&HC4=KT(G#IUKIGQ%-2]=:(YNA9?(F;:U9U9Z>E:F]GYK,(RC'4RJL?E6:
M31S9-ETL+%JJAD;D7J61->U(XE;S,Y$<NC7.3HT1,_-?KB<.2O-##ROZ)C'E
MMSRHK)L;N/C=JI;'8MW*V@M-$Q(J6D@LU UC&)ZG'BJ]*JO%5XJ96XG+M.,T
MY>N6->&O6,(OR=4+_DNS]VJLO7/\&RZ;%,MJZ2*@O51XE#<:6NC@:C6/DIY7
ML1)$1J(CD=T(G#IUKIQ$174M76CHZ,%E\B9MK5MJSWKWMOMG3X"EVN5;=)L@
MR_(9F5-_R"J8R&2H?$U6QL9%'JV.-B*O*Q%7IZ=-$2O.SMYA$1A$<T+,K)U,
M9QQF>>6=FNO                                              !BN
MYOHVS'YCN?Q24OX?Q:]<?>Y_U'Y7-_V6_P",M!=GG+<5LF R4=YOEOMU8MPG
MD2GK*N"GDY',B1'<LCVKHNB\3L<;EWM?&(F7DOHG%9.7PT1:]:SC//,0VRNX
MFW_G79_Y0I?TAI;G,V9[G9\]P_[E/[H_%"NX> </_P"*[/\ RA2_I"=SF;,]
MR//</^Y7^Z/Q0.W#P#3^E5G_ )0I?TA.YS-F>Y'GN'_<K_='XH/K"P'SJL_\
MH4OZ0;G,V9[D>>X?]RO]T?B\7<+ ?.JS_P H4OZ0G<WV9[D>=X?]RO\ ='XH
M5W!P+SIM'\H4OZ0;F^S/<Q\[P_[E?[H_%XNX.!>=-H_E"F_2$[F^S/<>=X?]
MRO\ ='XI:[@8'YTVCR^F_2#<WV9[CSO#_N5_NC\4*Y_@?G1:/+Z;](3&3?9G
MN8SQO#_N5_NA#]/\$\Z+1Y?3?I"=U?9GN8QQN1^Y7^Z$*9]@GG1:?+Z;](-U
M?9GN1/&9&W7^Z!<^P73^D]I\OIOTA.ZOHGN1YS(VZ_W0@=GN"Z)__$]I\OIO
MTAENKZ)[D><R-NO]T//I[@WG/:?+Z;](-U?1/<CSF1MU_NA [/,&\YK3Y?3?
MI"=U?1/<><R-NO\ ="1)G6$+T9+:O+J;\LRW5]$L9XS(VZ_W0II<XPI>C)+6
MO\.I_P L;N^B6$\7D;=?[H4K\UPU>C(K9Y;3_EF>[MHE7/%9.W7OA2R9GAZK
MPR"VK_#(/RR=W;1+">*R=NO?"E?F&)+T7^W>60?EF<4MHE7/$Y6W7OA3OR[%
M%7A?;=Y7!^63%+:)5SQ.5M5[X4LF5XLJKI?+?Y7#^69Q2VA5/$96U'?"G?E.
M,+T7J@\JA_*,HK.A7O\ +VH[X4[\GQI?_6:'\%3#^43%9T*YS\O:COA3/R7'
M..EWHE_A,7Y1G%94SG4VH[U,_(L?772[4?E$7Y1E$2KG-IICO4TF06%4X72C
M7^$1?E&<1+7MF5TPHY;[8UUTN=+^?C_*,XAKVO72QW(LLI:2#J+5*RJK9N#7
MQ.21C$Z-55-45?40R:]YT-V[![&24#H,^S6%S[Q+^[6RWS)QAYO^^E1?^\7]
MBB^M^_T<#CN-QQI3M>_^A?1M2(S\V/U=$:'2S>"(AQ7MGH    L>3_O2'_Q/
M^RI(O4?^K9]Y/\! B                  %%=_XMJ?Q/\8$NQ?Q53_Y_LW
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MO%>%;J8UV1O098_A%?\ &Y"WC_&GL5<#X,=K>)H-\
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M]Z%Z     %NN]12TT#'54"3L5^C6KIP71>/$"X-5%:U431%1-$ ]
M          %/6R1Q4DLDS.LB:W5S/53\($-NEAGHHI:>/JH7<W+&FG#1RHO1
M]T"J                   "VVFII:CK_%H$@Y'(C]-/"7CZ@%R
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MR-8B-37GT\'AP$B?N]DM?BN"5]PM$JPWJ:2"DMSVHCG==/*U%T1R*FO)S*G
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M9E.!VNYW)ZR76-)*2O>NG,Z:FD=&KG:<-7(B.7[X&:@
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M+X$@                  XVQ[^W-=?X1_-+3MW^4CVZ7%I\W/MT.R3B.T
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MB?MN9=.(%"E.ZW6[=B^8U&Z.FLU/38Q:EB7PFTT#VPU3D5$3CRMZUSDZ555
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MP"Z                   !QMCW]N:Z_PC^:6G;O\I'MTN+3YN?;H=DG$=H
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M]!*'J$PA-9W"1.;TF$LELFH*A]YAK6HG4,:B.77CT+W/PDP+L
M        %LO=#/74\<=.B*YK^9=5TX:*@%Q8BM8U%Z41$4"(
M      4UPA?44<T$>G6/;HW7@FH$%KIY:2ABIYM$D9S<VBZIQ<J_XP*P
M               +79J"HHO&.O1$ZQR*W1=>":]\"Z
M !QMCW]N:Z_PC^:6G;O\I'MTN+3YN?;H=DG$=H
M          &L^T+Z%<T^;G^S:;7">+7K:O%>%;J8UV1O098_A%?\;D+>/\:>
MQ5P/@QVOFZAZ=YR'H2   &2[=>D+$_GFW?&HRK.^"W5+/+^.O7#ZVGCGK@
M                :S[0OH5S3YN?[-IM<)XM>MJ\5X5NIC79&]!EC^$5_P ;
MD+>/\:>Q5P/@QVMXF@WP
M                     .&^S;Z0]Q_A'_53G9^H>'1R/I_QW]M+IQIQ783F
M"4)B=* 3$!"8T)36 3$Z0)C0A-0D34(2FMZ$)0C0"-.D@36]!*'J$PA-9W"1
M.;TF$LEFJ)94R&GC1[DC5J:LU73H=W"8%\                   "S9'++%
M2Q+$]S%6315:JHNG*OJ$B[Q\6-5?43_ 0(@                 !1W1SF6^
MH<Q5:Y&<%1=%0"79'ODMD#Y'*YZ\^KG+JOKW=U0+@
M%DQZ667QOK'N?RO33F55TZ?5"%["0                  <;8]_;FNO\(_F
MEIV[_*1[=+BT^;GVZ'9)Q':                                !K/M"
M^A7-/FY_LVFUPGBUZVKQ7A6ZF-=D;T&6/X17_&Y"WC_&GL5<#X,=KYNH>G><
MAZ$@  !DNW7I"Q/YYMWQJ,JSO@MU2SR_CKUP^MIXYZX
M &L^T+Z%<T^;G^S:;7">+7K:O%>%;J8UV1O098_A%?\ &Y"WC_&GL5<#X,=K
M>)H-\
M      #AOLV^D/<?X1_U4YV?J'AT<CZ?\=_;2Z<:<5V$Y@E"8G2@$Q 0F-"4
MU@$Q.D"8T(34)$U"$IK>A"4(T C3I($UO02AZA,(36=PD3F])A+)02TE*ZZQ
M53JA&U#4T;!JFJ\%[FNO=)@7(                   +?=J6FJH6,JITIV-
M=JCE5$U71>'$"O:B(U$1=41$T4#T                  2*V*.:EEBF>D<;
MFZ.>NB(B?A @M\,-/1QPP2)-$WFY9$5%1=7*J]'#I J@
M   MUKI:6EZ_Q:H2?G<BOT5J\JIKPX 7$                   .-L>_MS7
M7^$?S2T[=_E(]NEQ:?-S[=#LDXCM
M UGVA?0KFGS<_P!FTVN$\6O6U>*\*W4QKLC>@RQ_"*_XW(6\?XT]BK@?!CM?
M-U#T[SD/0D   ,EVZ](6)_/-N^-1E6=\%NJ6>7\=>N'UM/'/7
M        UGVA?0KFGS<_V;3:X3Q:];5XKPK=3&NR-Z#+'\(K_C<A;Q_C3V*N
M!\&.UO$T&^
M           !PWV;?2'N/\(_ZJ<[/U#PZ.1]/^._MI=.-.*["<P2A,3I0"8@
M(3&A*:P"8G2!,:$)J$B:A"4UO0A*$: 1ITD":WH)0]0F$)K.X2)S>DPEDL=3
M_22G_%3_  .)@7\                   +'D_[TA_\ $_[*DB]1_P"K9]Y/
M\! B                  %%=_XMJ?Q/\8$NQ?Q53_Y_LW 7$
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MWP
M  2*RLI;?25%?73,IZ*EC?/4U$BHUD<435<][E7H1J(JJI,1,SA#&]XI6;6G
M"(Y9<(["7ZRV#.<\KKU7P4%'7S\U%/4/2-DR>,S.U8J]/!44[O&Y5[4K$1,X
M/-\#]0X:MKXYE8[8][H--R]O_.2W^4,[YR?*YNS/<ZOJ?"?NT_NA-9N;M\G3
MDMO\H9WQY7-V9[CU/A/W:?W0C3<[;W7^DUO\H9WQY7-V9[D>I\)^[3^Z$Q-S
M]O/.:W>4,[X\KF[,]QZGPG[M/[H1INAMWYSV[RAG?'E<W9GN3ZIPG[M/[H3&
M[I;<I_6>W>4,[X\KF[,]QZGPG[M/[H1INGMQK_2BW>4,[X\KF[,]QZGPG[M/
M[H3$W5VW\Z+;Y0SOCRN;LSW(]3X3]VG]T)B;K;;>=-M\H9WR?*YNS/<GU/A/
MW:?W0F)NQMKYU6WRAG?(\KF[,]QZGPG[M/[H3&[L[:(G]*K;Y0SOD^5S=F>X
M]3X3]VG]T(DW:VS\Z[;Y0SOCRN;LSW'J?"?NT_NA&F[>V6O]*[9Y2SOD>5S=
MF>Y'J?"?NT_NA,3=S;%$_I9;/*6=\GRV;LSW'J?"?NT_NAZF[NV'G9;/*6=\
MF.&S=F>Y'J?"?NT_NA,9N_M>FFN6VSREG?'ELW9GN/4^$_=I_=":W>':Y.G+
M;9Y2SOF,\+F[,]R?4^$_=I_="E?NYM,ZX1O7)+>Z?3P:GQEB,;P7I57)_@$<
M+F[,]QZIPG[M/[H5_P!;VUWG=:O*XN^3Y7-V98^J\)^[7O@^M[:[SNM7E<7?
M'E<W9D]5X3]VO?"]V'+<8REDTF.7>DNC:=4;.M),R7D5W%.;E5=-=.!5?+M3
MXHP;>1Q.5G1,Y=HMAHE>2ML@              %ON\M#% Q:^)TL:OT:UO2C
MM%X]* 5[=%:U6\$T31/N >@                 "GK70LI)75+5? C?#:G2
MJ?W4 AMSZ:2CB?2,6.G7FY&.Z4\)=>ZO= J@                   MMIEH
M)>O\1B=%RN1).;NKQ^ZH%R                   #C;'O[<UU_A'\TM.W?Y
M2/;I<6GS<^W0[).([0                                -9]H7T*YI\
MW/\ 9M-KA/%KUM7BO"MU,:[(WH,L?PBO^-R%O'^-/8JX'P8[7S=0].\Y#T)
M  #)=NO2%B?SS;OC495G?!;JEGE_'7KA];3QSUP                  -9]
MH7T*YI\W/]FTVN$\6O6U>*\*W4QKLC>@RQ_"*_XW(6\?XT]BK@?!CM;Q-!O@
M
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M                  .-L>_MS77^$?S2T[=_E(]NEQ:?-S[=#LDXCM
M                           UGVA?0KFGS<_V;3:X3Q:];5XKPK=3&NR-
MZ#+'\(K_ (W(6\?XT]BK@?!CM?-U#T[SD/0D   ,EVZ](6)_/-N^-1E6=\%N
MJ6>7\=>N'UM/'/7                   UGVA?0KFGS<_V;3:X3Q:];5XKP
MK=3&NR-Z#+'\(K_C<A;Q_C3V*N!\&.UO$T&^
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MUT[Z:DFJ(T17QMU1'='][0""VU4E9115,J(CW\VJ-U1.#E3NJOJ 58
M             6RT7&:OZ_KFM;U3D1O(BITZ].JKZ@%S
M   #C;'O[<UU_A'\TM.W?Y2/;I<6GS<^W0[).([0
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MZ5&]S,N8WF&$Z.AO4Y[?
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M_P!FTVN$\6O6U>*\*W4QKLC>@RQ_"*_XW(6\?XT]BK@?!CM?-U#T[SD/0D
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M^*@GDC<K7M;JUR<%10(+-+)-;89)7*^1W-JYRZJNCU0"N
M    "S6"HGJ/&NOD=)RN1&\RZZ)Q O(                   <;8]_;FNO\
M(_FEIV[_ "D>W2XM/FY]NAV2<1V@
M:S[0OH5S3YN?[-IM<)XM>MJ\5X5NIC79&]!EC^$5_P ;D+>/\:>Q5P/@QVOF
MZAZ=YR'H2   &2[=>D+$_GFW?&HRK.^"W5+/+^.O7#ZVGCGK@
M       :S[0OH5S3YN?[-IM<)XM>MJ\5X5NIC79&]!EC^$5_QN0MX_QI[%7
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M+;_S[.^3N;Z)8^=X?]RO?"!=S=OO.2@_/L[Y.YOHE'G<C]RO?"%=S-O]5_\
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MQN0MX_QI[%7 ^#':WB:#?
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M0:CK/0              +'D_[TA_\3_LJ2+U'_JV?>3_  $"(
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M>+(YSJ*FJZ2YTS575&/N-.DDS4UZ$YN71$X=(&RB
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M*V"@LSIT1)WT--% ^1$75$>YC45R)W$53&^;>_Q3,LJ9=:?#$0OY6L
M  -9]H7T*YI\W/\ 9M-KA/%KUM7BO"MU,:[(WH,L?PBO^-R%O'^-/8JX'P8[
M7S=0].\Y#T)   #)=NO2%B?SS;OC495G?!;JEGE_'7KA];3QSUP
M         -9]H7T*YI\W/]FTVN$\6O6U>*\*W4QKLC>@RQ_"*_XW(6\?XT]B
MK@?!CM;Q-!OM8TT#*O?JNJ*EJ+);\<A91H[CPFJ55SV\.&FKF_A)%E?;ES7<
MW<!VG64]KL+<=IU773K*^-TC]/NHO.U=/5 Q3#+E599CENR"[1JF';;6OK8(
MI$\&MO%- JL5475%; Q&HW_*7U': 6JJL$U+M3@%PN<L]/9Y[P^YWZOIV\\D
M'C;W)#4JBHY-&L1.*M7IT[O&1D<E+:LQR:SXQ;LKO>8TL4\=QKYHY*;Q*C2!
M=6/D?U"(JKQ3E:NOX2!'>KKB%^R&\WRKO4^W.X%FF?0K*LW,VL@@1.KE?"YC
M.M:[31&MZ41/7>"!15EZK[I8]L<US&@;!9XKI4U-^J(8%CCZU7M;2U4C&HJ:
M.Y5<Y=./<Z= ,GS/([5N3D6)XEA\[;HE!=::^7:X4VKZ:FIZ1'IHZ1/!YG\R
MZ)ZNB=T"VX+EENI;MNSDLU2Q+['-53PT3^$Z4=I:YD;E:J<$57L9]\"ML>F$
M=G.:XHG55E7;IJI\W0YT]T=R0O5>ZJ))&B?>0#%KYCC<<DVNCO=QJ;%8:2VR
M,?=J9$TI+K.WKW\SGL>U.=SN5%5O<U[BZ!?\<I+9D^?T$U)D-XRFV8NCZR2]
M5#X$MT-2YNG5(J0M5ZJB(JJQW^,#$9I*FY[4U4\:+\I;DY9R1KIX2QOGU:B)
MZC7PZ?AT)&SK%24MTWKNTT<:.I,-L]':J-.E(I:M%EYD_P KD5[/O:D"/!I6
MWW=?/K^G&*V^*6*D=T_ZE'+4)K]R1@%[W@QZXY1MW>;1:6.EN+FQ3P0-7C*M
M/,R56(G=56M7E3]MH(%CL&^&WS,9I9KI7_)MRI(6PU=H?%)XQ'/"U&.8UC6K
MJFJ>#_?TXZ,!8+GN9G"8C43U%%XED&6UJT.$6OD5E9'2R:-Z^75>E$<G*JHG
MA:+ZU0)B[/938<#N6/4&8N6W24M1+4VUEMI7-GF?&KGM69VLJ\RHC4=KS(FF
MG0,1C-UN[LFV:V[Q:)ZK4WZOIK3(U%XI!0RN@7^XJ1+]Q ,SW&V6Q9^,55PQ
M*T04.06M%K:1(V=8R?J?#="^)_,UZ/1."*WUVG<UU8B[VAM3N-@-@N&(7A<1
MC5JNJ8;;!&YK96:QR0HW5B-:CT54X<4T4#&=PK'=Z/'\>P"ZWV?(*W)L@ITD
MJZEC8WMH8T8LC$:U5\%CD:_\(%OR.HOU!N7EF%8RQ8KAF\=L6&J1%1E)31P2
M1U51JFFBHU%T^ZO#BB(!=L LMNAW=O%):H__ -(PRSTMEI%X?ZVH=USW.7]N
MKNNYE[JZ@7C:^2/(,RS[-Z7PK;<*RFMM!*GK)66V'JG2-]5'>"J*!M0@
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M]_;FNO\ "/YI:=N_RD>W2XM/FY]NAV2<1V@
M       :S[0OH5S3YN?[-IM<)XM>MJ\5X5NIC79&]!EC^$5_QN0MX_QI[%7
M^#':^;J'IWG(>A(   9+MUZ0L3^>;=\:C*L[X+=4L\OXZ]</K:>.>N
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MCE3_ ! 50                   6VTW!U=U^L;8^J<B>#W==>G^X!<@
M               XVQ[^W-=?X1_-+3MW^4CVZ7%I\W/MT.R3B.T
M                       #6?:%]"N:?-S_ &;3:X3Q:];5XKPK=3&NR-Z#
M+'\(K_C<A;Q_C3V*N!\&.U\W4/3O.0]"0   R7;KTA8G\\V[XU&59WP6ZI9Y
M?QUZX?6T\<]<                  #6?:%]"N:?-S_9M-KA/%KUM7BO"MU,
M:[(WH,L?PBO^-R%O'^-/8JX'P8[6\30;X
M                                  '#?9M](>X_PC_JISL_4/#HY'T_
MX[^VETXTXKL)S!*$Q.E )B A,:$IK )B=($QH0FH2)J$)36]"$H1H!&G20)K
M>@E#U"80FL[A(G-Z3"62U3TE2^^P538U6G:U$<_AHG!Q,"\
M      !:;]2U%731,IV+(YK]51-$X:+ZI(NC$5&-1>E$1%($0
M       I;E%)-0SQ1-YI'-T:WU5 @M$,M/;X89F\DC>;F:O<U>J]P"M
M              "T6.DJ*7QGQB-6<[D5FJHNJ)KZ@%W
M  #C;'O[<UU_A'\TM.W?Y2/;I<6GS<^W0[).([0
M           -9]H7T*YI\W/]FTVN$\6O6U>*\*W4QKLC>@RQ_"*_XW(6\?XT
M]BK@?!CM?-U#T[SD/0D   ,EVZ](6)_/-N^-1E6=\%NJ6>7\=>N'UM/'/7
M                 UGVA?0KFGS<_P!FTVN$\6O6U>*\*W4QKLC>@RQ_"*_X
MW(6\?XT]BK@?!CM;Q-!O@
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MPF)B54G28I36]!*'J$PA-9W"1.;TF$LEJGJZEE]@I6R*E.YJ*YG#1>#B8%X
M                  "TWZJJ*2FB?3O6-SGZ*J:+PT7U21=&*JL:J]*HBJ0(
M@                 !2W*62&AGEB=RR-;JUWJ*!!:)I:BWPS3.YY'<W,Y>[
MH]4[@%:                   %HL=7457C/C$BOY'(C-41-$77U +N
M              '&V/?VYKK_  C^:6G;O\I'MTN+3YN?;H=DG$=H
M                        &L^T+Z%<T^;G^S:;7">+7K:O%>%;J8UV1O09
M8_A%?\;D+>/\:>Q5P/@QVOFZAZ=YR'H2   &2[=>D+$_GFW?&HRK.^"W5+/+
M^.O7#ZVGCGK@                  :S[0OH5S3YN?[-IM<)XM>MJ\5X5NIC
M79&]!EC^$5_QN0MX_P :>Q5P/@QVMXF@WP
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M\6O6U>*\*W4QKLC>@RQ_"*_XW(6\?XT]BK@?!CM;Q-!O@
M                                             Q7<WT;9C\QW/XI*
M7\/XM>N/O<_ZC\KF_P"RW_&6FNS-Z.9/G*H_W<1U..\1YGZ#\K'7+<+S2=U*
M<2P2GF3"4E3/H1*6\0PA*7I4S82II5T:(82M54J:+PU+H4RL]2O3P+8:MEIJ
M53B60UKK5.J%T-.ZT52M5'(Y-47@J%L-+,:WN-%=<+O,678A*ZFDIW<\D;-=
M&?MO![L:_LF]S_!9:L7KA/,YM<V^1F1?+G"8=7[3;N6?<>U,:CDILAIVM;74
M"KQYM/7L]5BZ'F.*X2<JV,<SZA]+^K9?&4T7CGALI#2AVTUG<)$YO282R6.I
M_I)3_BI_@<3 OX                   6/)_P!Z0_\ B?\ 94D7J/\ U;/O
M)_@($0                  HKO_ !;4_B?XP)=B_BJG_P _V;@+B
M            %AQO_P Y^.W_ !A"_!(                  .-L>_MS77^$
M?S2T[=_E(]NEQ:?-S[=#LDXCM                                 UG
MVA?0KFGS<_V;3:X3Q:];5XKPK=3&NR-Z#+'\(K_C<A;Q_C3V*N!\&.U\W4/3
MO.0]"0   R7;KTA8G\\V[XU&59WP6ZI9Y?QUZX?6T\<]<
M   #6?:%]"N:?-S_ &;3:X3Q:];5XKPK=3&NR-Z#+'\(K_C<A;Q_C3V*N!\&
M.UO$T&^
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M>;7EUXZ'CN3'D?:(QPC'G5C.X$IS>DPEDM\J6_Y6B617>/Z> B:\NFBDP+F
M                  %NNZ4"P,^4%<D?/X/+KKS:+Z@%P;IRMY?6Z)I]X#T
M                 4];U"TDOC*JD'+^Z*G3I^ "&W)3)11)1JJTWA<BNUU]
M<NO3]T"J                   "VVE+>G7^(*Y?"3K>;7IXZ::@7(
M             .-L>_MS77^$?S2T[=_E(]NEQ:?-S[=#LDXCM
M                      UGVA?0KFGS<_V;3:X3Q:];5XKPK=3&NR-Z#+'\
M(K_C<A;Q_C3V*N!\&.U\W4/3O.0]"0   R7;KTA8G\\V[XU&59WP6ZI9Y?QU
MZX?6T\<]<                  #6?:%]"N:?-S_ &;3:X3Q:];5XKPK=3&N
MR-Z#+'\(K_C<A;Q_C3V*N!\&.UO$T&^
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MXJ?X'$P+^                   %CR?]Z0_^)_V5)%ZC_U;/O)_@($0
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ME2II'Q-1S.3D<O5.<Y%_OI52*9^-8KJS$8QA_JMO-\G"9MK1CA+H@YKH@
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MLSV)*UC=5C7H7[G0H$-NG94T<4\<20L=S:1MZ$T<J=Q$]0"J
M       "VVFMBK.OZNG;!U;D1>547FUUX\$0"Y                   !QM
MCW]N:Z_PC^:6G;O\I'MTN+3YN?;H=DG$=H
M      &L^T+Z%<T^;G^S:;7">+7K:O%>%;J8UV1O098_A%?\;D+>/\:>Q5P/
M@QVOFZAZ=YR'H2   &2[=>D+$_GFW?&HRK.^"W5+/+^.O7#ZVGCGK@
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M*LRHUK426637E5ZIKX1M9&9$:UHIJ1$<O7H:N?ES.K6;ZTX\GXNSSANT
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M7D                   .-L>_MS77^$?S2T[=_E(]NEQ:?-S[=#LDXCM
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M(U53BU%T,KYU[QA:9E%,FE.6L8,K*5H
M                  '#?9M](>X_PC_JISL_4/#HY'T_X[^VETXTXKL)S!*$
MQ.E )B A,:$IK )B=($QH0FH2)J$)36]"$H1H!&G20)K>@E#U"80FL[A(G-Z
M3"62USUM2R]PT;7Z4[VHKF:)Q71>[IKW"8%W                   "U7VL
MJ:.GCDIG\CW/Y571%X:*O=10+FQ55C57I5$50(@                 !2W&
M62"AGFB7ED8W5KM$71?P@06F>6IM\,\[N:5W-S.T1.ARHG!-$Z$ K0
M             M-DK:FL\9\8?S]6Y$9P1-$77U$0"[
M !QMCW]N:Z_PC^:6G;O\I'MTN+3YN?;H=DG$=H
M          &L^T+Z%<T^;G^S:;7">+7K:O%>%;J8UV1O098_A%?\;D+>/\:>
MQ5P/@QVOFZAZ=YR'H2   &2[=>D+$_GFW?&HRK.^"W5+/+^.O7#ZVGCGK@
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M.GR*PUDM%#27.FJ'W)DDMOZF9DB5#(%TD=$K55'(W]ER] %S
M                          .&^S;Z0]Q_A'_53G9^H>'1R/I_QW]M+IQI
MQ783F"4)B=* 3$!"8T)36 3$Z0)C0A-0D34(2FMZ$)0C0"-.D@36]!*'J$PA
M-9W"1.;TF$LEOFMT\EWBKVN9U,:(BM55YNA4]33N^J3 N8
M     6Z\6^:X01Q0N:US7\RJ]51--%3N(H%P8G*UK5Z41$ ]
M      %/70/J:2:GC5$?(W1%=T?WM0(+;2R4=%%32JBO9S:JW54XN5>ZB>J!
M5@                  !;+1;IJ#K^N<UW6N16\BJO1KTZHGJ@7,
M           .-L>_MS77^$?S2T[=_E(]NEQ:?-S[=#LDXCM
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M.OW7/<V16].B(O<40+ID%L7%+?L[%$G)7T-SH;=([HX5T21U*='[)=0-W$
M                                    X;[-OI#W'^$?]5.=GZAX='(^
MG_'?VTNG&G%=A.8)0F)TH!,0$)C0E-8!,3I F-"$U"1-0A*:WH0E"- (TZ2!
M-;T$H>H3"$UG<)$YO282R62I<OTCITU73E3A^!Q,"_
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M0"Y                   !QMCW]N:Z_PC^:6G;O\I'MTN+3YN?;H=DG$=H
M                               &L^T+Z%<T^;G^S:;7">+7K:O%>%;J
M8UV1O098_A%?\;D+>/\ &GL5<#X,=KYNH>G><AZ$@  !DNW7I"Q/YYMWQJ,J
MSO@MU2SR_CKUP^MIXYZX                  &L^T+Z%<T^;G^S:;7">+7K
M:O%>%;J8UV1O098_A%?\;D+>/\:>Q5P/@QVMXF@WUAK<6IJK++9ET<[X*ZWT
MT]%+&U&JVHIY]'(QZKQ3D>G.W0"_                   !"]'.8YK'<CU1
M4:[371>XN@%CQ;%*#%::ICII)*NOKZA]9<KC4\JU%3/(NO,]6HU$1$\%K6HB
M(G<Z0+\                                      <-]FWTA[C_"/^JG
M.S]0\.CD?3_CO[:73C3BNPG,$H3$Z4 F("$QH2FL F)T@3&A":A(FH0E-;T(
M2A&@$:=) FMZ"4/4)A":SN$B<WI,)9+'4_TDI_Q4_P #B8%_
M       "QY/^](?_ !/^RI(O4?\ JV?>3_ 0(@                 !17?^
M+:G\3_&!+L7\54_^?[-P%Q                   "PXW_YS\=O^,(7X)
M               !QMCW]N:Z_P (_FEIV[_*1[=+BT^;GVZ'9)Q':
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HASMV=DF.2+8VQ)(QS%=/7/:CD5-6NJI%14U[BFCQWC3V-[@?!A__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>tm2227887d1-pht_key4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2227887d1-pht_key4c.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ 9P#0 P$1  (1 0,1 ?_$ +(   $#!0$!
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MHHHT44:**-%%&BBC115!.-A^LQ'X^*HB_P!'FNM@K-X"]:EE7[B!5L4Z./\
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MU-(I,DG[=%]:1,_+*V*1BV9SGT_5Z?96M_D<@OH5-O\ #UZ<8\21Q?15^/\
M:F/)YC%A)529)/AX?O/]KTG7<TGG_P#'@QVD7R5TW7U1/'Q^CL)KM^%'M^IC
M_3^]-K<YD,;11J/F2?[5#BU[:<KYB8]Z6$.9QB%8UR%[D@RJON,0LJ_+[7&T
MA9?79RHY%2+.K?MC[,^L2$[%-_U+;POD@GVD%RTY>XL?B9^%Y&+'FD;&XXQ.
ML@,2N&BZ=XW(.X:AMP4@BP\]'9^:R(8<9VC((!>Y! .H/TGTN/C4RU9EK+#$
M:'+A/"$=AF.CS3@NJ2--BT)&! SMN([KMOX^2:JM\-F)9"+DWI$G.(6MD1D?
M$&_\C:E+&"DM4[S0M24W17&U<> Q^H2_U&"<$PW($7?9$7;P72.2.6-K-<'Y
M#^U.<$F+DKNB.Y?,7(_B+UYKQY@-D;9RL>BN/LNJ^VIR)J*CJO/OJX"C*'Q5
MV09;?YOEKB<G-AU1SM^0_GI77_B>(R;=2%2PUU+?/37XFM9^;/;/8YJY!H..
MZ3&<2J'%;^[93,DVDVT(7(LB(K$2$W;QE;BQ <$B\>X\2(** HJG(.&[ACP@
MTN>TDLG^5 %"WN#<FVI-K>5O'7PJ =W=A3\PT>%PD6/C8NG4F+.9/ BRKN\
M+'U8Z?2!<[-\9<98QQ3C36-XU'(0-WU=G8R")VPN+(VP;=G3Y!D;CAJ+:" J
MJBTV* /@GC'N2Y')Y.<Y&2;FU@/)1Z#]M:G_  / <=V[@C!X];#Q=C<O(U@"
MSL223IIK8#0:5R[<+,(_^Z5RZJ^)QO>_E3J)\D_ZU6'BB_EKTUSS;?:_"_U<
M)&/_ .85*.) >+*/H&_QIU?W;I8M6_LB-U4%N'>>Z6M+X(#=3R1A=;T+Y;=
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MY%9R"0BLD;LK.0K :$D@'HG;O/2$A</)W:V!C<%BKI&RH" 797=%95!92=0
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MV2R^WU@IL@T)[J:[%TR'![6S<Z!YA)&NURJ^)#%38D$> N-#Y^E5QS_NQPG
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MJ5U)-KZ$@7M>U[7!M>]KV-1CENS^W>:14S\:-E$BL;* 6VFX4M;=M)MN (W
M6)VD@^F8\,\<9]9.W&4XY'LK1RD#'&[#NOQYT.F2)D\%V%73(SC4JM"7%R^:
M+ZL&V3V[:FJJRUTUMW%[>]I=U9K<CSN(L^>V-T.I=E=8MN2A2-U(:/>N7,'*
M%2]T+$F--ML]O>X'=G:V$O'<'EM!@+D=?IV4HTN[&<,Z,"LFQL6$H'#!+.%
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MT=&GA(DB7;$H5;DV&@N3<FWQ.M12=\C(E$TY,LH54WL2YVHH5 =U] JA1KH
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M@NN;PPRF\JJQ (U .C:$:^1&A'GYUT2:6(6C9E!(.A(U74'3S!U!\O*O(:^
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MIEN=7BL0\=KV9;U\T^P5Q(88?JYZ.0ZP84Z%#2P<KHK<AX6VW29<-II ZM/
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M&<]9SRY8XW9Q'(^X+%2(I/$0[.,*G=!XX_(X>)G.;#*RF-@+./N\K?IZ&_\
MFOH+Z'PJ(\]@]WY*Q#A<S%B<3H23"^B _7N/7(=2--FP%B1]26W#YR0SS$Y:
MS/Y#E3VH2X-:A1_;EP9NM#.O19!V7LK#*X$^X<@J\59]M&M(6D?%_P!<JLJ"
MI3O>,??[Y\O_ *L\JXIXV40;#A;!F;)]IROR8WE*7_&_'&/9=XE_)_3*VO;L
M^3L%,"+_ -H2)LH<E$9]XS-YP]\&X8OXTB1![?D=<Y&YMAB_&_4#7P6#0^>7
M<N)O+[:XCX/(Q&_9BO3FN,UR.#>R,HG+03+8L<KI$!S(X.-&R)MQ67:9>@2+
MN.]8DU]LX_N@_/%.?GR$[:? G"EQQWY"3-DOT'E_'C9#D)CE05C5L0V!.]]R
MET[ER/;%.!#<#!COW(N? 6"'D/QWA7&3KI%^1(KC'?(#$-(RY8N0-B;6&%";
M[JZ'#8$>+48IF^5-M5@/S,B^SP)3KSN*XM-N';)S'KO&:-P&,QLK>+&])$84
M85:P)B\;Y3--RY/OCQ?;T44,&#R7.!8PSS])&).-C/*9#!-CPD+ER944?2B2
MT./$&$C2G(IQ;']D>4[@EEFGSN-X,M(0D'5=0!DY*1",3PY$P+8D>+))U97O
M-D2E3&L0QZRLVZ]T(2[2+ Q7CEV.P[E2U=L^U)!J<S BY0>)MG6#GZ267+^5
M"J0?<)T$BI-=W!4:4M+LGD?>I9YX,7!XAHE;)Z<K!@'"+DG%!C_.W SLF*'8
ML.GUGNOT7I#C<=[+M!!/E9W+K*RXW4B4J2A=L89)$GX6TB!7R2BA3U.DEF&^
MU4O7?NF*7.8CXEQFS%8L&&H5B\4V4MA6AC]P[(E%7AFD,X4B3DL:(T+9/&D>
M*_NJO%UDSB3D?>TSRQ18'#+ LH"2'>V^,02EFZ8S$*,V0L2A2YV1O>\AW&/,
M?'>R@@CEESN8:=HB7C&Q=DAGB"KO.(P=5QVE8L%&^1+6C&T2>-7;>Z-MR<L_
M',)?%9DR4V,D8S38QVL,LY$.LJ'*_,%=[%AFD.*P3TT%>A,RB7_W8?ZL?GA9
MWO6KR_E8?&L.H[#=M VC$D9(XC'EWVR9:1H6F&Z%)#_OK]<73-P?99EB_%R^
M14]-%.W<3N.7&KR2A\6VZ/$>1PL)VS/&/]AOHE(^0>ZI7:4G\(XW6/*O5B7;
M?J9$6164+%7C2_=6' S2Q:ER+.YF62"P(J4.-$!5]09#W,1<K[X=3&,O&\/T
MGRMLPW,K1P+'C_JJ1ER!FDF?(L@%XHXEOUF8;R7B_9$)D"+DN7ZJ8VZ$[599
M)FDR/TF!Q(RJQQ)CW<FTLDK6Z2J=FS6KFJG*-%%&BBC1133Y8"JY7FG^*6"_
MF7IU'_E73]AG1A\JA_,#ZHS_ /=_A3;<DYC4\?<>9-E%Q8G5,0*M]F/.9AK8
M/,6,\%@U9LP$!SU9I/D-KTD*CLB]7@BZ=,##EY#.CQH5WL7!(O8%5U:Y^0/A
M47[DYK#[=[=RN4S93"B1%5<+N(D<;([*=&.\KH=/72N:;-$IY<N1,B-([9-N
M.63\N2;+(A+DL2 9D1%FP93@] "XJO-D*$9JAKLH;7B0!?;Y5\_,=IC]4C?<
M=?$^>M]1X_'72]:+YE2P,2I95C]P?DQ83YKDL)V57V 28[R^D7&;!DAC,SEE
MJ,)QL'09,Q!>A# B:UDDZGSJ6<>?R\I(=MF<@*0""#>^X'RL"1YV^%02<ZXE
MQC=39&8<EYGG-:4N;D#.6831TDB1-?<B29,RMFUUNQ .@&+*AJC;+$I0%'A5
MU'T8-.FJ.X\SN:.;)&)AQ9"$QG'<3=,:A1(N0K*S#8VXJ\0?<EKH&7Z_3?%+
MR6$L>'QT:J$51U'U4:> 4,&))U)-@/B;7T)R![V]09KMQB\+,+F%,BPW*W"K
MQYQE:-U3C++BY!E$$JQVZFM--D'=A,Q8\@W5>$&$ 8Q/O;K<%B\8DO<Q?+YA
M+AEC4Q12:@A@-Q>/2ZJO4?0;F:X >8L_/Y-HFZ<"JYW./K+ #Z=BD6 )U;=J
MH^D;B=PDK_:DGS Y;Y'FX'CTR+C#F'4LJQA6UQ(<:IY\9_=XXC[<F.-@$B0V
M?8-Y@W4V1%%$12T]<7/A9.=+D<="V/B.B?IW+!6%P=K$EB/B3>Y/@+54'NXH
M_P"*Q1R$B/EB9[%5\5(^D,+':0+7 -O CQL-^(>=/R,ES>D=INTD"SN0C+-Z
MR?K9%5;S,98KV7 $8\SU51 94MB;[9.  D\GB,EEC4*K7N3;^E_ZFP]=:K-\
M #'BE#G<RB]O,,H?7TLQ(%KWL;U.!^RU@,'*^?\ ,\\3'ZR[IL9Q".#AR+"M
M21BF2S3@#47C-3,;6;91Y(5<N/$>C""1U7K-47HZH7WMF'&XI<>.1DDFDU !
M^M0#=;CP&H)OXVMK5E>T?$_F]QMEY,*30XD+68L+QN[C8VP@DFRL 1]IUN#8
M5TWS6U)#1-MR1$1-O[RILGYJJZJR-@!\17HV=2=!XFG%@"OJ$7_")[K_  Z?
M^]=-.0;15*,<?J?NKDWX@O:VO_=;Y2JYIB$BQ]\&5MP@(D0B?+FJPZ.D=]U4
ME)%_+7J+F\>63VIPY4'TKP<=_E^,M.W%2HOY*/XL&M_.NN37E&N%"JB>*^"?
M-=%%8"ZRG'<=;B.WES JV9T^-5QGID@&6#GS25N)&-XE[3)R7$Z 4U$2-4%%
MZE1%[18T\Y(A1F(4D@#6P\3;X>=J1Y7(X."JOF2I&CNJ L;#<VBK?P!8Z"]K
MFP\2*S3C[+1-BZ\TT3Q&+0N. !.D#9O&+:$J*9 RV1JB;["*KY(NDSR1QD*[
M*"Q-KD"]@2;>M@"3\ 32]8Y'!9%8A0+V!-KD 7]+D@#XD"K5+6K)E) V4!8Y
M,NR!?29'5DF&'18??1U'.A667S0#+?I$U1%7==<!G81CZHFBZ14M?>MMJG:3
M>]K D GP!-CK7<X.:).D89>J&"VV-?<1<"UKW(!('B0+C2KP'&W-NAP#W '$
MZ#$MVW.KMN)LJ_0YTKTKY+LNVE"NC?:0= =#Y'P/R-C8^=)V1U^X$:D:CS'B
M/F+BX\JKUM6M&BBJ2, 4!(Q$G24&Q(D%7#0#<4 1513)&VR+9/'I%5\D76I9
M5(#$ L;#XFQ-AZFP)^0)K8*S E02 +GX"X%SZ"Y ^9 JK6U:T:**I P<12;,
M3%",%("0D0VC)MP%455$)MP%$D\T)%1?%-:JRN+J01<C3U!L1\P00?0Z5LRL
MALP(-@=?0BX/R(((]1K0)@:F(F)$T2 X(DA*V:@#B :(JJ!*VX);+X])(ODJ
M: RL2%()4V/P-@;'T-B#\B#0590"P(!%Q\1<BX]1<$?,$52X\TUVT==;;5UP
M66D<,0[CI(2BTWU*G6X2"JH*;JJ(NL/(B6WL!N-A<VN?0>I^%96-WOL4G:+F
MPO8>I]!\:;_)(RN0R<1-SBNH_P"7CT>+;GRV04/J7\!T^8S[7 \B*B_)Q%X"
MP^Y#?_ _UI!WN/4F78_8T.0TL'(*NPB&#]58 )QI) BFR/4NQ,.B\@J#@JAM
MFB$*HJ(NG&+(FQ9EGQW:.53HP\1?Q^8MY>=1[,X_"Y? DP.1@CR,61+&-QH?
M3X@W\&&JG4>%<R/-6(M<;Y?F$._BW-59U4ARD&@@.SK J>.YZY\G&3"WB(:2
MXDP5%R,2GT&J_P"HJ_3>.+DPYF*F3"P974&_KZ_+]A7@3D^-S^'Y67A\N(0S
MPR$,I(TU^D7UN+6^HG7QN?&M:LL+%<JI9=?;4+TN[M$](_'GS&H3,,42RC,L
M5DF0D9Z;-,&U=<C A*"'U&;KC Z4C2Q!UK7&?*@F#1O9$-P0-?(W/CX'S^=K
M VJ*CGCA.QRAX:$:D(:FY8-S:EUZHK[IP(YR*NJO)\59"PY]?;Q("-PD:<Z7
M(XB@M@B]"LN?QSR2;H;%#J?0::^/[7KT/V_WYQ__ !H.>;-&%&Y S;B1<C[?
M%- ;V_EKH'E7L1*EGX@TQ27I.9A6Q+^,ZD8Y;;-:<U^'-ZNT#\<9M>4!P76$
M$B3J14W3I56F/@9))")5LI]/+6I:_??%RX4LF'-<P$HV[0%K BQTN#<6.E_*
MI..#N"N+>&(EA'C-6E;39!7MPJ?,:-B#E)NR'&AF!#NG9S-8422W8"#<=@FV
MS,FNLD_7J5X\$.+&(H% 7Y#R^/C;^%4;W#W%RW.A!*$,L9)*&Z>%P2MB;BVI
M()MX4M*&L*[N;NNRB\*3>PH\6N8L7*J [7.2(BO-OPK9F%LS-DS6) ^I003I
M(33=2;$M=[ZZ:4S3OT5C>!;0L=UMQ+:VU6_@%MI_$BNGW]F+@NMXLXWS/,<;
MS_&,NH,^@8HQ:U-<@'DF*YKCDS*(US4Y ) Y*@QEA28TJ"A/$,J/-0U;!6T<
M>JSOG*>7*CQ98G22)FLQ^UT(6S*?,W!5O0CXUZ1]G\,K@Y'+IDQ3092QW0"S
MPR(7#(X\OI*NIT#!KV%A>9IL/43F&NG<4<1X]O) :^OQ_P JF@C^:ZA1^F(M
MYG2K;1>ID*OD#?\ <-?ZVI?5P;]TUW^ _@N_U+_9IJR3X+4CQ1J6J#_$N?\
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MNJDG65C(HG;-N4K<IJ'$F--''1]5)=1WN?GL?B\9\.*1UY-D^G:M]M[V))(
M!L1<7(N#:K ]ONR.0[CSX>7R\>-NWHI+,KN1O  !4  DD75]I 5@+7N:ZO*^
MBQ[&(85V.4-/C\!AIAAF%35T*KB!'BLC'C-#&A,,,BW'9% !$38139-DU3S2
MS3MOF=G;U8DG7Q\37J5<?%Q$Z.+%'%&   BA18:#0 > TK-U49>DI)BHNO[
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I-%%Z-%%Z-%%Z-%%Z-%9HT44:**-%%&BBC111HHHT44:**-%%&BBO_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>tm2227887d1-org_clinic4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2227887d1-org_clinic4c.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ M@') P$1  (1 0,1 ?_$ .T  0 " P # 0$!
M       &!P0%" ,)"@(!"P$!  $% 0$! 0            4! @,$!@<("0H0
M  $$ @$!! 0*!@4'!P@+  4" P0& 0< "!$2$Q05%I97(9345M:7&%@)&947
MU]@*&C$B(]-403)R)'0E-;(SL[<XN#E187%"0^4F9S15M39VMB<W=RB8$0 "
M @ $ P(&#P0'! 4)"0$! @,$ !$2!2$3!A0',2*2TE.405&1T3(CD]-4%546
M5A<88=35&7%"4N(SE0B!8H,D\*&SA#9R@K)#8[2U-SC"<^,T9'0U90EU_]H
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MN?GVK/G<M>;GR@(L]>K/E@1Y_  7+&>:.=4=9$D;$_7M(VN*$AR2LVNA3-V
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MP3,,P4$L3O6]O;?ID6* 608%O^D1%^1+)TVH2;5.FFQR#@D[/M9.OR;668-
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M92JKL$ S;BP))SUM]ZJ[R-MT;'U(UJM9BA9=%BLL5AHYJTE0F5Y(EGF!JR/
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MF!3PHC"KOH@DW:U-Q%T.L!(CQ&Q0C]?(G'$! P=!HP A6,E%$NS?-H ^97B
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MO9Z\Z$N;!>V6**QM\.X:XW2MMM,JBOO4=_M"2O=6P3'11*J4#(("U>'59_\
M6IQESN,>#8<88<88^Z+<^G@NY:O&$2R9*K6BO%(]GU]L !EI%EH-R'H<2.L
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M +-D\V:?_P";B_\ O%_](8C-Z_\ X:W_ /MI?_0;$?U-_P#M7K3_ /C^F_\
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M\A,25*B1GF6&+PU=M>;?<PXA02("%E-V[)(='-2B*VWJW-J3#;E>EL!U!;4
MRW:/#DD6YL=4>8TF-F+YCSK(^A&6&+LY3##C##C##C##C#&U"?\ %(?^FO\
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M(SZPJ#*,R,CQZ(T!V=.Q7X:52%M*?2VUW$K2A:TJ88PAVJ]8"(DL>)UQ0Q<
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MFQ^VVUNK0TTA;CKBTMMMMIRM;BUYPE"$(3C*E+4K/9C&/ASGE55G8(@)8G(
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M9RK.>S'P\OCCDED6*)2TK$  #,DG@  .))/  >'&.66.&-IIF5(44LS,0 H
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M^<D R).TC+(@8A<$8,;D.(0X_AUZ2YAO<VWK3:IHXJ]@1QOK21SI= (*=&Y
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MLMN<DZP9QR\Z[<:>&>*3B%E6NRUYV96UB"#1D%.<>;W2B17;&-?"@14PS#,
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MH*/D2_/8?S4_XA/N<Z-/J]W=^\/Q^3_37I[WEQ?,X?FYU)Z"CY$OSV'\U/\
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MM"/:Z9:;&9V%8PK!24\=8DS V5QH#JXDV+S']4;&KHLSR(TDD2:1/"_+YC3
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M1AM+KV.\[C*7)_;KFV[COD5N:UN,]\02K&98(D4J(9.!99V.0!.62GV!X/!
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MEN;EUA4IM25KC1U=K>)S;-P^L%F)4(T4[QY!M6>G+CGD,L\_!QR]L^'$+N5
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M_#EIV%+3U:[(ZK%[:3':P27U&0?Q,\;'6QA*<-JGXV10D6+#2L=F<=[&$?\
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2EJM/APQ8'&&'&&'&&'&&/__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>tm2227887d4-bc_adverse4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2227887d4-bc_adverse4c.jpg
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M%;'A(M(C%,%B,S15-@@80I,U&?%R<R2"LB4)HL)#1";B8],X@T5D)S<H_]H
M# ,!  (1 Q$ /P#W\
M
M
M
M
M                         ^;J^&TXY_!H4L_.0DU&7HD0"$'L\*0S&F2.
MQ.&F',;B.%OECO.2. 2B]': FR,[QX[+Y=#[+3Q%WB<02R+S<"4 ^X
M                                                      !CT%W^
M@
M
M
M
M
M                                                        $;YP
M7'4K0RNOZZ*.9%5*!:5P5>GF98EVNGTF7+CXD9D1EQ62[H#'ERA]5&:VKG3
MWF?F\ZV[="KONRD&III#2>QTJL/1(9;K:W"^HH+N@,JH          T5C@9E
MTD6/S/W0%+4:X9-4J]6ISE..,S3C03<HW264C>/N((L4X *J           !
M2DBXI+-QQ*&FG&XQ(2I2YW%21-&2=XB-OI/$!58           *6N6X)%"*'
MV>GJG=J>2TK!PF^'O*(MX\>D!4S:M]"%F6!K0E6'>WB(\/0Q ;P
M!T]=J;M(I<F>S&.6XP1&F.2R0:\3PPWCV$ WT6HN56FQISL<XCCZ-Y3!K)9M
M^8:BZ0':@           I-%QR57*Y0O%JBCMH)13^*6ZHS21X</I+:8"K
M         4I7;AD4>=3(;4$YB:@M27'2<2WV<B/#>,C\(@%5)/%)'T8D1X>>
M6(#4          4_<U9>H-+<J#$,Y[B'&T%')PFS5OJ(C/>/9L(!VD"2N7#8
MDN-<%;K:5J:WM[<-1$9IQ[N&(#F          #BS9"HL5^0ELW5,M+6ELCP-
M9I29DG'N8X .HMJM/UVFIG2(1P'%..H-A3A.&1-JW25O)V=8!4(
M VK,R2HRZ2(S+T"Q_9 4M0[AE5:I56"]3CAMTY2";?-U*RDDKO)+:C=Q 56
M
M                         /A*^YI'\0[]C4 L%G$10:\1$6'CN)W"^_R$
MV:%V*8Y-N^OTIO\ 1T#^11?L#8A:<T
M                             %#YF5N?;675]7%2S(JE0K0N.KP#,B,N
MV4ZCS)D;$CP(_5F2 8T.4'JQS:U>:>:GF%F^XT[<,6\[HHS2FFFV4]BIE7?A
MQ2W6W'"V,H+N@,LX                          Z2X:J]1J5(J#$4YKC&
MYA')9(-9*423/>/86!& Y-(G+J5/CS7&.SK?02E,[Q+W#[V\6PP'9
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M)H;U.:8IRIQ37>&M1.DWP"Q(B49'X6("J4*WD)498&I*5&73AB1'ACY@#<
M                        *3=N*4U<D>AE3C6P\A2E3^*DDHW4[Q%P^D\0
M%6                            I:IU^3 K5,I;5/.0S/-?$E<4DE'W>C
MJ'M5B JDMI$??                           !2<2XI,BXIM$53U-LQ"3
MN3N*DR>,RQ/!OI3@ JP
M
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MF@\%J2:#5M[J3VD J4           $9-.,_G DH[4OB\%LNS\%6YX'3Q/!Z
M$F@           C6]%QT5NV^-)6RI3KA(2EI3A.'O%L4:2,D^B DA'@(_>I_
M:(!N          %$9@K;;MQ\W7E,)XS'JB&S<47JA="4[3Q 5#1#(Z7 ,E&X
M79VS)9ENF9&A)[4GWP';          #KJL9%3IAFHT$4=W%1$:C3U%;2(MIF
M0"ELO5MKM]LVGE/I-^0>^MLVS,^(9'U5;=A@*Z          &U?@+_>J_:,!
M'-GK:57KE)$EQY27&R6VII2":V_.J/8OH[@"2
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M\0[]C4 L&G_<5>_MN+_/R$[R]'J+\Z;_ $= _D47[ V(67-
M                                              !&6=/Z(,T?]GUX
M_D]40&%OR?$B+2+6L/A&O?\ [?D ,^(                          I.]
MU-HMR<;CRF$>I$;B4&X9'OE@6Z6T\0'-M@T'0X)MN*=2;18+4E2#47FI5@98
M ._                          '07.I":).-;AM)X1XN$DUF7G)+$SQ <
M&QU(5;D)3;JGTF;N#BD&V:NN9>">!E@ JT
M4!F&MIND(4[(7'24ECKH:4Z>)N%@6"=N!X *VA&1PXIDK>+L[."C+#$N&G \
M.X Y(                          C6[7&4W-;27)*V5J4[PVDM*6EX^\I
M1%@C#S0$DI\%/=ZI;?0 :@                         "-K\<91*H279*
MXYJDGNDAI3G$,C+89I\$!(K6'";PVEPT8'YFZ6 #Z
M       ",Y3C/O\ X*#E+XIMN81R:7N^!CM<PW2PZ0$F
M            C6XUM)N^W$*DN-J6;V#26EJ2YAMZRRV) 22707G$ U
M                   #\PL?, 1G37&CORL(*2M3B4MXL&THD)Q+N.8;JND!
M)@
M
M  "&]0OZ#LU_]G]W?]@5 !B'\GU_W)6_]H%]_E ^ SN          #17@J[G
M5/;Z ".;4>XERW&@ZGVOAK;(HW9.#V?':9<; N-CWP$C@           C6=(
M--]TQGQF2"4E>,#LF\;N*=A]IW<4[OG]P!)1>:6'F            CJ_GS93
M3"*I^+]Z2DC^U.U<7KEU>@]W'O@)!9^HM;=[U-'6Z-[JEMP[F(#Z
M  "E[Q<X=O3E]J[%@E'VSP>/P^N6WA8'OX@/M:CG$H4%?:>UXH/U?A<'?V]/
M#P+= 5$           "-FG_^_LAKQGC@TC[0[)X)J07_ $G#;B1=_8 DD
M        $<7D_P *LVZDZEV)+CBRX79.T=I/$^KOX'PL._YH"14;4)VX]5.W
M##'86W#N8@-P          HJ_P!W@V\\YV[Q>9/,82.S=JPQ618<+ \<0%0T
M56_2X2N+QL6&SXNYN;_43MW/G?. =H          .NJRMVG3%<3@X1W3XN[O
M[G45UMWY[ !3&7[QO4!M9S_&.+\C[8[-V;>P<PPX>!>#T8]T!7
M VK/!"SZ,$J/'O;# 1U9\@WJ[<2#J/:^&M!=G[)P.RXJ+9Q<"XV("1P
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MG^4[Z X>;?O%0[?$BR4UGQ(YF6BT:N=O)D]N[ ;A3"1V(V">^?XN[N[>@<?
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M<1^6OICWG)B>%B<+B[O&77OL/-MW;,6^30N52>)$?_#I'"T[^ZY6C>W&H
M                        /A*^YI'\0[]C4 L&G_<5>_MN+_/R$[R]'J+\
MZ;_1T#^11?L#8A9<T
M                $99T_H@S1_V?7C^3U1 87/)\O]T6M?[1KW_*"0 SX
M                       "E;T=-FW9SA2^PFGA?;/ [1PNN6WA8'O8]'F
M.;;:^)18*^T]KQ:+U<FN#O\ F\/ MT!WH                          Z
M&YE;E$GJ[3V3!HS)_A\;AGW^'@>]YP#@V2X;MN0EG,[<9F[]M<'L_$ZY_P":
MP+=PZ %6                          "@LP'S8I3:RJ'B_P"V6"XO9NTX
MXN$6[N8'AO=_N *TA'C#BGO[^,=D]_=W=[U-/6W?G<>\ Y(
M             CJZ7B:N2W$'42B\53A=F.+QNT8'T<; ^%@ D1/@I[O5+;Z
M#4                          1Q?3_!E4/_210-Z0HMSLO:./UD]3>P,V
MO/ 2(UM;;/'>ZB.MAACU2VX=S$!O                          $:R9&%
M^PF?&6YBVO"#V3'B'N??.'5P+S0$E                            CFX
M9!HNZW6O&91R7Q<879.)VC#'9Q\#X6[Y^T!(Q=!=WS0
M         ,L=A@(VIKYG?-69\9[Z4)1A3^R;O!Q(]O:<.OO>?L 22
M
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M3(S(C(C)"NDCV&0"F;"4ZJA-\5Q#BR?D$:D)2A)^J8EL21%LQ 5L
M  -JO!5^]/\ : 1[:*WE5RX2<>;<22VMQ"&TI4WMV[RB+$\<0$B
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MCCZL1>3N53'FC1'H6\FP49?EMWA[;9LMGRU:92\71WAQ63LB-$;C4
M                    'PE?<TC^(=^QJ 6#3_N*O?VW%_GY"=Y>CU%^=-_H
MZ!_(HOV!L0LN:
M            ",LZ?T09H_[/KQ_)ZH@,+GD^7^Z+6O\ :->_Y02 &?
M                     4O>1N%;TXVEI;7@W@M:24DNN722MA@.7;9K.C0C
M<62U<,L5)(DD>PN@BV .]                          '17*:RHLTVU$A
M7#/!2DDHN@^DCV& X5EFXJWH9NK2M>+F*D))*3P5AL).S8 JH
M               4)?QNE2D<%UME7:&2WG$)6G#B)Q+!6S$P%90\3B13,\3.
M.R9F18$>+:>@B <D                          1W=/'*X[=X;K;;9F[O
MH6A*E.8'T),]J>CN )#3X)><7[0#4                          1W?/&
M[11>$\VT7:>N2T)4:BWB\$U=!X )!:^I-]WU-&W_ )I -X
M            CJ2I[W\PT\1'"X;A&V:$[^Q&.)*\(MH"10
M             1U<!R/?;;^XZA+9\7>;4A!K618EU5&6*< $B%T%YQ -0
M                      RQV& CBGJD'?%5)3K9LX(W&R0@EIV=U1=8\< $
MC@
M
M  (;U"_H.S7_ -G]W?\ 8%0 8A_)]?\ <E;_ -H%]_E ^ SN          #1
M7@J[O5/9Z "/;7;6BY+B4J B,E:F]V0F0ETY&'=-LC,V^D!(8
M(WFLK.^J:[V!"T)0LNV=H22FS-/03..*L<0$D            CV_&7'4TPD0
M43<)*#/>D$QP\%D>)8J+>P 5\SL9:V8>IHV8XX=4MF/=P ?0          4Q
M>"%KM^<EN.4I1I1@PITF27UBV<0\"3@ ^UJI4BAP4K83'42#(V4N$Z2#QZ-\
MC,C 5"           ".&V72OMYWL*"0;22[9VE)J5U"/#@;V);OG )'
M      !'5XM.+K%O*1 3+)+CF\ZJ0EDXY;Q=8D&9<3']@!(:"P0@NC!*2P[V
MP@&X          4;?;:G* \E$1,U7&9P84\3!*ZY&9\0S(BPP =]1DJ33(A*
M;)HR9;Q;)1+)'43U=XMAX .T          '7U5)JI\PDH)P^ [ZF:MPE]0^J
M:NYB IJPD+106R<AIA*X[_J*7R?)/JA[=])F76+Y@"M0         !M5X*MF
M/5/9T8[.C'N8@(]M)EQNNW$M4%$9+BVS2\E]+IOX'AB;9&9MX%WP$B
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MAW[&H!8-/^XJ]_;<7^?D)WEZ/47YTW^CH'\BB_8&Q"RYH
M                                            (RSI_1!FC_L^O'\G
MJB PN>3Y?[HM:_VC7O\ E!( 9\                          !2MZ(6Y;
MTU#<=,I1\/!E3I,DOKECZH>!)P(!S;:2::+"2IDHYDV6+1.$X2?.66PP'>@
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MC$U*D$QP2WB,U$1F6_CY@"0&OJ;>)8'N(Q+IPZI;/0 ;P
M          !'$IAWW]072@(4V3:]Z9VE.\G%!X>H8XGCB D<
M               $=W TZJ[;=6B$AU*>+C).02#9,\>AHSQ7O& D0N@NYY@
M                         T/HZ</-PQ 1S3FG"O>K.]A2AM26]V64A*E.
M;-I&SCBC#: D<
M
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MY.FP;F"B/#BD9&GH W7TM)M+5!@H3'.(1(/!@W>,:-O1Q#,S4 J0
M  !$S$;HC-J.@K_D/^+E;YMH^WNU'@?4PP[/C@6'G"1)>) BV&H)
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M4-5^XUIIZHAK6WB^<E3Q23WBVDV9GPL,!,:=P20
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MA.\O1ZB_.F_T= _D47[ V(67-
M                        !&>=!&>4&:)$1F?YOKQV$1F?_AZH]PMH#"WY
M/E_NBUK_ &C7O^4$@!GP                          %)WNT3UMSVSC',
M(^%C')TV#61.%_G2,MW !S;8;)JB04$QV8DM%@SQ>-N>9Q#,]X!WX
M                   Z&YDI71)Z5,')(V3Q9)SA&O\ Y^);H#@60A+=N0DI
MBG"21NX1S>-\T%OGMXAF9GB JT                          4#F$TEZD
M(0N =0(Y#!\),@XV&#A=;?(R/JGMP[H"M81;L.*G=W,([);F.]NX-IZN]W<
M')                          $;79'0Y<UMNG3SE&A3AE(*2;/9BQZ3:)
M1$[B DA/@I[G5+9Z #4                          1S?3"7I-$-5/5-W
M)!F2DR3C\$S4G!6!&7$\X!(36QILL-WU-'5QQPZI;,>[@ ^@
M              C:2P@[]@N^+34HFEGV[M9D2.H>SLV]@K'S@$D@
M                   C>X6D+N^W5JIRGU(XN[+*4;1,[,3Q9Q(G=XOF )(+
MH+N>8                           ",Z;'0F^ZN\5/-M2DHQF]J4HGO,*
M/O8(W<>]M 28
M
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M7-DW-['_ (*N)('C&F_UC"]E,>N"W\XRCXO#?YMW]Y5^7Q717GLU<1XQIO\
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M4E1$:5),E)41]!D98D9& U
M        &BBQ+#H$3;9HW1M2DT]W9WL!1'+W-Y+>+B
M             ?"5]S2/XAW[&H!8-/\ N*O?VW%_GY"=Y>CU%^=-_HZ!_(HO
MV!L0LN:
M     *7O2NS+9M>MUZGTU=8GTNFS9<*EMJ-"Y\IF.XZQ%)98FDWW4$C'N;P#
MSEYM\S3F6R+6S6@0N77-1;GB:ZZ7$K2KG=,_%2H-1B*J7!-6.R&?%P] !+WD
MZLB54=#S-9JD<Z?6ZM>MV3:M23/>.FS)%66_(BFH]JC9>=4C'S &?X
M                    4E?&Y[VYW$WMSU+'<)1J^J%T$G: YUL;GB2#N&9I
MX>PU$9'Z.]MV@._                          %/W3N>(YW$,R3PCQW<<
M>[T8;>@!P;&X?O;@\$U&WB[NFLE$K8O \=[;T@*N
M      $>YBFSXH;XIN$1R6=K9+,_JA8$>YMP,!7$'#L43#:79F<,=G^;3W]H
M#E                          ",[N-@KFMK?-SB&;FXE!+-)[3\,T["+
MNZ DI/@I_>E^T W                          "-+^-HI-"WS<)1RNKPR
M6?SZ?"W=F'G@)':^I-]WU-&W_FD ^@                          C&4I
MG\X$$L7.*;;F!$2^'AN;<3\'' @$G                            C.Y
M.![\+;-Q3A.$;VYNDHT;>G>PV='? 26707G%^T U
M      $<4UAE-[U9Q+CANF2,6S)6X6SI(SV'T@)'
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M'YS%<Z?2?XEM6OZQ5[^[=?\ PD'RO+N@HX(XC\YBN=/I/\2VK7]8J]_=NO\
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M'!'$?G,5SI])_B6U:_K%7O[MU_\ "0?*\NZ"C@CB/SF*YT^EHO4MJT)I\_\
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MN#,#15JX<[7GYDS)=I17%)<2B7744UQN"\TXRY*6X:FUMK5CN%T /6N
M
M                ^$K[FD?Q#OV-0"P:?]Q5[^VXO\_(3O+T>HOSIO\ 1T#^
M11?L#8A9<T
M        ;5(2LL%I2HCZ241*(_/(\2 1CG U'B939FOLQ8B7&K!O!:#.,RI)
M+3;U1,C-)HP5M[X##!Y/HHUZ2*ZXKPEYCWP:L"P3C[X))[$EL26WN ,]X
M                       I2]GB8MR<X<HX9%PR[03)O[F*R_S1$9JQ <VV
MEDY18*TOG))36/&-OA&OS>'@6Z [X                          =!<[A
M-T2<LW^S$EHS-XFN-N%@>WAX'O .!9#A.VY"6F4<U*C>PDFSV<U=<_\ -&1&
M6!@*N                          % 9AO)9I#:U5 Z=]LL$3Q1CDXF;A=
M7<)*O"/9CW %;0CWH<56_P 3&,R>_N[N_BVGK;OSN/> <D
M            1M=DA#5S6TT=2.*;BG?M8HAO=IPQ/ WMTR:P 20GP4]WJEM]
M !J                          (YOJ03$JAXU X._),B244Y''P,NIB1'
MP^GI 2$UM:;/'>]31UL,,>J6W#N8@/H                          (VE
M/H*_8+7C$R4;2_M'LIF2^ICCV@BP3NGWP$D@
M   CBXI"&[NMUI525'-?%PB%$-TG^DOJVZ9-;I?- 2.707=\T
M                %!074'>-3;*::U)2C>B=G-)-XI_AL,%XX8@*]
M                                           'C9\KN0VO*S2GQ&VW
M,,TJ5@3C:5D7^FHG1O$> #U&:-2(M+^2!$1$19<VE@1$1$7^@J?T$6P@&*OG
M^:D-8^C_ $OT;4=I0J;L1JQ+FH[>84-J*<OM= G3]V0I;9*1NMMQD*Q,S(B
M=_FWS2VK7Y.I:_Z%482KBJ67E,.DK);"DO7I-A]C4TEHI9)-TJLVL]PEF98
M+/=..MG78WR/LS-;^>%QNMYZU2GU.Y;&)^$;"J70H\M2J>7 6ZG>*3&/ CWO
MG0&*K)GF9<]S63HZJ>H_(^B1K<L_*V559ERWBZW%4]=]-I+[C\M+,=UYQPBC
MPV^MNJZ $JY&<WSFV\S'3G6*;HNRYBVMF3DFU/C9K9D2'8Q-5RH4MMPEL08C
M\AYLWWG63+=;P4>W8 R@<@?FJYYZ\K0SPRJU)TEJ!GEI_D/TVXJDCAMJJLIA
M;<)Q79T2'=S<D[Q]"0&+2;S=.:CF'S(]2&A_3O36;UE0:@N)9$N0PTVQ9+$9
M;S;DN0^\\XP;;B5$KK$6&YMP 3/HXYN_,$TJZ_K;T(\TNB-S'\V):4Y>Y@MM
MM-,$B6[&-E+2FGVFY*4DM1$9$HL.@!9%Y1I===RXYM.CN^+.H)71?<9Z*NS*
M&A'7GSJECV-9+(C-)-OK;,!+6H?FA\Z?EX9S9"YG:LK>IZM.&;57H%$*U(Q0
MG3I3<U^ P2)$MA]E2))1Y&\HE'OD9[0'HLYF/-ALK0/HGMO4@ND)N&],S[>H
M:\MK-)PD.52M7)2F7V&T*[0TI10Y4M!;#5B \[50U>^4?T#)V-KNGVFU(R8-
MEN\Y64*8T8IK-B.22F)D\(L)!H\5EAO]_N@/01I'YRN3^HCENW+KRJ\5%N-Y
M:4"<68MK+>2IVE7+3(FYV%:E25&29]1;4@L5D9;0'GSLCF"<^WF$6IF!JST=
MVXS9.GNVZM5EV7;!L,/2+NIU$ER5R&V%*<=>D*>A-H,\%*,B/$!E.R>UR<Q7
M4GRI\^<SJOE;5<B-7F2D+M-/4_&D/*NPJ,AYVIR8\-:4J;)U#"E'N[,"+H 3
M?RA^:76M5O+4NW49G?4HL?-;)NFWHWF6T[P8ZH]1M^-**G]H9.4I32ILJ+NE
MO&G$S 6 <M/6[S*.8WD%KMS>I]?.E4-B5<- T[PW:>E$=4: NHPJ@4=]:W6E
MN.1B(TJ2K$CP/I 82.1!9O,45K4SO=R$N1NCPJ/?TMW53(E\-_QDP5Q(7';+
MCJZQFTE>"2 9H=:?-IUU:F=;U7T!\KIJD4ZYLKXC2,S\RJI,IL9A-1)AY3[;
M';I9-(W)!)3@DB/8 K[EI<W/5K:6M^I<M7F2T^CGG-*2@[.OJGU&G.QZVX33
M)J;/LDQ32MY6_P!"<2/ !ZSMY.[O8ENX;V]CLW<,<<>]@ \H7,^YONJRJ:S:
M)RVN6S;#-:SW4I97I>2ULNL6R:VW<"6A;YMMH9,DF9J07=/' !0>CW6SSM,@
M=:MGZ:-;^3<S-C+N^UQT)S0I[2V8EO-2DL_;"GXJ38=2T>]L,S+: G_G-<Y3
M.?3UG7EOH1T-V>B_M5N:1LMN+:W7_>@<M+B&C<8)Y1+4G?0H]YO8 QXU_F8\
MYGE6W]EA?7,?MEK,?3OF168-*K5;A]G;]YLBIRHC"67G8[K1-.Q2=7U5*[V)
M ,GW/*YEN<FF[E_Y9:IM(MS-T\\PYMK2H-60TB0E5/K1L.O,;O';3OH2_N'U
MCP,@$E9SZXM0MH\D<M8=#J^YGD>7=)K_ (UX)'C49,1;KKG"XQ$6\I)'X8"G
M>5[KNU&ZDN3Y<>JO-*NE/SDI]&O69&JQ,DV1+HT9QR$Z37&61$6[CX0#"=I
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M\?ES7=SR[=U(+R_UL6G;]^9'&I"59GT>M4>3V1+B8YH=4BG.NF[O)):L,>Z
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ML@)ME,3,;CY/?4G/WBOVC%N]TW=43JE=N?M7L6I5S2,_\(M'_E*_\O ?<?\
MH!C_ /P#HUS]-+X\?^XAIVAHMYWZ)6)-?4FOXIO_ "$CV$^:='JP^@*@
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MQE%.HR&9S<:02,")39OJ3UB/H ?I\
M                                                  /A*^YI'\0[
M]C4 L&G_ '%7O[;B_P _(3O+T>HOSIO]'0/Y%%^P-B%ES0
M                                             1EG3^B#-'_9]>/Y
M/5$!A<\GR_W1:U_M&O?\H) #/@                          *5O12T6]
M-4W(3&6DVC)Y39.DCKE\X9&1X] #FVVM:Z+!4XZ3RS:+%Q*";)7FD@MA .]
M                         '0W,I2*+.4ATF5$WL<4@G"3YZ3Q(R <&RE&
MY;T):WTR5&;N+R6R:)77PPX9$1%@0"K                          !0E
M_..-4A"FY2(A]I8+B+92_LXA8I)*B,MO? 5E",SAQ3-6\9QV<588;WJ:=N!=
M&(#D@                         ".[I==;N.W4HEH82M3N\RIA+IO8=PE
MF1FWAYG2 D-/@I[O5+;Z #4                          1U?+SS4FB\*
M8B,2I!DM*F$O<4C4G81J(]TP$A-;6VS,\3-"-O1CU2VX=P!O
M              $<2''??W#;*8@FR:6:HIL)-2NIW'<-XL,<0$C@
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M#J$OGB25D1^%L(S >OCE@&D]"VG<D[^"<OZ&@^(A3:]Y%.BI5O(61*(]XNZ
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M ""C_FGZ)6(M?4FOXIO_ "$CU^^:5'JP^@*@       &A]!^<?[1@*DS&_\
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M+9<VN5659DZJ09%.:>;GSS?@HI[4F-NJ::B/-F6XO#8?<V@/T%@
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M;B_S\A.\O1ZB_.F_T= _D47[ V(67-
M                             !&6=/Z(,T?]GUX_D]40BR-,[@PO>3Y(
M66D.LK-*B0K,>^"2HTF23/WP2>A6&!B+;9F8]4T[\,]PD
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M<@                          4#<L.=(N&WG8T!4EAM3G'D$9X1\#QQ/
MC+;L$<JF)TSI+)5ZG8DBPPP(MG>V= D:@                         "@
M;SAU"5)HYPJ>J:AN09O*3CZBG$CWCP(Q%M,>M-@KMHC)MLC+ R0@C+O&22Q+
MT!(W@                         "/Y$*>=ZPY2("CADVO?F[=U&"3+#HP
MVGYHBVFVRW[2;)W=Y( E                           *!KL2<[=%!>8I
MYOQD&[QI1&>#/=VX%@6P1;3&B9TED[N\KTN@O.(2-0
M!#3:$[FC=-+41]*02  ?F'AYH"A8*7??=4U*903>"-QTG$FM7F&CPBPP 5T
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M#RIR@RYR0LND9?96VI1[.M.B1T18%*H\&-$:0VVA*$FZ<=IKC.;J"(U*Q/8
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MX2ON:1_$._8U +!I_P!Q5[^VXO\ /R$[R]'J+\Z;_1T#^11?L#8A9<T
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M>'F@*"@-)*\*DZ4#<-24XS.T&KB;,?J&/4^8 KT
M                               !\)$6-,;-F7'8E,GM-J0RV^V>'?0Z
ME23^8 ,1H\5HF(S#,=E/@LL-(9:3^]0VE*2Z.\ WNO-,-.//NMLLM(4MUUU:
M6VFT)+%2W'%F2$(2729G@0"R+,/F0:*LK+IDV7>VH#+^DW%#?3&DP#N"F/J:
M>6XIHFUK:EJ02B6DR/;LP 759?9D6+FK;-.O#+VZ:)=MNU1A,B'4Z)4H=1CK
M0K:1+7$>>)I>&![JL#P,C[H"MC(CZ2QZ?V>D!Q&Z=3VGER6H,-J0YX;[<9E#
MR_WSJ4$XKT3 4O=.8=CV2]3HMT7/1*)+JSQ,4R#/J4./.GNFHBW8<-YY$B3@
M9[=Q*L %8MN(=;;=;/>;<0EQ"BZ%(6DE),O/(P&\!1&8N8UFY3VA5K[O^MQ+
M=M6ALG(JE7G.);C1&2)1FMU:C2DBP2?= 4SDOGME7J$L^/?N4-VTV\[4E/.L
M,5BEO(>BN.L*)+J$K;4M)FA1[=H"O+JNFA65;]5NFY9[5,H=%AOSZE/>/!J-
M%CMJ=>=6?T*&T&8"'L@M4>1VIZCU2OY(WU3+YI-&FNTZI3*8LE-Q9;+BFG&5
M]8^LEQ)D G]QMMY"FW6T.MJ+!2'$I6A1'TDI*B-)D8#CQ8$&"E2(,*)#2L\5
M)BQV8Z5'WU$RA!&?G@.6       "/\S\T;%R;LRJY@9CU^';%HT1"7*G69[B
M6HL1"B49*<6M24I(R0?=[@#ILFL\,K]0%FP\P,I+LIUY6E/<=:BUFENH>BNN
M,F274I6A2TF:#46.T!+(                    "!<]=3.2>FJDTZNYU7W2
M+&I57F-0*;+J[[;#<F4ZLFD--FXM&\I3BB+ !+-JW30KUH%,NBV:@Q5:'68K
M,VFU".HELRHK[:76G6U$9D:5H61EYX"H0         !3EVVM2KTMVJVO7&W7
M:36H;\"H-,NJ8<=B26ELOMI=1UD&MI9EB0##CG#R4>753LM,TZ^>3U0*I>]>
M[*^N<=VUI;QU1JEU&>V^9+=4UAVSK&6[@)W=^Q<NZ(O+R(G<82N5%GCFSEII
MDKUD6-<[U(M6VKPNNGT*G[JG>R1(U>7&91Q.*DU&3+*2,\",\!JV89MC[O&>
MYNJYBZ>0^U3;;:/)MLK_  .57TT8*++(X?&R.?XJM0Y[3OR3MP_S:_7QP?FV
M.B?VDV.O8[2=M(BS\Q/!]9_BIU#_ (]ROK:_7P^;X[I)3WD[:?$3X><_Q4ZA
M_P >Y7UM?KX?-\=TDG>3MI\1/AYS_%3J'_'N5];7Z^'S?'=))WD[:?$3X><_
MQ4ZA_P >Y7UM?KX?-\=TDG>3MI\1/AYS_%3J'_'N5];7Z^'S?'=))WD[:?$3
MX><_Q4ZA_P >Y7UM?KX?-\=TDG>3MI\1/AYS_%3J'_'N5];7Z^'S?'=))WD[
M:?$3X>=N+57J'(__ !W)/89?4U]!EA]\!\XS#I).\G;3XB?#SN%'U-9_Q)#\
MIB_)?%DF7%Q2X9;.C C?P(3\YS'?O)\/.B.TG;2W1B)L\/&Y?^*G4/\ CW*^
MMK]?$?-\?.[>2GO)VT^(GP\Y_BIU#_CW*^MK]?#YOCNDD[R=M/B)\/.?XJ=0
M_P"/<KZVOU\/F^.Z23O)VT^(GP\Y_BIU#_CW*^MK]?#YOCNDD[R=M/B)\/.?
MXJ=0_P"/<KZVOU\/F^.Z23O)VT^(GP\Y_BIU#_CW*^MK]?#YOCNDD[R=M/B)
M\/.?XJ=0_P"/<KZVOU\/F^.Z23O)VT^(GP\Y_BIU#_CW*^MK]?#YOCNDD[R=
MM/B)\/.VKU5:AR0X97W)Q)"S+U-?223,O^D"GYOCXFWWDV*:^TG;.:)B<1/A
MYT,<Q#5IJ3RTY8E^9XV)F+,HN:5'>AIIUP-H=4MA+K\A+A$V3Z<3-*2+I':?
M9;%.<YC-SF,S>4;T<#OOLLVBSC.MGKS%YE?3>31N[T[WE>0^E\Z7FG/0([SF
MHZIJ<6G:9PY&)]'>J!=\>BKW9/(:;Z*:;IN-&98N)FJ)GDVZ+7/^.@YIGZQM
M3]A2/PB*>JF0=%Z?J7/F>-YQ\=!S3/UC:G["D?A$.JF0=%Z?J/F>-YQ\=!S3
M/UC:G["D?A$.JF0=%Z?J/F>-YQ\=!S3/UC:G["D?A$.JF0=%Z?J/F>-YQ\=!
MS3/UC:G["D?A$.JF0=%Z?J/F>-YQ\=!S3/UC:G["D?A$.JF0=%Z?J/F>-YQ\
M=!S3/UC:G["D?A$.JFS^_=:/+]1\SQO./CH.:7^L;4_84C\(B>JNSV]=1P_4
M?,L;.B:G$E\Y#FB3R:)_4=52)DR4C=BR4;<<=N%1VB)V6R#?NCYABK/6<SXY
M[FEDDB_Q'5,]TB27VF_T$1$7_P 1[PB-E<@Z'T_4CYICIGUFGQT'-,_6-J?L
M*1^$1/53(.B]/U)^9XWG'QT'-,_6-J?L*1^$0ZJ9!T7I^H^9XWG'QT'-,_6-
MJ?L*1^$0ZJ9!T7I^H^9XWG'QT'-,_6-J?L*1^$0ZJ9!T7I^H^9XWG'QT'-,_
M6-J?L*1^$0ZJ9!T7I^H^9XWG'QT'-,_6-J?L*1^$0ZJ9!T7I^H^9XWG'QT'-
M,_6-J?L*1^$0ZJ9!T7I^H^9XWG'QT'-,_6-J?L*1^$0ZJ9!T7I^H^9XWG/E(
MYR_-)EL*8>U&U0FE].$20D\2[QE4,1/5;9[<FZCA^I'S'%3.FK2,<YGFD164
M1VM1M4X;9=7&'(,SQ(L<3.HXF$[*Y!.Y=19Y?J3&98R-RI]?CH.:9^L;4_84
MC\(B.JF0=%Z?J/F>-YQ\=!S3/UC:G["D?A$.JF0=%Z?J/F>-YQ\=!S3/UC:G
M["D?A$.JF0=%Z?J/F>-YQ\=!S3/UC:G["D?A$.JF0=%Z?J/F>-YQ\=!S3/UC
M:G["D?A$.JF0=%Z?J/F>-YQ\=!S3/UC:G["D?A$.JF0=%Z?J/F>-YQ\=!S3/
MUC:G["D?A$.JF0=%Z?J/F>-YQ\=!S3/UC:G["D?A$.JF0=%Z?J/F>-YS4N<_
MS2\<3U&U,O\ ZS?_  B**]E,BF.33=>GZDQFF.IW*MUPT\X_FAIFG44ZCZIV
ME721Q9)IV;/!\88$**=D=G;>35<VTIHS?&W4S$U3-KF?'/\ -._6/J7L*3^$
M!7U0V:Z#TJOG.+Y\GQS_ #3?UCZE[#D_A .J&S70>D^<XOGR?'/\TW]8^I>P
MY/X0#JALUT'I/G.+Y\GQS_--_6/J7L.3^$ ZH;-=!Z3YSB^?)\<_S3?UCZE[
M#D_A .J&S70>D^<XOGR?'/\ --_6/J7L.3^$ ZH;-=!Z3YSB^?)\<_S3?UCZ
ME[#D_A .J&S70>D^<XOGR?'/\T[]8ZI>PY/X0"=D-F[-%QI\I\YQ?/EI\=!S
M3OUCJE[#D_A 6^J.SOP_I^H^<XOGRO*Y:?-3YA^<G,%T_9>9F9]56NV;6ZN^
MW5J.IE]IJ8P4B&E2%_;JRQ]4V'T;>@87/]ELFPN2WV(N+JF*Z*?3O.=@,XQM
M]?Q=WU4S]J/)9O\ GW-]^E_"6MR%#<6HU+7%CK6H^E2U-(4I6W':9F//E433
M7-D6QY6\;L.0M24(4M9D2$I-2S,\")*2WC,S[Q$01Y+$O'3SC.?EGAEIJ6@:
M">7U:B[OST?D(I]9N" 1S7*?/F*<B-QF&8SZS2<=\T*-1H+ MIGT$)&.K*[G
M9<V/ET:I\M,L.919]<K]A9FU.F)5_HN:X4)BN3H4-N1%F;R&]Z,I_K)(S5MQ
MP,DG@'Z =CW92;\M&V[SHJS<I=S46F5N$I232HF*G"8FMI4D^A24/D1EWQ$Q
M$Q9.X*J$4TQ3HB+ V]\/M(LG6;>^'VBR=9M[X?:+)UJ,OQ1IMZ1L=6E3S!*2
MRZME9EQ"V;[9DK#$-.JT^U&Y*H*.I2Z9#,]_Z@WX:C6K#<3ABI6TSP#3YDS:
M[/;WP^TBR=9M[X?:+)UFWOA]HLG6;>^'VBR=9M[X?:+)UFWOA]HLG6;>^'VB
MR=9M[X?:+)UN!5#4FGRS(U8DP[X!FE1^IJQ(E),C(S#2:8TQ.E3%@KW[?:W4
MO(23\@DI?=6\LO5#QZ[AFK SVAIC<A,\J9TJVV]\/M(LG6;>^'VBR=9M[X?:
M+)UFWOA]HLG6;>^'VBR=9M[X?:+)UFWOA]HLG6;>^'VBR=;:K>)*CQZ$J\SN
M;-O<$Z32CRTEDY7[D4:7R7Q&]Y3KSCB%=;YQ*S-*?0$3=TS,53P*IG[.C=2*
M18"KQ;RF(L\K4$@                                #%_SCLZJKD%R\
MM0&85$E.PJHQ;3U(B265K;<:55HLN.M25H<:41\,CZ#&8R'#TXK-;JZK]6:H
MMX7#QM4T82J:=VQ^3/:ZGY,*H5B6\N34*Y7*U4ILMU1N//KFU!^29N.+-3B^
MLX?29](]2X>[IPF"IP]U$:*8=:W\S>7G*GUO#Z=U49%@*[(B-")FV;0$.%4X
MK<ZFS8KR"6VMAUS \-CC3:EMK+$CP-"B(R\X39-431O2IJJJHTT[K] 7R3G/
MRXLQ]&%Q965NI2*BQE-5F8M.5)=<>6TQ44,*X:5.NN*)""21$6!$0\]]H&!N
M\)FEMW%G*MM;[D.(JO\ #S-6Y$Z'J@NBI'1K:N&KD>!TNAU6HI/IZT* _)+O
M=UH=:9EBJ,%@+[%5[E%W5/GLFQLF&N_>XB[NN=7$<,P_-BT>9?4OFI\_[,VK
MZB7'KKM#+JZJB]!MVI.N2(*RHM44N(RW%D]MCM(+=P,B2DCQ'.[+\%A\/LKB
MMI9B+S$WDS9,Z9B9\<Z='EUZUGM'QV)QN98/(\+/N\)1R8JLT:-]^A'F+=FF
M;3!8-._.$67^7MB0(3%'AE4Z90X--.*Q'*,AA2'&&6'-YEO!6)=;NBWB<51>
M7LTXB?MWEOGMW;%6$P5=-U_VM,\BC?U>67G%NO0-R:,S-<UM:S+4U,6=:-\.
MURFU6'8]JU*EPXDZNHDDHG&BIKC"2[7*=\'I(E$6W <K9FXQ&38BNO+HFN:^
M593JBJRV+/)8X^T-_=9Q@HN<=,4>[LY5=FF;)T>'E2MY2GJTS[TBZ2,M[\TW
M9AOV74#J, UU2.VM\ZG3X[*78S74?9492FD)+'$_"&HYQF&*P.U> H_^E>5S
M%=&N>5^ALV29?@L;L_C*ZY^U1=TS15JT+#=&<OG>\SBW=/VHVEY]OY(Y(4M^
MFNU&CJ@]J=ON'$73CJ!K-2W%M$^PI6TS,=DWV7W.3Y_.-QL<K#5W<33=:K8X
MVAT9C7F>4U9?@X_&NZ[)O/)/TV+XN:'F7SI+LSWR^TN:&;%>M++BI4F#3;IS
M]6\1LKDQHG GSG$N&E$9!O>J8&>W# :?E]%[G^<8FG&5?E,MHF9H\>[/G;1B
MZ<-D618>_N)_,8^K15&JUAHU8ZDN<]R3KJRLS&SYU,4O4#8%_5Z#3ZM;S2X2
MW8Q.RV"FQ'8[$U+C9I0VI"346!J4.;EV:7$9[=;-7UW[R;[U:_%;9$_I</%8
M"\O,NO,VP]5E[=Q;-/EBVQZQ<TN9O9N4O+6CZ][GIB(T6;E]#K<&AN/-I[37
MYM)4ZS%2I4A!&DYJ#Q(EXX;!:VXKJV5Q<X"[CEXR]JBFB/+Q6PN;(W%YM%=Q
M>UQR:*:9FN=44\;R]Z-LZ>?%S5Z]6M7N4&;K^2V3-!K,M=D6<NG<>'<\*+*7
M)8IK2W%NLXR(JDMXD9]\<_"Y;B,GP%&/S2??8J]HF8HW-%C@UYEA\QS.\P&!
M^SA+FJ(JJ\;&GF+FIGOF[SSLD$:G;179^=5G7)3:16F3(R16"B5&-"8ELI(M
MQ*'TH4X1)V$1B[V0W6"Q&=X_.,)'(F^BKE4[\39IM\[B]I]&,C(,)@<5^RNJ
MJ>15O3$R]6O._P"<7>>@JD92Z;-.-#CW5JASLBTFD6PP;S:3MQR:QV-B6ZA4
MEHM[B+0LL4F1;!KE5[C,]VGKV>RFKD5W=4S>5ZHMW(GR-EN[G#9/L[&T6:4V
MX7DQ%%/.T;O##$[F?'\H:T'Y3)UV7_GK S6M:"U3[IS#R>-V"7B:WJFZQ/?C
M)=[0GCFU#-2=A^:,GC<?@MG\9=8?%4^\R^JN+NN\U53HW/-+$9;A;S/;F<==
M53=8BJB:[NC739;'HEZFN5QS!++YCVE:R,_+:9:I=9G1B@770$.H=72JU"98
M:FH6:7WS)*Y*E88GW!G<ZRB<NO+N^N].$OJ8JHG7$[WF8W*<QKQ=-Y<8B+,7
M=5651]$^=D:DFLF'^%]5X+O#_C-P]S_TA@Z]-,Q&[,,S1,17%NY:\=>LKDD:
MHM>&JK/3.W5YGQ6*;I:LNCUFO9:981)<Q$28BGT^=,2B2PP3C));61^&6TC&
M ]UA<KR>_P VS2/>9I3/V+=RG3^EL&<8J,RQ.&PF21[FXBF(KB-^=_P\3']Y
M*;$A476OJVM.E-DU1K4K,FBTM);,8U,FLT]I9["Q-;4<C/80[2RG%U8_L\IQ
M=>B:IC1YW7F:8;\KM5<W-,VV1-L^9^@V--AL()                 !\)7W
M-(_B'?L:@%@T_P"XJ]_;<7^?D)WEZ/47YTW^CH'\BB_8&Q"RYH
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M1J-O?,/P^::-1M[YA^'S31J-O?,/P^::-1M[YBFJ+N8]4T:G0W$1]CI^T_\
MQ%;_ /VI'%5W%,6V19/)GZ%,S95%D;[];GE.?[@>GC^Y<#[ R/*^U$_^LXBW
MGS]+L[+YF<)1._8R-#".8  "@("6BO*IJ)I9.&2-YPW%&A1;N!8)\$L %?@
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M3Q,+UQ^T\TO%1RU4D>1=]8ECA?=Y?E)(&BYM^_P\,=L?\\7WEXU^ X#K)J
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MQV%NJQ/T# 1Q9SR'*_<J$3%OFA;>+*HZFB8Q5W'#(B=Q\P!)(
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M?]Q5[^VXO\_(3O+T>HOSIO\ 1T#^11?L#8A9<T
M                                     %"9H_HRS%_N+=WY/U 47G[.
M?(1NOQILROT^9X_W\N?\HZD/179S_H-/AJ=>9Y^_U>53PWEB@
M
M
M
M                                '1W#]QT_^\5O_P#:D85T;_\ RU?0
MIGUH\L/UM^4[_N!Z>/[EP/YNR/*VU/\ K&(_YY^EV=E_[I1Y&1H82-QS 2 "
M@8#J#O"IME*6I9$@SCFR9);ZO1Q>A0"O@
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MQ2BI-">JX6X2<0%(YF:8-5.LKEHV#D-5*QDC9F25Q6S:OO;O-B9EY#K=/[+
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MTC^(=^QJ 6#3_N*O?VW%_GY"=Y>CU%^=-_HZ!_(HOV!L0LN:
M                                               "A,T?T99B_P!Q
M;N_)^H"B\_9SY"-U^--F5^GS/'^_ES_E'4AZ*[.?]!I\-3KS//W^KRJ>&\L4
M
M
M
M                                            Z.X?N.G_ -XK?_[4
MC"NC?_Y:OH4SZT>6'ZV_*=_W ]/']RX'\W9'E;:G_6,1_P \_2[.R_\ =*/(
MR-#"1N.8"0 4)!>5[[JBSVY*TI2G")V<DFWL/_/88KQ 5V
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M:=U6W?03X>8_P@:B_P 3G/KW_L ^4XOFG=5MWT$^'F:'I!U&8?\ @YSZ[_[
M/E.+YI'93MUT$\/U-5:0-19H<2=FNXJ;61>JGTFD\/\ ,=\/E&*JB="NGLJV
MXFBJ/<3RIC1I^I#?,"T8:D,V>6=?N0-AV@Y5,WZT]#72K;2\:%R$M//J<P=X
M"\,$K+YTQV9V87V$R',IQ69U<B[CZG>W93LCGN0;,WN"S2[FB^JG]/D>2JF<
MASFN,PF&7<AY1+0G!1>,5;-A?]7^8/056WNS/+F\B]T5>&MM]&18^BB9LTVN
M?\1!S6O@)D^Z"OP>+?7K9GI?#A/D^/YOAP'Q$'-:^ F3[H*_!X=>MF>E\.$^
M3X_F^' ?$0<UKX"9/N@K\'AUZV9Z7PX3Y/C^;X<!\1!S6O@)D^Z"OP>'7K9G
MI?#A/D^/YOAP'Q$'-:^ F3[H*_!X=>MF>E\.$^3X_F^' ?$0<UKX"9/N@K\'
MAUZV9Z7PX3Y/C^;X<!\1!S6O@)D^Z"OP>'7K9GI?#A/D^/YOAP-/B(.:U\!,
MGW05^#PZ];,=+X<*?D^/YOAP/@_R+.:;#)!S,CY3/%/=;PFJ7O*QP(ME/V8A
MUZV8Z7PX43D^/C_"Y'Q$'-9/ RR)DX&1&1^,%;2,L2/^C^\'7K9GI?#A3\GQ
M_-\. ^(@YK7P$R?=!7X/#KULSTOAPH^3X_F^' ?$0<UKX"9/N@K\'AUZV9Z7
MPX3Y/C^;X<!\1!S6O@)D^Z"OP>'7K9GI?#A/D^/YOAP'Q$'-:^ F3[H*_!X=
M>MF>E\.$^3X_F^' ?$0<UKX"9/N@K\'AUZV9Z7PX3Y/C^;X<!\1!S6O@)D^Z
M"OP>'7K9GI?#A/D^/YOAP'Q$'-:^ F3[H*_!X=>MF>E\.$^3X_F^' ?$0<UK
MX"9/N@K\'AUZV9Z7PX3Y/C^;X<#Y.\B?FIQD&])R,E-L)PWW"G*5NX]&SQ?M
MQ$=>MF.E\.$^3X_FZ6Y'(EYJC[1/Q\C)+K*R,T+[>HC5@1GAAXOQ(3UZV8Z7
MPX3Y/C^:F_)?R</F69LIJCEV4)O*ENFK0AA4R2V_XP4LDF9(XT$CZA&>.'>'
M$Q?:%L_<41-Q,WE4^&M=NLBQU[5-NB(3G\EAU\_"'3?IXGM(<*.TK)[--W/A
MYUWJ[C/%Z3Y+#KY^$*F_3Q/:0GO*R?HY\/.=7<;XO2?)8=?/PATWZ>)[2#O*
MR?HY\/.=7<9XO2I&_/)AN8?9MJU&Y*#7(=ZU6G-\1FVX[D=MV<6ZHU$E;<$U
M%N;O[(NW7:/D%[>67]$Q2F\V<Q41^',6^=:2SR).:TZV2SR&E-GO+2:3J"C\
M!6!'MI_SQ;1DNO>S$Z8O+(\/&XLY-CZ9LLM?7XB#FM? 3)]T%?@\.O6S/2^'
M"CY/C^;X<!\1!S6O@)D^Z"OP>'7K9GI?#A/D^/YOAP!<B#FM8_H)D^Z"OP>'
M7K9GI?#A3&48^-/)\.!\/B+>::<@X19'RCFE@9L]N5@1=_?[!@(Z];,QI][X
M<)\IQ\Z.2^_Q$'-:^ F3[H*_!XGKULSTOAPH^3X_F^' ?$0<UKX"9/N@K\'A
MUZV9Z7PX3Y/C^;X<!\1!S6O@)D^Z"OP>'7K9GI?#A/D^/YOAP'Q$'-:^ F3[
MH*_!X=>MF>E\.$^3X_F^' ?$0<UKX"9/N@K\'AUZV9Z7PX3Y/C^;X<!\1!S6
MO@)D^Z"OP>'7K9GI?#A/D^/YOAP'Q$'-:^ F3[H*_!X=>MF>E\.$^3X_F^'
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M<.N7$I?#W>(@F]S=WO"/'>W0$A@
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M61(!$6 ) !I@0;L6;PU$60 D!%D ) /$-, C1N'C:@ %F^!N[H  BP!(
M              #X2ON:1_$._8U +!I_W%7O[;B_S\A.\O1ZB_.F_P!'0/Y%
M%^P-B%ES0
M        4)FC^C+,7^XMW?D_4!1>?LY\A&Z_&FS*_3YGC_?RY_RCJ0]%=G/^
M@T^&IUYGG[_5Y5/#>6*
M
M
M                                                       !("
M    ='</W'3_ .\5O_\ :D85T;__ "U?0IGUH\L/UM^4[_N!Z>/[EP/YNR/*
MVU/^L8C_ )Y^EV=E_P"Z4>1D:&$C<<P$@?F%CY@"A(/$*[JECN&C!&!EN$LC
MW=N.&T!78
M       &1&1D>TCV&7F& L[K&@;29<&<QZ@*YDU:=7S64^W).Z:E3HLZ2;S*
MR<;<W)++J-Y"RQ(^X8"[]IEIEMMIEIMEIE"6FFFDI;;:;06ZAMMM!$A"$I+
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MPCF^48E8+VGQ#,B+=(!4%'+=IL,C;X1DPV1MDK?W,$)+=WMN.'? =F
M    .NJQ;U.F%P^+BPZ7#WMS?ZBNKO?.X@*8R_94S0&TKA% /CR,8Y2"DDGU
M3$CXA&?A%MP[@"N          !M7M0K9CU5;,<,=A[,>YB CRT6%-5ZXS.GE
M$WUMF3Q22?.1M+:;9&?"P 2*
M "+(&FT)F=Z$:=;3##H+]D3$S.ZF;)W6I"+(C2&)8X=T2-0
M                            !\)7W-(_B'?L:@%@T_[BKW]MQ?Y^0G>7
MH]1?G3?Z.@?R*+]@;$++F@
M                     H3-']&68O\ <6[OR?J HO/V<^0C=?C39E?I\SQ_
MOY<_Y1U(>BNSG_0:?#4Z\SS]_J\JGAO+%
M
M
M
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MV
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MMU]+D54Q/'C^HI>-@S]4+;OD9=!@*@HA$5+A$ELVBX#9$@U;QI(DD6!J[N&
M#M0         !U]5+&GRRW.(1L.$:"5N[Q;BL2WBP,M@"E<OFFV:"A#<14,N
MT2#X2GC?,C-S$SWS,]AX@*Z          &U?@*QVENJQ+T# 1Q9[33=P7&:(
M2HZEJ;WGS?-TGS(RP,D&9DW@0"20
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M%7O[;B_S\A.\O1ZB_.F_T= _D47[ V(67-
M                                 !0F:/Z,LQ?[BW=^3]0%%Y^SGR$;
MK\:;,K]/F>/]_+G_ "CJ0]%=G/\ H-/AJ=>9Y^_U>53PWEB@
M
M
M
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M-QS 2-#Z.G#S<,0%!06VTWC4EE%6E9I1O2>,9I</#^"QP3AB KX
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M^L:",C,BQ+9T& N<\HJT3:K-1<[2-G#E?;-=S6T\92T6G2\X<HJ+7)]%=K,
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M2L-IF9F9@)RSZ_0MFK_L_N[_ + J F%[#V>]BW<>*?EJ*+\QE\X?CW>7F_\
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MB[X62<NET=>^IT8__P :+:_[7BA$Z*J?U9^@B;;RE^NYRQ_]QW3_ /W&I/\
M,HX\L;0_ZQ?_ //+M#!?NM'D7ZJ,DI-1]"2,S\XBQ,85RGYP/E'>NFY,X.8=
M9&EW,NC7@K2QD?<=-K-XT.D4JN.P+T<9F.R<)+L'?9>)28IIZR#(B,!:=S?^
M:-D9S!\C]/>G_3KE34<J;)T_OTR1%ASZ5(I,=UBFMQT.QV$NM,(=)11"5X)J
M-:E&9F9@/8CY/KS);$UF:<Z=E%;%G5BVJMD);5&MZM3)T29'B55UF/"8[3%<
MD[R'#4IW ]P\,"+8 ]#X      C%E;'YP)">.YQN&CU'A+X>UOZ/P<3Q 2<
M          "-;T4R5;MPG7W&E&ZO<2AM2B</?+$E*+P2 2.W]31^\3^T0#>
M         *(S!6A%NO*<>6RGCL%OH0IQ6)N$1=5.)X8F J*B8>*X1I4:B-AL
MR49&DS+<3AB1[<< ':@         #KJL:2ITPU&:4]G=Q41&9EU%;2(MIF1@
M*6R]6VNWVS;>6\@WY!DIQ"D*^J'B6"MNP!70          VJ\%7[T_V@$<6<
MIGWP7,AMYQQ9.-FM*VU(2CK'AN&9$2BV]P!)(
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M%J_KJN[FNNB+:XHF8CQQ"Y=TQ7>4TU>K-4?2_/9U,6GS5.<KS%KZT^MUJ_\
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M$K[FD?Q#OV-0"P:?]Q5[^VXO\_(3O+T>HOSIO]'0/Y%%^P-B%ES0
M                                                   4)FC^C+,7
M^XMW?D_4!1>?LY\A&Z_&FS*_3YGC_?RY_P HZD/179S_ *#3X:G7F>?O]7E4
M\-Y8H
M
M
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M_P#=*/(R-#"1N.8"0/S"Q\P!0,%;2KQJ22<7Q$I1O-FA6ZGJX[%^"8"O@
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M]S!"NMN]W !2^7[_ &B@-K.?XP/CO^K]F*+CZH98</ L-W]D!7
M VKV(5MPZJMN&.&P]N'=P 1W:$A+U=N-!5+MBFUMXL=EX'9<3Z.)@7%W@$C
M                                   L2YD-1GTW29F"]3M\GG#@,+-L
MU;W!<6[Q"ZNW R+:.#F$S&$JF-33=OJZZ-F,3-$V3R9^B6 BRVFF+/HK;!))
M&ZXL]W BXB]U3G1W=X]HT73-LU;KP)555>XJJN\G_%/TJC[I@IWYU-02WH22
MT24*\!4.62L2Q+#@+Z<=G0*:[8BV-U:OJ(KNYMW8G0R)\GV;,51<VJ49J\5P
M*K$."G$^$DW#+B<,O +$^G ;;D55=6'^UN/8W8A>7M6SG)O)F;+/T,P-\KDM
MV5=[D/$Y;=L5]<;=QQXZ:5+4UAAMQXA$.3G/OXRG$?E_VWNJ[/9EWM@XHJQ=
MU%YZDWE-ODMA^=%R.$4^L\_+4#-S ;8E74S<MS'2?')-N2&UIJ3G#5&*<2G-
M\C+J[FTCZ!GNR^BB.S7$7MW/)QL3/*C?LMT^-CMO9JJVJPU.(MJNIJILMW-U
M[)>;9S)*KRT,B(V<E)RHJF;DB3/1!3;],:F..)-9K(G5G#4E3;9&6U1G@1;3
M&$Q6/_+8JZPW)Y4WLV>2QLF69/&88+$XJJOD4X>GE>.?%$;\ZGG&L+RK^RK[
MS:R]HESZ"HU O6]JQ2J,S<]Q4^/$K,3MT^)!)UF14]VHK)KM&)&A9EL&Q9-E
MU&8YM\NP]448BN+:K-W<MTV?I:IG&/G+LMJQEY$UW-$V1;N+@O*U:C'N70-E
M)<ZFGXSM9ET>IPX\>0XP<5ZJPVI3)8MJ+?*.N06P\<<!UYM-AJL-MQEUW37,
M7M-[5=\%5EK<]F+S\[LGC<7/V:*KBFN8\UMBKN2)R9-)N9&D?(74YJ$MJHYK
MYR2XT2MT6M5NN5-;-O\ 9"@OQ&X\5TS(W&W&B/'>-.!_,[AVANOD.91<X:S\
MW-U3-5YOSRH=79#CNL> O+V^M_(TWU5%-&KDV:?/:E#FN<MWE[Y@:B[1U,ZY
M-6+]F6!94>/'8R28K2T-U2%":6VQ"*FQ):WTD;#1HWC9VX=WH'7^658#+,PO
M\5B)_,8N^FVS=LW>#PT-ZQL8S'95=8##4^YNKJS[6N-'D\-]Y4^<?6>5[1)^
M3E>Y5\.Z+-O:V[GHR;@NFGN7/1:;.-%5)#)MNR'642L30V9J)1$KO$&37^9]
M>L)>X>W\C5-E=$[^G3,1O1XM/IL5XVXP-]LY7=7_ ":[^+=,;L19HB9U[KU/
M:U];^;N0/( M#.6FW!+_ #J7CEW1[=:N,G7BE,]JI2X3\CBE(0\;FYN];?,^
MZ.=VN1-QM3=;/X/\.,573;9JT6QYUKL_NL/^0KQ>83;%Q159$Z;9TV<%GI6+
M<A'DCZ8=4>DI.K+5C!KF;F:><,VJ5&+5ZC<=7;DVZZ^MN8E^(XLUKXS3\DU)
M,EFDN\-ES3+KG9S"7& P4<G$>ZMJJUS-+6<%CK_-,SQ%YBIY5S=WGV8\5K$_
MFWI2FZ-^?9DSDHU<U0NJS7KL@2++?JK\B5+ID&5567DQ#D2L75\!A*48[2V;
M!B.Q_'?F\]Q]Q?TQ^8NXKBJ8W[-#D=J6$P]QDF!QUU5,7=<T_9U3J9#_ "G/
M5I>MR:IM/FAE=^UC+C(=+5O2\WZK1I4V._-ILEE+LDG"@2FGEI[ :TX;O<&K
M913=9WMQB*<PJF,MPM4\F-ZVWT[[;\?[[*MA;K%Y?3%6/Q-,:=46;VK>6Y:T
M,N?)^(.BR=&TGYIUFWM5%AT"D5:U+OI#EU%7ZW=4&(F7-*>24,D92:BUO=5?
M5,L.MCO%S=I,7CKC&W><9/')KN[Z(Y$;E5W;9;/CLL\6EB]F[G#7F$C+,[GE
M4WEU,S5.[%<Q;9'BBV8UZ'HB\F1UP9@ZN]"\"BYJ5"HUJ]<IIB[<E5JJ-R42
MZA36N"Q3'%KE//..^H(QWL=N\-]VBHPM]A<+F>'B*;V_H^W$;U41%K4<EKQ-
MSF&+RZ]F9N+NJV[MYL^$/22Z6*3(R(R[I&6)&7=(R/I(R&I3-C9*HF=S>0%G
MOG7D?I5RUNO.O-BK6O8EL6W3951J=7DHI<"7*X##SZ8T=2CC/3),CA&24DHS
M,QP,;C\-EES;79%=7JTQNU3O:(\>[.\Y>#P=[F%]%-W%LZYWHWYMEX$+VN[/
MWRECF1V.=@VA7+?T49"76U(1<TZ),13:A"I-50\J8TZ\W+BO+FH<)6","P/N
M%@,IL5D%%QC+S;+:&.1?6?@T[\:HC_CHX;+&U6:\O+XV6RF8KB9^W5&Y/.F;
M'Z'&7%BTC+6Q+2L.A,(8I5JT&E42*A&!)-%-@,0]\B)*"]4X./072+^/QE[F
M&-KQ5[-LU3Z-Z/-#A8#!W>7X.C"W.Y3'IWYX5;D6&PAPXB*8LARYFUJ)
M            'PE?<TC^(=^QJ 6#3_N*O?VW%_GY"=Y>CU%^=-_HZ!_(HOV!
ML0LN:
M    "A,T?T99B_W%N[\GZ@*+S]G/D(W7XTV97Z?,\?[^7/\ E'4AZ*[.?]!I
M\-3KS//W^KRJ>&\L4
M
M
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M0 4)!=_[WU)KM_$(DHPA]FW>%U?X?#KXX]\!78
M                                         'F@&'0?>Z &AEB6 #4
M  #H   !I@6./= :@&'0?>Z  RQV&       #0B(NCN@-?-   B(N@L/.
M!H9$?2 U "\T\?-    (L-A    8?L]/F@-NZGIP+'IQ+9^T W    =.PP B
MPV$   #0B(NCN@*2OJM5>W;2K]:M^D*KU;@4R7(IE(2YPSJ$YN.XJ+&W_G>*
M\24X^: \V^<FL_G+*L?-CAZ%T0K9.D7/!BU7WR-+6W0G(=1CO3^%O;QF5/\
M5,.X)IBVJ(4U3$:9]7?5ER%LHLH+UT)TRY;]HE)7>U<NV[9%W19DJ.E<&:Y5
MS>D1U;YDOU*6M2<3[PPV.Q^SF%OYP^,Q6&HQ=/K4UWE%,QJT3,2P.8; 9%G&
M*JQE[@JK[E_XN3,VZ]YFC_PX:;/Q=MOV=$],,?\ .]D/B\%_FW?WG [IMG/X
M97[%7W3_  X:;?Q=MOV=$],(^=[(?%X+_-N_O([IMG/X;7[%7W3_  X:;?Q=
MMOV=$],'SO9#XO!?YMW]X[IMG/X;7[%7W3_#AIM_%VV_9T3TP?.]D/B\%_FW
M?WCNFV<_AM?L5?=/\.&FW\7;;]G1/3!\[V0^+P7^;=_>.Z;9S^&U^Q5]T_PX
M:;?Q=MOV=$],'SO9#XO!?YMW]X[IMG/X;7[%7W3_  X:;?Q=MOV=$],'SO9#
MXO!?YMW]X[IMG/X;7[%7W3_#AIM_%VV_9T3TP?.]D/B\%_FW?WCNFV<_AM?L
M5?=;5:;=-2R)*K<MLR)25E]O1=BFSWDJ+K]*3+$4SG.Q\_\ W>"_S;O[QW2[
M.:/_ $VO1^I5]U#>;FB?21J77"H>>=G6M?M#LE1(LV!4I<(FJ.R^3A2";PZR
ME+-?3B18=P9_+=N\BR:CD95F>%HF=VR]N]'_ ,3:KC9><+AJ<+<X.]HPM&BF
M.15Q(A+D]\L B(OS"Y?8$1$7VY&Z"+ OGN\0R7>K1.GYOAO\Z[^\GJW5N?E;
MWV*N)K\3WRP/@%R]]F1O3AWJW?\ %\-_G7?WCJW5\+>^Q5Q'Q/?+ ^ 7+WV9
M&].'>K=_Q?#?YUW]XZMU?"WOL5<1\3WRP/@%R]]F1O3AWJW?\7PW^==_>.K=
M7PM[[%7$?$]\L#X!<O?9D;TX=ZMW_%\-_G7?WCJW5\+>^Q5Q'Q/?+ ^ 7+WV
M9&].'>K=_P 7PW^==_>.K=7PM[[%7$?$]\L#X!<O?9D;TX=ZMW_%\-_G7?WC
MJW5\+>^Q5Q-2Y/G+![F0N7WLR-Z8.]2[G_\ J^&_SKO[R.K?_P#:WOL5<30^
M3WRP>[D)E][,C>F">U>[HW<WPW^==_>1&S/_ /:WOL5<3IW^4!RS$5.,E&1=
MG)A&ESCI*5!* 2B+%O?<4R9D6/\ ZPAD<'M_F>94>]R_'47]S&[-%=-41YZ9
MF'$Q648+!_OEW[F)Y_V;>&QVI<H#E>'L_,5ES[H0_7!RNN&>;OYJ>&'#INLB
MF;*:[FV/UJ>,^)_Y7GP$Y<^Z$/UP3UPSWXJKAA7[K(^?<^U3QGQ/_*\^ K+G
MW0A^N!UPSWXJKA@]UD?/N?:IXSXG_E>? 5ES[H0_7 ZX9[\55PP>ZR/GW/M4
M\9\3_P KSX"LN?="'ZX'7#/?BJN&#W61\^Y]JGC/B?\ E>? 5ES[H0_7 ZX9
M[\55PP>ZR/GW/M4\9\3_ ,KSX"LN?="'ZX'7#/?BJN&#W61\^Y]JGC/B?^5Y
M\!67/NA#]<#KAGOQ57#![K(^?<^U3QGQ0'*\+_\ ,5ES[H0_7!'7#/?BJN&$
M3=9%9IKN;/\ FIXW4U7E#<L-GLQ1\E+&CO/.H2AJ'/IRER$[Q$:=UQM\SQZ"
MP()VQS^;(HQ,S/E^LIPV15U11%=U;.Y953-OI58?);Y;;S1$>FVTU)6E)X[F
MU1&6.)F2,,3Q[@KZVY_\14Y7RC 6:*(L7)9;:"M)&4ULLVA9&1]B4VA1\>%&
M>H-,G++>-)GB_*B..GX)=T8^_P \S2^K]Y>WU<U>6>-R:<'AJ*>1313R?(K.
M5I?TTP&52)N5&6T-A/A/R[<M^.RG L3WG7H:$%@7FBW\US#I:^&>-/Y6XYL.
M'3M.6EFL8^*,M\J:INX[WBZC6Q.W<.G'LT9W##NA\US#IJ^&>,_+7'-AVG^%
M/3JK_P#,[E__ *JT0O\ ]Q$3FN85:)O:^&>-/Y6XYL(FS;Y<VC+/"FP:3F)D
M19%6A4XU'$;C4:!3E-FHU&K%<.,TI>)K/I%_#Y_FN'FVYOJXGRRIKP>&KIY-
M5$6(.+DN<MTB(O\ #;:6PB(NH?018%\YWASNMFT'Q%;B_*<OYD'Q+O+=_5MM
M+Z0_2!ULV@^(K1\IR_F0?$N\MW]6VTOI#]('6S:#XBL^4Y?S(=17N3'RV(]-
M<E.Z<[7C'$=8E,R&$H2ZU(CNI<CK(W&7$X)=21GB1BKK?M!%/)F_JJIG>78R
MW!1991$6,C^4UG6U8-@V]:-GPFZ=;E$AHA4J&T22;CQ62)#3:22A"<$H21=!
M#7KZ_O,3>U7U[Z\RYM%%%W3%%WZL)&%I4 /FXTT[AQ6FW,.CB(2O#SMXCP ;
MDI)/@D1%LP(B(B+#S@&X      1NVX_[_'FS?;X)-$9,\)&^1[F/U3PO- 20
M           ".KR<=15[>2V^VV2G'-]"FTK-9;R>A2BQ3Z "0T> C]ZG]H@&
MX          49?BG$6\^IMY+"R?8ZZT$X6&_M+=/89F [^B[QTR&:E$M1L-F
M:B+=(^J6TB+81&0#M          !U]5,RITLR,DF3#N"C+$B/<5@9D?26("F
M+ 4ZN@H4Z\E]1R'RWT(2V6QP\"W4[,>D!6X          VJ\%7[T_P!H!'MH
MN/*KMQI6\AULEMFVE+24*;VEB2E%M5B D0
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M*^YI'\0[]C4 L&G_ '%7O[;B_P _(3O+T>HOSIO]'0/Y%%^P-B%ES0
M                                     :&9%T@-2/':0
M   H3-']&68O]Q;N_)^H"B\_9SY"-U^--F5^GS/'^_ES_E'4AZ*[.?\ 0:?#
M4Z\SS]_J\JGAO+%
M
M
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M/$!7
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MEF;#O4-6Z2NHK8:NYB IFPFG&J"VER*F(HGW\6DO)>(L7#V[Z3,C-72 K8
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M,K]/F>/]_+G_ "CJ0]%=G/\ H-/AJ=>9Y^_U>53PWEB@
M
M
M
M                           '1W#]QT_^\5O_ /:D85T;_P#RU?0IGUH\
ML/UM^4[_ +@>GC^Y<#^;LCRMM3_K&(_YY^EV=E_[I1Y&1H82-QS 2 "B(2%>
M^NHK[(E*#2C"23Q&I>S^"QQ3T@*W
M
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MH^UR>-CB=<CPXI&1IP ?:TT$W08*"CG%(D'@P;O&-&WHXA^$ J,
M  $9M1_^_P"^_P"+3+%I)=N[4>"B)!%AV;'89>=M 28           "-+V82
MY6;<6=.5-4VZYNNE*..4;%1=8T;Q$[B?<V@)(;\!&!8%N)V8XX;"V8]W !O
M         %$W^R3]NOMG!.H>K,&4<I!QC5U^GBD988 *AHB212X22:-DB8;+
MAFO?-&""V;VW>P =J          .OJJ=ZG3$\/BXQW?4][<W^H98;VS#: I;
M+YDF* V@H1P,'Y!\ Y!R33BX>WB&9X[V&("N0         !M7X"]F/55LZ,=
MA[,>YB CFS8Z&J[<BTTXXAK=1B^<I3_:.L6TFS,R:P,@$D
M                        #JYE(I%0,RJ%)ILXCZ>V08LG'S^,TO'I$33$
MZ9B)6:Z+JN;*Z*9\L1+X1;<M^GJWH% HT172:HM,@QE8]..+3"#,(BGQ0JN\
M/<7?J4TT^2(=UAAA@6!%T=XMG<(2N:=S>:@
M                  ^$K[FD?Q#OV-0"P:?]Q5[^VXO\_(3O+T>HOSIO]'0/
MY%%^P-B%ES0 !Y;_ "KZ1V7EW5)[=2K"M0D&2B(RW5J?2H]NSP0'D<TU6*]H
M>O?E^:Y[?>>CTC,FOHIE=?9);$=DI51I<))/O(*.V9'_ ,IPP'I/\IFS:E9K
MT31II*L^IJDU#4(EFNSXL)XWCD4XH;<E"7V&'7-XE,K-76;46"@&#?EBY84W
M([GK6'D_3HC<5JUHU)-]E*$)-,B5%IRGC,DH;P-;B3QV$ ]*'E%7-5U2\M^?
MI[BZ=95(BQLP:S"@7 NJ4:#5=YIR:\SPFNUK2;:GTMI01ET&K$!WW.2S(N'.
M#D13LS;O)E5RW?9-O5BL<)IMIDYDZC27WS0RC>;;+B+/86P@%">2N7'2K+Y5
M[EX5U]J%1+;=N&L526X:&VVHM/8*8^I2U&A&]PF3Z3VF L?N7GB<R3F(:P;W
MR!Y8&72(MAY>5F53*K?+J&WXKZ:-*<CRGY$IQV1%81+,B[I$6TS(BPQ#$AS[
M=3FK7-&KZ?L@=;65)6)FKES=5NG#NII:7Z==29]80IQZ*XUC%)&"UGU-AD8#
M]#;EXENZ-L@TEAU<OK=3LZ.K2H9;.CIP 74WQ<#-J69==S/K2VW0+<K=8-2U
M$E)'3:;)F$1F9D18FSWR >!KDK2ZCKQYY^J/5CF(A=9<RRKU3@6H4TE3(U-X
M$]<-I40W^UM,F1$1EPU) 7-^6 ZE+YH6762.FZSJ].H5%S,N&+#N]$)]]CM\
M>1-D1&F7#8?;WFDH/:DTJ(R/:0#-)R5.7!IFTT:+LH:E1LMK3KE[W=:<"L75
M=5:HE,JLVIR:E#AR%$I4Z"I221@7?,S,SQ/$!;?S3?)S,EM>>:66V;V5-=IF
MGZ]K:K3=2NJK6W2H\0Z^EB:<QG<13Z=C&62E88I41E@1ET ,\^2N2L;+?)"R
M<G+OGQ\Q&K3M^FT.74*Y";FM58J?#:BH>D1IS;J'#-+7SQ8[0'GP\J'R_P O
M+6Y8&8DRW;$M*A5./.II0ZC1K=H],DQDJ5*-9)>APV'L%F>.Q72 JCR:'+W+
MBZ.63EC,N"P+0K=4?.04RHUBW*-4Y,HN%!4DE/3(3SW45M+%1[0%L/E:.H:Z
M\A-%]CY'Y624691\UJNU3*K%MUI-(:*G+?DPS9913EQ$LMJ+>Q)*3(^Z0"[3
MR>GEM:;<CM#.5&:ZK#MRZ\SLSJ,FX+EN:OTBG5:0MV6B,X;*/&$%:TJ2XC>,
M]X^D!W_-Q\GYR1YC;UF758$NBY$YE6[64SZE=MN4:)"75(J7#<;8-FG4[%M;
M2W%F2B-.!X8;2Q 9C='6GZ?I;T[9<Y&U.\)=]RK#HL>DJN>:;O:*@AAAEI*E
MF_ZI@GA;,>X \6/E".<%QZVN:%I8Y=UAK?K-$MRZ(#U]0*:I<IE3<BHI5,1-
M9BN24'N,K-)\1K9@ M5YOVG=GE&\RG1GG[DW27[6RUF.6C J<JGLN0X3DAPX
M$6L%)?C,0&$F3L=9F2EX[-H#]#?)_,F@YO9,V7F-;<UJH4FZK+I=69DLN(=0
MIR71V'WT$MMQU*C;=<,CZQGL ?F]Y\YQ94:<O*);BSOSWAPYV4UJ5QQRXH\Z
M"Q4(QD[+>-A3D1])MO$CAJ/ P'IOE>4+\E)M/$<]YSG"C-FL_P VEO%NDVUO
M&U@<7$R;Z/0 97>7KK9T?ZW[)KU_Z28=%9H%,DM0ZO(I=LTZWEJ?5NJ0V\U!
M89-PT_\ *Z, &18!X-O*X-3U[W1?6GG1/9U6J-"I5[W#3V;I*%,D,)J:*A4%
MQ$\=+$A*5MM-O)Q2M"B,@'HCY37*]TN:+M*>694_+RT*O>=8M"F5R\+SK]'I
ME1DSY-0IT.:\MQVHP?4D,DG$S/;CB9F8"U7FL\GS0AS,:133M?-S*;(K-FW*
ML4ER[[<J%GPWG&V7'%*8?BPS0ZTZTXXO:1=.PR+ !DFTH9+(T1:!%97V7FTC
M.=[*BPKBDTB^4S&*AVJ93Z$MZ.1R(\F0A:6WH9&1;Y8$?< >._2QS\^:[J:S
MBS5TMY0VBSF!FW,NBOTBS*FIEEB-:\6E5:1"0](4J4\P:."2#,UD1$ ]-V0.
M<G,:TQ:%LV<Y=;5N%FGGG;$-V?:MC6^32GJBZY%==;A$Y3B6I1-/-X&1;3+8
M6&(#"AEQK#\HNU?6A=N?F5^5C63>7E"D5J;2K2N%N/3I52IU(.1+=:2=3X3[
MAE$01;.G#S0%\'(NYX6:.NO,_,S2]J3LV-;N<N6DAZ&_48CK2D5.13G40YZ%
M--2'$)-+R'%8I3T8;0'QYVO/<O;1SFM:FCO2/9Q9B:F+RD,0EL,D3[E D3S?
MCPT*C-2#4M2G=Q76;V ,:VL[59SCLI-"F8:=>63S=TY79P6WP7;AI[C!/63&
MJ%/5+:8J#$/U7>,G2,R=VIPP 75>2'RJ=0-'F<]8>DMHI,2N/UV5),DMHCQ4
MM*J#^^HS))<!DE8XGW '1YW\[373K?UBWOI#Y4F7K53@98R9D.[<U'ELJAI7
M =E,27#-V0]';0VZA.)]4BP\\!56EWG8:R-*6LZV-#W-;L-FW*KF(_#C61FB
MTXP4.8N6N,TPM)-268[J'EJ5@>"MA@/83#EL3XD6=%<)V+-C,2XSJ3(TN,2&
MDO,N),C,C);:R,O/ 4;FC^C+,7^XMW?D_4!1>?LY\A&Z_&FS*_3YGC_?RY_R
MCJ0]%=G/^@T^&IUYGG[_ %>53PWEB@
M
M
M
M             '1W#]QT_P#O%;__ &I&%=&__P M7T*9]:/+#];?E._[@>GC
M^Y<#^;LCRMM3_K&(_P">?I=G9?\ NE'D9&AA(W',!( *!@,$5X5)WL1I4HDX
MR^T&9.;I8%ZAC@CH 5\
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MTX?O=G\4E&C=1B2<=X^L71N[0'TM$T'0('#)1(W#W249FHBQZ#QV[ %2@
M        C%HF/S@R#P<XO!3B>*^&?4[W@XD DX           $:7H;)UFVR>
M2YO&ZYN&@U8$9*+PMW89 ))1X",.C<3A\P@&X          41F#PO>X^3I+-
M)OQ_J9J)7AET;NWN@*BHF[XKA;N.' ;Z<<?!+IQVXX .U          '75?
MJ;,QQP[.[CAT^ KHP[H"E<O.%[WV^$2R1VB3@3AJ-7U3;B:MNS !78
M    VK\!?[U7[1@(VLTV??!<G")PC-;>\:]_ SQ+P=[87=Z $E@
M                           -F.T^X1=T]A%W]HLQ,Q-L;F_*9BV/&H:Y
M<R[#M%)*N&Z*-3U'CBV[4(O%3ACX3?&):?![I#$9EM/D&3TVYCC,/=?\U=$3
MP6VN=ALLS'%Q;A[F\JCQ4S/Z'4V]G+EA=+_9J'>=#DOGL)OQA$0:CQ(L$DX\
M6\9F8X&7;;;)9K?^XP&.PUY>SO1>4\:]B,ES7#1RL1A[V*8_5GB2<TXAU"5M
M+0ZVHL4N-K2M"B[Z5),TF0VFB:9BVB8FF=6EBIY4563%CZ"L
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MV<3W2V; 'GQ\F<CUV1RHM9;%K$\5>>I5VKI!-;_'-DZ5.<5PMSU3%4/'=P]
M!APY)UKZ_;ASFU.PM!5^4>QLQ8%YW >8;5=9ISE3G)\?/;A$W4S3+<:\'>+:
M1ET[ &4#4UR3N<EK;SHRESHU&9GVM4[GRON"D5&C/1Y=%I\YF'#JL>7(2PF.
M@WS23+:TI3CND1X%ALP#W,Y/42X[9RPL2W+MD]KN*@VK0J/59..]QI5-ID6&
MZO>+PMY;![>Z YV:/Z,LQ?[BW=^3]0%%Y^SGR$;K\:;,K]/F>/\ ?RY_RCJ0
M]%=G/^@T^&IUYGG[_5Y5/#>6*
M
M
M
M         ='</W'3_P"\5O\ _:D85T;_ /RU?0IGUH\L/UM^4[_N!Z>/[EP/
MYNR/*VU/^L8C_GGZ79V7_NE'D9&AA(W',!( * @&V=XU7=)?$(F]\S-6YWBP
M(SW?F *_
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M*IW+?*SM)/%)&1DHC+$E%A@9'M(RPV8&0Q\[K(6Q.F-QN$
M    ^$K[FD?Q#OV-0"P:?]Q5[^VXO\_(3O+T>HOSIO\ 1T#^11?L#8A9<T
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MIX-*DJ+WEP,%),E$?VNQM(R,R,>6MJJ8^=XB)C1RW9F65<K!7=7ZK(V,"YP
M *"@.D=X5-LIJE&248Q.SX$WU?X;#!8"O0
M
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MO_,J'X1#JYD'00?,,9XSXS[F0?K-U_YE0_"(=7,@Z"#YAC/&?&?<R']9NO\
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M=5P_4?&?<R#]9NX/F5#\(AU8R'H:?#S'S?-.=5P_4T/F?<R##_><K_S*A^$
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M93)/D77+9PS(R/$!W]&,UTV&I3A.JX*/5"3N$HS26*MTMA8@.T
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M=?.;3!S,J)J7T:9PTG+O(!JOL5N50&+CBFE<-^23\^C.4Y"H[+R-U*4$1H/
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M#T.!$BO/GTONQX[;*WC\UU2#5Z(#G@
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M+NG<A/XXBX  "A8+KAW;4&SF)6A)%A&)@DJ;V?PN&*@%=
M
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M;>5'+8R/SQR;R'=S S:S8H%+C6OEQ14G'A4F74(\=!27G8*2888AK?2>W!.
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M%#J:Y<1K:;0C?;W%H6E2E[?GDIVIPP 2(
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MHL9>>9[6;EH'DUF5+5L/SV(E0M:W&*N[%<D$YV%459(0\ZRHEI;4VH\24>&
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M)\4Z6M9!F5YF647>.OZ;+RJ-/FFRWSIQ(\2Q&(IJBK<9N-,6M14
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M5@  !^8>'F@*%A<3WVU$C:03>"32X2T[YGAB>\GI+H 5T
M
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MT<F?HER<#]K&TTQNQ,/V'K8_\-6]_8=)_F$<>5KS]I5Y9^EV;3ZL>1W@H2
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MN'O;F_BA75WC\''O@*6R_9X% ;;[#V#"1(P8[1VG C<,\>)B>.]CCY@"N
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M3?8R_JQ-],U7M4VVK^%PES@\/3A;B++JF+%0D6!8"Q$1#D1%D6-1*0
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MNO7AXB^6W^BG-3^_MV_E+(&C9U^^R\1]M7\X5^7C7\%T#&NJ8W&H
M                                  V._4'/WBOVC"K]G*B=RKR,W7+G
M_0NW_*5__0#;<C_=(>P.PG^58\K(2,V[Q        =!<Z.)1)R"C]J,VC]0X
MO!XFP]G$Q+=Q <&R&N#;L)OLO8MTW/M;C=HX?7,_JN)[^]T@*M
M                %!9@,\>DMI\7E43[2P9,G)[+T+\+B8EX/3AW0%9P2,H<
M0C1PS*.R1HWM[<]33U=[NX .4                          (YNM@W;DM
MIPJ;VLFUN&<GM7![-M/;P<2XN\ D5/@I[G5+9Z #4
M       1S?3).R:(?BWMYID&9*[7V;@=9/7PQ+B^< D-HL&FRPW<&T%NXXX=
M4MF/=P ;P                         !&\J,?O[A/^+241-J^W^UX</%!
MX%V;'K8^< D@                           $<7$P3EVV\X5-[0;?%QF=
MKX79\3/_ #&)<7']@!(Q=!><7[0#4                         /S#P\T
M!0<"/NW?4GC@[AJ))]L[02N+LP^H8]3 !7@
M
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M)K(X[N*2,TFKJ*V$9;2,P%+9?(;;H#26V%,)X\CU-;BG#+U3:>\K;M,P%=
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M*;9LCTKGDD6]YO=';=%%7*Y=Y/VIW&FQR9^S&\^@NJ@!M-)'M,B,RZ#,B,R
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M 6#3_N*O?VW%_GY"=Y>CU%^=-_HZ!_(HOV!L0LN:
M                                 ^+L=AXTF\PRZ:#Q0;K:'#0??2:D
MGNGYP#P">5H&I6KC1)O*6HBO&CD1*4I1)+QV6!)(S,DE@?00#W$Z82(M/N3V
M'P>6E_V#  >*;RO%J.6;6CEVA$U[[SO&D%#-HT]JV5Q1;"1ZL7< >R_18FNI
MTM9(E<G%\<?F\M8Y7&W^)B=%@[N]O];P0$NYO_HHS,_N!>/Y/5$5W?KPN77K
MP\1?+;_13FI_?V[?RED#1LZ_?9>(^VK^<*_+QK^"Z!C75,;C4
M                               ;'?J#G[Q7[1A5^SE1.Y5Y&;KES_H7
M;_E*_P#Z ;;D?[I#V!V$_P JQY60D9MWB        Z"Z$H50YQ+;-U)M'BA*
MC09^<HL#+ !U]BH0W;<)*&E,I)3N#:EFX:<5X^$9F9X@*O
M            $?9B-M.4="76%OI[2P9)0XILR,G"VXI,CV *V@?<438:?M=G
M!)GB9%PTX$9]\B <L                          1M=B6CN6VC7'6ZO>=
MW'4NJ031_P#*26Q6./= 2.GP4_O2_: ;@                         !&
MM^MLKE4(W8ZWS3)ZJD.J;W#WBVF2?" 2,U]2:_BT?Y) /H
M            (SEI:._H*NS.&X2%X/DZO<+%'=;QW3[P"3
M              1I<;;*KPMQ:HRW%H-[!Y+JDI;Q+#K(+8H!)1=!><0#4
M                      /S#P\T!04!#2;OJ2B863BB3OOFXHT*V'T(Q-*=
MH"O0                                        %'WM?UH9<T5VXKVK
M]-MNB,*2EZIU64S"AM*7L23DB0MME&.'=40#EVQ>%L7G0(UTVO7*;7+?EM+>
MC5>FS(\R ZVVG><6B5'<<9,D)Z>ML 47;>>N4%WW/+LRVLQ+2K-T05K;DT.!
M7J7*J33C1FEQ!PV92Y&\E18&6[B1@.XOO-7+O+)J ]?UX6_:J:H^F-3DUJJP
M:>N:^M9(2W&1*?94^I2SP(DD>T!P+HSIRMLIZ@Q[KOBW;??N@FSH#-5JL&"Y
M52>))M'"1*?:5()PE%AN$>.("3&76WVFGV5I<9>;0ZTX@R4E;;B26A:5%B1I
M4DR,C[P"EKUONT<NJ%(N:]J_2[:H,12$R:K5YL>!"94X9D@G),IUIE)J,MF*
M@&ZUKXM*];>CW9:UP4FM6W*2M;%:@3HTBFN(;(C6I,QIU<<TI(]I[V! .WIE
M;I%:0MVCU.GU5A"C2N13ID>:PE9=*.-&<=;-23V&6.) .T  'S>=;8:=?>6E
MMIEM;KKBC)*4-MI-:UJ,\")*4D9F8"-[.SCRQS J]6H5FWM;MQU>AN&U5Z?2
M:K!G2J>X2MTT2F8S[KC*M[9@HB 28 C.JYQY8T2\(=@U6]K=@WC4,.Q6[)JT
M%FK2<<,.#!<D)DN8X]Q)@)+(R,B,CQ(R(R,N@R/:1EYX#4    !L==;9:<>=
M4E#33:W7%J,B2AMM)J6I1G@1)2DL3 1S:&;^6E^U6K4.SKSMZXJO0G.%5J?2
MJK!FRJ>X2MS<E,QGW7&#WMG6(@$DD>.T@     _,+'S $;*S@RS3>Z,MU7K;
MQ7RYL1:YU6"595YU/-_M9_2 /E.SEROIMZQ\NI][VY$O>423CVR]5H+=8=)1
M8I-$!4@I2B/N8( 2<1D9$9;2/:1^88            #JG:Y169S=,=JU-14G
MC,FJ<<V,4YS L3W(G%[0HDETX)V .U  %"WWF98>65/:JM^W31;5IS[J&&9E
M:J,2G,.NK424MH<EO,H4LU'AACB [R)*MV\Z&S+8\67#0*HPEUI2T1:E3IK"
MTDI"MU9/1WFU)5B726!@.12:#0J P<:A46DT6,9F9QZ33H=.8,SVF9M0V66S
M,S\P!VP   *4J5AV-6'RE5>S+4JLHCWBDU*W:1.?)6..\3TF&ZX1X[<<0'?0
M:=3Z6P4:FP(5.C)PW8\&*Q$83@6!8-1T-ME@7F .:          *&OK,JQ,L
MZ<W5K\NFBVK3774,MS:W48E.CK=<5NH;2[+>90:E*V$6(#CU^!1,V;"J5,IU
M70_0KJI3\1-5IDE*TNPYL=32UQ9$=:BZS3NQ23\T@&"#-WD%:/HU@9H7-)J^
M8":FJ@79<C\MV]:\IA4UJ!4*FDE1^.:>%VCYW RW=@1%JNB*9KB*M,,='*+U
M2YOY/Z49N6=ES6_>Q9%W753J$3\=M]Q+,:MJAI6MQQ>^XI;,<L3/:9C6,?FE
M_A\;-S=^J\N=I7:EM+LQM9>Y3@?W>=S?LW?&R9EKXU&8;9T/W/8]..-.<8JW
M=:+WV;<<ZGV8XVO^/C49]_0_<]CTXCYQBM:>^S;CG4^S'&?X^-1GW]#]SV/3
MA\XQ6L[[-N.=3[,<9_CXU&??T/W/8].'SC%:SOLVXYU/LQQG^/C49]_0_<]C
MTX?.,5K.^S;CG4^S'&?X^-1GW]#]SV/3A\XQ6L[[-N.=3[,<9_CXU&??T/W/
M8].'SC%:SOLVXYU/LQQM/\>^HT^B=#+_ .U\?TX?.<5K\.$[Z]N9W*J?9CC<
M>3KYU(--MJ34(>*I,9L_]'Q_ <>2A7^<[QBW.=8J--LK%?;9MS35335>TQ$S
M'^&-?E6"\[OFP:T]$^7^G&YLBKB@Q:CF8U4EW,F128LI!+BMO\+<2Z\V2#]2
M3T8CO#LLV?P&TV"O+S,[9KC<T^1Z6V?VBS/,-GL/F&)J_&O*;9E@21Y2ES6#
M0V?OII![S:%&?O>I_2:2,_\ I7?,=H=W>SM.BJF;?*Y56?8^-]N^4I<UC\::
M1_J]3_;0=WNS?-GAGB4_/\?K/E*7-8_&FD?ZO4_VT'=[LWS9X9XCY_C]9\I2
MYK'XTTC_ %>I_MH.[W9OFSPSQ'S_ !^L^4I<UC\::1_J]3_;0=WNS?-GAGB/
MG^/UGRE+FL?C32/]7J?[:#N]V;YL\,\1\_Q^L^4I<UC\::1_J]3_ &T'=[LW
MS9X9XCY_C]9\I2YK'XTTC_5ZG^V@[O=F^;/#/$?/\?K/E*7-7_&FD?ZNT[VV
M([O=FN;/#*?G^/UN,ORDCFLJDHDE>=,2A);8I4&"2%'WS24O=#N]V:MW)X9/
MG^/UN4?E*7-8Q_\ %-(_U>IWMH3W>[-<V>&>(G/\?:T^4I<UC\::1_J]3_;0
M=WNS?-GAGB1\_P ?K/E*7-8_&FD?ZO4_VT'=[LWS9X9XCY_C]9\I2YK'XTTC
M_5ZG^V@[O=F^;/#/$?/\?K/E*7-8_&FD?ZO4_P!M!W>[-\V>&>(^?X_6?*4N
M:Q^--(_U>I_MH.[W9OFSPSQ'S_'ZSY2ES6/QII'^KU/]M!W>[-\V>&>(^?X_
M6?*4N:Q^--(_U>I_MH.[W9OFSPSQ'S_'ZVA^4I<UC#_Q12/]7J?[;".SS9J=
M')GAD^?YA.Y.E*NG/RAWF>YHZG<D<M+GO.FQ[7NZY8%.KL=BA0F7),1^I1([
MOJK<K%&#3IEW>D<'-=@]GL/EMYB;BF;:*9FVW?U.5@L\Q5]79?565Q5$1&NW
M=GS/TB*%)>F4.C3)![S\NE4Z2^KHWGGXC+KA^BM1CH2N(BN8C<B9;O3-M,3X
MG:BE+RK\Z+G^7!HSS?I&C[2G8$K-'4E6W&X\J)&8<>.BR9:9#<1I#33_ *N:
MW4)QZA_,(!CTTO\ E'&M?('4;9.3O,XR2D6%;N94V%#H]R26E0BIIU61$9AN
M)-UZ,A_:^9F6"L, 'N6MBXZ5=UO46YZ')1,I%?I<&KTZ2@R-+T.H1FI<=>*3
M,L5-.D?28#O0    %+7FI";>GFX\J.DDIQ>2V;JD=;I)!8F8#Z6BM+E @*0\
M;Z3;/!Q39M&K ^Z@R(R 5*           ",6G6?S@OM]L<-PF4XQ> >X1&G8
M?&PPQV]\!)P           (VO1UIJM6YQ):V#4ZX26DLJ<)XR46Q2R(R1Z("
M1T> CN]1.WT" ;@         !1&8+B6K=>4N0J*GCL8O):-XT]<L"W$D9GO
M*BHAD=+A;KAN)-EO!9IW361H(\33\[B [4          ==5C)--FJ-9MD4=T
M]\D[QIZA[23W< %*9=NH>M]M:)2I:3?D$3JV5,J/!S R-"B(]F "O
M   !M7AN+QZ-U6/G8'B CBSEM+KUR[DQ<A276R4TIE39,;2V)69$2\?, 22
M                                    T,R+I ;.D\24?G8&8%F^VJWB
MZ3/ _P!GT!17,[D$-Y*Q/##T<?,%419!HG<W&\2
M                      ^$K[FD?Q#OV-0"P:?]Q5[^VXO\_(3O+T>HOSIO
M]'0/Y%%^P-B%ES0
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M>*_:,*OV<J)W*O(S=<N?]"[?\I7_ /0#;<C_ '2'L#L)_E6/*R$C-N\0
M   '070HDT.<9O''(FC]5)!N&GSDEM,!P+'6ERVX2D/JD),W?55MFTI7JA_.
M'M+ !5P                          H#,-UIJCI-V4N(DY+!<1#)O&9FX
M1$G=21GU@%:PC(X<0R5OD<9C!6&[O%PTX'@?1B0#E
M       "-KJ=;1=%M(7,6PI1NDEA+!N$]TGM61&2.GN@)(3X*>[U2V^@ U
M                        $;7XXTW)H?$EKC&J3@E*&#=XIFI.*3,B/<V
M)%:VM-F1XD;:-O1CU2VX=P!]                          !&<IQLK^@M
M]K63AMN&4?@*-)EN=UW#=+8 DP                           $:W$ZTB
M\+<0N8XTM9N[D=+"EI>PV]9PBP3@8"22Z"\X@&H
M     H&GN-G>%404E:EI)&+!M&26^D]CF&"L0%?
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M,?;'9^T[O7+9PL#QQ 5!15;]+AJ-WC&IALS=W.'OXH3UMS9NXEW ':
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M_P!Q5[^VXO\ /R$[R]'J+\Z;_1T#^11?L#8A9<T
M                                 "+#80#KZLQ)E4JIQH;O ER*?,8B
MOEMX,EZ,XVP[AW>&ZHC] !@XT#\FZ%ICUB9_:W<W<P_SN9OYP5)3U!E3(A)7
M9T(I"E<",M^,:L5QSW2-#@#.N CK-_\ 11F9_<"\?R>J(KN_7A<NO7AXB^6W
M^BG-3^_MV_E+(&C9U^^R\1]M7\X5^7C7\%T#&NJ8W&H
M                         V._4'/WBOVC"K]G*B=RKR,W7+G_ $+M_P I
M7_\ 0#;<C_=(>P.PG^58\K(2,V[Q '6N5FD,OE%=JM-:DF>Z4=R=%0^9XX8$
MRITG,<?, =D1D9$9'B1[2,MI&1]!D8    #H+G4:*).4E_LQDT>#_#XVYYO#
MP/> <*R73>MV$M4KMIF;I')X)1^)@O#ZD1%NX= "K
M       !0=_NFS24+\8%3_ME@N*<8I6]BOP=PR/#'##'N *SA'C#BGO[^,=D
M]_=W=[U-/6W?G<>\ Y(                          CFZ7C;N6W4^,BBD
MX;GVJ<7C=IPQV<; ^%@ D5/@I[O5+;Z #4
M1U?,C@R:(15(H!KD&6Z<4I''VIZF.!\/SP$A-;6VSQWNHCK888]4MN'<Q ;P
M                         !'$J097W"8\:$G%I9^+^R$9KP0?_2<,4X?L
M@)'                           !'=POJ;NRW6_&11TN&Z793BDZ;^&W#
MC;I\+=\_: D0N@N[YH                           *#@NJ.[JBUVXE)0
ME&,/LY$;>)$?U?#%>.("O
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M?Z@+9S$M>G9?IL)5.I=7K$--5ADMI4&@%&GR6FTF77VI5T=P!;WS]+\S#O\
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M:RH,TT*2E6ZDB-9)-.T\-N]L ;[4-PZ%!-TTFO</>-)$23/'N$G8 J(
M      $<MF\=]/%OM\)+:>J24[YGN=!GX6PP$C            CJ\3>*L6_P
MEH27$7O$LDF9EO=S';L 2&CP$8].XG'YA -P          HR^R<\0/*:4A*R
M>9P-9)-.U?>5LQV *@HQJ.F0S7@:N WC@1$7@)Z"+9T@.S          ' JA
MF5/E[N&]P'<,<,,=Q6T\=FP!35ADZ5";XJD*/CO_ %,DDG#B'AX.S8 K0
M       ;5^ K]ZK]HP$?VEQCK=PFXIM2>(WP]U*"418[25N[3]$!(0
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M6YJ2R:LO-JV76UP[CIK+DIEMQ"SC5!MAKMK"MQQS=X;RSPQ/' >T\JS&YS?
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M5M4IAI2C[YJ;29_LF,3>Q$7E41N15/TL[<S-5U35.[-,?0^XH7
M       !\)7W-(_B'?L:@%@T_P"XJ]_;<7^?D)WEZ/47YTW^CH'\BB_8&Q"R
MYH
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METF\5Q6]N*;2WO.<0E$DU'M(NKO%B6&/< 2$GP4X].Z6/S &H
M               CN^#=[312;4VDNT'O;Z4F>!&71O%CM\P!(+7U-ON]1&W_
M )I -X                          CB5Q2OJ#UF^&;:\4X)W]B.X?A?\
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MYNDP2SWB_P X9D2< 'TM-"FZ# 0J.451(,C9)TGB3UC_ ,X1GO *C
M    !&S3*SOQ]WQ<@DDT7V]VHMY1FDB,NS[V)8$7> 22           ".+S9
M<<K-NK13TRR0XYO/'))GLY8D9&2#47%WN]M 2*CP$;,.HG9WMA; &X
M    47?C2G;?>)$,IJN,P? 4^4<CP<+;Q#,L, %049)IID,E-DT9,HQ;)6^2
M3W2ZI*[N #M          !P*HG>ITQ)-DZ9QW?4S5N$KJ'LWNYB I?+]M;5O
MMH7"3!,I$C%A,@I!%U]A\0C/:H@%;@         #:O:A6S'JJV8X8[#V8]S$
M!'EH,N-5RXE+IZ8J7%M[CY22>.1@9]+9&?"PP 2*
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MXE@%^V]J1M'GIY)9;:J:TY=F8-GW13X%%O%QHVE5^F(J<9B#(W#+H5$:WO\
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M1?L#8A9<T
M        $=9O_HHS,_N!>/Y/5$5W?KPN77KP\1?+;_13FI_?V[?RED#1LZ_?
M9>(^VK^<*_+QK^"Z!C75,;C4
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MYF6Z X5E-J:MZ$A<8H:B-PSCI=)XD8KQ^J$9DK$!58
M        H/,!E;U(2E$%,X^T,'PE2"CX$3A&:M\S+P2+'#N@*SA%NPXI;G#P
MCLEN;V]N8-IZN]\]AWP')                          $=72PMRY+<64
MI*$&[C(.231Q_-)HS(W-H"1$^"GN=4MGH -0
M !'-\QEOR:(:*>F;N2<5+5))C@%O$>.Z9EQ,<.@!(;6QMLL-WJ(ZN..'5+9C
MW< &\                         ,\-I@(XE,.>_N"[XO2M'#7C-[21*;Q
M;V81\<58F D<                           $<W#'<5=UO.IIZ7TIXN]*
M.43:F,>C!G'%S>,NX D8N@NYY@                           *$@-**[
MJBYV)*$J2G"7QR,W<"_@<<4;0%=@
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MS:Q29'WMHIKFNJ8B9GD^551,4S;$1:D)GZDULW?4T=4NYU2V>@)0^@
M    I:\TI7;L]*HYRDFE&+"739-?6+_.%T /K:2$HH$!*8YQB)!^HFYQ31MZ
M-_$\0%2            C)IAO\X$A[Q>LE\-)'-[2>ZK%LL"X&]AL\X!)H
M        (WO1IM=8MU2X"I9I=<W74R%,DP9J+K&@C(G,0$C(\!&S#JIV=.&P
MMF/=P ;@         !15_-H<MU]*X9SBXS!DPEXV#5URV\0C+# P%0T4B32X
M1$V;1=G:P;-6^:>HG8:N[@ [0          ==5B)5.F)-LW2..Z1MDHT&LC0
MK$B46TL0%+9>LMLV^VAN&J"GCR#X*WSD&6+A[=\S,SWND!70          VK
MVH5LQZJMF.&.P]F/<Q 1S9[*&J]<AH@KBFI;>+RI"GB?ZQ8&E!F?# 20
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M_.F_T= _D47[ V(67-
M                 !'6;_Z*,S/[@7C^3U1%=WZ\+EUZ\/$7RV_T4YJ?W]NW
M\I9 T;.OWV7B/MJ_G"OR\:_@N@8UU3&XU
M               &QWZ@Y^\5^T85?LY43N5>1FZY<_Z%V_Y2O_Z ;;D?[I#V
M!V$_RK'E9"1FW>+R7>5P999_WSHAMNM93MW#.LFTKDCU+,RDV\=2.1-I;3JW
MD\5JFH<==:2RVO>(R,C+8?2 IKEK<SWE>6?RFJ195U5BT+8JUIY9U^@WME]6
MJ' 57Y5P.T-<16^W,0F3+D3)6"4N*Q<2I.SH+$,=7DJ5AYJW3K%U59Y6#3+E
MMW3#6[AJ[U#A5)-3BTF<W*K"I$1<"/*0B(KU%]LR-O:2=G01 /T"P   =!<Z
M$KHDY*F3D)-H\6B6;9J+O$LL#(P' L=!-VY"0F,<0B-W!A3IO&C%6/U0S,U8
M]("K@                         !0&8;2':.VER$J<GM+'J*7SCG]4QWM
M\C(^KT^: K6"1)A1$I3N$4=DB1CO;N#:>KO'TX .4
M       (XNIEI=S6VXJ"J0M*G"3)*0ILH^T]IM8DES$!(R?!3W.J6ST &H
M                        C6_6D.R:%OP5S#3),TK3(-C@GO)Q49$9;_1T
M )&:^I-X%@7#1LQQPZI;,>[@ ^@                          C64RW[_
M * ]XO6;A-.%VWM)[J2-&TN!O8'B DH                           $;
MW$TVJ[[<<. IY:#>PDE(-"63/9M:Q(EX@)'+H+SB :@
M        "A(3317?4G$PU(6I*-Z3QS4E9[IXX-8X)P 5V
M
M        #RC>4@<S+41I@C929 :,;EDP\],PW:A/G1J.R<ZIQZ;3FY+[J4Q6
M9"7B63#&\6*#(\2 7)>3P<QC,W6YISKUHZA*V=1U 922VX5[HF(*+4EMRBCI
M8>>ANR7I#7JBCV&1$6\ ICRD_65J2T:Z9LO[TTV7>[:%SU>^:+2Y\QIDWN)
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M          VK\!7[U7[1@(XLTVO'URDAQQ:R=;):5I4E*<%;-TU$1'Z "20
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M-M$Y<]:8B5:>MYM+!<9I<J)O-+-<=*L<3/':,I5F%_%'NKG[%W9O:)X8<"G
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M_(HOV!L0LN:
M          ".LW_T49F?W O'\GJB*[OUX7+KUX>(OEM_HIS4_O[=OY2R!HV=
M?OLO$?;5_.%?EXU_!= QKJF-QJ
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MD<5Q;:>TL;4)4I6)N%@75V[3 5M!,CA1#3B:>S,X&?29<-.!GCW3 <H
M                     1K=AL^^:VB<<<2O>=-*$I4I*MOSQD6!=WI 22GP
M4X=&Z6'S &H                          C._ULHE4(GG7&]Z09)W$*5O
M'O)V&:=A$8"2&OJ37\6C_)(!]                          !&4I;'O\
MX*>(YQ3;7@WN+X?@=.]X.) )-                           !&=Q\#WX
M6YQ'G$.8N[B$H6:%8&>.\HBW2]$!)9=!><7[0#4
M     1_ -KWY5,DK6:\$;R#2HD%LZ25T;0$@
M                                                          #K
MZK4&*32ZE59*DHCTV!,GOJ6HD(2S#CN2'#4I1DE)$AL\3,RP ?G]9,ZF<C=6
MGE F;^?>HN]*/1LHLAFZM;%A4NO.Q9%%GR)#$BCKW>V2'HB29>,][=,CV'L
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M+C,%VCL_:<,5]'"P/'$!W]$/>I<(^-Q\6&SXNYN;^*2/>W-F[CW@':@
M    #KZJK=ITQ7%X.$=T^)N[^YU#ZV[@>. "ELOG4NT!M29YU#[8D%V@XW9=
M[!P]G#P3ANXX>: KD          ;5[$*VX=56W#'#8>W#NX (ZL]_BUVXT>,
M3F<-;9&QV7@=FQ,L"XF!<;'O@)'
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MWL?0]# 75IN         !$[@VF1'TEB*9FR.5$:1N%8T,B/I M:D6&P@
M !H9$?2 U                   !\)7W-(_B'?L:@%@T_[BKW]MQ?Y^0G>7
MH]1?G3?Z.@?R*+]@;$++F@
M                     CK-_P#11F9_<"\?R>J(KN_7A<NO7AXB^6W^BG-3
M^_MV_E+(&C9U^^R\1]M7\X5^7C7\%T#&NJ8W&H
M                    V._4'/WBOVC"K]G*B=RKR,W7+G_0NW_*5_\ T VW
M(_W2'L#L)_E6/*R$C-N\0       '0W,LFZ).6J1V4DM&?'X?%W,-N/#P/>
M<"R72=MV"M,HYJ5&[]LFSV<UX+,OJ6!;N'0 JT
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M8P^SX<+9L]7PZ^) *\
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M'=^O.M)IG"DHCXR4[QK:2[O=8MA;Q'AB D!GZBUW?4F]N&&/5+N=P!]
M     !35WK4W0)RD/)8424;KJD$X23WR^=5L,!OM12U4*":W4OJW%8N)03:5
M=8]I)+80"H@           1PVX][^WF^U-FT3:3*/P4[Z?4\3/B8;Q@)'
M        !'5XNNHK%OI;DH8)3B]]"F4N&Z6.!$E2B/<P/O )#1X"/WJ?,[A=
MSN -P          HV^U+1;[QMOIC+XK.#JVR=21;Y$9&@]AXX@.^H^]XMA8J
M)>+*#-1$22/J%T)[F)@.T          ' JF\5/EFE9(43#IDLR)1)ZBMID>P
MR 4S82W'* VIV2B4KCOD;B&DM)^J'LW4[-@"M0         !HKP5=SJGM] !
M'EINNKKUPH5)0\A"D$EM+26S:ZQ;#418K 2(
M
M  /A*^YI'\0[]C4 L&G_ '%7O[;B_P _(3O+T>HOSIO]'0/Y%%^P-B%ES0
M                                                         1UF
M_P#HHS,_N!>/Y/5$5W?KPN77KP\1?+;_ $4YJ?W]NW\I9 T;.OWV7B/MJ_G"
MOR\:_@N@8UU3&XU                                          &QW
MZ@Y^\5^T85?LY43N5>1FZY<_Z%V_Y2O_ .@&VY'^Z0]@=A/\JQY60D9MWB
M      Z*Y345%FFEPFE$V>"U))9%YZ3Q(R <&S%*7;\);CR9"\7<74-DTE77
M,MB$X$6'0 JL                          4+?JWFZ4VIF2B,?:62-:VD
MNE@:RQ+=41EBKH 5C",SAQ34HE'V=G%1%@2CX:=I$6PB,!R0
M             !'=TK=*XK=0B4AI!K<WF5-)6;NWYU9EBGI[@"0T^"7G%^T
MU                          $>7PZZW)HJ6Y3<=*Y![Z5M)<-PB-.PC47
M5] !(#6UMLS/$S0C;T8]4MN'< ;P                         !&\IUWW
M]PF^U()LT+,XYLI-9]0\,',-XB(!)                            (ZK
MZW"NRWT)EH9;6;N\RIE*U.8'L)+AD9I 2(707G$ U
M       %#07%E=E2;.0@T;J-U@FDDM&!%TN8;QX@*Y
M
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M$R%F2,&EK)M*CWRZ5G@18 /I:B5)H4$EM)85N'BTE9.)3MZ"66PP%1
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M$I<1MA"W$&AQ+J7%/;2VJ21F: $A@
M                                                      #X2ON:
M1_$._8U +!I_W%7O[;B_S\A.\O1ZB_.F_P!'0/Y%%^P-B%ES0
M                                                1UF_^BC,S^X%
MX_D]417=^O"Y=>O#Q%\MO]%.:G]_;M_*60-&SK]]EXC[:OYPK\O&OX+H&-=4
MQN-0                                         !L=^H.?O%?M&%7[
M.5$[E7D9NN7/^A=O^4K_ /H!MN1_ND/8'83_ "K'E9"1FW>(       #HKE2
MI5%FI0V3JC:/!!K)!'YZCPP(!PK+2M%O0TK93'41NXM)<)Q*>N?0LMAX@*J
M                         %"7^AURD(2U&1*/M+!FVMY+)8<0L5;RC(L4
MX8@*RA$90XI&G=,H[.*<<=WU-.S$NG !R0                         !
M'ETLNKN*W5HB(>0E3F\\IY+9LXGAU4F9&O$^\ D)/@I[G5+9Z #4
M                  1S?+;JY-$-N(W)),@]XUO):-LC4G:DE'BK;W@$AM;&
MVR,L#)"-G3AU2V8]T!O                          $<2&G#ON$[V1!MD
MTX7:3>22T^IGT-8XF2N@!(X                           (ZN!#IW9;Z
MDPT/-I-W>>4\E"FC,]AI;,R-6("1"Z"\X@&H
M  H2 VY[[JDOLR$HP1A()TC4LC3C]3QWBP,!78
M
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M_P WB?"W<0$C@
M                                      #X2ON:1_$._8U +!I_W%7O
M[;B_S\A.\O1ZB_.F_P!'0/Y%%^P-B%ES0
M                                1UF_^BC,S^X%X_D]417=^O"Y=>O#
MQ%\MO]%.:G]_;M_*60-&SK]]EXC[:OYPK\O&OX+H&-=4QN-0
M                             !L=^H.?O%?M&%7[.5$[E7D9NN7/^A=O
M^4K_ /H!MN1_ND/8'83_ "K'E9"1FW>(       #HKE22Z+.2<?M1&T9<#B<
M+?\ ,XF);H#K[(1P[=A(*(<$DJ=+LQO=HW.MC]5,S-6.("K0
M             !0.8+27J2VE5..I?;#.#)2NRX'OEUN)B7@].'= 5K"+=AQ2
MW.'A'9+<QWMPN&G!.]\]N]&(#D@                         ".+KCD[<
MMMN'3CE$A3IG)[6;/9MO3P<2XN/G )&3X*>YU2V>@ U
M         $<7TR3LJAF=-.?NR3P5VOLQ,&9EUMW$N+T= "1&BP:;+#=P;06[
MCCAU2V8]W !O                         #/#:8"-Y3*#ON"]XM-2R;41
M3^U8</J;?M<CZV]T= "2                            1Q<+*5W=;KAT
MPY/#-W&7VOA%'Q_]1O%QL?.V )&+H+SB :@
M"@X,?"[ZDZ< T&9(^W.TF?%V'AZAC@C# !7@
M
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M-G;L\G4J6C=1BE*C2H^L70:=H#Z6CP_$$#A)4A&X>ZE1FI1%CW3/: J4
M       $9M$R5_R#W'#=-M.+F\K<+J$>&[X.("3            1O>:6CK5N
M<1M:C)QS=4A2B))[Q>$1;#QP 2,CP$8=&XG#YA -P          H?,'AG;KQ
M.H6XCCL&:6U*2K8LNZG: J.B;OBN%N$9)X#>PS,S+JEL,S[H#M0
M!UU7W?%LS?(S3V=W>(CP,RW%=!EW0%+9>\(J A+*5H;*1(P):E*5CQ#[JMN
M"N@         !M7X*OWJOV@$<6<315^Y=QMQ"S<;-Q2E+4E76V;I*V%AY@"2
M0
M                          !\)7W-(_B'?L:@%@T_[BKW]MQ?Y^0G>7H]
M1?G3?Z.@?R*+]@;$++F@
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M&=C:E)5]43@?5VX8@*W@X%"B$DC(NSLX$>TR+AIP(_-(@'*
M             $:W83!W-;?$0XIPE.$@TJ624XG\\2=A@)(3X*?WI?M -P
M                        C2_TL*DT,G6W%GVE1IW%K3N]9&T]TRQ(@$CM
M?4FOXM'^20#Z                          ",Y1,^_P#@^IN<7AN8+)2M
MSP.Z7@@),                           !&UQ&Q[[[<WVW%.$;NXI*E$A
M../A$75/'S0$D%T%YQ?M -0                         !'\!+97C4S)*
M^)@C>69JW%;,,"3X.P!(
M
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MQ'4U:?)PTO6Q/J]4K4B6O-J]GJ1(52K>>CLR4QV45)33\5MM+AD2ED1>:?0
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M=6E+)1C>*1@HCW361'PL.^ D9O:A!D>)&A.WHQV%MP[@#>          *)S
M=;9MQ];DQ4$N,P7:$L'(-/7Z";(CQQ 5%15$NEPE)<-TC8;P<-.X:NHG;N]S
M$!V@          ZZK&14Z89K-LBCNF:R3OFGJ*VDDL=[ !2V7KB';?;4B:J>
M7'D%QU,'',\'#V<,R(RW<</- 5T          -B_!4?09)49'WMA]SN@(ZL]
MU#E?N1*:@J6I*VMYE4=3)1MI8$3AD1.[P"2
M
M !\)7W-(_B'?L:@%@T_[BKW]MQ?Y^0G>7H]1?G3?Z.@?R*+]@;$++F@
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M^$H]WAJ*:+O5$1'T.T%3D        .@N=1(HDY2GC8(FCQ=)LW327?)!$9F
MX%CK2NW(:TR3EDI3N#ZFC9->"L/J9D1IPPP 5<
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MB)&,0V#)+>)8['L,%@*\
M
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MV/6@^18[73PP=RFV>J/#S'^ #4!]#&]EL>M!\BQVNGA@[E-L]4>'F/\  !J
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MDX^!F1D;A$7%Q 2,
M                                          /A*^YI'\0[]C4 L&G_
M '%7O[;B_P _(3O+T>HOSIO]'0/Y%%^P-B%ES0
M                                     1EG3^B#-'_9]>/Y/5$!A<\G
MR_W1:U_M&O?\H) #/@                          *5O1Q35NSG$R2B*2
M39D^;1/$@]\O\V9&2L0',MEPW:+!6;Q2#-HL72;X1+\WAE@20'?
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M#WI!D:%1B?XY&I)&DC,CX>&/2 D)KZFWB>)[B-N&&/5+;AW,0&\
M                 1S*?<]_4)KMZ$H-"\879B-2\$;#X^&)8& D8
M                    $>5^2XBZ[?91/2RE?%WHQQB<-[O8/88M[H"0RZ"[
MOF@                           H6$\M5WU%LYJ5H2E)%%X!$IL\-OJV&
M*L>D!70
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M[1@(^M,G?'EP&XAM);Z-PT*0:E;2VJ).TO1 2&
M
M    /A*^YI'\0[]C4 L&G_<5>_MN+_/R$[R]'J+\Z;_1T#^11?L#8A9<T
M                                                        $99T
M_H@S1_V?7C^3U1 86_)\3(](M:P^$:]_^WY #/B
M     *7O(EG;\TFR2I1\/ EFDDGUR/::MG< <NVDK318)+)*5<(L229&GT#+
M$@'>@                         #H[D)9T::3:24OA["49$1X;=IGL+ !
MPK,2M-OPR<2E*\7,4H-)I+K=].PS,!5(                          H6
M_2>52D$RA"U<=K8XI"2PXB<?#V8D K&%CV.+CT]G9+9T;&TEL <D
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M$X*)2=\\"Q/$O"V *X
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M,5Y.+*2+=,S-2ND!(/*?YT-#Y@MVYL9#WU8/YK-0^29R8MVVB4Y%0C2W8CG
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MBZO[^WK^4<@?GO\ Z\)__P"@<P\M/TU/HAV$?R1@O/\ 0R3CQN[U
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M3C3AD?GBL6.9%:#-#>@(LQ,ULK<N+4RQ\=,SZ]>ESU%V#M2RERH3'RFSFV>
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M7'.3MQ,S;Q/A8&8"10
M                                           !\)7W-(_B'?L:@%@T
M_P"XJ]_;<7^?D)WEZ/47YTW^CH'\BB_8&Q"RYH
M                                    IR[[CCVC;-<N62R[(9HM+FU%
M4=A"G'7SB1G'R9;2@C4:G3;W2P[I@/.1FQSUJ@NW<T[;;TEYAS(#%'NN@)J"
MX]43'E-JAU&G*E&DH1&3.!;YX&6"3Z0$M^3JS2KFAYJYN <+WPWK=M2\6+QX
MM/[75UR>S.$KK$IKC;IX[<4@,_X                          I.]FS=M
MR:@HA3C,VOM8WNS[^#A&?JN);F #GVTDD46"DH_9<&BQ8XG%W#[W$Q/> =Z
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MBBX4XIQID&>\<KL_ VI/?PQ(W/. 2&UL;;+#=ZB.KCCAU2V8]W !O
M                  #/#:8"-I<<RON ^=.)2>&LBG=JP-!J1AAV;'%73W@$
MD@                           CJX8QN7;;KOBPI'#-W&7VLFN!CT>H[Q
M<7'SM@"12Z"[GF                           9X;3 4)!9--WU-SL!-D
MHD83.TDHW=AX^HX]3 _, 5V
M
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M,!4H           (S;::_. ^OLB^(;23.3QU;AX(V%PL=TL $F
M  C2]6VG*W;?$BK?W7%FEU+JFR9Q46)J21D2][#N@))1X".YU$[/0(!N
M      %$Y@(:<MU]+L9<I/'8]10XII1GQ"P/?29&6 "H:(DDTN&1(-!$PV1(
M-6\:2)"2P-1[3,@':@         #KJL1'39A*2:R..[BDE;IJ+<5B1*+:6("
MELO&T-V\T3<945/:)&#:W3=47JAGB:E&9GO8@*Z          &U?@*QVENJQ
M+T# 1O9K3+=?N52(BXZUK:-;BGE.$]@?2E)F9(PQ[@"2@
M
M          !\)7W-(_B'?L:@%@T_[BKW]MQ?Y^0G>7H]1?G3?Z.@?R*+]@;$
M++F@
M #8XVV\A3;K:'6UD:5MN)2M"B/89*2HC2HC+O@(=S?MNV(F569DMNV+=-UJP
M[P>2:Z)35$;J;?J*B4LCC&2NMM/'I 8=/)\L/\(U;W4I0D\Q[X,FT$2&D?\
M>"2>ZVV6"4)+'81$1$0#/@                          *3O="'+;GH<8
M5(29-$;27#:-7JB<,%D9&6 #FVPE**)!2EHV4DUL;4LUFGSU'B9[0'?@
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M5U#0\IKA'OIZQD1EO%@ D5K8TV1%@1-HV=.'5+9CW0'T
M          $9RFFSO^$Z<-:G":612>,K<21H+_-8[IG@ DP
M              $:W$TVJ\+;6<5;JD\8B?)]2$LXXEM;+8O>,!))=!><0#4
M                         4#3VVBO&J+*,M+F",7S=,TKV=QLSP+#$!7P
M
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M!/L8NH:-U1&:\"+<21J/$!4-$,E4N&I*S61L-F2S2:35U$[32?09D [4
M      ==5C(J=,,U;A=G=Q41;VZ6XK$\"VG@ I;+YQIV@-J:?7(3QY'JBVU-
M&9\0R,MU6!X$9 *Z          &U?@+_ 'JOVC 1Q9KC+E=N3AR5O*2XV2VU
M-*036TMB5&1$KH[@"20
M                                            !\)7W-(_B'?L:@%@
MT_[BKW]MQ?Y^0G>7H]1?G3?Z.@?R*+]@;$++F@
M                                     C+.G]$&:/\ L^O'\GJB PN>
M3Y?[HM:_VC7O^4$@!GP                          %)7PI"+;G*6\IA)
M<(S<0@W%%UR^=21F>(#G6PI*Z)!4APW4FWCOJ2:#/STF1&6 #OP
M                !T%SJ2BB3E+<-I)-X[Z4FLR\Y)$9GB X%CK0Y;<);;RG
MTF;N#BD&V9]<\2W3P,L %7                          "/LQ7&FZ.V;T
ME<9/:6"WT-*=/>-PL"P21G@9@*W@F1PHADK?(XS)DHRW=XN&G \.YL <H
M                       1K=JV4W+;*5REL.*4[NMI94LG=O0I9$9( 22G
MP4]WJEM] !J                          (TOYQIN50>))<8,Y1DE*&5.
M\0S418&9%U0$CM?4F_XM'F?.EW.X ^@                          C20
MZR5_0F^UK)TVG<(Y-*W3ZFW%S#=+HQ 26
M"-KB<:3>%N)5)6VXHWMQE+*UI=PVGBLBW4X )(+H+SB :@
M           "@H*FCO"II*0I3A$G%CAF24;.G?PP/$!7H
M                                                        .EEW
M);L"<S3)U?HL*I2-C%/EU6#'G/GWF8CSZ'W/^:DP':O2&([*Y$AYEAA"36M]
MYQ#3*$$6)K6XM24)21;<3/ !P:96Z-6VE/T:KTRKLH4:%O4R?%GM(61X&E3D
M5UU"5$?<,\0'9@         #X2946$PY)F26(D9I)J=D27FV&&TETJ<==4AM
M"2[YF0#B4RLT>ML=JHU5IM7C;QI[13)T6>QO%L-/%BNNM[Q'TEB [(
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MX'9<5$6!N8%QM[ !(H
M                                            ^$K[FD?Q#OV-0"P:
M?]Q5[^VXO\_(3O+T>HOSIO\ 1T#^11?L#8A9<T
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M15(H&_(,C2<7M':,321(WL#-K;W0$AM;6VSQWNHCK888]4MN'<Q ;P
M                   !&LJ2:;\A,E4=TE(7]H]DQW^ICCVG=ZN'G@)*
M                       !'5POFB[K=;\9]G)?%^TNR$[VC#I+CX>I;O[(
M"12Z"[OF@                           H* \:KOJ31S=[=2G")V?#A[,
M#]7PZ_0 KT
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M<!PR,R(R(]P^DCZ2 4S82G54)OC+0XOCR,5-I2E/U3$BP26&)8@*V
M   &U?@*_>J_:,!'MHF]X[N#B.-K2:V]PD)21IVEL49;3/IZ0$B
M
M                 #X2ON:1_$._8U +!I_W%7O[;B_S\A.\O1ZB_.F_T= _
MD47[ V(67-
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M5R6\3;C:4&;F^A2$FI9?\E1[2Z.X D1/@IQZ=TL?F -0
M         !'=\*=*31>&MM!')ZQ+0E6]UBZ-XCP 2"U]2;QZ>&C'Z4@&\
M                      /S.^7[>W]@!'4A;WOYA))QLF^&X1MFA&^?4Z24
M?6 2*                           ".K@4][[+>)#S:48N[[:D(-:^X6Z
MHRWBP\P!(A=!><0#4                         /S"Q\P!0\)3OOKJ*=]
M!MX(P024[Z>DCQ5X6TP%<
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M\J),-UQ1E@EO$\< %2^4?Z+=/&AAC3#JATH4^-DQG+0<Q*#2H\6U*FY!>N*
MJK0D&AZE0'8STDN'@DU'BDR+HV'B$S^4IW#4LPN55I*NJZE2(E;NYBP55V8K
MB,OLJJ<.G,SI#A&?$0;Z7E+,S/N@)9NOE(Z!:AR57+D5;E&5=<;)F->$?-9R
MML.55BZ(U)35&7D511&Z@TOIW":)9+(]N/< 0+RI,U\P\Q?)X-2M,OJM5"X8
M^7<"\*%:=3J:Y+SRJ7$.1$82B7+==<D-I8BH-."L"[G2 H7R=KEZZ5L^>7WG
M;FYG+8D:_KOKLG,-3KE3?4Y'IC,"+4W$%#C.-.-,/\4B4E2=A&70 J#R6^MR
M; 7S,;#ME^<NFY=S;MG6?1W9DB2U"<IJYZX3$1MQPT-;6&TEN)2 AKD*Z:<I
M.9#K/UNZBM9K19E9FVK>]2I%O6;<U3<>;H<-NM/1$+:H]0<DF;1,*,NH22ZQ
M .RU2966)RS^?=I9E:/)CUJT3.62J'F+E;0:D]-IBN)PV'7GZ7#=:8C)4:=X
MDN(,TEL 7)<R_EOZF;-YEJ>8W:^2[.L;)RLTVC2:QD[.N9JG'0C3 4N8U&I$
ME#RG-Y1*+J)V[P"2]#FJOE/Q-9]MTV_M(9Z,=85PR6HUK0)=5E.1JC46SC-/
M,ML[T)E)JD["/<674Z.\%I7E/]DV_F1KKT'61=T]=)MBZ[A@L5.I-2EPTK@R
M*B3:6E24*1PTR8[QI,S/# !,O/UY7^B[(CEI6_G?DS1*7EIFCE0_9$RSKJH]
M9;;JU9>>1'>><*6QPYE1<>D,;YJ0YAB>PB =!S!,S;XS.\F7R<O^_)TBH7C4
M:7;=*FU"<EPI;\9*W::VZX;ZU/*6<9LC)1F9GCB TRWY:FD)OR?^=FO5,NX]
M=S)JN5TRYW+TEREO5)FLLM<9AZ*X^RM<5MGAG@E!D>)^%AL 3]Y//F[8=(Y*
M^851U W),IV3MC/WE3KFK<VH25NQ:&I3L<HS,IU\W4<2.V;:2)22Q/N +6J5
MGYE/F;H<U+V7RU-!<.JY$/1[J]]&>]?J3,J55G"34CG5.-/JK#T@E,N*2X6X
M[L,P$U>3)6G1KZY7NHO+N^^-=]E/NWOVV@5>0[/CQW68L^1(AQURU/H;*/(;
MW4FDL"W2 0%Y,9IVR/OC//6M>=WV11ZM4\J;]JC=D52849UVVHBJZZI],1M3
M9N-F3+>.^6!$2<, %Z%P:L]%R.8;G';>C+2S_BYU?.17Z5?MTU&I*E4BT'FH
MTF&VTW#G%,@,):424XDE'3W &-;DOP[YA\_744J_K<5EA=E4B5:=<.6U,J1O
M4:FN]C4_&;3'AJ1 (TK+#P-AI 0Q=UQ2=0?/XSWJN=V4<_4O3\LJD<.S<FJA
M7)-)I]/:4](8);,&0M^,^1(VX);+P@%U67VD355;_-_R2U7Z4]+<S3CDW(FG
M#S;LJ)=KLF#)ADXQ'-UZC-(88)*F.L6*#+ @$;:UL@LL=2/E0-GY<YD1),ZR
M:E'MM5?I4>8]#3493$-I3S3RV2,E)XRU$>)&1D>T!#W..T9Y&V'SC]'N1N3U
M ?ROLF^YM';O.#;M0DT]NKM,.L<9MPZ>4=1IDH2:3WR6>![3,!-GE%6CG3KH
MQNW0+F5IWLA.7UX%>-!;GU&DSGF)=88<JL-)*G2&28>??4ILS6I2L%=X!>WY
M4'+.X^5=ISK,\G%3*B65DI\^*LE*?>I](6XM2B/%1NNJ,SQ/N@)ESZS:T+91
M<HK1?'UR4F5=L&HV_;R\M<M(=5E4^1>E;;C1E,PW#C.H4ZA,I"$X*)7AX8 ,
M+'/5O[-;.'3/ICNA6CN!I5R/I-R6@C+ZXZ?/B1:Y*IIU:,4-UPXK$6HN+>AK
M0H\3WMF)[=H#W8Z"9$N5I#R&>FRWITA675KDJ5(6XX\\E-&@I0I:W5*6HS27
M29X@)TSFQ_-'F?AM_P#O?WA^3]0%-?JV)B;-+\::]?TQYR'T87Y=7Y15+]T>
MDNSBFS9F*9T<GZG7&??;S+0ZT;@QH                      '>\\OVR$Q
MNJ:O59T_)H__ #0Z3_9]5_F4(:1VC_R[YX^EG-GXF,5%K].'NCSE/KPWYJ*P
M         1Y?C#CQ4O<@HF;LE)F2I"6-SKEUBWC+>P+N *_9V,M;,/4T;,<<
M.J6S'NX /H          *9N]!N4"<A,<I9FE/J"G."3G6Z.(9D20'TM1LVJ%
M!0J.48TH/%E+A.DD\>XLC,E *B           !&S3#A7Z^[XO22#:3]N]I3O
M*ZA;.!CB6 "20           1U>+#CM9MTTP42DH=<-3JI"638VD9&23,C<Q
MP 2&CP$?O4^;W"[O= ;@         !1E^-+>MY]"(J9A\9@^ IXF"5@LCQXA
MF1%@ [^BI-%,AI-LFC)AO%LE[Y(/=+J[Q=. #M          !P*H1*I\M)H)
MS%APMPU;A*ZA]4U'L+$!3%A-K;H+:5PTPCX\CU%+Y/D6+A[=\C/'>_8 5L
M        -J_ 5AM/=5@7H& CVT&5MURXE+@IBDMQO==*03QOD1EM-!&?"Z0$
MB
M                           #X2ON:1_$._8U +!I_P!Q5[^VXO\ /R$[
MR]'J+\Z;_1T#^11?L#8A9<T
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M*=WGU2$M''(SZ2;,R-S'#O )$3X*>YU2V>@ U
M   $=WPRMV31=R"B9NR<34J03'!(E%BHB,RW_. 2"U]3;Q+ ]Q&S''#JELQ[
MN #>                         'YAX>: C>4RM5]P7>PH-"&UD<OM)$M/
M4V8,8XJQQ[P"2                            1U<+#B[MMUQ,%#R4<7&
M2<E+:F,<2V-&9&O>\X!(I=!=SS                            4-"96F
M[:BYV-"4K)/VR3Y&I>'?:QQ3ACZ("N0
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MD/I0VM,LCA.$9$V6TL-@"T+3WR,=6VH7618>M3F2YMTNY+MRNG-3[;MJW:/
MHQ2GT/1W\7'Z5#2DRWTKQQ672 LI\J=I,*[=8^AS+A5250WJ]58M)H]6;6HG
MJ7)9E+B0'D*29.&;;RT*V=.Z F_,/D9<R76#<>4&36I;5A)NC1[8K-KUF)3N
MSJ:=J46.W GIILIOANN2.$V2FB-Q.WI 9AN:ERO[HU&<MFB:)=-3L.V4VNU:
ML.D$LVVF%,4)#3<EQ?J.Z2I9MFL\$D>*MF "J[7T YLT?D^LZ'7ZLR>9[>6T
MFU#J>+?".<['6V2][A$WABKZ$!:;R\>3)F'E=RJLZN7YJ$N%#<G-217%MUJ
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M.5]/1PP>XQO,D_,-J@_5]OG_ %?K_P"#0^8Y7T]'#![C&\R3\PVJ#]7V^?\
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M-S>4U5VQ99,:;-UL.1X:^IOZ*ZK;9]:+-SPC2_2JQVX=X>?;;:[-3=MYJ*T
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M\P3YQS/U0MO$(R,L %145)(ID)*4&T26&RX1JWS3U$]7?[N #M0
M!UU622J=,2:.*1QW2-LE;AKQ0KJ[VS=Q 4OEZTAFWVFVX1P4D_(/@*D'(,C4
MX>WB&9F>]ACY@"N0         !M7X"]F/55LZ,=A[,>YB CJSV$-5ZXUIIZH
MAK6C>?.2IXI'6+:39F?"PP 2.
M                                                   /A*^YI'\0
M[]C4 L&G_<5>_MN+_/R$[R]'J+\Z;_1T#^11?L#8A9<T
M                                           %"9H_HRS%_N+=WY/U
M 47G[.?(1NOQILROT^9X_P!_+G_*.I#T5V<_Z#3X:G7F>?O]7E4\-Y8H
M
M                               ^@47GJ)AD+Y/O_F>Z;/[4E_SFG#!;
M7_RO>^3C9+*OWRA^L]"P['"[_9(^'UI \N5>O/D_2[%CU7,%8
M  (UNR.ARYK;=.GJE&A3GVP4DV>S;>GA8D3N) ))3X*>YU2V>@ U
M                  $;WXRV[*H9KIZIIHD*-*DR3C\ S-/6,B,N)T= "1&O
MJ3>!8%PT;,<<.J6S'NX /H                          (UE1VCOZ"_XN
M4;I-+(IW:3)*2X9D9=GWL%8^=L 24                           "-KB
M8;<O"W7%TY3ZF^+NRBE&T3/=/U$C(G<<?0 22707<\P
M          % T]I*;PJ;G8E)4HDXR^.9DY@D\/4<<$;" 5\
M
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M;3=%><,GS?+-<<$'QS_*/^%;+O\ U5HOI0ZJ;3=%><,GS?+-<<$-?CG^4?\
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M<5T$6W$!3&7W"][[?"4M2>T2,-\E$KP]OA;0%<@         #:OP%?O5?M&
MCFS39.NW'PS<W]]O?)1*))8G\[O;#] !)
M
M^$K[FD?Q#OV-0"P:?]Q5[^VXO\_(3O+T>HOSIO\ 1T#^11?L#8A9<T
M                                                     %"9H_HR
MS%_N+=WY/U 47G[.?(1NOQILROT^9X_W\N?\HZD/179S_H-/AJ=>9Y^_U>53
MPWEB@
M                                       #Z!1>>HF&0OD^_P#F>Z;/
M[4E_SFG#!;7_ ,KWODXV2RK]\H?K/0L.QPN_V2/A]:0/+E7KSY/TNQ8]5S!6
M             ",[M-@KHMHG%.)69NFC=)9I/#'$E[NPL<.Z DI/@I_>E^T
MW                          "-;]X/:J%Q361]I/=W"6>W>3L5NE@1&??
M 2,U]2;_ (M'^20#Z                          ",Y7!._H)&I?$)#FZ
M1$K=\ L<?G?, 28                           "-+CX'OQMKB&YQ,7N&
M225N'W]\RV%L[X"2BZ"\X@&H                         9X;3 4#!X7O
MQJ>"EFX:4;R3)6X6PCV&?5Z %?
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M%1@           C1J2D[_?8\9F:B:3A3^R&1)ZA'CVG#K8X]\!)8
M   (WO-]+59MU"JB<(W'5X-%%-_M&!^":\#X6!@)%;VH09'B1H3MZ,=A;<.X
M W@         "BK_ 'B8MU]9S3@>K,$4@HYRMW%>!EPL%8X@*AHI[U+AGQ.-
MBPWZIN;F_P!0NMN8%NX]X!V@          Z^JJ)-.EJ-?#(F'#W]W?W.HKK;
MOSV'> 4O8#Y/T!M93CJ!<>07'.,<8SP</9PS2GP>CS0%<          #8OP5
M=PMU6)][8>W#N@([L^0EVO7&VFH'*X:V\8YQ39*-UBV$X:2XN.("1P
M
M                   !\)7W-(_B'?L:@%@T_P"XJ]_;<7^?D)WEZ/47YTW^
MCH'\BB_8&Q"RYH
M             *$S1_1EF+_<6[OR?J HO/V<^0C=?C39E?I\SQ_OY<_Y1U(>
MBNSG_0:?#4Z\SS]_J\JGAO+%
M                                                           '
MT"B\]1,,A?)]_P#,]TV?VI+_ )S3A@MK_P"5[WR<;)95^^4/UGH1?:<+S(D?
M[$@>7*O7GR?I=BQZKF"L             $;77(2W<UMM'43B;ZG/M8HIO=IZ
M=G%W3)K !)"?!3W>J6WT &H                          CF^I!,2J&1U
M$X._),MTHQR./@HNIB1'P\>^ D)K:TV>.]ZFCK888]4MN'<Q ?0
M                 1M+>1[_ &"UXS-"N$LR@]EQ)SJ??&[U<// 22
M                     "-[CD);NZW&O&2HYN&Y]I%$-TI.W RXY)/@X>?M
M 2.707G%^T U                         #+'88"@X+Y*N^I,E.-9MI21
MQ.SFDF\2Q+U8RZ^SS0%>
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M2HD*X#N"C+>)/45M,CZ< %,V&XM=";XDI,I1/O\ JB&B:2?JA[-TB(NJ K4
M         ;5>"K;AU3V].&SIP[N "/;1==77;C2N6B0A+C9(;2REHV2Q+$E+
M(B-S'OF D0
M                                    ?"5]S2/XAW[&H!8-/^XJ]_;<
M7^?D)WEZ/47YTW^CH'\BB_8&Q"RYH
M                            *$S1_1EF+_<6[OR?J HO/V<^0C=?C39E
M?I\SQ_OY<_Y1U(>BNSG_ $&GPU.O,\_?ZO*IX;RQ0
M
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M+K=*/-0T9ZT[UK67^G_,QJ\+FH#2'JG!;C-M<!"TH4DS-$EX]I.%TD0#(J
M    (\NA;J;CMY+<M#"5*<WF5,)<-_NX)69&;>'F )"3X)><7[0#4
M                   1W?#CJ)-%X<Q$4C?/>2M@GN)UD[",R/=,!(+6UMLS
M/$S0C;T8]4MN'< ;P                         RQV& CB4MWW]06RFH)
M!MK,XIL)WU[J,=CV&)$73T@)'                           !'5P.K1=
MMO)3-0RE1N[T=3!+4[WMUPR,TX'YH"12Z"[OF@
M    98[# 4-!6X5V5%!R4*;P3NQR9(E(+=_A<,58@*Y
M
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M3N95FSJYTYY+5//K2_G_ %-VI71;M&=?9>IKQNOS'67$PH[:^(2DD6TU=)&
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M2\LR1@VI9()76+YY6P@'TM1*T4*"2VTM*W#Q0E9+)/6/H46PP%1
M   CEI#WOZ>7V=OA&V1<?BHWSZFPN'X0"1@           1Y>#3RZO;RFH[;
MI)=<WW%NI0;98ET)49&H!(*/ 3CL/=3B7H$ W          "C+\;<<M]XFF4
MOK)YCJ+<)LL-_:>\K9B6 "H*-CXLAD:"09,H+=(]XBZI;",MA[ '9@
M   #@50E*I\LDI):N Y@DSW2/J'L,SZ %+V"EU%"0EUE+"B??Q0AQ+A;5F9'
MO)[I@*W          &U7@J_>G^T CZTD.)KEQ&N.AI)N-[CB74K4Z6]W4EM3
MAYH"0P
M                               !\)7W-(_B'?L:@%@T_P"XJ]_;<7^?
MD)WEZ/47YTW^CH'\BB_8&Q"RYH
M                         *$S1_1EF+_<6[OR?J HO/V<^0C=?C39E?I\
MSQ_OY<_Y1U(>BNSG_0:?#4Z\SS]_J\JGAO+%
M
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M]#IW;;RBC(<;2;IJ=4ZE*D8]Y![5; $B%T%W/,
M    &AEB6 "AH+;GOLJ*C80EO=3N/$XDU*V$9XHQWBV& KH
M
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M*E8TSQB12D?]*[-PL%D>]X1;^'>[H"06=C+18;N#:-G3AU2V8]W !]
M    !3%X-\6WYZ"C=LQ2C[7XW XG7+9Q<2W< 'TM-&Y08*>S=DP0?J'%XVYM
MZ.)B>\ J,           $:-,%[_I#WBS ^$DNW]KQWNJ6SLV]LP+S $E@
M        CB\6.+6K=,Z;V\T..*)[M?9NS;>G<(RXN]@ D5&Q"=F'53LQQPV%
MLQ[N #<          *)O]KC6Z\CL/C S?8PC]H[+O>J%MXN)88 *BHJ=REPT
M\+@8,-EPM_B;G4+J[_SV'? =H          .OJJ=ZG3$FWQMZ.Z7#WMS?ZBN
MKO;,,0%+Y?L$Q0&T% \7%VB0?9^T]JPQ<Z>)B?A=/F *X          &U>U"
MMF/55LQPQV'LQ[F(".[08)JNW&OQ=V,UK;]7[5Q^U;<<>'B?"W3 2,
M
M                    /A*^YI'\0[]C4 L&G_<5>_MN+_/R$[R]'J+\Z;_1
MT#^11?L#8A9<T
M            %"9H_HRS%_N+=WY/U 47G[.?(1NOQILROT^9X_W\N?\ *.I#
MT5V<_P"@T^&IUYGG[_5Y5/#>6*
M
M /H%%YZB89"^3[_YGNFS^U)?\YIPP6U_\KWODXV2RK]\H?K/0ON.%_)(_P!A
M0/+E7KSY/TNQH]5RE)2M*D*+%*DFE1'W4J+ R]$C%:%NV8F65@63EUG9=-L6
MC;]*N.O6)=TJKUMBDP4U2<\S;E3)M4B<EA,IPD;QX$:S+$!X4_):S,^8MK',
MS,S7>-RFHS/$S/QVL^[YI@/T,9+[<6/(E.GNM1F'7W%'L(FV6U.+,\>\E)@/
MSTM4E;J'-Q\H8R]R%<F/U?)'3K7F7WJ?Q%RZ2;].F$\\Y(9)4V'O<5!GUD)
M?H-V_185NT*BT"FL-1:?1*7 I4.,PVAIIJ- B-1&&T(;2A"$H;:(L"(B =P
M     (XNR/Q;EMISQ;VO<4[]L]KX/9MI[>#B7&Q 2,GP4]SJEL] !J
M                    (YOMDG7Z(:J:=0),DSWNU]FX![R>OAB7%Z>@!(;1
M8--EANX-H+=QQPZI;,>[@ W@                         "-9323OV$X=
M,,]UM>%0[5N[A\,NKV?>ZV]YP"2@                           1Q<+!
M.7=;KGBSM!(XN,WM7"[-M/\ S&/JN.'H )'+H+N>8
M        "A(3.[=]1<[!N;R4X3.T[W%V?P./4P\X!78
M
M                       #';FUS/=*^2VJ*R-(=\7B=/SDO]246[0N E12
MC498>JF^DRZ2^=,!>9F?FC:F4F7=PYGWA-[#:MLTA^MU282=[@P(\9<IQS=,
MTXX-(,^D!;_HQUSY!:\,O)>9VGVY3N>U(54F4A^:;1,[LR"^<>0WNDZ[X+I&
M72 O&          %E&MO7KD/H%R^@9EY]U2K4NVJC4HU+CO4FD2JP^<J4\3#
M1*8B8K))K/I 7#Y,YN6EGKEK:N:EC/R9-K7A3&*K2'Y<9R'(<BR&T.MJ<C.^
MJ-*W5EL,!* #Y/L,26EL2&6GV7"W7&GFT.M+3W4K;62DJ(^\9 (+SPM&S8V3
MN:3Y6?:JU)L&[UEQ+>I*RWSH%0,G#)40R-:5;2/O@N75,55V2\C'*NSUS=L?
M3S>5$M.YG*71XE]WD4.$VV?"C).Y7R-+24N)2VG B(B(B(B&IYAF6+P^*FYN
M9LB7D+M1VZVMR3:Z^P>68B:,-;N</C9%3U4ZA.Y?#Y%L_P TOO?QPX'S#'SI
MFJ;77\=I^V=FG%U6^3ZVG^*C4+^/+_UISUX3^?Q_.D[T-LOBZN#ZS_%1J%_'
ME_ZTYZ\'Y_'\Z3O0VR^+JX/K/\5&H7\>7_K3GKP?G\?SI.]#;+XNK@^L_P 5
M&H7\>7_K3GKP?G\?SI.]#;+XNK@^L_Q4:A?QY?\ K3GKP?G\?SI.]#;+XNK@
M^L_Q4:A?QY?^M.>O!^?Q_.D[T-LOBZN#ZS_%1J%_'E_ZTYZ\'Y_'\Z3O0VR^
M+JX/K;BU4ZA2/'W\/GT[.$YW?_PPB<PQ]FBJ4]Z&V7Q=7!];B,:F<_8K\B2U
M?,CBR#+B8H<,MA[,"XPB,RS*G1;H.\_;+=_-U>'G<H]5&H7'_P <O_6E^O"K
MYCF%6F9FU$=J&V7Q=7!];3_%1J%_'E_ZTYZ\'Y_'\Z3O0VR^+JX/K/\ %1J%
M_'E_ZTYZ\'Y_'\Z3O0VR^+JX/K/\5&H7\>7_ *TYZ\'Y_'\Z3O0VR^+JX/K/
M\5&H7\>7_K3GKP?G\?SI.]#;+XNK@^L_Q4:A?QY?^M.>O!^?Q_.D[T-LOBZN
M#ZS_ !4:A?QY?^M.>O!^?Q_.D[T-LOBZN#ZS_%1J%_'E_P"M.>O!^?Q_.D[T
M-LOBZN#ZVI:J=0N/_CA\_P#\$YZ\)IQ^.UG>AME\75P?6N4T;YU9L9@Y\0Z?
M>%TO5.G(;?/LBDK2G$D-'W75%W3[@R.5XO$7N+Y%[IAV/V4;=;29YM5&!S&_
MF\P\[W!XV;,O#,_^'=&SS;;8]8V1$VQNR^@E(         C7,)#2TTKBLN.D
M4E.[N.+1@>^G:>[TD D5C#@LX;"X3>!>9N%@ ^H          I:\]P[=GDXA
M2T&E!&E*C2H^N1[#3@?< ;[0)!6_ )M*D))"L$J4:E%M[IJVX@*F
M   !&+2&/S@R%DPYQC;1B]Q%\,R)OHW/!Q(!)P           (TO1#*JW;:U
MMN.*)QS<4A:TDCK=*DEL/I[H"2&_J:/WB?VB ;P         !1&8*&UVW(2Z
MVMU!O,8H0I2%?5"VDI.T@%0T,B32H1$DTEP&\",S4>&Z6&)GMQ =L
M   .NJQ$=-F$9&HCCNXD1F1F6XK81EM 4KEXVVW0&R9:6RV3\C!+BS6KZH>)
MXJ,SP,R 5V          -J_ 7W>HK9Z!@(YLY#*:]<IMM.(7Q&^(M:U*2LS/
M9NI,\$X8=P!)
M                                       ^$K[FD?Q#OV-0"P:?]Q5[
M^VXO\_(3O+T>HOSIO]'0/Y%%^P-B%ES0
M                               4)FC^C+,7^XMW?D_4!1>?LY\A&Z_&
MFS*_3YGC_?RY_P HZD/179S_ *#3X:G7F>?O]7E4\-Y8H
M
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MVEW/;)N-.+6E3NXM*U)2C]\1;%>CWP$DI\$O.+]H!J
M        (UOY+2I-#XK+CN$DS3N.+1NGO)Z23TD D9KZDU_%H_R2 ?0
M                     1E*1'_.! 4IESBDVYNNDM6X1[A]*/!/$!)H
M                       (UN)#)W?;JE,N+61O;KB5K2A'?WDD>![ $DET
M%YQ?M -0                         !0,%+17C4E$VOB&E!J<-:C0>)8$
M1)/JD KX
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M*;=GJ7(.*DDH,WTMFZ:.N7^;+:H!];06E=OP%)?.01H/U539M&KK'M-!D1D
MJ4           $9-O-%F ^R4Y9N&TDSA]G5NI+AE@?'PW3Q 2:
M "-KT>::K5N)<FKC&XXX26DQU/$\9&6PUD7J>&("1F]J$&1XD:$[>C'86W#N
M -X          HG,!Y#%NON.2E1$D\QZLEDWS+KELW"(_",!4-$42Z7#4E9N
M$IALR6:=PU%N%@>Z?1L =J          .OJJB33IBC6;9)CNF:R2:S21(/$]
MTNG8 I7+UY#]O-+;EJEIX\@N(M@V%8DX9&6X9$>P!70          VJ/!*CZ
M,$F>/>V (YL]YIROW(EN:J0I+C9N,J8-HF<3+ B<,B)P_. 20
M
M               /A*^YI'\0[]C4 L&G_<5>_MN+_/R$[R]'J+\Z;_1T#^11
M?L#8A9<T
M       %"9H_HRS%_N+=WY/U 47G[.?(1NOQILROT^9X_P!_+G_*.I#T5V<_
MZ#3X:G7F>?O]7E4\-Y8H
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MUF[PV$L&X3YX[<7"(R;P 2.GP4]WJEM] !J
M (VOUYMJ30]^:N(:I)DE*8ZG^-UDXI,R(]S8?2 D5KZDW@>)<-&W##'JEMP[
MF(#Z                          ",Y+K?O_@M*FJ)9M.&B'V=6ZO!O'>-
M[#=+ !)@                           (VN%YM%WVZVN:ME2^-NQBCFX3
MV&)[72(R1AAW3(!)!=!><0#4                          4# <0=XU-!
M2UK624XQC9,DM[#_ ,[A@K$@%?
M
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MRI-QPG:E%1)4J.P\LVFW2,M[$^MT@/-1R,]46GS3MS4-=]I9XR*10Z_?EU5
M[2NFM1(BXL8XE6>.0GQE+-+<$E[AEB2BQ 2%>&8V76JKRFW)NOZ938NFD6#2
M)46^[PM>$ENC-RETPF$')J%,0Y#D&P\HNLXLC4>T^D!3- O>T-$_E+^9]W:P
MG%P+8S0AQH^65^7-3G)5!AN/0C:;*--J+2840C<(RWFUXHPQ+: DORF;4IIY
MU/7#I'T\:>)M*S/SZF9CTBJ4Z18\5JHS*#3W*G!5Q'ZM1DR7VD+06.X9DE/H
M@,Z.O[4EDKHGY4\2)JK*E7'4JWE)0+-IEDU8XTNI5ZYJC;D>GPV8T26LI*GH
MDQ1==*362BP[X#Q9\F.\H'+?U_Y=YHZR<K)5F9>ZFZS6SR:NVYH[KL&UX]8J
MJ'Z<[&55&8T:*MR/,0E)I5C@@L 'HU\K;K=(JV@7+JMP)L>51ZQ>UI3*?.CN
M-O1I,69/COQW6G6E*:4A;3A&1I49;0$;:S^9AFAR\^6-R\;+R5MV#-O74)1J
M';D*_JK2(U8IEDDMJ'![:IJ;]J,K)3Y+WC/YW9@ QD\^C)B],M].FF3-#4#J
M_8S^S1S&N&R:O'LF#'8\6P4SY-/JRTMHB/OQF(\,I2V24:4D9MF1;"(S#W3<
MOU32]'>0:V5-J;5EU;*DFTM+B"QHT$]TE(,T]7H 3=GU^A7-7_9_=W_8%0$Q
MNKV'TWGFEXJ.6F9'D7?6'X]WE^4D@:)FW[_;O/#/;)HVXOHG=MXU^ X%KK$$
MV@%H!: 6@%H!: 6@(M@!(  6@%H!: 6@%H!: BV Q$QIW"9L7@Z!]NH./_%2
M/L30R>31_P!]#M7L4T[:TV:I^B&?L_JA?\.X-TWWMB9BV(WWU$I
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M&X1$;N("1@
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MTV97Z?,\?[^7/^4=2'HKLY_T&GPU.O,\_?ZO*IX;RQ0
M
M                 !] HO/43#(7R??_ #/=-G]J2_YS3A@MK_Y7O?)QLEE7
M[Y0_6>A8=CA=_LD?#ZT@>7*O7GR?I=BQZKF"L             $=W2\:+CMQ
M!5$HQ*-S&*<8G3D%B>PGC(S:P 2&GP4]WJEM] !J
M      (YOI]34FB)34"A;\G!23BE(XQ&HBW2,R/A^> D-K:VV>.]U$=;##'J
MEMP[F(#>                          (XE2%E?4%GQBE*3;7]H]E(U+P1
MT]HP,T[/-V@)'                           !'-PR%MW;;K15!+"%F[O
M13BDX;^&W GC(S;W?, 2,707=\T                          :'T=&/F
M8X *%@NJ]]U1:[<E:4I3A$[.25-XE_#88KQ\\!78
M
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M[AX[N&[T]S#9@ J(           $;M%(]_D@SX9L\-.&!HXA8MET_/88@)(
M          !'5X\;QQ;_  R;W.(OB&LT8X&K9NDK:?H )#1X",>G<3C\P@&X
M          49?G$*WGS:)!K)YC#?-))^J%CCO;.@!4%'WO%D/?(B5P&\<,,/
M!+HPV8 .S          ' J?W!*Z/J#G3L+P%=)F IJPS=\0M\4D$?'?P-!IP
MPWSP\'9C@ K0          ;5>"K]Z?[0"/+1XI5VXB<)LDFXWN;FZ9^$>.]N
M[?F@)%
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M.?\ 0:?#4Z\SS]_J\JGAO+%
M                                                          'T
M"B\]1,,A?)]_\SW39_:DO^<TX8+:_P#E>]\G&R65?OE#]9Z$7VG"\R)'^Q('
MERKUY\GZ78L>JY@K             !'ET<;WR6[N$WPR4YOFHT[VWZ$E;0$A
M%T%YQ?M -0                         !'=\&]VFB\(FS^V%8[^YT8IQP
MWMO0 D%KZDWCT\-&/TI -X                          CF2EXKY@J)*#
M:-MS>,S1OEU,"P(^M@ D8                           $=U_C^^NW]SA
M\/%W?WMW?Z3PW<=O2 D,N@O.+]H!J                          *%A$[
M[[JD9DCAX(W<#3OF9%MQPZW< 5T
M
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M^S&^4<EX+(_JIF6& "H*,1IID-)M<$R8;+A$OB;F""+=W]N]AAT@.T
M    '7U5)KITQ)-\7&.[ZF:MPE]0^KO?.XF IBP&5,T%M"H)0#)^1Z@4@I)%
MBO''B$9D>\ K<          ;5^"HL,<4JP+HQV=&/< 1[:3!M5ZXE'3BA[ZV
MSX_:B?.3B9'B;9&?"P[P"1
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M
M                                   ^@47GJ)AD+Y/O_F>Z;/[4E_SF
MG#!;7_RO>^3C9+*OWRA^L]"+[3A>9$C_ &) \N5>O/D_2[%CU7,%8
M      (XNIA;ERVXX5-*6E"G/MDY1,]F[YDSO$;N/H@)&3X*>YU2V>@ U
M                       $<7VPIZ31#33DSMR09FLY11^ 6\D][=,RXF/>
M 2(UL;;+#=ZB.KCCAU2V8]W !O                          $<28Z_?Y
M!>\7)4DFG/M[M1$:,6SP3V8SQ5O8]X!(X
M(ZN%@UW9;RRIQ/DGBXRSE$V;!=T^#B7$Q+Y@"1"Z"\X@&H
M            H6"TI-VU%PX)()1(PE]H)1NGN]UG$]P!70
M
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M..[B@E;IJ+<5B1*V8&9 *7R]0VBWFDMQ51,)$C%E;RGU$?$,S/B*,\<<0%=
M         #:OP%8[2W58EZ!@(YLYIM%>N52(BV%*<:WGE/FZ3V![#)!F9-X>
M8 D@
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MS#P\T!&<IMH[_@N'#6;I-K(I7:%$A);F.UG'=/$@$F
M          C6XFD+N^W%JA+>6DW=R24@VR9[^+1&1+Q 22707G%^T U
M                     %!P&VTWA5%=E4E:DMXR3>,TN'@70UT)Z0%>
M
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M<5$1F9=16TB+:>!@*5R\-M5OMFV\IXC?D==;:FS/U0]FZHB/J@*[
M  &U?@+_ 'JOVC 1Q9RV55^Y4MON.K2XWOI4VI"6]NPDJ/8KT $D@
M
M                  #X2ON:1_$._8U +!I_W%7O[;B_S\A.\O1ZB_.F_P!'
M0/Y%%^P-B%ES0                                   05J4T^6!JCR7
MOK(_,RF,52T;[HLNDU!EYEE[A*?8=;8E-$\TZE+L9QPE$9%CL 6P<MC0#1N7
M/D:60=IWO4;PLV!6*E4Z BI(6AVDM5*2<A<-O>/#A-E@DL,"V ,B@
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M<3$T\J)\>BWC>RF,DF6&&3/'A,M-8]_AH))GT>8.K)B)FW?ELKD@
M     "-KL6R5S6REQ];2E+<W&TMJ63FWYY1;$X>: D=/@I_>E^T W
M                   "-;]6RF50B>?<9QD'N$VTIS?/>3TFGP2 2,U]2:_B
MT?Y) /H                          (RE+83F!!2M]SBK:<W&2;7N'@C$
MS-SP2PZ0$F@                           C6XU-%=UND<A:%F;NZREI:
MDN=..*RZJ< $DET%YQ?M -0                         !0,!;9WC4TDZ
MLW").\V;:B0DL,2P7X)@*^
M
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M%<3@X1W3XN[O[G45UMW;O8 *7R^>-^WVUG/\8F;\C[8[-V;>P<,L.'@6&[T
M*Y          &U?@+VX=56WIPV'MP[N ".;.D&[7KC;.I]MX2T%P.R<#LN*B
MP3Q,"XN)$ D@
M                                      ?"5]S2/XAW[&H!8-/^XJ]_
M;<7^?D)WEZ/47YTW^CH'\BB_8&Q"RYH
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MN$6Z:$D>Q71CW %9PU&J)%4:S<-4=DS<,MTUF;:<5&7<-72 Y(
M                CBZGU-7+;B/&?8R<4X79NR\;M/3LXV!\'#$!(R?!3W>J
M6WT &H                          CF^I'9Y%$_TCV#?D&DT]E[1Q]J>I
MO8'PO/ 2&T>+39X[V+:#WL,,>J6W#N8@-X                         9
M8[# 1M*D8WY!8.H[I<->$'LF._@CI[3AU<.D!)(
M      (YN&3P[OMQGQEV?B&[]J=DXG:,.YQ]T^'N_L@)&+H+N^:
M                 -#Z.C'S,< %"0'<;NJ+?;M_=2G[3[/N\+9_#X=?'SP%
M>
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MBMXZ[<2'7FW4I6WN)0VE!HQ,CP4HBQ5T]T!(@
M
M   ^$K[FD?Q#OV-0"P:?]Q5[^VXO\_(3O+T>HOSIO]'0/Y%%^P-B%ES0
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M0-&SK]]EXC[:OYPK\O&OX+H&-=4QN-0
M      :'W!*F=V%59>?I1L3^U(W\\CBY@OV\>6/I9?9W^9,-_P!2GZ8>H2G_
M -'4O^0Q?YNT-^G_  OHGA/W>Z_Z<?\ EAV8NKP             Z*Y#65&F
MFA9-JX1X*-)*(O/(]@#@62I:K=A*<<2XLS=Q6A!(2?7/H2G9T *L
M                  %"7\X\U2FU,O(9/M#)&IQM+A&1N)Q+!6S$R,!64,S5
M$C&9XF<=DS/##$^&G'9W ')                          $>72XZFXK=0
MB0AI"U.;Z%-I6I:B,]W=4>)I] !(2?!3W>J6WT &H
M       CR^''T2**33S;1*DF2R<;2O?+>3L2:MI'L 2 U]3;_>(\SYTNYW &
M\                          1S)6][^82"?;)HVUF;1MIWSZG<7X1;0$C
M                            CNONOE=EOH2\VAK%TE-J;2I:\<?!698I
MPP 2&707G$ U                         :'T=&/F8X *%@+<.[:FGC(4
MT1()#1-I)2<2[J_"/'S0%=@
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M@C,V\/- 2$
M                                    /A*^YI'\0[]C4 L&G_<5>_MN
M+_/R$[R]'J+\Z;_1T#^11?L#8A9<T
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M\/$7RV_T4YJ?W]NW\I9 T;.OWV7B/MJ_G"OR\:_@N@8UU3&XU
M                        !H?<$J9W855EY^E&Q/[4C?SR.+F"_;QY8^EE
M]G?YDPW_ %*?IAZA*?\ T=2_Y#%_F[0WZ?\ "^B>$_=[K_IQ_P"6'9BZO
M          #HKE2I5%FI2R3ZC:/!LUDV2O/6>PL '!LMM;5O0T+CIC*(W<64
MND\2>N?^<(S(\0%5@                         "A+^96]2FTHB(F'VAG
M%M;Z6"(N(76)2C(L4@*RA$90XI&G=,H[.*<<=WU-.S$NG !R0
M              !'ET,..7';RT0D2"2;AJ>5(2T;&W#%+9F1N8X=P!(2?!3W
M.J6ST &H                          CF^F77I-$X<)$LDR#-2U2$L\'
MRZQ$9EOX@)#:V-MD98&2$;.G#JELQ[H#>                          (
MWE-/*ON"X4%"FDMN8RSD))2#-'\#CBK'H 20
M   ".K@8>7=MON)A(=;0;N](.02%-8ELP:,\5XGWB 2*707<\P
M                 %#067$W;47#BH2A1),I!/$:E[#Z6L<4X *Y
M
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M)\XYJZY;>(1D98 *@HB232X:2;X)$PV7"-?$X?43U=_;O8=\!VH
M Z^JIWZ=,3N<0CCNXHWMS>ZA[-[YW$!2V7S2&J VA$$X!$_(/@'(.2:<7#V\
M0S/'>PQ\P!7(          VKVH5LQZJMF.&.P]F/<Q 1U9[)-UZY%%3SB;[C
M9F^<DWBDGB6!DV9GPL, $C@
M                                                #X2ON:1_$._8
MU +!I_W%7O[;B_S\A.\O1ZB_.F_T= _D47[ V(67-
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MKN_7A<NO7AXB^6W^BG-3^_MV_E+(&C9U^^R\1]M7\X5^7C7\%T#&NJ8W&H
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M]XI)Q^!BI/7P(RXG1T )#:V--EAN^IHZN..'5+9CW< 'T
M           $:2F$^_Z"\=.-2N&LBG=J,B06Y][[V"L>CH 26
M                "-[A92J[[=<53E2#1Q33+*4;91^D_J.\1.;P"2"Z"[GF
M                            H* R17?4G>Q&DU$G&7VC$G,",B]0QP2
MKT
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MSI]&.M7)GF>Y1<S32]EM-S;IM![#'K5N05NH6RY$:X7"4;$92BXI-)V[^S>
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M&6)$1GW1HW:-$QLYIWJH^EF,CY,8^FS??IT8];#O#SG/K0W]N%0
M(WS!)@TTKC\3[J1N\,U].^73N]P!(;'U%G#HX3>'TA /J          *6O/A
M^]V?Q=[<W4X[F.]X7<W=H#Z6ANE;\ D;VYN'N;^.]NX[,=[: J4
M  $9M<'\X$C:YQ>"C$CW^'X&S#YT!)@           (TO7@^.K<XO$WN(YP]
MS?PQQV[V[LP\\!)*/ 1AT;B</F$ W          "B,P3:*VW^,2S1QX^/#WM
M[P^YN[0%14/=*E0MS'=X#>&]CCX)=..W$B =J          .NJV'BV9O8X=G
M=QPQQ^IJZ,-N("E\ON$5OM$R2]PGY&!K-6]]4V^%MP 5R          -J_ 7
M^]5^T8".;.-HZ_<O#WR5Q&]_>WS+'$O!WMF! )(
M
M     'PE?<TC^(=^QJ 6#3_N*O?VW%_GY"=Y>CU%^=-_HZ!_(HOV!L0LN:
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M;9=-P40O_MM ]L .UCR8\MI+T5]F2RLL4O1W4/-*+_DN-J4A7H& ^P
M  #H+G)!T2=Q-[<X1X[N.]AW<,-N. #@6-P_>W!X6_N8NX;^.]X9].]M 5<
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M:7'P??A;G$)PW,7>%NFK<[N]O8;.CO@)*+H+SB_: :@
M        "@8!M'>-4(M\G")&]CO[AD9;"+YW$!7P
M
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MX_#/;?NY3_7 ZT;<]%5P2?+,EY\'Q3'D^/PSVW[N4_UP.M&W/15<$GRS)>?
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M62Z@J"2I*2+",<CB'OE@DR(CW<>^ D-GZBUMWO4T;>_U2V^B ^@
M I>\G$M6].6J4<,DI1C()HWS1UR+'A$1FL!];363E!@K*0<HC0>#YM<$U[>G
MAGX("HP           1HV^CW_OL^,E&LFDGV'LIDE)&@CQ[1A@K>[W< 26
M         "-[S>)JLVZ1U X9J=7@V48WRD=8NJ:R(^%ALV]T!(R/ 1MQZJ=O
M1CL+;AW,0&X          43?[R6;<?6J:< N,QZN4<Y)EURV<,B,SQ 5#1%$
MNEPE$Z;Q&PV?$-&X:\4%MW=F[B [4          =?53)-.EJ-?#(F'#XF[O[
MN"%;=W;O8 *7R_>2_0&U(G'/3QWR)\XYQC/!?1PS(C+=Z/- 5P
M-BR+=49[,$JV].&P\3P[H".;.=2NOW(@JBJ6:%M$;!QC9*-M+ B<,BXN("20
M
M                         !\)7W-(_B'?L:@%@T_[BKW]MQ?Y^0G>7H]1
M?G3?Z.@?R*+]@;$++F@
M                  CK-_\ 11F9_<"\?R>J(KN_7A<NO7AXB^6W^BG-3^_M
MV_E+(&C9U^^R\1]M7\X5^7C7\%T#&NJ8W&H
M          -#[@E3.["JLO/THV)_:D;^>1Q<P7[>/+'TLOL[_,F&_P"I3],/
M4)3_ .CJ7_(8O\W:&_3_ (7T3PG[O=?]./\ RPY%0:=>@366%;CST20TRLNE
M#KC*T-J+#;U5J(Q=7GB;U8<F/G$9J:F,T<Q\KM7U;M2P;GK#LJWJ*U4)B6H,
M)R0\MMA#2'-U'!0ON=./F ,%.M[*7FAZ-\Z<KM++NKV[,T\[,VZM3XM-H-!F
MU5^72FG9:6N-+3 E+=9;(C)2B6WM3B18 /T9.7)E'F[D?H]R=R[SUN>5=^:-
M)MZ,_=5;FK=7)>G38\=Y;#JGC-PUQE&:#QVXD OA         =!<ZR10YRC?
M.,1-'B\3?%-!8'MX>![P#K['<XEN05%).81FZ1R#:-C>P7_!&1&6'0 J\
M                       1_F&\ABD-J7/.GEVE@N*48Y..+A%N[A$9EO=&
M/< 5O"/>AQ5;V_C'9/?PW=[%M/6W>YB Y(
MCB['TMW);;9U XIN+<^URBF]VDL>@W<#)K# !(R?!3W>J6WT &H
M                 CB^WD-2:)O5%4'>DF1(**<CC]9/5Q(CX?G@)#:VM-GC
MO>IHZV&&/5+;AW,0'T                          $;2GDE?L%HJD:5*;
M7]H]EWB66YM^V,,$X>> DD                           $:7%(2F\+=9
M.HJCK7Q=V(44W4R,.^\1&36!?- 24707G$ U
M  %!P'B.\*DT4XUFDDF<3LYI)O$CP]6PZX"O
M
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MT341,9*"ZT<GM_%9%@6)'NXEW0$@,_46L3Q/AHVX88]4MN'<Q ?0
M  4Q>"UHM^<I#Z8RB2G!Y39.DGK=U!D9& ^MJ+6NA05+>)]1H/%U+9-$K;TD
M@B(B 5$           ".&WG#OM]GMR#0EM)E$[.6\1&@O\_AO'B D<
M     $<WBZZBLV\E$Y,1"W%\1!L)>-[K;")1D>YAY@"1$'BA!].*4GCW]A -
MP          HN_'%MT!Y2)28:B>9P>4R3Y)ZY%AN&1D>("H**9JID,S<)T^
MWBX2=PE=4NMN]S$!V@          Z^JF::=,-*R;,H[N"S3O$GJ*VFGNX *8
ML%QQR@MJ=E)F*X[^+R629)7JA[-Q)$1;I; %;@         #:OP%8;#W58'Z
M!@(]M%UU=<N)+DY,E*%MDAE,=+1L$9EL-9$1N8X=T!(@
M
M          ^$K[FD?Q#OV-0"P:?]Q5[^VXO\_(3O+T>HOSIO]'0/Y%%^P-B%
MES0
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MPH245$VV7*>U/1,89)I@MXC:<+:6P![OB(BZ"P(B(B(MA$1=!$7<P :@
M    .BN52D46:I#Q,*)O$G303A)/S4'L,!P;+6IVWH3CCZ9*\7<7DMDR2NN9
M?4RP(L %5@                         "@[_<<;I3:FIB8:BD,GQ%,$_B
M7$(MW=41EUL0%9PC,X<4S5O&<=G%6&&]ZFG;@71B Y(
M         CNZGG47';B$341TJ4[O,*82Z<C ^@EF1FWAB D-/@I[O5+;Z #4
M                          1U?+KK<FB$U-1$WI)DI*F$O<4L2Q21J(]S
M9W@$A-;6VS,\3-"-O1CU2VX=P!O                          $<275E?
M<)OMR4H-MS[4..DU*/<V8/8;Q8 )'                           !'5P
M.N(NVWT(FH92LW=Z.<9+BGN]@Z9;S>!]XP$BET%W?-
M         SPVF H:"XXJ[:DDYB5(222*+P")2,2/#U7#%6. "N0
M
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M8     CR_$NJ*EDTRV]]M(-6^XE&Z1+29[N]TF K]G'@M8]/#1CAW]T@'T
M        %-7<EQ5 FI:0EQ9I1@A:B0D^L72I6PL &^U$K30H).(2VOAGO(0H
ME)(\>X9; %1            CEM#WO[>5P6^%P4^K<1/$QW.C<\+ !(P
M      (ZO%+RZO;W":;<3Q5[REN)0:.L18I)6U0"0T> C]ZG]H@&X
M   49?A.';[Q-,H>6;[&"%K2A.&_M,U*P+8 J"C8E3(9*223)E!&1&1D75+8
M1ELP(!V8          Z^J8G3Y9)+>4;#I$1GAB9H5@6)@*;L1MU%#;XS2&E&
M^^>XVM*TD1KV8*2>!XX *T          &U7@J_>G^T CVT4/)KEPFXRVVDUM
M[BT.)4I>)EB:DD>*>@!(@
M                                               ^$K[FD?Q#OV-0
M"P:?]Q5[^VXO\_(3O+T>HOSIO]'0/Y%%^P-B%ES0
M                                       1UF_^BC,S^X%X_D]417=^
MO"Y=>O#Q%\MO]%.:G]_;M_*60-&SK]]EXC[:OYPK\O&OX+H&-=4QN-0
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M#?+$\5=X@%90B-,.*2BP44=DC+IP/AIQV@.2
M  (YNM+_ +X[=6AAMQHC<WUJ<2A39X]*4JVJ] !(J?!+SB_: :@
M                ".KY2\J31.$RVZ12>N:W$HW2WD[2)728"0FOJ;?[Q'F_
M.EW>Z W@                         ".)+;QWU"5P4<+AN&;IN))98)V8
M(\(\3 2.                           ".Z^V\J[+?-+"%MD;IK=4XDE)
M[O50>T^D!(9=!><0#4                          4-")WWVU$U-()LR3
MN.DM)J5AM,C3TE@ KD
M
M>/3RO>8Y&TQY',)BSY;,[,:EPY34&%(F*7$D5)EF4A:6$+,B6RLRV]..!;3
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MC6U6"N&W*!7TLJCIKE$I58)A1&2F"J<%B:3*B/:2FR?W3QV[ '=@    (XS
M8XZ:67BWM^$I!X]J[-P<%D>]X1;^'> 2&R6#+1888--EACCA@DMF/=P ?0
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M=+A[VYO]175WMF[B I;+YDV+?;0<#Q<9/R/M?M/:MW%PSQXF)X[W3Y@"N0
M       !M7M0K9CU5;,<,=A[,>YB CNT(_!KMQK\7=C)U;9\?M7'[49&6WAX
MGP=T!(P
M                                 ^$K[FD?Q#OV-0"P:?\ <5>_MN+_
M #\A.\O1ZB_.F_T= _D47[ V(67-
M                           !'6;_ .BC,S^X%X_D]417=^O"Y=>O#Q%\
MMO\ 13FI_?V[?RED#1LZ_?9>(^VK^<*_+QK^"Z!C75,;C4
M                     &A]P2IG=A567GZ4;$_M2-_/(XN8+]O'ECZ67V=_
MF3#?]2GZ8>H2G_T=2_Y#%_F[0WZ?\+Z)X3]WNO\ IQ_Y8=F+J\LJUD\OW3%K
MSH=M6YJ4L8KVI-I3RJ5$C')*.4:43A.<0\67B5UB[P"XW*3*>R<D,O;;ROR[
MI946SK3@-4VB4U*B646(RE*&VR424$>ZE)%T$ D@          =#<R.)1)R.
M!VG%H_4>+P=_S.)B6Z X%DM<*W8+91>Q$DW2.-QNT;G6_A<3WL>D!5H
M                     H',&/VBD(1V#QA]L,'P>T]EZ'"/>XF)>#TX=T!6
ML(MV'%3N</",R6YO;VY@VGJ[WSV'? <D                          1O
M=D;BW);;GBWM?#4Y]M=KX/9L5;#X.)<;> 2.GP4]SJEL] !J
M              (YOJ.;TJB&5-*?N2%&:NU=F[/M3@O=Q(W?. 2&T6#398;N
M#:"W<<<.J6S'NX -X                          C>4R1WY!>*FXX-.$=
M0[61;A[G@]FWNOO>=L 20                           ".;B8-=W6X[X
ML[0ELW<9G:B;[/O;,>!CZKC^P D4N@O.(!J
M *%@L[MW5)PH&X2DH/MG:-[BXE_ 8]3 _, 5T
M
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MS#RUL3->V*C9V8=JT2[;<JC"H\RF5RFPZC'4A9&DS;3+9>)IS=,R)2<%$1F
MMBRFY=VC?)&Y3N_+C(JQZ'</'5);J1T6GRWX[RG$N&N,<B*OLY[Z2,MS## !
M6V;FC?3IGO>=JW_FSEO1KTN:RWFW[:E5EI$R/2G65\1M4>(^AR.DTK+'H 5+
MG?IAR+U&VA!L7./+NWKTMBF*CKIM-J<",XBG*B$E,?L*E-*5$)M*2(B;W=A
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M(R/'$@%T,=AF*PS&CMI:8CLML,-((DH;990EMMM"2(B2E"$D1$701 /J
M C;,%#*RI/%CK?+M2,-QU3>[UTGB>Z>T!(C.QEHB+ B:;V=.'4+9CW0'U
M       %+7FEM=NSTNMJ=0:4;R$K-"E%O%T*3M(!]+0)";?@$VVII!-GNH6L
MUJ3MZ#4K:8"I0           1FTVS[_Y"NS.<7A(,W^*K<\#87#\'H 28
M        "-+U0TJMVX;D=;RB<7NFEQ2"1@KI-*3P5T]T!)*/ 1W.HG9Z! -P
M          HC,%#;EN/H=96^@WV,4(6IM1X.%AUD[0%140DE2X1(2:$DPT1)
M,S49=1/29[3,!VH          ZZKX>+9F*3479W<4D9D:NHK81EM(S 4MEZA
MM%OMDTRIA)/R.HMQ3AD?$/$]Y6TR,P%=          #:OP%_O5?M& CBSFV4
MW!<JD1W&EJ6WOK4XI:7.L1D9)/8CI[@"20
M                                                           !
M\)7W-(_B'?L:@%@T_P"XJ]_;<7^?D)WEZ/47YTW^CH'\BB_8&Q"RYH
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M*J0VEYA;Z>TL&24.*;/>)PMTS-/<(!6T$B*'%(BP(H[)$1[<"X:=F/F .4
M                        (TNU#:KGMI:XSCRFUN&AQ+JD);VXF:DEL5Z(
M"24^"G]Z7[0#<                          (UOUMA<NA&ZPX\92%;AH=
M4WN'O)Z23X6("1FOJ3?\6CS?G2[O= ?0                          1C
M*0R68$!9QEF[PW")_BJ)!8HP,^'CNGW@$G
M  C2XT,JO"VU+C..+2;VZZEU:4-[-N\@NJH!)1=!><0#4
M           4#!0T5XU)1,K)TR3O.FXHT*+ R+!'@E@ KX
M
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M@L5/=7SP%R='JT"O4JFUNEOIE4VK08M1@24>"_#FL(DQGD_\EQEPC+SP'8@
M#12241I41*298&E1$9&7>,CV&0#XL1XT<E%&898)1XJ)EE#1*/OGN)22C ?<
MSPVF      +9-1NL+3WI-A6_4<^\P:984.Z)[5-H3U241)GS'W28;9:Q4GKJ
M=/# !UF>VMC3AILRRMW.#.',"):N7UUI@*H5>=CNR6)R:DAM<,VTL[QD3R7"
M,O/ 3MEOF-:&;-ET+,"Q*JBM6I<D)JH4>IMH4VB7%>0EQMQ*%]8B4E1& K@!
MP*I2X-9@R*;4H[<N#+;4U(CND2FW6UD:5(6D\24E23P,CV& M5S=TU9 ,Y2Y
MF\3*2Q5ME9-W3'#3;-%2^N0BA5!TG>.<'?)WB;=[$S(]HIKF8IT;JJFVW1NO
MS7,F^=5KPT;NYBY"9%UN/!RTM6^[L1;]-<A,/H@-+N"8C=8WY31-X-LI3U4E
ML+ =T;'[%91FF3QC,;%M<[[3,WSC&X7%3=4U;^XF?Y25S3_QGB>YD7VZ-C[O
MMG-4\+@?/<PUGRDKFG_C/$]S(OMT.[[9S5/"?/<PUGRDKFG_ (SQ/<R+[=#N
M^V<U3PGSW,-9\I*YI_XSQ/<R+[=#N^V<U3PGSW,-9\I*YI_XSQ/<R+[=#N^V
M<U3PGSW,-9\I*YI_XSQ/<R+[=#N^V<U3PGSW,-9\I*YI_P",\3W,B^W0[OMG
M-4\)\]S#6?*2N:?^,\3W,B^W0[OMG-4\)\]S#6?*2N:?^,\3W,B][^6B.[W9
MS5/"?/<PYSC,^4@<U%EUYU=YQWR=,C2RJFQS2UAW$D<[ L15W>;/[T:/#Q'6
M#'TSK<GY25S3_P 9XGN9%]NB.[W9W_%'AP(^?9A.Y)\I*YI_XSQ/<R+[=#N^
MV<U3PI^>YAK/E)7-/_&>)[F1?;H=WVSFJ>$^>YAK/E)7-/\ QGB>YD7VZ'=]
MLYJGA/GN8:SY25S3_P 9XGN9%]NAW?;.:IX3Y[F&L^4E<T_\9XGN9%]NAW?;
M.:IX3Y[F&L^4E<T_\9XGN9%]NAW?;.:IX3Y[F&L^4E<T_P#&>)[F1?;H=WVS
MFJ>$^>YAK"\I*YIQ&6-SP\,2_P#AD;VZ([O-GY]6$_/<?$6U5:&5+DC<Y_7A
MK3U[4K)O/2Z&IE@NPZ@\[3&H3;">(Q'CN-GO(E.%CO.&?@]T:KMELAEN3Y1^
M:PM,15;&EELKS.^Q-]3357RK=V-6E[HQT_%EMC:05          C7,)YEHJ3
MQ9:XN]+1NFEA3V^>^G CP(]TC,!(K/U%K;CZDWM/9CU"VX=S$!]0
M !2UYK0BW9ZG'E1T$E&+R6S=-'6+:2"Q,\0'TM%:7*! 6AXWTF@S)U39M&KK
M'TH,B,@%2@           C)IUG\X#[935FYPDFJ)V=6X74(B/C8;I@)-
M       !&MZN--UNV^)+7'-3KA)0E@W2=VEL-1$>Y@1@)(1X".[U$[?0(!N
M         %$Y@/-,6Z^MV2J*CC,8O(:-XRZY8%N$1G@9@*@H:B52H2DK-Q)L
M-F2S3N&HC21XFG9AB [8          =?53(J=,-2^&11W3-9)WMWJ*V[NW'
M!2F7JT.4!M2)2I:>/(P=4R;*MCAD9&A1$>PR 5V          -J_ 5CL+=5B
M?H& CBSGF7*]<B&Y:Y"T.-;[2F%-$SMV8+,B)S'S $D@
M
M         #X2ON:1_$._8U +!I_W%7O[;B_S\A.\O1ZB_.F_T= _D47[ V(6
M7-
M !'6;_Z*,S/[@7C^3U1%=WZ\+EUZ\/$7RV_T4YJ?W]NW\I9 T;.OWV7B/MJ_
MG"OR\:_@N@8UU3&XU                                   !H?<$J9W
M855EY^E&Q/[4C?SR.+F"_;QY8^EE]G?YDPW_ %*?IAZA*?\ T=2_Y#%_F[0W
MZ?\ "^B>$_=[K_IQ_P"6'9BZO             #H+G4E-#G*4Z;*2:/%Q*#<
M-)=\DEM,!P;'6A=MP5-OJDH,W<'E-FT:NN?2@R(RP 5:
M          (^S%<0U2&U.2EQ"[2P7$0RIX]KA%N[J2,R)71CW %;0#QA1#)6
M\1QF3)6&&]ZFGK8=S$!RP                         !&EVO-HN:VT+F+
M84M3A)82PIPGC(S/K+))DC#'N@)*3X*>[U2V^@ U
M      $;7XXTB50B<F+BFN29()+!O<4S,L2,R(]S#S0$BM?4F\#Q+AHP/HQZ
MI;?1 ?0                          1E+=;*_Z>V<M9+4VYA&[.K=/J8X
MF]ANEL 2:                           "-+C=:3=]NM*F+:<<-W=CI84
MM+O[YPB,D8?L@)*+H+SB :@                         "@("VSO&IH*4
MM3F"#5&-DR0WLQP)W#!6T!7X
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M?*H&,MY=HWO#TEW94M.]P+HC4K-J4JH1(K"JLIA#RVTN*9C$W$4Z>TU*)1$
MSF9M<R*Q;2Y>-6U_V#2??G:$.S8MV0J03R6SE$\PAQZ(;J'R)*F'5[IGOET
M(RY>G-(CZZ="ET:RV<OSM%NVZ;=,Y5K'*-_C';D5Z0M''[0Z9<;@X>$6&(".
M.4USCZ-S+;7U$W=+R[_-M1=/M5JL&LR%R^U%+BTDY;TF6>])?)!(B0EKP,R
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M9SI^U,:,9VM*U'ZS&L"B4674+AI\FCS456G5&%%-YVFHA*2;\A2I!<-)ETF
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MR5+--1*!C)3CC%*2;O6+JEB1[F/1B D)D\66CQQQ;0>.&&.*2VX=S$!]
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M[F"%=;=[N "F; >4_0&W%3BGF;\CU<HY1B,B<PPX9$DBP_9 5N
M-J]B%;<.JK;ACAL/;AW< $=V@^;M>N-!U I?#6V7 **3)QMI;#<(BXN\ D8
M
M                         ?"5]S2/XAW[&H!8-/\ N*O?VW%_GY"=Y>CU
M%^=-_HZ!_(HOV!L0LN:
M                  ".LW_T49F?W O'\GJB*[OUX7+KUX>(OEM_HIS4_O[=
MOY2R!HV=?OLO$?;5_.%?EXU_!= QKJF-QJ
M         #0^X)4SNPJK+S]*-B?VI&_GD<7,%^WCRQ]++[._S)AO^I3],/4)
M3_Z.I?\ (8O\W:&_3_A?1/"?N]U_TX_\L.S%U>             '17(X;5%G
M+)\HQDT?JQM<;<[N/#V[W0 X-EN\:WH;G:RFF9NXR29*.2^O_!$1;N'0 JL
M                         4)?[JFJ2A29Y4_&0P7&.,4GI<PW>&9'X71C
MW %8P3,X<0S7Q#..R9KW=S?]33UMWYW'O .4
M  (YNIY2+DMQ!5(HI.*<+LIQ">.1M/$N-NF;6 "14^"GN]4MOH -0
M                  !'-]2#9E40BJ)0=^09&DXO:.-UDEN[V!\/SP$AM;6V
MSQWNHCK888]4MN'<Q ;P                         RQV& CB3(7[^X3/
MC%*4FTO[1[*1FO=09X]HPQ3AAZ("1P                           1U<
M#YMW;;K95$HY.&[O1.RDX;^&)_5C29M8>?M 2*707=\T
M           %"0'3.[JDUVXEDDD?:?9R(V\4XGZOAU\0%=@
M
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MQM#_ *DZT;DQ@             UP/O'\P P/O'\P"V# ^\?S +8,#[Q_, :
M   =[SR_;(3&ZIK]5G3\FC_\T2E?V?5?YE"&D=H_\N>>/I9O9[]ZCPU/TX>Z
M/.4^O#?VHK         !'U]\;<IQM*;+[83O$LDGLWTGLWNZ KUGZBUCT\-&
M/TI /H          *9N\UE0)IMFDEX(P-9)-/A%TDHC(!]+4-PZ%!-TTFO</
M>-)$23/'N$G8 J(           $<-<;W]R/5&^%PTX(W4[^)-ECM+K )'
M        !'=X\;QQ;_#-O<-Q9.$LD;V!*(^J:MI=/< 2$CP$8].XG'YA -P
M         HR_.-X@>X)H)9O,EBX233X9=Q6P!4-'WO%D/>PWN WCAAACNECA
MAL =D          .!5"4=/EDC#>X#N&.!ECPU=..P!3-ADX5#03JT*5QW_J:
M4DG#B'AX.SH,!6H          VJ\%7[T_P!H!'UI&Z=<N+B&V:2<;W=TDDHM
MOSV[M/9WP$A@
M                                     #X2ON:1_$._8U +!I_W%7O[
M;B_S\A.\O1ZB_.F_T= _D47[ V(67-
M                             !'6;_Z*,S/[@7C^3U1%=WZ\+EUZ\/$7
MRV_T4YJ?W]NW\I9 T;.OWV7B/MJ_G"OR\:_@N@8UU3&XU
M                    !H?<$J9W855EY^E&Q/[4C?SR.+F"_;QY8^EE]G?Y
MDPW_ %*?IAZA*?\ T=2_Y#%_F[0WZ?\ "^B>$_=[K_IQ_P"6'9BZO
M      #HKDW_ !+-X9D2^$>!JPP]''8 X5E[_O>A\3=->+F)H)))\+9@2=G0
M JH                          4-?INE24<$T$KM#.U9),L"<+'8K9C@
MK"']R1L3(SX#6)EL+'<3CAYF(#D@                         ".KHXY7
M+;W"4V39J<-PE$DU'AT;IJV_, 2(GP2\XOV@&H
M    CN^>,4FB\)39%V@]XED@SPWD[4FK:6SO )!:^I-X]/#1C]*0#>
M                    (ZDJ?*^89$;?"4VK$NIO^!LP/PO_ )@$B@
M                     CROE(]]= -M39-F;O$)1(-9_O3/:7H )"+H+SB
M:@                         "A81N^^ZI$9HX>"-TB)._B9;<<-O= 5T
M
M                ^3[+4AEUA]M#S+[:V7FG$I6VZTZDT.-K2HC2I"T*,C(]
MAD \\VL?R<W2)J5S:J&>N7DVM9"YJ5MY4FNW!9$EVFL5*2MQYU;SD&F)AHWE
MN/;QXF9F9 /MHY\G7TH::LW:3GO?]8N'/7-"WG"D6_7+TG2:A'IDE*F%H>:A
M5'M:"4EQG>+=,MI@+JN9_P IC*SF<4O*BE9AW',MF/E36HM8I"($=#J73BRN
M.E@TFDTMH4CJ[.YL =3K^Y065.OK(K(W(V^;HGT2C9'G0/$TZ+'0Z[-306(3
M#274&DR03B(9$?G@)MU,<NVP=2NAU.B&XJ[*I]F)H%#H!5=EE*Y' H<(X;"^
M$9&G%23QZ ')TE\NG*73!HJA:(#<5>N6+--K5+EIJ;#:52XU;92S(WFU(4@E
M))!&1X'@9 ,/]K>2TZ1;8OR[ZK%O6\4Y:W;(JDJ1EC%J4R)16GJDX^[B:&#1
M&=0RM[8DV\,"P 9%N6SRA\FN6W;&=-DY:UF95K4SF4XW5::\TB*J#$=B/07&
M67FD-F:E17E)WNG': QVYG>3#Y"UO,>[K\R@SPS1RD9OFI2:C<E%@7)7)L6:
MJ9*D29+1$4MI#;;AR#+### !E'Y=?*>TR\N2B5A>4]#54+]NK<5=]^50T2*M
M7'$$SZHMUQDI"#4MK$\5JQQ 905)(TJ298DHC(R[Y*V'^V \]6LOR>?3EJIU
M3TW5K1;PN+*O,U%8IE8KTZW'GF%5MVG3"F$V\Y%-AQ*'5%@>*CV )#U:\B[(
MO45F!EAG?9MU5?*?/O+FG0Z<69M'-:ZE6FH\-N&ZJ=P2:D.*?2D\=YP^D!#Q
M>3MY(EGUEEJ<<S+N29G78<V+/J5VSU.RUU]Z*ZVXV:FG^(N*22)1%@K82C 9
M .85RK=-G,;R\H-K9UT11W9:$1IJT+\IJDQ*Y0Y+;*T<=J4VR<I23=<->!+3
M@8#&1IT\F.TIY6YO6OF_G%>]Y9[5>Q):)MF0[EJU0[)1GHSK#T,B;D.22<0P
MN.G86[B0"_/F4\HS*?F0KR.3?=Q3;9B9&5.!4+=BPHZ)"72I\EM]AE9K2LTI
M)+24^<0"1->_+3R^UYZ3J)I1O6X9=#MJA1;6C1ZK%92](/WKQ6(\1>XI)D1J
M*.1F CF\\S--W)3T)6S:>9E7J\_+6P;=F4"#)BT614Y%24N ZTW$>AQ")1(E
M<'</9\\ \Q7(/TO4O5IS2-0G,4MO+"?9V0U/K+T_+!BNTJ5#:FRZJ^W)=EQ(
MU1@I21K6XES!"MF!@/=KF3EM9>;ED7!EUF!0H5Q6?=%.D4JLTB<PR]'D1)+*
MV%I)#S;B$K)MP]U6&*3 >82]_)3]+=;NZMJLW-*^['REN.L.U6M95TRJ5!%'
MDD_-=F/QT\!UJ.VVYQ33@3>& #,U8?*STC9>:,JOH7H%A)_,A7J.N!6J1,D%
M+D39CD<F_&#DA]A6+I/EQ"ZN./=Q 8P[.\G#RAMZP+DR,JV<EX5K3U5%U%5&
MRL-^7'@T5,YQYTFD.I<X3C3*W=B>'N[ %\.D/E+9=:2=)&:VC^VKOGU?+O,F
M'4H3*I#!(?H[53:=9>W2W22\K<=VF>U1]("I^5URM\MN5_E[>5@9<7',N2%>
M5P2:],D3&$1U-/29"Y!MI2E*2-*#5@7F$ ZGF6<G_3-S+*-1Y&9=/>MS,BUU
M&JULQ*$:8=:I2C)[:;\=I,I[!;V)>J%T ,9<[R6;2K7K(MFG75F#=]SYBVU5
MZ54XV8-:F2JE*--)FLRH\=N-.5(-A&XSN'NJ+$C 9+M>G*<RRUWZ6\M-,%ZW
M1,HMO9;(MY-/J<>,A]U_WOMQVV#6TM*DIWRCEW '3ZCN35IQU/Z0\J-*^9:'
MIY9)4^+'RWO9I"&JI0)D1M*43&<&E+Q-UM*L$FG:0"R',+R;W*?.[+BAV9GI
MG7=^8U9LU^"NQ[@GKD[MOL4];?!8*&^X^W(+@-D@S/#$@&>O39DNQIVR5L?)
M]FMN5V)9%(9I$6JOHX2WHL1IMIG?2>!(W&FR+O .[S@K5#?RJS-C)KE%2ZNP
MKO;)+E4A-X+.@5$B2LU/EN;=FWH%-46Q8F)LTSJ?D@1]&>L'-R_\W+URGR.K
M5ZV;-OZ["@W!"3,5$EDBXY^\IAQF(ZTZ1;Y>"HRP,>@-A<YRK!Y!^4Q5[31>
MV:+9:!G.!Q%[BIO:(JG3O1O<+N_BZN83^K-<?UNI?@\;5UER*-'OZ?1QN!^1
MQ?,J:_%U<PG]6:X_K=2_!X=9LBZ>GT<9^1Q?,J/BZN83^K-<?UNI?@\.LV1=
M/3Z.,_(XOF5'Q=7,)_5FN/ZW4OP>'6;(NGI]'&?D<7S*CXNKF$_JS7'];J7X
M/#K-D73T^CC/R.+YE1\75S"?U9KC^MU+\'AUFR+IZ?1QGY'%\RH^+JYA/ZLU
MQ_6ZE^#PZS9%T]/HXS\CB^94?%U<PG]6:X_K=2_!X=9LBZ>GT<9^1Q?,J/BZ
MN84?_P"C-<?UNI?@\.LV1=/3Z.-'Y'%<RII\79S!SV)TT7$I9>$DD5$U)QZ,
M2\7XEB0=9LBZ>GT<9&"Q5OJ3P.[M?EE<Q.\+FI-HP--EP0I]:>)F/,>34$,L
M&:TH-2UN4_<3M672+%_M1LW=1-=Y?Q;XDQEN.O-%W3.[J7I?)T.:R1(/\W"5
M;[:'-E1;ZO$22]P_M#8I&.!ETD9#&1V@;-4S/V_0Y?5_'S%LGR='FL_!LGW1
M;]H">\+9KGSP'5['^,^3H\UKX-B]T6_: =X6S7/G@.KV/:%Y.AS6C2L_S;I3
MN-K<VU%KK;B35N)^T-JEX8$7=,Q3&W^S?2:?)]:>KV/6775RR.8G9ET5:SY^
MFVX)\ZB.<&1-9*H+9?5O*3BAQNG;BBQ1W!E[C:S)+R[Y55]3%ODXW&G+,5=3
M,3$S/D=+\75S"OU8[D^DJ?X.%R-ILALTXBFWS<:G\CB.9)\75S"OU8[D^DJ?
MX.$]9LAZ>GT<9^1Q',EJ7+JYA6)?_P!,=Q])?.5/\'!UFR'IZ?1QGY#$3_@E
MFE\GGT;:N<G.8_2+TS=R5K-D6GXOJ27:Q/1+0RAU<:,A"4&]%:2LE$GIQ+;W
M!I.WF>9;C\E_+X6\IKJB8W&8RC!7EQBJ*YMT[L3%EC]%C':.BIT3:W3=:BH
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M;(SX6& "1@
M                                   !\)7W-(_B'?L:@%@T_P"XJ]_;
M<7^?D)WEZ/47YTW^CH'\BB_8&Q"RYH
M                             (ZS?,DY3YFFK819?WCM_P#R>J(JHFRJ
M)G<7+JWEQ9NO%_ROLL\R+GR<S0J=M6I)JU.=OV[N#+;XNZY_WED8[I):42L,
M>X-/S?"7]]C*INZ;8>.^UW9K/\SVLKQ6!PM5Y=S.[%OC\3(=^8_.O\0)_P!+
M(]KC&_+L9JG@=9=2]LO@J_3Q'YC\Z_Q G_,D>UP^78S5Z#J7ME\%7Z>(_,?G
M7^($_P"9(]KA\NQFKT'4O;+X*OT\1^8_.O\ $"?\R1[7#Y=C-7H.I>V7P5?I
MXC\Q^=?X@3_F2/:X?+L9J]!U+VR^"K]/$?F/SK_$"?\ ,D>UP^78S5Z#J7ME
M\%7Z>(_,?G7^($_YDCVN'R[&:O0=2]LO@J_3Q'YC\Z_Q G_,D>UP^78S5Z#J
M7ME\%7Z>(_,?G7^($_YDCVN'R[&:O0=2]LO@J_3Q'YC\Z_Q G_,D>UP^78S5
MZ#J7ME\%7Z>(_,?G7^($_P"9(]KA\NQFKT'4O;+X*OT\1^8_.O\ $"?\R1[7
M#Y=C-7H.I>V7P5?IXC\Q^=?X@3_F2/:X?+L9J]!U+VR^"K]/$?F/SK_$"?\
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MT?J)N<+?\SB?.X@.%9;:FK>AH7&*&HC<QCI=)\D8K_A2,R5B JH
M                 4'?[*GJ2@D02GF4AD^"<@HVPED>]OF9>#ACAW0%9PBW
M8<4MSAX1V2W-[>W,&T]7>^>P[X#D@                         ".KH94
MY<MNK* 4E*#<QD'))HX^)])-&9&YCM 2(GP4]SJEL] !J
M           (YOIE3LBBFFGIF[L@S-2I)1^ 6\GK8&9<3S@$AM;&VRPW>HCJ
MXXX=4MF/=P ;P                         !'$EAWW]PGO%Z5M\)9=M[2
M1*;Q1@1=GQ(U8^< D<                           $<7$RX=WVZZ5-3(
M0GB[THY1-G'QV8DR9D;F.'<Z $C%T%YQ -0
MSPVF H2 THKNJ+O8DI2I*<)?'(S<P+ _4<<4;0%=@
M
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MCW?3(D:WZ8RE!.J*HL1(K,ALS3T;R&TN&D^\1B)F9W9GA+(WHTI%PVXB$M0
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M;XI''=(V][=WNHK9O=S$!2N7S3;5OM):AJA(X\C!I3YOGB;FT]\S,]H"N0
M       !M7X"]F/55LZ,=A[,>YB CJSV6FZ[<;B(2HRG%M;SJI!ND_MV&39F
M?#P 2.
M                                /A*^YI'\0[]C4 L&G_<5>_MN+_/R
M$[R]'J+\Z;_1T#^11?L#8A9<T
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M7>)9&1D X-D-I;MR$A,=45)&[@PITWC1US_SAF9JQ 5:
M          *!S"::=HZ$NPE3B.3']22^<<RP<QWMXC(SW>D!6D$B*'$(D[A%
M&9+<QWMW!M);N]W< '*                          $;77':<N>VW%P52
M%(4YNR$R%-%'Z=IMD9$YB DA/@I[G5+9Z #4
M  1Q?;33DJA\2 J8:9)FE29"F.">*<5&1&6_YP"0VOJ3>!8%PT;,<<.J6S'N
MX /H                          (SE--G?T%PX*U.$VLDS.T'NH+<Z.!C
M@>/0 DP                           $;W$TTN[[<6JGJ?4DWMV44@T)8
M/HVLXX.;W[ "1RZ"\X@&H                         9X;3 4# 9;]]]2
M=[&I*S)'VT;YFE>">DF<<$@*^
M
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M^I25D>*\<<-AX8 /:7Y-TS%8Y7^3+<))IC$B7PB4HU'N\"!@9FK:>*< &?$
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MI"DI1UMFZ9E@>/F )*
M                                            'PE?<TC^(=^QJ 6#
M3_N*O?VW%_GY"=Y>CU%^=-_HZ!_(HOV!L0LN:
M                                    ",LZ?T09H_[/KQ_)ZH@,+GD^
M7^Z+6O\ :->_Y02 &?                           4E>YME;<\W5J;1Z
MCBM"5*47JJ<,"3MVF YEK&DZ% -"C4GA%@I1&1GT;3(]I *A
M              '070:2H<XUK-">$>*DD:C+SB+:8#@6,:#MN$;:U+1O.X+6
M1I4?7/'$E;>D!5P                          C_,13::,@W'%M%VEC!2
M$*6K$W"P+!.W S 5M!P.%$,C,R[.S@9])EPTX&?FF Y0
M          C6[%LIN:VR<<<0YO.<-*4J4E>/3O&6Q.'F@))3X)><7[0#4
M                       1I?YLIDT(W77&S.29))"%*)1[R/"W2/ @$CM?
M4FOXM'^20#Z                          ",Y9LG?T N*X3I-KP;)"MP^
MJ>.*O!(R 28                           "-;B4P5X6X3CSB%F;VZA*%
M&A7F*41;I>B DDN@O.(!J                          * @J;.\:D27%F
MO!!+;-"B0G MADKP3Q 5^
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MA42XK_F>419&7A.R?EZ6IM?DLD>6E-J[CT&I0D]FX#DF'![+$]4C&1X&WAL
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MV/=2C[8X/'X?7+;PL#WL0&^TG"<H$!92>UD:#]7X7!W^L>WAX%N@*D
M     !&C+Y>_^2SXS,SX*#\7]DPW>J6WM.[MQQ[^P!)8           (XO)_
MA5JWD'4NPDMQSU'LO:.T[2V;^!\+ !(J-J$[<>JG;AACL+;AW,0&X
M   45?SO!MYY?;CIYD_'PD%'[3ABX75X6!X[W0 J&C*WJ9#5Q.-BPV?$W-S?
MQ076W/G<>G !V@          Z^JJW:=,5Q.%@PZ?$W=_<ZBMN[W0%+Y?O$_0
M&UE/\8%VB07'[-V7'!P]G#P+P>CS0%<          #:L\$+/HP2H\>]L,!'E
MHO$Y7;C051[9PUM%P>R\#LV)]'$,O5MXRZ0$B@
M
M   #X2ON:1_$._8U +!I_P!Q5[^VXO\ /R$[R]'J+\Z;_1T#^11?L#8A9<T
M                                                          $9
MYT)4K*'- DI-1_F^O'8DC,S_ .[U1Z"+$S 86O)\#QTBUO$L#+,>^"P/I_I^
M1TXX8 ,^(                          I2]7.%;DY9R^Q$7"QD\'M'#]4
M+;PL#W\>@!SK:42Z+!44CM1*:(^/P^%OX]WAX%N@.]
M        '07.OAT2<OC]FP:/U;A<;<Z=O#P/> <*R7>-;L%SM?;<>)]L<'L^
M_P!<_P#-8%N[O0 JP                          4%F"]P*0A7;SI_P!L
M,%QBC'*Q,W,"3P\#\(]F/< 5I"/>AQ5;_$QC,GO[N[OXMIZV[\[CW@')
M                      $<W7)X5QVXWXS[(:UN%V7LG'[3@9'AQL#X.&("
M14^"GN]4MOH -0                         !&]^/DS(HA'43@$N29;O9
M>T<?K(ZN]@?"\\!(K1XM-GCO8MH/>PPQZI;<.YB W@
M       "-Y3Y%?D%GQF:<6G#.G]DQ)9[G3VG#!.Z D@
M          $<7%)2B[K<954^SFLW<(91.*<CS.-@?"W</1 2,707G$ U
M                      %"07R5=]1:[<:C2E.,/L^[P\2_A\.OB8"NP
M
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MR_%NH*EFW);C8R4XFMI+N]UT["WB/#I 5^S]1:VX^IHVEL(^J6TB[F(#Z
M       "F+P6MNWYRVW4LK(D8.*03A)ZQ=*3V& ^MJ*6NA036XEU6X>*TH)!
M*ZQ]"2V$ J(           $<-+>]_;Z#D-\+AI,H_"3OEZGT\3PMH"1P
M       1U>"G2J]O)1(0QO..;R%-)<-PMXL")1EU?0 2&CP$?O4_M$ W
M      "C;[4XBWWU-/ICK)YC!U;:7$EZH6S<5L,!4%'-1TV(:E$LS8;ZQ)))
M*ZB<3))=&)@.R          '7U0S33Y9I42#)AS!1EO$1[BMID>PR 4U8:WE
MT)M3KZ9!\=_U1#:6B^J'LW4]TCQ 5J          -J_ 5^]5^T8"/K2==76[
MB2N0AY*'&R0VEI+:FBWL,%*+:KH[H"0P
M                                                         !\)
M7W-(_B'?L:@%@T_[BKW]MQ?Y^0G>7H]1?G3?Z.@?R*+]@;$++F@
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M .]                          '0W,I::+-4APFE$WB3AI)9)P[II/$C
M<*REK7;T(UNI?49NXNI03:3P6>&""V>8 JL
M 4+?JW6Z2A;4A$<RD,EOK:2Z6UPMFZK$L3 5C",SAQ34HE'V=G%1%@2CX:=I
M$6PB,!R0                         !'=TNOHN.W$HDH:;4IS>:4TE9N[
M=I)6>U'2 D-/@EYQ?M -0                         !'=\+=1)HI-RD1
MTJD'ODMI+G$(E)/ C475Q\P!(+6UMLS/$S0C;T8]4MN'< ;P
M             !'$EQXKZA(*4CA&VO&/P4FL\48?5,-XL $C@
M                CNON.)NVWR3*0VE7%)3*F4K4Y^]698IP(!(9=!><0#4
M                        /S"Q\P!0T);WOMJ*3?0ILB1NM$VDE((R[JR+
M>/'S0%<@
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MCLMLM%B6&Q#:4I+Y@#D      ".)S3GOYICA0T*;)+F,HWTDI)FG'8UCO*Z
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M$X9L.EN&K=)6*%;#5W %-6$AYN@MI>BHB*X[^+2'4O)+U0]N^DS(S5T@*U
M        &U?@*PVGNJP+T# 1Y:#;S=<N+B14,(4XV:'4O)<4\6)>$DC,T8>:
M D4
M                             ?"5]S2/XAW[&H!8-/\ N*O?VW%_GY"=
MY>CU%^=-_HZ!_(HOV!L0LN:
M                     -#(CV&1&7F[0$;YQNK8RDS.<:W24C+^\33BDC(C
M][U1^=/89 ,+'D^6)Z1ZXI1XJ5F/?"C/##:=P2>X6P!GP
M           %+7FE:[>FI;93(4?"P:4X39*]43CBL]A8$ YEM)4FBPDK;)I1
M-%B@EDLB\Y18XD [T                          =%<J5JHLU*&B?4;>!
M-J62"5YAJ/81 .!92'$6]"2XPF,I)NXLH63J4XJV8+(S(\>D!5@
M                 H2_FW7:2A+45$M7:6#X:WDLE@3A&:MY1D1[I%B K*$1
ME#BD:=TRCLXIQQW?4T[,2Z< ')                          $>70TZNX
M[=4F&A]"5.;[ZGTMJ8Q/#%*#,C7CY@"0D^"GN=4MGH -0
M          !'5\MNKDT4VXB))%(/?4MXFN$6\G:1*/K'M 2$UL;;(RP,D(V=
M.'5+9CW0&\                          1Q(:=]_<-THB#;X:R.2;Y$I/
M4,MC6.)D8"1P                           1Y7VG3NRWU)B(>07%Q>-]
M*%-8]U+?2K$!(9=!=SS                           ,\-I@*%@I=.[:D
MHXZ4M8(P?)TC4OJXEZGCBG !70
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M+SL!TSVI\GWUQ%,61IT<+<-G;RN^IKO;R;:Y\WH>W@=0QNRV<$@
MC6<PE5^4QXZ:;BDI7A.[4:2:ZAXXQ\<%XX=X!)0           (XO^.3Y4K&
MFG4-V4@RPE'&X1[Y=<S(RWL.\ D-GZBULW?4T=7IW>J6S'NX /H
M *7O)HGK=GMG%[81I1]K\;@<3!1'AQ<2-& #ZVF@FZ#!048XA$@\&#=XQHV_
MPF)[P"HP           1JU'05_2'RIIDI32".=VLS(^H7_1L<"PP[P"2@
M        1O>C*':O;IJIQS-QUPR>[4<<HW6+::"47%Q[P"16]B$$18$2$[.G
M#86S'N@-X          HJ_VR>MU]LX1SR-Y@^ 4CLV."^GB8EAAB J&BENTN
M&7#X.##?J>_O[G4+J[^)[V'? =H          .OJJ=^G3$[G$Q8<]3WMS?ZA
MX)W_ )W$^Z I?+Y@F+?:04$X'J\@^ <@Y)EBX>WB&9^%T@*X          &U
M>U"MF/55LQPQV'LQ[F(".K/8)NO7(X5..'Q%M%QCE&_VG _")LS/A8&0"1P
M
M                        !\)7W-(_B'?L:@%@T_[BKW]MQ?Y^0G>7H]1?
MG3?Z.@?R*+]@;$++F@
M                 C+.G]$&:/\ L^O'\GJB PN>3Y?[HM:_VC7O^4$@!GP
M                         %)WLV3MN3D'$.<1\(SC$]V?B$3A']5Q+<PZ
M0'.MI)(HL%*8_92)HBX/$XNYYG$Q/> =\                          .
MBN5)+HLY*H_:B-H_4.)PM_S.)B6Z Z^R6R;MV"E,4X22-W[6-[M!HZY_YTS,
MU8GM 5:                          *!S"9)ZCH2< Z@126#X123BX8.%
M@K?Q3X)[<.Z K6$6[#BIW.'A&9+<WM[<P;3U=[Y[#O@.2
M           (WNUDEW);3ATTY>XIW"24LV>S;3VFR1EQ0$CI\%/<ZI;/0 :@
M                         "-[\8)Z10S.G'/W))GO%*[/P#-2>MN[Q<3H
MZ $BM%@TV6&[@V@MW''#JELQ[N #>                          (VE,I
M._8+WBPU&EI?V_VHR)![F&'9L<%8^=L 22
M "-[B82J\+;=.G'(-!N_;92^$4?'_P!1B7%WB\P\ $D%T%W/,
M                _,/#S0%!0&L+PJ;G830:B3C,[09DY@6'U#'J8 *]
M                                                 6E:Z[BK-JZ2
ML]ZY0)+L2JP\NKI.-(8)9NMFNBSDJ4CAF2R,DGTD>P!Y7O)&\F\K:_EMJ*SU
MKM*H]T9O7!F/7(]6K=88A5.JP8ZJQ(7N([:T_+CFXI">MO%AA@ ]*FL;EY:+
M-8J;+DZE\OK7GO675&JA;-0==I%!EM36'TR&2*:Y'0\_PWL%$DE;,0'6ZI-=
M&C_E?Y7Y?MYV7<NQK$DPFJ)9ZD->,R=BTN,EEIE+O&:)9(89+ RQ(P%E5_\
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MDX2E(W48I09DH^L70:=H#Z6@2"M^ 2$J2DD'@E1F:BV]W': J8
M $8M)8+,%\]USBFTDS4:E[GU/# D^#_\X"3@           1I>R65UJVR<2X
M:N*YN*0I1$D]XO").P^@!)*/ 1^]3^T0#<          *(S!)H[<?)Y*U)X[
M!X(-1*Q)??3MPV@*BHA$5*A$DC(N V98GB>!I+I,]N) .U          '75?
M#Q;,WB,T]G=Q(C,CPW%=!EMQ 4KE[PBM]LFDK012)'56:C5CQ#(SQ5MP/ !7
M8          VK\!7[U7[1@(WLY+7C^XS0EQ*B6WO&LU&1[?G=[872 DH
M
M                      ?"5]S2/XAW[&H!8-/^XJ]_;<7^?D)WEZ/47YTW
M^CH'\BB_8&Q"RYH
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MR=RVT:TK-S><)"DJ624[3Q-1%U3Z>Z DA/@I_>E^T W
M         ",[_2R<JA&ZAQ9E)/=W%*3NGO)P,]TRQV@)(:^I-?Q:/\D@'T
M                        $9R$LG?\,]Q9O$VLR5BK<(MS$]G@GL,!)@
M                         (UN-,<[OMTW&W%.D;NXI*UD@L=G6(NJ?H@)
M)+H+SB_: :@                         "@(*6RO&IF1+WS).*C-6X>SH
M(C/=V *_
M 47F+8U%S+L:ZK#N%A$FCW70:I0IK:R(T\&IP7X:EX&2BQ;)[$MA] #\]NO9
M,\SOR>_5MFA<NF/+FN9V:5,UJ_-KAT>FL37HJVI%2D3E-$S&CL(CK92P22,B
M/''I[X:7OGKSH.>%GKE)8=K997MI>R<M"Y(-8N"L-.UJELI8CSHKT]Z2ZDT]
MH3V51%NGL,D[3+# P]DNHCE<:>-9F0N3^3&JRD2,RTY64*G0F*JJ4J+(E5%J
MF,0IDMQQ3;RU&ZXVI1&>W$P%G-]<J_3+R^M%NK!.D;+:51[DO^Q)[<Z,R^[/
MD3W(=(D1XS++3,9*\3)*>@C/8 M/\E-L3,&R=%U\T;,:SZO:$]^_KD=1 J\.
M;">=8DU-Y7$2W-CQUFE:5&>)%AM 8U^:1HKS8T0<TE.OZE:=JMJ0TS9ARBD7
MY:-%E36)5,4R3SSB%.0(G',RP/Y\_"+S %W6@?4UE]JUU=VC;-B<K*I6/E"P
MIMU_-6Z)LQQ^VJ@WV9PGV$5B&IT^%+7O=518[H"U+F(96YN9:<\6A9W:P,O;
M]SDT,JCL^\*F429<2:#092(JBA)D4NF-K@NE%D(P/?(R46S#OA;_ 'C-O>\>
M=QIHU%6!IAK^6>G.!4(<.@5"+1JBABJ-;\:.N7-2S!;3&4747ZH>W;MV;0R*
M<]G1?J;RTUF:?N;!I4L:?F?-RW:IS^85F04/)E^+F6349([/'6\O?AL%T+(\
M3 =;,YX_,IU@9NY'99Z,-'UT6= *J0(V<%8N.'-X##!28D>HICNSV4-MLQFU
MJ-/2H\#Q,^X%=>5#9$ZC;^RHT@YW9:Y=5*_ZODM5:?<.85"I34E]]$EAN/4Y
M;26X<=]Q1',9=01E@ YNL34[F1S$.07F3<5-R*NFQ[WH-&LBB*L27#J;M2GO
MT6(U37UQHZXRYAI-2=[P3Z &1'DBY15&X.3QEYE+FI:+]*E5ZVKNHM6MRLQ'
M6W6BJ=-:C-FY&FL)<2:5JQ+%'20#R(Y&\N?51<7-.IVA*\;:N@]*6769E4NV
M"J5!JB;6C05W$W<$=YM]V*=,6:SWD[I-$6"<<0'L@YVG+SN76QR^Z]DME.VA
MN^;)I-(F633FT(0W+*W(6[XN:2F.ZE"I#,=*$X) >5_(C61&T[9"V]ISS4Y5
M=YW_ *I[*EE;)5!53KQ4RX21,9IG;5D48H26ULQS5@:<,% /:QRVJ+#:TT6C
M=:]/\33A7[KC-SJUEW%<9=[ LV&'&E.+988(UJXAD>*<<2VF DS741'I,ST)
M6Q!Y>W,E9[-B%4::2CV]XC >!SDG\QG/_E]92Z@JA1=/=?SRR3JMY70[1:C0
M')9NT6KIK$EN.AV+#0XMQN0^6ZHL"5@K89 ,K/(>TRZJ\[M;FIKFJZE[&J66
M$7,R+4$Y?VE4V)")<J*[&-MIM2949#S?"BO]U9X[H"/^47EQFO0N>SK=NVXK
M!KU"M.M51Q=/KTNGU%BGSTG(<4G@27XS<9TCQ^=68"__ ,I!Y;N=VK++W*C4
M'IGI*Z_F]ISK3-S1+:9,R?KD*#-74W6VC*.^LE$;9)ZIIQQ 8Q\\.=-KMU,:
M3V-$N7>B:^:)J9NZ@TS+.Z:_(;JR:52V6V6[>J54WG(YMK7))7$/$S3@1[ &
M6S1%RO<R-&7)LS-TYOM'6L[LR;(N:OW/#:,TK;KE9ITB<JEEN1VS-UF0XI)]
M0SQ/#I 8E?)_,X,X+(LW-;E19V:<;KM67>3^9,;\Y$V)56*;&74FYC$)2EOQ
MD1EM]HDDM)D1;VX7?P 6<Y&61=?)SSXU#9-:O]$5U:CLO;PK\ZMY6W]09M88
MC*14JF_4HK9M4N(VV9.H023QQ+K@/2+R9;X8U N9HYNS]!O^%1^D4Z<Q95TS
M9''JUQ0IL5#>XXE^*U,)79G2VJ49]4!BCY166.:]!Y^>LV[KEL&O4BU*L_53
MI]Q3*;48\"7BE\TFS*>BMQ7=\S^=6?2 [GEXY;9L4?RBW5M>%8L"O4NQZG(?
M[!=$FGU!FFSDX.;ALRG(R(KN)GW%F I7F>Y69KW!Y0SI-N^BY?5^KV;2Y44Y
MEQQ*=47:;%+J;QO2V8RXS>ZHOGED ]RM*2::734J(TJ3 AI-)])&4=LC(_-(
MP'BJ\HRRXS4N[F#\OBKV18%<NFC4B\(KM:J=,I\^5&IC?CQM1KDNQ8[S3221
MMQ49 ./Y2UEKFI>6H?EASK%L"NW7$HDR@JKDFETZ?+;H^[4F]_M:XD9Y+!(2
M9JQ69= "[SRE:Q\Q+SY6V7%"L:T*Q==?;1EEVJD4R)-ERVS8@4TG^(U$8?>(
MVU)/'%/26T!3>IKE]9LZY>0ED?E99='ETW.C+BU:)=-OV]*:=9E29M(9;GO4
M]2'XJWFW5K821%N$>("Q+*GGDZ\L@](MO:1Z-HEO>1JSL>%%L.BU5R+5GZ1(
M.!*12H]35OQR:WC0P1XF>YN'X/= 9"-?DC6GGAY/K?\ 5=4&7$MK4S<K5(J$
MFQJ7&=D2VVG5*>BH2Q!9==WB9<5B6[CL 7L^3T6==U%Y5F4MI7U09]JUUV)7
MX,RD5*/)C28:9<:.QO+9E-,NIQ)>.U)= #S5YQ::LRN5)S+<[,X,V]*]PZG]
M+.=M1>J=&GT*14HJJ,ZM^7*-2T4V&A2_54GTJ/I 9@N4_G1;>J_4M7ZO1>6W
M)R#RWMB%,=L7-NORWI-3C27XS2T\)%3B%,,S><26Q1>" Q>9L6+F9D%SO\T,
MX-?F5E_YS9 7#(QR6J$.1<<NVJ6:2<[$V=)BI>IIDZXG R-)$1'TGCL#J]+$
M;,.L^4&VEGX[INKN2>0MU+=8LQ+%+G^+2CL-,-,2'G6H;4=E4I*B49*,L,//
MP#*WS7M>%<RUU&R,F]1'+3>S^TT$TA<'-:DDYXU=1)8D>J%)A17IS)(21F1$
MHB(U=\!AHT/9/Y_9Z<U[+'//05D;F-I>TM6[4#DW_2:[7;GET>; XL=;Z%0:
MHEN(>+2DD1$6S=,!=OSN-%>=F0W,HR_YD%F9&U+4%D9-9ALYJ6'1WI4>4TY#
MB+*4\;D&*J0?$W5+\/YX!7VDS5GEQJGU49;V%EARH*Q1,M5RHCMQY@W1.GJ]
M[<V*Y$6J0P58AKVMR%;W5,MJ0'VYZ.CG4YD+K=T\\TK3)8$_,^D95=F]_-E4
MM#YRH4)E"R6RV46,IYQ/98Q$6"RV& Q_<W;7;K+YK.FNQZ%E?I$O>QLJK8N6
MV)F8LZ:Q5I,F;-;J#!*:CPE13=3'C/GAC@HR(C,S/H >V#EJ4VJ4?1+D%3*S
M3I%*J4&QJ/%EP)33K+\=UB#&:6AQMY*'$F2DGTD0"Z'.7#\T>9^/P?WA^3]0
M%-<6TV%LQIC=?C27LZPG.3.0ER(Z%>_RZNJMYM"B_P"\52[AJ(^Z/2O9_1R-
MF8BG>^IUQGL\K,?M.I[3&^^HOLAGTXV^.79N,?9&MKVF-]]1?9#/IP^WJ+/&
M=IC??47V0SZ</MZBSQG:8WWU%]D,^G#[>HL\9VF-]]1?9#/IP^WJ+/&=IC??
M47V0SZ</MZBSQG:8WWU%]D,^G#[>HL\9VF-]]1?9#/IP^WJ+/&VKDQN$_P#;
M<4O4'O\ I#/\&K_EB8Y=L?9MTEFA[4?(]EMJM;4V:'6G/5:+CPW$+PZ]-Z=T
MSP'3O:O'X^'GR_I;;LQ/X-;VUCIYM0          (TGO(3?E,:.H*0M2%[L+
MLRC)SJXF9R,,$X?L@)+           !&N84AM@J3OSU0M^21$:8QR-\]Y.!'
M@1[F)F D9G:RT9'O%PT=8RPQZI;<.YB ^@          I:\G":MZ<XJ2<1*4
MH,WTM&\:"WB_S9$9F ^MI+)= @+*0<HC09\<V^$:^L?2V>!IV *D
M   !&C;S?O\ WVCJ*C<)I!]A[*>ZDC06WM&&!X@)+           !&MZ/):K
M=N)5/5$-;B]UHHQO$_@K:DUD1\(!)"/ 1MQZJ=O1CL+;AW,0&X
M41F ZAFW7UKEG!+C,%V@F#D&GKELX22,SQ 5%1%$JE0E$Z;Q&PV?$-.X:^H6
MW=[F(#M0         !UU6,DTZ89KX9$PZ?$).^:>HK;N]W !3&7[B7: VI,T
MYQ&^_P"K&P<<SP</9N&1'U?V0%<          #:L\$+/HP2H\>]L,!'-G.)7
M7[D(J@J6:5M$I@XQLE&/$L")9D7$Q(P$D
M                                                           #
MX2ON:1_$._8U +!I_P!Q5[^VXO\ /R$[R]'J+\Z;_1T#^11?L#8A9<T
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M7),DI3&.1Q\%),T&9$?#\\!(C7U)O \2X:-N&&/5+;AW,0'T
M              $:2GDE?T%HZ@I*E-KPA=E,R6DD8_5]W OF@)+
M                  !&]Q.-)N^W&U5!3"G#>PBE&-PG_/>PP;W?V0$CET%Y
MQ -0                         !04!Y!WA4VNVJ4M)(QB&P9);Q3_  V&
M"\<0%>@
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MTRWCAW5$ ^-&KM%N*$W4J#5J=6:>Z9DU.I<R//B.&G#'<D17'6E88]PP';
M    ".)KRROJFM=O2A"D+^TSC$I3ADC89/X8HPP]$!(X           (YO\
M=<;*E;D],(E2DD>]&3(XA;Z>J6)'N&KHQ 2$S]1:VX^IHVD6&/5+;AW,0'T
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M@LT[Y)/<5@HT]W !3%@NK=H+:W)J9ZCD2/5DL)CD9$YL+<21$6Z0"M@
M    !M5X*MN'5/;TX;.G#NX (]M%Y;E;N)"IZ91(<;W64QR:..1GT&LB+B8@
M)$
M                            'PE?<TC^(=^QJ 6#3_N*O?VW%_GY"=Y>
MCU%^=-_HZ!_(HOV!L0LN:
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MI$U,$^T,>J*8*01D;A8IW#(_"_8 5E#/&)%/>W\8[)[^&[O>IIZV[W,0')
M                        $=74ZXBX[<0513%2M3N,=49+IR"[Q.&1FW@8
M"1$^"GN]4MOH -0                         !'=\O+:DT7<G)A[TC TJ
MCD_QBWB(TD9D>YACT@)!:^IMXGB>XC;AACU2VX=S$!O
M        #+'88".93[GOZA-%/0E&XO&%V8C4LB1T\?#$L $C
M                CNX'G$W;;S2:@EA*^*1QCC)6;V[B9>K&1FW@8"1"Z"[O
MF@                           H2"ZL[NJ+9S4K224X1. 1*;V?PQ%BL!
M78
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MR=&JW!6.69D]+N:OU"Y:JLIAR:M4I4F9*DKX4+%:WY3KSRL5&?2KN@,[H
M   CF<B1[^*:I+;?!-*]Y9K1OE@@RV)/K8'@ D8           $>WVA]2:8;
M*&U$F4@U[ZDIP+?3@9;QEC@8"OF?J+7<]31L_P":0#Z          "F[M)1T
M&:2$I6HTIP2M24I/;W35L ;[5WBH<'>2E"N'M2@R-);>X9; %0@
M  CAI+WO\D*X;?!X*")S?1OX[F)EN^%T@)'           !'=X(>.L6^IMIM
MQ!.+)9K4E)IQ47@DK:>/F )"1X"/WJ?VB ;@         !1E^)=50'2:0AQ?
M'8,DN*2E/AETFK8 [^CDHJ;"WB))DRC>(C(RQW2Z#+S0':          #KZK
MO'3I9)(C5P'<"/ B,]Q6P\=F!@*9L$G2H#9.H0VKCOGNH4E22Q6>&U.S:0"M
M@         !M7X*OWJOV@$>VBEU-<N(EMMH1OM[AH4A2EEB6U1)VEAYH"1
M
M                        !\)7W-(_B'?L:@%@T_[BKW]MQ?Y^0G>7H]1?
MG3?Z.@?R*+]@;$++F@
M                 H3-']&68O\ <6[OR?J HO/V<^0C=?C39E?I\SQ_OY<_
MY1U(>BNSG_0:?#4Z\SS]_J\JGAO+%
M                              $[CT]>2<?[VN>G\CA_S>".M^U'_3;G
MRMBV;_;2_0['0L;LMV!4                   H2_B>.E-\!MMQ92&3P<4E
M*<-\L?"V8@*RAXE$BD98&4=DC(CQ(L&T]!D Y(
M    CNZ$NG<=O*0TVX@C=)Q2UI2I!=])*VJQQ[@"0T^"7G%^T U
M                 $>7NEY4FB<%MM>$G%1K4A.Z6\6TB498@) :^IMX].XC
M'Z4@&\                          1S)X_OZA8--FWPUXN&I.^1</#8GP
ML $C                            CJX4O'==ODEMM3>+AJ4I226G \>J
M1GB>("1"Z"\X@&H                          H>$EWWV5 ^&WPS)/7)2
M=\^D]I=/20"N                            ! "0
M                                                           !
MY,?*Q=2N9&6&E3+C(S+JMS;?D9_7;"MVJU&!*?AR$0')AP'D)?CR&'$DIN2>
M.&./> 7!<MGD':"["T@Y?LYDY1T?,6_+_M&#6[ONRM[DVH2I%?I<64[P7I4,
MW&W6W'U*)1[^T^Z X6@CD$+Y?.O6]M2.2^==1IN1UTN/K1DL29!T]IJ4X;W
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MWJOVC!$[D^1E9Y87W#?O[Z-^VR-BR#=J>EOZ>OV&+\WZ&6=/1Z)_MC8KO?\
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M%*8:DHPCF]P.)URV<7$MW !OM)M35!@H5&*(I*#(V"=XVYMZ.)B>\ J0
M       $;MQS*_'WO%A$1M(_TAVO:HR075[-CU</.V@)(           !'-Y
M1S>K%O+\6]M2VZLS=[64?LQX^%N;Q&[CB D1'@(V8=1.SIPV%L] !N
M    %%7\RI^WGD)A>,/5F3./V@HN]U^GBF988 *@HJ313(23:X.##9<+?W^'
M@@BPW]N]M+I =J          .OJI&JG3")OBF<=TN'O;F_U%=7>V;N("E\OV
M%1Z VVJ!XO,GY'VOVCM.!&X9D?$Q/'>QQ\P!7           VKVH5LQZJMF.
M&.P]F/<Q 1U:#*FZ]<3BJ84+B+1]L=JX_:B)18*X>\?"PQ 2.
M
M               /A*^YI'\0[]C4 L&G_<5>_MN+_/R$[R]'J+\Z;_1T#^11
M?L#8A9<T
M       %"9H_HRS%_N+=WY/U 47G[.?(1NOQILROT^9X_P!_+G_*.I#T5V<_
MZ#3X:G7F>?O]7E4\-Y8H
M                     G<>GKR3C_>UST_D</\ F\$=;]J/^FW/E;%LW^VE
M^AV.A8W9;L"H                  !0.8+!OTEM)4\JCA)8/@]I[+A@X1[W
M$Q+P>G#N@*UA%A#BEN;F$=DMS>WMWU-/5WOGL.^ Y(
M        CBZXZG;EMQSQ;VM+:G#[3VHF>S;3V\'$C>QPZ $C)\%/<ZI;/0 :
M@                         "-[[CJ?DT,TTXIVY(49K[5V;@%O)Z^[B1N
MX]X!(K18--EANX-H+=QQPZI;,>[@ W@                         "-I,
M?&_(3_BTE8-K^W^UD6YBC##LV.*L0$D@                           C
MBX(REW?;SOBTI*4<7&9VOA'&QQ_S&)<7>\X\ $CET%W/,
M            !0=/:,KNJ;G8=PE$C"9VC>XNS$_4,>I@?F *\
M               &U2L-A'M_X>AT!&G<1,V;JV3/'65IHTX/18V<F;UFV7,E
MX\&#4JW3D3MF_CQ(9RBD-> ?A)+H''HQ5Q>7TW%%43>1NV+M5S>477OJHF+M
M;TOFX<O=MLW5ZD[!2V6&*CJT(BVG@7_2>Z8O\J)LC7-BW,<FGE3N+T<HLYLM
M\][-IV8.5-TTZ[[/JF^4*M4MYM^)(W"2:MQQM2TGAOEW>Z.3B,+B,+,1?TS3
M,Q;%JBB\HO--$VI1''5@
M                                #R^^5$:',U=5&D>V\S,FJ3+K][Y
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MD88@))
M                                'PE?<TC^(=^QJ 6#3_N*O?VW%_GY
M"=Y>CU%^=-_HZ!_(HOV!L0LN:
M                        "A,T?T99B_W%N[\GZ@*+S]G/D(W7XTV97Z?,
M\?[^7/\ E'4AZ*[.?]!I\-3KS//W^KRJ>&\L4
M                                      3N/3UY)Q_O:YZ?R.'_ #>"
M.M^U'_3;GRMBV;_;2_0['0L;LMV!4                   C[,1MMRD-DY&
M7*(I#)\-MU31XDX6W>29'@D!6\+#L<7=+=+L[."<<<"X:=F/= <H
M                  1M=K3:KEMI:XKCZDJ=-#J7E-I9V]*DD9$O' !)"?!3
MW.J6ST &H                          C:_&VG)5"-R*Y)-,KJFAY37#/
M>+K&1&6\ D5K8TV1%@1-HV=.'5+9CW0'T                          $
M9RVF??\ 0'#BK-PD+PD$\HDEBWW6L<#Z>\ DP
M    $:7&AH[QMQ:HKCBR-W!]+RD(9[G6;+8K>,@$E%T%YQ -0
M              SPVF H&GH;]^%4649:7").+YNF:5XD?0WCNE@1 *^
M                     '0U]^5'H-P28)&J='HU2>AI21FI4IJ"^N.1$6TS
M-Y*1Q[^J\BXO9B+)BB;."5>'IB;V[IO/5Y46^2V+7@ETL<L>C\VC6_K,OC7K
MF/=42HY=7@S3;3RYDU^IT(F*=*FS>%*B1I,A"'6$L'@9MIP(U$*-FLOPUSLG
M=X^G[>,OKRJ*JK;9ITS9;&ZYFU>(F-I_EMQ,4Y=1=4U4ZJIT19$^>9\S)U+\
ME(Y;$EE;"K@N1#:U)5A[^).S=/%)?5^X.333%/)LW:9M\K@56S;JL9^=#>D#
M*[0]D);.0>4$J5,LNVC?.GO2Z@JI/F;R6B7OREJ6I?U(NZ,QFN;W^:WE,W\1
M%5%,1YMQQ<-AXN)JLFVV5XHQ+E
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M_54-FZHCWR(B)"2,SQQ 5'1#)5+A&E1K3P&]U1IW346XG S2>TL0':@
M    #KJL9%39AJ4:"*.[BHD[QI+<5B9)+:> "E\O7&W+>:4U)5*3QY'JBVE-
M*,^)AANJ+'9@ KD          ;5^ K'86ZK$_0,!'%G.LKKUR);E+>4AQO>:
M4RIM+6)EB25&1$O$R[@"20
M                                               !\)7W-(_B'?L:
M@%@T_P"XJ]_;<7^?D)WEZ/47YTW^CH'\BB_8&Q"RYH
M                                         *$S1_1EF+_<6[OR?J H
MO/V<^0C=?C39E?I\SQ_OY<_Y1U(>BNSG_0:?#4Z\SS]_J\JGAO+%
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M4D9]8R 5M P[%$W3WB[,S@HRPWBX:<#P[F) .6
M    (VNQUM%S6TE<I;*E&Z2&4LFXEX\3V*61'N88]T!)"?!3W>J6WT &H
M                       C>_'&42J'Q92XYG)P0E#*G>(9J+$C-)=7 @$B
M-;6FS(\2-M&WHQZI;<.X ^@                          C24XS[_ *"V
M<I:7#;691^"K<5U.CBX;I=\!)8                           (TN-;)7
MA;B%2EMK4;V#"65+2[AMZRRV(P 24707G$ U
M  % P'$>_&I-E)6I1DDU,&T9)1@6)&3F&!X@*^
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M"75]=S75>SHF=#(>,"YH
M                 HB^\R;#RQHDFXK_ +MH%IT>*V;CDRNU:!3&S26.)-'-
MD,<56!&>"<3P(P$799:L=.N<-3>HN7.;MC7/5F341T^GW'2'IBS0:243,=$Q
M3KQD:BV)(S 7$%_P[H        #H*W==M6WP?'U>I%(7)42(K-0J4.&_+6:B
M02(K$AYMV0O>/H01F CW-O/S*3(JB0KBS6O:BV91JB\U'A3ZS-CQ&)#SQD32
M&W'W6TJ4LU%@1'W0$A6O=%"O.A4ZY;:J,>K42K1VY5/J$5Q+L>3'=22T.M.(
M4I*DJ2HC(R,!WX   -JE$A*E*,DI21J4I1DE*4EM-2E'L(B+:8#H*9=ELUJ7
M/@T>O4FJRJ6DCJ+5-J$2<<(U;21)[*Z[P7-G@JP,!%-OZF,C[JS*J>4% S"M
M^I9C4?$JE:L:H17*K$W2,U<6*AY3R<"+NI 3N     Z6X;?I5TT:H4"MQBF4
MJJ1G8DZ,:E))Z.\A3;C:C29'@I"C(P&-S-GED:(8V6>9=0<R0H"G4VE=M7<<
M3]77-;I%0EI?XBDGZH4CK8GC@8IKLY.DLMBQX1]-?/RU1Z%;>O#3)E?846MY
M?9>WM=L2V''G&2[)&57I3*6R)<IK$DLQTI\$N@=O[,;"X//LJC,*ZN39&EK.
M8YW7@[R;N(BVWQ\*XSY59KA^"JG_ $\;V\,_W999SI8WK)?'RJS7#\%5/^GC
M>W@[L\LYTG62^/E5FN'X*J?]/&]O!W9Y9SI.LE\?*K-</P54_P"GC>W@[L\L
MYTG62^/E5FN'X*J?]/&]O!W9Y9SI.LE\?*K-</P54_Z>-[>#NSRSG2=9+X^5
M6:X?@JI_T\;V\'=GEG.DZR7Q\JLUP_!53_IXWMX.[/+.=)UDOFBO*KM<*4.*
M_-53SW6G%%UXW2E)F7_3O,#NSRSG2=9+[Q/1%Y/_ ,U3/KF8TW.JIYU6_$H*
M;"<IR:(U&0TGB%+5$)PU*;><4K GSZ<.@=?[:[-8?9VJ[N[F;?>;OBL9_*\Q
MG&554Q/*HB-W7PO200T*-RS?9D$@         C::^HK[IK/C(D)-#AG [)O&
M[U=A]IW<4[OG@))           !'=^OJ933-VH]@QDHQ+LI2>*6^75VI/=Q[
MX"0&3Q9:/''%M!XX88XI+;AW,0'T          %+WDX;5O3EE**&9)1A(-GM
M'#ZQ;>%@>]B ^MJ.&[0H*SD]K-2#/C\+@[^W^#P+= 5&           "-6Y"
MCOU]GQD1I)I'VAV3 TGN;%=IPQ5CM[H"2@           1Q><@V:O;J"J78B
M<><Q9[)VCM.!EU=_ ^%AWP$BH\!&W'J)V]&.PMOH@-P          HN_G39M
MYYTIWB_=>8^V#C]JW<5]'"P/'$!W]%/?ID)PW>.:F&SXN[P]_%!;=S82<>\
M[4          =?53W:=,,G.$91W3XF[O[G45UMWY[ !2]@.F[0&U'/*HGQY'
MVP4;LI*P<,L.%@G#=Z/- 5P          -J]B%;<.JK;ACAL/;AW< $=V@^;
MM=N)/C'MA-K07 [)P.S&:BV<3 N+C@ D8
M                                                           ?
M"5]S2/XAW[&H!8-/^XJ]_;<7^?D)WEZ/47YTW^CH'\BB_8&Q"RYH
M                                                   *$S1_1EF+
M_<6[OR?J HO/V<^0C=?C39E?I\SQ_OY<_P"4=2'HKLY_T&GPU.O,\_?ZO*IX
M;RQ0
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MX K6$>,.*>_OXQV3W]W=WO4T];=^=Q[P#D@
M".;I?-%RVZWXQ[,E9K^U3B\;M.!F?U; ^#@ D5/@I[O5+;Z #4
M                1S?3YLRJ&15(H&_(41I.)VGM&U)$C>P,VO/ 2&T>+39X
M[V+:#WL,,>J6W#N8@-X                          CB5(,K[A,>-"21M
MJ_T?V0C-?4/;VG#J[OG[0$C@                           CFX7C;NZW
M4)J91B7Q=Z)V4G>T8&9_5L#X6&/?V@)&+H+N^:
M    !ECL,!0=/=,[NJ;?;M\DDC"'V?=X6S;ZOAU\3\T!7@
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MT&"<L
M!UE;J;5%HU7K+_U"DTN?4WL=A<*!$=E.8GL^<:,!^=[F6C5_Y1%S*<W,@Z#F
MG<&56E+(6NN4NIIHDVHL,]E;G2(KAN' DOI=4XA]7A)(!)>J[R;W5OH%39&H
MGELYU7_?N8EIUFEO5FT)-:K*/&"2ELN2'30?%;<CK4PC'>P,RQ(\,<0'LGTX
MYVW]9VC&S,W=:3<++.][>LQJ?F=XRF,H:@2:? ;5*?6\^XVEQ^1PUJW=[$S
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MHW9;4U$@         CF:I\KXIR4N(X1I42D&A&^>*3/8H^ML\P!(P
M    (^OI;Z$TPV7&T?;*-\EH0K>(EIV%O$?[ "O6?J+7=]31M_YI /H
M     *:N\UE0)QMJ2A9)1@I:24DNL722M@#Z6JI:J'!-PTJ4;9XJ01$D]O21
M)P(!4(           (Y;6\=]/(XC?!)E)DC<1O\ @[3WL-[88"1@
M   1Y=ZI!5BW^$MM!&XO?):4*-76+P3/;L\P!(*/ 1^]3^T0#<
M*-OOC%0'C86A"R?8ZSB4J3M66.Q6SH(!W]&WCID,U&2E&RC$R(B+'=+' B\T
M!V8          Z^JF94^69=),.F6.&&)(5@>W9L 4S8)NG06^,M"UD^^1FA*
M4I/!>S D[-@"M@         !M5X*OWI_M (_M)3RJU<&^XVI&^WN)2E)*26/
MSQIVGZ("0@
M                                   !\)7W-(_B'?L:@%@T_P"XJ]_;
M<7^?D)WEZ/47YTW^CH'\BB_8&Q"RYH
M                             *$S1_1EF+_<6[OR?J HO/V<^0C=?C39
ME?I\SQ_OY<_Y1U(>BNSG_0:?#4Z\SS]_J\JGAO+%
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MC>*E(-EQMM7:&<3<2E2<.(6/A;,0%90_N2+B>)]G9,S+HVMI/8 Y(
M                   CJZ5/)N*W4M.MH3O.&M"TI4I9&?SBE;2/9W.^ D1/
M@IQZ=TL?F -0                         !'E\+>3)HO"<;01R<%$M"%;
MW63L(U$>!@) :^IMX].XC'Z4@&\                          1Q*4][^
MH1;Z.'PUD:#2G?/J8XDKPMF("1P                           1W<"WB
MNNW\%H)K%TEH4E!K7W"W3/K%Z "0RZ"\X@&H
M  H>"IWWUU)*G$<,MW=024[Y8D?2?A;0%<
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M<G%8+&X*^LQ<3'*C1;O+5W>W5Y;%W9;&ZF <=<
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MUS.@LFQ[3O(]SQM;4W_&T7_+IHZ?[5]%]A[?'^EMVS'[&M[:2'3L;LMI:B0
M        1O.96=]4QWL"5H2E>,TY))4WU#P(F-[%>)GWM@"2
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MP0:MPE'N'L-7<QZ %+6"TIJ@MDN&F$KCOXLI?*02?5#V[Y&>.\6T!6X
M     VJ\%6S'JGLZ,=G1CW,0$>6@TXW7+B4N"F*E:VS0\4@GC?P,L3-LC/A=
M("10
M                             !\)7W-(_B'?L:@%@T_[BKW]MQ?Y^0G>
M7H]1?G3?Z.@?R*+]@;$++F@
M                      H3-']&68O]Q;N_)^H"B\_9SY"-U^--F5^GS/'^
M_ES_ )1U(>BNSG_0:?#4Z\SS]_J\JGAO+%
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M,U;QF6.[AB K6&1E#BD:=PRCL%N8[V[@VDMW>[N #D@
M        ".[K94[<5MK* F22%KQD*DDT<<L3VDV9XN8F8"0T^"GN=4MGH -0
M                         !'5\L+>DT7=@(F;LG$U*D$QP2WBQ41&9;_G
M )":V-MEAN]1'5QQPZI;,>[@ W@                         "-Y++AWW
M"=* E2$H<WIAR"(TXI[C&.)XF D@                           $=7#&
M4Y=MO.E 2^E'%WI)R2;-CZ'!G'%S>/O )%+H+N>8
M       "AH32RNZI.'#2A*DH^VB?)2G,"P+%K'%("N0
M        !UD^,B?$FTY])J8GQ9$-\B5NF;,IE3+N"BVEZFL]HHJHIO*)NYG[
M$Q-OG4W=?NJXO(_:6Q,>9X^.8?I%\G6T?7]<%UZN"DR,TKZJ)SYM$H]<F5.M
MG,J$J3(6J1XM(Y=.1OJ<,]Y98888=['83'X6ZQ=.6X"9Y=ME5D:(\L[GANLQ
MF5[CLPF,PS"R?L_9MW;(5!3N4=Y/[=&F*WM7]3I%P4#(&[3A%3J_*N^MMM(?
MF/I9BM/>I/+:-3JBQWCP&;S&[KR#$767X^8IQ%[,3=^.W2P>7W].;W%[7@M-
MW<V\O]6S_B]'.AO('3SIQT]65E_I<<X^33<--1M5\JHJL$[%G,L.)<*:LS4Y
MBVE.SN#F9KBL??XB*<?%E[3$<%FCT./@(N)NYO</5RKNJ=WR;J\$8QS@
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M&6=/1PQQGN,3S9\/,?F*U-_ !?'^K]P?@P/F&6=/1PQQGN,3S9\/,?F*U-_
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M9F:@%2            C)IALLP'WO%ZB6;:2[;VD]U1<,MG9][ L#\P!)H
M        (VO2.AZLVVM4!4LVWG#2Z4@V28,S+::",N)L(!(S>Q""(L")"=G3
MAL+9CW0&\          43?[:7;>>2J(<TN.P9L$\;!GURV\0C(RP 5%12W:7
M#+AFT1,-D39JWS01(26Z:N[AAT@.T          '758B53IB30;A''=(VR5N
M&O%"BW=[9NX@*6R]90Q;[:&X2H)$^^? 5(.0:<7#V\0S,SWNGS %=
M   #:OP%[,>JK9T8[#V8]S$!'5GLH;K]R*33U136MO>?.2IXI.!E@9-F9\+
M!(X
M                             ^$K[FD?Q#OV-0"P:?\ <5>_MN+_ #\A
M.\O1ZB_.F_T= _D47[ V(67-
M                       !0F:/Z,LQ?[BW=^3]0%%Y^SGR$;K\:;,K]/F>
M/]_+G_*.I#T5V<_Z#3X:G7F>?O\ 5Y5/#>6*
M                                     )W'IZ\DX_WM<]/Y'#_F\$=;
M]J/^FW/E;%LW^VE^AV.A8W9;L"H?)^.Q);4S)99D,K\)I]M#K:OWR'$J2?S
M'SBPH<)'#A1(T1OIX<5AJ.CZ5I"$@.2 X+M+IC[Z93U.@O24[4R'8D=Q])]]
M+RVS<+YH#G$6&PMA%L(B[@            "@,PV4/4=!.053R*2P?"3(.,>)
M.8[V^1D?5P]$!6L$B*'$(D[A%'9(D8[V[@VDMW>/:> #E
M           "-[K8;=N:VEJ@*DJ0IS=?3)-HH^)])MD?JN/[ "1T^"GN=4MG
MH -0                         !&U^M(<E4(UTY<[<DGNK3)./P#,T]<R
M(RXG1T )%:^I-X%@7#1LQQPZI;,>[@ ^@                         ?F
M'AYH",Y3"#OZ"[V!2EDVO[<*29$@MP]AL8X'B DP
M       $;W"RTN\+=<.GJ?6WQL)123;)CSV<2)S>Q 20707<\P
M                 %!0&4IO"IN=B4A2R1C+XYFES!'\#C@C !7H
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ML8
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M$;V:N.JOW*32W#63C>^E:5DE.TL=TU;#V]X!)0
M
M    ^$K[FD?Q#OV-0"P:?]Q5[^VXO\_(3O+T>HOSIO\ 1T#^11?L#8A9<T
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MAJ=>9Y^_U>53PWEB@
M                 "=QZ>O)./\ >UST_D</^;P1UOVH_P"FW/E;%LW^VE^A
MV.A8W9;L"H                  !'V8G"*CH-U:TEVF/X"5&HSXA$1=7;TF
M K>#AV*)AT=F8,L>\;:3 <H                          1K=JF2N6VM]
M;A.;SAMI2E1I5M+'>-)8%Z("2$^"G]Z7[0#<
M  (UOTV2E4/BJ6G[9/#<2H\3WDX$>Z1X;0$C-?4F\.CAHP^E(!]
M                 !&4I3!7_!(U.<4VUX)(E;G@;3,_!+ !)H
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M<\+L\>0^VZ\:2^A(P'7HS!L)VJE0F[WM%RMGAA1T7)1EU4\>C"GIFG+/']X
MJXE)/# \<=I8;2,C+$C(^CH 1OG*I2<H\SS29I/\WUXX&1X&7_=ZH]!D**YF
M*;83$15HG<L?C'7_ $*G3LZ,Y7Y7;3<5?MU&?!G/LH_\15+;N(62>X/3/9S>
M7E&S/*N^3;,:H\3KG:"*?S\4Q,Q&ETGO6I'_ %C[IRO3C:^5?>+@8?W?CGA/
M>M2/^L?=.5Z<.5?>+@@]WXYX3WK4C_K'W3E>G#E7WBX(/=^.>$]ZU(_ZQ]TY
M7IPY5]XN"#W?CGA/>M2/^L?=.5Z<.5?>+@@]WXYX3WK4C_K'W3E>G#E7WBX(
M/=^.>$]ZU(_ZQ]TY7IPY5]XN"#W?CGA/>M2/^L?=.5Z<.5?>+@@]WXYX7Q<M
M:D\)[^D?J+N/^DY71PU?^L%WWU[N:+?(KB[C?F?2]L?D=E.BP+7U.]F)_P!4
M=HIK-Y]QX]BZ;T&X9X#IGM5JMO,/%D19;Y]UM^S7+KB\O:YMF7MW(L!T[3RK
M+*MUM:&=0>==M:=\G[YSCNY+[E L:A3JU.9C-J=??3$CNOI9:0CK*6Z;6Z1%
MW3%0_-/YP/,^UB\TW+NLWK;N75W90Z%+*N1<5F?).JTPKLDPITB#VQ]2E(0Z
M:S)!F1]79AAAL >R3R;B.Q$Y7V3+$5Q]UAM$PFUR7W9+JD\*%@9NO*4M6)>:
M SY@     "-)LA)7Y362J1H,T.?:'93,G>IM/M&&"<,<>D!)8
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M>.PN(9$;N("1P
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M8'G-RB.6E!S&UJW='S=U4U8G:9;M(3P(BZU6I#*H\5*"1)9WDLR22?5QVGZ
M#$-9>>?E'>>&2#^O2U)\2V[$53I=Y6UDP9P^)5K.BK>G+Q)3F^A*Z>C=V].
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M-3KS//W^KRJ>&\L4
M                 3N/3UY)Q_O:YZ?R.'_-X(ZW[4?]-N?*V+9O]M+]#L="
MQNRW8%0                  "@,PW29HZ%G4#IV$A@B>*,<K:;A8)X9$KPC
MV8]P!6L%6]"B*XG%QCLGQ-W<W\6T];=^=Q[P#E
M    "-KK?0W<UMMG4CBFXIS[6*(;W:,.YQMTR:PP\P!)"?!3W>J6WT &H
M                       CB^WTLR:(2JB<$ER3+=*,<CC8*+JXX'P^GI 2
M(T>+39X[V+:#WL,,>J6W#N8@-X                          C*5(3[_X
M+)U$T*-MS"!V7$G.J>!G)PP+#SP$F@                           C>X
MWR1=UNH\9''-9NEV3LANE(\SCX>I;O[("1RZ"\X@&H
M        H2"\D[OJ+13C6:4IQA]G-)-]4L/5\.OCAWP%=@
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MO=+N#*YQD]>4WU%%5<5<JF)T>.'&N+^;ZVV++%[@Q#D
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MVKXYV>=6D=>:UP0J5E_<<JZVKQAS*BW5ZFMZHN5OL"Y39HEJ(E>I%O&18=W
M!*'/(Y?5OY8<P#2;8<3,6M51K/\ EPZ%-GRY,UZ9;+=.<33TO177#4ZTXZD]
MXS;/'$!>GS=<RLQN5'HYTP\N73EFQ<#-4SP[-%NO-"9(J$VLTRCRWR1.>8==
ME-3C0J$UOI).)X$6S'808R]4&5]+Y<.7^3FKO11K=S3SBSSI]3M2HYBV"JBW
MC,9K*ZZ_3Y=9:4RMPVDMQW36WCT8%B SW\YG4U>N<O(LL/4Q1Y]<LB\;HI=I
M3)RHS\^DU%BM]G)+SBR:>9E(WYZ#6I*E ,45.Y7>HG4;RIJ;KUS(U?WX6:5O
M6:Y>=E4&+/K<2'3V*(A"V8KK[$HSD/2":49[W5W4^%B> #)AR[*E?7-.Y#%^
MY:9Z9@U=BZ;,HUVQ%WJW*EHJ#K5FP*@[#:D/MO.R74R"CJ0K$]N_T ,=ODS/
M+]H&;&8M]:FYF85>I4[("\+AMRGVI3Y<^/3J_P#;;S*9\]EE2(SQ([ 1GOXJ
MQ5T +H]"68F9MR>4B:HZ56K]KLJR:#1JA(9M=ZHU!VEQ&*12WG#4U"7)5%2H
MTL&>Q!8X@(1K=5U)<_OFA9[9$0\Z[ER?TF:;ZE*I3E'H4JH1Y-5<:?DQ5(4Y
M!E&:G'G'#(C42"Q[P#ZW50-4/D]_,)TY6;;^=5R9P:5-2%8BT>I6[<,VH2':
M:MR;&@F@G)TM'70MK;N[Q8@)-\IPS"SEMO5-H4+)?,*N6)7<R'(4:&_3JA/9
MCL-W ZJ*^M^/&E,,OFT4DC+>(_! 6=\U[E^Z@N65E[D/KJL[5K?5VYKU"X;,
M7>T634*TQ!DG4WZ9+?0W$.6F,J,A;BV]ID:B2>PL0'N[T89G5?.+3#DSF-7W
M^U5FY;%MZ=4I&&!OS'*5$5(=46\OK+=,S/:?2 E;.;]$>9_^S^\/R?J HO/4
ME51NOQI[U_3)G'_?RZORBJ8])=G$3U7HCR_H=;[0_P"I.L&XL:         -
M%_4G_P"(>^QJ$3O>4G<>TWR/?_POJ;_C:+_ETT=0]J_[;#^?]+;MF/V-?AJ>
MV@AT[&[+:E'W[85J9FVM4[+O:DQZY;59:X%3I<I)*CRVL?J;J3(R4@^Z7=$C
MRP^5 Y=6-DSRI*AE]EC:=OV;:E/K< HU-HE(@0"+BR9#KAK=BL,K<4MQ1F9G
MB9GT]P!>YY-K_P"5QDC_ "9_^;4\!GS      $;SG7/?U36^UH2V:5XQC82:
MUF2>X[AB6&("2            1Y?CCK::9PI:(OVPG'?8)[?(UI+ L2/=,P%
M?L_46L3Q/AHQ/HQZI;?1 ?0          4S=ZEIH$U2'TQU$2,'E()PD]<OG
M#(R/$!]+44:J%"-3R7SW%>JI039+V].Z6!$ J(           $;M./>_M]!S
M$&V3:,(O 3OIQ;_AL,< $D            CF[UNMUFWTMS$1D+<7OMJ92ZIW
M!7SJE$9H] !(B/ 1^]3YG<+N=P!N          %%WXMY% =4S(3%63['JRVD
MO)+KELW%$9'B J"C*-5,AFI9.&;*,5DG<)1[I;23W,0':          #@53>
M\7R]U1(5P'<%F6\2>HK::3QQ 4O8*G%T)!NR4RG.._O.H:)E)^J'LW4D1=7
M!6X          VJ\%6W#JGMZ<-G3AW< $>VBXXNN7$E<M#Z$+;)#:62;4R1J
MZ%*(B-?0 D0
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M,U?75R3LV^8KI)O9Z32X%ZRJVSEW&DDZAN.Y7?&T:.N"EQV"ALS;<P(VT8D
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M]O+(:77DVUI8N)^'-D6? N!4:9+;2^JGTVHO3Y79)$TDEV4R;=6A7JAEB18
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M>/\ ?RY_RCJ0]%=G/^@4SO?\'7F>?O\ 5Y5/#>6*
M                                         )W'IZ\DX_WM<]/Y'#_F
M\$=;]J/^FW/E;%LW^VE^AV.A8W9;L"H                  !0M_+=;I*%M
M2D1%=I8+B+92\6!KVIW5$9=;H 5C",SAQ3,]X^SLXJ(L-[U-.W MA8@.2
M                       (ZNEQY%R6Z2)C;*%J<WV%,)<4]AT;JS(S1AY@
M"1$^"GN]4MOH -0                         !'=\K<3(HVY,1%(Y!DI*
MV"=XO63L(S(]WH[@"06MK;9F>)FA&WHQZI;<.X W@
M      ".I*W/?S"1VQ!-FVL^RFPDUJ,DGM)W#>3@8"10
M           1Y<#KQ77;[:9B&6U<7>9-A*UNX=!)<,L4X )"+H+SB :@
M                     "AH+J_?94FCD(4@B026":(E(V8[7,,3Q 5R
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M!=!"J]Q%_B*XJO*IJIB-\BF(TQNJB%(
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MMO+K-OFW'0\E*W#4XMU+9M8JZ4I49;V/F )"1X"<=A[J<2] @&X
M 4=?2'5V^^3+*)"^,QZFMQ+:5=?'PE;-F #O:*2DTR&2T$A1,-D:242B(]TM
MA&6P\ ':          #@50E'3Y9)22U<!S!)J))&>X>PS/80"F;"0XB@-DZR
MAA?:'^HAQ+A8;Y[=Y.S$P%:@         #:LNJK#:>ZHB]$@$?6BA]-<N(W8
MS;*5+1N.I=2M3I;WSR4[488]T!(8
M                                                      ^$K[FD
M?Q#OV-0"P:?]Q5[^VXO\_(3O+T>HOSIO]'0/Y%%^P-B%ES0
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M\:W4M[F*D[2)7A )#:V-MD98&2$;.G#JELQ[H#>
M     (XDMOG?<)PHR."EIS>?-Y.^7J9X8-^$?6 2.
M        ".Z^VZN[+?4B,AQ"3>WWE.I2I&/T*#VJ 2&707G$ U
M                %"06W"NVHKX"$MJ)&#Q.I-2\$ETMX[Q; %=@
M                 #H?%-MQZ@[4T4VA1ZNZ6#U13#@-5)SS')9-)DKV=]0B
MF(HIFFC1$ZM%I7;5,55:9C<F=[R.S1*AH3AVJ-W?^D-'T_\ .$Z=],S-6FK=
M;NV1/OJ-]?:],(F-]#ZH<0X6\VM#B3Z%(42TGZ*3,A3$11-FM+Z"M
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M0HK$1LS[YH8;;29^@ V2J32ISC;TZF4^8ZT>+3LJ'&D.-&70;:WFUJ09>89
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M-,HZ.XD@'8@     "-9L?&_*:_XKW\$.?Z0[7N\+J88=FQ+?W_. 24
M     ".;_C)D%2L::=0-$I"B^VNS<+!9'O8XEOX=X!(3/U%K9N^IHZO3N]4M
MF/=P ?0          4Q>+?%MZ>WV;MF\E'VOQN!Q.N6SBXENX -]I-DW0(""
MC=D(D'ZAQ>-N=8]G$Q/> 5(           "-6F?^_P ^[XKP]227C#M?3@@M
MG9M[9\S: DH           $<7DQQJS;J_%O;4H<=/C=J./V?;M/<Q+BX][S
M$BHV(3LPZJ=F..&PMF/=P ;@         !1.8#1/6Z^@X/C#U9@RC]I[+C@O
M''BXEA@ J&BEA2X1<+@X,-EPM_B</!!%N[^W>PPPQ =J          .OJJ=Z
MG3$\/BXL.EP][<W^HK9O=P!2V7S'9[?;04#Q?ZO(/@=I[5ABX>WB8GX0"N0
M        !M7M0K9CU5;,<,=A[,>YB CJSX_"K]QN>+CB<137J_:N/VG RV\(
MS/@[H"1P
M                                 !\)7W-(_B'?L:@%@T_[BKW]MQ?Y
M^0G>7H]1?G3?Z.@?R*+]@;$++F@                       8=)]_I
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M-NG>T;G#I\[/Y7EM6$JB9IBF8BR9C?G7I>MPNDQUK&MG]'G:B4
M         H+,!CCTA".P>,/MACU'M/9<,%^%Q,2\'IP[H"LX2=V'%3N</".R
M6YO;^YZFGJ[WSV'? <H                          1M=;'$N6VU^+3F&
MA3OVT4K@=EZ?\R1EQMX!)"?!3W.J6ST &H
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M+6N91>XF_B\O<3-E?+F.1S;&4P:RS(
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MCCNXD1X&9;BMA&6W: I/+M+*+?;0RTMI*7Y&QQ:EJ^J'W5;=I@*\
M  &U?@+_ 'JOVC 1O9R&BN"Y%MM.-F;B-]2U*4E>*OG2,\$]'< 24
M
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M-Q3Y'T1V2BJ=GL+IMGW5/T0E07;&Q 6 %@!8 6 %@!8 6 %@!8 6 %@!8 6
M%@!8 6 %@!8 6#H[D5N4:<>+A>I']36I"\,,<"4DR,@LB=$[B8FS3#K[*6IR
MW8)GQ<,72(GG%NN$1+/8:W#-1EB)T1HB-"+=:K!%@!8 6 ) 198 D
M           !0&8:&UT9!.-K<3VEC8VI258DX1EM3W,0%:PON.+AB1%'9(B/
MI(B;21$?FD0#E                          ".+K0R=RVTI;3BUDMW<6E
M:DI1^_(CP/''N@)&3X)><7[0#4                          1K?J63E4
M+B,N.F4DS2:%J223)2=JMWI+: D9KZDU_%H_R2 ?0
M       1G)2P=_PC-ISBDTLTN$M6X74/'%/@F9X ),
M         !&MPI8]^-MK6RXM9&^25I6I*$X].\DCP/80"22Z"\X@&H
M                    H&!PO?C4C2VO?4E)J<WU&@]F!%NGL+#$!7P
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MC6FQ
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MIV-V6U-1(         (RGOME?U+9[>M"U(<,H91S-+A)3M,W\,$X&7H@)-
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MN.EDWS+%?039$>.("H:*I*Z7"4EPW4FPW@LT[AJ+<3MW>YB [0
M==5CW:=,,UFV11W3-PDFLTEN*Q,DEM,!2N7KB': VM$M4U)OR,'U,FP9X.8&
M6X9$>P!78          VK/!*NYU58JZ<-G3AW0$<V>\ARO7(E,Y4HT.-DIDX
MYM$QB98$2S(N)B0"2
M                                           !\)7W-(_B'?L:@%@T
M_P"XJ]_;<7^?D)WEZ/47YTW^CH'\BB_8&Q"RYH
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MZS;WP+)UFWO@63K-O? LG6;>^!9.LV]\"R=9M[X%DZS;WP+)UFWO@63K-O?
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M9-#WYRHF]),B0F.;_&ZR<4F9$>YT]("1&OJ3>!XEPT;<,,>J6W#N8@/H
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M#%LF
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MG<>TSR/C_P +ZFR_];1?\NFCJ#M6_;8?S_I;?LSHNZX>VH=.QNRVH$@
M    CB<\97S36BJ*4D:5XP3BD9KZG24C#%.'[("1P           1W?KRVDT
MS<J"8.])3X48I'$P46*2Q(]S$CZ0$@,[66CQWL6F]O1CU2VX=S$!]
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M)'45UC2?3@8"EK!>6]0DJ7-*>?:)'JY,%'(^OL3PR(B+=+YH"N
M!M5X*MN'5/;TX;.G#NX (]M)U3E<N)"J@F63;C9$R48F3CGB>PW"(C=QQ 2(
M
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M)H.7U:ZO:1(]6+#$![,-%L2M0=+>2,:X#=556\O+6*2;V]Q#/Q)!W<=_K>"
MES-_]%&9G]P+Q_)ZHBN[]>%RZ]>'B+Y;?Z*<U/[^W;^4L@:-G7[[+Q'VU?SA
M7Y>-?P70,:ZIC<:@                        .+(^J0?[3IO\\:%5'[2G
MRK<_MKO_ *E/TP].N2?Z+[/_ +'A_P W:'8&'_8T^1]$-D_Y>PO_ $J?H2J+
MS8@                        !T=R+-NC35I?*,:6C/C&V3I(Z=IH/P@'!
MLMU3UO0W%RBF*4;N,A+),$O!9E]2(BW< %5
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M(G7,19/T-4R*YQ5Y7?YIBXY-[B+R9Y.J+='#:RR#66P@
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MQ-K<)2 &/07?Z        1S-2\5[TY1$WPS)>)F:.)X.!8%X6 "1@
M    1Y?J7C33.$ELR*2G>-:D%@6^G86\9;3(!7[/U%K'IX3>/TI /H
M    *9N_B>()I-$DUF2-TEFDD^&72:M@#Z6J3A4.$3I))9(/$DF1IZ>X:=@"
MH@           1RVE\KZ?49-FSPTX&1HXFUO;B6.]@6! )&           !'
MEWDZ=8M\FTMFGB+XAK-!&1&K9NDK:>'F )!1X"?WJ?VB ;@         !1E^
M$X=O/DT2%+XS&!+-))^J%W5; '?T<E'381J(B43*,<,#(SW"(\,-A .T
M      ' JA&=/E[N&]P'<,<,,=Q6P\=FT!3-A$X5!;XI()?'?\ TFG W#PVI
MV8X *U          &U?@+_>J_:,!'UHI?*N7$;I-[IN-FWN&@U88[=[=VEZ(
M"0P
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M7=^O"Y=>O#Q%\MO]%.:G]_;M_*60-&SK]]EXC[:OYPK\O&OX+H&-=4QN-0
M                      '%D?5(/]ITW^>-"JC]I3Y5N?VUW_U*?IAZ=<D_
MT7V?_8\/^;M#L##_ +&GR/HALG_+V%_Z5/T)5%YL0
M      Z*Y24=%F[A$:N$>&]AAZ..S !PK,2X5OPN*2"<(W<20:326*CZ#3U3
MQ(!50                          H2_N+XI0;1(4KM+!&E9I(L#7MP-7=
M 5E"Q[)%QPQX#6.'1CN)QP\P!R0                         !'=T<95Q
MVXII*%()3N^:C22B+O))6WI[P"0T^"7G%^T U
M   $=WPEY4FB\$FSP?/>WU(+9O)\'>/IP 2"U]2;QZ>&C'Z4@&\
M                 1S*XY7U!/!OA<->TS1Q/ PV%X7= 2,
M              "/:_QRNJ@&E"#:Q<WUJ-.\G'$RW2/K;0$@ET%YQ?M -0
M                       !1$-+I794#,D<,THP,C3O[$D>TL=[#8 K<
M                       =35WI+-)JS\))+FQZ;.>AI,R(E2FHSJV",SP(
MB4ZDND6;^V[N*[V[]>*)GSQ$V%U'+O:;N\W)JCZ7EXTMZN[3U_ZH]46BGF.Y
M>Y8$YE;6.#E<U<#]LH?J5.>D.M/)CU1^0<E+IQU'@E)D>./=$9-A\-G.14YS
M5$1F%W79.ODZ?TV*\[O\3D>T5.6W,53EU]=Z)U56>/>W653(WE_<L+3?=I7Q
ME78N25 N=IPW6JG+KUJ5%Z.Z:D+)3/;9"R94E;9&1E@9&0YMQ?WN'NO<7,V1
M/"X=Y@[F^F*KV)JLFW3N<#)E2*I1JO&9ET*I4RJTY2"1'DTB9%FP=Q"2(DM/
M0W'6#2DL"(B/80L3<U4US7><KESKM7Z;9MY,Q[N-Z';B50
M                                                /C(?;BL/27E$
MAF.TX^\LSP)#32#6XLS/9@E"3,!817^:#H8M>N5:VZ]J!LBFUJAR'(M4@R:I
M$:>BOM.+:<;<2N0DR4EQLR,!)&3VL327J,K#E-RMS4R\O:N0BWBB1ZE1GZB7
M@?<S;CZY#BL5EL01GM 7:$1%T=&!%LZ,"Z,.X1 -0 !Q9,*%-22)D2++01D9
M(DL-/I(RZ#)+J%D1E@ ^K;+;1)2TA#3:"P2VVA*$)(BP(DI21)(B\X!]0
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M<=XVR,^#AAT; $B@
M                                         #X2ON:1_$._8U +!I_W
M%7O[;B_S\A.\O1ZB_.F_T= _D47[ V(67-
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M1-W@[_F<3YT!P+);-JW8:#C=C,E.XQ^-Q^'BO'ZKB>]CT@*L
M              %!9@,J>I+:4T]-1PDL*-E4DHN&ZYCO;YF7@].'= 5G!(RA
MQ"-'#,H[)&C>W]SU-/5WOGL.^ Y0                          CFZFG%
MW);BTTPI9(4X?:3EDR<?:>)DR9EQ<0$BI\%/<ZI;/0 :@
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M+U5<LS>ZO"[I]T9?.,VHS2\HJHHBCDTQ'ELAP,'A:\/RN75RK97RC#.:
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M*75,F?7(\=])D988 *BHB232X220;9$PV1(-1K-)$DB(C4?2 [4
M =?52(Z=,)2#<(X[I;A*W35U#V$K9@ I3+UIMF@(0U&7%3VB09-+>4\HC-S:
M>^HS/:8"NP         !M7X"L=I;JL2] P$;6<TTW<%RFB(MA2W&]YU3ZG2=
MP/8:4&9DWZ "2P
M                                       !\)7W-(_B'?L:@%@T_P"X
MJ]_;<7^?D)WEZ/47YTW^CH'\BB_8&Q"RYH
M                                 (ZS?_11F9_<"\?R>J(KN_7A<NO7
MAXB^6W^BG-3^_MV_E+(&C9U^^R\1]M7\X5^7C7\%T#&NJ8W&H
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MR5-&\DVCQ;2LVS47>)1;2 <"R$);MR"EMA49!&]ZBIPW5)ZY]*U8F>)@*N
M                        $?9BLMO4=LG8JY:2DL'PT/J8/'B)V[R3(SP
M5O!(BA1").X79F,$8[VZ7#3@G>[N #E                          "-;
ML9;7<UM+<B+?4@W31(2^;1,F9GTMD9$O'S0$DI\%/<ZI;/0 :@
M               "-[]:9=DT/BPURC3),T*0^IGA'O(ZQDDRW]A= "16OJ3?
M<]31LQQPZI=WN@-X                          C.6TTJ_H"SA+-U*'#*
M7VA1(26YM2;..Z>)%W@$F                            C>XF6EW?;CB
MHBW5I-W=?3(4A+/?WFB,B7C^P D<N@O.(!J
M'YAX>: H."VV5WU)?9E)<W4$<@W3-+FS#$FL<$X *\
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M537%EDK\A@W-
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MZC%Q*#69=8L,$EM/$!];24E5 @&AQ3J=P\%J0:#5M[J5;2 5(
M",FG&?S@OH*0YQ>"G>8X2MPNH6!\3#=Z $F@           C6]%M)K=N<1];
M1FXLDI2TI9+,U88*418)+SP$D(\!'[U/[1 -P          H?,)2$6W(4X^N
M.@GF"-Q#9N*+%PL.JG:8"HJ&:3I4(TJ-:38;P4:329EN)P,TGM(S(!VP
M      ZZKX>+9F*C279W<5$1F:>HK:1%M,R 4MEZMM=OMFT\I])OR.NMM39F
M?$/$MU6TB(P%=          #:OP%_O5?M& CBSELJK]RI;?6ZM*V]]"FE(2W
MUBV)4>Q7H ))
M                                      'PE?<TC^(=^QJ 6#3_ +BK
MW]MQ?Y^0G>7H]1?G3?Z.@?R*+]@;$++F@
M                                CK-_]%&9G]P+Q_)ZHBN[]>%RZ]>'
MB+Y;?Z*<U/[^W;^4L@:-G7[[+Q'VU?SA7Y>-?P70,:ZIC<:@
M            .+(^J0?[3IO\\:%5'[2GRK<_MKO_ *E/TP].N2?Z+[/_ +'A
M_P W:'8&'_8T^1]$-D_Y>PO_ $J?H2J+S8GAQ\K)I^H7-6^=,>5V5.4UR7Y2
M(]55+5)I%-J<Z&Q5537NPN2E0XLAELD/[BC-9=! +&,Q+N\HTY?.2]@ZDZ]<
M,V/DO9U-HSTBPVXRGV:/;I18RSB38K?"0@I%*BFGKDGI >QGD_<R"A<RW2=:
M><B(K5*O:(PW3+WHS2D*[)5H[#"'W3W'W]SM#ZE'AB6& #*X
M         Z"YU(31)RG%FV@FCQ6E)K,O.26TS <&R%-KMR$IMQ3J3-WU1230
M9F2S+P3(C+ !5H                          C_,1;2*,@W7EL%VICKH;
M4X>UPMFZG;M,@%;03(X<4R/$CCLF1GLQ+AIVX>: Y0
M        C6[%LIN>V4N2%MJ6MSAMI:4M*S(_GE%L3Z("2$^"G]Z7[0#<
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MEW5--=.JR='"O5&&98
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M@           (U;D*]_S[!U/%)-IP@=D\'U,MO:=WK8^?L 24
M".+RD&U6;=1XS["E;J]YCLG:.U=8L$\3=,VL# 2*CP$;<>HG;T8["V^B W
M        "BK^>-BWWEE-\7X/,XR.S]IPZW@\+ \=[H 5#15$NF0U$YQB-AL^
M)N;F_P!0NMN?.X]X!V@          Z^JGNT^6>_P\([I\3=W]S!M76W>[@ I
M?+]XWZ VX<_QAC(D>K]F[+B1.&6'#P+#=Z/- 5P          -J]B%;<.JK;
MACAL/;AW< $=6>^;M=N-!U/MO#<01,=DX'92,RZO$P+BXX )'
M
M               'PE?<TC^(=^QJ 6#3_N*O?VW%_GY"=Y>CU%^=-_HZ!_(H
MOV!L0LN:
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M7AX'X71CW %:0E;T.*K?XF,=D]_=W-_U-/6W?G<>\ Y0
M          CB[)!M7);37C+LG$4Y]K=DXW:<#/\ SV!\'= 2,GP4]WJEM] !
MJ                          (XOMXFY-#3XQ[ :Y"NKV7M''(E)/=QP/A
M^> D1H\6FSQWL6T'O888]4MN'<Q ;P                         !&LF0
MOW^PF?&9)0;2_P#1_9,>(:6_"[3NGNX>> DH
M   $<7%(-N[;<;*I$P2S=QA]DXO:,.G%_ ^%NE\T!(Q=!><0#4
M               ,L=A@*$@.F=W5-KM_$))(^T^S;O"ZN'U?#KX^> KL
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M?9GB(Y-]B*YJL\5ML<-K*D-:9T
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M(8
M                            ^$K[FD?Q#OV-0"P:?]Q5[^VXO\_(3O+T
M>HOSIO\ 1T#^11?L#8A9<T
M                     $=9O_HHS,_N!>/Y/5$5W?KPN77KP\1?+;_13FI_
M?V[?RED#1LZ_?9>(^VK^<*_+QK^"Z!C75,;C4
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M:::%DVHF]BC22B+SR/8 X-EFM5OPE.K2XLN)BM"20D^MW$IP+H 56
M                   *%OY;R*2@V7FV5'(9+><;2M.'$+$L%;-I *RAF9Q(
MQF9&9QV3,R(B+$VTGL(MA$ Y                           CNZ5O)N*W
MB0^VV@S<WT*;2M;FWYU1[4X$7< 2&GP4]WJEM] !J
M       ([OA3J9%%X;R&L9."B6VE>^6\6)$:N@!(+7U-O]XCS/G2[G< ;P
M                       !',I;WOZ@I)Y!-<-9*:X:36KJ;,%X;Q;0$C
M                          CNX''BNNWR0^A",7=]HT)-:\3PZJC+$L"
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MRB?52T..N@
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MO)I;E7MY2(*96XZLU.JD$R;"3/I)!F7$QP 2&CP$?O4^;W"[O= ;@
M  !1M]M+=MY]*(J9B^,P9,J>)@E=?$\5J,B+# !W]')14V&2FR:43#9&V2B6
M2.J75)1=.'0 [,          =?52,Z=,(FR=,X[I$@U;A*ZBMAJV88D IJPF
MELT)M#D5,0R?D>I(>2^E.+AGCOI,R/>+;Y@"M0         !M5X*MF/5/9T8
M[.C'N8@(]M)EUNO7&M4)$9#BVS0ZE]+IO;>Z@C,V\"[X"1
M
M            !\)7W-(_B'?L:@%@T_[BKW]MQ?Y^0G>7H]1?G3?Z.@?R*+]@
M;$++F@
M     CK-_P#11F9_<"\?R>J(KN_7A<NO7AXB^6W^BG-3^_MV_E+(&C9U^^R\
M1]M7\X5^7C7\%T#&NJ8W&H                        #BR/JD'^TZ;_/&
MA51^TI\JW/[:[_ZE/TP].N2?Z+[/_L>'_-VAV!A_V-/D?1#9/^7L+_TJ?H2J
M+S8@                        !T5RI-5%FDEDGS-O8T;A-DKS-\S(B <"
MRD*1;T)*HY1#(W=YA+A/$GK=/$(S(\>D!5@
M H+,!IQVDH)N$F:KM#/J2GR8(BXA=;>,R+J@*TAD91(I&G</L[.*,=[=/AIQ
M3O=W !R0                         !'=TLN+N.W7$042$I4YO/J?2T<?
M;TDV9XN8X=X!(:?!3W.J6ST &H                          CJ^6G7)-
M$-J$B7NR3-2E/I9X18EBHB49;^SO )":V-MD98&2$;.G#JELQ[H#>
M                   (YE,NG?,)WL*%-DVK[;[0DE(Q1_ 8DHP$C
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M&N*+J*J[N;8F5WXQ3D@
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MC<33U1%+6C>>.2IXI'6Z2;,S)K# !(X
M                                                         ^$K
M[FD?Q#OV-0"P:?\ <5>_MN+_ #\A.\O1ZB_.F_T= _D47[ V(67-
M                                                   !'6;_ .BC
M,S^X%X_D]417=^O"Y=>O#Q%\MO\ 13FI_?V[?RED#1LZ_?9>(^VK^<*_+QK^
M"Z!C75,;C4                        !Q9'U2#_:=-_GC0JH_:4^5;G]M
M=_\ 4I^F'IUR3_1?9_\ 8\/^;M#L##_L:?(^B&R?\O87_I4_0E47FQ
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MIHDXDI,DX_!,U)ZV&)<3HZ $BM;&FRPW?4T=7''#JELQ[N #Z
M               "-)4<E7_!?\7J4I+3F$WM9D2"W.CL^.!X^< DL
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M1>X6_P 5E==7O+NXOJN37KB9G1YF9P:HV0
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MCDRGZ/A^"7_-QP 2:           "-;UX/CJW.)Q-[B.</<W\,<=N]N[,//
M20CP$8=&XG#YA -P          HC,'A>]U\WC6E''CXFC>WB]4+Z': J&A[O
MBJ#N8FG@(VJQQPW2PQQV[2 =L          .NJ^Z5-F;V.[V=W'#$S\!71AM
MQ 4KEXID[>:)DE[A2).US>WOJG>5M 5V          -J_ 5^]5^T8"-[-4R=
M?N3<-S?-;>^2R422VEX.]L^8 DH
M                                                     ?"5]S2/
MXAW[&H!8-/\ N*O?VW%_GY"=Y>CU%^=-_HZ!_(HOV!L0LN:
M                                              ".LW_T49F?W O'
M\GJB*[OUX7+KUX>(OEM_HIS4_O[=OY2R!HV=?OLO$?;5_.%?EXU_!= QKJF-
MQJ                         XLCZI!_M.F_SQH54?M*?*MS^VN_\ J4_3
M#TZY)_HOL_\ L>'_ #=H=@8?]C3Y'T0V3_E["_\ 2I^A*HO-B
M              '070:"HDWB;V[P]N[CO=_9AMQ <"Q^'[W(7"-1HQ=W=_>)
M7A]W>V@*N                          $?9B\#Q.CCFYN]H8^I[^]]4+
M^IMP(P%;P<.Q1,,3+LS&&/3APT]/F@.4                          (V
MNQ3";FMLG"<WS-W<-&^:3/;X6[L+T0$D)\%.'1NEA\P!J
M           (WOPV2DT/B\3$Y6"=S?\ HB\+=[@"16OJ3>'1PT8?2D W@
M                      ",Y),%?\+$W">X3AEX?#,C3T'AU<<0$F
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MLXN]BRV(B(U1&BQQLJRZC+,)&'B>57;,U53NS,[LK@AC&2
M                                            !I@6&&!8=[#9\P!K
MAAL+80    #3 B+ B(B[W< "(BV$1$7F; &H"S/7QHZM;7CIFOC35>56?HE
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MKPQ+H,!6H      C6;(;3?E-:.I&VM2%D4'LIJ)WJGM[1NX(PV]T!)0
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MW@$D
M                              #X2ON:1_$._8U +!I_W%7O[;B_S\A.
M\O1ZB_.F_P!'0/Y%%^P-B%ES0
M                        1UF_^BC,S^X%X_D]417=^O"Y=>O#Q%\MO]%&
M:OF7[=OY2R!H^=?OLO$7;5,1MC7'CXU_!&6 QCJF)BPQ("V#$@+8,2 M@Q("
MV#$@+8,2 M@Q("V#$@+8,2 M@Q("V#$@+8,2 M@Q("V#$@+8,2 M@Q("V#$@
M+8,2 M@Q("V'&D?5(/\ :=-_GC0JH_:4^5;F8]]=?]2GZ8>G7)/]%]G_ -CP
M_P";M#L##_L:?(^B.R?\O87_ *5/T)5%YL0
MZ*Y5$BB3E*D=E(F3]7X?%W/-X>![P#@60LG+<A+3+.:1F[A)-DV#7US_ ,T9
M%NX *L                          % 9ANI:HZ%JGG3R*0P7&*,<G'%PN
MKN$1^%T8]P!6L%6]#B*)?$QCLGQ-W=W_ %-/6W>YB Y0
M          CBZWTM7);C9U$XO$6Y]K%%-XI&!]!NX&3?0 D9/@I[O5+;Z #4
M                          1O?;R69-#WJB<'?DF1)*,<CC=9/5Q(CX?G
M@)$:VM-GCO>IHZV&&/5+;AW,0'T                          $9RGB]_
MT%HZDI)\->$'LIF2^K]\;N"<-O= 28                           ".+
MA=0F[[=0=14PI?%(HA13<*1AC_GL#)O=Q]$!(Y=!=WS0
M           4'3WB.[ZFUVTUJ22?M3@&1-XD9_5\,%@*\
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M[=%D0O>&(<D
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M^IN4F&?&8(WE,I?(L5D6&XHCQQQ =_13WJ7#/B<7U!OU0D[A*ZI;=WN .T
M        '7U4S33Y9DHD&3#IDLT[Q)ZBNL:>[@ IBP''': TIR6F8HWW_5DL
MDP2O5#V;A$1%NEL\T!6X          VK+JJ/H,DJP/IPV=.'= 1Y:+CBJ]<:
M5S4R4H6WNM$PEHV<3+$C61$;F("10
M                                                      !\)7W-
M(_B'?L:@%@T_[BKW]MQ?Y^0G>7H]1?G3?Z.@?R*+]@;$++F@
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ME)4P3W%+>3U2,R/<_; 2&UM;;,SQ,T(V]&/5+;AW &\
M         1O*=<*^X+934I0;:\8IL)-2^ICL>PWB(L0$D
M             CJX'GBNZWFTS$,H5QL8YL)6;^&.&#N&+> "12Z"[OF@
M                       H6"ZXJ[JD@YB5(2E.$8F")2//=PQ4 KH
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M>#3J/ BTZ$UCACPXL-IEE&.'<207U]>W]7+O:IJJB-^5VFBFC13%CO1:5
M
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MTN+-*=U"U$A*NL72I6P@'TM4EIH4$EMI:5PSQ0E1+(MN&Q2=FW !40
M     (Y:;?*^WUFPV3)LIP>XJ.(>"?X/PBZ0$C            CR\$.JJ]OF
MVPVZDG'-]:W$H-'63A@E1XJ 2"CP$?O4_M$ W          "C+\2XJWWTM,I
M?4;S'J:UDVDRW]I[RMFP!W]%)2:9#)220K@HQ21DHBZI=!EL,!V@
M  Z^JDI5.F$E.^KL[N"3,B(SW%8$9GLZ0%,6 3I4)!.LH8/M#_40M+B?#V'O
M),R 5N          -JO!5^]/]H!'UI-O)KEPK<9;:2I;6ZI#B5FYMP/>2G:G
M##N@)#
M                                'PE?<TC^(=^QJ 6#3_N*O?VW%_GY
M"=Y>CU%^=-_HZ!_(HOV!L0LN:
M                        ",LZ3,LH<T#+8?YOKQ_)ZH@,*'D_-,I<K2-7
M5R:; D.N9C7N3KC\2.\MTO?!(P2M3C:E*(N\9F(Y-$VZ-,K%YA<)?5S>7MW1
M5>3NS-,3;PPSQ^]VW_ZBH_N9"]9%/NKOFQP+?Y# ]#=>Q3Q'O=M_^HJ/[F0O
M60]U=\V. _(8'H;KV*>(][MO_P!14?W,A>LA[J[YL<!^0P/0W7L4\1[W;?\
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MX)4HDD?GF>P!P;+):;?A$ZVEE9F[BVA9+276V8*3B70 JL
M            4)?R'5TE!-,H?,I#.*%N);(R-PL3Q5W2 5C"Q['%Q+=/L[.*
M2/' ^&G$L>[M <H                          1[="73N*WE(8;<;(W.(
MM3J4*1MV&E)GBK8?< 2"GP4]SJEL] !J                          ([
MOA+RI%&-IAMXBD'O&MQ#>YBI.!D2O" 2"UL;;(RP,D(V=.'5+9CW0&\
M                     1S);>.^8:R8;-HFUXNFZC?+J%A@CPC 2,
M                     ".Z^AX[LM]2&&U-I-TUNJ=2E:>]NH/:K'$!(A=!
M8]/=                          &AG@6("AH*7#NRH+X*$H-*<'2<2:E;
M.Z@MO< 5T                         VJ,R2HRZ229EZ!&8HKF8IJLW8C
M]":8MJB/&\8&6M M#-GRE'.>3F\Q1K@C9<0F7[)C74_"72Z6XF$MS&+#JYNQ
M''#6G8E"249["'+V!P%S1LUFN<5S'S&J\C[6_$35ILWX9S;S"47-&37%,?\
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MS,1535ZLQ+E"4@
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M %9@^!VCLV."R/'B8ET88@*@HJ-RF0T\/@X,-X-;V_N=1/5WOGL.^ [0
M      <"J%C3YA<+C8QW2X6]N;^+:NKO;-W'O@*7L!DV: T@X'BXR?D?:_:>
MT[I&X9X\3$_"QQP[@"MP         !M7M0K9CU5;,<,=A[,>YB CNT(W!KUQ
MN>+>Q\5;1]H[7Q^TX&6WA8GPL,0$C
M                                                       #X2ON
M:1_$._8U +!I_P!Q5[^VXO\ /R$[R]'J+\Z;_1T#^11?L#8A9<T
M                                                  $99T_H@S1_
MV?7C^3U1 87/)\O]T6M?[1KW_*"0 SX                          "E+
MU;XMNSD=E[;CPOM;C]GXG7+9QL2W<.D!SK:02*+!24?LN#1$;/$XNX?>XF)[
MP#O0                         !T5R-\2BSD=G[5BT?J'%X._YG$Q+= <
M&RFN!;T-OLG8=TW?M;C]HX?7/_.XGO8@*K
M% Y@L'(I"$>+O&/VPP?![3V7#!PL%[^)8[I[< %:PBW8<5.YP\(S);F]O;F#
M:>KO?/8=\!R0                         !'5U1R=N.W'#IO:N&MS"4<K
M@]FQ,O\ ,XEQL3Q 2(GP4]SJEL] !J                          (XON
M.;TJAJ*F>,#;D*/>[7V;@;4]?=Q+B^< D-KZDWLW?4T;.]U2V>@ ^@
M                    C>5')5]P7BIF]NMK^W^U[NX9HPP[-O=?>\X!)
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M?43AJ(HB*(BSR0X&"PMYAJJ^75RJ:IT,A0P;(
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MP[@"20
M                               !\)7W-(_B'?L:@%@T_P"XJ]_;<7^?
MD)WEZ/47YTW^CH'\BB_8&Q"RYH
M                         (RSI_1!FC_L^O'\GJB PN>3Y?[HM:_VC7O^
M4$@!GP                          %)7PEI=MSDO-J=0?#Q;0LT*4>^1D
M1*3M+: YMK)0FAP"0A3:>%L0I1J47GF>TS,!4
M    Z&YB0=$G$M"EIX1XI2HTJ,L#Z#+: Z^QDH3;D(FT+;1B[@A:S6HNOMQ4
MK:>("K@                         !0&8:&ET=LG65OEVI@]Q#BFSV.%M
MWD[<",!6L' H40B(R+L[.!'TD7#3@1^:0#E
M "-;M;87<MM*<8<<<2MSAN)<4A+9F?2I);%>B DA/@I_>E^T W
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M:$18X]WSPBV=,[J;=%F\U$H
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M6X2D         1E.=;*_J6V<U:5FAS=BDPHTKP1TF]ANIP_XP$F@
M   C;,%YIGQ3Q9BXA*E)(C3'4_OF:B(B/ CW=H"16?J+6W'U)O;AACU2VX=S
M$!]          !2UYK0BW9ZG'E1T$E&+R6S=-'6+:2"Q,\0'TM%:7*! 6AXW
MTF@S)U39M&KK'TH,B,@%2@           C)IUK\X#[?;5FX323.)V<]U.*"+
M'CX;IX@)-           !&UZ.,MUFW"<F+C*4ZX2&TL&Z3VTMAK(C)O#S0$C
MH\!'=ZB=OH$ W          "B<P'$-6X^I<E40N/'P=2R;YX\0NKN$1GM,!4
M-$,CI4(TK-PC8;,EFG<-1&DCQ-)D6&(#M0         !U]5P\73#-9MD4=T]
M\D[QIZAXF2<#Q,B 4KEZZEVWVU)E*EIX\C!Q3)L'L<,C(T&1&6& "N@
M    !M7X"L=A;JL3] P$;V<ZRY7[E)$M<A:'&MYI3"FDL8GL(EF1$YCCW $E
M
M                          #X2ON:1_$._8U +!I_W%7O[;B_S\A.\O1Z
MB_.F_P!'0/Y%%^P-B%ES0
M                  !2]Z7'[TK6KMQE#=J*J/3)L]N P1F[-=BQG7VHR-TE
M&2GEMDDMG= ><;-GG0ZC7+6S5H<70%>TBDLT:ZZ''K+M8D\&3$<A5& NH*8*
M(E?")@^+@1EL[H"8_)U9SE:T/,W%(CG3IE<O2[*A*I"SQ<ICTJJJDN15F?6,
MV5O&C;]" S_                          "D[V6E%MSU+?5&21-^K);-T
MTGQ"PZA8F>)@.;;"MZB05$Z;Y&T6#IH-LU>;N&1&6(#OP
M          !3]T&2:'/-3IL$31F;I-FX:<-N.X6)F X%C+2NVX"D/*D),WO5
ME-FT9]<^ELR(R 5>                          (_S#=0U2&U.2UQ$G)9
M+B(84^>)N)P+=21GM 5M!P.'$,E;Y''9/?,MW>Q;3UMWN8]X!R@
M                !&MVNMIN6VFU35L*6ITB83'4X3NWNN$1DCN ))3X*>[U
M2V^@ U                          $:7ZXVW*H6_-7%-4DR2E+"GN+UBQ
M(S(CW-@"1VOJ3>!XEPT;<,,>J6W#N8@/H                          (
MSE.M%?T)OMJR=-M?VH3"C2HB1T\;#=+ @$F
M   C6XGFT7A;C:IBVE+-[<CE'4M+W?Q=(L$8 ))+H+SB :@
M            "@X#K9WA4VRE*6X1)WF#9,DM[.@G<,%8D KP
M
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M&X1%Q=XP$B
M                                    #X2ON:1_$._8U +!I_W%7O[;
MB_S\A.\O1ZB_.F_T= _D47[ V(67-
M                           &Q;;;J30XA#B#(R-"TDM)D>PR-*B,C(R
M1/F_2J/"RHS,E,46C$\S85X/-FNF0UI)U-OU%25*2;."L%;=O2 PU>3Y];21
M75X$1KS'OA1I21)01G<$G8A"<$H3WB+H 9\
M !2EZN&U;LU:910E%PL)!LD_PS-9?YHR,E8] #G6VX;E%@K-\I)FT7JQ-\+?
M\W<[@#O0                         !T-RN*:HLY:7RC&31X/&WQ=S_E;
MFW>P <&R7%/6["<7**8LS=^V$M< E]<R^I$1$G !5@
M        H2_GEL4E"D3RIYG(82;QQBE;%+PW>&9'X71CW %90L>QQ3-?$,X[
M)FO#=WS-M)[V[W,<0')                          $=74^;=R6XWXP**
M2S=^UCC$[VG:>)$[NF;6 "1$^"GN]4MOH -0
M !'-]/J9D43=J"8.]),C2<8I'&ZR.KB9'P^GI 2&UM;;/'>ZB.MAACU2VX=S
M$!O                          $;R'S*^X;7C$DD;2_M$XI&:^KTE(PQ+
M=P[X"2                            1W<,A2+LMYHJB3&_Q<89Q2=.01
M=)<8TGPMW'T0$AET%YQ -0                         !0T)Q7OMJ#?;D
MK224X1.SDDVL2QPXV&*\0%<@
M
M   _/JYAU@9<9T>4LY6Y4YJTE%QV972IZ*K09#:3CS$)8(DDLUMNM]#BNE)]
M(#UU6+RC^7W85VV[F)9^GBT:-==O]GE4:KQHK"),5U)-.-ND:&$^J$IM)XEA
MM 8&?*\7X=+TR:?D+,VF&LSK=9:2E!JW4-U>*A"<"[A)2 @WR@ZDUNI<EC1M
M<-(I4VJ4BWZ?E].K4F'%?D=ABH9I[RG7D,MKW$):09XJ,BV .EUW<R?275N0
M-:V4MHWZU<^9-RV-:M&BVI!C&],@U&GPG8\XIR67W%14,*6DB-9%CB>);-H7
MF\K&A:9KI\GCM.B:SG6V-/50BUGWRS7H[L@Z<E\F7(TE+#3$ASBQ'5&HNH?1
MW,0&..HTBS]'.GZZ<^>6]S58$O*2TWIM5MC(FJ6O'EOR"8=>F*I#<2?)2Z1K
M[*TR6".Z S*\OCF#YO\ ,8Y2&>>;F=]E/VC=E!LF]J2[4ET]RFQ[E1!HTJ.F
MI18BB)"6Y!H-PC1L,ED Q^>2.OTV;D3K0?:CQG7V[]N+?E.Q&CDF1/U0C0;Z
MT&\II1=*<<# 1ER%:TA?.JYB%-B*2TT]4Y92H[4<F&C-#[N[@222CYA .)R_
MI\9?E-VJ>&VL^*VU5#4C<,B+[6D8X*Z#Z '2:;)-+D>56YYQI4:/+E-/2&F.
MU16Y"6.(AQ*S9-Y"B0LB5B2DX&1@._YU%2IM-Y\/+]6IEB-**LMD3[,5"''$
MG*;3ZJZVE*E[/HC,!3O.1JT?3)SYM'&JS.>F3OS"SH-&:1<DBFR*G0Z4X<..
MPI;QN-=@CFEQ!GM61EACWP%1^4Y:]-*FH331D]E9DS<E,S O*MWA;%0BU.E4
MUIQF@T\Y<5QK?JS'$;C+=(]TVR5NI/HQ >KCEC(-O0UIY;/::+ H:#\]-.BD
M?[) +JLYMF469_\ L_O#\GZ@*+SU)54S9+\:>]?TQYQ_W\NK\HJF/279S$]5
MZ//^AUOM!-N8NM&Y,:!8 6 %@!8 6 %@!8-%_4G_ .(>^QJ%,S'I-Y[3?(]_
M_"VIO^-HO^731U#VK?ML/.]I_2V[9C]C6]M!#IR-V6U-14         ".IG&
M]_%.PX?"W%[V.YQ,=T]W#Y[#' !(H           ([OWCDFF<'AX]I21DYN]
M&^D]F]W0$@,_46L>GAHQ^E(!]          !3%X&M-OSC;W=_!&&^233X1=.
M]LV@/K:AN'0H)N;N_N'CNX;O3W,-F "H@           1RT;YWW(VM\'AHV$
M2.)B3?=/PL# 2,           ".KQX_CBW^$;9)XB^)ODG$R(]FZ:MO= 2&C
MP$8].XG'YA -P          HV_#=*WW^#N<3C,$7$W=WPRQQWMG0 J"D8^+8
M>]T\!O'###P2Z,-@#L@         !P*GCV"5A@9\!S#'##P%=..P!35AD]XB
M;-XT&HWW]C9)))$2SP\'9C@ K0          :*\%6'3NGA\P!'MI&]X\N$GC
M;/U1&X2"3CAO;=XT[<?/ 2&
M                                                 /A*^YI'\0[]
MC4 L&G_<5>_MN+_/R$[R]'J+\Z;_ $= _D47[ V(67-
M                                          !&6=/Z(,T?]GUX_D]4
M0&%SR?+_ '1:U_M&O?\ *"0 SX                          "E;TXOO>
MFFR:2<(VL#61&GPR(\25LZ# <RV36=%@[^[O<(L=W#=Q\S#9@ [X
M                  =%<N_XEG</=W^$>&]AN^CO;, '"LLW#MZ&;II->+N]
MN8;OAGAAN[.@!50                          H/, WBI"#9-"5=I8Q->
MZ98;Y8^%LQP 5G"Q['%QZ>SLF>'FMI/N; ')
M  $>71QO?%;I-\/=-3F_O$DU88EX.]M 2$GP2\XOV@&H
M          CN^#>*11>$;9%V@]XED@]F\G:G>VX@)!:^I-X]/#1C]*0#>
M                       (YE'(]_4$L6^#PW,2,D<3P,2P/PL,0$C
M                       CNO\ ']]=O[G#X>+N_O;N_P!.S<QV]("0RZ"\
MXOV@&H                          H6$;WONJ)&:#;P1NX;N^6S:1X=;N
M@*Z
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MYE@,PO+F<'>4UU1;;$;VZV?(L)>86J\MF9NYW+8L]#V&$.JZ8B(T-C:BH
M      $<3F%'?5,>334N)2EPE3CEDDVL4=R/O8KQ,N\ D<           $<W
M^TIQ-+)-/3.PDIZ9)1^%UTF:BQ,M[#O )"9V,M%AN^IHZN..'5+9CW< 'T
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M8-FO<)1[IX%O=S$!2U@,K9H*$N0DP5<=_%A,@I))ZY[>(1F76+: K@
M    ;5[4*V8]56S'#'8>S'N8@(\M%A35=N)9T],7B+;/CE))XY'6+$S;Q,VL
M $B@
M                             #X2ON:1_$._8U +!I_W%7O[;B_S\A.\
MO1ZB_.F_T= _D47[ V(67-
M                     !&6=/Z(,T?]GUX_D]40&%WR?)*BTB5E1I423S&O
M?!1I,DG_ *?D]"C+ P&>\                          4K>C:G;>FH1&*
M8:N']KF]P"<ZY;.*9D2< '-MMLVJ+"0;!1C)HL62<XI(\S?^> =Z
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M#,U'))C@EO)ZV!F7$\X!(;6QMLL-WJ(ZN..'5+9CW< &\
M           1M)84=^0G?%Q*23:S.=VHB-![F!)[/CBK'S@$D@
M                 CJX8[CEV6\LJ>F0A)NXRCE$V<?$SZ&<2-S>(!(A=!><
M0#4                          4)!:/WW5%WL24)42<)?'WC</#^!QQ1@
M KL
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M1@)ZY7>M:J:^M)MC:BJO:J;.EW:3ZU40GN/V9*$L+1U^*]CB3_T1] #(J
M   (SG,M'?M,=5!6M9)<W992%)2WU#V&QC@O''T $F            C?,!EI
MTJ5Q(*YN[)2:23(-CAF2TX*/ RWL,>@!(;.QEHL-WU)OJXXX=0MF/=P ?4
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MND:"4:#5BA6S>+:G$!2V7K:&J VA$-4(N/(/@J?-\RQ<QQWS,S/$!70
M     VK+%"B[Z5%\TC 1S9[+35P7*I$-<9;CC6\ZI]3I/8'TD@S,F\ $D
M
M                       #X2ON:1_$._8U +!I_P!Q5[^VXO\ /R$[R]'J
M+\Z;_1T#^11?L#8A9<T
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MJ)_SA&1IP <ZV$DBB04I9-@B:+!HW#=-)=XUF9F8#OP
M        !T%SI)=#G)-HWR-H\6B<-LUEWM\C(RQ <"R&R:MR"A+"HJ4F[Z@I
MSC&GKG_G#,S/'I 5<                          * S":;>HZ$N0U32[2
MQZDE\V#V.%UMXC(^KT@*U@D10XA$G<(HS);F.]NX-I+=WN[@ Y0
M                 C6[&&W+FMMQ<%<E2%.;KZ9"FB8QZ3-LCP<Q 22GP4]S
MJEL] !J                          (VOUEMV50C7!5+-$DS0M,@V.">\
MG%1D1EO["Z $BM?4F\"P+AHV8XX=4MF/=P ?0
M   1E);:._X3G85&X3;A=L*0HDI(T=!LXX*Q 2:
M      "-KB90N[[=<."I]:#=W))2#;2QM[K6)$O> 20707G%^T U
M                  %!06D%>%2<*(M"S))'(-\S2YU3V\+'!. "O0
M
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M21-XK0DUJ+KET$G: ^EH<,Z!!-M:G$&@S):DJ2I6WI,E;<0%3
M C%E37YP9*2D.<3A(Q8-M1(+U/I)?@GB0"3@           1K>BVDUNW-]UQ
MM9N+)M*&U*2L][;O*+86&'= 20CP$=WJ)V^@0#<          *(S!6TBW'S=
M=6T@WXY;[:#6K'B%@1)3MZ0%143=\50MPS-)QVC(S(R,\4)/$R/H/ !VH
M       ZZK&14V89F9%V=W$R(S,BW%;2(MNP!2F7AM'0&U-/+>2;\CKN(4A7
MU0\2,E;=@"O          !M7X"L=A;JL3] P$<6<IE5?N;A/..*)QO?0MM24
MH/>QP2:O"Z>X DD
M                                         ?"5]S2/XAW[&H!8-/\
MN*O?VW%_GY"=Y>CU%^=-_HZ!_(HOV!L0LN:
M                                  "A,T?T9YB_W%N[_L"H"B]BV[JB
M=1&Z_&ES+(OS^9X["_\ 'ES])$?_ ,HZF/179O;3L[3=Q/V(^IU[GT\K&S3/
MJQ*G\"^A3]*G]P;TQ%D&!?0I^E3^X!9#4B+$MB>DOG4]_P X4S'C2SB^37D7
MQIMN["^X:IT$1?\ 1(7>&F]H-L[-51.Y#-[/?OC].[NGZ \WVSR[-YOK45@
M                 *1ODT%;4\W%J;27!Q6A)J4GU5);"3M[H#G6N:#H<#<4
M:T\(L%*(TJ/SR/:1@*@                          %/W0:"H<_?4:$\(
M\5)(U*+SB+:9@.!8JFU6W"-IQ;J,7<%K2:%*Z^W%*MI8= "KP
M              !'^8BV449!O.N,EVJ.1+;0I:L3<+ L$D9[< %;0<#A1#(S
M,NSLX&?29<-.!GYI@.4                          (UNU;)7-;27'W&U
MJ6YN-H0I25X'CUE%L3T=T!)"?!3^]+]H!N
M$:7\ME,JA<5YUHSD*)&XA:R4>\G8K=(\ $CM?4FOXM'^20#Z
M              ",I*V#S @H-YSBDTX9-$VOAG@@S/%?@D98@)-
M                  !&MQJ9*[[<);SB'#-[<0E"S0OO[RB+=+ !))=!><7[
M0#4                          4! -KWY5(B=<-PDI(VC0HD)V=)*/JGC
M@ K\
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ML$CRS^5H8_%L5TL3(BKE,V$9D7U5XNCH[@"Z?R;;_P KC)'^32/YO3P&?,
M    1M-?0F^Z:SXS-)K0X?B_LN]Q,$=/:<.KN]/2 DD           $<W_)3
M'*E8U(Z>:Y2"+[4[3Q<5$6[T&:,>^ D%GZBUMWO4F]O?ZA;?1 ?4
M  4Q>+A-6_.<.5V(DI1]L\'M'#ZQ;>$1'OX@/I::R<H,%12>V$:#PD<'@<3;
MT\/ MT!48           (T;DI._WV#J9FHF4&4#LAD2<4%M.3AUMA=\!)8
M         (XO)\VJS;J?&78=]USU+LO:.U$1EU=_=/A88^B D5'@(VX]1.WH
MQV%M]$!N          %%7\[P+>><[;V R?8PD=G[5ABX18<+ \<0%0491KIL
M%?$XV+"#XN[N;V+9;=SN;W[ #M0         !U]55NTZ8KB<+!AT^)N[^YU%
M;=WN@*6R^?)^@(64_P 8EVB012.S=FQP7T</ L-WH\T!7(          VK/!
M"SZ,$J/'O;# 1U:#Y.UZXT%4>V&VMK&/V7@=EQ,]G$P+B[P"1P
M
M               !\)7W-(_B'?L:@%@T_P"XJ]_;<7^?D)WEZ/47YTW^CH'\
MBB_8&Q"RYH
M         *$S1_1EF+_<6[OR?J HO/V<^0C=?C39E?I\SQ_OY<_Y1U(>BNSG
M_0:?#4Z\SS]_J\JGAO+% #4NDO/+]L!G&\FO_P#--MW^0U3^:0AIG:#_ "W5
MYF:V>_?'Z=O=^9_QCS?;]NQOS45@                  *4O5TF;<G.'+["
M1</&3P>T<,M\O\U@>_CT .=;2R718*RD=J)31'Q^'PM_S>'@6Z [T
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MDF1)[+VCC[4GN8[I\/HZ0$B-'BTV>.]BV@][##'JEMP[F(#>
M              (XDR$IOR$QXSW34TL^P=DQW^IT]IW>KN][$!(X
M                   (YN)\D7;;C)U/L^^;N$3LG%[1YG'W3)K##T0$BET%
MYQ -0                         _,+'S %!P7]Z[ZBT<[?-*4_:?9]WA;
M/X?#U3$!7@
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M9)1@XI!+)/6+YU6P\0'UM12UT*"I;B75;AD;B4$@E8'W$EL(!40
M  (W:<>._'T=I;-HFBPC\)&^7J9'CQ,-[I 20           ".KR4ZFKV\33
MZ&MYUPE(4VE:G"(RV$HRQ3Z "0T> C]ZG]H@&X          49?BW$4!TVGT
MQU\=C!U;9.)+KE\XK88"H*.9JIL-1K)9FPV9J))))74+:1%L+$]H#LP
M    !U]4-2:?+-*B0? <P49$HD]0]ID>PP%-V&;AT%OBOHD+[0_BXAM+2<-\
M]FZG9B0"M          !M6>"%GWDJ/YA& CRTG7G*]<1+?0ZVEQO=0EI+:F\
M3Z%&6U0"10
M                                   !\)7W-(_B'?L:@%@T_P"XJ]_;
M<7^?D)WEZ/47YTW^CH'\BB_8&Q"RYH
M                             *$S1_1EF+_<6[OR?J HO/V<^0C=?C39
ME?I\SQ_OY<_Y1U(>BNSG_0:?#4Z\SS]_J\JGAO+% #4NDO/+]L!G&\FO_P#-
M-MW^0U3^:0AIG:#_ "W5YF:V>_?'Z=O=^9_QCS?;]NQOS45@
M      *5O-2TV]-4VZEE1&UZHI!.)+KD6U)D9'B YEM*4JBPC6M+BC;+%:4D
MDCZ-I)3@1 .^                          '17*I::+-4VX32R:,R6I)+
M(N_BD]AE@ X-EJ6NWH2W74O.8NXN)039*ZY_.IP+H 56
M          *%OU;J*4A3,A$=7'9+>6VEPOJA8E@K9B9 *QA&9PXIJ42C[.SB
MHBP)1\-.TB+81& Y(                          CJZ5NIN2W$ID(:;6I
MTEMJ:2M3F'<2H]J>D@$B)\$O.+]H!J                          (\O=
MQYN313;D-L([1UB6TEPU]=.PMXCW?0 2 U]3;_>(\SYTNYW &\
M               ,L=A@(XE..E?4)':4<,VUXL&TDUGU=F#F&\6!@)'
M                      !'=?6ZF[+?2F2AMM1N[[)M)4I>!XENK/:D!(9=
M!><7[0#4                         /S"Q\P!0T%;OOMJ2#>0ILDHW6B;
M22D;"+:O#>/T0%<@
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M'5X-O+K-OJ;AHDI2XOB.*?2TIDM[I2@S(UX^8 D-!8(071@E)8=[80#<
M      *+OQIQVWWB;C(E&3S.+*W29(RWRQ5OJ,BZN&("H*,6%,AD:";/@-XH
M)6^23W2Q(E;<<# =H          .!5"WJ?+3NDO%ATMTU;I*Q;46&\?0 IBP
MFG6J$V3L9,5?'D8MH>)Y)>J'MWDF9=8MOF *V          &U7@JV8]4]G1C
MLZ,>YB CVTFG45ZXUN0T1TN+;-#J7DN&]@98FI!&9MX>: D0
M
M              ?"5]S2/XAW[&H!8-/^XJ]_;<7^?D)WEZ/47YTW^CH'\BB_
M8&Q"RYH
M      *$S1_1EF+_ '%N[\GZ@*+S]G/D(W7XTV97Z?,\?[^7/^4=2'HKLY_T
M&GPU.O,\_?ZO*IX;RQ0 U+I+SR_; 9QO)K__ #3;=_D-4_FD(:9V@_RW5YF:
MV>_?'Z=O=^9_QCS?HY?C;\U%8                  "EKS2XNWYJ&HZ92E<
M,N"MPFDJ+>VXK/ BP <RVDJ11825-$R9-EBV2R<)/=V*+89 .]
M                '1W(2E4::26B>4;1X-FLFR5T]*CP(@' LI+B+>AI<83&
M61NXLI<)U*>MW%D9D>/2 JL                          4+?S3KM(0EJ
M*B6926#-M;R6,"W]JB4HR+8 K&$1E#BD:=TRCLXIQQW?4T[,2Z< ')
M                    $=W2T\NY+;6B$B0VA3IN/*?2VI@N^E!F1N8@)#3X
M*>YU2V>@ U                          $=WPVZN31>'#1*(GSWE+?2SP
M^LG:1&9;P"06MC;9&6!DA&SIPZI;,>Z W@                         "
M-Y+;WO[A.=B0ILFUEVHWTDI'4VX-8XGCYP"2
M    1W<#+RKLMY:8:'FT\7>?4^E"F>G=-+>.*\?,(!(A=!=SS
M                 4+!;=*[JBM45"$&232^3Q&IS89;6L<4X *Z
M
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M.9BE'VN3W XF"B/#BXENX /K::";H,%!1CB$2#P8-WC&C;_"8GO *C
M     !&K<9'O^??\6F2C907;^U&9&6X18=FQP+#SMH"2@           1Q>3
M"':S;JUTXYAH=7@Z4HV.SXGX1H)1<7']@!(J/ 1LPZJ=G3AL+9CW< &X
M      45?S1/6\^VJ"=02;S!G&*1V4U8++;Q<2PW0'?T0B12X22:X!<%&ZSO
M;_#(DEU=_;O8=\!VP          ZZK$2J=,(V^+C'=+ADK<-?45U=[YW$!2^
M7[26: VA,$X!<>0? .2<DTXN'MXAFK'>PQ\P!7(          VKVH5LQZJMF
M.&.P]F/<Q 1U:#*45^Y%IIJH>^MK%\Y1OE)V])-FH^%AZ "1P
M
M              !\)7W-(_B'?L:@%@T_[BKW]MQ?Y^0G>7H]1?G3?Z.@?R*+
M]@;$++F@
M       H3-']&68O]Q;N_)^H"B\_9SY"-U^--F5^GS/'^_ES_E'4AZ*[.?\
M0:?#4Z\SS]_J\JGAO+% #4NDO/+]L!G&\FO_ /--MW^0U3^:0AIG:#_+=7F9
MK9[]\?IV]WYG_&/-^CE^-OS45BC,PLP+2RLLRX;^OFM0J!:UKTR75JO4Y\AF
M.RQ$A,.2'L%ON-(4Z;;9[J<<3,!9!H7YFVF;F$/W^C3S<ZKD8R[J#U.K<@V4
MMH2^S)3%5PS2\\2DFM98'W2,!D2               !2EZMI=MR>A40YJ3)O
M&,3QL&Y@LO\ .D9;N #G6TDD46"E,?LI$T7J'$XNYYG$Q/> =Z
M                .BN5)+HLY)Q^U$;1EP.)PM_S.)B6Z X-E-DW;L)"8AP2
M(W,(QO<?A]?^%Q/>Q 56                          * S":)VD-I. =0
M^V6#X123C88.%U]\C+P3VX=T!6T(MV'%3N</",R6YO;VY@VGJ[WSV'? <D
M                        1Q=;25W+;;ATXY7#4Y]LE*-GLQF?2;.\7%Q+
MSP$C)\%/<ZI;/0 :@                         ".+[CI>E4-2J<<[AR3
M,EE*./P,3(M[ C+B>< D-K8TV6&[ZFCJXXX=4MF/=P ?0
M         !H9X%C_ ,.D!&\F.1W["?.G&HR:<PG=K,B1U,,.SXX*QQPZ $D@
M                           CBX64KNZW7#IQOJ1Q3*7VKADP>'\!O$3N
M\7S $CET%W/,                           SPVF H*GM$5WU)WL)H-24
MXS.T&?%V'_F,>I@ KT
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M=C=EM342         ",IW!*_J89I<-W<<))D:R01&@R/$L=T]H"30
M    1MF%P=RE<9+BOMI&[N&HL#-:<#/=[P"1&/J+.'1PF\/I" ?4
M  4K>B6UV[/2X2S0:48D@S)1];N&G: ^MHDV5 @$VE24$V9))1F:O1QV@*E
M          !&31,EF!(V.<4VDGO8KW,-PMF'@[# 2:           "-+UX)U
MFW#<)PU<1SAF@UD1&:D^$1;.YW0$DH\!&'1N)P^80#<          *'S!2TJ
MW7DO;^YQV#/AFHE;%]].W#$!4=$W?%</=(R3P6\",S,R+<3TF>T!VH
M    ZZK;OBV9O8[O9W<<,<<.&KHPVX@*5R\0TFWVS9):4'(D8$LU&KZH9=*M
MO< 5V          -J_ 5^]5^T8".;.)DJ[<?#2X2M]O?-1J-)F1EL3O>?W $
MD
M                           #X2ON:1_$._8U +!I_P!Q5[^VXO\ /R$[
MR]'J+\Z;_1T#^11?L#8A9<T
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MT$@Z'.XA&:>$>.[CCZ&&W: X-C\/WMPN$2B1B[@2S4:O#/'$U;>D!5P
M                     C_,0F#I#?&2M1=H9P)!J2KZHG#P>YB0"MH)$4*(
M2=A%&9(L>G FTEMQV@.4                          (TNU#)W/;2G"<W
MR-TFS2:R21X[=XD[#Z>Z DI/@IPZ-TL/F -0
M !&U^DR<FA\5*S,I)[NX:BP/>3@:MTRQ(C 2*U]2;_BT?Y) /H
M                (RE$R5_03-+G%-"\#(U[G@%CB1'N@)-
M              !&EQI8]^%MJ6EPW3-W<-*E[FP]N\1=7YH"2BZ"\XOV@&H
M                         H"!P_?C5,"7Q#2C>,S5N;"(MA&>[L 5^
M
M                       +$.9A85XYG:)<^K'L&D.5V[*_9=4@T:EM&HER
MY;L.0AMM)H0XK%2E$708#%AY,_IOSZTQZ(I=@Y_V;)LFZ??C<$YFE2N(;G99
M516ZRZ:G&65'OMGW@%I'-ST@:GLY.;GH8S=RXR]F7%E?E]5'W+LN%DW4M4I"
MI*5$;NY&<0HMWOJ(!F=YMFG:P]2'+\S8R^OBH4*CS*38Y7+1ZA5YD"*Y3ZO;
M5+<G,*C+F[>,;K6PDX*,RV /+!Y*EI]O//[._-;5AG'4IMUHR<J\^TLKZQ5D
MNRFTI8D,4M?BQZ4T^@FT,1S-)M.%@1$ OG\KWBIJ&FO(RG-RDP*A+OR.W29I
MF23CU,YC10%)Z#V2C2?H +*LPZASS,U-&66>@FW<FI=PVMFA:UNT'\^C<]1F
M=FOQX*EMN1TI<-"&:>\1[2,CP 9Z,FN3%1[8Y.TSES737&G:_<MLRJA6+B-A
M"^!>$MA,]OJ*BD1)CU,U),R1\]B P;:?JGSV^5UE36]#UGZ?)&=-JQI-8I63
MV8[$WAHHU.J\A^-%EI)"&R4B,RE#A)P(B/S0&5WD?<I[.72!1L^=5NJBH>.]
M6.HR!6Y]?A.==^W>UQ7)#-/XW9T*6M2G3:\-6! ,>_**Y8.9$W6[S#9NL#(A
MIS+G-:366\OZ]78[<II"ITF:A$F!VN HFU$U(WDJ2>)+/ND6T+B^3EIXUGZ!
M]2NJK03F1:]=J6E>]7+HE9%YG.39CT*V_'K<XT,QVG&T-$VE$DDI)!%@9$9=
M "SS0WI=UJ\J/6-JU]\NER1J9>U#56IO96YG5::FH(I+4^HRY3![E3AOH::3
MOH):4J+%OJ8X8@)+Y)FC37#I]YJ.I+-S4[E.[:]-SC.=4X=6CF:*=#;>4<R'
M&8:8B,14$AETF\",]J0%<:?-%^J.V/*,LV-1M;RYG0LCJ]3KBATJ^5<8XQNS
MJ=)C1G$I..3>]Q72/P]@"&LHM*VLSEH\U#4KGW<.FR5JLLK4!/D_F[O&J3W)
MC5NKDRI2FEM19T9YN-N*4E)[BDJ))[#(]H#MN7#I2U[9:<["_=4NH[)E5JVC
MG4505%E4]!-4VWX4II/9&29B1&8B=R._NGUOG0%2Z].7'K-T:\R2X.8YHORL
M@Y]67F&^W-O[*R0U&4W$=1VAXDD4F"M*B6M*2QWC\(!>[RWLSN:%G]JC*]<_
M-)%IY#:;VDFEN$[3*$[/8E$TSUXCQPDRDJ-U:CZAD9;N("T?,S1?JEJ/E)5J
MZF:;ES/?R&BN03DWJ2Y'9FS;;0EXL.SFT1)46!=? !Q.;3HMU49N<Z/1YG9E
MGEM.K^5=F3H:[HN9A3Q,TY*%M&HUDB,X@\"(^E1 ).\I=T@:E]3T;1@SD)EY
M-O95E7-09EU]E-W_ $:Q'JK;SRW";CO8DE"<=N&P!6'E FDS4=J%Y:.GK+')
M6P)=W7Y;C&6I5RAQE.I<B'2X%)34$J-N.\KU%;"B/JET +<^:)RR-7^I3ER\
MOY[*NA5.=>>F6%2JOF+DY&J,F FX&890Y,B'*X31ID$E+*D&2D=!@+<>9[EI
MS ^8?I&R(L3)[14SD]9V2\ZT4WE3(R82:C5W:'XNAR'&7XE,3*2P2H?$PP-2
ME&HU&9J,P'L,T!0+DI.D;)*D7=0GK;N.D671Z55:/(-9NQ)5.@QH;J5FXE"\
M5*9,]I$ GW.1*E929GDE)J4>7]X8)21F9_\ =^H=!%M,45Q;3J3$S&YNOQC\
MP*Q'AYT9S-.PJT\I-^W41KAT>?+9Q*XJCC@ZPRM!]/?'I7LYKNKO9VRNN-S7
MY'7>?4WGY[E3&BWQ?\71>^6%_5EQ_P"KU5]KC<8]W,6\J.%B^3/-D]\L+^K+
MC_U>JOM<+*.?'"CDSS9/?+"_JRX_]7JK[7"RCGQPG)GFR>^6%_5EQ_ZO57VN
M%E'/CA.3/-D]\L+^K+C_ -7JK[7"RCGQPG)GFR>^6%_5EQ_ZO57VN%E'/CA.
M3/-D]\L+^K+C_P!7JK[7"RCGQPG)GFR>^6%_5EQ_ZO57VN%E'/CA.3/-EM7<
ML,VGB\67'CP'</\ N]5>G<5_[N%E&[RXX3DS.CDS:]L/D=D]$RV-3R4Q:C&4
MV[1<2GT^3"WB-=,^IG(;03G3W,1TYVK7MS>7V']W-LZ?TMQV<HJNJ;R[KBRN
M++=-OIA[=QT]&[+9P2         "-)TA!7[2V/&"D+-#AE"[*9D[@D\3.1A@
MC#'O[0$E@           C?,%]+*:7OU!4$E24ELC'(XA[Z<"/ CW,>C$!(;)
MXLM'CCBTV>)[,>H6W#S0'U          %+WDLF[>GK.2<,B2C&031O&C%1%]
M3(C-6(#?:*TN4""I$DY:30?JZFN";FWIX9D1I 5*           ",VI#?O\
MWV2J*S63:,8/93)*2X9'CVC# \3/O@),           !&UY/(:KENDNH*AFM
MQ9):*,;Y2#)1XI-9$?#P 2.CP$;<>JG;T8["VX=S$!N          %$9@.(:
MMU]Q<TX!)>8PD$P<@RQ66SA$1F>("HJ(HETN$HG3>(X[7JAIW#7U$];=[F(#
MM0         !UU6,DTZ89KX9$PZ?$).^:>HK;N]W !2^7SJ'J VM$TYQ<=\N
M.J.<<SP</9PS(C+=Z %<@         #:OP%[<.JK;TX;#VX=W !'-GNH<K]R
MI34%2S0MK&.<93)1L3Z"<,BXN("2
M                                                      !\)7W-
M(_B'?L:@%@T_[BKW]MQ?Y^0G>7H]1?G3?Z.@?R*+]@;$++F@
M                                               H3-']&68O]Q;N
M_)^H"B\_9SY"-U^--F5^GS/'^_ES_E'4AZ*[.?\ 0:?#4Z\SS]_J\JGAO+%
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MW"(S+>[_ ' %:03)4*(I*M\CCLF2\-W>Q;3UMT^C$!R@
M         !'%UR&VKDMIM505%4XITDQTQC=[1TXD;I%@T D9/@I[O5+;Z #4
M                          1O?CR&I-#WJ@J%O2#)*$QC?XY[R>KB1'P_
M/ 2(U]2;P/$N&C;AACU2VX=S$!]                          !&<I]!7
M_!954%)6;3F[![*9I66X>WM&[@G##O@),
M!&UQO(1=]N(.HJ84KBD47LQN$^>&'U4B,F\" 20707G$ U
M            %!0'4G>-3;*<I9DE&]$[.:2;Q(_\]AU\0%>@
M
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M]31/$C%1%CPSV*Q ?2U%FY0H*U/E)4I!F;R6R:)9X])-D1$D!40
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MGE.5VXDG/3*2A39)8*.31Q\3+8;A$1N8X )#
M
M  'PE?<TC^(=^QJ 6#3_ +BKW]MQ?Y^0G>7H]1?G3?Z.@?R*+]@;$++F@
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M)XD=<O\ -F1DK$!S;;6I=&@J6\4@S:+U5+?")7=Q)!;" =X
M             .BN1Q3=%G*2\4=1-'@Z;9.D@^G'</8?0 X-EK6[;T)QR2F6
MLS=Q?2T3)+ZY_P";+ DX$ JL                          4%F ZXU24*
M;F)A'VAG%U3!2,2XA=4D&1^$ K2$9G#BF:MXSCLXJ(L-X^&G;AW,0')
M                     $<W2^MJX[<;1.1&0M3AJ85')TY&!X8$X9&;>&/?
M 2*GP4]WJEM] !J                          (ZOE]QJ31"1.1#)<DR-
M*HY/\;K)+=(S(]SIZ0$A-?4V\3Q/<1MPPQZI;<.YB W@
M         ".)3[GO[@LE/0ELVUXPSC$:E8(,BP?PQ+ !(X
M             (ZN%]U-VVZVF<AEM9N;T8XQ+4_AMP)[ S;W0$B%T%YQ -0
M                        !0L%U:KNJ2#F)4E*4_:I,$E2,2V8NX8JQZ0%
M=
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M3X*,2(R,BZI;",MF! .S          '7U3$Z?+))$9FPZ1$9D1&9H5TF>PB
M4U81.E06R>;0TKCR#W&U)4DO5#(MJ3,L=@"M0         !M7X"OWJOVC 1]
M:*'DUNX36VVA&^WN*0I"E*+'YXD[2Z.Z D,
M
M ?"5]S2/XAW[&H!8-/\ N*O?VW%_GY"=Y>CU%^=-_HZ!_(HOV!L0LN:
M                        8])=[I
M%"9H_HRS%_N+=WY/U 47G[.?(1NOQILROT^9X_W\N?\ *.I#T5V<_P"@T^&I
MUYGG[_5Y5/#>6* &I=)>>7[8#.-Y-?\ ^:;;O\AJG\TA#3.T'^6ZO,S6SW[X
M_3M[OH$/-_\ CL;\U%8VK0AQ)H<0AQ"MBD+22DF7>-*B,C <=B#"BDHHL2-&
M)9XJ[.PTQO'CCBKA)3B>(#E                I:\M[WO320A+BC)O!*U$E
M)]<L<35LZ '-MLEE1H1+22%</:E)D9%YQELP =X
M     .BN4EG19O#22U<(\$J,DET'TF>P!P;*)PK=A$ZA*%^J8I0HE)+K=PT[
M-H"JP                         !0M^\;Q4WP6VW%\=G8XI*4X<1.)];9
MB0"L86]V.+O%@KL[.)%MP]32 Y(                          CNZ4NJN
M*W3:;;-)&YQ'%*22D%C\ZD]IX^8 D-/@IQZ=TL?F -0
M        !'5]$\<BB&TVVX12>MOK2G=+$MJ25TF D)KZDWCT\-&/TI -X
M                       C>4E[W]P3)ILVN&LU.&M)+3U>XD^L>/0 D@
M                         $=W E_WUV^:&VU-D;F\M2D$M&TS+=29[QX@
M)#+H+SB :@                         "AX).%=M2]302#)!DX2DFL]G0
M:>DND!7
M                      H7-$B5EGF*D^@[%NXC\X[?J!& _,FY?G-!S3Y9
M6IS6"G*[(>JYY-9A7Q4_&L:BQICBJ;V.X).YQ%0<#+?[.73WP'9<TOF_9O<R
M<L@,O,R]--<R-I-NYC6W-;JM;C5!+-2=>N*$E7#.H$;9&39DD\/H0'HIYV&=
M^K?2=I%T,ZHM,MZ3[8L*P867M/S=H\&+(?9JM*J4&D1R7(4PMI#+9,I46*E$
M6P!<GS9.:+7<I.4=8VH3(RXVXV;&?5"LZE6#-AO-OR4UNJ,18U7=998ED\XM
MF:]M)*E&7= 1'G/FUK$TR>3X?GCOW,NH?XH95%HUS3+S?8D-3&#KG$J,&&<=
M;K3J?M=M*?"V[X#%GDG6^?WKHT16UJJR_P \)5AT^Q:?5+@MZ@'%-R3F% H3
M1SIN)FZMULC89W2ZQX]'< 9MN2?S>[MUA:/\X[NU&TU%&S6TM1:O$S/FNK2G
MQH]1(CQ%(4CM+AH<DR(2R,S-.)J 8=,N-4O-_P"=[FUG%>&D3-%S3AIHRLN2
MI4.V)C,<IC=Q5"#*FL-H)9/O[RY'"2>..)$D!?+RE>:'J\M+6K=W*QYB1KJF
M<M'C2$Y>YANI3'5<T>)&2M*DMJ?(W4.-H4HL$'AB6W !87F%KGYI]V\Y;45H
M=TU9ER$TRK.$U1C>8,X]EP8Z9':)B2=DJ:67 -+G@%X("+:+S!N<%H2USS>7
MO?=^KU"9DYO/1U6;57XI1O$#E509MSF4./D2DPDN$LL$;?- 21)UA\VCEB\Q
MS(2P=7^<KF:N6.I.MI)VE.QBBQZ6S.GL$U"2LY++9G#):F]A*,S2 ])O- D\
MP.];3RIL[1'5*-8%&OIJ-)S.S;JU5IT!-FT>47$=X+<]]DI"EPU[V"3,P'F_
MU-ZU=5_*MUGZ9K L?6,WJQM;-FMP*3FM;#4)M$:C3)E1C07VVYC4Y3#B2?2H
MTGWC[^P!F6Y[_-8S0T+Z<<GZ-D3#0>?^I!JCT^R7,4K=I$FKQ6F5R$-G)94I
M34J66!D2L#0 PX9PU?GWZ"]$-[:GLQ,[W\SH-[4FF7#7:*4;A2LNXE;B=LBK
M;-+J'W"2V_NJP,MTSP/I 9-=#6K741F)R&;QU&7=F))JF<<2@7+5(]X+:<)Y
MB1%9:D):)!R%KQCJ4:?# 8?M$^>//!YFND>\+BRMSQD9>VYE74;H7 NY40WW
M[V\5/S)C4(MY]YUHVFVC2DM[: S!^3P\S#4'JFRAU$V1JKJ15Z_=+JZC&K%Q
M.DEIZIQZ(E:)*G$*DNK+;$6HL23T@,:C&MGF7<Y;4[GS;6D3/RE:6\BLAJI5
M(E'ESI%/0=T3*3)F1W"WI4_%Q;CS:$X^8 OUY)?-:U%W]GQG[R\]9-39O'/?
M(JEU.9;M\QE-+:O&/1X"W^$VXQ*>;<-U,<U%NEW2(!C.M/63S+.:GJ_U&Y>Y
M?:J&-'-!R4N"H46U[(N2(Q34UU4:HRX##C$JK3&"<)]1H/%)=P!Z*>4=EYS2
MLLCO*W==^:-#S>LR,A2<O[LI4^ESER&D$T:=Y4!]]9$[NJ/ SV;X"!=5N7O,
M8S_U0WQ#NS430M'&CZRHTJ7;-654:5-JUV.HBR5$\JGG+9G)4A1$>!EC@G !
M9%R7>9/J:KO,2SKT YH9H*U"9:V;VI5D9IKC=B4MF"A"W32R<ITU$MMH^@OG
M@'4:_P#F/ZU]8W,=J?+3T'9C4_)"E6*[V3,'-F7(B(8<D.=H;;P.5-2C!+BD
M[-TO! <+1%S'M:6ACF2VERWM=^:L#/:V\T%JB6#FI"7%=8B2TE':42SB35)(
ME/I5B1I/PN@!&FOW7MS)K(YWM1T=Z5KZD/TW,"!2FK?MU3"E1Z(FJ0U&Y+(U
MR":7P2>0LBW.D@%MF9>O?G!<KK6K:NG;-K,M>H6NZA7F6K3H[T3LK=,E5A:&
MV7&<9"&S\6K>)6.Z9&E)@*TU':K><ERP=5VG?-74GG8N_LIM1%SQ(-3LE41#
M,6WX]1J$4E4Q:^.PT:XD>0:-N)[.@!EX\HRUG9^Z=-"656<FGBZ(=JW'=]2L
MF8]+DTN/5VE0Z\B!+=:2R^LFR,FY6&)&8"X>O9L:]\QN5MD#<NEMVD3<^,Q;
M;H:KLO\ J$JGT.%:D63$:*=5$LRW6XZCX;RED1*V;FP!@<Y@>H#6CRG4Y%9K
MVUKVC:A<P;EN.CQ,TLK(<2,]";\=3XR)T-,Z)45,*1'<-UC;ACACA@>T/;)I
MJS3E9UY%Y8YH3X/BZ?>%GT&L3HF]O$U-F4N+(E$1DI18=H=5W0%4YS?HCS/_
M -G]X?D_4!1>>I*JC=?C2WJ7_P!^3.,__P ?+J_**ICTGV=U<K9:[C5;^AUQ
MM#/_ *BZX;?9.MC +)U@%DZP"R=8!9.L LG6 63K +)UC:LL6G_XA[[&H-,3
M&G?-Y[3O(]__  MJ:_C:+_ETT=1=J\VWN'CR_I;=LQ^QK\-3VTCIRVUM2&=0
M&2ELZA\IKNR?O$WRMJ\Z>NF5<H[JF75PW2-#S25HZR>(VHR$CR%<_O0GIDT#
M\H^KY=Z>LMJ7:Y'<$9Z;<' B/5F:],F/2I#LBH]F;F*6Y(,S\+ BP[N)@,M/
MDVQF?*YR2,S,S5'D&9GM,S./3\3/S3 9\@     !&T^.9WW3'_%N_NI67;^U
M[O"Q1T=FWNOO>< DD           $<9@1S?32R\7=O),I)X=J[-PL%D9KQQ+
M>P[W= 2&R6#+1888--EACCA@DMF/=P ?0          4O>+?$MZ<CLO;<4H^
MUN-P.)URV<7$MS !];4;X="@H[-V3!!^H<7C;FWHXF)[P"HP           1
MJVQ_W]?=\688M)_TAVOI,D%L[-O;,/.V@)*           !&]Y1S>K%NGXN[
M;PW'#X_:NS]FQ/IW,2XN.'0 D9&Q"=F'53LQQPV%LQ[N #<          *+O
MYGM%NOM]B\88OQS[/VCLV]@OPN+B6&[W@%045)(I<-)-\+=8;+A[V_N=1/5W
MOGL.^ [0          =?52WJ=,3PN-O1W2X6]N;_ %%=7>^=Q[_< 4OE^R;%
MOM(.!XN,GY'VOVGM6!&YB2N+B>.]T^8 K@          ;5[4*V8]56S'#'8>
MS'N8@(ZLYDVZY<2SIO8B<<0?'[7Q^TF1IZW#Q,V< $C@
M
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MCM\&W(+9Q>Q&1N_:W&[1N=;'ZKB>]CT^8 JX
M  4%F#'.126TE \8;LE@^#VGLO0YCO<3$O!PQP[H"LX)&4.(1HX9E'9(T;V]
MN>IIZN]W< '*                          $=77'XMQVVX=.[43:G/MKM
M7![,9F>W@XEQ<0$B)\%/<ZI;/0 :@                         ".+[8X
MTFB&5-*>:)!F1G*[-P>LGKX8EQ,.\ D-KZDWLW?4T;.]U2V>@ ^@
M                  C63&QOV$_XMWMUIS_2':R+AGN;$]FQZV]T= "2@
M                        1O<4=2[MMYWQ:4DD&Y]N=KX1QL3/_,;Q<7>+
MY@"1RZ"\XOV@&H                          H2 P:;NJ;IP=S?2C[<[0
M2C=V'LX&/4P 5V
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MF6 "7?*TW)_8-!346EU>HH.\;<6YXMI\V:;!^.&34IQ45IS@F:48;<#/H[Q
M*W\IF.9\4QI@*-2ZM4'#CY2[\>#3YLV2V1TVB[_%98:<>1ND>W>+9@ @CFL9
MR:K,I^5)RX*3D2]=MLY-WI3J#!S[KUMTZL.5:G4,D1&E*?:IA(G123#=<Z<
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M:4\G=3BVE9MJ5UNXHMI /K:*"10("4MJ9239X-J6:S26/=4>.("I0
M    1DTTR68$A?95DX;2#[1QE;AX(Z.'CN@)-           !&M[(976;<XD
M5;ZDO.&AQ#JFR:VEX24F1*(_- 20CP$=SJ)V>@0#<          *'S!2VNW'
MR=CKDIX['J2'#:4>*RVDM.TL %1T,B*E0B2@VR)ALB0:C4:2))%@:CQ,\ ':
M@         #KJMAXMF8I-1=G=Q21F1J+<5L(RVD9@*5R\0VW;S26F%1T\>1@
MVMQ3JB]4Q,]Y6)];''S %=@         #:OP%8[2W58EZ!@(WLU#15^Y5HC+
M84XMK?6IU2R<P,MJ4J/!&&/< 24
M                                                     /A*^YI'
M\0[]C4 L&G_<5>_MN+_/R$[R]'J+\Z;_ $= _D47[ V(67-
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M^7+0REH^J_,_4+2KYH+3U,FWI8BW8''I#4U2)4N J.B2B0^E#;:VS,B,^G8
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M@98 .?:Z4)H< D-FTDFBZBE&LTG@6.*CQ,P'?@
M   "G[H2E5#G$MHWDFT>+9+-!JV'T*+:0#@V,EM%MP4M,JCH+B8-*6;BD];'
M:M1F9X@*N                          $?9B):72&TNQUR2.2P9-H<4V>
M).;#WDGT$ K>"6$.(1%@11V<"/;@7#3@6/F$ Y0
M     C6[6V57-;1KC+>6E3IH<2ZI!,GCTJ21X+Q\T!)*?!3W.J6ST &H
M                      C6_6V5RJ$;D9;YIDGNJ0ZIO<ZQ;3))];$!(S7U
M)K^+1_DD ^@                          C*4AGW_ $%795J=W%_;).J)
M"2W#V*:QW3[@"30                           1G<3;1WA;JUQEO+(WL
M'B=4A#)'LVMEL5B9 )++H+SB :@                         "@H2&RO&
MI+*.I*S2G>>-PS2OJX$1(Z"PP 5Z
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MX[0'7YOZ6\@<^>S*S6RML^\'XCA.,S*G0Z:_.WB,S(ES'(JY*TD:CV&HRVF
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M+$FR^8 E@      1E.<9*_J6@Y:TNFAP^S$PHT*P0>TW<,$[ $F@
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MG>-);BL3));3P 4KEZMI=OMJ:DJE).1(P=6TII1^J8&1H41&6!D KL
M    ;5^ O]ZK]HP$;V8ZTNNW(E$IQY25M;S2V5-DSM^=69$2\0$E
M
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MRDMN.M)555XDVX9&MLC+8>!EB N*\L?67CC129[A*:O"(:%GN$I)^/'3QQ/
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M62SB^37_ /FFV]_(:I_-(0TSM!_ENKS,SL]^^>=^G;W?^'FCS?\ X[6_-16
M                  I*^'$-VW.6X\;""X6+J6S=-/7+H01&9] #G6PI*Z)!
M4EPW4FT1DLT&V9X[?!/ RV@._                          %/W0I*:'.
M4MTV4DT>+A(-PT[#Z$EB9@.%8ZT.6W!6V\J0@^)@ZILVC5US^<,B,L %6@
M                       "/\PW6F:2TIV2J,GM+!<1+*GCQ-PB(MU)&>T!
M6\(R.'%-*MY)QF3)1E@:BX:<#,NYB0#D@                         "-
M;M6TFY;;)<MQA:E.$AE#*G">V]"ED1DWAYH"24^"GN]4MOH -0
M               !&M^N,HE4(G);D8U2>HE#*G>*>\G%)F1'ND1 )&:VM-F1
MXD;:-O1CU2VX=P!]                          _,+'S $92EMEF! 1VQ
MQ+AMN?:Q,*-"BW#,\7<,"V )-                           !&EQN-IO
M"WD=K6TXKB&E@F%+2[AMVN$1DG#;T@)*+H+SB_: :@
M       "@H#C9WA4T%)6I>"<8YM&248%M,G,,#Q 5Z
M                                                     "G[JN>C
M67;M8NJX910J)0:?+JE3EF6)1X4)AR3)=,C-)&3;+2CZ>X MATIZZ=-6M2)=
MDW3Q?C-[QK(J3E)N-QEE+)09S3RF%LGNOO8F3J3+N +O@ !8CJVYD^CS1"_2
MH>HO-BFV;4ZTI":;2&VTU"K236:R2:8#+R7\#X9]P!0MS\V70Q:F7^6>9=RY
MK,T^S\W9:(5B3IU-X*ZM)<?:C(;[-*?:<;,WG4EW>D!D4HE7@5^CTNN4IXI%
M,K%/AU.G/$1$3L*=';DQG2(C,L'&74GZ(#LE(0LC):4K(^DE$2B/#S#Q( 2E
M*")*$I0DNA*2))%YQ%@0#<          .%4JA%I-.GU6<YP85,A2JA,=/;PH
ML)AR3(<PQ+P&6S/T %F&F[F!Z4-5UTYFVED5F!#NVXLHER$7[$CQ6FG:0J.L
MVWB4I#SJG#)Q.'< ?#3SS%=*VJ2_,TLMLF[XEW!=F31RBOZ%(H\FGM4GL1K3
M(-$AY1HD$@VSZ, '9Z;>8!I=U:W??MBY%9A,7C<F6<]RFWE!990T=*EM2#BK
M;4I+[N]@\6'00"]    &U2B0E2U;$I2:C\Y)8G^P0"Q2U^9!I0O+5)5=&] O
MJ9*SZHR'UU"UU462W'91'0;CJO&)KX"MU"3/H =VQS ]+,G5'(T;,YB1UZ@8
MJ=Y^RR91QD%N;^UWM&]L3_R '#KW,1TH6UJ>I>CRL9D1XN?M8))P+,-A!O/$
MM)*3ZJ<@E%B1_0 +W4J)22470HB47G&6) -0        '2W%;]*NJC5"WZW&
M*92JI&=B3HQJ4@GH[R%-NMFI)D9$I"C(!C0SDY9>A^FY69GU=>1U"<?;M"[J
MNIQ!GQU3TTBH2TODXM)X+*1UL3QVB8B9FR-U7=TS57%C!UR@=8-^Y.Z5ZSEY
M;5&*3;EIWM>$:@M+<2:(<=-?=CMM)2IU)=1ELD["+H&N8W-;_#7TW<0\W=H?
M:YG6R^T<Y3A;F*KJW@W?&R@_&,YM?BVU],WZ\.#\^O\ 4T_OXV@Z"/1QGQC.
M;7XMM?3-^NB?GU_J._C:#H(]'&?&,YM?BVU],WZZ'SZ_U'?QM!T$>CC/C&<V
MOQ;:^F;]=#Y]?ZCOXV@Z"/1QGQC.;7XMM?3-^NA\^O\ 4=_&T'01Z.,^,9S:
M_%MKZ9OUT/GU_J._C:#H(]'&?&,YM?BVU],WZZ'SZ_U'?QM!T$>CC/C&<VOQ
M;:^F;]=#Y]?ZCOXV@Z"/1QM/C&LVR)1^]MD\$*PZS?21&9?Y[OB8SZ^U*)[>
M-HK/V-/HXUZ&BG4#>V?1W?/N]A$9--..F&P@DEN$KAX[4K5]&8RV68^<9;RM
M%<.W^RO;[,MM*+ZO&T\GW>YZ.-?XDL"_X=\QF)FV7<-D1,S#<"0        !
M&LY\RORF,^,MPE(<,X'9-XW>KL/M.&*-WO=T!)0           (YO]\V2I>%
M1[!C)21_:O:>*1J(MWH/=WNC'N )"9/%EH\=[%IL][##'JEMP[F(#Z
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MGQ=W?W.HKK;NW>P 4QE^ZIV@-J5/*H&;\CU<HY1B/U0]G#(DD6[T *X
M     &U>Q"MN'55MPQPV'MP[N ".[1?4[7[C2JHE,-"V_4"BDQV4L2+=-PDE
MQ<>^ D8
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M(]['H <ZVW#=HL%9OE),VB]6)K@[_=QX>S=Z0'>@
M     #HKE63=%G+.1V7=:,^/PR=W#[_#,CW@'!LMSBV]#7VLIV)N_;),]G)S
M!9E]2P+=PZ %5@                         "@[_=X-)0KMY4_P"V&"XQ
MQNTXXN%U.'@?A=_N *SA'C#BGO[^,=D]_=W=[U-/6W?G<>\ Y(
M                CFZ7UMW+;C95(HB7%.%V8XI/=IP/H)W=/A8 )%3X*>[U
M2V^@ U                          $=7R_P &31"*I% WY!ENG%[1Q]J>
MIC@?#\\!(36UML\=[J(ZV&&/5+;AW,0&\                          1
MO*?4=]P6?&!)3PU_:/9<37@@]O:,,2PP]$!)
M    (VN&0I%W6^VFI%&Q-S&&<3B]IVXG@_@?"P(^_M 20707G$ U
M                  %!P7S.[ZBVJ>2^JC=AE'(C:V;<7R(M_$P%>
M
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MC6C<)"4DI.TMBC3M/H[H"0@
M                                                !\)7W-(_B'?L
M:@%@T_[BKW]MQ?Y^0G>7H]1?G3?Z.@?R*+]@;$++F@
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MLVS.U6SF:8RG!Y7>Q>7M.B/"WQO7,6.)X^9L[PTRRS3K=F3#<"
M         4M>?$][TWA+0A7J7661&G#?(L#)6S: YEM&LZ+!-PR4KA;33AAZ
M&&S8 [T                          =%<JEIHLXT&E*N$>!J(C3Z)'B0#
M@V4;AV]"-U25+Q=Q-)$E)EOGA@2=@"JP                         !0E
M_&Z5)0;2T(/M#!F:TI,L"<+Z+NX& K*']R1<3Q/L[)F9=&UM)[ ')
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M IX[MJ1*4C<(D;J22G?+$L-JND!70
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M9X=P![:N31K;MK69RS;WRPM6G4^R<\,E+$O++F\[%@LQ:=4H]4I=%GTN--5
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M2         (WFQW??U37_%Z5MDAS&:<HB4WBC B*/B1JQ/Y@"2
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MU,U;A+ZA]4U=S$!3-A-J:H+:%0DP3)]_%A+Y2"+%>./$29D>\6T!6H
M    VJ\%6S'JGLZ,=G1CW,0$>6DPINNW"I4%,8E*;W7RD$Z;^TMIMD9FW@1@
M)%
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M9!F6TOYNS,^,A\MLVI]-*D2[WMFEUU^FDLG"B+GPF)*F=\E*)6X;N'28"?0
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MR).& #FVVVINBPDJ8*.HFBQ9)SBDCN8;^)[W0 [T
M      =#<R#719J28*09M'ZB;G")>P]AKQ+= <*RFU-V]"0J,4-1&[BPETGR
M1BLS^J$9DK$!58                          H+,!I;M*;)N$F<HI#)\)
M4@HY8<0C,]XS+'# !6D/'LD7%'#/L[.*"5O;OJ:>KO=W !R0
M             !'ET,K7<EN.)@IDI2IS>?5()HXY8])-&9<7']@!(2?!3W.J
M6ST &H                          CF^F%/2:(:*>F::)..\J23'!+>3B
MK S+?\X!(;6QMLL-WJ(ZN..'5+9CW< &\                          1
MO)96=]PW/%Z5(2VO&;VDB4@]W879\<5$9^8 D@
M     $=7 RL[MMY90$OI+BXRCDI;..6/\"9D;F("1"Z"\X@&H
M              9X;3 4' :45W5-SL24)42?MKCD:G-G\#CBG#]D!7@
M
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MRR42,6"=-DUEO%_G",C(!]+203= @I*.<4B0?J!N&Z:-O\(9F:M@"I
M      1HU'1[_P!]\X"TKX22*;VE1I66X6S@8X%@?F )+           !&]Z
M,(=K-N*5 5+-MY9I=3)-DHYF>TU((RXA&7< 2*WL0@B+ B0G9TX;"V8]T!O
M         %$9@-)>MYU*X9SD\=@S8)\XYGURV\0C(RP 5'14[M,AEPS:(F&\
M&S5OF@MQ."35W< ':          #KJL1*ITPC0;A''=(VR4:37BA1;N\6TL0
M%+Y?,H8H#;;<-4$B??/@K?.0HMYPSQWS,S/>Z0%<@         #8OP5=TMU6
M)=_8>S'N (YL]IMNX+C4FGJB*6M&\^<E3Q2=I'B39F9-8 ))
M
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MQJ"0!=QH-_WB('\7(_R&QDLIB/SE,[]L.U>Q7^=*?)Q/0/W3&[/;$;LM02
M                "D[V;2[;D]M<<Y:5<+%@G>":_5$_YPC(TX=(#G6R@D42
M"DF3CD318-&X;IH+ MF^9F9@.^                          '07.V3E$
MG(4P<@E-&1LDX;1K+ ]A++ R =?8S:6[<AH3&5#22G=V.ITWS;(U8X<0\35B
M J\                          4!F&PA^D-I<@JGD4E@^$F0<<RP<(][?
M(R/JX8X=T!6L$B*'$(D[A%'9(D8[V[@VDMW>/:> #E
M        "-KK80[<]M+73U2>&IS=DIDFT4<S/NM$>#N.("2$^"GN=4MGH -0
M                         !&U^,)>DT/>@*F;D@S)29!L<$]Y'6P(RW]A
M= "16OJ3>!8%PT;,<<.J6S'NX /H                          (SE,ME
M?\)XZ<I3AMK(IO:5$ELC1NF1L8X'CB DP
M$;7%';7=]NNK@+D*1Q=R24DVTL=)GBT1D2\<0$DET%W/,
M           &A]'3AYN&("@X#+97?4G2A*2I9(QEF^9I<P+N,XX(PP 5Z
M
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MO2U8-[VO6K4J:GD4^NP)%.FFPZMEXXTII;#R6W4&2T*4VX9$9= #"'FWR&]
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M<6OBMDHE)624[=NZ:MAX^8 DH
M                                                   ?"5]S2/XA
MW[&H!8-/^XJ]_;<7^?D)WEZ/47YTW^CH'\BB_8&Q"RYH        #R5>5ZQ*
M@_R_*>]&:><B1[IIBIAMDX:$D<A>Z;AH(R(MA](#)=R$B:J'*DT]L15-J-^U
MYD8^'N=5UR!#;P7NX]8C46..T!XV<UKGJ/+<\HO<S.SOITFD6)>EV1U0+BE,
MNM4U<:JU,B:>3,=*+%42$GB?JAD6(#]'*@YXY35W+Z#F33K_ +2?M"3;S=PI
MJR;AH_9TT[L!3U*<<*<;;;J&.E!JQ(]@#S.99^41UK/#FHS=$F1F52,S,L55
MU=$:S!ILE2V81PI"8TZ2\J+*D1TLH-18*5AB?00#U<L*4MAE:T<-:VFUK1T[
MBU))2D_\U1X /SQ?*@/_ #,-'?\ >^VO^VVP'OXRC3OY1Y:(QPW\N[/3CWMZ
MW*>6/[(#\YCFL%<&A;R@"QM2.8]*EL9875=-'=IMQ.L/-4\XDFJDEYXY2D1X
MY&PWBHRXA["V] #]#W*W/[)W,S*ZW,RK2S#M.J6?4[=AU5JK(KU*2TU%1 :D
MO'*PF**.MEK:M*CQ27F /-5F7Y1=-^-%M_1#I[RU8SJLJ?6X%!JEWT67Q6X,
ME;[D6HNI7#EOH7'A.LGO*,B\).S: N/\I&UIM::^7K7[3A33I5]YWT]J@T5E
MJ1PYB$2HCQ3X[3:)+,A1FMTD]4E8F6 #R <L?7MS'N7'DW/L_3[HZN/,.W+Y
MGJN!Z[BI52)=2D2EHE$ZI9Q6ENIW7-FU1=;I 6PZJ=5&J^ZM<>6FO_/7)"MY
M!WK$NZWCF+=B3J>S4X_CB,F02WU-16S,F-_'%P^C: _1 U79U4/4'R@[YS=M
MR2W+I]UY)-U!+[3J'DG,10"[7BMMQTMXI.]LWC/: \EWDT7+RT8ZX,L<]+DU
M76=0[OJ]L7K4XU"9JU7A4UYEN35%K??0U)0I:T(,S29EL(U /3XYY/WR<%NQ
M'UY,6F3D*;%GQU>^ND%PY4-]$F.YMC_..MD?H ,U>6-E67EU8]O63E\U%CVC
M;E/CTRBQH<AF4PQ#BM(99:0\QZFHD-H(M@"K*Q%7/I%5@M_5)E-G14?OY$9U
ME/\ Z2P'YHMDWP?*B\H>NFY\_84JC6+?-V2$L7'*:<9IIQZY55)9=:F.E$BN
M$1&9F9*-)8$ ]G',PTD6=S:-)U.R^RUU*T?+2EW#XMK\"\Z+7XSN]%4V4I+$
ME--E.K+>:>(G&S/H/ ^^ _/MUM:,)7+7UHZ=\EK;U>73GH[4KRME%8DTJ[JL
MZW3U%6XF+$F+!J)MJ-1L;JDFG L< 'KR\I'<</D[VZZ:W%K59]D&XXX:N*LU
MVS'-1N&LS6:U&>W':9]("X3R7VCP:=RM,II,6-'9?GOSW)3K;#;;KRD(A[JG
MG$H2MT\%;,3/ !!/.VYXF8NC;/'+O1YIEL"B7-GUF4_'IT.X:[&@2&Z#(J;A
MQ8*HR*@X31+0^XA>]N[,#V]P!B9YGFEKFN/Z"[ZU!:[M7E+E6S%I\6H.9+M)
M@,MS6ZG&DRV8,7@O$EXHJ'E(P01X8 +Q^1Y3KDKG()SSAV P]%N6;:MU>+68
M^^3ZDM4MXY!M$T7$,W&]NPMH"#O([KCL6DU35U9EQ/4N'G"U>-3.J-U(XC%9
MDI36V^(4?M)HFKQ41XDDMN&T!P_+%[AL2?6-(-"I51H<N^XMXTTYL2 Y >J\
M=A5;<-HIRHZU36NJ752X18%T )VYW\"\)?(*R'D6\S.?M^!:EJJNUN%QSP0=
M,:X*I*(Y'O-E@?A[ %E/+ RIYWUZ:.LN*UH;S\M.VL@ID1^)1+=1'H+DBGO+
MCQFYG:R-?&;D;IENJ<(E$9; %X/+5Y)/,-T_\RR%K@S[O^WZ\_7Y<R3F$Y1:
MA2S74G)2HQ[DJ#3TDGJFAS CVD:CZ>X'M@2>*2,^G L?/[O[(#P+>5&U765F
M[J:RDR?LK+&\;YR%LU^%<4JC4*)65TRY*DP\Y+[/45T]IV,M">'AZHD\<"+H
M,!B@UT<Q/6]J"TF6MI3SLTLU'3_D+:4&ETVG5%R"_!@NE2FN PHTJ988)3VY
MO'BDC,]H#/YY,/K4U4WE2X6EJZ<J:A"T_9>4MQNS<Q78\A$2<E34,S;:?41,
MNE@1'LZ-X!;YY7>J/4LW=&U&H3C97>]>5)[(EHT=KQ*NN%B1(,WL.L1]'< >
MS#1?3ZW2]+F24*X3=.K-9>6L4HWM\G,3HL$T[Q+P475 2WF_^BC,S^X%X_D]
M417=^O"Y=>O#Q%\MO]%.:G]_;M_*60-&SK]]EXC[:OYPK\O&OX+H&-=4QN-0
M !=SH-_WAX'\7(_R&QD\I_>Z?*[5[%?YTI\G$] W=,;J]L1NRU!(
M          *2O@VRMN>;JE(07"Q4@E*46+B2V$G;W0'-M=254.":#-2>$6!J
M(R,^C:9'MV@*@                          '07.:"HD[?4I">$>*DD9J
M+IZ"+: X-C[AVY"X:E+1B[@I9&E1]<^DE;0%6@
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MKA4P5W6\E;CB73-W<2E"C0??WC(L"Z>Z D@N@O.+]H!J
M         'YAX>: H*";9WC4R):^(E*-Y!I5N;4]P\, %>@
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M3W,HTLZ1,T<LLH<Z[U][EYYMS&H-E0.SI=*IOO/$P@DN&^W@2G#PQ(C =[K
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MUI<U?2/F-JQJ>C/+:]G+TSEMZ0J+<D&C0E3*-2'T.<-;;U9BNOQ,4JV'CAM
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MQ?@\P7:.S]IPQ66SA8'CB J"B*WJ9#,G..1L-GQMWA[_ %"ZW#Z4X]X!VP
M        Z^JJW*=,5Q.%A'=]4W=_=ZA[=WN@*6R]>XUOM*[>=0]7D%QSC=E,
M\'#V</ O! 5R          -J]B%;<.JK;ACAL/;AW< $=6A))ZO7$@JB<Q3:
MV\6.RFQV;K?PID7&Q,!(X
M                                               ^$K[FD?Q#OV-0
M"P:?]Q5[^VXO\_(3O+T>HOSIO]'0/Y%%^P-B%ES0        &)3G:Z5EZMN7
MGGIEY3*851N>#;DJXZ 26N*^4BB0YDQ:&DDP^HU*0G'8G'$@&,/R4/4&Y?\
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MP/?QZ/, <^VE$NBP5%([42FB/C\/A;^/=X>!;H#O0
M      !T5RK)NBSEG([+NM&?'X?%W/-X>![P#@V4X3MO0UIE]N2HW<)/![/O
M];^"P+=P,!58                          H',)_@4A"^W^+_ +88+C=F
M[5TN$6[PR(_"[_< 5K"/>AQ5;_$QC,GO[N[OXMIZV[\[CW@')
M               $;W3)2U<UN(543B*<4X112BF]V@NGZL1&36&'?(!(Z?!3
MW>J6WT &H                          C>_'R9DT/&HG WI)X)[+VCCF2
MD]3>W3X?3T@)%:/%IL\=[%M![V&&/5+;AW,0&\
M    1M*?2F_(+)5(TJ4VO[1[*:B61HV_;)%@G##'I 22
M           ".;A?2U=UN-^,NSFLW?M/LG%*1T[./@9,X>?M 2,707=\T
M                        %"07B.[ZBR4XUFE*<8?9S239&DL/5\.OB0"N
MP
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M5A@0#U4S($>93I5,=0GLLJ$_ <;P+=[.^PJ.M&!D9;O#5A@ \&3.8UL<EOG
MZQ7JX\N@93ZC:!-E6RP\I34&94YE+FOM&T:UPHY.%-))]7>,C(!C.T;T:_\
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MI(+86T!40           (X:6X=^2$=K;4@FD81283OIQ;(S/BX;QXF D<
M        $=7@X\BM6]PY2&$*<62VU,I<-TM[H2I1&:-A]P!(:#Q0@^G%*3Q[
M^P@&X          4;?:UHM]]2'T1E$\Q@ZMLG4EBOH-"B,CQ 5!1S,Z;#-2B
M69L-F:B222/J%M))=&)@.R          ' JF]XOE[JB0K@.X+,MXD]16TTGC
MB IFPEN+H+:G9*92N.^7$0TEI)^J'L)*=G5 5J          -JO!5MPZI[>G
M#9TX=W !'UI..JKMQ(7+;D)0MO=:2REM36WH4HB(U@)#
M
M          'PE?<TC^(=^QJ 6#3_ +BKW]MQ?Y^0G>7H]1?G3?Z.@?R*+]@;
M$++F@        .)/A1JE"ETZ:RB1#G1GX<IEU*5MNQY+2F7FUH62DK2XVLR,
MC(RP,!AVTA\H&P-%FL?._4[DS>\RC6OGE*3/N+*U$8FZ5&F\0WUOQE,H:9(U
M/F:CZH#,H                   !AT'WN@         PZ3[_2
M    .OJT1V?2ZE!8>..]-@2XC4@NEAR3'<90^7?-E2][T &'S0IR>LKM'6I/
M/;5?5;IDYGYQYV5+MLBX*O%23MOQRDJ>*-3W'D*>3ZF9(Q)1;" 9DP$=9O\
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M%)N4B,1R#WR6REW?+>3L(U%U=I )":VMMF9XF:$;>C'JEMP[@#>
M                 (XDNO%?4)LI2":4VO&.;*36?4[CF&\6!@)'
M                   !'-P+=3=EO)1+0TVHWM]A3*5J=PZ-UPRQ3@>T!(I=
M!><7[0#4                          4)!<7[[:BWQT*01)P9)HB4C9W7
M,,58@*[
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M<_+%YW&9>OJMSZ54\G+OBU.)%I$QJ)+6TW4(CL0S)A^,LTFA+AF1D>)&?3T
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M=_\ JM6_:8<F.=3PP<B\YLGC61^+EW_ZK5OVF')CG4\,'(O.;)XUD?BY=_\
MJM6_:8<F.=3PP<B\YLGC61^+EW_ZK5OVF')CG4\,'(O.;+:NJR.$\7O<N_:P
M]_\ )6M_0'_[F*?LS_BIX8.1><V7M9\COE+?MG4\ARGU6 MMZBD::E39=/-7
M7IOU/M33?$+SL1T[VJ5W=Y>X>;NJ)W;?2W#9RZO+J[KIO(BV-4Q/IA[=1T_&
M[+9@2,#WE VA[/?7EHOJ&3V0%*:K%XO5BGS"@NOHC)?CQW7%NH-U;3I$2DF1
M='= 3ER4=*F;^C;0CECD?G?$1"ORV6745)A#J7B1OLQ$)ZZ&VDF>\T?<(!EO
M      $<36W3OFFK*,V;:4N8R#>22T]7H)HSWE8X@)'           !'E^-N
MN)I9-1VY&$E.)+=0WNXJ3M+>,L0%?L[&6B,L#)M&SIPZI;,>Z ^@
M  IF\$+70)R6V4OK,D8-+63:5=<OGE8$6 #Z6HE2*%!)326#W#Q;2LG"3MZ"
M46P]H"H@           1NTV[[_)#G96R;-I)'()Y.^KU/HX6./< 20
M     ".[P;=<K-O[D9M]*7%FIQ;J6S9ZW2E*C+?Q\P!(2"P0@NC!*2P[VP@&
MX          4;?:7%6^^34=,E?%9P:6XEI)X+Q,S6K86 #OJ-O>+(>\DD'P&
M\4DHE$GJEL)1=.!@.T          '7U0C.GRR2@EJX#F"#5NDH]Q6PU;, %-
MV&EQ- ;)V.B,OCOXM-N)=277,\=].)8JQ 5H          -%>"KN]4]GH (\
MM)#B:[<9JBMLI4XV:'4NI6;O6VXI+:C ^^ D0
M
M   ?"5]S2/XAW[&H!8-/^XJ]_;<7^?D)WEZ/47YTW^CH'\BB_8&Q"RYH
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MQJ/J5JF:V8%;OBIR*E'GEXVJ$^:5/D3I4&3(8:*9)D<(FW7E)P+# ![5@
M            4K>B%KMV<EME+Z_4C)I2R;2K!PL<5'@6P@',MHE)HL%*FB94
M31$;9*)9)\PE%CB [X                          =!<R5JHDU*&R=4;>
M!(4HD$KS#4>!$0#A64E2+>A)<:2PO%W%I"R<2GKGT*3B0"K
M             !0M_(=724$U'1)5VE@^&MU+18<0L3Q5L/=+: K&$1E#BDI)
M)/L[.*2/$DGPT[",MAD0#D@                         "/+H:=7<EN+1
M&0ZA*G=YU3R4*:(SZ4H,\5[2 2$GP2\XOV@&H
M   CN^6W5R*+N142$E(/?-;J6^&1J3M(E&6]AY@"06MC;9&6!DA&SIPZI;,>
MZ W@                         "-I*'3OR$OLB.$3:\9)O)WB/<V$36.\
M>("20                           1Y<#3RKKM\TQ6W&O5M]]3R4*;[VZ
M@^LK$@$A%T%YQ -0                         !0L)#OONJ"CCH2C!)D^
M3J34O9A@;>.\6& "N@
M
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M)[P"I            1FU&3[_ .0_XL,E&TDO&':S,E=0MG9L=F!>8 DP
M       $;WFT2ZS;JSIIS22Z[ZMVHX_9MJ=NX1EQ<>\ D9'@(V8=1.SO;"V>
M@ W          "B[^9XUNOH.$<\N,P9L%([-CURV\3%/0 [^B))%+A))K@D3
M#9$UO\3<ZA=7?V[V #M0         !P*HDET^8E39NDJ.Z7#)6X:_4U=7>^=
MQ[X"E<OF"CV^VV4'L!%(DF3':3E88N=/$,U&>]T^8 KD          ;5[4*V
M8]56S'#'8>S'N8@(\M&.EJNW$XFG=B-Q;6+W:C?[21'L/AF?J1D D4
M
M                    ?"5]S2/XAW[&H!8-/^XJ]_;<7^?D)WEZ/47YTW^C
MH'\BB_8&Q"RYH
M            (ZS?_11F9_<"\?R>J(KN_7A<NO7AXB^6W^BG-3^_MV_E+(&C
M9U^^R\1]M7\X5^7C7\%T#&NJ8W&H  NYT&_[P\#^+D?Y#8R>4_O=/E=J]BO\
MZ4^3B>@;NF-U>V(W9<.I0TU&G3Z>M1I1.A2H:U$>!I3*86PI1&6W%)+Q!+SP
M9\<I/1YI'T_:S=0%MY?1KES?S(M>X:W5+OKQ,5&7$F'$G2$'![;&=5&2E;JC
M/=5CT;2VXAB6\C==6];NJEQQ1J5[[JDDL3QP2FMQR2DN\E);" >Y4
M        %)WLV3MN3T'$[<1DWC&XW9^(1+(\.+B6[AT^: Y]M))%%@I*/V4D
MM$7 XG%W,.YQ,3W@'>@                         #HKE03E$G(./VHE,
MF7 XG"W_ #.)B6Z X%DM$S;L)M,3L1)-W[6XW:.'BLS^JXGO$8"K
M                  !068+!/TA"#@'4/MA@^"4GLN&"_"XF)>#TX=T!6D(M
MV'%3N</",R6YO;VY@VGJ[WSV'? <D                          1Q=<<
MEW+;3WBXY)H4Y]M%+X/9]I[>#O$3N("1D^"GN=4MGH -0
M          !'-],)>DT3>IIS]V3L44HX_ ,U%UMTE%Q.CH 2&T6#398;N#:"
MW<<<.J6S'NX -X                          C>4PD[\A/>*]\TM++M_:
M\.&9I(ON;>ZV/G )(                           !'%PQD.W=;KITTY"
MF^+A+*6;1,=/^8WBXN]AWM@"1RZ"[GF                          #0^
MCIP\W#$!0D%G=O"I.G!-!J2C[<[1O$Z1)P^H8GN8 *\
M
M            0[G_ )E2,G\GK^S)BP2J3]H6Y4ZVW"-6X4A5/AO2B;-1J1AO
M<'#I+I >)>F^5@ZF[LJET0LOM%==O2';M:K%+?GT7QA4&D)IE0DQ"<6N _)0
MDW4LD>!F72 R2\KWRE"T=96>\+3'GUE'4LA,U:NZMBWHU;*1%\:R$\!)L*:J
M,A+B3XCID1DGN'T@/4X],B1V"E2)4>/&-*5$^^\VRSNJ+>2?$<4E&!D?? ;8
ML^#.0;D*9%F-IV&N+(:D(+SU,K61 -RID1MQ++DF.V\LC-+*WVDN*(NDTH4H
ME'@7F -&)T*2M;<:9%D.-_5&V)#3JV_WZ6UJ4GT0'P56*2B1V1=4IR)6.[V9
M4V,F1O8X8<$W2<QQ\P!V&\7?_8,!Q':C3V'4QWYT-E]6&ZR[)9;=5CT;K:UD
ML\?. <P!P7JI3([O!?J,%E['#A/2X[;N)["+AK<2O''S &E0J$2GTV95)+[+
M<.%$?FO/K=;0R3$=I3RUJ=4HFR1N(/:9X ,1VB'FVY:ZY]3^HG3UEQ1&8D33
MQ-8@5JY952CI\=27GU1=VGL')5QTMOE@>XD_- 6L7]SH[LM+G"6GRU8V5J)=
M%N%Y32[X.82."E)*4:S8[27522=I[G= >AR/.AR5&VS+BO/((C=:8D-.K;/
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M6]22JW)Y+2I:3)&*4&I*CZY=!IV](#ZV@2"H$ D)4E.X>"5F:E%M[IJV@*E
M          !&;79_S@2"X3A/$TC%PUKW,#;QPW?!Q 28           "-+W)
MCQS;?%;<69/.<,T*4DDF9EX1)V'CYH"2&_J:/WB?VB ;P         !1&8!-
M*MQ\G4+<1QV,4MJ4E7AEW4X'A@ J*AD@J5")!&2> W@1F9F75+89GTF [4
M        =?5</%TS>(U)[.[B1'@9EN*QP,NZ I3+PFBH#?!2M">T2.JLU*5]
M4,NE6W#8 KL          ;5^ O\ >J_:,!&]FDTFOW*2&W$JXC>\I2E*2KK?
M.DK87H )*
M                                   'PE?<TC^(=^QJ 6#3_N*O?VW%
M_GY"=Y>CU%^=-_HZ!_(HOV!L0LN:
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M#Z0'-M9*$T."2"-*>$6!*,S,MA;#,]I@*@
M%/W02%4.>2R-2>$>)),R/T#+: X%C$A-MP2;2I*"-W E&9J+U0\<35MZ0%7@
M                         "/\Q$M*HR.*VMQ/:6-B%*2K$G"P/J[=A@*V
M@X=CB88D79V<"/I(B;3@1^:1 .4                          (TNY+)W
M+;1K;<6X2G-Q25+2E.WYXDG@?=Z0$DI\%/[TOV@&X
M       1I?J6CET(W6G',)![IH6M.Z>\G:HDG@9 )':^I-?Q:/\ )(!]
M                      !&$I#/YP8*C0X3G#7@LEJW#]3/$C3X("3P
M                       1M<26/??;JEM.*=(WMQ:5K)"?WQ$>Z>/F@)(+
MH+SB_: :@                         "/X!-^_*J&3:TN8-XJ-2C0KJ]P
MO!V )
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M&_?WT;]M@;%D$^M&\]*_T]?L<7YOT,LZ=I>B?[8V.B9FVW6],QN-PK2
M    (SGOME?M+9.>I"S2O"$491I<P(S,S?PP3@9 ),           !&^8+R&
MDTO?GJA;TE)%NQS?XA[Y8)/ C-)&8"0V=K+1X[WJ3?6PPQZA;<.YB ^H
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M-PD[YI(D*VDDO" 4OE\ZAVWVU(F*FEQY!<93!L&>#A[-PR(]@"N0
M !M7L0K;AU5;<,<-A[<.[@ C>S7VW:_<J43U2S0XWO,JCFR4? R+ EF1$YCB
M DH
M                             ?"5]S2/XAW[&H!8-/\ N*O?VW%_GY"=
MY>CU%^=-_HZ!_(HOV!L0LN:
M                      ".LW_T49F?W O'\GJB*[OUX7+KUX>(OEM_HIS4
M_O[=OY2R!HV=?OLO$?;5_.%?EXU_!= QKJF-QJ  +N=!O^\/ _BY'^0V,GE/
M[W3Y7:O8K_.E/DXGH&[IC=7MB-V6H)4??MAVOF;:5;L>]*8U6;9N&$]3ZM37
MOJ4N(^VIMUI>P]BD+,@%O.F'0YIFT<LW"QIZRVIE@-75(7+KB:>9'VY]QTGU
MN.'N(/$W$D8"[8               %(WRM*+:GJ7)5$27"QD):-XT>J%_FR(
MS5B8#GVPHE42"9/'((VBP>-LVC67?W#(C(!WX
M   I^Z%I;H<Y:WCCI)OK.DV;IH+OD@MI@.#8[B';;@K;D*E(5Q3)]31LFKKG
M_FSVEAT *N                          % YA.MM4A"G9JH*>TL>JI8-\
M_JA=7<21GUNCS %:03(X<0R5OD<=DR7AN[V+:3WMT]I8@.4
M             (WNM]INYK:0Y.5&4M3FXPF.;I2,.DC<(C)O !(Z?!3W>J6W
MT &H                          C6_76VY=")<]4(U25$E*8QO\8\4XI,
MR(R0 D9KZDW@>)<-&W##'JEMP[F(#Z                         !^86/
MF (RE.M_G @MG4%)7PW,(11C-*NIL,W\,"PP 2:
M      "-+C?;;N^W6E3E,+6;NY&*.;B7]I]+N!DC#SP$E%T%YQ?M -0
M                    !0<!YM5X51OM:E+2EO&,;!DEO%.W![#!6. "O
M
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M)%(-@I!),U='#/$CW@%0451JI<-2G2>,V$&;A)W"6>Z76));$X]X!V@
M     Z^JJ-%.F*2OAF4=W!>[O[O4/K;OSV "F;"<6[06U.34SU'(D>KICE'(
M\%]'#(BPW2V>: K8          ;5>"K;AU3V].&SIP[N "/K2=6NNW"A4],H
MD*;W62C$R<?K%L-PB(W<0$A@
M                                                 #X2ON:1_$._
M8U +!I_W%7O[;B_S\A.\O1ZB_.F_T= _D47[ V(67-
M                                         !'6;_Z*,S/[@7C^3U1%
M=WZ\+EUZ\/$7RV_T4YJ?W]NW\I9 T;.OWV7B/MJ_G"OR\:_@N@8UU3&XU  %
MW.@W_>'@?Q<C_(;&3RG][I\KM7L5_G2GR<3T#=TQNKVQ&[+4$@
M        I6\W%-6]-6F24-1</=D&T3Y(/?+I:,CWL>@!S;;<4Y182E/E(4;1
M8O$WPB7W<=S MWI =Z                          .AN5>Y19JN/V;!OZ
ML;9.DCS=P\24 X5EK-VWH3BI*99XN^KI:)@E]<RV-$1$G !58
M               H+,!];%*;4B8F$9R&2-Q4<I!&1N$1IW#(RVX]("M(1[T.
M*K>W\8[)[^&[O8MIZV[W,0')                          $<76^XW<EN
M(34$QDK4YC'.,EWM!8]!.F1FU@ D9/@I[O5+;Z #4
M       1W?#RFI-$),],,E23)251B?XQ8EBG$R/<\\!(+6UML\=[J(ZV&&/5
M+;AW,0&\                         ,L=A@(WDO**^X315%*4J;7C!.,D
MU+P3T\?#$L, $D                            CBXGU)NRWF_&"8Y*-W
M&+V4G3?PV_5C(S;P 2,707G%^T U                          %"0'5G
M=U2:[:E:$)3A%X!$IO'_ -=ABO'S]@"NP
M
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M%QB:)'$1PS0:34>TO"W=I;.^ D,
M                                                     ?"5]S2/
MXAW[&H!8-/\ N*O?VW%_GY"=Y>CU%^=-_HZ!_(HOV!L0LN:
M                                              ".LW_T49F?W O'
M\GJB*[OUX7+KUX>(OEM_HIS4_O[=OY2R!HV=?OLO$?;5_.%?EXU_!= QKJF-
MQJ  +N=!O^\/ _BY'^0V,GE/[W3Y7:O8K_.E/DXGH&[IC=7MB-V6H)
M            !2]Y$L[?FDV237ZG@2S223P61[35L(!R[:)946$3A)2OAEB2
M3(T^@9;-H#O0                         !T5RDLZ+.)LDFKA'@2C(D^B
M9[-@#@V43A6]")U*4KQ=Q))DI)%OGA@:=@"JP
M  !0M_$[XI1P4H4KM+)8+-)%@:RQPWMF.P!6,,C*)&WL"5P&L<.C'<3CAAW
M')                          $>71QCN.W2;2V:-YS?-9H)1;2\$E;3Q\
MP!(2?!3CT[I8_, :@                         ".[X2\J31>$39D4@]X
MW%(+9O)\$E&6)@)!:^I-X]/#1C]*0#>                          (YD
MH>]_4)1$WPN&O$S4C?\  P+ O",C 2,                           ".
MZ_QSNRW^&ELVTF]Q#4:"66/1ND?6/T $AET%YQ -0
M      !0T(G??943-*";,DX&1IWSP+;B1'O=P!7(
M
M           *:O"ZZ/8]LUN[:^_V6CT"FRZI47\-[A1(3#DE]>&)8[K31GZ
M#!55_*4.5Q1*I5*/.SD>3/I$^939C3=*XI-RH,EV)(0:DS#\%UE1>@ O*T>\
MW+0QKCKKUIY"9PTJOW9'2:G*!-5'I\YTB2VH^RM.2UK?/!U.PBQQ,!DP   !
M1V8%\T++6S;BOJY7G&*%;%*FUBJ/,M*?=;AP8[DE]2&D=9:B;:/ BZ3 6EZ)
M>8/IZU]6_=ERY 5FKUBEV;6'J)67*M19=&6U.8>6PXAIN7UG4$X@^L6P!?*
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M."      (VG1U*OJF/G3"6E*'/M_M6Z;6S B[-CU]['O; $D@
MCF_XYOII>%-*H&F2D]LHHW"ZZ3WMIEOX=X!(3)8,M$9;IDV@MWO=4MGH /H
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MTN'O;F_U%=7>V;N("ELOF38M]I!P2IYD_(]0*3VK#%PSQXI&K'>Z?, 5R
M       -J]J%;,>JK9CACL/9CW,0$=VBPIJO7$XJG%$)U:,)!2B?[3@KI-LE
M'PL,/, 2,
M                                   /A*^YI'\0[]C4 L&G_<5>_MN+
M_/R$[R]'J+\Z;_1T#^11?L#8A9<T
M                           $=9O_ **,S/[@7C^3U1%=WZ\+EUZ\/$7R
MV_T4YJ?W]NW\I9 T;.OWV7B/MJ_G"OR\:_@N@8UU3&XU  %W.@W_ 'AX'\7(
M_P AL9/*?WNGRNU>Q7^=*?)Q/0-W3&ZO;$;LM02                  "D[
MV:-ZW)S:8I33/A81C>[/Q,'"/#BXEN8%M <ZV6U-42"A4<HIDT6+!.\;A_\
M)XGSP#O@                         !T-S(XE%FHX':<6S]1XO!W_ #.)
MB6Z X-DM&S;L-!Q>QF1NGV?C$_N8KQ^JD9[V]T@*L
M       %!9@-&]24)* 50^V&#X)R>S=#A=;B&9>#CCAW0%:0BPAQ2W-S".R6
MYO;V[ZFGJ[WSV'? <D                          1Q=;"G+EMMSQ<4HF
MU.'VGM9,]FV[3X.)&]B D9/@I[G5+9Z #4
M1S?,?C2J(94TIYHD*/>.5V;@;4];#$N)YP"0VMC;98;O41U<<<.J6S'NX -X
M                          C:5&5[^X+_ (N)1$A1G/[61&C%'1V8SQ5C
MT ))                           !&]PQS<N^W5III/DGB[TPY1-<#SF-
MXC=QP[VP!(Y=!><0#4                          4'!9_P"]U1=."22,
MDX3.T8FY@6W%C'J8 *\
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M*V52$FE.+*7#:->WH)98&0#?:*4HM^ E#*F$DV9$TIPW33UC^?,S,P%2@
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M5ZY%(B.1UJ6WO.+>4X3N"NE*3,R1T]P!)0
M
M^$K[FD?Q#OV-0"P:?]Q5[^VXO\_(3O+T>HOSIO\ 1T#^11?L#8A9<T
M                                                     $=9O_HH
MS,_N!>/Y/5$5W?KPN77KP\1?+;/_ .]1FI_?V[?RED#1\Z_?9>(NVJ8ZX5^7
MC7\%T#%VNJHW 3: 6B[G0;_O#P/XM_\ R&QDLHTXN/*[6[%8F-LZ9WO^#T#]
MT_0&[O:^^U$)                  !2E[);7;D]+C"I"#)K%I+AM&KU1.&"
MR,C+ P',ME*4T2"26C923>QM2S<-)=[>,S,]H#OP
M     !T%SI2NB3DK:-Y)M&1MDLVS/'9L41D9;0'7V,A#=MP4MLJCH(W<&5K-
MU2>N?2M1F9@*O                          $?YAM-NTALG8BY:"DLJ-M
M#ZF#Q2X1D>\DR/9T@*VA$10XA$G<(HS&"<=[=+AIP+$^G @'*
M               $:W:RRNY;;6Y#6^M"G#0\E]39,[<-K9&1.8X=T!)*?!3W
M.J6ST &H                          C>_&VER:&;D1<DTRNJI#YM<(]X
MNL9$9;Y&0"1&MC39$6!$VC9TX=4MF/= ?0
M1I*;:._H*SB+-TFW,)/'/=26YT&SC@>)>8 DL
M    $;7$RTN[[;<5#6ZM!N[D@GU(2STX[S1&1.8@)(+H+SB :@
M               "@8#317A4W"CJ)PR1O/FZ9I5YS>.!88@*^
M
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M]BNCN )(
M                                  'PE?<TC^(=^QJ 6#3_ +BKW]MQ
M?Y^0G>7H]1?G3?Z.@?R*+]@;$++F@
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M,SQ,!SK7-!T. :'%.)-HL%J2:%&7FI5M+ !WX
M   I^Z%(30YQK<-I)-'BM*369><DMIX@.!8RT+MR"IMU3Z#-WU52#;,\%F6!
MH,B/9T *O                          $>YC.-MT=LW9"XZ>TL%OH:4Z>
M)N%@1DG:1& K>!]Q1-IJ(X[)DHRP,R-M.!F7<,R <L
M        1I=JVDW/;1.27&EJ4[PVDM*6ET^Z2E)V)]$!)2?!3W>J6WT &H
M                        C6_7642J&EV0XP:I)[A(:4YOF2DXD9I\$!(S
M7U)K^+1_DD ^@                          C.4XT5_P4=I<)PVU^H$RO
M<,MSNNX;I8^> DP                           $9W$MHKQMQ"Y+C2U<;
M=92TM:'OWRRV)P 26707G$ U                         #\PL?, 4% -
MH[OJ9<=9NDE&+)MJ)*"P[B_!/$!7H
M
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M9IETQ92Z1\K*%DSDI0/>U8-NH4BETDG2=*.2D-(5UR;:(\2:+N$ N%
M$:S9"DWY3&?&>X2D.8P.R;W%ZNP^TX=7=(P$E            CF_W^$5+_TE
MXOWI"?\ HG:N+UTENX8'NX]&("0F?J+6W>]31UNC>ZI;<.YB ^@
M IB\7>#;TYPY78]U*/MC@\?A]<MO"P/?Q ?6U'.+0H*^T]KQ0?VQPN#O[>GA
MX%N@*B           !&S4C_OY(8\9X^I(/L'9?!Q06WM.'6Q\_8 DD
M     $<WE(X-8MY'C$H1/.N$;79.T=I,C+!._@?"P_XP$B(VH3MQZJ=N&&.P
MMN'<Q ;@         !1=^O*8MY]PIO8")YC&1V<I.[U^CA8'CO= "H**HE4R
M&HG.-O,-GQ-W<W^HGK;GSN/> =H          .NJQFFG3%$YP=UAT^)N[^Y@
MA76W?GL.\ IC+]\WZ VX<[QAC(D>K]F[-C@YAAP\"PW>@!7           VK
MV(5MPZJMN&.&P]N'=P 1Y:+YNUZXD'42F<-3>$?LO [+BHMG%P+C;P"10
M
M                      !\)7W-(_B'?L:@%@T_[BKW]MQ?Y^0G>7H]1?G3
M?Z.@?R*+]@;$++F@
M               C+.G]$&:/^SZ\?R>J(#"WY/H1*TA5I*T-KPS&OC S;1O'
M_P!X).Q2L,3+'OANE5E7K1$RST\%O^ 9^D1^X(LA3R+OFP<%O^ 9^D1^X%D'
M(N^;!P6_X!GZ1'[@60<B[YL-Z&FTGB33:#[Z4I(_FD6(E,4TQ-L1#Z@D
M               !2EZNFS;LYPI78C3PS[3P.T</KEMX.![^/0 YUM.\6BP5
MF_VG%HO5N%P=_P WA_.@.]                          '0W,K<HDY7:>
MR&31F3_#XO#/O\/ ]X!P+)<-RW82^U]NQ-W&5P>S\3!9ECPL$[N'1T *M
M                       % Y@O<"DMJ[>5/,Y+!$\<;M72X1;O#P/PN_W
M%:PL>QQ=Y?$,X[)FO=W=[%M)[VZ7@X]X!R0
M!'-UOFU<EMME4NR$XITNS=DXW:=I[.-@?!P 2*GP4]WJEM] !J
M                (XON3V>31"\8]@WY!EN]E[3Q]J>IO8'PO/ 2(T>+39X[
MV+:#WL,,>J6W#N8@-X                          C>5)PON"QXT))*;5
M_H_LA'OF2#V]IPZN'G[0$D                            CFX9!HNZW6
MBJG9B5Q<89Q"=[1AM^K[I\+=Q[^T!(Q=!=WS0
M   /S"Q\P!0<%]2KOJ+7;]XDDG[3[,1</ MOJ^'6Q 5X
M
M      /FZZTPVX\\XAIII"EN.N*)#;:$EBI:UJ,DI2DBQ,SV$ CI><F4C;BV
MG<SK :=:4I#C;MWV^VXVM)FE25H54"4E25%@9&6)& J2A7G:%T$9VU=5N7!N
MEBLJ+6Z;5#1LQZY09+YHV'W0&E;O.T;:?B1;AN>WZ'*GJW(,:KUBGTY^8O'=
MW8K4R0RM]6]LP21GB J1"T.H0XVM+C;B4K;6@R4A:%D2DK2HL24E23Q(RZ2
M;@        %+2+XLV)6VK:E75;T>X7OJ-#?K-.:JSN/\'3ER$RU^@@P%4@
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M9,.F1F1&1&2%=)'L,@%,V$IU5";XKB'5<>1BM"4H2?JF);$EALQ 5L
M    -J_ 5^]5^T8"/K1-WQU<!+>;<02V]PD(0E2=I>$:=JND!(8
M
M                 ^$K[FD?Q#OV-0"P:?\ <5>_MN+_ #\A.\O1ZB_.F_T=
M _D47[ V(67-
M           !&6=/Z(,T?]GUX_D]40&%SR?+_=%K7^T:]_R@D ,^
M                   I>\C<*WIQM+2VO!O!:TDI)=<L<25LV@.7;9K.C0C<
M62U<,L5)(DD>PN@BV .]                          '1W&:BHTTTK2A7
M#V*41*27?Q(]G0 X-F&XJWX9N+2XK%SKH2E*3(E[,"3LV *J
M              %"WZ;I4ILV74-*[0SUG$)6G#B)Q+!6S$P%8P][LD4U'O*.
M.R9F1$6)FVD^@M@#D@                         "/;H-XKAM\D/MH;4;
MF^VMM*E+P,_ 4>U.& "04^"7G%^T U                          $>WN
MI],BC<%UMLCD]<EH2O>+>+ DFK:1X@*_:^IMX].XC'Z4@&\
M             1U)6[[^82>*WP^&LC:-"=_P,2,E'UO" 2*
M              ".K@4][[;?)#K:$8N;[:D(-;G21;JC+%.Z1 )$+H+SB :@
M                        !ECL,!0\$W??94D\5!M$2"2T2$DM.S$S-72>
M("N
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M:?&8/@*>)@E=<MN^9D18=(#OZ*1IID,C;)H^ WBV2M\D]4MA*[N #M
M    !U]5(U4^61()PS8=P0:MPE]175-7SN/? 4S8+3C5!;0Y$3"43\C%E+Y/
MD6+AGCOD9X[Q8 *V          &U>.ZK#;U5;._LV%CW $>6@TXW7+B4N F*
ME:V]UY,@G3?V])H(S-L!(H
M                                                ^$K[FD?Q#OV-
M0"P:?]Q5[^VXO\_(3O+T>HOSIO\ 1T#^11?L#8A9<T
M                                         $:9SI4O*'-!*$J4H\OK
MQP2DC4H_^[U1Z"(C,P&%KR?+_=%K9'L,LQKWQ(]AE_W@D])=) ,^
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MJZV7'+BMQ:(")*4*<-3ZI"6C8Q/PB;,R-SH 2(GP4]SJEL] !J
M                ([OAIUR31#;@HEDF09J4J03/"+>+K$1F6^ D%KZFWB6!
M[B-F..'5+9CW< &\                         ,\-I@(XE1W/?U">[ A2
M";5]N=I+>1BG^ QQ/'S@$C@                           CJX6'5W;;K
MB8"'T(XN]).23:F,=FQK'%S> 2*707<\P
M%"P4*]]M17V-*4*2G[9XQ&I>!?P6.*0%=
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M-*,6"=-G?ZQ']4(R-. #Z6DA**# 2F.<4B0?J"G>,:-O1Q#,]X!4@
M    (S;CI]_[[_B]1*-I)=M[49DHMSH[/C@6[AW@$F            C6\V"<
MK-NK53SFFAUPB>*2<<HQXEM-!&7%QQ 20CP$;,.JG9TX;"V8]W !N
M   %$Y@-H=MU]*X1SRXS!DP3YQS,]\MO$(RPP 5%14[M+A%P^%@PUZF:M\T=
M1/5WN[@ [0          =?522JG3$J;XI''=+A[VYO\ 45U=[N8@*5R]:2U0
M$(1". GCR#)DY!R#+%P]O$,S,][I\P!70          VK\!>S'JJV=&.P]F/
M<Q 1U9[2&Z]<AI@*BFM;9J?.2;Q2#(R(C)LS/A8$ D<
M
M         ?"5]S2/XAW[&H!8-/\ N*O?VW%_GY"=Y>CU%^=-_HZ!_(HOV!L0
MLN:
M *7O2;7*=:U=FVS3O&UPL4N:JC4_?)LI-2[,YV-HUGL22Y&Z0#S9YKYG<]I=
MOYJ.QLDJ!%MKQ5=*:?A7*0N0U0DQ*BE3Y-$OBJ<[!UB3TX@)V\G554'M#S,F
MX$\&ZG[TNMRXXQ'BEBJ*JRU3&R,MA[LI2RV=X!G^
M      %)7NA+EMSD*BG,2KA8QR=-@UD3A']5(R-. #GVRE**) 2E@XQ$R6#)
MN<4T?\_$]X!WP                          Z"YT$NASDFP<DC:/%DG.$
M:RP/9Q,2W0' L=OAVY!248X9$;OVN;O'W,5_PIF9JQ/: JX
M             4#F"P3]);2<$Y^$E@^$4@XV'JA=;?(R\'IP[H"M()80XI;G
M#PCLEN;V]N8-I+=WOGL.^ Y0                          C:[(Z'+EMM
MPZ>J4IM3GVR4HV2C%B>WA8D3IF1@)(3X*>YU2V>@ U
M        $;WVVE<JAFJGJF[DDS)29)Q^!B:>M@1D3GG )$:^I-X%@7#1LQQP
MZI;,>[@ ^@                          C.4RD[^@N'3U*43:\)O:CP06
MYT=GQP/'HZ $F                            CBX64KN^W7#IRGS;XN[
M+*2;9,F98[6<2)S']@!(Y=!=SS                            4' :05
MX5-PH2D*-*,97'-1.8%_ XX(PQ 5X
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MR%K_ +QU22]=&@;.J1I\SXJSIOW5!A1C5 N24:7U]I6TPPVSM>4DS):L=G=
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M)-ED/H)         !&<XV??[3",W"=W5;A$2^'X)[V)EU0$F
MC?,$V"*E&\;A?;:,.&2CV[Y=.[W $AL?46<.CA-X?2$ ^H          I:\]
MSWNS^)O;FZC'<WC5X1=&[M ?6TC0= @&WO;AMF9;V)*Z>[O;0%2
M   C%K@'F$_M<XI,IV8+X9=3#I\'$P$G            C6]C9*LV[Q#<)9NK
MX>X2MTSWBQ)6[L+T0$D(\!&'1N)P^80#<          *(S!)KWN/F\:R23\?
MZF2C5M67T.WN *BHF[XKA;N.' ;PQQQPW"PQQVXX .U          '7U7=\7
M3-\S)/9W=XRQ,\-Q71AMQ 4IEZ3!4!OLYK4WVB3M<)1*QXFW8K;W0%=@
M     #:OP%?O5?M& C>S39.O7+P^)O[[1N;Y*))&9EAN[VP_0 24
M
M                  /A*^YI'\0[]C4 L&G_ '%7O[;B_P _(3O+T>HOSIO]
M'0/Y%%^P-B%ES0
M             1KG*XMK*/-!QM6ZM.7UY;JB[A^]VH[0&%KR?,S/2-6S,\3/
M,>^#,^^9W!),S 9[P                         !25[[GO;G<0U$CU+$T
M[V\77+HW=H#G6QN>)(.X9FGA[#5CCZ..W: [\
M   4_=!(.B3N(9DGA[=W''N]&[MZ '!L?A^]R%PS4:,7<-[>Q\/;X6T!5P
M                        C_,3@^*&^*IQ)=H9PX9+,S/B%@75[F("MH6'
M8XN!XEV=G;M_@T]_: Y0                          C2[.%[Y[;WS<)P
MS<-LT;^[B6.._N[/F@))3X*?WI?M -P                          C6_
MB8.30N*;A'VKJ;A+/'%1%UMWN )&:^I-_P 6C_)(!]
M        !&<DV"O^"2N)QE-.[N&_P]C?=PZN.P!)@
M        (UN+@'>%N;[BR=Q>W$I)1I/]\9;.Z DDN@O.+]H!J
M               *!@<'WXU,B-?%(D;Q'O;F![>KCU>@!7P
M
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M^X8"M      !&LYY)7W3&O&1H-25GV#LIF3F".GM&'5PVGT@)*
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M1W?5-W?W.HH][=^>P[P"ELOWB?H#:BG'/^V)!<<X_9C/!P]G#P+P>@!7
M       VK\!>W#JJV].&P]N'=P 1Q9SQ.5^Y$%43E[JV\8YQ38*,>]M(G#(N
M+B9@))
M                                'PE?<TC^(=^QJ 6#3_N*O?VW%_GY
M"=Y>CU%^=-_HZ!_(HOV!L0LN:
M                        ",LZ?T09H_[/KQ_)ZH@,+GD^7^Z+6O\ :->_
MY02 &?                           4I>SA-6Y.6J4<))<+&03)O\,C<+
M_-$1FK'H <ZVE$NBP5)D=I(VB]6-OA;_ )O#P+= =Z
M        .@N=9-T2<LW^S$31XO</C;A;=O#P/> <&R%DY;D):91S",W?M@V3
M8-?7/_-&1;N[T *M                          % 9A/<"D(7V\Z>7:6"
M-XHW:3VN%U>&1'X?1CW %:P3)4*(HE\0CCLGO[N[OXMIZVZ?@X]X!R@
M                    !&]UOI:N6VVU5)44W5.81BBF]VC#I+C$1DUAAY@"
M1T^"GN]4MOH -0                         !'%]OI9DT0E5$X)+DF6Z4
M8Y''P4GJ8X'P]I]("0VMK39X[WJ:.MAACU2VX=S$!]
M        !&DI\BOZ$SXR-)FVL^P=E,R7@GI[3A@G O- 26
M             "-KC?0B[K<;.HFPM9NX1"BFX3^'?>PP;W/V0$D%T%YQ -0
M                        RQV& H& X1WA4F^W&LT$G[3[.9$UB1_Y_#!>
M/_$ KX
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M2G'75[QECM/N@,]H      C><\Z5]4ULIR$M&A>,0XZ34LR3L,GL-Y.& "2
M           1[?CKK::83<U$3?DH(]Y@GM_KEL(S(]T!7S/U%K;CZFC:188]
M4MN'< ?0          4S>"EIH$U3;Z8RB)&#RFR=)/6[J#(R,!]+46I="@J6
M\F0HT'B\ELFTKV])((B(@%1            C9IUWW^R&^V(-HFD81.SEOD9M
M[3XV&\8"20           1Y>#BT5>WTIF(C$IQ>\VIA+JGB(\<$J,C-O872
MD%'@(_>I\SN%W.X W          "C+\<<;M]\VI28BC>9+BJ9)\B+?+$MQ1&
M1F9 ._HN)TR'BX3I\!O%9)W"49H29F22(L-H#M          !P*H9II\M1+X
M9E'=,EFG>))DVK;N]W !2]@..N4!M3LI,M?'D8NH9)E)^J'LW"(L-TM@"MP
M        !M7X"L-A[JL#] P$?6BX\NN7"ER8B2A"T$AM+"6E,XJZ%+(B-S'
M!(8
M                             ^$K[FD?Q#OV-0"P:?\ <5>_MN+_ #\A
M.\O1ZB_.F_T= _D47[ V(67-
M                       !&6=/Z(,T?]GUX_D]40&&'R?1EQ.D"K/*(N&[
MF-?&X9*(S/"OR<<4])"(F)39-EK/6)0                         *>NB
M).G467'IRT-RU\/A*<2E22P66.*5=4]@B9B-,[@Y=$C2XE,BL3E(7);1@ZI!
M$23/S"3L")MBT=L)   .@                      =%<JE(HLU27B843>Q
MTT$X23\U!](#K[(6MRW8:W'TR5F;N+R6R:)76[B"V%@ JT
M            4%F XZW2FU-2TPU=H9]44R3Y&7$(MW=41EU@%:0C,X<4S/>/
ML[.*B+#>]33MP+86(#D@                         ".KJ>=3<=NH;FH8
M0:G-]A3"73?P/$B)9D9MX>8 D1/@I[O5+;Z #4
M    1U?2W$2:*2)B(I'(P4E;!/<4MY/5(S(]P!(36UMLS/$S0C;T8]4MN'<
M;P                         !&\E;QWY#;*:@FB;6I40V$[R^ICL>PQ+
MRQZ0$D                            CJXGG4W9;K:9J&4*-W>CG'2M3V
M&TL'3(S1@?> 2(707G$ U                          %#0773NVHH5*0
MILB228Y,D2D;#Z7<,58F KD
M
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M&FTCQ2_7*F[#A1>R281%$C.REQXZDL.=*$%M(!8_DSRL\I,P^>7G5HZJ%X7
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M>+;RZS;W"CH=(G'-]Q3B$&V1J+#!*CQ5C@ D-'@)QV'NIQ+T" ;@
M !1E]I<7;[R6FD/+-YCJ+6EM.&_M/?49$6 #OZ*2BID,E))"B91BDC)1%@DB
MP(RV'@ [0          <"J$I5/EDE)+/@.8),R21]0]AF?00"F;"2XB@MH<9
M0RHI#^*4.)<3M7B1[R<2,SQ,!6H          VJ\%1?\E7[0"/[20ZFMW"IQ
MAMM*EM[JTN)6:\#[J4GBG#S0$A
M                                                    #X2ON:1_
M$._8U +!I_W%7O[;B_S\A.\O1ZB_.F_T= _D47[ V(67-
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MH7%Z)#^/U97>'6NWNSN R&;JK!4\F+S>X6Q9)F-_C.5[R;8>L =:4Z(LWX;
M"H                  !T5RI4JBS4H0EQ1M'@A2B21^>9X$0#@V6E:+?A(<
M;2TO%W%M*R<277/H4G9M(!58                          H2_B<52FTM
ML(?,Y#/56XELB]43MQ49%B0"LH9&42*1D23*.SBDMI)/AIQ(C[I$ Y(
M                     CNZD.JN*W5-L(<2E3F^XIQ*%-GB>&"3VK[G0 D-
M/@I[G5+9Z #4                          1W?+;JY-%-MAMXDR#WC6ZE
MO<Q4DB,B/:H!(+7U-O\ >(\WYTN[W0&\                          1Q
M)0][^H:B8;X6XO>>-U.^1[FS!&.\>)D D<
M $>5]#AW90%%';6A)N[SJG4I6G'HW4'UC] !(1=!><0#4
M           4+!;>*[:DI;2";-*-QXG$FM??Q;+:7_S *Z
M
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MX\IMIU/HD S[      "-I\?&^J6^5,W]U*R.?VO=X6*"V=FQZV/G ))
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MF+#I</>W-_J*P3O?.XF I?+]@H] 0@H'B\NT2#X':>U88N=/$Q/PNGS %<
M        #:O:A6S'JJV8X8[#V8]S$!'5GQR9KMQJ*G]CXCC9\;M7'[3@9=;<
MQ/A;O> 2.
M                                   /A*^YI'\0[]C4 L&G_<5>_MN+
M_/R$[R]'J+\Z;_1T#^11?L#8A9<T
M                           %"9H_HRS%_N+=W_8%0%%Y^SGR)C=?C39E
M?I\SQ_OY<_Y15(>BNSF/_P ?IICU?^#KS/)MQ]5NM3^)]\_FC>+(8G08GWS^
M:%D&@Q/OG\T+(-!B??/YH60:#$^^?S0L@T&)]\_FA9!H,3[Y_-"R#08GWS^:
M%D&@Q/OG\T+(-!B??/YH60:#$^^?S0L@T&)]\_FA9!H,3[Y_-"R#08GWS^:%
MD&@Q/OG\T+(-!B??/YH60:#$^^?S0L@T&)]\_FA9!H,3[Y_-"R#08GWS^:%D
M&@Q/OG\T+(-!B??/YH60:#$^^?S0L@T&)]\_FA9!H;5F?#<VG]3<[O\ R%";
M(1-ECV->1_\ ](:H/_M-^U31U)VJ:/R_G;5LQ_C>YP=,1NRV\%0
M         #HKE:XU%G(X':<6C]1XO!W_ #.)\Z X%DM<&W83?9.Q;AN_:_&[
M1P^L?^=Q/>Q 58                          *"S!8[12$(\7^,3[0P9,
M]I[+A@O'>XF)>#TX=T!6D(MV'%3N</",R6YO;VY@VGJ[WSV'? <D
M                  1Q=<<W+EMMTJ9VO<4YC)[7P>S8GL/@XEQ<< $C)\%/
M<ZI;/0 :@                         "-K\8)Z30S.F]OW))GO=J[/V?K
M)P7NXEQ<>\ D9HL&FRPW<&T%NXXX=4MF/=P ;P
M   !&DF/C?T)[Q9O$EM>$_M>&YU,3+LV/6Q\[8 DL
M        $<W%')=VVZ\=,[1PS=PF=KX79\>[P-XN+O?L )%+H+SB :@
M                    "@X+)%>%2=[ :#4E/VYVG>XFS^ QZF "O
M
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M=W%)&9&?45L(RVD9F I7+Q#:+>:)ME;"2?D%N+6IQ7U0]N\K;U@%=@
M   #:OP%8[2W58EZ!@(WLU#!5^YE-L.-+4XWOK6XI:5GO?.$>Q/1W $E
M
M                      #X2ON:1_$._8U +!I_W%7O[;B_S\A.\O1ZB_.F
M_P!'0/Y%%^P-B%ES0
M                4)FC^C+,7^XMW?D_4!1>?LY\A&Z_&FS*_3YGC_?RY_RC
MJ0]%=G/^@T^&IUYGG[_5Y5/#>6*                              !M7
M]3<_BW/\A0$[CV-^1_?TAJ@_^TW[5-'4G:K_ /;MIV8W:WN<'3$;LMO!4
M                I^Z"0JASR6A2TFT>*4J-)GYQIVD X5D$TFW(266U-(+B
M$2%J-:D];$\5*VGCB JT                          1_F(AE=&03S2WD
M]JCF26UJ;/$G"P/%)D>!8@*V@X%"B$1&1=G9P(^DBX:<"/S2 <H
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M4%#!7A4U):63IDC?<-:C0K$C(B)/@E@ KT
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M*D\2:N'O2DI(TQU/[^*R+ ]TCW0$BL_46MN/J3>W##'JEMP[F(#Z
M  "E;T4A%NSU+?5&224&;R6S=-/6+YPB,SQ ?6T5H<H$!;;ZI*#09D\ILVC5
MM[J#(C2 J4           $9M2&_S@/L=N6I?"2KL?9E$E/4+ ^/A@>SS0$F
M           C:]'6VZW;B5S5QM]QPB;2PITGNMW5D1\/#S0$CH\!&W'JIV]&
M.PMN'<Q ;@         !15_K;;MUY3DI4,B?C^K)9-\RQ7AAN)(^G$!4%$,C
MI<(TN&Z7 ;,EFG=-1&DCQ-/<QQ =J          .OJJB33Y:C7PR)AW%9)WC
M3U%;=WNX *5R]>0]0&U-RU3$<>01/*9-@S,E[2W#(CV *Z          &QSP
M%'WD*P/O=4P$=6<ZTNNW(A$U<E:'&]]E3!M$QB9;"69$3F("2
M
M               !\)7W-(_B'?L:@%@T_P"XJ]_;<7^?D)WEZ/47YTW^CH'\
MBB_8&Q"RYH
M         *$S1_1EF+_<6[OR?J HO/V<^0C=?C39E?I\SQ_OY<_Y1U(>BNSG
M_0:?#4Z\SS]_J\JGAO+%                               VK^IN?Q;G
M^0H"=Q[&_(_OZ0U0?_:;]JFCJ3M5_P#MVT[,;M;W.#IB-V6W@J
M         =!<ZR11)RE.FR1-'BXE!N&@N^2"(S,!P+&6ERW(2TOJDI,W<'E-
M&R:^M_!F1&6'0 JX                          4!F&ZVU1T*<F*AI[2Q
MZJE@WSVN%U=TB,^MT8]P!6D R5"B*)6^1QF3)9EN[V+:>MN]S$!RP
M                  !&EV/M-7/;:535,+4IS=CICJ=)_IZ7"29-X )*3X*>
M[U2V^@ U                          $:WZZVW)H9.35Q-^3@24QU/<4]
MXL2,R(]P!(S7U)O \2X:-N&&/5+;AW,0'T
M$9276TW_  FSFK)Q3:S*(4=6ZHMS:9O8;I=("30
M      1M<;K:+NMQLYRF5K-W=C%'-PGC\UW#!&&("2"Z"\XOV@&H
M                 ?F%CY@"@8#C9WC4D%+6I9)0:HQLF26]G1Q>A70 KX
M
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M7;J3R(S.U1W-'K.1&H.ZH--B9?MLQDQ[>C3I\/=@+D(D,H2[%ARB(R/$R/N
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M1A(-DGR;ZQ;>$9&2L2 ?2TU&NA05*DE+,T&9ODT3._MZ>&1$20%1@
M    C9IYP[]?:\9I-)-I^T.REO)]3+;VG=Q/HZ $D@           CF\GUM5
MBWD%42AI<<<Q9.*3YR3Q+ B69'PL $B(VH3MQZJ=N&&.PMN'<Q ;@
M  !1=_.K:MY]:)A0#)YG[8-@I))Z_1PS(R/$!4%%4:Z7#4ITGC-ALS=).X2^
MJ6W<^=Q[W< =H          .OJIX4^6?$X6##GJF[O[G45MW>Z IBP'5.T%M
M2II3S-^1ZL4<HQ'ZH98;A$1; %;@         #:LNJH^@R2K ^G#9TX=T!'M
MHO*=KUQI54$RS0MHB8*,3)QRQ+$C<(BXN("1
M
M  !\)7W-(_B'?L:@%@T_[BKW]MQ?Y^0G>7H]1?G3?Z.@?R*+]@;$++F@
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M&/< 5G"/>AQ3W^)C'9/?W=W?Q;3UMWYW'O .2
M   ([NAXV[DMU!5%,;B*7]K'%)WM&!GL)XR/A88 )#3X*>[U2V^@ U
M                    $<WR\IJ31$IJ!0=^09&DXI2..6\75Q,CX?G@)#:V
MMMGCO=1'6PPQZI;<.YB W@                        !^86/F (WE2%^_
MN"SXQ2E)MK^T>RD9KP1T]HPQ3A^R D@                           $<
MW$^M%VVZTFI$P2^+C#[*3AOD1]!/X8M88]PRQ 2*707G$ U
M            :'T=&/F8X *%@.J.[:BWVU*TI2G[4X&!M&98X<?#KX@*[
M
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MW1]8?_;%MC"9US9Y.GV7CS^JN8C'8"W?M_2R/$>(^ML:-#R+OM1(
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M6[Q&^'N;N]AO?/;NWH[X"00
M                                                !\)7W-(_B'?L
M:@%@T_[BKW]MQ?Y^0G>7H]1?G3?Z.@?R*+]@;$++F@
M                                         H3-']&68O\ <6[OR?J
MHO/V<^0C=?C39E?I\SQ_OY<_Y1U(>BNSG_0:?#4Z\SS]_J\JGAO+%
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M>X1X;V&[YF..S#$!P;+)PK>AD[N[^+N.YAN^&>&&[L 54
M           *%O[B^*4<$D&OM+.QS=W<-\L?"V8X *QA8]DBXX8\!K'#HQW$
MXX>8 Y(                          CZY^+[XK=X?#W-]S?WMW?[F&YCM
M^8 D N@O.+]H!J                          ([OCC]IHO!X9EVA6]O[N
M/2GP=[NX )!:^I-X]/#1C]*0#>                          (YD\?W]0
ML";X/#5O8[G$VH/##Y[88"1@                           1W7^/[Z[?
MW.'P\7=_>W=_IV;F.WI 2&707G%^T U                          %#0
MC=]]M1+J<,DHPPW-XCP/''Y[# !7(
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M_*29D W@     "-YS"ROFF/^+DN()+A'.[423:(T='9\<5X^< D@
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M,VR,S:W< $B@
M                                     #X2ON:1_$._8U +!I_W%7O[
M;B_S\A.\O1ZB_.F_T= _D47[ V(67-
M                             !0F:/Z,LQ?[BW=^3]0%%Y^SGR$;K\:;
M,K]/F>/]_+G_ "CJ0]%=G/\ H-/AJ=>9Y^_U>53PWEB@
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MFH)@I)FT>#)N<(E^9O\ SH#@V4VIJWH;:HI0S(W?M<GB?W,5G_G2,R5B JL
M                         4)?[2G:2A*8!5#"0P?!.24;H<QWN(9EX/3A
MW0%90R,HD4C3N&4=DMS'>W,&TEN[W=P[X#D@
M ".KH96NY;<7XO3*2A3A]J.2EGL_3MX.)&YCB D1/@I[G5+9Z #4
M                  1S?3"W9%%4BGE-W)&)K.24?@=9."L#,N)YP"0VMC;9
M8;O41U<<<.J6S'NX -X                          CF3'<]_4)TJ<E2"
M:69SNU$2D8HZ.SXD:ND!(P                           ([N!@UW9;SG
MBTGR0;N,LY1-G'Q[O!,RXF/G; $B%T%W/,
M _,/#S0%#06C3=M2<[ 39+2C[;[02C=P+''@XXHP 5R
M                                                      "R34%S
M$](&ENZHUEYY9PT"Q+DEMD['IU3<)#KB#0I9&6*T_.H,!!L+G2<MFH3XM-BZ
MFK(5*FOM1XZ53&4)6ZZM+:$[ZGB26*UD6WH 9);-O6U<P;=IEV697J9<=O5B
M*W,IU4I,V/.B2&'4DM"DO1G'48[JBQ+'$@%4    M*<UQZ8VM0:-+2\SZ,G/
M-Q9-IL0UEXSWSZ"W=[':?F .-?.NW3#EQGM;NFR[\R(5*SCNO=\1VDN,\N1-
MWTDI.Z\DN$G$E=TP%WB%I<0AQ!XH6E*TGWTJ(E)/T2,!N 1OF+F]EOE-$@3<
MPKOH=K,U24W#IR:K4(L1Z=)=6EI#41A]YMV0HUJ(NH1[0$8ZB=7>0>E.Q(&9
M6>E\1+*LZINQ&856E,NOMO+G;G9"2EHC5ZJ2R/T0$MY:YDV=F[95"S"L&K-U
MRT[EAMSZ/5&D*;;EQ74DMMU*5D2B)25$>T!78       .._&C2"(I4=B0E/6
M23[+;I),NZ7$2HB 6H1M<>F!_/[_  N1LSZ(>=Z3-LK#2I*:D1IV;I()6PB\
MX!=N L_S UWZ7\K\\;9TY7KF1"H^;]X*2FW[4<C/KD3S41&1(=27#3X7=,!=
MZTXEYMMU!XH=0EQ!]]"R)23]%)@-X  MYU':I\C])ME%F%GO><:R;3.6Q"*J
M2F77F^TR7":9;W6B-6*UG@ DK+/,NS<W[)H.8=@5=NNVE<L-$^CU1I"D-RXK
MB24AQ*5]8B4E1& KP!25\WQ;66]J5J];PJ**3;EOPGZC5J@XE2T18D=M3KSJ
MDIZQDAM!GZ "#M,VL33[J_M^KW1I_OJ+?=$H<]VFU.9%8=CIC3&7%-.,J)XB
M,S2XDR 7/      #H+HMFD7C0:G;5>85)I%8B/0:A'0XIHWXLAM33K7$1@I)
M+0LR/ !BBS3Y/O+Y@Y?9EUQ61T94LK7NRN.O%6JF;JY[=*J$XGR-QU:264GK
M%B1D1]P1,V4R1%K\WFW==6L_("Y<R,ILD<[JO8^6=KWG<L&W;8C]J<8IL-FN
MS8[32%(F,IQ2U'01F1%C@._MALCRC%9%=WV*NXKJF-UHN<X[$W6.]W<6Q%NG
M3HL\EGZ54GS2^9-^LU7?K<[\(C:9V;R&W]A'"Q_S#$Q_C/C2^9-^LU7?K<[\
M(AU;R'H(X4?,<3SSXTOF3?K-5WZW._"(=6\AZ".$^8XGGGQI?,F_6:KOUN=^
M$0ZMY#T$<)\QQ///C2^9-^LU7?K<[\(AU;R'H(X3YCB>>?&E\R;]9JN_6YWX
M1#JWD/01PGS'$\\^-+YDWZS5=^MSOPB'5O(>@CA/F.)YY\:7S)OUFJ[];G?A
M$.K>0]!'"?,<3SVJ^:7S)2;=/_$U7=C+IE@B=L/<5MVU$Q$;-Y'.Y<0IC,<;
M;HJEZU_)6=3>HO4?1=1M0S]S,J68<FD.4@J0JH*D*["3BJ?Q-SCR'BZW$/H(
MND=5]I.59=E]YAYPE,17-MOI;1D&*O,1-Y,VQ1XYMGALCZ'K_3W?//\ ;,=6
M0V2'%J%0@TJ%)J-2EQH$"&P[(ES);[<>/'890;CCCKSJD-H0E"3,S,R(B(5)
M>.'GX>4)V]DO:<_35H>OMBOYY5&8F'<MXT$T38-GDQ(E-.1TS8D_L[QNJ83B
M9X8& S(<B'/'-O4)R^LKLR<Z[D=NN_:QVLZK6'B4E;ZDMQ%$1I6Z\9;BG%?/
M& S-      "-)S39W[3'#@K6LD.;LLI"DI;ZF&!LX[JL0$E@           C
M;,%EITJ5Q82YF[*29$F0IC<P46T]TRW@$B,;&6=F'J3>S''#J%LQ[N #Z@
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MZ1H)1H-1&@R,B46&&) *5R^:0S0&T(B*B$4B09MK?-\\3<Q,]\S/IQ 5T
M       -J_!5WMU6)=_9W^X CBSFD-U^Y5(AKC[[C>+RGS=)\R/I2@S,F\/,
M 22
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M8     X=1GQJ5 FU.:XEF%3H<F?,?4>"6(L-E<B0ZK_DMLMJ,_. 6@9&:_\
M2?J1OVX\LLF\V:)>=Z6G(?BUZBT]1*?@OQG#9?0YUCQ-MTMT_- 7E@**S#S"
MM+*NT*U?E\U9BA6K;T1R=5ZK),B9AQFDFI;KF)EU4I29^@ A'33K,TY:O:?7
MZII]S'I.8,&V978JV]3%$909)+X?#<+>49'O@+HP   4)FC^C+,7^XMW?D_4
M!1>?LY\A&Z_&FS*_3YGC_?RY_P HZD/179S_ *#3X:G7F>?O]7E4\-Y8H
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MR,@' L=*$6W!2B.<5.+N#*G#>-'7/_.'B9XX *N
M     % 9A-MN4=!.0U3$]I8]32^;!_5"ZV\1D?5Z0%:P2(H40B1N$4=DMS'>
MW?4T]7>[N #E                          "-KM9:=N6VE*A+?6A3II?3
M(4V3)X]ULC(G,?- 20GP4]SJEL] !J                          (UOU
MIMR30^)"7+W9)FE:7S9X)[R<5&1&6_T= "1FOJ3>!8%PT;,<<.J6S'NX /H
M                         (SE,MG?T%TX:S<)M9)E%(424EN=!LX[IX@)
M,                           !&ER-(5=]N.JA+>4@W23(*0IM+./?:)1
M$O$_, 24707G$ U                          %!P&6RNZIN=E4EQ1(QD
M&\9I7@6W!K'!("O
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ME;T4A%N3U.+4VDDMXK2DUJ+KET)+;M ?6T30= @&VM3B#0>"U)-*CV]U*MI
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MGG'%)6WOH6VM"48J+P35L5Z "20
M                                                    !\)7W-(_
MB'?L:@%@T_[BKW]MQ?Y^0G>7H]1?G3?Z.@?R*+]@;$++F@
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M:PLM<BM*]T:H6IOOOL2GVYXVI\RV2.M%-1/I[\B MI--6ZI:34E._@>*<=N
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M,K]/F>/]_+G_ "CJ0]%=G/\ H-/AJ=>9Y^_U>53PWEB@
M              ;5_4W/XMS_ "% 3N/8WY']_2&J#_[3?M4T=2=JO_V[:=F-
MVM[G!TQ&[+;U"9FY=6OFU8ET9=7E3F:I;=V4:?1JI#?2E:%QYT5V,I6ZM*DF
MI!.F98D>TA4/"9G+Y/!S)-(&>][W=RQ\\IE#RZS GSI\RA(FN0FZ:FJ/R'UQ
MNRDB.RHXR5H01D1X$GIPP 9">3GY/_F?I[S]DZVM<V8!YF:A52%R*1%E833I
M<E\F7G9*Y3T=>_NO)41$2]GS3 >N0B))$DB(B(B(B+81$6PB(N\1 -0
M        !3]T*0FASS6LT)X1XJ2DU&7G$6TS <"Q3;5;<$VEJ=1B[@M:30HS
MWCQQ2K:6&("KP                         !'V8BV44=OC.K:2<E@M]M"
MEJQ-Q.!8)Q/ SV *W@X'"B&1F9=G9P,^DRX:<#/S3 <H
M          1M=KC*;EMI*WEMK4MSAH2VI:5X'CUC+8GT>D!(Z?!3^]+]H!N
M                         $:WZZTW*H1./.-;TD]W<;4O>,C3TFGHV@)&
M:^I-?Q:/\D@'T                          $92E->_\ @IXRR<X:\&N&
MLT'U#QZ_@D9 )-                           !&EQ+93>%N)4\XAQ9O;
MK:6UJ0O C(]Y1;$[# 24707G%^T U                          % P5-
M'>%223RS<(D[S1MJ)"2PQ+!?@GB KX
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M           !&K;_ /W^?:\9[":3_H_LG09H(L>T[O6Q\_8 DH
M $;WG(-FL6ZDJEV+B.N$;/9>T=J(C+J;^!\+#O@)&1X"-N/43MZ,=A;?1 ;@
M         !15_O<"W7W.W>+\'V/MCL_:L,5]'"P/'$!4-%5OTN&KB\?%AL^+
MN</?ZA=;<^=Q[P#M          !U]4/=ITQ7$X.['>/B;N_N8-JZV[@>. "E
M[ ?X]!;7V_QC]L2"[1V;LN.#AEAP\"\'HQ[H"N          !M7L0K;AU5;<
M,<-A[<.[@ CNT)'&KMQ(\9=LX2VR[/V7@=EQ/HXF!<;>P 2,
M
M              /A*^YI'\0[]C4 L&G_ '%7O[;B_P _(3O+T>HOSIO]'0/Y
M%%^P-B%ES0               0CJ2_0/FS_<&Z_^PYX#\[/D6:3LL]<>;W,@
MR$S.IT:6NJU"Y56M47V677:74F94U4;@J=9?4DU27DGU=OH@*$T8ZO+[Y84#
M71RO-4"JI'L^O)K\"P#JZI1L0V%^,&82J>F6]'0;<IIA*CW&L-O>P 9A_(_V
MSI&66K"6GU5#=?G5.*?\+&>G(FQL"+#PFB3\T!COB4)WFL>47U:P-14VHUG*
M/*NX7RI-@S)\ENF*:I<Q7!;33GER(KA*ZV.+>!D9 /4%SCN6GI#OSE\9L1DY
M36M;56RVLEZHV1<- ID"C52BS*-#=7$=[;3X34AP_4]IXD9JP/$!C*\E2SSO
M74#H5STR'SDF'?\ :.5CU?HM"9N-)UA*J632X11EKJ:YA.[C24[N)=4RQ(!B
MLY+^7>7MT<^/4K9U?L^C5>U*1<5>?HU!J%/A3*737XD]Y<=QF#(8=BH)+J",
MMU!& _1VIM,I]'@QZ;2XD>! B-I9C1(K2&([#2")*&VFFTI0A"4D1$1$18 +
M!.:-JB@Z1=$^=V;ST]B'4J?:-6IE%2XZVAUZI56G3(K!,DIYE1K09F9&D\2,
M@'B!\G*UN:'M)ERZC-1^L3,MFV<ZLV+BJC]-<GPE3Y3=-G5#>?2U(<=2X?$8
M<46&^9;N("U+5#J[T_Y4\[:RM:.C*\&ZGE?=5WT9-SO0650(R%U6KM-S%K0A
MYHEH<4Z1]99[.D!^A#K$O>C9D\N[,V^:',8J5+N3)J566)#*T.LN',MER4M.
M\E2TJ-"W#(]I[0'C0\E T09(:@;\U#YZYK4&%==5L:\ZTS;-OU#@R*7"<E5E
M!..R:4^R]%D(QQPWBV8@*]\JOTFY/:5[RTSZL,@;?C98YHRKUIK%2E6H2*(U
M/[/5^(VKL]*:A)(L4I)1;V)D0#(YS?,R*[FKY/M9F9%UF4VX:W95IE4'WD;Z
MGGO$W9DON)6;AFO82C,S,S/: ^/DRO+LTWKT)T?.^];-H5_WSFBJ8U5I-PQX
ME:C0HC;+#:H\6).C/HB+6EPMJ#+H 84=<>7=N<O#RAC)1S2\T]EW0K\N.BO5
MVVZ-(?C4ITZK.;7+;[#%5$C&TM2BP(TJP(B 7B^5P*.1F;H5J"SQ>J%5MF2^
M>&&\XY4-]9^B9@,LW-E0ASD$OH<0E:#ROM'%*TDI)X6V]AL,C(!91Y/3?M2R
MAY&F>&95 0::U;=&O293UM)P6W+<@2"1(+<-*M]M?6QQ(\2Q 6A>2T:9LL-8
M&;^K#5IJ'H[&9^9#-Z5)NDKNO<K;%-2]624>$2JMSDI2DG5)+!1;#PZ 'H'S
M7\GXTH7QK4M?699TV3EC>%!J$"J'0+52U2*;.EP7"=-1QZ<W$1N.+,\4X'LP
M+N .ZYT=*Y4L3+>P*QS*I#%79LN.V]8%M-U9U%0K,V!Q74->*&%&Y,3)>;41
MFI/=PV@/,OS%N8?IFU%Z%[KR2TO\O1^V<KH=+;@4#.:1;945RUX,*._&8G%*
M<I+$I\Y;7#7O*=,L>@!E5\EVEU+XKC-2E2ZO*JL&!1;T7#1(D//HC=HH$Y;S
M+1.N+)M"%;").!$6P!@:Y$&D[*O5ES7-04C.. FX;?RSO:[)E-M9Y]3,.?+5
M77GF'9<<DN-RVH[Y[QI418EL 9I/*J-#FG2U-%,'/BP[ HEBYD9=5JDIHU<M
M:%$H4A4="G":2MRFQ8[RW6S3CO&LC/9W0$\Z4<U+NS@\F_JMPWM4I=6KM.RL
MK5)55)CKK[TJ-#I,=,<E./N.N+-I+IEB:C 8^/)5KM?RZT*<P;,""A:ZC:\B
MYIL#AX[Z)10JF<9Q.Z9*/@RB0OI+P0&'GE=:M<A,J=8&HS5)J^RAKNI*_P"X
M+SK[=I.2(-1NABVVVJX^A1*ISK52809(29$2BPV] "JM<^I:V<W.8'IQU::$
M-.>8&3E5H-V4AG,#Q!;5QTBF5IF568S2U2H5-@18:6R97MQP(L.\0#]-C)NZ
M9-ZY5Y?W1-C/1)U9M&WYTV.^E:'FIC])B.2DN)<ZZ5$^I6)'M =AFC^C+,7^
MXMW?D_4!1>?LY\A&Z_&FS*_3YGC_ '\N?\HZD/179S_H-/AJ=>9Y^_U>53PW
MEB@                              ;5_4W/XMS_(4!.X]C?D?W](:H/_
M +3?M4T=2=JO_P!NVG9C=K>YP=,1NRV\%0                  #H;F<X=$
MG+X_9MUHSXW"XVYYO#P/> <&R7"=MV$X4KMN\;A]HX/9^)UOX+ MW#H 58
M                        *"S!?[/2$+\8>+C[0P1/=F[5TN8;O#P/P^C'
MN *S@GC"B'O\3&,R?$W=S?Q;3UMWYW'O .4
M (XNJ0EFY;=;54>R$Z;F$?LO&[3MZ.+@?"P 2,GP4]WJEM] !J
M                (XON23$BB)\8]@XD@T[O9>T<?:GJ;V!\+SP$B-'BTV>.
M]BV@][##'JEMP[F(#>                          (WE/I*_8+!5/=4II
MP^P=DWM_!O$S[22>KAYX"2                            1U<,GAW=;C
M)U/L_$-W"'V3B]I(NYQ]T^%N_L@)%+H+N^:
M !ECL,!05/?WKNJ37;M_=)/VGV?=X6S^'PZ^("O0
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MU.)X,EW %W0      CF<MTKXIB"?;)LTK-3)MH-:NJ?0OPD]("1@
M   1Y?JGDII9M/H9^V4X[[:'-_KI+ MXMA[0%?LX\%K'IX:,<._ND ^@
M      IF[U+10)RFW$M+)*,%J02TIZQ%M2K88#Z6HI2J%!-;B75;A]=*"01]
M8^A);" 5$           "-VG7COQ]LWVS:)E.#/"22R/<Q^J>$?0 D@
M      $<WBM]-9M\FGFVT&XOB(6VE:G.ML))J\'#'N )$1X"/WJ?VB ;@
M      !1E]J=3;[RFGDL+)YCU1:"<(BW]I;JMAX@*@HQF=,AF:R6?!1UB3ND
M>*2/81;"V .S          '7U4S*G2S2HDF3#F"C+$B/</I(]AD IJPUO+H2
M#>=0\HGWRWT(2VD\%[.JG#;@ K4          ;5>"K]Z?[0"/+06\JNW&3CR
M'$DXWN(2VE!MEO="E)VJZ>Z D4
M                                                    ?"5]S2/X
MAW[&H!8-/^XJ]_;<7^?D)WEZ/47YTW^CH'\BB_8&Q"RYH
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MILROT^9X_P!_+G_*.I#T5V<_Z#3X:G7F>?O]7E4\-Y8H
M              &U?U-S^+<_R% 3N/8WY']_2&J#_P"TW[5-'4G:K_\ ;MIV
M8W:WN<'3$;LMO!4                   Z&YE+319JFUI;639F2U))22,MN
MU)[# <*RU+7;\);CB75XNXN)03:3ZY]"4[-A *K
M     %!W^MU%*;-I]#!]H9(U+;2X6'$+9@HC+: K.$>,.*9GB9QV3,R+#$^&
MG$\.YB8#D@                         ".[J6\FXK=2W(0VA2G-YI325F
MX>)]"CVI 2&GP4]WJEM] !J                          ([OA;R9-%)I
MYMDE2<%[[:%FHMY/@FKH,@$@M?4V_P!XCS/G2[G< ;P
M        !'$E;WOZAH3(;X7#5O,FVG?,MP^A>&\6 "1P
M           1U<"GO?7;Y)E(;09N[[2F4J4ON%NK/:G !(A=!><0#4
M                   ,L=A@*'@J45V5%!O)-!)1NM$VDE)V;<5X;Q[0%<
M
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MUC8JF[W78>PW:#@-N;N\KP=$T3=;OAYUWJ.@R[W[IC(;[L339IW6\
M   1O.:=.^J:X4)"FB0O&6<A)*0>[L(F<=Y6.("2            1W?K3CA4
MLVX:)>[)29DI]+.Y@LMI8F6]@1@) 9^HM;,/4T;"/'#JELQ[H#Z
M "F;O0M= FI;83)69(P94X31+ZQ=*S,B(!]+40M%"@I<83&42#(V4N$ZE&"C
M+ EEB1] "H@           1NTT[[_'W.Q()LVD_;?:$[ZL$%LX..\ D@
M       $=7@TZNLV\M$-$A*'%[SBGTM&UBKI2@S(W-@"0T> G]ZG]H@&X
M       4;?;;CMOOI;CIE*-YCU%3J62/!>./$49$6& #OZ,DTTR&2D$V9,HQ
M02M\D]4MA*Q/' !V8          Z^JD:J=,)*"<,X[N"#5NDKJ*V&KN8@*9L
M)IQJ@MI<BIB*X[_J27DO$7JA[=])F1[P"M@         !M7X"L-I[JL"] P$
M?6DVZBN7":X:(Z%K0:'4OI<4]@KI4@C,V\,0$A@
M
M    #X2ON:1_$._8U +!I_W%7O[;B_S\A.\O1ZB_.F_T= _D47[ V(67-
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M"@)W'L;\C^_I#5!_]IOVJ:.I.U7_ .W;3LQNUO<X.F(W9;>"H
M       !T5RI-=%FI2T3QFWL;-9-DH^X1J/86T!P;*0INWH:%QTQE$;N+*7"
M=)/7QQWR,R/$@%5@                         "A;^2ZNE-I:AHFGVACU
M);Z6"+U1/7)2C+P0%8PB,H<4C3NF4=G%...[ZFG9B73@ Y(
M             CJZ6G5W);JVX:)"4J<XCRGR:-C'H,D&9&YCY@"1$^"GN=4M
MGH -0                         !'5\H<7)HNY"1*(I!FI:GR9-K!2<#(
MC,M_$S[@"0FMC;9&6!DA&SIPZI;,>Z W@                         "-
MY3;GO[A.%#2;>XLCE&^DE)/<PV,X[QX@)(
M !'=P-/*NRWEIA(>;+B[T@Y"4*9Z<,&C/%>)]XC 2(707<\P
M               %#04+]]E16<5"4&2=V03Q&IS9CM:QQ3AB KD
M
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M]DFZ]<BRIQQ#6MO%\Y1OE)VE@9-F9\+# !)
M
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M3WGC_?RY_P HZD/1?9Q%NSU->]_P==YY^_U>53PWAB@
M             ;5_4W/XMS_(4!.X]C?D?W](:H/_ +3?M4T=2=JO_P!NVG9C
M=K>YP=,1NRV\%0                  #H;F0ERB3T*C]J)31^H\3A;_ '<.
M)B6Z X%D-I;MR$A,0X22-W",;QR#;ZY_YTS/>Q\\!5H
M         C[,1@I%(;2J =024E@S93).*98.$9*WR,O!/;AW0%;P2(H40B3N
M$49DMS'>W,&TEN[W=P[X#E                          "-[L82[<MM.'
M3CE<-3OVR4LV>S8F>W@[Q$[CZ("1T^"GN=4MGH -0
M      !'%]LH>DT3?IRIV[),R44HX_ ZR>M@1D3GG )#:V--EAN^IHZN..'5
M+9CW< 'T                          $:RV4'?L!WQ::E$VO"=VHR)'J>
M!XQ\<%;WG )*                           !&MQ,)7>%NNG3U2%M\7=E
ME*-HH_2>U@CP<W@$DET%YQ -0                         !04%E/OPJ3
MO8#09DG[<[0:B<P+#ZCC@C# !7H
M
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M &!4!,+UQ^T\TO%1RU%%^8N^MO\ \N[R_*20-%S:)_/P\,=LFC;B^C?MXU^
MX#K)J         VJ\%7[U7[1@B=R?(RL\L+[AOW]]&_;9&Q9!NU/2W]/7[#%
M^;]#+.GH]$_VQL=$3%MNMZ8C<;A6D         1G.)CW_4PU$YQ=Q>X9&K<+
MJ'B1EX/2 DP           $;9A)8,J2;Q.'A+1N\,UD98K3T[O< 2(Q]19PZ
M.$WA](0#Z@         "EKTX9V[/)W>W-U&.X:B5X1=!IVX@/I:!(*WX!-DH
MDD@\-\S-73W<=H"I0           1BT3'YP9&QSB\%&)XKX9XI[W@X@).
M        !&EZI9.MVX;O$Q)QS<-!JP(][YXD[#]$!)*/ 1AT;B</F$ W
M      "A\P>'[W'B=WS1QX^)-FHE'URZ#3MZ0%1T3=\5PMW'#@-]../@ETX[
M<< ':@         #KJOAXMF8XF79W<<.G#<5T>: I7+SA>]]O@DLFSD23(EF
M9J(^(6/A;<,0%=@         #:OP%?O5?M& C>S>#X_N0VB<)6^WO[YKPQQ+
M#=WMA>@ DH
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M-Z<#,=1]JT33^7Y6_:VG9BJ+:X>Z,O\ AZ Z8C=EN+42
M   I^Z"0=#G<0C-/"/'=QQ]##;M <"QB;*VX)-;Q((W<-_>-1]<\<35MZ0%7
M@                         "/\Q.%XG0;R5J1VEG$FS41F?$+#'=[F)@*
MU@&1PHF[CAV9G#'IV-I+;CW0'+                          $:7:ED[G
MMI3A.&YBZ3>X:R3CB>._N[.[W0$DI\%/[TOV@&X
M     1K?J6CDT,W"<,RE8IW#46![R?"W>YL 2,U]2;_BT?Y) /H
M                 (QE)9_.!!/!SBDVY@9&OAX;FW$O!QP,!)P
M                  (TN(F"O"W%+)PW<7=S=-1(+;MWL-FT@$E%T%YQ?M -
M0                         !0,#A%>-4PWS<,D8XFK<V%@6'SN) *^
M
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ME*,9!-&\;>*R+'A$1FK$!];16ER@0%HD'+2:#P?4UP3<P/IX9D1I 5(
M      ",VGV_?_(9*I*-9-(Q@]E,DI]3+;VC# \<0$F            C>]'T
M,UFW254%1#6ZY@T44WRD8*+%)K(CX6'? 2*WM0@R/$C0G;T8["VX=P!O
M      %$W^\ABW7G%S3@D3S'JZ6#D&77+9PR(\<0%1451+I<-1.&\1L-F3AH
MW#5BDCQW>YB [0          ==5C(J=,,W#:(H[OJA)WS1U%=8D]W !2V7KJ
M7;?:4F:<\N/(+CG'..9X.'LX9D1ENEL 5T          -J_ 7MPZJMO3AL/;
MAW< $<V<ZVY7;C)$]4O<6V2F3C&SV<\2P(G#(N+B D@
M
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M.S^S[;G*MKJ+Z,OHY/N[-W3+.$W\]Y_[N/[(QT1$;CLFF9FB+=U]!4D
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M]U*8QR.,HE)ZIF1'P^GI 2(U]2;P/$N&C;AACU2VX=S$!]
M            !&LF0DK]A,^,32HVUX0NRF9++<V_;&&"< $E
M                C6XY"47?;K2J@J.:^+NQ"BFXF1TD>+Y%@WND0"22Z"\X
MOV@&H                          H* ZA5X5-OMBE+22,8O ,B;Q3_#88
M+Q 5Z
M
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M1$D!40           (X;?<]_;S/;D&CAI,H?9DDI.#98GQ]W>/> 2.
M     ".KQ?4U6;>2F:B+Q''"4TJ.3QOD2BV$HR/AX8@)#1X"/WJ?,[A=SN -
MP          HR_'5LV\^M$I,-7&8(GU,D^2<5X8<,R,CQQ =_1E&JF0U*<)T
MS9;Q<).X2SW2ZVZ6PL>D!V@          Z^JF::?+,E[ADP[US3ODGJ*V[OS
MV "FK#=6[06UN3$S5&^_ZJEE+!'@O##<21%U0%:@         #:OP5%WTJQ/
MO;.G#N@(]M%UQRN7$A<Y,DFUMDEE,=+1L$HR/ W"(N)L 2(
M
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M=_9IU&Q5RJ+2[HDTZONR'6HS_ 02IA;ARDFXPX9*V$>]C@6. "U[6?J*UO\
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M*.9-'@Z;9.DGN[4'L/H <*RW%.V]#<7(3*4HW3-Y+1,DKKG_ )LB(DX *J
M                        %!9@/+9I+:D3$PC[0SBZI@GR,N(75W3(RZP"
MM(1F<.*9KXAG'9/?W=W>]33MW>YB Y(                          CFZ
MG5HN2W$)FHCDM3F\PI@G3D$1]!.&1FWA^R D5/@I[O5+;Z #4
M               1U?+[C4FB$B<B&2Y)D:51R?XW626Z1F1[G3T@)":^IMXG
MB>XC;AACU2VX=S$!O                          $;RGG$WW!:[>E*%MK
M,X9QR-2NILP?PQ3@9=\!)                            ([N%]:;KMYH
MIJ&4K-W&.<9+BGMW:6#II,V\#\T@$AET%YQ -0
M   _,+'S %"P'5'=E2;[6E24DC[5X)$IO9_#88KQ 5T
M
M             /(!S0^:KS8]->K_ #!RTTYZ8ZG?>2]LM,R*;=S$.0ZQ*CDW
M*=EN$XA!HP8:9)1[0&+FR_*,^;GFZ]7*;D_IN>O:K6O+;BW-$I\7BKH[W%X2
MFI!1G'U(,W.KUB(![..7#J&SBSNTD9>9IZIK>B95YIU\GTURVZQ)9IJHKB$1
MN&1%,6R9FM;BB 7^2JO284,JC,JE.B4]1)-,Z5-C1X9DKP3*2ZZADR5W.MM
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M@           $=7@AURKT VFFW$$XO?4M:4FCK%ANDK:>/F )#1X"/WJ?VB
M;@         !1E^$ZJWW29;0ZOCL&2'%)0DRW]N*E;"P 5!1M[Q9#WTDA7!1
MBE)D9%U2V$9;#(@'9@         #@51)JI\PDIWC[.[@DS(B/J'TF?F@*8L)
M+B:$V3K:&E<=_%"%)6DNOLP-)F6W !6P          VK\!7[U7[1@(]M%+Q5
MNX3<9;;3OM[BT+2I2\3V[Q%M3AAW0$B
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M?KPN77KP\1?+;_13FI_?V[?RED#1\Z_?9>(NVJ/_ ,PK\O&OX+H&,=51N-0
M                            !M5X*OWJOVC!$[D^1E%Y8WW1?W_UK_\
M4!L>S^[6](?T\^KC/+'Z&7PO^,_VS&S2]/M1                   #H[D)
M9T::2$I6KA&9)49)(S(CV&9["Q <"RR<*WH9.MH;7B[BA"B4DNN>&!IV;0%5
M@                         "AK]2\NE()EIMU7:&=CBTH21<0L3ZVS$L
M%80MXH<4EE@HH[)&18&1&3:=A8 .2                          (\NA#
M_OCMU:&6UMXNDM:UI2I'3X!'M4 D)/@EYQ?M -0
M    !'M[I>5(HIM,MNDF21K-Q:4;I;Q8&DE=)@*_;^IM_O$_Y) -X
M                   CB4EXKZ@F3+:FN&YBZ:T[Z3-!EL1X0"1P
M                   1U<#;YW9;ZD,MK:Q=XCBEI2M&&)EN)/K*QQ[G0 D0
MN@O.(!J                         &6.PP%#0$O%=E3,VFR;/=W7"6DUJ
MV&1XIZ2P 5R
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MJP,B(^'B?"P 2,
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M]%.:G]_;M_*60-&SK]]EXC[:OYPK\O&OX+H&-=4QN-0
M            !M5X*OWJOVC!$[D^1E%Y8WW1?W_UK_\ 4!L>S^[6](?T\^KC
M/+'Z&7PO^,_VS&S2]/M1                   #H;F1Q*+-1P.TXMGZCQ>#
MO^9Q,2W0'!LIHV;>A-]E[#NF[C&XQ2-S%9G]5Q/''I 58
M           *"S!9X]);1V#Q@?:6#)CM/9=I.$>]Q,2\'O=T!6D(L(<4MS<P
MCLEN;V]N^IIZN]\]AWP')                          $<74PIVY;<7XL
M[83:G#[3VK@]FZ=O!Q+C8X )&3X*>YU2V>@ U
M   $<WVP;LFB*\6]O)$@U&KM79^!M3@O=Q(W=I] "0VBP:;+#=P;06[CCAU2
MV8]W !O                          $;RHQ^_N$_XM)1$VK[?[7AP\4'@
M79L>MCT= "2                            1S<,<W+NMQSQ9VA*.-C,[
M63?9\>[P,?5<?V $C%T%W/,                          &AEB6 "A(#)
ME=U2=.#N$9(PF=HQXN*<?J&/4P 5X
M                                                           *
M(S,;==RWS :8;4Z\[9%UMLM((U+<=709Z6VTD1&9J6LR(B+;B8#R'>3"Y?YE
MV9J+YB$N^[&K5I0:Q>JW*)*JL&?$;J;7C[?WXRI<9A#J=S;U35L 70^5&Z2\
M\]1^DJS+HR.MB7>%8RENR%<]1H,!MUV7+AQ9137.$TPP\ZX:41N@L,3,!@IU
MJZ^=8VNSE<6[I3L#1Y>5N%8L"UJ)F;<4B+6"4OQ VW":5%AKBK<<):TF9F23
M] @&7 K"O]OR8V;9#-EU@[X:R_.)[U.PSO&BY;<E@EME#[/VO>WB/YS'8 [S
ME9V1F+1?)ZKTM2X+.K-(O%=JY@-LVU+B3F:@I;T)1-(1%>81*Q=[A$C: IWR
M8.Q,Q[+T ZB:/?-FUFU*O)J68RX%.JD&="DR">CU8F#::EQV'5<0S+ R2>..
MP!;QY,WE;F51]1/,CH>9-@UVT:-?U:N6EP)M6I]0B,U"/4:G*BJ=CN2XK*'D
MJCO'X.\6T! .3<[6#Y/)K<U%)E:?[CSITHY\5Z?7Z+7[?:G.+ISLF=*J#2TH
MAQ&TI<)2,,3)73YH"3,B<KM7O.OYI.6&M/,K)ZM9&Z7,@9J)5J0J\4CME9/>
M9=;02)L4U&\X2L3W306)'L(!*GE+6GO4A;NIC2'K4R<RRJN9]I9)S8RKDI%)
M9E2)$>/3G243:D0XSKOJD:.6W$ND@&,[F[ZN=7/,VM?2;7+>TDWG8&3UBW5:
MZZJ^]%K$V5-GE4X+$QU48HCKL=E@\"3B1&2$;3/I 9;_ "B'+[,:[N4_I;H%
MF636KDKL)O+3MM(IL"=+F0RC1Z7Q.*Q%CO/H-O<V[R2PP >B_EI4^L4K1'I]
MI]>I\BEU:+8-"9F0)3;C3\=U%-B)4VXV\A#B5),L,#(@%Z=P_P! 5S^QZG_,
MGP'YNVD+5+G?HWYN&M3-7*/*JI9R68NN2_SEVO27G69T=OMTDHCS79R6XIQM
M#6\1;JBQ,L2 7PZ9K?U5<Y3G$Y=:T+TR2N#)G37IV.3XC;K[$U+\Z6264[I=
MMB'OK7(5@9I-"<2V$0#C\P'+_-3+SGJ1,[M9V7&8&;&B1R-&9R[A429<:[?H
M\F+"X4)Q^E4U"X#A]J9-2B66!XD6'?"!:I+O&\.>7ITU"65IEN#*_3GVZ)"M
MZ?&HU13%J+2%1XRYDQ+4%MN,I1&A?7/;MQ/OA>GS\<N\T;KYL7+QN.T+ KMR
M6Y JU-DU6LT^G5"5$IC3LN.Z1RGHT9UEC!&)GOJ(!UOE)>6^:EWZQ>6W4;&L
M&O733Z+4;:769]+IU0ELTLD5&-Q#E.Q(SR&"0WBHS49= "ZKRG^Q<Q+WY>N2
M](L>SZS=E7:JF7JYE-I<*=,DL\)NG&\IQN)'?=+AFD\<4ET ,]'+.I=5HNB#
M3[3*W3Y%*JD2P:&U,@2FW6I$=Y%.BI6VXV\A#B5),L,#(C 7*Y\D9Y+9JX$9
MG^;Z[]A;>B@5 3"]A_VL6ZI>*CEJ'_\ >+OOS+[O'NE^,DC]H:+FT69A%KPQ
MVRS33MQ?6SO\:_'YGTQ?NCA_8UNL>5=\Z#YGTQ?NA]C6<J[YT'S/IB_=#[&L
MY5WSH/F?3%^Z'V-9RKOG0?,^F+]T/L:SE7?.@^9],7[H?8UG*N^=!\SZ8OW0
M^QK.5=\Z#YGTQ?NA]C6<J[YT-%8;JMI>"KNEWC\T4\JA$U463IC<96>6'AV&
M_<.XJ-^VP-BR&(^U5&X]+_T\S3-QB[/%^AEG+87S?VQL=,63+TQ&XU%27EA\
MK2<PY;E7:2U(><D7#26FT1X[LA6^M]U)&LFDJ-""-6U1["+I 71^3626Y?*S
MR0>:1(;2<>26[)8<C.D91Z?CO-.I2LOF ,_8      C.H-L>_P!I3G9EJ>)#
MA=H)U9)21IZ#:(]TP$F            C?,%#2BI1N1ER"*4C D.J;W<5EM/=
M,L0$AL[&6B(L")IO9TX=0MF/= ?4          4M>:4+MZ<3C2GD[J,6TK-L
MU=8NA1;2 ?6TB;308)-MJ93N'ZFI9K-.WZ)6TP%2            C%IMK\X,
MA91EDYP48R.,K<,MPMG#QW2V$ DX           $:7JVRNLVX;D9;RDNK-"T
MNJ;)OK%B:DI,B7CYH"24> CN=1.ST" ;@         !1.8"$+MQ]+K"Y+?'8
MWFT.&VH^N6!DI.W8 J&B$2:7")*#0DF&\$FHU&DMTL",SVF9 .U
M '758B.G3"-)J+L[N*2/=-1;BMA&71B I;+Y#;= ;2VRIA)/R/4UN*<47JF)
MGO*Q/:9@*Z          &U?@+_>J_:,!'5H---U^Y#1&6TI2VS4ZIU2R=VET
M)/8@!(X
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M#1LZ_?9>(^VK^<*_+QK^"Z!C75,;C4
M;5>"K]ZK]HP1.Y/D91>6-]T7]_\ 6O\ ]0&Q[/[M;TA_3SZN,\L?H9?"_P",
M_P!LQLTO3[40                   Z"Z$H50YQ+;-U)M'BA*C09^<HL#+
M!P+'2A%MPDMM*921NX-K6;BBZ_=49F9X@*N
M $?9B(:72&R=CKDI*2P9(0ZIH\2<+ S-)D>"0%;P<"A1,"P+L[.!8XX%PTX%
MCW< '*                          $;W:EH[DMI2XSCJB4[N/(=4DFMN&
M*D$>"L<>Z D9/@I_>E^T W                          "-+^;97)H9O1
MW'\))[IH=4WN'O)VF2?"Q,!([7U)K^+1_DD ^@
M    C60TRJ_H:SC.&ZEI9E(XRR06",?J>.Z>S8 DH
M        $:W$AM5X6X9Q5N*2;V#Q/*0EKST$>"L0$DET%YQ -0
M               !0,!+97C4S)A9+-*<73<4:5;"PP1X)8$ KX
M
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M95XZHE6IT"J15>%&J,./-CJQV=9F2VZV>SS '3'9%EG#;IYVA:YP&5$MJ"=
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M0"I0           1FTXR5_OH[:X;G"3]J\!1(3BG$O5L,#,!)@
M (UO5;2:S;I.2UQS-Q9);2RITGNL6Q2B(R1@ DA'@([O43M] @&X
M  41F XAJW7E+DJB)X[&+R&E/&77+9N)(S/$P%140R.E0C2LW"-ALR6:=PU$
M:2/$TF188@.U          '758TE3IAJ6:$E'=Q42349%N'B9)+:> "ELO7&
MW* VMJ2J4DY$C!U;2F5'ZI@9&A1$9;N "N@         !M7X*N]NJQ/O;.]W
M0$<V<ZVNO7(A,QR0I+C9FRME39,$:N@EF1$O$!)
M
M      ^$K[FD?Q#OV-0"P:?]Q5[^VXO\_(3O+T>HOSIO]'0/Y%%^P-B%ES0
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M/;KV0F;UX5^GZ<<GJW(;19<*J3X<25$HTQ9KCJ99D/-+5*22D&9H3L/ SPQ
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MFRDFCQ<)!N&GO8)+$SV@.!8RT.6W!4V^J0DS=P>4V;:E=<^E!D1E@ JX
M                      1]F(\VS2&^+*7$2J2P7$0R;Q[7"+=W4D9EO *W
MA&1PXAI5OEV9C!6!EO>II+>P/:6(#E                          "-[M
M>:1<EM)5,6PLU.)2PEA3B7L3,^LX1;J,.X D=/@I[O5+;Z #4
M               1M?KC:)%$)<M<8U2<$DEA3O%/>+89D1[N "16OJ3>!XEP
MT;<,,>J6W#N8@/H                         T/HV;=I?L&0"-);K97_
M1VM:5J;7]K$PK=5@WW7L-TM@"3                            1I<;J$
M7C;B%3%M&KB[K!,*6EW \3WG2(R3AYH"2BZ"\X@&H
M       H& MKWX5-!25J<P1C'-HR2C L=CN&"@%?
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M)EMUC,TKB;:YBFW_  ZZ978?XC]2WPP5OV1/]MCKKK?M1\77Z>-Z<[CNQO\
M@EQP4_=/\1^I;X8*W[(G^VPZW[3_ !=?IXT]QW8W_!+C@I^Z?XC]2WPP5OV1
M/]MAUOVG^+K]/&=QW8W_  2XX*?NG^(_4M\,%;]D3_;8=;]I_BZ_3QG<=V-_
MP2XX*?NG^(_4M\,%;]D3_;8=;]I_BZ_3QG<=V-_P2XX*?NG^(_4M\,%;]D3_
M &V'6_:?XNOT\9W'=C?\$N."G[I_B/U+?#!6_9$_VV'6_:?XNOT\9W'=C?\
M!+C@I^Z?XC]2WPP5OV1/]MAUOVG^+K]/&=QW8W_!+C@I^ZT5J/U+;J__ +\-
M;+!"SQ[1//;NG_[V$[7[43&C%U^GC33V'=C?*C_T2XW8WJ?NLZ_)*S'S+S"@
M9L.9@W=,NER$J#V1V8IY:V-XXI'@IYUU6W$QWQV*YOFV;W=_>9E?57G(LLM\
MSYE_^X5L1L;L?FN4X?9/ T8*+V*N7R;/M6<K5$,^;1&1'Y_3W]ICOOE15I?-
MN+(T0^H)         $;S7U)OJG,^,B02D+/L'9"4;G5/:4G=Q3N^> D@
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MHI,=FVEL-PB+B[P"10
M                                           !\)7W-(_B'?L:@%@T
M_P"XJ]_;<7^?D)WEZ/47YTW^CH'\BB_8&Q"RYH                #$MSPU
M.(Y9^I,VH\F4Y[U7R2Q#CO2I"S.+,P)MAA"W5GYA$ P:>1_4ARJ:*\[K=K-+
MJ4%FI7+5*9,8J=/DP^+'J"7HKNXF4RA+R#:>/:6);0&+C6GI,UG\BOF,UW7/
MICL2LYA9"WM6IM6K46AQ)DI"(51F/3*O!EPJ?&90C",A?29[5=TL, NXSO\
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M;?Z*<U/[^W;^4L@:-G7[[+Q'VU?SA7Y>-?P70,:ZIC<:@
M              #:KP5?O5?M&")W)\C*+RQONB_O_K7_ .H#8]G]VMZ0_IY]
M7&>6/T,OA?\ &?[9C9I>GUMVKK4'1M+6G?-#/*N(2["L2V*G5$,J6ELG9C4*
M0N$V:EK;+!4A"<2WBV"!^>EIQRUYG7E$&9^=>=K>H&YLJ<G[,K53A6M&I;]4
MA4\W&%RW:/3(R(KSK+CCC2MPS29X;NS86T,D_(AS<YF>EG7%>.A#5#1KXO;*
M&/+D1*=?E?BUQZ!3%Q'DQ8,N-4IR>"\W*CMXGMV&H^X ]S
M  .@N=?#HDY12.RF31X/\/B\/IV\/ ][ !P+(7Q;=A+.44T\7?MDF> 2^OA]
M2(B).!; %7                          "@\P'C9I"%%/*GXR6"XQQBE=
M+G@\,TGX71CW %9PCQAQ3W]_&.R>_N[N]ZFGK;OSN/> <D
M            1S=3RD7);C?C(HB7%.?:QQ2>[5ACL)[ ^%NGYP"14^"GN]4M
MOH -0                         !'-]2.#*H:?&10#<D*+=.+VCC[4]3>
MP/A>> D-K:VV>.]U$=;##'JEMP[F(#>                          (XD
MR5>_R$R=2)*3:7]H=D(S<P1X7:3+%.[T].T!(X
M     (ZN&0:+LMUKQD4<G#=QA]E)PY&[MP)XTGPMWSRQ 2(707G$ U
M                    %"P7C.[JDV<XEX)1A#[.1&UL/'U? M_$!70
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M$D]O<W=@"H@           1PR;OO[D>J-FUPD=7=1OD>YM+'P@$C@
M    CJ\#=16+>X:FTM\1S?)9),SZQ>#O;>[W $AH\!/[U/[1 -P
M HR_#=*WWC94A*^,QAODDT[5E]%L 5!1M[Q9#WS(U<!&.!$18[I8X8;.D!V8
M          X%4WC@2]W#>X#F&.&&.XK SQV; %,V$;IT)!O*0I?'?^II2E.!
M.'AX.SH 5J          -JO!5^]/]H!'UI<;QW<)N*;-)N-[A)))*+;\]N[=
MF'= 2&
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M@E=H9Q-PDF6&^1'L41EW0%80L>QQ<>GL[)[.C:VD]@#D@
M          "/+I-XKCMU3:FTH)3AK)1)-1[2\'':6&("0D^"G'IW2Q^8 U
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MT_4U]P_H3$3,6%,QRH\L?2] /(>+_1^<!_\ *@_Y40>B^PC]WQ4QXOT/E/\
M^Y3_ *UDODK^BIZ)4]'_  [YCT-&X^6E&EN$JP        !'$UAQ5\TYWQ>E
M:$(7]N=J)*D8H/HCXD:L<0$C@           CR_&%/)IA)@)FDF4@S)4DHYM
MX++K%B9;V "OV2P9:+##!M!88XX=4MF/=P ?0          4Q>+9NV_.0F,4
MLS2G!@W29)?6+_.'@2< 'UM1LVJ%!0;!1C2@R-E+I/$@\>CB$9[P"H@
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M[096W7;C4J F*2UMFE\I)/'((CZ3;(SX6&("1@
M
M   !\)7W-(_B'?L:@%@T_P"XJ]_;<7^?D)WEZ/47YTW^CH'\BB_8&Q"RYH
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M5Z<.Z K."1IAQ$FG<,H[);F.]N^IIZN]W<.^ Y0
M     CJZF%N7);:TT],E*%.[\E4DFN 6)]#1GZH D1/@I[G5+9Z #4
M                    1S?;"GI%%-,!,TT2<34J23'!+>3BK S+?\X!(;6Q
MMLL-WJ(ZN..'5+9CW< &\                          1M*C+]_D%\J>E
M2=Q>,WM)$;>+>S[7QQ/>Z $D@                           CJX8ZW+L
MMYPH"7T(XIG).439L&>.&#..+F\?> 2*707<\P
M     %"P65)NVHN'"2@EI3]M<<E&Y@1?YG$S1M 5T
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M%*TX] ";LNLKK.RLR^HN6-FTTJ9:% I*:)3*<DR43%/1'*,EDE$E)'@R6'0
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M&.6E24$;"739-?7(_JA&1IP ?2T6TM4" VEA48DH/U%3ANFC;T&LS,U *E
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M!'5H,MMW!<JD051C6MO>?.0;I2,#Z209F3>Z D<
M
M     ?"5]S2/XAW[&H!8-/\ N*O?VW%_GY"=Y>CU%^=-_HZ!_(HOV!L0LN:
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M$V                Z"Z$)<H<Y"V3D)4T9*:2X;1K+O$LL#+$!U]C-H9MN
MVB,J(DC=PCJ=-XT%OF>UP\35CT^B J\                          4#F
M$RAZD(2N"J>GM+'J*7SCGL7CO;Y&1]7IP[H"M()$F%$2E.X11V2)&.]NX-IZ
MN\?3@ Y0                          C6[&&UW-;;BX"Y2D*<W7TR%-%'
M/OFV1X.8@))3X*>YU2V>@ U                          $:WZTAV30M^
M"N8:9)FE:9!L<$]Y.*C(C+?Z.@!(S7U)O L"X:-F..'5+9CW< 'T
M                  $9R64^_P#A.J@*,R:<W9O:3W4=3#=-C' \3\P!)@
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M1;OU.5N<S%2W1Y,2JQ[282M]#KLMR+.X1OJ4T>*3\' NZ>P,D')6U29P:O\
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M)F1=G=Q,B,S(MQ6.!%MQ 4MEZMM5OM<)2UIX[_66E25?5#V8*+' L0%=
M      #:OP%_O5?M& C>S%,G7KE)MQQ:R<;WTK2LDHP5LW35L/I[@"2@
M
M                     !\)7W-(_B'?L:@%@T_[BKW]MQ?Y^0G>7H]1?G3?
MZ.@?R*+]@;$++F@
M              CK-_\ 11F9_<"\?R>J(KN_7A<NO7AXB^6W^BG-3^_MV_E+
M(&C9U^^R\1]M7\X5^7C7\%T#&NJ8W&H
M VJ\%7[U7[1@B=R?(RB\L;[HO[_ZU_\ J V/9_=K>D/Z>?5QGEC]#+X7_&?[
M9C9I>GVH@                  !3]TJ0FASC69I3PCQ-)&9EL/:1%M,!P;&
M-"K;@FVM;B3-W!:TFE1^J'TDK;L 5<                          (_S$
M4TFC(XKBVT]I8VH2I2L3<+=+J[=I@*V@X'"B&DS,NSLX&>PS+AIP,_-,@'*
M                         $:W6MHKHME*UK2LU.[I)2I25=.Q1I+ O1 2
M2GP2\XOV@&H                          C2_E,E)H9...(4<@]TD(4K>
MZR=AFG' !([7U)K^+1_DD ^@                          C*8MHLP*>D
MW'.(;;F#9)5N>!CB:O!Q(!)H                           (UN);*;PM
MPE.N)<,WMU"4+-*MGSQD6[\T!))=!><0#4
M4! -H[QJF"U\0B1B@TJW"/=,\2/HV@*_
M                                                   !;5K#WO\
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M>.]BV@][##'JEMP[F(#Z          "F+Q<X5O3W.T]CW4H^V.#Q^'URV\+
M][$!OM%PG:! 64DY9&@\)!M<'B=8]O#P+= 5(           "-&GR]_TAGQF
M9F323[!V0RW>J6WM.&W'SP$E@           CB\WR9K%O).I' -QQPN&47C]
MIZQ=7?P/A88]/F@)$;VH0>.]U$];##'86W#N8@-X          HJ_P!TF;=?
M6<WL&#S!=H[/VG#%9%APL#QQZ %0411*I<(^+Q\6&\'=SA[_ %"/>W/G<>G
M!VH          Z^JF::=,,G.$91W3XF[O[G45UMW;O8 *7R_>XU ;/M_C$R?
MD?;'9^S8^J&6[P\"PW.C'N@*X          &U>Q"MN'55MPQPV'MP[N "/+0
M>)VN7$GQCVOAK;(X_938[-M+9Q3(N+O )%
M
M'PE?<TC^(=^QJ 6#3_N*O?VW%_GY"=Y>CU%^=-_HZ!_(HOV!L0LN:
M                                                    ".LW_P!%
M&9G]P+Q_)ZHBN[]>%RZ]>'B+Y;?Z*<U/[^W;^4L@:-G7[[+Q'VU?SA7Y>-?P
M70,:ZIC<:@                             #:KP5?O5?M&")W)\C*+RQ
MONB_O_K7_P"H#8]G]VMZ0_IY]7&>6/T,OA?\9_MF-FEZ?:B
M      '17*HD46<HY'922T9\?A\7<P[O#P/> <"REI<MZ$M,OMQ$;I%)X/9]
M_K;?4L"W<.@!5@                          H+,!XF:0A2J@=.+M#!<;
MLW:L3-?@</ _"[_< 5I"/>AQ3W^)C'9/?PW=\N&G!6[\[O=. #D@
M                 "-[KD&U<MN-^,3B;ZG,(W9.-VG;T<8DGPL#(!(Z?!3W
M>J6WT &H                          CB^WR9E4/>J)P"5)/JE%[1QS(T
MX)WMT^'M/I 2(T>+39X[V+:#WL,,>J6W#N8@-X
M    C63((K]A,'433BVYA [)COGN=/:<,$X>> DH
M       $<W"^EN[K<;\9''-PW2['V0W2D=.)<? ^%NE\T!(Q=!=WS0
M                     4'!>([OJ+7;S7N)3]I]GW>%L_A\.OCYX"O
M
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MUQ^T\TO%1RU#_P#O&7T7_P"/=Y?E)(&BYM^_P\+]LDV;<7T>/C7XC@.LP
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M8P=6V3J2ZY;-Q6)& J"CJ-5-B&:B69LMXJ(B22NHG$R(MA8F [,
M =?5#45/EFA6XHF'#)1EB23W%;<.[@ IFP5.+H+:W9*92^.^1N(:2TGZH>S=
M3LV *V          &U?@*PV'NJP/T# 1]:+CZZW<1.RD/)0X@D-):2VIK%7S
MRBP->.'= 2&
M                                     /A*^YI'\0[]C4 L&G_<5>_M
MN+_/R$[R]'J+\Z;_ $= _D47[ V(67-
M                              !'6;_Z*,S/[@7C^3U1%=WZ\+EUZ\/$
M7RV_T4YJ?W]NW\I9 T;.OWV7B/MJ_G"OR\:_@N@8UU3&XU
M                &U7@J_>J_:,$3N3Y&47EC?=%_?\ UK_]0&Q[/[M;TA_3
MSZN,\L?H9?"_XS_;,;-+T^U$                   .BN52D46:I#I,J)HS
M)Q2"62?/2>)&0#A66M;EO0U./)?69NXNI03:58+,BP2G BP(!50
M                 H2_G'&Z2A3<E$8^TL%Q%M)=+#B%B6"B/PN@!64(S.'%
M,U;QG'9Q5AAO>IIVX%T8@.2                          (\NAYUNX[<0
MF4AEM:G-]E3*7#=(C^=698HVGW.\ D)/@I[O5+;Z #4
M         1W?#CJ)-%)N4W')4@]Y*VDN&X1*2>!&KP?0 2"UM;;,SQ,T(V]&
M/5+;AW &\                          1Q*<>*^H+?:D$TIM>,<V4FM75
M[CF&\1$9 )'                           !'E?>=3=EO)3*0T@S=(V5,
MI4IS;\ZX>U. "0BZ"\X@&H                          H2"MWWW5)!OH
M4V1(W62:22D%NETN88GB KL
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MM;^YB9F1GB8#GY=<N [$Y9T?0$F].UFQ9$^T??=V?#'MC*V^T< V"\$U=&X
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M.[ZP'RS'<T[N]LOA*O3Q'^&_/O\ $&5].[ZP'RS'<T[N]LOA*O3Q'^&_/O\
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M]31L+:1=4MA'W< 'T          %,W>E:Z!.2VPF0LTHP:6LFTJZQ=*SP(L
M&^U$J30H)*:2PK</%I*R<2G;T$HMA@*C           !&[3;IWY(7V-LF^&C
M[:)].^>#9;.#TD D@           $=WBVZNKV^;<5M\DNK-2UO);-HL<<4I4
M9&O$R[@"0D> C]ZGS>X7=[H#<          *+OQ#CE =2W'3*5QF?4EN$TD^
MN6TUJ,B+ !4-'2::;#2:"09,-XI)6\1'N)V;Q=. #LP         !P*IO>+Y
M>ZDEJX#N"#/=)745L-1X8 *7L)"T4-"7(R8J^,_BVATG4_5#VDI)F76 5N
M        -J\32HBZ32K#S\-@"/+1;>17+@-R*AA!J1NN)>2XI[ RPWDD9FC#
MS0$B@
M                              #X2ON:1_$._8U +!I_W%7O[;B_S\A.
M\O1ZB_.F_P!'0/Y%%^P-B%ES0
M                        1UF_^BC,S^X%X_D]417=^O"Y=?M(>(KEM'CE
M1FI_?V[ORED#2,[IF,;,R\1=M>C;*NGQ\:_DN@8MU5&XU
M               &U7@J_>J_:,"=R?(RB<L;[HO[_P"M?_J V/(-VMZ._IYF
MS\Y3.[H_0R^E_P 9_MF-EEZ@:@                   Z*Y4J719J4-$\HV
MC(FU+)!*\]1X$1 .!927$6]#2ZRF.LE.XM(<)Q*>OCL6G8>("K
M                !0E_H=<I"$M142E=I8/AK>2R6'$+%6\HR+J]("LH1&4.
M*1IW3*.SBG''=]33LQ+IP <D                          1W=+;J[DMU
M3<1MY*%.&MY;R6S9+'YU!F1KQ\SH 2&GP2\XOV@&H
M       CR^&W')-%X<-N5NR#WC6^EGAD:D]8L3+>Z $@-;&VR,L#)"-G3AU2
MV8]T!O                          $<26WCOJ$OLB#;)M?VR;R26GJ'T-
M=)D8"1P                           1U<+:UW9;ZTPT.I0;N\^I]*%-X
M_0MF>*L3(!(A=!><7[0#4                         /S#P\T!0<%MWWW
M5%?9T);P1]L$Z1J<Q3LQ:QQ3@ KP
M
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MG%[82DH^U^,;'$ZY'AQ2,MW !]+2;)J@0$)C'#(D']KF[Q^'M/9Q,3WL0%2
M           C1J.17](?\6&1FT@NW]K,R4>Z6!=FQZN!%WMH"2P
M  1O>,=+]:MU?BXYO"<<,GBE''[/MZ=S$N+B D9!8(06&&"4EACCA@1;,>[@
M W          "BK_ &4OVZ\V<+M^+\?"/V@XV.#A=;BXEANF J&C)W:9#3P^
M%NLMEP]_?W,$)ZN_\]AT8@.T          ' JB253YB5-\4E1W2X>]N;_45U
M=[N8@*5R^8X% ;1V'L!%(D8,]H[3ABX9X\0S/'>_8 5R          -J]J%;
M,>JK9CACL/9CW,0$=V@QPJ[<:O%QP^(MLSD=JX_:C(_X/$^#NX@)&
M
M                   'PE?<TC^(=^QJ 6#3_N*O?VW%_GY"=Y>CU%^=-_HZ
M!_(HOV!L0LN:
M           ".<X,"RGS-Q/ OS?WCM__ "=J(JHFRJV5RZ_:0\4O+)M&]:QE
M!FG*HEL3JI$7?MW<.2PU(4APRN:3B23;:41X>8-1SJYOKW%S7=TS-#QGVQ9)
MG6/VQO+[!8>N\N8W9B)\?B9!OS>9H?B'5O8TWVN,5^5Q/,EUA&S>T7PEYP3Q
M'YO,T/Q#JWL:;[7#\KB>9*>K>T?PEYP3Q'YO,T/Q#JWL:;[7#\KB>9)U;VC^
M$O.">(_-YFA^(=6]C3?:X?E<3S).K>T?PEYP3Q'YO,T/Q#JWL:;[7#\KB>9)
MU;VC^$O.">(_-YFA^(=6]C3?:X?E<3S).K>T?PEYP3Q'YO,T/Q#JWL:;[7#\
MKB>9)U;VC^$O.">(_-YFA^(=6]C3?:X?E<3S).K>T?PEYP3Q'YO,T/Q#JWL:
M;[7#\KB>9)U;VC^$O.">(_-YFA^(=6]C3?:X?E<3S).K>T?PEYP3Q'YO,T/Q
M#JWL:;[7#\KB>9)U;VC^$O.">(_-YFA^(=6]C3?:X?E<3S).K>T?PEYP3Q'Y
MO,T/Q#JWL:;[7#\KB>9)U;VC^$O.">(_-YFA^(=6]C3?:X?E<3S).K>T?PEY
MP3Q'YO,T/Q#JWL:;[7#\KB>9)U;VC^$O.">(_-YFA^(=6]C3?:X?E<3S).K>
MT?PEYP3Q'YO,T/Q#JWL:;[7#\KB>9)U;VC^$O.">(_-YFA^(=6]C3?:X?E<3
MS).K>T?PEYP3Q'YO,T/Q#JWL:;[7#\KB>9)U;VC^$O.">(_-YFA^(=6]C3?:
MX?E<3S).K>T?PEYP3Q-Y9=YFX]:R*F@MN*EL2T)+9CM4I@B(1.&Q$?X)1.SF
MT7PEYP3Q-JLN\SR,R38M467<4EB6I)[,=AICF1A&&Q$_X)3U;VC^$O.">)I^
M;S-#\0ZM[&F^UQ/Y7$\R3JWM'\)><$\1^;S-#\0ZM[&F^UP_*XGF2=6]H_A+
MS@GB/S>9H8'C8=6\%7_1IO>/_P!W#\KB>9)U;VCLG_M+S<U3Q,F7+7MNZJ#)
MOSWQT"71>-V;@=J:?;XN' WMWC-MXX8'T#/Y'=7MWRIO(F(EZ#[!LMS++HQ7
MS"ZJNJJK++8F-7B99R[O>[@V.7I+3RIMW&HA(                  .BN5!
M.46<VJ/VDE-&7!XG"W\>YQ,2W0'7V0UP;=A-E$. 23=^U3>[1N8KQ^K&9[V/
M2 JT                          4#F"QQZ0A!P3GEVA@^"4DXO0X1[W$(
MR\'O=T!6D(MV'%3N</".R6YO;^Y@VDMW>^>P[X#E
M      "-KMCDY<EMNG33EFA3N$DI9L]G/$RQX.\7% 20GP4]SJEL] !J
M                      (XOMA+LBB*53SF[DD^L4KL_ ,S+!6&)<3HZ $B
M-%@TV6&[@V@MW''#JELQ[N #>                          (VEL)._(+
MWBPU&3:R[?VO D'N88=FWNMCYVP!)(                           (YN
M!A+EWVXYXM[0;9N_;G:S:*/T_P"8WBXN.'H )&+H+N>8
M          !^8>'F@*$@LD5W5)XH)HWB3C+[1O$[U=GJ&/4P 5V
M
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MF:E%M[IJV@*E           !&3)-%F!(/AN$X;:,5[RN&?J?5+=QW<=@"30
M          1I>ILE6K<XC;BU<1S<-"E$2<5%X1%L/H[H"2&_J:/WB?VB ;P
M        !0^8)-';K_&2M2>,QL0:B5L7WT[< %14,B\5PMW$D\!&P]I^ G89
MGMQ(!VP          ZZK8>+9F\1FGL[N)%B1X;BL<#+;C@ I7+PFBM]LFD+0
M12)&Q:E*/ZIA\]MPQ(!78          VK\!7[U7[1@(WLU+7C^YC0VXA?%;W
ME*4LTJQ,]J25L+H 24
M                                            /A*^YI'\0[]C4 L&
MG_<5>_MN+_/R$[R]'J+\Z;_1T#^11?L#8A9<T
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M>+'CX^$;++;6/GFVE.(JBF++9BQ51=T439=44TSKB(ARR$15REV(L:B4@
M               I^Z22="GDM*EEPCZJ3,E'YQEMQ <&QB05MP20E24XNX$L
MU*5X9])JV]("K@                         !'^8B&E4ALG4+6CM+&QM2
MDJQ)PMWP3QP(P%;0<.QQ,,2+L[.!'TD1-IP(_-(@'*
M        $:7:EH[GME2T.*62G=Q25+)*-O2HDG@?3W0$E)\%.'1NEA\P!J
M                        (SOY+*I5"-U#BS*0>Z2%*3@>\GK'NX8X )(:
M^I-?Q:/\D@'T                          $9RB9]_P#!/AN<7AN8+)2M
MS#<VXEX/08"3                            1K<1,^_"W#4VM3A&]NJ2
MM9)+]\1'NGT ))+H+SB_: :@                         "@(/#]^52,D
M+)S=;(UFI6XK9T$1[,2 5^
M
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MOD>__A?4W_&T7_+IHZA[5_VV'\_Z6W;,?L:_#4]M!#IV-V6U-1(
M(TG/ME?M+9.>I"S0YNPBC*-+F"3WC.1A@C##O[0$E@           CC,!Y#2
M:7OU!4'>DH)))C*?XA[Y=4\"/<Q 2&S]1:VX^I-[<,,>J6W#N8@/H
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MZ9N$G?-!;BMN[\\ I;+UUMZWVUMS53T\>01/KCG'4K!P]G#,B,MWH\T!70
M        VK\!>W#JJV].&P]N'=P 1U:#R'*]<:$SU2C0M&\P<=311\5%@1.&
M1<7$!(X
M                                 ^$K[FD?Q#OV-0"P:?\ <5>_MN+_
M #\A.\O1ZB_.F_T= _D47[ V(67-
M                           !&6=/Z(,T?]GUX_D]40&%SR?+_=%K7^T:
M]_\ M^0 SX                          "DKX63=MSEJDG#)/"QD):-XT
M=<B^ID1FK'' !SK863E$@J)\Y)&T6#QM\(UEWS09%@ [\
M           =!<ZB31)QF\<<B:/%XFS=-!=_<(C,P'!LAPG;<A+*2<LC-W!\
MVC9-9$L_\V9$:=WH 5:                          * S"=0S2$+7.5 3
MVA@N*E@Y!F9N$6[N)(SZW?[@"M8)DJ%$4E6^1QV3)>&[O8MIZVZ?1B Y0
M                       CJZ7FV[EMM"IZHRG%.;L=,<W2D=.PW,#)O !(
MB?!3W>J6WT &H                          C>^W4-2:'OU!<'>D&1)3'
M-_CGO)ZIF1'P_/ 2(U]2;P/$N&C;AACU2VX=S$!]
M      _,+'S $:2GT%?T%@YZTK4TLRAE%,TJ(DF9GQ\,$X%YH"2P
M                   1O<3S*+NMQM=06PM9N[L4HQN)>V[<7B(R;W0$CET%
MYQ -0                         !0<%Y"KPJ3135+4@D8Q38-*6S,CZ'L
M,%XD KP
M                                              'A@\HNY.NJ[41J
MCLK/?2%94RM/7PY"I^8SU&E+ISC#32WX_:92HL0U/H)IW%1*49F2@'J Y4FD
M/_!1HHRBR3J%)8IET4FC-3+K)"&^,[6IS$=R7QW4L,+=4AQ)EBHL<<0&%SF[
M\HW5'4M7-B<RGEWU<H>H"T7U2+HM%DFXZ[H:8)UW=XR8Y&KC8)3M7B0"R;,/
M1=SBN<OF)E+8NM2UCR TW99W'3:O=5/[2B05U3J=*A/..J;2T\;JI!-*^=,R
M(@%[/E G+LU 9Y9$:+LG=*-BKN:D9)W#;K%1CQW#8*'2Z2[3V7))DB,Z1FXW
M$-P]B=I@))YVFBO4IJ4Y5&3V1F3%G/7%F?;]/R\:J]%0ZM"XZZ3%A(GI-79W
M3/@J:47@D D3.S2%J#N;D,N:7*1:CTG/%>6U&HQ6T3JN+XQC-))YGB<!2L4F
M1EX #K^4[H]U#9$\FB[=.V:-HNT+-Z=;=[0HU 6XI3CDBI4YYJ&C?-ALR-QU
M1;=T!;YY/3R_]3^F73;K0RSU"V>]9=9S:J=Y,6H3[JG>T1ZU%K$2-(+>C,X$
M2IB5=!@+8.4'I-YKG+HU?WYD55<I_'FES,J[[FK]<OOM:":BMS*E)D4J2VWP
M&24?97U=&/A=("X+1[R_=4N6G/OS]U1W)8ST+(:ZX#WB.Z%.J-J3)D07$N()
MLXR$XD\K#PS =%D-R_=6=K>4.YN:MZ[8DB-D'<$A:J5=1O+-E]*B42<&^S$G
M89_1F ['FM:!]66>/-VT<9_Y5V*_6\J\NJFV_=E<0ZI*(#?:&U&:D%'<)6PO
MHB =_P \'ENYLYMZA,C-;&CN_K;HFK3)J)3C>L.I5FETF9<Z8\5"B2T[,6RZ
MHUDT2#P49$ PB<["M\QS-'2QDYF-KJJENY=VY2[OMEFE9246O4BNU"YJB=5C
MP),]Y%-E.RC6XIDU]9)GL(![H^6I#D0=$6GR/*CNQ72R_H*R8>0IMQ#;E-B*
M:WD+2E18MF7< 709RD9Y1YG[I&H_S?WC@1%B?_AZH=X1,6Z%5,Q$Z=RQ^,??
M];IT+.C.5B0M]+J;]NDE)1&=<(L;BJ7SR2,AZ6[.Z/\ \<LJF(LCB=;9_P F
MG'S7-LQ:Z;WR4C^$D^Q'_2C<(HT;L<,,1[RC5/ >^2D?PDGV(_Z43[N-<<,'
MO*=4\![Y*1_"2?8C_I0]W&N.&#WE.J> ]\E(_A)/L1_TH>[C7'#![RG5/ >^
M2D?PDGV(_P"E#W<:XX8/>4ZIX#WR4C^$D^Q'_2A[N-<<,'O*=4\![Y*1_"2?
M8C_I0]W&N.&#WE.J> ]\E(_A)/L1_P!*'NXUQPP>\IU3P/F[<E(X+WJDKZB[
M_P!#?_@U?\D4<F+8T1NZTS>41O3Z7M@\CKJ,2=:VI[LQO&:'J+O\5E;1>'3?
M!-9$2NGN#IWM7FBJ^P\TZI_2W79NF:+NNF=W_@]NQ%ACYI_NCIV-UM-NAJ)0
M         (XFO.)OFFM%/2A"DN8PSC$I3F"#VD_NXHVEW]H"1P
M 1U?KZV?%6[4$P25)21FJ,4CB$2DXI+%)[AGT8@)!9/%EH\<<6T'CAACU2VX
M=S$!]          !3%X.&U;\Y922AF2482#:)XF^L6WAF1DK$!]+36;E!@K5
M)*69H/%]+9,DOK'M)LL-T!48           (W:?7[_'VO&*#3PB^T>S%O)ZI
M&9]HPQ/$@$D            CJ\7EM5BWB1/1$WW'"4TJ,3QOD2B(B)9D?"PQ
M 2&CP$?O4^9W"[G< ;@         !1=^NK9MY]2)905<=@BD&P4@D]?HX9D9
M'B J"BJ-=+AJ4Z3QFPWBZ2=PEGNEUB26Q./> =H          .OJAF5/EF3A
M-&3#F#AIWR3U#VFGH/ @%,6"XMV@MJ7,*:?'D%QDL%')6#A[.&1%ANE\T!6X
M          VK\!6W#JJV].&P]H".[0><<KMR(7/3*2VXT26"CDR<?;@9&X1%
MQ<0$C
M                               #X2ON:1_$._8U +!I_P!Q5[^VXO\
M/R$[R]'J+\Z;_1T#^11?L#8A9<T
M                          $9YT$9Y09HD1&9_F^O'81&9_\ AZH]PMH#
M"UY/B9'I%K6'PC7O^4$@!GQ                          %*7HXIJWIJT
MR2B&1M%QS:)XDXK+9PS(R5B YMLK-RBPEF]V@S;^J\,FM_S=PB+= =\
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MHNY/3")4C!251B?XQ;Q8IQ,CX>!=T!(;6UML\=[J(ZV&&/5+;AW,0&\
M                     1Q*D.E?<%DIZ4H-M>]#.*1J61([C^&*<// 2.
M                         ".;ADJ;NVWFBJ"6$KXN,4XQ.&_AB9>JF6*,
M# 2,707=\T                           %"PG5G=U1:.:E:4I291> 25
M(Q3_  V&*^@!70
M                                                     -BFT+PW
MT(7AM+>22L/.Q(\ &\O^'<  &U"$-D9(0E!&>)DA))(S[YX$6)@-%--K(B6V
MA9%T;Z25AYV\1@"FVUIW5(0I)?.J21I^89&0!PV]W=W$;OT.Z6[]+A@ );0E
M.ZE"$I^A2DB3\PBP :)::1X#:$=WJ))&W_FD0#=N(WM_<3O]&_NEO8=[>PQ
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M#Y/URN/@ C^Z3?M .NNT'3?3QGRC <R#Y/URN/@ C^Z3?M .NNT'3?3QGRC
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MT[VT^CN )#1X"?WJ?VB ;@         !1E]DX= >)I*%JXS.Q9I)/AE]%LQ
M=_1B45,ADHB(^"C$B,C+'=+' RV=(#M          !U]5WO%\O=(C5P',"/#
M SW%;#QV8 *:L,G"H3?%0A"^._L0I)I(C6>'@[-H"M0         !M7X*OWJ
MOV@$>VD3OCVXC<;0A!K:X9H4@S,MFU1)VX[>Z D0
M
M      ?"5]S2/XAW[&H!8-/^XJ]_;<7^?D)WEZ/47YTW^CH'\BB_8&Q"RYH
M                                                         IB\
MZ]*MBUJ[7H-.<J\VETR9,B4QHS2Y/DQX[CK$1*BVI-]Q!)Q[F(#SD9N<TSF+
M2+5S5IL#ERU)-OHHUUTB+7%7*^9JIBH-2AKJALFK;A$]6W?0 2_Y.I*DU30Z
MS6ZE'.G5FKWI=LZJT@SWCIDN15UOOQ37\\;+SJD>@ S_ (
M            I:\]_P![TWAI2M?J>"5FDDG@LCVFK8 YEM;_ (E@[Z4I5PMJ
M4F1I+SC3L =Z                          .BN4EG19Q-DDU<(\"49$GT
M3/9L <&RR<*WH7%2E*R-W8DR4DNL>&!IV= "JP
M   !0E_I=.DHX2$+,I+/U122+:X1GX6S' @%90L>QQ<>GL[);.C8VDM@#D@
M                        ".KI2Z=R6\:$-F@C<):E*02B+IP22MNT!(B?
M!3CT[I8_, :@                         "/+W)TY%&X:&U%VC%1N*0G#
M!18;N\9;?. 2 U]2;QZ>&C'Z4@&\                          1S)2\=
M]0U;J.$32\5&I.^?4V8%X6!& D8                           $=7 EW
MWV6\:$-J29N[ZE*02D8;2W2/K'B1]P!(A=!><0#4
M     ,\-I@* @NNJO*IMJ0V3:21NK)236>SNI(]XN@!7X
M
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M^<WV7MF*4?:_&X'$P66SBXEN8 /I::#;H4%!QBAX(5]KD[QB;V]'%Q/? 5&
M          "-FHZO?[(>\5D1&VC_ $AVO:K!M.SLV]LP\[: DD
M $;WDQQZQ;JRIQ32;<</C]J[/V;;T[AF7%Q[P"1D;$)V8=5.S''#86S'NX -
MP          HJ_FS>MY]LH/C#>>8^USD=EWL%XX\7$L-T]H"H:*G<I<)/"X.
M##9<+?W]SJ)V;_SWG@.T          '7U4MZG2T\/BXL.EP][=W^HK9O=P!3
M%@LFQ06T' *GF3\CU I)2L,7#/'B$:L=X!6X          VKVH5LQZJMF.&.
MP]F/<Q 1U:#"FJ]<2SIQ1"<4C!\I1/\ :<%%M-LE'PL/0 2.
M
M              /A*^YI'\0[]C4 L&G_ '%7O[;B_P _(3O+T>HOSIO]'0/Y
M%%^P-B%ES0
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MPN)BGP2VX=T!6L(L(<4MS<PCLEN;V]N^IIZN]\]AWP')
M          $<W4RIRY+<65,*4EM3F,HY9,]FVGB?!WBXN("14^"GN=4MGH -
M0                         !'-]1S?DT0RIQ3C1(,]XY79^!M3UMW$N+Y
MP"0VMC;98;O41U<<<.J6S'NX -X                          C62PH[]
MA.^+24E+:_M_M9$:,488=FWL5=/> 24                           ".
M;BC&N[+>>*F]HW.+C+[6379\=F),[Q<7>\[8 D4N@O.+]H!J
M             'YAX>: C2FQE%?56?.FD@E)1]O]K)1O;#+#LV]BC R[P"2P
M
M
M$-ZA?T'9K_[/[N_[ J #$/Y/K_N2M_[0+[_*!\!G<          &BO!5W>J>
MST $;6DVVBY;D4F*ME2S:-3JGE.$]MZ20>QOT $E            C*>AGW_4
MM9Q%J<)#A=I)]1(3BD\"-K'!7S $F@           C;,%IIQ-*XL1<HBE(/J
M/*:W,%%@HR29;Q$ D1C#@LX='";PQV[-PL-O= ?4          4K>B$.6[/2
MXRI]!I1BTEPVE+ZQ;"61D9 /K:*4(M^GI0TIA)-G@TI9N*1MZ#6>)F J4
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MK:-;BGE.$[MQZJ#,R1AB70 DL
M                                                   ?"5]S2/XA
MW[&H!8-/^XJ]_;<7^?D)WEZ/47YTW^CH'\BB_8&Q"RYH
M                                           (RSI_1!FC_L^O'\GJ
MB PN>3Y?[HM:_P!HU[_E!( 9\                          !25\(0Y;<
MY#C)R$'PR-I+AM&KKE\^6TL.D!SK82E%$@I0T;*2;V-FLW#+_G'B9@._
M                      %/W0254.<2VC?2;1XMI6:#5L/82BP,C <"QD)1
M;<!+;*HZ"-[U%;ANJ3USZ5F9F>T!5X                          C_,-
MMIRCH2]$7+3VF/@VAXV3Q)PC(]Y)D?5 5O"(BAQ22G=249DB29XFDN&G C/N
MX$ Y(                          C6[66EW-;2G(JWC)3AI>2\ILF3QZ3
M01D2\< $DI\%/<ZI;/0 :@                         "-+^;;7)H1KBK
MD&F5U30\IHFS-1=8R(RW@$CM?4F_XM'F_.EW>Z ^@
M       C*6RT=_P'3B*-Q*',)!/JW2Q1W6L=T\2,!)H
M          (TN-#2KPMU2XBW5(-W=?)Y24M;VSK-D>"L3 24707G$ U
M                     $9TYIDK]J[A17$.*2WC(-Y2D.8)[C6.ZG##O ),
M
M
M 0WJ%_0=FO\ [/[N_P"P*@ Q#^3Z_P"Y*W_M OO\H'P&=P          :*\%
M7<ZI[?0 1K:;C*KGN1*)2W5I4V3C2FE(2T?>2HRP5Z "2P           1E.
M6S[_ .F(5+6ESAN&F.3*C0O!/==PW4F6P!)H           (WS!<90FE<62N
M/C*1AN-*=WNN6P]TCP(S 2(S]1:[OJ3>W##'JEW.X ^@          I6]%(1
M;D]2W5,I)*,7$H-Q2>L6TDEM,!];0-*K?@*0XIU)H/!Q2#0:MO=2>TL %2@
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M,A;RT+:WD*:-!-];#!*S(B7T )*
M                                                     'PE?<TC
M^(=^QJ 6#3_N*O?VW%_GY"=Y>CU%^=-_HZ!_(HOV!L0LN:
M                                             ",LZ?T09H_[/KQ_
M)ZH@,+GD^7^Z+6O]HU[_ )02 &?                           4E?"FT
M6W/4Z\J.@N&9NI0;BD]<NA!8F>) .=:ZD*H< VW#=2;18.&@T&K86)FD]I .
M_                          '07.I":).-QPVDDWM<))K-/G)+:8#@6.M
MM=N0E-/*D(,W<'5(-LS/>VD:#P,L %7                          "/L
MQ'&FZ0V;LA<9/:6"):&E.GO&X6!8)(SP,!7$(R.'%,E;Q=G9P4988EPTX'AW
M ')                          $:W8MI%S6T3DE;2U*=)MI+2EI=/O*46
M))]$!)*?!3W>J6WT &H                          C2_G&T2:$2Y3D<U
M2>J2&5.$X>\75,TD>Z D=KZDU_%H_P D@'T
M $8RG&BS @MG*63BFUX,<%6XKJF>'$PW>@!)P
M    (TN-;)7A;B%2EMK5Q32REE2TO88GM<+8G= 24707G$ U
M             #+'88",J:XQ[_*LVF2M3I);QCFTHD(Q3W',-U6./[ "30
M
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M%N *D           !&S,@U7[(8*J;Q):29T_LF&YU"+'M.'6QPZ,0$D@
M       CB\G^#6;=2=2*$3CCA<'LG:.TGCX._@?"P[X"14;4)VX]5.W##'86
MW#N8@-P          HF_G#:M]YTIWB_=>8^V.S]IW<5]'"P/'']@!45%5OTN
M&KB\?%AL^+N</?ZA=;<^=Q[P#M          !U]5/=I\M7$X6##I\3=W]SJ*
MV[O= 4O8#W&H+:CG%4#X[_JY1BBX^J'LX>!8;O[("N          !M7L0K;A
MU5;<,<-A[<.[@ CJT)!NU^XVSJ7;.$I!=G[(3'9L5%LXF!<;' !(X
M
M                   ^$K[FD?Q#OV-0"P:?]Q5[^VXO\_(3O+T>HOSIO]'0
M/Y%%^P-B%ES0
M           1EG3^B#-'_9]>/Y/5$!A<\GR_W1:U_M&O?\H) #/@
M                  *3O9SA6Y.64KL>'#^V.#VC<Q67^:P/>Q <ZV5\2BPE
M\?M.+9>K<+@[_F\/ MT!WP                          Z&YE;E$G*[1V
M7!K$G^'Q=SS>'@>\ X-DN$[;L)92^W8F[]L\#L_$,EX?4MF[AA@ JP
M                    4%F"\;%);451\7&<E@N*<8I6.+A=7<,E8;W1CW %
M9P3,X<0S7Q#..R9KW=W?]33UMWN8@.4                          (XN
MR0IFY+<3XS[(3BEEV7LA/=HVGLXV!\'#'I 2,GP4]WJEM] !J
M               (XOJ0IB50R*I% WY!D:>R]HX^*D]7>W3X>'? 2(UM;;/'
M>ZB.MAACU2VX=S$!O                         #+'88"-9<D_?Y 8\8[
MI&A?VCV3'?P1CCVG#JX=/2 DH                           $=W!(X=V
MVZUXS*/O\7[4[)Q>/AC_ )_ ^%N^?M 2(707=\T
M      $<4Z1C?-69\9;Y(2V?8>R;O"Q(]O:<.OO&?? 2.
M
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MPP$>VDIU5=N$W'&UEOM[A(2E*D;4XDHT[3]$!(@
M
M     ^$K[FD?Q#OV-0"P:?\ <5>_MN+_ #\A.\O1ZB_.F_T= _D47[ V(67-
M                                                           !
M&6=/Z(,T?]GUX_D]40&%SR?+_=%K7^T:]_R@D ,^
M       I6]%+1;TU3:TH47#P4M*5)+%9$>)*V= #FVTI:J+"-:B4HVRQ-)$1
M'YQ%L =Z                          .CN,UE1IIMJ)"N'L4HB-)8[-I'
MLP <&RS6=OPS<6EQ6+N*D))*3ZYX;$[ %5
M"A+^-Y-);-EQ#:NT,EO.)2I.!N%CX6S$P%90_N2+B>)]G9,S+HVMI/8 Y(
M                        CVYS=3<=O[KK:$&;F\E:$*4HBQV),]I='< 2
M"GP2\XOV@&H                          CJ^C>*11":<;;(Y/6WT)5O%
MB6Q)JZ# 2$U]2;QZ>&C'Z4@&\                          1W(4][^89
M<5LFN&YBV:$&LSX988*\+: D0                           $=U]3I79
M;Y(=0A*C=WT&A)K5TEU5'UBV=X!(9=!><0#4
M  1U 6\=[U4C<;-K=;)*"2DED9)PVJ+K'T=T!(H
M
M                                       "']0#;KV26:K;2=Y:K NW
M!/1B14&H&?</N$ \W')CYAFCW3_I1?R]S/S59MN^J3F!?2JU1GZ=)=1#0[<,
MDFC2^R2^(:S2?22<,.[W RY?' \O_P"'.G>Y=0]: /C@>7_\.=.]RZAZT ?'
M \O_ .'.G>Y=0]: /C@>7_\ #G3O<NH>M 'QP/+_ /ASIWN74/6@#XX'E_\
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ML\:9QXR%D1&PXEPC46!?:BUIE*Q_Y+:@'<_' \O_ .'*G>Y=0]: /C@>7_\
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M'BRCCL["[F\1]X!S8_-VY?<%E$1K/*G<-A*4),J?.=29$6!8.MMFVO8721X
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M>Y=0]: /C@>7_P##G3O<NH>M 'QP/+_^'.G>Y=0]: /C@>7_ /#G3O<NH>M
M'QP/+_\ ASIWN74/6@#XX'E__#G3O<NH>M 'QP/+_P#ASIWN74/6@#XX'E__
M  YT[W+J'K0!\<#R_P#X<Z=[EU#UH!VMO\V?0?<]P4FV*-G;39-9K<AN+38I
MT^<WQWW74,H1Q%MDA)J<<(MO? 9&(DIB=$C38KB78TR.S*CNIVI<8?;2ZTLO
M,4A9& Y
M#X2ON:1_$._8U +!I_W%7O[;B_S\A.\O1ZB_.F_T= _D47[ V(67-
M                                                    !&N<S;CN
M4>9[;2=YQ67UXDE..&)^]ZH]T!YD>3#S!-(>GG3A<N7^:>:C5MWQ3,QKU75J
M,_3I#R(;:[@E$V9/L;^^I:B[Q88 ,P?QP/+_ /ASIWN74/6@#XX'E_\ PYT[
MW+J'K0!\<#R__ASIWN74/6@#XX'E_P#PYT[W+J'K0!\<#R__ (<Z=[EU#UH
M^.!Y?_PYT[W+J'K0!\<#R_\ X<Z=[EU#UH ^.!Y?_P .=.]RZAZT ?' \O\
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MW+J'K0!\<#R__ASIWN74/6@#XX'E_P#PYT[W+J'K0!\<#R__ (<Z=[EU#UH
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MW+J'K0!\<#R__ASIWN74/6@#XX'E_P#PYT[W+J'K0!\<#R__ (<Z=[EU#UH
M^.!Y?_PYT[W+J'K0!\<#R_\ X<Z=[EU#UH ^.!Y?_P .=.]RZAZT ?' \O\
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M\<#R_P#X<Z=[EU#UH ^.!Y?_ ,.=.]RZAZT ?' \O_X<Z=[EU#UH ^.!Y?\
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MC#JW%FG8K[4;4N4C _HD) =U\<#R_P#X<Z=[EU#UH ^.!Y?_ ,.=.]RZAZT
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M(@%UVGO53D?JDH<^XLDKRCWC2*8ZAF;*8COQTLN.$2D),GTI,]XC[@"X@
M
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MFS/3@'Q2>@KX#:1[-F>G /BD]!7P&TCV;,]. ?%)Z"O@-I'LV9Z< ^*3T%?
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MUO&KAQXS2664;RC-1[C:"+;W@'-
M                    ?"5]S2/XAW[&H!8-/^XJ]_;<7^?D)WEZ/47YTW^C
MH'\BB_8&Q"RYH
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MFS/3@'Q2>@KX#:1[-F>G /BD]!7P&TCV;,]. ?%)Z"O@-I'LV9Z< ^*3T%?
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M ^*3T%? ;2/9LSTX!\4GH*^ VD>S9GIP#XI305L/\QM(Q(R,OMV7TD>)?/\
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MTV+%==>2\XV1$A1FZ9F6!$ N"
M
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MQFHDNYNUL[[K#+!1T(X>YB6#18>$ N62I*R)2%)6D^A23)1'YQEB0#<
M     +<LX]+F2&>UY9=WOF?;+%>NG*^4_-LF6Y(;:73)$I:5O.(;4VM3F^I)
M=&'0 N)9:0PRTPT6ZVRVAIM/T*&TDA!>@D@'T         ;%N-MEO.+0VGZ)
M:DI+YJC(@$*9\Y%Y2ZE<OIN6&;U(BW-9=0F09\NEKE--)=E4U\I$1PUF3A%P
MG2QZ $A67;%M6-;=&L^U6F(=$H4&/3J9"0\APV(D5I#++9;N&)(;01= "K
M        !3MV6[0[MMVK6S<C+<BB5R#)IM1CN.):2_%F,K8?:WE8D6^TX9 (
MUR#T^Y5::["C9;Y/6^W;=G1ILZI1Z<TZEY"953?.3+=)Q+;9'Q758] ";
M       !\GTM.,NMO&DF7&UMNFHR2G<6DT*Q,]A$9& MYRATM9)9)WUF+F7E
MI;#5&NO-=^-(O:J-/H>*KNQ%;["C)+:-S<5YJ@%Q8
M
M       ^$K[FD?Q#OV-0"P:?]Q5[^VXO\_(3O+T>HOSIO]'0/Y%%^P-B%ES0
M                                                           =
M96:1!K](J=#J;7'IU8I\RF3V#/#C0YT=R+):QP/#B,NJ+T0$-9 Z;,HM,EIO
M63D[;:+8MR149U5=@H<2Z2IM1D*DRG=Y+;1>J/*,^@!.ZE$DC4HR2DBQ-2C(
MB(N^9GL(@&U#C;B=YM:'$XX;R%$M./>Q29EB W@
M  B7.C*++7/W+ZN95YI4V-7[-N#LQ5:D.2&FNT=D?3)8WC42]W<=01] #NLL
M[ LK*FS:)E_841BEVS;\8HE*IS3[;O9V"P(D$:23CAAW@$@
M            -BUH;2:W%H;272I:B2DL>C$U&1 *%S*RXM#-ZR:U8%\4]-8M
M6XHQQ*I!WR2F3'41D:-_=618D?>,!TN3&3&7FGS+NBY797T=%NV3;O:E4RED
MXE:(Q2WE2'_5-QLL%.J,^@!*B'&W2WFW$.)QPWD*2LL>]BDS+$!O
M               !\UNM-[I..-MFH\$[ZTIWC[R=XRQ,!!6?^FO*'4[:3%D9
MQVTBZ+<CU&%56H*W2:),VGOIDQ'MXVW?J;R2/H 3!1X%(MRE4N@4XV8E/H]/
MATR!&4Z@C9AP8[<6,U@9I,^&RTDNCN .R*3&4>Z4A@U=XG6S/YA*Q ?<
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MX8\/?3Q,._N8[V #Z
M
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M5UZ>43YQY9S^8A9[=<H6GJW9CM:B4&#3Y;G:+?:E.2VF68+)J6ZVJ!NIQ2>
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M9:[M5FLJXM!7*NI#Z*Q:\URC7#=\))NN2I+3\F,X:U-R73CH;>X9GBDBV>8
MB33MSB^:+RP=4MA:?.:I1YEPV%F'58E+I]S2TN-I@O521&AM2(TEU]AIXF5[
MQGAB6.&PP'OEM*YJ5>=LT&[*');ETBXJ13JS3GVU)6E<2I1&9C![R#4DSX;Q
M8[=A@*B
M                                ?"5]S2/XAW[&H!8-/^XJ]_;<7^?D
M)WEZ/47YTW^CH'\BB_8&Q"RYH
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MU)DVK4NWHL21P'J!39#LQ*&&VUK0^GL!(Q-*NYM >HSD)<WJH<R[)JX:#FK
M9H.?F4THZ1?4)2VV79[[*V8CDHH9R'7FUG(4>.PMA]&(#T&@
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M+Z(2'912HZYW#:X:V%MH2A+>..PS4>.)XX&1$'K
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MN2%-IDOK1VAXU;#PPPZ &8
M
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M0M2J1;?/1S_L^VH**3:UK52LTRA4IK#A0XL-_LC:$[A(3L::27@ET /T=0
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M^83I3R]U!VVRU3YMP4UIJX*,A:5JI]7C1XY3$GNO/;I./N&9%CL 9 @
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M974>CQ(UW5&@4^X;[K1,M>,:Q7:S#C3Y2IDGL[$ASAN.8;J\3)1 ,H0
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M].U;KDIR949%C4MMR0ZI2EK0Q$CM-8FI2C/!M)=T!D1
M
M        ?"5]S2/XAW[&H!8-/^XJ]_;<7^?D)WEZ/47YTW^CH'\BB_8&Q"RY
MH
M #H;I>./;%QOIQQ8H-7>+#IQ;I\A988;<<4@/SP^2DZU>/E">IRXJXPF?/BU
MJY$1'9Z"E.1]V6ZA*FE22=4VI)%L,C(R/H 75^6/Q(+%5T652/$88JS5X05%
M4&F6VY9[E=?-!+D(2EY6[ALQ5L >N'E[5:?6]'&0=1J3SC\MW+VW$N.N+4M:
MB:I,-"<5+-2CP)/=,!><                     LDYB]Q7M:VC//>K9>4:
M77[L18]:C4RDP4/.2I:IE/E1W6VD1R4ZI1MN'L(C ?G3\M_2YSN*O:N<%=T7
M6Y7LD45NY:U5;MJ]6B3*74*RZW4W*@U&C%4(C$AY:E&2$$G>->[L+N ,[7)=
MYV.J]K5C/Y<W,78<>S6C/N4NW+KJ#10Y:Y$-QB,IM\GI"'GD/.I<P,V^[L >
MU="DK0A:#Q0M)+29=!I46\1EYY& W                      #'_S*-'UR
MZZ-,ETZ=;?S G9;(O&3!14[DISLAF4S3VEN(EL(7%]6(GV'E$> #PL<_;EA:
M<^5SILTFV7DG2WY-[U^\HR+XOR>^<BJ7&\BK-/*F/N.M)D$:Y"%&1*6H![D>
M6TZIGEZY)2$^&WE4P^1ECCOIHB%X]...\0#QC<J%J)F7Y1KGS>EP,%*J='KM
M>1"*H([2IDVY:T$IHI*730I))(TFDRP/H 7J>65TZ UEEI<KS$-AJNPKWA=E
MJS;3:);24U<S2CM"4D]NI5M+K; 'I_Y7U5GUG0KIVJ%3DN2YCN7U!)Q]U:UK
M63=-B(3BI:E*/!)=\!?X                     PR<V3E2'S1_S1V=<N:=
M:L#+.R:FNHW?1J._+97=;)2%.E"=[-@DTNM+-'7V8 /%SS,M,.3&C+G"Z0,A
M\@[6;M.RJ75;63*CH6AUR?).3"X\A]Q+3)K6Z\R2SQ(]I@/TCITZ12\E9-0A
ML+E2X.6+DJ)%;)2G)$EBUC<CL()/6-;KJ226&W$P'YDVG[(KFT9B\P+4UF=H
M[RTN7+',ROW/6R>ONM0:E%CQ8<>JS"8=CR*C$::4VZPI!XI<,B(L0&2_1KSB
MN99R^M;]I:,>9_)?NVAWK6&Z53KCJ#9H5#?J<IB*R_%GO/,-OH2\2U=7$NL6
MPRQ >^RD5"-5Z93JO#6ER)5($.H1EI,C)3$R.W)941D9D9*;=(P'8@
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M::/2ZE<%03-IT7!B/()V:9.;[+/":4:\3Z2/I ?HQ%M(C[X
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MB2X5$9O.HFQ -2N#&W:\V22::-6XW@6S81 /=\
M
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MHLR=5D+I?R:RL<2:'[7L>@1I+9E@IJ4NEQ')+2B-#9[S;YJ(\2(\2 71@
M
M                     /A*^YI'\0[]C4 L&G_<5>_MN+_/R$[R]'J+\Z;_
M $= _D47[ V(67-
M                =;68BI](JL%!$:YM-G1$$?0:I$5UE)'CLPQ6 _-VR.S0
MH7*=\H8S<J^I9F9:>768U;G=FNN5#>;I;#%5E/;DIJ4Z4.(^3:$J6>ZHR+=
M5SY1?K7R9YE.I71[ISTCUC\ZU6I%U45^IU>W8[TV.A,JL$ZZDU0SE[B&$2$X
MFI"0'O;TGY;R<I=.N4.7\TC3-MZQ;;B3&U%@IJ6FD0^TM*(TH,C;>)1'L+H
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M%/.1EF<GLZEXDE75P,C,CP 84.;'J(LKFP<W73/EKH[C>_\ IU@731W*Q?-
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M&M6SJ+/:REMBN5)Z)6%Q9"(4ULYA%#<9D*;=87QR-"L$N]!X] #]$X
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M1Y0M9-_:7Z-+G9:Y?5N"52O>FT]V/3Y,>CRFN),?FQ6Y$;>D-[JS-2RWM[I
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M:5*29'L,![2P
M
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MYO677<O<Q;=IUT6E<D%^G5>D5.*Q*CR(TAM3:R)#[;J4+W5'@HBQ(!YNKO\
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M*)6P!FG26Z6!88$1$DB(B))%L(B(NX1 -P
M                                                          #X
M2ON:1_$._8U +!I_W%7O[;B_S\A.\O1ZB_.F_P!'0/Y%%^P-B%ES0
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M<ZQ*83@>\6 #.\A)(22$DE*$D24(2DDI0E)8)2DBP(DD6P@&X
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MFU$>3):0]2N>-^Y\9A7!<$^[+^G'.J*EO+63#JENJ^UU.)<4T9)<P(TF6!$
MM^D^2!:!)!+/Q[>:75K)1K56IRR(L<5$2%;$D?<[P#T0Z,-&F6FBO3/:FEZP
MDOU2P;5C3HC#585VY<F/46FF934CM"5$ZVXAO R41E@8#$1JO\F2Y>.I[-5_
M-9VTYECU>JS"GW#"MR6<"!5I"Y#LF2I4>*PVA!/N.F9X[P#+?HOT(Z<M!N6<
M7+#3W8T"U:2EICQE-0TPNI560RTAOCRYB&&GG-[<(\#,]H"\@
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MAY/Y%V93;-LR@QVV8T.&Q'2^^M#+32GI<EIAE<AQ?"(\5=T!<(
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MLL,L1V6TMIW^"VT3CAI06\HRQ/ !)H
M
M
M
M
M
M^$K[FD?Q#OV-0"P:?]Q5[^VXO\_(3O+T>HOSIO\ 1T#^11?L#8A9<T
M
M
M
M
M
M
M
M
M
M
M                      !\)7W-(_B'?L:@%@T_[BKW]MQ?Y^0G>7H]1?G3
M?Z.@?R*+]@;$++F@
M
M
M
M
M
M
M
M
M
M                                            /A*^YI'\0[]C4 L&
MG_<5>_MN+_/R$[R]'J+\Z;_1T#^11?L#8A9<T
M
M
M
M
M
M
M
M
M
M
M     !\)7W-(_B'?L:@%@T_[BKW]MQ?Y^0G>7H]1?G3?Z.@?R*+]@;$++F@
M
M
M
M
M
M
M
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M>!"9FRKDD3$QXVX1RHML 5
M
M
M    ^$K[FD?Q#OV-0"P:?]Q5[^VXO\_(3O+T>HOSIO\ 1T#^11?L#8A9<T
M
M
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MH5 B.':#DV.FK/D9$9&B,;I/'L/Z$1AJHQ=55.'^U51-E41O(Q$QA:*;V_\
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M^S?<DE$>(KLT6HB8EJ(2
M
M
M
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M=0&M33WI;RA@YUYYWS LJT:E2HM6@-R5M.5>:S,@E/9;A4HWFY<IU3)]"2/
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MZ>[T#AVQO.798^@D
M
M                                                        ?"5]
MS2/XAW[&H!8-/^XJ]_;<7^?D)WEZ/47YTW^CH'\BB_8&Q"RYH
M
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MSLHB%*,RQ,L#+'89&1EAL,C+I(QPHJB9FG_%&ZYGCWGU$@
M
M
M
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MK4];*3,\-XMO0?FF72?HC$1R;9JHW9W7.G1,1&F'V%Q
M
M
M                       #X2ON:1_$._8U +!I_P!Q5[^VXO\ /R$[R]'J
M+\Z;_1T#^11?L#8A9<T
M
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MHFVF(C3YG/$K@
M
M
M
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M#$S,35,1NN;%,T4Q3.I]!(
M
M
M  ^$K[FD?Q#OV-0"P:?]Q5[^VXO\_(3O+T>HOSIO]'0/Y%%^P-B%ES0
M
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MQV=9EEUW,?FK**;N/%%,1^AZE,BH<R#DME9"J4=<2=%L&TH\R,X2B7'DLT"
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MS;5%,1P18[40K
M
M
M
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MC-%LV8-LI;07S F9F+)W"R'+(B+81= BR+;=\:B0
M
M
M                   !\)7W-(_B'?L:@%@T_P"XJ]_;<7^?D)WEZ/47YTW^
MCH'\BB_8&Q"RYH
M
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M,_:BRK3#MD(0VA+;:$H0@B2A"$DE"4EL)*4I(B21%W"$SIW461$61N-P)
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M70"6H
M
M
M
M                         IFFT!4
M
M
M                #X2ON:1_$._8U +!IYH[!7C(R_IJ'@>/?GI($\J;+-Y?
MG3?Z.@?R*+]@;!#F@
M
M
M                       !9:T(L-@:"=TP(4\F$VM14@
M
M
M
M
M
M
M
M   ;'4$ZVXV>PG$+09]XEI-/_& @]W(^C.QIT94QS=G3&Y:SW"Q2MM_CD1?\
MX!-L=DH\=B.D\4L,M,I/ODTA*"/YB0'V
M
M
M
M
J                                                     ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>tm2227887d4-lc_rapidly4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2227887d4-lc_rapidly4c.jpg
M_]C_X0 817AI9@  24DJ  @              /_L !%$=6-K>0 !  0   !D
M  #_[@ .061O8F4 9,     !_]L A  ! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! @(" @(" @(" @(# P,# P,# P,# 0$!
M 0$! 0(! 0(" @$" @,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,# P,# P,# P/_P  1" 1>#M@# 1$  A$! Q$!_\0! P !  $#
M!0$!              $""0H#! 8'" 4+ 0$  00# 0$              0(#
M! 8%!P@)"A    4# 04$ 0L,"@T&"@(3  $" P01!08'(3$2$PA!42()%&%Q
M@9'1,I+2(Q46H;%"4C-3D].451<*P:)#<[,D5'08&?#A8G*RXC1DU"4U5E>"
M1$4F-CCQPF.#A+25=B<WH\.DQ&5UM48:A4<HI=5FEN.&Q;8I$0 " 0," P0$
M"0@&!P@" @,  0(1 P0A!3$2!D%1$P=A<2(R@9&AL=%2%!4(P4*2(S-3%A?P
M<I,T5!CA8M)#)%4)\8*BLG-$)37"8T4V)H/B_]H # ,!  (1 Q$ /P#/U4DC
MH78,>Y'VXR])/%-=Y96\UGKXU/Z)58(K3NRLW4LJ]).8;O+/E\CT@TD7,>;W
MDUZHLV+KO;M*PW1-(SKEJW9VG[0U6:X?&6@2\^_J7)*5JPR&1&E)[3C%M,JG
M_P [&Q/;U*-82U.+C?BHJ4T1_7X]2E*_0^!3^_B^M_*Q5]WPI3FU*'D4?N^R
M=PZ6_K!6<6FXM_I0TS1=K6ZM#;KL26S'<CH6ILE.IX91D9MIXCVD8IC@)J46
M_:["F65%3JU2V7].D_KFT+ZOL=;GZ<9+#1D3+"'+KB\E]AJ?#=4EI1MMH4Z:
MY!)-TBJDM_8,&YMT\:#ER4MOM)CEV[_LVY5EW'M!ELVTT,]O;ZGNC&MT4>7M
M1E/5U-85D          ,\Z]4NL+O3_H1J!JK'@*N,S&K/(D18J2,^*2MIQ+"
MC(E)J3;A$H]O8,3<KKA8YEQJE\9>P,=7+RA+AJS#"5YPG62C4A6H99-;?F]6
M1$U\R_-,/B*W?.G*-CF\_BXO1?#6M:C9]HVZS>QU*;UIK\)Q.?FRMS<(Q]F+
M,SOI9UC<Z@="< U7D0E6V5D]GCOS(QD9&F2VRVE]1$:E&1..F9[^T<3G8T;5
M]VX=G R<6_XMM73T61$14+<+"5%1&0VVZLD20   'GOJGN,^TZ"ZE7&UR"BS
MXN.7%Z-(-!.$TZB&\:5&@]BJ4'%;W-PVZ4NYKYSD-KBI9L5Z'\Q@#WKJ;Z@R
MO5W;1GD4DMY6^R@OF9C[D5Z6CAKQ?:=HV[ LV[F!:FUK1'%WYW;65=C7V=3.
MD\O*^7;).DO2J\WR6F==9MI)R9*2T3).N<MGQ$V6Q.PQ8W:"AE\J5%RHQ-OD
MYV7)\>9_D/; XTSP                     *%HX^';2BB/UZ&1T^H*DZ$2
MBI*C,/\ \[#6C5G!NJ.V6C#\J8M%K.(PKT9RW-25<1QY)J/F+.NTR'$]/J,]
MWW!27N\M#D\]NWMV-*.C=3GGD:ZO:H:@:X9S!S7)6;Q"CQVE,,MP&XIH,F8I
MU-:#,S\2C'8=_%MQZ?C?2]MOC\)J?VF<]T5J3K$RQQJ!S0%,G2+:!;,\V/*,
MCP[HSU"O^*7!%KO49$;T>8ME,A*"-,@U$;2SX3K0<3E7*Y^+S<')G+[?"EB_
MWJ)ANZ3=2VO\O4?3R-(SN*[&DY1;69+96=A)N-KN\5"T\5?#Q(48WVWBPN7X
MT7L\OY#4<C)NQL2K+2OY3]"G W7'\)Q%]U7&Z]C-C>=52G$X[;(JW%4[.)2C
M,<#DJE^:_P!9F=B.N/%^@Y8+!D@ 6;_.HS7+L&Z7Y5WP^[MV>XIDDGTAR,F2
M1EP/'3@69%O(<!O$GX^/'L<S8MBA&4+\G[RA^0Q=>F#J-UWN_4#I-;;GFT:5
M F7V"U)8*TLMFXVJXPDJ(ED=4U2HR':^R8EF]DUE'16N_P#U3KO>+UY8[I+3
MQ.[_ %C] 6S&:K3:%*VJ5;(*EJ]4XK1UIZIC1LA+QW7@I/YS8;7[)>I?,?21
M[TO9^N8ER3E1!<"L"0              #;+0V;[=2\1DHSW]A;!2V^9+LHR)
M5=*\##*\X36_6#"NLG([)B>6L6NS,QXBF8B[:U(4@ULRC55U1D9UH0Q^GXPN
M2R53A/3XS-W:5RU8QY1=*P5?B/97D,:IZCZAW_55O.<@9O3<,H1Q";A-Q.49
ME$,Z\!GQ;3,;EDXUNSLT9)>VS77?G>R[2FZTJ9-2B(E$1;ZG7?W[!J>*O99R
MEV59Q1N13&/,5FW<;WF15VD1%7?7U>R@N7;O)"GYS*%;3G7@>0NJOK8T-Z0<
M9<O.I63PV[S(8<7:,<COL.W&<\VEPR:4R3Q.1TJY1E515K38*;=?<_/[47E;
M;7._<[S']U9_6"LWNMQ<;TJTR1:[<TM:&9$N8R^Y*0E;A(>5Q2DDDW$<)T(B
MH.0LX-V]JM$4\T(]G,SBV _K >KUJNC,C.=.8UYMAN()V.S)9843?$DG#);<
MPCKPD8N7,/PVHOWF8RO\USE:I$O>]'7FA=/G5VMBP6ZZ1\3S]TDG]%;G*80X
ML^!HUH8DK>(G7"<<)))(MHC(V>Y8MQRZ5[WW%N&XVOM<L-/VUP[F>SM=,YN.
MF^E6;YS:64R+ACEGEW"(THRX'5,Q7'4E4U)311D7:. W.:Q,?[7']HJ?/0YO
M9\;[RW!8;TB_HJ8G<CS[^I1NYW:(C$8'+A72X0VSXHVU$66\P@_\K[4H(;!C
M8$KV);R'*G.JF%FSMXV7<QE'W'3B1_7W=2IG0L1@&?<1QC/VBEF8N_=K^L8C
MS+:_,^4J+S[.I@Z?]38E-NVD?_2A0]OUY(R]HKGDPC;4W$I_K\.I3=]$(%?[
MZ+W$>W^-[*!]W2C[\M2NW?A.'-R_*<QTQ\]#J-S'5'!<0FXI!;MV17F#;YCA
M*C<2&I,^-&6HJ2C.I(>/L%^WM3=IW7*J,*_N$;4U9<?:?:9<MEE',M-KF++A
M<FVV#+<3W+D1FWEE["ECB9JC:[$VC,@TTGVM5/J4*IGVGO\ 8%!62 *%UX3I
MO/87KGL(6[E=%2J8X:GA3K%Z]-%>C#&%3\ZN\:X99,:6Y9L1BR&%39BTH>5P
M.$3I+CD9M=I5,465;60L6+JW\AE>!.Y#Q?\ =KM,?K/_ -8"U@NMYD2<#T\C
M6BRJ=449A]]AU?*2M9),U.2ZF:D<(Y)8ESQ&GI"-/A,/QH*L:5?>=LZ&?K \
MUJZPK5K9IYRK=.DQV'K_ !)32?F]+CC3:G5-)E*2M*24I1E3L%^>WMSC"T^9
M2^0QK>;;=J<KJY7#Y3([T?UCT]UXPFS:BZ:W^'D6.7>.VZTY&>94[&4MMMQQ
MJ0TVXXMI:.90R,8>;B7;$OLMQ4UX_,5X^1;R8_:+;JCMITTH9<4>Q*$*6?J$
ME)J/ZPQDO#MM+L3,FG.TGVLQ?^MKSCM:M ^HS+=*,$QV+<;#C[R&FI9\A1N&
MI<@E5XI*#*AM=PM].QCN.'<DG24&Z?&7MR_X3*MVHQJI+4\LGY]_4J14^B,'
MB+?4XI'ZFPY8Y:WA./[9F)<R(5I;C5^LA/GX]2A>^Q&!7NXHO^EBJ6 WK;?L
ME$<J"=)1U]9[E\N7S9-:>JOJ/MVDV:X]$@V68S+<5):4QQI-AIE:2^3D.*VF
MYW#)M[6I[?=RF_:MF%?W+P\ZUC1C17&9&CT=*W5EO*A'W<)4VF9U[!P5Y<ME
M3C^:SD8NMYJ7!HME=;/FD:(=&Q%C2WF<VU$(E5Q6!*9K',VG#:]*?;?2:%&X
MV9&G89=]02Y_;@JU[2[&"@J2T18ZR?S^]=YMY?DXY@D.WVA;QG'B+>CN*0UQ
MJ-)&M4RI^"@S[.%<FO:98GDV[?94]=]-?GZXGD=YL^):[X>>+E<9;,5>5,R6
MUL-K?7'93S6/2E)X>8LSJ5*4&2]KG.-;>K788TLZW!^WI5F17A^98YGN.VG*
M\3ND2\V&]16ID"?#?:>:<9>;)Q%3:6XE*^$]I5J0XR4)0;C+1HS4TU5<&<B?
M6VVTXX\I#;3:36XXXHD(;;07$M:U*,DI2E)5,SV"ATI5\"I*KH67^LKSF=$N
MFJ^S<#PN&WJ5FT G8]PB0I;3<2VRBYZ$DIY$DB>X7&MNTMH848[E.4+?"/;]
M!=G;5A5NNC[BT5=?/VZ@I%S<?MF%PHMN6Z:FXRG(ZE-M&LS)!FJ94SX-@R\?
M#N2<G==(1^4QU>A+V8Q]H]F]-OGZX=DU[M.):[8>>)IGR68ZLH;D-N,(6\ME
MDN:QZ2I/#S%&==E!?O;?+EA*W[7,8=K-@W.-SV90,AG"\OQK4/'+3EV'WB+>
ML=O45J9;YT1UIYMQEY"7$D9M+625$E15*M2&!F6K^->C:N1:?:9.-=MW[3N0
M?,GP9S04ET        --95,C[CW=]3(A17]:EV4(EPJN)CA>?EJ9J!IU;M(E
MX+?FK*J:=P]+YD-$OG</I?#3C/PT,B&!ML%+>KU==$<W#_Z:Y)>]5_,6M_+
MUYUFR[K2TRL649A'N-EEN/\ I,-%K:84Y0XG#1U)U3M48W_#L6YQNZ<(_D.N
MLS)NQ5I2EIS?E,WM*?EF3W$3*:>KL_M#5?<C/NJ;+K*<95[#>$6TS[Z?4%J$
MG*"J7J494*@                     !%!1*/,TP2*P
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M+*-*.A[]'!',
M
M
M
M
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M>=JCN*D7P+$;UN;<8NLD>CDG4B,RH9]F^@L%SUD@
M
M
M
M
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M&7DXUS&F[5Q<>!AVKT+\?$MOV5Q/3 Q3(((B(J%N#B#%Y_6'O>Z.$?:5P_\
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M6DEXJ-3P+5QY,[U&H,R[$G4O9/ZYC6GQ.:3JJHJ$$@
M
M
M
M
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MXW;O%5-@ZJN\EC&Y.*B_F+U'D1]-ND6>83F&J&:XK;\DRV'<(2+=)N3#4EJ
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MU;J4)**HE0^X1$14+<())
M
M
M
M
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M.?\ WJ?_ *C^<V#&TL0_JKYBS1Y[=/Z*ZJ_RPZ?@WAPV9_?L?ULVG8J^%?\
MZABH](W_ 'DM'Z[?]?0=O_YQ@]P[3Z8_O5WO\-_^4ZSW76*?_P"S_P#(_0)U
M3T[_ $LZ-7;3M-S59U9-C#-N*X)2:SC$_ 2WS.&BN*G'N'6^YVEDJY8?UO\
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MUR,(=.N\_>K^4\[^1Z9_TSH=>%1';[B2DJ2E5:Q(Y$9$>XR':%IP72]^U/\
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M29&<.I&A6S<.U,%6X;1D1EI/E5/B.O=QO2CN]B$>#;,]1I*22V:4(0:D)-7
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M?>*]*E9'4JBHEZ B(BH6X.)!(
M
M
M
M
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MGM=J3XF+NZ2W&XEIH9E'DID1=&^)F7:X]_@1QD;QI"U%<$CB-I]J5V;]YLO
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M.LMQI;R;4X^\WJ?H00$EZ%"5V^AQBKZG)3[HZ_G%>(WVILV:/N_ 81OG<_\
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M/MY_R(M3>4/LZY=.?5-^GM0AVE@3=W9\RX^.AU+DS\3=<6;XMLSNRWM_WO\
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MZ&E0P?<*R7)M+-0+3D4)$FU99@E_2;T1]#L607S;<6^<UP.<EVCOHIEV#?\
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MH?<)/W0SVE78-BS]N^RVHW8_":SAYGVBY*U+BC(!'#')
M
M
M
M
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MSN;N\\VRK4H\L4<+CX%O&O2NP=926I>5*AE4MVWZ^WZHXDSD2
M
M
M
M
M                                             *5)XBI6@LW;7B4U
MI0E.@42CI17#M[JU%XI>IXBZM^@;0?J^LCD?/\;AL9,RRINUY1#CL-3H;BDN
MI)QTTLFJ30W3/Q'6HM*'(W-.DWVF78RI65RM5@^PL*:E?J^.<6NYN'IKJBW<
MK8XI:VD28;3*V$*4LT-*)<0R,VT\);#,9UG.O6H^&XU7><=>P[-V[XT7RNO
MV>GOZOKJ-=;DTC4+4]FUVQ*TJ=5'B-/+6A*D&I!)1$WK34AF6=PC;NJZXU:(
MOX_B^SS>R7P.C[RT>GSI$0U=L;L46_9P2.![*KE&CNO&:FFD+6PRMCY!9J:X
MB,CJ1[A9S\Z>;?=ZG*GV(MX^%:QVW'4N%JC*56KI[3+LV$1;B(BW4'%NVW=\
M1,S^9)JB]E=AKFV9I21JVI*E:;Q6U4HE[3JM#S'U=]-5NZK=%<AT=NE]>QV+
M?R:)=T883)<8Y:7$E1I=4JKS!@Y^ LV,4Y4Y6G\1G8.:\)R:7-S)KXRR=CWZ
MNW@EAOMBO2=;KL^JR76)=$,G8XR2=5%F-2R;-1)J1*-J@VS;MZN8%Z-U14G&
M-/DH<!G[;8SK#L2JDY5^6ID7XCC[>*8S8L;9>.0W9+5!MB'U%PFZF%%:C)<-
M);"-9-5'$7[KOWI76J.3J9MJVK5M6UP22.1"T7     "E2>+MI3;[)&1E]80
MU54)3IQ/!O6;Y?.B7698.3FEJ8MF81&U)M.6PX["9D11H>3Q/$3)KD4-VNTQ
M@9&"[T/U<W"Y6K:[3+LY;MQ=N<5*VUI7L]18,S[]7VU4MEX=:P34N/=;.;I\
MEU^*RTI+7$OA2:7(=:H10AS=[,E>PK>%RT\/M[SC[6/"W*<^;67R'=.A'ZOM
M 8NEOONMNH*KI%@RH[[F.18C9)F$VXTZI"WBBH2A!\!I.FW;N&5?W65^Q;LQ
M@H.WV]Y8N8<)V7:;=7VF1IIAI-A.C>$6;3[3JRQ,=QJQQD1HD2*RTA2B0A*3
M<><;0V;KJ^':HQQV3=NY,^>X]2[8L6\>SX5OXSL,FE%]GM[3X=Y=QE46I+FD
MGV+L+RTAR_G=Y;IZR_+-T"ZP6';K?[1'QS/.#ACY;;HS"'BHVZA*I#*&/EU$
MIVM3.IBQ.S+G4[4G#77TF7:RN2+C<BIJFE>PL99Q^K[ZK6^\.Q\+U)C7.T)=
M5R9+T5EM9M&M7 1H7#J1I10<K'/FHJ$HU2,&W8A"X[O-Q[#O;0K]7WM$>XVZ
M^ZV:@+N[$*4P\[C<6(T2):6G&G5(<?*,A*$&25)V5WC.AO+C;Y%;2?>8N1@V
M[\JR9D2Z5Z08!HOA-KP#3:PPL<QNTQTQXT:(PTA;G VELW)#K;;:GG5<!&9F
M.$RIW<J:G.3T9DX]JWCQ48+0YXW;U-G4GU&=>TME.TC+M(R%.5'[2DN"7RE5
MN+MII/5LMB=;?E4Z'=8,P\J-MG!]1#2OFY1;HC)E+43;A,G*CH8/B4EQTS4K
M:9]U10XS5%:ER\KK0SK>7RVW;NKFC2GJ+)^0_J_>M,2[O1K%J+$GVA#JB8E+
MC,(6MKC/A,TKAU+P$0Y2>Y7KLU<E&C2H<3;P86H.,9Z.53V3TR>0C@6&W^R9
MEKCE1YLY;I+,L\71&;:C&\PXP\WS'CC)29$XV>RA[Q=L;G/'L>%;7MZZE.5A
MPRKRN7.",A?&\9LF(6.VXWCEOBVFRVF(S"@P(C+;+++##:6FR)+24)KP(*IT
MJ8XR]*=]N5QUDS+A&-N*C%:(WTJW1YT=^%-;9EP9;+L>5$D,H>9?9>2:%MN(
M<)25)4DS(ZD8L6[,8VW;G[294Y3\13BZ4+(?5EY(.B.N60W#-M-KB6F.13B>
ME3(\6*V]!G35F^ZM1(3',F"<>=K2AB[8=RQ.L9-V?JER]<\=+Q%62[2U].\@
M#79%P4U$SZ&[ )XTH>4Q')7*)9\*J'#J1FFACD)[@_\ =0Y5V^DQUCPC6DOD
M/9O3SY V"8Y>+-E&MN9+S'T*0S)=QIJ*VTPM3+C#I)<?]&2FAJ;/<1[Q=CND
MX+V(\K,*_MUN]DQR)2;<>PR#,)P#%=.<8M&&X5:(5AQRR1FXL*W0H[3*$M-(
M)".,VD(XUT+:9E4QQU^Y<R).=QUF^TY"VH6XN*6C.:%LV"VE14 $@V$B Q+:
MDQI:&Y,66TMA^,\VEQIUEU)H<;6VLC0I*T&9'4CV"U>M*[)/A14?IJ1#FA)N
MO$L*=9/D=:;:RY/>=1]&[TC3O(KD:I<RRLQFEPI\UPWG'G&U)C&3/,?=XJ=Q
M;Q>P)SP,AW[>J?87[]Q9.$\.6G,^)XBTQ_5]=0;KE$8]4=1V(6.1I+;SZ8\1
MA]V6Q'>;<-A)%$*AOH2:=ID6T<@MRGR\CAVU,/[-"+33T2H7%-=O(_T-U1Q+
M <6PK('].48=&<9G2X=OC3';XXXT:%.O&;*#0?&?%3:,:YE7;N<LR;KR\$7[
M2A;PY8C55)\3M+H+\JK&>A[-+[F-HU$G9<_>VDMKC2;<U#2SPH:14E-D1J^Y
M?5%^YG3N6G::T9C+'@KD;BXI%V9Z&S(:=CR&VI$:0EQ$B.^VEUEYMTC):'&W
M"4A:3(Z&1D9&0XR=OGFI?'Z3(M^PJ=M="R[U<^2MH1U"7R;F>#24:8Y9/-Z3
M/?@Q6G(<Z6LWW>(V41S)DENNU.A&(C&=N^K\'P[#(5]2ES7565*5+4EU\@'7
M)BZ/M6S/X;]M2Z2&'EL1R-3/,,C6:3AU(S1M'*O<KEV"A<CP./6'"-YWE/CV
M4/;W3=Y!NFN%WJQY9K3E:\Y=A/-2WL:1%;8C$\TXRZA*W_1DDJCC9[*&5#&3
M:W>5FQ*S;@JOM+.1@6\BZKDF]"_WBV#8W@^.6O$\0M<*P6*SQFHD*# C,QVV
MV64<M!*)E#9+7PEM,RJ8XJY=NW;OBW9.3])GV^6U!Q@EJJ'2/5!TK:<=5FEM
MTTSU&@MRX\IEPK9<S;;5)M<E2%(0^RI;:U42:S,R*E1@YN+#*<9P]B[%JC+F
M+=ECP=N7M0EQ1C;9_P#J_&J=MR"3$P'4EB?C2WG#CN/QVFUM,.+6;;1H7#K5
MILR+V!RUO.N0@K;54E0Q5C6^;F3IK4O >5[Y>EZZ&\>RY.192WD%VR[T7GM-
M,(:3%Y"6*GQ(89)53:]7>,C(W261@6\'DHK;K7O,6&!"WG3S5*KGV=U"X9K#
MHCIMKQAEQP/4[&H&26&XLN-*:E,,J?CFMMQLG(TA;;CC*T<TS*G;O'".Q"5'
M/6:X/M.4A=G;?L^Z^*,>+7']7TM3\ZXWO1?4-=K8ER7WF,;E1&S1$2XMYQ"&
MWSC+2M"24E.VFX9-B[>M+VY.<NQ]Q;S(6\I<MI>%'M])T#A?ZOOJ_<+RPQE^
MI$2V6E;J2?DMQ6'5):-:249(1#-1^ S&?#<I)+Q(*4^\Q+&#'&N.<+E8OL+V
MO1EY5V@'2*\WD<6WL9IJ V:31E5UB,&;!\#9.*CQ5LFEM9N-$9*(RIZXJRMT
MOY$/"7LV^XI6#CJ^\AJLRYN3"B(B)95+85$D2226Y))+822+93N'%-2<6D_:
M9R"G%:4T+;?6GY8>A76(D[W=H+&*:@)1PMY=;8C!.J)+3B&SD,(9^642W#,U
M&=3%NQ:\!N47[<G5OTUJ9-G+\.U.S**<)+XBQOEOZOWK%;[S)BXKJ/$N5G2Z
M91I3L5AM2FN-9%X5PZE1!$.4AG3C!0:K0XQ8MODY8RHM?E/5'3CY N'8[>++
ME6N69JRQ,*2S)?Q1F,VVPZIAQAY).R/1DIIQH,ME:U&1]ZRY*0BDZ&.\&#E6
M3;,AS"L#Q;3O&+3AV&6B'8<?LL9J) @0F&F4-LLH)"./E(;)Q?"6U1E4QQ=R
M3NU<]6S+4$J*.B1PC7K0K!>HG3+(=+=0K:U<K#?HJV5<;;2G8S_+<0S(:4MM
MPTJ:4Y79O&&\6,HQB^,7H^XR+=V5N7,N':C&9U4_5]\]MF0S/T4ZDHEXY*?>
M?CL28S32X;3SCJTQS)44R,V4*2G89[AR5C*N6(>'Q13=4+UYW_=;7 N,>6%Y
M863]%^0Y)F67Y<S>KI?6T-E#98;035$,(49K;CM$?W,^TQGY&\3R<98SA2*[
M3A\?:88V7+*C/FE+B.L[R:L4ZOM;+GK)=-4KAC$NY,QVE6N/:F93:.0VXV1D
MZLC,ZDX->V7&^Y]POYT7SN_*M.[6ISV;?CFXUK'G&GA*B?>=U^7YY9N/="%Q
MR^X67/IF8JRLF$NHE6]J%Z,3),D7";9>*O)^J-CSMWGFXT,>4:*!Q5O#MVKB
MN1XHN=/VR)+CRX<QEF7"G-N,RHLAI#S#S3J5(<;<;<)2%I4E1D9&1D9#@YP<
M[CFWHU1HS(>Q!17%,L>=6?D?:*ZWY%<\YTPNA:89%/)Z7,BQ8K;T"?.6<AY:
MB2F.?HY.ONUH1&%CGQY\]IOE[B[<E&^DKJ]KO+8ZO("UV3=C93GT-5LYY)](
MY$?CY/,H:^'T/BKR]HSXYD^:LU4L3L0E#EC*A<QZ3O(ZT7T5R&U9QJC=2U,R
M"!R9<6%)BM,P8,YLV'D5)4<N>3;S53*A>N+ZW2];C*-KV5(Q)X%F:@IZN+X]
MY?+B6V+;X\.% 99AP8++;$:)&:0RPRRTA*&VVVVR2A*4H21$1$0XOVG<<Y.M
M3+<$TDM*,L[=;OE"XKUF:L-:I774N?BLEMIMH[?'MC,I"B;;=;(S<61G^Z_4
M%K;K7W?.])/F\:5?5K4R,F[')M6[4HT\-<3EO07Y5V-=#V8W[+K1J)-RYZ]H
M2A4>3;FH:62)#2-BFR(U?<ARSSY/&ECTTE3Y#C'A6_M,<A:.-2ZY=8";I:[E
M;%K-M-Q@3(*ED530F7'<8-1%V\).5'$W[*O6966Z*2:^,Y&U/P[D;BXQ:?Q&
M.GG7ZO;@N:YIE68.:U76&YD]SDW)<1-ECK3&5)EO2S;2LTU41&]2OJ#/QLF6
M-BQQDJQCVE&8H9>1+(DJ2DM2\-T9]*MKZ0M'K3I-:<A?R6-:U+45RD1T15N\
M9-D=6D>$ON8NYF;++<:JG*C"Q<2&+S<GYQZV&"9@ %J3K[\KW&^NC(<7O]XU
M FX>[C:74H:C6]J84CFI=3XC<(^&G-^H,2SB^#N2W!/VEV&;/+\3 >#.-8]Y
MUOT2>3WBG1KK C5JU:G3\JEH8?83;I%K9B-T>:;:,^8@J[";&TO?)O NX/(N
M6[37NH<)>P;=S+MY4=';KIWU/9/7+T:VGK3TN_1K=\HD8HQSN:5PCQ42UD=%
ME3EK(R^R&HY.!'(S+.6W25EMI=]38</<7B8U[&Y:QNI)^BA:WTF\@7!]+M1\
M1U!9UENER>Q6>Q.;@KLL=I$E3$AE\DJ<(JIJ;)%[(V[;]\N8"NQC%-7(T]6E
M#7,C;K-^C>DHNJ,AF'&*)$B1"5Q%%C,1R4>SB)EI+1*IZI)' 37//G])R"T5
M"SUUS^4=BW6KJ?!U*NVI,_$Y4-E#/H,:VLRT.$AMUNIK61F6QWZ@QL+&^QYU
M[,BZN\E5=U#(S+T<S MX,U[,'6IONA+RF\7Z)-1+OJ!:-1YV6R+HT;1PY-M:
MB(:(VVD&9+053^Y?5&R7-XG<VW[O<53O..GC0E=MW5IR(N_&FI&7>.#A'EDY
M=YDO54--QGF*2KBH2>SO%SF]EH+2?/VE+\=$AMQEPB4T\VIIU"DD:5MN)X%H
M41[#)23H+%^WXUF5KAS$IM24EV%@[K>\DG"]=\RNVJFD>0-X)E%S4;]RM*(K
M:HMQDJYZUN)4F,I+9J>=K0QE8F1/!CRVH\R+MR:OI^+[S[3P_I1Y!^KUNU&Q
M?(LPU"BL6VPW>%<5*3'8=4XF%-CRDIHF'Q%QDT9#E=JWF6V.Y/DYI7/D,#['
M",^>,N_3UE[KKB\O:Q]:6F&":<7?-96*-83%8CLSXT)N6J4;4%J&:C;<*B:\
MNHUW)M?:-VAN?"5N4G3^MJ<O@9GV':KNUI<UNZDF_4>'M O(EPK0S5W$-5HN
MKUSO,C%'TOM6UVSL,HD&E;*Z*=2FJ=K/U1LNW[W=P;-ZTHJ2NKXC7\G;;61.
M%SA*#+_;#1,,,LD=29:;:(^\FT$@C]F@X-NK;[SD4J*A98ZU/)RQ/K$UHF:P
MW74^X8O+EQXS"K9'M;,ILBCM.-),G5EQ;2<&+@8_V')O9$75W95IW:U,G+O+
M+Q;>--:6ZT?K.U.@'RP,;Z%+]E=\LV?S<P<RA+*7&I-O:AE&Y1,EX3;(N+BY
M/U1LV;O=S,P+>#*-(V^WO.,6';C>C=CHXU^4NDSK;#N<65 N,9B; FLN1Y<.
M4TA]A]IU!MN(<:<)2%)4A1D9&0UR=F%VV[5Y*4'V,SU-JE/>7:6/>JWR/-#]
M;,@N6::9W(M+\@G$[*E1XL5M^#-G+-]Y:B0F.?()UYVM"(PC"["4:3?@QX1[
MB+DE>UN+V^\MB2_(#UW*YJCL9["<MO/X"DFQ&)1L$OAXN$X=:FC:.3EGSYN9
M1T[BP\6R]5*DBX1TQ>0]I!IG?+/F&L%^/4:X0E,RTV-<5N/"CRFE,NH):_1T
M\TDNM5,J4,CWB\]SN<G+;7*RQ]CM\U9:I%^O'\>LN+6B!8<?ML.TVFVQF8D*
M#!CM1F&66$);0DFV4(17@253I4QQTYRG+FDZR9DQC&"I'1'V-M3V[.PNX4E1
M(  #IS7W2.)KII1ENETZY.6F+E4!<%V>TV3RXZ5I4GC2VK8HRXAC96,LJVH-
MTI)/XB_CWO N<]*Z-?&6 2_5S,#*03YZY7<Z74KGP_,4;WQ3?2^7[W=794<Z
M]SF_#T_9T^&A@O'M.U.U32=?E,@/0C2>)HAI7B6F,&X.76-BMN:M[4]QLFER
M";2E/&IM.Q)GPC&SLMYN3+(DJ.5/D+>%BQP\>./%U2K\KJ=ND5"H,5NKJ95-
M*'D;K-Z4[9U?:.W322ZY$_C,:YJ0I5RCQT27&^!+A;&ED:3KS!@Y>(LJ["[6
MC@ZF=@9CPN94YE)-?&6;,;_5W<$QZ_X_?4:W79]=BND.Y(9.QQDD\J)+9EDV
M9TV$HV:>R-HP-YN864LE14J1I3X*'!9VWV<W&>/+1.5?EJ9%^+V-O&<<L>/M
M.F^W9;5 MB'E%PFZF#%:C)<-);"-9-5H.)OW7>NRNM4<FW\9F6K:M6U;78J%
MJWKV\J' ^MW+[)F\K,9&#WRV-*:ER8EN8EJN"30ZA',4I'$1H)WM,]PQ,&W+
M!W)YT)?JY>]#L9R=W+A=VW[#*"\3LGVH[1Z /+KPOH1L^2P[%D3F777)E,>E
MW>7!9BOI0P31$E)(1Q%Q&T5=HY?-W"64N6*Y+?<C@K&#:L7?%6LZ'L?6W2V+
MK-IAE>FLV>NV1LHMK]O=G-MDZN.3R%HYB4*J2C+BJ."S,19F,\>;I5K7U.IS
MF!FRP,N.5%5<:Z>M4,?5W]7+P-U<A9ZY78N?=%W*GS%&\)KF'+Y?O=I$9TJ.
M;P\^>(K:2KX:H8&5"WDY,\AJCGV%^SIPT1A=/6C>)Z16^ZN7J)BT$X;=R=:2
MRY((TI3QFTG8GWHM[AEO/OROR5')4+.-96/'E6JYJEIOJH\DG$.IS6O(]8[C
MJQ<;!+R%Q#CEK9M+$AMC@4Z="=61J5]U&%LD?N;Q.3V^?Y#D-ROQW)6E<C16
MOE.@3_5U,#-)$>M]U.G?8HQ_^*,ZUERMSE)JM3!G8LR5$J$?_DZ>!?\ &^Z?
M^P8OQ1>^\']4I^SVZ4H:;GZNA@;B%(_3A=4\14J5AB]OL!]XR^J%CVUV%WKH
M<Z*[+T7:72-,[9D[^6Q9*S-V;)B-Q%*2I!-J0;;9$FAI(6LW,>9;C;DJ**:^
M,M8N)'$NSN6W[S3]5#P]U4>2%HOU$:E3]2+)E,K3Z=>9"9%ZB0H#$IJ>LW'7
M'=[:>7S%.GWC!V>,-H3C:58MM_&SE,[(EN%'D:R2I4N%='_1SIET<:<,X%I[
M&XGGB;5>;RXA"9%U?;0V@G'$I0CA+P5IMWC-R\R>7=YYZ1[$<?8QK>/'EMZ'
MKH89D  4$DRIXMA5V4IO]D5-ID)4*CK38=#[]XI)!5IM.I]^X 2      ((C
M+MV=A=WL[S!U?  R,RI6A]XCL!1P%N(S(CWUJ=?9,Z@E27,132A4::F6TR(J
MU(JE6OJD9&5 :)),4SDU2A)(K(*#0?"2>*GJD7JU[]@EZD4HJ%7J;?;,_KBS
M5\[790J/D74R.TW;90_FR?MJ9[/1G!CIRG9NI\>5_,RN*I)=U4?G9=9;T?\
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M0  $&52H1T]4 S30VI*C4;BE$9;C,Z%[!F=!/90BFM34(J%2M?5!ZDK0D0
M     *5)XO4,MQ]P:=I#52:'0MNWOIO^J0#4%7M.OU ))     %,4UQ=4"DR
MKO,Z=A%4O7W'M$M56F@)+8*81<51NH)%8 4[0 !2:249&==G81F1>R1'0PX
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MS:=3[]P22D$2)  %/#XC49UW4+NV4/UZAKP[!1<>TJ
M
M
M
M
M                                              2IH"FA\1GQ'3L+
ML+93O$@J$                            (2H""*G?[)F?UQ()$)4T0 D
M  13;7;[9T]K< )$+T@"0 !!E4J5IZHE:!ZDB         $;:GMV=A=P D
M     !&VI;=G:7> )$-:I@"0    0U71@"0          /[.\
M    0_0""K3:=3[Z4$@D                             %)D9[E4]BHA
MJH),J]_MF7UA(':>WUB[O=J&GP@D           014*E:^J)81(@
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M!9K[*KQ+B33?<:@%0
M05:;3J??N $@              !QX@
M                    "F5:>SQ!&T1'GK[7 DD5D
M 'F?JEZ8\-ZK--INF6<K<38YRDJ=Y1%QU22R*E4J+[,8DK$I9D,BOLP,W$RW
MBN32KS*A;7Q#R+NF+#<JQW++8].*XXW/CW"&9DFANQY#4E-?DBWK:(<QCYU[
M'N^)!]E#BLC%L7[,K5*<SK7Y2]G;8A0+?"@I]Y"B1X:/51&90R@^S>E%1@\T
MYSE.?%LO17+%1[E0WHDJ           A^@ %6FO$ '6FG$ %Z0!(    *?:Y
MO]4 5                I2GAKMK6G8);J0E0J$$@
M                1*M/9X@"0     !3&O: *@4EQ5.IU+90]A>ON$NG80J]
MI4*%7M)((C+>=?8H*W3L(521!)&VI;=FVI4W^Y0 -HM_K*U["=!0ZUXMG=0O
MKBYV>DCM)   0=1;GS_FDZ$BJ/-3VN) %0
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M   (E)156#;+EL-KY:UDE7<?J[!,?;]TF:Y(J<M(LJ.2T2N'B\1[B[P)46Y<
MO::X%(                $&9%O FE20(                  "",CW 32A
M($#>   @C(]P$TH2!                         !!&1[@)I0G>!
M                                 01D>X":4) @;@
M  W                          !N                  -P  "%*))5,
MZ 2DWP%2+M$-TU9%"$K2NO"=:;]XE.NH*@
M                                         'PK[D-OQ]EIZX.<MMYQ
M+2#WU6I1)(MY=IB4F^!*53[+2R=;;<+<XA*R]91$HOJ&#T="#4$
M
M
M
M
M
M
M
M
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M6VLCKM)2%$?LC6'"=JXXW=&=DJ\I6H7K6MJ:JGWIZH^N6TB/O%9<
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MP^+!N1
M
M                                                  "#,B,B/>=:
M>QO$5[ 2)          !%2J9=I;_ &0!(    ()1'N,2TUQ(33)$$@
M
M
M
M
M
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M,?I)7X!.A:?WO(_M)_03_4?VO_B;<O7](F_B0_G[O?\ A[?Z,?I'^03H:O\
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M:KEU'3-ZZLJ]*[-4=6_C/<V+CK&VVS@0=8V8**]-$E^0Y,*2Z
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MKZ(+8YS;;,>M+U\BM\[TM]EYZ*\:GFWG"CI2X:#W$0R8Q45SW.!84V[OAP7
MZAN'6KYFW0'E^+.]5-M?R+!+]<(I3%J(WXY1WI#:'5E+YB&VE---K[:BM1MW
M$U!:EZ<N2C>L>\RBM"=7\7UZTQQ35;$7T.VC*;8Q+22%I633RFD*>8/A6Y0V
M7%TWUV#$<6GKQ)IK5'8N0WA=CMKT]N(N:MK=';,R4NM:4H1]I").BJN(/.F=
M9O/OT:W,OV%^W(1*0\3SBC5Q<"R,D4,B+Q4^J,O&2:K4IN*BU.VHF<S#BVX_
MF&15]FBB)2J-\M"2*OAW+[!BW%RSIQ*TJJIK-9U-<4RD[#(3S"=,S-1T3RR,
MR^Q^R$5)Y2EO/)BRCF=@DD;YND955X";,R(S\/V5 3T'*:C>;S7'(Z?F&07.
M)ZJN(Z-FV52KX?LZ".9_ 0XKM--.=S5)9-6/R2YIN\234?@Y9G2OA^RH)YJ:
MD\J96C.IBSB%\Q2"]()[BJI7R7*K3B\/V=!%1RZ&FSGDUTV:V"2CF\VIFH_#
MRZTKX?LJ"4]:#E-5&;S5)BJ^89"?23=)=5'5OE5(N+P_94#F? A17PD(SF8M
MR.VJPR"2\3O$KB.B#;J9$?A^RH)3#CV%",\FJ1&7\P2:OF]QEQ'\D31F2:^'
M[,4U;)Y2IK.IJSBDJPR$>D$]Q54KY(VJT)7A^SIL$MD\I#6=S7"8/Y@DIYW.
MKXE>#EF9)KX?LZ!4IH&\ZGK.'7'Y!%)Y_&9K/Y'E$9EQ>'[.@CF^,GE[R&L[
MFN>C\5@DHY_.K52O!RJ\-?#]G034.-"MK.ICGHM;%(2<CG<535\ERJTXO#]G
M38(JR>4AG.IKJHY*L,A!/$^:C-1_)\HC--?#]G0&Z$*-2J-G$R1Z.1V-]OG-
MRU*-2E?)G&2I225X?W0R"KI4-&-YU?\ F;]5.EVON983A5QC6G';-<(<>%">
MM[$A:6GI#K:^)QQU*E<24E38,JQ;4XU99G/DE2A?(Z6M9LPU$T!TVS[+8*[C
MD640I#EU?923*4.,(;6E1-)-1)2LW#(J#'EHZ%[E6IWZWF\U9PB.Q2$^E%(-
M7B,^5R:\/%X?LZ"-2*<30:SR<X<8E6"0CG\_B,U*^3Y1G2OA^SH%2>4U$9S.
M6F&KYAD%Z5S^.JC^2Y-:<7A^SH%1RH,YS-=7&2=ADH)\GN(S4?R?*K2OA^S"
MM.)%'V$(SF<IN(L[#((Y)O\ $7$KY+DF?#7P_9T"M2::%;6<3'%1$G8I"?22
M?-9FH_DN21TXO#]G00Y48Y=#2:SN<YZ-6P2$\_G\55*^3Y-:<7A^SIL!.JJ*
M!O.K@OT.N/R$E)Y_&9K/Y+DUX>+P[>938)YNSM'*^T,YW.<**:K!(1Z1SZU4
MKY/DUI7P_9TV!7N%#58SB8]Z'6Q2$'*Y_%51_)<FM.+P_9]@)U(:[BEG.9KK
MD9!V&0@GR?XE&HZ-\FIE7P_9T 4^(I;SN:XF&KYADD<DY!++B5\ER3.G%X?L
MZ".9]HH5,YQ.=<BH.PR$%()\U&:C^2Y1&::^'[.@FI-$4HSN<HHAG8))>D&^
M2RXC^2Y-:5\/V=-@5#2-1G-YKOH5;#(1Z43_ !54?R7)(^'B\/[H9; J13O-
M-K.YKAQR.P24<_GUJI5&^57AKX?LZ!5CE94WG,Y:82CL,A)2C?XZJ/Y$F:\/
M%X?W2FP*LFB(:SJ8XN.D[#)23Y/U,U*\'*(S*OA^SH#>A%-2$9S.6W#6JP2"
M]*-_C3Q&?*)DSX3/P[>.@5[ARU1J,YQ,=5$3\Q2$^D$^:JJ/Y+DUIQ>'[.FP
M*NOH)Y32:SN<YZ-6P2$F^;Y*+B5\GRJTKX?LZ;!',.7B4M9Y.6<.N/R$^E<_
MC,U*^2Y%>'B\.WCIL$U9'*5-9W.<*,9V"0DY'.XJJ5\F35:<7A^SIL!,4?$U
M&LXF+3#4JQ2$>E<[BJH_DN56G%X?LZ;!%7V$J)#6<3G%QTG89"2>)XU*-1T;
MY1&::^'[,34BA0C.YBDQ5'8)*3D&\2RJJK?)J1<7A^RIL$<S)Y5Q16SG,UTX
MY'89".>3U:J5\F;1'0E>'[.FP2W0BA0C.YJ_1JV"27/-[B+B5\F35:&?A^SH
M(JZ5H*:E;6<S7#BD=AD).1SN*JE?)<JM.+P_9]@AR:XE7*4M9U-<-HCL$E!N
M\[BJH_!RJDFOAV\5!/-V,CE[@C.IZDQ%'8)*2D\_B\1_)<JM*[-O'38)J.4E
MO.IJU,).PR4&\3IF9J51'+(S(C\/V= KKZ!RE*,\G*1&5\P22YYO<1<1U;)H
MS(J^'[,*Z^@<IJMYQ+<..1V.0DGR>,SXE?)FU6A*\/V5 ;T%-:&DWGDU9,&=
M@DESN;Q;5> FS,DU\/V= J.4EO.IRSBD=@D)Y_.XJJ/Y+E5I7P_94$584:OT
M!K.YKG*K8)*.9S*U4?AX*T^Q^RH)J.7TE3><RW/1O]12$\_G<535\GRJTXO#
M]E0213XREK.IKBVDG8)"2=YM5&H_#RZ\-?#]E38(JR5%?"4HSR8:8RCL$DCD
M*=)1555OE5)/%X?LJ; KWCE1K-YQ-6MI)V*0DG"69J-1T1P5H1^'[*@5'+Z3
M0^GL[A:,L?DU<-SB+B/P<%:?8_94!M(<IJMYS,64:MBD)-_F\1&I7R?+(Z<7
MA^RH%:AI%#.=3731_J"0CC-RIFH]G+W5\/V05[!R]IJ(SB:HH_\ J&01O<WB
M+B5\ERSH7%X?L@J.4H1G<U2DI.PR4\7'MXC.G!7^Y[:"'*@Y2$YY-4EA7S!)
M^6-PC+B55' ="KX?LA+=!RFHWG$U9M5L,A).$LS/B/P\'_)[0J.4TRSR::&U
M?,$GQFLC+B/P\.[['M"HY?25HSF<LF3*PR/E>.OB,N'@W5\/:%=:$4["@L[G
M4(U6"2FO%7Q'LX=WV/:%25$J;SJ:YR*6&27.YE:J,N#@K2OA^RH!%"&\[FK<
M)M5AD)KQ;>)1^](_[GM"M> :(+/)M&#.P2B-XUD95/P<![*GP_9$%=*DI:T-
M1&<35J)/S%((C)1F9J/93_D]HA/4EQ5*FD>>3B)!_1^151K*G$>SA.E?>]M!
M-1RFJ6<336RCYAD5=)1F?$=$\)5(C\/:"=2'$H;SJ:O?8)!;3+WQ]E?[GU J
M3R:<2HLZF&;?^H9/CXJ^(_#P_P#)VB*ON(Y?24)SR::U).P22).X^(]O[7N$
MMZ:#E)5G4Y*6U%8)!\=:EQ'X:?\ )$*50HU*TYS,56MADE2GV1_%$U)Y31^G
MDZE?H_)^$?Q0J.54K4U59Q.)22*PR#)5:GQ'LH5?M>T*D<I06=S> U'8)!&7
M9Q'\4*CE?P%7TZFGP4L,CQ5KXCV4_P"2(KJ.5%"<\G*4M)V"27 =*\1T5MIL
M\(FI*BGVE1YU,2E!E89'BK4N(_#0_P"]VB.9D**X(K+.)BC72Q2/#2GB/;6G
M]SZHCF9/*:2L\G$52Q^2>TBIQ'V]OO3W">;O0Y355G$U*B25AD'4JUXCV;*_
M:AS=W <JI5LI^G4W@<45AD51PT+B/;7_ )/8'-WD<I!YS-V5L$BO]\>RN_[$
M.8GD7$)SN:?I'^H9)<G@X:J/Q\6^GA^Q$U(IK0+SN:G=8))[2+WQ]M/[GU0J
M3RFJ>;S2-XCL4CY,D</B/Q\6\O>[.$&Z%-#07GLU"7%?,$D^!2"21*/Q<7;[
MWLJ%27&A6YG,U"UD5AD&2209JXCV\5/[GLJ%70<I2K.Y9<X_F"29M<'#M/Q<
M7OJ>'L(.:@Y5Q[3C>=:Q(P3"LAS6Y6.0<''XBI;Z./A4XE++CID1F1$5";,A
M2M7S"B[66T=/?./TOU"SNSX':\-GIN5XNCMLCJ]+;47,:EIB+50E&="4JHON
MU*-OQ'P(T;HGJ75I&;SF> RL+[J5QHLE*TK.AIE,H=(B\)[4$NABU5=G *-5
M5O4I/.9M7_\ 4$BK/!PU4?CX]]#X?L1-63RU="AS/9K?-_ZOR5&V;9$1*/Q<
M9D1_8]@IKW#E-1><S$+<05AD*X";,C)1T5QTJ7O?L:A4BG:0K.II%(/YADF;
M)MDDN(_E.,Z'3P_8AS$\I+F<34&Y2P2%<OE\)\1^+F4K]CLH#DT.4I5G<Q/I
M/^H9/R'*X2XE?*<RGO?#]B)J*![.YK1N%\P25$CE\)DI7BYE/[G9PB*CE])0
M]G,]M4@T6%Y1L\JA<2OE>92M-GV!&(:N-U7NAQFHU2JB',[N+;;[AV!XR:-J
MA$:ZJ)RG$>[[$C%48O@RW'Q).E*&DYG\IEQY'S!(437*X%D:O'S"V[R,_#45
MJ":T>IDQQI.',Z5-5W/9Z42%HL$A26.53Q*JYS*5X?#]C40T^RACRYTZ)5)/
M.YJ3?)./R#Y?*X:&9&OCW_8_8U$<MQ:RX%?(UV43-1><ST-RE_,$@_1^5PEQ
M'5SF;Z>'[$4U8Y?C*5YW-;YQ%C\DR:Y7!11^/F4XJ>'9P5$\VM.T<NFA*\ZF
M)]*/YAD'Z-R>':JKG-(J\/A^QKM"K'+V]I#V=SFTOF5@DJY/*X?$?CYAD2J>
M'["H5(H5.9U-0N2E-ADKY!,\)DI5'.:53IX?L!%>\EI5H2O.9J4RU%89)G'Y
M/ 7$?RO-I6GA^PKM$U9%"'<YG-\__4$E7)Y7#11^/F4XJ>'["H5% O.9J2F*
M^8)"CB<C@HH_E>=3BX?#]@1B.;L0HJ^D.9U-0;Y%89*B9Y-#)2O'S*<5/#]A
M4376@H5N9O-;*89V*0?HW)X**/Y7FTKP^'9P5V@G\0IK0TWL[FM)D**PR5<D
MV22555<YID1F7AV<%0J3RDOYS-:<DI*P2%E')@T*)1_*<ZG%3P[. C"NM!RH
M.9S,04I7S#(5Z,;/#12OE"=I7A\/V%=H5:1%%Q(>SN:V<DD6"2OD<GAHI7RG
M-IQ4\/V%039+C3@%YS<$(F*^8)"CB\CA(E*^5YU*\.S9P5$U[B*</20[G<YO
MTC_4$E7(Y/#11_*<VG%3P_85$58IW&HYG$U!3#*PR%>B\CAHI7RO.IQ</A_<
MZ[1"95RFF]G<YOT@DV"0LV.1PT4KY3G4XJ>'["H5^(AQ*WLYFM+EI*PR%>C$
MP:3)2OE>=2I)\/V%=HFHHNPE>;S4-S5)L,A1Q>1P))1ES>=2O#X?L*A6NHY>
MQ%#N=SFO2*6"0KD<BE%*^4YM.+A\/V%0JR*?&2YG,Y"9JBL,A7HOH_#12OE>
M=3BX?#^YD>T*BA#N=S6SD$FPR%\CD4HI7RG.IQ4\/V%=HBI/+W%:\XG(*92P
MR%'%Y'"1*/Y7G4KP^'["NT*MBB*'<ZFME),K#(4;!L$DB4KY7FTKP^'[ SVB
M:Z5%%VA_.IK+DM!6"2LHY1^%1*/Y7G$7%3P[.74*CE*UYQ-0F8HK%(5Z*;'#
M12OE2>I7A\/V%=H5=!0TW<ZFH5)25@D+)CD<)DH_E.;0U4\/V%03?PAQ[ O.
M9[:9IIL$A11.1P44KY;G4XJ;-G!7:',GKVD*+6@7G<ULY)?,$FC')X:*/Q\V
MG%3P_85!MA1TTX%3F=3$',)-AD*]%Y/!12OE>;2M/#]A4*NA--:%+V=SF_2"
M38)*S8Y%**5\IS3+BIX?L*A4<I6]G,UI<M'S#(448F#09*5\KSB*I)\/V%0K
MW$4[@O.9R4S%%89"O1N1PD2C^5)ZE>'P_85"I*12]G4YHY)?,$E7(Y%#)1T<
MYM.*GA^PJ(3J.5E3F<S4)F**PR%>B\CAHI7RO.I7A\/V%=H<WQAI(I=SN:WZ
M32PR%<@F.&BE?*<VE>'P_85VB:A1U]!4O.)R$S%?,,@_1>1P44?RW.I7A\/V
M%0JR>5%#V=S6BD&5@DJY)LD1$I7CYIE6GA^PKM"NE2FA+^=36G)*$V"2LF"8
M-*B4?RG-(C53P_85^H%2>72I6YG$U"9:OF&0HHW)X:*/Y7FTKP^'["NT0Y4'
M*4/YW,:4^2;#)7R>30R4=%\RG%3P_85"KH.4+SF>@I?#C\A7HW)X")1_*\VA
MGP^'9P5$U;XA179P(/.)Z7'&TX_(4:5,)(R49$LW5$1TJ7[GQ!*3(C%4+?74
MWYH6 ],>I4O37)\4ES+C$:9<Y[4I#:%\Y"UD1$I1'L) O0M2N+F1'LQ2J>EN
MGGJKMO4/IA'U-QK&I4>VRE\+$=;Q.+713:5F2D\1'P\PA:E[+IVDT354=YNY
MQ,0N4E-BD*]')@TGQ*^5-VE23X?L*B(NJJ*(E>;S4HDK389"C8-HB3Q&1N<V
ME:>'[&H-T%.\H=SJ:VIY)6&2KE<JADI5%&X1&9%X?L:B.:C)Y2EW.IJ"E&5@
MD*5&Y/ 7$KY7G4KP^'[&NT37XARIZE2\YFIYQ_,$E1M<OA(E'XN93BV\.SAJ
M%=".74ES.9J"DF5AD*-CE<)$I7RO-I7A\/V-=H$I5(7G4U!/'\PR3Y7*I12O
M%S*5^Q^QJ)[*D4H0YG<U#DE!6"0HF.5PJ)2J.<RE:>'[&HBI/*0YG<Q"7UE8
M)*C9Y7"53JOF&1'3P_8U"HY574E>=S4F^16"2HVN7P^(_'QTK3P_8U"M.)%/
M4/IS.2F32P2*L<K@22E?*<P]O#X?L.T.;M["5&B)5G,Y!N)^8)'@Y=*+/;Q_
M\GLJ)J%$+SJ6DGS*PR5&QR^$JF1KYE".GA^Q$5? <JXOB4/9Y-;-RF/R5&V;
M9%XC\1.4K3P]@5UH1R]IJ*SJ:1R"389)\@FC(^)1<?,(JT\/V-0J3RA6<S20
M\HK!),VC;(D\1U7QTK3P_8U"I/*J<0O.)J5K3\PR#)'!PJXCV\=*T\/8(YNQ
M$*-=2ES.YB$R#*PR5<GE\.U7CXSH=/#LX1-=*CE])4K.9I*-)6&0="1]D?V6
M_P"Q[!%:D\JHW4.9S.0E\_F&0?*X.$B4JJ^+?3P[.$3734II4I5G4XB,RL$@
MZ<'V1_94_N>P*E7*0YG<Y#CB/F"09-DBBN(Z*XM]/#V!4*.A4O.9B4K7\P2#
M-!I(BXCJ?%2I^][*A70CE5?24GGDSC-!6&29$1'7B/M*M/>]@A.I/+3B3].I
MI-N+*P2#Y9I(DDH]O$?]Z)3;XD<J16O.)R#(CL,C:1'[X^TO[T*ZT'+\106=
MS3)TRL$D^72GB/Q5_P"2(<J#E'TYG&HT_,$@RJ15XC[?^3V!S=I/)5T? A>=
MS4N.(38)*N DT/B,N*M*_8]@<R"C7M*OIU-X%*^89%2,MG$>VIT^U$U(Y259
MS.)S@^89%*$?%Q'VE6GO1',%%5U*%9Y,2VI?S#),R,J))1[:_P#)$<PY2HLZ
MFFI)?,,C:53/B/9LK3WHFI/*N\?3J;PJ/YAD5*E"XCV_M0J.5#Z=33)NEAD5
M7Q5(U'LI_P D*ON(Y44EG<XW%(/'Y)$1;%<1T/97[42G4GE7?H5'G,WEI<^8
M)'$=?#Q'LVT^U#F(Y"$YU,4XEM5AD$2B,S/B,Z4W;*=I@FZD.*H0>=SB:)PK
M!(,S49&GB5LH=*^][1%=:%2A7M*_IS-JV7S#(\:3,_$>RG9[T5(IIK0TTYY-
M41G\P2-AF5.(^S_DB*D\IJ)SB<LF:V"01.\5?$?AX=I?8[:AS4="'%<&4_3N
M::S05AD;*[>(^S_D@W0JY45HSB:I"%'89!&JM2XCV4_Y(5(Y>PH1G4Y;B$'8
M)!$HE&:N(Z%PD9_:]M!'-K0EQIVD?3J:;:'/F"14S47#Q'4J'3[7M$MTT*>7
M4U2SB::VD_,4@B<)1J5Q'X>$MA4X=M3!.I/+Z2@LZG&A*OF"01J-=2XCV<%?
M[GM!NA*B2C.9J_1_]0R"YW,K51^#@W5\.WB!Z$)>DH3G<XW$(58))$KBJ?$9
MTX:T^Q[: GV]@Y1].II(:<^89'RQJ(RXE51P&9$9^'M(370*"K6I4C.IBG66
MSL4A).I69KXCHGA*I$?A[1 H4'GDTVVE?1^29NFX1I-1^'@,Z&?A^RH%=1RU
MXFHC.9J_1ZV*0GG$X9U4KY/@*I5\/V0DBA0WGLQ:4*^89*>+F5(S.J>"O]SV
MT$5UH3RE3><SE^C_ .H9!$]S>*JC^3Y9'PU\/V8-BB[]2EO/)JS:([!)+CYG
M$?$?@Y>[['[(*CE*V\YFN)8/YAD)-[F5(U'5' 9D5?#]E0*BA#><SEK92=@D
M)YO,J9J.B>76E?#]E0176@Y2E&>35(84=@DD;W-JGB55'+,R*OA^RH#=%4<N
MM"IO.9BU1R.PR$\_F\:C4?R9M$?#7P[>*@<S[. Y54I3G<U:635C\DN;S*D:
MC\/+,Z5\/V5!/-3CQ'+7U&HC.9B_1#^8I!>D\[BJI7R7*K3B\/V5 J*+AVFF
MWGDUQ;"3L$E).\VJC4JB.76E?#]E00FVZ#ETJ:B,YFK*.?S%(+G\WB(U*^3Y
M>PN+P_9&)J.70I1G,Q;K#:K#()+Q.FI7$=$&V1F1'X?LJ!7NXCE["$9W-4W&
M7\P22-\WN)/$=6^69DFOA^SH(JQRE;6<3'/1JV*0GGD]Q54KY,VJT)7A^SH)
M;8Y2AO.YJTL*.P22YO-XMJO 39F2:^'[.@5^,4#>=3U^B?Z@D$4DGN(S4?R7
M*(S+B\/V=!"=1RD-9W.<]'K8)*>=SN(S4KY/EUX:^'[.@FHI3B5-9U,<]$K8
M9"?2.=Q54KY+E5IQ>'[.FP0F3RDLYS-=7'3\PR4D\3YFHU*\'*(S*OA^SH%2
M*?$4-YY-<3%/YADD<@WR47$KY+DUI7P_9T$I]X:[BIK.ISBHJ?F"0DI!/\1F
MI7R?*W5\/V8AN@2J4MYW-648SL$E)OF^2BJHS;Y5:5\/V= JPU1&JSG$UWT*
MMBD)]+*1Q54?R7)K3B\/V=-@D4-)O.YSBHR3L$E)/\_B,U*^3Y5:5\/V= J.
M4K1G,Y:8BOF&0DI/.K52ODR:K0U>'[.@BHH&<YFNKC).PR4%()^IFH_D^5NX
MO#]F)K0BC[ C.9RVXBSL$@O2.?QEQ'\ERC/AKX?LZ"*NO FFGI*D9O,7Z'_J
M*0GTHG^*JC^2Y-:<7A^SH);H136AI-YW.7Z+6P24^D<_B\2OD^36E?#]G0$]
M*]A-$&\ZGK]"XL?D)*5S^(^,_D>57AXBX=O'0*_&.5AG.YSGHO%8)"/2.?6J
ME?)\FM*^'[.FP*CE-1C.)KWHG^HI"3D<_CJH_DN49TKX?LZ"*_$*4(8SB8ZY
M'2=AD()\GN)1J/P<FM*^';QD0FO81R]O84-9Y-<3$,[#(2J2;Y*+B5\ER3,B
MXO#]G0*LGE^(J:SF<ZN*GY@D)*03_$9J/Y+DELKX2]^%2*%*,[G**+6P22.1
MS^,N)7R7)K2OA^SIL"I+B:K&;SG?0N*PR$>E%(XZJ/Y'DUX>+P_NE-@5%$:;
M6=S5JC$=@DH)_G\1FI7R?*KPU\/V= JQRTXE3><3EIAJ589"?2N?Q54KY(F3
M.G%X?LR+8%0HE+6=S'%1DJL,E'/)\S,U'\GRJ\-?#]G0*D4^(-YU-<;AK.P2
M"])-_C3Q&?*Y)G2OA^S(BH%7\(Y:^HU&LXEN*B$=BD)]()\U54?R7*K3B\/V
M=-@ANC]!/*:36=SG/1JV"0DWS?XBXE?)\JM*^'[.FP$]*]@Y>)#6>3G#AD=@
MD)]*](XS-2OD>36G%X=O'035]PY2IG.YKA1N*PR$&_SZU4KY/E5IQ>'[.FP1
M5D4*F\YFK3#4=AD)]*Y_$1J5\D3-:<7A^SIL!.I/*@SG$UUR.GYAD)YY/<2C
M,_!R:\-?#]F1"JOQ$<O:::,\F&F(I5@DI5)-\EEQ&9M<DS)-?#]F1;!%=!RF
MHUG,YPXQ?,,A)2">XC-1_)FU6A*\/V=!#?Q$\OI*$YW-5Z+_ *@D%Z1SN+Q*
M^2Y5:5\/V5 YM*CE*FLZF+]#XK%(1Z5SN.JC^2Y5:<7A^SIL"K"C4,YS-<-B
MM@D(-[FUJH_!RJ\-?#]F1":O@.5$HSB:M,0U6"012N=Q$9G\ER:TKX=O'38%
M7Q'+5T9#>=35J82JPR4<XGC.JE'P<HC,B/P_9T"HIK0^S8\EDWCD$Y;'81O&
MZ1FLS/@)L]YU(O?$)3[Q))<&<O I
M
M
M
M
M                                    #XF0W^V8O9+MD-ZEL0;59K?+
MN,V5(=;9:;8B,+?<-2W5(0D^!LZ5/:8E*OK9';Z#$_N3F5^;UUO9,PE<YCIJ
MT48O*#6:GU6V5)A-2$(5Q%Z3$>4^^9;J;QFI1L03?OEN;<G1<%\IP?RFH%NL
M?F0Y_CUG:*/:;(_>;9#933A),$_1.(J$1>(F2/<(R;CN11;L/FN3]!=!\^C(
M;I:^E4K9#DN,PKQ.)J>VVM22>0A+I)2HDJ(C(N+MJ*,6/-/TEZY^S9WGY,F+
M62Q=#FF]QMMNCQ9MX])=GR6VFTO2E(;B\)N.)0E:Z&?:9BW??ZQKM15%4BBS
MWYZ=@MF.]36B&96YAN+>)M\LYR),="6'7?1KAX#4MI*%J5X-IF9U&3CJMMIE
MB\VI1EW%RCS(-0[[_5;Q[W$?<;DWO$L?B3EDI27'&T6HFMJR62O$15/;M&/9
M3^T*/>V7[G[*3[:?.?%\A7#H-BZ4OGYF.P4S(;@N1)E$RV4AQ2$M&9*>X"=-
M-5[C49&8G+4XW&Y%K&BU92?$\J_K#6)6J,6AF:QF6(MZ8O3%9;++;4ASDS73
M2;CS:$N+,C+M4+V)&4HR:X)%K*6BDN*/8&L&6WF1Y/CU]1.?^<9.G\".Y*-U
MPWN7Z(M!ES.,U[2;(M^X8MN5;J?I,NOLU]'Y#J?]7QQBUV[I_P RR%N(Q\Z7
MR_&[,FFTVJ2X;:OOQHYI)4:JF7$9&8R<Z[S))<$BBVDH*AP;]8ILMK+2[2/)
M3B,)NULR!Q3,U#3:9)I;7S4H-Y*"=-*%&9EXME1&'<HG1Z-$75[%>T]!X[J+
M?7O)L3F$.0\U=F].G8I/FZX;O"3)1U>/F<=#;73>+:=;]?27(Z5]7Y#S=^KM
MXS$+"M9LODQH[UTNU]JN6XRVY);4N2AQ9(?4@W4<:B.M%;1?SI.J78BU:]W7
MTG;OZP%B5INW3CCV1OQV"NF/7<WX$DF6RD)4Z2B/Y;@YO"C@(R+BH1BUB3:>
MG!E5VK@T=J]$F97ISRHF;JU,>*Z6O"K_ !F9:EK4X3?S8@DD2C7QEPDHR+:*
M+E/&JBN*JEZOR%O?R",5@7S5G7[.KFPS,OD6_7#DSI#:'7VS>N""6;:W$K<;
M,^(]I*+:+V2O8C3W3&LQ]MR[67(_.ZPZV9'T;Y1<9;$=4NRNMO0WULM*?;4I
MN09\MY2%.(*J=Q&0MXE7<]!DR58-'$/(CR:\7CI*B6NXRG)$:RRS9@H<4I?*
M0I#)*))J4K8?#Z@IR%2Y0B'N+O+WZDI45%))1=RB(R]H]@L$G3>KR4(MEM)#
M;::SV-I(21_=D[*D5:;!DX_O,IEP.V8;;9Q(I\MNOH[)^\3VM)K38,>7%DK@
M;GE-_>T? 3[@@D<IK[VWLW>!/N !RVR_<T;-W@3L^H '*;^]H^ GW  Y37WM
MO9N\"?< #E-?>V]F[P)]P .6WNY:-F[PIV?4 #E-_>T? 3[@ <IK[VWLW>!/
MN !RFOO;>S=X$^X '*;^]H^ GW  Y3?WM&S=X$[/J !RFOO;>S=X$^X '*:^
M]M[-W@3[@ <IO[VCX"?< &FZVV33ADV@J-KIX$_:GZ@ PI?,AV]7^I&PBK=;
M3L2DB+9*>["H0R\>JB6K].>K[S*5Z DI5TGZ3<24G2R[*I+9M+U!BOBR_+C\
M![)Y;>SY-&S=X4[/6V;!!2.4U][;V;O GW  Y3>SY-&S=X$[*[Z;  Y3?WM&
MS=X$^X '+;V?)HV;O G97?38 '*;^]HV;O GW  Y37WMO9N\"?< #E-_>T;-
MW@3L^H '*:^]M[-W@3[@ <ILJ4;1LW>!.SUM@ <IO[VCX">W?V=H <IK[VWL
MW>!/N !RVRW-HV;O"G9]0 .4U][;V;O GW  Y;>SY-&S=X4[/6V;  Y37WM'
MP$^X '*;V?)HV;O G97?39LJ '*:^]M[-W@3[@ <IO9\FC9N\"=E>[8 '*;+
M<V@J;O G9]0 .4U][;V;O GW  Y37WMO9N\"?< #E-?>V]F[P)]P .4WL^31
MLW>!.RN^FSM #E-_>T? 3[@ <IK[VWLW>!/N !RF_O:-F[P)]P .4U][;V;O
M GW  Y3?WM&S=X$^X '*;^]H^ GW  Y3>SY-&S=X$[*[Z;  Y3?WM'P$^X '
M*:^]M[-W@3[@ <IK[VWLW>!/N !RFOO;>S=X$^X '*:^]M[-W@3[@ <IO[VC
MX"?< #E-?>V]F[P)]P .4W][1\!/N !RFOO;>S=X$^X '+;^]H^"GW  Y37W
MM'P$^X '*:^]HV;O GW  Y3?WM'P$^X '*;^]H^ GW  Y3?WM'P$^X '*:^]
MH^ GW  Y;?WM'P4^X '*;^]H^ GW  Y;?WM'P$^X '+;^]H^"GW  Y3?WM&S
M=X$^X '*:^]H^ GW  Y3?WM'P$^X '+;^]H^"GW  Y3?WM'P$^X '+;^]H^
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M CU2X4_5V"H$<IH_W-OX"?< 5)Y37WMO;O\  GW  Y3?WM'P$^X '*;^]H^
MGW  Y37WMO;O\"?< #E-_>T? 3[@ <IO;\FC;O\  G;3OV !RFOO;>W?X$^X
M '*;V_)HV[_ G;3=79V !RF_O:/@)]P .4W][1\!/9N[  Y37WMO;O\  GW
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MW][1\!/N !RFOO;>W?X$^X '*;^]H^ GW  Y37WMO;O\"?< #E-_>T? 3[@
M<IO[VCX"?< #E-_>T? 3[@ <IK[VCX"?< #E-_>T? 3[@ <MO[VCX*?< #E-
M?>V]N_P)]P .4U][1\!/N !RF_O:-O\ <)]P .4W][1\!/N !RV_O:/@)]P
M.4W][1\!/N !RV_O:/@I]P .6W][1\!/N !RV_O:/@I]P .4W][1\!/N !RV
M_O:/@)]P .4W][1\!/N !RF_O:/@)]P .6W][1\%/N !RF_O:/@)]P .6W][
M1\%/N !RF_O:/@)]P .6W][1\%/N !RV_O:/@I]P .4W][1\!/N !RV_O:/@
MI]P .6W][1\%/N !RV_O:/@)]P .4W][1\!/N !RV_O:/@I]P .4W][1\!/N
M !RF_O:/@)]P .6W][1\!/N !RF_O:/@)]P .6W][1\%/N !RF_O:/@)]P .
M6W][1\%/N !RV_O:/@I]P .6W][1\!/N !RV_O:/@I]P .6W][1\%/N !RF_
MO:/@)]P .4W][1\!/N !RF_O:/@)]P .4W][1L_N$^X '*:^]H^ GW  Y3?W
MM'P$^X '*;^]H^ GW  Y3?WM'P$^X '*;^]H^ GW  Y3?WM'P$^X '*;^]H^
M GW  Y37WMO9N\"?< #E-_>T? 3[@ <IO[VCX"?< #E-?>V]F[P)]P .4U][
M;V;O GW  Y3?WM'P$^X '*;^]H^ GW  Y37WM'P$^X '*:^]M[-W@3[@ <IO
M[VCX"?< #E-_>T;-W@3L^H '*:^]M[-W@3[@ <IK[VWLW>!/N !RF_O:/@)[
M=_8 '*:^]M[-W@3[@ <IO[VC9N\"?< #E-?>V]F[P)]P .6WL^31LW>%.SUM
MFP .4U][1\!/N !RV]GR:-F[P)V5[M@ <IO[VC9N\"?< #E-_>T;-W@3L^H
M'+;V?)HV;O G9ZVP .4U][;V;O GW  Y3>SY-&S=X$[/6V !RFOO;>S=X$^X
M '*;+<V@J;O G9]0 .4V7[FCX">W?V !RFOO;>S=X$^X '*;+<V@J;O G9]0
M .4U][;V;O GW  Y;>SY-&S=X4[/6V;  Y37WM'P$^X '*;V?)HV;O G97?3
M9LJ '*:^]M[-W@3[@ <IO[VC9N\"=GU  Y3?WM&S=X$^X '*:^]M[-W@3[@
M<IK[VWLW>!/N !RFOO;>S=X$^X '*;V?)HV;O G97?39V@ 3;9;FT%3=1"=G
MU  Y37WMO9N\"?< #E-_>T;-W@3[@ <IK[VWLW>!/N !RFOO;>S=X$^X '*:
M^]M[-W@3[@ <IO9\FC9N\"=E=]-FRH <IO[VCX"?< $DA"?>I2GUDD7UB %0
M
M                                              BI=Y>V )
M
M                                                J
M         "*EWD %2/<9 "0J@
M                          !CT>>EU>9EIEIW:M",$BW=B5J,E;-]O%LB
MS77&;<CGF[')R(I*DI<;;V[ZU&=AXWBRYI.B1%RL8U7%GA#HR\T'IWZ/-!X^
MF%AT3O\ +RNY0YBLPRAN%,;D7RX3(O 3DEQ;27^6AU2JE4M]>ZE=[&EXO'V:
MEMW+4(\K;^(\6](765C/3+U69;U!7?%9]_M687>;Z'9XB'U2X17R;PI4:6SY
MA*C<ZOBKN[1F9F/%8\>7B6K4HP<I3T3+U7G$YZWK7T$Z?ZN6:WR8-IR92;@<
M20VM+T)*D*42'N)-4G11;Z#B\5-W:+B9%R-8-+B>ZO)XN,6;T):4M,.M..14
M3$/H0XA:D*-$6G&25&:#.G;01DP<;KJ2E[*+.GGT3H\W7W06SQG4N7!-\MB5
M,)-*G$<VX*)!J01FNA\6S8+V-[C[C"RH\THI/VCWIYD&/7B-Y5-K@>C..OPL
M7L#LLB2KB90JV<Q)J3PU*J>\6+*D\J/PF7-4LOOH?;\B#)(=ZZ0X$".E*7K3
M-6S)X5DH^-:6=BDDHS0=4GOH*LM/Q&GP*;#;LIL\J_K$=U@E8=#[5Z0CYP>O
M#?*C$I)N*XISQ%X"/B^H+V(GX<Z=Q:R>"7I/2.K5LFL^32N&;+A2&L"@.+;X
M%<:4&PM5>'AXJ>(NP8N,DIZ^DR7P7J_(<5_5][E%E=-N2PFG4*D0+VI$ELEI
M-:#6HJ<2",U)W=I$+F4ES_ 4VG^K1P7]8G=9_0QI=$-Q!295_?;8:-1<:U*/
MA+A17B,JGW"K$2J^X76_#:.S,<QR[PO)3.SJB..7!> //%'2E7&;:TH61T)/
M%0D)KN%*I]HTX5*X*GQ'4GZNU=V7=-=7[)PI3)MU\;4\1K(UD?.2@TFBO$1$
M:NX7LYIR319LQ:2?K^<[B\_BYP(?3!;8DF2AF5.N9(AM*-/$^I).<24),^)1
ME4MQ"UBNDM.!=G3PGWG).B6V3&?*46GD.*=F8=?W&6B0KC4@K8UXB22>(R/;
MV=@IFUX^ONID6TXQIVGB/]7XO<&+GO4'87U);N;M]FJ2PI1)<HW<4&JB%&2C
MH6_8+V3)."+6/1*2KJF7+/.HNL&V]%F;-RW4MN2S:;CD:DD:U\N14DD9D:CV
M]E18QJJXN\O2=(MG4?D+VZ9$Z4_2)#+C;,N<:XZUH4DG$\+1U29D1*W]@B_[
MY$/V:KQ+Z0LE1TWK#MMUL_GS'\*D7K+:>A#.VX?^1Q/YLQ_!)%I\23<B
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M'+W%P6W7.W7>(U.M<Z'<8;Z$.,RH4EF4PXAQ)+0I#K"W&U$I)U*AB"DWP
M
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M"5S'J^]J5/J^R*[D5[,NTMVM&TS="@O
M                                       !B&^<2M)=5TFJT)_B,"I*
M6DC_ ,F?[#,C&9BT56Q/@EVE[#RD%$KI&Q R,C^5DU-*B46YCM+8,>]^UD52
MX(NA"V4@
M
M
M
M                                                    $**I&6X*
M\NK(:KH;)YE1FHT5(MFRI[]GJBU"3>1QT)>D6:"KE CFAN5<8##B2VH?F,-.
M;=U4+6DRW"NXG.J3*81DDJHJ^>K-^=K9^7Q?QHE*BH5&JU<[;(5P1[A!?6>Y
M#,MAQ1_\E#BC!\W8@;SA(MVROJBF:E./<PJ(D@AHN5OV@2*P
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M@DG7:9BA77-\K5"%!1U161U,R[J?5%=-*DUU)$$@
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MZ(]0BD'3>L!&=NME-_IS'\*D7K/$AG;</_(XO\V8_@DBT^))N1
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M6XQ<6+E8[Y!CSX$N.IMUMQF0TAU/B;4M/$1+VE4Z&,5-%>IR<02
M
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MPJ5_=4VB)W*R4"]&-&WWFJ)*@
M                               --U2TEQ)+BH>TO4J0E4^$AU["USU5
M^5]IWU3ZEN:E9'DDRU7%UAAE<9F.AU%&&W&R\2DG]N+D+K@J+@5UBTN9:H]>
M=+_3K8>F+3"U:8XY/=N5NMBG5(DO(2VM1N<&TTI(B^P%J4FY5?%D-]BX'HX"
M
M
M
M
M                                             "%;",6[M.1U!MH[
MIN<=3KPG3=3UQ7X<8Q4UVHMPN<[:[F88GF_:_:YX/UHY18<-U*N^.X_';@\F
MVQ)$UIELU-R>*B693:/$9%V#'VB7VB_>MO7VM/C.:W:UX%G!E;T\2WKZ:(\
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M*_-9Q4MPM1RWA_[U%_5JO+0:CVFDE'V4J5:>Q4<>^)GK@:@@D
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MYDK320S'BJ?=-Y\H<Q+)H2I:W7'.%%2(B.A%48%V*C-I<"^_=3[2^.+92
M
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MGE\[/TD].6KUG8<2S>;\98]M/U\J.[&Z4H2N*G;2G:.+CK)MG.T<='Q-07"
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M"X./E(=0VELE$@FC31"%K(O?GVBS=24Z1+E?9J>Z1;
M           0>W<=#[Z5%*:D]'P!":]JJ^Q05=GI%&N)IF:^.A'0N_88M*VU
M+F<M"O1PJN)61[:&=?8H)\6#ERKB44?%D<*C.O%2FXMA^N*XKE37:R))MIIZ
M&H))
M
M
M
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MWQKC[%'L+EPP8R4E5&2!(
M ,4#]85/_K;I3_-[A_!3A8V)N.[Y-Q>_'EHSF<N3CL,:=K9V;^KRPH,[%=8F
M)]NM\U).VIQ*ID.-*<0:4Q$T0X\VM2$F2]I$=#,;OOC\;9L;)N:WY2=7W\32
ML-\FXSMQ]SE+S/61T;:3=3&DV4V&^8O9XV0QK)<)%@O<2WQ(TN'-C1I#S-5L
MQC6XEQ1FG;MVEW#KO<[%R5M9-ATOVW6OH6K-JPK\83\*[K9EHUZ]#!CTRR_,
M.ECJ@M-TL\Z1;+UA>;_-4E33CC29,!=_1#,GD(6PE:3C,4\0[ Z:SK.;8\;,
M]K%G&B7II3YS5MYP/L^5)XZY;D'7X]3] C'M9<1=T6LVL60W6-:\:^BT.]W.
M?(=;0RT16]N1)+C6Z2#43G%0N+:8UK<K4,')G;N.D4]/AX')X,WEV(3BJR:^
M;B8X/5!Y^E^<R6[8CTX8H4F+:YDF!'R5/+N#MR=8?D1C4U"1)6="6E)E1/:,
M/'63DW%R0?A=YE9,[6-#ZUQGEG&//*ZSL7O425J#CCTNUD^VZY;IEC5:?28W
M,2I9(>?6S^Y$>XQL>/MN,X.5Z:4DN!A3N9$K7BVH.B,DSH9Z^]/.MO3R5?\
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MQF2N*BC+UJ&?UR&@PLW;4F[CJGP-F4XS]WL-8720
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M=ZNC&-C&C;_N_*Z+N.*V:492N<G!,OO#23G0
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M)9?2IEY!+;X^2XX3;A$>U)G4A:<:54O>++33.5BD
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MTI^PJ1$>[<,*_7GJ7=.77B9- M$
M
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MTWXK
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M4EQ/L"LH
M
M
M
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M;#D-E4=A9F;9\24LH,J%0]I#K?=LRY@8\L[&5+\[B3IZ6;QL^)#<,J&!D/\
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M&LIVD_UOYW>7=&$)2GPE2N\NXRW_ %1P<)-P49>\CE>2,9-QX,UA42
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MBG%S3+(K%ZR!M::.M^DM-/1&EFIII?$EI6TCW5&!*;FZLNO1<I<Q%)
M
M                                  !@J_K-FHO3/HKU0=/W4+A^>1+'
MU6Z,7JWW*Y8H<1)NY+9GI:Y"FU2UJ:-M3<1@RJ2B+:0XC:'#:NJ+FX0;G&[%
M*:^KV5]31RNY6<G/Z;ABY&EB,F[?I_[&9 ?0UYW?0WU7:0::74M8<8P[/[Q8
MK?$ON'7JZP8<JVWJ(Q&C2V>>_,4E3:W5$9&:N+:9'NJ-ASH0MY#E!UA-U5/2
MZG#XENY*RD^,$D_@5*EV>PZHZ:Y&TEVP:B89>T.(0XDK?E%DF+2EQ*5I-2(\
MUQ::DHMY#%<9<OL+4K<XMUT5>PY+'^:I*SFQ$VB6LJF<J(45YTJ]O.:)2JF?
MJBU;ADM*-R2^(FY*$8U5:GU6E&=2/LI3V:F)4WS<LO>(2]E/L/.?5UQ_T>=3
M.6VXZOZ/3:-M(4XXK^+N[$H02E&?K$+T?>15'B8=_1^BY)ZI-.5+L]V:1]++
MI\HY;9J&TE\\M[5+6P22(QG9#MNQ2OM%NU&DZ]AG+6__ ""#_,XW\"@<>5/B
M;P       !INMDZGA/9ZHI<4W4B2YE0TDQDH*B3,MW#MW&6X_;"['Q6F^PF+
M<8*'<>#.M[H8TTZR,1.U7AN/9=0+,PZ[C.5LLME*BO\ *?4E+RD,+=>2;KA;
MSV#8MBZEW3IR^LK;YM23X:T?_:=9>:/E9TWYH[#=VK>;<)7>5J$J*L'1\KK1
MOBZZ&(MU,:#:J]'F;1\$U*A_.Z)G-5:+RP9_QN$A:TLO&VA*"(ULH)6[M'L[
MH+K;*ZNZ=>;GK_B(.A\3//O\-_\ *?>X8?VR#C?4I15*52?I^ Z3M%VN%_7)
M:L&.7*[S(S1NR8\2+)>6RBG%Q*)I"C(B25:F-KN]3V,.W;LY3497'15T.I-C
M\I^H>J?U?3ZED>'%RGRJM$M:_$<:7,RB^RF(B(CMHMOIC3%Q<62B<2QSTHE(
M-*O$A26C47J!>W#*S,>6-C^S-K7X>!CVMMZ9V+,M6-S?B9]NY2Y%Z:J5'\5#
M-=\M/3/1+"NFS%+CH]!@D]?X3#N375/*=GRKHEEOTGG.DGGI22C*A&>\>&^O
M;6[6.H+V/NKESJ3I6O"KI0^_GD/9Z.M^76!D]%PMK!G9@Y<M*\_+'FJUZ>\N
M$E'<)!H)55?;;]XT90\-57 [JN23AR6]%VFHS$2T:#29G2O%7M,]M?;%<-8U
M?$MVT[<>1<&;P22                         0H^$C/?0 ^!IMN&X1*IP
MEMJ0AZ<>!$)<T:]I35TE5WHV[/#[&WUQ4W%Q]CB1'FYW7W0V\:S-)IX3+U1$
M^6VN-61&7,VDM$:BN/9P^SN_9%";:T16Z]A4FM"XM_;N_8%2KV@D2
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M*^!O:B7-<O,M4RL$=>P6X7N>7+1HEHD7R
M
M
M
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M3-B0@D<5#WJ-1^I4S/\ 9&BP4N,O>-CHDM.!J"L
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MV0I!2VXS:7$F9<)*==IMW4'9^*[.0HY,/VL;?#X#3+UNYBYLL*E<>4JU^$R
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MH21)2A""HDDI25"+<1##3^(KI\9J""0
M
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MV5V'ZM2,>5HRDI\DF?4SDH]>!+2U*==(]Q<-/:%ZY'E<6NTLP;<I)\$;D"L
M                        I4?"DSI6G8(;HJLE*KH</R[/<2P.T2+[EU\M
M]DML9'&IR9)9:<X22HU<#*UI<<.B3V$1B_@XF1N<E:Q+<IS;X),Q,W-Q=MMN
M[F7(6[2[6TOG/%&7^95TUXR\;,3(W[QPKY:EQ8BS;XB4I*N%1+,U%4M]!O6!
MY7=49=OGC8:B^QU^@T#</-CHW;IN%_*CIZOI.4X#U_\ 3=FTF-":S!NU7&<X
MAN/&GL&PA2EFA)$;RW.%)FM?;0A@[KY<=1[*O%R+$I0?=5T,G9/-#I'?[G@X
M63'Q%IJTJ_*>RXEP@W2&W/ML^-/B/-H<;DPWFI#2T+22D&2V5K1M28TR]&_"
M?A.+CZ]#?;<H7HJY:DI1?<ZGTFS,T$9[S%,(RBJ2=65E8K
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M'19U1UPR/9Q<"XQFV9["%+K77B'7M.= 0
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M4"Y[--'J5C(*0
M
M
M
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MIG[F6VN_ZXXTY"Y[YJ@4
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MACV,-PN>//6:+WC"S6DS/;4_V3^L->LW)SE)2[#E&TXIHUQD%(
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MZ/RO25%Q'0DT(_9')7[&/<_6)JLCB;=S+MW7"E8+@7&_+,Z%^MB^Z^6/J(U
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M,['$
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MK3M[S"_'7Y31ZIZ-CUCMUIW-SV_V7R\7;;;DW1:TI75]ACRZ(:E3=(-5,*U
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MJ*GH2!
M
M               :$F2Q$:-Z0LFVR,DFH]U5;"]L0W0&JA:7$I6@ZI41&1EV
MD>TA(*@
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M\"F4>:2D^*-ZA'!7;4C^H'904=6V5@2
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MS(BJ>X.()      $$9&52W!P!(  "*E4B[3W>P ) $$9&52W!P J52+M/=[
M 5*I%VGN]@ #,B*I[@X@&9$53W!Q ,R(JGN#B"0    01D95+<' $@
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M_=H&CX#UDU*IEVEO]D 2   BI5,NTM_L@"0  $5*I%VGN]@ *E4B[3W>P )
M  14JD7:>[V !(  "",C*I;@X D      02B/<8EIKB0FF2()(,Z&1=]?8H)
MII4$B    $5*I%VGN]@ 2   @C(RJ6X. !&1E4MP< 2    "",C*I;@X D 1
M4JD7:>[V !(    (J52+M/=[  D  !2HS25:5+MVTH)2J0W0J$$@    $$9&
M52W!P!(           VLR''G,FQ)1S&C,E&FIEM+:6[N, :[;:&D);05$I(B
M27<1;" %8
M
M                                                  @RJ7LD?M'4
M1)56@+5G7SY7V&]=%[QJ_7S,I.*S<=2XELV(#,PGR63I;>8A1IH3HLQLKQU?
MEV=A<E<YK/A4-?HM\J30;I!NQ9=$91F6=L\)0LDN,5E!PBX6B6IB/RJ)<4;1
M&1UV#E;V=<N6_"A[-LQ(6(0=7K(NEE3]CNV%N+V!QRGS2<>XOTIKVE0K
M
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M;'DDJZFRE^UNPC=-PCXU&KA)L]AGL+WQ G55#5'0Y:)(
M
M  #;R7RC,J>41F2:;"K7:=.P4SDH1YF->Q5- K@S4B55/%3AKVUH";=OQ"94
MC!2;U9N4/H69$1T4>TB[:"4ZPYWP*6TGR]I/-]3ZO]H5>SWD<PYI=WU?[0>S
MWCF] YOJ?5_M![/>.8<WU/J_V@]GO',.;ZGU?[0>SWCF'-]3ZO\ :#V>\<PY
MOJ?5_M![/>.8<WU/J_V@]GO',.:7=]7^T'L]XYO0.;ZGU?[0>SWCF'-]3ZO]
MH/9[QS#FEW?5_M![/>.;T#F^I]7^T'L]XYAS2[OJ_P!H/9[QS>@<WU/J_P!H
M/9[QS#F^I]7^T)HJ5KH.8<WU/J_VA'L]XYAS?4^K_:#V>\<PYOJ?5_M![/>.
M8<WU/J_V@]GO',.;ZGU?[0>SWCF'-]3ZO]H/9[QS$\PJ'W]A=_U!'L]Y-2.;
MZGU?[0GV>\CF'-]3ZO\ :#V>\<PYOJ?5_M![/>.8<WU/J_V@]GO',.;ZGU?[
M0-):-CF'-+N^K_:#V>\<WH'-]3ZO]H/9[QS#F^I]7^T'L]XYAS2[OJ_V@]GO
M'-Z!S?4^K_:#V>\<PYOJ?5_M![/>.8<TN[ZO]H/9[QS>@<TN[ZO]H/9[QS>@
M<WU/J_V@]GO',.;ZGU?[0>SWCF'-+N^K_:#V>\<WH'-]3ZO]H/9[QS#FEW?5
M_M![/>.;T#FEW?5_M![/>.;T#F^I]7^T'L]XYAS?4^K_ &@]GO',.;ZGU?[0
M>SWCF'-]3ZO]H/9[QS#F^I]7^T'L]XYAS2[OJ_V@]GO'-Z!S?4^K_:#V>\<P
MYOJ?5_M![/>.8<WU/J_V@]GO',.;ZGU?[0>SWCF'-]3ZO]H/9[QS#F^I]7^T
M'L]XYAS?4^K_ &@]GO',0;A&5#3]7^T(G5+V7[0K7CP!.$14I]7^T(CP]M^T
M*]W <PN[ZO\ :$1C"+;KJQS$\WU/J_VA7[/>.8<WU/J_V@]GO',.:7=]7^T'
ML]XYO0.;ZGU?[0>SWCF'-]3ZO]H/9[QS#FEW?5_M![/>.;T#F^I]7^T'L]XY
MAS?4^K_:"BI6N@YAS?4^K_:#V>\<PYOJ?5_M!14K70<PYI=WU?[0>SWCF] Y
MOJ?5_M![/>.8<WU/J_V@HDJUT',.;ZGU?[0>SWCF'-]3ZO\ :#V>\<PYOJ?5
M_M![/>.8<WU/J_V@]GO',.;ZGU?[0>SWCF'-]3ZO]H/9[QS#F^I]7^T'L]XY
MAS?4^K_:!)/1,<PYOJ?5_M![/>.8<WU/J_V@]GO',.;ZGU?[0>SWCF'-]3ZO
M]H/9[QS#F^I]7^T'L]XYAS?4^K_:#V>\<PYOJ?5_M![/>.8<WU/J_P!H/9[Q
MS#F^I]7^T'L]XYAS?4^K_:#V>\<PYI=WU?[0>SWCF] YOJ?5_M![/>.8<WU/
MJ_V@]GO',.;ZGU?[0>SWCF'-]3ZO]H/9[QS#F^I]7^T'L]XYAS?4^K_:#V>\
M<PYI=WU?[0>SWCF!NE785?5W?L"/9[6*CF^I]7^T)]GO',.:7=]7^T'L]XYO
M0.;ZGU?[0>SWCF'-]3ZO]H/9[QS#F^I]7^T%%2M=!S#F^I]7^T"2>B>HYAS?
M4^K_ &@]GO',.;ZGU?[045*U',.;ZGU?[0>SWCF'-]3ZO]H/9[QS#FEW?5_M
M![/>.;T#F^I]7^T'L]XYAS?4^K_:#V>\<PYR"]\?#_9ZPC3@F513FZ):A+I*
M(U;DEVBB4^6?)VD)Z-]P)U!F1$JM:[NR@K:<71\284FFX]AJ@
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MEN.B=O?ZVT%1\1KV<"KEHJ?R:*=A\*=OU !/+1V(07=X2]D- .6W]HCX*?<
M#EM_:(^"7N !RT=B$? (!J.6W]HCX*?< #EM_:(^"GW  Y;?VB/@I]P 03:.
MUM'K\*=OL4V"="/63RV_M$?!3[@@D<M'VB/@E[@ <M'8A!?\A(#U#EH[$(^
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M-?>HH>\N MOLAH1J.6V?V"-N_P );?J 2.6C;X$;=_A+;3=78 '+1]HC;O\
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MRT=B$5+=X"V>L U*>$OO*/VON":+O(J^XK)"$^]2DO621?6(025
M
M           VTUUMB))D.TY<=AU]RI5\#*%.+V?WJ0U>B561*?AQ=QNB2J_4
MBV5E?FI=*>+7^ZXY=L@=*Y6*:["DMIB&I+;[#JFG4$LGJ&:5('8N!Y2]9[Y@
MPW# LIXLE6M::'F#?/Q>^2FP[MD;+NN=<CN>+<<)I6VTI+BDZTKZ#Y:?-PZ2
M"6E99(_S%)[(A^$M_BJ\9$,U^3O63AI832?><7/\;'D)2,EN5WG?_P"IZ>O4
MU/ZW?I*_WGDU_FA_6YPN_P E>M>W'C^DA_G6\B*5^\IT_P#3?TC^MVZ2_P#>
M>3^2'^.#^2G6G'[/'])#_.MY#K_^2N:__K?TC^MVZ2^S)Y/Y(9__ %P+R5ZT
MX?9X_I(/\:WD1'CN4_[-_2/ZW;I+[,GD_D9_C@_DKUHM5CQK_61'^=;R'3H]
MRN?V;^DI_K>.DJM/I-+KW^A*,O;YM!*\E.MGK]GA^DB'^-CR&4N5[C=_LG3X
MZDEYN_2495+)Y7LPS(_:YP?R5ZU7''C^DB5^-?R':K]XW/[)_23_ %NW27_O
M/)_(S_'"%Y*]:5TQX_I(?YU_(?\ YE<_LW](_K=NDOMR>3^2&7_UH2\E>M?\
M/'])$K\:WD/+AN4_[-_20?F[])9%4\FE'ZT)1G[7.$_R3ZT_P\/TU]!0_P ;
M/D-%5>XW?@M-_E(+S>.DK9_UFE[>^"K9Z_RVP3_)/K1?^WAI_KHA?C:\A73_
M .1O:_\ ZI?+KH5?UNW27_O/)_)#_'"G^2W6G^'C^DBY_G6\ATJ_>5S^S?TC
M^MVZ2_\ >>37^:'];G O)7K1_P#MX_I(?YUO(BG-]Y3I_P"F_I'];OTE;_I/
M)_)#_&[0_DKUKI_P\?TD%^-7R(?_ /)3T_\ UOZ2DO-XZ2E5IDTO9WPE%[57
M2$_R3ZU7_MX?IHI7XV?(9_\ \C=^&TU^4?UO/22=:9-+V?YBJOL%S=H?R4ZV
M7_MX4_K(C_.SY#4;^\;M%_\ JE\FNI5_6[])?9D\G\D,_P#ZX0O);K:M/L\?
MTD5O\:WD.E5[E<_LW](_K=NDOMR>3^2&7_UP/R5ZUXK'C^D@OQK>0\N&Y3_L
MW])!^;OTEEM/)I7L0S/ZSP?R5ZT?_MXU_K(A_C7\AU__ "5S^R?TD_UN_25_
MO/)_)#_&[!'\E>M?\/'])%7^=7R(T_\ DIZ__K?TC^MWZ2O]YY/J_P 4/\<'
M\E>M?\/'])#_ #J>1%:?>4Z_^F_I*3\WGI)(Z'DTNI=T)1E[?-%7\E.MNS'A
M3^NBW_G9\AJT^\;O]E+Z2K^MWZ2SW9/)_)#/_P"N$?R5ZU>KQX_I(K?XUO(=
M<=RN?V;^D*\WCI)(J_2B4?K0SK[7-#^2O6ST^SQ_21#_ !K^0Z5?O*Y_9/Z1
M_6[=)?\ O/)_)#^MSM@?R5ZT7_MX_I(G_.MY#TK]Y7*/_P#6_I(_K>.DK;_U
MGE;-_P#$SI[!\VAA_)7K;B\>-?ZR(_SK>0]7'[RN5_\ 2=/CJ"\WCI*V?]9I
M6WOAJ*GKU=V"?Y*];5UQX?I(A?C7\AY)-;C<U[[3^770G^MVZ2^W)Y/Y(9?_
M %PA^2W6G^'C^DBI?C6\AVZ+<KG]F_I'];OTE=N3R?R0_P <(_DMUJ^./'])
M$K\:OD0U5;E/^S?TC^MVZ2_]YY/Y&K\<*OY*=:?X>/Z2*?\ .QY#_P#,KG]D
M_I(_K=^DLC(OI-*V]T)1E[)\ZA"?Y*=:I5^SPI_77T%+_&SY#52^\;M7_P#J
M=/CKH3_6[=)?;D\G\C/\<*7Y*]:4_N\?TD5+\:_D.W1;E<K_ .F_I*/ZWKI)
M[,EF?D"S_P#K=PJ7DEUJ_P#V\/TT6W^-OR%CQW&]_8R^DK_K=^DK_>>33L_B
MA_C11_)7K7A]GC^DB\OQJ^1#_P#Y*?\ 9OZ1_6[=)?\ O/)_)#^MSMHG^2O6
MC_\ ;Q_21'^=;R'I7[RN4_\ 3?TC^MVZ2_\ >>3^1G^.V _)3K1?^WC^DB/\
MZ_D/Q^\KE'_^M_2/ZW;I*_WGDT_FA_7YP?R4ZTI7[/'])$_YUO(>O+]Y7*_^
MF_I*2\WGI),Z%DTNOJPE4_A1/\E.M5K]GA^FBA?C9\AVZ?>-W^RE]))^;OTE
MEM/)Y7L0U&?\,(_DIUIV8\:_UD3_ )V/(:G_ -E<_LG](/S=^DLMIY-*IZD-
M1G_#!_)3K3LQX_IH?YV/(;_F5S^R?T@_-XZ2=G_6>5M_S0Z>R?-V _)7K5_^
MWC^DBK_.KY$)T^\KFO\ ^M_2"\W?I+,J_2:5[,)1'[1O"?Y)]:K_ -O#]-%"
M_&SY#255N-WX;37Y2?ZW;I+_ -YY/Y(9?_7"'Y*]:+3[/&O]9%2_&OY#OAN5
MS^S?TC^MVZ2O]YY/J_Q,]G=^[!_)7K6E5CQ_207XUO(=NGWE<_LW])!>;OTE
M5,OI/*J7?#,B]CY;:'\E>M>/V>-/ZR"_&OY#NO\ \E<T_P#U/Y-=2?ZW;I+_
M -YY/Y&K\<)_DIUJU7[/'])#_.QY#?\ ,KG]D_I(_K=^DO:7TFE;-]82B+V#
MYVT'Y*]:KACP_21"_&QY#2;2W&[5?_J?R:Z@O-WZ2SVEDTKV82B/VN<'\E.M
M:Z8\*_UD%^-CR&:JMQN_V37Y0?F[])1%7Z32C]0H9J/VB=J(7DIUJW3[/'])
M$R_&MY#PCS/<KC7HM-OXJD%YO'24K=DTLJ?;0E%]=TA+\E.MEJ\>'Z2*5^-G
MR&?_ /(W?AM-?E*OZW;I+_WGD_D9_C@_DKUHG_=XU_K(J_SK^0__ #*Y_9OZ
M0?F[]))%7Z3RC]0H9F?M$[M$+R5ZUK_=XT_K(2_&MY#Q3;W*Y1=UIO\ *4EY
MO/229T^DTO;NK"41>V;M!+\E.M>+QX5_KHIC^-GR&E+E6XW:^FU)+XZE7];M
MTE_[SR?R,_QVP/Y*=:OCCQ_215_G7\ATJ_>5S7_];^DC^MWZ2JD7TGE;=U(:
MC+V3)X%Y*=:M5>/#])!_C7\AXNCW*Y7_ -)T^<G^MVZ2_P#>:3^1G^.$+R5Z
MT_P\?TD/\Z_D/_S*Y_9OZ1_6[=)?^\\G\D/\<'\ENM.W'C3^LB?\ZWD.E7[R
MN?V;^D?UN_266_)Y/Y(?XX/Y+=:]F/&G]9!?C6\AWPW*?]F_I'];MTE_[SR?
MR0_QP+R6ZT_P\?TD/\ZWD/2OWE<I_P"F_I*?ZWCI*KPGDTNO?Z$HB]OFT!^2
MG6W'[/#])%*_&QY#N7*MQN_V3I\=2K^MWZ2_]YY-/YH?U^<'\ENMJ?W>-?ZR
M*O\ .MY#UY?O*=?_ $W](_K=^DK_ 'GD_DA_C1'\E.M:?W>/Z2#_ !J^1"=/
MO*?]F_I(/S=^DHBK])I7J4AJ,_:)ZIB5Y*];-T6/'])$2_&OY#Q57N5RB[K3
M?Y2?ZW;I+_WGD_D9E_\ 7 _)3K5?^WC7^L@OQK^0\M%N5S^S?TC^MVZ2_P#>
M>3^2'^.#^2G6C_\ ;Q_21/\ G6\AZ5^\KG]F_I'];OTE?[SR?R0_QP?R5ZTK
MKCQ_21+_ !J^1"5?O*?]F_I(/S>.DHBVY/*]8H9F?M<VH?R5ZV>BQXT_K(A_
MC6\AU'F^\KE/_3=?BJ"\WCI+,JEDTKV8:J^USJA_)7K:M/L\?TD1_G7\AZ5^
M\KE/_2?TD_UN_27VY/)_(S_'"?Y*];4K]GC^D@OQK^0[=%N5S^S?TE)>;QTE
M*W9-+(B^VA*27L&;NT'Y)]:I5^SP_31$?QL^0TY<JW&ZFN^TTOE95_6[])?;
MD\G\D,O_ *X1_)7K5\<>/Z2*E^-;R'?#<KG]F_I(+S=^DLRJ63RJ>K#41_PP
MG^2O6G!X\?TD4K\:_D.__P"2N?V3^DG^MVZ2_P#>>3ZG\3/\<(_DKUIP>/']
M)$_YU_(=JOWE<_LW](_K=^DK_>>3^2&?U.<(_DMUKVX\?TD5/\:OD0E5[E.G
M_IOZ2DO-XZ2E5IDTLO7A**OK5=VB?Y*=:\/L\/TT4+\;/D-*M-QNZ=]IKXM2
MK^MVZ2_]YY/Y(?XX/Y*]:-T^SQI_615_G6\ATJ_>5S7_ /6_I(_K>.DHS,BR
M>54O\S.GL?*[0_DKUMQ^SQK_ %D1_G6\A]?_ )*YI_\ J?R:ZD_UNW27_O/)
M_(S^MS@_DKUK77'C^DB?\ZWD/2OWE<I_Z;^DI+S>>DHSH62S*^K!61>WS15_
M)+K;MQX4_KHMK\;?D*W3[QO:_P#Z9?25?UNW29_O/)_(U?CA'\E>MO\ #P_2
M17_G8\AO^97/[-_2/ZW;I+_WGD_DA_CA'\E>M.W'C^DB?\ZWD/2OWE<I_P"F
M_I'];OTE_P"\\FO\T/ZW.#^2O6RT^SQ_20_SJ^0].;[RG3_TW](_K=^DOMR>
M3^2&7_UPE^2O6G^'C^D@OQK>0[X;E<_LW])3_6\=)15KDTO9O_B2O8I\KM#^
M2G6W^'A^FBG_ #L>0W_,;O\ 9/Z=07F\=)9[LFEE3[:"HO:J]M#^2?6R55CP
M_313'\;7D++AN-Y4[[4E^4G^MWZ2JF7TGE5+OAF1>Q\KM$?R5ZU6JQX_I(N+
M\:WD/)T6Y7/[)_23_6[=)?\ O/)]7^*'['[ML$?R5ZTX?9XT_K(?YU?(C_F4
M]?\ ];^D?UNW25_O/)KW>B'^.$KR5ZTX_9XT_K(?YUO(?C]Y7*?^F_I'];MT
ME_[SR?R0_K<X'Y*]:5_N\?TD/\ZWD/2OWE<I_P"F_I*3\WCI*32N32S]:$HZ
M>O1W8'\E.M7I]GA^FBF7XV/(:-*[C=U[K3?QZZ$_UN_25M+Z32JE_F2BKZWR
MVT3_ "3ZT_P\/TT%^-GR&=:;C=T__4_DUU!>;QTDGNR:47]]#47M5=$?R4ZU
M7_MXT_K(F/XU_(>7#<KB]=IK\H+S=^DNIE])I6SOA*(O8,WJ&)?DIUJE_=X_
MI(B/XV/(:4G%;E=JN^TTOCKJ3_6[=)?^\\G\C/\ ' O)7K5_^WC7^LB7^-?R
M'3H]RN?V;^DC^MXZ2JD7TGE5/=2&9E[-'=@A>2O6S=?L\?TD)?C6\AX\=RN:
M]UIO\H_K=^DLJ%])Y53W?Q-5/9/G!_)3K3LQXT_K(?YV/(;_ )E<_LG])!^;
MQTE)I7)I?L0E'[9D[L$_R4ZUI_=X?IHI?XV?(9.GWC=J^ZU)_E)/S=^DLBJ>
M32O8A*,_:)X%Y*=:RXX\/TD'^-GR&BJO<;OP6F_RD_UN_26>[)Y/Y(?XX4_R
M6ZV[<>/Z2*W^-;R'7'<I_P!F_I(/S=^DHBJ>3RO8AG7VN<8E^2O6KX8\?TD1
M_G7\AZ5^\KG]D_I)_K=^DK_>>33^:'^-#^2O6G^'C^DB5^-7R(?_ /)3_LW]
M(_K=NDJG_:>37N]$/9_]-MV!_)7K7_#Q_20_SK>0]*_>5RG_ *;^DC^MWZ2M
MA?2>54^Z&=/9^6V!_)7K9_\ MXT_K(C_ #K^0ZI_\E<U_P#U/Y==!_6\=)1&
M1?2>54^Z&9E[/RVP3_);K7_#QI_60?XU_(=4_P#DKFO_ .I_25?UNW233_M1
M)KW>AJ_&B'Y*=;+7[/'])!?C6\AWHMRN?V3^DI_K=^DNIE])I6SOA*(O8/G4
M,2_)3K5+^[PH_P#71"_&SY#-M?>-VJ__ %.GQUU)_K=NDS_>>3^1G^.$+R5Z
MU?#'C^DB?\Z_D-_S*Y_9OZ2"\W?I+J9?2:5L[X:B+V#YU##^2O6M*_9XU_K(
M+\:_D-*7*MRN57?:=/CJ#\WCI*32N32C(_M82E>V9.[!*\E>MG_[>%?ZR(E^
M-CR&@Z/<;K;[K3?S,G^MVZ2_]YY/J?Q0_P <*?Y*]:?X>/Z2*O\ .KY$?\RG
M_9OZ1_6[])?^\\FO\T/ZW.$KR6ZU_P /&G]9#_.MY$4K]Y3I_P"F_I'];MTF
M?[SR?R-7XX3_ "4ZU7#'A^DBG_.QY#?\RN?V3^D?UM_21)^35D[]-]51:$5/
M5YQ"Q>\D^N)PI"Q%3_K&19_&MY#QG[6Z3C'_ -/_ $GT[1YKO2?=[I;+'!R=
MYR5=93,*(GT2B%/R'4M(0:N<9$:EK(AB9OE1U=LV/X^=:C%)5;KKH9^#^,'R
M+WC=;.S[?N5RYEY$U&*\)I.3T2;K15+B]LN<2XPH%P@E6/<H[$MFI[VI#27F
MU;3,]J5D8Z]OQ=N;A=]].GQ'IBQ=A/&MY6+KCW8J2?H:JOD9R06R^ !%2,J]
M@B34>(6H-1%O/>)6NJ(;IQ(XBI6NSO%,I*+H^)/97L-,GVC,R)53+>)C)2DX
MQXH/2/,^#-82  (,B/?V"4VN!#2[2"6D]A&#37$*2? T),EF*VI^0\S&CM)-
M;S\AQ#++:$E4S4XX:4)(BWF9E06YW(6U6>B'+*3I$M.=9_FMZ1=.C$W$\%?8
MU#U+<1(AL6BU.(E-0IBB>984I4=X^<I+Z"V%L&&\FY>DK>+%RKV]QR%K&M17
M-E3Y%V+O+2FG_3MUN^9YFK.>ZV7Z]X7I,N6T;$9[TV PW;S<)UF,BW*2;;A*
MB/J3L3V#D(8-F$?%R76_W&->G*$G''?ZLR).FCHVT4Z7\:A6? \6MYWA,1IF
MZ9#)C1Y$Z=)039+D)<<9);'&;1;$[?5$3E*,:I:=Q9]YZZL]8$DMAT*I=Q4]
M0BINV$*4^>/M"E'Z2L5           ^=<;1:;PSZ/=K9;[HP1U)BXPX\UFO?
MRY+;B*^P)3:X$41J0;? M<=,.VP8=NB-_<XT&,S$CI[^!AA#;:?8('KZP;I1
M&9IILI6I]W<(3IZ@U4^)<,:QV[+)R[8[9+FZ1U)R?:K?,77O)4EAQ1'[(.7+
MP>HU-] MENMC?(MMM@VUDJ?)08L>(W^#CMMHV"*MNA)OS*NPRJ1[]M*4VEZN
M\5 ^-<,>L-W56[6&SW4RW+N%M@S#_P#LEEPR$53;1&IN+?9[3:4DU:K5;K:U
M2AHM\*+"01=W!':;(R,1K7T$GTA(/D7&P6.\$17BRVFZTW?.-MAS2]@I++M!
M$7)>@$VVR66T$2;39K7:TT,C3;X$2$1%W4C--D9&"ES5&I]7M%#BW.JX$GS+
MA9K1=DFW=;3;;FV9$7!<($68FA=AIDM.I,O8"4Y1=*51!H6_'K':$&=FL=GM
M"SV?ZOML*$=-QU.*RW6I"M2<M9 ^NDC30CVFK>?K?7J*N*]1%*,VD^U6NZM\
MFZ6V!<F?O4^''F-_ D-N)^H(JUP)-C!QO'K0KF6C'K);73V\=OM<"$NNS;Q1
MV&E'[8-N@;;/ME7>>SU-FSV>VHC6OH!4)!TWK"=+;;2[YT?^%2+]AI2J4RX'
M;<+_ ".)_-F/X)(LOBRI<#<B            !IN(XRH1T/UB,4.-'SQ]]$-<
MRY7P/G2[9!F)0W-MT*X(2?$V4V*Q*2V9;:I)]"^$R/N%-BU24KLG[3?P_&1*
M4HQY(<#BN9:=8/J#896,YYC%BR2P265MNVV[VV%,MZ6.!:%D3$IEQEI)(6>T
MB%N[&U?FG?7N\&_I,BQ.YCINPZ5XHLWYWY9?DQZQ:D7G1Z\Z7:2734NZ-K7<
M,?L-PLY7AE3Z7%JI&A<XX[J#=.J3;\)[#(A>Y/&LMVZ\BTJN'QDW7<M\LKRI
MS<*]IX+US_5*?+BS*W.NX _>M(I:G'%HN3-Y4Y&9XE.J2E++B6&4\OB*G]Z*
M+<)V[E;DJQ[BERBWI&C1;]O7ZH7D^"9U@69].W6)D7S%8\CM5TNL YUP2MQN
MV7.//-IAZ"OE)0ZTR2%)-:DF780RL:[<LW_$N-\B>GT%F_&%VTXPTFU1_29O
M>E.+2\#TWPC#+G<%W&XXYC=FL\N<X:EN2G[=;X\1U]9K\1J<6T9G7M,6\O+C
M=RJ07M/L*<2Q*U947K0[&=^Y.?O:_P#!,"LPH/,A,RZOM2:?G:U=W\K?'*82
MB[;Y^X7.*,I?R_\ _NG:3?\ WE_\8AQLO>=.\JE6NI[,%)2      !!F1;Q%
M57E[1Z2E2R(B/?4R(O5J=!+TXD518]\X?K#O.EF$P-#M.+L</,=0&7X]VFQ7
M31)M5N)#YJ;JT^TZ@Y*$;Z#L[RVZ=M[KN+S,Z%<.UP;X-U-VZ-V:&X9OC9,?
M^'AV^DQ@(<"/"2M#:E.//K7(FS'3-U^3)D*-U]:W7*N&9O*,]ICT<H\EM0CI
M%:)>A';6.XV9<B25M<#76@D'5"S4797MV[?4%<6Z4:U*+L%.\IQ>A6;:5-D?
M%19=E=_=VT%'-)2X:&3*U9=KF<O;[CZ>.9+D6"Y+8\YPZXR;3E&.S8\B/)A.
MNQS>BI?;<F,O$PXUS4NL-FD^(]QC$W'"L9V-/'OP4K<XOCWT,&["-S%N8]V*
ME&472OJ._>LYN)JA!P;J@L4-#!YU#3$RZ/%;+E0Y=K8..;SYLI4A*I+U5'Q*
MJ9F/*'5NRW-GW-X+7*W*L?3JSI#><%8*I=5/:?RMG,/*UZC%Z ]3MAM]RG+C
MX?GKQ0;FVIXT1R>>.)'BFHC>::J3BME:CCKEA1L)7'^L2.!M*FD?=9FZ1GVY
M4=B2RHEM2&6GVU),C2IMY"7$*(R,R,C2H<<7C6
M
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M/IRHD%4LLNE/9O+=1R&1'_AN8IA3G5/29SMO_P @A?S2-_ H'&K@#=@
M  ()1'N,2TUQ(33!F14KV[A%"3';\[[4)I:=/M/D.T6X<F4XV1_OY&I1$KUN
MP>DOP];=XF?E9UU4C%)1?P(^:/\ U"NK8X.S;?TVM9Y%9T]$6TW\Q;L\LS3[
MZ<=5&%+4546%U4LZEQ)(TK8,C/PJ+8FO<.R?.+<XXW2UZU)ZW/91Y/\ P2=+
MO?/-_%W-QYK>&^?U-Z5^*IF81VU-H0D]G"TTV1=W FGU1XBI^LE+L9]WJ).B
MX4-P*@:;G 9<*Z&2B4DTF524E14,C]@&^5.3X(AT;Y7VF*=YN_3D>GNLK&JE
MG@&SC^?$MZ>XRWPL,36.=[XDM(;2;AEWF9CUYY(]4PR]G^Z[]VMZTZ17;3XS
MXX?CX\J%L'4]OKG9\9K&STW?FN"N5I'2E-4N_L.CO++U^+1/J)M,.Z3G(N.9
MDZW;9Z%OJ1'-:W6&XYJ)3K;1'Q*V5(QS?G/T_<W;IYW,&WSW;'M)):ZK7L-"
M_!%YEV.B_,F&S9UWP]NW)*W)M^RFG6.C:57WF8W&DHEML265I6Q(CLR&EI,C
M2IMY!+09&52,C29'[(\4RI"3M2TNIT:/N3"2N15V#K9DDT^],W1*(]QBF34>
M)<6O D2  +,WFV6J8_!THN[:UH@VZ;.3+41*Y237QF@W%4X"K7M,=]>1%RS'
M?+L+C56E3T\#SO\ B+5Q=)<\4^1/5_&6SG%<7*,C(^)ABBB.I'\DFE#+8/5<
MM)4?$\4XL>>TKUMIP[6:>\]I;_V I33M+LY<R\5/0JX%4,B]2HGE?$M+*LO3
M6OJ*=M2*O;N$T5.1\7VE,E.KRK;YH1_--3"-)Y.MFN6"81#E'&<><?\ 3'VT
M\Q3"$F@ZK)*%FDN%==I#7NJNK+?1.S7,VY#Q5):?*;/T-TY>\RM\CM%B;QU:
M?MZ=G_87F+!Y;6G\-33EYO3UT4AMGC(FB02E)2GC+:T6PS(Z#S?N'GUU#DMQ
MQK2A;3TU[_A/5.S?AMZ5VSV[LG<NR]YT6K[>P]#8_P!&6@]B:9(L18ER&B*K
M[ZDJXE%3::>5WD--W#S2ZRW!.$LEP@^[_M-^V[R=Z%VZ:NPQ%*ZNUT^@[ELF
MDVGF.$CYIQ2TL<NA)_B<9=*$1%7C;.NX:;F;WNV;'_BLB[-?UG^1F^XFQ[1@
MJF+C68Z?4C]!SAFW6^.1$Q;H3!=S49ALBINV(;(<8\B]+6Y*<GV5;9R$,>Q;
M_9PA'U)+YD;EPS;:,VD$9E3A05"+?W$*:.Y&D=&RN3Y%5*IMU%)6T9I/A6HN
M\MG[)"FQ84)-WWS,FXY2MKP])'RKI8+=D-GGV2^06+A;+I'>BSHLAMMUMUMY
M"FU>%Q*TD9)4=#IL$8>3DX66\K';@X.J]:X%O+L6MPQ'BY<5*W./*UZ'HRQW
MU ^7-J%@=]N.8]/3AWFP7%Z3-GX2HTMG%)2WI#A,.&R=254O>[AZ6Z&\YO%4
M,3J1\J5$I_$M=3RIU[Y *:N9O3'OMN3M^NK[CP?>XFHF)+7&RC3*]0IJ'#:=
M:9ASY*3<2HT*,EML4,C4DQWC#K?I.]25K,@]/1])T/>\J^ML9.W<Q9JC[W]!
MNV,4UMR6W.S,&TNNLHF6E.O29#4N/Z.@D&LUI0['\? DR/8+=OKCI#[8L6_F
MQ\23HEIK\-3)7E?UPMNGEVL"3L056Z]G?2AUIBV*7Z!DT3.\MEK?RBPS4/PK
M8\@THM[T:0E;C:F5I)*O&V9;2+<-URWAYNWSP8)/#NPU:[4U_I.M<6]F;5N]
MO+M5^W6;FD7I1IU?S&3!TG=0%NUOP"&B2\RUE-DC,QKK")3:%F33;:&W$M$X
MI7B(RK0AX,\PNDLCIC?+D5;:VZY)NW+6CJW7L/H[Y9=;XG6&Q6G.:^]+4$KD
M=*K1:\3U@E=$I215/;7;3M]8==W+C4M=$=F\JC[,37%U$
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M?_1GZ#,QN!$TJ(O9>4<A+?2-B"4E0B=D[O68&/>_:LKEP1=$%LI
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M7T>:KKP-1-:J,RI6G;7<"ES$E8J)
M
M
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MVY,24VEUA]I1*;<;61*2I*DF9&1D85*:4-X
M                  Z<U?\ ]GVS^?,?PI"]9XLIEP.VH?\ D<7^;,?P21:?
M$J-R(               !9/\^GKMRGH-Z"M1M0]/GSB:A7]A&,XO-37BAR+P
MB1#7(11YE?&@U%0R.I#6]^EE7[V/M>,GRWYTDUQY5V:?TT-@V3$M7(7L^ZU_
MP\>91^L^SB6,OU=/RIM=3S;'O-9ZC-:\@NF09Y"O=_A89/F7*6U+BW8VYKDZ
M4J8MQLFF$J6E!<9I02:$6\QO%UV.G]HGMU')JWS-M^ZE&NGIXU[S5OM%[>LG
M[3>34E<I%>IZ:=W Z7\USS#^O+S ?,&N'EP>7!DT^SVG#'EQLKR*R2'([+\Q
MKG-2'ID^+)>3'98)23/B).[>15&L[%8N]01N;Q!O[!;3IW*E:^MNAS^\3M;'
M9M8:2>?=2YNWWN"]%#K7HS\PKS+O*!ZW<!Z1/,@NUXR[2;5*?!@6'(KHY(E1
M?2+D[%B19D&YR'FF32TM1D9$:CJ==I'0N>V6_C;Y?N[551S+/Q_T9P.\6,O;
M,:UNEOV\6;7-3L[Z^E'Z!MKFQKI!M=XMYD[#O$"'<HRR42B]'G1VY+*B.ID9
M*:<(]@Q9*W"_*S=_;Q_(VBZ[LKUJ%VU[LDOE1]Y[[B[^]K_P3%)6C"4\R2:V
MGK U)+D3ETNUJ\3<&0XC_+'ZT6A!I,B'(8\J6O2)M<R,J'R_%I<Z3-)5I):2
M.R;"<0IM9>(O?(61*2,!\653X_ >SA!2      !0OWI^Q]<@44Y)]J(? H+W
MI5W%51^NDZE]84.7-)Q)27+Z3#&\TO*W\FZV<Y@O\TRQ\H3$/C4HT-(X)+9$
MA*C-*:D781#U#Y:X<;'3$+ZI[;=?D.Y>CEX>TZ=IX#552J'WGM[_ &!V"M%H
M;,G5:CA*@AM\R+L(U@V-V_V_[0DL\2HCIQ?O;A>N1H,C^H(%:(N<]%ND/])_
MI#ZG=-8L0WKU@T2#<,70M/&M!H8.9+*,I3;JDFI)'[TBJ.B?.&W"&YXF2TN=
M5_*=9]=68RY)/WG_ *2S<E5UQN\J6V;L*^XED&VG&V^TNSW/:7V#B24<7U!U
M/*X[]R:?<CK>4W8MT7$SG_+IZC(G49TUX3D3]Q;EY-:;='M5_C\9*?8<B,,M
M,+=+FNK(W$%VTW#C^7ET,I/FBIK@SWD
M
M         Q"?UDWS4M<-"I6F_0]T@3Y<;7'7.25EN<NU&OYTA0KDXY#;C1E,
MR$O-+>-:#XN!1)K4ZT' 8D\K?^H+FQVHN%BQ1R?9*OI[$CF[]FQM.RQWG(E6
M5QTC_JT[3V3Y,'3GU)>79T<:CY]UTZB3KO>YEI>SF8U?KU(N2K)'3;/GE^$<
MJ>ZG@<4XDV^$S*BM@V+>,C$V[;/ CJK-57OEJDOC.(VW&RMZW&,X^_>2HNY:
M-OXM3'/U+\[[SF^N36W5W)/+JPF[-:%:27BYM&U;+<Y(8DPK-*EH=D*FMRS1
M,.5'0E1$2E4[AQV%]JLX*S\Y_JI<%3L_*9^YK%^U_=6!&E^WI.7&K_)JB_1Y
M#?G>7_K_ (>6=.G4C:?H9U2Z9*7$O#$MGT%_(UL.,QY3B;>Z^;K"X[Q.5\!$
M9$-C^R0RMN^],)5LQTDJ\#@\BY<L9"Q)IJY+@^ZADS1*(4;1[7"KQJV^(^_V
MQQ,/#G#Q;2I%O@78SY7X+U://O5S0^GG4RID7_5Z;O.A?Y.Z6\3VKUEV/$P[
M^CU*4]4^G7C0?_6RZ;E)_/+?JCD,B:EBT+5E4FOA,Y:!_D$+^:1OX% XY<"X
M;L2       (V$?JJ^K03K3T$:5])I<:5+H6]'U:EM]H4<^O*$E)U[C$U\XK)
M"O/4FQ:4.DZU8H;;1$E520M:7B<+8HR*BB'L7R!PTMEN94E1.7$^,?\ U ]Y
M6=U_C;<I)QQ[+5.ZKU^8Y[Y*F-?.FLF7Y"MDU)LL-M#;YI/A);R62,B5PT(Z
M&7;VC \_+\+6UVL=\9SJO@.?_P"G?LMV_P!4;GNM&K-FS%)TXMO7Y&C*'BR%
M/+?(RV(69)]8CH/)K5$CZ^<U;DH]B-X*2HV\DB-LS[2VEZE!1*?*U'L82C6L
MNP\.]?&@T/J!Z>,KLL>*3^162$]<[,\2"4\T[%8>=<2@R:<7XB3V=PW3H7?K
MG3N_6;\)4M.2C)>AM'27X@_+3&\SO+K-V>Y!2R(6Y7;?>I0BY)+1OB889-W3
M%[PX;G.@WO'+T7#[]I]E^V3B_O%E5;'J5'OCGL;ILD;MEJ3N6]>W1H_//>CG
M](=5JV^>SE8F1KQ34H2^!]AFC= ^NT;7GIVQ&\KN").16F"Q:KTR:R4\R[$8
M9::4X1NN++B26\Z#P/USL<]CZCO6I0Y;<I.2]-6S]"WX?_,/%\RO+' WJQ/F
MR(VU;N*NJE;2BZZMZOO/:RN+Y-!;RKQ>T-*\:+ONVUH=V\LU;37$W0N%1![C
MIOH#X Q_?/YZDX&A&@6$6R1$;>N6:7KD0WC<2AV,F(?&^I!FXA=.$]M.X=J^
M4$[F/U)"ZG[,>/QG57G'M7WMT1DVJ5FHU2^!EN'134&SZFZ=V"\VJ?'FR?0(
MJY))>;4OB5'84:3(G%J/A-0]JW;\)S5VWK%I? ?.S$VZY8L3Q;TW!QD^/K.U
M5;=Z>'9N.I4,4<T9MIZ2,J./>QH)P?/9*2)78JI]M/:!VVE6NA5;RX7'R2M*
M/I-.1(BVV)(NER>;BPH;3CKCCJTH]ZA2RV+--?>BW%7+L_#BB]DW<'!Q_'G-
M5?8=.>7-UCX^]YEL+3E3D>;!R3T^%%GF\VM$-UI#3#9-IYZBJI9EN(=+>>N2
MON:&%;=5'C\IZ/\ PZ;;@VLV_O%.6_=2IZ>!F8-&1UIM)1$LE=Y+J94]8AY"
MMJ:A[7#6A['<DY4]!JBL        !IEQ&1\1%MV4V4,NT1/V=8$1J_>/ER+'
M9)AF<RRVJ5MJ2I%OAOF9GM,_E&5&1BW#)O1^LO4V1.Q9FO:C%^M)FDFWVJ.A
M49BU6YB,M"FUH9A1VD&E:>%2>!MM*3(R/N%R&1<N0=ZTY>,O3K\91&S!/[.X
MQ5EKA14?P<"R%US].;FG.3N:F8O"6>+7YY3ETC1VU&U;WCYSBC,FVB21.*57
M>/7ODSUY'J#;5T]N$U]YV52+;UDM%VL\.^>WEU/IG=GU3MEM_=EZ7ZQ16D'J
M^Q=IY>T-U>N^BF?6G+[1)=.TOOM-7J$E:R9>8><:0LUH)Q"/DVR/>.Q^L.EL
M3JO9;FV9,5]IC%NW*FJ:3]%>)UET)UMF='=06]YL-_8[DDKD:NC3:7?W&2%A
M&9634/%K/EM@F-28-SBM/DII:5<MU3:%.MJ)"U<*FUG2F\>#-VVV]LFX7MOW
M"+C>MR:U^1_"?1S9MUQ>H-ML[I@34K-R">C[6JT[>!S5M9+36M:#C8U>OYO8
M<QP5.TU!4                   \2>89U)L='_21K/U"$T3D["L4N#MOJ?#
MPW"5$D,P5D?,:VMRC2HO$6TAP>]YE[#Q>3'UR;\U"*]=:_(CE=FP[.9N$+=Y
M\MI)MOU&%-Y(/E]]5?F6]2Z/-.ZB]8LFM>+V?.+E=<(L;TVZO1K^PW="=;@L
M,J=?B1XL>,^HN$E$2C(C/<5-NP]ON;#@V[N2JWKL-$_31M_&<1O%];KGW,=M
M*-F79Z*T^3B>[_U@OS2.J"U:[Z8>6;T%7*X0M8\X.) S"Y69#CUQ2Q(_BT>(
MEV*\MZ(GA-*U*-LZ4KMH1#7=NA?ZAW.[B8Z_X:RW5UT;5:NOHX'+9#L;-M$<
MK(7_ !-ZG)7LC_I_*6H8/4'YSOD4ZUZ.YAU?Y=?-1-!M5;Q;H>1MRY,NXPF$
MSID1,QJ2^X^TU!?AH0OPK54Z=ATKR^#D8]S/CLMUI2_-KVUT5'VJO=4XG.P<
MR[MRWG%=>5^TN[2NOQGZ(VANJ>*ZX:783JWADQ$VPYSCMJOD9UM9+2AR?!9E
M/L\9..$9LNO<!^(]PJS,:>'DRQ[OO)_]A:QLN.9CQNPX=IVZ,8OF(9YQ*TEU
M722-22I!@5(S(C+^*OF6S>,W%6@GK%%['RD3(^DC$:&1_*R=QD?V+':0QKW[
M615+@O470A;*0
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M2A"4I214(B(=:IW9:WG6X^+--<Y3;G*M6;\20
M
M
M                                                         :3W
MW%W]Z<_P3 IG[C]3/%,\S*[72GW]S^$6-WVY+[-KW'2&5_?[WK9LV]J5)[*[
M?5VB_:IS-^DPW[I4+A02!-*D 0   $@2T0!!($L@"          "0)( @
M) FFE2 (  G<!.J( @ "=@@E4[2!)  $@2_0"IV@%3M( @D"=:^D@""0)=>T
M " (            D@)0 $ 02!+T( @D">) $$@2 '#@/7 =NI $     $@3
MH.P0*:5($D  2!) $  2!( :4]) $   !/[($]A $  3^P!/80!
M      !($MD 0      !($M4 "M" () GL  @"       ) D " (
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M
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M.!NE.#N%N;YI.0;5.4]2"@@
M            AJJH"A)DI)_5(1RNRM74A-3),RI4]@MT5[A5,JX$>^(N%5"[
MZ;_;%::7ZLCCJBGAY9&=35NW[_V>\4^$_P UD5455E3:JI]4M_MB[27YQ/,I
M:HK
M
M
M                        &D]]Q=_>G/\ !,"F?N/U,\47#_:UT_?W/X18
MW?;?[M\!TAE?W^]ZW\YM&_>GZ^_V1?L\7ZS"?NE0N%(      $@3PX$ 0
M$@20!        &J<032@A.O EJG'B0#:7$4J3]82M57L#^0@.)    2!*]!
M$  2!) $          $B"=>#X$"2  ) E:   "9 $       2!+T  @""0)K
MI0 /5Q "M  ( @        ) EZD 0           !)@2^) $   !($D 0
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M!)TWK#LMUL_GS'\*D7K7$AG;</\ R.+_ #9C^"2+3XDFY$
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MTSWEL'3'F%T!][W)]0;57[Q592CW\>'P&C=2])W,Z$L_&7MI:KO6K+@GFY:
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M49<9$=",B,Q3)5T%&COL1%-:/@0!4
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M=YEQZJVO[FW*ZEO-A))/C)*GIU+A#2FE&9E6J=BCV^(]U1TC&-N%CF6EN1Z
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MU':$V+4?+8B(=VN*W4/,H))$7+)OL2M9?9]XM7(J,J(ETHFNT]I"@I
M
M
M
M
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M@@EZ:$"2         D"2 (  D"2 () ET[" (),02U0"0M2 (  D"5Z>! $
M    $@20!  $B"JG80)*0 ) E=Y $     $@32A $   !($TUH #T( @D"5Z
M2 ()KLH!-=*$ 0   $@372@, W4@"         J2VDU<Q79]393O%MU<N7L+
MJBN7F?$E?"HMWK[?:%UVE!<Z*)3YM"DU$="+LWF+<+SN>SV(F222H0*R@
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MFBIO^41L]?: '/8(Z&\U7NYB*^U4 .<SM^5:V;_E$;*[J[0 Y['WYK\(CW0
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MJ'N^41M^J '/8,Z$\U7NYB*_7 #GL_?FOPB/=  GV#I1YHZUI1Q!UIOIMVT
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M?3;MH '/8/<\T==WRB-M-_: *DNMKIPN(57=PK2=:;Z4,P!6
M
M       #2>^XN_O3G^"8%,_<?J9XHG_[6N?[^[_"+&[[;_=Z>@Z0RO[]>?I?
MSFT;IPGWUV^V+]GB_68;X%0N%!($^H@"     "0)( @   ),"7Q( @D":T(
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MH0)() D@"  ) D %J0!  $@3ZR (       D"5Z2 (     ) D@"
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MWZNXN6<?E-EN232<>!7] (JD.-%<9)FHTF9\Q=2I0R^R%WBO04*/+JUHRH\
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MJ<N$D
M                       !I/?<7?WIS_!,"F?N/U,\4S_]KW.N[GNU_"+&
M[[=_=M.XZ0RO[_>]?Y6;-LO"9]Y_LC(L\7ZS#? K%92M2 () E:$ 02!+]!
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MKXU9N3.M!=?!>HM5;XD"D   !($D 0 !($D 02!+UU( @   ) E,@"
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M^J*ZZ2*^K0<6L:4H\\>!QTKGA^S):FY,BH5#J(C-5Y.U$.*Y5-<"@5%LD"2
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M_P!@ *%4S[3W^P '"1UV;Z5]C<)JR*(D02          10JF?:>_V !(
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M ZEV.@U4XN%:#41UH0I^<AMO5G8P$  1PE6M-O\ 80FKI3L(HJU)$$@
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MFP_4'2<5%6U'\]'>RE=<FG^S[#?""L   (,B,J'N#@"0!%"J9]I[_8 $@
M                 "*%4S[3W^P !D1E0]P< 2        @B(BH6X.() $$1
M$5"W!Q!(      @B(BH6X.() $&1&5#W!P!(       "#(C*A[@X $1$5"W!
MQ!(                   (,B,J'N#@ 1$14+<'$$@         @R(RH>X.
M)      $$1$5"W!Q!( @B(BH6X.()      $4*IGVGO]@ 2
M
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M+M]Z-@L7HJTHQ[CJW=5:=^L:<67G$UVUW5.GMF.,<'X_/V''*7L<I6+Y2]"
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M\GQ:HT>P77F37 Y<1GQ**NPJ4+UR!IU3KH%Q*@)
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MTNL996;'>J.PTO!7I+^Z>!=VFS;P%3<D_;?H[#-5Q+5O2[.+!:KO8=0<*O\
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M424;-I#)O6X0M<T>);M3G*=&]#-2@F:H4-1G4SBQS,S[3-E!F?LF,4K-T
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MTUDD_$OV.'OW;2&+&DU[*,MOE>K*B49F5"V'V_VA9YY>)R-:%>CC4K%T@
M
M
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M-2*^+915/6KLH*X0:CSRU7<4<SE/PUQ[S<(.J2,SJ??2@AZ\.!<Y7'1ZLJ$
M
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M3J>W/DCRKAJ5BA-T52@   ) E>D@""0):H0!       $@2]0 ( @D"6R (
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M\GA0H1'[XH42/$2K^^2PVV2O9'%Q2BJ(PY2<G67$5$U93Z"     2!-" ()
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M/,K22B70C52OKC)FU"%5[U#"BW.3^J<Q(ZBQ;DYJK+K)%P@
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MZ.]FC-[8Z5%I[!P=BY.7O<3CHS<=$;E*3):S/<=*>P0O<JKS=I1K77@5B20
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M9EU=:-:&J+Q(
M
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MA"=20)!^IM^H -FFXV]4CT1,Z&J5M_BR9+!R-F_Y$E\S9ZP W@
M                                     #2>^XN_O3G^"8%,_<?J9XHN
M'^UKG^_N?PBQN^W?W;X#I#*_O][UOYS:-UX3[J[/;&1:XOUF&_=T*A64$@2
M'K( @D":4( @      "0)6I $  2!+U IE[K"XB47$EOAW&=/9V=@HN0<L/G
M+TYKGBEJSB>HELEW? \LL5N1SKG=K//BPF=QN//P9#+::T.E7'"(<?N6//,V
M26.NVAR>S9$<#=[>1/O,6W!O+,ZP;)KK;,MN6$&S8&,O=NKDOTM)\$-5[*:3
MG#Z-VQRKO%WI^UX.+"VU3E-JZLWB&=%*W+5)?,97$9LVK?:&%'\K$M%LBOE]
MJ]'@L,NIK_<N(,AR5VY6[3O.NXQ]BIK&(:IH2W4@00           !($OY
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MU>CQ4JXR3QFDSV\**UX"[!RT\A78J/YR. NSE.].;=5([&%HM@    $@20!
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M#7B15RTO9*5S6]+NLGW'V2VD1BDK
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M\1>T-?VGS6ZXV*_]JP\N[XU>/-+_ &CF,OH[8,VWX4[,$GZ%]!W;I5U,:O\
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M3A(6::H2:Z<^IFDB,QTQO_D/M]^,KG3M[EOMUY.SYCO7I[\1>\84X1ZGQ_\
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M2FFJH$@
M
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M;=4HO>]@NY&):M6O$@]2(3;<HR9EQC *@
M                   -)[[B[^].?X)@4S]Q^IGBF?\ [6N9;BY[NW_SBQO&
MW?W;X#I#*_O][UOYS9M^],NX_P!D7K/%F&^!4+A0 !($OTD 02!-:D 02!+U
M( @   ) D@""0)?I( @"&JJ@X$GMX?[DZD)J_"\'\TG\Y3[44N5<=0\9\*T;
MNW^T$?8M.SQBRJ[-W+JN\)(W*I4A:C,W"H=-G"785-XHLQ\"O+VE4[L[LJR>
MAI\?A---_;[(J:K-3[44J=(N/8S2(J5,SK6GU!7*3EJRA*A5ZHH)?>0)(
M"?4$$UTH!(( @   ) E>D *5X#8 T !>D " (     ) GCQ   &J  ]=0 (
M@   ) E:$ 0           !($L %IJ #U   'J.T!Q>I $$@2M" (  D*D@
MZ$ 0     2!( $ 0     2!*52 (     ) D '3L !Z@!3M  @""=P$ZH@"
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MJ;+MI6F3DT I:X1+X_1SJ1</$2E5W]XL=OJ$DN"[3O5)4(B$MU=2E*B)$$@
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M7B6I1DFN*:9<)J5>'M]D54=*BNOI)
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MO^@[A2M--B=^_:?]L</;EXT->)S<X^&S53NJ6X1"#A5,BM2H7
M
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M Q+_ "E#-7F0ZFJ4=3.]Y4=2+A(JS73H1%L(B'(WE7%4BU;7MR;,Q<<<70
M                                            -)[[B[^].?X)@4S]
MQ^IGBF?_ +7N==W/=K^$6-WV[^[>FATAE?W^]Z_RLV;>Y1=Q_LF+]GB_68;X
M%8N%-" ()_LH!/#B ! $     $@2U0@"    D"0 ( @D":]@ +4 /20!
M     2!*]) $       2!) $            2!) $     $^L!/;H0!!($O0
M@""0)7I $ "53M( @   ) D@"    DP)?H( @          D"7H0!
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MGE'-(:Z1L1)'%]UD[5+-9[F.TQ8O/]:RN3]E(NBBT4
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M^&M6>QG/F=.Y&HE7$5:4%:=6UW#LJ5"0
M
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M$+\I2I>9#J55/_364[:[OXZZ.8O)?8$T6XQ:G)F8R.&*P
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MLI2#<XN90K=')''Q^*O#WC8MS48;C*$*<E6:WM\IO MR=>8[E''G*(
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MCRO<K@_==3+-:.J2,OM4E[)5K]4<0VG)I=YE1U29YQZNCIT\ZF'_ /P]-_\
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M^7CI5Z)\3R?^,/RL_C[RROYF'!2WG!CXD'2KY%5R5:-F++ISD,S'LJMDEE/
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M?&;BD7."+UWE)&7]$?$3[.;)^LP,>[^V97+1*I="%LI
M       (:JJ,&W-D^-!DK8FO%^P+D9QA!IEMP;FFGH?!O=SMV/VV=?[K*;C0
M;5&?DON.*2VBC;:ED55*253X=FT3A6+^=DQQ[$6Y7)**2UXLM[CE8^!8EN&1
M)1LVX-NOH1CE]3&LDS6W4ZZWKG.)QRSR'8UEC\Q1L\++C[+ADGF+0?$15'N[
MR\Z1L]*=/6\>B^V7DG<=-=:/N/G#YF==7^K^I[V5&3^[[,G&VJZ:-KOH=Z="
MF@3NIF9GG^1PC7B^-O-K@H>;,FIK]6EHX>-I25<"D]AC3?./KC[AVS[CVZ=,
MV\GS-/W5JN\[#\B?+S^(MS_B;=[=<2PTX)KWGH^U%^%A#;3+;3*4H::0EMM"
M2(DI0@N%*2(B(B(DD/'_ #^(W.M6WJ_2>XHP5N*MI4BE1+T&J!(
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MMH;UOWA>S]<7I<2F#K'4K$%8
M
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M8')LF&7"ZY$]"NSKCAH=;E2UKCJ)*HZ"HM!]XY"[?@\96EQ%&G)O@S*3''D
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MS1G!5]=%4[[0HU%6E.[;4<#5-M+BCGZ-<2L2
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MI?I_%Z:V*QMF-%1\.VJT7&5-:\#M-!<*2(RH?]L</&$;:Y8\#GZREK+B5BH
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M.6E<I+M3/;[5/9]!J(V)(C[/=%SF4FTNPA*B*A)(
M
M                                      0=>P0ZTTX@T6N;59N%2IEP
M[MQ5[A$7)^]P*(\U6V:4UIIZ*XS(CM28[R%-/QGD(<9=:<\*T.(61H6E23H9
M&1D9&*+KOQH\?61<I&:<;E*-=NIC^]?7DJXIK1<[OJQT\RF<%S^6HIDNR1D-
MLPKM+/GO.F@FHY-L&X\LMGU1V?TEU_E[+<A;RG)VH]M=5\IY8\X/PT]/=<0O
M;EM$(6-WEJU1<DWKV):5+ FH/2+UM:&75ZRY'IG>;^B*I32)T)B5(2I+2EH2
M9DU&H?$EJO;O'H#9O-?9\NQX5RXE<[*_]I\[NN?PA=68V1/)N8<_#KQ@J]]-
M*(X%:],NKG)YJ+;9=%LE])=6EI*G+?/:22E*)!&:EQR*A&H<SD>9NRV++4KT
M%)+O-+VO\)O4N;=5NUB9,Y-\'"B^-HN2=,ODC:^:U9'8\KZC[FYAF$\;,]^P
MD:G)-P90IEXXQH5'XD$XE2T5.A5[1TYU+YI6KD+D,.<IW75)UT7RGLSRH_!I
M]U7+.1ORA:QHT<X4]J6BJJM>LRN-%-#, Z?,"LNFVF&.P[%C]HBM,FMAEA$B
M4ZAEIMQZ0ZTTVMU;BFJ^*M!T/N&;E;A>=Z])N39]!=BV+;NG<"WMFUVHV\6W
M%+1)5HDNQ([>X'B)M*2H2??%LV^X+.D8/E]_L.9N5YUR>X:ZD<9T6E*T4VI4
M25$>SM(Z]HIB_8U]X/WO0":;;+Y)M#?<2$)07J["(BW"5Z> ?HXFHFM"KO\
M[.X'2NG *M-21!)0M"7"X5I0M/VJT$LO:/8 U["4I))<*4I2DMQ)(B+VBI0
M5   -%#+:%FI++23/>M"$)4?KT*I[1.E"->W@:P@D
M                           "E5:'3?V>WZHIDN948U[":;*"8KE5 ]01
M$7?[)F?UQ"5 2*@
M
M
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MMYQMY]IU"4UX3)I;9%4AZPZ?\R)[I[&;:5KE]Z3?^DL[;U]CW+JLYZ4(^O\
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M24I0DB))(HE)%W$DMA$0MRM2G1REJ7HM<$:POE(
M
M
M
M
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M)?L!1$59'S!:*&GT)FA[3+@3WU[N\*"K).Q6JI*]!9,RK0^%-2KO[""B%6N
M^8+1P\/H3/#W<">^O=W@35CY@M!D1'"9HG<7 G9ZVP*"K'S#:JF?H3-3I4^!
M.VA4[NP$DM5Q(JP=@M"J5A,'3:7@3L^H K0@K#:3-2C@LD:J<1\*3K3W :03
M9/S!:3(R."SXJ<1<">S=N+U [15OB2=AM)F1G"9,RV$9H3ZW<%.TFK(*PVFB
MB]!9(E^^+@3MINK0@H$W0GYBM1'4H+)GZJ$[?;(*5XD%'S!9SXC]"9\?OO 7
MBIWE3O(*4T)4F5_,5JW^A,G_ ,A'[)!1,BK7 CYAM/B_B3/B]]X$[?7V "D[
M!9Z&GT%BBJ&9<"=M-W9V"EW&GR4T9/82JP6@ZU@,JJ1$?@3N+=6I">6+(JUP
M!X_:#(TG!9HKWQ<"=M-U=@GLIV"K//75?;H,/I[U,-B.VW6P2U>%)%XBC/)2
M9T+;0E&"T=451K4P^^D!AA[JET[:D-I<;/++F:TFDC)1E>6^$]QEL,<IDQ7V
M3F7 IMIN53.#C6:V2(<-;L-E:CA0T5-"3/A;8;2@JT^Q(AQ5$R:LUSL%H/BK
M"9/CIQ> O%3=79V!1,@?,%I,E$<)DR49&KP)V\.ZNSL$@GYAM-5'Z$S51$2O
M G:2=U=G8(HB>9FC\Q6=7%PP63)6UPN%)5I[VI&78#3='V%,_:GKK)'R+ZQ9
M[78K]<_1&6CB6BXNK6:4[FX;RR*IE_<BNQ!7+\;,56;DM/A1:W"\\/"N7Y.D
M8VI.OH468,_4MD2LFURU'N_$2FY-\F-MJ(R--&I3[9$5#478/H%T):GB=.85
MF2HO#U]!^<_\1>;C[KYP;OF8TE.,\IZKMIH9'ODYX0FS=/,J^3(1$YD,KC-2
MVZ&ZTT;)HVF@C41[#WF/,'GAN,<GK&=B+K"Q%)>M\3ZS?@9Z?EMOD]9S;T/#
MO95V;]<:JC^*AXW\\;$,"P.9I]J7C3$6SZ@7.1(3=7(B6T*N4=LGR9Y[+1(,
MU<1'4S[AX3\XO*W;.I8_;\:*^];L7[.GM43UX'O?9_QKR_"O?Q8[G=:VC*NQ
MB^+44Y)<.9::/U%G3'M4[5<&66;TDH4M#3)FI!\XG#6A)FM1)4?!7:8^>747
MEUO6Q9<XNU/E;>C37"O:T?9;RL_$-Y;^;^R8F?TUN>/=W"[:A.Y;A.#E'FC&
M5&HS;_.[3FK.3XVXLB:G/O*453;9BN/G2E=O+)1EL&HO9-[<)?J9.2>B57\R
M.Y[^_8,;7L786U%:.32KW\6CGFGNGNJFM=_9Q/23#+O=9<]Q+'SO(A384>$E
MQ2&U.&MZ.;1DDG2/>.SN@O)/J7JZ[&YD69PLMKBGKP[:'4?F3Y[](=$;5*Y=
MR+=S<4O=3BWV]TJGDWS'[-DW0+9ST\R:[1[MJ;J'")3SD>0TN3;V7F)"C29-
M+:<9(VB,BV;1[)\B_P +._;KYGXNX]66.3I+:Y*48/6-VO*ZZQHZ'B;S[_&+
MT]_*:[A](35OJG-C*-VC]J*]I<5*J,=EBW2;[?8<"Q-/RKU?Y^PBYC[SBYDD
MN>:E46LR2;M>T?7'><_9^EMFN;E84;&VXEFM'1)*$>'8N$3XU;5MV;USUGCX
M.,Y7]PR;^K2<FY3G\+T<C]!_R%=.^G?0;0"#B;#]IA:\Y8PQ-SM<PHS,V828
M\5<5IE]Y#3U4<1>$CVGZH\$+\2G2'F[U)D;-@W8VIV+CA;@VDIT;4FGS-5KV
M'O'J3\.'6OE)LMC>-TQIW,._;C*5U1?L\RJDTHJB2[3(+5:;0IQ1K@,F;_"H
MW"2E272V&1UI0QM\;<(PYDT=:IW)-KET1/S-9%\:3AL'Q&GF50FA\/O:U+L$
M-T59JE>!$9<SY8ZLU#LMG,U+.(Q\H2>(^ CXB33AKL[!6W15? /V='Q)^8[0
M:5_Q)BCM./P)\7#NKL[!1&4)KV7H3[1UWJAIOC^HN Y=A,Z SR+Y:)C!*4TA
M?RR8CR(ZTDI"J&E:RW$.1V?,O;/FV\O'DU-23^DU_JK9L?JGI_+V'.BI6;UF
M<4FJIMQ:3^,P<-:--+GI1JGFFGMR9=0_8;U--LW6UMF;2Y3SD8T<2$5239%2
MA=@^AG1N;CYG2EO(QZ7;EZW66JT=-3\X7FWTCD^7GF!N&Q75*$\?)DHU37LM
MU5*I55&M49#OE Z^6K/=-KQI-D\Z,]?<1X#@-SWFT+>B+Y!$ALWWC4LVTTW%
MV#R9YN](WMOW1[S&W3"OOAZ=?1WGUL_ MYM+JCH9]';IE<^Y8%6N;CR.BBE5
MZT6GP%Z1BU6%Q"FT-VYYQZG.)M]A9KX3+AV$53H.E[<(Q=>7E/=RFW:=IR3=
M=#=?,UE2VLG8;1$9IXS-LJ*-/O=I%MI0(QFHOF>A7+F7*I<7P*SLUD<XE'$8
M5S>'B/A357#3AXME=A;A"E&4>9<$3)N$N1^\:3]ILK;3KJH3!LDDW)"CX$I)
M#95-2S,J40DJ[:;A%;4JJ4DDM6^[X2BX[T6H1BY.3I3OJ6 /,EZLXF57=[0_
M364EBSP5&SE-S@NEP37$^D))HU,/>]:65-I&/GW^);SIN[IDW.B=BN-[?:TO
M.+TD]531]A]-OP@^0MO:(P\Q.HK%,^Y[5B,EK%>RZT:[?66S]&M(LHUMU#L6
MFN)0GY'I<U@[I-:0XIN''2^RJ0MYQ+;B"XVW#/:/,W0?2&X=9;S:VW;K3NSN
MS7,TO=555O1]C/9OF3YC;3Y<=-9'4^]78PO0MM6[;I63HTJ*JX-=AEJZ*Z'X
MAHCIK9M/[% C)2S#8*YRB9:2[,E$TCFK<<)I"E%S$[*CZU>7O1>V= ].6=HP
M(J,U!<\J4<I4UKHN!\-O,WKW=?,?J;(W_=KDI.=QNW%MM1BVZ)5;[&=JILMH
M0:D.0&B)9$;SBB31PD%4C49D6Q!#=7K;=R>D>UFC2]A0A6LGP1XEZEM8;1;V
MIVG^(M,JN,W@;NTQA2%<LB):$I)2%[*&.O\ JKJ:%FU]WXLM):/Y3T9Y/^5D
M\_.M=6;Y;:PX:Q4E[W#6C1BS^8]JI=KKE^-Z"6R8^W%<6[(R-UI]PE.>-YQ#
M;IH=,S(R5N,AI6UXRO9$\B;K9AV=[:K\YY"_ZDOGKN>S[=8\KNEY>!:RXM3G
M%THES)JB:XKT'AF+!1;D--6M:K><5"4-K09T):4DE:C)-",U&FHS+DXWFXWU
MS0[CXK[9C;WME+^QYUW#R4Z\ZE)U;U;I7O.0P\MS2WD:&[Y*>+<2D.O-4+=]
MBXGL%J6'B/\ 9^POC.W>GO/SSIZ+LTQMRO9W8FY27_Y>@VTW(LMN9GZ5>I*6
M3J3C*W'5FX1U)1<2EF9>$Q?PWB24K>1'F:X,XGJ'SG\X.N<I2W?=+^-A2JI6
MU*;YDZZ5YGWLX=D6-Q;U9WHR#6Q/B&FXP)Q.*])8DPE'*2;;I?*I-3K9'L,A
M-C(OV,SFC^RK_P!AU_"UD;7N,-RVZ[-9\9<W.Y-O1U>M:Z^LR=O+0U4D=870
MY<\(R%LY>HVCS2H;=Q?7SYTV.VVVA@UK<6_)HEIO96F\:?\ B%\ML'S;\J\K
M!R+2O[S@6G.PZ:UHVZ:-Z'VT_!IYQ9EW;L#<\JY6%Q^'<UX4Y8I\>UFU-R7;
M)B%*2MBX6B?0R.J5H]%D;2/<HN+ECX60M[GLNX1E8<K756V9/'5248W/@?!'
MURQK6+NVWW,:=+MJ]:;K_6C_ *2\[H7F-BU'T]MEU.*S(N+$9J/=$&:#<XF6
MVT-J7M4HZ^KW#[W_ (=O,S&\TO+G$RY7O$W;'MPA>5=:QBEKJSYS^9/3EWI;
MJJ_C1MN&/*;<?A;]1W0W:[,HS1Z$TIQ9I-SP)VFBAHKL^QH0[WN.5O7&T<>Q
M&@QMJY[^K[SR+UE=).-=2F SD,08\+-[5%==L-V:9:0^MQMIU1,+4AA3CAN+
M50JF.E?.7RGQ/,7I^=ZS",.H[4&[<Z*KT?LO1UK4[Y\B/.K>/*;JBU+GG/IJ
M<TKENKY:56O%)42,6?,L+R/3S);GA&60)-MR"R35MM*=2ZPM7(?64=YEU:&S
M.O))7A'RVWC:MSV+<I[7N,)8^58FTTTUP;HTZ+C2I]I>F-[V;KG9[74>W787
M]OOVUS133I5*J:J^_M+PGE^]8%OOMEF].FL$MHUS[;+A8Y>;@X@RD<4-,9$9
M;DAY6TS<(DU[2'M3\-GGN[-_&Z+ZGNTLQFE8N2?"CCHVWVL^>/XNOPZJU]IZ
M\Z)QV\6["7VBW!<*J6M%'L/%-]QB;@&I^H6GMV8]$DVRZ/S+<R>Q$F+/EO2&
M%L*X4I<(V#(_"1C[Q=';E#<>G,;,MR4UX:HTZIZ+M53\Y/F)M#VOJ_*VZ47"
MR[CK5-4=771T[2CA,C(NTZU]<J[!M$HMT;]YFCV[MKVX0ULP[2333U/4$23C
M[Q<M7K=Y?JW4%2A'NJ1[>_V!3S4,AVIRC0ZYU;O4?','E2)#I).7)AH:2:B2
MHT&\273(C41TX:B[X;DI7H^ZH/7X"]L-N6Y;O9V&,7/)G<C2*U_.1D;]"$3%
M9G2KIN]:F(\B%+MYNR#0E!\R2HT&X:^$CJ94+>/ 77=SQNK<N%UTN>(SZ;[!
MM%W8-EQMM<.1QM1=.'%+T>@]B?,-I,C+T%DR73B,TIV\)>&NS:-244EH<O4G
MYAM)DX1PF3YO":ZH(^+@][6I=@F@JPJQ6E9*)4%FB^'B+A3MX/>U,BVT$42)
MJPJQ6I1KK!9/G</,/@3MY?O*[*G0.TC4*L-I6E:50F3)9I-9<"?%P>]KL[!(
M[:@[!:%<583)\7#Q> MO#[VNSL!JO$5H/F&TF3B3@L\+G#Q^!-%\/O:[-O"%
M$B:L%8+0E1J*$S4S2HS-!'4T&2DF=2[#(13459B1^<,A".JZ8:4)2:X4!1F1
M%51G&?,S/9ZHS<?6+1$^"+TWE,VV!)Z1L3)Z,TLW'9',JA/BIR%%4N';0R&/
M>_:-=A7*B2H7-SL-I,W#.$S5PDDOP%XN&G#79V4%JA15HI.P6@R61PF:+IQE
MP%XJ;J[.P235TIV#YAM.TO06:*X>(^%.WA][794Z!1$5=0=@M"B<(X3)D[P\
MSP%XN'WM=G8 [:@K%:#)5(3-%4J? GQ4W=E=E :[PI.E.PJ.PVDR61PF3)RG
M'5"?%P[J[.P!4@[!:%$9'"9,CI4N!.WA][79V *A5BM*C5Q063YE.,^%.W@]
M[79MH%%Q[1V4["%6&TFE1>@LJ)7#Q%PI\7#L*IF78(?> =@M*JFJ"S55.+PI
M.O#[VNSL$T7#L)JVJ/@5?,5JHM/H3-%TXO G;P[J[.P11"K*/F"SFI=8+-3X
M>(S0G;3:79V"::$)ZD_1^T56?H3/CIQ^!/BINKL[ )JP=@M!U(X+)DJAJ\*?
ML=U=FT0Z+5D%/S'9E<=8;)\5./P%MINKL[!-"=4N;L-*1:[#%C29#\:.W&8:
M6_(<4E"4I0P@UF:C50J)2DS]@4VHQOR\.WK)NE/24W;JLP=ZXZ0BFV^Y+5E@
M3K'UM9U6U$E6#'W>'$L<><8X65T9F.-+>;<-1(<4A7"LNTA[8\I.B[/2^PQS
M;UNFZ9"JVUJEI3L[CY_^=O7E_JSJ.6WXMUO9\9TT>DGJGVTT/C])>A\K6C4B
M&_+C+^B>-OM/W%XVS-EU3:V'&4%Q-J;54RIO&;YH]7V>C^GKGA23W6^J0C75
M5K5\:G%>3_2%WK?J:'BP;V?%DG-TT=*-=E#(&C8W98T:';(]K8;B0F6V&DMM
MMH226FTH3X4H)-:)'AU9&1F\^9F-N_-MZ\=3Z&6[,<:W#!QURX\(I*FFB7H-
M^5CM' LO0&E)53CJE/B-/O2W;:#'MP>-6<:\\GJ94GS>RU[,>!6W8[2X@C]
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M6[U:"I)M578)-0DHRXLU2,C*I;2/<8@DD
M
M   0W158*%.(33B.E=WL"%.,FDNT/3B22B.E-M?4/L$N23IVH+557 &LD[R5
MZY)49>R9%00Y)+F? E*KH4FZV5*J(J]X1G&:3CVAQ:57P*R,E%4CJ1]HJ()
M                                                       $&9$5
M3W!Q (R,J]@AM1XA:D&I);#/ZABI*JJN!%4BH02
M                                     $5*IEVEO]D 2
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MTZ#[;=+-TL:5V^]0'[9<8]F),F%);<;>86:B\*T.)2LCV]I#!XM^LF;UU/8
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MO]I%09F,Z18GP1>S\HUQMSI&Q$VZ\/.D[R,CW,=XQKK3N-E3X(NBB@I
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M'/+KHG"Z'Z<M;?BQ2O<J=R5-6VEI6BX'I!LR4A)^H0U-)K1\3?4U+5%8$@
M                 "A "TOYF&&DNV8OF;#7^1FZW(=2G;6CO"1J)-=I*+>8
M](_A_P![\/.R-DG_ +Q57R'DC\473RO[7B]00XV)4?PMGAGI,S).%:ZXC<73
MX6)[W(<37A2KG*8;+B\22[>T=O\ F-M;W;HW,LI5G#7XJLZ8\M-V6R]?[9<Y
MN6%U4:^+TF22PM+K33R=SS3;A4[EI)1?4,>$9+EDX]S/HY!\T5+O2-44E0
M
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M&D&9,2&'S+>3+S;AEZ_ I5 !K@
M                                          %*Z#@<1RG*,?PJP77*
M<IN<:U8]98KTR;/ENMLM-,LH4XX?$XM"3/A2="KM&*Y.$Y2G[,(\"N,'?I;B
MJLQPNJ;S]+3CM_N^(: 8@>0,6F7(B_2Q;S:D2G&7'V#)B(4DBX4N-D?;6HSK
M-B[D68WHZ5>OH13DNWB>S+65.!Y2P+S_ /7JU7Z/*SC D7:R(>0I^&II,%3C
M!N(-?"LY*%>%LCW#E7AXO,H*2YFOE,+[5)X_VCE:C4R)NBWKKTCZV\.5>\,E
M-VK*;8VA608F^^RJ7 4M+*B)!D\I;Q<3N\BV##RMMO8:5UQ]A\&BJWE6K\G:
M3HSW:TGA02:4(MGM;!Q=B=RY%RN<:F6TEHN!JB^0
M                                   0=*;=WM"')0U8I70H);1;.-'K
M<9>Z#7/Q' DR14J[U;M^VGK;!'/X=(MCEKJ5BH
M                                   4<:>(D5VGV"WS^WR@&MM)G5:4
MF>^JB(]GJ&8N"A)&1[C(_6,C^L*8J7YW :%0J
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M^8X?&BE:I7\Y_.7,!@F4
M=-ZP%6W6PO\ /F/X5(O6N)#T1VW#_P CB?S9C^"2+$N;\TDW(D
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M2RZR^@G&S-3*UI2HTJVD>T@(X'(0
M'%<UQ2RYQC=TQ7(62D6>\1G8LYI2B22V5H-*TF9D9%4E $Z/3B>(<(\N+I4P
M/+[7F>-8S'C9!:ICTZ&^F:PM29#SY/N*))-$9U<(5NY.4.1OV2JJ[BX*VA+3
M;;:-B&T)0DO[E"22GZA"@I*P    ;;EDVJM=BN(C]2I>Z*;C]FJ)YO94.P\
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M2OK;-9\PKN,\7&A3_B/1\)DQ(.J=IUVF5=VXS(OJ#H2+36G ZI::T?$J$@
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MV[O8^S;I?L4HXW9:?"SZF[/D1RMJQ\B+JI68>G\U'-QQIR0
M
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MX5%K74MHP[BY).'85-*M4>HA;
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M1T[JEN&C:+@;,G55) D
M              X[E$MZ+C&238YFB1#L=VE1E$1U2_'M\AUI1;C,R<01C'S:
M0QI3KPBV58[<KRC_ *R7RF$]+\T+K09ZE580C4!\\=^GZ;1Z%R%$10/I(<(V
MN+TK^3;-PY3I*Q#<(MWM='0QNJ;LL"%8*BT,U_$Y3UQQ7&9\LS7)F6&T2Y"C
MJ1J?D6^.\\H^WQ.+,8>X6U#*E&/!3:^)D8%QSQ83[7%,Y E9F:JENI01)J,4
M^-2]%MMKN-025
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M?#KVM_&=V&9$53W#%XEXD
M'36L/^SK9_/F/X5(O6B&=N0_\CB_S9C^"2+3XDFY$
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MR6S(:;?:6DR,EM.H)QM9&52,E(41BR5FJ
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MUO5'6<91?M+@SN!5BE75FX2DDD1%N(05MU=62!
M
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MC:X%25(I%S<6@
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MO,86?B/!R)8L_>K_ *3)P\B&98CDV_=DCO$8YD@
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M)8;P;<-Q\_DR-*''WD_*<3I$1&6T4SL3MKVB527NZHN1<1\LE\:330U&NJ>
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MV>;]BVTTJ^HNUMKXE&1[TF9']4>:XQI!/LH>LJU3]9K$>\4PGS-KN!(N$
M
M                                                       !!TIM
MW!Q%::FR?C)?,S(]BV7FR]0UIX:_5%E6TI3GVR5![TX3?"$JF%5UY8B_IGY@
M>:>G$IN/D<AA^+(<2:4.)6J0X7 I1(2K8?94?.SS\V&]8S,^#3;JFOAYF?6[
M\+?4-K<NFL;)32=J/*]>U**.++H2J;T*(E5]<JD=?5'C=0ESU_.K0]I+EOVU
M+O(5MH?KE^P+KER^PRN*45RH@"0)I70'2.N4M+M@M%C1XY=WNUMC,M)\2S4[
M.0T5$EXCVJ[C'8OEKB2^_7E-?JX-)_"T=>]>;C'"QG8TYIVIOXHLS-^AC"I>
M!]*>D6+7!M;4J)C\5U;;B5(67I32)":I4E!EX5]P^K_0V%+&Z3PK+_-C7X_^
MT^''F=G0S^M]PR(NJG>DOB9UWYHA$WT2ZP=I(M2#V[:D27S,O9&^V)?K4S0'
M'EMT[C%J\OWR_-4^L3"<IR; -9+OIE$L-Q<8?@VV1-9;FN2'N)!.>BF23,DF
M9[?M1R&1D*-(OB6\6JCS)Z,N0XMY!N<9'?(:]9NHJ_Y3CD%]IY=KD/SY*92$
M.MK6SRY!+;^4+B+;2A&,*.1R.J6K+T[<9RK)U,@/0OI\TWZ;-,86G.FEECVB
MSVRW*;<6VVTE^6^B,2''WG&VVU+-9HK0ZT%B4G.57Q94M*)&)X?,=\Y8DIXE
MG](MA%6NRX?"V#D.51QRU-MY)F:0R,HD4C(R,HS!&1[R/E)J1^J.-+IK*(SH
M9;RK3V1%*\2'WH\ ]??71@/1;I7<+W<9<>XZ@7F)(BXAB[#J')TV<XR^AIXV
M&Y"'T$R\DC3L\1B[%<TJ/W0J159<"R1Y>?1+JGUL:SRNM;JUCW)W'WKJJZX;
MCMZ;E(1/0B6U,B);BS6'"8;C(>[#(E$,J[=C&WX<"6FY<TN/8NXRK(D&- BQ
M($)AN/"AL-1H\=E"6VV66&R::0A*"21)2A)$1$78,%=Y#57Z#> 2
M
M       4*-/ 9F9$DB,S,SX2(BWF9G2A$0IE6"I'B%[18!\VCS1+=H;8[GH/
MHE=V+AJ;>(S\'(+O D-N_1EA]J6TMI*X\M/,=>25#H54F,/G6;)X]FO'5]YE
MV[?V5*[<795(LG>7/Y?.HG6[JB>H6?)NS&FD"\(N^19!=FI9KOTA4MBXE&CJ
MG,.&Z3BUK3X5&5/4&[XEJWL.-#*E3Q9+2'?Z6:WFY4MYO2PE7DBZ\WJ[#-\T
M^P/%M,L3LN#X;:8UGQ_'X+$"#$BLMLH)MELD<:^6VV3CB^&IJIM&L9&7/(O.
MY-MSD]?0<I9M1LVU:@J1BCFPI+H
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MNQ2"B%%?4@D*=0DB*IH(B))T(8N=F/<\UYC7]*%["Q5@8D<6+T6B.XQBF8
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MT7 R/Q4KM[OJCB(0N<W._=.0;7#M*Q>(
M  -+8I9;-J:G7OV$+=IIQ<TO:9#XT,77S?M><0M&ON+6S$L-NMLUCTVEQI\3
M-K=#FO>G-K<<D<A9Q44,B)JFT^T8FV9;L;I-6UR\S:F^\YO(VV63M,92G5<8
MKZOH.>X!Y\96;$;):\WT6R:[9)!AM1;C<HS<N.B:XPTA!R%-+0Z9+<41F>TO
M6'*7^7Q7R>Z<5;QI1@E-^V<S+S]<1,C/] ^7;*?92.W_ ,P+5&5^!Z3U)T=^
M:[C_ %:ZL)TMMVEF08E)6P^\FZ7'G''HPTVZHO&VDJF2]FWL%U6_8YV6+G+&
M3@G5HN]$?89U,M_['U!;??V%*^4D02 !Y_ZB>G+3SJ8PA[ =2(2IUAD+);C"
M5D@S-)*+>:5?;=PQ,K#AET4^",S$SKN$V[3HY'@QOR8>C9"4(+%'S))4(O2B
MV[/WG;L&2E&W;\/A$LW,BY>FY3=2?ZF/HW3OQ1\JE1)'*+N_>13'DL_K$Z5[
M?6/'D_8?#N+5761T2:6]"VMND&IMGM*\@TOO^118]RQQU?+*UO-SFN4OG<M!
M+H9)/>*^GX.SOTX)_KIQK%_T]1E9,U=VRYDS7ZJSQ^'@92&G=SLM]P?%+K84
M)1:)EAM3T%DMI,,K@L*0R1]O*29)]@7\Z-Q94O&?Z[F=6<3BW83M*Y9TMOL.
M;BR7@                  I47$1E6E1#54"QOYOW6A-T[Q&W=,FD4ERXZOZ
MK*.U.,VIU:Y]G@ODXRHW&XK_ *0DWS5M+@.A$,K&@J\TNPMW).$:1XLL!]%V
ME=]T8\P?3K!LU0H\L:F-W.[*>JM_F7=V+,+F+6E+G%QJ/?M'(W76TY0T*;$9
M0E6;K)F8-UN:KW/17I3U,S^S.FS<[7BSK$-Q.Q279D)UGB29+09*2DS,C(ZE
M0<5:BI7*2+S9CR>35T7:;=4Z=3.H#7^V.9W.G7Z5\TP[N^[(;2J5).0MQ1R4
MOF:&C49$1+^R&1?G.TU&#HBBTW3G?O,^%YQ/2-@/1SEFDFO73[$=P1Z3?XJ;
ME!M<AV.RAR'*2\XM/HY,?)NDE.PU'N%6/.5SV9:EK)E*,5<BZ-,OIV;J=N:O
M+O:Z@)<PEW9.FRG%3"H9^F%;/1$O&9.F9N$[15>*M1C\B\;E:TJ9%=*^@L->
M4%TH8-UI:GZQ:Z]0$>1FY6Z^3E0+=<WWGV)"Y<TUQU*](]()+;'-/82BKN&1
ME3<$H1TB8]AN3=R6K9SCSFNB?3/IIMVG6O&@%E5@URMUY97=6;0^[&;4<1_T
MEMQ)QT,FA+AH21D:_L13C3YJQGJ7YQ3@YK2:X%[;I2ZC+IEO0'C^M60NKE7B
MW8)<"E.FLU.+E6RU)3'<4HW%*,R4:3.JJG06903O<JX-D6VYKTF/+Y=.@MF\
MP'K'U8U6UV])S#'<=OESX;)/D2'8D@DSEE#;,G#D(;0T3E#(C34NX9>7^IC&
M-O1]Y9MRE.]*3>BX'K+SBO+ZT4TAT:M>MNB&+-X%D6&3V9$M=E=>8],2TI;T
M=2N0A*D*;6V53XR(R(ACV[DKCY;CJNPOW7S0K^<N!<]\HW7RZZY](V$2LADO
M3<AQZ*BUW":^XMQR0AEIA#!K4XXZLU)*I5,Q:NQ49T7 )N45(NCBQ)5T).F]
M8"K;;894,BG1^TOOR2_9&3CJKHRF3H=MP_\ (XO\V8_@DBR^)4;D0"*EWEM
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M+4X]SC%_.CJ;+]-ULPI=PPMU4*X&TX3D8S-SFMK2X3II,RHBB#KL'?\ Y/\
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MF9>UWGA[E9RJZ1NPE\"DF83DZRN8UFV=8G)8<C3;-D-U4\ATE(6I,BYR30?
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M4W^'+N=QI<L7*M/A/7?CH6W;V[O8&KQ]Z7-P.)EZ"HCV;Q3:KR>T2^)4+I
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MW5*H D *D>X      14N\@!(  "*EWD )J7>  5  "I'N "I;J@    5(^T
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MGX.(]W<*9J,9>P]"6N]4+GPM@
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MZQ3]!OQ22
M  %*D)67"HJD8$IM<#X.3PG9F+Y!;XJ>)^98[M$C(K[Y^1 D,LIKZKBR&)F6
MX7,:=N:JFF56?9N1:[&C"OF^5/UK+ZDU9W] W3QL\^1>3G%(/_(/I'Z?S. H
MG9'V[QS'2&3';X\EYT@DZ&-U!!YMF2CK/0S2,7A/P<5QFW24F4J%8K3$?36A
MI>C6^.R\FNSWJT&,3.N1GESE'5.;?P-LIVZ#AAPC/C&*1]]M!&:J[:&5/4%N
M:5N"C;5$^)<C64GS:M&Y%2+@
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M.QR7';DZ31I2/-YZ+D1WGD9\3S[2%*;:*.@C<,DF?"1^D[#.@I:5R'(U[->
M>/*,E+Y2REU]^8%@76'FFF^%8TD[/IYBM_8GWO('EH=.6TW-2XI:6B=5P))I
M)=GLBSM%R?\ %$9_F6XT^#T_&<CR-[!F8DUI=I1^HO!85YJ/1%@&%8OB\;4-
M)LV.RVNW+,HR=C[$-AE[?)K]T08Y#,OQR=PG*G;HS@]MPKEO 5'7EXEQ71G6
MO!=>L'M^H.G%S*[8W<N+T67PI1Q\)),]G$LMG$7:*.3D?))495S<RJN!V\*"
MH                #SWU/=0.(=-.CN7:I9=/CQ8]DMDI<%AUYIMV9<#CO*B
M,M(6ZTI=74%7A/8*[<>>:CWD-TBWW&/?Y8VE$GJSZB,[Z_NH:_V9Z-$ND]K3
MVR7JZV\D>CK4XMF2<.>\YZ.S$9.IJ(R*M!DWFK4?#CQ+=NDUS_$>9W[I;)WG
M42;@[=[<W:/GEE"+F4N*FVMLLRB2RA,OFE%)*4$1;%4H,RU&N,^^@E)1N),R
M ?-)EV^?T':KR(4N+<(GS3%Y<F#(:EQW"3&D$2D/1UN-+29'O(S+:..L/]:7
M9)T?>>-?U?[A_HQ7BA$7^N7:TI7WZ=_:*LK]H4V_V:H=;_K%A'^@_351'3AO
MLC81;3.ATIV[!7A^^RSE?L6O2CEF)$9^1\YSC6=<%D&?%Q<7[E3?MH*-7D>F
MI?C[OP'%_P!7>Y?Z'=4#+@YGS\BI%P\?#S"WT\5*TWB[F4TH8V*ZPKZ_G.X/
M/N_[J;9>&GSDWM,B,_W3WM=OM"WB*DO4C*E7PI4-3H@5_P#\DYAF9F18C?MB
MJT+_ %8U6E?7!_WA>LHLK1GDC]7O2GZ1]1"JH,RO\JFPN+;<6ZTKXAD9[KRU
M+5K2;H7*/.9.G13GY$23,TM4XN$Z?)R=W$,.S[Y?DO9?<CH/R#RITN2JG_TC
M[WN\+7L"<BG/H(5\-%\/(8]VE6YUJS2O0YJJ$AZA'P[Z[!97I*E2NO \Z9S9
M<R@QK<[>K[Z:P<E".7RJ4=4X7+.O]R9C-LSA2D51T+4E37L.UXUFS1,6V<%Z
MVH8+G> O&2FT\LMN[@+8,&Y5SK#W2ZJ4UXF[19\Q2;!JO)*H3O.\'OC5[SUN
M$1JA2/;P-)%DS-)1?]=54V;O-5P%XR69FC9V< >GM#H5(LN9)<C+.]$HT$[S
MO 5%FHCX/4\(D:%!6;-B2QQ7NJDF_P [P%XR57E^MPB*:$U52IFS9F@HA+O!
M*)!/^D507RG&1\O;V< G4BD2B/9LU0;1+O/$2>;QF:"VFJO!3^]$!\M#5;LV
M:<,0G+V7R1O<_P"3*KI*KR_6X1% Z5TX$LV7,$\E+EZXD()[F>#WYJ(^6?J<
M)AKP[!I4H9LF9I;AI7?.(T&_Z3\G[\E5)K;V<)4"FI.A4U9<P;<C<V]\;39/
M<WY,O$:J\L_^29BK5NB*?9IJN!#=DS1)1^.^$I31O\Q7++QDNO+];AJ =.PH
M:LF:$J&;MZXN7S_2/!3F\=>5NW<!^V(U*O9-1JR9E_%S=O?%RN=Q^"G'Q5Y7
MK< A5X$:5X$-6;,B*%S+WQ+:Y_I7R9$3G&9\GX!"?:2%(-DMV;,TKC<=Z):$
M\_T@N BX^.O+]4N'8'#@*)HAJRYBV48W+Y]R*2N0KEUYE24IHJ'NIL!\252A
M:/U]\V.%T]:JW;2N[XX=\E8Y);BS9QN&V<E4QUQIE5/24&GDFGNVB]&S.<>:
M/ B5(Z/B7&M$\\R+6S3##]4+7<#A,9)&>E'"-/$2&ED1M$2C4NO :J;^P6FN
MQDT2T9VLQ9\T;.%QWFJ4$^4HN JN\=2:];@$:OB1[*X%#5ES5M46M[XD).0;
MY&@BX^.O*W[2X-@DC1\4:C5FS/\ BG-O9'RB?)XN BYO']RKW<%1"3^$ET(9
MLN9I7%)R]<;;7/YW@(N9QF?+];@V"J-.5UXAT98*\]_*KA:M.=*<(F7'TJ5=
MGKB[-2GPFHFSE\HU))1;D(+L[ M6IW+E%P*56C1CO8H@DL+,RH2FFTDJFS8@
MD]U1WMY48O@6LB;6NGY#LSRZMJ4;\5^UT_(<MM:RC2C=/[FPU(XU'NJM"N':
M?>8[TPTU&[E+W+=N3?P19UK^+CJC$Z7\C]U>X34)W[7+&O:W&:[UVG"\<L<_
M.<A39H*'%<4LDRTH)7O5O\#9$:25LJ8^77G3YA;1L.X;GU#DW8J[)S4&Z.KC
MS>GT'Q+_  W>2?4WG?U!C]*[1S+9K.2YY;5?<E<35-'71O@7EM#.FO'\*L4*
MX9 R3LV0RRXF!L3PGP-+(W%<M/%Q&5=H^-'F7Y_=3]79&5A;1D7HVH3?NSE%
M4J^Q2[C]/WDQ^'KH'RBZ4Q<3I_#M7,SPH^)<E"/,Y*,:\8UXH].MVVVQDDU%
MM\5IE)$26U,,N;"W;5([AY_W#.O[M9AD7[ER.?"6K<I-O77BST!BY>WX]G]B
MN>'^KP^0V]SQ^PWAHV+A;6C2I-"7'),9;9F5"4E32241D9U',Y>Y[IMV/8SM
MMRIQR(4;HVGI3N?H*LS"V?><9W+UM2?I2^@ZRO<_.M,"CKC7^Y7K39UU*9ME
M=DRG"@)4JB3XUN>))%[ [-R>J,[S&Z;CM6YYE[Q;<=%XDES-+M]HU6SL6#@9
M:R<+%@IIZRHM/3P/4.E.F&0ZTO02Q1A:+#()I;]U)!\II!DTIPB5P*2HTDO;
MM[!?\KO(?K/S7W*&T;?C3M[19FE<NM-*,:K6KC1U3,7KCS"V/I#$>3DW%<W!
MQ]A)ZUIPHGWET_3;0]G2RVP(..R(ZKD3*OG6>MAI3CKBFT<!I4ILE)X5I[!]
MH/)CR7Z+\FNFX;9@V+<]VG%<]]Q3=:+@W&JU1X:ZVZRWSKC<GG9UZ4,.+]FV
MFZ-:\=3LB/:,S1Z'S;N:C:](]*\'W7CKR?834=LW+-^Y--7*V^XU&5RS:7L1
MU8;LV:H<BFJ]$9-F\;I<!?*<53:K_>#)NW[4;?@1TN/M+<XJ:YX^^BV%YI71
M9,ZA=$DYM;";5J9I_$E3BE1HB#DW.(VB4ZIHU-1W'?DVSH6W<*[.UXF]06WY
MJ3N:T?#5\#S1^)/RN_C;H^YNNU-6^H,.'/&2C5N*JY1T3>JT,0=^-(D<^!<&
MWH%WM$QQAU'RC,F),M[RFT+2JB7FS4ZU790=6[[LN;TEND[-V+GC?FR[&OFT
M/E9;E+.M\D^:U?LS:N+52MR@]&NU<S789$_E0>8?>;JNU].&KF2IA2X#:(6*
MWNY.$I<A*?1FV6#>E2C-1$9T(AS?3NZ7';\+(E6W+W/0?1G\,OGC+J#"ATKU
M9-0W/&2A!R>MQ)14:5=>!V[YK/EOY-K?:8_4#I$TW/U2L$61+R&U0VVT?2F
MTS)<96E3$9=38CJ*FTS,QO5FZX+7M/:V3.UE)6E^P7 Q<I*)UKN$JS9%;)^/
M7VWO.Q;A;+E#DPU-2&'%,N<"Y3;/,)3B#I0J#)MM/VD8"=V,O#:_4K@:A<)[
M3<9X^PN<V1J]8N+L(7%7M*FZKTFV=FLL*2W1^3)<43;46$PY,?>=6? VV34=
M+CGB69%L+M$2K3T"NFG$OA^57Y:><:C9S8NH[7"R.V#!+&HIV$8Q<6%$]>'3
M.*ZW(=8E1"<9)EPN(N*E:#$G)K2++D(M/GE[QE%,63+4%%1\[(:9CMN,):0T
ME*290G@C)(DD1%P)IV=@LT=:LK='Q*&+-F;:(A*O7$M)O^DJX/?DLSY6_=PD
M#%4N!+5ES)LXYG>R439/\Y/+^Z&NO+];A"B?$5IJ::+/FQ>CDJ\U)!O<[P%\
MH2Z\'K<-1&M*4T#I6IJLV;,D>AI7>B6ALGSD>#:X:R/E^J7 84?'M)]D^6S9
MLR9?0MR[U2V;W-,T?=.,SY6SMI44QE83\*C5]]I5?_XJU2%(S1:_\VG0NY:@
M]-#%T;5'1>+1.87=9C;;4=R6VX^\INJ4M\2N!L]OJ#3-[O=(>7N3>\T<G%M1
MZBQK-Q0NJ,4^:4&EP2UKZ37.K^F][\PNEGY;W<B<]HR;UMW$VVDHR3??I33@
M6(,UZB+-TWZ>6O3[3-B-=-4;O#;9N5Q82TL[2:6>7QJ4A:2)1\/KU'S*V#RM
MZJ_$'YC9O7?7<KT>G)7Y2M*<I>TN9NE'72C-S\VOQ,>7OX//*_$Z'Z/5J?4/
M@J/)",=)<M&_9<:.JKP/ ]]O>;YG<'+SF>672Y3I9J==CHERV6FC<-2^ D)>
M-%"XS(>W=BZ&Z1Z7V186%A6(QM*B]B#;X*ONU[#Y&]?_ (DO-+S WI[ENM^^
ML"^VU*-R<5!2JUPEZ3X",>CM&MYB?<F)*MO&FXRR,C,ZUH3A#FK5G;WRI8UF
M6,U1MPCI\AUP^H.N-LR8[C8W;*N.3JDKES36O9([CTQU\U=T1N+4^SY!+R3&
M"<:*[6"8MY[BB\;9.$2WWC]ZR@]PZB\QOP\=!>9>)<>1B6\7<8IN%Z-%[5&U
MHH][/7'D9^-;S#\LM[Q_OS/GD["YQC*U.LM*Q3JW+N1[-NC..=2&3Z3Y[I8\
MW:;E-OMJ=O=J9X2?MTABXQ5O5)!J<+FNK&H?A8W_ '?R(ZYSO+SJ"_=N8&3)
M1LN3ER-52TJTN"[CZ(^<FP='?B-Z7VSS/Z<5B.;CQ4VHJ#G&357JDY<7WF8/
M9++EC6-XFS\[4.%C]J8DU10W'6[;';,U=IFE:1] <B497G?MOV'K3N-3V^W.
MU@V\;(_:QBDWWT21NSLV8J:BJ*]DM39N^D>"G'6O+^#46)1C?M<:)F?%6TW;
MGQ*F;5F;*FTKNS;K1)=)]IUA#C;I+*B4J2LC29;1>Y;4+'+-MW>QHQ[DIRNT
MM52[RWSU<^6A@/4O:E9!#=BXGJ.TS,?5=(4..TU=)/"^Y';=:9C4;-2W"*NT
M;OTCY@[CTREC9C=[$;22;=4M#<-CZIS-HBK4_P!9!=_88OFOW3;JKTW93,P_
M5#&YS4)MYQ,"^M,2'XLR.2W"8>3);CI9;XFF^+8?:/2>Q[]M^_8RRMLFO$[8
M\&O12IVGMV[8N[V_%N23MM<#G/3-UDZT=*MX:EX7?YMVQ!]YDKACLJ0]+8.+
MQL\PD<Z22&J-M[B(AQ_4G2>U]367]I@H9Z3Y9I4UU]!9W/9,#<X.,H*,5[O>
M93?2QUF8%U7XY;I>.9E"L.918B?GC%7U,-NG(Y+/%RE.25+</FN[DD9CS3OO
M26\],WG')MN[C5?+/O573LT.H-WV#,VQN;3=FNC^,[>U1UDPW0:P'DNKFJEM
MQZ&WSR;AUC/S))DA;B4E%)]#].%.\BIZHX3"V_=.H+BQMNL24Y<'V+LXG&X>
MW9.9<\.RG)]I;KROSG^G[&I,:-;>?DT5#KK3LYMM;/I%5J0APD>DF22*E>[:
M-VL^5G5#MJ%RBN_T]!L,>C=U:YZ';NE7FB=-VI\V#:)FH+>%7B<LFXS$J/QM
M*=?-M+2%ONRN!!$IVE3[AQ6Y>7?4VV6_'N1<[/H_[#%R^E]RL0<N5NA<!M\>
M^W:#$N%ER^'?+=(;YS=PA.,/M2&GDDXR?$PMQ!&2%$>PQJSL2C#[/D*EQ/MT
MI\9P')*PGSIJ\NQGS\BT^NF:8[<<7RB<U,L]SB2FGD.,MJHZIIQ$=234E5.%
M:Z[NP9^U;AD[)NMC<L*35RS)/1\574XK==KQ-^V7(VO/@I1O0:U7#3CK\9CM
M:OZ8W?2//;]@UZ:633<QYVW2%),FWV'GGG&C;4:$)/@;(MP]\=,=26.IMFL;
MICM.ZXI37:FDEKZSYN]6='W.E-]R=JRDU9C-NVVM'5MZ.A[IZ#=;KVB<_I%=
M[YZ/&67#CAR5$9),^3QI2IUTBWG0M@Z2\\>B/$MQZHP8^W_O4EZ^Y'>WX<_,
M:;S;G2&ZRKA+]@V_55:LNJLV7-"/A.\D9HXO&39442J\%/8'E]-J?AI>R>P+
MTHSR'*WI9-RW9LT(F..][4<PG/ 7B)7O?6H+C3>A%55Z%*+)F*%U^>JH\=4\
M':9;-OKB=2J/(W[7 VS\#(;9;[C/O-Y1\VP[7=)%Q2XA!H<C-QG'%I,U421<
MM)U]01)M0>O!"4[5F,KKX)5^(P(>J[Z%Y[U9:FY3A4=$/#H5YD(^;VC(H\J6
MW-EID.)X"-O:_4QH>[[G*U&5N?Y]4O0?-#\17FIF[OU3<V#:[LO L-JZE6CK
MS)=IUXI2E<))2E#:"HVA!$A*4EL(J)H6XAIMRTY2JF>9/&M4HUJ#*NW^SZXH
MC8A'WBG[5I6$-45)5MHI)+;41DI"R)1&5/%L41EN,6<GQX->$VF7'9Q<^2G=
MC2Y'YSDO3^SB6&=3VEV5Y5#1(P]Z_0TS8#AI..U(7<(B8SBDJ(F_"[MVC<^G
M<V[&*G.7"E?D/1OD#YH9N!U58Z1OWVK%UTCKPI1=YG\6V->KM:+)<+!>F_F:
M58[4];R8;1RTL.0F5-D1HJDR)!D.Q5-7/;CP9]-[;B[46M:Q7S&Z*S9H? 1W
MK=Q<1\&_NH(2:*BI%FS(C/BO/9L,D;C[]HG6FI.BX%'S+FG#MO=5F9[>65"*
MNZGK M-"-"OYES,G$F5[\)5J7 53V;ZB'KJ3H05GS4B7_KJJCIPGR]A>OL[@
MH*HD[-FGR9_/>TJFOY,MOJ%[ 4%53TDE9LR(W2^>JDKAX/ 7A[_7H8"J*2LN
M9I2=;WQ&=-S9=_N!3L(T*OF7,TJ697NJ3(N$N67JUJ#3%44'9\W-)I*]D1&:
M:51N(CJ?9VF%/C)TH5KL^9J.B;U0J%^YUKNV[*EO!+M(;7<::;/FQ)<([T7B
MIP^#=M]:IB55!TXE2K/FBCV7JA;*51M+O/=VA2A.A4=FS/Y;_75>/@Y?@+PT
M]]Z]1"6HT*567-#-1IO6[@I5!;:4XJ^N)["'0K^9LS,WC.]^^X>7X"\-*5#7
MCVBJI2AI%8LT)+I_/GC,T<!\&ZF_Z@<?4*I=AJ+LN9FXM17SPF2. N66PR]]
MZ]0I31"JIJBA=GS8TO$5[JI9M\!\!>$D[5>IN(-1H?,OI7:R6V9=LER"/&LL
M)HGI[\IAIZ.VPA-73=;=^36FA'OV"4FW047!'2=EZB.G3([LU8L6U%PR5D,]
MY4>V1HEDLS<DI+;A-/);<:03G$IT]IUJ1BJ5JY!5? EU1W^=GS%:#4S?"X'"
M;4T9-EX4F1'6G<9&*%S<.PBJXTU*CLN:$<CAOE4KY?*3R_>4]_M[:@Z]@5'J
M^)0]9\V4AQ*;U3B-OA/@+PD1^/=0CJ0A)H:/B:SMFS%9.I*]$25$WP> BX3(
MO%7OJ9 Z]G%D/EIH;1RW9='@WMQ^]D:$6V6M@U-E1M:(SA[3/=4TBJ,'6$%I
M+F57\)%V<88D[OYRMR:^!,PE>JR\2K]U$:FW&8\<F0N\RFUOF9F2^0^\W0JF
MHB(J#Z#= X4=NZ0Q%%44K:9^=/\ $KN-[=O-[>,R\ZR>4UZJ:%_KR:\0NT30
MO)<BB2_13OLQ"8QJ9VH]&6R:]II+B)24GVF/,'G?FQRNIXV8OV;457X3ZH?@
M+VM87E$L^['6_=FD_P"JU\Y:+\X?.BRGJT5BLZ:5P@8]&<A/((R4TDI34II1
M\OB6@J5/L(>1.HLFYD[Q.WB^];E%KX#IW\6O4*RO-?:<.#:>#SMJNBJV]=?0
M8K749HG>M-,OFY-;X,B7@5^?4\S,C,NN,P%&MU;A+Y3/ DC,NTQZM\L/,[I[
M*V^SL6?DQAN4$HN#:K71=KK\AVAY4V=RZ_V*]NNV8ES(MXT5S3BI-))*NJ37
M#TG0:F6>2F1$=YA*(C3MHK=M(T[R,AZ!=JWR*Y8DI0DJJGQG-;GX>5B6\K:X
MR61;FU)4:::='7MXDI=4XGY9/#PT(JD8I4G->VC+N7;DG'Q?VE%7XC57)CQF
M3/WRCV(2@C6XXH_>H0VFJEJ4>PB*HK=VW9M.;X(JBX1I;;K.3T2U9DQ_J_/E
MAYCK9JG;^JO5;'Y=DTYPF2U(PZ)>+>\T>0R%G"DI6VU-@^$FE(,R,CH=!T;Y
MA=56LFS]WXLJNNM/A])W#T%TI<A=^]<^WRWM'%_%Z#.D>LN6DJ2B-=4L1TH8
M8M[*6RX6&8Z21381%XD$.D+D9.?B+B=U\T/"4/SC379,S-#R6[T:>8;7!X*F
M@D^_]>HN1?,JEM)+B5JLV9UEJ1>:$Z3),)-'W+A(B<]?BH*J-:#1ZE,BSYNM
M+Z6[WP$HV39\!'P<-#<]?B$5Y5S<631,.V?,E'(-%XH2R:)GY/WAH+Y0^_Q;
M0C*%^/,U1B3\+2.II':\T24HT7GA-U37HZN67R? :>97OXZ"FYXK5+3U1-N[
M"&MR&A:#\XIBU,:2X];[K!A/91D#W*BW-IB/'E$<8WC>JM"$NN52?>>\>:OQ
M+8^SXW3%K<I68+=551FDJMT;UT])ZH_"5D=49/7L]OP<FXMGDXN5NLN6E5Z:
M+XBQ;;HB;9;8=I9;+D,LMGQD1$9J6@C54Z%7:/F;DW;SRY;C<E_Q,WPXGV$6
MU8]FS!X[I.*3:[W0^@A!)224[MM!@WISG-SN>^<E:N2N6U.:I+N]1JFGA*M=
MO=06%.I4G5T[#1<3QD2$GPFJJ3/O2?OBIZPS<.VE.61<UA#6GI["(7;D+W*X
MUM'MORT-0+UIUU*GA]OO!VW',](US6W'#]'1Z&F.9FEM;B&DFKA["'M+\*_6
MV?D[]':+\O\ @Y5YHO1:4IVGSO\ QJ]%V/NE]36L?_BVTHR2[W+N1=NZBM9[
MQ/NT_";#?%N65HDE.E1U&CF\1.<226VYNJ/5W7/5JLY:VO"@I6Y:2IKW]QY[
M\E?+&>'CV^H=_M<V7/6"EV<'P:/-N$8?=\[OD3';"V](]+?24MWA6LF$&X@G
M%K=X5[TKKM&D6<?[?3$QK?\ Q,F=Z]4]38'2^!//SI1C>A%\D=-='3N+F^+Z
M 6W&\7<QAZ+;KI#EML<STV)&D<!\"#D(H^PJM3J6X=Y=+X,=@P8NXVLM:U3H
M_DHSY^==;U+K[=KF;OZ5_%<GR6I)2BEKV.JX,Z,U0\N_075*//8E8Q"L[T]!
M<N9$9CMFTY1?,43;44J54LS'8VV>8W56'1X>3)6X<$ZO\IY[ZW_#KY4=;XKC
MEX%F&1+BX1A%]O=%=Y;^U(\D2WG%F2M.L^6R\E*EPX#['V=%J2@UG'4FAGPE
MO':W3OGWEX]IV=UL*]/MFOHJ>3>KO^G[TCGRG/I[*EC53HG5TT?^KZBW+J;Y
M9?53ILEZY*Q9>1VZ(;BE/0C4M:V4<PR6EMN/XC-+=?9':>T^<71^Z6? O5LY
MCX-OM^,\A=<_@>\T^FX36Q8_V_'3U<*ITUU55ZBV7=L8N]LU6N-OR6U2+->+
M(9(=@2VUMK:49J2=6G$I,JFGN[!O^S[ABY\5=G*-^P^#5'0\^]5],[YT!L,M
M@W^S.QGRXQDJ/1]YR]3SA&HJ=IE7MI4;,E92TX'4\;<-&R"HFIJWGVU%FY*5
MU4CP*YTN22M*B[@?$2%4*N[:*XVH7TE'WD4\JYU&7$J2LU,.H,B6E3:T&1D1
ME12#*M*;:#"RKM^U)095<L^'?3B]8M.ID!>1OEM]FX;JSIW$O#I-6.9"E6QI
MU2W$0S>=C+>)M"UFE!+2HRH1%O'CSSXV_DW:%ZU2-VXE7LX5/NI^!;J3(WCR
MT>%E-RMXTFU5U]YKO;[SH?\ 6/.A";J9HW;>JC%K:F9E6ET=1Y*B)'(Y4R&Z
MW*0AU?)C+><0R2R+:JA#B_*S?/L>XK;K\M+G#UZ'I#S"VJ639M;ECV^>[:;5
M/777X#"NT#UBR+076C M8\6ER+?<\4R&VF\J.ZZRLH_SG#*X(<Y;K)T)ME1&
M1F7JCOK.QK&?C7K-U+[/<BT_71T^4ZGP)2P=S5EZW[<DXZTI75GZ9^(9?9>M
M_I%P_63%Y\:YHO6*P)L-B.;+SD2?#@-IN:5N-+DK)QR22CH9UVCY8?BY\E[?
MF!T3N&T>'S;KAJ4[+IKHI2TT;[?D/;?DMUQ]Q;[C[BI_\'?<835=%P7>>!&E
MS;5,0^7&Q<K/-VTXD.%Z+([?>J*O*]0?!F/WIL&7*WS2L[[@9"[TTH3^!ZJ)
M]%)2PMPP_NR%)861;JWQ7M1KZ>\N[Z*9CD.IV M7*%>THGLMQF%,T(W(I,(;
M09*\:E'S"(]X^]OX<_-#!\S_ "MP=PC)/=[%M0N:U=5&*5=6SYU>9W2F1TMU
M=>QHQ:V^4FX]VK;.YCLV8'Z0E%X(VWB82E*D$9$@O#(3M^W34AWO95F":G^T
MEQ-%CK+7W*:&/KYGW2%E>GFH4KJ3P.W/7?$+YR_II:+?&6I5M<;2_1_@C1ZN
M$M7B,ZCQI^(_R?>^VI;]M$/UVK=%P:J^Q'O'\*7GC8Z;4>D-[GRVIM*+D]'5
MQ[WH6MH%PB7)E,R%(2XRX6UM5$/-.$1<;:VE'S$FA1TVD/GWG8&7B2EAY<'&
M];;3K7O/J!A;IM>58A=PYQE&:3TIVF],S,Z&1^U[/<./A*4%KP.2E9C-5:*)
M"VF6ENONH9:0E2EJ6M*3(B3Q;",RJ="&7:M7K]/"3<JZ>LQ;V3C8RY;S2MTU
M]"[2O1W%_P!.VJUCQ5XG(N#QBF?.=P6A:6I;J$I]'01*2I"JN*IVCWA^%S\+
M_4W6N<^KMXQY0V?'E"=7%T='&2I6)\U_QE_C)Z2\I(8W1W3^3"]N>;/D7+)-
MJKDI)TGI\*.E]=\5^@VJ6684B+R(5M4UZ&CAX:H(W.!9%PH]\2"/</M9TU9L
MVMHL6K/[*U!07_=2C^0\^0WI;IM&)NMM?KLN*E/T\RK^4R/O)[S._P"8=.EV
MQ.+=S:E8N]'1&;/QFREXXRE;#6HR)22IN(="^;.$[&]PR+:IXB;?IHSJ[S"P
MU9RH7;*HY(NX.6C,UHE\-YX7'28*.K@+Y+E_=?AF.K'6-U+L9HC<905.*(<L
MF:<$CEWRBG#8Y?@+P$CAYGK\5!=45&J7 -IM-E3EFS1:Y:DWHDDZ3')+@+Y/
M@IS/7XQ*T5.PI?*]4BE^S9LM$M#=[X3<-@V5<LCY9(IS?7XR!I5JAH2Y9<R6
MJ03=ZX6W"8Y7@]Z:.$G3[_$=1%'\(K%ZHK<LN8FQ,0B]T4X;/HW@+Y/@IS#,
M^WB"FM>T&DY9<TX7THO7OS8Y9\!>'AIS"]7BH(UKZ!H^*X'2^>:SZ,:>WJ18
M=4L\Q6UY"LF%LL7:T6J5)91P\1GS)2%.*)PDGW4%V,7)>SJR5%T]!SO$KU$U
M"L99%IAE-NFXQ,-HK?(M<2-&BD;1I-\D-QB2UMKO%$HN,M>(:IV<3F#MES)P
MY1)O7 A:6?1T\!?)F@OE-O;QB52FOO%.B*'+)FAMRDIO=%+-GT<^ JM\%.,_
M5XJ"A5*GR\>TU';/F:S>,KT1<1-$UX"\/"1<?K\0FFGI*:Z\"ARR9DHI9(O-
M#<-GD'P?<^&G,IW\0$Z-=Q#MGS4U.\N\4(^5RSX2\/#3F>OQ4$4?:3[-#4>L
M^9J3*Y5Y)"G.1R#X"/E\-.;Z_$)*4E77@4.63,R0]RKW12^3PGP$=.&G,]N@
MFK)JJ\-"M5GS13DDTWHDI63/(+@+P&DB)SU^,4\M>T52["'K-FBD2";OE%K-
MHFCY?O233C]?B$I->H:/BM0JR9DHG4IOE$K)O@^3]Z:2HNM>\PU3(JGJ'+)F
M1LR$(O7B4;7)5P;4$FG&?J\04UJ35,H<L>:>)*+WX5<LB\!>"E./UZBB:FU2
M)/LU3[$6R^NO7>\69F1H_9[[Z:[<D(1>'(Y\"XI))VJ5+:=)7CH9&1D/2'D=
MT,KEQ]3;I"MJ#K;KP?#O1Y8_$1YAQACQZ0V6=,JZJ7:/5<='1EMG3? KKJ3F
M5CP>P1W'WKA+;]*<02U$TCG-F^M:R0NG$2S/:/1?4.^X>P[9=W?,DE"W!T6F
MKHZ4/)_2W3&Z=1;C#8<&KN7;BJ]=%S+FKZ_29#.F>D=WTRPVVXAC\YJ+'BQV
M%.NH90E:GE--\XE&2$&=%I,MH\!]3[_E=2[S?W+)D^>4GRJO95T/IQTET]M_
M273&-LV#%*Y;BN=T56Z*O9WU.?G9,T2T^VF]$2EFCE*X"V<-.+VR(:_9C.+<
MY^\<_>Y:)6N/::OS/FAJ<4=Y[&R;+@+92G%Z]17JY>@A4H2[9\S4B1PWJBUF
MWRCX/>$1%Q>O6@E+3457<4KLV;*4HRO=/></@+L]][9B%7AV$J@<LV:4D<%Y
M\;G+Y9\!>"GOO;!52(]ENM 5FS1-2*];3X:'P$9%]L1B6JC2A6Y:,TYCIMWH
MB2LD<)<LO":=Y^R(IKIP":IJM2%6?-%)<25ZX3,T<!\!'3=Q5]<*:JA-5W%2
MK-F7$Z2+V1(42. N66PR]]7UQ+[B-"@[-F1MN)3>C)2C1PJ-!>$B/Q%3MJ(:
M8T"K+F/%4KT?#0MG+*M:;?JB54513\RYJ?._UW3BX>6? 6RF_P!L0T^'83H%
M6;-5>+Y[H>S]S[C+U.T5,A<J?!T*U6;,EJ<XKWX3)/!X"V'3:?J[A11DIHH^
M9,SY9_Z[^4KL/@V$6[<*M:D:#YFS6O%\]%MI3P;ME#]L*:4)]DJ.RYERUDF]
M&2E4X3-!;*'M]L0ZU"H1\RYIQDKYZV%_<%MJ5 :TT(JN!2NR9F1*45[VG2O@
M+L,1+FYM.!3"D:MGB?KOT^OEXT;>OD^3Z6]CYI4A9(\3?,-XSVDDSH?L#N?R
M-W66'U1]EN.D;_!>JATA^(;9[6Y]&RS+4?UEA<:=]2S[IGD:\6S[$;^TX:%1
MI[$=2R,TGQ.R&&B,S(T[C+O[!ZUZ@Q%F[)E84E65RVVO@BSP[TEE2P^HL+<D
MZ0L74G\,D9(MHB95<K%9KE&OI4E6^&]QD@C)1.QVUD6\]W$/G'F8E^QG7;5S
M3DNRK^D_R'U0Q,_%R\&QE65[$K4?_*ORGV/F7,JI(KWX2(Z^ MITW^V*N:,D
MG#W:%2XMR[1\R9ERD)^>Z+(SJKEE2A[=U!"K6I+:[BL[/F7&T17NJ$I42O 6
MTS+VMY!3N":[M31^9<V.I*OA5(SH9-EV^QV"4J"J[BH['FADT9WW:7%S/DR\
M6SP^M012A-5W$ILN8G0E7H_"2MO!3:>X336I%5W$?,N:$TV1WNJTFOB/@]\1
MGX?5*@:IBJX,J39\S2MM1WJNQ7,+@+:=/#ZU!&JX!T>A";-F9(;([U51&OB/
M@(M^X'Q%405ES/B:5\\[4$OC\!>,S][ZU#$NO$GV2D[-FRD)3\]4/Q\1\!;=
M_#V;!"JM7Q&G#L*F;-F:"C<5Z]YS.:7!7BXBHDZ^H)2?>4OT$HL^:(61G>N(
MO'Q%R]^P^&AAJ3IP(19LT,F25>J<!N<?@]\2C\/M$(II3L%5QH5MV;,B4A*[
MWQ(22Z_)TXC47A]H3V4%52K6IIMV3,T-,).]FI23<YI\&U1*,^$O8(*:^@51
MJM6;,$&R2KS5""<XRX/?&9>$Z]E##6M.P+E[BA%GS3A:)=ZJ:3=XCX"VDJO#
M[0AU?$.G%$%9,RXHIG?/N?,YU$>_XJ\'P1-&%0J39,R,VC7?/N9.$9$V7B,Z
MDCV@UX,A46I#=FS0FHY+O=7$&[S5<LJKXJFCUN$0T552*D6;,DFR9WHCH3G-
M\!>+B+P?!$T["%Z2EJRYDA+!'>ZJ2;O,/@]\2J\'K<(GT]H=.X(LN9DN.:KU
M4FTN\WP%1PU5Y?K<(I5=:\2-*<"E-ES3EL$=Z\:3>YI\!>,E5X/6X0H^PFJK
MP*F;-F22B$N\$? 3Q2/ 7RAJKP&?=PB=?A'LE+-ES1LV25>^,BYW-\!;>(SY
M>^OO=@C6M1[+T? EJRYH2(R5WLB)LW>=\F57"5[SX(FE7J*KN*VK+F*#9)=Z
M)2&TO<Q/ 7C-9>#;V<)AJ]&%1&FU9,S2B*2[Y523>](/@^Z$LSY?K<)"> T*
MV;+F+:XQ.WOC:03W.^3+Q&LC)L_^2(57H4Z*K9#5ES1!1R7?.,VU/&X? 7C)
M5>7ZW"1B*.M:E552A*;+F)'!-5[XB;YWI1<%.9Q5Y7P*B:/M%4$V7,JL&N]U
MY?.XRX"+BXJ\OX(:T(5.XH;L^9D43CO7&XT;Q2?DR(EDLSY7J>$@J32)J-6;
M,VUQC7>B622>](\!>/CKR_6X*@TV-*:<3319<T2F+6]<2F^?SCX/NO'Q<O?N
MX-@:C0EFS9D@X2E7KB-HI'I)&C[H:Z\KMIX#!IT]8K$ANS9J28A*O7B0;_I!
M\!?*DNO++U.'8(7,'2IJ,VG,T>ADJ\52V4@I!<!?*\9'RCKV< 4?%DU1I-6;
M-D*C<5YXFT<\WDF@O'QUY?JEP5$Z_ 1[)J-6;,Z1.;>R/E$^3_R9%S>.O*];
M@J% Z=@9LN9(.,3E[XT-^D<WY,BXS7Q$UZQ)$T5-.(JN'84LV7,T-Q$N7OC4
MDY'I)\NG'Q&?*];@(1K2@]GL1+-ES!M<;G7HW&VR?YOR?O\ CKRO@; 56R*K
MBRAJRYHDHO%>JJ;-_G*X"^4)1GRJ]W!L$ZBBX%;-FS,E0C<O-2:Y_I)<!?*\
M1'RO6X##7O)?*]4M2ENRYJ2XQKO?$EOG\TN B)?$9\OUN&HA5[12)4W9<S),
M+CO=5M\_TE7 7CXC/E>IX2,2M![)4Q9LR;7$)=Z)2&RD>DGP%\KQD?*[Z<!T
M!JI"IW%#=ES-*8G%>JK;-_GGP?=277E>MP"-:^@G3L*F;-F39PE+O7'RRD>D
MIX/NAJKRJ_W@4J-%V%*+1F_#%2N\D9(-_GGP)JOC,^77NX:A0:5)9L^9I*$E
MR]$:6_2/2O 7RO&1\KOIPF&O%<1[+*&;+FB#C<5YXDIY_/(T%X^.O+]4N$2B
M'0J:LN9GZ$3MZJ37I'I'@+Y0EUY6[[2HA*C*G1E35ES!*HI.7GC0US^=X"+C
MXJ\NO][L!U[.)&CXD-V7,THAI5>ZF@W_ $H^#[H2J\KUN$J"7J0DD5,63+VU
MP^9>N8AHG^?X"^4-1'RO6X##7L9.C*&[+FA%&-=[JILW^;X"^4)5>5ZW#L$:
MD/EXDM67,R5!-R]<1-$_Z4G@+Y4U&9M'ZG )527R]P:LN9$<<W+UQ\OG\SP$
M7'Q5Y7K< C4-1JRE%FS,D0^*]<3K9O>DJY9%QDLSY?J>$C#5(>S7TE;5DS%"
MXO'>^)M"7^>7![\UE\GZI<!A3XPZ4HBEFRYHVB)Q7OB6DY'I)\OWY+,^5OW<
M)"53M&B6A+5DS)M<51WOB)LG^<7!L<-=>7ZW =!#[AIQ9"+1F](J5WHO!S^<
M?+*JN.O+,_[VH4%53TDLV;,D%#)=YX^ G_2?!3FFNO+];@#7X"*+6I0S9<T0
MICCO/$E//YI&@O'Q5Y?K<(:U*O9IZ246;-*P^.\D:6N?SRX"+F<=>54^S@J%
M"&T_62Q9<S0E@G;UQDGG<PC1[[BKR]NVG"#3="-%V'V;%;,ABG&.YW+TG@-W
MG%PTXR5]S+_DD0GM&G8<Q $'O+;W[.__ , =@*#21U)15(]Y#&B[EJ?,)*,E
M1GR[O:[;<[9,M5S@L7"USX[T6=#DMMO,OL26U-.H6VZE2#(T*/L%Z_;M9EIV
MLF*E;DJ--)KY2[BSNXMZ-[%FX7H.J:='5<-48X76YY.-^+(KIK!TD2B@W"XR
M)%PN&"M&EAHUD;TMU4=Q,<B43SJB(D[ZD/,OF'Y(PW!W,O:X*]8G5NS1:<>#
MIZ3VAY,_B8EL$K>T]9UN8\:)76WIP2JJ]E"SG>T=0NE]R?L6H^E60-2H"UL/
MR&;=<I#:E,J-M2B<;BDA5>4H]ACR-U'Y-7MJDYW[=RU&K]E1D^_M2/<^Q>>?
M3.]7+<,/,M_8YKBY17+\',?%8U(U#O+IQ,<TQR:3+6KEMM_,]V21K5X2V^C'
M0B6HAK^#Y4SS[ZLPG<HWP\.7S\IL>[>;NP[9:E<G=LRQTO?4X_,I>@]>: >6
MAU6=5]YMEPU(BR].=,W9++DR3)YC;SD8EM.J:3&=C\Q1K9<41[-@] ]#^1>Z
M6KD5C8WA6:JMV7=I71KN/+?F+^*+IS!C<>V7WEY7*^6"T2>O:I=YE1],_3+I
METKZ<6O =.+3%83'8:1=;N3#)3+G*0VEMR0Z\EIMPR4:"/A,SVCVATQTKM?2
MF L/#@E<HN:7;)KM_P!!\\^K^LMVZYWB>][K<E/FD^5-NB5=%K\YZ*)@C63A
MNF1'M+94J[QSEN=VY<K)?JT:E)*4_$7!&[<89D-&U(;:D-J(R4AYM+C:BW&2
MFUD:3]DAE:K0I;3=5P*(T&#"2:8<.+$29U-,6.U'29]YDTA!&(J#="$J:( 2
M#:R8,*:DDS(<66E/O4R8[3Z4^L3J%D0 U&(T>*V349AF.T6YMAI#+9>LAM*4
MD -124J*BB)1&1D9&52,C*AD9'L,C( ?,.PV-1FH[-:C-1U49VZ&9F9[S,S9
MJ9F%01\P6+\RVG_V;#_$@#>18,&"2DPH<6(E7ODQ8[,<E?WQ-(01@#=
M
M           #H77OIIT@ZE\<8Q36#&DY-8X[BG&HBG29X5J(R,^(VW.PQ:N6
MH7&G):HN6[L[=>7M/("/*#Z#"23:=(F3)!4IZ?79V5K&[*#)AD3@O#C+0MR:
MG+GE1LU?ZH7H.W'H_'IW>FE_HH+(N0>DG4ET:I14/K8[Y4'1!BN16C*;)I.S
M$O5CDMR[=**8E7)?:=0\A=/1B,Z.-D>_L&0L_*BJ*3H679M-U:52XQ'8;BQV
M(K*>%F,RTPTG[5IE"6VT^PA)#$;JZEQ*BH:P@D
M                                 IK4U%3=3ZI"&DU1A/4@R*I>%-#K
M787L?5$.48>L:OU$>!)EN+AW%W5$N'/+G>I":BN5:%="VGW[Q))(
M                                                 "DTU/;0R]4M
MOMAI\(UJ214W4]@1K77@"1(                                 #9I>
M);W+:5L+?VT[>W?44RMR4E*/#M',HMVY:2["P#YIO5'K+>=3\6Z0] YLJ#D>
M5K;C7R1 4XF4:)!NMI,G([Q/-DV3A'L3V#B\=7]UW:>%;?\ PMOWCG(7,':]
MK^TY'_V%S]G7Z"V5U(]#'4;TOX-9,^S35[([@O()D**];RN]S2J+-N#B$K0:
MB=;,U-..[2KL&9?OV<:_;P+2]NXZ1^#B8^/<\3&N9N6Z\B]KX>!W#_55]64W
M2]K4S'-8LANS\BQIOT6P'=KDVN1%5"]-4VE?$9FHF_"5#J9BYEJ]AIJ4:N/'
MU&/@W87TU<?O/V3MGR9=(/G;6++-0,JSZYJSS!G9EMN6&7.9+>=-U:FH:W"3
M+=4I7"I*CV$.1MSLW<"-VUK7B^XP,J%ZSG2M7./<9023JI14H94J??6M/:(8
MK^0J7RE52K2NWN^J%'2O8*KAVGP+WE6.8VN(B_WJVV?TY?+BJN,R/#;=74BX
M4N2'&T&=3[Q0YQ3H^++D83DFXK1'2?4/T\:;=5& /8+G:473'92DN&<*2VXE
M7A5PJ)QKF),C)>RG8,7+PK>8DKG8S,P=QO;?*4K?YRU/ #?DH=("$DA-BE^'
ML])__I#,L*6/:5J/N(QKN0LBZ[DO>947DH](I?\ 04O\I_\ Z(B*Y9\ZXEQY
M4G%1:T1NT^2[TDI(TE89!(I2B7B2>ZFTR9(Q9Q[*Q\F65#]K/B5W,ZY<MJVZ
M<J-FYY)W2$X@T+L,LTF=5?QD]M#KVLBYROFYJZEJW?\ "C*,%[,N)<;T T%P
MCIST]MNFV Q5Q,>M?%Z,RXOC47&2"557"G[0A?N7)7)\\O>,6,5%<JX'=XME
M0                %L_S*.AW(.N#3_'L+LF:O8@W:)C\B9P<Q34Y+J%)0AU
MLD.(62.+M(Q5"<K<U-$-*<7!\&6D8/D/:VV>"BWV3J2O5DMD9A7*M]M=G0XY
MJ2V=4FS$0TV?,-)%N&5]I4G6<2(V^1<L9%I5SI2R]_K->Z4/T@2T9HB:F.>=
M%)>^<#7SB1Q\TC])K49\;EOP6UP:+3C%W%7WN\RDKST;9S@GEKYUTY3LHG:@
M96G&YTEF\2UOORI"FHC<@VZOI<>,T$RHB*G:.)BX6[E8<*F512=):EK;R1>K
MO3C0:-J9T_ZU7EO!\@@7Z05H^>2.&W(.-*Y#J#.6XQP$JAF1\.V@OWX.=)QU
M+<(I1Y>U'P_.QZI].^I6_P"D>@>C%Q3F]X9R&,=T>M!',;0J;+2QRTG$7(XD
M((R,S-/:)L1Y(\SXEJ]%37A]K+T-KZ9KN7ENM:#.PN7=U::*4</<LY!VSTY+
M9I)JO--5"IPUJ,=S_6\Z+WH7<61_):ZG,!Z6M1=8]"=:9ZL,N5POLQ%M?NY*
MALH5#FDVA*O2UQR)#O+/:21>NPO7:7.,2S:2A['YQV%YW76+IGK3C^GV@^C.
M0LYK?KQ>V6[LFRD<U,=4F0<=A!'%<>-=%*(S/AV5%5BW.#K+1%<Y+EY%[S+O
MW21T]7K&O+SL6CU_:<@WRYX)<G'FU-F3J9%QM"%QFU(-M"N)1DDJ&FI5%B<F
MKW-VE4%RJB+ GE?:[X_T2]7^K>D6MDMW#[9D=\NJ8]RN;3T:,APK@KT2JI!Q
MD&AY3>\B.A#.R(^+:4DZR+<(QC-]Y[8\Z+KCT<S'0F'H[I?EL+,,IS2<RPJ/
M95%-.*VYQM1S,HSJU*6ZMRE.$Z;!C8T%S-R["JY)*%.UGO\ \GW1&YZ.]'^$
M*OL=^%>\FC_.DN%(96RZRTXVPIA2DN-M+(UE4]I"S=ES395%.,5'L+JPL2CS
M$G3>L!TMUL_GS'\*D9%FJ>A#]/ [:B$2H<6M?\F8[3+]R1W&++)-=*"29G4Z
M'2A5/9W[SVU$)4!49$94/<8D%"&R0DTU,R]7W1->XA*A7PEM]7U3[/9"K%"=
MP@D@R(]_US_8$UH*%*D)45#K0O5/Z]1';44*B*A$1;B  R(]_P!<_P!@36@H
M#(C*A[A'  B(MWUS_9$UJ 95V&( IM(_;]79L]H372A%-:D&DCK4M^_:?NA5
MBB*4-D@J$9F1;JF?JU[=N\&PE0._<G?WM?\ @F(I30DPH/,B))]7^I*E)2:C
MNMIVFE)_\[>]0<CCRY;-%Z2W>D^:AE+^7\E*.D[29*2H167<7]\0X^3K)EZ7
M$]F""D@RKL, #22M_P!<R^L8>@%%:*).XNSMK3:8L*<W?Y?S2:*GI,1?SR\W
MD7OJ$Q;#.=S(^/QD*4T2^+DG+8DJVIXSX357N(9N/*4(3N6_?35/RF+FW+EG
MP_#XR>I:<L[!L6MJNY1;^W90QZ=\OL"%GI^UE4_XB_[_ ,%*'>W1N%9V[9WN
M,5_Q,TOR'TY"DEC]ZE)V+8-BAUIO/L.O:-GZHWF73_2.?DVW1RMM)^N+3/GY
M_P!2[=[D?+#!VV_/EGD756*=&Z2E30]9=#V!PKW=TWNX1"5RW5N.FI)*XR2M
MI;)F9H/<6W>/SJ_B]ZVOX&9+;;%QO'NSDZ5[6Y5[>\[J_P"ESY68>U]"1ZQR
MK"COD^UKWH>QRUT[O279%)3Q&1'1"2)""+<24$24T+<5$D/G@KDKV:[]M).7
M$^Q,'&W%79)<Z[.PC8>PBH?]GN"YD^$Y>TDIEFW.LY3Y4X2] /PE2GL_V&+#
M:E%QDZP[B[.YS0\-)*)MYT&+=K9/M<M!.QI49[C;41&1K)I?+,JD=**,,>[<
MPKT+N-)QI-/XFC'5JEJ5J'YT7\Q[T\M7)#7@V3X XVTAS$IE65T2;RFI2DTX
MEUYADFI;#H/N'^$;J#$WOR[MQLV[<;]I14I1BDY:+BUK\9X(\X<"_A]2R\:4
MI0;>C;HM67+2B)41\RIJ7[\R.AG0]FTMP]47HRNIV9_LWP.HY1@Y51N4-)21
M%M.A4VF?NB+>/&U).+>A+E54[#25%2I9.&I7$7JG]:HKG9A.XKC6J*$N7AQ/
MF2HR91R84LT/PYK#T5^*XE*D+:?0II:5$HC29<"CV'O%<K[L.-R"]M-4H)6+
M5VQ.SD).-Q-4?:J:_&C#]\U#H_D:!ZQR]0,8M2V<'S>0Y,-QADRCL25NR77$
M&3<=#:#-1]^\AVC/I7!\R>B[V+A)+J3%@W7M=$WIHVSY#?B<\N<WRO\ ,*/5
MF#;<>D=PG6[1>S&7-HG1)*OY"U.U+N=IN=MR&PRW[;D-DDLSK;-C.N,NH6PZ
MF023-I2%*XUMEO,>0K$=RVK<;NW9L90N6YN+BTUP=/R'5\]SR7D8W4?2]UVM
MVQVI6Y1=$UQ::6C^$R\_*X\P2S=36 1M-\[FQX.JV)PF;?)C3GV^.]Q8\9EH
MG4(>D+<<62:5*GB(QV3L>[PR8_9+[_7QX-]O_8?4/R"\Y,/S(Z>AA[C.-OJ?
M&BHW;;:JZ))22;JZ\3T=U&>7=TR=3CTR[YI@D&#EJT\+=^MC;$%XG")PB==:
M89)#YFIPU&9[3/:-EC<E&3A'@OE/1;<O#2N)<I;CN7D!Z22[XW<XFI5UAQ&G
M#-$ K>TM)-\1F3?'P[:)V"[XUSX2A1M=L3V3H#Y2?2KHG<HV1R,69S#*H;K#
MT6Z74D.,-.,J;<X_0E-&VI1N-$>VI;Q$KDWQ>A'L)^PJ%SV(Q"@,M0X,6/"B
M,))MF/%9;CQV4)21)0TRRA#;:$D5"(B(B%/*Z5*.>->4W9&1[2%+6NO$K) %
M))(CJ6_US$U;T(22=>TI<KP*H?BIL%//&#K+@&G)46A\]B3(4:TK3M3MJ?A2
M22K4S5N*A"J4H2BY6M:%3MNU'VI<TF>7NHCJUT9Z<+'.NV<Y/!?NC3250[!&
MD,/RWWUDLV6S;;?):.);=-I5]0<_TWTKO'4.3&SC6Y5E^=1T5..M#J_S(\W^
MAO*_9KFY]2Y=N#A2D%).<I2TBN6M=7H8TW6)YFNI.N<+)+? 8/'M.XZUIMMM
M(S-4XGB>90ZXKGG51(41E6I[!7^(#R/5GRCR,G+E7(YH-KU-ON/)OE7^-++Z
MW\XY;;MEM6.E+4+E)-ZRTT;3EH6@[:T^^N9?;@ZN5<KNZIQQY]2G5-IXS4@D
M&X:C07"?88\N;-8M8&TV,6Q%05N*5$DN"2[*=QY[\UNJLOJOK_<<S.N/*Q'<
M?(Y:J.LN%6U\1]0E<.Y/B.NTSJ,Z:=S)65-UDNSL-"E>Y]O>W/\ 8@]I&9[R
M[?[0JF_$3AP@RQCREC05J#;AZ2HCH1JV<.TE)/:2B,J&1D>P]@B[SW%&#D^6
M):5JS"3A<5>9_%VG8/3OG=TTEU^PBYPI"UV:[7>*X[:C4KD-\B9&4KA(UH;3
MQ\/8.N?,K:MMQ=GAUDK"EF;9[<FM')*LN*U[.\]T_@P\Q]SVWKM>76YY4[FR
M;G2-B#;:M4Y4^+IKZC-6Q'K,T[NEMM#-X;<M;RX$ G24HE))2X[-3+QE0JF9
MEZ@X7HW\:'EUO^V*]G_\,H-6Y<TEQBU%\77C4^K&^>1/4V+E);5_Q5MKG32:
MT>J[*<*'?]CU6T[R(F_FW)H9\TDFVAQ]ILRXJ'3:YZH]#;#YP^6N^6K=K:-R
MQ[GB+2//%/Y_3WG5^[]'=48$G]X8=RVX<9)-\/4CLA$F ^REV/+CR$*(J+;D
M-K(]U*<"S[#'8&)E[?E)2Q[MN<'PI*+^9LU^XLC'A2<)I=M8M?.:Y+CI;)9\
M5=_AXCW'789;!DRMQ@Z\4_A+-NXIZ?G=QU'J_HGIIKWBLW$M1,:@WF#*9>;;
MD/1V"EQG7&5M(=:DK:6ZGE\=:5H.5VS>-QV3(65@W'&::TKH_6C/P=QS-NOJ
M=IN+7'N,77K2\L'4GITEW/,M+XDK--.%NNR'68[+BY%I9<-]\V388BJ6OE-D
M1=VP>A>E?,3;]ZA''W22LYBTKV/T\3MG:.K<#+QU#*?+DEL2PZE9;H[=X^5X
M3=+GC^8Q7Z18K;DR*KTA#A$M+L5+C'$2'&_LB[!V%=P\3=+?V?*C&YA26KT>
MGK-MCMUO=L>5N=/#I^0Y'GFJ>J.MUX^EVLN573)+]);:)N*J9+9A1$-H-*/X
MIZ0N.HS0HZ[-HQ,39=JVE.UM5N,+/J5?CH<3M^W8FW7.2U!+5Z_"<0)MMLN4
M3;7 GWI*;0OZID>Z@SDF_:?$Y:[-J5(^Z:*XC+Q&ITG$N)H:78[JXSK:OL5(
M<:-*R-)[=A]@7(0N+EDDUZ3'BDG5I.I<MZ ?,,U"Z8\SLF :C7N9D^CF0368
M"7)\AY]W'GI+D>'&<)^5*XU$DU'Z@ZPZWZ"PMSQ)YVWQY<]*K2_.2K7@C5^H
M.G<3.LSR<=*.7'73XS+OLEU@9/:;7?;),:FV:ZPXMPA/L.H<0XS*:0^WPK;4
MM->!95*NP><'8NXKE9G57(NE'\IU#/QK&1*,E1\'\QX9Z\] V]0L(7G%BADK
M)L7;6\ODM_+2H_ ZI7$:&E+5RR/O'<ODWU;/9M[CMF1<I@9#2=7HG\9T#Y[]
M$1W_ *;GNN);KN&-%O3BU1UX*NA9&L5^NV-7JUY':G'H=VLD]LU*0IQMPBC2
M4>D(425(5MY1EM'KW=<'%W+$N;;D)3LWX>OBM/G/$'36=F[5D0W>PW:>-<U7
M!NDE7N[C)(Z>]68&L>FEBR6%);^<$166+DP2TJ<;?:9;2M3B26M1<PSK4^T>
M".LNE,CH_?[VW7D_ <FXOO3>E/4?2+H#K/ ZWZ?L[KA23DHI3CVII*M=7Q.Z
MB<?2:#)?$CQ$HJ>KL.O:-9AR3T7O&YW7)7%.'[ UC-\R2@U5-=:**G9[@M3;
MBJKBBY-PD^6*]AH\U=7.17'$NF_5:\Q''#EP<<N*6E-&HEFEZ(ZA1$:3)6TE
M'VC'W"YR8LKBT?+J<)U!=E@[%DY$GPLS:]'LLP&H$SYT5=+PM"D/7&^7I;Y+
MKQK5\XOJ,U&?B/:H=29U^WDY#C=XQX'QJZESK]_J/,W2XG-7;TE\4FCZ)'2A
M>T,*K.$<8R?-0IJ9&9%V^X(DN9:F1:NRM>U&A.VI]IEO]6NT9,?:M_K$1&:5
M[FEK7L/CWR>BS0HUW6DU.0[Q9G&%$JBFU%/942DF1D:?$FNR@S-NNUN^%%Z=
MQ>Z8E#;>K;.Y6&XY$;L:-/ODC/7Z%LDF99TL:27R<\;\F7C4,E.*<-PS2TRV
MV@C4:EGX4I+M'9VV2YL.#/L_TO?NY.P8M^\ZW)68-_HH];+3Q%2M#[_9]<AG
MOA0Y\FA4IV>N?U]X"A(  !O  BH (,J[# $@""(BW?7,2W4"A%W^V?NA4BB)
M$$D<);]OMF?[(FK(HD*%M]7?M,14D$5-A "E:"65#J7JD=!*="&J@FTD1$1'
M0N\S]?O"K%$5$1%N^N?[(5J22(!!E79_:^L#50>;>KI)'T\:F)JM)?1V=M0M
M2%E_%W=RTF2B,50XHJCQ,.OH[CF75/IS_&[DHOI9<SX5W&4M!_ZX;I5"G#)1
M#-RI-V:=A8M5<T_69S< B]!A'V^AQBWG]Y1[HX]<"Z;LB(BH6[US/ZX)4 (B
M+=]<_P!D55J* RJ5*T]4%HP]50Z@USORL.TDSV_1W.4[$QZYN)6:J46<)\DT
M,U)I4_5'([3C1SMSL8]SW978U^-&N=7;E+9^E\W/BZ.SBW6OT)&"1EM_F9=F
M&07V859EUR&;Q$9U,R=N+J2*M3,]BQ]%=IQ8XNU6<./]WM6DE^B?FRZRWF]U
M/UME;AE:/)RFY+CQGP,Q#R_\5AZ=]'^-32:3%<78+A=Y)F1(H34 G^(ZI1]I
M4>$/,F\[W5N6^:L(R:^*I]]/P[[+B],>3^WVL=<MM8_B?^!/T&'5U29[)U,Z
MD-7<NN#RGC1>IL6*M2C41(8FRV$$E7$LC]@QYKN.5O<I95OWW+7XW7Y#YI^<
M_4+WKS0WO=,^?-&W+DMONK6*2^$Y;I1@6.Z@8;$PO,[+&NMEOC-RD3693;9K
M3'BMJ<-2'G&U*:,FS,]@\<>9W5G4.S^<5JYTI?G"_P"-:CRQ;H^:23T3H?HF
M_P"D_P"5/3F-^#W<NI.KL.W*=^W>GS7(JO+1.-&U7AKQ,>KJ7Q?&,3UJSRUZ
M7+Y&(6F9RX$5*N8VTM#KZ9*$J]Z=%(H/N/T-C[E#H?;\C*FWGRL0E<KQK*$7
MV^L^?'7\<;;^IMUO[3"*VZYE35NE*)*Y).E-#WGT+^45U3=>&%_I+P!A$'"&
MI#44[A)6B.V\XX39JY9O17$K4A"E*H2C]Z,;J'K2WL-V./D>U>DG\!;VGH5]
M28D-PL3Y'^<_K&2/T6?JRNF6 7^P9YU.926HS]LDLS486B.VS%;D,+C2&RD2
M2AH2XA+S:BIMJ0ZLW?S%W7-C/'L2Y;+_ *=YV/LOEOLFWRCDY$/$RUVUTKZJ
M&4YA&$8GISC=IPW"K%;L=QVQPV(-MMMLB,1&&H\=LFVR-$=MM*UDA)$:C*IC
MKB]<NWKOBW'5MM_"=AVX0MQ5N"2BD<J-LC3PF9^O4^_UQ#U5.PJI\96223N^
MN8IC%05$2"(B*A;A5Q -)'MV^V?NB:LBB*.61IH=3]6IEO[MNP0^%%P)C[+K
MVE*6$)*FTRW[3/9]41!<GN]I5<EXB]HL2>=C9)DG'M([^VMQN#:YUP;EJ22C
M;(UDZ:./9PE7C[1Y<_%%:ORZ7M.$7*U'FK\3_)0]A?@ZW"SC]97+%QJ-RYRT
M[^*+)YJ6XEA1TVL-4+U";2=1\S5%PL2<?V;;K\9]>E"%N*DJ^(HIKXBHC,B(
MS]S=ZXQZI.M:HBU<=Q<LU1@EU,RIL[/KBOFMNCIRE:A)2YJIQ[A0N)*J[*E0
MAD1@KMMPL?M2EN-WV'531RG2%RZ'KW@YXY)<8GLKD<_E&HE);4;?%4T&1I(T
MCO?R#>X6]]2M)QEV-?!4Z'\\L3#W78H[?NZC.Q!UBG3BJLN_1[;.R&^1+/;&
M'IUTFJ8:=X2<=4I:S0AQ2U$2S(DJ7VCV;8LY,]T<85G-M5KJ>9\S<L78MF>=
MFN,,6U#V5HN"T[NXNQZ$:,V[2^P1WGVVG+_<6&W)T@VT*6TM2$JY:5<!*(TT
MH=#'=.Q;!BX$5ERC_P 5*/SGACS$ZZS>L=UDU)K;[<GRJNE*OTG>90HZG>(U
MJ4HC,^&IEOKZHV65JLN>1USXJ=QR7O4-PB&RVLUD1U/L,]A>L0)*,'".B90H
M)3YU[Q*F3))F@SXBVIVTI7?V[19A:C9B^7MXEQSFTUWDJCLNIH^TVZ2BHI+J
M$N),CV4,ED9&1D+T7RI-.A3)\T>65*&'+YL>#(POK1N]U1;DP8N:169$%QF,
M4:*X;27E.DC@;;9-1&?94QZV\A-RM+%G:RY<[K1)OT>EGR _ZA.P3QM[Q-RL
MV^7&E;DVU&BX]Z5.TMV*7PJ/B2=*G]<^P=]79MSI&#2KZ3YH\B>D&4*=:70C
MK]49,;%_DYK6C+D;5ZR^9$DZ5"0BJFS/;L]O;Z@KCCW\>7/;_:,H=IUY[FDS
M5024K<X7";233BU$=*%PH-2JUV%L(49-UV[?C95OFN%#E/E3HW)R2^-T,@SR
M(L-4BRZM:A&R\U#N\N-%C/+;6EI]3!L<:FU*025D7+/<9CQCYW;HMRW^%J"Y
M5;5:?&?<S\"?3V=M'EK++RHR4,B34:IK@X]Z1?6U)T[L&K. 9AIYEUO8N]AR
MFS7&VR(4E*%MJ.5%>9:69+2XGB0MPE$9D=#(=/8F1<V_,ADV&U=C).OJ/<%V
M,+^.[=Q)R::H_4?E@]?_ $MY#T>=5&J>CE_@.P[,Q>9MQQV0IM:6)D&[S9\M
M@HSALLMK)IBGO*T'K#IO=[6\[7#+K6+C1KN:27SGF;JC:LO S,B^X^'CVY<:
MZRJWP,B7]61ZXF[9=LFZ.,YNBUP[D7I.G+4^9X$DPQ%^<(S")4JADZ;AEPI1
MM,=7>:'3UF[C_;[<:IIJ>G%.OH.P/+7J&W]FAB2?(F_U=7JVJ?"7T.J/3(\!
MU"?N<-HV[)D2U/LFE%&D*,W7'"J2$H(^)7>/SH?B_P#*3+Z(\R[V\[;;<-IW
M1N2DE[*IS-]B6I]3?);JVWO_ $N\3)E7<<9)>GL2[3ZW2=J8>%9U]'+@^;5F
MR%2&T<3E&VU$;*4&1&XE)5/U!L7X,?-M=$=8KI3<;W)M>5)12;TJ^5=K2XF)
MYV]$W]_Z<6Z8\.;+LIMM+6FK[NXNXFE2N6ME?%'6E*]AU\*RJDR.NZAU'V<Y
MN>[#)BZQDJKU-'A=Q<5X2X1>OKJ;.]6&SWRU3[1?8,:YVFX1W(TN%-8;DLNM
M/-J;<(T.I6FO"HZ'2I"[<QK679EC7HJ5N:::?<UJ7K63>P\F.=CR<+\&FFG1
MIK@68.H'R@\.R2\7#,-"LA^@DF8ZY*D6$FRD17Y#BG7E\DS84EI*GEELV4(>
M<>L_PZ=-[[.]D8<5#*FVTM-*U]'I/4WE]^*;JSINY8L[K-W\"TDGQK14]/H+
M8.O70GU/Z%XO-S2Z(;N>-6U1(E3&5-J-"5<? M;;;*33Q)17:9#S'UY^'Q=$
M[5/>,M<^)!ZM:]_<CV/Y9?BBM>8G4]KI[&?@W;J]E/T47;+TGB[&<4NF4WR$
MSF%V7\V.N>.$BJ.,TK29H-2?9(:IY/7^A,SS(VS8=\QT]EO7XQN-OMYHJ/RG
M8'XA[7F%LGE5N_472MY_?%C&E*-%V<DV_D/>.(6ZS80NR%CT)$!F%+A((FR2
M3BDN/,DM2W$I0I=2*NT?I>Z6Z7V'I;I6WL?3]F%K;GB1<:):\UM-<$J]A^0C
MK/J_J?K/J][_ -5W[E_.AG2YN9M\KC==:5;IVGG+K]M#476J-DL9*3CY);HA
MI=0@B0I341PE[4I(C,C/;M,=9=+PN6+-_#O/6%QZ?"?9;RIWBWU#Y>;?G66I
M>':BN_A&*])[Q\CK41=LSG4# 'GJ)NR&76&U+]]Z.B*LS0DUENIV$-&\W]LA
M>PK.:OS'])?Z^AXMBWD/62_TF3:ZV:&U&W7BV4V[MNVGKU'G3+\6-M7(NMU'
M5:=5R]AK-$HD%QG4QDVY.4%*7O-$2I6B*S(CW]GJF7UA<K0II4$5-A" "(B*
MA;@X@FG;W@  ,0KSB637U7RC])G-$<&!1+$V0RC9&?W(;622]H9F-HM"W=DZ
M)=Q>Q\I!!HZ1L22;C[M79/B?><>6949^S6HU#'O5=QU+B=81J71!:HJ4!2:=
MQ$9D1>O[HJKWD-%*6DI4I53\5-E3V4*FS;7:(55ZA1&H!)!E4RV["KL[_:$I
MT(:J"*FPA!((J;"  TDK?]<R^L'90$@#92GC9))(50S/=2O?VB'"Y+VT_97$
MA:M6X^^PV^I1+*M332BJ4^H*G3DYT]"5.+N<C5*<3I?7_5^V:.:<WK)Y\AI$
MXXKS-KC*6E+KDEQIQ*%((UH4? NA[!M/1G363U9O%G!L1?A.59OLI7X32^ON
MJ\;HWI_(W6])<\8M07:Y4=.WO,;C)<GO&6Y!=\KOSSLNZ7N:Z:>-2G%T>D.'
M&2@E*6K83A%L,>\]KVO&V?;[6SX:4<:U!>C@M:_$?-G=-US-ZS[_ %-FMRS;
MUS1<:)OV:+7O+R?0+T]%AN,'J1D\-)Y#D2$NV]+[5'84<TM&2TDXTE:3<(N\
M>5/.GK2&Z[E_#V%/_@K#I*CTDZO31GM3R*Z$M[3M4>ILZW_\EDQJJK6*HM>'
M:7(R802E*V^*FSB5LI[(Z+<55/M1Z%I[3EVLK-!&:3V^'<53^O433VN;M*NR
MA))(CK[1;=G?V]HJ;JBFFI4()-)9DC:HS]:I[?<H%M7'5,IDXK5E5"5MVT/U
M3(1[2EZ"6E):FDDR92KC,D-I\2EK5PI27>:E;* Y5E2*X!)Q6ILSO5FXN6=V
MMA+K3@]/BDNO=P\WBJ*^67<Q6+[4;DE*71;3B%L**J5-J)9&1]I*36I5]44\
MZC[ZU(49.6C]DH-PV4$2C,S4>S?4MM:"86YSE5-<I%Z<+?LI:F]2?$1'W@U1
MT*UP)$ @B).PJ^V9_7,P[* D    %"4$E2E$9^*FPSJ14[O7#7M%*%8 CA*E
M.P_5/W1-7Q(H;9QOPDDE'0SJ>T^RGJB8---$7:S:?<=3:[XL67Z59;831S>?
M:I+J4F7%XH[#KA'2BMI4',=)[A=VOJ?$R;,N6EU+XVC6^L=ML[MTSEX5]5A*
MS)_"DZ&,5+:<MLR3'VH?M=[<.AU)1%'N"J&>PC+8V/H=#ERK,9O6$[/SQ_TG
MS']O;LF]9MK];'(U]2G_ *#))Z7LG:SC1/#KDIXW'&X:([GBJHE,-MI(E>)1
M]H\$>8.U2VKJC+Q*4@YM_&V?1_RVW2&]='8F36LE!+XDCT4V2BJ1[BI3;78-
M+MQA"VHQ[#?JR<G7@:HK)  @B(BH6[US/ZX+0$@  (IO/O $)223.E=M-E3.
ME/7,PT!)E788 CA+;OVTKM/L]D.VO:.RA-"V^K2NT^S<)J"1 (H5*=GKG_X1
M-=:@&5=AB 2         "#(C^K]4 4);)!F9&=#W$9GL[^W;4-2*(K,B,J'N
M,"2A#?!0B49D5=A^K[/>)JJ<"$J,K,B,J;:>N?K[ZU$/4G@2 (,B/?\ 7/\
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M0
M                               !!E4J& --#24'4M_]GJBF45*7,$J&
MH1$6[M%;;?$4)$
M             (X2KQ4V]_U (IV@RJ+<K<9NKXE52E2$JV]O>+JDUIV%#BI<
M2L05
M   $))< 4DDDF9EV]G<*FZD)).I4()
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MVXN+U.U.(SH:2)23(C)1**AD95(R]031=Y3KW%0@D
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M&UW(^O?3^'+ V3'Q+FERW;BG\2H9#B2H1%6OJ_5&0W5U.52HB1!(
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M:5(\M?C+I2V^/M,C]D_J5&KQC36KJ;#72A*4$DZ[S%;G5\A0HI.O::@%0
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MYFX&24@       !B'^<.?_ZUTHO\Q@4_)GQF8_"I:N]A>P\I/_ND8A^^2?\
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M;ZG]0S+L'0-M4E+N/1U:HK%T
M
M                             &B](CQRXGWV6$][SJ&R]M:DD -%JXV]
M]7"Q.AO*^U:DLN*]I"S, ;E)K,U$I/"1'L.M:D *P
M
M
M
M
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MF;AU513E-W8,B5M0?M/0XYR;]S4]HBR5@
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M6?$7%MVC$G!P=&553X<#TPFM/%O[?["%J,JCUE0J
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MI*W5,R/U#.H\@UKJ>X:12]DU (
M
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M&'\D<)V\E 0EMJ6LE<9&;2$I2DR41;A<YW*"784OC4[F$
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M01;!H?F+U+D]3YT+]]MRN\7_ %6_2?&?JC;;?3_6>X=+=,^SLF#=UBN"3?\
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MR6FWV'6U)6AQIU!.-K2I)FE1*2HCJ1C#2IH737
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MB*?#-=5(Y2F2_O\ @K0J]E1ZG_Z7/6%R&[[OTED7*69\OAQ;_JUHJ_D/'O\
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M4+(Z[=Y*'S^N6I6K\X2XJ37Q,^E=F:N687(ZJ44_C1O!!<
M
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M/FTVMZ.9I6O:RMRF_:,62Y7ROBBKTH[F%)(
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M382R-*H[S\=MU;:B5M(TJ73:,>[6%WPEQJ(2YH<[1V")*@
M                           .F]8=MNMG\^8_A4B]:(9VW#_R.)_-F/X)
M(LRKV$FY                        !IO?<G?WM?\ @F ,*#S(?^]_J13?
M\[6O_P!<?'*8:4K6G!(7.*,ICH *G2?I,7_W%_\ &(<9+WGZRJ6K^ ]EB"D
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MM/N&7CJL6).B1>Q\I"G]$?$.$B(N;)V$5"W,>L,::<9M/B52X(NA"DI
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M:5(KJ2()
M
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M((C90TE*6R:,O#P)01()/#NIL%]0Y(\\N+,923FXKL-\)*@
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M#;X\_:?0FO+8M4QY*N%Q? E!]ID?A/UQC^;N\PV+R\S<V3I=:2BN^M>!Y?\
MQX=41V;R\AT]9E2>8J-=Z7-Z3B5HA?.%UM5L:+[M+96=/LC)YM2M@\%=-861
MU)U/A6-7*[>B_P#Q)^D^-N3&.+AVL;'5(IU^-ZF6MY:^)Q\.TORS.Y39,MQ+
M,VEA:TDGA6J S7A4:4[S3WCU[^)KJ:'2?02V]248XF"WZGX;]*[:'TQ_"%T+
M"["SN4(_K<N<%ZZ<M>SNJ=#93>G[]DF0WUU2G%3[@^VE1F9F9>E.H32IG78?
M>/RD]9;]?W_JG<>H[K;O7\F45W^_**^<^].S8EO:=OQ,*QI&%M-_HHNR=(&&
M_1O3"%<74\$F]?+.D::*-*20:3,S2DS(Q]GOP8]$0Z5\I<;/N0Y<S-]N6E&U
M14[$>(_/7>/O+KF_9MRYL>U1+N3UJ>L1Z\.EP           ..WHT1H5XFR7
M$I@L6BXN2TKIP<I$5Q:^+B.E"0DQ1!NY?5E*J;2^,MW)0L6IW[ON*+;]2U?R
M(_/?ZH\BM2NK?5B\6""5OPN[7Z4PRI'B8-YB;*2ZY5/@3QNJ'#=>>7.Z[;8A
MOT(2EARCS+1T7&O8?('SHZBVKJ'S3S;&V\D+MNZXSI2LJ=OQNGP'#N7X.9Q$
MX@Z*0M!DHC)1<2?>U+<9#JJ.XK)ARJ#7+IP-$R,1X=M2DZR907&HMI;]Y;-Q
M>K7N%EY,>9.FJ,?QFXMO@^)4DE&?$@JTWF>PDD5.T]@N^)"Y!J7LQ$+V&[E<
MF/-'\WU]GRG7>;W5Z:J)CMD0<QYV7&:N"VZFAHW'B2@S4GB31-1V%Y9>7NX=
M5[Q;R\-2\"S)2>CU2:?<7,_)CMMOQ\ZZED7O9BFZ4JFE374R;_+W\K+%,BPG
M#M7]7+LW>K5+CP[C:,>0A')(N7'69NKY*DF1+2I)[3/:/6'5WFOEXNT0Z2VR
MWX*LQY)27&J5'P]1ZL\B/P<]/VLBUU[UK..?E7Z780I[*K1JJ::>E49!V*8I
MBF#6>'8\4L-OL=H@-(8C-PHS$<S024H(U*9;0I2J)*IGO'0V7E9V;==V_*4[
MC[6VW\I]!=HV[;MGQ8[=M=FWCX<%11C%17Q*B^$Y4E*3<)Q-2,]O$95K[8L0
MM2BFWQ.1YK49.,E67>?1 @ "@^%M)J(J=IBK6;HREM153POU^7Z1:]"9\>.2
MS9N<N&U(2CB+B23BBVF5*%M' =3779VVXJT=#L3RNQ[63U-8G-5H_P J+<=G
M8;BVBVQVDDVVF,TLDEN(W&D*5L+O,QT([DKK<I<:L][V(QC:CR<.5?,C?B"^
M26TMIT(O4[P(X%)J/BIO(]Y]U"V"IT)HJ5[3AN2S';;D^ WF,D_3(=XAH8<0
M9DM"79S27*&1DK:1CF=A=R.9%VN/,OR&E>8&#C9?2N7X[]R&B[W1LR"+:\ZN
MTV:41<3C]LMZGR/MXXK2CK7?4S,=\IMV(P3I=<53XCY[3:4IZ5]IZ=VI9U\T
M3H+C:N8S+UFTTM33.>X_&>EWB##82ER\QVD/O.+4AF,I1K05*[:F.\_*+S"G
MT]F1VC<[E,"\Z>UJDWIP;IWGAW\7GX>+'F+T]/JOINQ%=28=N4I<B2E<BJRE
M6D:MZ+MJ8N<FU(>D/0)\5<*YPGGF);#R%-.-/-*4VI*T+2E:3):=QD.[^M/*
M?H?KG"E?G8A;R[RTN12XNNNB])\9]IZFWSHS<ZWN>YC69M2M3JG7@TT]51]A
M]&W:.9WE%FN-WPZW?2/YH2:Y]I9\<CE;5&I#*$+=<X$[=A#P;YG^3'4'E3EJ
M[B\U_:<AM\Z3?(M:527<CU/TQ@Y7F+LT>I.EHJ_NMK]KC5U:]6O ZPQK(<EP
MG(_G;$KS>,#RVUR"5):-V= Y<AAPC2GT<W(Q+(W&J4IV#JBUNV;MCC;O1<[#
M>CU3]-2YL.;U-L^_SR-ER+NS;M:?ZRU)R2;7"B;2U:["^+TB>=-FFG_S7A74
MA <OMA;3'@Q\P(_EV&B4RR3CC9R5*624)4H^*NPQN^)U)2TIS?,M-.%.'QGL
MORX_%ED[9>CM'F7;\''BE&&0O:=SLJU73A7U&1/I_K%H;U.X$]+QC([%E&,7
MB 2;A;I$B"3S3<AA*E\V.XZXMHVDN>^I0C&PUPM[P90R5&>-<C1QDEI5:\?G
M/<W3/5NS[W:M[IT]E6[D**2Y9)O5)JJ3T[#'GZTM6-%^D'4.98=&\M:SR7<)
M,AV[X%%6AZ/87S<DJ)M,]I[E*)2T$5"W#P-YM?@\Z?ZRWV>X[%...I2;E**4
M6JMMZJ->WO.T=X_&SL_EAM<-GW24)9\51:J56E15]K3AVENB]^8=K-.G*5CV
MG-O8AI41FAY,1Q7!4S]^M1F9T,=<8?X#_+Z4:YNYYRS/SJ7[R5?4M#SAO/\
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M-IQB^HN*SF9UIR*UQ9B7&7&W.4^MELY#*B;<<X5-/*,J&=:#$HZT+[T.T!!
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M_P!"OT_TJM'5A@&/)7D. DMK-9$-KBE3X;K4M$-Y]+49;JR8XZ&9J(BH-_\
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M$1TV'7Z@Z=BN8[RF^3B2DR/;2E?V-A"WS^WR,E<*E8K
M
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M$XEMM:T(XJ[B&%./))Q["I>U%2+A8ME0
M                !I/?<7?WIS_!,"F?N/U,\4S_ /:]S[N>YM_\XL;OMW]V
M^ Z0RO[_ 'O7^5FS;IPGWUV^WL&1:XNAAO@5"LH)$$\?60)(          )
MFNE" () E4[2 (  D":=A $       2!-" (       D"::5( @D"2 (  D"
M2 (            D"=*>D@"          "0)]':0!!($@ J=I $       2!
M(   ]-" (  D  )T( @ "0)6FI $   !-0)JR (       D"0 J0!
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M4C(Z&0L$FJ .F]8?]G6SL_CS'\*D7K1#.VX?^1Q?YLQ_!)%I\23<B
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MH^/895;1(X$FV9*0LB6E1'4E)5M29'N,C(]@QW*KU)I0U!
M          #A&HV#6K4G#;[A-Z-16V_PGH4GA]]RW4*0JFP^Q04[16C+9>FO
ME&:$:::@V74*S3):[I9+C(N45"B3P\Z1**4HC,D;B60N2N3E#D? *,(OF2]H
MNPQF^6TRT7O8[3;23W\1(02*]E*DD4:I49&C=4;H024+<0V1&LZ$9TW #@>I
M=_3CVG^7WE9DA,.P75Q*C,B(C] ?-)U,TTH8S-NAX^Y6<>&LW=CI\*.&ZAR[
M>W[%F9E]\MNWC7'7NI!F!YJE>T9/J#FMW)9J7<<BN1$H]IK([A(2FFTZ^^[Q
M]%>G\66)MUEI4M6[,>;T>RC\V/F+NG\1>8.;G6Y>):NYDZ2_[[1D(Z=S&="/
M*6O]]<<]!EY%9IB6%*/EN.*EL&DC(S-I1D=%]ICP;YZ[O9R^H<F]9=8\R7Q-
MIGV3\H]JL^7_ .&&3NRY/&Q9SKPUN0KZ.+J8K5JCOWA3,)-3DWN]3))K.IJ\
M4Y;E>TSKQU[1YMW'*M8/VC?I/]18LSK\,6?/+8]IS.I]XVCI3"BWE;KN6LN+
M25Y+X:UKVG*^HC(6K=F.A&!&\26I5PCE<&S415)J2SPDM'$7=VD.K?PG=,7^
MI<[JGS MQYIV9^Q+T-ZT?^D_51YAW+WEGY/>7WE-:]A7L:/BPX?F1U:T^5&2
M9@+,>-@^+(@)+T!-FMW)-)D15.#'XZ$6S>-DR<WQ<Z[-+VG.5?@;.Y]JQ,?"
MVVQB8[]A6XOXTCE:C4NA$5$C#OSNR?H,^*C'CQ--?*+87OBW;]^P1;CR*BX=
MI5'Q'Z@EY2-BD[.X9'@0N+F)E;C+@SJ77"0Q'P"X7*89-M0%-2"4="JEE2W5
M;Z;TI&7B6H2N*RG63X'&;G<QL7&EDY#_ %=M5?P'BFX>8GB-EAPK5:,57='K
M:7H[[QR%((S:HV9[7Z'4T?5&^X/16;D05RZN6T^W^B.@M\\^\';K\\7;+/B3
MBZ/7NJN\U&?,_LL9!$G3#T@Z%QD<VE33M^_]IC8\'RZPL;_Y'GYYQ_-:TU^
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MPE0ZEV'NV"I.$I.2XD4HJ%8K
M
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MW+=:9-4>I-M;65).NP8]R7/)R7 E4C%11[X%L
M                      &D]]Q=_>G/\$P*9^X_4SQ1</\ :US_ ']S^$6-
MWV[^[_ =(97]_O+TOYS:-&?"HNRO[(OV=6V8;TB5"X4  2!+T( @
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MB2U15["229[A,ER.C"554@_JBVIQYN7M)<6M628N27(JRX$/5Z<2D00
M   $@20!!($@ ]2 () E:D 0 !)B"IZ:(@24@  !)=X$KO( @
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MTJ(R,E$95(R,MAD9#25*2E29N7'5%!+)1\-/7VB[RJ"YD4*2D^7M-40G7@5
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M&\WU(N!W/(YKCZ9,LT<!K)!-&GP\:Z4XC[19NI*XXKL)?!=Y[W%LI
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MJFJC95/VM-O?7:$8I>TNTJ7=W%8J)
M
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M;65.Q:%$8NWK?A7SCXR4X?ZI4HJ&1?V;A?R)*237 HBJ,@1Z".W4@"
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M\8)UHM9)+T([M_!G^)'*Z(W^'174]^4^D\J:C;YY?L;CEJU62T:TI32AXO\
M,+P2+@W6#GJK>:9MMS XEVM5V:62H[S,HI$RC2T%RG#2APB.AG0?._JFQ>Q[
MMW%RER9,'3E?;J=X?BEVCP^O<+J*S^MV;*3FKJ=8Q5&UPTU]9X_XB,R/:=3,
MO4+AV>L-4QX347!Z)'FZ[N5K.W!8-M4LO\[L).M3(MQ;BV;11I)TA5LR)XT<
M)>%^8NWU@BH="[>SV!0[D.#?M$).4>9<"AQQ+#+[KJR0T3#Z%5,B*KC2DI2:
MCV$:C,7E"5FF3;]J^W[O^@APRK=R&1:FOLTO9:]+T1E*>1!@"L,Z<KYE,IHX
M;.8W(I,<GOD^:F*3:5+3QI1Q$9K[#,=H;.Y7L6671^)-+3U(^I7X;>G\WI_R
MVQL;,JZMRK3LE1EY34+#\0U(L,JPWU4)XGV74QI"N0I32U(4@Z*,EU27%M(:
M9YI>5/3'F[TU/8M_LIWX^U:NK2Y:N+6$HR2YDE*CHCU+TIU1NG2.XK>=OG)6
MX-<R[&JZIHQ<NO7HKNFGM_N.98M"YD0W7WGRBMU1,:2N2LC23,<DEP(3MH8X
M+\,OX@.J_*?J*'D+YV3GX//X>VYMRO+<A6,4G*327+%):\3U9CWMI\R=J756
MW.,;UN%;L%2K=.[CQ+8&$9ME.FV5VK.\)N$JRY)CLYI]*&7'F%.<A]MR0T\V
MA;1K)9,\/B'U$R<;"W3#^R9/+=Q;L*J6C5)*J:>O?4Z\N8[G&[>:IB2K%P?Q
M=IF$= 77'BG5=I]%9N,N);M2;%$CQLBM+S[+;\AQMII)R6TKD+<<4XM=3(B'
MESKCH^[TYN#:3EM\VW&78O1W'2O4&PW]IONZHO[/<=4SWZ=QMZ2<)R0S554+
M;4XCWNY14XMI&0TR:<X)VO<2K5&K4Y8NY->S+0LH]?.B#&)Y''U6Q=I"[1?E
MJ.\,14D:&74<X^(R:;(J+4==_:/4_D5U[]]8$^F]QERY=C2W5ZM:=[[#QK^(
M'R^>V;A'J?;;7-9O_M$EHGJ^Q'ECI\U:G:.:GV+)(;[B;-<)++%W9):DLK0\
MXPW5:"<0CPIKO':?7?3-CJ3IJ_8NKFRK<:P[ZI-Z:'4'E]UOF=(]6XLHUA@W
MI<MS735I:ZI&2-C^56;(;/;;[ N$9Z%=(K,AI276S(C6TE:DF9+.AI-5!X,R
M;-S%OSQ+\7"_"333TX,^DF'?AFXL,[&DIXTX*2:=5KZC[9W*"5*RV-N[Y5&W
MUO$+-/9YOS3)>D>9\"E-S@+]Y+CG_P"=;^,*9\T$GV$P]OW2GYQMQ.)_C3'&
MJM/E4;=Y']D"::JB'<I+P7Q,<?SPNF%NY6VP=1>&04/W*U*-C)UQ$I-2V.%[
MDNN<EHU*W[S5V#5.I,"$K$KL5[U>;UTT/$OXO?+S[=LMGKC;[//N.$Z.B_-D
MVVW1:TXZEC3IDUPN_3WKQI_JI9ICD2W(ND*+?TMK43;K,F3'9>2Z27&DGP$5
M=I[*#3NG<EXUYV;CI>@_97K:/&OEWU?=\M^OMOZHQ+KCM63<C'*IP?91JO8_
MF9GHX5G.,ZB8-8,J@38<^SY-98L@SXV7&5E+AMN/LN%QK09%S329'4=L8]U9
M%F-R&L6C[+[=F6MQVVUNF.U+&NVHS37=)51B3>;AT>?H&U</5_"("6]/=0WW
M),B/";)4:W2B5+>D<1LL(;03CJNTQR-N<7&DG21?DZKQ%[G:SS#T ]5=UZ3M
M?<?OZY+Z\#RV;&@91;2?6B,:)3T2,RX:>>TRDVBJ>X]PLWK4^*7^DJM.-?\
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M!P'SE HD_2X]%UX?E6]M-]#XJ&)!)7* K@I+CGS.+@^51XN'?3Q;:"*@@KE
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MV@ )N,%7#27'/CXN'Y5O;P^^IXMM/4 !-R@J,B3*8,U<7#1UL^+A]]2BCK0
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MA4EIH45[S[ @D
M                  TGON+O[TY_@F!3/W'ZF>*9^R[W,^WGN?PBQN^W?W;X
M#I#*_O\ >]?Y6;-L_"9=Q_7,9%GBZ&&^!4*R@          DC E.A $
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M0)>@ +0@"     "0) #U$ 02!) $  20$KB0!    2!/80!!)D!+5" (
M )(C/81&9^IM/VBWB5&3U7 E)MT[2KEN?>W/@*]P&FN(:<>*!MK(JFA9%WFE
M1%[9D*6TE5A)LH$<\>\<K JXD       3V"">P@20   $@2] 0@*G:0)() E
M=Y $  5%V^M[HM7.!=M]IO+!_MJ!_.$?PB19W'^[OU&;L>NY0K];\I[3:^Y-
M?O:/\$AI+XG=D?=7J-005  01D95+:0-=C%:\"0!%2J9=V_V0X+T D0FGJ@0
M1D95(ZEWB6J:,$@    \G=:'41'Z9=!\OU,)M#]UM\)QBT1U*(C5,D,O$RX5
M7&ZFTX@CI7:.)W/<XX,[5C_>7IT7S')[;MUS.N2FE6W;59&-]H5T?=5/F37*
MX:S:H:BW[&L'O5RD+MSA2[@U'=C*D&M#;,4E.-T;CR#*J=]!RN5L;VF[;NP=
M9W$FU6O'4Q+^[+-O.Q826+;='3M/8=R\@VP,VUYVRZX9&F\MLFY&4XJ4ALY"
M&S41$XGB7XW2*E2(4WH^+=C/@DRN[D1G#PK<:6SR-BF6]5?E9Z_8MB&?W^ZY
M/I7EMTC6]I<^1+DQ9L1Z8S&;6AV0ZVTURVFJT+O%W#S8[GOLMMDJ4CI\18R[
M,L?;UDVW6*9E>8W>X628]8<BMRR7#O=NA7!OA,C(BF1FY!IK4_>\RGL")8L<
M"_<A+WV_Z,L0FKV.FN'$Y8(*UP                    +=GFJF1=#^LE3(
MO]5M[3,B+WDCM/8+V.TKR;X$,M]?J]AI/0#-N%25%\^(VI42BW]Y&8R<Z2E)
M4(@ZP7PEU#K[TQN^KO2CJSA%B85)NL_'Y4F&R@C4M:X<=]U1)2E"U*,T5V$6
MT8EA\DU4N1XE@_R0.K;3C0V!J3H#K->VL)R*!?I";0F\D<-$DXTGD.H,Y3C'
M 1T,R/AV\(RLFTYKGCK&A"7L\O!HX[YW/5/IUU&WS2+0/1NZ(S6]-Y"Q\ZNV
M@O36VE3)91B;2<5<CB2FI5/A[15AQ2C*3["BYPY'JV7F[%TR78O+::T&=A&S
M=W=-5N*A[EG)<M?IR6Z<HCYBE4*G#6HQO$2O>)V5*TVM5QH63_)4ZG<!Z8=0
M]8]!=9+@>&W*??YC=K=NY*AM(7"G$RE*O2UQR)#O+/:21?R+4KC\9:MEB$XQ
M;MOBCLOSP^KO375_%\!T*T?R*/FN07B],HO$>R?QTHQ27S8CI,XKCQK,U*(S
M\)D513C1<)<\M*"Y=@ERK63+MO2+T^W?'_+PL.D-X:<@7NZX)<G'FEMJ)U,F
M?:4KC-*0II"R4HTI+:FNT6K]QSN<U:I&0I5HRPCY6VN5AZ,>K[5S2'6F4YAE
MOO\ ?+J4>XW5MR-'YA3EG$(U23C)-#ZF]Y$="VC)O0<[:<=64QK5P9[6\ZGK
M6T?R[0:%I%IIED++\JS*>TP<2S.IEJC-.DMIA2BC/+4I3KCE*<)TV"G%@[<^
M:6A3<?+&G:SWIY/.AUUT;Z0,*7?F7X=YRA@KI*@2&5LN1VG&V%,&I+C;2R-9
M5/:0QK\N:XV5)4BD70+]9&+_  '+?)6XAEWWYMJ-"ME=RDF1EO%M.@//F?Z?
MV;'(MNDQ7)"G%2FVJ./N+(TN.))1\)F9;C&99NN54^%"F7?VG;<7 ;,<6VEQ
MR#Y#"5(^7<\7,;2:C/;WF,*=92JRM.AJ(T\M#;C+B7)'R).$@N<O]TK6NW;L
M,11]I-4N +3RSI2RDER/D%.FCY9P_NIF:J[=N\&B*LJ1I]:&UQUI7(K')TD_
M++_=2,E5*NW>%-*"KJ0C3ZT)0RDG)%&C<-)\Y9UYM>*NW;M,&GP%>U%3> 6E
MOT:BY'\5)XFZO+/:][^M3V[Q(KJ4-:>6=HVS2N3\ESN"KSA_=O?5V[=@A53J
M*DIT]LZ41D<4BD4W#1\LO;S3,U5V[=IB&FPG0,Z>V=E3"TKD58)TD5></[K6
MM:GMI45/T"OQ!.GMG2B,V2Y%(INFCY9S;S3,U5V[=IBFFA+DR6M/[2UZ/PKD
M?Q<G23\LLZ\WWU=NW>*B*]G80UI_:&$L$2Y'"QS:5><.O-K6NW;O$<J?K',P
MS@-G:*,I+DA28I/<JKJ][QF2S/:==_L!2O <U"$:>VA')X5R*,\[AJ\X?W8S
M-5=NW>%$*LEG3ZT,IBI2Y(_BG.Y9F\L]CU>(CJ>W>%/B%0WI]:&EQEI7(_BY
M/$DN<YMYQ'Q5V^J#3;%=#4B8%:H?)4A3ZSC-2T-$IY>PY25)49[=M.+8"2BZ
MHBOQ&-7UA^69U1ZE]06:9GI_869N*WBXPI$"2[<6D+-M$EUQXU)6RI::)7WC
M,MY3A'E?<''F=:T+ZG2MHI>-.^G_ $VP/-FUQ<CQB ZW<FFGS6GGOH2A:>-)
M)2HJ)V;!AO5LJ;5=#O\ :P"T,E$)*I'\3)XFOEE_NY&2Z]^\*::D590SI[:&
M38-*Y!^C\[@^67^[5XJ[=M*B.5DMKX#SCU=?-^F?33J3D49YUIVTV*>IEY;Z
MRVRX[[)H,S6GBXN9W]@F$56J)3J]>!@MX^ZNXW2_7A[[I.O-S?4H]YDY.>61
MD>W>2N\=Q>55F<MRNW4O8TU^(W+R_MM;M+,:]E',U/\ HO-7]BAM1&9TWJ0=
M-H[0ZUW6QM/3.7D7G_NVE\*:,CS_ .I[/2'E?G;U<?*[EF26M.,9+T'7K#*G
MGTMH1QO2YC*:5WD;Y%NV]ACYP6896[;W:Q+5?LTLI<R]#N+Z3\\KI>R\[=[>
MN5>O2?P.39DW] 6&,83HGD^>R&^1(@VMDK>JO+JN3#:)?#X45.O<8]#?C@ZP
MCY;?AZ6!MTU;RHXL4DG1OF@Z]J/IO_T_^A5O75]K<YPK8JM:=OL>@PT/-9R^
MY9/UH9XJYLO/I@RT^BJ6;AI2AQV8>PC-1$-"_P"G'C8USR1AOL[:EG95R<IO
MMKS1?'CV]YW[^,2ZL?S.M0DI3LV8J*CK2B3[.&E"W<^^Z]P,LLNK<4=$1V&U
MO.'781<+9*47M#W]D9*C;K-J$%WGF;)GD9=E6\.T[UU_FI5?R59SBR::ZA7>
M(;UKPF\SDK34C*!.29%0C)5/1C/:1D.&GU/TYAVVLG(MJY_6C])LFU=#]1Y^
M)KA7H)]G)+_9/E7;",OQFKU^QB[6Q":FHEP9JB26W:=6"H6P]XOX6\;/EKQ<
M>_;:_K+Z2SE]/;[M%5DX=Z-F/:X2^@XP<MJ2KE-LFLEI4E:J&E2",C)1*3L-
M)T/M')J];OR4(KF@^U&LYF39E>5F%IR;T?93UF9/^JK7IVXV_J%PYUN25IL:
M+2<-!NO<DSE)M_--"35P$=3["(QY]\U;.-8SXVK*HW_I.^O+B%_'Q/ C/FQX
MZI\>--/@,NQ.G]D;2R25O$;"GS1\NNORYGQ$95J=*CJ6KLVVX\#M!I2G7\\U
M6, M#)1*+D&<,G^49O+_ '>O'6N_>"?-[1+>I#.GUG9)DB7(/D<[@J\O]VKQ
M5V[:5$TIPXD\Q26GMH2F&GCD4A<_E_+.;>>9\5=NVE=@>LAON*F=/K.R;!I7
M(_B_.X/EE_NU:UV[:$84^,5^(T#T\M"$14$[(_BQO<%7E[>>?BKMV[Q9NS4(
M\JXLJJY1Y'[AY ZM^I'3/H\PEJ\33^><[F,2F<2QM$PRDR9#[3R><HDOMN(2
MTXDC(S+:-'Z_Z\V[R_V&YN&3*+RW%^&FU5NG'BCL+RW\M]W\Q]_L[+MD)+ Y
MUXDJ.B55VT:[3&AU6U1U8ZF;PY=-6;B]<[8N2^_:,;;BJ4Y!CONN.--*EHYR
MW#2T]3:8\&[OYA^:'F%<G?V.=Z.WRDU%UDE2K6BKZ3Z;[!Y->4/EQ@6</?L>
MQ?SU%-MQC)IT3>O+WIG%8NB!N1.;'Q"<4=I![UR"JDTTW<JNPAKJ\J?-O,MO
M.GD7JRU]^7K.P+77'EC@V5MUC"QOLR5/V,.'#N-3$#S31*_M93I7)?Q#)8SG
M-6I^(N04DFUI6ILE.I;)!K)LBK78,S%WCS?Z%Y;V1=OSQ;3UI*;T7HKKP-8W
M+H/R7Z_A<P<7&Q[.YWDZ3Y(*C?#\WO9?\Z#NM[%^I HNF>J1'8-7,>86W&<D
M332G(B-II+SC)+D*3QIXC,DD0]K^4/F]MG7NUPQLF<8[]%4?-1-T2KHW6M3Y
MS>=GD=O'E7O<YVE*]L<Y5C-)M*K=-4DJ%P?+YFFNGC)3K_=^%^(VZJ-$*5S'
M'#>2LS(VTN$HB,ZTK0=I[OO.+T]C/*24LIZT[6=5[#TKOO5V9'%P+,G1^_1I
M+X:4/"FHW4))NKC=LP]N3:K=$4^AB8E]U2G$O&X2C41.U+89>L- W/KG)W3&
M=FTO";7?_I/3'1/D-@;7-;CO\E>R]'R/T4]'H/.CTB1)?YLQR9=YDM9\OQ/R
M3-Q9[N"KAIJM0T*Q?G.])R4IW7PU9WJL;"P<?PL=6\;&MQ_U5HEWZ'H;3+IK
MS;.38E7J.NQ61Q:5\QQ)DMQLU(50D*:XBJA8W':NC]XSW&_E2Y<63X/N^'T'
M4O5OG9TYL2GC;<_'W&*:TX)ZKC7O1[VPWI^P/"HS:X$!N3<VVN%4UXD*JHTI
M)3ADILR21&51V9MNR;'M\U''LQ^T16LN]_,>6>J/,#J?J:[*>3>DL23T@FU1
M/TU]):W\R+S5>GWR^,6N-ALMT@9YKX_;Y36/XK N3#I6MR;$D<M^4<>:VAIQ
MEU&U"BJ1E0Z'L'9_370^5U7=5^ZG'"MM>BM.S@=0;]U3;V+&EC69*>9--TJF
MUZ6^P_/SZG>JW7#JWU(NNI&L66W:ZN2KA*DVZSN39GH-MCOR9#C,9N$<IZ,Y
MPM/\.PNP>C]GVC'VG$CBXUN,+44D]%V+OIZ#H+>.H+^ZM2L\[FI-<VM%5ZHC
M3?I'U3U;L<_-L%A/15P&N;Z(\A;'SBE*"6? 3C.RB3+=O'G;S2_%%Y9>5?4\
M>G\[(C'>9R2=*-:NFM))(](^5/X2_-#S:V'^(]JM3>R1BY<SJN;2NB<6=+93
MBF=X7/>M>38U=;;<X[JVWU%#EO-+-M:D*43O)2BA\!F.W.G/-/H[J79+&]8F
M=84KR3:YX55:=G-7M.C.M_*?S'Z5ZDN[#9V[)Y+,FG<Y)\LJ-]O*EV'S"1"E
MFV<5-Q.6E/RS*(,HS6NGO:$W4]HW2]O_ $E"Q'(>?:C5:UE%+YS7[W0W5%V[
M&]9Q+_VB*]J*4]7ZDCN32CI_U<U:NT5C&,:G0K&4E@KO=IC#[!-V\W6BEK2V
M^QXS*,LSV#H'S/\ Q1^77EA!PGEVKM^2HG&49:Z]BEIJCT#Y0?A:\U/-JYS8
MV%>LV(>]&<91JM.V4>YF=-Y?O2)TYX3T:VUWIK5#N.H]NA-/:MR4$VF[3;@;
M2%K0;7)*4A#"VRH9;ZCS=O76>U^<&WRZHVB=;\$VX5K3M6E7WH];^7&R9OD#
MU(^BNI['@XEYI0FUIS<'KHG_ $^#LUB?+M;[4ZU./P;I!D))\D*<:=JPZ1.H
M41&A?B-!EM'6&Q9&5XUS[;6,8RT[.T]3YN#B[OBSQ,V,;N!>AH]&M5IKKWET
M;0W)L3U2QRW\QY3.16EGE3HQR#)Q?$VA)KH;BE*J9CO/IS>+.?M_V6+7/'TG
M@OS#Z'S.D][NN,)?==V3<'1TXOT4.\&]/K(RILTN/5:YI%5Y9_=:UK4]M*C8
M9\RMT[#KQ2A[O<06G]G::92EQ\N0;AMGSG/W4SXMI'7>8MV(IQ]K@5.;A&D-
M4>:.JWHZP3J4TO>Q:Y1VT9/:(DM_&[TI"52F)9-/N-MFZ;+CJB<>61;QN'2/
M5F;TIN<,G&DUC5]J-=)*JJ=2^<GE+L7G!TG>V;?+47E\C=JY1<T)I-QHZ-\6
MC#NU<TKS'1G4&]:=YK DVV[62>LH4I:76?26H\APHTAAY3;=3,FB/P[A[KZ8
MWO&ZFVB.^8C3V]Q]J/'5KAVGY_\ S.\N-]\G^K,C9-RMSAD6KC=NYJJQ3TDM
M%6M.S@<DR2;.U]PVV6F=(YNHN!QG56&<^YQ2;Y&4E1.1W''#6X:H[!$DN^NP
M>9O/CR:CD;//KK:X5O1JY02];K1(]8^3GG#;\S>G7Y:]>W%+<;=O_A;TGK/L
M4*MZ.*IZZGDI+KB),JW2XSEMN<1Q;4V#,0J.ME;:C;-:.>2#<)PR,RH0\)J&
M9.[]JNIQM0;4M*</08>\[+=Z7RI;/GX\K=V$FU)IT:;T:E2CT-<R(J$FJC*M
M321F7L4V'O%VQFPC<E<MP2LOAJCCHX][<I5YO^#7!^KB0@C=(TI6A!I*JS<4
MELB).U1U69;B&#<MQNY*NM4A7L+4\VS:D\.Q65[A2AVOT\]/NH/5QJI8])L
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M3NFW4Z\NGDMI;2>'.RY:R7+9;;CFZRVIZ29F:2/81%V4''78Z\W:7H2=?49
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M;?&DOL,SX+LR*5Q:DLM2&&U\N,THO'N':>_[38W3 G!T=J4?1QI])H>/N5[
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M_"HE4]D3'Q/S^ =.P*X*^+V-_P"P)?*GKQ92Z=I6*B0
M                                               #2>^XN_O3G^"8
M%,_<?J9XHG_[6N=?O[NS_P XOM&[[=_=O@.D,K^_WN^K^<VB*$@S]7;[8R+*
MHV83U16*R%Z2 () E>D@"            ) FGQD 0  %,E6+1*=&0:3,FU4/
MPF9J,BKVT*M-PMV)W+-MQIH7KKC<C&/<6M/-<TKUIU8TSPNWZ'-W15YA+?\
MG,K5+EPG?$N1R^-<2BU>^3O' 7;-U9'B:\K9N?2V3AVKS5]I-KM,</6#I]ZF
M=,X4.\ZRV/)G;8WRS]/FRKK<(S:",S<0OG(4TWQ$A15,RWBBY^IS(WI<'WFY
M;5?Q[]^[9MM<O8^\OE>4=U#Z!3L?=T>L.+0</U26A!2;JXXP[)R1:$Q:FA:U
M$XR;9]A#;,3FN[:TO^TZTW_'<=QG?A5\KX]Q? 5QD9DX5%D9D?J^K[(M).*H
M<!*3D^:7$I$E(   3L G0@"    D"2 (               ) D@""0)XD 0
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M9 D@ "0)]! $     $@20!!($CL =@ $ 0 !($D 0   $@30@"
M    D"0 [" () D 'WG6>M^=S-*=',VU-MS!S)V*P_28\,BJ;RN2\[0J&7:T
M7:.,S,Z[BWE"'NG+[5@1S;JYG1F/%_7FZPNJE)/3Y[Y&9+C$?C*J8[ZVDG3T
MCM) M?;\B[H]#=I]+6N133JZ=QZ8Z//-;U'ZC=<K!I1D&&NVRW7E3B%S%<5&
M^ V=M3>67[KW#D<%3R5+G[#5=ZPUMSA&*KS%]9]HF7";(MG A1G7=Q))7[(N
MW,9)NK-?<N5T-(5+2/*N!2_E( I) GUD 02!+( @D"?1V$ 02=.P"73L( @
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MEQ#H$*;,S)!_7_9%;JR%3L-002
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M-MII?$78&W%&M3:BW;CV>OV#SC9C^KYCU+*<>?E7$UQ62
M
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MMTMDMB7'?CR&TNM&:X[CB4+-"B,TF=2&A.+B^5IIITU]!N*:>J:9RX0
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M3=_:.G"IUK.2D^9<*&V%!02!) $  2!.A $          $@2U0@"
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M8!+IV$ 0 !)=X$KO( @ "0)6I $            2!-" (   "0)>I $
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M%7.X-,6:3+DN-2(S<HD1FC)U3R#YC2*;4D15'*;;%YNV+?)*JEI3T\"K</\
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MO(^!F>PID>X1(LZ(ZA^+,CLR8[S:DK0XR^VEUM:5),TJ)2%$>PQAE9N0
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M776SX3XE$14'@KK'.CNF2Y07M\U/E/K;T!LBZ>Z3Q<-Z7903?PI,Z>T2Q?\
M3!U=8M:9L?TS&=-_2)<U'#QL$\XE#\8EGPN((S<+MH8WKR^P(6,;Q)1K*G:=
M%^?V\\D[6RMTG*OY3(':;0TA#;940VA+2"[D-EPI+V"(=ET?,V^!YE7"BX&H
M)!!)(MQ4$MM\2$DN!(@D
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MO' VZ_U!=C2YD4HZ>HNFL$@DF:/LMIEW;_KCSW'5<U*?Z#U')_F]QKBHI
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M?4>+;;I;4.U'OJGM<R[34%14
M
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M<:;8AE=S034^^62WW"4V1$1)>DQ67G"(B,R*BEF,22I*BX%Y'9(I
M                                     !I/?<7?WIS_  3 IG[C]3/%
M%P_VM=/W]S^$6-WVW^[? =(97]_O>M_E-FWN5Z_[)C(L\7ZS#EP-2@K*4JD
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MXJG4B+U"&-*:GJN!P=&M&!232O @""0) "A $       2!) $     $@20!
M      $@32O  " (  D"2 () FE2 (  D":]Q $    X35L+>(HGQ)5>SB42
MDID0+A;7?\GN<*7 >/>9-RXZXZU;>Y+AC$NVW<JI:I&79O\ @R4N-"TZ?D_:
M$+U"/40LF6=S.]%?#C<E9$4CT_YQ)-?1?OI4WC'QL>5G)C-.D4SG[O4=R]A2
MQ9:N2+L,="(D"WVUK:U;8,2 UZK<2.W'0=:=J&ZCF<B<;VK-4BW%47 U1:MP
MIH]45.5=>T@"DD"2 () FI $  2!) $        !($M  ! IIZ2!)
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M25,.2&&WE-FE6TC0:Z>P(OM1]GLJ68.L3L,22
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M'4-W(;JK4FHOU-_D+K:%I654GQ=YD.;4JMK@:4M8J78RL2
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M';&Y)?$VCZ?85]9.':OKA.W%_&DSZHL&4
M
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M$Z>PS.@S(7%+FA'L+$XJ,57@9P/3?MT0TV/OQ2S'_P#L^,.,G[S,A<#N\4@
M                                            TGON+O[TY_@F!3/W
M'ZF>*+A_M:Z?O[G\(L;MMJ_X>OH.D,K^_P![UOYS9M^].FTZ[>SM]H9%GBS#
M?#4U!<*:]A $       29U ENH >@@"    D"2 (  D%Q <-2RV=E*4V'O\
M8%-R,9E57V&YCS'V"HMN-(+L*9&9EE3U"?2N@HA;2XEZ&1>L^XVBLY3A&:FX
MEM9KN7'M\1A9>J1M-)41U$KV=>\F=Z_+M-HM3JS,UK4I9_9*.OU#/=03K)_Z
MI9?,N/$I(B+U"$J/+H1QU)%1 ^L ^8@""0)](   _00!    2!*]) $$@37M
M( @D"73L "E" (  D"2 (  D"2 () FFE2 (   "0)3H0!  $^H()7&A D@
M  (.M#X=X4;%:&JVFNU6W]G?W!3EC67$J6K]!!DPG8FA+[-]?[>P47)QY&OS
MBI149:=I07:??O\ 5H*+"YM6).BH2,B5Q0XEM)L"@ENI D@      "0)( @
M"0)( @DJ=H$JG: ! $     $@20!          !($D 034":@!6I $
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M;8CLI)#3+24H;;0DB(DH2DB2DB(@DE*G-V%"TX&Y$@
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M3IO6$_\ 5MM+OG,?PJ1>M<2&=MP_\CB_S9C^"2+3XDFY$
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M[64Q2BJ1X&H))
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M"%ZL6JKB2DTW7@5@5                                        %/
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MBX*C=16NJ)%0
M
M    @RJ6S8?8(:BVJAUIH;&0VMR)*:3[YZ-(;07>I3:DE]4Q,G^NCW%$$U;=
M3\KCSAL3NN">9WKO#OS#C3ESN49Z)S>+QH6_/<2:#4E-2-/=4>D.@[MM8-J-
M:U7T'1O5EN;O94YKV&U0\$.K(DF1;J%[%1V;.5(^@ZMN7HM^RB&GD<M2*5,]
MWM^L(A<@X.--651Y.1J7O=A"4\/J>I_;%*21;TX(DSWI+M^ILV"?0BY"4O=_
M-.'YN@OF:)#VF]+NMK8:(MJE./36VTD1%M,ZJ[!Q>]M6]NE'M:.?V/EM9RO1
M]R+/U-_)EQ:YX;Y<?3A8;NVZU.CXH3KB'B6EPD25)?:J2TI5M0LCW#R;O;3W
M.ZUPYCTKM+<L"W)]J.P/-&)/]"?6'B][\UM\7K4>K]0<=834TCD)4:=>!BL]
M ['F(OXAE2>BXG#QOTYTLB-"B319/I-@B+M4=$[NP<CD.S^>O:H6<1R4*+A4
M]=9CTI><-U7-Q-/]:KG,LN&')::N4KTQ;#7HKCORYN)(C2]1EU9D1D=:#'A<
MQHQYDO;,F2YN+T,@/H9Z)L/Z)]'3PVQOINF27&$4C)[\3:6UW"8F*V9IH332
MN%IU![]XQ)3E-U92DHZ1X&-NX\L_.6)]*ZN'D5*D6ZEPIZVX9EKF\'VRB44K
MM&9E\,S.)%,]YQF#/US:28P2LX'JQJ-9-)=/,JU!R%TV;7C-HFW%Y1)XN)QB
M.XXRW3B3]T<02=Y;Q,(.<TD##7TNZJM#.H;KKO74GU>94Y P+#;Q);P;&9<9
MV7"4J#-4B(ZAA;SK2"9-LE&1&FM!RUW'NVK"4.);BU-U>B7 Y!YLW5QHAU3:
MAZ,7O1J^%>K+@]R@KNKJ8YQD,0(4HU)X&N8XDB3'(J$5-@LV<:Y&T[C]YE%^
MDHKE,DGH'ZNM#^H;36S8OI9?CNEUP:P6B!D,3D&T4.0W"B-+\1N+XZN*]08$
MU*,J2,A4<:IEP04D
M &D]]Q=_>G/\$P*9^X_4SQ1</]K7/]_<_A%C=]M_NWP'2&5_?[R]+^<V;6Y7
MKE]<Q?L]IARX&H+A37L !Z$ 0      !($D 02!*KV$ 0 !($@ 0!!*?#N$4
M1-6*F9$780D595QJ[Q'*FJ=A*DTZD&HSV!%*/ .3?$@20D0!         2!)
M $  2!/H( @D"2 () D %J0!!($^H@""1!-:K7B0)(            D"2 (
M  "0)( @D@JT2OE%3#B2VT4&A)G4RV]]3%#A%ZOB0J]A74512CP#;?$@1**D
MZOB$VN %1              2!--:$ 0   $@2R (       D"7H0!
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M6;X'C.4S8BH,J]6J'/>B+2:5,KDQVWE-J2K:1I-=!;E1.A"=54YZ()
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M/KOY3?A(Z=\M/*;(V;JBW#,W^]9E^M<4W%N/IC71GMZ^=$&677!;#J!I?/\
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MR@O[ELN B]HAV0H)M57 \R2?L<36;3P())]E?JF9B9--U7 F*HJ%8I*@
M                                             #I3J-MS]UT+U5@Q
MT&X\]@N4<*4UJ?#99Q[*$9U%VPZ7H/\ UX_.C#W"YX6%=N=UN7S,_(LRJ.N#
MGFHD*2DTOQ\UR@G$J(TJ16_SZ5(Z&/7VQ-3VNVH_47S(\M;S>KL\<R2]J5V2
M]?M'SW/N:*]Q?LCF6VHHPLF/+:MOO7Y =>P08BIV@]]?M=IA6FI5!T=>P^1.
M(S1*E+^Y\QA%#W54XDB(O5,S&->?+;NWY?LTOR%W9+4H]3K,DOU*[>P_36\A
M6$]!\LC01MY*DF['N;Z4J(R,D+5%(MAD6_A'DSJ?*AE[Y?NV_=YZ'J?8'7;X
MR3XO\B/'7FSZ<KQK6*R9S&8-IC)^6MYQ"#)*G(Q/FM2E)0DMJB[Q\QOQ3;/=
MV;K?$ZBQ8\OB7(2<DJ:P?-\Z[SZ\?@CWO%WOHG/Z8RI<\XV9PHW724>5*GP]
MQYCQ6:<JRVUY)\2E-((SK4RX4H+OKV#[B?A7ZS_CCR)V7>I3Y\N-IQF^+]F,
M(KM9^=7\:G0$^@OQ(]0;-.WX>%>O\UO2B?-*;?8D>5.J6QI:FP+Z2/!);=)2
MB(BH:4NT,_"7;ZH[1WVS)WHY'#F9Z&_!5U-:6TY72,95E92TKW\OI+W7D<9\
M=WTLS+"Y#U7,>DQ78[:U[>6\AGCX4FLS+:LMQ#S+YOXG@[E9RTO9FFCT)USA
M3M9JR?S95+\ Z<C&C;-")%0   "VYU,>97H_TR:AKTZS"-)=N[;++RE-&DD\
M+S:W$D55I[$"Y"U*:;782Z159/B>I^G/7W%^I#3FV:DXDTXU:;DIQ+*7#(U$
M:"1Q;2,R/WXMR33]0:[>P[\ @      #;RGD1H\B0LR2F.PZ^HSW$EIM2U&9
M["H1)$6[?C7HPI[;:7QLHNW%:M2NR]V,6W\"J8UW5#GIZAZVY5=E/&Y#MLA4
M:)154$3"WVC)/B4GL[![X\O-FEL/2&-CRC2]<C5_#1GS7\S.H8=4]<YEZ$N:
MS8E1=JTJO2>V_+8T]-Q>3:B2V.!*S::M[BFZ\7$EDG.!2D;*$788Z<_$!OW)
M"QL=A^W'66OI=#O7\-?3\IK(ZBO+V)Z0^2I=T62G"(BV$>X>:+4ZV>9^]0]:
M7(MRY5P-R14(1;BXQH^)42+@
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MG]!&E"16
M
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M%0N%  $T FG> %2 (               ) E^@@"              D"=*>D
M'J0!    2!+( @   ) FO80!  $@2M  ?H( @          D"2 () GTD 0
M    2!) $          $@3Z" (            D037L["!)     !($D 0
M         !($U[" () D@"  ) D@"  ) D .P   ( @     D">) $
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M-R][4[-AP(T".S$AM-QXL=!-LL-()#;:$I)))2E-"(B(A3)<RU*4J/0W@DD
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MNONVI2O&FA..$A*E,U5V%L'?W2OGU&<%8ZLC2_5)2[.Q=YY?ZY_#1BVX2O\
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M5-4541K/7[,&SE\%@XTMICFP?,^Z<PB-W9_<;1+=%KQ(TXUT*'<@R]")BTV
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M##4C3X2EK(,O44;F6 TFYZ1S_E#^3Y=>7\.@)A4;*6LAR]?H?'CYIYWI'/\
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MN) M[*(\6,TDDMM,MH)MM"2*A$24)H*7KQX@^D
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M?\5&7/AX4I1GKI'62UU9[<Z$,93-S2YY*MOB3;R3PO4J1<?)_N3+?ZHR?O?
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MJOUO4^<O6&]WNI.I<K<KDJTN->M)NAV?PE4]A4["H6S_ ,(V+0UPFA=Q>T0
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M-O6V]&_2G1_E/OLI023HDB/M*A"F,_%CS]YD.B]A>ZC6H7<7M$*B!0NXO:(
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M?O3G)_&VSMJA=Q>T0K*!0NXO:( *%W%[1 !0NXO: "A=Q>T0 CA+;L+U-A;
M!-"[B]H@ H7<7M$ %"[B]H *%W%[1 !0NXO:( 0:>XR+OV$=05.T:]A-"[B]
MH *%W%[1 !0NXO:( *%W%[1 !0NX@ ,B/NKWT(P0%"[B]H@!'"6W87J;"V "
M:%W%[0 BFZID??L+;W>T&G<1J30NX@)%"[B]H *%W%[1 ".$MFZG:5"V_P#@
M $T+N+VB "A=Q>T %/6IVE0MO=[0 4+N+V@ H7<7M$ !D1]U>^A&" H7<7M
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MWLIW4+Z_KB=/A!-"[B]HA (-)_8F2?\ DD8=@)H7<7M$ %"[B]H@ H7<7M$
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M@W*6+=7L5='WK_0>B=BWBSO&#'(MNLZ4:[:H]W<);-A>KL+:.!.:)H7<7M$
M(X=O93NH7U_7$Z?"":%W%[1" *%W%[0 4+N+V@ H7<7M$ %"[B]H@ H7<7M$
M %"[B]H@ H7<7M$ %"[B]H@ H7<7M$ %"[B]H@ H7<7M$ %"[B]H@ H7<7M
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ML6(\MJ*BO0CM<FD)4:B*JC[3,S/VSVBR]>)=H:@$@
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MT. /..8:&].657Z5?,OQ_"I=]?<0N7(N,BUHEJ<0HU(YI/+)PE$HSW@I.FG
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MDQY5<'#BZGLF,U/@J(UA!6
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M%5)_95+ZWKC%YI:::E[YBL5@
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M:A%MK4@J$OT  O2 )
M                    Q3).2HG0 (J2XNH J
M
M
M                                         09$94/:0<!QXD@"DR49
MD9*H7=0C^J"])&I4!( &+/A#1K\X2 3:"-?HUM.E"J1%&8[:=PN=$\GW)EI^
MZJ4*NME<^],*4-7K4NJ>;=FF2X=T?YDK'E2X[ES*- ERXG.2MEEY+S:R4ZR:
M30E5=NT:KU+._P MFU:KR2N*OQFT=*V+$[UV[=2YHVW3XCHKRA>DO2W'M ;%
MJ_=K%;<BS/,'GIKUPN46-../3DNK2128ZS-:G%5VF8WK.=JQB6,6S%).VG*G
M:W_V&BXD;WV[(E=DVO$:5>S4NKY_HSI7J5C=UQ;*\&QZ=;)<*0TZ@K3;V7$I
M6PXW5MU$8EMFDG#,O5' 9%JWD6)VI+1)_&<O:R+EB^HQ;X_ 8^WE[6Q[I]\P
M_5?0?$Y[KV$SY,Z04)MU:HT4D+-UILD)4EI/ 2"+WO8+O3\KM_8/$R*NY&32
M;[JE>\NV]V;LKE@XK3X#)K%XQ0   \G]7W2S9NK33"5II>[_ #,>B2G"<5.A
M)-3I&DED14(R^W&)E8OVFFM&F9V#FRPY2:55)%I]KR"],VFR;_2WDBN'<9MK
M^,+_ "/D4*Z%+RHNYXCCJ:O]0?IGM_\ BSD=*4IRE[^P_?=XMPLN+6H>4N;F
M42VKU%= MHZ0.H'3*R9[D5SO&D687R FW9 J5*:]'D,3F5$T^TG@2A:7$E4J
MF0N;/D7GU'**6O+IZ50JN8]J[M=^\](Z5,O?2ZSVFPZ?8C:[%)]+M$>PVOT"
M3Q<?.C*A,&TOBVUXD4,9.5XCR)<ZH^9G%8W)X,?#=8T.?"T7P
M               *335/"1F7M^[4./$CU!*>$B+NK]4ZAIV$E0 I(E;:JK6E
M/"6SO]>H=M>P=GI)(B(J%N#B"0     !TWK#_LZV?SYC^%2+UKB0SMN'_D<7
M^;,?P21:?$DW(@                       !IO?<G>SY-?^"8 PO?,5S/4
M"V]6VHT*V9M?K? ;NMK)J'$NERCL-I5+?XDI:9DH;22B[B&5CVU*/-34MW7*
M,Z+@90/0/,G3^E32J7<IK]PFO6;B?ER7''7GE<1>);CJEN*/US&,]'0O2XGL
M404F(]YV^9/9!U)8EAA/<Z/CS"'%L$KBY*I#4E6U/&JE3/N(;%T3A/<.IK=F
M6L$Z_,<EM%CQ]QMQMJMRI:G7P$R^\I1$;,<TDJI%0S;,D_5'H3S!W!;5TAEW
M8RY9*VDOB:.1_$CU/C](^1FXYUR2AE7+#BM:.KC)=Z.LHC#DLH41Q2C=EW%I
M![ZF2I24I[ZUJ/G[L&%=WWJ*UB8ZK=NY"D_4IIOY#\^.+D7+O34]RRY/[7=O
MSJWQ]J;I\YD#:(6)O&-,L:@\!(<3#0XX5.$_E([*R,]B=]!XL_ZI?76-N'6^
MQ='X=Q.QA691N1K6C<9+55[_ $'Z,/\ IC^7E_IOR<>[[E"F3EI24FJ57L/N
M1[ITIR[']"M$-<.HW+5HB6[$\:N!093JDMEZ1(MZTLDVXXILB,WR26Q1&.&_
MZ;/EED;GOM_J?)@Y.$X\K:[&X\-.[TG<GXG>J+5I6=GC-1QN63DJZ>S6G;WT
M,&KIGPR_]=?F$S,TO)OW6U2<WO%WNTF0IR4VF+ OKDR EQQPI222;;A4J?9L
M'W"\U>H+'2'2#AAM*[<MJ-NFFO+27<>%/*GI'*ZZ\T,7FCS;99NN5_M5$ZQK
MQ7:OB,RYTX\6'%BQ&D,Q[9"@VIAEM))21QXZ(:>!"2(BKP=A#YXYV=*Y&[F>
M]=DW7OJV?7O P[6W8MO$C2-F$$O0E%?0BZGTFX%]$-.HMRE%2XWXO2))K11Q
M*/#RB,S0E1D9#L[RZV>6%M+SKRID9+K3T(\4>=?5"WSJR>'C2YL'&TBZZ5UK
MVGJ=!*2DDF5=]3V>ON'8L:TUXG3G U!)(           &DM!KXD*(C:4E25I
M,B,E)4FAD9'V'43I3TD:U]!A(_K$/E9Y;9\PE=:>AV.2;U8KE1S4^PV> M3E
MM<8:FN(FML082W'T2%GQ'MV&1U';OEYU9#!G]@RG1-Z.OJ])U7U_TM/+M+==
MOC_Q-M-M+\[Y#$A3+2^1\!+:>;4IM]I]M4=]IU!\+C;C#I)<2I"ZIVE78.^X
M9-K(BKEB29T2K\IRE6+C<3U3T%9/81\/?38?<);OMU7 R.:?'0DWR;2;CYI)
M"*[S+BKW)1[Y1GZ@E7.1<UVG(BW*ZK?[1_ M:EZ3R7O+1U!ZW>H'']1,HQVX
M6K073BXQKK=;S<X,B-'ODJ-(A3X,>&W,AFU*XW$4JA5*5/<.K.ONKL>QBRP,
M>2E>DJ:/UG8G0G3.5N.='=\B+AAP?LI]NNI^DQ9+/!Q^S6JQVUAN- M%OAVV
M&RTA#;;<:#';C,I2A"4H31MHMQ$//$I.4G)\6ST$DHI17!(^H()
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M5Q[.D>ZM67/"W;=XV5)+@=;,D20
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M?8'6?/XB3.W8P46Z=IJ 5
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MXV24$V1*:<23B7$K)25(7M0M*B,R-*BW4[!TA&3NKQ)*DSMBD8M07!F\ J
M
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M%OV'V[>PNX7N+T(X<2O>!(          W
M                                                        (KMI
M_9_:$)ZT!'&1$7%LK6A;>SV!536B(KI4J$$@
M
M
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M*&78,C<9J[E2N6_<YCB,2#LV8P>DCMD8Q?
M                Z:UA_P!G6S^?,?PJ1>M$,[<A_P"1Q?YLQ_!)%I\23<B
M                       &F]]R=_>U_P""8 PH?,A*O5[J3ZEVM/\ ZV^.
M4PZ*W[7:F47%6XFC*7Z *?T3])J;OF7_ ,8AQDO>?K+LN.O<>QGW298>>/<T
MTXZ?K-H-1_4(04F#QYB&;(U ZW]2+JEXWH=KD,Q6DDKB0@VE2F:%XE)32GJ#
MLORMQN?>U>IJNWXC;.@;$K_4/,U6W#C\AX[O[;K5GE&APTJD+;-%#VDDE'7<
M==I;!R'G]N[V_;L7&N?L+RDI+OXT/+?_ %#][NRZ"Q.G<"YR3OSU2?9%RKI7
MN]!O]+; >3ZC8I9D).BID=QPR3QE\D\PLZE11%4=!^1^'"SUG/?LU*6UXEF[
M*2?IBVCY/PVV[U%F8'2&T^SD7<BS73NG&OQ^HR!X\5,*#;H3**(3'ML1I)?;
MK::9.A%WJ/N'PC_%AU%+S'_$-U!E8MQRQK.3&-O6J]^2:6K^0_6OY#;%_"GD
MUL>P8\5;R+>'%W'2G"W%NO#N/)?GJ]0)]/?0-@/3Y99Z(N0ZUM2COD9AQ*)B
M6HB)2HY.H;=:?(G*;"-)U'W _P"GET(NGO*_&W:]9Y;UZW[3:I72&NJ1X)_$
MWU-'>^L<C9[5[EJ_U;3T]E.NM>V53Q5Y('3J> Z0WW6F[PC;NN;FVNS/OM&3
MJ29.(<A3:G64K+C[:*/>.PO/GJ6SE;]'INW.JQJ^KVJ^FAW'^#_HR6!TS>ZG
MS[?_ !6:Z)M:I0IJJKM+_&GF)R<]U"QS'(C9K:5*3*NE"JE*676WO&?"HMI5
MWCR]M^U9>Z[O'!QG['.G+U)U/4?6_4]CI3I?)S<U5N7(.-OOJTT7L;9;$6N%
M"@16TMQHL9EE*$T22>6VE&XJ%]B/2,;:MV;=K'5%;C0^>EZ[<OY-R_=;D[DF
MVWZ74^HCFU/CW>Q^P,Q4Y%7WBRN;G?U>PUA!4             'Q[[8[3DEJ
MG6.^VR%>+1<XS\.?;Y\=B7%D1Y#2V76W&)"%M+)3;AEM(6X2O6KBE!T2(E&,
MXN,E5,QJ^M;]6SZ>M<LBO.?Z$7E.CF07#FSY5FC1&I5MN-Q<5(??-L_15^BD
M_(>J22(R+=4;]LO7>Z;5'PY-S@WK5]GQFC[WT)M&[3^T0@K>4DZ-:+XJ%F.\
M_JR_6$QD7HUHR^WR+"3QH*4IR*A7))7#S#;.&1[4%6@[%M^;&+X:YXOF2U7?
M\IU_/RGSG&<+>33F?LNGNJI<4Z5_U7K!;%>K)E_4CJ YF#$&3'D2,(C1&FF7
MU,KCOJ2],*&@B2:D*3LK6IC3=Z\Q]QSU.SC^Q:EV_P!&;9LOEMM>%*W?S?UN
M3#M[.SL,J/2+1O3G0K!['IQI9BMKQ+$<>B-PK?;[;%CL&;3:22E4AUEII<AZ
MA%5:ZF=.X=9Y61E95[Q+LG)OBV=DV+%C&M^'9BHQ[DJ)'9_BXO[GV.[V]X:4
M])7K7T%0@D               T7R\'$15-.TO;(4--S27!\2&VE5<3'J_6+N
MF%>MG1E*U*MT5+U^TB4[<XY-LDN3Z--;>1(-*T,N.<"#ILJ1;1V-Y<;A##ZA
MC8N2I:N:&E=;XUR_LSO6(UOQX>BO$P!](]0KIIAJWIYJ'97W8DW&,KLI/.M.
M+:63;-YA)F)4M"VU$7 R9'M(>B-WQX;CASM?[J4'\QTEM]Z>VYLO#7-?4ER_
M'J?K)],6KEJUPT$TPU-LSJ'X>1XK9G5.-N)=(Y3=OC-RSXTK<*OI"5=IF/(&
M\8,\7<;F,OS)OXJGI3;<EY&!:OS]YP5?70[^21$9T[:;.Z@P^:OLOB9R7:N!
M4!)H25FW&D+3[Y##JR]=+:C+ZI"'P9*U:18(RFX+R37352Y7-)G-BS&6V5N5
M-7"EYQ"23Q'4B(NX=(=8SM1RI*%:MZ_*>Y?*#'^S=,QE:IRRCK\AK/.+2M#9
MG5OO[_:&MVK<;6&[W:=LP49)S7OE2B,MV[^SV18A+GCS=Y"I\)3L[2K[-!6G
M0G7L*N6U,:D1G*<M,9\E$>ZBFE[ZUK0@;M0N0N9'[.OSENY*=F+N0UFTRU+E
M5RDX'K!&R*QO*959;Y'D&ZTHT&E!7!+BRJ@T;#2BF\AYTZ[W?(Z \W,#J>S+
MEM7KD5IVQKKW=AV1L'2%KK_R?WK8MWAXN;"TY6JJK346]-'VF6]T]ZGPM5M(
ML1S:*ZAY<ZU16Y9(6E2DR&&6FW.+A6X=3/;M.NT?17$S\'=,.SO.W^UCY%J$
MD_6DW\3/C[?P\[:<W(VC=%R9^->G&4>U)2:C\B1W:AY*T\6TB]GW!G2K%593
M%\RYEP*TJ)15(0G4DJ$@    AUIIQ!ID1G[\MI;CKW[]A"APYO>8]90\A:DT
M1V_V;ZB6G'2/ GG<5[/$\J]56G:<TT\E3&&N;=K(VMYA2$5<X.%U;FU*%*V$
M/*OXN?*S'\P?+#(OP@I9V%!SBTM:)-]S?$[;\E>J_P"'.K[./DRI8R'1ZZ)M
MJG:6BXDIIA2$7&*B= -U<*Y0'VTK2XTI?H[QJ2LE$7 CBWD/B1T[NFY=)]28
M?6NU7;EKJ?:LE<O*W%\L;BYE))JND>T]Z9F"LVQ?QKE).];K!\5K&J^<\(=;
M_1?-TQ@0M?M)X#MTTORTE/W.%!;6\5A>(GEO\Q##!\*5K[SW#]5?X7_/C;O.
MORWV_=K\XK=_ C&:JJUA&"=?:?%GC?)NO W[(Z?SGRYMN;I7M3;I0\?=.?4+
MFW3-J19M1<%N$A,,I;)7^TI==]&F0U/LIDMNQR>;:JEA!EM(=_[]L>)U'MT\
M+.2>GLOM3UIKZRYG;;B[A:>VY"7BR3I+NT,T?IDZE,"ZFM-[1G.&W&,X^]%8
M^>+4EYI4FVSE-)4\TMI+KCA()2MAF/*/4&PY73>=+"R(M03?*^QKO.A]VVO(
MVK,EBWTZIZ/O1Z+2M*BJ6V@X-W*0YVN)Q:U=$0X9<!F>W=]<5PE5*2)Y%-\K
M+?7F0=-5NZE.G#++04%,C(\?A2+M8G4MDMYMV)'>><2VHF77/&1%L*FX<;NV
M'<R+#E9_;I.GJ[3J7SJ\O\7S$Z&R]E<5+,A!W+;[5.";BEH^TPB&&;C:)TVU
M7#F1[MCUQ?ARVW$J2XSZ%*4RDS2HDJV&UW$.L;.YW>E]\L[ABU5Q7%JOZVO=
MW'R2VB67C9E[:-[]C><&XXW$^Y.D5\%"YGHIJ(Y=,,@IOI.JAL)2S&NR$+=;
M2=&T$EY234EHO[XR'T\\N.O-FZIV&Q=LSC]MC"*FFU6M%Z:G=&W6\[=\&U]C
MC*6/]95=*'H!*4+;2ZVZTZAPB4VIIQ#G$E15(_ 9T,R,=F6E%)M]O MY^3<E
M=C9MIKPM)E24*XN$BH>RO%L+VSH0B,>=T[45Y&3#%M*_/6W(XOF.86;";1+N
M=QD-NOLL.KC1&5)=<6X3:U),R;5Q%PK2*+JE:LSON+=N"J_4B[9G]J=N,'25
MUI+T59<6\GVS87J+"S/6J1-CW+-3E(B>AK-OGV5I26^ TI/C<3S6TTK4MICR
M#YM=:V>H<]8&WUACVG1KO:;1[K\F^@K_ $QM*W#<&IY5Z*:?<J)]Q?1>EI9-
M!&DSXME2+M'3"E[+;XH[M<DIJ/>;I*N))*[RJ$9<T:E;5'0J%1         >
M;>KK;T\ZF?\ N]-_]7=%4722*H\3#PZ//^]/IR7_ /%=S]C_ %RT.1R8TQ>9
MD03<E0SCX3Z$QH+)^^.'%/VV4CB)W%;HGVD\KHGWG2W4[?T8UH7J1=E.<KT?
M&[D@G*\/"IZ(\A.WB3VJ[QL'2^,\[?\ &QE^^C\54:+YD[C]T]#;EG=L,2[3
MX821@F3I3CLV^S);ANNR;M<WS=.IFKFS'W*]N^H^A6=RX6V/,M:8UG'?R09^
M:W=[[W/JBYD9#;=S(;EZ6YZG C=*3+4O@W*J>_WJ#K]8?(7KG-N;QU?F9UN5
M;-R[)?\ B:/6&R8ZM;/&5K2S"VM.'%(M6=7F1N7C4N1!BN\;=L2A*4D=214G
M25N,R+Z@]E>1VUO Z"L:4RI-\S[ZTH>N/)+#<.B\C<K*I?C):]M*JID ^1/I
MBQC^DNI6J4B-P7')_06[9)6CA5\AZ&3W+6I"3,MG8HQU)^)[J3EN8/3EETON
MKE\I]6_P<](8U^Y>ZNY*V[U.5T[4E7L[T7BM0);T:R,V*+Q+NF27*!&B);J;
MBD/2T-/T)/B,B)>W>/+^WX-W=-RMPQM/#:YO3P/:W7^\VMIZ8R<VX^5Q@TOA
M31?,T1PA.FVE.'8HPA*50[;'>D)2DDGS9;2'W>*B4543B^[L'H&Q9E;LQM+W
MHQ2/GC>R;F1.YDY%7>N3;7PNJ^0[F2=4D?>+E&M'Q*5P) D
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M=?[/4%N[-6EKVD1ES<#6KLJ"G['.5=M"15&2DJH 2
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M99S;[;R"22#J:9'C^S%F=N5J7++B'1ZK0]PB@@
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MR$N)6+I
M
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MDI0G8A*2+81)20B790M07%RU9N122
M          !TUK#_ +.MG\^8_A4B]:XD,[<A_P"1Q?YLQ_!)%I\23<B
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M-?&7"BKMJ5/9J.V%%1X'F6K?$J$@
M         #2=4:>$B3Q$=:E6G=0)-0@Y]J*6_:4>\Z@U]TPLFLFCFH6G%_CH
MD6[),8N\);2T)<23ZX$CT9?"I#A*-#QD>XQE;3F7,3+M9D'[:FG\JJ8V?CQR
ML2YCO@XM?(?DY:^:6W#1O6O5+2^ZQG(DW&LHO;K33J%M+0TJ[SUPE)2MMI1>
M%LC+PCV+L^3#<MMA=T:E!?,>:MQLK;<_D3K>A)U?K>AG0?JU'4])U=Z1Y>D%
MYGIDWG1^0U&)IUXER?1+@W&-.Q;[CO A1D6XB*H\X>86TRP-U>5!/DNM_&FS
MNCHC.=_;_LMZ2E?AJ_4Z&2:?%LX?5KN_9'7=FDJRGQ-XE7L-07 4K22T*0>Y
M:5)/UE$9']0PXZ L6=1>.2M..H^^(>:5'LN;\E^V25(-ME;C9.N/(YAI0W5*
MMF\QU1UCMC=UW(K1GK[R(WE7]KEMUZ:<X]C?J])Q\O$W5144DJEZI'M*E>PR
M'7,.=+[-/@>@&N6=(^ZS3XN+:+G(K?L+@BJE-"HJ'LIM[_[0$/34V=TE1[9:
M+E<)#I,(:C/)-1F1&XXXTM+2$$9D:C4LR+8+MZ'_  L8VES7Y]G=0QLG+MXL
M?%O_ +!?(6CLY^<G\ENQ7.*_"5+D/+93(;<;6M'-=4VLDN)2JBB,C(>(O.S<
M\[<.J8XN=&4;V(_9K5=YZT\G,;!Q^E9[C@SC>CD1:=&G2J2UH7H_*0UK)<3(
MM'[W/-;L,VG+&RZY4U%P,\U+:5NGV'V$/:GX8/,%=4](RZ?RIIYFWTY:\6FE
MZ>P^7?XN/+271'F"NI+<*6=WDW))447%R:[$M2^"B4;:UM.%M0=2H6\CW#TG
M;NSG?E;?!'EV:ASJ,>#1N6'><DU4H,IQ2E5/0LIOA+B:X%0       &#Y%Q@
M,2X\MB0A+D>5'>8=;41*(^:VIO<9'V*&'EXEK==ON[9E14K%R$HM/M4DU^4K
MLWY85Y9EMM7HR33[J.I9$UNP9[3O4>]VPV31;[B\M^"9I,FZ/+></@\*4GL'
MP&\^N@I^4WFKN6W94']VYTW*RZ::N3TT2^(^CGE;U7:ZFZ(Q\Z]*N;;2C+77
ML7?4[TZ6[MC^96K*-#<]B1[SC621'&(T&<AMU*2<:2A7(](XR;5XSIPIWCUA
M_P!/CS0W/8=YO=&9]]QE<?-CQYJ<.5Z*OY#I[\072KPI8_56VKER(.MR2]/"
MM%ZN)8AZ_>AS(^DW4&5>['!DW/23))<B5;IS++CC=LY[LB0[&?Y4<D-&WL3M
M/</O[T;UGB]0X2M7VH[G!)-5X\*-'6/3^[/J/'Y)-1RK:5==3J3I"ZM<SZ2=
M2+?DM@F29N#7:7&9R6P<]U49<9QZ.VMPD<]#39M-),SH0Y3J7IK&ZGP98^3%
M++BJPE36NK789^_[/A;K@\D$I945Q[3,[T8UBPO6_ +)J%A%SC7&TWF$P^XA
MEUI;L22IIM<AAYM#KJVS;6Y3;OH/)^Z8&7MFXSV_+BTX-K5<5V,Z,S]NO[5?
ME9R(M23^,[/2HR-QU2N)&RB:>V,"RFVX15(&!)N"\1E;\9B9%?C.H2IF4PZP
MZA1$I*FWD&VHE$HC(R-*C[!<E5.C):4X.+X26IA4>:ETRO=/'4C<,DM$!R-@
MNHKSDUE]#:DQFY+BY+TA!FEEMHCXC[SW#K3J+;H1O2G<6E:P^5GRN_%3Y>1Z
M0ZXM=4[;"5O:\Z3>1)<.9O2NB7#T]A1Y:&HV!1-6W=!=:84>=IKJ5_%+:[)4
MALX<LTLHCJ;DK,U-5>49[",<YT3U'N6QY<<K!R'%_G1KHJ-=E4<Q^'+K79]N
MZJ?0?44(RP,Y)8S=-6TJZ]G!EZ3./*UOUHDO7'2/4!?S7)4[(@V:2R2BCLOF
MMUE*9"VE)6@D&DB.NX>K]J\]LO&Q8XV;8\2_1>W7L7PGJ;>OP^;;FYMW+V^Z
MH6KKK2GP]QTA<?+NZGV;%>I<[*&"5"8=?80RAIQ;K++:W'*$ADU5X$C<MM\[
M]KO9=JS.S3Q))-M\&VEWFD;Y^'C-AM=VY;O\W@Q<HQIQHF^X\.6K2RV0Y-P9
MRMYV\WA*YL*24@UI2PZDW(YGR7$F1>,CIL'?]W,=_#C"%/LTX)^OF1YEQ[3Q
M<OPIU639N:KNY9?Z#=>7]K!*Z1>LUS KS/=@Z<ZGRU1Z/.+1#;?<<8;BFGF.
M,LD:7#[C'A+S>V#(V/JB63"#6)>=5IIQ?H/HKY.]36^J>FK=JW-<]B*4E7N2
M7>9?I+;EQVGV5)6V^TT\RLJ*)3;J4K0M*B,R,E),CJ0ZW_.7<^)VC)55%Q-P
M@C))$?\ 9M%QTKIP(2:5)<2L02        'FOJ\42.G?4Q1I6LBQZ;X6T*6L
M_P"+N[$H01J485HZ^DJAQ,.;H[F)/JHTYK$N*?\ K;<RXEV^4VA/^N6RJI2F
MR21#D+\G+'HR+-'<=#.8A(0IF NOB*#%,O5(VD_6H.)NQJXON*N9<O+VIEOG
MS0]03P7I9S#@7P.7A+4$J'12^:EY'"5%).AJ,AV9Y5;;/<>L,=055%U?P4/.
M7XI>IX=+>3VY9LI<LIQ\->ES4DE\+,-FYNFQ'-W>;ZG'*[Z<TUJ.OLJ'K+S8
MWJWT_P!!960W2MNG=Q37H/@/TMC7-XZFC&*XW&W\=3B++B8S<N6\HN&/$F.J
M,Z$529<6G;ZY#Y)/Q\_?[=NU6E_(^>?^D]:VTK-NWMT-7-Q7S(LEZA7=S(M3
M+W*6:G/G"^1H#!%59JYL\XU$D1J,]B^P?2OI?!CLFQ6L9)1Y;"E_X4SW+Y?X
M]O9NGL7"C']7=Y5-)<>:BX?"9NO0;IBUI-TDZ4XXB+Z-<)EO5-N1\'+<=*8Q
M%?:-Q/ VK87>0\ ^<>]RZ@ZKO97-S*S.D?@;1]MOP]=(X_2/E_C8D(\MR<%-
M_P#>2?<>R=#,17J;U'8Q:9;!R;-AJGI=Q\)N-$L^6^P2S-*T$9*W5H,/H_ 4
M[ZS.R7'X*' ?B#ZA=G"L[%CRI*Y[WJU+[;;*$DTE!4;90EHB_N6RX4E392E!
MVK5K0\H-.BB^!NA
M                   #"P_6:>C$H%PQOJ@Q2W\+,_F,9>N+%H1/L(F*:6^M
MF,7OR56JE]H]#>56]7-PVZ>QS=9V]8:]AY:\S]EO;'UE8W6U+P]FW!TOT6G-
M%Z5T7]&8O'2IJK,T8U^T[U#C3U08L"[1(DXB6:$NM3I<6.LET<:+8D^T]E!B
M>??EYM?F9Y5[OT[N5I79/%F[:X^U&$Z:4?:;9Y>=23Z4\P]OW+&N^#B8]V'-
M_KQFUZ5Z/B,YRWWN#D=AQS)[-(2]$N5OM=Q8DLJ(TFXJ.Q*7PK0:B,R6K;M'
MY&NH,7=>D^HLCI+PY0W/;,Z3G5--15UN/=V+T'W$VG(M=1;1:S;$U+&RK";[
MJ.)=UTRN4'6GITN6/SS*5)^8)T"6VLR69N(A+)@U$HW#KQ4+</N/Y&]18?F7
MY$VL3Q5=SX8<K=Q5JU)0]FNK]1X@ZQQKW0?FG#-V[V+,,J$HM:?GKF[C&<L4
M"1B&I.?8.Z@VG(UZF$PA2309(].>W),D["2GN'+?].C=9])^<&[](9]RCRKS
MHFZ<)*FCI\QV;_U2^DUUI^'39/,C;H^+E8F.G<DM7K!\6D_G.;9M:FKQB5W@
M+22ZQ73X:5VH9</N/M'VMWFROL\[,?>XGP8\C^H;^U]=[=OTI.-KQ5%_I17>
M<@\FC.EXKU+7W!'GN2UDBIB$LFLTI4J+R>67":TD=33LV&/.?FKA*]T_#(I6
M=J7SMGV.ZQM+<]LCO%G6U.U;:_1U,LA9'XFT[E'4O4J?$?KCR_=F[,XVX+23
M.H5%-/T&LVDDD14VEO&1SIW.5<$4JJC1FI_9[8N Q!O.,DDCJPE(]'G.4@V^
MJF(,A]&V,_2BVT*2>X9F/I%L3I1%[/RC7$N=(^(\*'FZ.R?"^TXRX6QC>AQ*
M5$,6XZW&RI\$RZ,*2D   - WD$KAKN)2C.ATHDJGM]06Y6[J:Y==?G#DDJ]A
M8#Z]=0#R_6A=DC/\R!C)$T24KXT&I9/(4="6I)'Q>H0]K^3.QO:^E/MMQ4OY
M&OS'@/S^ZECNW6:VFV^;'QE1]U:,YAY=V G?]3;CF,B-SX6/H+D.+1Q(0XZA
MGA,C4A152OU1Q?GMO\-LZ>AMB=+E_C\%3D?PY=.SW/J2[O=R-;%A:>MT+X:S
M4IQ1*5P-%L3ZM!X_Y^2S&ZM9'NE*4IRM4XI4-Z@R-)$1D=.TA-:KF[R5IIW%
M8$@                                              :#[9N$2:=HI
M4O;Y7[M"B<:K3C4TG&_E&J'L3O*F[U:B(PC9QY17!L-MW8R[46?_ #+<,]%G
MXMF;+?W8G6Y+I)][P$\E)*,D_7,>H/P_[N[^'D[3-]SBOB/(OXD-BC;SL/J"
M*IRU4I?'_3B>4NCC,%8?KMCJE.\N-=W#9>29T2KC-A"2,^(B.H[)\U=J>\=$
MY%N*K=M*J]'$ZH\G]Y6Q^8-F[-\MK*=&^_@C(K6TS.AJ8DLMR(LR.;<AAU"'
M&G67VZ+0M"R4E:%(49&1U(R'@_&K8BX3XQ9]%&U<2DO=:^<P./U@KRLST%SZ
M3U::'XZ[^CW-7EO9]9+3"<5'QZ>@IKSDHFXL(DDW,?5Q[5;*T'H7RTZHGD6'
MMF3*MU>[5\5IZ3IOKSI^Q8KE6H<MJYQDOS7KV4[2PQT9=8^?=$NN]AULTRN$
MLY5K6I-]QUM]Y$2]17S92_&E1TR&63/DL\/CK2HWS?MJV_?,&YBW(IW7P?:C
M3>EMRSMMO)JOZI\&_>1?1U5_6<>J7,'2F:685!PB*F/'1Z(\F-<#<>0WPO.\
M3LU1ES5[:=@ZYP_*A7K+G<N>U7^G8;?D>:5RUE?9UC^SVNO^D^EHU^LX]3&)
MW:WR=7<'A9M:C>1Z?%9]&MQH8XVN8HEM3DG5+9*,3E^4[A:?@S_64T_I0HM>
M;'ZU*_8Y;*XO^C,I3H'\UCIFZ^+$PC!LE@X]J,S'X[S@MSEQ69L1PFF%J;C+
M=D5FGQO4HDJ[.T=3[QTQG[/>;R[;Y$^/8_D.S=AZEVWJ#%\?!FI1?8]&GZN)
M<T;XRD*)2CX4^ILV[J>N.%=^S=3LK2X<LK4X3YW[A]$A$8J*HB_Q D
M
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MO7!;<F0XXPHW)#9-K69$9GO,A&5)*D$56-$Y<6S*&&&70      *'/>F7?\
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M\VEQ"VRA))DR4@R/8++;;U*76NIR4
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MZXU#E4=$;'6I(D
M
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M>XK)S1"D9._:(3EZ2JI*3.5&:4_4CVUYM11<Y>9J+]GL,:"<8T[3L44%0
M                                      '36L/^SK9_/F/X5(O6NTAG
M;D/_ ".+_-F/X)(M/B2;D0                        @SH1F>XB,S]C:
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M?]^R=TN-M2N.GJ3=#L(<^<$
M      %*J$5:5I^SL,4O7V:53'#4T5<*R][Q)61H<2>XTJ\)UKL,J"IN-I4E
MIW%%7)UCP[3\]/\ 61^F%_1OJ[B:RV6U>AV#6!EIQQ3#/!'*3 :G*EK-2&&V
MR-QTC.G$9CT/Y:;I*]M#QG.MRT^'HT.E>O\ ;HVLMO&M^W>U<NZE3@?ZO%U*
M?H6ZX+7@,V[G;\3U:;?BW$G7S;B>E,-0&H?$2GVVJ\^E/"=1G^8NV3W/9)9.
M'%35JCKVKC4Q.AL_'Q-SA&Y)^/>T?=I1'Z-B'6W$H4A1*2XA+B#+:2D++B2H
MCW4,AYH44JT.]^9:>DU!)( 'EKJ=T!M^O>%/0&TIMV7V0ER\:NR2+FLOI0I1
ML\1-J4:7U$1;]@X[==MMY^*XO6Y30V?I7J?+Z9WBWD8\GX',N;TJNI: <O%\
MP2\/X-JO:IE@R"WN'%9N*HSZXMQ;:4;3+A/FA#*:H;KO'26\;9F8F2V[;23_
M *=A[AV+K79-YQ;5S&OQE=<55::.B])R=$J"ZVEYN?#4RO:A:I+":D95+8;E
M=HX;EG)NJ=5Z#<[5ZW=CS6VFO6?*NV48[8(ZI%UN;#9(2I26V5H?6X=#-*22
MVLU>(RH)5N=.:FB*9WH1N<E5KW:GT-!,)G=3^H\.#--RR:?X[)1+>9=JVN^<
MEQIYM!(<(S.M:;J;1MO1NVXV5N#R,IJJ]V/Q'5/FUU!G=-[/-6(NY:OQIS+\
MWBCXGFJ: 1,*O6(ZD8M;D1;*['3"N;45A*&F516'&D&X;3*$5<))'M/M'FK\
M6O0L\?+L]7824<>YI<25*-)^C\IVG^!SS*GD8^9T+N4W.\_:MN3KQ:>E7ZRW
M7TW:IR]%];\,S2(ZMF"=PCQ9_C,FW&YLB.R9.>-"3)*:[QTU^'SJ^?2G76-&
MY=Y,/(ERS[M7%*NIW!^+WR[EUSY97=SP['/O&$JQIQ27,VUHWP,P2SW6'DEF
MLM_MS[<B'=+?%ED^TI*D&3T=MXMJ3452XZ;Q]8;,+<O^(BTU.*:?>FJH^,OM
MJY&,5^LA)Q:[FM&O@=3D,0T*2:FU\2=U*4IO%NTY:J2+KE%U2XF\%X@
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MJ'W"HJ1(
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M?\XUVFR;01$5._;7:+M6UJ4I):]K-0"H
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M<QP=7+5\3ETJ*AJ 2
M                           =,ZHZ!Z2:S.V]6I.&6S*'+5Q>@*GLMNG'
MXR5Q<!K2=*\9ASR7"HKV'5)]"/2HLR4K1_%ZEWP(U>[[R8JYY27%T)3IW5/M
MXOT9=-F&9!"RC&]+<<M=]MR^.'<(\)A#S"ZI5Q(431&1U27M"*LER;[CF&I7
M3AHUJ]-AW#43"+3DTR CEQ'[@PVZMI'":"2DUH5L))T%7/)<&0FTJ'6G]!#I
M4_X/XO\ D$;\2(YI=XKZCE6#](W3UIQD<7+,,TTQ^QW^$9JC7*'#CMR&3/AK
MPK2VE15X2W"&V^+',ST,_$CS&519L6/+BK3PK8E,M2&5)H946TZE:%D9;-I
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MD+:4EMLDK=>>><42.7LJ>RHIRK:MSHB+<N:)?!&*5@
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MJ.6_O,=@=5^SCX\G[K3.O^G9RN9>0WPK^4R2&SJDO7/ZYC2TV]6;8BL2
M                                                  !P!P#.]4<#
MTSBQYN<Y+;,<BRS4F.]<I3,5#JD>^)!O.-DHR]04>)#FY:ZLKC;G-5BM$=9_
MTL^GHBXOTHXK2E:_.L+=W_Y0+RMS?!,I:IJ=DX'JI@.IL:3,P;)K9D<:(9)D
M.VV2S)0T:J4)9LK615J$K<XJLE1%M7(-\J:J=A"@K
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M<%#2M7WPAQ65@96'%/)C2O SK=_'O/\ 42YCW2,%-/@70)
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ML-HT0'7*K;)=625'/B6HCWB-DMQM[$TE1\S^<N[M>E+=?#;K[*^8R<MXJ+(
M  6L?-ZP+)LWZ1LL^C;,J4Y:GX<R;#B)><<>AMJ=4^9MLI6I24-D==@UO?<:
MY>OX]V*K"-S7XS9>G\FW95ZU)I3G!T.3^5C(T\G](FGC.*1[0F?#COQ[['0S
M#*Y-7!HVVW?3$$7I1%5)4XRWC==QE=F[;E^S\-4[N!I^+"$)W.7WW-U+COH4
M/;6)%_ -;?V@XZAEU9/H4/?Z)&J6X^0U\0 ;@J%X2H5*;"*A%W>H% 2
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M31W8((  Z;U@VV^V?SYC^%2+UKB4RX';</\ R.+_ #9C^"2+3XE1N1
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MP\*4T2@NSA3L*GJ#T"W%^S'L/$4%)5YNUU-T(+@
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MKG;=-'SRDW31?(7'XIM54EM14+>DJ;^T=KR4O$37NG4U.5TE[QO!62
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M*:GQJ[2J/1,+%O&A&Q:]R$4OI/GAD9-S,R+F5=]^<V_C>AVD)+(
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MA;M17R(Y:...2
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M9E4O"D=%^;.!"UE0OQ[3NGRKRKCQ[V#-<JM]GQ&<T1$14+=[NT=,';Y(
M
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MY<AZ'*:87]H\XPM#2_\ DK41BEOL!B@WCK3ZI.@GKGR.W]1<N_Y%H7>+C*]
M=*)/<@L0I<AWT=]J3Q)C?Q5A)JH1F6P9<+<;D$H^^6Y7'&?M^X^!VEYB/F]Z
M+:QZ W?1WI].YYKE>HD6-;I/HT"1QVQ4CB0;'+9<<4X9O+21G0Q<Q[+MS\1Z
M)$7)Q<:1UD>UO)-Z:<OT'Z;#OV;0WK9>]1'FKPNVR6UM/QV32A;:EH=996GC
M-1[#+L%K*GSW"JW!0@EVEZ(8Q6
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MI]Z/)<<.YT-FLM2MJ2[54^^+1<
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M%IA.7EM6PTSEQFE/D9=E'#,6[DE%Z<"B*^,["$$@
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MP'2W6P_\^8_A4B]:XD/5';</_(XO\V8_@DBT^))N1
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MIL&ZQ;E[;[3K%::&H*B0
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MQXGA)PBX3TE%T?P,^@-U1E)7(:PDJI^L]=<2:5KL[Q=K7AVENJX]A(
M #S=U<_]WK4S_P!WIW_J[HJC[R*H\?@,._H_(OZ4VG)G_O9<]G_YX;&7E1;L
M/330L6H>)<2?8V9R4-PF[;%49^\@,.&7]REA!G]88#3:HN)==(U]!AW^:#J
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M=?'U:^DOBLI2VTVVCWC:$M)]9LN OJ)':KXU/)L6FM#5$$@
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MU!'-O1K:QE5/XGW&0"DB2DDIV)21)(NXD[*>Q0>.:UU?%GO!))47!%0$@
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MU_V!TTFFJK@=O4:T9(D
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MM-$E"$)25"(BH0M-T=.\)?(;@"0
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MKE7!:'T!25
M   !"CH1F)2JZ$-T1(H4:.J[22@C,RKW]E-PB[)PTBA'5:DT,S(Z[MQ4[RIO
M%:=8D4U*A":? D"0
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M+4:E'1*2N$0U*,]Q$1/5,S"C!N9-QM\/@]+GPXO,*J/293#'&6^J.:M/$7K
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MW2W/O*]ZTS-C.N*]9"'5*/V@HP'KO:8SALR+I;H[J??-/38S3A>NA;J5%[0
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MM)QG'B HEP
M                                            *%W!V4[  !;HZU_+
METHZVYN.3\^FR8<C'$O(BJ82E7$3R74JJ2DJIL=,468_9\C[0J*XRY.YXMC[
M/+6WZSEO1/T):<]$=DR&QZ?2WY;&1KCN3%/I2@R..EM**$24U(^6,[)S9Y:4
M;CJUP,*QBVL9UM*B:/="=V_B]6E.T8G R:UU*@
M
M                                      !LW[=;Y*^.3!AR%_;OQF75
M_"<0HP!KLL,QT$VPRTPV6YMEM#:"]9*"2D@JWQ!J@
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M;'?XL>;9;O;;I%E-(>9>@SHTI*VUI):3(V''"K115+L$T?%< ?9$
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M;\G\1=*E='75"YT#1= V-79S>L+"#)W+^<^<I\SIO?KS2IZXLN]#Q.>FA?\
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M:[M;)4]@Y\PTR(L:;'>D-J+CH?,:;47LBMY%MK2.HK*M>;0N%>8%T5]5NO\
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M'7^Z:@:1ZZW/%L,EQH*(UDCRI,=MAQAAQ#Q\#:B3XUJ(+>1;4=8D:Z4=%W'
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M:"U*K12*TW'4B^L)<N2D(HIC)Q-V+O'4@
M
M           *$HX:[:U$R?,J$**3KVE1$+$+7*^9O4J;!$1%0MPO<2"0
M
M
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M$DL24*2HB-*DN,K6DR,C*AUH+<E-/AH4J6FA](5$
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M_P"^Y.Y76W.=QZU[*NGR',^!)]]>_B57VZCE4J.JXG#O6/+V%?\ 9WB0
M0TF )     IV@  %.T  !"23KV@"0!%%6O: ) $45:]H D"G;W
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MJ]BX'CWA.O::Y%0J5,_5,"KUD@         "*=H D    $))< !( A)+@ )
M$))< !( A)+@ ) $4[0!( BG: )        *            "*$5?5WB$DN
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M:=3A$G5FX]45RI']8^!3Z"17&2DJH@"H
M
M
M
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M[3UTJC!M35U<\>!WP,<O
M'3>L/^SK9_/F/X5(O6>.I#.VX?\ D<3^;,?P21:?$DW(@
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M2V%]0=X1O1O04X^Z>,H6U;C_ *SXFY$E8
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MV#9ERN33]XZPK62;-PW7A+BW@3.G-IP*P*0
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M5F*A;EVN7 ].3<YS3BZ4-ZDJ$1=PF"DHTEQ+C=74D5$
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MTJ9GJ"HDMO%VU[R/:.FK=M0]9VS)U=2H7"D
M
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MCS,+]J3,;Z7]?+GS,ZL[2(6)WJ>Z3;MUCQD,-^CJ7)E&I9\3AT.E:CSUYF=
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M9V)PASO@0IVW+D3]HO=PY!2XD661&12H[,A)&5#2E]M+I),N\B5062HW(
M
M
M
M
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M?+BMUL*M/X\Q_"I%^SJ0SMJ'_D<7^;,?P219?$DW(@
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MT''0IM'">XMA>Q]4;19A&W;48\#KQM-+O-P+A2
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MUW.W&_N%S6[=N2;?H;=#LI+2$IX"+P]U3_L[!=>LN;M,$U-P
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M+BJG<_+01UIM+U3]T:XE147 VU-I416)(
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M:[:_Z2X2CBX2XCXE=IC7(NNO8S8.S7B5B0
M
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M+47!:4+SD53"F&5176G8IM(]'6RI"VE-$DB;-MQLS0M!II0RV"QV^@I1N
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M37J*%6NO$UA)(
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M$MH2A)=R4D22+VB';)X[7 K
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MXVX^[%)?$5)2I*O[GM/9W>WO%*22])*33]!J%L("M\20(
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M?0$$@
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M9C'R+?ARH(RYE5EXH8Y4
M     :3WW%W]Z<_P3 IG[C]3/%%P_P!K73]_<_A%C=]M_NWP'2&5_?[WK?Y3
M:-[E'WG^R8OV>+]9AO@5"X4     $@20!!($^L@"    D">) $   !($TJ0!
M  $@2]1O <2 (   "0)>I $  30":,@"            ) E:D 0   $@20!
M   2!+]! $          $@20!    2!) $             !($K0@"
M    "0)  @"     "0)( @ "0)6A $        !- )H %:D 0
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MF:%%09VX3^TY;OP[SBL:V[5I6Y':B7$+(C0I*R/<:5$HC]DJD++YNQ%TK$@
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M:5,7'XT?%Z]S/;B(O"[S5+-6_9V;1V$U653S[.DI\RT-RE))*A"26ZNI4!
M                                                  $*+B(R[Q*=
M'4AJJH4DV1$9'XB,J&1E4C(]AD?>1A)\S3[@HI*G8?GZ_K*?3/(THZKK+KA;
M+.F)9-76:R)$=DD,'*M[,XY!K-MAMM*END9[5&>T>AO*O<XSVV>-*5;EOL]=
M*'2?F#A3L9G/CV_VRJY=U*L\X_J_G4M'T#ZZ\<Q2]W-4#&-5#D0;@2WU-QN?
MPP8T-2TJ?::4:7#(RJ1CD>O]NEG['=E!>W;HU\K9PW0.Y6;&ZVY7$_'O54GZ
MM$?I+-.H?;:>:,EM/-H=;61E12'$DM!EWD:3(>:*4X\3T+6OJ-3:+=9\W^J2
M"K3:5#[MXK!(    *%IXJ=I%]C6E?9]0*)Z,AUK5'3VN.GD?43!;K;.6DY\=
MAR3!=X2-;;C3:UFE)\"E>/U!Q6[X%K.Q'&<:R2=#?/+OJO(Z4ZCM9<)?\/*2
MC-=E&UKQ+-ZXDF%.G6RX(4B1$7)AR&5I,C4@S6RDS)1%L,B[AY]NX\[.\3LW
M%7'=53LUT/?=F_C9N#;R\>2E;N*,DUWZ,ME:^X*K$,QE/LLFBW7A:U1S2FC9
M&HW5+*I(2G:9CPQYO=++I[K&[<:<=NR&VJ+1<7W(]=^5'4$MXV&.)<:E?L*F
MKUIHNUGNGRH];%X3J+=-)[K)Y5NRI:5VQ+SU&VWF$L%\F3CJ4EQF9EL(>EOP
MC=;PN/*Z4RI+ET\&KXM4K2K/$/XZ?+Y6\K$Z[VJ+=M562TN]NE6E\[,C53SE
M3X"(RH1IVEM(RJ1^R/<M_GC"MOCVGSK5=)OW&51G''$F;E".N[8)@^:*?:7)
M<E%RFY%10        &WD<7"1(WF>_NH+4X*<EK1H<[AJE4\.=:.FRKUBT;,X
M$4CGV2OI2VT56I"B<X35PH,SH1]ICY]?CS\L[N^=(6NMMJM.>?@/VJ*KH^;7
M1-_*=_\ D7U7/:]_6T794Q;[7%Z+AZ2W%@N4RL0RRQY-$<4TJ),:1(X5&DS0
MI]I#A*X334B21]H^8_EWU;N'1OF)M756-)V[,;L8W*-I/VHIUU7#TGKWK'8[
M>_[7D;3=BOL\[58?HMZ%]K%KY#RS'K3>(+J7&)L-APU),E46;2#<VI4K:2C'
MZ(.D][Q.I=@Q-_QI*5J]8BZIUU<57Y7WGS4WO;[VR;M?VFZFIV[C7=I70^_'
MBDPYQ(55*_?>N52'.P4(-JOM,XZ+:CR<4;PD$2C41[^SV*=XO5(IK4AQ'&5*
MT_MB'3\[@'7LXG76JFE>'ZPX+?, S2UQKK9+U"?BN-R&FW%,..-.(:D,K<;<
M-MQI2ZU+:,G;-PR=LS(9N#-QN0E73YC-P\V]@Y,<FRZ3BU\)AH=;/1OEW2/J
M-.MKT65<]-[U+D/X_?$QW51VV'G9#O*6HHZ&V^4A)$53'JSI#JC%ZDP5--1W
M""]J-?4=W[/OMK>L2-QTC>B?2Z)^L"Z],^4RL7R/BR?0_/$_-&6XW.6<B(TU
M.2U";DMID/<EKT=*S7X4]@P^N.C<3J[;)0E!1W&,7RNGH?H,;J+IW!ZEQ+N#
MF14G.VTZI.M4U^4Z[ZXNFZVZ*9VSJGI@M%]T'U6-=TLMTA))V+;'I9O2YD5U
M##?*8Y;CO"7$?8/!_5.SW=JR)]/7XRAD0DZ2::KJ^T^'OXDO)W/\H.J\G>,7
M'E+I[-F_$HGRVZN25%RI:\3DWER=9MWZ2=:K5;;O<'WM*<ZEL0KG$4^OT: N
M0]&99?3Q/MLM\)[=W8,?I?)O[=>E;RW^IX>OA0X;\.'F[=\MM_M;!GW7/I7<
M)^Q5Z6FVJZMTUX&4CU::>6/7W1)K,\46Q='X-O;O%DFQ.!XWHS["I+A$ME+I
MF:4.%4J[*CTUY2=77M@ZGMV[DO\ XO(HGKI5T]-#W_YR]*PZVZ%ED[326;&"
MG;DJ/V6F^*J6%;A;6+W:[OC]U8)3;J)$5YE:2(RDQR<::511&:32Z52V#VO?
MLVLVQ*SH[%Z''UK_ $G@>7VG;59N3;^\,6XG3M]F6OS%QWRE];YT>TY7TU9C
M<>7=,+D&[BC<E9F[*ARC0XXADW'.)9-),CH2:%0>$?,3IY]+=1W<*S67/)RK
MV*K?Y#Z6^6_5_P#'/1N+N]R*ADP@H2C55I%)5?:7N8Y.$CY7W]:&??38-,?<
M;HM=>TUQ!(%,H\P/-W5S7^CUJ93_ '>F]E?^;N]@KCQ15'B8>71X9,=3V$RS
M,DE%O61R*["^XSC=K7LH:1R%RCBK?>TOC9:A<<%.Z^$83?Q)LT^N_.%9QU&Z
M@7E2S6:U0HQ557A1%94U0CXE=IF8[_\ ,7<?X3\AH8EC^\7[:IV-UK4^$GFQ
MG_?_ .)?<-PW!UQK>0U'N26B7QMGD7!<87G6H6(X>E"WVI]R94^R@C/B0V^E
M2^,TI5PEPGVD/GSB<VTV;F;#]M+55]+1V%Y9](P\RO.[8^B\Z,I;7D9$>=13
MX)U5:)TT[^\R1\?L\3$<8M5KA$EMJ!:XS9-)(DI2M,1M%*$22,^)%!KV;>N-
MPA)5FY5;];/U<=)[#8Z=Z8PNGK'LXF)C04>S2,(KT=Q<8Z'\-7#QV\YQ<8_
M_?74IBN+30R;9-!*-!FDCVG3<9CN[IC"AC;:K]OW[B5?B1X[\X^HKN\=67<>
MXZV,=TC\J/?A&1D1EM(QM$51'4_'4D2
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M/"R][NJMV;2BW\%:%W9LJ$:JUXCK]4QYN>B4>X]:17YW>:@@J
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ME)R?-[B[3=I)**IK(U2.M>PRWEOH+BJ]?S>PIK\94)
M
M                !2Y)-)]H-!:3YB5>P9>IVC'R)OFC%+2I,8\68=WGF:'W
MG2[J2QGJ!B6]WZ-9B:&[A)CLK-AEY@I"5G(6TTEMLU*V^)0]/^3V]?;MMN=/
MSHN1:?(=J]#[G*Y!82XK1_(6VF94>X16+A%6EQF0TVM*D*)1$:D)49;#,J[1
MV3*$H2=J6C3-XTMS;EQ"B,J*^Q[?K"%7AVE;G::<NTGC(54+:Y*ZA/C5P]U*
M^H7K[MPC6GI"Y*Z<#B<#$[SK9K/IOH[B41ZYS+ID%M7.;BH6]R8\>Y1EO*=Y
M2'>$B;5VD(SLNQM&QY&X9346X/EKVNC,?<,N6'B3G5*+7Y#]!31; (>EVE^$
M8+ 02(]@Q^V1%)))((GT0F"D>$DHI\L1]A#Q+N.7=S=RN79\)3;K\)T+EW5?
MR)WN^3^<\E>:0I*>B/612S)!%:$[3,J%X7^W<*K#3N)]AA23:H6OOU?"SV&\
MZ0:IJN5HM%U<1?8Z.;.@0IR^!1DHT<<AEU1(-1$9E6E2&1F<5W%K'35LR*8>
M)XK <)^#C./P7B.I.Q+-;8[I'W\QF,A5=G>,&-*51?X\3[$ELU19""VJ5'>0
MFA4+Q(41$1$%*/F[085VK.2V/0WS<Y&7:E.N6'%X-]0_*N4EE:&$-.S5.$XA
M;O)0X7"@SV&.0MW)7;-.U%+A^M4GVF8'H]K+IOK;B,++=,<CC9-CKS32&9\:
MG"JC2#HHB4HB41**NT]HP91<71\2MJG$[%O,!-TL]UMBB(TW&VSH*B/<92XK
ML<Z[^QP$Z.I!AL:?Y/-\LCS,,JG:H6R?#TXS*[S5G>?1Y!0>3=ICBD24O\$:
M,LHZ/%O/<.3E<>18H^Q%AKEN\[X,N6^9IYG73I?NF#)=/=)\LCYUE^HT-%M@
MP+:WSG(K<E)\"G6VG5.&ZMQ1)H25$5>T8V-!VKG.UJB\Y)<3L7R+-!LOTGZ:
MYN5Y=;Y%KE:B3DW2-"E-N,OH8(FW4K4R\TTXE*R<V5+:(R;BG/0E1Y(I=I?'
M&*                                             #2>^XN_O3G^"8
M%,_<?J9XHN'^UKG^_N?PBQN^W?W;X#I#*_O][UOYS:-^],NX_P!D9%KBS"?N
ME0K*0    "0)7I( @ "0);J0!!($MU( @D"0 >H 4J! 57HBHT*(JTV>N+,)
MS<J-:%R4.5>DA*:G3<+_ !X%M+O*5)<(]A;.S=[(M^WQ["NBX$E2OB.A"M/O
M*/614CVEN$AD@%J "T( @ "0)KI0 *]@ +O( @D"7J %*@!70@"
M "0)( @             )IMH!--:   #U( @               D":5( @
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M@BB&T3GR2SKSJ<--FW>(K\8Y62[J%;&CD$IF16/R>*C2SKSJ<-*%MWB>*JN
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M]0K:DGCY$@R8)!J,FE_NFZFSL"I+C0G](5LVGR9%"X=O)6?OMW8%2*:>D+U
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M  $@36A $  2!-:$ 020$H@"  ) D@"         FFRH$TTJ0!!($D 0
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MIS8;9(.IEMH=2+<9=Y&,"U=4Y2A+WEV%:3<>?A$W7]FPA==7P8)$@
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M!P89J2HXL>J:T^1;+?O^Q!:*BX$-5XDE!A%PTB1RX:\)$RW0J[Z%PTV@24E
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M;B4<)\)<-"0E"22E*2V<)$6PB(AK:3DOUFK.'A52;DZHUSK38=#[Z?L"O3X
MP5:;3J??N $@""K3:=3[]P D      0+;C+FYD22+A
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MU(BN;CP1 K*0    "0)>I $$@32A $     $@37L( @      "?V )[" ()
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MK=49[3[1S65;E8NJWQ@U6IU/!-0?UTWS([:%HH     ) D@"  ) G0@"
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MZVD?\N8V]WRJ>SM%^S2NI#X:';</_(XG\V8_@DBR^))N1
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M/-7'4G&/=HVGVG>B>+A+B]]MKN[]F[9N&T/T&BE0@
M                                      0HZ$9B4JNA#=$4UXB+9L/>
M6_9N,C]<8]V4E<2CP3)5&M3  _67NF67IEU48UKK MB6;%JPU2?(89)#*9%N
M:G$ZIU3;"$$I;A5VJ,]H]%^6&[QR,-85R7MVM*>NATEUUMDK6X?J;?ZJ_K*7
M=2IY;\A7J28Z>^O?%K!=[JJWXCJCS[==$J?-N*I]2(46$I:3?::,T.J(R(R/
M<.1\S-GEFX$KUI:6U5?*V<3T7NUG;M[MXZK^OT;[-#])HGTR&V'F3XV7VFWD
M*(RHIMU)+0?;L-)D8\T\_)<\.1Z!=7%21NR,C*I;A-*:%7$D       !0X2C
M09).AGZQ[.TMHJCRU]K@4SYN7V?>+;?5QIK\TW.-GUMCT9E&KYT)I'A0HN9P
M&K@10N+U3'5O7.U^&WGXZ]=%ZSUAY"]7O*Q)=,9L_P!;'W*OU=[+=FJN$Q<_
MPVX0E-I5-;CJ>@+X2-:3;;<<623X5*VF=!Y_ZXZ6L=8],9/B17VNU%N+[=$_
M0V>MNCM_O]-;]9R(MJRYI2^%I'CCI-U0G:#]0V-7.4\N%#>N:K;=VU&I#:TO
M2F8C7,2:VDF1I+M'FCR/ZESNB?,>QC7Y.WASNN%R+T3]I15:M'8?XF>@\#S"
M\K;V[8D5/<,.VIPDE5^[*3UHWH9=-KN+-T@6VZ1%H<BW*''EH<0HEI-+[*'4
MF2DFHMRQ]8U2_:C=MM.L4T^]/4^*KK;NRMR35).+KV-.C^8^P+B*P
M    .O-4L-BYWA%\QZ2VA1R8;RV34DC-+S;2U-T,TJ,JGLV#KOS3Z*P?,'HC
M/Z8SHJ4;UB3C5)TDHOEIH^TV7I+?KW3>_6-TLMKDFJ^IM5+$5WM4FQW>ZV"6
ME;4RUSG#(S)254:D+-HRJ23W(*@_/'U1MV=T?NF3L>7%PS<7*ER-JCI&XZ4X
M=Q])=MW'%WC8;6Y1I*.3:2[^,:/YR[;TCZCEF.G\>T2WR7<["A+#I+61NJ:X
M6R14C6I9\-1]IOP?>:+Z\\MK&!GS3W7"BHRJ]7%))=K>AX5\X^CI],=1RO03
M^RY#<EII6K]!ZR,Z#UM<DXQJN)U @1U"U/GC5\0T2+A  &BHTDI1[U;*>N1=
M_JBQ*]%3Y(:S95RZ<Q;WZ[^BK%>K+3F>N+"C0-2+#%D2,?O#3+2)#SR&GEIC
M.+3'6XZ;RW*$9F-[Z,ZKS.F-P4;C<L";]J-=*-\?@.?Z;Z@G@7_"N-_9FTGZ
M/28>>;X7E^EV87C",SMLJTY)C\UZ,:)#3K7I#3;ZVFW&UN-M$X3J&J["I0>H
M<:_A[M@J_CM3Q;D?7Q6J^4[LM9&/<A&:Y;F+>BXR6C5)*CK\#.O<DC$XZ5_B
MD:#/A3=6"3]TW)0?"14+U1Y%\YN@[FR79[]LUJMB[7G27N\>Y=I\AOQE?AWN
M^5_4-SS<Z4MR?2^9+FRK<8MIMN36BC14?I.\^D+J:R+I.UIM&?6E]Z1AE^>;
MMF66DEK]#<BS7&HRUNQ^<VRHVFE*.ID8\_[9F9NV2M9UB3B[<ZM<*ZJIY;\E
M?,Z]Y>=6?Q/-R?1VYM6[\=>6WK1>S5+BWJ7>=:+;CCV0P-1L%?9F8-G[#-R@
M/Q5(4S'E.M>E36E<JJ$&3[O#O'U"\I.L\?K/I&QE*?-EVH)/OX)=[9WCYG;#
MB8>[_?&R.,]BW"*FW&CBJKF[-.TZZTHU%F:#Z]X5JC"6M-GN$Q%NR9E"E(9<
M;G/LQ&S>)*VT'1)U\1F.)\X^FEN^QO<+,*Y]K5NFO;Z#=_(/K);)OBV+(N\N
MT772";T3TKVF4S:[E#OMEM]XM[S<B)=(4::R\TM+B%MRF4/%12%*34B<VT/8
M8\;V;?ARI)4EV^M<?E/=#N>SSQX-*GJ_[#Z<=I#232V9FFM=O>=1$W)WJR6E
M"BVDHZ'0O5-=+G9=!]1+G9Y;D&XQ+#,=BRFC4E;+B6'#)232I*B,C+L,2RXE
M5F%3D.N>LN86N]6+*L[NEXLCMQNS;D"1)EK;6EJ7(2VE27)*TF22V;AOO0N7
M':-X^W/11@_F.COQ%8OV_P H]QQKBK6V_FD>=<,QQ[.]0\5Q!M*W?3[LTJ4T
MV2CXD-RDKJI1$JA<!'[8Z$\PMT61U+F;M;_WLO9?J;3/E-Y"]%WNO.O-C\M5
M%SQ\G.?BQ2;HHW*JM$Z:)]ADH6.S-XYC-FLT1*6HMKM<5M"$$22)91&TJV))
M.WB2.J81C<O.UVR>OPGZXNB>G\/I#I/!Z=QDE:QL:W'N]V$5Z.XN0=&&&J@X
MS<\OD,4E7AQ!1W%),E<+1MDHR,TD>TB+M'='1>%]EPGS<'P/)?GIU ]TZ@6%
MCRK:LOL];/=M%<!GQ<5:=E.ZOU1MZ24CIF3K!4XFL*20
M
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MC.<E+W%P/93Y(RJO?9O!>)
M                        I69$53V$5/K^Z+=V//&GI)3H6;/,MPST*\XK
MFK#6R23C4AY*>U"7B22C)/<9;S'I_P @=WN78Y.RS?ZN-&EZZ'D/\2VQVK3Q
M.H;7[554G\9YJZ*,P5B.O%B0I_EQ+Z:FI)&JB5U)A!$9<22[?5'8WFQM4]TZ
M.O*VJW+.J^4ZN\F=YCM'7EB4W[&5H_3P1D3)42TH67O5I2HC]11$9?4,>%;Z
ME&[1]C/H;%IQJNTE"JD=>SM]?UAE-4*8NI6()  @JU.N[93]D3I3TD:U--:#
M,R-._?O[J4WF(UXU(:J8\GG]>7/"ZI.GV;K5@-F0YK!I-#E7*,U"AI5+OMM*
M-(4^TZXQ$>D.+B)49E4]I&.Q>@.IULF?]FR77%NZ>IU]9IO5VR+<,;[79C7)
MMI_%34_/LQ+(,FP'+K7F-FES+%F6#9"P^RMI3\67&D62YMKE,J)*F7B)QR&:
M3*I5'HR6-8W/"D[U)*<'1>M?Z3HO'N7-NRVK<G&W*55)^AZJGK/TW_*.Z]\>
MZZNEO$\H?NL5>I>+V^'9\\LQ.M>EQ94>*PVQ+<;*0\ZHI22,S,^W?O'E/JO9
M9[+N=RVHO[.VW%_'H>ANFMWCNVWPFVO'BDFO@XEU T\1F=:>I3^V-9MW5):<
M4;"XZE=2K3M%'B+Q/#[2JFE21<(
M
M  &X 0K:1[:>J(<E!<SX"E="E.SM,Z_V=YBA7E+@@HT*Q<
M                                                     &D]]Q=_
M>G/\$P*9^X_4SQ1</]K73]_<_A%C=]M_NVO<=(97]_O>M_.;5OWGLG]<9%IU
MD_687YI(K*0 ) EH@"    D"?2 "T  @"    D"53M( @GU1#]'$E=_8>?\
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M:X%-SBDN!2+I;        ":;*@332H $ 0           !) 2N( /0@"
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ML=DML%9_^5C0FF7#W%O6@Q3D94<C,G"E570X3&L^%846_:7Y3FPDN@
M                         ;=<2*XLG7(T=QPMSBV6U++UEJ2:B &X$)4;
M8*%MH<2:'$(<0>]"TDI)^N2B,C#6O'0&FW'98V1V66"5[[E-(1ZU222:BI4[
M2'7L-<4:U]!(%0.F]8?]G6S^?,?PJ1>M<2&=MP_\CB_S9C^"2+3XDFY$
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MHVUI[*/!%RY&\O%6MYR;^-GT&U<2",]]-OKB411KWN)J"0
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MUNNX7LV]7VYRI7UZ'/&B>0E?$53J7"6SV1ER=3BK2:;4M(FZ%)6
M
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MAUO.;KRP7M=QVPXZ*3-T*U6FO$ 2
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MX3[S;G$HR-)DKM/L/?N%N,;<Y.[$NMM>S(W N
M
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M?7]P5*+:J4RDHNC-04E0!.NJ
M                        !I/?<7?WIS_!,"F?N/U,\47#_:US_?W/X18W
M?;O[O\!TAE?W^]ZW\YM&]Q^OO[]OU*"_9XOUF&^!4+A0     2!*IVD 0
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MT4_*8UQ4;;7M'LQI1&E"C+Q.%4S]7U?9#V*<_P"<1!5BVC<"X
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MY50UTI).PBH!6VWQ) @
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M\7[)\O8SA*')+WS6,D*XD4H2>&OL[2%RC\1391127*:I$1%0MPKK74DD
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M"2[B21$1>T0[F/%G'5\2H
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M/5RG)_&SZ=8&%;P]LM8D%2,+<5\21R)NAH29=U/:%N[&E[F7%F9!U@:HND@
M
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M]QF^Q;:]KB:XK*@
M                                            "#[!:FFY*A*-J;W
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M.Y!P?LW.)U/EV%8DWV19ZRX_$39;B+8?L#CEIE?8E[E#%XV_$[2!6]'1%L
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M[_!<2Y#O%MA7!A2*&7#,CMR"(C(SW$Y08MVTK.1X3XU,2,U*'-'W3[PK)
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MSBWO.O[MN=W<+[<KERY)U]%73Y#E=#))%3B*FZM*4&=%UU>C,-NO85@
M                                                      @Q3.O+
MH 0B%>74%!&9F9&G9N/:1[R[NVHB%OEDY=@K70P"OUE[I?F:9]4>-:^V^W(C
M6'5II2)[\=HDM%+M;$WG*=Y3*$)6XOQ>)1GM'H/RLW;Q\66#>E^RX+UT.EO,
M';/"RU>LP2C>3<GZJGDCR$^I4NG_ *\L5L5SN*X.(ZFK>MUT)3YM1EO*]!BQ
M5+0I]IDS)P]E2,<[U_M,MQVB[<@DY6U6/RFO]$;E'#W2W%5<[C:F_51(_2H:
MDM/,L/H55N0TAYH_MD.(2M)[*EM2HAYD4)*J[4]3T.YQ23?::G-1OXNV@I;2
M="MIKCVFH)(     (,S+<FOLD0 &1&6TJB')Q54*)\3CV5X]#RFP7.R3FDNL
M3HKS5%I2HDN*;42%%Q)50TJ,8F7CPS<2=BXO9DF<CM.Y9&T;A:W#%DXW;<TZ
MKN33:^$LIYGC,_3S,;MC$EM27693QQW%),DK9==<,B29I21D39=@Z"W/ >UY
MER5YM0;:4>],^A73.\X_5_3V/N]MJG(E)5[4E^4\!=16,S,&S3%]8,:0Y&DV
M^Z0Y$Y<?B31*):7%FHVR10C2V>\QY:\T^FKW2._X?66T)QM3NQE<:TY:2KV4
MX^L]$]%;I8ZFZ-W'H?=$KCG9DK2EKKRM:5K\QDG=.>IT36'2+"<WB.H<>F6R
M.W,2A:5&F0Q'90[QD2UT,U&1[3[1]!NA^H[/4G2N-O%IJ5NY:CJNUJ*KW^D^
M0'773.5TGU=E;'EQ<+UF]/1I^ZY/E[NP[T=<0E22/:I6Y.XU=WM#9US3M<W8
M:PYJ$U]8W!5H52H?=O$1]U%1(J       &DZDS29EO(MGLTV^P+<K?/--\"J
M,N7B;;@03+D9\R6EU*T*(RJ2DN$:3(R/894,8OAQO*>'<582BT_4U1A2=MJX
MG2=:KX.!9IZF]/OH)J3-?CQC;M-_6;L=1)X6T*,WEKI1"4[S'Q%_%GY7V_+_
M ,Q<G-QK5-CW!N3E32+?,^Y+B>^_)#JM=1=)+"OW*[I95$NVBHN_N.=='6HK
MF+9H_B4^3P6R^&11^8JB$.()NG#Q+));>XANWX%?,^_TIU7=Z%W"YR[)EO\
M5.3TK[-*)O2K[D:OY]=(O=]I6\8\:Y&'[U.+3KZ"[&VM!K42#J=$J]A15+Z@
M^R4I-QC)*L6M#Q0E%2:_.KJ:X%0    !&\6G[:T]Y$FP5%;6MYM;2'6'T*;?
M9<2E;;J5$?$E:%52HE$>TC(7(7)2IS*DUP9$;:M?K;;I(QTO-(\NE;#ESZA]
M&+29\!.3,NQRWL4,^$GWE2VF8T8U&DW%U.F[M'=_EWURHJ/3^[RI;>D)M]^E
M-7W':O2/5O*X6<G7(BJ1;[5HFG7XC'ANL=RY,',994B]6QQ;,B*M)M.FIM:F
MWB<0HB75JA[R[!JGGIY;7,^W]_[/']8E6YRKWEJUP1X2_&U^'6SO-F7G'T/C
M<^[VM;MJ"I5/FYI/ECK1:ZLT\1R>XXI?+?DMH>6EV$^V<AI*E(YJ>8@GB6DE
M)]Z23WCS-TKU5G]"=0X^\X<I14+J5Q:\*I.NJ[$SYF[-N-['LJ[B5GG*5)QX
M233HT^W1UXEUC&\FMVIV&P[]:GD'+2F-)6E"D\R-(A$V]]BI2TFITO4'U6Z>
MWS:^O>G;65A\KM7K-)1JG1N*57J^UG;6R;W=V6,-[<JY<91:BN*HTWP,AKH3
MUD:U7T:MMMN;_.R?#FT0+DEQPE/&A*4)CK-*G%N;4%3L+</%W7'3UWICJ/(V
MZ5?#YFTZ:4;>A]-?+;JNUUOTIB;W<:>1**4EVQHDM=6>O<BR*RXS8;ED>0R6
MHUEM422_<7GT)<:;;;;-9FI"_"KPI/8-)QX7)W(QHZMT^,WR]=7M*V_92,)#
MK!NL3J*ZQKU>,5)F;B]SR6.S;WH;;4:,<:%,6V\HF&.)'%QF==G:.6\W+UG'
MV3!M;1+GNQM4N=Z;J?,G?O);S7ZX_$2LC*P[U[H^]N%MVVI/D\)2C5THUHZ]
ME*%X#&K(SB>%V.P1FTMQ[7;8J6J$22YCD9OB*A$G[(O9'EJ'+#*^SY#I>EV=
M]3])G0'3.'T?TG@]/8*4;-C&A5))4?)&O=VIESSHOQ$[7B5QRN6P29%Z4@F5
MJ1MX&R;(S2HTUVG3M'<'1N#<PL:3OQY7*E/2CR;YT[[?W/JR> Y5QK'!?'4]
MQC=CIH
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MI4E&U.WL*OJ[1-WV_6+:<8T-P(X:%8
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MY<&<C&49UY>PU12Y)<2H"0
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MFFEU2V==M=XQ\F497'R>Z(QY53M+H QRH
M                  TGON+O[TY_@F!3/W'ZF>*+A_M:Z?O[G\(L;OMW]V^
MZ0RO[_>];^<V;>Y1=Q_LF+]GBV8;X%8N%     !($Z4]) $   !- ):H0!
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M/]LP/YPC^$2+&X_W=^HY#8__ +&'K_*>TVON37[VC_!(:2^)W7'W5ZC4$%0
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M8L/VI^]1]BJ7,T>]+V:;*;*G3Z@[8?$\C1X%0@D
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M63^5U/2>V7OMN!:OS]YQ7QT/3JVTE2G;^Q0<5%)NK[#DKDI227<;@4D@
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MUI<'K2M%^4O@.H:6:5GM6CWH]>W'.W8<5P/#:C"<U)\3<%N$VVW!5*V2*R
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M6.7&MPEHU%?,CYV;_N5S>=XO[BW[]R7Q5T.P1EG$
M
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M+U_VGWTTH>[1U*=V@
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M(G>\(0C#Q(<)&\.E2[SW X*3J^PJKV$BH
M
M !H/U2S(47ON2X9>NE"J?5$IZI>DIEHF_08@O48[+G]?>>JO!J6IB410R>XJ
MD7,D$?#QU/VA[O\ *>PK70RO6Z5:5?D/G3YU797/,&5N:;A5T^4YJLJ*,CWD
M?[.SZ@W7BN8Z]4FY\KX%':(6I7)55 9U(B[A-!0GOH>ZE-F_O$.M!6CYJG0/
M4PEO]'L=TJ>E-7& <;[8E>E?8]M=@S,:+>-?B_<=MU^(P,N\UF69Q][Q(_\
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M2U%80PV24I)*4D24%N(AB%1O@
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M $   !($KT\  ?H  "!6KTXD"2    D"?2@ ( @FH$U9 $$@2Z=A $
M  !($D 0      !($UJ %.P@" 'I!-54IQ*V=ZC/]D*@ 3PU( @G>!/'UD 0
M   $@2U0@""0)X  0!!($L@"  ) GL "E05.T J=H 5J0!!-0)JP TIZ2 (
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MNLXMTH]'F ]&N*7;%,!N!7H[X;9W"Z*9Y;KIMFVHMIM-J*AMD.4A#D@DN/\
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MM8?]G6S^?,?PJ1>M$,[<A_Y'%_FS'\$D6GQ)-R(
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M;N^]69%_G<[2FU'NHFSNTC(RJ6T<T::N!(
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MBE27'>;>33OXFU*(92HEIP+$HRBZ233])K\15I4J]U2J)(HZ5["=X)UX$
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M<^2/!'BJVI)/FXMU-Z!6
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M6YWMPNZW+EQOXV>WMFP(;7M5C!MJD+=N*^)*ORG+1AG)@
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MQ)B.;$E1Y3?WR,\V^C;N\;2E)$E]--56J-<E$=2(ZF6\NX2TUQ(33X$B"0
M      @S(MYT#MIVCT]A(#TGRY=\LD!7!.O%KAKW<,NX1(ZJ]W"\\@^P15%$
MKMN'ORBO6TC;-Y3C+JTMM9%8G7%;$H;N]O6M1]R4ID&HPJN\ICD6).D9P;]#
M7TGVT+0XE*VUI<0HJI6A1*2HN]*DF9&0DNDU(C(C/:>[U:!1BJ)
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M=92\DG5JW\1D8G(DG+E13"/+'TLOXC'*P
M                   -)[[B[^].?X)@4S]Q^IGBB?\ [6N?[^Y_"+&[[=IC
M_ =(96N?>?I?SFV:*K9GW'^R+]I^TS#I[)/JBX4^E@ J=I $
M     2!) $$)/B,Q3&NI5IH5J:,JT[:;?[50:T%*%!%0@42&ZFHE1)VTKW;:
M"H)T(,ZU,]X@.CU[2D202!*IVD 0      !($\>( /T<" (
M              D"2 (                              )  "7Z" (
M "0)( @ "0)( @ "02[@ )=.P@""0)( @          J-LMBNTZ_4V!<E2+I
MQ*XPJR!C0@YRU*I/E)-)D53[1D**7 H:?%D DEP(JV0:2+QF7L_4$2:CI34E
M1;-1"D'2J?9V[=_8(4V]-2JB[2E2TN["+=_9ZG<*DJLI;3=$0)*2M*:G^R*:
M%=$0LB(Z%_9L$HAJA1Z@A]Q!)I,MAARAJA G@B">P23V$ 034":]I $
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MDVUU(Z%0AR=UQN-<BI%(QI2;6O$N(F1&5#W"P02
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MJ-7DHJ==F_UQ7%U52U%2C&DN)KB2H
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M87(^):?M'F6$LBU=E;N+0^^*2Z
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M7A2C;UK4R++<VATBF-O)?;D-MO,R&UDZT\RX7$VXA23-!DI!D9&1F6T<G5?
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MTMXRYQ<GS]IV+."C[$7H;LDTW>I]0"KL2)
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MKENCEUNCEG@Y7$**]<&FR>6P1$X1*2@R,E;5U]@51DTZOB3%1CHE6)YS\O\
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M\-!-R].2I+W2%S4/3=",R.FTMWJ5WBW4 S(BJ>X.()
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MMZT];]!?+;22$$DMQ5IZU=GU!NJ32HSI"4N=\Q6)*0
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MNG#GC0@
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M",D)(]IT!T[.!"32H^)6!( $4*I'VEN]D 2
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MA%W8M03XZGKII*B:8(CVI;01EL[$$0TYSC*3IQ.W;:48*+[D;@2
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MX"U\4?H(^G.8[#^E,[M_YS)V_P#TP/SJ\S'_ /S&3_X_]H+HSIM+^X6OBC]
M^G&8JV?2B?\ E,G\=01_.OS-CK]\9/Q3_P!HG^#>FZ?W"U\4?H'TXS$Z5RF>
M1;:_QB3M_P#IN\%YU>9J>F\9-?\ O_[1'\&=-]N!:^*/T$%G.8E_^-4X_P#T
MB3^.%3\ZO,Q__P QD_\ C_V@^C.F_P# 6OBC] /.<R/=E4XO_2)/XX1_.GS,
M_P"<9/\ X_\ :'\&=-_X"U\4?H)^G.9&94RF=[$B3M_^F$_SK\S%_P#S&3_X
M_P#:"Z,Z<_P%KXH_0#SG,CI3*I]=M2](D_CA"\Z_,U?_ ,QDT]4_]HE=&].<
M/L%KXH_02><YEM_ZT3MG^<R.W_SPC^=?F8Z?_,9/Q3_VB/X,Z;_P%KXH_04_
M3C,3/;E<^G\XD_CA5_.OS-6JWC)^*?\ M$_P;TW_ ,OM?%'Z 6<YE7_M5./_
M -(D_C@?G7YF-U^^,GXI_P"T1_!O3?\ @+7Q1^@%G&8]F4SZG_G,G\<)?G9Y
MF5K]\9/_ (_]H?P9TW7^X6OBC]!5]-\R,Z_2F=5/9Z3(VU_\\*?YV>9G9O&3
M1_U_]HG^#.F_\!:^*/T%/TYS*M?I5.IW>D2?QPE>=?F:O_YC)^*?^T1_!G3?
M^ M?%'Z"?ISF1;?I3.H>XO29'XX0O.OS,6GWQDU]4_\ :'\&=-T_N%KXH_0/
MIQF6_P"E,ZG\XD?C@_G5YF</OC)K_P!__:'\&=.4_N%KXH_01].<Q+_\:IU3
MW_QB3['[L#\ZO,UZ??&33_O_ .T'T9TWV8%KXH_026;YEL,\JGTV_P#.)/X[
MO#^=?F;_ ,XR?_'_ +1/\&=-_P" M?%'Z!].,P(S,LJG'7_.))4I_P">$+SJ
M\SM*[QDZ>B?^T/X-Z:_Y?:^*/T%3><YAS4&>53B(U)*OI$@Z;2[.=Z@IO^=G
MF2K$O&WK)A"G&D_]HKM]%]+N:5W M<GJC]!XKU9R"]Y!KI";O=RD7),%O^*J
MD..+2@UMJ-? EU:R34S/</T.?]*??,K?/*.[NF\9L\W=Y_G2JGQA3BZGQA_Z
MA6UXMCK[$P]O@K.#'C%<*^UW:&_4GQ&==QG3U?[*#ZM.U!V_$;]NI\_%NF4L
M]X,(5QDJ5IZ"#(MYEM[-N[W1;H9?/).G:B2+97N$47 >+-U52ILSXB46\]A[
M>PZU^H)4DDT47+$JQDY41UQC.07_ !C5B],X]>I5G;FI:.245YUM+AI21D:R
M:<01]F\59NR[1NVWQ>?9A=N>FE?E1D8O4N\[#.3VV_*VO17\C.YEZBY\2E5S
M2Z>^54_3)??_ #@<0NE>F[2\..';HO1'Z#-L]<=6Y4%D2SKJ<OZWTE/Z1L]_
MWTNGY9,_T@/X9Z=_PEKXH_07?XPZLIIGW?\ Q?2/TC9[V9I=*?SR7_I ?PST
M[_@[7Q1^@?QAU9_C[O\ XOI)_2-GI;3S2Z?EDO\ T@/X9Z=_P=KXH_01_&'5
MG;GW:?\ >^D%J1GJ2,BS*YGZ\N7L_P#L@/X9Z<[<.VZ^B/T%J[U/U5?ES/<K
MD:=GM?2=*=26?9O(T(S=B3EMSD,/-,)>8.9+HXE27B-)U?,J&1C0_,_IK;,3
MH'/SMNQH1S;:CRM)5[?01=Z\WV&5##N9=R5N<9)ZRUT]9:%Q=M#..PN07"EQ
MV0M9;ZJ4YQ&9GWJ4=1\S-^W/(S-TCB9-KDE%NK[SHG<K6+D9][/YW/*E)U;>
MO%GW?%NXOJ#CM.!QW)"O-34HX:F1&=.Q)BAKE7-#WD9,+NG++6WVHU=J2-/V
MI^WW"XY)V^:6LB,)RRKDX2=,=<$<9R])G8GY/%RY$1UAR*\GPN,.$LEI6A94
M4DTK(CV&6X9FW2C).3UDGP.6Z?MW,3<)9>)/P[UJKC)<8OT'.K)KCK/#L]NC
MM:NY$VVAI+;3!3KDHFFVT)2A!&<K82$E3V!GYFYY$HUMPDDO2_I+VY^;/F5C
M9/@KJ"^H5HDK<M$CZGZ>-:R__2]D1U_SZY;/;E# L[IF-UE&7QOZ3"EYO>9B
M7-'J"^__ /7(K+776SPTU=R&BMW\?N/9_P"E"I[KE)M\LM/2_I*EYM^9TN6G
M4%_VO]211^GC6LBV:NY%ZWIUQV?_ &6*OO/,XTE\;^DA^;GF=_S^_7^I(C]/
M&M>P_P!+V1;*[/3KC_I8C[TRWQC+XW])/\W/,VG_ /8+]?ZDB?T\:U'L/5[(
MBK_GUQ[_ .=B/O/+^K+XW](7FWYF\7U!?7_<D=;Z@:@YYF]SQR!F6;W3*X#:
MUFS$GR9;K39DHS+P2'W4'4S/L[1RN-EW[^'SS337I9R^%UWUIU/AW-OWG<;N
M98EVN,HT.0*X2--"HE+;:>$MFQ*2)-/8&OY<H^+S4]HU2>+':;DG-\S;U*"/
M>:3,Z[BW;A$W.23GP*'-7_UO>*D2C/M%&M"CP8/6FK)(E'2G:>WU-NR@LW80
MDE%]Y-[*N8EKGM0Y^RAQ"\W>ZXQE>/Y!CMVDX]>TK7PW2$ZZS(;/BH5%QUMN
MGN+[+L&TXV1?Q\>,;56DC<>FMXW#IC:K^[;1?EA9C57))OLKP5*G;[NO&MIU
M_P#C!D*C2VW4SF7+B,N$B_E51Q\]YRY3<90EJ^]_2<)A><?F'NGB78=1WU<@
M^#MR5=30+7?6HB+_ .+N15*O_/KC_I0I^\LMKW9?&_I*I>;OF;%5?4%_]"1/
MZ>=:MG_Q=R+;_GUQV?\ V6(^\LOCRR^-_2/YN>9VG_\ D%_7_4D2>N^MB:D>
MKV15+_/KCMK_ .E MSRZ:1E3UOZ29>;?F<G_ /V"_P#H2(/7C6JG_P W<BV[
MR].N.S_[+$_>67QY9?&_I(_FYYGJE-_OU_J2*F]?=:R=VZPY#5)'0_2[E5)T
MWU]+J8MK>,YS4(1DE7O?TEK*\Y>O;%R,WU+D.^FO]U+2IU0S?K_EVH%UO.57
M^5DMW:2@T7.<Z\^\1&1EX52''5IK4^WM'*W[V1D8K4ZJ#[#G.K^I=WZAV?&S
MM]OSSLZ*5+C37'T.IRFAF9F9[:G7VSVC7.16WRI<#6)7[EV*G-<KHM.XJXC+
MMV=G[(4J6:)^L@J5,S]\8OVIRC[*?L=I<N7.7%E#BV:R%G4^$Z*4A25%3>1I
MH9=A;A3+DMWHRMZ.ICW8PCB1\15=3C&%9OFN"Y3?V\)S&Y8C'DF@Y;5NE26$
M2%;#(UMQGFDG3A[2[!L.=F9%O$@U64WZ6C>\OK'JSIKIS&73VXW,#&:?,HIR
MKP[$=FGKQK45#+5[(N%1G0_3[CW]O\;'%?>>6OS9<WK?TFO+S<\S6DUU!?Y7
MV\DB/T\:U\7_ ,WLBH=*'Z=<?]*$_>>6_P V7QOZ0_-WS,7'J"_3^I(J5KKK
M6DR-6KV0]M*3[B?_ -M$*%NN6^$95];^DK?FSYFQX]07_P!"1IGKOK6>W]+V
M1;>ST^X_Z6*_O3+X<LJ>M_24_P W/,VE?X@OU_J2"=>-:^W5W(B]7TZX_P"E
M@]TRV_=E7UOZ2/YN>9SX[_?2_J2-"=KQK7\VSVSU>R)278SS2D^G7*BD.-+2
MM)GZ5N4DZ&)CN.9*:K&5*ZZOZ2[9\WO,G[5:MRZ@OR4Y)4Y):INC.J< 2MRT
M2K@\^J7.GR'G)LQ:C4[*<-TUFMQQ1FM1\2C/:9C,WBZG",9>ZT<WUKE7,K+M
MW;[<KMR*<F_SFU6OQG-B.IU_L/\ L(<'S<EOFM:-FE0C]GRH_5[@K9NV$5*>
MI[0HBY/66LF7[MS]>[ELIJ9F1]O;^P)[*=A:E.4GS2>IQO-&T.XG=6W:<LU,
M*.I5*J3/A/;VD8S]EE%;G%+21@;OD1A8QU:TR5?MZKC[Z,Q?R?KEE:^AS2UN
M"1W"(RBXH)YQSB-LR*,;:$FLS,R(BW$.V,!UQEWU/M%Y<S<^@\"=U_KOL\/_
M "1+G4>9GJBB\VW-EQ<[TBKB"--*\FG?Q#*=4S=(:P3E[Q0W-S\TQC7;6TF?
M/](3S$'PTKR:=_$(I+AVDKE]-"IJ7GYG#-RW-))7/]*+FMGP4(^33OXA&M2?
M9(9EY_5@W;>T1'SN<1.H,TT^XT[^(3J1IVE3,W/5%%YEM;2:N?Z3\JCP4KR:
M=_$)H^T>R&I>?'Z/S+<T1'SN?1YOPTKROA"-1H&Y>?&47F6YHC,WO2?E6_#0
MSY1EZY ZTT%%7B&)F>&<<WK<A*3YW/HX@S*E2:H1;3X@=4'3L(;FY\:8_%;F
MR49O<_Y1'AI7E?"H#4B:P*F9F>UA\VVM45S_ $LR>1X*5Y--NVH:T'LD-3<]
M,V"=MK95YW.HX@R32O*IW\7U U(]D@IN>TBF=M1XN=Z3\HBJ*&?*H7;41[31
M.C=0Q,STU1^=;VR2HGN<7,1X#37E?"$ZZD51]FQ2,I<6P5XB(8(S>)_A4E1)
M(ON5#+8?$0*H=#F0D@   -%Y:4$1J*NW92NS=V!S4*6TN(X4J(S0GW^\_P#P
MB(23?=0KE*3C3L-%UU#9I(TJ)1;2H9F7U!+LQE+Q?SBWXOA^Q31FNVX2_7^O
MO]0*:5*DT^!2KF'6B2H9EVE]<5)0CJN)2W)NE-#6(J%0A2]2LG> &X
M                                                        !2I*
M5I-*BJ1[R E-Q=5Q*#89.E6F]F[P)]P35D+3AVE7+;^]H^"GW!%2.6/<ARV_
MM$?!3[@FK(Y8]R'+;^T1\%/N!5CECW(<MO[1'P4^X%6.6/<ARV_M$?!3[@58
MY8]R'+;^T1\%/N!5CECW(<MO[1'P4^X%6.6/<ARV_M$?!3[@58Y8]R'+;^T1
M\%/N!5CECW(<MO[1'P4^X%6.6/<ARV_M$?!3[@58Y8]R'+;^T1\%/N!5CECW
M(<MO[1'P4^X%6.6/<ARV_M$?!3[@58Y8]R'+;^T1\%/N!5CECW(<MO[1'P4^
MX%6.6/<ARV_M$?!3[@58Y8]R'+;^T1\%/N!5CECW(<MO[1'P4^X%6.6/<ARV
M_M$?!3[@58Y8]R'+;^T1\%/N!5CECW(<MO[1'P4^X%6.6/<ARV_M$?!3[@58
MY8]R'+;^T1\%/N!5CECW(<MO[1'P4^X%6.6/<ARV_M$?!3[@58Y8]R'+;^T1
M\%/N!5CECW(<MO[1'P4^X%6.6/<ARV_M$?!3[@58Y8]R'+;^T1\%/N!5CECW
M(<MO[1'P4^X%6.6/<ARV_M$?!3[@58Y8]R'+;^T1\%/N!5CECW(<MO[1'P4^
MX%6.6/<ARV_M$?!3[@58Y8]R'+;^T1\%/N!5CECW(<MO[1'P4^X%6.6/<ARV
M_M$?!3[@58Y8]R'+;^T1\%/N!5CECW(<MO[1'P4^X%6.6/<ARV_M$?!3[@58
MY8]R'+;^T1\%/N!5CECW(<MO[1'P4^X%6.6/<ARV_M$?!3[@58Y8]R'+;^T1
M\%/N!5CECW(<MO[1'P4^X%6.6/<ARV_M$?!3[@58Y8]R'+;^T1\%/N!5CECW
M(<MO[1'P4^X%6.6/<ARV_M$?!3[@58Y8]R'+;^T1\%/N!5CECW(<MO[1'P4^
MX%6.6/<ARV_M$?!3[@58Y8]R'+;^T1\%/N!5CECW(<MO[1'P4^X%6.6/<ARV
M_M$?!3[@58Y8]R'+;^T1\%/N!5CECW(<MO[1'P4^X%6.6/<ARV_M$?!3[@58
MY8]R'+;^T1\%/N!5CECW(<MO[1'P4^X%6.6/<ARV_M$?!3[@58Y8]R'+;^T1
M\%/N!5CECW(<MO[1'P4^X%6.6/<ARV_M$?!3[@58Y8]R'+;^T1\%/N!5CECW
M(<MO[1'P4^X%6.6/<ARV_M$?!3[@58Y8]R'+;^T1\%/N!5CECW(<MO[1'P4^
MX%6.6/<ARV_M$?!3[@58Y8]R'+;^T1\%/N!5CECW(<MO[1'P4^X%6.6/<ARV
M_M$?!3[@58Y8]R'+;^T1\%/N!5CECW(<MO[1'P4^X%6.6/<ARV_M$?!3[@58
MY8]R'+;^T1\%/N!5CECW(<MO[1'P4^X%6.6/<ARV_M$?!3[@58Y8]R'+;^T1
M\%/N!5CECW(<MO[1'P4^X%6.6/<ARV_M$?!3[@58Y8]R'+;^T1\%/N!5CECW
M(<MO[1'P4^X%6.6/<ARV_M$?!3[@58Y8]R'+;^T1\%/N!5CECW(<MO[1'P4^
MX%6.6/<ARV_M$?!3[@58Y8]R'+;^T1\%/N!5CECW(<MO[1'P4^X%6.6/<ARV
M_M$?!3[@58Y8]R'+;^T1\%/N!5CECW(<MO[1'P4^X%6.6/<ARV_M$?!3[@58
MY8]R'+;^T1\%/N!5CECW(<MO[1'P4^X%6.6/<ARV_M$?!3[@58Y8]R'+;^T1
M\%/N!5CECW(<MO[1'P4^X%6.6/<ARV_M$?!3[@58Y8]R'+;^T1\%/N!5CECW
M(<MO[1'P4^X%6.6/<ARV_M$?!3[@58Y8]R'+;^T1\%/N!5CECW(<MO[1'P4^
MX%6.6/<ARV_M$?!3[@58Y8]R'+;^T1\%/N!5CECW(<MO[1'P4^X%6.6/<ARV
M_M$?!3[@58Y8]R'+;^T1\%/N!5CECW(<MO[1'P4^X%6.6/<ARV_O:/@I]P15
MD\L>Y$<IJM>4W7OX$U]N@GF?>QRQ[D5D1%N%"C%.JXDDBH
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MJ")*$I+<DB27K)*G[ [.3YE4\TE0D  #*NP U7B        "G;W@*
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M5MEW962W#:]%E-U+F,NPTH963B:FM)\:3+;0=2YMIVKJIQ3/7./D?:L>%_\
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M8[6Z/P79A*=*'B+S6W];IN\[*U4)-?$V7O!O1U&
M         *=O< H   "GU          -P            "*;2/NW>R )
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M(R13895(=I8L';LQB^)]CNG-O6U;'C;>N%NU%?%%(]QD1%L(7ZU.:)
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M6BR(Z$95.@Y*SDV;JK!IG8>#NNW;I:C?PKT)VWW23^9G?(N')@
M
M
M
M
M
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M=IU!K#LMULI_+F/X5(R+*IH@]3MR'_D<7^;,?P21;?$DW(@
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MT^.IZY2GA22:UH5!GQBHJBX'!%0J
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M9!B@
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M;C,6S7/"F79#7(0AIW)(S#+[BHKJT1UJ6[0J%553J7:./S\..3;=5735=_\
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ME!$22222H7J#GHQKH^!ZON\UJ*C0W23J1'WBCE46Z!.JJ5"0
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M4]AMO(<)!H6EQ+B26AQM1+0M)E5*DJ35)D9;C%+IV%-7P9K""0
M
M        @CJ*(S4JI<4!MJ(K/GI^:3V$BX0
M
M
M
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MS=M5112H2?$DCW5"+;6O$%0J
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MW]E2&=&*7M+B<6WV,EXC-M1%OV?7(4\.(E5K3B&J\":[]OUS#3L)7 U )
M"#.AD7?7Z@FFE2*ZF@]'0_3BJ1D=2,CVD8MQ3K613<@IJG:<&S[3#"-3K*Y8
M,XQZ!?[>\GA7Z3'9-]!<)I+EOJ0IU!T4>XQ;R,7&RURWXQDEV-&3CY65B23Q
MYRC+O3H6P^HKR^M%<&P+4#43#VYUAG6VU2)\".B8\IF.ZTRZHD()*2]\NA^L
M0XVYL6U2=?#BD;?@=>=08-OPH7I->M_28\?31/N.==1N#8UF5PEWFQW'(YD2
M= =D/\M]B+<VV6DJ):UIIRZEN[1R2V+:<>SXMF"\3U?Z#BLSK_J;.O.Q=N3\
M&6CU?TF;!@N#8K@>/6ZS8=8X%DMS45C@;BQV&W#(VD?=G6VT+=50BJ9B]:MV
MK:I%)(X3)R,G*ES7IN4^]LYF32242J;=M3V[:B)7&I4+$816JXFL*BH
M
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MQ5DSD9JY*2=MTB;TMA$7J$*RLD
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M/BR5
M                    0W35@X;G.H&':;6"=D^;9!;<>LMO94_)EW&6Q&+E
MH(U*Y277$*=51)G1-3V&(;[7P*HQE)TCQ+2VL/G?=(.FMP7;['?U9BMJ0F*^
M[#X&&DO&ZIE1(4I[QI):=A[*B_AXD\F;5N-/247YPQU6ZZ%R_IYUMQ_J(TGQ
M?5K%VU,V3*8ZI$-I:B4I*4<-:J2:B,_$*LFR\:?ASXTJ6[5V-Y.4?=J=V#'3
M3U1= D
M
M
M                                  !%!;\-$U(--2,B,RKVD(\*GNMH
M5)21D5#.OJBN*:6KJ04&A7$:B695ILI['?M"4>;A5,CMJ1RBYA.&9F9;BJ?=
MZXF*:XD]M2EQI:RH3JD^M4OK&*DZ24EP(FN>')P?>:G!X.#B,]GOCVF>WMJ8
MAZE2='4A*.$CH=#/>=.[U-PIA'EXZB3KPT*MI$53K[%!3<;C22X=Q".G=8#_
M -76P]W\>8_A4C*QZ2U9#5=#MN'_ )'$_FS'\$D6GQ)-R(
M      !IF@S5Q$JGL>P)]FFJ*6G6J>A695*ABB47):.A4:;A$EEPBW<M?^"8
M132HW4&%!YD"3_I?:D4W_.UJV_\ IC_[ SK-N5V&DJ%FXLJW<YK%WD3[*&4Q
MY?\ _P!T[2;_ .\O_C$,1JCH9$N:M9:R/9@@I            5(4\\>\ 2FG
MP $@                                                   "*5*A
M[2%,(N/:'1D<)$1DGPU[=_U#%4JR5&12G DB,BVG4^_<(2HJ$D$E);2+;[(J
M;;5"*)$D5*GVGO%*32HV2095V'N%"A).J8>I)$)C'E!(K     !IF@S7Q$JG
MJ4KV":Z413R^U5E9D9TH=/8(ZB"H@R578JGJ4(Q-5W$:DT.FTZGW[A1./-PT
M)0,MFPZ'WT%2TXCU B,MYU]B@ET["%4D02        %*D)65%%4@(:4E1\ 2
M227"G81;A$ES*A*T)(4QBX\6"16#34A2J>/=ZE!4I)=A0XR?:2I!J(O%0R[:
M?L"$VBIJI45:;3J??N$$D@       ((C+>=?8H)=.PA5[2"30S.N^GU!;C%I
MU;J2>;>K@C+IYU-J=:X_./\ ^QW2%=(Z)+2I,:IO4P\^CZG]*;3K94_I9<__
M ,,-CD[[A]EI%4=!%II1IJ9RMO\ \@A?S2-_ H'&+@0;HR,]QT]BHE4[2'7L
M)$$@           !#:6K "J?  2
M                                  *32?$1UV%V":JE"*.M>PD6^5\W
M-4DT76E.*2?&:4EO21;_ %^\1<@YJD71D4UJ:Q%LIV;*>Q_;%:6FNI)B)></
MLZK91TWP;?7\F?&7C2]JC]T3C'E37O%ZWRDO^Z1B/[]*^LP+-ZGBNG J:I%+
MT%SXTF:B,E4IV4%GEMR=6JR10^:NCT*Q42
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M\-Q=D1V%/.J)G8E1*32A[2''WKCN7')EQ</@/5PM$@
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ML*$8*D75%]-OBJ,U!)(
M            4.+)"34>XA3)M1JN)*3? ^3>+K\V6&[7DD<?S;:[A<";^W]"
MBNR.#L]]RZ#&OY$K&+*_2KBBNU!7;D8=DFD8WKOGVR&M93TL/24N%.5ECAW'
MTXNV\?-?.X/2_P#E;AS6R8<=ULPN.7*Y)_(6-^N?=#DHKFY:?*9']HNJ[G8[
M+=B;X#NEM@3U-UKR_3(K4GAKMKP<R@QKMM6[\[7U9-?$RS:O.YCPO4]Z*?QG
MV>+WI4WU]B@Q8S;BW3@9/:5BX
M                        @42DTT"16 (3KJ@!(
M
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MQ]-L9_.L?X1>Z')(49)9KC*CH5UC>RM)?7,1R2[B'H1]-L9_.L?X1>Z'++N
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M!F&WC;MP.2I2HII9J3:Y)J-2201;CH*<A14_9)M_LHUXE\H8Y4
M
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M="+:,_/V=PQOM5K6W37T''V-Q4[_ -GN*DR^"6X<%;AR1HSE&ZDBL
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M[;=4SFXMEP
M     TW7FF$*=>=;9;055N.K2VVDN]2UF24EZXIYHUY>T4/D?27'/]X+)L.A
M_P"M8&PRWE]WWBH49J-7^QR%DS&O-JDOJ]ZPQ<8;KJ_42VV\I:C]8A4HREP3
M*92C'WF?30OB,R,J**E2WTKNV[CJ0LPGS-HK:TJ:@KJJT[2 )
M
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MMW_QA[XPCQ9]_ BA!Z5X29U.U'7^<O?'!79K@P1^BK"*4^:CI_.7_CAXL^\
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M<3XUSO /2K"#_P"BC_*7_CB/%GW@G]%>$_FH]G^</?&#Q9]X] _17A/YJ/\
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MLPHS(_FHZE6G\8>[?^4(\28(/2O"3WVH_P H>^,)\6?>/21^BK"/S2?Y2_\
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M@-ATYP"TLV?',?B-1HL9I#:34I#3;;CSBD(;XENFW4ZD,*3<G5\2OT'9H@
M
M            W "P7Y^K:CZ<K LFU+2W.D54DE43\D[3BH1D5?5&N;I&5S><
M*$=*REJ;9L=RW;V7/4]9<BI\!9[\F'0/3/7/J N#VIMJBY#&QF-S[9:)7 IE
M<CDQ7&W%-K;<):6G3J9;*D.WKV'=CTQ]J<JIT1UG;G9S<N%R*I%.6ADN=:?1
M7H5J=T^9O:?H38[1=+)CLN38;K @18C]OD0(CKS:N-F-Q.)4A!D?;7M'6FYY
M'V7%\;M4DE\+-QVV2^U*$U6W+BC"WZ5\DO6EG5MI_*L\QUF?:<V=LYOQUK;-
MZ,5^9@T7RUHXRY2"+:.P=EE<S<!8D_>G!M/U*IJ._>'9WJ-NRJ:GZ*-D?5)L
MUIDK.JY%L@/K,]YJ=BM.*,_94-1N1Y9RCW-HYN+K%/T'TQ05
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MRWP^ KVK%NV,"./>?ZR)Z@'&'(
M                     'F7K!LV97_IVU+M. >D_2R;8Y#5G]#<=:D^D&TL
MD\IQ@R=2KB[MHQKB=)-<:HO6'%7$Y<#"H;Z5_,RYUP(VM0#)5SN+B/\ 7F1T
MY2Y;RFB+Q4IP&5!R.)>L<E)HM9+OS]W0]U^6OH!UUX9U<85?M6VLQ3@\=UX[
M@=TNM[DP^$SC<'&S*,V3W'O'+6,K#MXEVW))W9\#A;EG.ED1G)_J4^!F!)(Z
M(.OV)5V;]A#7G&EQR7 YE<$5]H<KYN;L!(K
M
M                                     $&9)*I[O;W[.P0W0&VEN1$M
M*;F/,--NI4DR>=0T2DF1D956I-:D8E5:!L[3!M4"/RK2EA,=2E*_BZTN(-2C
MJH^)!FG>#KQ%=?2?5,R*M>RE?9W":,BJ)$$@         $&HBI4Z5W;P!\R7
M?++;W4L3[O:X3ZS(D,R[A$C.K,]A$EMYY"U&9]Q"4F^"!7-@6^]1.1+:;E15
MFE9$>U"N$ZI4DRV&7:1EO$#AJ;QAAN.TAAE)(;;224)+<22V$1 #5
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M2HE)$DB[B(J$7M"2"0            $&9)(U*,DI21FI1F1$1$53,S/81$0
M^7%OEDG/JBPKQ:IDE!F2X\6X1)#Z#+>2F6GEN),NVI "#LEL5<DW8XJ#N"",
MDR/LR(RH9>T!-3ZP$            09D15/< -G-N5NMC9.W*X0K>T9T)R;*
M8B-F?<2WW&TF?LB4F^ *6I-NN\97HTF+<(CR32;L5]N2PM*MAD3K*EMJV>J*
M9-+20I46ZV0K4P4: PF.P2E*)"-W$HZJ/V3!*A-3?B2               #X
M-PC6"YOQTSG(3[\99J80J0SS$+J5:(X^*NP*$ZH^XC=0B+A(B))D>\B*F[L(
M@UKJ021D95+<' $@          #3<>::2I;KB&T(+B6MQ1(0DB*IFI:C))$1
M>J''@15'SHM\L\]3C=ONMLGNM'1QJ'/BR7$'6ADM##KBD&7JD)Y7V\"0W:+8
MFX.W1N,V4YTB)R01>-1%NJ9EZ@BM0?5              !LYEP@6YKG7"=#@
ML[N;,DLQ6OPCZT(^J)2;X HC3;==6%JA3(EPC.)-"G8DAJ2RI*B,C(G65K0>
MP^\&FN(*;=:H%I9-B!'1':4I2S0C81J4=5'[)B!Q/H@              ^2Y
M?K&S(3#?O-J8F+,B3$=N,1N49GL(B86\ETSKV4$T^(BI5<+/;KL;*IT9$CT=
M1.,*50R2H]O$0)M<"=>!]-)$DB26PDD1$7<1%0OJ" 2             TGGV
M8[:WI#S3#+9<2W7G$--H26\UK6:4I(O5, ;.#=[3=./YMN=ON)-GPN^@S8TO
MEGW+]'=<X#]>@48-.+9;;"F2)T:*AN5+,CD/)WKINKWAH#ZH
M  (J1&1=I[O8"M ;*>=O6PN/<'8Z&7D\*D2'FVB6D^SQJ34M@4!1:XEO@Q&X
MUL2TF(DUJ;)E25MU4=5&2DF:3J9B.&BX!^D^A4JF7:6_V1()
M ?*D7VQPY!0Y=YM466HR),61<8C$@S5L(B8=>2Z9F>[8)HP57"U6Z\-M%-81
M);0I+K7%M(C(^)*B,0#Z*4DA*4)*B4I)*2[B25"+V"( 5             -)
MQYEE*W'76VFVRJXXZM+:$%2M5+69)(J>J(3KP!L8=ZL]Q6MNW76W3W&SX740
MIL:6MH]NQQ+#KAM[NV@JHUJP&K/;F+@_=&HR$SI)$3SY>^622H5?6$"O8?3
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M                =)YS_P!O<.]=_P"N8OP_82]9*XG=2/>)_O4_6(6""H
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MMM.J3J^_U?+4ZVL7D3]=]]F-P\GRF)9K:MQ*7I+<QAY1-&HB6HDI8,_>&9C
MM].R;]JUROL=:G%X7X6]ZCEPN9V3;G8K[2Y>*^(NY=''D)Z':(WFUY[K-<_T
MIY='-J8W$FM)*##FM*8>1Q(=C4>)+[1F9$5#(]XV#$V6-M+QGS)=G ]!]*^2
M?1_33CD.Q&>3I6J3UT[&M.!?XM=HMEAMT*TV:#$M5L@,-1XD*%'9C1V666TM
M-H0RPE#:2)"2+<.:4*+EBM$=SV(6,>VK=M*,$J)+2A] B,W.(MI$6_V!=;I"
MG:4*+=SF[#7%LN@
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MB*2BV5]':2SNV4]X-,<U<DY+M9SBX&\ D
M                          *%UH9D=#+U*B4JL-T3.-Y;S58=E' 2E.GC
ME\Y:4U-1K^;97 E--IF:MW:+>3&MN<5VQ?S%6-+VX2?9)?.?GFS\*U'_ *7B
MYBL%R0XYZH(<])^9KJ;/*^EW'S>;Z)P</#MK6E!R_1TEB9'(W1-,PNJXRRG<
ME#5)(_0OPDG2P[$4N$I*RQNR$ZE524E16N*1I41[242MAC SV_MT^7@[DOG&
MWI_8;:G[R@OF.2J4:"(BVU/:HSW>QMJ+49*<J&1)\BT-4"L
M                                          I4A*R,EI)23WI41*(_
M7(ZD8I<4Y<W:#;>@0?Y%$_)F?B"H%28<5L^)J-&:66Y:&&DJ+UC))& -PDJ$
M1"6ZNI"5$*G6E-G?7]@-*>D:U)$$@
M
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MJB]L47+-RVN::HB5)2=%Q/52%I<0E:#XD+2E:3+<:5$1I,O7(Q:)*@
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MI1U":1:W?.!Z8YG:\K^:^#T_YN>0[Z/Q\/#S.!2N&O$6_O%F4)0]Y%1W0*
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M2$DX9F=5$*)6;D%62T*DU)T7$]2)4E1$:3J1I)1&6XR452/V2%FJK3M)*A(
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M1R>+AN#:E6*_Y',XO1K9#DM+D.\'#Q<*4N&9TXB[!;E9N1U:)YD>EQ;)
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MQ"5>,<8O,E,6RH5,/FI>A-3$,T;)"MZ:&1#/LVI7++4>),KCBUS.D#(@LWF
M])DVRVJ>WJ_CB694**M!.RF4ND:F&U&EQ'.4:5I,Z'M/:,?[->?84<\>\WRN
MOWI+2II)ZQ8R2GG6V6R]+9\3CJR;;27RN]2U$0G[->[ASQ[SU?C^06C*;1"O
MUAFM7"U7%E$B',842VGV7$DI*T*(S(R-*B&.5'V0              =)PO\
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M2LR5_8?9]075)QT*'&,M65$94\.VG9N^N(:==2I/30J$$@
M
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M5&^+/2S"32@B45#[?[/7&,O1P+\HQBZ0X&L)(
M                              "E1&:3(MXE:,A\#04V:VEM*02DK2:%
MI50R6A6Q:3(ZE0TG06KJE*XJ>YVB%8P7><+_ $8Z>*DG+/"<9.4ISG'*.R6S
MGF[Q<?,YOHW,X^/;6M:BY'V/:@Z,F3<VXS54SEW+6PR33#9(;024(2FA$A":
M$E*2*E"(B$6&[EUSO%%Q<EM0M=AND)/A(E%Z_KUKV"WRR5ZJ]TJ6L=>)JBZ2
M                                                          $4
M%$H\S3[@-M3V;.P^\5@D4U=:4T %0
M
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M7X?L)>LE<3NI'O$_WJ?K$+!!4              "E?O5?WI_6,2N(.E,*_\
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M$?":J*]4J?7$).7 L.<8NC-0ZT\._L_L,2J5U*NS0D02
M
M
M
M
M
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M8?=^HB/(C:F2#D?/#<I*T.D1$SR^)+GC+M&!/232X%]][XGML4$
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MZN(,^(<+T0L95-:?:-SB..3_  D\15I50X^_&$)4@ZHNIR?O*C+S@LD@
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M0CVFH8.1",;GL.J+D')QK-49?'2:CXJ[JG3=N(S(6^STA?(5""0
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MVT\NNM;3S.I,JVFO(VWTK2ZF34J<25^(CIWCBY)*32X%RM=3U"*0
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M5/AIP,D^;CGOBW$8J=N<55K0';HH
M               $&9$53W!Q!(
M
M
M
M
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M[L,7(L)N<&\6"3Q>CS;<ME<5VA%7EJ9-2-E2W"Q*4U*BX$/O.9"X
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ME&30]&8MD>/Y98X-_P 7G1+E9)[?-@S(*FUQGF_MFE-&:#+UA0TTZ/B0<A$
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MIMK#I7J@F<>FV2V/(?0.'TTK.[%<Y/'P\/-]'4KAKQ%O%N3DM%Q*7H=LB0
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MY?K)DUGA7O'9D:?9YS1.PI<12%1WFC(C)3:FS-!IH?8+? --.CXGVP(
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MV#K3U-I"/2"L         '4NH6N6EFE;T6/G^8V?&GYI&<9NXRV(ZGN'B,^
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MH-)D?8+9!]8              '24&GZ7+I3^3LU_!$+\OV*]9/8=VBP0
M           <5S7_ +-73^;J_P $P)7$^1I<=<+M5?\ ./X90E\0]#L$00
M             =)YS_V]P[UW_KF+\/V,B5Q.ZD>\3_>I^L0L$%0
M     *5^]5_>G]8Q*X@Z5PK_ .8&7?WS5?J"_=7ZJ)1%MREW'=@QRL
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MQV&$OK51QVANK49[QA3CRR:+RU53UV*0
M                 0HN(C+O$IT=2&DU1@B(BH6XA'$GAH0:4F=3+;ZYB:M$
M414()
M
M
M          (X2K6FW^PA-72G8115J#*ID?=7ZH5TH*:DB"0
M
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M!?CRIU7891%NCG#M\&(:N,XL.-&-9[U&PRAHU'7;M- QBFM=3>
MM=>9IT'Y+UR89BF,X[G,O"7<=D29"Y$1U]I4@Y"5HX5&RE1GPDKM%_'NJS<Y
MFJD2A&<7&19U9_5[]5&B01:^W91$E*5(<DS7&U\)$1DM"FC2HCIVC-6X>@M_
M9[7P%7_Y/7J4E2W&-=)T0W-JVX:I$5LS[S0PRA)F>\2L^->9QU"Q[2==2G_\
MGNU2X%'^GZ\\2DJ33TR?VD9%^YBF>;"YQ16[4:4JRZQY8/EU97T*IS[Z2:AS
M<X5F'HIM%+>D.^A^C\BO!SDIIQ<KL[QAWKD;E*+5$J*@J+4N[BP2
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M,7D$P7A)Y"2+BY0P,BYXUWF2I%%V$(6X<L=2\R5:G7=LIN%MT["%7M*A!(
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MN$MN0F=*=>=6V2$I+A(WDI5MH,.[<5QII4*DE&/*N!<I(R,JEN%G@"0
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M&.&>CH;]%\T%+O1J""0
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MTI:0WS7'&T(YJW"01\0H]+XE3?9V([*(B(J%N#B02            B@ D
M           $45:]H D
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MO2GI&M2H02            $47I $@              A)+1 "0
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MFE)553:*'S/7L([:'-A)(            11>D 2              4%/+'N
M%0                                    AI/B )2IH
M         .DX5?TMW39_S=G^"(7W^Q7K)[#NP6"               #BN:_]
MFKI_-U?X)@2N)\C2[_L7:J%3_*/X90E\0SL$00               =)YS_V]
MP[UW_KF+\/V$O62N)W4CWB?[U/UB%@@J              !2OWJO[T_K&)7$
M'2N%G_\ $#+2_NFOV!?NU\.)1'WF=V#'*P
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M9&2>\A@7FI7&UP+DNXN*"T4@
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M&H(*@
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M'FX%W3#<RQO/\<MV68E<X]YL%V:Y]ON,51+8DM?;MJ29D9"TTTZ/B5'*!
M      "#,B(S,R(B*IF>PB(MYF?81 #X47*,:G7!VU0L@LLRZ,UYMMC72$]-
M:-.\EQ6GE/I]E(CF5:=I-'2O8>:.K+J^TMZ/=.Y6>:D7-MIUUMWYELB7&RE7
M1]IMQ9--DIQ"B2?!2O>+B@Y2Y8%',DJO@6";O^L%9Q<[RNY8GH/=W\5COJ\;
M4>;);D14.'1TY#;JD%QM$2M_:,J&'*2U>I3XJ;]E:%VKH0\S_2/K7:E6&.P6
M$ZBPN#G8C/?1SW22VVIY4?F/&ZHT+<(N&AF+-RT[3KQ1<TE&L67018
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MH/I]J7?HJ85URBS,3YD9)D:6W'&T*,BX5*+[+O,)1Y9./<3*E=.!Z&%)2
M     &RN5QAVF!+N5P?1&A06'9,I]PZ(:890;CCBC/L2A)F /(+WF =);$F3
M$=U?QU$B&^[&D-G(15MYE:FW$'X]Z5H,C%WP;G<15&G_ %@W2+6GZ9,9K_.V
MOQ@>#<[AS1XU1;&ZF/-VCX1U*Z98/I3?;7D6EUZD--Y=D#1Q7&;>@W$I<5S/
M2R+A25:&=*D*HX\VFWQ(\2*:7&I=ETXZR.G;5+(;7AN%ZE62^Y5<H[3C%IBR
M&ERG%&TVM9<#;J_$DU[2*M!0[4UJUH3S(]1BV2           !;D\S/K!E=(
M73W>LHQXDKS>^H7:L52I224B:^EQLGVTFZTI2VE4I3;4Q?QX*=Q<W!!N,8.<
M_=1COZ(^6'U@]=%B=UNU;U0O^,0<T==NMG2]<;C\M'D/<]!HAK-?*;2F09$9
M;#X1F2O8]I^RJR*>5SHY/3N-YK/Y3W5[T=XXYK)I%JM?\G1AA)O-UC1[C<4&
MW$A.D^M2H[?+-Y!DRDC["KM$_:+5R/+2DF6W8Y9<]N6I?M\JWK,NO5WH+'G9
M:1?3W##;LN4.522WI#"&V4NN-DZZI+AJ2JIG0S,8%ZWX<J+@78R4H\Q="%HD
M          MC]7WF4X;TE:NZ;:47[%9-[FZB3V(,:8S*;83$4^^E@E*0I9<9
M$9UW#)ACN=KQ%P(;HTN\]]7[4+&,.P-W4;*[DS9<;BV1B^SY<A2$MQHST-,S
MAXEK2E2B0JA%4JF,=0YI47$)4,=76[S^XK.5W7%M"]+KCET"TSI$7Z1QD/S/
M3.0\ZRHTL1GE$VBK9&6S[(9T<&?*I2T*7<5:1U9VCTH^>CB&I>?6?3'6W"96
MFUQN\EN)$OD_F1VER'UL,,MNLR7DT);SE*D6SU18GCRBFUK0E3BW1Z,R"84J
M/<&(T^&^W)B2V&I,>0TI*VW6'VR<:6E23-)DI"B,C+O&/3M?$FC3-\!(
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M00               =)YS_V]P[UW_KF+\/V$O62N)W4CWB?[U/UB%@@J
M          !2OWJO[T_K&)7$'2F%4_2!EW?Q-5_8%^Z_U<46X5YY=QW:,<N
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M+24MMM--()#:$(21)2E*2(B(MPQ^.I-=37$$@
M                     &D]]Q=_>G/\$P*9^X_4SQ1</]K73]_<_A%C=MM7
M_#U]!TAE?W^]ZW\YM&Z\)]U=GMC)M<7ZS#?NZ%0K*            ) E^@@"
M     "0)?H( @ "0)6@ 5J0!  $@33L( @     D"2 (  D"6ZD 0
M         !($O74@"    DP)?$@""0)6A $$@3\Y $  21@2G0@"  ) D@"
M    "0)I0@"       )H()II4"0 #T( @ ":[:@376H /74@"  ) EH 'W$
M0      !($@ 0!    2!+KV@!V$ 0     28@E\0)"T&\!Q9 $  28$OB-P!
M:$ 0     3V@2WK5 !Z2 (  D"?20!  $@3QX$EN/UA;N<"NWP:-Y8#_ -=0
M/YPC^$2+&X_W=^HS]C?_ ,E#U_E/:;7W)K][1_@D-)?$[KC[J]1J""H
M
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M2U22;<<FL1UND7&C@-"5)\-3+9V$,">0YIP:]DNPMVX+V5[1?/&*5
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M-<N+.,6R/;FYCIJ-;Y,-H;YBC61'51)[1Q_%U9?DZ\#M,0
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M 37L'I!$1%0MP D
M :3WW%W]Z<_P3 IG[C]3/%%P_P!K73]_<_A%C=]M_NWP'2&5_?[WK?Y3:-^]
M/U]_?M%^RZMF$_=*A<*0           ) D@""0)( @ "0)($.M-.)!NHT5QY
M)FDDJ[_$2:=W;VB%HM67HVI254:9L/H<H:"V5J7&6W9WBGF==.!3RR4M42:'
M#V$R5>_C%VU<MUI/434].5 XSY$9J;(B+>?$6P6YIRG6+]@*#4?:6IHF+CTT
M*'Q @+70>L [=" (  FFRH$TTJ0!    3]8"?F  @""0)( @D":U( @
MD"7J   /0@"               "0)  A2N':8HE+D525QU*B(C/N$)2DJU)?
M+6A6;5",S5W4*GMBI6Y<>PJ<?9KV&D*BT     20$H@"    D .P">P@""0)
M?H( @      "0) "G<0!    2!(W@.+'K" WW$"2"0)[" (       D"2 (
M    ) FO8 %:  O20!!($D 0   $@20!    2!*507> 7>0!!($OT$ 0 !)5
M%NYP*X5?#@;W'Z?/,'O)]OV?E$"SN7]V?J,_8_\ [*'];\I[3:^Y-?O:/\$A
MI#XG=D?=7J-005
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M\AP<H)RYBX?3%0          -C-N=MMI)5<;A!@)7[Q4V7'BDJGVION-DKV
MY7+2E0<4R)W3_+;)<<=R*Y8Q=K/=8KT.?!F7&UOL/L/H4VXE3;CRT5-"C(CI
ML%5)1=:-$%C#7'R..E[4K,+AE.GFH473-%R?<E/VJV7""Y'-]]QUUY25,K0I
M*3<=J14.E!>A?NQ7>BF5NS/LU/G:/^17TQX#F%KR?4/4QK42+;9#4HK1<KC!
M:CN.,N-.MU<?<7X24WW=HN2R+MR/)%%$,>S"7,E[1?EP>S87BN.6W&,$:LT:
MP62,U#AP;,]#6Q&9:0E#9**&9IXC215,RJ8Q.1UUJBZY+UG-!!(
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M:P;'HS<6U8Y:(-M8;:)*4&J-';9=<(DI01&XXV:MQ;Q8JFRMZ\.!SD
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M
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M;+%QA,PC4I;!RHS;E3;?6::-K.NP;%MR\?$\26NAK_4FV6<"BM1]@RK4T*/
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M\NC^$2+&Y?W=^HS]DK]Y0I];\I[2:^Y-?O:/\$AI+XG=L?=7J-005
M
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ML_YPQG(V">BO<)),E$VA3B#(E*(S3S"[19NPN0ERQ[]2.6C.XQ4
M"GEUJ"E2$++A6A*R[E))1>T9&0J!"4(3[U))(MQ)*A%[!4(%77N8IV]I6
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M%QW4;"9OSAC>30&9]ND\/!5#K:5*+AXE%5*E4WBCD<).NC(:HSL42
M   "A;:'"(EH0M)=BTDHJ^I6I$ *B(DD1$1$1;B(J$7K$0 D
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MEZ\0DEP.0@2               =(P2IJY=?5CL_P1"_)_J4O25=AW<+!2
M            <5S7_LU=/YNK_!,"5Q/D:7?]B[50J?Y1_#*$OB&=@B"
M          #I/.?^WN'>N_\ 7,7X?L)>LE<3NI'O$_WJ?K$+!!4
M     "E?O5?WI_6,2N(.E,*_^8.7_P!\S]8A?NO]7%%$=9,[M&.5@
M                        !3**DJ "4J*@ D  ::VR69&>PR_L[Q*??J0T
M:@@D
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M&32OAXE4W5HGN)!'1!%V4)(IYE+5&H-4T?$I CU@ M  ( @   ) D .! $
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M;K3Y3JK$NQO8RN33YFV;U-#(ZU2HOL3(ZEZXHN/PXIOBRY!*;8$E/!D 0
M$@3I7T#8 T( @      "0)H   .O:0!    34":]Y $       2!/H "O80!
M!($K70@"         D":]A/+6HO"9%[7[(J2JBKD;AS5)0TNI\:BIV;OV!1*
MBT13"+?O< 94IMJ1_P!G8+4Y33T+B4>#*1=7#4M]I D@           "0)(
M@   ) FGQ$ 0 !)%6OJ"W<>A7"-:F]L!?ZZ@?SA'\(D6-Q_N[]1G[)3[Q@_]
M;\I[3:^Y-?O:/\$AI+XG=D?=7J-005
M
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MXZ78WI/@,9<;'<<8-J.E:N)2E*0A*UGL33BY9=G8*)W%.6OO#U<#NP4@
M
M                                         CA*M:;?["$U=*=A%%6I
M"^(T+)!T6:5<)]RJ'PG[!B"3$%ZB-7+QT?\ F])UHUBM\V[85/>*/ G2V7EP
M8T.<;C)R(JY!)C-JC,D:BX5;#(95J#O6FEHT16DJ3X,R(<<\Q'I%R:QQ+]!U
M?QU,63$;DJ0_*9:>9XF4NK:<;-XSXV^*ATKM(696IQ=&M2JG;I0Q\?-[ZSM+
MNJO+=(M&= 9BLLR*S9;">5D-G96X^AUV>TR;3+L13KZ66G$$9'0O?5&5:L2A
M%W)<*%+:?L+WC)VZ;;'DV.:'Z:V?,'77<@AXM:$3UO+6XZ:OF]CA2XI?CXTI
M/;7;4A@O5NG>52I4[S @          TW%I;+C<6AMM)&:UK4E"2+L,U*,B(A
M/SC6IL#O=F(Z'=[81]QSXA'[1NB* H7=+)*;<CG=+:XE]M;*T)GQ34I+B30I
M)$3IG4R4%&"W!COE;]/>/]4$GJCBPWG,J?DKG1XQK3RFI+KG/-PG2;XE$;IU
MWBZ\B2M\DGH3IS<R]XN9(2E"4I25"2E*"+N2DJ)+V"%B,E)51!6*@
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MJ7QF24(2E2C.A>^4FHIE/G;;?M$-U=>P[-%(
M                                                Z2A$1:N70^^.
MS_!$+[IX*[R>P[M%@@               XKFO_9JZ?S=7^"8$KB?(TN*F%VJ
MO^<?PRA+XAZG8(@@               Z3SG_ +>X=Z[_ -<Q?A^QD2N)W4CW
MB?[U/UB%@@J              !2OWJO[T_K&)7$'2F%?_,'+_54S]8A?NT\.
M)1'WI'=HQRL
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M_(PT_._*>T&ON37[VC_!(:2^)W9'W5ZC4$%0
M
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M$PFDK2X3#YM(4^QQ)6LCY2W*;S,<?<BD^6785+75<&=S""0
M
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M&C%>);=8E4;G-)QEHU\ID85''\_M\E"Y0D7"
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MT<#L "
M                  .DX7_S;N?\W9_@B%Y_L5ZR>P[L%D@
M  XKFO\ V:NG\W5_@F#)7$^1I>5,+M7_ *1_#*$OB&ZG8(@@
M   Z3SG_ +>X=Z[_ -<Q?A^PEZR5Q.ZD>\3_ 'J?K$+!!4
M"E?O5?WI_6,2N(.E<++_ .(&6G_=-?L"]=5;<?041]YG=@L%8
M
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M1EIKV?E-J14_9/O!3YU6E#&:HR1)       $@33M !:$ 0
M       !/K 3VZ#L =A $  2!) $$@20!!($U[" (   #B6?X/9-3,.N^!Y,
MCF6"^M\FX-UIQ(X5HW\*MQ.'V#!W#&CEVE:DZ1J9F%DSQ;RNP=)+M+>]R\IK
MI)A6?()K5G(I$6V7>YLKXSH4EN'(E)_YK]]2+.YQAMV!^KUC3\AL=K>KVY7%
M8;?,Y+YT8O#F/V[]//T&0GAL/TQ*S$W6I'#^?/03+=]X]0<7TTKFXY48S?+;
M;X&[=0RR=LVG[7%-TBO@T,HJW^4QTE3;)C\YZRD<F5;+-<GE<P]LER)'E*.G
MHITJ\JHV?(P[.%DN:CJI/3X>/PT.M[>^7LS%2G)T9<)P7";)IMA=CP+&628Q
M_'VC9MS)'7A1PH0>TDIWD@NP,ISR81<72AQ4KCYVY:U.5&"X%A\2!)
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MQ.[8^ZO4:@@J
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M2APB-!;"H+5UUNN7:7(^XDRY +14
M
M                $'N/UC^L ,7=B^7A7GIN6SY_NOS:3]"M'SA,] .I;2]%
MYWH^W^]&2E^I*7I*AE$%6OJ4*GU:C&^<GM]!($@         'RKZP[*LEYC,
MG1Z1:K@PT9;R=>B/-MGLV^^40+1@Q!>B?5_!^C/S#=;L?ZAT-65W*[[/5;,D
MO47B;@)DSW#84V[+2V9)615XDUX2VD,^5N5VTG#L)JO$DGI)_*9+".N?I86T
MVZC5S&.6XA*VS*='VI4DE)V<W9X3&*[%U*K3)Y6;.Y=>?2A;8$F=.U=QGT2.
MRXX]27'6:D(0I:B)!N^(S2G<*%;G6G%D-4XF.3AV<67K.\X.RZBZ%Q7&L+QE
M]#=SOUNB*8B2DP#;0Y)>=C)6P2I!449FHJF8RW/DL<LN)8@U*]I^:9>C"#;9
M9;4=5-M-H4KO-*"29^R9#"[:]I>-4
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M-Y@XW%<DID$LG4E)9:>:2LG$I61DA1;#(8LTE-I%Z-::\3V6*20
M
M  .DH-?TN72N[T=FF[[T0O.OA+NJ3I0[M%D@               XKFO_ &:N
MG\W5_@F#)7$^1I>5,+M7_I'\,H2^(;J=@B"               #I/.?^WN'>
MN_\ 7,7X?L)>LE<3NI'O$_WJ?K$+!!4              "E?O5?WI_6,2N(.
ME,+_ /F!ENW<IK9[0O74O#B41]YG=HL%8
M
M                   &D]]Q=_>G/\$P*9^X_4SQ1/V7:YF78^[_  BQN^W)
M?9O@.D,K^_WEV5?SFU;,^ ]NPSW>R+]E*K?I,-OV21<*  ) D@"
MD":T( @     D@]9*))DN>IU:J1XK#TN0KL)F*VI]S_Z-!C'S)RC:I NX]KG
MR(\S]FJ,13S5NI5W73J%EXKCR;O*Q/"I:;7;&V8$Y<=R5(>DQ'B22.8V9$\O
M?0:YB8\\C(_6>[4[DL6]OP=JC<@TKW+K\1>W\JC0#]#73E&RFYPO1\GU$9;?
MDF^QRY3+3*8CC5>8RVZCB;]4=@WU9AB1C#WHK@=2;AF7LG)GSO\ .T9<V2KE
MMJ29[=FVG;VC@;*YKE)/0L3?):Y5Q-%'O?;^N,J5.;3@8T:TUXE0I)) E^C@
M %2 () D 'Z2 (             "0)?R$ 0     2!+KVD 0     2!) $
M !($D 0 !.X"=44+J=$UWGM^H*)Q<DJ=C)3[S;7EDY%FO-N1L?N5IN$&.?\
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MZ@&7W]%?PB18W+^[OU&=LB3W&'?S?E/:37W)K][1_@D-)?$[LC[J]1J""H
M
M                               --YYF.TM]]UMAEI)K=>>6EMIM"2JI
M:W%FE"$I(JF9G0@!:$ZY.K#RY<UQZYZ*]0N?6N\-(EH7+MEN<3*.-(B.N4);
MS#RD?=$&6PC]@7H6[J]J.A#:K1\#TKTR:V=,6-]+=KS32V\Q[+H3AT9,2)=9
M2N%B,R9H(C5Q*KXC,NT6W&?-27O,G1ZK@>L=.]2,+U7Q6WYI@-^A9%C=T2M4
M*Y07D.M.<M7"LCX%*-"B/L/:(E%Q='Q!SD0          #K'5W2# =<<&O.G
MFH]AB9!C5[CK8E1)+;:E)-3:T(=9<6A9MN-\PS(R$QDXRJAZ.PQ\M3_U>C$)
MMTN%TTKU;O&*1)DMYYNRIY[;,5MUUUQ*&E,-FA24$HBVD6X9D<R:6J*/#@W4
MZG__ ">/,E&CBU_N].)/'\M-W5+B_<>PA"RZ2JXZ"-F"[6>TNF?R*=#-'\NM
M&<ZE9!,U4O-J6U+C1;F2CB,S&E,/-*,Y#1J<)#S53*A5KO%-S)<M(JB)G;A)
MU2U1?3@08ULAQ+?;XS4.#"CM18T5AMMIIAAAM+3+:$()*4I2A)$1$78,25>P
ME5^ WPDD
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M2242C:);)'RB,Z'M&/.X[CK+@5**CI'0]N)J1%7?M^N?<+57VDK@5"20
M
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M2>!"$I31)$E);"+L&'6XYZ^Z7=*>DW(K(
M                                             Z1@F9ZN77U([/\
M!$+[_8KUE78=W"P4@              '%<U_[-73^;J_P3!DKB?(TOK]"[57
M_./X90E\0Z=AV"((               .D\Y_[>X=Z[_US%^'["7K)7$[J1[Q
M/]ZGZQ"P05               I7[U7]Z?UC$KB#I/"O_ )@Y=ZBFA>O)^'%]
MA1'WF=W"P5@
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M$%0
M                                    6F_.&ZCLDZ?NE/(%X>^_ R++
MW$62)=(ZG$N0VY276'32IMUI235Q%M(]E!5#6:78'2,')EDC"?*XP27T)Y)U
M9:F9)<,EU"O]AE93%3*?>D(A*>4;I-D\ZEQ2UN.N*.G%0B[1E2O2<^5(MJTD
MO:UD>_\ RX-)['KQY6^8:4Y*Z[%LMSBY$A$IMU3'HZ[8R\Y%6;Q;B2I!5%B;
M?B5[:E45^K39P_R%=2[["?URT$N%PFW:QZ?Y',CX^^^\_);899N'HW AQUU:
M>%3:>PB%[*7NR[6BFRJ1<>XR3!B%P
M
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M8S:7Y*5\1+4^4!CFN*XC4JKBR,]I]HQI*C:7!%<ERNAW2*2D
M
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MXB%>1*1D""P5@
M                                            =)PO_FW<_P";L_P1
M"^_V*)[#NP6"               #BN:_]FKI_-U?X)@2N)\C2XZX7:J_YQ_#
M*$OB'H=@B"               #I/.?\ M[AWKO\ US%^'["7K)7$[J1[Q/\
M>I^L0L$%0              *5^]5_>G]8Q*X@Z4PNGZ0,M_OFJ_4%^ZJVXEN
M/OL[M&.7
M                                                       -)[[B
M[^].?X)@4S]Q^IGBB?MN]S+O?<_A%C=MN;^S:\*'2&5_?[WK_*S:-GX3+N/]
MD9%GB_68;]TJ%PH  D":T( @   ) E^@ .! $     $@2Z=A $       2!-
M.T@"                      ) GT( $JD 02!*TU( @D"6J$ 0   $@20!
M!($D 02!-.T@"  ) D@"">T">+U( @ "0)>I $  2!) $
M       2!*=" (  D":D 0      !($\>) $  3ZH$Z\0 ( @   ) D 'W !
MQX$ 0     2!) $  2!*U( @               D02^.H+M%%S@5P[4;VP?[
M:@;?^<(_A$BQN/\ =WZC.V/7<H>O\I[3:^Y-?O:/\$AI+XG=D?=7J-005
M
M                              !X0\Q'I73U9]..7:?6UE*LM:C^GXRZ
MJE4SXS;KC;*:M.^)Y9D14+>*[=%<C*7NBJ:<7P,6QGKCZCNG#03-^B;7+36^
MS+;&8F8[8KVNWW D6^ AUYE))>-*$OH6;1J+90JCDI0L3GS1>I;YY)4FM3BN
MCGF,ZOZ<]+KW2=HA@%]<R7(I$Z(>4Q;?<%NI1>WE,K2EMJBV_ ^23/AW"V[$
M'/GKHBE7*0Y8JLC()\FWHWR[IMTAO.<ZF1E1\_U2=1>;C&D(,I,5N1RI1DXI
MQAMWB>=4>\SI06,BY"Y)<I5:B[<*2XEZ,8I<
M
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MAV-XE:F4,0K#9[?;6T((B2:HD1EA:R(B27RBVS/<6\<=)NM>)>XG+A)
M
M                        6SO-(Z.YW5ST]W2SXPV2\^Q,EWO$DT3Q.2XR
M7'E,MF;3JN8XI)4(BJ9D,C'O>%.O81)<T>4QH,NZ_M?\5Z8,KZ)M>--K]Z7$
M;;L$#)Y%ON!>BP[9(6RA*#62><E7),R,D[C&0E;E/Q(OB6W-K2>C1\[&/,/U
MQN?2EB_1-H?IY?V[E(1(L4_*8D&XJ7+B7:0ELVS2SXF4I-XC,^&@.W;B_%F^
M!$;BFN6WJS)-\ICH^OG2CT]16LT9]'SS.%-WO(V%)+FMKD-M2&R=6;+3AK4;
MAF9'48EV<9SK'@78KECROB75!:)
M                                                           Z
M2@E35RZ>K'9_@B%^7[%>LFNAW:+!               !Q7-?^S5T_FZO\$P9
M*XGR-+SKA=J_](_AE"7Q#5#L$00               =)YS_V]P[UW_KF+\/V
M$O62N)W4CWB?[U/UB%@@J              !2OWJO[T_K&)7$'2F%;-0,N]5
M37[ OW72W%%$523.[1CE8
M
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M_N;?U4$9#2)-1E1\3NJ&L4UW&J!4
M
M %OWS$>K7+>CS1I>IV+X8_F!QY"6YC+*7#**V9+,G'. TD23X>TR%RW!3=.T
ME42;?8<:Z:;IH[YB?3SB&KFI>F>+2[E>$OIF1%1;<N:RXV2#/TAQDG)"%5?,
MO&H4NL9<O:AZ>P](:?\ 2!TYZ871%YPS2_&;7<6SXD256^+)6A7AHI//97PJ
M(T$9&6XR$N<VJ:T#U/2B$MM(2AM*&VT$24(0DDH0DMA)2E)$22+N(4<2.!6
M
M
M       H<KRUF15,DJ,B[S(JD7LF0)T9#546.<U\SS(L?Z[&>D+,--(K>)W6
M65O3>[RTRN%.:>=Y%4E.63"JD9_8G6HO<D7:YEQ*Z+@^++A5[Z&>E7+[B617
M;2/&),Z8:)BGFXD=M"U.GSR4266DM*(S7785#%M2DN#91RKA0]!8'IC@.F=J
M9LV#8O9<=@LEPH1;H$6.Z9$E*");S32'7"X4EO,PE.4O>9*5.!SRI5(NT]WL
M"D$@
M                                 ME^9?UN9?T1Z<XYG6,X._F$>Y7,
MHES<;2X;5M:XO"X\:5(0E*O[HZ;!<M6_$?*1*2A&K.6Z+X_H?UX:%X#K+J%I
MEBDZ?E%L*6^RB);S?8=V\:'WHZ5N<9*</8I1F$DX2HB4W0[^TWZ4NG_2:>=T
MP733&K//H=))6Z(^Z@SX?$VMYE2D+3PE0R,C(Q2W)JCX#E]!Z((B(B))$22(
MB(B(B(B+81$1;"(B%()
M                                                    =)PO_FW<
M_P";L_P1"^_V*]9/8=V"P0               <5S7_LU=/YNK_!,"5Q/D:7?
M]B[50Z_Y1_#*$OB&=@B"               #I/.?^WN'>N_]<Q?A^PEZR5Q.
MZD>\3_>I^L0L$%0              *5^]5_>G]8Q*X@Z3PH__B#EW]\T+UUK
MPXHHB_:9W<+!6
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M!>TDB&IRUE5\:G;\%2"7H-405
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M0C-91S<X#?(N+:I6X<=?A&+I#5(RFVU62HR^R5>WO/VJ[/J#'*"0
M
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MK68S[-#>OK;J%-N(EN1T&]QH5XB/C,ZU'%K6J*I:,[P$$
M
M             !93\Z^ZZR/Z#V?!]+,"<SJ'ETJ4QD49B"<MZ(VRRX49UM:&
M7G&3XE]A;1D8W(Y^T]"W=YO#;BJR,?\ T1U6\T?ISQ)&#Z5XYE%KQ<JNL6]R
MV720F*;O M2&N-M!-D7"1;"(9GA6;DJMEF$[\(I<M3N ^M/SD"2Y_JO)*\"C
M2?S)<=ADDS+['O%5S%L07.I(KM7[TY\LH:%[3RB-9NL35W&-1I/5E%N,>?;9
M4!.-G<(<B&I;3B&CD<"9!$:J*,]PP+L8+6'>94JM*35'W%Y@6"@
M
M                      #I&#_\W+KM_P";L^Q\D0OO]BO65:T.[A8*0
M           #BN:_]FKI_-U?X)@2N)\?2[_L7:O7D?PRA+#XG80@@
M        Z3SG_M[AWKO_ %S%^'["7K)7$[J1[Q/]ZGZQ"P05
M   I7[U7]Z?UC$KB#I3"O_F#EW]\S3VB%ZZEX<641KS.IW:+!6
M
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M[9_(H_X)'Q1'-+O8\*U]6/Q(?-%L_D4?\$CXHGFEWL>%:^K'XD/FBV?R*/\
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M+9_(H_X)'Q0YI=[(\*U]6/Q(?,]L_D4?\$CXHCFEWL>%:^K'XD/FBV?R*/\
M@D?%$\TN]CPK7U8_$A\SVS^11_P2/BB.:7>QX5KZL?B0^:+;_(H_X)'Q1/-+
MO9/A6OJQ^)#YHMG\BC_@D?%#FEWLCPK7U8_$A\T6W^1Q_P $CXH<\N]D^%;^
MK'XD/FBV?R*/^"1\4.:7>R/"M?5C\2'S1;/Y%'_!(^*'-+O8\*U]6/Q(?-%M
M_D4?\$CXH<TN]D^%:^K'XD/F>V?R*/\ @D?%$<TN]D>%:^K'XD/FBV?R*/\
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M(_8V>H*G<F]&ZE*M6^/*D_4;X^*B>#86ZFSLV%O%IRIZRXTUHC4%1(
M
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MORT)J(!NP
M
M                'GKJ1ZE=+>E[3^X:AZH7Z-:K=#9=5$B+=9*3<'TH4M++
M#*W6UJXC12I5H"MRF]-0^]\"PI<?UAC3566K8:T*7/Q'THV5Y$XA+CJV2>X/
M23=-PV:&WXJ&0S%B32JWH6_%@]"]OTI=4&AO5UI_$SC3-RRREDTU\\6=46!Z
M;:I+B27R76TDM:DDE1>*A;1CSC*#HRXM55<#U-\RV;\TVS8=2_B$789;C^Y;
MR%%6#Z*$(;22&T);0DJ)0A))2DB["2DB(B$ J
M
M    1S*M.T&QN5PB6J#*N5PE,PH$".]+F2GUH;:8CQVS==<6MPR2E*6TF=3$
M]HUJ6"^J#SU]%-*LQN6$Z<84G5F19Y*XLJ<VE#L5,AAUUF2EMMMXS,D.,F53
MWD8R88LVJ\"V[D(OE9W9T4^;5T]=663LX!=L=MFG>>S"2FW6:XL02;G/?($M
MM#CZ^)LR4[0B.IF9"F=BY!5*U.$E[+U+P)6BRJI2U6LR41&DR@Q#)23*M2,F
MJ4H++;IQ%=3>1X4.&1E$B1HI*]\4=AI@E>N32$D8@DW(
M
M                #I.%_P#-NY_S=G^"(7W^Q7K)[#NP6"
M #BN:_\ 9JZ?S=7^"8,E<3Y&E_\ V+M6VO\ E'93]V4)?$,[!$$
M      '2><_]O<.]=_ZYB_#]A+UDKB=U(]XG^]3]8A8(*@
M4K]ZK^]/ZQB5Q!TIA1G^D#+J[C4U3Z@O772W%%$?>9W:+!6
M
M
M
M
M
M
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MCP) D
M
M            8F/G$72^:]];6CO3._=94'&RG6],EAMYY,>0S,>/GI=92M3;
ME6WC+Q(,9N.U"#EVE%R+DX07!EXZQ>5)T>0-'F,(>TUMDN6YC)-O7Y9(*8Y<
MEV[9/2KT?PI2^9+IPU%J63<<N)71+L+,?EA6VY=,GF1:F].4*\R%XO+F3DQH
M1O.E'-!.?Q1"&#6VT1MI;26Q KN/GM*3XE$%RRDE[IEN#$*P
M
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M-4=#L\20
M                                         '24$ZZN73U([/\ !$+[
M_8KUDTHCNT6"               #BN:_]FKI_-U?X)B&2N)\G2\ZX7:J?YQ_
M#*%3XD<#L 0               #I/.?^WN'>N_\ 7,7X?L)>LE<3NI'O$_WJ
M?K$+!!4              "E?O5?WI_6,2N(.E<+_ /F!EO\ ?-4^H+]UI6XH
MMQ]]G=@QRX
M
M                               !%2[R$50HR1(
M
M
M
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MY5IM.I]^X4 D
M
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MJ=%#%6JJ5-.+H<[
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M
M                                #I&"1EJY=3[X[/\ !$+[_8KUE78=
MW"P4@              '%<U_[-73^;J_P3$,E<3Y.EY4PNU4_P X_AE"I\2.
M)V (               !TGG/_;W#O7?^N8OP_82]9*XG=2/>)_O4_6(6""H
M             %*_>J_O3^L8E<0=*85_\P<N]537[ O74_#BT41?M-'=HL%8
M
M
M                &T6@UN(<2NB4UKW;NW:+4;DK<I1EQ["B4>=QE%Z(\SZS
M=7_3IT_.FC5#4JRV262"6<%$J/+E((R6=%1V7N-"Z(/8J@J<7>48ZN2?9VEW
MD?,[CX,Z+Q3S4>B#-[DQ9K/J]!*9(>2RR4ME,5LW%K2VDN8<A24DI2RW[!?>
M-=D^1IJ31:E*"DH-ZGNVR7RRY+:HU]Q^\0KU:9K+;\:9;Y+,ME;;J24@^8PM
MQ!'PJ*I&=2&-'$G;DHMNL:\?C+KRH\G/%)Q.2LE1M.VNS>+BFIZHI]9JB0
M                                                     0HJD9"4
MZ.I#5402:$15W"W=4I^[H2M#34A1JWT+^T+L&E&C]XHE&3=4Z(UA25@
M
M
M
M =1ZY:-8EK[IID.EN<1SE8WDC*&9[)&1&I*#,TT,TJ+9Q=PJC+D=28NCJ6OT
M>1YT=(1P?1UTRXUK*JVSVK4:C_YOZHO_ &F?9Q(:@^PW#7DB='K)U1CKI'W\
M;=?_ %<3'+O17$MNS;?!&FKR/^CI7%7&W:KKQ'QM[:U_S?U1,LN[+BR%9MKL
M/672=T!Z(='T[(+AI7:UP)&1DT5P4HTJXR:Y?#2C2/O1"Q.Y*?$O57!:(]S"
MV0
M
M       4J5PTV5K7M$I5(;H6Z>I3RS>GOJBU _2-J/:7)=^-IIE3B5I(C2RA
M;:-[2]R5F+UN_*VN5<"JJI1H\_\ ]1_T<T,OHV[\-OOK_)Q7]JN+5<2B<+<U
M1HU3\D7H\4@FU8ZZ:"W)YC=/_5Q+S;G>0K4%V&D?D?='/,C.EC3A+BRH\MH^
M)K8Y&>0\@_\ )_MD"U<OSN1Y6R5"">B+L>GN#6337#[#A./M<FT6"$U!@-'M
M-++#:6TEL(B]ZD64J(J;J]3FH
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M
M                                Z2@U_2Y=*_R=FGX(A??[%>LG2AW:
M+!               !Q7-?\ LU=/YNK_  3 E<3Y&EW_ &+M5"I_E'\,H2^(
M9V"((               .D\Y_P"WN'>N_P#7,7X?L)>LE<3NI'O$_P!ZGZQ"
MP05               I7[U7]Z?UC$KB#I3"O_F#EW]\U]8A>NU\./<41TDSN
MT6"L
M
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M.;MKS+2_60BGIZ37H2NX>X_9>.-V^LR[4D1%0MPTRW!037I-CK4D7"
M                                                "&TN(/F7:XMV
MNU7.Z.%5JV09<]TOMFX<=R2XGLI5+9D+63*5NTYKLU*K5)W.3MK3XRR(]YYV
M@K.IWZ,E8].^=/I 6/\ /]);X/23N7S;Q4YE:<W:,G:+<MV_9Z,M;I<AMGON
MK+W-HN2+M:K5=6RHW=8$2>T7<W,CMR6T]NY#A$+63;=K(</JNGQ.A&//Q["N
M]ZK\9]%*S4:O4I03<]A*G%E495;7<:@DJ
M
M
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M5[%2.AKE5+_-G/<$_9I]Z)T[S;3M8,<;AR%QE25R":7R4>BNGQ.<)\/9WB/
MDGKP"2J<@TYO5SR''&+K<TK0](==X4K2:#)M*_D_"K:54F*+B2E2/ /B<]%L
M@          @R(RH>X. %"(S/M.E?8$45:@&9%2O;N%5&R*I'4N:9I<,8R*S
MH>:=*PODYZ8\VTMVAD1\->#UA/+5>DJT[36_2]BM*\<NFPZ^C.]OL"J-N4I<
MJ(5"K]+N+'7QRME*_P 6<[?8%S[/+O1.A!ZO8J6]<K\F<]P%CS?:A1 ]7<6(
MJ\<K\F<]P/L\N] C]+V*T(^.5M_S9SW ^S3[T*(G]+N+5(N.5M_S9SW ^SR[
MT"K]+>+[/'*V_P";.>X(^SR[R-"/TN8L6SCE?DSGN"?L\QH3^EO%Z5XY5/YL
MY[@C[/+O&G I/5[%2WKE?DSGN"?LT_03H3^ES%OMY7Y,Y[@C[/+O!!ZO8J6]
M<K\F<]P2L>;[4*(DM7,6.E%RMN[^+.>X'V>?>B-"?TMXOL\<K;_FSGN"/L\N
M\:$?I=Q:I%QRJG6G\6<[/8$_9Y=Z)T)+5O%SW+E?DSGN"/L\N\C1$%J[BQG0
MERJE_FSGN"?L\N]$Z#]+N+'7QRME*_Q9SM]@/LT_015$%J]BI[EROR9SW >/
M-=J)H@6KV*GN7*_)G/<#[-/T#0G]+F+?;ROR9SW!'V>7>1H/TN8M]O*_)G/<
M#[/+O&A0>L.))(UN.R4-I]\M49PDI+U3,J"'8N(FG=Q*DZOXBXDEM/R'&U>\
M6F.XI*N^AE4M@>!,CYR3U<Q8BKQRJ?S9SUNX2L>;&E:$?I>Q6E>.53^;.>MW
M"?L\ZTJB:(G]+F+4(^.50]W\6<]P/L\N]$: ]7<63O7*V?YLY[@C[/(G1D?I
M>Q4Z>.5MK3^+.=GL"?L\^]"B*CU;Q<MZY7Y,Y[@C[/+O(T8_2WBY?9ROR=SW
M!/V>0T*?TNXM4RXY6S_-G/<#[/+O1)4>K>+EO7*_)G/<$?9Y=Y&C*/TO8K0S
MXY6S_-G/<$_9YUI5$T*CU<Q<BJ:Y5"_S9SW ^SS]!&@/5W%D[URMG^;.>X(^
MSR)T8_2YBQ_9ROR9SW ^SR[R-!^ES%OMY7Y,Y[@?9Y=XT(_2]BM*\<JG\V<]
M;N$_9YUI5$T0+5W%C*O'*_)G/<#[/+O0*CU;Q<MZY7Y,Y[@C[/+O(T8/5O%R
MWKE?DSGN!]GEWC1D?I<Q;[>5^3.>X'V>7>20G5W%E5HN5L_S9SW!/V>?H(=$
M/TO8K6G'*K_-G/7[@^SSI6J)HBE>KV+$VLTKE<7+<-!>C.;5I29I3_RE; ^S
M2[T"K3/*;OE35TFW%M;4=+Y)A(6VINC53H?BWU306[D%"E.(=.P[4%L@
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MW:,0@
M
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MON[3-#09&DJ%0BJ1>LDS(O;(AI5N[&]'GB<Y1QT96+@
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M+%SM%Q;)V)-C+2ZS(095)2%H-1&5#[!CSM7+<O"O5YNRI=A*$UXEOW3D(%8
M                                                     !0M7#M,
MTI2FIK-1DDBV;*F>X!KV&AZ="_ED7\H:^. HR?3(JMC<F.M78E+[9J/UB)1F
M*9*<E['$52][1&JDU*27BH>WL+;M%-N33<;GO$S6OL\"O:)]KF_U2"16
M
M
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M2[Q4'CUF/8=NB_@6_BB')L59]1AAF,TEEAM#32"HE#:20DB]0DD1""#5
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MMT7\"W\4.:3[14^C&B1HB.7&8:81]JTA*"_:D0AMO5D&X$
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M&I4K3V1*[Q6C-CB]D+';/'M*7.8F.ISA72E26LU=Q=X,'(1
M   .'WS$F+S>;1>5/&T]:C6:$TJ2^,Z]QAVBIR\BH1%W$1>T0 D
M     $&52,N\J #A]IQ%FU9!=+XT]55SX3<;I[TT^K0NT5RFY*G8'JSF(H
M
M
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MU:ZFH+@
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MNND3BS+U1@[W>M96Z2NX_P"RKI\1E[3:N8^WPMW_ -HEK\9ZV'&')
M                                                'F;K O>9X]T[
MZEW?3]4A&60['(=M"HK;CKY2$LN&DVT,_**54BV$,6].Y%/EX\R^(OV%%W%S
M<*&%BSU3>9Z;MPK=LY)*+I<4-%\QW\_D43'4M4\.TB014')X<;5R*\30LW97
M4_91[H\MG7SKQS3JVPNP:PW#+)&!R'7_ )Q;N-KN\:*9).-P<;LDB:+WQ[QR
M\;&':QKDK='<IIZ#A<F>3+)MQE^SKJ9?22(S2?V1)37V2]H:S*+=_F[#FTWR
M4["OA\7%7V*>I07ZZ4**:U*A!(
M
M
M                        4\7B,MA$7:9]_J"::5(KK0G:*/:YO]4G0D5
M  (5>T 2
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MK3S+R$K34VUK2E9)452KL&.TXNCXF0<I$
M
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M[MF5IZ\#*6JYEP/>PLD
M       !!["V%7Z@ MZ=8WF2]/\ T<$U:\UO;5RR^0GC9QF"ZRN42#;<6DWC
M)XE-*5RS*AE47K=F=Q5B4N=N+]MT1UOTC>;5TV=5EUFXS#NS>'9-'9>DLVN]
M2&8Z),>,VEY]:)#SR$DI"#J14VT$W,:Y#BM"%<M27LNIYGZBO/=T7T@U'NN
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M3D6YWC9@RB-YM;9)COFMU2'6J=F_<,O%Q8WHN<W1+Y2W<ER47YS/*>E_ZPE
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M$X:214E551<DMUPB76%%N,!Y$B%-8:DQ7T&1H>9?;2XVM)EV*0HC%)&IO0
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M8\#VJ7JBU#FI[7$K)%0
M
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ME]OB;:2E1U[:F0TUNKKZ38$J*GH-T()
M                        "E2>(J;.W>7$7LD>\!V'$\M2EK#\K<)I@W6L
M=OBTF3"#JI-LE*3X*'Q;2W=HQ<^,OL5R,723@U7X"K&=;\4^R2^<_.QFOROZ
M8)J7;;H9'JFD^,K7,)K;E^^O)X.#ZE!SO0]REI1N<(IF)UE)RB_#]Z5/D/T3
ML,;;<PW$UK99XUXW8U'5E!;3MD4Z<-"X1@9\^3+FH=MR7SD8//+"MN?O<B^8
MY,WQ<?":222?>D1$1%4NXN\6^3EA5.LF7XR;E1JE#< 5@
M                                       &@_&8E-K9DLM2&7"X5LOM
MH=:65*&2VW"4A1'ZI"*$U?8?#+#L1*M,6QPJG4Z6.V%4SWF?\5WF)%6S6CXO
MC<-U,B%C]DAR$>\D1;5 COHW>]=:80XFM.PQ5&3BZHHE",U[2/MI222_9^L(
M;JR4J%0@D
M
M
M         \<]=M^U:Q'IQSK+]%ISL+.,<@JN4+DM*=6XPPV\Y(\*3(_"22,5
M1I74F/$Q6L&\SCS--2X]Q5@"[GDRK)+D0[L4*#(=7$=8?4Q1U##KRDFI9=M!
MR'@V.5-EF4KU?U:T.>?TY_-YX:_1?)/7^:;CLV]W"(\+'3HZ%'/E4]W4G^G7
MYNZ$+_ZJY(:TH4?^R+CM/A,R^QWB';QZ:/0JC+(_/CZB]1Y3.M_5GK/C&?3N
MJ.U7&V7"WOPTV$KA%D15.(<)DWN%,@B,R(U'N&+>\-.EO@74Y-5FJ,O#"R2
M
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M1-/+\_:K8_*<>=4I@GN27 X\XLU)X62I2A%4,B/+,BVW*VF^)?F%@J
M
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M3!42=4[#(7KER5RS67O(JCQ=.TR[4*-2$J,J<2$JIW&HJF7L#$!6
M                                        ^;>7W(MHNLIJO-C6V<^W
M3?S&8KKB*>KQ) &'3TQ:'XUY@OF&ZT7+7Z<Y<+5B%]F-LXW<)BF_3V8L]U#3
M49J2;Q)JVHR+A(JU'(2F[%N+CQ9CRCXMZ7-^:=O>;QT'Z)]+.$8WJ[T_N?HU
MOWIB;5,MUON)LR9[3Y*:6ZDHY1GN#@45=M#X17CY,I54U43QH-<\71H][^6W
MY>/3->NE[$,\S/$;9G67:A6Q4^_7NX+:F/&I]"4J:);C;CC;R5<2CJHS\0QK
MN1<;<4Z1+D+,+>BU+:D;!++T5><!CN&:-FXSBN1267)%C@OJ7'CMW,VUN1WV
M8YM-*-E)DDR4G89"\ZSQ>:152EQ)?G?D,O>*X;T:.\HJ*=8:<47<I;:5&7L&
M8X\J-<         %B[S[.$^DE2%(2NMVB;%$1_NB^PR,9.)%2OI,IN55MM=Z
M.[.A*X2+=Y9>()Q^=;2OJ--,CD1HQ3XC;J%E;9)*2:2=)33Q)14B.BMW>094
M/USBD5:^\6E_)OZ2]*>H'4+7G5C6>U1\MR:P9E,C0;;=74R51G'KB\Z;RFY*
M7G'&D*09;R+:+MYRM0C"/:BF*?ORXLNS=?70;TPY7TY:@W.1A6.XO><>Q^7/
MLM_C-18#D.3#CON-I(R:23AN'V%152+;L%O%NRC<5-8LJY4U1GF+R ,ZR2_Z
M"9OB-VD2Y=HPG(W[=8I$EQ]U#D9+QM$;*W5J(T<#1>]V"K,25W0I@ZP5>)D"
M##*@         #$[\X;RY->LKUFR?J?TW:NN5XS,CLR+S8[=.F-/6UN.W)4M
M;<6,VI;I'4MPS\2=M>S+B8N1"[)5AK0MT]'_ $>]/W5!='L(S[J#N^BNJ;;R
MHK>,WM$Z.4R4E;31LE(N*VD(,G7#(C.A;!?N9/A2HE5%=F,7;I+WT>@NM?RD
MXW1GH\O6"#J],S^*B5'C)B+-YR(M,E:DI=0Z:.2I/"1&1UWGL$0S>=T:+DU%
M1JN)W+TO^2"UKSIGI?KRC6NZ6)R\2(%_^86TRN0RB%,C2B92I+2DGS%-&D^R
M@L7LGGE1K0KC&"UHZF61@V-?0[$,=Q?TE4SYBM%OM?I2J\3_ *%%:C<TZT.J
M^77V1@DMU.5@0        '$\\N;]EPG+KM&0I<BVXU>YK"45XC>C6V2\WPTH
M=26@A*XDKB8BGEP]+FG_ %\=2^OVI'4-)5D2L7R>:RSC-RF'SI;975;;2&D2
MN>XE#2%F1\--@S9WY6XI0T+:BG-R9N/-[Z)=*.D6?IYG.@%S7I_].;TBQ7?'
M+=<5,N<DU)9=?4F,J.[R'$/4\52\)D)MY,IOEEJ4W%2/-'1EX#HQ\MCI2_HU
MX;)R+!+-E][RVP-W"_9')4U(DRW[C%;<=-+QM*X%-*<,]O$?%M,6)WKD9MIE
MU/V>5<"U;TCXQ#Z3_-_R;0G328[(P.\3)!284.0MV$RV^LC0VI#*D1ZL)21;
M4[*"N]?\6TN9>T6+,5"Y)+M,N$MI$?>,0O@
M
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MCM159P[=J;G%>VRX@0PH2<E5F42*@
M                        ;>3&9EQY$5]!+9E,N,/H/<XTZA3;B#]12%&0
MM7H>+;Y'P)B^67,N)Y77T0=,+E^^DRM*L>.]G,*?Z<<9KF^ED_Z23U>7[\GO
M%7O%[%E+#7_#^R1DI9:I?]I'J>-%:B1X\6.@D,166V&$%L)MEI!-MH*G8E"2
M(6KRN7;G.WQU^$BW%6X<D?=-Q0JU[3W^P+G90DD
M
M
M
M                                           'Q,ELD+),?O5AN$=$
MJ'=[7.MTAAQ*5)<;F178ZDT42BK1SN E<3'FZ!.ESJ%Z2^N#5[&W\,9D:!:A
MW*9,8N\F,W)99-R2<EDV>;&0EJAD7O1=G?4XJ*T8?%OL[#(@^9;,9?[)ME/Y
MA%_%"VZ]I%>TGYDLWYHMGY!$_%" ;J-"APR-,2)&BDKWQ1F&F"5ZY-(21@#<
M@
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M$E-WR=!$GB1)DH:>2VXHFFE&XE2CK4JD8KR+RO3YEHB(0\./(7*ACE8
M
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M%P
M
M                 @R,]QT]BHE4[2'4&1F1D1T/O[A")-'A=(O?\1]]"*@M
MJ#YN=MU[B9.ND4:O#789U[^RHIG:4I:>[VA.GK)+86TZ^KN%ZB6BX$$@
M                                                   "#K38=#[]
MX ;:;Z^KN%,N;\T+TD&2J[%4]2A&*U3M(U*A!(
M
M
M
M                                          !2?$9T+87?L/Z@E4IK
MQ(=:D<IKCYG+1S/M^!/'\*E1!)41$14+<'$$@
M
M                             /EE9;/Z85R^:+:FXE6DXH,4II5WTEDT
M3^WM\0-()L^FDJ$1"6ZNI"5$?#>Q?&Y%S*\R+#9Y%V(B)-QD6V&]-12A%RY3
MC*GD'L[%$(*J]A]M)&6PSJ6RA$DDD1%V%0205"
M
M     !%-E#.OJ[NWU!-=="*::DB"2DRJ9;",MM3,B.G=03I\(U^ TW8[$A)H
M?9:?09D9H>;0ZDS+=X5DHM@BH*T(2VDD(2E"$D1(0A))2DB["(J$1 "L
M                                               :3K+3Z.6^TT\V
M?OFW6TN(/NJE9&GZ@ TFXC$9!HAL,14F=31'9;:2H_5)!)+8':&;298[+<5I
M<N-HM=P=30R<FV^))61EN,E/M.*(R]<37N!O&(S,5*68L=B-'3N:CM-LMEL[
M$-I2DO:#2GI(]JOH-R()          -,S/B,DEM/>=>XNXQ4EI5\"&^Q<2LJ
MTVE0^[>*201$6TB(C/?0@!HG%C&\4@X[!R$^]?-ELWB]9TT\9>V -<
M        $;:GMV=A=P X%J!IA@6J-G<L.>8O:,DMKJVW#:N,&-(6A;)\39MO
M.M+=;H9_8F0E-K5$IM/0Y!C.,V3#[+!QW'+>Q:[-;6DL08$9M+;$=I)4)*$(
M))$6SN!NNKXD=I]X0            -!V,Q(1RY++,E%:DAYEMQ)'_>K)21+I
MV$*I4S'8C(Y<=EIAO?P,MH:17^]0E*1!)\Z58+'.=)^=9;3-?2=2>E6V'(=(
M^\G'F5K(_9$U:X50U/I,LLQVTM,--L-(*B&F6TMMI+N2A!)2DO6(0#4
M
M
M
M
M
M
M
M                             !YVUVZI=&^FYS&_TNY0SB\3*'78]LF2
M"2;*WFCH:5FIQ%"KOI6@JC%RX#1'8.!ZO:;:F6>/?,)S*P7VWR4H4TN)<X2W
M32XA#B#4P3YNHXDN%2I"'&2XH'8Y*(R(R.I&1&1EM(R/:1D9=AD*57M!(-TU
M8 D
M                                                   !YOUSZKM%
M>G"YXO;]7LKCXHG+U.MV:5*(C8>=:4I)I6HUH-!<23[Q<MVIW:\G%#LJ=GX3
MJMIWJ+:H]ZPW+[#?($I*%-+AW.$XX:7$(<0:F4OFZGB2LJ5(4RC*+I)48.P2
M,C(C(ZD>TC+:1D>XR,4@@C)15+:1@"0
M
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MJ=TXMD4+++!:LBMQFJ!=X;$Z(H]ZX\EI#S*^WWS:R,4/0EGWP(
M.,9AF..X'C\[*,JN+5JL=N)"IDY\Z-,)<62$FLS,B(N(]YB(OF54"O%LOQO-
M;%#R3%KQ!O=EGM\R-.M\AJ4RM-3*AJ86X2%D9;2/:0B4N15:!R W$$E2U*)*
M$$:E+4?"E)$53-2E4(B(A$9\SHDP>7<BZP]$+'K'8=!V<M@774N^N*0U8;>^
MQ)5'2@BKSW&GE<#A&=#32I&6T7.5J/,^!*53U(D^)*5=Z2/VRJ(]!!4
M
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M0Y).C[2H02
M
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MG6^2S*9<:=22D'QLK6E*C2>X]HQN24'1\"X<A$@
M
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M09.,+<21FE1;*U(6"L^R2B/<8EIKB0FF2()
M
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M(I(:6ZU'DL)FM$XVEQ).0^<IY)I2LB.A&1&>\87+RZ%UIKB=[BE-/@0!(
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MJ4V;BV#!C)25422*@
M
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ME^:_V_\ C"?N=]Y'\;17^Y^4?IF+\U_M_P#&#[HEWC^-X_N?E'Z92_-?[?\
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M,Q?FO]O_ (PC[H?>/XWC^Y^4?IEW?ZK_ &_^,'W1+O'\;17^Y^4G],I?FO\
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M7YK_ &_^,'W0^\?QM']S\I'Z9B_-?[?_ !A/W1+O(_C>/[GY2?TRE^:_V_\
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M0E1>IQIK^R.(:<73L-Q4HS2DC6$$@
M
M
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MUC-4IP])DNC!+@
M
M%J+S0_, R'H=Q;#5XIADK+;_ )TN;'@^BLO2%0W8R'20HVFE%Q<2T%V&,G'M
M1NRI)T2(<E!-M598M:UZ\V_KEE_-F"VR_8KBUR41I2N'.M++,5XZ<1J424*)
M+4@JGZ@RIXN-#VU+4HK=?#V4>I-'_(FSS/Y[&9]4>J+T^\+<:?F6=#*92W5*
M-MUQM4A3!D154M)GQ=HLQR_"?ZO@0[$'K/VF>N=<_(_Z6;OH]<H>!6J3B><X
M_9)]PAY-$>43\J9;X3\EM/+CQB<);SK94IVB'F2NSYKA<C&$8\B]TZ4\BC4#
M7*"YJYHEJ1!R21B^!W5V!C%UOS-T;^2BRFHA*9=N)%S4+::,RX=FT6\AVVT[
M;XE23I21D>%2FS=M^O[HL.O:4JE-"1!(
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MR7D\#TB%$>>094X77&$+<33LHI1D,+M*>TWP
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M..NXZ4')/V2];FINCT9D.)W%ZQ#%C%05$5DBH
M
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M3[J((:9.7-+T5.Z+4%&"IQHC<"@N
M
M
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M7M49BV./$^P
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M9:4ZHS[5&8MK0J?M<>)]9%2*AE2GJ[]XETK5$*M"H02
M
M        <:R?'K%E5@NECR:$Q-L$Z,XBX1I)ER'(Q(4;W-KL)!)(ZU[!+;KK
MV$1TU18RU@\T'H?Z(<FD:2Z7Z?VF_P!QMTMT[XFP0K>E46:MUXG4JEH2MYSA
M=9VU,MNV@R8XURXN=]I3<OPC*DWJ=?*_6&M&V.6D]+KV2#(J<J2E:4)IL)7
M9DBA=XJ^QSIH4?:+2[3M#0CSM<3ZB=;L(T=PG3.XQUY4^XB1>''U2$04MJ:3
MX^4YP(J3I>^+L%J[8E:567+4X74^5E\9W'\?N,F-=9UAL\NXH0A;4Z5;84B8
MP9I(_DI+S*WFS(_M3(6"K5:'VTE0MQ$>ZA;B(MQ$1;"(B$OT<"%Z>)4()
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M+3C)1U]UAZHN#(V)+U-GM&9"TEV]Y2N!6*B0
M
M                   TGON+O[TY_@F!3/W'ZF>*+A_M:Y_O[G\(L;OMW]V^
M Z0RO[_>];^<V;>Y7K[N[:8OV>+]9AO@:@N%->P@"  ) G@  J K\1 $$U$$
MUU!_4$DO33L( I)J!-60!     !($U( @ "?4 G7@0!    2!-*<2 (  D":
M]A $$U FK #CH0!  $@2 ((      $@345 5( @D  ):H #]) $  2!) $
M     2!-:@!QT( @D"06\ N(  !32I $     $@2M 0!$ 02!-: !Z6 ( @E
M.@$CT#: JR ()[@)]) $$D()2($D  2  $D 02!+=14P%60!!($UH*B W45,
M2*L " () D@"    D"40!!-3 FK%0%6*@*L 0 )KV !6@J8"K( @ "0):H0!
M!($D 02!( @ 20!!47;ZPMW.!<MKB;['SI>(7?ST4_")%C<O[L^^AF[(J[E#
MNK^4]HLG5EH^]ML_VI#27Q.[8^ZO4:@@J
M
M
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M&.2
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M:T7S"[S(M5]N4=MIOYX-EPHT9Y7+*AT0Q7V1:R&W<YGQ8BDHI1X%[\6"0
M
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M&O$A)>*Z=IEDEM*O?M&$5$B0
M
M       &D]]Q=_>G/\$P*9^X_4SQ1</]K73]_<_A%C=]N_NWP'2&5_?[WK?S
MFU:+P&?;7;[8O67JT8;UB54%TIHR (       D"7H0!    2!*]  4[>P@"
M   &9%OV5!:\!PXE1)4K<E1_WJ3/ZQ&%&$.%15JA9?WR%)^N1 TUQ!!>H()5
M>P"11H@""0)[  >NI $$@3I3TD 0     2!+]) $       2!) $  2!/#0
M" (   "0)( @   ) D@"     "0)( @D":=I $   !($D 0        $[@)X
M$ 0                  $@33M( @ "=X$\60!!)E0"6J  0!         2!
M) $       2!*U( @             ) D@"    J+96O<+=S@7(-*J9O+!_M
MJ!_.$?PB19W'^[OU&=L?_P!E#^M^4]IM?<FOWM'^"0TA\3NR/NKU&H(*@
M
M
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MEN)<-7%6NT8UR;G*O87(Q48T1<[%LD
M
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MC"R+OC7.<KMP\."B7'ACE8
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M9OFFJ4X(R_;7 9M5N@6N,@D1;;!B08Z4D1$341A$=LB(B(BHALAQ]:LDWXD
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M\S(Y&*G75$@2
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MZ4( @           "0) !=P <=2 ()]8"?40!         2!-.T@"    GU
M)UX @"X@ ]" (             ":@35D 0 !- )H0!  $@3Z@ K0 'J0!
M    $@36A $        !.\6[G KCJ]3?8^1G>H-.Q]'\(@6-Q_N[]1G[(U]Y
M07^M^4]I-?<FOWM'^"0TE\3NR/NKU&H(*@
M
M
M   "#,DD:E&1$1&9F9T(B+:9F9["(B %K3K&\V'IUZ2;HYB<VYMYCGC!J3(Q
MJSOLNJCKX7>6VZ^T\HB<4MHR---@R+>-<NKFCP*97+<'2;H6SWOUB2.IU:HV
M@]V5%)9FAPDS#(VN*I&:B?I[P7%AS[R'D6$M*L]E]*OG2]-_45EL3#LNM[.F
M^637&H]L;O'(4W*E.*8;2V3\ATEL%S':%4SW"F>+.,>9:DQN0FJQ9>JC/M26
M42&'VI,=Y"76'V%H<:=;67$E;:VS4A:3294,C,C(8S^4E5-<02
M
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MTZTI"VUMJ+B2I"T&:5I4D]AD=#&+1KB5&L
M
M   #S+U,]5^C?2EADC,M5\HA6EHVGCMMM-UA4^>^TTIPFFHZGD.\*^$_%2G<
M*K=N4Y>SQ9-*\>"+&N2?K$F)_.DAG#-&[K>K0PZXA%Q_C+IR&R4I*7$DT\24
MDI)$>[M&3]CN-T3+<KUJ+:K6AR73O]8.TER"_P!NL>I^F4[$;9.E,L.7>4E2
MF(J77&VC<<8ENJ)7#QF>RFX+F'.VJ]I"OVGVZE_;2C533W6/"[3G.F5]MU_Q
M:[,)>A2[>MCA2E:$KX'665JY#B2654F,1Z.A6G55.R0)
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MK%--<%P>3/F8KC-HLDJYN&[/D0(,:.]*6I7&:GG&FD+69JV[3,6J]A)SD
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MH]8O@>]2.I;J;]GK'04T2T7 <20
M
M           :3WW%W]Z<_P $P*9^X_4SQ1</]K7/]_<_A%C=]N_N_P !TAE?
MW^]ZW\YM6BJ@U=M=OMB_:?M,PW[I(N%!($TH0!  $@2]" (        "0)(
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M E:D 0                !/U0)T( @ "=N\"=>( 5[" (  D"53M(W 0
M                 2!+U( @ "0):H0!  $[ )T( @D":T( @D"7H# /0 /2
MR ()WB">/$@20     3Z@$Z\" (             "0)?HX$ 0          3
ML[!!4Z=A DI  D"5Z2 (     )+97ZPMW.!7!TJ;VP?[9@?OZ/X1(L;C_=WZ
MCD-C_P#L8?UORGM-K[DU^]H_P2&DOB=UQ]U>HU!!4
M
M
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MHRYH\Q>"&(2
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M(QBH
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MRW",H3</S>S\IE=C!+P
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M,)]PN>G6$3[JTIFX2L6L+TM"Z\7.<M<53BE<6WB4HS,ZCCGQ=.\J.=B
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M?7&&22
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M?CH2:DEURM>,N[>,VRD[->TX_*Q;V->Y+BH=J*,NPA9M^TW4MSHE1<2@5%H
M"0)6I $   !($^OB0!!($O0@""0)( @ "0)( @D"2 (       DB E*I $
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M
M
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M;:7)H9+(P2H
M                                                         "Q'
MY^FWI-0GC6@DW>,\9HXCJEE:UJ(R3O\ "0OX]><HNJMIGDSH[\YSI_T$Z=--
M]*LCM<Q=YQ2TI@S%L^!#JBX5<TR4Y[XZT[-PN7<>;=>)19N1DJ<&CTR7G_\
M3/VV:Y%ZG&GXXC[)-*JX%WGMUI74Z=Z@_.ZZ==5-&<]P.V6J8FYY)8IMNB$]
MXTDX]'=23A$ETMJ5&1;:EM$VL:XY(MSOVX*M3DWZO&X3NC^J[R5K4B3DR9;:
M5$HB2W*<4^@B(]A>%9"<R#A<H^X6)-V49&0PRZ
M
M    !Q3.#KA.95\-,6R#:1[?]D2SJ5-U &E:&%CT ];^FW17K]K]>=1(C\QC
M)<HO#<-Q*5\UCEW=Y*E$HUHV_)'WD.5N6W+&5"Q"7+<G7@7@S\__ *9?L;1<
MSVG]DGV#^Z=HQ(XMR45)E7C6EI74J_K_ +ID)9)7:KDDCK4^))TH52_=.T4Q
MQKC="/'M=Y:NTJZ@\3ZGO-ZQ#6'#FWX%DODLO1F*+)1\A;1*4I25&1FHW"KM
MH+]Z#M6$I"$U=O57!&: QM89/_R3?^ 0P"\:H
M                        #XV1?]G[[_\ >:Z?^I/@#"9Z/.L;3OHWZR]?
M<PU CO2X-YR*\,L*)*S6P9W)]LU)5QHVD:#IV#D';E.PDNPQW<4+\N;1,O$G
MY_\ TS$I1%9[D9$>P^--5%V']T%I8EPJ\>RNWY!_7_\ 3-7Q6BY$52J?&GM_
M\X(EBSBN9\"5?LMTKKZBTS*ZE\-ZKO-1TTU9PAAZ#9YLN"PEDR5QN*BN,-*=
M6LE*J;IK)1[:#)N1<<.DB4XRNQ<>"J9J,#; A'WQ(W\"@<87#=@
M "W;YE/1P?6+H!><2LJD1\ZLC;ESP^69)YB+BRAQ:&6G#:<4VMUSAH94W"J$
MG&2?81)<T>4M]],O2WU&ZO= &KG2YU&,RV,TL:2C:>7*X<U]YE5N2M,4FG9#
M;BS)XVB21D6RHO3G&$U.W\(C5PY)EI*YW'S4\"P"Y=&",<OTK#RG/V*'+1$G
MN&NV2):XC9%<$MU)DX]%</O1=_4M^*GJ44NTY$OA,C_RJ.C>\](O3]%MF8)Y
M6=Y<M%WR:/L,V'W$-N(0M7*:4;G$I5:EL&/=N<\O051CR1Y2Z(+14
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MNWU*'+'1$PCR5K[S+]B5$HJI.I#&4E+@5M4*A)
M
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MIF[Y,;V0G#@7$:=XQ[7%G&37:R!64:5]! $               $@2G0 %Z2
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M-(?$[LC[J]1J""H
M
M                                             Z-U^Z>]..I+!I>G
MNIUJ^=\=F*2MZ-QDBJDUH?$:%TIQ'V"N,W#@.RG8>"T^3%T2)3PEIZFE"WOM
MF>SU3BB\LJZE2I;=J%:T*B\F3HE+_P#1XC\,U_HH?:KG>/"AW$?U,71)M_\
MAZFID9?=F]QD9'_S7N,4RR+CES5]I%2C%+1'K[IEZ/M&NDZW7JUZ16'YDB7Y
M;*[@CF$YS5,$DD'4FVZ4))"BY=G==9%5$CU.+8
M
M                         \_=0_35IAU.8?\ 0C5.T?/%BYG,]'XR1XZ&
M5:FA9;E'V"J,Y0=8AI-4?!GAHO)CZ)B22?T?D9$1$57FS.A;MIQ1?^UWJ4J1
M&,(]A7_4R=$O;IZG\,U_HHAY5YJC9+4*UH4EY,?1*5?_ (?)VD::\YJM#*G\
ME$PRKL'5,IE;MR>JT/9?33TF:0=*5@N6.:26,[);KL\T],;-PG.8ME/"@ZDV
MW2A$+=V[.]+FGQ)C%1CRQX'IH6B0
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M)*4I+<DB27K$5"^H+142
M        T),=N7&D17BXFI+#L=U/VS;S:FUE[*5& +761^4#T:Y1D=ZRBZX(
M3]SOLMZ;/<-]%''WWG'W%4.,=*N.&8OQR+D%1,IG"$W5K4^/_4R=$I&9_H\1
MM_\ +-=G_HHK^UW>_0H\&WW#^IDZ)#I73Q&S_P LU_HHIEDW)1<6_9*HVX)U
MH<XTW\J7I)TLSBQZ@8EA7H&18^[SK?))Y!DVOC;77A*.GM;+M%,K]R4/#;]D
MK2C%U2U+E+:$M-H;05$MH2A)=R4)))%[1"R"L         &BI2B6>TN%)556
MA$14VF:CW$0H]KFIV$5U+<75IYH'39TH/R;!D631;_G$:O%C-K?8>>09H=,D
M.O-OF3;AK:-/#2I'O&3&S*2YN"#<8^^RVO\ _E$>DS:EJ9T?O/+4LRYR)*4I
M<22C(EJ4FA;2V[3%Y8M>TL^,FSW%TI^;#TK=3]ZBXZY(M>&9Q/<0B#:KVB"2
MY#JE-%PE.>61DYS'2(N\Q8G:G!T["]&<9JL7P+L+2B<X76E(6PXE*FUMJ2MM
M;9IJA2%)J1I41U(RV;182E74GMT-P*@          8Z/6IYLVMG2;U4Y'ING
M3&YY1IW:W(AQKBQ;I9LNMN<TWN&2WPH5PI9/M[1DVX6YJKT91*?*Z4JF<TTP
M\_7ITRUQN#J'CUPP1Q?+;D>EIYS/$LVTN$;3KI&24FH]BC[ ECNM8\"%<AWZ
MEPO3GKHZ*-678WT7S[!I4^2EM1-3XMIB2$..<NB5./U+BXG"^R%KEN1[RXVJ
MT;1[-M%_Q6X165V.\6&3$>0E;)6R? <:4E:2-/ F*Z:=QEL%&JU#UT/O(2DC
M4:3K7A/9M+=LV]M12DTM2-.PU!)(        <5SFZ3[)A^37>UMF]<;98KK/
MAM)2:U.2(D%^0R@DEM4:W&R*@4J2J=IB]XMY]FJ6 Y?D%@U@T6O,J#:[W<[>
MF9Z#-A?Q:-<'HS3R5&I*?N37$1TH,]XD6ERO4QWD1C)QDFDBX!I7YWW1[J2B
M+%S2<>'R7Z$Y$NT=F6TRM1-D9*-YTD[UF1[.P8\L>XN"J5J_9DJQD7!=,NI?
MI7U2Y+^ 9II].<D<)M&D[+ ?4I7 9;'3;7Q567LBW*-Q>]4K3B^%#TQ'GVR<
MDO0IT&8FA<!19;#R>&A4X29<6FE!:E7E:9/I[3>-$DD\)=F\MOL;PC&,>!"=
M>/$U142
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M'&.JT8$D  2!) $          $@3H0!  $@37N( @D":@!32I $$@2J=I $
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MNKU&H(*@
M
M
M
M
M
M
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MFJ[XY@6).9*2BOZ\?M*KL2ZDKT\X$<Y/$1[:\ZM:CA]*Z<#):HSG $
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M;\7_ 'O S"2K0J[Z%7U^T8I<)
M
M         !I/?<7?WIS_  3 IG[C]3/%$_\ VM<_W]W^$6-WV[^[_ =(97]_
MO/TOYS:-EX3/O/\ 9%^SQ?K,-ZQ*Q<*5Z" (     ) EZD 034"6ZD 0
M    $EO$->RRJ+?,5\2V5I<;/:5:'WUV'V[!:A!SAIVER4E:N57%'D?4OH@Z
M9]7LZ=U)U"PE%YRJ4I*I,M;_  DZ;9JX2-!L+(O?'V]HQ+6+&%_5:G+QWS(L
MV*1>IW;IOH_I#I'%]%TUP2T8_P 2$H7(5$A29!\"4D1H>5&2X@_ 6X^P<JEX
M;]GWD<==S[U_VI-\S[3LE9J6KC69J7M\1F9^QOV$1"U?;E%Z^T8RK6K*=Q4W
M$0MVDU#7B)NKIV 72@ "0)( @      "0)X:D 02!+T'J@.&H +TD 0
M !($D 0 !($@!Q  @"         D"7H0!          !($UJ0!!($D 02!(
M)5( @ "=P$\&0!  $^L!-:<" (   "0)T';L!CMT( @ "3$$O31$"2     "
M0)XZCU &O  &ZD 0        $@2M0 >H  !H0!    2!+] W -40!
M   !-0)3H0!    27;M%NYP*X*M3>V#_ &U _G"/X1 L;C_=WZC/V3_[*%._
M\I[3:^Y-?O:/\$AI+XG=D?=7J-005
M
M
M
M
M
M
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ME7ED\$*5H3%T[GO-I0IB1<)UM?ENFDF32I2+AP&IQ7AV$DJF>X83\7WG4O\
MHTU+G=IM^-Q&&T8["L3#+:")HK2Q :0A"2*G!Z(@DTH0LZD'(
M
M                                   !I/?<7?WIS_!,"F?N/U,\4S_]
MKW.N[GNU_"+&[[=_=M.XZ0RO[_>]?Y6;-OWIGWG^R+]GBS#? J%PH     )
MEZ$ 0        $D0$I5 #L( @D 1VUK7N]3O]L5PN>''EBB&N9U9J<2*4-LC
M]>A_7%I1I-S[67>=.'(T:9$23V%0NX5MMO7@6U1<.!J*7Q%2E._;7]@0J)U*
MFZHTP*0    "0)( @                         D":=A $$@3\Q $$@20
M!!($D 0   $@20!         2!/K( @ "0)]0 4J-X#CH@ 5>P *=I $
M    !($K0@""0):H0!       $@32H 5J0!     !($O0@"
M           D"60!!($\>) $       2!+T( @GLW>R+=S@5QX5H;VP?[:@?
MSA'^&@6=Q_NK7H,_9-=RAZ'^4]IM?<FOWM'^"0TA\3NR/NKU&H(*@
M
M
M
M
M
M
M
M              /+'5CTH8%U<:?+T\S\W4VI3G-)35#42J*+<:5%]F*X3=MU
MCQ#2:H^#+9Q>0ETJ422CF*-)$532WMH5/O(N_:;A3R6^X?U"/2E_GGP6_P 0
M)^U7 [=M]A"O(1Z5#(R(YB:I4FI);^R*GWGL$?:;@\.WW%P;HUZ)--.B[&[[
MC>G*GEQ;^_'?F*>(B,U1T$A%"2A!;B%NY<E<=65))148^ZCVF+8
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M29]HXW*5M54>)DV7<>MS@9?Y;MN\8!<
M
M                -)[[B[^].?X)@4S]Q^IGBF?_ +7N==W/=K^$6-WV[^[:
M<:'2&5_?[WK_ "LVC=.%6S;7U=FT7[/%]QAO@2+A0 !($@!PX$ 020$K0@"
M   D"2 () FE0 UIZ" ()J!-2 (     ) D 'J0!!.\">/K  @"    D"0 6
MI $          $@3ZB (        "=X$ZL@"       ) EZD 0 !($D 02!)
M $$@3V !Z6 #]  )5( @G:!.JU( @D":]A $  2 (    !($D 0     2!-"
M (     ) E4   0 )( @           "1!4J5IV 200!              2!
M/80!!($Z5]! $  2!/ @"  )[#VT%NYP*X]JJ;VP?[:@?SA'\(D6=Q_N[]1G
M['_]C'^M^4]IM?<FOWM'^"0TA\3NR/NKU&H(*@
M
M
M
M
M
M
M
M                   ,:/KM\N?K0ZGNJ_*\EP[-[MC&CT]4-,$F+U+C,<M)
M.D^IN*VK@]Z[V%V#+LWK<(TDJLM7(7)^[+E1JZ;?J]^)FB)=-6]6[WDTY9-N
M2;=Q2'$)5X%.(4\\DC.JN+OWBJ>4OS$(6HQ7M:LN1Z2^4KT8:5Q8:F-,8%\O
M$6AG=+H:7S6M/+\1-&R2:\2*[:[QC2NSDJ-Z%Y4CI%:'O'$M)].,%@M6_%L+
MQRTQV"237HUGMZ74DDDD1$\4<G=A)+M[!0Y2?%L-MG/T(-)GN)-"(DD1$5"*
MA$1%N(A2J\64FH))        #B>=P;G<\,RBW68U%=IUANT2W*2HT*3-D07V
M8RDJ*AI-+RT[2W!PU!B<VCR9.M/5S,[]<M7-6;YC]BN5^NDF.T=\G2>7 DW)
MYUA/)JNA%&=V%3L'(?:;/*J1U,65F[*3<I^QW'N73?\ 5^]!<>>AR]0,PNV=
M265-KD)?XVVG5$:%.)JXV9J)1D>TR[18ED-O0O1M0CQ567+--?+GZ0]*41?H
MII'8FI,9+7\;FL,S'G'&R;^47S6>&IJ;(]PM.[<:HWH7$DN"/8=GQ;&L?::8
ML=@LUI;90EMLK?;(4,R2A))+Q1V6U&="+:**M\0?>$
M
M                            VD]],6#,DK*J(\60\O\ O&FEK5^U2(;:
MI15=2W=DHVI2?!1;^)%H+(.M[IXM&3Y!:IV3QDW"!-?CRHZC;3RG6Y#K2BJ<
MDJF2TF.X,'HW?+>SPW)P;Q[BT^+U'DG>O.'R\VO.R8YV=:A?M3:G%RC5.K7U
MCXO].[IP:(R5E44C/;[YL_5_E/8+UKHW?HV5D*U)VY<-']!Q;\[?+*48R6X6
M>66OO1_VBDNO3IN/=E,79OVM^Q_SD7OX)ZC[;$OE^@M_SP\L%PS[/Z4?]H?T
M\^F__>J+\)K_ $D/X*ZC_<2^)_03_._RP_Q]G]*/^T/Z>G3>7_XU1?A-G_\
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M "PK3[?9_2C_ +0/KTZ;R.A95%^$W_I(?P3U'^XE\3^@?SO\L5QS[-?ZT?\
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M"_\ ?V?TH_[1']//IO\ ]ZHM._B:_P!*#^"NH_W$OB?T#^=_EE_C[-/ZT?\
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M:VKD+F/#(MNMF:33[TU5/XCZ8%P
M
M
M
M
M
M
M
M        "#J>PME>WN_\(E4XD,G^SO$$@                05:G7=LI^R)
MTIZ2-:DB"0
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M(Q3?=%47S'*Q!>
M
M
M
M
M
M
M
M
M
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/HCRM<.VOQ5/K"V70 /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>tm2227887d1-bc_single4clr.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2227887d1-bc_single4clr.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ B '( P$1  (1 0,1 ?_$ -@  0 " P # 0$
M       $!P4&" ,)"@$" 0$!  (" P$!             0(#! 4&" D'"A
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MOT*>D+YT/.!N?J,![S8]RW=;ZENM<S\Z?.!\2OM=M+\-WZ%/2%\Z'G W/U&
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MCH6Q1S]I*Q[&48*BNQDF;5^R6%)9 5FCQ CALJ*+A-)=$5$5 'HG*4Y>/ 0
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MM",#OI56QU^MU2>5>NA1ZY967K=/BF+@PCTE6T>@0PB"9>&0>X4 T+&PPF)
MB?#ZECG&D-0NS]:YUO4%U.L8K@HK",SJ [C(!2K,'Y3F3$Q9)I7%>Q$<@/:
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M0'/&=\OAPW7W;W4VCM^Z;0VC,O-SNDR:UKS*LN<QI< Z$L&!A3 @K]#[I/\
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MX@K#O"CW6ZO1RL.A&!AX:5C;;&$1'_KH*V)_-Q,6ZAF4B_;,W5ADE8B$074
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M:L<[";FH2=>4G/A7$Q$0!RV8TV6.["+-]*]H$HP"_6]+J^CQ+PX\1X?G6_\
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MA<7$T8, Q(T8>$K8)>&:/FJ22RK\A2/X]8!1DGR9A,F]1X (@N/$H@/=^_\
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MC+65YM';S21N\C<8--XFK&H/K!0'@5A1*6E&G@4L+4]@760;F,1(RHN5V=?
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MP4X5MN1580*U7@F5;%X#B1GERMR*S1H]J:4,1HDHBV)VXR0N2E016.4H 8
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+1,(F$3")A$PB_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>tm2227887d4-bc_mostpreva4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2227887d4-bc_mostpreva4c.jpg
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MP8]2WF:C6\( VT59FLU6MCEBBF1O%3'8M+=6\TV]K+9-*M1;<9*"D$! 0$!
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M5U\BV+KIBE(F57Y]_<FW[D]V7->_A+JD!M3A4[%GT8YXQPEJ;G4\.;>B9?H
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MMR4CGIA*(OBO+.;= 1S1TKQ,=L&(Q:<?*<4F9MGK12+HZFML55A 0$! 0$!
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MK7QRVSTMT3@SRCZ@6MM8QN[6>^<8CI;E9EA 0$! 0$! 0$! 0$! 0$! 0$!
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MAJ:56;>:4:6XG1C"WEB:4H\[::LZNEXDTF>:8SK6E%Y4;^%D;7NJ]]>'#T_
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MZUI"^X8^W@8\B0-:"TO:20:;:E=GM<=Q9/\ 3COA\OLQB[A,Q+U@_HN[9_\
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MRJ69"D"A6OIZ7)?6M:)F5,C>*F-*;UL8<5K+J)<WBICL_.\JF+HACF*JU"1
M0-N"2-L&QP %SL :-..!<?KE8M#1NTN:*UK*9F+IBWBZA?'2YX<T.G/PUNH+
MF[R<S^33&N].93:P9=FL8+GQP9H9[*[[NDL1:\PSU!#@014+C??&Z;[]KH<]
MUD7:]D3,32:36O<[KW!U=+0\XKJZ5NK31OFV+HB8BZ*4G'H>0-K'G%S?U5GV
M:YYGG-GF%?9QFM_>9C<F36.HS&;B\N9KFX[ILF9/;"SO)30 \(&Q=IIZMU^G
M97\RWNAS'G>M=J[_ %-2^G--\]F<\'/?2)U/]1')7G/R\UURWYQ:\RC/X]<Z
M1RMOM>I\\S"Q=:YCJ#+;:\CGLIK\6DXFC/"2YI(;@*57U+\.YUM*_<^%RSIW
MVQ%T76\T4XYY329Q[*Y.3\TT]/4T/7C&(F8IAE#VL.5-W<YQH+1&:7LIDO<R
MT/I#,+Z8U/?WEYD-C<74IJ30R32$^E<#YE;%NZOB*?:7_6E/D6K70FZF-+?J
MQ7XW(-XSB,5#0@G9OIVT7DZN,QVO3U(YJ)DP;%YC7ST5=>VM]L1TLVVC]5/2
MQOOI1( \*3F[4U/M>2;?V>[/FW+BO>O_ !=Y-TUU/JP['W(B(\C\WB<?U?%Y
M1V6D<%P?C 1-H#6@(9N!V+Z9L\=*:XX..W43]XNX>M\J[WP]G./55RBQ/$[7
MNF* ]@U'E.\KZ?\ A%--]O/V-_U9?*?QANY_=>V./CZ7UX>VGI1O%I'2?K'^
M+.0?^;+;R[Z+Y/?2W=:TYSS3WR^CZ<3.ST8_H6_5A]<S93L7G:$UF[M;W"$@
M*=*V>:O""52V4""ES>*F-*5W*8FB)BK1 [FM3Q<7HI3W>U5F<3&&C.[N^&E7
M$G8/SJK!J[>=[2>:;.3'M5\7P>%:JGW)'" PFO9C1-M=][MOMF)LY<,>*=2_
MPYBF-6K":U]&^JMI:/A5QK5FU.#769C$!!HF*M/6V>3\]7YXACG3K3')K*E8
M9%+6\-<:U\BFZ:HB*'#Y5J_=YK7FG->J'-XJ8THMJV:,=T3,882V7"?6Q/J^
M_6BBK+I32L2W$/V0/YJ+)J<&MHUK,];:7["XQ4<1ZVZN\^0A3MK(MYIF<V/=
M8S;,5K5OHV\(VU-!\"Q3A5N3=S1#0DC%QPU=P%AW'XRPZ>MXD71,4X,ME\:5
M<*U:\;>&M379Y-BUMEI39==,S,UE2^[F:;[<N?&[C(X"30;]GUE?>[6=W-LQ
M=-O+/!2R>2:YM;@%2=YI7T+/J:<WVQ;6E$\V%%85[;>6VBHK HK *:P"#3:R
MA!K[WYZM-U8HK%M)5T6*ZWF64O=04IM!'YO=62+:Q1$S1LF$0<8Q?QG;78"-
MBU+;)V\YS=5>;9MI+4A^4XL2*4^KY5FT=;FKA1&I,:E(R""X]E"/2L\3SK1,
M:,=-6E<,[_NB"6!IW$X^XM/7T9UICUN7EFJD6>)U4;AT/$[BXR,!@/(%L_DT
MZF6W5BRWEI#4C;P5QK5:&UTIT^>)F9JB^[FI*F%M./&M?SUC\OT;M&;YF9FL
M\4ZLUB$L'!Q&M=I]Q>AXT:ET6M>VSDB9K5L+2[-P)SW9C[EU,:GCH=H\ZRZE
MGA6\U:J;36\:Z;9MIBKXC=5)#H^ 8;??]U:^EO)MNIRYRV=SMHY8I=BBWF(/
M=\).)];'=5;6MMYOGQ*TCH:6CK9:=)[6YN8N/@?Q%O=XT&_?BM3<;C[OM[_5
MYJVS'Q,]VCXMUN-*2P9?I2_A==1W/+4_+SJ<Z>M"7_,C*,DL\Y?S+L[%KO:L
M@@MH+V2RFCMHK>6>\;+&2WU27!U,,5\U]P?(9\LW7F&[MOF;-Q?S4Y9BE;IP
MRBO2[>S>SNMC9H:<6^+HQ-8F<[>7.,^,PP*[C0?,S*[FXL+OE5S&CS&">>VO
M8G:*S\=S-'(Z&2-C7V#7$MD:1L"^L[#<6:5M\TYK;H[:?,X.R)F;IB<*SQ=]
M7@4>$[U-]3W5ERLYEZBY1ZCR'IST7GL&:ZPUAG]E>Y$_+WVLUCF.7MAL<SLH
MI[R6::, !K2WAJ>+!=![G><Z/E>MN=Y?28BRZV(K29NF,(CIB8B<:_ Y_P X
MT?OFC&TTXF=6[4MF["L1;$XSW1\+U9;7+([;+,ERF"5T;<KLK.PB>&D!\=G;
M16S#0; 6QKF-Q,:FK-\X5NF8XYS5T.XT,+;8NI-.#Z.-G=,:TNXB !Q'S4JL
M>OK4RC-FT[9MMI,J(F4)/%^8U6GMMC.UOF^;YNK-62=6+HI2C5:VE<>SWEL7
M3.OU<LJ1'*AS>.GK<-#[JU]32G>3%)FWDGAQ7B[D^%JK>C"**"D%%8&B64W^
M]^>HOUHLF,,U>1,C0[A.&%=H!K58]75\.F&:U*J8?LO0MJ_*)8=+BZUO%TPZ
M"^?=-^D<RK_Y/O5^?OQRLYM#R_\ ^IL^M+O_ '!FGG6/]5?W/%HS]X;J751-
M<=09QPCB( _A&Y]!VK[OLXG[EH_LK>Z'%;^OWW4Y?ZV[ZTMSHL_Y<Z).S_*[
M3AH<1_C>TJ>Q;6VK]XL^G'?##O/W>_Z%W=+V\.@3'I7Y/FOQM"Z6_P#N>RE=
ME^(<5\]OMC#]5I_5<9[D1R^7W1_3N[UY3&TKY5\_T(GUHEV]TPHBPXMY)6'9
M:<Z<WXS-97OQH2CXH!IM_-M6UJZOA4BE:HTYS:P% !V++7"JDS6:E:X+#;JQ
M?=RE%+6\-<:U33TITZXUJFZZH1Q-<-E0KZ4S$JSDV=O&62?&+JUVUP]];FI=
MS6Y-72BES=O;4C%>9K:=;JUG%NVW4:$LG=#AIQ5IC6FTA;>VT.6*UJP:VI3"
MF:KAX:&M:XTV4V*NMI>-3&E$V5TXZ:I$G"*4KZ>WT+4U-3[I2WVJLMOZRO :
M>$5VAU</-_16WIZGCVUR8^7PYIG"B1AE+2'<'"?=K[G8JQ/W>:^U5%ULZM*8
M4:SF<1:>+=3ST62E<66V^+8HU *!8[;.6N.:)FJEK.&N-:K'H:'@UFLS5-UW
M,TVMX75K56OW7"C'9I\LS-6NLRRAP#Z4<,*^7ZJM$S"LTEH2-X2,=_F7E;^9
MU+[;8K'+-6;2BD2UGMXP,:+T=*^)LKTPPWV3=A5#8RVE75(\E%K_ ';UJUED
MYL*-4+8MMY;:*M+N_P"F][\]9>;J4Y9KG@U&B@ 59FLU6B*0I>*TQI2JQW:O
MA\,T\M6FV*AKQ$J;KO&TIMRJQVZ?)=6M4?>3^BXO11>32=A?6:W\WQ-K[2.B
MBAT)E#3QE@KB.W%>SM]Q%^GS\N,M74T9F:1.3\O4P T]GH[,AS@#=_<,M5J;
MW]TUJ?U5_=+8V]/O.G7/GM[WBM^+%_U[>> :3P_C9FW$!4 _PQF>WM7S_P#!
M['W-T:Y^/K?7E]!_$FG\4T8X>%9W.NNZP$-'$D T!)QV=NRB^G:E>:WZ4=[Y
MYJQZL8/57^BD$GPV=)5.R\N:?UMFOHOOI_8?E?[.7$^0_P"(O,NVUE +YL[0
M0$!1.0I VK%I6QC7I3+&^^E,@CPHN;HK_=V2>])>?77+>>71_>+RW"*\U_=#
ML?=RR?X)YECEI?.\E<.?POJ]YP9M<X]G:<%UO0Y":UFLUFORKYO#W%>J7DR2
M2>+76EMM?Y0Y1O.U?5/PQTKK]YKS;,Q^JO\ JOG7XD7VV>03-T1,>+IY_2>V
M]H]_#I'2F&W361';_P"++;R+YIKV?ZSJ8_ES'QR[K;7?ZMI_L[>Z'TK7<5<*
M4IO6&8HSQ-52A(@V%Y@Z*GZ(?"MC1QB:M;<3C:W=!1N Q W!:&O,VS%.EM6Y
M*)(^-S#@ WB)P\BR3T=2DVUF)867TPYH/)3D%3#\(U+0]E+2\]Q?-O,\/>WR
M^OYMWUKGUCW%_P .^;_L[/E>;@PO+W_*/X@]X'KN];UG5KCN"^G69P^4ZOMW
M<?6GO=WGT=TG_2P=../#_"%_0[?[S]Q?3?<#]V\PCAX4]T.7]ZOW&VG]9;WR
M]ANR%;*UJ ?P:# _L3.U?+YKXVI].>^72:'V&G]".YNB!V#W%CU9]7ECBRYY
MJ6MX*XUK[RP:>G.VSF;N;XEINYE6U9<=7JHKD;$F?"QSJ9J.#BWTHJ76SKTX
M46YJ*FMX:XUKY.Q;4S6*,<106GQ^%=6MR,E6TDM^*GRA!KN\JM.YC3I6(Q8)
MT)NXRW+&\+0VM:#:HNGFQZ66V.6*)HL/A]:]4.;Q4QI3R+-;-%9BJI5K"12"
M @(-J]G?EIJ6\%:4.VJB^Z-.F4U7T=6E<,&G- Y_".\( KL_HJML1J? Q:U+
MZ4P+>(M;("XGBIB=U/25%]GA4FN"NAA,REWJ.%3Q<==^R@"G2UN>[DB&37OB
MD13!N0T5!#L!N\_E6&-O,37FE;GBB6.XJX4IY5LQ9R13-2)JK1*#L/F1,9OB
M-:,X=%:SQK72VHMVS^"+Q>)[P>MY=JX?_+ZOU+GH:-W-N-+Z=O?#Q*>N8TZI
M>;DWK'N]>ZJJTU(DKJ+-_C5PP7B_A;=3W8T>;'U[\^UV'X@Z/+O-.ZL^Q;W+
M0LZN@^*)H:!6H-#Y=]-J^B[B^)U=.D1%+H^)\]TII;=7.GR/60^BV?ZJ3E!C
M_=F<>^^U7;>_GV/E]/\ 9H<7[N?VYYE^UAD=KYR[40$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$&VN&UX/)7#W%AU:88
M50U_L?1]11=^[W?1GN6C-YJ'TQX__,IR/%-N49X=M/[LF%*[MJ^0?A?_ &OY
MQ^W^678>??V)Y?']&YA^98!*RX)(BDBC:7,!#N[HP<)J#ZU2ON6PB;HO_-HX
M[3BE>AWA_1KK&SS7Q?.G7Y[L\MSNTN&:HCEL,TRZUO[&=ILX(@7VMW%-;F2(
M2<37%M6D5&*Z'W;V$;KR[S+=1=RQHZ-T4I6M8SZJ/ \^W%VG9I7<M::^G/HG
M+L>MH.6O+5Q;_P!'FAO6%?XIY!V5_P#!ZY6ZVD3/0]NS5YHMGIBJL<L.6M*?
MS>:&_P#=+(*?X M>O/PC#IQ99QS!RPY:?_#S0W_NED'_ */2RZ+JQ0E3'RVY
M;\1+.7NAV/C<',<-*9""'M-6N!%@"T@BH(*O;ZLUR[,%9GFPS?4VT$%F&M#(
MX2X<$<44;61PL:*-8QK &L8UHH , !1-QN.:V(FM9^%3;[:;8FZ(BGH5R@1G
MO!Z[I,/5V4]%0IV>C-M9F<S=:M8MMZ&I%;D#B,A/%CYEGOUK9FD1&#'&A,8U
MEJODCMHB^:6.*-@)=)*]L;&C;5SGD- HM6[5FM9B(CKFC8LMI%,WRUSS"T#9
M2.BO-<:/M)6FCHKG4N2P2-(P(<R6]8X$$=BM%U9PF/2FC0;S-Y;O<&LY@Z(>
MX[&MU7D+G'S 7Y)5D/H<NSW)<X9WF3YOE6;,Q/'EV8VEZV@I6CK665N%5:(G
MC6BLST9OT3(0<6T\YI]13%M<I1-U)5-?Q5W4\M5$Q1,71*M56;:6'O:GC+:]
MGYL52W4C&9I#-9J<L4I5HVML82\EQ/%VJGCSN[9MFV;*85Z6II:$:,S,36LM
M5\9;0U)';V>=>7K;6_2F)MFZ8F>MN6WQ.;3DM>-W$)"!@>'S+V[=>-*S"(FZ
MF37UK?&BV,J2_&S'5VD]/N[C/-4:<R:4 ?)9KGF6Y?+CLK'=W,+A5:FEA,SA
M6>%<5YB(RR1EVL=(YW)W&3:JTUG$S@ZD.69[EE_*</L8[6YF>:5[%GT=.Z:S
M&/9C3M5NNI'4_3L' ]_3[$GZJ:^AX=DWU_)GN:^VOB^9B.E@P_3-,;+HM/9=
M:[/_ '),?J+A].ZN^T?H3_\ I+GUWW)_L;S3Z-O=+SXW35S&_P")M:R. -?Z
M8KOM&O+AT/EF^F?O%T_TI[W?-]&8'!XOO3N*UJW48KYX+-?1/='#W<\X_8_(
MY_WBCFVVE'^<L^M#UX)&X-/YJ!?-=&.2[4GIF7LW6S=9;$<**X7\8)#>$;O*
MM;:ZLZLW881-&Q?9R8<6J=AIMHMRD9*/SK28N,X<PM+#0AU0=_:L5^E]VI->
M:+OB8=+5\6L4I17:R![I!2A::;5?5LC;VQC6;DZ6KXLS%*4;J+[+T?55-+1\
M*)FM:LTW\S0<WU2[>W'SJF\V\;CEF+J<F)H83,3G+4AJX'"FS'M6MI:\[Z)I
M'+%DTZ:IY/#PK695.9Q$'&K:T6SI67<U9K%$74IUMG'*+Q[F81F(D$5!)QW@
M'!9-SMO$F)YJ4E@T=?Q)G#&'Z2R1A#,(" @TFR<1I2GI5KK.6*L=M_--%=5K
MQJU9:)!JLEEW-%4/G,TU)IC)G\&<:ER'*7C[#,\WR^P=_6W5S$=RO.M;&&'I
M5G1NNI./H?D_SG<M0*_SAZ&[*_C;D%*[*?XPVK'=-,J8K=4OV<MU/IS.CPY-
MJ'(<W<14-RS.+"_<1Y!:SRD[5AMVUU\8SET8HNOB,J5?L&0M<&EI%:[339Z,
M535TO"B)MF9J67\TTF*(D/$!CP\6WZBV-*^;XYIBC/;2*JHHC$U_K<7$,!3R
M8+8OU(NF.%&K;IS97&M7Y4,LK7.<;:1P+Z-JQQ!QI4$MPH%Y?G>^G93HQI:<
MZD7S3#AVT5V.GXO/XD\M)X\>RK]HUX":5);L[33 +?MG")G#)FNRF(?DY=/)
M(^<2PO@X7D#O 6\0)P(#J5&"MOK?8Y<NII[/5YYOYHI27Z4D7> >O2E=BIIQ
MX<8TEZ%M_+7#-M(FF+O"3Q!V\G9^8J-2Z->ZL4BC!H:/+-V,XJ[:+XYXN($[
M-H&.RM>Q8M35C>3$6TB+)X8HTM.='FQK,MTQG!7&O%[RS:MTW6\L1PHFRSEF
M9KQ:7L]*^N:G'W]W8M"W83;=S<\MGQLJQ"M^(;0[*XCR46_HWQ28C@UM2V;L
M81$W'B[/?5-'<^/$Q2E)IF>#X<UK5J!Q<'5:1396N/O+)?9$S%)+;IFM8HVM
MO+QND;2A%=^.!IL5]U;R:5>IBV]W-,]JLF@+G$-:T$N>X\+6@"I+G'  !>).
MI=G$>KT\&_A\+YJZY@Z#R^1T%_K?2%E.PD/AN]2Y-;RL()!#F37K'M((WA>G
MH3^KB)F)GJFK%=$Q/%J66O=#YG*V#+=9Z3S"=YHR&RU'E%U*XX !L=O=R/<:
MG<%GI,]*DS1]$UYC!=3B#J$.!]4C<0=A!!46Z7+6:XL<7S6DQ2%8/?-:?BG'
M"M?(M35TIW&=8HS67TCM&_)_TU=W93ZZQVV?=.,W<S)/K]2'2[,-_:LUD1NN
MKE8=2[PJ<:MPMBL=,)4N<UC2YQ#6M!+G.(:UH&)))H  %%TTBH^8OM<:*RQY
MCS+6&ELOD::.9?:@RFT>TXX%L]W&X'!1%U<IM]*:/SOYS^6I(#>8>A23N_&W
M(*GS4OS57I*LS1^ME^J=-9V[@RC4FGLT<"!PY9G67W[JNV MMIY2*[EAOT;M
M?*:4Z,4VWTZ)^%] 3W8&_;C6GUU.G9.G%*U+KN+3J):5HTC=4&M5AU='[S3A
M1-M\6J98ZAHKLWC>K<WW:(MSJS:=^,RJ / YH?790[:?T4\?J8[Z7SA@TF-<
M:GA(&XTVK=BZVE8I\##?H<E*75:KR74JPBF\X#WZ+5T=2[5YN>V;:95C-DNO
M\*(IC$J'L[^A#N#@]-0IVVZB_FBZVE)XJ:NC-U)B:-5TD=O"Z2:5D<4;2Z2:
M5[8XV-&)<][B&M:.TE6NU>::Q$<O:FVWECEXOD9^9'+NUD=#<Z]T7;RL):^*
M?5.1PR-<#0AS)+YKFD$;PK1,2FDOTLLU?I3.W]WDNI].YO)_8\LSO+;]^-*>
MK:7,SL:JT1,]*)F(Z'[CY.$@$4KVG;YNU5NT8U,8G"%9U.7"53'<5=U*>^L&
MA=S3.%*,MT4HIB%.+'LIY-JV)B+(8[<5!:6[^*OHI^:JC2OB:UP1=$QEBUA1
MHI6M.S$[>P5*K?J1$X+VVTBC9WV:99E<7?YIF-CEL./RU_=V]G%AB?E+B2-F
M \JF+JYX2FDODW<R>6\,A;+S"T1&]I(<Q^J\A8X'90M=F (*R3=6%(MI+]"R
MUWH?,G!F7:RTI?O<:-99:ARBZ<XX8!L%X\DXJJSZ;O6EC9(R)&.'$'L<'-+3
MB"'"H(/:K1;6:3A*EUW+%>"0X.;Q"F%32M=BQ:FES71U+6WUMJVPN!('M+*4
M--O9YE.YGP+8KC%T&WOG5NFF$Q+\G,<BRS-X)8LXRG*L_M7$.M[/,\MM+Z&+
M"C\+J&9GK#R+S=AMO Y]2)BZ+N$1$?&V=6ZR_EMF*71G/ROF1RXY=M>PQ<M-
M$-+'5XAHW)&NC>,0YI&7BI#MX7J;6^+^::S9,3V-;=\\3;A&I$_]ZGS/K[:S
MBL8HHK:VM;.VC!9[+:6T=M ]M/5#+>-K6Q=V.P8J]]_BVW6W5G#"9X+V6\](
MRM;J.VBK%*UQ)BXC'B: NVBFPKQ-KL?#UN?FF<>-6;Q)MMG2I%):[9P:C@ I
MYA6B]#7UHT)B*1659TJ16K0>/:B/UL,->VOO*-+5G7K,QR\K7OLFZ8BN3>LP
M:&[:8+)&K-\S2%Z4?B9CJG3&4.X,VU'D.5OQ]3,<XR^R=A6OJW-Q$<**]MU>
M@F*/Q?YSN6NS^<+0]=E/QLR"M=E/\8=JM1#]*PUEH_-7<&5ZKTUF3SL989[E
M=VXDTH.&WNI#C58_"FO&A6'ZKI7"GR9+211[35C@=C@ZE""%FU=M&M$4OI,<
M&O&O-F=N$\5;8.[Q+N+CQQPI3^BL>OI>/-M)Y>7XU[(\.LW8UZ>#5B@$8-7<
M1)VG=YE%]TZU(CU:?&FS3Y*UFM6JQG!7&M2LDW1*;+.6N.:'.#30-#CV85'P
MG%:>MNO"OBRV*S/1+-%O-G+1<Y[_ -;>VG:TBOO+%O;;_4\.)FN=([Z,G+;;
M&<2TH(C$ZKB1Q CUAP^7:=J]&V(C2B)FLM&V)C4ZJJK=U., 5Q.%=BQ:VIR4
MB(K,O1UK:T;+,M19#D@XL[SO)\G:14'-,TLK $8XUNYH13!8=#4FZ9B:1/17
M'T,$VTRR?@?SE<N97-;'S!T.]Q/"&MU9D3G$D@4 ;?$DU6Y;\+#?\'POJ[*^
MM+Z$7-A=VE_;OIPSV5S%=0NPJ*2PN>PU![5,X]2+9[)[);KO?(/+BG(GGQ:J
MHN(" @(" @**P--@I7?^=58HUYU,HP@BVC\#,-8:2RB0Q9MJG3F62BH,>89W
MEEE("*U!9<W,3L**]MW-T?!*:2_)_G.Y:G_]8>AMM/XV9!MV4_QAMJKH?KY=
MJS2F;O[O*=3Z?S23#Y/+LZRV]?C2GJVUS*[&JPQH3&-9.:.I^U)4TJ"*;]QK
MY?0M;?:<W1;RS/P+Z5V=5;&\(^-YUEVFC.EITF9FI==$RJ=3M4Z\5HK#2[K
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M:JH;?NN+UN*N.S8HUKHU*3%(HKIZ7)6LUJF,AC9'O(:QM7.<\AK6M%227'
M!:VAN_O,3/+RQ;-.UDC2\.<ZU?-7>O\ 0N7R.AO]:Z2LIF&CXKO4F3VTC#B*
M.9->,<TU&\++%\3-*V^E:D];:-YF<N)'-;%S T/(YQHUK=69$YSCA@T-OG$G
M%9(BJLS1]18YIE^9P]_EM]8YE!A\ME]Y!>18BH^4@?(S$>53-N&-8A6+XF:1
M29ZI;XT_1 >E:\Z-TXUE?FA!."Q75B%H5 U6?3OYX1,*&OJ0*>_^<LTVTBJD
M75EJ*JR*!#)2UO#7&M?)V*9FJ(BC9W$M2T#97W?S47D^9;O[K=IQ2O-/31GC
M1K&+?;O1]1>I;C$=C#.3\<ND$K>*)[6AU.)U6MVTJ:@!:._V_+-MUETSCP4T
MM6Z;O6MF'Z%Q(&,&%>*F(W=BWK:<M:QDV=&WFFK1N<PM+"%UUF%U:V%LP?*7
M%[<16T#<"1Q2SN8QN WE:>EO/$OY;HBV.N:5[.E6;>C%\J_F;RYC<6/Y@:&8
M^M.!^K<B8ZH-*$&^K4$=BV[IFV8RCM5F*=+]3*M2Z=SWB&1ZBR#.7-%7-RC.
M+#,B!MJ1:32D8+8F*9Q-.QK3=T3%>J7T8-0*X$[CM6*8X1DS1-8QPDIY5KSH
MS,9RM4I7>DZ,UK62J&NXJX;*;Z_FV+8F.6%8FJ>(5I45[*XK!XL=2U)SX)!J
MKV7<Q,4?,9GJK2>42=UF^JM.Y5**CN\RSK+;&3"M?4NKJ)V%.Q98U;8Z/2QS
MI3-)QI#\9G,CEMB!S%T,7' 4U9D#C7?A\X*+O9I++??XD13@_=RS/<CS)A?D
MV=Y1G/%B3EF9V5]@!M'LLTH(V+!I[>=2LUI$=&7PL%]_A=<R_:C>Z8D.:8RS
MM&)K3<MF-.-&R(B>9%M\ZLXQ2BN6,2 5<&@;#ABJUFC:LOC3CM;.O=N#!4U-
M/-]=1MXK%T]#3U9F*-X6@AHX@"WS5Q\E5BG5MF<:1/;#;LF;;<JM;<LDQA*C
M9R.=#0\)<":$[ *]NY:FVV<UNNNNF*<.DU=;EB(IA,T5V] '  $X5I0'&NU3
MH;S[Q=-G+3E(TO#BM<WX6<ZMTGD4C8<\U3IO)9CB(LWSO+,MD(.\,N[F)YV=
MBV/5F:1,53=;=2)F)H93JW2&<2=QDNJM-YO,?BQ99G>67\OEI':W4SSM[%EB
MS4F*Q$S'9*E;+9I,Q5^[<3=UPX<5=]52[;QKYS2BM^KX>45JV,T468QOM;JU
MM;VSF]6:VN[>*> BFQ\4K7,D!KV*NK3;\MMEL3-W1A\3+MM7FBZZ9NMOCH?+
MOY9<O>,R_P W>@WO>2Z0G2.1&61VWB,GL6VO;6JIJ3=93EB)KU*Q''"'Z=KD
M^59&TVN39)E63VI+730Y3EEME<.'Q.+V6**.793R+<VMG)%UTTQRB&KN[:3;
M-(FV7[O>S&..41C'#N!0X;*\0V4VK!;,71CDWMOR:EOKX71Q;ES.];3BX??^
MLM2+)U)K,TI*)RFV%#HRVE*NKV X>Y5>C;=$Q2>AJW63;,4K.*J1YB+?5JUQ
MHYVP"N&)V!8-'0BEV.,LM^IR4K&"A]OQEI[PBAJ:?T53:V1M>:L\W-TFM;XU
M)RHKGN;>TA?/=3PVUO$VLD]Q*R"&-HVN?)(YK&CSE1XLW8TB(Z99(MG*,7R,
MG,KES"\QS:_T3$\$@LDU5D3'@C @M??@@@J\3S5K2G44H_4RS5FEL\?W>2:F
MT]G$GZ#*\ZRZ_?C2GJVEQ,=ZIX%TXUG!$W1'0_:<_A-"*'L)^#M2-I7'FP4N
MU8B:4Q)*>K3?N6GYA=-O)$=+8T\:U:C64%*[:;NSTKT++N;3B>IBB.676KXN
MH_\ D'Y^>32&9G_^'WJ^)?C3%=EL/_J[.]V7N/=R^<5_S=W<\5O4S>+/]1.!
MI74&<>@>WS;ZK[1M?5VNC^SM[G+;J)G7U+O\Y=WR_3T8^NKM$&E.'5NG1YZ9
MK:^YL7I;>::VE/\ G+>]H[B8G1OC^A/<]O;H%PZ4N3536NAM+4W?^KN5;.U=
M+[\ZOB^>W7X1^KL^JY?W/LY=A=3^LN[UW=]F.797 Z[S.^LLNMF5XKF_NH+.
M!N'V4UQ)'&,.TKC(NB<\'7/E'\R^6[*L=S!T0QU:4=JO(6FM:4H;^M:I9;RY
M=(_5RS.LCSVLN2YYDV<LC]8NRG-+/,0!A7B-I-*!M"G<[:=>(GUK8CJ8;-2;
M,J7=DOW^,@"K34[EKW7SH_JHB9ZV:SUXK.$I8SA)QK]11H[:=*>>M5KK^;!6
M#59]._GKADI*5D%#6AM<:U]&Q3==$HBVB:U6O9JS?PR6F'R>9ZJTAEDC8\TU
M=IO+)6%U8\PSS*[-]0:$%ES=1NJ*+;MUK8B8PQ8;M"ZZDXX2_,BYD<MZ\(YB
MZ'>X[ -69"XGS#YPKN59NY8JSWW>)3"E'[MGG63YHSO<ESC*LY:<:Y9F-I?8
M ;1[+-*"%J:VTG>W<TW<L6]&,?#/!A\7[O$1$5F?2_6@<9.(.!86;0=N/:,"
M%FT=M]TLIS<T26ZOCS2E)AJ. GP#N$-V$';_ $%D;,7>''3,OSW<3"UO$:AV
MW'>??P6QH1')RSP>;J^K=3K?J%X:U@!!) WBM33<O/W&XMT;HB:8STM^RR9C
M%J@4\W9V+-P0VEPXQD.X2X$@$[ /.5KSL8UKINYJ45NU_#B(I6)E(/'Q 8<8
MV[:8;?*L&COJW1IQ;6D]/0R:EG-ITRE\S?:HTCD%SW&=ZOTYE5RW$VV:9YEE
MA-0XBL5W=0R 4\B]6=>-2RE(JUK-M?9=SUF8[&O8ZJTKG\@CR/5.G,WF:2>Z
MRO.\MOY#3$^I:7,SL*]BPZ.G==%TTK;'1%:=O0S?>+-'"9MK/"9B'TK7-+0:
MM[#1P-/<*PWZ?)/467<\5AJK-$Q3.!2]S6M+GD-:T$N<XAK6@8DDF@ "BZ:=
MB8?,7VN-%Y8\QYEJ_2V7R--',OM093:/!QP+9[N,@X*(OKE-OI*2_._G/Y;&
M@;S#T,2=@_&W(:GS 7YJKTK'6B<'ZV7ZHTWG;N#*=1Z>S1P( ;EF<V%^_&E*
MMMIY#CN6"[1NUN.71B6WQ&5'[Y/=@;]N-:45M/3G3BE:EUU94U$M,0VFS$&M
M?<6'5T9W%/R:=2UM\6J)8Z\ XR.$UJ/=5HN^[1%N=673OI6:5J_+U+_%_/1V
MY%F_^!2J-[/^IZW[*[ZLJZ$_ZS9T\\=[Q6_%DJ.NKG@&FG^5F:X;:_PSFF\[
M%\__  >_P;HS_G];Z\N__$K^U-#]E9]5UT71K[.:[C[U%]/O]JWZ4=[Y_JTY
M7JM?12*_Z-C2.-?PRYW;/5L_=7T3WT_L/RO]G+A_(9_]Q>91_2M9/Z^;.T$!
M 0$&-Y]*8Q\*;FX#L]NR4^Y)=KA?/;Y_O/Y7U\_<[OW7MYO)/,_V,?*\F%C/
M6GC!K1L?K 5V@+N(QHX;7]76NCKE?3X?S0WJ?Y*4&W7>F,!M'^4.4^>M5]C_
M  KY;-QKS6/L;_JOF/XEV\WN],8T\;3^L]L_2$?%I'2F-*::R(>YEEM]=?)M
MQJQ]ZU(Z;[I^.7T#;Z5=KI=6G;'Q0W^99MDN21]]G&<Y7E,1%>]S._M+".F.
M/'=31-IAVK%.I&7%L6Z4P_!',[ELXT',+0Y-:4&K,A)KLI07^VJHR/IK#-\L
MS:$7&59CEV:0$5$V77UO>Q$88B2W?(PC'M5N7IK$=BO-'"DJ[TCY,4Q)P/9Z
M%FT.+7W,TY6Z:*,8*UP"T-S-;HGK;5F$4G-J&M1CA0U':LDQQZI&%I],,_S*
M\A>WVK4X'_$[Q?-/,[O_ ';Y=$Y<EWUKGUKW#_PYYO\ L['FU!HXW5&R67BQ
MV5<:>=?3[,;GR34GU[OI3WN[CZ.Y_K7NG"AK_"&88^FT7T[\/_W7S#]E/=#F
M?>K]QMI^?;WR]AZQ_<=K^]H/VIJ^73]OJ?3GOET>A]A9]".Z&Y<L6MP9>#;,
M]8T[:^6E*K;F8FVN&37MK%\VRUA\F&M'K$5V;17R8K5U-3PJ12LRV;;:QCDV
M=[FF79;$9\SO['+81^NWUW!:1^6K[A\;13SK'9==KUB8Y9CAQ3,4RQA\R_F5
MRXA<62\P-$QO&!9)JO(F.!["UU^"LEMOA\8QZ59:L',7E]=.X+;76C;A]0."
M#4^23.J=@X8[YQJ5F0^D9?0W$3)[.2&]@DJ6S6LK+B(C U$D1<T@@]JO99%W
MM3$2Q7ZDVY17L:\4PD#< ":X5QPKN]"7Z?+6$V:D715$@H1Y5X^YMF+Z15M6
M3@UQL"]'1KX<5S8IS4N=PTPK7RK+$55F:*B0.SW5BOOBWH6B&F#7#?O&VBTN
M:;II%:K4IV-AF.=Y+D[ _-\WRO*F$5#\RO[2Q81CB'74L0(P7H5A6DR^;?S-
MY;1N+'\P=#L<-K7ZLR%KAYP;\$*49-U::_T'?O;%8ZVTC>2/-&1VFI,FN'O/
M8UD-Z]SCCN2A6'U4<D<T;989&2QO%621O:]C@=[7M):X>9*<$5P?GL)XRTX@
MG U[/(O.\QT+HY)K,HV^I,S,31OHSZI!&RGIJ5?973-LVSP9KHQK"9304V5W
M[%;>1,VQ;THTXQJ_-GKQ- !-">T[:>16\LT.6+YFZM:,&ZOQMBC=16_"WB,E
M>*GHVX;?*MZ;XME2-&>F6I-/;643Y[NY@MH&"KYKB6.")@ ))=)(YK&BG:5C
MNOMC&Z8B&:VV>#Y.7F3RZ@<63Z^T5"\$@LEU3D4;@0:$%K[\$$$*(NB[*8E+
M]&PU3IK/*C(M19#G3VBICRK.,OOWD8?8VEQ,=ZI=M;M6[FK,6]F")U8LMF<Y
M?GZPD,FC-9,<S@II7/ZU\N4W@V$#M6'SC1KY9KQ$UKH:D?\ P2OY=J\V]THI
M_P"9;]:'B9==K*]1?.AU>%PU]JGA]7$?Y1YOC7:*KCOP]MG2]WM*SC%]_>^K
M_B3;'WV)BF&E9]59%."(3QGB/JUJ?<[>U=_;?-^K9']..]\BC.:/6A^BV@?Z
M*?E#CC[5G%?Z^SQ7T7\0(IH[".'W:WN<?[M_VUYE/^=CY61ZOFSM! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0;:YK1
MM-E37WEAU:X4S&O]CZ/J*+J_=[J_FSW)C.'FF_3(&TZD^2;ZU!R;/,-F/M4Q
MV^A?(/POG_>WF\?Y_P"678>??V)Y?]&YARY3<>SMG>6<7>1FI+]M6X;3N7V_
M;ZG)S1G5R%F-7?;]&7=WGBW=.3J4X6ZH\OQXK$>BE5WWN;;3W;\\NX^';W.;
M\_MYM&(_SMGUGKHX\4--E/6]P+@)IRW5S>MHY63_ $8[F^;O7GZ$4KVMV1XJ
MQPV8%;-M(FJLY/S;0>NX8[Q[A6?=6\VE3)J;>O-\+<EI8YS@WO!(?6J?BC9A
M[J\W;:<3?-TR]#4O_5Q'&/C?EYEF=IDEE=9A=W$-AE65VEU?9C<W$C6106MM
M"^YGF=)(0 V*%A<=V"Q^8[Z-ARS?%LVW1-:S$4B/ABO9Q5T-*[<W^'IU\2L1
M$4K6K$G\1KZ6%TV=,>H[SEITMZ6;U):PM/GG)]29S%F!R;*-'YU9F\LJ![9B
M[-#;7<331G".W=7S=OXNO'-I13;W5F-2:Q=\$1,_-W/5NVNE9$>)-=>,[(F/
MCK\?''!B*<\/I)'BP<YLUU%;9?SYETAHS/Y[PV&ELFRFTLCEEA*9P+-]]#*^
M::2*&4LXR[&@P!V^A9M8B(G<77WWQTS-/0Q7ZDZ<QX-MEMLQQB*^F'3;S ZE
M.?\ S(U!>ZCUCSAYC9SG6:3237<K-9ZC@MN]=)(]]+<9B8& OD/Q6C!;FGIV
MV>S%(:FK=,TF9?&6O-7FIEUPR>#F5S$ANX"',=;:UU'$X5-?5DBS%D@!&VA%
M5M63RS$XUCK:UT<T47]]-_C$^(STJ6464\E.HO5N26$;_4@S>ZN]1\3>*+BB
MF.<7-X71R"(!P.T5V56;[QJ73RTMY9Z84FRVL3-:LN?PIOI8;]7ZAT3R'Z_L
MGM\KS'.;B#+)>?<#XK:SFS*]?96-A%=Y*R[<R!L]W,27L'J@U-:46Y9M[-:/
M4]34B,(X7=7I:&I??IV\UU;[)XXUM9RNF<]RK46597J'(\RM<ZR3.;"VS3*<
MVLKF*XM;VROH([JVECE@?)$[BAE:<"=JU=:R8B;;HI?$TF$Z&I6[FSMX3TU^
M7J?4@]]#5PX:UP!QP/U5HZML1/)&+TM*^9CGHXAYO:]N^7/++7VMK&P.97NE
M=+:@SNTRYTG="2;*LHOLPB;WKBT4<^V&\+A_?;SB/(_NT\DZEVK=2D32E<*X
M=$O3]WMG_%=W=HS=RV1C.'1C3X7EP\Y_I.?BVZCYHZ\GY=<[LMY>:1L-39YE
M^4:99I?)[]UE:Y?F-U#%$^\O(KR25XB:T$AP%0NRLB[3T=/4OF;INA>[1MW-
M]UFC;99R3,99T_ET+]/!Q^D,^(USOZVN4_)_J1YG6W-'E[S OI\ON\OCT_EV
M3W-H]D]I"V3VFP]F#HR9#4<)VUKV=_[K^1;?SS2U+-7ELOMTK[HNZ.6VL88U
MF?Y=?#^?[W4\LTOO-LW71%]L3;7.LT9,/C=^.;R]\,[EXS1&BW6&JNI/6F33
M'(-,6]W!.[2QN;.3V;-,R9#>-DC,,_"0Q[<1L!)7P[3W&X\TW]^GM(NLC3U)
MB^^LQR4NNBD8XUB(EW6AM[-/0MW&YBMEUOJV]-8K7O[7F4=5/B(]8_6)K:[Y
MA\]N>&M<ZS._NI9+:QRG.\SR3+[>!TTSHK6#+\ONX[5D5G',6,X@XT&T[5V5
MFG%LQ.=],9^5YE]8KT<(?9]%G73U5]+O.30VLN4'.[6V574NLM*99>6N;9[G
M.=V<EAF.=Y;;7L#K*\S#V7AF@]4^J#2JZSW8NI=JV7\LZ5U(NCEK6)F([I>;
MJ771$W4]:(FG6]G[E+J)VKN6^AM4R2">?/\ 1&ELUO9A^N7N89%87MW)M-"^
M:<FE5X7GNC=M?&T^B;J=DS-/B8/)]>->V+XBE:1/;$17TS5A/_3+\<NZ*J8<
M%SKT]N!L9</U*^9;/5YM[HVTRTY__27/M?N5%/)O-+HSBVWNEYZCIOPZ^]7%
M\LE<=X>Y?1+)Y:3U/E6OCJ73_2GO=^?T9=Q/B]].'$*8:CIC6E;>UH<-N*^B
M>ZDS'NYYOUZ7R0\/SWUM'3C+]9;]:'KDZAS63)=,YYG4<9O)<GR+-LVCA;@Z
M>3+[&:[C@ &-971 !?.=6>2R^>$5^5[.A35G3IE-/D>7QUL_2</%,_G_ ->9
M9RDUM!R$TKDVI<]R.PT'=:;R_-[R"+)\VO[".Z?>9LVYE(NHH ZG"W$8$A<[
M[J63J;74W5NOX^CJ75MB9FEN4S$=<3-)['6>].ST-C?HZ6EI>%=R^MTST3V<
M?AC):/:_2;O&:AO;263J9M[J-LS'R6KM$Z==#<LB>'/AD#+1CV"1H+?5<PX[
M=ZZ:^*TKA%>#D[YY;)GJ9_W@.^)]FGB3=+1U!S ?:R<Y=!LMK/F(Z"2&,W-Q
M<PV[K:Z]D9<3/MVS\;B 0T#91>WYYY7H1H[;<[:>73OB*VYTF.GM>+Y?KZVE
MK:VAKSSW1-:SA6)IW8N\FV86\1QQ(W%<EYYS1X,169B>#UMA'MS/%^LUO"*=
MOO+9UKY\.+>,PS6VQ;ED^1UIJBTT9I?4FJ+Z:)ECIO3V=9Y>&:1D,;H\JRZY
MOS&9)',:WC9;D;0O"\P\UCRK3Y=2WFG4MFDS-*32:1UUG#X6]M]O=KZED8TF
MZ,NBL5GX'E\=:'TH3Q)M0]17,>]Z:N:MKRHY06.H\UR+36C7Z?R?.9;9N2YC
M>Y?)<R7U][9),+P0MD%'- [%?W6\OW6QV=T[J^;M74NF[EF9FVV)QBD<)^%L
M^?6[73U=.-M]G2DS&$S=$S$U_P"Q;5D'TGGQC,CS_)K[..HNRU/81YA:RW^G
MYM%Y'&R]M&7,3I[+OK.TM98GW40+&N:\D<5:%=1IV4UK(NCFB;HBD=ORO,MO
MMLMGFB)CEGX,,_@S>E!X4/5KJKKFZ+>5'4WK+1LNAM3:WLIV9ED,D\LW>SV#
M+>*7,&.G<Z1K,PE<Z5H.P.V+W_>[R_3\GWMFVT\KM*RZ;<*VS=&6'&',>[FO
M?J_>;;[O$BW5FV+_ ,ZF.'9D[+US+HQ 00[XI\Q^!3&:)R?@&YDM@_NHS<W;
MB>YAKPA[0X\9X]@X!BLF[U.33PRI\C5VEL3?,WS3%Q/SQY^<JNG3EOJ'FYSF
MUIE>BM!Z1R^?,<[S+,[JWMY'LB9Q]U903S0R7DHH:-CJ33L!(Y&[7MGU[YGE
MK3#.9FM*1T5BE70:>A?=6S3MKJS%8Z(CC\/4P*O$K^ET\SM4YWJ7E=T#9-%H
M7(\HS6>SRGGM?-;F5SJ*V;WL;IK7(IY7VUI!PEAC>2Y_%4T+:+U]+2U[[(NN
MF;)I[,5BO7VL5T:&E=-EL<W7-,\J<.+%MZ@_$=ZX^K3.OG?G=S^UKJ#,I72O
M'S7GV;:>C(D,IE)CRR^MH>$B9U 6G:LGW3;6_K)B<)XX_$VM+7U(TIMOY:3;
M.6'QU6K7&LN8L#V,=S1Y@MAF>'10C6N>.<9 ZI)(O0T$/WTJO0VUENO=RW32
M8<_%\WUI&*\'I^\3?KQZ0\QM,RY)=0FL,GN6!H@9F^:YGJ&(,:(APN9FM[<0
MO;PPM!%*47KZFK?L[+;+>2Z)BE)BN'7BPSHV3,3=$\T<8P99/A6?2ULVN,VT
MAR6\0W+HKR#,+XV69=1EDV.UCM)[I]K;9?%?Z>MYA$8G2/<7RQ@<+07. &"R
M[?;[7?V739,:&M9&$<+[IPB.,QCEGGQECNC4LCFNK=;/IMB./#A\?4SK]%\R
MM'<R]*:?UUH+/LKU1I'4UA:YEDV;Y3?6M];W5K=V\5S"\R6DTS(GB*9I+2>(
M$T*T-QH:FSU/ U8IK?%\$\6&-Q&I2ZRO)\>'3T/J\SO,PM\FSF^LX#-<V>4W
M]S8,KC>W<-G-+;1 ;6UF8&^6J\7S&;=IHW[F9K-MET\O3,1,Q'PO<V?+N-33
MT^%U\1V5F(EYEGB*_2"_&)Y(=7'-CE5D?,>WY-Y?IK/;RTR[1%SI7+LPERW+
MH[Z]BL;CYPOF3.G%[:Q,>,*+R?=C=ZGGVP^_WS=IW5GU)NG"G3Q=/[U>4Z7N
M[N-/;:<V:UMUD3S<O3%<XF(6,L^DO>,X'OE?U3VA? 16U=HG3_!(*[*QV# Z
MM-SETNVCFB:4I'3C5QFO$Q,16:7<8FE&5K]'<\>KF/UT:FU+TZ=7>H<NS#G3
M%':SZ SR**WRL:K -NS,HA9MNN"*6U:\OHUA!!"][;;+3\QV&MO=O%NG]WB.
M:W.;HF)RZXFCP/,MQK>6;W0VNKS:OWBZD3/Y&4Q,SECDS$YW.CB:R$<3G#UG
M!]2W"CJ"M5R._P":VRL1,NEC5NOF*4K@VPF9W$I>.[BMV.DE+W\($;072RES
MB*-C:*G<M3876Z6GK<\TCDG/L>E?;=;=;,XW748"OCP_20.ICD#U09YTR]#^
MK<IT1:<MIHX-6<PH;3+=3P:AO+@7;9;6T;-<75K;/R^5K6D\!^+B*KF_<.S=
M:FENMYJU^YZNM=&E69K,6S[5.$3PQ^"C9\WVUFVC2TY_>ILB;\,J\.]T-M^D
MU^,V96,_*DBD#NS1&G. @TJ2YF7M>.'R$+N[=/Q+HMB9]J,J]+Q=;"RLTB*<
M&;C]&[ZV^NKKAY+<S=?]7F<2ZDRFWDRUO+O7#LL&609P'MM79BV*VCI"3!QN
M!+:;=B[GWB\JVGEOE^SW&G;;&MJQZUL<?5SZ8QZ:N)\DW^ON/.-[L;[[]31T
M:4NF:YS[-<(^*,V3+'*Z.WF<QM1;Q2/+"<;@B,N-"=E2%\[LU+8T]69C*)GX
MG:[>V=2^S3F:5NB*]LO/"\;KZ07X@W(#KAYF]/731KRSY.Z/Y6S6UK+<R9/E
M^>SYU).)Z2EUZ+MD+20 !W8/J[M_+^Y^IK;G:7>87WW>%JZEU-.LS%M+J?'1
MU7FWEVEM+9VMD1SVV6S-],ZQ.71DZN^4OTGGQ=,@YB:'S#77._+M=:3O=1Y3
M99IIF72N3VCLTL[B_MXIX8KFV9;2V\LD=0#Q4];9V=[9$83?;;2:1DXNVDS=
M;9==-UO3+T>=9>(ER)Z?NC+3'6#U*:DRWEID>;Z*R;/)<KN+N"?-\QS;,,FC
MNX\ORO*^_%Y>SWEX"P!@=PEPJ16JQ[RML<N=M,/DA3:<LQSS[<S_ "E@8^(C
M]+ ZO>?FHIL@Z-2_IWY=90_-\IS+-?P7.,VUG82RW=K:W_M$DLKLM%Q:2-?P
M1AKAOI3'Q;=M=?=,ZMTQI3^1$S$?"]W3FV+8G3B)U(_*G'T=<,8;F?U,]0'-
MK5.9:LU[SBYA9YJ3.9WW-U-'J[4%M:R2RR/ED<RU&8&WBJ^5WQ6MVK>T-.W3
MB+;(I:P;C4NNI%V,]3];E#U:]2O(75F6ZUY9<Y]?9-J#+)(YH'3ZKSZ^LV2Q
MR1RL<ZRES'V9]'Q-VM-0*;%Z6G==HTFVE>O%HWV1.?Q8,MGPJ?I7W.S1>LL@
MY6=?\K>9.AM19C891#S=CBCR^]T="Y]I:P2WEFR=K,SB(+N\>[A<#ZU VM-_
M3LT-]=ZU-+4XW12DS.44KQF?YV'6MOTK>:WUK(X37^6#T(^6/,_0_-S16F^9
M7+G/LOU/HW5>76N9Y-G&77=O=6\L%W!'<-:76TLT;)&,D <WB):<%JZ^AJ:5
M\Z&K%+X^/HQ:^CKVW4U+?9K\>%</B<ED\)X]O'3#L]*\S5LYL.AZ]D\]D=2B
MX(CC,CB UC7/<YQ#0UK6U+B3@ T8E:6MK_<+)NIS54\+QKHCKAC?^*/])$Z5
M/#RS?/.5.B[1O/KJ$TU=-M=0<NLMN_F^PRAT\<A@=<Y]'*^&5\;XZR1QASPR
ME,31>3M=74W%T>!;S:4UBZZ:TMGHBDXX3$O9W'EU^WBNY]34FV+K;/RIMF,Y
MB<8KEVQ+"_ZI/I1_B<\[M9:AS+E'S&'(WESFC98+?0.4Y9:7EW80RF</B.>7
M#I;VXB=#*&X%A!94U7L:>VNMB;-:ZZZ)RQFGH>/-\1-(PETF<W^LGJFYYYS=
MYYS.YV<P<\S6\E,TKK;5>?6%OQR.D>[BMK;,([8M)E=AP$+/;I6:=)LAF\2Z
M^S'XG"D/,KF?'(WAYE<P;>>-PI)'K+4 X2XC%A9?M<T@X[5GAJWQ3.DPO.Y$
M>)/UQ=)M]!FO)OJ#UIE=[*Z!XDS3.<XSYI?"8C&2S,\PN(V\!A;@1BO5B_4V
M-L>'-MTW1QBOS-.S2LF9FD_,R:/#3^EK<]M&:HRCEYU[V%OS4TWG^:V5E=<V
MK**VR6XTA:SRV\$=Q<Y;;SQV^8LX'.,CJ,?Q8TI6E]'1V^YI;/ZJ:8W1E,SE
M%,XQR1J^)$<\>M;T37T\,?G9_')GG;RWZ@^76EN;W*345EJ[0&KK"#,,DSNQ
MN89&RMFC9*Z&:*&67N9(0X-<UQJ#[IQZNE=H3.E?]KQCJX35HV:WB4U+8_5Y
M5Z\*Q3JF7,L3Y+AK?5[L.#JFM>#A'OU7.;K1NW5]M)FV8>]M[HC3FZ?0_%S;
M,'95D.?YFQCGRY5D^:9G%4GY4V%I-<"/$BG&8Z>E;F[FW8[#4UHI=%FG=-.F
MELS\C%Y?=&KO+;+HFDW1'IF(>9!U_?27O$[RSJ7YB9/R,YDVO)K0>F\_S7),
MMT6_3^59W,T95F>89>;I]]?B\=(+AEN'<(X*$;]BY#W*W>OO?+)\QUINNMU;
M[J6S,S%D1.45^/AWNW][?+-KY;JZ6CM;8B>2)NFF,S,5?']&/TE[Q3;SG[RY
MM^<'-^VYLZ#SK4^29'F^CAIW*,EFN69MG&7V!D%[E\67OB[IEP[ E]5]:]V_
M);/-]:=.^^+?5F<JTIB^3^\^MN-ILHW6A?=;RW16*X71/"E/1C\\>A?UC^(_
MTY="7('+>=O4#K"PTZ_-=*66:Y+I1MQ;SYUGN<WN2,S&URJ"P]ICNFB:Y<(A
M)0MJ=]%\]\\W-VT\P^Y[>SQ=:+YB(C*8B9B9F8F*9.Q\JV]V[V=NM?/)H\D3
M-T_D^K$_"\\7KW^E)==O5!J?.LGZ>\U?TW<I;^"\RMVFK!S,SS7-LN)N((KN
M;.N\,T+[NU>V1[(P&!].$T"S:6VNF(OU;KIMG'DK-(F>'P-WEBR::<6Q?&$W
M32:\*QCQ8WVLN=_.;5N>9IJ+4O-GF'G.<9G=S7EY=/UCJ$-?/-(Y\ACB?F#Q
M$SO'$AK: 5P"W].V+;8MB*0\[6CUIF9K*XSIC\0/K2Z5\Z9J;D;S[UII?-)I
M&31NS//\VSJWD? 8GM#+3,;V>VC:WN6X!@K1>EH771$<LQ\,5K\;R]:S3NNY
MKJS3HX,V/P9?I1G\ZV<:3Z;_ ! [BTRW7.8W'S?DW/-W<V5IJ3,;J:VM<OLK
MW+&W4<%I*Z=Q!D:RC@ZN)!:-VW;6:VG,:-+=>(]G"E_3,='8T=6;]&8OU+IN
MT:XW3G;%?1/7@S@<LS2WS*VM;_+WPWMGF-M!>6E[;3,EAN;2XB;-;3L?&7,(
MEA>#@3M7BZ\3HS$3$UKC%*4>KH:T:TQER4SB:OU'R!O""*%U:"O9Y5H:^I6F
M=6Q%(FE6PFF?;.#YG,; YCWO<][61VL<32Y\CY'$-X0!4DG!>9YIN9VEVE%*
M\U>-*4;&E;&K;,_EQ\-6*QXPOTF3D[T'ZMS7I\Z=\AL>>7/2&WS++-67]GFD
M4>1\NLT?;W++"8W=M<20YM=13,:XQL-&5]99]MJ3NM.;M*ML<;^N.BDSPF,>
MWJ;6KMYV_).XI-TQ6+.B)RF:TQS^)@S]37CC^)IU0V5[D/-'J*S=FG+ZYO9K
M;(].PR9"W);:YDG=#:1SY1<P/D='#-W?$7//JC%;FEH6X73-]]T1G,UK\T*:
MFI-OJ6\EMD\(C+X\9ZW5CF'-3FOF4]WF.8\R^8MYF$TKY9[N?66H93*7N+B:
MR7[I"*'9Q4 7HVZ=(IE#SKNERCRGZNNI?DQF5GJ+EMSQYA91FUK.R9MO)JC4
M%S:PR1R1O8_N)\Q?;$%T8)'#BJV3,7Q2E5+J<7?_ -$/TG_Q&N2W,W1%MSRU
MHSJ!Y6S9EDVGIM$W]O!EU\V&_O+.Q;)%G3)8K@.@B)+6.X@YYQ(!P]W;^!J5
MG<VQ=-TQ;$VQ$3%<*\:TK'H>?K:=_)72NNB(B9F)F:33&G#-Z@7*#7^6\U.7
MNE>8641]Q9ZNTWDF>,@X^/V67-<JM,PDM:\3@XVSKK@)KC1:._T+MKK^!?CR
M_!A7#XF'RG=QO="[7MCEFM*5KD^ZAC(DF;CM^-N=6M<%SOF]TZW),96O5VEL
M:=UU<9F6!3](!^D%]:W2?UC:EZ4.EW-K'E):\M8LNES36=SEMKG\FJAF]M<W
M+ RVO))(K,6[N%H/ 22TX+4\LU+]>=6SFI;I:EUM(G.E,?AJZ+?;.S1VFAKT
MGGU;(NK,88\(XUCT.A%GTF+QG'R6SORHK'Y9X#H?Q)T_PQ / '>'V,.(D'8[
MW%[FTMB-:-/&8F8QNFKG=S=&4^K,?FX,TCZ.#XMW4#XC^AN=6E>HFUM<VUER
M-9D1N-?6L4=DS4S\Z$3>$Y9%/)':NA#7.]4 %KQC7!=MY]Y3M=EM=+7VULVS
M=-)P]KU.:L=5<.UXD;G5TM;DU+IF.6M:Y>M%ORLGJV>ZZCD=Q=W\5S(P02P;
M75QWA<99K1=&-M,7L:%TS=SPK#HWEI9*7BIX1PEN(P/NE>#YOL[[M6W5FZ8X
MT['HV7\\999K:NK3K*Z?^B3E#GW.SJ*UYE6AM&Y##5PFG@GS;,[J9L@M+3+,
MI;,R]OI[F:+@ C:0''$A6M\PMOB+8MB;\HBV8F9G*.:(G"*]*+=O-T^K['&9
MBD4X]K 3\0[Z7'U&\RLRFTET.Y%%R2R++<UO;>#F7>BVS^]U=E[9)XHKF'+;
MB:2'*BZ L<VK7/:\&HI19=#0UN?Q;YY(IC;;,]>.,SBW]6S;Z=L6:4<_&+KJ
M3'92*8?.QI>HGQ).N;JASF;/.<74%KC.+IAD=-+E&?9OD<%;CO>\(@RV]@#B
MXS.PV"JW]+2T[:<L35YVXNOYL:3V8+38N8W,Q_$]O,_F QY)=Q?CCJ!I>XXE
MU?G"M25N6V1RUK-6E-^$5C!S_P D^N3J[Z>LU;G?*OGUK[([V.:*9AO=3YYF
MD ?$^)T=(+R_G@:T&)N : LD5BD1,5CX59MMNG+#T,A7HC^EB]<W3_J%[.JA
MD'4_H:^986=E9O,&GLQT[:L?;PW5Y'F%N>*\FCMHW/8R<%O%M=0T&[J1I\D1
M=;'BWS[5N%.W&>NL\?C8?"NYO5NGEM_)G'YGH$]!_B.],7B+\M,OY@<@=>Y?
MFMY:V5A)J?2DL]M!G619G<VD,]U82V1N'W$L=G/+W9D#:5&-%CW&VNV?K6TU
M-"^/5NCY>ACLU8W7JW5LU;)QMZ>BB^Z"[?=OX!'W<<3BV1Q-"2,!2N.)"\W5
MNG;TBG--W'H;&EJQN*_DVVSZ6[+W<32*AHXA3;4G8?0O,W,SMN6(]:+_ (FS
MI73JUX4^-T*>/MXAW-OP[.E8ZUY+1QQ<PM42SVF5:CG8RXBRB6"*Z=WKK*2:
M)DP;1IICL7$>=>8ZWE?O+Y9Y)H\UU_F-U]=2)G]7R1$__%DZSW>\OV^ZV6[W
M6XLYYT;8F(Z:_,P)7?27/&?=<"=O5)EW#-*7"S;HC3PC@:]]6LH+#O0U@-*&
M0GRG:OK&CM(T^6)NMOQBM8K\L.1UYBV^ZW&(B99CWT:[Q7^H_P 171_/[(.J
M7.+#/L^Y*-R2<:W9;VV2VN919JV$R>TP1S>SVWL[>)Q<0T%IKAB!Z_O=L/+M
MKY?H[S:6^%,1ZUM?:F+>:L8Y<&#0FZZ_UIK_ -KX'QC/I.7*OHMSG/.GWI7R
MO+N;W.UEOF>6:HU3;YA&[).6F:,$T5E+$^VN)8,\NA(QKBP.X&M/K8D+Y7Y)
MYEO/>O;W[F="_::6G?33NKC?$3,3A6*1UXO<W^A.UFRR^ZV;YB)Y8X1P^'-@
M==6?BT^(-UCR277._J"U3FEHZ61UME^G[Z\TO;VELZ2<QV<<&3W5NWN((YRP
M EWJC$G:NETM&VR8YJW:G&<ZL6XF^-.(CEC3ZH_GS^58S8<U^;&67$%]EW-#
MF+;7$$K;F.6'6NHHR)HG"5CR(\Q8YU)&@G'%>A;'+C;6CS+J712Z'==T0_2,
M/$7Z/M1Z#BS;F5?\T^2^27D8SOEKJ("Z?J#+H8XX7119S<SNS"SN61P- D#P
M"*U&-17Q)OF(NBL51&CR^Q,Q,O2(\,#Q6>0_BC<EK?F%RKN[?(N8&1P60YD\
MN)KJ*2_TC?W+8GMA#Q/(^\BD,PHX8C8<:$^C.WNTK(U8]?0F,^B9KA/9$/'U
M-U75^[S')KU^*L16*SC69R=LK?BM_2CX%Y4YO=C*%2A(@(" @V\H>YCPR3NW
M&G"Z@/#3;[JU;M>V<*4NA-MLUQQA9'UN>(1TR>'[ROO.9?49S#RS2UH;>\;D
M.4"6&YSO/LSAM9)K/+[;*XYFW=;V=@C#^'A!=MJ"M.=?*VDSJ3[-,8G//'#)
ML6:,W37\F,^KLZ6 +UT_2VNL[G7FGL72#D]MTTZ8R6ZO[2YSJ5]KJ7,M1Y?W
M]Y%99@U]T]\5C/<6[XI!W;'<%*;<5.EH:GB1?J7S;%WY%LS$?RZ>%<FUX=D6
MS99$3='Y5U,6.)S]Z]NLOJ5U#%J'FWS[U[GV9W$D\PN,NU-G636Y=(Z5\W';
M9=?6T%'&9V!;3%>AHZ5ELTLBDPU-6;I]J86Z1\QN99!=_.=S 8T/#GG\<=0"
MKPZH?^[QCQ8@]JW(LI&<M29ZL5T/(;Q".L[IHSLY]R:Y_P"N\BS.1T#GG,M2
MYSG;&NMC"87"+,[^ZB '<MP#=ROS781$QP:GW?3SOK_+J9&W0?\ 2W^K?DMF
MSLCZQ<ECZD]/9Q?97:LU/ 8-,YCI++G7%I#?7[FPO9!FLEO;-DD=QM:75PQ6
M?6MTYY;)B(F<[HB(C^4*Q;JV73?%T\L96S6?Y3T/0&Z/>MOIYZZ>461\Y^GC
M7N6:OTUFMM&_,+*.>"#.,JOFP0ON["_RHSOO+62RN)>[)>T EN!*OK[+5V\1
M,TG1NKR71C%.OMA,Z\5RF+HS_FQZ5U45V>&7CC[SB(X0'8NIAL&(HO(T-.Z(
MNF<HEM:&I-^K%G3Q=%GT@7KXYJ=!G1;GNLN1.H6Z3YOY_+;QZ2S^2TBS!MB(
M/:GWQ%I</$,C^Z8VA<' '<N+]Y=]=I^?>6^6Q-UENM?=6ZV9B:6XTPZ78>4>
M76;S8;K<S$7:NE;-(F,*TSGX7GXYS])$\8O660YUI7-NIV*]RG/LMS#*,TA9
MI#(;:27+\RM9K.^MQ/;V<,C!);3N;MKBNPWFTT=Q9;I;B.:S#"N$]%>ER^GN
M)VM\S$5NKG.-.S&*.D&ZGN<PS/-,TNY?;KO,[^ZS+,+AQ[GO[Z^G?<W<@82/
MCSR$^E;>&VMBRGJS#)I_K:W3V^E#P8+BRN^[#(K26.=_"0_NI(W!\+J"M?6:
ML=\>'=;=;/K5B8]+2T+HF+[;L8FL?!D[@^4'T@7Q2^G'EEI?D_R?Z@X=,<N]
M&6WL&FLE=I/)\QFMK,FHA]JOX+F21C3C2K0#NQ7J>;[S4\PUK=?6QU>6(F:S
M6:13I8=CL=#R_2G1VUO+I3=,TX5G/A"^OHW^DM^*5FO49RRAYS<]&:ZY;W^J
M<DR74FDAI?)\M^<;?.LSL<O;P7%C%:3P/B]IXJ\9%*BAJ*>U[F>2Z'G.\U=/
M<5G2MTYGC,UX=D?RX//]Y=WJ['R_Q]*:7Q=&4TK'&O2]1C2N:1YMIC3&;.;W
M3,ZT_DF</9Q$GO,SR^WO'-.)(HZ9<+YQ'A;V=.>%\QZ)F/D>SY3Z^VB_3CUI
MLMGTVQ,][ZFYDX3&T##"AKN- MVV*VQ*M]\VW8]+6EJ[@X74[=AVT6IN)Y9M
MCK9[;9:Q&V@%32I%!6G;VK9X(CK;8$,W U2[0YZ8Y,,ZG+ATJX8>Z+SQ5XC6
ME-BM,U399RQ,])#CQ=M<"KZG!71G&>BK'W^DY_ZI3GZ-U,F.SLGN#]1?/_>B
M9_CWE<</%GNE]%]QZ>%YC,_['=]:UY%<$_ '.-7>LZ@!/JXT\QK5?0++J61'
M4X#4CFU;IZ;I[WT6DKCO=;:+/=EG!JG3YH3\:F;6=%;:13<Z<_YRWOA7>:G/
MM[XIA%D]TO;NZ /^JYRB!%"-":4/NZ<RC8NT_$'^W9IEX5GU7 ?AY/-Y7?,Y
M^+?]9>G7;Y%P.G?SUZGT*C8RS<1'J[#V_F[%I>86<W)/1-6:GA_"KN'\ C(:
M*$XTH*;/)BO3V]WB6QTS#1UL*=K=@@@'M *K+/%82@@J)BLC9ALC6/+#Q7!(
MX\<*5P'D]55QMSQE6*SVI#B^5Y=%C"!W;^*@>7#UL!@*%8_O'JW12,I9O#B(
MMF9S^)8?UV>(ATV^'KRIS#FEU :XR_(.&TOOQ?TO%<6]QG6I,UCMYI+++[>P
M%Q'=-%U.P1A]"T$[Z+EM+=WZFK%EMLSN)G"VN$Q68FLUPRR;]NC%ULW?^5'Y
M712.'2\]OKE^E=]=O/O5<C>F&X9TQ\MBR^R\6,#8,^S/.[0.N+>"\FS*9SWV
M<MW;/:][(VAH=L-!C[FGM[YQU+KN6E>2)FD5QI\&)$Z>G$<EL<\?E3$37KC'
MT3T,>'F[UA=4?/S45_G_ #-YU:_SS.LPF=<7!MM5Y]86TCB^5[W&T@S!MKPN
M,SL.#!;VEHV1=')@P:FK?JQ2ZE:\,'&V2\V.<6G;R#.\AYJ\Q+)^6W$-QQ1Z
MWU%'\K$]KX^-D.90B5@>T8' T6]IUT[JQG#6G3FE9R=P_37](P\4+IKNM&9;
M;<[;C6/+;(+NV]LT+GM@W,!FN70]RV2U^<KF22]MYI(K<,[P2' G DU&7<Z]
M^K=;.IRS$=$4PZ&AH[6S2BZ-+FB9G'%Z!O@[>-GRU\5C1&?1MTFWEKS>T%!E
MK=6:.?F#;MMQ)="U@;>6,[YW2S0W,\KG</#Q,I0T-0O4N\NKMIW6WF;K+8]>
M/S*Q6F#QMUOXVVZLVVO'+??/JS6?7I/:[XV"2-O']\;*!ZN [N@QQWKF]/1B
MV^;LYJZ?7U8Y(B(RC&6S#711RR1S<)>126G%7'XH;6E,*+'YMO(T-&(F,9ZV
MOL-&;M29C%TR>*QXV_3/X7>BY6:FO;+F)SUS:U?/I'D_E.96WMF9.A,T<S\S
MO8;DG)XHY8P/E&M<XN &*YG9ZVKK:LVZ5G/2:75KRV]=8G'X'0QL:Z<:FK=%
MFC,>K^==.=*3EA7/BP$NL+Z3-XEO49GVLKK0',(\F.4>HG26]IRYR6UB?>91
M9N,[.Z.>"?VZY$L4P%210MJ.U>[H[>:\FM?=?,98S3T=34U+XT_6T;8MPQKG
MWNB;6/4'SUYB9W+J#5?-GF)?9E>ODG+SK'4C(622/DEF?'"[,WLB+WR'XM,"
MO1T]*-..+1U-2;\9H_+R/G3S@TYF4&:Y+S7YD6%_97$,[)X]:ZD#))8GM?'Q
M,BS&+O6A[14.)"S6ZG@WQ,8SUL%T<\4F,'=GTH?2*/$UZ9LQT7:7'.6XYD<K
M-/W$'SKRXSJV9/+F=C&(&&V9G%U,;ZVEDB@#3(V0FA.!)J/4B^+YC4UXLOI&
M$4B)]-<7G_=K+(NLT9OLKQK.+/9\)CQ\NFGQ,<OLM&YE[!R=ZB88)'7O*W-,
MU@DBN6V\4/'<Y;FES=#VL7$KSP1\/>;C5V"QZVVBVSQ-&>:W.Z.-O&F#'9K7
MVWQ9K12Z<+)QI=PK-9PJ[[FW8+F!\7"&ES1,'5#230. KZS2=AV$+0OTHY9O
MB<>AN:>XQB+K?5Z6\C+HH@)IN^>TU,@;PU#CZHH,, O,UL+HB<X>C;;-WL\6
M([]+LH>C?1W_ #AFA'_%+@A?,_>[_P#$#W>^EK=T/H_N7_87FL<?#M^5YAT9
MK&:XT,@.Y?5KLWSC3C]9?]*7;MX#?^LVZ="!3^')?\*R_M7T3\//[0U?V5_U
M7%^^\5\FN_:V?6>RQEP_ <M_>5M_@\:^?ZF&OJ?2^5U6C'ZG3^C'<_"UY_$C
M6?\ [*:B_P#,]XO(\S_<]?\ 8:GU);VU_>=/]I;WP\0[K]('4WS4(V?CUJW_
M .Z/-ES7X>?X<L_:7][Z/^)]?XIH]/@V?5A9FS[W)4XX?"N\T?M]/Z=O?#Y=
M=#UK/HM?^JHY1_OS./MK-?1_Q!^SV'_T\=SE?(9KYKO_ -I'RLCY?-76" @@
MF@)[!5!^?WWM#7D@L:QU!7:<=HWXJVM=]UI,17F^)K673N(FOJQ'QJ+BY>T!
MD;:/):&&M33?0;\ M#<TT+;9M]:ZZ9;FVMG7YJ^K;;Q=?/B%^)OTR>&]RMFU
M_P ^-9Y?9YUF=K?-T;HBWN;:;.]29M:6IN([(68G9<6L=PX<(D<VG$:"I!II
M:V_NLFW2T[?$U]3*V)RC&LS/"E,OY1O;79SKUONGDT+<[YP[*=+SW>M?Z5=U
M]]06LLR;TW9VSIJY;EEU8Q:=M8(<WS+-[.1\]O#<39Q,Z22WDGM7M<]L=&\6
MQU!0Y-ML=3;W7QJ:DWZ=\S/+68BWJC&</C9+;].+OU5L6WVX5NBM>OAFQ\.<
M'5AU,\Z=59OJ+F?SHY@9UJ2]D;/(+?5V?6MG,^5\DLCA:P9B+5OWTG!M0M[1
MTM.WU].M)S:&M?===//2O4X^T[SNYSZ2S2VSS3G-?F+97UA/#.R5FL]2-:)X
MGM?&9(X\RC$S62,&#JA;T71;C$SDU.7Q)Y9AW5=*GTDCQ/.F[/M(6N9\X+GF
M?RNTY<6XS/E]G]E#<?.V7Q,A8;:/-YC\X6LKHX&MXVO.!-03B%NIXEWK1$LM
MVG-L=$/0D\('QF.4GBR<L,WSC(\B=R]YP:$9;?SB<MI+DW;,L%S)!;V=W99@
M^4ON[:]F>XM'"'- H[$%>K=LXMVGWG1F;K*TNC\R9BM/0\7<[CDW-NEJ4BZ<
ML?:QS=VLQHV,=OU@N;WO[IJS_0N[I>S;C-O;#S5_ICF/4IR0[/FG.17_ +;F
M7R#\*_[4\V_;QWR[WWFG_P!O>5?0O^1AGN'JL(& IOV8^^OLSAM3"C+H^B($
M?ED:[&\VN6T_X[;U7T+W8_PMYM]"SOE\T]\(_P#</E,\>>[Y'IZN+@SU!5U!
M0>XN B(YL<GT:/8CL:48I5SB*@'B\H-?<HIUKXMMF>%%=.VZM>-7"W.WGORK
MZ<^7VHN;/.35V4Z)Y?Z6L9\PS'.<UOH+=S(H6E[VVMM/-%)>2N )#(ZNPV4J
MN7W&Z]>+KXF-&M*Q-9K-:4BL889O8LT+]:WDT\=;.8IA3MZ8JP3/$S^EWZLS
M',];<J/#^T_'DN7Y7F'LVG>?]^R.]?G43#/'/+;:>N+AT$,(:&.C<>,DX_%I
M7;VVWW=\6WZD^%'&(F:S'3.>./\ ,PZD:&E=-D1SW=,Y1/\ VYL6CJ,\6CQ#
M.K.&>'G/U%:NSRW>:RQ93F5[IP,![P\#!E-U:\+0)7  8!>IX=D=-2-?5P]G
MERI$+')N9/-&<]X>9O,29]SQ&02:VU"]SN&OWQS\P<YX[*U62)X=##=;$XUG
M'A5RERGZN>I?D]G>79WH'G7S RZ]RRX=/9PW.J]1W5I#,'1N:?99<U$)8'Q-
M-* ''M6]H7S;28HU-6R+K<7?;T;?2E_$7Z?M79++SUU&.HOECET4-H=$WT-O
ME5^+=IBC(;GL<L=P6QP1GA:_B'$:EU-F[9X=\5U[8F^["L4B8PSQZ&EJ:5TT
MC2OF+8SB:TGJP9Z/AA^,!TQ^)_H#YSY:9Y8:6YP:?L[277?*3,LPMHLRT[<7
M9C;$W+YI;DG.XGODH7PAU' @@$5.77V-VC9XNC=&KM\*W1G$YTF(ZJ8STO-N
MW46ZG@ZMLV:^<1.4QE6)F<ZUP=N%NQX8U_$6N=]_DJ7<0%*>KNH%RWFUGKVW
M6Y2Z+RZZ+M*8OBM_!N+AU#">,O9(2&M'JT(._MJ5N>7VTT?E:^]F(OMLNB:U
M=3WC4]:VO.@CH5YG<^N6-BR?7>316-IDDTK@Z*SN;\W,+;N2(R1B5MLZ,/(W
M@47!^\>ZU+_/]IY7HS=IWZLS//$S%(BO>[3W<\MT]WY?NM]N8Y]/;:,S%E,Y
MPI\KSG3])H\9O,KZ=]IU-6=G%)+),VV;HO3_ '-O%*\OC@XGVLTE(6N#1ZQ.
M&)*^A;;3NF++)Y9PSF,^MQE\VQ==6;HK,_!CP977T:/QB>KCKWU5SCY7]56I
M;/7N:Z1MK*^R75]MEUID[;6$BW=<1W$%M((GGNRXEW T8[MB]+6V^E.WNOMB
M(NLG&G'#^?XF&WGMU8B;IFV<JXT7.^,-])&Y#>'UFF<<D.2EIEW/#J&MX;NP
MS[*<LS.$93H&YNK2X;87MY?VUT8KZZM[B/B? PDLH 14T'%ZUFKJ[J=/1B8T
M^-^/JS%<(IA-<'LZ-EM(NOQG\W#&.G%@$]6WC*^(IUI_.5MS>Y]Y^=)R7=V_
M+].:;N+G3,.4V5S-<O@L6291=P2.-O#<\!<7FM*T6]I[>RR(YYF[6PQF:U;4
M\T6^IRQI4RB,<NFN?6ZVAS+YKVUP);;F=S$CS&)[9C*-;ZA:^1P=QAS)8\P9
M('@@&O%6J]*_U:9U>-;/-=,84=LW1UX^OB-]'V9:7RW2W.3.-2\M,GO[1V;<
MO=1]_G4>:Y=;N@;+:C,,QN)+J*>6* -$@D-.(X8X9=*8NN]:*V='%.I;-,)I
M=#T@_")\9;D7XJO+"6]R!EMH3GKH^TM3S Y6W=]";BPEF;;Q1W>63S71ES2W
MNYWO/J-)CI1V(*]#5V_AVSJZ$S=H<8XV3.-)IA2(IQ>1=K3&K&GJQ35_)Q]K
M&G%W46DO'&[B%)6?';7R5"\S6LI=%/8EZ&WOYK)_/C-ILN#.7U91C7<(-=I!
MWK6W-\;*+(MCFF[XE]&Z=Q-TSA;'QJ9)PUW"YI>)7 !HKA3#=VU6CNI\#EF)
MYN:>'#BV]"S[Q;=^3%KK7\2+Q5.F/PT.6<FKN<FJ\OEUEF=C>OT5R[M+RUDS
MK4E_;0RRLMGQ"X;-8PR.A+1(]M"< #C3S]QYC.GJ6:&WL\7<WS[,36(CC-TQ
M.$QT2WMILOO'/?JW<FC;%>:?BB.UY^_69]*E\0;J-U/G'Y.N:Q]-G+9UO=VM
MQD%F(LXS&ZM)3/%$Z7-YGR212SVT@+VQ#AXA@ZFW-MMC?MKYG7U;KK;YK%D3
M,6Q,\..$>G),:VGRTTK+8OMPK,5F8Z>&+'@YD]4W4?SDU/F.IM=<X^8V>9]F
MTTLUU*S5^HK*TD?WDLDA%JS,&VK0YTA.#12M%Z]NC;ITI%(:-VK-V$SCU8/B
MLJYK\T<LE9F5CS2YB6][ETS)88(]::DC?WC'!XX98<QCJWB:"0*5IBLMFI-E
MT3PAJZMD:EDV=+M3Z8?'A\3?I:@R/*M!<_\ -+W1=K?64M_I74,)ST9E96DL
M!ELW3YI<27$4MQ;0F,2"0%O$2O1T=:;^6-2+;M/HICZ6G&VLMB?"FZW4B,ZL
M[+PE_I*/3_UZ9_D7)'G9E=ER'Y\9C#9V&GK#,LV@FRC6E]!;6K+ZZ;FEU>B'
M+I;J>1\C8I""[8 *46_/E\:NG.KMKH\>DS.E-*Q;'YM(QX12.EHZFYG;W1;J
MQ,Z,SAJ8XSUUG#CCU?"R>K6[CN?4:V-\#V1R1W$4[9(IV2-#XY(WL):YKFD$
M$&A!7CZVA'+SS[6.%,GH[?<\]W)2.7#&N;]393W %Y$7<MW-.;?I5H$TQIM7
MJ1C#6NGEFO&6XKQMKLJ#]9:NKZMT,UL\UM6S%L8R2'<7$:]E-ZV+]7GB.J#;
M:<:/-6:U;E\9<-N-#AZ.U:]EGAS,US9(OIP6\]1'-:ZY&<DN9?-&TR_YWOM)
M:9SK-K/+7/$(?<V667MU #(YS!0RPBN*Y?SOS;^'3;=,5NNNB(K-*5PKGP;G
MD^QG>[B=*9I&,SAT8O+WYR_2B?%LU#S+U7=<ON<V7<O=*09[FUGE>F8-*9'F
M L[>TOKF..*>\O([N65\<7"*M<!5N]=%L=+4LLYM2^;[KJ3C.$5C)@UXCQ)B
MR(BV)F/0T.4GTH+Q;,BU[I._UUSPL.8.F;C/<NM<TTL_2N3Y<^ZMY[ZWBDA;
M=V45G)$^2,N:VKG"I7K:5EMMUMM\6SS3$=F/\N#RM_IZMVGS:5\V3;$S-.,1
M&3T].CSGEF74;TX\M>;^:90W)LUU;IW+K^^RSOA,&7,V7V<\SN\[R0#BDF)I
M56\]\OC:;R-O9.$1$Y4S:ODV_CS#:3K4I=S3&=:TXKE(&B /<:O;+7B?0BAW
M"GG7F[_6G2T)NNBMT63W/1VNE,7>KC6<V$Y](X\;CK'Z%N:NE^272[F=KRSF
MF:ZXO]:SVEIGLF8Q/-V>"*QO))(K=[6M;0NB<!P["OFWN+YM?YEYAOM"DVZ>
MWU)BG-6N,XYNT\W\OT-IY)MM]%+];<1C-*<M(RAC26/TF'QFLMO;*\N^IFPS
M>VBF@N)K&32&0MCN[>.1DDT#C#:6SF=]&"VH((K@OI]ET:VK992E;HC".F:8
MN%NNMF)I=?$]KT4?##\0F+J1\,_EOUG=0V995H3VG*,[N=89CFF86UI9R_B[
M%%[5>V\MW=,;(;PASV1M?Q'91;_OQMM#W?WEMFGZ^E.E9=2*5K=;6E(Z,I;&
MWMNY(YKJ\6*[XJOTL_769:CU=R>\/&T9D&3Y!F,MA;<_;J.*\DSC@?<VMW[#
MDTUPZ*VAB=&TQ2$.))XA447(;?1WWFEENMKQ=MM&W\F)FMULQ7'MB>O'.'JZ
M5FG%E;8Y[^F:4CHPS8@7/KK5ZM>IO5M]K7G3SUUUG^=7TKIKRXL]29UEMI(]
M[I),,OL[Z&TIQ3.I1F"];:Z6EI?J]*)B)^%&KSW64OF,.AQMR]ZA>?/+#4UK
MJ70_-WF!EV;Y=+%<6DDFK]0NMGS0R1S1ODM_G*.&7@?$WXP.&"];0ONT)F8Q
MF>EY7M168XLFWPW?I4G6'T_:NL-/=7M^[J$Y2Y@<FR*UGE-ME6:Z LA<6MG/
MF1O>^BDS**WM Y_=R]X10XFM!MQ9I[FOB4C4NGVHPI2E,*S.+'JW76TNC&G#
MI>C%TV]27*3JLY/Z.Y]<D=56FL= :SL8[W+LSMGL#HYGQQ23V4\+7O=#)9OE
M$9!.T;3@3AW&C?I:GAWQ2.$],8Q7XJO/TM:VZ/$MFLQGU3A6*=5<UQ$4C^&)
MYA[I\_WP\7%W8'Q<-_%5>??;;;?-)P>SH4OT^;HX/T50$!!!V'S%5NFELSU#
M%*^DQ^*EU*^'GHKD9I?I>U+!HG7?-JYSF:\U1/86^:#+;/*!< QQVET\Q&2=
M\5 XL>&TK0[#Q^Q\POW.^C2TXNLLMKS^M.,\](^*8ET_E>QV^YV>XOU<=:V/
M4K%8B:58-G47XZGBA=5G*'5W3_SUY_6VM.6&N;6.RU3D4>F,IRM]_:V\HF9$
MZ]L[:UEC:)8PZF() P77[[9Z.I;IVZT1=$71='5=&4_&\G9ZU^AJ77Z<1%U)
MMG#AZ73+<VHM@:/XQ(X^C$^[19]32BRF/!Y_-,UKG5]/I+.[K3U]:9C:XWF6
M9EE^;Y7.306V9Y;<17EC/P5 <(;F%KJ;Z+>V&Y\&VZ,?3T8PQ:EO/;2?Y0[R
M;?Z2MXR.G\MRS*+3J@M;.QRNPLLLL6,T=I^=T=G8P1VMLQ[I;.=TCFPQ %QJ
MXTJ2O/NOFZZ9G.98MO999$663=,1%,9PBF#[K0GTF?QACKG1,>>]2MEF^2WF
MJ].V>:6+M%9'&RZRZ[S:SBO8'=S:VCZRVI>T$' N6SI:<3=;$Q'+-T1.'3,?
M.RZUTV:5UUN<6S,?!#U1^G?F*.;?)W0/,8,[FXU3I+3N9WA/ZY?WF36-Y?2A
MO$[@$ES.XTJLWF6WC;;F=*)K;GV1.4? \OR3=_?-"=>ZVF-*5XQA,_#.+HG^
ME-%Q\*7FMN)OLF<[T/N_A7ROWFB/[Y>3='-J]T/I_NS$_P "\SGHTH^5Y.%K
M(XPOD90 @"1F^C<*^D+Z3I3RVX9N*ON\2Z;NM>OX?]Y:0]5?)R>YGBRZPAUQ
MIHSWMP]D<$31J#*7.=))*YL;6T!J20 %V/N)N)VV^UKJ5KIW<:<' ^_^EXWD
M4Z>4SJZ?"OY3T5_%9^DG<BO#\RZSY#<D+'+^>/4#9Z.RJSSRTRK,8GY#H2YS
M+3K793?39I:73K;,[F!YCE?#&7<((!K6BX/<:E^IN+HLCU.::ST37*'T;9;6
MRW:67ZLUU/#B8MCC%(I/9FP%^K;QB?$1ZQ_:K/G;SYU'<9#<7=S+8Y)IZ[NM
M-0V%I//<26]A$[)[N#Y.UBN2P5)J!C58_!T[J3=6ZZ.,HVNOR<\6^S,3$_S=
M#KT;S-YL6URQ]KS-YBQ9A&\2\8UQJ%KWEIXPYDL>8,>UP(VUVK>O]6F=6E;/
M--.#MGZ._'T\1KH^S32^6:6YQYSJ3EGDV86;\WY>ZB[[.X\VRZ!T(FM1F&8W
M,EW%/+'"&B02&@<<,<,FE,77>M%;.A.I;=,5B:70](CPC?&0Y&>*GRJ=FNGF
MVNB.>6DK6U_G"Y4W5]$ZZRR>9MM''=Y=/+<&7,[:\FD<[U&DQTH[$%>EJ[6+
M+?&TIKMISZ;)F*TFF$4BG'Y'CWZ]UNMX6I'ZWA_2BM*]OP.YVWD8),&T?(/E
M7<1(86#8:X#%>3K6S&'#@]31OB8GIA++@S%WJ\+&NH#7:L&YOC9Q;%L<W-GU
M&E=.O,UPMCXU,MP&N#'-,C9'4#1M;3#&G:M#<S&A28];FZ.#<T+/O%MWY,6_
M&ZUO$D\57IC\,_EE)J[G'JK+YM99E8WCM%<N[2\M9,[U)?VT,LK+9\0N&S6,
M,CH2T2/;0G97&GG[CS*ZS4LT-"SQ=Q?/LQ-8B,:S=,3A,=$M[:;+[QSWZMW)
MHVQ7FGXHCM>?QUF_2IO$%ZB]3YN.G;-(^FSELZ"ZM+G(+(19QF-U:3&>&%\N
M;3/?)%+-;/!>V(4XA@ZFW-MMC?M[YG7U;KK;YK%D5BV.-..$)C5LIRZ5EMM]
MN'-,1,SW8RQX>9'5/U&\Y-2YAJ;77./F-GN?YM-)/=RQZPU%96CWE\DCZ6K,
MP;:@.=([8P4JO6MT;=/&V*0T;]:;L)I7JP?$Y9S7YH95*W,[/FGS%MKW+962
MQ01:SU'&\2->'"DL.8QU;QM%0-M,5FT]2ZR^)X-74LC4LY>EVI=,7CQ^)OTN
M0Y'E.@>?^:W>C+:]LI;[2FH83GK<QLK66W,MF;C-+B6XBEN+:$QB02 MXB5Z
M.CK3J4MU8MNT^BF/I:7W:RR)\.;K=2F=6=IX3'TD_D!UZ9_D/)#G9E5ER%Y\
MYE#:6&G;#,LW@FRC6M]!;6S+ZZ;FES>B'+IKN=[Y&12$%V( !%%OSL(UM*=;
M:W1.MC,Z4TK$1^;3/A%.O.M&CJ;B[0NBW5B9T9FD:D5QF>FLQ3CCU?"R>+2]
MBN1W;6QOB>R.2.>*9LD4['M:^.2.1A+7->T@@@D$+Q];;^ISW9S7"F5'I;?<
M\]WATBD<:YOUL!0>@!>3$\EU:8M_-MR:47IQC#6NNFV8;D&H![5JZN$Q#/&,
M5;:YDX#'AB3@:^99(BL? QZE_+3KEN:U:3Y/J*EE_-,U98C%;?U)<TKWDUR3
MYD\T,MRT9SF&CM+YYF]CEIF;"'W5CE=[=P$RN<T82P TJ%\]_$;?7;"S9ZED
M5F[4B,Z4K+WMEH6[C4C2G")MF:]-.#RZN:WTH3Q<\ZYEZNN=%<]+#0VFH]09
MM:Y/I6'261WS,OL[:]GCBMYKN[ANYIY8F4!<'@&@\Y^A;>9OT=.<YFV,^R,W
MBZTQS3%L1$1,P[6? X^D(^(!U$];_+_IVZFM76O./2G,^6XL[=\.56.17&GY
MH! /:N.R= )XFDU(+#2N\;.P\H\MV_F>RUK9BVS6T[)NY\,HB,*3,S6:YQ\3
MS(T[_O-MT7W>'/"9KCC_ "XLIGQ6_&UZ:/"WT)-^-.8V',/GIG-@;K1?)K*,
MPMI;R^?$)(Y3FE[;7)=E-O!,UH)D#7.J*4J"OEVWW.OX^II;?3F^[Q)B:SZM
MN-*UQK3C2'KQR3=$7S2.K.?Y=;STNM/Z15XB?6)F^LLOM^9UWRJY,Y[<2_-_
M+/3S)+:6RLWBX:(I,ZM9X[Z>5L-QPAYD%*;%NZWEEFM=;?NYOOOB:VXS$6Y9
M0S3K<D?JK8MMGA3&?A_EQ=)F8\U^9^;W<E]<<T^8]U=R2RSODEUMJ.3NY)'N
MD>YCY<Q>YM7$X KWYG[Q$3.%T1$>AH7UF:SQ7B]*_BA]>?2#F4N9\@^H#5V0
MO=)$Z[;GF;9AJ2WN61NB+K>2VSB]N(S!*V$-<UO!5M1456Q;K:E]+,.7*:\8
M:4Z6E;=6:Q=6L49ZO@I?28=#]8V=Y!TV=7EIE_+/GBZSL,OTAKNXO(+?)N:>
M:O?%'==^R>Y9;Y)>,<]Q#>)T<@ #?6#EG^YSKQ,[>EMWYL\8C.8SXS$(NUHT
M:7:M9MZ>BO#XF7(V_:YL5PYK7LE8R2W=%(V2-T,HK'(U["6O;*P@@C"A6EX,
M36V)RG'X&3[Q-8B;<VN9&MHX3%D< )GCX"[C[P>K1VW K!=A./P-BM8:<3_9
MVS32R4BJ.'"I]8CAH-JG=:MENG7C$,.UT[[M28C*JW+JBZK>1_1ORDU+SQZ@
M=;99HG1.F+1]S>7EW<P&_O'EKS:VF696^>*YS":=[.$-C!(.V@J1RVMKUNYY
MB9NF:1$8S6:TPK6DSA5[VCH3K^I9,1I1%9F<HC#FQZ8K6G0P _$4^EQ]1W,[
M-LRTCT*9(WDOIS(\UNK,\S+H09YF.JLO[V>*&]M<ON)9(,L,D+HW,(#GM<*D
M4HO6T='5FE^I6RL8VVU[ZRPZDZ5GZO3I?3*Z:3'9V?.QE>?W7[UD]4&H9-2\
MZ^?&O,]S9SI)6R9;J/.<EB?),Z5[R;?+[Z"WHXS.P+:8JUNVT+;N>VV:QTX]
M[+9K:E]EUM_+EPP^.JW&#F#S)$D+AS-YC-E#G$%NM<_:Z U^-QMO002<<"%Z
M&G;.XGEB:6]>+Q[IY)F.*^OIP\6SQ#.C@10\DNH[567V((HS/;J]U+$Z,.BX
MK>2/-[JY$D<C86M<*XBNQ>A;,[*WPK>2_2OSB8_G8;]&W7FV^^)B^W*C,+\*
M+Z61D6OKW1W)?KUR>+2^>7\UME;^>D4K(\OSG,[Z6TLK**\R7VFEDQ]W*2Y[
M/4:TUQH5ZVGY?M/-].9V4>#N+;<+)F)B^<ZUX3PQZ(P:5^IK^7VS?JUU=.9Q
MGC$?+2&;/E.J<FU5E&49]IK,+#.L@SFTMLQRC-,KOH+VQO;2\BCN(98[NVEE
M@?Q12@T#C2JYW6MU-E?=I:ELSJ5F)BG1AWKV[BS<\LV4Y)QC'OIE/3#ZF1Q
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M6BZDX9,=]L712<W<UTS?2-O%!Z=[[1]K/SRNM?<N,FN8#>Z$SNQBO)+^Q@,
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M57*+M%UFX]UUFOI?XAQ32V$</N]O<X_W>B;?./,.O4B>]D?+YF[$0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M+HFYE<R<MS6Q@YFYYDMYDF@LFDNH8;W,;G,;2ZM;F:UB=<V\KS9QDOXF5+7
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M[I^UAFG+KG)H'4FB-5Z=O'VN8QYMD^86V7-E8]P+(<RN;6&UF;\D1Q-<6DC
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MRZ.M'-IS=$^B:MT^]O[X7689QFU[FN87GJW.99S=7%_F%UP>I%$Z]O9);E_
M!PM;Q'R+Q-2W]9S3;-:SPEV.A%MNWY8NCV?D^*C9C0NN\T9%<V7+_75YESN)
MUK+:Z5SNX@F#L2^.>.T<U[2"#@2MV(B(RES&EG=,3$W3.-)?-7.4YMEE_'EF
M<Y/FV69@TNX+?-;*ZRZZB&TU@N8XYG4 WA8K[HIA.38T;)F:Q$S7H:C&.]L@
M:)1-%;D\1X.$QN)H012KJ++L\=2LK;C"W%V4>&EUFZRZ#.L#E'SWTA=W4UA:
MZBR[(M0Y##>36MEGEAJ',,ORZY??P1W-O!<"TMR7-[RM*+JMK.E/ZG<74V]\
M4F.N:1#GM[I7W:?BZ%O^M:?K6S/"F/QT>RMRQUGDO,CE_I'7&2SPWV4:MTYD
MV=B>WE;(T2YGEUK?R1AT;WT<Q]Q0BJ\'=Z.IHZTZ6I$QJ6SA6*>K7"?0V]C?
M;?I6WZ5)TYB.:DUI-,8]+[=S*M<QOJ,CH'>4&E-W8O.U9\:V[3NPPS;VEHQ=
M?2)I25E/B =9>@^@3I<YE]1FN[J!UIIC*WMRFQ=-"+F]SJ\M[B/*X;:W?-%+
M< WK6\09C1<?J;S4\OU?NVA;XNXUII;%<LXK\#H=GM(W]T^),Z>WT;)NONIA
M2*83UR\>?KHZQN<W7IU!:RY]\V]1YEFF99WF=T[)\IFN[I^597DL-U='*H;+
M+WW-S9VO!8S-:>[ K1>KY/Y5I^6;>8NF=3<ZETW7WSC,S=C2N=([>MG\RW'W
MSELLB-/2THY;;8GA&$5Z:Q$+6=+Z=S?4^:V&0Y-E]_G&;YY?6F5Y9DF66MQ=
MWN9YA>7$=K:11V]K'+.6FXE:TD--*KJMEY?=NYCDK,]$17TTK3MRC.7+;S=6
M6Z<W:D^'%G&<._.O!EO=%_T1+JCZA^7]AK+J-YI0],UYF5E;9CDVF?F7\9KR
M>POX+>ZM'SB(68MIGVUQ5\<DA<PM(6SO=+3TM/D\2NM;-+K;:4B>WMPGN:&V
MW6IJZU?#F-&Z*Q?=6.:.J,L<X[W/?.;Z%KS/T=H?-L]Y2=5UIS-U=EMM--8Z
M1O-(OR!V8SL@FEBMXKL3WT41FEC:WUJ?&V%<UN=SJ:5_+I6>),QC$5K#WM#3
MLNPU;ILCA/!A_P#4OTK\[.DWG!J'DOU!:4S/0',73%R^WS'*KJWN'6DD0,C;
M>YR^^=#%;WT=RV$N!C)P[#4"^UWEFI$W:./+./":\<,^+-K[.8I6<XK%,ICA
MCE.#AK3F?YKD><97FV1W%_E&;Y!F-KF%KG-A>W%C?Q75I<1SVSHKF"6*XB'>
MQ@^JX>Z*KW-GNIMU+>6L3S1QZ)B7DZVAS1=;=C;,3&657JP?1T/$_P#R\^F&
M/EMS&U ,RY\<C,LRK+-97-U*UEQF-C);V-EDTK.]NYY;AT<;>%SAM<,<:KJ/
M>+9V7:>GYIM8B8OBFI;;C%EU)NK-,JQ2<?E<GY;-VTW-^PW-WJ5YM*Z9I-^-
M)B*]%)9(E7 -!^6GBH21ZHH[WC0%?-=Y?'B^K%9AW>E%W)Z_JV7-S+L9ANV>
MXO1V\^IBTM:,<&I&/4;Z?A5=6V+KNM?3PM?F9FXM-N>$D\=, 33'?0%6B[EC
MK:^YPFVC](?%\[-GH6II8:E6Y'!87X@T3_R/.>T<<;F._$C4A(XR"X?,69EW
MK8;E\B_&G5NT]#RZ8B9KKVY?2==Y';%V\B(FL>%=W/$YU*1^-6J'4[F-VJL^
MX3\9S:YE-ZG;@*!?9-I/^IZ73.G;W.6N^TOZ.:5QO2#U,:[Z1.>.0<_>5LGL
M^OM&6.:19%,X5I+F5H;<W/ Z2( V]0X#B&(7H;'S&?+M2;^6;[;HFV:3.%6A
M2;9KUX/BN</.GFMU-\R-2\Y^=6M\TU9KS4=]<W^89IF]Q<3Q-)J>XLK>ZEF9
M9P, H&L(:/*:DX]OY=9?IW7V>K;,S-/C;$7\LXXN+\JR#5^>-=<9%H_4V=64
MSW1]_E&19IF4,Q8>%P9):6TL9=4X@'"JPW^O2*47G4LF:88(SG2&I--POESW
M3&K-.Q/+.YBSW3F:97#*7'UOPB]MX6@''>IOCP9BVM>:..'?2JM+KL8B:1T<
M'ST4<(FK*Z2&-X!!:'$ CLI@ZJKI7<L]=35MF,8BLN1].YG?Y-<Y/J7);RZR
MC/<@S&SS?*,QLKJ6SO&W>77$5W 8KB!\4\([V)M:."Z+:WS%ENI;A=$Q\-)K
M\F/3E+S=6VMUVG=C9=%.RL4^5ZQ/T?+Q)1X@'1EI^QUQJ:+.>>W*"PL<@YEQ
MO+&RLMXK6SMLBGD)N9Y'OGM6BKC0EVW$IYCHTBS>V6Q$:OM6QPNQF:TZ?D>=
MM=6(U[]G==CIXQ,S[481$17H=_<9<&BI#XS\7 "NS;YER/F&I-E\33BZ';VU
MLPR?%\Q]=Z:Y9Z*U1S U??V>3:?TGDN99UF-[?7,%M;"'+K*>\,;I)Y(H@^5
ML)#02*E:.^W%OA1J:MT66Q&%9SFF$9\9;^UT+];5C1V\3??=G$1C$<9^!Y'G
MC6^*YS-\3/J+SN]^=LQR?D7RUS;-\CY::&MLPF98-;:7U[:9AF&81P7DMKFC
M\Q$;7M<]M6M-!@:+7\LVNI97<[J/UU]:6YQ;;6L1%:X.BW,;;1V]NAMICELS
MFL1-UT1RW5]&4ND;+;;VJXJQLEK5XB8(XW2B:61P9'&R)@/&][R   23L77;
M#;SJSA7X(K3M<9O=:E9F,NNE61EX9OT:[JT\0'2^7\T]<7]QT^<FL^M_:=(Z
MYSK++F[O\^A[R(2RC3TEO!>PPADGJ/<YC'$$;!5>GK>7:6E;-NYU(MU9MYHM
MBDS='#HI-8F*/%M\VU=34C[KIW7[>+N6ZZ:Q$37''&M(I/R.X'/?H36:663W
MMSI_K?\ G3-[>QN9H<ON="/M(;V\C@DDMK5LT-U<NA$\S6LXG TK5<EO]_J>
M6Z-VMIV3?/"V,)GXI^1TFCIZ6K-OC3=;;/&E8]-88I7B >&?U5>&UK:QTCU%
M:%NK+(\^GS$Z(U3;=[>9;GUA9W,\(NW7++>."W?(R+CX"XN%=]#34\N\[M\U
MCPM6V=#>632ZR[":]5<_@AZ&IM/NUD:FE/BZ%V5T1W]"P3+LSEM00^(S^T8V
MC&/,$D+F&O>1S-+71OB(J""""%T^SW7\,NF^;9OB['.F+Q]S;]XCA:SU?HK'
MBPYKG3H?#WYUY]=YH&DR\C[S-[^6ZO&QQ"TDS>SDO[V^DF>R)SBZ-E*-&#:"
MH761M9]X_)M;S>(Y-UM+8K%*SJ6Y]N%9K/'BX[<W:?E>^LT+HF=ON;^FENG=
M,^B.:GHCHAGF7SN[?;\-7,=1II4BC0 #A7 KB=M?$S=S128P=-NKIIIVVXQ7
M@M_ZJ:2=/O.F-T([L\MM:-Q( QTOFV(K@:+Y/[_;;]=HW5BDZMOUG>>[%O\
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M2>9SY)"3CB2M?96374B8I;'0]3SG7\6-&DS%T6]-7Q[8A[3F+:_%X"UQ& [
M 5&E'Z_3F?ZRWZT,>RCFT;ZY\KUD/HM[N'PKN4( XJW&<G;39)8C_9+Z3^)5
M_AZ>PIC$Z-O<XGR'^U]]']*.]DA+YHZT0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MUD<UNG"ZGESK(LCS:3,-,Y[):NMH+W*<WN+R\L+>$N@@C?[%:!L9+1]BO/\
M=CSC^+Z$VZLQ]_T+ILU+>B;9ICC.>?I>AYEHV;:?&T8YMMJQS6SE[59F/@=>
MGMKC(/EA$'^K-08!NRA&S$+J]U,7<M.'1@Y*[&9F<6:[]$%ZIKC3G-'G#TU9
M[GMQ/EVO#D\VB<JEO)##9/R]V7NS!UE;/N0R,21?&X&8G:NVV>G;YA[N:^XU
M(I=LZ<O9=;2:_#->#BO/]QK:/G&QT=*::>M,Q?$<:3ACVO1<=%ZL8!IP #ST
M "^8[_0G7NLFVZ8I/!WFG=RQ3J8XGTID?_>I.;FRHOLDQH*@<=W7R[%Q_O%'
M_NWR?MU.Z'9^[D_[E\RG_-Q\KR<["$N[ZY#@"R,5J=M&U/J^A?0KYI$4S</O
M*SK3;.4S\K?Y)=]]=11V]A)<W4TO=QQ1L?-*^5SPQC&,:USG.D<0 !B2:!;>
MPYHUXY;>:;IB*?"QZM]FGIUNFEM,V9=X%?T='\K>QTIU:]:64WV6\A''V_2W
M*._M+C+;[F"T,A=%=W[I;*"^RZPM9P]I;7Y=IH,"2.I\\MVWEFG9MYY=3>W6
MUF,*:<\,8SEY>WW%^XNNNMPVULTYOSNF(].#T!N573AR#Y6:1RGE[R_Y2Z!R
M;2NF;&#+\IL'Z3R*>:*UAB9"&RW4EAWMR\QQ@%SRYQIB5R>\FZ=.-;4BMTQ\
M'H9/+]+2T=2^S1C"9K6<9]/R,?'Q]O!>Y#]1/3MS'Z@.37+')M-]1VC,LN,Y
ML;[3V7VF709E9V<%[=Y@R6PR_+^Z+Q%5U<!ZO:%\O]YO,]SY+O-OO=O=-VVO
MOY=32_.K,TF)X1#ZC[H7;?<QJ^6;BRV-6^R9T]3C;,9Q\/\ +-Y;U]!<Y3F&
M=65U /:K;,[S+)9"0W@N<NNI+:Y' :4K)&5]%T;XNT[+[8QFV)],.)\QTYC=
M75GU8OF,LZ3,-N_,WV=YE=ZQKC\WYC87HH\@AUM<,G%""#4EF!W57IW7_P"L
M:,S/Y<=[2U;/$TK[(]JZRZ/3#V*_ .YJ7?.7PQNGW7-_+-+<WN4RV#W3ROFD
MIE=O96;6\<DDCJ 1]N"ZO\0[[-3SZ-72B(T[M#3F*13\EQ?N'M-;8;+7V>YF
M;M;3W%T36:\:NXB4%[VQ12\ 97O13XX=M%>VE5\_W.E-VWNNK2*3W.YNU)G5
MBDTFKSO_ *7SUKW^>\T.6/2MI+.9QD>B8KZZYC9!;7+^ZO;G,/:QEXO8(KDM
M?P0@N;QQX$+YU[J7QY_YMN=:ZR;?N5TVV3G'M36:\>CX7T+<ZL>0^1[>^D7W
M[^)NOKT4PB.]A*P9A%$2"UT$3G-;'5I=4$_%-1A2J^H_>\;=.VR)F9IZ<'!:
MVV\74G4YIB(Q^5F.?1/.@31G.[GSS&ZH.9.209A_,;)DS^7UOF-A%>Y9F-SF
MXLY+F<075I/:ODMF'U75#FN=4=J^@:>TU?='RG5W$TOW.^MY;+N-ELVUNIUX
M4PRS</[T:G]Z=_MME9?X>QVUT7:MD1]I,71%L3,=O-,3A,/2:C8R..-C&M8R
M-C6L8QH:R-K6@-:QH #6M:* # !?-JS-TS,S,S.+M+8BVR(B*1$-NQU0]P.P
MXX;?.=JP[ZV;;8F,)1M[INNF)QQ8:?TN[HXTWKOIJTIU897E.7V.I.3MQ+;9
MOF-GE]O#=9O!G+KUEN,PNX;7OKDV\HJ#))@N6VNI?9YG9X=U-/5B>>*9S6?1
MA1U6TU(N\LU(U8YK]&9FWIB*9=_I>;-F=T9!#)PELLC6N+6"AG- :EK:$<%5
MUNGZN4X/%W<QS11D6_1>^H+4O*_Q+M <NX\QEL]*<V#-9ZJB]H?%#.ZP=:S6
M'?#OHXW\,QH.(.VKZ3[FSJ[GR'S7R[2LY]74T8NB9QIR9TZYZGS'W[VEEN[\
MO\]U=2=/3VNM$3;&5W/ACV4[WK,V[!PL((<SA:Z)W:US014[\%\QMTIMU9B[
M.V9?1/%C4T[;[?RHAJL&WT?563<16;:=+'9Q5N;Q4QI3R++;-()BJJ@.T!1&
M&26G+]CZ?J+4W6=O:O9Q64>(DX-Z0.=U=GXA:F'F_@+,>Q?)OQ<BNUV,3$?O
M%O>ZKW-P\UFG]7=W/$3U60-7ZNJ"0=39[05('^-+JAHOKNVK]VT_H6]T.7W%
M?'O^G/>VFGN+\9=.<3G?X^RBAJ:C\/M]F.%%O:,4U]/Z<=\-3<8[?4K^9=W2
M]J[PF1_\C/)(G$_BKE&)Q/\ B;*]^U=C[_?VY_\ DV?5?._PS_L;4_;7_6EV
M.-%6/V 5&   ]Y<-NOL+_H7=TOI&A,UK..+R_/I<Y(ZWM+4)'\'/V$C]<GQP
M7P/\%</>#SZF'^M?+<[[WGQ]W/*ZY<MS%'@''&"X&81<1?&03(WBI0BM7':O
MT!N9]G'%Q>TF*W<T8.:.G7D_S)Y_\R\JY0<HM)9AJ_6^L<RLLLRC+[&TGG%N
MRZN(+6>[GGA@G%NRU$X>2X4P]"]SR#3NUXU-&RSFU)C"9PB(C/'+YWD><:^G
MM.77UK^31MG&F,S7+!Z6OA ?1NNG7HNTSI3G%U&9'E_-SJ3GAL<[M;C-[>&?
M*]#S74,$]SEARN\L_9[Z:*>/A+I&OH*C$DTUIUHTM2;=*(NNB:3=,9],?*U=
M;2G<6Q?J73RYVQ$TIE,3/P5CI9(NH.3')?4^G\PTMFO*OE_F.39IE]SEEWEC
MM&Z?CC=9W-N^UF9#_!P;;N9!(0TMH6[B%XVM$W:=T3,TF)XX^E[6E6.6Z,.M
MYL?TESPB>6G0CS,T9SVZ;M-29)RFYNS9M-J'3-I%(^RTCFUL+VZO)6W+;5C6
M09C._C8TO/"*-\JY#R;=:FGK7;/5ONG;WS,Z475F8MBZ8I->B(^)UD<N[V_C
M1;'CZ<4U,,\,X^'Y6)*ZZ$8<& S6[W/[[UJ.>23P<+JU;PKL8I$Q'&',:F?P
MR[3?!=YIS<G/$1Z?->E\C&Y3J*"P:\2N:>'-\PRVTX2X2,P(D(..*^D>X5EF
MMNM72U<;9TKXF)QBDVN ]_+HT_))U+,)\73ZJ>L]G?);H7V3Y3>X?AN66%WY
M_:+6*:OE^.OGNXMB-:^*81?/>[/;_863_0M[H?J+$S" @*)R'Y.9Y)DN>0&U
MSO*,KSBVK7V?-,OM,P@K^Q7<4L?O+6T+;>:9I%:]#)%]]L4MF8B>B70C](TT
M5HC(_"5ZFKW*=$Z/RZ]&5Y3'%>V>F,DMKRWXKJ1Q?;74-DR>WD]0#B8X&A(V
M$KC_ 'KUK_O>ST8I$?>;)K&?Y6%<Z=63NOP\MMN\YU)OB+H^ZZN$Q6.'3QZW
MD-U),F)^^/Q./V7E7?6^Q;3/ECN<+KT\?4Z.>>]S#R0#'\P=&\<<<C/YQ^7X
M<R5C96.8[5&6!S'->'!S'C @BA&!7T3\/8LG5W/-$3ZG&(GO>5YGAHS3HGNE
M[>_)[E]RZNN67+V6;ESH R/Y?:)F>]NC=/L+GS:<RU[Z\.7@4XG5 W+AM_9%
MNK?,5]N[#AG+6\BU;M73BRZF%MN,12?9C.>/75RU!RWY=PO;+#H'14,L9:YD
MD6ELCCD8YI#FN8]EB'-<TBH(.!7E:.I-TSE%.A[=T1E.+ZU\<;!&UC&,#0&M
M:UC0 UH :T   -:-@W+:MF<:L-UL1,4I$L<+Z4W7_13<WL?[NR'T_+7J^?\
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MZ^Z:TB6_CF:]SF.:.%[2!45W&M<-A63>[>W4VEW-3V)SQX,FEK73JTBM*X?
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M..^&CK?8:GT)[I>WKT  ?DL<H"#MT)I+_P"YO*5V/O\ ?V[/[*SZKBO<"?\
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MT>!NM"-";;H]:Z9F>QWT?1F[R_R_Q<.0MI:W4D=AF,>H#<M:2UMQW<-DY@+
M6AU'=H*[?W.B^_W=\YMKZD:<3/73&'(>]6CH[G3T-W?%-QH:EM)Z*SC_ "ZG
MK;VUYQ0<8A((<&TWN H*^^OFFI$[G6NC*+9I\;J_+8\7;VUP]6.YB7_2[/\
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M98]J(ZX>:K],<I^4IR/IM^:,Y]^[F7R#\*_[4\W_ &\=\N\]YZ_W=\K^A?\
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M^M=$7:NMK:M9_P"_/%VGOYI1.XVVWT:VZ.EH:<6QG2ELQ,_"Z<+C,(FNB;W
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M:*NJ/*0OH$Q2G11QLTK,<.:5ZOA[3$=4W*)QX@6:[TIZPVFNH\H&%*$+Z?\
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M?I72VE_"EZ>IM.Y+EV5W&:6>9S9M>6ME:QW^93/?;.+[^\AA9<W;FG89'.(
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MSW^F*VG/GD]K[E5?=#+;*#6VGLTR W\O,!U[%8.S"SFM&WC8VV=HY\MLZ;B
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MO;(LLMVVL<7&96D/%*B @;0=GKT7:W:_@V1;RUK#6TXYJU=KG@67 N?$UZ=
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MW?1GN6C-YIWTQ]Q_*2Y),(P.49XX&NVEU./1M7R'\+_[7\W_ &_RR[#S^?\
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M=W/#0UK7\=M:4%:ZMU'7'LS:[7U[9S_JUD?T([H<GN/MK_I3WOPLJ_QOE/\
MSG8?X3$MK:?OFE^TM^M#3WO[GJU_JKOJR]EGP)</#:Y#BE*90*_\2RY=Y^)G
M^(O_ ,G3^J^5?@[$1[OZM/\ :-3ZTNX=?.WUX0$! 0$! 08^'TG/_5)<_L:"
MF2[O]OG7#>\_]M^5_MI[G>^Y/V?F/_T5W?:\BR(?)TV<3G4]!Q7=7>Q;V0XC
M\N_Z4][]K2%#K31Q&TZGR'#_ .MK19MO^\:?T[>^&EK8:&I']&[N>WQT!?\
M57Y05.'XB:2W?_8WE*[#W^_MR?V5GU7$^X']FWTS\6[O7H+B'>B @(-*/[+T
M?55[\E+9QF.*7-PK7XM3L]/U%AT[?#KQJM=%6RK&([B=C2)9897;2:F)I IN
M&*TKKO4U)X\EW<S:4Q=J66SE-T1\;Q]OI%5S?YIXL?4;<WK',?[=E3"T5J(H
M_:F1$TV@M;5>#[FT_A<S^5.K?7])WGXAZ<;7=;70LFNE]VTZ<,.6?YG2;_=#
M8XW 5DA-1MP<,#3':NMLPU;)_IV][@-M$W674SHSX_H9S:W76\YI:&?Y#"45
M!V061%1Z2OLGOUJ:=_E>PY.6O+C2F?+QIU.-W43&[T[?R:37]*/E9Z67'O(&
M"A% W$XUP"^,;_3K=;=;.<\'4[*^NERTR?K' $TV _ LD<(9YR?GL(<TU;ZU
M3PU&.W=V8+)J6\D4B<*2KMKIOF;IR3,_N@/5XN.HQPI5:FPT:3?,S3$W&KRS
M;%.+A[G5*T\G>;$;0YK8>6VNSQ NP+M+9N<",<"N&]_[[HMVO+6G/C3M>[HV
MS%]NI-)FZ8^1X=_-YY_'O7_>/./,76_&#4\5-29E2O;BNQV41&C;$9<L-WSZ
M+KZ<TXX]\O@X(X*M<'AS)6CVB,^J(>$>KPN/WRODV+UMK,S=-MT8<')V32M7
M[%KR]UEFS3F>3Z/UWF5C(3[#>Y3I;.\RL)N&G'W%Y;6DD$H[>%Q"C=67:5T1
M-9KTUCT5S^!,ZL81;3TP_0M^6_,FDG%RUYD!U*\3-$ZA=Q'^FX;'!8+=6=/#
M.O6R[NDS9RQ2*\<._-L;CEES)E+2.6O,8$$EW^16?BOD/X#@II3X637NCU<*
M13CAZ&_ROESS&B;-7EIS&-1ZO=:(U"\>45;8GA*W=G%O+=-U?T9GNB6#6N]F
M<J? T;CEWS*GD!_FSYBM;&:D#16?DN%<0[\!PJ%J:5M+YNZ)X8MG4U_'MB*4
MF(X8LF[Z+UT8]0FMO$"T9U*0<N-0:<Y1\C1?0:OSG/\ +,QR<NFSJUM6V;+.
M+,;*$7U>(N=W3CPAOD*[CR3S+1VWDF_V^IZM^M9RVQE6>6OR2XOSV_5MUM':
M6V3?%]]LW7<+8BZ,_AH]1&"1M*!P(D?6(\.P'M'EJN!N_5ZDS,XW3+K;+/NE
MEMDSS5MCN8EGTNPD='&CA_P_,\?+[)<[O0OEOO?_ /B![O3QY];NA]*]RY_W
M#YKT\EORO,/C]:+9ZQ,E?+M] I5?5;GS?3^TOZ.:7;MX#9(\3;IS-/\ OY-_
MA67KZ)^'?]H:O[&_ZKB_??\ L:[]K9]9[+&7?N'+OWE;?X/&OGVI]OJ3_2^5
MU>C]CI_1CN?AZ[_B1K+_ -E-1?\ FB\7E>9?NFO^PU/JRW]I^\Z7[2WOAXAW
M7Z:]3?-,[QKK5O\ ]T>;%<S^'M/[N6?M+^]]&_$^L>::4Q_4V?5A9BP LDJ:
M?%IAMQ7>Z/V^G].WOA\NN>M;]%K_ -53RC_?F<?;6:^C?B#]GL?_ *>.YRGD
M$4\UW_[2/E9'R^:NM$! 0;"_<YN6W[PRDC;*Z<&UKBV"0M]U:N\MY]IJZ<83
M.E?%>BMLPS:,TU[*<+X[WC;^.WFE_G7B@]2699DQT<\>=1,FC/$WU63WK(R1
MO!:N3_#J/NONWIZ<^M,ZE_UI=7[XW?>O,;;Y]7ETK*1/9+J,=.][;2&W;\I)
M(TRCXQ(#Q3RC!=U?%DZNG,_G1EVN7KZF&=)[GH<_0U8Y#I'JM+W,X'3:0#6^
MJ2TBVLN(NW[1O7U_\0].-+W>\KFR8FR8_P#"^6^[LQJ>]WF7-$Q?R16N7MPS
MCP%\4T[9YJOI7"B'-XJ8TI7=7:MF)HK,5:;6\5<:4IN5YFBD15JN6EKQ,S':
MRPTIR*-\ZC>?N>I^SN[I1^5';#S5?ICG_65Y(8?]Z,Y_PJ;!?(/PK_M3S;]O
M'?+O?>?_  [Y5]"_Y&&A)7AA%* $[ZUQ7V>.+AM3*&7+]$1_ZY.NL=EI884_
MX9;XU7T'W8_POYM]&SO?-/?#^W_*_I7_ "/3HX ;8AKO['Q@#S;/0OG>KRQI
MZT1'_EW]TOI6SNI997A;@\M?Z5_F&?W7B"W%O?MX<FRRRM&Y.XM^^&2.]=<B
MN^CFKX3^"<;?3\U\\G2K.K.YFM?I31W?OESQ[M>46W1A.G=WQ+%MM[GO(;CA
M91C2*DG$FNT5J=J^_P"M=S4BE'SV_'EF<X9:7T1Z2%W6+KF*5T8N'0Y:8"X,
M+W4NK,.[NOK#U1C3M7T+W1U.7W0\XLB,)LL[Y?+O?^NI[T>2W=&I?W0].FY:
M0(:5V 8#WU\\VNG&ESS7-]+UIK;9\"MTG<%CN$N!VTW"GD4:5WWB+HG"A=^I
MFVF-5!F:TDQ,+A+3UC6@W';@%JTBRV?S9J]:-.;[8\2:3;P8+OTST0G*>C!C
MBP.%[KQ["0TG&QN!@=_K47+>';I>8:,:=)CP\:4_K+IQH[_W.MMO\G\SYJ5B
MVVE>R<J]3SW'PF7OI"=LTG"010>N0/5&Q=KJY6QU/FFI,Q?-/SI[Y=R?@06&
M87?B;=,5GEI>;L9O=NC[HN#PQMSESGXL]:G""OJ/X>1IV7ZM]\QRVZ5]?T>+
MC/?*;KO*)Y8QG4L[WL;V'$RQL6O^.+2V#J[>(0L#J^E?*MY?%NYNFW&)ON[W
M7[>/U%GT([F.3]*:_P!5+S<P_N[)?>=>%?//>2?_ 'AY-'3.KW0[KW<_L/S+
M]E'RO)@MI'=Z]M#L:ZHJ!A3## +Z)IX70XJZ9ONNNCIGO7Y=!,XNNJ#DH0T,
MX=<::::8G^,&4@EQ':OJ_P"'>A]]W>I;$\LV:5\X<?5?./Q+U/ ]V[KJ9ZNG
M]9[7NB[<.T;HQW%3@TKIYI':&Y3:4^%?(?-]"=;=76Q=3EU;OAQ=]Y=AL]*Z
MF,Z-GU8?7/CXZ8TH.Q98PB(;=M_*^3UVSAT7J]VVFE=1;O\ Q1=GR]B\+W@M
MB_:W7=&CJ?4EGV$4W.G'3J6_6AXCO7I&?RG^;,E2XG7FJZUJ2/\ *+-]YQ*T
M?<F[[QY';?EC<^@?B-H?=O,]*,ZZ=O5^2LUNWE\; UI #AB#6E#O77[>*[K3
MCAXEO>^=:MWJ3,]#UW_HS _^]"=-XP^]YZ=G^WPKN?Q&M_WKIVQ_LNGW2Y?R
M+#>[W]K'=:[V<^8TZ>U%78,CS9IQ.Q]C.3[E%\FTHFS:[B,<++NZ786376T^
MF;[>^'BT^*W*6];_ #ZD'>2B;5V9^L>)[V]WG.:@CB-7' +D_P *M7Q_<_2O
MR_7ZWUY=O^(.G]QW^GHSZTZFE9CE3U77G ]W>,K#W=O>@<#W8N!8/6P.+<5]
M/LU/ LI2O,^<V:<7369R?0LTAJ[,F1W&G])ZLSN( @7F4Z<S3,;1U?L>_M;:
M2)QIV$J^IHW[68F>:8NBN,3'HKFM?KV;N.6D1=9G$4F?AZ&R?RTYFAP(Y<:^
MWD\6D-0-J3MV9>=ZP<V/4B%$G+#F;)2G+G7U!7_U0U :UI_P#R).(U6<M.9K
M*_\ 1SK^I^*?Q0U *=M/P%5FWI7MNHT/YL>9Y<#_ #=:]-/_ +$M0N./E.7I
MDK.+NY\!?HNZA>?77YRFETWR^U7D&F- 9E;9QK75^=9!FN6V.368O;6:-H??
M6+8)YY76X' #Q-:ZIH*5ZWW:WWW+4OW5\?ZO;9,737C,88<7.>\6C][VL;*)
M_7:ET<L4KE.+UW,N8;:RR[*VOXY;#+[&SN):4 ?;6\<1<*T!XW,7/ZGM7ZLY
M773,==7J:<S-MFE;PMB)GHI$0_9;.-E*D$ X_F[%Y.TGQ)NZI;^M72Y>MNEL
M@@TI?L?3]1:FZSM[62SBLH\1$$](/.ZG\@M3?^8\Q7R;\6_W78U_VBWO=3[F
M_P!JS^SN[GB*ZJ_C?J\G%HU-GM1V_P *7._R+ZYMOW;3^A;W.6W/V]_TY[Y;
M/3W\9-..I0G/LIWUV7]O1>CI?;Z<\>>WO:FX_=]2OYEW=+VKO":->ACDCC7_
M "4RC=2G\#96NO\ ?[^W/_RK/JOG?X9?V+J?MK_K2[&OUMWG'PKAMS]C?^SN
M[I?2MOG\,O+]^ETC_P"=K3!W_-KJ?U]S5?!?P5Q\_P#/H_\ UF>^YWOO-_AW
MRN/Z-WR,2$/+V/ !HTC"M=_NK[W=FX.V)QIFS5_H;7J\].?SN$$>RZ=;CM;^
M&6FP[=Z[/R2VONYYA7ARN(]X[ICSGR^.F;GI'M:.%A[&C=MJ N.NG-VEEOJQ
MV*ZK%;=S+L?#Z3D:>$GS_;N<W)?>N+C=Z5POO',:7G_EL<;M2?BK+OO<FSGT
MO,.K9W]]KR)>['R32XTD>_\ J<<*>>B[^^*6V]CA,]6Z/Z4]Z^OP^(>#JJY/
MC"GX\:7I@#7^'\HVKZ]^#EGB[_>=6C=]5\U_%Z?"]V+9Z=;3^L]M?1)_R,TC
M_P"S&0?^:K1?)M_=R[S5_:W?6EWNPQV.C/\ FK/JP^H6!M" @*)R%(PJL&C'
MK7=JTNB+Z23_ *HSJ:_YOR?_  B=<1[U_P!H;/\ ^HL^5WOX=_VSJ?\ TNKW
M0\?4$@W'8V0X=OK'>OH5OL6S_1CN<+KT\>_Z<][F+D?3^<#1E#4?SC\OZ'9_
MZT97N7T;\//M=S]!Y7F=?"^">Z7N2<E?\U_+O_\ ESH3_P"YG*UP_F'VM_T[
MN^6C[O813^C'=#F!FSW%XNWSN[707*)=K/.MVS*6#4KS13I8WWTILT\*;F\-
MYO<A_;KU<![P?XK\I^EJ=SM_((G^!^83_F_D>3%;2N[US:$U:PDBN% #3#8N
M]L]N)<==,WW73QK/>ORZ!YVW/5%R5]0,='KC3321M/\ E!E J2%]8_#O;SOM
MUJ1;/+R:=^7T>+YQ^)M\Z'NW==TZNGU?E/:_T9 ':.T:_CH&Z5T\.&FWARFU
M^NOC_G&AXNYNMBZG+JW?#B[[RWU=II79UT;/JP^O>P/ [1L*RQA$1U-NVZ;9
MZGR6NV4T7J\DU'XJZBJ*?^*+O>O"]X+>?;77<8T=3ZDL^PPW.G'3J6_6AXCO
M7E'_ /,_S:?4N<[7FK"*U)'^46;[SMP6E[DW3N/([;\J3/>[_P#$71^[^9Z5
MM:UT[>K\E9M=2\4;6-!8 X8BIV'MW+K=O%=UIQ.?B6][YYK7S-GP/7>^C+C_
M .]"]. [(L\.SMG@^NNY_$:S_>FG;_\ JNGW2Y7R/#?;W]K'=#O7S]C3I[4=
M00&Y'F[0ZIV/L)R2OE&E73VNYB*TY+NZ78Z=)U]+KOM[X>+7XK<K6=<'/F6C
MYA-J[,QQN+G.'!G&:BG$:G8%R?X4ZL[CW/TKXP_7ZWUY=Q^(&G]QW]FC/K>)
MIVXSP]5UXPR2&1OR/!!> "-SFU<."G%@<1BOIMFK.WMI2LW8/F]NE%TS=7+%
M](S26KLSC9/D.D]69["QKA[9E.G,TS&T)<"*=_:VLD3B =Q*R:FC?M:3=7EO
MBN,3'HZ5[M>S=Q%D1$769Q%)GX>A^>>6/,P$_P#1SKVI))KI#4#2*DG9[!C5
M8.9$*7\K^9KJ4Y=:^J*U_P D-0;]G]P8)..5:):T7+3F;'4CESK\@]FD-0#W
M/P T4<M>E:+J5ZV@>6',\N#OYN=>DUQ/XI:A)-<!B<OW*,IJB9=W?@+=%O4-
MSXZ_>5%SIGE]JO3^F- 9E:YOK75^=9!FN6V&36?MMI-&T/OK%L$\\IMP. 'B
M:UU304KUONUO8V6I?NKX_P!7MMGFFO&8BF'6YKWAT8W6TC95_7ZE\<L4Z)>N
MUES#;6>796'E\MCE]E:7$M*-#[:WCB<X; >-S5S^I&-^K.4W3,==7JZ<S33T
MHX6Q$ST4B'[+9\2*5H0*U[=Z\G:3XDW]4M_6_51;UMTMD$&E+]CZ?J+4W6=O
M:R6<5E'B)!QZ0.=_":'\0M35.&SYBS)?)_Q;_==C_P#46][J?<[^U9_9W=SQ
M$]64_'#5Q<:G\9L]-*?&/SI=;QLJOKFU_=M.GYEO=#E]Q]O?].>^5>G)6/S_
M $P]OJ2#4F2_)'=3,("#4[BO4V\_K=+KU+>^&ENYG[O?;']7=W2]IWPGVR#H
M?Y%]XX%_XIY874 H0<GRH@>2BZSW[L\/SFZR,O#T_JOGOX<UGRN9G^MU/K.R
M)T7$[BK^<N&E].C4Y8HV&8MX@RFX.V;\/)YEDT+^>R^/Z,O/W=M9M[6$U],,
MBTM_-GTJS9J(SJ&.ZU>-.\;F@@G+Y_:/5<<<&@KY;I:5^CYSH19-;;HNK3A'
MB7YTZWW'\/;]&[W5\X\:VWFY+*<U*Y4PKU='2\[N/Y,WK&- X9)3,_C $O$Y
MQP%17A!7U+3T8U+(FM,'QG>VVV[N8G\Z>]V->$##)<=?G(6"&)\SG:GM'-:T
MN)]7-<K)(I78OH7X?ZTZ._UHB)G]7=E7\UPWXCWS'N[%T?UNG]9[0F0M<[(L
MC!'"69+E9Q%:GV*'B'D((7S7?ZLS]XB(F)FV_P".)=MH61.AI37&EO=#RN_I
M5+Q#XD>I7'CDD=99;1KW.+6M,-\T<+2:"E=R^*_@;==9N?.XOQF=S=V^W+Z7
M[YTGW9\FY?ZN?D8Q<Q:QT3@XX!_%2HVC96N_8OMUWM35\\U9B8B(?1:2R//,
M\%\S(M.ZBST0MK/#D&39CG$C"1\F9Q86\_<AQ_14"]#963=IWW8\MN=(F>YJ
M:]UMLVQ,Q%TY5F([WZ;N7G,V5K>_Y:\P7MC<[N8FZ.S]L;@23ZS_ &'BJT>0
MKS;:6W33*6QJ3.I$=2&<N>953P\M>8= <>'1^H"=NP_@/E4\:R:E9B.':W,O
M+OF:\ -Y9\QF"F[1FH!LWX6(WK+K7\]*Q2(-3"F<=N#5L^77,4V\@FY8\Q7<
M6$%W'HK4#A&0<<18T./E6SI767V3$Q.$=$S\[!?$Q2DXN9^FCI9ZA>>G/;E[
MRRY<\J==YWJW4.L=/2VEO>Z7SG+;=MOE^:6D]U<7-U/9&*TAAC%7.=04\M =
MCRS2NU-QR6<+HNF9PBD71,_#1K[S5C3V]VI?GRS%,\9B:/:?Z5^7^8\K>1G+
MK0></_A+3^C=,6F81D8V][%D.6PW<%>%I<8;B)S=FY;'GV[T]WOIU]+V:4]&
M#QO=C9ZFVVEVEJYS=,T[9JV_5E&/R=^;PB=0R\N]:U<1N&F,VKMV47PG\5KK
MIMV5L_UT=\/J?N-9;9YO-V?J7=SPX-<BFN=<@CB/XZZH%:TK3-[I?4=#[#3^
MA;W0YN^GCW_2GOE\WEIX<WRAVVF:6!#?-<Q';Y5Z>TPW6C^UM^M#SO,/W+6I
MGX5_U9>R=X$X+_#7Y%_8\63B@IL_ <NV+Z%^,-T:GO-=,4C_ %?3R^@^2_@E
MZGN]J9T^\ZGUI=O=N[NFN)'%Q.I0X;,-Z^/>4Z,QXF,YOM.\U8B;8;N2IX-P
MQJ,#V;UM;BZG+VL=L5RR:I'JN\QPIY%GO^SGZ,]R(QF&"9],R-<LZ+1_PS7Q
M\];&4+YYL/W^SZ/_ /$O?5O<W^P_-.CECZLO/9(I<WF%/E9-^WUW>XOINA['
MP/D]WMW?2GO=\WT97_6^=//Z74G^#VR[OW0_L+S;_P"G<W[S_NEG[6SZT/7P
MA^]1_I0OG^I/KS'6]_;_ +O9]&.YQ%S\!=R<YH5P Y=ZW)&VO^3&:^YL7SKW
M^TYU-/;TX72Z#R.:;ZR?Z=OUH>'/S0D,?,/F(,/7YAZY&T#9J7,MB[_R*ZFS
MBO\ 5V_5A;WAQU[?IW?6EQ=#%+;WV7O!!9/>V_'VT-Q'Z<%M;&;;M_H]/C6?
M6AXN_P!.+=M=.<^'=W2]@CZ/(V-OA8=.[(S\7+[_ &BH-661.&P4)7T+\7+O
M"]YIMSMG0THC]%\\]P;IUMMK7WX:D:MU8^&'=I=R"+N_5#N(T\U5\RLGP8Z:
MN\U>'#%LKV O[@\;J%U74)P!\@*VMK.$W79,.^GQ>2(PB.ABN?2SK?3;^@V&
M3,&@YY!<.^8'=YPEA,5V+GU/LZQ@+Y+[VV3_ ,0O(]>)F:SJQ2.%,:_&^I>Y
MOJ^[WF6G;A=R1W/+IX UKGNC> RO'4EI)(PX:[,>Q?6YCEBLOG&AC?J3PBZ>
M]</TE<3N=_+@ACI''F+H>D;02:?C1E&SAQ."^F_A?7[_ +C"L^%=]5QGOQCY
M+=2:1SV][W%N6A(Y<\O@6\).B-*U!^Q(R&PP]!7S3=1_K.K^TN[Y=3LL-GHQ
M_FK/JPL(\74TZ".?QI6FC<TPV?\ >^]7P#\;/L/+XG_:K.^7TG\.O[>P_J=3
MZKQ8L[:3G6HZ?^'LTP[/PZ;>ON6A%-IHS_FX[G";F?\ 6=3Z<]\M]HZ:FN-$
M X%FJ].N.. X<WLUN[+#>:4_YRWZT-36PT-3Z,]TO;QZ!#7I6Y/5&+=#:5H3
MB:'3N5;.Q=?^(,<OO#?UZ5GU7)>Y.IXGEMTQ_67=Z\&X!)9YS]1?/O#G5OF9
MPAVDSRS%&I+\0_I'_ %;_P"6OMZ+9[I5K$:EGTH>03])2<6^+3U&&E:29#3&
ME/DKK8,5Q_N)%/+;_P#ZC4^L^A^_<SX?E_1]TTOJ.B:;%D W<4?EIBT^=?0+
MIIJ6=,W1WN THPN[)>DM]#OQY#\\Z;&WVFAY_P "M37R+ZQ^(T?[@\HG_-W=
MSY+[F6T]^//9_I:;,^>/5=YC\"^*[VWFVU_1R7=TOK5N</)!^DY?ZV_GO*V8
MAUO:Z;]1Y+A1]K=D\#75 J -BX;\/8NLT-U3CN-3'X8=_P"_%UL^[ODEM,9T
M<?@BKH0RSA?!-(PM9WK7.X2&U!:*D@''%?3_ "^<-2)</JQS:<4PBC5T]ENH
M,_;>Q9!IS4>?/B</;!D.19AFYCHZD??^Q03=Q4[*TJM2[3I,SC2KR[_5U+:\
MM8G"LQ'_ &OU[[0O,EW")N6/,%KZ?)OET=G\1:*4'"PV'K)?67J;R^=>;*Q,
M<L=#\[^;?F8YK#_-MS#;P@T>S1N?^M7M(L1@LNG2;>,_!5KZGK4X0T1RUYE^
MK3EQS"P)( T?J #MW62Q4F_/XF2;^3IBOP/UHM <R.Z<X\KN8;GN ;[0S1NH
M",,-UC2M/*LVUOBR+HBLSU8T:E]LQ=%9B+97']'O2)U(=1'4#R[Y5\K.4>N,
MWU/FFL],YE''F.G,XRFSM[+*L\RZZOY[F^N;#V>W;#!ZWKD5 -,5[ODM;M2^
ME(LMI==,X12)B9^&G!J[[6MT]O,W8\T3$1&.,Q3_ +7M.\EM(W>BN6G+K2-Z
MXQW^0:)TMEN81$5[F^L<ARZUO(>(@5[N>!P6GYKO8W&[OUHCU*S&?")F(^)Y
MWE.UNT-*-.9QS].-/D<#>(D6MZ/.=]14-T)J0'S_ #+F"^$_BY;-VALJ9_>+
M>]]0]Q?5\VBG]7?W/$EU,.+6FM7#['4^?.IMJ/G:\P\B^K[7]VTOH6]T.5WO
M[WJ?M+OK2V622\>HM-CAH&Z@R@[>R^A"]+;W?ZQI=6I;WPU=W/\ J]\_YN[N
M>U#X4)_^2+D6*?\ JEE5#7<<FRK=Z5VGXA4GSR^>G2T_JOG'X;73?Y7,\/%U
M/K.R,LJ*#"E?3[J^>:,\LR^F7UN4&3!^ #V;L":=ON**>+.&%%[J61$YVR^0
MUOK3(M"Z:SC6FI<QMLITUIO*LRSC.;^[FBMX8;3+;26\F+I)GQ,KW4#J G$X
M+Q//_,8\MMT_$BNG?6,Z8TPCX9P;7EVWNWVI.CHQ,ZTS%,.'&?@>93XX7TB;
MG7U>:RUET_\ 2[JF_P"7W3)EES?:=U!F>3W4MGFW,66QNKFV=<LS"TO3=Y;;
MQT)#8W,[P\+M@%7EVWU-WH1J[RVZSFGFC3K,Q;QCJRE[>K99Y9=R[2ZS4NI,
M774C'.+K>F*3$?SY,4V]S.YSF[FOL^S3-LY<'$LDSF]NLSNIY)7$O/M-V^60
M>NXDXX[\5[EVGRTY?:GC#FYW$WW<O),17C,SWM"'+<TO[V&/(\HOLQOH/[DR
MG+9[Z5K9, 'LM(I'\1#L,*XK/;9?;ZW+=R]DT9-Y=IWVQ9,Q%W1$OK/YO.96
M#ARTYBN+_69)^)>?D&M"[AK98A16W6CLZ,>YKZ%_@VS$XS/3+\W,=)ZPR=K;
MG.M&:OR*!C@U][G&GLWRZVXG;!)+=VL<4=?*53GBVZVLQ7KG-?:Z=TS==,Y]
M6$?"_$N7.AF[ES&N#VGO&<0=6K26D/Q 6?=Q6+9-.*<SMC\""@\37IW'9GDQ
M'F]KR\TKOHOIGX6S7S#<1.?@W_5</[^S7R.8_P [9]9[*&7R4R_*S3X]C:FG
M96VC/O+Y7YCN/N^YOB+:\VI=WNQV]L3I617*R.YM=3?Q?S[_ )AS?_ I5K;W
M'9:L_P":N^K+9V_[Q9].WO>*UXL8'Y=7/$G$#5N:^2M<XS3X%P'X/?X-T?V^
MM]>7?_B5_:FAT>%9]5UTW1/# -Q!J/0%]/U,;K9_I1WOGNK[$3Q>JS]%'/\
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MUW>G6,(U+9]$P\<3QI= /Y<^(OU%:.F91^69^V\8V5O=N>,ROLQN X->QA(
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MS:=\T_)N[I=SM[YBVV*84>1_])]!=XNW/)M#0VVF@3V4MKKX5PON)ZNAN_\
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MELG8#?7CIZ%]-]S:?W,\\U,)GET_E?%OQ)TKM3WS]WYK,<NKJ?#D]62-@;W
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M_P!9?]9W_P"(=U=]I]>E9]59QW),,^-'#AH*;?2NXIR:VG]..^'SS0MK9?\
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MM\VT_-=M%\8;FR:76S,5B8B(G"M:5R^>K1C:VZ5]])]2^LQ,98XK5F9@^-W
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M2A+;LEH9P1M+(YIPVKWOD(;$UK "27.-*!;-VM$4B(QEKV:-TUFZ:6P_1O\
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M?*R/E\X=:(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M^YW]JS^SN[GB,ZE_CIJMM*DZFSUH)W?PK<CWU];V_P"[:<_YNWNARVY^WO\
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M@LGGB)NP:AB,Q[N60/:*<;."F-/T6_%:^CK<MTVXUGXD7Z5TS%TSZJ)(FQL
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M%TS2G0WL,DG&QC8287 ETG%3A(&P@]I6]=;9X?-7UJ-72K%\Q3"JB\K6,@'
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MMUMOB3.-S+HVQJS,32V(CTOU!L&[ 8=F"R*I0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M,4E]7\TB.>SDFL5?MOCJW: .$8  ;L=BS:V=.MM:=T6QEBT;*O"\$;';3O\
M1Z5L3;RV6QQHU=*LS=7I;V@[ J,^10;:#W$B(C(*#L"!0': ?0D89!0=@0*
M8  #L43$3F)28B<P4A0*(B(RB@*1% -@"B(B,A*D10=@]Q",,B@.T H)H#MQ
M0$!!  &P >8(% -P0J4'8,=N""4!12.@1PM_0CW IK**0  ; !YD369S2@@
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M<"5DSS2 !L%/,@(%!V("".%IV@'T!*09YI\B"*#L'N)ED42@(" @((H!L "
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M$K(@0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0:;V<=,:4\BM;=1C
MOLYZ=34561M+B/CX<10X$%H<'#L(.T%>-YKMXW$Z?]&>BK-I74B8?-W?+_0>
M82&?,-$Z1OIWDN=->:;R:YE<22272363WDDGM7K:?V<=C%Q4VO+W0&7RBXL-
M#:/LKB/UF3VFF<EMI6.&(+9(;)CVD$;BKQ&/6K.3]G++40&<U!+W@@!@:&-!
M-&M   : : # !9MS'B<M>#4VFG&G-U.,]%'["PMP0$! 0$! 0$! 0$! 0$!
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M5J4P94J)R&B'TKZNT^;ZBP;:9OFZM8Q3?ZM&LMA @(" @(" @(" @(" @("
M@(" @(" @(" DX8C2C^R]&[SK%9K^-6*3%$\G(TIG%I:*$U/U?,JZ%9YJX,V
MG;$UGJ4RGAX32M?>I1:6II3?=$]?RJ<U,&I-+W?#ZI<7$;/S8+TON_CQ%9IR
MM>_5\.F%:M<8@'M 5J4P9$H" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @B@[![@0G'-* E(! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$$4'8
M/<2HE 010=@031 0$I (" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(""*#L"99"4! 2@(" @(" @(" @(" @(" @(" @(" @(" @(" E H@**0
M%%((" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(-.:0112RD5$<;Y".T,:74]-$%NKNH2Q$LL;<BN9.YFFA>8W\
M=#%(Z.I#02WB+:XJ)F@C\H2SX:_B_>U[/7[?TJ"D=0UEA73][Y?C^BGJJ)F8
M$?E#6?\ )^\P_3_64U$MZAK(UKI^]]'']RD34E/Y0UC44R"]-:U^/]RE1 ZA
MK&F.G[VODXON4B:BH=0ME3'3]Z.WXWW*B)JBL*1U#69-#I^\I_5_<J4GY0MH
M?_5^\_5?62J*P'J&LP:#3]Y^K^Y2OI2#J&LL*Y!>[Z_']'V*5XR)_*&L:_X@
MO:;S1^'9]BHJ(_*&LJ_Q?O:?U5?M>U37# 2.H:QH*Z?O<:_HJ?:I,\($?E"V
M= ?Q?O/+\?MP^Q2IU'Y0UE3^+][7^KI]KV)4!U#66%<@O=]?CX=GV*5QH)'4
M+9;#I^\!_J_N4K-*P8#>H6R.W3][^K^Y2I6$#J&L]^G[VGDXOK)$A^4-94)_
M%^]J/TU-OZ5143^4-8[M/WM-_P ;WO54Q,S'6(/4-9;M/WOIX_N5$7 >H:RJ
M0-/WNZGQO37U5-<3K!U#66/%I^]']?\ <J*SF)_*%LL::?O?)\?'M^QW*:R(
M'4+9UQT_> #;\?T?8I7HS$GJ&L=V07M?ZO[E16@'J%LJ5&G[W]5]RIKTE<:'
MY0UC4_P!>TW'U_?]53D!ZA;*E1I^]]/%V_I569I)ADI_*&LJ#_)^\KO^/Z/L
M4YO0*CU#6(('S!>^7X_H^Q2LG6C\H:SH*:?O*XU'K^C[%34/RAK+9^+][7^J
MI\'8E<:"3U"V0)_R?O:#]-7[7M4E0=0UC3'(+VO]7]RHG"! ZAK,FAT_>?J_
MN5$23@?E#60-/Q?O:?U5=GZ53$B7=0MD*4T_>_JON5%2)J#J%LL:Z?O<*;.+
M?_4J:SP*GY0UENT_>TW_ !O13!,?A%/Y0UE0?Y/WE<:_']'V*B)FHJ'4+98?
MP!>>7X^'9]BIQ%/Y0UG_ "?O:[_C?<I7&@J=U#60I33]Z:U_1_<I7#K$#J&L
MS7_)^\KN^/Z?L4KB ZAK/?I^]IY.+ZR5J ZAK+$G3][A39Q?<J*R'Y0UE3^+
M][7^JI\"F9IV"?RA;*H'XOWOE^-Z/L5%9*X5&]0MD1_B"]KO^/\ <I63"%/Y
M0UEA_D_>UW_&]%/54S- _*&L_P"3]Y^K^Y2N%0_*&L_Y/WGZOZR"H=0MD:M^
M8KGO-T7'\KY?D_C^\D3,@.H2TKCIZ]']>/A:DST"/RAK.N&G[WT\7W*3-!/Y
M0MEPU_%^]K_5]OZ5*XT*\$?E#68!KI^]KN^/Z?L4KQ$GJ&L</X O:&M?C_<J
M*X"D]0UGNT_>4W?'^Y2+A(ZAK+?I^]'93B^Y4Q-1)ZAK'_P!>D;_ (_H^Q45
MD0>H:SH#^+]YC7]']RG-,< _*&LL*Z?O=]?C>BGJJ:T$?E#6=!_D_>5W_']'
MV*5D3^4-95_B_>T_JZ_:]J8B1U#6._3]Z#_54^U45FE1!ZAK+['3]Z?Z_P"Y
M2L\0/4-9;L@O3_7_ '*1.%9#\H:RH?\ )^\KN^/]RIQ$CJ%LB3_D_>TPI\;[
ME*HF: ZAK&E3I^]KO XON4B4J3U#6=<-/WM/+Q_<I7T"?RAK*G\7[VO]73[7
ML2*_ )_*%L<?X O:"E/C_<J9$#J&LZ$_B_>84_1_<J*@>H6S!_B_>4W?'^Y4
M<WI,S\H:RPKD%[OK\?#L^Q4S-.P0.H:RWZ?O:>3B^LE>@3^4-9TQT_>5W?']
M/V*BHD]0UCNR"]K_ %>/ZE3,T#\H:QW9!>U_J_N5%?0*?RAK/^3]Y^K^Y2HD
M=0UGOT_>TWTX_N5,B?RA;,-K^+][7L];M_2J.;"J*PC\H:SI4:?O/+\?#L^Q
M4Q-4AZAK+=I^]]/']RHK.<@>H:RQII^]W4^/Z?L5-9#\H6T_D_>?J_K)$U*P
M@]0UH/\ U?O/U?W*5$GJ&LMVG[WRUXO1]BD361(ZA;*E3I^]J-H]?ZK5%< _
M*&L:_P 7[VF_XWO>JIXBG\H:S_D_>8_I_K*.; 5'J&L=VG[VO]53[6JG$3^4
M+95%,@O:&OZ/=_4I,R8('4+985T_>U-?T7W*BLHK"#U#66[3][Z>/[E*S2J0
M=0UGA73]Y0U_1_<J:] D=0UC7^+][3=\;W_52H@=0UG0_P"3][44_1_<J.8#
MU#66[(+T_P!?]RE9$#J'LM^G[VGDXOK)S= G\H6SH*:?O"=_Q\.S[%341^4-
M94/^3]Y7=\?[E)F@J_*%LJ?Q?O:C=Z_;^E[$F>@1^4-985R"]WU^/AV?8I,T
M =0UG7'3]X!V^O\ <I4/RAK*G\7[WB[/7Q_4]B5D0.HC+Q\?([EAPX6O>6.=
M7#U6N )]"5$_E"V8!KIZ^KA04?7STX:THDS@9I'4+9&G^3][OK\;#L^Q2I,T
M1^4-94_Q!>U_J_N>Q(FL]0C\H:SI_%^]\OQO1]BHK(J_*%LMVG[W'9\;TU]5
M34K .H6RQXL@O1_7_<E2('4-9;]/WH[/C_<JM9Z '4-9[]/WE-_Q_N4F[TB#
MU#6=<-/WM/+Q?<JPJ_*&L*?X@O?-ZWW-%&<"/RAK*G\7[VO]73[7L2*_ 'Y0
MUCC_ )/WOD^-7R_8T45D#U#66[3][Z>/[E(FH#J&LM^07H_K_N4F:2('4-9X
M_P"3][7=\?[E(FO8*ORA;/BI^+][3^JKL_2I,]"*QFI'4-9G_P!7[VN[XWI^
MQ2LI/RA[/^3]Y^K^Y2HG\H:RQII^]W4^/CV_8I61/Y0UC3'3][7^J^Y4S.%8
M#\H:R]:FG[W"E/C[]OV*5H*?RAK.F&G[WR_'IY/L4K45#J&LMAT_>U_JON4K
MQ$?E#66%=/WN-:_'^Y2M<@/4-8[M/WOIXON4K.<9"1U#6-<<@O0-WQON4XBD
M]0UE7#3]Y3^K^Y4<W2*AU"V1/\7[VG]57[7M4UP)F@.H:QWZ?O?U5/M5/$4_
ME#6G\G[S]7]RHJ'Y0UG_ "?O/U?W*5PJ-3\H2Q_\ 7OZO[E(G!%84?E#652!
MI^].RGQO37U4F:)1^4-9_P G[VN[X_I^Q2HG\H:RH#^+][4_IJ;?TJ1->P/R
MAK+"NG[W?7X_H^Q2O&<@_*&LZ?Q?O?)\;T_8J*B?RA;*G\7[VHW>OV_I>Q3$
MU%/Y0UE0_P"3]Y7=\?T_8I6HD=0MGM.G[RG]7]RE?2=1^4+:;/Q>O/U?UDJ5
M@/4-9UPT_>4W?'^Y2HD=0UC3'(+VO]7]RDX=@@]0UENR"]/]?]R$KB'Y0UD1
M_%^]K_54^U[$B>/ 5?E"V.'\ 7N/Z?[E161'Y0UA_P" +W]7]RIQJ*?RAK,_
M^K]Y^K^LHYA(ZAK.M#I^\ W_ !_N5-<:"1U"V1)_R?O:84^-]RDSBBM%)ZAK
M*N&G[PC^K^Y2O0E/Y0UE7^+][3^KK]KVI7I$?E#68_\ 5^\_5_64<PD=0UD3
M_%^]I_55V?I4K)DC\H:SP_R?O:[_ (_H^Q4UPJ!ZA[%HJ_(KJ,'XID<8VNIM
MH7@ I7&A5)ZAK/'AT]>EN%' /(/F(;0I$U$GJ%L=V07M>SU_N4KQ%/Y0UG_)
M^\_5_<I42.H:RWZ?O:>3B^Y4BH=0MB?^\%[^K^Y5:S7$4MZAK(FAT_>^2G%]
MRE?09)'4+9&G\ 7N^OQ_1]BK"D=0UF?_ %?O/U?UE$3Q#\H:T_D_>8?I_N4K
MC05'J&LJT_%^]IO^-Z/L4K(C\H:RI_B"]KV>O]SV**XT$GJ%LM@T_>D_U5/M
M4B<<3K#U#6-*C3][7=7B]/V*F)$-ZAK,G'3]Y3^K^Y2IDD=0UCC_  !>T%,?
M7^Y45Z!'Y0MI_)Z\_5?64UQHBL)/4+9 8Z?O*]GK]OZ7L45GX$X2'J&L=V07
MI/\ 5_<A6$?E#65/XOWM?ZNGVO8HF<: [J&LALT_>GM^/]RHKB)_*%L:@#(+
MT[:_'^Y4S-!'Y0UD!_%^]K_54^#L3'X!+NH:R%*:?O36OZ/[E*X=8C\H:RQI
MI^]W4^/Z?L5'-B!ZAK+#AT_>G^O^Y4Q/2'Y0UGC73]Y7"GQ_N4KZ _*&L=VG
M[ZO]5]RE<>H/RAK*O^(+VG]7V?I>U*S\(?E#6>[3][3^JK\"GM =0UF:_P"3
M]Y7=\?T_8J*X]0?E#67"#^+][4_I^W]*HJ ZAK/?I^]I_5_<J>'6#NH:R%*:
M?O36OZ/[E*T[0'4-9;]/WH_K_N4B:Q42.H:QWY!>@_U?W*3-)#\H:QQ_@"]I
MA3X^/;]BHK(#J%LB!73][4U_1[OZE1S2!ZAK&F&07I/]7]RIB9D1^4-98?Y/
MWN^OQ_1]BK"K\H6QQ_@"]PW^M]RHFHH_*&L_Y/WGZO[E1S"3U#66[3][Z>/[
ME3$U$?E#6?\ )^\_5_<J15^4-8X_Y/WM-WQJGM^QHJS-) ]0MG_)^]\GQO37
M!3$HK"D=0UGA73][3^K^Y2OI2?E#65#_ )/WM=WQ_3]BE<*B1U#65"3I^]PI
MLXON4KT"/RAK/^3]Y^K^Y2)J)_*&LJ?Q?O:]GK]OZ7L2N%1/Y0ME0_Y/WM1^
MFI]KV)4J@=0UECQ:?O?1Q?<I7T"/RAK2E?Q?O/U?W*5P%7Y0MC4UR"]IA3X_
MW*5X\",4?E#66-,@O=U/C^G[%1$Y"3U"V(!/S!>@"E7.+FL'G<0 ,%-454_E
M#V+OO>0W<C=SHRY[</Z9H(2<$GY0UI_)^\_5_<I$U$_E#69 II^\KO\ C^C[
M%1S"#U#6>[3][3R\7W*L)_*&LC6FG[W=3XV/;]BHKTB1U"V./\ 7M!3]'O\
MZE*].8G\H6Q/_>"]_5_<J*R(/4-8TPR"]KV'C^Y4S,QV"/RA;.AKI^\J*4^/
MO_J4J)_*&LJ5_%^]K_5TV_I4XB/RAK.@/XOWF-?T?W*5$'J&LJ#_ "?O*XU^
M/Z/L4K3L$CJ&LZ'_ "?O*[AZ_I^Q2H?E#65?XOWM/ZNOVO:HK.7$/RAK*G\7
M[WB[/7[?TO8IK.8G\H:QJ:Y!>TW?'^Y45H('4+9UH=/WGZOL_2J:E<*AZAK/
M=I^]INKQ?601^4-9_P G[S]7]RDS0#U#6@_]7[S]7]9)DS2>H:R%?\G[W"E/
MC^G[%161/Y0MEC_ %[3"A]?[E36?A%/Y0UG_ "?O/U?W*5QH ZAK0_\ J_>?
MJ_K)4R5#J%LJ@'3][OK\?T4]53W .H:QJ:Y!>@;OC^G[$JL3('J%L16F07M?
MZK[E3B(_*&LJ?Q?O:_U=-OZ7L4YB!U#65<=/WE/ZO[E5KZ14>H6R _B_>U[/
M7[?TO8DR1BG\H6Q/_>"]KV>M]RIF9@4?E#65#_D_>UW?&]_U4J)/4+9BM-/W
ME/ZO[E*X(K"?RAK+U:Z?O<:U^/NV?8J>*4?E#65!_D_>5QK\?T?8J =U#60V
M:?O3V_'^Y45Q$_E#6.-<@O:;OCX]OV*3,P ZAK&@KD%[7^K^Y4U%)ZAK*N&G
M[RG]7]RD34/RA[/^3]Y^K^Y4<PJ'4)9X5T_>[Z_&]'V*F)16 =0MEB3I^]']
M?]RD_&D'4-9%U/F"]I_5]GZ5*](I'4-9UQT_>4_J_N4K(D]0UENR"]/]?]RH
MB:B/RAK3^3UY^K^Y3FKP$_E#66/^3][NI\;TU]5*XT =0UEOT_>C^O\ N5,3
M6*@>H:RQID%[NI\?T_8I7&@C\H:S_D_>?J_N4J*AU#61=3\7[VG;Z_9^E2O2
M('4-9T_B_>5W?'Q[?L4F:!^4+9@&NG[RN[X_I^Q2I4_*&LJ'_)^\KN^/]RF8
MC\H:T_D_>?J_N4F:#4'4'9U/^3][3=@_TU]7"BB)F1 ZA;!Q]3(KF0#XW=O[
MSA[ [@!X3YU.-!0.H:RKCI^\ _J_N4KQ$_E#65/XOWM?ZNGVO8HK(D]0MC2H
MR"]\GQ_N5-9 =0UC3'(+T'^K^Y45PKQ =0ME2IT_>@?U?W)4U.I'Y0UE7_$%
M[3M]?L_2]JB)J)'4+9D_Q?O:=OK_ '/:E<# '4+98#\7[VN-?CX=GV*F9Z '
M4-8TQR"]KV#B^Y2N%0'4+9&G^3][OK\?#L^Q45%/Y0UG_)^\_5_<I%U8J)'4
M-9?9:?O1V?'^Y4Q-1)ZAK$$?Y/WOE^-Z/L4KT .H:Q-*Y!>U_J_N5$7"/RAK
M+?I^^K_5?<J:\> #J&LJXZ?O*?U?W*5$?E#6?\G[S]7]RE<:"3U#68-!I^\_
M5_<I7T@.H:RP)T_>XUK\?T?8J(FL5%0ZA;(D4T_>TW_&P[/L5-2J/RA;(.I\
MP7E/ZOL_2IV"1U"V1 KD%[4_I_N4F9X%5)ZA;.@/XOWN^OQ_1]BE2L'Y0UEP
MU^8+VO9Z_;^E[$KA4/RAK+#_ "?O=]?C>BGJI,TF@#J&LOLM/WH_K_N5',);
MU#61VY!>_J_N5-<1#>H:S)QT_>4_J_N4B0_*&LJ?Q?O>+L]?[GL45$_E#6-1
M_ %[3?\ ']'V*F9F(KQ$'J&LMVG[T]OQ_N4K/$3^4+9;M/WOD^-Z:^JA5 ZA
M;.M#I^]'9\?[E1S28'Y0UEC_ )/WNZGQ_3]BE9 =0UG7'3]X/Z_[E3,] D]0
MUC3#(+VO]7]RE:9@>H:QH2,@O<*?HON5$3A61(ZA;''^ +VF%/C^G[%340>H
M:QW9!>D_U?W*BLUZA'Y0MG0'\7[SR_&]'V*F9I)7@D]0UD#_ !?O?+\;T4]5
M161'Y0UF:4T_>UQK\;WO54U#\H:R _B_>U_JJ?:]B5K/4)_*&LN*GXOWM/ZN
MNS]*IJ9'Y0UB!CD%[7L'%]RJS(@=0UGOT_>4W_'^Y3F#\H:RK_%^]IV^OV?I
M>U3%>('J&LJ5&G[T_P!?]RHYL*G&@.H:R-:Z?O?U?W*5G@)/4+8@C^ +W?7X
M^'9]BIK(I_*&LJ#_ "?O*[_C^C[%145?E"V6!.G[W?7X_H^Q4XB/RAK.F&G[
MPG?\?T?8I6@'J&LMVG[T]OQ_N4KA43^4):4/^3U[44I3C/\ L5(@=0UB7</S
M%<%_]C$E9=_ZW\?=V*)F8 =0UEC73]Z/)Z]??:E9#\H:RI_%^]K_ %?W/8E?
M0)_*&LB133][OK7B^Y45D0.H:QICI^]KY.+[E3B'Y0UG0?Y/WF-?T?W*5$?E
M#6?\G[S]7]RE<*A^4-9_R?O/U?W*5$CJ&LZ$_B_>84_1_<J.;T .H:SPKI^\
MH?T_W*F9H#NH6S!PT_>4W?'^Y2O09GY0UE3_ !!>U_JZ?:]B5FM. ?E#6>-=
M/WE<*?'^Y45$GJ&L:@?B_>^7XWH^Q4UR,U)ZAK/=I^]IY>/[E*R)'4-9;\@O
M1_7_ '*5D3^4+98?Y/WM#7]%N_J5%9H51^4+9X?Y/WE=_P ?#L^Q2I6 =0UD
M2!^+][OK\;T4]534/RAK/"FG[RN-?C_<J.8!U#61-/Q?O:?U5=GZ5*DX ZAK
M'?I^]K_54^U4UFE0/4-98<.G[WT\7W*BLP!ZAK+=I^]]/']RIB9XB!U#65#_
M )/WE<*?'^Y2)J*ORAK&I_@"]IA3X^/;]BI =0MB14Y!>^7X_P!RHB>D4GJ&
MLJX:?O*?U?W*5$_E#65*_B_>U_J^W]*HK-1/Y0UC4_P!>TPI\?T_8J>P0.H:
MRH?\G[RN%/C^G[%2!ZA;,'^+]Y3=\?[E14B:GY0UE4 Z?O1MK\;T4]5*X@.H
M:RKCI^\I_5_<J>P1^4-9T/\ D_>5W?']/V*BLBH]0UB*TT_>U_JON4KT >H6
MRQII^]J*?HON5$SZ$5A3^4-9_P G[S]7]RIJD'4/95QT_>T\G%]91S<($_E#
M61;7\7[VO9Z_;^E[$KA4/RAK*@_R?O*XU^/Z/L5;,#U#66%,@O3_ %_W*KS=
M('J&LA7_ "?O?)\;TU]5361'Y0UG_)^\_5_<J1/Y0MI_)Z\_5_<J*E1W4-9#
M9I^]\M>+[E1S$8I'4-8[]/WH/]5]R4K(?E#6-1_ %[3?\?T?8J:B!U#6A_\
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MN4J'Y0UEA73][Y?C>BGJJ1/Y0UD1_B"\XNSU_N>Q17'J%/Y0UG_)^]KO^/\
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MZGQ\>W[%*SF'Y0UC05T_>UWTXON4YA/Y0ME0G\7[W=3XV/;]BIF:'4@]0MF
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MHPR.:9A/S%DH<[^#+8DTP[F+</TB=L8(K,Q2,T'(,DI3YKMZ-_VJ+"O]0I^
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M5A6>_;AW@(/D5;JQ)$]"*2X5DIMQX1_15LZ3)E,]"/E*??<1_2C&JBOI,/@
M)7$#O*']*#N4169*Q"KY8@?*##:*;*GWZIC$5,)P)'.;:7[ *EUK/V8?(O\
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M4E<<<U3C/B>.E:?8]G8=B36)P(F(BLJ.&4'&2G]2*^XD1.? JJ)D_L@!&XM
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M+BT2>J=OJ^3L\ZF8B95K@HK+N?AYDQX9%8XYGRU?O@]Q16ZB<*T"9B<9!Y<
M?-@HQI3@FM)K*2934F484^QP/IW*8K1$S!64\($@KY0!7L\I5JW3%(A%;<QW
M?$T=)1V&%*.] .*K2<N":QGQ.*:A^4H-YI]5,:E8A4._ -7BF%<-O93<IQKC
MP16**?EMO'AO]7#TJ.:4X%9B!\H"-Q K7MH=Z1.*9F*=2H=[Q>K*,/Z7'W K
M3$SV*Q,0H^6_1[-OJG#S]BK64X*OE"&_*@;:^J/1BK5(H@"4G"05W>K]7<JX
MS)6V(3\L!A)Q<6T 8BAW@8A3-:1/$K&49 $M,)"[^IK3SGRI6D&<H E=AQX;
MR&UIO%=M%%9G,PX)K, :2@UVBFRG;V52MTIPB$ R"M9*']*,*>7:D3/PJX3V
M(^5V]X,=U!CYNU*S"U,%1=*=D@H/Z5)G&N2,*44GO*??:UVCAV?T4QF"L1D
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MA$" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MJ23N;^]N8G\'>2NLW0U+3A\:;<1N]*F=O/"<$UB9K,*G>.]T1LXYY\SOFSM
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M/K3@:<(]8F@V_&)HT>DJ9I,*Q7.%D?5GU^\C^C"\TU8\X.]M;[5O?&W="TS
MMMQ)0T$C:80G8L>CM^:^LRF9C*BT:3QV>B\MCC=F%W.\8M8VS<WA!KO=,25N
M:FA.=5(HEWCK]%[86N9>W1C=\9GLN-?)\MN*TM;1IEG\*TW1$Y8/IM(>-;T9
M:SS:/*;;/I<ME>0!-<6Q:*^J&G&X:,'.W]BVMMH^I68PI_+-$XY82["^574'
MRFYVY='=<O==Y-G]Y>AIN<N;=V4-RYH#2U@A]H=*TAKQLK6JQ^'.->":S;CF
MYG<'07#76_R3K)H#K%PXN(/ XG!Y^/3;@L$Z5UT3BS:<Q.:BKI9GQQR=[%,
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MS<308"GOI,=!#Y+7YX=%9X-CNZ;CMK@_T;%6Z,%HG%^#R<(&BHZXUDE\E?E
MHLI3%-U:11R8'"IPP-,*]BM$TP5SFJGLPH?A3A3BG&<3:H)Q3@*C;V'8IFA"
M2*-^-@=U-M"IRC#)7JDK@VHPQ]/UJ)VY)ZZXJ< ?T0]Q,*]2#8!V'WU%)36
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M%[5>O@90]XVT=0]NR4E7LT)X&G.G,4B*45_Z>#HI$)?-F-ZVV!#0!8O+BXT
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M*-ZFA5%*&AP2F)"J@- #6OH2F-(6K%,5%%")B<E5!6E<.VBFD5ZCAAFDU!)
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M]]3E-$YP@X$MKAA7X5,UA7! J:@;]WF417(3BZI.-$FLXI@JYV&T[M@3&3+
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M#.<G3YSFZ==5NR'F'EVH-!YWEL['7$\%QF0M;B>.1SK9UO=1,@@>&/BJ0T[
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MX<*@-6W9;RVTXL-8K2.E;WS8Z.LUY*=+.G><6MN.PU9JB".;2^1S1&.2"U+
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MHWU4X*HK2HKMVX**S2D+4BN*$[%55"2:_&PH.WZFQ3,5S(FBV;K#->FKFA7
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M=CK=T+GQLM87&.*XCC);$6M80Q@A8!LP("P<LVQ$9UCCP3.&3'M\?33VE7Z
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M7.>C !IG**?WI%]HU8;LTOJ% (" @(" @(" @(" @(" @(" @(" @(" @("
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M3AV5WK4G&<%X:; .'%NVN-=NT;-U%ELSF%;FZ8QLL(MX.\EN(:OD8)'1T^R
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MO>%C6D@#$K+I63$S%)KV(FVZF%&+UXQW7)RYYTQY3R4Y1ZC;G-MIZ:9N>YM
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MY(ZX5 TH :$UXL*^936."*>E&)HT8[<-GE416<$X0C"AP[*8[.U,"DT!MQ-
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M7V\D9XT1$5NHRG.D?P;(^E'FC:<T8.>ESK![3%<?,TN1P6;;JA@DHV9D8>&
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M<&YN:ALM6=UP@T;3&E<"LGB5RC$G+%\OS"TRW5^@=4Z)9>>Q7.JLGO\ *O:
MSO1;NO[.:U[^@#@>Y=,'4H:T66ZZ)NB<Y5F:TI[#&QA^CK:C@EO!-U:.9<76
M:YQFULP:5CX86YG>37@M^(V8XQ$)>&NW#>L]FXY:TMKZ/G1/+3/-UU]8/AI<
M\^C?)7ZWOY;C7/+#++F,YGKRTMGQS"?OI#9/.70VK)&CO(0:[@5L6[N*90PS
MI5FE9Z5XGA<>)ES'TIS2T;T]\YM0B]Y::E8;3)LXNWB*/2SHVVD=G:RR277K
MF^=1M"*@G8M*^ROK0G1F9K$Y598L4D$\<]W$#/;1PP3PV[?5;=P73&R03L<,
M#6-X=@M?4GFIA@V8C+'%2W'^EKC2GQ:X\-/)L474PZ%KIZ,U7V(-:4\E=ZRV
M71?%)X0I$&!/8/=W+!G/4=N83L Q KCVU\B5K%"E,8R17 >38E9.":BFVM=H
MIV;$QI@8<4#817LP[?3NHG 5'UB*8GMV5]&ZBF<<.)%<T8!W:/<W)A$DYXHJ
M:\6_\P45Q*8)&VM:>6E:>CRI&9-."*;R-NST)-8Q3G.*JA=0G:=GEIM\U%/7
M.:O!!-34CT5VJ*XXII@ESJU -1AN_,5-:]B,$85PV;OS%1-*X+6IIC3A]%?J
MJ>.2. ,0[&@PK@D1Z$2X:YWGAR#*C3;.WT_*N]S8J716(6M<BZ3'^3.4DX!T
M#37;^ML4VTP+JUGH?O;4R[$9YE17 42>I,4A)J<3OV*<<SJ2['::$?8]GI4R
MJ-Q&.QN[S^5.&)&:"2=IV*M?0MQ"21BIF:HPH TJ:T(V;_.G!-<<0U)PQKOV
M5I]9)QE'!%#0GW5%$Y9RG=MV;!YRIK7M12F/!+L#2M2=HI3S*9K'PF$H(IO\
MX[.Q1,4S.S(K6M,*TPVU].Y37H1C,@%2!6H[:**8X+1ECDD $BF_:.RGPU4X
M3*.XH#LP/Z'\]*1.6:.J4!CG"@PK@/3AYU%)35T\^-\>#HPU+82_*=W-8/BF
M':9KHFI&VA"W]K%)B>+%;-<88=EJZ^CDMAE]M?7F;301>S,RR2XAO&AD;2XP
M/M*3AP%/BXDKVK+N6WEI4FN>3]#\8=?QS&V,W.84PX>+7G VE<&^MPEH.SR+
MSIU8KE"8FL8-U:W_ #,S:<64=WSA<U[VQQME_'A["9"&M:YKRYI!+J&NY;&G
MN+9KZL5H1C"Z_D_X>75]SOSK+X,DY;9G;:1S2:V.::VS&6YCN6VLDD/>/=;7
M5J9BX0RDG:5IZE]>":5CJ9>/0KT2Z*Z.>7MAD.465MF&MK^UC?G6HI(XH[CO
M706[IHR7012&DC"-J\NZ9NFK)7##-?3 :7$SG8ET<M?TW :G?7%3IV3S5KDB
M9K&3#!\9ZAZH+<4^RNJGM'X<O0TZQ;1CO=A_T>DDZ#Z@:8?A^2TWT_ CV[5C
MU_M+*]*-+\ID2T/ PNQK7'M6OJY1#)6*T4, H[T4*I-/A9=3%5MJ3CV^;^@J
M35CB*N*>=_.73/(+E9J_FGJF_M['*M/95=265K/-%%->WCX'^SMB9++$^1W?
M-V#&@*KM]"?%SFBD16)KFP;M59QS4\0/JCNA'G#'9AJW4IBAN\SOV6EE9Y1#
MFKF\+/:YI+>,&QN*8+VK=";;>6LHI%9FK-+Z2>1/+?I?Y-:;Y;Y)F^E!=PV-
MJ_-KF/.,K:^2]=;VSK@]_'P.G:+B,XXCLP7FWQ$S,5G">A;EK%)I7@ZE?'@O
M+>]Y8Z>GL,VR?-G$N[ZVL<TL[A[6AUYP<4,4KI!A3:,5M[?2B^V9MK$$UXSB
MZL/!CE%KUPZ'S"ZN[/+\OBRK/6SNOKF"TC#WV,#6-;)</C:YSG; #4[DW%M=
M.;>CY&'1GUIEFILN<KO);R2QS+*,Q[R1\DGL.96UU+&"XEM8XGN()KN6C-T3
M2.%&S,3"&"G$*4(_/43"]^42U&C>=F_\VU1$=+'6@*UPV[OS%(K7 X())-2G
M%": D?8@U\NQ)Z4Q2<$AHH2<!A0^GL"122<$8885VU\OUJ)6"G0 ^J17S"GE
M[5/!&12F)&!499IQ*$T\OFW)3H3CQR2 !3#B)KOI2B1V(G#+-34C$8%1%8E,
MY*@10X><?HOK45JJJ:U.*B<93$I<:X#8/S;\4F?08RG:WLX??J4QF*089RI(
MH!Y?J)3B3T V[<-Z=J8ZGRFO1_D3GIK1HC;44K7!U,=H43E*(SP?.\G?XEPC
MB_7):"FWUQOW446QZJUW!R=04K7'LI]56PIUJTF)&M))H=FTI&)DC$FN])G'
M$B,E7K.V# ;L,*J:UFD&(1B1M)IY/SMB<:3F< T::;:;=U:[/-11,<")H<-2
MWRU]%%-"<\5+:U%-JC&N"(IQ2*4/;A3:F''-:G1D4%*UQ[*)%*=:)SQ02*X"
MB3B99'PJ.Y/>4PJ=^SR]JFF".]/8": 5QHD37#@36)J4!#0-N-5-(G+-';D'
MR&JK,4FBW"H"-XK[RF)B$9C=M*8]O9O]*9Q0PA;;UB&O3IS2+A4'3U^#Y/X-
MOJ&B;6)\2LS+'$4EY\M@Z3BOXHRX.&?Y^]KF5$@X<SN2#&6^MQC=3&J]_*,.
MAJS7%] W.->1LM;FVS#F]+E\_$R,6GX[LMF]W44B; X1<'93"BU;KHB:X9F-
M6I'GW,&5[X(+KG*QLSFL'$[7='O<[A8RI. >X@%;.GJ1C6V&WC.#GWEWT@=5
M_.BZMOQ!Y6:AU+?7SX8Y[S.KC,H)\I@F=&TW;Y<PMWR3D1R\="3V+%N+[9Y:
M(Y>+*-\-CPQLGZ5<JM>9?,*Y@U-SAN(&32S3VD;7:>EE9;/DMX0^U87%CF%I
M+2%Y&IS4KP9:Q$Q$\7< UP>0[XI+V<6VGQA@!N"P6?F3Q6N_.XL;SQ\Q^!Z7
M!Q%*@;*'\,7IZ5OZN+HG-AG#-9AX&/\ UN;O_FRY_P "M5&XF?#+,\68W<NI
M++45^5EX=W%\HZN[U:+5UN:EL<**1$-I0=OFPVJF&-&?'"H*BA^Q)'IH?=3'
MX$-GG!>_(M6\!]233.=$5&'$W+YF@T.&!*SWT]J<JPI;%(I'M4EYQ>OY"SF'
MKID3JQ7&N]06C7UKPR7.HKZ$$'=1[ZKT;;N6VG4UN.#*T\+#P^.3VC>6&0<Z
M^8&5VFK-<YS#'=P&]MXKB*+O([2:&MO-:N8[AK3;O6MK3='LY<9;,1Z7<5J_
MD]REY@:6?HK56@]+W-GFEM-:MC@R#++:6V9)#)!$]DL=H'QN:V6N&%16A7EZ
MF<9UKTL]L9Y485_B6=)63=*'/F736GXW_B;JZ2YO;>1S3W; XW=Q'$WY)C&&
M*@;A78O6LF+K(GJ:\Q-:3D[1? ,YD2VT&O>6=Q<W,L.9N@EM(Y[J640"V9;-
M)A;)*[N@Z-Q^**8K%J3%>>F,)B9F.6,F2:6"-TC0[8XMK3]"XCTJ)NB[@O6N
M 0304Q[%AU8QB PKLP.ZOU5BK%<2G0#;2E3NQHICL)F4&KCVGW%&,R3A@ ;J
M5)2*\#+-)%#LIZ:J,\DTH$=NWL[?J*:4[49]H?**.&T_![R36N*8Z@@8X^;#
M;VI&2)B"FPJ)B:)BE<$4'#MQ[*>53A3K1P*&@\M4I,8G"D)V>LT[-_GPWJ<L
MLB<<08X4Q/E]*B,>TRPE.)IC4[QL_.28KVIK3!&(;2N!V>ZF-.I&'PI%3B!Z
MPVG#?Y-FQ36N2,L\U+Q\C=TQ'LESC_N$B1F=3@3DE3V[58&/X4ZIV?K_ &*E
MF:]V5'/8-#V*U<5<$@$ N]SX"IBN:,$*JT3!LV8CM2>HC#L5"K78[OJA3[,F
M:*U=6GHKY$XXHCJS2 ",!4GT44]YAGP!M]4XC9AM[=O8HIF5Z$5& I6E=^VJ
MFM,\B<9P2W#$X5V.VT]&]1C&)$1*FAK3?V)2:E0GL%/?2<RN"H5/"!A2N.U3
M&*%)-3LP[%$TJG'BDB@VX=OYR3%,LD\,<T*.M&$X))K2NW?Y?K44S/I(QS&F
MA;78*T]*50_/SXC\6M68[,@S>N!P_@VY5-*R?$BJD3CZ7GF=1#^'G_S;<X>J
M,_O2:XTX<RO#45VD;J+W-O;RVQ=G+6NKE+C*#.=9V=G[?DU]S-&63>JTY"-6
M^QMIZIX8<M(@ %!L"W+KXMZ)FBL<V4-<:AUXUK7RYESHNHACP<&O8R*BM*U!
MVE>=J:ELS&$-O.(B'*.A>1'4)SF[]^BN7VM-:27DD+,LMM1S9[%(Z0N8VIDS
M6&5S:.D"V+]2VD81EU,TS7*,60#X;GA%ZBTIJC(N=G5!E,5GJS*.&YRKEQ=,
MCNK6-]+6:"62XDM!$3 YI(&VH]S0U=6D8>DRG"C(V< &LBC:V*.VCBMX(V@<
M$,,36Q,B8T4: QC0,*;%BNI$5C)'<ZL?&,]7I-S5H-0(]E,/B76[8GY?P_)"
M(XTRHQ4.@C_KH\B*^K7.+NM/W[:[:;5Z&ME'9\C5TIGGGM>@-(1Q6HIB;"SQ
MK_M(W;EX]ULS'1&+<K3L;<X85KY=E5BT\9GIJMJ3ET*"#44%.PUV=OGJO0MR
M5CBK=4G'W/0M2<^I7,?Q.( .!(X<-_P[53PZ8U6YN%,53W0L[ZZN9!!'EMM-
M=YP"0&OAMXG3-<34 !K&$E9M.:5CI88F(K3-A->++U10\_.HO/<OR?,#?Z$T
MA.,JTQP2<<;<Q8^[LKSNV-FE:QTUT*8 ;5NZ=M+:3G0F(RC*7<-X'O2XSEQR
MGS#GEJG3\MGJ_7;8Y+=EQQB0PVWL9@D:)(6. ?&*[2O.K69G%FRBDN^!\DLD
MAO6D07)P="14!IJ!7=L4^M./!%(R4U=MV<53VX[3[Y4XQ%41C-$$8#>?@5<*
M)FH&DUINW=M5,14QCL".W!P]-:^\*!3AEQ5QS#O&RFQNW;MQ2>LB*Y(V5QV;
M!VJM(F*\4UF)IP2=F&(&T]M?(K4Z"L\05(H=@]ZOOIC.>1'0D &E#1V.XG\[
M8D1$]J,@G&H-7'?2E/1LV*<NTS'$@EN[\Q43T1DGKE!!K0"GDK]512LF5)16
MF.](K$DS6.M)(X:'$_!C[]5.%">O-):!0GRX?GI2F,DTG#@HPILQ[5'>A(IO
MQINV5KY?(D4SE.,X0G 4QJ-^[S*:17 QI1J,XFO?1V%!04&&!/I4TSB"O%;Q
M8&G/&<[!OW_8JF',O29B>E<*[XSAPXDX"NRGPU5J8J5PQ4&@V&OE_.59C%/"
M%6QM/T7O4/OJV4(XT0:D TQ-<>WZR3TG44JT&GIKY>Q1PJ1C@ =HJ7;,>S:D
M9''%)'"/6VGWJ?#53ARG'%+:BI.P[_-Y-J1AF3BIXL<, -@\^U*XX(,7'M*B
M*S*TT*FM:X]M$K-:HPRE+JFM1LIAV5^&JF:S/8C"@0"2:X;W4]S!*5GJ3A3K
M03NK4;MWG43T<$UXRC>:&OEHDTC#@1656 %*X.W^;R*V6'!&'PH! VBO9C3S
MJL4,0UKZV/:/1AL2E,#-K!QPKZPX7@NV4J,,%@V]L6ZE9R7NBD,(WQ=J#K;Y
M@;AQ6=3^A!%W5V.VB]W98T:FO%9HZVK',]26CY&9)F>N)[5@]9^E8]0PQBHV
M/&3$-=P^5;UUW+.455T8]#5@U'KZ..;ANN<]RR0UX7.UXRA'825@U-2W#"/B
M;E9G%]EI31/.3FM)'9Y%D7,C4\K7-8,JSL:J$<3W.:(P7YBR1LH>YXW856&=
M2V(]F/B31VZ]$?@]\Y^8FJLLUQU#Y!_-QHBTFM<SL+9\C;U^:,M9;:XCBEMW
M6M8!*6.;ZU 2M>^^9RIS=%3+/@RR=,Z7R31VE\AT9HRVM\NR#*;2"T$=O"R"
M)T=M#%"7MC8UC6.D$/$: 5)6M%LSZ]V2*QCTN).JXV_Y/O,HVGWF'(;X22XD
M$_-]X#7MQ6#CAT_*1Z:O/@SFGXTV9 P/,[+=^W_*Z+W%T-_LQV?(QY3B]&GE
M@US^5W+7AV#1VG,,,/X"L-^]>%KQ%LQ"G&9?52T#Z 4(.)J3C7R^5:ELS.++
M9Q5XU];!IH';-AH*X=BW+,IKT)[E09'(\E[S);6F%J1ZA>^3 @G::$KR]"W]
M;CTRR:E8X8S#K]\17K/L^CODSFN>Y/! [F;F=K):Z:M72QND[RXCN8Q="(S1
M&7V9S6OI0[%[FVLYHMMU)K9T->G+E&+#S9>]1G7/SKR[(\QEO>9G-W568R2V
M-]%;3V]J+*>YXWF>=@N(;099;W?V1''PK>OOMTXC#"C%I3C/&KN'R3Z/9KW,
M<@MLWSWJ)^8\X=:1W&89%'D,<[([A\+)/973BRQ,4KBRHK4A:4ZD73%L9RRT
MK&&;K,ZI.B[GOT(ZWRK.<\DF?DT]WWNBN9%O"Z875Q9/=.Y\]K%!'[&8C UX
M#R*@]BO==%:1G"*.\;PFO$HU/SMDEY*\^\TCS;562Q6UII_5<CFVS]51!EG%
M'&RQ-TXQ>PQFAHW%8=7A$9K1,5=_)^2E!800]O$#M]5PXF>\5CU,*="TY-(D
M\?$[?4_FIYUBB*231&))!-!A78?,DUQ(QPX'#LH:UKNIL43GAFF*TQR *C9B
M=AKMH<?-132*=:*].2/6::;/<*BLPBA@ 1VTKY*?#536D4XIF,0-)KCL41%2
M<\4 X@G$)&9CQ":GM48R5A422!7RX_G*TUF",)4X4["/?^M1,)CK04P!IMV%
M128,%1KZV-1A4TI[RG'@G#BH*K!/QJZ@^8;&]M?*K5CX$<%)INP\GYZC.<$\
M%9H&T/QA]?W-BF<J3F999(X:NBJ<!Q5%-J4Q@K3!;WS6H-;:3H:CVC;_ +J-
MRRW3ZTU6E<3*X=W;G[+V>"HQ_L3/0LDQ@I;$Q..30!H:C:M6N-4Q$ (&ZOO)
MQQ3U1FCS*$=BK&A[-_U%,5F)3,90#UJ]OP_44XSVHP"2=NQ1,S.>:>S) )!P
M4(B9R5 [2=],.VGEW45HZSL!4$BF.['9]=(PPXHZ^!O+AA2GEVX)UPF<\44K
M2FTUP\WE44KVG ;6N&U,8R,\9-@[ ??HE9B$TC@'"H(QW>1(I1$UJ5!VXD^B
MGUU/>=2!2APKZ=BC"G6@59RE:9PQ5FM0:THYM6T&\BF*U=".;5B%)RGL8OWT
M@5U-9<CP,21F],=Y%[0>ZO>V]O)$8U:,Y,>F"ZS6U>[YEBU'%FC?O_XL29J+
MH"E07.R@B8X=JW9Z96B);N+4?,#Y2UBO><S72_?'._'SU2.QQ=N\FU:E]]LT
M]6&UCP?L:>LN:.M\QCT[DC>;.I+USPR3+<R9K1EM*7.#1&Y]VU\(;ZV\;UGO
MUK;HKRQ%(ZF::32KL+Z8_"GZGN?>L<N9J_1=QRXY<"YM+BZS*YE?*ZZ@9+;R
MRB1DMH7!TC'$8[UIWWV1'-*U&8/T_<B]%=.7+;(^6^@[6VBCL[2*&\N(8(HG
MW$[((8Y9)7LBB=(7/B.T;UIW\T3CDI=CCP<HYV\V^GM1-D F+LKOQZNQGX'-
M6E,%@U*UCM3;CD\_KK) '5!S@X1@;^8]E/PB\^NO:NOYHBG0PSU,O#P@0?\
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M8QV)(H:%1283-/24)I04!V"O9M5J8UA6O#@.-<?='9]>J32M>)W)-7.(&/\
M043,5JG')3[RA-:=H=@H=E<*;/KU4\$<:PK KP [/65NB$()P&%!C3&JK.,=
M2T4B7#W.TD:?R7]\LQ_W59IC*N)&<N<-&"FF<H_>D)_[&U8;O:E9]0J@@("
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M-)66:_.>N.9&8,NI1.VZNX;N>!AN8)_:1<B=[11QX.)6OI;%9&:WR+Y'<O\
MITY?Y#R^Y:9)9Y-E&46T<,38H877.87(BA9?3W-TV&*5_>RPES0\X5P6"Z8O
MG#"3"G+.,.8RZX)=,R(0V@'K8U=5P(<>'XVTI$Q%U)]EDBD81[2&T@:X1N[Z
MWN #([L(QQ.[%8;HIC&-3#*>#3'#A78:X8X=GG58HC%-/5Q_J?=Q4SDFF* 1
M4D8;*#;YTKQ@CH3PUK3&E*>7M41%2<"@%*BIQXA7W%,T@QH'$@;!C3R?F*5K
MU03&/2.J/C#$[#793;L2>M%>A'JD#M[,<<>U1A3K3G/4.K4@FOHVI,34KA0
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MC&VDK&,;#"X@FT8&MBG -0UC6@,A#<-@%5:V>?JF$>SVI#>.6W=/&+.V>UX
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MFG%/#J,0[ 4/96N[M3&IP4@TQWJ*S$G7*0YPH!]1(F2@:UQV]B36N)F!P!)
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MM140,2-F\=GUZJTQ6*PB*1A* XC ;1L/9VJ*X8G8BI]S9Y*I6:&0:$##'?\
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M(0V-BW.S$^M1(Y[;XG#?ZRSZ%W-?3BIC3'I6S^"!W\G4AJ"4QAT7%;\0) (
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MKY/D'T4QG4GHZ' ?),#V[5A!I2[=CC_9^Q8[,ZKW4<_8NV[=P[>W%9,U,N&
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M:_@D6.S[!OPK%=FL^H4 @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MI*(C.$@-(<T5+<*OWUK48%89PQ7SPC,H:$]FU;$5SACGKS3B1AL'U4QF">I
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MN6]Y'I;/LP==7#;*&)@@,DYGEDPCM.[:.*4;5MQ-+9NOPB%+*3=,6XNM;-_
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M^^5.2,P&E016OHV)$\$3!7"@&W;]11C2B9QR12F*@ZX3B[SGW_K45L\\T<
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M4)V#;L%>S:DP@))VJ)K.:<L(*$5KNI[ZBDIKQ,2.&E>S=Y2K8SAQ1EV!.ZE
M$FL]A@8$T&/8=GO)3H*US5.!Q)&WR[*?#5)Z41T* "<!O44F1)WCBP&S#;7:
MF>:<IPR*X_H0?3L_/4]7!&6(0*"F.VIQ]"B:<$TE24B))Z58WM&-:8[-F*GJ
MA$=>2*NQ/FKL]&"5G,2:#"F/979Z=]4FD=J8G"B0: FE*4J.VNSS42,JH*.:
M^*IH*NK6E#Z4C"8A,TI*WGFHT_CKI4[O:/<^4!H?.J73',O$^K"XF0.[NWJP
MAQMX"!M('=,W>4+)=,?"I2<^#0!%:G'TT]]5PXY&->M504)&/O</UZJ:8=:)
M^(QHVHJ,:!,>.2>S-&!J2:=@[5&.1A.,I-:4(V;?)7RI-<C@D?%I3XVP]M#7
M9Y%.-*4.XQKP_%'9M\NW;M29X3A!$37 WUX<!M%4Z^!]9&%/*/?^M11A3K,0
MAII]CMKM/F4S2J*85"*4-:@UW443'1DF)QQ*# 5V;Z'S[%.' I.7$K@23B:5
M%-M-F*5]**>A.TD\-0-WG3C6F"94XX#L4=N1C"<<2W"GU?.IXU@X4J"FROJG
M::=GDV[5$S/ B(SE)!.S$#9Z??2:_ 44CLI7L\G:G>=N0*X@;_J*8KDA(:*5
M.'9O\^Q1$2G Q;3MW_4\B>SVF,@ (I3'X?J"@4Y]J$[1LHW<=M.W#::E,\\@
MIP^0[CMKV^:B9=J<*]2,:##;LWJ)B<Y*]" !0^A,/A**G5- 0:BN-/K),R8*
M<?.HHF9]"HC"H;PT\M?)O5IQ[%8^-%-N.&%,-O;[BC#@F*R8#=6NP_#@II@5
M#N:10BOOI-:4(S =A H1M/:F7:1C*?6. %.+8-M:? G9E)7THQI4[_J*M)S3
M'65Q!.)WC9YL5;#BKC"KAV#BP=7=V)U1E*>U20<<-GE[5%)A,S7#BDM)\^_R
M=GD."FD_"C!2:#9B.W8JXIPB.HH=O;L\JFDT1G*=P%>W"FSZ]4Q/E-M23CAN
MVIUSF1DJ%2"2*UIAVT^"BFG&4]4**>@[A11@C'@FI)KO/OJ*2FJ2:C9CVU^I
MYE.<8YE)X((%*\53YE-(X*XYR .VC:/-O\ZB*UP3,88H(IAL[?J)C$XYF%,$
MU!-3CVC9Y IKTH[$';08^A13HR3,RK+'<+,.WL4YP3%'#W/"HR#),*GVEH--
MI^5W@;%2[@6XS,.;]&4_%G*:?WI%]HTHN^H0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!M[O\ <MS^]YOVMR"U3E ^
M".]U>R9\,3YK^HXYF,)X;DU%7.!I@HC.2?B<[OO;&:XD+O8W,8UM&B\A;3A%
M*_?,>U7PZ,%)G#":2T3F%D"?P^T !P;W\'N5X]R5FN:>7 -_8D/_ (2M:GAX
M1WT-!V_9[TF9IU$1TJO;[ <-,PM-]1W\.'9]FE<<,BF%>*GV^RW9C:8[3WT'
MHPXT^$IU)-_9&E,QM!3_ &Z#']6IKUHI/0I-]8[LQM139\M#AV_9J,*UKDG'
MH5.OK$M &96H)V_+0^C[-)QSG B*8QFGV^P+37,+2NX=_#C^K29(A#;^QH <
MQM6[:TFA^[41,Q&$XIICBD7]A4?PC:AHK^O0X]GV:M6F$2BDSF#,;('#,+3?
MCW\/W:BM<*E)A3\X61Q.86@.[Y>'#M^SQJF>,SB4E)S"SP/SA:"M?U^ _P"S
M4S6>PB$.O[,GB^<;2N_Y:"AW#:_<JTI&$IQF<82;^S(QS*TJ?LN^A[>SC*ME
M&>"N,R>WV5:_.-I3L[Z#[M*]92>@;F%FTM/SE:X5K\M!C7M]?<DS$\4XPI]N
MLB17,;4TK^OP^M7M]?<HPF<3'@DYC9BG#F-H#^S0?=I,D11/MU@<3F5KC]AW
MT--O;QI6N$Y%)I7B@7]D *9E:<0V.[Z'?Y.,;E.$YR16$&^LR*?.-IY3WT';
M^G436F!&>.;5]NRX?]\;6@^*>_A]/V236(*5F5 OLO:#3,;5Q&PF>$5KMKZ^
M%%%:8\4TF>Q)O[# _.%H3C7Y>'U?U>-5-<<T4PZT',;,EH^<;2@K7Y:'?_5I
MQS*32@W,+)FS,;1U-E9H=_\ 5^5,*9F-:H]OLW$4S"T&VOR\'H^S4UKQ*4S3
M\X65?\86E/V>'#]7C5*XYHI@',;,\/X?:4;6GR\&-?ZO<JUQK"U)I23VZRHW
MAS.UXL:_+0_=C<K8S-)E&6*H9C9&@?F5H:;^^A^[*C+*3&1V86)=7YRM#Y>^
MAQ_5[DCM*35#LPLL0,RM<:5/?0U/ZL)'#%,UX!O[ 4KF-H7"M?EH</U:93C*
M*88(&86?"0<SM?(.^A[<:^NG&M4\*2@7]B"3\XVF-,._API_5J:Q7-6DTHEN
M860<#\X6C:UK\O"=@P^S59GBF(X2D7]APD.S&U)W?+0XX_IU->O IQXJ1?V)
M<"[,+5M*_K\)KA^GW**SGQ33"G!4W,+%N(S*TQW=]#1OZO>IZJX(QSXJ#?V6
M[,;0?HCWT/HPXU->LQS5?.%EPC^$;0<-:,[^'&O:>/<JQ-,DTKFGYQLJ$#,;
M05_VZ#[M3-.E$5A)O;"@'SG:XUJ[OH:X'LXU-9SDI%5)O['_ ,(6E=Q[^'[M
M,.E%)^! S"RICF-I7]F@P_5J(G#&<4TQRP2Z^L-C<QM138>_A]/V:1,%)!?V
M0P.8VA/;W\/W:FM.**3.(V^L W',;4D;/EH<:[?LU&'2FDY\0YA9.H3F-H#^
MSP_=]BB,HK.)-:]0<PLCP@YC:\(.($T.(J*CXZGLG$QZ&K+>V%&-@DM&?HOP
MR$U--M>,[5$S!;6N.339>V-7.FS"TC.UK?:(2,!L^/\ 9%*UG$I-*0X&R^2-
MO.^:^E? +4M+6R&9G":MH'5XN'WU6W"[%,Q-,\7/@O+.W$@&8VCXG$D SPU'
M$ZN]^%*T5U9K$UG-I>WV7$3\XVG#N'?0_=[E->LI-.L%_9- 'SA:&G^WP]OZ
M=16D82FDS.*HW]C7#,;0C]FAQ_5[DB>F28Z$?.%C4?PA:;\>_AP_5J:XYHI-
M$"_L@6GYRM:MK^O0XU[?7W*)I/%,5A#KZRH.',K4D;^^AQK_ %8V)7"O$ICU
M*CF%D6AHS&T &SY:'#&OZ-3A&4GK3F?.-EA^'VGE^7AP_5IS(Y3YPLO_  A:
M?VZ'[M*]9207]B0[^$[6II3Y:'#M^S2M.*:5Q0,PLP37,;0C"GRT/I^S45ZR
MG0GYQM*$?.5H>*E7=]"*4_J]Z85PDQ!?V V9C:FOV/?0^KZ>/>E>' F/2@7U
MB: YE:T%:GOH<>S[/<ETUBE2*Q-4_.%EM.8VA.\]]#CV?9G<IPC*2:RCVZPI
M_C"T\_?P_=JM(IGB>L&_LB<,QM!7:>_AW;/LU-<<)(B>*LYC8C!N8VE/V:''
M]6$SQF<2DQ%(4LS"RP#LPM-]3W\.'9]F4YI^$Y4>WV0+?X1M#2N/?P;_ .K2
M<XQ*9JO;[#A(&8VK3NI-#VX_9J:TRG I.<YGSC9;#F-I0;/EH?NU&&=3&<%#
MKZRXB6YE:T.WY:'"@_3I$\2F"OYQLZ$#,+0 TQ[Z U_5I6O$B)A'MMB!_C*U
M/%N[Z'"G]7O2F%*X'&L9I&86(:?X0M*C8._A[>WC3FDIBI=F%DYQ)S&T';2>
M#'##[/"B=,5*REM_8AP(S*U;2M?EH37#"OKIA$)BO%/M]EB1?VAV5^7A^[4]
M<*TFM)1\X6/JCYPM*-K3Y>'?M^S44BM8E/K3%$_.%C_X0M/[?#]VIKUJTE3\
MX66!^<;0TKAWT K7^KW)6G%-$C,+(8',+0TW]_#C^KW)7K*2?.-F"*9C:#;7
MY:'[M1..%<$Q%,0YA9<7^,K1PPQ[Z'']7N2)GC."9CHS3\XV9+B<RM,:4'?0
MXX?I]RBN/44PZU(O[,M_QC: [SWT';^G5HFL55F,0W]EC3,;7&GZ_!ZM.SU\
M:I4I*?G"Q.W,+3^WP_=IA/$I*1?63>+BS*U)PH.^@^[29FN92L)^<+$T!S*T
MH:_KT/JT_J\:JM>A:F&*D7]B!49C:@G['OH3PT_J\:J8G"G!%./%5[?9'UCF
M5I5N[OH<:[/L]RF*Q&$X$XYYJ?G"S(QS&T)[>^A^[2L91)29FLPJ^<K*G#\X
M6E/V:#MK^C3"M:XHQI12,PLL2<PM,=W?PX?J]Z<U>)24#,+(8',;0^7OX,/U
M>*5QS*)]OL1B,RM?TO?0X>GCWJ*]>"9CTCLPLB>+YQM =_RT..X?9[DPC*3&
M<T"^LQ3^$K4@;:SP8U_JU,81G@B>S%/M]C4'YPM,/]OAW_U:CC6I20W]B=N8
M6A&\=_#CY*\>"F9ZR(F.UK-OLL +1[*TG#C]MA.RN/WQ5K$<#ENK69P: O;!
M[Q3,+6,#$?+PNKO/V94X3.&"8K'!P-S2N(;G5VE9(C#<,M[CBDE9+'PM]?:2
M'$4]*S3-4PY_=>63C;SNS"T?Q6\(,(GAJWAB:-G>;E:*1QP1#2]OLJN_A&TQ
M. [Z' =GQU@F>M%)Z YC9X4S&T'8>^AP_5XU48=.:<?0>WV="?G"T/\ N\ _
MV:GA6)JBE9!F-D#7YPM*C8>_AW[<.-1A.$RG&,E)OK(BGSE:UWGOH<>S[/<I
MPZ3UJU5?.%B-F86F&[OX<?3QI6F4HI,YI-_88'YQM">SOH</U>-5%<:S*:88
M S&TJ*9A:#;4=_!Z/L]R>UVE*(]NL<1\Y6N[U^^AJ?1Q^A*S\*:>@]OLJU^<
M;2G9WT/W:FO6K2>A+<PL6TIF%IA_M\/W:C"E*X)QK4&96=:G,+2O;W\)_P!F
MD8Q29)K6L S&R'%_"-I1U,.^API_5[U-8Z3&E% OK(-I\XV@<=I[Z#M_3TV*
M(I$9DUJJ]OL:U^<+3R?+PX=OV:G#.J*3D>W6.[,;1Q-/5[^$4IY>/>F>":4Q
M5OS"P()&96A=A^O0C?\ INQ5K,8)ICB@YC8UH,QM"-WRT/I^S4QTUQ1-<D"_
MR^G^,+2HV#OX=^W[-*]$X%)XH^<+*H_A"TIC7Y>'T?9J:XQBBF"GVZS&!S"T
MP^Q[^#?Y>-1E%)E.<UA7\XV9H#F%I1M?UZ'&O]7A1(SS)B:(^<++_P (6G]N
MA^[4UZT4E(OLO%*9C:C;Q?+0GS?9JO8MVAS"QK7YQM'4V$S0CWN-3%*8SBB:
MU#?V0Q^<K5]>V:$4IA^C2)FA,5E2Z^L2"/G"T!-,>_AW?U:F:<91%<X5,S"T
M#3_"-IQ;AWT&./;Q]BKC/:MA"!F%D&NIF5IQ&GZ]#CC^GH*!3/3&9'7D&_L:
M4&8V@\O?P_=J:QPE6DYGSA9?^$+3^W0_=I7K*2?.%D/^^%H?]W@'^S3FIUG+
M\"?;[  4S"T\H[^'#]6HK3"N"9B<^*D7]B-N86A/;W\/W:G"M:XH];X$.O[/
M$C,;3R?+P^KV_9BM5$RF(E)O[(T_A&U;YIX#_LU-44F%1S"PPIF-I7&H[Z'T
M?9J*XYIIAUI^<+$@M.8V@!V_+0G9_5I=CQQ+:PI]OLA@<QM">WOX?NU->M%*
MY(]NL:M/SC:>K7]?AQK_ %>Y1%.E.*3F-F:DYA:5PP[^#S;>-(FD$Q,C;^P/
MQ\QM/[?#A[C]ZCACFFG0D7]AL.86@'[/#]VIF:1A**3,XH]OLB33,+05ICW\
M./ZM,^)2F>2?;LOXJ_.=J!^S0GBP_3[DK-.LITY(&86. .8VN_UN^AKV[.-)
MF>$D1CB@7]E4DYE:.)I^O0C9_5E(I&4DUD9?6(!)S&UJ:4'?PT'ZM1&'%,Q4
M;?6/$>+,;3=0]]#AAC]FD_&4]"KYPL@:C,;0?[M#]VIG'BB,. [,++$-S*UH
M:?KT/W83KF<4XQA"#F%F>$?.-I@<#WT V[OC[U&$36IC2G!J.NH"0!-9T W7
MEOO&W[YO4Y8(PSXM)U]9\7K7]H!C5G?PGAP[>.I29B<>!2:.)><T\5QD>5PB
M>WN2R9IX8YXJM'>']"YU<%2Z:IB'(&E+ZQ&F\K[NZM[6:.)K2U\\536-@.#G
M#!6BG*BZ/6?OB\L'<1&8VA+:4^7@Q+MOV?:IC*O%$U&75C6GSA:#]'\O">'
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M3OY6YA[CQ\#DIP =/3AB-6YA7^K^[41;TIJ?D\N_E;F'ZO[M60?D]._E;?\
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M::Y99YJZRAOH+N>TMAPL ;<2!HK3&@.X&OH2*T)<B6_3W,P-<_5M\33%H$A
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M:X9,,Y]:[F#[Q#^Q1_:!69FJ@(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(""V7GJ";[):$M^4PIO]8[?2JW8
M01/0YMT-7\5LIXMOL[?S>XIC(E]:I! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0<+\[333!/8_ =I(<-NY1
M.26XY+U&E8@>T'W@EN2',"D$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!\=KZOXJ9O0T_!W? 4E,9N%.0CO
MELW:,/E#48_HFJMJ%SBL" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @TI_O$W[%)]H4%HW+H@\UKL[3WEY0G
M:,<:5V*(R%WRD$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M]P)&"',2D$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$!!\;K_ /BGF_[W=\!0S<*\A&GO\Y)QI)@=FUPK@%6V
MI.:YQ6! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0:4_WB;]BD^T*"T7ER*<U;L';WEY3^N/HV*(%WZD$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 06>Z_'_2G$?\ A-MC_N@6;H[$6TIUU7>P?>(?V*/[0+"EJH" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @M<Y[4]ORNO]D9]NY9[%)S<[:&_BOE.[\';\ 6*[VEWUJJ" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@XJYNDC3$U/T0^!RB8J-SRH _%&RH=[\.SXJFD1$=*,:]3DQ$B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @V]Y^Y+K]
M[S_M;D1.2T#DJ/\ +/,R-OMMZ*_[L5MZL>K'8U]*M)F.F%XZU&R(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @M Y@?YU+;]\6_VP5;LF&<97=0?>(?V*/[0*S,U4! 0$! 0$! 0$! 0$!
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M$:J @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(+7>>IIF&4G_;6?;N6:S)2<\<G.^B/XL95O_!V_ %BNS7A]
M6H! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M93^P!3&29S?7*4" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @X6YW?Q7=V\6'N.42F*\&KR5I^*[!2A#L<:U
MP"1D<',BE @(" @(" @(" @(" @(" @(-+N_Z;WOSU?F5Y6JJ+" E00$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$'QNOOXIYO^]W? 43%.+A3D*/
MPG.*"@#\?26JMJ%SJL" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @TI_O$W[%)]H4D6B\N*'FI=D"E)+S?\
MTQ41D<5WZD$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 06>Z^J>:<513\)ML*UJ.\"S4R[$QDN]@^\0_L4?
MV@6%#50$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$!!:[SU_QCE/:)&T_KS59K,84G/J<[:'/%I?*C_P=OP!8
M[L+J+0^L54B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @XJYN@G3$U/T0^!RB9H-SRGI^*%C3;5]=O:%.%(H
MC&O4Y,1(@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(-O>?N2Z_>\_P"UN1$Y+0>2O\<LSP_NV]P_W8K;UO9CL:VCE/;"
M\9:C:$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 06@<P/\ .I;?OBW^V"K=DPW>TNZ@^\0_L4?V@5F9JH"
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MX[7W\5,W_>[O@*B5K<W"G(0$39O4_KA]6G],-ZBWBK*YQ6! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0:4_
MWB;]BD^T*"T3ER2>:UU7^R7OPE1'0+P%((" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @L^U_3^=*+#$7%MC
M7_; L_".PLQBJ[R#[Q#^Q1_:!8!JH" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @M=YZDB_RH_[:RG]>Y9K,
ME9XN=M$?Q8RK][M^ +%.:SZQ0" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @XLYM?Q9F\X_V25B@UN4XII*R
M![7_ .Q1#DU$B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @V]Y^Y+K][S_M;D1.2T#DK_'/,S2OX;>[Z4^7/NK;ULHQX
M?.U]&<YC->.M1LB @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(+0.8'^=2V_?%O]L%6YAN]I=U!]XA_8H_M
MK,S50$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$!!;)SV -[DM<?7\U!Q'W<56X<VZ$_BME-,/D!AZ5,9)G-]
M<I0(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @("#A?G:*Z8(I6KOJ.5;LDQE+<<EQ32L0VX_4"F,L4.8%((" @
M(" @(" @(" @(" @("#:MFXG&,8/!H<-M=F--RRS92.;@PQJ5GD_+<":LZF>
M4&BM29QI/5FHAEN<9&+=UU"Z![P6W+26%CF'$X+);H:DQ%^G&$L<ZUD8:N<=
MCYS\L/I].S6=?^U)OKK-&SW4_D]_S,$[S;1A6?3'SJ/RP.G[^67_ ')+]=9?
MN.\_-_EZ&+[[M^%W=\ZO\L/I^_EE_P!R2_75/N6ZZ(^/YE_ONUZ9],?.?EA]
M/W\L_P#N.;ZZC[ENOS>_YC[]M.F?3'SGY8?3]_+(_P#$Y?KI]RW71W_,G[[M
M>F:=L?.?EA]/W\LO^Y)?KI]RW71W_,C[[M>GXX^<_+#Z?OY98?O.7ZZ?<MUT
M=_S'WW:].';'SGY8?3]_++_N27ZZG[CNNB/C^8^^[7IGTQ\Y^6'T_?RR_P"Y
M)?KJ/N6Z_-[_ )C[[M>GXX^=(ZP^G\'^.7_<DOUT^Y;KH[_F3&]VT3G\<?.?
MEA]/^)_'+S_@DOUT^Y;K\WO^8G>[7C/QQ\Z/RP^G[^67_<DOUT^Y;KHCX_F1
M]]VO"?CCYP]873^/_7*A_>DOUT^Y;K\WO^8^^[6F$_''SI_+#Z?B0/QRQ<0T
M5M)1BXT V[RGW+=1%:=_S)C>[69I$SZ8^=<#I?5&4:QR.QU'D%R;G*;UKGV\
MG#P]ZVHH:5-,"M&D\U)S>A6(MJ^E'92@W>7T;E5/<E$B @(" @(" @(" @("
M @(" @^-U_\ Q3S?"OX.[#9N*)C-PKR"/RN<CLD^%P5;>*)SA<XK @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(-*?[Q-^Q2?:%!:+RYQYJW9.WO+S[8J(P)S7?J00$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!9]KZIYI
M15;3\)ML:UK\H%GIA'86S7#@N\@^\0_L4?V@6 :J @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(+7.>W[ORK
M]D9]NY9[,E)C'')SOH<$:7RJNWV=OP!8KLUXQ?6*H(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("#BOFW7\69
MJ&F(W5W.43-!N.5&&D;(;P7X]M>'<IC+K1Q<F(D0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$&WO/W)=?O>?]J<A.2T#
MDJ1^.695WWM[^WD+;UHFD=C6TJ8UZ87CK4;(@(" @(" @(" @(" @(" @("
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M>7N-?Z8[E$5^ 7?JP(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @L\U\*<TXZFOX3;;J?K@6;"D=B+8A=]!
M]XA_8H_M L*6J@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(""UWGK_C#*L:'O&4\_$Y9K,NI2<W.NAZ_BOE5
M=OL[?@"QW4YL,EWUJJ" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @XKYM@'3$U>T? Y1.0U^4Y)TC95[7_44
MQDCBY-1(@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(-O>?N2Z_>\_P"U.0G):#R4 _'+,QN]MO:>3Y<K;UJTCL:VC2:_
M O&6HV1 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$%H',"O\ZEKV>T6^']7MJJW,,]"[J#[Q#^Q1_:!69FJ
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(""V3GM^[<GI_9!7RCB/N8*+B'-VAJ?BOE5-GL[?@"1D/K5(("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @("#A;G=7\5W$;G?4<B6XY+$G2L5>T>G *MJ',*L" @(" @(" @(" @(
M" @(" @I=L*6SZTPIJ>RZ,NJ\TZ@-<]ICRW[1Z[KR7["WL^9P_G/VM_;/RN
M-U *X#BQINP72\'(3FC"A!.VBU+L&]IXU,*[<.VGU%><8Q8C##'SX;.SSU48
MTZ@H,<>RF&WZU%-)# 5W]AV>\@ 8$]E/?2N-1)Q).VE,=GO)'Q@=]1CAC_03
M+L%*12M1-#2O;L3KX@IZPK@!V*HHFVL_9(_MFI=/JSV2K3&.V.]WJ=,_^9K1
MO[V?]1?-=[^\7_RXOJFQ_=[.SY(<_+2CK;XI$%8=7@F$K+&2!2" @(" @("
M@(" @(" @^-U_P#Q3S?][N^ H9.$^0@'M&;ENP/-?2X=JK;3X25SRL" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @TI_O$W[%)]H4%HO+D4YK70[)+WWRHC(7?J00$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!9]K_ !YI
M18[+FVPI_M@WK-PCIHBRLQ7K7>0?>(?V*/[0+"EJH" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @M<Y[?XPR
MFNPR-J?ZLK-96F"O%SMH;^*^4[OP=OP!8[O:6?6JH(" @(" @(" @(" @("
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M=U!]XA_8H_M K,S50$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$!!;)SV!]LR<[N\ /EQ./H"B[*")BKFW0H
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MG9\D.?EHQDWQ2*2L&MP3"I9HR0*00$! 0$! 0$! 0$! 0$'QVOOXIYO^]W?
M43&#A3D* )\XHW[/;79ZPW;ZJMJ)7.*P(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("#2G^\3?L4GVA06B\N2
M#S5NC3;)>[]E"HC(7?J00$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M +%3&1Q<F(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M^M500$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$'%?-ROXL3"E1Q#"M-SDF:%&ORG-=(V1/:__8I&1Q<FH" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
MV]Y^Y+K][S_M;D1.2T#DH::TS3#$WEYZ?ES[E%M:T81V-?1G/I7CK5;(@("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MFYRB<ANN5'\4K)VXE^/]:II-,485ZW):)$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!M[S]R77[WG_:G(3DM Y*4.LL
MR/\ PV]_;RMS6K2(ZFMH81->I>.M-LB @(" @(" @(" @(" @(" @(" @("
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M! 0$!!:[SV'\(92 =LK*^3UCV[5GLRJI.;G;1&&F,JQK^#MQI3<%ANS7?6*
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$'%?-P<6F)AL]8? Y!N>5%?Q2LB13%^^OZ%*8=2*XT<EHD0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$&WO
M/W)=?O>?]K<B)R6@\E<-99E^_;W#_=RMO6]F.QKZ-8B5XRU&R(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@L_U_P#YU+;]\V_VZK=$9\6"M97=P?>(?V*/[0*S.U4! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 06Q\]\;
MS)MW"_;MKB2HNPH1FYNT+_%;*?WN%*9S?7(@0$! 0$! 0$! 0$! 0$! 0$!
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M" @("#X[7W\4\W_>[O@*)APGR$]6XSD$XF3#RT<*JMJ)S7.JP(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("#
M2G^\3?L4GVA06C<N /YT[HUQ[R\PI_3%17&@N^4@@(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(""SS7K0.:4
M8V_A-L:[*?*!9\XCL(I,+OH/O$/[%']H%@&J@(" @(" @(" @(" @(" @("
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MS _SJ6W[XM_MPJW,,YKNH/O$/[%']H%9F:J @(" @(" @(" @(" @(" @("
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MPV?HA78JVHG-<VK @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(-*?[Q-^Q2?:%!:-RY;_P!*EV:4^4O*8U^R
M58%WRL" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M?744%7]/<+7MK4#4,;R[L(_#R0"LMVGI6SC$,-DWS'+$R[+?#J\2_/.MS/\
M4>39GRZ;HGYA9$\D7HNS)QLA=0TGEV][[RT]7DC*,6U;6E*NWML;2]\@'!*<
M":U% <#39B%ANB9B%L/A<,\\^H'E5TX:+S+F%S=U;9::TW8,#B9G1NNYG<,A
M;'9VG>-GNGO=&1ZH(!VT43;,SU(F^([70AS)^D)95E>H,UR[EGR(GUEINTF+
M++4MQGL5BS,(>\>UL[+47,3X?4:UU"3M6]]WY:73.+7F_P 3U8PA\7IKZ0YF
M4>;20ZBY 3766WUS;=Q):9[!&[*H 6LNC(9+B87#6-)=AC@L$V1,X3BRQ,1'
M3$.[+I4Z].0G5K85T#J2TAU%9P1R7^07D\%O<V\LD43I(8>.<NN#'))PX!3J
M:5UD5K6)6MF)PA>@]YC9&^5M.$N#G#UN'B-&X#:"O.W,1$QRS.:]O]*&]!J
M1L(J%LQD)4@@V]Y^Y+K][S_M;D1.2T'DIAK/-*X5O;W'M^7/N+;UJ\L=C7T<
M(FJ\9:C9$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 06@<P/\ZEM^^+?[=5NCBPS-9P7=0?>(?V*/[0*S,U
M4! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 06R<]B1>Y/3'U\?)B?=47<!S9H3^*N4[_ ,'"F$SF^O1 @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(.%^=W\5W?IMO9@[=O1,=37Y+_Q5BH:XCX HMR0YA4@@(" @(" @("
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MS%UQQ/@@92M<:;%UGF.A9J73KVTMK&,13/''MESTZ=VWNBRLW1S9TGJPZ*?
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MY2TVR(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M @(" @(" @(" @(" @(" @(.&.=H!TNZNYWU'*)R&MR6_BI%YQ\ 2,!S"I!
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M=\K @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(""S_7P(YHQ5-?PFVPI3]<&]9^$4Z$6Y882N[@^\0_L4?V@
M6!+50$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$!!:YSV%<PRDDTI*S[<K-9DI/Q.=]#_ ,5\JPI^#MPK7<%C
MNS7A]8J@@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MXZU&T(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @M!U^1_.K;5%?PBWPV?9!5GXF&[-=S!]XA_8H_M K,S5
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$!!;)SU_=N3^5XK[IP5;N YMT* -+94!L$ 5HR'UR @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(.%^=I TP2=SMG;@Y1.28:_)?^*L7G^H$A#F%2" @(" @(" @(" @(" @("
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M" @(" @(""S[7U?YT8FG'\)MC7_=1A19L)B.PMC"5WD'WB']BC^T"PC50$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M7X>Z0HNG(<VZ%PTME(/][A2/KD! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M-Q1,9N%>0CJSYR/]LP']4*JMJ)C%<XK @(" @(" @(" @(" @(" @(" @("
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MT-.?'LB<IAO50$! 0$! 0$! 0$"@Q-,3M/;3M0$! 0$"@]W;Y4  # 8#R("
M@(%!LIAV("BD I! 0$! 0$!!M[S]R77[WG_:W(B<EH/)3^.69?OV]_;BMO6R
MCL:^AQ7C+4;(@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MXI*;<W"W(2IFS@UP$G9\;UAZ115MXHG-<VK @(" @(" @(" @(" @(" @("
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M(" @(" @(" @(.%^=M?Q7=V<6/N.HHE,-?DN*:5B'E'P!(R0YA4@@(" @("
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M! 0$! 0$! 0:4_WB;]BD^T*"T;ESAS4NQ2GREYA6OV140+OE((" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@L[UX!_.E$0*#VFW\N/>A9YX5Z"WXUW\'WB']BC^T"P#50$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!:[S
MUQS#*J;>]9]N5FLR4FE>MSOH@UTQE1K7\';CZ L=V:T9/JU5(@(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(.
M*N;M/Q8FJ:>L-U=SE$Y#<<IZ?BC94%,7_P"Q4XTQ,*N34! 0$!!^;>,XVQ!]
M./B.P>7#$+#KS$6TZ5+XYIB8X+%/$BR+,<XZ.N;V5Y3')<7L^5,E#(FN<_NX
M(YI92 QKG>JQA."Y;SRSDV]E<8OOC/AFZ7R?4Y]US4RTKJ?$PM>BO/,ITWU5
M<N=19E=QBUL=3363X+GA8RYGES6WMR'OE+1$Z*4':15?H#\+]Y&W]W-SMKHB
M9OT\YF*QZO"KY+Y_L9TO,(UINF8F^9I2>EZ#N3.;=Y9D_<D&"3*LNGE8UP+7
MMDM(GQ<,@)! !&S:OF,;:-MJ:MTS,W7:DTZL9=?MMQ;=%FG;%*6Q6?@AJZI%
M--ZAK@#D&<"G8/F^XPP7A;^/7OF:XV7?5EZ.E3FMCAS1WO.AYQTBZ@L_< ,.
M9\=!3MU:_P!RJ]C\+8F-[N.V.^'O>]^/EUM?ZOY&?_TVESN4?+^1T7<N?IC)
M:QUKP_P38XU\JZGWIOB?-=2(PC!\P]V[.7:Q3IGO<Z2OG;Q1N;PQD8W(-<3L
M'!M\BY>^ZVD_FTGN==IQC'&[H8N'T@7F3E][?\I.7F67,%SF.4OS6;-[-KXW
MS,9/%<MBX^%Y?#0,KB!5>'[GZ,_QB^)F:6S2,/Z4S\KHHWT>1^6_>KK(OG6B
M9I6E(H_'^CYZ2GS347.G/8^."QR\Y.!,YI(N'O%DXLJ6T' 0=Z^M^>WV:&RB
M+L;KJ1$?!+Y!IU\[\XC>1ZEMETUC/.?YV56Z(-B8WB^]"H_IMZX6;N>_HJ[C
M3N^[Z5,\%4<HG'Z$MP[:U_H*;[?#GIJQ673JUPI1NEB91 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$&WO/W)=?O>?]K<B)R6@\E?XY9G7^_;W]O*V]
M;*.QK:,UB:Y5A>,M1M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(+0.8'^=2V_?%O]L%6YAN]I=U!]XA_8
MH_M K,S50$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M*V)GQ)KDK$>';RQC+<K&N(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@V]Y^Y+K][S_ +6Y$3DM!Y*?QSS.F^]O:G_=RMK6C")ZFOHXU^!>,M5LB @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(+0.8'^=2V_?%O]LJW,-V:[J#[Q#^Q1_:!69FJ@(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(""V3G
MKC>Y/3]&*CMQ._=@JW)C!S;H4UTME)I3\'&&WSJ8R)S?7*4" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @X7
MYVT_%@_IMGG#O@4780F&OR7:&Z6CIM)%?<"1C%4.85((" @(" @(" @(" @(
M" @(""EVPJ8S4U/9=&/5@!^4!KGM,>74_K'KN?)/L+>R/D</YS'ZV[MGY7 #
M11K<,:8#X?)L72TZ,G(<2F.&(]Q:MV;>TIPD';2H&W&GF4XY,2?(32GIVX[D
M #;44I3'L]&^JF,\!+21L%:^6FQ)@4IQ BGGWCL[$@*D4\FSTIU  3@%&0FM
M *'97=L^O5!!VX"GD4TQ$N\IQWCL[/)L4#3G^,S]DC^V:HN]FG5*.,3UQWP[
MU.F?_,SHW][/^HOF^]PW%_\ +B^I[']WL[/DAS\M&,NEOBD4G<L&MG':F%2S
M1D@4@@(" @(" @(" @(" @(/C=?_ ,4\WPK^#NPV;BB8S<*<A#\OF^%29#4]
ME'"F&PU5;42N=5@0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$&E/]XF_8I/M"@M&Y<_YU+H5J!)>[NUQ58SQ
MS%WRL" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(+/=?_YTXC_PBV_; LW".PMRKUKO8/O$/[%']H%A&J@(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(""UWGMCF&4T&/>,W[?6=[BSV>RI/M.=M#DG2^5$[?9V_ %BNSPR6
MC"'UBJD0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$'%7-PTTQ,=OK#X'*)IQ&YY3U_%&R!W%^'I"F)P1A7K<
MF(D0$! 0$%#V\0IL.X]AW'T+!JQC%%K9I-76%XBOAYZ2ZT- NN\M?;9!S=TS
M;7$NF=3QVL3I)I.[G<+*Y MI'3^T.?PASB>&JT/ FVZ-2V9\2N-,*^AZFANH
MMGP]2(\"8]6O##K88?/+IYYQ=.6M,QT3S*T-GNG,^L9G"XSJPAS">T-JQ\GL
MEY!FEK;QP1B\ABX_5>*571;+5FRR+;IF:],Y>EXVZT[;M69LB(CA2%/+;J>Y
M^<G[2_?RZYBZ@M\OS&(V<^7YAG&99E6)[>XF8TW5\>['!N&Q>G,6ST?$\V-.
M8FLU<7YMG6:YSGMQJ?,;T19_-?0YN<PX>\X[^&X%ZR0QU<"?:!4J)MC\FEO9
MAW,EO-$TNF9[9F>]>%G'B/\ 6QG.BXM(WO.6;\7([./+697961LIF6-O;BUC
M8R:"Z9(PB!M*@#8JW:<73C-9Z\6Q;9R1AQ6=W^;9[K'-&W]Q=ZCU;G]]. ^W
M,N:Z@G-Q/*0 V#BO)(@^23<!11X-M8F8C/H6QY+HK,>K/<[]/"]\)[5&M=4Y
M!S]Z@\BDR#167N@S#3VB<PB,C]7O<;:XMKNYBN+9DEA'8SQD\)H74IVD>GYA
MYCI6:7A:5ML:M.%(IA..'7#EO+MGJ7:LZNK-UVGS975G*8K$599=A8V>76]I
MEUA;Q6ECEMO%;6MO#&V.**"*%L,4;&,#6M;'&P# ;ERMUUUWKW36Z9=;RQ%*
M1$1#4(5XHP71,8PW3/B!8;LVQ;7EBJM0L(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @V]Y^Y+K][S_ +6Y$3DM!Y*D?CGF8_X;>_MY6WJ^S'8U]&DU
MCL7C+4;(@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(""T#F :\U+;]\6_P!NJW,,S6:KNH/O$/[%']H%9F:J
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(+9.>U!>9/CB9!AY*D547<*9CFW0G\5LIH:_@XQI3WE,)E]<B!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0<+\[OXKN-:4=\(<HG),=#7Y+?Q4B\_U D(<PJ00$! 0$! 0$!
M0$! 0$! 0$%+MA2VG-/2IJ>RZ,NJ_P#S_P"NOV/+?M'KNO)/L+>SYG#^<?;7
M]L_*M_!J&XT< =WYAL73<,'(3F"NX8_ M2_/K;VEQKDJ:X@=H'FW^_M4L2G
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M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M"!Q'>L%\3./!FF*6Q/2EXX@/L2/3V+%XM,*8*S;5J-%  L]:XD8)0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0;>\_<EU^]Y_VIR$Y+0.2E?QQS/=
M^&WO[>5N:V4=C5T<(FG3"\=:;:$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 06@<P/\ZEM^^+?[=4NSZV&<
M\,EW4'WB']BC^T"NS-5 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$%LG/;]VY.!C5X]&)]U1=P3#FW0O\5L
MIKA^#A2B7UR @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MW=-G>7GVWE\JB,1=\I! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$%G_,"O\Z46&'M%M39_90LT91V%OQKN
MX/O$/[%']H%A&J@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(""USGOAF&4&FV5M#V>N5FLR5GBYWT/0Z7RJ@
MH/9VX>@+'=FF,(?6*J1 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0<5<W!73$PV>L/@<HFG$;GE03^*-D*4
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M(""T#F!_G4MOWQ;_ &P5;LF&[VEW4'WB']BC^T"LS-5 0$! 0$! 0$! 0$!
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M1*UN;A3D(#WV<4. D/\ 55</2**+>*LYXKG%8$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!I3_>)OV*3[0J
M)R%HG+C_ #JW/[)>_;%(^(7@*00$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!9YKT#^=*/"GX3;85K^NC%9
M\Z5Z$VTF%WT'WB']BC^T"P(:J @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(+6^>_P"[\J_9&?;N6?3R4G"Y
MSOH84TOE(_X.WX L5WM+OK54$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!Q5S<I^+$W%LXAV]CNQ1.0W'*<
M4TE9CRO_ -BISA'&7)J)$! 0$#!1-(S&G(X,:YQ( :USB20   222< *!8=;
M.%K8K-.F71/XC7B[:=Z<\TS#DQR5MH-7<Y9(9H,XS".XB]AT+(6S>SW#G>TM
MAS"20P_$& KB*[//MW'B:G+IQ,W5SC&GHZ7M6;*++?UDQRS&4_!,3->,8PQJ
M.9W7GU8\YKR]O-<\W,SN"USFSOR_VK*(G0N,@BMHX+6\:R-MO&_@! W+I-CI
M7:EM+JQVQ\[P-S?;9?-L3$QU2M[_ )TN81+B>8>K27.+B?QJSH8N-2:?..%2
M5OSLXC*ZWXGG<T]:IO-#F(:G^<+5I&%/\J\Z].W,%$[2(SNBOP)B9E!YG<PG
M4)YAZMX16I_&O._)N^<>U5^[Q7/'X&U;=S152>9O,(;>8FKA_P#;7G1]/^,=
MRKX$=,+X].#3EYG\P&Q/;=<PM7/@+9.&=NJ\ZXB2"&T:,QJ>&J]'8;>V=2:S
M%'E;W<7<LQ;$U9E'@L9IFF:]&^EILUSJ_P [S"26\,E_?WMS?W!;WEIPATUS
M--(:-/:LWGNG;9X4Q28I.5.MJ;#5OOFZ,8NP=Q[?B,\U/S_2N)W5>:*.FLRQ
MZ&H-BR:5>2*YIG-*R($! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0;>
M\_<EU^]Y_P!K<B)R6@\E:_CGF79[;>X_[N5MZWLQV-?0X]"\9:C9$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 06@<P/\ZEM^^+?[8*MV3#=[2[J#[Q#^Q1_:!69FJ@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(""V/GL.
M*]R;R/\ =Q)4784'-VA?XK93^]PI)P?7(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @X6YW8Z8-/T7U'*)3
M&36Y+$?BM& [BH[92E,![J0.8U*! 0$! 0$! 0$! 0$! 0$! 04NV%1;[<J:
MGL.C+JO_ ,_^NOV/+?M'KN_)/L+>SY(</YS]M?VS\K@!M*5I0&F-:U]"Z6G"
M<G(<4$4=MP&^BU;L\&]I93)BX^4JT58D[?6./:-GD"C 0#@1VT]Y!)IN.SSX
M_6HIRR$##$)0 *[$IA40H$^GS>5(D0IS!0*L6UW>XIIA4:<WQF=O>1_;-43[
M,TZ)1CS6]-8[W>ITS_YF=&_O9_U%\VWO[Q?_ "XOJ>Q_=[.SY(<_+1C+H;XI
M%)W+7UL[>U,*EGC) I! 0$! 0$! 0$! 0$! 0?&Z_K^*>;T-/P=WEW%)3;FX
M5Y" =_G&-2V3#"E*N%?/55M5G-<XK)$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!I3_ 'B;]BD^T*"T7ER*
M<U;NNT27GVQ403FN_4@@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(""SS7X_Z5(OWQ;?M@6;.([$6Q3LJN^@
M^\0_L4?V@6%+50$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$!!:YSV_=^5?LC,/ZMRSV9*S6KG?0XII?*A2GX
M.W"M=P6*[-:'UBJ" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @XJYNDC3$U/T0^!RB<AN>5 _P D;(CXM7T_
M4^E3&545QHY,1(@(" @VG<\+B>,GB-0.RBT=[ISJ3929BD\&?Q8F*4C!P3U.
M<QQREY(\Q-=.D$7S5I[,6QS%W#W4MQ8W,44@/&RCF2.!%#6JT_.=S.VV]LV\
M?5G'IB6[Y;9IZNXMLOQB,?AC)YW.KM09UKO7.=YSJ"ZN\\NM1:IS"/*[_P"6
MFO;V:]SB=EI"]W%+<!C'SM:*DBBZGW!\KY='6W=TUYHB:3%:4ITP\SWDW7AS
M&C'&N->UD.=%_@@#7>C\@YE]0F=2V$N?107KM ^S!I?82QVUQ;NENC:A[.]M
MY",*FI7L>9>9V3,:5MD1,5K,?"YOR[:WZETZMUTQ;7#K=H#?!.Z!>%@=RON"
MX,8'N^=7^L\- >[]SX<3A5>!.O,S7AVO?\.$_P"A/Z!/_A=<4W?PJ_\ Y.GW
MB>B:=IX:/]"=T"8_]%UQC2O\*NW?]KJ/'FG\YR)_T*'0)0\7*ZX((_\ "SQA
MO_N=6C<3T(FR9C-M?]"OT ,,#V\KYC##WC '9K*X R@MJ1[+C0E;5NYNC*W'
MM:?@6S2MV'8OUZ?>G#EATQZ!L^7'*?*'9)IRU?+)%#),;@@O+21Q%K!2C0-B
MP:VYNU[^:^O+&4-JW2BV.6*8\7/ZTYHSB @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @V]Y^Y+K][S_M3D)R6@\E,=99EV^VWO[<5MZ^4=C6T.*\9
M:C9$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 06@<P/\ZEM^^+?[8*MWQ,,Y]:[J#[Q#^Q1_:!69FJ@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(""V7GJ/PW)CN[P>D\1IYE%T3@12M'-NAJ_BOE5=OLX_.]Y(R)?6J00$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$'"W.ZOXKN(W.^HY1*8;CDL:Z5B[:BON!1;**4<PJP(" @(" @("
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MU6! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0:4_WB;]BD^T*"T3EQ_G5NOV2]^V*B!> I! 0$! 0$! 0$!
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M*S69*SA5SOH?^*^55Q_!V_ %BNS6?6* 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MS,[C>WO[<5MZT>K'8U]'BO%6HV! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$%H',#_ #J6W[XM_M@J73P8
M9BDKNH/O$/[%']H%=F:J @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(+9.>N%YE![)!\)4790.;="FNELI-*
M5MQAM4CZY 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$'"W.[^+!%-K_ +I1.28JW/)@ :6B [1\ 2W)#F!2
M" @(" @(" @(" @(" @(" @I=L*BWVI4U/8=&75?7^?_ %U^QY;3^L>N[\D^
MPMZ*?)#A_.?M;NV5OPJ-II7R5K]9=+#D)S30E:M_6WM*:50IQC%B55Q!W[SV
M^C9L2G0(W'#T]BFDY *4-=N%/JJ!()K4X_T**8BHBF%>U.P :&H44$)$":XU
M./;N0,,</3V*9I6@8F@\]/JI-!IS$<3*XUECI_7-5;J<OP2B,XGKCO=ZW3/_
M )FM&_O9_P!1?-][^\W_ ,N+ZGL?W>SL^2'/JTF^(*3N6#6SCM3"I9HR0*00
M$! 0$! 0$! 0$! 0$'QNOOXIYO\ O=WP%$Q3BX6Y!@B7.*_V39V>L%6WBK.<
M+FU9(@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(-*?[Q-^Q2?:%!:+RXH>:EV0*4DO-^SUBHCH%WZD$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 06>:^ ;S3CIA^$VW:<>\"S5PBO01E5=]!]XA_8H_M L(U4! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 06N<]L<PRD5I\HWT4>5FLFD*79N=M#?Q7RFF/X.WX L=WM+OK54$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$!!Q9S:_BS-YQ\#E$C7Y3T_%&RH*8OWUWA3A2*(XN3$2(" @@[#YD(?DO)<Q
MW'7O"[]":NILV;* *UNG.K%+J1'<G>3;9$1;BVEYF L[&_OY(RYN6V5U>$;.
M,6T#YW,'Z81T7D>>W6Z7ASGA,X=454V$W:DS928K,1Z6&QXF?6UR/ZH,WS?1
MC.1D64\Q])YC>Y=#S"9F,#;B,6MQ>6I,T4!#KH2<-1Q5(JK>[.YGFUMS%O+-
MV<16/AQGBZ3?^7SH[2++KXOB(F8PCHR6<=&W7CSEZ--27M_H>]N<^T/+/;.S
M_0=Q/+W&9-A=%P-M99KF..T/!#0E@%:KZ/Y)M]+SK1UM/7I9;I16.;C-.%7S
M74U+MOK4LK6;LXK'%W#L^D;7'#\ITL9IQM:WC+=76+6EQ&):'$D-KVE<O=M8
MBZ;8NRF8]#I(U,(GJ2?I&\W%PCI7S8__ &WV%-E=M5'W7K.> _2-YMOY*^:T
M_P#:^Q^OVJ?NO6<\)'TC:4D4Z6,UIO\ \K[!/NO6>)#;N^D:7#'3/9TI9EW;
M15TOXW6'$["M2T'B(!VJ]NTF["LM7[QRS[,5EW:]#W5K<=8_)7+N;)T:_0<>
M8OD:S+GWC+\M,9B+AWC7O_LE-NY-SM8T)B8F9YNEFMUJYX47LC8,:X#'M\JT
M)ZVPE 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0;>\_<EU^]Y_VM
MR(G):%R5_CEF7[]O?VXK;UO9CL8-'C*\5:C8$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 06?Z__P ZEM^^
M;?[=4NK7J8,*KNX/O$/[%']H%=G:J @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(+9.>W[MR:G]D!=_7'!1=
MP3&;F[0QKI;*32GX.W#:D9$YOK5*! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0<+\[C32[NWB^HY1.28:W)
M9H&E8B-I./N!()Z',2E @(" @(" @(" @(" @(" @(*7;"EOM*:GLNC'JOI^
M4#KBO]CR[#M]1]?<7=>2_N]O9'R.'\YPU;YZY^5P".$8[P!7;O"Z7A@Y"<T5
M(!H%JW5Z);VGQ!MQ-/+M5JS':Q!%*UP(W=JB9J(4S'"!6T=F/:-GFQ4"A33T
M"=VS\],LPP\X[-B3U9!MJ2<</2HRS$[02=U/K(*5(G<<>S"FWZU% HN-L9IA
MWL>-?Z9NY5NC">Q&<QVQWN]3IF->3.C#_P %?]1?.-[^\7T_EB^I[**;>SL^
M2'/RT+<+<6^*PI.Y8-::3':F%2S1D@4@@(" @(" @(" @(" @(/C=?D#2>;D
M_P![N^ I*;<W"W(7[]F]#AWAPIM]8;SB**MO%$KFU8$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!I3_ 'B;
M]BD^T*"T;ERVG-6[\DEY[[BHC$7?*00$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!9[KX <THA2E;FV_; L
M]<(KT)MRQ7>P?>(?V*/[0+ AJH" @(" @(" @(" @(" @(" @(" @(" @("
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M/XL&GZ+ZCE$Y)C)J\EN'\5H^$4/%B,3N':D#F-2@0$! 0$! 0$! 0$! 0$!
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MK<BG&'##A<=O#MP6GJ6S?E.4^EDB8X\6_&P5%#3$=GD655* @(" @(" @("
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M1_:!69FJ@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M @(" @(" @L\U_3^=.+=^$6WE_7 LW"*]"+:4Z)JN^@^\0_L4?V@6%+50$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$!!:YSV)&8Y13^RLK_7FBS69*2YWT/_ !7RK?\ @[?@"Q79KOK% ("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M(R1+F!2" @(" @(" @(" @(" @(" < 3V*)R'Y5Q'[3&)(J@QR-+00<:.H[
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M^]W? 43&+A3D(3WV;UQXI#V"E'#W:JMJ)7.*P(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("#2G^\3?L4GVA0
M6C<N:_SJW==HDO/MCV>15CXA=\K @(" @(" @(" @(" @(" @(" @(" @("
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M^]Y_VIR$Y+0.2E1K/,ZC;>7M3_NYW+:UJ4B>IKZ/%>.M5L" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(+0
M.8'^=2V_?%O]L%6[)AN]I=U!]XA_8H_M K,S50$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!;+SUQO,G&_O
M!CZ3N47901FYLT**:6RD5K2W&/P^^D9)G&7URE @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(.%^=M/Q8-=G
M%]1RB<(3PEK<EZ_BM&"V@XL,:[@D=2',2D$! 0$! 0$! 0$! 0$! 0$!!%!V
M**1&1GF\POQSJ'Q<.JJK0:6NCZ$@$C\"FQ!I@OU!^&T1_ +/H0_-_OECY[KX
M8>-?\CJ>FI44[<<%VNK-*4Z7%V8Z<5CC+=/X?5J <,,/,L\T1,3-(C!ID5.
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M OF6K;&I?S9.WLCDLB)X*89^]+Q0-X3V@K+?I\D12:JZ>ISS,4R;A8V00$!
M0$! 0$!!M0*E\Y>7L )B92G":4(\M2%?ARQ&*)FF,Y,/SQJ-*<W>:'4=D4&4
M:&U'G&5Y*RYCMF64&:7%DYO!>ACSW$,MO6E"LML1$89&:ZKP*^F.+*'ZVYF<
MQ=!7.5:QR9T%ID]UG5G*UP;=Q0"5T4-_:-(=&UA <TU:<0IUM3FB.ACMCCP9
M*C72B220/,H=016X]4, P<2[8ZHQQ6K;=$X2MCG\3H*\>SEAI'/N2^DN8=UE
M5J-::0N[K\7LW;W44]J;J.878FHSCO6N90-#C1IQ&U>IL9F;;K>$(OCCQ='7
MA-/N9/$2Y !C+J]9';Z@]N="Z:."Q>8;;NWW)C^3E!=B ]1J^Q/9*L5YOA9X
M$\@MVRS%E6,BDED?Q;!"PO IYFKSHRZV:N%.#!(\67F SF!UDZSSVTOYN#+B
MW+;*R[Q[XF.@%[:1M:.-T;2YS0"11>EIZ?+;'11K7WS;-,ZN]?P*>2V5Z;Z>
M(N9&=Z;L[36>?33"3,)(X)[KV>ENYCV7!A[UI<P#8["JP[FZEL1&4IT<9F9X
M.]MS0>-T<;IV7%6RASSPAH!;0-=@ 05IS=.%(R9HX]#$3\>;DWD^E>;W+WF1
MI_*8,G9GS;[\9WV<<<3;IS6WHADD9#$P$EV.)*]71U)C3BN+7MI6<*35]_X!
MO,.YR+7FNM 6W>3Y9J6**XXW/<61/M(K5[2UA=1I.S +'NKN?3QC)GLREDX\
MW]3P:.Y9ZYU#='ABR[3&>R"3B#2U_P V71B(Q&(D WU7FSE@BZ9RI@\Y+4N=
M9CJG7F89OFUW)F;LZYE7%A)#(7]Y?6V9:KDM1"Z5SG/8&PS\(J5[&V^SGL:V
MK&,/02Z/N3FG.1O(#EQHK3.26NG;&VT]EV87-E$R*6X-QF5C:W,IGNV11R3N
M,KJU=4C9N7DWWUG'I;49X+@M19-:Y_DF?Y-F,=O>V69Y9>6;[6ZMXKB%C;BT
MFA)?',R1DGQZBH-**++Z7Q,)F(FL<7G[==W)VRY0=1.O=+V=F'96<[DS01-<
M(61D7]W>M[I@9&T#B9@&A>WIXZ4=*L3,,J[P:>;>8<S^E3)HKE[IH=-\%A91
MO<7.8P0V["TN<]YH.'!>9N>$\5HNK&$9.W[WO(M980$&WO/W)=?O>?\ :W(B
M<EH')6HUGF?#OO;VO]O/:MO5IRQV-?1KC3J7CK4;(@(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(""S_7_P#G
M4MOWS;_;JMW0P4I*[N#[Q#^Q1_:!69VJ@(" @(" @(" @(" @(" @(" @("
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M=#M?9]D=M=ZXS:YW=KK+\FG#]GYUOZF4-;1SGM:X6MIYRV)2LJ! 0$! 0$!
M0$! 0$! 0$'QNOZ'2>;U_O=WP%$QFX5Y"'Y;.6TI2396OV0*K;Q1.:YQ6! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0:4_WB;]BD^T*"T;EP:\U+LG^R7GVQ41P1.:[Y2D0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!9
M[KXG^=*)I-?PFVW4_7 L_".PMI2D+O8/O$/[%']H%@&J@(" @(" @(" @("
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M(" @X7YVFFEW>5WP!RB<DPU^2_\ %6+?B/@"1@AS"I! 0$! 0$! 0$! 0$!
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MDFW[9[H=KT9KQ=O]%<7M<[NUU^IDHA^S\ZW]3+X&KHYSVM<+6T^+8E*RH$!
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M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(.*>;W\5YOTP^!ZB<AN>4U/Q0LL,:OQ](4QE1'&KDU$B @("#93
MVW>DO#J# D=O#C3WDG&.5&K$WVQ;ERMK[0R\M[IDL!$+6/AD8X5$T;VECVT.
MT%A6KYEH4T)OK$Q%LX4SZ81LM:[6U.6(Y9B<)[&(WXP_0'G_ "]UQF/4KRPT
MU<YKH#4[W2ZTM<MM97OTE,WVM[;AMK:VIDNF7TKBXXGAWKF_=GS"_;>:W6VZ
M=\;>^ZD5F:1C3L=KYEH:?G_EUDZFI99O-M;/-A$3?2(Q^1U.]-_5?SRZ4]2N
MSWD_J>\R6WN9F.S3++F2:ZLLT@9)"9;3YMFN([>S,C(N ^H#BOM>\V&A&G;%
MU]DVW17"G0^1:&XU-34NFRRZVZRZ8RG'%W[\I?I!>075G9Y?S9Y439)F<4<$
M-UF5OF,<C)GM9$R6Y,9N) T2.XG\(I2M%S^MY;9$QR74>GH[K4F[EOMK7BO=
MR3QN^B"\RZ.7.M<7&5YEP!TE@,O=,(W4!+>,7&/#4^XO/U-K-DYYO2T;ZQ%<
M)<.<R_'IZ<M/,O)>6F1W?,ET#3Z\<L>4]\ZC^%H$\KW#%H'9BO/G3OCAZW9+
M;MLB>+I>ZO/%TZ@.I^QO-,Z9?<<I^76;-?!?Z1M)S+?7]LT3,<79Q;7;98QW
M<E2!1N&Q5MT;K;H]J;>BDT9(LMB8FL5[869=+G37S$ZJ>:&0<OM"Y#F$V0S9
ME%<9EJ&6*YEAN+?VN";,W7%[)!,SU8Y7'UG+MO)=#1VVVOW6M=;;9;'1#DO>
MK>:V]UM#:Z5DS=$S&$S-6>STU\D-.=/7*#2?*C2<4=OENF<O@BXFQ-8Y]W+!
M";TN(CB+B;AKL2%X/F>[^^:\ZTQ2W*(Z(AM^4;2W:Z')%)NSF:4K,Q'=1SP)
M:,<2W%NT=OO;UXNC=6ZCVK8Y[N66T??EG"/9W'C(!H-F.TT"V)BL8J;F?NW+
M3UJ]#],&H![0"H2E 0$! 0$! 0$! 0;1Q;"Z5\DK3&QO>$/HR.&-HK(]TCCP
MAH;CBKSC;CDIA$TC.&/#XKWBFY3R_P GSOI[Y#9S'?:]S.&?+]09[ET[7LR6
M*1EU!/;Q36]V ]SRVA(Q!631LI?$RB^8B*1DZ1>@WHGYA]:/-O*'7EIF+="Y
M3FPS77NI+Z.Y>R<RWD%XZ-MQ<03BX$IF<*!QI5>O??9IVUNF*45B9RAG.\KN
M6NDN46AM/\N]$99;9/D>G,NMK&U@MH8XVO,4;6RS/+(XQ))*]I))%<5XFI6[
MU^%62.B,WVV;?XJS/_F^\_P:14C-9Y['7&>+J5U\*AQ&HKBC017_ !G=]B]3
M3R^!H3A,LN'P@,.D;2-=S3MP_6K=:VZX0V]/!VJBM-M3VT^HM1?AUL=7Q^)6
M?S1:9MQ=,.9=Y(ZUC]4.+>.]+Z"M< MG0KSQT->SFCFB_&759X+F6YG>];^@
M<UR^%WS=9Y1GC<YE#3P]X^PMQ$":4^,>U;&O]E,LMD,N3K$('3GS/)W:;S+_
M  *Y"TM//X%KN';\DO/+AI^.&54=MYJ95L%?_7*#W5[&C$>%1JZF%'I0Z!_B
M)HK_ -DM.?\ F>S7C:D4ONCKEMQD^LJ,<1AMQV>?L6.(QKTI80?C4R-EZR<[
MDB<U]JV*C@UX=Z_=7H=@"=Z]S1B/"CIHP\9=M_@ VT[>0^J9W5]DDNHFQX&A
M=^#.-#2AP:5YVOPGM4LNF^Z>C^=D'+5;+3E<612/:.)S(WN:W]$6M) ])"1F
M+4\_UCSSN,S+\@TT6Y>R>6,-+AZS&/<UKC7;Q- /I6_9HZ5Q@_.GU-S^,CWM
MT\2TPN;..\ ;''PGO' ;*M;BMBW;[>G+==$0B(F:]C0Y(<9U9=N?A*^25TH_
M0S.<#,/0^H6GK1AU-?1QK3#%>0M1LB @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(+0.8'^=2V_?%O\ ;JMT
M,,YKNH/O$/[%']H%9F:J @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(+9>>@K>Y0/Z?ZI47<!S9H7^*V4_O<
M)&,)G-]<I0(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @("#A;G=_%@[_6V>ARB[),92W/)?^*L6%,1AMW!(R0Y
M@4@@(" @(" @(" @(" @(" @("B1YA7CF?ZW'JK_ 'MH_P#P*5?J'\-Z3Y!9
M]"'YL]])G^.Z\_Y[4^1U/S5JVO::+M=6(F8KTN-TYKIQVRW3_L?-]0+// FG
M+26F"!OP\VQ0I291B0/379VH81*#Y13LQ]U0M6O%.RNXC9O\Z(SB(X!P'PGX
M$,YKP""*DXC#T_6HI1V*L#1$4I&*-]#L/UE"TY5@(&P8=N_S*41TSF@D$XXC
MTX?7JA20_%!ILK\*3C;1:WVVE/\ %MZ8_A=M^W-5-:?U?_=GN9]I-->LO3S\
M%#_5O].O_-%W^V!?E#WN_MW<_P N+])^Z7]B;?MGNAVO1[#^;M7%[7.[M==J
M-.'[/SK?U,H:VCG/:UPM;3SEL2E94" @(" @(" @(" @(" @(/C=??Q3S?\
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MI^*L5-E?J!(R0YA4@@(" @(" @(" @(" @(" @("B1YA7CF_ZW'JK\MMH_\
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MY5^R,]/KN6>S)2<W/&B*_BQE5<#[.WX!V+%=FM&6#ZM52(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("#BKFZ
M2-,34_1#X'*)ZQN>5%?Q3LZFN+_)^A4HXN3$2(""DK!K3&"82%ELNYK:H2K
M@H# QM&C 5PKV[<2HI6Z)K@<%/ U@:&@U;7A%3O^-BIBV/@A$S,99M.XM+2[
M;P7=K;W+/T%Q#%.WR^K(UP5:S6DPE^4[2NF'.+GZ<R%QVU=D^7EU>TDVYKBK
M5GX!NK?*,HLW5L\LRVTE'Q7VUA;0D$8@@QQM. \JM%<\:*ST1FWIA<YG ]Y<
M2:D[-]1A7<K1?$75MA6;)FWEF<4M8X--'XG8[A&X]BQZG-=A&$IMMI#4V[\0
ML5VE-U)F<5XD(HL=ULVSTU2J6Q&2!2" @(" @(" @(-+BX>(.;PL! :ZM>+B
MP\^TJ<91$1;'4Z=_%,\1"VZ2](-Y?:/ DYE:TL;JVRIW$ ^SCFM[N.65GX1$
M[B  (-*A1&?PK<*L-F[SZ;56OI-;ZYDN,TO,_P ZCO\ 5F=W=W+/+-;&_%S)
M%''-)(^(1PO>W XKH,*1V-/QNID>\A_%_P"CSINT#I[E]R\T*RWL<OL+:/-\
MVMV117.:WS;>-MQ+)('LE/=RL(HZHPP 6EJ[?FFLW8<(3XU/9AS4?I /( ET
MK,EE-LV@XCQ\0V5P]K%2%C^ZZ<<9_E\!]XF>&"6_2 >GOVC+;49#<2_.68V.
M71.:\MX9;ZZBM8RX.N7$_*2A4OT+(QK-?Y=1XWY+O=T1JFTUQI/(-563:6F>
MY;99I TBACCO+>*ZC;B2<&R ;5HV36)F<VSQB(QAC;>.;TB9A//8]36E;">?
MN8A;:QCL[5\\@9!#=,MGN9!;N>ZL>)/%M7HZ$Q-G+&<,5T4FO%TR=$W6MK/H
M[UY;ZATU+=7NF,YDX,]R66::-HC8Z%LC76TD\0:>&(C8MJZV-:WENPB$QCVN
M]C4GC]\L3HV^@R'2[I->FP='8VYD'=,O'0.!DK[7@634-*T6K]WLB>++,TAC
MB\]^>VO^IWF?F&O-<&\S'/=2W_<Y=8P":]EL.]N98[2.*"-]P]@(N , %DF^
M*89-32QK7I9=?@V]+&8<@>GJ'5NJ+=]KJ_F4RWO[^VG@=%/;V<,4#K0.;)!%
M(WO&BN/8M#4FLX-B(B/A=N]]:PYC:7^77C>.SS&TN+&5E/CP74+[>9NP_&9(
M0JQ%T36,X)NMC"<I8+_BF=).>],74/J&]R_*KF'E5KNZ?FFD+BVM)'PVES/+
M=WF8\<L-NQD3A.3B3M"]&S5B;8NCBU]:)MQI@YHZ!?%LS_I4TC:\L>8EN_.N
M7F4D_,=S),Z:2(2]P)6@.NQ(T#NSA0*EVE;?FQ:>M=9AG5=IU)^.YE6L=!7V
MGN2.5OM<YS>RN;&\NW.+'PPW4,T$O YUV"/DWC8K6:%ED\T8SULWC3,8Q@Z%
M>6'+O774GSJR72N2Y=?9D[5FH[>_S6]AAN+I@=)FD5S.99F1SM:![0=II16N
MIFOC3K>@3TX\I[3DGR<T7H&SMXXYLHR>R9>-8&L+[OV:%LY-&1XM+*;-R\V[
M/J9HCTN=U5(@(-O>?N2Z_>\_[4Y"<EH/)2AUEF7[]O?V]RV];"(Z:-;1B)B8
M[%XRU&R(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @M Y@?YU+;]\6_VP5;F&<97=0?>(?V*/[0*S,U4! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 06Q\]J&]R:HJ \>2GK'W5$IAS=H4 :6RFFSV<4_,5,(?7(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @X7YVU_%@[_6V=N#MZB<DQTM?DO\ Q5B\X^ *4.84! 0$! 0$! 0$! 0$
M! 0$! 0%$CS"_'-_UN/55Y+;1_\ @4J_4'X;?V!9]"'YN]])IY[KT_K=3Y'4
M[-M'G7;ZF>#C+,-..&,MV_[$]@/P!9IX(N]FG%I[Z5QWX;?K44*<*IP.T8A$
M99*0VN)2B9N5#R##M1$_&@G#$UKZ$3V8&R@VD5\B&>)L![<*_40C/'(P(/HK
M]1"<\,D[?JCX,41DI)&%/+3R>ZH6B)G,</5H,?Z*FZ8Y4Z<QS5EI7& MZXTN
MK7W.^8J:L?J_^[/<S;.D:_-#T\O!1Q\.#IT/9E%W]N%^4/>_^W=Q_+C+]*>Z
M/]B;>>N?D=KT>/%^;M7%[7.[M=?J9*(?L_.M_4R^!JZ.<]K7"UM/BV)2LJ!
M0$! 0$! 0$! 0$! 0$'QVOOXIYO^]W? 43#A3D%]]SG']<V4V>L-^^JK;Q5G
M.%SBLD0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$&E/]XF_8I/M"DBT;ES_G4NAM DO,=E/6.Y5CXQ=\K @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(""SWF ?^E.*G]\6W[8%FX1TT1$UBD+O8/O$/[%']H%A2U4! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M\3HXQ(80^!KXB7QU!!"U;]6;L(K1GBW#'-?O' X"-TS^^FCXJ/'J \1KL&&
M6*O",(6IQXMRJI$!!M[S]R77[WG_ &IR$Y+0>2AKK+,S_P -O?VXK;UO9CL:
MVCQ7C+4;(@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(""T#F!_G4MOWQ;_;!5N89PE=U!]XA_8H_M K,S50$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$!!;)SV!-[DP!H2\>6OK$>A5ND<VZ%%-+92#_ 'N%9,S6:OKD0("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @("#A?G;7\6"!^B^ .*B[),-QR8-=*Q;\1\ 2,D.8%((" @(" @(" @(
M" @(" @(" HD>85XYG^MQZJ_WMH^O_$IE^H/PVK_ '?L^A#\V^^?]N[B>/C:
MGR.IZ7:/TR[?4SB'&V373BG3+=N%0*]GUEFE6^<(IFTACC79Y.U0K3A$)I7[
M'WT/A0<=NS<>SMP0C#M*C"AI3?10MPGKX))WTK]3=Z:J>M68I/*%O9[B4.;A
M)O!./E_.4)SBD9H-=G9M^HI1$%*5(VX>CZ]5">Y.#B=X%**5<C[$8_FJHO\
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MJJ1 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M,S!,6]$5:CF\5,=GD66)CC"LQ54T<( VT^NJQ%$PE2" @(" @(" @(" @("
M@(" @(" @(" @**0"D$! 0$!!M[S]R77[WG_ &MR(G):#R5'^669?OV]_;RM
MO6RCL:^A$3$QPP7C+4;(@(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M^%?P=V%:;BB8S<*<A >_S>NZ0\/I<*[%6U"YU6! 0$! 0$! 0$! 0$! 0$!
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MO%/ZV<_ZF^>>>Z-RG.KEO++0-[-8Z3M+*ZEM[6ZO(WW5IF<MT;>Z=#=.=(S
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M]Y_VIR$Y+0.28IK/-*;[V]P_W<[UMZV45Z&MHS6)HO'6HV1 0$! 0$! 0$!
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MHM^(^ )&2',"D$! 0$! 0$! 0$! 0$! 0$! 42/,*\<T_P#WW'JJ_>VC_P#
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M$! 0$! 0$! 0:4_WB;]BD^T*"T;ER".:MV-OREY4_P!4HC'$7?*00$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M" @V]Y^Y+K][S_M3D)R6@<E&_P"6>9;J7E[A_NY*V];V8[&MH9S*\=:C9$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 06@<P/\ .I;?OBW^V"K=DPW>TNZ@^\0_L4?V@5F9JH" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@MCY[5]MR>@K5X\E,2/2HG@.;=" C2N4@[?9PIA,YOKT0(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("#A?G<
M*Z7=V<6WT.42F.AK<EJ_BK%44QP-1C@$BO%#F)2" @(" @(" @(" @(" @("
M @*)'F%>.;_K<>JK][:/I_Q.9?J#\-O\/V?0A^;O?*O\<W%/Z[4^1U/S5J/.
MNVU)QCM<7IT\**=,MS)L:>P?#19Y1/"% K7S;NROPU4*S2G6.\IIZ$(GHA&'
MN_8_GJ$S6,S81Y*^FJ%*Q7I/6([1Z$Q/5A5A4GS>A2KC2BFH%/)[]?@HB:!%
M-N_?^<H3%)* GL!V?54HJD8&E/37ZB%:\<!VS;3T52[V4Z<>LT;G9!^^K7]N
M8J:OV?\ W9[F?:?;0]/+P4/]6_TZ_P#,]W^V!?D_WN_M[<]OROTM[IS,^2Z%
M>F>Z':]'L=^;M7&;7.[M=;J9*(?L_.M_4R^!JZ.<]K7"U=/.6Q*5F0(" @("
M @(" @(" @(" @^.U]_%/-_WN[X"B8P<)\A:&?-CL^4=1NW[(5Q46\42N=4@
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M/D=3\NT?IEVNK&,=KC+/LXKTRW;Q7A[*&ON!;$\%;II#3QI2GO\ I4*S29K
M3_4^^A3CF8"M,-F.WWD,<)D!PQ/GP0IG@@'<!2N_;L0F.,I).&&S://L0B.'
M24)%:X]F"$3$3@<1-=VQ0FD<05./YC]:BE$T16N(&.[\VS8H32D=278-PP_H
MJ;O93IXW5:-QB(,,?:K7T?+,5-7[/_NSW,VTFFM'0]/+P4!3PW^G7_F>[_;
MORA[W?V[N?Y<7Z5]TIKY)MYZY[H=KT9^-V?T5Q>USN[77:F2B'[/SK?U,H:N
MCG/:UPM;3SEL2E94" @(" @(" @(" @(" @(/C=?T&D\WK_>[O@*)C-PMR$'
MR^<N.TR;.SU@JVHG-<VK @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(-*?[Q-^Q2?:%!:+RY->:MT=GRE[0>
MGM58%WZL" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(+/M?D?SIQ#?[1;8_[H-RS84CL+>M=Y!]XA_8H_M
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M@\E3_EGF=?[]O:>7Y<K;UJTCL:^CC7X%XRU&R(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @M Y@?YU+;]\
M6_VP5;F&[VEW4'WB']BC^T"LS-5 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M%GVOPT<T8J?WS;$[?[(%FX1V$5SX+O(/O$/[%']H%A&J@(" @(" @(" @("
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M[>T_MYJMO6K,1T4:VEE,\:KQUJ-D0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!9_S '_2I;8_W1;_;JMS#
M,4FB[N#[Q#^Q1_:!69FJ@(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(""V3GL#[9DVX%X!\_$?J*+JX=!$Q6C
MFW0H(TME(.WV<?F]Q(QA,TKAD^N4H$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M(" @(" @(-*?[Q-^Q2?:%!:+RY->:MU7;WE[]L5'<+OU((" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @L[U
MZ:<T8P#4>TVV.S'O0L\SA'81A"[^#[Q#^Q1_:!8!JH" @(" @(" @(" @("
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MV9MX"/(.[S)UUE>I;S++-SF$6OLT<Q#6'XH<Z*A!&"V8W'3'QL4V5R<J:/\
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MWK>S'8U]"F-%XJU&R(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M%HG+C_.K=88]Y>X]GK%1'QB\!2" @(" @(" @(" @(" @(" @(" @(" @("
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MD$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M?U.D\WI_>[O@*V$0X5Y"5[[.*'U1(=WQJN'I%"JV\43FN<5@0$! 0$! 0$!
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M5 (TC9&E!5^^O8D12$<9<F(D0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$&WO/W)=?O>?]J<A.2T'DI_'+,L*?AM[Y?U
MXK;ULH[&MHTBOP+QEJ-D0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!:!S %.:EK^^+?[=4N89BDT7=0?>(
M?V*/[0*[,U4! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 06R<]:^W9/05]<5W4Q/U%6[@8<7-NA/XK93A3Y
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M)R6@<E#_ )99F=WMM[0]ORY6WK1-([&MHX1,RO'6HV1 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$%H',#_
M #J6O[XM_MU6[HAAG/'-=U!]XA_8H_M K,S50$! 0$! 0$! 0$! 0$! 0$!
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M/M"@M&Y<_P"=6[W_ "EYCL^R.Y5C,7?*P(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @L[U[4\TH_6K^$VP
MV?[8,%GX1V%M>Q=_!]XA_8H_M L U4! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 06N\]\+_ "DT_7&;]OKF
MGFHL]F6*DYN=M#DG3&5$[?9V_ %BNSZEHBD/K%5(@(" @(" @(" @(" @("
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M)7.*P(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @("#2G^\3?L4GVA21:+RXJ>:EV?]LO*_UQHJP+OU8$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 06>Z_->:40W"XMOVP?76:F$=B+<87>P?>(?V*/[0+"EJH" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
MM=YZX7^5;OE&5.W#C=N6:S)67.NAZ?BOE5-GL[?@"Q79XK/K5 (" @(" @("
M @(" @(" @((.SM416F.:>+:2_N:Y_8)/VMZC<?9SV2:'VD=L=ZR>[+77%S4
M^M[5<=O]F=Z%Q^YB?%F7VS;4G;VQ/YD=S1?2K:[ /J+%;$M78S2;^UI5!-3L
M4]K?RC IOVCW*I3BBO#BC$X>XB<L4U](]Q2BGI1L.(4)SR3B=OH\O:I1A  =
MH]'E[5'83/"0;=F!^I[^U.XGXS>*&I\WUU*>TIA@*^6OU%"*]("01C2GIVHF
M)IC!6H-=N[ZJDXX-W$ZD]J1C^%6W[>Q3LOMH[6#6^SN^C=W+W;;]S6_[!%^U
MM78V8V1/5#XOJ_:7?2GO;>]VQ?IOJK+:U=;AVM\-@\P^!59TH" @(" @(" @
M(" @(" @("#BKFX::8F/],/@<@W'*?\ BC94-<7[J;PHC(XN35((!43D/P<Y
MMI+O*,XM8*RWLV59C:PCXH,ES:RQQM[,7N"TIFE;IBMU)A>.C@Q!N9W@M=5>
MJ>8FKM3Y=;V4^59[G>9YA;POO+:&1D=UF%S<QDAUMQ8,E"R:&G-8OG"&:[6B
MDQ3A\CXD>!YU;N)I%9 5%*WMJW#L%;;&@*]S2W5NA;RX36,7E[.+_7\:V8QP
MJKD\#SJX8*LCL"?)?6I(-!0T%M4T*SQN-OI6W39,773$\*-K1TXG6CGGEMZ5
MF_53T.<P.D>VR<\TL_L69[J .?%8VT]M/+%'%WCF]Y%"UCXFO;&:%PQW+FMG
MN+]]O;=M=')=%_37BW_-[=/;;6W7T[HNLNB:84<6=/\ TO\ .SJCU9)ISDSI
M.\SVXRD,]KOIF36F6F&0,,DPO9+=]H\0QR<1];!?5/-]OI;;:V:E]UL6Q;'"
M.AR'DVO.\NU+LN2<JUS=C(\#OJX+65BL*N8QTC?;[4<#W .<P'V;$,=@N/NW
M6C&4U>U$WW5K;16WP.NK>KN**PHZ@K\X6FRA!_N?L*PW;G3NHF;)G@T9? TZ
MKII&6[[6T]DA/%AF=N.\)/%2HMZT!6*_6LKZJT61GQ6[]1'AB]5_3OIR?7^?
M:&DS?2.5@-NGY7,<QN(FELA=*^"SM72TCCC+C54^\4I%&6VWFF>6*0M'Y,<M
M\LYOZ^RSEWG.K8]*LSJ?V.TS.YB:P1WDDD<+(9A+3@='/+PGBWA=OY!N=.="
M8I;6>RN#P?/=*^VS3F*\<&<#X=?37J/I8Y!Z?Y8ZDSV+4&90,-U#FUOP=S<6
MUX+::$@Q-9&:1-W=J\SWAWVVWL6QMYK;IUKA3I:OE.CJZ6I/BQC=EB[ IH^/
M@!KA6I]Q<7M=2E\NDU;.:(5V\?!Q5-2:8[/>6WJW<U%-*R;9FK<K$S" @("
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MW)^<,HH*?*-J?.\K-9DI.;G?0XX=+Y4.RW;\ 6.[->'UBJ" @(" @(" @("
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M_D36)^&(=P[:BBX_3B;=3J=3P:<VUJVI9-/*6L-@\REBG-* @(" @(" @("
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M08]Y@<<?6%5%JLUJN=5@0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M @(+0.8'^=2V_?%O]L%6ZOP,,YKNH/O$/[%']H%9F:J @(" @(" @(" @("
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MV)F+;(K/1'S-;1WN^MMK=K3-7Y.>P9PRR>6ZKUB\D$4&J\].T$5QO3L6KO\
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MF:J @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M(Q<*<A".^SC"GRAX<:_9"JK:B<^I<XK @(" @(" @(" @(" @(" @(" @("
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M+0>2A_RRS+';>WN[_;RMO6C".QK:&<]*\=:C9$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 06@<P/\ .I;?
MOBW^W"K<PSGBNZ@^\0_L4?V@5F9JH" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @MEYZ@^V90>V04]TJ+N$D
M3CUN;-"8Z6RG][A2F<WUR($! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!POSMK^*[J''B^H[X%$Y)AJ\EN$Z
M6C(^-4<6WL'H2.HGXG,:E @(" @(" @(" @(" @(" @("B1YA/CF_P"MQZJ_
MWMH^O_$YE^H/PV_P_9]"'YM]\J1YYN.GQM3Y'5!-M;CO/PKMM7"8<7I?91VR
MW3_L>VAI[@JL\EV4=#2(I3LQP4*QBJ/;6E/(B(GA0--^_;]1"/C0*DX[O>4+
M5B,8P12NTXGR=B$S3"B:T%!Z"A2O:;JTV;/=4HXTD)PQ'O[4(SP!0$TW[%"9
MC*J":GM!W;$*4BO%)I04\M$NGU<"V)YL6E<?W/\ ONUI_;V*FO\ 93]"[N9]
ME'^L1/7'>]/'P5/]6_TZ_P#-%U3S]X%^2/>'^V-?MGOE^G/=[^R]#X>Z';&N
M?=(@[O.%,*W?*\SCQ]O]:?S^ -?X.TAAV'V*YQ\J_2_X:_X=MF?Y9/SS[[?X
MAU_Y=+IX.RFT_F*^A][@)C&O ICCCV_44$5IAQ#L3N(G&O$I3&OIIL4T1-TR
MC#8<.P;:?7JACP379AVTQ]U">-9-A..S;Y>SS40X KCO._=3L0FGP(-0:[?*
MAA,43B2/)N[,/?JB." 2!LV;?3L4+3&..:2T;O2I16D5EIR8\/I^HJ3,YL%D
M8]#;W^-O)^D?AV>J?=4:D^I/8RS3FCM>EG]'ZP\*_IOIOM<[]^\7Y9]^<?>/
M<_ _2WN)_AW0[9[H=TS=ZX7;\>UVLOD-??Q3S?\ >[O@*V2'"W(6O?9QN^4Q
M&W[(;U6U$YKFE8$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$!!I3_ 'B;]BD^T*"T;EP!_.I=[Z27F.S[([E$
M8=HN^4@@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(""SW7W^=./]\6V'^Z!9N$=A9%(^%=[!]XA_8H_M L(U
M4! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 06N<]\,PRFFWO&U/9ZQ]U9K(K"O'K<[:&_BME/[W;\ 6.[VEG
MUJJ" @(" @(" @(" @(" @(" JVSPI2@VDO[FN?V"3]K>K:WL3V2G0^TM^E'
M>LGO0#<7=<:74Y'D^6=]=<;N?M)?;-M^[6_0CN:+MG;2E/<6*UJ;.(K?7I:"
MEZ"1YZ>BJ$I=PC!N-?.A3% IYR?11#$%:T!I5"48[/S=J&&9N^'ZB'%5\;R_
M4^O52C)30GT[%&?8FJ<* TK3;]1!.% !Z3\"'#+%&. &(W;J]J=4(PSXM["*
M3VU!LNK;?L^69\*MLY_6_"PZWV=WT;NY>W;_ +F@PK\A%A_4-78V?9V]D/C&
MI]K=]*>]M[SXT7Z;ZJRVM36X-\-@\P56=* @(" @(" @(" @(" @(" @XKYM
MD#3,U>T? Y!N.4XII*R%:XO_ -BHC(XN3%((" @(-,,H0:UIY/SU:;JPK%M)
MJK(KZ=JQ76\R]6DZ&-[0US&O: 1P$!S""*$.:?5(*Q1HXUGA*_B78TG/-9AU
M#] ?2UU.2LO.:?+;*KW.F6\D=IFF71PY9<1S=W(V.>1UK &SO8^3B/'4D[UG
MBEM\73FM;J76Q-*3;UNH37WT>;2^<9C/>Z!YZ7VC8'RRNBLGY!;7L;(B^0PP
MF5T;G4B86MK3&BV_O,7<&K-DY1Q<2CZ.QJKBD ZC1WK3A='(1\I0G9'[#AQ4
M2+K9QF8AK3I4]FLP_=RCZ.MF)DCN,YZF;IC>-AELK;3-N]DC&.'$USY8(2TO
M:#L!VJ\;B+<HJ6Z/-/-.#L9Y#>#5TC<I'9=G.?Z:;K[5V7/@F^>\Q<V*WDN(
M#$]LKK%L?='Y2*M":8J]^_U(MI;'+,\6S2V<.AVKY7D>5Y)8093DV66&4Y;;
M1QPP6N76MO:0,CA8(XVB&V9''ZK&@;%YT[F;;N:8F95G1K%,(AOR'L<QQ=Q1
MLK2C:$5PQH%J:NM.K2Z(F(9M/2IA,MV-H33LF-2)E:6A(XN(P(H?=7HVQ$0U
M=29F8Z*MTL3/&0B1 0$! 0$! 0$! 08BGT@8_P#35R:%/5[G,JTP_6KPX]N*
M]+;^PU-7/!RK]'@QU+U#$;.[R7[6Q4;G[,V]:ST,I9><VT8U./F'8@QU/'@T
M+S)YA:6T$=$Z*S'44>F/;Y[I]FRYG BE;>&1_=P0R^LV( @4J5GT;^6L,=^7
M6QSN2'35U#=0&=G3?*GEUJF2Y8_V>[O)V9OIYHD:YD<K91+;1"9C'OIC4$+;
MFZDXJ1'0O'U1X.77-D.1G-,JY5V.J<S[HS367SU:PRL8UA?(*^S<<LH:,!B7
M'!1XML\8.6D\:.NK.<GYA<HM>#3&96^=Z!UQI2\;,_+X)[_+/8[NVF[QT;'Q
MFT]N:Z> @T!% D6UR8=+"Z>B67IX0'7SF74CH"ZY8<RY8X.8&AH[2QR^[N+D
M/N=26#+>$22M8^YED#K4D#9C4K#NK(B8NB,\VY$33J=CO6&*].?,[ &FF\R.
M(!_N*Y&P^=:MM:X$O/,BH=6Y7N!YJ93CM_\ 7.%=%LOLI[)[FK?G#TG]!#_(
M710WC26G/_,UFN9U;.:^.J9;<3@^L VA8].V++YA,XPPB?&K$;>LK/71!K96
MPTX6@-!K#>DDB@!->U=%H?86QU,&5TNV?Z/XV3^8K5+Y'DN-S$.#B/ T$VQJ
M&?%;Z%YNXSCI39G@R$5K,H@VLMQ"Q[0Z[@BH?68^2,%WD]9P(5HIQBJ)B9C#
M-M[J]LG6]U&+RU+_ &>;U?:(:BL;J$CCP"CEGH3C1:5R5--9YD!OO+T@[13O
MSL[05M:WLQV-;1SF(ZEXZU&R(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @L_Y@ ?SJ6Q']\6_VZK<PSGAD
MN[@^\0_L4?V@5F9JH" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @MDY[4%[DQ/\ 9 !_7&NQ1=PIF1.+FW0M
M!I;*:;/9PD9$XOKE((" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M>M/G#*J_V1GH]=RSV9? QS[3G70_\5\JQK^#MQV;@L5WM,CZU5! 0$! 0$!
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M=%(UAH]S'M:>QQ:0T^@H+6LZY&:MU'?29CF.N[NSI-*]D4(F #'/<6-HPTH
MZBV+-2VV.T[FQFZ>]1LC?-^/EY2*-\A'RU9 QG$&'?ZW#17\>RJ9RI+\SDB#
M'JV[B)XC%)- 7;"YT+Q&YY\KRVOI36CU8[&KHUQF.E>2M1LB @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(+
M0.8'^=2V_?%O]N%6YAF:RNZ@^\0_L4?V@5F9JH" @(" @(" @(" @(" @("
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MB<USBL" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M;/[KJWZ%TUF*^BLT],/4VWF'WW2LU(BEG;QPKZ*N1H+1ULR8=\9#*12NUH[
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MDYZ_NW)\*_*"NZA#C15NZ."8<W:&K^*^55_O=JF,D/K5((" @(" @(" @("
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M 0$!!I3_ 'B;]BD^T*2+1>7(IS4NJ[>\O*>EQ^LJP+OU8$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 06>:
M^;3FE&-OX3;'W90LTS$Q%>A,9+OH/O$/[%']H%A0U4! 0$! 0$! 0$! 0$!
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M>?\ :G(3DL_Y*@G6F9U-0+V]KNH3.:>=;>M[,4Z&MI<:Y8+R%J-D0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$!!:!S _P ZEK^^+?[=5N89SZUW4'WB']BC^T"LS-5 0$! 0$! 0$! 0$!
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MUN9;1@!G>3A0U!V"N*Y[=863UV_(]/:VSXG75C7?2%)<CBTAR-==B-^>LO\
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MW0;RLU)I'8BV)7?0?>(?V*/[0+"EJH" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @M<Y[_N_*?V1M3V>NY9[
M,E9SKQ<[:&_BME/[W;\ 6*[VEGUJJ" @(" @(" @(" @(" @(" JQ%,AM)?W
M-<_L$G[6]3K^Q,]4IT/M+?I1WK*;W[_=?OJX_;G+C=S]K+[9M_W:WZ$=S;N'
MQ:["-G;A[RI;7%J[+";YG*K0I3;A[Z-^M<E6(]4?T=ZGJ12,Y"#COK3' ;$*
MPC&G%O[>S=Z:J#C0.-3MV8[/>3#-,S,SB5% "*T\JDH"HQW*(Z432<.*.VFS
M"J)[<TT)!/;3LQ3&B,(D (P(K7R]BDSQ*5!-.RF/NJ.!6DA)J=U:5")AO8#6
M>VIL]JMJ_P!N8K;*/UL5Z6#6IX=W3RW=R]RV_<]O^PQ?:-796>Q'9#XOJ?:7
M?2GO;:]VQ?IOJK):U=;AVM\-@\P^!59TH" @(" @(" @(" @(" @("#BGFZ2
M-,34_1#X'*)R&YY3_P 4K.AKB_ZBF,D<9<FHD0$! 0:;&<%<:U-?,K77<REE
MG+7'.6BZ-LCI6O <Q[',>PBH<UXHX&N%""L&M$>'/9\C9K2R.FK%<\8_PX<V
MRG/,TZI^3V139EEV8N?-S%R?++=QFRYD39GPWL%G:6KI+ADTLGK4V$8KE_!O
MV^IXFG==R3/"L4F9G":4X15N:FM&XT^34B)NB../#/%T<<ANI;G7TUZG&KN3
M&L\QTUF&42&/.\JNVW,MM-%(YC)[5V3SSQ15D9'P'U%]0\GU+-78WZ6O'/;-
MO&:S&'"KF]70GQO$TYY9KPAWB\N_I NHFZ7_ !>YE\F7YQ?7.675G<ZHMLUA
MLV232V?LYDFL/:'.[M\I+J-X30TJN>TMO/B3S36LSPRZGH77X4I3!T!:UU7;
MZGYGWVNN#V7)<SU=%G[X!Z[K:,YX<Q=&2"2:-<16NY>OH;*8TXY)I/5%.YHZ
MNISS2:SVS7O9*N5>.SRHY5\N-+Z4T[RZN]7YQD&09=EHCM\QBM8YY[:SCA+G
MN?*X@E[0#B,%CU=A,SS3=,S/2RZ>O;-T6<L1'4ZF^L+Q3>?W5>W,]/OS6[Y;
M<OLP?5G+[+9)6S31_+-J_.+2[[PTCDQJ<0%Y]^PNNNMFZ[*Z)RZWK:.XLT]&
M>6,9B<>.2VWI,Z5]>=6W-;)>7.C!?VN6769VESJ?5#K*YFL[6TMKJVFN8Y+I
MUO-"\SP/<"2:[UW6ON]"S0BMEEL1;&,1$3A'4XBS3U-3<4NFZZ>:<YF<^UGP
M\C.3NF.1'*W1G*[2%I%:Y5I?++:T88F,87W3;>)M[-)P1Q\9GG:YV(KBN0W.
MO.XU;M2ZO+T3-7NZ&G&G;;%L17JBF;FQ>?2&^B@[![B&>:4! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$H" @(" @(-O>?N2Z_>\_[6Y$3DM Y*U_'/,J&GX;>
M_MY6WK91V-;0RE>.M1M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(+0.8'^=2V_?%O]NJW3P89S7=0?>(?
MV*/[0*S,U4! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 06Q\]S2^R4_T_P#LBJRF'-VA:'2V4T%/P<8*8R)S
M?7*4" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @X7YV_Q8=A7UNVFYRB<DPU^2W\5(O./@"17BAS"I! 0$!
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M^:S6'R.OS32>;G_@[O@*V58S<+<A 1+F^-*2&HP-:N%,=U%6WBB<X7-JP("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @("#2G^\3?L4GVA21:-RXJ>:EV:_KEY7^N-%$9"[Y2" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(+/
M=?5_G3BJ.$^TVWE_7 LW".Q,9+O8/O$/[%']H%A0U4! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 06N<]O\
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M4[*+!?J<U(RZ(9-*SECIGI;]591 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0;>\_<EU^]Y_VMR(G):%R5_CEF6[\-O?+^O%;>M[,=C7T8PGADO%
M6HV1 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$%H',#_.I;?OBW^W"K=TL,YKNH/O$/[%']H%9F:J @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(+9.>P)O<GH:?*#RUQ-/,HNX$.;="U_%;*:[?9Q5(R3.>#ZY2@0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$'"W.ZOXKN':[ZCE$Y8)CXVOR6 &EHR,:D5... W)&1,N8E*! 0$! 0$!
M 0$! 0$! 0$! 0%$CS"O'-_UN'57^]M'^C\"F7Z@_#?^P+/H0_-OOE/^_M>O
M]=J?(ZGI=H\_UEV^IFXVS'3BO3+=/^QW4&WLV;EEE%^-)XJ!MQQ(V>E%.%81
M44 WX^A0G&)J.P].WT(1,3E"12@KN^JI1,3$]I7'9CV?GJ.*:^K3@4K]EM\G
M8I17XC ;</)BH3C3!.(&)][8I1A7#&$$D;]OO(82>2GJ_F].U.XG#M#\45'G
M_,$NPM39[6#1G%1;_ONU_;F+'K?93]"[N9MK/Z^)CIAZ>7@JX>'!TZC;_!-T
M!Y/E!CY5^2/>'^V-?MGOE^G?=[^RM#X>Z';&N?=(@[O.%,*W?*\SCQ]J#Q3^
M?W;\W:1)\WL5ROTO^&O^';?Y=#\\>^]?[PZ_;\[IX%:5[?>HOH>+@9IS4G)!
M)_._/426QQ3M\E-H4YHB>7L!6@W]H^!0F<)K.82=HV?F].U2B(C*<T.KCV8(
M13X0>3&GHK50F9PITGZ*H[,*J4=% X"E*5\O8H3&=0D'"N!\FSZ]5*(@H:;/
M?4)KZ 'T=I^!*IY>K!0_:,>WZBIG,->VE.6<&WO_ -SR@848[WQ^>FI7DGL9
M,.:)GI>EG]'YQ\*_IO\ ):9W_A?UU^6/?G_$>X^!^E?<3_#NA]*>Z'=*RM,=
MN_W?(N&V\4F[M=O=2N&3Y#7_ /%/-_WN[X"ME5POR$<#-G/[)_L@JV\2<X7-
M*P(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @("#2G^\3?L4GVA21:+RX(_G4N\*5DO*?UQ41TB[]2" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(+/N8!/\Z,79[1;4\_>!9LHCL+9BE>*[R#[Q#^Q1_:!81JH" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
MM<Y[$C,,I.X2,KYN,K-9E12<W.^AP!I?*@#4>SMQ] 6.[VEHR?6*J1 0$! 0
M$! 0$! 0$! 0$!!&VGEW?GJL37%+:2_N:Y_8)/VMZMK5Y)IT2:/VD=L=ZRB\
MHV>Y;7'VJXI_;G+C-U]K+[9M_P!VM^A'<T7;M_;Y,/?5(:>TSN[6@CT3R'T>
M1#K@IY?-Y>WS40JJH00=I/HW)2G:BM816M214#R[%)2B=W8WX/JFI4=QQZR@
M!^-LWT1,]6,*0:;,.U(R*5S2=@QJ,=RD@J1L. ^JB*1QS0/)MW*$S\233#A_
M-[J2B*\6]MW#OX!PT<;JVQK_ +<Q6V<3XL4R8=:/4N^C/<O;MOW-;_L$7[6U
M=E9[$=D/B^I]I=]*>]H7OZUC]ELI[]5DM:NMP;T;!YA\"JSI0$! 0$! 0$!
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MJW,,S6>I=W!]XA_8H_M K,S50$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!;+SU!]LR<TP[P>DAQ(\RBZ,(
MZ"KFW0W\5\JK_>X2,A]:I! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0<+<[OXL$4KZVS9N<HE,9-?DM_%6+
M&N/U D#F)2@0$! 0$! 0$! 0$! 0$! 0$!1(\PKQS<?%PZJ_):Z/_P "F*_4
M'X;_ -@6?0M?F[WR_M[7CAXVI\CJ?FVM[*FGO+MM7A7*KC+/8CIK+<2_8^;Z
MRS3P)K$1T*3B*C?[_NHQQ-,T4J#0>;'W5"9FF" ,0"/.A,X55T-3[WU5*H -
MF\?50D&.)]!0G#(!V#;6J)G&LSFC97=6GE0SZSAP(&W\]$5Q2034>:B%8BG2
M@GU14_FJEV-L+VQZU*-&?9;T_ONU]/R[.U8]>G@S7\V[N9MI-->.FL/3R\%3
M#PX.G0'$_--UCLH>\"_)/O%_;&OVSWR_3GN]_96C\/=#MC7/.D0=WG"F%;OE
M>9MX^P'^E0Y_>3+M(GS?@5POTO\ AK_ARW^70_//OO7^\&O'7\[IYVFE<.RB
M^AYN G":IV$TQ[1_11&<8AIM[=W;3X*(17(!K4T[-^U#&*&&_&GHI]>J%)CJ
MDK44WG<A$4QE(K3%$3-94X'&M:;<#Z$3CDD"A[.P;4*X422:;/SD1$15&P>M
MC7=^>$3QP >W:??HA,=#3?NKOKC[BI.=>+#$Q$3;#;YA0VS_ -(_[4J-2)Y9
M[&6*<T5S>EE]'Y_U5_3?7#\%SNGE_#%^6/?C_$6XH_2ON)_AW0[9[H=T[=ZX
M;;Q3F[7;2^/U^0-)YN3_ 'N[X"MF46YN$^08/?YN1B#(:GL]8>[55M1.=%SR
ML" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @TI_O$W[%)]H4%HW+BIYJ79_VR\^V*BGH1Q7?*4B @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MS$QA/IHU?_I%&K32G3<UOGS\&O\ W:INV,64K=$UZFW9O*YV_&#Z15JX4_\
MEM94UP.?-.S_ +>P6'[A=/Y?Q,MFYKP2/I%.KS7_ .6UF&VF>M!_P[!5G:TX
MLMNM%V4*?_I%FKJ"G36PCM.?-W'$?NY9?N5M?:9.>*5H'Z1=JP-N9'=-388P
MT!CSG[7%AI\8,]NQ"V[O+=.(CEK,=6+!=N*9TCXG>'T'=6&8]8/(_*N:^8Z5
M_%22_?,T6HN1<X,,6&$DI%.]IMW+1U]#PKHI$Q$\)BC%9K3J3-*33HG+)?#&
M:&G;]0$K2NF)XMNUK*JX@(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@V]Y^Y+K][S_ +4Y"<EH')7A.LLR/_#;WM_LY^JMS6]F.FC6TJ4FO3"\=:;9
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 06@<P/\ZEM^^+?[8*MV3#=[2[J#[Q#^Q1_:!69FJ@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(""V3GK^[<GPJ"\5W4Q/NJ+L:0.;="T_%;*:&H]G&-*)&29S?7*4" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @X8YV#_)AWD=]1U5$Y#7Y+_P 5H\*#B[?($BJ7,"E @(" @(" @(" @("
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M\+_H/>K-D;I_8+,W,F!:W,;=P:!L-!;847I^5Z_\.U)OF/$YNGAZ7F>\]O\
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MP5;F&<UW4'WB']BC^T"LS-5 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MPJ-2/4F9SHSUI=$1F]+/Z/R?_O5_3?7'\%SO_#%^6/?C_$6X_EQE^E?<2?\
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MFG3"\=:;:$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 06@<P/\ .I;?OBW^V"I=GUL,YTX+NH/O$/[%']H%
M=F:J @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(+9>>M/;,GW?* U])W*+LH'-NAL=+93O\ P<*1]:@(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @("#A?G;AIAQ['?4<HF*PF.AK\ES72L1\OU D9(<PJ00$! 0$! 0$! 0$!
M 0$! 0$!1(\PKQS/];CU5_O;1_\ @4J_4/X;TCR"SZ$/S9[Y_P!NZ]<O&U/D
M=3TVT>?ZM%VNHXW3FNE;7IENW'XGE!^ +// OBD8YM+ X;.P=GIWU559K":D
M$5_H_6HI1$5RS3B!0>ZB,)FLHPJ,=FZGD[4. :5.&/GVHF*TZD[1L]%4*4G'
M-!VGLW_40C+K*TPW]GYZ$XXIWBN&WRHCA@@TQ)%=E/@1.,8<4N.'U$N]G TX
MCF:$XJ+>NT7=M^W,5-?[*?HW=S8VDQX\=L/3P\%,D^&_TZ5V_--U^V!?DCWB
M_MC7[9[Y?IOW>_LK1^'NAVRKGG2H.[SA3"MWRO,W\??_ %I_/TC#^#M(@^7\
M"N:GW%^E_P -:_W=M_ET/SS[[?XAU^WYW3QY!M_-VKZ%V.!GHN2-E:>_M4Y*
MSZTT-E37LJ/STR)GF*UPKCV^_L3,I-LU"!OV]J$3Z$'$T_-L4<4Q,Q;U&WU:
M4]-:;U*,L4^;:=A[>W#=1#JX& /EWG\Y":SBD8U/:B)BB*'BKN_.3BFOJT3M
MKN._>A68IT-*3['T_46.8PJPVS/-/2VU_A;25QJQWD^Q4:DTLGL9:5F.IZ6G
MT?K#PK^F^AVVF=^_>+\L^_&/O%N.R/E?I7W$_P .Z'1S3W0[IF[UPVWX]KM9
M?'Z_ .D\W!_O=WP%;,EN;A3D)0SYN7&KC(>'T.%=F"K;7%$KG58$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M!!I3_>)OV*3[0I(M&Y;_ .=.[_9+S[8J(Z1=\I! 0$! 0$! 0$! 0$! 0$!
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M_P"$GWN_^4IGR';Q_P!A_.MG^T0TKNXB:?JMZG[W?$UA'\ V]*?(C^=74((
MBV;"7'>,?LT^^7P3Y!MJ5^15_.KG_"?DJUICQ;*?U2C[YJ?RD_@&VX=R/YT]
M0$T;":]G%A]L$^]W<>]/\!VW\H2WFGJ#:(SZ7?\ X03[Y?;P/X#MIPGN4GFM
MJ $M;#OQ]8_=JO\ $+J98=K)J>[VUBDQ/Q?S#N:6H'$%T)H-P<?NUAMW^I/9
MVJ6>1;:V)IW-$\TL\F='$YCHVON+=A(.P.E:T[';P5Z.CNK]2G6KK>3[?0MG
M4C.(G@N@MI#+#$XC$PPO._%\;7?57K17.N$N'U+8B?AEN5+&XJYNT_%B:HKZ
MPWTW.0;CE/\ Q1LMXJ_'TM41D.35((" @(/S[IX#N BH>0#3"FQ9(T[=6R8N
MI%&#5N\.8F8K$RL/\2C,K_)>CGF_?9:9!<V^5QM#HG.:X,E;*QY!86FC0^I[
M5P'O)IW1;;-M:>);''K^9UOD%UMV]MFZF.E=\C"EZ/LVRO).J7EOFV<1LN++
M\:'=_=2D,BOYKK-K;@:>,AK70RN\Y7Z ]R+8CRF^,/LO_##Y9[RZEU_F$S2:
M1?/3TO0VR:<_-&1=U$V2&XRG+GM < (V&RA<T5'QA0X+A=33MOOOF["8NGO=
M!H7WZ<61;C6V/@PA](%J4ANM+O-OJ^_M]Y7Y>M3FG'#!H1\3J/#^",$@@BM?
M2=BO=2)I,5N8[:S%8PL:[@0 QK 6$.J:C####?5:]_L3V2SVX3#%?^D&9CD<
M^9<D,IM&PRY_!+G<EV!(SOK>,MO. O:"7M#L:5I5<][G:=O\:U(BO-S8]O,]
M_P XG6L\ATYU)B;+IF;>SECY:OP_H^&>70UMSKRR!TT]M.,G$[?7;% 8Q8BI
M%> ';N7V?SO2C^'W77<(CTT?*O+[^;=QRV\?E973F\-/+[U*+Y_$U=G,4:K/
MBCT_"52[-:,E2A(@(" @(" @(" @(" @(" @(" @(" @(" @(" @("#;WG[D
MNOWO/^UN1$Y+0>2E#K/,QV7M[^WE;>M.$=-&OHQ6)Z,%XRU&R(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@M Y@?YU+;]\6_VP5;F&[VEW4'WB']BC^T"LS-5 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$%LG/:OMN3T
M%?7\U/6/NJ+N YMT)CI;*<:_@XQ4IG-]<B! 0$! 0$! 0$! 0$! 0$! 0$!
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M<U9PCL:NE2D]%87DK3;0@(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(""T#F!_G4MOWQ;_;!5N89S7=0?>(?V
M*/[0*S,U4! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 06R<]?W9E&[UQ\)4791 YLT)3\5<IIL]G"E,YOKT0
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @("#A;G=_%@_IOJ.42M'4W')?'2L5,,1\ 2%7,*D$! 0$! 0$! 0$
M! 0$! 0$! 42/,*\<T__ 'W#JK\EMH__  *9?J#\-O[ L^A#\V^^6/GNXCIU
MM3Y'4_-M'G7;:N,Q+C-.GA13IEN7_8^;;V;-V^JSRB[*%&T$D[?J%0KQI"",
M !CM\BA,85JJQQ.S9Y5*,Z1&*#B=FSWZHB, X;-_U$E-M)PE&ZI_H[O110FM
M,(2>T^CR?7JI1%*TX)(--J$3%:Y(J0<?0H[4S$3A:@5 J-_O8J49S1+JAO;V
MI?[*;*3<T9SA;@8UN[7R?KS*K'KT\*?HW=S8VL_ZQ$STP]/'P5!3PX.G0#_P
M3=?M@7Y)]XO[8U^V>^7Z;]WO[*T/A[H=LBYYTB#N\X4PK=\KS-_'V_UI_/W=
M_!^D:'R^Q7*_2_X;1_[=MG^7!^>/?;_$.OV_.Z>#79MK_17T)P6$5E.VG%NK
MZ?<3M13\WBD[MQQHI1%,N"G&E*8[_)C5#C5-?Z;WD)CHA-!CY?J(4F/@4^M7
MRGS*%IB*5X'"<$HB+HB4\-#6M5**US!C6F&STIV%?SL2E=AP/YO/M0KC6<T4
MIO[=RA.<*),*>GZBK.#7MF9C'-MKT_@TH_VMWP'ZZC4]B6:Z*W1/%Z6GT?G#
MPK^F_P#>N=_X8ORS[\_XCW/P/TI[B?X=T/I7=T.Z5@ P&Q<+H9W=KM[IKC+Y
M#7XKI/-Q_P '=\!6RB*\'"W(3[]G%#ZO>;.SUAVX[56WBB5S:L" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@TI_O$W[%)]H4%HW+BG\ZEWO^4O*?UQ4107?*00$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!9YKX'^=&+"
MC?:;;"H_LHQKM6:<H[$12<5WT'WB']BC^T"PI:J @(" @(" @(" @(" @("
M@I:[BKA2E-ZF8HB)JTYW\#":5\BBE<$7SRVU=8?5*6NU_$=E:G&O^VKS=>/U
MKYQ[QZG^L75C"BVTCBD?VT!6IJY0^>:VXFZ^)B)QFG8FF !- *[!BL?%ZG\/
MBGMQDCU<?>%?=2I_#XX7I+?+2FW&J5ZC^'1^?".&FTBGG"8]!_#X_/32E 2*
M"N\)4_AT3^7"0 3@<#]3L1'\.C/GA :*8NP._#<G8G^'?TXJD@\1-14;=F\4
M2I_#X_/4D5VD [_J8**D>7?TU8 &PU]S'^@IJC^'=-\(#:$T(-*4_-@G>G^'
M]-\(I4C83C6F_#!*D^74QYXHF05X<*C@DW[:-<LNE6C9V.G$7<M<G9OTN4_F
MFT[V<=Y]O&O2T'U'R;["VJYM;3WA 0$! 0$! 0$! 0$! 0$! 0$%KO/7_&&5
M88]XW?\ TY6:W)29QZW.NAOXKY33'\';\ 6.[VEWUJJ" @(" @(" @(" @("
M @(""*5V[U$=/$;27"VN?V&7]K>HW$^I/9/<G0BFI%/SH[UD]X"+BYH* W5Q
MQ"M?UYRX_=?:R^V;?]VMI^9'<TG;O1\"QV]+4VE:W=K0V8^YY>U'H9X*@.($
M[Q[_ -:B&$1B@TW'#X%)'6@84.S;CM4'4D8''!29PDX5;6HP^NH)B*U@VFHQ
M/P>[MJI1U3D. &%:TV8>ZH3QPR4T[,?>0K3-52A&';Z?K44HK6%-:;/3Y5":
M5S,*=I^#Z]4&^@H9[8U_NJVIY?EF*VSPU88-;[.[Z-W<O;MOW-;_ +!%]HU=
MCI_9V]D/C&I]I=]*>]H7=.*(D['++:U-;@W,OWF7]B?]H52[V9[&UI?:6]L+
M)<W;_"^9#>;B4G^VN7&3[4]L][[9;/J63_0M[GYY;1L.ZO%AMI[ZBE5YPQ5\
M .STJ",8PS1P&FW ^3L4]2*\5 \N_8?-Y%%$UFO6FI<>TGS;D3/64(..%-IV
M[4)K$]9B[RHBO!40>(!V/]#R*<T3AVJ,*;,>VOU%"<?@,*>7X/KU03B/(0I.
MY70NK7#9Y:_65[[)MB*36K%.KCC!@0"_9C3^FKYL11:UUL6]K=LF>6J68/MZ
MXN%W:\+>WY=N];^Q]J*Y/-\TOG[O=%,XE>NQW#9V0H23;P"@W?),78;>*VUZ
MGQ/=W4U9^E/>_3&(!\@6.<UXR<5<W:?BQ-4T]8;J[G*)R2W/*:GXH60IC5]3
MZ0IX=:.+DU$B @(" HF(G,4O:'M<TT(<"T@BH((H00=H(5+[.9-LTFK'1\5W
MPKLSYJYE?]0O3UD45UKR.&XN]9Z5MA';C4D5O%=S":(16A;#);1FM!B\K0LT
M9LU:Z<S%O56/2]O1W=FK9%NK$<\13'CAU],L6&^RO4NB,TN\LS.UU!I'4$5V
M^%TCAF>17$=S8SNCE9'<$6DCFMEA(!!HX!=/LMS-UL1.?7+P=WIV7ZLS;$6Y
MY1"[OEIXCG6ER9RBVR/E]S=NLMR6+NV&VS6VDSXO;&&,%9+V[D->!@Q6U?IV
M7X71#SHB^V<)ESM)XS/7I ( _F5E[XPWY6X;INS<2>$>L6-F.]8;MKHSE2&2
M+]2.,S+\/4'B_P#7[G&631P<X[7+K.\CD@EDATU;QW!CD:Z-[8RR<2Q$M?M"
M1MK(I2(K#8I=QF5@NM.8^O\ FEG,^>:SU5G^IL]O9'S7-S-F.975L]\KG/?P
M9,^XGBXB9#1H;OH%CBSUHPC..")FD329QB787T >&GS3ZM-79-J;4&69EI;D
M[DM[!=S:NS++[BQFOC;R6]V;"+*[VS:YPNV-<P' 4-=BZ/S#>Z&EH6Q%ML7S
M&%*1,X=3G]#::E^I7FNFV)QK6>+-<Y;Z$TGRKTAD6@M%Y;!E&F],V<%E%:6\
M+(F59$R/OSP-8'/G<SB-!M*Y'5OOONF^Z9FZ<L<HZ'M:-EMM++8B+(SZYZ7)
M8((!&PBH\RUF\E 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0;>\_
M<EU^]Y_VMR(G):#R5K^.>985_#;WR?KY6WK1ZL=C7T:XSV+QEJ-D0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$!!:!S _P ZEM^^+?[8*MS#.$KNH/O$/[%']H%9F:J @(" @(" @(" @("
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M%Y<4/-2[(%/E+ST>L56.D7?JP(" @(" @(" @(" @(" @(" @(" @(" @("
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MGZZV];&([&MHSA-5XZU&R(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M_J[>Y^;O?*?]^;C]M?\ (ZGYMHWXKM=2:4[7%Z?V4=LMS)\4>;ZRSR3&4M/
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M5MXDYKFU8$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$!!I3_>)OV*3[0H+1>7'^=2ZP_7+WT>L?=JHB1=^I!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M!:!S _SJ6W[XM_M@JW,-WM+NH/O$/[%']H%9F:J @(" @(" @(" @(" @("
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M 0$! 0$! 0$! 0$!!9[S _SI1?OBU_; LO"",J0N]@^\0_L4?V@6(:J @("
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M-M4HKC0!P.'GQ]Q"<RE0X]E%&$X+4GADJ-:5I0C9C7:I4CH4G$X?T5"8PC%
M-"$3.22* ;BDHB<>I/" "3C[RDK5 !V4QPW[%%$UQA4=GDH,$MSP8O-L]+M:
MG939O]_M4W=+)KTY;*="HTXX*&E;NT\M?EV*FWQU(3'V=_T+NZ5[]I^YK?\
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M0*S*U4! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 06R<]?W=DWZ<8]GK'#RJMW <VZ%%-+93N^0"F,DSF^N4
MH$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M=P50LD8P-ED[Q]3Z]*8'8*>19IQ)IP5D+5U+)MF*<4PJ"V+(Y;:*BL" @("
M@(" @(""B@'%P_&^OLVX*9K.>2M(BM,VW?(R)A,US'$8ZETDI;&T XXEY:VE
M!M41;=%N/$K$S2)QA;SS<ZKN1')2QO;_ %QK_)+"2UBD>ZTAO[.XN)7QLD(C
M$3;D.!)C(6>S1U+J1,4A69B)K5P9TC=?_+'K$U=S!TQR^@<^UT.^!LEX#47
ME<SA>>&61H#N\!&Q3JZ4Z5)K62)B["F"_P">&BCRW&/!IJ=^&SR+6NRK'M+H
M  # XUD];AQI6NWR8!1RUC/X4=[87N8V.5V]WF%_?16EIE\3YK^XN'MAA9&R
M-S^)SY"UC0UC3O4TQP(C'-U>=1'BZ]+?(2[=EDNHXM69C&^6*6VRQT,C631.
ME8^/O&3D'A?%38%GLTINQRE6LVX3BM.@^D!<@>\;+>Z9N[2P<X-#^_:^:CB
M'4%Q0#']"K_=\,YJ<\UZG8WTW^(1T^=3&76/XJZNL<KSO,2&VV4WUS;1SN)[
MN@8'S\3CQ2@4H%2_2FS+%/-7J7QQ  <0?[1-P-/&#1KVN^*X$5;0M]Y:TQ-L
M=,I[VH6N;&6<7 !3U]M>(XBF)&VB4KAQA.+XW76OM&\KM-9AJK6^?6.0:>RV
M(RW-Y?W$4+6  NHSO7L,KW<)P'8LUMETXVQDKZMN%<'3MS/\<_IDT%JC--,Y
M:9=1S9?*8H;^WX6VTYXI&DU;<$4(9N.]9_!CA,TE$7=.;XS3'CY].^;9I!E>
M:Y+<Y?+/-'%%<,D!BX7O8UTAXKAY 8'5..Y1?HQ;E,D75QP=N_)/J/Y2=0F0
M09SRXU=EF?!T$4US8PW5NR[A?(V-YC= V:23Y(R +!-LV83BG.G2YVX7L=*Y
M\G'&>'@CI3@V;QB53EKGDG&,\FY4K" @V]Y^Y+K][S_M;D1.2T'DI_'/,]X]
MMO:?V\K;UO9CL:^AQ7C+4;(@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(""T#F!3^=6V/_"+?[<*MU&&9K/4
MNZ@^\0_L4?V@5F9JH" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @MEYZ?NW)_P!D'PE5NX#FS0O\5LJQK\@/
MA4QDF<WURE @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(.%^=O\ %@T-/6VTKN<HG),15K\E_P"*L7G^H$A#
MF%2" @(" @(" @(" @(" @(" @*)'F%>.;_K<.JK'^YM'T\GX%*OT_\ AM_A
M^SZ$/S;[YU_CNXZ/&O\ D=3\U*MQWG#LV+MM3.*]+C-.OAQ7.LMR_P"Q/DQ/
MH%%L3P+IK;$* W&NSR?GJ&.9X& %-OU43C./ W4I7WD)SQPD)W>Z??0B*S6
M"NWT^7ZU$)PFB*;ZU'PJ%J^E)PH*4[#\."F5;8J4]SX/KU0B9G",RM*4^+^;
MT[4[BGI-Q)&W=[VU1UIQB>6 [!AVJ;O9+*5:4^RWW?A=K7^W,6/7^RGZ-W<S
M[.OWB(IQAZ>'@J #PW^G4#9\T77I^4'N57Y)]X<?.->O3/?+]-^[W]EZ'\N$
M.V1<\Z5!W><*85N^5YFWC[C_ .^G\_3_ .+M(_X%<K]+_AK_ (=L_ET/SS[Z
MS_[@U^WYW3R :-PKMJOH;@;II=, (H!NQK]10BDXR#]$3[WH4HGH,</3Z5":
M1$ST(V;-AW^9$Q/I5;*[AAY5*M:X3B;:X5V;Z*$Y=2<:5V=N]2K%*](,!AC[
MR)F)KB@.PJA3'HA'K##ZRA.$XI)J  -OU%*.-9:<GV(\_P!18YB*TEAB8QNX
M2VU]A:R4-?4?04IN*G4]B>QDG&^.UZ6GT?FG^BOZ;_WIG=/^.?67Y7]^O\1[
MCX'Z6]Q(C^[NA]*>Z'=*RE/5V;O=\JX;0X]KMKJUQS?(:_--)YN?^#N^ K91
M&;A?D+7OLX\DFWM]8>Y15M1.:YI6! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0:4_WB;]BD^T*"T7ER".:M
MUY)+W[8J(%WZD$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M$! 06R<]<;W)QVO]S$^ZJW<!S;H6GXK9339W 5HR3-:XYOKD0(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("#
MA;G=AI@T_1?4<HE:&OR6(.E8@-H./N!3DJYB0$! 0$! 0$! 0$! 0$! 0$!
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MN<]@/G'**FGRC:>4\9]Q9K,E9<[:&K^*^4UV^SM^ +'=[2SZU5! 0$! 0$!
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M5V>C[$=D=SXCK?:W?2GO;A96-Q5S=H-,35%?6&^FYRB<AN.4_P#%&RPH*O\
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MQ2?:%!:+RY!'-6Z_9+VO]<:*,,Q=^I! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MMQ\FRB$=,&P8''S;5":5FG W8X [-_G4HX]:7?%I7:EWLIL]NL9-*:E+??\
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MWX]KMKNI\AK[^*>;_O=WP%;*(<+<A!\MG&[Y3 =GK"N.^JK:B<US:L" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M]!B?X*S#_>U/AW(\2UI_Z9SP[O\ X\6'_DC,_P#>5'AW]">:WI1_IG/#N_\
MCS8?^2,S_P!Y439=T'-;TO@M?>-=T69%D<^8<O\ 6S>8><11RR,RV"!]AQAD
M;G!@ENG0GB<6TP;O6+1V\>-;$5K=-/2V-/\ 663'-%*2NTZ*NK/+.L#E7#S4
MRK3$FE+"ZN)H8K26<7+Y1$]C>.K7. !XP<%[GO/Y)=Y59MY\6;_$BN63RO+]
M>-2_4I;$1$^E>=(:!F^OU:+Q]&VEM&WJ74F$3;G5WC!3%W+\)J6\U.&+<*K)
M&0@(" @(" @(" @(("I92;1B*?2!R1SKY,#=W69>_%>?"O5T/LX:FKFY5^CP
M #4O4-3]!DWVMDHW/V9MYK,U92Z\YMOSLU &4YD-WS?>_P"#RJ-.:Q$]9D\]
MGKFJ[J3U^65[XZBFJW?_ (RN^'!=!;[/51J:W">++B\(*)S.DC2#IV<-R]AX
MR'<0<T16M#08-.*\C<9K:%*S'%VI=VVK33%M>$[:56"9JV(B(BD,=CQ\9;(\
MK-,VPOF?.0,CC"0&ES*WA:-M30+T=O6=/*D-;5BDNJ[P4,FS2]ZU='YQ';.=
MEMIEN<]]+4@->;.WX",-G%Y4W,TTE-*/UD,MKK*#?R;^:32"3+IS,!A7XPLI
MW#9Y&+SH>A9G\#ST(WF35^1$MH?YT\K$E,*4UA!PEU%ZVVQT_@>9N(BL=KTH
M-!-/XAZ);Q .&DM-@.H#B,GLJT![5Y&I%9GIJW;/8BG1#Z_ 8F@PJ?1O)5;8
MG.<UZL('QJY89^LO.'6LS9W2Q<,S64(:(H;W \.%11>YHU\&WL>7K8W?#+MV
M\ *U<>0^I\Q8.&WGNHHA389 ;<D]E1P%>?N8G!N[>GAQ$,@E:K.HE+VQR.C;
MQ2!CRQOZ)X:2UOI<@M9SV]ZB,TOI79+EL&26K)I&QMDDBE[R(2.$;R']K*%9
M?4C#"B.]^7-^4LT.8_V:2(,/>O A;5E*2</:[AV42.2E43%<)R;/DEQ?C;=<
M>$HDF%P?^$<8[\?VP%9];*.QKZ.=T]:\E:;:$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 06?Z__P ZEM^^
M;?[=5N8.."[N#[Q#^Q1_:!69VJ@(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(""V/GL0+S)Z[WBGND*+L:#F[
M0G\5LIW_ (.%(^N0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$!!POSM_BP<:>MMV[G*)3&37Y+_Q5B\_U I0
MYA0$! 0$! 0$! 0$! 0$! 0$! 42/,*\<W_6X=5?[VT>3_Q*9?I_\-_\/V?0
MA^;??.)_CNXZ?&U/D=3TM*C],5V^I%9CM<;97PXKTRW;]V[# ^Y59Y1=A$-*
MN.S'SJJLQ2*25QP.'FV>ZAC.$IIA2E*[<:THI5J;/6(Q_,$3GA"G;OQ[*?54
M)K3#@JP)/8?J*44F(J@[-M>S"F_%0F*\,@5)KV;!YT(I&$Y)\FX;?J*4936,
MT8G&F)V?54)X4G@/V"H]'YZF[V4Z?M-.?^Y^SVNUK_;F+'K331GZ$]S+M/MK
M>V.]Z>'@J4_T<'3I39\TW7[8.U?DGWAK_&-?MGOE^G/=W^RM#X>Z';(N>=*@
M[O.%,*W?*\SCQ]S7Q3^?P[,NTAZ?P*Y]S!?I?\-?\.6_RZ'YY]]O\0:_;\[I
MWH#3#SX^XOH;@)FDRJIL&[L_/16O'BI%: ;0:X>;RJ%L*IQKL]%1@G$PBWM0
M?)O]^GP43L*\;LTX$GR_44HI,0G$"@'YO2B(I6LF_9Z:_40KA1&T $XGZA0R
ME%2*]I]Y0M2)[$XTH!7R_G*4936<PC?7'MI]1$5X--^--YQ^HL<UK5BMPB:Y
M-O?_ +F?O]1^.S[$IJ4Y?@98]IZ6?T?K_57]-^_\$SNFZGX8ORQ[\X^\>X^!
M^E?<3_#NAVSW0[IF[UPVWX]KM9?(:^_BGF_[W=\!6R1@X4Y"BD^;"E:2&CJT
MI5PKAO5;>*%SBL" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M[XM_M@JW,-V:[J#[Q#^Q1_:!69FJ@(" @(" @(" @(" @(" @(" @(" @("
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M"K;Q1.:YQ6! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0:4_WB;]BD^T*"T7EU_G6NL*?*7N&W>HCH%WZD$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 06>:_K_ #IQ<6'X3;8;?UP=BS84CHH1ECDN^@^\0_L4?V@6$:J
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MOS8>'PKO(/O$/[%']H%=F:J @(" @(" @(" @(" @(" @(" @(" @(" @("
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MRY6WK3A'8U=&N,\5XZU&T(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @M Y@?YU+;]\6_VP5;F&<)7=0?>(
M?V*/[0*S,U4! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 06R\]?W=DPK2K]O9ZQ&S>JW#FS0M/Q6RFF/X./S
M_?4QDF<\7URE @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(.%N=QII@_IOJ.42F.AK<E@X:6CJ<.+#9V!(P)
MP<QJ4" @(" @(" @(" @(" @(" @*)'F%>.;_K<.JK]ZZ/\ \#F7Z@_#;_#]
MGT(?F[WRF8\\W'[:_P"1U/2[1^F_.7;:DXPXRR:Z<3URW;Z4;7L^LL\JW5I%
M&D*; =OD[%5'7*=PIL[.WTJ44GB@]E-F^O:H3&=4^K3R'SXJ45G+BI K]7ZB
MA:9B,56-:# !2KA2LYHIAMPWE11->'%5L\O:?@P4JTKDAPWT\_U$3$\$#;7L
MVGS^10G&8HJ.SR=JF_V46>TT)]EM7^^[;]N8L>O]C/T+NYL;6MNO%.F'IX^"
MK0^'!TZ4V?--U^V!?DCWA_M?7KTSWR_3GN]_96A\/=#MD7/ND0=WG"F%;OE>
M9QX^W^M0Y^XU(R[2%!V#V*YIYU^E_P -?\.V_P NA^>/??'W@UXG*OSNGD4P
M)VG\WF7T-P$\8C)34;/?_.4)FLXIPK39Y.WZU$)F<\PDXTW44HB(G#B$[C[O
MYR$=(3Y<#Y$(CTII7::D?50B:9(-*4V>^H329FL8@</,I1,3./$V[_11,R8Y
M4'=4X=M/J*$Y=H=M*[=N'9L0C%1)M;Z?J*MV./%KZ>$TKA#;WU/9I!3[!U<=
MGJE1J4Y,<Z,\S=6(B<*O2R^C]?ZJ_IN_>N=_X6ORQ[\?XBW->I^D_<3_  ]H
M=MW=#NF8014;%PVWX]KM[HIA+Y#7^.D\W_>[O@*V57"O(2G?9O3#Y0T']4%6
MTE<XK @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(-*?[Q-^Q2?:%!:-RZ+OYU;H'^R7O9^B*B*"[Y2" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M84K5^/\ 7$*MW0F'-NA?XK93A3Y 8;5:$2^N0$! 0$! 0$! 0$! 0$! 0$!
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M.QKZ,TMF>OY5XRU&R(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M3S?][N^ K9(<*<A #-G!/QFR>Y5P[,%6WBK.:YQ62(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("#2G^\3?L4
MGVA06B\N,.:EV!B.\O,=GV141T"[]2" @(" @(" @(" @(" @(" @(" @("
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M03M6]N]_?JV1%.72IE7&?C>)Y=Y7&AJW3=?=?J<U8KC$?!,+]PR-@XRT/$H
MGD;VMP: T?%:U<_.M,S6(]5TUFAARSA?T4S:[F4#:'#=ANPIO6U;=5KWV37-
MJN9Q4QI1:.MMIU;HNYJ,]MW+%&HMF,(HJ*00$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$&WO/W)=?O>?]K<B)R6@\E/XY9E^_;W]N*V];V8[&OH92O&6
MHV1 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MZ)B?@9IU(OK-T=D]#>.;Q4QI3\Y;$74:DQ5IN;PTQK6NY7B:JS%&NL:X@("
M@(" @(" @(" @(" @(" @(" @(" @(" @("#;7G[DNOWM/\ M3D%H/)0$:SS
M*@I6]O:XU_7RMS6]F.QKZ/'H7CK3; @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(""T'7X)YJVP']\6_VP59
MKP8;LUW,'WB']BC^T"LS-5 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$%LG/:OMN3 ;WU\WK$*MW!,.;="U
M&ELIKB?9PK$YOKD0(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @("#A?G:::8/Z;ZCE$K0U>2HII:/U:>MMK6N
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M91&0N]4@@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MTHZBNK_P*<\TQD6?\Q>G/4$FHY\I$MS8\JW01V@]BC9<3R"',6VQ?,^"%C0
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M[0H+1N7-#S4NG5Q[R\P_JB-JK$\!=\K @(" @(" @(" @(" @(" @(" @("
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MII>Y/Y7BGNE1=P3#FW0F.ELIQK^#C'8I@G-]<B! 0$! 0$! 0$! 0$! 0$!
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M(" @(""V3GM0WF3X8B08^2I-%%W"F9%8ES=H7^*V4[OP=JD?6H" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@X7YVT_%=U?T6WLP<HE,-?DM_%2+SCX IS0YA0$! 0$! 0$! 0$! 0$! 0$!
M 42/,*\<W_6X=55=GLVD*?\ $YE^H/PV_L"SZ$/S;[Y33SW<=/C:GR.I^88C
M#:5VVK3"9Z7&:<UTXXXRW3_L?,<>S ;M]5GE%V4-,;1NI6H\ZA7A)YSZOFV_
M5VIW$Y_TD[#\'U4(QCJXHWUI_5?G(4G+BDUW?4P^O5$13BI- ,=OYO1L4+5Q
MKP34[/?_ #E*)BF8*4..'P(8Q/6C $5%/35#-4:''ZZ(K.0:\/9[Z7>RM;/K
MUG%H3U(MCO\ :[7]N8J:_P!E/T;NYGVN&O$=</3R\%7_ %<'3K48_--U[O>#
M%?DCWAI_&->G3/?+]-^[W]E:'P]T.V-<\Z5!W><*85N^5YG'C[FOBG\_1O&7
MZ0]SV*Y'P+]+_AKA[N6_RZ'YX]]O\0Z_\NET\;-@Q-/3VKZ'DX&<9KP55'NH
MK,3"D4)/DV)";IFD512N%:>3;3TH5IBD>:GU?K44)G',P/J^Y\*E%)B:R'#&
MFS9Y:H1CAQE'94U&*A/5"3LV^\I1&=8A&S"E*[ZU4)B9SZ#?B*G=N1,]-57Q
M0I4SEI2;1Z?J+'.3%9E#;7H(MI</L'[Q^A*:GL3/5\C-,^M$1TO2T^C\C_[U
M?TW_ +TSO_#%^6/?BL>\6X^!^E/<2G]W="?Z4]T.Z5A!%1L7#;?CVNVNBF$O
MD-??Q3S?][N^ K91#A7D(VL^;NXJTD-,*?9!5MXHE<XK @(" @(" @(" @("
M @(" @(- 3 ES:8MI7'M]"O.G,6UZ5.?&;2-HC#G$\(VFIP'G-:+3TK;IO9)
MI"AUY W9/;'MK<1CX2%M\MW1*UME>GT*/:+=XJZYMV^:>,_[):^KMKM2:Q6%
MJ3;A$3/P*C<VVZ[MP#_ML7O>MBHC;71A64<E_P";/H1[3;@_NRW_ +;%7[93
M]WOSK)R7_FSZ%7M-M4?A5OY1WT>/ZJJC[O=TR<E_YLT[%/M%O6GM=O7L[V.O
MVR?=KNF?C.2_/EFG8J]IM212[M]^'?1_=)]VOZ9.2_\ -GT*?:;;^_+>N_Y6
M+[M/N]_3)R:GYL^B4^TVYJ1=V]/V:,T_5)]WOXS)R7_FS7L/:;;#\+MSMK\M
M%CV?9)]VOZ93R:GYMWH1[1;_ -^08;?E8L/U2?=KNF?C1R7_ )L^A)N;:O[L
MMQY.]B^Z3[O?2E9.2_\ -GT'M5MC^%VX[/EHC3]5C53&WOCC)R:GYMWHD%S;
M5_=EN?)WL7W2C[M=UG)J?FSZ&FV]MJAC9[4DF@ N823Y@'U*S6Z,V1-(Q[%Y
MTKIQGF]$MVYPXFM#Z$[J5JK1E.#7F)JU%"1 0$! 0$! 0$! 0$! 0$! 0:4_
MWB;]BD^T*2+1>7/^=6ZH*#O+W[8JL= N_5@0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!9]S /_2E$-E+B
MVQ_W0+-PCL+5WD'WB']BC^T"PC50$! 0$! 0$! 0$! 0$! 0$$55+;N80[8<
M:>7:IOMYK:##L\:![V]5MD!6@8:G=][N]RX?SO:VWZUV,5?S:_YP-;4CWGV=
MD1-/6_\ $ZGJX@T[:^[[RY;[C&/K1ACD_)4S?JTNGGB;9ZT%S<<:TI0TVUV[
M=E%@C>TPY(_['I?Q.<HTYF8HDM?Q8'B'E.WWU'\0MF,;,4_Q&Z9PT\ T! -*
MDXX?%]*1O^,68'\2X>'-51#0:%XKY@??4??ZXQIHGS2(PG3FJBH)HVA&[956
M^_TSLHB?-)YJ>%*KA''P5'GP[*J/XAZM>1/\4GGY?"FB@$8XXC9Y?25/W[^A
M!/FN%?#FJ0:TH<3M;V>:JC[]$9V10_BDUY8TYJF@XBT_%&UPH*'</24C?X5Y
M,2?,IXZ<T !L>>'L\OOX).__ #;(3'F>&.E1 &)W.W##\P3[_P#T,%?XGC/Z
MN:I/JBHQ(^,!N[/=4QOXRY(I,)_B=8F)TYJHNQ2&3?Q034&_[TX;=JQ^6X[B
M+>,RT='1U/&MOCFISQACTPR[O!HE='T5\O@&N-+G-ME<?E[;LVKZSY)I1=MJ
MUC%_5S\#=6Z/<C:Q,36+>OHAW!PS=X&^IPU'U%[-]G+Q?=+-6;YRF'P?->OX
M@ZCH*GV&6G]8Y8II2:Y44WEO-M;XK3U9[G3;#Q5NZG;=W&%!_9G[UX$QC-.E
M\-NCU[OI3WH_6SAV;_*G<CL5[S0]F*C#)$8JJ#W=_F\BMB=Y@<:TKY%$29 )
MIA[O;Z$[2,<U-2,:^G\Y,?@,X3@#5OYO=0B,#;AL3-/9F4%//L^JF>!QI"=@
M(I3MQ]Q,)1 :?8_F]U)Z>@K-.M+J5[*>\HMCTL6E&:C&I)W^;ZBK9.=&6')'
M)''FUH_"OK7&&S>Q;]E:U=#Y)^\V]KN"LJ"UAILX&]O8.U>G;E5]8T?LXZ*-
MTI9%KG/8D7^5$?V1GV[EGLI3%6:UZG.VAOXK93^]V_ %BN]I9]:J@@(" @("
M @(" @(" @(" @@UV#^A_141%,LDX<6TE_<US3^PR?M;TU_LY[)-##4B(_.C
MO63WCJ7-R'?WU<5_MSNQ<=N?M)E]MVTQ]WMC.>2.YIFNSM ^!8HGBU-E69OB
M.EH4H=M#OPV?7JI;Z!VTJ @J!()PJ2I1,13J4U[17WE%4TZ$U(-3M_.3B4K&
M",.SW]B": "NT>Y1*(KP-E.T5K]1,NTS[ C&@'O[5)$])7?LIM/P8*.LZBHV
MD8_"I,8R2ZI(-,3]1$UKFWL(/?VQW>U6_P"W1IL_M8[6#6GU+H_HW=R]JW-+
M: _[1%]HU=E9]G$]4/C&ICJW?2GO;>]&,1W<2S6M36X-U+]XD_8G_:%8[_9G
ML;6G]I;]*.]9'G!_AG,",/EY?VQZXOC/36>]]NL^SL^A;W0_/%.&'']'44*A
M,Y8*^$D$TQ[:_42?C(Z8R16@&';0_#@I13%%#CY%":IH*#&FWRJ45FJK$#BK
M0GR5K]90M$4Q4D..WZBE6L(.U0F,C;M])_.0R/J()I2N.RGI0B<8:Y83PC<-
M_G%=B6SFQ>;32=)30UQ&W;CLI7W:J;J47UXPMGIA631T!K0>UVFZM?EV*FV^
MTA:/8O\ H7=TKW[3]S6_[!#^UM79:/L1V1W/B.K]K=]*>]N%F8W%?-P@:8FQ
MH>(8[=SMR9P-SRI!_%*S.XE_^Q4\(E'&7):A(@(" @V%W#WA8:T+2<:5KZ-R
M\_>ZG+-D1C64SI\\5Z'X&I+EYTWJ$-C<',T_G ;P@EY=\WSTX:>MQ$C"F*Q^
M=;F=I9;9;;-_B671AP]65MC=XNI$3A2^WO>=7SQM-6R\Y.81ERK7]S:SZGSL
MRL=E.I;JT>!FU\8N!A@?"]G904HLWX<^41K7;C=WWQ;-F-)BE>RKVO>&_P "
MW2LMI=SQG'#T.)#DN=/<;EFB-7LNK(_A-V[36=E@$F#." V7"20=P79ZV_\
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M"V3GM^[<F&VKQAY.(CWU%W C-S;H6GXK933 >SA3&29S?7(@0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$'"
M_.W^+!']-\ =\"B[),9-?DN/\EHSMJ1CZ D02YA4H$! 0$! 0$! 0$! 0$!
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M1M#61QQMCC8UH #6,: UK0!0 !6K/&<2+;8RB&JH2(" @(" @(" @(" @("
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MEU^]Y_VIR$Y+0.2O\<\SH*@WM[7&FR<]JV];*.QK:7&.%87CK4;(@(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M/X%,OU!^&W^'[/H0_-OOGCYYN*_UVI\CJ?FVCSGX5VVKG%'&:7V5O;+<R4H
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M_2WN)/\ [=T.V>Z'=,RM,10]FU<-M_RNUVUU.#Y'7W\4\W_>[O@*V40X3Y"
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M,.!7^M_-Z=J=Z.\'P[ DDE/<[$J5](<<-_9^>G6GC64[1MP*9(R14 8[!O\
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MJ@(" @(" @(" @(" @(" @(!V(/G<YSBQT]E\F:YJ\100!SI'X'@:*FM*BN
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M^=']T_-_ZN?1/S ZCN5A /S\:8_W.[']7@I_OAH5]F/3'SG]T_-Z8Z<^B?\
M):1ZB.5;:CY_)K_M#L-_Z-;=WO=MHIZL>F&&WW0\WNB8BV[T3\PWJ+Y6,Q.?
MDUVUMW84[/76CJ>]^WF8]6*?2_G;$>Y_G-N=ET_!/^2K=U"<KY8^\;G7JO('
M%W3J[1NXPIL][-#&(LBD_P!*/G5O]TO-9B:V71\$_,_1RGG5R^S_ #BRR#)\
MY-S?W9/=Q"%WK4I45XJ#:M[3]Z-'GMLLLB8NI&?3\+4U?=GS"S2G4U(FV+8K
MC7&GP.:!B ?(%TT36(GI>+2F"5((" @(" @(" @(" @(" @(" @MEYZC\,R@
MD8<8^$J+HP@C.CFS0G\5LI_>X4PF<)?7(@0$! 0$! 0$! 0$! 0$! 0$!5B)
MB9D6%=;]?F_1E-OM-]^UE;NUKC12]UZBM?A7L:>3'?=RR''B&_!988;KHFB!
M2E:T]]8_#Z)5[TG=V_#]:B>'UHS0 <,/.GA]:8ZDD$XG;O4<G63'0@8X[OA4
M\G1)URDX@4'Y^*>'UH[D$[ ,:>BB>''&3!.%*U]*>'CFF?C/T0'DP_/3P^LH
MBH% 1CO%?<QV;$\/KP1D4V@8GW$\/K3U ![/,*[5$Z>&9%*POTZ%C63F,3_?
M.6?M(7B[CA\+T)=ABUD" @(" @(" @(" @(" @(" @(.%N=QII@_IOJ.42F*
M<6XY+?Q5B\X^ )%>*',*D$! 0$! 0$! 0$! 0$! 0$! 42/,+\<X_P#WW#JJ
M[1;:/_P*5?J#\-O[ LI^9:_-OOG6?/M>.$ZNI\CJ>FK5H..*[;5C&(<9IT\*
M)CIEN9, T^3W-BSR3PC@I&)K[ZCBI-.6G%%:"E:>BJ$XS6F!A2AW>?>A6>'%
M)&!WDHB)QZE-#A7';A^>B:I![!ANQ0F.M.W"GGQV=B(GI4U-/*-ZA:E,.E)
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MG&<&O92LTR;>_P#W/+CL8[[51J1ZD]GR,V4VTXR]++Z/T?\ [U?TW?O3._\
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M 0$! 0$! 0$! 0$&E/\ >)OV*3[0H+1^76/-6[(V=Y>?;*L<"<UWJL" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M,EY3^N41D+OE((" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M#F!_G4MOWQ;_ &P5+J5ZV&[-=U!]XA_8H_M KLS50$! 0$! 0$! 0$! 0$!
M0$!!Q9S@_B'GW["/3ZKUS_O+_9UW9\DND]V/[6TOY=#JUA^--4TI-+ACAZ[M
MGG7YD\TF(W,Q2M9GO?K'R2:;*)XT'ESB:# [JCX2MO9S$Z7+2,$;J(NNYI&N
M._'WO@6+=S%W+$11.AE245WX^7'9[RC[M/YTLO,<1':/3^<GW;^E)6#B([<?
M*GW;^E)6"OD]_P#.3[M/YTG,5/9[_P"<GW;^E)S Q_HI]VX<TDW42#6HICNQ
M]U/NLS/M2GFH@'S^7;A[V]1]VG\Z43=ADJ)#C\; 5]"QQHS/&89/+=2G/A5#
ML:5-.Q1=H3TK>8:W+R<L17%-!W;V_%Q!!&!.ROPJ-#3F[4C&39:L19=,Q$S+
MDWDF .:NE@,/6N/5 _28X+NO)=&8WFE-<.:.^'SSW[U(_A&XMI'L_)+M.;L'
MF'P+] V>Q'9#\QSFE60(" @(" @(" @(" @(" @(" @MDYZ_NW)NSC%?/Q&G
MO*MU<$PYNT,:Z7RH_P"T!3&2)P?6J00$! 0$! 0$! 0$! 0$! 0$!!81UPT^
M;M&=OM-]3^U%;6VX_ I>Z]1LVU(I7!>K##JXVQ*MHW[/?1J:O"D*378<.WX5
M+)U'P(GMR/@4%(SX)%,:BOI(1-"H(-=N[\WF4HKA1!QV>Y^>B,9[2J%9E.Z@
M% =GH_/1->"*]HJB$UP&XXXHF)HBGE4%.,F(4HQA?KT+DF7F-7^^<K_:5Y^^
M_)9]OQ=A:\]LB"D[E@UN':F%2S1D@4@@(" @(" @(" @(" @(.%N=U/Q7=V\
M6'N.42F&XY+?Q4B\X^ )$UA#F%2" @(" @(" @(" @(" @(" @*)'F%>.;_K
M<.JKM]FT?Z?P.9?J#\-YG^ 63/YEK\W>^45\]W%,O&U*_$ZGYMH\Z[;5G&'%
MZ?V4=LMR_P"Q[*8^]19Y1=E'2H(PQV[SV>A0K$\(1L%1[GO;5"<*TG%(PW4]
M.U,BG-.&2:84IZ%*M<4$@[=GP_6HA3TF/G!V[D37AE0KLJ.W&OUD,\DCL!V;
M<.U$5XS"*@FGYC]:B)QB%)J/JCX%"V>*LUH/?4W16U%E.9H3[+>A_NNU_;VK
M'K_93]&[N9]M/^L6SUP]/+P513PX.G4#?E-T#_; OR3[P_VQKTZ9[Y?IOW>_
MLK0^'NAVQKGG2H.[SA3"MWRO,W\?:G^E/Y_84KEVD17;7\"N1Z,5^E_PU_PY
M;_+H?GCWWK_>#7F.GYW3P&U&.![>U?0Z.!F[&4MV)"+D!W;[JA,Q,XIV@G97
MWJ?#52COA&R@/EK]10G&?D3MKA0X;U*(FG8G#A\GYZ(QKUH-?3N\O:B:Q3((
MW>YY>U11,3&<YE6G;Z-JE%)C(QICB3NV>^AUQP03^AVGZGG4<4T]7&%$IV>G
MT;%$S,M:R,*MK?"EO)C@6/IY<%&I[$]C//M1VO2T^C]?ZJ_IN_>N=?X8ORO[
M\?XBW+]*^XD_^WM#MGNAW3MWKAMOQ[7:R^0U]_%3-_WN[X"MB4VYN%.0A^6S
M@ 8=X:X[/6%//51;Q5G-<XK @(" @(" @(" @(" @(" @("#YK61II349&[)
M,T_P*=(]NS]I;WPV=G%=S9VL:B&OM6=4V_/.:_X?.OT+J>Q9]"WNA]+VE/5Z
M*-R* 4W=GYZQ-O5X3Q1\"EA$.TQIV'W:)W+9"*GGVHF?C-@*$&W:B*^D[/37
MZB)PIUGP(@Q0B:&VH!I[Z)[A$/L^5P!YF:2KNS&WJ/\ MF"F/I6#?1_N_5^C
M/<\[S+#2^"?E9&]C^XK/]ZV_[2Q?![_;GME\YN]J>UN"M;6X(@::[J46:"85
M*4" @(" @(" @(" @(" @(-*?[Q-^Q2?:%!:+RY/_2K=8U^4O=VWUO>HHC(X
MKOU((" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @L^U_7^=*(#9[1;?M@6;&D=A;%(P7>0?>(?V*/[0+"-5
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M8P!XF>WUG."F=MJ1E24Q=7!>9IS4VG]5Y=#GFFLTL<VM+V*.=DEE>6]R#$\
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MIN=*L1[4?(^>>_=E/*MQUQ\[M+&P>9?=[/8CLA^:Y2K @(" @(" @(" @("
M@(" @(""V3GK^[<G_3C#MQ/N*MW <VZ%!&ELIKM]G"F,DSU/KE*! 0$! 0$!
M 0$! 0$! 0$! 0$%A76^3[!HN@K^$7V^GZTMO:\:*7NO0$AM"?11>I##JY1*
MIHJC4U9B*( J0//BI9.$ KM[/JX(FM9QR1N'YJ(A54XX[?)V*%J*>Q2B<:"(
MK3(!VX;=GD0[$DBE-M-AV;<=B$]:-A[0-R)G"1"(XSDDTV[*[NSTH3'2@@C!
M$9=B_7H6^^\Q_P!\Y7^T!:&^_);&AQ=A:\YL""D[E@UL*=J85+-&2!2" @("
M @(" @(" @(" @X6YW?Q7-</6^HY1*8REK\E@!I6(C:3C[@4H<Q(" @(" @(
M" @(" @(" @(" @*)'F%>.;_ *W'JK_>VC_\"F7Z@_#;^P+/H0_-OOG3^.[B
MO]=J?(ZGIMH\_P!6J[;5I6)<9IQ,:45Z9;J38T=H^LLTY)G&8F,%!J=@J/A1
MCC#M,=K=_P!3SH892#MWG9Z$)Z,H*FE?S#%#"M!U< $DCI17?2E?J(42" *[
M*^<[$1-94UQP- -BA:F'6J%0:4H#LQ4JSTE!B!AV_41->E#L -_O*+LJ+:<5
MEIS"@MQ_PNU_;V*FO]C/T+NYEVLQX]LSTP]/'P5J_P"C@Z==],INC_V0+\D^
M\./G&OVSWR_3GN__ &5H4Z^Z';&N>=*@[O.%,*W?*\S?Q]S_ /?4.?M!LRW2
M%3_VG<K]+_AK'_MRW^70_//OM3^\&OTU^=T]#&G8/?\ K47T-\_NPF813&@P
M&_ZB$33&3M.PX5\GUZJ$]49 J<?S'=Z**43/#@@$D8;O?JH3-*XI:-N\;E-$
M<TQDBM#6N!W]M$*5CK,=AV;_ *BA,1$8F(P!V>3M3(IS8I-1CV>_]:B$3PX(
M .!VH3,4I4-: D5I6OU%*(ZE$GV-/+]14G"*L-L75I+;7Y_!93OX'5]PT^!5
MU/8^!FG"^+>MZ6GT?JA\*_IOW?@F=^G\,7Y9]^?\1[CX'Z4]Q/\ #NA]*[NA
MW3-WKAMOQ[7:R^/U_P#Q3S?"OX.[#9N*V2,W"O((UESD=DGPN"K;Q1.<+G%8
M$! 0$! 0$! 0$! 0$! 0$! 0?-ZQQTIJ/#B_@3-,*TK^!3[TCV[/VEO?#9V?
M[S9VL:F"ANLY[1G.:^G\/G]Q?H74]BSZ%O=#Z7M/R>QK;UC;>KG$",(A@(5Z
M1 -"A7H-BA.4BE&78(5](@(G+)"(2AGD^RY84',S2/9\XV^'GN8-ZU]_^X:O
MT9[GG>8_9_!/RLCBQ_<5G^];?]J8OA%_MSVR^<W>U/:W!W+6UL9CM1 W&I\V
M"S02J4H$! 0$! 0$! 0$! 0$! 0:4_WB;]BD^T*2+1>7 _Z5+OR27GVQ41T"
M[]2" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(+/M?_ .=.+#'VBVQK_M@W+-&4=A;'%=Y!]XA_8H_M L(U
M4! 0$! 0$! 0$! 0$! 0$! 04O-&DCR?"L>K[$IC-AW>,\XCJML_Z5AP[:QW
M2^?^?Q^NNCC5_-__ )OJQ[S;*OL^M_XG4Z["IKB221V5\JXW4X0_+NA]C$]2
M@$>C?Y%EHP3&*#7UJ8UIALI]=%<8Q3CN'IJB8IQ!CYNQ,DST\3S##SIVH[<T
MD@>?<D$*:D4K[B8)I$I&& W;O/Y41$8=2DDU(I3TUJIA,5KU)IB:XCX/KU4(
MCF^ H,'=FP=G:G43%9ZRNP#';Y$G*:IITJ9_O<V-/D)L:5_6W8+)Y=]K\+3W
M\_K-+Z=O?#,.\%C_ *C^@MWX7FGI^4AQ\B^H>45\/X/F?UN_ K_ NV^C'U8=
MMJ]U]F6L]:'_ %;^9?\ S%??X%=K!N/L=3Z,]SD??K_"V\_8W_4N8$]BZOS@
MSAX>'.\ZWU_[X3KXG,4F9_I3WOXQ:]/OVO$?U^I]:6Z-'.?ZN(X:FNS=L5IK
M%5NB:>LI< !M\X[.Q3,UR9=2D3'2IV>8;O/Y5&;%F@UV;:[$PS3%,U7U-W95
M$=JG#$UKVX43O6CHR13;A[ZDK&?!)PIZN&-<?<16LUH85Q_H?7JG8G&F"KR#
M"BA'7(-@'G0FDG#0@#M_-BK6SG,K;6*1=1+\=V(_.JJQABQ67>O<NMZ!37K7
MY&4']U7U3_NEMN7N>4_:V5Z?E?:/P(F)]_MM3\_Y;6=[EY_@^R_>EM^TL7U'
M2FNG'8_K#I?9V_1CN;Q9%UKO/>@O\IWUD97^O*SV9=:DSBYUT/3\5\IIL]G;
M\ 6&[/%=]:H! 0$! 0$! 0$! 0$! 0$!!2=H._L[?2HI2:IC)M9?W/<_L,G[
M6]-?V)[)[C0^TCZ4=ZR>]#O:+K&H]JN*X ?KSO2N.W-/$E]LV]?NUOT([FD?
MK? L5K4V=/7[6C0[-YVC\]6>AUI!&()J-V"0B:YQFC<!3''X4.(0:G?2B)B<
M 5IVC>-GOHB3XVW;\/UJ(9 .W&GHJH3*?B[?1]52C-2-U-JA,]>0=V%/35""
MF-#A[Z1%"N #Y//Y>Q(J4;V#&>V/_"K?]O8K;./US!K?9W?1N[E[EM^YK?\
M8(OVMJ[*SV([(?%]3[2[Z4][0O-L1V>MM_.66UJZW!N9?O$O[$_[0K%?[,]C
M:T_;M[8629L[ASC,1\;\(EJ=@^^/\BXJDUGHK/>^T6:7ZNW'\F.YL31K(N$;
M>+'^BHSE?PNLJ*^0[1YMBFGI1X<J@>(M[<5%(IF>%,J2['#TJ:'A3QE5QX T
MVUW_ )R4GI/"ZU(>=^/O?42AX76FM#4B@=LQ[$I4\&8BM45-2:\.RN]33I1X
M?1*2XC=2NS9AVJ)A,:<=)OP%:;,=E=OGJDQ7)'A]9Q^GR[/J),53X?6KBKB?
MJ[52WXV+S"SENTISK*N0EH:/BD^GM5J\SV=Y=2VRG1\C3KQ2P"E.&[M3MQ/R
MS#YU.WPO>96+M._Z$]R^&R_<MM^]X/VIJZW:S6WX([GQ;6^UN^E/>W2VF)Q9
MS:_BS-YQ_LD&XY4?Q2LSN)?3]2E)B(JCC+DM$B @(""G#L'N+!=K3&$Q*>6'
MSVI/XMZA(<YI&19N:MJ'-(L+BCFD8APW46ER\]9G\V[N9[?;M^E'>\Z/G-E^
MH]4\_.8>696W/M69A=:OS*SL&TS+/)GRW&=W<,438J74EM&U\@;4  !;_EFG
MED;V_P!2L9N[/H1\%'4&JI\FYC=5<#\FTS&;3,+7EP2'3:@BF9!>6LLUT;42
MVC81M;M)-*;:=7.]TMKI\ED1?J4QZL',W6:NK?S75MLX9XXY,GWEURVT7RPT
MYE6C= Z>R_(-/Y1;1VL$=E:6]M,V.)@:P33PPQ/N7D-'K.J5SVKO;M[===J5
MBG"N$_!5Z6WVNGI64B:UQZ^'%R&?O<CF#A)X0U^]U-N&T;%KVZDZDS&40]#2
MBV)MC\F'YN86UMF%M<6N86=O=64\?=7,=Y;QWEO/$]I:]C[:9KXR'-<1B"%K
MZ^K;MH]:.;F^)M:=MM8B,;JX1EZ71KUT^#1RVYUQ9CS'Y",@T#K\QW=]F&4V
ML,8L]571]HE; UHMG-LG/DF PP7FW:-_ENK&MHS?JQ?/LUF9CCPX0FM9G3UI
MB+HXL4SG1R4YI\@]5YCHKFQIS-]$9ODMQ*S+N&WO6V[.[EE#9HLZ;!!$77/=
M<6#O579^1;Z=>8BZVE>F7A;[;QIW3=$U9AG@J9QG6<]'&D)LVO;Z^DC==,MQ
MF%[<7]Q%&UUH ?:[J6621KAB!7!>W[QV6VV:5*==*=$]#S]G-;IGC#N&D=B!
M39]6B^<[O6FS5Y8B71Z=OJU:[35H*]#1FNG$]3'=%)HJ65 @(" @(" @(" @
M(" @("" JV>R.M7Q7]0MR;HWYE6/>.9/G%K%;P<$AB?01W)D#7-<UV-!L6[M
M8B;N;C"*T8//+7E?K+FGJ?+M#:"RV^O\ZS"\NQP17EQ([BDG&T-[QWZX-RW_
M &(PQ)E>D_PL>KEK[:&/1F<23$!X/M-X!PR#CQ/LU-CEAYL:8)IQ42>%AU<M
M%U"S1N<QODX1^ZKUP':1^#45K]2J'=CX-W2!SJZ=]7ZQON9F57MA;W<,383=
MRSO:#W=J*-$L48%3&=BT=6^)BB>%&167!LM'O^,"Y@(H&AH]8EVS8L$5IAD,
M6'QA_$AUF=>:DZ4N3U_<9 [2W='6NHK"\=^&BZCN1%!!-:W3"P0\-"!C6M5N
MZ.E2VO$^9T5<N.1_/#J(SRWET?I;46L);J5[<RS[VO,Y(K6=SP&R]YP3L=Q/
MDKM6:;XXY-:VR8K5R!S6Z(.J#D7;R:BUOH/4$VF,I;'/>ZGM[K,0;$R@R6[G
M10P,+Q&6XFHHK1.*]%R_A]>(;S-Z;>;&2:;U?J:_S3EUJ.]MK"^^<;JXN([6
M,SVEO''^%7G#$6AM-FY8]2(FVDIY\8PP9N.BM797KG3.G]5Z>N([O)\\L(+Z
M.9CFEM)X(Y: ASZT<^FU:-UM)F+LV6E'V*Q@@(-O>?N2Z_>\_P"UN1$Y+0>2
MI'XY9EC_ ';>_MQ6YJ^S'8U]&8Q[5XRTVR(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @M Y@?YU+;]\6_V
MX5;J,,UKBNZ@^\0_L4?V@5F9JH" @(" @(" @(" @(" @(" @XNYQ _S?9[5
M]"(?C4\CMP\BY[WFCF\MNI_+"70>[%W+YQI3UNK-@(EEHXO^4DQX:?9.7YG\
MTMKN9[7ZR\DN_P!2BN=/F#QDD&(5/].!VK9VEL6:=8QJQ[W4GQ<<E1+B?O(!
MPJ X=GD6'=6S9%O&M63;:D385(VQ##^F6KZW1+/XEM:8(QP^1&-?LE'K=:>>
MWJ^)/K?V(>?B2*_ 3J6TX5^ JXB@C&&PU'I3UNB41J6]55)+J5[H?UP3UNA/
MB6]2KUO["/ZY/6Z)1.I;U?$CU@2.[!I3[(!*W="?$MF.!1YV1#S<0Q[$K=T2
MB;[:</B:GKLQ,0(WGC'::8!8[9NGIJOY==%W/E#3)D:03" ,:#B&WTG#8EU>
MM?S"GJ93FK[B5[72OB%01]G3#S*-O,^+Q9=A2-.<J4<F\E6_]+FE0(13\(J1
M)A@(]E,-Z[WR.OWS2SKS1WP^<^_]T1Y-N,8R]&;M+&P>8+]#V>Q'9#\PSFE6
M! 0$! 0$! 0$! 0$! 0$! 0$%LG/:GMF4;O7%3Z3N47Y01FYMT* -+92!L]G
M"D?7(" @(" @(" @(" @(" @(" @(+">N'_%NC?WS>_M96UMN/P,=[KU[/,/
MJKU8R8=7&D<58[2:@_&PILV*6IJ9Q3-37:!L*,M4!$QF>=04Z<@88TP\ZDZS
MR(BO!.'G\J)P14BM-F]$=A3 %#@'# [?@0X"A/>GS"E4(RPS*GXI_-O4HC'!
M?IT+??.8XW>TY7^T!>?OOR6QH1$3<["UY[8$%)W+!K32G:F%2S1D@4@@(" @
M(" @(" @(" @(.%^=HKI@@;>+#W'*)R3$T:_)?#2L7G^H$A#F%2" @(" @("
M @(" @(" @(" @*)'F%^.;_K<.JK"GX+H_T_@4J_4'X;3_[?L^A#\V^^O]NZ
M_P"UO^1U/34J*&N./D7;:F<.-LF?#BO3+=/I@3N&'DP'PK/*M^41#2 %01Z!
M^>JHGHX %0 ?+3R_6HA6DU,*D >CM].ZBE'6$4/8/=4)B:Q*13'L%/S=NU3W
M(QB>M.#?J!",4>MO-/<*&$X1&*7>3W>Q)1;C@88'<*^^ACEQ00-YP[/S]NU$
MQ,Y1F$GA&%24N]A-D1S=31GQ%O7;[7:T_M[%36KX4_0N[F?:?;QT5AZ>7@J8
M>'!TZ XGYINJ>3Y0>[1?DCWA_MC7[9[Y?ISW>_LK0_EPAVQKGG2(.[SA3"MW
MRO,W\?;_ %I_/[?_  ?I'#_M*YWK]+_AM_ARW^70_/'OM_B'7[?G=/ \V \O
M:OH3@L)FG&4^0;!M^$*58I&,YAI0&E1YZ(1,UZTXT (\_P!1$=BD@ >5$Q-9
MZE0'EP\R(GXU-.S8?S;U'8O$TQN5"E:A2K-:5E- B*RIK7ZH^!0M%(SS,,:[
M!2GI4HK.<9G;7 =G]#':G<5KVM.3[&N.W#W%69GBP6Q'Y+;7Q_!I , &.^!5
MU*\F'0S4CFCFSJ]+3Z/U_JK^F[]Z9W_A:_+/OS_B/<_!WOTK[B1_[=T.V>Z'
M=*P "@V+A=OQ[7;737&7R&OOXIYO^]W? 5LHB*N$^0?W_-Z_V0\/]<*JMM<4
M2N>5@0$! 0$! 0$! 0$! 0$! 0$!!\WK$5TIJ,5I7),TQ_[2G2/;L_:6]\-G
M9S3<V=K&HA%;K.:[/GG-?\/G7Z%U/8LC^A;W0^E[3\F>IN*$X +$V]:*41A4
M^12Q4BN.2 /=1"4,NT0-J$YHKCLVHE..VGHJA&$UX"($#:@@[.SWTXIRP3Y\
M$)SQ?9<K\.9NDCM_A&V\E/PF!:^^_<-7Z,]TO-\R^RB.%)^5D<6/[BL_WK;_
M +2Q?"+_ &Y[9?.;O:GM;@K6UII1$*EFC) I! 0$! 0$! 0$! 0$! 0$&E/]
MXF_8I/M"@M&Y=4'-6['^V7E/=58%WRL" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(+/-?"G-*(5K^$VQ\W
MR@6>N$=A&,47?0?>(?V*/[0+ -5 0$! 0$! 0$! 0$! 0$! 0$%$GQ#Z/A"Q
MZOL2F,V'=XSSN'JMM2-O!A_:[H+@//HKK7/YO_\ -]-/>79XY\W_ (G4^[:3
M7\[!<9?P?ES1QT(F<<&D<:T-*TH?-M67)@FM*1P0:\1'F]."G@1UIX?*HJGF
M30UP& V(84ZR@W85]^B8U.'6@#$88%2<.M. Q&Q1U$XX<2FT;L*)5%>/$&W\
MV/UJ)P3-:=1MQ.Q.PRPXA.T'R8)0B"@([$G K25,N$$M!PN$$^&VOR;]^Q7\
MO^VGHJT]]7FTHC">>WZT,PSP6#7H>T$3M]LS3]LA7U'RC#3^#YG];OP+_P "
M[;Z$?5AVW+W7V9:SUH?]6_F7_P PWW^!7:P:_P!CJ5_-GNER/OU_A7>?L;_J
M7,":P<."^'V0SO.JC_ZQG7Q6;9FZ[HYI[W\7]>Z(WFO3^OU/KRW;\7. 'Z&I
M_.2E*U9;L9M:;RW>*#SDT_HJTY+ZN74@8BM=GDV?7JH5[,DEVP#:=GH44Z5<
M(FDE,,</*G&JTSZ#$C'^C]:B8(P,&X##WZ(1"3[Z@4@5IO 5EIP2*8>7WZ*)
MZT3.-8* >4CT;4[D3CV%1\6E.$XBM??5[>E.URNMZ%3AL[/Z"QQ/'BI;2)FB
MZSH&I^6QR,&\W5]3T26R][RC[:SJGY7V;\"</?\ VW7='?#.]L*^P6-,/P2W
MK_:6+ZAI?9QV/ZQ:-/"MK^;'<WJR+K7.>Q_A#*1_MK/MRLUF2LY]3G?0YKI?
M*B!3\';AZ L=V:T5XOK%4$! 0$! 0$! 0$! 0$! 0$$5Q [5&%>M/!M)?W-<
M_L,G[6]->G)->B>XT/M(^E'>LHOB1/=85_"[C?L^6<N-W/VLOMNVBNVM^A'<
MT7 >KC0T[-F"QVSP:FSCUKZY5:!%-]5+?B:I.-,-OEVT2<41@FA XJ[?Z"E,
MQZ%.T[?33ZB@X*@32@VCZZF,D3&.(=@J,>VOU%":Q3!  ._'S;$@FOP&-2",
M5)W%!@3L-?>4'8GBW]F[MJI13@@[]^S'\Y1)",/-[]/KU1.+>PCY>V!-?PJV
M\GZ\SL5MG,>+%.EAUOL[OHW=R]RVQMK?]@B^T:NQT_L[>R'Q?4^TN^E/>V]Y
MBZ+]-]59;6IK<&YF^\2_L+_M"J7>S/8VM+[2WZ4=ZRG.)"<RO!W0I[1+B'CU
MOE';]IHN,FVMTTRK+[=9,6Z=M9CV8[GYL!(8XF,;J5>,/=5>6BT716D4:G$:
M'BC;3#[,)R]!-T4QF* PP[MI!V_*#=Z4HFL4X)KB:-:7#[+C VJ)MJB+HKGB
M@DX<#&D8T/&,.WW5/+3"2+HZ@GB!^3;NX?7';ZRB;8.:)Z)3QFM>['#N]<8_
MT"IY?2<\=,44BHJ&M%13[,)R\>">>,L,$N]7UN%I/Z<>;M"1;64<\4K@@N:#
M@P"G].#M2+)S.>V,!Q-#6)IV5=QCT)RQ/:GFMCH&8!P:T$[_ %Q]4JL6Q$8O
M/\SUL=.O3\JLOXG#U!0;B\;=VTU628P;V\OB;+,*8(C(=?V8N(VLD-Q#PT>"
M#\HRE:8*=OI_K,9XO-LU/5OX^K/=*]ZQ!;9VW$?[GA_:V[UUFWLY-.,<X?(;
M^;GNB[/FGO;M9U7%7-VGXL35%?6'DW.42-SRG-=)61\K_P#8I&1Q<F*02L @
M("5$$@;2!YU$VU@K1L<TM!?Y;F%B7]V+VRNK,R4KW8NH'P&2F_@#ZT439%V'
M3$PB9F(K&:P;IM\._D5T\9_G?,&UTU8ZNYFYSF699A=ZOS.WMY>_^<[E\_!#
M92P&*VDM'.P>TDX5!!33MG3BA[78OT]F#S""]IDM@2TL:&11-(H&-C;ZI  I
MYEL1JQ;$Q2ELL4Z4W16N-6[<WO W@D$?: !5U-O8M/5T_%RFD1T,\Q-F$M"6
MX<QT;^"L(K5PVN.SXOG"K%]>&$*3=RX\%$4[Y9L&AD9!.(![XC8*'XM*K/'+
M,8Q6JME\S-*3'6ALDC2]XC+Y&&AA!X1$T[P[8[B&*II[?PIFZZZL3EU-J+N>
M(LG")SGI6[=1O2GR4ZJ=$W^C^;6BLLSZVN8+EME?MMX8,QL+N6"2**Y;?LA=
M<.%O+)QT)+21L5-OJSIZD76TNFO#A2>-&+<Z==.=-\)T9]+D/2)ROM>4.5ZD
M=J7*LKO+R;+,Q=;M@?:6MU<-DBM'L:QHD]GBC:RN^B]O6WEVYTXB^VD6],Y^
MEX>CH7:6M,9]$PO0EP+0<2?S=B\'6VT:M_/6CH-*O*F0T#/S=BW-*WEMY>AK
M:EU)CM:ZJR" @(" @(" @(" @(" @("K$\T5C(=&_CDZW.F.06295WG"S/KF
M\A<WBIQED$P;AQ"M"[RK=VL3,S3)%:8NF'P1-(0:HZK,QEN;1CG:=(NWNEX9
M6,9)[)/4A[7M%1LV+9U+HMMF[BF.6,:X,U!USD<+FQR7&4Q2$4:QTMFQYX<*
M-:YP.'DV+S)F8*]+<Q-R^>IA;93=IB$$GNEE4GFC.HD00,-&VT43IJ]X8V,8
MX\&(J6M!<L&IJ4FET3,$15\AS&S^/3.@M:Y[</%I'E.F,\NX;@O I+#E=U)$
M02YM")&"F-5GT(B^E,(F3&M'G):[U?G?,CF5G>H\WOI,YS+4O,6^RB>]F+FS
MW5M<:GGL8F/DD<^2D4,U&U)\B][2CFT^N(12N/!GB]!?3-HKIVZ?=$Y#DVG[
M&#-LSR7+\WS:_DMX'W=W-?V-K<M#IGP,D:UI=L[15>%-W-7HJ4B)PR71:^T'
MI?F+HS4.DM6Y%89IE&=97=VEY87%M _C:^%X8YKWQO#) 3@0*A6B9MF)M]*L
MXS2<J//JZR>3IY)<]=8\O[2U,=E::CDS+*Y \L=;01YI<W;8V.#8R V.,#"F
MQ>A;C##-W++, \(SG'-S9Z5=--F<Z1N0016#7OD<]_R,%K%PDNDD=M:M76]J
M+N.2;+^>L4]5VK+5; @(-O>?N2Z_>\_[6Y$3DM Y*T_'/,L=M[>U%-M)SO6W
MK1'+$\:-?1QK$KQUJ-D0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!:!S _SJ6W[XM_M@J71C5AG/K7=0?>
M(?V*/[0*[,U4! 0$! 0$! 0$! 0$! 0$! 0<7\UK>[O=!Y[;VL#IIGQ@1L95
MSG8.^Q:"5XWO)$_PZZF,4Q]#U_=J^(\TLNFD4GY76V[16LFN+X\JN:%\F AE
M- 7G;2/>%^;/--OJW[C]5;==;6<HF7ZC\IW^UT]I%NIJ61-/SHZNM0=$:N=B
M-.W=1\8\$V-=].[WK9V&VUK-+&R_'^C/S&YWFUU+JQJ:?Z4?.I_$?5V _%^Z
M!WU;-Z/UM-UH:VIR^I=AU2G1WNULMF/$L_2CYVK^)6KAMTY=$;CPS'S[8TC8
MZO&V[]&?F5_B&VRC4L_2CYT#0^KP #IVZWU'#/C_ -C4_<=3A;=^C/S(_B&V
M_/L_2CYU(T/J_P!7_)R[WU]6;'_L>Y/N.KT7?HS\R?XAM_ZRS]*/G5#1.KR!
MQ:<NSMIZLWI_6T^XZG"V[]&?F)\PVW]99^E'SI.B=6D5_%RZ_K9O@[M1]PU*
M>S=^C/S'\0V\3[=GZ4?.?B1J\5/XN7=,,.&;_>U/W'4_-N_1GYD1YAMJ_:6?
MI1\ZG\2-7EO"-.W9.X\,PWU_L:?<=7/EN_1GYD_Q#;YSJ6?I1\X=$ZN)%-.7
M8I_2S;_]S3[CJ\;;OT9^9$[_ &]/M+/TH^<.A=7-..G[JCQ4"DQI2O\ M:K&
MSU*X6S^C_,G9^9;>SGYK[(Q_.CYTMT/J]V'XNW6&XMF&WSQJFKL=7"MMU?HS
M\RVZ\SV]U)MU+)_[]OSHFT/K 1N8<BNSQ$ D";X S<L>W\OU;=2)B+L_S9^9
M;:^8[>(F;M2R)Z.:/G<C\H='ZBRKF9I.[NLGN(X6^T\<[^\:QF#/C.<P-'DJ
M<5WODVSOLW6E;;$S-8X=<.#]\=YHW^6Z_-?;RS'YT3T\*NRX;!NP&"^V6^S'
M8_/\YI5D" @(" @(" @(" @(" @(" @(+9.>O[MR?]D'PE1=P(<W:&K^*V4U
MV^SM_-AY$C),YX/K5*! 0$! 0$! 0$! 0$! 0$! 0$%A/7!P_-^B^+^^;[M_
ML1[%M[6F-<L&._XW7KN]Q>I##JTI%,@(U=3@*66@-A[<$(KP34C8:TV'S[41
M0W>4>_7X*(G'BA#+-)).W<A3J-IKV[T(1[W:>U#N$17!)(/D[/(B<)SS*D8!
M$3T(P![1[B"_3H6^^<Q_WSE?[0%H;_\ )9]OQ=AB\YLB""L.KG"82LL9(%((
M" @(" @(" @(" @("#A;G=_%@[O6^HY1*8;CDM_%2+SCX D(<PJ00$! 0$!
M0$! 0$! 0$! 0$!1(\PKQS?];CU5?O71_P#@<R_4'X;?X?L^A#\W>^<_[\W'
M1XU_R.IZ;:/TQ^LNVU<)BKC+)KIQ/7+=/('"?)A[@JL\HNQB(A108 X_FJH4
MQSX&.%!2E?151V)BGY64I.S$X;\-O8I5[$$8C"M??1,9&^@& ]ZJ'#&<S=AB
M#[WN[:H1-)K.:!2N'H^JH[$]'-D5Q-<#[M,/?JI1P3Y-I.W=LV(1''*%-,:>
M_P"A0FN%51-1YTO]FI;'K-*?9 !_?=K^WL5-:*Z4_0N[F?:3^OMF>F'IX>"H
M /#?Z=-U,INL-N/>#!?DGWAQ\XUZ],]\OTW[O3$>5:$_RRAVR+GG2H.[SA3"
MMWRO,W\?<?\ WT_G[C6N7Z0'93\"N?=7Z7_#7_#MOP_(_//OM_B'7[?G=/%/
ML?<^%?0NIP,\9!C4[-GEIN4JY8&._?N[?2%"<Z1"2VI4HB<$8#SCWZH8SV).
M(!V[?)7ZU$(B>!NX:^]Z4(SKP <?/]0(3&":UK3'8B)C)%<?(?S>?:B:8=9L
M.&/:/SRA6L8IQI]7\Y$3%):4FUN-!C]14GXF"V)MQXMM?X6\N^K'8_U/8JZG
ML3V-C":8<7I:?1^O]5ATWX_W)G=,-OX6ORS[\_XCW'P/TG[B?X>T/I3W0[I6
M # ;%PVWSN[7;W37&7R&OQ72>;C_ (.[X"ME$9N%>0=1-G/9WF']<*JMO%$Y
MPN<5@0$! 0$! 0$! 0$! 0$! 0$!!\SK/^*>I/\ F3,_\"F4?EV?M+>^&ULO
MWFSM8U4/[JSG_GG-?\/G7Z&U/8L^A;W0^D[3\GL:]/+58FYK<*"EA$(P$)IP
M,=V[=VHF)$17 1/4(99E:[]J':@"E:;#N0F:A-*X(A*%?2;_ #(G)]CRQ_SF
M:1&[YRMO\)@6OO\ ]PU?HSW/.\Q^RKQI/RLCFQ_<5G^];?\ :6+X1?[<]LOG
M%WM3VMP=RUM::41"1[^_ZBS1D3\25*! 0$! 0$! 0$! 0$! 0$&E/]XF_8I/
MM"@M&Y<#_I3NC2GRE[CV^L?<5?RA=\K @(" @(" @(" @(" @(" @(" @("
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MPUP8.W:O,W&I=IS;$3A<];8[;3UK+[K\9CYELW0;XM&==:7-0\O\TY1G0P<
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MV/%"P+;NF+:1*MELW<7[VINMGK6OKN?4^<\U-3Y3:B>2:W>+#->['M,CGM:
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MK8_[\?.QW_\ \OK86QS6^]5\S^SG_)5?Z7'F+)B[E!:'"M?;(!L'[.O-U/\
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M?U*\WFNRBV[T,'\0LC"(M],<$G*LU(H<MG\IX)/./L4YKOS;O1*9\PLZ+?3
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M7/W:P:<75GU[_P!*?G5GP_ZG1_T=GS-&02<0I>WYI_PVY\A_LBSVQ,13GO\
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MB[@RZ&?$;^E;\ 7]<]+[*WZ,=S^)]WM3VJED5$! 0$! 0$! 0$! 0$! 0$!
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M38)+ST>MY56.@7?JP(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @L^U_3^=*&FWVFVKM_L@]"S='8BV.A=Y
M!]XA_8H_M L*6J@(" @(" @(" @(" @(" @(""E_Q34TV8^E8]7V)3&;#N\:
M"AZJ[*IH. X[?UNZW+@//OMKG\X?^;VG]Y-G7^E_XG4Z15Q&SR^2BXW4X/RQ
MH8:.7!1CNV'?V>[M63)CF9F:79)V8=NQ0C.*\0X;_>2#.<,D$\/FW*<SA4.-
M*''<G:F(PQR1LK7?3WDC%,TKZN2K9LP)^HBN*FG%MP.\;?,F1$S3%)KOP'NI
M&:U(I6,TTV**JJ0.W\WN*U>A->$9I %/.HDF<5,G%W$U33Y":II7];?V+)Y?
M3Q:\*M3?<T7:7T[>^&89X+ _^1[05,/PS-/+^N0XKZAY3CIX='S/ZV_@5_@3
M;5_-CZL.VY>Z^S+6.M'_ *M_,K_F*^_P&[6#<?8ZGT9[G(^_7^%MY^QO^I<P
M*;(4%^7?'.>9U4__ %A/3R+XG,UF:9<T][^,>XPWVO7/Q]3Z\MPYQ+I&[?B\
M/PJ^1S>M$1DAV(J<2:5W**UPAFU(RFN*D[2*5KY48^%45VU/IHA,4BJ:>Z=G
MYMFQ.XK$QU(H<23Z,$PJ1A.'%-10;MM$Q1BG >CZJC,Q]*"-@_,%-4Q7,=B#
M4=F_RI&:*1. -NSW]F"<$\%3MH4V<4[;*ZB'@'A)VXX^YN41G-&.V)F9F<UU
MO00*];'(PC8+N^_;+5>]Y//ZZRO2^S_@1_C[;=/-\MK.]L"!867[TMJ#_<6+
MZ?I4\**=#^L.C%=*WZ,=S>K(NM<Y[NI?Y2!@3(T>?UC[BSV4HI.;G;0W\5LI
M_>[?@"Q7>TN^M500$! 0$! 0$! 0$! 0$! 0;.%O=N(J7<9)\V^BIKUBE&2[
M6\2D4I1M,T)$$\PK6TMKBX#=TABB=)P'R.X:+-%_AZ=TTKZLJV[/[UJZ5O-R
MUU+8],Q#K]O^LO,+&[NX&\O82+>[N;?B]HC!>+>9\7'\?[,1U7R?6\XU/'Y>
M6,+IX];]4Z/_ "^Z6[VVGJ6>;W67766W>S,^U$33+A5^-+UMYB^4 <N&5814
MFZBH17].LV^\TU>6S5I;ZN-*YT^%/_35==///GTQ'1R2WIZWLRP/\V\0%/[X
MB)P_JUD_XA61A.SR_I0V?^G#0RCSB:_1GYE7Y;N94)/+B*O;[1&?]F$_XAZ?
M^QX?2@C_ )<=#_UB:_1GYD?ENYG0%O+>*O[XB^[3_B%9QV7_ ,4'_3CH9?QB
M?T9^8_+=S/9_-Q%AN]HCI]LG_$/3_P!B_P#BA'_3CH_^L3^C/S)_+=S&M!RW
MBI]E^$QX]F''N4?\0[/]C_\ BA/_ $XZ'_K$T^C_ #'Y;N9T->7$1.[\)C^Z
M4_\ $.S_ &/_ .*#_IQV_P#ZQ/Z,_,@=;F98C^;>*O[XC^[3_B'I_P"Q_P#Q
M0?\ 3CH9SYQ/Z,_,AW6[F9P_FWB)WUN(_1]FG_$*S_8O_BA/_3CH1']L3^C/
MS*ORW<Q.+>6\0.XFYCJ.W[-/^(=E?W/#Z4(G_EQT,OXQ-?H_S'Y;N8FA'+>*
MF-?PB/[M/^(=G^Q__%!/_+CH1/\ ;$_H_P R/RW<SJ:<N(O+^$1^C[)3_P 0
MM/\ V/\ ^*$?]..C_P"L33Z,_,@=;N9$$'EQ%3  ^T1X<6!.#U6?Q#LF)B-G
MP_.A/_3CHVQ7^,36,?9GA\"J/JZO[F>QA_$J&(7=[;0&3VB,EG?SLCK3CKZO
M$O(V7G>I.M;,V>U?'QR\R?P=V^CIZM_WN^ENG?/LSCRQ/4[#LKC!M;>[<WA?
M=6T$SHZX,,D3'EHW>J747V6[5G4LMF(X0_+<[?[MKZEE:TONCT3+=&3O,>'A
M<W?6OO>A5BW"9G.BUNI-N<8/S;EYN+/,&?$K97;0:_HH)!7T56GIV\NEJSU2
MV-IN/];THI_YEO?#I'U9ZNH-0-IB,QN@37LNI5^?->L;K4^G=WOZ1>28^6;6
M?\U;]6'S!J>]'#CZM,?,L$<:/8P]6:]+<-:X#UO)V+#9G+%,VS.#1E8ZH[=_
MO46>W".MDLNBG4U0QVVE?)58U.:$\!)IN'U4E'-%*\4=VY#G@[MW9[^SZ]5%
M3GA/ X"FVOFPHI.:$&,CS?F\J'/ (W>3W4C$Y[3@=V5].Q.)S0U+5C@):C:.
MWR+8UL8MZ5=>Z)FUMN$AVS>?A"IY;%(U*]#-S8*^ >WY+7!IS7+<?^W(5J^4
M?OT3_G(^LB^?]3W-,_ U/J2[X\C%,FRD#8,ML?\ !HE^G+?8M^C'<_F-N_WS
M6_;7_6E^HK,#BKFY3\6)J[.(=O8[L437@-QRF!_%"R.XE_PA3PA'&7)J)$!!
MMP\R%X(I2GEI\%5J;B.A-EV/8QR?I!@KH#E *[;S-_VF=>)N[:7:/P?6EUGD
M$QX.M\/=#KZ\#4@=4E]AB(1AYXK3?Z5]EW$?^WKHC\VWN?*M]$QY]9=_3GO9
MGD4G%A2FW?V+A+[:.BT;^:*-8CT+!?;-_%G=>_BB_P#4MYN_TN61'WY?KK@?
M?B_PM#0MS_76_*Z#W;_?IG_-W=S#6Z$"7=8/**N/\/W.W'_OC:T]Q?J/\/;>
M;W>F<OU'_@?$_>:Z9\XG]K_XGH2Y?_BZR_>5M^T,7R+6^VO^E/>^D:?V=O9#
M:V^+G[O6^J5AB_G6VN$7/U3L]!^!8=?*?HSW+1G\+!2\8K'KPYL[P;+(\/-;
M7.WMHN3_  RU/&]Y]Q;E_K$_7=![P8>0Z$]&E_X60=X(&/1QI\;A+= ?]SK[
M_P#B;I4UMK;,X19\SY9[IW5LUYI3UG<H<6GU:TWUV>CRKYK?%(AV6WNK,UP:
ML 'K%NPT^JM;1IB-PLX(" @(" @(" @(" @(" =F&'E[$&WC]7B#I.)[03(:
M>0\/N!3@775PC*%@W.WQ.>C?ISUMF'+SF[S0;IC5F6</MEA+E=S.X!PD+7!T
M))<.&,XTW++&E=?E2BD74C'-SWT\]4/)GJHTC^/G)'5D6K-+M>8_;F0.MC(^
ME2WN97&5H;48D#:JWZ<V4KG*8NKV.>Q*1PNF^1<XD=W\8OIL-1LHJ76Q=A&-
MJ:TSSET3>/)F5NWIADR9TUN<PNYX'6D#C$VXN0)+OC[IQ/>-X ,:+>T8I96,
M(F6"/:FN-'1QX0$19UP\KH76?<.L&7)CX)>/OS)'9\;B&G9&34^99+\IZ:,F
MG.=<F9AU+:=N=3<B.9&40O+KB72N<RM>&DGY'+KJ0GA =6@"\R:?&M=A#SL7
MMB@U7%#+.>*RYIVK[B<LH)Q9ZP:20, T1<!JO?VWV5.-&KJX\L\'HX\F=1V.
MJ^5W+_/LKNV36,FD]/Q/FC<R2.XDBR:Q8^CFN<T<$I(V[5XNK9-M_+$UQEM\
M*RY)GD?%'>3R>K'!;RRQO!!(#8G.<2T'L:J6QZT1UHG.O0P0?%2UA;<P.JS6
MES97T=Y'EUU);2S1R-<&RB2]B8SB:]^(>0*57O81;AT,<U^%D">!+IO-LCZ7
M7S9O:.M;B]NPZ-[XRQTL09$6.!<UI>*4[5Y.XFLQT57MQQXN\E:JX@VXM+45
M(MK<$[2(8Q7S^KBE9&WN[6U;:W+A:V]1;S&O<1;HW']#BIK*)R6D<E2/QRS*
MG]^WH'F[XCT +;UHFD=C7TL(FG3"\=:;9$! 0$! 0$! 0$! 0$! 0$! 0$!
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MFVGI3(RJ5P%!MKO1%%(/E]Y2M2**JTJ:UV>10BDSV(.X]M<5,)RPA) KVD[
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MK3#@HD.(IY<?<5;LZL%D32DY-"^_<T@'Z!_OM*C4GU/@9*5NB9Z7I8_1^O\
M57]-W[USO_#%^6/?C'WBW'9'>_2ON)_AW0[;NZ'=,P 8#8N&V^=W:[>Z:XR^
M0U_7\4\WH:?@[O+N*V91;FX4Y"MI<YN0,.,U_KAVXJ+<D+G5((" @(" @("
M@(" @(" @(" @^;UA4:5U'05/S)FF%:?W%/O2/;L^G;WPV=I^\V=K&H@H+K.
M37_OSFU?)^'SK]#:OL6?0M[H?2]G^3V->NT$=E#7ZBPMO6X"EAIZ#W_*A-.!
MYQ3R51,X3U"(/@0F*"!Y\4*^A&R@[=B)I,I1 AEF4/U_+V)@G@@5ICM23L?9
M\L/\Y>DJF@^<;;"G_"8/K+7WT1_#]69SY9[I>;YC]E3JGY61Q8_N*S_>MO\
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M7B;L$?1=SF#S(R-F6Q%KN!SR>(G8*5I4T\E5P'O[H>/I;.8F8IN+.NN,O?\
M+=2(UIOBG-X5U:<,&'#T&N8>L/E-;]T[VDY]<DBA/"/G"V(-=U0OONKJTVNE
M;9A^IMRFGY,=#Y7IQS[FZN?B79_2>@GET9=89?PES)186-7%IH*6\=1B*5*X
M:^Z8FZ)RYI[W7:<1-)BO/%L=T/V*?FH/S8K6F)X80V> 56^)FV8ZA@J>,2 [
MKPYL1-;W<S+/)7M<34/_  :Y)7(?AYM+M'WJUHQBNX_\;=]^=3F]W-G;$TGP
M_D9!'@>N$W1]IV0#@G?)="1VT$M=:TH-FQ?HC\4>;QM"(_,CN?/?=#+4KG_/
M#N:<< !B7U];9L\B^/[>VZW4B9R=KJY3;DT&,<TTXBZI[*;*+?U9B:4BBNUB
MG-5^B-@6)80$! 0$! 0$! 0$! 0$!!I#C;PM(XP>+B?LH-V"#X'F)R^T;S.T
MKFNA==Y':YQIO.+=]K/:W44<P>R5CF/=&Z2.7N9&B0T(&]9;:S/-&?%7"/58
MX_4GX!LU_JO,M7]/FOFZ4R*>6XNAH9UH+OOWS/FE,3+AUE\F'.>!AL6S9KV9
M3FMVYK"!X*O5ZW,+AATRR/+1.V,7/?L>^=IDX3/W?L9<T4]9;<:]DQ.-N73"
M*4FB^KIM\!&]MM795JSGOS(=F60V$UK=.Y=LRQC&R<#X)G1.OG6C&EH<PM.)
M.*\>9FN:8BVF6#),Y><M-%\J]*9=HO0N1VF0:=RN%D%M8VL4<?JQ,9&UTDD;
M6&1_#&,2GQHQE]L ]KY'.DXV'AX(Z4X-VW:D146>=7719R?ZQM*PZ?YFZ>AN
M<QR)EX_2N=-<R*XL+R\M7PF=TC8))960O+7!A-*@]J1-U:P4C")8V?-3P&^?
MVCK^Y9H#7(YCV;KBXEM('6+;$06SY)7VUL'NL@/D(@UE=Z]&W6MNMBZ9BB7P
MVA_ _P"JS4-\(=43C1EN9&,=,(VW@X"X-,AI9FH:"3Z%2[4B,8I/PHICU.]S
MH+\*'E=TAW!UMJ.>TYA<T9VQR#4=U:0LCLG<$)+8+>2U8UDC71?&"U]35YYB
ME4\*<';*(Y&Q'Y0,F>1Z[6@M#6F@:UH]4 -P5*Q,X16R%<(G'VI;T;!4U.\]
MOE6-80$&VO/W)=?O:?\ :G(+0N2>&LLRPI^&WO[>5MZ^4=C6T.*\9:C9$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 06@:_PYJ6W[XM_MU6[">MAF*31=U!]XA_8H_M K,S50$! 0$! 0$!
M 0$! 0$! 0$!!:7UNX=-_,$@?W"*[OL)E\K_ !BBON1NZ_F3]6Y]8_!+#\1_
M+_VL?6M8DL.(D(_ON\_;GK^.]T?Z[K_M+OK2_O)M_P!VTOV5GU84M^R["L>E
MA6O2VKN'2J*O<K$0)G'4)4@F(((45!37 %'5P$J1#MGH4ZF<$17!0-_G*IN.
M#5VOY7:J8*-'I6:W&RVK;N]J5TG0T">KKE ?]MS+###&WWK[1^!$_P#O;1_:
M6]\/S-_S1_\ X9;Z9_JY[KF71'][9^D;]J%_6S2^RM^C'<_BK?[<]LJUD5$!
M 0$! 0$! 0$! 0$! 0$! 06R<]?W;E'Z<?"5%W AS;H3^*V4XU_!QBIC),YX
MOKD0(" @(" @(" @(" @(" @("#29(PE\37<3XQZPV4KB%-:R1@L.ZVV2FPT
M3W< >T37_%60-[NL/:=M%M;;.>ACOFN>;KS#'?V4X_TOO;-R]>VZ+8)CC*>%
MU".^/D]7W<:*TZD3P1-N.(8R *2G?N\OF3Q&G28F:3@C@=_9C[GYR>(F:\59
M9B3WV V>KMJGB%)IFIX"!]^V_P!+LIZ$\1$Q,3@<#O[,?<_.3Q.I;&N:.[/]
MF/N?G)XG4CECI28S4_+><T_.3Q"DR%A&R8GRT_.3Q#&@&.KC-3T?G)XAC\)P
M.I7OL1LP[?0GB$U^$,9!KWU3YOSD\0BO&1L9)^_4[,.WT).IA/8B,U_'0RXM
MFYCVY '<W.5T(-:AT(-5S]]:X]+T.MV#\0IQ5P_,%2DUIQ1S12O!4H6$! 0$
M! 0$! 0$! 0$! 0$!!POSM!.F"!MXOJ.43DF,I:O):GXKL_15'%M[!Z$C+ Q
MIU.8U*! 0$! 0$! 0$! 0$! 0$! 0%$CS"O'-_UN'55^]M'_ .!S+]0?AO\
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M<-M^/:[:[J?(:_(&D\WK_>[O@*V40X5Y"??LY-:UDV[-CAN5;43FN<5@0$!
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M>K^73$ZOPM;?1'/I1,8<]O?#,*\%BGY#^@J;/:\T_;(5]1\IF/"QZ/F?UK_
MNO\ <7;5_-CZL.VY>Z^S+6>M"GY.',NHK_ 5]Y/[ANUK[BO@WT_-GNER/OU_
MA7>?L;_J7,"6Q<#'? ;1GF=8?_6,Z^+3%+KJ_G3WOXOZ\3&ZU^GQ]3Z\MU5Q
M,F-!5M4Z62)NF(KD@X;#AVT4SUYLNI2L4R1CNQ]ZBC!2D1.(#V^CRI,(F.A
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M>-JZ>E-U8BDR]2S5OY8MC*%7^G&ZMQ0=[8=G^+[7'R_NG>M?P+:XMB_6FRF
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M+@QAD(!I&7;3C7UOZ8IA7!&>;0B<6Q1QEAMI7UHRIDI0X^MY4FLXD4AOE"1
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M(" @(" @(" @L^U^3_.C%7 ^TVV&W]=&-5FG"(IT$957>0?>(?V*/[0+"-5
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M7 /@$\]"/X^VU1L]2##_ +D[%DMU].V<9K"9TIF,T#P">>C?BZ\ML=OJP_\
M)%ELW.E$^MDQW;:9I2<842^ 9SV#)V#7L$K7 <+.YBQK\:CO9,%35U]/3NLO
MTO6]:)GA2DJ[[2OW5EMG1#(#\/#ICU'TI<BLEY7:HS$7]]8NF+GA@;B\PG!P
MCCXOB'<O6]ZO/-'S"-"-&,++:3CGA1J>7;*=";HF9I/51V!+F'L"BG$%(("
M@(" @(" @(" @(" @(" @BBP^%/2FJ5F0(%!B:8G:>VG:@  8 4'8,$! 0$!
M 0$!!M[S]R77[WG_ &IR$Y+0.2A'XYYGC6MY>TP_V\K;UH]6.QK:.<QQ7CK4
M;(@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(""T#F!_G4MOWQ;_;JMS#-)G!=U!]XA_8H_M K,S50$! 0$!
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M1CL_A3-,.W;>XU4TA$X*CSYY]4)'-34E33_OGFN[_MU12)["(QHI_GYY^_\
MQ5U)_P"4\T_Y:IY8*=([GQS[=3_I3U(*?^-,T_Y:E(315_/SS\W<U-2&G_C3
M-,:^7VW"BBD0KE%91_/USZV_SI:DP_\ &N:;_P#MU.6(3*#SYY]DU_G4U)7=
M_"F:8=O]VXU3EA-%7\_7/H5(YIZCKM_QIFF-!^_<$I"*2R ? 6USK[7-QU)7
M>MM3YGGTEOF&F([1F87UW>BV+K-I<Z$7-Q.(P[&H%*U6G?2M>ME[&1H, L24
M"M,10]FU J*@;SL]""4! 0$! 0$! 0$! 0$! 0$'"_.VOXL$#:7?4<HG)+6Y
M+ C2L=3]ELH,,!OWI"',2D$! 0$! 0$! 0$! 0$! 0$! 42/,*\<W'Q<.JOR
M6VCZ?\2F7Z@_#?\ P_9]"'YM]\ZSY[KQTZVI\CJ>EVC]-^>NVU(R<;9%-.(Z
MY;M_V)[!\-%GE$XQ$-(BFW=[]?@HJT5YIE. \M-@[*^52B*SATIKC2GI1%,*
MJ2:$^]Y%"T8QU)--G;M/F4HB)S !7R'=VT0K3'B#:*[17WT)C"L9%*;3@/J^
M_M0KT9RDXT.WR;*HB,,#R;*;/2B<L9RE#@>"GYMJ7>Q"UE/$ZFC-LMAVW=KZ
M/EV+'K_8S7\V>YFVM/'B>N'IY^"J/_O<'3MY,HNS_P!D"_)/O#_;&O7IGOE^
MF_=[^RM"G\L(=L2YYTJ#N\X4PK=\KS./'WK_ *4_G[7"F7Z0(/;^!7/U%^EO
MPUG_ -N6QQ_GA^>??;_$.O\ RZ73Q7#94=J^B. F/6SQ214CTHK$TCK01B ,
M-OE1,93,FT4I3M\F_P!-41U@I\:N'Y@H6F9R,!CLIM&W;L4HQR37;ALI[Z(B
M*HJ  ?/1$XUIP*G>:=GU4*5R0=HKL_-V(=B:FG;[RBJ>7'J*5W[?)MHI17JR
M42&G#3R_459QFC6MQK,MM?$^S2 [F/\ 35JKJ5Y);%+>:)ZWI9?1^O\ 58=-
MW[USK_#%^6??G_$>Y^!^E?<3_#VAVW=T.Z=N]<+H?E=KM9?'Z_--)YOA7\'=
M\!6R1-)<+<@R3+G%?[)M[?6"K;Q5G.%S:LD0$! 0$! 0$! 0$! 0$! 0$!!\
MWK'^*FH\:?P)FF-*_P!Q3[DCV[/IV]\-G9_O-G:QJ(/W5G/_ #SFO^'SK]#:
MGL6?0M[H?2MI^3V-=8FYJXS$GD1AK40GKS1M%1A[Z92F:)1'48?61/88(B@@
M("$B)R,<4!$1@^RY8D_SEZ2QP^<;;#_MF#ZRU]]_9^K]&>YY_F/V4=D_*R.+
M']Q6?[UM_P!J8OA%_MSVR^<7>U/:W!W+6UN$(A(KO6:,B:<$J4" @(" @("
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MD?\ GZGUY;NE"_A-0.'B%/JE6KG+)%LX6QB/]7=YQ79Z=]5&>#-JQ%8Z5&S
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MZL" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M.S_>;.UC40?NK.O^><U_PZ=?H;4]BSZ%O=#Z5M,K>QN*D8UQ6)N:TY(1AJ?
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MT*2+1N7'^=.[W_*7E?)ZQ]U1'Q"[Y2" @(" @(" @(" @(" @(" @(" @("
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MN;&U_>=/]I;WPZ.=3?QAU!0_]\KS&G_"I5^<]SAN;_IW=\OZ0>3_ -E;6O\
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M.,>A/][][^;=Z9^=2><'-"N&LYJ'_:7X4_W3>G\/LZ8IV'][]]^;=Z9^=/\
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M%#I&R.\E^'9LWJ8BD=:.,N3$2(" @(" @(" @(" @(" @(" @(" @(" @("
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MM'Y@?YU+;]\6_P!L%FN8;LUW4'WB']BC^T"LS-5 0$! 0$! 0$! 0$! 0$!
M0$%IG6X:=-_,']X#[29?*OQB_P $;OZ$_5N?6?P2_P#Q'\N_:Q]:UB20T(DI
M_?=Y^W/7\>+OWW7Z?$N^M+^\>W_=M+]E9]6%+/LCVGZI6/2X]K:NX)=7"BR7
M=/!$=:4I3)"4! 00D"4ZQ"C$2I$.V8*VI2L4."CM]*Q[C@UMKG=VI8/4;Y.+
MWUGMIR6T;5\XRNEZ&2/RN^4) _7,RH.S&W]VJ^T?@37^^NC'^<M[[7YE_P":
M+'\,=]]">ZYET1_$9^D;\ 7]:]+[*WZ,=S^*U_M3VJUD5$! 0$! 0$! 0$!
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M*%//T5)\IK_YIQ4.-#Z0HYIXG\)K_P":5 'GW5&%/KJ>;M3_  KAXF)Q"E*
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M7GES8[]]O^,?'.&N<QQBX1@TD8F2FU8+_+=.(I.78P;/WV\QU=68NB8B.O\
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M_JY[KF7/'\1GZ1OP!?ULTOLK?HQW/XK7^U/:K6140$! 0$! 0$! 0$! 0$!
M0$!!;)SUK[;E%-O&/A*B[@.;="X:6RG][A2/KD! 0$! 0$! 0$! 0$! 0$!
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M7<!S;H7#2V4@_P![A2/KD! 0$! 0$! 0$! 0$! 0$! 0$&.AX_P'XL<C"?\
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M0I:G=WQW?[BG]X/*Z>W!/GO#P8IVGY.'/O\ D%+YN^=_O*?W@\L_K(1_'_\
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MZ,513\)MJ"H_L@6?A'86Q$1UKO(/O$/[%']H%@&J@(" @(" @(" @(" @("
M@(""B3XA]'PA8]7V)3&;#P\9T$=5MD6XG@-1V_)W07S_ ,^IXMU<G\X/^;W'
MWFV4?2PZ?:=3C@.)WG*X[4RA^6]&*:<3U*"6C X$[L3[ZR1'0PS=-2M?-O\
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M[?HQW/YD;RGWW6I_77_6E^FK-=Q5S=I^+$U33UANKN<HGK&YY4$'25G3M?\
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MCSG7X#?-WEWG>0ZOY':S',WV75>29B=/S10Y++EN76F<PW4P;=BWI)W-K$,
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M'P.0;CE/_%&RH*8OP]+5$9#DU2" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" =AH:'<>SRH/Q+[,!EMCF=_*\.;E-A>7UQ4!@F9;6\EP
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M/!NZ7;?AG7^+:G\J.QJZK1E/T1K[JX?4QI3)]XU*UBF3=@@ 5(5]/V&1:%S
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M%O6WQ9%)R8-UML;?66I\P/\ .I;?OBV^V"P7,5V:[J#[Q#^Q1_:!69FJ@("
M@(" @(" @(" @(" @(""TSK=_P"K?S!QI^ #&E?L)E\K_&+_  1N_H3]6Y]8
M_!+_ /$?R[]K'UK6))!3ADIL]KO/VYZ_CO=^_:]<_$N^M+^\FW_=M+]E9]6%
M+.WM^NL>E%9F&U<J5KE16Q$IUB$D%$5J)4B%$1PD$J)4@5.I7"9.#3[?.53<
M<&MM<[NU4RG"*>59K:\EK:NKS35=+T,NIU=\HO))F7IQ@P\B^T?@3%/?31U?
MS=2W#X;7YF_YI+J?AGOK>G3^2YEOAX:UF%:QL/O?GK^K-^[GDTXY9]FWXXA_
M%B+(Y[IK'M2H:[B#ALK4;=R]'6V_CZ7+6;9HG4NBRDQBT0UQ'"6EH!J*.KO5
M-IY?]TMNCQ)OYNG@PQO;JS/*I=<&1[ 08V@T)[<:!9-.EM9JBS<TK$VSB_0$
M1W/P6QSQT*<EW3)W9_1?F]U.>$\EU,\3NC^C*<\=".2[ID$1'V6'YO*DWP6V
M3&%<#NC^C3G@Y+NF3NC^C*<\=!R7=,G=']&4YXZ#DNZ9.Z/Z,ISQT')=TR=T
M?T93GCH.2[ID[HC[,ISQT(C3NB*1,G=']%[WYZ<\="8LNXR=T?T943?$Q0Y+
MNEHXVPHQID!QV[/A6GM=OX/-ZW-6?0V[;8U(SI126.D8V7A(>=K*^7M\RS;B
MZ(Y>BK!.G%M^=9;E[N%HPK4;/0L&ZU)T[(NB)F5K+:X-K!&:NJ\TJ" ?.33$
MK'L-W.M-T3;,,=^WFW&LS*W/GM7VS)B#3Y0#<:^L:>9;UV42M&='-VAJ_BME
M-<3[.W\V"1E@2^M4@@(" @(" @(" @(" @(" @("#'0\?\ Z6Y&U_P#">H/\
M$<MG;\93#&C:/4;CM:-WD6U5BF<4FN&_;C^<D$!V#R;?2D'%&%1\'YZ8Y'4$
M>X=@^'%#J#O(P"B0'%NQ]S!.U':85.- :>\IZ^)EC.: 4S3A*:["!3:D&9C3
MA][#S[5'"J,*5!Y?<_/5DXA'N_ AF4!J??[/0HZ^*.OBR,OH^-.]ZFZ"G\*:
M4_P):NXX+VLEE:RS\C/P/F'.AL!RC,AAAMLYD'GE<][3O.?'-=SLUSQ@&I<S
MX6,SG,FL;3-+W!C6SAK!NH MW2JQ<<7&7L8 _=V?>2N>9ECV_P!T+)2.A6;:
MS6LT/8\#6^S[=_W]S+'_ +H4\,86I6<,CV3#]W9]A_X]S'_E"BD=&"*=,!LJ
M?W?GQ/9\^YD?>]HQ4TZB;8F$BSJ?W=GWE'SYF5!V?W1O441,33K1[%3$7V?&
MO_CW,<*?]L(M2)RBJ?8JX&_SX$[1\^YD*4_[8WHB(I"!9U_N_/@/^?<R_P"4
M*:=6":11(L^V_P ^'_U[F7_*$IU$12.L-GCA?9\?_KW,O^4)\!,>D-D?[]SX
MC_GS,O\ E"9\$3%<$"S-?W=GP'_/F9?\H1-.K %BWB=7,,^XA3_OYF1W?OA6
MN1;3@HM[(?.VDS\Y9^/\L])G'/,RH:9]94!_",0=ZP7QDC",LWHV\OJ_B%HB
MI)/XH::J7$N<3\S6527&I)/:M.<Y[6=]>H'"W.X$Z8--O%A[CE$Y)X2W')>O
MXJQ5VU^H$C)#F%2" @(" @(" @(" @(" @(" @*)'F%^.=_K<.JGL]ET?_@<
MR_3_ .&W^'[/H0_-WOG$?QW<5S\6_P"1U.S;1YUV^K,85Z7&6373B>N6ZD%0
MW<!]6BS274Y8Z5#:$?#]1(8[IFM2A!%!@$,*=8*C;@ A-)RS0"*CLQP[/KU0
MH>4X]GU=BA.,X0JWFNS=]53VHBOY.:#0>2GII5"(F<>!CLK2NP;??0P[3?MJ
M?<4=Z<9BF5I6M#N']!2BD16.*#\4$#MPKY4N]A:SVJ2TI\/9Z;?:[6G]N8J:
MU?!GZ$]S+M?MH^E'>]/+P4Z_Z-_IVK_X(N_2.\&'D7Y(]X?[8UZ=,]\OTY[N
M_P!E:'\N$.V-<\Z5!W><*85N^5YG'C[@CQ3^?N.!R[2&%-YLKG%?I?\ #7_#
MEL]OR/SS[[Q$^\&O7^6;IX.#:;?+Z5]#X/G_ .4>7;Y=GDV(=2-_81Z5"<\L
MDD ;=F[R=JE$5G(/:1[ZA,4RB4[]GIK]12KP4D@TKCY>ST*%HB8QX)&X[A7T
MU4HG.D%!3R;SC\"%9R@.VM:4]ZOPU4)PI1 Q QV^3L2A-W3&2H [3_04JS3*
M,FE)CPC;M^HJ3/"&&R(B.;@V]\![-+A3Y-V_^E4:DTMIU2SS%>6ZO%Z6?T?C
M'PKNG"NZTSO_  U?ECWY_P 1[CX'Z4]Q/\.Z'TI[H=TS=ZX;;_E=KMI?(:^_
MBGF_[W=\!6RB'"?(,COLYH*?*#>37U@JVHG-<ZK @(" @(" @(" @(" @("
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MGRU6*^VW#H6B?2Z .M?P8<[ZL>H?6/._+>;T6D6:IARV(Y<_*67;HFV$4L0
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MX4YIF.R9F7H;70\.V,9QB.Z/E?8Q#Y-I_-@:+QM6R;[IO^)[%GJV\K76>$B
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MBC*D9(.X$^?!3"821CV^114K7/-%<!7&M:J:%,2K0,3\*C'-$X8HH30U_/\
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M$="-J)2=W9N^JB(^,IA6GI0KB@5V#>AU@IO-/0@(E/V/F]^I2$<6\LQ7-,G
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M?+5K65W4'WB']BC^T"LSM5 0$! 0$! 0$! 0$! 0$! 0$%IG6Z:=-_,$_P#
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M -BD9(XRY,1(@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(+8>L;A_)PYIM>QTQETYF#8XV-))?[',6CU:F@+*U6;1I.I'1 \]-QN&:LR
M:WE^3S&]YJ902/L>"+6-OP@[A@O4TXBDTRHTM2<IEZ2NAQ_D-HH,:))H-)Z;
MH [U17*+($U&!^*O%NC&L9U;=LX<O&D/L2\@/);0-9Q!U:U-"3AY%6R;9G#I
M6G!@Z^,IG5KFG6/J&>&:KX(WQRMIQ<(CBOF-[:8!>[HX:,=4/+U;JW?"[D/H
M_P#ET<?3AG>:QR<8OK\,(+>&A:83V8TX5YNXG&&[MX_5N_Y:S.("#;WG[DNO
MWO/^UN1$Y+0.2E#K/,SO%Y>U/D[X^A;>M3ECL:^CQJO'6HV1 0$! 0$! 0$!
M 0$! 0$! 00=A\Q1,9OP[J$QY=FCN+^XKRE!3^YY,0?(K;:^+]>VL1[<=Z/,
MKXG8ZEL83X5WU981/6;?YO!U6\V&PY]GL4+K^,BWBSG,8X8OE[FHCB;<".-I
MIL "_:_N)I:6X\GB9LB)BV.'5#_/Y_S,[SS':?B)N-/0W&K%EVK=-.>[#&[K
MPCJ6W'.LW((&?:@)IL^>LR-/^Z5]$\N\OVL:^-EE*]$?,_.&KYUYWITIO-:?
M^_=A\;\\WN;O=Z^H=1%HV-&=9EA6O;.5T7FFWV-L:=-+1KUVVMG3]Y_.(PU-
M?6NB/Z=WSRU1?9QA_E#J+RTSK,O13\(6+[IL^&GI>BUA_O+YS7]XUJ?3N^=/
MMV;X_P"4.HZ;OX;S+W_PA/NNS_J]+T0G^\WG%<=QKT^G*/;\XW:@U%Y/X;S+
M#S_A&*F-IL_ZO2]$$^\OG&--QK4X>O=\Y[?G VZ@U$?-G>9#_P#*"GW39U^S
MTO1;\R(]Y?.:8[C6K].[YPWV<XTU#J*G_/>9?\H3[IL^.GI>BTGWE\Z_)W&M
M3Z=WSGMV<?RBU%Y?X:S+_E"C[IL_ZK2]%OS$^\WG5/WC6K].[YT^WYO_ "AU
M)Y?X;S'_ ']/NFS_ *O2]$+?WF\W_P!HU_\ 22CV_.<?\H=1 ?\ />9'X+@*
M?NFR_J]+T6_,K/O-YU7U=QK<OT[OG3[?F_\ *#4?_EO,</\ LZ?=-I_5Z7HA
M;^\WFW^T:_Z<H]OSBG\8=15_Y[S*A_[H3[IL_P"KTJ=EJ/[R^<4_>-;F^G=\
MZ'7^<4_C!J(?_7>9$G_NC<HG:;.GV>EZ+2/>7SGFPW&M3Z=WSMQ;7N;F]R@?
MC%J.OSMEU3\]YF,/;(ME+BH*P[G:[.-O?^KTO9G\FWH['I>2>\?G&IYIH:<[
MC6B;M6V)GQ+N-T1AC6)ZZLYWIIMWW/)'E[/)<2R/&G\O)=-(^:5Y^;[0$ODD
M<Y[CA7%?SI]Z-&-'SK<:44FFK=/INE_I+]R]G.A[K^7VSJ<\QM-&:UK6NE9.
M;FYT[G0B'@<WA) ?CC5VWT+G8OY8RR=;H;CPY]FKCOFAI/*M5Z6N\ISS/;')
M;*;@K>9C<P6L#'>MPUDN7LCQ)[5M^3[_ %)UYNMTKIY9X1./H:'O)I[;=;'P
M];4T]"V8GUKYMB,NF:0M59T]: $'<?SLZ:M[N1V$\6;91/5@IM'M #00:+L]
MUYIO=>+;K=IJ\ML<;;HK\3Y+Y;[H>3V1JS_%]I=6<8MU=*:5_P"\W_Y.?+OA
M;7FUD%:8GYRR45.%2/PO>5ACS3?_ .QZOZ-WS(GW*\FF9G^+[?'^GI_Y2/R<
MN78V\VL@'_UEDO\ RM3_ !3?_P"QZOZ-_P R/[D^3<?-]O\ IZ?^4G\G+EX!
M3^=K(,?_ !EDN[L_"T_BGF'^QZOZ-_S']R/)O_5]O7Z>G_E'Y.?+SXW\[6G\
M?_&62T[/[[3^*;__ &/5_1N^8_N1Y13^U]O3Z>G_ )2!TY<NS_\ K:R ^;,L
ME_Y6G\5\P_V/5_1O^8_N1Y-Q\WV_Z>G_ )1^3ER[V_SM9!CO^<LE_P"5I_%-
M_P#['J_HW_,?W)\GSCS?;_IZ?^4?DX\NZ5_G:R#S_.62T]WVM/XIO_\ 8]7]
M&_YC^Y'DW#S?;_IZ?^4J'3GR\]7_ *6L@WT_A+)<:[?[KQ3^*>8?['J_HW?,
M?W(\FX^;Z'Z>G_E(_)RY>8#^=K(*BM/X2R6OE_NM/XIO_P#8]7]&[YC^Y'DW
M#S?;U^GI_P"4@=.7+L__ *VL@/FS+)?^5I_%?,/]CU?T;_F/[D>3<?-]O7Z>
MG_E)/3ER[K_G:R '_G+)1_\ E:?Q7?\ ^QZOZ-WS$^Y/D]</-]O^GI_Y1^3E
MR[&/\[60>3^$LE]/]UI_%?,/]CU?T;_F/[D^31_^U]O3Z>G_ )319TZZ!/'-
M)S5TU<1FHI\[92QIIA3C$Y )6;8>?[FSFF-EJS7/U+JQ\3=\N]W_ "7RZS4Y
M?-=G?-_^=T_G<G\F^5VE]$:AS#,<BUEDF=32\+7V-AF67WLH%&@EWL\KWMJ!
MA5>7Y[YGJ[NRV-30OT^V)CO=9[F[+8;6_<1MMYM]Q=?,?9WV7S';%LRNH@(/
M'AY2=Q-??VKC=.)OF8K.#NKK(TXK%)?F7&8F.9L?L[L'@<0-!BZE?*KZWE<:
M_+/B\O+\;1NWUVG/+R3-5KW,#_.I:=G?VQ])<#19;L,.+)6)BL+NH/O$/[%'
M]H%=F:J @(" @(" @(" @(" @(" @(+3.MTTZ;^8)I7\ 'VDR^5_C%_@C=_0
MGZMSZS^"7_XC^7?M8^M:Q)(?BR?ON\_;GK^/%W[[K_M+OK2_O%M_W72_96?5
MA2TXN\ZPZ6%>N6W/!65EOX55$! 3+ 0H[03* 204\1*"';%;4PH*.WTK'N.#
M6VN=W:J9\08UV[EFM]BUM7872NEZ&3Q=7?*'?\IF0)[*]Q]=?:/P)C_WII?M
M+>^U^:/^:*Z(_#'?TXV?)<RSH<O[C@?WSG%S6XG8!PC<OZX:.I'A63G$61W0
M_B3;L[HNOGGGVIGXVXG^19$P.XZDU(Q\NZN]:F_U9YK9F,)EO[/3B+;L:S#Y
MG5/=YCD=[E<LL=G#<PNCFO)GM9%$US2"][GD-:*=O8O0OT-/PKO$NLBV=.<;
MJ4RZVEI^9ZFAN[;[=*^^Z+XI%M9G/JQ6EP<@=#.-RX\T<@;!=RO>Z./,<K<0
M\O+BTGV@4+7&A7R+R[W<\KMNUKYWNTF+KKLKM.:8]N#[ON_?3SJ;=*+O*=Y;
M-MML>QJXX1CA'%K?D^:%_P#BADE-P]NRL[/^V%I?W0\LK,_Q/:YS^7I_.VO^
M(GFL4_W-N<OS-3_)/R?-"G_]:&28_P##LJ_Y0G]T/+/_ %/:?IV?.?\ $3S7
M_P!&W/Z&I_DJ3T]Z$V?SH9("=GX?E5</^V$_NAY9P\SVGZ=GSG_$3S;_ -&W
M'Z&I_D@Z>]"8?]*.2&FW\/RK_E"?W0\M_P#4]I^G9\Z?^(GFW_HVY_0U?\E4
M>GW0AV\T,CH/^'Y5_P H3^Y_EG_J6U_3L^='_$3S:/\ ]C;G]#4_R4'I]T*[
M_P#6CD?HO\J_Y0D^Z'EO_J6T_3L^=/\ Q$\VC_\ 8VY_0U?\E/Y/NA?_ (HY
M&2/^'95O\GM"?W0\L_\ 4]K^G9\Z/^(GFO\ Z-N:?0U/\E'Y/NA3_P#K1R,T
MVCV[*OJ7"?W/\M_]2VOZ=GSG_$3S6/\ ]C;G]#4_R3\GS0M0?YT<DIN_#\J]
M/]T)_=#RS_U/:_IV?.?\1/-9_P#V-N?T-7_)#T^Z%&/\Z.1C_M_*A_\ E"C^
MZ'EO#S+:?IV?.?\ $3S7_P!&W'Z&I_DGY/>A*G_I0R3=A[?E6'_="G^Z'EG'
MS/:4^G9\Z?\ B+YM_P"C[C]#4_R4?D]Z%I_G0R3S^W95_P H4?W/\LR_B6TK
M].SYS_B+YK&,^3;G]#4_R53^GS0\K6%_,K)WQQ[&MO<LX1NQ<)\?2HVWX>;'
M1YICS32F+NNSYU-W^*/F>IR5\EW$4_H:E9_^%^]I;DGI/)=391G5OS"R/,KG
M+2]UC80YCEQFEJ07M:(Y3)(<-P6QY5[E[';[VW4M\RT;YB[*+[9G/JEK^>>_
M/F6_\NOV^IY3N-&R;9]:=.^D83TPN<.;.F=&SN'L#:,!!-' 5'$",",%]JT=
M&W1THLBZ+HBV(K&/!^>-7>7:NI6;)M];KZ7T3).%K213BI3':O)G2C2OB:UQ
M>YRQ,1%>"W#GK^[<G[>/#^N/U5LW,+FW0M?Q6RFNWV<55A]<@(" @(" @("
M@(" @(" @(" @QT?']K^*_(V@K_">H-__!"MG;\2,V- VH:VHH*#?5;3'6G8
MJW?I=OI3(RS3Y!C[U/KU3B=:*TW5&_<DD]17=V_43M#XN^I]RB8HQE KCY/>
M3BFJ1B*5QW"FSM451B5[1@/?JIE/2G&I(WTH>SM4=2.I2*C?M4T33I30@>?=
MYO*B.PVGRHG)%1AZ4[D5IV,C/Z/C]]ZFSVYII3_ EK;C@O;T,EE:JS\G/O\
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M.!/:J;GS'4W$3%EL6:-,8C.6G;L;(U(U>:9U)FL=$?!1?^R'AX27<7"#3"@
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MB12F".+DU$B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M_P J3FV7^SZ?Z,?,?WE\_K^]Z_Z=WS@SG/B:?C)J4>7Y_P U_P"5*)NV4_\
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M_P!=W'[2[ZTO[Q;?]VTOV5GU84MW]N]8=+CT5;=RHK+>B!,4"BG2)4B$F!*
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M#=6TH<"V6WN(VRPR BHH^-P/I5+M*G&LL=FO%TTG!^A4>[L6)G$! 0$&E/\
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M\J#725EC7%^.S]#N2,AR8I! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MW/\ /]=]MJ?2GO2HP5%-(K4$PI2@)2)PH)2D1C3 $I' 0HI FI4Q00E(!(B
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MA2A]<@(" @(" @(" @(" @(" @(" @QT?']_BOR-_P"<]0?X*5L[?B,:!H)
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MGOE^F_=[^RM#^7"';(N>=*@[O.%,*W?*\S?Q]J_Z4_G[N'S?I'T_@5ROTO\
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MS._S=:Z_]D=1?^:+Q>KY=^_Z/[2WZT,NV_>=/]I;WP\_FX_QGJ/_ -J]2_\
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MGE05;=]>W"E>Q$9(K4@'#^@G%-/5EIR?8]N/U%698+<,8RX-O?$^S25WL?\
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MZO%]E/98YLOF?:D;$ 7-K@*'9M)Q2;YS+=.(K$Y-? X=GU5BFV)S98Z(2I!
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M7>?L;_J7,"2Q+3\XT:6GY\SFN)-?X1G7Q6:Q=-<?6GOE_%_<4G>[BF$>/?\
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MMU9_IW=\OZ9>7S/\.T.CP-/ZL-A* 6 ^7ZJBW*9;%DSS*VTW^XJ*S7@;42G
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M&K]]>Q6X=:.+DQ0D0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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ML!#S4^84\G:%-TJQ,]JB'_&NE:X_Y9:3\G_?ZQHL&IG'PG>]%_E_CH+1!_\
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M]?Y9NGC:,#Y\%]#<!6DU1B3V>_N0PHD_J=_YMNU.XI3M#4>7MW5[/-1"*?"
MT&VM/)10G.<<TUJ:4]*E68IGF@4(I38H6FL8QE**84.'EV[^Q"M4DBI';M/Y
MRE$1A4Q!Q/FP]U"*=",*;/-C[JC@F(];I :5KMP_-@A2M(X*)-WI^HJ73$=K
M!;%?G;:^I[-)^QNH>WU3N\B:GL?!\C+-9NCJEZ6?T?D5\*_IO/9:YW_AB_+'
MOS/_ +CW'P/TI[B1_P"W=&?Z4]T.Z=N]<-M_RNUV\OC]??Q3S?\ >[O@*V40
MX4Y!D]]G IZIDPQV4</3BJVHE<ZK @(" @(" @(" @(" @(" @*)R%+=ZU]#
MVKNU,OB.9W^;K77_ +(ZB_\ -%XO6\N_?]']I;]:&7;?O.G^TM[X>?S<FF9:
MDK_*O4O_ )ZNU^T;(_5V4_J[?JP_1NI6>7Z%O=#6<00VG8%%JFY_)[$>08=B
MEAZT8U(KCNP4]:>L(K3X?SDJ51A0@;?A4]:>M(&)[,%'!$Y'DV]NY#K2<1@F
M4D8285/;O4(1Y\*[1VT4I3LV#S8J$()P!V*:)IBDX!.)&,N6^GL?]/7*H;#\
M_P!CC_\ 6%FO*\Z_L7=?0GNE3?\ [EJSPY9[I9YN3?XHRK_FVQ_P6)?CC5^T
MN^E/>_/6I]I=VRWLGV/I^HEO%ANSCH;5X#2,:G"OU%2&75NRF<(;]%8R$! 0
M$! 0$$ 46.RSDKC5,RE9$" @(" @(-*?[Q-^Q2?:%!:-RY_SJW>-?E+S=M];
MWE$'%=\I! 0$! 0$! 0$! 0$! 0$! 0$D=;OB3D?S0VG9[5A[COJ+[S^ <_[
MZUHXQ;'>_-/_ #'17RK9T_.N[G2>SXC,:UCCW;/4"_5>%9?D&9GECH5"F](K
MFQ75X*J .H=GYR9Q@N#&@V[<-GOJ9$DU-*X=M/S':HIQXHCK&N-14X),>DC#
M!305VX=M/J*2O Q-!V;$)FF:H@N-1B-RB)B,RG$]4#M/I"8BD=M*@;5(;AY$
M$DU&.)]RGUZJ*$XX2@"M*8GL_/4DUX.QOPT:?C[S$/8,OP]%OO\ (OB'X]5G
MR79_][Y7Z!_Y;KHM\]W\4K7E^1W6RBM.S&GEV+\F632LOVEJ6UH11M;Q$&I=
MM/O+7LOYYN7BV+<>+\NZE%AW8+FN;(^GK.:WAJ?*17:MC;:-.;C,]3%OMU%;
M9PCX7Z'% 1C/%C_3L][UE:E_YL^A'-I3%9OC'KA/' /U^+^O9]TG+?\ FSZ$
M\^G^=;Z8..#^SQ?U[/NDY;_S9]!SZ?YUOI@XH/[/%_7L^Z3EO_-GT'/I?GV^
MF#C@_L\7]>S[I.6_\V?0<^G^=;Z8.*&OW^/R^NS[I.6_\V?0CFTZX7QZ8..#
M ^T14_3LQ_5)RW?FSZ$\VG7VX],''!_?$7]>S[I.6_\ -GT'/I_G6^F#BA_L
M\7]>S[I.6_\ -GT'/I_G6^F#B@_L\6.SUV?=)RW_ )L^A//I_G6^F N@I3OX
MA_5L'^R2E_YL^A6;M.8ISQZ8..#=/$?ZMGW2B8OB*\L^A//I?GV^F%+;JW)(
M+X 0?[)'C[ZT[-?5ONF.2^/@EFNG1B(GFM],-0W-N/U^#TS,'U5M6V:ET>S=
MZ)8YU=*/RK?3"B.XBD=1LL3MOQ96.^ K!?LK[/7NFZ/@E%FO9?-(FV>R85D-
M::TJ7[<>Q:-WJW1&-9EM1,W1U0W"]*,F)9[KZ@YI1@##VBV]WO MCACT%LUC
MJ7>P?>(?V*/[0+ -5 0$! 0$! 0$! 0$! 0$! 0$%+OBG"ODK18]7V)3&;#N
M\9[#JNL2!4\#L*TK\G=? N \^^VNZ'\WO^;^(GWGV73ZW_B=3I!)=Y"??7&Z
MF4/RYH3^KBO0T]_GV'\Y9.#%*213SI&:(C$ ->WR_G)P*X%1OP.]*%)^!%1Z
MM=]4IPA-9B[K".(>3L[?2F4HF(G!-#[N[S>5*IBD8!V@4KMKY$5QC+)!I0]J
M1\2T?$8@BIH!7#M4]B)K,X*U5".W''>4G+J3W*9J]Q*TNK6":N&SY-ZR>7_;
M32.+5WT3-VE;7'GM[X9A?@L"G0]H+]^9I[@DA7U'RF?U?P?,_K;^!7^!=M/]
M&/JP[;E[K[,M9ZT/^K?S+_YBOO\  ;M8-Q]C?]&>YR/OU_A7>?L;_J7,"6P<
MYWS@#_X<SK</_"$_NKXK=;$3=3\Z>]_&'7NF=[KQG^OU/K2W1J'2 ;/5P\_E
M4K8VS;;P2]I'#39O=^B]&ZBBM<99]:*448UV5IL3@Q4P3M/E'U5'!$8(\QV^
M3;12GX,#L.S;Y:(932<T^;=N_/1':@]E:GLV)UIKA@$ X$>;'ZR=BLQ@ UIA
M[^Q*)C*DX0FIKL]]"D!'K\1-:TP[%:V:Q1;:Q%O-,XQ/!4=@6.&..*ZGH(J.
MMKD61A^%WW[;:KH/)\=2R)?9?P)B?^(.VF/SOEAG@6%?8;&FSV2W_:64VKZ?
MI133CL?UCTJ>%;7\V.YO%D76N<]S^'Y4#ND93^O<L]F2G&7.VAOXKY33#\';
M\ 6*[VEWUJJ" @(" @(" @(" @(" @(" @_+O!3+\RIOLKGT?(2+#K371O\
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M8K. "<2!M\J$Q2(J5.S?N\OU-BFJ.7CP2,0#M\J(G":1DIVT]YOYZA:DPJQ
M\^T_!@I13'#(QPKMW#X<4)ZLE(P)&XJ,%IBZ.U(!KLH![RE7"G6TY/L?3]14
MIZ&"V8QB,FWOZ&WDJ0"&/P)'Z'#>JZE.7&8R9HK%T4QBKTL_H_) \*_IOJX#
M\$SO>,?PS<ORS[\8^\>XICD_2GN)A[NZ$3^=/=#NE:0:T(*X?0B8K7I=M,P^
M1U]_%3-_WN[X"L\EN;A3D(0)LX';(>$]M'"OFHHMKBB<USBL()#15Q  VDD
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M5U/[/O\ ])=\Z3UNY0,0;OBW#OIO]_[%'_"*Z<)U;*?1CYC_ (]7<?+KX_\
MS)_RD'K<R? 5NBT5_7I\/3[1O*?\(;OZVVOT8^9/_'NZ,?X?J5_:3\X.MK)J
MG&[H*4/?3XUV_P!T;D_X17?UMOZ,?,B?Q[NB/[/OG_\ ,G_*3^6[D]1Z]UA6
MGRLV%=OZ_C5/^$5W];9^C'S(_P"/=W_IVI3]I/SJ1UN90.'&[%.+]=G]6O\
MVQC53_PAN_K;?T8^9;_CW/\ Z?J?Z2?G3^6YE+G4=[60-_>S#=Y)U'_"&:8:
MMOZ,?,6_CW-*_P /OK^TG_*/RW,G:06F[H:U/?3X?]GWI_PBN_K;/T8^9$_C
MW=,8^7ZE?VD_.TG=;.3NK5MWCMI/-\/M"RQ^$O+..K9^C'S->?QPWFK;S6['
M4Y?VEWSM)O6EDG%7\,KN'?SG$_\ ;&.)5=7\*YTXF;;[)N^C'S,^Q_&'<;G6
MMMUMO?;9/].?G7&],G4?:<T=5YWDC))G&P,!CC?(_P!42=WVRNK\=?+_ '_]
MSK?)MC&O$Q-UO"E/CH^W>X'OC=YMN[=&+9BR[CS5Z.MV/0.<;>VD PH:MK7
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M>W\OK'_>PI_XOVTPVD?Z2T_Z%K__ %V/_M[_ )AOAI<^3^L05W^L?1^MJ/\
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M_LD?Z2T_Z%K_ /UV/_M[_F5?Z,_GQ_>\']<?][2/Q?LK^Z1_I+?G/^A;4_\
M78_^WO\ F0/#0Y\X5M[??7UCZ/UM3_Q?MX[2*?M+3_H6O_\ 78_^WO\ F!X:
M'/G?;P#^J/\ O93_ (OV?[''^DM^<_Z%M3_UV/\ [>_YD_Z,_GQ_>\']<?\
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M "4_]:^C_P#N_9_IX_RD?D$\YNQO]L9_O*?]+]\8_P 6O_T,_P"2?]:^C_\
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M/^5^_AYO?7]C/^2?]:^C_P#N_9_IX_R@=!/.4[>$#]D9_O*B?^6"^E?XM?\
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MJ_1GYDGZ/AUQD5]D@I^^H?\ D:?WWMK3P[:_2CYR/=O2C+F_1GYE)^CY=<0
M(M(<?^%0X_\ <6"?WVLR\*VOTX^=;^[EE<.;]&?F!]'QZXG;+6 T_P"%0[_^
MTTGWVLC/2M_2CYT3[MV?TOT9^9/_ -'PZXJT]D@KN_"H>RI_N-/[[V4KX5OZ
M4?.?W<L_I?HS\Q_]'PZXQC[)!3M]JA\W]YI_?>S^KMK]*/G1_=O3R]:GT9^8
M/T?#KB']R08;3[5#OV?W$G]][/ZJW]*/G3_=S3G\[]&?F/\ Z/AUQUI[)!4_
M\*A\_P#>:?WVLI7P[?TH^<_NY9_2_1GYD_\ T?#KB)(%I!A3^ZH<*_\ ::3[
M[V?U=M/I1\Y_=RSCS?HS\R!]'QZXC3\$A]:O]U0XT_[2PHD^^]D1]G;^E'SG
M]V[)FL\U8_HS\P?H^/7$2&BT@KC7\*A\^WV-/[[V4KX=M/I1\Z/[MV5KZU)_
MHS\RD_1\.M^@)MH16O\ =,.X_O-7CWRT+H]FVOTH^=AN]TZ?G?HS\S\V^^CP
M=<ETQPC;%&2T@GVF$T!&.'L>.!6CO/>S1UM.;(B*_2_G9=O[F3=?&K%\VX\;
M9Z>QF*^%QH;,.C#H;Y-]/7,NY?<Z\T)'F<>;1L8X8W<[9&$D-BH,2!4#8OCO
MG<?>=]J;NOJW1&&?2^Q^1>7>!L]/:<T^I,S$TF,Z8?$[$(^>6E8HQ,T/<37O
M,344\[BN?NTYOPX0Z>S8VV75YJR_/S[G3I#.\EO["&:5D\T+VL#HG?&+'"NW
MM*U,.*G'L<:\KN8>0Z..8NS223@GD)8\0N- YX[*5P5K/9F)R)C'!S'_ #^Z
M+J2)Y7-(JVD3@=F.\U5N3@BKY_57._36;:8SJUR>YN(LQEM)H;5_=/#F3R1/
M;&X4(/JR$*;+9BZV?Z4=Z8FDX]+K0AR;J7,EU(-<7HCEN[B6 5GP@DF>^$?'
MW1D!?2XU?+HMMYM&R?5CC'0Z"-Y%(I;;EU-;YGZE\#^.UZ=M/6F^[4^-Y9&/
M@6>F%IWML?DV^B%1RKJ1ICK2]Q_II=W]6I\7R[+P+/3"/OO&EM?@1\U=2.)_
M'6]_KI?NT\3R[^HL],'WW#*WXD_-/4B!7\=+S'^FF^[3Q?+N&A9Z83.]Z8M/
MFGJ2 _CI>8?TTN_^K4>+Y=_4V>F$3O>-+091U([1K2\P_IIONT\7RZOV-GIA
M;[[PI:'*NI'8=:7O]=+]VI\7RZ?_ "+/3"OWV(X6_$CYIZD/Y:7M!_33?=IX
MGEW]19Z8/OW5;\2?FGJ1(_CI>T_32_=I.KY=_46>F$QO.JT^:NI*M/QUO/ZZ
M7[M/%\N_J+/3"/OE.%H<HZD10?CI>[\.*;#]6GB^6S_Y%GI@^_4X6_$'*.I,
M #\=KPG''BF^[6"S5V%U?U-F'7#);OXXV6X]BCYKZD\/\MKP5VGBE-!LK\?<
MIF[R^<M*WXFQ&]LBOJVX]CZCE\>?&0Z[TY?ZKUS>WFE;29[[R)T<_"YG&PD.
M)=C0-.U>9O;]&-&Z(LMI=V-/7U[8F,(RGH=C;.?FBVRLMX9Y96,CC;+.Z)[6
MAX8 [:ZF+@N.U-&+,:X2YV_5BN/3*I_/[1[9. .F<T?&>(W4%=FP[U@U-K.E
M3'/M:5^^FS\E\9K7FSI74FC]395:W$T=UF63YE86S.ZD]::]L;BWB%:G R2A
M>AY;I1J;JR_FB.2Z)SSI,/<\F\UBS<V:M]D83EAP8P5UX:G/6>^SBZ,K8X[[
M.,UOX6 --8+Z_GN83^Y_['(%^C]O^(7E$Z=L:]L67VV1%*URBG2^MZ7O'9KZ
M,7761;-/SHZ.UM8_#-YY/]070![* 4&W;[/O674_$7R:R*V1;==VQ\[%J^?V
M6Q%+;9_[T?.UO]&)SSK3V@5WXM[*_P![K!_Q(\M_J[?TH^=BGWL_S,?I1\X?
M#$YZ U-R,=F(\W][J(_$?RW+P[:=L?.C^]E?_(M_2A \,7GH3^Z1Y!ZOI_N9
M/^(_EO\ 5V_I1\Y_>RF6A;^D?Z,?GION1[H_Y,G_ !'\M_J[?3'SD^]D?U%O
MZ7\Y_HQ>>6SVG#SC_DZG_B1Y;_5V_I1\Y_>S_,V_I'^C&YY_WR/)\7_DZ?\
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MCH\UE8FC4//_ $:!\:XKV=R]1R-8_* T97X\].WNG?#L3DDC$_* T93X\_\
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MOTYM^^:D3^SF?D5?DM<R-W#7?ZP_WO>L<_BKH?[)9_I(^=/_  1UHG'S"_\
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M_BMHT_=+/])'SI_X(:F?W^[_ $4_Y*K\ECF(/L8Z;_BX=GZTIG\5M'_9+/\
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M8Z1D4I:2QF!#74/Q-RI;JTG+!6;8RC.5O_+G35AGNM=295=-9)9VDW T%C<
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M&#^9[3.PL>?)48^\G+J?GW_I3\YX.G^;9^C .3VF*?$<1OQ&/O;DY=3\^_\
M2GYSPM./R;/T8:0Y1:7>X@,=0^?"GG:%2_:ZN?B:D?\ >GYV>-QHS,6^%I_H
MQ\S4_F<TP=K'GT_G%1X.K_6:GZ4LWC:/]5IU^C'S(?R<TA(UK)+8E^-275K[
MK5N:&K=I1$73==3IF?E:\Q;,3,6VQ'9$.*^;FB,FTEI&XS'+&QVQCEA97NFN
M=1[RTX\ .Y>[L]S;JVW671;6F%:/+U9NLI$<U*\*OIM!\M-.YUI?)LUN8VOG
MN("]QX&^L7 =K<""*KQ]:^>>;8RAZ=<JYOI7\E]/DR&-PC+R#A$PT .(Q;O"
MU9B."7Q/-'E[D6F-$9OG-JUD<ME'&]I$3,27<+A@T'UBY;NCK5B-*A@KY7<O
MLAU-HC*,YO(V237T;WO/=LK0.X>&I:3L'OK5NFMW5$JTBC[H\G](PNG+;406
M[^$<+34DFE3@S>5FC5Z(Q8/N]M.&/4/Y0Z7X[>)EN?9J.):#0XX@U#.U3XT4
MRQ3]VB8X8=35_F<TINMSY-GW*CQ^J$?=[?Y0?S.:4I00$5VXCT?8J/'FN28T
M+8FOR-(\F=+$$=V3L]'O*WWG^C%6>EO1'H@')G2C2?DG8[JC=Z$G<?T8*6]$
M>B%/\S.E *=V['::BN&/Z&BG[UC[,5.6*>S'HA/\S&E!^LNIY_SD^\_T8*6_
MFQZ$_P S.E12D+L*TQ[?0GWG^C!2WHCT0I/)C2E/O1]W9^I3[SPY8.6WHCT0
MG^9?2AV1.\]1]9/O/]&"EOYMOH3_ #-:5I1T1\N/N;E'WF/S8*6]$>B%8Y.:
M5Q^1-<-X^Y43KUX0Q7:43T>B$_S.:6 IW+CY.+?N^Q[4\?JAA^ZV]7H0SD[I
M0<4S;+N[EP(+N.HIL_0[PK3N+>$,EFC%D\*=C2BY-Z28P.=9B2Y8ZM211O&:
MDT+#N59UXRY6[IS%D3;/LS$XN!KO3N4?SRQ:-!:VV?&V0-[IO#BSC+?B\-0,
M-BPYS7%J[/8VZ%=:;HG&M,'/'\S^F). .9'Q-!#J1L'%7;]@LMNK%LY5>U=Y
MA%,;(I3J4GE1IBT8Z")A#"*EHJ2:[<0U9[;^:.:8B(>+K[C3G4FZ;+9^"%3.
M4^E9F#VBVD[G<1(\$G"F :#2JC4NB,(B*]D,^TWMMME)T;)B>J&[_FBTSZM&
M/P%-N[=NW!5^]6Q^3"_BV?U=E/HQ\R1RCTT#7@<:[<4^]6QE;!XMG]79^C'S
M Y1Z9 IW;J]M?*H^]6_FQ1/BV<=.S]&/F3_-)IK?&ZO;6B3NHF?9CXD>)9^9
M9^C'S!Y1Z9/ZVX$>5/O45K-L?$>)92GAV?HQ\R#RBTU6H8_'RI&ZM_-CXB=2
MR8^SL_1CYC^:/35/B/KVU3[S;7V8^(\2RGV=GZ,?,?S1::J#P/PK7':GWFW\
MV#Q;/ZNS]&/F/YH]-5'R;L*[]M?K)]YM_-CXCQ+.&G9^C'S!Y1Z:W,?[J?>K
M?S8^+YCQ+/ZNS]&/F/YH]-?H'5&S'9V[DG=6S^3!&K;'_EV?HQ\P>4>FJ?$=
ML-<=H/YR?>K9BG+'Q'B68?J[/T8^9LOYH]*MC?'#$80Y[73R\1<YSFNJW:VN
MT+S9VL3C7CT-^_=Z4VXZ6G6F&$%QRGTPZ5SIX&W#I^ 2/(!)#*!OV)I@%Z.W
MMBRV)ID\?7W/K1;;;$=F#@+/=/Y19<V<KTG!:L-K?5#F%HX0&T!KZM-W8O9T
MM2)T?%NIDT+M:;]7PJ3@N#9R?TN"QS(6->T O 8SA)([. !>'N-6W6OYJ1$5
M9XVF$3=+4/*'3>QK7@'R_!@LD;JV/R8>C&I92DZ=F'5'S(')_3;10-?Y<?3V
M*?O5OYL'B6?U=GZ,?,U?YH],_P!C=[NWT@*OWF/S83XFG_5V?HQ\R!RCTUO8
MX]F*G[S;^;'Q(C5LXZ=E/HQ\P>4>F20>[=A7?^<GWFWC;!XMD?\ EV?HPAW*
M+31^P>/2GWJWC;'Q)\6R(PT[*_1CYE7\T>FL:,=Y,=G:D;JW\V/B1XEGYEGZ
M,?,@<HM,XUC<:TW]B?>K?S8(U+(_\NS]&/F#RCTV006/\F.Q3.ZMG\F#Q;?S
M+/T8^9'\T6F:4X'^>OE\RC[S;^;%$QJV9^'9^C'S*OYH],UKW;O+CM[-RC[S
M;^;"/$L_J[/T8^9'\T>FJ?$=[JG[S;^;'Q$ZFG_5V?HQ\S39RFTV74+''TG=
MZ%35U(FF$)MW=E\TG2LP_HQ\R3RATR?UL_F/F6O&XB<XC^7P+W:VG,?9V?HQ
M\S3/*731FD!+BUX'#"?BMH*;>&F*S:.ZMLNG")EJZFE&I9A9;$=-(?)ZNY;Y
M!DV0YM?P11PNBB<X?)M=BUCB/L!M(7KZ?F$1;2+8R>)K:%UD5K.?"KY#DWH[
M*=8:;NKC-H(Y'"X?&WY-E0&OP-2TTP6AN;O6YJ9O6LQBG"CE.;DUIV5D(MB(
M61&HI$P\0XL1\44V+1IC5/)%,&AFO*?3$.7WMPR)@GL[264.[MOJN9$]U11F
M/$0MW2U;L+*8SQ12W&LN(.2NF<JUDW43\RB9+'979MXFEC30!Y%<6G<%37BE
M*D1-T9N<3R:T;4N]CI3XA! X:[?L=Y6&+HRI#+C&<J6\F])LQ9; @UXJT];L
M^P.RBGFMXQBF+[K?9F:'\S>DZ4]GP&P4::?J4YXZ&7Q9CI]+2/*#21_N4>79
MCV?K>Y7PS^9A^\W94GTM8\F])G'V;S8-P[?L53Q(Z&6-6>OTG\S>E*D]QB=N
M#=W]2I\2.B$^+V^D_F:TC@/9?5&ZC?AX:[5'/C6F)XL]?I2>3>DJFEK2M,*-
MW?U*<_4B-28XSZ4#DWI(5I;8&F%&[O+PU3GZD^+/"OI2.3FD@/W,"=QHW[E.
M>.A$ZLSQGTH_F;TGA6VK2NYOW*3?'0GQ9Z_2C^9K2&)-K7LV"GZE3&I3@>-/
M7Z6BWE'I,B@M0*;Z"N__ &M7I$<&M;N+HG*?3+6_F:TE_>W9V;L1]BL?-'0W
M/O$]$^F4GD_IOO'/;&UO$ *!C-@P_0]B<\9TBJE^M-_31HGE!I5T19[.QV-0
M[@&'K5)^(K85K,-*Z)OI,5PEP9S@TQE>D;_2<66M8R',KKN)1P-V&0-J:-&&
M*R:/FDV7Q;-G,]37NC=:=)Y;9C#AT.<;7E!IE]I XPL,DL,,DC^[C]8EC23\
M3#:MJ[S*9FO)%'D?=K<HG%J.Y0Z5XN P'AP%:[_ZWM6M.YLF:\MOQ-JW2OY:
MQ?=7MGYVH>3NE"&@0D%N^HW^A9]+S"S2LY?#LGX(>5N?+M77OB_QM2*3TS\X
M>3VE<:0.%:5Q&[^I7GSNXK[$9]#?C1NBGKWUITS\Z/YG=+ $"%PK3>-W]2GW
MOHLCT)C1F)]N_P!,_.G^9[2HI\@[#RC[E/O7]"#P;OS[_3/SG\SVE0".X=CY
M1]RGWJ/S(]!X5WY]_IGYT'D[I4T^0=A7>,?U.Y/O?]"#P;ISOO\ 3/S@Y.Z5
MK7N'>Z/N5,;J*^S"/!N_/O\ 3/SI_F>TK2G<.]T?<J)W4<+(IV)\&ZM>>_TS
M\Z/YG=*X?(.H*[QC^I4SNOZ,'@W9<]_IGYP<GM+8?($D5QPQ\_JJ/O?]&*]A
M.C=6O/?Z9^<_F=TK2G<.]T?<I][_ *$>A'@W?GW^F?G5?S/:3V>SNH=N(^LH
M^]S^9'H/!N_/O],H_F?TLVI[AW;B1N_J5/WFN5L1$IG2NSY[ZQUS\[:,Y6:=
M,I:( R+%H:6UJ*$;>#>MC3T[-&>>(MGX(6^_ZU\TF;\/Z4ICY,Z/]9K+<=X:
MN<2-A))J*LWU6>=Y,1[,46LOXSQ<(<ZM+Y;HYNE(<M#(X[V^[B8"-HJ#(T D
MAHP]9:ETQJYQ2C8G4B_*(BD.;K+E-IE]C9ROA89;BV@D>_NVXET+''];PVJL
M>K6(RAY>XV\Z]T7Q=RMX.3^D6BIMCQ;W5&.[]#Y56=Y$17DAG\'4G"-2[TS\
MXWD[I)M?P9WDQ&';]CBI^^1'Y$5/!OF:\]U>V5/\SVEO["["M,1A7^I4?>H_
M-CT)\*[A??Z9^=/\SVE=\#B!NJ/N4^]?T(]!.C=^??7MGYT'D[I6F$+AZ1]R
MIG=6\+(KV'A7<;[Z=L_.G^9[2M:]P[W13[51][_H17L/"O\ ZR_TS\ZG^9S2
MN'R+O+B,?U*F-U_1@G1G\^_TS\Z?YG=*_P!A<?2/N5'WK^A!X5WY]_IGYT_S
M.Z4PI ZN_$?<I]Z_H1Z#P;H_+O\ 3/SG\SVE?[ ZN^I'W*?>OZ,>A'@W_GW^
MF?G4_P SNE?["[R8C#]2GWO^A'H3X,_GW^F?G5?S/:5_L#L*TQ&_^I2-WC[$
M>A'@W?GWY],_.TF<F]+@OK'Q#=B,/U.Y;?WVL4NMMGX(>AN=U=KZ<6Q-T3$4
M]J?G&\G])D@" U[:]F/Z&FY5NU;>7V+:]D/"C;ZLW4\2^(KTS\[5/*G3T9D/
M=AS  . L&PBFW@6*S5MMK6V/B>WHW7VQ%DW73$QQF?G;4<H])Q07;FV@,[(9
M7M<ZGJO[MSF[68@$!/OD6S,6VUEJ;C:Q?=%TS'+/4X+Y2Z>RS4FI-399F,;)
M(\OG<QC3&TX!_"*'A(V%;5\\EG-*G+,S2'/3.3VER8GQQ,I&XEOR3-M3N+-R
MT[KIKC&*\1$XQDY(R7)[7);-EI;- #<"[M[,,!@ J33@M%>+]=0D0$! 0$!
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MQ'$(R\UKQ$[J4J:K3FGPLU^ISQ$=#1DMB^GKD45_O'A\*U:DZ'--:MRQO T
MFM!M*I,\TU9;8Y8HT7Q->X.[P8>9(P9[=6+8I2&Y4,0@(" @(" @(" @(/S[
M@]RQ],>*.3R4]5Q^HL]OK_ U=6NG\*U'EUCSJU1B>+B!)-22!C2I*3;ZDS/!
MMZ.K$Z-)C-=EW@F;*VC06GM!+J5^LJ7V<E)Z5-#5B;\8I13!)5P9P4\I^#%:
M]VCS8UR;>K9$1S5AOED:P@(" @(" @(" @@F@)[ 2@_.C?W[9&&D=#2M1NWK
M#.KR<#;ZD1=6F$-O$SNB[UN,5V#R'L"S6W<]M>EZ%TVZD4PAPQU$.$G+C, 6
M\-+BU.S;\J0MW:;?[QJ396F#S];0CVL'V'+ \.@-.X$DV[0*5P]5H.Q:VKL^
M74G2B[V>/2UK=3P].,*S,N3VFH'F"U].9QMG@V>#BGG:0.6NHZBH[AF']6%G
MTYY;XE,17!M>0Y#N6604& ;./U=5.K=6ZL="L6<F#F)8ICT)118_#GI34HH\
M.>DJ44^'/25*)X?65*)X<])4HGASTE2B>'UX%2B>'/25*)X<])4HGASTE2BC
MPYZ2I13X<])5I<8_0?F]Q8?O4Y<LK>'"6OJ0.&BF-S-TTY9)LI#4VA;%EW-'
M-DI*T'.C7J.RT _K301_N8"]+1PTJ]4L&I9SRNL;:'BJ)#7#=Y%Y=N]I,QR<
M4?=9BD\TMQ4<'#2A%/6W]OD5-3<S'Y,XMNS3C3IDJX@Z@V4PVK4\2[6NRF%L
M+<:Q*B:4-<UO '>6E:5('H7HZ5G);0MT8U8YJTHU WR^]^>L/WOARRP^'CFG
MA\OO?GI]ZG\V3DZS@\OO?GJ?O7]&3P^O X?+[WYZC[U.?+)R=9P^7WOST^]_
MT9.3K. ]OO?GJ8W4_FR3I]$XG!Y3CY/ST^]S^:>''2<'E/N?GJ)W<_FR1ITX
MJ>+C(%*;?+];L6EMMW,7TY99+]/#-HBU(->\=[Y7J3O?5KR-6-O2?:E5&.Z#
M1\:E<3OK7ZZU=7?S,^Q-);%FERQ3F:_>#]!^;W%CMWDW?DRR<D]*6 %@#?5H
M:G?OK1;.EJ^+%<E9I%U96BZZ(;SVTT2-N .\$C:#NHO8T]C&MM8U>:DQ7"C5
MUM&[6CEBZ874^QX1GOMK14=OJC=7%>1=H\TTB:43R3;-:RU"_N@QO!Q5.V@P
MQ\Q41L9NQYYP3]YFW"DMV&X UW=GYZB=S-N'+.#)R5XG!Y?>_/3[UPY9/#Z\
M#@\OO?GI]ZG\V3DZSA\OO?GJ)W?]&3P^O X?+[WYZ?>ISY9.3K.#RGW/ST^]
MXTY9/#XU.#R^]^>I^]?T9.3K.#RGW/STC=S,>S)X<=)P^7WOSU'WK^C)R=9P
M^7WOST^]S^;)R=9P^7WOST^]S2O+)R=9P^7WOST^]3^;-#DZU,T'?</K\-*[
M-ZV-&^W2CA*FIISJ4QF*-*WB[M]>/BKNI2F'G6;4U+;K:11CT].;;JUJ^6YB
MT_$W/*[/8Y?M'=BT=Q6;8IG5NZ5W+?5PST\LXM*W K4"[FW'^S-^!;6SF8TJ
M2\[7B9U<5SC?BCS#X%6<VW&3\[.,,IS/=^ 7>S]@>K:>-\=J8P6R]-;0W\=C
M3 YD[T^N_P!*S[B*<IUKK%J@@(" @(" @(" @("" **EEG+,XYI2KH%%<:"T
M_J4%<RT#05(S08>3OF;RO;\JIR:M>A$KIK+]Q6G[UM_VIB\:[VI[4MTH! 0$
M! 0$! 0$! 0$! 0%%:S,"U/J6.&BZG;F;:@BH/KLVC8MO0SDC+K7,9)_BC+/
MWC:_M$:PZOVDIE^GAA@L4SC3I0E2" @(" @(" @(" @("#0NOW-<?L$O[6Y3
M&8M/Y#@#6^N:?WT[]N6_J371N^!*[=>>A2_XCOTKO@*1F+1-'"G/K/L*?&J.
M+ 8'T%;FK;33JQ6YKO5ILH@(" @(" @(" @(" HCK!2*7'A!=2OU5,16:*W3
MRQ5PAU ._P"CG,C3]=MS^J<MC1BDS/"&/4NX=,/V^44)=H#3SR_]9<ZE.T!M
M/118]?>\\\_+GAZ&+3VDV1$3=,N4F@- %*TK0^=:=^XXTS;=MG+%$D<=,:46
M33U8NJBZVK;20XM/$=_U%M6ZF>#!.E2:S,M?NOZ;9Y/SUCYV7D.[_IO>_/3F
M3RG=_P!-[WYZ<QRG=_TWO?GIS'*=W_3>]^>G,<IW?]-[WYZ<QRABJ*<7O?GI
MS]2)LK%*G=_TWO?GIS)Y3N_Z;WOSTYCE.[_IO>_/3F.4[O\ IO>_/3FZD<L]
M.!W?]-[WYZ<R>5J[%19PWSV=Q<L\]PP^1PK_ $QVK;VMOZVE>#6UIYHBG2W?
M)$@\MM/8 <,,@&']/M'9M5-U;RZTPRZ4\UKE<BOD6CJZ?B3&-*,L311W?]-[
MWYZV.93E.Z_IO>_/4\Z.2N9W7]-[WYZ<YR'=?TWO?GISG)3([O\ IO>_/3FZ
MCEGIP.[_ *;WOSTYD\IW?]-[WYZ<QRG=?TV'F_/3GZD397C@=W_3>]^>G,GE
M.[_IO>_/3F.4[O\ IO>_/3FZD<L].!W?]-[WYZCF3RI='4@UI2N%-M5KZ>E&
MG=S9K3BH[FF/&5M>)U,/@S7.5?'0L%/C5]Y8VQ%N$]2T:X:?REH!7#N6GS5B
MJ/A7HV3'W69ZFIJ[.9OC5YL*Y?"N]7G-D06@\Q?\]>ESOXA3WJK+;[*)7=1?
M>XZ[>!GVHJL26HE(!12 2D E(!*0"4@$I )2 2D E(!*0"4@4\*UXT*3FFJI
M;*"GOH/D==_Q4SK=^!3?M;@KZ<5OB"E<'"?3FXC3^:,X11UW(<*84EI]5;>X
MCFB.B&GH[[Q+YCDI-L]*YFF'G 6A/2W8ELRT,<27_&. [**EE_/A2,&6[5B(
MB*-?NJT(=ZW;2H5\%>>,J>JGNO+[WYZOSS7)@FRIW?E][\]1%\\8^-/+UG=_
MTWO?GJ?$CT'*=W_3>]^>D7Q,51RS7,[O^F][\]3S)Y3N_P"F][\]1S\$<G$[
MOR^]^>H\3UN6B>4[O^F][\]3%]<8.4[OR^]^>DWS&4(Y(G,[KR^]^>G//1@<
MG$[O^F][\]1&I$]J>4[OR^]^>D:E<:'*$MXF@-!K6IIL]Y4BV*UADY<)F7Y6
M?BN2YL*  6-S3R_(/632N\/4Y\TVVQ=,1Q6Z]-0_!M5$[\R?A_NKU;4W/C\*
M4+HHN>E );VXT]Y4BWF8KIQAK*%A 0$! 0$! 0$! 0$!! -:5%/?5(OK,=$B
MTSJ*K^,>@AN]M9[UPO<\MMB[2O\ A8]3)=79_N2U_>T'[4U>/=[4]K(W*@6K
M=30'LVE"=V9L]TRL6YM/RH1."Y/(<<ERO&OX!:8TI^L1K!K?:2E^MZ%AI C?
M3W/*E(2BNS#;7WDP*)K79C[R8%.EI]W7[+WOSU?FCH4Y4&/RU][ZJ<W4<D3G
M)P8TK[WYZ<T=">3"J!'Y<#LW^=.:.A'ATXX)[O$"NVN[\].:.@Y3@[<!^;RI
MS=2>3HE/=^7WOSTYHZ$<JG@( J<4YHZ$Q9UM1KN*N%*45>7E[2)JK1*ASN'=
MM^HIB*HF:-A,#W%P:_W//N[8W? KQ9$3':P<\S.6&*U/D>/^D?7A.ZX%32GZ
MY0+TM[;,:5N.%$:>YMNGPXB(7;.'$00X>;\VU<_XLQA,-ZVZ(BC6:/S46>R^
M;F.8A#F\5,:4KN[5>)B%9BJCOL:</F-=O;N45*AE.YM?3^<E?0CF1WII\3'L
MK^<E2J>]_I??_.2IS([TU^)AVU_.2OI*I$O:VGI_.2I4,IW-KZ?SDJ5.]/Z'
MS8[?>2I4[W^E]_\ .2IS'?;N';Y?SDJ51WIQ]3S8[?>2L%1TIH0&5J#O_.4Q
M..),X-M9U'>D@XFN-?JK+NIBRRL1P8-M6MU:YHNY/DW>KB8Y?>8Y:^SGQ>:<
MJ-G4UON\5I5:GRW_ ,\>HSM)<_%;^O=RV<C6TO,/OMTV\G+3K7;RBI;Z5K6Q
M%)9+XK,=".^-/B&HW5_.[%CKZ%ZG?5&#2?3^<E?052)JXAOO_G)4J=[_ $OO
M_G)4YCOMM&U(W5_.2O25.]_I??\ SDJ<QWPQ]79MQ[?0E4U!*=[:>G\Y*HYC
MO<3ZOO\ YR',@2G>RGI_.29*I,O8VOI_.2I5 FK3U=M=_9Z$F:5357QXCU=N
MPK6C<S,TY9S7Y(B*\1[^"F%:U6W9'/%88K[^1M8[HN+6N92O%C7LJKW[;U<+
MLF.W7F9I,4<)=0O\0+DT!K/;]AIZY7G:VVNF;:7783PKTM[0UK=*)F8MFO8^
MVY4_Q#R#"GX*WX O2U?;^"&#KER*L0XFYWT_FTU%45'<1X']D"S:'VD"CD;_
M )L].[OD9?VPK'?[0Y<(!P./G500$!!H=\:TX,.VOYRBJM4]]A4MIZ?SDKT%
M3O?Z7W_SDJ<RGO\ ^E-!O_,.U3WIJJ,U!7A]_P#.41G1%0S ;6GT&OU$JFJ.
M^Q X=M=_YR515/>_TOO_ )R5.9K*5A 5:^D1]537&@L_S'#J/L0&U--N_%HP
MKV"J]*VVNC%^'L_(T/"F+[IK-)GK7:1Q%SY#Q$?%^!:MU]+8P9HTYFZ<9:PB
MX2"37T+!J:TVQA#);I4FK4J-E!3L6O&XF[A-6;EB$T\J1HSG62I3RJ?!ZY*E
M/*D:,Q%*R5*>5(T:<9*IHI\*:UJ51P^55G0F>,E2GE4QI3'$JFBF-*G$JBGE
M4>#UR5*)X/65*>5/!ZY*A;4$5VA(TICC),MD;,G#O#2I/NG>M^-:(X-7P)_.
MEJ1VW=FI?7$;<=A5;M7FX)MT*<:K2M5%O\_N2U&PBG;Z#YULZ5WZJ*MN-IC&
MM$YKO!@UGZ4? O)U[N68ZU8542-*D9E2GE2=&9XR5*>5/!GIDJ42-&G$J43P
M>LJ4\J3HS,UK)4IY4\*8XE2GE3P9Z9*E/*G@STR5*>5/!ZY*IHI\*:UJ511(
MTIKF54L?Q$@BA'OK+PHFZSEBL#CPTWUKO6.-"O%6;J-&0AS2, <,:_G*WW?"
ME4V:M+JOB^8T8_$W.P2"3:OQ.X".3W2LMMO/,65IC#8T=2V+^:D4I+C+IOQT
MC/\ OR;]L*W=]AR]C4MI6:=*XM>?7*F4K/S,Y ^:,TP&.7W=?^+R+)I^W':K
M=DMIZ9_O6K_^='_MTBS:^4(M74K67$! 1%($2(" @(" @(*&LX:[Z^13,U5B
MV(5J%A!!&!':@M)ZC&"/,-#!SB>+,6TP^+6Y!)]QRR[?8^),ZO-3EX-#6T+M
M:ZD3,4QX]*Z7+X>&UM'<=?P2V%/-"P5V[Z*NK//'+E29;6GI39C,S+>N;6F*
M\[4TKK9SP;%MRIHH*=BRZ-L^A%TU4]YY/?\ SEM\L,?,=Y_2^_\ G)RP<QWH
M_0^_^<G)'4CG.\_I??\ SDY83S'>C]#[_P"<G)'4CG.\\GO_ )R<L)YCO/Z7
MW_SDY8.8[SR>_P#G)RP<QWG]+[_YR<L',=Z/T/O_ )R<D=2.>N1WG]+[_P"<
MG+">8[SR>_\ G)RP<RJN)]4#L.&/:M>=>8X+\L-M,\4!Q!%=E<?<[$TM:=2[
MEF*0KJ1%EM5K74>\/;H^K?\ OA'B<:?+@8+T[+,XCI>=.K=;JV1P7.9=)W>5
MY7A6MC:#S?@\:U;_ &Y[7J:-G/;V0_0[W^E]_P#.4<L=+'S'>?TOO_G)RP<Q
MWG]+[_YR<L',=YY/?_.3E@YCO/Z7W_SDY8.8[S^E]_\ .3E@YCO/Z7W_ ,Y.
M6.E$W3P@[S^E]_\ .3EA/,=Y_2^_^<G+!S'>?TOO_G)RQTPB+IXQB=Y_2^_^
M<G+">9!DJ#AN._\ .4<L',_+@C+Y'-XG-XB3C4UH2=_95:<:<<V<L48^JWXD
M[D".G%0?&V5J2MNVV8BDMNS1K;6N+78[C!);0?"F:+HY>+\V^D^1N0&G"UN<
M1OK"Y1;M*TGFIC#5OUN6ZE)6P<A"W\<]<C?[2:8=LJ]3<6<NA7L+?;KP7:[%
MYC.(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @("" :U6+3OYKKL$RM@ZE2/F_3F('\(Q]G]D9M[%ZVPB)B^9F,B+8N
MB5P6F/\ $&4]OL%KMV_>(_A6KN?MI12F#]5\U"!PG\WH6MJ:7-3%2-3&E%?&
M:  ?F]Q9.3K6Y^H[P;A0CR]OHQ4\B.?$$E1\7#LKL]Y.3K1&I6*TQ.\  PV>
M7M]"<B9OX\#C(KAB:?FV*.7K3S]1WFW"GEK^<G+UHY^G)/>?TOO_ )RGEZSF
MZCO?Z7W_ ,Y.1'-PXG>'</?_ #DY>M,7=2.\(P V;?+7T)R=9-]:TC$#R-V'
M9^8*.3K3SUX8I[S$X>BNSWDY>M'-U-556$&C<_N>?]AE^T<@M&Y-/ YD:MH,
M3</VFGZZ1@#MVK=OB)LG%K1J4G)=M%<&1Q;P%OE/YL5KW:466UB5[-6;YI2C
M<K$S-*6/O6\-2WRC:D8356Z.:VC\R6Q=Q,I,_P!4U(%>T;=G8KS?'0PQLYNQ
MYIB'ZH=0 >3X M/QY_-ELTI@GB\BC[S/YLIH<2G[QU%#B\B?>.J44.+:-XVC
MLJGCS^;)0XO(GCS^;)0XO(GWC^C*:'%Y%'WB?S9*'%Y$^\_T9*'%Y$G<3'Y,
ME#B\B?>)I7EDH<7D2-S-?9DH_.O&<+';3Q1R?U/J.7HZ&4_ U]S=S<L46G<O
M9^#G5J@\/%ZS6- /Z(T)';2JB^<*/4T?+XNVT[CQ(BD9+K8\M,;S*9W.!)?P
M[-I+J>^I\:F%'BV[.FI$\TYM:7Y4MH"S@=V;:?432NBV)[&QNM.8Y:2WP=0
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M5V^\+Q+O;AG2LB! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$!!%!4'>-GI3(?)ZDT5IW5\<<6H,O%XR&1DD0=(YO"^
M-W&QPX3@0Y3EC$HBN/!]):VL=I%'#&*-CC9$SR1Q-#(VTV8, 29J1%&Y4)I
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M^+5S@Y0:QTWHGG#G=[JGEK?W-ODUK99HV:',LGENI;2PCFN77MT+F(QO-:R
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M\=XTCXE=@VK).C9=/-=FW'=WX9_79G/6[IO6.>9GE<>429 ^V8V*.5DK09#
M"!PSS 5[TK7U-.++:YXT3,<7:@M9 @(" @(""*U%1C[WPJ:8TE%<, 5IB:GM
MV*$I0$! 0$%-*<5!PX;=N[;3R*>A#KD\3G1/,77/2YJO+N6F77N;:BBB?*UV
M7YA/EUQ%$R*X,D@DMG"2C12JV="8K,<93WL'?-,QYJ:5SZ?36=9UK9NJ+>[F
MMAEF79[G^97#II9W1< BM+F24\+\/BX+9Y.'%@K->I]LW1?4FQO=LLN9ML^W
M8V;VLW6K'E\=RWO&U;6H):56M"(F9?G7^ENHS+(GWMQ#S/-C$USYI!<:MJ&
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M?J3+.6,,L=OJ-T#IN]?5P$#6 AP[MC:UC!&U:&>+9F9R7O* 0$! 0$! 0$!
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M]Z'>4_1EE>=95RLMY(;/4!B-\)'\5#!W986^I'7&(+#J:O-$VY)B<%[:UT"
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MHF)C@K2..;%HZM? XUI8:IOM0=/=Z7:;S.>^S',,OC($]LZ:2YN1'"6VA?&
M7AOJFBV[=>VYCY9KDZQ,T\,OJORB^DM_Q/U5>TD=&70YIF\33PN<SBHR$"A
MJMC[Q;2*Q"8K&+FWE;X-G59K^ZMYI8K_ $Y9/F@;=G-9Y[IL=K))$+@M-[;.
M#7")[MFVBP7:L6<,#EEE$="OA_<M.C'1D%GE$%OF^M+RWA=G&I)((C.^=\,)
MG9&YUO'(VDT>VNP+2NOKA&3)$4?+==WAUZ+ZT\KLY<VSRZRO/LID8;>X8^4P
M20A\G'"Z!L<C271RD;-RFLQAE"*U]F7/G1]TH:,Z2N6-CH'2<$(X(X_;+ED4
M8EGD;'&QQDE$,4C^)T8.-5C67:  "@V)F)0$! 0$! 0$'QFM=$::YA9)<:8U
M=E$&>9%?L<R[M;CA=#(*.: ^,U:[!QW%+8I&>*,:K)M2>&'TE9[%<1P\N["P
M]I[TRF%EL/7EXR7-I: CUG*\7S'24A:7KGP,.F+5\=M';R3Y3[(^9\?<PPGU
MI7.<VI$(/J\7O+-X_4G"O6_9Z;_!KY3=.7/+1O./)<W.;W>E#>.M[>XC'JNG
M$? 0UUL *&,;"%DG<V\D\M8N*1\+N(U%ELN9Z>SK+('\-U?9-FEA;24P9)=V
M4]O&:;/5,@6M;=2[FI@5Q8S^@O LSO5G.S5^N><^IV2:9S/4$V<65FUC'RR1
M_.3KUD7[E)'$UQ&)IBK<\1VHF(^!D7\I.56D>3&BLDT'HO++>PR?*K:.W:88
M88G2NAB9&9)#%''Q$B,;:K'=-TYD3$Y.2B"\O;(WY,</":XGW/*HSRS,L9R:
MRA(@(" @(" @(" @(-I/'%+";>YBCNVR@M?#-&R2.1IP<U['M<QPX3L(5Z5F
ML80.J?K5\*3DEU16=]GN3Y38Z1UR^*YF9F=C!#;LN+HLN'Q4C@M2(W.GE%2*
M+8TMQ$1RW^D8GW4'T"]3'('7+-!7W+[/M7Y;'J#)I<NS:T;F%]&;+YR8^*5L
ML-H]K6N@8'>0%;$W1?;6,C+%G!]&V2YED/3=RORG.<N?EE_::<R^.XL9FN;)
M \6EN"V1KVM<'!P.T57GW3C6%:5K7I70JBP@(" @(" @(" @(" @("#:7EK:
MWEI/:7<4<UK<1203PR,;)&^*9IC>US'!S7!S7':"EM]9PG%$Q'%CN]>W@OV_
M-+4>;<TN0)M<GUKG$TD]W9AL$%N'N?<RO,<0M.Z]<RC9C5;>GKVQ&.$L?)->
MITCZN\+?JOTAFOS1/IK4><S!SF&>TOLT@AXVN<'%K8(!&!4%;GWBWC$(?2<N
MO"1ZM.8&9.L(<HSO(6AS"^;-+R^NH!&2WC<YMW;NC]5I]Y/O%L8S$)BLVPR&
M?#J\*C2/2M=VO,GF![/J'FC(WY.XG@BD;8RAL!+HFOM6B,AT9^*0O.F;IK$+
MS,1%9R7Z=7G2QI;JVY8YARUU#F%QEL;F/,$]N^2-K)70R,C#VL:X/95_8:*D
M88SQ66^= GAW\ONBW+LRNH!!F6L,]GD:[,71M?)#!&Y@9P/-O&X.<R(&M=ZH
MC)V9M#J<)=Q/'V5-E?SE/7P.]J*$B @(" @("#\N_P OMLXM+W+,QM6S6%Y"
M^">-Y!;/%(PL>UPIL+314MBM>$(XK)M6>''TJ:LDS&\O.7.7-S+,I7S3WC66
MK'&21SWN>>&S))XWD[5EBZ8GB+4];^"GTOZR;F;#:.LG7QCIW4<([@-XC1O#
M;UWK-;K<L8QA*?@<+9?X!/(?)=09-G.4:AG@CRG-LNS1L$D1>'/RZ\AO(V%G
MLI80Y\("R1N;8CB9YTH[[\NLX,ERC+LMC(9!EMA9Y?"6MP#+2WCMXZ-   X8
MPM3&9PS,H8Z?5!X/VONISK(UYS9U'J5L'+[5%QEKXX"QM?9X'R=\QI]FD()C
MD(-"MBS5BR,,C"KN6Z4.DGECTD<O[30?+O+8(8HHXQ=WQAA]JN9.[B$CGSB&
M.9[7OBJ.(JFKJSJ4C\DKZ5U!%2#V5]]8JX41Q2H2(" @(" @(" @(!V%!MG,
M<Z$QLI"YY.#FB1M*^L"'5!#FJ\4B:SC!59!U7]!W(SJOR&\RO5609?89_P!U
M)[/G5G96UO.V9T<W=/E>RV+WTFEJ34E9;-6^,;L81A':Q+.L'PON?W3'G#)]
M+Y'FFM='YP_,8["VL?:[Z*&)AN! &P6]JYL#N[:PG '%98U8F)F(P)Z>#(Y\
M%#1.M-"=%&C<JUSI^\T_GT5WF+G9=>QS0S1Q2R0. <R>.)XP&\+%JZG/$1E!
MUNX):Z1 0$! 0$! 0$! 0$! 0-N"#;LX*OA:WU6_&)%00<2,=O8D3$RKAE#I
M[\0;PL-#]5O>:XT9'::=YBQ1RD74,4,++R=S+DATC66K@29)!\8K<T]?DCEO
MS4Y;;L88Y/,/PD>KGEU?NRV[R?.-06)DD[EV5WEY;1OB#WB-P-G;M;1S&C9V
MK;C<12M(H3CEF^9TMX6O59JJ^9EMCIK4N4,?(V.EWF&:3QU>YK143P.;3UL?
M,I^\6]$*X5=SG0EX)K.7^K\OY@]2!MM0W>1S6][DV0N,4D++J-]M.QTP%KP.
M[N6,DUQ7FW7QC3I9Z1$8._CF1RQR/F7R\SOEMF[76.2YWE;LK@@LSW'L4++9
M]M%W;H0 &M8[8,*"BK68FL8PBL5B)=7?1YX1O+7IAYVY[S?ENV9[F=OF$USI
MF6X:V<VXO91-<'AFMFD%I92M:U*QXUP3A#N3<P4;&(QW>PT/"&!NP #<F9DU
M4! 0$! 0$!!H3L$D,D3H^]9*UT;V<5.)CP6N%?*"J61$Q.%()JM#YA="W3;S
M-S:;4&I- 9=/G%P7NFO!%;\<CW\=7/+[=[B0YY.U98F;9I5$36%J6N/!PZ6=
M8Q21MR09:Y_'1\,5O4<7%3XMN/B\2RZ>MR1C%4QA*V7,?H_?3]+<B?+=47UG
M'W[)GP.MV.8X,DX^#"$BF%%EC=4B:Q)-)RAW-=//)K).GSE5I7E'I\A^3:5M
M3:V$S6AHE:ZCGN< QGK%U=HWK4FG ^!U4>*+X<G,KK-YD<H\[TGG;+/)--RW
MC<^9*&&,6\[IFAKF/@E:XB.7!9]/4BRV<"*+H^AOPY>5/1M;7N;Y5:6N:ZXS
MN"V%SG<T4<DEJ]EO$V=MN7VT;HBZ6,&K2HU-3GC"N&9/0[&X&21L8V>7OI:N
M/></#4$U H,, L4]62LTK%<VY55A 0$! 0$! 0$"@V4P[$! VHB8JX!YZ]-?
M*GJ$TW=:=YA:9R[,HYK>XABO#9VGM<#IX98Q()W6[Y3P.EXACM6;3U9T^%<$
ML4CK>\&WF9T_R9CS'Y#"_P!8:0R^62YN<BM1.'21W[[B3NI+6"V(E-H*#81@
MMFS4B_M(K*\OZ/MRPY@\OL_ZG)=<:3S338SJ73C[=^8VMW;BZEBAMFO;"ZY@
MAXVQU<#PD[%7<71-D4SK\YCQ9-5!AY-BT@0$! 0$! 0$! 0$! 0$!!IM^,06
M -9\5U:UKMIO"CFK,PBD+!>MKH/Y:]8NDKFRSFUMK'5-K;3>PYNV&)L[IF0S
M^S-EF%O)*X-EDPQI1;6GJ3I87>RK--2(Z6+ES<\'#JHY:WUQ/EL-]J3+)9YV
MVSLIGGMJ6K991 WBL[9E#W36UWXK?MW-MT5B*PK=6*.#<N\,[JNO[YF61:.U
M39LG>UG%+FF;R,)<0"2'PEM!Q*)U[8X0B,:3+LFZ5/ RY@7^L<CSSG_==QI&
MVDBS%^72/;)<RFW=;W,4,A?:]Y\J6%OK88KRIBE<<66D3FRD=(<NM*:&T#E_
M+W2EC!E&F,MR=V2V\%K%'%6"2V=:/>>Y9'\H[BJ74K56BL3C%;D1-<LG3Y=>
M"WRJ?U-VW.UV8R7^5WF:.SO-,MO7&X_"HKOV^&.D]M(UP,XPQP2;\.M9W:6]
ME#EMG89;:PMCR^RM8+2-D8#&Q0VT3(8&M8P  !K ,!11;C])#]4;!38J)$!
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M,W&S?%9Z.-C-5Y>,1LM;,;\3A.G+=.<R5B(PAO!XLW1PQG=LU] 'M&,$<,3
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M)I2,4#7=NZE-NU)A:GI:@(H.$5'N?"HE'+3"52($! 0$! 0$! 0$!!IN<X.
MX/5H:OJ,,.Q(%'$X1$M^6=C2GJ\6.ST)7H'Y\V6V%XZ.:]RW+I93\<W5G!<R
MGA^)261CG MW;5?'M5K$89-]$&QN,4<#(8F@"/NPUK"!N#& -;0+'=-*1FGB
MW*E(@(" @(" @(" @(" @((.P^9)R&V9(2&O+>!KN,R<1H&M9O-=@6'3LBDS
M$\5>:9IA@MYYJ]5O(?DVR\=K;7^1Y=>6;29;*/,+*>Z! ?ZKK=MVUX/R9VBJ
MVK+>;/)69BN&:TO_ $KW1S/.[CU;9/C8YP,[[>T<:M)!(XIR=H5[M*;>-4Q=
M#7A\6'HUB>XMUO:V\>SO66]NTG=B&W#3BL?+,QC4YE?^EHZ/W/@:W743S/=6
M]I$[A@H9;J9L,8!]IP)<\*>2:82MVNQ;3>I<MU;DV4:CR"<7F39O:Q7MO= <
M!?!-$R6)W"<<6/"BD16)SX$8Q5^Z"QP9)3BX:T>:U::]GE5:5RS1,\N>34.!
M.-"ZE,*[%/#J@K%>N5:JL(" @(" @(*&U<WUV\)[*U]\*<IP)B"OK&HH&[#7
M;7;@G!-(PF,TES0X [75IAMIY4*)P-#V5QK@-RK$S,=J&F[B#*4[UW8: ''W
M,%%LXTXE,,<@2AQ<UHJ]@'$W92OEV&BM2:56ITY*VDTJX</IJA,16D8J7$L;
MZC>([A6F_'$K%J:O+,1QE%L1\#465 @(" @(" @(" @'8:&AW';3RH-*-KV1
M@22<;L:OH!M.'N('=AS.&0A]=KMA(KAB.Q*T);6XRW+[T,9>V%I>,AKW7MEO
M#=<'%\;@[YC^&OD4Y8Q.*O&DQ@TRV#+(66^7V4$=3\C:VT,=O%2HXR!&UK&T
M&.S<B7Z0)(!(H2 2.PTQ'H4)2@(" @(" @(" @(" @("2-':2ULE'C%WJXD;
M1AOP6&RR,:34F:RXIYE<[^5G*;+)<PUWJ[)LD@A:Y[X;C,K**\' '.-+66ZB
MG)JP[ MBRLSAFQS-OLTP62YGXK71M;W3K:XUQ9W,K'OC!=#:RXM<6FCC<.PP
M62=*;8S.;J;0>*WT:Q/:8]7V3)#\5[;6T8:[O6$X*KX=Q6,Z8M3_ $L_1_$U
MW'S @,S1Q3GNX^!C<2W W>'J]BGEB?HKQ'I7M\EN=FA^?NA\IYA\N+X9UI3.
M#.RWS)H#&ET5 \ ![P?C;BJW6Q$5B<RDQ-.#E<-=&"UD)(A/R59*\7$?6./8
MJX#5<\"2-I>6EU?4I4'R%VZB42UE (" @(" @((KVX#M0#@$(C@AI<15S>$]
ME:HF:<!PKA6FT'"M:I%UM:3FC'@TF QDL;'2-N+7%U:UQ.VI41A@G"F*6N80
M9&D\)-'8'$C#SA21;,S2 N;"TEP(8VG"[%Q/$<?+M*MC*>7HS'M);2-W 74(
M=3BP\QV5"P:FI,3RSQ5BV(:HV"IJ:8GM\JRB4! 0$! 0$! 0$!!2#4'<[>*@
MT[*J9ZD168Q0T.#:.=5WZ*GE[/,H2T;BWCN8^[N(HKF(@A\,\3)8WU_1,>'-
M- K1,9(FL8PVMCEN79>)(\OLK&Q<2#-[%906H?M(XA#&P.IY4K%:\"8F8PS?
MIJJ1 0$! 0$! 0$! 0$! 0$&W[MP8UC):&IQH#Q;\,=RPV:=*Q6L#X_7&N]&
M\O\ *GYUK3/\LR++(&O>^XS"^M;.O PO]1L\T)DP8=E5M65I2,V.Z*S'YJQK
M5/BB]'NGLP?E5_KZRNI8Y'QGA9;7,=8RX$APN7M.+5>[2NMQKBF)BG4^8_TK
MG1@#WC=7V/&VE'^QV@<VN^O?<6"IR25BO6U;GQ:>CZ.)K8M>0WI=@X-BBA%*
M[@;H_%"SW;>F,31>)K/4N>Z>.K+E!U,#.ARNSQF:LT\(#?MC:PM:)VL+:EDD
M@%#(%BU+.3&9K,E*+GCV$8N!PKLIL\BQ=<<$?*T6B9QC+G\/!Q=ZSAKQ@_%Q
M.S!5YHXX217BW*E(@(" @(" @H#C5U11HI1U:U]Q,H33H30DXG#]#0?#YU.%
M.M7N344KN4)*;:XC<*;$"IPJ*;:X[.SSU4X(4>L_A<UW"!6K:5JDQ22)K%85
M4!)H:.%,<32OD.&Q*S3')%(K6,T.+@"6@..% 2 !VXJ%E: @(" @(" @(" @
M(([0#C\""A@(!#G<;@=M*4KL4\$*)&U8YKV-FX\"QX!:X;""""TBBFO1@B,,
M\VQM\GRJSG=/9Y1EMI._%]S;6-K#,YQVETD43'N/G*5K%9DF;JTB,.E^JJK"
M @(" @(" @(" @(" @*)R&A&PCAH\\(K4$;?3NHM73LK=,5G-/"'Y^<YSE.G
M["ZS7/,RLLMRZVC,DMS?W,%G!&V-I>ZLUQ)%'4ANPE;<6<TJ3-%C?,/Q)>D[
MEY>C*\_Y@Y=+=.D?$^*U?:7L=8WN8:OBNW,I5A63DGK*TQXN.G>*ST7<7"W6
M>7N-*T]BM-M 15W?T!*GDFG&I$UEK,\63HY;&QDVN8K?B)#(FQQ-&&%?5N6B
MBM=I3;C$YK_*Y@Y)]?'3OS[UDW0?+K5#,USA[260M;&*D!A JV>0XEX5)MG/
MBBD3DO2EC'$V81E\L=6L =PX.P)[-BK$S3EK@CKXH[ID<7=QQ\0!!+.(@^L:
MU+M]$F9G&3JAN1L&[R*J1 0$! 0$!!02X.: VK37B=7XO9@@AK7 GC>'!WQ6
MD 4IM\ZF>I$5B,<PM:WUJ8C9B=^!4XW82BD6XJ27@T;%4#8>*FW;@L?-?C@8
MQE"AS*2&01%SQ0 \>!!VX>17KA1/')KN#G-HT\#L,:5IVA0E-,:DUILW4PH?
M/537!%,3&M>+#LH/A\Z84ZS&J5"1 0$! 0$! 0$! 04$D--/7<-V V_ J?DT
MMD2,1B*'\V]6MF>(I#.'A##1HK5NVM?*5>M<\Q^:_)\N==MNCEV5F4FIF=E]
MNZY+AC7O^#C!"1,4XU'ZVS 8 *H(" @(" @(" @(" @(" @TS&"WA.SLJ>VJ
MUITKJ5F:0G"5,LL-O%)-<2Q0P1M+Y)9GLCBC8T5<][WD,8UH%22:!9-.RE>,
M2A9YS5Z[NF;D_*ZRU5S&R7VECY(I;6RN[*_,;V%[7,D,5V>$\3"*%9K+,<*J
M1=6>IP,?%;Z+S)W;M96 >:D<5G:.+CN_7]Y6S&CPF91-U,E8\6/H[AC;''KJ
MUCN7<5;!EO"RM/BDRMN0S$>16G;TRFLLM<>M])HCQ/.EG76LM/:)R+5L4NHM
M43F"RM?D2Y\C7LC;2ER21ZXV!8K].;8BLDQ1V(0O[T02 =X'QME$P]4<$C>)
MNS;5JPS3.%>+6+.(N#SQ,=3A%*<-.PK'SXQ$1A*:-57! 0$! 0$!!0UC6MX0
M/5\Y[:ID*CL. /D-*>^A*@N:UX'V3Z[_ -"*^BJB;IPA7")ZY2"YP'$RE:UQ
M&']%5BZZ<HP6[5+3&T.C'V%*@U.WS[5>,>T5!KN)Q+J@TX13XOUT&B\2-##P
M]\]I./%P4KY-^"'$#W@_*;7_ !8J5I3;5RG#)$USAN5"1 0$! 0$! 0$! 0$
M!!H!T@D+.ZI&-C^+;O.'G4S2E>*(Z.#:7.691=O%Q>9;E]U(SXLUQ96\\C<:
M>J^2)SQBHB_.(F3#-NH(F0#N888X(&?$9$UK&4.-&L: & 'L0[FM\8M<#@*^
MG<IRP,YK&2I0D0$! 0$! 0$! 0$! 005COQFD9I'$ $DAH )))H !O).  5Y
MB9BD9H6U\U>J[D)R5-R-?<PLCR[,;:,NFR^+,+2XNVD![@UULRZ:YAI&<#0X
M;%:RR<9QQ8XI,U_*6FS>*_T<2SV[':LLK@73I6OE?:VK@PQ.<"7\<QK4A;/@
MS&,7%:QC#79XK_1W#ZMOK:R;,,'F.V@B:&@TW7()P\JQ\E9QK0K,6TBE4_Z6
M;H[]JM8X]<QOGO+FWM 2V,4FN9FPQM ==4Q>\+',4R)FV)KQ=C6GL^RC5>1Y
M=J/*)_:LHSNUM[VVG^*##-$V6)U*_9!XWK',1$]4KQTR_<[LNXG"L<AH.*O%
M@/>V+7C3K=29FJ8Z8;D>ZMH$! 0$! 0$! 04N+6 N.&RNT^1)FD(PAIN<2YH
M$G#Q5IZH(--N*IXD5I,$]I,).[/=$=Y4>M08BN/O*W-&<9%)^%JBM #MICY]
MZBL\U."5-7>J"W UXCQ?%ILV;:J:T[4=RCBP9W8X@:X;*TVXGL2;NK%'13)K
M*5A 0$! 0$! 0$! 0$$5%*U%.W<@VSW2-,I8>^(X:0_%X?ZK>IKT(;+,+'+\
MQC9%F65669["RWO;6WNF"F)(]HCD8*>96B,,Z6HKZ6[MK.WM8X8K.WM[*WC!
MI;VL,4,(J!@UD36, %-P5:II7&8Q;EG$!1QXL31V&-?(-E% K1(@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(,7GQWNJ37=EG.D.16@M3WFGM/Q-NI>9,-E--#/F,=W#
M<C+8HYK>XBECH -@K4KT-&RVS2B[.;I8;ZS=3A#I\Y">'-U5]1VF6:RY::2S
M:\TY<.>^TS;.<[NX_:7/+72.:^_C?@_O0<'%+^6VDS2BL1->ESY_H6.NW=I"
MV%/_ +)X,:^3NU3Q=.>.*_+.8/!8Z[!4_B?:N-*C_*:W%2!4-KW=<=B>+ISG
M*.6>AV$>%SX;75-TV]1D?,CFGI"#(=/U<)'QY_#F1(I;-X^[;&""X1E8)FV:
MXXLN.3*":X/ <TX8[MN[T+%DE6H! 0$! 0$! 0$'Q6K]=Z4T190WNK\XL,CM
M)W%HEOKN"W9Q"M*/FEB&ZJ6Z<36F"LW4S<=_E(<CSQ%G,G2LT]L!6(9[E8?\
MI@/5-X 0!Y5EMTYF:<.E$W1$5XMS^4AR1&WF/I0'L^?<IP\A_#=H3PKNHYX0
M.I'DB33^<?2GG^?<II_AJK-DQ\*.>.,2'J0Y(U(/,?2F[;GN4T/_ ':K>%=2
MJ>>.B57Y1_)$<7_21I/U14_P[E797^_%'A7=1SQT2^QT?S'T5S$,\VBM5Y3G
M\.7.#;]F67=K>AAD:.[[QT$LG!M]]4FV8QE:)B7WH((J-BC)*4! 0$! 0$!
M0$%-&M .P-V;<*J<91A"33!IW[O,D5S@F8REI'BD<^-\=(Q0M?Q?&] V)A$5
MXF->I57#BXO4[*>C;MVK%A,8^RGK5 U%1L*F*^U'H,)233S4))[*#LWJXV3)
M6RM+HJSR1.(Q!CVFAP.!HIITY(KT-VU@!+Z4<ZG%C79N[%"5: @(" @(" @(
M" @(" @Z>?&7ZD]6<D>FK,M,\O\ ,Y,@UGKV)UKEV?Q/(DL+2)MRR^9&ULL3
MRZ:)M*BM%M:&G6.;CEW,<W1.3$\Z=^DGJ&ZOLXS0\K,LU!JK,\M>ZYS?4>:9
MMF,=G;3W;FRS.XKT3P2-EDN*[?5!6_=IVV6<U]T1:I$16L8RN^_T+/7::\6C
M[4G>?QG@]8[S0Q;RM>[5T>$U^!,VST(_T*_793'2%L:;OQGMQ7R?>UANOLNQ
MK2>PY)HYHZ:?"*ZT>7G45RIY@ZFTK;Y?IG2&8/N,PX=00W56.N+>0E[&QU?Z
MK#2I6+FC.K+$8LPW+R^SRK+8;L=Q-%96D,K&CC#9(X(V/:"!L#@52G-,S&),
M<(FC]8&H!&\55$I0$! 0$! 0$!!^'GV>Y3I[++O-M07EMEF5VC0^>[NIXX8H
MVU^,Y[W-:/=5LO9S(Q<3Q]1_))U8G<RM*-<"0'.SS*6\7"=@I>.Q%*'8K3;2
M:QDC.*0U3U'\D@.+^<?2A\V>Y34XT_OU1R25/RCN25*CF-I,CL&>Y3\'MH3D
MDJ@=2'),@G^<72HI3 Y[E%3YOPY3.E=;G1*?RC^26P<Q])X;OGW*=^S^[=ZC
MDGJ5YNJ7T&E><G+36N9')M,:OR+.,R:"YUG89IE]W,  #BRVNI7;#V*+HFU:
MN+D]5! 0$! 0$! 0$! 0$&G5Q<YI9ZF%'5V^C:IRQXHFM:<#"@<YO"6UH*UI
M7#=MJL<S/PP89RG;C6K3NIZ-NW:HF:1A[*<\5%',X8V-]0AWKUKPD[,#M63"
MB&W#9>Z=%[3^$ @NF+ !3BJ!0^KLP4XTZD1$1/6W1KZCN/U1\;#XVZODQ2DU
MIQ3,Q$5X-10D0$! 0$! 0$! 0$! 06E=:O.E_(SI^USK*UNC8YG#D]]!87#1
MQ&"XFLKH1R"CV$$/:*8K/H:<775X0I,SRXL$;1^B>?W61S9NF97-J/7NO]6Y
MWF?=<.9YG#9V4#;Z3N ^(/GMV-[JX&T4H5OZ>G%)QB,&//"%\+?!:Z[G $:/
MMV5:#3\9H :N%2'#NQ0BJQ7ZNC$^K-4\DQ.2#X*W79OTA:D;P=36^(WC[WO&
M"IXNG'$BV>AH'P6^NSVW)O\ (F&TRRSSW)K^Y9%J:*YE,-GF5O<S.#61%YJR
M,FBUXNMKFRSDS/>2NF\VTCRLT5IG.K86.;Y1D&59?>1->)0+BTR^U@E/$ !B
M^,CT*LS$XYQ1&%LT<K@846-9* @(" @(" @(-E?7L-A:S7MQ(V*WMV&261Y#
M6MC:*O>2X@ , *O;;$S2<U9F:5APW/U&\DX+B:&?F5I:WELWF.ZMYLXRV.2-
M]2WAD;)<M>PAP4<LK8X)?U'\D6@D<R-*2AM.(QY[E3N$.%17\,:<0IY)F*Y0
MBJ7=0W)%K(V?SD:2,4M2'#/\JX6<./K'VP.%3Y"HY9%+NI#DDW <QM*N_2Y[
ME)I[M\%:W2NNRHF,3\I#DGM',32O$=WS[E'$3L /X<I\&_X!NLOZ@.4&:YA9
MY38:[TU=9K?N++&P@SK+);BX=4-(C9%=O+J$XJMUO+-.E&,_ YC:62-:\$.!
M <"T@@APJ"","""M:ZRV[U;IR6JU%F0(" @(" @(" @("#1=&7.<'OJQU.%F
MP@CL.TJM)F<<A2P$\<;H^&-M. \5>+9Z5,VQTJQC&,4;A*84C!92>W N PV5
M\WDJHB)B,\1H";&)DS>[DE+Z,'K \/\ 3# *T33M1GF2<)=Q,89)8J4%2VG%
MO[#13'1P)Z>+<C8*BAWCL\BA(@(" @(" @(" @(" @^"YB:NL-":.SS5F9/,
M<>495F-PV8"H9-':3RP\300""]@"SZ=G/=-L80QS,Q$=+ -ZD>9G.3JMZE]5
MV6<YWJ#5F9YKJ&>PT3E&5WN96MK%&W,KBVC8ZWLYI8>$,E:#5J]#3TXF*88*
M1-<ER&5^#1USYK8P9A#H,63KB"&XB%SJ1C9#'-&V5E1-$'!U'"HV@JE]^E9-
M)NB93-MU:OT6>"SUW2<)N]'VKPRM W4T .\@X18XK#.KI\))MN:=SX+/7:;>
M[8W1%K-)=AK>/\:;8&-H%/['C0%:_-#+$=+* \-#D5S'Z:NE#1'*KF?:MRG4
M&GY+PW-NV=M\0;ET!!,S&CB^(=R3-M<JRB:TZ'8B,0#6M0,=E?*L*R4! 0$!
M 0$! 0:,Q'#ZX^3 <Y[N*G#PBH^!3$>D<09ES]Y49#>SY7G^M=/Y-F5L\L?9
M7V;9?!-@XM%&37+'[6G: K392<"6U/4?R193O.9.DHW.V-=GN5D^?U;MP439
M,=:*MN>I7D=$*.YFZ4E<3L;G66<6/D]J P!4Q;,\*''-KGJ0Y)@ _P XNE<<
M?\>Y1AV5_#L*U4VZ=UV5$QC-%(ZD>2.P\Q=*M\ASS*,?-2^*MX%^> G\I#D<
M6QN=S)TDWO)&11M=GN5<;I)7!C&!@O"2YSB /*L<Q-N"(FLN8K.^M<SMX+RQ
MN63VLT;98Y8R'1RQR-#HWL>"6EKFD$$%:]]G/,53E+?K," @(" @(" @(" @
MT6Q-:Y\C1PR24XL>+9LPV8A3W([P/D,A;W?R>%).(8]N'D3@8U:RA(@VA:P3
MMXY.)V/<L ^)AZQ--M?*K5F85IBU(HPPE]>-SZ\;ZX8;*#9Y%%<$\6NH2("
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M(Q6KN*<]N4QT,EE>FDNRL+0;@@(" @(" @(" @(.$^=//;0G(K*+#/>8-_\
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M$\I[0:CRG3%P;;-M5,D,439V/[N01,[]XF8)3@0,0D33&,TS%>+LX H !L&
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M9D_1GX=G)+I TKEL&0Y#EN>Z_%HUF=:XO[6"ZN+ZZ=' )98(YX&FV''$2TM
M(K6H6EJZMMTX>QWL\1=&<8]+L! #>%P<  .$@#U304 :/L /(L,UG#@MUU:R
MJL(" @(" @(" @(" @(-!SVCADX3PBM'BOJUP^+O%5:+8GM4F:37@X/Y]\A-
M#]1.@\RY<\Q+=V9:?S8#O+5KS#Q!K7@CC:Q]*M>=RRZ=\6UPP5NKE,NMFW\#
M;HHM9(KFRT9<VDKS(Z\A=F4DT<[GN)J"ZWJS#R*\Z\1.583RX=;5=X'G16Y\
MA.D+AC7$%Y;>N^4.WXOLX:RA[$\?*D'+$=BIW@;]$CA_$ZZK^_W4_P '4SN8
MG@<DJ7^!KT2&2RG;H^Z;/87MIF%N[VYQ#;BRN([F!W[GQX98P5CNU8NX8)BV
MG:[<]):9L=&Z;R;366U;89)86V76@(Q;;VD$=M"W #XL<8'H6*9FZ4TB,7TE
M!4G>=OH55DH" @(" @(" @(.'^=7)/E_S_T)FW+OF3DL><Z9S2,LN+:0M'$#
M&]G$"]DG"6AYW*\3RSUHSBD>RMIZ6O#^Y%=(V<YAFO)W*;K*(<W?(^_:^]FF
M9.YSFD!T1CC91A8 -JO.,9^MT&%,5^RPI$! 0$! 0$! 0$! 0$! P0;=SF\)
MK01@X@.!)Q\]<"HG3I.>#'-\4K^3#B3G1R1Y;]0&B,XY?\S]*Y;J'(,VM9;<
M.NH;=UU;/?'(QD]G=.C?/:R1.E+JM(KO!66/5RE'-69I&'2PR.OOPX.:/13J
MEVN-#OS3,^6#LU=F&2:HR@73;_3LC+F6\M[8NL(([AO="-C7>N 1Y%O:=-2V
ML9,,W4NQC%9=;9AS/ZJ^;^B]+ZPU/?YEKG5+K;*K#,<VS.X;8-@M^YLXI9+>
M\N);6U?;QRU((!>05$Z$]/Q)\7&E&6KT#^$CRCZ9\OM-:<PV99S/YI7K+.__
M !CNXH9;"V+HK>X$4.7/MA:DV\C0 X5!&.^JU[]6D<MF?%FMB)Q=QL$<%O&V
MVMXX860-#66]NUD443-C6LC8&L8T-V "BP3''\F5HGA/M0W*JL(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @MJZM>I#(NE#D?JOG;J2Q.8Y1I=D/?6S96PF66Y$K8&<;G,
M #I&4.(VH0Z]>@3Q8<IZP.8E_P MLSTFS3F;RFYN,GDCNF3"XM86LEHX"XE.
M,4@.S<B*Q+6ZU_%FRKH[YK7'+:[Y?_C.;>WMIG7 OA;O N(I)< ;F/9P=BV+
M=+GMYYE2;HMPA9Z/I#6GI&QOBY,U[SBHPYL 1PTJ2[VT T5ON\=)S@^D,Z;.
M)Y0-!_0_.@/G%?;MR>!;7J)F^$CZ0QINN'*%I _\:-'_ .7)X%O3@CFNXKL>
MBKQ=LEZO>;XY6VF@?Q>N)!ZDWM??</"(23^Z9:_?>S<HU-*VV,&6*<7=0  *
M#8M;,2@(" @(" @(" @(" @(" @(" @(" @(" @("#8YG-);Y;F$\3N&6&QN
MYHW4KPR1V\CV.IOHYH08:745XL'69R]YR:YT=DFKLRDR;)\XO+:S=#DER8VP
MP7MU'$QKF2AI#(XP*[UGI%,,T37*'"K?&6ZX7DSG5F;=X*!C?F.[W"FSOJ%.
M7AP1BUXO&5ZYVR]Z[5N:2$"G!\PW0!!W4[Z@V+>TM&V8BZZE.BC'$S,UJM8Y
M\]8O.'J:)'-,SW,H<'&[9IM\5T[%[O7N61OF?4R':Y>K9=;;;%L4I")K.+XG
MDCU$\T>G/5,FL>5V;:AR_,R&4MX;',V6LA9W=.\MV.BAD^]#:%%]UM\4FGQ$
M88RO2G\9?KI;;RS.U9FL%R>%L<8R*Z(+1NIWVV@7EZFC;$<$UFL5EE3>&MSI
MY@]0O21H3FAS+NY<RU5GKKL7AFA=:RCN#!P\3'N<\5[PG$KRXSGM99RA?\T/
M:2:U! #8\,* 5];?1,#%JJ$B @(" @(" @(" @^-UMJBVT'I+4&KKYAGMLBR
MR]S2[ <&$PV5M+<N J0!5L=$'1CR1\<72'-SGW;\M1HEF7Z5S?.KK(<KST7L
M<CW75E?C+I'&/VMV+IMN"(K&7%?#U[]?F7=$>G=&ZCN](#5$.L&ROB:;H6_=
M=U$Z4"G?PUJQHQJ=JO99S<:*Y2ZQ&_2%].S1/?\ S/M@+>$U=FH-0<3_ '=O
M6:S2MFZDU)OX<4#Z0SIG_P"$+1_]:-Q_[N5_ LZU9NNX('TAK3A%3R?:!C4_
M.@V8U-/;MRI?I6V4XIBZZ9<@<F?';TYS=YNZ%Y6VW+'V>36-T^V9=B^QC(EB
MCJ ;M]>$R]AK13?99;2;>+)-&0A877MUE97@;W?M5K;W)CV\/?PLE#:_TO&M
M:41,3.#>*$B @(" @(" @(" @(" @(" @(" @(" @(" @(,77Q1/$6ZFNG7J
M3S7EWRJU-?Y-D/<6CFLBRJXO(R_N;AS@R1LC6C%FY9K;8P1.3KE;XRG7.[NX
M3JG-HI8.)K;EV1W9#^/ DM,U#@L\:,<9Q30F\9'KC$(LSJO-IKEK@]KVY#=M
M)->+XPFQQP6SI:5O-7"C5Y)SJX=YV^(MU)]0VG/Q4YKS39A:LC+!,_3+G3AA
M:\$-G+996FDAV=J]/2NLTK(MB+8]$$Z4S%:XK2M#:]U3RZU%D^L=#YGG^4YU
ME5T;IIM<OS*W>^1LS90)#$(B]O$P8$THK7WVW8S17PIZ<78B?&2ZX(HX8+?5
M6;16>76T<,8.17;G/$438V<3N^JXT;O7E:FE;$UMI7X%ILFL1S8.^WP<.KKG
M=U7:=YB9QS@SBZOI\BDL66,5S926I/?M@+GM$CWGU>,@T[5Y4UKBVJU=W=*4
M#13;CMI[NVJ=<HZH5*$B @(" @(" @(" @V5[*VW@FO#'WGLMO/.*/X:B*-S
MRVFPUX:*>K@B703S9\;W3.@>H>3E!8:+CO;+(\WCR?/;EU[&U[9)[UUFV7]U
MM'J%M: !1Q3@[,>>_5[E/)SIQMNHBRR,:BR:ZRRVS'V47 A#._MG3]WQ=ZVO
M"6D8.5K8YNQCC*O&73K;_2'M*3@._F>X(3)-'QG-0,8G%NPWV\A9K=*)G&IA
M[,9)_P#I#&F^*G\T+:$FG\*-P Q']W;UD\"RG&IS74!](8TX3CRA:!^B^=&G
MTT]NQHL=VE%LQQJ<US0E^D-Z8[[+K1O*CN_;<SR[+S=',*AIOKN.V!X3>XT,
MB7Z=L8P1?G#(HY;ZUBYAZ%TUK2UMC;QZARFQS-EL75[H7EM%<<'%4U#1+VK6
MQ6B9IUONE*P@(" @(" @(" @((H#M -=N&U!* @(" @(" @(" @(" @(.C+Q
MA^L?GCTJ99H6;E!FMW9S9X;KV[V6PFNBW@]IX.+NGMI3NQM66V(F,$5I@Z)V
M>,CURACXI]79K+#;M8X4R*[:Y_$ 35PFJ[AJLNG9%]T<"OH4Q^,IUPNFGEBU
M3FK+68 #BR*[-"T4P)FWE>IR:>%8MFG8UN28G"ZCY;6OBM]7',C2>8:-U[G-
MQ?Y'?1RP_A>EWW/$V6-\3^$S=[PNX)" 0*A(MT[<8B(F<SPIN_*=?#\_N8<P
MM,[RMN=V.H++,!F-O<VN6YA!+',;H71='+#&U\8+Q6@(P5L.I7P9C.78SIKQ
M;.M31V26&F\CU5G3LLR^VAMH#/E%[<2AD44<3>*668O-&L&U5FW3G&Z+9GX"
M=*8RG!VB^%/XB/4UU)=0.;:!YJY[?7^2VPB+'SY7/;,=QMMCP\<DCV[9#YEY
MNM%L<&Y%9ADZ%S:D5HZ.E33 <5-VPU6I'0K=3-JJ%A 0$! 0$! 0$! 0:;N(
MMX0>!QV;]AQ]Y33HR17A.;I0Z]O%OT_TD\SV<J,ITV,\U%82Y=+GCWS-C$5O
M?5+* W$6R-A.Q0F:1'6OLY4=6V0\U^FNXZA<ARQLMK:9++F,N6B=H#I8+-L\
MD?>=XX <1(^,K6S6>6:T8XZ?RG3UF?T@K(<HS7,<IN.3A?)EU]=V3KAN;-X'
MFUN)+?BX/;*U<8UM1H:<USK_ "ZD1J37J;+_ .D,Z9_^$+?_ "JW_EJG[M9U
MK<R/_I#.F:BO*%M/^=!C_P!W55? LXU5Y[NC$_\ I#6F7.HSD[0<#R7'-12H
M;4$?ANP%3.A9$9S0YO6=TO1=U,Q=6G(_3W.&#(QD4&=R7,<=JV<3 =RYE<1)
M+NDIM.Q:UT1&$+Q-<5VJHL(" @(" @(" @(" @(" @(" @(" @(" @(" @ZY
M?$LYZ<P^0O(#-=;\MLVFRW.X&N$)@LWW4CRQD[Z@,+7-]9@WK);&-.*.W)BX
MV_C*=<\A?/-J_-9'1R2QQL&0W;?5:\MJ1W^. 5YI$X1AQ1,UR'^,AUQU#OQJ
MS:F)</F.[QV=DW:O7BRRF$1DU?"F?RLVG?>,+UJ9M9SV-WJ6_N;>X@E@G@N=
M.3SPOAGC=%*QT4TCXW<3'':,$Y;+?9B(E/A3,>U5UV:OUK<:XU#F>H]06>86
MV<:DN?:IS:Y)=0117+)7S=XV.&$,C)E>3AL*M2.-#PNM>-R=\2WJSY#:3M.7
MF@]6Y_)D.4-X;8W>6YA=O;&X,X6MDGFXN%K8P*; JW6VW1C$)C3F)B(G%>MT
MC^*_U@<T.J/E9R]U=J#,Y=-ZMNYH,SDER:Y9 QD<MO& _CE,8XA(=H7FZT6V
MQ%O!M4F:,Q++'3.L+26XG]H?+;02.EX.#B,D3'%W",1Q$[%J=7%'7P?HJ$B
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M7JK&C9,\?Y? <\QV.0N37CK9!S;YQ:(Y61\KA:R:QN3:QRLS%KG1'OH8@_\
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M*RBD)4)$! 0$! 0$! 0$#9L0$! 0$! 0$! 0$! 0$!!I!I<^KV_$^(^NVNW
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M3GROYYNLX^9&16V?0V0>+.&XBA=W7$'<7"989:5XRLD733#@.!1X<72FV**
M\N,LXR7\;Q%:GB&X8V06;Q^HBD-9WAP]*)A$ Y<9<U@[(;/MJ?[D&TJOWB5.
M6*UE,OAT])C6,;<\N,I$$=>'O&63!6F!+G6@%05/WB:81B<OH:<'AY])HF#F
MZ"R.3O X-8UN7%SA2@X:6I+N'R)X]U,I1RD7AP]*K*N_F]RYQ>27_(V="*[
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M,SEN4'Z/]=DX:ZB%=OX.SS?WFJSJ6X4G),6S&:'> !?0N:^/745S(YKFND=
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M>PDMM_9Q"0"(1PU]FBKA%VK'JW63ET)B)SC-WF+691*P" @(" @(" @(" @
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M-%=LS:0'A?* 6UI$0"UKW$ F4;ECNTN7*5YH[5 00#7:*CRK#E@)0$! 0$!
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M.!PPI0D'T)RQ2B(K7)JD@;2!Y2HBV>&:44!J6FA-,=NSWMB3;C6,Q4K @("
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M644;,XL72,,[9A' )7&,SRR'Y60A:]W33!:DT=A--I&T[?0L5U9BD2E*D$!
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M9SK-"L3/6U%F! 0$! 0$! 0$$5H*G#MW_ IIC2$5Z72[XKO6[S1Z-(>7^?\
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M@4"Q_=IMQLNQ/%KG%8X.U[0O-7EWS L8+K1>JLDSN.:-DD<=EFMC<3<+VL<
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MY:'/[IKH9X8K=S8@X,:)"P;&K+JY*6]/%F$+39A 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M');EX<QCP3;-;M"T>-899]:*2[!BQI<UQ&+:TQ[5"52 @(" @(" @(" @("
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M4;87M'<1PPQM.VI8 VF&)V+RYFVE?RJKXUI/LMVJKB @(" @(" @(" @((.
M)K3 X[:8;:;Z(-@Z!EU:7,)EXS=03VYD<*82,='@T[FARCFB<;<CM83G6'RW
MN.0?B4Y+=:FLWMT;?:GLKZ/-KNT<S+;AM_FAN(W-=-%':.X*]I6UIZDS&,-/
M5I6*Y0S-N6>;Y=G6@M*YED]Y;YA83Y#E)MY+7NA$&>P6U& 1%S&\(.Q8M3/)
MFTI]69K6'W9/""36F& &S=NQ.*PW3AA$LR16@KM5L.&1'6I%237$':*U#:?#
M56[U8B:XY*U580$! 0$! 0$! 0$&F^1D4;I9GLB8QI<]\CVM8QHQ+G/<0UH
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M\//G+;:)U->Z@O=.Z3S.UM\ZY=9U-F+FWMK<W4,=Q-#FU_/")VVT5NYWJU%
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MH=KZ>-YP;, TR$AD/QN$#<XC<>PX)3C;PXHK$9L>/QK.B#G/U'ZQY'Z@Z?\
MEW;Y]>96W.VZWN[(Q6$LT;H;AM@+F2&V>^9P<_:X[U:V8Y?6G"J>-(AV,^%_
MR9Y@\BNC[EUR^YEY5)D&KLM.8NS+)Y)3/['WLD0B#7N:RH<(SL VK'A%TS)-
M:8.PF,</$P,X6-^*:UXJXE0EJH" @(" @(" @TPYDD=2*L<"TAPJ"#ZI!!&(
M*FF. Z&/$O\ "9FZC;[-><')>]M<NYEP5GETY';6UK!G;R+IX8VX;;$0R%T@
MQVD^5;5FM%(B_#!BFW.C&*YJ],/43R0S4Y;S'T#KZ"XMY)K>6SLIM1YSED C
M?)&"VUMX7V;FS]V=C<*K*C%\KI7EWSIUU=V&A=.:2YCV-MFDA;#EEK9:IR:T
M=*7-#/:G10102M>^0?'!HIPR12[AD[SO#M\&[F%=ZZROFEU1Y/\ ,F2:<GLL
MST]IJ:=EY<9^1):W<$MV9;;O(>X<PGU\2L=^K;9AG*W),XLJFQMH\N9#E]O#
M';6%K;P6MA!$QK&1PV\0C:UH8 UH#0!2@HM.<<>+)U/TFUH*XG\_R)-*X9)C
MK2H! 0$! 0$! 0$! 0$!!TP>,1U8:SZ;^6&G,GTIE]GFC==VV<9?G,5[#;S0
MLM'VMS ']U<.$;R,:8$@BJSZ5E;9F9QJQW81BQ/N0'5#S>Z9=5WVM^3VJY<D
M?GUY=WN?P\;Y[2.2ZG[\PNLS/' YKCZHP( 6_;I1J83.$*1,X]*^W_34=8V'
M^4\6S$]S$.*@^,![9AQ'%/NUG5Z%JS.4J3XU76*T5.IXZ^2&(@>>EYA@HG:6
M3C$VIB9B7,?33XNG5=S(ZB.5.A=0ZD9<:>U9F$EM=1=U& 6"XMXG!_X6[=(=
MH6MJ6VQ2(B*,DTEF Y:Z2ZRO+Y;DA\T]E:33$8 RR0LD>13"G&XK4G":$36*
MOT5 (" @(" @(" @("##Q\9^#FSK;JQ_$C2L.MYLHDMLLBB;IXZ@%F]\T$[>
M"5^6<4# YT@!XNU;>A[/4Q79N%.0O@W]6/-7,<GNM49!)H#1>9LCE9JC.<Q^
M=+YUM/P5N'9=?6\ER/5D<<1M!"R77V6X3.*.69QAW8\A/ TZ?>7EM;Q\VLTE
MYN36SFS1&:SARB)LX,<@XFP15?&)&'# D%:G/CZK+&3MNY<\C.5/*?);73^A
M-$:?R3++1K&0QQY7923M#&,8VMT^#VAWJQC:[:%6;YF,<RF.&3E!C7QO+&QM
M9;M:!$& ,:P 8@,;04KN4^KRU_*,:]3J<\7GIBUOU)=,F;Y/RET9:ZGYD6\]
MN[++AHAMKV* .F$P9.())BVLFP'>IMFDTX)<->"STF\^>F32_,B+G=I=^FI\
M\^:6Y+ ;DRME$,-N+H\'=1 $/C.-%2$91-'>0Z("7U8BX3XROXZ</ /5P4#=
M(D0$! 0$! 0$!!UB>(?X>.E^M+2D%Q97=KD&N\AM[J2RS)EG#WV:2"";V2UN
M)Q;R2T$S\"30 K-9J<DTECF*QAFQ&^>70OU5]/V87<6O]&:OM<ORR61F57&F
MLPSJ]L,YLW/E;#/)9Y3$+9P,,7%0@]BW++K;HK&2DQ,3BX!T_I_FPS,!D>GM
M.\P\ES?,W,BBOK+(-3V+YB]S6%DMQ;VD3O6XJ$DJ\S'3%")EV>](7A ]0'.K
M760ZBYNY1?Z:Y7274&8YAGF:W4MQF.8B"2VO.Z]GOK=UQ64.<#4X5Q6*ZZVW
MCCP@B)S9C?*WEQI?E/H;3O+_ $?8PY?D&F\OMK'+XX61QB0PPMCEF<V-D8<Z
M1X)."TKLZ\>+-$UQ<AL! HX\1WFE*]GN*LS$SADE4H! 0$! 0$! 0$! 0$ [
M#0T.X[:>5!8UUY\]-2].?3WK+F!I2PCS+.;:U=%/+.6=U&RXAN8V_(R.8QU0
M*+/I:=8YKLF.9B,.+!PBZB^8^7<[\PZ@=)YX-$:WS',I+V:++R!;L='=.F([
MBVECB^5.!Q6];I1?QB**125_,7C3=90;$Q^K8#W44<7$+6$=X8V!AD=2[JYS
MR*D]I5ONUF<\OHA;JB95-\:KK&K0ZO@-.VTBP[:CVO<J7;6R8SMCT$3,=,M&
MY\:?K"[[*&76K8I+.]S[)+"9K+>*)SH[O,K>W>WU;P&A:]:M]MO"(@MNXLRO
MDMJ7,]9\K]%ZFSMXES/.,ARO,+J0 -XI;NPMKA[B 30ETI6K$W1FM$1=-9SB
M7*B+B @(" @(" @(" @QV_'NSC7\6B.6>F]&RZEBAS>2\9=1:;9FLES<$NNX
MP'NRKY5H+:#%9-**5HPW4B:<'2AR1\+OJ]YU0Y+J')-"YO::8OWQ>U9OJG-;
MR23NIS$9)S:YQ"]X<QDI=P[30K>B^VVWFNF*(I=.6;NUY"^ KR[TC?6&?<W=
M=/UOQQ037.FX\N@M+2V>]L+[BU-P+=IEX7!S*\._!:\[B,HC!FFE'<!R;Z0N
MG;D+ +?EIRSR/(N)CF 3VMO?R'XE7B6YBE+7N,8Q!%-U%CF^^8I7U4S."Y&W
MM8X&L;;P16<="'PP,9$R@%&%K8PUH(&\+'S84GX$8\%KW65RGO.;73GS$T+D
M>G[74F?9GDMS%D=E=,BDF]K[J4L,,\T4SXGA[SBW&A2+Z35,9N@;PC>@/JAZ
M>>I#--;\VN7UQIC3-Y>9I+!?&_DF;*P31NMFNC[B,$49A4THMS4NI9,]7>FG
MJLJ @.>,>)T9-12@/%L\F 6IE'1$JY-=42(" @(" @(" @M2ZN.EG1G5MRGS
MSEIJA\%EF,\+OF;41LXI[G);M[7-$L/>12.X'!Q#@WM66R_DFL1@K,1/P,.?
MJ6\+CJBZ=<_SF3+\@U#FVBC=7#<GUGIG-<RCFS*& RRO$V7Y3$R2 QV[6GA<
M/6JMW2NMNK26#5B<)X+$;;(N96G[HYC::5YA6V;9=,+2RSZ/3NIC?2OGD$%Q
M2=MF+@$.VNXL=JRSU3"MD85XKW>0'AG]574?JC)+LZ8U!!H3/KBVFSS6VI+_
M #$SV5HZ6"2<"QS6"26,R0S.%!0K%/)9'-=,,VGT<(9EG2-TJZ Z2.5.4\LM
M%0Q/]BAB?F>8]S&V:\NC#$V9Y>V*-Y896$@'MV+0OF9[&2)QIQ72-,0C!'Q
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MRYECD>F+"WL\OC86-[PL@CBFD<UC6 N>65Q"U+KN>:S.:\1RQTRY'6-<0$!
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M"-RUK[N?UJUCHZ%Z4]6,)74+ R" @(" @(" @(" @(" @(" @(" @(" @("
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MG/6,?,#E'RPMM)ZGC#@+^&]NIG.J&--8[@OJ1W8V4V)6^9H1$0OB5$B @("
M@(" @(" @VAJ_OK>=GJ2,+./ B5CFD/;PTH*--%.?8KC&'%\AE.D-":5M[B\
MR[3^GLDC,C[BYS.6PRZVE<][^*26XO9(XY#ZV-7OP*MR\LTSGJ1%U8F<GR.I
MNH'DSH]X@SOF/I:TD.%(LZRVXX:5!;2*Y>UI;PD$;EAMTKHK$3.:TW1.$/F&
M=673Y,VD?-+35?T?SE95PQ.'>TW+/X.I;G$HF:X1.*H]673X()K@\S=-=S U
MSI'_ #G9;&@EQ#1/Q&@'8HG;W7XT.:'['*KJ$Y.\[KK.+3EIJVTU/+E#F-S/
MV'UHH'5:&^NTEHJ7#SK#J:5:3,T(F*N=.$88 TV5%:;L%=9.S8@(" @(" @(
M" @(-L"Z-P%*L-=]3%\)/%519$SEDKC#Y35^O=(Z R2]U%K+4.5:?RFR@?<2
MW>8WMM:N=%$USGF**>1CI7-:T^JT$FFQ9>69FD16BL36.WBZRM8^+MX>F6YG
MF&677,#)L^S;+971Y@^3345VQG=.>V0F><,,I:6FE,%DMTKIQNP@BZ)RSZ5U
M/3#U+=-W5?D68:OY%NR/.LKR:2.*YS/\7K&P?!*]H)#:1E[0!OXE6:Q&<TZ#
M.<*<W2Y5N.?O*"TYC9=RDFUODAUSFS)G6&0QW=IWE+1I=*RK9ODW@"@:<2<
MI\.^(Y\CFQI.,.7Y988Y&0NJZ2Y^], -'=V 3ZXP&"PS=-(A,V_&WBA<0$!
M0$! 0$! 0$! 0:8+VEK2.,&O$_ 4[,$A$=:VGJ'Z2N0_538Y=E?/+1$&K\OR
M,O.61S7<UNU@D$ADI[.YKZ@R.]U7MNNC"WBK=3.<EJT?@Z^'H\-DCY%9<XM
M /SKF/%A@.*LVT#M5N?4MPK)2VZ*PU/]#QX?)E$IY'Y<9F5''\ZWP< =Q D
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MI&3PQRLHZ.6-DC#A1S'@/8ZGE:056<)7C)J<(%* 8;,!AYE"4H" @(" @("
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M)(,\L(Y+JR9)$^2UO6Q1>UQ.X))'1ADC\*G$*O+G7(F9PIFY]6-<0$! 0$!
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MRSBS*:[R2/,,SMYN"21MM+2>.. "$/$7R?"/L5DNBL35$,RE:Z1 0$! 0$!
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M!7U(Y(KTHI3!F3+62(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M\_4OPI#%$8Y8,M9K1&[AXL' -8VFP,';YEKS=$X<5K;>7MEK*%Q 0$! 0$!
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MRZQRNVB_!<OLK2QMVAP;2&TAC@B;NIPLC"\BZEWK3.,RR<:4]5^BJK" @("
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M4*UFGRS-90L(F\.;D'9]1NG^IC(<G9I[6&02SW4<.7PPPVTEQ>.X[A[HH(6
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M&A\_RV"^T\<D@R">RN(674;K2*S;8,/!(R1O$V,8&F!5(MX1BF+J35T9\V/
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MDOEWUQ6>+J32ZJLQ$K*>5_@,<F=.ZKRG4.K<Q^=++)[MEU'EPP9,()XY8VR
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MJX0L;F^D"<_(YCW/*&SGBE<[@=\XV[>!@)#33VW>VA63P=/H3S37K?><M?I
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M&CZ&.:.1SVQR->6\-0T@AM1AB*@U43;,1$RL=Y@X,'&]E*BG#M/U%$D-50"
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MTT=GN6Y[8MED@?>9?=0738I(G<+VGN7OX22**DVTSS'V*J" @(" @(" @("
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MX@<0?5<<"%2,(QA,U5OBKQ.C=P2.I5VW ;J'#%1$^@F*]K6&P5-3O/;Y5"1
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MYII\#%R36O%UXZR\%WK/TU->RVFG[[-<HM3+)#<Y1J2>U<(X^-S9/9[*-A8
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M!G_,K),WR&SU7:.FABN<]O;A\D44+GLJZ7NW!Y8VNTE3=IQ$Q28F$36K+/\
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M4I2*YL67EMTN]6'6WJ3-M<9*-6:IS6Z;=W^=7<V99Q897*V(.N#[-+(9;-_
M)B*,<:K=MBV<YB(A2(FCZ+HAT-GW+/Q&.1ND]5G-&YWEF;9K:36;K^[DBMYH
M;J"&02U>&S .B.T;EL84X9+4X2R2/&>Y,<W^9?3K#G?+O4V8978Z5MO;\[M,
MOGN+626."">=LCG6Q#W-<:#'91>/;='-,1A#)2*5XK>O UZQLTY@Z2ON0VL;
MN>\S?3+IH,OFN[E\T[C:"WAG!,UQ)(:D$[-J3'JS=&<%)KCDR-E@2(" @("
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M=)P&XMVO8XGAJ :5W*=>Z9B(C"&+FI/-\?PNF?QMWN'6)D;@^G!J?0-'4X0
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MR;9F!UNV(%K0V-G$TF/#R+1PKU,E)IUNR, 4\GYCO4)2@(" @(" @(" @("
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M$'1SX[G,.;(.E>303;B6VAUS<\,DD+WL>XY<V>3NR6/:[A(/E"VMOE*86\^
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M@7'=YR^U9;/G]H,1=6)K6@?>^S>M.ZZ)NKP12:8+GU1(@(" @(" @(" @("
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M53Q+HG*5?5I1UI\U?'<Z5],VUZ.6MW-S'O+4RM]F[EV5ATK#(&,$C[H M+V
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M+O11VN#QE/#S(!_GWR^A /\ BG,MA%1^LK#X&KT+<]J?],GX>?\ \=\O[?\
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M"5HS6LT(I2DLE/I0Y:>%V^"#->05KH.0D1/9+G%_9B>1P$+F<46;O:TO<>'
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M034U=$!M6AX.IT)K"?\ 3)^'G6G\^^75[/FK,MW^Y*? U>A7GM/],GX>8_\
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M?"ZBD#<>"L$K3Z5M\LQ'%CXL_K+J_-]A7;[':U\_<,JO.N]J>UFC*&\4)$!
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MK3S=-:VRA][)F&3MNFW;8!/W!8!<-:T/IPD;-RP:]UM]*3A"UN&'%V)+59!
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M606%IE>69=;06MO;6=O%!#;P01LBB:(XF,83W; ":55(FLUG&2>B'[JJN("
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M:YD@CQ<PC:LL:5\SCA"L3$1TRL/YM^.ER(T0)_Q*TY<:[FA<6QB*^@LP\5>
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M[ :'!3$<N6:LV\T>L./ X.=)1APX>&N/G1$UB:S.#61<0$! 0$! 0$! 0$!
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M88V-:*#<J\UW3*\V65X-V<".%P:UGQFAN!KL44F43,0U5"1 0$! 0$! 0$!
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M4*5FK],M(EH(?5?\>0.I\7XN"1,]*)BO8U0'!S\>(8492G#Z5%.G)/8U%"1
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MYDX6B DD1W$CMDAW+4NT;8B:<(F4<UTLA5:C*(" @(" @(" @(" @(" @("
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ME<5W=O(GS&_OYY&LEF'!/Q75N]U"V3BI7!>W.E;%L3-T9-*-2Z<)B789RU\
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MZC?["%6Z_P 3"F2<+<^*^X;.WRK N(" @(" @(" @(" @(" @(" @(" @("
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MJHAS&74SPYC8GMC9(P1=VT&K(P*K'=JS=%*+3$8.TT;!4U.\[*^585A 0$!
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M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!M'S'C,<4??/:1WM?5
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M.S%:U44SGA+755A 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M9 06JRB @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M"ULK3WL,PVN%%NW32&*)K+.9M8NXMK>#^PP0Q?VN-K/J+SIS;$811KJ 0$!
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M^]:16I..TXBA5)@B8G)NU"1 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MS2DNZU:S((" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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ML)8YX^R6;5FFGAFRY1ULQQT3'/9(1ZS*\)J=_:-ZT:S$40U% (" @(" @("
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MFSBVM;S45P&-[SVB2WA)A<X0Q/K&^M0L6IJ3?,6QP99^)V L:0&\1XB*T.S
M_G+!,XX"M0" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M(" @(" @(" @(" @(" @(" @(" @(" @("#:WEG;W]I>6-W&V:UOK::TN87
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M7.E;WL+N"3B-0ZM0<4C7BF$3628ESDUK6-:UC6L:T -:T!K6@;  *  +.A(
M&  'FP02@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M/0H[TI4 @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @V5YEN79@&MO["ROFLKP-O+6"Y#:[>$31O#:^13$S&4C;VN1
MY)92&2RR?*K244)DMLOM('UW'CBA8[WTF9XUH/T2SB;P2'B)). IL-=W8DXX
MQDA\#S$Y9:'YGY.,CUSDUOG65\51;7#0Z.N.UKFO:=N\%.M.6"K0/*[0?+'*
MV9/HC365Y%8M/%2SL[:&4X #BEBAC>X8!3,U1E@^[+0&]W&[A=6M<3Y3M[5$
MUG$K&354)$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MUN+N\-?(U1S5B)MQA*LUI@:'MVJ8ZQ* @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(*15S?6;0[VU\N&(58N
MZ/:A&<8M.5M*2-9QR-P XJ8';Y,%>.B2<,>+6&P5%#O'9Y%"1 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 00
M  *#8F8V_$\R/#X:1BE).+XV[8%:)G*%9IG+<JJP@(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M_2=/&;- .J0;_P#U'TECY_X/0/\ Z3IXS>)_*DV;?\A])?\ H]!)^DY^,V*
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MYBTO)':7'W%,(FK(#& 4)$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$'0
M#])W_P!3-U2__:-_]UF7H/(GTTX#/M/5%?X>R<[=PO8<%$K6SWLVG+CQ9'IB
ME<-*Z;]8DDC^![,[\=JUWI:?2UW$T V5W>92W+K)NICA"7' [P?12GPU2K6Z
MN*"2"=X&[SCW=JC I"H[Z_%P_-ACM3$R-N)P(W;:5222IW8D>BGUZH1BCXQ&
M%0-I\X]W:I2C# 4J<=Y'E40B$C$AWO>]M4E8CM#2IWUIQ?44"75&/YA]>JE*
M2?)7WJJ*U16)P4C T]SW,4CXR/C5PEPDC=3]<94U&-'C<I)QABN^)30]9/->
MGJCVO+^+?0^Q1U]];#R)S^%F%?0@\6==)W\?+#WQFWU4&?T@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @P!/IOG_["O;7FAC_ .2$&.9]'%_UO?2MA7^%
M\_P_^I;E1.1#U"[G]U78!H?:):NI\;Y5YQ\RHMP;8$[ W9Y>U$*0-CJT&.ZM
M-WIJ@FI.QV/90?"@@>M2IJ<?5I3WT$MW8[*X4[?*@ ;G?U/U=B"D=E*UW=M/
M*@FHQ(^-N'9N/D-0@FFX#],*^YBA :8D[</5QP](030;7#SGX, @5 J'&OHI
M\""D5JTTJ37?MW>BB#\S4A=^(W,JIV\K^8G9NTCFR%/2\7SF'3\?=>]OXY:E
MH,</X<OED0]<CZ,5_J9^EC]+K?\ ^ZO,4'?X@(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M! 0$$5':/="B9B,\",<D@@X@U':%((" @(" @(" @(" @)4$K$9@@(" @("
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MJR(>N1]&*_U,_2Q^EUO_ /=7F*#O\0$! 0$! 0$! 014=H02@(" @(" @("
M@(" @(" @(" @(" @(" @(" E8D$K ("B)B<@4@@(" @(" @BH&TA,\C)*9
M@BH[0D8Y"4! 0$$5 VD>ZD8Y":CM43,1F9E0I! 0$! 0$! 0$! 0$! 0$! 0
M$! 0%%8!2" @5"BL5IQ!2(J,<1AMQV>=!* @("""0-I \Y3/(RS2HK$Y I!
M0$! 0%%8!2" @(" @(" @(" @(" @(" @(" @BH[0DX9F>2:A#+,0$! 0$!
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M$! 0$! 0$"HVU3/(*A 0$! 0$! 0$! 2<AT2^/$XCIBLV@"@NR>\)%?B3
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M-F'8M;;YW=J+E,?V7H^JMV[@Q6YST-547$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MPQ]*!@:FE:;,2*UVIA!A#6A^^QX8B1GJU_IAO\J<2C%:\2DC\LGFO48>V6
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M#]!WBG]6VO>J'EWIGGUSIRN^Y3YG9YO>:A:[(K+*F.;EUO%.&.N/:&"(O#7
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M;)6^H2.+A,;=^Y?0K]2=GM:V1-\1;3U>RG!\UWEWWG<1J7^K34X_2ZU]DGC
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MC>M+2SEFE1']EZ/JK:O4M:E5AMOJLI#N+BPI3R[5;4MCDF.F)1;=66)+](%
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MO0KA;Q.LG^U0!P+X[EMO*+F)]))">[ED(KOHN1]R;9G6WUUV$S?QPX\*O?\
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M25A0[6>D12FJM,_U6?98/<_"356BR>,3Z$3=T3#7@S[+,R<WYJS3*\TC8:7
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M(3!HJ*8KC?+]/4]XO,)V\77:-NEJ1,TK-9B?FP>QO=O&TV^CNIQG7QB,J0Z
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M+"Z+K?/+J;VIC6.,%TZ,BTD%#5NY9/=;0_CVMKS;?.GI;:G+6/;AT/GFYO\
M<O:[?QM*-?7WMLQ=$3]G6*1,S\:Q3PXNCS,^K7GMDME>6-Q_-QHF^L\PUUG!
M@D-L7Q3V=UET+7.@DAE,A]4X^=?1-GN;=OM-35OLB+M*,*Q3FGJJ^7;G:7;'
M=Z.A9J3K1N;IF9B:\E9KC1G8Z5T]DVD<ARS3N06\-EE.36-G86EG;P1P11LM
M;>*V:]C(V,961L0)H!BN*\S\3?ZL:VK=,75X=N3L-':QL+8C.RZE./!.NOXI
MZG%:'\5\_P!GDRRY7*^\.G-L:5)F/5NRP_)ENZ$Q,_##S<M?N:WF%KTG8-7Z
MF)%-E,[S UKO-5TWNAC.E7'&,^V'O>]TQ9Y=9RQ%>3A%.#M#\,OPV\VZO]02
MZ]U]+=Y;RER2:(S&XBFX=2LK;R.MK>2:W>UGR9<VK78+Z;[]<L6;3DBV)BW&
ME(G+C1\<]V;;]37UIF9FWFXS.&++*Y1=&?3+R2R-F2\N>5FG;6Q>T1AM]86N
M9S2NB#&NE?+?6[W!Y[L$T !.Y<#;JZL5BM(=QA;,<9?"<^O#XZ6NH?+;NTUI
MR[REN<&SN8K#-<LM;?+'V-W+%,R"?N[6U;'(()9>*E,:+G-YH6Q=A??%\XUK
M-'JZFKJZE+[[;?#C*,&&?UO=&^M>B[FWF6BL_$V9:-S6YGET'J8P/9#FUH^2
MXD,'%W$3(C9P1ANW&B]#W:U;M#=WQ?6<>,RIK:<:]L<L1Z%X?@U=56;\H>?D
M7*'.\SECT1S-F:QYN;MYL[.>T]DC@%O%+<-AMS*XT/ W&J^EZVE9OME,1$1J
M6Q,V]M'S[SC6OV6_LOMF9MF:3$<<?YF9_9\+K.%[*O;<,9*QP=7BC>UKXB#C
M@YI"X76]JG1+K?+XK9XDYT[\5F_B \^+SINZ7N8_-/*1(S45EECK'++>%KYY
MI)[V.: &..-S7AT;?6!&((7(^\VC.KIZ7A:EUFMS4PKC;,3$Y/;\HTHOW$WZ
MEO-I6XSV\& Y?9AJ?F5JZXO;X9YF6HM:ZC8SOKVTS"XGCFSG->&,]]<-ED#(
MGWFRM %]*_#O9V^6[34NU*:DS$3ZT?.\CWSLG=1I<LS;2N7P]#,6Z"/"EY(\
ME-$Z-UMS4TS::PYR7=E:9I<9CF$;)K>U%W!;7,,1LIK5L+GQTH:U Q"S^\7G
MUNZU(TM#3LLMLF8K%*SC1X'N_LKME==J7WW7:E^,1-<(I$\7;P_0FB([<68T
M=I/V7N^Z="-.92&"+AX.#A]D#*%N&Q<W;?==6Z9FO:][=3.I2L9SQQ]'0Z:O
M$A\+KD_S>Y::MYG<IM'VNFN;V1VUSFK+K+8F0V]Y!;17-S<@V4%LZ,/#:D4
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MZ8B</AEZOEN\G8:E?:MFWEF)XU^:C ,ZDN0.KNE[G%K+E9JB&ZDSG3N<MO\
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M<0" :4P-5T/GW@>9:FEKQ9X>M%L1=,S[5'(^4:^MJ:OA673&G%V-,?2Y#'C
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MG'KA?7OT-MIS&E;;6<\86BV.G^IGFS</S&UAYOYJ7O?(1[3K?+6/<\EQ<T5
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MNE]\X_WE=$?U=OROE'NI,7:-_P!.[Y'9MLKAN-?+@N$T:^)B[>?9;*U=21P
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M;$67:FG?-)I$QQZF:CE=Q:W67V5_92QW-K?6\-U;RP2-EC?!/&R:(MD8YS7
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MQ2:4[63=V7Z]D>+6E,*+T>0?3;R>Z;--2Z-Y,:9_%;('"K[07#[AK:!E #(
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MJSN<+[CQ,>77Q/\ 6W=\N;>HOES:\T^3.O-#W+&OCS33V:=VQS!('3PV-S)
MWA+7@DRT P*^6>\&C.KIZ5EOMQ=S?!&,OI'E6O;M]S%\^S,4]+SL=:Z:S#0^
MO=79!G-C-;76G]4W\C+65DD<LAM<WN'VCPU[&/B ,((P"^@>3^:6ZNGIZ?+%
M8MB,XZ(ZWF^>>6S;$Z\W5FZO#M9JGA(]1N7<Z^E[2^37.8PW&M]"0-LM09=)
M<L?>0Q.CMFV1X'3R3/ A\@ I1;/G&A;&K&M&6I&/QN7\NU;HB[3G_P N:QPS
MF(=K<+Q,SB#ZN^R)]7'<*'L7&[S8WQ?$Q=.;J=#7MOL[&H[NY'MA>]QE8.+
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MOFD1&I;%(F8CHZY>SY;JSMM&^9C"^M/1FQXNA 5ZN.3'V)&:,#FXGA(NK($
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MH))(%'"M?,-GF0?FZC+?Q(YDC<.5_,6NW^2.;>G:@\7GF'_'[7G_ +8ZE_\
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M.V;MO9'#DM[H=3GC0<E+GFATEY_J#*;5UUGFB2+ZQABA,LW<SME;<N9P12/
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M&KY)J88Q$.+WFES;W;37C++Y!;W(/Z $;\-Q7 ^83R:%UT]#J-O28MB&)/\
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M>A!ECZ9;E3?T5A9^BEM$OC6_NIN[_P!I=WR[C:VUVUL]%EO<_3*Q:G!=^)G
M+<CSLTQ^:LP-.W\#F63<>MHW6_T9[D;:WEU8KQNCO>=AU6'BZAN:=1PN^?LT
M]3_ZQOQ7R+2]P[/NV_U+YQ]:.KC#W??F_P"\>7:=O"+.W@RI? C'_P JS3V7
MA'ZF'ZR^F^^^MXMNVG^C/%\L]SM+PIW'7?#O$:[BKA2GE7 S;1VT35IS;!Z5
MYWF/V5&;3S8XOT@FHY?<H -OMF<4%*D?(38TVKG]OIUW>E/5'UI>WY=?RV7X
M<?DAT:^&L#^6GR8+34NN[C 8T)EM,,*UQ7Z3]UKXM\IULJ>'/U7RWWPTYO\
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M>%O=I,S&IS>SE%.&,ND\EW?W?5OT;HCUXSK1@J7%MJ'1FHIK#,Q>Y+J_2N<
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M8-M,36.A^@D9-@4@@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @("#H!^D[_ZF?JE_^T;_ .ZS+T'D1Z9!^?\
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M%PV%COE8&DF@CWD;5V.EYC/W+4V4V5B_C7)X?G.G.MN-MN*\DZ4Y4S=ZL3*
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M.E2RVLMI>ALKHB&.!?M.)V4W;L5&E?%E_+3VLY-W;,Q9$SE+5CB)@DCDK*"
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M-&(CVI;7+W%QN6O+G<+JX@C UI0^9:=W-;UM/0G&:9M*0/>0 \\#B?DPP@N
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MS)KRZW#6'N@34TK4$8>48K8LOG3QB*QW-'>6\UUD\:XIL@WO)7/!K%PAAH0
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MX0,-QWKSM"Z9UIYHF:2WM6(\.+HPK"+3XTF'V1^%>MN\K://V^=W:_05(R;
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M" @(" @(" @("#H ^D\?ZF;JE\^A?_NMRY!Y%>27<%OFF2W4PI!8YGE%S<7
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MGFFB"* [0"@4'8/<2,,@H.P()44B!% =H!]"DI":#L0SS%$1$9 I! H$RR!
M3+($!!%!MH*]M$K)2$T0$G',10=@]Q1%L6^S$0FLI4H%$1$9 I! 0$$4'8/<
M43$3F1ADE2% =HJ@(" @((H#N"99!0=@]Q!- DXYB*#L'N)2F0E 0$! 0$!
M08 GTWS;T*TVUYH4_P#X0@Q9/!-ZCN3G2=XC_(/GKS\U--I#E=HR]SF;4F?P
M9?+F4UK'=9;+!!PV4)$LG'*\##8%$Q7 9[,GTA/P>YIG,9U)YS#9SS3R/N#H
M7,G3P_*%S?P<W)D>)*[=R1%!2/I"W@^BH'4WGH;6E?YO<SJ0/BD#VC>JTE-4
MCZ0OX/H!_P#F:SW=0?S>YG7;C^OIRR50/I"_@_BA'4UGGIY>YG[_ .$!.62J
M?_I"_@^D@GJ:S[&M1_-[FF'9^OIRR5E/_P!(7\'PN_ZS.>T[?YO<T&[]G2DE
M>"/_ *0QX/U:GJ9SRHWCE]F?O#V@I22J?_I"W@]DC_YFL^IC7_H]S0>;;.G+
M)6J#](8\'T@5ZFL]XNP<O,TIM_9^Q.62)HG_ .D+>#X!3\IS/O+_ -'F9FO9
M^O[DI)5 ^D*^#X1CU-Y[4_\ ^O<SPQ_9]ZCEDK,H_P#I"W@^T /4WGV__P#5
MYFF'_9\:J:25#](6\'XG_K-9X:;?^C[,\?\ N@;$I)5+?I"_@^"I/4UGWD_Z
M/<T_W].62K\_._I"/A"76E-<Y=:=2^=27V;:#UGDV7Q/T!FC&SYAFVG<PL+*
M$O[YX;WEQ.T5V8XD)RR5>7]K2_M<VU?J_-K"0S6&9:FSV_LYBW@,MK>9M=7%
MO(6'%I?#*TTW55T/74^C%_ZF?I8I^@UO_P#=7F%??0=_: @((H.P)ED)0$!
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M5K;O=Q;^JT?M.K@R:.VFOBW3ZG1TLD=L BCC9;M$;XF1Q6<#6AK;>&(!G!@
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MCT,#^;+F10?]&NN<-I_%/4'H_P"]Z&"#RQYD@?YMM=5[3I+4 _\ S=V)QZC
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MKS[[K8FD82].R+N3JAOU0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$!!@.?38].:EU%/T-0Z>TUJ+/W01\T9;A^2
MY)F>:PVPX\E:UEQ-8VT\<$LI?5C7$.< 2*@%!@6'ECS(=P2#EWKZ1X/RX=HW
M/.[:-C0TBQ=6H[0$&L[EAS&=)QQ<L=?!KQZL7XHZA<T<(HXM(R^KJ[?(AVMJ
M[EAS)J:<N-= 5V'26H*CR?XOP04_S8<RO_ASKK_W3U!_Z/05?S8<R12O+C7>
M^O\ DGJ#T?\ >]!3_-AS*_\ ASKK_P!T]0?^CT#^;#F5_P##G77_ +IZ@_\
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M';ZNP8+6T+IC3QCU7IZL<\6TGUH;]0" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MUJ67\]>IH,E[6#;V@_4\J1J<T="^G9S5JW1%:'W/)58M:)K"8PP5++&2!2"
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MJ#V8XCWUJ;2[GYF[MXI%TYOT8WBH;3:![P6;<VUY9ZVKIW5NF&Z5XR7%(("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(()HJ7W\J0&JBR_G)A*R($! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$!!0Y]-VVN]4MGGB>%"9HVT4GJO=PX8;UI;**3?T,M>>84O> 6M_1G ^97
MV<\W/U2RVVYST-X#L\RRSK>MDUYA4MA40$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
60$! 0$! 0$! 0$! 0$! 0$! 0$'_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>tm2227887d4-bc_frequen4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2227887d4-bc_frequen4c.jpg
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M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MWB>%UA8NMO!)^$18;]A_**X6TV+J[1Z.5HB[Q7"TXV+JA#3K' 49+O$\+/\
MM-SPC@E$_E%<*QA[&[+I^4OH]['B3^45POIR]Y1P<9#@WLHQS7^43POC\WO0
MZ6/1RN'2C[Q/#&C+W7V_B$FR=AYNV67\HCA?^X75UL<$F&R4?>)X7BOL%V>+
MC@6+)8<4] ^\3PLFDK%UIXN. FS'#)E;C%9PD_E$\+_W"[X2<"X=)_**X6TV
M+J[1P241]XKA:#:L76U"49XC@DHO\HKA7^XW)=(X)*'\HKA;^X7>B>.L<!0_
ME$\+3^P78K1$< ?RB>%O[A=\(X)*1TG\HGA;^X7?"7@2Z8C+%%WBN%FX?-[Z
MZY%]'/3"3,0G\HKAAQAEKS6CX1)Z/>G%C1?Y1?"^G+WNP3IX5B648S25?>*X
M57]IN^$G!*T/Y17"N/L;D^D<$E&5/>(X5J</97%V_*."4G#-/Y1/"W]PNOM'
M!*X=)_*)X6G&Q=4.D<$F&Q'WB>%5C9N>$<$H?RB>%O[A=\(X%I'2?RB>%O[A
M=\(X)*1TI_**X6_Y/>+P;RF^$_E%\+_\FOPT/RZ1Z.>E)F(P9?RB>%HM>PO*
M&MX]0]'+'BPKL/Y1/"W]PN^$G!+.D=)_*)X7_N%V/6. PZ3^43PO_<+OA' 8
M=*/O%<+J3RU^7PEK+Z/>QJ+O%\+.7S>^NN2\H]'/3"PO\HKA;'V%[PS\ X)Z
M5I'2?RBN%_[A=[6/1R4CI/Y1/"_]PNQU1)P%!=XGA?\ N%WKB. 5]XGA9?VF
MZUKB.!(Q%WB>%G_:;JZW/RC@)P8_RBN%TG4[%U)80<W.!>#"M4KC1E:[PW#M
M^[:MVLI=:O7*+=-5524'74J<(SFS&ZVD5C%8I+?K(9RC/Y2QG+<J,Q;IN4]5
M=*J7B9B3@\M-Q::@E"#CCKEH@3&HI0
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M?3E2MF$%LXQ_WLDW05/P.<'*ENI4IK!;./\ 6$XX6<$_ WP>Y.FG\=Z.&KZ
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M*4M'H_\ P#BM3;$3G)^!W@QSH5-6N6&KZ G';M(C>BY/<&0JJA2X0@MGL?\
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M4,:9S@]%M:3+BMG%CE*?@@X-@OL=,'AZ/_\ ;'%;Y%P5\G^"XP]G2J984_\
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MLKYI9E'!>RI-$9,I?VR@
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M*IPIU1DYS"TIBBJV4G"+JQ>&& %E'V>S+K?7Y1N-VQDULI/:VZJOH80PZ<,
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M[?V+9_0Z3&,E?W"@
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M#'9E'KQ"BI>SLMX^*<>T;"F&**I4T^CZ26+PA%]*'4;,%JJ7HU8PC!:XR?5
M3TD]*)R:54%3]%",8]&B .H3IFJ).4,9Z7CA =1AL9;3I5.UBXQ>J'4"M,V+
MC552JJ8+TM,8RZ,!M-JNE4M.E3G!1<^UX0&1DE47Z52DL*9:98KI&^3?)LJB
MI5?0Z>B4%K;BQD4I-=@I0=*@ZH^C]-#I>$,0,DFFH*"<=I1CU 54TU5PJ4$_
MHH]&H$]2.%*J6SZ*PGC/PJ8.Q(-*.UL+5!.';IB#%-G:Z8_1_P#P^(4*56BE
MTIN$6X>C&&G7@((K#*-M-[=&UA%S]&4I:8B4E)U2JI@M>U\4RJQ7JNATQ=,)
M1A&+CCH)N-E&5*JMQ=#C4Y*7QL4IUE,&*VJG34W%>EH2AH[8A(9+TG4W.FJ$
M.F&/3B%CWF--.S4H.,([6B$5+PBA$4)NG9I45HJBISC@P;B*@X+:HU8;/AFX
ML=AV*G%.>WA*&SIU@]]8JF=7HNK'%X=0&-.U%M+;3A.*IPE@#%E15M1E"$-,
M<? (FI$U2NE-MT>FG"#C"$).6F(ZDQG%:FZ8O%=BA\<0LX%%*IBHQ<HRA#&
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M1Z<7UBF!3!$DDU&"JA"K7#&0.Q:HMIUTPI48SCCAA/$=9UY#JPB]<*_+Z/B
MRG"EI;;G/U>C "-TTK93V6NAN&D&$8(G513.F2T[2TOMUC(QB&I352X.I[*<
M>G M29PJTU2U4H*2C&J.,I2T0(15E-54JI1<X58:)R0.LIA32IQ2T]OQE,H*
MFE50WAZ7D))(JTZME8:^R.$!4KBKJ:IVFIZH],,2FQ*7;@Z%3':TQ<H3TDPR
M3;AD84?2?UT)^.(V+L8M.%+KP4=KS8#K.LDTMA^KHZ^L=1U,MJ+;I>U"'HPA
MXV"O0Q3]6NJK7!0[- WF^2+3J=7H.J$/HL,< =;4I6RDL8?&58:3J6RDZ/1>
M$^GPXD[$K[C/8IU>-_&*04A:JJG4JMB+6#BEX@E*90E=;KI]I)5+"&B<!LJ;
M*PDXNJM02ALSC",GAC$=:[Y2F,W31*J$/26CY0;X95-;,*O1CVX/H'63O6*@
MZH^C*$L-'6XLIOV"KK=%6RH1A#!QG/J)L3/%()MNEPK4)SE'Q307M50@ME^C
M.4,?#-093JR2I-1JIDY1Z="QP@966\5U"=S1;=4)1;TQQ^*!LNTHB*1L2FUJ
M^EMNF2KJV=E-I*4FW5@CG\[BI&3&;Z3,1FUZLNE!?.\DZJH>U3S5I.B&$HS,
MXBVLQ,G^96*QYLYM:NQ9A"C/Y)/6\Q;EV-DHS\YB[%J%*IWAD91VG\XM]DHB
MAYU-[3^;.M^AG,D]GU73F+548R<HR,IB*5C,ICCDES*YFBK[%L7:VHTNBNFJ
MFM1G-1A!(QX:Q68Q85NB^D-"Y56U;5*V+M,5=MM:>MP$1-V.3.[!CMP3:]:6
MVO)HAX!,Q;6NQ8BL[F.U3";]%8+K?88:4SJ1.Y=2SAGAMREJNM*G:P3TXP["
MS-\32AA2JJE;"J2^QU8N+EI3AB6W*LY,)F,H97$E53<3^QZ'TM3E-BL>4KCN
M8[<?56UKG"&K%"O0M>A:JFZ:4ELUSBI/:[<)()B3@JMGTE&"CKECA@5>UITQ
MH?I*&UICJZHZR1@D89L_3?H4>E<[%T]6!G$6TQG%=M&#MW*J6]N+7T*2BX.<
M->!JFZ:TMQAE%L4K?GL>31855O;JOY;*NJ&S3=O44U.#TTU341$:D8;&JV9N
MMXH[U<F56755"]GFLI=K@W7;HS%MU04XJ#F94NK3^BL<5*R\-/T75"%2<*9Q
MQ<'T&W@BG%L(B=N;4<8NFOZ))TKQN:,+XB+J,MTI5"E*G!.,]4)]L3$RP5U5
M4K::[(KT=&.F(-ZTSHKIJG4X?D9QT8Q"4F1R@VX)8RQC)=4RJQ].$75L]&RG
M#M)B8D**&G@YPQ?QZQA!A!MJ,=N6K9\\(BI56VDHUP<Y[./Q%&=$ZDZW"F<:
M<?&I@FNQII4U15-4:/I80QFIXXD@C'J9.MM*E^C"";QV4\/JHH516MFK9I4:
M%]%'MPQQ"Q5I>SJIG2XOJ[-+)28QC,IO9IJ.O:PJ^FAC+1 L;UK%<$IJJ@ZJ
M\)0<.F#P0C>D3TKM51<HN4:8I;/;IB VMJE2BZHPICC!ZP,L%2D]JKZ/1LQF
MNL$3-:,(*A0VH-_10;P>J>AC(R*Z74TL$HSQQ6H3B3%6+:I]%K:V=,88SP&Y
M*TPE::MJJ:ZNB4^N(B:K$U9*NNM*F,-C3!3C'P8#%(90K5.TUZV%,5*&,^D8
MK5@FVH1F_5JAC#&6B %JJ=,?1BEIBO("98:*E6X.J$\8PZAUG6U*MJ*V5%3B
MHI=6)3%%%*:].K1'&'3@H(G:=K*EPKGZ5*]:F4I2ZX@FNQC@W4U!58_C8277
M$&]BZYJ%<$_QN$%TXQ!5E6VE)P>J$8X>" DE*56DJ80_'13TQP&)CD*2III>
M,85:H3P&XW0E7I.F#DXPEJQU8C,SZBW%.*IA2X0<<(1[7%B"/>:E3K=3JC'\
M;!+HQ+B4IDPJIFWL[4>F$(+QQ(4(SG.I84ZI3]+!Q4QVG:SCLT.E5;-+A%PC
MIZ2DPFTG4U3Z5*^BPT:B5(FK!)T-).=6F&&S/"<8C(W-6IU55)M]:ACJZH%*
M48T54T*EM;5$XO#3*6+F3+J39ADQ:]-QDJL%K@M>B 7:PIH4%54Y3E!ZX8J9
M*;4IM9.AQ:4J7#IP7AQ+3W%I[BMI0K2CTQ:AHP&\WK5LM)M1IG.:AHPQ<6##
MR,;*A5M-1IG!:\5V0$)2=C*GT:?2<%JQA/6L<1DL81BQ5-<8QA'UI*4,/",2
MDFVX.J$<(K#9T8PG$%=K4A!04O'IGCK*=3)[,6TH1A'L0(BF>;3=23<:M4H.
M4M>F)*E5I;:VM#P6J$L=,2P04TJE=.EZQ$$11@L%315)1BX81FI,G4;H91?J
MMP;PJ@IZ7+1 &Y*:8;/HSG%QPU2TQ$$10DULJ2?JN;C!Q<M$!N-RJ#J<ITPG
MUHIM8U-T)U[.,(J.$)*>F)C,S$5(9Y5)7K2JJ=-6-4L,(0AK+;C$7;6,Q,3N
M<4><SCQ[NY-2^<6=GI^ROXC;.E$V3?,XPV965VN8G#?[1[M_8MG]#I-:/[@
M
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MIEI4<)RZP;,5MM-NITR?3CBO$(3&8P2&RE.%*C&6,7+IE$9+DK=-+BY.KKG
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MX(8SA@XF\YW_ -_MVSQS-J,O]T9T?^#<SG\&YB<-_M'NW]BV?T.DYHR1_<*
M
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M:2B],'5IA';AT?0P1%@=-%+]+!X*<H8X"D%(AC5[.#V<='K:^GH)AL3#8O\
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M[)M?HE1T_P#@7,Y_!PYB<-_M'NW]BV?T.DY8R']PH
M                                            V<YW_P "L[V>2HRA
M?Z,OPG(+TN']Y)N$73/J=!LV3.YC,?Y<0WI3V7<>,-GHB<\)&$,E%PIK<75@
ML,'K1>M>MDJ:Z*XU--TJ4E.*%)VI2N8ZJE2Z4XU5QT8Z^A2&RBT]UI[*@VJH
M4/&4=,-,\1V'8U(TTTNE4QJ?JSPTN;!U,8UJ4-KIBE'L&)BQ]6F-,XXU=L,'
MUCJ,HP944..RZ]FE8."&*8P5;+@VHTS]*:AHPQ<6%SA$U<AZ,81C-^CJU1C
M9F93+9IC!SC3#&,U/! C!B]JW&B$*I1<8]1-VUC$X8,FZ5"B$M.,M*ZXLNYE
MAD)INJEJ#<-,8P71A(!34J4J:G!K'%XN.@9&6"VZZDXMS?JR4\8X"$SS3:;H
M;J4>V$9]&$!LQ79BL&VE4MJ'T48>) 8U4.JJ,9/'H@NN<10F*RJJ;FE'"-.&
MSVPG$%15O0MN&+]7Q0%2JU*JJA-*572I0?G&<)6N$);I=,8Z8><0L11:4U0E
M&#UXZ8C8;!550A"-2]::4(X=#D#M$ZG5%>IV:O#B.PV[D<:MNG&&S!2ZV#I9
MTVT[<55M4PFL(/%].(C)(Z)R84N+K=,_5AHC+I"PL6VH4QJ6*CZL>G!Q0#9;
M549;4)8PAY8@3"E0<I^EJGJTQ8.H=.VD]K",X8]DM0S,T=%4(+TM3PV?'.(Q
M,63BUZL8XK:A#M*,7LJF*IC2\9M:8+&>).PPIN*=J"6W",8*$</*,3%6]I3>
MS#UECCA,#42=;=-+A4I]6G3C(=I,L&TW3#%[4*M4,9/6!%M0VE5M+5!4QT8Z
M( Q32WA<<(+5*<\'&D=IVM1M)1>!58[35+>*6#PVIZM$")7!BJJFXTS6FF2A
MJF\05Z&HU%0AM82C",]95E*XJK8=,8_CL=/B)N2M6+J]*"IBUA.&*F"J-NI3
M6S3I<4],NG$9]1GU%+I32IFW&+FL)J3!%$=NIU3<OII:M411*2MQITIXQC!Z
MIJ,ND3DLY,GM)3J_)07H]FF(%=%+<6I];^,M"D,::W4_5EI<</$2)(FJ/TG%
M4;2>G:A'1@P,Z6FL=IK%PAB4AIJ*C6J&Z=$\-#UXLB=C)3]!TP2A'TL(SB-R
M[F>TG4U3Z5*^BP\0J1-44;B25,8QBMJ&#U]@S@F<&$TZ6Z=FFF.F.,M$\0;]
MAMTK:J3BW"4UA+& K!6,V3I@ELJ:]7HBYXBA3H8;#DTXQ]90A@=%VK$]21C.
MYYV0I2HSM>U)9>]LN&CV;C+H,>/CMB(V2SNFV8PZ'1/][*E_+'XEC..:KG_O
MF=/)Z,S'F_T:./7NBGE<N_<HNU1SPW?<J6U4JY-*,/UGBNHFKP4F/Z3HTYGT
M<3_1=O'.TUK>%S-54;=MT6Z;=&U!J-*3=2TGCHNM]'PSFLS%>AX%5JW;N7;"
M3<*J*JKE+<:74\)$T)MF)BXOC^E1QY[X/#^YN)^0?&UC?N0R^=LY#<>\+N6>
M9MV[RIK6[LXZ:U[6BM*I-+I.C2MI6^UHU+;K[XMMGS7SZMX;%CC'B+V;]M[/
MB/.K*U*G9IR]-C>MU4TTJ"I4%2H0.NV;;>_FU3;=%+HR[7<>]VKQ[OW<O<JX
MOXSL.J_O;A_=%%_)V[K;IV[.2M.AK;J@DMC6C1KQ9J:MML;<V^S4B;)NB*0]
M+_-KWUW>URO&_&W+^FWD:-QV<QGMVJ[;MY6FZ\M5=S&7=.U3FU7!VZ9DC0BR
M_BG+8ENKQVTC-ZG^.>)=X<UN)-Y<9<00IWCO6_7F;B4XW:KE=VJ:=4MNX])Y
M71Y;5X.*>[+'BB)\Z?.<R.1'O0^\'W3.7_W@<MZ<M5N;+^G1:OT6;D;E-*II
MKIINYBW"I4T0PTG'SEEL^9/>C)EIWVS.$8NS1[J+OB\R^^5RPWCQ+S3=FG>6
M4:=I6J+=%,6\OHMW;J_MK/$:G*:L3&K7S8;8MNK69PE[5[E,W0E!1:ZE2Y.&
MG:@8=3+-HM4TR<:O"H?BC!,(9*XVX*F;EC\@J5;9<YN3?"G/3A1<%\:4TO=*
M:JNJ"?M'Z22@Z:UA5J,]/6MU*QI]Z=C"DS%)CS>E^,Y6]T[D?R@R%-&X^%-S
M[PJI]6O-;NR%ZIM;$&W<RK<G0M);M6;(X;X\\F++/.AM?[Q;+;OR'<CYQ4;O
MW9E-VY:GA^NFSE,KE[%BU0MFM)TT6:***7TI&6AQ:U](G&29K;$QA%70BY=1
M^^'=$9QX@S#<\([REUGF(GT6G%MW>:K=2M;9S=^OW?[2[K?"=2FOF-F&B/ZG
MRAXO7BNIA&,M]L>;CDYBIMTJI+'!1\YSW1,,\88;3=2;4%1&,X^LI8&*;2E;
M,:MKT>K'1UJ#'8;]BM?14*+>F.$)8,=1.Y(M+T$TZNG"#TQD.K,ZLV3I>QLJ
M;\&F(IA0IA0VG"JK&F6SHCH?3B*E=JUMJEM8R\J+)*54RJ@IN&G4_B(3N5IU
M)K#"#QCI<BB5.J:IIZG%>1D,6--*VE53ZKCV:-,W%CJ(W%"2JCC'U7.</6ET
M#:1F41IC*+EM*,(8PGIBA!'OLZO9U5M;,'*$W.4= PJD;\T<%4FJ8U..F&'B
MP*K3=+VFJ<%",\(KI9-N";<&I33MI[/J4X_CHSTS4&-Q6,F-2I:5--.S6L5&
M,>W# B49>C7TPZU"/@U&3+"1QVH)0=7T6."U$%IC56IPMO3+\7$=A6=B)M5;
M,=J+U0AJZX@JE5%5N+]5R]&3Z,0F^&:V7#T85KUG'6I=& [2(QJQJC%4PVMJ
M26$(0TZ8A4<;;]G"+73#&8RP2)V0.I4NJ<6X>C/RX!:DW4GJC%2]&*E/3$&U
ME*#JI46X:81A+3A IOAC2ZFFW/4I*,YDBI%:#I;V^G9AA.&(.EBJX^C0H:IQ
MZ7B*]"5V0D=A[*<-=4(QE%2&6!E@R2VU4DYO9C5#'5+1 9KL97*:U4DE!TX.
M*<8I"8E,\F%55.TJJ9N<<5H@L14K%:M2JITJ,(K3.$"RLX--QK4J.I[2USE+
M43-,V6TJ*5..,.F<_ ,ERA&E553.-+C!80@O#B#:S<-JF4YP>J4RC(*TEMM-
MJJ*E"24=?5 F*8E2;J^FV<:<(16O3$$YM4JL5L-55NOU8;*A#&3ZXDWL:[6'
MT4?H_I.R'K88#M7?M&W';QI7JK",9/I4QO-ZSJBUZ5,H4R4=<\5!@[$:6S[-
M.-7@TQZL!N-E!U4QBJMEO&3<888X PJU*7&JF-;5-490E)?&7:3TPE;>U531
MZ4(>E%:>A]!.HK)3&Y!JF:CL^EV,9E<*IL4Z:8/2HM^<4*1)2E33&GTF^R,^
MG" ZC+)A33LX+:J6*C#9CXG%#M2(IULJE6FW2\<5*4%TC%9KL9/:V9*%6J*>
MGP8%,:;T5<=K9480A.$8]:E E2K"EJW4Z7A*>J4<)ZQDF4LHU)J/JJ,:I3CA
M)34&%Q\C-.,&IQ*JW+>Q1L*K:JTK5.(F,*,8K,48NK9?I*"T.<]>C02JU:=S
M:=.Q"+>#BE&#3<M$"3D;:,Z*533;B_3BU#5YG(61YM2>]$-C.?O[1;N3G<=5
M4?ZJN&$COTJ1I[VN.],R_;<GJ=G@6BKUG313!8:*'XC@F*75V5;8FL/WBJ;;
MJI46X1480A)3>,2S-9K#&V*13:NVME50QP74X8P%<%KA4])-^CM-XU12CV=
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MGMJI*FEPJ6-4/6[-$ 16N;%0HIC2MI/%QAI@I=HR7+)EM-4N,ZJ<5ABY:(8
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M1#F)PXH;DW:G_P EL_H=)S1-868I+^V5
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M%Q8[#"FYDJEL[3DO#I@6I7"K%0J4JHU4_10PCT88$,^M8M-N'I584QU8SPP
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M?_?_ '8HS68M?HC[#HF/\BYMCNPYC\/?M+N[]BV?T.DY[.ZEV;^R9,0
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MJ,H/2AF82Q=6U15*$(:8Z1L)R9U55R4=FA:9>-8N8["F++;J32VH.>Q+"7I
MI[[QM[IKAG?\?3?W)WDTX);,,E?\,3&Z//B=D$S2)Z7SZ.^1"[WJ^9NU3M-[
MUOK9<H/YWG)SZCV7EK[;]*+8RAR:D88-J>%N=W-+E+>]KR[XOWKP[FG&F[5N
M^WG+BV7!366NT1]&E&C7FWBIL73QB:3B_85]][O04I[?-OBMVV]K;5K?$=K'
M#YU%3,?\JZRE(F65^IJVZ58S85]\?O0;[I62N<U^*[[S%+M++NUOBE7:;B=#
MI<<RU-5&.'1%6OBU+K<9>+N#DOWA^;^^,OF=T<)[]XJWGO6]13>S5ZUO"O\
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MK^V4
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MVJJHX0<(=>"%2)>9DZE[+.4J:66OSP_M3T&>GGNK"3DZ)OO9MO\ EE<2U?\
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M<*F_5^4NS>E9Z&DW/;4UI6$)01-YO9Q2J@E-XN<H*705=JPIVF_HE"..E>#
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MV+M-K-T6[V4O45)WLI53<VZ:M8YF_3TXPQB6F++]28CH=SK@?A#</++@_<O
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MG%$STMNA&;?JW<H=MU1@W4_1<FX.;7:8:EULQ$0Z(G":,EM5TMNB%&+<=6K
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M&2/[A0
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MP<=2C@4JGHNE.I[26F:Q>I$,*8HG33&$DX0<6]KLT0!@R:4*5M1KG/9DH^+
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MM'NW]BV?T.DYHR']PH
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M_=6;\]&Z&4UBV*Y.8?#?[1[M_8MG]#I.>,A_<*
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MU*IN&.MQE#Q$-XZ*(I0FXPF]&.D4@I#'9DJ75/Z&6$)OK!N*MF-2=4&X:'*
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M3AO]H]V_L6S^ATG-&0_N%
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MFJ%TZY2CVQ&XW%?J/L\J$Y$Y,6JMJO9</5T*<NG" -J^M;]%8X*/X[I&PSC
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M.2,E?W"@
M          #9SG?_  )SW9Y*C*U?Z,OPG(2NFGAW/U5*2JI2GBXT+L-DY3T,
M9PLBF;>KT6W2U!N&ESTZ,(&C C?FL5C5)TXXN$>J3B@'H;/XSMU^'$84W&%-
MQ7[.F-">TI2FL9XC#)-E&-+=-+34Z82CC%C8L80S=3C!+::QG"&K'6!BJ'1%
MIQZ()1[9X"E"E&-$-II52ZL9/P0$9I&:U0J:>*ICM0CIPZ<1*RCHIVH)P>J#
M>C6*04AGL--[-6RGHA'RL4Z"G0M&SM;-54WBX0P3:Z,!@9=;&Y3/8MN-*Q[9
MK$;DQG!$G)J:IC#1M1QQP@%2NEP=;EAZ..I8B>E)C:RQK3C*>STR]+I4!M7:
MM-2;C"#JPG&,,>J (EIP<-E.*?JJ"]*#BYZ(!-VQDG!R]18]'AGB.Q>QCZ"<
M::H:O1;\HP3!E.E;3IC5I<8="Z,!DN6.TAM)*.RJHPIA'";F!E12KE3I4TH;
M*FH:^G$9X)AY%;<6DHM8SA#PXA:]"I1@VH-1TQA$JL:YK9TO!=339)26#:J;
M^E6%7TNN6+BT ]6ENAS4(RQU8X#9@;,&475!4U1^FJAX),&>3.FFMU)1VHZ9
M*$/+$N)EFTZDZ:MO%+%80E D])/2--JOZ9[,:8X:IX30.T@J6OQL=MSTKT9?
M$,C)5530VO5PG-QT^(9&!35);-,88J.$7K>,01N85TMU26.'8IB828Q:SA&F
M.,X8ZIE9-/TO2T550V5%/#&>&!$Q\JMQJI=/I;,8Z,<,>H'4RJN1:=3V7IIA
M'JFA7I3)C3154JZE.EXU88+4"N+!*32GM0V=$88]4 ;*,UZ2J6U'">S"'QX!
M453:J]*2A"K9\,@,MK4HQ]6<-K7U0!4JJV8R^IGCKZH JKJ2?0O6>J.'7$M2
MJ1FG53!*,XQA&6"UD.MC%4NF-.S",'&/7) 9/9VI*->J+6CP8#M.UDMETJM/
MTJO66J$D((S2II+'9;P<(X8E)/5=-*6,>R$R#3BMET5>CTXQG'0-QNE4]E55
M.=4HK"&A3PP!OVLJ8J"V(+ZI,$(U<GZ480A*F>OJ@,3%E3&$=K:3PE I#3IB
MU3LN#IVHO5&,)/&)$AG&BAM8/3B_CUC"%PAA2GL)TR;QPG-K3)0&S!(RP9*I
M.$]NI1AC3CCT8#M6ONHDMGV;<*NJ.F/5@-QLHE6PX)502C*#8PR,,FI56ZJ5
M14HM84?_ !):AN.U/1H;G!50@IRAX=8R,BJM4]+U3\L!4F:#3J4(0CC-.$)K
MKB"<15)*%*E]#/UM>.$ %,VVY.4:8R4O XI V[VFDVZ:55Z+?HN"Q7CQ)V)N
MV-6Y4Z7Z<'<I6B*4'V0P+A'612(8Q3A5L^DXP47.$G/# =J[]K.I*G9JJE&.
MSCVX%*Q4HIJV7Z.RJ>E/$05V%=5+KI=*V=CUNB*EUB:)MQ8.%=.W6YO&KMA@
MB;"(BA3=V:J6JHX[3V?!* J326,[E+>-6A80B^Q.*0S,X7:3=-3]&$8:8QD\
M%* 7>M,53"$:J<5'6XXX8"",MX]A5QC!K&3G%00PJ85WCV=K:C!T^M)Z5! P
MK5:H1CM0V<91]8"^E&J<%+9<GUE5A%4MSVJG"4(?)@R9=:9=;*I54UNG!UI-
M/&$%J&U*URVL:TZX.F:G#1#PB<5G')IJBIMJ&$(S6GM)1C1J[.R_1HCT[7QE
M999,JDVTOH9[7FZ<2G8C3AZ54:=*A#JFIXD[#KR1+9=,%L[4=I1C@I3 NTXI
M_0:7KT88J8K[A7W!TT[47-U8*>A3P&TIBQ]=5P4*GLQGC/L6"':9];*J-:4'
MZ+C%]6&,'BAGU&?44QVG%0=4(*,8P6L&W%+M+C#Z7UNB,(=8E,\BI[2_&OZ+
MMU8XCL7/J-JK:J26TE#2E"7CB#&J[5?TG]<AB8]"+U=EJ+6-,=;BIX8 V;T2
M6TH*$([2C&$5+K!M6FIP=56$H/MAHF"ON(J*G3!U06J">F.(I)26<*'2[FUL
MU*$'!OHP+AFD])%).+BZ81<->& 5I5KTXMP3TXX):.LDYI.;4I25,:?2;[(S
MZ<(!>I55%]?JO7#'J@!A*FFFFM2<8SP@XK =9E%)91I5*2>RG@X-Z9XC890S
MJH=+IC"I3A6FO(6DPD35A%*JJ$ZG#T<,%KPP)VKVL75&.U1ZN/I81!7<*3]&
MF?T=,?!-^8'4RI:VF]%4-GIV5/J M-2J;2T0GKB4JPK:A4HQ<H*&&&G22222
M3=3VMJ&B$8#+$V+M4[53H4*)=DM6.(CWDC#J11=2;JCCLRA&4^J 7:M-4E"G
M&.RHXZYZ( JD6G56O5E+Z;1UJ#&\W[&6RFZ]NK9I>SZ6.'0"5;:J>F/J=,,9
MZ %53JI22VJ>O9P\82G0EMO:;N+:=.MZT(WE)E*ZJ:ZHI0HIQ[5X<1GU$8YY
M+MJ#:G"&M8]A5KT&W#UELZIQCKP1*])7I1NFJ$/2>A377/ 8%8\H]<(5O!1C
MACT8#M.T7HTQ3VEH4(:9@V*HN,MAN$XJJ,.@#&N*I:JJBW"$H8-1P$Y$Y,XT
MU6W55_4ZYZ^L;$K[C"G8V7.*EM.:ZA%*+%*-15*K!QAUE6I31.%-.,8N.$%+
M$B802<]MT)1BTNSK4P3/0K2<4YHJL4J:7!2=77. 3"#;I@G&3PD]'8*E3:4&
M_H90>O1ABH,5*^XTX6UZR@]4:GXT3!,-K5G%2E.+CA\<2LF%-.SL[6,]E:M<
MUC$B0QJ:;VE3%+UG&$907@ RVE30G"$<%VZQL*X)4G36ZX177T0ZQMJ;:GM'
M3*JF:Q<?B3%3'(J?I40QF_(8V8VU@FM<,X;&<_8O<>[ZFMG:J:ITQ@ZOC._2
MBFGY&$4FZ9?M>3D:>!HPCZ-.F$94'#,>=1LB<,&X-NXJ:*J6I?3=?1")88PC
MK@HPE+9_':]$H!:CK:JV53%]<-$=0*FTUZU,%I<4_$@58TIT-JGTG*/T,-6.
M,1D99-2BE*KTJ_6TP^E183+K:>Q5535L3MKS3ZYLQ[$KLV*J;=6"C#ZHN#*D
M#5-&#V6],WAU]8P,(9O%3AC*&,M>B!5';:5#3V5.&G'K9*)U,'%+TWM4O%PA
M#5A-Q8ZSKR8*O35-KU=&.."%4JSBO2J56,)P<M&&F(7>NU4E2FHU.,HI8>+
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MZ7,/AO\ :/=O[%L_H=)R1DK^X4
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M;C.JZ*:-R1AITV.8G#?[1[M_8MG]#I.6,F3^X4
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M^>_%52:>[+T'C"S4H^,O!&\K/0?AXXKDGNN[!*%,;-7QS+PQ0XMRKGOQ2_\
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MWNR\W3&'V*O2H/23@CR)Q1MA%SVXJI2IIW9>5*C%.U4\>T<,$7;E_#OQ8O\
MJV[T?8:I:_HM)>&W>M9Z!<]^*<%NN[+_ '&J,_R1."(Z2LYT'SWXIJ4/N7>2
M>/V*I-^.0X$KN%SWXI2@MV78+7:K;\.T.#K.+<OX>.*]&[+RCJLU_EB\!7</
MGQQ7A]S+SZ/8U_&/1Q6A7<?AZXN_<J]^<5_&7T4=*UCH%SYXLA#[EWDO[S7\
M9)LB-Z3/1"/GOQ55CNR]U>RJAX(DX()F9BE,%7/CBM0ANR[*,/L-6G\D6D)%
M=D(^?'%;G]R[K>I6:I_UV@<,2M9VP?AXXI_<R[U>QJ_+#AMIMJ5VT1<]>*?2
MJ^YEZFIPBO8USA+",5!#@CR+6=D,GSUXIVG5]S;S=/JOV-?T2@],Y#@,>A5S
MXXI]'_)EV-,?[55I_)&,V1T%4_#QQ7""W;=@_P#<:ORTB\,9T3'8BY\<6)Q6
M[+L-*]A5\<1P1EC5:ST'X>.*5CNV['^\5^:HO#8F+)\]N*4H_<VZWJ]C5\<1
MPQ3)<8WPGX>>*XM_<R]%X_8*X.$E*)/1P5GH/P\<5M0^YEWH^PU>>H<$;RL]
M ^?'%327W,NQ49^QJ_+0'!%:XE9Z,6+Y[<550VMV7W#"%NM?V0X8V),ST+^'
M;BJ,?N7>_.JH>"(C3B3BGH/P[\5/_JN[V6:T_*7T1Q3T'X=^*Z4E3NJ]!1A]
MAK;6N<1Z.%K$]:_AXXLI<MUWGTJS7!^/0."-LD3"/GQQ8YO=-[\XK^,G!;TE
M8Z!<]N*HM_<N\FX13LUZ,(1<B\$;,3.=RKGQQ5&6[;J?]XK_ "PX+:;S&=RO
MGSQ6I?<Z[#7[&KXT3@BN-3'*C%\]^*YI[NO54_WFJ+\<H,<%LP5G.(5<^>*U
M_P!67OSBOXQP05GH/P\<60@MUWDM?L:EYXXC@MB:[2N[%%SWXL6&[;L-/V&K
ML^B'#&\K/0KY\<5I?M9=GJL5/#M'!&96:9'X>>*XI_<V[&<%[&KXQP13:5GH
M9KGQQ55'_)MVG#^TU3\98MB(I2L&,Y11I_AYXK7J[KO/7"S7XYLG!&VJ1.Y?
MP\<58?<R[/\ W&K\L."-YQ;C\/'%;QW9>?79K_+#AC>5GHE'SWXJJ33W9>@\
M?L-47V[0X8R*ST#Y[<5-;/W+O0U*U7'RCA@K/0M//?BQU)?<N]3C'[!7.72]
M!>"TFZD80BY[\6*/^3+WYQ6O/,<$3D5W+^'?BO\ <RZO]YK_ "P]&5W,WSVX
ML5/[676M2LU:]<2<&.)Q1T,5SYXJ?K[MO40P?L*M..D<-L;R9%STXIK33W;>
M5,HPLU*.E1F]*+PQ7#))NIL8_AYXK4WNNZGTV:WXXP'!T,J[D_#SQ6U#[FWG
M_O-;\XFPQZ%_#SQ7HW9>AT6:X>4G!!CT'X>>*W_U;>?1[&N'UQ>"-YCT'X>.
M*OW+N_G%?QDX(*ST)^'CBO1NJ\^GV-?QEX(Z2L=#-\]^+$V_N;=BH12L5SBM
M42<$4Q3BKE#%<]N*DJE]S+SVO6C:J<>J<BQIT)F9SA*>>W%E"V:=UWX+3[&N
M>G0^DOHX6O3&*_AXXM_<J_\ G-?QCT<=)6"GGOQ0E!;KO2PC:KC.<YQ)P05W
M,GSYXL:ENR[%XPLU>))RD.&,Y*[F"YZ\54TK_)5Z#CC9KE#6XZ1P0G%'0R_#
MOQ6DE5NV[&?]HK^,19;G*R?AXXLI</N;=:T?8:H=.DDV6[R9GH9+GOQ7%_Y-
MNZ)NS4X_UPX(Z)7')@N>W%-+VENR]%QC]BK:\$9#@KGDF^B_AYXK<_N9>_.*
MY=4QP05GH7\//%D(?<R[^<U?&9>CJD32*4E/P[\5*+^YMY0T>QK?1*<B>CB,
MUK,[*)5SUXIJIA]S;JCH]C5H?63A@K/0QJYZ<45PVMUWI1A]BK6/;T%]&E9Z
M&?X>.*YK[EW9_P"XU?EAZ,XMQ^'?BK]R[OYS7^6'HCBG*C%<]N*J4J:=U7H:
MO8UOIG/6."(S(GIA?P\\6_N5?_.:_C'!;TK5?P\<6-3W9=:_O-7Y:(I%*,<:
MUI. ^?/%<(/=E[\YKCX8DX(SVK6>AA3STXI7J[LO*.,;5<X82;+P>X5GH9+G
MMQ73&&Z[U6UC]AK?@@Y%]'Y"O3"?AWXKT[JO):7[&OXQ.G$;5KN/P[<5))4[
MKO-4X+V->G7.9.&,DKCE@OX>.*W-[KO1>NS7HU**@2;+:U@XIRI55SXXK6&[
M+OYS5^6'!!6>ADN?/%2<?N9=GC]AJT8:9#@C>M=S#\/'%:22W7>@M'L:YQGK
MG,19;'2<4SG!^'?BQIO[E7DE"*]C7./;H+P1TE8Z%?/;BJNAJK==U)0]'V-:
M>/6."J5W*^>_%BA5]S+K;C_::VY2UCT<%=S'\//%K<?N5>CK]A6O.)MME:JN
M?/%BC'==Y1UV:Y^%DFR-Y6FQC^'CBMO:>ZKVTL/L-<^R,X#@C+85AE^'CBM8
M;LO+JLU_EAPQO2L]$GX=^*VU'=MY+^\U>=CA@QG8KY\<5O:;W=>I4ME*U7VZ
M1&G1:S.Q/P[<54.J&[+T:IM^RK<>J>@O#$),[A<^.+&ME;LO+_>:XK3KB3@M
MJM=D0?AWXJI7[6W:HX_8*]&&D<$3D8]!^'?BR#CNVZXPE[&K7H](<$;,EV5H
MCY[<4U4M/=EZ$HI6:TW/K' E9Z$7/CBV$/N5??\ O-</!$O!:55<^>+5".Z[
MTM+LU^=B;+9*[:'X>>+(0^Y=[ZGV-<?+$<,)7'(_#QQ7^Y5WH^PUSU_1:"<$
M;SBW+^';BMIM;JNRA_::YQ[= X(.*.A:>>_%U2:6Z[M,(8V*]/:."-E5XHC.
M$_#SQ8W/==U0P^PU:>TOHXG*IQ=$'X=^*HM_<N[%X_8:M':/1)Q3T'X>.*\/
MN7=E_N-7Y8G!$%9Z#\/'%:PW7><,%[&OM^B'!$X%=S#\.W%BJ=:W7?3>*]C<
M^,R]'"UW%7/CBUI4T[LNIK_<*Y:=<<!PQD5W-6CGQQ6Z_9/=]5-24?2MNGRU
M+28</NE:168:;Y]<2I[+R-<5C5[-^>HLVQL,67X>>)YPR=4/J'YJB\-NTF9C
M8Q_#MQ,ZE5\TJVE+\S<%X](FRR8HD7;L57/3B6BY[5Y"J#>.RX3Z-K0R1;;$
M4I6(*]&>UMYQ+Q)FN*]^Y+?&?M54W+=VTXM.F"IN*78BW73%DQLE>*>[&USK
MX+SE&=X=W;=HJ3:R]NFI+0U12H> T5B<FV8G-^J*@
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MY4O'<4@^\SAK]R<K^=T_E1QW'#!]YG#7[DY7\[I_*CCN.&#[S.&IK[DY6?\
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MJ7BG-*1DR^\WAK]R<I^=4?E2<4UKM*84%P=PVI+=65_.J/RHXI*0?>;PW/\
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M-$QBSF9K38W+
M                V;YY?P%S_9];6;^7[RPVF[O7YO5U5_V)GKY).<.7IR@
M
M
M                                                         ;+\
MZG_W?H6B-?UM18F(QVK_ $:MN.0L\_FM$JNV5):UC<D95<KS$
M
M
M                                               #C9SW4*,FUBTY
M_P!4O(7CF(H1F\OD4OU+FW^-ICX*&8S,S.*UP<B"H
M
M
M                                       '&GGKAE>FNCRU%K6*=!&4
M];<KE7_!G+?44?64F,9D]YN84
M                            ;-\\OX#9Y:VO)4O.;]"?.)FD3+:;N^>C
MF&L8[?1]*9ZV,58VSQX]#EZ<K(
M
M
M                        -F.=4%P[2X1@Z_K:B3.PGNMN.0Z_RAF5'!5/
MR&V;*658VW5F7*XUL@
M
M
M                XV\^?1L9*K'%0[:_B,O1\6-6,S3%K\BKC>6S25,MFF+C
MA*C0+M.F-2+JX;7(LQ9
M
M
M                 !QHY[."RK_'T>6HMN,T(REN;RLIAPQE7'&FGZRDDVT2
MM9;E!0
M        &S?/'^ ^>ZUY&;M#OI=W9;3=W[]=?U?]B9ZW=8Z67D<O3F9@
M
M
M                                                     !LOSK_@
MXNNKZVHDYP3W9;=\A_VPS?55Y*3HN_!L+<Y<K#0S
M
M
M                                      #C;S[_ %MDNWRUF^W*&%^3
M4Y$)/+YJIXJFCR4$OR8VX74<CC2V@
M
M
M                          !QGY[^KE?JZ/+46SO$92W0Y7?P7RGU-/UE
M!;MB1G+<@Q4
M             !LUSS_@+GOJJ?K:S?R_X1C?W);4=WS]<_D;GDH,M;)AI=UR
M\.9M
M
M
M  #9?G7%<.*'TU7UM1/Z4&QMQR%BMX9O:?I-5>2F&$C?=W&%LXTARO-+,
M
M
M                                                       .-O/B
MG[%DZGH3AT^O\1MMK%B32<&MR*<<MFGT4^2@SU.ZUV]]R,.=M
M
M
M                                               #C1SVPROU='EJ
M%G>6W:W,Y6?P8ROU%'UE)LORAC/>\C<LUJ
M                                     V;YY3X&SR6,5];6;M#OL;^Y
M+:;N^_KGK5S^P,];)CIQ,11R].9L
M
M
M                          #9?G9#[W*4]-5?UM1-L&QMQR%]'>&;I;C*
MJ#ZU3UF^[N,+:5PS<KS2S
M
M
M                   #C9SW?V/*+1!Q_KH&VV)FUCQ1C&UK\B?UMF^A4^2@
MSU)P86]]R,.=M
M
M
M           #C7SU_,;'U=ORU"S\(6Y^5N3RL_@QE?J:/K*39?L)[S<LU@
M
M#9SGC_ ?/=GD9NT>\QN[LMH^[ZU\Z<*82KTO\:9ZV19DY?G,R
M
M
M                                               #9GG5#[W%'77X
M=FHF%8J3DVUY"Q^Z&;V\9PPU4PPEB;[NY@PMI6:.6!I9@
M
M
M                                          !QKY[>IE.I_P!D;[.Z
MU3WI:_(G];YSJI_L"7Y$=Z'(TTMH
M
M
M                          <:>>R>QEJM"KHCX:A9WJ+;T-R^5G\&,K]3
M1]929WYDYMRS!
M                &S7/-PX%SS6,5];6;M#OL;^Y+:CN^J&9<-5<>GU? 9:V
M6]+'+PYV8
M
M
M       ;+<[/X/4?55_6L1FL92V[Y$)/>.:ZGY*3?=^#:K<Y<K30V
M
M
M                                                   !QJY[RHRG
M2G#HAM>$WZ>-M&%T1$3=&;7Y$?K;.=5/]@2]KLFMT5<CC2W@
M
M
M                                             !QIY[;.QEH^MMVX
M8ZZH] LKQENWH;F\K5#AG*K\;1]92;=2VD1*5K+<DU*
M                                              V:YY_P%S_U5/UM
M9NT.^EW<EM1W?H?.>RN'@I,M:M&-E:.7ASLP
M
M
M                                  V6YU_P>H^JK^M8C.JQE+;SD/\
MMAF^JKR4F^[\&UVYRY6&AF
M
M
M                    '&KGROL>3;P2J_LC=IQA5C?W9Z6OR'_6V;^IH_\
MEC4:K*\45S<CC2W@
M                                                   $F8C&0*
M
M     ),Q&8")B<@*          !QGY[3IRL/IZ/+46SO$1-);G\KOX,Y7ZBC
MZRDVZLQPQ#&,VY)I9
M                    -F^>/\!\]UKR,W:'>8W=V6TW=]A\Y=.A*MPZ5LM&
M>ME5CIX0Y>G,V
M
M
M           !LMSL_@]1]57]:S&=G6RC*6WG(?\ ;#-?4OR4G3=^":K<Y<K#
M0S
M
M
M#C?SY2>7R?0JO[,W1^#1GR)<<MFX_2T?V OG!KC"]R--+:
M
M                      8W6Q=&(&0
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M3R<OSF;
M
M
M      V6YV+_ +NT/557]:S&[..M:TB6W?(APWCFNE/R4G3=^#HU69RY6FAL
M
M
M                                                          #C
M=SZ<,ODNG:_LS='X-&KR*4,OFECZ-/DH^(M]>&K7'?<C#0V@
M
M                     !H7;SMU44TT;6U&,X0Z62JTPKL/;+TG4MFFF&T]
MI2CAUQ%>C-)PS:R::36E174(FIO&X-+7'Q%%            #&%7T_\ 6HM8
MZ$I/2J36+CV0$TV$54B@ DUB,,Q)ZC#BO^Y7!3.V9F,8H@4
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M.'>+[FY*MFY>WQ1<WVK67JHC6W5539HHI2=MXLL:4SAL94QXOZ3=/NW=_7O
M=UOBCAC>7#W$V\;W+7<><RUO?VX\S?S.8JS>7N7LM170U>S=-5.Q:LM&%W*Q
M;%);Z3;%<X=Y+NH]X_A;O2\G.%^:_##MV+6^\I;><R#NT57LKF:+-JJ[350K
MERNFEW+KA$\?JZ?H[NLG":.2IJ     ;.<\?X#Y[X:&;M'O,;^[+:3N^SS"?
MU?\ 8FS7R32R<OCE9@
M
M
M               !LOSK_@Y3]55];48W9QUD]V6W'(G]L<SU?E3IGN>1KL[T
MN5YH;
M
M
M    XV\^_P!;Y'M\M1NCN'2U^1?YAFOJ:?[$RO[K5;WW(LYVT
M
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M#_>FC]S9_+RG_NH^[]_Y7[PZ_NE:_P 9)^S3Q#[J?Y>0_P!Z:7W-M.O^<_\
M=1]W[_ROWA_G*U_C(_9IXA]U/\O(?[TTON;?Y>5/_=1]W_\ \KMX?YSM?XR/
MV:>(?=3_ "\B?[TT_N;?=_G/_=1]W_\ \KMX?YSM?XR/V:>(?=3_ "\A_O33
M^YM]W^<_]U'W?_\ RNWA_G.U_C(_9IXA]U/\O(?[TT_N;?=_G%_2I.[_ /\
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M_44?64F[5[L,8[S<DT,@
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M SULDLBCE\<S,
M
M
M           -EN=KAPW3]55];43^E"[);;\A:F\_F6WCM+1^-.B_NTV,+<Y<
ML30R
M
M
M  #C;SXG9R:>"3:_KS=9C9BQNF8C!K<B9Y?-Q^EH_L"ZF5-C7;WH<C#0W
M
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M!_\ <;/5:)3ZU4;]#O,;L;)HVE[OM/ZI3ABJWX-DSULMY9+E\<S(
M
M
M                                                  -EN=CAPY3K
M=57UK).<+2L2VZY#[3WAFI0DXJ*<H4Z3HN[FYKMSERN-#,
M
M
M                                            .-G/B5K*1U/^R-UG
M<878X1FU^1,LOFXZ::/[ NIE5A;WH<C#0W
M
M          XT=\'^;7SB_B3O_P#T5F3IY7Z5I?#M^,YN;^BZOP+NQ\DG>;AQ
MCQSI3XNXDBO_ --YW2?8OA_T>SY.WLA\S>,_@-.GW=_;+&F4.GS'==2E'JVK
MW3S:2;FRV(ICD.,]4IECWV,>^-I*!8Z5CI'@VM,"0;:+!23Z15*SFB4)OX>
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M8B9Q6,8G$BIPDM>/B,NM)(:/'\@KM*[1QU=FOMT0(A&+ABM QA<H(K'3\.S
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M31]92;-68F(-M&Y)I4
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M=4L/5@9:TUQVI;1R\.=F
M
M
M                  &RW.S^#U'U5?UK,9V=;*,I;><A_P!L,U]2_)2=-WX)
MJMSERL-#,
M
M
M       .-O/C;]CDX80<,/Q\3?;7@:\.*:9M?D7^M\U]31Y*2W]U+>^Y%G.V
M@
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M3(B@       '&CGOZN5^KH\M1E"V[>MN9RL_@QE?J*/K*3*_8QGO-RS6H
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MN7)QJ
M
M
M   &S'.I)\.4O555#^IJ^(E*S!5MQR(;6\<UU/\ L3HN[E&NSO2Y7&AL
M
M
M                                                      #C7SY;
MJM9.F,E'1]4;K>XUS/G2\GD7^M\U]31Y*3*_NI;WW(LYVT
M
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MPJE&$4CLT+J75SA)K&+:ON]4*F[4X^EZ>U^.BJ.F1=6^;NIE,817-R[.=B
M
M
M                                                        &S/.
MG^#JUIUO^MJ%,8)R;;<A:MK>&;<(2J6/13\9NN[E&$82Y7FEF
M
M
M                                               '&OGOZF4ZG_9&
MZWN-4Q/%+6Y&-JWFJ=&S3+LH%_=6V/.JY'&EL
M
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M*5*5Q)N:7C+N,(PDE&$/'T#8F-"$I/Y9C:NT4,<-7G$DUR50FDB).0\4M#T
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M=#E=_!?*?4T_64%NV)&<MR#%0
M     )5"#VL-(S)WOSO$?$>YN$]S;RXAW]GLMNW=6Z\K>S5_-YJ];LVK5%JU
M5<J6U<KHIJ=5-,HLML3.$073PX3DZ9/O.O>.\9<^N8.^>57 N]+^0X#W!F,U
ME,S7D<Q<ILYZFFYG+.U57E\W517MTM:#RG*Z6G-O%M<>O;=QTC&7%GW?G=2W
M?WK>9]&2XFWODMT<,;DSUB_O>YO+-Y>P\S;68RURXG7FU4ZMJFNHV:L4FMV%
MJ:=DQB[K7)VON[\B.!MS<N.!>)>%-U;HW'E;672L[SW6J[UZBU;MWKM==%RC
M:==5F,&I'C-2W4U*S,8.J+K8PVMSGSDY4+:J^_?AWT(1:WOD/2VO^<+U>PPC
M1OV05MP9/G5RJHK5+X[X<55;I5-/W7R&+:22^SXMLEVA?3'!GQU;@[MWCN_>
M]FC>&[,Y8SN4NI56[^6N47K-Q.G&BY;JJH:@U@S&D1%-L&/D=?\ ]_;R+XMY
MC<K>#^*N$MWW\W3PY5FZ]\O+VJ[C5FFG-W=JMV[5<$J*M+6!V\IJ\,\+5J6Q
MWYV.KUR.YN[ZY&\P^'>-^&KE5-S=F\<I]UK"C3<MTY3-9?YRFMNW5AEZCNU9
MF^>'^@U1J66S7.Z7>%[HWO"N1O>0X+W-?RG%&[]T\09+=V2L;QRN?S.6RL,S
M:RV6MWGM7\TV]J[4XQ/':NA=-TS;M;K+XFW.K?SFSWK>2?*+AC/<3\1<:[EN
MV<GEKURBSE-X9+,W+URFU<KHHV+6936T[<):S7&C?=GDLW1$3,9NE5[PWO>Y
MCO5\U]Z9]5_]Q]U9F];W/3<K]"W1[7-TTU4557KJ6TJTY0/*\O3@K_2<-UW%
M']6KF5[BCDMG>*><O$?&6_-W9FYN#=?L+^Y\\[5U9>MVZ<E<V:;WLG:KBUHJ
M.7G8NFV8=.C28=Q]6Z%13;AZ--*II4<%2DDO CQ=TQ;%'2RI@TMG#1CKZ9XF
M<HR  #'S9GAVC9CGHG]X^=ZZ?[(VV1,W8,H[LMJN[_L/,IX2JE.;]&'C-E]L
MVVTC)A;$Q&+EX:%
M
M
M             #9?G7_!Q==7UM1)S@GNRVXY$_MCF>I^8Z+NXUV=Z7*\T-@
M
M
M                                                         <;>
M??ZVR76_[,WV]V&%V4M7D3^M\W]31Y+9+V%O>AR--+<
M
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M.VE8Z4C;+='EA_!;)?44_64&6HEN<MQ34R
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ME
M
M
MV7YUO_N[2M=5?UK).<+2L2VXY$_MCF>K\J=%W<:K.]+E>:&P
M
M
M                                              .-W/A;=C*4QALI
MN.,?7\!NMGS6-V3/D2Z58S=*?T-,,9PV!?E5KMQNB7(XTMP
M
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MU=NW'#75VF5N9;G/2W-Y75[7"^44(0HIT_C*.@ROE*4FC<@UJ
M                             !C5#9<9*$^HL5KAF32F.3\_OWAW<G%N
MZK^Z-_;OL;QW1?A[7)YJU3<M7&H^O1734FE'QF..,;"(HVVM]WGDRJ5[/@+A
M]4S@EN_*I1C.7L=9E;==;%(,)Q:G\GODY_X#W!_@&6_2C+TER4AB^[SR;>/
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MZ69J;G!5P_K=1EK88;$MF7+TYV8
M
M
M                         ;+<[/X.T==Q^"ELQG8L81+;CD)4J\_FW"$%
M4L8X*GJ.B[N-=N<N6!I9@
M
M
M                  !QOYZ_F.6^I?\ 9FVWNL;LF7(IKV.;A5"*4H8^IIT%
MO[K"S.'(XTMH
M                                               .-'?!_FU\XOXD
M[_\ ]%9DZ>5^E:7P[?C.;F_HNK\"[L?))WI_#'CF>/%_$D5#_MO/:3[%\/\
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M*:<$HQ4,=4]$#FQJR4H
M
M
M                -E^=?\':91G6L80C2QA7$G)MQR$HV,_FU&,JGAT4]+-U
MW<JPMS<KS2S
M
M
M         #C?SXE9R4/HE4GTPVS='<2<I:G(K];YMZX>2@RU(P\C5;W_ ".1
MASMP
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MC*3.])S;EF
M              V<YX_P'SO6O(S=H]Y+N[-&T_=]7ZI])Q<*X*&'J:C+6RPR
M2VKEV<[(
M
M
M      -E^=;APY2H1C55I_&U$PK%2E8;=\A_VPS?U-7DI.B[\&PMSERL-#,
M
M
M                                                         .-W
M/AKV616E;7]F;HQL39+4Y%M*QFJ7C!.'91V&5\^:UVQY]7(TYVT
M
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MO*R'WL9:'TM'UE)G<;<<VY1@
M                           -F^>/\!\[UKR,W:/>2[NRVG[OZAF5#57_
M &)GJ]TL^PY=M)M-XJ,.W$Y:;54H
M
M
M                         -EN=G\'J/JJ_K68SLZV492V\Y#_ +89KZE^
M2DZ;OP35;G+E8:&8
M
M
M              <:^>_J9/JJ_LC;9W9)REK\BE&QFZGBDH/LHD97]UJM[[D:
M:&T
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MI[=N#U3JT%@MS;E\K/X,97ZBCZRDSOV)/>;EFM0
M                                         &S?/*7 V>?2O)4_,;M#
MOT2[NRVG[OVR\S)0<*YQ>A4_&9:N3#3G##)R\.=L
M
M
M                                      #9?G6O^[M+U55_6LQG..M:
MTB6W'(>*WAFDWM13G"&*IU'3=W-S7;G+E>:&8
M
M
M                                   <;>?%/V+)..*J_LC=;%+.MC,X
M4:O(Q1M9JJ/T-,NM4?$6^/-86SYU'(TT-H
M
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M$_I-RS!0
M          &S7//^ N>^JI^MK-_+_A&-_<EM1W?/US^1N>2@RULF&EW7+PYF
MT
M
M                                                           -
ME^=?\'%UU?6U&-V<$]V6V_(2"S^;5+VE"J+PT4G1=W&,5KBY8&ED
M
M
M                                                  '&[GS^8Y'\
MEY:C?'<AC<UN1?YAFOJ:?[$M_=86]]R+.=M
M
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M=?[ ROVM;/E*_N7/HVS*WJ^P\^WZJ[?*:.7[GE;;\UH]5=OE9T79L(R9$4
M      XS\]_5ROU='EJ+:1E+<[E;_!G+?44?64F5V4)M;E&"@
M                                                   -G.>/\!\[
MUKR,W:/>2["V6TO=]K;S,(:*U];T&6K%(2R'+TYV0
M
M
M                                       ;+<Z_X/4?55_6L1WEI6)J
MVXY$*&\<REA!R_J=)NN[C7;-9ERP-+,
M
M
M                             .-O/;\SRG4_[(W6=R4EJ\B?UOG/J:?[
M 79-<=]R--+:
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MR(H       !QGY[^KE?JZ/+46SO$92W/Y7?P9ROU%'UE)NU>[#&.\W)-#(
M
M!LWSR<.!L\^E+PJKXC=H8WT2[NRVH[O\%F%!:*M+_&1?89:N4U8V3,N79SLP
M
M
M                                                          V6
MYUSX?H737]:_B$9KE;,MN.0SVMXYIP@DGTQE2;K\+:-5F<RY8&EL
M
M
M                                                  #C=SV4;65>
MJE_V1NLGS&,M7D3^M\YU4_V OR86]Z'(PTMH
M
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M)J9
M      -FN>?\!<]]53];6;^7_",;^Y+:GD!^N:>JOR4%U>[/6QTMKEV<[8
M
M
M                                                        &RW.
MO^#]'77];4(S+NY+;CD+//YKH57]BSHO[K79M<L#G;
M
M
M                                         XW\]?S'+?4O^S-MO=8W
M9-3D5^89WJI_L"WY>1KM[T.1AI;@
M
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M &!E?M:V?*5_<N?1]F5O5]AY]OU5V^4T<OW/*VWYK1ZJ[?*SHNS81DR(H
M    !QGY[^KE?JZ/+42.\1E+<[E;_!G+?44?64FR[*$VMRC!0
M                                                   &S?/*? ^>
M72O(_C-VAWV-W=EM/W?G'-0U*O\ L39KQ$6X,=+)R\.5L
M
M
M                                           #9?G7_!VEZ4Z_K:B;
M8)[LMN.0_H[QS24E!_V.LZ+L;&NS.8<KS0V
M
M         !X&>S3RZMJE/:N.":44NE]1A=R^OKXZ,TB,V%VOIZ-T1J1,Q,O%
MMW\S3G*+=RN-JJGUH2BU+HTG1;;$:%+OPD-5^I=/.<-D3Z*F3R+-68IS%VFY
M7MTRV%"":A''1!'+9J1==-M,6ZVV[CFL^;V/,]K2JJ:'4JG7&$(:,<#;.$T9
MQ%;:UR:I*P@*P!:P   2L *P K "L 4  K $K "L *P K "L 4  K $K "L
M*P!0  "5@!6 %8 5@"@       2L *P K "L *P K "L *P K %  *P!*P K
M %  2L#0N75353;3A74G#H@M/69<-TQQ1W2VZSCX9S>!EZLT\W6KER-JG"F&
M,O$+]2RVR(B(JTQ%_P XNQKI[&O>N7:KRM4/93FZM"[3BNT]36NX]*ZEL-\:
MEME\12LIE\TW?KRM475;^CA)Q.K3T=6VSCOFL2U3KVW:TZ=*2_H&38
M    '&WGNVK>42TIQ_KC;;W6-S7Y%_F&;Z::8_UIE?W6NWON19H;@
M
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M&5^UK9\I7]RY]&V96]7V'GV_57;Y31R_<\K;?FM'JKM\K.B[-A&3(B@
M  '&GGLHT9;ZJCRU%MS2/LMR^5D^&,J_QM'UE)E>M,6Y9@
M                                                 -G.>/\  ?/?
M#0S=H]YC?W9;2=WR/SEMZ57_ &.HV:^261@Y?'*S
M
M
M                                      #9?G7_  <I6MU_6LF<P4K$
MMN>1";WCFNI_V)T7=QKL[TN5QH;
M
M  \?,5;"53H55*3VG)M=29R\QJ\SIW6QH6UK.+*(LSOV/%MT6[E,JZ:J*IJI
MM*JEK1KQ-NI&K9K1&$64QQ+-6W5_S;8K,;BS[=W+ENK9IMI052:J=2@9^AT]
M.8U+9QEHB_4OONMOMFC&C+547UZ2=$Y[2C-1ALQ-]^M9=;3#%=/E[+/.B;IU
M.J:/,=NVL:E\.TT^9/\ ]6=)C.ON'LJ'A4OAVCS/Y2M+OY0FQ:^G7P[2^;_*
M4QW^XU-I?W5>!%K;N]U,=_N)52JH;5:EU+'J9C,VSE-/*RI=&?8Q5JAX5KX=
MI,(V^^4F<J^XGL[>.VOAVE\WR]:8YXTZE]E1],IX?"(\S^4K2[^4'LJ/IE\.
MT5L_E)2YE32J8[-:6$<'U8LL39'_ -4I=_*%VE_=5X$6MN[W4QW^XP]E1],O
MAVF-;/Y2RI<.W;6-2^':/,G_ .J4F,Z^XFQ:^G7P[1YO\I,=_N+[.WCM*'PZ
M1YG\I,<\?</9VUC4OAVCS/Y28QG7W$V+7TZ^':/-_E)CO]QJ6U13'9J3C",^
MOI'FQDL5WL]JF<U+&8K!CO:/L[>.TI_#6/,_E)2=_N#MVUC4OAVCS)_^J4F,
MZ^XFQ:^G7P[1YO\ *3'?[B^RH>%2^':/,_E*TN_E"JW32XJI)KX:Q6R/_J4N
M:D_[HO OC+Q6;O=3AN854JJ&U6I=2QZF29MG*:>5:71GV,/9V\=M?#M)ATF.
M_P!Q?94+&I?#M+YG\I3&,Z^X>RH>%2^':/,_E*TN_E![*CZ9?#M%;/Y24N9J
M%/HJXE#1!=>EEK939[J4NW^XL8R]HO B\5N[W2EV_P!PCI]HO AQ6[O=*79X
M^X1;_MB\")Q6;O=*7?RA9_W1>!?&.*S=[IPW)%K^V+P(<5F[W2EW\H1PJIG<
M3I?0EIZ]8K;EA[I2<\?<:?L[;PJ7P[2>9_*3'?[BNW;6-2^':/,G_P"I28SK
M[@K=MX5+X=H\R/\ ZE)G*ON'L[<([2A\.D>9E]DI.>-.H]E0\*E\.TD\/33R
MK2[^4'LJ(1VU#X=(PRK[Y2<\:=2>SMK&M?#M+'#_ "E,8Z?<56[;PJ7P[1YD
M?_4I,Y5]Q/9VUC4OAVCS/Y28[_<:BA2DE<26B2?G+$V[O=*7;_<93_NB\"^,
M<5F[W5X;FE[*CZ9?#M)6S^4E+CV5'TRG\-9/-V33RE+OY0>RH^G4L?A$8=/O
ME)9J%*25Q):)+XS*)MRV]:4G/&G450:@[B@^A?&)FV<(SZRD[_<:>Q;^G7P[
M3&D=*X[_ '&A7;A?HKI:V=+VOC9MMX?1S;-V+1?%]VM$TFG4U+\$HT;+JJQ]
M):(>0Y8Y:S4GS[J0VZE]^EC;;-9W*XU6E!4JY4G!.I)K'!F5FG&E6-.ZL-FE
M=Q3;?J1,>1HY:NGVKL[*5RTO3:@VXX>EI$7<SQ<-]M-+I+IT+[INLG_,Z.A_
M1-K$          .-O/A/V63JT0<_ZKXC;;%+:L;HJUN1<\OFFM5/DI,[^ZPM
M[[D8<[:
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M       !QHY[^IE=>W;AX:C*"VN-.EN9RL_@QE?J:/K*2W["<VY9@
M                                                        -G.>
M/\!\]\-#-VCWF-_=EM)W??UPOR?]B;-;(L^PY?'*R
M
M
M                                       #9;G7_!ZCZJOZUB.\L92V
M\Y#_ +89OJJ\E)ON_!M=N<N5AH9@
M
M !XUZ==NCZ9N*UK3XC3J1JS=;.G-(KBN'#,3T2] OO#^]US]Y+\\MV\(\MM^
M5;KW/=M4W+EFFG;53=N]6_[=1II6@^)/K#^TGUO]5O6N>7\%\0NY7EK;;?-I
M6M8FNU^BOU5_87ZG^OGL]U/&?6#E+=;7B^8B9F,*3&Z>EPRH]XIWODJK2XQK
MMJA2CEMJ<-;S&D_@/-_6#]I&KHZ4_G2ZV(V\/>]]]&:?U4/99Q\>IX=;,3_6
M_P *4^\-[WS@WQG6ZWA5\WPT.7S@YY^L![0YGTGYSOBZ/ZL_;=-_U6?9';32
MM\,MQWQ_=9?[0SO@_P#C2O\ P;_^8+_$-[1(_P#ZEWWL_;8?PJ^R7_MEOWW^
M%'[PWO@+_P#76KJ^;?\ \P7^(7VBSC'BEU/@S]M?X5?9+/\ _,M^^_PG^T-[
MX$(_?I5U?-E_C!?XA?:+_P!TO^]G[:_PJ^R:OZ-M]V/[JKWAG?!_\9U+_FR_
MQ@G\0WM$V>*7_>S]M/X5O9+_ -MM]V/[I_M#>^#A]^E4]>6PA_S@D?6%]HLY
M>*7?>_SD?55]DN?YLM^^_P *OWAO?!?_ .NM79EDO_X@O\0GM%_[I=][/VS^
M%7V2_P#;+?OO\*?[0SO@?^-:G_S:7VP3^(;VBQGXI?\ >S]L_A5]DW_;+?OO
M\)_M#>^$E'[\ZG#!?-NS'YP6/K#>T2N/BEU/@S]L_A5]DLX?FVW[Z/[I_M$.
M^!-KC*K1+YLO\8,OXA?:'_W2[[W^=?X4_9'E^;K?=_PK3[P_O@.F#XSJ3U_-
ME%3U^W,;OK"^T2>[XI=3X/\ .?PJ>R2(_1ELS\+_  L7[PSO@?\ C2K_  9?
MXP7^(7VB_P#=+_O9^VG\*OLF_P"V6^[']T?O#^]\HK[]*G#3\VU_[_,G\0OM
M%_[I=][/VV4?54]D?_;;?OH_NB]X=WOZL.-*I?\ TTY_\X$_6%]HL8_G2ZGP
M9^VD_54]DMN7AMOWT?W5_P!H9WP/_&E7^"K_ !@G\0_M$_[I?][/VT_A6]DO
M_;;?OH_NK_M#.^!!_P#?.J.OYMA_T@?Q#>T7_NE_WL_;/X5O9+_VRW[Z/[JO
MWAO>_A+C*I/7\WC_ /Q!/XAO:+_W6_[V?MK_  K>R7_MEOWW^%C_ +0SO@?^
M,ZO\%_\ Y@?Q#>T/_NEWWL_;3^%;V3?]LM^^_P *_P"T.[X-,UQG5_@J_P 8
M,H^L-[0_^Z7?>S]LGZJOLENS\-M^^_PK_M#^^#-??H]'_%5/3_R@?Q"^T3_N
MEWWL_;3^%3V2Y_FRW[[_  I_M#.^!_XTJE_]*O\ &!_$/[0_^Z7?>S]L_A6]
MDO\ VRW[[_"+WAO?";C]^=7^#*"\.8$?6&]HG_=+OO9^V?PJ^R2/_P";;[O^
M%/\ :&=\&/\ #.J&OYLO\8)_$/[0_P#NE_WL_;7^%;V2_P#;;?=C^Z?[1#O?
MTR^_2J7_ -+V_P!W,OXA/:+.,>*74^#_ #K'U4_9),5GPVVOPH_NHO>(=[Y8
M\:5O5^IL/#F!_$'[1O\ NEU/@S]M?X4_9)L\-M^^_P *_P"T2[WF'WY5I:OF
MR\OS@?Q">T7_ +I=][_.?PI^R7/\VV_??X1>\/[W]48<9U1T_J53U?\ &"?Q
M#>T2(Q\4NK\&?MI/U5/9+%*>&V_?1_='[PSO@P_AI5+_ .E7^,#^(?VA_P#=
M+OO9^VG\*OLEK^C;?OO\+)>\/[X*_P#UU?\ @J_Q@3]83VBS_P#T[_O9^VG\
M*GLE_P"V6_??X6+]X?WP:?\ ]='!X_J52U?V_26/K">T2?\ ^I=][_.O\*?L
MEG_^;;'_ -W^%/\ :(=\/_QB_P#!E_C!?X@_:)_W2_[W^<_A3]DO_;;:]?\
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MOM%F:?G2[[V?MG\*OLE_[9;]]_A5>\1[WK6S]^=>U],\LNO3F-1E_$)[1?\
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MTE\#MY^[PS3U^=U/23?9;/NQ$OR)YV>6T_$^8T.7MX8MU;X]RZ8^P_4GE&L
M         .-_/G];Y/JJ_LS?'X--J\BE&QF:F\*:5"'10-2/-81/GT<CS0V
M
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MBCZRDMZ3WFY9@H
M                #9OGC_ ?/=GD9NT>\QO[LMI>[]#YRH8>G_8F>MW4TYK#
ME\<S,
M
M
M   -E^=:_P"[M+U55_6LE:2M:1+;KD,V]X9N*A*J48Z*3HN_!M=N<N5IH9@
M
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M1I+?.#"V:W5<CS0W
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M1%:MS.5G\&,K]11]9297I/>;EF"@
M                              -F^>/\!\]V>1F[1[S&_NRVF[OOHYF&
M,KGCV3/6QBK'3R<O3F;
M
M
M                  V7YU_P<775];42<X)[LMN.0JAG\WZ.S*J48Z*3HO[C
M",W*\T,P
M                                          !)R=7SWL'\XW=*<E[&
MVX]=K,'YF?6C_7_F?D[/BR_8CZC_ .ZJ^?Z]W;#U\55?8Z52HR23PC*!\HQ;
M_GXYU?6>E/\ FW4S8T)JEI]/D-W,?2*NB^:WQ1",@
M                "&M0RM13(                    A)R P5@U&NA=/G-
M^G-+)2^(G3FK6O*:7;$U:DX5WM&A/G3+]/RU_P!:_+W]^LE]OY4]Z]0/UKY7
MY6SXT/5_:+^[_P 5^0N^)<[HO"W\&]P?O+NK[1L'[,>'?H[E_D;/BP_SY\]^
MD>9_*-3X\O[YV.8          .-?/?\ ,LKU/^R-]G=:[\IZFMR'_6V<^II_
M^62_)AIYPY'&EO
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MO-RS
M        ;-<\_P" N>^JI^MK-_+_ (1C?W);4=WS]<_D;GDH,M;)AI=UR\.9
MM
M
M                                                           #
M9?G7_!Q==7UM1)S@GNRVXY#+8WAFE&,4YX8JGK-]W<86S69<KS2S
M
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M^]SA]1G]Q-U?:-@_9OPZ/_+N7G_@V?%A_GSY^8_.7,QM^<:GQY?WSK<P
M      <;N>Z?L<JZ:H>C5M*$?IX8FVWNQ+&[*6?(?];9SJI_^66_)JL[SD<:
M6\
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M9^>_JY7ZNCRU$MC$C*6Z7*_^"V2^HI^LH,I8QG+<8C(
M                                             !LUSS_@+GOJJ?K:
MS=H87I?W);3]WQIYE_4W/)09ZV3#3CS7+TYFP
M
M
M                                   -E^=?\':5K=?UK)G=!2L-N>1"
M;WCFM23[?5-]W<:[<Y<KC2V
M                                                          "3
MDZOGO87_ /D9NG5[&U/_ 'K,'YF?6BC_ -P.8Z>#3[)?L/\ 4>_=7?\ #N[8
M>OFN/LJ9P]%0E&'H^,^4<)YBF]]:Z=?374SJT[?J5&[F8IS,1&5'1?WX"*
M                                       $XB&/"*91@ $)6!2UJ
M   5*)<&,S,;$(R!6@A*P*4  &%34:8N$S9;68P8WQ6R6=;4H.2Q[8&K5B>&
M.MIT.],/UG+2*YK\OE#_ *ZR6G_Z[*GN_J#3_=G*?*V?&AZQ[19_]O?%?D+O
MB7.Z'PM_!O<'[R[J^T;!^S7AWZ.Y?Y&SXL/\^G/_ *2YG\HU/CR_O'8Y0
M       XW\]I6<K'Z*EI=+],VVQYK&[*6?(C];YSJI_L"WY-=G><C32W
M
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M*ZI/A?)I.:HICC])06Z)A(PFC<<Q4
M                               !LUSS_@+G_JJ?K:S=H]]+NY+:?N^0
M68ZZ:_)0;=?NL-.LPY>G(V
M
M
M                    !LMSK_@]1UU_6L1WEC*6W/(7:^Z&;VL85:L(4ZC=
M=W-S7&>#E>:68
M                                                DY.KU[V&/\HS
M=4</96OT*_'I/S.^M#3]H',=/H[.R7[$?4>K^RN_HX[NV'KZK<;-$)^BNCZ'
MI/E",.:QZ7UGI3_G74Z6%OU'VF_FOI7D=-_?@,%
M                        "&M0RM13(    4" !"3D!@H9QDBE #2K4:J4
M;=/*2Z*Z<LZE#T7C^(S7K8V1,=+FT<+WZSEJG^%?E]T;ZR7V_E3W;U!FGK9R
ML3^-L^-#UGVB_N^\5G9Z"[XESNB\+?P;W!^\NZOM&P?LSX=^CN7^1L^+#_/I
MS_Z2YG\HU/CR_O'8Y0          XW<^?S#(?DO[,WQW(8W=V6IR)_6^<^IH
M_L!J-=O>AR--#<
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M[K_8&5^UK9\J7]RY]'696]7V'GV_57;Y31R_<\K;?FM'JKM\K.B[-A&3(B@
M      '&GGM#8RTY[=N"USJTE@MS;E\K/X,97ZBCZRDSOV)/>;EFM0
M                                    #3K=:FGU4P7I=NB8P,<XQ8U5
M7=A;-'IQ2<<$GIC@Y"*4JD5G/!:G7%*A*7K34H]9<*+3>K=3;2E"&A:5TD,]
MS*EQC2\:81[9KHP)6LX%**DTIO:>N$/$(R%* 'CW;E5%7H^GH]G"#4E..D@U
M*:ZG#T&D\'&/AE(&T=52K@O23[-F"UZ8E6**J_2V83T]$HK06F%4G"69
M &S7//\ @+G_ *JGZVLW:/?2[N2VG[OGZX7U-?DH-O,=UAI9.7IR-@
M
M
M                                                    ;+\ZX_>[
M2TOHJYZHTU:-)C,S$Q1=DMN.0Z5.\<TE)0?CV=9T7=QJMQNFKE>:6P
M
M                             2<G5Z]['+O&;HAILVV^RS?/S.^M#/\
MZ_YGY.SXLOV(^H[C[++_ (=W;#U\M[5E)J2I4^S4CY/C#FHQQJ^MK8CTTTZ4
MH4*'"1NYSZ5$[FV['4QV(1D                 $,*RH9QDB@
M        !#&9FJ@B9J*9(  (2D"EI0         $)2!2@!#"LJTZ\5,W:4SB
MQO\ P<M308:_=CK<VAWWZSEIM?A8Y>PP>^LE'#_E^5/=_4*G^[.5KGZ6SXT/
M6O:+A[/O%>CT%WQ+G=$X6_@WN"4/\B[J^T;!^S/AWZ.Y?Y&SXL/\^G/_ *2Y
MG\HU/CR_O'8Y0          XW<^6G9R2TI5?V9OMI-C"[)J<B?UOG/J:/[ :
MC"WO0Y&FAN
M                                             !QH[X/\VOG%_$G?
M_P#HK,G3ROTK2^';\9S<W]%U?@7=CY).]/X8\=.'_P"M_$DXX?Y;SN@^Q?#_
M *-9\G;V0^9O&?P.G\._MECJ\OR'9<]4U>Z.6,]?3\4#+-L@G'&+6C#$"XX8
MH=9EGDD&EC#LB-JX2BPPQT]NHIMWKIP@]>(V;C9N1+M\1*RRFF43BKTIRUZ1
M%4I3::>G5\I6.S<1>"_%%(VJ+&6&E>023O)J<)+I!A/6L9ST8OKZ"4Z#.-\D
M7*")&),1%8EC+3@L$98^59PR6<H:(S"8;2,91AT#),AP:Z-#^0F1&"PQC)O1
MU!?L#U0BUV RW)&>IOQ?'$I0E#4E@PF-=Y!Z%#M"UC:0<<9]0["ON&,EAJ_%
M'6=>:+2GX"85J3CU"GHC M(A9GWV2AHTDZV,[\V*4,</*7J7/(G!P<ET:P+'
M!/M\PZBG0**QP&$]9-)ZRK5CJZ-9((DC''!><N1C&"J$9R9-FXV;DZY_#H%9
MV0M+=DD9QT+1UC'(I$#CC'##M+@D43&;PTL;H-T+2M,.T2DHG%]#\PRA<H6*
M\./9@*24D2>C!Z?D$DG2W%:\(?'$B;B498Z"]>2]>2=2QPGX0=;)..GL^4DI
M.#%)IQ>!<UF:K)/5#'S 1ISU"*$49/",8+J(C&,XQCYRKLH+HQU?*2:THO7D
M2Q7XA9JL4RE7*"T:QO8[]K*G\TIGI\$A;FQGNN<?NPXU>\"Y%1FUONB&C_CN
M[_B/3O7J(_V]S/5'V7O7J]'#S7)Q_6^R^JQNV6ZMW/2LADX=N7M)GRG=E,;'
MT;;W(G=#S$VJ%#I\IHY;N^5MOVRU4DE!8&_-BH        #C3SW;V,LM#KMQ
M\-1E;F1MG:W,Y6J'#.5^HH^LI-FK$1;$L?Z3<HTL@
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M@
M
M                                                           ;
M+\ZX_>Y3.'I514(Q]&HQNS@V-N>1*?W1S/4_[$Z+NXPMC&9<KC2S
M
M                           $G)U?/>QP_E&;HTKV%N/0_8WS\S?K0U_:
M!S/P+/BR_8?ZCU?V5WT^[N[8>O=NEV52L=E:]7RGR?$3\ZB9RJ^N+:>GF82E
M^@_AH1T<WCS4=3.<+\=J&+,           J      0PI*AG&2*
M         $,9B94$1-13)                !!.0&%)5IU)NJF"-NGA6J7_
M (.8:CE)XF.OC9$[W-H1Y[]7RUI7X6.7STK?63^W\J>[^H-W_JOE(Z=6SXT/
M6O:+C[/O%?D+OB7.Z%PO#[W>'YS^XFZY0_\ H+!^S7AM8\,Y>/\ @V?%A_GQ
MY^GYTYG''T^I\>7Z$ZW.          '&SGO^991ZD_[,W63$62QNB9C!J\B6
MO89M:733#^L+J9586Q/%#D<:&T
M
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MHRST*NW'PU&5LQQ4VD;8VMS.5KCPSE8?24?64FS4F)B(8Y7-RC2R
M                                 C:2;>"FR3%86,W'CO+<].'^[URA
MXIYE<05JFQN_=^9HRT:J;;JS5S+9CV#]*NB"HNT)N#3,]&R-6:QE),TCHF'0
M&[R'.[C[O!<V.*>,^,N(]X[_ .'\_O>_3P]D%F,S[++V[F=S"M6[5M7[M/J7
MDI'D='3C3LX8S<>O?=&I$W]S8]GO<F]SCQ5WD^&MR\S>+=[7>"N%[M5%[=M&
M8L57J]Y6H9>Y4MF[E*ZH;%QSB2_5]'=2[*C?IS6.*8Q>P[F_[A?A'B?ANFUP
MCQI9W?OG=N7CEJ:,E10LW>HM."JJIR*2VZX>$FGSD1=3*UINT(NGBF,77$[T
MG=EXE[M7,?,<K>,+.9IWGE[SIRF=I5ZS;=-%=Y6KU%=-JS2Y6=J1Y#YS.OA$
M^9#COT;K(B;\JO:U[F;OR<:<O^;^Z^[1Q-F,SOGAC?\ <IM6=XYK,7;M.4KH
MIRMJP[;O9EI;*J:E2<?.TOI'0[="W&M<W<5HK5RBBNEQIKIIKI>M5)-/P,\4
MZ2I[-+<(PT8"1A3]1"I:(ZQE&&U:16D90XS][/O$<.]VGDOQ1S%W[79CD]WY
MJSDLJ\Q:MW:LU?RN85BY135=MUU*W=2<C9I:=U\X1A#&;HI69Q= #G#S3W[S
MGYH\6<;\6[YS.]:]^;US>8W)1F'=OT96Q5G,Q<IHI=RY>IH5-NY#$\YH6V19
M6<;GC]2..^>+)K\FFESKX!IA2X;URBCL4Z,WEDM'0+[I]'-&&C'G[GT*.[K_
M *G>"?WGR7VIESPNO^$>2L[K>TTL@    ;-<\_X"Y[ZJGZVLW\O^$8W]R6T_
M=^_7"ZJ_)275[GE+'+TYV0
M
M
M                    ;+\Z_P"#BZZOK:B3G!/=EMSR)3^Z.9ZG_8F^[N,+
M<YG8Y7&EF
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M*&97Y-4=^KD<:6T
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MT-.:N7QS,@
M
M
M        V7YV.'#B^JJ^MJ)M@GNRVXY$-/>.9:FI_P!B=%W<86]Z7*\T,P
M
M                                !)R=7SWL,/Y1>Z8.?L;<O]ZOGYF_
M6AK^T'F/D]/LE^P_U'IF/97?\.[MAZ]E.BEX02\2^0^4KL-?ROK33FNM*TM-
M.!LYCZ3Y&^Z)BZ*L2,P        !"3%0)PBF0
M       (29H!.(4R               #%I[5,'#'0F9VTVI=W)95+8<G-X_"
M9KU9K;&Z6C1CSIJ_5\M5'FOR^G#_ "UDOM_*GO'J#=_ZLY3Y6SXT/6/:+^[W
MQ6?^!=\2YW1.%OX-\/\ [R[J^T;!^S/AWZ.Y?Y&SXL/\^GB&'B/,_E&I\>7]
MX['*          '&_GO3]@RCCBG_ &:-T1YB3-&?(E0R^<6JFE?6"_)KC&Z)
M<C32V@
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MBVDM;DBE8C,BM:\(G#,7IT")B<AC3535'9JIJACLM.'7 %8E8K6O"!0
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M9K9     V<YX_P ",]\-#-VCWF-_<EM'W?/UPOR?]B;-?)-+)R_.5F
M
M
M                                                    &R_.O^#B
MZZOK:B3G!/=EMQR)_;',]3\QT7=QKL[TN5YH;
M
M            !)R=7SWL,^\7NGHLVX_G.8/S,^M%^\'F/D]/LE^P_P!1_P#=
M7?'3?=VP]>[E9IA3![*E''T7/H/E*['F*5VOK33PUIZV-N=%36@V<QAS,1+H
MOF)OB@&0                                          !#&Y0Q%-B
M              $TT]9G&27=V6=;A!:_,:=7NQUM&AG+]3RT<.:_+[IWUDOM
M_*GO/J#%?6SE)_XMGQH>L>T7]WWBL?\  N^)<[HG"_\ !O<'[R[J^T;!^S7A
MWZ.Y?Y&SXL/\^G/S7Q+F?RC4^/+^\=CE          #CCSW_ %OD^I^6LWQW
M(8RRY%?F&=ZJ?[ E^7D:[>]#D8:6X
M
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M<5K/0!0
M
M
M    ;+<[(_>W3#Z:KZVHQNSA<*35MSR&_7^9V_6A5Y*882.F[N-=M.*:.5YH
M9@
M                                    "3DZOGO84EWC-TM8^QM_H.8/
MS,^M%/\ [@<Q\#3[)?L/]1['V57_  [NV'KW<?8K;FJ4H^"6$SY2GZ1YN=7U
MGI_A9JE$Z*FI0T8XFSF9IS,1TNF_OP@9      0PG-01F*9H
M                  (83FH(S%,T                  !@TG<H3UFVV9X9
M2^(G3FK6O.E;,L<*I^"!HU(F8\K1H=Y^HY:*/-?E\XR6^LE]OY4]Y]09_P#5
MG*1_Q;/C0]8]HT?^WOBOR%WQ+G=%X7_@WN#]Y=U?:-@_9GP[]'<O\C9\6'^?
M3Q#])<S^4:GQY?W3L<H          <;>>_YAENK\N;+>Z-7D3^MLUU4^2@V:
MF35'X1R-.=M
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MT5)N'11+M-7-<Q%\=:6S6,7+9UTJI4QG5&$GH/'VZEMTTMS9TFE69F@
M
M
M                                                    V6YV*/#E
M*_'5^*FHQNSA=DMN>0C7S_-*GTEZ47AHIUZCIN[E&NWO2Y7FAF
M
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MZ*?)0C*^:PPB/.KTN1AH;
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M;YV4$3$6X9N7J4XG/99$73,34F5-R
M
M
M                          #9;G9_!ZCZJOZUDG9ULHREMSR':JWCFG3-
M)..C!4ZS?=W&JV*72Y7FEF
M                                                         ).3
MJ^>]A7_Y%[I;P]E;_0KY^9GUHI_]P>9^3T_BR_8?ZCV/LLN^'=VP]>U=+=%#
MT*E=LO$?*,3'I:;WUKI_AY2CU7!0Q-W,?2&^_OP$9
M                     AA.:@C,4S0                  &G7&-+3A".@
MV63BQU/P<M1[52VG@NK6D:]:D6Q&VK3H=Z:OU7+3_6QR]_?K)?;^5/>?4+];
M.5^5L^-#U?VB?N]\5^0N^)<[HW#'\'-P?O+NK[1L'[,>'_H_E_D+/BP_SZ\_
M^D>9^7U/CR_NG6Y0          XU\^/4R755_9&VSNRQN[LO*Y%_K?-]2_\
MEB]/N>IR*-3,
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M^?NO*Z6I%*:?=C!KU6;;C4EZ3A..KY!=-NI$:=T^:</#=QQWFN(B(BD9,@H
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M H
M
M                                                           -
MEN=?\'J.NOZUB,9HL92VZY#4JG>&;V9*#;TZ*=9ON[E6NW.7*XT,P
M
M                           !)R=7SWL+_P#R*W4GA[*W^A7S\S?K0Q_[
M@\Q\GI_%E^Q'U'OW5WS_ %[NV'KW=4;=,'%;*AX('RC,1&OY7UII8ZUS"VTZ
M&UIB;^:BG,1TTAOOQOA3!D
M ""D *0*                   &G4HUT2C,VV4I-4O_  <M:YH[?,:=7NTW
MM&AC=,OU7+3_ %K<O_WYR7V]E3W?U"_6WE/E;/C0]9]HD1^SWQ6-GH+OB7.Z
M'PM_!O<'[R[J^T;!^S7AWZ.Y?Y&SXL/\^7/X^(\S^4:GQY?WCL<P
M  <;>?%#=G)U)Z*M'U9NMBEM=C&ZG#+5Y$-O+9R+C*G_ .6+VNV9F8B7(TTM
MP
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M7/Y&YY*#/6R8:7=<O#F;0
M
M
M                   V6YU_P>H^JK^M8CO+&4MN^1"CO'-="?\ 8F^[\'5J
MLSERM-#8
M                                           ).3J]^]AC_*,W4FH_
M8;4)Z/97X'YG?6A_>!S%/Q=G9+]B/J/?NKO^'=VP]?$&K5'U.'8_,?*%TQ/,
M>6'UEI137NZV-'J,W\W](CJATW]^ P9
M                 %=@               :;CMT0UFW3I2:Y%U?1S1JW/H>
MWS&G5QCRN?0SE^KY:?ZUN7_[\Y+[>RI[MZA?K;RGRMGQH>L^T7]WWBOR%WQ+
MG=#X6_@WN#]Y=U?:-@_9OP[]'<O\C9\6'^?+G\/$>9_*-3X\O[QV.8
M    .-O/F/L,D]J"A5HP]?PF^R)I&.#&[*6IR'_6V<T^C3/\[&HU6=YR.-#>
M
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M#=Q<,Q-?<;-+5T;K.&:39.5']S+^HZW2J$X:G'ID:XB(\V,F-^?3O>0FFHK
MN3%0                                         ;-\\?X#Y[K7D9NT
M.^EW=EM-W?\ ]=?U?]B;=?NL-+*>IR].1L
M
M
M                                #9?G7_!Q==7UM1)S@GNRVYY$0^Z.
M:GH?]B=%W<:[.]+E<:&P
M                                                       2<G5[
M][ H]XS=+U6;?Z%?/S.^M#/_ +@<S'_#T^R7[$?4>_=5?\.[MAZ^<+*=6+I4
M/!+ ^4+L>8I'2^L]/\-,STL*%"EQZ3;S'TET7S6^ C(
M                            (:U#*U%,@   (8W 8JIL0     #2N>M2
M;+"_\'+4T&O7[L=;ET.^_6<M6ES6Y?K_ +:R4/\ #LJ>[>H,?^K>4F,O2V?&
MAZU[1?W?>*_(7?$N=T3A=K[W.'UI>Y=U0[,A8/V:\._1W+_(V?%A_GT\0_27
M,_E&I\>7]X['*          '&WGW^MLEUO\ ^8;H[D)+5Y%T_8<S5'"BB791
M\1;^ZUVSYU'(TT-H
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M>*:3A#SJ6VDVH-Z,3=%:8YI,1$TC)D5
M           ;-\\?X#Y[L\C-VCWF-_=EM-W?9YF+E*N&F/JFS7G"FQ-.)AR]
M.5F
M
M
M &R_.O\ @XNNOZVHDYP3W9;;\A=E[PS6QA...JF.,S?=W&%M9F:N6!I9@
M
M                               "3DZO7O85'O&;I?\ N-O]!S!^9WUH
M9_\ <#F8_P"'I]DOV(^H_-/97=\.[MAZ^DX6%U+ZT^3[L>;B-[ZRT9KKSUL+
M?JOM-_,Q3F?(ZK^_ 8J             $X"&/$*91B
M           $,>$"Q%!2@   0DQ4"<(#B L344H   &E7.JDVZ<5JE_X*6K4
MMF"QB:M::VQ'1+GT(\ZK]9RU3_"OR_G_ -=9/1C^KLJ>[>H,_P#JWE*_C;/C
M0]9]HO[O?%?D+OB7.Z'PM_!O<'[R[J^T;!^S7AWZ.Y?Y&SXL/\^?/X^(\S^4
M:GQY?WCL<P          <;.?+VK.3HPA%Q_J_C-T=QA-V,PU^1:7L,T]*IH\
ME"\Q;^ZQMGSZ.1AH;0
M                                                    QJIVH3A
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MZ,=9RV3P:_H;6^Z)L\YY*4%!'4U9@
M         ;.<\?X#Y[X:&;M'O,;^[+:/N^3S+B\%7!0^I,];WBRKE^<S(
M
M
M                                                       -E^=C
MAPXOJJOK:B;8)[LMN.0M>UG\TVH1526G13T'1=W*,+8I,N5R4%#K\;B:&R9K
M-5"
M                                     $G)U>_>P_SC-T_WJW^A7S\S
M?K0_O!YGY/3[)?L1]1_]U=WP[NV'KZKG:I2Q5*^M/E&,.9\KZTTL->>MA;?H
M5+7YC;S<5YJ)Z(=%_?A"*            !"3D!@H9QDBE
M           ,"@0         $-:AE:BF0   &G5ZU/6;M+:E_P""EJW/H>WS
M&C6R\K1H9R_6<M/]:W+_ /?K)_;V5/=O4+];>4^5L^-#UGVBX^SWQ7Y"[XES
MNA<+?P;W!^\NZOM&P?LWX=^CN7^1L^+#_/ES^/B/,_E&I\>7]X[',
M   '&KGMZF4ZG_9&ZWN-7]*7E<B_S#-?4T_V)E?W2WON19SMH
M
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M,KJU'%RA-#(B,*B4)J99Z$J-S<X=A*8&>*VY5TRFGYC*,92[NRYQ^[$JVO>
M\B='^6[:6F/ZNW>CTOU[C_T]S,[H>\>KD?\ 5<G/];[,/JL[L_:W=?[ ROVM
M;/E6_N7/HZS*WJ^P\^WZJ[?*:.7[GE;;\UH]5=OE9T79L(R9$4        XS
M\]YTY5+Z>CRU%LS(B:2W.Y6_P9RWU%'UE)E=E";6Y1@H         \'.VZKE
M*H44FFXK\:HFO5NFW2NNSHRB*VTCON+7?)X2WAQSW8.:_#>Z[=QYW-\.9^NW
M3;IJJKK66RUR]6Z::::JFW11H3/7_'M2^/ [YMBMTS$4\KR7A-\Z?.V7W]$]
MCIL>Z>YI</<C>_=NJOC3-T;LW;OC?V_MSUYK-;-FFSF;N?HR-O;JNU6J;<;J
MTN<#^L^K?.:-OJ'?X/;,3KWVQ,>2DY/1N?\ #M7D/6&><U*^BONS\KOC9:Y1
MF':S5B]1F<IF;5J_E+MJI5VJK=U;:N47*'517352TTTW%'HNGHQRVEZ&,XXG
MLW'Q37^C1TX??YMV>\CP%>IN*BO;MJ#IVHQ>8CU2-_LSBOCW.3=LO^RT>T"Z
M9]5^2I-)BKL0^ZWJV>Y%RAJJ]%+=]YU1A5M1]CKPBV><]9I_\XU7B_5^9GPK
M3F[.CESSAYA<,\JN6/&W''%V\,KN;<FY]P;TOW+N:OVK5-RZ\G=ILVK?M;EM
M57+MQI;*<83/4_$;O^BUK9CO63$>6*?9>R<II\?,:=ML_P!*)G=BZ"?*BK>?
M/SO]<,[TW9E;F9L[VY@YS.9.BQ35<=S*9?B2F\KC]FKK5/L:TXZCW3V0Z%WJ
MQZNZNOS6$71?3RO7_:/S%OB'BVCI:$\7=BO4^A5NC+?-]Q;IR?J597=.[K#4
M(NGV64M6H3^I@>M<S_G<Q=K=-TS[LU>5Y>/1Z=EL91;$>Y#SK%%5O8I<X;4'
MKCT:#BBR?G4W?T6_5NBZ:[7F'8T@
M        ;-\\?X#YWK7G-VCWDN[K:GN__KI_4U^2DRUDM<NCG9
M
M
M                                                !LMSK_@]1]57
M]:Q'>6,I;=\B$GO'-=3\E)ON_!M5N<N5IH;
M
M          !)R=7WWL7\XO=']YM_H.8/S,^M%^\#F/@:?9+]A_J/?NJOZ>.[
MMAZ]I^R2>*I\S/E*^?\ /K'3#ZSTHIKRPH4:6S;S$S/,>1U7]^%(H     $,
M9F:J")FHID@                    "&,S-5"5D!60,XR10       #9)DA
M#&LJIF@              !IU>M3UF[2VI?\ @I:MSZ'M\QHULO*T:&<OU/+3
M_6QR\_?K)?;^4/>?4']:^5^5L^-#UCVB_N^\5^0N^)<[HW#'\'-P?O+NK[1L
M'[,^'_H_E_D+/BP_SZ<_^D>9^7U/CR_NG6Y0          XV\^_UMD?R7]F;
MH[C7_2EK<BDEE\U#Z6CR4%O[M4M[[D8:&T
M
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M%W#-^$^:\A1@HXP4>LZFN<\%
M    #9OGC_ ?.]:\C-VCWDN[LMJ.[^U\YCH:K7;Z*\YGK1+&V7+LYF8
M
M
M                                                     ;+<Z_X.
MT/557]:Q&%RUI$MO.0_[89OJJ\E)ON_!M=N<N5AH9@
M
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MW#'\'-P?O+NK[1L'[,^'_H_E_D+/BP_SZ<_^D>9^7U/CR_NG6Y0
M XV\^IY?))8TQCT1VS=;C;@PI29G8UN12AE\U##9H\E!;Z4WL8B>*LY.1AH;
M0
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MRW0NBV<+(PB(?V<K4G0Y0;<6L>V/2<FGJ<4TNPN=$Q3'^C+RC<@
M                                #9SGC_ ?.]:\C-VCWDN[LU;3=W[9
M^<2P]+7ZWHP\9GK58VTP<O#F9@
M
M
M                       !LOSK_@XNNKZVHG]*">[+;?D-/>&:>WM2>B&&
MR=%W<86X3+E@:&8
M                                                  DY.K[[V'^<
M7NC^\VOT','YE_6B_>!S'P-/LE^P_P!1[]U=_P .[XT/7P_4_(KR'RG/TB.M
M]::?X>6G1ZK[?(;^:^E>1T7]^ P9
M                              :5:;JI-NGG1+YIIRU:ELP48Q-6M-;(
MZVC1CSI?K.6G^M;E_#]VLE#_  [*P/=?4+];>4^5L^-#UGVB_N]\5K^(N^)<
M[H?"W\&]P?O+NK[1L'[-^'?H[E_D;/BP_P ^?/U_.7,U_P!1J?'E_>.QR@
M       !QMY\?F&6ZORYNT^ZQNR>1R+_ %OFOJ:/);)>FVWRN11J9@
M
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MF[1[S&[NRVF[OK:S,(Z*]&/JR,];)+)F<W+TYF8
M
M
M                                     ;+<['#ARE0C&JKZVHQGO0;&
MW/(=*G>.:5,DT^G%4ZSHN[C"V9FZ7*\TLP
M
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MKF^R8X-[&[)K\B6WE\W]31_\LFHPMF9F'(PTMH
M
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M@       '&GGLGL95Z%71%]M1G;F6[8;E\K/X,Y7ZBCZR@M^4$]YN6:P
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MI]RLO9-.+XY;&?.X8['EY55^V;KI=+>G6=>O-MVG$6['+H\<WUN?UC4ZP
M                                     -F^>/\  ?/=GD9NT>\QO[LM
MIN[Y+,X:+DHX>J9ZV3'3R<O3F;
M
M
M                         V7YU[7WN4PPVJHX?2U&,]Z#9O;<<B?VQS/5
M^5.F[N-=G>ERO-#8
M                                                   ).3J]>]A_
MG';H_O5O]"OGYF_6B_7_ )GY.SXLOV(^H_\ NJO^'=VP]?52A;3CC2E_6_(?
M)V>M3>^L]&/\Z>MA;G14]!OYC#F8B>AT7S6^)@#(
M                          $),5 QI*J9H         ()R PI*M.M.*9N
MTHS8WS_ERR;A!:S'7QLCK<VCWWZ[EH__ +K\O>G?62^W\J>Z^H,?^K.4GHU;
M/C0]:]HO[OO%8_X%WQ+G=$X8]'AW<%+Q^XNZ_%D;!^S7ALU\.Y>?^#9\6'^?
M3Q##Q+F8V^GU/CR_O'8Y0          XU\^:8VLDVI0J_LC=9$Q;5C=W6OR)
M_6^<^IH_^674:[>]#D::&X
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M#OI=W9;3]WW]=/ZFY_8F>MDPT\G+PYFP
M
M
M                              -EN=?\'J/JJ_K6([RQE+;GD3^V.9ZG
MYC?=W&JSO2Y7FAL
M                                                  $G)U??>PMK
MO&[I:_Y/:CT_8LP?F7]:+]?^8^!I]DOV(^H_^ZJ_X=W;:]>M4J$EA!>0^5)Q
MU_*^M-+\-,);;V:EH>)LYB(GF:SFZ+^_ 10           0UJ&5J*9
M       $,;@,5 !E:BF0     !#"<U!&8IF@           (:U#*U%,@   -
M-O9KH<(SZH&ZR(FV4OF8TY:MSZ'M\QHULO*T:&<OU/+7_6QR]_?K)?;^5/>?
M4']:^5^5L^-#UCVB_N^\5^0N^)<[HW#'\'-P_O+NK[1L'[,^'_H_E_D+/BP_
MSZ<_^D>9^7U/CR_NG6Y0          XU\]_4R?55_9&VWNR3E+R.17ZVS?9Y
M*#/4[K3;W_(Y&'.W
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MWLVO33LMO%M)-X882P1(XJS7)E,QLR9%0
M              !LWSQ_@/GNM>1F[0[S&[NRVF[OL?G+<-%:Q6G9-FO%+6.G
MDY>G*V
M
M
M    !LOSK7_=VEZJJ_K62M)6M(EMSR(A]T<U/0_[$Z+NXU6=Z7*XT-@
M
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M>1R*EE\TNBE^%4?$9W]UA;WW(PYVX
M
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M=;2N+^[L)U[52@U!4N.,IR-=UD737;#96D4V-0R0BAD
M                          &S?/'^ ^>[/(S=H]YC?W9;2]WS8^=506BN
M<7CZ.@V:]*;V.EDY?'*V
M
M
M                  !LOSK_ (.+KJ^MJ).<$]V6W7(B/W1S4-3C_6G1=^#W
M-=F<N5IH;
M                                            !)R=7SWL/\XW=#U6
M+2_X&^?F9]:+]?\ F8_J6?%E^Q'U'_W57_#N[;7KXJVO9TZME0P^E\.!\H1^
M'PSJ^M-/\-<PH]1]IT\U](CJAOO[\!@R
M   "$G(#!0SC)%*                          TZO7H-EN4L=3\%<U:VG
M"&B,35JX61UM&A/G2_5<M/\ 6MR__?G)?;V5/>/4'];.4^5L^-#UCVC?N_\
M%?D+OB7.Z)PO_!O<'[R[J^T;!^S/AWZ.Y?Y&SXL/\^OB'Z2YG\HU/CR_O'8Y
M0          XU\]O4RG4_P"R-]G=:I[TM;D2TK&;6ETTP_K"7Y$=YR.-+:
M
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MJF.RHN+@HO"/2;HF+L8R8,@
M   V;YX_P'SW6O(S=H=]+N[+:;N^_KNKZFO^Q-FODPT^ZY>G*V
M
M
M                                                !LOSK_@XNNKZ
MVHDYP3W9;=<B$GO'-=3\E)T7?@VNW.7*TT-@
M
M           DY.K[[V+^<9NC^\6_T&^?F9]:']X',? T^R7[#_4>_=7?T\=W
M;#U[IKV.$/16GK/E&_#F*[WUII3_ )T];"V_0J6OX(V\SCS,3/0Z;XGCB=@%
M                                 %*      $,9F:J")FHID@
M            -*MO:I6AN?PZ3;IQA,L=3\',M:M)0A*,?,:=6:V17I:=&(XI
M?J^6G^M;E_']VLE'_#LK$]V]0OUMY3Y6SXT/6?:+^[WQ6GXB[XESNA\+?P;W
M!#]Q=U?:-@_9OP[]'<O\C9\6'^?/GZ?G+F:?ZC4^/+^\=CE          #C9
MSW2=O*IZG_9&ZWN,)SEJ\BU2K.:7T2IIACJHCT%OIPL;:\6YR.-#:
M
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M*        <:>>R^QY=PPKM^E'"=6C2+8K>6YMR^5G\&,K]31]929WDYMRS
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M/+UV;.AS\CST:\>CU,-6'M8I6S32HQ@DHZX(\;;'#$6]#R;(H
M                            #9OGC_ ?/=:\C-VAWTN[LMIN[[^NZOJ:
M_P"Q-FODPT^ZY>G*V
M
M
M               !LMSL:7#E,=-5?UM1-L$]V6W7(AM;QS74_P"Q.B[N-=G>
MERN-#8
M                                         ).3J^^]@GWC=TP_N-J7
M^]7])^9GUHOW@<Q\#3[)?L1]1Z)_95?,9<=W;#U\-?8X_C5'HEXSY0NFNO2.
ME]::<?YTSO:5M>BS?S'TB.IT7S/'$;%(H    (2L"E
M               0QF)JH(BF,@6L(I0 A*P*6M0      !"5@4M:@    -&Y
MZU#U8&W3G"82^*Z4M:I[4'"$#5K12R.MHT9\^7ZSEI_K6Y?_ +]9+M_5V5\I
M[KZA?K;RGRMGQH>L^T7]WOBOR%WQ+G="X6:^]SA]:?N+NK[0L'[.>'1_Y=R\
M_P#!L^+#_/ES\Q^<N9C;\XU/CR_OG6Y@          XU\]VE;RD7"*?]D;K.
MXPF:3+6Y&->SS4HMTTS[*-!;^ZQM[U=CD<:&T
M
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M][+R^IZ70LU,N*V)]V'ZPYVX
M   &S?/'^ ^>ZUY&;M#OI=W9;3=WW]=U?4U_V)LU\F&GW7+TY6P
M
M
M                                                 -E^=E,>'*7J
MJJ^M?Q#:3DVYY$)O>.:ZG_8F^[N-=G>ERN-#8
M
M            ).3J]^]@C_*,W5LX^PMP_.LQK/S-^M%^\#F.CT=G9+]B_J.T
M_91J5SX[NV'KXI=3M3Q5*CAJ/E":>GPZ7UAIS/I9Z*L;?JOM\ANYCZ2Z;^_
M10   A)R P538@                                 $).0&"AG&2*40
MUJ&5J*9      $-:AE:BF0   &G6X-+K-ED8I?'^7++1\-9AK]V.MS:'??KN
M6L/PK\OH_NUDH8_\ORI[MZ@U_P!V<I3+TMGQH>M>T7]WOBO3Z"[XESN@<+I_
M>[P^]'W$W7]H9<_9OPZ?_+="-OH;/BP_SY<_'_FG,SL]/J?'E^A.IS@
M    !QKY\).WE8Z$X?UQOL[K7=E+5Y$)/+YMZ533#^L)?DQLF9F'(\TMP
M
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MV!E?M:V?*5_<N?1MF5O5]AY]OU5V^4T<OW/*VWYK1ZJ[?*SHNS81DR(H
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M?H=]C?W);3]WW]<QCBJYZY4> RUIK#'2R<O3F;
M
M
M                                     V8YU.'#E+6NKZVHQG.">[+;
MGD/^V.;>NE^2DZ;OP;"W.7*TT,P
M
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MI2^JZ3=9-+6,PU^1*AE\XM5-*\&P+\FNWO0Y&&EN
M
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M2J=2@;8GBBM*58Q%(HR*
MV:YY_P !<]]53];6;^7_  C&_N2VG[OGZYQT5Z,94>4RUNZQTLG+TYFP
M
M
M                                                      -E^=?\
M'*?JJOK:C&[..LGNRV[Y#_MAFOJ7Y*3IN_!,+<Y<K#0S
M
M                   $G)U?/>Q_SB]U?L>S^A9@_,WZT'[P.8^!9V/V(^H]
M^ZJ_X=W;:]>RBK*4(O92A&&B.)\I73$\Q795]9Z>&M/6QM4NFAISQ-G,?271
M=WH4C(   (2<@,%4V(
M            !IU>M3UF[2VIJ?@I:UW%0ET&C5R\K1H9R_5<M/\ 6MR__?G)
M?;V5/=O4+];>4^5L^-#UGVB_N^\5^0N^)<[H?"_\&]P?O+NK[1L'[-^'?H[E
M_D;/BP_SY^(?I+F?RC4^/+^\=CE          #C?SU_,<M]2_P"S-MO=8W9-
M3D5^89WJI_L"WY>1KM[T.1AI;@
M
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M/M1ZG/FS/%@]CXN*D[6L(F+HK&0%
M         -F^>/\  ?.]:\YNT>\EW=;4=W]1S74J_P"Q,]9+9['+LYF0
M
M
M                                                      ;+<Z_X
M/4?55_6LDK&4MN>0NS\_S>SA"K7C"G6=%_<QS:XSQ<KS0S
M
M                     $G)U>_>P+_\B]UZ?L-N"P_M5_2?F;]:+]X',? T
M^R7[$_4>_=7?/]>[MAZ^'!V:(*'HKIT,^4+_ *1/6^LM&8]/=UL+?J/M-O,_
MA_(Z=3\) :V09QDBE$-:AE:BF0
M                      P:C<MP<&GCB;;9\R82^*Z<RU[U+:3;C!X0@:-2
M8I2FUHT*\6#]1RT7_P!U^7_1OK)0[,]E3WCU!F?]V<I&STMGQH>L^T7]WWBO
MR%WQ+G=#X6<>&]P?O+NK[1L'[-^'_H[E_D;/BP_SY<_^D>9_*-3X\O[QUN8
M         ..//?\ 6^3ZGY:S?'<AC)R+VO99N'JP4</QG;B2_+>PMSCI<CC2
MV@
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M_4F>ODED.7QS,P
M
M
M            V6YU_P 'J/JJ_K62E9HL92VZY#;2WAFXO:DYR4%"DZ+NYN:[
M<Y<KC0S
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MCZFG$E^3"SO.1QI;@
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MGOAH9NT>\QO[LMI.[[^N5/17_8F>MD6?8<OCF9
M
M
M                                    !LMSK_@]1]57]:Q'>6,I;=<B
M&UO'-=3_ +$WW=QJL[TN5QH;
M                                                           !
M)R=7SWL+3[QFZ5I]A:_0;Y^9GUHHG]H',? T^R7[#_4>_=7?\.[MAZ]ZHU6J
M8R6SAC&">D^4;J1K[ZOK32G_ #YHQM^H^WR&W7^D>1TZG?@"@
M     !#6H9QDBE                                         -*YC2
M;-,O_!RU-!AK]V.MRZ'??K.6CAS7Y>K7OK)?;^5/=?4&*^MG*3_Q;/C0]:]H
MO[OO%?D+OB7.Z)PQZ/#NX*7C]Q=U^+(V#]FO#OT=R_R-GQ8?Y]/$/TES,3GZ
M?4^/+^\=CE          #CCSW_6^4^IJ_LS?'<CK879'(C];YSJI_L"7Y-=G
M><CC2W@
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MW36-CS'%'#%NV&O=H=5/HN%2P?E,=>RZZWS5LF(NK+46"-FGA9"3FIF@
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MZV2:>3EZ<S(
M
M
M         -EN=?\ !ZCKK^M9)6,I;<\A=KY_F]K&%6K"%.HZ+NYN:[:5FCE>
M:&8
M                                      DY.KW[V!?_ )&;I>GV5O\
M0KY^9OUHOW@<Q'_#T^R7[$?4>C_VKO\ AW=L/7TVO8TPFH+:\'QGRA_^5%<Z
MOK/2IZ:8CI:=$-EP4,>DZ.:^D^1T712Z(#!D
M             (29H!C654S0                    !A&%RAO6;+(F;9B"
M[\'+R+KIA!8M])HU:[>ESZ&<OTW+2?-CE[%_]=9+[?RA[UZ@_K7RORMGQH>L
M>T7]WOBOR%WQ+G=$X93?#VX*F\-R[K\>0L'[->'4_-W+Q_P;/BP_SY^(5GQ/
MF9G\?J?'E_>.MS          !QPY\1^;Y.#A*J?]6;X[D,;LCD2_L.;]+Z%:
M/6]2?02_)A;G#D>:6T
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M? V>I6+=/UM9MTIB+\28F;)HVH[O_HYE)K14OK$;=7&,&%F3EX<M=C,*
M
M
M                                                     #9;G9_!
MVAZ%57]:R3C,+&4MN>0_I;PS+4U!^)4QQ.B["QJM[TN5YH;
M
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M\.;@<9?<7=<H8_J&P?LWX=^CN7Z?0V?%A_GSY_\ 27,SL]/J?'E_>.MS
M      !QPY\N&6R<X134<?IS?'<AC=D<B:/L&:<<*:=&,=B>,B7Y4:[,X<CS
M2W
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ME(USQ3$VS@VY^<U\$:[IC3L7-3.)K%4"@                    "5-)-O
M%:-E^=_.O@SD+R]WYS XWWGE-VY+=N2S-[*V\S?LVJLWF+5BY<M6;=-R[:=6
MVZ(.#B9:6G=??2,DU+^"R9VNA!WY.\I<[U_/G>W,^_[7*K+YZ[D-QV5=KKM9
MJS;OYG*Y6FW9]K=H@Z+E,('EHM]%;AA#AF^+XI'>C[+W_P#N0^YI;W/PW7S\
MX^W!7E.),S79>X7FK+IKKM7+>7N_.*/:Y>EJE;"P>DY=?5FW!U:5OF\4]YV2
M$H*'R2T+L1P];:ZPW](6J_R#R]4/^4:=?SP[.3BNHT\Q,1HS5ZF_=42[RVY]
M/ZKR71_;LB=6IL<?+YR[Z6[_ -89']AY;]!H/%W=Z>MY&,GF&*NJ'_2%VUO?
ME_#Z2Y];G#R?(Y->%;JN#WN>OYQF4CZWSC)0_J\CJD7FLKFC_P 29=Y?+_K>
MQ_>;7UE)XJ,G6UBB.,).#UXDFNS,3TDOIGJDHS\"@C'SZUV E&%55,*E&"C&
M$9:).*+A;'6-FN>*J^\/.J.S4H32C/9K1U<M9QWXQB9=3:?N\M_.*DW%PKB]
M<J"Z]D6QO2,JN7YS*
M
M
M               &R_.O^#BZZOK:B3G!/=EMUR(<-XYKI3_L3HN_!T:[,Y<K
M30V
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MWQ+G=!X6_@WN#]Y=U?:-@_9OP[]'<O\ (V?%A_GRY[](\S^4:GQY?WSL<P
M        <;>?GZVR76__ )AT6=V&%V4M;D3^M\W]31Y+9C>PL[T.1AI;@
M
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M]HMMK96)R9NK;VJ=,H+RS@.:MKITC-+)QQ:RP,].)BR(G.A*F8
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M!1FZGC)LNE9;$S?IET8Q5NIR$2HSVS1)0JCTRH\$SFUZUI)A$8.71R
M
M
M                                                     ;+<['_W
M=H6NJOZUDG8L16)JVZY$)O>.:ZG_ &)T7?@ZM5G>ERN-#8
M
M                     ).3J]^]@=+[QNZD]%FUK_N5\_,WZT58]H',3'XO
M3[)?L5]1V(GV57SMB^[MAZ]ZZJE10E-06I0]'QGRAPQZ::]+ZRT_PUR6W&VX
MS>LV\S])CHHW3WK0,P                      !"4@4H
M           3@(8\0IE&(        :;4:Z%&$S99-(E+XKIRUKC6$)KIUP-6
MK$\,3.V6G1IQ4?JN6L?PL<OH37W:R4?\/RL3WCU!I'K9RE<_2V?&AZO[1?W>
M^*_(7?$N=T3A>'WM[@AA]Q=U?:-@_9GP[]'\O\C9\6'^?3G\/$>9_*-3X\O[
MIV.4          .-G/B=K)TO"#</ZKXS;;,\+"YK\BY9?-_4T>2CXC*_NU86
M]^CD8:&X
M                                           '&COA?S:^<7\2=_\
M^BLR='*Q7F=+Y2WXSFYOZ+J_ N['R2]YRXOXZ>OB[B3Q;[SI]B>'>=R]D_\
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MRHZ1JWS?%64THY>&AB
M
M
M   #';IC#:ICJBHEI*5BM-K(BD8X3          -EN=<N'K;_'5^1F,YQ*QE
M+;SD55'>6:<,4_)2=%V-C7;G,.5AI9@
M
M     "3DZO7O8E'O&[I:^ALVWUPM7S\SOK0S3U_YFOXO3[)?L7]1W]U.I\.[
MMAZ^6XV:-KZ5>2&@^4+J?.)Z*OJ_1F?3W=;"WZC[3;S'TGR.F^*7Q$*1D
M                                               0DY 8*&<9(I0
M     !A5ZU*2GH<3993&I=7T<T9U1G'&7F\QKUJ<%M,JN;1_"8OU?+5/\+'+
MWHWUDH_X?E3W?U!G_P!6<K$Y^EL^-#UGVB_N^\5Z/07?$N=T7AC^#FX/WEW5
M]HV#]F?#_P!'\O\ (V?%A_GTY_\ 2/,_+ZGQY?W3L<H          <;.>_YG
MD^I_V1MM[K"YY'(O\PS7U-/]B9W]UC;WW(LYVT
M
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MG#(PF'JO][1W=USM[O.\MZ46O;7>",GGMY46J;7M;GLUELQ5750E:NUN#AA
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M\/X#Y[X:&;M'O,;^[+:3N^_KA=5?]B9ZV2V?8<OCF4
M
M
M                          -"Y175LJF:48J2^412)KF75NC":/&IR=I7
ME4[E3:GL1>/Q&<ZDS%(PEA&C3SY>7<V%1LU/96C'1T]1KFD0V6SP8P65130E
M0]JF<'K$71=C&1-TW36<VJ5        #9?G9_!Q:/2J^MJ)M@GNRVXY$16\<
MS%Q<YPA]+H.B[N,+>]+E>:&8
M                                                           D
MY.K_ .]AJ3[Q>Z5A]@M*/59OGYF?6B_>!S/R=GQ9?L-]1Z*>RR^?Z]W;#UZN
ME^RBO1<%/'0SY1BZ/G$1O?7$?A9ZV-'J,W<W])MZFV?PDH1D
M                                                 !BTG52WH?2;
M-.9K@QOIP37)G<QI[?,:M6,/+#1H3B_5\M(_A7Y?S_ZZR<>G]797P'N_J#3_
M '9RGRMGQH>M>T3]WWBOR%WQ+G=!X7:^]WA^4_N)NN<</U!ES]G/#OT;H='H
M;/BP_P ^'/4_.?,]/I]3X\OT!U-           <;>??ZVR/Y+^S-T=QK_I2U
M.15<;&94,:*=.I4=!;^ZEL>=5R.-#:
M
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MM2JXZ\NJOIG#5A49\U9=-D6PD3PR\JEQI3-NG%+(C<C(S
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MSGC_  'SWPT,W:/>8W]V6TG=]C\Y2:A#;T_4FS6B>'<:<UAR^.5D
M
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MRO-#,
M                                        2<G5\]["H]XO=,-%FW'\
MYOGYF?6B_>!S/3Z/3^++]A_J/Q,^RN_X=WQH>OFIIV:5K2[(+Y#Y0B.'F:ST
MOK:RZ+M>=TL*'&A_#0;^:\[F8F.ANNBE_6A&0         "M!"5@4H
M                                           Q<=JF49ZX&RRF,U8W
M_@Y:EU>E3*'1&)JU9\WRM&A&,OU/+2'X5^7T?W:R4,?^7Y4]W]0:_P"[.4IE
MZ6SXT/6?:+^[[Q7I]!=\2YW0^%XKAS<"A+[B[KG'_P"ARY^S?AWZ.Y?I]#9\
M6'^?/G_TGS.&'I]3X\O[YUN8          .-O/IJJSD:,'Z3^N^,W6XVT83%
M)F6KR*2=C-N$Z::5C]0BWY48V]YR--#:
M
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M<;8
M                                     &G6HNG\E+7+7T#SLXR*6SF\
M"[F:G76K=4K-N[<KJAAL4MPAV&5.'&[)HXYOOX;-CU <Y_>[\ON3?,_B+EIO
M+A:[G,WP[F5ELQFJ*JX5W(UIRIS"4E3JTG]2\ ]F'B?K!X1I>+<M7@UHF8QB
M,O(^3_7_ .MGZF>SWULYOU3\6F9YSD[XMOI;,XS%:83T3'NMMJO?@<L*:H?>
M;F'J]*N.$_\ C)YJ?8KXWEC7KC^Z],M^O9[-IQK=P_ G^\G^W Y8?^#LQ_55
M_P",C]BOC6_W8_NK_'5[-ONKOO+O[RKWX'*_3P=F?ZJO_&2?L5\:V5]V/[I_
M'5[-ONKOO+O[R/WX'*__ ,'9A_DJ_P#&1'L6\;VU]V/M$?7J]FWW5WWEW]Y?
M]N!RPE_W/S/2]JO_ !DG[%O&]]>N/M)_'5[-ONKOO)_O'^W Y7Z>#\SX:_\
M&2_L6\<VQ/NQ]HCZ]7LVZ;OO)_O'^V_Y7_\ @_,^&O\ QDG[%O'.B?=C[1_'
M5[-_NKOO)_O'^W Y7_\ @_,^&O\ QDO[%O'.B?=C[1_'5[-ONKOO)_O'^W Y
M7K_]3\SX;G^,D_8MXYT3[L?:/XZ?9O\ =7?>3_>%[[_E?_X.S"?77_C)?V+>
M-[_=C^ZO\=?LW^ZN^\N_O,5[\'E>\.#<QV55_P",%_8KXUMB?=C^Z3]>GV;[
M;KOO+O[R_P"W Y8?^#LQ_55_XR/V*^,[_=C^Z?QU>S;[J[[R[^\O^W Y7_\
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M?]B;[NXUVS6Z7*\T,P
M                                                    !)R=7WWL
M#7\HO=*2QLVX_G5\_,SZT43^T'F/D]/LE^P_U'OW5WU^[N[8>O=MNU3'Z673
M)KR'RC?'^?ATP^L]*?\ /GK86_4?;Y#;K_2/(ZM3OP!0        !#&X#%5-
MB                                                 -.I-UT):S=
MIS$1,RE_X.6O=@H*$]<3GU<J[*M&AG+]1RT4>:W+[]^<E#_#LJ>\>H,S'K;R
MG1Z6SXT/6?:+^[[Q6?\ @7?$N=T3A;^#>X/WEW5]HV#]FO#OT=R_R-GQ8?Y\
M_$/TES/Y1J?'E_>.QR@         !QLY[^ID^I_V1ML[K"YK\BOS#-Z8*GL]
M3PF5^3&WON1AH;0
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M7[6MGRE?W+GT;9E;U?8>?;]5=OE-'+]SRMM^:T>JNWRLZ+LV$9,B*
M <:>>S]#*_5V_+491G!;TMS>5W\&<K]11]92;=7NPQCO-R30R         '\
MO-VK]>9L5TU[%NB,</2>,(&?';&E-E*W2Y[M/5OUK9M[D9ORW'>_<]POP?Q1
MQ-E+:OYK<6Z,_O2G+22NTY#*7<U51&4ZZ;3.&SF-+0OF_6GS(F,'D9LNU+8T
MM/O3&#@UW&O>%<J^^3DN)=TY',9/<7,?A/>N?W;OGAG,YJS;S%7S/,U96FYE
MU=S5=R\ZZDI4TZ3RE^C?JZ<<QHQ/S;=C1X^W4CE[YT+IIS$YQ.%:/8?E?:5[
M=%?V*I.#MPC@]?8<MUMEFIA-;NET>DMU+8F(I=M>5<N[%5"U2J6UA'".N1KU
M-;AOC3B*S=M(MF8K6E-CQ<RW3517L575)551?HMN"2HTXF=UN,59Z46W85IO
M;4\Y.>'+'N_\#[UXXYJ\3[MX:X?W78KO5O,YFQ\[S&S9NW5:R^4JN4WKU5SV
M;I4%".,#FYF^RDZ>I/GSE3-MT=._6NC@CKG91UM<A[V[C_O7=]CEURRY8UW.
M"^3.6WW=RKO4U>TJXFHM9RW85^NFG-5>S]I152X;,%$\KX9X9KSHW:O,5C3V
M1T0\;XIS.IR>O9H<G.%?.GI=I[)4.Y18=U[:IR64=.A.IVDZZNUG-J</!2<F
M<6\>I,W;G]%TVX514G#:C'1)&K1X:?Y;=,=+-)))+!8&R<<9%
M       #$#"FW31%4J$7%S8W&4UVLDDFVL7"/9@!0)LJ$(2^#+6:UVI2*4$D
ME!8$S4:52@YI@4 !-E0:A)XX@G'-A[*B2V<.E^6,24*LW2FTVIJ,.V3% V5"
M$)/KT%)QS14TIQ2F^EC,C#!D     &S?/'^ ^>ZUY&;M#OI=W9;3]WUOYU4M
M&S7_ &)MU\F&GDY>'(V
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M^S/Y+^Q.B[NL8[TN61H9
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M?'YGDH2<'%XQ];0;K9\UA<U^1<LOFX?2T?V!;^[5C;WW(PT-H
M
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M9>9MB:1=.UG<IJJHV4HQ^0<O$VVS)=BU:5"E+4;IFLU(R9$
M                           ;-\\I<#YY]*\C^(W:'?8W=V6TW=\GFZGH
MV:_[$V:^3'3F)AR].5L
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MS^#U'U5?UK).,Q$,HREMUR(A]T<U/0_[$Z+OP;39WI<KC0V
M
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MW6NWON1ASMP
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M<,UIL(O2X=@*0D8KI\HPA8B=C*.,L"3@G#C1C%QGH+0I%,%G/7*1.Q.PVG#
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MY[ZJGZVLW\O^$8W]R6T_=]_7/9<\E!EK9,-+NN7IS-H
M
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M%CL8VG^K]U-S?W5W=]N6C3SOT2^8^YGL>9\"_2FC'_$M[8=[3NLSY"\MG_\
MLWN[[5LGYX>M/Z?YGY6[ME_I<]F?ZB>&?D>E\2UR!/7WO8          ;+<Z
M_P"#U'U5?UK$=Y8REMSR)_;',]3\QON[C59WI<KS0V
M
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MQMY[_F.6ZO-6;+>Z,^13:LYE8)TTN&,]FWI,]2?-:[>]5R/-#8
M
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M4<0JZEA&/3 B;T@\=/P0F=BQ29IL2+[5@3RL^'=[ZZM2\Y8Q8SU4D[(0TQC
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M\$3YS>_+Q=&TTJ=J#23CZ+CLU=J-'8V1===,S=F\@QNMXE#++
M                               V:YY_P%SWU5/UM9OY?\(QO[DMI^[Y
M+,S>--<):U276QBNQ+(I%(<O3G9@
M
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M]@         !LMSK_@]1]57]:Q'>6,I;=\B%'>.:Z$_[$WW?@ZM5F<N5IH;
M
M                                  !)R=7SWL;_ /R,W1"?V&U'H^Q7
MY'YF?6ABOM YGX&GV2_8?ZCW[J[XG[N[MAZ]Y>RI@H/949QT?&?*-_X?ROK3
M2PUYC>QM^H^WR&WF,>8\CIO[\(2D*I0
M       "E1"4@4H 0E(%*                 !IU>O1%PF;M.M)HE_X*6K=
MII=2JA!X+%FC5F>&FRKGT(BLSM?JN6KAS7Y?+7OK)+_I^5/=_4&*^MG*3_Q;
M/C0]9]HL_P#M]XK\A=\2YW1>%Y<-[@_>7=7VC8/V:\._1W+_ "-GQ8?Y]/$/
MTES/Y1J?'E_=.QR@         !QKY[Q]EE5&36']6;;8K:QFZE7D<B?UOFX2
M2II_L#+4G"C7;WZN1AH;@
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MSU2<O*\Y$^=,;'EU.";QAH-/!Q78Y,YFD,C,
M                 V:YY_P%SWU5/UM9OY?\(QO[DMJ.[\H9A:95]&B@NKW?
M*FG-7+PYV8
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M9_U"<MOXM[N^U;)^=WK3^G^9^5N[9?Z6_9G^HOAGY)I?$M<@CU][V
M   &RW.O^#U'U5?UK$=Y8REMYR'_ &PS?55Y*3?=^#:[<Y<K#0S
M
M                          $G)U?/>Q+9[QFZ(Z;-M_\  WS\S?K08^T#
MF:?B]/LE^P_U'L?99=3[N[MAZ]_[52]=/F<#Y0O_  _EA]9Z59U[J]+&WZC[
M?(;=?Z1Y'5J=^ *
M                !IU>M3UF[2VI?^"EJW/H>WS&C6R\K1H9R_5<M%_]U^7L
MH_Y:R4XP_P"/Y70>[^H,_P#JSE/E;/C0]8]HO[OO%?D+OB7.Z)PNW][FX)17
MW%W7/_F-C0?LWX=^CN7^1L^+#_/GS]?SGS,4P]/J?'E_>.MS          !Q
MIY]*-O*1<()Z(X[1T63YK7=M>5R)_6^<^IH\ELQU&-O>AR,-+<
M
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MC_ ?/=:\C-VAWF-W=EM/W?:OU1!J;5>GZDSUHPJQTHPER\.9L
M
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M
M                                   $G)U?/>P?SB]T_P!ZM_H5\_,W
MZT4?^X',?)Z?9+]B/J/?NKO^'=VP]?#4+2;<8TK1#Z&)\GWS77\KZSTX_P ^
M>MA;]1]OD-VO](\CIU._ %           !#6H96HID
M                             TZG"NAK6;M.(F)B4OPTI:UQX+7\AHUL
MO*T:&<OU/+6+YL<O6E_UUDOM_*GO'J#,1ZU\K'_%L^-#UCVB_N^\5^0N^)<[
MHO"\^&]P?O+NK[1L'[,^'?H_E_D;/BP_SZ<_^D>9_*-3X\O[IV.4
M  .-O/?\PRW5^7-EO=&KR)_6V:ZJ?)0;-3)JC\(Y&G.V@
M
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M_=EM%W?%#,QU[?\ 8FS7R32RER_;<4DHIQBXX:I:8G)C5FI0
M
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M=GHQ+LHM*89K4Y)PUR)DD1BK@Y53^'03J(KG"0DNV"^4RB8B:R;2+746L5G
MI"0<<-I/!X0,96N'1*RA!>'Y"Q%4WI'%/L\XHI%/%S?0-F!U+&,DO'VDI2:I
M3;*QC.&'G)DF28*>G07-<YP&L)0\8!0AA/1/$$I*&'C"K"4?AJ%=B;:"G-SZ
M1.&1U)VF4>^JPDWX"5FJ;:$%"4V3'R&/D1MP<)X= 7;BLHSP+1.U8J,8#AP*
M31BU%03GU?&3%:].2R3A&6GS#-,Q8ZFO&))RW%C]L-U_OKNV/1^J[)KYR?\
MI;XG[F>QYCP3])Z'REOQH=[3NM?ZA>6_\7-W?:ED_.WUI_3W,_*W=LO]+OLS
MK_L3PNO^CTOB6N0)Z^]Z          #9;G7_  >H^JK^M8CO+&4MN^1#AO'-
M=*?]B;[OP=&JS.7*TT-@
M                                                      1M)I::
MHPZ88BIL=7WWL27\HS=-,8-V+7A]E?\ *?F;]:&?_<#F)_J6=DOV'^H]^ZN^
MOW=W;#U[0V+*VI>BO(]43Y1N\_F*1TOK+3PUIG>EN.S5**6+B;N9B(YFFYU7
M]^ Q4           $,>$"Q%!2@              !!6!16H
M                :=2G2]7F-NG-,&.I^#F&K4U4D],Y>#2:=:*1$[VG0SE^
MKY9_ZUN7_P"_627_ $[*GN_J'AZW<I\K9\:'K'M$G_V]\5G_ (%WQ+G=#X6_
M@WN#]Y=U?:-@_9KP[]'<O\C9\6'^?3GXIXES/Y1J?'E_>.QR@         !Q
MNY\*%C*/6GXMLVQ'F51J<BH_-\TDHJ%/I8:*)0Q,]3)KCO[W(TYVT
M
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M,F1%        .,_/?U<K]71Y:BV=XC*6Y_*[^#.5^HH^LI-VKW88QWFY)H9
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M8OTXK=5LTOPN.5'FTN*3<F=.C=-VE;=.=$G"5-J
M                   V;YX_P'SW9Y&;M'O,;^[+:?N^)4YB$8N%<)?4F>MC
M%6.EE+EX<S8
M                                            ,7ZU'Y+R%C*4G.&E
M?]5=?Q$GNR3G'6QS7ZTS'['O?H=1-/*&.I^#N^#/8Z0/?P27>LYFZ_NM7/\
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M?DI-]WX-JMSERM-#8
M                                                   $:3:>FF,.
MB.(H;'5\][&H]XW=-48?8+7Z#F#\S?K033V@<S']33[)?L/]1W'V67S_ %[N
MV'KWJ<;%+VHR4X0A)Z#Y2I_U66U]9Z>&M/66_4J^$3;S7TKR.B_OPABR
M                          $,)S4+:BF0
M    PKT=OD,[,V-_<EDX04IZ_ 8:_=CK:>7SE^NY9_ZU^7_[]9+[?RI[MZA_
MK=RGRMGQK7J_M$_=WXK\A=\2YW0N%_X-[@_>7=7VC8/V:\._1W+_ "-GQ8?Y
M]?$/TES/Y1J?'E_>.QR@         !QOY\_K;)]57]F;X_!IM9<ATUELW%Q]
M&GHT6Q?&#7'?<CC0V@
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M=;JKFWC3J[>LY^5O^<\M$:N,U;9MF-2EKS5""A@=41$12,H83GBI0
M                                &S7/.7 N>?33];5\1OT.^QO[DMIN
M[]^N?ZO^Q,M;NL=')R^.9L
M                                                       &+]:C
M\EY"QE*3G#2O^JNOXB3W9)SCK8YK]:9C]CWOT.HFGE#'4_!W?!GL=('OX/\
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M:C^ 7EO'_P .;N^U+)^=OK3^GN9^5N[9?Z7/9E^HGA?Y'I?$M<@3U][V
M      &R_.O^#E+U.OZUDVP3-+9;<<AW5]T<U%;,G**<94F^Z9X*;&NWO31R
MO-+8
M                                       ).3J]>]BVEWC-U3_M%N"@
MI?8<P?F=]:&G[0.8^!I]DOV*^H[$?LIU)_KW=L/7S%NS1&<:5T0]%GRA=YO,
M5CI?6&E,SKSUI;?V.OI-G,UGFHG<ZK^_"!0
M    !!2!12@        03D!A65#.,D4                 TZO7H6AXOX:S
M;IQA,[4O_!RUKGHJE4N*CAAY33JXQCTM'+YR_5\M/]:_+_\ ?K)_;V5/=O4+
M'UMY2OXVSXT/6/:)'_M[XK'_  +OB7.Z%PM_!O<'[R[J^T;!^S?AWZ.Y?Y&S
MXL/\^?/X^(\S^4:GQY?WCL<P          <;>?#?L<HM$'_9F^S&S%C=-,FI
MR)2=C-MXJFF#[*$-3*C"V?.AR.-#:
M
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MW\O^$8W]R6TW=]_7*_)^2@RUNZQT<G+XYFP
M
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M<N5BZ5 T-B@
M                                             ).3J]>]AIAWC=UM
MJ,;%N"C#^TY@_,[ZT4_^O^8^!9V2_8KZCLQ^RK4^'=VP]?":]BJ7*%*BL=$I
MGRA?%>8XHSJ^L=*)C7GK2VH4/M\AMYC#F8KT.BZG'$1L",@
M                           ()R PI*AG&2*          !78      :=
M3A71**C.<#=IUI-,TO\ P<M:ZU!0IG'6:-6,,9VN?0[VY^JY:M+FOR_GCOG)
M?;V5/=_4&)GUMY3Y6SXT/6?:)-/9[XK7\1=\2YW0N%H_>WP_*7W%W7/_ )AE
MS]F_#OT=R_R-GQ8?Y\N>K^<N9Z/G&I\>7]\ZW.          '&SGO^9Y3J?]
MD;K)\V6%^37Y$RR^;C]+1_8%U,J[&%O>AR,-#<
M
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MVO#Y!38JQC@B48T34TIOS%[%[",%C'LQ)2=I2JZG'7H!3"4PD]./8)G:8S.
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M/;9V,OM*>W;V<==4<!;6+J["/>;G\KVGPODTL533'^HH+*0W'(H
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M7AUO*QY\UFM<<:/?[EW<J555=*47Z+EAHIAJ1Z_,UB(VO)1$<4W1D\DC(
M                                      !LUSS_ ("Y[ZJGZVLW\O\
MA&-_<EM-W?5^J4M2K\E!EK=VC'2G!R^.9L
M
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M7_!Q==7UM1)S@GNRVXY$_MCF>I^8Z+NXUV=Z7*\T-@
M
M                 DY.K[[V)?\ Y%[H_O%O]!S!^9GUHOW@<S\G9\67[#_4
M>BOLKOG^O=\:'KT?YFM$O,SY2_\ 'CK?7-GX:>ME1ZC^&A&SFOI,,I_",0S
M                                                      AK4,K4
M4R "$G(#!6G5ZU'6=.CE+'4_!2UKGT/;YC3K9>5HT,Y?JN6O^MCE]K^[>2@M
M?ZORI[QZ@5_W7RG1Z6SXT/6/:+^[[Q7Y"[XESNB\,?P<W!^\NZOM&P?LSX?^
MC^7^1L^+#_/IS_Z1YGY?4^/+^Z=CE          #C9SW_,\GU/\ LC;;W6%S
MR.1?YAFOJ:?[$SO[K&WON19SMH
M
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M/ XK)OK,SM;;HMC"'FG;%:8YM84
M        V:YY_P !<]]53];6;M#"]+^Y+:CN^0^<1UJN"ZU0;->*6L-+)R\.
M5L
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MY;]/#F[OM6R?G;ZT_I_F8_XMW;+_ $N>S/\ 43PS\CTOB6N01Z^][
M   #9?G6_P#N[2M=5?UK)2LK2L2VXY$_MCF>I^8Z+NXU6=Z7*\T-@
M
M                            DY.KY[V!_P#Y&;J_O5O]"OGYF?6BBOM!
MYCY/3[)?L1]1^?\ VJOCION^-#U[U)^S3<DZ5#3]"?*?_P"1$1TOK32F?33&
M]*'Z#^&@V<U'_4PWW87]:$9      0DS0!$U%*
M                       !#'A L104H !.(ACPC3KE52;]+#!+_P '+5J>
MU!X0-6M%+8GIESZ$^=1^KY:TQYK<OI_]=9+[?RI[OZ@S3ULY2/\ BV?&AZS[
M1?W?>*_(7?$N=T/A=K[W.'U@_N)NK[0RY^S7AT3^;N7G9Z&SXL/\^?/S'YRY
MF(S^<:GQY?WSK<P          <;N>]/V+)..*J_LC=;'F58S%6KR*<<OF^BF
MG^P+?/FL+>^Y&&AM
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MK_8&5^UK9\IW]RY]&V96]7V'GV_57;Y31R_<\K;?FM'JKM\K.B[-A&3(B@
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MVX7Q,UCII-'.S*55U4-5TJG9@E*$3P]UL<<S1Y:MM,)Q>7%%,\@
M                                &S7//^ N>^JI^MK-VAA>E_<EM+W>
MZ7\YCC*IOHE2;->,*L-+*7+\Y6P
M
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MYU_P>H^JK^M8CO+&4MN>1/[8YGJ?F-]W<:K.]+E>:&P
M
M                  2<G5\][!#^47NJ./L;</SJ_$_,SZT5?V@\Q\GI]DOV
M'^H_^ZN[X=W;#U\/T;:=3QI4^S4CY3SYF(CI?6>GAK3UL:/4JZ3;S41/-1.Y
MTW]^$,60     $,)S4$9BF:
M               !IU*-=*-EDTQ+OP<LVFHI]!KU\;(ZW-HX7OUG+6'X5^7T
M<?NUDH8_\NRI[MZ@U_W9RE,O2V?&AZU[1/W?>*_(7?$N=T+A=PX<X?36.Y-U
MSZLA8/V;\.I^;N7^1L^+#_/ES\S^<^9B?Q^I\>7Z ZW,          ''#GQ^
M89+JJ\M1T6_@TG)ER*<+&;I>+IIE_4=AC=W6N.\Y&FEM
M
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M,:CC7SV@Z,M*>U1!ZIU:-)G&="V:3Y6Y7*S^#&5^IH^LI+>3FW+,
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MK:S?R_X1C?W);3]W[]<+JK\E)=7N>4L<O3G9
M
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M[<+G*LT-@
M                                            DY.KY[V)1[QNZ'JL
M6OT','YF_6AFGK_S/P+.Q^Q'U'OW57_#N[;7KXJI:LITS>RO(]9\HS2>9I/2
M^L].*:T]-6%"A2X])LYGZ0Z+YK?"&MF&<9(I0
M                     0QN Q539&*            Q:;=,'#'R&RS-AJ16
MR1I/$PU\(B(Z6C0[[]=RS_UK<OOWZR7V_E3W3U"_6WE/E;/C0]:]HW[O?%?D
M+OB7.Z'PO_!O<'[R[J^T;!^S?AWZ.Y?Y&SXL/\^GB'Z2YG\HU/CR_O'8Y0
M        XU\]_4RG4_[(W6]QJF9XI:_(R/LLU#U=FG5JH[2WUX"VG%O<C30V
M@
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MH>:N0J:J2IIJ4'LPA"A+0C^:Z.M=J<K-]W3<]RNMMB^,,:9NG![_ "A5WD>
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MP%SWU5/UM9OY?\(QO[DMI^[]#YRIQE7Y*"ZM>''I33FL.7ISLP
M
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M!F.\WL5I>HJ[F48*>)C+&E9PR8V4_G^ZGI^ZN[I?\\M/$U\WARM\?U9['F?
M_P!*:,?\2WMAWM.ZS_J%Y;_Q<W=]JV3\[_6K]/\ ,_*W=LO]+GLS_43PO\CT
MOB6N01Z^][          #9CG7'[W*9P]*J,HQ]&H5I,&QMSR(5/W0S2IIA!-
MX_4Q-]W<JPM[TN5IH9@
M                                                     "3DZOGO
M8'#O&[I3TV;<^NU?/S-^M#C[0.9G_AZ?9+]B/J/?NJO^'=VP]>T(VE3'%*?8
M]!\I3/\ U-=[ZRTY_P V>LI4*6NLV<S'_44=-TUOAB8<+)3*,
M                                   (28J!.$4R            8N+J
MI2<'/1'$V6S$16F27Q6R6==#HAI3TREXV:M:Z+HCIJY]&/.P?K.6?^M?E]^_
M62^W\J>[>H7ZV\I\K9\:'K/M&_=[XK\A=\2YW0N%_P"#>X/WEW5]HV#]F_#O
MT=R_R-GQ8?Y]/$/TES/Y1J?'E_>.QR@         !QMY\4.FUDZWA4G#LVC=
M;W,,VNZ*3,SDU>13^P9O945LTQ<?J-#F+^[O2VDW5<C32V@
M
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M/^ N>^JI^MK-_+_A&-_<EM-W?OUROR?DH,M;NL='NN7QS-@
M
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M-#,
M                                      2<G5[][#_.+W5#^Y6_T*^?
MF=]:']X/,?)Z?9+]B/J/?NJO^'=VP]>Z_,E]2O(?*&I^'\KZRTL=:>M+?J/M
M\ALU_I'D=6IWX H
M                &FZ=JY0HP@YR-UE8ME+XB=.6K>BZ53&4?(:-3S9XM[GT
M(SA^IY:IOFOR]AHWUDOM_*GO'J#,1ZV<K$_C;/C0]9]HO[OO%>CT%WQ+G=%X
M7C][>X(_N+NK[1L'[,^'?H[E_D;/BP_SZ<_7\X\S7_4:GQY?WCL<H
M   <:^?#?L\DHRA5_9&[3[LPQN[K5Y$U0LYJF&--,^K8+J9586QC$N1YH;0
M
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MF
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M_P"#M"UU5_6L1C<M*Q+;KD0VMXYKJ?\ 8F^[N-5G>ERN-#8
M
M                      ).3J^^]B]'O%[H6"=FTWU>ROGYF?6BQ]H',? T
M^R7[%?4<B)]E6I7[N[MAZ]\;:>NE0\!\I71_U%-[ZQT\=>[K86X;#@XK7@;.
M8PYFCHNFM\2!D                            A)F@&-953-
M          03D!A65#.,D4       #2K]:DVZ<I?^#EJN:3;B]4,#5K]V.MS
MZ'>?K.6C7X5^7VB.^LE]OY4]V]08G_=G*?*V?&AZS[1?W>^*Q_P+OB7.Z%PN
MU][G#ZC/[B[K\61L'[-^'1_Y=R\_\&SXL/\ /GS\_P#F?,QM^<:GQY?WSK<P
M          <:^?'YGE.A.']<;K.ZPNG"6MR(_6V<^II_^6+\FNS.'(XTMX
M
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M1ROU='EJ+;F1E,MS^5T?O8RD:8+8I@XQCZ%&C097S7:D4K@W(,%
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M_8F>M'FIIY>1R^.9D
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ML2:<7@,R9J-> 1)$^ZR<6G+QD3")8J"<8RTE64M?K[=7[Z[N^V[)JYWZ)?\
M!GL>8\"_2NC\I;\:'>T[K/\ J$Y;?Q;W=]JV3\[O6G]/\S\K=VR_TN>S/]1?
M#/R32^):Y!'K[WL          -EN=?\ !ZCKK^M8CO+&4MN^0S;WAFXJ$JM,
M=%.HWW?@VNW.7*TT,P
M                                                    !)R=7SWL
M357>-W.E.%BTG^<WXGYF?6AB?V@<S\#3[)?L3]1R8M]E>I7[N[MAZ^*MFFU2
ME+T4GC]+\9\HW5NU_*^LM.D:UT[VG;3V7.1MYB8CF(B<Z.F^G'"A0
M                    $),5 QI*J9H                  ""<@,*2H9QD
MB@       :5:;JI2Q9LLI&>1?^#EJ--13Q->OC9'6YM'OOUO+1K\*_+Z.G?6
M2^W\J>[>H,?^K.4GHU;/C0]9]HO[O?%8C/T%WQ+G=#X6A][>X(?N+NK[1L'[
M->'?H[E_D;/BP_SZ<_3\Y<S3_4:GQY?WCL<H          <:^?$K65;U/^R-
MUG=IM:[XPEK<B%#+9SZFC_Y8OR869PY'&EO
M
M         #"M-PAHCYC*V8C-)AQK[X/\VOG%_$G?_P#HK,F_E?I6E\.WXS1S
M7T75^!=V/DE;S:^_#CM:7Q=Q)#_/>>/L7P^?^FL^3M[(?,WC$_Y%D?U[^V6%
M,7U_BG;.$8O5M6*V4@Z='P0RAG&,1;.9!06AOMP+5,<]B04,<,9%Q*R--SAX
MT*P81"IQQ<Q*3[Q]##X8DKMV+2>)=4)8](WDQ2<6*CHE'!%ZSK5P;4!D8Q!'
M0W!^$E.@IM%"$"STI-:U6"6@F9CDDDYN?4.HZB277\9=JXU.R,>G& !Z%"77
MB-Z;]JPDHZ(^,E5J.,5*:Q76"E,))14]>@)DQUZ%+L*O:R<888]4H$P,(1J:
MECH^4IL'*4):!GUD8]8EZ70OB&PK@*"<L-/F':=>9.,816C1UD04%CB6<5G$
MC#I\0I5*52'8_#$56JS75V#"3">M<4VL2;:%*9Y)&>,-4A3:N44HLVF^J& P
M2D$=<M0IT)3H2+G!R4"T6B]!CAD5FO$BQACTEF(A9K,3*K1VDZ\TG;3NHXZ7
M#L+'OF%?-)Q3:@D$,9K$N2Y=1*$Y->=DF*RL3,3@/P/5\HI'D.*?(-2<H?BC
M:D8RN$7CXA)2LT1M8C<4FFY5 E:DVSG*:(QQZ!,3."Q,1LQ112;,I3"953GC
MYOCB383T"DHPFNDN9F0C&&$A7W3M'X'J)LQR6VM<!I:X$PVK''7>C\F+,H3&
MN.;.CUJ(]/D+;C+&[*7.'W8</]H#R*_?NB'^';O\YZ?Z\X>KW,]4/>?5ZGSK
MD^'*OV7U6MV?M;NO]@97[6MGRC?W+GT;9E;U?8>?;]5=OE-'+]SRMM^:T>JN
MWRLZ+LV$9,B*        <9^>_JY7ZNCRU%M(REN=RMV?O9RL&V]BB*G!>A1@
M975I%3&N+<HP                !M)SW]I^"'F%59NU6+M/"N^ZZ+UNIT5T
M5T;NS+IJ55+52::UGC/&+^#P[5NZ+9>1\)BOB&G$8^<Z*G<7XFX_O^\$X?6?
MXTW_ )_=U7&^^Z+V[LQO?>5S+.BC?U*HI]C=S55II4J2@>P^S71OYSU8U^8N
MBLQ6D]#P/M"UOFWK+HZ,32)I6,G?RR]Y+*Y1J=7S/+51>G:M4GB.9F+=:*],
MO(:5LSI\4Y3#65Q._%2UXZI:#KU+::/%#GMNF=7AAYQA;-8JVA0
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MY@'(R
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M);<\A55\_P UMXI53EJIAA(W7=S<U6YS1RO-+8
M
M             ).3J^>]A:?>,W2M*LV_T&^?F9]:*)_:!S'P-/LE^P_U'OW5
MW_#N[8>O>K9]E3LX[*CCC">/2?*4U^<8]+ZUTJ>FGK8V_5?;Y#;S$UYG'H=%
M_?@(H                "=XAK4,XR12@
M             &G5Z]!LLWETTTYEJU[+BXQC"4^@U:M8LMZW/HTXZ[7ZOEHW
M^%?E]+_KK):</U?E3W;U"I_NOE/E;/C0]8]HO[O?%?D+OB7.Z'PO_!O<'[R[
MJ^T;!^S7AOZ-Y?Y&SXL/\^OB'Z2YG\HU/CR_O':Y           XU\^&_992
M"C)Z8?3&[3[NYA?DU^1/ZWSGU-'_ ,LNHPM[T.1IH;@
M
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MCDQM\V*.8!Q,@
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M<Y<KC0V
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MG-]D4MWRPOR:W(AQRV;?XVC_ .62]A;A=#D::6X
M
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M^UK9\I7]RY]'696]7V'GV_57;Y31R_<\K;?FM'JKM\K.B[-A&3(B@
M'&CGNO0RW17;\M1E&:1E/6W/Y751X8RE,/5HIGKC10+HIB1FW(,5
M        &TG/=I<H.8<7#_NIOS_1N9.'Q*)GDKZ9T=OA_P!+LZW1![B[57O!
M-PPFOOYWU#0OV_ITO$\Q[+)C3LYJ+\^&>QXWVEVQ/S>)^ZCM?0,R:CN_)K#]
M29;Q6J#EYC&Z^G3++3QT[>J'E4+94#EY:V;8FK;+,ZF(
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M<?2\M!MOF)MF8VL8F9C')R_.=0
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MXT-@
M                                       DY.K[[V*7>,W.GB[-J'YS
M?/S,^M%^\#F?@:?9+]A_J/?NKO\ AW=L/7O5^9Q4_145JEXSY2__ "8C>^M-
M*DZ\L*/5?:;N:^D^1T7]^ Q9                           0UJ&5J*9
M         AA.:@C,4S0                  &G4FZZ$L8F[3F(B92^OHY:U
MQ-4IPVG'&*1HU9B9IE%6C0SE^HY;?ZV.7O[]9+[?RI[QZ@?K7RORMGQH>L>T
M7]WWBOR%WQ+G=&X7<>'-P?O+NK[1L'[->'_H_E_D+/BP_P ^G/\ Z1YG\HU/
MCR_NG6Y0          XV\^_UMD^WRUF^WNPPOR:G(C];9OZFC^P)?DQCOPY'
M&EM
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MR\45X=K(,@
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ML          -EN=G\'J/JJ_K62=C*,I;=\B&EO#-=3\E)T7?@VFW.7*TT-@
M
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M[:
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MA&3(B@       '&CGNO0ROU=ORU&4$;8WMSN5O\ !G+?4T?64ENV#<DP
M   &-:;I:2BWH[9^('6_ \S-Q[PX@Y?<9</[HHIJWCO?A[>^0R%%;6S7F,WN
M^_8M4MM-).[<6)IBRZ8NB<Y;]"^RS5MNO[L.E)OCW*G?TS?%/%6\K?!6Y;F6
MWCO_ 'OGLI=>]]W*J[E\WO',YBS4T\M)NU<6.!V>'7VZ&E=9K1C+'Q?AYG6M
MOY:?-C/!X;]R=W^7)\%;D_SQN[_%3N^<Z#Q?S?6Z4_V)G?W<WP7N3_/&[O\
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MIJ@NE;/G/&Z],HEE;+EHJ:]O:V_1AZL%Y3AMLF+N*6R9BE&H;4
M
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MZCZJOZUDG&8B&492V[Y$-+>&:ZGY*3HN_!T:;<Y<K30V
M
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MKM[]=CD<<[:
M                                              #C1WP?YM?.+^).
M_P#_ $5F3IY7Z5I?#M^,YN;^BZOP+NQ\DK>?\,.._P"-_$?^F\Z?8OA_T:SY
M.WLA\S>,_@=/X=_;*4RAT8G7=-8>LWVW6V\4QYK&,IXF4Y;DF*]T2ETO M:X
MLYPPG(<<</&2GNI$_P!&N"N2PBBPQVL80TSU%F8VY,HB9ZE<X:,2)&!HV=/P
M9=YMKL-*:G&(ZS9B+1''1YR2D[ASAJUB,,%C#K5KHCVB$B1I8_&(J5Z"+DTM
M8,$3P7668)C:33<,!LQ79B.<93\GQQ$8%2,(0PF3KS*5SS%C'%^ H2CTZOE'
M8=A&"DNOH)F3&.*P3;TBO036$32F\?AV8#L,=F2J+<=8W$^^:<)KSA$FU-RZ
MBKA$X9I#QX><3CFM9A>A?B$QC%(C;)!1273Y!L,9@<>UX]A8(&NUO 1/N'8.
M+Z&B8)@O2NWX,;I.M(N$Y/7B.HIT#P;QU/RE7:32?8,S"98X]"*O:R34,,.G
M61*+&2C@X^(A24<)+XY%Q,5P:TZM!-F!%)W0QQ?2*S&QE2(VKUJ+ZPQPV9)H
M<%*785:*U!QT#/!*UP&E!P[?,((WB<<?AX!U$QT";TZ,63J2G01C"&.H46E,
M\AK2YZ]!8DB=C*&,? 1.UC'TO)X!L-@E%:EI>,1&'6RF:R:X]O1J&*338):R
MS),FB&GX,;:[#;78M$573T1\@BE8E+N[,PYQ>["?_P"\!Y$K2]^4=GZNW>CT
M[UZ_5[F9W0]Y]7:SS7)S/W7V7U6MV?M;NO\ 8&5^UK9\IW]RY]&V96]7V'GV
M_57;Y31R_<\K;?FM'JKM\K.B[-A&3(B@       '&CGOZN5E]'1Y:C*,RW;U
MMS>5K_[LY;ZFCZRDMVPVTVMRC        1I-0> R$C5M0V?1^FBM6K'$F-1D
M4        (FFVEBH1[<"5V"E                       !^5XW_@EQ#*/^
M2L]]K7"Z?X3RI.3Y\??[@^\CQRU^Z.8^V,X>:C\'@U4\VKLS>X6GW:<\]/SJ
MU+\A8TGCN8-/9&[[+WP'*W-&JY2G6L*ELSU_B(1.-)R)C##-Z+_?H\G=\<SN
M17#V\MUY.YF+/#-_/9G.W+=NJOV=IV+U=+J=-NN"33U'1RGTFVN37JQQ:<QT
MNJ%W?>-KO+SF]P5O/+74[-CB#=^7SERII*S39WCE;5S:;JIALJAXL\MS,=$U
M:[*6VQ;,8/HF\I.*=V<9\M^#>(-TYRQG<IG>'MTU*]E[MN[1[2G(6%<H;MUU
MJFJFN,HQ/":D3%\\6;=;,4P;C&#)U8/Z1)Q+N??&5Y8\/;KSUG,[XW*\T]XY
M6U<MUW,LKKSCIVZ:*ZJDX:TH'DN4Y>:1J7X6SDT:E+XFFQZJ?=I<+;SXP[P_
M"5K<ENYF[F1WANZO.TVZ:VZ%1F,C5Z6S35""UG1J1$3-NR&B-/SIFE9=^;(4
M.WD-WV;BA51D\O;J4_6MV+:J78T>%F:78.Z(\VCSP   !LYSQ_@/GNM>&#@;
MM'O)=W9;3]WYU?.4GJKU8>B9:M*8);O<NSG9
M
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M[NXU6=Z7*\T-@
M                                                DY.KY[V+^<9N
MG^\6?T','YF?6A_>!S'P+/BR_8?ZD'[J;_AW=MKU[PA:B\-E>0^4)NCT\1MJ
M^N+?PTQO8VX[#BH&[FIKS,=39=3TF &0
M                                 &+46EU^0SMFDL;^Y)5BH.*U^ QU
MNY'6TZ/>E^NY:J/-CE\]6^\E]OY4]U]09IZV<I'_ !;/C0]8]HO[O?%9_P"!
M=\2YW0^%ZE][FX%I>Y=U_:-@_9OP[]'<O/\ P;/BP_SY\_,?G+F8V^GU/CR_
MO'6Y@          XV<^)VLHNA_V1OT^Y+"_)GR(>S8S5*7K4TN/4J"7]UC9&
M,2Y(&EM
M                                          !QH[X/\VOG%_$G?_\
MHK,G3ROTK2^';\9S<W]%U?@3V/DE[S2^_'CMO1Q=Q'K_ ';SNH^Q.0QY:SY.
MWLA\S>-U]#I_#O[9::4.T[;HAZOK7S-G#L1-02Q6OQEFLUHRI2.)6_ \'U%C
MI@I3K)Z5&/3J*8;!-IP$])/2DTH,&$S56X./PP)-:8,K:4Q73%8/S#<PV8HM
M;Q99)Z-BJ:PD3(R8Z4WIB7<NY7"3^.8Q3'(V15:K"+GAH\Y$KT,7".,]+\A5
MAET8Z]!$WG1A'!8P F'Y'QQ*N?E-GI\0J5$YRP^&L4PQ-^U'..ER@2)P6:QC
ME"M/5,1.PP@;A'7(M&,1[A*$\7YNHG4=1)+I+GU+GU*DH-:=)))E'II79Y2[
MS>.:PF_, A@GT]OQ0%4KM6+E*;Z2%",-'5TC,S1Z(OQ?$7J7J-E12ZR;RLR0
M@M6O2$/''LP*>\DXO6,/(N'D9:9.3\R)L-B14(0[/E*F-:C23QAV1&:UJ/5B
MWB-^PCIV(Z8+$5(E6DM'C$)$S*2A*2TZ>H*LX+Z;1\,,"=B=A5HU""$EV/3U
M%[5[2#4QA*UB5]*&$]<B8,<"/3VPP+1:))..@;-YLWK+%:.L8ICE))=+7G&9
MC/4.,7#3U$PVK$Q2A!/##3YL2]9UHYN0RS(PS9*#703M3M9+UZ>WR%MS2<IH
MYP>[#C_M ^1$?W<M_;^[ST[UY_5[FNJ'OGJ]7YSRE<^+[3ZK6[/VMW7^P,K]
MK6SY3O[ESZ+LRMZOL//M^JNWRFCE^YY6V_-:/57;Y6=%V;",F1%        .
M-7/:E[&5JT;='EJ,[<RW.8;E<K/X,97ZBCZRDM^4)/>\C<LUJ       C2:@
M\!D"22@L!F*                                  #\GQHJGPAO_ &\?
MN5GHX?\ )[L,.@MF%U=Y.3Y\7?\ KBH[Q_'-5=2@]XYF"BHT_JG.=KB>;_\
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M0  ;-\\?X#Y[K7D9NT.^EW=EM+W?6UFZNE5+ZTRULF.G%8<OCG9@
M
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MZCKKG^19)K$X+&4MNN0SIJWAFFIR>O%*DZ+L+-[7;A,N5QH9@
M
M                       "3DZO7O87'O&[I7^X6_%:OGYF_6B_7_F/@:?Q
M9?L1]1_]U5WP[NV'K[7YE3*4%M>!GRA.',4WOK/3NF=:YA3ZK@Y:H?&;N9I/
M,NB["^*YRA&0  AA65#*)JBE                !!.0&%94,XR10
M                            -.M^E2M#?E-NG$35CJ?@YEJW5"%+PQA\
MIIU9PK'2TZ&V-C]5RT<.:_+Y:]]9+L_5^5/=_4&*^MG*3_Q;/C0]8]HO[OO%
M?D+OB7.Z)PO+AO<'[R[J^T;!^S7AWZ.Y?Y&SXL/\^G/_ *2YG\HU/CR_O'8Y
M0          XU\]YT9-:&JH_UQNLR28B8FK7Y$)++9R&JG^P+?DUV]YR--#:
M
M                                   #C1WP?YM?.+^)._\ _169.GE?
MI6E\.WXSFYOZ+J_ N['R2]Y1^_'CI1E]]W$DH?\ ;>=/L7D,>6L^3M[(?,OC
M?T?3C9QW]LM-2T=IW16<WJ]TUB(E7Y21E5LMK,]281T.182<9Z5Q6J/F&292
M*"71K^02N<[T>O%> 4K@L33"!IOXA$L8D:Z.V)8(E)P<%)].H*RQG@R;DRPV
M#E&<(]&H$8I&<M.CY2T6F DEC/PC$K)&"4X8C:;2+3@O!V#.#97::>G5\N&
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M;9NK38LW1%T6SG+652JP<<,.G QK%:;54H !,TS 1-<@$S3&0)$Q=%8 H
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M&GEY'+\YV0
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M0B=B98#FY?"0C(C"$;GTZ_D"T70I1QT](VIM1:=I0[8^08[%G<KBUT:_D$)
M\(Z]'5T@CH*G$F4$0KG"&CX:1UIEFD=#,HB*K1/$)5DTH=)(QE*S5C LX*RE
M!P45I\Q,4QVIT-372-YOV#FYN'C+$099"C'"2\Y)H31DXZ"13:D4VL8X16N?
MXA>I>I%/"?B+LJN6;)QA'2O.8X)@QT=>!5)S4-4X@PP93A+M^#)UIUI"$7I<
M"X%:X;#%PA!]8,HW(L1*SDRI_%Z"2DHL&M+T%-NXE*/3$&)HZO%,;3:DWUO#
ML"JG"3?8*5R2<<C"*UP^,;Y-ZO#";\Q((8RZ_$91CFN+)1T*'3&)BQ8VW^K]
MU3C_ )5W=]MVC5ST?]-?.SAGL>9\!C_S31^4M^-#O:=UG_4)RV_BWN[[5LGY
MW^M/Z?YGY6[ME_I<]F?ZB^&?DFE\2UR"/7WO8          ;+\ZU'AZC4JJH
MO\C5H[#&<XA8FD2VYY$0^Z.:GH?]B=-W<:K.]+E<:&P
M
M                  2<G5Z][!_..W1_>;?Z%?/S-^M'^O\ S'P-/LE^Q'U'
M_P!U5WP[NV'KZJ7V&ET8I+PPGB?*/_Y-)Z7UEI_A;J=+&AMTN/2;>9^D^1TW
MQY\(1D  (:U#.$4H                ()R PI*AG&2*
M                   !@XNJE+2S;ITB)F4OBNG+5N+!ZOD-.MEY6C0SE^IY
M:1_"OR^U?=K)1ZOGV5\Q[OZA4_W9RM<_2V?&AZS[1:_L^\5^0N^)<[HG"T/O
M;W!##[B[J^T;!^S/AOZ.Y?Y&SXL/\^?/_I'F?RC4^/+^\=KE          #C
M;SW3]GDGHA5_9&ZW"W'))REK<B?UOF^JF'7Z'F+?6C7;WW(PT-H
M
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M"8GCZ7;=?%UU(>>  ,QO[LB(61,6TD'@8ZO<E82DPT,IC82R-Z
M             #!V[;F[=#>MTTOS"LC)4TTJ%-*I6I))>("@   ".E5*%252
MU-)KP,#%6[:PMT*&$*:5YA61F       !LYSQ_@/G>M>1F[1[R7=V:-I>[]M
M?.IK17JP]$RUJ4P2W>Y>G.R
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M_;',]3\QON[C79WI<KS0V
M                                                        "3DZ
MOGO87#O&[JZ;%K]!O_$?F9]:']X',?)Z?9+]A_J/_NNOG^O?VVO7O#[%C!P6
MB,H1ZCY3F?\ J8Z*OK/3_#3&VK&CU'T1-O-?2?(Z;^_ 8L@        !#&Y0
MQ%-B      0QN Q538@                 0PG%01F*9H
M    #3J]:GK-VEM2_P#!2U;GT/;YC1K9>5HT,Y?JN6BCS7Y?.,/\M9+1_P#7
MY4]W]09IZV<I'_%L^-#UCVC?N]\5^0N^)<[H?"[?WN;@E%?<7=<_^8V-!^S?
MAWZ.Y?I]#9\6'^?/GZ_G/F8V>GU/CR_OG6Y@          XU\^FO8926AQGC
MZ_D-^G2F&;"_NM;D/^MLW]31_P#+)?DPM[T5<CC2W
M
M                 XT=\'^;7SB_B3O_ /T5F3IY7Z5I?#M^,YN;^BZOP+NQ
M\DK>:_[X<=/2N+^(_P#3>=/L7P_Z-9\G;V0^9O&?P.G\._ME@H=ND[;J/5=7
MNF.&&GP>'$=C.8\V!I)16)<R)JJ>B$.WM%-J[*L:83>HLDLH:=.LE4K[@XZ/
M,,-I%$AI3$Y4AE7&ERJ$NV G-,<>@4(1P$I-:T35"48].!511CU^88$T,/JO
MAV8#L.P<(2T=8QVE9VK*;QPZ"&.28X:,.W'$89R=:PDDU.<BIMW$HQCX@N-*
M"@V^P9$X$(RA"';B$RQ->UI\W4.I>HA"6*9-Z;Q?0]I3I2#@M0VLMJMP72]/
M5T!*$G'LF3),A1:F_$)W+6(G(BIO7"'G%%B9C""'@?PZ\25]Q<\^^8QAT%CW
MDF?NLTBTH?$7"4PEE";U&.)6*;TA.&.LM:]:X\-=A+0H]K+BF.U8-*3(F%<4
M48QA%]9<%P%#K3[,!)5(0FI0T?*-QN1-HJT9)N?EU$I"&+EAI\Q,H,DBVG'#
M44HJ6"C%./1@#M2:ZEYQA)A*JGID2J5(N$=*P9=M%VT5SE' F25HDX1?@^48
M5P7J(Z/'\A:;4IM3S^8Q_HMG]-6FX3\1:L(F%BFU!]@HDPQA%P7PD6N"UPWK
MIQ@WHA$)LW(G.+8E9RI H-0TZ!EB3ABRH<:Z9Z_(6.\EV4T<X_=AR]X#R*>G
M[MT1_P -W>>E^O?ZO<SU0]Y]7J_.^3XONOLOJL[L_:W=?[ ROVM;/E6_N7/H
MVS*WJ^P\Q?F7P^F-/+=WRL[\F=OU%V^5FV,DC)F50       #C/SW]7*_5T>
M6HR@C*>MN=RM_@SEOJ*/K*2W90FUN48*     !X]QU;7HUPAC3!.&'E-/H)X
MN*N9QVTF-L-*F[5<<Z=E4M0>N<_(=&K;$:4\,UEILU9NOI,4=77^D3<O]YO)
M<J>8-K)7\QN;*UY[+9[-6K=RNWEKM5.:5OVKHH=-"]-8M'KO+<SJ<GZR:?,7
M1_DWS$Q.Z)_F>TZ>GI<YZOZ_+_\ BVVS[\2_,^Y:]X-RQY5\-;RY <X^(,OP
MQ517E;O"6\<ULTY/,[=K+4W;-=ZJ]3;MINK&$8H_M/K9;'CG):7.\O-;;+(B
M8\F;^0>KL3X+K:G*\S_2OF>+HQP>_;F1WE^[[O7ESQAN^QS2X8N/>'"^_*<K
M11O;=]====W=6:]G133\X3>W56I'\9]9.4NCPB;+IFW&*89S7)_4?!-6^_G[
M-31B+Z9X[/\ Z.G5[L_?G"W#?O%[._.(MXY+<VY;?%7$M^C>V9]AE\L[-S>[
MN6Z_G%VJW::KHGZQ_8O5#3T]/V><Q=JQ'I(LCL?S3UAU9UO7;3X9I$73Y<7=
M5J[TO=^R]QVZN:'"E-=NFFFI?=C=[;6RE3%K,.,%J/YS9=&K''9C;,O>/1W6
MYYT/Y5W=\_\ -'A3_.^1_P 8,^&[H.&3^5=W?/\ S1X4_P [Y'_&!PW=!PR?
MRKN[Y_YH\*?YWR/^,#ANZ$I+^AN?O+\D>(=ZY?<6XN8?#>]-\9Q[.4R&4WGD
MKV8OUQ25-%NB^ZJIU+!:3*S2NNG+!KU;XTL)IQ3DWOLWE>IFMFO9IJJHC&"K
M4:7%2FC5J6X3$9,K;JYYM6.RF\35H1C1E=-(JS-R
M                     ;-\\G#@;//I2\*J^(W:/?2[NRVG[ONS\YBJ8>C6
M\7JI^,SUHF(Q8V36'+PYF8
M                                                       Q?K4?
MDO(6,I2<X:5_U5U_$2>[).<=;'-?K3,?L>]^AU$T\H8ZGX.[X,]CI =^_P#G
M5\S/WVK^OO'WW[+OU)Y*F? _SP?6B_?9X_\ E7V(<3J5%K1#QGOUSYUNFD,^
MN8G>Q2AP;A.,.C6+]^9=EBST0C%_!F&]-[&$HQ*NU-2;UZ ;X9):6I:Q*3NS
M$FIZAG@5K@BQ6EZA*RLNKHF6NY,2$8)J4_CT$*[85I:7/J)!$I-2TZBX9F&:
MMZ/%K^*!(A(A*=+C*4H%E9]\J<&XX,D8X;2,<LRF,6]#\7QB2:4%",(>,NPV
M&AMSPB#:DDGM*>K\0+GD;,I37PUBI7I6,6IP;CXD,H39N(P<L!3W2GNCC&"P
M^#&\CI2&#:PCIUC:NYE#1K\4"58UVI",HX><N2Y)*&$]84@HX^(%5BVH%I3%
M*4Q(RA E*XE,2,<7!/M!EUHM$9P[ O4L)/IAY17%-JPBIOY"9)E)".F*ZH#(
MK1(+1IP\Y5JKBE/'1YR=AU9(E!1C#L+.="<Z"CH4/ATCK.LB]98MJ4@@XQ6'
MPUDZRO2:WHE+6-QNVB?8M0F"8]U'T3?@"PSTQQ;P(QV;D>O%""/?18*.&GX8
MXE[5V[V373"!(2$;4!$$1-4FE!E7"9J*$8K'5\H)0JF#$8F<"<M:$V[28QWJ
MM>KQQ),2D]"/'7XAE"["U'Y_NII_]:[N^V[1JYWZ+?\ !GL>7\"I^=-'Y2WX
MT.]IW6?]0G+;IX;W=]JV3\[O6F:^/<S\K=VR_P!+GLS_ %$\,_(]+XEKD$>O
MO>P          V7YU[/WNT[6.U7#'Z5RD-I.3;CD/%[QS45LN#E&/TNHW7=Q
MKM[TT<KS2V
M                                             "3DZO?O8%_^1FZ?
M[U;_ $*^?F;]:+]X',?)Z?9+]B/J/_NKO^'=VP]?;C[!:?1IZ(>B?)]8GF?*
M^M-./\Z:]+0M^E2VG\$='-5^=8NFZ[SHCI9&(         (28J!.$4R
M (28J!.$4R                  A)BH$I3$!Q"F48@
M:=4-NB+A,W:=:31+_P '+5N?0]OF-&MEY6C0SE^KY:-+FMR^B_\ KK)?;^5/
M=_4&*^MG*4_&V?&AZQ[1OW>^*_(7?$N=T+A?^#O#\\=R;KE#']06-)^S?AWZ
M.Y?Y&SXL/\^?B'Z3YGY?4^/+^^=;F          #C9SYV/8Y-/%IQQ_'0-]E
M.'#-C=C#6Y$K9R^;6/HT>2@7QA5KM[SD::&X
M
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MR9A0       #C1SWG3E?JZ/+46V:S0MC"6YG*QQX9RWU%'UE)E<F5S<LP4
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MBX]JRHSCCUQ1+,(K#*^)C"7D4>JBW9D9,B*
M              #9KGG_  %S_P!53];6;M'OI=W);3]WS]<?D:_)0;>8[K7I
MY.7IR-H
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M#8
M                                     ).3J^>]@_G&;I_O-M^&S?/S
M-^M#^\#F/D]/LE^Q'U'_ -U5_P .[XT/7Q6F[-"6.ROK3Y/M^D>5]::?X:[K
M:=MIT-K"9T<S%.9IN;[\;X4Q9
M      0DY 8*&<9(I0                8.&W1'#X:C;IUI-,R^GHYJU*Y)
M)83\QIUL<=[GT,Y?J^6B?X5^7T'#_+62T?\ U^5/=_4&8_W9RE?QMGQH>L>T
M;]WOBOR%WQ+G=#X6_@WN#]Y=U?:-@_9KP[]'<O\ (V?%A_GT\0_27,_E&I\>
M7]X['*          '&WGPJ7:R6N#UZZC=;3APS8W9-?D7^M\U]31Y*3*_NL+
M>^Y%G.V@
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M@97[6MGRG?W+GT=9E;U?8>?;]5=OE-'+]SRMM^:T>JNWRLZ+LV$9,B*
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MM>1F[1[R7=V6TO=^C\Y4=5?]B9ZW=+/L.7IS*
M
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MAF=G!IZ_QL<9G3=W,6NVO%-7+ T,P
M
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M=9W:[6N[:U>1,K&;245LTSCAZFC%C4R8VYQ7-R.-+<
M
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M_L#*_:UL^4[^Y<^CK,K>K[#S[?JKM\IHY?N>5MOS6CU5V^5G1=FPC)D10
M    #C1SW]3+/57;\M1E;A.!$Y];<WE;_!G+?44?64ENRA-K<HP4
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MQ26RS4MOQLFL-R/:T;3IC-8QE#LQF:VS;3:U"1=$S,= %
M                           &S?/'^ ^>ZUY&;M'O)=W9;3]WR6::2@MF
MO3&/JF6ME5C92<7+PYV8
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M9EN3@Y8X;.GI.B["QKM[TN5YH9@
M
M "3DZOGO8I=XS=/]XM-]MF^?F9]:&L^T#F/@:?9+]A_J/X^RJ_HX[NV'KV3I
M]DJG@THN<Y>(^4[HF>8BW>^L]*L:DSO*8*EPP^0V<Q%.9\CINKQ15",@
M (8S$U4$1-13)
M      PG[2B"BT\(P^&)LLI-LQM2^L:<M2YBNC'M@:]6G#7IG!SZ-8NH_5\M
M/]:_+^7_ %UDH]'ZORI[KZ@T_P!V<IT^EL^-#UGVB_N]\5^0N^)<[H7"[_[N
M;@245]Q=US_YC8T'[.>'1'YNY?Y&SXL/\^?/S,^)\ST>GU/CR_OG6Y@
M     XV<]XJWE'T/^S-UG=875C%K<B:89?.2Q5,?ZP7L8B>*)ER--+:
M
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M_@/GNM>1F[0[Z7=V6TW=^_7797_8F>MW6&EDY>G,V
M
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MS'.K9^]VC:UUPQ^DJU GNMMN0TL_F>E51_K3HO[M&%F<N6!SLP
M
M                        !)R=7SWL/\XO=/\ >K7Z%?F?F;]:']X',?)V
M?%E^Q'U'OW5W_#N[8>OIRLJ+DZ:90_&ZSY0SYGROK33_  \];2H]5]OD.CFO
MI7D;[^_ 8,@
M            -*OUJ8J)LLKL+OP<M1SIA"#UZYFO6[L=;GT)I=CF_7<M/]:W
M+_\ ?G)_;V5/=?4'];>4^5L^-#UGVB?N]\5^0N^)<[H7"W\&]P?O+NK[1L'[
M-^'?H[E_D;/BP_SY<_CXCS/Y1J?'E_>.QS          !QKY]->RR:JP488_
MCM1OLQMWL+\GE<B_UOF_J:?!]CAXC&\^Y<BC4S
M
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M>?33];5\1NT.^EW<EM-W??URGT5^2@V:\4M8:64N7QRM@
M
M                  Q?K4?DO(6,I2<X:5_U5U_$2>[).<=;'-?K3,?L>]^A
MU$T\H8ZGX.[X,]CI =^^'\JSF;^^U<?ZN\???LNC_P!$\E\!_GA^M%^^SQ_\
MJ^Q#B?3@>^S-)?.<LY*<,=$<!$TG%CCDQI5+36OK%U?(RF9C%7**"9XI)3U>
M<OFSUF.2XN+^$N@E*1AF;*0L5"/T7P[,"=B4]PE.<(]HQ,6,%ABEV?+B%QSV
MK"<(^+H+68BI7"JOHPT><D15.O-7&'E$1BD4J0;<_AX!DM8V(G-1%"F&"3>&
M"&2Y'0UV1P\ .I8PEIU_(,TSQ-"T1C$5Q#2UCA'0*UQ-E5TI)_(38;&+3;\J
M^4JQD+KAV"25<$\/&,4BIA!K"< 9]:3:7:%6"AY_D%4K-2,%+3I^09F:1?;I
M%%HD(J;EH7EF"N.&9-).,<="!A,RK;9:%%;DM4R;4C-/(%6,U$LVQ&24PP1Q
M6"BGV$S6*2JG&.CX:!U)ED/1##0((]\C!2Q^7P8#:4K..2P<W"<H$3#+8DW+
M3Y?B@7>N&>PEUKP0&)BNA:IQ\Q-N\V[T6#Z,.TIM-,-'R#94V5VI&4!1:8U6
M4)SZ F-4CC/5VA62G&<=<B,<DJE-*>B8A8QZB<,/1U?">)>T[5TP\'1K)LJ;
M*IC)]G094I%3)'&49^#S$BFQ<-@YR>'PU RR6$HBJ5Q'.$XZI R6,7"'PQ)3
M!-E4LP^Z.ZM/^5=VPT0_5EGPFKG)F>5OB<N&>QYGP+])Z/REO;#O:=UK_4+R
MW_BYN[[4LGYW^M/Z?YGY6[ME_I<]F?ZB>%_D>E\2UR!/7WO8          ;+
M<ZV_O>H2TU5_6LE:3"TBDUR;=<ATUO#-0P@X^"F.)T78V8M5F<N5QH;
M
M                              !)R=7OWL*3[Q>ZM?L;</SK,'YF_6AF
M?V@\Q&ST>GV2_8KZCE/V5WU^[N[8>OE)TV:>FE?6Q/E"^?\ J:[(E]8Z5?3W
M=%6G:25%<%CTZC=S4S=S,3N=%\4OA2,@
M                            3@(8\0IE&(  -.I1KI-MF$3.TOBNG+5J
M>U0H_"9HU<(CK<^A,\3]7RT2?-?E]+_KK)?;^5/>/4&9CULY2GXVSXT/6/:+
M^[WQ7Y"[XESNA\+I?>YP^]*W+NJ'^ 6#]FO#OT=R_P C9\6'^?3Q#])<S^4:
MGQY?WCL<H          <;N>\':R<:L%5Z,/J])OL[K&[*6KR)<<OG.JG^P)>
MPMFLQ'0Y&&EM
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MJGZVLW:/?2[N2VF[OKCF%T*N/@H-NOW6.EDY?'(S
M
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MIH;
M                                      !)R=7SWL#7\HO=2UVK7Z%?
M/S-^M#^\'F/D]/LE^Q?U'/W57S_7N[8>OEI4VJ(+&E1_J6SY/OF9U_*^L-/\
M-/6TZ/5>C'R&[7^D>1T7]^ ,@
M                    $$Y 84E0SC)%  :5S&DVZ>4I?^#EJOU%V^4TZV4=
M;GT.\_6\M/\ 6OR__?K)?;^5/=?4+];.4^5L^-#UGVB_N]\5^0N^)<[H7"_\
M&]P?O+NK[1L'[-^&_H[E_D;/BP_SZ^(?I+F?RC4^/+^\=KD          #C;
MSW5/L\FXSV:I0^JTFZSNX9L;JTEJ\B/UMG.JG^P%[79&-7(TTMP
M
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ME?M:V?*=_<N?1MF5O5]AY]OU5V^4T<OW/*VWYK1ZJ[?*SHNS81DR(H
M !QHY[T1HRM4/5KMZ=;J,K<TC;&UN=RN_@QE?J:/T.DVZO=@AN2:%
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MT.^QO[DMIN[W%9AQ<(JN4(QE1X#+7Z4LQC%R^.=F
M
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MRQE+;KD1#[HYJ6A_V)ON[C59WI<KC0V
M
M      "3DZO/O8?YQVZ?[S:_0KY^9_UH?U_YGY.SLE^Q'U'?W5W_  [NVUZ_
M&W[*&C9I^M/DZ[#7K&=7UGI_AYC>T[;;H;<G/X2-W,?2?(Z+^_ 1D
M                                      $-:AE:BF0         (83F
MH(S%,T:5S&DV:9?^#EJ0<(Z/E->O/FQ&]S:$>=78_6<M(_A6Y?3A_EG):/\
MZ[*GNWJ#3_=O*?*V?&AZU[1?W?>*_(7?$N=T3A:7#>X/WEW5]HV#]FO#OT=R
M_P C9\6'^?+GXIXCS-?]1J?'E_>.QS          !QLY]_K?(_DO[,WQW$G*
M7D\B?UKG/J:/);,-7O0FGW7(HUL@
M
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MQBM5BIV5;5?I)QC#I^(ROB;]M)87SQ36W!Y%%.S2J8Q@H1,H2&0
M                               ;-\\E'@;/+I3\%-7QF[0[]6-_<EM+
MW?'#,2TJO^Q-FO&%=J:=)AR^.5F
M
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MNT-N'I50Z?1J$9K6D-N>1#:WCFNI_P!B;[NXU6=Z7*XT-@
M
M                     DY.KU[V"F/>-W4W)>QM]OV*_P" _,[ZT4T]H',?
M)Z?9+]B/J/?NKO\ AW=L/7TH*TELP:I6F.A^4^4+L>8BN57UGI_AIZV-#]"J
M$D;>:B/G,;H=%_?A",@
M    ACP@6(H*4         $),5 1%!2C"JF-5+A&$98>,SLFB7_@Y9-^BEM:
M_1ATZS#7[L8;7/H9OUG+7_6QR^U_=K)3_P"?Y70>[^H/ZU\IT>EL^-#UGVB_
MN^\5^0N^)<[HG#*;X>X?J;FMR[KT8QR%A=A^S/AWZ.Y>/^#9\6'^?3Q#'Q/F
M9_X^I\>7]X['*          '&OGTXV<E3JVG'^J-UGG6T2<GD<B'^I<WTJCQ
M*V-2VOG,++J>:Y&&EL
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M7;KI5IT++VTJ59MT*U10II)4J4$C&;N.*6][:L1-M;IFKSPH
M                                V<YX_P !\]\-#-VCWF-_=EM'W?/U
MPOR?]B;-?)-+)R_.5F
M                                                   ,7ZU'Y+R%
MC*4G.&E?]5=?Q$GNR3G'6QS7ZTS'['O?H=1-/*&.I^#N^#/8Z0/?Q<>];S-6
MK>U?UUT^^_9?CZD\E']3[+_/!]:']]?CWY5]B'$VD]]NSA\ZW-2&$%#M$5G)
MA5C2E!RFA=6K*ZM66,8+5I(QZR+QA+X=N([3#RD(83;P%:E:]1-?!#"3"2,<
M?AX!3H*= DF^@8T,:(FFYKK8QV+28C!4HQG*6@),C;3Q%((B#3TZ_DPP'8;-
MQ%:H+2#'RB6UU^49&28PUZ1EU+EU$=$9%-^U9U$PA,(*G.$.OS"",E<%V:.L
MB)-OJZBX+A0<8N'PD-AA3%'JU"%CI,%)03PGJ!G.\;A.K#X:AAL(QR64?QJ\
M_CQ':G:C;AT#M7M%&,6Y/HU PR-F4(>/I!7&JN&$(>,;TWCQ@D(Z2.F444^D
M=B]BZ(.7C&]-X_#J?E$$+%0<),FW$VXI'PZRT*>XC:4$\9R"YXPRTP>&H8^5
M-^U'5T3%"B1CI+'0M**H."U>,DI.#'7/&'B#)E!KI6K E6-8\I'1#QEIM*;2
M?K?#4,)P,,EFEA#MB3,S2$<%U3*50N-%5.3Z/C)3%*8K]=\.S G8=C&.C1J+
M1:>Z.<]6+,IPG "!KT=&(C,70^SRDG--I@Y2\9=D29PF#D12U^V&ZGH^ZN[?
MMRR:.=^BWSLX9['F/ OTGHQM]);VP[VO=9_U"\M_XN;N^U+)^>'K3^G^9^5N
M[9?Z6_9G^HGAGY'I?$M<@3U][V          &RW.R'WN414?2JAT>C4-IL;<
M\B?VQS/4_,;[NXUV=Z7*\T-@
M                                                           D
MY.KW[V!+^49NI_[E:_0KY^9OUHJ_M YCY/3[)?L1]1[]U=_P[NV'KY^@_(KR
M'RC/TB.M]9V?AY8V_4J^$#=S7TKR.B_OPABR
M                                      TZFJ6GI<?)X#99$SU,;YI9
M*O08:_<CK<^A/G/U_+27-;E_T;ZR7V]E3W3U"_6WE/E;/C0]:]HO[O?%?D+O
MB7.Z'PO_  ;W!^\NZOM&P?LWX=^CN7^1L^+#_/IXA^DN9_*-3X\O[QV.4
M       .-//K\SR?55_9&[3RE)R>3R(_6N9ZJ?)097]UKM[_ )'(TYVT
M
M                               '&CO@_P VOG%_$G?_ /HK,G3ROTK2
M^';\9S<W]%U?@7=CY).]%'C'CIZN+^)/]-YT^Q?#_HUGR=O9#YF\9_ Z<_U[
M^V6-,8RE'MP.R_)ZO=T";QT:3+.6<Q%-XHM8SZL!+&<%6,NWS8B=ZX[<T2DI
M1_%+M3:0A&4I SZQX0A!>$;UWJI:(>.))2J24O"YEF*KCF8J/PQ,8CI7*?-1
M:O 7,G#&%;?:A&=-A3#=)!Z'&'1K&Q*QY!-):HC%)J)33Q19E9D2P>C5\I)2
M>@BE5\-1=BQDB@WAB-F!E T^Q"/?(GW30FI?" S-TJEI3A'M$I.\@\-&L5VE
M8SVD5&>C#SDV%,,%BF_)B,87&,B*CTCL3L-/D\X-B)SBEV:_B@)A<BG3*3Z<
M("2??)1]*</AH+U'4*<5AJ&\RQ(0@X0QB$SP&]6DE)6-Y!XZ05CR+!R[1@=2
M3@XR4ND=2=1&#@Q1=F Y0B^V&'QQ*@]6+\!-Z]60X*$O&(J0/"+T:/E$)'0*
M,(/L7E+O7? EI2AJ>(E)%!RU$VD]*)MN#P+DLQ0CK<(= *,G'2XK42M",9HQ
MCHC!"(G;FLQ&Q=6E/1@(BB3-9KE(UH6C1J+$D3TC@WC+5 8F(NA^(223TJ/;
M 8;##8R@HQTD8U8IQ3B]0F.AG&$P*&.D8Q&*3&-(R(P6M:RTJ9K1Z],.F6J1
M8S2[NRYQ>[#G[P'D3''[N4=OZNW?X)GIWKU^KG-=4?9>\^KLS/-<G7[K[+ZK
M6[/VMW7^P,K]K6SY2O[ESZ-LRMZOL//M^JNWRFCE^YY6V_-:/57;Y6=%V;",
MF1%        .,_/?U<K]71Y:C*",IZVY_*W^#.6^IH^LI+=L&Y)@
M    FRIRQA'LP"UV;&#M4-U.$ZH1FYPP),3.4T*[&H5&G[*B*:I@Z8P[=>EC
M90VUVLTDH06 VUVF44V*
M     ;-<\W#@7/-8Q7UM9NT>^QN[DMIN[ZDLRH:J_)29ZV1IY.7QS,@
M
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M_J7\9C.<+&UMWR(2>\,UU/R4G3=^#JU6YRY6FAL
M
M              $G)U>_>PQ_E&[IU>QMOPVLQ _,WZT5/V@<Q\#3[)?L1]1_
M]U5_P[NV'KXPM)0@U3/3H9\HWS_GUCIA]9:44UY8V_5?;Y#;S$UYC'H=5_?@
M(H              !#&9FJ@B9J*9(  (85E0RB:HI1#&9FJ@B9J*9(
M                         $$Y 85E6%3<:4=&CCBQU(_RY:E:22>#G+'Q
MFK6Z-E6CE\Y?JN6<'S6Y>QQ^[62^W\J>[^H5?]V\I3+TMGQH>L^T;#V?^*TS
M]!=\2YW1N%_X-[@_>7=7VC8/V9\._1W+_(V?%A_GS\0_27,_E&I\>7]T['*
M         '&SGO\ F>4?0_[(W6=R6,S@U^1<LOFNJGR4EO[K"WON1AH;0
M
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M        XT\]TMC+1<'MVX*&,ZC*$C;T-S.5O\&<M]11]926[*#:W*,%
M     &-5=-+2;@ZL"Q$SD+%)I:7AV&-86DYIMTK%PZXKP1Q+.";]B*Y0\&O)
MY37.I%9LM[RTV[!UTT^LX>/R1%LWSC.0S,XFN,(QVZ=K9CZ6J#U1QPP$W1&8
MR*                                            #9KGFH\"YY+&*^
MMK-VCWV-W<EM-W?FGF5#0J_[$SULC3R<OCF9
M
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MKMSERL-#,
M                                            2<G5\]["H=XS=739
MM?H-_P A^9GUHIK[0.8^!I]DOV(^H]2?97?\.[MAZ^FE[.CII4?ZD^4+L=>F
M]]9Z?X:YITP2:-_,1_U'D=%U9NB4(R               (8S$U4$1-13)  !
M#"DJ%BL=0%K"!)BN,*"DBF2                   "M!"5@4H 0E8%*
M  03D!A2585)[5/6=&EA&+#4F/1RUKB<EA5.6/CPT&G5F*5C*K3H9S5^IY9K
M_P"ZW+Z.*WUDOM_*ZCWCU"K'K;RD1^-L^-#UCVBTGV?>*S'XB[XESNA\+M+A
MSA]:]R[K\60L'[,^'?H[E_D;/BP_SZ<_3\Y<S&WYQJ?'E_?.QR@
M!QMY[_F>4ZG_ &1NL[DL;LFMR*GE\W#Z6G^Q+?W:;6NWON1AH;@
M
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MJR%A#& F.DVUR'@M"<1&&*YS.V5>#\0K$);$SD-:E,0FZ4]*.M=B&!@R:>N
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M_H:M$U,QG@G.<646W3C&36,F(
M         V<YX_P'SO6O(S=H]Y+L;9;3=WZB&9[*_P"QZ3/6R2W#W'+PYF0
M
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MZ+OP>]KLSERM-#8
M                                                  ).3J^^]A_G
M%[I_O-O]!S!^9GUHOW@<Q\#3[)?L/]1[]U5_P[OC0]?#2IM40^E3_K6SY1NF
M?G'E?6FG$>FGK:=MMT.+CB;N8QYGR.BZ*71 1D
M0DY 8*&<9(I0                   "&-P&*J;$0DY 8*&<9(I0      !A
M5ZU#V8SQC"'9I-EN3&_N35J7/H>WS&G4[OE:=#.7ZGEK_K8Y>_OUDOM_*GO?
MJ%^MG*_*V?&AZO[0_P!WOBOR%WQ+G=&X7A][>X(8?<7=7VC8/V7\._1_+_(V
M?%A_GUY_'Q'F?RC4^/+^Z=CE          #C=SX2]ADGI:JC_7G19W&%^34Y
M$_K?.?4T?V!-1A;WH<C30W
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M=&LN$+A!)]+\!,83&$DIQCV%7&5ZU!+I"=6:-KM$56*LH3C$E4KA1'%*,9Z
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MZE,?7PBXZ-E&-LUNI+*8BG]9Y5NJJJA.NG8J>-,8P*QEF
M                         &S?/'^ ^>ZUY&;M'O)=W9;3=WVIO-/:E*M+
M#53J,M9CIS6'+TYV8
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M3A_6G1=^#WM=F<N5IH;
M                                                      !)R=7S
MWL7\XS=']YM_H.8/S,^M%^\#F/@:?9+]A_J/?NKOC^O=VP]?"<;5*2@H*.G0
MUYCY1OBG,5WP^L]+#6EA;I5-%2Q=6+ZC?S4UYF*88.B8I= 8LP
M            !"4@4H        0DS0!$[!2@         "E1"4@4H 0G"*4
M       -.I^E2NDW:<1,,=3\'+7N5>BJ8:<3FU8ICO:=#.7ZCEHD^:W+]P_Z
MZR7V_E3WGU"F?]V\I\K9\:'K'M%BGL]\5I^(N^)<[HG"\?O<X?G+[B[JBH8_
MJ"QI/V:\._1W+_(V?%A_GT\0_27,_E&I\>7]X['*          '&WGVX9;)-
M=/\ 9G1;W8AA=E+6Y$_K?.?4T>2V8ZC"WO0Y&&EN
M
M              #"MM0AICYC*V(G-)EQJ[X7\VOG%_$G?_\ HK,FWEIIS.E\
MI;\9S\U]%U?@7=CY)F\DWQCQUI7WW<21_P ]YT^QO#\.6LI^+M[(?,WC<_Y&
MG-?Z=_;+24?"=\XX;'J^I28I*SCCCT:B1C%=JQE2=AHGI+BLXS6"<)R\8P3
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M3;=O;[+[+XK;,3:_3$9@
M;-\\?X#Y[L\C-VCWF-_=EM)W?'M9IZ(*O^Q,];"*,=+)R_.9L
M
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M-RW_ (N;N^U;)^=?K1^GN9^5N[9?Z7?9I$1ZB>%T_P!'I?$M<@3P#WH
M     -E^=?\ !Q==?UM1)S@GNRVVY!K]79K\EVRH-]_=81&+EB:68
M
M                            DY.K[[V+^<7NEZ%9M?H-\_,SZT7[P>8C
M^II]DOV'^H]^ZN_IX[NV'KVD[5#2@X*'7#XSY2NK\XIO?6>E,3K2E*:I:>/R
M&WF/I'D=-U..*(1D                                 !#"<U!&8IF@
M                        :=32KI;FO ;M/&*1FE_X.6K<>U2EC3'JP\9H
MU<,8SJY]"DS+]5RT_P!:_+Y1A'?62E"/_'\J>[^H/ZV<I\K9\:'K/M%_=]XK
M\A=\2YW1.%_X-[@_>7=7VC8/V:\._1W+_(V?%A_GTY_])<S^4:GQY?WCL<H
M         <;>?GZVR76__F'19W88792UN1/ZWSGU-'DMF-["SO0Y&&EN
M
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M/2)B;9FV<XE[G%W%$71E,/)(H
M    -G.>/\!\]\-#-VCWF-_=EM'W?/UPOR?]B;-?)-+)R_.5F
M
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MUM1)S@GNRVXY#Q6\<U%[3@YPA]+J.B[N-=O>FCE>:&P
M
M                  2<G5Z][$O_ ,C=T+79MOPV;Y^9WUH/U_YGY.SLE^Q'
MU'OW5W_#N[8>O>N'LJ$E""IZ=!\I1])QZ7UG9^$OZUH]1S^4V<W](BF5'1?W
MX0Q9
M      8.=26I^4V1A$2QOBMDPU+GT/3$U:D>;7?#1HS2ZG2_4<M(+FQR^C..
M^LEV?J_*GO/J#6?6OE/E;/C0]:]HV/L^\5C_ (%WQ+G='X7GPWN#3_D7=7VC
M8/V8\._1_+_(V?%A_GSY_P#2/,_E&I\>7]T['*          '&SGM^9Y7J?]
MD;K>XQG.6MR+VO8YJ<:=FF<M5$.DM]>%A;3BWN1IH;0
M
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MZ,@     V;YX_P !\]V>1F[1[S&_NRVF[OJ_5,-2N/ZTSUIP8Z<X.7IS-@
M
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MB[N89,+:5FCE>:&8
M                                                   DY.KY[V%_
M_D7NIP_M-I0ZK5\_,WZT/[P.8^3L[)?L3]1[]U=_P[NV'KU<?9TQQ@I=A\I3
M3YQNJ^LM*OIKIVE'JOM-O-37F(C<Z+^_ 8L@
M                            A*@.(4H     !CC70H:3.,J]"7173EJW
M&H+T8..,35JQ,1GM:-#.7ZCEK+FOR^G#_+62T8_J_*GO'J#^MG*8?^+9\:'K
M'M%_=]XK\A=\2YW1.%OX-\/S_P"I=U?:%@_9KP[]'<O\C9\6'^?3G_TCS/Y1
MJ?'E_>.QR@         !QLY[?F>5ZG_9&ZWN,9SEK<BHNQFW&2IIE!3]32+Y
M\VC"WO.1II;0
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M+MVNG-VEE[2]HTU*6L[;>9U=/3F+;N&VC1.C%]W%?%;G]GF%WX^Z3R=XCRG
MW%/-+AC<>^LYFK.1R^[=TO+7[;S-Z[\WM6'7N[;M45.ZMF$5 X_#^:T_%N;N
MY+DYF_F+<XQ[71SO)ZWA_)V\YS<<'+7Y3AV.4^3WCE-];KR&^\CF/G.Z\_EK
M.<R5Y)^GE\S;INV+L(N/M+=:9OUYLY:L:WFS$XN?1IJ\-T8VF\,[:W=N_,[R
MWK>]ANW=V5OY[.9A*/LLKE;-5^[74E-JBS;;9SV<UR^KCHXXNFZRVV,)\CCQ
MRD[Y?=HYX\1;UX9Y;<T=P[YX@W1?OY3/[NN9FUDK].8RMSV%RS1;S==NJ[<I
MNRA1%MG;=X3S%NE'.\,QI0X[>:TIOG2MG_,<GJ:V[E-JJJ+J6TW"5:QI=-6E
M&$:=;/23DRG4_P S@VL\PI*+2I:J5VN&-,/5:U-'+?;&O_EVSYT.BV^+*W4\
MU^*O\%<O\Q<>\JN$^&7O#VE-SY]=W%NNYG%=5>TJGF*\K5>VG5.,8Q-^EJ7>
M%V<=E;(NSIA7W&K5LCQ2EET\?#E78_>VDE:MJE)4JBE4JE*FE)))))0226@1
M,7>=&4KP\'F3L:@                   85;2VGM)+&+@E0EBVWBGXB8K%-
MK8'F?WG^1?)_VRY@<>[FW)7;3=VU<S5FY=3HVGLNBF[%-;#U&VW1OOQB,&N=
M2V)IM>J7O,>^TY1<MK=RURHHRG'EVA7$KE.8LV6ZJ5=2:2SJE&A>$Z(Y68CS
MLVN>8LB)Z7I-[R?ODN?'/KA[-[IX=MYO@'+T>UHINY',754E7[6FE[>7SL6]
MFM> RCE^"*SC">GB^,,)>\SW'/'/'G'O=[WIO?CSB3.<2;QJSEMT9K.W+]V[
M2JJ;-4-J_=NU0GK-?,6<%L-EE_'C6N#W@G*V,%#:KG%^C%:I2\)C%*C\[Q1Q
M7N#@K<&\^)^)-XY?=6YMTY6]G,[F\S=MVZ*+-BBJY7LN[70JJ]E."C,V6VW:
MLQ;&<I=PZ<3,NJ_WX_?=;ZSW%F_>5?)'(5T;@;S>[:N*\KF'&NY9>:RSNT^Q
MSBA&M4U2/(V<KPQE6YI]/;2EN+T@V^\EWI^-.(L[E<CS*XNSV\]XYBY=L6;7
MW:N6[%-=RJM4)T9BNB"5:P-L:-TS6A',SW9:F^N>G>UX,SEG+;UYC\6;ESE-
M=%=-VY]V***H5*I1=5^W3![)?03,TI"?.*86[7M&[H/OI.9_)G>W"W 7-G+W
M^,>'L[F+%C>G$F;S%S]34U5Y>S3=?M<[)JA5.>LU7<I']**2W3Q1;&VNUVYN
M3O-C@[G;P)N+F+P5G[.\-S[\R=J]1<M7+=?LKE=JW<N6JE;N7%&AW$L3QVII
MW:=W#L9;=[=,P     ;-\\?X#Y[K7D9NT.^EW=EM/W??UT_J;G]B9ZV3#3R<
MO#F;
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M^M8CO+&4MO.0_P"V&;ZJO)2;[OP;7;G+E8:&8
M
M            DY.KW[V'^<7NG^]6OT*^?F;]:']X',?)V?%E^Q'U'OW5W_#N
M[8>O=^I3]2O(CY2G\/Y7UII_A[DH]5P4,39S'TEOO[\!&0
M                                      0QNC&JAB*;$      P:C70
MNDVZ<TB92^*Z<M6[BH3Z33JY>5HT,Y?J>6D?PK<OI1_RUDM/_P!=E3W?U"I_
MNWE/E;/C0]9]HO[OO%?D+OB7.Z)PM_!O<'[R[J^T;!^S7AWZ.Y?Y&SXL/\^?
M/_I+F?RC4^/+^\=CE          #C9SV_,\KU/\ LC=;W&,YRUN1/ZWSGU-/
M]@+LF$=]R--+:
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MOGE+@;//I7DJ?F-VAC?1C?W);2]WV/SE:X5Q_K3/6[K'2QAR^.9L
M
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M3NL_ZAN6_P#%S=WVI9/SP]:OT_S/RMW;+_2W[,_U$\+_ "/2^):Y!'KSWL
M        -EN=?\'J.NOZUB.\L92VYY#I4[QS2IDFG'3HI6DW7=QKMFMTN5YI
M9@
M                                    "3DZOOO85_\ D7NG^\VW_P %
M?/S,^M%^\#F/@:?9+]B/J/5GV57_  [OC0]?$_8TO:C!*$H:'YCY2GZ33>^L
M]/\ #2PH<:'%3G/Y#;S6',X=#HNCSX8FNLLPRA%*(85E0RB:HI0
M             A)F@&-953-        "&,S-5!$S44R0     "&,SC101.P4
MR0         8U)1I;Z39;6C&^:63T-2N:49/0L?D-.I6D5QQ:='.:/U7+3_6
MMR__ 'ZR7;^KLKY3W?U"_6WE/E;/C0]9]HO[O?%?D+OB7.Z%PM'[W.'U"7W$
MW7./_P!#8/V<\._1W+_(V?%A_GRY^OYSYF*8?.-3X\O[YUN8          .-
M//ENFWDX.$4_[(Z+8\R&$S2KR>1$?FV;CCLT?_+,;\F-O>AR--+:
M
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MUZ5D,I#MR]L^4;^[+Z.L[L=3S;?JKM\IIY?N>5LOS9))*"P-^;%0
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M[*M)OY>//8W]R6T_=^4,RHJ35<)_43,M7NX,=+)R].9L
M
M                 &+]:C\EY"QE*3G#2O\ JKK^(D]V2<XZV.:_6F8_8][]
M#J)IY0QU/P=WP9['1_[]_P#.LYF_OM7]?>/OKV7_ *D<E\">U_GA^M%^^OQ[
M\J^Q#B?3)):H^4_H$SC#YTNSJS[,<&8VYL4IA!QQE\-1E.2S6NYEC"/3/Y##
M)CDB@OB^4;EFLK"$X0AVA-R8O4%RADM:7CQ)N2>@G&+4O(.I.I(RQ[(%6F(E
M.,,>DDDSA0CA/",_D*&/6\.PN 5=$WH7RF,$>\B;7XWQEV+[ZQZ>V&/Q0%$H
M.<].KY2TG(@2JA",^I&.!6VJ.&N+ZBK!CB_$,LC+)6IO0D*I7#>Q4X/Q:^W1
M +."U>!^001[RM2GBQU9)&[)4NU/22??)GW4C.,8>,ILHK4<,21*1-.I)04X
M8EVKM'X88]H@@44FQ-*F%:$E2FU)?&-IMI"2;:6C!=87+&10U1 :H8S!V+C&
M<I: A'1#QBFTIM'A/%"/>(]Y.C0].J'0,97?M71%J/B%*8)NA):O&%Q5-*.G
M 9I,563A":1.LZTPZ(8OR2*9K-P6AZ=?80RQ1X2P^';B6/?(SQS8PC/5XAG@
MM:,M:QC#HP"#27;XA!$U$W."A"$/.3K)B-HTH]&GH+4B2,\>V H4P&DYM=D>
MP;:$3,80-QTQACVB(G,B*,NB$NOX/$G:G:PE'H+VLNUEC.'CQT=D";F.Y(+'
M%%JM=FUC9EO#=/[Z[N^W+1JYO#E=3X,]CS/@7Z3T?E+>V'>U[K/^H7EOT\.;
MN^U;)^=WK3CX_P S\K=VR_TM^S/]1/"_R/2^):Y!'K[WL          -EN=G
M\'J/JJ_K6,IK*UI$MN.0]5-6\<ULN,GH?XW6;I[C59G+E@:6P
M
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M%O<AA=&=7D\B(_-LW''9H\ELQO86]Z*.1II;@
M
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MOAV8#L.Q'!Z?$6*P16%;?4M+\A",D>M>'Q8%CH2.B4<E#PB.E8Z2277HU_%
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MQX3=H3&.'O35Y+PS6]!SUE^R(F/=ATU/=/<T-S<C>_7N_P"^Z_;W7N?>N_\
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MPC(H  -F>>:;X'SL%II\E1OT.\EW=;5=WZ>8ICBJ;DNRB9=7*4MZ7+LYV0
M
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M9_U"<MOXM[N^U;)^=OK1^GN9^5N[9?Z7/9G^HOAGY)I?$M<@CP#WH
M   -EN=?\'Z%TU_6U$DN[K;?D)0OG^:A*57;ZIT7Q2RK"S.7+$T,P
M
M                           !)R=7WWL7\XO=/]YM_H.8/S,^M%^\#F/@
M:?9+]A_J/?NJO^'=\:'KV;^QT>G&2^AZ/@CY2N_#Y4Q?6>ECK2QH<:7'I-O,
M?2?(Z;\+X",@
M             ,'#:ICKQ-NG6DT2_P#!RU;FCX1P-.MEY6C0SE^JY:?ZUN7_
M ._.2^WLJ>[>H7ZV\I\K9\:'K/M%_=]XK\A=\2YW0^%OX-[@_>7=7VC8/V;\
M._1W+_(V?%A_GRY_](\S^4:GQY?WCL<P          <;>?GZVR76_P#YAT6=
MV&%V4M;D3^M\W]31Y+9C>PL[T.1AI;@
M
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MJ.#F+;;<(E8P<N%M;54?5ELX:I].)QQ7:K(H
M
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MS#E>:&8
M                                          DY.KY[V%Q[QFZ5_N-M
M?\#?/S,^M%'_ +@<Q\#3[)?L/]1Z?_:N^/Z]W;#U\-QMTN.%*EJ@H8Z3Y2NI
M',8]+ZTTIKK75:=N=+;QG\)&[F9_ZG#*CHFL71$YJ8L@
M                                             -.I-UT0UX:S=IS$
M1-4OQTI:MW1"3UFC5WY5<^AG+]3RT<.:W+Z6.^LE]OY4]X]0HKZV\I/_ !;/
MC0]9]HD_^WOBOR%WQ+G=$X6;^]SA^4ON+NN<?_H<N?LUX=^CN7Z?0V?%A_GS
MY^?_ #/F>CYQJ?'E_?.MS          !QLY\^E9R=.$(N/\ 5_&;[.[5A=M>
M1R*4,OF_J:5X/9HEZ1%)AR+-+8
M
M #C/WP?YM?./^).__P#169.GE?I6E\.WXSEYJ/\ IM7X$]CY)>\W_P!\>.E"
M,>+N).C_ *[SI]B^'?1K*_B[>R'S/XUCHZ=/N[^V6FGAY#MF*S1ZOJ16,,%T
MPA$1&%6<3,6Q$#@GTK098RF,BPQPZ,/CB))S2,H$FNQE%*XC>E2CB6G2QI[B
MN6&D1B1CF1FWHTF.,K,1$4VI@G+KGX#)%QA'3'L&1D*<91US!D.$M4S&8F65
MLTV8D82Q^$3)C2N(HXPGUD[$[$P>O\0O8N<+CU/'LP)DF21DM3T?*7M7M73%
M*.J8W)LHB6,)X0).5&5:34;F2E5B<(W*G!1Q7@@93C+'"HX17CQ&)C0FHPP4
M/& A%1T:OE!4@X*$FM!$J3Q?AU> O48;".+3U$HO1$Y&E=L]?8*%<,<B$>A:
M"UH5IUCP45%S'41N,)K#4-R9X3F1E-Q6G1 E/=7%'#0OD+C4BNTEJATX^("S
M72EYQF83UHGJ4^L=93I6+C"/P@-B84J1CU:24E8BD;TQ>HL^\N$6XK.$8DG!
M(B)NH-QCY1'2LQ2=ZX=7D^.(S8Y]:+4WV?*7>L])J@\(SAK NI.>)$ZB$%-R
MT@V[TAICXBUV%=A!136$R=97I(QECTEIM6E,66G Q1BI*/A,I)SH/&6.D1O(
MRQR2;C F,3CDSGAB-ZR^AQ[?.7';DQZ\EA*>&KY252>E(+3@O.55H;VUV^1E
MC":I=$1#G%[L-Q]X%R(_?RW]O;O7F/3O7B:>KO-1NA[SZNX\SRGPOLOJM[K<
M-V;L6O(93Q9:V?*-\>;=+Z.LGS;>IYUOU5V^4T\OW/*V7YLJ7%)G1,4FC")K
M"D4        XT\]ZJ?9Y5;,]NW./346V?.2-L[&YW*ZIOAC*+511XZ*#.^:T
M2,);D&MD         !C-T1-!HU7:8NE*+ATK1U&?#7!.*&UG-'E/P#SMX/S_
M  #S+X6R'$_"V^+-RSF\GG;-JY78VE52KEB_<HKKL5[-3@Z8/K.>Z[T<\,XV
M=+=IWS%D3&%\^^ZZ_>0_H_.Z\[G-X;_[O/&WW"6>S68O6N'LYE[5VWD::Z[U
MZBBU?KRU=-=#=5-.B$#OY'FYT9I,\5D^\X=?EIOF;K)X;I>OS>_N+.^7NKVE
M64RV3W[[.M4TNSF\M9>8IJJ:5S8MY7T=A3.V[FM.^=S&.6FV/-G&']C</N'N
M]]O*[:IWMGLAN6VZK;5^YF,KF79HK=+N*JT\JVW32VIZC"WF-&W&F*WZ&I=A
M;=1[7.Z7[B#E%RKWMNGC?GAOK\)N_K*LYY[@N9>WEMWY+/6*K5ZRFU8I5Y47
MK,6H)-.$3*[Q'A_ 6\,]+#YI9-O!J3Q5V/?1NS<^[-R;IR.XMP[MRNZ]S9#+
M6<ID<CD;%K*Y?*V<M;IM6Z:;5BFBB5%"T3A,\;S&I=^$O\[4EUZ&EIQ;P6TM
MMMRA_<R=-=--6W<]IJJA#LAT&G3XICBNSENOFV<8PEYALSS:PD13" *
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MC\/W?&WFKD7&57]C FO?%\X9IGE&#EX<TUK'0H4
M
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M&54\,53Y#?=W&%O>ERN-#,
M                                                         2<G
M5Z][!_.-W3_>K?Z#?/S-^M'^\#F/@:?9+]AOJ/?NLO\ AW=L/7XX>R_';*CC
MJ?8?)]WTC=5];:=/3RTK<-BK7H\YMYFOSF*9.B_OP%4
M                                            #3JE72];1NLQMHET
MTTYEK7<5"70:-7+RM&AG+]5RT2_"OR^Z-]9+[?RI[QZAS/\ NWE/E;/C6O5_
M:)^[SQ6=OH+OB7.Z'PM_!O<'[R[J^T;!^S/AWZ.Y?Y&SXL/\^OB&'B7,_E&I
M\>7]X['*          '&OGO^9Y3J?]F;[.XUW;7E<B_UOF^I?_+,;U^YZG(H
MU,P
M                                      <:.^#_ #:^<7\2=_\ ^BLR
M=/*_2M+X=OQG-S?T75^!=V/DD[TA]^/'4O\ ];N))_\ Z;SI]B^'_1K/D[>R
M'S-XS^!T_AW]LL="G)';$UEZO=OS6'A$9*BA&,8OJ,L5Q6;6&))C81A+%:(X
M*)9FBTG8J<7$A.5!ZM.OQC>QWB]5RE\I=J[<$BTC&)K-&4VX55J+\O095P8Q
M-((XZ'+I(A"*4M<OE"Y2148Q["[C&E%TXQAT:R)L2,WH?A'8=@H^#1+RC!9H
M?0X1_%&TVBP7DUS+M3:3T8Z?,.LPVY+TI8])#<DNQ^8ICY11?;IEHZ!-%PR.
ME8O#L"=A&2CIQ^"(=0VH82ZR]JT]U=$G!=1$VXYI'%PU%H4V"C/7(8>1</(*
M.&#\(WD])./5IZR;$V$9IOI&Y:;"#TXOS%"+<HQ6E8 6+U=FKXXD3!)_38]
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MUFV8AM)W?FUF8J6U%-=$:3.^VEC&(F*5<OS0R
M
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M?='-1U.'@I@=-WX-JLSERM-#8
M
M).3J^>]A3_E&;IBXKV%J4/\ <;^D_,SZT5/V@<Q\#3[)?L/]1_\ =7?\.[MA
MZ]G%6U1&4%VR/E.<>8KMJ^M-'#6E*%"EQZ39S'TET7XWP$9
M                       $-:AE:BF0                      :=4-JB
M*CT8&RR)G(OFFG-6K5!*&SLM],35K8VQCM<^CWIP?J^6O^M;@#]^LG]OY4]V
M]0OULY3Y6SXT/6/:+^[WQ7Y"[XESNA\+?P;W!^\NZOM&P?LUX;^C>7^1L^+#
M_/KXA^DN9_*-3X\O[QVN0          .-G/?\SR?4_[(VV]UA<\CD7^89KZF
MG^Q,[^ZQM[[D6<[:
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M97[6MGRI?W+GT59E;U?8>?;]5=OE-'+]SRMM^:T>JNWRLZ+LV$9,B*
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M52:<%#HI.F[N-=N$RY7FAF
M                                                         ).3
MJ]^]A27>-W2XQ;L6I?[U?TGYF_6AK/M YGX&GV2_8CZCT5]E=_P[NV'KX@G:
M4ME[*TQT><^4I^D;JOK32FFM,;V-OU7VFWF8IS/D=%_?@,5  $)6!2UJ
M                           !#'A L104H                      8
M5*-5+A'HPCVF=LI=W)AJ5;*4(0JU1;\>!KUJ\,=%6C1IQ3TOU7+5_P#W7Y?+
M7OK)?;^5/=_4&*^MG*3T:MGQH>L>T7]WWBOR%WQ+G=%X7EPWN!?]B[J^T;!^
MS7AL4\.Y>/\ @V?%A_GT\0_27,_E&I\>7]T['*          '&SGO^9Y3H3_
M +(W61YK"Z6OR*<<OF^BFC^P^,M^5&%O>KTN1AH;@
M
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M\HA(++_5^ZM+^ZN[OMNTC3S?T74^#/9+S'@<?^::/1Z2WXT.]GW6?]0O+?\
MBYN[[5LGYW^M/Z>YGY6[ME_I<]F?ZB>%_D>E\2UR"/7WO8          ;+<Z
M_P"#U'U5?UK)*QE+;GD+4J]X9MPA!-8ZE2^C6=%V%E&NV*3+E>:&8
M
M                            DY.KW[V+^<9NF'J^QMQZ_97^T_,WZT-/
MV@<Q7/@T^R7[$_4=K^RN^GW=W;#U\4_F2@X^BI]A\I7?28ZWUEI_AYZV-'JO
MM\ANYKZ5Y'1?WX#!D  (:U#*U%,@
M                       !C#TZ:L8.1G;.%$NQLEE<]?X:D8:OX..MHT>_
M+]5RT_UL<O/WZR7V_E#WCU!_6OE?E;/C0]8]HO[OO%?D+OB7.Z-PQ_!S<'[R
M[J^T;!^S/A_Z/Y?Y"SXL/\^G/_I'F?E]3X\O[IUN4          .-?/?\SRG
M4_[,WV=QKNVM?D3^M\Y]31_8#48V]Z'(TT-P
M
M          :=SZ'M\QG;M8SG#C9WP?YM?.+^).__ /169-W*_2M+X=OQFCF_
MHNK\"[L?)*WG'[\.._XW<2?Z;SI]B^'_ $:SX%O9#YG\9G_I[*Y\=_;*4PC$
M[+LGJL[V.F&G7\AGO9UK&Y%!OX2"Y"PPEUC:FU8RQB^H4*+IZ_,B;$V)T1CT
M8>,+O%A!:-/R"4GI(S>N0V&P6J,'J@65GWF4^KQDP3)$U#' 236J8+I+G.Y<
MYW#DX_#4(Z$C&*$G!O#5\I-RY802V?AK+M-I"&B/3$)6HI.&+\ S7,ZY:M)*
M3L6*4RJG;V$K'7+/SJTV,L'%KY-';$NYKW(T\%@,)S(F,]I.>N0F86E:= YM
MRC#I@$V$8):<>@9R4K)''2I=!:>Z4]T@EZ2PU>(D8RM,,2,5-PAB7),I,91P
MTPQ)D9$5C"9:%)RV$6GKB,S-<7JAYR)E#'%MX>,NY=PE&6C7J[ 98F$L8><F
MV%C*962@T-I%9B8D<5%Z_$(8QBB<NK3U]!5DDM$>GY!F9JI1>"\(3/K134,/
M.-ZSABL%&$/*,4QI4=4-$R4*"JZ)"A06A/3XH#J69KB2PP0KCO6(K'$4PGY1
M+&5C.$/AB-YLJ14WX1B4E%T2\<2RL[TGHE'S PVLDJ7\&2:E9VHVG]%+J*1"
MM0P<(><B(E%><LRLS22,XZ'IZA1*8;V5"].A=+GU]!8G%+N[,N</NPY>\"Y$
MJ.._+<>W/;O/3/7C]7N9G=#WKU=QYGE.GB^S#ZKFZ_VKW=^P,G]KVSY3U,I?
M1UG=CJAYMOU5V^4T\OW/*V7YLS>Q         '&CGOZN5^KH\M1E"V[>MN9R
ML_@QE?J*/K*3*_8QGO-RS6H         \;,JETIN<-$Y^#4:]:LZ-T0MM.*)
MELQS]Y>4\U.3?,#@2X]E;]X>WG;RU26V[E^C)7JK-"IV:_6O4TK#2>O>.<O=
MS/@WS72CSIQ\EN+MY;5C3YFV_*F'NND][OOBNCNG>\7RNY^9>5KW(GQ5OC=F
M8NYY/*JQ1G=[4Y3)U?JCYNJ:;M*BGA _L/JMXIH:GJ#K^'S3TG!$1TY4R>F^
M,<EJ:'C5G,W5FR;J[LZN^!DLQ9S=G*YW*W[=[*YRQ;S%F[9JINVKM%VA5TU4
M7:'5152Z7)IP9_/]'2G3MF)FN->C-[+%ULV1$9OZ)L0 PK]5^CM82US1C=7A
MPS.MXM4KM-3G50G&G9@E%*$\)L:<3;;2[:RFE9X8Q:N7CZ45LU1BZ,88P<=,
M3+>DQC5Y 0                      $IM$:52@YIB8J,:J*:FFU.G";,HF
M8BD#)4I-M*;A'LP(*!&DVF\5&';B2@;*C&$_@C*N%-B4BM5(H  $X8K7:,*Z
M*:X;2C!Q4X%R28B1T4MTU-3IC";TA65-*I4%)("@  &S?/.7 V>>F-/DJ^(W
M:'?2[N3+:3N^55/,N+T5Z%JI,M;)+,8<OSG9          !QQ[VEFW>[OO,N
MF[3M4KAW>%2480:RE]1CT)L]A]5)U8\?Y?T5U+IU([8?SSVK19/L_P#$[KMG
M*ZD^7@N=$[)Y?(Y7,[]7LJX_=7/Q^R58_/+L'C,^^>1\-\4U]"S4C5BLQ&S<
M_P VOK)S/B.MXK=%NI/#Z2Z,YZ99W+>3VU55:KFHP5RK3KG(]@Y3D?$>"=.-
M6/<ARZ^GXORFG;&IJ3COE78R];^Q4UTI8KVE4Y]?2<&CX5XA.K?.OJ1=;7#!
MRQS?.:-U.8ONF>MA\T<<:TOJW\9U3X3KT[T)/B&MLON]V5>3U.M].W5\8_-.
MK3&ZT_.&M]W=7KD^9]-?]75VZ1^:=7[JT_..M]W=3K/F?37_ %;^,?FK5^ZM
M7\X:OW=_NI\T>NO\\?QC\TZWW4'YQUME]].N5^:/0Z_ZNKXR3X7KQ_2M2?$-
M:O?NIUI\T_OG]6_C'YKUONK5_..K]W?[I\SC]/\ U;^,L>%:WW5I^<-3[N_W
M5^9_WS^K?QC\U:OW5I^<=7[N_P!T^9]-?]6_C'YJU?NK3\X:OW=_NI\SZ:_Z
MM_&/S3J_=6GYPU?N[_=7YG_?/ZM_&/S1JQ_2M/SCJ_=W^Z?,_P"^?U;^,?FC
M5^ZM/SCJ_=W^Z?,^FO\ JZOC$^$:OW5J3XCK4PONKUI\S^K_ *M_&3\T:GW5
MJ_G'5^[O]U5DNFM?DW\9?S3J[+K6,^(ZVR^[W3YGTUQ^K?QE_-&M]U;[R_G'
M6^[N]V3YITW/SQ_&/S/K?=6K^<=7[N_W3YITUOH]I5V:2?FC5IWK:$>(ZU<;
M[J=<GS1?C_SQ_&8_FG5^ZA?SCJ?=7^ZGS35M_P!6_C,H\)U8_I0D^(:NR^[W
M3YGC%URA]'5\9?S5K=,)^<-:O?NIUR/*8QJKZ/3J<->D3X/J[;K?>7\X:VRZ
M[W9/FFK;_JZOC)/A.K;E=;4GQ#5KW[J=9\T>CVG]75\9/S7K?=6D^(:OW=WN
MLZ<G2Y555IZ_:5?'J$^%:]*Q,);S^MQ>=J71;Y192C9KCMU52V:O:5+9GJTQ
M,?S3S-8GBBFUG;XC?%LVWS=-\Y36</(BR2C-U_U;1E^:=;9=:U_G'6VWW>[*
M/)-8.M_DW\8_-.M;G=!'B.O/].[W93YG]7_5OXQ^:-3[JUE^<=7[N_W5^9]-
M?7MOXRQX5K?=VI'B&K.=]U>M/FBA)UQ^K?QC\U:]>];0_.&MLNN]T^9K77_5
MOXR_FG6^ZM7Y_J?=7^ZOS/ZO^K?QE_-.O]U:GYPU/N[O=/F?U?\ 5OXR3X3K
M;;K:+'B&I]W=[J?-:?\ =/ZNHGYGU?NK67YPU?NK_=59--XW$M/IU=@_,^KL
MNMJD^(:M>_=3K3YF]=;Z=NKXR_FG5MCO6L?SAK;+[O=D63>EU_U=7QB/"-;[
MNWWB/$=;;?=[LJ\G]7T^F_C$^$ZT1WK97\XZLSA?=[J?--$:_P"K?QF/YJU]
MET$^(:U,+[O=59-./I5RA/;8_-6O,=ZU/SAK4[]U>N4^::W7_5OXR_FK7VW0
ML>(:OW=_NGS1:Z_SQ_&/S1J_=6GYPU?N[_=/FBUU_GC^,?FC5^ZM/SAJ_=W^
MZOS3\=7^>/XQ^:=7[JT_.&K]W?[I\T6&U7U;=7QDCPC6^ZMHQCQ#7KC?=3KE
M/FG37!?[H_C+^:=6/Z5J_G#6KW[O=/FG37^>/XR_FG6^ZM7\X:OW=_NGS3IK
M_JW\9/S5K?=6I'B&M7OW4ZSYITU_U;^,GYJUONH6/$-:O?NIUGS1_C_ZNKXS
M+\U:O3"?G#6^[N]V3YIK=?1Z;^,?FK5G^E!'B&MMON]V5^9SA&O^K?QC\T:U
M*3=:1XCK;;[O=E;V3R<6Z:+BBE'[)4XN1SZ?AGB$7Q_F6X3A@SO\1YF=3_)O
MNC2V1,S);L9-T5VJZ*TMBJ;KJE)].DV^(<AXG=SMDQJ1.'1'06Z_/ZE\:LZL
MQ9$YO>E[BS(Y>CC#FE=LTU4^SRN3A&MM-57+*P>D^;/;WI>(Z'*<K;KWQ.E-
M]V%-S]-__CPONYGUI\<OYB9NU;.6TJ37^MT.S'8MUT*K;J53=3<5JBSY<MMX
M9G&L/UMU;[;Z<&$-<S:@        !B_6H_)>0L92DYPTK_JKK^(D]V2<XZV.
M:_6F9_8][]#J)IY0QU/P=WP9['2 [^#7\JSF;##[K5_7W3[[]E]/]D\E$_</
M\\'UH:_MK\?G_P#:^Q#B=0^B#\.L]^NQFCYUNCW&IAHGKB2,V&?4PIA-U3:A
M\)2+=C1E.[)J145VF%&-$BH2D]6)>LITC;4'#LB0B())8ST2\)0A**ET>(;C
M<B@H2\87%9:^W4,4Q1R<(2TS&*QDD7*'AU?'$%(VLM.OQ:!L38DM4.G$8KBL
M9='D^.(VIM2,,/ .M:=)+J\8,66U"3QT(E$I[B24G.&C IC(HQ:ZH/Y"&%*K
MIPCT1P*,'-K3TZC*8AE&$*^G'RF/8D>\K4(:YC-(Q24,?$%50B]6O4,:42:T
MWJV]<.CY20D42#PAAYRY+AF*>B/B&1."J.$,,>T3CB8(E/4].F()GW"&EN7E
M&XW1F:M"GTP N*4HXZ8$3*4VH0UN/B"TKU01C/5H^4L5C"#+!(]$M4?.*>ZM
M/=$WABM0WD](],)1[2TZ3K6,L>SY2)M1PE +B:/+Y@;4J:6GRCK(B96<.@&%
M=ZRT*2Z0F/E,6H2Q[/CB 34</D$DUHQAHJ\/XA:]#*O0J\(V)(\(1BNH@OT*
MCC/RC:FW#(JPU-]N!((SW#IA%X=!:E=@YZ80TPCCT$R(P&WI4M18(ILS-,_A
M(5I&!LP7%O5*/@%<-Z;-["TX;PW3^^N[OMRTS3SOT2^/ZL]CS7@6/B>C\I;V
MP[VO=9_U"\MNGAS=S_Z+9/SO]:?T]S/RMW;+_2W[,_U$\,_(]+XEKD$>OO>P
M          V6YU_P>HZZ_K6(QFBQE+;GD.E3O#-)2BG+&,J=9ON[C7;-9ERO
M-#,
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MFF+CT4:.D7]VNU+>\Y&FAM
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M'>U[K/\ J%Y;?Q;W=]JV3\\/6G]/<S\K=VR_TM^S/]1/#/R32^):Y!'K[WL
M         -EN=?\ !VAZJJ_K6(PN6M(EMUR(3>\<UU/^Q-]W<:K.]+E<:&P
M
M                                  2<G5[]['/O%;I4(IV;6F$/L5\_
M,SZT/[P>8G^II]DOV(^H[,1[*[Y_KW=L/7Q2G[&G3"E+JD_"?*=WTGRP^LM+
M\/,QE5C1ZK[3;S7TGR.F_OP&+(  !6H"M0
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MU7**6E55!O VV^=;QQW6,S$32<V:<3&VZV^*VY*ID
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MO%2=-WX.FUKMG&8<K30V
M                                                       "3DZO
MOO8OYQ>Z?[Q;_0<P?F9]:+]X',? T^R7[#_4>_=5?\.[XT/7NJOL*26A:>AH
M^4KHIS%9G:^M-*GIIHPMKT*GUQ\QLYB?^IZW3?WX H  AK4,K44R
M                        AC<!BJFQ  !#&<U#$4V(AC<!BJFQ
M    :=3:KH:UF[3B)B8E+_P4M:\XU4O7+P?BFC4CS?+#GT)I=1^IY:IOFQR]
M?_;62^W\J>[^H,Q'K7RL?\6SXT/6?:+^[[Q7Y"[XESNB\+_P;W!^\NZOM&P?
MLSX9^C>7^1L^+#_/IXA^DN9^7U/CR_NG:Y0          XV\^6_89*6BJ$\?
M7CU0.BRO#38PO[LL^1$?F^;E+9IBXX>IHTDU,F%E*PY'FAN          #^+
M=LW?:77E4U<QG5!/%IQC*#9AH7Z$WWS%N,>^NMZ6[1BR)QV-:QE\S"U<S*IJ
MN^E[6%2A^-@8ZNAHZE\W\-9V)I7ZL:<:=\LZ\M>N5JJJI44T_01CIU]1U6WZ
M=FEP6QL<\Z>I=J<4S@\VC:22V$H?COD.?3B.'+AW.F[/":LHU?2_UR^(V4CI
M8XD:OI?ZY?$1<2-7TO\ 7+XA&],2-7TO]<OB+2.DQ(U?2_UR^(G4N)&KZ7^N
M7Q Q(U?2_P!<OB!B1J^E_KE\0,2-7TO]<OB!B1J^E_KE\1:1TIB1J^E_KE\0
MI'28D:OI?ZY?$*1TF)&KZ7^N7Q"D=)B1J^E_KE\0PV&)&KZ7^N7Q$7$C5]+_
M %R^(1O3$C5]+_7+XBTCI,2-7TO]<OB(N)&KZ7^N7Q Q(U?2_P!<OB!B1J^E
M_KE\0,2-7TO]<OB!B1J^E_KE\0,2-7TO]<OB!B1J^E_KE\0,4A7]-XD*[O?2
MD])"I:8]$$O&*UV4,5C5]+_7+XBTCI,2-7TO]<OB)U+B1J^E_KE\0,2-7TO]
M<OB!B1J^E_KE\0C>F)&KZ7^N7Q%I'28D:OI?ZY?$1<2-3E#9Z8IP[("-Z8D*
MOI_ZU%K'04GI(U*4-KIBE'L@2=QB1J^E_KE\07%BW<>"AVI^85GH3%E&KZ7^
MN7Q!<2-7TO\ 7+X@8D:OI?ZY?$#$C5]+_7+X@8D:OI?ZY?$#$C5]+_7+X@8D
M:OI?ZY?$#$A5]/\ UJ+6.A*3TGI+\=X*8?'$3N,2-7TO]<OB(N)&KZ7^N7Q
MQ(U?2_UR^(&)&KZ7^N7Q Q(U?2_UR^(&)&KZ3^N7Q Q8O:<O9J&GTC&RVDUI
M1+JT:-=%53@[2=.G[)!X>9C5LB^W.I;,QL84JW175;:@JE-3<5HGI-<>AT8Z
M+FV^9OB-L/)LT*W;III4$HRC'2;8NB^.*,6ND6X1DU"@           .-'?"
M_FU\XOXD[_\ ]$YDW\M])TOE+?C.?FOHNK\"[L?))WE_#+CG^-W$G^F\Z?8W
M(?1K/D[?BP^8_&_P&G\._MEBG)([KGJ^KDACL;[(I;%%@DNDSK,L(QZAOHDQ
M3W2('%Q4/&5,(Q)3@X+J'6O60;4WXB8)6#0G#7IP*;:)A/%#<N>&U8.,<7X"
M5V)781FM,(]$2T6F!"+Z?)\<1D5H>EVZ,!@8&$$_#\A*5Q,\AI:7CT#-:S&%
M"$7#0O.6J5&Y+4\5U$IB05=74Q!!CZ."7XHW[3?))]"7G*8QUC:Z]?F)!$2D
M)PQZ-9:E<%;A/3JU]I$SP1N,7J+&#)E+P=>DF+'%,(SZF7-<R>#E#'S PV#G
MA/Q0)D9$8M:YR+0HC6N2T:>L'4R<)1(F).,UX\ 848N3D\,.W$L*N,=.'0$R
M5XJ47,A"0A/"&G$M2JQBUH:[8Q)L78FF.K%]A=B;$<9Q[<!@N"ZWH9,<EB(Z
M<4PZF7&5F(V3BRJP9(S81FD6X+!/S#)<A*:G&,2DY"2G.(E)JBC. E9IM%C)
M>,22L="4_(-Z;YR-,5/\0;%V4DEIQ[1CL3'9D3T*':A@8;1SP6.GJ"PL6UA&
M/22E#M2&F/;#LP&XW"QC#'#L+L)R(M.,,1F4B896Y5T:FW$L5JEV4N</NPX?
M[0/D3##[N6_M[=YZ;Z\?J]S75#WKU=^D\I\+[3ZK6[/VMW7^P,K]K6SY3O[E
MSZ,LRMZOL//M^JNWRFCE^YY6V_-:/57;Y6=%V;",F1%        .-'/;U<K]
M71Y:A9WEMREN9RL2^]G*PJB]BF6KT*#;J90F-<6Y9J         !C5%R3@WI
MQA#HTQ),1=%),6&RDJ'2X4T[4\81QDYN8BR,KLX*X/'N9JE;5?HTVK2;NWKM
MSV5JVEBZZZFJ4DC3;JQJ1,Z4UHRNMNMNB+XPEQ;YN]]CNR<B]XT[KYE<U^']
MR[RIMJX\K:SMG/5K;IJJV:UE;MS9K6PY.#34S=H:&IJS-UM9NV]$+G-(R<-.
M*??6=R[<&>^:Y/C.O>MJJ[3:MYFU8HHHK=5;HI:CF))M'5X;RFIXEK3HZ$>=
M#5XI='A>C;JZ_P#2>R#DCSBX6Y[\M=P<T.#;U5[AWB&S7>R-RJ55=%&S.3JA
MZVL<YRNIR?,7<OJ]^UJY7F+.9T(U]/NR\KF-S9X!Y3;LL[ZYB<5;NX7W7G,Q
M:RN6O[PSEBS5<O7[BMVJ**;MRFM[53A%)GC-;4MLU[-*9X;KMG3+LT-+4U=.
MZ^R*Q&>Y^NM[VW?O7=.1WCNO-V=X[LWA9M9G)Y[*9BC,6,Q9NT4W;==-VS57
M14JJ:E@V=T6W1=/I(I,;'%JWUB(LQK5_7R53KMQ:5.'HJ$$H2P-45F9NG*6S
M2NB;:1F\TK8                                          V;YX_P'
MSW6O(S=H=YC=W9;3=W[]<K\G_8F>MW4TYK'D<O3F9@         !QW[UW^H#
MF5*/_=S>$O\ FUX]C]4HKZP<M\I':]!]J'Z@^*?D>K\2YT3ZE'-;Z6'^5,_T
M_P#&[A^@G@_T3'HA_FI\=_3%\_\ %N^-+-O[%AA\AY/1MI95X[FL>:GJADYT
MT]1SV_A+I<F5TL)0Z39C7<RQKN/$UXRQ)V"@TG''H%3&M%;[?$*8;T'"/PE\
M<2016B-I+'#QQ"TJR6A)ZQ-*H.#<(3U_(-A&56+4^EXKJ$+$X;E@DO(Y^08I
M6:D<-<Q0I[A!N?C%:%8A8)/X2^.)#-):_$4QZ"*6"%"DR3:GAK!A7#-<?R7F
M(GV"3>OQ0"Y)!+&7G^*!>HKT#Z,%YQ!&_-#+"8Q4QQ?7(Q%T04_Q1M3:E44B
MQ*Q2HVQ-M"D+'6\<>S D[D8Q7AP[,0RI+*#77H%6-8\B.+E&>@+%(QV$M?;J
M&)B/0]8&2@HO'Q%F=B8S@2V?AK,=IM'%KHU_(.T[6+6U%Z-6LNY8P649,;,4
MV8I/'3H&Y=S*&*\/1\<2)5CA-8EZUSSR$HN!9P":F,##)DFNHDQC@QF)23G&
M'8,5QA(+2I/IU!<=F;)."Z-?R$[6,^^**T>,325FDI+67:8HYLM*8[%RAE*"
M6AZ?D,=J;:L8X2PB55DM$&ND)C/4NB&GX,FVNPVUV,8.&,$]./B+VK6*[PHS
MNTOV=-3IE.%4<.PG*S$7WQ'0VZ-DQ;-],.GH2U2O2T>C7/L9+YIRU\SM:+YR
MC?#WP>XI_A)S>G_Q7=LO]\M'SO[>,?5[P_Y2]^H__P <]?\ <?C_ .3:'QI=
ME0^4LGZT@         !B_6H_)>0L92DYPTK_ *JZ_B)/=DG..MCFOUIF/V/>
M_0ZB:>4,=3\'=\&>QT@._A_.KYF?OM7]?=/OKV7_ *D<E\!_G@^M%^^SQ_\
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M/^H7EM_%O=WVK9/SO]:?T_S/RMW;+_2W[,_U$\,_(]+XEKD$>OO>P
M   V7YU_P<I^JJ^MJ,;LXZR>[+;GD0F]XYKJ?DI.F[\&UV=Z7*XT-@
M
M                             DY.KY[V%Q[QFZ5_N-O]"S!^9OUHH_\
M<#F/@:?9+]B?J.VU]E6I/]>[MAZ^-I*RDU#T5/'0?*,Q7F8ZWUEIX:T];"W#
M8J^$3=S6'-4CH=-_?@,5  $)P@6(H*
M   I40E(%*  ""8J!*0*4!2HA*0*4        (29H B:BE&E7ZU)NT]J7_@Y
M:U4TJNN7B-&MAAO:-#.7ZKEHX<U^7W[]9+[>RI[OZA1_ZLY2>C5L^-#UCVC?
MN^\5C_@7?$N=T3A?^#>X/WEW5]HV#]F?#<?#N7^1L^+#_/KXA^DN9_*-3X\O
M[QVN0          .-O/FE.QDG"<*M?X\WV1$6UVL+^ZU.1*3L9MN;5-,'_4#
M4RHPLK6(<CC0W          !Z3/?@]]+G+W'^Z_^$[DA>HRW$E><]B[U=NFZ
MJ:'1>J3V:[MK32M)[;ZG>KW*^-<Y?9K;(C#I>J>M7C6MX5H:<V3PV7S29Z'4
M@R7](X]X_P#,K%ZK>MBY772JJJJ\C8JVMI)R56=<(1/ZCJ>R_D;[>/3BZG7/
MVGI]WKK\WU.#TMU]U/Y;7]:S_2+_ 'C5RAW'O;+IP35/S"Q#[<@=.E[*>0OT
MJS%W76?M)9Z[1-_G:TQ/1_*6C7_2,_>.;2;WIEJ<94[OL)/P9PY[?93R=L4\
MZ?+/VC6]>;(U*1JW4W5^VQ7](R]XWIWK87_,+'^.%_97R<Y1/NS]IJ_WU'XV
MZ?Y=9_[C+WC<(_=:QU?,;'^.EGV6<EG2ZG7/VD_WS;^/N_EY3_W&7O&_W5L?
MX#8_QT?LKY*=EWNS]H_WS;^/N_EY47](R]XY^ZN76K]0V)_]-$>RODYV74ZY
M^T?[YM_'7?R\K+_W&7O&U_UM8?\ S"Q_CH_97R=,KO=G[1_OJW\==[O\Z?\
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MEE_OFVOX6?=_G1?TC+WC;QWMEU_S&S_CAE^RODJ97>[/VF$^O,?CKOY>4_\
M<9>\<_=6Q_@-C_'2?LLY+HN]V5_WS;^/N_EY1?TC+WCG[JV/\!L?XZ/V6<CT
M7>[*QZ\V_CKOY>5:OZ1E[QO1O6Q_@-G_ !T1[+.3G*)]V4GUYM_'7?R\K'_W
M&?O'/W5L?X#8_P ='[*^3Z)]V?M'^^8_'7>_]MDOZ1E[QS3O7+_X#8_QT3[+
M.2C9=7KE8]>;:?AKOY>5/_<9>\;3?^5<O"7_ !&Q+_IH_99R71=[L_:)]>8I
MAK75_EO1_P!(S]XX\-[9=?\ ,+'^.E_99R71=[L_:2/7J)SU;H_EUB_I&7O'
M/W6L/_F-C_'1^RSD>B[W9/\ ?-GX^[W_ +:_^XR]XY^ZV7T?\1L?XX6/97R4
MX4N]V?M)_OFW\?=_+RLJOZ1;[QR/[:VNM9.TM3P6=-L>R?D8SXO=G[3J_P!U
MV76U^=W1/E^V_C;\_I''O(LGNO,W<OO6W[=56MBOYG:]!1>TIY[2C5K^R_P[
M3TIOF)BFVL_:;N6]89YG4]''.W1A,[=GE=RKW-?>QYL]\SN=\)<X.<E5-SB[
M>KOTYJ]313;53MTY=KT*;EQ*=;TG\C]<?5[0\(YB.4TYPGWGMOJMXMJ^)\O=
MJW3Q<-U.M[;K:2H23BE'RGJNE9Z.R+.A[/=6N.;,V,0           <:.^#_
M #:^<7\2=_\ ^BLR='*Q7F=+Y2WXSGYKZ+J_ N['R2MY?PRXZ>C[[N))_P#Z
M;SI]C<ACRUGR=OQ8?,GC4?Y.G\._MEC2H]"?F.VZ<'K&I%8HDH=7G$PSMPP(
MSF\/.5)I3!4H2T>0A,Q.Y$IOH\Z+7 K@1PE#&#Q*&S+">L5*FU/&0IAO*8;T
MV<=&I?**E8%#'X+XXB25PZ(]N S3,46^A^89=:Y=9'3XOE%-A38D/ L7\@Q5
ME*&,M?:2,$F:W51-2UH4F,":S)!P:T:!7:E=HMF;U:9Z1BLU1/#HCXRK18*,
M\7HZB=3&O00Z.R. 6I--Z6\.D)FCCAXOE+O7>J?@6GY!,),>ZCA'X3&-%CWE
MQ>'R&-96D1M$\8LN*3$;".#;UE3=!!I.&.HA4T1<_$7;2%VTA(PGBV-QN6.G
M1HZ11*>Z2;?3#Q$RQ7(:B]3\,2E:$9].E?*3 V#CA#$1TI'2=+Q6*+N7=L'.
M.K7\)XCM3M(N'3H>O60HK>F./02F-&44VQBCC!QT0+$8GF[(,5"$%UE8Y3O,
M&M2C,9KF*:AXQ/23A-5:QC*,.F!#;1$H)O2H%F5SZAZ6UXR5DPRB3%=>/8,F
M.222UI]F!<US90G'X:B)7"B3?;BRY+A U)2^2?CB(S(S)-X3TSPU$3)<5A&/
M2#*43EC\A9)S(+1/Q#%96WZ]&N?R%CO8I=E+G%[L./\ M N1+>C?E$>S/;O/
M3?7JD>KW,]4/>O5W#F>3B?NOLP^JUNS]K=U_L#*_:UL^4[^Y<^C+,K>K[#S[
M?JKM\IHY?N>5MOS6CU5V^5G1=FPC)D10       #C/SW]7*_5T>6H6=XC*6Y
M_*U)<,Y6"GL43_(4&[4BEL)$S5N2:5         &G=J=%#J2BTB5\Z(V)=-+
M9EXJOTTV;ERZ]BU;MUW;E=4$J+=M.JNI]"2-/'37OMF?,B%MCCMB+<Y=6[WK
M_O8.+-V<4;\[NO=UWVMR9;==-W(\;<:9.NF[7F/G-%^S<R66=C-47+7L;UJ$
M5-OP'CO#>9T^>C5MY6)G1TYIA$S6:Y]CRO,\G?R-VE/,S$:M\5I,Y>Z]$_+O
MNS]Y_O0;PKWEPCP?QGQU5GLSM/B+>N=W[:L5W<S=I==RV\[;O6ZK>UF(J#:2
M9[[R6AH\IX9'-:TQ%TQ/7[F;U7G.8U-3Q+T&A'%IUBLQE&/2\#O%]U/F9W5-
M\;CX2YR;KJW=OG?5[*W<IEG?=^JVMO;A[16[;:A0S3ZD3&IXAJS-*\7V6?KY
MK</AVE-DS2F='=U]UI;5GN0<G:-C9I6[;KV8QC3]A@:?6G4B/%M6=E8AS^KM
MWI/"M*Z-L2]8OOXN[AS^XZX9W!S;X2XDWMO?EGP31<S._P#A3==>;RMS=6RL
MQ59SGZCC7FJ/:UIMN&RST3Q&[6CU@\.BR)C0NOF+IV5SQG*,.E[YX5=H3X5S
MNC?/_4<%;8Z:9MMO<@^\$XDXASMSNI<W-^W-Y7U2[/+?>.\;K^<VK63L6:,U
MD;ES-9FJ]<V;E4DUBI8G]0\>\.C2OCF-"8NI9;7A\Z,NF*P_G'AG.Q-MW+<Q
M,VWS?,1Q8;:;7:(R=MV;?LJDHIOTXQ]HHRJATH]3NI7#)[%9;%L<-NQYABS
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MG3=^#HUV9RY6).+;<4X04,-<],3GQJV*4
M
M       ).3J]>]AC_*-W3*/V&WIA#[%F)GYG?6A_7_F/D]/LE^Q?U'?W4ZGP
M[NV'KZC5[&EPC!*4E]"]/4?*,T^<TWOJ_2KZ6>FK&CU7!0Q-W-?2?(Z;^_"&
M#(
M0PG-01F*9HTZH[5,,3;92DU+OP<LVW"&CY37S$93O<VA/G4V/UO+7_6MR_\
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MJTKM/YOR?I9Y>V=::ZC^HZE..:9-4Z6            .-'?!_FU\XOXD[_\
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MB@       '&?GOZN5^KH\M1;.\1E+<_E=_!G*_44?64F[5[L,8[S<DT,@
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M+V;]NZHR:4NSSG=$TT8M:;;*:LWSD\LP;0
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M^-J:FSKA[Y?<4/\ [Q\WEI^:[M_1+1\[>WC]7O#_ )2]^HG_ ,<WZQ^L$_\
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M0A)Z=6R=%T>8UVX3,.6!I9@
M                                                         "3D
MZOOO8OYQ>Z?[Q;_0<P?F9]:+]X',? T^R7[#_4>_=5?\.[XT/7NU5[)1<&Z5
M.$=$?(?*-TQ\XW5?6FG7TL]-6-#]"J<8XRAA@;>8I/,Q.YT7]^$#(
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MNF??>9THBW3MLC9;$>\_HUNI4QI6T]48&C5G*&V-[-8&RW) H
M                            #9OGC_ ?.]:\YNT>\EW=EM/W?YYJ6JO^
MQ,M7NI9,>\Y>'.R          #COWKI]W_F7_%S>'VM>/8O5/]8.6^4CM>@^
MU#]0?%/R/5^)<Z)]4LWOI*;6],_+#_C=P_07PC#E-](?YJ/'<?&-2?\ BW?&
ME=I^Q3=,.B/4>3TL,GC=>MW,S7":,XIJE)1\1S6S_F7.>E)F4Z7-+LB;3=M(
M0Z4*E:]9#HAT%K%<2IHU+5VZR;3;O2'3"&/F%>A:JHI_31P>'6$FD[A)K'#2
M.K,KT9K"*Z%IUDJ5HQ>F7CP,HB95DI8+'1U$G>C%M8EFD158C8)[2PGH\)-Y
M,4G<-%P%FTH*763),EA)+3,F\KM8ZYZM&)51224<>C4%G&:LH3:UZ?&-['>0
ME)Q3!MWHL1*SDRC..A><O]&FUC3#>C71#M$3181)3?P8E<5<\)Q\4"8Q&*1@
MBBG@)6<AXB",E<8J,_$$PHKC!]A!.C&'CCY(%WF\;6.#\/0.PB)RV+JEKA,B
M>4::GB]>H;EC'!C%0>LNU=JZUH>GY!CFF\4X3BGT0P(9=<#<=)8RWD"C!0[.
MGXH PJDFHKLQ&*XUHR;C&44(CW6-/=2,<?!\HI3!:=!".G'H%2M%_&^/QDWF
M]'3!8EJ1*04/)YPJZ-2\/RXCM3;O$]#P%,2FU'#7/J"XJG"*?@%*I2J1VIK2
M,H7+-EHA".N9-[';5(M/94VM/C&]:;95QPT^7XH#>1TI!.&B,>DM2LPC>&@R
MX<5B/=97$O153V4ECCH<)&'*UB_4IDV:5M-28NE;325<,'37#P,EWT>^9:M2
M,8ZWO?\ <4?PEYO_ +$W;^B6CYW]O'ZO>'_*7OU'_P#CF_6+Q_\ )M'XTNRH
M?*;]:           Q?K4?DO(6,I2<X:5_P!5=?Q$GNR3G'6QS7ZTS'['O?H=
M1-/*&.I^#N^#/8Z/_?P7_P"5G,SIWM7XJ[Q]]>R^/_17(_ E_GA^M%/_ +V>
M/_E7V(<4*)3AXSWZZ*S1\YW8LHPCJ+-:T2E6-"TO#X=I)FJW3LVLE&*)*2LL
M8P[(A,5<&^G5\I(2$@UU%PE<)582TZ22DYI&,)1<^@N74M*=20;+,PM85*<Q
M,QL2O0D'X"+5827BZ=?5 (0G!O ;S957",_!\I.HZA:H2>'8.TGWV,7"4WJ^
M5E6D;62ZNM1P[=).M)8REH<XE57%ST"/?2/?7\;\-9-Z;TC%O7H\Y>Q>PA'!
MQAHAKZ05IF):7@)DF=D9C47'1K&[:1T;64I/0B;DW,&L)QB5D:.OS VLNI16
MB?P>).UCVHY2T:"PL8X[1I)] B2)1O"+ZNG6%C<JE",H><)U+.+T8=)!C%24
M(XSP+25I.9+5$L[@Q<8"(FALHK4NK'M)"0A55K'L@2J1*0<WHT#:M=BJ2;ZA
M,).)&4/AB*8U*8U&HO5KZ-77$$*X*4)$W[4W[6.$_ 5EN9.,'JE D,8-*A)3
M@QUKUBDX"<8J3C%6)G564M$XX+J,$Q8P:FL-9=R[EBXSG#!^41'%A"4B@L8O
MM$]!.5$4:DM4Q59I$[U7A\4!BDI!C/",UK!9EO#=3T?=7=WVY9-7.33EK_@S
MV/+^!?I/1C_B6]L.]IW69\A>6_\ %S=T.KYK9/SN]:?T]S/RMW;+_2Y[,_U$
M\,_(]+XEKD$>OO>P          V7YU_P<I6NJKZUF,Q68,XEMUR(C]T<U#4X
M^"DZ;OP>YKLSERM-#8
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MY493I3_LC=9/FM<VS69V-;D4TK&;48MTTZ'^,+?&%4MQNKL<CC0V@
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M9?5<W7^U>[OV!D_M>V?*.IE+Z.L[L=4/-M^JNWRFGE^YY6R_-F;V(
M  XS\]_5ROU='EJ+9%)J1E+<_E=_!G*_44?64FS4NK$0QC-N2:F0
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MAG&G.IA"77Q9FS332:P>!*4P99XJ
M        &S?/'^ ^>ZUY&;M#OI=W9;3]WW]=/ZFY_8F>MDPT\G+PYFP
M     .._>NEW?^9?\7-X?:UX]B]4_P!8.6^4CM>@^U#]0?%/R/5^)<Z)SGFM
M]/'_ "IO#[;N'Z!^$Q7E/)#_ #4>/?I?4C_BW?&EDO1L)-;,\(QU'EM.<,ZP
M\7KQ_P!1,4I-&HW"FEXG-$5U+FBF,L52^HV56HFEI$DUE"J06N6F1"JRBI3T
MJ/G"$%JCJZ?B@#%)PZ!VKVKH7BZ FU7!X8F5:12#+/)(-N>DQK7':5B(P6.$
MHN?PU8$I[B=A!M0T:_D':N_:0EC+J^#Q,J3.)7'>Q6))6<B$NEZ!4JRE!:7.
M!-J;4G!0T1+@8(W"3Q?F"Q&V,E2A%K%X/JQ"3/3D.:CA 1@1A-!.*UQ[, 3%
M#!ZD^T9F<;U4%V^83&-"<4;A5\-0C(C(E&,8]@V&QCA%F5)HRSP9PE",4_$8
M5VL=N])N;PUE,(RS.G'7Y!N-QIBI_" W&RAC]5\.S =AV)HQ[(!=JPE&(JE<
M:$(1,HNP*HNN!*561+#I)4J81CX-?:#-8[2C"$- A*4FBMJ C"4B)J3TN-/P
M[<1/OKVHM6E8+RB2?>6+6.+\Q,S-)PAI\FDN\WJV\,7K\9-Y'2C;EH+0I!M"
MA04&W&8,8ADHPU/63!,&$=$9%9;]J)0P<>D4P)QS9*KHF*)0>AZ9S&XCH(J+
M?5#SBF!2:4(QT1Z-18K&1D75"FA=?G'*UX]2N;+2FM\S*6GZRA]#7Y&2_P"B
MWI?&4[X>^/W$[CQ'S>_8N[?T2V?.OMXFOJ]X?\I>_47_ ..>*>LGK!^2Z/QI
M=E,^4WZT@         !B_6H_)>0L92DYPTK_ *JZ_B)/=DG..MCFOUIF/V/>
M_0ZB:>4,=3\'=\&>QT@._?+O5\S>G>U<>RN\???LN_4GDO@/\\'UHOWV>/\
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MV          &RW.O^#U'U5?UK$=Y8REMYR'_ &PS?55Y*3?=^#:[<Y<K#0S
M
M                                  $G)U??>Q?SB]T_WBU^@Y@_,OZT
M7[P.9^!9\67[$?4>_=7?\.[XT/7S5^94?4KZUGRC'X?ROK33_#7=;2MKT*GJ
M-_,X<SBZ+^_ 10           0UJ&5J*9
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M?POLP^JWNO\ :O=W[ R?VO;/E+4RE]'V=V.J'FV_57;Y33R_<\K9?FS-[$
M       <:>>U+=&6>A5V_&ZC*"W;#<SE;_!G+?44?64ENRA-K<HP4
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MVLL;ENB[3LUJ*Q@;;;IMFL,+K+;^\S25*26"P),UFLK$1$4C)2*
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M
M                                   ).3J^^]B_G%[I_O%K]!S!^9GU
MHOW@<Q\#3[)?L/\ 4>_=5?\ #N[8>O:,;5/13YFCY1NCAU\.E]9Z,S.M-6-O
MU'V^0W<Q](\CJO[\!%           !"4@"T@4
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MZ2RM(G%OFJE4DTXII-/6G-/M-38H
M          &SG/'^ ^=ZUY&;M'O)=C;+:7N^QIS34)-5S_J=!EK8XL;8<O3G
M9@         !QV[U_P#-_P"9?\6]X?:UX]B]5/U@Y;Y2.UZ#[4?U!\4_(]3X
MESHGO]=;Y<(O[J;PA_A=P_03PCZ)Y(?YJ?'OTQJ?*W?&EFHU6?24''#5-:=)
MY72B*82\9S,W?.9F8I-/L,WZM+U?B'-;^$NAS1G,,&DM,^HV,HE8M/S"B4BA
M!M%F[85-&';'I)M-J2^7Y"XYKBRT1U8/Y#%BBBIZ"RLTG#:*F.F0J5(K5%:
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MJW.7*TT-@
M                                            DY.KY[V%_P#Y%[I_
MO-I?\#?/S,^M%^\#F/@:?9+]B/J/5_95?\.[MAZ^'%44U-0DM,=#U'RC,UU_
M-QQ?6>G6=:4HG14_'J^.)MYFOSF*X8.B[O0Q#(
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M$WYO%@.QCV)T8]&O3B7>;R6B<='RA<=H],7&&*A (2T8]HQVF.W)%+!RTR\
M7K5)N,<9 (N$82ZR42B12P7:5:3M72XX2B0V;TZ(RZO@\2[SM6+;U$PH3$1G
MF34O RX24KB2F\8Z,,"8D*X1CI[25V%)F,,F5$=NF,L>G09VYX,9[LT<W_=A
M_P#J!<B9Q_RW;A+']79#P'IGKS/_ *>YF-T/>_5VOSGE/A?:?5;W9^UNZ_V!
ME?M:V?*E_<N?1EF5O5]AY]OU5V^4T<OW/*VWYK1ZJ[?*SHNS81DR(H
M !QIY[)[&6JT*NB/AJ%G>HMO0W,Y6?P8ROU-'UE)E=F3$Q.+<HQ0
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MHIUF^[N4:[<)FKE<:&8
M                                                      DY.KW[
MV'^<9NI:/8VI_P"]7XRZ#\S?K1?K_P Q.WT=GQ9?L1]1_P#=5?\ #N[8>OEK
M9MI1B]E=&@^4(QUXZ*OK+2C_ #IKTL*/5?:='-?2?(Z;^_ 8,@
M                     A)R P4,XR12@            $,)S4$9BF:   !"
M3D!@H9QDBE #"O1V^0SLS8W]R1Z.TQU^Y'6T:'>E^OY:1_"OR^E_UUDM.'ZN
MRI[KZ@T_W;RGRMGQH>L^T7]WWBO1Z"[XESNA<+Q^]SA]0E]Q-US_ .8V-!^S
M?AU/S=R_R-GQ8?Y\^?K^<^9B<OG&I\>7]\ZW,          '&_GQ^89'7Z4%
MK]<W1W(39+4Y%?K;-?D?)09:G=:[>_Y'(PYVT          .M1_2=?YC]7[Y
M4?6WS^F>S+]*W=3^4^U7]&:/PWS_ &U+=]AK^XV_K*3Z.N_!4?Q?Q>9CEKIC
M[F.QY.7_ #%=7Q&6G^#W.?PJ/^CNIG15HZ?B$9-&G'FS.],4DL9ERQ;B<<?2
MU?"6 [$[%C!/7I\Q.Q.PA.<XX%KT%<,!_B^80L)+96O1X1M-J8]+95RZF6"Z
M5YS'.6.<D-+?PP+NA=T,DXHC&6+DXXQ+&*QC%!8+6M'63K61I04]>@I$F/3K
M\P3(@M+C#Q1!CL->N1*1+*)F,ECJ9)P+8W5%&+>!6.%$Q47X>TNU<I$YSQ1.
MK))W9&F&E8/Y!V&_8L88OJ\XZBE<D2<8Z2X9+6,B"36@F,IC*:%VE7;(T^UZ
M!7W"ON*H0CI0DFM:;!I:H=/R""*DVYX$P\J8>598?&,<S'-).;1<=BX[!--Z
MGY1L)P@AIJG'Q> ;H.H@L,'X1CY"L^0;78])*>ZE/=)PA#QEPK5<*U,>AHF2
M9&#F\.C65<X,-,.B$?& 2A)Z23B2)QA*+785.Q)Z)DI#/BG:L'/L@,$XIE7&
M$(>,11CE*2;^$Y>*!=AC0TQ<OA ;C92!2C$3BLXY&$(],1FF8TM<UC+P!8DP
ME&'9B,TS10PQCV8!5<(J/3$=1&XU1E"/;X!U'4CC!QQ4/&.HZF>5_-<->DQT
M?PC9H3_FS%7\;?'ZWS_U5'G.77BMUT;X>=\(^G?_ .=W8^CE_1RE#W=7+S^_
MYSZW*GSW[4/TW'4_J_LLFO@ET_\ $N[7OT/YD_J            -.Y]#V^8S
MMVL9SAQL[X/\VOG%_$G?_P#HK,F[E?I6E\.WXS1S?T75^!=V/DD[T7_?'CIZ
MN+^)/]-YT^Q?#\>6LG_AV]D/F;QF*:.G\._MECICH9VW9/5-3NHH0\ G.6^W
M^BR@G+46M,6,5J3U>,)@>E&>'8,":>5BNK#3\A<5E=$(0?P8WF\BHQT&'])E
M3S$239;5O53FL?AV8&6[8PRZD<&Y3\6@;#*#0XN<I#L.PFU!8#?)OE5+"<>P
M23CF+%QQ^0;$V;B#AA#QQ%5J3URUP^#Q':8>5<)8:M)$S1O!4_#PEZUITC:>
MF$!&!%8)8OPZ_B@#'8F$7@]&GK!FLXQ3Q\W62#K'&'1Y?B@7:1F/#5#1UB",
MTA'#1X_B@,BO2L4\7V?*#&,B4M4_AKQ':8^4TP2\9*1G*\4](^F7CB(2)F@J
ML(]I:)1%-0P2&U=JI1EBEV"<#'9F:ZFNJ?82>@W+A"'@U^$=9CM1)M-ZX%PJ
M$6XP\ P@I$*]7BUDA(8PZ<"3M;(V>4C%SP,J>ZPI[K*$,%XR=:9YL<&IP?D*
MRS5-IO2Y$S39AD;/XNHM2M2+PTZ_&0I&>QE&71I%$W;6*DI3\0)QS,'+#3T:
MAG"YI)34X8^8IUC:E#1$=9$=*PZ,-$<0E4@IZ7H\X9+"4=/RDRPV%9FX4(N&
M DK2*2-X14$7J8]68H1CH^"&[:M=FUE3#;I@I)MPCB2(GB)I29K27.'W8;3]
MX'R(</\ KNWIT_/MW^<].]>/U>YKHI#WCU<^D<I\+[,/JM;L_:W=?[ ROVM;
M/E2_N7/HVS*WJ^P\^WZJ[?*:.7[GE;;\UH]5=OE9T79L(R9$4        XS<
M\V_L$%&%=&GIJ+;FNQNARM_@OE/J:?K*2W9LK\VY)BP         &E7:55=%
M<8.GQF43A1)BK"Y8INQIN;-=JI0KM54JJFM:JDXITO2M)RVZ$1G-8F6SCI&&
M</Y-OAWARMU5+A[<E+;BZON7D(U-QBV_F\8Q.F*VQAA#52)SAG][?#N'W W+
M_FK(_I!C&K=Q<-9]U>&VF4'WM<.?N!N3_-61_2#/BNZ93@MZ(1\,<-554UOA
M[<;KH]2I[IR#JICCLU/+QI["5F<YE:1&40]>7O%.XKRR[T?)/BG9X3W5E>8G
M#^YLYG^%M_Y#*Y?)9K+7<G8S.8N6[CR^6=68]K2VH.<83/'\[K7<C;^<M*V;
MM71B;J=,1F\AR&G;S>M'A^M=PZ.M,6S/1,S2'7"]T%WON,>[QWF,WW=>-,]E
M;O ?$F^\]N:JSG<G9=[*9O=^;M[MRU=C,WZJ+EK[)0XJE3TGO7JU-GKYZNZG
MC%W^1SFE&%N=:>Z]7]:-+_9'C-GAFE/I]#4V]%7=3RU:HRM%RT]JW>HHOV8N
M,+=Y*NE1U*EGJ'-Z\VZD:<Q6<8]QY70LII\?3%7D6+]=QM54PA@93$6Z,76]
MY;+INF:Q2'EEMFL59A0                                       &S
M?/)PX&SSZ4O"JOB-VCWTN[LMIN[\OU2H+17_ &)GK9;TLER].9D
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M$(5G)DHN*:BM>$2)-(QVL5#2O&7%9KL98STZO$3<QW(VU+47/%:5Q)02CAT
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M4Z_K63*2OFRVZY$?MCFI1D]/U)T7?@VNS.7*TT-@
M
M               DY.KW[V'^<7NJ']RM_H5\_,WZT/[P>8^3L^++]B/J/_NJ
MO^'=VP]?"7V)?4KR,^3YF?G$=;ZTT[>'6GHJQHCL-PQC'H-_-3_U,=3HNI-_
M4$4                 (8\0IE&(       ACQ 6)J*4  G$0QX13*,
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M33CXBX+@2AKAV 7#&<<7Y)$1(:,88:,17%9RB>DDNAZ\16L[EF,*["$)X>.
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M-;-,/AB.5I%U_4RTN_):4%4V_H:I=C)J5CEKIC)C?-:1OA[X_<4K_O'S>?\
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M/^H7EM_%O=WVK9/SO]:OT_S7RMW;+_2Y[,_U$\,_(]+XEKD$>OO>P
M   V7YU_P<775];42<X)[LMN.0M*HWAFE&,JM&M4]>HZ+L;&$367*\T,P
M
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M          XU<]O4RG4_[(W6]QJ_I2\KD7^89KZFG^Q,K^Z6]]R+.=M
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MFJG32G2HM.4X0C")JF^WNRSNFD5V/(H;=-+>+18R91CBR*
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MX0&"8'0I/2AUG7D:(>#IU@VCBNT0119:<?AV8$ZLDQV9,8*"UEVLMJQ4<9+
M)C3>--MR!A$"ZI]9=I/O%[U:.WR,<KWKY71[\EMMJKZFJ?8S"_Z->E]*QUP]
M\?N*?X1\WOV+NW]$M'SQ[>?U?\/^4O?J)_\ '-^LGC_Y-H?&EV4CY2?K6
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M<<A]G[H9G9PGK_&ZYF^[NL+:\4U<L#0S
M
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MHY_T<O\ ].KEY_?LW];E3YZ]J./C=)Z']6]E7Z#N^4N[7OS/YD_J(
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MR-.VEN36JG;C6HOKU-"EML\5[;=$7869->G!2AT1B9UB<8R8J
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M!22>GZG6=%V-E6NV?.Q<KC0S
M                                                           $
MG)U>_>PO_P#(W=,</8VU#_>;^D_,WZT4?^X',? T^R7[#_4?K^RN_P"'=VP]
M?*A[)*$/14X]#/E&['F(Z*OK33IZ:>MA;3V:FL%B;N9I',TW.F_OP&*H*P!*
MP*4                                                   $,>%0L
M11%*   !I5QVJ8&W3C-+_P '+4JC3CB\.G U:V-L;I<VAW\7ZSEJE^%CE[/_
M *ZR4/\ #\J>[^H,_P#JOE<,/2V?&AZU[1?W>^*_(7?$N=T3AB/WN[@<9?<7
M=<O^8V-)^S7AWZ.Y?I]#9\6'^?/GZ_G+F>CT^I\>7]XZW,          '&WG
MO^89;J_+FRWNC4Y$M?-LRM+5+AV4&=_=:HCSZN1QH;0          ZU/])T<
M.X_7K^Z5/UM\_I7LTBOBT]3^6>U.[A\+TM][Y_MN'W.L:_8VX/\ (4GT?/X.
M'\4\8^C7]-+>QY-C\R74I^ V6?@VCPJ*<I->@Z5,QMC#%ILI,3.]C*&$]9FV
M,L7T$RC>F4;Q1AKCV8 ,&HO##SC,KT9CE5'X8$QHL1$QF:6GI\PQ)B*5B2'I
M/H^(;&.QCH7:6&6UDU">@1*1->LI:P2@228D:<>A^8NPC(<\- C C#-7UP["
M0D$-<X^8=1O1SPT%A8P1:TH-?#22D0=;)3<UAYPB)3BL-!=TK79)"3AI@*]*
M5QQ$X036 7/(<U$0D8317-2TX$@C"4T0A#5,N\VU5N4OQ"4Z5ITD?EZ-0HE$
MDIPF*U68FM%U0PF.O,QI)TO\3P#J3J2"PPJ^'9@-M=BUV[",%+PEI7,VU)ZY
M:X(8)AY1Q@X]@P7"N#*$L";4WL(Z=(I.3/#*F"J3AX1CM29B8RQ33Z/P\):X
M8ILQ&XJ>(I2=QC7<J4(/KCYB;H*U%*49EGWB?>(I/K\1-B4K H;/PUEVKM1X
MP6C#RB*47>J<>AHF3')>AX_!C?L7*:[$G-8KP%WF]4TFX^ AV,=4,9_#5@7L
M.Q9*3G##M!CFC4Y(1)$KZJQFQF9B2AA,5]PK[BJ#32)EB=J)8-+65)Z$4XRC
MXC&DQ#.Z<J-3+15Q2G!R)H=_<V\O2;XZ8?Q=\/\ 4^?Z:J#GU^_=UP\UX1-.
M?I_P[NR7T<_Z.7_Z=7+S^_9OZW*GSU[4?TWY']6]E?Z#N^4N[7OS/YD_J(
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MGIZMO>BI,V[9>8FFDTTT\&G%/J:.B*TQS10
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M,<=JJ&/TM6H1GN-C;KD,FL_FHN+A5."6BG0;[OP;7;G+E::&P
M
M                        2<G5[]["VN\;NB*QLVH/H]CF('YF?6BBOK_S
M/R=GQ9?L3]1[]U5_P[NVUZ^H/V:;7T*\GR'RC$QZ>(CI?6.E7TT];3H]5]IO
MYKZ3Y'3?WX#%DAA.:A!38@
M                    TJ_6IZUY3=I;4U/P4M>\HNE5:/@L#1JS2,.ESZ$>
M=7:_4\M8OFQR]?\ VUDOM_*'O'J#,1ZU\K'_ !;/C0]9]HN'L^\5^0N^)<[H
MO#'\'-P?O+NK[1L'[,^'_H_E_D;/BP_SZ<_^D>9^7U/CR_NG8Y0
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M[8LUKK(RB9[7LFE=Q:5MT[;8GWFXQI;
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MM=?UM1)S@GNRVYY$5-;PS2T-/^Q-\]QKM[TN5II;
M
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M99-ISA5V>MX3?93@KM8W3,1@U>1'ZWSGU-/]@2]KMKQ15R--+<
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M_:UL^4[^Y<^CK,K>K[#S%^9?#Z8T\MW?*SOR9V_47;Y6;8R2,F95
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M+E>:&P
M                                         2<G5\][!/O&;J2Q]C;_
M $&^?F9]:/#V@<Q\#3[)?L/]1^?_ &JOZ>.[XT/7O%U6J8Z*?,T?*-\?]1AT
MP^L]*9]-->EC;]5]OD-W,13F,>AU7]^ B@
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M\]>U']-^1_5?97^@[OE+NU[\S^9/ZB            !QH[X/\VOG%_$G?_\
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M)Z">A9.#T"M%BM:;5BB3@D6S.3&$E#1\-)>LZUI_-%\-!8KA0N[KG%[L+_U
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M5    !LYSQ_@/GOAH9NT>\QO[LMH^[VE\Y[+C?9LFS7R8Z>$.7YRM@
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M?K4?DO(6,I2<X:5_U5U_$2>[).<=;'-?K3,?L>]^AU$T\H8ZGX.[X,]CH_\
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M6P
M                                     2<G5]][#_.+W3&7V&UV_8<P
M?F9]:+]X/,? T^R7[#_4>_=7?\.[MAZ^*FG9ITPI4='T)\I9<U3;5]::4Q.O
M-.EIT>J^WR&_FOI7D=%_?@,&0              !#"<U!&8IF@
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M**7S>U1:@M&%!ZGJQ.IJ3=,X5K[KV?3B++(BF$11_0+$4P4
M              !(SAX.G7U0 XD=]/GEE>17(WB[B3YTLMO:_NK/9?=56VJ*
ME?JRF8:N4OVENJ-#I6#-VA,1JQ5+L+:N@'S!XTXGYR<PM[<2<49[-[UXAWKO
MK.6]W5W;UZY5=]OG[U%FW2J[EUR]LDNL\I.M;;.31%V,Q;WGOK[@GN9K7,SA
M'=7-OG-G+^X;F;]G>W=N"O+*\\W8NV[-[VU?M\K2J;:3ABXQ-&KSD1;A&,L[
M8FZ<8R<@^]7[C7@W/\*[YXVY5[[O+BC<F1NYS*;CHR=NU;SBR]J]<KIIJLY:
MOTH4K0:(YN9PVDZ<9YRZNO'/#6_.7G&F]MQ9NUG-R\P>%-Y446,Y;KOV+V2K
MRV:JIVUL>RK]+V,=&!W3HQPUZ4F*=_8[D?N<>]AF.;W)/=7+CBS?->^^,N$L
MLK>8WA?O57<Q?M>QRE%%%?M+]VYZ">E'CM?3X<65E9ZGNM.9L    !LWSQ_@
M/GNSR,W:/>8W]V6TG=]IV<UC&.W_ &)GK8Q5-+*7+\YF8          <=^]=
M_-_YEZ?^[F\/M:\>Q>J?ZP<M\I':]!]J'Z@^*?D>K\2YT3ZOUUOJ$O\ *F?@
M_P#G=P_07P?Z)_\ ;#_-1X[^F-3I]+=\:64'[%)N+CC#JT'D]*E,,GC.8K',
MS6:S1F\*7J7Q(Y[8_P RZ'-MF&!OMB)S9LEZNK\4UYRQG-CKGJT8E9,G"2A'
M'21C#%SC#!><O:RZ\UCK4F*)3W56U'\0F!@B<-/9\I9)Q'!]>H9=1EU$9='D
M^.(VFT6,IZM DG(AATQ%2IIC&#ZH@V;CKP6/:.HZD>C5H"]JQPZ(BB4/6?0,
MC*-XUI6&@RFZL1!'OJ\$L8]F!@FU@DTYOQ&5=L,NIDNB?B@29KFD[Q1<>F$R
MUH3@O9!Z)_!8&/8G8F$8KQF55'%QBH)0AYR0138J23AB_()Q@G&$A*)8FF!7
M&B]L8Z>HQ/L(VG'3J\Y8@I+$JJUC*$""I1@X8=.(2NP2[=:P+7I))MQ:]'X=
MN)-VTRRS6I1QGT8>,A$TR'""4(1Q>(2*UJBBI/P_B#-9I.0M+4H%ZSK)->EI
M^&@G48Q.!#1KTZRUVE=JZ(:=7C$9UV)MKL2.B$M1>''>M$BR\.-%I"N<8+MB
M8Y)EFG;/47&JLO5T>,QS8YL7BM.O1U%91DR@HXSZB=B5]Q)8^+Y2[C')'!OS
M_(%5Q4H^(9IF-:WVZ_B@((W+)-Z,.DF9FD:H.,FM$F4I#.NK8V'",(RZTR<M
MC=J6RW<I?Z/5XZ58VG*J#GLUP>J3T=HOMKRUW2U:E>*LY5>^#W%'\).;^OYK
MNUQU_9+1\[^WB/\ T]R'RE[]1?\ XYOUC\?_ ";0^-+LJ'RD_6D
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M8YGJ?F-\]QJM[TN5QI;
M                                                      !)R=7S
MWL7\XO=']YM?H5\_,SZT7[P.8^!I]DOV'^H]^ZN_X=W;#U\N+M4*I0]%:8_0
MO5T'RC.',UB=KZTTYGTT];3MM.FJ#C#&4(1ZS?S7TGR.BZ:WP&+(
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M?1S_ *.7_P"G5R\_OV;^MRI\]>U']-^1_5O97^@[OE+NU[\S^9/ZB
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MZ_V!E?M:V?*=_<N?1EF5O5]AY]OU5V^4T<OW/*VWYK1ZJ[?*SHNS81DR(H
M     !QHY[^KE?JZ/+46)QHMNUN9RLC][.64/H*/K*3*_8DTXFY9@
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M9;G9_!ZCZJOZUF,[.ME&4MN^1"3WAFOJ7Y*3IN_!M-N<N5IH;
M
M                        !)R=7WWL7\XO=/\ >+?Z#F#\S/K1?O YCX&G
MV2_8?ZCW[JK_ (=WQH>O9I^RIIPJ@NG0^P^4KOI'3%7UEI1,:TUS8T)JEJ,.
MB7E-O,1'SF*YT==\QQP$4
M             (8W 8JIL0     #3JAM4Q<%K-ME:31+_P '+5J]50?;#I-&
MK/:T:%.+<_4\M4_PK\OI8;ZR7V_E3WGU!F/]U\K'_%L^-#UCVB_N^\5G_@7?
M$N=T7A;^#>X-'^1=U?:-@_9CPW]&\O\ (V?%A_GTY_\ 27,_E&I\>7]X[7*
M         '&WGO\ F.6ZO-6;+>Z-3D4MJSFJL(44R[+:Q,K\FN,+J.1QI;
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M]@97[6MGRI?W+GT79E;U?8>?;]5=OE-'+]SRMM^:T>JNWRLZ+LV$9,B*
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MZZEK**<,QM;6=WZ-5].GZ6K:ZO0CCK,K[)B)JQPB(C:Y=G-78!0
M<=^]=_-_YEQG_P!W-X?:UX]B]5/U@Y;Y2.UZ#[4/U!\4_(]7XESHGO\ 7>^M
M7W4WA+_G=T_07PCZ)_\ ;#_-1X]^F-3Y6[XTLU2J;22^$T>3T<H>,YF*<S,;
MF3E2CGC\)<YXSEBIN?:;)P6<()N3[!7:8;!.&"DM'PZ10F.G,C/H^';B*>Z4
MPWIB]07*%JQ8A(R1]..D0L>\.,E L=IO7:A!1ACTBZ(K2$IM'+J\I((Q&IXQ
M98PQV$3AN.AZ-'7U$ZCJ&VI:AGB4KBD)*<-4HA=JSDUC,;DPRV(VXS'4O4J:
M71Y_B@)28)M,8080)RZ5YRQF3FD6Y"9KBN&8XIR^$A_1(QC%5.+TZ_A+ G8F
M74.;A\,!&1&$51QTB%BFQ4Y-QG(D8]2;:;$BL$XQZ-15I.UEC.&.,_ 1CD).
M*E!(&%-Z**?66JS283#%>,=2YY,FX+&9*>XQB/<1PI3B\8%C%8QE(O%XEI"T
MAE%0E)DF,4IBQ6(E9R5.+G,99).&0O6U?B#83D*/9\.W$3[Y-/*D9Q%,*+3"
MC*$H:\7\A*L:[4FW)R7G+._-<HQS1M/KTB%A7-N&D)E&)"4IEXMA7I(.,$*U
M*HO6^&H7+.2SPTO%$3#R$$NF/9@,RLRD8-P<I#K7.,<V24>K0B9=:3-.M%!O
MHT+Y2Y$X*HN>'3K^*!)2:(WBT\,.TJ[D>O7YA'0L="WG"FB<)/0.6CS[Y33S
MDM*&U/Z&OR,7?1KO*7S6G7#WQ>XH7_>3F^]>5W;^B6CYV]O/ZO\ (?*7OU&_
M^.:?_4?C\?\ ZVC\:793/E"W)^M(9          Q?K4?DO(6,I2<X:5_U5U_
M$2>[).<=;'-?K3,?L>]^AU$T\H8ZGX.[X,]CI =^]I=ZOF:M+WM5'^KO0/OK
MV74_V3R7P)?YX/K11/[;/'ORK[$.)]"P6AQ@O#I/?[JQF^=+NEFGLZ"S@QF*
ML$EZ2:BI=!+H93.5&<Y:YF.#'!=,7+X0)N392$T14VL%JBR[5V[DALI^/S#!
M<Y755UQ\@W)N6*A!8_#63K2G2**:6@&$Q7:Q2<%.,?,5E6*F+PFQD9$VHM?#
M ;C",(93FL7*!-Z;R#6 K$YE8G-C+5XS*FU<5CCTP\0HE"$9HE2O2*;QF6M,
MC(BXQJ75->83,W%(RA(>#6.U:^ZL=,9]1$I[@T^P5@K!-J+[/.-IMP1-0?8%
ME7"<L-,1"0*$YRD.TGWUBG&<I0)0HQC"2[7K*O6FI8)1GXP;]K)1C''Q#8FP
M;<>KSC BA%.</*,2DQ@)N20H4C.3!X30,QMN.HI2(ZR4WH4"&/E6,5'2O.2A
M1BVV5:*U!,52M97I4F_' B=>3%3A%0QTE93N/2;A'LD2(VF&8JL(RCCTPZBE
M.A=IP4YZ11*#GA@O.,LS+,:377@NH$30>"U/0#;O(N&';VC:851+%K&0E9G9
M.3+Z*&A?$38FQBL2RLY*VH06 IM2(VC4$]4IC"2M1*:CI$X$RC6&M1[(C:L3
M[ZIN/6)A)C MO9WCNE8_Y5W<]7_&[1KYRGS:_P"#/8\QX%%?$]&?^);\:'>S
M[K/^H7EOT\.;N?\ T6R?G;ZT_I_F?E;NV7^ESV9_J)X9^1Z7Q+7((]?>]@
M       !LOSL<.'%]55];43;!/=EMOR$V:<_FH.,55Y*3?=W-[&)K+E>E"2-
M++-0
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MNR7T<_Z.7_Z=7+S^_9OZW*GSW[4?TW'P7]5]E7Z#N^4N[7OS/YB_J(
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M!V'8DVXKX>$&S%9*+T:/.-QN)RABX^(&'D94^NEJCY!;TL;HI;+G%[L*/^T
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MPN$X/&[OMMV<U71=?IJ/HP<G5L-36)IUYNIYL8),1DY>G'%*ST@4
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MLRY7FAF
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M4)0B)R,L4E'7XHA5<,<5X"8QEF1T3-#KG#Q1&[85VQWC&,-,.PN29$YP<Y:
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MR8LNLXIVL-&+KM2D90_HIQ2>M)^$QB*12"<)HI4
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M<M\I':]!]J/Z@^*?D>I\2YT3FG\ZWTUC]T\_#H_5=T_07PCZ)Y(?YJ?'I_\
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MAH9@
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MCE_^G5R\_OV;^MRI\\>U/],__:_JWLJ_0=WREW:]^9_,W]1
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MII:;3Z&IQ/(766:6E%L,>4NNG4XKLW]JGU:>I>0U0V7=Z600
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MH&YRP6 ZRG253AI:[,00LUT><9IA(G!:WIT=0H3%>I5.F&GY2;3:FJ,H1[?
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M5B=B5JQ;\+\PP94]Q5*?PU$GH2>@G-EFE:&&0L8,;*D])%:=./F(42.$9]&
M6@VF]7C&1DK<\(/K'8D1[@G-1%"F&!&,L/A$DP98L;<MX;I_?7=WVW:-7.X<
MK?\ !GL>9\!_2>C\I;\:'>U[K/\ J%Y;=/#>[OM6R?G?ZT_I_F?E;NV7^EOV
M9_J)X9^1Z7Q+7((]?>]@         !LMSL_@]1]57]:R3-)JRC*6WG(?]L,W
M]35Y*3HN_!M5N<N5AH9@
M                                                      "3DZOG
MO8I=XO=6OV%IK\ZS$/ ?F9]:+]X',? L^++]B?J.Q$^RN^OW=W;:]>Z]*TFY
MO97B1\I71P\Q$;*OK/2_#3UL:/5?:;N9FO,^1OO[\!BR  $,>("Q-12@
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M<,T:E=+2=3IV$X1FGY#'G-2;=**=ZIIQ2^NQY2P1T:?<CJ8SFIF
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MERL-#,
M                                         2<G5\]["O\ \B]TK79M
M/PVKY^9OUH:?M YBOW%G9+]B?J/33V5W_#N[8>O:J5%*_&J'@/E*<=?ROK/3
MPUY2WZK[?(;.9PYET7]^ B@ "&%)4,H12@
M                             #3J;5=$,8F[3I24OFFG+5N8+35&3\O0
M:-7&*QE5HY>8BZDOU?+3_6MR_P#WYR7V]E3W;U"_6SE/E;/C0]9]HO[OO%?D
M+OB7.Z'PO_!O<'[R[J^T;!^S7AOZ.Y?Y&SXL/\^GB'Z2YG\HU/CR_O':Y
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M6MP\I\I7]RY]&V96]7V']"WZJ[?*:.7[GE;;\UH]5=OE9T79L(R9$4
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MBC^$O-_]B;M_1+1\[>WC]7O#_E+WZC__ !S?K%X_^3:/QI=E0^4WZT
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MERQ-#,
M                                         2<G5]][##^49NE_[A;_
M $&^?F9]:+]X',4^XT^R7[#_ %'J?LKOF?N[NV'KW?I6:5K2\29\I3%.:B[H
ME]9Z4UUKJY,:%Z%71YS=S<TYJ-\.F_&^$,60   0DY 8*ILC%
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M\ACH5G5F6_EZ6W<-N3^-OMMY?/?54'/K]Z_KAYKPRZ;N?BOXN[L?1S_HY?\
MZ=7+S^_9OZW*GSW[4?TW'P7]7]E7Z#N^4N[7OS1_+[.Z_J(9
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M\PG$AQHY\1=.4G)5T2ATU&45K!&4MT>5W\%\I]33]90;-7*&,9RW'-+(
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M[*G+M6MC:GY)K3V&S4F;K*3FQF+>/BMR>1;IV:53&,-)IY>+HB>)99G0@
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M4Z_K62M))[LU;<\AJ4MX9I)8*IZ=5)T7?@ZL+<Y<K5TJ!H9J
M
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MT_HY?_IU<O/[]F_K<J?/7M1_3<=3^K^RO]!W?*7=KWYG\PB*11_40H
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M
M                                  !)R=7OWL/\XO=7]YM?H5_R'YF_
M6A_>!S'R=G9+]B/J/?NKO^'=VP]?$?L:T^BNB$CY1NC_ #\<JOK+1C_J+^FK
M&V_0JA@_,;>;I\YMZG5?'GXA%                     0UJ&5J*9
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MK-M.K:VK-J['HNTJI+I@>-OB;JW96R\A9A'!,UF'ER2C&1KLT^&6<STLC,
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M_O'S>7_TN[?T2T?/'MX_5[P_Y2]^H?\ \<^'K)X_^3:'QI=E,^4WZU
M    !B_6H_)>0L92DYPTK_JKK^(D]V2<XZV.:_6F8_8][]#J)IY0QU/P=WP9
M['2 []_\ZOF;']UJX?U=Z)]]^R[]2>2K]Q+_ #P?6B_?9X]^5?8AQ/IT/KCT
MGOMU:OG2>AG."U,1C=BQVL4J9K##66ZM5FK*$%%,QW)MI(VU&?B!2!8_#4)R
M)R-">C5\H[3=M8U*.,FOAU8!8FF63*<)3>KY6)3"N*SE&<='RDP,&*BVW'5
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MK]?;J>G[J[N^W+)KYV*<I?\ !GL>8\"_2NC'_$M[8=[3NL_ZA>6W3PWNY_\
M1;)^=GK1^GN9^5N[9?Z7O9I%/47PS\CTOB6N0)X![R          &R_.O^#B
MZZOK:B3G!/=EMSR(;6\<UU/^Q.B[N-=G>ERN-#8
M
M              ).3J]^]A2_E&;J>GV5K]"OGYG?6A_>!S'R=G9+]B/J/?NK
MO^'=VP]?#;V*5^-7UI\GQ'^?Y7UII_A[F%M>C4]>/8C=S./,NB_OPI%0D@8U
ME5,T                  *;0
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MM9C'3.;9?29\W)KJ,%''3\$)I7#)%(
M          V;YX_P'SW9Y&;M'O,;N[+:;N_1^<J.,*_[$SUNZ637W'+TYF0
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M_P ':5K=?UK)_2@F*VRVXY#J&\<UM51<'"4-%,,#?=W&NWO31RO-+8
M
M                             ).3J^>]A7_Y&;IA_<;3_P""OQ/S-^M#
M/_N!S%?N+.R7[$?4>_=7?\.[MAZ]ZH>SH=*C"E;4X:$GB?*$1,<Q2[I?6FG/
M^==3-*(;+AA/7YS=S/TENNFMT2A&:&,Q,@2DJIF@
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MO3&75\'B.UCVHDHP:AX67%<?(/1&4<>S )U$*DE\@P7 ;TI]D!UE"&I36GY
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M<Q+^@_6H[?(6W&VNUNG-D%
M      &S?/'^ ^>ZUY&;M#OI=W9;3=W[]=?U?]B9ZW=8Z67D<O3F9@
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M1WEC*6W/(G]L<SU/S&^[N-5G>ERO-#8
M
M      ).3J]^]B5/\HS=+T^QM1QQ]E?/S-^M#7]H',? T^R7[$?4=_=9?C_3
MN[8>O=15E2GLJ4=$&\3Y1OI\X\KZST\-:>FK&VH4U0E''IAY#;S$UYC'H=-]
M(OA2*
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MG\S%>5CH>QV_29J_HI+'3\AKT9G@W-\LC:@
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MPM81A.#EB:68
M                                               DY.KW[V+^<7NE
MX0LVIXX6KY^9OUH:_M!YBGW&GV2_8CZCT1^RN^?Z]W;#U\Q2L4U-Q>RH.#^E
MU'RC=7YS2.E]9Z=/373O84-[-73YC;S,5YFLNB_"^ C(
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M'/\ HY?_ *=7+S^_9OZW*GSU[4L?&J?U7]6]E7Z#N^4N[7OS/YD_J(
M      '&CO@_S:^<7\2=_P#^BLR=/*_2M+X=OQG-S?T75^!=V/DE;T:^_#CI
M:7Q?Q)V_Y;SO@/L7P_Z/9\G;V0^9O&9_R-/X=_;+3I^'C.V<\'JVMW=RJ$(P
M$Q$-G%-ML3 H)1C+05C*X+6,S.2#6#\0K$K-*HWC+'3U#&F&:V[\D:2T=OR#
M&F\B8F=S*$<>TD>^QFE<$C%/5*1E1:$FTFYD0>#CHT]986/>&W&&D89E(S$I
M='E^*!.U)]]7*+^#^* ,\&,]4WI^0O8O8KBUKZ<";4VB@\<7H&-%Q@G&$?%T
M%V&%!)8:O.3>E=I"K'5U:2X+AY"48:-0W[3?M1M=:\$!B8F*\GG K3;Z";-Z
M5PWD4E%+KF%G&:+^.PCCY!N2FQ'.,.TN69EF03>J JM4:273K$8D35>M02[<
M2%>@Q?07*-YE&\@VOA/XH R)14,5HZ^DB$U-Z<2YKA)BX.?B!E"J3</Q/CB1
M-B)RV?'XRTIBRRQ(NI?"8R3)(QEIU_(,C+%DTL<'K)N2.@U3UZ,0#T2C'#0(
M6,DPD]'C^* I4QSC,;GC\DA0C)8+#7HZA5*RBUMX=&LNY9Z$A!+1''S (XO3
M* H4V;"$<,- KTE>E?2ZNB1,$P-":E"(G!E'>I(WI\'G%)(I]M4FE*3\(ZTK
MC6,B;4'VA,*IHBYZB]2[:0/3%X]&H)U+0VZZ>WR%C,NPMESC]V'/W@/(EZ?N
MW;^WMWGIGKU/#ZO<SOB/LO>?5VZO,\I7/B^R^JQNS]KMU_O?E/M:V?*E_=N?
M1UO=MZOL/Z%OU5V^4T<OW/*V7YK1ZJ[?*SHNS81DR(H       !QHY\N-&34
M/5KH\M0BZ:TV$;9;F\K?X,Y;ZBCZRDSNRA-K<HP4     ",TZTTMB=ZPQK45
M",&X3QTZBW32Z+MJ9X-J^=4N4W'S2F^%=_1_S5G-<L#Q'K)2>0I=CY]KS/J]
M^DK)W7=CH-=T)4KW@' T7!??_O\ :>B?$:CXV?V'U:BZSU7G@B9M]']AZ)ZQ
MS.KXG?.R+_LOH69"M4[NR"BH_,LH\?\ <*,#^:\QJ3;J3;$;?LO8M*VMEO5]
MAY==:BJ5!S47%>C-0CUEOQLW28TF8V.L%_2)6UN7E0U5&6\%LX_0YWRG-X!;
M%WK?;%L5G!Y;Q.Z-/U+U]28VSV-[/Z/O/D7QNJELU?/-VJJ?_P!-;1_1_7:;
M/3:/#,3YK^;>IL7_ #;4NOB8F;L'8&=%2S%6E.$'K]$]%YF8GEJ1T_9>VV5]
M/,R\_08V=V&Y-JG6I=,O"99^45--13B@*
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M7]U-KED:60
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M_%W=DOHY?T<O_P!.KEY_?LW];E3YZ]J/Z;\C^J^RO]!W?*7=KWYG\R?U$
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MK]K6SY4O[ESZ-LRMZOL//M^JNWRFCE^YY6V_-:/57;Y6=%V;",F1%
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MM5VZJZMY-W*J7"5.;6#2T&/JG71]:M35U.Y,9O(>-:MU_J+?R\=[CCLAO?\
MT?ETU<B>.JH55/YWNU5M4N%3^:6_5<(-L]C\<NF_7B8WT>N^$SP\K%8B(B(R
M=A2VH4)-M]+33[8G@=TYO*Q2<82ZJG;J246U@L3"9U(QC-8MBZ:3-(?SW8NU
M6?9JFJEQDW%0G.+ZC*VD6\5^9,16;<[7F6(4JJFEQIIV5&,9PGXS7-UUD4NS
M2+8C",FM52JU!F6GJ3,TDF&24$EC VS-9J0I
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M]T<U!R@Y2U4Q-UU>#<UV9RY7&EF
M
M  ).3J^^]B_G%[I_O-O]!S!^9GUHOW@<Q\#3[)?L/]1[]U5_P[OC0]>S7V*C
MT8>BM/1\&?*4_2,]KZTTOPTL+<-APPF;>9^DNBZG%;3)2,@
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M[LE]'+^CE_\ IU<O/[]F_K<J?/7M1_3?D?U7V5_H.[Y2[M>_,_F3^H@
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MNM1CZ=RG:JGB>&U+(O\ .GO/*VS2>&(PAYJ4#&VWA9*9@
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MN=?\'Z%TU_6U?$(S)FELRVZY$-_=#,O7%0\!NN[LVL+8VN5QI9@
M
M                         "3DZOOO8OYQFZ?[Q:\=K,'YF?6B_>!S'P+/
MBR_8CZCT?^U5_P .[MAZ]JHNU3"J,$M&B&!\HS,1KUF-KZSTOPLQM8T>I4TH
M&WF)CYS&^'1?WX R                                    (8\0%B:B
ME                      #3<JZ8J*CA@;M/*:9I?\ @Y:]UJ7HP<<8G/JU
MIY6C0SE^IY:1_"OR^@H_Y:R6G_Z_*GO'J%3_ ';RGRMGQH>L>T;]WWBOR%WQ
M+G=#X6_@WN#]Y=U?:-@_9KP[]'<O\C9\6'^?3Q#])<S^4:GQY?WCL<H
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MC$\<35_&WQ%Y?/\ 0Z/.<_,36ZZ9Z8>;\*NBWQ"*[;+NQ]''^CE?^G5R\?\
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MM>/8O5/]8.6^4CM>@^U#]0?%/R/5^)<Z)_\ QO?3_P"U-X?;=T_07PCZ)_\
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M7=R6W'(?]?YCM\QNNVI;DY8&ED
M
M ).3J^>]B_G&;I_O%G]"S!^9GUHOW@<Q\"SXLOV)^H[^ZN_X=W;:]?+E:7HP
MC2M,=#/D^?PW3B^LM+\-/6TK;6RSHU_I'D=-\>?"D4
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MH+$S!1'32X16&$WI[2&;(#&FBFF,%"/686Z=MDUM6;INS9&:
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M/JJ_K6([RTK$Q+;GD1+>.96A1\QNN[M=K59G,;'*\TM@
M
M                   DY.KY[V+^<9NC^\VOT&^?F9]:']X',_ L[)?L/]1Z
MO[*[_AW=L/7S5'V-,XO94-$/1/E'".9Z(J^M-*/\^:Y5:=#]!]IOYJ8GF<.A
MT7]^ Q9             0D@8UE0SC)%    $,*RH91,RBE
M                       !BTFZ8ZS9;,Q"78V3&QJ7&VJ:7A'R&G4C"NVK
M1H83+]1RU<.;'+[5]VLE]OY4]Y]0(KZU\IT^EL^-#UCVB_N^\5K^(N^)<[HO
M"[CPWN#]Y=U?:-@_9GP[]'<O\C9\6'^?3GYKXCS/Y1J?'E_>.QR@
M !QMY[MJWE$L&G'^N-MO=28PEJ\BDG8S53Q@E'LH[#/4CS6NWO4V.1ISMH
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MK>]"0W/Y7I+A?)M8NBF/]109ZDX0D9RW&-3(
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MT'SQ[>?U?\/^4O['ZB__ !S?K'X_^3:'QI=E)--M:5"/;-'RA;T;7ZU*9
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M4Y.<U]*;[NY3:UVQC+E>:&8
M                                                          DY
M.KW[V%Q[QFZ925FVHQT^QOZ#\S?K0Q_[@<Q\#3[)?L/]1^/_ &KO^'=VP]?+
M4+5$?I?+2SY1G'F*;WUGHQ/I[NMA;]2HV\S$V\S&&#JO[\!%
M A)BH&-)4,XR10   !#"DJ&41,(I0
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MX_B[NR7T<_Z.7_Z=7+S^_9OZW*GSW[4</&XG^J_J_LJ_0=WREW:]^9_,7]1
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M^P,K]K6SY3O[ESZ-LRMZOL//M^JNWRLT<OW/*V79K1ZJ[?*SHNS8QDR(H
M    !QHY[^IEOJ[?EJ,K<TC:W1Y7U)\+Y-)S5%,?ZB@ROG)(SEN,:V0
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M]55];43.8*5B6W/(:N.?S3ABJEC]3T'1=W*,+8I,N5YH9@
M
M                    "3DZO?O89]XO=2_W*W^A7S\SOK0_O!YCY/3[)?L1
M]1[]U=_P[NV'KX:V;%*C&--/UI\H9\W$[WUGI1_GSUI;?H5+7YC=S7TJ.IT7
M]^$,60
M       &G4X5T-:S=9$<,U8WS33EKW:GZ*C&/1 T:MN%>B8:-&:74?I^6K:Y
MK\O8?NUDI?\ /\J>\>H,1/K9RLS^-L^-#UGVC?N^\5^0N^)<[HO"\?O<W H2
M^XNZYQP_4-@_9KP[]'<O\C9\6'^?/GYG\Y\ST>GU/CR_O'6Y@          X
MV\^_UMD?R7]F;H[C7_2EJ\BIV,TTY;-$H=%&G$M_=2WO.1IH;0
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M)9R5K!=8J;TPAH:B <%+2O'\4!7I6%G*>/1J)@BM=$1"0C4<?Q/CB*T6,J]
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M&"@
M     -F^>/\  ?/=:\C-VAWF-W=EM-W?$J<TX2BKG]B9ZV,58Z>3EZ<S8
M       ''?O7.'(#F4__ -G-X?:UX]B]4_U@Y;Y2.UZ#[4/U!\4_(]7XESHG
MM_JO?3_[4S_BS=T_03PB:<IY(?YJ/'</%]3Y6[XTLTU5934UK[4>5THI%)S>
M,YBZ+N9F;<J,FX*GM.:/PESGC&93"<<>@S-R)1CY3*;IF*+6B0DM.(7:@&45
M":P).>"4FHU-P%2N&(H80QZ1)-<R2DE):/&(,\=I)RA 98F6*QABL>D1$3U%
M*Y,4DH04]./8)P69G:N,$NF03+,:CZ7PU$C.A$TP3:>"T:#*E5I&UEBIOKET
MF.UCE+&77X5 N++%5C)>,2DK-O4].DFPV"2CU>.(J58J,X/J4/.7;78LT5:9
M1[2SCBDK""<R1C-$K645*4DH^* JM:XD=EO2,S-6O L%UD[2)]UBFXO1TEHM
M(HNCZ:&C#$8IMZ"4&TH- '%X.#70M/B)V$4CJ2<'#HEK[2RN%<5C&.MP\0R3
M(70L,)X"22*AACC,8E)$TH^3Y10I,I+5XPN*N*6,.Q#"4BDR1;Z]!:6TWF$,
M<7+!^*7G%(JNS%E-.+)ADF&216KQC%<2$,5CTZAU%:Y+UZ-'6$ZA1>,GX2UI
M&!EED/U8I1?7TDVFVFQ7&,46+J)A2DBGUZR5I-5G#J8Q?@P+2%I#)1QQB+HM
MC*6,T$IZFNW$Q6K%PCK\159370EH^4C'">M']*OQ=)<,X7?*S6+AV##8G4*+
MC/Q#:LTA+WJT=OG'*]_471[\K::2K6/H5>1_&8W_ $>^J:D36)WP]\7N**G]
M\?-^G1\UW;^B6CYW]O'ZO>'_ "E[]1O_ (YOUC\?_)M'XTNRD?*;]:0
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M8V_4JGV:S=S7TJ.IT7]^$,60           (8\0%B:BE
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M)D10       #C/SW]7*_5T>6H6SC0C*6YW*W^#.6^HH^LI,[LH3:W*,%
M                                                           ;
M-\\?X#Y[K7D9NT.\QN[LMI>[ZU5FG!X*O^Q,];"*,=/)R^.9L          #
MCMWK_P";_P R_P"+>\/M:\>Q>J?ZP<M\I':]!]J/Z@^*?D>I\2YT3W/-;Y_?
M3>'VW</T#\)^B>2'^:CQ['QC4C_BW?&EE33LV:5&,''PM'EM.:XO%Z]O!S$V
M[FI&%*.:/PESGVL8/#5YS95E4TQ>#!LI&::,.V/F&U=I!-RP&PV*]*P\XQ2.
MDC!=.D9]1GU)"72O.%JJG+#S_% 2D](IK",.D$E6CM$$"C-J>$M8G&3#:.$9
MJ>K4"!ZM"+%*5D@A)2F_,)PF8V&U'&42+@)S@L7^*))C;L5QFX>/ ;DPR'@O
M$OE!M''3IQ[!!%$ZE"'2%7&4(>,RQX4R70W''H,8SH;F$VG*$(3^0+M9>JF\
M,.DB9R+!K"'QEVFTPFGU2!G@D8]>LM%["4=?BB09-N*EKTD2('BHJ"F.HC<Q
M>B4.TJJL,8:Y"4D3ETKSC:;1J?2].N'0"N XSCV82^.(PV&&QDTM.")"0Q6.
M$693T2LK'5@O.8TZ<RG3F332C*8S3-(R@6BTQ6>E1[2)AL8PBEH:P[<2LLNH
M34)/'Q0&9,+LBJ59+I<]1$G<QGH4(EZUZR*45 LQOQ,11$QAB2JFVS&4G"&,
MH819<66+)Q@]"U$BB10CV>,O#)1CT+\4+UJU*.'1\HJD3L+S]&CM\C'*]Z_J
M71[TREI2J?XVOR,QU/HUYJ3E&^'OB]Q1_"7F_P#L3=OZ):/G?V\?J]X?\I>_
M4;_XYOUB\?\ R;1^-+LJ'RF_6@          ,7ZU'Y+R%C*4G.&E?]5=?Q$G
MNR3G'6QS7ZTS'['O?H=1-/*&.I^#N^#/8Z0/?PC_ "K.9DX_Y6K^OO'WU[+?
MU)Y+X#_/%]:/]]GC_P"5?8AQ-I;>)[_?C,/G.89D8HI)O!2ECXRSL6<9WLNV
M6F7@,6/:D'$56J],)=?8-R;MJ3CTA<*;B&,90%2JI1<I>,2DBP:T>0&W>0FI
M0QZ0;!:EX?D$])/3(E!1\7B&XGH*7/K$DHI*.G1YPJX14-4HA,QSQDT.HZB#
M3<!AM,-JNK2UXQ%M2FR$BG M*804HF!9B,E7'M\Q)I$5A,DZ%^*1>LG!1QUZ
M^P'4LG%]4AN3')9-1AXR;C<QB]4%HZ?@RQ"TCRKH@Y?BB8Q3;6#H6*P\X.O(
M3P;4_+H[(#<4V1D1E#Q:OCB*%,4C*!:;5IC4T0U"F=06*$Y$KC+7I^0F],L2
M<$X24?& P>L9F<&CK\P-HNJ/:))%'1VB=Y--J3GV1"X$(X(&6;*,>B&G5V$H
ME*(H)J?B*8S"8J,?%V!<IHJ<(]@I64F"$L.V(*XBBU",A.&)."03CH7A"K!1
MZ-*U:@E5BY1D]?R$ZCJ1:83AAH+)*)I=+\@6<52<<,/.A.232B04M"85EM82
MF*3DE&.+&4+E!9_;'=7[Z[M^W+)ASE?FM],^&>QYCP/])Z/REO;#O:]UK_4+
MRW_BWN[[4LGYV>M/Z?YGY6[ME_I;]F7ZB>&?D>E\2UR!/7WO8          ;
M+\[*8\.4N,(55Z(XTU?$(S-C;?D-'Y_F75B]K5HV=1OOBEK"VG%-'+ T,P
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M.9IN=5\^="F"@           AK4,K44R
M  !#6H  IL0           &FX[=&SC'P^$W63'#-<DOB?1S1K7$Y=&/; T:L
MQ3RM&A$\4OU'+7_6SR\CC]VLE]OY7XCWGU _6OE?E;/C0]8]HO[OO%?D+OB7
M.Z-PQ_!S<'[R[J^T;!^S'A_Z/Y?Y&SXL/\^G/_I'F?E]3X\O[IV.4
M   .-G/O];Y'\E_9F^WN0DY2UN1$\MFYQ]&B<(:+9-1JL[T.1II;@
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M*39=E";6Y1@H
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M_4)RV_BWN[[5LGYW>M/Z?YGY6[ME_I<]F?ZB^&?DFE\2UR"/7WO8
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MK_\ ,O\ [Q^R_P!4/]'R_P#R[/[JKF7S<C_K'W[_ (?O#_&B3[0_6'\=K_\
M,N_O$^R_U/I]#Y?_ )=G]U/PE<W/_,??W^'[P_QHO[0O6"?_ !M?_F7?WC]F
M'J?_ */E_P#EV?W3\)7-S_S'W]_A^\/\:)^T'U@I7TVO_P R_P#O'[,/4_\
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M2ZVVVV>].V(B79^3PZD?HMQ?YTP_)ZWN1.Y:5!)&^9K-4B*0I%
M $G)U>_>PQ_E&;IB_P"TVH2T>RS$#\S?K14_:!S'P+.R7[$?4>_=7?\ #N[8
M>OIJ%NEZZ5];$^4?_P CROK/3_#SUM.CU&M43?S7TFFYT7]^ P9
M             $)=D!@H9QDBE
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M,_C/X#3^'?VRP1W7O5-7ND8PUS^&K 7-E/<5J6I+MQ,BIHC&*ZH!-N\45)^
M23047&&/E^* 7#R+"<W%LB;-R3>B*\!5'T^'Y!"1N(-MZ'X1L78)X075,4,L
M2$5CCB22M)(RC##"8W)38*,8%E9I2I%N6"9(,B$\9K3K*FS<0BO)T"M"M)6,
M7/'0M1*46:D5&+D^UC$QV9)!)]'E+VF?6:$M<?*-IMJ0;@L,14K!"6$(XDJE
M11C''Q%V47#*5<%!:-1$Q\J2AY'/67&JXU5:5J)*3THE#K?F$DXKIQ[(=&L;
M#8F$\(8KY0N9*$?HG\.K NVFPW$EU/S#'RF/E%",-&@DUSVF^1IJ"CXNTM=I
MOVD(."?B&PSBLB6.M0F383*QBI8_*-J8(Y*'A\)=M5C,<U'X8B,TC":*G*2C
MVX$F%ZQSBO@OCB$RQ222TXP*8S)4WV"%@32C#\44F3%=.$(].HB;$:2726LU
M6)JD8XN$!D99,HIP@Y]1.LI2$;:TXC"2,5T8QCHPP 8M:'/I^3 9=0=#E#%8
MXX3!C7>D904V7?)3;)/5V1P^.)$72IQ?5T#8NS!CI@Y0T8X])>HQ\K.C&F>$
M2QWDNK1SC]V#_P"H%R*J>G?='V[D#T[UYC_T]S-.B'O/J]=-W-<G7[K[+ZJ^
M[/VNW8_^S\I+JRU'EB?*5_=N?1MF5O5]A_0M^JNWRFCE^YY6V_-:/57;Y6=%
MV;",F1%        .,O/:F'S:K2Z[?9.KPF5N:Q.$T;H\KOX,Y7ZBCZRDVZO=
MAA'>;DFAD
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MOGV-3;?-8C4L^-+M,355$,'&/@D?IA&G/I)NW]K\=(F.&(VT:AN
M    DY.KW[V%+^49NF&+M6YZOL5_R'YG?6BFGM YCY/3[)?L/]1[]U=_P[NV
M'KX<[-,7M+9490A+H/E"M.:PPFKZST\=:8WL:/5?;Y#?S7TKR.F_OP&#(
M                   @F*@8\(IE&
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M?V2^CI_1R_\ TZN7G]^S?UN5/GGVI8>-5_JOZQ[*OT'=\I=VO?F?S)_40
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M8RJA/;HG'IJ,K9KAM2,IZ&YW*[^#.5^HH^LI-NKW82.\W)-#(
M                                         (XP<%%ZHPB21M?QYS8Y
M?<K,M;S/'O$^[^'K&:;>7>>S%BSM*G:;5'M:Z'5#99G;9??"3%L32,6UF0[Y
M'=QWEG,ON_)<R=QW\YF*_99?+T9W)U7*JJVJ84JG,N.TV9SR]^G;7-)O\ZDQ
M/O.1VZ,]DMYY2SO'=]^G,Y+.T4W<M>IJ55-=%5.U%--J#1IFVWBK2DK;,S;C
M-7]8J@    V;YX_P'SW6O(S=H=]+N[+:?N^_KI_4W/[$SULF&GDY>',V
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MUG_4+RW_ (N;N^U+)^=WK3^GN9^5N[9?Z7/9G^HGA?Y'I?$M<@CU][V
M     &RW.S^#U'U5?UK,9V=;*,I;<\B?VQS/5^5.F>YY&FSO2Y7FAL
M  (\'U,L9CPK'KOZI^<Y]?Z1:EG=GK<./> ?S9>._P!C4_H68/Y![=OU!YKJ
M^Q+^Z?5V_>AR'PX^-:ZF6YOUI5'_ )5FX=7MJC\F.<^EZW1Q?9E^Z?\ X6G3
M\7;V0_JG Q                           AK4,K44R    AC<!BJFQ
M                       0QN%6@SG)C=W9<\_=??SJ'^Q[_P"A63ZD^JU^
M\'E/D]3XL/D?Z[G[FY^4L[9=I?Z*CJ?D/TWC.[R/QSC*&89            !
M)R=7OWL"_P#R,W2_]QMK_@KY^9OUHOW@<Q']33[)?L1]1_\ =5?\.[MAZ^:E
M"S3TTKZT^4<^:B=[ZST8_P ^>MC;7H5/5YS=S7TJ.IT7]^$,60
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M_5T>6HMG>(REN?RN_@SE?J*/K*3=J]V&,=YN2:&0
M                                ?R-[[SRFY\AO#>V\K]K*Y'=>5OYR
M]>O7*+5M6\O8KOW(UW*J*4]FVY1%*T,'20]ZQWX<]WG^;]S@G@?>N=W3PWP)
MG<SN^Y7D\Y?M49FJB]G,M76Z\OFG37M.#P/+:6A/!'#MAS7WQ,TEZZ^2E&_+
M7.O@6E\4[YNVZ]Z915VZ]Y9^JFJ&<RT8JJ^T\"ZELVQCF6VQ-T4?0N[NVU^!
MW@C;N57:ON-DHUUU555-_-;&-54VXGC-2)BZDMUD4K&]O8:V8    -G.>/\
M ?/?#0S=H]YC?W9;2]WU_JE=*N?V)GK9%D0Y>G,R          #CMWKOYO\
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MCH-_,S,\S'4Z+^_"$9
M                ""D *0*!C_;*.LSM[LEWX.6I<<:G'1"!KU>Y$],N;1PO
MF-C]5RT?_P!UN7[_ .VLD_\ I^5/=O4+];>4^5L^-#UGVB_N]\5^0N^)<[H?
M"\?O<X?G+[B[JBH8_J"QI/V;\._1W+_(V?%A_GT\0_27,_E&I\>7]X['*
M       '&SGPXVLFG@D_[(VVSYK&9F,FOR*4,OFX?2T?V)E?'FL+>^Y&&AM
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MK^K>RK]!W?*7=KWYG\S?U$           $:3QT%B9C(HXT]\'^;7SB_B3O\
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M496X34C*6Y_*[^#.5^IH_0Z3;J]V$C-N2:%
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MGNR3G'6QS7ZTS'['O?H=1-/*&.I^#N^#/8Z/_?O_ )UG,W]]J_K[Q]]>R_\
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M_0Z3=J]V",VY)H4
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M=_P9>8\"_2NC\I;\:'>S[K/^H3EM_%O=WVK9/SM]:?T_S/RMW;+_ $N>S/\
M47PS\DTOB6N01Z^][          #9;G7+AZA]-?UK$=Y8REMWR(4=XYKH3_L
M3?=^#JU69RY6FAL        (\'U,L9CPK'KOZI^<Y]?Z1:EG=GK<./> ?S9>
M._V-3^A9@_D'MV_4'FNK[$O[I]7;]Z'(?#CXUKJ9;FEDZNG-9I_\-4?DOSD_
M]7K?"^S+]TL]+3^3M[(?U3A0
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MCE?^G5R\_O\ F_K<J?/'M0_3<=3^L^RO#P.Z/^)=VO?H?S)_40
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MU_L#*_:UL^4K^Y<^C;,K>K[#S[?JKM\IHY?N>5MOS6CU5V^5G1=FPC)D10
M     #C/SW]7*_5T>6HMG>(REN?RN_@SE?J*/K*3=J]V&,=YN2:&0
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MR2^0\KHS,Q6<WBN8I',33*C.,*4<MN.I<T4K,L:DX=6GY#:L3%13@M6C7\4
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MYK]&J/R7YO'F];X4]K]TO_"T_D[?BP_J'"@                % @
M   (29H!.(4R                       !"4@"Q%!0     AC<,EJU^8RI
M2(29IBYX>Z\IV>]/4HQ^P7_T*R?5'U6YXO:#RD_\/4^+#Y%^NW%/8W/REGQI
M=IGZ*CJ?D/TUB,Y?CI&QF1D            $G)U>_>PR[QFZ8X>QMR_WJ^?F
M;]:+'V@<Q\#3[)?L/]1^?_:N^(^[N[8>OFJIJU0W3)4K3HA#R'RC,1/,88XO
MK33G_.GK8T0V*M'1B;.8^DQ3H=%_?A R
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M=W8^CG_1RY>[IY>?W[.?6Y4^>O:EAXSAGPOZS[*YKX)=/_$N[7OT/YD_J
M          '&CO@_S:^<7\2=_P#^BLR=/*_2M+X=OQG-S?T75^!=V/DE;TA]
M^''4O_UNXD]*/_;>=T'V+X?]'L^3M[(?,WC/X'3^'?VRP3@Y**ZSMNBL;WJ]
MTS3$U+2O''R0+&,5ED1T-077VEIM,<QJ,\5JP\9,DRP,6UKAXBKE"X1?5(FY
M,\!MPZM(PJ9I.+E/2M0#!0>&OY!VF_:**75HZ^DN:YJW"$_E)FF:)83\0JM>
MD4,-#P\X[4[1N*U1[13%8P1Z]?F+N6,%TR6'3K)L2M8Q67@\X3%&XO"'C+#+
MJ)PA#Q](VIA4G"$/&A@F%1IZ%)")6)2:DL=*&?483U+",XQ[("NPK04<81B)
MH31)SCT1'4L4P5.6$NLDX)$5FE<31!R6C3UE.H4%CX=9,9,U71AY1VI/OHXQ
M7B\!=AA0ATPCHQP"BA&6GQ_% B3O5P;FNKS@ZDZ(PZ,?&7>N\TJ&CSDZTZT3
M4)]GG*RZECVOP$HQH8.+G'27,SC 6F#\7QCK7K1N<809-RQ&&Y8^+3\@CH28
MZ-IT:]&J I$E?>)+%0[8E3&5QCJE F1EUI".F,=/44,8RZD,ER$GX,%UC F8
M7!0CVDSE,T2A.'4HA:JITP^&(VF%=Z1T1C'HP*E!S4=&KQ8C<NY<7JAVXDV)
M.Y-$=&KY1MWKVH]<(]/R%VD+&:BXXZ("F!Y&5*A6M4_(6W>DXVN</NPE_P#O
M N1,Y+?=#C_S[(,].]>9_P#3O,]4/>O5VGSGE(K_ $GU6MV?M;NO]@97[6MG
MRE?W+GT99E;U?8>?;]5=OE-'+]SRMM^:T>JNWRLZ+LV$9,B*        <:N>
M]#]GE:M&W1Y:C*V*3UD;8;F<KOX,Y7ZBCZRDVZO=AC'>;DFAD
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MA'S>_8N[OT2T?.WMX_5[P_Y2]^HO_P <WZR>L'Y+H_&EV4CY3?K4
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MTO\ PM/Y.WXL/ZIP@                           "&-P&*J;$
M                        "&-PJT&<Y,;N[+GG[K[^=0_V/?\ T*R?4OU6
MOW@<I\GJ?%A\C_7<_<Y/REG;+M+Z:.I^0_3C9+\<XV,S%D            $G
M)U>_>Q/_ /(S=,=%FW^@WS\S?K0Q7V@\S'_#T^R7[#_4?P]E=WP[NV'KU@W;
MH>M*'F\1\I7?AZ;:OK/2_#RM%,*:HXK SYB9CF(ZG5=-;HID!0
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MA(REN?RN_@SE?J*/K*3;J]V$CO-R30R
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MIL6::TU"NFW0JU)J52IBC=HW7<5*REV6#:OD!^NEU5_V)EK9%GV'+PYE
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MV\9PV82IT=!NN[C7;G+E@:68        "3D\.U^:/K\QSZWX>U-+N3UN&WO
M/YLO'?[&I_0LP?R'V[?J#S75]B7]U^KM^]#D/AQ\:UU,MS3RE71FLVO^&J/R
M8YSZ7K1_6^S+]T\M+3^3M[(?U3@8@
M           $,;@,54V(                (8W!H+;L2<G/'W7<?Y4SC_<+
M\/SFP?57U7:?M"Y3Y/4^+#Y$^NU^YN?E+/C7.TU]%1U/R'Z9QG=Y'XZQE#,,
M@            DY.KU[V)?\ Y';HA_<;7CM9@_,[ZT$_^O\ F?D]/LE^Q'U'
MOW67Q_7N[8>OM[7LZ6_I5##Z4^3[L-?#I?6>G'^=,;*M.AMTN/2;N8^D>1T7
MQ2^ C(     "&$YJ",Q3-               "&$YJ$  96HID
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M;J]V$CO-R30R
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M"3F_''YKNW]$M'SM[>)_]/<A\I>_4;_XYOUC\?\ R71^-+LJ'RD_6@
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MC]59OIC]FJ\!^2_-_2];X7V9?NG_ .%I_)V]D/ZIPL0
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M4FL1"4I<W*-+(
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MP/E&ZOSC?5]::7X:>BK3M^J^WR&[F/I'D=-_?@(H
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MLI+>D]YN68*
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M                $),T QK*J9H                 $%( 4@4
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MIG<W*-+(
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M8]IMYF:<S%<Y;K\;X0,@                             !#"<U"VHID
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M<ER,<9M:, G5D3;45+K)D9(UJDM?R%K*U]TU)R4_A(=1U+)PTOP1!D06E>/
MF)5$GBBRL[U3UOJ\Y&-.@GB]'CB4PR@4&XZ=7RC8LY4(S7BZ=?5 B#6G#7IZ
MBPL2D90A\,1O-M5;G!R6DF13H&DG*4,?,4ZQO3X'Y1$)$$9QC+3Y@;*;2$$X
MSPZ"!*;Q?@+N7<DH>3SA5TIJ9-TL=TBEA./865G'-<5"..F&HB;4PDIOX,;Y
M7?L&I^7H+6D)6D+%X0CTX$P,$TZM>F&H5C)8BL,J/6I2GCXT6VZ.(NMFDN<'
MNPU#W@7(C]_+?V_N\]/]>OU=YKJA[SZNQ,<SRE?NOM/JM[L_:W=?[ ROVM;/
ME*_N7/HRS*WJ^P\^WZJ[?*:.7[GE;;\UH]5=OE9T79L(R9$4        XU<]
MMGV>6CZVW;ACKJCT&5N,ENWH;E\K6GPSE?J*/K*#9JS$VPQI26Y1I9
M                                                         -FN
M>?\  7/?54_6UF_E_P (QO[DMJ.[Y^N?R-SR4&6MDPTNZY>',V@
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MWZ'433RACJ?@[O@SV.D!W\/YU?,S]]J_K[Q]]>R_]2.2G^H_SP?6B_?9X_\
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M49S[ BSB^R9-B;$4(QCZ7P["T7'+8)2:3CKT$ZRN-<B*ATHNW<4QW&AZ<(Z
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M+3^3M[(?U3@8@
M               (8W"K09SDQN[LN=?NO?YU3_O%[]"LGU1]5O\ >!RGR>K\
M6'R+]=S]SEWREG;+M/\ T5'4_(?IG&=WD?CK&4,PR            "3DZOGO
M8G_^1>Z6Y0LVH=/V&^?F9]:']X/,? T^R7[#_4>_=5?3[N[MAZ^$HV54WBEH
MZ#Y1O^D<.]]::7X69WL+?JOM\ANYCZ1Y'3?WX"*     !#"<U!&8IF@
M               "&$YJ%M13(               *U J1-4(H          8
M5)MTP>G"!LMI1C?%;)B&I<3D]"C'Q&G4F.'?5IT*\4OU/+11YK\O=7W:R4?\
M/RI[SZ@S$>MG*]/I;/C0]8]HO[OO%9_X%WQ+G=&X7A][>X(8?<7=7VC8/V9\
M._1_+_(V?%A_GTY_#Q'F?RC4^/+^Z=CE          #C?SU_,<M]2_[,VV]U
MC=DRY$?K?.=5/]@6_)JL[SD<:6\          .M1_2=?YC]7[Y4_6WS^F>S+
M]*W=3^4^U7]&:/PWS_;?[6Y=J?V&W'1#T:?"?1TT]'#^+^,5CEK^JWL>787V
M)0U?$96373:?#(B.4FF5$P4(^(6Y.?3BD4SQ$E#"++7%LF<4GH^'A)MFJS2D
M56?QX#"LDTX8-":DI](VI3I)0A'Q=HQS,:U(1AT:=8VE:"Q73IU_% J;$E!0
M<UT:PJX--](ZC.*0N+D\-/63(R33#%OLP*+/7"&F&)$P1PC/3XH%ZEZAQ[.P
M11(IY64(+&2Z"9RM*Q5C*,=?BA(4-S)1Z_% 8)GDPEK\15QZ!+4Y:9> %>E8
M*$]!-N"5QP71/X3&W VX,936AP*N/E916B;T$HE)\B.+4\='G+V+U9$G@NN8
MQ$T:X^8DS3K91C..4+U3?@@7K8[MB)0@] GH)Z&4=*[.DDIDD6UK>DN4KE)*
M,?%XAN-RN$(^,FY-R0:C#PEPE:Q)"3@M1*I55!2TC>3THH)OL+FLXI!:7+R@
MQ\JO3V""-B/!=I(PAEG<L&XZ/&2,)29K'3(G.4WKP,J)O(+",_@QO3'/8DI)
MN#7G&VJ]3+QQP1$102@_ 7?"[X7&#ZR98)*3T./9\9>M<-I%PZ43;N2F.Y4\
M.F(H3")XZWH^4M"GN'6XIXRU!>TBW@O(,$PC-=.,GH@01X-PQQGJ&Y=K/*/[
M+#5&)-'"^DMO+3Q7Q,;'\7?'ZVSW2Z9]K.?F*1?=3IAYOPC](4_X=_9+Z.?]
M'+_].KEY_?LW];E3YZ]J/Z;CX+^K^RK]!W?*7=KWYG\Q?U$            #
MC1WP?YM?.+^)._\ _169.GE?I6E\.WXSFYOZ+J_ GL?))WHG]^7'3_\ VNXD
M_P!-9T^Q/#H_Z:SY.WLA\T>-8Z.G-/Z=_;*+!+K.ZYZEJY,9:_$Q,=+;-9MX
M5<&UVF61&!&:>B<Q1*8;Q)P<M0JLR:8MS!LI&2S4DB8;4ZV*D\)]996<8W*\
M8:-1-E4V5(2FL/C+M-N!%1C\9,<EH0<(?#$5VF%34\%Y!2,EXIB=Y''1XQ1*
M3Y&6$%CTA)8IRCH6CY2K04'%X/PDR)PZDZL=!+6=_O M+EBHMZ'AV%:Z":TN
M;+,+,&,(]/:,C(_&^/QX#>F\TO5(FPV$IMX2+N,<MIC#1&/B&1D:8*4/.#9B
MD'-8X#>M=JR[/)YW%CM3'RD]#GI\Q.PZ\DQ4^SSX%ZEZA)14X@QH1;3CAKU
MI1DE"))E)FHYR7;YADN76.,H"$BFU):<'X_B@51M1C\'H[(".@W"AH4]0Q\A
M-?(G5CK^0=9UY&N4M*':O:RCLKIU$SE,YK"3BFU!((J<IO#&0E:,4VET%P\I
M-/*J4O*M8VDSB2FGT=HZDQV$X/:P^&HG4=1%QC]#\.W$=I3W1239<S.4@M<M
M,@RJK]*:QU#),NHBDWKE(F:4JC6ERCH&RBQT;%2:PP)Y%GAZ1=<NH5B.LFV9
MR6CUZ5HGY#*)B9B$NB>&9<XO=A_^H#R)34_NW;@]7ZNW>O,>H>O'ZN\UU1]E
M[QZNQ,<SRE?NOLOJM;L_:W=?[ ROVM;/E&_N7/HVS*WJ^P\^WZJ[?*:.7[GE
M;;\UH]5=OE9T79L(R9$4        XS\]9K+)O"NCRU%L[RQ&#='E>ZOO8RB=
M,$J*8.*GZ%!LU,H8PW'-2@
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M]MW6G'D+RV_BWN[[5LGYW>M/Z?YKY6[ME_I;]F7ZB>&?DFE\2UR!/7WO8
M       ;+\ZU_P!W:7J=?UK)6DDS2V:-NN0T5G\U%Q<*IPAHIT'1=^#86YRY
M6FAF         DY/#M?FCZ_,<^M^'M32[D];AMW_ /\ FS<=_L:G]"S!_(?;
MM^H/-=7V)?W7ZNW[T.0^''QK74RW,H9.O3^JLT_^&J/R8YOZ7K3_ %I[9?NE
M_P"%I_)V_%A_5.!
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MJGPQE8N*5%,%#\90;+\H3"+J0W*-:@
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MXI_A+S?_ &+NW]$M'SQ[=_U>\/\ E+WZB_\ QS_K%X_^3:'QI=E4^4WZT@
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MB_G.:AC_ ':H_)?F_I>O7[K[,OW2Q]%I_)V]D/ZAPH
M                            "$G(#!0SC)%*            AC< C8.>
M/NO/YU%7]XO_ *#8/JKZKO[PN4^3U/BP^1?KN_N=N^4L[9=IKZ*CJ?D/TTC.
M[R/QSC*&89            !)R=7KWL-2?>-W52U'[#;6K^TYB!^9WUH8_P#<
M#F)_X=G9+]B?J/?NKO\ AW=L/7RU"PHR]%0_J3Y0G'FXG>^L=&)^<3UL:/5J
M[3;S?TGR.J_OPAJ9!G&2*4    !"3D!@H9QDBE
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MHH^LI,[\H2>]Y&Y9K4
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M=$E-^8G6=:02QGJ\Y<RM<B>+T?#0.HPV"A+MB":HI.8SA9QA=F#;C#I%4K7
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M!BJFQ                  AK4,K44R
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MHNS81DR(H       !QHY[>KE?JZ/+4+.\MNUN9RL_@QE?J*/K*3.])[S<LP
M
M  &S?/'^ ^>ZUY&;M#O,;N[+:;N^-/-.&BFY_8F>ME1CIY.7IS-@
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MJ&Y;_P 7-W?:MD_.SUH_3W,_*W=LO]+OLTQ]1/"_R/2^):Y G@'O(
M   ;+\Z_X.4K6Z_K63.8*5B6W7(B'W1S4=3A_6G1=^#WM=F<N5IH;
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M_?A J$F*@3A%,@                 (8\(%B*"E
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MPFJV[6YO*R7#.5^HH^LI,[V/])N68*
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M           "&$YJ",Q3-       $).0&"AG&2*40UJ&5J*9
M  "&-PJT&<Y,;N[+GE[K[^=/5^Q[_P"A63ZF^JS^\#E/D]3XL/D;Z[W[F[OE
M+/C2[3'T5'4_(?IK&=WD?CI&4,PR            "3DZOGO8$_Y1FZNBS;C^
M<WS\S?K1?O!YGY/3[)?L/]1_]U=WP[NV'KV:7LJ'T>9GRC?,^G\L/K+1_#SU
MI;]2HV<Q-.8CJ==_?@"@
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MHVX#T]D/.(6"$80PF*I6F>:X-N$<"3D8&5_-EV^1F&ACJRW:'??Q]\?K?/\
MU5!HUN]=UP\YX1]/_P#\[NQ]'/\ HY?_ *=7+S^_9OZW*GSW[4?TW'P7]6]E
M7Z#N^4N[7OS/YB_J(            '&CO@_S:^<7\2=__P"BLR=/*_2M+X=O
MQG/S7T75^!=V/DE;S_A?QW_&[B3_ $WGC[%\/^C6? M[(?,WC'T>SX5_;+36
M$GV^$[)R>JZW<@4X:]!;LZ0SNCS(HJZ)/1IZS*3&$47'3K!A"MIQ0HE)@<92
MQ\PA8]X<802EUDWI'2K</B%"$T0T_#LP+OV&VNP4%.,B;MINVI+"/7+$NU<5
M;C+3I1,((Z5CX-?R"GNI3W4<(*<-4F7%8KY2$H.4!5*XD'"$/&M8PJN%:D$W
MYNPFPK-$@X3DD6O05Z%4%/1K^0$F.,]6CK)D9$(/H6+\@PG!:SGTBF^G0,,X
MR)K&&PZW+JQ\^)>U.T<DNWRD_I,HRDE&.AC;'2D=V>D<W%8Z?@R]:=8O1C$9
MIF2BWJ@38;#5L]/PF7K.M%/K\OQ0&2Y*UI$2D2DX0T^72%WK%QAI\A,"D9JX
M)S?5YPG4/%0G#S@V)&+DHP\Y3*,2<GBYP7RA=Q&<U"&/:$V#>K1ATB(6(%*>
MAZ?D':20T)]?F'6=:+'7##S@D379I\P663T+61CO8O"6&GS%VKMQ6#@M<YZB
M)5(50AH["X+6%T;6GX(;DVTV"QCB_ %(Q4(Q83*:[!*>$(?$)R6<B"AYQ5*S
M4<</@](CI6*9D)-+$F>>17&HHP>N0PRV$XXSD8O'L@(G"I28V,J8[=,98^0L
M9I=A;+G%[L)?_O .1+U;[H:Z/U;N\]/]>?U>YGJC[+WCU<^E<G\+[+ZK.[/V
MMW7^P,K]K6SY2O[ESZ.LRMZOL//M^JNWRFCE^YY6V_-:/57;Y6=%V;",F1%
M       .-//=-T99I25=N/AJ,H(VQM;F<K?X,Y;ZBCZRDMV4)M;E&"@
M                                                         -F^
M>/\  ?/=:\C-VAWF-W=EM+W?6WFG*$%7IC+T39KTHQT\L7+XY6P
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M;)?^&]W?:MD_.SUH_3W,T_&W=LO]+?LSK_L3PRO^CTOB6N0)X![V
M  &RW.S^#U'U5?UK\Y)PQC-<:31MQR'VONAF=K&>K\;JD=%W<:[:<4T<L#0S
M        (\'U,1F/"L.-;CK?G-&O](M33PMGK<.>_P#_ ,V7CQ:'EJ8_G68/
MY![=I_\ 0/-=7V)?W3ZNT5]J'(?#CXUKJ8[FA\TJ@\,UFE_PU1^2_-_2]:/Z
MT]LOW2RTM/Y.WXL/ZIPH  (85E0RC'- 4@4H 0E(%+2@    ""D *0*
M       $%( 4@4        !"4@4M* !"4@4M*               !#&X5:#.
M<F-W=ESP]V VN]3UV+\?SJP?4WU6?W@<I\GJ?%A\C?7=_<W=\I9VR[37T5'4
M_(?IK&=WD?CI&4,PR            "3DZO?O87#O%[J481LV]$?[5?/S-^M#
M'_N#S$_\/3[)?L1]1[]U=_P[NV'KW:7LJ(/:>RNB,5'J1\I36>8I.57UGI1_
MG7;9JEOU*I=NHSYG#F8ATW]^ *
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M(VSM;F\KOX,Y7ZBCZRDV:D1%L48QWFY)I9
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M*/X2<WI?\5W;/_?+6@^=O;Q^KWA_RE[]1O\ XYI_]1^/_DVC\:793/E-^M(
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MKJ9;F@LI7/'-9K]&J/R8YOZ9K3_6GME^Z6>EI_)V_%A_5.!  !#"BAE"*4
M                                                       (8W"K
M09SDQN[LN>'NP/YU*_O%_P#0K!]3?59_>!RGR>I\6'R-]=W]S=WREG;+M-?1
M4=3\A^FL9W>1^.D90S#(            ).3J\^]BA_*-W3%_VFW+_>KY^9_U
MH?W@<S\GI]DOV)^H]^ZN[X=W;#U]U;/L*/I=E:_I?#B?)^,\SOJ^L=.GI;NB
MK"A-4.*AB;>8^DNFZ:WP$9
M     $)(&-)53-               #"+]I;6AMQ,[<IE+^[+.YZ_PU(PU?P<
M=;1H]^7ZKEK_ *V.7O[]9+[?RI[OZ@?K7RORMGQH>L>T7]WWBOR%WQ+G=&X8
M_@YN#]Y=U?:-@_9KP_\ 1_+_ "%GQ8?Y].?_ $CS/R^I\>7]TZW*
M  '&[GPU[+(K2E5'PU&^R8X:,+FIR)_6^<ZJ?[ E^3&.]#D::6T
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MZ<MKIKMQZ)U&5N9;#<[E=_!G*_44?64FW5[L,8S;DFAD
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M[HYJ6A_V)ON[C79WI<KC0V         ).3P[7YH^OS'/K?A[4TNY/6X;]_\
M_FR\>2_XM3V?8LP?R+VZ_J#S/5]B7]U^KM^]'D/A_P#_ %:ZF.YI92KIS6;?
M_#5'Y+\Y]+UI_K?9E^Z>>EI_)V]D/ZIP,0
M              (2<@,%#.U%*                 !#&X5:#.<F-W=ESQ]U
M^X=ZGKL7_P!"L'U+]5F*^T'E/D]3XL/D?Z[O[F[OE+.V7:9^BHZGY#]-HSN\
MC\<XRAF&0            2<G5\][ _\ \C=TJ&-FWX?97U'M/S,^M''_ *_Y
MF?\ AV?%E^Q'U'II[*K_ (=W;#U[X40TNE>2)\H3CJQUOK+2BFM+&A0I<>DW
M\Q](\CIOQO@(R  $-:AE:BF0                      0QN Q538@
M                         TZH;=$7"9NTZTFB7_@I:UW%0GTFC5R\K1H9
MR_4\M4WS8Y>O_MK)?;^5/>/4&8CUKY6/^+9\:'K'M%_=]XK\A=\2YW1>&/X.
M;@_>7=7VC8/V9\/_ $?R_P C9\6'^?3G_P!(\S\OJ?'E_=.QR@         !
MQMY\[7L<E]+"K5^/[3HLKPXY,+^[+4Y#_K;.=5/_ ,LQU&O3SAR.-+>
M     '6I_I.G\Q^O]\J?K;Y_2_9G^EIZOM/Y5[5/T7I?#?/]M+_)V7>JS;^L
M3\Q]'_\ A0_BWC'T:Z=T=CR;'YEV&=F&G@Y_"_HD]0H2U_(8QDT:?=\I5"*,
MH;81K%MST@[%BDW''7K(E*HXQBL/@B[ECHEDE%14O'T$J4IFB6KP_(4F104(
MN.KSDQ"*<=4AVI3W5CJGKT ITHHQ4?,7 PI@/6M.'0(Z%CH%'7"/1C 230?3
M+SB$@TO3A'006,X"A3"J1<4M,X^8%!N$WCH7EF#= GI>C3UEF"8Z%3[=;P(3
M"1CI@D*%!X0Q8W[".G8..O#%P\ "3@L<2XYJ.&E]7G)"1N&H+I7G&<F<I)-Z
M]!<US9J+Z%X2)2&,L5X=7A+UKCM''7AYR13):13K35'"8B:Y+,47#"3?F&UA
MGU)5"3UEA86<8H;I,*4DAJF8\+/CZ4E/2D6E)2;JQ17BY14A#'H%!]2P+.!.
M"I+'QDF4F9'5#&;\ HN;%;.N/A+B8JFV^C22E$F*"P@] GI)Z4;G%%V,HC!4
MWU4_#MQ':D^^=+FW^(-QNV#E+1J^$\1'OD8]9%-3Q&.PI.PC/&$,) I@N.B*
MZR)EUF$W*/F!GDQE'H+VLL:;UUI=$!O8[R3DI0P&2XQB>./9@2<AEE?S=KHP
M[":/?ALY::ZDQ[S^-OG];Y_KM^5G/S&%]W7#SG@V/.UG[B_L?1S_ *.7_P"G
M5R\_OV;^MRI\\>U/],__ &OZO[*OT'=\I=VO?F?S-_40           :=SZ'
MM\QG;M8SG#C9WP?YM?.+^).__P#169-W*_2M+X=OQFCF_HNK\"[L?)*WFU]^
M''2U\7<2?Z;SI]B^'_1K/D[>R'S/XS3T&G\._MECV0[3LFCU35KPU8XJ/46=
MK=;APPJQ3UQ,F,Y4/5CV#,S3%07:,,S*<54TO&O(2<R<,2$,'!%S3/K&M*?P
MPTDW2N6 VFM3+C!28-J6,R4]PICN7#TM/P0W&Z&,%.<$H%,?*R6$GU2)*3F5
M)X>$10C#-'%88:"QBL4GK$TDB3FDQBD$VX8%K1:T5S2?PQ&TRFA!)N'XGQQ(
M9HXXK!8%Z\SKS9:6S&LL:X432M>LL2M2.$>F):%$EK\07'H6#A"';\A-M2L9
MB6$5US%2I-J.G1T:QN3+ Q3TN4]95R'-I?# ;$RBIZOG\Q%S5I]C$42,,4?I
M.6"+DN2II1AVXDQ3'(PPPT^89KC,$L/C&.:8YCUZA!'0C<8K07+K6FW:-Q</
M'XR;TCI5:(X@ZLD6A>'S%WKO10UR7G':=JQC/3H\Y,A8O%36@8)EUHM;<BST
M+AD8J>*T]8ZCJ2,&YQ\_Q0%"B^KVC-,R*A*3%/<6GN#A"#EXR;TVC<5J3TEH
MM%327D?ED28J=J1CICT?*5,EQQ7C(99,5A/!EE9W9LJ<$24G-(/PXX%K"UAG
M1'VE/7+P%MS8S3A<X?=AK_\ >!<B7_VY;^WMWOSGIOKS^KW,]4/>_5WZ1RFZ
MY]5G=G[6[K_8&5^UK9\IW]RY]&696]7V'GV_57;Y31R_<\K;?FM'JKM\K.B[
M-A&3(B@       '&CGOZN5^KH\M1G;F1E+<_E=6JN%\I2L::*?K*#+4RB4B)
MB6Y!J4                                                !@ZTMK
M\;"/;V"2)K-&QG>.YN9'DKREXMXXS&<L9;.;LW5G+N[:+U=NEWLY1EKMRU32
MJ[EO:A51&3-NA9&IJQ;.3"^9BV9C-\_;O&<\./N\MSLWYS!XHWUO&O>>\]\9
MK)9+=CS>9KRERVL[F,OEJ:,M\XNV(54W5""9Y2[2BS"N#EC4NV1YSV9=S;W.
M_-#G1EMW\;<P,HMR\'YZFF]E:<Q;5%5^W=HL78TT7,FZFJJ+KPB:K]6S3FEV
M:6Z=]\U_HM]N\M[COB?AC<&>W_R=R]K.UY'+W,SF,I0J*KE5%BU=N7*E0LEM
M84+#6:HU;=2:-GH*8P]#E5/,#D3S'KO[FSV\=P<<<&[SM>TRV7O9G)NY<R^;
M6W371:KRZJ4<OI1U:EN5MN-M$X^.:W84=W[W87>XO=Y7D7N'[[M\6,US!W+E
M+&6WOE?:6ZLQ[.UE\K;MUW$K]VYM>EIQB>-UM/ANXHRET6S$Q78]G6U-J&$/
M&<VI=P6\3.,9HJ%ETW6UG,4R  !LWSQ_@/GNSR,W:/>8W=V6TO=]=7SF;T5J
M$OQIGK1A@636'+XYF0          <=^]=_J YE2C_P!W-X2_YM>/8O5/]8.6
M^4CM>@^U#]0?%/R/5^)<Z)[_ %WOK1_E/>$O^=W=)^@W@T5Y3R0_S4>/?I?4
MG_BW?&DHJVK,80GYT>2THI#Q6O-=>K4A!)]9SQ^$N:JUFC#:VI1C$V8+2F*S
M@HJ#ZP;<%<=<8] A(H-)N,8:Y.>KJ@2*D5I0<7/091-,".@AHC/42I7W%;@O
M2^$^@FW B*S@Q>A:BJJA&$)/S"4D:7:(J159*$<9DS,QI0<<'#Q!(GH1*"CX
MO$7<L] E&6KSB<),AP6CQB"*R2T37@@6(F3%%BGJT:R\-<%V)!1C"+ZV28*S
MDLH/7H(+&&F"UZ^P)GUF+\_R%B*Q789"PGAH\Y-IMP,(PZ)@SS9+KC'HU$E)
M8)M+K\Q<V6:XQ<=4X!,B$=$%X16A6B1C'LD%HKQG*/B@6V:)")3@(FF*UPJR
MFHZ%X8&*9I"3U/3\A>T[5<8^3SDA(I1,8PPD6O2O6-J$T6+:$0D7&.D1%<%&
MXL9$#T+40,8+K+A!EB0:J4/A(FPPIBNUB]8I@E"$TO@QC2I7"I*4),L14ZT@
MHP>!,X6LTK&8G!ZT,RE66AMO'S$VIM8*&C K+';FRUPFW""P\;$3,35CUD8+
M7T8>,;:E,4A\G26JBA35!*3Q\$C'89QCFLG'1XS+**)D2@I16AX$%FX],/$-
MM#)+OJT2U^<<KA=>RT>_-"TO74<*:I0Z&2^OS:^&-^S#;#WQ^XI_A'S>_8N[
M?T2T?._MY_5_P_Y2]^HO_P <WZR>/_DVA\:792/E)^M0          8OUJ/R
M7D+&4I.<-*_ZJZ_B)/=DG..MCFOUIF/V/>_0ZB:>4,=3\'=\&>QT@._?'^57
MS-U?=:OZ^\???LN_4CDO@3VO\\'UHJ?ML\>Z?G7V(<3J5!=9[],^=#YUN9Q;
MQT:=?82,9IM8THE$DVGJ+=L6[.BJ"GIU?*8I/08O6#*",U"24>G$4**TWBX=
M,GXAAL2)C8)3;C+1Y'TXDW$SA3:="<8Z(%.LJU*7CZ1'21TR813PE%C/K,^M
ME./1K)@F#!N4-!=[*FU<8OJD-R98(X0@M&#\> 7;65BY.&$1N3#)7-X1ATZR
M0D80*,H8:_D!AMS2F,<8QZ"SBLK"4G'5X2;4VIZ*<Y=$WXRU7&8P72X8R@1-
MFY5B^P23DTW%2C!OMPF5E'2JT*$<9QAX@3TK#P^3XXBJ5]PE&,8+1IZP(X/'
MM?R!8K"Q<)8:M0ZTITH\1"QDL%I4/&$Q%&"AHPZ085%4DE'M),%)F2+U^(M"
MD$8K'Q=(BE2E)3R!66MXJ4=$"8HQQQ[69THK*&*3[#&J5Z44=&&EZNPLY033
M:.4(=,7\A,R,5<8QPZ<2;C<D4W#2M/CP+D4IB0A-^ 1C-"J/J@7=M57%O"?6
M2$A)MC)<E4XO3(33R).&&Q(/",(]O2-ZUC-8N&';VBE93"HGHC@)C"I,&/6_
M$,C+J&\(KK0@A7U2722$CWT<%HCTQ+FN9.F+C*6@F9A.&U=HLQA5*);_ %_N
ME?\ :N[OMRR:N=C_ *2^?ZL]CS/@7Z4T9_XEO;#O9]UG_4+RVZ.'-W+_ *+9
M/SN]:?T]S/RMW;+_ $N>S/\ 43PS\CTOB6N01Z^][          #9?G7'[W*
M8.'I51ECZ-1*TF"<JMN>1$/NCFI:'_8G1=W&NSO2Y7&AL        (\'U >'
M9<;C?2_$FCGU_P /:FG%+9ZW#?O_ ,^[-QXM66H\=K,'\B]NL?\ H'F>K[$O
M[I]77]Z'(;KX^-:ZF6Y?UG7H_56;[?LU1^2_.?3-;X7V9?NG/X+3^3M[(?U3
M@8@   $X"&/$*91B              (3B 1-12@                "<1#'
MA%,HP                   0QN%Z=1E&.#&[*CGA[KU[7>G;3A"Q?BO]ZL:
M3ZG^JW'#[0N4B?Q>I\6'R/\ 7>P]CEWREGQI=IKZ*CJ?D/TUC.[R/QSC*&89
M            !)R=7SWL#_\ R,W3.,+%N*A_N-_2?F9]:*/_ ' YCX&G\67[
M$?4>_=5?3[N[MAZ]_P"U)ZZ?,SY1NBFO3>^L=''6EC;]1]OD-NO](\CKU._
M%  $,>$"Q%!2@            $),T G$*9      $),5 G"*9
M                    P:>U2UK-MDX3$EW<GI:MQ8/5YS3K9>5SZ&<OU?+/
M_6OR^3_=K)+_ *=E3W;U"_6WE/E;/C0]8]HL_P#M[XK/_ N^)<[H7#$N'-P)
M37W%W7Z7_,+$)=)^S?AWZ.Y?Y&SXL/\ /IXA%/$N9C9\XU/C2_O'8Y0
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M_J%Y;_Q<W=]J63\[?6G]/<S\I=VR_P!+GLS_ %$\+_(]+XEKD$>OO>P
M     V7YU_P<775];42<X)[LMN.1/[8YGJ?F.B[N-=G>ERO-#8        1X
M/J98S'A6/7?U3\YSZ_TBU+.[/6X;]_[^;/Q[^QJ/T+,'\A]NOZ@\SU?8E_=/
MJZ_O1Y'X<?&L=3/<OZSK_96:_1JC\E^;^F:WPI[9?NG/X+3^3M[(?U3@8@
M!"3D!@H9QDBE             (83BH(S%,T
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M &!E?M:V?*=_<N?1EF5O5]AY]OU5V^4T<OW/*VWYK1ZJ[?*SHNS81DR(H
M    !QGY[^KE?JZ/+42.\1E+=+E?_!;)?44_64&4L8SEN,1D
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M    V:YY_P !<_\ 54_6UF[0[Z7=R6T_=\4<POJ:WXJ#;K]UAI9.7IR-@
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M_"7F_P#L3=OZ):/G;V\?J]X?\I>_4;_XYOUB\?\ R;1^-+LJ'RF_6@
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M>MPW[_\ +NS<=_L>G]"S!_(?;K^H/-=7V)?W7ZNW[T.0^''QK74QW//*5/\
M^JS?Z-4?DOS<?]7K1_6^S+]T_P#PM/Y.WXL/ZIPL0            ()R PK*
MAG&2*!#"LJ&435%*                   AC.:@B9J*9(
M     !&DU!X$G 5:.LG]$ESN]U__ #JG_>+WZ%9/JOZK/Z_\I\GJ?%A\B_7=
M_<W/REGQI=ISZ*CJ?D/TSC.[R/QSC*&89            !)R=7KWL,N\9NK^
M\V_T+,'YG?6ABOM YBOXNSXLOV+^H[^ZF_X=WQH>OAO[!!X[*\C/DV8_ZF)C
M*KZSLC_/F=E2CU'\-"-_-8<S;U-D_A)0,P            (20,:RH9QDB@
M                          0PK*AE$U12@   0DST 8UE05 L8XHID
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MN5O\&<M]31^ATENV#<DQ
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M?NG_ .%I_)V_%A_5.%B            !!.0&%)4,XR10(84E0RB*(I0
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M*&&5W=^B6CYU]O'ZO>'_ "E[]1/_ (YX_P#4?C\__K:'QI=E0^4WZU
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M)CF_IFM\*>V7[IS^"T_D[>R']4X&(                          $-:@
M"FQ               "$G(#!0SC)%*            AC<*M!G.3&[NRYY^Z^
M_G4/]CW_ -"LGU+]5K]X'*?)ZGQ8?(_UW/W.3\I9VR[2_P!%1U/R'Z;1G=Y'
MXYQE#,,@            DY.KY[V#^<7NK^]6_P!!OGYF?6B_>!S'P-/LE^Q'
MU'_W57_#N^-#U[5.GV5"IQ:6O&#CCTGRGC\YQZ7UGHT]-*4>J^TW<WCS,=3H
MO[\!@R                                         A)R P4,XR12@
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M(REN=RN_@SE?J*/K*39J]V&,=YN2:&0
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M=\XKO?6MEMMNO/#E5C0EL-Z3=S,S\YC?#==,^DW0$9
M                        (2D"E        "&,R K*J9(     !IU+TJ8X
M3-EF[-+ICT<M26STZ<=?@->O7ACHJY]"G%O?J^6B3YK\O6]&^LE]OY4]V]09
M_P#5G*1TZMGQH>L^T:*^SWQ7I]!=\2YW1.%Y\-[@_>7=7VC8/V:\.BGAW+_(
MV?%A_GTY_P#2/,_E&I\>7]X['*          '&WGTH9?)U+%Q7UYNMPM83'N
M-3D/^MLW]31_\L7Y,+8I=%'(XTMP          =:G^DZ.'<?K_?*CZV^?TOV
M:4_.TUZ/M/Y5[5/T7I1_7A\_RVH[NL+_ '&W];2?1\X:</XMXQ'%RU\;K>QY
M=B=M=4'XD96863+3X7,3R=U<V+I<6E/Q$MRJTZ<1$+&<<$_,9;-[*F%-J:/)
MYR8^5<.+#)6HP?A$3AB32)IL2+C!X?#47J2G0L''6O 2*1DLW5'+'#1YQGCM
M2)G804G""TEQR*JHPBL2;=QE.Y)]NGS%3#R*H0703<MWO2DG'5IZ=0Q)BF22
MQA%=9>T[53EU?&)C%)C$2:^+Y1,DS$FF+EJ'4;*081:PEVC=M7/K%./CZ1DF
M0L7%:HS)L7)<&WHE,;DSA(QGA#SEH4I@2?2^T8F,=2+^N^'9@.Q>Q8**EB2L
MI61.+6N95H1DWITD["F--B*$W#"!9)Z%73I\W43."M,8&NQ(12E")V[2>N6O
MY,<2X>4RZS0]*4.@&W>K:A+$E.G(HD'&'T/P[<1VI7W2.MP:^'5@7L.K(6C4
M\?,2FQ:S6NU&FG+L\Y<"M8Q9.+<UX_B)U$X=:Q\> 3K8)Z83UQ+N6FQ8*.'C
M JTZM!$[3!)8.8WKAFCA&.O3J@7<;A1T36C0)2:>4E%M3?@)N-Q'I\1:+3<)
M:<.G6)DF4E!]@5=4)PC'01!Z%CKT%WIO64,)://TXDQ\JXI@NK%=8DSE=*:>
M/F0V&S>1U3UBG2E.E)[,(=L?,,,UK'E9Y2'M5+7/7V:":$1Z29;-"L:L1.3^
M+OI_8,\OQU'@F<^O$Q==7IAYSPJ[_P QCI]'?V/HY_T<O_TZN7G]^S?UN5/G
MKVHX^-Q']5_5_95^@[OE+NU[\S^8OZB            !QH[X/\VOG%_$G?\
M_HK,G1RN/-:7P[?C.?FOHNK\"[L?)(WI#[\>.M?WW<22_P#TWGC[&\/^C6?)
MV]D/F7QFGH-/IX[^V6*<''QZNP[9Z'JVIA;AF+'R",<=K9$SPXXLD]"?PQ+O
M8QE5C%8XLM/<6GN,H):):?,3%(E)N>C0@M>'"%:?6]8P\A$TDEV+$4H8UQS.
MASCI&]-\).,81[1L-@I3T:?ACB-VU>O,4(N4-2QT G+<N.F,<-& -J3P:F^G
M44))0C/J)GBF>(YQCHA#M"P2ZV^P8A.*CC,NPV&F&CY!LJFRNTB\(Q?D!AGL
M'HE)=/P>([5[5>EZL/.1-R+!I^#47J-N!J34%X1VKVGU/XOAP@.LZS!12EI\
MPW&Z3%N<D2D;2)FU,<%US+DLSTRRT[+\/C)O2FTBE(4F4QECCB_$7)<EBDEI
MQZ!F9BCHDGVX#K*[))Q<YK!]9$%]*Y>/I$]*[:[!:%UQ+O)Z24Y2E.+&)CY2
M,:NCY!L*8#TI+Q]HWF^3%J*\8V&PC!2<?-\<0;<2+A-=<R;<##80A@YOS#,S
M'&$$I=8WI'2K@G'X:A'0N[8=+E# =2;H2.+?;TZAU+.*026O5H+B8LEM3UZ,
M"8&%<"4.CY1M3&N\4^E>" 7)C*3Q>GS%HJRP;CV$ZF/41>A0AU%P,!06B6OY
M"=IVC6$!AM6+IA:(;:U3[9&41C6<R9F+7./W8?\ Z@'(G]^Z(?X=N\]-]>)_
M].\S7HA[OZN1_P!3RDQEQ?9?59W9^UNZ_P!@97[6MGRG?W+GT=9E;U?8>?;]
M5=OE-'+]SRMM^:T>JNWRLZ+LV$9,B*        <:.>_JY7ZNCRU"V9XEMVMS
M>5CCPQE?J:/K*39?,S2-B4B);E&L
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M/F]^Q=W?HEH^=_;SCZO^'_*7OU%_^.;]9/6#\ET?C2[*1\HQA#]:@H
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M3&DQDQ;<8/L,HCH91$4K"Q>L<,4JE(2S^V&Z?WUW=]N633SN/)W_  9['F/
MOTGH_*6]L.]IW6?]0O+?^+F[OM2R?G=ZT_I[F?E;NV7^ESV9_J)X7^1Z7Q+7
M((]?>]@         !LMSL_@]1]57]:R3L91E+;GD3^V.9ZORIT3W&FSO2Y7F
MAL         2<GAVOS1]?F.?6_#VII=R>MPV]X#_ #9>._V-3^A9@_D/MV_4
M'F>K[$O[I]7?]Y_(?#CXUKJ8[E_6=4/^4YJ/7[:H_)?F_I>MT\7V9?NG_P"#
MIU_%V]D/ZQPHA)BH&-)53-         !!.0&%)4,XR10
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M 8JIL0     #"K1V^0V6166-_<D>CM,-?N1UM&AWI?K>6K_^Z_+[4]]9*/\
MA^5/=O4"(_W9RG3Z6SXT/6?:+^[[Q6/^!=\2YW1>%W'AO<'[R[J^T;!^S/AW
MZ.Y?Y&SXL/\ /IS\U\1YG\HU/CR_O'8Y0          XW<^OUMDNW^S-T=V&
M,L^0_P"MLW]31_8"_)A'>AR.-+:          '6H_I.G\Q^O]\J?K;Y_2_9G
MCXM/5]I_*_:I^B]+X;Y_UIPW;8?^XV_K:3Z/GN0_BWB\S'*:DQGPV]CR;$[5
M*Z%\/&9V863+G\)G_HKNFB^K+$QMQAITXI"/0VNN9E#*!:FB5Q93&'%")=$>
MV!:XT)PA8Z,(=H2GE$U'IUZR2DP*,%!]2@5<*I-PE''M!DL,%AC+$52IBX-S
MT><;UWP0?9I\QC"W3O(1;+7HS2LQ; TH2PT^8O:=>9&;TQ@*%,!::G\- W)N
M5--]7G)D9(W&$,2TZ2G3D1:QT^(G44KD2[%US+CY5Q\J1]*<OQ!LH;,&6+<)
M0[=!-A7#<QC!Q>):+U*\,<>C'XH"$C,4(+63?L)]Y(.*3PF7J*]"RP6G\4D&
M.<HE&$I3F69*JI)SE*?R D4E$3C-"<9HN*>A>'23*2E)1N*AB_ 7>4VB49Z?
M)H)/03[Q!1PZQ64K(IOH7G&4&4$W)]N!<#"%T>E\/ 3J-N"1E.<>S M.A=JK
M%^-?*1-A!I=*%<=R[=Q!?"(K*5EBUC*$.W$JK&E:>R<B8F*N>B>A1\X3JR8M
M=FI8EAE$JG*9*=#&8Z$4<$IZ<"X;5PDQ<81UKY1D;E6,L%YR23ECF-*2C"!=
MZ8YD7)O!1F-R[A)1CHT><DI,C<H:2Q"Q"PPE"$2(D4\5@7(QC(AC*4B%>EEE
M8.ZE#7/6-"/\S>VZ$SZ6/N7\7?3;R^=CHJH2ZE$YM::W7]</.>%Q,>(Q7/T=
MW9+Z.G]'+_\ 3JY>?W[-_6Y4^>O:CAXW$_U7]7]E7Z#N^4N[7OS/YB_J(
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M/+4+.\MNUN9RL_@QE?J:/K*3._-)S;EF
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MG\G;V0_JG"Q           !#"<U"VBF2
M                 !#6H96H"X7Z%]GE,K,X8W.>'NNU#O3MZ[%_]!L'U1]5
MV?\ W"Y2/^'J?%A\D?7>_<[=\I9\:7::^BHZGY#]-(SN\C\<HRAF&0
M      2<G5\]['#^47NA/^XV_P!"OGYF_6@K^T#F:?B[.R7[#_4>C_VKO^'=
MVP]>_P#:Z=ER5*AX.F9\HW8<QOJ^M-*D:\L;?J5&WF8_ZG'-T7]^ C(
M       "$G(#!0SC)%*(:U#.,D4H                               $
M,;@,54V(     !I52JIZ<3=IXQ1+IIIS,9O)KV=A;.OIU])SZU:X]+1H9R_4
M\M/]:W '[]9/[>RI[OZ@_K;R?RMGQH>L^T3]WOBOR%WQ+G=!X6_@WN#]Y=U?
M:-@_9OP[]'<O\C9\6'^?+GOTCS/Y1J?'E_?.QS          !QMY[_F>4ZG_
M &1NL[DL;FOR+_,,U]33_8F5_=86]]R+.=M          #K4?TG7^8_4]6\J
M?K;Y_2O9I^EI\C^5^U.?_*]+X;Y_MO\ :_+P_N-OZVD^D)_!/XKXQ^ NIT6]
MCRLO^9+J^(RT\+&CPKZ'*N<$2W*K5;,8]9TO\307<NZ&,6H/2\2T6,R$53V@
MZ64'''Q$2J2:GBBY2N4BG.K#X:AU&4X(UCT0\8@B5Z&L.DQFZDLHMKC$I.$-
M XEX&96IBXSC->4JX;,RE)-]!)RP6O3D*<5@M1<C+K)K'M?D)N,-@WJ[?@Q$
M=)3I6,4XX2'5F981FQ3E!OJ+.9MJL(J79YR1)7'$;6G'X:AMP.K)9PZ?E&U,
M*[D<4L?$,"*+"&"!GFQ3DXSP*JRP<O'$8F)K>UUR!Y!*4T29295XKM&PV,5C
M\-19R6<E^ACI?QC:;5>*[2;$V(D].!9E9E5%SB8S$).>#%QQU%B8EG3AR79Z
M?$6K"JPE E2N*:Z>J'E+O-ZI*&M$VDYI"*0PR7*54&XK$;DQA%T*+ZRRL^\*
M&#QTB>E)KGL1.3C/ *1;?7YADN2[*>#D*I57*?@)N2.@AI4O&*])5*GH@6%@
MAT1>F8*^X0:Z%ITP!FD%C@A7W2ONLH)+J\Y,TS(>#R"I643;[/&))B@FH.."
M$K.;++*-Q+#$G+_A);M"::D0_B[Y_6^=6JJ@Y];OW]</,^%37Q"*_B[^Q]'3
M^CE_^G5R\_OV;^MRI\\>U/\ 3/\ ]K^L>RK]!W?*7=KWYG\S?U$
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MW]7*_5T>6HD=XC*6YW*W^#.6^HH^LI-EV4)M;E&"@
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MZUTI_P ^>MIV_4J-_,37FHZ*.B_OP"EM<\%)%X;>D)#AMZ0$Q;T@.&)FD2+
MOH]Y5"<-O2!>&V<I29HA?1QTIQ*B<-L9RL34)2WI4D.&WI ET6[)"!CP4V@9
M1;;3,.HLVV[)Q29I%2#U&'!'2QXX(&<6;V475(%X(Z56 ]'O*I <$1G*5"3%
MO25GH!%L3C4J0+P;U"1%O2 I;TA(<-O2$APV](2'#;TA(<-O2+ O!$Y3@5(#
M@WE4),6]("EO2$APV](%X;.E*ST!)BVF$E9Z DQ;LE2!EPQ.4A <$=(L!Z/>
M51341P;R2!.&.D6!>#>52!?1[TJ08]'O*ST$#"ZR*YK$I PX8Z18,W>CWI6>
M@,9MIM(D$1;TJ2'#;TA(<-O2 F+>D:=?K4]9LTZ16B:GX*6O=;E3&*ZH'-JQ
MA7;5HT,Y?J.6K_\ NQR^6O?62\>?RJ/>/4&*^MG*3T:MGQH>L>T2?_;WQ7Y"
M[XESNC<,4[/#FX%&/^1=U?:-@_9GPV:^'<O/_!L^+#_/KXC;P^)<S\OJ?'E_
M<.UR          !QMY[_ )EE7J3_ +/XC;;-+$F*M;D4XY?-/HI\E'QF>IA:
MUV]]R,.=M          #K4?TG3^9!4M>\J>ST;Y_2_9IAXK=.[[3^4^U6:>%
MZ7PX[7S_ &W^U^7_ +U;AT^BCZ/G\$_C7BNGQ\O=PYTM['EV/S)+3#PELG_+
MK.UAX7HTY._'*!-ZO&(IDX=.>**STRD-$</.6K9OZ5VEKEH)4FW""24?"*S)
M,;*XL8*$='E^*!D5)3EU$KTYLJ3L64?A(1.R$I=$)&4-!:%%C!=#T:A1*558
MQA!]9$2*?22M&5MLR+2M$BUKUEU8P)81\7:*I%9FL#BX=,9"N&"Q%)I)U*#7
M3K'6DT\B)XQ^'@%8V%.@C!>3PC#/84Q93E">/0$P8N490CYAA"YJY)Q<WYA4
MC%&U#'L^45A<5QPQU_(.Q.O))--M_(7(RPA8Q1C6DLHLVG0M&GK+@QPG&2&C
M&'9B*]&9AGD-IP&,+$#C@YQTC**D1$S@CC'' 914B(EE%0Z!+'M2G6E)B<5G
MWR$5'2*S"5F!QQ)2JV74V$82T:_D+WLB;9S1-+3V0%8R)K*PDYX_&*FW$6,L
M-/@'63EO6&.B(2:>1(Q@],Y?**+2F>1BI*$?,*DSB136N'9B(W&*J"<-/:,4
MZV,82TC"JTKBL))/&<!7$KC780:2@,-J8;2#TJ,<=&!3!'!16DE5QSV*X80P
MZ2P17-5T8+QQ))/2Q<(QT,579O6*I?PD7-,QU8P[!1*#P>N4PJ.,^R/F)$UE
M<*1*N6&D;Y2(FYGE97M<=)-"?\QMY>)])$W9OXN^5^I\]]50^O$YM;O7=</-
M^$Q_YA&[3O[)?1S_ *.7_P"G5R\_OV;^MRI\]>U**^-1']5_5_95^@[OE+NU
M[\S^9/ZB            !QH[X/\ -KYQ?Q)W_P#Z*S)T<K]*TOAV_&<W-_1=
M7X%W8^23O.'WX<=K3]]W$G9_EO.GV+X=CR]DQ^+M[(?-/B]LSH:=O3??VRE$
M(IX>/6=L^=#U>^REU)E(*;?1T"M89V:<7Q2M(%3T]1E6K"[":+!"J1,SA&8X
MIX=<\=0PH4KAM2,L<<)"2(K-#1!_#2,:F&9M?#63 X4@U,RSP6L2LX)=9,)2
M)QJL8=2\Y,*&>,YI@V_'J^.):X$%,5,3-5PZ<5G+QX$K&Q,)2F>"\928,(+3
M. KTF%=PW/&'8$B-PY*!8QFJQC-43FA-%D4NTDRO#6C.>/B^48,&+A!>+PEV
MKC4?C7G)"0L%IFQ5:32L9)-+J\<16"FWI$UCC#LA\<145.46Y$S)B,H13>,8
M=&LRE)PA8:I$J5Z4CV^*'QQ%%H..J$?' 9$4VR:5KT^;HP%8R*T&\8X2D,$B
M:]8\%''X=F KCN7JR,>W#SC R2,5%S@3"M5K'=C-6YO26E2)FF$HY.0BNW)9
MI,8":CJ\+%6,Q*X1[!6-JTF<=B3?G?D%8*3"^1>.(CI2DQ..8TM$EI\Q2%JP
M)&:1FDX].H5BM&5(X:H\>LE8HRX:8'1CJZ-98FN*3%,5C%PQ7@&45VL8CR"6
M.M0+,F>>2I3BB5K!-8PG-/5>,F)DS2:<$2*0LW1=Y%4-0RFBS7AK,I"(ZLUF
M:9Y+H3T"D,9FM8Z4<-4Q6L8E:378SHE73V^0ML4E+KN*USB]V"VO>!<BFU_U
MW1'H_5N0\)Z?Z\1_Z>YF=T/>/5Z/^JY.,IXOLP^JSNS]K=U_L#*_:UL^4[^Y
M<^C;,K>K[#SJ7"B/PQ@:.6BME-[9?.U:/57;Y6;ZUQ8QDS"@       '&CGN
MO1ROU='EJ+;;B6Y2W-Y63X8RK_&T?64F5^4)3%N48*
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MH916BN&@D52*[5Q4_#\@G":&4X).#@Y+HU@'C\-0C(C(F\=.#\I:TBAED0G
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M+RW_ (M[N^U+)^=OK3^G^9^5N[9?Z7?9E^HGAGY'I?$M<@3U][V
M &R?.[^#MOZJOZRHQGO0L92V_P"0J2SV:@M%6GZDW3W5V2Y6&MB
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M7.HSMC$MG&C<OE9_!?*_4T?64EOV$YMRC6
M                                     -F^>/\  ?/=GD9NT>\QN[LM
MIN[]M?.5'57*4O5,M:E,"R(AR].=D          '';O7_P W[F9_%O>'VK>/
M8O5/]8.6^4CM>@^U#]0O%/R34^)<Z)C_ %UO=O3O3>/BS=[4?H-X/]#\D/\
M-5X]^F-6(_&W?&EG;HI]BFGM4Q<7"'E9Y70B^8Z)>-OOLMYKSO.MHU6DTG2H
M*$EJ[3CLKZ2[CSJT7WVS?,VQ2$V7J-N$8,*PD&*8[UK"P>H1,1%$K!L-8XKQ
M_!&58G/,XNC)'0XI-:](B)G&%BZ*5%1*F/3\,1/%0XL99;"4$G+JP\9(FF16
M)2JA8XZ]'G+%9RR.+8B3> X9*Q U"0I=M*UQ2$9$I3$K1DJ*G$5I."3=$&PU
M(5B8I,G%$XFRQGA4K"*EZ- X+EF>DV6UT,M+LBL0;.EN57B@*3&)7HV&RX0@
M3"(H5A?9PDL=(I$Q2)Q3CJQ@HQTB+&5=BI,1'#N2938>F?B\XPZ3BC8R@]19
MF(F4K!LO42,8DK!LQCK0I$QO*^XFPYOP].HF2\49*J*FXZO.6)Q2;HB%]G7K
M7B)4X[6+H:Z]?R=07BCR&PVG'1B6ONG%%5V67ANF$XH'3 G#<1-1TPQ?B%+L
MBM142DY"+;B;ATRVL8?B"DQC,'%L-E_"!*3Y"L(E'L+$TSE:T1TQ<UCTC"3B
M9;+U#S9P2L)LLF$K6%V7J+,QDE839BTF6*SEDM:16%@XP'#=DE8I5BZ9]7G1
M.&ZJQ.#)41PG#LQ)28W)Q4S1TMZ!7HE>)(-BEQ@K3AJ\ Q(F!4SQGKAB91%Q
M,LMBJ6F,9X8$I2<<TXH'0U'HAXQ%(Q.*&&QKF_ATBL1E*\3)IIP8SG!(F)1T
MPAI+%MT9+%R7J(JE8&/*Q/'?,YLM.ZV)E;5#554I[-6G\:+XB.6OB6-]U8CH
MK#WP^XF_A+SA_8F[?T6T?.GMX_5_P_Y2_L?J/_\ '/\ K%X_^3:/QI=E4^5'
MZS@         !B_6H_)>0L92DYPTK_JKK^(D]V2<XZV.:_6F8_8][]#J)IY0
MQU/P=WP9['2 []J__*[F;*/^5JI1_'W3[Z]ET?\ HKD?@3VO\\/UI)_]ZO'O
MRK[$.)^Q%J6O3\I_0+HGJ?.G%2&3HUZ/.8XUHQBYBJ)-]45KU:2S6<F4W;%V
M'&4GX1,7;4XL,<F2H@X+#7\D21/N)-U1T3BI^+SEFDSB<6%"#U$K$X)6&.S"
M1>&>EEQ5Q(-J&(F"M,55+7P1)FB3=$JJ*DHN?@+6B<5M:(J)ZNGX,F%<96;L
M%V&L,!P3*<4;4V7"*\Q."8Q6L+LM2)%(3BB45+75J^#,\L\5XHDV<98](K&)
MQ#HA&'A_%9CD<4;5V6I+ RQF4K""DJKI9)G%*PD&3RK6$V.CQ_*)NF=IQ*TU
M M)F,")79?9V"DU*X58['1CT_*2L'$KH=,=&$\2YY9D71(U+H9E2>HJ;+C Q
MX9B<,BN%2#C#27AG(K&:NAXQGHZ!PW53BC+8FQ5&;AV+XR3%,UXK5V9XRUPZ
M/#B*P5@V7\(%B*;<$K!L50PD2L57+%CL/LU?+&.(K%<\#BCRJJ7@M!:3.,%8
MVFRR4DK!!PB6;9*XT54MPAC,QFL=:<5%]FXM=49^ M8C(XX39<&]4"84.*$@
M]"GUDI7):PNRTH^(SX;O(E8JD(:>LE+HR6J[++PW)6$V&E,<$[<EXHF5V6]
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MDZD]%4F)C*&7H?W3Q$])/0GG=#"7TZ\!EZ22G]7WR7TZ\!/23)3^K[Y+Z=>
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M5G\&,K]11]9297D]YN68
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M_MWO_P R_P D+O II+@O,MJ,OLRC&>/L-!?VK>I_X_WOYTGZHGMD_P"W>_\
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M\G\[.SZH/M@NCSN0X?+/VF=7= Y^-?P/S4'@X7M'^\$_:OZI?CO>_G;/X/\
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M^!'\./M4_P"W?V_YD_B?]C?^OCW/\3#^39SSA_!7,]?V3])+_#E[4O\ MO\
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MO^)C_)KYY_\ A;,_\)^DC^'+VI?]M_M?X5_B@]C7^OC[W_$O\FOGG_X6S/\
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M?^%?XG_8U_KH^]_Q*N[9SSI__57,/\\_223]7'VI3_\ S?[?^%)^L_[&I_\
MSX^]_P 3/^3=SS_\*W_!<_22?PX>U+_MN/P_YF'\3WL;_P!?'WO^)C_)MYY-
M?P4S"_//TD?PX^U+_MO]K_"R_B?]C?\ KX^]_P 2ONV\\VW_ -U<Q_PD_P#@
M= _AQ]J>SPW^W_,D?6>]C>7S^/O?\2?R;.>?_A.__P )^DE_AR]JG_;O[?\
M,R_B=]CG^O\ [/\ B8ONU\]-I-\+9BFG3*M__)-^E]7'VKS$\'AW]O\ F:-;
MZU'L4T/\K5Y__,G+S?\ $U:^[5SR2GPQF*GU5]$U]@6!C=]6[VL3&/AO]O\
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M97^(E_WKZOQ_^3[R_P"U/$YCZ'[['_9B]^Q-K\#>])8_KK2H_P#(1_O7U?\
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M;WII_P"5=?\ R$?[V]7HP^<?V5N]5?%+IXIY/^T?[,3OVPC^!K>G5^JM</\
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M:WI#H^=>3YB7_>WJ_MYGWC_:GB?^C_M"]V'W[6H_@;WI_P!*_P 1'^]O /\
M4_V?YU_VGXG_ */WV*]V/W[(N')K>LH?\JT_\Q'^]O5__4^\3ZI^)4^A_P!I
M?]F-W[7CR:WI_P!)_P 1'^]O5_\ U/O)'JGXG_H_[3)>[#[]W_DUO.#_ &5_
MB)/][>K_ /J/>_G/]J>)S_\ A_VD_P!F+W[6X/DWO2/_ #KK_P"0B/7;U?\
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M<HQ
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MQ[R5<M-^[2^QY5U+3\SLZM7LM1?SI'W*?FGPS\5!^#/?[BW;RT7#_B5F4/\
M>1^=(V6LI\(\+F/P<>\Q?+'?J4[>6@O_ **S^DECQ/\ JI^9_"_Q<>\+EAOY
M-5*WEFIR^96>K'V(_.D?<GYH\,_%1[ROEIOZ,'9RT\/U%:A+I]B3\ZQ$5H3X
M/X9^*M]Y?P9[^_N.6_P.U^DD_.]OW*?F7PS\5'O#Y8[]J]:WE5#_ .CM:?\
M>B?G?#&U9\'\,C_PX]Y*>6._MF%5&6Z'\RLJ$Y_VD1XM/03X/X9GZ*/>7\&G
M$#QHRO\ @5G]),OSI_53\T>%[-.WWA<LM_Z+66;>*^96>S^TC\ZQT+^9_#)_
M\.WWE_!EOY*%-O*OI^9V?TD?G7HM(\'\,G_PX]YB^6&_TU"WEI?_ $5F,_\
M>1'BM)K%I/@WAM/P<>\OX,^(%!NUEH3_ .)6OTD7>*UQX<2/!_#(C'3CWF/X
M,M_[3>QE8.$OF5G0O[R8?G:<YA?S1X7^+CWF?X,=_O9?L\L\9?,K7Z2;+?%)
MG.U)\'\+_%Q3R)^#'?S4?8Y5;/\ ]':G'_>2_G/^J?F?PNE/1Q[Q^#3?\/S/
M*Q_85K]),/SOCW<3\S^&4_!Q[PN6F_DE&C+-SB_F5GS63'\[S&P_,_A?XN/>
M8/EEOU-U.C+:(?J*SU?W$L>+1.P_,_A>7HX]Y5RTW[)^SRVF'ZBL]O\ :2_G
M:F4'YG\*C_PX]YE^#'?\/1HRTO\ Z*SI?]Y'YVFZ,(6/!_"_Q<5\B/EGQ!HH
MRO\ @5G]))^=IG"B?FCPS\7:?@RW]5C;RTO_ **S^DF4>*US@_-'AGXN/>/P
M9[^:CL9;_ K/Z26?$Z84)\'\*G_PX]YD^6>_8_F>6?\ S.SYK)/SK'0?F?PN
M<]./>'RTWZE^9Y9-X?J.SV_VG42?%:8\*?F?PO*-./>8+ECO_:BZ<JO^96=4
M/[B8_G>>C!?S1X7^+M6KEKOY0C;RT'H^96OTDR_.N&-N!/@_A?XN/>2GEGOZ
M.S3;RT=?S*SU_P!Q'YVC.+3\S^%U_!Q[R_@PWZVXV\LO^96OTDGYVZ+3\S^&
M1AZ./>*>66_Z5!V\J_\ F5K])+'BM<[5GP?PS\7'O,GRRW\X)6\JFXQ_45F>
MK^TR,H\5B)[K'\S^%[=.*(^6F_VFKV7RRM25/ZBLQBY*#]C'$POYS;2,7!I>
MK^G&K,V32WH?R;G);?#N^TS%-YU5N-O8JKIHI3G*BFG91J]/-*?TGF-+P_2T
M+8B*;VI3R1WK<P5_H?M*X=/T+-5]^%9<^O;-G=R2KDEO1)TT4W^GT[F*ZJ3*
MW4P32QMB;XK*+DMO9XT9A==R[^5+&K$S1GYL[$_ IO9-068@H_1W=/Y$3JQ!
MYNV*2MGDAO>MM;%^<(QN7-$==)JU;XNB(C.K*R(NGHB'X_C3@6K@7+VLWGG>
M5-UM-57:THMM8M4K0>2T[^+1CBPEAJTRMR?V.'>5.;XDW18WWE/;56;RC3"[
M<E&$4H)Z]9XO5[U-[59$TXH?V_P);RII5I47]G%PKN:5'Z36=LZD6:/!5US%
MMUL2BY*;TH3V:,QU;=S\KTFGTL0US99.V6*Y,;VHI5.SF%0X[3VKC:C+Z03K
M1,TG!,(RQAH7.3>^<C3[6S;OYA5)O8=5QSA%XTZ4BSJQ;-*YK7BC*E&A8Y2\
M09M.NO*WK*JJ2@G6MF#AHI)Z:(FDY$O/JY([T245?KDH+;N144FY[(G5MI@1
M$UXKLFFN2&](.-&8BOQ]R?\ 6D]+$+2PIY'[T>UMK,.$(+VEV4?R)(FZ+JUP
MELK9-E9?F.,N7M_@[=]&?SWM5;KP;NUJ,-J"T:F=>G-8W./6BR;HIF\GA/EE
MFN+MT?=C**]50UZ+5VY)8.$G'$TWWQ96C=I12D3E+^[^!3>B<'3?B\/LESM^
MA-5NI6,89W\/%A.#)\EMXO:VJ+[V=F'IW)1Q^AF9>ECH2*1E+&GDIO-J,+_Y
MY7^5$ZFY)ILEJ/DGO.I0V+]3U>TN?E1Z3"L-.M?P6UMS/P);S^BHOIK!.Y<<
M8_D66+YC'8TQS$Q.4M2SR8WI8K5VBW<IV)UJXZKE%45+T*Z72<VO=2>+:[='
M7OFEV5C^C^"_?[;J]G8JMN5%OYG:6S#&'V+$XM*R_5YBWTDUL=U_/3\UF-&*
M:T93MAI_@PW[_P GL_X+;_2CS$\CR]<*4>&_.'C&W5N]]G3RMX@JCLY:QVY:
MVO\ Y)C/)<O'0?G'Q>/_ !;O<EC^##?VG+V8ZOFMO]*+\QY?=0_.'C$X^EN]
MR5JY7;_I<*LO8_P6U^E$CD>7GH)\1\8G+5NIU2Q_!?O[18LPT_J6WV?VH3R'
M+Y8'YP\7_&W>^OX+^(()_-[&PO\ Z6W'5_<M9/F'+Y8'YR\8R]+=[Z/E?O\
MA^86=K]BVM?]ZU%^8Z&Y9\0\7_&W>^CY8;_^AR]GI_4MO]*+\QY?<GYP\7_&
MW>^S_!CO])PRUE_\TM_I0^8\ON)\1\7G_P 6[W)8KEAQ!"/S>PJE_P#2VWI_
MO6H?,>7W)/B/B^7I;O?5\K]_PE8LQT?J6WK_ +T3YARVZJ_G+QC+TMWOJ^6&
M_7_:;+_YK;_2B_,.7C*A^<?&)SU+O?8_@PW[_P GL_X+;_2A\PY?<?G#Q?\
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M_P FW8W^]&4_Q>!?GEU,<SYKIL?O%XPFUE-V:(_Y(R?9_P 7,/GTLOFNFR?
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M[7+'@K<]_<NY;&4S$KE--*:U)4I:EJ.;"8P6(FNY^O(R
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MG6PMKM;E\D$OO W33H5&'Y"V:=>V(U)F,V'+XV8MW]FG4O C1$4BCH-FG4O
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M6F;=6)C.&%_=;3]UA)[FWQM4IOVU.S4X-PC3%:\8';XE_1Z*%E)BKEELK4O
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MO C%E2,EV:=2\""J
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MOI_ZU"L=!2>DA5]/_6H5CH*3TD*OI_ZU"L=!2>DA5]/_ %J%8Z"D])"KZ?\
MK4*QT%)Z2%7T_P#6H5CH*3TD*OI_ZU"L=!2>EC534TUMX_C4)IT%)Z6'L:O[
MH_!\I*0E)W^ZSIIJ22V\/QJ+%.A:3TLH5?3_ -:A6.@I/20J^G_K4*QT%)Z2
M%7T_]:A6.@I/20J^G_K4*QT%)Z2%7T_]:A6.@I/20J^G_K4*QT%)Z2%7T_\
M6H5CH*3TD*OI_P"M0K'04GI(5?3_ -:A6.@I/20J^G_K4*QT%)Z2%7T_]:A6
M.@I/20J^G_K4*QT%)Z4]G0_H5/$DXE(C)G@%    !B]!HUJ5BO2L.*W>E_@]
MNE:\Q4>6Y&F-6C7BMC<OD?+@'=7U']A;-',_A9-")BS%O <[<       FDTV
MUG4F=B['&KO,I/A&Q&7V5P?3!GE>1BMTPYM>*Q#^]W>_X!Y37'^QI@:.<_"3
MPMNE^#AOM3&$\3AT9NQXFVZFQD;F(    !+II%1(FKTD]"T(CTD]!0B/23T%
M"(])/04(CTD]!0B/23T%$CT$]+/04(] ]-/1)0CT#TT]$E%CT%C5F=A0B/23
MT%"(])/04(CTD]!0B/23T%"(])/04(CTD]!0B/23T%"(])/04(CTD]!1(]!/
M33T24(] ]+/046/06=68V%$CT$C5F=A0CT#TL]!18E])/04(CTD]!0B/23T%
M"(])/04(CTD]!0B/23T%"(])/04(CTD]!0B/23T%"(])/04(CTD]!0B/23T%
M"(])/04(CTD]!0B/23T%"(])/04(CTD]!0B/23T%"(])/04(CTD]!0B/23T%
M"(])/04(CTD]!0B/23T%$CT$]-/1)0CT#TL]!18E])/04(CTD]!0B/2ST%$C
MT$]-/1)0CT#TL]!0CT#TL]!0CT#TT]$E%3Z#*S4FZ:4**;4    !A<_,Z_J*
MOK66,QZ^-X)_AW4H?JRB*_WX\[=3YK$[G/I16^>)[!;7YE;_ +W1]:CU^^ZE
M:9NAJEB:Q4"@  D#&ZV+LQ1;;%L4@8NFES:GULSK-*)2&C39V*]I526B!IF+
MK9XLX94MIO:\2>DGH*$1Z2>@H1'I)Z"B1Z">EGH*+$OI9Z"A$>DGH*$1Z2>@
MH1'I)Z"A$>DGH*$>@3JS&PHD>@GIIZ)*+$OI)Z"A$>DGH*$1Z2>@H1'I)Z"B
M1Z">EGH*$>@>FGHDHL>@L:LSL*$1Z2>@H1'I)Z"A$>DGH*$1Z2>@H1'I)Z"A
M$>DGH*$1Z2>@H1'I)Z"A$>DGH*$1Z2>@H1'I)Z"A$>DGH*$1Z2>@H1'I)Z"B
M1Z">FGHDHL>@L:LSL*$1Z2>@HD>@GIIZ)*$>@>EGH*+$OI)Z"A$>DGH*$1Z2
M>@H1Z!&K,["A$>DGH*$1Z2>@H1'I)Z"A$>DGH*$1Z2>@H1'I)Z"A$>DGH*$1
MZ2>@H1'I)Z"A$>DGH*$1Z2>@H1'I9Z"B1Z">FGHDHQ=NFMQJ7C9;:ZF,X0DP
MJMT+!>-_&;ZS"4ABJ;CCM5>*GS$NBV=\&/4M-*H<(SJPEJQ\IA%MELX9LIFZ
M<Y:AF@    .%'>9H_P L;C?TUZUV?9&><\.MB[1F*;):KI\ZCE'R]4.$-RI:
M,I;^MI/"736Z>N6Z?L/VA$        .''>F<:-QK!J\IZXUU'FO"8MNOI+"Z
ML36,G(+E1_ /</1EJ?)2<7B$1'-74R9\7%BW$I4$D<<S6:I$4A2*
M
M            &U'.E;7+O?BA'['3XJ;AERG?PS2_)M)W6/VFWS_?E#I]*F/@
M:/(<_7ALJEN3ED>-9
M                                     !CI-$W?YW"NQP*Y[4I\UMSN
MI87LJD_R:U'L?)1;/*S6:2YM>LS$6N<.XY;GW=./ZCR_Z%0>&YCS;[J=+=9W
M8?UD:K.ZR#(
M                        #9SGH_\ [?[V^I7UM9LT*?.;)WK7"C;?NM?P
M?WH_]VI\J/(^*374CR-.FY5GBFT
M                                                '\S>Z5>[-X4K
M%92_'H^PUM%THCTL7;TF:15P;Y*I?A:WBW.I9C-3P_MD,,,#V'F;Z\C,=359
M7B<]SUUN
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M/*8J$/[=K[3S^K?'S>.K[#3.>][!;7YE;_O='UJ/7YB*RW-0         )2
M%( 4@!2 %( 4@!2 %( 4@!2 %( 4@!2 %( 4@!2 %( 4@!2 %( 4@!2 %( 4
M@!2 %( 4@!2 %( 4@!2 %( 4@!2 %( 4@!2 %( 4@!2 %( 4@!2 %( 4@!2
M%( 4@!2 %( 4@!2 %( 4@"@         X3=YF>^-R*/]OM1Z/LC/.>&W4TKN
MJ5G)RDY=J'!VY%C^H[;_ *VD\)=WYZY+LW[4B        '#OO3P5G<;4XW5'
M1#[)4=GALTYS$F*X-_\ E1_ /<'3E:7X528<W->8NG>RN;B4Q@HX_#4<\TKA
MDPBM,5(H
M                            ;4<ZE_\ ;O?>M4+QT7#HY+_+U8JQOR;1
M=UBE+<^^*E*-U)KJJH/(>*7<463.::<^9,;W+0\.S
M
M #1VZ5==/T3A%SG!2.>8GTT3L94P<#^>OH\U=T..-_*RA^/3Q//<O=;&A%<\
M6BZ9XJ.<&XOVGW;TY/+OPVJ&>,U._/6VQD_K&
M                                                    #:WG!NK/
M;XX)WED=W67F,W=IA:LTQC4U37J3UELF;=2V[9$F$X3F_!]W;AG?7#>X<]:W
MUDZLG?OWMJFBJ,4DUKIIQ.SG=7TM+K6%L<,TV.1QQ,P
M
M    ?S]ZV[EW=V=MVJ=JY7EK]%%*E&JJU52EX69632Z)29I%9<.>4O!/%.Y^
M9V>WGGMWW+.[Z\Q>:NU*K9:KN134:$L.D\CJZ]M_+SI[6$36ZL9.:QXQL
M
M                  !QP[Q/#F^N(]Q9"UN;*5YRY8NNNJBB,8-O534;M&8L
MBE6%T73,P_>\H-W9_=7!>[<CO'+U9;,V:%MVJHQ3V:5I2>@:TQ-U86V/=;I&
MED       D'%N,M'1^*84GCKL&P/>!X>WMQ)PQ;R>Y\M5FLS3<B[=*<4FG!R
MIJ.WEII,U87Q6']GD?N;>>XN#<MD=ZY:K+9FASHJCJIUI:35KS74F8R6V*6T
M;RTM5)-33--M:8YLE*
M                                     #"M-T5I*+=%22UN#@BQF.$5
M_@7BRKG&M\O==RG=[S2K5];3IV5=3C'8AA/$\G?KV7Z,6QA,0TTK=-,G-RWZ
M-%NER>Q2H=*I43QF>+<U"
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M98K.,LBH
M                            &V?-O=N\M[\#;VR.[+#OYR]1"BS3-U-4
MUP4DS9H3PS,W3BET5AMCW;N&-_<.;HWI3OW)UY.]F+L:+=4<%53.=-.@Z>;U
MK=:+:;$MPCA<FCB9
M                                    !@MG:JAZTMK'5+Q&$Q$W0.&/
M.3@KBC?G,K=.?W;NZO,9"W>RU5R]3'9I5%2;;:H>A:SR.CJV1I1&V&JZV9G>
MY@;IM56-W9*Q7*NSEK%%:U54VJ4UV-''?YUW$V6Y4?T3%0
M
M8UT[5+4NVE5+'4Y#'9F,::5)["H:C)0TRT01(K.:UPHS@HMZ7CV%10
M
M                T:-EU-T4T)+%JE)U1\#4&C&LUH8;&L9
M     ,0
M          -*MT12N4ITO!M;2ET0>D81UIC5J))*"274H+P!2*BEI>'8!0
M    8*J+:A)0@]<>C1 DSPSYV!&.0Z*7%PIBX1;2JPZ&,8RS,-JTT[,805,H
M4I)):\,8E&0
M                                 8*BG%TTNKZ;9421%.HFFQ6FZJ7'
M",H8Q7B@7'R#(
M                                   ,/9T02=-+2PBMJ$XZ8Z1& R22
M4$DEJ2@@*       !$TU%8"<,S-C71M)>K&.-5*JEVDFM/-S6*;5IBE#95/5
M"'@1=F=98JDTH-Q>N$/$2-ZJ4
M                                             #3K6+5"J=4(Q:A*
M2DY&,^;BL4VL;<$DH4TMQALI+:AC@I0+-)G"<DK$Y12&L4
M                              ".C2
M         !"5BM-HTO9T4T^DJ6Z?HG0FU%]KTB.B,S#:U)*"6!KNU:746(9&
MU
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MNFJFJ.*9,KJ&6;5M.M5X/9JQ_&P3@XZ8FNET:DT[J12(IM>49@
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M;LYW*5I56;^7N6[UJNFKTHT7;55=%2::P9(B;9I*UB<G],R
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M2R6]LAF<S4Y>K8LWZ[KQU$G1OMFMVPXJX;7[RF,%%[3UPA'L,8WBE
M            ,0 $22;:Q<(]F!*;12@     &+II=.S"6J+UQZ\24&10
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M0                "4VC'9IG+&$<=&!8PR)FN$JZ4VFU-1AVXF,VQ,UD4R
M
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MC+X(M)K3:E8S8JY154Z4XM$7*:,\ ,::Z:H[+C#&36/6@,@
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MQC;/OLDFE!N+UPAXB1O%*
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M#?L;F7M*(1C+J?Q#94VTVKMTQI49U1A)SAB*&<5%72]F#CM1A#3#'P 9
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MR+,Q*1O:I%
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MRG8>&U^^[=/+<]E1H;0
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M(4V;MJN&N=%50PKN6(V/)HVHU*JK:A#0E"*Z"IMHS(
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MM.FQ=&^NICWG>ZI]6GZE>0\<[)S9!
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MG>.4NU?2V[UBNIZH*FML328IM)B:U>9;3IH2>*CY6%9@
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MD(**A\[R\X]/M8HL4B*$U\CR+-RW6J7EKEJ_9;]:U<HK5,H^M0VG%BN-!Y0
M   \>]Z]MJ3C#:U1@IZ KTH>^.[Y>2Y*<HLWRGX?WG1EN*N8&2O96O/9/-+Y
MSNZV[.9IV*J;&9HNVW6[=.C0=?+Z5MT5NS2DYNFSN/*[\WE=SN8SM[.;TS_S
MB_FLWO2_:OUN]\YN57J(WKBJVMG;UGDK-2+?,IYKEU)FE.E_>X%]'G1RIHK_
M #6GBG=*;6#AO?)%U+J6S8T61YT/I(< _P  ^#/XJ\/_ .BLH>"NSGK>1MV/
MUY
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MROHXK;BRT^8X[J3%(>Z*[<N544UV:E[.M454W%"I.FI)IJ&*:9Q[)Z736:N
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MHGCK1[QNXO[ZS>>;XUW#RMYUV73NS-U9;=UCB'-78-YFX\KEE7&]G)[5VMN
MU.2TK+(X)Q86:]]]\\7==H?=F]\KOW=&1WSNK-47\EO'+9?.Y6]0Z:J+EC,V
MJ+U$*J6T_1N+2>-NI;=PW2ZM[^FJZ]I[4*:82P<7I?1 QQSV+A$8]YZR^_C[
MR/EYW.]QO(6J\IQ1QS?HOTT[EM9FRKF5JV+WLJKBIS-NM5;=O!H[>5Y>W4G_
M #):M2^;(JZLW>#]ZEWD^<6\,SOCA;B?>?"&5OWJZED\I<S5;MVMNZ[=*HLY
MR/HTW%X#HGD="S&Z6JSF-2^*SA#9CEE[R/O2\NN+\KQ-OOF1Q%OO)Y2Y;O/(
MW;&\G;OTVJJ*W0]O-;*VMAKM,(Y33G"_"UE&O=E6LO<WO;WSE?/SN?<P=U9*
MW7P-S?L;OR^5W1O'YQ[+,9J][.%R_1:^>*^KCK<9,V1X?H712ZZD4:_G-U9B
MR,8>GKD/WQ.^)G>:_!>X]^<VM\9K)YK?L+UJN_G&KEBO>-I4T/:SC33MU0P,
M=3DM&VRMLXII:^K=?YV3OF<CMY;SWMRKX-S^^+U68WCF-S9*O-7JFW5=N59:
MU556VVW&IL\?J6\-]'7;/%%6[)@H                             ),1
M,4D>COWXO)S,<T.[YNS-91-9C<%[,WZ[E%IU554>QOUP=5-NMTJ,7HQ.OE+Y
MT[O-87TB)N_I4=2;D=S*SO)OF[P7GLI17>S-/$>Z\E<KI=5+5/W4RF7K=4*J
M,%0=FK'IK?.R<MEW#=2-KZ+'*W?%OB/EOP5OJFJ6?X<W-F'5':].[D,M56L7
M'TJCQ,Q%GF['=;,VQ2'K-]\%S6RG!_=OWYP9<SE%BKBO)7J*[?M*:;EQ6[&<
M2I7V2FMJ*P@SHY?&^K3J3_1V.IWW->[=FN\"^*.'\E;K5W*WLW?HJHHJN5>G
M6KBJ>S:N5?VP\M/.:VG;$1'FPU6Z5D8?T6UW'O+W,<E.\#POPGGKERO/\-<0
MY*][>I56]A6]Y6Z_2;5N$K/0:+->[F[YMU,D]%&E2ZW%W]>Z?S)RW,WD;P1O
MK+WZ+^8M;AW=E+SHKIK6UELCE;<75376HSUGCN8TXTKYMMRAUQBV-]YWQG>X
M)[F_,_>=F\[6>KR%-BRJ:MFNK;M9IM4PJI;]5$Y>WBOB+LTNR=#O@;=N8YJ<
M9;JW-GE4\UQ%Q!.JJ-5<MY40;BJV_7Z3R]_+:>GIUMGSG)&I=?-)PA]!KN/<
MN_P6=V7EGP<Y59#<]J[5Z.R]K,6;-4ULT:$M!XC6KZ28ETZ=.'#)RLJN5JW3
M!;5RIP2EK\&!KI'%3)E/%2ML5AQ+[UG?"Y:]U?@K>&_^*MYY.]OZUEJKN[MP
M59BS;S&<K]G>KI6R[]JNE1M0EB;=+2F^:SW8877\.&UU6>]'[ZCG!SDKWANG
MEVL[P#E*+E^UE:LI7?O.JA57Z*:T[.<?K4U4OL._2Y#1U9KJS2UKU-6^RWBM
MAZ\=W=_;O;Y'.V;]WF]Q+>MN_P"UNVJK&]-EJBZKFSM/-0@TH&=_A_)V1,5Z
MFF.:UYBL/:)W=O?B\RN6N9W#NCCO==_B[=.9S&4R^\LUFKURU59MNYE[-=]J
M[G%52Z:-I]IQW\O9IX0OSF^,=2/*[7G(7GUP'WAN7NY^/^!-[9;.Y+>.3R]_
M,V+-VS=NY',7+-N[=L7*;=VZX6W7"+.6ZV;<9AUV71?%8;U)UU-.FKT)S@I]
MCGB85RED_.<5\7</\$</[SXIXIWIEMU;CW1EKN;SF?S5VW9HMV;5+JK@KE5"
MJJ:I<HQD6,:4)I6NQUKN][[];)[DX@XAX Y+[DISN[<K7F,A1Q?E\PJ_:U4U
MYBQ5711:SD*85TK [(Y6+K8Z')\XOXYZ8>BWCWWAO>OXKXBS>],AS4XAW1DK
M]RN[9RUBSO*NFWM5UUJE.WFH06TCL_-W*1969\YA=S>M-U?Z+?7N\^]D[QO*
M&]1FN*>)=[<95>UHJJM9MYNUZ%-=IP^S9Q>LJ'X3FU.3T;<=/-;>:UKI\_N0
M[-G<']Z1RW[V.1L<-\27<GPES$?L[>6W+>S%IW-Y-TV575;3S-RM5JNZI0F:
M-31MMBMLXMFCK3J5KA#VQTU5[:34:<:*]::CATG#J:EUM\1;%+73$88XRZ[_
M /2&W#D/P*]"WGG?T*X>4Y'3MU+INNSAS<S,\,1&UUT.YG337SIX)K6%S>FZ
M]BF,XK-9%G=KWW19-,J-6E,Q?P['T). U=^\OAE/T*EN3=BA)Q2R5B&.!X.Z
M<=\NZ)B<=CU;>\[]X+P_W9^ -Y<(<*[QL9CF)OK+7<OEOFV9MU7=V7*[>9MI
MU4VLS1<5>W0L4=.CHVW3_F;8<VMK<,\-N;J=Y;O@=^'COBS*[AX=YG[^O;UX
MEWBZ=V;MRM>?O54+-9I*FE^QS5QTJE7DL#=/)Z,>=":>OJS/#_1=NSW:7(WO
M#\ <NLAQ9W@.-MX;VXBW[E;68>YL\[]==BB_9R]RBIU7WM4_12Q.75BRR[AT
M\G3;6G2]J9J4  8J,%'&<<.S LTKAD1ECF_G[TWGE-T;NSF]\_?HRV1W=E,S
MG,U<N54TT46<M:KNW*G54Z4H46V.&MT1M*X.D=[W#OGYGO \W+O!_"6_+U_@
M'=.:O;J>0R]ZJJS?S5J[G,E%TVLQ<HJJKOM:-)Y;E^7MB/.R<U_,3;,<+DAW
M&.XANZWW.N9_.KF9N/YEOG)[MISW"-6=L0N9FU5EZ+MRJW[?+*M+9>*JF87:
M]VGK^@T^Y#9%LZFG%VKM>B?FEFJ;W$G$E5%CV.7M[[HL44_C;6\+EM02P4*3
MR%]D6V3=&;EU(X)XW>B]TPH=R7E;3#_B]YXZ[.4?G/ :TS-U9=>GC;$O92:F
MP                                         !^#YG[KS&^>7O&F[<I
M551F<UPUOJBSLQ=55S[FYA44)*+;K<$2M)K&<).$5?.5YM\-\0<,<W>8]OB+
M)7=VW*.(M[U6+&9IKMW<TEO/.NG9MW:::ZMJ&A,\_P GJ4TYZFK#O.QO[BWO
M,\M=V;@XCY6\4;UR/#G%>^,SE%N3=^:NVK-6\%:IR]JY2JJ[M#53JK34CQ_,
M63?6;=DK;=&<]YV9:72K2JLU45T5*.W0U6JJ7.FI5**J33/'TFLQ=E+;U+L4
MT^E4]IVFG2H0@V^V.)A9YMM8A9FO6]<G>W]V[RM[V7$V5XPXENV\AORQ;HMN
M^\M:NNI447**(UO+W*Y*YK.W0YW4MTXBF$-%^A9?/%/>;*]WKW0_+7N\\X=R
M\Y.']^K-[ZW)7578L*PK::K=K:])96W&5O6A?S.I?$Q3-LLT].S':]PJKKV:
M'2UL;*3<%Z+2A@\8LY9F:Y8,_-I-<VU'.'G1P9R/X,WEQGQWO;*;LR>3RV8O
M9>S>OV;5>9NV+-R[3;MJ[=M-[?LX2-NAIWZ]TQ2D0UZE\:>.<RZK_>H]^#QM
MQCO3?O"/+3(7>']V9>_F\MDMZ96[75[9*K,6*;RJLYSTG#9:._YGI5X;IP<T
M<S?29H]2&:[^'>YO[TS&:JYP<29>Q=OUW5339WI73135<JKII36:V80<#?'A
MO+4PE/GE]N$YN7_(;WOG>'Y07LIG.)-Z;PXRRUJ[:HO49RO,6W79==I7:G1?
MSB;6Q2WVFG5Y'EM.SBLG$GF=:>]B[4'<<[_W+WO><*V+F6S>2W5Q99L6GF]U
M5YFPKERY5;L.O8H>8N5NM5WH0TG)JZ$Q;Q6.C2FZ;:W/839HJIVG6]JNISJ6
ME:/ CEXH\K=L=77WTO/SGURLY@T;OY:\<Y[<.[Z[5JXLME:[]OTKM&9KA&U?
MM>JX> \ERW)Z7,6\6I.+FU=:_2PC*7#3W?/O'>;W*_CFG>?/7CO-<2</U9?,
MW*LAG<S=II=5%NU5:I5=_.[*;JMM=IT_FWEH\ZK5',:EL>=B_%]\_P!\%SGY
MQ\=[TW=RJW[O;@K<>ZJK]O)VLC9SEVU?MKYS3M4W<OFG35Z+3,+^0Y>V>*)\
MZ6VW5ONMZ+7/WW!O>(YS<ZN*^:>5YG<<[VXIL;L66JREO>-K.4*U4UE&]AYF
M]<7K5/ X]71LTXK&;99?-T8S5VA+V9]E8N9B[<IRUFS1=NYB[<:5%BU83JN5
MU5."ALTMS<CDB)K$6Q6V6V:>6'I+[\GOC. >[CO7-\'<O\EE>-]_6Z+EB]FL
MKF+;HR6;IIS%NM?8\VE5[.]:TI'D-'EK;HI?WI<NIJ71=2W)UJN=_O->]'S2
MXHN\0;DYA;[X7R6<O7;BR&2MY^[19I==RJBB-C-NF2K2[#IM\,Y7AK,X-7SO
M7[ML8O'Y6>\F[T7 V^,OO'>O,7?N^[.7NT7/FV9M[PHIO>SKHK=+=W-I+:5$
M.TOYNY6_*<&_2U=2^)NN[U'8#[A_OK>'^=/%&4Y9\XMUVN&-YYBK+9/=V_<Q
MF;:ISEZIY>PMM7,X_7N7&W*)S:W*Z5F%LM<<Q=;=6<:2[!UC.V<Q:L9FQF*+
M^5SENB]EK]ITW+==NY0KE%5-5$:73514FG&<3@F*9['3QQ-(C.8:U5=Q/:PV
M6D[>,=K"9C7ASFM648QDX==[[OJ\KNZ-P5F=]\7;UR.8XENY:Y<W+PW5F+-&
M9WC<IMWJU2U\XM5VTG:ATF_0TIU9K.$,+YF(\W&75K[RWOJ><G.&WG<EP/;S
MG 61HKS%&6IRE=Z[7L*J_317&SG-INJFJEGD;?#^7U)K=-)<GSG4M[N,0]=^
M[^_OWN<MGK.?JYQ<2[%.8]J\O5EMZ;-5%-U5NC:JS6S!TJ$3*[P_E;</Z:V<
MQK771%T^;.Y[7>[=[\GF+R]O;AX=YC;IN\3[IOWLM8S>?S-VJBNW;=67LWLP
M_:YW:IV:%54<WS/2CN2W:FK-F$YNT[R#[P'+OO&< [MX[Y<;YRN\\EG,MEKF
M=MV+MJY<R&9N6:+MRQ=IHNW8;%5<,9G'?9P74G)LLOB^-[?#VRKMW-F*:HJ@
M];2<6NIFMG.#IT>]I[RO>4Y?\^>(-U<NN8V\]P;KR^8IIM93+UYFFBBFJYFT
MTE;S-NG"E:-!UZ'+1KS28S:K]74MMXH[S=7W:7O#-[\O-P<3;[[Q?,RYORO+
M;MO7LAD,_?=-R_F*,K;N46[;S&=CM5W:&EUG3K^':6E9$V3YS5;S&I3SHK$N
M*7>7]]IS;YN[_P!_;KY?T;UX+R&[LYG,KN^]E;><N45Y>F_F;5J[35:S3IJV
MK;IJD:8Y;2NI6:-UE\W11PDX<[^O>ZRV^K6]:>;N_LSE5>=ZYDK]&\+-+IIN
M*MT)W,VE-*!MGE.6MMPG%/27U\^<(>_?W=/OA,SQYQ%N7E!S:M1WGGKEG(Y+
M>^;S"MU^V=65L;3=_..*JKK;P-4\K9P5LS:XU;O24GNNRA:S%-^BS?M7:*K%
MZU1=MUT.FNBNFNE5)TU4MIJ>AG'2E9G)T<4=W;+:KGMO'>>Z^4?&^\MS9IY7
M>63W!O/,97-4IJJU=MY/,.FNE)IQIJ2,,)F(G*9)NX8JZ#/&W?/[Y-CF=Q/N
M_)\W-\6LAE>*KMBS:IOYS9IL+>]VW[-)9Q*'LU \O;R>E.GY&G4U=33[N4NY
MI[MKCOC3C[D%N/>7'&]+V]]YU9/*U7,W>JK==RNK+95UMNNNNJ+JJ>D\=K61
M;?2,FVVZ:\.RC??O?[YWSPUW<^:.^>'\_7NW>^1X=S]_=^=MQV\M>IRUVJBJ
METU4U152CBC19929IC4U+IBVMN;HE<$]]'OCU<?Y6UO3G#O>WN*UQ7F[>:OU
M7\XZ:,G;WRZ72Z:L[""L+J/+Z/A^EJQ69P<<<QK<.,NPKS-]\7PKR)Y [ER'
M#^>IXZX[HW7EJ,YO2S>568MYJO**FJIY>C..[54KM)JU>4T[(F+9;+->^Z^E
M'H7YN>\T[SO.#BA\0\-\QN(>$[=RJ[75D;>5WFK;IK=QT4>CFMA05:\ CE=*
M+>*OG-DZTVVS='3D_?=W_P!Z'WG>2N\EO_BCB_>?&EJWF++N;OS->9I5=MW+
M6V_LN=E&BA^$ST.0T=2V;IS+-6_5MJ[;'<)[^7!W?*X(M9S)>PW?Q=NO+6GO
MW=--ZU77;N56[+VME7[M:;JO3ZC1S7+VZ$Q-LUB6R+JO80ZMFM*JN"JE33L]
M&LX8F=L,Z=#\IQCQKN#@#AS>?%G%F\LONG<>Z<M>S&:S>9N6[=&S;M5W4D[E
M5%.TZ:'!142Z$7ZL\-,:I,TMWNL%WO??B[USF]^(N7O)[='S3*9:]F<A:XDR
M^8VO;NW<S-A75[/.RG335(\G?R6G;;$YM/'6-[TG<4=_7O<[PWQF]X4<V>(,
ME37?]K3EK%&\;M%-%=VJO9I=O-M-4JJ TN1Y?4F(F6B>:U(CHF'L&[GGOLN9
M7*#?/#_!W-"G>7'.ZL_F+5K>F\,]3F<O["EUY:V[WM,QFX4[%&T^TE_*:=MT
MV6Y.BRZ+K?21-9E^2]XSW_\ G/Q]S[L<3\A.9N?W+P#>R&5K60R5^^[67N+*
MW*JZ:WELXK=52KK2>&!MLY#EYBLSYU&.KJZD1PV83M>S/W)_/+G=S5O[P?,S
MC7.<2*W)4YFN]6MG]2)P]K?NSA4_"<?,:%NC/F+I7W7VQQ.RBDDVUBX1[,#D
MIM;E*                            !CPXU'\_>>6IS6[MY9>I*JG,Y'-
M6'2TFFKF7N6VFG%..T9Q,CY_'O!N3F;Y5=YOF'G+ERK8XBWKF<W9IKH=-%"H
MSF=OPI;HHIG"$CR6G,S29:=2(X9H]S?N!.=>?XJN<P> ,Y35;L[@M999155M
MJXJJ,FJG0G<:ET(T\_$^DMIW3E[IOLFNQV:=Y9RG=>0WEO+,7%38R>4OYIQ@
ME33E[-=RIMZ/5.2V.*Z(;JNA[[U#F)EN;?>XJWI9S%.:MY??%.[G<HN*NW2E
MG<SE::(4UW*5#:A \YH\O;I:4ZMD^=1X_5UKL;*85>/S?[E>\^$N3F[N<-%5
MZQNVYNRG,WK7LJU1<5W*.ZI^P5+CUF%G,7:D^BN;+XC0TXU=/.7,KW"7-'(<
M$\?<5;@OWU11Q=F+=BSE:[JI;JL7,G;=5%%5RF,'3H3->ORVG?;,Q-+H;^7\
M^.*<Y=PZFIU*BXG]CKH5>A0BDTXXSB>'I2<,FUTG_?<\R,YO/O:;QX.IS-56
M[,E;M4)T5.JW353;S:JI@JW2_2Z#S?*:6G?I1?=A-KBU->ZV^D-RO<<\DJ-^
M<]\ES7HH=%&Y:<Q6ZW;;IN/9RC7I.VTIKZ8T\Y$\,Q$X0V:6I,W1$[7<2JN.
MFN$(-RC)[26#AH/%Q$UK.3HF8[O])XN\=YY3<^1S&\]Z9FUD\CD[-W,9O,WJ
MZ*+5FU:H==5=5=3225-+,;>*Z:,IIL>@_ON^^DX2Y,;ZWGP/RER%CBK/6%=R
MMS?N6S5#HL9BE9BU<=%%&;IC[.[;DX1/*6\G;;IUN[[DOUYXJ_T77-YK>\C[
MU/'_ !3F.(]S<QM_<.;NS%ZY6]VY>C>%VBVJ[EUTTKV6;:@MOQ"WD]":\4X)
M',W3-;,(?K>37O/>\[RZWQ8S^^N/-]<1596NF]3E<W1GK=%=-#MUNEN]FU3Z
M2HAVF^WPWDM2*72QMYK5B:1WG8R]WW[XK@_O*[WM<O\ F9ELOPCQ9<=O+[NS
M68O6Z*=YYB&7MPA<S=26W=NO!1.7F>4LTIFW3FL0WZ>IQ6XSYVU[SE=VZ5=L
M5TWJ*Z**[>PZ73716HTUTUJ*J34T>-FM:1FW,+E=[9V;7I7$Z=IM04WAJE$S
MMC;,^0V[G COK>\%Y3]SWAG,U[VSV2W[QY79=>Z^$K69LJ_F6[5ZN-RJG,VJ
M[3IJMX0.OEN5G6BMTTAIU=7@C!U;N\M[Y;GMSFIS%OA/-9_@"Q<N7*<GE\C5
MF+[MT*N\J9Y?.-^K6O =5W(Z/%T2T_.;HBGON%>X?> =[;=.^,GO#,<W>),Y
M:M7U<N9.YE]YT4UTJY37L.JK-)0=*@9V>'<M,SQ30CG-6L1&3W"]U_WY_%/#
M>^>&^$>:FZ+F\MR7[V6RN=WOF+U2>6IKKR]FN_4[F<C3!.JJ9EK^'\MI:$WZ
M4UO+N9NXX=I7E7S:X(YS<%;LX[Y?[\RF_-Q[TRMF_:S&5N6[BM7*[-N[79N*
MBNYLUV_:0<]!X:^RZV>&'77S:R_;;TK=S<F]*GB]VY]?]&NDC!8G:^<MWLE2
MN]9S@VIK[X\Q+7_E/.GF=/3M]#$[:./5QUMSLS>XPI3X/XFJ=4(V<KL48P2H
MR<?"CBUL+*;73;69PR>^GC;C3A_E_P ,[UXLXIWEE]W;GW5E,QF[]S,UVK5+
M]A;KO*BEW*J%576K<E$X[+)NNI&39..3IG^\!]Y[S?YF\T][93DAQAFN&.$M
MSYJ_E:+F4S%Q4W%E[N:LJI>QSJIJ=<*7(\OH<EHW873L<6KJZMM_FY0ON]\O
MW^N]KS,W1F+G-#B.WP!NK.6KV\]ZW5O.WEU8M7LM<N+:KN5V[BJMU/2>+U;8
MC5NLCNVNJVZ:1.=7<XX,W%FN&>&=S[CSN\*][9K=V3LY;,;QN)TUYF[:M447
M+K54_3KI;,5RRR?J"*  -/:K4&U!3VE%.&A3TQ$5GK,/(]<_O'^]GN+NU<E=
M\Y>K>UO)<7<4;KSV5W#53=HIO6KOL<S2[BMTW[5Q5)VX(Z>6TK;YKJ3A#&Z:
M4IM=,+D1R_X[[W_>5W&KEC.\2[UWGQ/[7?\ G:J;]U6<A>WK:K=5QNG,+966
MS#QE [K-3T-O%#79;$36<9E['_>P<B.!N[AG>'>"^#,I8LY:K=6[:L]=LVZ+
M;N9JK)UU9A-46K4(7J(8&=O,7ZMD771A+7J:5ML5<>/<_-5=^K@K^UIW+NS;
MQVI9.+[##FM"SYM.IMAKT*W:L.]_3ZM/U*\AXAWSFR"
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MNI91U597+55N-=67LNMZZG;I=3[6>/=+R
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MOW,CD[U^Q1>SN9M6:[E%BW37=M5-7'3")LLLFZ=S7=?PVUF,75G[SOOR^/\
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M3?;WG);,Q..=7TF^ 5_W$X,7_P"RG#W^B<H> OF:3.UY&S*'ZX1-8JH4
M
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M.YD&Z$J+=FNK,U4*FIVK:]2VM!Y'3OF:4RES7VQ9C;MV.<ON,.>/$&[.\/\
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MW3'\R7E9.,<M>G_O.4\AZ[JYNS2[D/94:FP
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M1R<O7T\=#OB4^K3]2O(>$=\YL@
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MM;,VX9.G%RZHHIYT<L_8O:M???NRJM.3HVM]91RTGD^;C_)GJ<-LXXYOI.<
M_P !.#/XJ</?Z)RAZW=W9>2M[L/UR%G=4,@
M
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MU;52]9PAC&'B+,4*^XU"
M &+4=!IOLFZZL+$T5I---)IJ#344T\4UI3-L80CB7WC>YCR+[SVZ*]S\Q>$]
MWYBJFEJG-Y7+97+7W573=A77<HR[KKJ3N-MMS-^GS-]N$XVPUSIVSEM>AKO+
M^XBWK<S-RKN_Y[+V<BTZK&7OU6:';3]JU0W7E/2AZ*Z3MTN<LMFLX-%VA=$>
M;..UZ@^>?N]>\;W:;==[?^Z=[[POTTW'>KW1E,XU[-*N%5-S)92A-.BTYQ,Y
MYBV]+-.:4BM6R?([O \Y^[/Q4N*N!-][^R.]Z<U;KSVY]X9O>,;/L;MNJI/+
MYK,6H15G"!KNLXHX9R;(NX)B9POAVVO=J^].W!WL[N7Y7\9U6LKS2W=EJJ\U
M>J=NS1GJK=C+U7(4O,5K;VKCP46S1J\K=9;QQW6=FM%]TQT/<U?K]G9S=U5;
M7LLM=N4I82MU5)IX/ Y;IBZ*,Z3$S,Y.BY[V7CC-\P.\/OG+9RJJ&Y,WG:+.
MW4ZY47<]2E3M55NE0ZCRO)VSP1,-,3G78YQ?T>OAK*;\XEYA\0W\I8O7=R*S
M1;N7;5NY5:JJ63IIJMNNBJJVXSDT:.:NNBZ6=F,NV><#:\7.V*,WE,SE+M.U
M:S67O9:[&'YG?MU6JY0<8TULL3,3$QFQNRH]0O,[W,W=AYH<7;PXOWQDW;WI
MO'.7L[F/96[%.U=NWKE^IU0L1?IW'B=4<U,12(Q:[M'BQOS<X.[#W5^ NZMP
MOF.%.!*;BR.;=MW'6\%:IHII22HI6%".?4U9U+J;6=ML61$;7KF]]NV^1VZ:
M&O1AG''I=K,IKP(Z>5I3'I:=;"^)W.H)RL]'G+RLEAQ7NYI?_IG*'E.9QTX_
MEL:=*/\ ,I+Z1? -6UP-P;4]/"VX/]%Y5'@)S=[]9!804"#KY>_@YVKEYRWX
M1X-=R[3;XMMYNU7;HN5TTU0ISEOTZ5<I5<]:9Y#D*3-T4QAJU9FVWB=53E;G
MMV<)\R^!.+-_4J]PSN7?&7WGO;+.E;-RQ\^R^;J55,D_L=#Q/*SQ<&'>AS:=
M\8WW92[:NX_?F]SWAS<&Y]S[LINY;)[MW7D,I\VRUFU:M6*\OE;5JNW313<2
M>S5;A'%P/#ZG):M]9OQK+HC7TXVOZ%/OY^Z;4G6OGD*6MENFVG%N#A&[&1IC
MD+^*L6QQ0OSC2IA.#T[^]*[Z7=][ZU?!6=Y>9>JC?O#5O,T7,[4H7+_M5F51
MM[-=?JJZEH/*<I9JZ,<-TX='0UZFI;J6TB<G&CW;/-BSRM[S' ^X+]52KXDW
MG8L5U4NJG:AFLE;IC"NB/C+S<5MW,=*_BII[7>&YX[]^XW([C;?=-;MU6>#=
MX7[=2>RU77NF]5;@XII[36D\+$1-U)PQ=<S2*OG1<7\0[\XRX_XUWEON_<NU
MU\2[UHJ=VJJY7\V^ZN:I:55=5527L6])Y[E8GAF7'J73PS;&;W[>[L]Y%W6.
MYURGO\!;XRE64WSFJ[&8SV:LTJJYF;M%JBFJFJNJY0U3M)N$,4<W-Z6KK3%-
MC9IZNG;'#,X0]@%/OYNZ=M5MK.4VZ<:X6YPG@KL6>/GD=29[M6R-?1G*YM/S
MW]]#W2>;')_C;@BG+W=XYS?^Z,WN_(Y+,44M?.;]B[;LWJ:O:MT56[E2[&=.
MARVMI:D71A;">FTYC-U4=S6ENSF#N[?.92N;OJXFKWEDZ(?F=BYO59JS3'1L
MVVCR&M%TVQ=&;GMBNK/#C#O]]P'F9;YD=WKA#-VE4Z=W;NR>4IJJ;J>S;RF7
M24754Y,\-KVQ9.&;LBV+8I#U&^_5?ZAW#*,+%S3CZ&;.C1IP1/0QU(REU_\
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MP<JLTJ;5^W356E7<6U]D43R.CI7Z.E%M\M5]^G.-L^<_3^Y[YLY;@?O+<-<
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M,\5C)F
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M%R!J=7*+@=M0:W'D5_T6SU:SPVKWWD+,F\9K9
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M);ZSURNB];LNWL/9IM/"W<N4J#K>DX]2R+)HZXNBZV)B*/8J:@
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MNYEFX->?.K.;V5^X;B[V\HXJM*.N>3U8&C7BD3U-VC,4P=IDX'0
M                      '"?WA'!M[C;NH\TMTY2S[?>*W+>OY*%$:E<HLW
ME!)4UO"MF[1U(T[OZLI-M>MT*.6=C>/+_G!N%;WMO*[SW+Q+F+U3N)I[-O>J
MKGM;&S"FWT'E9U8F-U,W%\WNMOBZZ<'MU]Y'WI+'.?NY\*<)_/Z+U.Z-W96S
M[&F]3=J3MY:JVXI7[CQZ#GXIK2<G7%\S96CDK[A3D);SM;YRU9:G:W=:KM4Y
MITINIW;63I5--?LXMP_'&O7U;>";9C-KBR;KHOC"*NTU?M57;6:M/TE>LW+:
M4EZ]MTI>,\7;9PZLWUS=,SYL1&;H[^^3Y&V>5/.O>G$?L/9OBO>UK,[2HV5<
M2S>;NQ52MT*K#6SRVC-;8LVT<6KJ<%\5QAO5DN^)E^ >X5PSRJM[R6UO/==_
M+592BZG6E<RRMP="S"J2_(F=W+WWQC.1\XLB9I'G/5MW9^5U_G)SYX8W5DZ'
M=KRW$V2S[I5+;V:MZY;-51I5-<8JO4;;[^'0FVXLNBZ>&<Y?0_X!W4MQ<#<*
M[J5/L?F'#^Z,LTJ?5=K(9>W4MF"TTZCPM^UUP_3YNFNO*YM)3>5OTT83=5I^
M<FG-;8)= ?WC7!&_>&N^'S+W_O7+U4Y7>6\:JLHW%*NCYQG&VFZ4I4GG^4[M
M)<E_+S??-T3@V@[OW=3YI]\;?V>X-Y/Y"WGMZ\/6Z[^<]I=HMV[5NJFFY55<
MN5V[M-*IIN)S@9:L1I6\>IDENC;W9FMT.6+]R1WX[+NPX3LW4XTNA9BS![,H
MTUK)P:<,4<<<QH6W5FLQ)'+WQ%*PQ_V(W?<NV[?MN$J;=5MQHIIS%#GBIK)Z
MSHL\0Y6V?.MI#..4F;*UBK^A3[E[O[TQHM</46;?LJZ&E?MPAL-+#**,46_Q
M/EMELL)Y>ZE;9Q>W?W,_<#[QW=(XQYB;ZYS[L^Y^3W\K-.[T[BK=QTK+*JJ5
MBTU^9L\1K<W9JSPQ%'5;I\$9OT?O_MT9F[W?MR[[3=64R=ZNW<46E34_G52>
MSI<*T=7*3$QP[:M>M;,VS,9.J'P1P[G>-LQNGAW<%=%6^]Z7+.6L6[M5-NFN
MY?JMV;=,:XJ=5Q'DKK>"(G:Y[-"Z<I>PK(^Y:[[6^=WY'?63X6L5Y3>MBWF\
MLUF;+J]A?MTW:*ZJ5E&Z5717+6<VIS.C9-)[S.>6NSF<(>57[D?OQ*FB'"EN
MNW;;=-'SBVJTW-^C\SC"1+.>T+<)B>%?F\S-9GSFK8]RMWZ[=^O,9?A6G+U-
M)-?.*$FH0BE\S6!U3XEREMOFVU3YO,0WI[O7NA^^MP+S=X>XIXGW'['<.[-Z
M9'.9B][:ENFW9S>6O7(4?-4WZ-MGC=?G].9GS9X6VW3QCBV.XCNW+7LEP%8R
M684+^3X764O+_=<MNKV-S^OH9P1,78VY2Z)S?._[T;AWK^<CU;_SDG+_ *PS
MNGI/,:%];:.#4PU9NZ'@<G.0W,SO$<5O@_E=NG,YOB2]4E85JU==E0=$75>H
MLW;=*A<6)TS?%D<=V4'%;J1PY2_D\Z.4?,'NZ<Q[O+7F5NS-;LY@[IJL7J,Q
M7:O46J+C;NVZK>9=JS;;C;C)G-=K1?%;8P/0\/>G-V0O<U=_RQOFWEN[KS,W
MS11OW+4*UN?-[RSM*IJJIMY6BW:5S-9MIJJ,%!')J<KJWUU+<;>ANC6MMG@N
MPF'90]LG3371LUVZE2Z+E%=-5-5+2:JI=,4TTY:SBI--[>SIJJ=52=,*5#9J
MCCKD2)B8K S*-*NYLN&S&&+C#5T"E<(2N-''_O-\V[G);E!Q7QK9R]6;S61W
M9G%8V8K8NU93,.W=E53.W52GCH,]/3NOPC-+II&='SX.>/,/>O.#FOQKQ9Q1
MOBO/TYG?5_,44YG-55596FC/YB[1;HHNWKCI254((\OH<M=9/',UAHU/\V,<
M)<W.[Y[U_FQW6.$5P5R^X:W7F=V.FTKN;5&25V]5:MT6Z*JZ_;VJZFE1IUF7
M/\O.I9;PS26NV?0SA%:M_:/?_P#>9IKMU5<+[OKHI57M*8Y11CZL'\\T'C8Y
M.^,9G!L^<1$4F,7"+O,=]SF1WR-YV-]\?9.UD[F4H5%FW;JMU*W:IIKIIHI5
M%Z[ZM%R".O3LG3B(C8:FM9='#2DMKN[SS[XH[J?,W=W.K@++49W?F[W<H67O
M[*5RBXK=%RE^TJMI*JFU#$Z;K9YC0G2CS;IVL=+3X;XOB:P]U'=0]]OW@>=O
M><X'Y4[^X<R.3W!Q-FJ+%^FAY:JNU3[3+VZJMJG-5U3]J]!XW4Y&_3SNR=/%
M6ZE*0[9.5K]KEK%YJ%5ZQ9N5+IKMTU-=C9Q[F6W>\@
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MFOP=(<W+Q%LXY.]ME/UKEOV/9_0Z3PKR+R
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MUQ*#:AMULY+K>">%TQ-<6Y9B
M
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MWW'O'+V;^7S-BJET5*Y;IN.F--52IJIIK49LY;[+K9IM;<G!'WI</Y+W%?\
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M^K;%O#9.;J]]W^P\KSCY>V[DZJ]^6KJ4Y>UWAEZUHT1.W4PT9Z'-H=^'T/\
MD''\$G!,7'_(F1T0_P"*V3Q&MA>[M/NMX34S
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MEGLC=M9G(9W+V\U8S-FNBY;N6KUM7;<*[;JI?H5+!L\;=IQ_2[T.F)PQ?U"
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MM74C4R=%ML6X6Y.8AJ9
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M>&<8<.I/%=A&+W+>X96U<WGT.,=<'D_*<7-QGU-NAA$=#M+GC'4
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MHPA%44*E/MV3CC'&<R<Z-<H
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MWOD;F9L6\S9S-G*9:U>]"J_<KJ3KKA'$\-JZ>I;C.;HMU+)G@VN3^\]\\/\
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M0I2AM5(\5J3QWS1TQA%7Z>C8I;5-4-B=:@W&.'5 YXF-2<>]$LIZ7IF]\?R
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MR[M&3R]O+JMJ4'4K<3COGBNJZ8R?LS%0
M
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M^"3@B%6TON'D)PA_Q6S(\-JS6^9>0MI3!O":V0
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ML5_HO9=95%$;=,6U!U5.<6^G3 YHK3SLV<M8H
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M#?S6I/S:8M:="V;->+:N^M0H:/H:)QQ@M6B!XB,ZO(,DDE!8%)QFLYJ
M                                    #1KJI3JJCLNB$7C':4I:(#;C
M&13'!ZZN_?W .!.^)P;FK-=.6W)QI:LW*K.^Z,O:KO7W18O>QM-K+W;CJ=RX
MYQTF[0UYCS;L&C7T8OC"'3O[PW<)[P_(KCG,<,V^"=\[[W'NC-5W,AQ!E+6=
MI35F[=KMW?:6<I2I>Q3Q/)V:UDX3%6FW1NLBLY/QV5[Y/>\Y16,OPW9YB\0\
M/4;NI67R>Z[EG>5Q6:;=*MJB-68H4E;AAH+PZ>K.,8KJ4MLI;-(>1>[_ -WP
M.(Z7NF]S6W]G;N>I=IY*W9WA0[M-Q.AT[5.:;4567YM9;G&#5Q3-O%7'H?C]
MT<D>\/S?XFRV:R7!V_N(-[[\S%M9_>=RWO&]#YQ<IC<JV[%[97V:,V9\.E;C
M$9,HT[[X\W-VC/=@>ZORG(M9+FUS3LV\YQ1G;-G-9#=&;L45UY2[<MY>ZKE7
MMLK14O9W+3E&)P\WKZ?!.E;%:MVGHS7BNV/?I1;HHIHIIH5%-%*HHIIDJ:*5
MLTTI*22I1XR9B+>&[:Z:17!QS[S7=RX+[RW+??7 '%&6R]%[.9.]:W=O.NQ:
MNWLE?N6+U-%5#KM7*E3MW9PF;]/4FR:;&-UM<=KI+=['W?G/#NP<<[UW3NOA
M?>7$'#+SM^_DM]Y2QFJJ:;#S&8NVZZ;EG*4JE*W;I<F>2MUJV^;.#1,7W83D
MV(X;[YG>AY*VGP3PUS(W_P .V\LMA[NNV=X7O8I2V557F*,%;AA*!E/#PUNQ
M:.*[B\V9>/Q9SJ[T'>;R:W;Q5OOB#C[(45+V&1IIWE:INW&Y4JE7+RG5<:PT
MF$ZE8K$4AL]'=,TKB]C7N\?=5<PN?'%FY^,N</#^;X5X/W)FLOG*=W9[+7:?
MG%%F]E;]"_5&2]/:43&[5MMCBELC2KGG#N5\!\';AY><([DX.X:RMK*;HW#D
M,OD<K9M446Z=FS;IMNIJBBBF-6S' \=J77:E]8VNB(I;78]-_OO\UELGR*W1
M>S-=RBBIYVBEV[=5QJI6<RXPI4<&='+7Q;=2<W/K]V>IT\.5O$.Z;G.CE98N
M7<TJGQ9N[8?S.\D_\LY3%[,HGEN8U)]'$V[,TTZ4CI?2AY>5VKG ?!E=G\S?
M"VX'3&*</N5E,4\&>!OGBNF71;C#]B8J_B;TW9N_?N[\YNC>N4MYS=V=LW,O
MF;5U4UV[UJ[15;J3HJ52:V:GH$3%N4E9F*RZP/O.O=-[PM[VWESBY#[MNYY;
MPN9C-9_AK)9=IY6Y^JKU6R\MDZG6KE52/):&O;=%;N\Y=;3XHBV(Q>@O(9?O
M#=W;>EW?%G*<1<![YR5ZI4WJ;6\Z4ZK=<-K95-A0C9\1VZ<V7SA1KG1G;A+]
M[>]XIWP:[=-JYS@W[533LV:<NLMO!.?V.E;7SN+9N]#H9Q;%4NMU)B(F<'\[
M,;E[VG>AWGD:]Z;KXFXZO[PN6[5C,U_=7V5-.9JIH=QTNF_0E2LQ$T7^CX;N
M'"C/T4Q29R=GSW1'NTN(.Z3D<]S0XUWOF;/$O&&5LWK^X+M5VI96FNUEJDJJ
M:[-I)T[#6EGBM;5B;:;719;-O4][=2:NII*ESFX.,FW-X1B<LTF6S&F]ZQ/>
M)^[DX$[Y7 ^\MX;ORV7W)S3R66KN[LX@MV;=5_,U6;%[V.5JJ67NW-NNNN":
M<XFZR[@PKA.UA,<6/])TY>8W=.[Q_(?BC.;HWEP9OS+VMQYK,TVN)+-&?H5=
MO*WKJHO4U6\M:3VJ<NJL3S&G.GP1?&3D]'=,37)I[B[]_>LX RU?#>X^:6_M
MU9?=Z]@LO79WA=V53Z&PMO-4PV51# W^CTKK>*Z(DMT[J4LF8Z7F7^\IWQN>
M&4O;FN\4\2<6Y7>2=B]D:*-Z44W:;B=#I2INW4MI7=6DU3P17*(.":TB:W.?
M?N[?=4<VN:''^[./^8&0WKP%N3<V\<KO:JYF7FU<SM5.9RF<:C=RM-;VW'2<
M6KJ61=/W+999?$4NC&'<^W#NRWP]NC=&X[3JNV=U;OR>0HO51C4LKEK>753U
MNM41[3QM\SWG5GGFZX'OWMY93(;OW!7F%>J^PWH^SLW*X0MYWZ5/ [^4NF)I
ML<^O%8K.QU\>X/Q!N[,]\WDY9L7<Q[6O?6%64NTI?JW)XMTP4CMYJ>.V)C"C
M3I76Q?'2^BODMI9#=EQ50HIR66VJ?IHY>W"9X.:5G#%WY0\3?]=7WN[]N5^C
M3]QMZ-TR]%+(W].+B8:<I=2F&5'SU._)Q!NNSW@>-K5VYF:+M.]=Z+T<I=KI
M_7F?TTIIR/.:5UUE+HZ''JW4K$X1@]UG]'JWCDLYE^-5DZKM;27M:[EFNU']
M9PAMI:SEYB_BMFN;JTKIFVD]VCM)9F67SCC&.7O-_C86ZMGKBCQ\75FD;&=)
MC&<GSZO>E;\W3EN^;Q_9NW<S1<6>N>IE;URG\VSL4JE3!S/-:6I=Z.E<'#K3
M74BN#W@>X6WEE]X<+9EY:JZJ:*+KJ]I9KMNI;.4PVTM9R<Q=YE*XM^GCB[)F
M\JJZMW;U3IA33D,ZJ?QWZGN3\1P6TV8MSYR/?<W]D,GWO><F6S%>8MYI[_K5
M5-.5NUI)[QSN#5,'(\[RMT6Q&V*/':_?F+MSL<^XBWEDLSN/B&G+7+MS:L6/
M3N6*[4]C)14*TCDYO;,.[3FNG&YV0*G>MTT3VVG5M04(J,O$>+OF,K<-S.V)
MX<<WJ,]]9F\OE^Y/QL\Y<KLT5NRZMBV[M2:MYEM)4IMG5RL^?#7JS2W<Z+EW
MB7="W-N!^US37W<R%-M?,K\7_E&ROI3OOONMP<ML6</'M?1+]WY?5SN@\G+]
MA55*OAG*54JJFJFJ#MVHQIJ@U(\9JS%]TUR=D81%7*+C7A#<_'_"6_.$=]6;
M>9W7OS=V:R%]7***U:^<V:[2K5-RFOTJ*JXX&.G?-MU>A;HXHPP=*[O_ /NR
M>9_=_P"/=\[_ .76XL]Q;P7O?.9O.U7LIEKRHR]O,W\W?JIJILY."V*9'G.3
MU;=6V>*8XG-J:<S=2(Q>NC@WGASM[M>8KW;P-Q+OW@C/7ZJG?W>J-X5T456W
M&M.CVME8VM6@ROT].9K1AZ'#BXO.;OY3O;]_?GCN^_N#AKC#B3C.QFKEK)YK
M)96UO.S4J+]:L51=J]=;35W5I,?0Z-ET4C&2=+6OMK7)X_.[NM\Q.0W"7#/,
M7F9:SN1W]QI;N9B_DL_[=WJ;E5+N-U/,6K=<=IU8MG3?;IQ9YM*M-^E=;;,R
MY$^Z=JI_E+Y&NIJG:SN3J3>G:O9)X=$3BYF9X(IFV\M&,N]GD_UIE9Q_4]B>
MO[%3/M/#3F[GD                              ,:J56MEJ*?887Q,Q2
M%B:*DJ4DL$96QPQ0F:S677$]^MR5RN^N&MS<T\W:KNKAS+W:J*K=EW'1&UG<
M73:J;PUG?H8VXY.?5G9M=2K-<1V-\;LRUG=;SE_>&:S]FQ:R].3O[3JHS5%J
M$%2V\3R-E]OHILC.&-W#%)G)WU?=)<"T\*=SCEUO#.[NJR._-\96J[GW=MNW
M>JH5G*^SVJ:[=%:C#2>"NF9F:]+?;28J]G-,(M+!0AVQ;Z<3&E<995QIM?D>
M/N'<CQ3P9Q)N'/VJ;N6SVYMXVG372JTJZLG?5%>S535%TU5:A;=2ZD;$F*P^
M<OWD;%O@OO*<V=S;ULYO)TY;?>>64I64O>SKHISV=V73"BFB&S3H//VZL>AM
MIF\=?=$ZMUFV'L/]SERPRG.?GM;WYE+%S-5<+YRSF:KE[+UVZ;%--[)7:FG<
MMU)074<7,3/#2<W3RU)BKN_6K.Q9L68[/L[%JU"&/LZ$NR$#Q<1/%Q1DZHFF
M$Y->FVDJDYIPZ,.V(MBF<9)O?R.(^&]S<6;EWCP]O_(V=X;IWKE[F5SN4OT4
M7+=VU=H=NI0N4UTJK9<G SLNG3FMN$PDQ7-U*_>2^Z6XSX(XLWCS.Y![HO;_
M -Q[]O9G-YG<>4L51W95'-9BY1LV,F]J52@>6T.8LOLK=WFNZR>_;L>F7<7$
M'>'[N.?OYC<]7$7 ><IN-9Z\J=YTTTW+532A;3R],%59\1LB;-2/.Q<U]M^I
M=T0_<WO>)]\'.NSNNYS<W]5:N0M95TY?/JJZV]A4Q6;C&+@2=&SBRBDK.CJ4
MIQ/%M<L^]GWI>(<G<WSN3B/C'.[[N6LO;WE=6\W:LV<S73;JO.FNW?H25O,Q
M,;M*RS&<B=&^<9S=M'W3/N\]X=R7EWGL]Q'OS-9_B3C3+Y?,YG=%^JZZ=U55
M6\K==M57+5N<:&H0.'6U;*399'E;-+0X)XIG%[B8**<)J/CQ.2(IDZ7IH]YQ
M[KWA/O:</YCCO@BS8X>YJ;KHS.<O9_+6*7>WZK5B_=LV*W1EKE=-Q7*G.,XG
M=R_,\,>BNR876<4YT=23C#N^]XGD9Q!GJMX<'[^W'G]S9F[;R^][5O>-M7J<
MG=N4+,*NW8LIITV-K$[XUK)\V-K3J3=$;W]+<W?Y[U_".3JW)NOFMO[)6,JE
M966KL[PNNG8A1L*JK-)RV(&,:%DS6<VGT5^<3,2PWKSJ[XG>'R%_<V?WQQ-Q
MOD=Y.FU>W=;IWK0KE-?H*"IN7E-7=6DPNTK(\ZZ,%]'?3&:S+VR>Z^]U;Q_O
M?C3<G-7F!1O7@?=W#V;L[RM[NS*S=-W.W/:93-*VW>R]%53KJI:FS#4U-.RR
MNTC0FZ8K@[>&5R].4M9/*6GM6\IEK.647/9L6E:IJ<<8TTGC)K==,S#MMI;$
M6PZ2OOY=\9/)=\S=EG,UWZ(Y#*0]GEKEVFJ.5S6-=-+4CR.A^!BF;GU+;9OC
MI?I_<F[VW=GN\1N6UE7F*[BN5^T5=B[:I];)0BZDDL3#7\V.MLTIXIX8RAW3
MFVME4-127HR]):IS4$>.F8KAWFW;N>A/WQW<%R7.;@:]SCY>[NL[LXMW!9S&
M>XESN3L4^WS^6L6\S=HN546LM5<J=+J@W&9V\MJ1,TG8T:]E;:;74FY?\W.(
M.2G,7=_%'"&]MY[DWYPEO>PM[9JS8SENK-K)9VVK]%5-%5EM5++-.9V74SSA
MITIB(G[IWP_=]=]7A'OA<I-S[\R%YKBC<V[LIEM\V+E+MW+M^UELO1<S&S5=
MN5-W+E<SQ^O9$73=&4NNR9X(>P6C:V5M>M..&N6$L#GADR* $5*3;2FX1QT8
M$I04H >DSWV.<RV1Y%[JO9EW::8Y]-VZ*[DOFV9;C33$Z^6F8B9AA?2;9Z73
M*Y=<1[G?.CEDJ;N:NJ[QANU*E9.]2Z7]W,I3CLZ#JG4FDUZ'!J4XXMMS?2PY
M?0JX!X)5NMU4OA7A]J*:</N1DZDG&#E$\5,168NZ7D(K$1TT?M:'4Z4ZI,QM
MK&$LNMF9
M                                                        CBL%
M'M@!HU6OLFW".M83P4RQUI,1A,1B\3,[ORN\K5W+[TR.4SMFJET;&:R]G,45
M45)JJET7:*Z<&]!C-\Z<UME9B)BCB%S5[@?=>YS9BO-\<<N<AF[UVIUW/F].
M7RU+J=5=3<*,O5#TJWI.B-?4VL9MKDV8I]T3W'%78N/E59==BM5T?JJW!.EI
MTP7S2>!8YB^$BS!R<Y>=T+D%RMN9*YP=P)NS(O()*S3>R^4S*]%4;&TKF62;
M3MHEW,ZDVT6VV+8I.,N1EFS18MNU8REG+6J94V;%%NU14E)05M4TTP1PW7ZO
M%2GFMM+:;WG&_8P:5=.W2G51%J+V-K3HFC&+8F>*<UKA1_/WCNW);UR5S)[T
MR&5SV5OVJ[5^SFK%G,4.BNET0V+M-=,85:C*V;HNK"3$3&]PFYC^[=[I7-C>
M#WIQMRVRF\<][2Y<5VU58RR55RJNJJ%-&5:QK9T?.+NC!(PMX8?PN$_==]S?
M@K.T;PW#RPRV6S5JNBNBY7=LW?2H=-5,::LJE)THE_,771T01O<WN&.#N'."
MMV97='#6X]W[JW?DK5-JS1E<KEK->S32J5M7+-JW56X4I1<S1==?=."S.V7Z
M6BFOT:G+&-.,):\7%F-]9MG@-N+\OQEP9N;F!P]O+A3BC*4YW<6];-5C.92I
MTPNVJJ:J73%TU*=-3T&O2NOF8FZ*4+HZ'K\WQ[H[N/[]S.8S.\>5>7O7<QF%
MFKM7SBTG5>=QWMI_J-_VQQ.Z>8NICDPBR'.GE-RIX,Y+<%;KY>\O]TT[EX7W
M+0Z,ADJ*U73;I=-%.*HH7JT+0<U]UUVI6GFLHMB(WMRBJ\>I7*:JZJ:57M0A
M@G3!0$"^SV;4'2KM4'Z-6#CBFG%,QOF8MK;FL8YMI>8W(SEES:R%>[^.>$MU
M[QL54545/YIDZ;U=-:K56U=^;U5N5;Q9;+[\[L)2Z(RAPUWC[I3N/[WOW<QO
M#E38NW+U;N5JG,VJ:=IU.IP_4DE%G3\YOIPP9-].4'<<[M?(VNFYR]Y>;NW;
M515151\YMY;.*ET.ATP5>6I3@[:,+M>^Z"?.PERDIL*QL6<KE;.6RU$$[5BB
MBU0EA2E3;5-*2ZC#"(K.,M<VW7S2)I$3[KR&K],70I."V6X[.MFNDS=Q2VU:
MU--=-,:G[2O7AT04<#/<Q?PM_P##FYN)LI?W9OO=&1WEDLW:JM7?G66R]]TT
MM0:I=ZW<=+:<$UK-'I-7BFRV*1TLJ6Y[7!SCWW8G=!YC[\JX@XEY:Y3,Y^Y5
M57<=NJQ8HJJK=;;V:,HTIULZ[->ZW")R3**0T^$/=@]T#@7>EG>_#O+;*Y?.
M6+E-VAW:[%VEU454U*564AC0C9=S-]V>1$S$4<XMP\)</<)Y++[NX;W'NW=F
M6R]%-NA93)Y:Q6J:*533M5VK=NJIPI4V<U]]]T[DMMBV,']B[EJ[]#2C:K;3
M]I':;:>J6,#&8IW891..+\#S/Y3\&\X>$\UP=Q[NRC>^YLY0Z,QEJJE33<35
M5#BW17"-%;T&5FI.GAE"71$Y.">8]T3W&[V9M9ROE7EGF+.;MYVBX\Q:]',6
MK].8HK2^9O\ MBB=-W,ZEUD:<80UVZ5L7\4O87PEPENC@7A[=G"?#&2IR6X]
MRY6SD\AE:6H6K%JW3;HH35-/JTT+0:+L?.EG$S&$0_3-WH;5*3PDX36GI4#&
MDXUPE:URR<1.>'<5[N/>'WS]W>:/!5G?N\:H.J[5<MT-M;;?K6+C_MCTFVS6
MOBVFQA-ELSCM?C^4?NX>ZAR)XRRW,+EORZL[JXDR3VLMFJ;UNIJMNVHK9RU#
MDZ%IT$F^^92S3MB-SG733<JV=KT:%"-$G&$&E%809JGO4V-M:QE1Q5Y^]RKN
M_=YO.;OWASAX,M<1YK=:J63N5W;=.Q35[1-0JL7?[HQ;=J1.,M=]EMS\ER>]
MWGW7>17$*XFY<< 6-Q[VIJIKIS%N]14U51[-TN66MZ;2TZ#=.K=,4E+-.+)K
M#FLU5L4T*B&S#844X*W"$^I&J(B[SI9W32D1%7#GGUW".[5WE.*<EQES:X&L
M[^W[D*%;L9NJ[;IJ5.S51![5BY]#6])LMOIE&*3$SG.#P>4'N]N[#R*XCM\5
M<M>!;6X]\V:E7:S--VW6Z*DZ')4Y>B,70M)LGF)FV;6-FG%DU<T?9WFJ%2U;
M=*V:GBJJ:9*6B1QW16Z*Y-ML]+^;OG<N2X@W7O'<.]<HLSNK>N4OY+.675#;
MLYFU79O4QGZ]%;,M*:912DE^73+UR7O=$]QZ_F]Z;PS/*K+7<SOC,9C-9^MY
MBVE<O9J[7=N5?K-N=RXWVG1=S%TQ2&$65I#EGW?>[)RG[L7#5_A/E'P[;X?W
M-FKJNWLK;JH:==,%35&FU:CLI:C3=?,W491E38WX_5$;E,4U_:Z\,<46F%5G
M&ZD8/P_%',+EYPEF=W;EXMX@W+D,SOJMV,EN_>>8RFWF[E=3MU4*S?KC5M52
M@T6*YQ%)8TQF8GS7'+FKW!>ZWSKSBWOQSR]W?O*]>;S"N9>G*Y>W5[5U7-NE
M6\LU"KVC:ZS*.8NLBLRM,.&'X7@7W8'<YY>\19?BKA;EMELKO7+7;=RU>NUV
M;U*JMU45)>SKRL&HT(RNYJZVW'.<EMF:[G#'WSG,?=' 7(JQRRW97NO<^7WQ
ME':RVZ,K:RF7KOTVK&:MT^A;=NI+8H4/1FYFJR_6C7MX:TE+HC@F-KJC]V7=
MWW6Y^\M-PQ?MLUQ#;=FTDW56[F\LM!8-I-U:CSFO2S2FV_#!PZ.EJ1J5NC:^
MBIRMW%<X:Y?\*;FO4[%W);EW?;N4QCLU_-;.THP6#D>$OF)NFDU=S]^8@
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MB+O-G)N;:VTZDZ-FE05,XOIB],37&/G=+.6L5
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MCY+\ZLI>RO'O!6Z]X+,6W;NUVLME;%VNEJNE[=RG+U.IM7'/&+-UFO?;YO\
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M&Y'<,9;@_E_NQ[KW'EJ53:RSO.Y3;IHHHHH5,::5A0E)&FLS-8GS5P\K=LR
M     .(O/7N1]WKO'[THWSS7X,M;]WE1333;OU7J*7LT*M)3L7/55;TF47S$
M48W1$R_$\FO=P]U3D/QWE.8W+C@"SN;BO)-O+[P5VW75:BJ,*:<M0W'V:TZ#
M*[5F;>&[:EMD6S6W-SN;:3<,(2CV&O'8SG#%D
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M2229W\U=;%G#.$PY]&V_3GSHZ'>/L4*W:MVE_:K=NW_4T*E>0\.[:32K5
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MA_4IVH+:QT^'HZ"0L[F0
M
M
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MW328PEW(,I;=FBFQ3^96+5FS;ZK5"M_V)XO&M67:\L
M
M
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MB;JQ/FMVG%W=ESXL75=VG1.VI450A&&/@9SVW6SW64UKB\@R
M
M
M                                        CP?4QD-DN?'$^^^#.37'
M_$O#%J[=WWNS<&\[^0HL6Z[U[V]&4O.CV=%'INI5)-0,M"+(U(NGNU98UI+H
M5;@[ZW>*Y:]Y??G/;,9_?F0XGL<1YVUF<GO2YGZ+->3HWI<MNGYIG+]NWL56
M*'+"!YF;9YJR+=D-%^-,<8EV1.5'OW.0>9X1W11S/KJW?Q11E+-.]*["MUV[
MM[V=MUUJE9FI4^FZN@Y=7D)B[S5X[(C&<GYGO"^_8Y04<O-]Y?D3?JWCQOF<
MM7;W;F+ENBFFS=KM7:%72OG-/I45NEIS@2SDN&:WYDW1.%LNK7Q_S!XZYW<=
M[RX[XGS&;W]QMQ-O"Y57E:*KU^JCYQF;GLZ:;5-=_1?A!'79R_H)]+&3"*6S
M'#WNAVM/<M=QY<H^"ESWXCR-[=W$_%MC:HR>:LUT7Z;=5G+5;35[+VKE"ATO
M$X><OBZ[^LW1-T1CM>_ZR]K;JA#::<,=?E9P61/#6[O2NYKF0
M
M
M
M                                                854;2A'0U@FF
MJL5#":!U9."G>L]W]R2[T^ZJK/$FY<ENG?C=U_=S*9+*K,U^THNI>UJ67=RM
MJNZW&)NT=;T-_'T,=2V=2WAEUP^\Q[BKG)PEO'-7>1.0^^?=]R[6[=2O*E[+
MJN[,:'DXTR5/A.^>=K;6N+F]#$7TBKC)N'W+O?@S6=R-O>O SL93VB5VY\XI
ME1552JG#YGH39/GMFW%?0X>;A#VO=W'W#G#]O[D\2<Y-Y7,KG\A?RV8JW)13
M3>]M7;JL7JJ;E565II5.U34G,L\_PQ--I'+QA$3+L1<LN5W!_*3A/=?!W!>Z
M<GNK=6[,M9RZIR^7L6KE_P!E9MVG7>N6K=MUM^S3G$\9J7W7S6N%74W#IHIH
MCLJ$7%F(R
M
M
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ME3132E3332E!))04$L-1RWV\5O#M;(FC.BA4*%,EH24(:_"++(LC>3-69F@
M
M
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MCMJK(
M
M
M
M      E44G!1>J,/&8W16V@TXMJG86U1.,>C#UIXEC&*5Q%3IJQI71)/KA*6
M!<.FJTF,X'36TTZHQ<H*$$:=2-2;JV9&%&H;D
M
M
M                                :"MT/[)1CH<]<')F%EEL9Y+,S2FU
MDE7%NK%0V9K3CAYS/;N2,L<TK==/I4T+\=A%X)1:G(3&.$U(I_2PAC2ZU36_
M1BH1:I2VOQ$)PS(SZ89JJFE4SA3/0W&/A:F:HU)XJ46FUJFU
M
M
M                                           &--=-4=EQAC)KRDJ-
M.[5#9I3=+JCZ4(P[.DPU(NFDPL4C,IVL/7I6$<7'I9G$3E*84K#.C:GM06JE
M+U<=*QB7"M(79O(51IG%3BY+JD:;HO\ 25CNF#,W(
M
M
M
M
M
M
M                                                 !2
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M  !(ZY=H7J::O4MI37PZC*G1+&NYJ-I*+P,<U$TU%"<,),U%1&X*.)8QDG!X
MU>;M4:6^I,RMT[KNIJOUK+8WLZ,Q172ZL%*'3'L)=;-LTZ&5E\7VQ=TM<Q9@
M&F[BIVXJ5"3CKBHZM C&:)=,6Q62U<INTJJGQF5ULVS24LOB^WBAJ&+(
M
M        2JI4S;AUFO4U(TXK*Q%6-->U&4(0TZQ;J1=DE)VL7=I44U/0M>O1
MH-M)F*PQFZ(F8G8S52:491C#L).$T9168JKJ2C%J1(QF@T/G%+>RDV_AI@87
MZEMDTDMGBK3.&=-R,6U!*'PP,+=>VZ:0SNMX=K4BHI:X^(W1=$Y,:858NJ=,
M%%51GJAT$ONX(K*1BRB:[=:)6BQ-L71,51&TE%X"L#QGF[:N>SFWH<'#".HV
M196WBJU3JQ%_!1Y%-2JI52P?:8S%&R)K%61%
M                                                 3-,P$37(8NN
ME-J,UC)Z>P1CD3-&D\Q;53I<5"$X.<>PU7:M)I18BL5V-9.)G;=%V24HPJKV
M6E#MCAV0,EB*LMK&.C4X^0UWW\$8E*Y)16JU+%8K5J,K+HOBL%T<,T9-P=*U
MQ[((M44H
M
M
M
M
M
M
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MDQSQG-J*JMN=$%KVDX=@B9VC)I5)IS3Q*)10J*52L$)Q&0
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MLMOX[<\5MLMBEV"96ET;:=6THQ2^EB6M8R9:DVS2(>6&H
M                                                         :5Z
MMT6ZJDHM8(</'YJ77<,586KKK<'0Z>EDC3BRM)K"6W<41.3R(HG%;TLD@L8(
M4MF*C#94?54.MF$ZFOQ4MB*'#;3%X]5A5.+NI>#XS=;==_2AKOTXF:UF(:E%
MFFG"N,=+:?G+Q5SB%X<,VN:^&*4C!FD)KI\QJ]%/%%U66QD;V(2)B<@*
M
M
M
M
M
M
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M0PTB:3+.^RVV-[S4E2H*20:5
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MUS!F
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MB*3_ $62KN[>PIJJ#]I!>CI:A@S&9NB:;&RD4KM>4;&(
M
M
M
M
M
M
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M45MJEQ:Q@3;3:SFV8B+MDLP@
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ML@J146M*Q[0)M4P;C)8R>DLQ3,C'"&1     $BD%I*A
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MJL'& W"@                               ")IMI8J$>W E=@I0
M
M
M
M
M
M
M            !XNQ:=VN"^R5>M5%REJ)QQ6;%NOFZW@V,:LO9HM/:3:IBVXO
M7%DCS*S.3'BG3BL82\>IVKENBFBEUT1<:<(N,E'K&G?9,3']-GJ6WZ^,XV[6
MT/.CG5RZY$<(Y_C+F'Q!DMQY3=^4S.9L6\Q>LTW,Q<LV+MVBU13<NVV_:56H
M8GDO"O .:\8UXTN7LF^(G&?*]<]:_6[P3U0\,O\ $O%=2RVRRV>&)NB)F8BN
M$3,.G9W[O>^\T>\'O;?'"/*S/9KA7@7+WLWDJ,YD[UVBK>&6]IFLNZU['..5
MRU6G'4?0/JOZA1R7#KW:<3S%O3CCAN?FA[7OK#>-^M.OJ>&^!\Q?I^#7UBD5
MB;K9KECMB<WI>JM7MX9R[O'.Y[-9_?6\+E5=RJ]<O7ZZZZJ]JJNIUU5N+JJ;
MF?U'EN>U>5O]#K1'%.&3YEYC6NL\/MNU-6G+6[)G&>F9G.K]UN7EUO/>UQ*J
MBNWEJ8-7'150O2@ZOH(/UCRG+^%:W,WQS5MF<YO5?%O6CP'D=&Z_1UJZU(PS
MZ]K=?=/*3)Y9T/,5*M4J-"<W%P;C&G6>3T_ M6S_ #+L9G.'\_\ $O:1;S=L
M\OHQPVV=V[^4]+]S9X!W+1!7\E;KK2I;J]"4%#Z0[-#PS3B*Q&#U'FO73QG4
MU)])J3,]D/+JX*X=52J^96JJ4I/9I6&CU#R>GH1P39P16=SBL]8^?C5FO,73
M9Y<=V;^=FN"]QYA5T49*W135ZJ6S%8QCZ,W,YM3P.RG%;3B>=Y?UWYFVST>I
M7T<;Y^V_"[[Y36<Q1MY*XK3_ +FE':J])J>Q(\5K>!W3/%,8P\_R?M TK+HM
MB,)G^6-6UV]> ]];JN5IY>JY;I^BV75%3_&:D>+U/!]:;*\.$8^X]^\/];N0
MLUO\O5CCNMQVYQUOR-FG.[HSM.\\CF\YN[>65J563N9>_>L54W:'%5)VZJ&M
MFNE/%'@+.:OYGF[N6U+8K9TP]KY35G6Y&Z_F;[IY2<8I=2:]L4>ZGN ^^$YF
M<BMX;GX#YP9W,\1\&W<QE\K7O7.7;EUY'+JYE;%#;O9Q->SLT.+U'\Y]=O4G
ME>=KJ<GIQ',W='3B^J_91]8[G_56RSD/&]>[4\*TZ1%:W3%L4C''9$9NX=R@
MYP< <\>"MV\9\ [\R6^-V[RRF7S-=&7S%FNY9N7;-N[7;KHMWKM5+I=<)L^=
M^>\&YKPOF9TN9MNMNB9SB:/T>]6/6OPKUL\*TO%/#-6R_3U+8G"8K$S$32E9
M;LTU-VULJ%*C%8MPZYJ$#DMFRV_AKB]BU:TK;BT*[%G,5T7*5Z=+BUM0:F;(
MK'P6S2YF8B8SFC3S64JN7U72_122:BY2\YG;?PVN'4THOU.*:O*RUM6ZJTL(
M*>MFJ9K=7:[[Z1IVQ#S T@
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MF$8:2<5TQO6D1D*,6FH)0@XXZY:(&-F"RR-B
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M1/%&Y_8>0YS1\0Y>WF=*:Q,95;V96Y355"E-8Q3.>GFQ.QUSA?,5P>>&0
M (W";!FH   )6*TVB-JE1;@E^(2:Q-:X"F0$K&0%               "173X
M'\06B_# (
M
M
M
M
M
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MYOZ=N[:O4JNU<HNT-)JNW5370T\&JJ6Z66DI$Q,TA55%I0QCIU$C&*K.$LP
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ML47MB,:O5VX8Z#EU(]',PSF*31N,81-8J@4
M
M
M
M
M
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MV[]==<G'2>,YK3C3UYMAU6SQ:<7=+W NY-04GZL_6UZ)0.6K*E,-K5,D
M                              \3,VZ[E-2II53ELN*6SKZXELF./&<$
MNXN"8MS>KKWH?>EH[NG(/?EKAC>-NCCK?.6N97(9.W?I69HHNV<S:O5[--^U
M=FD]!_'?:SZQW>#<AZ'EM2+;]2)B<<8K795_:O8KZN:/B/C]G-^):-U_(VS&
MR9BM8ILF'2RO;ZWIQ/O'>G%F^KUW,;XXBSEW,9OVU5=VY35=OUW);=5=2@[C
MTGQOSNI?KZ\\=TW4F9KTUQ?J#X+X1HZGA]D>'6VVZ46Q%,(IA&QR.Y3< V,I
M0]^[RL[5-[8N9=UT[4UL5."JIUG\@]=O6:Z[_P OY2ZE\871'E?T'U9]6=+4
MYCBYFV9U(RJY 7W36[==#2MT)*BA*":DH04E _EENM?YT5K,YOZGH\'*V>AI
M3H2JM+#Z&&@Z+=#CB.#;FPU^4MYFDWQA#+9VZE7##3'H--^I2FE,MEET:4>B
MI2%,6T(!1%4M!C.KC1A&C%N,CJ6EEB;KL(94MMQ(HM&5)8^CM*CU:JX0KZ5A
MU%C3U-+_ *B.ZY]?5C1MX[L(?SN(-V9/>F[[N[L]11=KNT5*BITTM[6RU3Z4
M&U-GD?!><YW3YV.<Y*:4G&,G#SOA?+>+<O.GK6Q,TK$N%/%?#&:X=WOF+-5I
MT47'6MFI1I5%;J@TVDL#Z!\*\3T_$.3MNK6ZF/7#^ >L-^IX3S\\A2[@XJ1A
M-'.WW8G>TXBY"\_]P\#YG>-W+\"<0YRBSO2J]?K67I==[*4VU"Y?MVU-:C^O
M>SCUA_VIXO\ /N.FGS<Q%\;,*1&V(?PGV[>S[E_6+U?MY[2TXGF-.R9B8C&)
MI,[(EW9=S[TW=Q!N_=W$&[LQ1F\AO'+9?,6KMJM56W3=M47*6G0ZJ7ZVL^X>
M3Y[2YKD-/F+)B;;[8FL;XW/S+Y[D];D^=OY;7B8OT[IBDQ3MZ7]UYFRKBM[2
MVG\%X3IB,*[&'H[Z5I@UI14U/#RFJ-.>/CCNL:[&1M0 ZZWO\?9O@'@I-+;=
M&:A)ZLYIT&5D\.I;=O2_\%+JG96Y3319M5)4MINJ[!8J:7:>=GF;;IK.3Q?%
M,64C:Y'\L^Y=WI^?&Y+G%O*?@V]OO<=$-J]0ZJ*:5Z*IA#+W-K:VU@R3S>G;
M'G3YK*(FZ(X(F9;@OW8W?V6/++-+4MJY_B9(YW0G;BLV:L3DT[WNTN_GEZ(W
M^6F;J@FTU[1NFE8X9/4C7=JVWW>;+'@OB*W1+COS,Y$\W>2MUY7FIP;O3=]Z
MINBY7\US=5NW':I;=:RU%*7H,V6:=E^-TQ5EQ39A&3;7<UW>/#E^UO?@_>.;
MW)O;+7:,Q\\M9B_1<VJ:Z;M*A1715%.E:=!NC1QQI1)C;E<[)GNJ?>A;]S&^
MMU<C><>\Z\U:K]CD]V;ZWAF'M>T:RF7H]/,9MO%L\7SFE34R=O+8Z=)SAVB<
MK>RN:L6,UEJZ+MC-6J+UB[;JVZ+EJ[0KE-5-5+=+55#B<%*3CFW5K&YG2ELU
M4T+U::MFK&=7XWH:,;9F<9R7#8Z<OOC.;W.GA+O#;XW=P?S'WQP_NVU>H5K)
MY'-9VQ;IC5G(RL9FU3H6@\OX?H1J1=,Q@YN9NU(BV;)I#U1;A[Q/>67%/"SO
M<W^)+UF[O;=MNY0]X;T:JIN9W+TU4U+Y[!IIZ3=?RM)I$1PM=NI==.-WG0[]
MG=(WGO;>W=]Y=;QWUG;F\MYYK<62N9G-W:JG<OUU97+MU5.MU51GI;/$\QPV
M7TV.K3QK7#%R3-3(   ,**U6M36*U3?Q$BF0XZ]YSO#\*=V_EGOSCCB',V*<
MUELAFJ]UY&[=HMUYS,V\O>KH5.W=M2IJMZ&;='2XIK3S88W74AT6N]9WP.:W
M>OYB;^XDWIQ%O')<*4Y[-6LKN*C-YE97V%%_,T40HIS5=IIVKFH\G;I3,98.
M2_4B9KI32'&C@K@'?W'N_:>&^ =RY_>N_LQ<IIHM6;&9O4UW:ZJ4HW:+5VGT
MJZEX3=;KQ9'H\*0U3=;Q^?C+F!D?=J=_'>67LYK)<M<U8R]="KMUU>T555%=
M*=$:7DHINEF4\W9&,SB<$SW(FDMIN:7=,[QO(O)_.^;7 V\-VY*[M-YFFQF*
M[4%M;6U<IRM%%/J/%D^<Q,5MEC,Q;,\4./\ D7?W5?HWEPOGLSN3>N7N4WK6
M8R]Z]171<M5TW%^9UT5+TJ5IT&K4OC5OB2)BF%:R[.'N=/>(;ZXASECD'S;W
MQ<S^:M6Z<ONG?&\,Q54U<IIRENU;VLQFJV]MRPE$Y-71BZ9FWO.C1ONB[ANF
ML.SA171<IIJHJ5=-5--=-5+C3534HTU)J331PNQD
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M=TO=%ZK,[JW9F*WM5W]WY.[75"$:[F7MUUN&B-39XZ^.&Z8Z)1_0,0
M!XUS8]HE%TU5:813EIU"O1FM*QCD]*?O>N^EN[DERQO<LN'-Z6_OFXIRN8RN
M=MY6_3[?+VZ[.:MT45.SF:+E#J=,6H8F_1LVRU7Q,X1DZ;M5_,YS-Y[>6]E[
M?>&?S%_,O-9G[/<;S%VJZO2N[=3AMZSRNA;9,5C-RZLW1YLXV2_K\(VZ5QUP
MA:JMV=NC?6[G5=]C1..\,O"'HZ#HU].ED3.TY6ZLS;:^ASW5ZMKD)RZV:5Z&
MX-WJF"V4_P!1Y><,%B>O\S%UM](S=\1CBY"TI4J"DD<]DS,S4ED;$
M
M
M
M
M
M
M        !X-ZFNNXU35[-2C5C&4%(YKZW:G!$X+&&.UZQO>B]Z/(=USNZ\0W
M[F8CO?C#)9O=>25-[V=ZV\QE<Q8JJHV;UJM1J:PU'O7J5X5H<UXC&KJ1YEDQ
MATOX9]8GUSO]7O4+7T>3GAY[6MX+9B:3C6-DQ.,NA-G<[?WIO7?&_LQF+^8W
MAOC>&9SE%=^NY?N1SN9N7_6N55U?VW6?5G@W*\&E6;:6S&'V'Y'QXC,ZOSC7
MNF=>.*9KC69K69KTN1O*KA6C*[N6?SV63O5)5T7;E*C5'8<E53&4SW'U<Y:;
M[M35YF:\,X5?P#U\]9+]76NY+EIG@NF<IWRW@JJC4X4^@H):EHPPF>UVWZF-
M+IBU_,(BD8SYS&+2DVD]$=7RFN8BZ:WXRM(KO/QL)ZR[-R\4YUFB06"I@Q6:
M9X%=M5]'&$'T2%;^DB;XPB9H04E">K4.*_[J2MTQC. HS2F.M,-HYN'PP)LP
M(PBHX1U]!E6[RF+4N;2MT3<%&'4M"ZR:-UMMT\-.+:RMMNMF+KH\V6--W9]*
MFG9IJE4L4]!LUYX=/IEGS$VZVKQ1%*-G>:'"MO,V/NA;M*U;MIU55T)13>TU
M%4TQ<6>G>*<M=%W%IQQ7R_K?L[\;XKOFO.WS9REN$8]7NU<<]WYW/\/<5</<
M1Y#,7\EF-Q;RRN=]OE[MRS76LIF;=]1=JJBJ$+>L]>YKE]*/.OMB8I-8[7]R
MTN;OY/3B_EHFS6F8FR^)QK&4QMA] /W:?>EW7WH.[WPYO>Q=V]X<,Y#);JW@
MZ[NW=N5Y7*9:RZJZ:KUVY%54XL^2?7KP_1Y;QS4U-*WALNFL1&6U^MWU?_6^
M[UG]1="SF-3TO.:-L6773GA$1C%:X2]B68KVK:HMSJJPA*$#T;F)FVQ_;YK%
MW!E<U[.TJ$JO62439ITX8D:IF 'JZ][<H]TWB^4?L<?^!S!NY?\ #VM',U]#
M-'1J5Z5_9<Z<QF(.&#]K7+#2>?LI3&,7'ITPKD]K_NV.X1R[[[&8XDHX]WI=
MW<MRT6Z[=JU0ZJ[T:<NX)^RKI3?M'BT>)YVZZV^ELTJ[K+-.N,5E[?/_ &_O
M=PVJVN(-X[-6RDO86W#9QG[,X[-74MF)F9FC9P:7W.+2_P#;]=VUQ=OB+>.U
MK]C;J2U2V&;YYJ^9W+=;I3%(M<3^\E[BG>W"&X,UO+D+G+O$&\[%BYF%8K7L
MJZ:;-%VZZ(?-&JJH4+!Z3;;K1-)KCT.>ZRF$0] W'W ?&?*_B/>?!O,#<^8W
M1Q'D+]>6S=O-6;ENBX[=RY:VJ'=MVJ:OS-X(\GH:L81.UHU(_P REMK]UW>^
M=/%_(#F7PQQ=PUOG.[OW5D]Y92[GK%K-9BU9N6OG66JNTUVZ;]JW5353;:F:
MM:S3FZ9I%6NR;[=3#NN_)W7>>^YN\1R?X6Y@[GNT57,]N_+TYNW1736_G%O+
M6/;5U0N7=EUW*XS9X?6TYT[J1W7D;)F8JY#TM[5%$]JB+KE*>$\)FG&F&2UB
M)B-KJQ>_HW?8S?$O#?SRRW;>7?LJJDU2_L6<PJ:@\3RO)6VS9/%&;EU;KN*8
MK@ZUOW'W15:RV7>37SEYO+;+VDHI7Z4IM'3?;%,(Q:..Z/-F<'>T]TME;65[
MIG!^7MV7:A8I54GLO[!EE*J"3EJ/$<U-UT4B<7=IQ3?#V<44>E2DFJ:H[=+C
M]#A.6)PZ?I+=28NFK=6)MW/*G!.$'JBO*;V,;Q))06!<Q0 &W/-KBS.\#\O.
M*.*=WV5?S>YMU9S.V;;<$Z[&7NW:<6H^E0C*R(F<4F9C)T?>]C[QSO!\^.->
M)]QU[]WAPON[<F\,WD<K1D\[F,G2[5G,YK+J'L,[2H*CH/-:%NC;9$4B9EIF
MZLS-LT>N[>O$7&6]ZJZN)^(-]\449NIM6;F8S^\JX[4U2JKM]S;?A-_%I_T8
MB9<MUMT>=.,2\?+9'V%JJM;DS^ZZ&TZ?GN3S.6]I--[-68M6XF$Q$S$D95B*
M-;,UIU6:Z/0H]I;VM/T5/E+$TG!B[K/N8W35W7MW.F5.W;@L/[38/"\U7YQ-
M7=H3,Z45>X(T-H                                  #^9O+-Y?=V6S
M&\LU>]EELC8O9G,1PV+-NJZZFVTI4T,E^I9IZ=U]^416O11GI:&KS&M9I:>=
MTTB'2E]Z[SSO\W^\QG+6X=Z5YCA;<MRK)U9:F^[F73R[S=BINW3>KM)MXR1\
M-^U7Q?2\6]:>:X;YNTK*19%<,*Q.U^F?U=/5?E?#?52R[G]"V[F.&M9B*UFD
M[8>OK@;A][\XCRM%%#^9T7$ZX4QHBJJ6]#I1_%_6#Q*/#?"[]2Z::U,/<E]"
M>$>%<WS7BEGS>9MT8NQMC+-S>RV7M9&Q9W?85/L+-NA))))/94<$D_5/G*_4
MOYKF;^:U9F;[IE]!<MH6:&C;;;%+HB*SY&M!2EA@*QT-\Q%TUG,$771A$X*I
M,)ZRFT(   *6] % 5D8NFFIIO%8/4;++J1PSDQNLMN[T5AA6ELQJ6U4G)O%3
M1A-]UMU=*>&-S/")KL;5\U>&J=X[HJWI:IVK]NF->RO2@E7",*6\#WKU(\7O
MY?G/FFK/^7,O1_6_P_EM72G6G3B=;IIUN'MZ]GMW7,KG=T5UY;>^2WAE+M-V
MVW1<HIL9JBNI[=.S6I4:S^Y<O=9=JQ.M/^3G&.W8_D7!9J<MK:7,6Q?9,3$1
M/E=W;W8O/?(\V.[QPGN3,9]9OB'AS=UG*[QJJNJ[<E9RU-#KC=N5IQJ>,#Z\
M]CWC.KS7A\<CK7\=MF,5QFF#\N?;GX)?X9Z\<UK6Z?!RVI=6*1AG+V&WLK>J
MS*JH=5,*H-P<(>/4?W#4[D1#^+<W?=-]D6Y;7]JW:V:J'54W4E/IE(FG?,V1
M5G-.'"'EF;6&-V0Z[/O\:55R^X)^IS,'_AAV\M;$ZEM6O4KP3#JAJBJFW3!Q
MG3&24)K3,\SK6V<%8BDO'VS%-SN;^Y'N_..[.[5VW9KIM9BSLOV-&W^8V8IU
MPVJD>$YG.'?I1;%M8>Z7YOE_[A9_.J/RIS-K!V,HZMAV+#JU.S0]$?I88"L[
M"C8+G7W8N3_/;<>]=T<;\([JS^8S^2O9>SGGE,M3?R]ZJS<HLWE7["MMVZ[D
M7I9E%]T3$UE."*98.D1W]NZ;OGNJ\YMZ\.V+%S,\.9C-W<QN^]31519IRU^]
MF;EE;:LVK<*;5*1Y/1NF8B9EQZU+<+<(<,=U<0;SX2XDW%Q%NG,7+&<RF\]W
MWZ;EBNJU70J<W8K?IVJJ&UZ&L[8X9LF;L;F.E=3S)GRN_1W ^=%OFYW=.#][
MYS,^UWANK=&5R^\;U=WVCA9RF7JV[E55RXU!-XO0>%YJV(U*V[7=%-C<7?/?
M#[MW#F^<UP]O?FCPWD-[Y2NY:S.3O9_+TW;5=%55-=-5-5Z*:JI9HMT[IFML
M8R77Q;$<4X.H][W7F!P#S*[P&\M^<O=_97B#=U=5MU9G)W+=VU76OG3JV:K=
M=::552F>6Y6V^R*3A5SS=;-TQ,81D]6NXZZ%Q1PQ=N-9?+6=[;MKS-RKU:+=
MO.Y>JNIQDE332S/5XXNI7 \R)K#O0=V;O?=V;AGD=R_W+G^:?#^5SN[]PY*U
MGK&:SF6M7;69IRUFFY2Z%F')*E=IXW6LONNXIC!OB8F'-#EMSHY7<UZ+]_E[
MQ7NSB2WETO;5[OS-J^J(I0CL7*X>LC3-M\=6UEA'F[6[)B !X,DY#PK53H=V
MJM>E"JM5:*J:4WV0.?1F[CF)R97>^ZH'OS^\-O#B?B;<O++<.=KLY'<CO6<_
M1:S#I5S:><HJVZ*+\'&.FD]BY6V-/3X9Z7-?/G3#KY;KW?5O//[JX?W;]CO[
MTS-C+JJF=5=R]>HM.2BVW7<U,[[)B(XIC!QW1$Q-<)=SWW6O<9Y?<J>3^XN/
M.+.&,EO'CO>E.6SMO>6>RMJNYE[3L9:^MFB[EJ:FZJX.,6CU[F9_ZFZ(G!W:
M%LQIQ6(K+W'V;.67V*G+Y>BFVE2J*+-%--*2]%))022Z#1,XTJVQ&&,4ELOS
MYY%\"<_.7N_N!>+]TY',VL]DLQ3E\U5E+%5[*9AV;E%NY1<JLW*U2MN:18NF
M,$NLMF<8="WO><C;W=ZYX<6<#6::ON3D=X7_ )I4Z72O97<SF=A4QMVUZE"T
M'G.4I/+S6'%KTC6C"EK\5W?.+]Y<#<X^"]Y;EOW,O7<WSNY7KEJNJW6Z7GLI
M%;5%5#<E#$U:N[-=&8XL<I?0PY/;\JXBY9\&;XN5NY<S6X=V5UUMMNJOYG9V
MFW&IMML\3?6)FKLB&Y5-2JC#0:XNJK(R
M    VTYO\Q.'^5?+CB[CCB7>%K=F[-R;CWIFGF;U=-%'SBUD,S=R]M555T)5
M7+EM)31T\IR]_,Z]NG9G6/<<?/<U9RG+W:M^=)IUT?) []O>%XU[RG>ZYL\3
M<6[TO[VW3D.)-Y6N'JKU^O,6[>4IWEGJ+/L77>OTT)VJ]#1]#>KVE=I\M;I\
M-(BV/YW\,YV:\Y?S.G?-U]]TU_JQL^RXX;GR%=>:5UT1HIA!.:A%:UT'M7+Z
M4W:W%=L>M^+<Q%FG'#YTS_.W2MNCYJZ8*-*IV9)=#P/9K)MGELL7K\W1.G/%
MWY>/+!&$13&&K&,2+?2_!#XRX1U+,].T6.MOQ0),0DY;H'"+CYQC3 Q)/I7D
M^.)4QCK(J;QC 4*2."2AIZQULHF>DT1\Y*5PDK,S2<88PIAYIDFW%:QE3!E"
M4I?BZQ2DX,9X>*M,4KJ;IV8Q3333ZH+'K)=68F)R9^FUL.*Z:0VSXGR=NS<=
MQ6J5=O-K;II2V8Q6A'KG/:5NG?A'G2\]R>MI\SI3%L9;>ER"[AG> XT[LW>R
MY3\0\,[VO[KW5FN(]W4\07[-^YE[=>5N;QR*N*]L7K%+3MT:7"!ZAZP<O/,<
ME.A?;QZ4Q/D>>\)U]70U_37ZTVZFG=%(^ZC&L=CZWG)OF3P_S?Y7\(\<\,;Q
MM;QR&^=Q;JOU9JS736EF:\AEKN9IC1<N)M7+C6+/G[Q?D-;E=>=*<+:S,=59
M?WGP?Q&SG^5MU+<-2D5C>W7L*%M)?#I[3Q^A%T85K#R=\1$TAKG2P )5@^I^
M0#I0^^A]+O0;TC_=%]=G#R6C,Q&$M&M,Q&&;U/\ #6Q;XKX5>S34EOG=BJI:
M3IJ3SV7BFG)IHZ-:(F*N/2F>/SN]5]!SNI;FX;SO=^Y9WOO>W*E<X<R":>ZL
MBW76LM;J==;^;QKK>MS/%:EUT7YS%'D8MMF,8C%R&^]?AK_P[N+_ #1N_P#Q
M<Q])?]U/NG!9T1[C^=O#@O@W>%C,9'.\+</W;&9M5VKVUN?=K;HKH:J@WEFT
MX/$>DU(VS3K.&VE*11Z>>_3[J'E)S<X)XEXNY8[CL[FX[R66S6\;5&7MVZ*<
MU79MYK,W*:*;>4BG%R4)FRS4NFZ+9E.&,XC!T]>+.%]\\$<6;]X1XHRMW+YC
M<>;S&0=-VBNV[CLW[N7C"JFB/YGJ/*:4W[9P<-V<T[T.6ON]^?>_^1G>*X/R
MN[MY7LCN7?&\[%K/VU<K5FJW7F<I1"NE7;=#C0M,3'7T_2Q''G&3+2U+K;HF
MW*<W?>W#Q-NO?_"NZN)+&=RZW;G]W93.O.7;]NU9H5RQ;NUNN[76J$J74X^D
M>'OLF+N&W9+NXHI67Y3B_C?@+.<(<5VJ>-.&%3]Q-ZVKE5&_MUU547/F-^FF
MG9^=1=6TH0UF5EETW1:EUT1;,R^?IWHW:?/#C%6<U1G**=^;QJR^8LUTUVKM
M%6?S;C2[;JH:=,,&>=LLGAB;8I=#GC4B+^&[+I;@]P2[8H[UW ES-YVSN[*6
M-YY=W\WFKM%JU2OG.3<Z[U5-"7::=6V;<<Y9VS2_"?-=^;=G'/!%K=6[5]^7
M"]5-.0R=*J^[^Z:77LY>VH[/SN3<(PT'B+HGBG#:W<44J_5Y/>60WGE:<YNW
M/97.Y6YZF9REZUF;-4'/9N6:JZ*O":[HOPI#**9SD\\J    ),TBHQC"J=7K
M>JH804Y](RQG(;+<^N<O"_(OEKQ'Q[Q/G+&4M;NW?FJ\O9N7K=%R_F5E[KLT
MT;5RVX1HFTS=I:5VI=2V*Q#&ZZ+8WN@IWK^>_$'>,YU\5\9;QSU^]N&YO/,?
M<NFY>N7K=-NC-9G85JFJ]=I7HUI2/(V:7!ED\?=Q773,SBV"K5[8V,SE+M-$
MO87JJ*Z::X)-3=*1UQ2)P70MI=2<7]7A6NI\;<&47:=F]3OO=L<5%?=#+;,^
MA&O6FZ+<9=&K-L3$VX2^AUW5W'D-RZZ.']W)=7S++OSGB-?OUW-UDS,5ER$-
M%(S9A0
M
M
M
M
M
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M&Y:+=&><FDS=E[S?94*BA-RKJC+'QG\XLB."+MKWR-6;]28G!"-@
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M'#N['4FFFHY*P]*1XJ_-U6MY:8[53A!.&F.",*VQ/#&;*DYSFU"@
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MEW_%_=WVEECQ.OW_ ".K3[OE<A32V
M
M
M
M
M
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MA^3T_P"7S6I%N<72_HI).6DPXIX^'8RW[61L0U&,]Z!UVO?X.'+[@KZG-?\
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M=VGW?*Y"FEL
M
M
M
M
M
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M7@/7^:K%TT=-D13#)R%-45ICFR"@
M
M
M
M
M
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MCYVN[%[F3^:]NZ"AZ=K] L'A.=^E7._1_!P]P)RM@
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M8HRV4RUJBQEZ+5--NBW:LTTVZ%310J4O1H2P/'5FZ9F=C;39&;^D0
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MZG"E8MR---C*NUDJE5@X_*#950
M
M
M
M
M
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MC<.*KNQ^YDA_)>W=#!U6OT"P>#YWZ5<\AH_@X>X$YFP
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MUJW:MT6[5*HIBK=%%-54%-P/&W7W7W5NS;[8B(PR?H#%0
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M9QU-8
M
M
M
M
M
M                    ?FN(]UV]^;IWQN;-65<RV\-WYNP]I*I1N9>NBE.E
MIIS9LY"Z>1\1LYRR?.BZ)IU2T^(<O9S7ANKHSWKM.Z*=<2^?)[QOE]F>7?>X
MX_W5>RM63W;>WC=O91JVZ:*U7?S=3:6Q13BD?5GJUXG^?-'2OLCAFVV(IY'X
MQ>V#P#5\$]>>>T>8\V-35FZ+MU9<:^5N]J+?$%O)NJ-&TU%R4VH:8']-\&\1
MOY'6^;S96+II5\[>T#POTO(SJ:4\?F[(W.4MUJ-#56TFHKIBOE/?-7EHY:V+
MHGBXXKU/GFR)B9B8I,2T&ZDHPPCJ[? CGX^F,VR(MZ15TUK:3BDX0PQ[=#-U
MT3;,1TNSYI;Z&[5B[&W8R=+7I?#47A\VKAB8G!BG!F+*5BG",L98^,F*4F,D
M4=!96:;63PG/Q$AC"347U3D7!<)5N<,/&394B,%KI5&RXQVL$DS9;;%T9Y%G
M%?/#$8HJ*MK9J6RU!N<9.'F.>_5G3FL16&[6T=30F;;X\Z([6K=5%E>T5<:4
MHUQE"";QZD32U[M2ZDVTAIMMB^RV([\SET.+',[>2WMO^K)Y7[)39CM1J]%;
M*J;@XM:#U/U@YR>8YF?"XBEOW3Z!]GWA5W+\C;?J1Q<>6QRP]U]R[S',OO<<
M#[OKRM5_=^5S]%Z]>]FZZ++M9C*-17L[E)_*?6WQ;_;?(:EMUOI8OMF.C8^F
M_8IZOZ_C?K_R4:43%NE?%UTYT\Z*._\ Y'(T;NW=D-QV;>S9R61REBFXE"E>
MRLT42I22^A/E+F>+F.<GG)FD3=,T?L=R_)V:'AEFG%V-ML1[E(J_LY2AVMJW
M"*IAZ>$>PUV:L:E8RF&Z;IFEO1#SC- #U<^]NIVNZ=Q:HP]".$?[3F3;R^KZ
M+7MOI6&CF/P4NC57+V\9M7LST1^RU'G;/\VWBRB7)PY4VNR;[@6\UO#C^TJ+
M;MW;5F*KMTUNF%.3G354FZ7U'B^<IIS%F=7=9,4X8=H=Y>TW!6K.S&-:=JA[
M6K0<%:S3H;&7L+6BU:AI7LZ9ZM&@N(Q^;VFWM6K+IELKV5$H=,-8&55I5+9<
M%2_624$]75 =6!UHK-*V82IIT:]4XZ&2:S%)G PC+-EL?9-M50^F6N4$7K*1
MY6H!U8??QU0XCX<HAZUG'_>\X>1Y2SBCBZ&G5F8RS=;2OT+.5J;E\[R[PT>W
MI/(WZD4AR73Q1CA,.]1[IBJ/=/X0J2]!V*70WC5#+Y6,L5 \-S%9NB=DNCEI
M\W'-[/:*W4ZE53LNEX1C)X''Q5OX753"):AF@     &&%7U7BV5XXEF*VTZ$
MRGK=:[W_ )%;AY>M?2YJ*URS<XG;RGG4LV)?W)=6ZI1MV?[Y:_1*3S%L>CAX
MW:[L?N8_YKN[?JK7Z#8/ \W=Q<S=+OT?P</<$<[:
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M4EBS*(F<B9B&%-RET[3E#UIX:IPTDFM:*M%RBMM4N.SC^*!F
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MV9KZ..,8Z.HT16(Q;*6UK&;6
M
M
M
M
M
M                                       '\Z[==NXVU'::I2Z&TJA?
MPV1Q3GL2RZ;IFV[N0ZKGO]^[GEMQ+<7.S<.[*[^9WQ?JL[RNY>Q4W:KI>:JJ
M]H[5F5,*TXNK2?VGV:>-W:<SRUL^?'3Y'P)]:_V?<KIS;ZU19,<5U)NC969S
MP=9_=^>N;HSN0SV6^Q54UVWF:Z9N%3IBFDTU"!])Z5ELV6ZUT9Q$O@&^S3YK
ME+M&<;HBZ,8ZW,S<6]LKOG=64S&5K5>Q:I]K5%1VMFG%1;FV>T^%\]=XCHW5
MGN/F/Q[P^?#O$-31F)B>*=VV7]IK:IV81I6&B$?*>5LT[(I-VUX3CNI%=CQ&
MOH7@NOXS9-D1C#I]-?=9%M?-C)JJ*H7PTG/6L[FB:3<D?QWB!Y%G""FM?R$V
MFVHYN*JDNC6#=1,'!26EZI%S@SC>L)S_ !25PP*X8,7%32ZBKGA)1=A=IVL%
M'R2&E/%=-NV77R<V:6M&I=DU$ZG55M*;:TZ-!VW\MIS;6.AKYR^Z_7FZ=K^'
MQ-O&WNO=V9KNN%2MU0FE&--6IG@.?YJSE+-D3+S_ *J^!ZGBW.X1,V63$S[L
M.'>^,Q<S]S/YRBJ"LUUNU1'T\PZG5*,=IS9Z3S&O%VM/,SC?CB^EN0Y:S3\.
MC2TIBS1T^&*;9K2KM >X)[MV5SVX,YSVWQNVYDL[8S%5K(+,Y>JFJ[5'*PJH
MJNV$]F%#<54?P+VI>,Q-EO+7=ZZ/<SQ?H3]53U"T+="[UFNBL\4QQ3&=)BE,
M':&KKVJ]A-0JEZN"72?PJV^LX9/NB["8MV/*HI5"2U&466Q=-T;59&0 >KSW
MM?\ -/XN_O;_ $',B._#1S/X*71HNO\ -_[]F?T2H]BY;\&Y8SM=D7W O[:<
M=?WJU];DCQ7B/X6/Y=+KLS=I76<$=Z6X,@    $3BVM4/&6F%4KBZQ_OXMQT
M7+O"V\E&+LW(RC.FWG%C"4$CNY6;K+9NMG%A?9Q8]#K$7+CHR^7BHTT9O+]B
M5^F+?4D=TS.I;'2X;IQFCO*^Z.W_ +EWKW6>%\ID,]8O;PR.7IISF2HN6W<L
M;5C*P;IIK=23?0>.YNWAI,.KE^&8>TZBVJ:JZH0=<&YQ.+AB)K&UT5F<VJ4
M     Q?K4?DO(6,I2<X=:WW_ +^T'+R&.SFY]F;.[DN]'0EV4]3JX5QV+,O[
M9:G^3IT'F)I2KQTQM=V'W,;CW7MW?5VE_P !8/7N9_#W._1_!P]P1I;
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M.;D];6PW0J-FFF&RX^M^(:[>&WS:XK..+5-B
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MN9M+YIN[>&6NW[=3E:MK,9:NJK:=5*]6AZ1K<4UIDXXU9O=V_EU[QONK[_X
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MC#1 T1-<6>RBT_8ZZ+<X3])N,8Z]4"Y]9$TBCR
M
M
M
M
M
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MEGN[-<NTV<Q8I^<6(6\SE[N7K7V&S]#=IIJ9XKF9B;L';H?@XPH]W)RMP
M  $@HIZ5&':!P+[_ -W.MT=[OE'G^&JZ+=/$.[,IFK^Y:W11M7LPK-]VK'M'
M:NU)U7;B@;M'4]'=Q2TZNGQT='GG-W=^</=ZXAWON3F#PCO7)Y+=F=S-G(YF
MWE,WF*;UBG,7K=%:V,M2FG;M1/):?,1,<4..+9B[ARAQYO9S=^\+WLKNY-]Y
MF]4JJ;;HW9O"A-U1335-G6SINUJ16C=-G#%(G%V7?< \-;RW5O7C'-W-SY[=
MF3OVJ'33F[&8M;2=.4@U[>W0<?,WQ?I3PMFE%*<6,NU(>*=  ),5B@TEC"G&
MF,5JBI3>,192,)S)K2EN3J%_T@;>RM\<<-6;V4WIF:K==2M?-<KG,Q:III><
ME"Q151@CRFA;;;%LVYS$.;5QPG!U_P"GB:U['+/[D;YIV+-*J:W3G]-"I7]I
MZ3R-NI%DTVN:;>%G;XD=NULV]V[[MTUQDMU;PBM&/LHHUW1$W5K%6&UXSWQ:
MJ;56[=_O:FVMW[S4\?[GK,[+M./-G-G&-(EG1O>UHW=O]+5\QWF__EF<^CGH
M;K+(MNG'!C5OJAJ>[=_MO3\PWG*'^]F-]UEL4M8ZO>>+O#>UKYC=AN[B"+IJ
M_P"(;SG!5?[F<=]^%8AC;97"N#M6?T?[.T9C@+>]/L-X6:MFK9^>Y?-6FTOF
M<9YBFD\?JW1,;W79PX4S=E15T^VJIJE5+871--]IRQ$<6]NFM(J\@R0
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MSMU0A%/)V'%K\DSPVM'#J4=%D\48X.0].SLK9]6<,=<\9XFMDR
M
M
M
M
M
M
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M0W_;JH=5MU;3J5-JS2_[7;A!TO0>(U[K=35F^SNRZM*)LTXLN[SV5&EM
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MNF658K%<F[--NI7=JI[73!+1# PA&N4
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MCZ-"--]W'-99QA,UR?KDH)(Q7J4
M
M
M
M
M
M                                           -.Y0ZU!5;+UDB8B[#
MO),1=%)R>+755:HJIKHVE4I**Z8F&M=-NG-T9P6UMNW/X&]-TY+?>[;VZ=XV
M+6<R&=M7\O>RUZBBY;KMWZ*[=>U3<IKI<*:WBC5X9XGJ\KS''&&K,X3U-/B?
MAVAXKR]W+<Q$7Z-T4F)VUP=63WKWNH\]NNYG.=7(7<CWE575F<_OK<.[LJJ'
M0MK-YJ]<5.5R<&Z*5'$^B/4GUWTN9TIY;G9X=6W;,YX=;\]/K#^PSQ7DN=T_
M6#U:L])X?-?2:=MN59K-V$;(]VKK..K>%C>&8W7FLOF=T;ZW9?KR^>R=^S=L
MUV[UBY[.JE^TIH<572T?UC0\1TK[8OT)KJ3E,/C'QCE9\.MGE>8T>'2B:71.
M<SU9MV.&^9&\]SU6LMFT[EFEJF%5<8*-*;BZIQ@>9\+]8/$-'6]'KW7<$S%<
M\???S?U@]4-#Q[1CYCPV:=M9BW##.<Z5FK?O<_%NZM]VZ*Z<Q0KC2?L=JF53
M2_'/!L_I>AK^&1HQS%TV^FNC<_B?B?J[XAX5J7:=UD\,3G_*'Z2=2=5%5%RE
MX0JIZX8])E.MR]\5LF*^1X2G#/#?$Q=U-6W7;IHJ3M1VH0?TLW'RG)?H:M\\
M5MV,-D:M]MEVG$]ZGO,%?H;@[+JC]$]!KLY?F+->WCNF=&N+"ZW4F)FZ_%IU
MV[E2JHMU;&U-OLCXCV&ZWPZVEU+:=<-NEK3;'#G$M*BQ=M45559I;"G5%I1A
MUGCN8U_#\J6UCJ7TME\\,6>=.Q_$WEQ5N7=-J]57F;;OVE%IUTM[23@E&I.;
M1X;F.?Y33M\RG$\WX=ZM>+\_=.I99,:=M/<EL%Q3S+WKOV\LINRJJUL;25"J
MJIHKI]).+V]EJ#/6-?G..;KM;S;(RWO[AZI^H_(^ 7:?/WS&OJ3C-LX4GRML
MLK3FMZ;XRVZ\CD\QO#B3>>8HRV5R66L7+]=^_>K5M4KV5-;]>KQGA>;\3Y6S
M2G1TIB+J/=YY3G?'>=IRNG_E771$1;G$Y4B(=GKW4_NF,SELUN_GUS\W-13<
MV,MGMR<,;PRZJ5#_ %+F[=VJG,Y-I-H_A/KOZT:/*S/*<K/%S$Y71.6<;)?=
MWU=_8+S&E?9ZQ>L\1/)S;%-&^S*DQ-9XHQK&'D=I/<]C)Y3=N5R>[[-G+Y/)
MV;>6L6+%%%NU:M6**;=NBFBVJ:*=FBE*2/XIJ:UVOJ7:M\\5]TUF>M]Z:7+\
MMRNG;R_*6VV\O9$1$1$1$1&&Q_2352BIIF#8H     396I>!"@BAM5)-2A)*
M$(K7IB2,QD4       8NFEQ36,(XZ,!.. .J&UM*%*A!XQCT*:@R5IGD"2TT
MI> *R@5         !-E:EX$2D DE@H%!MQ22BG&+CAJEIB3&HI0
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M-S$
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M=2>W%P]75%:CDMLOK-\Y-_%%(MVO(-@
M
M
M
M
M
M
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M      D%%/2L.T"@         $25*@I)$B*"E
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MC&MQJ;<8_")US??='#=-8ASV:5FG,S;G+R2-@
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M9S:Q%
M
M
M
M
M
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MR^3S'.RY1O\ S>4]C<JM>SH3O5T>PK:;>32]>FJ,S^:^)>T?7FZ[YK$Q7?\
MSOI?U.^J_H\K&G'K%K6ZMFG,33AB*Y?U7O"Y5\@N5W)#A_(<,\ <';IR60R5
MNFW;K^8Y*K,4;--NG:]NLM1<B]A/$_G?/>L?BGB>I,<QJWW6UZ9A]3>K_J1Z
MM^KVA&GX9RVEIW1$5FEM9IY&\JIIMI44)["]6,9:THX)'C^_-;IS>SW7SI>;
M$8;&M31"FX_9PJ=/IKZ:4EX"3-,(FL0PI99/'9WER$LNJ?9^SV6Y:XMS)7BQ
MV$ZEVK/'=F\TJ
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MPI*76S;FU#:Q
M                     &,W1$Q$C%I/%1@+II%3,4%)*1K]+C2BT:5VJKTD
MEM8>C+HZ#?G9Q1FPQF:0T$J[:IJHC7M^N\(0<'+H->I;Z6[BMFD,K/,MI=B_
MF[YX>W'Q#DLSNG?^ZMW;TR6>LUV+MG.9++YBFY;N454W$U>MW$G"ISZ39R^K
MS&A?%]ETQ,;6O6T='7T_1ZEL3;.</7#SG]T)W$>=WW3S7$G)C<-K?^<5RM;W
MR=BQ8NVLQ<]K4KCH^:UT5+;NMP@>R\GZU^*\K,777\>E&R7KW.>JW(:VC-G+
MQZ*^[;&WK>G_ )U_T8/DGQM>O7.".(\MPS34[KM*WE;;V::G==NE[.[OH%4E
MV'LNG[1KYI,\O[_\[U6?9_;,S74\[9+@=Q!_1'=_YR_=KW3SQHR=MU/82R2<
MHU-?]7=*.NSVAZ,]_0GW?YVR[U+YRD6V:T1$;OYF'#W]$=XCRF8HN;TYY47Z
M%53%/)4N2:CCN[3 V?M"Y6V:QHS,]?\ .1ZF<[2;;M:)MG=_,YX<DOZ,5R;X
M,S64JX_X@R_%=JVZ/G+KR]NGVE*=K:4*MW2BJ6NT\;K>T'7OU9X-*FGLQ_G(
M]0.*(F_6F-SW!\E/=!=Q/DA3E,SPUR:W#F-]97V5=S>F>R^5OW*K]OV=2N4T
M?-*-GT[:>D]9YSUH\2YR^;K;^'3Z(>S<AZJ\ARFG%NM'I+]DR]C>XN'-Q<,9
M'*[FX?W1N_<^1R-FBSE;63R67L44VZ%LJE*S;H44DHMSD>O:U^KK3-UUWG3M
M>Q:.GHZ-L:=D>9;&3^S0H^G<])J2JGTKU=!R6S?H^9/G7SM;)I=C.15730G3
MZSJ:A)K"9U66S3_,S8W71;'%9#RE@HJ'0*1&$9+&,5#'B\[A%,@
M
M
M
M
M
M
M                                               $$ @B4@1IZ'#L
MB913:DUV/$S62R.;HV<[E,KF:-68L6KRGT7*:L8CCNMBD3,>5C=IZ=V-]ML]
M<1/:_A5\'\'YBJJJYPMN"^]-5S<^[JXQG]'EW$D3=,4X[_OI^VUSR_+S-)T=
M*GP+?M/!JY?\![>T^">&-I.,?N%NK3_S4M-2<./4I\*[[;'YORLTF=#2XH_J
M6_:>;:X/X2M-.QPKN*WLP:JM[IW=;AIELV*8&,V</]*[W9;+=/0B?-TM./\
M[;?M/[V6R.4RB:RN4RV43A*S9M4)Z%*W33"$"VQ%L4B9FN]GPVYQ;;$]4/,#
M()2 @M10 8
M                     "4@"@   ((    2"U+P"LE(()XI/L%2D$%C!1UP
M%9*0H  *  %
M                        "4@"@
M
M
M
M
M
M
M                                             TZ[5%<8J;A.+T=$
M8:"4VG6RII5"V:5!(HC5<9.74O.3%E'#3'-E"4%(J=;&FETQBXQ@2)NGO,8B
MC,J@
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
J                                                    ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>tm2227887d4-tbl_selct4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2227887d4-tbl_selct4c.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@!2 0N P$1  (1 0,1 ?_$ 14   $$ @,! 0
M       &!P@) 04" PH$"P$!  (# 0$! 0            $" P0%!@<("1
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M6/;J&/3Q4N&=ECZK?XP;_"WIAC_XASW\PZ,H?U#[_P!5D,M?C!P_^5?3%^%
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M01]5O\8-_A9TPQ^! Y[V^4=&*A_9]Z/JM_C!WE]UG3#V_:'/7S#J61_4/O\
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MOY@T90_L^_\ 5'U6_P 8-_A;TP_A0.>OF$-&*E_4/O60RU^,'#OM;.F'V?\
MW!SW\P]FC:MU_10_L^_]4?5:_&#OX5],3X/M#GK;U.T?0M_+HQ=AX(2P<C\4
M#EO\8.#RVSIB?N#GK;XOH.C=>BE]6("Q]5O\8._A9TP_W!SU\PZEE#^H??\
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M;ZL(D[ACR$=?$P,V_P"R-?7HJQD) D:L']@Y"#_]H@>]<1*(>756(WT*EP=
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MRWMNV>QICRHL4(@B"B"!T^UR4P*"!1 5-5T\N';YP,:<GMV9EPF=WP9>7,
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M3;Q+$PLX0E.K1P.$9QY2?BY826($?S\S$'_%QK#%NG",N,2#L1*6D=>1U)
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M3HQ]F0/76TN5G6'BR*A"2+GP&0G2.7Q=R' L&JP9IP&_ZH1$B"0 !+Y29DB
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M_P [6Y*V0UYB7]&L5?6.C)5MED-XW3CW3]PB1@T,U%.06;HG[VM[N5M6;_\
M5%%4 ;\KO8A&0^'D!B53A&,A\0G&,3,_W@.3B5<1+GX7FXW:OIC)LG*->/B7
MV3#.TA93 S,=08\M&#RY3CH8F<HI[(/'7.^'Z)4*=<J->+1-R?1PY2<?62],
MK-AO$?"9*/8([(]>Q?*2D$QD",WT;2XH(Q@JOW$Y%XT(W0,==1,AM#O5Q-G<
ML(SE9GRL[$39&)(MECS-&3:3XF7E3,I%YM*<]:R1T/I^-?D864T8T_XGW69@
M=/*KOYSH@ ' '$FN,8$B/ D$&<@I,,'S_CI<LAS6:..N9<X0?)GB3QEQOBN-
MQYB"8R4)5,=XODX.\X*NZ!6Q6F/%)*US(R@+32C&+<>E&\1<%VWAAL]]JLS\
MWO79\.H?XOD]WR;J;' C;7=1551<+"6$:;*9G0DQWA BSDN7VC*_B=L[-W*-
MAACT8<8SB/GKLG?99H(_*+(2JJE(@F7"42.+$2&X,\>;IBN,BJGFFM(2=WK7
M!S >,926?1YYID@@%ZY#R4MC9"PNTG#2:5@(E]%M))%%4Y5.X@8Q>X=,1GZC
MLCFXO<*:)\X6X\!;(?\ S$X8O V$D"0YR>;$:.Q (6+"IIQ\O%R<:OR::LG+
M-5; >5"_+,JP "0#7'@),6)BP8)W^F!6K!3>!G':KVFOSE5FX.LV!@YKMCBI
M"#F8=)*\6<6+-U$RJ#9^P*G'G2\)-1,NR(E$H=T0UL=PL-IHR)R,[Y8&'R)U
M^+^-3S]_.<M=]_%;&1"BONF?5CQ$*8]QO$!';RXW9,8Q/^[&/V#P"GEV;]N_
MY>M!5]B-_B;[ZA%C13IT4*.G_P#AC>I?Z^ .'/QJBX_MZCKZ>I!\OO\ U7H'
MU*A&B(T1&B(T1&B(T1&B(T1&B(T1&B(T1&B(T1&B(T1&B(T1&B(T1&B(T1&B
M(T1>93 ?X83K'>?>0X@_68D0TZIT5GQ-O((!VB/;OMY0VU(;8['\%.H^*):0
MV]1Z'W*%O**MWBIY"PMREQSC2T9HF\,,<CTJU8KICR(:7&>QUE%A K3$_2DK
M!(Q41+6JJ3]+C3IQJBZ)I%DX<D34*L1$#:\*Y8G<[LVN,C_)Q(T'@.1'EV1M
MKDS%V,2)Z%P7T9;-1JNPAC$1_DUY1N@9R:+SI--H<L 9/SC(EHR#:\F41N3=
MVY/<QN)G+&JUWB#EG%=-E<-'@Z-6,N,H9GG;)^27ELKZRC2'QY5K/8V5<J=>
M@(UT!U7CE5S*KND#(>$DW6\6V7CB^>'G90IE7+NN#,<6F95PR:Y666$$"$H@
M!HF/P[N5L]HRH8V0<;D8QKP<J,I$ 1E(T61B(G]Y,Y.9P(!&@ <+:\Q>*.5L
M]S\M0\=M7M+9V?IV9-PO&78&@(5N$O#W).(9N$HLB^3#:,]O8JN.D/8D.5)I
MXRH%4!,2&ZO=I3MJ[E?42<C_ !#MV5&#L;1BV9U]D0=0# 3KXAF+APQ /(^G
MS'MP[37'EPKHS:Y3ZU^=@T51F"VAC/S!J_P\P7.T3,'<7^1]IM%AN]\K7/)&
M2Q3Q5SWBMJSY1Y?P;9H&5R!D*BA6RT#"54Q?C"-E[M0')T$7*$XM)Q2!7#=N
MFFU4,537([Q$97TUWJWMPE/)[C@V45^9$SR;(<OY'S$C@8SB#$F) Y3 'Q:;
MO8HPP^^=DQLJ5?'%[C5<9P;RZXPKX2F#X61(B8DMQ,"22-9-8$P'E*M9KZ7L
MY,8NL,1 8<Z?UJQYD*2=1/AM*!D*0K>*F:-5FU0W-&S[I>-?)^&'LC"FKV@'
M>'7<R[J9?4?U!E52![?D8-,:B#M$9<N3'9Q!N7A\71:7$6?3O:H!QE?XQ=?,
MN"P.%<('7H3+C_=^/Q 3:8IQKR%XJVW%'(H_&G)^:X8,2Y?PA:L:X]2KALLX
MP>RW)&Y9(JML@JG99J"9SE8O<7+H)R)VSM)1DV;HKJ$4)NGKGUW>36<.T&0S
M>V]IA"?6%N+BF%V+,MH#)RWA&3CX5FOKCEF5M)A&6+W7N-THDL)5YDXV0OAK
MK.)KXC4EK(']R963Z=G(NTNN(%;F8^1H;U*S<SLWVY.!0A[MC?#UDR79(S*&
M,L+7EP=JK%6BC.[(V08RS9N"*<DF5R@BH1(P;TPI7=O[A_0F,B[ ^G\2JN;F
M,,W*HS:+IU<XGE&,(R'ES$N4/X]=D2\'4=PLH[I_(ME5*&/F]]G-RTIT4V8&
M30;H @#G;8YG\/&?G3B?F!*NYHX[Y/\ *FD,;:MQDR'7KK(\#>1^)[C0FL2K
M(-&&5GV;, &:U:!=@*0RL1;HJG2,E!K%#]=Q:0G =RCOFKCCQ[T<VOE9@7Y/
M8+XRF->$,^Z^V%A#?'3#B+6XN_(LY?<Q;O([4,:1C'(Q[.XP$($<)"6#.H7Q
M=S&%TI0 K!XD@DN1%I_\L^.=_P Y5I+&-$.XIJ]CX9\C,1-[D#,0A:I9[@[P
M$2LP\BJ@(':)RJ%:?)@4@"8&[98Q2F,4"CH]\H&=F]POC*%U)-$P>MG#*C<1
M%M(S )'(!M92E$DE:_T[ECMN-APM>NB!,)< T81GC1C*1W<&R3';VJO;C+Q0
MS[;<CTQQE6H\W78X/PKE>A3L/RXS1AI;!4C9<@X_2HI*#A8,5XJ2LURQQ86Q
M!.[E_28DD2BT:@"+E8/#UNY<Z>YX'<+:ZZ[9Y./Y4(WG^K*<KOY$_CTC P\O
MG7,AC(<8C<+#1YV#GX5,YSC#%SAD3E2!PB*X2KKFV\WE>TX@\N.KI^^G;4>7
M^-,A0>+WU$S[CWC!2:!*1%HI_)Z;QI>4Z+>&7M4A4:CQ<RC33-+K?\5-6@JE
M])G6J:*+9(I-O20W#:%_\O$NR<R^^T3X"BZS^EDSG*7)[X]:XUEX[.P(8,M6
MVBFDU0QJZ8V^8!="OX\<0$3SG6[&,Y7 B0)+$GQ972FVW'M\O;\+U_. ZT)Z
M2(<EBSG<MHY]N_O6XT02(_)T]G3[E53U(?X[>DP'J]3WCD._P)4_Y.HZCT\%
M7]I]OZJY3JC_ (-CGS]QYR,^M-:]0I3%8U_BWQW_ />'3?H<C-#NIZ):[]FW
MK[_&VT4+(#M\?^SU]2-E!"R!M@VV_P!7XH#J!H7&Q9QT+%Q]^_B"0DOCCQEL
M-O$>]<O%'UQ#L';<=@]4-O)L(ZF32E.PAK;)1,C'X>7#0 @:&+$N-]M=$,1(
M1C( U@DL=?B.@F#N)1&@;3U*L5+G3?F?4=EN(,Q0ZN3#X1];@H?([=W+$MC?
M*-HQ?-Y4@X69;K.U(0T),P=,F44#(HIK^DMT]Q$##O7M!'=!F47R,,G&NNAC
MMM(5#&E:'_;*,,KG6(:&$9F0(U&;/C=B?PY80Y5VUUV7#Y3$77YE=1T^(@68
M]4)$G0VAB'"UT/U$7;CG1EK =BBJ+5.-N*\39-MDAF>7E)-I++6_#DCBMID?
MTM1PZ3@6E2KKC)AV)S B9P9_'JAX@@'<U7M^95?V_)[CFF%=,IBVE_B/EV9%
MN&'.AE.[)Q[95"+N(P9^8)V[.WVU'#A@O9DF=<9DL.)G3_,,78?!51+&LGS)
M86D%N+I3S_4PPE9L(\C;]@:0E[/=\'X:M>78FMY%QOD['45<8.#;'(RL5>7M
MM?JREQI:TDJ@DJ_B%EDB"X2_1"^*F)L'<,O)Q.W_ .(" %D;J(2J/PV@SMC$
M"RO2496 F420 6U!XE:^#BX]^97CV2)\R$I"4?BB3"LV$PL'P2:+<A'Y!J4Y
M60.?O'O"K;&3/,EDFJ_9+YCNJY$EDZUCS(-UK='K]E9 *5@O=BJ%;GH;'U85
MD4':3=W-.&B:I6:P@803,;78SL>BCNV1VR,HB%%\Z1*SX83,)283.T+(1C'1
MB?AT !7)[5D9&=V7%[J($Y.53&TPJ<V D1Y2 ZPYD@[/\.NJV.;N?_%;C],U
M^ R#D-\XE;#5&%_10HE)O.34H;'LHHX2C,@VMUCVN65I4Z,^.U5\*5D#MVAP
M3,)3B4!,&G+S/.LP[A*%M,^-GF_TXUR<.)W$&/(O$PB8RBQA_><[U0KNKISJ
M&GCSKL\L5#S)6QGQX2C4-9"(AR)<-(S&IB4Z=*Y+X8R-'92FJ5;T;%"8=:0S
M^[S4;'RB\2C&V#'$1E>&DH5Z#+PK(P?T2=:O4U(\7 &!3P_\* D!F&/;NWS[
MEDB7\2%E_,2_<<8P%HUT9YQ8[%W  ("I@_\ Y2[G5VRAO\1M\B<&U:.1*0!'
M4'X2&\7&X*8>C\VJU/9*Y/I6=U 5[!^",3X!R]#9!72F6LM*U?,5%E[JZ=34
M<[[[@JK1LQ039-$&I'9SK D9,RHE*$0>GM^9DY(/G8_=I8(A'4$^518) ER)
M2E=&+.8CC)HMHMS(K$LG"A20!E]KEDF4AM"&3;CF ;]L?*%G+^[&1V"450Z@
M/%Z[8UR+E.,NEBCH3$Z44>_5NT8TR/4LGU\;&]2C*L4^*K+5XO(;T]ME%B-8
MDK>/5]L7)RI(]X^Y0R6Q--5.5D"4L>?]&(B'D)N)&L@//S!'@8Q)(8\M1&0.
ME7.7\H89!A?Y4[(>86B:8M+S2=(&,G:5@BSR8%R$X_'KE3ACD_$V.4Q)8)I\
MZISYA&VZL6ZFW#'5VJKJ6:G?PY;!2;]!5RT1:4RR3.LT55:@DNFF82&'8=AH
MD,0S!$JK>4>42)!R"#R(TC8Q/PG4#5F51=&=PK@9PMJK(U^&7&1!:/\ >K).
MI8/R(6Z1PK%!GEQGZ1N60)V82I"U&K%#F)J-<8TH;:2<0[BS3]-@$(1M)L+1
M;PK[)*1=+OW13HH 1)-(IC@:E<I0.2Y>.28\AL!"'Q0KB!M$6 6=29 :MHLN
M1&N^&/$0KK.-48Q,!QY2,)UFVS4\I^79* .@ )T)+IYQ'< #U V_LVV#0R)B
M(EN,=O?J?M.J, 7'5ON C^ "-@W#U//V@.WP_)J%*R(;;^?UP\GP]%"K$ZM'
MV-V*ONQ>*OUS&_E^%JLOE^U9*S\?V?B%<5U,OP='._[D#D9]:2V:E8SLJ[>G
MM]@GP[]?C7AOZ!(7;X6GJ5G8^G@IA#Y?[/[-M3MHHWU1^1J$6/R=%/1&BA<M
MO4[1\_G\ODV^!Y]2R*"_(#/N<:YR@P+QJPLUQ.Q=Y<QQEK($K:\HPUOGVL67
M&SBKH(QL=&5*S5=8329;"83**K' @I]A?+MBPIVY>?EXGPQCC8<+HN=;3.\T
MM'H  'ZESKHMC*JAC=OQLL"<[,C+\DM\M8\B5W*9_P!J/EG9I.#J&39\I^5?
M('AKA=K>,J%Q)=K7=LK8\QI1%,9XBSM+0-?2LCYQ[I9JX5J G;Q;[ >.B&IU
M&#-BHP.]=@5L4YU52%UEG93_ "ZNW0Y?R9BXSD8$PC&NKF(AM1.4B Y+1CRL
M(XPDL!D*L6_N,0+,6JN+1Y1C,RF91/(2TC",09\C\VD1J0F7P9U=*1=LB9P:
M92<ML>8KP=4,>HK628PAR I%PR)D2Z-HTZS.N5.[0A'\'XTJZ5:Q-8.A(V*7
M2$'J1O14EC#(GR[>,@\C;+.EBU5QB9V2-8A8.<AI;SB;)>7'C+'%?]1S(*#B
M0A>>V0$9#^+&ZV=AX1$)S(<<@#4($5Q%DRUDID0#,[EY/S#PKY1T"(Y 9 SM
ME6IX8XZ76)=Y!Q)88^VXJA++>U)6M6+'+#+^(K?1HW)=CD$)ADS=5UBW!ND_
M55,7N.=Q*6U<Z>V9F/W2,H2R"9BB$#S(LAS$N(&IR: 92((TB(D@"))L!9D5
MSP@)1I _J6$?\B1$6,BW*F9$8F0V)(U)TT>=>KQA7'E-P==<=P60+G%9,Y#P
M^&[DQE<,YMA[;0X=)DWE;2\>4@]'1LY+D,++,',)$KMTUYAN\\=J1<B1BZGM
MU<;^[X7:)Q'\2ZJZ<2W,SE"+&'EEQR\\U&XM_0C/E(D&)%13&CM^7GP:61C1
MKC7$R_IS%EH;XOV0#<(3+FPAAJ-9&6#J0\1*ODPV*;#D:9B)M&5AZ]+V-]CG
M)*&-*Q;)]-FI%T^X90&IC0:I;%3R39-2/?2"+I!9<J:I2*;E":8677^7$_\
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M%@VS#JJL&;QDY/4N^GLU.GK1N.WD#R^7S^KMZNVJ@"(,:P(Q,2-/7OX[J?\
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M)''ON?R' U9D\R+D?+4?CZ/A\=8N;5RQ3SJ[56))3G+SVS23:MUEDF0)E[1
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M&^S_ /,2%U*E3$]CZOQ0'M]8/4TW1<?C:A%D1W'?U=$6-$1HBI,ZF.&H&_\
M*?BM<\J<0\V\NL%5'&&;H>W5C"E-D+?)PMOGW]-5ISV028VVD^BH@#%T;<S\
MNX;^P/Y U,$5P[WG#)@91L[=175+5HR&3*RQF(W@WLZ=5NY$S;V'%\DB,QF\
MYQZRC_&E'5_]><3IU]2UE%QYCA?']7H_%S@1R?XMQ4-RVXQY.N4;EO&[NL(6
M./A+RT"9LL4LXR3D-VY:5*'8>(^-N@DV1,4_E$=>B[799'+[;DSDU--V6T6&
MALPLB D20Y!EQC\3@.XW=><[G"NW$[A3"L2R<C!H!D_SQJS<>0@P(B&!E(D
M2+,_0H7DCQCY%6/D+R1S+2J/EAW!TOE5QHS)$1V.I&&J-\R92ZUQLM>-KA)X
M8GK6U=5^0O%&E;*55N@L4 <*)J($,"YDA#D]KR1VSM=$K!=.([IW6$Q6?ZG#
M+&#PL 8DR/EF)$3&0C*0$HZ@]3NN/=W+/RZXRIJC;VWMIB;'\N4Z+LHSKD00
M8CC.N0)>+Q 8O)<)S!^=<IUU'D!5</<LI]_B?D+QIRE'XMYAVRALLRYNJF%
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M^DHPT@S>DD'#ITJZ.) M],2.-WGLG<\GR_X^*]>1R9X66U\)-$#C'$>4A*R
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M,*)VBR=F/*/Q>;;$D,\OC!B (_"L/=1"/+NYJ$LJ6#&'FP(\V=@A(0JMA(&
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ME.=%#% ]2/@)]N#Q^'_UCP ?^$ZG1&1[Y'P$\G\\+C]_G'@?FC571NJ ZD?
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M/KW_ +?R'V#P"O/XR92U)9_=M]BY>^2\!1 -^8/'[<!$0$<C0 [;AMV?KD1
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M ZA$>^1<!/MP>/W^<>!^:-2C+'OD? 3[<#C_ /YQX'YIT1D>^1\!/MP>/_\
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M&B(T1&B(T1&B(T1&B+S?\5,"8-SGUDNLPWS7AG$^86]9=<.UZZAE+'-0R"E
MJR^'G9912$3MD1+$BCR1&"!7 H 05P03 ^X$+L3^Q7#>]_<#?M)>(OWMN&_I
M,T1ROBDN 7 ]&.?JI\)^(Y%$F3I0AB\;L- 8IR(*&*(#[C.P0$-&0DLNF&X!
M\$7$3'++<*.)"BBC1$YSGXW8:$QC"0-S"/N+ -Q'4D,5 )9;/WOW@9]I+Q%^
M]MPU])FH5G*/>_>!GVDO$7[VW#7TF:(Y1[W[P,^TEXB_>VX:^DS1'*2CK@3P
M6);HYF7A7Q)!JK'J*'0#C=AKPSG*#T0.8ON+[3!W ^(&ITXOU523R"5?O?O
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MY0[XE7324(8FCZJ2-/6M35,@=2+'BC)OD[BSQYR75#J'*X<<;N1LR%ZB_%<
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MQA$#BSR$B20YE*1!YRD\I!@2T0%GR+OY6?=W.\"69?K(G;2)C  =(P!'&(8
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MDUFHP+_/D)4DU04*!3+"D7<-]]"W3= [^I6F@8IOS(@/P! ?R-0I080 -S"
M ':(B.P!L/8.X^OHBK,X9JS2'(WJ;QE3!)>C,^8=:<Q82 .B1[:W2_%7CM*Y
M);PRI$DTUDC6MT=9UW3' K]5<!'O=XI0;W(7]/!1$ZRIY@<K]'SVS28)E#JI
M<=O"%FHN83&],7W X*@ ;#YMNW0L^B:\3[1^:L ZHWX-CGSZW#SD8/Q,36OU
M.W1%('#JEG'$.*/T"(!O]3FACWA4=BL"7N9B1,82[;"<";]GD$>P=2&23N6\
M5";HZ"NYX.5R9GR&+DNQYPY8SN:Q<$2))?5F=\I,P(Y#;RA4=R O'338S5
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M\JYWAL?OI(C8?8S*U31>HIG.'?49MR%W$J1 !UU4_MTW?[M58#XEN_Q>"_\
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MF7,3QX'4P]S(Q)A2]Y0(^H[%J*:-8Y0U/$D%9YNEY8KXHD2-/,(<M>LJ*I'
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MB+-I(VNVV%\)"*.31\8V:MFC-!G&1[-NDW:-4$2%3 A+^Q2%T4)F.0N!\?\
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M" #Y0 =NT-PW[=$2?K  ,0B.W_P[SM\_[+6\_JZD[JL=DH=0K(T18$I3!L8
M,'EV$ 'M]7M\^B)ALA\?,"9&N%:LN0L(8AOEC;J.4F]@N>-:9:)M!)LU56;I
MH2TW"OGZ2;=;V1 *H $-VAL.IW!='(9O%/DU:-63=!HR;-VC5JD1!LV:HIMV
M[=%(@)I(H(I%(FDDFF4"E*4 *4   #8-0B^C1$:(HP9-X;<9<JWEMEJW8?K
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M?8%9Q?\ [.+B_P#<[<Q1^)>.'&G52-CZ>*EYJ55<#%*(#N #OMO^1^1HB3T
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MW[/S5WNI54:(HL\WVXNN'_)9N "/C85R$GW0#??O5Q]\?7/[MKVO)'_L+/\
MPE>I^ASQ^LNU2\.X8_\ [V*\105,=]P;*B.X[%$NX>?UMO)KXIQ/5E^_SD,'
M=<O<F?\ Q,__ & ?VM.(5/Y7L^U8"I'#_<1_A%_U-2P\5/\ *"] G0FB!BWG
M* 11%'QV^&0V,&W>\-7*?:'8&_YO7NOHG261_P#T_P#[:_-W_J%L%D.T-T.5
M_P#BR]"VOH"_-2-$1HB-$1HB-$1HB-$1HB-$1HB-$1HB-$1HB-$1HB-$5#/
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M ^SBXO\ W.W,7Z.>&_\ ;TZH-C[?R*EYJ558'R?V>;1$G:[MO-B'D&?D?SY
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MRQ=%&;F01J&-J)!).)BS39F31197NE3;-$""LY612 3Z$@;J "5'!OR9Y>W
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MQ4Z^24:.&4<Y!$SS/7-]US<G&\D@QU!?T]/]-K^LJTUQ.<I"B<P@!2]HB([
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MLJE#Y+K=XI-&M6-(>\2Y"Q\=))KV",2DG35N[=H"X(<,%F+96'.H4<?!U9.
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MUBS4['N0L85!_+N4TO;9%O8HF/%4GIKY$O?4)@MP[*ARW 4==/'T]/>K/2'
MX=X/)O\ V? UJ(J#>DO^$!ZXWW5^-/\ (N2-1U5CMZ> 5F^0/LXN+_W.W,7Z
M.>&^G5!\I]OY%2]'L#?U-2JJN7E9U/\ CEQ4OJ&&Y",RCFO.RT0RL#C"V J4
M-[N4! R9%CQ4S=9![)5^E42/EO!V:C+RK-5R4Q3IIF3,!QULC,Q\4<KY ?C]
MBZ?;NS]P[K8*L*!E(O[/M_513A>M;C&G/5E<V\3.8F&:;)R2LFXR,]H^.\HU
M2M1SU1/=W<&F$<G9'M\&V8)F\1VL$6NW03 YQ4$A#F+KU]WP;I"$)_%Z>++I
MY?T;]0X-9MNH/ :EB#T]2N@IMRJV0JM7;Q29V+M%0MT%$V:L62$>(R$1.P$X
MR2D8B6C7K<QT73)^Q7(JF<HB!B& == $$.-BO-$,3$[A*;4J$G[5:ZS1J[,6
M^YV"%JE4KL>ZEK!9;'*,(2!@XIDB=P\DY>7DW#6/CH]HB03*K+*$33* B80
M-]$57COJ@XUR*_B[#Q[XY\R>3N.(AX8WU7L+8%=N,8SGLVJJAZ98L@S^/UKR
MS2%$">F1#=XQ4$X"DNH4#"$NP3BY!<*7G&_F+ACD^C86%'<VJIY$I+I)ED+"
M>6:G+8TS7CY9SW#,'-JQS94FTVW@Y9)0#L99N#F(D"[^C.E1*<"PBE/HB-$2
M9N%TJ&/:Y*W"^VFNTJHP+11_.VFVS<96ZY"L4A*"CR6G)ETRC(YJ03!NHLJ0
M@>KH 3H$48^._,;B7GFP3]2PCR<P!EVUH.GL@K6<:Y?H%UL)8Y =U9((6O3\
MA)J1J??#=R5(R&_D..LED)P;D-PJQ!'L4PM8U9&B)C.0O)'#'%?'$GE;.MWC
M*+2XY=G'HNW@+O)2>GI1;T6%JE2K\<B[G;9;IYX((L8R/;N'CE4=B)B "(02
M!NK0A*R0A'YBH<PG+[DIEZ'96JC\))6HTMTY;3%8_G"9NAL2Y%FXQ,BBC9Y)
M8VJM#RR^IRD@F/>2:2KUK()@(>D-T##W=:TLN$"RZ4.TY%H\#[/3TZ)18QZB
ME9E\P5GCYR!PKE7BSER].7$;C4^02UNTX@RY-,V2T@[@<89IHLO,U:3L0,VJ
MJJ,3,)P4RZ33$4F9A]CK+&Z$AHM>_!R,<$V#X7;T]'5B^LJTU2%Q:_#E=4G^
M0#A?]!*NHZJW[/L_-7>ZE51HB:G.*'I>'<FM_P#;Z+94]O+OWXMP4.SU>W6I
MW"/+"NC_ .SE^!77^GI<>^X<_#)J/_?"HP]QAA'\P/\ V)O4^!MKYUY?K"_2
M?\SUG[5CW%F_N3?$-^4 :>6?$)_,]9^U'N,-_<C\0WY8#IY?K"?R_6?M5A_
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M58BOI$/7%6?= CQ0P8[9<0WBMK$KYV@G9U.TH%3*!"E#N%*4I2EV* %*  4
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MR#N%8<+LK/'<:L+-:8%ZI]=EF[MFK!267[%?XBMJODQ4<-HEX_.B3O@51/)
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M:ZZIF+U--=RBO.ZF,Y1T&R8-/-_5-JAH^IVG@GQWR79E_&1+D+&O,=2DX_D
M34.FE)'I^0,,/KS"E,D4JRS4BD@*??[B2ZP@(C!C)ED\XG;T^Y*W'_$'+V<K
M*URIU"+'3KJI#S<'/8TXH8ME)Y[QGQ9+5A\G*0=QLCB=BJ_8,\Y/0E4BN$WT
M^U3A(HY"^U\6DL4'(P(Z?%J525AEM[U9D ;  =@;=G9Y/A>MJRQJG?/5*N/
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M#4*RHCZTO\:O1V_K5N.WRXXU'53T4[>J/^#7Y]_<=<COK26S4J%*7#/9A_%
M?^C6B_0O%Z@;*TOF/M3E:E520EOWSUS^\>?G.SX^K#8JI^8)7ZJK(T1&B+X)
M7YUR7R \^5U-2-U!V6GIW[WV?]\Z^6U]);H-O3UI3ZA2C1$:(D58?WP5?Y(5
M_5&^K#8JIW"6NJJR-$1HB-$2<JOSG)Z[R0^75P_*U)W4!*/4*52UUW/L/\5_
M=K<2?KH,]5EMZ>"O7\WV?B%,;J9?@Z.=_P!R!R,^M);-6"QE:CI9?@V^"OW*
MN$/H @] K%3VT4),S/S[K/R1(?*R>K#K[%!Z)3:JI1HB-$1HB15$^<RWR<?Y
M49ZM+=5AM[TM=55D:(C1$FI[?TRO;?\ VLGO\#8-2-BH/3VI2ZA2C1$:(C1$
MCJ:/ZUE/6EW(?[!+5I?DJQV2QU561HB-$2<DOWP5OX$Q\II[:L-BJGY@E'JJ
MLC1$:(OE??L)W\BN/U(^B+4U7YP1OZ6K\L+:'=0-DH-%*K(Z@?\ '?TJ_P"L
M(;_Z)/*G4J1Z?85(+GW]@GS5^Y*Y'?6=N6H4)@^C9^"YX1?R&5[Y;D= IEO[
MA^"LQT4).3'SVK?R8[^5#:M'8^Q5EN/:E'JJLC1$:(C1$GJO\YT?T]Y\M+:D
M[JL=DH=0K(T1&B+22/SU@/DA_P#*"NI&Q4'<+=ZA2C1$:(NI?M16#U4E/S@Z
M#="DG1OG(/R:X_.I?E:M+=5CLECJJLC1$:(DQ.?/6M?)Z_ZB75AL5!W"4^JJ
M4:(J"NDO^$"ZXWK<KL:?Y%R0.H5CMZ>"LYO_ -G%Q?\ N=>8WQ/=QPXWTZH/
ME/M_52\U*JL#Y-$2=KOEF_V^D/R2:L=@JQZ^U*/559&B(T1(NR_/JJ?)ZOZL
MPU8;%5.X2TU561HB-$1HB1=.W )H!\TJM\75I%U2.Z6FJJZ-$1HB3%G_ ,#$
M_M_&_P#SNI'Y*#^:4^H4HT14A<6OPY75*#_T <+_ *"5=1U5OV_9^:N]U*JC
M1$V^87 -,5Y$<[B'@4VPJ[AYNY&.! ?*'DUT.T1Y]UQH^-]?_B";:JF[W9B
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M["I!<^_L%.:?K\2^1P?_ *';EJ%"8/HV?@N>$7\AE>^6Y'4!3+?W#\%9@(@
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MTD;"=&2CJC0,?P'AFM.4,F6,'"=2H%;*KNDD^EUVJJJ[A0#),6+=PY4*)$3
M-+[J\>J5UI KB')*V,'"R.XY<,/%B97V28  DDG8,.I7D?R/U'^H9GQ-S(W_
M #Y(8592CATY:XNXV)LZ3 UB,<G S.'?9!?L)+)EMF&C8"D=/?;%BT65[PHL
MVY![NOG?</J_)LN,>W\1C^+$G[7;[E^J_IS_ "([-BX5=OU)*RWN,AR,83 A
M ':,AQ),QU+CIH%I<=<Z>?.&X]5'&G+2_P OX0BZ9P&<6%>S7573HISJ^BRC
MFU19<A-XUVH/=4+&V!@<@#N00[0'!C_5_<:[ ,GA*E]=-?6VK?<NAW?_ "-^
ME<W'LEVR613G\?A/F P#;"8,22_1I#[%ZO>FWS=8<Y^.L7D&2:UZNY>I4J]Q
MUGR@UYT^<L*9D^"*@JY]J_;3:2]RMO@WC.<ACK"HH,;())G4.LDMM]&Q<NO,
MQHY-!>$@#Z>FB_)_?.S9?8.Z7=ISH\;Z9F)];=1ZCN#U#%0FZTO\:W1V_K5N
M.WRXXUM+E=%.WJC_ (-?GU]QUR.^M+;-%"E+AH0##V*=Q  #&M%[1'L_>O%^
M?0;*9?,?:JVN0G+/)^2N1TWQ;XO7YICYG@UM$S'*3,:-+AKE*P<U;V",C0,+
M8Q/:@E:4WOSZ$%69GGLA$S"$/'G9) W,X>;H:.9F#' $3\17H>Q]E/<K.5H/
MD^(T^_T^],+,<:9:R3);)9.5O-:6LOB**%EF?).XTULB<ZACB5M4\>DJ%#9H
ME _=!)**(EW=@$H[!KCG/RGTE\/@O:__ $QV>.AK)/B3K]S#[E]-@Y4<C^#,
MC W[)%SE^27#%B5I'9CG+?$0ZG(+C['KN/10RVA8ZE%5F*R?B6N^.52PLW\<
M>Q1S3OODGSI)([<N]B=PE,^7:SKS7>OIH8T/Y.$)&K<OJWV :*\^)EXR<B8R
M=B)!E*0\S'LI6*E(]RB[CY&-D6R;Q@_8O$#J-W3-XU6(HDH0QB'(8#%$0$!U
MV%XXABQW"H!D,A6/J.Y,O]EL4NNEP6Q%EU2HX7QG& U2B>2MYPS/NV%IS+E-
MX"+EU:L7P^3(TS>JP(*HQCQ>%]LWR3@?14TN+W#+D/Z,#H07(^Y>T^G.TP(_
MFY ESB08>#@[[:MT;[PIFD*1-,B1"%*FF4J::90V(FF0H%(FF0/8D3(4
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M$';-X@DZ:NVJI%VSELN0%4'#==,QTUD%DC 8IRB)3%$! =M=%>?7TB(!VB(
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M*NAESQ7)JX.VX?E'4>XK\R_^IGLF#F_2^'WZ4(Q[C3D^4)?N-9KMF8D[D<H
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M!A$ DM]R>KJF9PNN-^!/(BQ8X?S](N+VN5^F1-T8F,RD:D7(MXJU D;'&/2
M)V$I$15F77:N"^R;N"$4#M*&MVXF%9D#JN#C 67QA(:$KZ,68SI&&\=4W%N.
M*_&U>D46!95ZN0<6F";9DP8D[O>,81.JY>/%Q.NY<*G46<N5#JJG.H<QA\S8
M3.1Y:EU])C"%=8K@ (#9+_;?LV#8?]</B"&L6Q8;%_N62$C&3A1/X22Q,/\
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MY)SW0H:5%7T13+.2LNP&&UKDVC_8-'4Q1J#%2#$C@X'59(V<?#$HN#"-,DD
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MUF4N[/(Z,",^JZ1DD+F<'XHEE?%,/>)Z4 F$^LV5+^19"RO^G*$HF)CH8\
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M&LC&OT$G3&08.$7C%ZV6("B+EH[;'50<H*D$#%.0QBF =P'7DR""T@TNJ^L
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M>)V  'J 4;>+7X<KJE?R <+_ *"5=;'5<[]OV?FKOM2JHT11.YW+@UX9<H7
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M-6&Q53N$K=55D:(C1%\$K\[)'UV#L ^"+=3;4C=0=EIZ> A7V6_9N9UV>?\
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M[DZ!R]S10<&Q:O*/(=$DKOQZK2L"3'V14FMAB%'5P8V SEV!9YF0L>]%$?#
M!(8 <M9#<Q9VU8&,9!_#YF]H(Z*2#%A( <M1]I _\)4^B=+:./WO_P H#U2P
M !#;;FK:Q$0V\HA[G@[H[[A\+0%R8]1^?^@J?:/Q7/WK.-_I >J9]^I:_I?U
M9-/#\?U1[UG&_P!(#U3/OU+7]+^B:>'X_JJLN='#;EWB/E#P H7'+D]U4\BX
M7S#E:0K_ "BNB6?<L7U+%](2N6)(MM-N+3 PZ41CLBE?L4XX!W(E.D<6/B
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M:=,H2Y:RC.,93C)HE,Y\.5ELPV)&VF UY$>?P%4B0P,9FR )8<)R$9.=5:$
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MVN@$MA(B-F5H%R6X42X4"2]/0:-'J@H1-TAH.2<L_!>$ %TTC(F/WB@;O$,
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MFY!9$91YG7I-/NZ^*E*U*@X;+MR@_"N8QK\N(M5% 53\)VE^B$+ON7<HY(&
M!)'*1BSGQ??1M1J%2?*; ?" 78:]&9R^[#[_ !)4HPWV#?L'8-P]0=0I6=$1
MHB-$1HB-$6!\WP>WU_6U!?HB@AF&C5?+W)Z)H;ES?L?6Z P&_M\9EO%60IRC
MW,D+)9#;0LC2'S=EZ1 S=><N6"3T ?-G1V[@NZ )"<YC3$<,/*R#.48QG0)Q
MWC,&&1*+Q(()AQF(EN0YR (!+K)M+'KE&,A8,DQ)W@8?QA(Q(8CF+ XV/").
MH!"<XF8KX[9GQKB3/M?J60%O:VY7JYUI#)60[7:)$<D1UIL=(F<FV9BK9G\!
M8;R])$*%:OW*:YV#$R:+4K<I"D)DA7_#-610! W85<HL/EKRJQ?*,7^4V>=+
MS9#X[23YADLF9"PV9';\L\S7ER$^CV46",78!Q7*N)A'Y(F(E$ ZJQ/R:QK&
MC1$:(C1%\CY-RJU62:+>CN%$E")+^&17P5#)'!-7PU! A_#4V'8>P=M8[8SE
M5(5'C:VA\"IB0)Q,@\7U'J5"-KQOU1L3SDNIEOE#R/R=C]W)O%X6Y<4<7\6K
M(_@H15=8Q&%MQ%D'$B%V5<LVQ2?HL,^FP7 =NX!_+BJ\NNB,,ZS^N(GXN+@E
MB-1$&0/AQ@W4RBP?/<]MTIX<6AR!$ 6+> ,OA/\ O2?P!U5A'3O#'"F#["^Q
MOEJ;S(WDLIVIY;K):L4TO#-NB;T6*K3.>JULHU(H&-F#.P1";1 RZKJ.,^4!
M8H*+J$*GW=TQ$:*8PA&-7E?"8EXR'*7Q#4@.7<1+.#U=:<01;:)F1M\SXA(-
M('C'26@+LQU#L1T93QUC61&B*&^>,GW&L<F>&V+HEZR)2<Q2^<V.08AW%1\A
M[<M*7BEW9X!,CATW6<,2M)A(JA_!$OC![ ^Y1VTP3"S.R:;CI7VV5U8V:V.9
MAUB3C4D5V6!CIJ[<A$C:G57_ (1/(XO;_-HJ?_4LIRI3BVWQ&N'1]&!8R??\
M1,XV+/>*96]6R.B(B1CLK9DHA&\&DZ28'B\=Y,L=*AW1RO%W2P/G,="IG<;&
M @KF-W2E+L4*5//!PLQ_BR<&FZ4?"5L(S(_W7(6'(B*<R_%'RTV<0?'X8R<?
M]IO<I4%,!@ Q1W ?(/QM76-9T1<#@(E,!=MQ*8  ?((B&P;B(#L&^JR=B 6+
M*1NJ&<@8YZH.-[K;']PY <A;WBUS9)1]6K#Q<J/$R?FJW6'LBLXBHB=Q/E##
MC&VNG4-&J$(JI&2\R=8$Q$ $Q@#6+#$:<.%.4;#D1A'E-@8D@,6$1&41X@1F
M">L1H+VQE=<9XYCP?2#D'IO*1E&1/0DUD.P$CJ;#N"UY@<@8GE9J%Y,73E%X
M-QF(R5MN0:14\?6^HS;)"-1D\>SM8J%)H+:.DJXZ#]&(X8BX*HJ)14,0I-MZ
MZ!&+C6< *K*YF%@)(N ML!GN0.,GK:( (@),223I52 RLBOS";(3B)0( -9,
M(_"2P))&IY$D$L&9E-O6!;*-$4%.<F,>9.0ZS2E^'6;HC$-AKL[(O;I&R<=5
M3*WR!<QZ*;.*B[%:\>9-CZY)1[U QDSGBS)+>.(*'(4@;X)F<+HS/&6/Q(E$
MRX[L1('C+D0Q' F,2[DO$++'RC1*N0(OYQ,9#H ) Q(?0%P>0!D.+#215=E,
MOV:<=Y)Q[5.6O,OE_@*SV"XP$77:WD;$W$^T8FRM)J2<> 4^OY@Q;A1S'B:;
M6,+44W*L+)E34!1,A1$#AOX$H9&8*\:$K9\)$0F.)(#.>49F)9PS3Y'K'9:7
M</Z&#.S(E&JH /;#XHQ^(!Q&<0>K'E!OB<;$B_T!WW]81#XFM?=;"SHB;;,-
M(IV2L59#Q_D$Z*5)N=.L-;LZ[AV1@DUAIB+<L7KLSY4Z:+0S1%85"J'$"$,4
M!'L =:F92+\6<.9JDSB8WA(:QF-=XR DVQ9CHMG$NGC95=]8$IPD"WBQV]^R
MJG@<O<RL7P<1A^(FN$N8PKT<>N4;DU9\]Q]06B8!LV1CHU_D+$S"*DY61M)F
M"9#.PA9--FZ.@.YB"?8-N^V[N'FV9'_294HGG,,03-FG"(TAYD@)")'",F^%
MAQ6I75BX4*X4 V8D2(UP)U!B/EYES+C%^IF0^KE6!<1<5US$.'6%=A+VPRE,
M3=AM5XR%DJ-/'';WC)=QF5YNZV $XE=Q',".99T8B+5(W=;MTDT_*41UFLE"
M%./AT5FO"Q\:%50=VA'JYW,Y&<Y$:&1DJ@FVZW*LGSONLY2.@U$8UQBPT'"N
M$(@> &BD_K"LB-$4 <H7#)EUYPXSP#5;_)8VH=.P^XY"WXT!'0*\[DYPG?6-
M.KU 5D9R*DU(NI(F;.'$J9B"3MR15-$%4BCN-,&,K9=PS[#RQL044"LAN5N3
M7E3\YPTFIA4! /P-D_B!(63* JQ\00#79$\@\MP(T?QQY8!T>9O,I'<1B&(U
M47L65/E%A5?BGD3+&;\PRUUR1GNUXPS)B2]7.)ME&=56W?5-6I+NJ1;5D(P<
MI7FD)$/_ !$'2OZU*N10"@)@!"ZG'RL/MI(MED=N:R6IXY=>'#)M+D.(^97;
M2 _$^;$@%HD;6?'&NM[AE8@X8M6:](V_HSRA3&#?N^"V,GD\F@[[JY_5UHHT
M1&B(T1=2YQ(DH8H[&*F<Y?/N)2B8 VV$1 =M5E+@#+4L-OT]?@H+]%4%#Y6Z
M@V4'&'6L':<7UO'G)UO+7&*RI0\92UCF..-8A(1U:F%2LB=@E)BI6V<MS3T2
M-))/48U)!\5X0C<YBH;(Q)C*N<I1MKQ1?&?%X7&7DQ\HZ/$B5WF1XZSJKDQ,
MG:\I0JE*9'/_ *F5'!_DX&9\V1T>!C4:Y#<660+@*77"S-%^R[1<@1F3WD#.
MWK#69\A80L5SJL>$36;XZHKB/,VMT1$@X>%B1DH^61([:E653;ODEB$-W *
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M7M\FM4;*5RT1<#E(<HE. "4=MP'R#V@(>3U]00"&.H**E?FUTY\<,JIEK*N
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MTW2L%*N&7I34%@\9-%8I#B)RF,.2<J+*:,O'Y"C)HC;$2W )(;P+$;]=]EB
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M%1W(C'1SEX#!LF!3"JX>"CX:90 1,<P!K4[AE2PL"_-A$SG33.8B Y)C$R8
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M,W3YY"9;Q\I@7BT^R]TO[;4&1S58Y\,YQG3Y<LK1O'R;M)Y7:&RI,-5YNV+
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ME5F:987U1M4G%/(*8<5^?:,95F1\D4VP*I%-N00\W9NQ$:NS=NQ 0;*<>X2
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M0$KS2[;=F_8/G#8?R \NJP+CWG\51<M71(G(\=.RU$MT968.H66P/J]*M(:
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ME1*5,V[CP$)1LSX2ABFLD0<>9.1^5P"?+ +$B?QD?L (D=2^0E"56)(2RA(
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M$1_FY%%$I\09B-ELJWE+YI,#,N2"06Z +)3C5Y]V2+S+CAX^1:(N>)-&,<@
M1^4&7$0!;0[-JKG43F.7O"  'L0  '<0';V0#V!V!YM4  )B-P=?L'Y+'$\@
M)="%W:E2OF==WP3=\HCL!MN[V#OW#>J8OE#LUKY)/\>P1?EP/X*T/G \2RIG
MZ=[OF,VXDXZ3QM6.-;RE%F\IA"+WJZY1B+2HD.7+X9P:4CJ_CV9B&Q@=]\$P
M1<J 9("F-L81 -RZ5WD8'GF)/^%X(TWUQ*=]/F'[O7U*SYG\>7=^X&D2%4NY
M93;#3SYLVIT;;U-LK5L7*Y@6KRYLTL,;QMJ"37*V0Q?,V:=@#PP-VGHRKAY:
MX"N2)),[KQ_$3(@*14P(('$1, 8V' #7GU6KKR_U?O3EZ*4:(JB^KHSJ5EQ]
M@;']WC>0$Q6[?E]X\E8_CM:Z]"6_VOH="L]^?RCNLV6IVEADEG -*Z=\E!E]
M$7<.6Y#)'44(1%32Y5?XUC1M)A&NFZXV.\:XPE1#G* >1:5T/CB)<!R)B76U
M$6?X?;"KC*RZRNF,&ULE,62$(R) '(5RTD8QD6!G'1V8CZ;3*IC/$/)C$_/C
MF]GB@R.9,%U".K4CG>G$J;WW996I]*=0]SAF^)TWZ;:#/- 62AE"LW1R)*-C
M&;B8#E[F+5:>[58]O&9O%O$AI0EQINF# N(ES#0\F!#[CBN>90E@9,G-?\:F
M<I CXX& ^66['XAT(9B'T*O5;CNBF.^^Y>\ ]O:!A$0'M[>T!UH:OKNLHU (
MV(7=HI0(;@(#Y![-$7SMVJ#4GAH(I(D[ZAP(D0I"]]9119938H 'B++*F.<?
M*8QA$1$=5B#$",?D 9O4/0(PWZ^GZKZ-61&B(T1&B(T1&B(T1&B(T1&B(T1&
MB(T1&B(T1&B(T1&B(T1&B(T1&B(T1&B(T1&B(T1&B(T18$-P$/5#;0[(HUY]
MXNTKD![G922M&0\9WVG'?C3<L8?LI*7DJKMYAL1I-Q<=/'82K-U"3:2*8NF+
MUHZ:*J))J"GXB:9RX!0(V^;$D2XF);3E$D%I>+$/$]'+;K)YDN'EG6 ER .K
M29G'M&_BP?9:'!/#^E8.LDG>ULAYHS/DJ5A"5E;(V=<@N;W9F=<!XE(KPD(@
M@QA*W76,@_;(JN@81[8[HS='Q3'\(FVP2T!54T*Q)R -9:'0DZG4O[0L$8D2
MYV$SEJS[!PQ8#0::*6"9 3(4A=^Z4 *&X^8/)JD8\0SDZ]=U?0!ALN>K(FNS
M5CA#+V),DXM<2KB"1R-2+12E9EHD5=U&$LL(^B!?H)'42!8[0'??\/O%[X%$
MNY=]PT.XXAS<*W&! ,P&<..0((+.'V#AP_BMG#R!B9=>21R$) D;$CP!U8^!
M8L=64"H;D_R<JM?BL/K]/C,4GDF%K[:I,++!6?&!^/,BYBFB4,TG5+^YMC2=
MAJP_,B1T+92&4?-VQO#$AU"COOY;=SNNMK'DBPS)%OP@<R20./+FSG?@_1G+
M:E$1A5UPL)MC 1#UEY'BS$\N/$GQ:;%R0='EUQ/P@ZXZ<?,6X:>3B%@?46 4
M8R,HR9J1\:YD7[]W+R!(M@HNLJSBF;U^HBT3.8QRMB$ VP[@&?*M\^V$@9$0
MIKK>1>4A77&L2F>LI"/*1ZR+J(@RLMOE&$)77VV\8#C"'FV2LX0CJT8<N,?4
M.FRD9K KK AOY?@_$[0^/J/8B@WG>0S/AG,+?..-\&2'(6IV;'->QY?JS3;#
M PF4*B-&L5SLE?G:E&6EY&0UPCYTU[=-WS('S1RDHT;JD%0HJ 6OG>2)5SC,
MTR,3RA\1! D#$UL.0((XR$QP/)Q+E\-YQ\V$# Q\ZLV,#H")^7M-_A(X:ACR
M!&S:M=3V.8N6/(3!V<K=@RW<:\9<>E+U+UN,RHX@ S-D*UWJIO:>^8/:Y59B
M>BJ=1(=@\,X,==^Y=R+LB/=123()ARX<88MM^?,O;9A3QHP#AHV7472G,]9#
M^/&,(,/+,IRY2< 8,B<KJ:\(1'EQR87RD=2)UPMA&,1T<6RY2?XHDP9B7LT*
M4"E H>0 V#;R:J[ZJX#!NBY:*4:(C1$C\@5US;Z/;JHSE7$$\LU9GJ^UFFA>
M\YB7,Q%.X]"30+N F58*N 6*&X;F( :YO=L4YW;KL,$QE;7* .NDI B)T(.A
MUW6W@7PQ<ZG*L@+*ZK8S,#M(1D"8G?23,=#H55/@KE&3B=B:D\8,G\6^1,=D
MO%D A2(>/P_A^P9,H.3V\"B#1G<Z=?JZV]R[!"V'_7*Z$TYCW;5XLJFMW^Z*
MQNMF9D>\7SNQZX0G.7&56T*F;X(G;RXC2)X_*VQU7-JHG@4PCEVSM+_\66LY
MDES*7KUUU4RN%5(N=1Q18I>\T=OBR:RCEC).6T\6-WS:3''<;>IT\A'5Q\]8
M'-&J3:C=,'TD1K^MD9%XNFF)B$ YL55 P\*C \SS31&P<NC3OMMC"+N3&J%D
M:HDDDQ@-@T1O9=XRLNS($!",A6-W,C"JNN4SH-;)0,R&^'DQ,B#(R^U*P(T1
M5E\L*1G:*Y(TC-N&E./+XI>/>1<,3,'G++%@Q@L4+=<ZG9 G(%:#HEV&3!DG
M7 2.50J)0,KY=:4J;;<?/P7^#.IJB9!WAY(R "W5QD/N&X]>6FZ,BL8]$"#Y
ME.1.8\#SC7$#U,8>MWZ,DQP61Y4X?J&%N.]W9\/Y3'E!JP5AY:\;\A+?:LBR
M*<;'O'#1XPI#W$\%$J"N[ @+$&1*"*/>.!C"';V+KH9MTLJ0XR\L?#'XA\(A
M#?30LY+:$MKNN;+G5.46'F3OG*0)9O,E.SP?KH---5:R4=RE$/()0'M\O:'K
MZU%E7+1%\CTZR;5PHW1])6(DH9-MXA41<* 0?#2!8_L$1.?8.\8! //V:Q6R
MD*Y2@!*8&@]:D &0!+1?4^I>>:V<9,IVVWS5N6Z1EBAO=+-24_::W2>I1!T2
M@7*2EW*CJ5>6C'U5<Q52F!F%53&=$69B5<3F\0#"8PC-8D("-IE.L1 $)GG&
M(Z1 .C : ,S=%:T\I$Q($G/Q1'"1U=R8L23OKKZU=7QRD+K(8L@4K[@B+XX3
M,2"L,TQ-#7*L7R*KL)%+*L8,8Z?I\?&P MG4:BF<B"*11;E,!#=H:VL@QE8+
M1,V&8#DAF(Z=7V]GV+6I' &OB(QB=.K^OTU3\ZPK,C1%7#S3X<QG)6U5&QOL
M#\7LN^Y>OR$2>7S]*9)82T(DYD!?&8P0T9NJT-%'V\17T@P'*IY.S?6 F5)E
M8#"(X@$G0&(Y.^[L#H[;G4.LCB50K+DB4B![>&VG4P#_ .S'332M_B%@^FK\
MO:^OAG@_P\<T7#D^8USY68CMV3CUZHW!)B^3<U+'+RS%4:7ZYQ:3M$KWT9(T
M>R!P9-5P58AB%W<"VN['E>)S&'Y8A4X^*? <1\)_Y8 $1,$B3$@&+$X>XQLK
MNA7*).89F=H.G SES));64B938ZAP#J[>C[6'=61HB-$1HB-$1HB-$1HB-$1
MHB-$1HB-$1HB-$1HB-$1HB-$1HB-$1HB-$1HB-$1HB-$1HB-$1HB-$1HB-$1
MHB/)HBQL >0 [?+HBSHB-00X9%U^$GW_ !.X05-N[W^Z'>V[-P[WEV[ [- X
M3\O3\A]@79J41HB-$6AM,0>P5FQ0*:Y6JDW!RT0FY,05"MCR3!PR(X,F4Q#'
M*B9?O" " CML ZU,_$_G8-V%RX&ZJ<.3.W*)B[.'9W9Q[0L^-?\ QLFO(;EY
M=D9-L_$@L^K.W@JJ:WPJY>UBI\5:>RS!QN<1O$F89S-'<O,59-].L2K''=JQ
MP@E:CM\J)(G2]K;4JY,#0K;]<)E ![G>*/7EFV3RIY<P/,GBFD@.(Z^5\8#D
M_P#*'PDD/(ZZ!M6-54,6S#@#Y-F0+2^I<7&X 'HQ(!.Y ]9"LGQ>VS VA71,
MSS.-YFR&DUC,'&,:[9ZU!DAA;-P01=LK7:+8_5DRNP5,=0BY$A3,0 ( @83:
MIX,.((/5R_Y!OO5@[ER&Z)S=54HT11;Y)X C\TM(R0>9?SEBY:IQ,ZHS2P[D
MUUCY&;6=I(K@-@2:LG)I<S,60>!N8OA%44_N]<_--F/3=ETD^;&@D#H\!,C3
MVD/KKH--UL8_"5U5=L0:S8']A,01]FWM4*^GA@!S:</<?N1UNY(<H;A>):"<
M3\O6;3FF0F:!+/5G,U#^%(U)Q'=UTU30[JI4C*^Q6(4V_9MKL61KHG0:P)6R
M[=BRD3_>MQJ;)EGWYR/]JYE,Y6B\3)$(YV3&/^Q7DVPK\?V1B_Y*W8H 4I2A
MY"E  \W8 ;:U@   -F6VN6I1=:J8*IF3'R'#8?+Y-_6$H_'U!#AD_!03<\.<
MC0$O828:YA9GP]0++9)ZSKXUCJGAZY0M9>6B27FIUGC^6NM#EIZI13V<>N7A
M6X+NDT%G!_" A *0N*FB%./#$ !QJXQC ?W81?C!^H@"(PT>,(QB- %ELM-L
MY76![Y2<RZDG61/B9'61)U+^)4EL(X7IN L>Q.-Z.604BHY:0DI"6FW8R5CM
M%FG7[F8M%PL\J8B0R=DM$V\6>/5@(F0RRH@0A" 4A=NVZ=O$285PB(QB PC$
M;1 Z#K[23U6O&N,9SL _J62Y2/C)@'/L $1X1 &P3M:Q*Z-$1HB-$42>1?&6
MR9JO&'\ET7-MCPA?,-'NY8&>@:;2KN1ZSOL.SA)IH\B;Q'R46'ZT9AX:@)&.
M43"(;#L.L,*I5Y%F17(B5N,:9#IQ-E5H/3:542VQT\%-G"VFNFP.*L@71/\
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&C1$:(O_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>27
<FILENAME>tm2227887d4-lc_pt4comp4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2227887d4-lc_pt4comp4c.jpg
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M\6)RLD,T%H*2)36B4W,7TF,V"<)49#>#LT1T)^*31288_]H # ,!  (1 Q$
M/P#?X0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
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MI-!7WE8QYQNWI3FJ11-V$W3H=:<3U8S5C37FX#C2G=Z%DI16D>!2VGP.:D!
M$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
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MLC!H[C4=O</=5WI7F*4.%-2N$;JMO_Y9Z:NE 0! $ 0! $ 0! $ 0! $ 0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M0) XE115KS!U;R[M+.WDN;VYAM;6-I=+<7$K((8VMXETDLKFL8T =I-%9OY5
MK%2G==(OF51M3OOHMIN7@CQL7J33N9B?/@]08?,6T//XTN,R-ED(H>3XWB2V
MLTK&<O?4BBNWK<86EE7DXV*5J]%]I$91\QXJ_P"I7+G]A(VH-[]G-*W'L>H-
MS=$XZZ>YS76EUJ;"Q7#7-)!;)"^];)&06GM [%:LI92_46)]5CV:K[2Y<M78
M-6+\7&X^3T?WDN_[2/3XYP(W;T'5Y#6C\*L)Q+N  _LWB22J$K7GJU!OSY<
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MSE*[1I/\KF>FKY2$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
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M! $ 0! $ 0! $ 0! $ 0&J=])QRVJ+;1G3GB[":[ATUDM:0,SQA$QMWQ_.#
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MG8[\)0NXEZ7&OTRDVN.OB97VFK104'H][@O/>!V]:ZG) $ 0! $ 0! $ 0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
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M/4^JN%(0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
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M2M.-:G8UCY26KL/Y2-KTU:/N+@;CSPV.JM0-M_$BFO;L2C+W=K+X=LU[W1R
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MU[>-> HHC;<I>9S)DU%5?!G-KFNJ6FO97M^!7.*%**OB<T 0! $ 0! $ 0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
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M^7%UA_ ^W#_O_P"1)U#RUXC\N+K#^!]N'_?_ ,B3J'E+Q'Y<76'\#[</^_\
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M^7%UA_ ^W#_O_P"1)U#RUXC\N+K#^!]N'_?_ ,B3J'EKQ'Y<76'\#[</^_\
MY$G4/+7B/RXNL/X'VX?]_P#R).H>6O$?EQ=8?P/MP_[_ /D2=0\M>(_+BZP_
M@?;A_P!__(DZAY2\2#_/'U;%#/<2](&X,<%M#+<3R.-\T1P0L,DLA)L@*,C:
M2HZM:$>6ES+A/+N\X_:+S!]P=:;;:-TOD--:DT,1'F;2]N&3.AF!B:^)P#BY
MKF/DH:@=BK>A;HG7I=:&95" @" ( @" ( @" ( @" ZTT[(:NFDBAA:*NDED
M9&QO"O%SR %1<5IQ4)-*X^"\2%U]6B^5'DR9O3LW*U^<PY<#0 92SK6M*?U>
MM:J;?G0BX*G6)1BVI>![4+XI(VOA>R2-PJQ\;VR,</2U[200D8N"I+21/4I:
MK@4YW@W*Q>S^W&K-R,U$^;%Z3Q%[E[V)AHY\-G;R7#P#W'EB*JT)2JZ&O;H#
MZ1=HS>*?40V>Z?-6Z]L],9.\QF4N\9<2RLAEM+N2T)=[-%<!O.Y@(!IP*ANG
M$JBHRX/0J)^7'U?_  /]PO[_ /D2A2TJ5>6O$C^7&U?_  /]PO[_ /D2=1/E
M>T?EQM7_ ,#_ '"_O_Y$G4/*7CJ/RXVK_P"!_N%_?_R).H>5[1^7&U?_  /]
MPO[_ /D2=0\KQ8_+C:O_ ('^X7]__(DZAY2Y,?EQM7_P/]PO[_\ D2=0\KQ8
M_+C:O_@?[A?W_P#(DZAY2YL?EQM7_P #_<+^_P#Y$G4/*7-C\N-J_P#@?[A?
MW_\ (DZAY7M'Y<;5_P# _P!PO[_^1)U#RES9 ^>/J_\ @?[A'_T_Y$E0[:7,
MC^7&U?\ P/\ <+^__D2=0\KVC\N-J_\ @?[A?W_\B3J'E>T?EQM7_P #_<+^
M_P#Y$G4/*]H_+C:O_@?[A?W_ /(DZAY7M'Y<;5_\#_<+^_\ Y$G4%:7-G'\N
M-J[C_P#)]N%[O]O\?[R23I&M*A6T^9;MO7Y@NQ?4Q80XS??RXM1ZXMK=SG0N
MDAN[&Z'.'AX?<VN.9+,#XCOCDT)5JU2<JT<7[R[*5SIZ7-N*X)ZT]U3S]D>N
MWIYZ:([MFQ7ELZAT4;TL]JG\*[R4Y#.0M\*6[QKS :Q-XLH>':LE[CE1C^EB
MVK*\-"S+!M-^?)UN?VY<"N>K_.+AW%T]?:2U[T/:RU-IC)PNM[_#9"&\EM;B
M)S'1EA:ZP<&^HX@4]*Q[V'C9T>C*@II:Z^/O+EJ_?PGYF--PEPT\"Q*\W*\O
MK(W%S=W7E/9_QKN5\UQX-YE8(W2RO=(]S8X[ -;S/<3V*VKBQVK,(MQCPUJ7
M;BG>7G7)+KEQTH7$[*>8%L3TVVUQ;[&>7%J31#+KE\>5D=Y?7#N7DH(YKG'/
M?#0Q-XMH>"V%W)NQL=75IX+1F';PK,I:4^)<3^7%U8YG+_L>[@EI!;R4O^4M
MI2E/8:4IW+'Q:9<6YZ+VEUV5;=*T2\"T;>#K"Z6.H/4-KJS>?RR]2:LU):RQ
MSQ9/GR-B\S1/=(R22.WL&QO<'NJ32I[UBV8V\/,<[<>F3?'BOL+DK]Z]#RYS
MK%>)7[3?FV:?T;HV';K2G0;JS#Z%M[#YKCP%M;W;87V!C$+H9I6X\2S.?%P+
MG$NIPK19FXWW>I^I_-BZ<5IIPTX:%K$L=-QSLOHFN?/7VC07FVZ?VFQ\^)VP
MZ#-5Z.QEY.^ZO+?%V]W%[1<R$N?++(VP#WESW'M)"NW+TYXT93DW"*TCX? L
M1L1CDM)+JEQES9/GY<75PX_['NX/-W@>WU_67H6,W2"DHZ,R965!T;*5Y#S2
M] Y37UGNWD?+[U-=;FX]H9::O=;WC<E"&@-8>=M@"\AH[Z^ZJL:]."=NTW;C
M+BEHG[TJ(IG#SX*U=:E;7"O+W>!57\N-J[]+T?[A4[O[?'#_ -"[E+>H\FFE
M2/Y<;5_\#_<+^_\ Y$HZAY7M'Y<;5_\  _W"_O\ ^1)U#RO:/RXVK_X'^X7]
M_P#R).H>5X,?EQM7_P #_<+^_P#Y$G4/*]H_+C:N_@?[A?W_ /(DZF/*CXD/
MRX^K_P"!_N%_?_R).ID>6O$C^7&U?_ _W"_O_P"1)U$^4N3'Y<;5_P# _P!P
MO[_^1)U#REXC\N-J_P#@?[A?W_\ (DZAY7M'Y<;5_P# _P!PO[_^1)U#RO:0
M_+C:O_@?[A?W_P#(DZAY2\2/Y<;5_P# _P!PO[_^1)U#RER9#\N/J_\ @?[A
M?W_\B12(\M>)'\N-J_\ @?[A?W_\B3J)5I/F/RXVK_X'^X7]_P#R).H>4N;(
M?EQM7_P/]PO[_P#D25(=M+F4]W#^D6:,V:.GI=X.GW5VA+'4N3L\9C+O)3RQ
M,FFN[MEH.7VF*W#BQ[ZD G@%*JW1(I:C'BS8,V<W-Q6\FVFDMR\'$^WQFK\/
M9YBSC>0YS(;N".>,$U()#) I3KQ*91HVD5/0@( @" ( @" ( @" *&Z*KX ^
M;I&@AO:2JE%7(U_=*7-)TYG6N+RPM!XMU=VMJW_E+FXC@;]65[1W*U"[!MVH
MM57(GH7\3[SJQ9S!2O$<.9Q,LCS1L<>1M)'N/=RL;,7'M5?3*2^?4G1'J'E-
M.\=Q!]/HHK<INTU%?2*)DF;C:XQ>VVB-2ZXS1(QNFL3?96Z (!='9VTMP6 D
MCB_PZ#WU<K15)2JZ& /"^?D-8.RUYH7I>UQJC3V/RE_C+?.63[J2VO76%Y):
M221.AMI8R"YE>#CVJ'*CH7(VU+5/0]G\N/J_^!_N%_?_ ,B4*3\"?*7"NH_+
MC:O_ ('^X7]__(E/4':2YD?RXVK_ .!_N%_?_P B3J'E+QT'Y<;5W\#_ '"_
MO_Y$G4QY4?$?EQM7_P #_<+^_P#Y$G4/*\&/RXVK_P"!_N%_?_R).H>4N;'Y
M<;5_\#_<+^__ )$G4/*\6/RXVK_X'^X7]_\ R).H>5[1^7&U?_ _W"_O_P"1
M)U#RO:/RXVK_ .!_N%_?_P B3J'E>#'Y<;5_\#_<+^__ )$HZGX#REXC\N-J
M_P#@?[A?W_\ (E/4/*7CH/RXVK_X'^X7]_\ R).H>5XL@//'U?\ P/\ <+^_
M_D25(5M/F1_+C:O_ ('^X7]__(DZB?*]H_+C:O\ X'^X7]__ ").H>5X,A^7
M&U?_  /MPO[_ /D2=7VD>4DCR\OYU.1U!9S8_4'13K+,6%Q%)!/:Y"SGO(I(
M96EDK.2XQTC1S,<14*AV+>36U<BJ25'_ *UJ5=4\>EVW*DDZEC>6WPZ%L_J]
M^O\ +>5;J.XU;+=B_DR8O,O&TW8F]H;((!8\H'C&M KN-;CM,7'$^7[RJ[.Y
MN&M]J7PH7G:>\X>UTAB(<!I7H6U3@L)!:"PBL;&PF@!LFQ"W\&66/&MDG!@
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M+(P@CCWIU.OL+GEJNC/0_+C:O_@?[A?W_P#(DZB?*]I#\N/J_P#@?[A?W_\
M(DJ1Y:K1L?EQM7_P/]PO[_\ D2=1/EI\&/RXVK_X'^X7]_\ R).H>5[2/Y<;
M5_\  _W"_O\ ^1)U#RO:0_+C:O\ X'^X7]__ ").H>4N;(_EQM7?P0-PO[_^
M1)U,GRH^(_+C:O\ X'^X7]__ ").HCREXC\N-J_^!_N%_?\ \B3J'E+Q'Y<;
M5_\  _W"_O\ ^1)U#RES8_+C:O\ X'^X7]__ ").H>4N3(?EQM7_ ,#_ '"_
MO_Y$G4/*]I'\N-J_^!_N%_?_ ,B3J'E+DQ^7&U?_  /]PO[_ /D2=0\KQ8_+
MC:O_ ('^X7]__(DZAY2\1^7&U?\ P/\ <+^__D2=0\KP8_+C:O\ X'^X7]__
M ")51^8AVZ'DYOSJ<IJ?%WF!U%T6:YS&%R4$EKD<=>1WLMO<V\K2R2-[76)%
M',)'IXK%NS3FK5R"E"O/4JAUVY*=N3C+Q6C)&V]\UK1NS^(O]/[6] &J-&X3
M)R2RY*PQEM=QQ7K[DN\<STQ_KB0/(([%G94IRQE"[)SM+]UZI?!Z%$5U9?F5
MI??[_/[>)\-$^:+M_MAG<YJS;KR^-2:5U)J9_C:@RV.MKJ.YR,I=SETCACZ@
ME_$TXJ,6Y*6*[49.%A?N\OL*<NOZA2N_/=_Q/B54'GCZO/\ ]'VX7]__ ")8
MRFI:4+KM):U)#U[YMNGMV<?!B=S>@W5FL<=9S-N+:URD%Y*VWG:[F9)&YU@2
M"'"O;15I*$U?Z4KL>#YKW/BB/FZ':4FK<N*Y/WDU8?SJ\KIW&6>%T_T7:YQ>
M'Q\++>RQ]I'>QP6T$;>5D;&ML0*-: /2IGD3R)N5QN5Q\6]2B6/#%L_ET45R
M1(>YOFJ:*WOQMOA]W_+]U+KO'8^9MU809BTN)G6D['![9()7XYTC"'-[ :*B
M$8VKT<B,5&]'A):-?'B9.+*[<L3A"XXVY+6/)DZ:>\Z2]TCB+'3>E>BC7&#P
M.+@9:X[%V4=[';6EO&WE9$QK;$ @- %>U9ERY/*;OWIN=Q\6^+^TQ+6/;LPZ
M+:48)\$4]W2\T3;_ 'VP5QIC>#R^M3ZQPMSS>+!<VUS!<DO:YCB+R+'-N*%K
MCP+B.-:56'=Q+%U)7(U2\-#)C.<'U*>OMU*&;2]4W2#L/J/\+MI?*^U!IG4@
M<7QY&5^1R($CG-<YXM[K'OA+@6"E05EPOW<7'_3V94M+E_<RW>LK):G>?4_N
M^PO)@\[K4EA$RWL^C775I RH9#;0W<$3!P^+'%CV,;\ 6#^HG<E\R;]Y5'&A
M6B:1]QYX^KR.'1_N%_?_ ,B5YNA#M*M*U(_EQM7_ ,#_ '"_O_Y$G41Y2YLA
M^7'U?_ _W"_O_P"1)4A6T^9'\N-J_P#@?[A?W_\ (DZB?*7B/RXVK_X'^X7]
M_P#R).H>5[1^7&U?_ _W"_O_ .1)U#RO%C\N-J_^!_N%_?\ \B3J'E>+'Y<;
M5_\  _W"_O\ ^1)U#RO:/RXVK_X'^X7]_P#R).H>4N;'Y<;5_P# _P!PO[_^
M1)U#RO:/RXVK_P"!_N%_?_R).H>5X,?EQM7_ ,#_ '"_O_Y$G4/*7)C\N-J_
M^!_N%_?_ ,B3J'E>T?EQM7_P/]PO[_\ D2=0\I<V/RXVK_X'^X7]_P#R).H>
M4O'4A^7&U?\ P/\ <+^__D2=0\JO,?EQM7_P/]PO[_\ D2=0\JG,Y-\\75[N
M<_[(&X(;&Q\KW.=?-#8XVE\CB394]5H*=1'EJM$RJ/0MYW6T/6SU 9?IRP^B
MLII'7^#CF?DK&_N&R.MW01QO>Q["X2 @O(XM'8IJ_@4-+5)ZKB9Q0 !0=BGB
M4D4 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0
M! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!0TFJ,%G_77U.XCI!Z6=
MV=_LM+;1-T/IJ_O+!MS+%&V7)/M9Q8, EF@#S[0P&E>Y:_.RGBVW"+2NN245
MXU_LS.V[%CF9"C+2W1MOPH?GO;#_ $K3KRR'4CHJ#<N_Q4^S>HM>186YLA@[
M>U:S$9#.16L+ADG7#(W>Q6LG*\M>>*W>UV%E7HV;SUDOV&NW&YY%N<K*^E_@
MZ'Z4>V^O,%N3H'26O-/7UOD<-JG XO,VMW;2LEA>+^R@NW-:^-[VDL=+0T<:
M$+&S[=S"R?*FOGZJ?V^!3CW(7["N1^EK[R=ZAT9%: #M''OK^<J;E5)-<RY%
M-_+S,('GQ=<&]/0+T9YO>;8:>VM=8V]U!#'<7=M'=PV\,C9O%N70S2,:[P6M
M#J=IHN8W7='@;WA8,-(Y4I)_#@;K P+=[;\G(GJ[*5/B41^CL^8MU!^8UT]Z
MSW!ZAKZTR>>T[F(K"QO+.RAL(IV.:P22>#!+(.TFE:'BN_S,*.-@X^0OJO)M
MG.6,F;R+MK]V-"T+Z1_YO'5IY;VM=B]/=.F3L,/CM<27#LW=7V-M\B97037'
M+:QB>5G(Z:.'@>P4[5QNVY\LO>LC;_W;3C_\1O<C%A8V^UETJ[E?N,_?EF;]
MZ[ZG.BO9'>W<MT<FM=;Z<BR&:?%$R&-]PYC"7-BC>]C ZM: KJMSQ?T>6\>/
M!)?>C28UQWK?F/CK^)?LL R @($@4!/;V(/9S%0%1*Y"*K)Z"A N:VE2!7LJ
MJU\RJN X<1S-IS5X>GZRI<E%586O ![":!S2??"JXD57#F1!!["#3T)[>1/.
MG,$@=IHH<E'BQ2H+FCM('OD!*H$ ]KN(<"/2IJJTYD)ID/$94#F;4]@KVJ')
M*K\"7HZ/B<U-4^ ($@<2>Q!Q=.9Q;(QXJUP(]].'$<Z<SD"'"H-1Z5":? $4
MJEQ 1-/@ I! D 5)H/24!Q\1@X\S?JIRKR +V-I5P%?=5/7%NB8>G$Y5%:5%
M?0I33X$T?$%P'::*5JZ+B0VEQ(J*JM.8/G(0&FO <./PA0Y],DJ:,AJJ,)7G
MQ=<&]/07T4:AWJV(GMK76EE>6EO;W5U;17<-M#/XPEG=#*]C7B)K0ZG;P6BW
M#)N8VX8N/:?3;NR:;_ Z#:L"WE8.3DW%U2LPJE]I:]]'&\RWJ0\Q[9_<S5W4
M3D+3)Y;2F1M+7%WEG8P6$<K)! V5WA02R \7FE:'BNROXD;.VVLI?5-T?PK_
M ''&V<R5[<KF+3Y(1JOM1LM56K4E+@;,)55IS 4@@"#V*')1='Q"U(HY).C>
MH($@=IHE5U=/,>WD*CTI5,&L9])'\SSJ7\MK;39S473ID++&7^M,G?VF:N[V
MP@OV1QP";PJ1S2QTJ6#LJM+=S9VMZL[?#Z+D*OVNK7[#H,';;61L^1GSUN6G
MI]B+_/)1ZN]V^MWH6VZWQWLD@GUQJ)MQ\X3V]O':QRAD=J^-[88GO:VIE)[5
MVN];9':[EN2XN-3C,#,_71N5X1DTO@VJ_$RY0BC>7F!([O1Q/YJTTH_/U^)L
M+>BZ>:/LH*PH;2X@*4ZZH$*CL]':E4"*BJX U:_I)GFF]3WELZ5V2R/3ED;'
M%W.M[V[ASEU>X^"_:&Q2738VADTL9;S^"!P!6ELYUZ_W%#:X?2Z:>-3=6<"W
M+9;VX2^N$J+V:(RR>4=U+;D]8'09LSOQN\^&77FM,=/-FI((8[>-\D3+=S'M
MAB>]C*^*30%=EO6"MJSEC</D3^VIRV#DO-QW<DJ?,U]E#)9$ &CA3_?6GZDY
M-+@C.C7I5>)]$33X$D.84YJ\/2JJ.M.9%52O(@U[7"K34*)?)]6@BU)51$D#
MM-/?2JX$TJ<0]CJT<#3MXC@CT57P(33;7-'.H5/5&E:Z$G'F:30$$_[E?S%-
M5T]7[HJJTYD00:@'B.WW*J4ZJJX !S3V$(_EU833X"H[%1UPZNBOS"A O:#0
MN%?17BKE&15')4MI<20CE%:-@*00J 0*\3V#TT3BJ\@10!155IS 4@( @" (
M @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
M @" ( @" ( @( @]A0<" <TF@()]"FCI7D'HZ/B<E35< %(-=3Z35%'+Y<6M
M&R,:\?.V)X. /_=9Z]H*C]Y$M?ELN,\B'#8+(>61T]R76"PLTD>,O(?$DQ5B
M^20-%J\.D>Z ND?63M/&G#N41X$R5&9@OP7TS^QW!?<C'_)U44C\%],_L=P7
MW(Q_R= /P7TS^QW!?<C'_)T _!?3/['<%]R,?\G0#\%],_L=P7W(Q_R= /P7
MTS^QW!?<C'_)T _!;3/[',%]R,?\G0#\%],_L=P7W(Q_R= /P7TS^QW!?<C'
M_)T _!?3/['<%]R,?\G0#\%],_L=P7W(Q_R= /P7TS^QW!?<C'_)T _!?3/[
M'<%]R,?\G0#\%],_L=P7W(Q_R= /P7TS^QW!?<C'_)T _!?3/['<%]R,?\G0
M#\%],_L=P7W(Q_R= /P7TS^QW!?<C'_)T _!?3/['<%]R,?\G0#\%M,_L=P7
MW(Q_R= /P7TS^QW!?<C'_)T _!?3/['<%]R,?\G0#\%],_L=P7W(Q_R= /P7
MTS^QW!?<C'_)T _!?3/['<%]R,?\G0#\%],_L=P7W(Q_R= /P7TS^QW!?<C'
M_)T _!?3/['<%]R,?\G0#\%],_L=P7W(Q_R= /P7TS^QW!?<C'_)T _!?3/[
M'<%]R,?\G0#\%],_L=P7W(Q_R= /P7TS^QW!?<C'_)T _!?3/['<%]R,?\G0
M#\%],_L=P7W(Q_R= /P7TS^QW!?<C'_)T _!?3/['<%]R,?\G440'X+Z9_8[
M@ON1C_DZD#\%],_L=P7W(Q_R= /P7TS^QW!?<C'_ "= /P7TS^QW!?<C'_)T
M _!?3/['<%]R,?\ )T _!?3/['<%]R,?\G0#\%],_L=P7W(Q_P G0#\%],_L
M=P7W(Q_R= /P7TS^QW!?<C'_ "= /P7TS^QW!?<C'_)T _!?3/['<%]R,?\
M)T _!?3/['<%]R,?\G0#\%],_L=P7W(Q_P G0#\%],_L=P7W(Q_R= /P7TS^
MQW!?<C'_ "= /P7TS^QW!?<C'_)T _!;3/['<%]R,?\ )T _!?3/['<%]R,?
M\G0#\%],_L=P7W(Q_P G0#\%],_L=P7W(Q_R= /P7TS^QW!?<C'_ "= /P7T
MS^QW!?<C'_)T _!?3/['<%]R,?\ )T _!?3/['<%]R,?\G0#\%],_L=P7W(Q
M_P G0#\%],_L=P7W(Q_R= /P7TS^QW!?<C'_ "= /P7TS^QW!?<C'_)T _!?
M3/['<%]R,?\ )T _!?3/['<%]R,?\G0#\%],_L=P7W(Q_P G0#\%],_L=P7W
M(Q_R= /P7TS^QW!?<C'_ "= /P7TS^QW!?<C'_)T _!?3/['<%]R,?\ )T _
M!?3/['<%]R,?\G0#\%],_L=P7W(Q_P G0#\%],_L=P7W(Q_R= /P7TS^QW!?
M<C'_ "= /P7TS^QW!?<C'_)T _!?3/['<%]R,?\ )T _!?3/['<%]R,?\G0#
M\%],_L=P7W(Q_P G0#\%],_L=P7W(Q_R= /P7TS^QW!?<C'_ "= /P7TS^QW
M!?<C'_)T _!?3/['<%]R,?\ )T _!?3/['<%]R,?\G0#\%],_L=P7W(Q_P G
M0#\%],_L=P7W(Q_R= /P7TS^QW!?<C'_ "= /P7TS^QW!?<C'_)T _!?3/['
M<%]R,?\ )T _!?3/['<%]R,?\G0#\%],_L=P7W(Q_P G0#\%],_L=P7W(Q_R
M= 2GKW3NG+?0NM9X].X'GATEJ.5G-A\>6ET>'O'M#FFWHYM6\0>!0&EA]'*B
MA;Y@_6B]D$,+G:LRYY8HV1L;_AAQ 8UC0UC1Z HY(F.G53V&\PI(" ( @" (
M @" ( @" (#&-YH6[UQMYLM%IS&ZJ_ [+:VN/F^VSC)?#FLHO6CGFC#9H7N+
M&/)X5[%R>XSOS[LVS'@W^FZI.Y3DN5?])TNW;>KW;NX[@E6[9A'I^+J_P,7V
MQW2'M;N-+IK%V77[G,GKZ:6WRE[@W>VP"2>26&[=9-FGO&Q&CG\O;Q7H]VS#
M&WJ>;B+SL:"6G+AX'"X^4\K:4LA^4[C:K[G3X&Q]MOI4Z#T/@=,W&9?FOF:P
MAMGYBY>.:[$<;6^.][G$>N!6M>]:W+O+(R)7E'I3?#P,W$L^18C:KU4YE >M
MJYQ^3Z5][[6VR6*DE.@-2'PWY"S;S<N*NPY@YI?6?Q[!Q6*]5H9<5\QK+?10
M\=B[S2?5;9WN(Q=VV+7UW(V2ZQUI<2!S<L]A#)IH7N$9YS4 T)H5+KU-/@4Q
M_AI^UFX+^"VF/V.8'[D8_P"3H15C\%M,?L<P/W(Q_P G0FK'X+:8_8Y@?N1C
M_DZ"K'X+:8_8Y@?N1C_DZ"K'X+:8_8Y@?N1C_DZ"K'X+:8_8Y@?N1C_DZ"K'
MX+:8_8Y@?N1C_DZ"K'X+:8_8Y@?N1C_DZ"K'X+:8_8Y@?N1C_DZ"K'X+:8_8
MY@?N1C_DZ$58_!;3'[',#]R,?\G0FK'X+:8_8Y@?N1C_ ).@JQ^"VF/V.8'[
MD8_Y.@JQ^"VF/V.8'[D8_P"3H*L?@MIC]CF!^Y&/^3H*L?@MIC]CF!^Y&/\
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M #(XFL8P#W J5P1+;<Y_ WOE44A $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $!Q?7EX'E/ 5I7M-$)5*Z\#2'^F"]:ITGM!MQTBZ+SQ=F]QKXW&L\59SN
M$S;%AN([2&XBAN&O^S'L#HR#SA<MTQWKNB&/%-2PVM>3<_9SIH=%BW/Y;L5Z
M5V*_S*I%^'3Q?XF#CJ[\K"7:SR0^ESJGP.!EAUC 9\_KB[ALWQ9"SCNI_;+.
MZGE98LN&M(C+@7/ X=JZON?(L[+ON'AXSI&YQ?M23H:'8[/\PV[*O7-9QUBO
M%-O@;;WT8/K>MNJ;H)T]MIF[\7NMMD8HL!EW7%YXUY-9NBM6VI<R2YFGY8R3
MQ( ]9;_?+$+N/8W>"TN1U]DDO]9HMO\ ,A=NX5WZ8.L?=4V5&\\<C8VMHRIK
MW\%SDTKDDT^!MW*3I_BY_L-8WZ5Q3\FUJSC0^T-H/3]@O*KA>XDGW3M%?\<_
MV'3[57^2YWATQ+8?H<W[SK<G\98?^(O7MU_]IPO]QG#XO_6W_>C';],_)_;)
MZ5!W>UWGP\<E^8O-]FI_W3F4XUM_L.KS?_9K'_B_:;:WDD\?+.Z8?Q*M_P#M
M8UWN^Z[E/W1_!'.8?\!>]F5M:@RCBX@ U-/=5%R<;<>J7 F-:Z'ER-E?S<D@
MYF<9'D\H8.VKCV  !6TKSUK^3(HF^J?R:31:'U ]??2'TN1%N^&^>B])3M8'
MRVS\UC[J\B_JGJR6MO</N(G#PG5#F@\.Q4W)XMR7DO6G]N1?A;ORTX2^PHUM
M)YO?EU;[YV+3FW/4GHC,9>:>*VCMI\C;XT/FEDCBC8)+V:)G%\H';WK*MV)W
M%Y=JJ+-R48?+<,D5M>X_)V,-YBKVTR-C,SGM[JPN8;RUF:YH<UT5S;R212-(
M(((<0058FHP:LWDTI<_!D)N/S6^7(M6ZFNL?IVZ,M.V6L.I#7L&@-.Y>62.Q
MREY;7$]I6)KG.$DL+2V$T:?C4[%CW<CR\Z.+*O0UH^3?MU,BQB7+MJ65;7!Z
M^PZW2MUT]*_6=C\WD>FK=?!;DQ::? W,,Q]PQES:>U,:^%S[9[A,6.:X>MRT
M%>U9N3;RXVXW;4?RY?864[;NN%Q_F)%W+G&3U":/::EM:<M#Q)/H 5N=B$U6
M4M*"%V4/W=3&_OWYLOE^=-NYD^T&\?4#IK3FX5K<65I/IUKS?7,-UD'^%;6[
MO8S(&S22"A:>(/:F+>MYG5;Q7U.+HVO9I\?@7KEB]CP5V[I&:JJ^!=??]0.T
M6&V=?OYD]61XW::/$-SDNI;N*2WB9C'0^.RY=%( ]L;HCS#AQ"IRLBUM\8SR
MM$W37Q?#\&6<:V\OY<9/K;_ I)TR]>_2/UB6.J\QT^;NX'6F/T)*Z+5>1CF;
M8VF'+7!CC=3W;XXF .(XD@4XJ\K=N%EW9Z67K[/'[")R_P SY#UR:?'["AFY
M7G-^6SM'J^XT)KGJ;T1C]2V=VZQGM8;V*_8VY;,^W<SVBSFD@-)8R*U5C%OV
M<R?DXU:KX?B9%[&NV(]5U:,O.V3ZD=C>H_3\.JMF=S=,:ZQ-RUI:W$9BPGNB
MUT3)6N?917#KJ,>'(.);17KV+DXR?%RY?ZRS&:ZE-:%:A QCG<M6@]K.8\3[
MO&H5E7YRMJVX_G/B2K;=[SF_E9QN+_'X>RFO,O?V6,L8 7RW>0NX+*UA8T<[
MGR7%R^*)C6M%220!151=J&L727.O^DIZ)5:6L3'CO!YN7E[;%9:3";D]2.A<
M/D89I8)(+?)VN2Y98'R1R-+[*XE;ZKXG!%*U/VEYV;D55K0ZVT/F]>7COMG;
M?3>V_4EH?+Y>XFC@AMY\A;8T/EF?''&WQ+V:*/BZ1O?WJ]&VZ4AS+3T=7R,C
M5KE+.^@M[W'WEID;"Y:'V]]8W$-W:SL<.9KHI[=TD+VEI!!:2""K%SS82;?T
MH)Q:]I0CJ1ZIMB^E'0<^XN_^N+#0.C87!DF7R',8@XAQ#0&>L20T\%0\RQ:\
MM79)3N?2O$NV\:_?4G;BW&/%^!XFS/5OTW;_ .U)WOVOW1T]E]KHV32R:JN;
MZWQ>-$=O%XTKO&OY86 -9[O;P[5EY,)8=C_,KIMW%5-_L,6W_F[JA9=9P>J7
M[2T/57G3^65H_5TNBM0=3NC+?4-O=>Q26L=TVYB;<"9T')[3!(Z @2-(J#18
MUJW9NI.WK0RKUJXI]%Q+J7(OXVDWSVBWWP%KJO:+<'36M,/=L;(V3#9>PO9V
MQNCCE:Z2UM[B2>*K)!\8!7;UC)QEUVXU3*(WE->7*E"L#7,> "*N;6@J1[A6
M/"\TZK^(^(G"-/\ 9);U;K/2>A<'>:BUEJ/#Z7P=A!-<W.1S62L\;;MB@899
M"V6]EA8YP:WL!)*KGT6?S;DJ2%N-R]+IBJF,O.^=AY9.$U:_0.5ZG]%P:B%X
M+%UHRY9)'[3XYM^3VIDCH*>**5K17K<XS77%U3)G9E&L9(Q=?2:M=:)W:\IW
M4&N]M]4X+5^D\A)87-IE<'EK+(M=!+#<F)TC+.:8QUYA4.H0>U<OO?FX^Z;?
M!1;MRN/7XHZSMIPN;5N,$_F5K]C_ +?9XEIGT,[][9O6._Y[M/\ MK9>E;@D
MMCQFM75_@SS+$DGO-]<U#]J-T?EFKRM<2YY))[F@'M/<!1<W&=E0<;2^8WEQ
M7'*L?I+7]_\ KAZ5^F"P-YO=O/HO1S6L+I(+C-XZ:^CY?$J)+&*Y-U&1X+N!
M8#P5MWK-NXDW\Y>C8NRAU4T1;3MAYRWEN;P:A@TOH3J:T3D\S<W#+:"WN+Z'
M'L,TLC(6M$UW+%&*OD XE9?DSNQZH\"U.:A\LS)9B\KC,U919/"Y;'YG&3L;
M+;W^+O;:_M9(I&B2-\=Q:R2PO:]AJ"'$$&JHG9;FE-4:^\1G!?.G5>!Z/B,>
M0.<\Q_34[?10#WE9E;@KO7)_-X$MOZ%S*<;I;P[7;,Z=OM5[HZYTYHW"V$)G
MN+G-Y>PQ[C&QCI#X,-U<12SNY(R:-![%;GTQK*4NF3\"N,)3:448]M->=/Y9
MVJ]9PZ#PG4_HNXU-->BPBLY+N."(W1G;;AGM4LC8 #*X"O-19>/:>3_ UI]Y
M3=A+%=;O,UQ?IE.9Q.ING?IGU#I[*X[-X3(Y?)3661Q5[;9"TN(Y(99V2LGM
M)98G1OBF:0:T*YS+C<AW/C*2I%17_$SIMKE&7;V8D]>/_P *,P?T9QU?*XV=
M)[HI_=[+:P7J?>?SW+27%VU^!YWL:Z;<_P#>?XFP5#& YT@/QO\ =!7(=7Y:
MAX&[<.FXWR9V522=>64A[8PWBX5+NYH'$D^@!'"W)5GRY%$I24E&/%EJF_\
MUP=*W3%8>V[V;SZ*T>QC7.?!<9O'37S.7Q.826,-TZYC</"=P+0>"LJ_:4G;
M@]5X:F1^FNNVIR3Z?L+;-KO.3\M[>/44.E- ]3&B,GFKJ>.VAMY[V&P:^9\D
M<3&B:\FCB%7O [5<5OS'\M:E,NJGS<$9+,?F,9EK&VR&&R=AE\?=B.2UR&,N
M[>_LYHW\LC)(KFUDEAD8]C@00X@@JB./<C.MQZHM.2G'\KF:-'TTLTT!TS4[
M\I=U^"YOJ+GMOZEWU:ER73^)TMF5.V<B/C)_@C8&^CY_Q5?3B?\ HBY^M!8+
MU/O>2O;TVN=J'[3AMHCT8LG_ +;,S\US;VML^ZO+F"U@@:Y\US<21P00L'QG
MR2RN9&QH':20 N0E&,5TMTB;:#ZOFI4L WT\TGH-Z;LM+A=VNHC0V R4+W1R
MVL&7LLF8WM,C7-?[!<3<I:Z)WU%8AD8\9]$/J]S+TL:\X^9+Z3M[!^9[T+=3
M.49A-GNH/0VI,E,2V*TER]EC9)7?8P&1MOKF$O>XR-  XDE9T;%Z<7<A5NG]
MM#%K!)P? OPMY(G0,GM)(KBVE:)(YX9630RL=V/CD:7->T^D&BQXJ<F_U3U1
M/3&VEY2JGQ*(]0_4ELSTO:"O]S=]-9V>AM#8P#VO-WU3!&7->0#R^M6D9^HK
M%W+Q;3C"\TI3?R^WW&9CX>7E2;QXMQ@JR]GO)%V#ZP^F?J7VWR&[VS6[&!S^
MW5ES&_U+-=PXW'6XAC,LCWSWTL,;&,8.))H"K^5BW[-A3R6XXTE6+?/W>)C0
MG"].5FTJWTZ-K]I;!K/SI?+2V_U1/HC4_4[HNVU!;71LIK>*[CNV-N!*Z L]
MIMI'0&DC"*UHK5M6IVO*MM]!>E:NVVG+BB^+9?J V4W^T]'J;9W<;36N,7<!
MKVNQ&8L+NY:U\;)FF2TAG?<1 LD':T*]<LW86.F*;A_;F6(>6KKE^_\ @5FI
M&&OY92T_ICZ*?F*PKZFECQ5+B*DO+3G/6#/+OKZSQ,$F3RN4L,1BK=KY+B^R
M5Y!8VD43&ESWR7%U)%#&QK&DDN<  "JTY6_FR6ETENVIR?Y.L7\3'!NMYQ?E
MQ;+ZBFTSN%U,:(Q>9MIWVTUM!?P9!C)HY)(GM\6REECX/B([51#R+MSS8+Y_
M$R5:O*/77Y5[BO\ T_\ 7+TD]3T;;K97>G1>L'/8)([6#-X^WO)12.@BLY[E
MMS(X^,W@&D\5F/'O2AYJKT(QNN$I=+^LNWD-><CUN +1V BG AW80:+%34I4
MNJG0RN2?2Y1.C+?06]O->Y.YML?9VS7/GO+N>*VMH6-XN?+/,]D3&M'$DD *
MF=NU>FKL9:+D39E/H:E]3,>&\?FW^7KT_9R?3>YO4CH?#9B":2">WAR=MD^2
M6)\D;VNDLIY6#E=$X=O<JHY-J]+H3K)%;QYVN*I4G'8/S,.ASJ=R<6,V=Z@=
M#:DR<H=X%K)F;'&S3.'(.2*.^N8G22.,@ :!4DT"RXV[EN&GTLMRMT^=E]T,
MD$T;9X9(I[>1K7QSPR-EBD:[L<Q\;G-<T^D$A8\I2MR2IH2VIZOD=F@[5/3&
M3ZN9 #0.P*XVWQ(22(J"0@" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
M @" ( @" ( @" ( @" ( @" ( @" ( @" ( @.N&M9(3^E=[I[O]]3&2N0I'
MBBERDIU?,XB MEYAV?[GOJ97*6U!*K(Z6[SN/@=C@ *_F'\Y4=*EQXE;?,Y*
M0:Z_TF;^+DUG]ML3^JSJ.:*O^6_@7-^0M_%C=/\ _<-[^IV*B/ 2XF8U5%(0
M! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0
M! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0
M! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! 2;N+^Y]KO\3=3_>2^1\ :3GT<K^,
M$ZT/QKRWWX<H\"OG+X&\JI* @" ( @" ( @" ( @" QL=>W2YLMU/W>WNG]U
M]S8-#NQ5^9L5CIIHH79ISY3XEO&Z5[>+P2W@M=M>!8AW'+/4O.NN*3M<Z>SP
M-E<W+.Q=CNX-BMJS>>MRE4O8^1:OUD=$&Q'3GTVY_=G9G#7.F-PM'V.+NL?J
MFWRMVZ6\="QA\5\8>QA\=T8=1I HK&Y[YF;/W'@_I)>5A7[[A<M\5)/@M=:K
MG^!5V[L^#NF->VO.7F0E9E)3X.,EKU::4_M4K%TYZVWNZF?+BGNM.YN>RWBR
MNGLMB,'G)"^.0WL$ @LY^=[W$$.<.-5Z#W=A6<7<8SQX]%FY;C*G@VM?M.-[
M9R9)7L2_+S'8N2BI>*K1+X4-7/=#RZ_/DT]H/<_4.O=\;Z]T/9V^I<KE<:W*
M23^-I]OMLQ86-D=1@LG<I[N*Y/JZ):1^5'0RE<N2K&6GN+Y_HFI:W074A;RC
M_"-IJ"&URC^^3(07<$5Y(3WE]RQQ5;GUOJ#^E(W$D* @" ( @" ( @" ( @"
M ( @" Z&3OF8RQN;Z0%S;>)TA: 23R@D"@X\:("E^B=SXM496ZQC[9T3V2N;
M$>4C@UW+QJ3VU":5H-:5*OH @" ( @" ( @" ( @" ( @" ( @" ( @" ( @
M" ( @" ( @-/7Z61_F#TN?C[:??6-16DEXDTK&7P-E#H0I_LE['T[/P"T]]Z
MK-(\"J?$NZ4E 0! $ 0! $ 0! $!Q=3E->RG%0TY*D=&*].ITHVBE6"HJ30^
MX>VI]U42FX+R)/7I>OO(BHW9>9+34Q1;U=!_3=U#=4MEKW7VXL-]JFQ ;=;;
M-NXK>YN(FM<WD'K^, 8WD<!WK&[1Q,;9+^5G6/\ ,W[K;K_@;\:&P[@SL[<M
MGL;0Y>3A6VM:?5K[2RSS!]IM)]!]UM-KOIEM;K05YD]265EFK*VO[RYBR4+[
MV)AYHGRLXN: #Q/O*YVSN>;+U#CM,HN[M^3;K.-/I?-^[F4YVT8&?VSD;I?^
M3<L.GEW*TY<'R;+Q?,&V[ZN.I?HDP-GTGZFGT=O#GL%AKPWK9W6KP^7&LDD>
M9:@MYY9 [M6]WC'AMF\WL>'SX\9.E/;_ '5I\#1]N[C/-VRWEWUTY$JI_!TK
M\35UW(\N'S]L+M7J:]UGOK?WF QME+?9ZV;E))W3XJVC<^\:6MD)Y#;\P/=Q
M6J=%K0V2<GJI:^XV<_(I#[?R_=ML;?\ V3/XV_S-IG;D_&N,C#+!#=2'OJZX
MC>?A1%+KS,R*D@( @" ( @" ( @" ( @" (!V("V/JMZAK;IPVPR6N9<9-E;
MB%CFVUM%&]X+@Q[BYW(6TIR>E8F=D_I,65^E:&^[:VF.];O;P+DNFW+BRF?1
M5U>8WJMTA<9;YHFQF5QKG-O&/9(UE.:/DH2]XK23TK'VW/>;;<N#1M.[>U[6
MQ9-+,^JW_K+YFD&H IR^[[ZVC7,XQ.IR4$A $ 0!* )0! $ 0! $ 0! $ 0!
M $ 0! $ 0! $ 0! $ 0! :(?FN?Q]'3K]L\%^K0J%^\51^N/Q-Z?!?XCPWVJ
MQWZTA1<"D]52 @" ( @" ( @" ( @/.RHB?CKZ.>3P8);.ZCFFX?8HWP/:^3
M_L&DGX%BYJM2QIQO/IMM--^%="[9DXW8RBJR4DTO&C,/.W7EE=(>M-V]RMP<
MKJV#=F]U!>F;+:?AR A&%N#.^0,G;;/,U!(\CC13M6-8Q-I_3QAU]3TN:K_1
M4O\ <&1D;GN5O(S/R^A:6W[OM^PM5S5_>]&GF';;;2;.OO,=M?K"5L=[H]MU
M=7<$37&-KBWGE :RC12K3P6[].XYG<$]UV[=+ZO6L1OHX5BN7Q^PU/?EBUM.
MR[;O>#%K,N2:DE^]RX$V><WTO^8_U"9+;"^Z%MP;K1EG96[Y-4QPWC[02NFB
MG?'S4<T&CI&?46N5;.1*#58IM&6KM,2%S'TO7$NI4K2IKH=3/0QYRNU6BM.Z
M[ZF=WKW4FS>$U7I4:KQ3LA)<1RM?F+9S&RQ\[@>9K'TKZ53)KJK31CR_+CT1
MGU+F;X72O<X^[Z?-J)\9%X%H[1> :(_1(S%VC9C_ -E("45::DRXEP2DI" (
M @" ( @" ( @" ( @" @0"*'L*<!QT+3>H_J0@V/BQT,.,EO;F^EC#GB-[F,
M87D'B'-'8TK%R<KRN/$WNS[-#-3G)TB5IVJW!M=R](X_5%I;OMV7L3'.8]KF
M^MX;'.H'$]A<JL>^K\.I<C%W3;_Y?D.W6J94I9!K @" ( @" ( @" ( @" (
M @" ( @" ( @" ( @" ( @" (#R<]_B/-?:G(_K.9"5Q-%ORFN/GQ=2'N9+-
M_J\I5"X(G]Z?P-[I5E(0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0
M! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0$"X"E
M2!7LJ4Y5Y#V<SR,_F+3 8+,YV\FCAM,-B\AD[F65[8XXX;"TENI'/>]S6M 9
M$>TA8^7?AC8T[]QJ,8Q;J_N^\N6H.Y=C;2JVTJ'Y2_5)JO57G!>>=!IC3S;G
M,:5L-R<?A[.RA?)=6<&&TKGVQ7TC6L=?0,CE #30 $ U5WT[VZ_%W-VS4IWX
M]4Y2:I6K^5?9P]QE]X95N-NWMV&_R5%)?'ZO[>T_1GZJ>BS1F[WE\ZRZ3L?B
M[.PPS-J6XO%V3;:%[(,CA]//$#HHS;O:R6:ZA[6L!JY:_NQW]QM7,R"ZLFU/
MKC[$JU2_\/VZ%&PSM85^%M_PG'I?MK_I/SVOH]W4QF/+Z\T?4/3EN/E[G :+
MUAJO-Z/S%M>/EMK=^0MLLW&XNX?#/-:Q-,C86.;5AK3@NJ[<SOYSLDL)2J^C
MJBGK2G'[S5]QXL]HW.-Z2JW*CIX2JU^T_4RMIX;J.WNX) ^"[@BN;=X((DBF
MC$C7 @D$.8X'X5I)]49]*Y/4R$U)*7L-8KZ5Q_%LZM_NAOZA>+A^XO\ [Z=H
M_P!^?[#I=J_]ESO]V);#]#F_>=;D_C+#_P 1>O[K_P"TX7^XSB,7_K;_ +T8
M[/IG_P"Z3TJ?W7></AR2\WV:G_=.9[[?[#J\W_V:Q_XOVFVOY)/\6=TP_B7!
M_P!K&N\WW_W*?NC^".<P_P" O>S*VM091U[EQ$=&BI<0T?"0HE:C=34M:%,I
MNWJC6%^D3^<QDO+LVBL-H-CKN*3J#W7MKJPL<A YL]SI2TFANK5UX;5EW%,9
M9G.')1I(-*<2N?>7<W/.>SXLFIVU^9RXNBBG[=#;V,2.#BK<\A?+)_+7G36O
MPU-:KR[OH]/5SYK&"'5/UA[U:ST+H_7MS<YW"#*7>4R.2S]M<7$5S(Z+'7[)
M?8;><W<A8&EK>T5-%U=_:X;7&-FXOSVDVO!/Q9JH[@\^X\A.J3IIHO<B]SJL
M^A[9G;G067U_T@[_ &I[O<#3UFZ_Q^DI'W6,ERMQ96T]S6VOK1GC,G?-"P-#
M7M=S$4JM5F9>3AUR;$:VHJK2XI+5OVZ&38M8^1/R[[Z:\'RJ2/\ 1^O.6W_V
M ZD/R<?6YE,M=V+<S<Z5TSF-5SW?MVELK8W%KC1:RSY*\9/=QW<D#N1Q9Q::
MTJNBV^5GN;!<;23RU#J5.:7%>]&JW)7=HR%*ZWY#:3^/!FY]YA'0_M7YA/33
MK;8_<.S;.S/X"ZN=*YJ(AL^,RK[.9V.NH9!'*\,,DHJ&BI!JN7W'$G<LR=I]
M.7;JXOGIR^/ W>WY:QYI3^;'N:27L/S2^BS>K?GR#/-*N=L]THLU;:'DU=%I
M;56+NI\A%C,WIJ^S+;#%YD&:6QM)?!M6<SG!IH/<6Z[5W:QN>,\+)T\S1UXJ
M?!>ZK,'N+:[F%?69CR;MI-IK5./&GP3/T /,\\VG9OHRZ$CU*:?U-B<UJ'=;
M2G+M+C+.^M9KG*9'*8ITK9HV17S'QG'RS-J03ZXIW+0]Q+,V[,_DEM..9=EJ
M^*BJ5K\5P-CL-O'S;+W2]\V%:C5KA5^'VFD)Y('EQ[G>;YUIZIZONIJ+4.8V
MAP6L)]79N\R\^19#G<J<E#D\7C+">[BNHYK:U:X-#62<O:?=73[5M]O8]NCF
MW%3E%?XJJKD_O-%N^;=W?-EBVWTQXMKDD](_@;V?FY:6PFE/*]WZTEIRS^:\
M%I_;\X?%6ML\P^#9X_'R6UN&OB##411"IX57G7?KR+V%8O6Y4_S$']O5H='V
M_;A9RU:CRMM?$_,!\O7='K3US^&G03T=3Y[&YKJ+U*<?K'.XJ\R;;MF*@R3+
M>:?VFTD#[-MO;2"I'%W;Z2N^PL2>XXD,5Q_)C%.4N2YG.Y+A@9\]QDZWNII<
M]>' VW]K/H;>U^2VK@NMZNH#5>6WASV*BOLAEZW4T>$S-W;MEEM^:>,2W!MK
MMYYG$.<3QJ3Q6/E6[4*VL-I-<)>/^@S,>Z^KKR5U1?)F S?_ &;Z_/HWO6#H
MS5.EMQ-49K::\ST3M/9F:\RMQI[5N!9>O^<+&YQ<C[7'P32V%ERU(';0A6MG
MWEW,G^7YRZ952DG_ (7I5-^S7PXF1N&V=.*LO&E6S+@UQ37)_@?I-= ?6!I+
MKIZ7=L^HO2\D-JS5&#M)<[CXYHYG6.3MK*U?D&.$<LW*'3/) )X ^XMENN%_
M+,J4K7S8<TVI>*I7_0:G&RUG6U9MO\R$J/XFE;])%\W3J"W*ZDH?+QZ5\IJ3
M3N+AR6.T[J;)8)N3L[K5&5S4]SC(;6WN[.Y;-'';S3 .>UE &KC=D61O^9/+
MDG^GC-QMKV)O5KW?W'4;E9_DF)",U^?."D_[J^)47I,^A]WFY.V^F-QNK?J"
MU4S76J,9!E\CH^.2[R)Q+LC:V]W$VXR%VTSRW(=.[GYG.<'=JZ2[:C:D[<'J
MG0T=NZYI3EJFJEHOF<?1<-?]#NS^HNH_IFWMU+JW#Z(MY,SG,'&Z^QF3Q5M;
M&6:.ZMKBPC9,X1N9&*\_ ]RUV5GO;G"Y=_A.5*^#Y?@;'%PX9ZE;M5_44TCX
MTXF3OZ)QYEV\>^>G]==*>^.I+_5C] <C=#Y'*W$USD+>VB991W%I/<W=U/<3
MF)E020.(JNJGC+/VC^8)4Z*)OQ_M6ISO5+%W#](^$EP\&M/V%ZOTLBR9>^7=
MD*R31/M\G%<QF*9\1+[9ES*T.Y".9I+>(/ KS7>J0WC;M:-2?[#O=@B[FU9R
MHNEP2?WHTW/+MPWF&>9MMAHCR^.FO.9_;W8[0\DT^XNJ,;?92.)]G>W$+KCV
MV[M9*@1P3<Q8:#EX5[EWUW$ENTK>9G2Z<'&BHQ7PI\3C,?(AMD;F-CJN7?DY
M2?QK\#/=G_H7&*&A;[*6/5CJ+)[D18:2]A9<V$CH+S-,LG3>R^U.M7R RWPY
M0XLIQJ5J<CS;<I3L4=J/!<W]QFVI1G!1N_Q7Q?@8%.CS?OK \DKS,,/L7N%J
M74@Q%GK>QTQJ72V0RN3NL1EL/F<K;8RTOX+>[NK>VA$D%O6C6\O'LXK;=K[M
MB[Q%V9KKM3K'7BI+D6=VP;F!2=5HE*JX-'ZO6*UKA[O;JQW-N)XX,-<:+MM8
MW4CI&MBBMG89F9GJ]SPT!D1([:<%K-QA_+<JYY](VX-Z^[A]I1B+]6HRM5;G
M33\3\SCS5O,?ZN_.%Z[G=&/2MFM08[:K#ZIN-)X+ ::OK^S.3G@OSB<SFLC>
M8FYF\6$,E-6N:*TIP 6/M6WWMUNO)O+AJER4>*]YLMSR[6TVUCVGJTNIKBV]
M*+PH94MI/H9FC,IM=99'=WJ,U-!NSF\5!?7<MK;23,TYE)X&R.MG2/ACDG?;
M7#B'$@GAVDU6POJW%^78Y<_$U]N4W\UW6OW& 3S/>D?KZ\H?2&K.E;7>O,_N
M?TH;M32-TKGKZ?)W>/E%E+<AHB9<4@QKBR#F+6AK:F@ '!:R>?8S[\=OR%3(
MQ]8U7CKHWQ-[AW+NVX=R]C4E:OZ3IRIXFRU]#/:6].&]?&H.9LG#X3:E=7F*
M2V6Q)\.I_@SAL54WN_X.W^U&4+Z0)YNDOEF=.3,7MQ<VTN_>ZL%UB]$2"2&2
M7!%[+B*3+OM6W4,Q? 8R6T!I2HXT7#9EVYDY/Z'"^6;:\QK]U4X?&IV.%8C9
MM?K,M-VXUZ4]%)\C46\N_P C[K3\YZ>[ZH^K'>C6NC-N=6WD^2L,QDKG+W4F
MH!++'>S08_%WC)8+2*3VY_+R$4% 74750VW'P<:,\CZVOECS][-+/<+N9D25
MO@GJ^7N1DLZDOH<&/TQMUE-4=+W4#J8;E8&R=>XW!7++BU;G[JVADE$$=U;,
M,T%S+.QG(6EI![#W'37KF;9N.Y9^>PW]/!Q]ILXO$O6U;FNFZOWN-2TCR3O-
MHZGO+_ZO8_+WZW<SGKK1=SJ :0LWZLN+V:\TYDFW%OB,?-#=96\BGG@NQ&YS
M#RGO[5TFU9&+W%ARQHT_50KTRX/2E8OVFIW'%R-HNJ<_X,DG3BJ.J33/T#]\
M=[]'; [)ZWWTUADX(-)Z4TK=ZECN9'1MBE'S?+?6$(>Z6-A%PX,:#S<05RNY
MW%A6GDS5;\?E7M;T^XV>VXMS+N1Q[6LI5?P2/R_]P-T^O/Z11UXYK;?0&J-3
MXK:ZSU#>6^/LK"^RMIIW3.EL??W%HV^O197-Q:7#W8^X\0-D]6C1P6PV39K]
MS$EGYLJQ6LI^_5)(HW3/MVKD<7&C15HESKSU\#.[/]#"VZ@VW:[%]3FJ+;=F
M'$^V-SL=M+' _.ML_%$/.R$/;$;[U0[D%!QH%=R94DOT?RQC]Y:L--4ROF3^
M[_4:JOF;:?Z\^CYL'0%U99K-ZIT5M[?&?:W468FR-[%=82XN7/M[BSR%\]_C
MB6V8/5!J&]Y6#8EC[EN-J5RGZRU-*2YZNAL9V[^UXESR7U861'1_L/T._HSP
M:/*XV?#>Z*Y![>SV:Q"[WN^7^8M)JE(+\#D]IC2W-KG)FP:PLXAAX!<9TM/J
M?!FY<^ITYGT4@U[/I!OFT7WEH]-4=GMM+;.WOW5AN\1HJ8S0OEP;'1W,,^6-
MM[3#,7P%A+2 :<O#C1:3.R;E[+AMV*_FD_S&N,53A\3=[?A6WBW=QO\ "TOE
MB_WG_H-.?RWO)8ZSO.KRF4ZC^IS>76VCMK\Y?2W]OJ3(W67O!GW7,K;^>WQ>
M.O&SVUO'+[9(&\A%*"KJ+J7LL-HQXRO45R2JHUJZ>WF:&>ZW-QNM1=5!T?)+
MW>)DJZO/H?=QMKM+GMPNDO?/4V4W)TEC)LI;:7FDN<:_..Q]I/=RFWO;9AFA
MN.:!I9RN:[FI0K4Y61<Q5+*@GY:UHN27%HV&-"QE=.+=^6X].KQ;X)KVE/?H
MVGFY[^[4]13O+MZI;W4^>Q$^3O\ 3NF<AG692_N=*9;#W%KBY[6XO+RY=-)%
M+-$0U[F %IX=ZW6$X;WCMVVG>C&J]OL]YJ-QC/9K]+Z:@Y)/V5X/W%Q_TTES
M9-O>F5[>+79"Y>P_SS77%Z0?A!7$X,FN^K=AKYHN/WLZS'BI]MWKB?&3_!?W
MFP-]'R<W\E3TY<]&L;B+HN)- &BWL"23PH  O3>]/R]W<I:)68M_><5M3<L=
MQY];_8:^?TE/SN=V=&[BP^7YT?YZXQ&J<E-;X?<74>!F,^1O),K<.L;7 V4M
MA=F>V>^8CB&U!%3V +SO"=_?,Q.Q5X4&U&G[S557W),ZZ[&QM.!UW*?KI^/[
MD?=XZ?>6K=!/T4G>#JKT'C]\NMC>S5VD\EK&WASMCI*XGR.5R=U%E8X[YMW=
MW&189HF?9WCEY@ :4;3LZ7)Q<?&2A%UO+CPT.>L9-^])SFJ6GPXDJ>8?]%PW
MUZ)=#7O4/T5;SZQUK'HB)V?R^F;";)XO,XN#&.DO'7=I)C&LFN(P(8P6EQ:3
MV@=^KO;A/;Y1NW7^36E?"OBO#0V>/AV\Y.W!TR.2\?B9&/HU'G>[@;Z9K_85
MZJLO+D-Q<%&_&:"U%EYS'D;F/%>%9W&*O3>7CIWW$5R75JVO,/=(6^G"SNN&
M\JTJ75'5+][2M4:B4IX&1Y&1]/5Q?C6E'P,C_P!*0LF7GEHZXMY)96!LL,HD
MAE?$XNBAO',)=&07-J.SO7G6_J,-SP*Z=,VZ>ZAZ)VE!WL3.M\I6FG\4^'@:
M-7ENS>8)U[;<8'RXNEC*YW1FVK[N[O-S-7XV]RD$9QLUW'+<FZO+64>S-AMI
MB>6HJW@"%Z)DX&7O>-9S[^FV8244O:TOM.&LYN/MOGX,4GG9#;ZO8FZ&PS>?
M0M\7/H6;)S=6>H\AN2<,Z]Y;FPDDM9,W["9_9?:WVSI277_J<Q93OJM3D5MS
ME+&5;:X+FRY;E&24+E=>?@:_>R6Y/6AY$OF383:#6.K]06UAC-98C$9O#7.4
MR-[@=0::S>5M;&"]BM;BZM[-GCVD0=ZK>4 ]BSNV=XQMPE+$NQZH-R@XOZHR
M6GO5*/3Q+>][9>PK4<FQ+224E)<UQH?K!;=[@83<+;#2FYMA=,.%S^D\;J>[
MG! 9''-BH,C=@GF( B+W FM.':L/<\;^7WKL[JH[:;]R2;^]%K'N/-LPC'A+
M2GM_UGY[WGA^<+U)=;755<>7CT-9C-VND(M0,T?E+[2DMZR^U-E);FYQ-T3<
M8J\EGMH+-T[2\\O8M;L.%E]S7WE/^ DY1CP22:JV^9M\^];[?M_IM%=:2;X\
M4VDBXKIB^AT7&M-"8O675?U ZEBW SMD+O(Z9@]JOWXBYNK>&;EN+V[C\::>
M.>1_-S.>[F!JMS<A8LR=NWK3GPU-;"<J5?!HQ_>8GY#'6-Y/=A'U6])&]VLM
M;[?:'N[;+YF\L+O*6%UIV&*>2ZACN\99"&.^MXW64?-S$@@TYA5:R.\W=LS8
M6LA4M7'2,OW7SH^2=/\ 09L<&SDX[G9E_F%QCSI[#:^^CX>;S<^99T]2Z<W0
M?;V^^NU%O:8C55RZ:&.;4;(HK:WCRC+0W,LXE>7@NJ!6M3QJNGW#!M7L6&ZX
MR_)E]27[LGQU-%9ORMY$L*]7K7!^*_T&+CZ4YYJ&\.T-QHOH>Z=M0W6E-0[C
MSVMCK?+V,\EG?36V4FDLK*P@O8+J&:T;-),RK@"!6IK0+B<.%_<]_P#Y?:JL
M>W147.3?'X5^XZN]CQV_9H[M-UN7).GL23;_  +6NB/Z)-<=0.S^D-[>JWJ#
MU-^%NO<9%GY--V]S<9@6\63M[>\@G?DYPXRE[IWU^R/-0>Q=5N&"MNORPY+\
M^*57[T<]BYD,RS^HC5J7"I:-YIGT;K>GRTMM)^JKI/WDUKK/36@[BVR^HL9B
MI<K89K 1PW4DT-S;18IK)[R$&&,.;S%I["!WZ19>5BY$(375:E*B?A[&OA_I
M-E:Q;>7:G25+L4W3QIX?:;'OT8CS$-\>L?INU%MUOYCM13:EVA;9XO&ZNSV.
MR5J_4%FV.RA#6SWSG^.8?$J2#VUK0U74[A"SF8D<ZU!0N*BDOV_::&Q.>-E/
M%N5<7JG^PVC2YPH[LH:5]/=V=RY[&FY)QEP1L;JHTX?8=EI!%1WJJ%* BJP$
M 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M 0! $ 0! $ 0! $XZ ^+2V5M>\'ZA_W0K?\ !35=2''K6IB.ZR.L3?O2F\6$
MV$Z:=)6>J=>7X:ZX9=7EM:LA#VR.;S/GF#&\"WM"Q-MN7\G-N69:V(5U]QN,
MO$Q\;9%N"=;S? ^FP^N?,LN=Q\;8[W;9XS$:(G?'[7D<?DK&^$+'&$NJ;5SJ
M$ N[UOL*WBSLS=]TNJM*Z5.8SLB];E!6(_*^)EN:7^&TGX_(SF XT=0<PIQ[
M"M=3\UT^DSZMQ7B:[OTF9KCY<>M"&N(&6Q-2 2!]EG[32@4\T5O^%(N8\A04
M\L7I_P#[AO?U*Q2+J)<?@9CU)2$ 0! 0!!KV\/2"/S1Q3VD)U%??^H?T$)(%
MS6]II[_ ?5[%3*48JLN!*3? CS#CQ[.WW%4M4FN#(YTYGS;-$^O*]IIV\0I:
M:5>0_>Z?WCZJE-/@ IJJTY@@""*CB$X#CP(J*JM.8"-I<00) [4<DN((I5)5
MY )7D" ()(!XCM^%0I1EP!#G:>PU]X$_F!52^55? )I\"-1]3T<?S%3U*E>1
M-&<#+&VG,X"O97@>'N'BJD^I57 ID^EI/BSES-X<1Q[%%5PYE5&<D33U7 @*
M00J*T[U1YD.KHK\PH 014=BKJ"* ( @" ( @" ( @" ( @" ( @" ( @" (
M@" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
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MP6%O)KZPLV17$Q)<^@X5-32@"G3D*OF30H 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0&GK]+(XZ"Z7!_[^VGWU8H_>0?T2KPT-E#H0_>E[
M'_B%I[[U6:+@5S^HNZ4E 0! $ 0! $ 0! $!Q>*M([:A0W15)3HZG5<9(XR
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M,]S@>)9&S@".Q6,/"MX%OH@9&Y[OE[O=\W)E4K*LU.NJ-4%(" ( @" ( @"
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M?XCS7VIR/ZSF0E<31;\IH4\^+J1K_E+-_J\JH\":?-/X&]TJRD( @" ( @"
M( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
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M_$_^%&>7R)KM]EY/6S5[$2V2ST'J:ZC()!#[?"12L((H00YB]&]07T[C??\
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MJUUY$0 .Q+=N,*T);KQ(JX0$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
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M.!/7*O13Y2!(80&BE>T?F=JAJ=^7RZ./$FJAQYGW62@$ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
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M! $ 0! $ 0! $ 0! $ 0''G9S<O,WF_G>8<WU*U0') $ 0! $ 0! $ 0! $
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M@;W2J(" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
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MY/[RV_Z'+RCI%W5_&*TK_P"+C7LO>/1;VC ISQE7_P J1Q6'KD7/'J-R@%O
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MZ?,CYFL4_P#680]Q^J?J.Z0NIW,7&^!RV:Z:LP^1^#R%CC;J\-DT^(0>2V'
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M=_YM=5WX\7GWX33J92OH1N+*2 @" ( @" ( @" ( @" ( @" AWGC[P]'Z*
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M+>2%3_8NP5/V4:J]/^4RB#K15,Q:DI" ( @" ( @" ( @" ( @" ( 2 "3P
MXD^X$!(MWN#IVVR$V+-XPWD;7 -!:09 '>K7FX>L$TYD:UHBWV36NH9==QN@
MNWF%]PU@A!/(6.D X#FY1ZJI;:?L*^GD7<0N<Z&)S_C.C8YW_"+03]=5%)]$
M 0! $ 0! $ 0! $ 0! $ 0! $ 0! %#:6KX *0$ 0! $ 0! $!HA>:X?_P!O
M3TZBG_.>"_5H5"X2*TGUP\-3>HP7^(\-]JL=^M(5**#U4 0! $ 0! $ 0! $
M 0! $ 0! 89//%X='60_&O2_WT:H94OI9D#Z/"3TW;3$]ITCB/UC;I'@3/ZO
M@7,*2@( @" ( @" ( @" ( @" ( @/C<7$5K#)<3O#(HFE[W'L#0*E 4SRNY
MF"^;<HZPO6&[MHY&Q@EHJX!X)!Y^UI"BJ:JBN$'-TIH41VCW$R6=UA<6,EZ^
M>.::4.C<210/:!2KW <"D9)T5=#)GCN,>MK1%X"DPP@" ( @" ( @" ( @"
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MV*I;4]I+C]5QX+36GU5KQ,V2HZ(YA5PBXUJ0159 0! $ 0! $ 0! $ 0! $
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M^IN+=C]/7)+_ ,S-]V'KVCE5_P#EO]I('T@N**Z\M;R]+2[8)K2YDT RXB<
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MWC)]$[CZG[-.)V>Q*F+F)T<5:^\O1\D8E_EH]-G.2X#2S6M))J6,9"V/W?B
M+T?>(Q>5%+5*$?P.&VNGZ>5/_F2_$RQ+6FQ" ( @" ( @" ( @" ( @" ( @
M" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @
M" ( @" ( @" ( @" ( @" ( @)-W&_<^UW^)NI_O)?*'P!I-_1R?XP3K0_&O
M+_?AR>!5_B^!O+*2D( @" ( @" ( @" ( @" ( @+3.N?]ZCO=^(>H?O5>*&
M51XFLY]$[_S;ZKOQXO/OPI?U,A?0C<60@5'I[.WW$ 0! $ 0! $ 0! $ 0!
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MHTZM2Q;R0J_[%V"K^RC57H_RF40=**AF+4E([>Q $ 0! $ 0! $ 0! $ 0!
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M'&TN#@UW.3P#:NX*W.%5H7;5SHE7D>/L'H&7%YJZS-Q:R-=&9.620/;0DM%
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M6+FEQ)+[FSCMHMN.)+PZY/X5H93EJS9A $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0$F[C?N?:[_$W4_WDOE#X TG/HY7\8)UH?C7EOOP
MY/ KYR^!O*J2@( @" ( @" ( @" ( @" ( @+3.N?]ZCO=^(>H?O5>*&51XF
MLY]$[_S:ZKO1^'%YP_\ 7 3F4KZ$;AMY)+%:7$D+.>5D,CHV^ES6$CZZDAE
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M)<N_MOJM1;XM'SA?@GD7%#5*3_%EZ;'A[6N!!#FM<*<11PJ*'L*DQN=#D@"
M( @" T]?I9'^8/2Y^/UI]]8U'-!_3+X&RAT'_O2MCOQ"T]]Z[1%P*Y_47=*2
M@( @" ( @" ( @" ( @" ( @+7NL[ATS[M_BEE?UE<*)<"J'U%BGD@_O+L'3
M]E&J?OF43J3+@C+'K*_R6.P%[=8J,R7<<9+ VI(X.J0!QX*7P]I1S) VGU)J
M+-QWK,S#(V.)[O"DD:YO'F%:<QXJ%5CA[BM"D! $ 0! $ 0! $ 0! $ 0! $
M!UV6MM'*^9D$3)9*<\C8V!YIZ7  I36O,'80! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0&.SS$=7[H8G:;(8K;#VJ*\N;>4Y.YM1*)66YBN.8-=$0\48*\%I=^5
M[]%^37J]AV/8OZ.6_0CFT4&Z*M*<4:XVUG4IK+:?.W3<YG\O>XZYGF^<+.>]
MO6N9<>(221)<M(Y96GN7!K=;V'=_-;1]+;IV?@;AMJ>+&,IM<DO#V(S:>7OU
MSR;MZIN]K,Q)[0&-=)A[N><!S&L9$Y\=9+AY>2'<!VU79[1OMG/:L:=5-#PW
MO3LI;+@K,ITW:ZJG)U]AF6#VD\H/$+I*-*O(\I4DW3F1YA6E>/H4+557 FNM
M.9% $ 0! :(7FN4_+T].OVSP7ZM"H3TD5)_/%>\WJ,%_B/#?:K'?K2%2BD]5
M $ 0! $ 0! $ 0! $ 0! $ 0&&3SQOWG60_&O2_WT:H97'@S('T=U_V;=IJ]
MOX(XC]8VZ+@)_45#W5SV?P6)AEP<3WOE>6RO8USBT<:#U>(J4?W%![6WV5RV
M7P,%SF(W,N2T<7@@NJ*G@[CP*GD">T 0! $ 0! $ 0! $ 0! $ 0$"T.!#@'
M \"" 01[H/ H#Y0V\%NTM@BCB!))$;&MJ2:FO* A%*'V0D( @" ( @" ( @"
M ( @" ( @" ( @($T!/H!/U @+.]V=97=_FWXJ3Q;.PM'<A)+V-EJ7@&I('
MJ.I+1F1"+DJ1U92EDF7Q1==8C)3R-:!*QC9I)&4920BC7\H[$34_IU$.B-[H
MO:-ETFR.Z UYB[BSO'QC*X@MBN6F5GBO^*UOV(O+^'O*>&C^HR,O$=J*NQ3\
MM\^17<&O8AK^(0! $ 0'DY[_ !'FOM3D?UG,A*XFBYY3?'SXNI#W,EF_UQ*J
M/ FOS3^!O<JLI" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
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M ( @%!Z$!"@] ^H@(H @" ( @" ( @" )2G ! $ 0! %%$ IH@*! $ 0! $
MH$X\0$!"@] 3G7F"* ( E $ 2B 0! *)P H/0@" ( @" ( @" ( @" ( @"
M( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
M( @" ( @" UU_I,W\7)K/[;8G]5G4<RK_EOX%S7D*BGEB]/_ /<-[^IV*B/
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M[\>+S[\*7];]Q"^A&XLA!U(K"S@F?/%;0QS2?'D;&T./P@50';0! $ 0! $
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M\IK'1P@L'NDGN+_&.='"31]S(XQ,,3"XFG<N%W[8+5UN[%T1]$>F/?&Y67'
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MBWY37\?%U(C_ *2S?ZO*51X$U^:?P-[I5E(0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! 6UYZ>Z&]F#B%Q*+<M),(D>(W&G>P'E/%9-N*\N4N9.I<F.P>\%C/
MB010! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0'%]*<>S_=5JY<Z%PJ2E70^?A-#
MP\=O=]2A5+\R,?D^DCI5:\SZU5R,^JGB2159 0! $ 0! $ 0! $ 0! $ 0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
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M@" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
M@" ( @" ( @" ( @" ( @" ( @" ( @" MGSI/[=^%']#_Q5FP7Y!*9<N.P>
M\L(A\2* ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
M@" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
M@" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
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M5'B:SGT3O_-OJN_'B\^_"F7ULA?0C<60@( @" ( @" ( @" ( @" ( @" (
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MV&.:-DC'=K7M#A]0@H",44<#!'$QL;&]C6-#0/@  3B#Z( @" ( @" ( @"
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M_%6;#^ 2BY@=@]Y81#XD4 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
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MF1^LQNANLX3<7\*?L+_%J#9! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M$ 0! $ 0! $ 0! $!)NXW[GVN_Q-U/\ >2^4/@#2;^CE?Q@G6A^->7^_#D\"
MK_%\#>64E(0! $ 0! $ 0! $ 0! $ 0! 6F=<W[U'>[\0]0_>J\4/@5059&L
MY]$[_P V^J[\>+S[\(W63(7T(W%E) 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
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MNO[$LK^LKA1+@51^HL5\D*G^Q=@J&O\ UHU5W?\ 291:DRK1&8Q24! $ 0!
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MD\\;]YUD/QKTO]]&J&5QX,R!='?'IMVFK^Q+$?K&W1<!<^HN94E 0! $ 0!
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M-^%'H;_Q5F6]+&I*KR+EQV#WEAD/B10! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
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M$W*RKF/)235=&7IM %0!1:N%US=)\38**BM.!R HJHP4?B"*K 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
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M_/3\OS/]*6C-Q]4;SX;1^7PFW.+9J'2F6:VVS=GE<7@H62V=MCYKD7-RZ>2
M!G95QIP[5TG<71C9F2[7S-]3BO&M6E]KH:_:,>7Z>S:5.E45?8O]!A'\F?26
MH_,0\Q;K5\Q0:6RVG]LLYB=3Z8V[O,A97EG%J(WN-O<39W%J;J!S7L>RY;)Z
MDCA18,<.]8],<G;*]&[7I=4%[FY4I[>!M<_?99'=^-Y,%Y&-&CERUT_$QR]
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MS-[EY6X2Q,-^9"WI7P7^MFNQ+=J"\Y+H<M:>)>DL7W\2\$ 0! $ 0! $ 0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0$F[B_N?:[_ !-U/]Y+Y0^
M-)SZ.5_&"=:'XUY;[\.3P*^<O@;RJDH" ( @" ( @" ( @" ( @" ("TSKG_
M 'J.]WXAZA^]5XH95'B:SGT3O_-OJN_'B\^_"EZR(7T(W%D(" ( @" ( @"
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M71WPZ;=IJ_L2Q'ZQMT7 7/J+F5)0$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
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M! %#:6K 1-/5 *0$ 0! $! D#M(%?20$!% $ 0! $ 0! $ 0! $ 0! $ 0!
M$ 0! $!CA\SO Y?/=.>:M\3;7%TZ-[99HK>*25Y8QDSJ\L37NH /0M!W!;E<
MQETJNIW_ *=95G%W^$[\E&'BS5HR6A<5J?&^W9BMA'BB]LD<\1B)+26O%)&
MGB"O.=PL.$TY:'UGB[K"YTSPOS(^S_09=O*%U3I336M<MI/$7D;?GD"-D#7
MESH6VS34!PI5S?0NN[5NQG-QKK0\,]9/-NPMY$X42?'[38_7;G@ 0! $!HA>
M:X!^7IZ=?MG@OU:%0N$BI/YXKWF]1@O\1X;[58[]:0HN!2>JI 0! $ 0! $
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MPPO_  ?^*LV&E@E:ES [![RPB'Q(H @" ( @" ( @" ( @" ( @" ( @" (
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M/^\R:#L%.'?]7BMOQ.6I31$4 0'DY[_$>:^U.1_6<R$KB:+GE-T_+Q=2%/\
M*6;K_P"D2JA<$3IU3^!O<JLI" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
M ( @" ( @" ( @" ( @" ( @" ( @" ( H;2U8"D! $ 0! 0!!%1V("* *$Z
MZH!&Z:L!2 HKR 4@( @+9\Z3^W?A1W<O_%6;#^ 2N)<N.P>\L(A\2* ( @"
M( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
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M?<5"E27ETT)]IP<X,IPK6O?3L^#W55&$85:YE+9]%62$ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
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M/F:32O'_ '*_F*A-,KH_L(U 5,IQBZ2(H0#@ZM#6G:J^5>3(33=.:.2$A $
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MH>17+4;5Z48.L%)K[STD(" ( @/E)!!*6NEACD<SBUSV-<6]_ D$CL0'U0!
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ME64A $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
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MW%_CO%DA$MO)+%,&1VDSCZCXJ5/I69##DX]<]$4]<:T7$X]//GM[5[E:\L-
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M,Z% 0! $ 0! $ 0! 2;N-^Y]KO\ $W4_WDOE#X TG/HY7\8)UH?C7EOOPY/
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M5\S8KZ2+*YQ_3KM1;7<?AS#1^$>6_P!#)CK9[#W=K2I7 B;3E5<"XY24A $
M0! $ 0! $ 0! 0(!!! (/ @BH(]!![4!T+7%8^REDFMK6&&64UD>QC0YQ)K6
MH%>U >@@/#S^?L=.V$E_?/Y6,!+6CM<1QI4T X!"4>9I766+U7 Z6R?21CB'
M1\#0 ]M02B=>' C7F3>@" X/>R,5>]C!Z7N#1]4D(#BR>&4D1S12$=H9(UQ'
MOAI* ^J ( @" @YS6@N<0UH%220  .)))0'B6&HL1DKF>SL[N.6XMS21@<VH
M-:</6->*#V,]Q 6S;U9N\9>VF/M+MS8J5E9$ZA;\?MY'#ZZI?$:%&69;*P-
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MON*W>CU1U-AA9$,1J[^\6GW>GMMM'W%I/=PPQ7E\ QL(8U[W/=1IJSE!'K+
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M)@CLQ>NB?+<6TE+:&/PW,D ['"M$Q;DFW"6J+.6WT=2^I&4+RCMXLQNYT=Z
MN]0WDE]F\/:_-]S/,]\DIABAMVP-<]\DCG<HKVE8]^/3/A0R+;<H*3XF4%6"
MH("V?.@_MX83W6\/Z59D&G8IS)K0N8'8%AD! $ 0! $ 0! $ 0! $ 0! $ 0
M! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $!
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M7ZU%4[C@J(I<%)U9%H(J.X4I^>I;3UYDI4TY')02$ 0! $ 0! $ 0! $ 0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M$ 0! $ 0! $ 0! $ 0! $ 0&NO\ 29_XN36GVUQ/ZK.HYE3_ (;^!<UY"O\
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MB]\DM4J,VA^DS(764Z=]J+N[<'3'1V#C)'#U(<;:QL'P-:I13)49<6I*0@"
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M48NIOFVUN/9I9/ ?S"4S>#0,[2.=15UIR)II4[]QN-IFVO<+8R7,OCYYCI+
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M\N:6T>UW*1Q[>*5KJ^(I33D>T@" ( @" ( @" ( @" ( @" ( @" ( @" (
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MW_U'9.W7.?\ _2:+U"P(X'J7=E%4Z[2?W&T8N#,(( @" ( @" ( @" ( @"
M( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
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M6-HZVABB@@C;%&T1P\C2[D:*FG%:Z=9NL]67S#WYY&@-0:SZ1<OD,';27,6
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ML/TK@9)K*X?CX738YI;9O+03 TBA##3A4)RH",>EL%%-?7$>/A;-D6AMX\-
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M ( @" ( @" ( @" ( @" ( @" ( @" @2!VJ$TW1<1P (/$=ZEZ.CXCB10!
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MTO'PN8X%KHGW,4CHW \:MHKEN[>Q+CR;:Z;BX-:/4HFXW8>5*KM2Y/@:Y?G
M9[5N$ZPNB_'Z<U%?8/$S9J9EWC[&>XM[:Y8V^Y6QOAMY8XBT-% ""*+?>E6-
M'<.Y]ZEE.O1"-&]>1WUZ&/C>EF=DV4OU$'%)?$V-]+R2R:<TZZ6OB28/%.D)
M[2\V$#G$UXU)6IRZ+,NPC]*G*GVL\[PY2GB6YW-)N"_ ]]63(" (#X2U#XW
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MK75][KAF QN+DM\/"\-N+ES74D:' 5J> X+7W)7%E=%/E-]AQQ+F"Y3:\PK
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MO]7E*HKP)K\TO@;W*K*0@" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
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M>I8^-8Q+2L8\8PM16B2I^!/U K)>" ( @" ( @" ( @" ( @" ( @" ( @"
M( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
M( @" ( @" ( @" ( @" ( @" ( @-=?Z3-_%R:S^VV)_59U',J_Y;]Z+F_(6
M_BQNG_\ N&]_4[%1'@)<3,:JBD( @" (#XSQQ2Q/9/%'-&6D.CE8V1C@10@M
M>'-((]Q*M<-"&HR5)TZ?:23C=%:*Q]])E,;IG$6V1>YSG7#,?:"3F<[F<X.$
M0(->-0KT\[,G'HG*;2]K-?C;7L]FX[MBS:C)NK:@DZ_83R.+!RT' 4   %.%
M .R@"LN*D_G-BZ?N\#F@" (#X7-M!>6\UK<QMEM[B)\,T3P"V2.1I8]C@>!#
MFDA6[UJ%ZV[=Q5@^)5"<H2ZH.DD4VTIM9H#;ZZR5_HO3&,P-WEI3+DY<?:P6
M[KU[G<Y=,8HV%YY^-2EN_#*QEMLV_P!+9^F/)>XP[V-&WD/.C%/)GQES?O)^
M#Y 2Z.+BZE2K<93O3E&M(0T1E]-(*=/GEQ*5[K;';5;X8Z#!;IZ'PVKK&VE9
M/;#)6=M</MY(SSM=%++&Z2,AQKP(5C^6XCO0SKO_ %L.:TYUY<2]'/R;$98=
MNOZ::UYK@3?I'1VF]!X&UTOI7%Q8C!6$;8+*P@ $4,3&MC#6  !HY&#ZBSLC
M*R<VY_GZRCHDWQ27 PK>%8Q$_P!-2,I/6A,L]A;3V=Q8W;&S6MW#)!/$]H<R
M6*9ACE8X$$%KF.(-1WJU<LNY'HXQ3,F-[RJ3CI)$E:"VHV^VR9?-T'I?%:<9
ME9WW.0&,M(+7VJ9[R]TDOA1L+W%YK4K(4Y>7Y=7TK@O 7;D[]Q7;CK*G$J.J
M2@( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" @314RDH*KX ^ <YQ((
MK[G97X5,TH0\RWK(HC)RETRT1%TK(F<\A;$QM>9SW!H;\+B.TJW:F[JK)4DB
MMKI=%P.<4T4[!)#(R1AK1S'!PX<.T$A70?1 $ 0! $ 0! $ 0! $ 0! $ 0!
M $ 0! $ 0! $ 0! $ 0! $ 0! $ 0$" 000"#P((J"/00>U.' %MN[&(SUM=
MP7&#M_ LG.K*^$<E34EY<6 ?74/&N9&D9*-OF+=UV[ZBE6#6I;_N5KS16AM+
MS9O4V3AL;J*TG9<7$LC(R9'PR-:6\\C*D.![.*R<;:]SW'(MXVUISBI*M->?
ML-%W-O6P]D[=+?=\RHV,:472K2XI\VU^)K&Y[7VT&_76E/M?J?5TAL\O>R0V
MMV_GE$TDDQ;"R-[I):#GE X+ZWQ]WRNP^R[=RVNC+<==->'AIX'Y?9GH[M/]
M1'KK?W*QG.YL-75)U3YZ274N?)D[;E[>Z_Z,]],;/H>URD^*EDLY\==6T5T^
M+*6CWB9S7F-D;0/"8.T]ZW/;6X;-ZJ]KW+6^7;<<B*=*T33^)Y/WAV+Z@_TV
M>KD)]BX]^6W=:^6/4_-C&3;3:2\*HRG;->:';V&N]):"S&GKYDN8]CL\K&ZW
MN&^'/(RWB#ZND'Z9Q/8O$-P]'KF/#*S8WH_I[57#5:JK/MOMG^LS;-^[@P.T
M-RQKMG?I=,+L'"6DVES;\3/+AKVVRF/L<Q!S,@R-I;W,4;@00+B)LH!!X@CF
M7B]VQ*W=E8;K&+:^P^U;=V-RW#(;TG%-+WI,]>($<U>SA0^GM[NY&T]%R+VM
M6WS/JH 0! $ 0$F[C?N?:[_$W4_WDOE#X TF_HY7\8)UH?C7E_OPY/ JYR^!
MO+*2D("!]"MR;<NCDR?:*#@?17BJH04%1$/74XA[75 /9V\#^>DI1BZ2XD+5
M:'*G!3[B>' LTZ^'4Z3MX>>C::5RG,213^TKFA)[%SF^WIV;^$XZUR(+[SN/
M3JW;O]TV+=U_+5U,<'T?U[)>D.>-I:^/\)]0U<UP-?\ "5.T5[*KW'U"A"%G
M!<>=E/\ ^%'/]YPC:]1-SC;^A*%#/1&WD8&^A>9O5Z&EBNE4.:@J" ( @" (
M"TSKF_>H[W?B'J'[U7BA\"J%>K0UG/HG?^;75=^/%Y]^ I?U,I7T(W%D 0!
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M[3^8J-*Z$>=;IJ0-7'E)X'\[BH]I35/6/ -] X5[_>KW(_N(]A%P#02.WO\
MA*A-5U+>5-SI']U'SD>V$,>>\\1W]PX#M3J7!EY=2L+0EW469N\(ZUO!&9L7
M*X"8-!);5U 2!Z"K?7):+B7[%NL:O@3!;W$5S;Q7,)YHY6M<!Q!%16AK[ZCK
M;T9&19YDOWFEK?)Y2'(WMT]\,!YA9 N#'.[17]+P(5[R5%*?B789/Z>U2'!'
M//Z@&G[5[S;.D8U@9;M8">4\I#?BT[PK;N.+JN!7MUB&X7FWQ/IIJ\R.4Q@R
M%_&89'EQCC=P(:3ZO;_0E7$U+4HRK,;<Y0\#WR:]H4<S C=E!Z$"&=KA3T.X
MU^MV43V(K3JZD6/N86N9:W4UN7<6R-D?P('H#@>U%XA\3T+3-9RTEBF;DYW3
MP@CF+Y#S@@5!J_N 4Z^.@.O>W4]_.Z[NYG33R<2Y]30CT5)3BZ#2A\WN;]CY
M/5DC(<'<:\PX\./"I45;]Q' GI]_C]1Z8D=D0V++8UE+9_#FG%.7TD\ IU?'
MB5>TG[9"^RTS[NU=<!V/A_[@XBK2  TM!->_N4JK]Q%5Q\2Y%20$!IZ_2R/\
MP>ES\?K3[ZQJ/WD']#^!LH="'[TO8_\ $+3WWJLT7 KG]1=TI* @($AH)/8.
M)4-T50?*-T<PYP!VGW_J^ZK5N7F+KI0.A%]*'F-/=HHCURE\VD45=/5HCY%W
MA &G%W8?1Z>'PJ%&-NMR*UD)/]V/ P;>?=(R/I E>]S6L?J73M"YP:/\8U[2
M1W*YVG^3ZG8$W_#<)'J?IW&Y+%SU#ZE9E_PLR&= Y#NDW9L]QTOCR*&H(]B@
MX@A=3WLE_P!Q79QX)GC&T]2QYI\?.N?\3+QNU<F^F]&JXHV? BKY 0! $ 0!
M 6O=9_[V?=NO[$LK^LKA0^!5"G5J6*^2%7_8NP7"G_6C5-/NF41#IRXF8M20
M$ 0! $ 0! $ 0! $ 0! $ 0 \>!["@)%R.WV R68BS,UNT3L=S.:UK0)'5K5
MWJ^DJ*($[0Q1P1LBB:&1L:&M:.    'U@I>H!=RN)) 8 222   .))[@$I&G
M5S(^;JIXE%LSO%B+'5(P%E/:WWLKPS(>SW$,QB+SRCF\*5W*0?2K,;L;D^F#
MJD7LG%R,;HE<349JNJ*8[HYO!YG(QFQBY+J,!UQ-7XY<'&A%3V55UT^):C5:
M\BEE1PH?^#[OI4+4$>)J_L[/T.U*$D"V@XGCZ/\ =4UKIR(.0%. /_"-/J=J
MBO-@<U0>' =H]-?=[J*$JD\"% 0*<":\/3\*FOB01YJT X$_6_1JHI0$!4.Y
M:\/]RJ:$D'$D\>[N4KV$$06GXW;Z>/'ZB:\@"6EOH([!Q]*:U '+RBONT[?3
M[B:UT X_IA7X0/S$7L! @#L- [W/1]?M3V<P<FDGO]\4_/4/0$/C'LIS=A]%
M.U3P^ /F]O,37@?2#0_5"4KPX [EO?9*R')9WDT0[!21_P#]X=@4>U$G=M]0
M9NU=)X&0FI.")O6?ZW#W7<*JI>TAO[#S.8RR&:7[)(XDO>2>:IKVGM-252_$
MGV'9AOYK&YBO+4<KXWM(X_&%14'L/&B+1Z@FG5EQB\C8X_-6U(\Q(![5$P?$
M<P>J:COJ*J4^?,AEPNT]YD;S3L;[VX$\;0&P\1S, :W@>)(H%4N'M)=*5YE5
M$(" T0O-<H//IZ=?2<G@OU:%0GI(K3^>"]YO48+_ !'AOM5COUI"I10>J@"A
MM+B#B[EI1U./I4T?[O$AT6CX$ 0X\#V=O#MKV<52NI?63H^!R-!W*F=Q0EJ*
M5/@V0\Q:X<013X?@5YQA**DN!1&4JM-<#6B\XRYB'67T71RO8QWS]/X8<X-+
MJ9#N!-2M]Z(/]1W3W$KVEN-N-/A$] S;,%Z5YTX_Q'*'XFR/I=WB::T[(>UV
M#Q+OZ:PMR5I,B5<JZO\ [I+\6>>8SZL>V_\ 87X'O*T7@@" ( @" (##)YXI
MIT=7Y_\ >O2_WT:H96N#,@?1X2[INVF)[3I'$?K&W2/ 3^HN84E 0! $ 0!
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M^U.1_6<R$KB:+GE-_P ?%U(>CYRS=/\ TB7\]4>%.!4_JG3AH;W*K* @" (
M@" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
M@" ( J9.FH"J 0! $ 0! $ 0! 0[%3*73[P150" ("V;.G_XX84>AO#^E69#
M^ 2BY@=@]Y89#XD4 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! 0) [52Y)2Z>;'*IQ\1G\]]5)SC;^O2
MHC\ZK'@=/)7UAC;.?(9.^M<=8V<3Y[F]O9XK6U@AC:7R233SOCBC8QC2220
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MA@=0>I4U)HBBN? )Z_-P10O<Z>STY?RPX"V=<6T'JW0:QQ+0SG!- *_I5-/
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M[YRS=/\ TB7\]4^%.!5JI37N-[E5% 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! 6SYTG]N_"_P#!_P"*LR"_(J2F7+CL'O+#(?$B@" ( @" ( @" ( @" (
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MOX%S7D*@#RQ>G^G_ )#>_J=BHCP$N)F.512$ 0! $ 0! $ 0! $ 0! $ 0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! <'NY1[_ '^A2E7@
M4RETJK*6[N;-;;;[:0O=";I:4QFK-,9#E,]ED;6WGXLK0QOFBD=$?6->7M3#
MW#*P;_7;;C(LY>%C9MKHOJL2&T.RNVNQ&D;+0FU>E<9I33%D7NAQ^/MX(A5X
M:"7OCBC,GQ1V^A7<O,R,R\KM]N4F3C8UC%M>595(HJJ&M:*- :/0  /J!62^
M10! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0'QN
M(O&B?&3ZKFN:X4K4$4(^HBJI)HAIM46CJ6F;BZ-O,)E9\S:PEN.NQ(T.9_W)
MSP\<QY6\*%U44+%S+A=O<$R^XV%EVYQURNEI/VM4,.>Z_0AOQN-U#8G<?3VL
M;Y^FS?PWL<\4UR&XR"&=TTL1C:'-+9&.H:^A>][/WSLFU=N7-M<(5G"CT6NG
M]OM/@KU$_IJ]4.Y/7&QWU'<9K;K=Y3MQK*EN*;;6FC33U]QDYM[)V%QF+P<U
MW[9?8FTM[>[O#P-Q+'!'')S5X_'8?JKPFZK%S<[F9AOI<I-_>?<6S_KMFMV=
MMRT[_3;49/X),L7ZRND3&=0&"BSFE;6"PUWCR#'/'&P>V%SI28Y R%Q<'<P[
M2O2^P.^MU[6W/IR[CEL\_K5?LXOD?+W]2W],FT>LF)&_M*CC=P6W6$Z<FVY1
M=%K6M#'KMZYWE\:TP^;UJ'2:VRL[(Y+")S@R*W$\;.9P:813E8>WTKV??[63
MZNXCAM&FW6U5OVT^)\>=BPQOZ,NZ%:[AD[^^93I36G1U)/33A[3:.Z?-R#NO
MMK@M:QLC9:Y>UAF@Y)6R.]:")[@\![RT@O["5\I;EARVS<;VV-->3)QKX^)^
MKG;_ '!A]U[#B]Q8K5,NVIT5**J3Y5*WA84)=7'B;4BJE%+@ I 0! 2;N-^Y
M]KO\3=3_ 'DOE#X TF_HY7\8)UG_ (UY?[\.3P*O\7P-Y924A <'<33N )/O
MCL5B5Q)RBE\ZBV*5IX&E_P!6VA-/]47GTZ%V8WCMKC5&WF%EL[K&Z<FFE?8,
MEMVMFJ^U?X]LYI?4FK.];'T8V=6+&[=YW>F>96Y2NJTKT_9[S;^K>_O'].-L
M[5BODRY1>FCXU>JU,B'GF=%_3Y%T93[@X+;K"Z<U9M0,5+I+,:?QUIB;JR]D
MJ86RS8^SAEE>#$"27"I"X3/W?<]J]4=DRMOE*/ZW)DK]*TDJJBI70V_:NWV-
MT[:SMDOQ4L>WAN<$_J32IQ^/AQ+Y_)YUUJC<SR^=EM0ZKNKB]S7S?=8\7=R^
M6262#'>!!;5?*^1[^6,4K5>X^K4,:/=5VYBPZ8NU;=$N;CK]IXSV"[KV26/=
M;?EY%R*;\$]%\#*!:>*Q@CFKSBO$CM'#L/?1><VW-0BVM6=U+I6B9V2[UN6G
MPU]RO8KDK:E2?-%'5K0Y U40FI\"2*K 0! $ 0! 6F=<W[U'>[\0]0_>J\4/
M@50=)&LY]$[_ ,VNJ[\>+S[\!2]9,I7T(W%D 0! $ 0! $ 0! $ 0! $ 0!
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M/ ["O%00! $ 0! $ 0%KO6?^]GW;I^Q/*_K*X4.E-2J/U%B_DAU_V+L%4_\
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MS*CY[_$>:^U.1_6<R%2XFBYY3?'SXNI#W,EF_P!7E*H\"=.J=/8;W*K*0@"
M( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
M( @" ( @" ( @" ( @" ( @" ( @" MGSM/V[\+Q_2_\59MO^ 2BY<=@]Y81
M#XD4 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
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MY8/?="]X5SI:56M J2ETJG4=M0" <'=AK3WT%2* ( @" ( @" ( @" ( @"
M( @" ( @" ( @" (#B]H<TM/8:?FIU.'S(AI25& "*"E1_VOZ-5#I)5:^8<-
M.0Y?6#NST^[PHIC*L0UK4Y(2$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M 0! $ 0! $ 0! $ 0! $!\WDU Y>8>_2OI]ZBJ2YUU(;=>FFC).UKA)\[IZ[
MM(9&Q2&-SASAM/5#OTQ^+VJB5I7I4>B$I.Q^9#6XN#*>;3Z;DQ]KDXKJ]9<>
M(7130<S7N8#45:>): *]BHC9<).-QN4>1*>?'\V[=ZG+EX%.-5:<TE::D=9,
MR7(Z=\CI>!)CD)<0WW:G@J+EEZ.WHR_^OGAVZPAUW9?<2#>V\V&R?@/:]MNT
MCV>=S'!LK"?C<0!V!3D6I_HI8_6Y7)T*%C],?.RKGSSUK_A,'WF7[+;AYK7^
M.W!Q-A=YK39@F>#;023&V,8FD!Y61OX>IZ5]1>B/=FV[7L4]MO78V[CXUYZ)
M<3\KOZ[_ $L[ZWON#%[FV7&NY6#1QZX)MQJW31+V'S\GKJDZK\SU%7FR.?PF
M7?LCBPZ/YTR-K=6T-FYK;=D$<7M%&>Y5H"X_U8QM@CDQR<"Y"63<;?RTUXOD
M?3?](UKO?#]/+6V]V6[B<(KR^NM:::4?^%(VOC+&"1S"HH2!Q/'L[%XAU1Z^
MG]X^LTF]%R(LD8^O*:T[>!'YJK*%)2X'-"H( @)-W&_<^UW^)NI_O)?*'P!I
M.?1ROXP3K0_&O+??AR>!7SE\#>54E 0'R</7)]+2!_2JW>5;$^GZ^A_@0J]2
M\*FBQYL5WUF]*WFL8WJOZ==G<UN4R*)C&"RL[V6!K##<,D!DAMS'1S8A7U^]
M:7TP[BS=IV7/[=R8MJY=GQKJG(Z7O+;<7==BV[*34K^+%-*O!T+<NJ?S4?-=
MZL=F=1;*Y_I!U%B<7JAEO'=WC+#(U;X'.?TL+R>9SO1W+,N[5;R-]P=V4JW\
M&XYJ/)MT_9H8.R[M?VWS79A6]=M.''@FJ/\ O.72YYI_FT]*6Q^E=BM+]'NI
M<UCM'-GCL[\XW).+HKJ5LCA0P,X,=4]@[5U_=?<<=_W-;K=73=FH0<?"FARV
M#MKV>*P;:35R<YU\')U9M>^4WU<=3G5GMMF]1]2^U=WMAG<;[/['97<<L,ET
M96VYD^QR@/!C,CA\"V?<&R8.U;7C9&/=5S(OJLDJ/ITJ:[!S-RO[U?P\B'3B
M6DNE_P")F7$^NT/;7M_/HN,L2='%O0Z.[!IU7U([ 5-J/2GX%1%72 @" ( @
M" M,ZY_WJ.]WXAZA^]5XH95'B:SGT3O_ #:ZKOQXO/OPI:I)D+Z$;BR$! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0'4O;*VR%M+:7<398)6EKV. -001PJ#0T*
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MH_$O863D9&W6[U^/1>:U7@R=8BTMX=O?V]JQ?,@Y."XHS^EQ6O$^JJ 0! $
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MI''E[%3271U<Y%$7U)PGR9;CU"=3VWO3A@8\EJV_B-W=-D-ECVR1^-*YC9"
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M;\"M\%3D5D4 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
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M 0! $!:9US_O4=[OQ#U#]ZKQ0RJ/$UG/HG?^;?5=^/%Y]^%5+ZF0OH1N+*"
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M6<3^25D#A5TC:M<*@LJ*@E7*)ZM&*X1QKK\OB72XW'6N*LX;*TC$<,+0UH
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M7+7,8*7(-LKG7]SIVT?;NA?<&#VB-[[>2V8&LF8ZC:=JW.!L>][AEV,K=_\
M+X*DGT/1N-5S>O#X>!JMRW#8<+$OXF%_F-T46DT]$VM%1:<?C[39MZ)+#?;&
M]/FD?]I5L%ONS=P^T9^T@AC@BMGRQV\C8FQ0M9&WD>7#@.Y=+WC+99;PEV_K
M9C"*K6NM*2XG*=M?S2WMU-YT;FVE3DW5%Y [ N;UY\3I @" ( @" ( @+7NL
M[ATS[M_BEE?UE<*)<"N'U%BODAD'HNP-.[5&JOOF41#,Q:DI" ( @" ( @"
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M7\?%U(U_REFZ?^D2_GJEUT)7U3^!O=*H@( @" ( @" ( @" ( @" ( @" (
M@" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
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MCG&UP)+N/H5N%V<W22HBKI2UK4^O>I4?F<@158" ( @" ( @" ( @" ( @"
M( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
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M3%^T"5\KB"V1C) ^A:X.!!#J+7QM_K+[2^DWN/G6^W^WE9;IF)/3WEUV5?\
M@9%:NQULR>(L@@E,#&@ M:V,N/A@ _%JM_8L^72+1PV'D7\^4Y92Z92;:J3?
M;RMN+2*X J)V!SVGNY@TD4[^U9+^941I&G9SG:M_5X""RMX7NEMV!KCQ<!0
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M[ \;;%=I33C\"O;VN:ZE>#:4]VOZ 6TMJ/[VFAR.%B6OT;G<E\R.#7AC@\D
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MS#%!*PM8Z$\*A9<<6VI*<E62Y&!G=PY5_#6V6W3#CP]Q>7R"H] % T"@  X
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M4A $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $!;1G6__&_"G^A_XJS;;_(:1*+E
MAV#WEA$/B10! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! 0+@.TJ4F^!#:0!!%1V*.!(JJ>N.KKP! N:.TT2,E)5CP'L.O<3,B
M;X\CXHK>)CY)KB:1L44,;1ZSWN>0UK0!Q)( 52A"YI2L^2(DY1TTZ>9@@\QC
MSD=']/\ E).GOI@QIWLZG-3/EPMAAM,AV3L],7]T]]K;WMW=XZ66)TD-R 2#
MZH!X^YZ!VYV-=SX?S/>)?I]OBJUEHY+PHSA=_P"\;6'..V;/'S]RNU45'@GP
MJVN%/:6Z]$OD_;E[T;A6?6#YF>H;W<C<W)W+<]I[;'(7$[\/I1TSH<C8-N+2
M9DEK)[.^0M+* \"#1;+>.];>W84]D[?48V*4E-+5TTT-/LO9%_*W&&^=PW)7
M<B.L(.M(UUU7!FRMC<3887'6N(PN.M,3BL=#%:VN.L+>&TMH;>&-L,,<4-NR
M.*-C(V 4 [EY9#(G>G)SKYCYO7\3T^5J-N$5;24%R1[$79\3E^'MIPXJA3GY
MCA+5KF5Q2450^JN$A $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
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M5>SCP)VTAY]WF*;AXJ#.Z"Z9H-1XV\C;-;_-^6@O9_#>QDC"Z&WNIY&DMD'
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M>1<N[7;G.VK<W'6/@3U;M 9PJ0>/'W5K8>5.;N6^)LFG%49V%=(" ( @" (
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M?3%Q<FZ2,R]*_?AU-%(-VL;K7+18^RTK+)!!+*PWCX^8%K6O)'%O&A!6KO\
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M @" ( @" ( @" ("V;._NX87_@_\59L/X!*]A<P.P>\L(A\2* ( @" ( @"
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M]QLL?=<FU:6/<I/'_P +_9X& 7<'Z.EJ_8?*Y#<;H8W@.DM2P3RW6'TKDK.
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M(8^UREK+97D39K>4$/8X @U!'>#Z4&O(H7FM98G;F[.#PV.H&U=/(UGQW&I
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M,23PH&E+JHG[3%L1S8Y?Y-:)E-=,XW;.UU#=PX7)65UGFR$S6398!)$XNJ:
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M3^!O=*L@( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
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M]$/E?B1M_%:[DD!) 'K5[>"F-N4KCOUI"7+P*8RDEY<M6N9W%>*P@" ( @"
M( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
M( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
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MX,R!='8ITV[3 _L1Q'ZQMT7 3^HN94E 0! $ 0! $ 0! $ 0! $ 0! $ 0!
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M 0! $ 0! 6SYVG[=^%X_I?\ BK-A_ )1<N.P>\L(A\2* ( @" ( @" ( @"
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M--4ZJ%1Q:?\ "AXM<.#@?2$3J'[#,4JBD( @" ( @" ( @" ( @" ( @" (
M@" D[5&ML/I:,&]F!F(JV%I;SGM]T$=B-I*K*92Z55:E+-;=16C=%Z2DU->R
M%[VBK++AS.^-VNYQ3@U6;UZW;M]3U-KM>VW=QEI\L26M ]4VD=?X.XRF/MWQ
M31->! 3VNH.45YB:$D*U8R8W(T7$;CML\"YTR=44MSF6?J#)SY*6-D)E>^@<
M6@<O,ZG$GAP*O]77+V&M2ZN!,NWMMG[G/11X6XD\"!S7W+&R.='RU:36A+:4
M5>K]Y4^I*DN!>E#SB*(2?U01L#_^$&@.^J5);7#4^B$A $ 0%&=Q=3:2N0--
M9":*:XFYB][)&N]D+.;C(&NX5IWJU.2:HC(MXCO.LE\I:3)G\%>:CR&F\&#+
M\T\GC7=#X<GB5I0U+?5K3@J8<3/R;4;5@[Q):#P'HJ>/9_NE5RUHC56[:OQZ
M6^!2K?32FKM<;4ZET_H:^.+U'<6DAMKQK_"X-BEYF^)4!M00%B[]#(_1J-OC
M0WW;&Z;=B;[;MY<.N%:/GX%FW0QM;O'M3!K+46Z^8FN-+L-U*Z"2=U_$]L'K
MR<I<7-]<1N[%I=DL9=A2R,M/].D^)WOJ%W%VQN$+&U8-A0W"32ZJ4I70]W1'
M7GM#D-Y<KH.+#V^"QINIK?YY<R-@YX93'(\DR-#>9P)XJ[B[KC6,MRC2E3$W
MSTQ[BQMCM[G@W)3M2BG15YHD[?[JITAJ#<''[>:0R,#VLNK<NS[7QEA:Z8EP
MJ)BW@"L?<=UQLO*\NJH;[LOT]SK&R7=\W!T?2_E?C3W%Q>INH'1F@M"X*UFR
M]GG9I+(#*PQM@YW., $?KMDYAQ64MWQ[-GRX4K0XC:.T-ZWC<[J2DL93?CXF
M*_=G>G4VK]57LNG<1='2%KSRNCBCFDBC;]D>XOF87L:.4]Y"X[<LS(OM_IZN
M7,]X[?VG;]EQ%A9=/FT^/ F;I-W5VRW$UEFM(ZJP<,]S:0SBUN9"QQ@DCC;S
M&CB\D\]5D[%<Q')QR?XS-;WWM>^;%MT;^UMK%GR7@RU+J@T!-D]=93+:;%Q)
MC(KE[;'^J^'1LLS2UHY>4<O!:7>,*_+.=S7]/70[WTXW3 ?;D8Y=%N%-:\>1
M;'B.GO4>Y.O-(83,3R6MAE,K8PW$DA/J,-Y P\I<PTJV0JSC8CR;BAS31TTN
MY'@X.5&Q]+@_P9O3=+NS>(V&V1T/MQA9G7%EBL39S"9U:ODN;.V?)VM:: CT
M+UO;L:.)B0M+P/A'>LR[G;K?R;KK*5R7XLN"6<:L( @" T0_-=I^7IZ=?MG@
MOU:%4K]XJ7\2/CJ;T^"_Q'AOM5COUI"JBD]5 $!1+J#V_P!$[I;/:XT'N!D8
ML1I'46%OL?FLC)(V*.TM9[::*69SW>J R-Q/P+G^YK.UY&"K.\T6,YIIOQ7#
M]IM-DR<S%W!7=M5<B-51>WB:;EU]'T\GYFI<SG<;UGZ=Q>;GRV0O'GYSQSGV
M%U<WDTTT; 7@QNCD>6U!'8M]@W79QX2P72RH))_[*2T]U*&)N?1<SIK<;:5V
M4NIQK^\^+]YVYO(7\L.9[6N\P\M\1P8R*/5CHXJN/*UHC9D Q@J:=@5QW7DR
M\M/JN%E8_EQZX1I9]C+E=COHT/20W6.F-R]O>JG.:[AP&0L\I!'C-1MR,4SK
M6YM[R-LS+6_G?&'&(?& X%;S8,_<>TMQ_F5V#<.EZ-:4:\>!SO<.VX'=&V2V
MKS'"LE5IT=5[.)M=:*P%OHW2V#TQ;S/N;; 8RRQ<,\A<7S,L;:*U9(XN]8ES
M8P2M+N%^]NVZW-QG\MNXZT-I@;>MHVRUAMN3MQ23?$FV*G.X@T!IZM/<]*LJ
M'3+5U,F*;76OH9V545! $!\+F1L,,TL@!CBADF>3V 1-+S]8*W>N1M69W9?3
M&+;]R6I5&'7)1YMHU@^I[5>B^H3JQU)B=?\ 4ED]GM Z'F=;RV^+DO)Q-(]T
M\;6NCLKK@2\D=@I1:_LS"QMRVC,W.$V[MR:\M>YZT-CW9<R-LN[?MG0E:OPE
M67/1&0#H8Z3MMM(ZEBW7VSZE<OO!AC\3'WMS<M#32(T?:W-S)*VH8./+3CVK
ML99F5B[<\7(M)J2TG[O[<SF;-BPIN%F;K%ZIF7.YO;"R<TWE]:6?,/5%S<PP
M<U!^E\5[*T7+NRY7?-E*B?(VJ?R]-##IYV[K7)]&.:N;')8JX;9ZJTJ98H\E
M:.N"'Y1O*8H!*9)@:?I0:+*T^ 6B,@/1T:]-FTQX_P":.([01_\ F-OW%%P)
MG]1<TI* @" ( @" ( @" ( @" ( @" ( @" $@ D\ .)/N! 4ZU%N7@=/SBV
MDE$\W.&/:QS?4-2#7CW445Y<R=.93;<3J2T=H.UQTSB;^:^(#H6^KX0-.UW.
M*FJQ[E]PN="6AL<+;IY=MW%]*.M<;_:>SNG&2XL$W>0A+6PG])SL%17F_HE=
MA=3U7$P\W%NX\^A>)0BX!DDEN9>5LDKW2$-=4MYG<WZ7CWJI5;KS*8PE+Z^*
M*W;.P:DEO/:V7$C\2W@YKW.+:?8QPYB16BE5J4-=+HRZ!20$ 0! 0<X,:YSC
M1K07.)[  *D_ $!;MKC+:.U?F8\--<B*YLR\.NP:M/*'5;2I'!RC1K4GA[RA
MV8BLK7)2VN,?XEK#ZH?_ #]*BO'WE%$']YX3)@^X?;MB+ RA+^YU17AV>A."
MH.9VRX$$-' 4[_YNTHN-0/BNHWZGP>DIRU()*UEK8:(^;C/;FYM\I(8"YKJ&
M+F=X?$!P]/>K*RI6+KIP-IMN!<W*;MO6$3[VVAM*7,\>H'6-O+<738[@7,CH
MOL3G@2CUG--.)]*Q_P!-"Y>\^7&M2,S==PV_(_E5BOE/3]AW=409-F(GNL+&
MV6:R@>ZW#*2!_)&YP (#@*!H6=F)PQ/-M/2A:P[BQ<_R\BJN2:J6S[5;J:ZS
M.N;W$9O%R>R&9\,Y>QP,(:\,:1S=M15:+$RLJ[>Z'XG>;KLFTO;/YDZ>>HU^
MXJ!N9I;-760@FQN1ECBNG-$ML"]L8B=7Q*]C>#'%9V5;ORKKH<UM.=AVK"OI
M+SJ_@R49-I,1AKJVR]SD(/P>:ULERZL?.9" Z1O-3FKSU':L*QCX\95NF[GN
MFXYZZ,:M"FUIM7HK7^^VFVX;(GEFO('BW),C2;6:)U>4APXFBU\[,/YD_*^B
MIT6)F9FW[-<CD/\ ,I^)GHPUBW%XRQQC*%EE9VUNQP% X10LCJ!PI\5=;&-+
M<?&AY!=NN[>G)\6V_M/38"&@'MX_FJJ5*Z%N-::\3DH)" \G/?XCS7VIR/ZS
MF0E<31<\IS^/BZD/MEF_UQ*J? G]^=?8;W*J*0@" ( @" ( @" ( @" ( @"
M ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
M ( @" ( @" MGSH/[=^%/=R_\59L/X!*+EQV#WEA$/B10! $ 0! $ 0! $ 0
M! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $!BR\Y_169U_P"73U Z;P,$
MUQD;C Q7$<4#7OD=':^-)*0V-KW$-9Q/!;KM^<;>ZVI2T5?VHU.]IO;KC2JT
MF_L3/R^+:P.'Q%O9S3.EG9D,I!.PU)@D@NI(W-=7XIYVD<5];X4E#;;23KIQ
M^!\HWKUS*S,BXH]$NJE/'5GU9'(6!Q;ZIX@U'9[WNK*C&?35\"A=:5)#EJ:]
MH[_S/S4I5D1?5\L>*/I%&[VB(=C#7F(X\H[SZ>%%/3)35.!,WT8\KDN1M)?1
M;]K=02=0>]VX-J)KC3EK:6$4MWZ_@%\L-D&M#N4QEW,>RJ\-]4[F.YQC;EU3
MK_>>O>E4<GRI7KL.FW-:?;6OWF]J&GF+CPX\/=X4^!>*0E6&O&K_ !/:&OFJ
M?122$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M 0! $ 0! $ 0! $ 0! $ 0! :Z_TF;^+DUG]ML3^JSJ.95_RW\"YKR%?XL;I
M_P#[AO?U.Q41X"7$S'*HI" ( H=4M.(.'$EON5K\(5NW/K@XR^IAK5-&NAYU
M/G%WG0PW$[6;-&#)[LY>*4Y!OV-\N&;+#="W=R&[C<'$QAP-*BJ]%[)[-AO+
M>1?7Y%?M.'[H[HEMEV.'8_CRK]WX&K;H?SV>NK;[7YW!N=7W6<M+J_BN,C@+
M@R/@-G)<LENX>63(&.A@YFKU;)].=H6.XJ"ZFO[<CSR'>^;/<5<G?T3^GV<^
M9O9^6QUYZ4Z^^GS!;JX:W9CL]#;6]MJ7$-D8\VM\+> R2>K-,0)97GOX+PCN
M?8KVP9LK4U^6^#\4>R[)NV/N^%'(L2K7C[S(BM M=3;! $!3_=5Q;MQK8BM?
MP8S@]4D'CC+D<".(/%<7Z@3NVNU<J=AM7*+\4;OMQ.6]8R2J_-C^*-2?RKNA
MWI"ZA]WNJO4&_6D,1J?-V&K'#&SY[5#8'Q,FR,[IFQ6D]PV:G,\^L#RCL[U[
M#C[+MN)Z,=N9MB,/U]_K\UIIMT556FJ^)P&X;MGY?J_O>%E2EY=B%OHC2B5:
M</'X'#S?.GCIYZ$++9K</HNAM=OMV,KK3'6D>.TIFI<I)FF/R5LUC9[2RN73
M1-;( "YWJD"E.!7/^F^9>R?51;5:E*]9_22<H/6,6XRY\."6CU7'FCL-_P 3
M;KWI]G[EN;4+]BY#RY_O5T=$N/V%AG7QE?,<U)YA'1GJ:_AGAU#D+?3\^BH1
M=&%LT$MO92Y%]Q;AX;S/CD)/.":E=#Z282CW=W!8M45B,GYO-4J^'^@QMPSK
M\_36QF+ZI4Z-.+\?BS>XVC?K9^W6C6[C-;'K5V#QWSY&SE+?;?8H/: 2WU:B
M?F7,[U&T]WFL%_\ I_6]#6[/<R_Y?!;CIER6O["S3S%NJL=/VT&4TKHF9MUO
M%N#BLGB=$X>T<)KP3SVES!+>>%#*)XS;D@@\O:N"[MM;IW!BW>W]BZO/<4[D
MU^Y!5ZDZ>*.QV%;;MLUOF^2Z,*U-43_>G5=/PJT:P'D$: W/T'YBF][M[,YE
MLQKS4%S>Y65N1R%Y.+5E^Z.]CB$-S(X,#62$< O?.U?Y5'T/CB;9-3NV9Q5U
M^$DTN/O.4[WENN9WY8W'<;;MX=R+\C_:5/#W&] O.#)" ( @" ( @" ( @"
M( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
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M<_PM/[-35FZCOHQN@.H'>G6.\4W4GKS3MSJ[(2WTN&LYK[V6T,MQ<3F.(LG
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M7<Z(W;SV!PMX[(1SOM9A))C6.E<9@X/'/+)S=JV6]XZQ=WNV8*MJ,W2GMY?
MY[9;U_/V6W=O/HRJ4^SG\4:N>X_E8^>AIW:S4V2U9U#92]PF*LI,AF[09:>X
M]HQELQTEXUP$AHPP M/=Q6%15K0W:4Z44M:>!L[^14V2U\O[;;%Y ^+GL9?Y
MFSS=P?C3W\$L$-S(3VDON(W'X45>92ZF9!5$! $!3?76O[?1[(6NA,LDK@.
M) !)'I'H2I#3:T)HTUGHM0XN#(1L,?B-!+2"*5 -17WT)]A," ( @" ( @"
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M@X4)='5JZ<3]*GR7_+_=T(=*NGL)J>V;'NAK>RL\YKF0AKIHKB:"&2WLI)/
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M2U::H;\4$_CQ02@$-GABF:#P+1(P/H>^O%<FU3X,QTZ^YG85)4$ 0! $ 0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
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M&Z[JCXL\T]4-WR-OQ.BPZ)JGVU-I*VMX[6W@MH6M9%;PQPQM: UK61,:QH
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M,MC?B7$,D<&@1EQ:X\SF@@^E=)C7'=MJXT>9;DX6Y/'BNGIY%XJR$ZJIJ I
M0! >3GO\1YK[4Y']9S(2N)HM^4UP\^+J1]W)9O\ 5Y51X$_O3^!O=*LI" (
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M]W#"_P#!_P"*LV'\ E%S [![RPB'Q(H @" ( @" ( @" ( @" ( @" ( @"
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MPR2* ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
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M;RD'@012AJ%/!Z E%F@M-1Y,95F/C;<AQ?V-Y>>O-6G+Z52DEKS(:3=7Q)Q
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ML;I__N&]_4[%1'@)<3,<JBD( @" ( @" ( @" ( @" ( @" ( @" ( @" (
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M $ 0&B'YKO\ 'T=.OVSP7ZM"J5^\5+ZX?$WI\%_B/#?:K'?K2%5(I/50! $
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M?[Q>VJ $!;/G0?V[\*?Z'\Y9L/\ IZBJJ7,#L"P@$ 0! $ 0! $ 0! $ 0!
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M=/\ _<-[^IV*B/ B1F.51 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $!Q>]D;2][
MFL:T$ESB  !Z2>" E?4.J<?A<-<Y03Q2AC'B(,>UU9*. ['=S@CX!-,MALMU
M=26^4ENY)W26CY''P#Q')SU ^.>UH4)N@HN95K&[U8::-OMT)MW\ 2"""> )
M(YO2E:^X?B51PNHL5GK=MQC[F.0.'%G.T/:>'#EYJ]ZD<JGNH @" ( @" (
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MZKQ0^!7#21K-_1._\VNJ[\>+S[\*7];*5]"-Q9" @" ( @" ( @" ( @" (
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ML3 6\Q 7,;Q&:O5MINX>L]GRP,G$_3[G))4YEU^QVJ=4:SVYQ.7U?8OQ^6?
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M $4 0$":<2G$$4 0! $ 0! $ 0! $ 0! 0) %3V)Q!% $! D 5/8G$$4 0!
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MKG9FWX]YNU<;3Y^*\3Z)VW^G[LKU>QMG]2]RQ?TV?CVH3A#ATZ1E1KIUU\?
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MOW/M=_B;J?[R7RA\ :3GT<K^,$ZT/QKRWWX<G@5\Y? WE5)0$ 0! $ 0! $
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MC4?O(/Z6O<;*/0?^]+V._$+3WWJLT7 KN?47=*2@( @" ( @" ( @" ( @"
M( @+7>L_][/NU^*>5_65PJ9?2R8\2Q?R0_WEV"_&C57WS*E!\$9BE) 0! $
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MDH" ( @" ( @" $ BA%0>T'B$!TX+"SMI'RP6T,<C^+GLC:''C7M J@.X@"
M( @" ( @" ( @" ( @" ( @" ("%!4GO/;\" M)W]M79BY&(O;KFM)HGMBB8
M:&(N9(!7E->UWH5F^I.-(HO86;?P\E3I6"9:!IC:W%;?9&ZU)D,@?"#W2P N
MH '.YZ$'EKQ"UT=M4Y_J+SHSI\G=KNZP5G'5;M.!5?&9FTSL3KNS?SLK2H%
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MY.V#W<LQJ#XD9/9WK/E/JQZ\C C195%P-^C"_P")L3]K+#]:Q+3OB9IZ: (
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MF%:5%?145^H@(H @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
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M^;?5=^/%Y]^%,OK?B0OH1N+(0$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
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M_P!*LR%?(]A*H7+#L'O+#(?$B@" ( @" ( @" ( @" ( @" ( @" ( @" (
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MT\SL1-<UQ]2@-.-??[O?5NU*=R-;JI-$M*+I'Z3[JZ2$ 0! $ 0! $ 0! $
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M_P ,#TFJVD77%J8=/\V;N.%_Q/B?M98?K6):LS'Q/30! $ 0! $ 0! $ 0!
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MW?B%J'[U7BA\"NW]1K-_1._\V^J[\>+S[\*7]3*5]"-Q9" @" ( @" ( @"
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M/^=2C#$3776G7\M:>\W&_8E[MR"GN5%U<HOJ>ON,@\6YVAKC1+MP[/46-O\
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M)F.512$ 0! $ 0! $!UW6EL^9EP^")TS 0V0L:7"O \2*H#L( @" ( @" (
M@" (#S,Q+=08V[ELF\UTR&0PCM]<-)'UPFO(:<^!1';3+ZSOM09!F6BF;8F5
M_/X@> WD=1I;S^GW$7M)9[6[4VJH;6S.GVREGB#Q/"YZU!)X\G'N">[B4ZD[
MZ'GS-Q@+23-L<R\Y '<U>8@ =H/%">&A." ( @" ( @" ( @" ( @" ( @"
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M.&.WM;6&.W@AB8V-D<430QC6M8&M #6]P7H"5%3DCYIE)SDYR^INK.RA 0!
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MWETS=8HM3C&M8Z,N_<[E'N]RQ(.4IM-?*BJ3HO:<U42$ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $!;-G?W<,+_ ,'_ (JS8?P"47,#L'O+"(?$B@" ( @" ( @
M" ( @" ( @" ( @" ( @" ( @" ( @" ("!<&]JB3Z8]3X(>PX^(T<:_FJCS
M(]'7R9-'7IYEB?F*]8^D^BCIDUYNQG+N YP8JYQ6D,09F-O,GGLG!+:V M8?
M&AFD=#.YKO5J:@+INV=CR-^W*&-:7Y*:<WR45Q.=[FW[$[?VN>;DSZ'2D=*M
MR?#3WF*_R*>CK4UG@=:]>&_EI/DMYNH')76;PSLW',_(Z?P$ERZ6S; ;V$W$
M(N8'@ AY% NM[ZWZU)0[=VR26!823IP;Y_><MV1L5Y3N=R[I"FYY.NKKIQBU
MX:&QO"RE7GXSR2?<XGAV^ZO*HKRINTM8^)Z2OF^=Z,["O$A $ 0! $ 0! $
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MQUDU[3VM<VVB#FGW00L R#T4 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
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M;O'YGN=B*OP!$<SN%>'?V? CTX$BK1Q''T#C\*:\&00]7T5]VI'UDH34B '
M"O97ZZA\2#B*5X]BJ?B#F&^GO[1^9Q4-@XM]![_SN*/Q!R<  .%0/=[*J$P?
M2"ZN;1XFL9W6TP_3L+JTX=X(*ARIQXLN1MRG]'(KSM1KJ^GN),3EI_$8T%S;
MB5] *-;_ #SE<E%V]9\RBC;IQ9<!8Y2PR/B>Q7,5QX1Y7^&]KBT^\"5":DJK
M@'%KB=X$'L(/O&JD@B@" ( @" ( @" ( @" ( @" \/4&"M=0XV?'W50V5A#
M'@D%CB" [W@A*T)$T)MK;Z2N[F]=,99I'.\/B0 TGMI0=P4=-'5$%5U(" (
M@" ("3=Q?W/M=_B;J?[R7RA\ :3?T<JOY07K/X?^U>7K]V')X%?.7P-Y924!
M $ 0! $ 0! $ 0! $ 0! $!:;US?O4=[OQ"U#]ZKQ0^!7#21K-_1._\ -KJN
M_'B\^_"E_44KZ$;BR$! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M4EW?P\N3TXZ>.I%GS/<&DUHX&I( -:(3["W'1.J;S366MYV2R.L"\LGA+G<M
M06M["X <0J.M+@3)=*^;@>GN%EG9G.,OW$>"YC?!+2'?I34&A/95'),A]2C7
MD2#XD?.(R[USV#^;MJBDI.G,JC;G*R[ZIT1XGF:DR4V&QK;ML;7MG<V.KGAA
MB!<074)%>'%75:\6M/:58LI94'/'C)QCQT9YFI&BWV^S%V_P,I9W%D\S1\T<
MWJO@>7MY*O[&NHL#)N8UW\MO@9FUSR([G"]B)J47KRYEM.S6UVR^JM$YV&'
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MZNO[9N2A=<9IT9XKZBX\<W;5G0FNB/M57QY&P0WL!I2HK3W^*[H\'X$4 0!
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M=?Z3-_%R:S^VV)_59U',J_Y;^!<UY"O\6-T__P!PWOZG8J(\!+B9CE44A $
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MA<QV\4YC<YAE@>WFC\3D+RZG<M=^D_08;E+1FUSMYRNX>X+.-@)RA"2X:\S
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M-#W<>Q8]U7/W:])D6)I349?26U;IY;<+)7,N!M#=6<E&QQ20ME(<\5#36/\
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MMF-"$8KRE_ 2T/35PJ"IE]+!2_=K;R/=3;K5.@)KQ^-@U-C;K'/O8B0^V%Q
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M7BG*ZO;Z>W@J)17U1^HB44OG6LA"WF95\?(2>RONGT4HJH.:X\0W*:^<YB(
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MJFA[NG-;X/4TL\..N0Z6%Q!8Z@+J&AH*U* G! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $!)NXW[GVN_Q-U/]Y+Y0^ -)SZ.5_&"=:'XUY;[\.3P*^<O@;RJD
MH" ( @" ( @" ( @(.<&BI-%1<FK<>IDI5.H+Z$R&(U#VCB*<!\*N03G:\U<
M&6W*E[RN?B?07,;A4$FIH!\*MQN1DFUPCQ*W5*K/L7!HJ30*'<BJ-\&2DWP(
M,D;(*M^$*]*+CQ*5)/0M/ZYOWJ.]WXAZA^]5XJ'P*X*LC6<^B=_YM]5WX\7G
MWX4R^HA?0O>;BR$! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $!:
M/OKT]X+6UZ-9S7<MM<V%)IK8%SH[@M+G &C7#M/>L>6,G)R3-SM^Y^1%V[O"
MFA1AN)QDV-&%DM8_FN/EC= UK6<_A#EJ2&BM:55MXT>3-6LO(CGNZ_X7B4,U
MAMS\S:JQ&O<9FW8K#8B2LF-?*60\KG5/QBR,\ K4[3QOGN?0SK]HSX9N)=L9
M2K<I\J*SNS&&RV)9J##,LLK+#"WEEC;;RRLD;'ZYYF\[QZP]*OV<B-_Y+*3H
M<O;M[A9O3LY;E#&;TX\*DKZ;U;D<WDI+:ZL7,$;G-;*X$<HK0 5K12HSG-Q:
MU,V_M6/BV5?M2JWJ3U&9FB668\&\0WW!V?F*Y7R])FKI.]*DOI*<;E#/:AT/
MFK''1R,$\$D0=&7-?0QRL/*6^M6CEBYEJ=VRU859-&]VN6/MVX6\BVE*C52Q
MSILZ4,OA=S'[AZBO;IN/L[R6:"WN#,X71DF8]P?XL='!IKVE:7;]MRK61UY2
MI&IZ7W?WWC9^PK!V]+]0DE]A3?KFZ7]Q=P]W[#5FC()I\5E9+:%MG:M>VVM8
MXW/C<_PXHC$"YKJ^ZL;N#8[^7>C<PE5<S9>G??>Q]N[5);M%/<))TKK30R']
M(&P.N-"X'#Z-O XXZ..";(7)A+2#RV\I:7>$VO+0K>;;@>1AJW=_B\SSKNK?
M,+=MSGN4(]<I-T7VF6_'6;,?96]G'Q;!$R,'T\K0"?AHMJE14.(G+KEU4H=U
M24! $ 0! $ 0! :>OTLC_,'I<_'ZT^^L:C]Y#3IE7V&RAT'_ +TO8[\0M/?>
MJS1<"NY]1=TI* @" ( @" ( @" ( 33BH;256#K^TQ@%SCRAIH:_[R55$_$B
MNM.9R$["SGKP]'?_ #45-N:NR:CR*KB\OZCB+F,D@$GE%2:>Y52I1DW%<40M
M6EXG&*\AE<YC7'F::4(52:<>I<"F,NJ3CS1;1UGBO3/NV/\ W2ROZRN%$N!<
MA]18KY(=!T78(?\ O1JFOW3*(.M%7@9BU)2$ 0! $ 0! $ 0! $ 0! $ 0!
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M $!HA>:[_'T].OVSP7ZK"J?$F/\ $C\3>HP7^),-]JL?^M(540>J@" ( @"
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M,'$\O%<+W\0KW[N+JW"-W 7583.6JK1N@\+!80!TUS<\+BY=&7$#C0-) Y>
M[E3*'EV?*G]17CW)[AD+,NRI!\CS-,:6&JGAMUCI9[&Y:6/!B?5YD#6]IC<:
M O6-8P(7)_,_E,C<=PN8<:XT^!?3TS]-VG]L)KS5MM9B&_R8YH&D4>UK^4O)
MK&PBM*+>6,2W8:Z>!S6X[_F9^/\ I[KK%%YXK3B*'T+)-$N!% $ 0! $ 0!
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ME5'+C4\.'"AKV_H45)410! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
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MD]_>XGTI3FR"+>PT'K#O]_ZW8C]O  'E[N/?Q^HE*Z@A2G!W"O8?13W IKX
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MHXJ7KH2[TGJ=[";4Z<QUOX5_;0Y.0.+HY)HVN,8K4<I<VH*A?+P*97'+7F5
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M#!#!F\6&M@ACB!_LYG%PC:WF)])6/V+>;[GRK4-6K?XQ,ONRS'^2XMV7^/\
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MEM36JH?*WENQ>E8EI)-JAW@:D@BA%.^O:HTY%53DA(0! $ 0! $ 0! $ 0!
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MPJE>TJX\"*D! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
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M_,'I<_'ZT^^L:C]Y!ZQE\#90Z$!3I+V/_$+3WWJLTCP*Y\2[I24! $ 0! $
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M[0"UE >'Z8=OOU*TTK3M*EM5JW4U%J\E"DTZ]*U/1%*"G8JJ4%:ZD4 0! $
M0! $ 0! $ 4.M-.(*;;M;:X/=S;G5>W>H8&3XK4V'O<=*QX:YK9)[>6.&6CF
MO'V*5X=V'L6+>L2OV':F]7K7VHOX]]X]U78:-?M-/C#ZUZK_ "9-^-58$:7S
M&K-B]29N3(L@@M+RZL;JPEOI+B,QRQQPP6A9:0TJ*<"MYM>?#/L+;<_2[;^E
MF)FXMO$N2W&Q\T;G'^WO*/=7_F#:$ZJ^H?9[>S':5N]*V.WEW9W><QDYDFFN
M'6LS)G-<[G-'/(/9RK)[6L0PM[R<I?OQHGXZ4,;?Y.]L]ASUA&5?=J7H=27G
MH:NW9T1%M+TQ;?YNPU#G+"' S9RU@N[Z5K;JV^;GPPLMI'/BCK*VAH2.\K59
M&UY.9?G:^FVWJ_'5F;@[GA8RA>?SOIT5.="_/R:.A35>Q>F,[OWO+;2LW(W,
M(RD5K>A_ME@R\,5Q)(]TT#)@9G<PH3P6US\W'V_;8;3B?P8\:<V8$+=S+S9;
MA?\ K;T]QGG,C>TMI2E/A7/W&U"D%HS9.*33;/NKRX% 0! $ 0! $ 0! $ 0
M! $ 0! $ 0! $ 0%LV=_=PPO_!_XJS8?P"47,#L'O+"(?$B@" ( @" ( @"
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M&NO])F_BY-9_;;$_JLZCF5?\M^]%S?D+?Q8W3_\ W#>_J=BHCP$N)F-512$
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MN:X%CZ\"5JX4A%6I*EY<49:I*"O1=82X,J3'NMIN;*0V$4W-%*0WV@TH'.H
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M,NI3U(L=:QL%/<:U%P(G]1<:I*0@" ( @" ( @" ( @" ( @" ( @" ( @"
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M>5S7<\G$+$O6)6N/!E-N:N*JXF4@+&BVU5\2X%4 @" ( @" ( @" ( @" (
M@" ( @" ( @" ( @" ( @" UU_I,W\7)K/[;8G]5G4<RK_EOX%S7D*_Q8W3_
M /W#>_J=BHCP$N)F.512$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $! D
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MI5=#DR)\@)8USN7B2 3_ +U$F_+TEQ)Z76AP( -*]G \#^8I::75R)Z72H(
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MZO>9 *%E6O%"TD'WZKE>/ WA\RWL 'IX^G]"BK3YD -KQ[%&BX$\3Z-?R/\
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MF#TN?C]:??6-1^\@_IE\#90Z$/WI>Q_XA:>^]5FBX%<_J+NE)0$ 0! $ 0!
M%3675[ 0-:<!4^CL50(H#XW$++F":WD%63Q20O'I9*PL</A:Y6K]I7K,K+^F
M<6G[FJ,JA+HDI+BG4M6VRZ/]J-IMRM1[J:3QCH-3ZEF?-D9B\$2/D?SNH P4
MJ?=61M,Y;3L;V#&=,)RJ_?6I;W:*W?<K.Z92KDV8M1^*H>3U2]%6T75?A[6T
MU[C#;YBPJ<?G<>YMKD+4GQ*TN88Q.>,G\\L';L>6U;M<W/"?3.ZJ3_VC91W&
M]+;)[7>^;%N4JO"A0_IV\K?8+8#6<6X$$61U;JBRH[&WN?NY,A[&YOA\OAMO
M6S$4\(4H0MIA9E_;(77A/INW7\S7%UXZFIS<>UN%JSC9.N/9X+\#)7[.#R&G
M)R !C&@!K0.QH H* +#K.+;6O5Q+Z48R73],5H6T=9W[V?=O\4LK^LKA5/@5
M0^HL4\D(UZ+L%[FJ-4_?,HB)4HJ&8Q24A $ 0! $ 0! $ 0! $ 0! $ 0! $
M 0! $ 0! $ 0! $!\9_$Y1X;>8U[*T]"B5::<2'*4=8G(#E!(;ZQIPK6I_.4
M/J4=.(II7F==K)GR.$K6F%S2US'4>UP/"E#P[$74_J)4FX],HJOB85/,(\OO
M.;P:ELM;;;6XBO[J>,9""!E!5\DO.[U+=U/ZK7M7.;YM-_/2\A5/6?3_ -19
M]JJ5K*E6PUI]WM+W.B#I=@Z:ML[3$W9$NH\G!$_,2EHYN<1P<K"?"C-6NC*V
M.S[>MOQ%:N+\_F<GWKW'_P!R[P\ZRW^G?!?:7M'T@5(]VBV?,Y+D0)=S  5:
M>T^A22DJ5?$Y(0$ 0! $ 0! $ 0! $ 0&B%YK@__ &]/3K]L\%^K0J$]&5IU
MG!>\WJ,%_B/#?:K'?K2%2B@]5 $ 0! $ 0! $ 0$'5IZO:I5*Z\"'6FG$DS7
MFCL=K_364TCFH?&P^;M9;3(,K0NADC<QS1P/:'+ W+"AGXCQIZUDG]C,O;\[
M(V[,CE6-))/[T4CV"Z9MO>F[#93![<X\VECF+F2YO(WO#N:223Q'?I&U!*W%
MW-O7L2S@7=<>U&B^RAKHX=A;C?W-?+DWFG)^+1;=U)^6CL=U(:KCUUD[>]TI
MJH\PO,E@;I]A+><WB5,QLVPN<3XI[7%:#&VM84[L;,W^GN.O3R1O;N\7LW$M
MXV9!2E9^A\U\2H72]T*[0=)\=[=Z!QC[W465 ;D-09.07=_)3PP2)[B-T[:A
MG\^NECN%Z&UK:[;Z<>/)<_><\\*U=W-;AD-RE33V%Z<+9P7E_&M#2H[>]:Z<
M5*ST?O&0E)7&_P!UO0PW^>+^\YOZ\/\ K7I?[Z-5,4U!)\47EP9D$Z//WMVT
MW&O_ %2Q''L__,;=5+@)_47,*2@( @" ( @" ( @" ( @" ( @" ( @" ( @
M" ( @" ( @" * =+(64.1M+BSG8U\<\3XSS &A<TAIH0>()4C\"SS.;9:CL\
MXZRM;9UQ93W ?'.T$ ,?(3W,IV*94;312X0ZZKZ2ZG2.#_!_"6F/=3Q(V R4
M'8XM;4'@*T(4%<J5T)G0@( @" ( @" ( @" ( @" \G/?XCS7VIR/ZSF0E<3
M1<\INGY>+J0IV_.6;K_X^7\Y4+@B=.J?P-[E5E(0! $ 0'%_Q3\'YH4QXD/@
M4_W3 .V.O0>_1^I/O1>JUD?PI_[K_ V6S?\ N>/_ /5A_P 2/RY-?V+?VXMV
M#W.U9G/1_EJ]^HO!<RKR)^"D_P 6?J1M%'L.+7CY4?\ A1+S;$ \01\ "QNE
M+F9$6D]"/L !()/#WN-?=HII75$]2Y#V!OI)/OC] **,CJ?(@<>.)!XFG:?S
M5-!U#V #O+OYO>"):CJ?(J9T_P!@UG4OLB^I!&JL6?33_"]AVJ[B1?\ ,(+_
M &X_BC6;_D6[?:>=:G];M2_X6?J'Z4+6Z5TP">W3^& ]W_!MLO?):J-#\N,E
MTR;G^_+\6>Q+' T<\@KR<>_O4.VG/JEJT6+CK'JEP1UF31NDYB2 X4[#2G9^
M:IN2E%]258(JA&4[7F2?R<D?=D,;&GE90/-2*UK3C7W%=A)W4I,MJ,+&MI59
M]2US?6)_['T?"JW*'TO@0^NO6OL/NTU /I5+5&5+5$5!(0! $ 0! $ 0! $
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MQV=JN2R(1I.9DD?*7N<YPKS&M.SW>Y<S1F^!%.SM/9^>E:\>!!'@2"!6O?\
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MRNC>V.75&JN1Y!#74R9[">!1$M/F9AU)2$ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0$" >! (]T _FH"* ( @" ( @" ( @" ( @" ( @
M-$3S7FN;Y]'3F7-+0_)8(MJ*<P\6'B/<5*YE23\R+Y:F]-@O\28;[58[]:0J
MHI/50! $ 0! $ 0! $ 0! $ 0! $!AD\\0%W1W?M'$G5>EZ#T_X4:H94N#,@
MW1_%)#TW[3,E8YCOP1PYHX%IH;&WH:$ T*+@3-UD7*J2@( @" ( @" ( @"
M( @" ( @" ( @" ( @" ( @" ( @" ( @(%K2:EK21WD GZJ B@" ( @" (
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MA4C8*V+>H_9=Q9Q&JL7Q]WYWL.RO8LO#3_F-MOAU+\4:3N95[=RW_P#<I?\
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MX87_ (/_ !5FP_@$HN8'8/>6$0^)% $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
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M\<V4R?/[3;PW'*3=L(,7BM=X1;7@1V+.RY=<>KD6,:O2V;;K&,C:&,:UC6\
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M_1@.Y.'\[S47FT755.[:I\O@<'6\\'*9&<K7BK>(-0JFU\2DX-:*M8UPYW<
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MZEP)HTY>92POSE+;,X^QNVP7%R1E+RU8^XBM8C+((K:\E:9'!C.% 35:Z_\
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MX+9&ND@:2'Q1M/9WJ%2FCT'S\X_>5B/FL^?8VE>G3(]]?\!S?UE1H^#)I/\
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M7,G7RG)]*\%R.XV':;6S[;;Q()*:BNKVRIK]Y>PM,;D( @" ( @" ( @" (
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M 0! $!\R 7UI4CM/HX<.'?56G%QGU\F3HU1\4:O/G+;'93;C>+2?4;B+::?
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M6&T;KJ10! $ 0! $ 0&NO])G_BY-9_;;$_JLZCF2_P"&_@7->0K_ !8W3_\
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M!TSAGXZ:WB<ZYB?%'"V-H#!RFCJT''@I9*+3F0MNO:;IKO"CYW/8QW#F#B2
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M&G3I6E"BG7WYN6F^B;>336S[-+W63R%YD+:RS,K8IRU[;JY= QS")HP:-;W
MK>]N=K6.YL%N+2N07["G>^Z<?MJY&$XIN3XF4_:;<3&[O;:Z9W+Q5K)9V6H\
M?;7GLLC7L?$Z:V@G<"'DN[9EQ&X8\]OW.YM=SA;9N\&4\S#CNO\ RKNJ*@$
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M)R<FY(2=7H7T?,>$[\-BON?:?UE6>N259K0CW$?F+"?Y'Q7W/M/ZRKB::JN
MJQ\Q83_(^*^Y]I_65(JQ\Q83_(^*^Y]I_64%6/F+"?Y'Q7W/M/ZR@JQ\Q83_
M "/BON?:?UE!5CYBPG^1\5]S[3^LH*L?,6$_R/BON?:?UE!5CYBPG^1\5]S[
M3^LH*L\[+8/$'%Y1L&%Q+Y_FZ]$3#C;-P?(;:3D:6F$AP<\@4[TH^?TD)JOM
M-,CRQNGCJ!TKYW'47KW7&TU[B=N<O>Y<V6?OL1-\U3QODE\!]J)[%EHP\I!!
M8[AW**VXI0CQ*81O2N3N2_AZ4-TCYBPG^1\5]S[3^LJ2NK'S%A/\CXK[GVG]
M9058^8L)_D?%?<^T_K*"K'S%A/\ (^*^Y]I_64%6/F+"?Y'Q7W/M/ZR@JQ\Q
M83_(^*^Y]I_64%6/F+"?Y'Q7W/M/ZR@JQ\Q83_(^*^Y]I_64%6/F+"?Y'Q7W
M/M/ZR@JQ\Q83_(^*^Y]I_64%6:ZWTDW:#<S<WHB&F=FMO#JS-2:DQD\]EA<3
MS7PCCN":B6QLY;AL;:5IV<4C:\R2=:)#J?2XI5DS(-Y26W^>TAY?W3YIW<71
MUM@M78O2D4&4Q=]C(8[N"0%M/']HMHYG2=HJX5X442I!5Y(-RJ9(Q@\(?^9\
M5]S[3^LJ(R4H]2&H^8L)_D?%?<^T_K*J%6/F+"?Y'Q7W/M/ZR@JQ\Q83_(^*
M^Y]I_64%6/F+"?Y'Q7W/M/ZR@JQ\Q83_ "/BON?:?UE!5CYBPG^1\5]S[3^L
MH*L?,6$_R/BON?:?UE!5G!^%P;2T?,V*-:T_P?:?UE4MM<%H1U-'PNL-A_9+
MLPX;$OE;;3F-IQMFYKG^$_D:6F$AP<[@0>U3[BJCCKPJ:8'2=L'OYC?I".Y6
MYVH-JKJRVRO[C(0QZCFQ,HPSX)1)&UT#'V+;%CO#=4%KJ@]BB#2BNKZM2J:J
MVX\'3[C=)."PG^1L5]S[3^LI+J7THH]X^8L)_D?%?<^T_K*FM%5D5'S%A/\
M(^*^Y]I_65(J/F+"?Y'Q7W/M/ZRA-6/F+"</\#8K@:C_  ?:<".PC[#VA"*L
M])D;(PUL;6QL:*!C&AK0!V  4#0/<4UTH1SJ<U!(0! $ 0! $ 0! $ 0! $
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MCXK[GVG]90BK,%7TA?:O7^XWEYZ^TCM#H&/4^HK_ "&)>,?B,4U^0<V.2?\
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M>'A*B[DRG%I<650C&'!:F>:-O)&QG\XQK:^GE %?K+%5::\23FI 0! $ 0!
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M$_JLZC]Y%7_+9<UY"O\ %C=/_P#<-[^IV*B/ 2XF8Y5%(0! $ 0! $ 0! $
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MMP456&L674V]'Q/JJR0@" ( @" ("5=7:RTWH?$7&=U1D8<9C+5CWR7$[@T
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M$L)UMLU%M9%R<G)-0CP]I<M%.V5I<*@ T-5J[WY-*\&9%N77[T?=0G55*PI
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M/-ZOFDJ2?(C[,!W<#[@[E&G,=2K4>S T'+Z>-*T_WU'5<<J/Z2JW.-M.FC.
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M=PPO_!_XJS8?P"47,#L'O+"(?$B@" ( @" ( @" ( @" ( @" ( @" ( @"
M(#YRO+&%P[1V>^J)UT2X5&O+B8N?-BZX\5T4=+6I=0V=_"[=+6MN_2VWF!C(
M?D,AD\NR6Q]HMX&313D6IF!#F@D.77]G]OW=^WF%J*_R\&I3;T5%[>!R7=_<
M%GM[9)Y-^5+LUTQIJZRT3IQ+8/(RZ&LKL)LOE^H?=N*7(;]=0ES+JG4M[E8#
M)D<=CKZ5E_86K+B\@%W&7LE%1SD4"V??F[8]W-6U[;IA652BX.2JG]AK.Q-E
MR<3!>Y;G+S-QOOJZFJ/I>JT,[Y9*USG-%7'WN*\]Z:7-/H/0&J6Z\;A&)LA<
MUTC:$5[Q[JJGU>92'\,B&L*S7YAV5)(0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M 0! %#>J0(!P/8:T4M-<2$TSK.N*. Y305YC^8L:[<E%J2X+D7(1ZDWPH4XW
M*W0T[MQ@WY3)RMDO)6N;C[!A#Y[F<APC:(VN#P.<4J L/<=VLX&([DVO-:TC
MSJ=1VCVAG]W;BL?$BUCQ=9S>D8KGKP+;]OMN]4;PZE&X^YS)8L(R7QM/Z?F+
M_#$0<'Q/?&\.;R\I[UR>W8&9OF2L_<$UC)U47S/4.Y>Y]J[+VI]J]J-?KVJ7
MKRI6O!T:+RX;+P8VVD4,<%I;MCCMXXFM8QK& - #6@ 4:%WKMQ4%:M)1MT/!
M)7+N1==W*;E=;;ZFZMGIL!;P[@!3ZG'W>U+<>B/22W5U.:N$'$@5:?17ZZMS
MG%?+)5J*<RRGJOZ\MA.D?#/N-P-36<NHIHZXW3-C-!=9"ZE(E+6211S>)!5T
M1'$5JN@V/MG<-[O*WAVW[SSGOWU2[4]/<-Y.^Y$8RJOE33>M::5J82]=>?QK
M#V^6?;_94Y'"R/(M9[F\? \QM>YK7%IG+N9["#V!>N[=Z*;C>QW=SIN#Y4U/
MD3NO^N+MW:]RCC;#;MY5G7J<VX=-'HE1NK*J[/\ GT:;O+K'6>]FW5SHZTOY
MX8GY6&1UPRU\1\;'.D:+AS.5O,X_ M+O/I!N>)!SMOK@D_[<#K.Q?ZSNQNX[
MRQ=PDK&2VE3DFZ+CU4IJ9X=I-X]N-Z])66N-M-48_4NG\E$R:&2TG@?-#S,9
M)R3V\<CY(7M$HJ'=_>O)LG:\K:KLK&4I*2?,^P-FWS:^X<:.7M=Z%VS))U33
MXJO)LJ@9F@5(^#O_ #%9A\Z-HWTTKQ9]6N#@".]"IJCH10@( @" ( @" ( @
M" ( @" ( @" (#YN:75'Z4]_#T?54K1UYD2^9=+1\H8G1%P+BX?I23^<JYSZ
MWPT*86U;54ZLY?9N2E/7]-1Z?=]Q6Y13G52I$5E3AJ?0 EM'=I[0J6I)MQ94
MM8TDM0UH;4!M![_;\'<C76JR^H)*.BX$:FM .'IK^<DDU#Y/J)Y^P,!#0#_-
MQ5%KS.G\SZB72OR\#DKI 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M!P>'&G+\/8E(RTD0^K]TY$5!'N?7[D22>A+X'F-]KYWES.7CZI!X4][L[%9R
M+,DU+&?O1%N58OK5)G==&7L:QW;WGAP/;]=3JZ/A-<A3Y>E\#Y<SV!L+!ZP[
M?S3V^XG7<4.J[];>A0]/DM\C7Z\]N,2Z5V<\5@(;J[$<A-#4_.S?<*L]B>9<
M]5\6-SY8JW+7X:&M[\Q[=[TWRZZS5Z#I]AFXV*%-H-N1V#\#]/T^Y5HNI[F_
M]\R/]]EKMRG\EQZ?_+7X%65H3=A $ 0! $ 0&NO])G_BY-:?;7$_JLZCF5/^
M&_@7->0K_%B]/_"G]@WOZG8J(\!+B9CE44A $ 0! $ 0! $ 0! $ 0! $ 0!
M $ 0! $ 0$A;@XW(W^$F&*8WVM@<X/:P&0#E(X. +NU0Z\N(JEQ)>VKQ^I;&
MRF^>WR%CW'PVR<U>!:. =V=Z*M-0^/L*O*0$ 0! $ 0! $ 0%.]PM#,UI8Q0
M>T/@EMS5E"0'U)K6@/$ H]50E:'LZ/TRS2V(AQS9G3.8!S/<2>- .%?>33D0
M?+6N M\_A;FWFYN:.-[XN6OQ@UW"@!K5 69RQBTDNL9/$8Y(7N#7/:6D@.('
M%P:> "HJ33ER(8W&R96Z%BR1L,A#N5[B /<K7@*IHWJ-/B51T1;X;1-Q>9?.
M7D;KN%I$$(Y9.</'+PIP!X*5XOB-:4/EK'<^;.M]CP5NVUC(/-.U@\0BCN/,
M#4<"I;TH115J3+M)JJ2'&Y6WR][62W:Y]OXKS4NY:EHYW=[D3H@>#'O'EH<E
M?MO+9MY8/>^(6Y <"RI;P',1Q'H2KK["-.9V]%:KQ66U!=8QF!;%:Y3F;*2T
M-$9< .:M/5^-5$5-*GM*A8?:/3UE>7MU,YM_#=.>YD1#2V(O]!H>Q2DE[R$W
MRX%.=P-!833&.??03$RR2.\-@;4L'K.->4=E.'P*EZ>\GCP)!TWK1^F'1264
M%92]HGG(H'1EP'&I ^*I]_$JC1.DB\#!:@L\UAX,I'-&UCH@Z2KV@,>&@N[7
M42I2U1T+7M6:@R%SK^".&=T<7M+61NB80'@R%O:PT/!7+-SRVY<70GKE!5BJ
MM<BX^YTW;YW%P6V4A;-2&,M<ZG,.:,5-2"1VE6K$[L5)W.++D;ZE<<[D?E:X
M>!(=GL]CK/-ORI<'V]O]DMK3]*Y[1S@$\M.#@J;/7",HSX-EBVG;C->+T*.[
MA9O*Y',307UB;:UM7"*$-B+&!C"Y@-6M -0%5QTY%6J5&>+!J3+6.,.+M;DF
MTN/C14X "E0:NH2FBT"9X<=W-:9"&[H?&BD;)3D)!HX./#W:*-:5YAJB*S7N
M[_SCAX,4VU++B>-MM*]M6$5 C% '^DA5LCCKR*89C3F2PS6WMU&YL-Z3(R0F
MM>>K^\>ZJ7]Q)X]O+)#(XQC^J-=#(SMYXIF\DC#[CV.(^%5+%LY:<;[^6.J]
MZ*K=V]8G^0OFEHS"WUM:!\N'I-WAP_5#OC@\?^&E[)+?V6!+8&NER4#IIX9'
M.$<1YG74-?C+ONV\WN?N+ ELVW3<<2/RU?AP.-[HP-DVB\MXO:7UJTO'CPYE
MC6U7GE[N;S=8^G-!:$V]RE]LSDKZTQ&)M;6TNWV\.-\:"RCF+XI9(PV&UD:[
MLI0+H,ST]P=BV*>5<<7N]*R=5J:'9N_9]PYL;-A2>W+12::X:<#8/W'ZK>GC
M:;6.G- :WUOC,;JS4UK8RV]C-<6K9+>YOH8Y/9WA]U&6N;*\MXBO!>=6MASM
MWQYYNWP?D0K7X<3T">XXN,XV\B24I%=\>V#,-M+C'7,=Q97ENV[MKN-S3'+
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MLN!DPG+BF4NHQRWCZ4+_ (H::_ I6FG,DJRI 0$F[C?N?:[_ !-U/]Y+Y0^
M-)SZ.5_&"=:'XUY;[\.3P*^<O@;RJDH" ( @" ( @" ( @" ( @" ( @" (
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MKX+^R,IC _F/..'Z7B.'I[.VJX^VFH4EQ-P_J]A]562$ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0'7N+:WN876]S;0W5O("V2&>..6)[3VA\<H<QX->
MPA0XQGK()N/TDKOT!H1P<7:(TDXN)+JZ<PW,XDU)+O8^))5,HPC&C2Z":N3^
M9E/-TMNKB\VZU58;78S"Z1UC=8VX&%RF+Q-A93Q7K89# >>T@B>>:2@[5K=W
MN[E_+_+VYM],HNE72B>NAM-E>VQW6W?W>/5CQK7[-##/M?YA&Y_2Q%J#:7J[
MP.I\_K2VOKVWP&<M<7D[R.^@GEEBMH721-=&&.#>)X>^MQ+<]OW[%M;?@V^C
M*\MQN/A5M4_::_+LWK&\Y.Y5_P#2E*+M)<DGJ3_T&=/FK==]0>N>KK56+N,)
MA=27#;K2%I=12032PR.9*[FCFA;(VD<G>[N6;V]AQ[([0R.W;3ZLS(E5^YNI
MB=V[I'OGN##W:VNG#PXTIPJZ4,WLL$DD\;NQK.WCVK76TG"MSZRY<54E$[ZD
MJ" ( @" @ZM#3M4/1$JE=>!\Z/YF&G 5YA4=_!46$U%J7,IG6M8\# 1YDNV>
MX&TW4)MYU=Z0T_>ZDP^F[F(ZAM+"">>:*"-[B_[';Q&1U8H_YX+"[3W"/;/=
MF1E9_P#[?DIT7*K-QW%:_P"X>RX;-@NFXVI5^"=2V;JNZQ-1>8,[;?878[;G
M4L5S/E\9/J>_O\7D[2&S9;W%O[1%XLT+H^2(.-*@GW5N]LV.69W/:W[(HMMQ
MZM-TJZMNICX^\X^S[%D;?.JW.]!1C3E149L?;*:%.VVU^B=&D 38C!XZ"\I0
M<MTVR@;<-^*VI$K2.SN61O\ N'\QW2>2N#=%[EHCF]FPG@8,;'-MR?O;J576
MM-J$ 0! $ 0! <7-YFEI[U*;6JXD-*2H^!33=;!ZHSNWFI\/HR^.)U-<XRZ;
MAKYG%T5[X$I@(IQJ9:!<]O"W+(Q)1QE_G5*+B_8GK]QL=L>)9RX/(_Z9<480
MMK^OS=;I.DU)M3U=X'4^H]3VN1O(]-9VUQF2O([NWGFF9#"7Q->P,<&]O A=
M5DYVV[EM6+MFWP_]8\N4;W)-M43^!@;A:GC[SD;G_P#XEN+M4Y>)/W1!L9JK
M=7J9UIUC:DQ-S@--YJ2.;1]G=P2P3S1N#'NYHYH1(VC)*\7++V+;\/M+MJ[M
M]N75N>8WYJ\-="WW;NM[O?==NS+JIB[=%J/Q5/:9P8V3>T/>X49V-[.([%JH
MZ6U%_5K4JCQDY>RAVT)" ( @" ( @.+CV"G:'<?10?GJFXJVI4_PL5U1KO[I
M:<U?^5MT!G(M-9*; 0S/,N99:W3K.,'B.:X$)@;P]+EF>EGE86Q[G;?RY5R3
MJO94R>_NO-V;;;6)K*U%=15+S4-G=?6&K=K^IS0.&NLXW;FXAN<W8V<4LTYM
MO$=+)RQPQ/D=]B9W$+FMAW'_ +-[SNYV5%O:\JO53Q?^DWU^*[F["N=NV6H[
MBFG&O-+7_06C]4W7SF^LS;'2?39L]MAJ@:LU/=8:SSUS=XK*6\&--@^"WNOL
MLD)9R5)/$%;I;&]\[CL;NFEM%BXYIOBZNOW&IVC=;/;>V7L3-K_-9V?+C3@J
M)JOO9GZZ3]JKS9K8G0FA,DWER>,Q-J^_;WLNIK6W,S#ZK*%CVD'@N@[EW*.Z
M;G*_!UMQBHK_ ,.AR>Q;?+ Q'YO\:Y.4F_>ZHN.6@-V$ 0! $ 0! $ 0! $
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M8#,MB',]V+OQ&WO<\VLP:T#M-7+6[[U+:+U/KE!K[B_M[C',M.7\-7(M_:C
M?Y;>F]78OK0ZEKW-::R.*Q=YD'"TOKJUN8H+H/G=QAEFA9&\$?SI*[O9'BOT
M?Q-LD_SY.?4N>IA]XY,=S[^_7V%^1",4G[4J,E?J8M=:]%/7))U.OTGE-2;<
M:QEYLF<7:75U);MB,E7EMK#4&D9/$E<)V9N\>VL3.[?W%-XMW^"_>=!WQCY'
M=&W;7E[7*/ZC#7YJ_MJ4MW4WGUCYG'4KLYI_:W;_ #V)T#MWD8[_ #V<REA?
M644W-/#.X$W,+HP(^?W%TO9VVSVO><CNC<*+%N1I:7-::OQJS5;UNUF?:D^W
M=MDWGWIIW/#DJ>Y4]ILV8'&'"Z=P^'@ #L9B["RIPH'6UK%"[N [6*SF7GDY
M-R__ (Y-_?H:[;\:&)BPQUPC%5]]-?O/;CYN0<_QJ<5BPZNGYOJ,HYJH! $
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MZ53+DK?3'JKH1;.'-#@#0]G^]178-32:>K++E15Y'V!!%1V(].)4M2*A.NJ
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M<;C^]:,V^<9C[7%6%GC+"".UL<?:V]E9V\3&1QQ6]K$V&%C&,:UK6MC8
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M9U[Y;9C7O@YW.))+>!:7'L!]"+AQ#XT) P&H[S5NH[K$YIWMEA>3N; QPX0
M/+>%2X'@4J*4545/S^U.EI,;;V<5S%C)^8?9GEE9JNJ1ZP!';P33F0OO/,U5
MH3+XO3-MC]*W4CXF%HN&QN=60</7!9W%'["I4>O,F'1N@K<V=ED<_ +C(Q %
MG.*.81RD%QI4D.")::\2FKK4JZ    *   #T < %(/A=7=O90/N+J5D,,8J]
M[R  /A(0%NVZVH<7?8^$8BUCO#.7">[A:TNCY2X"O)S'X5#K37@*4*#06M]=
M.CCL[>21[GAK>5KB6DN;4F@)%*JG1Z<R>?M+A++0>+Q6DWYC4<+9;YD+97T(
M]6H:6M-&\"14*JK2KS(_843R=YB[N;VK%V[;8QO/+$.(YHW<#W=X"I;KKS).
MQDM39G4%K9XF[/C"#ECMV-;1WK'E:*BI/:$J^(/CE-.973T=M/?,$;[CE?#'
M4%Y[VDMH'!52G*$6UQH7+:3;YI&.#S O+-T#Y@>#P,&H\K%I_5&$GBG%TVZ;
M-)/&R220L-B(YW,YHY".Q=+VOW2]APKG3!TE_;B:#>-B>\3ZU-.GQ^XEO1.V
M?E]^5UI?0%SKBVTU:[@B,8N#-WT6,?=W,\S8K+QO9[B.VFB+9("X%94,_N+N
MJS>EB2DX:Z:\/O-9:Q=D[;MPC=C&+;Y)<6RR?K#\JBZZU]^="=36U.Z-V_1=
MU?V.;E]@O)G6\5NRX;?,B9[.)XV@1S!M [@%MNU^Y5L6U7=NSX4R:-?$QM_V
M.>Z95N[AS_RTZ-T,[.@=-?@#H/2NB67DE[-IW&6=D[(O<\R3/M[2"!Y<74<:
MNA^NO.[TKNX94_EZ;/55?;4[7'M6=KQ(6.KJO..OV%%-X.CGINW_ -5X/7.Z
M>@,9FM4Z<G9=6&0=#:LD?/')XT;Y3[)(Z7EDX\2MG9[FW+!M_I;4I*WPY^XP
M-P[<P<N*RI)=7'^VA<19V5EB[&RP^*M8K#%8RWBM+*TMXV1Q1001,AB 9&UC
M:B-@'8M9=E>OS_576W*1DXCC:LK&MJD4??C0MIQ[S7X?>5/.ID#B>^M.WAV>
MCWU:N3Z=%S'1U_ YL8Z1W(T=Q-2>#6CB7$]@ "RG&-J*2^IEF-R<Y4_=13YV
M[FT@UE^UV[7>#;K2H#<1\XX\S.?V>&&^U<_-S<*<M:K+M[1ESM_JIQ?EEI;K
MC1O?IHM.Y4GY[7,/*[U7=HX5#@>+2#W@CB"M8KLYWO)EK0V<H6XVO,CS/K"6
MM>>;L,<C![CW,+6.X_SKBE['G>E'ITC!ILIP[:OW*.2C\KX^-#$5O'TV=1^H
M^IW$ZOPNH<A=:8.4CGM'0RW$5OCK83\[XG1L'AR<S%]%[)WGV;8[0_E]RW;6
M:K=&]*R=*5/SL[]]'O6+-]>H=R869>GVVLA2A%.2C;A75::.O$NQW[ZY.GGH
M]&C='[WZMM6:JSS+*PC8\Q^)'<.:RV+G@W,3A]E8X\0O%K/;.?ON7>R]J_Z=
M-NB\&S[PN;M8V&QC6]UFIW7;BGXII)/[RZ;2^I-/:XTUA]9Z2R,>7TUG;6&\
MQ^1A+71R1S0QSAOV-SV^JV4#M6L\K]!<EAY:Z;JT-JKGZRW'*Q/FMTK0]D=I
M[>'>M>]O_377D*?5&?*O S9;@\JU''<%%QYD10. ]%>/IX*XW5%D&G/Q[/\
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MW"LN-RY&'EIM0\*EJ<(7)=<TG+VHFP-I0>A69PZ[G4^14DHJB.2N ( @" (
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M]]5)*.B)DZZGTYF\/6''LXCC[WI4E(J*TJ*^BHK]1 .9M*\PIZ:BB U@_/\
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M$)Z:\2)!J*=G&OYRO*$5KS(U^!'E%:TX^GZRJJZ4Y$45:\R*@D( @" ( @"
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MG:*M7K2CTI>"1\9WKL;UZ<H\'-O[SNS20F-\LCVQP0-?),]Q#6M:P<SBXD@
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M9EGT0! :@OGO5_VE=H^/#YYPG#T_V<5ML;_IS'R>"-G_ *8/W!]L_P 5</\
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M,25]R7BG/V"M%0\"QTMN#%I[5EG<9\R9/(W+'X2XY>-C$V4N+1Z06&B/54'
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M:N;QLF-O>3^H6XG+RRG_ 'K@J&F5/E0[F4T[KE_X)/ASAABQC9!G0&DF]Y@
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MZTT)TJO8="YTMN+)I/ XZ/4);FK.\?)D;SE_J]O[0'MC(_[UP4):4(\28KC
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MVU,S9CP8>[N4QA*;HB?:6M:2\TSHEUKG(-.X/>#&OR5S.+>%MTR*VA=*9&Q
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ML3^JSJ.95_RW\"YKR%?XL;I__N&]_4[%1'@)<3,<JBD( @" ( @" ( @" (
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M^C53P!Q(I4=O9Q4UKP ?ZSFM/ .<&G^A!(%?=]*IY$DQY&?'VN*@QEIRS2O
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M7EOOPY/ KYR^!O*J2@( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
M@" ( @.$GQ'>\H? A\"P[S*&,DZ*M[62 EC](Y-I ):>-A=]A'$+S_U%5=GL
M/_\ .[7_ !':=@14NX8)\/+G^!AB^B^6D%ITY;J,@#VAVL[YQYY'2FOMK^(+
MB:+Z7[^H^W=E<?\ \F7_  Q/++#2[PW:VN"NK\69WNMR('I;W=C?4AVE,M4
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MU<67.B'@81-R-&[R>5!U>Z;L-*ZVS%]I&[SM@RR,EW>FROL==W\;2WV9\MO
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M6Y.&$O\ +-*FE#"V*[E/;JY>N0I.I6EKN9H/I6K:IH;J+ZE4Y*"0@" ( @"
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MZ5X\=&6X9?=+:/R/>ES3F@;N[O=<Y7)%L-[9W$MQX)#7-9S1R2R6T;.069-
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M]L7-W[:WN;C=PXS4)<-;K;33TYF.#ST-M\5M#H#H:VZLPW^P-4XJ[E?R@/\
M:,IEX+B1CO5:XEDCR.(6I]/\J>Y?U.;AG1CT;?Y$8J/).,*-KEK0V/D7=O\
M0',P<ENY=5YMR?&2<NJ.OL31=%YW?4;J#;_H@V2V"VR=/F=SMP=+Z09%I/'O
MD]NR=M;XBV,UORVTGCM$K6T/J$>LN7[I=[>O5=8^"G=Q\&\YSI5I/J;5:5Y4
MXFR].LC'[=]-+_<62E&Y>LNW;K2OS::<'S+3]D?,(ZI]K.D2PZ7F^73GKRPG
MTKD,=<7HO;YD5S-E,:(WWLD7@"LCIG<_%M5O/4B['ONS.Y-N&3;\NG^SY?-?
MZ#F_3ZV^V9VK^5^9<N79S:?[RF]$V^5"?_HZW47JS1>Z.]/3+O'IZ]VVSM]F
M)LII+1N7FG\2$WMY#=2Q6PO'PN(8V0M]2/N7I$';[H].<6_B-7,K;8-79<6U
M2FO%_::+NK]1L?J'/-R4K.W;I3RH+Z4UX4HM66N^=A@=VM7>:AL[@M@\W^"V
MZ$U[",/EC&)/"G\24,DY'<#5[F'X%XKZ&XV]9/>>]W]E;5A.77[N9ZSW[>QL
M;TPPK>=]-QJC^.AD _V9//ZO+/'VSNJ"W;9SV=A:748L+6-\=BZ"*"XCX$.#
MV6Y(KVU74.%F[E3Q\I?Y2Y*74_>SAK#5NU;E;=9**:^"T,EO0?Y6^GNG36,_
M4)NKEG:^ZB=26[9M0:GNPV1T5Y(R+QO#=-"7M(E:XBCJ"O!;N.XXFR[-/MK8
MDH;9)UE*FLN9K,^SF[[N=K==XEUW,>JM0Y17X&81HH.)KQ)^JN>-HW7AH<D(
M.E)$PR-#X8I>((=(QCG-IVEI=4@@*BLI3E54AT\0U2*H]:\#4 ZYHN;SO-C>
M)(-U: DU)'KL  [30+=>@/3C[UO,+=6I.?'XG7^J/3+T9Q%-:.XN'^\;?N+;
MR8S'-[>6PLV_TMO&/SEK\G7(N/\ VY?BSB<54QK:7*W'\$=]6"^$ 0! $ 0!
M $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M $ 0! <)'B-A<16E."F,>M])3.73&IKM_21K"_O>B&6YM;>66WM\YBG7,C&/
M<(6NN)*%Y:TAH/NT7)V(->LG;4N2E=5>1Z'VWDQL]F;VZ5D[*HN?!\N)?;Y0
M0$/E[["O<:M=I\/!;ZW#E@9W=_,TKV;U&K_W9>2UI&/X'B?9=IPV:DOWKUQ^
MZK+7_/YR=C;]&E]93W$<=UD<G8LLXGN:U\[^>448US@2:GN!7A>?=A:]4>W5
M*K?FRX:\9)'L6R6;E[LW>U;57Y'X)F+[K#L[O&^0MLK:WD#X+EAAD+'!P=RN
MN"]CJ$#M'$+T#UHFUZ\["XI."Z:_8CF/Z?%U>G^\>V%S[NLXY#2.=POEJ=$G
M4%H''G\*-&Y6/YYRT$7V>WLKB_LFSNEECC$C6^ T\7/'!=3W5NL>T/6.WFY+
M?\LS;,8N'*O11>"-%Z=;7>[K[ W+8G-+INSEKQ^63>E3+?N[JJSZLLUTT;:8
M29F3T_FL?B\AG\A:3-N(8KW$V=E/<-G="^X8PB<$'F6BVK:MSQN^\[N2\Z;)
MBVI.,'S\R+:_$MV]RL979,]KPY.WO4[L8QEP=(247[>1APZBL;'8>?#M'A+)
M@;;8D8VWC#:-:(K2&&)SJ"@'J1<59_IMO2R-P[LRIZ6)-MM^QLZ+U?QWB^GV
MQW<:5;S:4URJZ'1\]?J0W#W$ZN]E=EMD-'7N\EEM;-8Y+7>A<8^<Q2R<[[NW
M9=&U=<,^,P#UV"E5Q7I]E;A>]1\_NJY%O:L!N-FYKTMO25.6C]IN>Z^C9O2[
M'V'1;CNZ4G1_,E'[^%#P^LGK[ZJNIGI*R73H/+RU!IRVL,/AVV67CO;]WS4-
M/V=9+BWC;"XL)\+FHT"JVG=%E[KO^-W)CW90S<;(ZW-\:2DNI)^%/::OLJX]
MCQ;F%Y:N8=RPX.W723:TJGI52,L/D,=3-UO1T7W>WVJI'V>M]L[')XW*Z>O9
M7'(8Z$6C8!#(V>5UR6QO'+Q:%Z9ZK6MMW'9OY]MZZL*_ARC.:U3DK;KJM*U3
MYG"=J_JMN[DO['E_EW;>1&<8/2BE*NGW&N3H?0'6!KWS>=^(^C+7S= :NL<M
M=R9&Z?;,N&F%ES<.D<6R>KRLCY2?>7GWH_C]P8?HT[L'U;+<NSTK_M'I'JO/
M$O=ZXT:_YORXZ^'RZF92+HX\\/7F1ATGNAU/1W.W.<>ZUU1!;VT,,TV.N"8;
MF-KX29&\]M*\</2L[&P-IW"MG>E_EZITXZK5&MMY]S;I?J<&CR5&B]CIQ^TS
M5="/0'MAT,Z+R6'T3 R]U)JE\5[JS/R,C]HR.0<V.6XD,AACEY77(<[B>];;
M<MXNYF+:VRU\FVV%2$5I[*OX'*[=MMY9U[=]TN>;N5_C)ZT5:T52_?E(>'D4
M %#QK[W9[JY]0E"/3!U-UUNE&M#FXD--.!'?\*LTG-=,5^9XDZ+5\#Q\[%$<
M+F)A'&V;YIR($H8WQ1_8DPX24#OKK%W>*6T9,9.GY$ZO_P ++^&ZY5KP\R/X
MHU&?*W9R>;7U.D\2[,2T)XD_V6:\?<7H/IA<N2]#+G1_ ZW_ ,1G^M=M6>\=
M@CS<)?\ ";?C6D32.(X$-H:^YV47&PM=,W-\6]#45/LKQ 0! $ 0! $ 0! $
M 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M!#L^%68IVW5\V3Q-/+Z03C+]O5ETE9&2%\=A)JO%-9<.:[PW.&7:" XM#:_"
MJOZ>[-R7KMO+:I%XZHWHOX:YG5>H%^T_0J[:6MU78Z+5_5[#;5T 3%M_H1A%
M3^">FAPX\?F>S'YZV&ZS4=XOVW_\ZY_Q-'![1;D]HL4XJS!__"C5V\_J9F6W
MXZ5<)C"+C,LUGBI'64;@Z8Q?.\3B[D:7/I3W%HO1&4Y^NFXVTF[/D*K\/E.C
M]3L6</0R64])O)^7W57[:E#_ #]J6VYO0?#,TMN(WZ'BF!]#F8Z.1I[*=X6W
M]*?-_P#^A>X+>)25B<)J;\*II%KNR-U?TP6Y3:5N,[3DN>G2U]Y>/NX,ATQ=
M=/3%NGAK=F'T!N'I? 1ZOOVAMO:R/CPE@VW]HE @B)+Q^F<5F=C9UC:]\W[L
MO);N7KTI2A%_NZMZ?ZC3=PX-[>/3O9>\G=_,PU&/0N-'1?@7IW&*9U#=6NK=
M72P"YT]M?I"^N<#?-=XMG='*X&:1WAO'C0&CI!V$+F[.-D=N]H[ON^;\T[SD
MHUXQ6IM=^L8FXY&RV]GR:75*+O6USU3U7]YAP\F>ZBMO,EZMLG=R-AM,7=9J
MYN)'$-C@@Q[YI7N))#0!%"3VA=5Z>Y=O;/Z>LS<[LETJ3EKS;=4OMT-MZQ8,
MO_LC['B8JZY7;5$ER?31EI&['6%O3KGS7M=;];7;&93J/VEVZRQLL#;6TEV+
M'&W=A=2VUR('L%S P^/".PM/%<KZ-9&9LW;6X=UYL)6LW.E)*O%JM$U7V:\S
M*]6'&_9P>P\:<96L6$97&O%JKK3V^*.CYGG6SU2]4/[4&Z67Z*M2[6V^RN?L
MKN]U2+W)2OAMYL@QQ+N2+F,$432?6< *=JR^UXW]G[[L;QFW(VL')=+CX55=
M.IZ:\N)CXD[F?V?E]M1L>==O1K:7%PE&.K2U\.2-H'26_>-ZB/*^R&X\-W%D
M+JZVFO;++PLD:^6VOK' .@EBG#99GM>T@?&-25K?ZC-IL6-IRK6"G'"OWK$K
M;Y2K<B]'[ZF'Z'SG=W['V[-N=6?8=R-Q<XZ.BIQX&IEY2&T/F:ZWBW]RW1OO
M''H#1;M8Y&#)X^6SAF$D[\M/) P/EI1W(RM?0U>G[Y#>\?M+:([HJV_TT?*]
MW0C0[H\&7J%NEK'=+L)KS/M=#-!I_P N'S0.I?*MV\ZX.H0ZCV1NIHI<KB+2
M&.%UY%;O9(('> '\PE#Y&\13BN6V[!V*=RWO.Z1Z]TQ&W:CRJ_N,S)W'<\;"
MGM^U-15_24^#2X<>/#P-AOITZ?- =+FT.E]G=L\5%8:9TQ;>!;1L9&R2:1XC
M\:>5T<<9>Z1[*\5D[WO&5O>:\R_QHDER27"B-3MFW6MKL.%OYKLI-RES;?B^
M)7:$-<T.Y:.[_JGZJU"K37B;)-OYG]1\Y7>$RI;4GMIQ[^'!8]ZME/(2K+P*
MXQZX]->!:OUG<G^RUO-(V)D!=HS.F01-$9DIB[NG/RTYCQ[UQG?MJ>3VO2+Z
M9^=:E3_Q\#J^R8JYW-9@N%7^!@V^C42AVS>[8X^KJ_-5X?\ 2X7T5W;.Z^QM
MENWN/E+[H'";].T_5/=[5I--1C4V<HIFS.JT'U20:KRZ2\JDI\9<#,C)3>G(
M[2K*@@" ( @" ( @" ( @" ( @" ( @" ( @/G**M)["*4/PBJ5T(9*6OB3H
M?5]>'_5S,\/_ %=<*WD45F5/\+,W;6UGVO\ ZD?Q1HAZOA:-Q=>^I6NH<K7[
MIW:\7RFOU,]/WF?>.WRA_*[#MK7RX_\ "CQ#;5)HSBJ(WNE4:J9MO(O0TE%4
M!MW<*-^LJ'<3U:(<^J3;(^S_ -!7X/\ =3K5.&I3U,Y"VX$EG TJ.'=V=RMT
MBI=:6I-S(R)4C;2Z2'LU3\7M[#P]!]Q7EDW8_2M"[*\_*Z:+KYDZ[1VW_P :
M]L*#E=^$./IP]&2LUF[=<4K]:?-5?B:K>[-E[)DRXW';?X,WM<(*8'!U[1B<
M=]:S@7L-EORE3CTH^"LI+]1/QZW^+.\Z&7Q#*TCF-*M-".'N=BI249:1^5\0
MY=5OI>DEP)5UEHK%Z^TYG-):DL;6[P>H+"XQN0MWP1.,EK=1/AG9S.8^A?'(
M0#3@L7.VW'W#&EB9?S8[:=%IJG5?>9FW;A?VV_'-L.F1&M/#70HETR=(FSO2
M-I_)Z5V7TY%I[!YF_N<E?V[/"<Y]W<2F>20O9#$2'2$\.*WU_<,C*P;6#?DW
M:L1I!>"X&JO6HW-TN[FE2[??S_ N:\ N?SNX<:^FJU$)7Y2<+J_+9D24**G%
M';5Y*BHBD*0$ 0! $ 0! $ 0! 0(!%#V% >!G]0872.)NLUG\A;8O#V3"^[O
MKN6.&WA;0FLCY7-:!0'O5FY<C"+<W2'B5VX5C2/%&*WJ:Z ^D3S$;.ZU=@,C
MAK;6MJ\Q2:TTT;.60/$<K(_:66K'\TC99"2ZM3[ZR$KV!CJ%OY+=S5:43U]A
M'F1OM.[\ZAHO88H<_P#1[-Q<;?S,TWO-<9&S\4MMI[D2&:VAYW!OA/FMB^.C
M .RBS\7-C:C243#OXW77HD]2NFQOT?/2F(U%C]2;V[F9'7-M8W5M<?@_/XLT
M<_A20S%CYKB$AC*L+>%>U3?S8S?R12?B46L/RU24FT;$>W>V^C-J=(XG0^@\
M'9X#3>$M8[2PL+.&*)K(HVAH,CHF1^+(0T5<14K NW;EU]<G69E0MPMKI@J1
M)Y5!6$ 0! $ 0! 2;K/;_1^X>&GP&M-/XO4.,N6&.2WR-E;W-&N#FD1NFCD=
M$2''BVBB+FG5BBI0M9QGEX](V(S[=2V6T6!9DV3"X8Y\$$D#90\2!PA=!3XX
MK2M%?_474J)Z$)4+P</A,5IZPML3@\;98K&VD3(8+2QMX+6!C(V!K (H&1L!
M ';3BK$ZR5>;)UK["2MT=G]NMY]//TON3IG'ZFPKW!YM+^"*4-<*\6/>QY96
MO&BJA*45[2:TX'<VVVNT+M'IJUTCM]IZQTY@+.O@6-C"R-C20T$DL:TN-&CM
M1NKJR"H"@%M^[?27L/OEG,9J/<S0]CJ/+XB6*:PNKGDYH)(7\\;A6-Y]5W%5
MPN2A](*\X+!XS36)L,'AK5EGC,;;Q6MG;1_$A@A8V.-@X#@UC0%3)N3J^(/7
M(KP/$'@0>]0"V[=/I'Z?-YKN7(;@;;:?S%_,&^+>BQM8+J0MYO6?*R N>\EQ
MJ34DE5JY-<&T35TIR/MM3TG[ [*W#;S;S;G 82]8US67HL;6:Z9S!H)9,Z .
M8[U!0BA"ASE+BZBK+BU20$ 0%LV=_=PPO_!_XJS8?P"47,#L'O+"(?$B@" (
M @" ( @" ( @" ( @" ( @" @3147).*JN)*%1V=X[?A4UHDY<R#'MYF'6GI
MGHBZ8-;[E9"\@=JZ^Q\V$T/A!(SV[*9W*126=H;6$3PS2&WFD#JLJ:@+J.T=
MCGOF[0L37^73K/P25-#FNZ]\M;#M-S*E*EUKICS=76FGO,<GD4=%><T;H75'
M6IOI;SY'?3J(R-SJ#Q<U#+)DL#@Y[@W-E'"^]@]IB%Q%**4>10+I_4/?,>[D
M1V/::+!L+IHN#=/8<OZ?;#D8V-/?-X3ENV2W)R?^%NL:)\-#8?:*OYZ</?\
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M&A@8QK6,8UK6,: UK6@4 #0   %VZ4>NJT?@>#UG)=5QMR;K5\3L*X0$ 0!
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M)_59U',J?\-_ N9\A2OY,7I_KV^PWOZG8I&E-!+B9CU)2$ 0! $ 0! $ 0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $!3_<;*Y/%X"XEQ
MD#YI9&NC=R DM:YKJGAQ2M$2J%F\S97%T\K'-?,][I*@AW,34U:>(XE4)O\
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M$ H_ 5T(65A<9*0VUA&^:X(J&,:X_%XFI -#Q4*O$:<SC);WN+NFP7<4D5U
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MLY+&4ECVU/ZNB-??15.\K)>" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
M( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @.$@)8X#MIP]]0ZM40I70M,
MZSNF7 =7?3UKG9#4+HK<ZBL?["O)(V/-KD+=LLEE*WGBEY?LQ'8%S^YXEZYD
M6,[;]-XQ+BE"?.G[R^*.D[9WBQLVX.>5'S-ON0<)QY-2TK\'J:_NVO5#UI>4
MIH-O3[K?IYS^_>EL-=3MT%E,))<Q>PXHS2&.)\EO 6R12P1<U*"A/OKM=W[F
MP.X;T(VHN.Y68QC?DZ_,_P#6<SB;!?Q+^1DV)K^77KCE;C_AJ]3H[E8CJO\
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M&QSF,?SM#9*=RTN];Q:VVRXKY[[6D5QU.V[([+SN[LJL%Y>#;UG-Z))<>.G
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M;W]3L5$> EQ,QRJ*0@" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
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M6-=S!H) H/C!7(680K=GSX%64Y6G&W!UN3/KN?J?,X^^L(,3,R/%MA;X0CE
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MO<X:T;:3/Y6RL  #CQ'8. XN4\->9&G(JGH"72.E;-LN2EAAS,L9?().5Q:
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MM]^')X%?.7P-Y524! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
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M'GCW5-5Z:\#VJY]F^QX/F%MXS_ J2:U\.BS\=WOT\7>_C4U,/*6-^JE^G?\
MEZZ'SN-/?20/#'@:KTQS^)'6L6#^)S#G_P#LJY655X57V<RRE;HZODS.OT,X
M_JYL]JVQ]8&2L\EN*X1\TEDRW9$S[''S@"V^Q_'YEOM[EM/Z+'_DZ:S%'\RO
MB<_M4-VCEY"W*75B.2\OW<R\]]@T-:\6]K)<-^+,^"-TK!6O"0M+JK078N_;
M<7\LFN)O;:C!.+;<%P1Z$+"R-K3V@<4M6_*@H5K0@^JN ( @" ( @" ( @"
M( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
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M2-Q)JK:5Z&1^6HK&]BH5N3=M5DW<IS/2;9"*(001PVT#*"."VC;!"T ]@C8
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MFEMXIFF8 5XFE%B3E5^PN4Z53F9Q500>!JH..E]2!H+G' 9@-: 27...N
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MNFK.PXN'%OP_65JVH];5!)NE4?17"0@" ( @" ( @" ( @" ( @" ( @" (
M@+:,\1^W=A!_0_\ %69#^ 5)ERP[![RPRE\2* ( @" ( @" ( @" ( @" (
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M\JW)UG\#:N<H3_+U@=J(2 NY_<IV=WO*F/7U.OTDMU/LKA 0! $ 0! $ 0!
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M;^!<UY"AKY8O3^?_ -!O?U*Q2*HA+C\#,<I*0@" ( @" ( @" ( @" ( @"
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M8R2PO'@GPG-(@XGF!# :4!5:C!_64=4DZQ9+.HMM,]A#"+>'VX/87O+#ZS
M7$<K6UX45+<HNO[I=<E+3]XDAUI>1M=+-:R111$M>]X< P\1^F '$J9M2UYE
MNC7$X,C,KC1W* *@\%1R)]I-^WEQF6:HMH<,:U>/:&]E6 L#NWTM52X:<2*\
MB]=G-RMYOC<HYO\ A4%?KJ0<D 0$F[C?N?:[_$W4_P!Y+Y0^ -)OZ.3_ !@G
M6A^->7^_#D\"K_%\#>64E(0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
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M#?\  _XJS8?P"8ZLN7'8/>6$0^)% $ 0! $ 0! $ 0! $ 0! $ 0'QGC\1E
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M-ABK&WE'*UK6UFB@9*Z@8*5*59%63LA 0! $ 0! $ 0! $ 0! $ 0! $ 0!
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M]Y+Y0^ -)OZ.3_&"=:'XUY?[\.3P*O\ %\#>64E(0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
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M $ 0! $ 0! $ 0! $!\Y2X,<6BKJ</?5,E&5(RX"C>D>)97UY=6FE>C'IEW
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M:'XUY;[\.3P*^<O@;RJDH" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
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MKZE>*JE*C2*G!*?0FFR$-ZV5SF<A#F]WI"C(N0LVU<3JF6+<G<FX-4H=T.!
M([U#G1*JU96&FH!5UJCH0G5$5!(0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
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M6LA<69ORT>(*BM/_ +JU/3T+J7 Q>+2/NJHNJJ2%(" ( @" ( @" ( @" (
M@" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
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MSV.GS)>%:.AA!U9U_>:[M%K.#=_<3IWD=TKONXKR?,6Q$UW;X"[G$L5V^WB
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M&O&@'9VGT<*CWZJE-MTH 74I7L->/H_WU6E4ANA$$$5'8H)(H @" ( @" (
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MX0DTN3DJL\$]/\N_F]O]60W)V[]R*?LC*B^POZ'9V4]SM7"T2T7 [HB@" (
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M7.[BU?2OJ5DXV1/"GBM./Z>"JO'I1X)VKAY<-^W7SJMRR&TO9U2/<\]7JQV
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M"VHR;YLO-Z$5< 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0%LV=_=PPO\ P?\
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M@:0^*-SO4B>\<'.*LW8=$J+@7(RZHJ5*&4Q6DJ*A(4@( @" ( @" ( @" (
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M'*HI" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" 50!
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M\[XW/K7W5=V^_ON"Y)79*P^568-S8MNRLF.\;UB6[F3'52<4W]K53V@6EPY
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MYDC#B*$U^LDXJ$NE<"];;E&KXGU5)6$ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
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M=+;[],6U&N-+YBPR\$VEL59W M+FWEDMKBPL+:UEAN889IGV\C2T<'T*Z;U
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M;";C;5"00SZDP=Y#9N+>;^S(K>5UJWBQX^R3$-[#VK5[OBRS<)VK;I)24O\
MRNOX&TVC,6W;A&]=58T:^#T-?ORPNJ?3_0IJ/7O2%U13PZ%R&)SEV_366N9!
M);W,+[IT<3)'\\(8V9C*UY:BBZ][A9[@V:S>P[?3^FATS]KT53GLK GL^]W)
M7[G5;S'U07ASH9UAUW=*I#2-WM,4<UKA_9UOV.%1_P!UX<"M,H2?!,SJ,Y'K
MLZ5@"3N]I>@__3K?^NIT3?)BA5#;#J&V?WDGOK7;;6N)U3<8X--Y%CKB.5T'
M-R\O/R/=2H<%+MSBNJ2:B4=<:T3JRM#AS CLK3C]=6^.A4SDI 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0%L^>'_QOPA]+?\ BK-MZV/<2N)<N.P>\L(A\2*
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M:G39MCY>&P-KL?D-^=&:RO(+^\OI,I\^X.W%+R02 !C;F(5 '\ZO3NYNY_\
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MI9C;C'XQ6IY7VYL,MA5]]59W;LI?!MM?B7[,SNDVO+SJG .<ZG,?GC&\:?\
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M^E82S?\ 91E.U'D?/^3O:B+2#OYEZD$5\:][_P#P*/-UTBJ$^5'FV9*O+?\
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M^P_57PMH<=A\1CW_ ![+&6-FX?T5K:Q0N^NQ?+S?4W+VGU M$ESH>HH)" (
M@" ( @" ( @" ( @/A.]S&@M^'ZRI<NED-2:^55.8=ZK2_@3W=OYBF4>M:"M
M.):SUHXN\RO3CN#88\$W,EC&YC6DAQ:QSG/#:<2:+6;HXVL";F]/]!UG9+<>
MY\2254KJK[JF&_:2VEAVWP\,['1O@GNVRL>""'"4--0ZAXFJ^?-RN7+F?+RJ
M\3]#K-ZU-0=JB^2.GP14-[AST8/5 'YBN25+:3^HO13Z:RXD%9).<+29"0:4
MBF)]%&QN))KV<%#;X+@4W&E:E7@3]Y>&-R%SOSNOF8>:3&#V=AD;4Q<P$8^,
M*LK7W5ZMV59<8=?L/EKUUEC^795MKK;_ +S-G0\_-^E_W*+T:NE#YDH^JO(^
MBI*@@" Z\SY&E@8VH=7F/H5$VU'Y55E+;4DEP/.D8T.D?*61QQM=)+-(YK(X
M8VBKG.>ZC0T-%22:45-5)*$56ZRZZ6H^=)I2IJ_!)&&7K(ZMM;;MZ[9T?])C
MY\EJG+3_ #=K[6>,\2:UT[9R/,%W VZMI)(7E\;^WN*]J[,[3Q-AP8]X]TI?
MHXJMJVZ5N/DZ/A0^%?7#UJW[OGN7_P"P7Z-3E/?;TO+SLZ";CB0;I**<6U+J
MB^/)E\G2#TD:+Z5MO[?'V,$61UMEXV7>J]47+&SW]]D+AL4UPTW$L0N UEP'
M<.9<7WGW?F]U;F[TFXX4=(06BBEPTX<#W[T2]%NWO1OMJ&UX*\W=+OSY%^6L
M[DY4<JR:ZJ=5>++RHGU%*UX5]-:U-5Q,.OK:>L4>V22I5<#ZJZ4! $ 0! $
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M:S^VV)_59U',J_Y;]Z+FO(5%/+&Z?_[AO?U.Q41X"7$S'*HI" ( @" ( @"
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MH?D*KO\ A4[B\/\ ]*R?RU3TD^:P/(JNQ_\ 53N+_P"E9/Y:G2/-8_(57?\
M"IW%_P#2LG\M3I'G,?D*KO\ A4[B_P#I63^6ITCSF#Y%=V?_ *J=Q?\ TK)_
M+E'2D0KK0_(57?\ "IW%_P#2LG\M4])/G,'R*KL__53N+_Z5D_EJ=(\UC\A5
M=_PJ=Q>'_P"E9/Y:G2/-8_(57?\ "IW%_P#2LG\M3I'G,?D*[NM?]JG<7_TK
M)_+E'2N!'FNE!^0JN_X5.XO_ *5D_EJGI)\YC\A5=_PJ=Q>'_P"E9/Y:G2/-
M9%OD67C35O55N,#[EWE ?JB^3IY$.Y7BD1=Y%EX\U=U5;C$^DW>4)^O?%.DG
MS6<?R%5W_"IW%_\ 2LG\M3I'G,^C/(OOH^+.JO<=I]+;O* _6OE*2(=RKJ?3
M\AIDZ@_[5^Y7#_\ 3LMW_P#GZCI\"%-+D?(^1=?.?SOZJMQGGW;O*'NIWWI3
MI)\SV'$^17=GMZJ=Q?\ TK*?+DZ0KK1]H_(RR$5?#ZJ]QVDTXMO,J/S+Y*,>
M;[#YR>1=?RT+^JS<AQ'\]>91WYM\4Z? E7:<@WR+KUA!;U5;C CO%WE!^9?(
MHT(=Q/D?8>1ME.8D]5^Y1K3A[=EAV"G_ )>G3I0>9[#@?(QOG&K^JK<=Y]+K
MS*'\V^*=/@/,TH?$^15=GC_M4[B_^E9/Y:G23YK.;/(MO&?%ZJ=QA7MI=Y0$
M_#[:CCI0AW$W5HXN\BR\<:GJIW%K_=>4^7)TD^:R'Y"J[_A4[B_^E9/Y:G2/
M.8_(57?\*G<7_P!*R?RU.D><Q^0JN_X5.XO'_P#2LG\M3I'FL?D*KO\ A4[B
M_P#I63^6ITCSF#Y%5V?_ *J=Q?\ TK)_+4Z1YK!\BJ[/_P!5.XO_ *5D_EJ=
M(\UC\A7=\/\ YJ=Q>'_Z5D^__P ^4=*(\U@>15=C_P"JG<7_ -*R?RU3TD^:
MQ^0KN^/_ ,U.XO'_ /2LGW?^?*.E$>:P?(JNS_\ 53N+_P"E9/Y:IZ2?-8_(
M57?\*G<7C_\ I63^6ITCS6#Y%5V?_JIW%_\ 2LG\M3I'FL?D*KO^%3N+_P"E
M9/Y:G2/.8_(5W=*?[5.XO_I63^7*.E<2/-=:C\A5=_PJ=Q?_ $K)_+5/23YS
M/C=>1O<V%C?WCNJ;<)WLMA>3L\2[RH8V2*WDD9(\MO'.Y6.;4T!/!.DCS*\C
M$-Y)FY>^>,\UO?78?56[.>UQH+0]SD+'%VN3O<C/$6V[Q UP9=W4K!00U^*.
MU$J)4(=6Y)\%0WE546P@" ( @" \'5/^;F<]W%7X^K:2JW=UMR]Q=L?QH?[R
M_$UNL_;TU7J;AVY2\)[?_+)EQ%Q/S9.E=3WS!N)85I+_  _L//\ 9^W_ '51
M23,KS8CV;W/YOSE-)/@M2/-7,>S>Y]=127A]P\U<.0-N?YJE*2Y\"?-1'V>J
MBDGK1CSHTT9,N@K9S=Q=&  \,G;5X'_RN#\Y7<?^*BQF7$MHO4_PO\&;(./X
M8^Q]RSMOK0,7;PJ[:\>E?@?/US6Y)^U_B2%N-HK%;HZ0U!H#4#9#@]1V%UC<
M@89'0R.MKF&6"5C9&>LTN9(0M'N^U6-YQGM.XINQ*2:]ZK0R,'<+VW9D<O%^
MJ-?O,%;/HW?0?B\OF\_I2QU#IK-:@O;J^RV0QV<NK>YN9[N>2XD<9K=L4H^R
M2?SRWMF61B;;#;8S:P8*E."\"QEW+.?G_K;L5*_]I=%TE^3WL'T@[ALW%T%G
M=5WN9:[G;'E\[D;^!Q!B)K%<RO:?ZD%G8V9*Q:=NTET2-3G;7#.R(Y-6G!F7
M!K@7\AJ'4#3Z!RC\]84KBC/5&Q4JP\OFCM  "@[%-:ZD\"* ( @" ( @" (
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MG_BY-:?;7$_JLZCF5/\ AOX%S7D*BGEB]/\ _<-[^IV*B/ 2XF8Y5%(0! $
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M/KGBH;H"-I>6U] RXM)F30OXM>QP<#3WB5(.R@" ( @" ( @" ( @" ( @"
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MVK>AS&W&*Z6MG[2Z(,OX)8N?@0?4N+.":/B.'Q'A(\"NY]1=DI* @" ( @"
M( @" ( @" ( @" ZEY?6EA$9KN>.",$#FD<UO;V4J15![#[0S17$;987MDC>
M*M<TAP(/N@D(#ZH @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
M#QM1?YOYW[39/]93H2N)HP^3;3\MYU3D</\ #.9_74JI7!(E_5-^XWMU44A
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MU^,V;VIT7MUBHVQVVG,)86;PQC6!UTVUA%T_E:Q@JZ=I[@L5ZNI6RK2@! $
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M-[^IV*B/ 2XF8U5%(0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
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M" ("3=QOW/M=_B;J?[R7RA\ :3GT<K^,$ZT/QKRWWX<G@5\Y? WE5)0$ 0!
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M @" (#1.ZE!7Z2[HL_\ 2-K^J!4\G[RY6DX^XWI[+^T[3^Y8/U)BJ+;.T@"
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ME_K7!_"E"21[W*?KUHL"UT=<J<8F;<BXT7B?=7BD( @" ( @" ( @" ( @"
M( @" ( @" ("VC.FF]^%';5O9V4]7ZZS+?\  )7$N6'8/>6&0^)% $ 0! $
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MKXD EMV-DC-"""1W!6KEQS=>1*2BJ(R,*V2$ 0! $ 0! $ 0! $ 0! $ 0!
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M2/@?0*F"E%4DZLED56 H 4@( @" ( @" ( @" ( @" ( @" ( @" ( @" (
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M $ 0! $ 0! $ 0! $ 0! $ 0'&IK3EX>FOYRI4J_$')5 ( @" ( @" ( @"
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M*Q*'2]24ZE>U!(0%L^=I^W?A>/Z7_BK-A_ )1<N.P>\L(A\2* ( @" ( @"
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M=24[ZXMG#[[ZF]R[Y!VK4UCXKX0BJ:>]>PKC%86MO'%%;0Q6[(A1K88F1"@
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MT4C98V2L-62,:]I](< 1]8JOB#F@" ( @" ( @" ( @" ( @" ( @" ( @"
M( @" ( @" (#1Y^DAG_Y[^B7W-78O[\M5*TJ5\''XFZEMO\ N=Z"_$O2WWCL
M544OB3HA 0! $ 0! $ 0! $ 0! $ 0! 8Y?-?_>*;V?:RQ_7C%#X%</J(>4]
M^\3V4^UN0_7LB+@1/ZC(VI*0@" ( @" ( @" ( @" ( @" (#YOE8QKW%S:1
MM<YWK#@&@DUX\. 1M+B/<4RQVZNGLEJ%^GX)XG7,<AC/++&YW-7E(+6R$CC[
MBMJ];<NFNK(A&]*/4X-1*H@U%1V'BKA(0! $ 0! $ 0! $ 0! $ 0! $ 0!
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M<+G+Z66=]5W3OJ+8ZTQF'UIU!YW=+>C7[A;X7;K%W&1$EM/<.?"]\TEG,YT
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M6@=W!@ [%;@KG&XZLI5.GA21WN-3QX=P]"K!% $ 0! $ 0! $ 0! $ 0! $
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MAV\*J$M=2E\"\-5 ( @" ( @" ( @" ( @" ( @" ( @" ( E0$ 0! $ 0!
M>-J+_-_._:;)_K*="5Q-&'R;/X[SJG^W.9_74JA<$5:=4_'0WMU)0$ 0! $
M0'EYS_$^4'IL+L?5@>H<>I4*[?UKWHPQ9:Q#L_G'!D?K7UQ^E;_R\GN>XN=N
MQDKC5>#._A<3L1C[#H"S#*AK0">P@ ?73YO'4F%R4%2NAR]EXC@/@526FO$>
M<U[R M*C]$HJ$^=RY#V:@I3M^'\]1\O%<1YOV'$V;7&A8TD]IY1Q^&BI2FB?
M.@WIP/9TE81LUEIQP:V@OH*GE'_E$5.X*YC6KCNZ,B]>MRQY::T9F?LO[3M/
M[F@_4F+?KAJ>>S^MT\6)6M:*M: >->'O*$G*J@RW)J*UX&-;S7]+:HU?T9Z]
MPNC\-<YW-3.LC;XZTCEDFF#3<<W*R&.1YI7N"\\[[QLB[;Q7:BY.W>BW37]Y
M':=G9-JSF79RDH5L32_\K.KY2V U1I7I!T5A=7X.YT_E[-]UX]C=LECF9S>"
M!S,F9&\=GH7MG<F79R,7"R(RU_3Q37@TJ'B_:MK(MY^?&]%K\^5'XU;9DT8[
MQO6IRT^&M?J>A<O!*OF+5,[-2ZM.%#L*2L( @" ( @" ( @" ("!K0T%3Z$]
M_ A\-.)2C>;0%WN=M=J[0MG?.QUUJ3$WF/COFN,;K=UQ!+$V1KF\06EX[%CW
MK3I)0UJT7;$U&2E/@:PEQ]'PW2DR&5NAOIF V^R5_>L OKXAC;JZFG:P?8^Q
MHDHMOCYJA"4)16J,:_94[G7!@?1[MT?]>V9!_NV^_-\-6+=]6Y-M5+4L2NO5
MJ3;I3Z.WFK^^C&O=],G/BF/8^6W\:XO3-&U["Z(121N:.=M1QIVK-_F$'%]4
M%7D4+%DE3JK4ST=)71MM'T>Z"AT1MKBH8;NXCB&:SKXHQ>92:)L;0][FQL<Q
MI\,&GI6#=RYSHKK^7DBNSA1LQ?0N/%EW@(K2O'_<5BG[QDU7 Y(2$ 0! $!X
MFI?\W-0?:3*_K"=2N*]Y#U5#2P\N8-'FAZF('_MAGN+O6(_PR_L)XCM6TG_T
MK91#^(_ W4,]_F[FOM+D?UC,M6N)<-*/H.+H_--U$(GNCYM89JO(2VO^&'=M
M"*K<7:O&^!B6OX\DC=RB_J4?_>V?]J%IC+/E>?VG=_W-/^I.0&D#N0&CS=;R
MK0ZNK<>0'^L/\;CL#J@46VL_](_$H;_,3H;N%A_B&S^U%O\ K-BU)6:2_4$Y
M[/-YF+'N83JS$4>PEI_QLVOQ2"*K;6/^E?@8MY_YA/F;875]@-6:HZ3=?X31
M5G+?ZDO]%,CQ]K"7B69YQXYVM+ YY);Z M;"GF*O"IEII<34>Z.=H/,<T_<Z
MYT?L5I/,:-N\AE;XZBS5S;7EN7$WA="6/G@BYP[AV56VRYV)156FZ&.HS46E
MH5;U5U0>9_T!ZYP^3WPOLGE=)WU_$)FW,5Q<6EU:&Y:+L.FDDCACI#"^E3WK
M$C:LSC\O$B,KT%6XJHVJ^DOJ1TSU2[+:4W4TX^-OSQ80'(V3'M<ZSOVPQ&X8
MX-DD(#GOJ*E8=R'1+I,CE7D7+DAH)<0 !4DF@ ':23P 5 )>DU9IV*9\$F6L
MVRL-'L,\50>RA]?W%5TRI6FA-"W_ "N1Q]UO/AKN"ZBEM8F.,T['M=''RL)-
M7-);19:BUC-M%%*R]Q<,[4F$;:LO79&U%K(_D9/XK/#<_FY>4.YN6O-P6#U(
MJH?9V<Q3;J&R=>P"ZN&%\,/.WQ)& <Q<UM:D<O%2#YLU#AY&W;V7]NYMC079
M$C#X%:T\3UO5K3O451-&@[46%9;6]X[(6PMKMW);S&5G)*[FY2&.YJ$AW!3[
M2*ZT/N<SC!>C'>V0^VN9XC;?Q&^*6<O/S!E>:G+Q3GT\QRKR/BS4.&DM[NZ9
MD+9T%BX-NI!*PMA<3R@/(=1IKZ4!%^H,/'#:3OO[9L5^7-M'F5@;.6FA$9YJ
M.H?0HJ33D?09K&.O)+ 7D!O(H_%D@\1OB,9R\_,YM:@<O%*H4YG6;J7!OM9K
MUN2M3:V[_#EF\5GAL>7<O*7<U >;@E=*BC6A]I,]B(G6K)+ZW:Z]!-JTR,K,
M *GPQ6KN'HJI]I!%N<Q3IKBW;>P&:U:'W$8D87Q-(J"\<U6BGI2H/@-2X,V@
MOOG&V]D+_#$_BQ^&7\W+R\W-2O-P0<Z<SLNS6+9<6]JZ]@%Q=-+H(C(SGE:!
MS$L;6KA10VD.)\FZ@P[S=M;?V[C8T]JI(P^!7L\2A]7X4K55Y!Z',9S$&T@O
MW9"TCL[EQ;#<S3Q102$'E(;+(]K#Q]U2M2:,X297#.E$1S&,;,X5;%[?:^(X
M4!J&>+SD4X]BIK%Z57VCHEQ2=/<<AF\2V">=E_:S6]I3VJ>&>*6*#F^+XCXW
M.:VI])52C2->11&<92Z%]1P?J'#1Q6L[[^W;%>DMM9#*P-G(-"(SS4<0?0A5
M[#ZNS6-]L?CF7<+KYC!(ZW$C?$#*<W,6UJ!R<5$I1AK+@*-JJ.K^$F#?;S7(
MR-LZV@?X<\HE861OKRAKG<U >;@I2<X]2X%$[D(:3XL^,^8PMFR*ZN<C:PQ7
M0+K9TLL3&RM:*DLYWMK0>A6[BA:75.2BO%M%RW6Y*F-"4KCY)-_@4GUOU [>
M:/$T0O&Y3)L']IV31-QH:<SXW.#>+5HL[NC;\27EQGUWN26IZ'VYZ7]P=P+S
MY6_(PWJYS?3^)0J;<;=C=5KIM.<NE-(W3_"9EY'M)Y'.Y:>L^H/KCO[ESW\T
M[FW.]TXUEPQ9<_8=W_(_3?L6*N;S?CF;E#]Q<*_#VHG/3?3[H^WO[:XUUJ!^
MI<[=4N(8YKES6/<WED)9$\D/:#Z.Y9]CLV%Z<<S-G)WN+53G]W]6=UNV)8G;
MMF&)MW!-)5:]ZUX%Q>(?I+#V\MAB#CK9F-8T7 ACMVO@;0!OBE@:02&]ZZVS
M8LX\59A!=$5Q/+,O-W+<)O(RKL[EV3U;;_ ]5VH<(+6&]?D[8VL[_#AF,L8C
MD?S<I#7!U">97W*BKP,/RY+ZM3N.S.,;>LQQO(!>R,\1EOXC/$<SEY^9K:U(
MY>*H4E)T7$'R9G\.^.[F9?VSHK$AMT\2L+8"30"0\U&U/IHJN51SIS.+]0X:
M."UN7Y"V;!>NY;60RQ\DS@:4C/-1QKZ$Y5)HZT.P,OC3?.QHO(/;6Q^*ZW\1
MOB"/EY^8LKS4Y>/8@H=8:CPCK6XO6Y&V-K:OY+B82L+(GEQ;RO=S4!YA1155
MH*'-^?P\8LR^_MVB_K[)61@\>G ^'ZWK4]Q344.8S>+=<3VC;V W%LT/GB$C
M2^-I','/;7F IQ45UIS(]IU_PEP?L9O_ )QMO9 _PS/XK/##^;DY2[FY:\W!
M2.=.98;YGV$?KKHIWAT[AYQ+D;[#QS6D$+N::<0"69XC8SF>X")I)(!I1%]2
M0]IHY:6M(K+2]A8LG\::SO<E#=,)JZ*2.X=&6N!]8'F;WT6PA1K4L*BU9ZY^
M,!]3A[E2CTE4E2BGU21$U;P/;[U%74=<7])]K>GCM+C1K6O+B>P-#:N)]X*B
M5WRY*O,JN1?D3NTK&)FB\A?23V[V;R:S?)#-@9&6,,4]U$R6)TKX[6,"!\K"
MUCFN-*M/ JSDWX448Z%W#QH?I(WE.MVYPB9Y.M?K/TWTU:1=A=/F+4.ZNI8S
M8:3TOCW-FNA<7+7PQW3XK>831>SR4=Q:NM[,[1O=QY?FY#=O;;6LYOA1:TUT
MU1X#ZZ^MNW^E.R/'P(K+[SR5T8V+%UG*4JI2:3JNET=*%LO1)TD7DN:O>K'J
M:R;-3;GZFE;D\98Y:07%MI6"9T5S;,9!=,DCC=R24H".*Z/O?N_%LXZ[;[;_
M "MMLKIE*/[[X.M#S?T']$=WO[G<]8?51/)[WW&ER$+BJL>.CBHJ2=-'30RY
M-SV'@%LYU_;,BO:,L0)(VME:P !L3>8 AHH."\CCUN/5+F?8]8.*A#1I'<&:
MQ9NYK$7L!NH&!\T/B-YXVD<P+FUJ!3BJBEZ:G7;J3!NM'WPR-J;2-_AOG\5G
MAM?S<G*7\W*#S"G:HJ30^K\[B8Y+6)]];B2]!-JPR,YI@!4E@YJN%/0I(#,[
MB9)+J)E];NDL@#<L$C.:$.%07CFJT$>E ?$ZEP8M8[XY*U%K*_PV3^*SPW/Y
MN7E#N;E)YD)HSLG-8MMW#8F]@%W.TOA@\1OB2- YB6MK4CEXH1QU/G'G\/*R
M[DCO[9S+$@7;A*PB GL$E'>K7W4K55\ U1T.+]186.WMKM^0MFV]X[DMI3*P
M,E<"&\K'%U'&I[D_:%KP/N,SC#??-HO(?;3'XOL_.WQ/#Y>?FY*\U.7CV)P=
M!RKR/@S46%DM[N[9D+9UO8N#+J42L+(7%W* \\U&GF]*5)HSE)J##Q1V<LF0
MMFQY"HLW&5E)R.T1GFH[X$X$'T&9QAO)+ 7D!NXF>)) )&F1C.4OYG-K4#E%
M5%5Q)II4ZXU+@S:2WPR-J;2!_ARS^*SPV/YN7E+N:E>9$ZD4H?5V>Q+'VT;K
MZW:^\!-LTR,!F %28P7>M\"D!F>Q,DUS;LOH'36C0ZYC$C"Z%I%07CFJT$>E
M!P^)\/PFP7LK;WYRMO97/\-LWBL\,OYN7E#N;EKS<.U =IV:Q;;J"R=>P"YN
M6&2"$R-YY& <Q<UM:D <5":8/FW4&'?[667]N[V&GM=)&'P*]GB<?5K[JGE4
M<70XNU%A66MO>NR-L+:Z?R6\QE9R2NYN7E8[FH2'&BBI-&?;YZQGMHQQNX1>
MEGB"VYV^*6<O/S!M>8CEXJJFM".5>1\&:BPLD%U<LR%LZ&R<&W4@E86P.)H!
M(0ZC23Z5 YT(NU#AF1VLK\A;-CO21:O,K V<@T(C/-1U#Z%%2:<C[#-8LWC\
M>+R WD;!(^W$C/$:PMY^8LYJ@<O'WE+TXBFE3X-U%A7VDU\W(VQM('\DTXE8
M8XW\W+RN<'4!YN"BM!36A]'Y[$,=;,??6[77@)M6F1@,P':8_6]>GN*:D')F
M;Q4EQ<6K+V SVK0ZXC$C.:)I',"\<U6BB Z_X2X/V3V[YQMO9.?P_'\5GA\_
M-R<O-S<M>;@@YTYGV?G<3'<V]H^^@;<732^WB,C>>5H;S$L;6KARH/V!F=Q,
MGM7)?6[O8O[:I(P^!7B/$H?5K[J5J'H?-VH\*VU@O'9&V%K<O,<$QE8(Y'AP
M:6M<74)YBHJ30[#LSC&WC<>;R 7CV>(RW\1OB.8&\_,&UJ1R\5+TT9'*IVK:
M\MKQA?;3,F:"6DL<'4+30@T)["@.R@" ( @" \3-9O#Z<LKK,9[*V&(QMG#)
M//=9"Z@M(&1Q1E[R9;B2-E0UIX5J4DX*.I;G=5J+G=DHVDN9BRWX\Y+I V9N
M;W#V>L8=8ZAL72QSX[$F)\0EB,K71MN6SEKCSQ4[.]::_O>'9GT)UD><;_ZK
M]G[!U+(RK<KD>*4H_P!Y8_'](TV.-][-^UCG6V@D+#=BX'(&\W+S\OHIQ6,]
M_@I]*BJ>]'FUS^J#L"%WRW.;UI6G^DOGV#\XSI WLN;/#SZTM](:BOGQQV^-
MR[HHHW22>$T,-R^<!KN>6G$=RV&-N6/E:<)?VYGI?;OJKV?W%8C>Q<JU%RX)
MRBGK\?:91L/GL1J+&6^7PF0L<MCKF-DUO=X^[ANX7QRM#V'GMY)& EI'"JV?
MTZ1X'HMB[CY<(W+$XSMM:---?<>J' 4<WXKN[WAZ>/>54OF6O$KDG"5#[*@D
M( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ^<L8E
M8^-WQ9&.8[_@N!:?K%6+MISX<T5)T,?FYWEF=+F[FL+[7&LM-9>\SV0D,MS-
M!G;RVC<]Q>XD11CE:.:0JU9PX6*N++MR^[D>EDN:1\J_I,T+JC':RT_IC,MS
MF%<;K'&34%[(QL\9$D7,P^JX>)&*^E9F/E2VYRRL;^*HOXZ<#'RH3W#%C@Y$
MG^C36G DW3W7YB],=46:Z?MU] 6.A++#L%O@M>WT,4,-^R&/PX ;^=T<='MC
MXD&JL]N3GOVQWM\NW8V+D9M.RTDY:\?'VF7NF$]OO6;>-%W<1Q7S\>G30LJ\
MP*3'=4_4IL7IK8^\9J++:?S=K=Y?,X0^+%:PQ7D<CQ+>67C-+>3^>([5'IEM
MES;/4'<>Y\M/^73M12KPJHTX/0J[KW*P^QX;+%*YFSNUISBOQ]OQ,P^^?2=L
MOU1[3X7:?J TK%K'3$6)Q<%SCYY!&'W5K8QP2$N=%+0EP/<L[)N3N9MZ]:ET
MVIS;2]C;9JL:W3"MXUS6?2D_%42-8+ST?*WZ'^DWH1U9N+LAM'9Z/UOC<EB8
M\;EH+EDCV,=-*YQ+?9HR7$M'80*!8^O5[S+X6Z>!F=\AJ66?RR=@99G<TCK*
M]))_[U8T]*+@3/5_ S%*2@( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @
M" @0' M(J"""#W@\"/A" D-NW>GV:@&?;;-$X/,(Z-Y?$[2[XO>Y11"K/"UU
M8Z*M[RURN;=$R\MRU\47JUE,=2P<M.RHHDFDG*7@0ZNB1@(\UORTL=YB^H-*
M:LQ.JIM*7&DIF2W$399!;>R0OF?+,YC8I(6D0/+J\.Q=KV/WKD;18R,+RETS
M6CH<QW+L$,C+Q]RA.F1;^*H^.G P5]=G5]J_H;TYMQTD=,FY1O+;;KD&K=0V
MUV9W9">*I?;N\.\86<LEGR_%':N_[*[<?<5_)WK>K:4I?2GX?8<OW1O=K#\G
M9=GN='.4UP3\/BR[/:OSY]09CHEUR[/X7(X/=+3V&BQMEJ]EM=/;>SS67LCI
MA,VYY6'G];XRU-_TUQ;G<ROPFOT?56GQKX%RWZ@W\;8G@78/]<E1NE>.B=?O
M,2W0%LAUG]>?59;;XX75FK?FG#ZD&5SNKYKS,>P0V9R<%VV)L$CY[=X?!+RT
M#EV'=F1L^T;*]NM='5.-$J*NB-+V[8RLS<UDW5*61!UE.KIKKPX&_P :)T'F
M<[C,-B'R33387%6=ID<JX/C%]<VUG#!(\@MH:RL)^%?/%R$(JC^JI[)9=?F?
M"AU'Z1U!'GFX>&SF\1EQ&&7 8\-Y6R@GU@RG8%8:K[&7Y*#^;F7LX2UFLL59
M6MPXNEA@C8\GB:AH!''CP*DM'JH @" ( @" ( @" ( @" ( @" ( @" @2 "
M20 .))- !Z23V(#K175K=B1D$\4I;5CQ&]KBWN-0"2@+:]R-!W6'O':IQ4TK
MW\Y?( Y]8C5S^[M%3Z5#X^TFI26\R]WEFM.1_LBXC%!-V$4JWC0DFE%'50/7
M@>6:<K@3ZQI0^G]"BF-FW?:A>=+9$\O]'!RI5RT+ O,VZC=S^EOIAS6O-HM/
M7FH=5WD#A#-8PS3S8LAET _P[?UW5,8*Z/M;:=IR-W5F_*MCGX&@[@R+VS[6
M]P2<KKX+W\_@6]>3+UD;N]7NUV?LM]F,QFKL',Y^'DRLS;.^S FDMC)'':W<
MYN/['$I' =RW/>NP[;LMV&5BPI8N<EJD8/;&XO>+3G;N]=V.K;T^&I4/S?NG
M#>#J/Z:KW1^T-E-D-0V$;W38ICWM9+&SVMSR'".1KO4=7L[UK>R\[ [;WZ.X
M9+K&;Y\JT-CW5@9V_P"RO$QU1PU^PUA-BNKO<;RPM&:XV@@TCD,-NEKBVN,?
MG,K<&YA%B]L3K8.@\5UHU]3"3ZH/8O:-W[?VOOC,LY^+<Z?+HV_'G0\IQ-\W
MS88SQ[MFL^"C6E*:5*K>55U\YS:3>?<?</=C<N5L>8;D;ZWQ5[SN.0O)FBXM
MH1-/=M^+.>7M*Q^\NU,>.WV[.+;ZIZ:K_49G:W<]W!WVYG9\HIR\:?9^PY;E
M;\;J=?F\VJ,GOG'<,V\QF9:[08,KY68VT;?//CQV_B7 ?XL4P=P"ZGL;LO*P
MMM69CN,9+ZDZ>P^8/ZD?7K8]CW.6S;Y"Y+;\MT^6OBU6J>A7C7WEV]1V_F(P
M&B]CL.[);:7E@_YPU-=,]G<##;DQ-CAGMG%O%S1P[5D=R>I%O9:;9UQ=O@Z4
M]W)G"^C']+>T=P[W#U/V-W(8,OS(J3DZ<)<USJ85-[>B;J%Z>-8ZCT9KO2=]
M86>GG/>_/7,,\-C=,=XSB8;F2UAMY.40GXI5.U]SX&Y8\?TEU2N/BM*KA[3Z
MHW+MG<<?JW.,>J=G1ODU'3A\"4-K.G?6>ZV"R^>P\=+3%LE<UW_*F-M7T^QN
M7;X.!+.AYKT5#Y;]3?ZB.U.S]ZQ]FSHI9=V:C+XNGBB6-N;RPVVW0MAK/'LN
M8\;?<ES#-0L;X5PQO,0^@-/#)484X;;G-945*OW'7>HNQY/?'I]"]V)ENQ?R
M;5=-:]4>'WHR1:JPNC.J<1XW23+"SBQEFSGR4++:-[7>S_$\)C7N=1SP/@72
MRL6=PMMVZ=--?8? V-G][_TU[JMP[DE>ORN7*JW\U))RU\%R98)!HJSVAWAB
MP.MKQU[IZUOV"2U$Q]FE:)F\KI(@6Q'EY">(7/6L"S@[@GE4=IO0^T\KOS=O
M57TCGN_8UJ=G?YV?S51UUCR^TN#ZJ-P- :BTYI_3.AKIOC7#+:"-MM((XX"]
MIC(<V)X8>+P.(6SW3(C&TL>VUUSX49X!_3-V9W+VYWKE=Q]WV)2PK+E*3G%M
MUX_O+V,KEL?L!HO [8V3M9064E[GX&NGNYG6[VL\2.(QGQ'LH#5Q[UN-MPL'
M'P:9$4[K6OQ/*?7#U?[MWWU4R'VY=N0P<2?R1CU<$W71/V%%]Q=AML-J]?Z=
MU#D,K'-IF[NVS26+)6MC!,WB,/JAK2 6K3W-EQW?_4]:BD^%?L/2>RO67U#]
M3^V,GMC$QIW=ZA;Z5<<772-'QJR_O3^1P.5QME/IF\BFPS;2)MGX3V2<@$+!
MZS6.<12H75X^5;N6(XMNC<3XI[BVO>=EW?(Q=]M2CND;KZ^I-<6_%*IT(=2X
M^#*S8:ZC>^_:?L<GAN <2>'K=G!6\JZ[2\J+Z9,S8=NYV5MJW3%G%8T->FJU
M\2JUWK?V[1L.GKC&1-DMB',O^5@>16K:_IC7@M=M^)TYOZB]56.9UN\=]8FY
M=J6.VXXT%EP^JXDJZ>WB=C26F_G*V?E,IXEIC&&)K)8R?L[_ !.5[2UG&@:O
MF'^I;^IO9O0>]9EM]IWIW7K5/1:^+7@?>W_X/+_\'3OG]96]9-_<K_Z3M*Q!
MN,^O6<]*KI2;5*HN$VNM]K- ;FVNKX]K;76&L[''WUUI;Q'Q>/+D(K3Q8IVE
M\9>'17$;7#CVK"[2[PV[^H+L5=ZX5R5B4:>9!II:TX<5S/:MX[!R_P"@_P#J
M-M^B63#]5A9UQJQ<3ZZ]+>KI2GT\T=7IN\T#J]Q&_&MKK>G&WHTM9Y:&UL\9
M.Z>-V(QD5TV*V;&U]PWG:RU;3A3@%T]GTAP]]V^7Z*DK\8:<%5T]QL/5S^KM
M>F7?.+M6XVXSC<G'J2=7"+YT3_TF>32GF([<[F7V(TE%GO9;[-QQ1NC>2Q[9
M2Q@\,M=<EWQWT[%Y9N/ICNF'MEZ3@X1QVZOQ^X]E[=_J3["[LWK$P]NRH+)S
M%'\MT3BZ*NG57F7(W$PQ&*O\U?2>#A+"RER-[<N[K:.!UT7]O?$TGM7G.)9Q
MXVI0;?G]5/CP/HW-OW<24,G%^>72G7WJI8[TY^<OTTZSW^S739@;]CL_'?26
M&,O"1RW%U;2^SSQD&\<!]EX?%"ZS)[*W3$V9[PG6+5:?>:7$WFSE[I^GW&ZG
MDWOIX<N1D6U=JB]U7D8(;F(AK1XEG&TU\7Q 7Q4(+OC!P^JN/Q<BWDVWCYBH
MVZ-F^P9*R[F)G<$FXOQYHPC]8W4=NYMAO98X+-:5#M'8QQ,<=W;B2"\8_P 4
MQ\LDP$?!K:KZ7].^S=FW/8;F-BW>G.FE22?#@?F;_4AZ_P#<WI]ZCVK^[[?^
MH[9M2:BY*L7JTN.G(MGLNO[>@ZLN[_2F)<-.V[6TTY8PN:R)K&\74MG\IJ!W
M!=C>]&>WL7"2WJ]U94G];=?Q/ \?^M7U"RM]EN';&WO^3QXV;=5HO]Q^!7[8
M[S*\OD==?,F[6+;:Z<S!]@DAO&UC$=R6VTK)8YY@T>I([M"Y;N#T5V_ PX[E
MVI/S,B";G3V*JX(]O])OZZH9G>*Q._;#QMNN.,8]5>,FDTZR5"Z?<#,=(_2A
M:2]0NVNBL)+JO5WAW4F5L8+&7FEN299#6WC9X3N<?SU5Y#L?:O=G=>[W-MS)
M2C9MMZ-M:(^PO4GUF["].NT__L@[7&%V=_I<>BC^KW/]ID'Z'=W=/=0.C3N7
M@7R1.E>Z*^M7QN;R2D1D-#G.?4 D]A6J[K[7R>UMQ_0WZ5I4Z[TM]5MJ]7NT
M+'<^W)QDY.,E2FJX_8R_I<R>B! $ 0! 2;N-^Y]KO\3=3_>2^4/@#2<^CE?Q
M@G6A^->6^_#D\"OG+X&\JI* @" ( @" ( @" ( @" ( @" I/OK^X]N3^)>I
M/O/>*'P*H\3#WY$1_P#@/KW\>M0??:=1'@53^E?$SGY"_M\99SWUT\1P6["]
M[CW  GW.U5%O5\"6-,:YPVJ9+B*PE!D@<1RD@\P!H2*$H-:DZ( @" ( @" (
M @" ( @" ( @.G-C[*XD\6:VA?)RN9SNC:74>"#Q(K6A0%,[?:7!V^HSG6N)
M;XAE;;<H'*XNYZ\_+7XR-)E77.E*Z%5VM#6M:W@UH#0/0 *#ZR%)% $ 0! $
M 0! $ 0! $ 0! $ 0! $ 0$A:_USB=O=.WV;R4S*P0O=#!4<\L@8XM ;S D5
M"IO7'&'4B_B8[OW5;7,QN9;KKUK97%])9::;>V+))?!?SM;R,8Y_*3]EXU:
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M.J&U[2I>H1*^A]NK32#I9Q,9YY'.Y7$?%:2*=PXT"BE'H.14Q $ 0! $ 0!
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M/2>TEA#30\*=G#TI&EJ*2X(274J+B<VB@ ]"JJWJ^)4M-"* ( @" ( @" (
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MQ])#->N_HE]S5V+^_353R96U]/Q-U/;?]SO07XEZ6^\=BJBE\2=$(" ( @"
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MG:T;I6+2F+981RF5U 7N/96@'#@/0H2H";U(" ( @" ( @" ( @" ( @" (
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M"\[RO>F?;39;I9V]N\)IG%2ZEU1A[7*:AS=Q9VT]Y>W,\44K?LTMN)&,90<
M>)XU77=R.-C='C6]+,4DEX:'*;"Y7L%7[S_-DW5\^-"YCJ]W?AV&Z==S-R'2
M0VTF&T]?1V9YF1!L]S:3PP>$/$B <QW$4->"Y3<[SMV%;M_Q9R4?;KQ^XZ3;
M;"R<JCTMI-_9_I-:3R3NF^UZC]\]R^J+<ZR^?HL-G[VYPHRT9O(;BXO;T75N
M[^RXIV2-A+JTYNP+L+EE;5M%NQ2DY)-?%:FBN9/\PRY0>L(MJ2\*<#:GW*VR
MT)N!M_JO2&I-+X2_P64P60M);9V.L@&L]DEY'0'P#X$D3@.4M I[RY7)I+%N
M.6C46_L54;7&G*&1"2X*2_N-7;RB)[[9?K^WLV1Q5Q*W3-_E<N^&S;(_P(HH
M;MSX6-C#F1CD8QH^*M[M,[FX]IQSKFKBZ??0UV[6H8O<?EVM(RBF_L-MLCU@
M?0M$X+SU(SJZ4.:R"D( @" (#BYK7M<QPJU[2UP/86N%"#[X* UC/,\\MK>B
M+>^WZL.F"V?<YR*XBRF9Q>/K#/;36DLUR',$%N)'B61C:T=WK-Q[JIT3X%JY
M%_5#ZBUW7?5[YH^].@7;"Q[:Y[%7^0M(<#D\[%8W]O+=0M8+(\URQ@> X&KC
M^FI4J[T68/K19E.^Y*+C1>)E#\HWRW-0=,5CE=W-XX.;=+5;1<,MI7<\^+]K
M9!+.]\CX&2.,I#NTUXK&OW>MT7 S$E%4XLKUYL6L>K#1NR%MD.EFWO9,RZ>1
MN;N+"*:>Y@BY)/ Y(X 97!SZ5HK5NCDD^!2VXQ;C]1-WE<ZGZD]5=.F)R74O
M%>-U<Z1WA2WT4T-S)'R1%W/'.!*VCB>U+O3U?+P$:M)OBRS+S<?+>UKU!7^#
MWWV)@#]RM+N%Y>64-(I[_P!A$L]O*Q[+=\A<Q]/TU:A7;%Z5N72_H*;D%-5Y
MHQVV76CYIVE]O?VB7[:YY^>BQ[M-6NI38W\LL5J8CCZ"?E+SZI/'NJLF5K'=
M9(L.=^O30NU\J?RR-S]&[EW/5!U+P31:SN)Y<G@\?>O,]PZ:_?#=232&>#Q6
MM;*7?INW@L>=WY>B!5;C<ZG*;,[/4OL)IWJ2V<U;M)J)YM[+46/FMX+M@]:T
MNO ECMY0>5YY6&3C0+'BZ2ZF9'*AJB:*V<\PORK]PM56.U.G,OK+;?+7UQ,Q
MT7M=_!D;)UR^2WI$V-K(^2*W;W+.K9NQJ^(:E"'RZH^&Y6G?,A\SS4^ TUJS
M1N5TKH6SNX?'MKB*YL;6UM3*!=RRLEB?#+]AG<>([E-;-I?)J8[\RXDI*BJ;
M1G1?TOX+I.V.TKM?BW175_864+\SDF1M8Z[O7PP^*'<L<51$]I X+"N3ZY5Y
M&3[%P+LU;(" MHSU/V[\)[K?^*LRW_ 9*+EAV#WEAD/B10! $ 0! $ 0! $
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M%X+I&<I<X U <.)'^ZITJ"?\;C;3$VD5E91"*")H#6BG<T-KP ]"4!WT 0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $!0;<[-ZQL,O80X6&7V4O8.:,/(>'&CP>54
MMO@B4CM7.V-GJ5V-S.0>+6[\-D]];  ND+0'BHY20:A2UX<2"0MP=682ZC9I
MG'V%#C*1LG#/6YF M[AS$5;5/-C;A*JJVM"N-^WCUNW8]2\#'QU$=(^C>H^[
MPN5S+GVV:QEPPOF<]U)FB1WJ<AC>!5KR%WO9OJ)O796VW5;A7'FO ^>_6?T
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MZSQ]<[GY?7.@9\%J?1$0U.RZBC?/!$R*[>_QBUX,<;/&JYSCW+,VWMR6S?\
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M[C?N?:[_ !-U/]Y+Y0^ -)SZ.5_&"=:'XUY;[\.3P*^<O@;RJDH" ( @" (
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MDA\>N[HE]S5V+K]V6JGQ*GQC\3=2VW_<[T%^)>EOO'8JHA\2=$(" ( @" (
M@" ( @" ( @" (#'+YK_ .\4WL^UEC^O&*'P*X?40\I[]XGLI]K<A^O9$7 B
M?U&1M24A $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! 4VUSN)9:/:V
M$Q&>[E:>1G8UI(=0DU -"%#= M>)XFW.X\^K+JZLKNW+)(_6CD HWEH#0FI!
M[46NI/*JX%9%) 0! $ 0! $ 0! 2UJW2^$UE@K_3FH+*&^QN3MY+>:&5C7 <
M[2UKFES7<KFEU051<LQOVW":K$O8V7<PK\;UIN-Q,UV=\NGNQVYW<U'IBSOX
MX[-[I+S%1RM8 ULOC3M:U[V-!X !<1NF$K5QI<#WGMO?;N5A1FVVO]7[2S35
M.-U#87$60G+H?FV\9-;3Q$L<!;3<XY"RA]<1]RU-)6FIQY'>8JMYEJ5N]P:-
MA[H/ZAL7NUMECM/7=P&:ETW;0VES#+.'SW$3(HFB2CY7R$M/UEW&TYRR;/1+
MZXGSWWKLKV_<97[2_(F_L=67\+<'$! $ 0! :*'4G7^4N:+IV_.-K^J!0N#]
MY7^_'W&]-9?VG:?W-!^I,4E!V4 0! $ 0! $ 0! $ 0! $ 0! 8HO.C_ 'AF
MXE?\O:4^^+E3(N0KRXESO09^]2V@_%BR_4(E*X$3^IEX"DH" ( @" ( @" (
M @" ( @" ( @" ( @" ( @" ( @" I-K+=3&:9G=8Q,-S>4<"*AHC< [TN%>
M+52V.1ZFWVN6:RLYGF$PSVQ]>H-'@T-0:D<.:BE.JJ"HJD! $ 0! $ 0! $!
M*VK]+V.K,+=XJ]8#XL3Q%(0*QR<I#7#@>\I["NW+HE4QP:DQYV]S=]C)\@'R
MPRN\.4OJ(VN>\@%M1V-'H6'.XHR:9NL;&>?\BU2.YA\_;Q>RYX9#QIXIHY*1
MNY31CVEP/(X=M%3YT:MF-=P96KZL)4,@N@M8X_6>!M<C9O;X@B8RX@#@7QO:
MQH/,.9Q]995N:DM##R,>6/<<))T)V%:<10^CM5PQR* ( @/&U%_F_G?M-D_U
ME.A*XFC%Y-QYO.]ZIS_TSF?UW*J.445/ZIOW&]LJR@( @" ( @.CE*_-M_3O
ML[C]1>A5'ZE7Q,9&1MJY?)'M/M4_ZL_\]84K=9/7B;E7?E2\#K^SL=W]G\W>
MH\IDNXT]!X#3P)[?<]">4VN)/FI 0,H3V? 5'E/DP[O)<2+;=M.)X=WY_>GD
MOQ(=VA 6P))[>S^;M4NWIQ"NJOL/6T]; ZFPI' -NH:GT_98U<6E$1DW$[>F
MIDQM_P"UX!_^#%_VC5D\C2<SK/+(V<SRV**-KY))7O#6M8RI<YQ<0&AH]*UU
M^Y*TG=C)0QXZR;\%KS]A>@NE]$:RFS#MU8>=ETI=*^X;]L\G/E]8:CLY1#EX
M],XZ?*PX]P?+&_QIK SM C,1KS4HL?:]VCO63Y>-!O K3S7I'P]Q<S<1[?;K
M?=+]*]//V%Z?21UL;&]9FB&:MVDU'!>RQQL=E,)</CM\IC7N$3N2>S=,;AM/
M% XM!JNIW38,G8K<,V"ZL.YPDM8_V^)HL#=;6Y.5J2E"Y%\'HVO87?@@<H:Z
MHX^ZM8W6MU?2;1)070^)]E6G55("D! $ 0! $ 0! $!P>"2TCNJJE2C12UJF
M8%_/MV<U)KKIWT_N!IZPN+X[;99F2O66T4DTC8>=\X/)%%(Z@\,U/"BU<W^D
MWK%W1JL+3HU[V;C#FKF!D8;^JY'3X(J=Y8O7[L3N!TV:&TGGM9XK3FN='XMF
M+S>(R=S!:/C-I%#&) Z>XJ75)!%!2BZ[N"*SLK^86_X4TG[J+@<IM<_+MO$D
MNF46TO;J8\_.LZ]-*;E8+ =,.R&>;J>^U!DH++5$N)D,[.>YEDL[>!OLL\GC
M-;(\<>0_&7-[?AWMTW^S=47^DL.K\'_J.DNY=K9]JNNYKE7%2/BO]9EZ\JSI
MJDZ;NE'1.'REC['JK4%C#E\ZUT?ARAUS!!) V6L43RYK#7B.]=!W+F>;?5BR
MZVXJB]GB<UL]I^5+)N*D[CJT76=0F_.VVP6UFL-;Z\U)BL9:8W#Y$,M7W]J;
MNXNY+*Y-O!':NN(YG>)(RA('!<SE5CBRLQK*Y-=*]\M*_"IO\6W.Y-:4C'7X
M+4UP_)6TIG-[.K#?'J<DLYXM/-S&1;B[N6.1D=Q#>7?V'P7O8YLE8I ?5>5U
M.&EL?:\-AE\UR7S=7OU-+DSEN.]/<(:68Z4]VAM>-)<">SCP/;PKZ/=6D2Z=
M'JS854E5'-"0@" ( @" X.BC>PQO8U['"CF/ >PCT%KJ@A%5(4//9A</')XT
M>)QC)JU\5EA:MDKVUYVQ!U:^ZIJZ4KH*'I 4 '#AP%!04[@!W44 ^<T$%S&8
MKB&*>)W;'-&R6,^^QX<TH#C%;PPL\&&"*"$4Y8X6-B8.\T9&&@<5";XOB/P/
MMRBG*0""""".!![01W@J27J>:["X9\HF?B<8Z8&HE=86KI0?2)#$7 _"IJ^'
M(@]%K&M#6M:&M8*-:T<K6CLH&B@ 4 Y(#JW%E9W@I=VEK="E*7%O%.*>BDK'
M"B:@X6V.L+(4LK&SL_[EM8(.WMX1,9VI5UU'N.T0>8&O 5X? JJJE.92T^JO
M(YJDJ" MGSQKO?A!Z&_\59MM?D,E<2Y<=@]Y81#XD4 0! $ 0! $ 0! $ 0'
M3R']H7W]QW/ZB]0^#)C]2]YK,X&+'.ZEMY))R3>#)_8.>O/7VJ6O*'<?J+QS
MNJ5V62UP57^T^T/1Y8W\J4E3]:DOV%?F,\3G;,*AI/AM)[>/I]Q<3>N7,2WY
MV,JY',]IOW(VEUIT\7Q):U!=9FPM'S8:Q]MN UWAVHDY YP:X-'-6G;1;O9,
M+;-ROPN;S>\N+:K\IR'?O<&^;!L$\SMK">?NG2W&%::ZT^^A;3E]9]3MI>OD
MQ^B(S9<Y\-GM4;CR!SJ<:UXMHO?]J[1]"\G!2W'/3OT^FE-3\Z^Y/6'^N&WN
M4\K;.UY+9HR=%UU=*NGW%$=9[A;P'7V@\KGM&2PYW%9&*:QLHKIU;R5ERQX8
M&L/>YM%TFR>G?I=:R?-VO=%"VWHJ'E_=G]1_]6$L-X7<?:UQXJT^II<S+O!U
M_P#4I@[:PCR/3AE+F.*QLVDLDNG>(UMO&/%JT5K)2OPKN;_8W:-R*_2;HG<]
MQXW_ /9T]6;4GY_:DZUU^=G<C\S_ '.M26Y7IMST!;\8L;D#05[>P@T2WZ=[
M)<7_ +E'J^!+_J)[XQE_G>V+L?\ Q29Z%OYJ\T3C\\;(ZELFMIS<EM?N<.P'
MB6.'!'Z86+SZ<'/MW+G@Z(B']4L\?7==ER;-KQ2D_P!AZ<7FU;?QD#)[>:KL
M>RO^#[Z2GI[(1V<59GZ4[JD_+O6I-?[2,A?U<]DV7_G\;+M+_P"E-_L/=M/-
MHV+E+1=XG4MH2/6#\/?'E[/2P+ EZ9;\GTQ\MO\ WD;;&_JR]+LA/Y\I27C8
MG_<3EC/-&Z<K\-,U]F+3F[/%Q5RWO X\U/2J7Z7]S_NP@_\ Q(S;7]4_I9=E
MT^?D)^VS-$^8SS%^F&_<!+K&:TK2AFL'M%33@:R A8>3Z==TXL/,G83C[)5-
MY@?U%^F.=*D<N<5_M0:_%DVP==_2[.*C<W&1^Y,QT9^H7%:^79?<<?\ ]VFS
MI;'K+Z=9'T;C:7OT_:>U:=:/39>T]GW.P3Z]E9V-_->%CW.U-_M*L\:Y3W&Q
MM^J785UTCN6-7VSBOVDVV/4SL?D0#:;A:?DYJ4_L^V;VT],H]*Q7L&\157CW
M*?[K_N,^SZ@=FWW2UN.*W_\ 4A_>3GC]V]M\F6BSUGIZ4NI3_"UBVO-V=MQ[
MJQ[NU;C9CUW+-Q1_W7_<;.QW1V[DRZ;.;BM__5A_]L31%JC3,PYH=18*4=M8
M\O8/'_V;@K&>+EI5=JY3_=?]QGPW3;+GT9-B7NN0?[3[MSN&>:,R^)?Z.7)6
MA/U!(5;\C)7U6Y)>YEY9N%+Z;UI_^*/]YV&Y+'R?U._L9#Z&7<#OS'E1*W>2
MJHNON96LC';TN0^U?WED76'UT[;]+6F70FX@U5N1F(S;:7T9B[B*ZN[R^G;+
M% ;AMO*Z6%K)VMJ" 2"IA9R)QJH.O,OR73!7-/+?.J,=6P717O-UC[@6/4EU
MK7UZS3?M,64T5M9)/*RT;9&5MQ8NN8"'1"*.,EM"*FE%:U;HU2A5*/3Q:K[R
M_P!\PC,0;*]#^ZUUHJSM\%:X72[<;96^,B99QPVK[9]H UMMX(J8V@$]I6#N
M5QVL5R3HVTCE.],F>+VSF9$/JC9F_P#X6:*&VCWSZ?NLM/S&?,Y3)W,I<272
M.DO'RDN>ZI/%Y[:KS3>\AQS5C*'5;?[Q^-NY9\MSW[(W#*NMW)W9+H?+YG0G
MNAX@\/YT5X#LJM>[EG'R%&TU.W3YG_A,._:R;=]^;%JQ+Z>9]&QL-!)P:2.-
M#_-Q63L>$MY[AMQ49/:HR75=Z71:JO*AB;KF1P<"2L34LQK2'!U9Z4]Q"RVD
MLK=U&36\S'R#@?6B<T"HX]I"^DNZO4K8.VMAM=M=E=,LRY"EZY&B?#V,\KVW
MM+>]TWJ&Y=Q5>VN=>CCI6IET\@W>.+0&X.[^W>KLXS"X*X?;RXH9*Z$5M<2R
M.MG.,3[F:.-GK5KRCL7C>Q9WF9ER=RO5/5ML_4[^EONO!C9R>WGDPMX6(H]$
M6TDW*E>+-KK%ZNT7?UN<=JG 73'D\8\UCWGC_0BY)';Z%UMN_9N_-"29]EQW
M#;K\O,MWK3G[)Q_O)CCRV*EIX63Q\E>SP[VV?7WN60J[U1\49"O6I?3*+^*.
MXV6.3C')&\>EKVN_[4E35%::?,^B-NFFI)"JHZVOJ5$2*A3YD10XND:VG,:5
M]PG\Q3&2EP(>A#Q8^''MK3@>[X$ZD15'(.:[L-:*4TR>/ Y))T500KQ [SV*
M(R<N7 ,@2ZO!M1Z:@*NB\2-3DH%4<7/:WM/;\*%48N7 @UX?6G=]= XN/$Y<
M:GAP[CZ4(/F9'"4,Y*M()YJ]]*THJDE2K*')J226GB2+K_<_0^UFG[W5&O\
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M\7)K/[;8G]5G4<RK_EOWHN:\A7^+&Z?^[^P;W]3L5$> EQ,QRJ*0@" ( @"
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M" ( @)-W&_<^UW^)NI_O)?*'P!I.?1ROXP3K0_&O+??AR>!7SE\#>54E 0!
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M[RNVMPPW;4:22X^XS]12&01OIZLD;)![G,WF^%=AT:]:>AX@VU)Q? ^ZJ)"
M( @-$_J4)'TES1=/\HVO'_P@5/)^\N477'W&]-9?VG:?W+!^I,51;9VD 0!
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M(0! >-J+_-_._:;)_K*="5Q-&'R;!3SO.J<$?\\YK]=RJE<$3^])&]NJBD(
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M=1OD%:BCUME=6=.>XE]@L3G+VXNW:;M[F7'MQYN)YYI&"6"*-LC:O%./<L_
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MZ2L67N>MK5TD7MKK:"6XD+_![0T@U7BWIQW-B[#W/-Y<$\><J)M5HFT?;?\
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M66/Z\8H? KA]1#RG_P!XGLI]K<A^O9$7 B?U&1M24A $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0'![^2G"M5#:2JR&Z$B;
MAZ6&I\%<1,J;JUBEGM6@TYI6,<YK>P\7."B4Z0;7!HKC%2FD]-3"9NO>YW,:
MRS&.U5II]I)AWO997[[9S/$#'2-#A*8QS5IZ5RV3!2N-THCUS:9K'P(34JU7
M"I3G3VJSIO+8#43H_$^:,A#XT(-"]ANHZ#M%/58L>U/HN+DZFTS<=Y&%)QYK
M]AG_ -N=66^N-&X+4MM"((\A90R"$/#S$?#:'-)!/>NOLW/,MJ?BCQ7+L.QD
M2M2XID\*X8X0! $!HG]29I])<T7]L;7]4"I7!^\KI6<?<;T]E_:=I_<T'ZDQ
M5%!V4 0! $ 0! $ 0! $ 0! $ 0! 8HO.C_>%[B?;[2GWQ*ID7+9<[T&?O4M
MH/Q8LOU")2N!$_K9> I* @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
M @" ( @" ( @" ( @" ( @*2;HZ)_"+'F_L^;YQL6N=$UM?7X.)%*&O J-?@
M3%M.J+,=5X^:ZQ5SCKRW_LJ.K"V2.A!',*@N:L3(AU)F?MV4[64J\:DI[06D
MNC-=8[+WC@8O'Y61 \H]=[&\3ZO8K.,NE]+-_N5_SK=7X&4ZVF;<6\,[:<LT
M4<@H0X /:' 5%:\"MD<B^)]T(" (#QM1?YOYW[39/]93H2N)HP>37_'=]4_V
MYS7ZZE5"X(JYR^!O<*LH" ( @" ("! (((J"*$'O![0@//\ FG&DDFRMJDDD
M^#%4DFI)/+QXH#Q<[HO3^H(XH[ZQA(B^)X;&1TK7^=;4]JB@):.T>CS_ /F
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M4 *TXFI]-*("* ( @" ( @" ( @" ( @" ( @" ( @" ("V?.D_MWX4?T/\
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M>*$ET5K-;W3@[EXL:72'A4- 4O9\Y?1>:,*WZ:>IF"ZX7<$NCDG"I]Y=I_-
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M:IUVX_@B^6-YD;4CE- :5KVK.:H=2]'0^B@! $ 0! $ 0! $ 0! $ 0! $!
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MZ0GBY6\R]&2\I<BU;MR4G.7,VA%KR^$ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
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MT1KW\>M0??:=(_253^E&=U26P@" ( @" ( @" ( @" ( @" ( @" ( @" (
M@" ( @" ( @" ( @" ( @" ( @" MDZL@RSV9U+DX;9DF1MV1>SS-C:)6DB6
MOK <U#[ZP\R,/+?4M3?]MPMRW>#DOE_THP!ZZS.?M<=9Y>]N_86W4DH,#'\O
MJMD<*NY7"M0N)S)=,M/IJ>[;/B[?G;@K<H4HOV&4/RZ;V:^QF2F.;;>PF-I9
M9!XHPN;!S'EYSQX^A=!LKE<7570\T]1+,;>;TPC2">GWF5$@O93XI/PTH?\
M<71M+@>9JK7@<U!4$ 0&CQ])"_?W=$_XW8O[]-5+YE<OW/B;J>V_[G>@OQ+T
MM]X[%5%+XDZ(0$ 0! $ 0! $ 0! $ 0! $ 0&.7S7_WBF]GVLL?UXQ0^!7#Z
MB'E/?O$]E/M;D/U[(BX$3^HR-J2D( @" ( @" ( @" ( @" ( @" ( @" (
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M.JJ@^"JZ^[[C/SL[^814\B*>6E3KYEZO19T#;$]#>A(]'[2X%D5],P#+ZCO
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MHFZ>\[T4$4(#8HHX&#_N<3&QM]'8P *=$J+@12KZGQ/LH)" ( @" ( @" (
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M,RDLM;7'VT-OCHK6RM(0QD-I:0100!C &M8R*%K6-:UH    HM^K'7\J5*?
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M)R&VY.JKJ?HIBXN/@V+>'B04;$$DDM*)*B)C;V)"3E&K5#*9R59 0! $ 0!
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MXFL8QK0.  [%37GS*6J^X[*@D( @" ( @" ( @" ( @" ( @" ( @" ( @"
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M6T>!61QAJ&$=RO>I.V7HJ.7D273#A]Y@>F]ZV\"^XZWNK5<J5TH9U>J+5FU
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M\.@S<3[?:4^^+E3+@5PKK3B7.]!G[U'9_P#%BR_4(E*X$3^IEX"DI" ( @"
M( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ("TWJ
M/NKZU=B9+)GB.J>9H[:>O7@.)X?FJU.E388/15]7$MSCU&;^&_L8\>?;HH/4
M<64!D\.M:D4^.L>6D3+<%.[TK@7(]+64R]SI[)66:K'=6]P3' 75+(R1V"O
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ML;I__N&]_4[%1'@)<3,<JBD( @" ( @" ( @" ( @" ( @" ( @" ( @" (
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M 0! $!)NXW[GVN_Q-U/]Y+Y0^ -)OZ.3_&!]9_XV9?[\.1<$5?XC>64E(0!
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MCZ2$/_GOZ)J_LNQ=/NTU4\F5M_3\3=3VW_<[T%^)>EOO'8J5P*7Q)T4D! $
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MS*G_  W\"YKR%?XL;I__ +AO?U.Q41X$2,QRJ(" ( @" ( @" ( @" ( @"
M( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
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MY'CHOP\3P3:/Z)MJV+N+(WZ[-W,F4W-OJ=$FZM-4IJ4"\B'J>U;)U/,V3R^
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MQFG+B2$8RR@MHY+D^*R-Y?+"&.D +12H6X[K[2[GVC,AE]P.4K4]8UK0\O\
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MW[39/]93H2N)HP>37_'>=4X_Z9S7ZZE5*6B)_>FO<;W"J*0@" ( @" ( @"
M( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
M( @" ( @" ( @" ( @" MGSQ_P#C?A!3L;_Q5F07Y!*+EQV#WEAD/B10! $
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M(:R@Y2:CT4I[JB/4N/$EZ\=3D !P'!3Q%$N XU/'AW#T("* ( @" ( @" (
M@" ( @" ( @" A4TK3CZ*_GJ=*^PC6GM/DUTI>X.CHWARFH]''ZZIDVI46J(
MBY/BJ',O#6ETA;&!WN< /JF@"FJ7$K:7+4ZXOK(FGMEIS>@7,)-?Z:JCJCXD
M],_!GV,K?#,C")&^EAY@>_M;4*5\VB*72/UZ(@R7Q(P]C>;C2E:?FJJ47%T9
M3U1EK!U1]6DD D<I]%:_75)410! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
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MAF5U+#F?:WMC$HD>WF=VA_/3L/>C7- K';0-MK>&W9\6*-K 22:\K0*\?31
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MK7&;(&YNI !( 8[F65OK\K@>)]*X3>,-9=S273J?1?:/<F5@[*L"-IIN%*_
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M!H]X"@0DB2 *DT [2> 0'!DD<@)CD9(!P)8YK@#_ -B2@.: ( @" ( @" (
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MWXX8(\;J-])8RQC+DD$EO!OK OJ>*LQNUXE*C+IJUJ5_Q^4L,I"V>QN8IXW
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M-?KN54K1(GC*7P-[A5%(0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! 6SYT']N
M_"G^A_XJS8/\@E(N7'8/>6$0^)% $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
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M#6\K0T=U?KFJ@E:') $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
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M9K^&:UAADN(8K&".X\28/8P!C@Z+TKWKL[O#MO%V.=O<X0=V4*:T\*<S\_\
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M-036>0:T6LTSHX 2!X?*_EX5=[JI3J'5%<\KF+##6;[V_G9#"UO-ZQ',[@2
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MI? WN%44! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
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M()HXY)"WPS)2II58ER$K;:+D7U*I7-6XNJJ2%(" ( @" ( @" ( @" ( @"
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M=["TT/S78CAZ#>1U"E\"N'U'S\I[AT)[*?:W(?KV1%P$_J9D;4E(0! $ 0!
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MWJK#W]U<YBY=;V7.\%D\A(FJX4Y?$IVT4+P#K0N&!!%0:@]A'$*0$ 0! $!
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MJ"3QM1?YOYW[39/]93H2N)HP>39P\[SJG^W.:_7<JI:TB5/24O@;W"J* @"
M( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
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M;\A;^+&Z?_[AO?U.Q41X"7$S&JHI" ( @" ( @" ( @" ( @" ( @" ( @"
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M8=B=B8>^KN3'P+4<V;^KIC6OOZ:_>3?:Y1]S- <DT798\<G,>4!M1P+B30-
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M>"45*(FI !K*-:UK0:_% :!0>@!31N.KU(T3!/)W5JJ+5GHKKQ)E(QT>:_\
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M61@@<2?C$GB??/:JG!2=9:LR7)M49] T-H!V#L^%5:UXZ%*T.2D! $ 0! $
M0! $!Q<[E'I/</2E&^!#9Y^5R^-PF/N<GF+^TQ=A:1237-W>W$-O!%'$PR/<
MZ69S(^#&^E6;^19Q;3OY$HPM156VZ%['Q[^5=C8QXRE>DTDDFWK[C&+O-YM/
M3/MA?W6)PF8DUMD\>^2*^AQ;0889HW2L<QL[)'-D]:.E1Z5Y5W!ZQ]J;%>5E
MW8W)OP:X_:>S]L^A'>_<D>JW8=KG\R?!T]A1?1/G;;#ZBR\-EG=/Y73>/?*(
MY<E-65D+2]K>=S.9O  D]O<M'9]?.TYWHVKK45+GU)_M.CS?Z9^^\2Q*]&'5
MTKA1K]AE-VDW\VMWTPD6H-L-6XS45@\-+XXKFW9>1\S&OI)9^*Z=I'.*\*5[
MUZML'=G;_<<7_++\9S23ISU]G]QX=W#VKW#VSDJQNN/.VJO5I]+H^3HBLC7\
MW=2G;Q[#_,%T4ETZO@:!-/3]XY U)'HI]=*:5%=:$5!)\Y'E@%!6I]-%1-M:
MHE)O@1=(&BI17$^!#T6IP9,UY(%?K_H*'<2\2(M2X',O:.TT4*ZGP3)T\2+7
M!W8:T5<9=7L&G(ASM]/UC^@J^EE+DEJ ]KNP@JAN4?J5"8R4N!R) %3P"J6O
M GAQ/B^XC9W\WIIQHHJBER2.3)FO[*CZOZ"MRNQCQJ5+YM3F'!W8ENZKG EI
MKB<E=(" *&VN"!BE\V'J7S.QNQDFEM'RO@UCN*V7&XZYAE,<]O:%DT-R]@9-
M'(>8>BM*+R#UB[MEVWL#LVM+U^,M:T:23]J/:O0WLM=U]WV;E]=6%8N1<U2J
M=6O8S6FT7I]NFL;*;AQNL[E'NO\ +Y.X)GN9YKMXN'#Q9>:5O*]Y[U^4O=F^
M9>\[K.Y>E+RE-T57XOVG[6[-L&#M>SV+.UPC;:A'@EX+P2)D];F<>(/IYJK1
M3Z8Q70ZG5)2E949/YZ<2(+FO#VNXCN/K-]VH/ U"HC<N0:E!_,BF-BTHN,E6
MJU/&QVJ-1[-;E:2WKV_GGQN8PN7L&YV"TED@@O[6XO8&R>-#"^&,AL+3\8KV
M?TF[YW+9MWA8=R72IJFK7-5YGSUZT^G>T[KV_??E*5RY"3X5HZ2X:&Z=LCN-
M8[M;8:.W Q[VF+.X:RGFY7M>!=>RP^U-YFO>*B9Q[R5^K';N[K>MCL;C;7\2
M"?QYGXP=R[-<V'?LC;;FDK5QKX5T*L<:GA[Q]*W9I"* ( @" ( @" ( @" (
M @" ( @.M<M^PW!'QC!,.';7PS2BMIOK:]A5'22?M-</.LN;;JLW<;D.8/DO
M83!XE:EOC2GU0[CV>A>(=X*F\4?B?=/I#*,NV(J'&B_851D(-"/2>/PKG;E*
MZ<*'J44TW4^:ME8KP(]-$( K7AVH'[3D2 UG?5W9\*JM23FX\Q%-S93G1C;B
MXZN]K#C@X%EQ/[2V.M:<T5.8M[.SO70]L*2WR/A4\E]7I.';,X3XT=/O-C:W
M!$$-?C>#$#7MJ&#M^%>[+@?#<OJ?O/%U9_FMJ7\7\S][KE%Q(7$T&<3O7J+I
MOZW-9;NZ4P5QJG-X34N6?;X:TCDEFN"_)W%0UD/V3AX8[/2MRH>9:2;,*Y.<
M+SZ54R:3>>_U+RQ31P=..HHII(C' _YKR;N29["QDM*>L \@K%>)!.CEH7E<
MFU51U+;]L.G+J^\S?J0Q.[6[& RN T7:9:SR-W>Y.VNK2*SM+:\@N8X(K:ZM
MY&T\&4M'*1V*9W(6K?EK4JA;<OS+FGL-F?JCV.VQP72CJ3$WVD\5E3HS14EO
MB[FXL[62X@NK;%FW=<Q320%[.<L+J"G:L.,YN:?,NO5/PH:]_D?Z%T-KK>K=
M:PUCIK'ZABM,M?OQK<A;6]S'9&"\8Z+DCN(I0 TCNHLR^Y>2M=#'QI-IKP-O
MK$XC&X+'V^+Q-G!88^T8([:TMHV10PL'8UD; UK0/<"U_$R#KZBQ,>>P.:PL
MP!CRV+O\>ZO8/;+66WYN_P"*9*H#27UYC=XO*[ZZ\GN<=+93(Z*O<W=W[;VV
ML[N6SO,??WTMS.'310PP-'LT9[7=ZVT90OV/+K0L4\J;ER9D8WI\\#%[P;6Y
MS1&P^W&?R.M-18:XLKN[]FNW6N';/:OCO>9S.9H $G N/9]56[6*K=VLWH7/
M,BU6&K++?) Q>3R76'J;,WP>R^;<9&]RK1S<L=Q=/BN)(W$<*B1Q'%5Y]>E)
M%FS#JFYLW.UJC)" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @-
M=?Z3/_%R:T^VN)_59U'-%7_+?P+FO(5%/+%Z?_[AO?U.Q41X"7$S'*HI" (
M@" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
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MVN_Q-U/]Y+Y0^ -)SZ.5_&"=:'XUY;[\.3P*^<O@;RJDH" ZSXVF0N+R*4X
M=G#@J'U]:=?D\ ETOK(>$T5<9/5/N>C_ '59\F$+_G1=*\O$J4WTTEJ<C$UY
MYJU/I[/K55<8.,VX_P -\BAI-)_O>)SY'4:.;BVOK4]/N))3N?*U2)7%J*UU
M,.WGE-IT&Z[- [ERV '*14'^RI.XU"P\2J[ZV>G_ ,R7[#T'T_N2MW\GI756
MS+\"X+RQ.9O1'LRYH )P["X  !H,4 (HO0_4VLNZ9-JE(P_ \RQ;:LO(475N
M]/\ %&0L=@KZ N-_ RB*D! $! UIP-#Z4#X$ "*U-?@HCI^[H0DUQU.05,4T
MJ-U)*3[Z_N/;D_B7J3[SWBE\"J/$P]>1%^X/KWA_[=:@XU_Z5G2/ JG]*^)G
M=4EL( @" ( @" ("#FM<"UP#@>T. (/O@\"@/.AP^,M[EUW#9P1W#^V1L; >
M/>.' H.5#TD 0! $ 0 \01Z4!;;KS;G4F0U-#D<=<23VUQ*QSCS. MP'5(I0
M]@*I=>7 +0KW@<?)B\59V4TKIY88FA\CJDEW**CCQX*K7F2]74]<BO \0>!!
M[T(/!D=@<1=M+_9+2ZNS0?U-CY"?J'B0@KR*&;V6MZYUK=&XCEL2*1V[7-)'
M!U?=H2:J'7X!<2@0[W#NIP]_AVJ.5 ":CB.SO]\^A-4].!(XU_HOS.'U.Q*K
MX$'%SVL(K\5W#O[A]7M1\*\R4JGUJ0*_&'U*?[ZC1D$*=C3V<?A[_@HG'4'$
MD5X=BG4B=9\6'4 IVE4?-7CH77-NWTK0YBH!X \P]9K@"#V#OJ.P*JD&UU*J
M+<JZ>6^FGAS.+75]2G"OJ]E!WF@[E=NRC.'1%4+TYPN6NB4?G\2DNZ+LKDK6
M+%X&=\=XQPYXFDL+N+CP<#QI5:S(5R-(1>AO=@MVTF[T?E\3EI;&ZWQNGW.O
M+LF>)H,$<G G@"X5?2M:*B,96X];=:EW+EMU_(\M)5/6BU+F8K)L^0L7P/MW
M4FD%2)/6H#Z!P69#)Z(IM&%^DQ+E5BSZKE.'@3I87K,GCV9"WHXN:26"AIRC
MUJ\319"O0R%_A:-4L>Y8O-9"I#Q/C'D8LGC\BS'N;-?0Q2M\#@0'\C@ :D@^
MM18UZ?F1:7(N_IU;RH3G_#;+4]#X[6;]T;@7SI[2(3R%T7+(+<L$E11M!$"6
MK56XW;MWIU3J>@;I>P%M$4DG+I_87K6&=RV%F#\==RL<P- C#I"P.]7F-.8#
MB6K>15(I<TCS2PU><N4:E0<=O;GL?)##DK;VQKJATG86]@!^/55+7@5+RG/I
MKP)KQ^]K/;)/G"&..VD8? YI&1D/I4#UGBO%3>E;A&L7J4V5<O-],71?>6-[
MK,W)UAN:-1XC+7=IC;.821,BEF$380\N<.5C^1P+"M)/'G>N5ZN+.PV?.Q+?
MY5^*6E/N*J8+445Z^TN+]YN9[41QWL[Q0EP#&$^L>-""5L)-6>F#=6SE,^U=
MAN#M6$Y6I/C]Y3?J V4P>IWXS7D=Z768?'/(V.KB_P $NDY*-:XM[*=JP\[!
M=V*FIZUX'6=O[W+"O_HKL-)*E2\SIMUS@LYH^TTYB[6:QEPD+(',E$CQ)RMC
M:9 ]_P#/>A9N/=<H*+7TJAI][QE9RY7$T^MU+DW<S&>J.8CX.]9:I*6II'6,
M=-6<Q6G$4/H5)4N!H\_20_W]_1-P[-78NIK_ ---5/)E;_=^)NI[;_N=Z"_$
MO2WWCL544OB3HA!Q:TM%*U'=PI10M"%H1]*CIK7J^DD\_FG]9D9IR_%X#C4U
M_,5ORE"<9J5+?-%2G&;::HSES2-'-*:<XIP%:%OZ*OSA!3ZXZM%OJE*T^K2G
MWG VTTKA+XQ:3V- X +&>ENL%\[*[3Z;G7+6-.!KF>?_ %]GZ86D"2FO;;M
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METJ..CX%.CZH ':T&GNU' )I2O('PMYI9GO9-'X8;3D=VU]/!'PT"XUY'8X
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M$G*E* FK:\?<_/[4K5Z<2"TCJIS>Y.,QV.9HJ*Y-JZ5G-);"0N!YY.WPN-.
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M5/\ ;G,_KJ54K@BIKYI? WN%44! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
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M #NX+(TCIQ1TZ5QV_!'T#VA[8_TPK\-15&J_,4*:3Z.9]E25! $ 0! $ 0!
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M_$R$60;)?"QB:Z&0R"2Z\01"-L?N=JJ[G].L"[@WMSPYJS>E6B32UU-IZ?\
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M2://TD,$==W1-PX'5V+^_33^>J>3*W^[\3=2VW_<[T%^)>EOO'8JHI?$G1"
M@($T%5#JEIJP27J;7FA]'-9+JW6&FM--?3E9FLWC,9(^M:<K+VYA>[L[@58<
MK,VK<VOU'@GK]A<C9R)1=Z,7Y--733[>!Z&!U3I?5=FV_P!-Y_"ZAL:!S;G"
MY2RRD0!H>+[*>=H[1WJ_+'S;4Z9,'&V^#>E3&M7L>^^BU*+FGJJZKX'O<_V1
MC1V$&GN>JJTJ0?L*FZ343 3YWVR^ZV[4/3P=M=+W>HSA-;6]UEQ:LFD-G;#(
M6\CI7^%#+P#&D\:++]/I0P>^)9N9+IL.RTF_&LCO-ASK6-V[N-EM*Y.%$O'0
MS?[8VEQC-N-#V5\PQ7=EI33]M=1'MCN(<3:131FH!!9(TCL[E<W>Y"[N=ZY%
M_+*Y*GVL\OV2U+'VZ-N>CZI??)LG=_,'AP[/]RBP$UT&S?5U)K@?=4EP( @"
M ( @,<OFO_O%-[/M98_KQBA\"N'U$/*?_>)[*?:W(?KV1%P(G]1D;4E(0! $
M 0! $ 0! $ 0! $ 0! $ IW]Z (#RLUDX\/C+O(RM+F6\3G<K:DDT-!PX]R
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M'5:HOPZ,-^>H#.W$/1EAMX;S2&W^59(+G5&1GF<['XJ$1.NF1W=U=-(Y;,N
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M4NZ-YEO^_9.Z7/JNW&_A4K**]Y^#T+>QKTJO$Y\BI 0! $ 0! $ 0! $ 0!
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MR:T^VN)_59U'[R*G_"D7,^0I_%B]/_&O]@WOZE8I$2X_ S'J2D( @" ( @"
M( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
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M27N-[A24! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $!;-G?W<,+_P?^*LV'\
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M^V=TN8RS;<)>72O!^_P.9_[O[0M;A_VO>R+2W.ND>J/57W5K]Q[W*6D\HJX
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M'_X$:]'HUWJ#[[3_ **B/#VE4OI1G=51;" ( @" ( @" ( @" ( @" ( @"
M( @*7[E:'.K+!AM &WT)]4U^,T@BG8:4JE*D-T]QV=N-)WNEL5[/?3.DF?\
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M)H/17W?1W<%"U)YD2>7W:_!V*.)!QD <!\/'ZBE+Q).->SW%)!]&^@<?2?\
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M.@;195C&E>BY-TH1*2CJS$9;>?%OQ@KS'ZAU9T\9JWT5=W >ZZDL[^*)ED9
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M>H.%?@6NO97E.B54=/#!PK,8SM35RX^),FUN=N+O#319;Q&Y*L@^S!U7$$4
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M! $ 0! $ 0! $ 0! 2;N-^Y]KO\ $W4_WDOE#X TF_HY7\8)UH?C7EOOPY/
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MZLE#G<M*$=H^OZ%332H'K$=G;VGAQIV>]12Z<""/ <*T(['>_P 3P3]I*T/
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M6Z&'M)].6\L-SXFI6/?9<L+R&AC0X^(0/4/'O2OV$TUH?2UW,P]WEL[B&17
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M4+Z<H/*CXT1%52I,. U#;:@AFFM62,9#(Z,^(TM)+'%IH#[H4@F! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
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M&UM"#;>,TTE>?#<.#VFO*HM7'/BBK-C:A7H=6V7KL8UC0QC0UK0 UK0  !P
M ' *\:PY( @-$_J4)'TES1?VQM>/_A H7!ERBZX^XWI[+^T[3^YH/U)BDMG9
M0'RDC+Z4-*%4RZN$> 7&I)6X6A\=N%HG4NB,G))'9:EQ&0Q-Q+$YS'LCOK.:
MT>]KF\06-FJN?[A[?L;_ +5/;G)PZFGU+DT;';=QGMN=',@DW'D:>.I/(9ZG
MN@_>S5'4]T3:WMMQ[W(Y2^U'-H/.8VWR,C727D^2?!'+D;%YKS1M;ZIX56_[
M9[FW[M#;(=NQLK)P9*DKO!Q5*>_@7=XQ=I[MW&UE9\O(C;KIQU]_O+(O,W\T
MSK!UST\NZ<^J3IFS>C-1G.883YW%XB^FLI(\=?ED]PUME#[/"SPHGNX   )M
M>1V_D=_;1O5N\U?PISZT_&=/'P,BT]VVC!W#;[:5S!R8)0EIJDF;.GE']:W3
M'KGI0V=VVP.Z>GK'7&&T_:663T[E\A9XW(V]]X-J'Q""]NF2.JZ0-I0'FKP7
MH'J)CSS]]O[EB2\_$FHN,HZO1<**KT/.>WKBP,#]'EQ=F_&<JI^UUK5F9B*9
M]PT31OCGA> Z.2)[7QRL< 6O8]I<QS2"#P*\ZLW(JP[TX-7/=K]G$Z>5)=/1
M*J?V'I05+>/]+2G*>/U57",NKK?TLE2JN%&?=70$ 0! $ 0! 8HO.C-.@S<0
M_P#3VE/OBY4R+D"YWH,_>I;0?BQ9?J$2E<")_4R\!24! $ 0! $ 0! $ 0!
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M<T4XDUX%6MN5V<7*3^4R>X+%K%S/RY>%#SM2:@PNUV8@RU]?PQPY>3PS9<S
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MU*H7!$_OS?N-[A24A $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $!YN:MG7N'RUFSXUWC;ZV;_PI[66(?7>@-)79
MR\;TB^:Y?6.NG_-N,R&K+R2>_O&^SPM&4R[G6Y#YO9V.!KVU*VL5YF+1<BQ!
M=-UTX,W$=T=Y-NM";3ZBU_J#5.&MM/0:8N[QET,C9/;.+G&RR6T<(%P!*^;F
M  :5K(6Y2GH7S4;\J;!'>+S%=;;@8F">73MEJ'-7[,@R&1UL8CD3<1DRM8^(
M>(QPIZRV%[Y+"B^%"U!]5R4C<FU5K+2N@\0_,:LSN-P.+MPUKKO)7EO:1]E
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M11$U9]'87%O?;R.LK=S[44MWF*,NA%*4C=RU;V=R41%2(PV,;)<2MLK=LET
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MY-9_;;$_JLZCF5?\M_ N:\A4U\L7I_I_Y#>_J=BHCP$N)F.512$ 0! $ 0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
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MV8R*WCCCC9$P-#8VQL#6M    H M0E5N;EU2;.N=4_+_ '(JB.^J@$ 0! $
M0! $ 0! $ 0! $ 0! $!)NXW[GVN_P 3=3_>2^4/@#2<^CE?Q@G6A^->6^_#
MD\"OG+X&\JI* @/C+*V-KWOH&1M+WN) #6M',XFOH"LY,XV;#ORX15?L)BG*
M?0N98YK_ ,R#HWVPU9D=%ZVWETSA-3XIYCOL9<9"P;<0O!>TM,;KUKR:QD?%
M[E:VW/M;K:Z\5U6OW&5D[=?Q*7+T4NI::E&M0^:[Y;^<AFQFIMW-%9FT>U\4
MD&7L,9D;5S7!S7-Y;N6:,@@GN[U>_3VLR4[,X)W8K5-*OP*+4KUI]=F5&O!F
M(/JQVL\@OJXGN\[E-TM+;9[@7,[9K#5>E[F/&>#>F21\+_F^P+(G#QY:\'-[
M!P6JQL*YCY,;VT7+EO-A-:-MUU6AG1W3]3BWK>;8A=M]#76Z*4=.-=:_8O>9
MOO+1VOT'M'TVZ<T?MENK+N_H>Q+_ )BU9,^21]Q:ED+8F%\KY''DA:WO7I7=
M>=FYSQY[C95G+5M)_P"UIQ/.^U;.+95]8EQW+;F_AJ]#(8N/.N" ( @" ( @
M" I/OK^X]N3^)>I/O/>*'P*H\3#UY$(_^!&O3_[]:@^^T_Z"1X>TF7!?$SNJ
M2@( @" ( @" ( @" ( @" ( @" ( @" ( @.C?Y*RQD)N+V=D$0(',]P%2?1
M4BJ ^MK=V]["RXM9630O%6O8X.!^H2@.R@*%ZWWRT5H'4%G@LG<?V=>2"-U"
M (RYW+Q]<5XJ+M]15)&RP]DNY$7?6BH5>L[K'Z@QL%Y"67-C>Q,ECYFM<"U[
M [OJ.PJ(]+74N#-??LRA-VI\F4"W=V(_#6.VNM-9+YBO+9X?-'&WU+NCG.Y3
M1M!4&G%6KUN4U\IF8.3#&?S+2AC_ .IS!;OZ?ET;M[HK3]U=Y/-7=NQ^7M6R
MAEO'#, ^61T+.4![17BM5N%N]TI0XHZ[M..WJ5^]E-4EPJ9,]M=&Y*WVOP&G
M-9\MWE&8V%M\YS07-F=;QU!);7F8^JV6WJ[9L=-WZG_<CD=T=BYN,KMAUM*6
MA9+NELEKJ;<JUO'RW$&B<8Z5]F(O$++@2\[CS<C* ,]U6;L;BFY<FS;V<^P[
M:5$2[I? PX[6&2C?D9[P1AHCM'-DY+?E ['.]4UHKL:].O$L9&7&/!?*5-N;
M.VOHGP9$6TEI+S-,=P81S-%6T:9>PT/<KT;5B4?GI5FAG_,+F0KN&I=$772I
M;WJCISP.:SARN-N_88'NYW6_&1I)-?5/(0 2>[@M=E[9"\F[' [;#[WN8F.L
M2[&MY*A->AMK;71>4-TUS9F^&YK2Y@=0N:&AW%@I0BJJQ=HC:75+B:_-WJ>X
MKS+CZ9+@B6]:;08'.R92ZR]U;7V0N6O?96SO"8]IH]P:*M)/$J,S!M.-'2AF
M[+W?GV+BQU!JVGQI[N9*FS6GM1:)N<I-D&?-NG;$R%T);RLE:.,=#1@/Q5BX
M$':4I<D;#O#=+6Z>78LT=UTK\2>\+NAIO7.<O=,Y,VLO*Z1EO:.GA#W\O $,
M,A=W^A95G<[61>>/.C=#4W]@W#;MMCD=,DG1\"G&I]LM39_4=M!B#<6>!9*7
M6K622-9%RO)[@!3L5J.!<=UR;I&INL7=\2WAQC.G737["O>(E9H3"VMIJK)-
M>]K61Q.E(!=V-'%Q!-"%G0A;L)]3.3RK,]QR&\6-=>1Z[]4Z:\6.)]S!<F1C
MI6U\.1K6M;SG],0. 5=S,M./2G\IARVK>;-]03:BWH6Y:FZQ-O\ 2VL_P:NC
M%[);%S)I@6M#7BK6@ 3 4+FT6GO;K"T^5#L['IKO&Y8T<EM^+_M0M.W.W]EU
MMN#:7&,A+M/W5W;6\4D()+63S"+F]1[B>$E5J)Y3O7DZUJSNMH[=M[5@N-W2
M45K]AGLZ;-%8S2.V>#DLGB>7*6D%[-<.C E)EBC=R.<6A_JU[ZKL<>-+4?&B
M/'-]NQO;E<Z/I3H7!J^:8( @-'GZ2'PZ[NB7W=78NOW9:J?$J?&/Q-U+;?\
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MAPME)'*;"KO#H'%W#@6BJIS=K5^_64J)F]V?N"U@;7^D23R*?$\7?"VU9A-
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M( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
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M)<3,<JBD( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
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MY[)E[+<5G<4X73)[+[_[0[^V;^<]OW?-LT_=U7W-D_B*=[3)REL;*DR.!#7
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MK'C0[5LVCI2&T:3Z>!]Y94HJ%(K@6X=/EIKZN9W%!(0! $ 0! $ 0! $ 0!
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M(?*0!5K5;=RU&+5UT,BDI?+@KJR? LW?N)9Y35-O9Z'MHLLZ2X?'G[R)S/L
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M>37_ !W?5/\ ;G-?KJ54*E$54^:7P-[A5E 0! $ 0! $ 0! $ 0! $ 0! $
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M$N)F-512$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
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MBM%6I]RQ=)]4M50^L32PO;W<"/AXE5-MZLIYZ<#[*DD( @" ( @" ( @" (
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M?=LWO<(W-MMJ%N$$FZ4K[3ANT-HW/:<*4-TN^9?G-OW*NB,@RXLZX( @" (
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M]PJB@( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
M( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @+9\_4;W83C^E[/@69;ULM(
MB3Z6EXERX[![P6&^))% $ 0! $ 0! $ 0! $! BHIV*4Z.H8H:=O'TT_.44C
M6M!K0@& "G;7M/I^!1)=6O,A*A$@TX&A]-/SE.M->)/N(4-/C<?33\Y6U"DN
MINJ'*G,B1Z#0^GM5=%6O,$ #WFOUE0[=;G773P'*AR5P! $ 0! $ 0! $ 0!
M $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! :Z_TF;^+DUG]ML3^JSJ
M.95_RW\"YKR%?XL;I_\ [AO?U.Q41X"7$S'*HI" ( @" ( @" ( @" ( @"
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MW)%->/L# ['M%SX+&FX<RLA#!7M[%ZKZ@=H[5M':EN_MF4Y7)4I1\=*GQ?\
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M7S4HR=.",[_E*:XLQY^:_P#O$]Z_M98_KQBA\"J'$AY3W[Q/93[6Y#]>R(N
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M$JT]I=A1ESO09^]1V?\ Q8LOU")2N G];+P%)0$ 0! $ 0! $ 0! $ 0! $
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M$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
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M_JLZCF5?\M^]%S?D+?Q8W3__ '#>_J=BHCP$N)F-512$ 0! $ 0! $ 0! $
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M?B4\/E\#Z*H! $ 0! $ 0! $ 0! $ 0! $ 0! 2;N-^Y]KO\3=3_ 'DOE#X
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M@TYGN#1]<A <X)X;F)LT$C)8W<6N8X.!^$$H#[( @" ( @" ( @" ( @" (
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MK\_XEO+TLR4!'-_U>8.%:G_\V'<MG;CYDG65#3V7.Y'KE"C7M+J^ECZ0)O\
M:1W=TKL[YB6P)VR=J^_M\?BM8W>+;96[+J>>VM6<KYO A>WQGN]/8ND[8V[;
M>Y;]S;;5V-K=+2;57]5%PI[?8:3N#(W?9>G=+<'<V66DDE7IUXZ&W/@<OB]2
M8;%:CPEW#>8?+V%ID;"XMC&Z&6UO(([BW<PQ.<SC'(*T)7-9&#DXF=*SDU4X
M2::>G]O8;/!S\?,Q8Y.(U*Q-:4)D"DOA&J\0<7N#&.>[@UC7.)] :"3]8*EZ
M1T'%EAVX_F2])NU&L<CH/6VN;[&ZEQ<GAWEG'A+JX8Q_,]M!,QW*[BPJUCN%
M^73'ZBY.$H<3S-'>9GT>Z]U/8:2TQKV\N]09-QBL;9^"O(6RRNY6M;XI):TN
M<\#BLF&)D7YRLX<?,OQB]4_88<LG'M+S+WRP36M/:8R=X]J>NG6W7#J;6.SF
M)&G]+F*VGTWJ_(VK+^SBB=&Z0RL@NX9(&\S7M<:%8?:VW/$_59>;+R\IO7VZ
MZ?W&][PS</+Q-OL;;%7)06K^'$KIH[J\ZB>E?=#1FU?63=XW5CMQ;IMIIW5-
MMC++'>SO$L<#:.@,(<*\W#B./O+:[-T[WDY&!;TRK&OO3U-+NMN>WV(;I'7$
MG12]CX<3(YU$=8G3QTF:6PVM-^->6.B=/:B#7XJ^O0QT<Y?")RUG-+'V,->!
M*Q,F?ERI<KUIT:7L*\=.<%&#7EM57AXF';S"?-KZ -X>D7=#0NB-^<%FM3ZD
MM,;983$V[6>T7MY->1>$P ST#"">(J:TX*'PT+L4TZO1&1[RHXI(NA39'Q&\
MOBX>ZGC_ **&>Z=+$_WGQO!1<")_4S(NI*0@" Z5YD;*P##=W$</.0UO.YH)
M)H.PD'O0';:YKVAS7!S7 $.:000>(((X&H0') $ 0! $ 0! $ 0! $ 0! 0)
MH">V@)IZ4!:MN;JC54F:.*M8;FUM2_DA=&V4B3UG#XS.%"53KS)YGF96]U5C
MM)PV^7O)X'R > P^('/:X=I?4$<%+;I0:+CQ)"CS>9%D^P]OF,,H^R-,CR:=
MPYN>O&JIU0/);1K' D]Y%:DDDD\3[I1K[0M2L^S,&"FOYQD0PY8.!LXW4)H.
M2I'#M4JC]Y#?/D74CAP'8%4 @" ("#J\IY>VAI[].'UT!:7KS(ZLL]5^UW!D
MAMH'_P!CM/-X+V@NY10D1G@%#;1*?!\BGN=S5[G[[VJ]H9&AK6AH#0*-IV T
M45?,C\#R2>/'O[6^]V<40($@'U>%._\ WU/O H1Q(X>^H7WDD10>L.[N]_AV
MI[" XTK3@13C_N=G8BUTY%455D>:@%?A^$\.Q*5X%"E62B29JO7>$T?=8NPR
M<[(Y,I)X;))"&-8>;E'%SFMXG@K5V\[$>M\#:X>V2SI.,$W0]V]D88[26&%M
M['=,:]DS2"UK9&@\P/$<&N52DKUNJ,9I6\GR+G!,H?K;06K<?GFZQTSE;AT+
M:27-D'2%@;0N(#>S@%K;ZG!=,3KL._A]"L3IP*@;/9_+YO4EA#E8/&A;/&U[
MGFA:YLD0/J$DFIJJ[-R46D^)I][L)_-;7RF4RW8V."%C&AK&Q,  H  &"BVA
MSR22/L@" ( @-%#J4(_E+FB@?\HVO_;CT*E<'[RNGSQ:\#>FLO[3M/[F@_4F
M*HH.R@/G*0UCB17W%#2?$JA'JETE-=UM1YS2FW.K]2Z8QGSMGL/A,E?8K'!O
M/[7=VUE-/##R<>;Q)6 4[ZKG>Y-PO[1M$LK#CYE_J2I2O%FUV?$MYVY1PLB2
MA8?,TNM6>>GYLF%UOJW VO1-/>XO$YG(V6/NSI$R"ZM;>^N(()N?V,\_/#&U
MU>-:K9[?=NY6V6<E_P :2U5*?<1O6''!W!XV.NJTN=:GA/\ />\VQH#AT/2<
MH()_ZF"O(TU>/[2[PMD[6BE%J*7$UDNMQI"'S/VE_'0S](*M=S-V\!L;UD[#
M0;&:US]S#9X?-Y3!QXR"]O)'VT#6-%X((B#-*[BP5X+I=IVG;]_MW+6V7E_,
M[46W"OU:5]Z.<W?<L_9';NY=MSPKDJ.27TZ^/#[3:CLI[>]M+;(8^6*:RO+:
M"ZM)(.0PR6\\39('QEA+2UT3@11<S?4XW)8U^+4HMK7[S>8\K5U1OVG6U-)_
M=4[L+#7Q">+NT>]4>E4)./R_NEV2CUMQX'851!\YI60Q232'ECBC?+([^=9&
MTN>?@:%3-M1;)2JRR?57F(]).B=29'26H]TK/'Y[%2F&^LGV5V]T,C7O86ES
M6%IHYA5JS=M7*JWR*Y6YKBCZZ/Z_>EC<K/QZ5T3N;:Y?4=Q#<-L\?%9W,;II
M/#HUH=(QHYBYPIQ[UD1QLW-LW(X,7*482;]]'3[S'N7\?%N6YY4NFVY+XU9A
MHOL%UZZBZQ=UM1[/Z-CQ8MYF'!ZCSN.BO;06DCI*OA.2MWP /A<WXKN"Q^T<
M7]-LMZ[<:MWKL_SEP<J/3VFX[\W';=QSMJQ-JMOJQ(2ZI+@^I%[&Q?6CNCMG
MNQ@NG[J_Q6'@W'U+*P8/4%ACL?8-G:_PP!6V$3)&O))J 3V46^VR&W=Q+(L;
M2VLO#TNK74T&Z6=QV+%L[KGTEMV2Z0?@ZT)B\SSS:-KO+$QF@LCN'I'.ZLCU
MZ)WV/S+!-,86PF?C)X+74!$)HM)&T[4I)+F9BE&4%<FZ1:->SK8^D8; ]7&Q
M5[L!IS;'5>(SNX.>TK;X_(9*SO&VMH\96 "1SR&,:X&8#C44)X*I=3=&B%.V
MG\KK(VU^A_&S8KI;V?M9W!SSI'%W%6D$<MS9P3,'#T-<ICP*Y_478*2@( @.
MI<7]G:OCCGN(HGRFC&O>T.)]XD)SH.!VP014&H/$$=A0! $ 0! $ 0! $ 0!
M $ 0! <)'%L;W-',YK'.#?20"0/A*E<06D:XU7J^]S[L=;"YM6LF#;>.-LOK
M!KW"E6D<"5#KRX('5U7G=5MP^-L\G=RVUQ&*EE7L<01PJ06D]BA_>30D#(:D
MRYL#:W%[//:M#0YG/)5X]'QZHJM:EV*IJSQ_;'''S75M$2Z)A<V(UK4-J>WB
M4YU):;G0KQT]WN#SMG=7;XV-S4$A:^-P =&T%H)'>22 IKS)O6Y12;X%T:&.
M$ 0! ?*=SVP3.B'-(V*0QCTO#26CZJ L^RNI=86>J+Z\OR]D;'R-CMY&N,?)
MS.#2T//+\4*FK6I/!4)"R-Y+DKF>ZGH9Y"XU' <:\*5IP1U>HXL\NU9)"VDQ
MJXN=0^YV_6JHY$<SM!KBTEI!]+00YW$GM:.(52O*"HRNUCSA<>4_H9*NM[RY
MM,!=6N,F9'EKR)PMASM;)7E<#3U@X&JPLNX^1F;5@W;FXK,DGY%?@48VET=G
M[BYR-UK>.2[M'2E[8+ASG#B\%A;X@(I[RL6(3G'KX'6]Q;QC8]I0LI5H5_&.
MBA\&UQHCBAAK2 %E6@]E!P/8/0L^S&*?S<CC+=Z[=@\BGREOFX\&K1J^SN\?
M:R.; [F9(SF+0UE2ZH;PXAJU>=&;R6X_0=IME[#RMJ4IT\W7P/5U=J[,ZCT!
M=VMA:S6.6LXFQ7,[><.E+FN8: 'AVJY==V.*_<6-LPL7]?UW*=%2WG R75OB
M)=/YFZG.1OGE]M+(906\LG,\!SB#QJ5IK=^Y;HZ5=3J\C&LV[KG8:I3@3-F=
M>ZLT'IIS].-FN!&SD>]I?(YG,"TD,#J\:*[/<+U*(UV-L6+N^7Y632*;XLZW
M27!J37V_F*U+J&ZD=!X[I'V=PQU"X.B<*"7FI0N3"ZKU_KEQ;-SW-8Q=CVG]
M!B-.,8\5[3/@QO*6AHHQC&M [@ V@ ^ +K-%"AXH^IW&WP/J!045)6]2*$!
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MN>(Z8D!M+H)IJ,'%_3O_ $4\ZX^+)<4SE^U-H,$GYCBJ:5]=_=\*>=<\2.E
M;3:#'9@XOZ=_Z*.]<?,=*./[4F@O\AQ?T[_T5/GW/$=*(C:708-?F2+^G?\
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M ;2Z#'9@XN']&_\ 13SKCYCI0_:ET&*_X#BXTKZ[^[X4\ZX^8Z4/VI=!FG^
MXN%:>N_O^%/.N>(Z4!M+H, @8.+C_1O_ $4\ZYXCI1']J;0=:_,D5?\ AO\
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M5$> EQ,QJJ*0@" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
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MYG<(8TUJUKCWF@KW=YX\%=C2*HN!%/M.8!'::_!14I/J;KH2150" ( @" (
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M+2MNAM8QAP2?VEW'D!6%OI?I6RN@L9_B31VJ,OB<22>9YMK2]-I&7//K.K'
MWM4+Q*I*D50STJ2@( @*4[I:;S>?QT3,/.]CHR.>-CG-)J2*^KQ/:A*IK4]O
M;_"Y+"82*VR4[YIJ#@\DEI :#Q=Q[0H5>9!/:D! $ 0! $ 0! $ 0! $ 0!
M=*\QUE?AHN[:*<,-6^(QKB#[A()0'DZAQ6'N\+<VN1B8VQCA>:-: (Z,(!
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MOIFKGZV,X]3M_52KZJ)<Z<*E9_+OW#WHM]J\3BM]I+J7*/DE;9RWO.;ID)?
M(O%\5WB<W(37W5A^I<]A7<D[7;ZC^DBE7IX5IK3XF=_3/+U*N^F]JYZGJ?\
M.?,N=+G]71U+HK[>GB7;[FZQRMKJ&QL\9>\EL'PN;X;N#N<CF#N5X'U5P#>G
ML1]!T_>\2O\ @KF>[Q-C<7)K-)!&Z0\.+BT5/#TJ42SUD(" ( @" ( @" (
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M=;TN[G:RL=&9NYN]%WF5GCM<;<Y-E+6YGF?'%$WQY)&1AKI)0*BJHGBW8<>
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MFD@AS2"K"ZDVI$G=50" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
M( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
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MW.:_74JI7!%7[TO@;W"J* @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
M( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
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M=BHCP$N)F-512$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! 0(![0#[X!0'SFFCMXGS2N#(XVESG'L
MJ2@+1=SM729_+FQM)^:PM'.9RM/JR'UQW.(X%4OVDE+ZD</0:D</?_,5^Q&U
M*;\WA0KMW';K1)RDJ)>T^,USC[)GCY2_M\?"XAL;[B:*+G<31H D<VM3P6-C
MV]UR<GRL2#E9KX,QHY5S;+<K&\W86;-SZ>II?BT=DM #7 L?$\!T;V.#VN:1
M4.#FD@U"R<G$EBW.F]_&\"_CVXV,5QL=,\>6JDJ.M?<<:T['?6_15CB4AH/
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M,5;5$4W+D[T^N;;9WE! 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
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M6[%BRI8ST;2T\"XW:NUU9?:BN=!:VS4DN"PD<T)==R.='"86<E&&9Q::EA[
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M#&VS&Q6^/MH+:)L;6L;R0Q,B;ZK !Q# N[HE'HCHCY_ORED77=G5R<JGI@
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M5 />*K:14N? X2TYV\CK?TU+2KW3,VWNYSL]?W,E]8W]QSN<Y[Z1\TA/8:<
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M&AY@ACCDEHUK #*]A=V#M6).77)R\22HJH 0! $ 0! $ 0! $ 0! $ 0! $
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MJ_Y;^!<UY"O\6-T__P!PWOZG8J(\!+B9CE44A $ 0! $ 0! $ 0! $ 0! $
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M)]Y[Q0^!5'B8>?(A_<(U[^/6H/OK.D>%"9?2C.\I* @" @T<H [:?HH$10!
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M @" (#1/ZE/_ -Y<T7]L;7]4"I7!^\K_ 'X^XWIK+^T[3^Y8/U)BJ*&=I $
M0! $ 0! $ 0! $ 0! $ 0&*'SI*_[!>XE/\ +VE/OB5#*X5Y%SW09^]2V?\
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M)>XWMU44! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
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M>9>:-AN,H8^U*W'^-1>\E7>'76\UGNI:X3#XR^M<)%)&VS\&&<PRP%Q!+GL
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MVFIWYY]R^5AD,K8:D$.+N?B: \#[J))+VBNI6$ -  [  ![P%$!% $ 0! $
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M=28I])=T43_E&U_[<?HJ%P976LHI>!O367]IVG]S0?J3%)0=E $ 0! $ 0!
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MJ?[<YK]=2JE?2B?WIF]PJBD( @" ( @" ( @" ( @" ( @" ( @" ( @" (
M@" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
M@" ( @" ( @" ( @" ("R/S$]#Z@W#Z1MV--:8F$.7N,,^YAK.+8216T,[YH
MO%) ;S1FONT54*N7R\08T?*@TUT@W'3!B<-K:ST&[<W!Y#+P:W&H9,.+P7#;
MUL<3A)>D/D82WNXUJK]RW?6LBF"26G R7OT5T0D'GLMI*=]9M-4X?]DJ.F\U
M34NZI<BY#;#&[9XW L@VNCT_%@:^J-.NLG6=:#OL:Q5H K,U-25>!36I4M"
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M" ( @" DW<7]S[7?XFZG^\E\H? &DY]'*_C!.M#\:\M]^')X%?.7P-Y524!
M$ 0! $ 0! $ 0! $ 0! $!2??3]Q[<G\2]2?>>]42X%4>)A[\B,4V'U[^/6H
M/OM<*(\"9?2OB9W%44! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
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M$JF2JBN#+G>@S]ZCL_\ BQ9?J$2E<")_47@*2D( @" ( @" ( @" ( @" (
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MQO<*HH" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
M@" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
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MZ8PFK,#<-NL5GL;:9*SF800Z*[MXYVBH)%6B2AX]JPVJ.A=:HZ$S*" @" (
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MA.M=2OF=Y $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! % "D'&M!6O
M!6^F2^D57,Y*X#77^DSFGER:S^VV)_59U'[R);I;9<WY"W\6-T__ -PWOZG8
MJ(\"9<3,:JBD( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @
M" ( @" ( @" ( @" ( @" ( @" (#J7UT+*TGNG-+A#&^3E )+N5I=0 >FB
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M! $!)NXW[GVN_P 3=3_>2^4/@#2;^CD_Q@G6A^->7^_#D\"K_%\#>64E(0!
M$ 0! $ 0! $ 0! $ 0! 4GWU_<>W)_$O4GWGO%$N!5'B8>O(B_<(U[QX_AUJ
M#[ZSI'Z29?2C.ZI* @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
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MK6L:&M :UH   H !V !2210! $ 0! $ 0&BAU)U_E+FBZ=OSC:_J@4+@RO\
M?C7P-Z:R_M.T_N:#]28I*#LH @" ( @" ( @" ( @" ( @" Q0^=(?\ Y"]Q
M/M]I3[XE0RY!T9<]T&?O4=G_ ,6++]0B1<"F>LJEX"DI" ( @" ( @" ( @"
M ( @" ( @" ( @" ( @" ( @" ( @*;[BZTATMBWLB>TW]RQS86@@EM6N!-
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M=#>W4E 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
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MM9$VZC<(VS.>7CQ'M8(A3N'8N/[/>7O^WY&ZYZ<<.W)J-/%.B-SW'96RW\7
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M3@WB:@I15J05_M(/9K>& N#C%&R,N  YN1H;7AZ:*:UX@[" ( @" ( @" (
M@" ( @" ( @" ( @" ( @" ( @" ( @" ( @" DW<;]S[7?XFZG^\E\H? &D
MW]'*%?,$ZS_<U7EOOPY/ K_Q? WEE)0$ 0! $ 0! $ 0! $ 0! $ 0%)]]?W
M'MR?Q+U)]Y[Q0^!5'B8>O(A_<(U[^/6H/OK.D?I)E]*,[JDH" ( @" ( @"
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M)AO3VEWMO!%;0QP0,$<430UC6@   4'915I4(/L@" ( @" ( @" T3NI3_\
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MA*XFC!Y-G'SN^J?[<YK]=2JE:I5*J_-+QT-[A5% 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
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MD&H'MME#<EM:GBTRT6.U1LJ)A0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
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M>/T'@S=>>\LTM))QD+W[+* 9VM]H?5H<\>)RD</0M7Z:783]*[[:7G^:Z_\
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M4N+U1AI3ZN1Q-Y:WUJ:4KRSVLDD3OC#O61T2BE.7T,QNI23C%UFB>U27 @"
M( @" ( @" ( @" ( @" ( @"AUIIQ!U+F2:.*5T3>9S0.7W13BHD^F->9%SY
M8)Q^HH9JKJ;V)T!EI-/ZYW5T9IK/0C^R,3F-08C'WD7QN+K>ZNXI@/5/=W*E
M7(37ROXEUV9Q:KS1/&@-UMOMT[%^3V[U?A-78Z%W+->X3(V62MXR:4#I;.65
M@)YAPJJKBN149)?*_O+2E'K<.+14)OB5-3P'9P'']"BBLFJKB3S]A]%6 @"
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M:YQI\;M2-.FCXD:U]A<8I 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
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MG^LIT)7$T8/)L'_[;OJG^W.:_7<JH7!%7.7P-[A5E 0! $ 0! $ 0! $ 0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
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MZ2&:==_1*?\ WNQ?WY:J5^\5<X_$W4=M_P!SS07XEZ6^\=BJBE\2=$ 0! $
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M3S#B0X=A6+^EMW'\S,^SEWMM58K1E1+:TM;"WBM;"&.TM(F ,B:&,:W@ >P
M<5E0QH6EYD>)J+^1<S,EWIZQ9-6WUC+=ZRQLME;23-MI"ZYD:7<D?,6'BX @
M\/=55%Q?U$N>G3R+YF?%;7MY1^8%)BG) $ 0! $ 0! $!HG]28/\I=T41V_.
M-K_VX4+@RY7YHKV&]/9?VG:?W-!^I,4EL[* ( @" ( @" ( @" ( @" ( @,
M4/G2&G07N']OM*??$J&5P;Y%SW09^]1V?_%BR_4(D7 B?U%X"DI" ( @" (
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MY:5R2D^*"=*^TYJZDD0<&,Y:\:U4=/S=1"5#7:^DS?Q<FL_MMB?U6=3S*_\
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M)QF&L8Z\EEB;"UQUHS_@6]G%#"SX&J&JQZ>1%%U=7[QZR)45$2>)J7_-S/\
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M/3@%U]G"L+:KF9D2I>3^5>/N-#?RI?KH8]F/Y=/F]A95YL7TFK=_H#ZS=?\
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MW&_<^UW^)NI_O)?*'P!I-_1ROXP3K0_&O+??AR>!7SE\#>64E 0! $ 0! $
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MAS+5O+&VC&.9R@@,X$+I,7#=E)RXH\HW?=/YAD2N1X-EURV)I0@" ( @" (
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M^[NV5>L^3)_)0NRTOI?'Z6QL5A9,%6M'C3<H#I7@4))H#17C6K14Y$RH @"
M( @" ( @/&U%_F_G?M-D_P!93H2N)HP^37_'=]4_VYS7ZZE5*X(JYR-[=5%
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
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M$N)F.512$!^;U],T_=SV0_N6[_4,DN2VK_[Y=P_W8?@;K-_]IQ?_ !?B4?\
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MFF7N!5KAP<#[BB)5/Z49VE46P@" ( @" ( @" ( @" ( @" ( @" ( @" (
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M,X<K&M#6M]X"@XJ>5".=3D20. J?1V*F4J BJ@$ 0! $ 0! $ 0&CS])#/\
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MC;K36.TCH_%PX;3^*C\*QQ]N*10,HUO*WX&A6FW)]3XLJXDV* $ 0! $ 0!
M$ 0! $ 0! $ 0! $!B@\TG>7JOV3T7I/4W2YA+O.Y1]Q.W.VEM:RW?-"SQ'C
MGBC#JAS6@+)QU:=5<*)]?[BJS&+I#SQ=_=L8L9B=^^GS/RY%PB9?9"/'9&$
MCD$K^1G(T?$>55*S"3_+>A;4YQUFB];;KSI.C3<7(V5CKW$1Z5RDYBYAF\!;
M73X97^'S^O>,#QR/>>_N5/Z:Y)?*JHK5V+X\3)%MIU:=-.Y!AL= [BZ5N'3B
M,1VD5Q98XDOY.1GA.DB =ZX%%8=N4-*4+O%5? N;@='(QLL4C)8I&M?')&YK
MF/:X5:YKFDM<T@]H4/C[2E4Y<#[*"0@" ( @" ( @" ( @" ( @" ( @" (
M@" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
M@" ( @" ( @" ( @-=?Z3/\ Q<FM/MKB?U6=1S*G_#?P+FO(5_BQNG_^X;W]
M3L5$>!$C,<JB @/S>OIFG[NFR']RW?ZADER6U?\ WR[A_NP_ W69_P"U8O\
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M:NGR<=PV*Y<3VU-RQY^%%Q8E]*,^"DH" ( @" ( @" ( @" ( @" ( @" (
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M.FN#R8VW<#)3B74+3R=A[>Q2E5%+G)TJ7=8O$6&'MH[6PMXX(V-#?5:T.=0
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M2R(@$2$<K@*\I[@BX%/#4NNL[*VL(&6UI"R&&-H:UK&@< *"M *FBJ(.T@"
M( @" ( @" ( @" (#QM1?YOYW[39/]93H2N)HP>397\MYU3_ &YS/ZZE5.M$
M3KU2^!O<*HI" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
M@" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
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M_P"E^T_,4\J7]_IL73]FF,^_&/7LG8FN5?\ _HR_ X7<ZZ4_^9_>?M<8$?\
M5K!G_H#'_>^!<-E_\WWR_:9MI?F0?M1^0[])1_C4]\_^_6/ZOD5R_:G_ $LU
M_P#=3K^[/XEG_<-R/Z(H#_L0YZO?D+'ZGLUM1>N=U?\ 0X7^X_V'GF!_U%[_
M 'OVF$_Z98:[^[,CO%G<#ZL607DFW0;[ARJ<XQ.YS+J?;V/#PD_VF'SR$_,D
MQ/EP=8F$SNXL\S-I]9NCQ.K'"1S(K3VY]E;0Y%P-Q!$X6K07<:CU5Z!B9J_0
M7-LN2IU.J_8OM.*OVGYL,NW&K6C]Q^G5F_-LZ!<'M-<[QR]0>BW:3CP\N8BY
M,ICY,C*#9.O8[?YO;>&<7$G!O+6G,:5[USU_\MU;^:C2]IM;,'=E&/[K:^P_
M*%\X'KDA\POK?W+WLT]:20Z7R.5^8])0-+Y'75A975Q;65Q$P2W!/M<4C2 T
MGNIVK V7!O8MO\QUO7)MO_Q,V&[W[+O^58?^7MQ27P5&?H0?18.DG4G3ST$8
M_7NJ[&;'97=][<U':75N^VNH[%C+9\)DCFMX)@U]>%:UHNPW[R\?#MX,)5<+
M=9>]K_6<Q@)7;T\JFLG1>ZO^HTP?I17'S3-V7>F*Q_[>]HO-^SZ?RR5.'FR_
M%G3[I'IE#_Z<?P-IWZ'3^]"W&^WT?YMNO1,O_P!LQ_>SC\3_ -WR/]U&R9YA
MQIT9;^?_ .O]1_>N]7$]R?\ M-[WQ_%'=]K?^\VOC^#/Q5]'_ODL/_\ [A@_
M_P"Q:NT[-_Z_$_W(_P#"CG.XOKRO_JS_ .)G[.FTVUV*WG\O/36V>9A$]GJS
M96#%>&0"#<7.E616QH6/KRSO;W%:_P!0L&YN%W*QK4G"YHT_;'6GQI0O=MY?
MZ&5G(I6FGVZ?<?CU=9&Q6ONC;K#W&V_U%B[[3VH-$[B7V<PK+B&>W\6TBU#<
M7^,GMY)(;;Q(RR$4+13A2JUG;VZ>?C6LFRW&[;I%^-8Z,S-[PO*OSC-5LW56
MO)]6M/ _2/\ ))\]SI;Z@^F'0.V6\6XN'T#O/H#"X[3^4L=07T%K'EHK*TM[
M>.]BN;N^?1XY@VG $"O!=)NT[>5D/,L.JDE5>#H:+;K,L6RL>:^FOQ.SYUWG
ML=+?3QTN[A;=;,[G8?6V]>O,)D<!A;' 7MO>,QL=]:7-O-=RW-I?,]8M!;3B
M*%<7O.-+<+2VR$6[<G64O\*3K]YTFV2M8F1^KOTHDZ+QTH?G#="_3EN5UR=9
MFW6WVEL/?9[-ZLW"M=1ZANH()YH8+0Y^VR61GNIHX+F.%OV8_&[:E=ALN):E
M<A"[ICV8ZOW<$:'<;BZ)13^>;:^#_P!!^L-UW]$?[9/E6:XZ4])V$=WD<+M5
M9Q8RT8QH+\EI[ R/G\-C8'>O)(QX #*DE<UW==EDQ>X68=5ZS-.-.-.#^ZC^
M!N^TG8V_*C8O.EB<7%^]\/O/R)=L-6:FZ2^J73^I,MB[S&9W:C<J)V4Q]TR>
MTN&Q8;4+&W;.206\O*Z*V=0\ 5T';VY6K-^&;<I*W*%'[.I*OV&KW;$E*5VP
MN4FX_!NGVGZYW1?YRW0_U,[#:+UU%O#I32^=@TKC/PKTYFLM865WA\C9V,#;
MN)OCWKC/&3Q'$NXD=U51N%JW;O3E:EU8[;:?LXT^!CX-R=^W%25+RT?OX&K!
M]($^D0ZNPF\>W^V?E^;NQVF-T*)[C6VJ<2?:+/,9!SYFMLV>S9$,,=O(UM'$
M#F#?=7-X4LG(W&Y?N1:PX44/;XG09-NSC8$8)UR[C;E_LKD9&/HW/F'^8[YA
M^;W U/U%YPY;9G1<%G8XW(RX?V 92\?!:,(AO9'/==<KBYQ(<5V<L*U9VW]=
MDKINS?Y?]YS-R_<N94,6TJVDJR?QX?@;-/6-L-@NI?IFW?V9S\4=Q8:MTAG+
M:-DD+)@+J+'74EARM?'*.;QVM (:3Q7%;[CWLG;)K%=+R?4G[N/W5.@VK)CB
M9T+DU6-:->QZ'XP&KH]?="G6#K&'&B\Q&L-K];:@M<8WEN+2;P#DKN&V((%M
M*&&V:*$4!HMIL&Z*[AQS,>59.#C[^4BC>,.-C/E9I6UU=7[40P<NONN/J_T>
M[,"[S&K]T=:::M<FP^/=SFV^<;*VN"YQ]JD+1;%QXU 6Q[?VZT\A8UB-+<&Y
MT^-7^)@[MFSN*=^;^9Q27V41^T#T;[$83IIZ9=G]F]/QLBL-):.PD#F1Q,A'
MM4V-MI;P%K(XA5MPXBI:":*[GY,<G.G-:<E\-#$Q[<[>/%2^OB_B6P><M;W%
MUY<?4I#:PNGF.B[QPC8"7$-@G<XT:"> "X+O*,GLT5Q?GP_:=3VW)1W2+?#H
ME^!^.KT^Y?'Z?ZF=NLSE[AMGC<;NG@[J_N7T#+:V@U1:RW$KR2UH;'$PDU([
M%WVPY3PKL+W-6J?<CG\Y=7F>%9?M/V?-A.M;I5W=T]MUM?H+>'2NIM4:BT+A
M\988;'Y*SN,A-X6G[.VN&OMX+B5T;X^?U@>P\%C9EF>7*_*"K&76_@Z_WE&)
M^3C6IR^E**^.A^7A](NZ1=0]+'F+;F7TF/NVZ3W#OQJ;3N4?:316=Z9[BYGG
M;%.;>&W<]OJU#7./:N6[;N2L6KFW7?XUF;T]C=4='O,+-V%K/L?3=@DUX-&S
M[]&V\WWI!O.F'3O2?U"3Z T)N#MJ!:Z<R.H\3A:ZJLKEMHV222_NRX^+#)V%
MX%0#QX +OLVUC7\.Q<QO^H4*3553F_?76GNH<GC^=;RKD+C_ "Y.J_"E2]WS
ME_/=Z;.B+9/V7I2NMJ=<]06I;EEK@WX_ Z6S-AIZS#G>/?W$<=8YI'",BA#@
MT<1QI3D[UV]+*MV\=+HZOG=-:+E\3=6[,5:=V]P2T5>)C)\ICZ1%UD]=G4_M
MIT[Y;IWV\U4W-W+CJ?6.)T=AK'YILHI;7GNYYK>S$5KR-D<15W,33T+?6,5Y
M'5>A6-B$:M^WP-9F9,;72K<?GDZ4_:9C_/O\TSJ:\KS2NV6L]HMM?POTCJ]D
M]IG\RZ*0V.F;^."YY!<NAHR&+Q(VTKPH?0N>OYMW^:?I)-1MM5B_\7C\3<XF
M%96WRROKG%ZQX4,'OE;_ $I_5>\'4M-MOU\7>D<7L]K=Q@T]E;[ X^:RTSD'
M".*W@N9IIN:9EPYS@YQ:X!O<>Q=!CV<6[ARA?UREK%^/^O@:F[*XKW7;TLOE
MX&PUU%V7D:[V:8U#K;>%VQ66QN2QLE_DK_&S:<L+]\$MK/<MDMH;(QO;<>'*
MXM%*<U*K495JU)==RJG%:>PSK,KTJ*%&C\L[KVL=A++JLW5QG2W*VXV:.HYH
M-(B <S'Q"_NV1QP!M>:C1&!R]JC;'E7+45DU\UR^[D5YZL*;\GZ4E7[ZGZ@W
MT9S0>O=%^6'M6=:07UM'EH9[K#V]_P"T,E;:N@LZ.;#<-8^-CN[A0T77]R7;
M#P\>Q;?Y\(?-\>!SNV6IPN79O2W*6AL*V[FN-!0%OZ7M]*Y>RWY='K[3:M)R
MJN!VU< 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M2;N-^Y]KO\3=3_>2^4/@#2<^CE?Q@G6A^->6^_#D\"OG+X&\JI* @" ( @"
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M @" ( @" ( @" ( @" ( @" ( @" ( HE6GR\04^W3V^TSNGH'4N@]800W&
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M! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $!C,\RCH:U-UKZ!PFGM+;@7^AK_
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MGSZ=OHZ_FB]3&;MWY?;3,Z8PL=W;PY+/:PREWXUC;S2Q,EF:R^AD\5S(97.
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M?E_O+!8 /V]X@*< ,='V?^G*5UR^9+Y?$HHNB4XM.,>)R'G^>6"YS:[\0U!
MK\W1GEKP)_MY4QZ)RU^OD3\R2_VC1J^E)=:?3IUB[Q;3Y_I_UG#K''8BTNF9
M&[BA$/*0R\C#@WQI26DR#T=JU&)C3M[ODWY+Y9))? VN3>C+;+5C]Z$OQJ5
M^BS=<W31T;ZJWAR'4%KB'1\.=9:,Q4SX1/S4;8->2WQXB /#=Z>Q=Y^MMVNW
MY6)O63T^TY">/+^:QO<J&Z3<^?AY6ER\.N=Z\?=/8:-?/AK65PIV<KI+MQ"Y
MROAQ-TDN%3L-\_WRP&M:QF^D#&- #6MQL36- [  +T  *.I^!5Y:;HFB/Y?_
M ,L*O'?:&OI^;H_>_P#+4;4UTO5>!;?3&?37YB)^D >6"T"F_$)'N8Z/A_?J
MJ4.A*"5/!%QP:UDSB[S_ 'RP7%I=OK"2WXM<='P][^S5'F=+Z.;(=J+^:JT.
M1\__ ,L(&G[>\7W.C^7*813=%H0DI*J9'\O_ .6%Q_\ CQ#]SH^/]_*VYM6W
M-+@53M^7.-N377+@</R_OE@%Q_\ CK#7O/S='\NXJ4^J$9TU90VW)VO#B#Y_
MGE@ \W[>T/,.S_!\8]SNOE5UT6NA*7*I]&>?5Y7^7'ANWLLKOEJ>2YQ5M(UO
MI(\6\<!4(Z^&A-/!G7C\_/RNL>Z2"WWMLK6AH]MOB+>%I(](BNV@T3J1%%S9
M]/R__E@UK^WK%7T_-T=?U\J>JKK0E02X-'/\O]Y81''?>+WCCH_ERKJ4N*X5
M'Y?[RPA_^OB'[G1_+E*A)OY5J'3FSI2^?;Y6-R\RW&]&-GDX?9)L):2O/ON?
M=%W!1*+AK)4)I5<3ML\_GROHHPR'?2VCC:/5CBQD3& >@-9>AH5GS[3:BVZL
M=-0?/]\L+PYW0[[P.DC@FE9'\W,'BOBC<]L0(O31TA;0>Z5<OQ5BSYTU\HMP
M5R?1!KJ,'W4!],>V8V]UEKW0NWNP^2UC!AX[ZRTYK)F=MH;*\O#%<,M;F2Q%
MSX@;'((WEO.*@K&LW+M^QUT2E*M/9[2[*$+=WIDZQ5#0[ZY.L_=GKZZB=9]0
M&[63FNL_JS(TQV,89'P8K%-FE%E8V\(EG9'[+!-R^KP-."KPL/\ 3P5FO5=<
MJM\6VW75ES+R%?:Z?ELQ5(Q^%#=^^CP]7WEU>73TB-.ZF\=EAMX=S;B/):NQ
MIQ,)NK!MM%;&VMC<.E@E<TU/ D_%6_SLF$L2WA6U\UI?-[6S18EJY+-NW;JH
MN$7[#8('T@#RPS_^O>(?^KH_ERT]3:]*\2!^D >6%V'?:+[G1_+D5&Z,BB7!
MZGRN//T\KBZ8&76]]G=,!J&7&)MYF@G@2!)>. -$J$O:0@\_?RNK9ABMM[K2
MWC[V08F")AX4^+'>-'8HZGR6I/2GHVC[#S_O+! H-]H0!W#'1COKP_LX=Z5J
M]>(Z/\-*'SF\_?RN;IHCN=\+.X94D1SXF"9E?3RR7CAV*JE?<1HM*GRM_/S\
MK:T)]EWLL;7G^-[/A[:'F_X7AW;:]BBH:2YGIVOGY^63=O>+??2%SFBKR;"-
MO #TF^IWJE.KJT3TZ:,^#_/]\L-KC&[?>&H)#A\WQT!'_GRFOL*:)G!WG^>6
M!(U['[ZP/811S7XZ)S7 ]Q#KT@A-$A[*GGM\^GRK6GQ&[R8IKP:APP-D'5KV
MAPN:UJIKX%5%XZ'H_E_O+"I3]O:( 4 'S='3ZGMW<E61T1>E1_* /+#_ ->T
M7W.C^6J$W7@3TK_$B'\H!\L/_7M%]SX_EJFI"2\2/\H \L/_ %[1?<Z/Y<E2
M>E>('T@#RPS_ /KWB^YT?RY*D=*IHT1_+_\ EA5I^WO%[_S='\N2HHO$A_*
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M_ER5#27,A_* /+"_U[Q?<Z/A_?R5'2JTJ/Y0!Y8?^O:+[G1_+DJ3TQ\2'\H
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MI]H_E _E@?Z]F?<UGRU&WR'2O$?R@?RP/]>S/N:SY:IJZ^P=/M(_R@?RP/\
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M,V1H:YX ,<C3P)[4I2B)TK-KAH;[2J* @" ( @" ( @" ( @" ( @" ( @"
M( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
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M-I:6P M[6WMP!0"&&.( #@  QK> "I(.PG$!4QCT@*H! $ 0! $ 0! $ 0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
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MBHJ/30A_)IO+?K4Z!R/W4?\ )E5*LBI="7330?R:;RWZ_P"860IZ/G5_N_\
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MF5ZO$L))('Z-+Y;YI3061'I_PJ_C_>RI5:U94^GDB/\ )I_+?/#\ <CP[/\
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M1J3\G@/Y-;Y;?^KN_P#NH[Y,FH^3P'\FN\MO_5W?_=1WR9-1\G@/Y-=Y;?\
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MW,O ;(UU*$<144X@@\00>P@A4N+7N)C-2]YS5)6$ 0! $ 0! $ 0! <7 EI
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ML;VR,D8\<S7-<TEI:6D$$<%3*+B^E_4BN,E)*2X,^JI*@@" ( @" ( @" (
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M&4Q=];9'&7L,=Q97=K-%/%+#*QLC'!\3GLXM<.]3=L/&N.Q-.-V/%,Q\>_\
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M\J"Z$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ [$!BVW-\JSIJW
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M="4TU5$5!(0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
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M0 @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
M( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
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M9D/ZM.!]54 @" ( @" ( @" XO=RM+J5IW)1RT6C(;HJGR;(Z1E6CE)K2O\
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MB.>"W?&>1[6.%6^XO3.\I6[>[JU;DI=%N"K[4CR;MNU)V<C(?T7+TVO=U/\
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M^$52G1'\#H[*W-OH_P U_<NQU+<18J3.7#'XN2]>VT@N@QW,1'-<.BC>2!V
MDDK0>FFY67V+F;-&GZJRW7QXFX]1(PE/:K]5T/F3#YMNH,#GM[^F71^&R5IE
M-0W.>;+[#830WLD$?MK2'2MMWRNB+FG], M3V1M5^YZD2W*#_P O:@^KPU52
M[ON5"SZ59V%=5+M^['H]RHJF>#0UK+8:-TO:3\);? 8>.0$4(>VPMPYI'N$4
M6YW6XLC<KSM_XW3[6<?M%J6/MMJW<XJ"_ FQHH .U8QL5H10! $ 0! $ 0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
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M\NIMQM-:<O6W>/TOE!/[(QL<\<T,1\:6>,MB$?*/5[%EX5Q8>;_,J=6<N$O
MQ<M?J(2Q[?R8TN,49K].Z>Q.E<+CM/X.TBL<5BK2"RLK6%C6,B@MXVQ,:&L:
MUM>5@KP4Y63>S,B65D2<KT^++6/CVL6RK%E4MH]9L3&/<\ \SNWCP5ENO$O)
M=*HN!]%!(0! $ 0! $ 0! $ 0'CY_$QY[#9/#2O,<63LKFQE>VM6QW4+X'D4
MXU#7K"W#"M;CC/$OJMF7'X&1BY%S$OQR+7\2#JO>6@]+O1-M_P!+NI-?:HTK
M<RWF1U]>.O,C)-&QKF/=-XQ <&!SN/NK=6\^]:VBULMO3"M<$8.=8M[AO,]]
MR-<Z:HV5YWLVSN=V=!9315GJ&[TO/D@T,S%ES&XM^4/!Y.1S7>MS^GN7/Y>'
M'(OV9MT=MU7M-M@9TL&X[L4I-JFOM*,8SI!T7?;%OV0W/O7[BV+V7 ;F<K$T
MWL4TC7&":-\PF?&^"1W,*%9N]PM[G*UE32MY=E)0FM&OLU]Y8P<J[@9%VYC-
M]%Y_-%ZI_#@6+Z;\G^RQ.L[;)97?#5&:T#:WXNH] SMG^;S;LN!-#:.<Z9T1
MCC8T-IR4HMEB9OEI2RHJ]=2XO77XEJ]-2MRMXZ\OJK6GMXF8'2.BM.Z'TYCM
M+:;QT&-P^,MX[>VMK>-D;0&1MCYG>&U@<]X8*FBM961=RYN=UU;^Y>PP\/&L
MX-KRL=4C6K]K?,F."VCM^81UH>XDFGII[ZP;%B-B/3'@93DV=A7RD( @" (
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M"^=4 ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
M( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
M( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
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MH!)]/:K:M14NI$U!54VU%N/$@!(-N-9<014I4T0"D! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0 BO H#R;_ X+*O;)D\+
MB<C(P@L??XZSNWM(["UUQ#(X44IM<&0XQEQ1Z$%O;VL38;:"&VA9P9%!$R&)
MH[/5CC:UC> [@H))-.VVA7:I?K:32^%FU2]G(<U/C[2:_:*<HY+B2%TK"!W@
M@J:M: G< #L%. 'N4'8 .P*FB;KS!%2 @" ( @" ( @" ( @" ( @" ( @"
M( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
M( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
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M5D4 0! $ 0! $ 0! $ 0! $ 0! 0HJ5%)U0(JH! $ 0! $ 0! $ 0! $ 0!
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MM7I1<[GPHTWB,TJ_&ALD:#R-WE-"Z,RE[)XE[D=,:?O;N3_E+BZQ5K/._O\
MCRO)6VW&S#'S[UBVORX7917N4FCA]KR+N3MMG(O.MV=M-^]HU_?.RZMNH+IQ
MUYT\XW9K5<VGK#5FJ\;8:@AC8YXO+6;*,AD82)XJ5B=3O6J]+*]Q^K&5VYN_
MS;3;M)PC[:5_$WG?+L[#Z29/=.#'_P!;MWE&+]CI7\2T;Z03UD]7NQ6U'3VS
MIOUU=Z6U1K/ 86[RTEK'(^2^N9L6RXF($=Q$X%TS_=7+YM_<;WK-D]O8S;[?
MP[BZXKDG)_L1T.SPVU>B]ON[<4OYS-?5[7%-+[69#/(KZP]T>HCIT@TAO]J
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MDJ,IBZJK.2@J" ( @" ( @" *F,5'W@*H! $ 0! $ 0! $ 0! $ 0! $ 0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
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MYBTKXFIC]*]Q%"H( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
M( @" ( @" ( @" ( @" ( @" ( @" XN[/A'YH4KB4R^EFK!])D<!H'8H$]N
MK+#[YN7&=L__ *>MG_W9'INQ_P#Z.MZ_W?\ \4ST]"G[U+9C\3</^L+9>U^H
M_P#]^&7[X_\ "CPSL_\ ]BM_[\_^)F'OZ16W_P"!&W3JT:-48WF/;_\ GY[E
MY1L&GKOVT_9<_$]5J_\ [$W<-/\ ##\"QOS<Y_"\L?HK>VCHS\S<X/86>);A
MP(/:"U=CWI!3_JJVZS+Z9QE'[50T?I7*GH!OTU]22?XG<V?T_A.DK?7I$ZGK
MUKK7#[QXRTQ-M;15BMG/=9X^QD+@P0Q$N<X]KG<5U.WSGD]^[_Z>P;AM>)",
MH5X5DG+3X^".)5VS_P#8FVC?]JL>9O4;UQ7YI:I==%7GP\69H.OS/9[<'6NS
MVU&C+MTMUEBS+9_'0N+P_'W$3+B,2LC<X.:8'5XM(H5Y?L^'#>^ZLZWDJF-M
M=F=&^$FXM\_@=CE;WE=O=KV[T+?4]RG&$9+E1I/[ZHP/;"X>PT[Y_9TUBX8[
M?'XZRM6-MXFM:QES['#[2:,:UH)F!KP73>BUZ>Y>G.[;DVZ]=Q?"+:_ L>I&
M!+;L#:-NN?XE+_S49<AYXO45I+<+J5V%Z.LEJN'25K^$&-R^H<G+=1LMS%%>
M,NBR=KKAL0 B81Z[>Y<QZ:?I.X_5._+=W'^5;;%]+Y=2J_:J]6AT&_W\GM/T
MVN9V$G+-SVH17-1^E^WVGB^;MN'TYZ:V8V!W.V6W/TK<:ZV;N-,6[!A[O%NO
M+VT8+..XE>;6X;-')+X#N8 @<5F7-VRL'U=QNY[?5+&RYSMW(K@E5QC6FG"G
M'P,;MSMK W[TVS.Q,RZK<%!7HR>C<DNMK[38'Z;=]<9U&=&F#W0Q-Q%<,S&V
MEW!/)'(R0&[M-->%<.<6RRT<^0D\359?K!M-[8L?.L0XRM>8G_OILY+T[W!Y
M]W%M7M+]C*C;DN=(344_BD:8/EY^8-M3T,]=?5=/N/IW/9BXSVI+UEI-AL=D
M,B8!\Z3M<XMLP6@_8C2H*VG8F\8^1Z,8&W*,EE]4ZOEHUXZ&[]3L-1]4OU*?
MR]$4OC$S7[B^?;MAO/H_4VU6RFVVN,MN-K3$9#3N!M;S3V8MH!<96VEQXE?*
MZ)K6\C[EO;PX]BY'?^T=S[NVV6U[9TJ+N0=R6GTJ59+XHV&T;E@;%N5O<<]M
MPM?-%>,E]/WZE7/(P\O?7G27H/<#<S>#$.PNX>[68NL[)BWR$OL[;(7;<C#S
M-,$)JYLE*&J]8[IWG9K/;6%VCL+_ "<6W%7'XR22?WG!P_F'</>&7W9NL>GS
M6E:7@O'[#8 8!&XD\"233^>KQ/O47G\9?*FW\M#HJK5-:\CL.J6'N)'I[/A5
MC)A*[9E;@_F:)CQU+5-5=,>T=MK?5_4!=:=9D=R/P7ST4&3O9!<V]M&[$74;
MQ%9RL?$UY83Q'I6GS[E_;NU\C&^IN+E[:ZT^_4V&'<G<S;-M.B\R/XHUP?(1
M?)+UA]8SW]^JK^E!1H:,NX-:UHH  .RB]:V#(NWO2*UYO^)&M]6H.'J;MK?%
MVG_PFW0W@YU3VG@*>BO>N$*Y-42YGT0I" ( @" ( @" ( @" ( @" ( @" (
M @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"AZ@T\_I$3A_M
M+](XK_[6XKA3_IIJQ/0:G_V=-V7/R(_\".Q[Z3_^P7>?_P!T7_$;:&VG#;?0
M _\ <_2_WELEO=W?_JF1_P#7G_QL\WV7_P!GQ_\ Z4?P-87Z0V'#<CI8<31A
MUMBNSOIF8_S*+2^C3\SUMR[=K^,K"_X3>>IL8S]$,B%=?U*__%*!^?@Z*3.=
M"-M( ZWR%KI&RDC<*M<VYM+& \P-0>#U?['QH9?]0V_X=U*4)PE7WI.A7NS:
M_IAM78.G3<MZ^SY2Y_I2TWC.C3S!\3IVXO'6>+W^TSI:7#6]3%:<T.&QS[@,
M9]@A)<?0'+LNU,J[N^R[MV[?J[V#<DXU\.ILT&_7+5K9=DW7:[*;E"EV:]J2
MU?\ I+^NL^^S>[?4CHG:G$2&^TO@L%G+W6%A']EA'-C+FXM73L:9(^\4YFA>
M;8.+:S+>Y[[D*EG#MN,)/QHUI7VG5[KNUG9]GQ=GG:<K^Y78=+\*27@8:O)R
MCAMO-!ZC<7;1AMIC[F:*-C  V/V9P8:!H  JQ=[Z82GF>A67FY#^5WFW7PC.
MJ+GJ_BSVSO#8L2=*^0Z?&!4_S%]]-(]3GF@[/],F5UCC-(X+8[,V^2SEUD,A
M:065\^>Y;<N;,+FZ\!Q;R4HYHI1<KZ,96%G[YN_>.[-7=GA'R\=/]QKY6U[W
MKH9/?'3V]V+CXEB5,[<:.Y'@^GBON.'FK;E[7=/_ %,],G4ALGKK2=[D[Z_Q
M.$UBS!9;$2R-LK)]O812RML;IKPZ:.+B"4],L[^3^JV?B;HIY.W[O'\B+KTV
MY+1KPT?,M=RXF1W+Z06MEQU&U/9Y=<&J=4XRI)Z\=-4; >]FN,7NIT0ZNUK@
M+J.[L=2;5760AGC<US#)/IZ2:9O,'/!Y9'$=I7)>N>'>[<V'+Q,U?F0R;6GL
M=Q-?<97HWN<\_>\+.Q%2YT35'XJ+3^\T^?)4\U'IJZ((>HO1N[;]0PYS)ZUO
M9H3B\'D<I$X096>)T9DMJQ-#BTNK2O!>W;KNT>X.T=HQ\2+ZL?&74G55K!>)
MQ&\6,K#[\W3<-PXY%Q4IRHWR,GW5UYPFT77%L/KOIKZ6=+ZLUEN7N%8LPEI:
M7FG\I806HNG^%+,9)(G,):V9O:"/67F<^T,CNO*P\>BCL5J_UWG77Y>"^UU.
MQVCN/$[+?_<=Z5<B,)*$*:R<E0R)^2QT09[HNZ4,1AM9V<N-W!U5)<Y;4>.D
M>]_LC[N6"YACHZ&&A KW+TKO/>L',6/M6V:X&)!13\72C/.=DQ[N;O>;W3EP
M\N[GSKT>"3JG\3,-""Z4/<[C0^[6@(^LN$AUN-9\.1TDXQ\YN/!'UG8R>*6)
MS_L<D4D3Z<"!(TLK7N[59NPMW[<K4G6,E0N1DHZ\TS&AO_TK;3;4[4=2>[6&
MPOMNN=7:2S-U<Y;(2^V&V?%C+SE%K'.UPA!YS7E7*]U7+NW]F2VW'E^7&[;]
M[K-?$ZWM&<K_ '-8E2E6U]QB_P#HU#G/V;W=<_XQUEFZ]P_QQW#N 7O?<\XS
M[-V9Q5/RE_PG";_;=KU1W:+_ ,,/V&SHWL^K^:5YE_SF9G[I&/X@^'\U7I<2
MB'TG-4E80! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! ?&X>8XG/!IRT/97A7L5
M$ZTXTU)47+1<36C^D*]/VKM=Z.V;WQT;@KS.P;6:DL;_ #\-C#-<3QV,>1-U
M)*(;>"60AL;'5XCL6H[7S-M[3]3+6];EI9R4HJ7%)_2J^'VG;;=<L;GV/N.V
M7))7HQZHKQTU7VF43I7ZZ^FK5VP6V.6GW+TYIFZ@TQBL;?XC.Y.QQ5];7^-L
M+>TNH'VU]=,G'+(WA4 U7>=U0C;W^_&$E<\SYX].NC75R/)NU5.6R6Y33AT2
MDFGI^\US,(/FH[G1=:O6)TV[![(VL^M\3AM06=[G\YB89;O$PBWR++AQ]OM1
M=6G*T.X$D5"Y3TD[?SLSU7N]]9#=K8]NMR59*G4W&FB:.X[JWG Q/3'-[:@O
M,WC.E#IBM:4>O HGYW,-KI7K.Z!]-.#FS8.; V;HV-+@V6 VL,@+F@#U9(BL
M[TAR;6]^O^_[Q<N*-J=5&/-TJC(WO#N[5_3A/!C'6#@W[&WJ9 /-@TW>[96'
M33UD8V::SAVSP&*^>I+1CVR74EWBX?963F%K'/XL%.9ZUEO?Y]E^IV7LN)_T
M?<-R=NXJ:+IDXUK]YC;1BXN_^DW7=M>=N^ H3MJNO3HW1<N#X%XO0]>P;T[(
MZ]ZM,ICG6NI]P-#YJWCN)6.;.Z&RT[+$):O#I/68?Y\UJMIZD;7#LGLB_P!K
MVFIP4'<;X_7K^TY_M;,AW#W?B[Y"<E8C=MP5MUI%J48RI70P#>27N3I/;#?S
MKIW%U/EF8W':8OM6/]LN&B.-E_<3WCK)G-(Z,$ON&4''M6-BYU_8_P"FY/'K
M*[ESC",.?S2Z6U]IM._]GGN_]25G&6L;=I2;Y44:D[= WEKZ&\SS<_>_JMZL
M[+,Y6:?5>0MM$Y&VO;S&R7%@S(W/@R17#&.)CCM7T]60]H6_Q.S=O["[-PK>
M.O\ U',AUR==55)Z_$L=T]S/N_NN>#8E3;]OI!PIHWPTY(OTW\^CI=&>2V=U
MP_1^.U(=88_%769TU?7^H\C?QVEYB[>>\AB9!,R<.,DL;>P#L7G?=.Z;ELV+
M'N+;%U[AB2344M6NI=7MT6OP-WVXMNGEVL#-3_1W&XMU_P 6BK[*EIO1!U$W
MFHO+/ZNNF+660GCU/L%C\EI_#078D;>7%B1<VP;&R:3QWM;';CL:!1=!Z[9M
MCN;THV_O3%7F9EUVUE4UHTTHUX\*LN^G>!>[8]8[FPY$E#;[S<L:/):?,UP7
M@5$^CB;7;/[B;![ES:ET!IO4.4AU3D&S9#,83'7LKV&_'.P.N[224$R$&M5W
M>9AV,;TSV"Y:22G9?4N;^5-5.$WC.NWO6CN3'DW)6I6NE\N=:<C9HT?LGM%H
M>\?D-(;=Z1P5\3_;F/T_BK6X:>'&.:&T9(PU;W$+CK>9>5AX]F35KFJ_B;B[
M9A=NJ_=BG<7!T15!]M&\N+@274^"@IP5B%J,$_&7$J;;CT/Z3E# R%O(P&GN
MFJF-N,8*')"KHEX'T[?<*IK&<]>*' I-OKS-V>W*<*^KHK4Y!'H&#OB[A[BY
M/OIQM[!.XU67F0_$Z/M*27<6,YZ0\V/XHUDOHUMY#=YGJH%NYSVQ:VRX>7,<
MRCOGUW#CV\5[EG2B_3;:^FGF47_"SD^_I2O>KF1=C_T_0J?8;65A)--+,Z4T
MY'$-;3N!('U0O/8W%]',O?\ ,E5<'H>LJBH( @" ( @" ( @" ( @" ( @"
M( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
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M:5-=OS1=9,ZT.O?IZZ>]J()=8V>F=1660RV8Q44EWB;;V:^CGE_PE:BZLW-
M';4+G_1C#OXGJ'G>H$NJ&U*'0G)-5HJ5HZ'4>J^3M\/2>/:>/1]Q7[RDXIUT
MJO#AHBGWTB..UTWN)T0X-[O!?B,KI.P\/MI)9SV5O(*\.QT15STHR8YG]0V\
M9#X7HUZO%.O[&7>[<&_B?TR3L05%;G!-<]%&OWE\'FE8"VVOV>Z:.M;#V4]Q
MF-IM.:7=<RVK9#+)%?8BSKS>$T/( 8>UX5%W<=R[;]7<C L2Z=FW*<X27*J;
MCQ^QFN[6Q\CN7THM;18:_56(*=::T6K]O)EX/03DK+J"T?J[K%FC<[]L#1L]
MO:PW+'%]M)C\$R*?D$WB.87<SJT<MIWUMD.V^T,[8H_\V#N57%JCE^)INWNX
MLKN??,;%NI?I,"[&"JOWJI?CJ8$/+0W5TKM!UU=<&Y6H<K;V%O@?PC%M+</C
MC#;^=M\+!C3+)&"77+6@<1Q6L[<WV_A?TOYE[;HUS'=A",>;ZIJ+?CIQ/4/4
M[;5NGJWL.-??585J3EX)1C6A[W0WY4VE/,XU?NUU>=3UWJ&TU+FM6Y2'2^2Q
MU]?XZ6ZQT>2N76TT<T0JZ*.VD %)3\8+>X':FW]@=CX6)9E7*W"V[EQ5^ERH
M^'O9P7=.\R[N[YR.O_VO!Z8QBN$J*FG)4]A=AU,?1P.G2UV9UEJ30N=U=D]?
MZ4Q\FHM-39/.Y._9%-AF27[X8H9?:?6D\$=@'8O/>XM[W+M#"CW'LL>K<+%V
M"CI5TG-*3^"U.T[16V9N_6L'=&X[9=C*$HUTJXTA7XZ?$GORX.IN7=[RWM_M
MH<]=.BU9L9IK4>FI(;EY%Y+;VV/NK*,B*65T[@TP?SH[5T']1^)CYWIKA]SQ
MNJ_?RY8[OR6JC/KBU7BES7$U7IEC9W;?JU?[=R(]&)"<Y6(O3Y91D].%>1:1
M]'-V'V.WFP?4K-N#MYI_5N3LM:W@CR&7QME=O9&[*R>)&TW%O)("Y[@:\W<O
M5^Y<>SA=E[)>Q(J%V>/%2:_>_+1QNX7<B7J9O%K(?5%-./@M3:9T+TJ].^U^
M;_"+1&U&DL#FXP>2_M,+CF3-+@T<S'MMPYI'*""*4HO-K&3>Q[<K5F3C;GQ2
M-O>L6\^Y']0E)PX5X?9P+AH YL9<\-%0 UK0&M:P<&@ <  %:K&3H@E**Z9?
M2N1]&1,'$<:_[Q4RDY:,02A7IYGS;#1YJ/5=[JQ7:MVKOFPKYC)595B_I+5^
MM5O@=+V]#GN(8-&YUS3Q-&_-5W5<CW_9E+9%>QU^>K]IO_S'7]B*<^Y[,9?2
MZT,%_P!&CO8KK9K=T0OYZ:OS7K<M*$9=?0?>4H7.R-GE8HKOE*OOZ#A>X'./
MJMN\;FJ<849L],>7-IV.!(]/>5Y9>C<4%-?5S,N$E*J\#ZQM+6T)K^<KU:JO
M,)4.:$A $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
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MZO4M>?$VO<&7=W^./#<M7C_27PCL"GWF(M%0B@" ( @" ( @" ( @" ( @"
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MTJN\('09_;=Q\;M;[W?\57I<(^]\"U+_ *F?'A$]>?\ J<?9\4_F?FJQN/\
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%! $!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>28
<FILENAME>tm2227887d1-lc_asses4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2227887d1-lc_asses4c.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@!;@'( P$1  (1 0,1 ?_$ .0  0 " P$! 0$
M       ("08'"@4$ P(! 0 !!0$! 0             ' P0%!@@! @D0   &
M P ! P(# P@$"0<- 0(#! 4&!P !" D1$A,4%2$6%QA8&2(CU-:7F+@Y)(=Y
M"C%!);75=SA9F5$R)E>WUWBS-#9VEJ:V)S<HR$F)N1$  @(! P(# P8(!P8/
M$0    $" P01!08A$C$3!T$4%E'1(I,5"&%Q,E345956@:$C,[-U-Y&Q0K*4
M%W*2<],D-'2D-=4VEG<8./#!4F*BTE/#A+3$);5&=H9'_]H # ,!  (1 Q$
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M , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
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MG\7W<\@721,QOH'%E0NBLTU,E)]XM; GO@# & , 8 P!@# & , 8 P!@# &
M, 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P
M!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# &
M , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
MP!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
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M9<[R.>5)!4=']2JNMK8JDSGZ*2E!#F=-4$?/KYFT3]HD.E9Z<^-#4?@)49K
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M1Q1@=#+-*,!L0#"S "UL(M;WK>M^NL _3 & , 8 P!@# & , 8 P!@# & ,
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M5E_C6XDS+4_\!9/^Z\;^CRBUG_MVO_4K/\:HFMF)+H8 P!@# & , 8 P!@#
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MKJUAC(SRFV-,$BLJY+ AE/MT8#$QDBV<O=Y1HLX9)NSAGF[#HP#K<P!@# &
M5 1S_/TN3_9 <U?XS^L, M_P!@# & , 8 P!@$!.V)G#X*\TN\3:5QJ'- I=
M71(765/K7'FT1J7L/C-Y5%!7.RI(EV8F9VE4K,#[O4"9,:;OT 6,6LG"VJK8
M<CS91CKF8Z6K2U?E9;T6OB]$W^)-^"/<;;\_<,]1P*+KY5T3E)5PE-QB[:*U
M*7:GI%V60K3>B<YPC^5))SQ0KD3FB1N3:L2N+<XI4ZYO<$*@I6B7(E90%"58
MC5)QF$*4JD@P(RS "$ 8!:WK>];UO,5&49Q4X-.#6J:ZII^#3]J94OHOQ;YX
MN5"=>37-QG"2<91E%Z2C*+T<91::::336CZGU9]%(8 P!@# & , 8 P!@# &
M , K%Z!\-?C4Z=GMAV[;W*=?/ESV:09^9+B2;>&VQ0N@8\FC#=(FQZ3.6DZ)
M]96I"G"E-^G&6 2<'O ,/N"(GIU!BE0^#[QE4_+(#9Z'F>-SF[:YF[39C#?%
ME.#K*+:.L-@E89HPS)RD %3<WGO3-(223DVRT1)!?P U\>_3?N];U>K!/_HV
ME6#I3GJ]^=)6Y.3-%[]IFT*5DCNS?!]W:F"U(0^05X<FKZD!B;[DA;GTPTCY
M B!\H0^[6]>N> KLF/CZZ+ON51ZQ>G^AZ=ELW@+URPWP<FI:#D];Q)3"J,[>
MYL[)LY=-&J673:2]UF5P*^;FME1EHU*-KC90S#?C<?F$$L#!W_Q/S%QLY7,V
M^Z8:".27HEGNV71USK=U4KAML9\I%9>1QHCS,YD3,E!I4XI(6MBJ\Y4B-+$:
MJ*7 #Z!,3# ^N6>)R3O,^Z*DS#T 6T)+9<.GYM6+W(&VZ)S)J:L?I^(*(R]K
M&J$/70Y7.I['%E+RZF$G(80UOBUO4(TFUR=0@&XK@-=;\-LZ=F*W6.2='(S2
M[YL#I1WGJ](U7#*I.R0+I[@BFN*9&TQ6PKFO.U['=[ @HZ>)?6]]?G9R(6[6
MB(^A0E$$E! S!I\5%IL(OS^S7;5>KR5H[+AK[(9K!.BKKA$B@-H4E%*<<UCV
MVWEUM8D^5SR/G1$A>UFE2%,TIV(TZ.;1B+.&[[ M6YRJI11//5$4@K>B9(JI
MNF:OJI3(DZ(;:G?E%>0ACB)ST0W&J5AC>2Z&-&SPD".-$4$S0=C%O7NV!N7
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MEV&:FL)R;GHVN626<0]C\Q0Y%2Y;1$D)J-T@LYZ,8GE)MW4J#"TK![]*1*0
M"<!$P[Q4]"[*6R)=.Z3E,RGTLHFT;I1J .4:!*;(;0]NR>^SJZL4ZKIQ)J:1
MG6MURE71MU9FT+\IB[$KCQBAI)=3%I &<\I>,JX.<E_/J-]4\U6>WPFLN2X9
M-9O+6.8OD\K%5R<U6"B0MW/93NU*!G,M@JYF%00K<7=J51=0<Y&[)>]KP@3
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M/,+KM@NR.,CG*%2&^;(LBT)>:Z+6D]4VO]HHD:!_1QL:1D1$HV=&2B!M&6J
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M,KN-VT]66^P6,(6-?+%H71Y?  6F)@:TF;2GN1."P")-HE$!6M/."5HPT8A
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M1N0R>1Z+^K00F,1IY52=V&2#:O[(TJMD@$=[ ; T*S>63G3],:BL&3-5B?\
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MI0TM<F;B-QNPG)UA\4;X3*(LL1OQLXDS^V+4+:6V&D+R%J01@32-A+-V2UZ
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M & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
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MG\CTE5FNF"& , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
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MMMZOQ(&/"KEAVO6*^1 WJ*IR(93M'W3R:YOP+*KK=2)%5LVK0<^>A2&P1/\
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MJZB,Y:!N"-U'&7AN92?2&B<FU6O;%XH4C,*:=FI3SDH]HO4DP96P"V!/W &
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M7W!W^&]8!Z6 , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
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M/Z,XJ47T;76+3T\5X-)F<Y:%J, 8 P!@# & , 8 P!@# & , 8 P!@# & ,
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M8?*R\G-OEDYED[<B7C*3;;TZ+J_P&79;%N, 8 P!@# & , 8 P!@# & , 8
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M;-?Q6,5\^O5#MK?8,F>&NK!+]_<-QE$G5. $AA^@%C6; R:_O(=#*FX C_D
MKZN)A<D-FB/F9QA-;(3TT0GK\1TW;M45/'&LXA>F=R&F61];:A)BMM-"(6U:
M,Q'LTL0OE !YJOR84RAZCF5"*F]4*NX3S5';\<+_ &U:J?X^YR.4RZK&1DIJ
M,P>/,;K+)--7:-WI"G9"!#I0I<=RA C2I#E!VM8!MA1Y ^04;'"Y"NN)*@03
MIRF36W$.$-L1 ]QHVN)JVUQ8JVTXTLB)$CI5AKZ?O2%E?7.8)&)N9W-<F3+#
MR35!(1@3)P!@# & , 8 P!@# & , 8 P!@# & , 8!SKU!X68;%;;M.\N??(
M--E,BC\-ZN@/#R8N)5#9,;X&?^EKOG<IZ!D<12I#4YEH29!::F2L16WTXA4V
M%_6MJHU0I2EC2@7.<B\T0CC;F.C.6:X7/#K"Z*K>-UVRO,A,(-?GX+&B"4ND
M+SM(4G1 =']S&<L/+3EE)RC3]@*  L(0Z D9@# *@?/5_E/=6?ZC/\25.X!;
M]@# & , 8 P!@%4GFT@UBV)XWK@CM4UM/+=FZ2T^/)DAKNL8ZJED\D316_:7
M/5B2X,<CJ+85#HL;(?%EZT8-""$)*88A""$.Q: U>[^3NNNE63I[ED[FWLOG
M6V@\)]%W^VMW4='I:D;Y#7402,]=/:V/'[F3^M<EB>2V(WEZ!I,$KV:-WLS0
M@!"/8N(?\K-K_K'&_IH%ANO_  7D_P"H6?XC+5:(_P#T/IK_ *J:\_\ PBSY
M9[__ ,.YO^Z[OZ215P?]I4_ZE#_%1BDQ_P"TK17_ %9= ?\ .U'Y"G(/[8N,
M_P!3;Y_2[,2[L']C_)?ZYV/^BW@D#DJD6# & , 8 P!@# & , 8 P!@&&OU<
MU[*EVG.402&R1R"06E"X/T79'A<%,4(P92?2MP0J%&B"QFBV$'N]NMBWO6OQ
MWFO;IQ'B>^9/ON];7MV9F**CYE^-3;/M6K4>ZR$I=J;;2UT6K^4V':^6\KV3
M&]SV7<]PP\-R<O+HR;JH=ST3EVUSC'N:23>FKT7R'B?HI3?_ *I:R_\ L'%?
M^BLQO^;CT]_4.S?Y%C?ZT9'_ #B^H/Z]WG_+<G_739N;F::580GQ90&$P.M8
M&EM28+DE:T?XB:00KU#,REJ7-J\1?24DZ1KI\5E%C^(EPMY[D@VU[+!_-H4I
M03$OJ9O> 8?"/$='8M7/Z:.?2-J/39$:$Y"Y]HM^11:MV*3TU'^#[F/O/F"7
M)E/Y==&6<SB(39&T'.AKN@.;GK[5K1B,HM0<5L#<2CQ\FRZJNLXG</0$VM*T
M.Q(2Q5U8=M'0Z#P\J-0F&-#\T02,P. 19O1LC:VQW<K=EQABY0X+ESBZ*!F*
M=)])4J8#,+KY%M&>] .%^T_U1*N>GF3TE%*)F2..U=7,^6KXU$)K8<T:7V-.
MU@)'9%&94E564N 4<8WN"0(RB1FIS@A$4,#X57C@YR;JLKNL:]83(!NNI)Q<
MZI)JEV)\F4A8N);PHBZH%'90[.IXA/)DH54"UM[JX&:VL."><JV(:C?J("-J
M'PY5FQ0TV*1F[+.9U&X3)(%M\&F:5JQYBIUY<[V=!X=,R_<FW*J]C56<OQ6K
M'1G&8GU(H"4I2'GDFJ-G  R2G_%.S4 4QBI;H6=5@X <K=;9BL@M>U1$T3[5
M]QWH5?SO7L/CL>C+9'*F.BDE&L:V)S84I'T;&Y*"CDRE86A7(P+:< 8 P!@#
M & , 8 P!@# & , 8 P!@# & <5'87CJF->>1*]V+QRK?(3)Y1^BL8Z.Z2B5
M:^477#<#K2,W5?W3EBM->U&[KX9+GR6DSNP#9L_$-*@"6*1!R5*59RTY6_*"
MTP'5!P/-H797$O*%B5S*+@FD%G5 59+XK*.@9*IF5XO++(X>U.Z-3;,N5",,
MD]@!+5^QT7A&:4K5@&:4886(!@@);X P"H'SU?Y3W5G^HS_$E3N 6_8 P!@#
M & , 8 P"BCIV(/-A>8$R QP"<V0SCP4=MQ!A+5GA2I3'F2]0<SLK6!2J'H0
M4R<:Y:#0S-ZWH ?7?_%F7X_F4;=OV#N&3JL:C,ILGHM7VPLC*6B]KT3T7M+7
M.IGD85U%?\Y.J<5^-Q:7\;)J<>7K;KM,9%RQ=5&L51S&AZ7IE\*=([;Y%IH)
M<S27\T1)$J$6G@,.+CZ@!\ .-$3\RW?H=H/NU[?<+;>9[!L].%5RS8\^S,PM
MPSLF/;/'=#KE#R[&NMUG>M+DM=(^'\"Q6T9V7.Z6UYE$:KJ*:WJK.]23[HK_
M  8Z?D_*R04Q_P"TK17_ %9= ?\ .U'YS-R#^V+C/]3;Y_2[,3EL']C_ "7^
MN=C_ *+>"0.2J18, 8 P!@# & , 8 P!@# & , P^$3^&62SJW^"R%ODS,AD
M$DBJMP;1F#3D2*(/:Z-R9I'LPLL6E;,^-IZ8[7IZ:-*%K6]Z_'+W/V[-VRY8
M^?7*J^5<+$I>+A9%3A+\4HR4E^!E&B^G)@[*)*4%)QU7RQ;37\#31F&616(D
M5KVU0UER/H2/D/JR%)^:Y(*/SR5V2%HAD+<DA,VGU6+9;%)(X/(D;C#V^VZG
ME44/5J?HA ?HZM(^/8 E&F@8W/\ R*<=0)3!VP-[5G-7NT(?:,WK1J@]BUTZ
M$SQFIW;87/ ,$I<I>S033@V*74!0"53LFV<,A5[=["C5B) DS;=EQVEZILVX
MI@!R-B53U[-++E!;,F*6NYD=@D;<I2]@:D9ZE&0K<AMC4;H@H9Q0##?:'8PZ
MW[M 5_.?E4K",LCBIG?.?6=?3(QKI=[K^K95 ZTU-[D:KWONLN:84KK%>Q7
M^5VO,26W<4;0NB=T?FE6W$.Q"@PKX3 BV!+2@>FHI?JR>1HF%V94UF5<HC@+
M"J&XX\U1RP8RVS1"N<(3)1EQV0RZ*/L3EY#0O @<FIU7I#%3:M2C&!4C4DE
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MA2;)$W*M([3.BI-8SRSU-%)H^SQAKR+R6Q)3(8G%T+V]*E*- )%&W)*(YE9
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MI*I(A?&5[)<&1"Q)4IHUB024T)9*DP"^# & , 8 P!@# & , 8 P!@# & ,
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MH^A96-M(3$_(,8_C+U[A;WZ[P#,L 8!"CISQY\H]@RZ-SB^:_>)(_,$7' '
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M(T96M*R"M!."?L@!@%8Z*'>"$-3R*++[6ZR,MD/>O.8I99$_;O(!KR5#[GU
MYNLYB \H9Q6P.K=.0JI_,J6,^Y@U&_MOW39&]*OJSL C;U#77BM?N'N&6F$]
M 0^ ^+!+Y'YE/I-++RB?8$HOUVMUIDMINEJ4-!65^K@N>MD#EZ0,U;)F_P ]
MT:B;&K9YAZ@\8B3RP+'>OHWX?UO7\ED/3-@="M$S;+MY+3W!!4J+LLWBV0]
M"4M8N5EUOK(S"73F$B5%J3D&O0YY0H/D*!]Z+V/9VQ@=!F , 8 P!@# & ,
J8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>29
<FILENAME>tm2227887d1-lc_itcar4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2227887d1-lc_itcar4c.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ MP&  P$1  (1 0,1 ?_$ -\  0$  P # 0$!
M       )!@<(! 4* P(! 0$  04! 0$             !0($!@<( P$)$
M!@,  0$#!0L) @L)   " P0%!@<  0@)$1(3%"$5%UB8,;75%I97=]@9.1HB
M(U/6&#AXN IYF4%1,M,T-G:VE[=9<4(S)-0U-RBY$0 " @$" P,#"PX)"0<%
M     0(#!!$%(1(&,1,'010(46'1(C*24].4%1=Q@;%2TB,S9-15E5:6&)%R
MLI.S5#5U%J'!0G-TM38W=_""0R0T1%>T9G:V./_:  P# 0 "$0,1 #\ ^_C
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M348ZRDO5>FNB?8??FNUIN%M$G&+>D9IO1+5\$=(9T 1@P!@# & , 8 P!@#
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M<.':;/S8Q:C & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
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M7JV]$F^!9K:K9:\EM$I)-Z*:;X<7P1TKG0A%C & , 8 P!@# & , 8 P!@#
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MBC'B^9(W- M;::WKET7=_%O8=CU=)DK8K#M.><_K .I!VO=D@]SZ[P"NN ,
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M7LCZ$*7_ #0U?^0$4_!./H<\(OU5Z;_1F%\0//\ .^&M]_+V1]"%+_FAJ_\
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M4Z&#,;K)F$A&WS)H4DOYBW5EH)#+K"6+GL\L[YR1S]8@"F2E)BQF 5NP!@#
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MZGDID5I2/R5J:XDRITZAH;&MU;&](L3^]T0+1RL*@"C> , D!Y^/W-OD)_0
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MZ\:WO(J,^\HA-53YXQC&?-!\T4D]4D9WEX8R, 8 P!@# & , 8 P!@# & ,
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M@T$_ZCPW_LK'OO0CR3K_  <?XJ^P;2VW^SL?_40_DHRK*R](@>,C]X?YV/\
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M & , 8 P!@# & , 8 P#PSFYO4JT2]0A1GKFWXGYN6G)B35:#XPK1*OX)2,
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M2Y8Q48<L816FK:27*FUOLOR\^/TP #-7-*O08 CU_P#KSTL+Y!:T+7\H%/C
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MT39)H=+V='((T_-^SRB#_@W9G<"3R]&  9H)FM""$7KK0&:8 P!@# & , 8
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M,7%+GNP:_!TDV=*.-N,4QGM@JY.[]&6)(W&3DR5S?S%2!0L?2%Q!91;?IO5
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M4&/C@E U)G "%.%,W)0$CT,"Z6 , 8 P!@# & , 8 P!@# & , 8 P!@# &
/, 8 P!@# & , 8 P#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>30
<FILENAME>tm2227887d1-pht_profnd4clr.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2227887d1-pht_profnd4clr.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@!6P'( P$1  (1 0,1 ?_$ ,P  0 !!0$! 0$!
M       &!0<("0H$ PL" 0$!  (# 0$! 0            8'! 4( P() 1
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MQD_7= 7RNA2HW4FM4KA[3/RMHMLNAZ?W F%$"4PX $F;AR#53[?\_P#]S$N
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M)_WE@*U:GVS(9-7D?/)_U*8E!@8<UA)I8MJP2P2*( &"PA^9&8U*V?M(\\8
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M R9G?]PH8&XD'/>%3$S^WQWU-NG6LM/3\=4R[))O[S8AD,\VUAI.$3)\0^"
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M-.--.--.--.--.--.--.--.--.--.--.--.--.--.--.--.--<,GG/?'9_\
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MZ'7=M]XWW6E9<Z2OI:^BUMI67]GV%=Q!!2X<VH/ELKBN9GJ_02FVT\P0D]=
M2D!#58L#Y1DF>KJXQW2)Z1TO(9/I^.:ZN $;J])A$P3EZUA-A9M6I-<F'XY;
M'D$B$IGEQ&-?>([MD?Y#4\?ZO]E=@4O$UJY&C)/@3D,FX"L@#E/.JR0743;K
MK-0M6)M'DWD2QU]:;M6TZPN]<ZBCRNT*"J_BJ[G9YSX(&5M/H; IX$=^2RQ
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M]&.<V1/2R_5G2_3N;ZI<SU)N*R&05].L=FF4P^KXS6272PI807RY@VQP+CY
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M\^8GF(K+(6YA^ V"*A/^C.1.^"O:L$CH8GM=_:Y4_HWFMPB*6&')Y?V"2ZF
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M?-C'K@%5C9,NFLB1<BLFL I&6+9,&J!B($Q&)S:: #[&D"85;:*K+G$AK)]
M@[ST"S\OP9I!YHY73T$0 4$?^["2MB^1B.3^J(O*F7Z1NYROB<E?J5L-<64N
MNH2VQ82+K@05\1198ZO9-SY@HLDL2B-^4$4;ZMS&?R)H=-/-8^O;LYMC4PBH
M_P =>IY?IMF*3IL4UU+E=2D00^"&D1;CP):RX:@[2(&3%-K/A:=! ,6X'Y92
M2:^*2>9E>]TSVDE.^S,$]/E]OND<US?Z^BIRU[>2ZYURE7ZK["RM9=T%SPEM
MA=4;R_$0D,I"1V7'*0E<04D0#.\_$:Y[R_8E#FS[CTVH-6KD&F0A*BLLQ[E.
M6V259L&92[80;YID>(-(-HB)G4@IME5Z0$ PZ,KZ1 81]7%,(8');NGA8R6:
MP@F&''$5))6NCBF<Q4:J.>C51S649:Z?G<0S[GK(XEN2\[(LP33FACU&LJX#
ML!V%FT3/FL08TX'@(3(3KL_'>S^H]G5&.]R1$UL1%1<4MJXKS&4L*:%IK)AT
M4W(20*)+B:FNLR%IM@3&(I[)*N$IL/PG16DX=B4&R1T4%5*H$L<+7A%!?[L,
M=!-,U[(9526=L<BQM>UJN2R;?9LX=]W5VN4/65%34QY)MM(HLBHB39FR)"<6
M0;"]Q 3"6B1# B0ZIFAT?JX8=/=T5WEWER\D]58+-&NL/ID\ M48I$LUG28B
M7P)F:G> U@4L8LYS&_78/-_QQ>-%S$/=/<WNJBJY&E7OSNG'F@(>\Z(<HN"&
M2O$?8RI(WVK.OQ-1D;DCB<L.]B7587J>8Z;;05ML8Z+"FU:P!4"2<[=FX,E8
M0 &(?(0WD,1N<2.U@^H,8_LWL#KOLO'W%T*W^9^D]-VZ;LBWA6K\51#*PM;+
M#432@'L6$,_,5;-DN]'G">OU1TXTTXTTXTTXTTXTU^>OYJDZ23RP\D3((10:
M@'N[N@8^6T#A+?\ "!O7EL/JB*PN:Q1L#+,I%AG%<UTT*IZQM5CI=/'L/.=7
MM*R/3C=B;D"ZJXZ[YG[<>1NYV4G'"-H9Q64P6T\2&.0[Q^37\@,'/:NRW^T9
M:N]U*<J^G036<N(450W*?]N# %)7:?!-AI.A\R< J#GE,1_*G1=@W(((MCGQ
M"BHX :*Q?6 TE7/,"&X>K/L2T$!CEK[!K6O2R:CD)8U)4=(KT63^=?'"]>ZG
MBXRM'._XI]>VVU:^U-AK:XVB\]3$U2)D3*6D1C7G\_.;&0(0N)F)^IV'V/MM
MGHG8\;BS[W<QPU<.XJZ516N5$M!#7F*XB")&T2PHDO-743EBTIDK8=TQ3&7@
M<.\I:2XO3Z2R"&KJ3\$..ZDNI:C/&UYU8(0#7,GL&,%:2CXUD'9(OS.C625%
M[/\ 4=C^//5NGCV7KE7*SA;KWTUUK\S;?=LE*R)R5FUAM\L&7!OP/C,MR4KC
M$R3V[C?=@=LJ]([&_!?[L\U"\.3IKBJ6ZP>FO-JP*5@+!\$'/,MA(1V*9WV_
MBO'B]!:0NK"CI?HDQCR59HY7U3:BQ$?GYJ8*N (B2 L<-)4<^>&422)J(Q'+
M[F5N[UX7=O\ +=KZIC'*1B; *J.SK!\8U&5S@JDHLPRLRI5EIR)L,MH9 ;E(
M#M7^"QO0>G9J]3[+D<K_ .:=?'63%U(B:L<E$&X>%BHR7&4?@FQ!0*I.&%Y8
M#8M7% BP>(KI:O=SY IR;>N6NEEN#3[7?J77PU-A096[#8775M!'5TJE1PL^
M&&:9\LT#7N<C75'&.]D=P)75?3&3[13Z1F<9->8R))"A6:Q4V&*)+AAGVWNF
M:Z8 8\FT V1$=]=#]W]?X?$=%QK?::Z-CN>(R*7W')<3+%O&&XZX@NRDHNG7
MQB(44,8H5+@8XL(MQUX!\!7O)[-W-?:6?T11:%,5F2;NF6MR]9!8.#G$A4E
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M*.W^Y&R(Y8?T+V1TOW_?NV^G9<L?[-Q$,I90;%5DUI6@@\U=F/NOF1JV0AA
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MA<R6V=JRI5E',:?7,!#L;<6&-(FI+&V%5E?)[?<C/2R,GT;#>O\ HU3$9;L
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M9"SB(,O PI9$$OX!PA\Q$[%^LZ\,I5H=(&R<N402*4-YGM1Y7]L,:M:-$/\
M#]=85:YG^1CO=Z>Y/1%]5Y8)]?HX-)Y/!4D+R@R3".9&&-(RY&LW'&_!D[?F
M13 1OM$;:Q1[GE.SN3A>XY2V[ R*TB$\I366H(4MJJRR&.:0Y<5" \YXS,EO
MK_:RBF<34U4KS)ZF*BMEK_24L-L3KBJN A!VM"BB6*'-R&BGADI]E)YA%9*U
M&N5\E)=YR&0/J5K*==RHX&*V7#RVJ;J%NP]%;8/KDIHBF&L2"@6),)ZAW/E)
M ._1GK'%XEGL*GUSM6(+L]M^#_;H9"KDZ%6G;MF+YLRU1G9BN#2>UIBA51Y&
M(B$ PR7FQ^MFT%B\WO%^JVA4T]P_LFJ"Q;E>-!*^P&-)L%;>#6R!V!LD65;(
MUBP0H4PMB22^K6R*Z)^PNN7L/ZL;9Z78I(P67:=JY#V$YQUQ2Q@)J?H,-EL)
MEDS$BM4/@8Y<9B<^KNX6>R>_L=0[S6M-S/75KH5OKJ)*0>1K4VQ:VW_;F9;(
M27&&3-?>)(IUWJ\XBU^I.G&FG&FG&FG&FG&FOS\?("*YO_.#R"@=IQ:>LD[X
M[ZJR*W0T]A3 D$$=IWP]-;3W<SX9 H*EH,['/:-,PJ B.7U:SXGK)?;GKC_:
M?K:/:O1JEO(8*[C0'(BF(.%M(8AD*3QED\'*ECB(X&&2)!, ?&?R#[.S#8_V
M;V3K>;341VK+Y^ZFL=NY8J5JZG>4UV+C5;K8AQ,6Q(%Q\35S/S/+C;*J6AR-
MIAP&@?5AIS8J,:PJ:_\ -#AU3QRD8^TKGD1"6C:89LD0\!3HH'2/C]5:Y6N9
M&\/C\]W/T]D.M7<A5\>/FY?175,E;)M91%#'MF.56@9F$2U404SQ#B1D&I=T
MSLN+ZWW+K^6]G/Q[^Q8G)61"]$A8"Y3\DBPCE &3;F.L?^"N%()M<CF9@8+;
M^+=F9O8C]5)L2=IU])>@$2=BW@SA2; Z:IL+^N)-!-:#;5Q"O#5"50=K R(/
M1$1BL>Z=>L)]IL_PG^5P^.K=M1UJ;6(4"4+&K42U</MS8KE* A1#Q4NS$.LC
M8B-Y.#@<#-8SIC_:>?S/:<@S*>KU988;;"LUEI]JXIT!B*_D>=@@%33,I")A
M9!/]L[3JF%7>7HZ@QU=*CS2*>W8>9;5@"09]!+2B+K+O.:5+N-J2SUWV1SHB
M@9U6.5\D4L2-7UM'UYT3W;W7/H[3[&S35^KLI<&\RM).";2TP436O5W5B35I
MEL#J_C<GRA "<QJ,=7[9Z<Z-T?.4^E8^U=]J+LV%4[ED$*?7"U(IKS45+H<U
MRPCQ.6*6D#))RX$#V'T55IJA,57 @87,,Z_RE91"NOH8627$99QQHM(+;GK"
M>3,$4 Y81W?=8D;H_8L#U7W-VMCI/K+,^W6>O#[)EJSKOEMUL8TA6"[>,V0'
MTH!8JXBH0M3L1N:)<I+YU-^P^X^R,]3U$]GZ9@<I?Q94+C<J"&-Y5KA,>J<@
MV6Q:EWV/-6!'D3460L603'"-1^ZEN[ZM./J:2''?:KRI(A1[&#1AT4T\:OD$
M(L%'J(-1&"2JM=*@PB$-1/1C7)Z\WOI]IS3\7;.VT\EV#(?2A(%7*P:S6'@8
M?Y@#J[3*9 $RTX0(D?(Y;.T([A';>W9O*^P^O=:OT_2XTK0 NM9#'I-,^,V.
M:>T@SS'*V$KQE)S K&9E<3$>'!$%J*<>@$6B]]A,6X?.U=0""4XATKYQ[&NF
M 6&*,V652EF@;!.LKFN;(Y)'HZ*V/276\_[$M4*.6K7NE]=M);.,M/>V4562
M;,C"H'8ECY1( B29)R,"PAF1DJ1OIOHH'1[?C9R'=<Y7K'3<YKIL(26RJPB'
MZL)XPJ4ER(?'M'S,$(^ZKC$N1W:&8 (>RPE_HLS>5-GEOE*G!D^(H0[.:\HD
M/ZL!B-&F<,.,5"7 4UBR,FA5KJ:Z+;SF;]XF.#OC2I12.ABK#O(M\RE<UJZW
M54**3<NL6[6FP9 BDXB8C;5_=6Z&SJWJ6SVO)-&ZRO=JM_QAMK*IW:Z5M=D8
MN;LAC;-&XQ:05$07X"$;\I&9-6=IW&0'9G,K72/K=%%?4EMJVTH9<\(1S 2G
MBWY\;XD"JT*J?K0NA@]5>]Z22-:KEY8WM/T3USN/8,5W;V'G<Q_YG7%P=16/
M_P"\0DL;R4UX J99 RMW)@JV$6<YF)B"G487W:OTS(9''^J)J8,DH:5JS=AJ
MKEI-U=5I54BZNSP_6:N?#!1#&"P2$3B9VM52_G32[9=%61'A5<[ !#LW9%58
M5P+8BODE++IFVK[VDLP9 UG^)LA3&!RMDA)E_P _Q6WU_P!B9S&YA7I?NF9)
MO9K"S!.6KE+9$V6%\:[1):@!@IF.#IDI61S$1$SOK0M]=8NL=?O/3*%S.^O'
M*R%@PNBM3 FFO>8-E:6J$1\RCX$2S<:3 U"(Q,R0H"G.  AI4LY3;N8RQM'5
M$$ 8<#6"C-K]"PQ+9Y<GVX _JHJ-FD9]>-%<Z/WK'+NG9G+X*K;GOV2Z]D!.
MTJM<R2' #51]4W>"VQ2EA)AQK@HV3$N\GY#$# S"[*&9CK]*EU;_ #+,EAT6
M[5JA<+R55+AH1)T51&\#"S)MF#&)$!D^91\ZN=G*R.?ZH91089( %I,ZS*B_
M,I831UT@X3)Y*B#VC'6OUVQ.]S&0QK_M=[/Z<_-W-W,QTVXCJ&#MSF<%DGJ9
M9K+)@5?&;H8/RU:V%P I=+5S^<-B CXU>_3L1?+(83H-8L:SL15<JIP' Y/&
MHF[L*T__ 'M8=A$L&?')VW""Q_.9@8UX\T-6@,,M+FDD&NFGSB!*,8P6S M:
ME66<>T&8$DT4H+@[@^&&97P2N>3*Y4]4]'1'VGB<(_V!FL?U!M8.J5=VK!OP
MMRVB"XJ(\LRQC184'*IB=UKF8*>6VJX+&Y/UFP\#W&ZZYF6185%&AD'KMT+B
MQJM1;? KE3@!8B*A4UD%PB1GFN-ZJ.+69I,C;:F^WCJO=ZZW$%+H,Q1V$-/2
MK43!T!!;6W\+[ =N@&GEL)71C/8.]C55T3'R)5B[&<M1<5@TU(^FNO$R;G@/
MDY0; .15/&!&!E&W+]R/C:=3_HW6<#?IX[LN3R>8ZYA;LVVWLDYD$HRJLVI2
ME@MD&6VF7[M.VN.0 <JYS&\^FMJ:K5]A6=C)D:$UQ%;I1ZP:I(?F0 V YF%%
MU:R$&N(?9AC9]#)&_96-5;[?141GMVM"C45@"C)YV<>RN^J<RX"L'8AEG9M=
M1 HA$MVP"X)<<QF?S#C.^D]=Y;KW<?:?^&L8BG<Z6X'Q<%;FT*H)IUVF=I#)
M)AK2,(B]"SG>++6QY(A@ZRZ_4!U_EC?V-](]B"LIS-&\_M0HF] 4@IME7!]2
M=EYC/L^N41./7V-;2SK#,9!Z/(5TJ(OQ3JU+$Z\Y:,NBA7=,U87,B!;1,3,3
M,Q'QO,_H1#,[#&WS,Q.NBO0EA>/]J8KIW6;]BWURGC[=DT,%0,JQ:DB"& A,
MDN2(9:T'.V$[2!F3. V[C>69K]#].--.--.--.--.--.--.--.--.--.--.-
M-.--.--.--.--.--.--.--<$WG=MH:OS=\V&O.K(L[8]N7E24==W!CDK;.I>
M-]U4&_W4(*(,ZO:@RD3%HGW)%;%$C8D3KS']%ZYWWUAUO(YM5MF.PC2;#4S6
M-HDUA5WKB&UG, 5%(O 5FHBA9E+8X@!_G5G/8G;O67OWM6-ZU8HU\WGP!?@>
M%D:[ 4C[-5K27;2MGV!@Z[C(2E9$J 6<$R8P?N\"77BY8:PJG0QC553<!'&M
M%%+FBO(&PQ7L%E4CP%P6I0%2CI?K^QCV.;&Y6M1(V6IZ[S7KWN>6R5'#Q%[)
MXG)642TJGUVD= P0X5O H GH9P'FH*WD$@)@EO+)YR[_ -?]X>N,#C<CW*^"
M.N9VG7M5TKL2]5>OEENM("U5;SGPN#RS$MA_"%$($1CM-Q>NNY'=6ZX+/6E;
M9[//;>EUN>?47-B>;GX8FNBU%G$,;8R%I461R"S%AM6-T"RC/<C$E1/=$/Y
M>A^C]\Z]BL12FWUWM+LS6OUKB*TVRF]61-=2,A E+'(8EOB=!LD? LQ@Q&9Y
M;3T=[8[]A.R9?L-NS4SV"Q^,;5MUVVXJ$6.L6(8]^.@_" L6Q4,"!%;";8$I
MB9GD%2,V)UWF&966T,#S^=MK*YRE8=(-++7N)ACC=#%8)$PE\+G0HY8T<C?=
MZ*C455YXT_6N3]<>U*/;\=@<?D;&<PWT.PVZBR&"8!@:VE3$I6 DN2""&(EL
M$7,1VB)L>OW+UI[4]&]DHY7M>7PG;^OYZMD.JX^\\/"VEXFJ-(7"#=EE+8!G
M%AB%40A:&,EAD'ESNZEJJY<ZE;&2%8?ER- V6>=K;40J"LCA@>I4!(%40',
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MX&31F8XC,%ZPGH ^*^&U$)=689]2(D>9\R",4.+U$(GC%D%]TY5:KI2B95?
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M&^J5P;0\]==1;BDQ$K:V7%6IE<6$^&39%29Y<9@H#Y7UHN?'*T&HOJNOQPH
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M.!M=28%NOD[C:U:ED+ !%T:_[)&UA[>*(0OR3#"\;@CG,?*GS4Y=BA0$T9L
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M3-MK MY)LKDC4O\ 9:PF[@8QS@A"=\CI/NDJWLAF+Z[2R.3P=K$LK4L<(V;
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MODC:N&B;$Q( 4;SKE+^35;USU'LR\JH>R6;65;C+F4_[<O\ &#-)OU_I%$2
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M)$&_PRQM21$:COD6R*5S#Y7(XVC:JJMW;(/K-\EM+TJBH)&'*N&ZR%O$R7N
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MV>&&%(V2(X,162(^23Y&P3KV.S^%]D?YC)6UGDLN5CG5?7E/&NB$("OCSYR
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M$@V)X^(9D5,V(N5B>PO1WMS)JL33[ UUHKU0\?$+>L%B@7R%=XUN05TUI83
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M-*181L7+1$BXP$@7DB9#\M?I!ZK[-CLW-6OGF5&^S)HH58:*/#YJSEDY4I9
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MI5K@1<6F46CELB9%"2; 3-<94)#N?<?\:O>G7.\9#I6<SHT_5J<$GSON9!#
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MJ&Z5J[-2[>7LDKJ*:K]6X#@HRMMM7TK-9LR7)==SEL@I]^=(O,M5D=3]A#6
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MPT-X^FUU7^-MJ^^U/<0ML%:BV.+J-)L$#J]3"!%,)6XLVT+T+XPH!:8B:Z*
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M4V2M'8)2ENKJ=,\SDN0QL.D=*Q_;,=9[YA+A]I=5*Y;K7&5H3CJQV3&CXO\
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M,BM=;#:6:9VJVC74H\M=019E@;*A]D"=<PFE)86A<WI*X9ZUK 9P_<DJHO\
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M.?+:_P!6HFTLF6G$Y8I\PVGK!RQ,&L-O)A"^.2Q*.Z:.?[G=P6.N],Q^+_\
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M> /DQ;[._'Q-BYYX&JK<UH+(JXBJ F6-Q,,Z'[TZ2,D;&]'Q-B<EI=/S?K_
MWJ73LKFL_4)N*@K+[K$):@'C!+?437('R#UMBP(R@4NF9B-I@A&GK78?:_L/
MKS.\=?P/6NQY#&Y*:%--)MB+F48N#_9RK&'*9E1UC5+5$9K64PV0@!*<C("D
ML1*C/=98ZAL;&JCU2T&GFW&9ZFMHKZ:G;=T5HN?GAM[K1GW.OAEB+)B-B0$6
M9)F0RRM^OSGIM:O498S?=:-O*=<M4/L7915L9!BS(6U%"UZO&%9"P@#E)UCD
MV"R"8R(AAVC96_H.3JX/.WE8E/\ GK248MS+$TY^I-=X,8MS""^@3M*,2GF^
M1"'\":6VK6^6%EN\SX]]J7&FRN::3J^C) QLW=65G?E![[$VUJS\P8MY)'!K
MJ21*ITD57!6N&ADE&4N:126(D?P.1P%SV+C[72'6:U:K?")"!48.5:J)EY,6
M@>"F%YU\99(S^)@(@*9B?[=ZQ8[5<S/5.O)272,31LY:+I&V4@]$UE34JS8W
ML@+95]A($H%!P)DNEK8Y8SW?5?D%Y.]9==8#-^07766K_'S%37W:=;O XA-N
MZ@[+JZ^WM6:^VN(M'E*2XIZ&<@0>N:+5"TT,KA99%2'VLO?L?LGHOH[N=WM'
MKA'8;-+M]M5*PMM&NQ<VZZOJ-) -$S-5HI:W\.1%,SMO C.N..G=-S/LYU+K
M?NBI5K6Z+66@N5'VX750R_#:JX\$I&RZNM FV/)!K%*!B.5@AFXEC>=Y^-?7
M4]R5MMGY)5N6MAEK\W^ %$O=.UMTV0G+2T]8I86R@J"JZ6=Y<(4<D\/RS_&Y
MS6^R26/26'[(&0+O'6&4WG4\=*W2<H7"YJ!E9F(+'EXUE*R5, :V00?G,?$K
MZY[:_D+ANWEBNET:=?U^-PE6'Y1)18>"UMKOBBLI^TGR3MX[*6^,U"/*2W,2
MN)I>YZ*SCLMKJ@=?AG;'&B;2[FTD&IJZ"WB* =>U LE=8,&$J7X_/3"L^FQR
MR1I PB5GHYWI775?2.,ZWBSN5;,]@KUZ]K_&GCZQ.=6M"@Q9%XPF)6Y;?W_(
M![_D4,+<>(_H!T#W?UOQJQ==-;KO6*]NHMC\Y]2JEBCE:K)8P^;?NNO03U/%
MJE&1>!?AX<3.M:KQEV.KP>OMNKNGZKK+N:]K9#,SW-1"1 (!945;5MA+TE2L
M-C);N.JVF0P$2M*G13DD$C5\$+$KA_M;#Y[MZKWL;M@NQT(4DTVO"XK4-)H#
M+&+'R3 1P$V"B6B"A%_ZR6N=O<'HO^.0X6EB>CU\3=1C+=UM=*:KE)0JU:AT
M0#H!8%"X\?B5)$M3 \JN,SQU$:GLGOS3ZD;(]U=61(1:YEZPLT.R#"4O8/SP
MUVFAZXTU^.CC*&+.T2'EUMP14^^:U<C$'>)\#Y_USIN$Z#B'^P^C9.*&"I7?
MKLE8L:U\>5@$*:J?"<-5!Q6^RM4R*8F9.8+?58([,>/39Z-F,(M>5R5]MJ;3
M+=BRNS56-1H+MU[<G70I1@LUUY!B&R,E&^QP-O.L^Y<#V-%C(K'-6O6Z=S]D
MF8/%%[,VWCBP^AK+*U'9C=(2'G2ZQQ^GCK70 R$K%-(9Z,CA>WY',V/LK!AA
M,=2SN6QR:UCKZI#(5ZRR79RJUE!G; 7'M4.L,0MH24_!>0HY1M%O]?\ Y3>[
M>GS79Z^SJ^ZXKL+3M$S(D-=6!\JTCXJMA0,9D0(O)9J2'%8E/C,H5$!J>O$A
MSI53JL-0OS8AF7I\UKUDI=/6V0J"TIPC,I>?F893;89;1QR2?)),$6D[YA9I
M8%17?'4\;C>T>R,0'51?5QDY>;6-9893?9F*C/L,<'$I2)5XB8$I%11P&;)"
MPBF9YC?<%Z?0'=;_ +C_ ,7VE=3&HK14^K%=CA>D*P'<&*K";7G(MV7%1C'@
M-@N0M/Q0?^S9&L7"Q5M"4O8O9-H%3VU3*'86@$6JVHPB(54-%KZ.NC:0<XV%
M7OEG="J R0L1T:M>^W;V9ZY@UJ]C^N;ENGA2RS:V63:FL#B5,L;7N&$V&A%8
M6(*32H)'@Y)L@"$ACE[^0/;>Z'C,7Z__ )0].1GK_P#@B76"E5LW@JO^Q223
MD.!"H*2IQ*PM/M2P6Q8!0%Q"2K(U-URHQ5=09+05_=(*25; KPZ:*GN;F44D
MNHR%WHK0J*UF"H^R#RY'*RHJ96@$OC57S1?:6PLQ_P">?4>S9WWIFO\ !3ZZ
MG%HC%6J$JLR=<F*$K(HJSY7K92F*YV76#))MAE5:Z_B0/-WI*WZ']@.5_'_!
M6+M6$9RQE;:LLIRAEN.58LJJL<_Q#7_<#RA45 -L%5_=\K9<9;-?U5XE&>8/
MC=LC[F@S^K%+[XHM=E YY;BSMKS^"Z.>PK_Y%!G89"*>C8\8@" TMC5@5TS%
MFFDDEEAF=[AV&M[+[+B\W4SF0PN<Q>'L8Z[#(_Q56LY4V!-:#-)#]ME6RN9&
ML1J: J88;\!G74K-/N2\3E.CQ2PRL4^ZO+X]L*+)N^N;4Q%AXPQSF)M9%+X8
MU\^53R.#; @9]@/-;JV].--.--.--.--.--.--.--.--.--.--.--.--.--.
M--.--.--.--.--<GWEOLJZO[M\E\PRNU27)/;Y;;6ZL=RS+T0M==:FW& GK[
MB*QL)*YL-=!-'&*@3_D^)'31?&B.Y^>OL[!7LA[:LY=SZ48];W"M05#L-(E
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M*B^-(5&C<+S;X[">J>QFWIU[L%BID+.;K7G6/JBF[B!R"H^^N&S#E++R"0*
MJX20R7DDR*#B==9ZM[*>K/9CH&,;D.QX&I8;CF5;4 FRZN]D8J+'VH212^%L
M<Q*9)U=@*.?Q9 ZR>ZQ?FL@%V<W>Y#4=2U&DJ3JFLWP5S53T5I5V;+ VN-ZN
MOV$'7XQKZ^5JH/+]B=I0BO5'1?"^2AO:/649WMU#!^ELN'82QEI$,JV5,2^&
MP( PLBHY!/ 7!(NGQ5U@!0'&2$V3E9+WE[+]C]6KXWW'5\62K'8,;:A4L6"9
ML6I2TJ)DD8I%;1(H_N9(Q,F)1&M>ZVW6=7V;ONX*3KOL#LZL ?0!RD5J6^F
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M15NGWMZ=H8[T=6N=5IT;W1\+<<K%UFG8=>ONL6U,WW)@V?(8F1#%7@(*&-A
M/@=!B,FRE[4KXSV'VB_U7N-RO6M6HK)KU:B&'CU5X\MB".K^;%'S\ZB%Y&F!
MG=8R4VT?;6 CZJQW7>I.-,U6<V@" WM"8K2S\_7G3_&^JT)$$;0/R%>7)" R
M-%^)T;)OA1&>WE68WU3VW ^W.P>U>N87'4_6,X]XQC\Z#6I"P8JGZL5_(R7N
M0WP/<'E,B6V!(R_*8\,WWGU5:]-8/UYGK>6G/=7S-8[5JC)N:A*9M[VD7P#Q
MBI@+DT\9B5A(1*PX[1!>M=#G8;G49:+-OT8VY-E (TET6<3>K6'_ .:H'=!%
M*VN>4)HHQ2R)V1RO)>U6/]L2?W=!>Z+'LOV)5Q';>W6:O5*G7*6]-%(D B;J
MQ@'A:*>5JOYZK#7261+6N-F*W=,SJO/XY=N]=XO(]LZHK%V^R8;-7EC8OO9$
M26.L.@!%]8S'>Q#V04RJ#99DS@9'AQF.TI-.'V1;]6[0<#*V>,R)EUG*,X%]
M]+?Z*]9<&AU)]T.&% ,45?R/:Z!DAA%8V<89LL;IHG1[SH^);T_J;>^="KV<
MFC.Y!(6K54S371U\7+1:R-8K7D9<)*084^(%(_\ TKQ8HBA]N=D+H*<ZCJN*
MH=;P@U*9JJJ>@&7RS1H.:M"Q]>(C'L$G"</>R63)E%8P>LF)]F8T%*?)V]E9
M<2Z>3)04&6T:5CIY8,EH;U\,M&=36][]T*^%-M)60&0AG2Q0#SMCD='(Y%Y$
M;&8R_=/9V%/KV?H)R8'8RB[K9MUYRM"K6EC$V1K5ZT56IK+FRMHUI.'+ABX:
M$3KSK=DS?KWI5G$]OZ]5165BZ]'(U0NUKS5MM7;%:O:6FR-AO@-YC_V[;_U9
M2V( >4L.8EOZHD?9:V2T O3IJ\JNK[X$@:VTBU"6#:T:*T_+XH:N#L11"+*%
MLA(#%CC>CH9'>Z.7V]0>J/>W4LAZ\55HKK4\&EMI07*C&8]]@H\EA45:5HGW
MA.T')F[2Y2&[Y+B!P-.=B]9=@GV*#ZH'V#MCE(^WA\L"[8T*KDRH;S;5-J*3
M4)D%Q64N(+<I62(*=YB-CD;?*MTUKGRWEY>_NZK-[(:K*;70G@/'2]I+Q^7F
M$,KTE'.P4;(9G-B+8B^SW_'\O/[T;/>M>R]JHUZ.*%7LFM%G-5?O66L31>4+
MIV2E[;1%8L6(:$0()% R<L& ,8C6U[WZY[GZXPCTYG(/=ZXO&NG=''!$VKBW
ML;>9":X(D<=1KN%Q\);)LXBN0@63,70I>P+;*T5O52QWY!=S29JMR+I#Y9*^
M;,5\Y5,7*W/VLI558B%ULDP#)8HFD"Q(YD$C6)*QU3^T?5G5.[#6[IA1Q[:=
M"S;N9ZM62(M&PT5M6@K%9*3JJ08A:9!'QLM5S:N6RHAN#H7=<OT?(%T?LK+-
M&M7K)J8)]HHE;:J99-B\JK8>]ERU8/G6@*Y0:4,4-:8!;(U9&UJLQ=!9,BH*
MLTJ()#V &%&:"\*A&&'DGI@C;.2&&2[CJRH(6NF.'<A;(7OD])%55V'1KG8L
M-UE3+9(MJJUTWO/ 1)J78F5/L+0!2L?*$R)JL3,C^,B&\[Q..Y+Z;W/+ULA7
M:U+,J)T@!G.JJ\VNL+5&NTW+BRN$LGR@580(I)PL+@ B6>GZP:[L.Q_81X^F
M7NE@(SN3TIPA(=Q4!B$W1)6()J,W!FRY[Z^LI(,A75JJCUD1\PUHD*MB:"D7
M*E94P_7X'$]>JL1B7-,H%:1$ (HEI$[Q3*PY%\ 6PP9%Q&-=&TF67K!MIL'8
M@ @_R*8DXB!+A)[D0[Q^,G/+C$;Z[I>>>MKIQIIQIIQIKGU_9CY X_QQ\E0N
M^>OOV#>.OCEVC_HB#TEM.J[/I$OR;[DW =%N=#N,L&F/R&LCT61$K;+5EM#^
M42N&GF,(>83-'%!].R>JXU^4Q4XZSC;5JI]B6@R&PA03("!3R(>);P,;_)3$
M1'&(F9Y5WV?(IQF3C(5\C6K6O!"B7*O.PH@I(?Q$MQB)*=OB(F9GE,[1QVU>
M%^V[5[&\8NIMMW:/JQ>S]#3VQFHBW'5*]':M7LT]X-4S7/4[]%JY<0030P"R
M-$D/GE6)[9)/C>]T3(9G44ZN6=7H2$U!*('@SRC_ &QOLSB//YW^=HC^D?ZZ
ME^$?;LXM+[T'%HAF2Y+\1?W3MNOD7'XV^-Y_U^/TUQL]F-QUEY>>5E[UG)EB
MNQLIW3Y'X:R"/T^6;BRX;OMF?6Z04J@T5.V@CV,-I5B?8GEL(9(5]Z(BR.E1
M:'[A@<1CNN6\KGU9AE>S=)D/0JT*T,7Y!VAE,H>Y9J8*VA)# S(3,>/B6KE_
M\WD=O[QC_4[L6:J75D8PZRZ9*$[2[M6NUUF!:DD_=/(+L</^N!5Y"W)VK^8?
M![*TZ:S&S[PJZFPTX>%I76];F+&OVE_45/Y*HOGUP.I3Z-5;3U]<XV"4L-[Y
M)H7>HQ+U5'OX?N=[J4^T'A_7#+M3S94F+E@DJG+_ !-K;S7VY3)R*)"#&8AH
MGY1XD,:L/$92,UF[6*L)QE+K.0F9(++61,&"IFO-NV(D9$NQ).DH$*_E(2)(
M0!'JRG87:]V4%1YVT_E-1;B$/M;FELLMGDSM[BKMMT#F*X]32(I3'U0UA)8#
MJHON2S%C?--[49ZVPGUDBR+,YCZ] Y40I9:3<>4_=F%D1@/$1&):N:[Q6[Q1
MS-80$S$:M;UEC>I'W7_%8VU8;AQJLOTV@TEV!?77QM(\:5&9^:)%\+GQNFM"
M"'FPBY?W9@!65H$3;C6^6IHS64]'?R[XH:ZTUO6U\U1#J+300 WX&:,IX0)(
MOQXY2QD-C1PLB.A<QOG@NW]LQ_6&];PE^LTJMV<@:AKP)UC(UCXT3#5,=#9;
M^V?$36/P[<9&9G%WM6/Z=9L]HR-G[J)H%%LEUF,J4*/ALWK29JKFNXN9F9-L
M-5$*"%L,>1[S;/07G9P(P%'D)1!>PNOPKBF:'=_#=826IN/>0+*8(&%IX;$H
MB2XG0R1HQ$DD,$#/D9Z>^+H_$^HQ[1DTX;KELK'7NQ8ZGEGV2\B;U<D,L5@5
M+8.;"A7P"!2)+F#.9D9@(W_*[JR,WV2]G\M?L6<4Q%[(8S&I3@:\X2]4\U*_
M]F12245K*:SPJ$SDYCAEK5+XB\HY4_*OQ@\][WMLLGN3KW7;727MC5W9P^&'
M/N<O6P[0\EU124JA_9JZ,60B&0<<=J-9%\;6>GM:SET8OI[,9C:]7!K78Q^W
MC!J)!L,.&$LN;5QLQTM@Q,BF3EG*)G?4N/&(PH\?$M 1"U\HCC&P#Q4'*=N7
M$=A")F9VC:-8H]N>)W??6MA8GVW2'9F?S")(? 784%K:0U-=*YDXP]_?!5D%
M1#9CAE0*1Z)"Q%D1R-1KF\S;F"S% 9.W6<L(B)F9&=HWVVWG;:)^8C:=OG7M
MX'C$28E^D?TG_3?^O_K_ .6L9YA"AGNC('FAD8QLCF2QO8YK'M:YCU1R(J-<
MUZ*B_P"Q45%_Y>:J8F/UUYZN/3XNYBR='M@I 277FP*RM/5BV Q&@GLJH>F,
ME;%1#G):*TK\W#'$YP[HYW*K&+[D5.?"SYV/KB,RS:)VVG:=YF(C?^L_'Z1.
M_P#Z]8"LDAF59B1%T6E)6V2E9PJ181B, W;@1Q*RD@$I,(D2*(@AF=L7C#X8
M^1?59]%Y,=I%KU7UMA]307NUK9-I;9+?Q8V33S46TBBJ,Y\5\/( &ST)%?-'
M// 5&P>.:5R-9,ZG7<S3<D\C2>6&L0R'D)A +3QV8+H\HLCS!)+&!!D3^4'P
MC8HWZJSEA%PMO%!Q_7:?F?UCX_I/]=_B==.V3V==V'A9-[EKV'38K7U-44.#
M':!S?S"H,OJ4VRN_S) -M^$W-571'**LDR,FDED@.1DLC7";;NOJ_ ]FH]=C
MJ..K;8MI_4:+24BD$U36+3KKD2NB!+0L:Y&$P7$_(/"=Y)7#ZR7NQT^ 'P<&
M2IA9%+/_ !)DPVF99$S#)F9\D3L<%&O][?[RN_''JJRVO7?7TNQO;R^RX.IK
M6V<&?J3QYB+&&Q%04*JBBIA*,&R'DDD&3X5"=-(02V6'VS\*^QO1>49[ #"]
M^R"78FES.EQ>7W"KS&ZK$@P2WEC>:R/D1@:8"!(#AD9)=]ZCT+!0/;LEC,8M
M ,*GYI!-AUTS A^KP3)7)2(0R*7Z[1,+,9GQ%\>K>P^B.\OYKU[0TCJWLC$5
M-3;0532M998JBK-W% 96V<V@]+6.F.,%K2E@:3ZACO2-TC'?(UKHDOK_ '+J
M-BKV+)W4L]?UVA]HV3CQR;)5Y1(:U)DI^Z@.:S-:A$XDIXM"=BU*NW?R"HW\
M@O*^K>QNST]AH\(MT:=JA7>=<]HKW7"N9H69B"7+F\&2L#3N?&1UEM7%4YV1
M Z9WP$Z6 F<K*>>N+ARA-_227(&B2EL"FI<GU,P4#*:<,2PKYR?>2.2XA XX
MY%YSIEK&7RW=KOL7HQ$FNYS'[PYP+;"^'F /Q6V":;/,=8@B%@Q8IE^\3K Z
M]F/]OY*G?:I9V*MB&BL]V#_<9P)S,D1",%P@YWDI#<IWF=:?MYU%U !V!K<Y
MI>Q)>L<[B]"09TR'UT?=35>O%U-5?T%%F[OL"L'&UF8:FYUI(E7\EE((0XAD
M3I&K(K4[MP^?[ICL-UNLW%ONKR,5YR'YA3NJ7)P#E^!H&!,D8F3.1,A"8/QE
M$ZJ#*=]Z5UGV4Q?6J%?']ORJ+MNMYF.96N9A8;MN$RLVL8M R7:!(0 QX063
MI*?C8_\ IT9?'>8?AM5+F-769S(&=KV96MV65QW6^QO3)NE^Z,Y@0]@!9NMM
MUKK+4X29+R:0:Q+@*L6%$ME4,.%C<[IMA^&[7>J%D;(8S+6;!UL:N]:MUURL
M@^RP@@5U1"LU<4Q:2$%,BL./DY1K69+*Y+O?>1[7GZ=#_-X_&!4L7#J)"[:=
M'CA-I+_.]X5K"H=+%,(C)D;P1+&"UW!<N#6ZTXTTXTTXTTXTTXTTXTTXTTXT
MTXTTXTTXTTXTTXTTXTTXTTXTTXTTXTUR\>:\HNA['[CPY4U58W^F[2V4&< M
MZUM8E@)7WTT%C75!LL)@8]V(#(^* V98_<Z5)43T1?3\W.T)9B_>6;[Q80V>
MO8VT46I4^9)9F(_7:P)GG*B+9A( 3"1 HF(DHB8_[&JT.Q^N6=5O5\?FKUYI
M+34M3]:6C&XE7K'&TQ9")GQV=PX\IF6#'ZZZ[7I?&2W#<IFK8K//$)H'[NQ*
M&FNUQAEP"37348VN$4"A(KQ;;XXS(B5^5\LC7L<OQR-;N*_<.V+QR\YEZGV_
MM(L%CU!$JFZI)\X?-4H)L&2X*5RK\1 9$AB2")X1SO\ %;JYYFITWJ[;V*>P
MJC<J;*[K4XL7H8N4U\HL5TFUQ=$#94\Y9)2#^4 !%&46@=5XK)V0EIIM?H,:
M+731;6ZT+;.V/M@[NJ!$HDQMLP<<!T[[-_O1\4[X1_=+\S51T3F4Q@YN=K['
M7=3JXZAV)S(BH"9@ 5(,/SG<6,DV1A<P)#Q@V_B*_P#K@^Q\Y8Q'2.I1ALIF
M<HSH5>M*,M?N#<<=D;E=*ZAT+0!(RV7SRF4L): A_E3LQ)CB^S0 X&AL3.N>
MRM=J<X*^UJ,C3G49$6<@/.@6:SKMJ*7+436Z*(6LH\C845CHW?\ ,1SD6^:7
M7[O:G'7[5B<51SZH58L$5F9M0M1;0V@$>18R)QQ;!S&\3\"4QN-'>K\WA_6O
M1NW9/U[VIW8.NTT/7CJN138KL3:$"LV1?Y$*.PPQY;%*AX\=C@=]YQXA%J,G
MILUH!]#2[B.KM\Q8)G6 7 [[!T\$5L>-(TP#ZY8,97H,YGN17S*J(U?^2VL3
MV?/#ALGB0ISCYR%"Q6*TU:&G7#EP%U<^?-+^,28M"(D0B9DA^-?GX*NN])[;
MU_MBLM5[$BI?QCQIRIXFX& -NR(@:!EJQLE(1^X(DW=0\C&8&_\ K;;4+(U;
MT),9E]0M&#G>CX[9E-+9J8L->CFU]1%4V.<J7' .):\U@_K(GHU[O5SF1#UO
MUKK5AEX^NVO\ID<;3NM=F7($^ K1+.0R\FHM6B%_A)*9:8HYLX[JVU^C]?L'
M;NM]L=V[(&_$]4RSAIX;K;$#+FM-*V>12*F[:BCM+8R1LQS$/(9D$'KW7D^/
MQ5,VY)N3^M^YI)IS;"IEAN=G"10WE\;[*'2,.FLZ:X:-FHFRQ,G?$Q[O3W/6
M21/9*^D]R]A=GSJ,+E<</9/3.1972!-<NEX<A70E:[]2RJO%K&3%C:!FJ,0$
M00B)"N(G0]N=CNC^NK7LKM/DZ_[NNFUADZ;EY2Z3+^T4FKEC*;5S6<!A5=L!
MS,DL(,"D+7UG3^!VY@MR+VK&'C7=;4F\L-,!-76LEO\ 58@$]%#3-.26EGIE
M511A&+*HR LC:Q?56\ZEQ?\ +;M71:)]<K=7Q^8[E5[=>Q*L>=<ZYKK- E!;
M?;A/"R#/$D[=IBUM>;3\DC QR@U_TAT#N=BSC&=KOHN7^MTLMD7J<+42:6D<
MKBF!G*?'S9%>J!&"!^%A,QK'C6GVU\Q2[FR2SN00ESKRY:N$*XLJ6IF(DKFH
M?, ,4?/%(1*L4\KG^L36HDCF,9ZVMT+#^I.S>T<QB>GX&S0Q.3JU;(G78Q X
MFZ0K$K*UR\4<#L. AB. R0%$*F72.N5^Y9+V$?V.J9WM(V,C3I3)UC2^ O5:
MKJ]RE.XJ\K&O!C)_=$9$*X@90/&9\N2CO,Q6G5U(7<Y)P6&:51$Y6DHKW7P9
MZBC'6M4%^I!OW,20Y!Q93H(X"D%D1D;EE>QRY7L_JGI_"=8P_K[(YY&:'&]M
M +2;#W)<GSP Y!2UUCAIJ,/,?B%3E2S:&1R66]H^AU=BJWLIV/*XBNCMO^VV
M7ZEB!5;8ZS<N/FE9)$<RKGN\5H*65R\$09<U;2%^L-:=7U^$VC7:76%;79C!
MAV!^OKYD#!A.#@NXQ:W-UT<C1J^6WHQP'/)/F(^Q(\GXH(W+$SE/V)U;N9>\
ML3W>@G$J]:LR#AIIQ9FDI2@QQTK-UE?D^Q-.P=EA156G^\1EW"9&Z.C'ZUS*
MLM0??LO][MH!C\F.50-FNYPG-BQ64JHP:SYDT0H-[A/%20*.(1.]K]RW4:BS
MJ,\(IN4NZW-!Y8PJS/L2L[*' >9;YH^PS MV)5%K4SW,SHYF2).BSR?Y&(YZ
M<Z?Z_P"O_7/2.@]D[93S%2[F>RJ:>-G'+,W*!1*3<0-HD?\ ]P8H6U;!41@,
MJ5$\XU$/8-S(^Z_877_3:\+D,#UK#@M^4\Y+JPRD,\:Y@ -.3K)W($R!MA9,
M_*(D2*+7P':[&"DQWU7%HM34#-"L-=&-5:;&WH,=$:);19.B=./*RY/OE^V*
M9-)$D;/[?C<KD>VU,%B\3;Z?5]7] RS<+>=BEW9I,\U7*-O);7LL7#?-#17"
M_*@JIURAJY%BSX!RU3TGAO6G?,?E?8Z'9#KAY%U:@1V5W:R\6V7 'RU+ELXP
MQ;I.O;ABH@U.3!&83$#=AV6_04@>_&@VC+<T4N76Y8W  &!QUD,AUY9V%=7S
MB4XH]5<%1A_5K&E&QL@EDG0>5KVI#O65NS1]=];H]5JU,?G,CFF4W*O3::+I
MD7>=EL;$E*V&*Q^N8>3G$3'DDY6.K+]BYG,!VVX[V.Z0KIJKLH'&A$DFK7:;
M!5B[5-$29"O[!NG)2A"SGC(D,S.IG-I9[?0U0>4#_#9G2#$A@ ,D*E+JQJ81
M$M='<M(8 HT]R>*0BJ*+##]DB%&M;'+\B2GK8=9]>XJ8["E?8KF/RK19>JH&
MG)7X:3XQL5G',L573,"33@A(I7$SOMMY_P"Y?9ONSM60QW3,J.'Q;L0,E6LW
M8M163(JK&TSJ***]QD0MVTL$^)M&0^"VV7?K&J8*;S=Z!:VR7<4,NUO:_-7Y
M=N^LOA6@XCT"O+*B:-9$_6LX8B6J*42U97S-*2=[V/@;SAVFSF[F4&J[$QU_
M-5WBR_6:V+NPMAX$FO:6 (DX>GR,("+QP4ID1*8+7:?J\SLX*G>G.*SN/FMP
M4Y=?ZTGR*&(<Q1SY5_\ ;;+@"&/+\/WW_7MHYK=6QIQIIQIIQIK0;Y#_ *4+
M2QIN_P!GA[Y(D]-Q^1^L.[![;ZR[4ZTP?9>%VNK)V]7V&QE?V)7T-#W7U[6+
MJ:J.=[8K:YA^-OQ-'2/T1MBXSO@"=;_-U8?-4(!;%L-9B/"0^0F94<\9V_M'
M_7??5?9+HY$%C_#693]DY-@, # BY0?P<1#0CE&_]Q1_3;;6Z#I0KN8WJ[(S
M^0E3UY2=S*$7%O*[J>SOKCKEEH-:'##%9$_4"A:*2ILJN(<EK#(FD0.F=$_U
M5GN6"WXHC;.,:32H[QPED1![;1\% [CO$[Q\?$[;ZFU&;I5 G(PL;NWYPN9D
M-]Y_MDMIVF-I^?F/TUPE>7?D/XX^.?<G:M;W'T5H6Z;=>6?E)/8P=5UF<"U-
M+5 ]N:TX+9]CU]/J?SY$78U0:';"%R5\"E5T#O5TKX%C?S-V' ]D[5VW(*ZC
MV@DXV0_>1:KRZNM\-!/CJ$<@L94(.)GC/\7R &$^7F$RZ1D9]:9\.^X$@/M3
M8$2E284SP(.6JKO*6G%B&&92$FM7 )D(WVG5?B,TUC068]?LC8L&[JK.VL-)
M,7.)H[;$3_CZP*F&S9$,^@KI,N+IH7Q%GP0RCA&!E1RPJL?Q:KK>,Z55S>%G
M(XU]<+6?MU)O<U2"<@H0-C?M1,?5!K(YNA>X<I8M@L%;.4T_\S@[UTY]J.LD
MWO ?]Q2QZ:UE,O@&L^RMJI\H-;:A**R*WXP4'#DR$',E!KKNNDZRK0J+L@BC
M@N>WBQH\:/=5TUSH-'99Q,[%5#Q3@R%@B@U(D\!$C"/ACF294(^5/[$MRQ_'
MOL>4R-*[DK@PVK7\.+K5K80AP2TRVBP/@6,3+I83SCRSMR Q+:=9OL+V/C.C
M8VIEO4E8>JD.*R5R^K()N.:C)VZB$E5FLI;W),B DM();"5C7) >2&R%[J^-
MP^/OI-';U^APE-?ST.?S$YUI#/4&7E,Z8V[EIB8W$B35QRS)$K'_  -<KG1+
MZO=S48C&]%R/<VX[M6#R&![%9A+7M\, D:V/>/E0V\IYDPK!)Y$2UK. *"DC
MB1F(]8]BW/6]>CV;,-"AVG$5"-[XN)LJ;7:GRP?BW9,K17,$N%Q3,\)ABP*9
M&(O%J\^-2]4;BDLZL_+;NP$7*Z@:SH2LA+;.>]T0-K9EEC0BVL9'H-' :]KF
MR3(Z2-ZL>B7QV'W+Z8?:N=1R9V6,HUV?84E35S',9*/$P(588$P1Q#41(S\D
M9;[SJOLO[$'!9;&]?)>3<O.01PQ")90DH<G<;#A_^QS%AI\9G/&0*=QF1&1N
MU=RY(N7;D:V83LNE H)+2^@S&H'FMX1+@BWH@;B54M +&@;#HJ<T1LBL]8U$
M?[8WM8C$J?NOOG%4O6=7J/K95[I_>(N5XI5+--@2-<)3<DH( 8 BZN\#Y@R&
MCY)F&1.\S9'4^F87W38'JCG8YF!RGF1Y6M_89 F26@#(B/(8-!JR#D.YB.K8
M=<UU-<AOS-C=4.86KSEG?YS#7<C("M)B1!&-,+%^TQE2935@A,;96L;Z-C<Z
M16M8WVKY].]_W*>0PF%[#6N6,3&2);+U=L360;H@(58AD<C$8(Q@>4L$Y&=X
MF-8??O1'KSUAF\=U#HW:&VJW6S,WU[5[E:K,CS"59]<Y,QI-$(93EW(M]X6R
M1F(C#T;QD\8O(K(D:O9^)%=B8*C>:;&EGW&*EQ[KPZE5AD^FS]WG:<"'39VY
M61[AS'N&^:1DT?HCD<G+[H^U_2_8L\76W,IIS(THN'Y?&H.)'Q(?()3$,CX8
M:RD9@#$YG;?43Q.2P/9,0G.8^/\ L&D7&?RB9F/GC(S'P0S! 8S'X&)#_P!.
ML5"?U%='F]\IV-2W>BQ75=%:_P CH.J7U+((M'+2'-DDMZ7;4^GOB&8&&W6!
M'%,5CW"L]()G*OV$@W5>X>N>^(K9"K=G&':>=8U"6\5K7&34J;#(7^ZP.+%C
M"O@]U3L8[SXVXQBKI53<"G^$FB,S_P#HQF!EQ1M/[0F0@4[Q/Y1.LW]C173
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M6-KG<L@^Z6.T6:?=N]5@"QB_,U\H4JP[R_5C8RXF1&37VG@225)+57@XF";
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M0K3O^*>MU5<P0BL^Y<Y.PL[Y\=I:6IC6*9#%),B,(5Z?$R"1$VM?JWL)??,
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M,@&88Z.!<6&1M(9.#@XF!+6TG]8>%["D\X^F;@F^RTM77Z?9;#2GYDX5*]@
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M0V'WZYG5?%I%43Y0(&SAY(O;J^VR-)F!<'H18-(OVH:FW?8XJY^:QQ5101R
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M9&YW+#U%7 &IRJ,I%6-[P!3:9C784@X@?#B%<-$>1&0RPK) E5NWWI6$\C-
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M;%<DDD_]2]5=A?\ )]<[^6125=MF^=V1AL<B/\:TTV\($S6$IF8)?AEHLAA
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M8E1D4L 9CFWT_P"].S8KM.$]D.=(IJ/7&7HUIJ 2Q:M[>9._,UJ9P"?$HHX
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MLK4WE6D=XB(>D&R)1,P>1GY7 JRU@K%N,VWMFE7L)D%D=3V-93=E5)%AK2[
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MJBH64TAP,M5.(P@E5(D5[4YG8ZQF,R-=?KVHO!^I,9%HA-F1EF2NV+3+"IR
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MT\$T*2/?&XD9899!XO=SDM?:?8_5NSGFNL5LS3NQE%WF2P.*+CCBN^O8J";
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MR1/+A=/[/>1'&^7E-_R4Q??NZ] Q_KW",79DLE3"FN(AN0OV(K0#B<X5J0H
MXM>KXE:E1([Q,:S.H=?13[:[M.2:;\TX#5!01"I2(9)I6M,D7$HCB+"'Y88P
M7^D1L<\(/%_IJU_=5XH^4?4Z4M$1F['O?-:RGH,V^K;9%7GCSV<!0DWI91 \
MAEN4)">4I34GD6)D<*QHB.DBEWJJYV"K@ ZKWAJR[C1#8][*7N;L4PW>$[0$
M5C($3SCF1;S\AQ*9!V#$V\/>&+5=M8+  Q8,4:OVV!S4P(.(Y"T-CB1^)B=]
M=PO+1UIM.--.--.--.--.--.--.--.--.--.--.--.--.--.--.--.--.--.
M--<LVS_5)Y7;KR=\ENQM1A<O-UWN.^>P-YAC:'L\>347F6TW85EH*ULX-W;B
M@T<9^=,2"P%D^-0WL:X/^][U95WL;I_8\Q7C*=$M5J?81$@('#/B=# (/++(
M%AK-6^\"(\604P6VT:J#->A/5'9^TO[CG<>V,XU<"3*UAZ"9'&19!PIR@DFQ
M/$B+?X^=XF9U:G;_ *3O*O4W[G5^=Q@E,H==&XC3=DU>N(E.I7$R4ED@QM/"
M^%P3Z\%Z#)*L0\R^D#VQQHC9KU!G:!];+Z#WI>(L,H2UE*RBN2&H)_#S(CZ[
M$K."*6&-BPMQ1&^X<R@AY [-_$OMV6]D+S_65_XGK$\U,$\D=QXJA15@)9N4
M3!%E6%*-1L<01)0#H 5C$SH/U">8%)UP?4SY/J^XVEC9+3!&%;P2$',XV4L>
MQ)(!DAK44RY.,=(A,\S)3'QQ1M9*U$;[99[>NY3L'9<=4Z1DG+Z%0Q*V-#@2
M&Y#+J":RCL#)G":M>OLQ%:O(U/.QY$C<YDKA])>G>Z^MO7>3G+5:%GVFQ+ZU
M$S,&5:]8H\@+B=A*?-9_-YD$M\0* 3_ 8'R]A_I9\D8M5!<=49;KZO\ EH8Q
M"[2P[%GC*KKI&K(V6@4N&RMQZ2 ID<BP.,;(^1J^Y7^J/;$O23NW=,Z1<QW?
M65KN8&X5BI7A<LJ,CDL?%D%P==;H8H2'D(R*YXG D<?/E[(_C>BOA?!Z9I*I
M98[L66L9;:IH,()WBC8G[!H$6$7D%D%YES*Y*0XQ$!L?TT>>]P=+=V@'4LUU
M:G-,OD$VHL%/++,SYK-:L(NNL#1ACK"1TD;"22I86JK5D?ZH[EP]67ZQI]<"
MEG$+=EZ6(%=)K4V"8BV"C"N$FJRL)KU2A<!LH8E?Q"XD=YB/M3TA[&[[DJO=
M<9AJ=;N$/F&UWY%%C'S7$^4B:"H"+2MS/-TS_:0;_,S&KB]6?IR\MLC93D::
M'-'TIA(3R<I6;VB?0O-BBMAPM25#:TI;3#LM':3J/721/KCE)1Q,;I117Q4C
M[[ZZ/NC)5\_ADTL#V1>)V?8CSMFQ95 !%;99K)060 (9<"1<KA.PEY#WG?I[
MT=F>B=%9USM5'%7F97*M?<2I:B77$QF*[4?9%B#*G.Y DZ[5LYR)1&W**U<?
MJ/\ ,:I.O:7#!=?2XTN.."J+TVQICM+5NBD(D))J2?P"#UHUN\TELHK8FQ)%
M/Z^GS(DB1#I/K.O'4V7NZNN(]B$?$UT;34XVU6*1GQ7%!(FPU2M1+,F-$B'8
MU\?[M77_ (YY_K^7RN+ZB^M_LE]654RO0#[=5T 4E90P$P*@>]SR93%:ZX00
M,$9;&XVHZ\_2]YLTFQS9FVHNJ-;AZTE9+O.6>\)G=;Q03#RUOV!PR*^IM$#9
M GO'LH#A2)6QOD8[X_1_1_N+$^INU^G#ZQT&+N,[R2H8#(DC(;DCM&]^S+["
MJJ_(Z&!2"LQ^\$))F=XCGI7U-[[]==RM7^RJQ62Z[D;4%;!EMQK,9V^RU=0?
M"EEBS*U"++/D%(<OVCY2,Q*T_3I^Q,/LVWUPW3WBCV#AKG9Z-T?7.K[0LJ0;
M/8DB4.;&$T9X6.M0X-CG#(YIB)D#;#/%+\*-<J-D2C<CT6]E?5N&ZU&=M4>S
MT$@-DJRN"[C%;QY+$RPX>RR)F!-+B:H%<CO.^U@=.]!]:I>P\SVO+=7KUL%;
MJ"%:L%H"E#3W\XI),)\-;80A2YDYWYS/&)XZR([F_5IYX]OV^HP7\>Z8SO3V
M@I0\P7,_9#VLEG1E9.H L#2,]-2N_&::D*M+NO F D$'^NZ N1DD\ S8JN]:
M?QYPO6\-&:SUJS/?AOFU8B9?70N'0P8\H&+G^7BN2!W(@CR!#I%A1/0O<J_:
M>SH#"X=M''54UJYHN,5%AR[:C^8*O,2N%PL!B# B+D6\#''EK^.I_P!/7DYC
M7B.U.6PVGCH-#17- "7W"?%50DAA&Y\ZPE!ESUQ'92_@RV^C2D1\B1+'[V_(
MYW,CN_KGO%JG =,L5*^1MT[5>VT@_*%L8#%0IG(# IV."(8_'G\1OO,5UZ"]
M=97U^.0R'>WV[_;KEKS.L?8Y5GE$2(D->!&8*!XC+7\W<8%<'"@!8QK:?IP\
MI='V;;=R9[KWKW$[R?-P9RH-I^Y3FC5D<P-Z/?FP5T59 #&3=?DA8&M9\;(A
M171K[OD]62+H7K"]AZJNK]VR1Y?I;7$;Q-*QL;P]#4E#=SDN K;R@H+D31+?
M<(VV_:^IGDL7FZW6,:W&Y;L:WLLVD7Y0U-F%@I4C'%T$%E8<&PLE0N/RXR9'
M,QI?TZ>>8.5?A: C(MSMD-EK"ZDT_8&9LSX=&*3\^@3/EAY:(H.H=)7BK%[G
M-+*8][2)GNB@='?O7U]>Z[[KL^V,E7KY-50GIQ-=/EK@JD(BBBNXIP-2UX5.
M:W.A9&#)YH8,F<ZH"OZ![S9];?\ EU5=6QF'N5JSKPN([+(RB_A]C'&AZ/ D
MQ%4)09PI8CPE4CO$T(O].G[((ZH;.4UIUL'6P6K=-(2WL(4=QUT(^2)(9EEH
M+0NL_)C&3>XR!TLZ->YKVJJ->Z._Y!J>\93N6(PF(H+RE::[*T##E0DY0;A
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M.22J\DY$P+EN)1^L3\:9W]U?@WJ-!1YFIO\ L=]IHKBLHZUDW7I\,+S[8V
M-LLJF*D42D$-]SE3T:G]>+7HOV!3K,MO37A*@(RGS#^@Q,S_ $_TC3'>W?7F
M6O*QN.R26WG' @ \MR*?TB/C60GESY'^0OCI-C+C"=#],]H8+;=F=(]-5]QK
M?)+;]6:\7L+O/M"CZJH%,R-/XM]L4R8RGN=."098,O7G?56=8Z]\D4;)Z^PN
M+QN3A@6+#TV5J:V8% ,'@I<LG8IL+GE,#,0/#;?;<OF=I7F,ED<;('7KH;7-
MJEQ).)9<VLA<;C"&1QB2B9GEOMOL/Q&]YL_WD#38+?Z#O<WK/K77=*9FQV7?
M%)B>P-#V5B^L<O!7W>IK;J;<:'K/J>ZM@BL#4):$*_/!J-)\T#$G9$PB;!;C
MR.RM>.AK4O.!3) ($PMX&8X"QD1/.>,?G._Q/QOM&<N^(5V,ORI3D#)-@3DQ
M =I*)Y2"YF.$<I_"-OF/G;>83K/.OQ.P^LL\/INY*8#4U&@ML>=5P4FNM/;N
M:6MDN2^O!C:C/'UQ_9)%1$\H+.#S2W=B,QT@@LS&JJ>Z>OYFPF+"D%*2&"B=
MQC\)G:#VDHF W^).?P&?B9C7@[/8A#I0UPPV"D9C8I_*(WX;Q$Q)[?,!'Y%'
MS$3KW7?FOXP9_&X3>']J@D9_LR+43XF.CSNRT^ENAL+8?B-\4N(S6<MMK6"=
M>W*H#H93*\>.A.<T<]P\SFQK\KP.6:]E<4S#%<>>Y"(QSC</S(H&><?(;%/.
M/D=X^=?UF<Q2TKL$V)6WEQV$B*>,['^(C)1PGX/>(X3\%M.I/3^5'C]H][C.
MLLMV=2:[:=@Y&EW^3K,<-<:X.PPNEJ+6^S&Q*O\ -UMIG:7+ZBIHS9:P\XL8
M:Q^K*T9\KXW-3R/$9)5=EMRB!"SD"DMAF#&8@AV*8*2&9B"B(F1WC?;7J&6Q
MS; 55-$WL"#&!W*) HF1+<8F($HB>,S,1.T[;[:^'8WEAX\=2;NKZU[$[0I,
MULK.+/D/K2!+LP//B:VVGH<F?N+^LJSL]UY7:J[%E$K";XNN@L"(9(QWR.8Y
M$_M7#Y.Y7FU621HCE\[Q$SQC<H")F".1B8DH""F(F)G;2SE\=3L15LM$73M\
M;3,1RG89*8B8""GX&3D8F?B-]4:7S&\>9]EI.M:+L:GO.PZ!NT"'HHAKT.ET
M&JZ_J+"XUV&SF]GI5P^AVF8&JB?RM37'FVE6@A*DC1J+.D?W&#R4("TQ1#6+
MC._Q,P)S$"9!OS$2WCB11 EO&T_,;^<YK'2\JJVP5D>4;?.TD$3)")[<9(=I
MY",R0[3O'Q.K2=:>?_76ER5EMNS*IG55&'B?&G35Z1V=SV!;Z&_\D.LH>QJS
M$9S-YO'1:70WE$CY!8XZ\,LFPB@D)^N.QCV-S;77+2G17J3YF2QXS\0$#"&<
M),B(N(Q/Z_,Q$;Q&\ZPZO8:S4R^U'A7"T%'S)S,N#G B(CRF8_3XB9G:9VC6
M8?7'9.&[=Q=+V'UOHP=9C="A_P"*NZ]"(XIIJFT-H[@$@4R 4^NM:6\K"0C1
M"8H2@S!Y8)HV2QO8FDM5;%)Y5K0R#QVWB?\ C$3$_'Q,3$Q,3&\3$Q,3M.MU
M6LHN(&S6*#26^TQ_PF8F/GYB8F)B8GYB8F)C>-3CF/KWTXTTXTTXTTXTTXTU
MK+\@_P!MGA[XR=OZ[H_M.YWPF\Q'X#\Z/2X8ZXK(_P"29BEUU9]:RA*CC)]]
M-?CN?Z(GLD5S?]K>0O+=]Z]A<@S&7B;%I7'EL$S'Y#!QM._^A1KJ+UU_$#W-
M[2Z;3[WU-&// 7O+XI;:%9SX7MKGR"1F1_<4<1_K&T_UU9G_ ./+^OW_ .D7
M:7_LSLO_ /-YKO\ S2ZG_P##?_\ 1S_[^IK_ /L ?R(_^UL5_P#=H?\ S=9/
M]I>5>_M"_"T#QJI\!;,\QJ_2Z?/WO;R:JMKJ3)5'3SNWZHHBLRZOLVVEK5^V
M!T+E](9'_P!57T7EL=>5C,OB6YIY.BF"$L& @8(H<0P._+XC:"B9_P#5KBGO
M..SO2NVNZ3:!$9NKD+5-^Y22Q;4(P; D/]T<UE E^DQM.OXR7F[!E9>U,)Y+
MYH7(=S=3=AX7KUN8Z8$W7<<7<,G:6)-WO7-SU)F:C'1]A6!MU0YZ]=8U#Z^>
M2C;G;$F<J2N@4[FP=@)=";&*.3HN49\F\%>+QG '#"DN$1$D'$N4<^8Q$04\
M=1U.=A4MKY08"ZE@!Q7S9Y/(,F$K&!YS,Q![CM/'@4S,C'+4Q-\^/' 6NPDP
M=IV7H-+V3%V?_$^L\OT7W3H^V9C^E+W*9OMJBO>MJG!DZO&Z' 6NVK4.!N1J
M\A8"/L0ME'8^5OB/7,I),@H4*E>/DPFJ%>S8(ES!R?$A.!+:1F8WC:=I^->Q
M=@QD"N8EI-;SX@*FDS=4B+(D(#D,A)#O!1$[3O&\?.HIVE^Q?QWQ'64N_P K
M<ZSL5Q_29O>E,S%=2=O;"MHL)*S1 9[6=KD9C$V$_4F9LM-F#P)9= VMG'DK
M;!9(V,KCWC>M3K&3L6_K.$%;6(5/)BQF3_&2%?(H\A0)1/X<HGD.T_D._E;[
M)C45?L*(V[HEL<5L*(#YB"9Q&?&,D,Q^?&8XE\?B6W^9WSZZJUN7<M79V-?L
M,V)TQ!V9:G]4=U6'4>(V?:9_3[(^MB.RJC%39@S=G5W<-5+7@0'33,A.@+)1
M@;")&?UO7+B7?G$2@Y;XXABH88KAGY\)+E 1*RWF8B-XD8_+:-%]@J.5^$S#
MAA7.96V5B3)7^'.!XR4PP=HB?ZQ,_&\Z^767GYUGV#F6;R^GFZARM5V3YC8G
M1P=HXCMK)6,U!XDZC6UE[N*<_58+*UPM2S(YR.XN4*;\=09(91NE?;U5B/"M
M]<M5F_77'G<2JQCXS64;V!&8"8$RG?D7$=O[HXLVX&,S_*O8:ME7V&?LJAMD
M9\@L&=JY%$E$D QMQ'D6_P#;/)>_,"B,@>E_);J_OBPT]+BDWU1HLC79J^N<
MOV;U3V9U!ITR^T==LQ^N S_9^4R=I:Y?229NPC',&BEB80%./-\1$4D3=;>Q
M5O'"#'^,E')1!+8M@\AVY#,K(H@AY1O$_P!)B8WB8G6QI9.KD"-:/(+ @9D3
M6:RXEOQ*(,1F1+C.TQ_6)B=IC;5OX_.OQH_E=_ES]G?4(>>7M"&;L33=<=CY
MOIJV-Z2K[NV[?K,UW/=Y4'K'26/7-;F;.>RB"M)E;'5'K%\OX\WZ^3/7LKX1
M:*Q(B\?X"8$V(;,0N25!2P8.2&!W&/[AWVY#OCQGL7YB41D,#S_,@,5S*HF6
M0+)& *0@2DMBG^TMM^);0C1>>G7I698;U]3[./8P=L^(^/-Q/<75_:72N@*Z
M]\GO)SK3H&'LK.TO9&4RMOH:( ;9'3P3BQ2Q0V03!34@?(C'9"NNV8;QLDOP
M>&R4$IBVQS0@W<"D"*(F>,1,3^HSN.^VL=O8*TJY5Q/S>:N,BP&*G@]X)YQ!
MB,S$<IF)C])C8MM]>+._L%ZNKL+0W_:0>LK]1<V??)QF<ZNZO[5[==E^M>DN
M[M;U%8=E[!.OLCJ",KEFK2"2$$G)"UTTT_UVRQ"D.A^F];ME8)=20E0PF()C
M%KY&U0L@!YD/(OF=HC?XB-]IF-_XOL504"RW!PTI;,B ,9Q!327)EP$N(_$;
MS/\ 69VWB)VS^CDCFCCFAD9+%*QLD4L;FOCDC>U',DC>U5:]CVJBHJ*J*B\C
M<Q,3M/ZZD,3$QO'Z:_OC33C33C33C36OGL']I_@;U7N-7UOO.]OP6TQ%[8YK
M44W^F'<EI^,NZDAXE@%^1INO+&J-^N1&K?D'GEA?Z>K7*G]>:1_8L-6<2'.V
M:$S$QP.=IC]?F!F/_5J5U.C]HO5EW*M7E6:,$,^1,;Q/S$[2R)C_ -,1.H?_
M /&-_7#_ .\9_P#=%WO_ /EASR_W1@O_ &__ .8S_P"9K(_\O>X?_:?_ /51
M_P#6:N)W)Y>;G,]Q].]/=)]==0;PGMOHSL#OP;8=U=_:;Q^RP&4P^IZER\-8
M ^G\?^[;>WT%_)VX(5%!.+7I",)/[W>]&L6>XK%T[V+9EK+G@@'+7$*3#2*6
M PX*8)R>,1"YC^L[S'QJL\KD;M#*!B4)25@E,,I:Z5"/C, D8D5-Y3,G_P (
MVB?G5Y?&SR+I?('QZS'D"941==4]N/MG7@=OH:VUHZ1W7FOT^,TEU7;6&.OJ
M-#@3#,F18U%ZV,8>RHYASOCB9-[&XV4QC,;DSQHEY3&1VF!F)GF(D,2/S(G$
M% D'S(G$CO.VO?&9(,CC@R)1XP*"WWF)B.!$)3!?$2&XS(G\00[%\;ZBM)YV
M^)>AS.OUU9W10_@\0/EC+M]A4ZJELR0-W:ST6!LLMG[F@K]!NJOL&]&>#GRJ
M,6Q'O3$^ !Y$JHQ?5G7LRMH)-!>1DE$;2,QN$;G!3$S 2$?)P<C(1\EM&O%>
M?Q#%&X'CXUP,SO!1.QSL$C$Q$G!S\!(Q,'/P.\ZB>T\ZNMP*#!:CK 8?M.CV
M-OW7G;.3\G:XFWQFCZ6Z/WW<UIG--F=!E7Z2ET)K<5$!,#8B@%@QV$9;HY6H
MR*;V1U^T3&*MS*6+%4Q\04$+6@J"$H+C(QRWB1F8G:1WC]8\GYZL*UMJQ#5F
M31GYD9$E*-DB0R/*)GCM,3$3&^^T_I,PR'FKT%H;CKG$V^VKLWV9V#2=?%)C
MWC:&RK*#5=CXJKWF<Z^MM]#GA\6#M+:AMH2*ZL,+"M+(:6&: 56SQH[Q=@<D
MM;; +DJBR/\ +\8F1 I C@-^4C$Q,$41(C,3$S\3KV3G,>PU(-D#:8(?C\S$
M$8P8A)[<8*8G>!F8(HVF(^8UEGS3:V^G&FG&FG&FG&FG&FG&FG&FG&FK#=R^
M16 Z+)H!-K#H99='!8$5_P"#KACFMCK9!(R/L*18 K&Y7&,]J(CO5/7_ &>G
M*;]J>\^E^G[%*MVP+Q,O@PE_74#(V5(07+DQ>T[F.VV^_P _IK,JT77(*5<?
MQVWWG_7_ -&K*_\ Q!>B/_[/??\ F]6_^/\ E3__ +;'IS_V6:_^YE?_ *QK
M+_PMS_4/_7/_ +VKD =BZ'R-ZU*O/'3>B=7VM=KTIB]!V%U@F^'DA JAC["O
MARX._P AZ.*;<BNC+6P_QK$]JPN]R.2__4OM7I_M;"N[+@DW#Q*;1UB%O%#/
M*"TMF8XRZ)#@X?\ 29G?]-OG492E?1$)0Q:GSM/*1ED;?,;;<@^=X_7?5H?U
M[]A^17=_1.%[W[P[)Z^TX_9F8EL:S&XGJ0W!?Q:P#T5K5S2S:$SLG9/T Y(M
M<GI'],-8WN]?<[T].6_V6MC*&09C\>I@2H]I(F0?*)&)_2 ';]?]9U'^NV<E
M?H+R%]JRAH;P(KD.,[S'ZR9;_I_I&JHGGQUH.[4:*ZZS[US_ $CFQNW"(?)8
M_#T]CTIH'='B: SL!M;-F=9?]E4P4;<I915%C>9NHJ-(0*D-06=*0(PCY_VY
M:G@I;:Y7SE?[$',-'RS$!OR& F?R'D(&1!$[F(Q!;?7^X*L<V&JP-$89^](Q
M*I\6\GMQ*3C^TN,D B<QL$E,QO;+2_L&@M:4:JS/7.WZH[/_ -6_#2MBR?<P
M_7%I+INGO(+R_P"FO'_8:[.3]1]J=C4XYU32;XF)X5D:#=4EB2#(=7-9*QDN
M6KK4@R3<U;JGALSR5SCBQ-9KA$O(L)VF0B=QB1,8*!+XG;%;V*#" 4IB;7FK
M1Q9PGDMUA:2(?&PXWB#GXF8(9D>0_/SXJ#]BH5",'F-AUOV#VEVG>=K^;U?6
M9'I*KP/Y87J3QD\O^U.@:;00Y[L/L_%W>^T*9[,5:$5&2BT&A.,6::"K;&^-
MG/ZSK),F6H:I-,4U9DFR>TL?66Z8Y LH".1%L3. 1&T2>^^OXOL@KB%.4QML
MG6H@50&_C188J)V,QDYV$=Q7S.9WF VUJSWOZ!>W=AN=GK1^_P#K@,?4:O0Z
M& 2;-:9\PL-U;F640\KV/]CY8(R4:Y4_HJI_3^G.AL9_(S$T,<BB6-L$24@$
MSY ^>(Q&_P#Z=M45V?\ C70[-V"WGW9-RFVG2R0%8S [_P!(F?F=,%^@7MW'
M[G&:TCO_ *X,'R^KSVAG$AS6F9,5#2VX=E*/$][_ &,EGC&5K57^B*O]?Z<9
M/^1F)OXY]$<;8$G),(GR!\<AF-__ $;Z=8_C70ZSV"IGTY-S6U70R )8Q!;?
MTF8^8UOL\KNE=3WKC.L,[D3\_7&XKR?\6.ZK671E6(@I&6Z/[\P/:>L KWUE
M5;S2Z"PS^5(AKHI&1#2F/C9-/!&KIF<QX>^G'O<UT%(LJ6%1QVG\FI-8S.\Q
M\1)1)?UB-]HF?C7166HMOH4I,C!!:0V=]_[5-!A1&T3\S S$?TWVWF(^=8J>
M5OBYY3=A0^:^5Z/EZ )RGFET [JVST':VN[%S6AZPT(W5^SZTF<!F<AUULJW
M<TVGK= /[3)+6EGH9TD(42X:UH;]QA\MB*TT'9#[,.H6?) K$"%@^03^2(QD
M)&8GXXE!QM'(/[HU&6Q66LQ>30^O*;U?QS+",9">!!\"(%!043'SR&0G>=C_
M +=7'"\3MX-HZ"X=9X?Z];^P/8^6)S6&W/V",'?]5;G"UM8QJYQK)=P-9Z,1
M\D+W-#8-"Y6F.>QD;L4LQ7E1!LS><:->/B/[X8!S/]W]FPS\_KO/]O\ 762.
M(L0T3W7M&1*Q/S/]DK,(C^W^[<H^/TVC^[^FK?9'Q<\F.CM:+VIU-%T3O]D9
MIO-ROO\ &]C[S>X/-0XCR0\T.P/*'K31T&WSG4W8=P/J<O3ZF '14DE(@5D2
MJ-@M(F Q$%9+LOBL@F:=W["T0%68(  RYHJ@@QD"8$<2D9D#Y;C'ZA/*8C'3
MBLI0=%NI]=CI*S$B9F \763>!04+.>0P408\=BG]#CC$S=#PT\2-1XPW&HGO
MM)F=0+>=)^/'7R6=(*=5F$ZKK&Q[JO-N4E$2(\:BQ\]OVHQ*$5AYLL D;XI?
M8L;7S8F<S*<L 0L#"1>X]IF)CBR%0'SO\ELO\YVC>?F/^&5A<.W%F<L(3@D)
M#>-X_();)?']!W9^$;SM'Q/_ !;GICR6H^VNZ[WI-.@[;&>2+^NSM7H.W['8
M?R;IW08W+U>!.M\QUW48C29GNFI)S-$&:#46-[D&"7*3OE))AG]D:O>Q3*2%
MW_LB^KS@87 \6012<01R8DJ>4S$D(,W';:(F/D^EE%W'LH_7E%GA)2R2Y+D1
M@)D0@2%L<8B8&37L6^\S$_&*.)_6_P!F9?;T]2:30W?6^'[*[4[*RFUT?E]Y
MNZJPM)-E'V*7D:F/Q+*T]1XU];:7.6F\8PR_$*O031QB'QT(\I[OK[A_:*C:
MY&,$-IBE@0C6JC$<>'*?L<9>8E ? 3 3$S&[)@?G4HZU:4\0*1*LMK#$IL6B
MF>7/C'U^4) HD_DXDXF(G]N)+XJ,GZ_.X1.HY,=/7]'=A6P^>\-JZ*BN^R>Z
MNK_G/\>>D"^L-=98ONWJ_.#]B=+:YFA+:?G]$!5W4D@$4PA=?"AKW#_$=DI3
M=\\384$E9G> 4SX<V&#!*87!H\8V,)(?F8*"GC\_7^W;HT_#,(8<#6C:3:'R
ME7 I%H#S46_R!P)?&\2,<OC8/XI]:]G=2=(9G#]P;<C?;D"UV=D9;%:F\WLU
M54Z+9W^AS>.?V)J:;.ZSL9V)SUF-5+H+4 .QN%$4J>")\JQMC>8M5+M\[%)<
M+KS Q$<8#>1&!(N R0AS*)+@,R([[1,Q&^I%B:MJG1%%QGD?$E,SRD]H(ID1
MYE$$?&)@>91$EMO,1OK(KFLULM.--.--.--.--.--<^GF_\ I*U'EWY0]G>0
M]=Y"4&&#["_A?PY8WKNQO2:O^)]>9/#R?+:P:ZKB*^[+FG$-](&>QLR,7W*W
MW+4_9O6K^P9M^7"V"A=P_&5R4QQ6 ?KSC??CO^G]=?HGZ*_G-BO3OJK%>N+/
M7+%]V.^SN\;@*$_L7+%J-ES7.1XP^ G\YWD>7QOM&*/_ /&XVW_O89;_ -DE
MM_Z>\T/_ ).6?_M\/_HI_P#K-6W_ /\ 3/!__P"HV_\ _(+_ /U36YK0>)'<
MV:S?@&G4.RZQ.V'A7BR<8;+V15ZH3-;J$WHH?IDJP%'S!)5I42>L;SHXGRRH
MWU;&KG>BN7H/JQT\+@2P60\K%S50KFOC$[ID9Y;%O&Q<?TW^-]?E+[3S%GOW
ML;(]^QJPK3>S-^]"6E)\!NM:R%R80/*5PS:2XC!3&^T;[:M7OOUP[CM62\[?
M[+WG6>N\CK[NS+=LE5SLKNZ'HR+(X_IW1=*4/2L U'O1>R65(%%K[*Z30I9-
M+DTA"S. _'J^M?)Z_:*].!I55M#%C7)>_();R)HMEOR'#>9$1X<=N$;<N6QZ
MKNQUI]N2N6F*/)$\6;<3A7$5RJ%?!\]H@B+GRWYSOQX_CJ\7C5X2VO178_6_
M8Q-S@(R*##>5M-K\_@\[H:6FGT'D-O\ Q3T><=1SZ70:B_LPL3DO&QE66=:&
MRG6<\\4[6#Q)]:'!RN>#(56U8%FQ,KR,F0S.R0L"6_$1B)(G\H@8V&(F/F?F
M<W&8,Z%E5F27N*WP4!$Q&[C04;<I*9@13QF2G<IF)^(^(M,%X'^077>#V&4Z
M;[=ZF +[CZ0DZ0[8F[!P>GT0=1#7:WN:[S>_ZY2GTE'(Z\90=U'UY]9;,GKY
MY@028G1)&7 ?F%V'&V; .O)=(HL>5? Q&9W%4$![C/QNJ)@AVF(DHG?<9'#'
M 9&M7--)R8ER/$SF!%$;$R1,-BCYV;,2);Q,P,QMM,%<S+^$6JH/'_L7IR;<
M9\BSVW>707; MS'76+00:[IX;QF@LJDB!SOL2&W"]$%K ]O]D:'P^_\ YC^8
MK<^EF25>A9<%UW+VWC>99Y]I_P"4>6-_^4ZRE8)J\>VE+!DCL)9OM.T0OP;Q
M_P Y\4[?\XU"-)^O38;W+WW7.M['S0.0([$_8'I<Y?9NFM%U-?0^;NGVW8=8
MMC6VA,M,7I>KMMV"8WU;*@-H &,CXHGOF:ONKLJ*[AM)4<OA5,2@ICC,U1 )
MVF/F!8 1_3<9F?F?C7@WKCK"BK.:,)EELAD8GE$6B(XWB?CDLCG_ (%$1\1\
MZS3Z:H/)<.XO[GR [$ZPOAY*:BHLUD.H\1<9K.0'5L]F1?;RWLM==Z74ON=3
M]P:".IC+6NJ1PD])3)IWS-T5YF*(!7C5-&>4R1,."+:=M@B!@1V':9Y;<BF?
MT&(VUNZ2\H)D>18HHXQ BL9&-XWW.9*2+<MXCCOL,1^I3.^L1;'PF[QT'4^X
M\3;3N[$4WBQ?57=M/5EYKKHV3NZQSO:PNW?EL;JK30:"UQL8/6-]MXS_ ,I6
M"BGW[J$*&5@<)![2-T&>QZKB\R%=A9<95,P1QXH)?#D0Q$06[(';B4S <RF)
M*8';3E@[[*C,0;UCB2AL1Q"?+(LY<1*9F1V"2WY#$2? 8GC$EO ,=^M[6@SR
MWM[8]%YG2";3Q3M*S_3+,]GJ,92=#>674/DEO3;.Y[+[!W=^"7V&)U,( !3A
MO8#5$,;*04>KD?!D/[0DH\:XL&J5V(GR$OXEU=B B(  B>'DF9*?DH^(@?ZX
MZ>M.&?(R:XM@T3' 3^8586X]Y,SF.?CB(&/@9^9DOZ>+M'];G8FSQ."R]-K>
MFUN<I8^0A%9OKK.=FYSLWJNS[I[JV':%7NNGNU.I-[UWV$!8T=9J(A[+/%6#
M*:X,K1)ED'^)WR_=3M-9#V.8#^!PG<()9+9"E"N08M@&$Q,CN)Q'(8(HVG?X
M^;?6;+T+4!IYA+MCF#$URUI'!+8LP.)B"V()GB4C$[QM\[<J"M(IJ*EIRK:P
MOBJFIKJTF]MG0.M;H@$.$6:VLW#0CC.L+&2)9IECC8Q9'K[6HGHB0MAPQA'
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MXS(1OM]Y"M3'3C33C33C33C33C33C33C33C36(ODYXQG>09V0,#UXF73+B7
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MZZ[&R_6IV6.N[751A#ZBZL]5 6")\BRR!-5SVQO5L?#.K9I?D 4,996P!E8
M9'^8$<%$0._&(&8F?]?_ %Z+[/AS\9DY85V 909F C^!B$C,R6W*9*)B/]/]
M-9*ZSR&Z P1F$KMSWET]B[#M)HSNL0=9V9B\Z9V,TSZGTW806XNPY]>TK[\'
MQK7M(^3YH_;Z^]OKJDXS)6185>N]@I_\21610&WZ\]HGC^D_KM^FMH[(X^N2
MQ>]($W^R",8D]_\ X&\QR_6/TW_75=J.W^IM!O;GJNA[0Z[N^S\Y537NAZXJ
M-MFK+>T5(/914T]Q<X\*SFT-750V\[!7D3CLA:2]L2N1ZHWGF=*XNN-QB6C4
M*=A.1* F=M]H*8XS.WSM$[[?.OL+E-E@JBVK*T,;R$$,G$;[;R,3O$;_ !O,
M?K\:Y_=MX#>6=OL]=;5W5'V*^ST]]8@D?SKK6+YPS;4LD:;XI]E%-%\L,K7>
MU[6N;Z^BHB_TY^/?8_XN^];_ &&_>J8/G5==>P"^[CXW VD0SM-N)C>)B=IB
M)C^L1.OV ZY_*#T70Z]0HV\YPM)IH68_2R$[&"A$HWBI,3M,3&\3,3_29C3$
M^ WEG4;/(VUCU1]>OK-/0V)Q'\ZZUE^ ,*U$))F^*#92S2_%#$YWM8USG>GH
MB*O]..N?Q=]ZT.PT+UO!\*J;J&&7W<?.P T2*=HMS,[1$SM$3,_TB9T['_*#
MT7?Z]?HU,YSM.IO6 _2R$;F:B$8WFI$1O,Q&\S$1_68C6>W[#_&CL;R.[$Z)
M"PE.;[LYU-Y:NJ=Q&L3*WKSN(G.=6Z/Q\T)\\D\"PS ]J8H,T945$60!?<YJ
M?UY^U/6<K5Q=:P5@HV)U?</ZFKDP7#'_ #64Q/\ SU^+G8\79R5FN-<9_%-C
M8OZ S99)F?\ DP8F/^6L4>N_$'NON_LN^[-[MP%]U9I?*_Q/\ZRNR+PF2.4O
MI7L3L?N7Q,JO&/.$6,)Y$H^TZWZ5Z.I#!EA5&#V&?F>WV.;_ ';FUFZ%"J-2
M@P7*IW*G"/Z- %6)>6VW]IM:<3O^L'&M36P]Z]:*U>62FVZEKG/_ +(S97A$
M;[_W I0S&WZ2$SKY]?8OLCR)Z_Z.\X^__'PKNRE[>[,#V/;GCWG:O&[IM7UK
MA^E])U5T'HZG):&T'S_:^)I.R#+O< A1$F2Q.[!2V$'>\!C(5E]7&6;'7\;9
MA!H5(K=,D&YFT6.&2&.2SD(!4SM$3X>!3^7S_*Z+.2KHSN0K2\'-@F)B!/8!
M42U% E.S!@Y)L1O/_C<XC\?CVY#PDM9M;0=C&>+--EHQ?&?]G]9T[G[K)=?V
M>RZ+JNS>V^@[;Q>ZIBM::2X&Q]RN7O>PC:&EK3Y1LJ#HK:I@? R0F%_R_/!"
M2JC<(YFW0EDP1P+96MT/9M.W*.4)@R*(ED@!SOM$Z^DX,Y<-DJ@AM5O0N)$)
M)4&Q4H7O&_&>,ND!&=EP9A&WS&H-7^*^ODLO(&E+\,=27Y#]F:GQ+F\>_*HR
MCP:U?4<_6?B#XAY"UTJ[DW0-VW7</4/8>0O22F!!K_)Y(I:V!IKF30LR"RZ(
M"L<7@C&*"QYJ\2>[/)9LE \('@?D @B-Y_;^#GC\3K''$NY6 FD<Y)IU_"^8
M#9?"O7&2YS/(/&8E,[1^?R,<OF-7JF\/A,YE<WV7I_%$3M!QG[$_,SM[R7PE
M=C\1==B=N]2Z7N;RZ'\?=5<5NG*!9VIE\0S5XK05^;(+>R,.*&Q%%E/ @@DP
M8S9-<=5-R5;8RLM!R1P"V"JMYAB1B?&1\6A)Q'Z[C,P)3,9TX:%J&TVI#=\E
M98\($9-BR98\)3!;>01Y*. F?TV*(DAB)M@+XVR4_:?26^[.\!]=V1XU5$OG
MY<8#QWBQ'5.X=X]T/<&O\-(^L!K;JNPTW\-';L[#$;*X#S]=(9)G1[Q?DA&2
MN(07+G*0=2Q6J9$%94OIP;N3 \TK&SY-F0/+\8-0R9;<Y#XF>4;XL8SA;18M
M8\VXP?MR">*R\,,*MPW7)<?RD6% 1OP@OF(XSM]B/&KR-R?679=!=]"NWE9H
M/'OP)Q<V(N!I>UJ[,8G">8'G'V5;];)DJSLWK</O*U\>NI^Q,A7V&?GT/X6[
MA1&S-N0W/ ._D97%NMJ8NQXS&S<+E'[<D1UJH0?*5G*H<P&$)P'(9_3QEL0_
MV<9DDU6K.OY!*M4'C/[D"(6+1R'&#"&RE9KB0D^)?UYQ^)68A\3>SI\GNOSW
MCWVY69.#RHC[2ZYI:WQ@\8-#BH0KSQBR/79VIU_A"^\+ZZM<GKK0&U#E6KM@
M-M2GO@+.? XL]L>?.9J0Y?CLIEWT_&<R]\'O#R.!&UM!P0Q(S^0RHHW$=^([
MX48BU*6>2LZ%?;\@1"$2.TH$)(JN_"1*8*/Q*&C.TEMN6MAGA3T/INL?(D7?
M=D>-N7ZWVNN_7MXI=:+N,/E*J:BS.IZDWW>PO8W5A>J?I-KJ:&R+PUSUQZ@3
M7%P 4/FQQ669S*023D9SV15;QDUJMHVH#)6#X&4[D+ 3P9QX@,QSA_S C,2<
MSP'R%&I%@\>VKDHL6:H*>>.0'(1C826;>:^7(BB9&4_$D43 1'(N$3K;1R&Z
ME^G&FG&FG&FG&FN=?]N/AOY+^0WDAB=ITUU3;;G,5G2.;RY]L!;9@"$>^"WG
M9-L57.ANKRL*=)#7W8LJN;&L:I,B(Y51R)4??NO9G+9A=G'()J!K",S$C'Y0
M;)F/DHG])B?_ $ZXT_D1ZV[OW'NM7)]:Q[+=!>+6HC$U#$,%]DY'8S&=X$QG
M?;;Y_7??6K3_ .%_YY?^[MH__.3 _P#I9R$?[*[1_P#:A_\ R@_^=JA?_(GV
MS_\ @9__ -(C_P"MUN\R_2?:O5/Z2?*/J3>8JWI.R4\7/- =F.B^I=7!!.CQ
M'9A%$('%0$VD9QEK&;#\,,+I)'ND1OM]R^G.A/4]*SB3Q5?(CXG!D%R4%,?$
M2^)WF8F8VV^?UUVCZQZYF^M>F3P><KFC+ B]NN9$B_.6D']DE$\HF)B(F9^?
M]=8(>074O:MIU+W!XP28#8S]4>(U/O?)+K(J&@LBZ[2W7DZO79'4N=HECK4;
M8-ZT([6[IJ5!C662MAJ*Q6HC&QJV[<=<IA<1EH8'W+I AD;QN,(Y^0I^?CGX
MZI;_ /5)'_QUO,C3MG3=BO&<U*8FX/B=BE_#QC'Q\\/)9';_ *8$-9#;/LCL
MDGS)I[J@E[AS.J!\[,=U[?4MWNO+757D72S^TPNM2R#L#2Y+$^(?77CWN<J0
MVSHY2UTTYB7(9#SFW[U436(JU8P9+9X#3./(XF KC'E\<G\')%9-P%^)[<(C
MB40/C_NV+[-J<T)K\PNB^(3$E8*?%Y("=P@1K@DA_(9GG,\AGEY/TI_Y:TE\
M?B_PV\\]JOSFN>GH*KRN@J-1WP%C<5VA:;'K=NVNI!=U(N.PS:?0QV '6TN#
M;!]O-%2.;&94,DGA^^ 1DHYKQQ=?%^]?<4R1+@3X1^'Y'N.TOAV^QQ_TGM$_
M/,YQT\&9",\2=K&Q-@19)!RG\OQ':=X3XMMPF?[@WF+E^1F8$ZJN_)'#?GO,
M6L[#RO6%"[]<-9@>PO*S:"W>NL\K<W*QA7(FHT.8['W\WD"9,+?";HHX2NR+
M:R$EHU"Z3UQ,6TKBZMCC1FL;I^[)A7'88*(^8D1( \,1(2J(F6<YC=FVLK)*
MBH=JORNQ9!4?3@#L%$E(S/Z\I$S\TS!PV9B%\(G9>^J-GMA>:;MWM@>NWWDU
M>>8V:\\\G18/*@:7R#FZ-I^C0MQU6[MBD'I6E?Z"D=(A8236/MI[5'VHIR1#
MC2LL&4,7/MB5JI)DEU!PAXXI,I%/EELBSQSO_P"-Y9/Q\8'\9C>9CC+)U\+<
MQMQT"RT69'(# #!.\4*@E^2-O_"\4!Y.4E^43M$3R\<:\F)Z]VGCST1XL=S=
M=Q>46A[%UFY\NJCLW!9WLCL2U)TF,'\;?-_MC&XK*=7:DJ^ZGQ5L-VAUODX,
MN6S.Q_'9S1-E4F2P*^W]/LHR60N4;7U!K NM*S( CB7GJK(B8.S"CQFR61S_
M +8G;:!CC_$5GXVA4NUOME9-EB#"#.>0^&TP1%9;K&>8+@)X?W3&^_*=[']?
M[;NH6WW=;U?JNYR\+H>A<)=]EFX#;^;?:NCFKJKRG\>J7O708KL#R&H,Q<6O
MDN%XZ[773,BP6>IK>*P)!11)"VU<(^PLHH$"RM@B+ V#@(,:JQWFNZ5"8)DH
MA$N%<?O&0[07SQYS.!7?>@V#5-\URKA)R!66%M#TPV1-T#,NA),^% );R/Q,
M\(BO:[<7I=WWQFO%KLCR"N?%VB[&\0W=B?ZD:_S"N@\AU/HNO?*5=P5AKM3S
MO(NNZPONXJ/'CZ.SS\WLC%CL89IXJH.?ZWFFNL5UVY=58<N2K/#@-:.3!.OP
MYQM"99"I9("<?KQF(DRC?T<]DLL*Q3;)8H65^?,K$\5R#^7"=Y= 2R%P9!/Z
M<HF8 9VIVN*[C;TY@R;KN3L>'KT/L[R'AZKJ+EW[ \AUMK\:[-]*?QFM%\@>
MO+FP\HP=1CMD'K)^MC]13W=-;59Y<08Y7XJH)D^DQ1^\R 0K[,J3Y)CZ9&)<
MF\I\)Q%>1(97#X60$)0,E,<SB/ETW?I+DW-^M#7>.)^V($/%7&/,$R^"$H9*
M9,2$AF8&)X!,]#W2=QH=#TSU)?ZW-ZC&:N\ZQP5QIL?M[(>XVF4T-GE:HVZS
M>OMPP*L2UU%%93R"V!,0HT<Y<4CVQ1M<C$K2^"U7G+28,2+3@2"-A*(*8@AB
M9F8&8^8C>=HV^9U8U$V,I)8X3!Q*"2$IW(9D8F1*=HW*)^)G:-Y_I&KG<Q-9
M6G&FG&FG&FN?CR!\0O([7]W]JZC.=76MI0W^ZT5K46,5KFHHS:\RQFF&)9$3
M=0$,;+$Y%1'L:Y/^5$Y8&/R^.314IC8A@KB)C:?B=O\ EKN#I'M+H6+Z?C<=
M?R*UW44E 8R#9D2$8B8WA<Q.T_Z3,:L]_P #_E3_ .J"Y_\ ]SE/_'_,S_-X
MK_VP_P#J+_WM2G_SA];?_A57_P!&[_ZK6?G?_AK;^1G?O2E7J*K1Y?,9[P.[
M?R=7W%GVBI==+^1 O=?B#NNH]1EK%)T>'N<U9]<G6H2QN^$F*LG@E<Z"61DF
MEQN<#%XUY*D3<6064J+]&I\5D&"4?U H.!G^L<HF/F(U^;O;\:&=[8YX<OI$
MJU(.']085E+$F.^TP4<9*/\ 6(F)^)F-8%YKI/R^L\>]_DMXMU5[I+WR]\D^
MP=_;TO45-Y)5 .LDZXZ.P>*W77/2^N[4P&$)QW;;:S5%UNBO0[^7*H..)].%
MQ\YD,B;?P@/VQ5LA4-) !$LE$R/-IF!M%9GR7NN" )#R;R7*>,#,)51S))_^
M^=2"85QQG,+AT07!0"8*)@!Q9LR1,X.5[1'&.4S'TR/A9VU%T\M<?XMV+>Y;
MSP3\G^C<;;V66ZKK;_(ZBG\A^QM)@>K++6T5@W+X0&]ZQL1:_/+7EQY)!',%
M%)B!2/AV=IS>Y#<CZ(Y!#2B"9,$,I 39 S'(YAD21[QY-_F8DM]?U.$N12XE
M4G[I4'J&9%<2)0XR!<E$\0B0F(#:?'M\1,#MK)WNKKSL+R[[K,TMUXM]K4?4
M5K_P"9FXH^XJ++!.V%)UUY;;G>]MCV^4J=3I&OR=#E+QC+(:R5C+(3YO]WG
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MYC(I(!WB368B93O E!3(Y.)QUFKG2<""%1&Z3)@!RCF4E'!X%!-$RVF!8!$
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M7_\ *OXC4?B?YML[SL'3_P"_V9_Y/7Z3ZOYJW_[3--^E]WZ47^[C_$+'[?\
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?IIQIIQIIQIIQIIQIIQIIQIIQIIQIIQIIQIIQIK__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>31
<FILENAME>tm2227887d1-bc_119ct4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2227887d1-bc_119ct4c.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@"[@58 P$1  (1 0,1 ?_$ 1,  0 " P$! 0$! 0
M       )"@<("P8%! ," 0$!  (# 0$! 0$!          @)!@<*!00# @L!
M$   !@(! 00""@H-!0H'!A<  @,$!08!!P@)$1(3"A05(1:V%S=WE]<Y&B*U
M=E<8.%AXF!DQ([355M:'M\=(N-A9TW65-I9!,C-SLR34-8@Z0K(E5:C(25)#
M-'24)J?G:.AI>9E11">Y87%B<E/#167&1XE*$0$   0" P80"0<'!PL#!0
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MY)U!O)FJ2DM'-IAM'2S5PHV.H58B+E(^2X*H3.0R0
M
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M*K5S9%-G+&[5C6KE](I-82,F74FX48,F2RRQ2)9RDDD<YNPI39P&7
M         ?/EI:*@(J3G9V3CX6$A8][+3,S+/6T=%1,5'-E'DA)R<@\41:,(
M]@T1.JLLJ<B:29,F-G!<9R \'2-TZ<V9(.XG7&V=9[ E&#/,B^C:1?*M:Y!E
M'X62;9?.V<#*OW#9GAPN1/Q3E*3OG*7M[<XP R8
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M><AXI]-N,M(5G)2;)BZEW6%&Z.6T6W=+I+/W&%G:1.XE@YN\J3'9VFQVA]@
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M2N4\HDP3O*84+W<9[V.T/4
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M2SYG%Q<6S<R,E)2+E%E'QT>R1.Y>/GSQR=)NT9M&Z1E%55#%(F0N3&SC&,Y
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M1K'.Y9I^+GN]Y3NX[WL?L@,_@
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M[1^/UQ1_- ;_ ,\^T0%SSH#_ $-O3V^("(^WL\ YHGEO?IM>!'Q@;!_F0V@
MN+^=,LEBK/ WBL[K<_-5]TXY<H-UW,)*/HIPLW]YO9RO@*K,%VZBB/B)E-W<
MYR7O8QGL[< /?>3$L,_9>EYOA]8YR8L#Y+GOM!HD\FY-[*NDFJ?'GBVL1LFX
M?KKK$;D67.?!,9P7!CFSV=N<@*<W6$Y([3T'UX^5FSJK9IQ\IIWF)7MB052D
M;'8TJG).J(\I]I90<I'1THR-ZCDG485%RFB9(QD5#X*8N<]H"5N]^7DZW?5>
MU<YY[<K.2>OW&Z]F5=39&J^.FT[1<D)6)JLZV+/5^CQL>QAE=;:%];QRQ#1T
M$WP9LU472Q+*L7)GAD C_P#+F=1_D]PFZD^@N*4Y?+P3C]OK=$=QVV?H*U2<
MB[K-=OM^F34:KV2NUR6=&94>\0&RW4<1^Y9)(KOF)%FC@JG:EE(+U?F*>JU9
MNEAP@;V/3KEBWY,[_M2^K=(/G["-EV])]%B5IF\;6<0DP@YBIHM(BO1F[1LX
M1<-S3$LQ,N@NU*X3R%!OIR=%[J%]>67VKR>L&ZVL74HVU.J[:^1'(N?O%UL-
M^V 9HG-OJW46J#>6E;":!0EVRC]59VQ8L$WB9$3*J]Y H?EZL=<ZL_3<H=#Z
M9/,?<,IL334-=&.^^,NU("Y6VPQKF!C("TT2;K%$NLP6&M4?6VI[(EF4JLJC
MGU&_;-UF)2-'I7#X+G_D]9^=L?2;L4A89J6GGY>7.X6^'TS(O)1YANG2M2&3
M0PY?++K813,H;)2][NXR;/9CV<@+4X".CJN<C.2G%O@MNK:/#W1VQ.07)HT?
M%U'3M%UMKBQ;5EHVT6Z3;Q"E^E:;5XN;DY.#U[#*NI<R66JS=V[:MVB^"I.#
M'*'.3X<="[JO]:F];GW9R7V9?-3R=,G&,%/;#YHL-KN+_:K9-,$;%BN4^G3D
M>E.-:_!0;]HLH?/H$6T0>-4&1%<8430#2K>E ZA/EU.?QM>4_>YJAM*HQM/V
M+#6G4UEGU]6;AU[855',8WN%-F6T0C9JZ\?0SF/E(:;8*)$>,E,I95(5L[.'
M2LYY=4R7XX=%%QU--?5J)=WK87'+0>P=4UU^1U(5V,O')AC06U3>RB:F&R\E
M TI>_P")-=NJ9N9^A'Y;]],ZV#8#GX].?IJ<Q/,;[2WGM?<?/.#9V?63R+S8
MY;=,U8]I;0?K7;UO)M2T#5K24A(ZOZWCEHLR"F6[N+C&!SHMV;50I#$1#+_+
M+H-=8#HY;;U3L;A/=]V<@5;O(.F\)L3A#4=OI;!KT_5<I3&(/:.M:>C8GR5;
ME&)SK('67E85XD@Z0>82^Q3<!T0.F=R,Y+[JX&:RV]SHTK<./G(^O5^P16[:
ME;*@[J#J2DJ,LZ1-L2'JZB9'+"+O< V0E/14T4TVSU=PV1)X2*>3!S1K7R(Y
MN>96ZD;#1=DY)0.D=>[-L5I>Z@U5L>]3<#HS5=&J+62G(."C*9"^.UOVWGL*
MT*0SO+8TC-2AC9RNT8IID:!NWS2\I9SJX-Z>E>3G&?D*QY+VC5BS&=D*1J.B
M7S76\6L>=XFQ7G=7,8:>N#JU2T(5UAPNT;.F3\S,BQFQ7"I"H*!9_P#+2<@>
MJA<=);"T'U-]$<EZN\U2WKTKHK>W([7USI]TO50DEW\9.Z^NDG?&,79;+9*:
M]:-G3"0?)K2#Q@^5(X6,5JB90(_/-7\J^J>>SU/B=PNTMR_KG&AI0VMPWKR
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M@^P7)LX3*XP3'L%P VO
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MNY$T1*335BW21:QB=W@5(ZPX9HD*BQQ+>CI]I$BFR$LX
M                            "J%YR3Z(^N?G?Z:]Q.W@%*CH$=&V2ZN_
M)JRQEQGW50XQ<>D:;9^0L_"/&*5OF$KD\L!:/K2GH+JF<,I:_P#M-EO%EO 7
M;1#)@LH;!G)VB*X24^:FZ+E%X/W;5O,'B7K6/HO%S9,76=17^AU-DN6OZGVO
M3ZXC%5:52)V*':P>U:?!%.HNL=99:QQKYPZ7,XDT<&"<#RE?5Y)R7T0;IU;R
ML1E]Z\:*KA_I.=F'F,N]F<>F#ANP;UI-1<^3.[-I59V@PPGC)3KUM9D9-,^6
M#Y<!-9U^/H;>H3\0$O\ ;V! 4P_)+_C]<KOS0''\\^K@#SM'X_7%'\T!O_//
MM$!<\Z _T-O3V^("(^WL\ YHGEO?IM>!'Q@;!_F0V@ M^^=H_$%XH_G?M_YF
M-H@,@>2I^BRWY^?_ +3_ +.O%4!2RZVD4PG.NCS0A)5#TJ,F.6#&*D6WBK(>
MD,) M4:/$/&;J(N$?&;K&+WDSE.7M[2YQGLR [)!"$3(5-,I2$(4I"$(7!2$
M(7&"E*4I<8P4I<8[,8Q[&, ..'J%%)OYD'5Z""2:""'6ZI2***)"II(I)\[X
MPB:229,%(FFF0N,%+C&,8QCLP L1>>1]L/MJZ;7C>D>U3VO\JO5W_!>B^V'U
MCQ^]=?[S]N](]6^@?\)]CW?^#]GQ $^GE4#U0W0_XJ%KQFII=.U<CB7O#<R^
M526O/(S:*C,K["N?#*ZS1SPQL82^P\#*><_9Y. A_P#/"^U+WDNGYZ9Z'[>_
M?4WO[7._XWK#VI>U+7?MU]&[O[1Z'ZX]0>/WOL^_X/=]CO@-Z_)M_1'V/\[_
M '+[B=0@+7H",;JV=3S5W2;XBS7)G8=:?;!GY*S1>N-1ZMC),D&[V+LR>CY>
M6CX=W/J,)4E:KL9"0#Z0DI$S5SX#5IDB2*SE9N@J%,31O5"\S[UL92]/."32
MAZ+TQ7)Q6M6JT:YK6M:+1JD[=,D9!E7W6V=VJ7?84S<&L4[;+NDZPKZ:EATF
MX.U;-UDL8"N[UE^*'-#A_P O(_7G/?D+^$OR)MNGZ7LZ=V#[X6P=GECX6RS5
MNC8FGDMFR8R&G5TX!6OK]U!!JC'MBK8(VQW,=N0Z;6D^&FM^H)Y??B%Q!VL[
M?152W+TUN&422QQ21'$K3[3!Z,U-:Z-=(ULHNU3?.JE=()A(>BG532>D;F;J
MFPDJ<!01Y1^63ZQG".Z+W+36N93D16JU*/G52VYQ/L[ES?&K=/Q2QSTVN"O(
M3;\)8'<><WC)13.5;-U>^B5ZMC*9U0Q7J'KD]=7IS7*-JU^WAO\ <XBW!3R&
MFN<50L]^+*LF"IDCP[I7<+)OMROQ;=3.$LEA9N)52*4J95"EQ@H#I =%SJKT
M_J^</E-X$I#?76RJ3;'NJ=Y:U(^+,0<;<6L'$3:<U57+K.9![0[A!SB2S/#U
M,J[=P1VR.9QZ)ETN%*SJ<^42YDZLVEL39'3YCJSR&X_3<U+V:J:G]M453]TZ
MUB9"0</LTK#.\2,;6[_$U=FL5!B^:R_K>112[IX_"^,97")2)Y@=?;I42C2/
MG=E\]>-\7 K(LHRJ;XA;]8=0X^R.DB6#I^\(2U:G?M7G9DI%F+50B^"X[IS=
MPN2A=M\NUYB&Z=4&X6OBARJIE1K/)>GT%YL6H[!U\U6@Z9MRH5Z1A86RM).K
M2,G(J5W8T0I.-GQB1ZIXZ29Y=*I-V&&?AKAC7KU>9ULG3PWE.\+N'>MJ/>]]
MU"#@'^V]I[1Q,2E%UE)VV%8V.%IU<ID&_@7-ON!:I,-)%R]<2249&'<HMSMG
MROI234(ZE.+7FV.I!JY_=]_\GW7$K2%CJ,K:U:S)W*M\?YJ0HYX9264AW.ON
M-=16V2<LJQP9OZKMZ[-PH7)B.^ZF;M,$&?E<?IU^#/\ VF?['G((!T$O,F\*
M<<UND]OZ,A(DTGLKCPBVY/ZRPW0,X>FD]4L)56[Q;5%)1)=VM/:GEI]H@W+D
M^%'JC<V$SG3)@!4<\K'U2JYPHT=U0]=;%>MU8/7G'^<YP:Q@GJCI)K-7/6$2
ME0[C4D/#4*DK,;"=S=,:-B$,BKW62IS'RF3)T0TP\LAQ3GN>'6'JFZ=EHN+5
M6^.CBS\O=GS<HU]*1FMF(3A"ZS(X>JI*M4K ZV]9&M@3(;&5%T(-WDG=R3)R
M!UF@
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M:S.LXSETDLFZ>*IJ(D,3O'";@
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MXFFM1N9>AT)DY(IVK)^F7(UIE$C?8$<,9!JI@N2]TY@ML@
M
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M/"[N3'*&>NN]Y<FG]5NPQ7(S1^PZ[HWES 5EG4I60ML6]<:NW-7HC*A:\TV
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MYJ:?821]9V2SSCUU)R;O)"&=R+M9;)<9/G #.X
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M*-(==7..\JL8QS9SDV<@,K
M                                               *!_5AZ1_F+^:?
M)'D3K"H;AF+YP(V#N^TWO6%/MG)FO5W7\/39>SN[75Z[:Z.:3Q;)"+HSQ5-.
M/8+LI)LQ]&;G:II^$GA(+!G02Z+\;T?N/=VAKG;Z[LKDIO6:@Y_<MVJK-\C4
MXF-JK-\UIVMZ4ZF&K":DZ[6E9F1=J2#IJR7?O)%3)FZ2:2!"A/(
M
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M#K[)V#,VV_&AW"R)%%FOK+T=95,AU"&.4IL!ON
M
M
M
M
M
M
M
M
M
M
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M@!Z@
M
M
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MC(9:
M
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MR::G?8DF"\L;VX<)'3PJN^BJT4W>*5/'@!>L
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MXX<%PYS(6':,O;7C@^.PCE'+53[+LQD!;E
M                                                        $8'6
MM^B/ZC7YH&\/<3* - /*?_0E<<OC Y$?SWW<!DSKX\".:'45TOIG0^@.0VJ^
M/?&9#8"]HYJR5YN5KJ%BM.N&+FNMXE"#S!T^8@)^OTZ+<3DR_B9N5B8V0?MH
MXQSY,V*8H0;\ONF?Y2?3_&R]TYCR<T[3-W0E%G6];VI0^95QWKN!.\QT&[<0
M;ZR:DI=XOU,>FD90S?+IBA4H\KA'.2-O1C&PH4/N>7AWCLC:7ET^I;0;[99:
MSQ&B*SRZHNLSS,B[D5JU0ICBE'6Y&F1V7:JOHL##V28D7+5 F<)H^GG(4I2%
M+C :V^7*Z'W%#J0\$7_(GGQ&7S=#>%ME[X^<9Z4AM"[TJOZ8UG6YUSL2>G:V
M6AV.!=.)RP;AVC9G664GZ5&)&,=?+54[O)B!_3IV< M5]>SGSRNV=R:F;A)]
M/KIV2E8XD\0>-=9LTU6:TZUG5$[!3]?0I;'6WL9*UZ+84C7S2;L.8E5I)3,W
M.(G],2:MO 5#"/F8.B3I7IK<?J?R"X,RM^UAQTVQMFF:OWGQH?7RY7BD9O,=
M7-@6?5>T8N0NU@GK&NM$MF$U&J$DG4@HU4DR99JH)N7::@22]?OGA;M3\.>E
M1T_J?O13C%5>:^M]6?A.<@F7KQ62UOQT@*QJ^KS+<S.JJ8M#ZMV%6U/GDPT8
M>$YE6$":,P<S=^[2,&J$7QE\E@TU"EKF1Y/3DM>?4^8]QOX]WY;,MG'DCMO"
M//-J\UHY=)MWB2^<JI(GJ2S4N<8*=-4O;C(?8Z-\MI7J":-ZC71CY$;5G.:'
M$OB=(9WQPOVN2QWFF3\SJ6G3,_#P$>HZ(>O6J/K<"^<P3]G$K_M4>O)/61>\
MR2:)I![CR</3WXM[%TI,]1:UTJ8?<K-"\M]SZGUG=T;G:F4-#TB8XRZJBW\:
M[I3252J<PX59[GL!<.'315<N71,X-C*"62!;1XW],WBYQ5Y3\GN8VI(JZ,]T
M\NY1]+[D?3MP=S==>O)&SN+<Y-7X!9NDA!)YF'1S8*0Y^Q/L+^Q@!(& K(^:
MYYVFXB],2R:BJ<YZLVQS5G%=$P"355(LFUU8DS3FMZ3J:2IL85BW%3,WK+HQ
M,&42-:D3EQC./$(&M&IK3T7JOT,L=**;ZB_"QO.V[C7-0=UL1]WT-PQ0Y*6[
M*NR7=Y.X:2;CUC'T_>"K=RPSVJF]71C9+&<E(4!E[RD?.97DMTZ7W&FYSJ,I
MM7@[;BZQ,3TYD^</-*VO,E.Z@DBNF2RB#IC$*L9JNMC)8,EAC MC>(?*G: T
MSWMT7^L)R,ZY/*WF#KO<L3PCTQM6NGH51Y5UNP5'8.QXG4T-1M;ZY:US5]!B
M++&WBE7VUQ=5,L>0\: ]!2.^.5_APL1)T&$N:7'CJ^>7<:TSGSJCJ2[DY^\9
M8[8%9K_(O3?(N4NRS0C2U2+>,8K2$1;-@[5C<1]KDC%C_;+$*Q,Y$2+ID3PG
MC<ZV<!+5U/\ J\6_9^E>)?$3I<NWEGYR]5#5]$N>K'K-T5K)<:N.>U*RE-S6
MZ[N^CCO%*A9&5?6>(,5<9[\1F/D9/)\*QS9!X$6O7NZ>&G^F-Y=O3W&34Z2<
MH^C>7>G+)M78SAF1M/;9VM,T':V;7>IO/>56(FY60(UC6IE%,1\4V;-L'/E(
MRAPG1ZD'#B]\\.@;)<>-5,E)7:LGQ;XZ7W6\&DJ1):RVS5#'7&QVU2;>+DB!
MY"X,*TXBFF%3$2P\>)&.<I2Y-@(H>D9YFO@5I/A#ISBQSXL%\XM\@.(>MZUQ
MZDX*9T[M2VQUSB=.PS:BU-6,3U]3[5,5FV(UR!:M)EA/M8OP)5);)53IFQD@
M:(5CF]=N>?FI^FKR;B]3;$T]J&UZ<L->XNEV%"I0-WV3QNCZ-R]AG>UY2!0.
MZ/%P][O;JXY8E444-F%205[^2&*8!T/                 %(+<G_?:N)_Q
M 6/^P_R5 7?0%+"T]%?2EMYO\I^:'F+^7?&JSUK9%B[.*^LE>7%FTO0*MK U
MCL1XZNS$K;?>)M$.UH=?)%1T?&P;XS!5TX?NW;AV[6\;(0(]2QCTJN O._@;
MOCH;<C&J]WKVTF[S;=!UCM786T:)6FT1::9FMK1VS;(]GUY2)V/%2<W#6"%/
M8)9N[CDB%.W1266PY"9CS7U/V!LKJ"]&#4VJ[E*:]V!NJQ[/T76;K"KX:RM;
M>;OV+I'4RTDP=^D,S-'"3&XJXPJ1=!1/O=XBJ1\84*&=NH[P*X,>7DX(;6YN
M<"M?6;7G,23UC&</M<;;LNR[E=Y0UAW98*T2W;92A[9+2U;KVTH>CTZ7>1[B
M!8Q3%!8RB?HG@'R4H?4Z;_E8>G[=^%6LMH<Y*SL;?W*'D=KVO[GO%_>;8V?2
M'FMIO:L"SMY:[6XNJVN,C9Z:K19DI)&2LB,VI)RQ7#CN)H*$;)A&ITC^)U\X
M,>:2NG$V\;0M6XV6E..UWK.L=@7-P=S/R6E'FH:/8=1PSLYUUTTC4RD3+2$R
MBCX;1N>.,DU21;$21(&$)#E+TX>K'U*^66\NL_S+FM;<7./NPI;5/"[B3%/M
MK-*W9:=&3LQ#O;K*36LX&>5KY9:,KC-],GCG#26FI64*7#]*/BFS98/+]0QM
MT$N,M*@^8_0TYJS6A>;^A+=3;'1]95&Q<DK/6]G0SBPQL1:XLSO>%;GGS22:
M1+T[]=L[G<0<K%MGD>Z8K^E)92#<WS(=/X_\V>D/PCZRSFCN(KE%M:I\7M4N
MI6/M-DS6JW2['7=S[(NE!9U8\C[7WOJ3:<Q*)HR:K;+\[<A2Y/@N,$P%FGIZ
M=)GA3HSIX7'0FK*):*OK[GAQW@D>1;;WPK;-RMA4VMH_%,MSN D[%)2ZM5<+
MPEI>%0PS*1)!0Q3X)VEP WTX1\*]'=/OCM4^+W'1A9(W5-+E+5,0;2V6%Q:9
MM-[<K'(VF;,YF72*"SA,\M**Y3+DN/#3S@N/V &V8#G@<2>+<;S7ZQ_F:>*T
M@1GX^Z].<J:E6W3_ +,,XB^_A&T65UQ87'>*;'AUN_QL;(?L?_@W^Y^R G4\
MJORW6W)TJH_4FR) L3L#@OL*\Z"NZ=@6]!>1=)C%3WFBR4RJZ4*T81L! 3SF
MODR8R>$DZV?*F,=GB'"NMJIG)\V^(WF;NLM:V:BC'>D1/<>-"/7[15*2C]7U
MRQ4>T/890[Y/#K"<5KV*UQ'=Y/PR'7CURF(7)"D(&6+E_P!QSU-\8$E_^4SV
M6 SQT\^5/FIZKP9XGUOBMTU>%&RN-T'HC7,9I#8%VO=/86ZXZT:5UFE4[#8V
M3SG[0'368DXHJ:JY%(2*.4YLXRV2S]A@))^/7*_S8%CW[H^O<B^F5P@H7'R=
MW!K2&WM>JG?J:\M5+TU*72%8[/ME::->H-='+JP5RDKOGC)-.'EE#N42%*S=
M9SA X2K=6[I7:=ZMO%Y3C]LRQ2FO+16;(WOFH=LP<8A-R6O+RU8/(HSIW .7
ML8C9ZO-Q,@LUDHPSIIEPGDBB2Z+A!%8@5NH/6WFX.EO$-ZCK29T_U,= 45NV
M:UME-O(>^6EC4XI,C9A'F0M$MIKD6^?FBVR2'J]G*65%F;&"MCJ$P90X2'],
MKS'\-RCY*1O SG5Q>O' [FE*.#0U:K%Q+8&U-O=G2C7$N6N9CKK7ZQ<=96B;
M8-S&B(^2)(M94Q2IH2)W3ALU5"::[=2KIS:UMUCU_L;G[PHH%\ITP^KUNI-V
MY4Z+JMNJT_&+F;24'8ZW.WMA,P<Q'N2&37;.D4EDCXR4Y<9QV *T?FRN4^HM
M\]'*F6?BUO'4N_=;S7/75>L-@W'2&R:MM:I1KF'TUN/8JM9F+%KV?FH-A-,Y
M1I7G2C1VIDZ:3QLIE+&5FZ@"T-P/J];I/!_AS4*<5$M4K/%KC_!US*!VRJ2D
M-&:HJ;2.7PNS32:N#.&J15#*IEP54QLGQCV0&UH"C]TS4B4;S=G5:I^NR]ZE
MVK3FS;+=6L?G+R.2L$U8^,5XL$P\RQR5HTD$-DV)XW,JMC)DEGZR!OVU7.<A
M^Y-@?H]>:>;*)Y-!\5^L177B).^;*$)%[LV#/IKG;II$4;M'=F)R0B4BIY,0
MI6,-L+N%\0_;DP2!>:ZYIO.-'3,D]#TAZXSN#G-<&F@JS$1)G![$MK=(K>=W
M%(1K%J;"\DSDH?#"JND2%5,?%L3+@F>]VE"4[I&<)&/3UZ>/&?C!EDW;7*K4
M-I9MN.4<$,>0W)?E#W'92BCHIU#/V\399=:,9*F-V^K6#8F,%*0I2A)&
M          *#OF*.D3U?><G4Q@^07%#0;K<>E]<:NU1#ZPE)S<?&R(K4!9J\
M]D;)9V#;7&YMH0)UFJUG<X6>D=Q"K*2[<$4\=+'=P$'W60J'F-Z_QCHKSJ^.
M[0OQK5WQ6&U()-W?A_96N-XGU]L]6M&38\?Y^5N23C%"1LV,+.4RQA2Y,50V
M%S-\9">WRD4!U<48;4T_L->:STBG6F=^H:)05LF@EX4NU2[X=I2YF];B)13?
MS-;V_M[EG*DHU(QR;)C$-X!VF3!=>M^A=&;"F3V._:8U/>+"JW0:*3UOUU3[
M+,J-6I<E:MCRDU#O7QV[8ILX3)D_=)C/L8P \O\ @F\6/R:./_R-:Z_BX H_
M^=2U#J;6&L>G\OK75^N]>+S%\Y"HRRU&I5:J2LHDSK^ICLTI%2 C(\[Y-J=P
MIE,JN38)E0V2]G>SVA:!Z _T-O3V^("(^WL\ V ZH_!C]91P3WGPJ]]'WE_?
MH][+_P#&7[2??%]K7O=;BU]MC_4WVW43UQZX]HGJ_P#ZU:^C^E>/^V^%X*@>
M@Z;W#7]7SPET'PY]\?WW/>/K]@@O?%]J'M"]L_KV\6BY^E>U'VT73U+Z+[9/
M1NYZT=]_P?$[Q>_W"ABGJM=+31?5GXT?@^;EEYZD2U<LS>^:JVK4VS!Y9-=7
MAG'/XG#[$;(]QI8JS,1DDLUE8I55N5XCDATUV[I!LY0"$_770YZV]=J,3QVF
M.OKL"O\ &* ATJG&JT/5,C[\J=*CT$8^/KL/;9&WL+?4_P#R,3+5NLE:WQ8H
MA4\))+D)A,!D#7/E8]"\;>97"?EQQ%Y(W34[KBPX@)'9U;V-15]RV7DQ/M;3
M9).WVRR7U'9>N65 LEYIUJ<0+CU=!.8QLW;MEDV63D7*Y#>>F]&KVI=;7;'6
M,_".]8>^AK^-HOX.GO0>B>H_5^C]::9]:>^[[Z+GUGXWO=^LO ]K#?N^F>C^
M)GPO'4#??GGR8XC\5.--VV%SEEX^'XS67P-4[(4F]>V[:%;DHS9:#RM&K]GI
MU)K%PFY.OV-)R=BXQZO60SA?!5>PINT!6'H/EH:C9F"&_>DGUD>5O$3BER6B
M8K9<;2=6*WR?@K-4+6V)(QC)C9JKN_1DVO$M(=T5FW;V:.EIACA/P7RBJZ:I
M0$2.^^F!QSX']=OHK\.^,=LNVU]NQNXM*\DN36Q[O*-IZY6N=C=\-MCKOYID
MQ<H1]7194/5<@]2CR$\9O'N$W:ZKU9P990+JW59Z0?%WJV:D@J+O$DY2]C:]
M<2$EIW>M$*P)?=<R$IAIF4C_  I%!:/LU+GU(]MF2B7/<PMX!%6Z[1T1-RF$
M+Z70_P"NVG35M ?6 ;M[P1V)JZ6>-K.SK[@S63LR-#-L6%:[YOC<V$.U'"!+
MQDN$<8QA7&,Y+@)INE-TB^,G22TY/:ZT;F>N=]V*^C)K<N[[SB/->ME2T.F]
M)#,U4HU!!A7J;6<RKOU3$H>)AMZ6LHNNZ=++N50@[N?EH^7&FN;NW^4'3;ZF
M=DXIT+?^R'&Q=AZV]2W&,=LB2MW<W>2HZBU#M$7 ;$I<7*23SU.C)-&"[%DX
MRR.HMVK.UPN*@-=.6/%+1G-K0.PN-'(RF-[SJG946FPFXLRZC&3C7S)RE(0=
MFK4NW['<':*U+MD7C!VEGM272Q@Q3IF.F<*P=(\OOU8N)$-*:5X#=;V_:VXN
MOWT@:!U_LC7*\U8]<Q$HX.JY85%\E*ST3&OC&=+N%7$ G4TG+TV5_1TE5#*8
M"3_I/]"[1?3)L]\WS8-I7[EES0VVUD6FRN4.V\+ISKEG-R#:7L;"HP+R;M+^
M%+:)9DBYE'\E+S4R_62Q@SPJ&<H /U:.Z-7O,]9+D;U;/PCO;)^$!K^2HOX/
M_O0>I_:EZP@M40OK3WUO?1E/7W@^]AXO@>UMEWO3N[XF/![RH2/\UN-WX87$
M?D;Q8]N?O=_A :?O&J/;W[7?;=[4O;G".H;U][6/7M8]?>K?2?$]%]8LO&[O
M=\8G;WL!H!Q0Z0_X,'1^VATHOPA/;Q[Y&G^5&J/?Z]Z?VM>IOPF&5_9^OO>M
M]\NP>L?:5[>>]Z+[8T/67HO9XS7Q.U,,O](;IO?JJ>&T+Q)]^7W^/4^P+W>O
M? ][OWK_ $CVZOFKWU7[5/;UL3P?5GHW=\?UD;QN]V^&GV=F0JG><;TO3]\\
MK.EYJ+4C-.:YE[D]NFIVE=9ML96E-?VN_4:%U(:R2"::KQG'H[(F[&6/\--9
M,I#R:JGA^$3Q0N^<8M"4_BQQTT=QNH"*:-/T;JNCZO@U"(%;J2#:FUYA"*3+
MTF#',I*3SIHH]=JG,=19TX44.8QS&-D,Z
M                                                       ",#K6
M_1']1K\T#>'N)E &@'E/_H2N.7Q@<B/Y[[N BO\ -7;%7L'-3I@\4>3^T]A:
M3Z9NTY8ULW];:3EXFUL$U%;&BH>VJS";5K*I2+K6=.7BW#)19A(%ALV!5\1H
MZ4(5$!^3D'K?RDO CCK;=A:C@>+G+'=[FER['4.OZKO2S\P[O>]ERL6X0IS6
M>II=DW>C4IGB7414?+R;");-T$CE(FJ[.DW7#"'EG9!DIT'.LQ%$<)FD&;/D
MA(.FF,Y\5!E)\-V;9@X/CL[,)NEXER4OL_LHF 3%>4-^AMI?YP&]OMY%@(K^
MDYRGU+T'>I9U)^GASUGRZ*USNO;L?NGC1N6T,Y(NO)BJ+2EU]JSR9L:+.3,R
MC;W0IN-P20<.#1L3-0,C'.W!7?;@!A7S7G66X><L^/&I^%?$/:U?WW(M-R1&
MZMM;$H.7$KK^L1-/JEKK59I["T*LDXFR3%CEKWZ:LM%KKHL$XPJ*RGB.?#*&
M7?,2Z%E:GI[HE=2&4TZUWUH+C+4-,TOE!K>6BD)RO2U"EFNH[C6X6S1[ML\C
MV]5OZ<9/U]V^=$(W;OG\<EWLJ.4L8"22B7WRBE\TLQWFE6^EU4Z^X@49Q_2+
MW3=7U;=,(?+4CAY!OM*/&IMFR$]'*Y,@=&-C'Z;A4F<M5'">2*&#]/1$WUQ)
MYD,N?FSN$?2DUWPXU31H>TZ7UYR0HS"(C;%R6C)?,Y+,JEFF0NM:ZX@I2+BX
M:&E96.2F9HK-U)LD<YR<V# -0/)@\F./%>X4;:XP6+=^JZ]R,N/-/9-ZI6CY
M^\UR$VC>*@[X\:-)B?H]*E)!I/7*/9EUM.J.S1B#K+%&-55<823[IC!;1U3S
M-XM[RW)M_CWJ3=E+OFZM!/'$?N374$Y>*V'7KQI+JP#EO/HKLT&Z*B,P@=OG
MPU%/VPN?]SV0&S@"B'O>G4[KP>9F=\<;[$^^'P?Z:FK[C7ME5M&6D(^"M=LK
MJB<9?&2\I#2$=(Q\Q+<@;;&0+U%JY\9U#TQ3),)]BRB83_?5O>B5^01K_P"4
M'=_SH *^<%KR@= ?S*VHJ7JJ"+K'@EU']6UG6D16\S,G(5FE62R/6-48L$I2
MS24K(J.J[OFJQ;U5R\<_^3H.X+$*KX6#$ 23:NZ^5WX]]6;E]P!ZL3O2O&O6
MD')(O^'FY6%4ME#HUFHZ\T_=U"3V-<[5>+K$IK;$U[*L7)I3!V,'&SD/)L%5
M6ZWAMRAJ]YD7JP\5>3_$']6-P;V?2^9G)3F3LS2]08PG':P0VU:Y 15=VG2M
MAPR&;S4I.0J3RX6VYUB+C&<:U=.EDT572KO#7":650_'*^43=W2?USMUKU#]
ML:"V?'<<.,FH+3%ZUUVD]+%S&E^..J-+6DD/=8[:=3DGT'99O7:LD5'*"9$R
MN2I9RKX>%3A#GUW>A!=NF_PEBN0E@ZBV_>4[![O&AZ[QK/9<)+1]=0<62OWB
M43M!'#W:US1S)11:Z9%(OH>#9(Z/V*%[,X,%F_I[\*>0_2*Z9?)7D%IK<E\Y
M[[?V+H#5_(37&GMLL;%'Q\"K1->2=HD]:5 L?=[;+RBDS!6)=%DBR(S6<O&3
M9(B)S*8(4,2<$.K)T2>HMH:M<L.?]6Z:.HN;%-<2+/:L1OJD:<97B)E(*4=H
MU2<U'8]SQ\EL"\P<G4&<<X2S$O9%S'NN^T/W3(D[P:S]-.Q.NK]YAO='52UI
M7[ VX3\)]1N^//':_P W O8)K=;3(TR7H+9A!,I%%BJDWE8G8ESLRK?PR/8:
M.DHA%^V;KOB8P%V$                !2"W)_WVKB?\0%C_ +#_ "5 7:9Q
M>4:PLPZ@V*<I--HN07AXQ9=-JE(RB+192/8JN55$DFZ;MV4B9CF.4I,&[<YQ
MC': YF71_P!9=)GJ$7_EUOOKS<EXU7FBZW;*-E]:<F>1$SQCI:%-3BX\WI\/
M9<W'6T@]FHNX+2D)[6F\TDC7(V'9IILB)+8S@-9NN5M+HY1FY.)VFND_K/5\
M/2=([ E[1R)WYKB'GW]9L\W9Y>E$I]+C]HVIU)6&]1]1B:A,2"JJ3AS#=K\F
M&*RBJ;W"86/?,4_30^7!_._HG]JWBR E5\RAPVV%S6Z3F\*5J.OOK=L_4T]3
M>05/J$6DY<2UI+K5V\)<XB%9-#Y7E)XVMYZ:6CV)$G"T@^12;(IY763,4-=>
ME]YBCIG7?@)HMSO[E'KO0FY]-Z<H^O=R:[V2N^A+ XM.O*I'5N3LE$C&L0;V
M]0=Q]4^LF+>"(_<MBNL-%4RN$C%R$(O2UYO5#J(>:[VYRIUNQE&&K+EIC9M8
MU=B:9&CI23HNLM64K7$39GC)5)%TR4N*]76E\-E\>D,BOL-E/LD<XP&$>!=%
MZ;G3FZG?/K@/UF^/&E7$1<-I>WOBMR%Y ZUB[/2VE.=S=M>PA7=MEHI^:&JN
MTJ;-1;MO(F,2*C9>'?LGRR3K/=($FO4?Y1>6;X8ZVA'?'+A7TZ.?V_[?;*S
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MK=*Q=JBYFK[)+;L4N;8V6$91[9G-.5Z))D>Q:R.,M\)IG0<.RF5R@$W@
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M+QC$D5%W*7BWE?V/%Q!%'"Q(:,V?3'];V)'0I7#M17#-&43;>,?*G<[_ -D
MUPXZ=!GI#<5+>ROVF>#.J65QBWR$I"V#8LG?]Z/Z_*M5&RS*6K1MZ7+9"=;E
MF"[0BC=TQ*W7;JXR=,Y3&-G(2Z /AV>M0-SK=AI]JBF<[5[7!RU:LD'()>-'
MS,#.L'$7,13Y'MQXK.1CW2B*I>W[(A\X :><-^F[PBZ?GO@YX=\?JOI!3:GM
M9QL!Q!3%PG75D)3O7OM91=.[E9+(Z;MXDUF?F(FW.BF8SDQCX-G!<X#=\
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MHD;&EY9G68V-1?/$FJ944C*8-A! I4T\%3+@N SP
M                                                 PWN3CKQ]Y%0
MS2N<@M%:;WK7F"BBK&"W)K&D[.AF:JID3JJM(N[0DXQ;J*&;IY,8A,9SDA>W
M]C'8'YM+\9^.'&Z.?P_'?C]I+0D1*F3/*1>E]4T35L=)'25772,_8T>!@FSP
MR:[I4Y<J%-G!U#9Q[)L]H9M
M         &HE\Z?? K:=S5V/L[A'Q$V-L-=X617OE\XV::M]S6D".<O2/E;1
M8*7(3BCPCS.5<*Y7R?"N>]V][V0&TL% P56A8NN5B%B:Y7H-BWC(6!@HYG$0
ML1&LTRHM(^+BX]%NQCV+5$N")I))D3(7&,%QC #ZP
M                                *(?GB_@KZ=OQ@<CO<YJ !8]Z _T-
MO3V^("(^WL\ E_
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M?G*<KELF3N83B5"9.N4+N
M
M                                             *(?GB_@KZ=OQ@<C
MO<YJ !8]Z _T-O3V^("(^WL\ E_
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MV:!9
M
M           %$/SQ?P5].WXP.1WN<U  L>] ?Z&WI[?$!$?;V> 2_@
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M\%=6#&*N,)7=FTZ&NL)$6V+C)2;C8VS1L;-I(OV[=Z[01=$.1-=4F,*&#+0
M @1U-YB7A?N7J2RO2WJFI.5[?D'#[PW3H5U:I>A:I2U&:U:(]O9[G.I3D;NV
M4NV:>Z;:\?+L71J\5R= Z1UV[?&5/#">X  :X\N^3U#X7\:=R<I]GPMRL.O]
M(4UW>+9"Z^CH:6N;^(9.&K9=*O1UAGZM".GQ<N\&[KF1:)8(4V<J8[.S(:6]
M*WK$<:^KS6-Q6[C;K[?U&A])SU1KEG4WG4Z%63RTE<8^;DV)*P>A[.V6U?EC
MFL&;+S#A5HHCEPAW2GP?.2A+
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MS^TH];G7$X]W;'78E/B&UZ:KR;K%>,Y;H(KG2;KX(3Q GN
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MQB'-DIBX":@                            !1#\\7\%?3M^,#D=[G-0
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ME[3!7%TMU@J+ICK-;+ZN3'CM+3SBT2VZ=C5'1[R_MFA('9V[M935+FD)._\
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MAH5JHUVK[B#EM<:[<H5:LU*89ZTEZ,F]4*WPN^_^<>%'"ZV3=XH6;@
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MKI9-LBD@F8B"229 VC  '.#\U-]/GT[OS?\ B1_;/Y#@.CX
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MDS4'=M=68Y+!ED;=AF2&QNJJ1R*"5@995,X?-5VDI]D=TZ*B%G0
M   !SP_/%_"IT[?B_P"1WNCU  O^:F^"O6GQ?TWW.1H#(
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M25?MU1D5_%:R,>LWE6,8YE(-5ZU47B)0K=%&8B56SY-,A'!2%#9\
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M6BGZB)EVQDSYQW3=O>33,4,D
M      "(;KL<0ZCS6Z7O)K4MMV=3=+XK]=CMOUW:>QI?$#KVG635$FWMS1S>
M9?PE\QM5F6#)S%O')4EU&B3[*Z:2RB1$CA6HZ.GFB^GYQ6X*Z*XC\F*+M35M
MZX\4]:@FL6L*+$WG66P&D?.2"[2U1R\-8&E@8VBQ)OC/)<KB.RW7D#+N".E,
MKX(4)4OK>71M_AIR ^0F<_?0!9"U9L>L[BUCKG;E+5>+T[:=#J&QZFM(M#L)
M!:LW>OQ]F@57S%0QSLGBD7)I951-G.4SYR7.<]@#W@
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MEBJI1*'7HNK56 88447.A&0D.V:,&WCN5CK+&*3OK+J'44R8YS&R&0
M       '/#\\7\*G3M^+_D=[H]0 +_FIO@KUI\7]-]SD: R
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M4 "Q[T!_H;>GM\0$1]O9X!+^
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M^,FSC': ]X                   #G!^:F^GSZ=WYO_ !(_MG\AP'1\
M                                               !SP_/%_"IT[?B
M_P"1WNCU  O^:F^"O6GQ?TWW.1H#(
M                                     *(?GB_@KZ=OQ@<CO<YJ !8]
MZ _T-O3V^("(^WL\ E_             0-[Y\RETC^->Y]GZ VYO>[0.S]/7
M:?U[?(9EHW;TZSC+36'ZT9,,FTQ$5%Y%R:+=X@8I5FZJB2F,=I39P Q+]; Z
M)7Y1NP/T=]W_ ,2 #ZV!T2ORC=@?H[[O_B0 ?6P.B5^4;L#]'?=_\2 #ZV!T
M2ORC=@?H[[O_ (D 'UL#HE?E&[ _1WW?_$@ ^M@=$K\HW8'Z.^[_ .) !];
MZ)7Y1NP/T=]W_P 2 #ZV!T2ORC=@?H[[O_B0 ?6P.B5^4;L#]'?=_P#$@ ^M
M@=$K\HW8'Z.^[_XD 'UL#HE?E&[ _1WW?_$@ ^M@=$K\HW8'Z.^[_P") !];
M Z)7Y1NP/T=]W_Q( /K8'1*_*-V!^CON_P#B0 ?6P.B5^4;L#]'?=_\ $@ ^
MM@=$K\HW8'Z.^[_XD )P>+G)K4',C0FN>2^@Y]]:-1;5C9*6I4])0,Q67TBQ
MB9^6K+Y1Q!6!G'S$>9.8@W*>"KHD,8I,&QC)38SD,^@
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M/MW_ #7@'UD+HE?E[Z_^3[=_S7@'UD+HE?E[Z_\ D^W?\UX!]9"Z)7Y>^O\
MY/MW_-> ?60NB5^7OK_Y/MW_ #7@'UD+HE?E[Z_^3[=_S7@'UD+HE?E[Z_\
MD^W?\UX!]9"Z)7Y>^O\ Y/MW_-> ?60NB5^7OK_Y/MW_ #7@'UD+HE?E[Z_^
M3[=_S7@'UD+HE?E[Z_\ D^W?\UX!]9"Z)7Y>^O\ Y/MW_-> ?60NB5^7OK_Y
M/MW_ #7@'UD+HE?E[Z_^3[=_S7@'UD+HE?E[Z_\ D^W?\UX!]9"Z)7Y>^O\
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M?;O^:\ ^LA=$K\O?7_R?;O\ FO /K(71*_+WU_\ )]N_YKP#ZR%T2OR]]?\
MR?;O^:\ ^LA=$K\O?7_R?;O^:\ ^LA=$K\O?7_R?;O\ FO /K(71*_+WU_\
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M-&K[5J,574K%;)->5E"0L:[U?*.F,:5TX-X22CE<Y"=F,G-^R PC]3;Z1_\
M"/E_\LM)^:$ ^IM](_\ A'R_^66D_-" ?4V^D?\ PCY?_++2?FA /J;?2/\
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MVQYF7EF$5",WBV)2?7P0Q&J."I8*7.,YQDV0V9
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M'4'SMFXCG3RKW6!866 =.8]V1-TQ<.(F32.=%4I5$C9R4V,9QG #W
M             .<'YJ;Z?/IW?F_\2/[9_(<!T?                1%]3CH
MJ</.K+.ZAL/*.3W-'O\ 2<3<8:G8U5=8*I-U6=X>5Y]-9FDYBFVHSY8JU9;>
M 9,R."%R?&<&[V,X"+;ZFWTC_P"$?+_Y9:3\T(!]3;Z1_P#"/E_\LM)^:$ ^
MIM](_P#A'R_^66D_-" ?4V^D?_"/E_\ ++2?FA /J;?2/_A'R_\ EEI/S0@'
MU-OI'_PCY?\ RRTGYH0#ZFWTC_X1\O\ Y9:3\T(!]3;Z1_\ "/E_\LM)^:$
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MVR'MD@G+PD.>$9EBG$/5JLFT9Y9GSDY#IJF,?V<&QCV $F8
M          *(?GB_@KZ=OQ@<CO<YJ !8]Z _T-O3V^("(^WL\ E_
M
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MG!^:F^GSZ=WYO_$C^V?R' ='P
M                '/#\\7\*G3M^+_D=[H]0 +_FIO@KUI\7]-]SD: R
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M  HA^>+^"OIV_&!R.]SFH %CWH#_ $-O3V^("(^WL\ E_
M
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M&, /2                  #G!^:F^GSZ=WYO_$C^V?R' ='P
M                                        '/#\\7\*G3M^+_D=[H]0
M +_FIO@KUI\7]-]SD: R
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MT7ZQ_#]P
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MBM;/3-3K+5.E7=^NW@JW3J&\M\>\440C<2R[N).5L4S,RG>;A:5
M          !S@_-3?3Y].[\W_B1_;/Y#@.CX
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MX]0P=([98APO?  "B'YXOX*^G;\8'([W.:@ 6/>@/]#;T]OB B/M[/ )?P
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M)M?*O&6/,"_<8;M".7T&K(&:+*E3(115$QB8[N< ,]
M  YP?FIOI\^G=^;_ ,2/[9_(<!T?
M                    <\/SQ?PJ=.WXO^1WNCU  O\ FIO@KUI\7]-]SD:
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MJX6465-@O?674.JH8RAS&R'O@ !1#\\7\%?3M^,#D=[G-0 +'O0'^AMZ>WQ
M1'V]G@$OX    "OYUT_ZK?\ +=_1$)';/WUO\E\)5H<XEZG^5?-JOV)'*T
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MM(4'UQK'CEE8L/6(F(I<$]GG;#DX3#F0=)-2+OW*;?OKKG45[F3&[,A=!
M                !S@_-3?3Y].[\W_B1_;/Y#@.CX
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M]H,-ZS6_2F.$SD 0   '/#\\7\*G3M^+_D=[H]0 +_FIO@KUI\7]-]SD: R
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MA%VW4(NV46;G(J8-OP !S@_-3?3Y].[\W_B1_;/Y#@.CX
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MJ[3*A#>D*-X]D599V[=.WKY9U)3$U,23I9Y(/W:R[Q^^<*N'"JBRASY#,P
M      "B'YXOX*^G;\8'([W.:@ 6/>@/]#;T]OB B/M[/ )?P    %?SKI_U
M6_Y;OZ(A([9^^M_DOA*M#G$O4_RKYM5^Q(Y6@            S#QY^'[1WQP
M:S]VD(/$S+Z.8AP*OV*9G.K#E*R]QY8=]4EZ85_.B4
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M_/%_"IT[?B_Y'>Z/4 "_YJ;X*]:?%_3?<Y&@,@
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M     K^==/\ JM_RW?T1"1VS]];_ "7PE6ASB7J?Y5\VJ_8D<K0
M   9AX\_#]H[XX-9^[2$'B9E]',0X%7[%,SG5ARE9>X\L.^J2],*_G1*
M
MT ZL7T674L_, YD?V==C *P/DAOQ6></Q_Z[_FZ< (R^MX@GI+S6?$K;EZ.M
M'4V3W+TW-S>GJHI($+2Z5L:CU*=?ME7#E-NY1;2&LI(N5#F1)A1(Q#9Q@F3Y
M"4KSN=PAF7#SAA0%UREL-FY*VFX1;7*B6#K0U&U=+PL\N5+)\+'*V?;#C2Y,
M4N2ERKC!LXR8N,A$CUP]'W&D^7YZ UBF6;I%G6*5EC+^(SPGAB^W[J: VS46
M#PY7*N6C[U!6'>/!.7Q3914[Y4CIF3 61=F[@I/U1:-NA) IH+]4GJ33^7)E
M6I,>W;.J:7H%2/P?#@Z63%V-VM,%[WBFSC!>YA3/AX"OST4]'W&W>6GZX5@C
M&;I1O;S;#+!()M,++R.=$Z0J.R+/EBEZ2FX=E6CY@J!,D3[/&3.5/*RA3I%"
M3'R1EP@WO#GF=06[GO66L\EZQ<)9GVH_M$'>-6PL+7G/=*L9?'I;_7LF7M,F
M4F?!^Q,;.#X($6?0^;^_AYJ_EKMZD&,_J$3N'J0[I5>HX1<)9IEVV/=:?"/5
M%TG&$BHKR>T(TN%$_%P8RA<8QW3=\H6J^JWY=[C'U;>0]-Y';HW;O?6UII6E
MZ[I)A!ZO5U\2 =P%<O&Q;VUEGF+73+%(^N%Y'9#I%3N+E1\%!+L)@W?,8(R/
MJ2_ 7\J[E_\ _*-,?-< K$]4OI<:AZ275LX0<<=+[!V1LFK76'XU;M?SFT#U
M@\^TG['R7V%1'42SS5(&NQWJ=".UNU63[Z!EO&75[3Y+W"E#K9@
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MRE9>X\L.^J2],*_G1*
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MY&87]82LF[:QQWZJ+-+#)$K+"BX6&@ !S@_-3?3Y].[\W_B1_;/Y#@.CX
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M=6'*5E[CRP[ZI+TPK^=$H
M              @U\QGQ&W+S1Z3V_P#5.@H:4MNSZ]*4#;$-084JJLOL&.UO
M:F,Y9*K$,D,'6EIP]=PZ>QS$A%%G\BR0;I%RLJF C.Z ?3AZ*/(?IT:(LQN.
MW'7?O(9Q65$N3'OO,(G8.V*QN*+DY!G;8.9J=H>R3R@0L<X[I(MLT91[9W%8
M:NCE566.L<)O/U*72/\ \.7B!\A])_>L!)#5JO7:/6*Y2Z?"QM:J50@8BKU>
MN0S5)C$0%=K\>WB82%BF*!2(,XV*C&B2""1,8(FDF4N,=F 'W@
M         <X/S4WT^?3N_-_XD?VS^0X#H^
M           (.>LY_5N_EA_HM$$]M;U9\H^ K(N;X];O)7G%!R()K(@
M 7C!>PYNP   '/#\\7\*G3M^+_D=[H]0 +_FIO@KUI\7]-]SD: R
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MP"7\    !7\ZZ?\ 5;_EN_HB$CMG[ZW^2^$JT.<2]3_*OFU7[$CE:
M     #,/'GX?M'?'!K/W:0@\3,OHYB' J_8IF<ZL.4K+W'EAWU27IA7\Z)0
M                                                   !&!UF.%6T
M^HETV>1_#K2D_K^K[-W![S_M:G=I2MCA*(Q][_?6KMI3/KV3J=5NU@;>DU^D
MNT6OH\6Z[[Q1(A_#3,=5,*(?U*GJF_?\X ?*GR*_NJ@'U*GJF_?\X ?*GR*_
MNJ@.D)Q9U?/Z0XQ\<]+VMY#R%IU#HC4.K[*_KSAZ[@'T_0-?5ZJ3+R#=24?$
MR+F'<R,2H=LHX:MECHF+DZ29LY)@,[@                   YP?FIOI\^G
M=^;_ ,2/[9_(<!T?                                     $'/6<_J
MW?RP_P!%H@GMK>K/E'P%9%S?'K=Y*\XH.1!-9$      "\8+V'-V    YX?G
MB_A4Z=OQ?\CO='J !?\ -3?!7K3XOZ;[G(T!D
M                5'><'XV>]ONY=_N-D*@->O*[C_#YM[*O7V<.0W+/%LN_
MG:JC4S=H     D;Z6'XV</\ </=?W$W$E-E'E=H\ N=[*B5MK<AMQQE:;^99
MQ%HBG    !JQS9U[Q/VKQ;V[K_G(_H\7Q3LD/#MMPO\ 9&S7FFZ0VAFUJ@9"
M&-/[,C[91GE4;FMC./*FL259Y67R1')C85RF<*U/ZM/R;?WQN '_ -UBO/\
M?( /U:?DV_OC< /_ +K%>?[Y "=[I?Z/Z:.@=!6^G=*Z:T_.\?)+<$_9;B[T
MIR%E>2E53W*\I>OXNPMI"]3&R]J.8FP$I,-7C*Q)9!%-!L=!QAN3+HRJP2/@
M        *(?GB_@KZ=OQ@<CO<YJ !8]Z _T-O3V^("(^WL\ E_     5_.NG
M_5;_ );OZ(A([9^^M_DOA*M#G$O4_P J^;5?L2.5H            ,P\>?A^
MT=\<&L_=I"#Q,R^CF(<"K]BF9SJPY2LO<>6'?5)>F%?SHE
M                                       &I'.[F)KC@'Q(WCRZVJ@X
MD*EIBGGG"5YBZ28R5QM$G(,:Y1Z/%O%T7*3*0N=RF&$:FX.DHFURY\90N4TS
M .;*7>OF9NNK9K;NGC>OR5;:=:6*0BX*LZ$VFTXJ\=*N9JHH]+486RV'8>L8
M;9<]7$CEPX<R4M.32!ED\+*IE503 96T3U1>NMT'.0FLJAU,H3D7L;CE<) \
M;/Z_W_;&VX,3%9C%F;";E- \@<V"[1^;90F;A%9*':6)>&41522=-D2N6SQ
M.F;K^]U/:5#I.S:%--;'1MBU&MWNEV%CW_0IZIVZ&96"N33/Q")J>BRD/((K
MI]XN#=Q3';C&0'K@                   <X/S4WT^?3N_-_P")']L_D. Z
M/@                                    "#GK.?U;OY8?Z+1!/;6]6?
M*/@*R+F^/6[R5YQ0<B":R(      %XP7L.;L   !SP_/%_"IT[?B_P"1WNCU
M  O^:F^"O6GQ?TWW.1H#(
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ML4S.=6'*5E[CRP[ZI+TPK^=$H
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MX(4-X0                   <X/S4WT^?3N_-_XD?VS^0X#H^
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M/M[/ )?P    %?SKI_U6_P"6[^B(2.V?OK?Y+X2K0YQ+U/\ *OFU7[$CE:
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M8N<9QGL ?V                   !S@_-3?3Y].[\W_ (D?VS^0X#H^
M                                 (.>LY_5N_EA_HM$$]M;U9\H^ K(
MN;X];O)7G%!R()K(@      7C!>PYNP   '/#\\7\*G3M^+_ )'>Z/4 "_YJ
M;X*]:?%_3?<Y&@,@                                      "H[S@_
M&SWM]W+O]QLA4!KUY7<?X?-O95Z^SAR&Y9XMEW\[54:F;M     $C?2P_&SA
M_N'NO[B;B2FRCRNT> 7.]E1*VUN0VXXRM-_,LXBT13@    P]O[0.H.4FH+M
MH/?E)8[&U%L9BQC;K2I)],1K&>8QLQ'6!BW</J_(Q$PW*WF(ALOC*#E(V3)8
MQG.2YSC(4]^7U1\G-PGO4]JK;.I]7V7:M6>*QUEU]IR4Y.;9E:[)MEC-W\/8
M)^I7IY1(&P13@ADW<8\ET))JH7)%$"FQG& \MQ0V3Y,O<>QX*"JFH=0ZTNSB
M2:H0$?R>KN]:_1Y1T=XU3;D?S6R;/8],IHJN5"%RC,O4,*DR;&2&3[X"[A48
M&IU:K5VN4.%KM<I,'"QL94X&HQT;$5:(KK-HDC$1]=BX9%O$Q\*U8E(1LDV3
M(@1+!<$Q@O8 ]$         HA^>+^"OIV_&!R.]SFH %CWH#_0V]/;X@(C[>
MSP"7\    !7\ZZ?]5O\ EN_HB$CMG[ZW^2^$JT.<2]3_ "KYM5^Q(Y6@
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M\7\*G3M^+_D=[H]0 +_FIO@KUI\7]-]SD: R
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M7J)D3J*2,#8J]K:NQCZMR)U2E.:0K1V^&"_[./%;F[#&Q]ED-WP
M          <X/S4WT^?3N_-_XD?VS^0X#H^
M            (.>LY_5N_EA_HM$$]M;U9\H^ K(N;X];O)7G%!R()K(@
M  7C!>PYNP   '/#\\7\*G3M^+_D=[H]0 +_ )J;X*]:?%_3?<Y&@,@
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M 2_@    *_G73_JM_P MW]$0D=L_?6_R7PE6ASB7J?Y5\VJ_8D<K0
M     9AX\_#]H[XX-9^[2$'B9E]',0X%7[%,SG5ARE9>X\L.^J2],*_G1*
M                                                   -$NHGQ?X>
M<F^)F\:-S2+"UC0;ZLPUGVUL<TS'468K%5U7:H#9R,JIL-1J=[!1L=(T] SC
M.#]BK7Q$>SL4S@!7,T!U\?+C\)=/TKBWI22V===7ZA:RT'4K/)\=[-:GTNSD
MK#,6)TZ7L-YA*S:I0II*96\([MD@H5'N$[O87 #*4IYL_HE:_CW=EHE0WA/6
M1JW73915'XZ5RMSSWQ$5#9;I2UBM%3BVS=<Z94SY.\+_ +_&>Z;&,]@6>-$;
M49;TT?IK=L;$.H".W'JG7FU&$"^<I/'L(RV%48>VM8AX[0320=.HU"7*BHH0
MI2'.3)L8QC/8 RL                   #G!^:F^GSZ=WYO_$C^V?R' ='P
M                                    !!SUG/ZMW\L/]%H@GMK>K/E'
MP%9%S?'K=Y*\XH.1!-9$      "\8+V'-V    YX?GB_A4Z=OQ?\CO='J !?
M\U-\%>M/B_ION<C0&0                                      !4=Y
MP?C9[V^[EW^XV0J UZ\KN/\ #YM[*O7V<.0W+/%LN_G:JC4S=H     D;Z6'
MXV</]P]U_<3<24V4>5VCP"YWLJ)6VMR&W'&5IOYEG$6B*<   8WV_J#6>_=9
MW+3FXZ;#[!UAL&'4@+I2Y]-5:&L4,LJBNK'R"2"R"QVYUD"&S@IRY[2X]D!&
M1^H'Z-O^'MH#_1$[^_P!^H'Z-O\ A[: _P!$3O[_  !^H'Z-O^'MH#_1$[^_
MP#>_B_Q"XT<+*!+ZMXKZ<I^D->S]PD+_ #%4I39VUBI"Y2L+7Z[(6%PF\=O5
M<R#N$JL<V/G!L%\-HGCL[<9SD-D    4-_,Y]=F"ML-=.DKP=<N-F7_8,PQU
MOR8V%2DCV%!JLXEVS53C=K9O%(/7-JOECF2HL;$JT[Y&1,GAT\+O5WA(\)FO
M+6=)VV=,'A;.2>[8I.&Y0<HYR V%M^OE4:KK:^K59CI)CJ[5;]XR<.6C^8JS
M2P2DC(*)FR1"2G'#0N5"-BK*A&!UU]S^8II'/RPP736A^5[WC GK#6KF*7U#
MH:L;!IN;DYC7AK>5"QRNNK*[5D"O,)^.EEUDJ1NS&"E[0$./X2OG)/X.<_\
M]$^C?,V B8ZJFS^M7L* TPCU98SD1'UZ+F+JKI/.\=0P.L6JLRZ95LEXQ75X
M:E5,TPX*Q0C/22*&7PB7*><8+W\Y,'3CZ _T-O3V^("(^WL\ E_     5_.N
MG_5;_EN_HB$CMG[ZW^2^$JT.<2]3_*OFU7[$CE:            #,/'GX?M'
M?'!K/W:0@\3,OHYB' J_8IF<ZL.4K+W'EAWU27IA7\Z)0
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MU  O^:F^"O6GQ?TWW.1H#(
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ML.4K+W'EAWU27IA7\Z)0
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M>                   !S@_-3?3Y].[\W_B1_;/Y#@.CX
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MG-GBWSRUM-[>XD;=A]SZXKEXDM;S=HA(>U0C5A=X>!K5GDH!1I;X&O22CAK
MW"-<94(@9#)71<%/DY3E*&TX  T@Y2]-G@KS9M5;NW*WC/KC>5JJ%?/5:Q-7
M=K*.W4+7U9%U+JQ;'#.39(IMU9)XHJ;/<R8QC>SGLQC& U?_ % _1M_P]M ?
MZ(G?W^ ;:<5>GGPIX/R%SE>)G'+7>B9#8C.$C[L[H[-^U5LC*N+23F#;R.7L
M@]P=.-7F')D^[@O9E8W;V@-RP !1#\\7\%?3M^,#D=[G-0 +'O0'^AMZ>WQ
M1'V]G@$OX    "OYUT_ZK?\ +=_1$)';/WUO\E\)5H<XEZG^5?-JOV)'*T
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M0+Q@  YP?FIOI\^G=^;_ ,2/[9_(<!T?
M         $'/6<_JW?RP_P!%H@GMK>K/E'P%9%S?'K=Y*\XH.1!-9$
M"\8+V'-V    YX?GB_A4Z=OQ?\CO='J !?\ -3?!7K3XOZ;[G(T!D
M                                5'><'XV>]ONY=_N-D*@->O*[C_#Y
MM[*O7V<.0W+/%LN_G:JC4S=H     D;Z6'XV</\ </=?W$W$E-E'E=H\ N=[
M*B5MK<AMQQE:;^99Q%HBG    !I=U#^',;U >&6].'LQ?'VL8W=T# P;J]QL
M WM#ZO$@KI6KD1RW@74K"(2)G*M<*ADIG2."E5R?MSDO=R%/:R^2>T)3(=W8
M;AU-;%4Z^P+WWTY9=$TR"AV9.S.>\[DY3=#5DW+V%S[)SXQ[ #Y=+\EUQJV0
MP7E==]4U]?8MJMANYDJ7IF@VE@W<9[W8@N\@]VOFZ2V>X;[$QL&]C/L>P M$
M=&_I5P'2$XQWKC77-SS&\V-WWQ9]XJVV;I3*B.HYU9=?:PH1ZZG$,+):$7+=
MHCK0CG#G+@ACF=F)X>,)X,<)9@        %$/SQ?P5].WXP.1WN<U  L>] ?
MZ&WI[?$!$?;V> 2_@    *_G73_JM_RW?T1"1VS]];_)?"5:'.)>I_E7S:K]
MB1RM            !F'CS\/VCOC@UG[M(0>)F7T<Q#@5?L4S.=6'*5E[CRP[
MZI+TPK^=$H
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M4J722W(&SM:VFWG=16:U5MI'XO;*R9(T7<$?)J944.GA)5$QP[%8
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M2],*_G1*
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MY78AK"N%4"+/TO6"B>"-#HJ.PO&  #G!^:F^GSZ=WYO_ !(_MG\AP'1\
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M4K+W'EAWU27IA7\Z)0
M          !HEU*^>%"Z:W#'<G+_ &! NKBTUM&Q+2KT*/E$(60O]]MDW'UB
MF5)O++M)#$4U?S<HFJ_>%:O#L(M!RZ*W7RCX)PY^;[SA?5\V!.S+_6FC^+3&
M";+)^% 5W2^VKHI#-'!W'J\LM+J[:<KN'SA) V#*^&U26,D;*:*>,9+@/\_6
MR^N']Y#0'Z-&V?G- =(3BSL.U;=XQ\<]KWMJS8W?9^B-0[#N3&/8N(N/9VJZ
MZ^KUDL+5C&O%W3N.9MY>26(D@JJHHB3&"&,8V,YR&=P
M  <X/S4WT^?3N_-_XD?VS^0X#H^
M    (.>LY_5N_EA_HM$$]M;U9\H^ K(N;X];O)7G%!R()K(@      7C!>PY
MNP   '/#\\7\*G3M^+_D=[H]0 +_ )J;X*]:?%_3?<Y&@,@
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MCRP[ZI+TPK^=$H
M       A&\Q+Q]USR.Z2G)BH[)VW3=&,ZP;7=^J>S=BR#Z+H$-L*$V%7(ZFP
MEO>QS.0=-(F_RLV6NE<806*R=2R+HQ#X1R7(1.]"#KG=)72O3HX_<:]G;DH/
M%/<6EJR[JFSZC:*]-Q\%<[:QDW6)/:D)?*["2U/MQM@]XCY=0S[#]-R91+*6
M6Z:"JH3.?K^.C;_B$Z _TO._O" E;IMOK.PJA5;]2YEG8J=>*W!V^IV"/,<\
M?.UFRQC6:@9EB=0B:AF<G%O4ETLF*7.2'QVXQ^P ](
M #G!^:F^GSZ=WYO_ !(_MG\AP'1\
M     0<]9S^K=_+#_1:()[:WJSY1\!61<WQZW>2O.*#D0361       O&"]A
MS=@   .>'YXOX5.G;\7_ ".]T>H %_S4WP5ZT^+^F^YR- 9
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MBZ:BH6#@        %$/SQ?P5].WXP.1WN<U  L>] ?Z&WI[?$!$?;V> 2_@
M   *_G73_JM_RW?T1"1VS]];_)?"5:'.)>I_E7S:K]B1RM            !F
M'CS\/VCOC@UG[M(0>)F7T<Q#@5?L4S.=6'*5E[CRP[ZI+TPK^=$H
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M                    YP?FIOI\^G=^;_Q(_MG\AP'1\
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MRP[ZI+TPK^=$H
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MU5M2:A69%B,H:P72F0\Y88EAAPLX7-'QLV[<((&.<YCHD*;.<]O: VC
M              !S@_-3?3Y].[\W_B1_;/Y#@.CX
M                 @YZSG]6[^6'^BT03VUO5GRCX"LBYOCUN\E><4'(@FLB
M      !>,%[#F[    <\/SQ?PJ=.WXO^1WNCU  O^:F^"O6GQ?TWW.1H#(
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MZ,XD4J8HFN+7LB7VQ-Q$W<[5>73F[SM8I]/DI).6M\K+R3=NM T2-2PW(H5
MAD3'*7!U#Y,&ZX        "B'YXOX*^G;\8'([W.:@ 6/>@/]#;T]OB B/M[
M/ )?P    %?SKI_U6_Y;OZ(A([9^^M_DOA*M#G$O4_RKYM5^Q(Y6@
M     S#QY^'[1WQP:S]VD(/$S+Z.8AP*OV*9G.K#E*R]QY8=]4EZ85_.B4
M                                                   1D=87@,OU
M+>GQOCBA"2\77+_:8^!MFI[%-F63AHK9VOY^/M=61F7#=L^<,H.R*1RL,_<I
MMW"K5C)++)IG4(0N0YD7*;G9U4.-/!>S]$_FIJ M4U?6IJL(5!WM.@6.)VK3
MHO7][B;U"06O=AQT\TI%^UDH]9&PS<Y93.,L7*964@1HF@E@-@$.2/5^\P=0
M.*_3DU/J"%C^./'YCJ>IO)/6]+M4+KB)-KFE-=>Q.UN1VV;--V!CZ5 5TSYT
MWBV2L<B[56R1I&/) C;(#J2<9M%5KB_QST/QOISE1]5]#:?USJ"#DUVB+%W,
M1^NZC$U1&<D&S<ZJ1)2;Q%^ENL]\^3N%CF,8QLY-D,X
M   YP?FIOI\^G=^;_P 2/[9_(<!T?
M      $'/6<_JW?RP_T6B">VMZL^4? 5D7-\>MWDKSB@Y$$UD0      +Q@O
M8<W8   #GA^>+^%3IV_%_P CO='J !?\U-\%>M/B_ION<C0&0
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MA!XF9?1S$.!5^Q3,YU8<I67N/+#OJDO3"OYT2@
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MU@                   <X/S4WT^?3N_-_XD?VS^0X#H^
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M_@    *_G73_ *K?\MW]$0D=L_?6_P E\)5H<XEZG^5?-JOV)'*T
M    &8>//P_:.^.#6?NTA!XF9?1S$.!5^Q3,YU8<I67N/+#OJDO3"OYT2@
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MM=8A7N;.E"A:5*T\TE.$=,*<DTT8RR:>AIW$L82Z='1T/J#ZGQ@
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M\&,<V,FR&_H                   .<'YJ;Z?/IW?F_\2/[9_(<!T?
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M/3--4K0IQEGTQ_5A",8:8;G1'3_*TCV1S%ZQFI]=WW:=WX"\>XVF:TI=IO\
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M*D"'CLT5'><'XV>]ONY=_N-D*@->O*[C_#YM[*O7V<.0W+/%LN_G:JC4S=H
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MI6#[ MG:7>+YFA=TJ=6$MM9:-W++-HTSW.G1IA'1I06>V>R_PAG/]+/_ /I
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M<X8/A,N4<5FEM;>$T,.N8PC"G)T/^#/_ /2N<BZQSX
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M:F^GSZ=WYO\ Q(_MG\AP'1\
M0<]9S^K=_+#_ $6B">VMZL^4? 5D7-\>MWDKSB@Y$$UD0      +Q@O8<W8
M  #GA^>+^%3IV_%_R.]T>H %_P U-\%>M/B_ION<C0&0
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MQ:DOE JYD4C*E3P;)"YSW<!F4                   '.#\U-]/GT[OS?\
MB1_;/Y#@.CX                                     @YZSG]6[^6'^
MBT03VUO5GRCX"LBYOCUN\E><4'(@FLB      !>,%[#F[    <\/SQ?PJ=.W
MXO\ D=[H]0 +_FIO@KUI\7]-]SD: R
MT>ZDGXD>_?N?K_NXJXS[5=Z>X=^TG[%41ZVK/P^YEX-1[[MU-D3>43
M RQ5?^I6W_&./^74'/!S@GXHL:X'AW>-!VJ<S-^ +*W&>-?Q:[>C$*EIP
M  D;Z6'XV</]P]U_<3<24V4>5VCP"YWLJ)6VMR&W'&5IOYEG$6B*<   1 =?
MCZ&WJ$_$!+_;V! <MO@5;>M!7]<W%MTU&O4)<:I6NQE[X;B!2MY6:D%V%ZBB
M$SELSO5L#*P[>U>ULC'M3<'*Y]$\$W=[F29R&]/OE^:]_P#-O6^^2;F!_$T
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M5UH=RHV*HX6([04,$^@  YP?FIOI\^G=^;_Q(_MG\AP'1\
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M--P9RMH^+CD'+YZX,4F<X(F0QLXQGV/8 0N^3.UOL/6G!7E)$['H5TU_*/\
MEFO(,8V[5:<JD@]C\Z>UFVP^:,YUBP<.6>7"!T_%(7).^0Q>WMQG "X2
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M5[=2+JM<CKO?3V).785NKHMF[M'99&V&V6YS$,T,?Q,X4P4@=>,
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MD^'</M^RR,:SEZ(8KQ;<]AG75!=TYX
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M'I,FP#-&8,6Q&%GB."7-A;1DFCU6>I+-+",.E+HA+".F;\G12.#Q&=
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MR9T8PVH /AV?_5JP_P"8Y;]P.!\&*_1=SP>IO(O2P;Z8M.$TM_*I'BC9T9
M     G^Z.?P:[D^[B!^T"@L*V,O1C&N'TNQ*N=OWTOR_Q;6[-!,<)G( @
M #1[J2?B1[]^Y^O^[BKC/M5WI[AW[2?L51'K:L_#[F7@U'ONW4V1-Y1,
M  #+%5_ZE;?\8X_Y=0<\'."?BBQK@>'=XT':IS,WX LK<9XU_%KMZ,0J6G
M   "1OI8?C9P_P!P]U_<3<24V4>5VCP"YWLJ)6VMR&W'&5IOYEG$6B*<
M               40_/%_!7T[?C Y'>YS4 "Q[T!_H;>GM\0$1]O9X!+^
M  K^==/^JW_+=_1$)';/WUO\E\)5H<XEZG^5?-JOV)'*T            &8>
M//P_:.^.#6?NTA!XF9?1S$.!5^Q3,YU8<I67N/+#OJDO3"OYT2@    "%7K*
M?ZM:%_SY?_W!5!"+;1^B\O\ "+O>4%B'-^_3&9^#66_N4#H@(LT
M   >XUC\)6O?NXJ?V_CQ[V5O2?#N'V_99&-9R]$,5XMN>PSKJ@NZ<\
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M[&WV)2E["X#>$                   '.#\U-]/GT[OS?\ B1_;/Y#@.CX
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MV5O2?#N'V_99&-9R]$,5XMN>PSKJ@NZ<\
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M42MM;D-N.,K3?S+.(M$4X                   HA^>+^"OIV_&!R.]SFH
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M\D.10A5$S%.0Y2G(<AL&(<AL8,4Q3%SG!BFQGMQG'L9P _T
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MO6I_T-B>_P#U)>U6!]UTOA'X;/$7\H_3_P#MQ"?]*#["9S\5WO6I_P!![_\
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M-$@:RUM<>T;R4R@U8V)",*\13(\=$(FM@N%E<8[Y@S<
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M     $_W1S^#7<GW<0/V@4%A6QEZ,8UP^EV)5SM^^E^7^+:W9H)CA,Y $
M  :/=23\2/?OW/U_W<5<9]JN]/<._:3]BJ(];5GX?<R\&H]]VZFR)O*)@
M   98JO_ %*V_P",<?\ +J#G@YP3\46-<#P[O&@[5.9F_ %E;C/&OXM=O1B%
M2TX     2-]+#\;.'^X>Z_N)N)*;*/*[1X!<[V5$K;6Y#;CC*TW\RSB+1%.
M                  *(?GB_@KZ=OQ@<CO<YJ !8]Z _T-O3V^("(^WL\ E_
M     5_.NG_5;_EN_HB$CMG[ZW^2^$JT.<2]3_*OFU7[$CE:
M#,/'GX?M'?'!K/W:0@\3,OHYB' J_8IF<ZL.4K+W'EAWU27IA7\Z)0    !"
MKUE/]6M"_P"?+_\ N"J"$6VC]%Y?X1=[R@L0YOWZ8S/P:RW]R@=$!%F@
M       #W&L?A*U[]W%3^W\>/>RMZ3X=P^W[+(QK.7HABO%MSV&==4%W3G@
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M4WT^?3N_-_XD?VS^0X#H^  #5[FS^*+R/^)^\?:1T,LR)Z9X7PVEOX-0:_\
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M/M[/ )?P    %?SKI_U6_P"6[^B(2.V?OK?Y+X2K0YQ+U/\ *OFU7[$CE:
M          #,/'GX?M'?'!K/W:0@\3,OHYB' J_8IF<ZL.4K+W'EAWU27IA7
M\Z)0    !"KUE/\ 5K0O^?+_ /N"J"$6VC]%Y?X1=[R@L0YOWZ8S/P:RW]R@
M=$!%F@           #W&L?A*U[]W%3^W\>/>RMZ3X=P^W[+(QK.7HABO%MSV
M&==4%W3G@                             &@'5B^BRZEGY@',C^SKL8!
M7!\DO^(+RN_._<?S,:N : <-O^^C;\^,#E!_9TF0'0\
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M"&GHQT=)->,6;70<]9S^K=_+#_1:()[:WJSY1\!61<WQZW>2O.*#D0361
M    O&"]AS=@   .>'YXOX5.G;\7_([W1Z@ 7_-3?!7K3XOZ;[G(T!D    $
M#G7*_P!5>.OW0;'^UM/$A=0/]+Q/]G0WU17'SAOT-E;A-]O+97;$EU7H
M  ,[I?\ !)_\63_Q<#DCS#]/WW#*W9)G^CYDOT.PGBRU[!(_H/'9,     )_
MNCG\&NY/NX@?M H+"MC+T8QKA]+L2KG;]]+\O\6UNS03'"9R (     T>ZDG
MXD>_?N?K_NXJXS[5=Z>X=^TG[%41ZVK/P^YEX-1[[MU-D3>43       RQ5?
M^I6W_&./^74'/!S@GXHL:X'AW>-!VJ<S-^ +*W&>-?Q:[>C$*EIP     D;Z
M6'XV</\ </=?W$W$E-E'E=H\ N=[*B5MK<AMQQE:;^99Q%HBG
M        %$/SQ?P5].WXP.1WN<U  L>] ?Z&WI[?$!$?;V> 2_@    *_G73
M_JM_RW?T1"1VS]];_)?"5:'.)>I_E7S:K]B1RM            !F'CS\/VCO
MC@UG[M(0>)F7T<Q#@5?L4S.=6'*5E[CRP[ZI+TPK^=$H     A5ZRG^K6A?\
M^7_]P500BVT?HO+_  B[WE!8AS?OTQF?@UEO[E Z("+-            'N-8
M_"5KW[N*G]OX\>]E;TGP[A]OV61C6<O1#%>+;GL,ZZH+NG/
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M.'^6LG+&*-N@"#GK.?U;OY8?Z+1!/;6]6?*/@*R+F^/6[R5YQ0<B":R(
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M;.'^X>Z_N)N)*;*/*[1X!<[V5$K;6Y#;CC*TW\RSB+1%.
M    *(?GB_@KZ=OQ@<CO<YJ !8]Z _T-O3V^("(^WL\ E_     5_.NG_5;_
M );OZ(A([9^^M_DOA*M#G$O4_P J^;5?L2.5H            ,P\>?A^T=\<
M&L_=I"#Q,R^CF(<"K]BF9SJPY2LO<>6'?5)>F%?SHE     $*O64_P!6M"_Y
M\O\ ^X*H(1;:/T7E_A%WO*"Q#F_?IC,_!K+?W*!T0$6:            /<:Q
M^$K7OW<5/[?QX][*WI/AW#[?LLC&LY>B&*\6W/89UU07=.>
M                 8 Y8[T_!?XL<EN2_M6]O'X._'_<F]/:5Z[]K/MP]Z37
M5CO_ +5O;'ZHL'M?]L'M?]$].] ?>B>-XOHZW=\,P4@OKSG_ -B[_P#39_\
MK1P#Z\Y_]B[_ /39_P#K1P#Z\Y_]B[_]-G_ZT<!>=X][7]_C06C]X^H?:K[\
MVG]:;7]J_K3UY[6_?$I<+;_4/KOU=#^N/4_KCT?TKT1KZ1X?B>"EWNX4,O@
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M;4:^QRKEE!UBL136$@8=GE=19?+6,BF*2"??.<_<)CMSG/L@/3
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M@J#OR.N#S%2C<J%["Q,9=];34@0F#&RFK,'Q]B3*> %T,  40_/%_!7T[?C
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MYKK=Z>2;P+C8=(@[<M"H2*K9FI((Q:DOE JYD4C*E3P;)"YSW<!F4
M     !A;DEM1[HOCKOS=L;$-9^1TYI7:>U&$$^<JLV4T]U[1IVVM8AX[;D57
M:M9)>(*BHH0ICD(?)L8SG'8 Y175PM_5LYZ: J'5)Y[P+C5''&7W16M#\7M,
MK1DU1Z\U+L&D;*O\C:M9Z\F5'L\YK>8W4F"2-IG%S/9U=XS(R5<,6WAL@Z+_
M $!_H;>GM\0$1]O9X!(1M#E-QCTA/LZINCD9HC4-ID(=O86%:VAM[7U GWT
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M<>T&"=W6O;3\)/CK]_S2ORIT;]_0^P6>?$N+=R7':SWEZN/:#!.[K7MJYO\
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MN'B!^DMIC^.HEV@R?K"> OY</$#]);3'\=0#]83P%_+AX@?I+:8_CJ ?K">
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M&B\\2,9%F5VI2I%PV6E"H8?*-\%0)C!#'R7L(7V/8P ^P
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M)E&Q45&LDD&4=&QS) B*"")")(I$*0A<%QC #Z0
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MOUOZ]]])3O\ ?]']']#+V=_Q,]P)W@
M
M              'YW;1J_:N6+YLW>L7K=9H\9NT4W+5VU<IF1<-G+=8IT5VZ
MZ)\D.0^,E,7.<9QG&0'S82MUVLMU6E;@(6OM7"WI"[:$BV,4W6<=PB7CJHL$
M&Z:BWAIE+WLXR;NXQCM[, /M                            T0Y0=3O@
M'PLO\1JWE1REUAI#84_3X^_P]4NKZ2:RLA396:L%=C["W39QCU+,>[FZK(MB
M9R;!O$:*8[.S&,Y#,_&7EGQOYEZ\>;8XN;@I^[-<Q]HDJ4^MM*=N'<4TM<0P
MB962@G!G39HLE(,XV>9KG)DG_!N4S8SG!@&OG(KJP=.7B3LY_IGDCR[U)J':
M45%Q$U)4BV2<DC-LHN?:8?0SQRBSBWB22<BS-A5/&3][),XSV=F<=H;/\>^1
MVCN5VK87=G'395;VWJFQO)F/@[S4UG#B$DGM=E74'-MVRKILU6,I&RS%5!3M
M)CL.GGL[<>R S8         UOB.7W&6?Y*V3AW [IH\WR=IE/3OUPTM$2*DE
M=*I4%DH)PC-V1FS06;03=5O:(Q0I'2J2QDY%J?!.ZX2R<-D &M][Y?<9=8;[
MUAQ>V)NFCTO?NZ8M>8U1K*R2*D5.WYBW5EFZGM:5=()Q<@\RX@W*1&I7'I*B
MI"D(F8RB>#AL@      (L-A=;GI/ZHO]XU;L;G/I"H["UK<+-0+W5):4FDY6
ML7*FS3VNVBO2::4(JD20A9N.7;+8*8Q<*)9QC.<>R DGI%UJFR:74-BT.=C[
M31[]5X"ZTVS1*N5XJQU2TQ+2=KL[&+Y*7*T?+Q#]%PB?LQWDU,9[ $7DYUWN
MD#6YJ8KLYS]T)'34!*2$+,1ZTQ,F58RD6[68R#-4R4(HD91L[0.0V2F,7.2^
MQG./9 2OQT@REH]C*QKA-Y'R;-M(,':.<Y2=,GB)'+5PEG.,9RFN@H4Q>W&/
M8R _8       #_)SD3(910Q2$(4QSG.;!2$(7&3&,8QLXP4I<8[<YS[&, -<
M^-O+OC1S"KMMM_%_<])WA4Z+<GNOK3:-?R"LS78VY1S%A)O8$DV1NG&R+I"-
ME&KC)FJJZ64'*2F#9(H3)@V.  &M^J>7W&7>&V-QZ(U1NFCW7<O'V4Q#[EUG
M%R*B=RH#XS]Y%X]<PCY!H\.SQ(,3I9=(%6;8/E/M4_;4N^&R           B
M8L/79Z0U3GYRK6/GQHB(L-:F). G8EW*S9749,PSU>.E(]R4D&<I7#)\V.F?
M&,YQ@Q<^SD!*G'3<1+0K&QQLDS>0,G%MIMA+HKDS'NHAXT(_:R23G.<)Y9KL
MU"JE4SG!>YGM_8 101W7HZ/,M(,8J.Z@&A'DA)O&T>P:(RTYE5T]>+$;-6Z6
M,P6,94774*4O;G'LY 2Y@        /GRTM%0$5)SL[)Q\+"0L>]EIF9EGK:.
MBHF*CFRCR0DY.0>*(M&$>P:(G5665.1-),F3&S@N,Y 8/XV<J./7,'7:VVN,
MNUJON76R%DE:B>YT]5XX@CV.#08.):,;NWC-GAVHQ2DT.^=+!TN\?NX-DQ38
MP&P #6_17+[C+R:LFWJ9H;=-'V=<- W!:@[IJE=D5#636=O1?S44>$MT$]09
MRD2X-*5R1;$.=+P5'#!PF0YCHJ8*&R     #&^W]OZST%K.Y;CW'<H?7VL-?
M0ZD_=+I/J*HPU=AD544%9"050176(W(LN0N<E(;/:;'L -&-+]9#I?\ (C:%
M/TMI/FGIC8NT[_(+Q5-I,!*RIYFPR3>/>2BK*/([B&J"C@K!@LI@N5"Y-@F<
M8[<YQC(;E[^Y":5XLZILV\>0NQZWJ?4M.4@T;->[8Y5:PD0K9)^+JT$DY4;H
MN7!E).P335JF4B9L]];&<]A<9S@-4./?5JZ;W*[:4+I/CIR^U)MO:UC9S,A!
MT:IR$JXFY)E78IU.3;ALDZB6J)DXV)8JKJ=I\=A$\]G;GV $B8        #"
M/(7DEH?B?K"5W/R0VM3=-ZNA'T3%R-SO$JG%Q*<I.O4X^(C&_:51U(23]TIV
M)MVZ:JV2%.IW?#3.8H9,J%LKM]J=7O50E$9NIW2NPELK$RW3<)-Y>NV.-;3$
M+*().D6[I-%_&O$E2E43(I@I\8,7&>W& ]$ \C?[Y4=6T6Y[,V!.-:Q1->56
MP7>ZV5\1PHQKM3JL4[G+%.ORM$7+GT&(B&*SA;)$SF*DF;/9GL >+T+R"TGR
MBU=7=U\>MFU';VJ;6:23K]YI,HE+0<@O#23J&EVA5B8*JW?1<JQ5;N$%B)K(
MJIY*8N,@,Q                            P%RNV78M+\6^2>XJ>2-5MN
MI]!;CV75TYELJ]B%+%1-=V.TPA)5F@Y9KNXT\G%)872(LD=1+O%P<N<][ 5B
M_+<=<3F?U7MW<D]>\H(O2;"!U/JNIW*KGU91I^IR"DO-6U2$>%E7$Q=;2F[9
MX9DQDA")I&*?V<FSCV %B#J-;^O7%;@=RYY(ZR1@5]A:0T%LG9=,1M$>YE:Z
MK8JG6WLK%DFHUH_BW3Z-,Z;E\5)-R@<Y.W&#E_9 5Z^@)UM.;_4]U#U*K9O&
MNZ?7N?%?6^J;%I>*U1KVRP_KFSWNL<C9)S'ST4[N5G>V/TF5U;$IM6[4S97/
MB+$QDYE"=P(5IGS&?F4J[$2M@L'!"-@H""C7TS-S<SP2Y*1D1#1$8U5>R4K*
MR3VWH,HZ-CF2!UEUUCD212(8YS8+C.0&)M6>:PZ[N\Y"5B=)<>=*;BE()FC(
M3D;JSBSN38,A#1[E;+9N^E6=2V/+N(YFNXQE,BJQ2$,?['&<Y]@!:%Z /4>Z
MI'.^W\FHGJ)<=?>+AM;UO5\CJQW^#UM32'MCD[+)W9M:V_I6QI:31L7JUK#,
M3>&TP0S;QNU3MPH7L"K1K3S9/7&W18CT_3NCM!;8MJ4:YF5*OK3C/MJ]V).(
M9*MD'DJ>$JVS)63)&M%WB)%5\I>$F=4F#&QDQ>T,MRGFKNN7QRE(>;Y0\)M2
MP-*D7S-NLPV7QKY#Z3=2:)C.%5&E9M4QL%HQ:2SQ%HKA-1=C)IEPD?.&YNZ;
ML"YSTBNKSQ^ZNV@W^T-6,76O]HT)U'PN[]%3LHE,6'6DY*D>J0KQI-I,(I"V
M4FT(1RZD7+)-6_C906160;N4%42!+*   #X]AL,#4H"<M=IF8NN5BLP\G8;'
M89Q\VBX6!@85DO)2\S+R;U1%G'1<7'ME%W"ZIR)(I$,<V<%QG("@7S/\VORO
MWOOMSQTZ.''/VYQZLI(0-7V%8=6W#;VY]M.F"JA/;!K;3=?51;U6MN$TS*H)
MR[&9D5VF2+.$(Y3Q&I UB?\ F,/,/=/^XU2:Z@'&8TGKZSOB((0.^>,TOH-.
MR-TL&6?QM!V12H>IQ3>S)-FQS?\ .&TV5L7.3JLSE[H"X#3.K)%\S.D5O+J!
M\!:W)6C;='U%LM>&TM/UB3NMGJ?(6C55*9-JRP5:JK-I&X+9<R#)=IF-4)F6
MC7K=9/"1U3))A4'M_F3/,=Z^K,S=+]PEK=(IU=9FD;!;+?P@Y%5JLP4>0Y$S
MOIF>F;HRBXQF0ZA2Y575(3&38QV^R \3JKS2_7TWLWFG>D.,FI=R-:VLR;V)
MSJKB7NW8;>!<21'*L<A-+5'84NG%K2";-8R!5\IF5*D?)<9P4W8%N#H%\[.H
M=SKU%OZV=0W1OO'7*B;(K-=UW%>\CL727KVLR584DI20]5[%DI)[.>C2I<)^
MD-C%23[>X;'> 3[ ,5[KWAJ'CCK&V[GWOL6IZIU918M:7M-VNDNVAX6,:(ES
ME-+"JYO&?RC];L09L6Q%GKYT<B#=)590B9@I <=/,]<G^:/6NU#QPT26E5S@
M;M3?3#6]5B;'KYNML^Q4./@GJ#BWR5C=N4GT%)726C%)-%GA IXMHY3:'\15
M)150+Z8"MWU]NO/K7I?:?E=5Z,N-)NW/>YFB&U/UV8J-I::?KSPZ$C)[)VU%
M-E,-(M$\*7",-$/%T'THZ?(NB(J,4'*A0S%Y=;J!\BNI3P"F.1')^2J<KLEE
MR#V+KA!U3:LUJ$1BLUJM:^E(M(T4S7<)&>$=V-SDZW>[3ER7'9]B FLV/LG7
MNGJ+:-G[7N]5UOKFDQ+B=M]YN\[&UFJUJ';=W"TC-3LNX:1T>U*<Y28,HH7O
M',4I>TQL8R%$6:\U!R"Y$]9'CKQPX:O:.RX);'Y9\:>/*<O;M;F<7W:-4NFW
M:G2MA["9.YPS";I3>U-K Y)"M56Z;MJP0;.'"*+M5=ND%\B[W6J:VI=OV+?)
MV/JU'H-7G[K<K-+*Y0BJY5*M$NYVQ3LFO@ILHQ\1$,%G"Q^S/=33SGL <^G;
MGFE.JCS6Y&6[5_2$XDEF]>5 LO+PS=GI6X;\W=9J;$N?5V;Y?&40\-5=?UV5
M67;&08DCS*LW;E)J>2=JJIDR$L?0M\R%:>?&])'@MSAU97=(\NVB-L3IDM6(
MVP52M["G-?H.G%UUU8*#;7TM8:%M:NQD2_?*MS.CM'2;!VGX3)=!-!P%ML
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MK]%+8<4QP1-K#;5ILE(4?9\<T:X.=5I%EO-<?*QY%>Q0T<JW4SCL/C.0W_
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MH,M25';+^O/XUWZGG(FQR$=(QSEZU5*VEU/'=D54PY])5#J\@
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M+8,8=LZJ4/+.DW35DT1;QV(@[?P\J(J9,'6P
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M,I&QK%2XNZQ]*E'.$H.>K\SF>]'(H99-F59R5P'TM ="GJG]53GI5^<77//
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M;%:FRX6<*!:+
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M\?\ 4"N64:RI\<YE9^P.K%9&E)K<%7R2J9([PHR-73(E@D@NF0)L@
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M_3>%7;6JQ32.=RU@E&-=J,&X/A%)S(/%%I1](O>\GE[E!()>
M
M
M
M
M
M
M
M
M
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MIXM10Y<X*5?"><YQG& &6P
M
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MXJ;-.X6:GHC8M;<Z?0JY'VOU'-<4BYB*?0SQ(V)%NFNJX;*KIX#?GK4U2O\
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MJ5AI"P<XQF7$%,1#\J3)HVD(Y0BF6Z1C]TH=<0
M
M
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M &@'FR_IP](?$!QH_G9V: Z?8
M
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M&KK?37U EJM7C5W,<I66:53D5&C3+#*!F1,$\'N9(7L#3SI]])_A+TP/?;_
MYUS8-?\ OX>T+WQ?7NQ+Q??6WO:>W3VH^B^W.;F?5/H'O@2G?]&\/Q_&+XG>
M\,G=#&_,GHC].[GOO^ Y.<F=3VBX[AK-;JM3AY^)VKL:GL6\)2YF6GZ^V/ U
MBQ1D,NHUDYIP<RAT<G5P?!3YR4N,8"6<
M
M
M    !YFY4JG;&JL]1=A5*LWND6J-<0UGIUR@8JT56QQ#LO<=14]7IMJ^B)B-
M<D]A1!PBHD?'L9+D!$7+^7GZ+TY836=[T_M-HR1GB;[+:(?[!KU>\9-QER4A
M:C 72-JA6>5,]AF^&6&YD_VLQ,D^Q 2@:3T+I/C90(W57'[4^O=+ZWB%EW3"
MDZSJ<+3:XD^=E2*]DU(R"9LF[J6?^ 3+EVK@[EP8N#*'-G': RT
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M\_'5&.EIN=85QG)2[-PY0AVDS9'[I- IL$*L\5/C':<W:&XX
M
M
M
M
M
M
M
M
M
M
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MV&K+8^OD7[Z7>I5TSU9!)PB61F&I4GT>\;2+IK)-S%"<@
M
M
M         !7\ZZ?]5O\ EN_HB$CMG[ZW^2^$JT.<2]3_ "KYM5^Q(Y6@
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M:\:1+9\F=5L])#%<-EE6ID#&"]8
M
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M@'4Y_$]O_P#GRA^[*&$>MJ/D:Q#A%KWQ32CV-^7S"^#7O>E55R%5BZ$
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M_026I3>V%@:]JM=DRED%GN9N4MEM>[ >IRZKEVM-HQ3AZJY657,<X7G
M
M
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MI&!GH-K>Y* ;U=]823MTLMR.Y<0+65FT(XS96QF0P4KI;!BI8/VXR;NX#=$
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MV'1*US9+S/,(V(9.5FC(A6[)FS:LXY@W+DJ"!#*+'5#?D
M
M
M
B                                         !__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>32
<FILENAME>tm2227887d4-lc_ct1119a5494c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2227887d4-lc_ct1119a5494c.jpg
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M! 0$! 0$! 0$! 0$! 0$! 0$!!L3 !HH ./ 4](5CA*3QA;;_%6@#RE.K(
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M" @(" @(" @(-#FM+V$M:3KJ0"1IZ#2H5CA*<X8[?XU\G_"AVD:G3;V[J?\
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M/GY)]:"&M!-2  3ZR!Q6+)% 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$&U-]7_
M *O6$6.$K;7XJ_\ 1*=6/YR[0_O^9$8EEG%WX#ON(,ME\*O^B,Z/?SCWE_"$
M*D?M'LSSU/T7?=+_ #0/W5)(89+($"YNR14#)79(]8$IJ/LK)(XRO;OA!^P[
MHWUFW]UB[K>LW3N+<V4Z/7N#BZ.WF9B=>8?"Y&Y:TY*[CQMY:S6.0F=#<.8T
MZF.AI0FJ1;72."]4Q'5/%D6X(?=X(;;'VT&-AC8&V]K;Q1Q6XBC \-D<,361
M0MY0!0 ::*Q,W6?VN?L2Z(BZD<.7^A8V_&2=J]AF>E'0WN(VOM;#X6_VID\M
M;;_RUA9V=K=9*+(0W$>+CNI(+9DUU(+M[R7/>3[6J+K,,?#:1WUO<;;NW49;
MRY&SDQKVR R1.ANX3(74/,T^)0ZJ5E*:5B69;\DK+7^9\LCMPR&1N9+G(9+:
M$GXR1SGNYH;6*%C7.>7&C60#TI,\*Z55C+/B$X9O^EL[IXFBLD.XK.M=-!;%
MU=:??I7J+J<WTSX8O],SVO?)_+@'YQM>]K]M6!E]U 00(!!!X$$'YB*%!+DE
MK[L&B AUNSG,4<D?B.8]VI/.X%QH[56)ZHZ)BEWBQMGIF9XV3R:K(2W%F;:]
ME?=N>7^\S .A,0!#HVT%"_0!)B;?)/&%MF8\]O-O6L;XS$(06,YJ/<ZKBYH=
M0?6^12>J8I,TIR91$1/5=;U3/"?!BR/BS+N4>91F+>XN&75G!A,3*+5D(A?"
M9;>Y(:Z9H#I*!QU*:3.D)QBDS7]BE#Y-%#YD';,1H#O6U('J'CMH/EHBQQ9I
M["?[S8C_ -&6']Z1(D<'9H" @(" @(" @(" @(" @(-L_7'V?N*QPDGE]K';
M_&O_ .-'M)_F]N_^_GK&.*_A^U9 ;!_Y=[*_G;MS^&+-5&=3[7_\W;HG_P#!
M=L3\U\6B1P6C'QG/^;?T$_G'F/\ P#T5C<O"DF=;0Q-+Y)C%%&P:ESY.5K&@
M>MSB$2>/V,K%\,EV#])NV_R]]D=?W]/K+']?.N-F,CO+<V8LH<CD(\=93LDP
M=I8,N[,3XV-K7.<X1NY7N<">"LTBD1'57C'WK$Q,3,STQ'-<P6]F_)6,MO<V
MHMX[QIAO\?>4O;6>TD')/$8)P^+DN(7$<M* &E%*ZZ:V<BDT\T4NEBE?BD>U
M>VZ#^8_NS>.V\%C=N;,ZKV&*R&VL1BX+:SM67EJRY.:NFV]M!!%%[S?2<U-3
M[7%(UFG$F*:SP4>^P+*9/ ]Y';YD\-=..7=U"VW%+&QQC-NUV;QT;F"4.;7Q
M(ZG0JUI-88Q%8Z6;1>]\G25\DGUW]..=_I]MVVG%VOIU*<F7-A%._+_/ [@/
M_A$W7_#MXH+F?X.+_.[ZI_S=MO[N-%Y,F4/U3]TH2BB" @(" @5'KX<4'!R>
M2QN(L;G(YC(66+QMI$^6\R&1NX+&RM86@E\MQ=W,D4$$;6ZESG !!C_/B'?B
M)+BXEW5V4=DFZ1;6]M<WN!ZH=3,+=B3WZ.DMKD<+C;RSOM&N KSCUU/H"D1$
M<>7!9NG[XU]JQ(L#EL_DCB[.WR&X\WGK\,%C;PW&1R>:R=[(7-\$1-FNI9W7
M#JT:'.>3\JO.J4F(_M3^ADZ/AE_*'F[+>AH[F>NNU8[?K1UBLK+(V-AE;"-V
M5Z?X9HM+O&MMW3V4=Q;SY%DU7\C_ &=0:I72D\/UE*ZQ/)=>6S3[U<>-&]]Q
M"6NMKCV@V5DE#HW@* K*G5-*TMCC[/WM.?)K2MT\/;^Y,8X"OJ"Q:B* @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M9:^GOI!+=3OEFFY73_LG'54JZFWO[JQEAGQ^3N[.XMW<T$UI+-;7$+@1K%-
M]DC#\Q"*FG_"9U#!)'4C?52 "?Y4[@J0- "??^ "(A_A+ZA@>SU(WR*5( W3
MN :_^/H)SV1OWJC-NO9ES/U$WXVTN=W;=MGW#=Z9]L@;)EK5CBT-R E8YK:D
M.!THE3FS@/;1<0OZ ]&HK>]FR,D/378KI)[E\AD>^3:^)<]TMQ,2Z9Y>XDN)
M)).JG5$S29H4F8ZXUH]"C@%00$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 00+FMU<0!ZR0/NH',T$ N +N J*GYAZ4#F;6G,*^JHJG
ML$4! 0$!! N:T5+@!ZR0!])T0 0>!!^8H(H""%030$5'$5U"" <TTHYIKPH1
MK\WK0:D! 0$! 0$!! D#4D"G&I"!4>L:\-4$ YIK1S33C0@T^>G!!&H]8^E
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MXN#/S3MM*!NA9S";@=/K<E5E-(BL<V&LSTTK"W=\Y_R%;SS;MV]*MR.[C?\
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M @(" @(" @(" @(% . H@A05K05]=-?I01H/4@A05K05' ^D(!:TD$@$C@2
M2*\:'B$$:#U<>*!0>I!"@K6@J>)IJ?LH-D>T7N(:*#0T'-P^^X\59CI8Q,SI
MR=3E+Y]AA<QD7<K1C\;D+QKG$- ]UM99PYSB1R@>'J>"3QK)%:4X,6KYDOQ#
M_F68ONB[A^E_2?N$=MOI ,WF=J8W:^,Q>/N_=\2UU[B;NWM<Q&Z>[8^6(N+G
M131BA&E1K/>SB:+8+<63W#NS(7^[]T9*^RN:SN0N<ED<U?WD^0O[^ZOKA\]S
M+,^>26X);)(XZDJ5A*36D<97/?PGW;CE>H_F08?KA!#=76V^@N+R,UUF!;S1
MV3;O<EK^2K-KYO!=!SCQY!0O::.!X).FOX5K=.GXHXLHQ<3B/*^[7,[K:>ZD
M<["W#:R,(KSW#7-%6^TTTU5_#U3\,)2.N(MBMTPFX,;[)<&N< /;+16M-2#Q
M%4&H-:"2&@$\2  3\Y]*"* @A0<:"OS((T'J00  %  !Z@ !]"" :T4HUHIP
MH *?-ZD&I 0$! 0$! 0$! 0$! 0$!!"@UT&O'3C3UH%!ZA]"!05K05/$^DH(
MT00H-=!KQTX_.@ARMT/*VHX&@T^;U((T'&@K\R"!%&NY  :$B@XFFGVT$O6A
MG86%T-+V9TGO+RZK6,:X\IY>%"U6ZE)NI\/[4ZM8Y6W?L2CU,WE9[+Z<=2-U
MW-_!C[?:NSMQY<Y*=S(XH;FPPM[>0/#WN9&2R2'05%2L:1;;6."S69U8C_N$
M^(,\U;JM!U-Z-Y;N6R4G3O+[BW5AOR;C\388Z]N,"W+9""TQ_P"6;?\ W1]W
MBLBUK1XM*-%:T5BLZ<RL6Z\O!0_O;BYO<K<9'+SR97)9&XNKS+">=SY7W-P]
M\SYY+E[G.>YTDA<:DZI''7@L1I[::+X?X,3I+E,WO3NGZB_DR\Q<&$LMLVN$
MW;/:3"TGDDNH'WMA:NEA$%R3;BKBUYY>;56D5ZIUMA*STTC2^60FFY'N$SYG
M"TDY&2!M:W\C*-YA0UA#'Z_*M*;NJ?9X+$6VZQ\:8FAM 0T#04--:4]?%:B(
MT%:T%?737Z4$4!!#E'J'T! H*UH*^N@J@B@(" @A0 D@ $\334_.?2@C0("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(-)<T<7-'SD
M!!PLEE,9A[&?(Y?(V.*QUM&Z2YR&1N[>QLK>,-+G23W5U)%!$QK022YP  06
M$_Q)7G][<GV[D>RCLPZB-R62OI<E@^N.\<*ZD.*9;3/MY<)CLG8W[H[IM];2
M!SG,J*'7B E(I'B716L3PG@L"[\22QMN;@M,<QN)HIJ S75S)[<\LA%7CFE%
M=4]LZ21,<(BK*_?"PO#?*6Z2,CM?">[/;O+Y@>8W%<E:4K][0'@D3;7AU71R
M-::STQX_L7'\TLC9Y&VD7B77XKQ8CI&P>DUIRG1+;K>,ZW23$S$1&D1S\7>M
MJ6@D4-!4>HTU'TH(H" >""@7\2)U3NNE_E*]R=[A<LW'[DR4>!PMAX;VV\[6
MY:[EM9S P/C=*&P,=S<M>.J1-(\:I,3=2)GX?T_TJQ#,%U;OLLG'=V[9[^]D
M9-;7'*UTK99'\TE#0O<9">%>)19HBW:^Y7L:]NV\Z]C@"U[<3D"UP/ APMR"
M"B4EJ_DKN?0_R9S_ !T_W'R-#_\ ZVJ%)3ELO;6X6;WV3)+M?/P.&[=MF0'!
MW[8RT9>S^J/=P7.=ZJ:J<8HNL3[&<;[8G2'MTZ*F4?C)NFNQO$:8?!,?)M?$
MM#'PD L<WEU! -5+8K332.1K&LS29YO1(X#7T#[.BR&S'=6TLLUO%<023V_+
MX\,<L;Y8.<59XT;7%\?..',!5!OU00J/6/I0<>:]L[:6""XN[:":Z<YMM#-/
M%%+<.: 7-@C>]KYG-!U#0:(.14>L:<?D0*@^D:\->* 3QH16A(%?^KTI^H4Z
MO,"\Q/MS\O#HUG>J/6C=>$M\V+:]&V]G19*RGS66S%M:S3V-NW'"[BO(899V
M-;SANKC0>FDB;HF?T03'52;OMEB*?,>[_P#J7YBG<_O?KYU)GO),?DKZ6TVC
MM9][<RV.W,!;32,Q]O9P/N)X87/MB/$\.@)]=*JZ<8X)3E77Q>L/A]9+8>;9
MVL7$=H(X;3.WDDD(?4S5@\$N!]?X\:?Z%29ISHRIRI668CC8TQ6$$<7-;"VB
M<\DD.:T1-\(%QU.JL4C28^U9B^E9G7FV;J=D<#[J45;%1LELUOMO=7EC;S#V
MM2K$36*:71Q]K&Z--=;)X*$WGK^:E@?+ [6,GG-MY.*T[D^L44^&Z0[>H+EU
ML8&EF6S4G+<PFWCQ<;F2-):>>0AH]K184F9GVLHF*1;')B>^M?7_ *P]?NI>
MY.K75+?>:W[N[<61ER>2R.7O+N[M([O(%Y?:V>.O9[B&"&(S.:UC!R@FHJ=5
ME&C#E3F^S=+^P'O(ZN]-\OU#Z>]!-ZY79=I;SWM]EG;<RD$EW:V377)GL(IK
M%KY8&Q^TPQ>R]I!:2"I[%B.?&CRS=7&Z=I7>/Q]R[/[8SV EDY,>;.^VSGL9
M<&7G>9)0VUR#9/%94$\KVD>@IS]BQ$<>$UX+[_X7;SM>H.].H,'8;W.[VEW-
M+N,6UMT+RF8F+)L2W#XUKLAA[G)Y"^DDNI+F&%TD8=5Q<VC>)5X3U52FE%_V
MT@@4(.@(((-01H13T%!$D4/ U!H*C7Y$%E'\90<[)VW]#+>PO+FVQPRN5FRV
M,BAE=:S,9%<F.2>X8/!8Z,L/*':FFB1,TISYL9B/BG[%&7X02'8-QWL[PO-U
MV&"O-TQ8'P]GY#,3XYD]A(&P&]&+M[X^(^YEB< TP^W7AJG!:1]D,B=W5;:Z
M>;ZZ%];-I]8K+ 7O3VXV!NF;(.W7[A;8ZTN(L)>W%E);766 MA/SP\S"TU!%
M/30R=9BO+]+*O3P^.?T,);-DH<;UDFEPY?;PXOK/+-)F+&Y=#+=6D6\I?R>;
M5UNYCH60V[:M\,TU!] 58UY?BY,W;VG=0+3JGVW]%=\0AS1D^G.T ]TCBYS[
MF+;V.AN)"2YQ)DF!/$E%?>8)(72W-D:@PEKG/.E>>A&II4J5I-"8T][M-!Z0
M!IZ?H5"HK2HJ.(KJ/L((H" @((%S0:%P!/ $BI^P@<P/ @UX:C5!% 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!MG1A+3IQ&G"G'Y357GYBE8
MB+.*2]_X>_W+LC=FW\7(8+C<&T]RX.WE;[+K>ZRV(O+"VN >(,,\X=]A2=9J
ML1,:<V+6[D_A=O-1V5U;W%D>E/3:SZW[?S>9SF1;N'^4..LKB07^2NYXG7D&
M2EM'\[HI XN#S[1X)$3=[)2M(K.L-SM@^%$\R_J?OMF+ZX[6L>W[:C7Q^+N:
MXS%AN*1[9I6BY;%C\<;Q@:R!YH7'4C5NE3./O*?AGC_3FO\ 7RN_*UZ+^6)T
M3_P2=/<?!N+<VY&6L_47>_@1V]YN&_MX(&LF+O=+>:)C)6.<&U.I]:RMMFLQ
M,T@FZVL1;QCBJ@>&V2Z=;OLS:1VXC&+R!=XIE-!XS>4U='RTIK2JD13S<?8D
MQX:)G H *UH *^O3BBHH" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M.B$$QGO3)6.*X:&P$&I!Y2"01PJ2K;IK'Q>#&9NF8B/O>2.]SHKO?KMVH=4^
MC/3_ "#\5N_=^ OL3:7C)70N N[:ZBUG:"0'&9M?D"PB8FLSQAJ3;,TFM(GF
MQF?6'X7#S9=K;LRD&Q^BUGU)Q,V1O;F+<5GNK$V<]Q[S<RN:]]K=NLRPN8 Y
MQ!=[3N "RUI7DG/3B^\=HOPCO?UU?W.RS[E&8_MTVVR>)UQE'9"TW3>7-GS0
M.FCBM[!DT<5RYCGM:2][06@GU)R8UUI1D-.QGLCZ.^7KT V?V_=%]M6T.#PM
MDT;GW.R&!F2SF9FBB;>Y&]FCMX;BX-Y<Q\X#B[DJK'Q1$Z0E:Q-(ZHKP>U8+
M9S8V@P\L;"'",FNCB"*'YC52MDS.G]YS]C*9NB*5I9'_ *7^AWPX#YD$4! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$ Z@A!X<[_N[O:/89VJ=4NZ+>>(EW5@NF=I#<76%AN&VTM[=W;_"L+1DKGM:
M)+B[DCC&O%_!7CQC3P)C2L?'/&?%C/?-)^)2[N/,%Q][TZZ>?E#MWZ'9FR?:
M9S86 RDS\EEVQE[;6YN=RVMS!=1%]M*[Q&1AC>>G*:"BQUBM=893-8BFEWBM
M\+/;.Y]R8?.[REQVY;S"8B1DV4W$[%Y3)V!N+B0L<,CN 02VT<KY!_JLH)KZ
M4C3CQ8TKQX0E23]]<TEM$Z "&0AA)=&Z,,(E<"?98>3[:NO-)F/M99#X5&A\
MI3I/76FY=X#4<*7\.FJ*N2H@.0&@J:U/I/M'B4&Z@(""#JAKN75W*>4>LTT^
MV@L>_C,NNV8V9T,[;^C5I.1-U6R6X+G.6$,Y:!:8:-PAFFBCE:)0;B<-;S-<
M >":5Z8XFL>YC[.BVS,CU"ZM=,=E;=Q;\GE\QO7;%B;9@Y_>A<9RPAE:6<KQ
MR-:_70Z*S^DTF/9+,K=.?+0[(<%TOZ>VF?Z$=/79([)VFW*?E2PP=O*[(,P-
M@V]E<^>SA<Y[KMKR?EJL8I$:\67"ML<'T.+RU^Q*^C MN@73FYC#=#:8K"S!
MH(%?:9 [A56DUZJI6NGZ6AWEJ]CY]WQS^WC8PM[&XM[ZWN#A\3&^"ZMIFW%N
MYCFVC97$3,!&IX*^W@D5C2-?&7LW"6-EA[1F/QL+;'%XNWMK"WQ4;0&6UI;1
MLM[9D/* .5L4;1H-**3-8Z[?C2(I=\NZ/*I:>;+YK72#RJNBU_OS>]\W=/4_
M>.-O6=&>D_.RRFW-D;5CO>I??W2Q>';V0:7OU#C0-'UJBUFZ(F[6L\5BV+;I
MMX4C@L&^S'XESO,Z1]YFXNO?7/>5_P!1>BW47<[(=[=/)0ZWBM\-=Y-EOBGX
MSQ;\QV+ML8R5U2P$2\FNAHI/'VQS2V>,3''DR:_;1W*=).[/H]M#KET3WACM
MX; WMB;3)6,]A<033XV66!LES97T$,LK[6YMI"6N:^AJ*BH(*DUKU1K/*%B*
MST\W;]:NO/2_MWZ9;MZP=7MTXW:&P-EXVYR>1S&3O+>V?=LM8_$?!9V]S-";
MJ<D<K6--7'Y 2,YY\[_U,;(UK;-+8XL8YYG?Q'7='W#=X.)Z@=J>_<GT[Z1]
M%LS,_IU86<LL46<>R<0WV0R+(KUT-]'FK>W9[+@"T'0@46/'DOVUUT7UGDP^
M;7TS\U7MYQVY\5+%MKKMT]QUGC.M/3KQ7W$V-NH@RPLLW%=/DD,UIN$Q^.PZ
M.8Y[F. +5=*ZQQ772>7/VJQ EN+::)C6>-!-*(^4OY18&1W)7G=I+SEU?D4\
MMLZSYY_2E)OI,13'S]BT&\Z?XE?.]B'67J7V8]$>EG\H.LVVL59LFZFWF1C9
M8;;N\QCW9" MQGBM==7,<,T+Z.HRE=*T64S$?#\'@QBLUZOC\6/B[GNZ_N,[
MW^J5UU/ZZ=1MS]3-^[NO96'#V[\E<V]B\7$S[:UQNWHI;B*I\8AK8H^8@4J=
M%@U)G2L?<^ ;DVSE=F7D^#W+ALGM?=6,9%)+C\SC[NPO;F&\9XD3IK&^AMY[
M:D)J.9@KQ5K1C$Z5KHJX_#U$GS;>U6OIW/>5'$&MI4@C@15259D*W_<X_P#O
M$/\ <E4<1S(HI7NEB'*YIFDD<:M:(1SU(-1Z$BL+3JB;N4<F*.^*A[I\UUW\
MR+>'26.X=>[6Z&,M\+MV9ET^6W=+D(7W&2,< FEAB+9B&EP#2>74)S3V2\">
M25V:[9[Y/,5Z']!M^V=S?=.+G(W^X=WNAC?X+;3;MK^48[>XD;#+'RWETUD-
M'BC@\U4K/*"(B)\TZ_K\&8OVIL?8NU-N8[:6V-J[;L,-MG&V6 9C[? XVVMW
M6F,MHL= WD@MHH'!T-NT?5U5\D6UCAIJE9K,<_#]2P7^+_\ +ZVCL?<'2WO/
MZ1;'L<)DMR^-ANKUQAL?;6./8+*WF&&OYK>QL8;5LUPXN8YSG<SW DU)JD\:
M<EC6VL++3H/U#W1TKZQ=+]\[#S-U@]XXC>NV[ZPSEE<R6DUN/RK:^-%XD4D+
MV,E8>5_M"K*A-$MK%U(X1P9P;MHZEXGK)T*Z5=2<->,OH=R[$VQ/=7K)63,?
M>C"63K^KFR2-<X7CW@GF)]:FE:^"SU5B.3[/SU#VL!D?"20VO+6IU)/R!7E-
M/C2-)B+O@4CO.A["W>8IV3[]Z';>M[6+J7<6\><V3N26)LK\-=X%[\A-9,_$
MS/>,PV,VQ#:'\;6JL71,^:.F9Y$VS;7IGKB.?#BQ*$-SW2>7AW%W&2PPWETA
MZN](MSWF-M\Q[EEL9";S&W+K>.XC=/%:V^0M+GP@YM>9C_5442I'Z'M'K]YS
M?FK=]O3.7H%U/ZX;SZD[,S5WCY[[;.S]N2X_(7<F.?6 7][MFTBN[F-P<?%$
MID:YKCSZ$K'1:Z*7T^W<UM7J#A;#-82?;]Y9;AV^;O%7,LDMU%*;^!U9VRAL
MQE>6DD.',#Q5KR*:UY,U+Y9L[[[L:[>IY6%KX-CX$%A!80!BK.FAX^S(%)C3
M5E28F)N>\'1V[I)HY-"YH?0:.HT$GVAJ:)6M8Y0QF-/>Z*'WF\EN[J&],]G)
MR^YV3AX3W.A_= .:CJ MXJQ%*W3K4B;IGHB:6QQ]KE0MEF='><QLKB;V;B'F
M\3PQ'H 173G 643=3^P3T</Q0[\2LH*NJ?2>4BOR\%B'BQ_??:=^L@>+']]]
MIWZR"#I6<KN5U#0T-#H::'AZ"@EB%GB31^\7;ILE#XW*ZAC8YAK1M-&Z-5F)
MZ9T\I%T1?%MT^Z4;>;F:QH:;4PR.'.YY<V,EP!J2:.YTTNB+K8I+&:_#,^>9
MT34. UKH-?7IQ^RHRC@B@(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @A05K05]=-4"@TT&G#3A\WJ010$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! IZ?2@(""%!J*"AXB@U^=!% 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MAU;R_0SJ'M+JUM*UC=N795V[(0.GH]K<FV1LN.N_#<1S>Z7437T]-$X2OO\
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MF(CAS^YE2(\\\+HTAB:X63VXM[MG-#("ZXM;ACSSMEM09&EH:>9A#VZ%8HS
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MY/6+1RM:T"@#0 *UI04I7TT62-2 @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @AS-U%14<14:5X5]54"HX5%3P%>* ""2 02.(!%1\_J0"YHK
M5P%.-2-*\*_.@B@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M""%1IJ->&HU^9 YFDEH(YAQ%14?..(010$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M"WR$,3FG4.BCG#376H5K2*SP8^WFFMKG.#33UZ:>U^M12ELW=4$5I->+>5!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MA^,YV^@1'T'BK%-+YTLA)F8\E:W3R_K>%^[;RVNS+OML;3;W=%T<P742?"W
MNH;ZRLX=OY260ND?&^;+XV&UR$SHO%=2LRLQ=,>:?M(FVWX9K'@\N]&/A_\
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M YY TTT5I,T*VQ%*TCP\*IK\N7R?.UCRS\-F']&]M0W?4/.@?E;>-VR.YOC
MQL-&Q2RVL4\0<R 5 <L(XTGC/"&4SIU4\L<55.)L%U$;F&.2(3O!N;HEW,9&
M.%0V(Z@.?ZEG;3C33P2ZL3K/FBB:FTY6TU%!0^L46(B@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @TOIR/KPY75^:AJGN'D;NJ[9NCG>)T9S7
M03KML>#>?2G>,,T.5=-R1W>-NXO&;87=K*^&:>"6"XEY@Y@!T2Z;YI-TUNGB
M=,<M9CA*B#VS?"[]@'0/K=@^JU]BYM\R;)RD^:Q&WLL]TUC;7LDIN<++.R>R
M,-P<<X"E#4@4J%9MK%/%-;9K5<SVEI;V5A98[&QMM[.RMK>SM8F#E9#:V<3(
M((6B@HUD48 ]0"Q]G)EK\4.:31\;0?773Y-/MJ3Q6DS%>3=63$0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$% ?X
MG#]#3W4?]YV;^<UDK",0-'^YR?,?N%0YLM#\*E^B6Z2?SBWE_"-NBKDF*O*Z
MG'T?/[5%>4)^*732S0R2MLY"Z.>3F?. 7<L?+K$2[@&FH4CICS7\/ \TZ6\6
MTW*8J-I@O,QAS,ZK;@.RELQ]![+!R&0%IHEUMO5-.#*)FFO%"VR&+FN'0V.4
MQUV^R%66MKD+>YFC#P"\R11ROD&FNH2ODFV-+TUB8F-;9=;NZXR$&SMUY';<
MADS=KM7<=S@@X$@9BWQES)C^9IT/[]:S0\4I,1U4J3%)Z.$L4UW"_$"^=OTY
MZN]0NEN\>Y&[V=F<#NS<>,N]N6VU<19NPEE;9&Y;9P^\P6+)I8/=J,87.>2U
MH)-2D::\Y2>%9Y?I5?\ X:SSM^L/5SNZW]T7[R^MLV]-P=<(<=:=.I]R3PX^
MP@S>(,EQD/"N[BZM[.V=<V$;O#C#.>1PH 20$GA3DL<?8O\ &ZM#=BZ;&^2\
MLXQ'-^3VM<QEP7CQ(70W7![#H002"%C%(FD\F75,QU1_I4(OB(.[?;W;7Y:W
M5G$Y',8^TZJ=1\?'A-C;3-_%%DKVWE+X,G<1@3Q3F.QQY>\D \Q]FG&F<3-*
M3QIK[4F(TFSA'#V,1E<Y%\[KB5\,C/?[B]N+GVGDW,]U))(QKQQ!A>^@KQ4K
M'!C6?L94[X4WHGD>F/EI[*WWF+-^,NNK>2RV2QQGM707$]E9W#8[>6420Q2>
M&\0NY"XD%HJ"K%OXHCRQQ6ZZ*4Y\FQ\39Y?_ '9]Z_;-C]T=N>^\O9XSH[C\
MGF-Y]&L2^\@?U+MXA>WK[U]S9TY_R-9L)$+ZMEYJ$*<Y\2FD1QEC)NB7;CUG
M[D.L>V^W_I7L/-;AZFY7+_R?&%@L;N.>VN&SBTN)\H! 7V,=D\U<Z5HX:BNA
MG \TQ-=9Y,KEY)/DK=(O*\Z16&8SN*Q>[>Y+>>+L[K?V^[NS@FGQ@D;;Y"UP
MF)9<V3)\=^2;E\D)=$\%]#4FI5YS;$K$:53#YTGDS]%_-+Z.7!]VQFT.X[9>
M+R,W37J):V,,,]U-X4]V_!9CW>S?-D8<O=LCB#I7GPJU%/0OBZ)TC[#'-LV:
MS6?'P^QBC^Z#M?ZV]I76O>';?USZ;Y;:'4W:60CQ=EA617%V+MUPV%UI<X2\
MCB#<[;Y2.XC>Q\',*NI0$42/;&J3XQ.C(F?"M=@O<GVD=N6>ZW]8=]9O&;1Z
MZP6%YA^BN8M\B7;9BL)8?<<Q##?M LGY:QE]ID36M'+ZZDRLQ.L>58MB=(^)
M=\M(<T$<" 1Z-"*A5$4!21B!OB<?TS'=)\^R_P V;)9S^Q'R_P"'I_2V=JO\
MY[O^]%BK,APZV\0I6L+-.%?8&B#H;B,W3QCF0\UC<VUY:9&,FHCCN8W1_6.C
MN<.5NCJUKY/UU2V8MY?WC$ _$-=%I>B7FM]Q^$L,9<XO 9/*8W-[4GDM9([;
M(6^4B%Q=.@E,,44IAG?*'<O-P&JDQ)-(G32(?9_AHNY[;7;KYFO3/!;KR=K9
M[.ZF37^ R&Z+^[;C;+'WLUG&; S&>:"W?')>QB+4FA?H%>'W'Q:LL?!.VZN9
M9+:3\H-Y(KJW@82VW9;WK1+!<17()CF;+&X.T)XJ3-L6],<^'M_<EM^2Z[JF
M*3''V>"S1^,/[J=O;#[=.F';3;9"WR&ZNJ]S=W]]8VUY')-B\=A99PR:]MHK
MCGC,\\H8T2,X"H36FO!E-W&><\?9S8Z;96WX\GN3;V.D$\^8EW/MJRL\-:VT
MM[+E(;W*6T<_((&R$&*,_5 /-6B<CA$^+-K]@'0RQ[=>SCH1TI@8RUML)L;;
MU]+!#"V 1393#V5_-"8F10\KV3RD.]D&HU2EUU8MT6;HMI-VM/ZWLFC#XD\3
MJNN.0!G[(<FG#B- L;>F[3Q_87W76QIK$?M=B *-J!4#U#0_(LO8G'7FCRM!
MY@T5/$T%3]GB@4'J&G#Y*\4"@K6@KZZ:H(H"#2&M%*-:.6M* :5XT]54$:"M
M:"OKH*_2@B@(-  YW&@J.76@KP]?%6>$)'&5 /XG?]#/W2_/L;\Z\>H,0;)^
MYQ_,/N!#FR^WPQOZ&GM:_ WG^<UZI?\ "6\9]ZOVJH@(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @((<K:\W**^N@K]/% Y6BN@UXZ#7Y_6@4%
M:T%>%::T0 UH% T >H 4^C@@B@(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @("#3RMIR\K>7U4%/HX((\K:D\HJ[B:"IIPJ?31!% 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M4!OB<"#Y-/=10C]RV:.(X_RFL=/G51B!X](Y*Z5!H3P.AX>M1>;+0?"ID#RE
MNDI)  W%O*I)H/\ ?*W]*"Y*BT:=:>K[?TJ\H3G,I.W/-)!MS==W:/Y;YFV,
M]<0R\M'1SV^/G=;O;P/L2 %8_BU^!E32D?&Q#/>'YL'F"[2[FNM^VL+W ;GL
M,/AM];@L<?C[6\NVP6ME;YB[AM8X_P!^.J]@%*@@4 %%?=P2MU=>*X"^%?[V
MNZ+N6[I.I6$ZV=5\]O7'8W$V=Q%;9:>>XY99'P1/8.:=\8:]K:?5J"3JIY?M
M9:ZZZ+_PP^,9( P'&74<\,[3IXK96NBE'^A #BM29BO]ODTXB8]K&]_%*>41
MU"Z.]:<OWU=$L'?;@Z1]2A9Q]0<1A,9)<'9.7C==#WR?W6Q\22WR;W.>]_.[
MPPX5TJ1C=.NNES**S'"L0LVL;G,I@<ICLQM:3(;9W'@KR*\M\ICKZYL<K:WM
MO)SQS6\]N^&ZM989&U]D@@A29UK' 70G0GXL/S!.FW2JSZ?[ZN<?U$S>#Q9P
M^/WS<6<%MD+>SM[6.RQ#KR 7$4=_<VD,3?$D<>:1U7$5*M:^Y(BGFG^G[U$O
MO2\QSNH\P?>-EO#N>ZG7^]7[;DO6;7P='X[&V5I>W4LHMX[:.>2W9X,3PVI]
M&@T4]JZSH]%>41Y9/5KS,.ZO:VQL7@\KANE6#RV(S_4C>,V-N1A,?A\=>P2?
MD^.\DLIK.XFR,;'1EK22&NJ="*J\IE(MF+=-:,O[T;Z1;7Z*]/-J=*]CXFTP
M&RMKX'%X;%82RAABAQDF,LX;::>/P8XF$WDD/,2&BI)/I5MMF:]4:>"W766V
MQ%EWF\?%]#NK 94Y#'Y"V:;)MK+9.FE:)H;RUO(G6]S#);O:Z.0/A>0:@C58
MQ%T3'3Q_%[?#[F5VMO\ 9GA[/'[W@;H%Y979OVU=P'5ON4Z5=,,+@>JG4VXM
M9\MFSC[.=EA+7FG=C+;\GQ,L9+F4@ET1!5TGW^)'ECIMX*@9M;HW<<T1=%!;
M5=/:FKC=NEU#N<_5#2>'H5BMM+8^#Q+9BM9TN\6IMI)+>78O)C)#-X3[:R#2
MPVSHP#SB84)J[5)G2.KX)YM.;NF[R\?#Q>#^YORUNT#NVZQ='>NW73I#BMZ=
M1^B-S<W6UMP-CM;$LDGN([F-N:@;8R?EZ*&>%CF-G<YK2P$< I?6O_A\H7HF
ME:_WCW9!B;6UMK*SQ=O;8JTL((;>QAM+:*"SM[>)H:R&*SB8R"-K6: !H '#
M16O3%(UM\$F)F.J-+HY^/V)F%0 #J:"IX5-/4HR100+F@@$@$\ 2 3\P]*#$
M$?$X@_\ 3,=TFAX[*_-FR64_L1\N^'JT\VSM4KI_QGN_[T6*LR'#3P(JD#\3
M']M@0=3:R5O+FUC<XFTH^1A90/+_ &FTD(H59BRD3'/C]C&)NCJF=9Y+/+XK
M7RN]Y=S?2C9W=CT2VTV\WCT2L<Q)U!Q^+QSKG+[@PL['302!MG:2W=S)8RT
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M7S;>.**.6]O(H()KF9HA:2Y^IX:#194B)I/*/N28OF.J(K'ZWHL,;RAO**4
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M0>"X$BH%:U.H.GJ*17A&M2=)Z_!RQP'S!!% 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M;$SKJRF9F:61Q3*WZH^8?<62(H" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @((.^J:<:'[B"W7^(E\MWJ[YA/9Y+9]#KJXR'4_I<VYRV%Z=PM$4
M6]!,)675J+@QR,BGAMW%\>@JX4J"15[XI3D>RM9GFQ_O:7Y%7F*]<^OFTNG+
MNAV>V9C]M;OQUQO#=>9AGM+3"6.,R4,EY=LFFMWQW+H@P\@ Y3QKZ"X<2D3[
MF7=Z7[/;T]Z?;+VC-.^[O,!M#:^W[B1Q<X2W&%PEAC)Y144 DEM2[[*3%U*V
M<9(FV)UY/H$LO)<P1@<QDYB1RZ-HWC7@-$K,VZ<8-(G^S+G(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @AS-]8^D(M)\$>'%*P
MB%0?2/I4ZK?& J!Q('V4ZK?&"DHU'K5Y5Y"',WUCZ0L;;[;_ (9B?<3$QQ*C
MUA69B.,E).9OK'TA4X(![#P<T_,X'[A1>F8XQ*-1ZPG%$4$*CUCZ4*2B@("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(""!:TBA (]
M1 I]"  !P 'S"B!0>H?0@4'J'T( :!P 'S (!:TD$@$C@2!45]1XA H/4->.
MG% +0:5 -.%0-/F0100H.%!0\=!J@C2G! 00+0>(!IPJ 4"@]0010$! 0$!
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M6(-D^I%^#^HU167W^&-_0T]K7X&\_P YKU2_X4MXS[U?M51 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 00J.%1]* '-(J""/6""-..O!!I\6
M+V?QC/;KR>VWVJ<>77VJ?(@UU'K0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 00YFD5#@1ZZBGTH <TD@$$CB 14?/ZD$4"H'IX\/E0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M! 0$&EY 8\NKRAKBZG&E#6GRT0?/ORG98^":_O,G;V.V'>-(_(92XBQUIB/
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M_O$X[_E_*KK3BWMVYZ;:3X)G;]5OS#[BY:)K%6PXZHJ@@(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M4?A;&_.G&J6\R6(-D^I%^#^HU%9?;X8W]#/VM5&G)O3\Z+Y6M-2(KI*OXH"
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MO)=EFIJ[VF-B]((TJ$I=.O3Y(YI%UFMEL_WEW+^M-+?JMUKH-?7IQ^RBHH"
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @((.X'6FAUXTTXT]-$'E
M3NI[8.D7>/T9W1T ZZ[9M]U[ WO:OM[UTL<3+BVEBY_=Y;:>2":2VD8]YHYM
M#0G52L3,3^%E$73Y?QQQ4*^@OPP/8)V_==-O=:KK%G=.(V9DW97%;6R#G7=O
M;Y(SMGQ4MPU]@YMR+2=C>)!#:@$55FG/X?Z?J2L5K;Q7.UE:VME9VEE90QP6
M=I;06UK!&P,CAMH(F101,8  UD<3  /0 B.4@(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MN6N (-0?L*S%LQ%9K='#V$1,3-(I;//Q<BVNG22/)OC=>[C]\1OA-N.:3]Q
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MI+&]CVNM;^UCNX'587 \T4K3Q6<Q%/<PB=:3QH[?BL60@(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M2*: UI\J1=%TUI,3!2ZDQ,UAS1H /4C(0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$'##H^8Q>(?2"WD]&O[+TJ:4K'"5B+H_P!9L2LY0&V[
MA;GF&H >':ZCEX"JRI/PW? PBVV=;)KE=D. KKH*Z<?EHHR10$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M'8[=NW;Z_F>QU'-MK.UR<\\[F$ZAK20LYOF[2=886Q$:VQ29?7UBR$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MDUISA8NUF::2[]M0UO-J[E',?6::_;62(H" @(" @(" @(" @(" @(" @("
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M-(B*QQARD9" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @*3P&P&@5T!XG@/4MI@_%[VI,^"A+YS7U^AWX>X#_P#F)EX/_.Y_
M\1Z:_P#E&3]4/TK_ " ?_#>JO_(L_4]R^6< >T'IL30^SD:5'#\<Q>C_ *$6
MS'HC#=SI'_9M>./K_3_ZY_<*_P"\G_M7/>D7+1SJ"@IZ*>OT +[-AZ^G7B^+
MS,5GP<A:X(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M)-@X#2F@TXT^2J(B@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@@X$M< :$@@'U&FA^P4'E3N=[8^D7>!T:WCT!ZX;<MM[[5W+;.@S%O<11POM
MBYD[;6>WN)+>=S'6_CEWL#4I/NXI'&L3PE0N[;?A?>POM^ZUX/K9%B[C?UMM
MK(3Y3;VU,K)SV?OK+AL]G)(RXM"PG%RQ MI]8 BHJL>J;:4UN9],3,]6EOZE
MS#86\5K:XZSQS&P8FTM8+.VMFL#&V]O:1,@@@:VFC8HXPT4] 6I2)MI,4NAI
MS,16*\>#GRL/B^-S'\70 4X\RD5Z9MIQX%+9OBZ9TCBY@U ^8*,O<B@(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(($@<=$G@
M-LT^[]Q;7%%.KWLU"/SF3[?0X^CGW!_X"=>#?SN?_$>FO_E&3]4/TK_(!_\
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MH :T    #@   *\: >M   T  'R((H" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M#+F.(,+C< %VA(;RBNII191CK;U3I$,)FDSTZRYRP9B @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M)'.<?]$%8BELWQ%<D?H2ZZMT6W32V[]-$QC@/1IP]2Q9HH" @(" @(" @("
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MLP48T>IK1] "TIXM:-(B/8U**(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M)ZY]1YM_@MZ=ECOF+(ZJ\[J\Y>H;8/A=S$%VI(_T6M:D!?7,>2S<8^FE)M?
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M-/5\GV%B(H" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M +$)UV%)\2COO_\ L0G784GQ*.^__P"Q"==A2?$H[[__ +$)UV%)\2COO_\
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M\=^.8KK;/.W50<S5_?YB\N,WGI)KJ[NY'W&2NYIY+B1TTKW2"-G.Y[AS/<0
M#Z5^?^]W>;U!W+/O_FY,<775Z9NF:5F?;KQ?IYV'8XO2/;\6RMQ8LMW3$6W]
M%L4I$1X1X/7_ &B=H6ZNX;<EGG,O:7F#V)8W$4D@N;69@NHV20.JTRVYJ'M=
MZ%]<^CWTSWGJCO-LY)RXL.*Z*WW8KJ7UF/&VFCX#^8#ZP]H](]KNPVWV9NZ9
MK9CILR1$VZ7?PW+ECIWTUVKTZVMC=G[6L+6UL+"W9%*YEK%$^X+8F,>9Y1$Q
MTH)CX.]:_3WTQZ7V_H_M5NSLLPYHNMUF++(KI'&D:_:_)+U3Z@[AZS[C?O\
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M'_=6>/\ JNE[[U7W;>W6_P"9[C<9HBNDY;Z:Q_K/N[&M#&CE;]5HT: - .
MH NY68\>.*66VV^Z(AU>;IF9NUU1Y&5!Y&U' \HJ/F--%J3K%)X,*16O-&@]
M0^A2(B.#*LE!ZA] 5*RBB" @(" @Z5LQ<)1'*636P'O$19Z':BCZ>U5OVTF=
M-.21$5X\5);S-O-L[??*UNNDDW6B"[EBZQ?EEV/-O#+<R1QX..*2XE\)L\5
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M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("#0WZ[_VOW%.:<U
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M.G('NK&1+ZZ>A-/\.[S>U;HUC)9%)\/%-8X#T:#3U:*L44! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$ \$%,7S,/,.Z8^6AVY[\[A=[8N'-;@
MM8H(MI;/?>1P7&^,E*71PVEN7S0& 1O80XM-:#Y=)6ZO1=I[$B+=;[=9\5J;
MVL_&/3[W[@\#M'K=T!Q^U.E>^=R8_#09VQS4]_=;)9?7++:"Z,$MPUMQ$]\@
M:^A/*2/14BTMI%L12%K,:SK*_4P6:LMP8C$YK'31W%CF,9896TDC>Q[3;9"U
MCNX'587 \T4H/%93$4]S&)F>/.*NX6+(0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MO3$?_3-Z>M<!_P N]I@C0C_E!8 CU$*#/!]+O\6?3O\ F+M'\W\>@GI 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$&D?6?^U^XK/"$CC*@#\3K^AH[J/PMC?G3C%+>9
M+$&R?4B_!_4:BLOO\,9^AH[6?P-Z_G1?+&_X17[60(" @(" @(" @(" @("
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M1KXLHC\<W:)S%*"G"@I\U-./R*(B@(" @(" @(" @(" @(" @(" @(" @("
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M/J1?@_J-167W^&,_0T=K/X&]?SHOEC?\(K]K($! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$$'<#05-#0>O3@@ER=EQ*^W886"UN/$?>-#6N$/
M@U=&:4()=1832*W6^68XLNJ*Q;=&G*' ;!^4'/EN(K3,V-TXML;>^LXI&6O@
M^Q+[,S'4Y@/LK4F=>CA7FTXK2;J]41PC]>K<M[)\%[R6LUK%:V3)"S%VEE':
M6\+WLT;2)K62<[M/D6-9I2>/CXLHIK/Z$+ W[[9TLEBW%9.>4BY=S"1K8VR4
MC=]Z[Q6_0GE\>FZ>1Y8Y5LA-S:\K:FIY14^LTU*HU(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(('@=*Z'3A73A5!*;[>1EPV2WL>8Q>(U[GR
M<S.204>71NTDTUHF2LTGFL4B?[$N+C[..&[E]VQ6,M[5VL.2M,?;V<]7&LS:
MPQL<#S:$^E6)F?/'+]*75LB++/C\4WTY/$<T$GV.)X^@G5+;8X^*777<^2)Y
M6TC%>=^M:>HZ5]"D::K%)TX0WT! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MK&V-77%KAL5#<6]"# [W2,$!W%YJ?L*ZVV]<QQ(I==-G+Q;U(O>)(RV2!MD
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MPQB(X72YP% !PH *(J* @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @ZYX>3X@AJ8B0(@[ZU=*GZ58K//[$F>GXHTGFUE[F1@N#8^:E8FT):?1
M0#UJ1%=)T6?")T<[B$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MG;\4.2C,0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MZE:5B=/O>?\ #;<W!O#.V.W=IV=SE,O>3V]M;LL[>65ME[Q(R+FE\%D@)8)
M3S!=8[-V'<^K-]M^WX[;[;+[Z3-MLW4UC69B)\>;NV/Z@]N[;L,^;NN&S#M<
M-M]9OOBWKZ8FG3U3'AR7#O9GV&83HQC,9N_J*V',[ZFA@O&>-;1O;"Z=D$S6
M!K[8-:Z,@@^D$+]'OIE]%\'IK8;;)NL]F3);;$Q-V.*ZQ$ZUMJ_+KZS?F W_
M *XW.;8]ALOV^SB^^VZF2:3$3=%?BYPJ@QPM=';<K1 Z(4BMVT: QH#:- H
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M:YY<QG-SNG;S!]?$XQ\K=:);-+8GFPNK==,7?"FIHH *4H *5K33A7TT55%
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MLHK_ *BB @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(""#@"UP/
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M=F=FO'Y:^NKB6\EOKF>YA\,S2/'ALN))(VT8\\%^7/K'U#?ZB[ED[GN;LO\
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M$-^6_P!6_,2[/;C&]#KA^5ZH=.'R9+#;$#&01[M>[WATMNRZ=#*(9HV2 L
MYCZ:JQ'_ %IA)X4F?+"P*[3?(,\QKK/W#[5Z=9'HUG-EXW;N[<5<;YW+F!/#
M:;5QV,R,;[BZ;)+:N@NI'AE6",N:>)(I0SVLJ:S;/)ES>F&T&]/>GVSMG^\/
MO+K;VTML;?GE=S$23X7"6.+FE%0*"62U+OLI/5RXII.G)/CY61W4,082Z4&N
MA(91OI/#T+*(TK/%*S;Y;>;GK%1 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MR-@#&BI] 0;E!ZA]""* @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M[\?<3MC\2,@@DT=Z"45,@<"YPJ#2E "*ZCZ5>21QEK440$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M^[CY73<W,&D/H1J:-T!5FD37EX)U3T],.Y440$! 0$! 0$! 0$! 0$! 0$!
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MTG3FQCKB:<9',>)8'NEYFMYJZ4K7@=./%8_AFLK-.,\7-5! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M!0$:D\ /5\RD3%L3%.)29F*3]CEJ*(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MF3]R-ILO:,&[.LW7#JIN"]O(+6^R.0O+1UQ</DN[E\K[R2[M\78VYE<[4AC
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MZ7_F-^=>/4MY_P!/ GDQ!<GU(OP?U&HK+Y_#(_H9>UO\#>?YTWJLHK_J*("
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M%(HO)/@F[/*"Q[Z\NVSNX\3>?X/K;%1S/G%I)=P,R4T\5MXE(2X"YC#G,UU
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M ^7E$C:1G4'B!S-2G5,S$4B.#&.JR(F[6O&7?"H !-305/K--3]E&:* @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(""#J\KJ"IH:#UFG#[*>_@)
M)N\O<6MW96S+6EM+[Q^6)V^V^P:WF,0+15SO' I\B3,7>6V:4X,:71,71&D\
M6Y#=XIKK"P;XC+;(ND=BH.22D[HG%]PY\A'L<KC4 K&+IB8ZM+IX<Z?Z5NLZ
MHT^"WC[?]"<@* #A0 4]2R4(!%#P3@(H" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(""!X'YBI
M/!8XNF#W1MY:4YW\:T/UEMNW1-\WQ,:,M_?$1;JX>=C,CK,^K4_93=7=-(;+
M/;U76^^'&G>/%M"T_N#'&E>-6^E:VUP_+QVUG2KL-M8V^2;?BFW]CRAW;[ ?
MU=Z [_VI:Q>+.^U-T"&\[VFSBN9_8(8]S>'H"^:_5_LUVY]-;NZ)X8IF-*_A
MN=]_+SZIQ>G_ *A[7>[C_"^;TSYJ:W76Q'-:G&":WENMORR<EYC[RZM@R1I8
M_P#>MQ)'3VN5W[#U+\B]YL8C-ENF9I&2_2G]J7[H]N[C9=@P9(MB.O';/Q5X
MVQ/BVW3%\HBO6<K8O9!;P)&G$?,N(NLX4^#P<QB^#JP_XDM1I4>K6G'AZ%M<
M<SUMUK3VM;F\WZ_J^5<C9=6GA5H765FL<7%MH>0O=6O,X5/"FO!;GNF:+XLB
M(X0;R_YVWFSX9I[W:2R!I-"-&Z#34TT^RN#FN2V(IS=<[9M/Y;+=?6:3[$R]
M+^GV7ZD;\VALK%,FFR&XLS9W-R(&O<ZWML=?6\TI<Z-KRP&('BO0WTK[#D[C
MO<%V.9K6.7+2O)TOZI^M]IZ=]+;G+N+;8PVXKHM\\5K-LQ'..:[\VQA+';FT
M]JX/'O$-A98W&V\5!7Q9X+6"*?2@(//&:Z+]-?1?;;-IVRVS!.D61RI32*OP
MK]<]RW/=N^Y=UO)_]ZR9KI^SJF8U]TOL+/J,_!;]P+M3B8X0U(H@(" @(" @
M(" @(-N9_A12R_\ <XWO_P!(TN_406+'F:;G=O+O6ZLY<22EEE/8VS6&1Y8Q
ML#KJ(!C2]S0*"FE%O</"3AK/%X;<X2ATS10-H&MX!AX.Y1P;7Y%N(BM97A&G
M%N#@?L*3Q:4\46\0I/ G@@>*L$<$1Q ]>GTH2V)8F1<T3*%X+7CF <.;C4<P
MH."M]*-2/'DKE>1CO'(8'K7OG;\KG&'?%O"YWM&A_)L-H6U',!H&_*MMN.GI
MBOW%)C@NQULP0$! 0$! 0$$#H"?D*#IGMCDEAO)*AL!>'4:1]8\K?9 %>*ML
M1;6)_P 2>23=6/['B\T=Y';[M?NB[;^K'0/=6/9E,7OW9N=@Q]E)&U\<F5M\
M;<28MAYXIFM<+XL(/*2/0D3%T3?*1$VTLMC1A6.Y/HCU9[4.N^[>C_5_:M_L
MO>O3C>%W/#@+Z&0,;$S+/N[9]I<.CB;<VTK&,+7-%*::'13CJRC28C\+*B?#
MU>8;TL[R^QCIKLZSW1B;;K?TKQL>"ZB; GO88<I;16G@V6(OK=DUP^>Y@R%B
M(9*L'LD\I T2(BE)^\GIK$3I%-%PF. ]&G#C3[*"*#Q)WZ=X/1OL:[;^I77C
MK%N?'X;#[:V]>VV)Q[[JV&2R.8S%O/98FRL<<ZY@NKUUW?EK#X8<6BI]!2VE
M)CG)-L3=%U-(87SN ZG;S[INX;>W4_)NOLWN#JEO?+S8V*QMI[W(2VE[FIAB
M8([2 W%S*YMO,QE&\SO55)F9UYD61;I;\-653^'?[#MR=DG8#L>TZE;6&V^K
M?4. [AW! (N6ZDQ^4CL<EA&WA%M;S"2*V(%)*EH%%;8NUIQ+YL\L73HKW1QW
MDID;*71S,,9\3D)#FZ&@TH- I2V)ZH^*4K,ULGX(X.\ H .- !7UHH'-/ @_
M,0?N((H" @(" @(" @(" @(" @(" @(" @(" @(" @(" @LB_/\ /)R[TO,9
M[SNE^4Z-[6M?\"\+);3?'4":YC9+M:0OD$,\>,$#KK*,;;SDN$9);I71)I$5
MG2$CJF8_%,\.5'KGRS?A@>U3LRS6V^H7<--:=PW67$WD.;VGD[NS?:X;"WHC
MBD=;SX>ZL?=KM]MS21!TI<[E/%2M(F[C=X,J3$QT\/%;T?%\6N,LNYWHEM7"
M[2Q.T,=BL#DH;6WQ5I965M)$)7LCD=#9Q0Q-K&T$5"L12-"9F=8^);/=B[/'
M[N^@@>?#8_J+M9L9:=7^'G["M::CF(33GP8U\.,,X=LP4V?M0>K;6"'_ /:[
M5%3(14$>L$?:0>$^^_L8Z#^8#T$W5T(ZY85N1Q%Y;/DP]_')X4VWMP1QS'"9
M*"1D,SG&SOY6RD-%3RIU<(B-(J3;,Q,U\TL2OYHOE;]=_*]ZX7_3;J3A\CDM
MBWM[D)^E_4N*SNOR-O?!^\-AC=<S>[0VMA<6G,1R/(+J5:*:"\->9[*5C]20
M/+R\Q+K9Y='7;9/5GHOE,E'C8+]O\NMN.O[H8?>N(-Q$Z^M9++WJ&SMWL@CY
M0ZFOI^23$3-9U2)GEI,*L'G3?$1]5_,DQ^.Z&=)8\ET>[=K2RQTN\[&ROIQ>
M[_ST,<-][S<SP7;GPV-I=3RP"(_NC1[517F>_BRTKI%(6[G23I;O/K;U%P'3
M?IALS*[MW?NW)V6'PF)QD%W=2175S*RV9=7#[6&=S8A(\.<YXY1Z>.I(UTY2
MRD?D7>1WLCRX-B8/K-U:Q_\ *CNYWM80W5S<-E-O%M.QN;>.2;"AC;:!I? [
MZQ<3J"-2218CJGS:4)KQY^"Y-N6SNE87-\4RNC><:UH86N!#I'ON&@<X8=:$
MJ]5WX9I^UCT6Q/FCJCE[%E'\03Y/'>SYCO>3TORO0;IW;Y#IC8M%ANKJ'>9J
MWQ[-MLN)W"5\=A<1E]ZV*&;Q"(B7$L H*U$T]T_TU^U8YQ[7M+RQ_A=>UOLZ
MW#ANJG7_ #=OW&=9MNW>-SN!O;['1V&"VMDA%;O,9Q%S:S097W8^(P.E!):5
M-9IHRUZJS/%;O?%^VV,Q/=GTGM[7#8RSQEO@KFW-AB+&VQ%G-':B>WMV"VLH
MHHFOMF#E+Z5>=25C%/\ I+6[2/P<H6S_ &&T/>#T!(% >HVUBUOWH.>LZ,KZ
M>7@LF+.';-_Y(;5_FW@_X+M4'*;>AL^0C/+2TA?+$WE #0UA>[7T*>-.2^:=
M9YL/7\1/NF7>7F[]U68B<V1MSFL790-\82LA@L+&*V9&Q_.]K0UEMP'I*1&A
M=I/N?5?AB]JY+</G =N6>L\?SX7;+MS7&4E+PX6SGX6:&T<UA#B2^^GC&F@!
MJJQTX1HRV4ERZ;)F"!E19N<+T4Y60,<";>0#A(9&:Z<$K-OF6EM\4NXJ7OG4
M;"NNIWEH=R^T8;.+)2Y#:LLX;)R-:6V$<UV)GAS7#FB= *5%>"3&LS'^E.KR
MVS_2.+#+9JWDM<ADK>0"*Z@R68M+MS:4_>T\L3HP!0-%6D?*E*S6>!K33BRC
MGPE/47(;H\N6PV0^ZC=9;$S68CM(/$9*Z"3*7-M<RET/B.,8<YAI5HXJ\(JO
M&8K&BZ6MW/BI!.TLN(W.+9?K AYK]@$*],W>:Z-(8S=-E<=DUNEY<[MNZ[M_
M[*.F^4ZY]QN\)>G.P\==8['W6\F6%UEX8;K)3>[V5NZPM8YB7W,HY&T:274
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MGJ\T<$BWHCIYJ,O<EYZ'EE=IG6[=?0+N$Z\7.R^KO3B2WBS=E'M;+WD,+LC
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M<\$%H(H?#X?,TBOR*I'#[67W^&,_0T=K7X&]?SHOE+_A_IXD<5?Q4$! 0$!
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MJYP>2R,_BG,ET\.K>("DQ,1%W.>3*L73-O&(X3[TQAK1305 H#Z:<./%5B
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M$! 0$! 0$!!C+/C&O\[[IK_-Z;_^,H+9CL)_SO>@G_PD;4_ARP2> SBVS?\
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M9I\8]_G==+?YN77]T]!;-=AO^>!V_P#_ ,(FU/X=LT&<.V;_ ,D-J_S;P?\
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M:+&)Z9ISE9I=JY" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$&,L^,:_SONFO\WIO_XR@ME^PO\
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MMG)(<&T H0:C@D3,32TG6.#G    < *#Y@@B@(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @'Z?D0=:]CPYL_(.1F@A T).E>'%2D<8G6&.L328
MT\6\"UH',&,\2G-$.4D::5 U.JRK6=?B6D1%/PN9I3Y%%$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M -U=ZOV7H^PJ4GQ/ ?\ ]U?_ -E^LB4GQ/ =_P!U?_V7ZRFOBRH> [_NK_\
MLOUDU\2AX#_^ZO\ ^R_658TGQ0,#R"/%?J"!];C33T>M%I/BZDQ7$D3;(":*
M=KN8W'AO+.4.KHZG+JEL1='3,>2$F:3-T?'*U0^+B8Z+R_;2Y8;EET,UCHV7
M,4TMN\-CFN'RM<UCFN<UP?J#I0ZJ^VWX5I_%.L,9-TPOKY_4KIP)<C?26_\
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M)&_ED;9P0Y&9]V6G0AC:IU?BE9MI%)>CQP&M=./K^7[*(5'K""* @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M?8$K]E;O+8M[[4F>&;:S+W\D>=L7NY6-LBYSJ#0#BBLZQTNTZ;=/:@M(V)M
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MM)&@+6Z*Q/3/Q<>$,9LK$3,5CQ=X. ^8(J* @(" @(" @(" @(" @(" @("
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MKMEV3-&#JP8_-%;+.J(C2G"E8A7Q\O\ [*?Y%XJ+K7U,QHO=]W,4<^$QEY
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MM_\ [DNEW]!=M?Q6G1/M.M#_ "6^V_\ ]R72[^@NVOXK3HGVIU0C_DM]M_\
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M$(%!IH-.'R?,@B@((<H]0^@(! -:@&O&HX_/ZT  -%&@ >H  ?0$$4! 0$!
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M "@%.%-/4L510$!!MN_=(_V_]R@MKOB$?]C=N?\ M[=G]X/5Y,)^)4C\H/\
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MRFZ9G72?%)IRUCP4QISD1>QV,;Y\IF+ET-M:BPM9)C?^.YL444C;9KR)(N<
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MNS*T!K7&9SOJ@.I4@Z"H]"YW;[>;,,65^'G[&WNWWR(BWIZNJL>YY4[I.YO
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MFVO3/WLH^")LTCG"O;;VUO:P1VUM;PVUO$QK([>"*.*&-C0 UC(XVM8UK0
M *:+1&]05K05]?I0100#0.  ^8!!% 0$! 06T_Q!W^Q.V[_;NZ_X/<LHX,95
M)O*$_P P/H=_M#*?PA,I+*."I<[]TB_;_<6$\1N+($! 0$! 0$! 0$! 0$!
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M1Q,E(,T==5^N?H/T9L_379;,.WNQ9<WR[9F>BV+I\L<Z1+\6O7WKSN'J[O\
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M/EITW^*8F_5%>-!]Q!% 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!H;]=_P"U^XIS
M3FH!?$Z_H:.ZC\+8WYTXU91S]Q+$&R?4B_!_4:HK+[_#&_H:>UK\#>?YS7JE
M_P *6\9]ZOVJH@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @((
M%K3Q:#\X!0;-Q:VUW"ZWN[>"ZMWTYX+B&.:%U-1S12-<QU#ZP@U100V\3(8(
M8H88ARQQ11LCBC&NC(V!K&#7T!!K#6BM&M%>- !7Y_6@U(" @(" @(" @("
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M-ABB?+[XZWCG $K"ZE2%I3-UVDZVSS\%B(MGS:70]54!UH-0*U%?L$^E8"-
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M GE&M='&@J1\A4.?M:JCUCZ4$4! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0:&_7?\
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M,Q'"*^*V<[\.\*ZZW9T[ V)X]OMG!WEU;9-MM>2QQ9<PS7$4KW.CN"TM@(J
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MI6<6CV)&D?87S+NOU/[5M-S\NZVV9C^W;'_KN[;+T#ZIW^/KVVTSS9_Y=_\
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MPQ_6'LD6VX^G#6>?S+/]IL+OH7ZYF^VV,.:VMW#INUU_U'9XCS!.U[>&:QV
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M_,;\Z\>H,07)]2+\']1J*R^_PQGZ&CM9_ WK^=%\J*_:@(" @(" @(" @("
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M[VXWON9W$@Z@Z*QT\V,S.M'U)T;*CC2@--3R^D?/5+9FV)I.A-L73;HY2BB
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M$VMF6;EXM#0/V7..7[)K0578L>*V8ZI;#+FNZN#:-NV>A=<!KM7!KC0D 5-
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M/3==CB(K2(TC3]3\VMUGC/E^9=U6]>L5F9FLZS7QJFMM.44X4%/FIHN1:**
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M-25)FLW1,4CQ95B(BZ=?8[P:@:UT&O"NG&GHJJQ10$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 00) !)X $GYAJ@\I]SW;1T=[R>E>[>A77O9M
MKNWIIO&T?;7$4[(V7+)XXY6136UR^&6:U=#),35M*^G2JLQTVQ/&>?L\$MNB
M9GJTB/ACQ\5$KMA^&0\O?MJZNXOK+D]OG>MSL_,OS.U,=D9S=V>/O3<"7'NN
M[>6Q,=V;/1HK4TKJ*J3IK/PSP6+HC3C="Y:M+:VM+2VM+2*."TMK>&WMH(V!
MD<5O#&V.&)C&@-:R.-H  %  @Y" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MBH[C4 +&9F/+=-;?'P)I/GLCIFG#C5,XX"G"@^XLF** @(" @(" @(" @("
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M4F\H/_,#Z'_^C\I_"$BT[>?O6."I4.,/_P"45C@SO^)OJL1 0$! 0$! 0$!
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M%J6"1KAR^*7TYG,KPY:UT6=UE\3KI+&R^R8F(BL._:26@D4) )'J--0L62*
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @("#9_U8?9_N0D<R.,J GQ./Z&3NC^;9/YV6
M*L(Q!TGU(OP?U&J*R^_PQOZ&GM:_ WG^<UZI?\*6\9]ZOVJH@(" @(" @("
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M]XR++\+&527R@_\ ,#Z'?[1RO\(3+"/VLHX?8J7.^O%^W^XI9\(W%D" @("
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MP<-.?Q/E4LUNU^.>3.;HBVE/+'&7>MKRBIJ:"I]9IQ^RJB* @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @("#9_U8?9_N0D<R.,J GQ./Z&3NC^;9/YV6*L(Q!TGU(OP?
MU&J*R^_PQOZ&GM:_ WG^<UZI?\*6\9]ZOVJH@(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @@30$DT !-?50<4$L![A/[Q!&;Z&\+N1KF\K81$3
MXCBUPH2*)68I$<.:4MNB9XSR_:X =X\GNE]/;Y*+*/<<8V[Q[)H8##43,?'(
MUS13AKQ4UCEY?%E/3,5ZHB[E%.+D6UI+%<1^[W-O%#8-E_W.M+)EI"USV^RT
M-C:UCN<A*Q$1/"WQ\6/&9K_B1R:+.W;;L=F+VW.*R-[(6WQ#C*U[6/(@]@>R
MWF: LK?-=.GE6^FD1.J<0:@&M:@&OKTXJ"* @(" @(" @(" @(" @(" @("
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M7S22!]!S4Y@#H=1I7T+<66V]-9XMEDR71=I6M?:[8<!\P^XMI/%OXX(J*("
M@(.JCFCGFNK=[:R6G*XGY' N'S5"RK%(HQF)FZ;ON=%N#<6!VU@LINK*S6EM
MC[:RN9[V>]GAM[8V]I!++*Q\MR]D-71Q$ $^UP6/./%E,4KK6%C%WU=2>G'5
M+NQWKU%Z/16]MM>>22PN+2V@CBA??6_O5M>7#8XO8(GN/;J/6N0MBEL5FLM*
M:1=6G!X]L1;XS%W&(C=XN;RL[Y8).)B:)"]X+OV(Y=%>.C&(FL5YMT>AM07
M &A!/,!1WR\05FU"H)H#4^H:G[ &I0:CP ].NGI^CBE82.,M+8Y[J6"UL[>Y
MN[JZGBM((K*"6[F%Q=2-A@/A0,D>*2O'H6CDXL><^*ZW\I/L6DZ#[-/6#J58
M%_4G>]M#=8:\NH#[U8VKX;>2,<DMLR6$R,;RZE;7),S=1G;;'36Z%;FT9<&.
M.>[B_?QJ" =(V@D ^H\PU6$:>6V?+/Z2.OIBZZ*WP[P<-5&8@(" @(" @("
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ME=(C5)FE+IG3P<W[B<&0@(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MTNC)%T773J12BR!#P'^(_P!+J4J?17YEK9[J71T\&]W-_3;;;2/U)@!J ?6
M?I6I'!H(H""%!ZA]"5E*0BBB @("#2^O*[E-'<KJ'C0T-#3Y"@D]]U;XO'9*
M^R.4@M?<XY+G-YBY++>WMK2!KWU<^4LB:&PM.I(X+.D1JE9F*\%JCYFWF277
M7'*7_0;H9E+BPZ3X6YGM,_G+.XDMW[XN[>2YANH8IXKADUE;V%RTTJ/QOS&B
MSB(CWLHF(XQ6.:B_8V,MY=PB&.6+)Y>>*TP4T,;[J7+W4TC8/"? QKWL/C/
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M" @(" @(" @(" @D7JA_BSZB?S%W=_ &008'WJ<UHZE=1 &M#1OK=H: ]K0
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MZ>Y)YXI/#+ YI',YI(&G(/I5MF;;I\U(GA"16(B9BL>*8!P'S!010$! 0$!
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M @(" @(" @(" @(" @(" @(" @(" @(""'*VM:"IXF@K]/% H*UH*^N@J@
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MOC+;8KIW/DB>F(=1;7+(7NBB9('5HZ+F<\5]9?4@ IEW=N";<?36^G'DW?\
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M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$$*CUCZ4 D#B0/GT010$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M]N_S7KS_ #/E=.M/TN<R8K,M*7VXXKXQ'!M66/\ =GO=XYD\0EX#VEI;7VJ
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M:U^!O/\ .:]4O^%+>,^]7[540$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M;FNMKI&2.,5Y]7L>A?1WT$]3>K,F"_HOQXLLQ'5=9=%(F8UI-O*)JI$]:?-
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MVH?R3V;_ .J^V_\ @'&_^2I0ZH]J/\D=F_\ JOMK_@#&_P#DJE%T/Y([-_\
M5?;7_ &-_P#)531O0;<VK;.:ZVV]@;=S#5CH,-8Q.8:UJTQV[2TU]243JCVN
M[,D7+RDM+0/JEGLT' 4I2@HAU0E^XFE/O,K8 ^6K&6,@D%+AITE#6UHSD:4G
MA-=;)Y+;']Y29K,<&J,OA!L()#:S3ECXFD&7PS4.E!D-:\U"DVS2+YTB5OF*
MQ3_$YIE;4- )J0!4^LTU/V2B(H" @(" @(" @(" @(" @(" @(" @(" @("
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MBVL;.WN)_P!VG@MH8IIO3^-EC8U\FOK)0<N@K6@KZZ:H(T''TH" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M\6 _OI@<T%M/"-O0Z<KM"^I]24ZI\Q\%OEC]KO6BC0.% !3Y@AQ10$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0:1]9_[7[BL\(2.,J ?Q._Z&?NE_YC?G7CU!B"Y/
MJ1?@_J-167R^&0_0R]KGX.]/SIO59Y)$UK[UP HH@(" @(" @(" @(" @("
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M!H:7:@MX'E!2O&R)XFMT1=='!WS1[(T -!4 : T_40:J ^A 0$! 0$! 0$!
M0$$*#U#3@@B@(" @(" @(" @(" @(" @(" @(" @(" @(" @(""5H[:41L#X
MQ:VD7,76-0XW;S]2CM"SE</0I28UKI)$^$>90&\]ORZNTSO1V3TGZJ=XG7!G
M0#9719^2QT&8DMVWK9SN6;D$-.4D&21C#Q _%ZI$1ST+IFNFLJ$&S_AJ/*NZ
MFY.SQW3OOYV_G;B_C@EL[2*?%,O+@73(WP,BMI7ASY'B9OL\=4K7W$Q-7IL?
M!F]M\T<<UIU]SD\4K ]DAQ4+6.8YH+',,<3P00:JIKQY-K^QA]OG]8+/_P#
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MS"XD  <H'IT_46,3;;;,<BZM8BOV.4JH@(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MRF[Q<\EK=/C;D+>V?,'3P/I0$:*1^A9KTUXW)(F;;LD='$X3M!!$SO8#J<:
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MNU]J80"  34@ $^LTU/V5BS10$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 00=]4T%=#IZ].""2+W+3VUW8V++4&TF]X_*\K?;DQ[0"8@6BKG>.
M-!ZDF[KFELTE*3$==/)SAJ@NL9 VSQ<;)1;Y)SWXB LD(F,)Y[ATDI'L4-2
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M_IA?_P"L(5CP1_LJGE)?^Z/<?]+[_P#UA$T]I_95?*2]/2/<= 03_P <+\:
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M-!0/-8Z/.N@'!93/X+M8KQ\$FV)GYEGE]GBF@<!Z-!HB(H" @(" @(" @("
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M"IT(H%[<[KNK.W;2;[(C)CF.$<='@+MV.[<;JZV^Z;;Z\)JG^&\9(2V2 "@
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MM)XP[8: #U+)B(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MOLYF;KZNT9Z?L?JK#-^%;>,M]:D<%%00$! 0$!!"@]0^@(M91H/4B""!:#Q
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MUI3AK\W!(I9,:>)2+J^#?1! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MST]M>G+W'=6W1.3'DI-D4NC6+;O;S7*%J(V0L@CC8R*WB9#$T1M#0R-G(T-
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M3SLJT<[:NKRCF%74X\HKK1!&H.H(IZZH(H" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MG'U_+]E41J/6@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MQ36=(QS/_JNZPGFJ]'!<V./EQ,GY2O;RTL829P6E]W/';-/*;@G1T@7"[?\
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MX0D<94 _B=_T,_=+_P QOSKQZD<_Z>"SR8@I_ ?@1_<1)XPR_'PQGZ&CM9_
MWK^=%\JJOVH" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @@
M!P 'S ( :T4HT"G"@ I7C3YT @'B ?G%?NH%!6M!7UT%4$4! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 00Y0#6@J>)H*_2@4%:T%?705^E
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M!<>8ZZ!6R9ZO/%4F*6UMFGZ7:"M!7C05^>BBHH" @(" @(" @(" @(" @("
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M;>.I%<;:S;.E+I:MW3,Q76VU]E\D3X@C;_F@[@W1T<ZB[ Q_27J_M>SM9<7
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MAI[6OP-Y_G->J7_"EO&?>K]JJ(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @("#26M/%K3\X!0;5Q:VUY"ZWN[>"Z@?3G@N(HYX7T-1S1RM<QU#
MZP@U1006\4<,$,4,,0I%%%&R.*,:Z1QL#6L&OH 0:PUHK1K17C0 5^?UH-2
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M$3RKX5?'>ZXL<_*LQ4UB-8Y?<F\: #U +E*UU;:$4! 0$! 0$! 0$! 0$!!
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M5N3:SNR6/OL6;6Z86&;W"XNK6U_*D0F=RB2/F:'--#H5$TY<5QE\.=YR>_\
ML^[AMF]O/6;=F3S/;GU5RC<+CG9_,7-\-G97(7T,-O<P&^R C;;2S<C6QT#6
M?L1RZ"Q$<^)6_P#"RGEA?6V2L;'(VDK);3(6EM>VDK7-+9;>ZA9/#(P@D.:^
M*0$$$BA0<IQ :22 *'7[""CYYUG:_O[O$\M+N6Z*;"E-]N;<.(M=P[;LFPGG
M<W9\KL[<VM&QROE?<"T<&BA<30#6BLS"128Z8X1S\6-:\CGNQVMY?/F;]--[
M=Q^1N]@].[&]SFU.HMYE]OSQW>$G\,XW&W<EO/';WMM%!>6K1(X!M&\Q(-$)
MFZ:Q,5X?;_H9,#O4\T3LW[>.U;J-UJR/6/:&6LMR; OXMK6N%S>(R^1R%]NC
M;UVW"M;C;7(NNV>)/<1\[2T.!THL*128CC*S.L:5F&+K\K'MOZJ]YOF-["M>
MG.V,IFK>;JK>;[S^9@M+IF)L,5_*9F;EGN;QEO-9VE6O#@USA4'Y K^LFO+5
MF9=NV3\;@,'C9:>-CL/C+&8 UI):V4,#Q7\*,JCN*@$ D G@*ZGYAZ4$:A!"
MHK2HJ.(KK]""* @VPYH>ZK@*\M 2*F@UHG-.:@%\3J0?)G[IR#4<VQN'\Z<:
MK'/W#$'2?4B_!_4:HK+[_#&_H:>UK\#>?YS7JE_PI;QGWJ_:JB @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @@'-/ @_,04 D#B0/G*#2)&&E
M'L/-7EHX'FIQIKK1!JJ-=1IQU&GS^I!% 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$&GF;I[3=>&HU^;UH-2 @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @@
M[ZKOF/W%8XI/!TUI%'#'=%KAS%Q/$5!KKI5:V7IFD6\*-#9Z9-?$LB/#EDYF
MD@.Y:$:\=* K3F(FZD4F'([K)-N/VRER"Y!NWAY<V6]+F1@U%.4EII\A7%=U
MRS@LK;K=$3^EPVTK=GF;HF*S7[E.[O\ NYBUZ,=/[_8VU[MC.H6Y8);>T=#<
M-=/;QS,N&2NE8R=LD58SIS#5?*>_]\Q;#MVYVMN3%&>,.3KKDMB8\MU*1,Q-
M7JCZ*^B<GJ/U-LNZ]PLR3VZ,MLV1&.9MGINMF=:3"VUN63E]S-/=27F6?<27
M6X[N61SI))+N1TT3&/>2Z0\TE* E?E9M-QN.Y[O/GNLONPSGR=$S,WS/GFND
MUGW/V![[V[%W/%MHV^:S9[/%BMBRW2V+J6Q$UX0K)>6CVN6>>FEZU[MCD@M[
M)T9VY9W]B6^.2V!TKVQ75N.<!PT(KQ7K[\N?TXO[_NLG?=[-]MFSOMZ+<F.L
M75I,TZXIRIH\!?FC^IF/T]9;Z(['=9?OL]MT9;\=\1T\8UFV[7QU5O\ '!UB
M^Y>.:9DH:QD1CJ&,C'*T-TH!RC@%[XWFTGN?RK++K<%F&(BD12)^Y^;V;:1V
M6N2;ISWYKIF=>$SJWL7<,E?=,#9&1MD8:EKF@$NJ0!36I77_ %/FFW<;?;66
MW>2=:5U]]&/:9F^,O77[>7LBKZ WZK?F'W%V.SX(]T->>**R! 0$$ YKA5K@
M1ZP01]I!% 0$!! N:WZS@/G('W4$:A 0$$*BM*BH]%=?H0"1PJ X@TX5K\WI
MHA^M(M_>XG%MS$UPZ%C8('W.>O;NY;9PP6T,3I2^.29S&>S"TDT(^5.J*]$:
MV0QZ(FN2=)GEX^"V8\RGS0OY40YWM_[8\G(W;,#Y\?OG>]E/(TQ2M?<PR6\$
MT=V'EDDK VK>- KI%O3'+@LS,S.3^DJ"%[=Y*2PAN<C=3N;).?$M!XEQD<M/
M<R'7QP773_$E=7B>*:ZTYD\(GE/"/!6G\N'RO\]UOO,5U4ZRV=QB>E,<]ID+
M'9E];26[\NZWDM+J%\DD]H'  ^U0Z%8W7?AMG3Q6.G29UN766VMKX#9>,M,#
MM+$6MACK"T@M!96<$5M"(K6".WATACC8YW)&*FFJRF(F*S_I:==:V^/!WGB.
MDGMQ,SW6;VO A YV24^OS$#E;0+&*\^'@U/MK+O%006XOQ!'_);H;_M_<?\
M>;EJ6<TE[W\G?_,-Z2?A9?\ N[52_BQCBJAK!F(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @XSV%\-
M& :FM*<:$^OY59I6B3,SKS2OO;:N/WQM+<NU;]MOR;BVWG, \W,,=S%"W-8R
MXQSYGV\S'Q3>$VXK0@UHL8K4FE&' \VWRN.L?EO=VN\-C[W@R-[TPWCG\]GN
MFW5-F)GCP>>Q%[>S78BGD]UAM+"YMIK@P\CC[09S-TK2TCCR)K36'T+X=_9U
MWU$\V3M?V6;W.QX";<&5R64M<3ELCC[2ZML187%XYU_[E*R*6#\5S<D@+7.#
M?31+N!%??/-DV?-U[/'=YW8%UWZ!V4#<GEKS;4.9VE;/ %S87^T+.6Z@=#*8
M9I9Y9)(J4 )<2$ZHB9Y71&OMYK-LTBFL3,T]G*?U,,YGMOS[;RVXL7DV7N*S
M&T\O>8E]I<13X_)/?97<EM'XEO*R&YM)+=L37>TT&JL4G6=4F(BL1-)37=]?
M.M>8V;8;#R'5KJ%/M/"/N78S;S]U[BEM',OG'WB![/?S"Z ,=0,<TL:- **+
MRUXOG$Q'CR1LM?<V<C&VHY_'<R=[#[+G:F9]RX>FI%4IXL:^#*,_"==FDW;Y
MV)WW6C-X>ZP>Z.X2^=D,O99"UEM;H6.%9;0X6X='<VT$GAW=I-SMU<W71(^*
ML<8Y,IF9MI^&?T+IVT;[L&BY?SF9SN4-;7EH=*N'R+*=-8X1PE(CK^'2O&/<
M[Y8J(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @@X$M<!H2" ?42-$%
MC!\9QW ;CVGTO[9.WO"9(26/4RZW'EMV6S'Z^!@Y&08[QF,ET,DTSR.9ITCK
MZ4A;J1'5^E8,=#]CY;J3U9Z>;&VI@'9?<.Y]\;6M<79^)H&QYFUBNHG<S7-?
M'.*\U0:!6?'DQF>7Z6:NZ;=LG:ULOIIL#%;AZ:]';&_BV+M"TOG9G;VS+>:6
M[M=O8Z"YEYKNQBD>^6:(N<[6I-5(C2L?"L:4B?B?0\?V\=K^3C=9XOI-T;R-
MLX>)XV.VSLR]D);K]6WQTA 'R5"3-(]A%O&8FES1/VV=N<UK>4Z+=.KB-\]O
M(8F[&VS:S6T]I('0/AD;B6R B5H-0=%)FMW#R\_8L1=$4F:WQP]K[798Z6U;
MC18N@Q=G9V_A7>&@9'X4EO%"(K6./PP&P"&)H% !P28B*5FMOCX?8QF;Z5I3
MPAX%\QCS"^D?EV]O>[.N/56XG\)EI);;)V['%(]VX=PO;(W'0FY;)$+;]^1@
M4+@75T^2S-LUI%)GGX_Z"V,EFLS6V.%OA_I8RZS^(-[ZH^^AG>?+OC*Y'&8[
M//BN^GHO+J+!76R9+B>"'#?DW\H"T;*,2YD7./9'+4^M*1]A,S-)K262[\N#
MS(>A?F9]#-O=6NDFY+#';RBQT#-];%=>V[LIMS,^$SWJ!UH+F:XD@CF> 'D>
MFAUU,B+8]E\\V4S-:W:V173Q>Y-_]1=K]*=DYO?G4?=&/V[M;9N-OLINS-9.
MXM[&U9;6MM-=LB9+=36\4DTL,!#6AU7'0+4B[S5MXQ#3IY8^9PEC$_/D\_G?
M/?EON]Z(=MFY\SL3MQZ;9^"6VOL)E+_&7_4[,8;)^/8YDW5AD&S6MK:2QCE8
MT@2@5X4KITUZI9Q,3'3_ $E=-_#K^>'B^_?IGB^V_K;<.QW<MTOP6+Q,62E]
MMW4G#XVQCM6Y+D-Q/):SV3(F1OYJ>(6EWUB:Y13EQGC*36:TX>"YYO+JYNKR
M]M89'7$=BZW%S9<IB$K9G U;/I^Y\: ^A8^%U:>,<:LK:SY8BLSS\%LEY\GG
MU;Q\LG,X+HATEZ2P;GW_ +]V]E'X;?MYEVQ6VT[R#Q+6-_Y+:]LE[.)BUX#Z
M1\K376BL13A.A72O.6-X[KN]+ND[ZNI#>H'<-U.W+U)WAE+E]N,% V^%A8M]
MX?);6MAMV"1]H\1\_*P-C<X-H*E-8U2O.(K+XCO[HKU,Z983;VX-\[0R^VL3
MNQCYMO7&;L;O&75U'&"][CC;^&WN(10'BP#U52D\(X)$V\)^*7V'L+T[O^W^
ME17J)M2M#2O^[MGQIZ#ZD5G"]GAK=I;4=0#_ (M82I  T&*M:<!P 5CA*3Q<
MY[(;N/EI5UQ(WD?R4<&QO]K6E= D3;,S$<((TI==\4L:K\8GW70=3>Z[IOVY
M8W(W+!T'PUW)FL=;W<K+6YGW8??&2WMM'<&&::".U8UAD8',!-.)6,5X<EI%
M:_B6W_EV]M&7[Q^\?M_[?;.D46[MWXZ9D88)2_&XN_M[[)Q24BF+FS6MM(W5
MI !5GV$1'XF:BZ1].MF]*.G>RMD[,VS@L%M_;VVL-A718O$V..$C\?CK:RDD
MFBM;>W$LLQ@!>YS:N2NGC<LQ7GYO!:V_%H]C_3OJSV.W?=1C,+C<?OGMNO[:
M(S8O%VUE=9#%[MOHX+T7TUK9"6]9;SOC>/$?1A<3Z2E;9K_%#'S1=_9HQD^(
MR[\-E-NYG%1309;!Y"SS/O,<[XY/'Q<\=X#'1S70N8^ &H(-46(ZIHS,/DR=
MT>:[O?+:[=.O6YHW2[@O]NG 7T'C.DD$NU_ V^YLKO%F<YP-IS5)J>/I5C6=
M3A&O-5,F,S;FVA>#/#.R1X8#RB)S&\P:7 Z\QT2+IZJS-&G28C3S0^&]?.X;
MIKVQ]%]Z==>N>8L]H]/-JXZXN,M)=^'- QS(I_=K2CBV.23)&(L#20"74.BQ
MX\?AB=&K2VDS9'GIJQ-OF;=T.V?-][U,?)VM=KMKT^ZDYO.Y#;%K:;8FBN)N
MJ+X,I<VV*S#K#'QFWL9IK5S9G/:34.+G$45TXQP8ZTB.::NM'P^/FV=(.@=[
MUEZE=)]P7.V-N6,N3W-M5N\I\_D</B8F?O:Z?A+7W@@P,(+X]?#.A(X*<=/N
M93-/VJAWPYGG(]NO83N_;O;/UKZ+8;9%MU'W!D,3N_N3GN6766QF6:\6F"Q5
MQCS&R6"RN,G&RWD+7ES"0\M(:5ER2LTK7263%QV4L<MBK'<.$G;?XS<6/L<I
MCKN)_-'-97UM'=VL[""1R3P2M</G28BZ*<+F-8MII6UVY8V1L-Y,PMEMV/<&
MAQT!^L:?LB %A$7<.;/KBDS'PRZ2W=-=32WL.0]XMI"XVED]O@O>YE><#FHX
M@$<:++S6Q-(\LL>FVZZV)G6WBY-OXI_?LY]TN)W<LL(=XGA!AY6CE!TY@%=8
MFOX*)-L74F.,.\$K*#VO1ZC^H%&0964.OH/H/J^9!T%RT-MW7SFNN)FN MX>
M8L+0YX:^@K5YH?L)2ZVZ>GCX$3,VQ%T44%OB:H?%\F?NF'C&V;!-LB22$^V2
M1N"PY;8G4^W)(TU]%$CX8Y2LVQ$TC6&(:D^I%^#^HU$9??X8S]#1VL_@;U_.
MB^6-_P (K]K($! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$$'?
M5-170Z<*Z<$$IW)G%K+)AVEM['( 87N+A*TOI(6DFAHVIT2D1=6/AYP73U1$
MSK/X9_6DCJ)UBZ;=*;4775#>FV=H8ZX#(K";,Y_%XV6[E<S\>QL%Y=V\GLNJ
M*TI\J3,3Y9BD$QT^;C/AX-S9N\=@[^PEEFMB[IP&?QMO66UN<!N#'YTVC)G!
MSC>-QMW=!AE!% \@BH]84MBV*UTB>7]9,W?%;K='-/(D;/<F6QF?*UA:,C$X
M.9XAH/#<VM*$'U++IK-8TMG]A%TVQXW)F' >C0:>K1010$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0:)"T,>7_5#'%U./* 2?M(/G;,Y;<LF2
MN&V=AM;&MEECSV4R,6.M;=K'$74ER^ZDB9$R-P-"\@4UX+*:1'3PB6%L7Q,S
MQGD^;[([G^@?4K>F=V#L?K)LG/;JVY*R&]Q%CN/!W$[Y7NY/"L1%D'/OW!VA
M\)KJ+&9B:1%OVLYMNCS3=SX/0,DCA'R/;RUH&O!J'&O'3UJTBAU:UHC(VC[>
M5[]&U'SDC3AH:J7=,E;H]TN:@(" @(" @(" @(" @(" @(" @(" @(" @("
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M#/\ TAN/^\GH1Q>^O)U_S#>D_P"'EO\ PELD<%GBJB(@@(" @(" @(" @("
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ML6)I$QQOY>UA$>Y:SVKAN[[?,.P[48_;$'6;)28^*WN?>&B:#>EYXCX'1GV
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MFM!>_GS#]^]V.9.)P5Y=[>Z)Q7<]K98*VEEC]_-K)-:NN)I[>XH_WIH:=10
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MG4B8F(FW6K#&Y6%N*RV4BAF$IM,IE+!K*5'A6\\L$<GJ+2T5"5\4G7262?\
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MM!$MJ&E\;6^G6ORK3NO\VG&.$L[;8Y^6)_0K4ELK+>-T< G? P-CLVAL3&-
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M=&XQF-I>>61WU2\>I*^.D),5GRZRZ8@ D4!H2*\XH:&E1KP0!RU%0 *BIY^
MKJ?H0<TVS))C%:.CG8&U!<YD3C7CJXM)H42&ZUDUU*VQ>Z228'PK>"!CKJ6:
MX=1D,+3&'O<Z20AH J:I34_M1%990?X3'L<RW;?V<;DZ_;GQE[M_<G<@^TFN
M\?E(I[2YM\9MMP&&G-K=V]O)&VZCO))!]8:J^7I\?8DS?6*12*<5V!%X;S"Y
MTAEEMW.#Y0WE!YCI0#3TJ7Q6:VQ2/!;:6Q/5K?XN[11 0$! 0$! 0$! 0$!
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M#MFAI#2 .%6Z#2HKIZJJ%.0&M%:-:*\: "OS^M!$ #@ /F%$$"UIK5K37C4
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M+K9F;Z^:.'M<UYD#S;LD%O/(6EEX&B1LU*<[2.#?4L+M:='"./L.?FCCP=X
M0 ":D  GUFFI^RBHH" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(('0'2NAT]>G!!)\V6F]YLVQVW/CW"X&3DI[=ARAPBJ![3_%28B9Z(FF1)TM
MB[E''VN.V>SD=86(\5EA>22&S@\-Y-\8W<SS))3\5R'77BF/II-UVE]WZ*?O
M6^RZ*1;.MO'^U7]R>&BC0 *   #U4%*((H" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @TT6W^5*U.58_(F-5JV^
M3Y?M?]=:O\S$:48=!R?+]K_KI_,QX'0AR?+]K_KI_,^PZ/:<GR_:_P"NG\S7
M2AT>UJC !-#5:6';_*OFZ:ZLYOBZ*0UT!K\NA^A;BO5,4X0QX:\W7"A>8(3R
MQCVGNYJT]) UJM*[:^6+YOF+IX0L;B+LO3-M:.HREQ8PVUUD[B]9!;XV":YE
ME?(V-@CMXWRS5+G-;]1A6CD[QCVFWONNBR;++)F9FZ(X1/C++_*-QO-YCQV3
M=\_)=$6Q$3/&8CA'O6Q??OW-OZ\]1[G;> NI7;)VK/-;8AL,S_=KZYCDN(;H
MR,9,^*:DH](T7YP?7#U[D[OW#<;/#;=&VNNFVWIR3--9CA%TOU<_*_Z3P_3G
MML9M[M[<_<M_%LW7764G'%+>$W6Q/!X@V%@-S=0]V8O8^W<=,[<^4O;>V=X4
M;Y_ LW3Q17#W!C) P>!(3J%Y_P#3_IS-N?4&UVMMU\VWWQ,>6;HC6)I.FKUU
MZ_\ 4&U](>FLG?8FS)LXQ3=$3=%FL6S-(K,>%%UUVT=",%V[=,<1M7&S137F
M0M+>:]E$$;)GW4MO"^<2S-C9(\-EJ!S5HOUR^FFPV_;_ $S@P68<=F;HBLQ9
M;$SI'&:1,_:_#_ZN>N-[]5O4M_=-S$X,>&^Z(B+INB(ZIX:S1Z1D_>$-EX=.
M>X?[3N<$C6OKJNQ=_P 4[R_%-L]$VS^&*5^Y\FQ3';KYPS$Y(GG/]:<&_5;^
M"/N+E;;8Z8KX%:ZM2RI$<!#E'J'T!95E*0BHH@(" @(('@?2@Z:1\SY#:SVP
M;$_F_?7B "HKRNY:A2:\>)I3311N\Z=XB[6,E9W=R^[@E>PMC;$6B.GO #C(
MW3@*?85I,<2L36(FFCYIY&>2M(>B>Z<?XSPTRV?A1-A>X$&.!M?% .HKR_95
MK3A#1MI,S;6L>"NPPO-S+!%:&**%K:73I/KB1NNCOD4NX^WFRLI2F/1P)+9H
M=-!),Y^/):8X&DA['U)+@X'F.I5Y4C696+HMGS:V\H>?^Y'NBZ;=KVQKG<N]
MLW;1WON5R_#8ATL0N\M=QP3.MH_"=-'+&&RQ 5IK52[2:V\%NNI/3?K?^I9C
M]V?=CU%[L]['<G4*ZO[C!P7UU'@MBV]U<06L%I%/.RRDF\&X?$6F%[3[0X+&
M/+Y9^+G+*O7YXTLY/@NP=A;RZL;UQ^Q]H8RXW!N:\N;>SM<)8VTLEMB(KB2.
M'GDN[>*6)W(R4$U]2U(BLZ?%RE(^&OX.<>'@NW?+\\M_:_:W@K+>/4&TM<YU
M)N88KB+WB"*<8RXDCMY71 26H#712,+>(((6,5F?[3+2+:_I57X&S2F&YD<W
MW@.(CB:  R/@  !1HY58GIC5)BNL?"F(</E]/SJ"-/3Z4! 0;7*&DAO&0'T\
M*#_KJ>^?,5TBS\+;9^*#80>9YJ2?5K76OK"LQ$UNNX)%M(I;R;G-_P#)/^Q6
M=/8E?:@2"""^H(-?9]'I^TE/85]JW#\_\O&U>B=I:-K6;.& 'UF"Y;+J[6H8
M L*,IF-;IXO=GE -FM.P[I;!>LI8-.4++ACN8U,ML>#=?KI%:^Q=(MC^+FJ?
M^\-\)URZ=W@.:&MC$9K0:#Y14+*V8N^&&%)CC.J)N(FP1R"9T3.8"G*23S$<
M:ZZDJ369Z;HI4I-L:ZP[4&H!XU -5&2* @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(('@?F*"E'YGWEA]#?
M-"Z78KIQU8M&8?-[9NYKO9FZVP-DN\5/.QT=P6R-M+B8L>"#2H .J1KK' GP
MF/.MX=R_!R=N6#VMN/..ZVYDS8G;>>RS8V8\NC$]AC;F[MJ'W42.BYXAS>S7
MU I%)CB16-*1,L=MNK;U_MS=^Y\+:VM](S!;BS>&@D-G."Z+&Y*YLF.+#&"U
MSF0@D$ @H+M/R4/AY^DGF2]M]WUFW_U'RVU\BZ^N+-UC#CY/'M)HW1<C@V>V
M#9(WASC7FU T2OBL\/;*L*?@PNWPDD=P>?H22!^0K?0$Z#]R] 5K" ^#"[?
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MO5 0:'\!^''_ '85A88S7XQZO^5UTMT/_)RZ]!I]9_IX*(MF.PO_ #O^@)]
MZC;5J?0/]W;+B> 09PK:/_(_;'\V,!_!MO1/UC>R+8&T==M>RU86F<M#C5U3
MX1Y6\?:4MF9K='EOGBSF)I%LZXHX*%_G\^5C:>95VCY4[0Q\=SUWZ564^>Z8
M7S@ULL[+=ES=Y+$L_>\TO-DX7EH:""3PU64\:\(HTJS2.=U6)1W1LW=G2?=>
MX=E;WV[E=K[YVKEKG&QVN9L;O&RVE]BKV2UNY8XKZ&W?*R2:W)CDY:.%"%)G
M37@SCA6/B5D^TKXA_P RKM3Z7XSHOM3K <ETZVQ8366VF9_$1YK)X(2L(B:S
M(7]T+FYM8Y&MY(R:,UIQ5K,ZSQ2EME8C6%/;N\[XNYCOJWQCNI_=%U*N^J&Y
MS'<PXJ&X'Y-Q^(M6O>[P;&R;)[I:Q!KJ-8P< !4J>6LS3S2=4Q2/PPJ/>0AY
M5>[O,A[NL#?[NV9D;GMTZ6Y#&[@ZIY:=MSC+)T+KB-^'QUC<2VC[;(3W4L3N
M>-CBYK!5VA2FAPGJYUU9=# X7';;P>'VMA(1;8G;.'QF"QMHQ@:V.RQEG#86
ML;2UH $=O"T:4X)X1/&6,W4K,<G.:!#+%$UI$;#62&A<"7Z@\QT-%=9UM^&W
M]JSTQ\4>:[@[L<!\P45% 0$! 0$! 0$&P?W4?9_N0I?\!'&5 7XG']#)W1_-
MLG\[+%90C$'2?4B_!_4:HK+[_#&?H:>UK\#>GYS7JK&.?O5^U&0@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @@[5KA2M0=.%=.%?E02BQS8IW
M.;*8HK*1L=S9&/F$C[MW)$X3?LN5SJ_(LIBVDQ.L^*6]=L]5NE>7A_I6K?G2
M?$=8ORW^L3>VWI?L:WW_ -4L!%9WN[73WWNL.-MLI#<3V;9S%=MDJ^*)IH6$
MU=ZEA,=6DZQS91.M8C7[_P!#ZEY*7Q". \SC=64Z/[[V/9=.>I=E%SXZTBR+
M;QV7B<+=CIK42WCYGQ\TKJT8.7EU2VEG"O3'/]23Y^-.I<MVADC:ZR;"2VUD
M/CU/,0'NJTB0^L:T6%+IB++IK?&L^WP9W3%9R8X\L\(_6F4<!Z- M1@B@("
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M0.;45%1Q(]%4]RHU%0*BIX"HJ?F]:"* @(" @(" @(" @(" @(" @(" @("
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MFV*\F,6VUF:ZSR=XT$- )J0 ">%2!J:?*5BJ* @(" @(" @(" @V3^[#[/\
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M8B.7,NNF.)RL:>6I\236OH%/M)%8U7RS/@Y*@(" @(" @(" @(" @(" @("
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M8G2FI8UH=J-=:54UF=(\T\S7C,^2.3FC@/F144! 0$! 0$! 0$! 0$! 0$!
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M^"J\U6P:P@(" @(" @40$! 0$! 0.'! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$&EQY6N=2M&DT]=!6B),TBJ2(\M)D9G,;:R6[6O<PN)
M=K1W+4>C6JRQ1;===,-';]VGX9QS6KOX; LY9!<^BM*UU_ZQ4YZ1JY._=1DL
MUMHE7<&4L=O193,YF\8S'V\;733OF;&R-C6N).KVM%&M/I6.+8Y,]TUOF/91
MU_?;_%L[;\N;IMPQ&LS,1^M\+L>[KH?"]UG;[VQ$GA.D8]KLA9<P>TEKM77A
M/L$+L>#TYO\ <X8^3;.D>']3J=WU [!MKZ9=SM^-*?,LC_UG%;W2=#29XHM^
MXV9]RYKGGWVU'U#4M'[[TIP6>/TYW6V^L8[YF/[,_N<KW#ZD^F,V.RV[<[.R
M+8YY\4?^NWX>[GH6QUY+-O;%AEKX36?OVT--*'3WLUX+8Y_2G<\UWS+,>72=
M8BV[7]#:;7ZA>F;>K#;O=E2?_'Q?[;?/=YT(NG".#>V,D<X5</?+5O#6@/O:
M8/2G<L5U;;,OS9\;;OVPSW/KWTW%D79-[LXQ<I^?BU^WK;%WW5]"I+9EY-O?
M%VTUB"(A[_:>TY]?9=^^]>;Y5O)]-]SNR3'RKZ3Q\L_N:^Q^H_IS!M<OR]WL
MLEM*S'S\4SIKIYVK;_=7TPW#D[+"6&9Q3\I</Y+1L>5LI7R\SFM!$;+ISJNY
MAZ%J[WTIN]KBGYO52Z-=)T_0ZOV[ZP>FN][OY.TR8KLG52D7VSK6G*7H^%LW
MALOZ$QS-8\'GJ"V0 M(%>!JND7]LMC+-,LS97A[GU793\^WYGPW717Q=PZWY
MQ&]\G)H#R\WS$"M5O[;(MGR:Q#6_F8LBET1Q:9[/WA[29Z!I:=#2M/NZK7MO
MMLCX=7'9<$Y[^J)F(B79@4 'J "T&Z10$! 0$! 0=>"2YT4VK'5\(G0 #4U/
M %+J:6^+*V9F9OCC"DCYX_7.Z[<_+"[FNJ>&NY8+^QV[#AH)(7O;(^?<$APS
M+<.9)$YHF-V&G7T^E2(_0MTQU35AM[Z[M[^?(WHMS/E\]E+F]@A#C7'.R%VZ
M=@ U\8W#)6CY%EPG1A[:?;_3[64"^%[\N?I!T'[)]@=V5UM6PR_6[KICKB;/
M9#)6=I?2X;'V]\7XZUL7W-HZ2REB9$7ET3Q4R<4F--?B\4X4]O!=57,4=U&V
M669[6M/.U@<YH+M#0:^@Z)$Q=H4F/-PK]K<>ZYGCAFBN/=HV!PD)9SE^E!5I
MJ?0EM(FMVI=%U*<'B7OX[/.CG?#VR]3NBO6':-AN;'9+;61R>(OY+6U9EX<W
MA,?>WN%FLLDZUGO; P9+D/XL@D:)YJ3=/P0LQ;Y:\9X,+/UHZ?[CZ,=1M_=-
MMQXZ3#9W:^Z-P86XP=T#)-B;&TR,]M:M,\K6NF$MO0 T!H 42;=9\)XPR%'P
M;'<-D>H_;=UQZ"WCIGV'1G)8F\L8Y))#%R;J>V>L8=*]C!XUJ\$!K>"5GIZ:
MTK),4\T1K']*+T.C?'9<S5B;'[,48JX-T#34"H-5C-W5;%MO^E9MB)ZIFKO
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M&/ D99P19&62Z(.A#&U5K=%G170Z+>OKF-?!Z.;P%370:^O3C]E144! 0$!
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MTJ:_?42<=M:1^'A^U:W\;HX\?V.W0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MS6-&-D39='1QUJ^#]RO1["]=^@/5KI/F;-E]9[SV7N*TML?-&V1CK\XBZCL
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MO/\ .:]4O^%+>,^]7[540$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M -(:.:KC2M *\5L.S;Z>X_.Z\<V7VS%*_P!;1C'?M+NC',3BNC5,[35H(X$
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M368TK]O%PN3_ )@WJK/=2STM=9$S_O,O[G0W/FZ]<H@\?R2R[W!I-88<@\5
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M" @(%4$"0-20!ZSH@B@A45I45]5=?H010$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$&EYHQQI6C7&GKH#HE*Z%::^"5\
M-DWW?O0%L(Q"]S=2/:'-2NJU-QA^1=;9%T:MOA[C._FZELQ%LT;US!XCF-$K
M6M',XT#30:DZ^I6S/;K$VQ=%T4]S._MLWQ;T73;,3X<5&SS(N['^1%O-TGV=
M,^VS>38ZWO[RSN7%[0]EQ& 3#.UT5?F7B[\R.]O[7MK\.WS4ZOX;J3%>K328
M]SW1^5[Z8[;N.]Q=_P"Y5NFR8FVR[',Q%.F:UF)A02GLKH3>\Y:XDO,K?RNN
M!=SSNN)&E[C(X%\CGN]OFIQ7@K%_[[FOB+KHV^/6Z)NFZO/C+]/\G?8[/M,&
M#%@LZ+XBV>FV+>&D<(C@[0BT?0OQTC'- %?&<:F@ =3_ $1%5I9.XX(FF/#;
M2.>G)S=EM\VQ=.:)K%::<^077.C+9WA-/[$MYO9X.%3ZPIC[I29FW%;,?8M]
MF*-+[HK/M;3HY;F/W.*%UO;U_&.YC4_?&O'56[N6')Y[<=L3'+19MQXK/-?%
MV1JA$-J!:8RS==3#69TCR!R?LR"_30!:^/?X\D^?';;X3HTNFL3DS7Q%E)T]
MJKYY:G=+8;:S\G1C<,%O:X3,NC9@KN22* 0SL]W;,USW2LYBZ3A5>K/RS^J8
M[/W7-BR6VQMLLQ$1-T13X==9BK\X/S7_ $VR]SW-_?=G=ENWV&)FG3=,71/5
M/&DQ%%>80FZ<*!D1#621W <UU8W .86_(]A^ROT2PYL6YQV9\<6]-*Q.EW%^
M=<1.RBZW-YXF9B8X:Q^YW=M'H[VZE@ /M \VGJ&NM5EDQS%9MNXQ]S"W>?,B
M8FV(HZ_(P.?);AI+0'Z\?OEUFR^[!?-:S6[]K#<V?-FW6E$R-^JW\$?<79(X
M0G#1J5$*BM*BOJKK]" :$'44X(2XD;601O>"2'5-*UKK2C?G64]5^26$4LMB
MJ6]R;MV_LS%7&7SN4QF,AMX)+J;\I9&TL7>[PL?-,]C;J:'G<R)A(:-2112(
MF9U9Z1[E"CNQ\ZG8NQY<ULSM[Q?\L]P7'BV4>\2]D=O9WT+IX)G,LWSATH@F
M8 UWU7#6BU(LBW^U).OLM6[?6WK_ -9NXG=%SF>L>_<I(;R1\S;."YNX+-L(
M=(]EL;2*Y=!0QREE:+.E=)XL9F;IK/X>#Y9AL;G,I=08W9>,OKRTN9&V\.UL
M?CKC(F\F<X1![LC;0S&,RR$$U.G,M6,L37JA;JQ28BMRKSVF^3[U?ZW^X[GZ
MUVDO2[85Y[O?08USO>+Z^M6.@E\(L?;":(7+'.;4D *?.B8BD>;E^TG2>J[X
M9Y+E/H3VF]">V?!PX7IKL'%8MT5M;QNSUU9VF1O[B>..$33B>6V$\3I'Q<VC
MO2M";YRW4MG2>3*9NF-=)AZ!AB\2_N+A]N^:UG:T>^$N:V)S&T9R6YT !]21
M$Q%+9I>=4],Q,Z331W4<3GP-@GN3-<$DLG\/EH :M%*>@+2GJMBLZ0QCHF:P
M/9<.@>(Y_!F80TW)9S<X]'L?82M>&K*8I2O!HFCNC;LMO$$Q<*22.C!;("14
M.8X$4/J5B)B:Q/F\&%>4_"HT^=5A\/'VN7A_DMC[VZ#VN,MI#;8^Y:7BX:ZE
MW#&R4 EM:5I4U6,3$SU<)91-W3\N=8?,/(NLL,[HCO*"/;%C97=A<63FF\C@
MR-RTOAB<:7<S'S%I=K3FI4!6-9\Q^'IB.E7E#I*01PR!K0*%[(N2-H'%K8@
MUJ76Q7S<(8]-9CHUN<US P>(V0,( YW<E>8GTTIZ5)F(\UW-G;$1Y8C6''>7
M1M,TH,T3RVM 01[5&DCCH2LZUBEC"(CCEFE': @@$<" 1\U%BR10$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!! \#Z=#]Q2=(J1K+S[U%Z*=..IE[!D
M-T[=L)LA:ES?>IK6V>Z1I+O^Z0/)T<K@]1;C9X9QW6Y;K8Y1==$1[J2X'U'Z
M![%ZINQ9-_@V^3Y6MLW8K+I\9K,VS/Z7S:X[2^AEV61P[,Q370TI)[I9@RGT
MD@VNO*N8]-^NN[;2<W^7SEPVW<8Z[IK^EP>Z^EOIGN..['EV^VZ+8I_A63_Z
MKK,GVI=';;%;@F&V\2VXM]O9J2U;^3[*,QR,QMP6/#_=&UY'T*Y3'ZEWV7=X
M[\E^2;OF6S='5=_%'MYNGY_I#Z2VO9^X9\.TV\71M<VORK*Q/R[HB?AK%)U6
MR?9=MBPW=WR;&VAN:SAN\!DL]NRWM[61K)8>2TR#FZP.:]@'*?O5Z$^I??=U
ME[/AI&2SY6./Q7:Q336K\C/RB^D^T^H?JW?B[E9;EVM^ZR1=%UL716+Z\)B8
MCCX+HW_)%Z(2DL_DEB6DT%?<;*GRT_>OI7G*/46_CA-T:^,_O?L]=]*/2D6Q
M=.UV<Q$?[G%_LN2[LVZ(\AYMJ8=VAYOWA8<!J>%I7@LKO4W<*<;Y_P"E/[VS
MCZ6>DXNZK=OM[?=BQQ^JU] V5TPVOL&Q;C-IV$%AB6D_B;>WCA:T@C@(XHQQ
M:N'W?>K]Q9U9K;INM\9ES_:/3.R[/U3L(LLB?X;8C]40^A6\PMW1M$?BCF:
M2#IJ-=5U+=;B^_-%_FMLNGVNU;>+L-DVTF;ON3D-0#\@7/V\(]S)%4$!!ML?
M70\?N\?HHLIBFL<&,35N+%D("#:#FGB&#[+3\ZTIR3')E7E$M7,!4BFGJ(6$
MYZ:4*.NEO"*UB<:</M>I2<T<:-*,U.$.O.2(YVMAJ""VM:\01^JM2,L\HE)W
M'7Y9LGBZ*'"B[!<^Z$1BD\3DT:'DNYP 5N9F9MBNLT;;/VC^7NMNMRZW35NW
M62\1SWB/PV6L;B7M-.;PVDDFGHHU:>'%-+<<_%-T1P\9=IMV]FVV]V2Z^V:8
MYGC'@LZ/,+R]_P!0.\;JDVX#Y8[:6T&V^>5QCMVVXN/>_"+G.8WQ-00*57M/
MT'V?'VSM&"+[XB;;(FZ*?Q1%'X,_F^]=;OU!Z[S]EP[;JZ<MT69(R<8B;JS2
MOOXO&#'3O9:7P:&,Q EADC<X:EY+*M!^MKZE]-RY;;+L,VUZ=>&CQ/APWV8-
MYAB?\7IUF:THZDFKG.^^<7?Z8D_JK?1P;2(I%/!!51!'YN/H^?T)QT(BLT;P
MYIV,?<QTL6.'Y0'-6IJ/ H-:U/&B[#V[8Q\N[JOB,5\5C3PAS=EM<<76XNO+
MMX\=;HN_3HK-^3;N*ZQG5C?&%9.^*QW.,>#:>(0QIMG6O+X;>8 U:!6@7D'Z
MU3-^\NC3YELS6:<M:/T6_P"7_P!^S8N_;_M=O5;LLO3\NV;YNI=$QU:3/NY+
MH=A\(N#A7E8 /]*O,NULB;KNG35^OV;)-MEE.;I??PQSV^'6KP">%:N_46W[
MC-;[*SPEJ[B+=MTQ;;6+H32#4 ^L _:6_MX1[FW15! 0$!!MR_N;OL?=")*P
M9^-FS><PDG8Q+A<[FL.9XNI\=PW%96_QT5P.;"N:ZXBM)X63R1<M&.<"6@D#
MB5)^.2/AA8J=--];XFZC[ B?O7=X;-O;:L3RS<N98_DDSM@QW*]MZ'-/*=".
M"JLZWTOUZ9].ZDN)V-M(N+B7.<XX#'DN<XU+G$ZDG4E!/-!QH*GCH-4"@TT&
MG#Y/F010$$.5OJ'T! H*UH*^OTH(H" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(-G_ %8?9_N0D<R.,J GQ./Z&3NC^;9/YV6*L(Q!TGU(OP?U&J*R^_PQGZ&C
MM9_ WK^=%\I?\)"OVJ" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@TN%6N'K:1](2.*3%8IXI3L<<^%U_&R4\LCZC2A K4_.M+N==QBBZ=+K8Y)L
MMG;L+_F1=U=4UHEW>F4BVIM?.YN:6D./Q&1F#W.#0)&V4[V:DBGM,"Z+WWU?
M'I?9Y=SFP_-I;/&:<(=O[%M,G>.ZX-AABEU^2WVZ=456>/5#>>;ZG=1-Z;RR
MUS),)LM?Q0MF+GCP[:\N8XQ$7O?RU;ZBOS%^L7K^[U9WNGR+L-O7=^.;HXS[
M9?LS]!^TX.T=AMQ3=96;+?PQ'*VO)\RCRMHP1>\8R5YB>1XI>]U"74:>)X%?
M-MIAOP]<3%V3KCPG]S[EW/L-G<K[9LSX\=L:\83%[P2!^-%" 0.3@" 0/L!;
M;_*<59GJGCX2V/\ DV2-/F\/:C[P?^ZC_2)_E.+^*[[I/\GR?[W]*'O7_P G
M'^E3_)\7\5WW3^X_RC)_O9:3=4:_EF /([5K*'@3Q JK_E&.L>:[CX21VC)6
M)^;I$MK;=[?87.[4S<,LT/)EK>X=+#(^![6V][%*[VXW,< 0S75=AC>9?3E^
MVW=T7]6.^*6Q,VUUCGHP]3=JV?J'L^[[;%V&LX;HFZEMT_#/O7>O1/?S>HO2
MK9&Z;-IDCR>,MX)KELA?K96D$1)(>^I+@:ZK]3OH9WZ[U!Z<C>7VS%++?+,U
MY6\YJ_ ?ZP]AM],>L]UVC#=U1;FOFO#C=/)]OP;7/=XAD>VE:!P/M>@_6]2^
MS[C2V8GA,OG>QLNK6:R[FX(C;$3'XQJ:D:<7 5^2BXS-AC+?;%*1#G<41?U7
M1,5=D. ]&@T6NV\\0\#K33CZOE0='+!*(YY8YP^Z80V&;F :SQ#0BE>4T!2+
MZ32[6?!;HB9ZK8< Y"WQ$;QG,K9V5O QTT]WD;J&QMG,ISEWO%P^.(", DZT
M &J1,3-(TGP)ZJ1USU>WA122[O/-SZ/=%C?[*Z47%MU%ZC0BYMA96LS&6-A<
M1BXB\5M_'="WN?#DC!H"05J192*3I'BPI%>J9K'*%M9U][RNN_<OG;V[Z@[T
MRF0QG.\,VWC[F[PD>$A#I3#$SW6Z:V[8QLE#0$$#59Q;;^#6%F9CS7>7]+S#
M;0W$EPPM9<Y'(7$C8[.\L[:6^N99'N#61NM8&2S<W.0TN(J3JE*QX3"S-T33
MC"IEVH>5=W ]R=U9YS>6+N>G&RIY8)&;HOV2&>]L7.@?/$W'7-IXC'36TC@/
M4I-U(K*1X?A7+?;1Y??03M@MK0;.P=C?211Q>\7.3LK6_EDO&1P^-<,=<6SG
M,\6>(NH"*56G-\W>:.#*9BM(C5[JADBCA<1"VVM(N1D4<; UG*#0!L3&AK0-
M. 2-->;&[PG@[&C7 : BFE1Z#\A6*H\H H  /504^A H/4$"@]00/2L8^*11
MF\[@D=I^2()!]Z9J#0_4F](H5D/E7D1:]'M\5U_?6+J3J3^]HN->*3QCW%W-
M7KC Y1H/3Z!ZUE=Q86?"W%BS0H.%!3U((H" @(" @(" @(" @(" @(" @("
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M6?3O^8NTOX QZ">D! 0$! 00YFZ>T->&HUIZO6@C4>M 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$&S_JP^S_<A(YD<94!/B<?T,G='\VR?SLL581B#I/J1?@_J
M-45E]_AC/T-':S^!O7\Z+Y8W_"*_:R! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M^:;C%,TLB;I_'['@#=WG,=&]JQR2;6VY<[SG:Z9MK"RX]S$C6EPA<2Z<\H>
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M;^L/N'_@2V_[594]DI6#^QA]NW]8?</_  );?]JE/9)6$?[&%V[_ -8;<7_
M=M_VJ4]DE8/[&%V[_P!8;<7_  ';?]JE/9)6#^QA=N_]8;<7_ =M_P!JE/9)
M6#^QA=N_]8;<5*@G_<2VX Z_L?2E/855H_*(\F/8/E+2=;_Y#;]N=^0=8VX!
MD\=Q:BUGM8\$R1D,;G,AC J^XE.CG?74C]!I376Y6M:QK&07-XSP'6Q(BH[G
M,8?I1U*UJ"FD?8L5G2(^UW8-0#QJ :^NJ"* @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@("#0WZ[_P!K]Q3FG-0"^)U_0T=U'X6QOSIQJRCG[B6(+?P9^"/[EJBLOU\,
M=^AH[6/^];S_ #HOE+_A_IXD<5?I4$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$$#P/S'[B"5+ITXMI)\2'>^B1K70.<2)F&0!Y:2::-]7J2(
MLK,6_#S@NF>F.=T_#/ZTC=1.K_33I/:";J?O/;.S\7<!L5A/F<_C,=-=2N96
M=C(KR[@DHUY(!I33BE?&*$6Q2(B=><-S9F[M@=0,+C\QL7=6 S]E:<\MK>X#
M<..SGN3)R'5O&8Z[NA&9010/((J/6%++=*3-(GA"W5ZJVQ6G&4[Q2>/<AUA,
MZ=S' 90.#F>+0#PRT.T'+3T+*8CC.ELL:S9%.-_BFD<!Z-%%]Z* @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @("#2\M:Q[G?5:UQ=^" 2>&O!!\X
MBW#$T7%_<BTQ^UH!)+'GLI?QX^UMVPN/O#[F2Z?''"UM#3F(! ]55E6.6D<V
M,1'5%U^MT<'SC9G<WT#ZE;USVQ=D=9-DYS=6UYH[>_Q-CN3!7$IEE=R>'9-B
MR#GW[N84/AM=18=4:6TX\UBVZ8F;;M(G6'H%\S!&R-SR"ZE'C4.^6HT%2DQ%
MT3#*9I-:ZHR0NDEA>X\T;-20:<1IH$IPCG"VW4B9F='.58B @(" @(" @("
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M"[J#1VOLD#T4HDQ=;=,QJPF(NMB9FD>#OFZM!&@(%!ZM$5% 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M:/J1;Z:RYL=VQ_FK,U*=45X>]0SB%K>-%N<>8<=C3R9^5TQ+L#*=+4M)UO\
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M<GZDC]1.J&R.F>!N=T;XW'983%P0R/AMGW<#II'QQO>QGAF9DA+RRGSKJ_\
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M-)I=BG7A--;7YU?6'\RFR[A=?VSL>VF^^.J+LEN68Z)UCE=JKH=/NF&T>F6
MLML[.PUAC,39PMB#8+6!MPTEK&E[[EL3)9"2T'4FB]M^D?2&W[)M\=F*<<V4
MUCY=L3%*<^F)U>&>\^HNX=YSW[G>Y<M^XKI$WW3''PF9\7>7,5Q!<MB='X<=
MJYA&0%#X@E->1T0^L6UHOH\;FW',]5ML89CQB*.#MV<;FWKLRS\_7R^/VIL'
M*]S(]' ,!-#Q- :D<6U6E-L?%'"6WF;=<5T>:'B;S$'RR]H75H6OBFXBQ0Y&
M1->Z5U.<.Y&,'.X<KM:#@%E;$3?TPPCINMUY+%I\CQ-=1AH!-Y=A]: D^/)6
MO"AKQ6[QS.O@PF6RV.WM:ON-7..GI%2:< M6WG4NB)I,0W?U=1\QU'VE6H("
M .('K( ^<F@^V@U6]O%>Y&XM\CE"QF.M)^2R9$>1IFA=R<_+[+*D^E;?-7EP
M\6<1K2FL\EY!Y-YR3>QGI9;RW ?98RXS3&B@Y98Y+F)T?++6C@WG*VV2E8MB
M*SXI$3=/5=/3$<E6D< L%:2MOEXK#4M>.""H(" @(" @(" @TO/*QSJ5HUQI
MZZ FBDS2*G#5(<%_^4KCD=$+4ATC7.>X#1KB :&BX:SO62_+T?*NI6G-NMON
M[(K/RXI'.='8-N+;'O<7W=J\$$ NNHF\13@7C@N8P67Y[8R?+NB?=+6R;G;;
MFRGS++)]\.F=##<2\PRMO%5Q) NXB-36E1(N1MR9(XXYFGL_J=?S=IV]T]=F
MZBGOC]Z8; 6MFT W=K<:>F>$T-!K]8^I<1NNXYK;IBW#?Q]K5V^#;X9\V:VZ
M?;,(W9M;EA<+JTC<.!;/"!]IP"RVO<<M]T678;HB?&JY<&WSZ1FMB9]L)9;=
MQ6$Q_?5M(!P!N(_6*_LPN3OF^[S19,3/L:^V[-MOCNW5G'A6'.BO+;(SM>R[
MM(2>/[YBUI3@.?4E;7)&2S%-_1=/V.:OR;7:6?XF.^??#C7.<=BKEMO%;NN2
MZ1C7.CJ]M'. #@6Z:!<+/=[HZ8G%=6M.<.)W7<++<D1T12><:_J?1&'F8QU*
M<S6FGJJ :?87+1-8KXI6NK4J" @(" @@>!^8_<2=(J.JM[IKW/8UE-3S#CZQ
M6GV%L9WT_P $\6.&)ZO8C+/;64,LT\UM"UC'O>^>6*)C6,!<XN=(YK6@ >DK
M6QYK\\TBRZGWL\^;'BQS-]]ML1'&9B(_3+Y!<=7.FCY'M&]]N->Q[V/;^6L5
M[+VN+7-I[YQ#A1<CCV]^28BS'DI_J7?N=0S^I>Q8[Y^;OMI;[\^./UWN5:=8
M.F4 I)O/;CR==<OBS0>NOO:3V?=Y=8LR_P#4N_<W.W]4]@F/+W#8S_\ A.+_
M &W,DZU]+N0NBWCMN4>D#-XL D< #[YKJLOY#>?#.#/'_P!"O_V6ZW'J3L>'
M'\S)O=E_^,8O]MU3.MO3J>0L=NS;D8!U S>,<0*\:>^5T"U([9FB*_)SS=_Y
M5_\ LN)Q>LNP;K+&/'O=G$U_W^*?_7=C>]8NEQA9X6\ML3OH:4S6*8:T]9NF
MU-?0$P]OW?5/7M\]MO\ Y5_^RY3N/?.S;*RW)EWFSFO_ (^+_;;&%ZP; N+A
MT+MU[?#WO9%%#'E\=/+))(YK6-;$RZ?)JXTT"U,_;]W,5QX<U/\ RKH_]5LN
MT^I^R;W+=CQ[O:=5>'S\<S_VN;[.QS7M:]A#FO:'-(X%K@""/D(*XRE-)=JK
M$ZQP:D!! \#\Q18XNOMN?F]JO$\?G2[1NLU.G2E6UD"_@VOHX!6;^B-7&9JS
M[74QV_BO =(17B7 @>H:G18?S&FC;QMKYGC-':"Q;R/:)Q5S'MKH:5:0#]@E
M+-Q-:S'-N)V<S;2LZQ,?>E3;VW7XV\GFDOWS"1TA#' T(<XTX^I<AO-[;FQ1
M%EML3'M;38=BR=MR_/G-=EMGE/M=M-@1,]TGO8CJ:FK&^LT!K\ZXFS=S?/1,
M2[79W"S';TQBMK[H<R>$0X\6S)0)':%Y-.&E>.BUK)NOB,ET3$5<=N;8WEUU
ML719$?8^<;MW5LWI]BILONO<V)L_ BFG<RXR-G'*V.&)\LCF12W$;Y"QK":#
MB11<_P!M[9O>YY8P[;%?-OCTS3]3J.[W/;^W679<^ZV_59-9B_+9;-(UG2ZZ
M)Y*3_6[S>NC6P?&CZ;8J7J3FI'W-G;W/C'%Q6]Q&Z6 N,?CU>R*5@-1Q'!?1
M.S?2S?;RVW)N\DV1SMZ9F?U4>:_K/^='L?TUQ1MNU;#'W&9\L=&:R8KK$S,V
MS-T1%.6JC/UW[Y^X[K%=SW4^[+_%86Z,_)MC'W-Q 8H93(6M]ZAN0]WAQ24]
M!-%]U]*?3C8[3'$4MBW3S76Q7[IA^9'U2_-1ZL^K.:=IL,N;M6VNF8NQ67WQ
M%U9FE+ZQRFG)XLN=P7]U'!/?W=U->F5YN)LI+)>32.D<>:ANW/>X@./K)7V/
M9]LVO9MO;/S,.;!,?#Y8I1YJS7[V[>SUY,]^^M\;[LG7,\YC7]/'WOJ/3W:^
M_P#=FY;/!],-AY;<^1N_9;>R8Z\;80OE#6U$C[9]O0ND'TK9=S]0['%@NS9X
MP6X++9K;U61/#QK5W7TK]+N^>J=[AV&RMW>W[I-U;<OR,DVW5Y3'32.//WN]
MZS]%.M/1-L=UU8Z<7&-;D:.]\;))X4'B\W)7EAC8* $Z\*+JO8?67;NX>;:=
M$X(F>,QX^]V3ZB_0KU%].?E9.]SER;G-%;IBVZ(CPK$6Q&OZ'QZ#'O\ =67%
MQ<!MKR<\36_C&Q^( X-YQ4'C1?2-EO\ %N<47VQ99BNYUB7QC)WS+M=Q&PW&
MWC)N<>EO+2>+KG%T1< TF.OLNUUJ=/M+4WVQC+9$]<3,Q/"&VC;1N+9W4TQX
M_"KF1V[9P'\PC<T$D'YJZKYAW#'?AW$6=5UT3?'CXM&-]CVM,48JW3I6OCI5
ML0O,TC[?VH^4\A=RN>WC2I.H%5]6C9V;7#CS3T3/1$\HY0[7L>X8?2MN6ZMN
M>[-;&FFG/]"8([9N)B,QG9,'-+F,>6LYG 5#6$TJXD4T75^\]XBZR+8LB)BN
ML3_6Z9W'>9.][K'=99?TW7?#%9Y\J*O7E5=J%WU"WM%U_P!RV\EA8820G&6-
M[:O>Q])+<MD#;B M=S5J""O,WU)]0V;'!?AKU;C)\,Q/OKI$\GZA_DP_+[.X
M[EB]9;K-./;88B?Y?)BG2O3,3%U]NM:_8N9(;2.!MG"XL (8SF#&L'+'1K!0
M !N@7F3=;WIOZLEO5DOG77@_73#DC98[-ICI-+:5I3DG-NC0!PH*?0M>-8JV
MDZS5% 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 00(!X@'YP@AR,JX\C:
MNIS'E%74X<QIK1!&@]00  .  KQH$$4! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$&R?W8?9_N0K/"$CC*@)\3C^AD[I/^9/YUV"D<9_IX'@Q!TGU(
MOP?U&HK+[_#&?H:.UG\#>OYT7RQO^$5^UD" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(""!J00#0T-#QH?0:()=@N#XDMA+)[T8^8RS-;X;8R[
M]R I[+M>*ELW5F8^&WC[:K-D1;%?CNX?8V8[E\,<OO%RXR6Q O8VPEU6R&D
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MM:+NX='<>';VLC(KBQ+*AS[EP9&X3_LZ.=7Y%,EME*?$RQ3?;/5=I,\N-/\
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MR^_PQOZ&GM:_ WG^<UZI?\*6\9]ZOVJH@(" @(" @(" @(" @(" @(" @("
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MBRB8ZM='T".)D;71QDBAJ:U<177TJS/5->;&R.F/%OHH@(" @(" @(" @("
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MX2RMNI,S'QOKAG9%+!'(SG>X<K)!Z>7V233CP5IU5CA$</:FNG.^>/L=HBB
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M^.WY1]IM]W];M[W;<Y\.VMQ[O+/3.2VV)F<E9B*S%:<OT+NMV:PKR8QF</&
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M:]4:)%MM-9U1:T\Y<YK&2.% 6T)-!Z?F6-8\%Z9F*1=5I,?-"8KEPN.8@\E
M.#JM/KT4F)Z:Q%8*VQ=TS-'- H  *4 %/5\BHB@(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(.ND8\2B1H),>GABM3S?Z,++6Z-)U83-)\T:>
M+<!=4EP8SGIS1@M<X4K2M-3585GXN;/2)IQM<R@/H"HC0?1P0$! 0$! 0$!
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M1+RR5P#)G%W* 7:M ) ]*U;-O_,>>^Z8MG\+4V_89V^2;XS1===K/L?,^O\
MUBP/1#IKN+J!N+PFVF(L)W6,;[MD4D]W-;W!@+&.FC<_EF:."[9Z;[)D[CN+
M-K9-VD_%29IK'L= ^J?K/9>A_3N?N^>;+[K,5T],WQ;U3%LS%-8YQR6>_73K
MAU#[E][7FZ=S96]CP]K>WCK:U==W#K7W4SS^ZCW9TTD)_$R#@%ZG]'=@_P N
MRV;:)BNFLVQ[/8_ CZX?7C=?4/N.;<[G!EMNMR71$1FOB*5F(\O53A+X(+YE
MK>O!A<^.ABYX 8&'BT<PCY0:KT_V/L>#_*,F>R_%&2VR9UBWPY5?&NQ[#)ZB
MW-N/>YILP6VS,_KB)EI@MPQ_*\ -)+PQW %Y#AQ%"15?&+LU^')?-O57KNY3
M'"9<;W+>1;D_EIQTMQ3,4B>/'7V^+D7<?,UA!!# *TH:CU5^1=A[-W+Y]\8K
MK.F;II69<-@SY-;9FZEW"M=/=5NX:^M;?(>ZYRV8["7;'\LQ#2]DC6D,(?\
M68?%I1<QWCTQ9W:W^7Q98LNQQ7JZ8FM=?!VRSM%VVPX.Y[BZ^[%FMF;HLF:Z
M1I\.L:O9_9/W?[N[9.H1GSMQD;[IO>W'L1375U=6[+?Q(FNY(GW BA:V./T
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M7X/ZC45E]_AC/T-':S^!O7\Z+Y8W_"*_:R! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0<*1S9&N?&:RMT8"::C33[[5(Z8NUYDS,VU\'S7J
M/U:Z=](\+'G>H^[-M[8$K@RUCSF=Q6)EO"7\I]UCR%Y:FXY /:Y.:GI4I;$T
MF1V.RNHNQ>I&*&<V!NK;NZ(F,8^<8+.XS+^Z^(T%K+H8^[N1;N<T@CGI4+*;
MIGBQZ8C6.,IY8[GC9<\@9(>+2ZHXT/'Y4I-:0M8C6Z'-440$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 00)H":TH":\:?+1!+EWD;/%6EQF\MG
MK#&8>U:^2]O<G<6^/LK6)E>9]Q=W<D4$#&CBYS@ %-)GJA=:='&CXELON7[=
MNHF\+_9VR.K.Q\OO"PD=&['66Z<)=7-Q(UU)&6EO#DI7W9!-*,;59<=4]CT@
M. UKH-?7\OV5 J/6-$$4! 0$! 0$! 4B8G@(5'K'TK*DE814"J IU6^," (/
M @_,04K BE8$.9OK'TA*P(J@@A4>L?2E8*2$@<2!\Y 1*Q!S-^^'TA6DE8\2
MH]86,W6QQF%.8<:BGSA3JM\86D@(/ @_,05DB*D3$\!#F;ZQ](5*Q'$J/6/I
M4F8CB4F6Q-=6MNTNN+B"!H!J9IHXAH-:E[@ %I7[C!9$S??9%/&Z(:N/!GRS
M3%9?=/LB9_4\[]3NX_H_TE@GO-Y[OQ-HT-<[PK6YM+]Y+0\@%L-PYS3[!T-"
MNB=R]7]LP77V7Y<$S;7AFL_VG<NU>A_4O=[+)P;/<1$SQG%?'_J2IX=2?-CZ
M<XY\\'3[:CMZ.'BQLF,XLAS4D:Q]#."0#0_97PSU?]2L6WMOG;=%T1$TIECV
M_P!MZ6]!_E:W/J&+,G<]]=M;KJ32<-T^'C:IS=4/,+[C=\LFL,-FG[)Q4[I0
MZVB;[R\02NDHP3,N"X%D<E*_(O,?J/ZJ;^[%=9;BOBW7AEF?'^T]2^FOR<=B
M[7EQ=R_S*S-N8UUQ1337A-KQOD]SY_*W4^2S.9RVY,C.7OF=<Y*]=$]TA)D:
M()9WL:'%Q&G"J^49O66YW63^]MSV5YQDOG]KT/VCZ9[7MUEF'-FP19;SC#9'
M"G]EU-JR&]?88NQM[G 75T+B5UA:PS9>69T=7@EL+97LYS\BXB=QO-YER98Q
M;G<;>VGFZ<G/V4U=FS]LV/;,<SAS;2ZRVFLSCL_71VTF*RT&/L,KDL+D;&"X
M=-'[_?X^ZL1)X3BT.,=S#'R\P&BT[^V[O'9&6[!GLPW5I,X[_P!L-QLNX;&^
M^_;8=UM[\MD1I;DLFE?=<ZYQI2@TUH>%!_UUP4S?9-T3U1KPFL.=CIFG"8EJ
M+00RL;AQTJ?3J#K\ZW.*F2)F9C1P^^W'\O?;;;;6L\O>U<>'_51:5)<O$Z1,
M^ BUB>$Q/VH:>L'YB#]Q0;D,4ES=65K%%+,Z\OK.RY((GS/_ 'W<1P#V8VN(
MH9/4L[,6;)EQV8[,EW5DMCRVW7<;HCE#')DLQ8<N6^ZVV+,5]VLQ'PVS//W+
MK'M7Z?-Z,]$MB;79;2>^7=DV[NB(WM>WWR"WG;X@#&.%*^D+]??H#Z6_R/T9
M;9?='S+\=LS6WIG6VWQB)?@;^9'UM;ZF^I6??X+9G:_.NMMI,S$=-UT3PF8U
M>N+*)G@F;G#'1LYSXI#&@EO,.9SM T4U/H7U7=;.W)DBVNEL^%7SC^;OS;>V
M^VVDW6_J4Z^[CS&.A_:O;9#&9/.66?ZDW<#SC]EX^6"\MYIQ'-X ??6]SX4#
M@^,<P=1P.AH5S>'8VWV=<3'RHMX_Q:>')>U6V;B[+&3RWVQP_IXK5CN=[T.O
M?=-NB]EW?G;_ &SM6>:8XS9MC=W'A"T,DQ87W%O=.8ZD,O ^I<9VG+TSEMI-
M(EQ^PP3ENR77W4F)FD/*\%K<73(=N8VVN,J^\E;'8"VMI;N]RUQ(\,\ MB9)
M/ 1(X-YB-:U6XF:33EXM2FDQ,TBNJM)V7>3AOGK5A,9U Z[S7/3W:,T]E>X_
M8$K'37>5M&/MYRZ2[DM1/;LFC#M/6:+";HBFM8GFRFML3%-.4+G+I%T2Z<=!
M]KVNTNF.U<=@L-96\$$,<%M +V62.)D,DLM\V%EQ*7A@)YB==11:=WFNU^"2
M+_+TQIT\D_7>.N)9(?=97V]]SA]QD2"\,'-S",PGV7<P%*^A69I%)BED<$BE
M*VSYIXIN;4-:">8AHJZE.8TU-/14K!47&C7'U GZ G$4[N]KL>VUWN6.R[3/
M;FDP)V3-D','NIF\5]^U\9.L,H^HX>K@M6D8YHD3,^V7@1OD0["MHK>#$]5Y
M+"YMN;WAW\G[*;G$NM*OA!%1Z5(R165X3PB*N"_R#>F#YO'FZI71R%><2C$V
MS1SU)KRB+TD\%8NNZ:RQNF*U<]OD1;0>WDN^KDKHCH S VG,&\  ]T+2313J
MB/>RX^:$/^@+Z6>GJ9D*^G_<BVXGC^P]:OS92@?(,Z6TTZF7]?17$V]*^BOL
M<*I\V2CV]V2=@V+[*;W?$6V-T1YR3>[K&2Z>_&QPN:VQ\(,!<+>, \D>NIXK
M"(MF:_>NL1TSI')4.@8Z6\N&7/,\ 1FW%"UH('M_)Q%4OFV;JVZ4X,8ZNB8N
MUNNXIAX:+%D(" @("#3SL/[)O^F'ZZE8\2L(U!](5$4$*CUCZ5.JWQ@I)4:Z
MC3CKP^=4G3BASL^^;_IA^NE82L'.RM.=M?5S"OW5*QXJC4<:BGK5.$5Y+37S
M>MN?D?N)?EV7$,L.] PN+)8WM8+!T[0'EI(86\*$KT[]/)N_R+9619,WV3.M
M)YOQ]_YANV^7W_MV]PY;;HOMR5LMF)G29B)FG#C^E2HR$?@W<;#^,]F.A::M
M.GI>-. 7I3M.2+]K%]FEE-?N\'@ST7N_Y/#OL6ZLGYU]FD3I73QEV<\YA8[P
MAH6 4:[TEIX@'T+KVYCJW%;JQKSCVOG.#:W[K?\ R<<Z3EY\/B]NCJ;:V%V7
M&M)7 DDC0T-?3\RY+#FMQTNNNCHY:OHGK;9V;.W91M[K;\^3'KTS'*.=''EM
MB0YI%.2OUA3AQXKDM]=_=QT\X=&PWW6Y8TFM8K1P"WFE# :CF /JX@5^TN$P
M71COK?&OO=N[U?,XK;L=>CIBNGA#O+ZVE$45E<DRXRY!<'M]D!S&DM (X^TN
M:[=EMSXYPUBR^(YZN&[99?DW$]RNMZ[:T\.KEI'*GL<S;^&AW#97=KFKYF-L
M<.'/L9'T9(ZHYN1I-'O#Z4TX+H/J[?1M]QAQ66=<7WQ;-/;-*Z>'%W;/L+]K
MM\>XNSS@QW1/3,5K976DTUFOZ'7PYQMNQ]O%9>$T.,0EAN_#Y@P\K9#R/&KN
M*[M'T[V,68[IW6+JNLB?PZ5BM'0KMOWR)NS8=YNIPUK/^)2?LJTQ7N2:_P 2
M++Y>V!_86^8O(Z BFG).*:+C\_H+;8HK_,XYCW1+>X>\=ZQ3T?-W-TVTX3?#
MOL5N;=6$F$^"WCN;&S5YN9^XLK.T$$$>Q[V =0N+R>C<%EL6WY,=T:_@B?V.
M>V_U#[IV_-\[;W;N+XI6F;)'#V1,?I?4++N0[A\2R.+%]8<M R,L+.<WDI:6
M$$5+KK6G*/G7 W>A]C?,?,Z=9I\$:5TKP?0]K^9#UOVJ(Q]NR;CIMZ=9RWSP
MY:WOJF-[].\3%!AM>MD]ZR-K!R/QTK=&!H#:F;704JIE^@?;LT=<]PQS76G1
M;SUIPY/JNP_/'ZXVML69MG=$Q$16<UT\.?Q<WUK;/FC=R6) 9N/<SLPYO+5Q
MBDCY^6E1^[Z<U#]*X/=_03MT:1O;8C_4M_<[IL/S\>J]O$77]MC+_P#1KH_:
M]![2\YW?F!=&,OTP;NEK1JQV7FMB^@',:&8<0W[:Z_N_H5MK;/[O>3$?^7'[
MG>>T_P#,+[C\Z+,_8<5]T\OGWZT?;\!YY&#NBQF4Z$R8PG262/-Q3L8W3G=[
M9:_V14^O1<!D^@=T6S?9O9K$3.N.>45Y1S=EV_\ S']O&:S#F]-<;HK-N>*1
M%=9\T1.D/J^(\Y/HCES##D<%-;8UQ'C-+ASPR$B@H)@XAKR=:>A?/]O].-[F
MS3BC)..^VZ8CR3YJ?J?<MC^>WT%W"*V[6ZRV+8^9-V2V*3,<HF8KKX*:WF/=
M[.)[E1@,#TSN;H;9VP7G=U@V2>"*Z;=&;W,M(G<R?PO$%: T7H#Z:?3V_LN"
MZ_<Y+8OS<)FV)X4\8T>5?S&_F"[3]3,'\GV/'-^PP1/5;&6E:]5)TNFM*J9V
M,S,,4<]K)^,86-(#:M#O9%6U!U+>"^K9NRV[.V)B^)I'LA^;G?.V7;G=3O)R
M?W\W?#32?9X:./<Y$7F/FCQUJ+>3G;5S]2X-=4T+A75<)'J++LLD;7Y=^2V;
MXMK$S'&:5T\');;N./MU\XL-G1\RV(F8FO*GV(1E]]&W01N# ![0XAM#K7UE
M?2/4O8,7;MGCSVYK<G79%VD1I6*TT\.#8[GMF?83CS5ZYS3,^[WRX0G=:/=%
M<<[@-&4:7"I/"H]:^78;)MOC-BUFON;O#L,>YB(W>2,-F./"M?9HY7+:NANS
M<2F+F8TVT):75TJZCJ::KZ;VWN,V;2RW-;%UTQK-8T=A]/>IL?8[-S.#%%UU
M\1;99=K$<IG7A7B[;:&Y),;:WF,R-DR_L+L.9:B0-K$.#J.?JVH70?6^TR=W
MWF'<67?*PXKJS3\5)K$:-:W>[;;X<F:SIR;_ "71=\C2D4FLTGA#CG;#G.\:
MPAN?=;R0O@P]C9RY*XEDYZA@,,<DK*OH%R67U?CV^&RZ_;6VY++8C6D1.E*M
M7>>N=YZHOCMFT[;?&WF(B9LB;KM--*:\7M'H)V,]PW5^6SOK[I_>8'9][)"(
M[J\;,R7W=SH@+@PSVO,WDCEYZ4KI1?(/57U,VNVOG'$1.36E,D1X^%ST;],O
MR>>JOJ%M,?=-QN,_;MCGI-UM]E\W4TF/BMTXU5GNBWD]=&MFW=EN7>N5.[<F
MT07+3)!X4$4K?"E?"ZW?;".D;VEO#5?$.^_4;<]QZL=MM\1/]N?V2_0#Z1?D
MJ]+>@<>+=;[=?YAW&R8GJOLBG*:4NM]BJC@.GFT=JX>PP.V=OX?%6.+A;&R:
MVQEC"^01L:&<YAMXW.<[E&IU7S?-O,V;+.3)?=69X3,S/Z7M[LO:.U]AV<8-
MIM\'ELB*6V66\/'IB-4W8F83QRVKK1T,FK:D:$-X$&@H*#T+3S8:6Q?U\>30
MLW\[O+-M^+Y=)F*-MD;[61XD+WPR.]J,M<X<=-:+;W673'3$TMAOMOL;(GYE
MM_5$^+L@QLAD8(&E@#3JT>JNGLJS-_3$-STXXB(FE?L2CF<.^_NH9674T#8G
M!P8P/ T=6GL^@\%N<&2W#9,39$RXC=>G[MY?\Z,\VV1-:1[-:.VLKET;F-\.
M4\H#27<^O+05U'IHMC;N9OK6WA+>3W#K_NXQZQ%*^[1W4MHZ] +93"=#2AU%
M%N[,\Q$1-NC99,$YK^J;IM;]M9>ZL>X/,A(T^7];52;XR3$<(9X\4X?-6;DN
MWK)99P.604D!TYM/:^3Y%K1BB(K$PW=O>?DV]$X>JNB=&_5;^"/N+:M.M=6I
M 0:)?W.3T^P_0?@E"O3YO!\HQ=ZRR?>2C'ONFR2R!L$\9D+*.-2U\K3H:+4V
M\798NNBZ;8B)IR:._P"^V=PQV8\FVBF/2M(U<RUGAR#Y7'$0Q^ 2XD6L<?-7
MT:1CFHMEL,63#;DNG+?K/"LLNW[S;9,WRIV]F/%=I-W3'[G(L[B,"Y>[$P.,
M=*4M(VT]&GXO7@MMW7)E_NHMR7ZSXRY;NFUVNUBRZS'9,3X1&I!=1LE8V2PC
MF9,X@#W5@#/:&G[G0K/OF3+M;<%\773U4X3/['%8]]M=S,XK=O;COM]D:IK\
M&U ;_N5:"H! ]WAKK\O(MS@W6;-;;K=;IXRW'\GMYUCH_P"K#2YT#3RG%P:C
M0^#%0FGX'"JW,7Y)MUNF?ME?Y#;<8BRONAHB=%7PI+.*T=K[443 -?JZ-:.-
M5L]SM+]SYOF3$PRMPXMOT_*BVL\HB(:HK:Y?+(R[<!"7-\"C1K0@^C@N,R=A
MB^>N<TW3$Q--8/YJ;8CIMI=K$N] H /4*+F[8I;$>$-O.LU15! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$&D?6?\ M?N*SPA(XRH!_$[_ *&?NE_YC?G7CU!B"Y/J1?@_
MJ-167W^&-_0T]K7X&\_SFO5+_A2WC/O5^U5$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$$#P->%#5!*DMW3)VEO/&^*LCCC@WF<+H M,QE(TC
MY!PYN*QFWIF;H\UT<(_7+*FGR[O+'.?U1]K%B?%,=R?<'NKS..J/2#=O4G=-
MGTPZ2VN$'2?;5G)E,5B[6TS5A;W63DADMYXH,A,VZD>3+KR\W(*$&N2>$<(?
M>_A,^X[N+QG?-D^BV W)N;=71GJ!BY;OJ)-E;K+9.SL9,5;VCL4Z*2]N9XL?
M(]X+*M +FZ<"KI&L:L9G2(F:3,_T^]DP'S2^_7-D Z5C?"]S@U8Q@:?QKC+P
M/K5K'&V?-XL=;=)X>'BFMNC6CA0#3U:+%FB@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(+5#XK3KQUWZ4=B60VQTHDS&!VKORXAL]^;IP<U[
M;7$-AXMPQMJV^L)89<?X_@"KN85^PG".%*_H2V(K-U=?UL;5V]==>KO1WKET
MQZA=*>IF\X=\8K>NVY;'*VN6S-S,R6ZR,,=S!-C6W1FRC)V.(<T\P=3A6A3]
M2Z3$3^+P9NKI!F\[G^D73C<.XHGG,Y78.RLG?/?S-DGOLCMS&7-]/)&3S,?-
M<S.<6G5I-$CC69+HBZ*1&KZ<0QI:'--90TD<Q]DTJ?MJZSIR2O#35S%%$! 0
M$! 0%)UB1Q&M(:[4_+]DKC=GBFS-/FGBU,DUMX:MF.%P?4UXU K_ -=<U=?2
MV><MC;BGJUK1S)(^<?6H?0M#G5O+;NELB(L#R90#RFG#30Z^C@KQC@MV29CB
MZ.QN><O#\B9W\SQX1CY* $Z5KZEQ<=GS8[YONR3,28KZST3,3<W3.V&*0PQN
MBDK4O+B\'TZ#_1+7MVUL6VQUTN][<78)I.M(0AR3GQ%DT)$_"@=7FX4)(X+*
M_'9;'3&2(B?:U)VL328FMC=]VEEJ^4&,D@M D)Y@VA]>E%;MK%]FE_VN/S6]
M,]-LUM=N9!''S$< !\]-%EM;KLE,=#+=&.VKKGY O]EL9XTK4<#Q^9;V_:S=
M;T]6K;V;R(NUMT:_"(<V7G(%0>)/J!TKZUL(QQ@F;INJY3YL7V<.35=61N3S
M"5S*-T K3AQT6MAW=L1-;:S27&9]M.6ZO5,.G@B\&0M-PZ34C0G2GV?0MELN
M^7;S+=@NPS;;$SJUH[3,4OZY<GW@@\HJSUU)^Z5H[KM-VXR79)RS;'LJY&S%
M;9$6=45<$RW,;I&MA,]L-74DH65U)T-2L-IV+INBZ[/-UU?;##<7_+CKLB)T
M1@REH(G-L>>68'\9;GF'+KJ>8G]B5SN3#.*?DQ$3=3C5Q/\ .S?%>F:UX4<U
MF4MH('337UE$UWUG7EU%:\E*UJ)7"@ ^XN(Q?RNPNN^9GQ73SB;[=/TN:G:9
M]Q$?(QY)F8TZ;)N_5#S)U?[M>A'1[V=V[ZL8[IO.6V]A/!D.>9O.1&76UP[E
MYGQT74N^?4[MO8++HFW!ENBO#+9RK_:=A[)],_4WJ;-;CP8=UCQ3,16<.2.,
MQK\'M4\.I_F[[>Q]M/C=F[.GR%R]LC+/,"Y($=>=L,OA-N 37V74-5YX]7_F
M@Q;:R_;[+ML79HK_ -['M\)A[)^GGY,,G=;+,W=N[]%ET1/3=BF/"::VJ</4
M+O4[@^I4ERZYWA>PXNZ\5L>.@,]HZ&&7G!;XL5RTDM9)3["\S>H/KWW3O7S<
M.7:YL-E]8K;DNFG'PN>K?2/Y8O2GHN^S)CS8<NZMF)K..VZM*3PFWV/+][=Y
M:]+[G(Y')9DE[I',R.5NG N>2YX#;F=X(YB0OAD[S?;O-==\W=6Y+IF?CR3Q
MGWO1F'9]KV^.W%-FSQTB(_PL4<-*_##K+:=UT_DAQ>0@=S!C?R?C[G(<SW$-
M8VMM%)]=QHN5VO9-UN\EMMV?<W3=_P"9+?7V[#;89S_,V5(BOQXK*?IAZ,Z9
M=J_7#JT^-NV]GY&V;)RCQ+Z"YM0(W\E)/WS; :MDK\B^F>G_ *,]R[S=;-FZ
MS1;/CCOG]<>UY[^H'YANS?3ZN3<8,&[Z:_#FL]OA=[%03IKY4F9=;07O4+=S
ML+>59+)8QV8NFOH6.?#X@MJ4?JVM=%]K]._EFOOG'=O.X3$Q-:3BG6E)I\/-
MY8]0_GYW5V6_%V[T]TX*71%WSJ\8F(FG4J$]&^R+H#TYN&[IQ6R+>7>V-#!-
M?7[V7,,SVB,>*VWN;?PVB4LK0>M>K/3WTY[;VS98=MBQ8K\^.-9G';K2(UGR
MZO(WJ3ZW>KO6>]OW?<,^;:[/)=/]W;DNTB9GPN]KE]V_;3MWKSTLO,)##A-J
M9RSM9;BTO(+:QL&-=;1SRM:',A8WVR0NO_4?8[:SLUV.S;X(W$6S2?EV1PB?
M8YOZ8^O-YZ7]0VY-QDW6YV&3);$Q\S)=QFW^TMA-\[3SW3C,W.'SX&2#;J:U
M9<1T# VUFDA8_F: VCA'6J_-OU'V;-W+NU]]M<73?,>6VM:S,<(A^R_H#O.V
M]0=BLRW76[>^W';,1?=$3-;8GC=*4\MG<?AX69&]OH)(BWV;6-\;GQ-<*&H8
M[F/* N5[7])LG<<4X\>XSVW129NC%?,>/\+A?6WKW:^D+]O6W;9_FS=7^^Q\
MO^DE3_"5LN&K/RTP&0U/L \IK]7Z_H7;]A]%]QFQ4MW>6.G_ ,&[_9=+W/UL
MVF?%\OY&WMNF./S[/]MVEMO?;%\S\5F(GTH #R-^O0#]E\JXWO\ ](,O;L%N
M:=SFNFDS_@W<JS_"[3Z.]8[3N6>*Y-K9-\\)SXY\/[3O;2"-]/=+UM]-=.:V
M&")P>]ID(#3RL+G:%_J7R[+V?);TS9&7KBZDQ-ET<Z>#Z'W?O6/M^UNW4?)R
MW66U\N2R:Z5Y2K ]@/9DZ[OH.IG4#*65_BW36]W;869D$LS'QOMI8?Q+XG2
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M11->]K_='P>)X8<YHH8=.>@^E<S;^8#M](PV[2M=/BMTJZWD_P"75NYMN_\
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M*AO/1P'J5F8YZ0D6W4UU7'MI%!:VF.MK*)MOB[.VAM(+=C.5L,-M&R&W@:P
M!K(HV!H T "4Y3":UK71S2QXEDEE?6+3PVT.E?FU5F:V=$1J=$=47UU<U1D(
M" @(" @'35!L0RB2OK'ZE5E?CZ)FZ&GCR=:)> XCEU--:\5LXRQ=-.G]+5X.
M/-,6/Y7<-.!K2OK X+D,=L3;7FT,MVM(G1MOMP^-[A-0\CB274#?9-.;70#T
MU2=S;CB9GII'M8?RTY(BDS$S[WDOJ?W-]+.B5M+/OC/V+)V/EI!:W%O=2/+#
M)[)$,X<"2S5?,.]_5OM_:K[\4XL<S;6*1DMY5\9]CZCZ4^B7JCU)%N;9_/\
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M1P0"QA+26M);]4EHJW\$TJ$$2 X4< 1ZB 1]M Y6Z>R-.&@T^;U((H" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @@&M!+@T!QXD  GYSQ*
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M%GDQ!LI'AQ#_ $(^YK]U!E]OAC37R:.UC_O>]!_[3WRHK]* @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(($@4J0*\*D"OS(%16E17U5U^A
M) I4@5X5-*_,@5'&HH@B@(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M<QGXGVJZ?,MKDW\_P31NL>*FDS66\YX=H6:'C76OJ6A_/W?P2U/EQSEQG1M
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MUV^7<?(W>\VT13+?@LKRY39KP5'8+6V@C8R"WMX6-:T!L,,<3    &M8T!H
M&@]"Z;=??=.LS/VO0&/#AQ6].*VVVWV1$1^AOT!X@?0%BUJS' H*UH*^NFJ(
M%K2:EH)]9 K]*+6>')I\*,@@QL(<"'#D;1P.A!TU!"L3,<$N\\=-VMOM=;^0
M<'K_ +C8K4DG_<ZSU)U)/XG4DK5C<;BWA??'_2G][8SVOMDZSM\$U_\ #L_<
M@<#@R*'"XDCU''6=/H\&BS_G=Y_O<O\ UKOWL8[3VJ.&VV\?_0[/W(_D+"4Y
M?R-BN7[W\GVE/H\&BQG=;F>.3)_UI_>O^5]LI3^6P4_\NS]R'Y!P?_F;$_\
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MBEO,EB#9/J1?@_J-167W^&,_0T=K/X&]?SHOEC?\(K]K($! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!"@]00;5Q;6]W$Z"ZMX;F!_UX;B*.
M:)].'-'(US'4^4((Q0001,A@ABAAB%(XHHV1Q1C71D; &,&OH"#<H 20!4\3
M05/SGTH(H" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @'@:"I] X
M5^1!1][MO->V?VF]3KWIIFM@39O-Q-AD#[?*0Q<T<S971.<'2U%61U( %*JS
MTQ[RD_AX<WF >?+TZG9;WCNDEP[)-:\NB=F88^1@XTYI^5Q#?6"I2ZDS6(\$
MF=8B(K+FV_GV]-+R!IQ_3&XFN&AX=9_E.%A#ZT<QK_&Y!K\BT_FUK,ZW>-64
MX^GV6N!9>>YTKLY;B7)])';3DG-)<A#-:W4MP001XCK-T,CBX@ZN)HGS9B8K
M%;?>LV<[9_0YTWGW=.72_O#IC+>L-*2G+6\/,/0?;G);4>@\%9RQ\,1YO?HE
MMEUW#A[I;3O/AV0Q[I_\#SXWT]NX.X;&3E8![3N1DP>:-UH#4J?-NITZ2O1%
M=:U58.T3NAV[W8=,8>I.W+9]K!.YT<D+PYC6O :2QI=)("&<]*@^A:DS-(B.
M*6TF?-\+U#RVUK)(X2/;,>4EGM/#23]L%6OCQ2)F/+R=P#4 \:@&OK4$'_5=
MK3V3KZM#JI=;U6S;XQ18TF)]J1HX)A/5D;KJW8Y[GRAY92A)X>F@7 ;?TW\F
M^;IW$S?-U::\Y<QNMY;&'2VVM/8U7EPS*>)';73HS"VCHW Q@4%''G)'-R@_
M979HMM[?CKDOMNF(K29B/UNI9[IWU\6V=5ONB4KWK['$6S+^YW!8"VMVRODF
MO<E;V+F!H)</#N)H^8MY=/25UWN?K7;[/^]MLV\1'Q5RV1.GLFZKD^U^DMUW
M&?E8KMQ?==.G3CONBOOB)>2^I'F =#>F;[W#3[CAR&<LFR4AA<R6*::,2$0"
M>.YY/QKX^6ORU70NX_6?LV&;[_E8;^FV[2,EG*)]M7W?TG^7#UCWC/AQW?.P
MX;YB.J<=VD73&M.GE6JFCU<\TOJIO.)[>G&!'3JUC=-"^X==17\EW$'2LCN*
M-G')XC"'4 T7E_OWYD=WDNRSM>WSCLNF8MIEK2DS%?BY\7LCM?Y+^Q^GKL.3
MNW<_Y[+2+KH^5,168B>G6WEP4Y]Z=6>HG4/)76X-X[PSN5GE+R8[>]R-C""_
MGK^+BN>0BKSHO,_J_P"H'=O4VYB<UF?'69K,9+Z3Q\)>N/I[Z+[#V#MO^5=N
MV^VBRV*5NQ63,<-:S;5\MM\M#<@X^>TN[TVKS*)7B>X>"3S^T\\[B?G74L>V
MWN3-&XB[-,71_;N_>[EN?2&WFR,MN\V^*RM:1=9;^B*.3/X6=EAO2YT$MJ>4
MQNJT -]D!S#I6GK6,=RGMULX<N*;K;JZ3I/OU<U@NG88_P"6L^7FBZ-;XF+H
MBGWNV' ?( /H%%PDS6:^,LD5 00) !)U !)'K %2/LA6-9B/:4KY?'3[W#MK
MBYO(9W>&V""%P=M\D@CFC/-<5KQJ0N;R;&)Q671=U7?CMCC=X?<X>[M%NROF
M/G=4S6;M*197]ZH%Y=W2S)=0^O6WNH%U:2/QFWW2#/O,3C 'GW<6A ,;H_K?
M*O0?T,]+;G<=YQ;S+?=\B+HGIZ)\NL<Z/&WYH?4^+LOI?-L-K=;_ #>2)BSS
M1,S6+JTU7.TS>6UM8^0<L+6,94 T8QH:W0CT@+]-^S6V_P E;9-:VVQ^B'Y+
M=UNKN9OXS-U9]\S66Q=N=(ZW<'%O*X<P:VG-J!Z%T[U+W>_#N<6*,=TQ%\16
M*\Y<QL)MC#6(CA^Q,[?JM_!'W%W3'-<=L^R''7<9][4LT$$#P/S(.GDNHX9A
M"YQ9$ZNC:R!U>/MC1JD36:SI<RF-.%;?%!C7.#K>R8Z <P<Z4DOT)!/'UA93
M6DS?##28CIEIR.8Q&'8Z7-9G&8RWB9S%^0O[6R% TESBZXEC &E4K%O"5F)N
MK6-'A_KCYD7:QT%?-%N[J#87%PUDK8X,4ZWR8DNF-E;##SVMVX-$LL7+4C2J
MFO&-"(_BGRPHX]=_//WSD?$Q/1;INS'7,CIX[?/RY"*Z!A<96V]TZU][Y/:8
M6/H14<%K1%M*3K#'6M8XJ1W6SN_[B>N5^^YZP=5<YDK!]3%@\*[(8=MBT\Y8
MT28^[:'M@\0Z>D!912G]DB.F[2=9><3++D6&Z?D)MYL-2+_(7,C+F$<6L$-T
M]\TCHZTKQ)4B?XM(93$S\,:^*;MF].-_]0+EMELW86=W7<OEB@AM(\=D;>W$
MT[FQ0L]Z%JZ+D+WM'-6@!JGMG@DS3RQK*IOT3\G3NMW]+CY^I&W[?I)C;TQR
M2-;?0YJ1EK+X3FND8VV>Z)YAD)+3J"**]4:S75IS-TTBGE?3.[_R@;[M\Z42
M;XZ7[HO=];LLVNFR5I'C'L+;6&)\UU<M%O:OK&UL;J5H=-0$MF;N1=TQK;.B
MB.)KE]RZYE%,) ]UO<Y"0>%/'=0.,=S'[H^DA\.9CAP]"RTF$B:\-8;TTY\5
MMW'&8L+P&9()>21H/=CK[1TJI$4C6-%G72U"M=0:@Z@\.8'4.IZ*C5;MDAZO
M30@EOWP]+*^CF&E4&ZYMM=7#60699%&*FSDD\-N)>.$_CNH+CQ'>U184B9I6
MEK3G36V//S]CV[V*=HNX^ZWK+B,7F[2[O=JX;*8_*?R[%K-;V5@,9=V=VRV,
M(MWV]QXO+R:G52Z[ILF9Y,XI-T1;]J^-P&!M<!B\7C+9D+(<;C+#&QL@B9!#
M2RM8K;G9#&UL;.<1>@!;"OWLZ:U=R>>OL@4]'!6.GGQ2:_8W%BR$! 0$!!UU
MZW1M!0!:VWGS75]C:[F)F(B&U9\7GU-.OV"F:E+8YZIM=;IA*U[%*9&NGNW.
MM'/=6(5:: ^DBE L8K2D?XO\7]3L>*;<=+;;8K,5X\/M==FMR6FW+)]W[W96
MMG;0RRON;N_MX?!CC8][])YF<]6L6^VNQOW5_1;$TGGTS^YU/NWJ#;;#JW&\
MG%;;96O5?;;$Q[YF'@OJ/YGG;9TN\=F:W*R^OF22Q.AM.2>LT+I&.:#%<G0O
MCHNQ;?T9O-S'3,W1[[9_<^,>I/S-^@^Q8[KYR8KNBL3%N2R>''\4O@KO.DZ(
MS.=<#"W3\>3RP3&)X,HK04;XVE11<C'H#/=%(OF;[>/EF'Q_<_GH]![*V+[]
MO/R9F8B8OMNF9]T2^T]+O-2[=.HMY%BY;N/;>3N7LBMXKN:%C>:4M8UQD?<,
M%#SK9;WT7O-K9%UEUV2Z>46SH^A^A_S4>B/5_3,768<E\QI=DLUK2G/3BJ$8
M[<>'RN%QV:Q.9QF3ML@QLK9K>YM;CV9@'L!$4LFO*[YPNH[S9[C:Y+L&2V^W
M)'"9B8>G>S]T[;WW#\_;78;K;K*Q%M]MU?MB9U]CNV6TD8>8Y36C9 "2 0:.
M-'$TUJN%LLR73T16+HKJTL6SF:S-TQ;-W#[4?R[&XO8U@;/&0"'#2O"M3HMW
MCP19;$16<L<W,1V^(\U]]LX9CQC1\ZZF=7=H=+=O76Y]WY3$6F.M8GS2RS96
MR@NV"-CY"([%US%/+I&> *Y[MG:]SW"_IQQ?2?[,S'WTHZ#ZO]8=F])X+\V_
MR;>S!CCGDLB[A/X9NB>2BGW#><[B(67F$Z"X67,7C6W5K/G)/&B9!*WQH!+'
M&)W"0Q.(<*#6B[WM/0LS..<]UVN2V*=/*9CV12'A'ZB_GQ['Z6[K_D_8.VV=
MRMNMOB[)\V;8LNUB(CIF>J9X^"B5U0ZY=5^L&2=N/J)N3*9J0W#YGW]O?WEM
M:P1RRO>()<9%<F*01-D+?:;Z%[*V?HOMO9NW8<6TOQ1LK<=LVQTVS=-TVQ,Z
MTKQ?G)]1OJQWGZE]VW.ZRV9]KWO+=6ZV,U\66V3,TCXNF:VS[TNP8:+.EEUB
MXIKJV 9&;O&V3[ZZ?</;RQM=86D<DQ+Y2 31==W_ '?'VBV;\EME^2)X5B-'
MQ6.R;K/W"_;[6S=Y=E;,1=?%F3)YI\)B)XSIIXO=/;5Y;O6?KID[:7=/O73K
M;<G)([.7EG-))+:/,4C7"UDMQR.DBE.AX>E?+?5/U%VFVB<V*WKNGE;?3[.+
MV?\ 1W\F_K3ZA8,.Y[MN<G:,$4FV+\5\W=,TFO"-9B?Q5CQCC"OYVT>7UT1[
M<8+?)XZ*RW)FXN3Q\WD+.TG;-./!YG^ZRV[V"LD510Z57PKOOKON?<^JVSKQ
M]?"E]VGZ7ZG_ $O^@/ICZ9=NQ;3IV^[W&.(KDR8L<S,TBLZVSQHJ QQ6\3&L
MBMK6)C6M#!%!&QH:!IRL:T!HH.'H71-QO,D36Z;KI]LU??,>TVV&RF.RRVSP
MB(B/T-F8\O[F\,!XCE%'4IH=*>E<5FW%^::=,MU%UMD5B(JW&2![2"P,T%7<
MM:_:6ZVF"++XFZ9EM+\MU]LVQ6(=9<8GQWL>9J%KVNU&HHX&@T-*KFHS6V_A
MBM&SGMUU_GZY\4S-%&M'J:!] 6VGBWE*:-2 @(" @(" @(" @(" @(" @(-+
MOJN_!/W$*TU219S/]ZG'+(UK7DM<>8@T)K1964NOZ)F(^UG=W?JMBR<7!S,M
M?V3,:^>\N8H+:%KC+(^9D88T DN<7.;0 "NJRC99=S=.#',UN]G@X_=;S!9C
MNW&>Z,>.WC68A\=FZA=,W$,_E]MV)H>YK@<UC'$.#J.!!O*@M(H?F6-_IG?9
MYI%N6(IRMN_<X&SO_8[II_F&TB^O"<^.W]=[D?X0>EMN^.1N_MO2D4<ZF6QE
M 0*U_P!E^BBXF_T1W:Z*Q\_HMB9^&_EKX.S[+-VC/9\V.Y;&-/\ Z:P_[:B3
MYQ_4';F]L9TMM-M9G'Y1N.CSAN)[*ZM;L32213-C:YEO-*&\IC]/WR]#_EP]
M7Y.R8>XX,>SS9LMW3$]5EUM.F?;'-^4W_,GW/;NZW>F[]MNL.3!M<F:;OEY+
M<FM^D?#,_P /_I/2?E7]4-J[.[1]HX_<.X,3B\PVZR;I[2\OK*VEY3/#X1+)
M[B-[!*W7AHNF_6SO^;>>I[>Y7;3/;\_2D8K[HBE?"'I?\G7?^P=G^D.UVFZW
M&VQ9XF;OEWYL=MT5I2Z>JZ)\W&G+@J/CKAT]O0UO\J=N0/=5T<?Y;Q3BSEU)
MK[Y4\ZZ/V_;9][@^;.'<676ZS7%?'['IZ_ZB>GL'DMW>SNB^L1/S\7Z?.[C;
MO6;8>=RC<?:;@V\^^+FQT&=QCGSFH:WDC]\+BZIT &JV>[RY,=T68\&?);7S
M3\J_3W^71I=L]5=A[AG^3AW6UNW-=+;<V.9GW1%TU?<FD.:' @AP!!!!!!%0
M01H0LXX.VHH" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(-(^L_]K]Q6>$)'&5 'XG7]#1W4?A;&_.G&J6\R6(-D^I%^#^HU%9?
M?X8S]#1VL_@;U_.B^6-_PBOVL@0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$$.8'0$$^JH0"0!4D >LG1!I$D9Y:2,/-7EHYOM4X\NNM$&JH
MUU&G'7A\_J010$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$$.85I4
M5'$5%4$"10C0FATJ!7Y/DJE8*33V*='6ORXNVSN$W]E.HG4+:SKW=DY969UX
MZD?[H/$>#!(&,'.3QH K?I%8F)_86QRMK%>/M4[.X_LZ\KGMIQK+_JQ?6<.0
M=#<2VUA87T5[.^6-DSH;6>.T_&6YG?%R>V =5CKTS-U)B(X,_+-.,75XJ-'4
MWJQV?WN,O++I-VUG!3%\\-MN$[@=*YT;72QP7ON[G5K*WE?1<%&>Z9FMEU:^
MUS<8<<?#=;,4CP>9MCY_:V"RTUYG\(S=./EE+SA)>6+D@+PY\(F?Z?#JVJG\
MQ?76RZ(^TG;8Z1YHNG[%0?HMNSRU-Z7=IA>I71E^S+JZDB@?+^69)F>-(Z*-
M\A<'<K07O)^0!)W$\(MFOCJ?R\W329B;/L5CNGOE5^79U/P%KN;IYA+;/1W<
M#)_=(-PQROB\1C'@OB8)9&^&) :$46O;?U6QT5NOKPX-MDK9?TWQTX?&E53G
MH7V_;%[>.GMKTUZ>PQV&(L7\\PC+.;5S"UCBQD9'*V,"I&JY>M(K%/O<9,6U
MF;HF(?=A,R42/BDBBD9X;?%+F/\ $ H*4)]2O#S3K:PF>43$.V#A05<":#TC
M73BGMY,J3/!Q+O(6%G&\W=[9VH#75-S=0V[1H>+I7M "VV;>;7!;-V3)CMF(
MKYKK8_7+6Q;7<Y],./)?_JVS/ZH>).IW>WT,Z,MN6;CW/;39*)\[8\78NAO&
MRO:Z0<OC0SN:.9T=-5\([K^87MFPC)AG9VS=9=-L3&2W7IF8\>='U3T[]"?5
MO>=QAR6VY<>UR4GJFV[A=3ET^$J:G5SS6\KN6"[L>G&S/R-; 2LM\W[XPR/<
MXR-BG,+9V_5+FNI1? /6OYD-SW*Z[!MMA./'PZHR^_72Y[3^G7Y->W7X8WG<
M^Y=>28B9LG%2G"L:VJ:V^^N_5CJC.]_43>V7S$KY)'0>XW5YBXHV/<\LC++:
MY#'<C7T^5>9/5GJ[N/J#)=FR7YL>6?#)?3]%WM>M_0OT;[!Z%V_R>V6[>[;1
MKYL=ETUBG.;:\GQZ[MS(\NR$TUZQ]"SQ9Y)YB?15[W/D<[[=5TS;_P U=97%
MFS]<<?-=-?TN\[CU'AV.2+,.WV]MU>GJI9'LK[$U;,Z?[UW]DF879VRL[G+M
M[XV,>^QR-M TN<T,_&NMS$6U<->!78/2WI_O'?.Z6;2[%NK*SKU8\E-::UFV
MGM;#UWZR[7Z4[/'=MWGV>:EM9BW-BF8TF:4BZJHSTG\L/K9O_P %W4/-CI;C
M*0RP,;:1Y-]U'2-[H7 V_P"+<]CBVI(HO3O:_P MF[[UBP_.[G."R[6DXIT]
MGPO&??/SK=GV4Y\6P[/;GW%E;8F,L17C$SI=R5']@^73T0Z>8\V6>M(=Q93*
M0^ V^DA8WEE$;8S,0;?V?$?[5/E7H/TI^7#;=FVE^*=_;EOZ?Q8[?#E6*O'_
M *W_ #)=\[[W+'N-IAS[7;S?6;(RWSSK32Y2 [WNU#(=!]YW5Y@+2[GVQE9O
M&@%M9SNM[>/FF?1\T5NV*/V0.)7CSZY_3?)Z+[];=BNR[G'DK-;,5TQ;Q_AM
M>]/RX_7/;>I.TV=KW.ULMR32V;\F>(FL=,?BNJ\5--6M]?*T<OI!  I3C447
MG2>,^][,ZK*1/5;28KQAJX<: ^HZ'Z#JE)\).K'_ !6?? E)\)(NLGA=;]\!
M&A!X$$.-.#2*$_8"FO+B=5D:]5NFO&':;'V-GM_;MV]L7;K+R[=FKH1XNXM+
M2>XAMP9F-N?>9H(Y([< /_9TJN\^CMEN>[=XQX;L.?'N+;HZIG'?2-8IQBDU
M?,?J+Z^V/8.SY\MWR,L763U3&:RL],3X75THNG>TCMXQO;KTZLK&X?%)F\I;
MP39Y_@1^,9#';NC:#X3'GE<W5?J+]+/2%O;^UV9[KK8SS;'5'1$3PB8Y0_'#
MZP?4>_UIWV_-CMOC9X[[HQ>:9CC-><O8A_?C:M;[+15HX5%*C[2^R33#'3$=
M3XA$6[JZLZ:MMLC6M \+ZI JX>L^L\%Q6X[?_,Y(R5BV8GA2)<KCP19;2+JN
M[:00"/4%OHBD4;2>-$54$'!OLEC<?$Y^1O[*PB+7$OO;N"T9RT-3SSO8   =
M4'@#K3YAO:MT+M;W'Y[J=CK?/6AN/"V_9B+*.OKF-\E8!=03EC&2.B(Y@_["
M5KIX&EL=4*1O6SSU=R96VN,+T@Z?';L;73,M]VSW<-[X]6R1P2,M!<-\-E>5
MU""?E2)\%TF=9TE2)ZR=Y_<]UX=*SJ3U%RMQ93.>T1XN2[QC&0$R!D8%G=AH
M#(Y"%:SPX,9Z9UC5Y?DM!I)%=7F9FE<#(<KDY[USBYU7 "\EE(<XG2GK4K[/
M,NM*S=2$V[8V)NK=><AQ6T=L[C.6N'1QPVD.'RES;ODD+6M/O;+5\+6N<X:U
MH MQQUG22)_!&MJIMT2\H?NQZG-M<GN4Q]/\+?.@>R]O(X[J<VTIB+G^ZSVA
MDJV.0FE/0L9FFOXBD1%%7?HAY)?;ML"6*_ZK22]7LU;".6.1P.&MV3CPG.+K
M>WB8R5@>PT!+20=:+";_ "^%R1%T7Z?X?BJL]/\ HGTMZ4X6+$;$V'@\-:L$
M;(H&8ZR?.QL;6L%;ET#I30,'%QJ152(K/FFFB\II][Z8XML8F-9(V*-H-(W2
M!Q;7T-#C4-;Z - L8\^M.J4NTI/5$6_K<"2UL<S87UED/=<GCKRVGM;FWFCB
MD:;>XC=%/&X/YZM=&]PU'I6=T6674K$7>]+;NJWAI'AJMV^^GR;;?<T]]U([
M8W1P7<4U[DKK8S',AMKF>5UU>7)9*+;P_;E=H.*U.K6MW&>3&^RL12)MB.:W
MNWCL+?G3G<%QMS?. S=KN.REEMI-KG#9#\FDPO?$Z3\K>ZMM/9,9/'59Q%\W
M5LMNGV1$S^IA?=ALM_O+\=GMNOMC]<PD\LD!(=!-&ZIK&8GAS34U90MJ>4Z?
M+1;SY>;_ '>3_J7?N/G;;_?8/_:6?O;L5EDKIPCLL3F+Z1[FQM&/Q5]?/:YY
M#&NY+:"5WLDUX*39DB*W67Q'MMF/V,HR8)^')BF?9?;/ZI5)>U3RNNO'<Q<8
M#(;JCN]E]*(+N"XR.YKVUEM+W+6[9+>X=;^X3V;;EM(7N:5M[K[+8UUA(B;J
M].D_K79W0OM^Z:]N6RL/T\Z<8&UL;.VM;:.]NVPP^]9:>.&%DL[[EL3)&5DB
MYJ5]*T)NC)7JF(M][5BEL1%KT@TCE;304 I7A32GV%H3=;$TK"\=6ASN8$-(
M]'M5 ^7@4K;,?%"^:V>#<YF^L?2$K'BAS-]8^D*U@10$"H]:E8&DN:/V0^D)
M6/$</G;, "0 *TJ1QJ?FJM/+?=CBD<99WXHNBO-M6_A,\7Q)&,U%.9X::#B0
M"1HF/KR376K;X[HQS-9B'PSKOU;V9T.Z?9W?VZ[ZTCL+>WEE@BDN88WRR1QS
M.Y8&.EC=(2Z.GLU78.R=LS]RW?R[+;IMBE:1,_L=<];^K-IZ<[#=N\LXX^79
M=,1-\6]6DSI,S'@M0NZ'OSZE=PV8S%OLZ_O]H[ M[F>WCF@NKELEW$))XQ[$
M=R7-;()%Z!]/>F]OMLN&V+9F[3JGHX</8_&/\P?YC>^]\W.?LV'%=9L,E\VV
M39FGS1$S$S6V[1X)ENB3XF1M9,E=!Q>U]Q,Z8R/<[F,CC*7?6.NOK7HG:^A,
M&>VRZ[<65NM_AC33W/%&;/O=UDF+=UELLNY3==-*^VNJ9(L^_P!U9%FH;>PL
M6"D$;+>*4BH'*#R@G5<AC^G."Z.F-YCB9_LV_N<U/HB^_98\\]PK%NM)GA7C
MQ=/-+9W4\MQ<8&5UM'3W;+6M\^TD@<?J3".%S7GE<:T6PW?H7#AMZ(W&/YL_
MV8G]C<8.W[KTW=.>S=W[G:132V^;:_;$U]CU]VU]WO5/M]S5M=39_(=1-IMG
MMW# WE_=P#'6;)(/&#9);FCS#!$:#2J^6>I/1&VW.UR8\D1?=;$ZQ;%9XZ\'
MHCZ:?F?[EZ![KM+;,>6[9WY+8FV[-?-/-;$Q\7/VZ+FK87?)T>WYTLM>H5AG
M,?)C;3'-GO;*XO;:UO(YHK=DEQ;LMY+H7$OAR5;H#6B\OSZ1WUV\NPV6Y/CF
M*]%WC[G[.9/K-Z?VG8<?=L]VWQ6W[>R^;9S63.MD73$1U5_:IJ]Q7G%;?NK'
M)[=Z)[6?-N"V?/:')RSF 02?CH!.WEG:)!$\->!0U7T+TW].+HNG)O>O)6GE
MZ)C]</$_U5_/1VOL^:.W>G]C.7#6Z)R_,FD3%>5MWC[%%[J3U7ZG=;,@[+]6
M=SY?/9#FFDLLE#D+RTLX62O>\6\F-9.Z!XB#^6I;J OO_IGTEML48]CM[L6/
M!'Q1=%L3'#G.K\_OJ']9=U]2,V7OW>8S8.XYJVXHC+?=;,5G3IZIB.7*J3,-
MF+BRGAQ5CMJXR60<_P ""XQ]E)?ONW7!\)C716L<CFDEP!--*KO=_P!-]MN<
M-^XCN>VC;VV3=69LB8Z8K3[:4?/.P>CLF^W.')3<QWRZ9Z<?1DOB_J]M)CF]
MY]MWEI=:>L^:9F-RMO.E>T\C)!-/#>6=Q>FXMI70O/+'+:TB,L<I]&B\\]Y^
MIN/8Y+L..V;LF.;K8F+]+NFL5I7G1[#^G7Y-N^^N]K9?W;<7['8Y+[;IB['=
MU4TFE:?K5].W/R]NA7;-EXMP8/;L>:W2VV#)LYD&,NK>>:6&-LDK;":W,,;B
M]E6D4+2=%\*[]ZT[AWV;K(F['ANG6VLZ_;5^J'TI^@GI#Z;]FP[;;6X-QN++
M.FZZ_%CF9TB*ZVS-=*Q/&'M^'$%FD/@1#4_DZWM66["TZT#XV-#0&E=+C+&6
MZ8S]75;[9YON.3/MMO9;BVF.RR9BG5$1RTX-E^/$5S QKI+4EP)QX#Y&'6M?
M$^KKQ2;9NGC6R.7];B_\KNR63FLOI;,UG7[4[^&7MHT4]EM?D( ]:T?Y:(UF
MY>OJBG*'#D+HS1T/-0_</%:MF/'9K,1+6MV_7&EU'/:\O: (]"-?13TT36*\
MYA+L=MO&76W3GQO: TGVF\*\*CU+97;J.N+9LFK+^9BR*4J[IO ?,/N+?1P:
M''5% 0$! 0$! 0$! 0$! 0$! 0$$'?5/S'[BEVML^XATD!)YVMCYO#+P\\M*
MA]?DUHN#V6TNQYHGKF[6:UJUINMR5QTB)IH^)=6NG>4WSLS=.&PN1N+&^O<9
M?P6WA^(TF>>TN(XV-<W4%SY!J."[_P!E[K9L-[CR9;(FR'1_6?HF_O\ V?/L
M[=W=BR9;)B)CE6)CE[ULS-Y8?=Y893*2OL,[/%<93(W$!?N')S PSWDTL1:0
M:-#XR#0<%]P[=]2>RX\=MLX+)NI_9A^:/K/\D?K3N7<LNXVGJ//&.^^9BV;<
MDTB9F:1+LX?+@[N'CPSM[,N]DMYORYD 144)U]("YRWZL=BPX^G^6LF??:Z;
MM_R$^O<E_5D]4;BVR)X1;E^YQ#Y9O=-:LMX[_;>1W U\CC:17F3NI1C^=]90
M?%B<#S_( NP^E/KQV+M5^;^9[=@CKYQ%D=5/U?:U^_\ Y"/5/<<5F&>_YK]8
M^7UVWW?+U\TTF*:^R(;5YY8G=]^4+AC<3D<+M\MC?#;6>5NPWF#>9[1'"QL;
M:N%/JK0[S^8#L?=L]EN#M>"+,=VDS%D\]>.KF=S^0?U5VK;6WV>H\V?+=;K2
MW);6D::1'3I[G4.\MGNL][ANHL?N%K6%S7L&9R@: W3FH #J!7BMQW/ZZ=F^
M5$[/M>#+=-M)B.B*33]+JO\ ]A3]0K-K=@Q]ZSSEF9K=3)3V12E?TOJ71?RY
M>YS$]4,)NJ\Q>=N<7B,OC+JY+]PY&T:QL5W!+*2Q_+XP$;7$MX%=9V/UG[9C
M[?O]MW+MV';9-SCF+)I9DG6*:>'O?7?H1^3CU-VWU!C[_P"HN^9L>7MV2V_'
M9YXC)-8XS/'2NE:>S1=28V%]OCK""4$2065K#(">8A\<$;'@DZDAS>*\M9KH
MOS7WQPFZ9^^7Z>8[/EX[<=:]-L17QI%'-6DS$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0;/\ JP^S_<A(YD<94!/B<?T,G='\
MVR?SLL58YHQ!TGU(OP?U&J*R^_PQOZ&GM:_ WG^<UZI?\*6\9]ZOVJH@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @@XT:2> !/VD$HWC[EUH9
M\4QPR E 9&YQI.SG D(KP#6U/V$MF*S,<.<+=-T61SK\,_KT27U%ZQ=,^E%D
M+CJAO3;.T<;=M9%:RYK/8S&RW4KV4E:R*\N[>3V75%0*?*K==U<8:<6S;,17
MWFRMU[ W_A+#,['W5@-PV5IS36M[@-PX_.&R9.>:MXS'7=T&&4$4:\@BH]86
M,6TYTCP9W73736?'^I/44QGF#K"8W#HW-&3:X.C\6H_%N;S<.7Y%9B/BG2V3
M6R.FM;_%- X#2F@T]7R((H" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MUMZ::PZRYAD]VD#GM%Y0B:>C6TMW5\4N/H:V+TI-8MZ;O-3AR)Z;IZHCHJM
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M+VN?@[T_.F]5GE[F%O/WK@!1F(" @(" @(" @(" @(" @(" @(" @(" @("
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M]7RH.F\,\L;I";B>DI:2?# I4@4X>A3)7IUUB&..+><TFJB1YVW4W-[6[?\
M;&T;*8V5UO>YNXI8&U<U[;..9Q:YH> ?Q;@>!6SR1/3$71Y(_>WN&8UI-;_%
M:AL#BVI'MD-+G5 )<15Q/IXKD=ICB8MI^ICN<E+8F/!!HHT&@H*^H?\ 5JN?
MPXHNQU]D\G#Y,LS/2@X_9/I/W-%P4Y=:1XL8U!J#\G!96S7D3I+57T%OV_\
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MVSV<X<SDW=VPW5N:+(RXMU?9,QP_PYB>/V+L7RC[UTW9_L**2T<TNN<LP5J
MWP9X&!S6$>R'TK4<5X ^HF*<O=KK](FVL_?67[^_E9]68N\_3#9[RS%..V^.
MBE9_[N+;9^R53G(;?=EKB.X][-N8J$, J=#7ZR^58KOY>L4ZJSQ>A=QLIWEW
M5%\V^RCO,>SP@6N?S",!HD(YB:4&GI%:+>UB8BV+?,WL[:=O9;$W3<[M:;,0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0:1]9_P"U^XK/"$CC
M*@'\3O\ H9^Z7_F-^=>/4MY_T\">3$%R?4B_!_4:BLOE\,?^AE[7/P=Z?G3>
MJSR]S"WG[UP HS$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$$
M'$!KB=0 20/2 $$N0<]S')=1R&.![Z1,<WVX2QWMTKJ>8I=,UK$=5QK,]%:8
MO'FY'LETHF8)?$#0^31KF4X<I^LK2.B)G2_P2LUX>7Q\7#NHO#)@CO>4W!:Z
M*VY/K>&:T\7B*@+&(K/3&D+;U=,WVZS#E&=\Y?2U NH  R(N $H(]HU_T(5B
M*Q$7:0G"_JCBT2%D7B.?)%;MM6>+<W,\K(XK6.G,]TDDC@UK0!Q)H D3-T=5
MWQ+2EW3$^51V[V_-;Z:=!+[)]/.EF0MMR]2/#F@=+:RQW=C:789<1AYGCNS;
MO\&5C33TK&W2>&C*O5&LUGER6['6'OJ[H^MT<]IOOJED;BSG?,V*WQ+;C#-@
MMY'R&*!ILKMG[E'+RU'$ZK.*UHPF9FV*0\H-S>],<]]Q:;^WA'-.X^(Z3<N<
MG:[Q#[0#7WQ#2:_85UGR\DF(K$QQ?<NDO=5W)]$LC#_@]ZVYG:,=N]LTUOD_
M?MQ,R )9(8B;R[>(Q*&<OR+&8CA/%E;-W"*45VNS?SH\?N&^M=E]SM@W:]Q(
M^VL(.I;9&/@R-Y,ZVMK428QMP\6S+FX>:N ]D&IJI,1,TF.7%(I2MLTOE<+8
M+/XC<N-@R.&R5CD+.ZM[>Z@N+&ZM[N)UM<QMGMY"Z"21C3)"X&A.E4X\%F/%
MW',2VCN4_*'"AUJ*>M6(T\VA$ZZ-Y 0$! 4K )6 2L K6!"H!I45/ 5U*"*"
M',*5J*>NHI]*!4'@1]*")('$T^=!"H]80*CUCZ4"HX5%4"H/ CZ4I)6$4$*B
ME:BGKKHAPXG,WUCZ0K24K"-5%0J/6/I0 0>!!^9*P-FXN+>UB=-<SPV\3?K2
MW$K(8AI^RDD+6A*QS6*\GF;K%W5= NA]K%?=3.H6#P\3^=[(+'(661G CYR>
M:"VNC.TN\,Z%M5IS$1=PFK*;,M(K;,6<II*VN\U#OJZ(]UM]LW;?1K,2;C_D
M6Z]\262U?:-D?=LN(WO:))' @-+?0-%I1-^6[JZ9I[FYMQ_*CHF8BL>*C,-*
M@M-:GF&NCM:_0:KEMA%TQ$S6/L;'/YK8B>#;)HP4%1KK6@^:O +LV"W^ZG73
MIG]3A<\]-]8XU .;3T'_ .-="BZ;KKM/Q3^MO:3$1$>"' F@U-*+?XXUI,)%
MLS'"?NE$$_>U/SK?VQQI6GN:%UM-9BC5RTK[%30\K:ZO=31O'3F.BU[+9^+^
M&8GAQIJT9RVS=T:168CCXM=J0"^'(7<N$E(/^YP8^[,H(]GF<*F,/^57O_K.
MW?;>,-NTC'-D4F8B*S32NCD<^UGT]9;NXR3FF8KT]7VM+([R"4R6F'=:QS5:
M,@;<W)D8:ASQ$8R14:_(NA[;O63;YHO^5?=$37GXN&CUUDWEW\O_ "M]MU:5
MK+:<;6R_>L-S;W!>>9S9X8R XFKA24>S\U%]*[?ZTMOQ]-^SMB9BFM/!SV#9
MY-SCC/-]]MW&E9;DA!:!&&,<ZA(L[D6M!I5Q$#FUH%U7O/:[N[;JS<1GG#$7
MQ/3$S3C6FB7?4*/3\QL_Y&-Q=?Y*S[=*_9Q;K+ET#CX>6N)#H.1E[+ X:?5J
M)6DTX+O.ZRXODVQ\NRL61'"-:1Q:&Y[7%EG\Q9?$3?YJ1'#JUIIX<&W<37]P
M6N;^6G4(=SLW+?P@4(/,.6Z TXZ+I/<,O7=-EMM)]CKV3)N,$S9U99UY771^
MJ6X;G+3'Q[?=&Z871<H(9N7,'E+:>S[-YP%%QN#M=V[OMCYDVU][E^V][R;6
M8Q767WQ[9F?UR[-VY-XS-CABWUNV(, X;BS3N%  2+VOH79=MZ&MS8YR?SM)
MB*T]VM'>=IZLLC#-M^ULG28Y<X3'B>J75#;Q Q^_]U0S #E=)N#,7 %*4-'7
MU/0MM\J(TBZ)B-/NT=4^=,W3/1-)F9^]]#Q7=;W+;?(?9=6,S'#QY'S7LKBP
M $MJZ[KJT42<<5UDG+--82UU!Z]=8.J%I:.WQN;(97:\HD9=6MQ=7,L;I?:;
M&]T,EQ(T?C'5X*QCF)TU/F771%(GH?*;:WN(S:XXD2S70EDEEJ'-\-M7Q OX
M>RS1(QTF)GQ2[+9K;&DTYZ-MU!S-]3BT_.UWS?(N=NS8XMCRV3IX1X.)V^UR
M79)K??$5]K4 *_\ 5ZOF7!9MS%T_X=M/=#G<.QNNQ5^9?^E!_,.8TIPI3T?=
M3;;BV+XB;+:>Z&.;8W6\;[J_:T.&CR?0 ?H!/SE<WBS8OE?#9U37E#@]QM;Y
MNB.N[CXRC(YTMG:NA>8;B1Q:^2A;2C@!5QIZ%UW<9K[;YQ]-U/M=GP[6Z,%L
MWQ=%U.=LQ^FB8=J;7=O3?&%V<V^D@O,M?V&/CN"UX<TWUQ#;"9C:%THA\;F-
M >"X3)FOX4NK]K.,,4I==;$>^%SET"\C;I#MFWQV7ZQ;IEZI/GMK'(-LO &+
M8SQXH+A\!<VV!<&$N:#37TK=X)NMNB;M+9]_/[&A-L4]L*L/3#M>Z&]$+06W
M3'IK@L0&,9"'W%G:WD@%&-YA)<0ODYVB,&H<."Y"+KIB<5T]-K3B9F>J(F:<
M7WMELRW@$,QA#6.:0;.)EJPU(HWPXN4$-I1:,3?,]-D?:U*5B>J9KX-Z1\KY
M?!]V#+8!O+<5H3ZB::Z)%?PSYB>CC>W@Z$N9#+()I/OQ1H;ZN'%93I%;(B(8
MQ=2>FZ6Z^22/E;&&7!K]7F:TL'KX_>K3TF-9K,+'C'!S X'TMKZ0"#0^I6FG
ML*PU(J%1ZP@<S?OA](5I*5@!!X$'YBL:QXK28XH%[&ZN>UH]9<!]TK*(F>"3
M=$<9B$#+&.,C!\[VC]5.F[PE)OLCC,?>X%SEL3;-<+K*8ZVJ"*SWMM#2H(_U
M25O!9QAS3.EET_9+0OW^RPS7+FQ6T\;[8_7+Q=UXZ[=..GFV-[XVYW/A[NZ&
MWLNQ[;?+64CVRWV-O&PM BNN8R-D(TX@KN?ISTWW#>9[,_RKXQW71^&>4Q['
MS7ZR?4WTUZ=]-7;S?;G;4OVV6V(MRV3=,]%T1Y8NKQ67DMP_(W63OIKF28G.
MYNY%R\.<\LN\C<3,:][BYW*&O%*FB]<>EMG;9FLNQ]49+8B+M)Y4H_G?]6=T
MW/<L^XW&>SJV5^:^[%6:S-;IF=?95LP\LA)):/#X5(-:E?4<F.8B)MF:3#Y[
MEK9I;6DHON6,?RTJ YK1RCCS&E?9]2ZYN]A-V2*3K$U<[V;LF/NN&^_/GC#\
MNVL1//G3[78W3V0%E&-=S-!(%-*M!]"Y&S8W9L7Q3$6^QQ>P[?=W'N$;*ZZ<
M-LW4K=7ESU<&3)-B81[B7FH .M-32OV%I_Y=,Y*QEH[;W'T;A[9LOYF=Q;EN
MCPF'*#1=Q<SN1KW"I;1K32FFG'1;7HG%?TS.D.CY,V2W)6)NK[*TET[XW17#
M&AYJ'&C TEI<34-)&@!*Y"+;;\4WTMTCQAW7TYT[FR>O+%O39,Q6(TT]KG?D
M^UO)#<W<3+2[C#?>8HWM,;!IX;N5GL$O]*XO_,-ODR]&7!;%UOP36-?%MMMO
M^ZXMM,;#<9\FUR73&:8MNGIBM(I'[F\(+FKI;"W?<O91L#FV;GU:='AM&.K4
M::+?8NZX;XZKXQ6YHXQ6UM-UVG?9<G1AP;V_93\-TVY8UYS&GBUVT.8BN:0X
M3+V5?K.BQ%Y>DDC5P:V C4K4_G]E?-+KL-D_ZUIC[)WNZ(NG%N<O+X+XF(^V
M';V&%WID+UT%KL[<><:[V6$[=R=OJ[1KO]B'0$K7M[GL^%]^WF(C^*R.#/)Z
M0[QUQT;;?63,_AQY;IFOLB)E]!PO;[URSC:6'3K.7#GGV(Y,;D8*!U"UO,ZT
M]%0NL;SUYL\&3Y<VXIB/"^W][Z-V7Z(>H^_8K,VTQ;JRZZFEV')'Z[7T#&]D
MO=9DSSVW1"_NHR?8>^ZN82ZM.71UMIZ%UG??4[MF#2[%;,TGA?'[WU#M'Y0?
M7W=*3;GOQVS3CBN_;:^F[?\ +D[O<TZ-M_T>DPD;R*RNOW24:2VA(%L#HTKI
M^X^K?;;=.CKX_BI^U]+VWY#_ %;NK8Z=_=MYTK6RZ:_^C$ON6"\H_K;E&P_E
M>X.&>]S ^,Q7$H9SEH=4B&GL@GZ%Q-_U<V-:W8;XX\+W8\'_ "^_4F6(MR]]
MLB)F(FN&^:>W['WK'^1UGLHUC,AUN9A&M9'(Z%F'FGHXAKB Y[6,J"3Z?0NN
M[[ZN[>G]Q@R]4U_&[_A_Y;V;!CMB[U5ARVW4TC;7Q29]G5$:)YMO)&VSC<1F
M;W*=8KO-W5KCKJ>,C%,BYIK:U?)$ T1%WMR1@:5.JZ]B^IV;YUD68)^+^.><
M^]V#)_R[.W=OVN?=[[OV3/DG%-T5P6Q$3;;,Q2E9Y>]03W_T[S/37=^4VGGA
M)2SR-_;6XEC='</@M[F6&*9T#VLE8)&1U^J.*]#>E?5MV]MLB+)\T16.N9I6
MGM?F+Z^]';[T7W_/VC<69)QX<E]ME\VW1U1$S%=8CP2--$Y\S8F%[K:(DU <
M8VU]#G?5;]E?6\%_DKCCS3&O-TW#N<F+;6W;F)G%=6D<*_O:OH---"#PT]"X
M[Q][83$UX3!0^H_0I6WQC[TF)CB4/"AKZJ&OT<4K;XQ7WD1,QU1\,<^2(!#@
M*.J""10\WT<5?;!$QQGX7+QMG[SDXK"V@EN)<]E<19 0-?-<1,FO(8):V\8,
MA%)/5P72O5G=K\VVNUZ8LB:QU5K^G1V7LNSP]Z[GMNV6X[M<MEMMT1,],771
M$\*UXKU3M5Z:Q=!^CO3[:MJSQ(KG$VEVR%L/+R.O;.TFE+J,CY7<Q-:BM5XQ
M]4=PMWV_R],5OBZ:Z^V7]&7T$^G&+TGZ V7;,>6+;,6"RZ(I_'9;,\H>MIKD
MQQQ/Y'/\8>H@M)%*4^2JZ3U1$],Q28?6MSF^1=%L6=4>+FV4'@-<[Q>8R:\A
M%*5UIK\ZW=>NEW"#+GC+%L1#M5&D(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(-(^L_\ :_<5GA"1QE0!^)U_0T=U'X6QOSIQBEO,EB#9/J1?
M@_J-167W^&-_0T]K7X&\_P YKU2_X4MXS[U?M51 0$! 0$! 0$! 0$! 0$!
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M^(]][E[^]N9+NZ]ZNW.G>T7-PZ24<LSR*56M6O"(I+3FFG\'-M4 J!P!('S
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M1T\<?ZET9T\ZD[.ZP[.Q.^=I9^WSNSLU;Q7$<MLZ/FB>YD4HCD=%)(YGAOE
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MY>&SCG;+ ZUCYO#830N.A&BF/).3JLITW5_I]YV_U/\ YAN[]KMMMDNVM/\
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M6HIZZZ?2@B@(""%16E17U5U^A J/6$$4!2L E8!*P"5@$K )6 2L K6 0$!
M0*CUH($CU@)JFCB,:VW$DLL@YC6NM:5X4"73%:R6VTB*)8W1N_![-P5SF<]D
MK"TM60SW!]]O;:T,L$$3Y9O"]XEC\5S(VDT;4K"9MZ+INF/AF>/@U+;+[[[;
M,=MT]5T1I$S29FFM."AOW"><;TPV5N ;0Z:V9W9#SW\%S=1SNACM[BV=.QU'
M"[Y7!LC-/6OE.?U%N(RW68,62<=MTTTN\7V[8_2[#V[%B[CO]YBFZ^V+IQ5M
MFFE8BJF%N+S=>Y?+YJ]?C8+1^R<C,\8NQOK>WO!;B)[P0&W,\G+336FJSM]7
M]ULL^39BR=/+RRY3'W3T;VF[_P!^[/AW>ZX=?7;R]CE[5\WGN5Q5\Z=TUM>;
M?V[+"=P8N"U@LFS-G<WW<1>'<,#PVE#12_U?W68Z;L633A'3/ZS<=P]%=Y_N
M=KV?#M9G_O(OMY^S[50O:GFJ='>XWIQNOI9UFMAM+)[BV_?1P3&7Q([JZBQT
MG@"OO+VQ.\=U/E6G9ZBSY;K<6;%EMLF^-:7:37^MP>]^E&/N>RR;GMV^Q8KK
M?-\OJMK,<9I/[%M-G+9D.2S!A%;;\MY<VCAKS69R%P;=^FE'P!I7VJR^R[';
M,76SY+>$QX/B5\7X[KL=T3%UMTVUF./3-/V.EAN2W34_8^?Y!ZUEUVQ&LV_?
M"169I31RN*RMBZZ*V1-T>R*_J69MC2Z8CWS1!+XNBWS1=$>V)C];*(F[X(F[
MW17]1IZQ]*V58GA,3[I:,Q=;K?%UL?VHF/UHTIQ_5"NO.)2)MF:6S$^Z:_J0
M=,ZSCN;R[8)K4S6T%LQOM.#YWM8VM 2.9Q64S''JB(]\-2+=?-;/VZ/0UEVM
M]QMYAY][V6U\E?;&DMX)K6./&W,I?%/&UX\-K+1SGU:[B*JQ6+N.C&D716>/
ML?)MP=.>H&W7$9+:NZ<* 27&':V7O>)-3^+L33TK=],SP:\3%*S,)6?B;V1O
MX_#;ER,K#4&?;^7Q_*X:AQ;):LJ&D:^A.A)N\)A&03NB(R[9(>0<H$F*=;EK
M6C1I<Z)NK4BV*D4TB77V<HCD<,8T2 >D3>"0*&I #A0BBM.7!:3&MKF,RV7:
M[\1DLK;.K0NAR]Y&01QIR3MI0K;_ "M>.B6Q-:UAVL.<W91I;O?=T!C<V1C(
M=R9MC2]A#V"D=ZT4Y@I../XHC[F5+KN$3+Z]M[NA[@ML<@Q>_<_9R1-;'&^7
M)Y*Y'+'RMC)#[TU-&A8?*LC\5OWPQF)B=8FK[CMOS(^][:[>7&=;I[6$-HV*
MYQCKP$ -HUWBW+N:O* K.*RO&)6;;:1-?TOHUKYMG>9?;6W7@]U]0;>\=D[1
M^/Q]Q!AH+68P7,+[>Z+I(YQ(.9CRMQ;@MB8NB)K/#1C-UEVD7V3,<:71^]39
MOA>Y1UUE<_))FKC(7MQ?7-SXKHIYI[J=]PYTC@[Q"&2/- 25ET71QB8IQT96
MV]59MK?9/"FOZN#; TT%   !ZA30?8"4MYW0DQ;;\=T6S[=/UT*'U*TB>$KT
M>'#W(T;]]]I3Y<QQB6CUQ&DS$3[X0HWTNT.A(]7II\P4Z8]BQ=7X=?=K^IQY
M0;QT>/:SFQL)+W7->5[->9Q!^L4^7.LQ71*7<.B_ICV2Y0FF=.R:V@;F<1!1
MKXY^5CH7-T#_ ,9JX1N%5C-E(KKIJEUWCI[])<GP<UF[X1V[)MPQNY6QVV/Q
MSV$$T:V(&VC<7%E0%PN\[]%ULX[8B;XC^./WM]V;M6:_=Q&2,EN*9XW671'Z
M8>G.DG97W$=8;J.':72_+6EM+R#WF^9=VS71/+.9X=<VE/J257SW?]XR9;^F
MS%?-]>4S^Q]M[7V+9[?:?S.YW&*W%$<XMK"JUT0\DK,WT<%YU4WG)MJSK$^[
MVU[D+]]P'&-TL0O'6M6!]7#0Z+:[?/N_F?,W&.^VWEK<XKO>^[5@Q6V=KR6[
MFZ>,Q;;%/OHK"]">P'MAZ$MLW;8Z:8]^78&&;-Y3P<BVXN(_#_'"VN[8L9S2
M1@THNP[??W4C'?BOZJ\:RZ!O<O7=U8[K8CG;2*_?5[A@Q]KBX*6.(QMJ\@-#
M;*RMK4!@ :T?B(V"@ %/4NU6[>V(\TV_+F(Y16/T.%NS=5:771?X5F7*; 60
M>*^0VY.KP:R@UX:>A3^2MMK\J:S++^:FD?.MK$?8!MR8RZ*=@A])\-O :Z#Y
M5N,>&ZV?/=%T^%&A=GQ3%;+9B/>VY+AIMW FH8TGQ1'0DL%:4I74A;BS%%LS
M?'3'W-O?GB8TMFGC[DIQ9A^;DE8;4VMK9$AY<.3GI4<PJ!6H"PBL1-W52>3=
M=EWO\[\R+L4Q;6D5U_6^1=>>L>.Z#]+=Q]3+RU;>Q0XZ\BLFNE9%RW;[>=MO
M]=S*CQHQ6AX+?[+9Y-Q?-9N_NYB=(F:U]SI_U8]>['Z?^F\O>=WAMR8\-DZ5
MBVLTFD<N,Q18]]7-][_ZN=5]Q=3=P7$]UN>_R-^Z:&625\,%G)<W!M61ASWQ
M^S!(!IZE]8[5.7RS;BR3%/X+M?T/ OI/\SW;?6'=,NPWW8MEBR69-;LM^*^D
M5B8I-\S^A\M-MF7Q7F.LWOCENGL?>,)=1CFNYARN.FI]2[AMKLMV*<48;[9R
M1-OPSSTKPY/0^7\T/8O25F#:?\/=JW-^YCHF^W^7CHK'3$S3PXN3-;YES?"?
MS5#6MKK^Q;Q73-]]$LT5W$=RRS%TS=3INTZM:<.3=W_47M?;8C>1&QOMOCKZ
M8S8M.KS4^+EP<5F&S+_;+B""#374 UH=%TW=?2?=X+J6[_<3_P!&_P#<XW+^
M9S8]JCY7^6;3+,</[_'_ +3?;#F)[IYN"Z.T@ Y6T)%6CC3AJ5K]N]";W!,6
M7;O<S=XTR0V]OYINW;Z^,=_9-A&/G-V7#=^NZ4&V^YGODOV.<ZTHZ%D)K[;7
M@QZ@BJ[OL/2N^Q3;?=N=S-L>,WKN/J]Z?[EL,^2.V=HMONPY*1_[M6O3--?&
MJJ=Y5?7_ "'1SJRSIWN.\G_(^Y;J!D=C<7<K;6U=)+:!I8^6=D+>9QKH%N_4
M'9YS=ONP6S,Q32[IUTX\GFOZ!?4;I]6;F[<19MXG<71=ANS1,6Q-]+>FMU)B
M?"%WFR]Q?NV+:W(V4 O8(;AY?>PD%LD;)6@%TE*4*^%9L.6<U]O1?/3-+9I+
M]/\ MVYV\;.W<W9,<6]$3\4:UB)TUU=G>Y'%\L7^ZN+8&G5TE_:L&@I7VI-5
MQD[;<6_@OGW6S+;Y-[L9\TY\,>^^V/VHOS.#=&P.SF&J*:')68'V#XPJMYBP
M;F8B)LO^Z?W,L?>.UX_+=N<'_M+/WM,NZMO1$1R;@V]"7:4DS6/8[7C1IG!^
MTM:-KN9BOR\DQ_JS^YI7]V[19\6ZV\3[<EG[W6Y/>NS,/;NN9=R;<87>B7/8
MR*H-22WQ+IM:?(LK=KNYX8\E/]69_8TKN\=HI_\ %[2)_M9L<?KN25-UCZ91
MV[I+C?6VV!M2\-S>+<10\*"]J:+<1MLUL^7#E_ZEW[G&W]\[+CK\SN&QG_\
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MO,6$TKII5;#_ .OE;9'3_)S?/C\WA^AS^X_Y:71G_P#=?5,6X+HBL1MII/\
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M,W?_ %CBVV?'=&##,3%<<TC6WG,47@LN.>R.U;%?-B9'#!$(FQ!@+8F-8!4
M>@+RGNLF6^^>BNLS7[7[L;/+ML&TMP_*BD6Q$36G!#)V$D[K7Q)@&1.80XZU
M)(.GKJM;M]]V"V><W<G&;[8X]_=&:+^FRV>%*IN8*,8/4UH^T$GBRB*13P:E
M%$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$&D?6?^U^XK/"$CC*@'\3O^
MAG[I?^8WYUX]08@N3ZD7X/ZC45E]OAC?T-':U^!O3\YKU2_6U+>?O5VI@UTL
MUQ+(8X"6\C*G\8X&G[6A"U:S%OFFEO-C;,3=$1%9Y)#ZB]5=I=(=N93=6_\
M/V6'Q4-K-<6S+FX@CDD$$#Y3%&V6:)SS*(Z:>M:7&:\;I9W4BW32WFMJ^[?S
MI>H>8GN-O=MI&W;83W=B[*R,;<O<V.2X@,S'NNO8\04=I0>I(MFM9^'P7JBL
M6VQYO%1]Z@]<.LO4)TV=ZA[QW-N/*W\K9)AC-P9;&LA,CW.<\1V=\&@1EY-%
MEII3X?!C-=>O6?%(N-W%O?&YAEWA>IF[_%C#)61R[FS;VL< '",A]_1W(11;
MV<-8K"Q;,1H]G=%/,D[I^C-\RSM-U7>2QEJ^*2YCOY9;[Q[*W=$^>+]\W;JF
M2&$CYRL9PUTF64Q2*1K*Y>[/?,@Z6]W&T=MVV.RUML[?N2B?!<XZ^G@:^&[L
MQ RZ/+<77,77DKCR@^DZ+3OV\TK6LT(FDTB*SSC^M41AB,5Y!#+*YC(>4VC@
MXO9(7T,DA<*@ME.H^0K2MB>F;[HX,)BVD4FM.,)P' >G3CZU@H[1I/"@.OV$
M'2BXE$7B0--U/(YS9"26>&QIIP]% I6*^6*KK$4OFB6]Y;IQVQ]HY[<]W=P6
MN*P6$RM_<SSS,;&V>VLYKB&/Q'O:WF?*P- J.*RG2==)81/5%+=86"77[KAN
M/KWUQZ@]5=TR7$K)\UD[&PBN)))K?W:SOKRVMW00R2RQ,!B((Y5N(B9U\6G.
MDTGA#XY;N=%C(F6E3>3R2.,;O:HPOK0-=P%*>A(C6BZ1#6-.%&F@K04UIKP^
M58M-&I]:*@=>-'?(X5'T&H1$0>2CJ"C"'TH*>Q[7U>!X(?J??NT[KOENW?N!
MVMUAP,MP]][E;'#7=KXDMM9FUR-W:6%QXMMXL,#@(2=3P64UNB;6=LQ%)CX5
M^1@-W[:W!A-O[BCSV ?)D<-CL@Z,YBP#6R7ME#<O:>6=P#F.EH0>%%HUI-&I
M;.E8XN^MMQ8,M,G\I,&]NO-3*V#FLH3^R;.10*1PX+2>;0_=FTJN9'NC;0>/
MK<V>QW,W7TM]Y-/LJ=/.:FD\W'DWQLR!CI)MY[5:UH)/-N#$-K2M0"Z[&JL6
M7U\UM/O6)CQ2E/UJZ;64A9+O#:PY7<KBW<6'=\A/^SJ:#59=,4]B4FK@W_<3
MT6QK"^ZZB[88 *D-S&->105.@N0/1ZUIQCUTC5DDNZ[ONW6WD+)^HF"<\&CG
M-R%@0-?6+WT+.+)83,<)2]FN^[M9VU"Z7(=4L*(VMYG&&>"=P&II1LXUT5Z+
MIXS!$QPBKYA<>:EV0VCWQW76&QMWLK4.LIW_ %:UH83*#P4Z)Y3$LZ3X.@E\
MWGL%MP?$ZWV.A(/^Y60K4'_O(&BPG2:2CBM\W[R_I"3_ (;[(N]1Q61!.GHI
M%3T(O%)>Z?.D[(\/'3![_FSMP [\6S%S0L<0'4#7/F::$@:D>E2*6QI"3,1Q
ME\1R?GG]$6.?^1MIW.8C%>60W<-OSC6FDDI(KHK-)C@D3,S2)T?.\IY^&Q[
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MM3M.'^^[YZ@R[FZ)K%,-MD1$4I'&Z9CWS+['M?R@.WZRDO'9VZ=N&2[C:R6
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MW;"G3%U_NB77N>;N$-&=OI'$5>R\GN;SGIZ'F=[^8_.M_C^G^#-'7'<L5O\
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MW^^%IX%Z.20'V:4#^.AH-5JSABSA.C#YG5%)AH?;Q-@CLW7#F@N8V,OKH[F
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M2 *5-"[Z@.CG^OD!U?3Y*I\SV'5"&M">(;]=P^JSU>(>#*_*LOFKU0A44J2
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M[HNFZ)X:^+?1EQ[>WIPVQ%WV)K9]1NE/9;IZM!HNT6_#'N;&M=6I4$! 0$!
M0$! 0$&D TXT/V#37[=4TB?&"=?9+B31R 'D#'$T^L /5]DK.V^V/CEI7V3,
M4MB$8X9!0O<P?(UH^BH"3?#*VR/!R'.>![#.;[-/^JBQB+;HUEE-8FE-&XHH
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M[[3OUD#Q8_OOM._60/%C^^^T[]9 \6/[[[3OUD#Q8_OOM._60/%C^^^T[]9
M\6/[[[3OUD#Q8_OOM._60/%C^^^T[]9 \6/[[[3OUD#Q8_OOM._60/%C^^^T
M[]9 \6/[[[3OUD#Q8_OOM._60/%C^^^T[]9 \6/[[[3OUD#Q8_OOM._60/%C
M^^^T[]9 \6/[[[3OUD#Q8_OOM._60/%C^^^T[]9 \6/[[[3OUD#Q8_OOM._6
M0/%C^^^T[]9 \6/[[[3OUD#Q8_OOM._60/%C^^^T[]9 \6/[[[3OUD#Q8_OO
MM._60/%C^^^T[]9 \6/[[[3OUD#Q8_OOM._60/%C^^^T[]9 \6/[[[3OUD#Q
M8_OOM._60/%C^^^T[]9 \6/[[[3OUD#Q8_OOM._60/%C^^^T[]9 \6/[[[3O
MUD#Q8_OOM._60/%C^^^T[]9 \6/[[[3OUD#Q8_OOM._60/%C^^^T[]9 \6/[
M[[3OUD#Q8_OOM._60/%C^^^T[]9 \6/[[[3OUD#Q8_OOM._60/%C^^^T[]9
M\6/[[[3OUD#Q8_OOM._60/%C^^^T[]9 \6/[[[3OUD#Q8_OOM._60/%C^^^T
M[]9 \6/[[[3OUD#Q8_OOM._60/%C^^^T[]9 \6/[[[3OUD#Q8_OOM._60/%C
M^^^T[]9 \6/[[[3OUD#Q8_OOM._60/%C^^^T[]9 \6/[[[3OUD#Q8_OOM._6
M0/%C^^^T[]9 \6/[[[3OUD#Q8_OOM._60/%C^^^T[]9 \6/[[[3OUD#Q8_OO
MM._60/%C^^^T[]9 \6/[[[3OUD#Q8_OOM._60/%C^^^T[]9 \6/[[[3OUD#Q
M8_OOM._60/%C^^^T[]9 \6/[[[3OUD#Q8_OOM._60/%C^^^T[]9 \6/[[[3O
MUD#Q8_OOM._60/%C^^^T[]9 \6/[[[3OUD#Q8_OOM._60/%C^^^T[]9 \6/[
M[[3OUD#Q8_OOM._60/%C^^^T[]9 \6/[[[3OUD#Q8_OOM._60/%C^^^T[]9
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M;=M=UVQ2)F/9JZ=N[8ZJVS$T\"0BH'!U1H33[M%O>FL:Z>]U_/=28TYM!H2
M"'4'H(/W%O,'RK(K-]E8_M1^]EFB_29MOB*<XD% #S$4IJ*ZD'B/GHMW?-M/
M+,37PFK:VQ%]T1,QI[6S/;VMX;9N2R#K'#6KJP6_*3+-,X^PWF^N.>3@N@]\
MW%]DW1-E\T]D\ZN^>G]O%TVQ$QTS['HKH)OSMZ[?]_XCJWWH;J_P9=)[.ZM;
MK#9.2%U]?WC[>6":V=%8M+;M_,Z _5#E\KSYMUOM];VW%9=U9;J3=$SY8KQ?
M58Q6;'M&7>7=,W68YI$Z1.DSK--(\9HKXV?Q*/DT6EK:6S.ZMTL5G;6]K$'[
M3RP/AV\38F:/A!^JU=UP?3^ZRZ+[^Y3,=,:3,1RX<9?"\O>:WW=.VNBMT\(]
MOOX>#>/Q+GDRRO D[HG-Y2"#_)'-\@(/KC@?5<AB](66<=Y,Q'+J86]TR5TP
MW1/MC^MV+?B9O)F;0CNIB'**4.S=Q^JG_P P&JY3%VFW!,3&:9I_:C]S&=Q=
M/EFV=??^]ID^)F\F*2KG]TT;CRD"FS-RU&A&G[PIS:Z+=X\<X_AG],-.[S<:
M\7R_>OQ!GDE=1\%=X#<_=*W)8W)Q30R,NMFY&MLQ[7L^I=0![=)#2@-5LM_A
MP]SV]^RW&.8LNBE>F-/;$\W;>P^N^X>DNY8^X]IPS&6.,16;9I3CPI6GM4-.
MO7>7Y2^YM^16G;YW0G/V>9N',DP]YM";%VC+N\E>R)D5S=F)CXS/*T<U-!JO
M@OJ7T5W'L,9-_LKK\^ULK=I6)YS2D:O4GIGZI[7ZM?(]/=TV^#MV[ITS?,VS
M$S.E?-PXU_1JZX]+<5=M9)A=UX"^;<,9=VS;/-XVZ<ZWN6B:W/+!.\M+HWMJ
M.(K1?+__ *]N^[7'\I':=U?K2M<D<-'=]_\ E9[?\F[<QZCV<S='52(Q<]::
M.))T@W@UW[V=;OB/%SIXF@Q\'4<0!]5=DVWK3=>HL/\ /7;;/@G#'7TS-^M(
MZJ:SSX/F7<?RH[/O5\8?^(]OBZKJ5Z;.>E>'MJWV]-]K;<L[C)[JWIM[:UK;
MQOEN9+S-XV6=@:TNE+;>>X:]QT.@]2ZCW;\Q_=._9+.U;7L&\BDS9U5RQ68\
MM?MXN_\ I?\ (YVKZ=Y;N]7^K]EOKYZ;OE71BF(X336/8G;MT[Q/*:Z>;DG@
MZ\=V%OA[[&W<3W00[4?D8GNMI8G/B\6V\8$.=$YM0%VCTSZ!]3^K;\>][O&;
M8[/+-9BMUTQ%:\)GVIZ_^HW8?0<9>W]KP['>=QQV=/\ W=D5I,=43;$UF)BM
M-/>KF[.^(L\DK8F#MMN[=[F;6#%VD$<$;&;.R<0(AC;&7<IM(7UDY*_5XKTM
MZ=]"[;L."W'@W5EUML1\4VQ,\/?X/#G?O5'<>];Z[=[VW)=DNNF8Z:S;;69F
MD>;AJF&?XE[R99V0QGNA\.-I.C-HYD>'3TNI;.<>:FE.9<ON]YGVV6VS#AOR
MVUUFV(I3QK-UK8;7+\5_"ZGX^.OAQ;H^)B\F,4'^59)H*?\ (W<WHTXC&T]"
MW_\ -7S'P3]W];9_R=E?CGCXQ^YJ_M,7DR'_ .NM>?\ F=N;^+4_FKX_!/W?
MUK_)V_QS]\?N;7]I?\F+^M3)_1#<G_D"?S-W\'Z/ZT_D;/XY^^/W-P?$O>3$
M*?\ U53M-?\ DAN3T:_^;U/YF9_[N?N_K9QLK8C2_P#3'[G*_M.ODS@ ?Y4Y
MTT_Y#;J/#3_S:I7V,Z(_VG7R9Z5_RJ/_ &&W57Z/R:E?8M&G^TZ>3/\ UJG?
MT&W5_%:)3WH_VG3R9_ZU1_H-NK^*T*>\_M.WDS_UIS_0;=7\6HI_:=O)G_K3
MG^@VZOXM00_M.ODT?UJ7?T&W3_%B)3VH?VG7R9_ZU#_Z"[J_BQ*E/:C_ &G7
MR:/ZU+OZ#;I_BQ"GM/[3KY,_]:EW]!MT_P 6(M/:V7_$Y^3/H'=TDLC)/2-D
M;F+64];18-D%?F*1;'Q:536-8JU,^)Q\F5K7%G="3R\ =D[F#M=*L$MDTE(T
MX%(K7FV8/B:_)I>7N=W53M=$]CGR2[*W%'[P.:H8&-QY=(P 4- -$F9X?AC]
M)QI-:3"P.^( ZY]J?<QWQ[H[G.SCN'RG4W&=6+?$R;@V];X3*[6AV?>8G&-L
M)6VD\KX6W=O?OMV/T:'<SB7:F@D3,\6.D<>$OK7P[O<)V3=I7=+?]SW>7W&Y
M7ISE-D8J\L=H;3N<-E-T6NX9,O;VT4\MS)"+ET3K;VJ/Y2YO(*:ZI[N!SI$:
M0OE?[35Y-$XGMV=U,]J9'E[KAVR]QT>2>;E:Y]@^C*: $#193-8I--8HL>7A
M6D?M+;XE3R98YO>6=U; XZ>')M7,M:?026BT''Y2%QN'TY9BF;XS8YMF:T\L
M26Y^J^O3?;/MK3]<N4_XF/R:P)',[IV,<:5,>U<R2=?0WP*'[JW_ /(VV6TZ
MHF/]:&\MGE,XZ?:T-^)K\FA[?\Z=WJH[9NXFNT^>R"X^[MEE:_,OG^GN:%VX
MZ9^"ONC^MLS?$Q^3-<>P_NIF;3@X;0W  2=.(L7?;HN2P88QV4MNB8]LZK9O
M;K9K\K[X_P#G-AGQ*GDSLY3)W5N<&FK1_)/,'TUU;':R._5647Q,],:3X_TA
MG?W6[)PPS'V?UNP'Q-/DSR,$?^52& 5H3LW<;2/L^X$+;Y=I9FFMUVL>V/VP
MTHOG)-?AG[OWMD?$O^3,-#W6$_*=H9\_<L%ABV=N">J+J_<L[?KTG)'W_P!3
M4WXF3R96GF_RJM?EV;N(\/D&.6ZG+/32C2_EK8FG5$_;'[F]_:=?)H'_ -=0
M[^@VZ?XL49']IV\FC^M0[^@NZ3]S&((_VGCR9OZTI_H+NW^+D#^T\>3-_6E/
M]!=V_P 7((?VG;R9_P"M.[^@NZOXM5JE$?[3MY,_]:<_T%W5_%J56B']IV\F
M?^M.[^@NZA]W&I5*(_VG;R9SI_E3GU?\AMU>G_YVJ57AJZ?)?$H>3+EX61L[
ML76KF%QYH]GYZ$GF^^$]E"#Q]:W&WR_R]TW],73/C/\ I:&X[9'=HBWYMN#I
M\9Z:MC$?$A^33AQ=!W=JZ[]XH:R;6RYY:>AGAPRZFGIHM3<9OYR^V[ILMFWW
M:_>FU[)_DU<G\S;GF[E%W53[G.9\2_Y,XA,?^5&YGUAS'9^8<^A.M VV?H5M
MLV"*]?7;7PB?ZF5^^R9;?E68\N./&G_SI<6+XE7R7&4_^JAFF+CJ'[1W"P U
M]-;2)M/LE;?);$6^:MTQX?TAJ;;:6W5OZXB?[<TK]E)=K_::?)I8QD?^5"(V
MM% &;0S4E0=/:++>:GVECBW%U^EV/)'OB(_5<MO3=,VQ2/?']3<;\3+Y,XB#
M!W0PN:ZM2[:>:#Q7TD.@813YEO;<-TQ7JLIX3=#6G!;K6^S[_P!T.)/\2MY,
MQ:QI[KJ-%2?"VIFW$UKH>2R)TKZ L+]K2ETWV4CE$Q^R''9,<3/1$Y*>Z:?I
MHXUM\2MY,,3Y'P=U<[22"[Q-H;@ =36C3-CQ7["?S%V.WIZ9NK^AN,7;K<EW
M5&2VV(_BF(K^AVW]IV\F<:?Y4W#3_D-NOT?-CJ+3U\9:G#1'^T[^3/\ UI?_
M &&W7_%R4GQ&G^TZ^31_6I=_0;=/\6*I3VH'XG7R9Q_]=0_[&Q=U'_Z&(4]K
M7_:=_)G_ *TO_L-NS^+D4_M._DS_ -:7_P!AMV?Q<@T_VG;R9_ZT[OZ"[K^Y
M^3:JU1'^T[>3.?\ ZZ<Z_P#WC;J]/_SM2H#XF_R9XAIW2L-:'39>Y''_ +&Q
MK5$B^;IIYH:'_$W^3/. '=TQ9_S*W*/NV#E8T\#Y<7SK-&E_Q,7DQ/.O=4S[
M&S=RT_@Y7JGPC^GVI=MXNXW?J_<T_P!ID\F-M:=U0/R#9NY=?DUQP&JRG)=3
MA']/M3^7B/Q3]\?N4$/B$O- \K7S%NS:[P/1+NQGNNK.P;R&_P!I]/H=EY2.
MVWF^=\C'VLV2N86P6'N_/S!W,:U]%-=O\V>F9BV:UY^#/YEUMO3;'E]W#[5D
MOT0VQL+)=7.G$'5'?HZ=[,M=RX._W-O86CLJ[;]ECK^UF#F6+/;NGSQM+F@?
M5+0L;MQ=-LS;;,SR]OBQNW4V1'19.ET3$>+*5;!^(W\F'96Q-H[0;W5MN_Y/
M;4VW@9+I^TLZV6=V%P]EC3,]ON[F1R2FUYG-!< 30%7YMU\5NLNBZ8U_I5N;
M]]ER368G3V3_ $T3B[XF3R: &L_RHH^4?LV[3S/HUU_$<_H] 4G)6=;;ON_K
M:/\ -W73\-VOLEN?VG;R9QI_E2\/_O&W7^ICUJ4GQD/[3OY,_P#6E_\ 8;=?
M\7)2?&1I_M.ODT?UJ'?T&W3_ !8J']IU\FC^M0[^@VZ?XL01_M.WDS_UIS_0
M;=7\6H(?VG;R9Q_]=.[^@NZC]S&H']IU\FC^M0[^@VZ?XL0/[3KY-']:AW]!
M=T_Q8@?VG;R9_P"M.[^@NZOXM5JE#^T[>3/_ %IW?T%W5_%J5*-7]IW\F?\
MK2_^PV[/XN44_M._DS_UI:?\QMU_Q<@V_P"TV>3177NJ<:^O9FY:#Z,?I19:
M4Y?I:45B:^;7W('XF[R912O=4[[&R=U'Z>7&D+'@U8IX']IQ\F3T=TSA\VQ]
MV:_3CDI4^Q _$U>3.[7_ "K'MX'39FYA]BAQI5Y?Z6G-.JM)JU_VG7R9Q_\
M74O/_,7=1_\ H6HSI[4?[3KY,_\ 6I=_0;=/\6)4I[3^TZ^31_6I=_0;=/\
M%B%/:?VG7R:/ZU+OZ#;I_BQ"GM1_M.WDS_UIS_0;=7\6HI_:=O)G_K3G^@VZ
MOXM0/[3MY,_]:<_T&W5_%JM40_M._DSC_P"NG=_07=9^YC4J(_VG;R9_ZTY_
MH+NK^+5*QX%#^T[>3/\ UIS_ $&W5_%J5CP*']IX\F;^M*?Z"[L^Y^3JHJ/]
MIX\F;C_E2_\ L+NS[GY.J@A_:=O)G_K3G^@VZOXM5JA_:=O)G_K3G^@VZOXM
M2HA_:=_)G_K3NT_^\7=?\6ZI4H?VG;R9_P"M.[^@NZ_XMT2HC_:>/)F_K2G^
M@N[?XN44_M/'DS?UI3_07=O\7((?VG?R9_ZT[OZ"[K_BU6J41_M.WDS_ -:<
M_P!!=U?Q:E2B/]IW\F?^M+_[#;L_B]13^T[^3/\ UI?_ &&W9_%Z!_:=_)G_
M *TO_L-NO^+E*3XR']IW\F?^M+_[#;K_ (N2D^,B']IV\F?^M.?Z#;J_BU95
M1#^T[>3/_6G=_07=9^YC4J']IU\FC^M2[^@VZ?XL4*>T_M.ODT?UJ7?T&W3_
M !8A3VM7]IW\F;^M+_["[L^Y^3JHI_:=_)FX_P"5+_["[L^Y^3JH']IW\F?^
MM+_[#;K_ (N4I/B']IW\F?\ K2_^PVZ_XN2D^,C3_:=_)G_K3N_H+NO[OY-H
MLJHC_:=O)G_K3G^@NZOXM2JT/[3MY,_]:<_T&W5_%J@?VG;R9_ZTY_H-NK^+
M4$/[3OY,_P#6G=_07=9^YC5:H?VG;R9_ZT[OZ"[J^Y^3:I4HC_:=O)G_ *TY
M_H-NK^+5*QX+0_M.WDS_ -:<_P!!MU?Q:E8\$HC_ &G?R9_ZTO\ [#;L_B]%
M/[3OY,_]:7_V&W7_ !>@T_VG7R:/ZU+OZ#;I_BQ$I[4#\3KY,X_^NI?]C8NZ
MC_\ 0Q"GM:O[3MY,_P#6G/\ 07=7\6I6/ H?VG;R9_ZTY_H-NK^+4K'@40_M
M.WDS_P!:=W]!=U?Q:BG]IV\F?^M.[^@VZOXM0/[3KY-']:EW]!MT_P 6(E/:
M?VG7R:/ZU+OZ#;I_BQ"GM0_M.ODSUI_E4/\ Z"[JI]/Y+0I[4?[3KY,_]:EW
M]!MU?Q8E5Z?:?VG7R:/ZU+OZ#;I_BQ$I[3^TZ^31_6I=_0;=/\6(4]I_:=_)
MG'_UT[OZ"[K/W,:K41_M.WDS_P!:<_T%W5_%J5#^T[>3/_6G/]!MU?Q:I4H?
MVG;R9_ZTY_H-NK^+4J(?VG7R:/ZU+OZ#;I_BQ"GM/[3KY-']:EW]!MT_Q8A3
MVG]IU\FC^M2[^@VZ?XL0I[4#\3KY,X_^NH?]C8NZC_\ 0Q"GM1_M.ODT?UJ'
M?T&W3_%B*?VG7R:/ZU#OZ"[I_BQ _M.WDS_UIW?T%W7]S\FU5JA_:=O)G_K3
MN_H+NK[GY-JE2C5_:=_)G_K2_P#L-NS^+E%/[3OY,_\ 6E_]AMU_Q>@T?VG7
MR9ZT_P JA_\ 07=5/I_):)3VG]IU\F?^M2_^@NZOXL2J]/M:O[3MY,_]:<_T
M&W5_%J51#^T[>3/_ %IW?T%W4?N8U6HC_:>/)F_K2G^@N[?XN45'^T[^3-Q_
MRI?_ &&W9]S\G500_M/'DS?UI3_07=O\7(']IX\F;^M*?Z"[M_BY _M.WDS_
M -:<_P!!MU?Q:@?VG;R9_P"M.?Z#;J_BU _M.WDS_P!:<_T&W5_%JM40_M.W
MDS_UIW?T%W6?N8U*A_:=?)H_K4._H+NG^+%%/[3KY-']:AW]!=T_Q8@?VG;R
M9_ZT[OZ"[J^Y^3:JU0_M.WDS_P!:=W]!=U?<_)J5*']IU\FC^M2[^@VZ?XL4
M*>T_M.ODT?UJ7?T&W3_%B%/:?VG;R9_ZT[OZ"[J^[^3:(I_:=O)G_K3N_H+N
MH_<QJ!_:=?)H_K4N_H-NG^+$2GM/[3KY-']:EW]!MT_Q8A3VG]IV\F?^M.[^
M@NZC]S&HI_:=O)G_ *T[OZ"[J^Y^3:H']IU\FC^M0[^@VZ?XL0/[3KY-']:A
MW]!MT_Q8@C_:=O)G_K3G^@VZOXM5JA_:=O)G_K3G^@VZOXM2H?VG;R9_ZTY_
MH-NK^+4J(?VG;R9_ZT[OZ"[K/W,:E0_M.ODT?UJ'?T&W3_%BBG]IU\FC^M0[
M^@NZ?XL01_M._DS?UI3_ $%W9]S\G54I/B']IW\F;C_E2G^@N[/N?DZJ4GQ#
M^T[>3/\ UIS_ $&W5_%JRJA_:=O)G_K3G^@VZOXM2H?VG?R9OZTI_H+NS[OY
M.HL:3XRI_:=_)F'_ -=*?Z"[L/W,<E)\0_M.WDS_ -:<_P!!MU?Q:LJH?VG;
MR9_ZTY_H-NK^+4J(?VG?R9_ZT[OZ"[K_ (M2JT1_M.WDS_UIS_07=7\6I4HA
M_:=?)H_K4._H+NG^+% _M.ODT?UJ'?T&W3_%B#5_:=_)G_K2_P#L-NS^+T#^
MT[^3/_6E_P#8;=G\7H']IW\F;^M+_P"PV[/N_DZB!_:>/)F'_P!=+_["[L/W
M,<@A_:=O)G_K3G^@VZOXM5JA_:=O)G_K3G^@VZOXM2H?VGCR9OZTI_H+NS[G
MY.45'^T[^3-_6E_]A=V?<_)U4&G^TZ^31_6I=_0;=/\ %B)3VG]IU\FC^M2[
M^@VZ?XL0I[4?[3QY,W]:4_T%W9_%R*C_ &G?R9OZTO\ ["[L/_T.0:?[3KY-
M']:EW]!MT_Q8B4]I_:=?)H_K4N_H-NG^+$*>T_M._DS_ -:=W]!=U_Q;JK40
M/Q._DSZC_*F<:#4?R%W7KIP!.- -?G054^V#N9Z-=X72';_7[M]W._?71O?C
M\A!C,TZTGQTK)\7.+6[9[O<4N6$7)Y2#JTU!X)-TZ6\H*6^:^^O5+[QCYVM?
M>8_W>6QM\4^-TD1YI/$$[@8RV0UYM#Z."EM)K,Q2O&&5T3IK6Z."=6D%H(X$
M CYJ:(B* @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(.*[P030T,S7-;I1HH"#0:
M:E6/-%?!)I$K3'XM^.>U\N['VK'2F(;AL?%+7O#''QIGCQ&@\KN4FNJG,IJQ
M>N-D<^^Q0H (K^S9S>GVIV$:^H!J>SDL\/:S-'D>8]EKY7W;/:LY'-?M9DC/
M#Y0T<XA)Y>2C1P-5;8UI/!C=,]-8XJM+;6)TCPT$<IB=HX_6:17TJ3K;,1PJ
MM-:RQH/QC+:=W72]S7\W^X-YSMYOJN\24LJVII[*<67*BV;[$[JZ9W==$I[<
MR-N&[^VLV/P'/9( [/XMC@QT9#Q[#C6B>YCRI+.![+CY=G[/(:7D;5V\UW,:
MDTQ5J 3S:U]:3=,1%.,K&OEY)P0$&()^)DFBE\YGNK$C67 YMH0Q.D<+5D4D
M>W+$.JYW*U_A.:YE?V10F/!03]WBF;"V"YMG3SAQGB>R*W9;^'J R=]&^T!Z
M#JJFL\77<U*CE9H:?L#P]1IJ/E44YJT'*S4TUY*:^O30(.T;;6\+)HKJ>WBN
M80UT/AB.YCF\05Y7/;S-!:/7PJKS36OL0@]T,UM"]S+-T8>9[QCA<,?45;0-
MJUH)T^2JG)>'%OP/EFEE@@<3:RN%1P+RSZKG2?L!45U*M*S[2*1%)^%MS-%R
M[W<LMX[V-X$]Q)-%&V?4!H:7D-!:WC34K&:QK)2FENL/J&!S(VA>[>R]A-;0
M7^#OK*^=+;7<4%PZ2WN(;B-HEADCDHYT0KK2BV^_G%W'!_+]-+:3#E?3_=[M
MCO+9MMGJF>,SI'V2NS^U+N"V9WE=,MOWE]D,3:]9MDXR"TBMI,G9Q37$<5K;
MV[>>-US(^=SF'TBM5YP[YW+<^DN[78;\63+@K6+JW1$ZS]G)[,](_1'8_5_T
M_&_L[W@[=GMMUQST3,UCVZ\WT#,8[+8;)21Y6SFM'A[FLFC8^:,T<07@M;RT
M-*KZ;Z*^M.+)-O;K]CBMMNI'7=EM]D<[GP'ZI_17<?2#%?O,&]S]XG6:8\5\
MQI7G;;['!<^SBF;*^N?>0?WHVMN65&M2WU+T1VOM^T]6[:D;K!M[LD<>NR:5
M^WVO,<>K=SW3-CMR]OS[>,=]:767VUI/MB.+9#XX^9EO8^X$FHYY>?EYO1[1
M]%?M+:W_ $&P6^>[O^.V)UUNMC]<NZ>K?JK=.TQ;7%VJZ;NBGEMF>$4KIXMU
ML,5L6ON72W/B$:Q1/?X9) $E& UY*UIZ5U3OVTVGT^LG).]V^]FR*Q_>V16G
M+XN=/TNF>D,&_P#77<_Y2=ON=G9%\17Y=\\9CV<JOI6S>G]IE&9;<.^<C8V6
MP<%;NR<^\,I=6^+,3[2+WN"-N/NW1&3E='33C1?$NZ_F4LR73LK.R6W3,],3
M;?%W.E=)E[X]*?EZG8[&S>7=UF9^7U71=CIPB)I68A;I^8KW?Q]Q_4N3;EAE
M+?,[5Z?&]QNW;Z.XCM,?D(HO>[60NM67#[9_AL H2W5=J].;3/N[/\XSV_(O
MW%+OETK,1I,:\N+X]ZZ]78>T[G_(\6'YMMDW6_,B:1-*QPCW*/;RWQ)*-;3G
M?3E<.6G,:<M-*4X+O</D,W5F9\4*C[UO$>D?1]E*)5NO,)-&1!O ?NNGSDU0
M;C(F.IK W45YIXP:5UXN'H0<NZ=:!HBA9"00WFD8]E6^LT!J2%K739,4BC2L
MZIFMSEVS[/'Q"XM\B\7)I41<T4K>&C9&$/:01H0=#JMK=9%_EOB)M]NL?=+>
M8,EV.>NRZZR[QB9B?OB7V;IYU^ZH=-;N+([&Z@9O&732'"&^R]]<Q,<WDI1E
MQ>"-K:L% !1<=G[3VW-6<^WPW3_J6_N<YM^\=PLI;CW.?J_\V_\ 5U/2TOF1
M]X)MV6ESUB#8O!>UK8V1DAOAD<I<R[K4C1;7_(>T3/5&"S28X6Q'ZH;_ /SS
MNEELV7[G+$3$_P#>7>'^L\A[^ZX=3NIU]-F-Z;RS>4O)'NIR9B]@B',YQ<?<
MQ=/802\^C@N8G:[&8B(V^WBZ.$QCLB?OB'5K=[W*V^;OYO=3;/\ %EONY\HF
M9I]CYK.ZW?''=W-]+?W#P0^&0R&1NNA?*XDFGRG5:T6VVQ2V(B/9HT+\F3+=
M,Y+KKI\9F9G]+J2023RCB2-0-*Z"GR!6C&K4TM+@"&@$@$U&@KJ:?($*NRD-
ME:S^%"Z*_MRUI+GQ,B>"1[0$CAS:'Y4/;+;C%G+=.:Y[;2#E-#R"?6E0 36E
M2D^PB*\7!<6AQ #2 2 :@5%=#3T51*@+20"&@$@$U!H/7]A"KLYHK*VC$MM>
MQ7,I:.:*2T:6@D:CVVD"BBSX0VHY;-L+I)(VR7!J!& &L%>!#0.6@5*<W#YC
MZH1\E(]/D1*H<Q]4/T1_K(5:W.BJ.6-M?3[8IZ/3P10L#FZ&%I_#97C\X/!!
M%SH&-\,,:\_]U#M:D:Z#U%!R9(;6*W;)'=Q2RNXPF%KB/VQ%0@X//_H&?]A^
MLB5.?_0,]>H93[(IJ$*N>!9FW=.^5GO)^K"(FM8*4_8 <OZZ1'M.,ZN-RQ>&
M9O%C,H.D/A@ CA]6G+HBMGG%:\C/^QI]%$2K4Q]'#@P$@%P(J 2*FHUT0J[.
M26UMYVQLE;DK8-:[\:P1D.(U >_6H*FJ\HF>+9C;937+P^1ME!1Q'L"XU] !
M(/$K+W'M=>6D$@.C(J:'V-0.!^RI1*@::BKF 5X^R:?+3TI0J[.2.RMHO%MK
MUD\Q !B?; CVN-"\&E$GP&U&^S; Z5[0^X)TCH&L%32H: &Z HK@U%:\K?I"
M%3F%?J-^EOZR%6[(8*@,9Z*'VZ@GUU]""'(UX%/"934UE8"17YQ5$@DDB< Q
MD88 15VA<1Z36E4-7,='91P!S+AKI3]9KH0\5]-*@TU5BAJX7,?5#_I8_P!9
M0JAS.]4/^EC_ %D*N6P6KX99I96,N-.2)L+6LTIKRM :@VPV$1MG\:,RD_N!
MB:6C6@JVG+1)]BQ29I/!NAT9=/XD#)I2&^'X+&QM'K(BC :=$*:5G2V&AT8C
M8QLL;&B8@QOH Z,5'-SU / ^E.7'5:ZS6-')>ZRM9O"B='D+9S6EQ=&V%X<1
M4@2$!WLGY4Y,=9TX0V(F64T[@^7W.&A+06^/0@:#FUXE-*DQ,>UPR6@D -(!
M-#4:CUT^5%JA4'0M:!45/LZ?+H$3B[.6&Q@A;+!>LN)J"L+[8$ GB 7 \%>0
MV6.LA Z21G/<'0,'LL'HKRBC5*11::.%0\?Q?S'D2AU>Q'7_ .1?8Y B?>W'
MR0D^Q"!^VJ#^LBZ(@,(&D0^0R-K_ -100E?%[+8V-:/V3M'.^4@^A-$UI[7(
M++6. .9<,?(:U8^%KSZ/O@2$6LN&7BI]AGT,_61*G/\ Z!GKU#*?9%-0A5S6
M^Z/@=-(]C;C]C$V)K6 #0>PT!I_53V$UBE&QRPAAD\5ID]$?A#E_TO!#G3DV
M.8?>M_[']9%JU!S20'!H!(!/LZ G4\/0$HE79/-E:W'A1.BR%MRM)<^)D+^8
MCVAXA'-H?E0FO#DVHQ9RW;FN>VS@(=J6"X'-2H J#2I3VK#@.J'GE+:!QH1R
MZTX$>JJ%6Z9IGCE?*>5Q =63F%*C4CF-:(:>#L)([*U9XUK?LGF<VAC?;  5
M'M <P('JT1C,ZTI6&Q$;(6SY90'W)/LLKR@5/'E%!HFAYJ^QPN;_ $#/^P_6
M1D<W^@9_V'ZR#=D,0(#8VGY><&O#Z$69@Y ]H-86GB1XL8-*_.#6@1/<A(Z,
MAK8V-:- YQH7>HD>FB#D&.UC@#F7#'R'BQT37TU'"H)"<R>#AEXJ?89]#/UD
M2IS_ .@9]#/MZ<$*N<T6;H'2R2L;<'ZL38@&#A3V0*)3QE:S72-&P60MC\9L
MT;I*_N)C;2GX)%$&QS_Z!G_8?K(E46N!(!:P D FC= 3J>'H"%78O]RM9Q'$
M^/(6Y:USB^-L+^8BI:)74<*'Y5?8-$?N<MR\.<RS@+33FC%Q0@: .(/$J5'!
M-14 Q&A.M&:Z\?4A5I )(JZ,"NI]C3Y:(5][M)([*W89;:\BN9"T5CDM6EH)
M&H D:6@CUH3^AM1/LFV[Y)&MDN"?9CY0UK:GB !2@2NJN'5WJ@^B- J[U0?1
M&@U/E@/U8.7]M\WHX!!K#(Y&U_%1D>N5H/'U5'H"#1(Z$,#&-:3Z9!QX_2A#
MDF*VBA#VW43Y' ?BS"UY;P)K4$A%Y.)S'U0_Z6/]9&-4.9WJA_TL?ZR%7,:;
M5T!FD?&+@GV8FQ,:P ::L:T-K]C53V*V0V(1F82QNEK00F-M/GY"*+)-:^QL
M<_\ H&?]A^LH5.8'3E9K^!^LA5VEJR.9C[010RW!Y?=YFL8&L]+_ !7@4DJ-
M!6M$94\$+ID<+&6ABBBN1S>\3.8QS7ZU9X3RVD=!H>6E4K]R4\>+K:N&GXDT
MTK2/7[2)7WH@DD5\$"O'ECT^7@A7WNRFBL8&>+;WL-Q*0*Q26K.6I&H <TM!
M!]*<B)K%)BC9ADLVPOEEC;).=!$&AK!4TJ!3ET1>3@\W^@9]CD_60 X5%6LI
M77ZGZR#>D=;C2.,'0:\^E=*H-/*'@?N3#Z:O8W2OSCT! F,5&B(- X..CC7T
MZ<::*S3D0Y/A6C(/$;<L=(>,;XFO(^8.!(0<(O%3[+./J9^LHE3G_P! S_L/
MUD*N<#9FW,KBSWGT1B,!FG^A Y4)<8",1^,9(S)6@AY&D#Y2VE*(K;U.OXG_
M +!!%HJ0'&$ D GV- 3J?L!!V,ALK:<10.BOK<M:7.DB9$\.(',T2N <*'Y5
M=(37GHVXQ92W3P][;2&A+?9$XJ :"NHU)325IR< EM31S:5('XMNH!T/#TA0
M 145<VA(!_%MT!-">'H"#LY8[&WC\2VO(KF4@5BEM6%H)X@![2-$CAJG"&B*
M2R;"Z65C'W&O+'RM#*DZ'D'LBB<UF*QIQ<'F)]$(^3ECT^3@B5]Z',?5#]$?
MZR%6[(Z$D\L+!PX2M(]%?245IY0?V,('_?F _=1>*,SHCRMB8UH_9.T<[CQ]
M=$27),5I% 'LNF/E(U8Z%KZ'U:@THAJX?,?5#_I8_P!9$JAS.]4/^EC_ %D*
MN8T6C[=\LDC6W-1RQMB#6"G^A: TU0FO".#9+(A$)1-&9-?Q7AMI]EM*55TY
M+[&Q4^J+_L%$K[T1J0#X0!(!-&:#TG["%78O=:6TWAPF&_@+6DN?"R%]2/:
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MPQWDTM<V1W:W(&BC>4;SW$&'T5<&W@=4I-T3KP@IRYM?]F'\F<Z_Y+CM=?\
MEUNO^,%:^Y*']F&\F?\ JMN/_/K=?\8)4HZS*?#!>3G?X]]I9=M5UBKKE/AW
M4&],Z;CF)TYW7$MVPM ]0!6,W4UI6?!ETS-OA$\VSA?A?O)SQUDVVO\ MNO<
MO=TK+-=[VS_B DZ>&ZVDLVAO+3C5*UUX%*12-:<W=?V8GR9_ZK!_ISNK^,EE
M3VL:G]F)\F?^JP?Z<[J_C)*>T:&_#'>33'*^3_)8?0"G*_>NY'PZZ58UU^XU
M"QF>:PEFX^%X\GJ3)^]?Y.^8MK'1SHHM\Y;P":UY&Q>"][6.X?6K3TI[>1,1
M&LIH'PQ/DST'_P!2TYV@]H[YW54Z<33(C4_,%DE4?[,3Y,_]5@_TYW5_&24]
MHT.^&*\F6(5=VN.-305WSNL_<OUCS5P[GX8CR:7APA[7[L.+7 "WWUN1M"0:
M'FGO'\I'HT(^14=;A_A@?)UQ=JXY3MQOLA*7R.+;O>N;DY6.-6,:;86KZM;I
MQ5@FG"KNX_AD_)E,8E':VYK'Z-\3>>YG$UTT!OGD*4K[$IIQJW/[,1Y,YU_R
M6GZZ_P#+K=7\8K+[A$?#$>3.#7_):=]G?6ZB/H_*.J?<):N/A??)\N,RRY9V
MV92*PY070P[[R\=L7#U0ECI.3UCGJ?6L>'%9G32$Q/\ AB_)J#F$]KDC0T $
MC>FXN0^CV_WX7$GY%*Z\-#E1J_LQ'DS_ -5I_P#3K=7\8K+[D/[,1Y,_]5I_
M _\ W=;J_C'BGW#J<G\,)Y.62QTUC8=M5WB;NA\.[@WGGO> [_1ON);MA: ?
M0 5C-W.(U\&5*1[)YH83X7_R<\;8QVN0[;KO,7E/QL]YO;/^(75_U,VTEFT-
MH/352)U]O@=/*M?:[G^S$^3/_58/].=U?QDLZ,3^S$^3/_58/].=U?QD@T,^
M&/\ )HCE?(.UAY;2@Y]Z[E?#KI5C77Y-0?6%)]NBQXI9G^%Y\GJ;)&Y_R=,Q
M:V7UG11[ZRPA)#OJ-A,+WL8>'UJ_*E/:DS$:SHF@?#$^3/0?_4LN=H/:.^=U
M5.G$TR(%3\RM"J/]F)\F?^JP?Z<[J_C)*#:?\,9Y,C2*]KKAS>K?&[/_ "_1
M8KPUEQI_AA?)HD:\Q]L-XVK2T>!OK<HY200'-\6\=1P)KP/S%7@<778;X7_R
M=L5:%^4[<[[)2.?(:7F],T_D8YY+&-]V%J\N:W2M5(F>?$I$\'>1_#*>3*8Q
M)_DL<K7FC?$WGN<GT\/W^XA7XO8E.GG5K_LQ7DSG7_)8.NO_ "YW5_&2M"I_
M9B?)G_JL'^G.ZOU<DE!+=S\+YY/=QEXKF/MLRD5C2KX(=]YB.V+A2E(2Q\G)
MIK[=3ZTTCBO"--93 [X8WR:@X./:U( P &F]-Q<CO15P]]YB3]A29(BFK<_L
MQ/DS_P!5@_TYW5_&2J']F)\F?^JP?Z<[J_C)%JZK*?# ^3E?XZ2SLNVJZQ5T
M6GPKJ#>N>-R'>@O?<2W;"WY@"L9F;=8UF.2],W17A$_T\6W@_A?O)TQEC';9
M#MMO,Q=TK+/>;VSY?4G3D-M+9@-IZZI$UUG2? F*1IK$<W<_V8GR9_ZK!_IS
MNK^,EE1C5 _#$^3/0_\ U+#N!X;YW54_(/\ =+B451\\\;R-/+/[1O+'[@NO
M?0;MZEV%U5V%)M@8'/2;HS&3GMGY'-VEC,[P[VYN8)89+>\K0!IJSCQK*4]I
MHQTSKALEDVT?)[SX,#I+9U.0VY>SGN6./%]#H$C]*3QT9=WX8C]#/VM_/OG\
MZ\@K*J_I^LS]M]Q(X2D\8:E%$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0=+);
M-N+BWFDE+I;4OYHQ[(/.?9#O0=/6K'*)TZDK2MT:]/[5,SSA>V2^[N?+S[DN
MAU@XQW6<VV[/6C0PR.,NUX)<VSPR(IBQQDL6FH'HIZ5(UF8974I'C+#%WVV;
MBWW/N+;$SFV\V!RV9Q;N=PI%+C;VXM)8BXT#JNA+5??\*<9I;\3)E?",]V.R
M>H_9#D.V&TSMN=]=$<C?7UWAKJ9D%RRTW)<P3!]G!+<&6YB9,"'&.,-::UXJ
M:4K&EY/A.L>"[ RN2.W\?ELS?W$>+PNW,?>92_R-X]D4-Q;6=O+=7,DCIC&R
M&.%D9]HD#Y5)\T=5\^:.'[2(IDB+?@GC'ZF'(\\#N3V'W5>9QW/=:>F>8EW-
MT^R^>M<+8WCW.8RFWH1A9([5KII6MB9=8\\KF'E=4D<5EKQXRD3--(IX^U[]
M^%,[5MR]:O,EVAUNLX6R[2[?&7V;W/"Z+G:R7,63K#"<Y,4C&M%Y-S:EI)CX
MK'R\)G65I=QMCRQQ95410W4T5R6.)MGR""X!+!"SF(#?#T#@1I59S%*6Q'']
MC")MF.J=:<W>+%F(-(:T4HUHI6E !2O&E.%4$:"M:"IXF@K]*"* @T  O<:"
MOLZT%>'KXJSPA(XRH!_$[@#R9^Z73T[&/_M7CU!B#)?J1?@_J-167V^&.H/)
MH[6SZH]ZG_VEODF.J.F.;&)I6?:KHQWK)'.+8VR$/<)*2!W+1Q'"IXKA[_3M
M^&9ONS3-L5GG[Z-*SNG7Y++-:TFDM-W:B^'.SDA I3ZM'4X@CA75:&S[IDLB
MW;SCF9MFE:RYW;9[,%?F6Q,3'.'%EL_$;';2".5D8)>#R2,=^$P@M</G"[-C
MC!?%T9,>.>N.<6S^MQ7=,=V>+=UM\DVSC_AF8G7W)8S>UMN9:.&.]P6!D+'.
M#Y'8?'O>:U%2]UN]WI71/4?H#9]]FZMV#%7PQ6?KBUR79O6/=>T6].++NKKI
MI'^)D_>8#IUL7&32F' ;>F<&_NCL)C7%A=ZC[M4:CY%P?IOZ8=O]/[N=W-V'
M-$S^+%9^VUSW?/5_?^Z[>(W.[W.D<(S9.?LBYSG;9M[1Q]Q;88]K7\S6V5E;
MVQY>:M*PQL)T7US!_EF&D;?!M;;J<K;'R[/MM[?-<NYW.2*_BOON_7,IOCC<
MVU;S /HUM"0*U% =>.JVNYNMMB>F(^7/AP_0YO8Y/E8Z7UF8\6DRQP$ QL(+
M@ 2UNA)]&GRKC8W]T1T19,:^+=WY;;OP5^Q,0X#YA]Q<A$UBK110$!! @'B
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M-"^[;-;/+^2R(K<-#->9VK&::Z'2JQZK9CIB)CP)BD]5:SS3 #4 C@14*B*
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M]_BDDM(-!0B@J5U+#Z#RXLDYIWN2D36E9_>YB>]6WV6V6X8K*8V0M$ B::D
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M(" @(" @(" @("#$$?$Z?IFNZ;YMC?FICD#X8O\ 3-=K/S;Y_-3(H,ON@("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(""P#^-Y_\ K$__ ,)__P!!U9XI'!8D=.?\:'3_ /GWLW^';%16=YZ7
M_P"+/IW_ #%VC_ &/03T@(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(* 'Q-WZ&7NC_ V;^<]FJQGE[V(,BX2
M?][=_<E1DR^GPQ'Z&?M:_P"?/YUY!$5_#]9G[;[BL<))XPU**(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M$ZD_XSNH/\^]X_P[?(+[GX(3Z_?5_P#@P^[ED%_X@(" @(" @(" @(" @("
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MFK^'ZS/VWW%8X23QAJ440$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 00/ Z5T.
MGKTX?902^P7+)?&=.&0$O#<<(10$DC5X%#7BK?=%TSSF.+&++K8I'XN"+67+
M)73AM7D5%G3V):CB#3E9R*5II/PV\/M6WA6-+IX_8T.\=K^5UBZ;W^HN7>(0
M*-'LM X-HL8ZKHB8FLQQ)Z++IFE)EU\L+8F''SL>]MT]KK'%LJWPA&\/D<;I
MM/14ZK*8GIZHX2L]/52W\/'VIQ8*,:*4HUHI6M* :5]-$&I 0$! 0$!!H! <
M^II]7[BL\(2.,J ?Q.^ODS=TE-?^0WYUX_@H,09(/8B/HY?U&HK+[?#&D#R:
M.UHDT')O/4Z?_=->J7_"EO&?>K^*J(" @(" @(" @(" @(" @(" @(" @("
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MY<<=/_NKR"7<OZ>)"OX2"YA!J/:X?,K'"4GC#6HH@(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MZ@J">$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M,XO"X:QM\/96KPZMS(R"QB@@9SO))HT54F(F8YG*>K2(3TP48P4I1K10FM*
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M(" @(" @(" @(" @(" @(" @(" @(""!X'YB@^>YC9>T,I<37V2V+M#/7LU
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M'3C\Z!05K05]=-4  #@ /F"!0:Z#7CH-?G010$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 00J"*@BGKKH@<S3P(/V0@C4>M 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M"H]?#C\B"',TFE17U5%4 $'4$$>L% J*5J*>NHH@B@(""%1ZQ]* '-/ @_,0
M?N((<S=?:;IQU&GS^I!J0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M2::\/ZW:\L5O<00/#Y9;D!US-S.#'4HZ.FO*%*S-UL\N3*+HB)MC6Z4Q 4
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M4I$UT\W*4TC@-:Z#7A73C1$10$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M;[J0!7TT&BK%F0(1^]XCR@N\".E16I# 17T\4)=)"Q\CYIY*MOJ\KF<YY8&
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MB8@XR.:Z0D@EP)/%2:4GJG0BD71T1K"8A0@$<"!3YO0J(H" @(" @(" @("
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M]2@'J:L;>J:1=-8MX_:RF;8NZ8C6Z-/8FA&(@(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M@/%6(MG7ADHE;N6MB:1P%.'H6*B @(" @(" @(" @(" @(" @(" @(" @("
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M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$$'"K7#U@CZ11!T#(7VIM8Q
M988C.>8N/L>)4G0C6H*3TS,VT\L\$BWJZ:3K36%OMYV7DA[C\WV\Z-3V'<?_
M ((,?TB@ST>/P%SMZ?+65]-FW1F:YD?;N9+X\3;:)K7&H:T.IQTLS6:SS8V4
MI$V_#RA;?[*^#^ZW]/.O^U;K<'47&]2^F.#W%B,E>Y"TM),9^5;6RR-M<RQR
MPSVLSXF&*%U6N^M6BQCEU:>QG,TGRQU?H9!_9^V;79VV]C;9P3;7%XK 8#%X
M9UECK&*UMI_R5C;:P%8;:.**/E%N*:#Y%)GSS/.>'M2M<<1$^2/T+1'XQ/\
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MQ6_.6NN7O=!& 7"9E2X'G_8@-*RG6DQR8VV:W1,4J[I1D(" @(" @(" @("
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MI;"R,R&'P&2Y0Z27$8ZZCK2O[ZLX9#1QJ>#DB8K[R;8KKR3 @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @((&M#3C0T^?T(.A>]MI
M-'SQD2WA<+FX$G,V'EJ&:5Y:N641SC@QY:\46^.;AC+<UBM@[VG.H'F05]/&
MA6,=%TUF-(94OMLI$Z2M[/B&?-=QWET=J&<V5L;=]OC^YOK;B,AB^F5K;PQ7
MMSCL8XG&Y[*SQ1W,4UH;**X B>YNKW^SJ$FO+@1$4K/Q<_:Q<O0/HGUB[S^O
M&T>DG3+;F6W_ -9.J>Z+B:^@?/<3767&2OC<Y*[N[J<7$EM';Q2.<][JFFNI
M5X),:ZKNGX@;LDZ<^7UY8W9UT!V?A\?#EK"*]NMQY5EA:6^4O<]D[,9'.-OK
M^*U@N[UEODGR-9XI) ;P"1&DS/PUT6DSI'Q1Q64.R8W0;\V7%(_FC;N[:SI"
M""&DY6T-!3U,JI6J^WVLYWVL'QNV_HIQH[IGL?7T@-VQBR/M!28B8I),S6L-
M/=/O6UV)VW]:MT7)Y(K/IMO:-KB>7EEFVUDX8G \S:$/-1JLJ:1'L8Q7C+!B
M;ZF9<[VWO=O!_?.[MRSQ4^J'29>[E<0.'!P4_6OMY2OY/@EMI9C'X'O0WE=V
M_+C,W<;%L+&1S!667'LGN)7L>6U#7>]D$ \6IS]J32DSX+\Z6)CWB5P(:6%[
MJ>M@YAKQ%:*Q,Z473C*S7^,5V<-Q]H?2;>K;>)PVWGKMHD="Q\D O1-&1'(6
M.=$'4UH16BQK/">*TAC8=J77N>YMMW+B1';[APMT[72EMD+=]:5 T 3293DS
M<7EO]0H^IW8_T"WE9O\ $;?;!V];L?S\]38XFQLS1W.^M/"]:SQQ$W4GA#&Z
MZELS'&7O18LA 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0=5XG+<
MPPEA<\\_.[@*<15W!36V:V_#)$Q$=-W&5!'XFYDDWDS]THM&22DOV2Y[8VO<
MX1LW1CW2$AH)Y6M;4^BG%94F-+N/(X:0Q"K6S.C>SE/*R,O<>4T #>>A--"
MH5Y,M'\*O"UGE(]()6MY7S;@WF7/Y1[7AY&W#=::\HT2L\^!SB.2X_;-&^20
M-]DQ@AQ- '$C0 F@T2E$TF?;"P+^-T?SQ=B$ H9"SJ5(6Z%WMMQ+!PUIS HM
M>:Q-V+<M.]>F]MREQM-Y[<,H:TESW.SMDX- %2X\H(HG%*\:,Y+VQF\M^WKH
M;!>F0W-UTWV6;CQ&N$K&C;&*,;9&N >VD8 U2ZE(B"*Q-7HQ%$! 0$! 0$!
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M[S(7%_.^Y+&>]233.\(R%K0":< KRIS_ %L>,5GCR7A_PP'DJ;DZK;WP_?\
M=P6U;G&=+]FY"X'2+:6X\4T#J=E(G-CO,I)99&R<ZTM<#>P#PG\)RXEM6CG4
MTYZ2SMK$TMUGQ9'B&-D,=O:PQLMXXFV\5HQC6AMO!%RM%NQH  $<;0W32@5K
M;PGXDCA-W%C4_C'?:[LNE 8)3SX*] +V/;$'LDF86L>X<AJ3Z"I6OOA/[/+B
MMD>Q.4X_NV[?[PQMD9<=1-K-+' /K3/X]A]DCT.HG%)]C.#[.?\ \4=J/HUW
M_%? .C (]IS\9;AW+30BE."E(FD\EKK1V.8Y&X7,>)RDMQ.1,C:@DM-K*34>
MCV?NJUI->24TK/%A;_.9OV7GF2]RUY$&\CMZ73 &4+6ALDL=*MJ/0BTIP5/_
M (3B"[?YG.U)H6W/NMO@MP^]&..5T(\:UMV1"9[06,]H:<U$GC$+R95XN:V=
MS7NY@\U#?5Z0*A6(F(K/-CI==%MNDQQ<Y11 0$! 0$! 0$! 0$! 0$! 0$!
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M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(""'*VE*"GJH*?0@4 %
M!ZJ:?0@@0.-!6HUH*\0@Q!GQ.&GG,]T=-*C95::5_P"+%EQ]>JLI#Y7\/3^E
ML[5?YSW?]Z**S(D/[A%7_N4?]P$'#+(YJQL(:V*X@>1P+^5[7$$\2"0FO5]A
M.C$>?%#[4RV#\X3N#S%S9.M\=NFRV9?8R<1>'#.(,'#9R\C@QK7O\:RYG$5U
M=JE:E*3_ $YODOP[VX,U@?-V[5,KB+B-V2FS.7L[D2<D;&VEWC9;6ZA+GEK
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M1,(-0#QJ*J*B@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MQ?\ FT-OX+9F-Q.S]N;>QFUMM82RM;';.(Q%E;6-A;VEM"R!H9!9Q101N,3
M2: DZG4JTK;K&D3Q\3RQ.LUK^A-\L4HFD?RAX;R.MV\X!/+0R:5]*RB*TZI\
MO/\ 8QBEO"//R]M>+'I_&J[4.,WUVA[J%NR-FZ\?N]LCFL:'F?&SD&-\H8#4
MQ7C74)/'Y%CK,\-%I$<>*RMZ&[FSFR^M/2K-X*Z]UR^+W_M"2QN" YL/B9^Q
MYF%KM*/YM3H4X>]>JL:_##.<;$G-[TUZ:7T5R8[FYV!M"XLVMK(#)+@+">5S
MJ$UYHY&TJK;%LTZM(A)BZM;8K+M-P7+XME[SRS8G,R$6T]P2^*YQ#97VN*N7
ML=R$@, >P*:5\O'P9?%;$S_ASS81[OUWM<;^[N.NN\KJ=E_#F>H.YXFSM<'B
MX%AG+ZV #@Y_+X;XO7J GM2==5T-\&IL;(;B[FNN6\H;2.:#:F"Q1OYG0,<^
MT;?31,C<R5T9=$9'5% 16B>6NO#^E$UY:3^SFR03!(Z5C6R&C)9#)<D:O)>:
M-Y3]4"J736*W1Y9_0ML1$Z3K'Z7?C@/3H@B@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @'0502Y*7W$\T3X*P U9R2U\<MUI4'V*'
M193$61K_ (96;X\NF6'5W.<L+&6QCN<SA,1!R2G(660R]G;S1-#3R5\>9L@Y
M@W733TK&;YNNZHFL'RXMMFV8X)7?U.Z?27ECMRUWELJ[R^2EDBPF%Q>[<-D<
MEDI6U,CH;&&\]\D\ ZGE8X:44I,UG\4</:332R.$QK[$[,]^M[<V\MXZ2_(:
MY][0B-U3S,8(?J$AIY:\5(K==T\*?I939%MD3-VL_H>./,#[8^GW>)VE]8^B
M?4O#6%[C,QL?<&1=>WMI:WEUB;S#XRYO[.?'W%S;W$ME)+/"T%\7*X-<[UK.
M)K.O%C,4BED^7Q83+>N&CQ&\=[8[&QD8; ;LW#B;9I?4QV=IE;JS@:":%WXB
M(*<D]W/FO_?@O.MVZ-T;%[J>B.XLW/=[/V==;7R.Q\1*^1T%F[*.\/+^ QTK
MF1\\HB>:,%3)\BL<:\TGA2=%7#XIK9AS?E+=9]QNB8^7:66V<^";PFR2&WNL
MI-;3N!Y'.B:WQ6AQJ!0JSTZ3&LS^AG'5K;2D1^EB;K=]K%;23DF*]A=;R63A
M4UDB<USW4X#E(6/)C$ZTXPR^OPY6Z\_O[R?.UK,YV[9<9VVM=Q8^*7V&E]OC
M<I+;VGB,:2"YUERN-?6%E'3,Z_#S2Z9MC3XN2N3&XF*VNGFDK)HHG24TE,DC
M6'V?3RDK&Z>B?AZK87IZ[:1=TW>+%F_%G;\M,_YE&9V/!>^\W.T\)A9;ZT#N
M;W4Y"">2!OUW<A=$\DB@X@J4U6OW*7ODJ;*FWUYEG;?M:"W]ZN;K=D$MI$Z+
MQP7VD]M=.<6%D@<&0,?K0T5IKHDUI[69KQL4]O:8^PY1%!:8G%P02#2CHK:.
M.1I8/O:4I319S-(B9^&>+";9NF8M^*Q-8X#TZ#[BP:D<$4! 0$! 0$! 0$!
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M*<500$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MPYY')XA!!H?^]GZ5CY[HB>+*[Y<5I%+)Y)D' ?,LV** @(" @(" @(" @("
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M/%C==?K%L=4>/@F-8LA 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MG[*!0$@D D<#05'S'T('*T"@:*>J@I]'!!% 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$$*#C05^9  #11H  X   #[
M 0100H/4-.&@T0*"M:"I]-!7Z>*!0>H?0@<HI2@IZJ"GT(%!IH-.&@TKZO4@
MARMU/*VIXF@U^=#CQ1(!X@'YP@B@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(-)8PN:XM:7-^JXM!<VO'E)%15!&@]0^A!%
M0$!!"@]0^A Y6TI04]5!3Z$$.5M*<K:>J@I]"#50>I!"@K6@KZZ"OTH%!6M!
M7UT%?I0100Y02"0*C@:"H^8^A!% 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$$.4<:"OKH$"@TT&G#0:?,@!K1H&@#U !   K0
M5XT U^=!&B"%!ZA]"!0'B @%K2*$ CU$ CZ$ M::5:#3A4 T^9!%!#E;4GE%
M3Q-!4_.?2@4%*4%/531   T  'R!!#E;2G*VGJH*(-2 @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(""% "2 *GB::GY_6@A
MR-%*-:*<-!I7C331!J0$&GE:"7!K0X\74%3\YXH'(S4\K:NIS'E&M.%=-:((
MT )( !-*F@J:<*GB:(%!6M!7UTU^E!%! -:W@ *\: "OT((H" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @TE[ .8N:&_?%PI]-:((AS3H""1ZB#QX((H" @(" @AS-U
MU'L\=1I\_J010J('R(" @(" @(" @(" @(" @(" @(" @(" @(" @("" ((J
M""/6-0@5%:5%3P%=?H0 0=001\FJ"* @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @((.%00=0013YQ1!(&[+MNW]I;IS4MN;V
MSVY@,UGX\2)C&^].'Q]UDFV_CAS7,$K[?EK72JE9K,<?!=-/TK%+/_&N2;:S
M^X,$WL7@?/A<WE,,;D]1C$Z9F+OY[%KI8VV$I9*YL +@)' ./$JZUU1P/[;L
M_P!/8?KZ?_IG'^)2@?VW9_\ 4/\ _P#IQ_B5!J_MO$O]1%W_ .T]W\3(']MX
ME_J(N_\ VGN_B9 _MO$O]1%W_P"T]W\3(.58_&X2WM]960[$92Z\N[:T8(^I
MP=*Y]Q,R)K8FRXF*-TA+O9#G-!/$@:H+T3MZZY7/7CMZVGW ':\NU7[MV;)N
MV;:$EXVZ=+R8=F1@M3>M/(PB23PRX:&E5(BM>?M6O328TA:%=>/C(KKHCU@W
M[TFE[)CE#L?<>4V^W)/ZA,A.0&-O)K3WJ.VAM[AK(YO!)U?S5K4+*8F-.;"V
M;;XK$:/NWE\_%<W/?3W<=*.V!G:.SI^SJ5D+BP_E"[>KLM+;2PL;(US;<V]B
MP1\@<22)#4 44X>]E$5FG)>),,[YFS!WL2Q1/<0:BWYFAW)05Y@1HD1SGX>1
M,V3I;I='%W* @(" @(" @(" @(" @(" @(" @(" @(" @(-+]&.-.;V7:>O0
MZ?902W"9Y8;:2.X_)C0Z6MD_\8Z3VR/K./-KQ]*1,<;_ (28^7[I>1N^_ND=
MV1]LO4?N5O=L2;[BZ>X_\H.P,5P;5[VNBG?X7.)(Z>.^,-J3H7K*9ZM(X0QF
M*36-9JLY3\;;=^,Z.Q[#SX4<D@?$_J(]LI:PFO-X6-+(I:#5M'4/I*Q9>Y6[
M\EWSY+_S>=X=6MHP]O3^C,/3/'X:_&79N8;ACNCE+EL MY&^#;.BE:X']@&T
M(U)X(B;IIRHM;>FL\5QZ 0 ":D  GUFFI^RB(H" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MS6503H'YBO93W1Q6][TDZ\[-S[;N!MQC+S(9[%87WD/CCDCB9#>W\,KI")F
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MH;0 G+E%L?##&O/\2C)&Z_SU_%"]F8W?E;YOAV4(DOLGD1RDN,<<(]XN9G
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M896-DCD8YOLECV.!!&E"@W00>!!^8U010$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MB?\ $AB3Y626,U_8W[3'DK*>7'^&6_N,T$CK>YC<*:N#FD?.L8^Z&4\*QQ9
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M]C'FC=F7F [2;?\ ;IU<P^1S=B&,R^V,M<V^,S^-O)C#X]K!89"\-[=U?.T
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M:;SE8'1>9%W%17P>R%VZ[IT D:YDG@NN;LL#PX!P)FYA4^BBL1R)K&E:SS?
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M?.0@Z-HN8;62V$/C2D/C,G.-/&J 36I ',%E$6S/5,ZRDSK,6QI;P8?CXC;
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M5B:<%Q7!+XCQ''.+B2V-)6%O(:.X5/$\BG'6)U6>/]EW2J" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @@X5!!U!!%.%:BB"6A*^V?):6=J9+:VYC*UTA+H^<%Q<
M"22[TFB1%;J73I*3,=/EXK;GXH^_AO/*7ZR1PY627PL_LX^Y26SH^7_=.Y#Z
M2.&I:!3["369KRCDM::<:L4Q"TP 17UX+.:TB;)8M;$)N87#:OYBVOUA]"1*
M35?L?!%!Q=WU/)YF//3<$\#*X')&M.+>4/\ ^S^1->?!EI$>U?\ :(<-4'S[
M>>1ADVYNZR+W W&TMR.C'(0'"+%7(>2_@TAM58MF(BL<>;&L368G@PA_?:^:
M;NOZT7-S:-M/%Z@[J'LRB0W36;BR36O<!]0O I]A36I&D1$/?7P_-F]GFV=J
MPFA%I#?9V],?*\2%L;+=KN?V22'.='PXZJ<M64>6=&8<M@VY;9NB<YS&P0>\
M U;4B)IB-30\=4BNO\,E:S'*ZW]K&N?&(W!_RO>D3G2L8RUPMZQT_*UQC$DL
MSBUS.+^5H(J59KX:$>_59[;<CMSN[;;82Z42[DP8 >QT8'-DK<.JX@ <_P!J
MJ>V2M8HS97EEN<.QWM\<^<2B+8^#!I3V!^2K,-C)'WI/VTXZIK$:O>/AMBF?
M*27&=\0#=?9U K\RFLS3P68B6*P^+*,UQYE>X(&V+83'A<,(KD2ASKGFM;J1
MU8]2P#EJKKSX$176%M)LIL?\M=B/9<>+<MWCMIAA=&8R/]U[0@DFE0'- ^RI
M[9YIPTX,YEVMR0#MQZ,7#:ELO3/8Q>*GZW\F<4PM'S43A%%CC-T367WAX;R7
M3"2R/P7$NU/*',-7 <3IJK2(BD$<:L.7\0R+4^;AW7&VNGY*U@W)9?OA\1MG
MD>ZM!;R. /L2/I7TIK/'B>7\/!X2[&X'6_=7T$R<\7@6+>H>U^1[7![W$9_'
MMUC:>>O-)1.5"8GA6DRS;^!EE&U-E/9![S;R[1V\)X0>61@=C+<L>7?693F^
MTI/5\-L5F.*VQCBV<E\TB>"DEYU_E@[;\S/M-O\ IECI+*SZX[9MY\YT@W#<
M01R.@N;%D]S>X9\IMYGMBR[:0D\S>7BKQTC2V$UF>J[XIXL3'W%=L?7'M5ZF
M[QZ'=?-G9K9&_>G&3DQ=UC[S&7'Y*GF+?%?+;9MT$=K=6LL&K7@\O$:$$"TF
MM(XI=,=/]GDG3M0[\.Z+LBW'/NKMAZQY_IKE\O$QF2M[>YGN,3&ZUG]YB+,;
M*Z3'ETTOUG",N( !- *7A22LQ%)UEZL[D_/+\T#NMZ>2],>M'<MG,SLR_$C+
MS&82RM=LR3L=$^WD-W<X2.RDE$D,A!YG&H.JQXS7G#*=(UX2I76F'N,ID+6Q
MP%MDMVY').'/C<;87=W>2W<SPR)L<5K'-/)))/( * EQ*?K2L1+(7?#)^1IF
MNA5S:]^/=7L:6TZB.QEM?="=O9,/;-M^#+63X+[+7N-NK,<US=V%X^)G,:Q.
MU;J"4_%K-(CBL16*1%;IX>Q>\LA=.T74]NVTN[0$PN$@<QHDU<.3ZH%#0!96
M7>:;>&.?Z?8PF)G^UDC[%EA\9L^*;MW[>QS5<_-YF2IBKS^'!,YGM$>P1("0
ML)K5E$W4TX,</-%;L<]D,S9(Q$7-F=$ 9'!NK&@CV"':55X'M98OX5&VC'E/
M],G-8UKKG.[L!<&AKG4O(&N+G 5=1Q4XZ3P6D1K'&5R1;,; V*S<WFKSDO\
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ME*SQEZ&A;;LO+DQ "27DJ:Z:"GS+3B*:61K:RXQU3=I=^QVZS8B @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M#5L+:T?[E"' 4D=[FYA>'.F%2R24CVVDFE#I1(CJ]ET<?:END=5>/"%';O\
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MV%%10$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MX$],12.,N4HH@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MW?A_G;==O_A%W9_#^24A(X,J%\,5^AG[6/P=\?G9D555_$! 0$! 0$! 0$!
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M!]A11 02UO/_ )'[L_FUG?X+ND&#F[\/\[;KM_\ "+NS^'\DI"1P93[X8?\
M0S]KGX6^/SJOU2.,K@!%$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 02+U0
M'_TL^H@]'\A=W?P!D$&![ZH$_P"$SJ(:FO\ +K=VM=?]_P#(>GB@DV?]A^V_
M409?'X9']#+VM_@;T_.F]5E(5_U%$! 0$! 0$! 0$! 0$! 0$!!0$^)S_0T=
MTWX&ROSHL5C9\(Q!4'[/]K^JLA.72_\ QF=._P"?6T?X?QZ#/"=+_P#%GT[_
M )B[1_@#'H)Z0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MI![M86=,>V&&&VQ\44(;&V"V:UC6!K&M8T<C*?,MM68BEVL0DW5F?XI3.!0
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M_P"+/IW_ #%VC_ &/03T@(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M]G^U_549)RZ7_P",SIW_ #ZVC_#^/09X3I?_ (L^G?\ ,7:/\ 8]!/2 @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MKK,L9B+HK=H[8$4:!KH-?DIH?LK'FU*:5'.Y03ZOUZ*QK*-2@(" @(" @("
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M" @(" @@0#H0"/E""-!PIIZD  #0"@]00$$.45K05]=!7Z4 @'B ?G%4$4!
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M<M1P4K%:%-*<EY9\-1YZ'5GJ#UFVYV+]T.?GW?+O:UBQ?37=66OG!]D[$V,
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M2_\ QF=._P"?6T?X?QZ#/"=+_P#%GT[_ )B[1_@#'H)Z0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M=IEK>Y@EMY+4"#WR"=MHYT<A]IE'"M005*3,4G6.7L+9I/7$TNCEXK:3N?\
MA0O+]ZRY//YOHY:W?0_/9XW-S';VTLF4QMED;HW,EQ>0V,UO)&QKKB<2-8*A
MM *JZ3%(E(B8UE2T;\$<QT\L;>^UK7,?6&(=..>9D3G$TD/Y2CJ_DXEK0*ZT
M]"5Y_A\37[7O;M?^$"[*^DLUK<=P>[LQW!.@//<P'Q-L1SOK$YM8K2"2L?,Q
MU6N.H=0E(B;M/^\GAX2DS2:QKCCCXPN<>WWMGZ%]JG3/ =+.A>QL/L;9^S[=
MMK8,LL;9>_F)X:T,O;^&SM[G(/(:!S2$D<H]04K=PNBDKTQ=YK9TG]+[1<RY
M$75E);M,3&/)%G3F_*37TYG.D_U'PAK0K&*196-;6=VMT]4TO\$W@D@$BA(!
M(]1IJ/L+-@B@H"?$Y?H:>Z7\#9GYS62EGPI=QCWL05!^S_:_JJJG/I=_C*Z>
M?S[VA_#]@@SP/2[_ !;=//YA[/\ X!LD$^(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @XXB<P$EY/R4I^JLXOF[28I+2BR;=:Z
M-N2Y+0?8X#U\?M*3;-=)/FTUIHZ.>^(;]0^G3F^5:<77<)97=QMQ\+:NG?DW
M\U/"?0D#ZY/&@KQ^59S?'.$CO5)I&&NKN[>UH6N$AK1KOK'TZFNJVUN[NNFD
MVQ#?W;NV^VL64=F&O<"T./+2GS<?E6[LNMF-:?>V66?F36(U<:2P,8YO>'$C
M]CKK]M:GSJQTVQ1MHVDS.MSC_C&%IYBX%S::_+K]U<=FV?SIKU3#DL>TZ8KU
MIB;P'S#[BW4<&A/%% 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$$B]4/\6?43^8N[OX R"# ]]4/\9G
M43^?6[OX?R""39_V'[;]1!E]?AC?T-/:U^!O/\YKU2_X4MXS[U?M51! M::U
M:TUXU -:<*H!:"*$ CU$ C3Y."!05)H*GB:"IIPJ?31 H-=!KQT&OS^M!&@]
M2#3R-IR\K>7[V@I]%*((T'J"!05K05]=!5 (!X@&GK *!RMK6@KZZ"OTH'*V
MM:"OKH*_2@4'J'T('*VA'**'B*"AIZ_6@4&F@TX:#3YO4@B@(* GQ.7Z&GNE
M_ V9^<UDI9\*7<8][$%0?L_VOZJJIRZ7_P",SIW_ #ZVC_#^/09X3I?_ (L^
MG?\ ,7:/\ 8]!/2 @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M_P#Q9]._YB[1_@#'H)Z0$! 00#FFA#@0>!!!K\R!4>L:<=1H@5'K'TH!<T$
MN )X D GYAZ4$4! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 00/
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M#/%8XLYM'N%$I-"MWXOL>I_ABS7SF.UP^O\ EJ?L?R8O:?:2./V23R9?E11
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MMF:_%TUBZ8B)G2:\])33$[\50_LF#6OK:M/KBR[2*Q5N<]O797@VHX#S5,A
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M.?<SN)+]234J4G58B8X:VT_I^MZQ::M::UJT&O"M16M/15$10$! 0$! 0$!
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MD<P-/37[/V%M]O99FR4^&:MEWV+\FWLOMF9TKI_4W;]T;[-S@ V3EK'05/.
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M_="L<)2>,+;;XJ_]$IU8_G+M#^_YE%8Y[R:/TD';)_/.S_\ "L18XLT[A/\
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M 9[)]H\H4\T4B[6S]2?W<6W3,].1.#=6M-*5:-/5IP^PJ-2 @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M"\G_ .2+#_AONO\ NMU_[+)_LL__ *X?:OXMI_[;%_M(_P""GJ+_ .INX/\
M@G)_^2*?\-]V_P!SNO\ V63_ &6I_P#7%[-_%L__ &V+_:/\%'46A_XF[@T!
M)_W)R>@ U_\ E7U)'ISNL:SAW5(_\+)_LK_]<7LU8CJV>L_[[%_M)<FQ][:$
MX?)V\MI-:N)?;W4+[>Y8022'PS-9*WZOI 7'=SC+AZ)OMNC)%8B)B8F/?5O\
M_<,&[FW/@NQ_*NI3IOBZ)KX4F8=%DKL27$1M(7.,/L%[26@Z<I-1IHM/MFPC
M);,W9(C).LQ-/VNV;+;6VX?[Z8I,1,<&_;,+N8^*-0/K,!(.E1J%N]QCNB/E
M4GR^']3I/JWU1=V/<8L5F&<G57A/[FU?7WN1A:(C-SN(HVK:5J*FGJ7%6[6<
MU]TS=-M/%S?IC)'>=C.\R6_+FV*QU17];FQM#R*'EY@#4Z\::?;6C?,QPBL^
MQN,V_G';K'.G@W7,\#BZM1J1\H]'S+#!;?GRQ;-M]L5YQ/ZY:^+-9N\?&R:^
MV)<662*Z=C+=U7.MS(\BOM"AYO;%:M^RN_X/2]EF.+YW-EME\5Y:TBK97=JN
MC'=?=,3$3I-$S8[ ;HW:;Z?;V%O;X6_ALD]RL9[PM '+^,$$,O(2#I6BZWFW
MF[P9_P"6VV//=CF>F9LLOF.-*^6&RWW=^U=BFS'NLF#JO_BRV6_HFZ';1=-.
MH0]D;*W ::U_)&2%2?4/=%R^[](]XR6]?R]S68B?\+)SU_A;+)ZS]/1-;=QL
MYK_XN+_:;LG3;J(&D'9&?'&A&(R7'_Q3Y5PL^E.]V36,.ZG_ .A9/]EI8O6/
MI[JK_,;*/_HN+_:<.YZ:=39OR.T;-W &0OD\1HP^2I3FKK^]*<%S&R]+=WOL
MZ?Y?=:\_EY-/_1:L^L?36&[)?CW6SONF.'S<7^T]1=K/3C>]IW(]-LH_:.9M
M;:SN29[B;&W\$309+>I?(^V:QM->)7>_2GI#N.+ONRON_F=,]FDX[Z1Y[>='
MG[ZR>I^U[ST+W+'.3:VX[\<TFW)CF>%W*+JKKBV!%M;APHX01!P]1\-M1]*_
M6G:1T[7%;X8[?U0_'#/2<U].'5/ZV^MPTA 0$! 0$&R:./*7?4XG@#77[21T
MZVTT)MNI%U5N#\5#8ON_*.ZRWK \LMLYLUSR&DA@&1N=7D"@!)IKZ4FZGEF-
M6-.J.N.#'%^3A>0X_P QCMLN)Y88HV[QL^:2>6.&,%TT)#3)(YK0XG0:ZE%X
M,T[@9XYL#A+FH#9</C)6@:T$MG$\4UU!#OM),TBJQK-.<.[0$'%N".:,5%23
M05%3PX#B5887<86!WQO7_P!8H?17J?KZ/_M13Z5A^+[&<?"I/_"5D#S+L)4@
M5VYFZ5(%?WO%0:^DJR,JRWB[Y_U2K/$Y?>U(""VO^*N_1+=5_P"<>T?[_G6,
M<O<L_#]K'/\ DU?I'>V3^>5E_?4:7<$9IW"_[S8G_P!&6']ZQ+(=F@V9OJC[
M/W0K'"4GC"VV^*O_ $2G5C^<NT/[_F45CGO)H_20=LG\\[/_ ,*Q%CBS3N$_
MWFQ'_HRP_O2)$C@[- 0=/>ACH9C1K9*M$;N84U(&AX536ZV(GA*5BV>KP4%/
MB7M\9#8WE!]Q<F(R$5KEKQ^UL,YKIXXKB6TRM[<07)MXW2,DF,;:./*#H%(B
MG#A"U\>,L4QVM=,<WUF[A.D&P=N/DGS6Y.H&V7"..!\SXG19VQDEEY8V2.(;
M$YSCI3356DS.G$Y,P7YD75_JQVO^6;O/J?TGS\>W^J73SI=M'W#+N@8\17N/
MV_'#)(RV<^)IY;N/GY131M$C6->,0D^76V-+I8VRX^)Q\Y=EQ<1CNIB:(YY8
MQR;'VL8R&/<T&,NQTCRPTTJXFG%%;7]IS\YC^M6S^@^U?XK"#<=\3=YRY#@>
MZN!A+'%SF[,VN3H"0UM,>Y@>[@.0#7C16O)*<]61&\CKN1ZT]X7E>=#.N7<)
MN(]2^J/4&ZWBS.YML$.)FN+;$YF]L[".1ML1&)((;,<Q;0$OT X+'ITGFSZM
M:VZ::L;1\0P.7S;NZYO#EW!9-Y?O.7&L')7T\E*5]*1P8K_GX5;]$CTA_G#O
M/^$8$CXCD]-^?9VJ_P"5GY:G7S9.*QT-WO7!XF+<VVKH6HNKNP?@#-D;AL'+
M!/,&RV[7\W+0D>D*S'FTX,8GR^6:^+&F^1[W$X;M!\T#M]ZC[XRDMAM;!;KS
M&SLFUL[K>WO9,W*W "&X:9H8C2YN&O'/4 L&BOOX+I.LLQF[*V-[@H=POF:<
M>W!Q;FD@JTM-L^R_*,;O$KR\H8WC6A"E)MF;X^%8F-;.-T\&(4\^3N0F[SO-
M5ZI7>W,S=9_8L&[]O;$V=86LS[Z"TCM+EN$OA9Q6\MTPR3WPD<[PQJ2-$)ED
M\?*V[5[?L\[%NW[MXAE NMG[1L,QD'LA\-\UUN.SCRMQXSQ#"9)67-X]IYAS
M5;KP5BLSU71Y+?Z?O8Z6VS;6F6[A/]/<MMOC,KQEKVW=NEC('/GN<[F U_*=
M!':N<:N]&GK4B8IKQ7VK7CX8K],OVM_-O3\U[Q6!E]7?7C_;_<2.$C<440$!
M 0$$*C74:<=>'S^I #FD5!!'K!%/I0*BM*BOJJ*_0@ @\"#\Q!010$! 0$!
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M01J" 1Z.(]2,D4! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M^O=^];,>9)TGEV9UV?U!9 YF'W,Y[+XVMDZWLK?PO>&Q^S%"R%M?775?F_\
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MM"^CRD,C)H7FXPMG.Z-O(YT;^;Q*U!.CE9FD1,?#=P8\)NLOGS6\9\7U-M0
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MAN)7ZO+J$F-L;SZ=%G7E;'GYI-DVQ/7IC6 _QB/?!%E<ITA[0MC[I:Z]V_\
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M:"HW%F*&@J/Q$G \0GX?M.:UH^&+_3+]K?\ ST_-:]2/V$LOTL845! 0$!!
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M6+?^_FRQ;ZW=%'3>>=Y&1QYV_;1SG7I>]PY34\VJRU3]23)>IO4MC"QO47J
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M4$M]"QMI6:S6G+W_ +F4W7:=$4\9_4F8<!\P^XJB* @(" @D/JC_ (MNH?\
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MOM8+Z""-L>7QEU:Q36]X)F<K?$$S'Q2A@/ @JT\U>4\")\O]J.+HQTUZ>0W
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M .'[]!)D_P"P_;?J(,OK\,9^AH[6?P-Z_G1?+&_X17[60(" @(" @(" @("
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M 0$$*#U#Z$"@ H  /531!%!"@]000#&-'*UK0W[T- 'T 40:J#73CQ^7YT!
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M8F(T3.HU! 0$! 04!/B<OT-/=+^!LS\YK)2SX4NXQ[V(*@_9_M?U553ETO\
M\9G3O^?6T?X?QZ#/"=+_ /%GT[_F+M'^ ,>@GI 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$$A]4?\ %MU#_F'O#^ ;U!@?NJ/^,KJ'_/O=_P##]^@DR?\ 8?MOU$&7P^&/
M_0R]KGX.]/SIO59Y>YA;S]ZX 49M+S1CS7EHUQYJ5I0'6GIH@DWDEG;9WT5\
M;ZW\62.YC='X)N&.>6.JTZM\!IT]:DS2G7\/.?U$63,3;9%;N4?KU8UKXL[:
MW?MF^[[;\G5C:^X<CV?8::_M^UZ^V]B'9FWM:X/$2[RDR,^/AEN;:^DO8FU;
M<.;^(C86U *NM)B2[6DVZ+0:-C<C<27=Y>FVF@/++,("'L<T\D'XMHK%)S"G
M-H6GYDTYI/5$TB*O4FQ>]3N<Z6=%NM_;;@.J&>EZ.]P5GMZQZL[.S5]<9VUR
MEKMFXEN<(^UEOKB08Z6%\M>:$ D!H->4)2NL+,<*ZR\J120274TTT/Y3:6ZT
M?[L&@#32HKRCT*:0:SI$J@79?YE/>9Y?6 W]C.U'J)#T^LNMD0@W+3'6F2N9
M(L?$ZV#K>6YD'N5S'#0,E +F"O*02G->$/#6:SV5WME<OG-P96]RN=OKZXR<
MDV7O)LCD;Z^NG^+?R3Y2\DEN7Q^*"X-<\C[)J;[^"3K&FET\)>B.TSME[J^Z
M+K3L+I_VP[(WKN'JGN.[NK[9]UA8<A@;'QMO6EQD[BZCW9'[O9V<5I#9/+I'
M31LYF@<P-$JD1I[68&\KZR[R,1V1=&L?W]6[?\J?#6^:Q>Z VXL[B5V*L;UU
MG@9;ZZQ[G6ES>OP<,;IGAQYI234U4BL1-O*641;-T3=%:*@-A=6PDM66@-Q8
MWCI/#<]IC-J^,GQ:N=J.9_TK*.F8K7S)2^LQ/PIM'R<% 0$! 0$% 3XG+]#3
MW2_@;,_.:R4L^%+N,>]B"H/V?[7]554Y=+_\9G3O^?6T?X?QZ#/"=+_\6?3O
M^8NT?X QZ">D! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 02+U0_Q9]1/YB[N_@#((,#WU0_
MQF=1/Y];N_A_(()-G_8?MOU$&7U^&,_0T=K/X&]?SHOE+_A(5^U1 \#Z=#H@
MEV22VD);.QMHZCS$SF \8,J7.:W35OVU;8ZKJ<;HX2QGRV16:6\[4C[DPF!W
MUMV^L,]LS!;XQ1BGQKK//XRQR!O+3(1NL\@R"/(0SMLZVKW-/L^T$I$>:=9Y
MLHB9TMX4T6G7F._"M=C?4VTP>Y^W'J)A.R[*64&\\WO&VS>0CREAU%GGBCRM
MM#;PYC)6IP\6)N6R!YMRZ)K)1^*HUI4FG+BL:TZM(GBQM>^-NQX3=>]\-80Q
MNL-JY_)[>DN6739A)+B,C/C'WD3@3X\=[);<XY?9 =IHD,9X5A\\!(K0D?-I
M5%:VO=5@+G<K3H.8^R"?:Y=?9K\B"X \E+R9]F>;%=]9K_=/<9@^@ECT?R^S
M+:'$Y%F.N;[>%OG77$N1ALVWUW:OA;'#:AAE;XG)),VK7)76D\2E+:V_##*;
M]KW:;V^]F/1SIUT3Z$].=N8#;_3S#>X82>/&V,V=N[BY#Y<CE)<\^W;D+NYR
MMU/)))*7&K7TT: $C6O3RG6"GAPGF])LN+R[#VRVGAW?L^);ND!;:M]#O')H
M><:D55B)_%.G)E-+;;;K(\W/]C?EC:T16CV-N(;EP,LL9;&V(L(+>4MH!KQI
MQ6->KEI'&6%W5$UF>/!,30 UH'   ?, JJ* @(" @H"?$Y_H:.Z;\#97YT6*
MHQ!4'[/]K^JH)RZ7_P",SIW_ #ZVC_#^/09X3I?_ (L^G?\ ,7:/\ 8]!/2
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MWGTI6Z.'L\4XMT:T#4 "A^PJB* @(" @H"?$Y_H:.Z;\#97YT6*HQ!4'[/\
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M;UI=L:WF=RBUGOV3N(:T_L?0L9B(BD3HL1KK#S;+YD_9':W3K&3K[L+WKQA
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M9T[_ )];1_A_'H,\)TO_ ,6?3O\ F+M'^ ,>@GI 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$$*@<2/I0K"*5@0J/6%.JWQ@*CUCZ4ZK?&
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M;/WH?].#L(Z#I;>M)T#G96W+1\K@'@D#TJQ]%-8KOM*_[N4G\^-M)_\ S?\
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M\305/S^M!%! ^CY_U0L9^*%AC,?C&_\ .YZ7ZG_D_>Z5T^O)Z%DCVG\$-_\
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M/\2-Y?G=QM_:6/WIONRZ,]>,[8M_E%T\SOL6%K=VT5O')[KGI[EUE-&Z:4@
M/JVFI*LQ$^63K\OL>N^LOG+^7)V]8W/[UZE]RV!M<=;"WCEP>*%OF[N2XFYV
M6L-I!C;FY?<RW3V4 ! !(J0$F)CW0ELTY>:?T+%'SH/.MZR^<!OW#]HW:!M+
M.VW0N"XR9;C<7[U=W_5=V-E?=6V=R5C;R7#L99XRVJ#&Y@-:$T]*LS[R+8CR
MV\%L'>;1W'L'J'A-K[EMF17N!W1AX+NS#VET=R,I")K>0@!P>V2)S#45%$UF
M/83^EFH?+2:9^Q[H#(8S:/.Q\$]FO-I^2L>.:GJ<&T^PIRI;S91-;JW1H]^
M4 'J "K%% 00=P.M-#KZM.*#Y5U'<(>GW4*V,KO$N>GV]7VTY!Y (\%>\Y=^
MQ;R.(.JRNZHFE_"&,39=;U63YKF"DZC3,9U#ZBM>YCN;?F[BSZI/-^7;VKCZ
M0QPX'@L9I6J^'.$F>,V&-[V"(R21R1T$C'&-LC2UQ#:FI<#]A-%T^UEVOADI
MXX?)E[7)"_PFNFWJQ@;^,(>-S7S'AP&H\21KG_("%=.?!)KX+@D&H!XU -5%
M10$! 0$! 0$! 0$! 0$! 00) !)X $GYAJ@M]?B;+J*X\F7NCFB/-%X^RHY
M[V"YQW+8QLH#QY)G,=\O*K6O!:3;-+F(E\1DL3)2(6311LCUD8TRM8T,;[%1
M0AK?LJ4MIJ:5K.L>"=.FTL;^H73D-+6N;OW:)E-15Q_+ME1X_P!"T<3PU366
M,129_A9UOIQ*)M@=/(6S.#+;I_LM]XX-(:]LN"L3#R'@>8U.BRC6.F(K=/#V
M+-+8ZIFET/JK:4%.%!3YJ+$10$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M$S7IONB.,TX2_<#\HOT8V/;_ $3?W?<1@R[7<6V3CC)ALNF*1;,SY[:ZJO\
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M\*WED=!!)9L<2YS6MY:^E..O-E2WDLF?(V[O,;V8>8YT#ZK[SR<UAL3(9_\
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MK7_\*^X/SCNT(X,MMY%'Z+OM@]/_ !3=IZ]6Z?(LI97<55UK9(YKB9Q\)LU
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M]:W3'5,:2]5[1V5MKIWMS%;+V+C;3;&W\1'R6N(L[>*."VC('LQMB:QC>8-
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, @(" @(" @("#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>33
<FILENAME>tm2227887d1-lc_carmno4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2227887d1-lc_carmno4c.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ WP'' P$1  (1 0,1 ?_$ ,T  0 " @,! 0$
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MQ _$<9')1V_HSJ8K3*VA+K[3:D^LO/"+1;I9K^H:T^2KY9 ='#I ![)CIKM
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M*V\HD91[AVATKJ:CT+GW)_#+C'+);*;)BX#["Y$T>R5XJX4H';B[33R46]M
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MS33\*1"?:6U*8F,R$J8>BO,*4EQ*\90I&<XSCPX1:SY"].X],U9)=7H5.O\
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MW)<=-NTQVEIL UJ"'UJ*%M-=;-IF.U*MFDPNO8IH;5Y9K7(@*8A5C79RF0J
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M2V34YZK"ZYL5JZT:K%:95BX?\P5DYHMP-/*FWALME+0_,/$'QQ^-2YJ/&_\
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M;H)_FZT/RY\7WE0/65M': BX1M76-3IZ*=7$^0[8@['MK6.M&0[<+HOVR:9
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M,=2AH:@@@$:X]4.V8KL9%+U^6#EA+U3 ->GV1U"H2ZY84DY!42X>JZ6B$HO
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MA%0#W+_Z@CX8/\/_ ,BO[LJOPBU I_\ *@ZF?K-T$_S=:'Y<^+[RH'K*VCM
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M]IH: [>X+_( [1Q]NN <0;SO_P!MVO)+ X0W;(A,1.7AKMM>VV#V0N!);O\
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MVZ[MV*+UH4H]AM3TJ$]4ZF2>(QVCDO#J&VP+TYWS-OM1WFM\X/FHL<^[QLK
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M8+)S8C),V7UN\L>VH-"/,1H134$=0LMY(*-75G 86S!2];L@@78*[8!9 &?
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M18.5.36E2FLR?)G-E>K<_N)9"\CK/<72>W==G(;6Q.L$=! -*".,.2RG=JJ
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M]SD:Y]3<^/2.\U8I9J>-EDP$G,5(TC,EH2X\['7F013'J387;35E.HU1>/\
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M-8,]E:]E ( <*0FKP_&UK):A 9!0P<ALNF,Q"+$I.4YR-;9@J3+R;?Q"M8C
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MW05<^/*%M!_5UDU?V!B;*H%G2#IK%OFC;=2]55"U[[NI)<^J&=R1;+2R63]
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MW96O9]78W1%-"=FVVI;%L6I1[>C++M M#*D;A:4TC79&M8 9.D)A=ZH0QO\
MODI.42G2*&>C>FM+:VLI _?+EUT)=H;-L"^AG*)KG>#N\F:+L6@5H97]J_;-
IRV2)K.TK-V /:^E G=LG5!@90^MH;(-PW)+6",PBM;X1.$3A$X1?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>34
<FILENAME>tm2227887d1-bc_cyto4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2227887d1-bc_cyto4c.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@!0@+C P$1  (1 0,1 ?_$ 0(  0 # 0$! 0$! 0
M       '" D&!0H$ P(! 0$  04! 0$             !P,$!08( @D!$
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M#Z;9TBRL\^K-4=5\XAG[1-1M$L$#2J@'T;< < < < < < < < < < < < <
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MQ;)@6^X X X X X X X X X X X X X!B3\LVL]J\3U?J#J76TFKV>(RV#[
MZ5J&/YXUG).!V2)9V'KCF[>MW2"B_P!R3JE9K&IS]ABFZX^J5U$F5;_MB8B
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M< < < < < < < < < < < < < < < < < < < < < < < < < < < < < <
M< < < < < < < < < < < < < < < < < < < < < < XV>SVE6>TT6[3U<C
M9.VYD^GI&AV%=,Y92LN;17WM6L01[I(Z9_:S4$^.BY;J>=!42)*&(*J")TP.
MRX X!QMSSVE:&E6V]WKD;9FU0N5;T*N-I5,[AK%W6G/?J=4L:3;SE05DJ[*@
M1VS,J4X-WB22Y !9),Y0.RX X X X X X X X X X X X X X X X X X X
MX X X X X X X X X X X X X X!R\)2:C6IRY66OUR'A9_1)B-L-[EHQB@S
M>V^?AZU"TR,G+"L@4@RLPRJ-:C8LCE;S+!'Q[9OYO2;I%(!U' ' .784FHQ=
MNLE^CZY#L[M<(>KUZTVM!B@2?GH"DKV-U4(.3E/+[MU#UEW<)99BV,;T6RTH
M[43*4[E8QP.HX X X X X X X X X X X X X X X X X X X X X X X X
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M@?L0EHIRZ*Q;2<>X?&CV\L5F@];*NC13M11%K)E;IJ&6&/<K(G(FMX>F<Q!
M!$0'@'H< < < < < < < Y6WWFFY_'QLM>+3 U*,F;53Z-$/K#*,XEK)W+0;
M/%4NCU9@L\52([GK9;9QG'1[4@F6=/'*:291,8 X!7S^73TV*JLBKV;Q5JJ@
M6]G%-[?H!B99/,H5:QWQ5F#QXA[]&M5]HX>KG0]0HM6;E4@F(V<"F!(N;]C<
M"V*=E*QE&S9GHUBA:_6[7*PE+N<#8I-A6K?#1-AK,ZY9Q;YRN2+FH*?8/$%O
M#R&;OVQQ$"KI"<":. . . . . . . . . . . . . . . . . . . . . .
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M5HZ1=)I5YM+)TY^,"I:FBC5T#Z/++G2,D'E#R+E*8?,'B0P%1NO5/^12O;#
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M@6+F3D=-RH1J+I@D]*8Q%RB\9H%\@"8%$P)&X X X X X X X X X X X X
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M:C7:Y,S;N.*#QY],8+MGJP'G_:/Y3?\ $WT _I*]BO\ BG\ ?:/Y3?\ $WT
M_I*]BO\ BG\ ?:/Y3?\ $WT _I*]BO\ BG\ ?:/Y3?\ $WT _I*]BO\ BG\
M?:/Y3?\ $WT _I*]BO\ BG\ ?:/Y3?\ $WT _I*]BO\ BG\ ?:/Y3?\ $WT
M_I*]BO\ BG\ ?:/Y3?\ $WT _I*]BO\ BG\ ?:/Y3?\ $WT _I*]BO\ BG\
M?:/Y3?\ $WT _I*]BO\ BG\ ?:/Y3?\ $WT _I*]BO\ BG\ ?:/Y3?\ $WT
M_I*]BO\ BG\ ?:/Y3?\ $WT _I*]BO\ BG\ ?:/Y3?\ $WT _I*]BO\ BG\
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M+U6!YS3(*PYJ'8;5*&E(7N[U"G?=UE-Y^MX_**C OIER1RS<,SL7KU51R@T
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M:3PEEUEKF59HH=':4),5HE)%(1!PHLD!'!!2,415(6X,F2%_D;?CP_Q.W_\
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MISK'V!;O0E2Z3;"SJ:";7M0V2-#HS8."1QQ**BL>5$ZAU%#&.8#N/LY\IO\
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MW'1VK6^A#WFJZ=!F]BSFMT"F4K-="=YLC!+R;"(6<MQDG#H#-8PR?LR@;P<
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M=N'F)ZG@<"3N . 1_I:15JY&D,5,P!H&3*^"HI@7S(:I35RF 5! OJ%,F D
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MMVZ0F+FI-8XB=O=^O]H^/#Y $K'1:<V(R=A8&,1&O&:TBJR!\R,Z23D@-_.
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MRI8J3&")'J381[T89.65<H12DJ#908\DFLS1<.T8\SOR L9),ZA4_$2E$W@
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MX^)O'Q$"2N . 1JW9*_?#,2(Q+XJ/W:UQD6=%PG]-65^U%J7/$E:>B*OOFQ
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M5:G.'%<::JKLH[SF:,*. >>XEHIF_CHIW)Q[63F/>?2(YP];(/Y3Z>B5P_\
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M*^::3'4Y:LS\_4ZG0M*=W&0JK:N1V2ZQ;+Q&1=1M"[E.#LL@X.BP<K';N@1
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M.#XD/_\ ='_BPW+_ &@-M_\ (#D.?X'YV_\ 9MV_]'D_^&2?_B/EC_W;9_\
MU^'_ .,: ]-64FQQI0LK"S\ Y<Z#H[TD=9H":K$P1J[MLDLU6<PM@8QLLS*X
M1,!R>JB03$$#!^ 0'G:7N5P,[;?=_C8>Y6+V/EQO7ZV[L)6YJMZ;5832DJKB
MJKBN)R?[Y,O#SN>;V1@7K.1C/&QDIVKD+L&U9@G2=N4HNCX.C='P*Y=S93L0
MRW7*T:@OV:99&IGLJ:K&ZO5NOV!]+=EU-/SYO78[:%YZ!G8J!S%MFYY54J\^
M9C33HGDOJ*X2*<&7DKD6&>5EJ7R8(5>Z76%TON.-P1R#NMJ4#3T6<*Y@E=GR
MGNNA&]3*0VA%:$J\/7[/U\FGO^H)5P1M,.1)P]!T=JV51 CGMEBG>'L%K-I@
M4J]V9LFG1Y_DQ@%H9S&I4[J^.(VCTH?JA2<MUU*'BH&O7+<NN+5""D7[.7,[
MC[7)2QYP[11O%G "P&A02NAY!N.:]#_CGT;JM-]@\IQKJA+Z9=LJD>N%>A8N
M[6Z9KUT93.44]%!XM"]>,0F[,_+?6B(LRRKZ-B89^]!PHHS BMQTW[;3ULZ_
M]5+-3,]H-;Q/N#LNT4+3:'@:>R]7J/BN_P#6KL%8(^EQ]3U5E'PAC43>)*:@
MDHQP<H0$9*U]-J9--5H0H$R9=U][09]\;':OKPURR)-9IK.N^L1KT9]#5J$O
M>]WT&J::]A9WJ5F><Y]"Y>KA.J2$["/:^R062?L0D7;.2.ZGVT@HL!$N'=4^
MPT'VJ^-]M:LAND?E?QY;G=\:R*SFCG/T6*Q':NCW?NS2LJ5,K(I6= H$+-X1
MER#U58Q"VJ$>LO B@E*(&J_RQ?V67R6?S .Y']771N 2!\>WZ@O1[^:!UI_0
MQ2N 6_X X X!@#_ZQ3_V_P!_\K+P#_7SJL_J$=UB)(1[6<JU??;'?+7&Q=!R
M:YV^M0]0C\\.]UF4DM=Z$?('7*9A.=1DDY+=9!>MP4>4TI% \E0(!&3L#?S@
M#@&8'RB_O=Z,_P#.?]&?TI< T_X X X!'N8J I6Y(P/6+\ T+7$_7CTCHMTQ
M2U:Z)&9*$/\ A,^C1)[=T?\ 84<I*&#\ AP"*^Z'ZG?;#^;3NWZ+K3RSW'[O
MO^9GY+,/S#]P9WJ=[T<BEVU?D;UK\V=\_BM*\AV/C+NFBYOU*]YJ?DLO5D"J
M)IR01+(M5W"618:96,(S]!['HJLKMZ#AP[]!$'K60.10$1\ROIG15+YP_N"3
M7;^;CW%WB2\7ZM;\W'O(GWGLKC@$8VU0"Z'DR0OXUL*CZY&*R=-CJR$B*=4=
M?B1;@J9@:F:@85%O,)0.F'AXB/@ @2=P!P!P!P"#.T"KA#K1V(6:6&GU)TCA
MFMJMK7H2;-6@UEPG0+ =&PWA*0K-UCU:?"J #F3*O#2R)F22@'9.B^*"@&=7
MPDT^,S_JG?*8RIZ.?2,%OMD)8J2X=6 UGK\M)9EDDVT+=(FV="_CNL]:FIJM
MR<?)LV+VD2!P@GL>NE,KMUT6$:!</;.B77KL'<EK]IC+2GUI38F;5]_ ;5K=
M02HT@Z:PL7,67/8^KW*)CZ/:K)7ZZRBY)_&I-UGL8FJV4$4WCX'($9T[XK.D
M5#DZV_K66S39G5%HUM#U9]INF35(+3ZY*5BQ4?+']+F;8_K4MD.9VZF1LS5Z
MRZ;*Q%=DVYE6"" .')%@.%^%R/CXCXX</B8EBSC(N,N?9N/C8V/;(LH^/CV7
M:[<&S-BQ9MB)-VC-HW2*FDDF4I$R% I0   . :E\ < C&651#9J$@:1:I.%,
MQUQ5*(.S\[U\BC:L3(O(MY#T# V:Q9UTTED?5)ZYWB1O*?T?$@$G< < CO4!
M*6M1@G>LX\/O$R$ 7?$5.BH8VLTHI&1 1,4X/),X@V;B(^0KA4@F 2@("!(G
M ' /+G#J)PLP=(_IJDBY Z:GMRO/34*T6$A_:&(H5UY#  ^F)3 ?^Y\!\> <
M[FASJ9Q0%%'2+XZE)JISO6[46+=X<\$P,9T@R,4HLT7 CYRI" "F40+X?@X!
M4'Y%_P @U8_/[@GZ283FZ<A??S]5O^BD4+_B+Y2[YG+;O[Y8W_.IZ<?UK\8Y
M),OJF7^'YGV6\4KG0OEQ\I'T'<@(O!P!P#!SX@D'+':>Z*LPY9O9^\6AKI"M
MO;%ND4TVJ&F--V"&CM=K\-.=<\2JS^ON).#?Q9'\7(38J&9^KY$6+J.<O@+R
M6#XN^CUKM%HN=GR"<L-CNGU)*T/YK:][DTIB.>-Y9&(K[B.>:@M%IU//'$\]
M>TN'31)%T24=JOZZWBWRAG @5SSS'LXQ3Y>J/4<UK2<#%$^,357+QV[DYFRV
M>P24AW!SN<DYRXW>U2,W<[O9):;FGCUY)S#]](.W;M9998ZBAS"!L7P!P",=
ML315QG7$G*<*JW5S&^IKI61S[*NJHGJLL55.?> Y9"TA3D$0=*^LCZ: F-YR
M^'F "3N . . 1_FGX*Y)?N>/;?\ G UG]KC'?O6QO'5+D/N%%O,?R2#O_/7:
M/C^YW1U$O /)X !QO9_]6KL/^8W6OX@V#FI\_>PN]?A.9]GN&W^[WV^V/\8P
M_M-LREO/[R;A_!:P?X)=\^;$O%?<.\L3ZU:\Y'OHU<R\Z1K38R%;0*:I,[QW
MU'3)=0U@<D-'6H4DYYN98Y$6K<?-[(Y2$!0#J@/F$GX/J1M_U"QYF'DH^=>Y
M?>-_ST_*9.'+LLAP!P!P#)#YG$['(=6*56JL68G)6W[W2X$N90]P:YXIL2)*
MAH<X>A/+])7_ ":&J+-B>%+8_</;3 H.%H!-H"SA5RE'O +U]2+(RN75/K);
MXV4<3<=:NO>,62/FG<A:)9U+LIS.*W)M91S*7AR]NDDX?H.BJG<3"RLHL8XG
M=',N*AA AQ?XU^E#N6?3KK%$W4O)*.%'K]SH.JKN%O+ 2]7K:?F5O)P2;YA7
MK _:49(@%2H"+U<*V6*]4XF J;WNZ<];,-Z;;W;LPS!C7K"XB<CB!D'<_;K-
MZ!&>JY"P=R[!I;+!.L8VVVA&K19[!.-TDIFRKQK1>6=/5FR*A -F> . . 1?
MFK$K)[J"@1:D8+_4)A\8RKY-\:3,: K#;ZH D.H9JFX*V I$#F$R9$P#P*7P
M(4"4. 5*LU=D"=P<M]"^Z6V@K)D6UWJ7I;:\S:-(<V#.;1UKJE94"LE7^GI,
MB1E\E#.6Y"@B[<N?65*90I!"TE%_3(>%+2X2=*NE4X)</ULPEZU+]^V:7;RM
MSL79N&MZ-5N5B,?!Z*4G*JZ&W5\3I]0M[C,)G3]-;U$EA5K.)1,B@0LM[!><
M<1%DMKE.N +>(EWS @F>@?W!$'7G%7R@B)B!YK3?MSELNS9.ZPM]=/'M2FH5
M<=;2X1U*,VJ]M1D_@9NG+NTQWW?,79YW>HADWHP=S2I:%)\9:7*"=.FCG%=N
M2Z2A,YWHO-%L5VUM[B5+D"R^:5"+^SD=N3Y9<C;.T]%NSB2:S7W.##O6<@GH
M7I@OYTV!&<>:23<KQ[Z*</X3RO>=N>V9>3OUW;<::N85J/5QS9-TQ_I%YR4_
MHFAJ77TU54%"V[RG*U=L3NSWB>Z?:=VPL7ERUNN5!V\Z]/K)8,4JY+QK"BX?
M3=<7%X]=-'<<[BL.W"]:R(6?PV?\H^O?G8O/^%C<YM]Z/\0MW]<EWHDN\C>Q
M6T^H6_VD\=96IG ,UBQ:<@#'MC,NCNSNDFYH,I^H!&(2B*2B2AWRBQW@,A23
M%,X$>&4\PE3,4W3WY>/8.Y^(W?1V3GOW\^UF)^&6_M&2:-<G8A(QW[6_KDV[
M^;+U\_2GVKY+7)_LTO7K_HL8M9?/OY$>_(_?TZ_6VE_YN<Y^DRG<I\Z?<%KU
MQ>CD+?S_ /8_:C7GD4ET. . . 4 ^.S\G78W^?\ ]]_ZTVE\ O\ \ < < <
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M!H!P!P#Q8VRUR9<+-(>?A95TW(*B[:-E6+YP@F4X)F.LBU7543(50P%$3
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MB=L_;,8QO3TI+P8]^1KSR+"Z' ' ' ' ,P/AM_L\,=_A_P!I/ZVFY\ T_P"
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MJG5D\+94ZN\L=?CINK/="M$C9_:2UQC'2:S@Z[! 8:LSZZ::)Z]/JL.R]NY
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MR'-Z/E]:?V%PR=S[Z H%8BZI#/)QU&Q\3'.9AS'1*9W*C=JV1.L8PD23*($
M"2. . . 8 _^L4_]O]_\K+P#?[@#@#@&8'RB_O=Z,_\ .?\ 1G]*7 -/^ .
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M_E]_\"KY /Z./^S+@#^7W_P*OD _HX_[,N /Y??_  *OD _HX_[,N /Y??\
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MLUTN3[3I^7Z+[K7I6B0TK$6^V,)>JUQ#Y$9Q&_.I#0#Q\0:/7?PH,HU\J_\
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M5"CXE,4PE$/V!X!^@3D Y4Q,4#F*8Y2"8/.8A!(4YBE\?$2D%0H"/[ "8/\
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M!9ED2BJ)+@\B_?GQ:U.LGQ;I2-$NBO\ D'RNM:J_7RWNOU.GKN1U"EBXN_\
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MCE%S)QBJ*J IHJ%.3@%V. . . . . . . . . . . . . . . . . . . .
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MD?"PD+'LHF&AHEDVCHJ)BHYLFSCXR,CV::+1A'L&B)$D44B$323(!2@!0 .
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M&_D8^*:*OY1\SC6*'I^N]?N46;1'U52(I>JY<'313]190I"^)@\3&  _"(<
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M9]3N3$>MG6<4V^?YHZ(DAC%!"?(=Y8]9144DSFK0-30ZA6)08@014!8COS@
M"3Q D#^2;U8_WM'7_P#VFLZ_\G. 1SITATOZ/U]MM=MSG/<ACS2S>G-K?F^
MOIRRE?SS5\X3C"M<>S^P6Y)B^:Q:OJJB@#0/(!5#@)B 8"@N_P#RH=#-3AXV
MAPG9#8<Z4M$;>X%QI%%ZV]O871J#]6I4LR86F@S".#+H1]BC)51 Z9G!1;B
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M-J.F6O2,3D].UNMI1E1@7<?H&KV+,8.4F%!6/&MG[$31+.,3<.DEP/H^X X
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MSTC8T4D6<)HUJA8^*.0V@@(NH)@P28KF_8.NW.8/P#P#MO\ );]$_P#$9_\
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MQMVK3^KSJ20B( H+5V"C*5C7  "C.3C7#Z'DVQB.6+MTU426.!)W ,P/F?\
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MSN4A6DT=HB:5;0\D_CHA](Q:#X5"-UUFC559("G.BF81(4#U. . 4\[5]F]
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M1,A1!VKG-:ERJJN=9I3="+!H>*4!)2<75*R(Z\/%B=P#D!**0& "1/NFRO\
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M,?J.A:=TIU:.91:VU9/TGH"4#&T.E=DGL)$PUITJ6E'21F+I\Z?R+I!/@'T
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MV.%-08AXT. "L_'R'*/KE\?;-P)$_DS?)_\ \J10/_=]Y_\ [N7 '\F;Y/\
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MAL=#0]T\)ZF9ZRK[(B7C'N/1M.+$]TY6\X>F\9^OY$"^4?.1=8?$/+^$"3.
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M])]M?"6T[>FD5.NFN),_M09PG!=+_I1&H3IVWOC;; G1^RBE6A+=;4[ 9T!
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MU3OL34GD+)=0Y_37V>RKV\?)S8B3,-6%;4K*.IB+Z\NX<]D!%BQF8A%,8F(
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M[E]PHF"'XR?[J$GXP_W)NR/<1_#;$\_D>GF<N>^WV^O>JXOH(%_N3"1(. .
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MI^GZA<QR=\Q?^7'O,R'+?WAE^9L>5D&H/-S-P,_>Y?Y0,6_@=LW^&L6YR_\
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M X!'^EIJ*UR-*FT>/3!H&3*"BQ.5-8B:.J4U55V<QC$ 6<>D05W!?'Q,W3.
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MW*Z:X&)Z7G+F.3OF+_RX]YF0Y;^\,OS-CRL@U%YN9N!G[W+_ "@8M_ [9O\
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M2TV-_+6BV6*9F)-R]?R<H\>2#]ZY6<.%E%E5#F PP1_%"2]7]K1++V0PBO\
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M-:^2W;.D:KUKV2G35[83&JV3KYK\PC!Q&+:[ET6S28XRE8)R$(XORD_'RDC
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M:&4@;'5XZ4BGEBF(F-3""JD@^-;;].,HE\^L#EG&,3-&%9KDU(R#YDFS1*[
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MX!I_P!P!P",Z&U]O:=I6^G)LO?:9%.O<DEOJ)I?R8YDS'ZBLS\YOH*B7L_:
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MI@Y2Z6DDHQ;;;X),X&I=_.N5ML+BODG+%7_2\2MYJRUIY'P,DJ9>KI-DF#]
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M4I]4%FPI0JA/$'1O43\J F'S%_9#/<G_ %^[YE>4B(?S+^QVW?B<O02*D]]
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M$0_#P#^D).0MEB(VP5R8B[! S+-"1B)N$D&DK$2L>Z("K9]&R3!9=F^9N$S
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M.;:YK\I=U>WBMY];H_/G.I]>,+7K;JRNIW0-&B5='L[>NR]J7A'NBWY\YEI
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MQ2Z=C\*N>1C=DUC^]'R.LVT=[SV"#?=,Q32:!(1M7B'@()EPGRIE7C*7%("
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M[OLLU!1%GGJS*-W>+[S/9M<EI6 ED)&/8@_SNX0,A88UXHF)#QCWW;%1;TG
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M;(&9M9)PQ CYS<_C!1GFL"S^,#(;&3[99;4WUIIG4K$[MG[EKIB(HGN%,O\
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M8V48J.F+IFZ$#:C@#@#@#@#@#@#@#@&=[C\C=4_L[_R@?]4?D;_*[-?O4_\
MS@?_ -W^YX!HAP"N^V?OQP[]7?\ ?Q(_EL_?C_>)Q^0[_P ./_KG_K'S\ Y?
M_J;_ /U/_O?_ /PW]]?\'_\ XUP"+T_WC6[^S_\ WX5W_._WC?Z4LO[[O_##
M_L=_^Q]YP"V&Q_O!>_DO_?!1/RQ_O!_?Y6O]._\ A!_V"_\ L][/@%+[U^]7
M_P!6_P#O?U+]_7[U?[W47_\ I_\ [Z?^MOIG +$1_P"^R)_5G_TQ6_[W_OL_
M?7</[T_]<?\ 8W_[*_4. =QBG[U9#\C_ .^!U^13]ZO][HK^^'_A!_\ 3?\
MK;T. <OK/[_Z/^KO^\?7?RL_O_\ WN-/WC_^ _\ WW?_ &.]/@$+[%^_'1?U
M#_\ ^<_EB_?C^26I_E%__'?_  2]AP"T&1?O6D_R7_E U#\D7[UORBV?^^?_
M .<#_OH_\(O>\ E#@#@#@#@#@#@#@#@#@#@#@#@#@#@#@#@#@#@#@#@#@#@#
M@#@#@#@#@#@#@#@#@#@#@#@#@#@#@#@#@#@#@#@#@#@#@#@#@#@#@#@#@#@#
F@#@#@#@#@#@#@#@#@#@#@#@#@#@#@#@#@#@#@#@#@#@#@#@'_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>35
<FILENAME>tm2227887d1-lc_polar4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2227887d1-lc_polar4c.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ K '' P$1  (1 0,1 ?_$ .L  0 !!0$! 0$
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M/#C[_P!'3M2JA\TI\*W^HVG\AHE4YI3X5O\ 4;3^0T2JK%<J<LJ/1;_)V_\
MLC7WJ;GWG4\/>:)54>:4^%;_ %&T_D-$JL"Y/6.IG38N4Q4@#W3EU'TC=!,W
M_1-O _5)ID-P]]QU2[@I'%7[O,L9E*55L3,U %UERSH,K$B4HK"3%U/ZBS9
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MJ*DW"O@@32\L:(L9THT)"8>M714I-FU5AESF9M0 _6*I#&F4377!1NH842+
M5&.J[RENG5DD.RG(9XB4"M!4(^Z;1KMVP$VCWW7M^"90E&"2;D$Q].CUO5G]
M,4=7&\%0>*RQU+;Z+_B%/@ZE0I#M)MS"G%WP\I?)U"@_J2^_T11^I;?1?\0I
M\'1$ZEM]%_Q"GP=$559)MTP^:_WI#]X4]A3]_HBI=2V^B_XA3X.B*BNQCG21
MD'2B+E$_D.BNS%9(X?KDU ,0W_B&J7L9(VR0!S3V$5'RIPX%0750I_%#ZS0)
M?F5O_P#P6?E]('E\C?WNL+W7MAU.- 3_ /;9]"KYD@X./G*IHUBK-C]:WCH9
MNH'#@HC"MDCAP]#TY$2F\FKK,'"B-8X8FGP,:/F"@O>>+CYRO7!%J   .P
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ME9-5$V_-+I)KNNJZY0A3G, >G;M+A9F;-)APB/ D<;8S0T:>PC4:\::@5H-
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M3H>%* =M!W$^%?@+*#Y05.(#Y0$#F^#J_0=RRE7455ZIOZXIZE3]6;V0WO\
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M1DZ3BWLDP7E8YG(G04*R=/XMK)0SF29-W(E.JW3>-#K$ 2%62$0.6IA8'@R
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M[1^'5[]=?K_=^CI]F[73AJL/7-YG4^X#S> 6"NXF;,5L[6I6YJ0]SN#UW'W
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MRZC7[97%*=*4"A'I5'LATV9K\E4\GR(/7[(+Y'&R57[S'09'D?(,"1/9YES
M\:JR+!T4+;S12M&XL[IODC=LZ9HF6<-\NP2S<@$,<#KH[7MOBB1.  /'I*%
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MT'[M!J)Q01<O4(UL190I0.H1NF!A$"%X:#'DD/5&9"7.,3<##(;4T!=-G!Q
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MC7-9Z0%1SJQ7!I=ZHKMMJZGZCZ:YIZ>EY,F0VR1P#*AM"*M+FN<QPJ1=&6O
M<X T)6B6VO9+YPS#TQ'MKU4=AZQ)&YU":/D.BOLVWNPUXK.3QZ\LJTK!S2^W
MN$<PL&ZI(SM714;6APVG4FS5RGRZBLFVKP/AW\ >G6/EZ5P-SBGYTD])GM].
M1SS+&+[LEQ:V01^@XL8T1ME9]ZQH=N]^^)GQ$ZFM9O6<'PC'$-K6AK0RPQN-
MH:T![V.>'O'I.:]\9/+<6KI.TV+T!V>-[Z9'S%;&$6C')LZ[$VYKB6OLSQ3>
MEMX\&RV%(?'=S<-&1<=0G5(R$T_#ZWEZP5!5<"MG^]8XOZGB8L;OM%KIC3PB
M=TD=?"(V^"BXGED^LYQ'F^:A^57:EL;VDA(QLT\P11YVP0[;E8VS6ML^N%J;
M)@U.S*H%HM+Z8L"CI- X@1<[DRQ#<#E.!P P6Y=[W:6,P'(D;C'_ #;#RX_)
M&RU@\C5(BC!K07=YU/G.JU4S-M-V^QVZO$;VW8^899B=TV1+E#3U(RFG&VVC
MXYEJ9@6[W?OGC"*=12<I"6:<E:(V.L+M^^9L7:[E]&H,7[E=RITFU[QN1Z<R
M(,.5V*<"(/:^%SXY)>;.UCF2N:[TF@2NI0-)HT.+FM:!9DC9SFEP#KS2AH0*
M"M1YET +@S$Z:;M%"F1[9L]9O(]=FS<R;-B#*0'))GC=LQ:OD6;)-;Q>L0#U
M)$^ 20@' $6X(\0YSGN+WDEQ-23J23VE97#0<%,4PYC155VL>J,^M>N'KIR<
MKJ23,=>0=VE^Z4+U;TO5=)Y=910@$Z)4C/#= "\"=&$63-$31$T1-$7-[<%.
M-D=WV*Z&ZK3=XTR CM^FG%RF\/R=BC:;+XARSDJVU=*MWV$C9%8]HMQI:0B5
M22)V3"J-W:;XC@32BK=<H[5TAT4K2:L_;;W2_?KJ_P"+-MXU<;P5L\5=79KQ
MB!@B7"'+<1,G&ODSB@@(CQ%)DZ0,"K1OQ$1!,R:Q2>0I (0 *',YW344TAEQ
M'\MQ-;2*MKX*4+?%J.X +(CR2T4<*A49V"7L'6,)MG!&8@JDL"2K4DX?KB$$
M 60+)LT6;5PF!Q AS(K"'$?(&M<>C8LJD>Y&.3'!!ML#JD=OIB@([#0GQ*Y[
M8YNL=0[QKW&S9%FW2;-R=6BB7HD+Q$PCY1$QSG,(G454,(F.8PB8YA$1$1$1
MUVD,4<$388@&QM% / L,DN-3Q4C5Q0JJWJP^5(>T)Z*2J6BA-$4IWZI#Z4;^
MUAH$471$T15#^I1^5C[:KHBIZ(FB*6O\[,OV"_MY]$431$T12#?.J/TPY]K:
M:(H^B)HBF#_1Q?IU3VA/3M10]$6,LJ2"<+6SSSM)TM'0A7LB]39I*.''1;,'
M"I!2;$X NLH"9DDBB("994A0],8-;SIYT8W -?2]S2&U[]/-I7]"L/.#N14<
M :GQ+1K;-VI*#D2;E'SA4'$RR9F9JN7,DD_ZY!U)H3D@_.)(X\VY8OB(N$$4
M@.D"8&,=1!1KT?4][8('PXACC:]D6I;K=6@UT':"=:G6O:N8P'<P/F#G%KGZ
M ]GBU/>/,MSJ]9CPSI!D[<@>,6\@I+*\5(\@&*3FVXG,)BL$3J$*L0>":1!
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M?#XC>W1K,1T)E>1L[;&[FDM,@RU 1O>W)*VQU,6R*BI3C3P,5P<)IO#(@N1
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MY3>M6SQ$K@B+MNBY2([:.F#HB:Z952%<L7R+9\R<%*< .BLFFJF;B4Y2F 0
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MZ503(LMZ(FB)HB:(HKTCQ1JL2/<MVCPQ0!!RZ:'?-TC=(HF%1HF[8G6 2 (
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M+@1H!<2 WZ@ ;V*,TS'*D.0VR:[5M*4/=18 B]LFVS&UE)=(G,4?35K(U9U
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M1]<.MTU3172'N!.U:%R?]&>*#CPR[#\:/!GQ!\0*KVIW([%_Y,=D^)W9W/\
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DV%UWBIZY_P 1=N<YV?Z;G./.^N=3J$72O12FB)HB:(FB+__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>36
<FILENAME>tm2227887d4-lc_persis4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2227887d4-lc_persis4c.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@"! .0 P$1  (1 0,1 ?_$ 14  0 !!0 # 0$
M       )!08'" H#! L" 0$!  $% 0$!              $" P0&" 4'"1
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M@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# &
M, 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# / 9P0H\&Y .>/+^]Y_
MAQX-H=%M/R#I,1$  ?3CX^G//P .>/C_ '!RGBJJQQ3Z!ALWCZDO/'B;D1$/
ML^ ?;^C'%MP=%ZO6'EJ?H%R^@"42CSQZ\#Z_'XAZ?#'&L>A>JH5:8[3^"Y*
M<^(CZ"/Q#GTY^SG[1#C)4HO8QNXG[D\J9P4(4X ( ;X (<#\>/4/L^&20G55
M6P_>"1@# & , 8 P!@'Y.8"%$P_9Q]H!\1  ]1] ]1R&TMO2#P?4D^P.?7C^
M47D/3G[1]/\ Y^4N>#<56A-/&?P79/("@ B80YXY#T ! !$?X -SE5:;:T\'
ML$/JIOW]'JJ =D$1#Q,''Z>.1]>!^[_*  $0#G](Y'&D^I_-)X72I^OJ"^/D
M)3 ''/J' _;]@_P8<FI.-'@*>,\@*E$.?LX$>>0^S^/)KA7=0BC/"#L@A\!
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M & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
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MJ5K.PLV\O:LYF]<L54(WKSOR3BU)JXXP\Y-M*+HU+2WW#J<GD?\ K)HY?(1
M>;3"^/( 7D"A]7\/T^OQS8UFLLGPN[!O]$L/$SK+[[>5:8:CD5'Z];]CSMGS
M3VOZYM3_ -I=$_RHA?Z;E7QK+?KD/TR]L??;RK_.61_;K?TQ_!W)JP1 ";(H
MIA./B0 M,*(F']10>^0CSZ 'VY0\YEDZ<</&O*5+FOE>3HM2R-7^S6_IO;,E
M(JD62363,4Y%2%4(<@@)3D,')3%$.0$I@'D!^T,R5BJGO1DI)2CC%GDR21@#
M & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
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M;*NPMWX.W*5IRE!32?SKG"<?#%FV>9AJXP!@# & , 8 P!@# & , 8 P!@#
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M^4@8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
MP!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
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M$1\2%Y$>>,.K=7N#VUVESX(& , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
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M2?W;>D:\M?72WA(U1(;A1K$Z&*M0D1 [Q&QP[4Z35=4O\Z<C,8TY3E,!PX.
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M>IC?>$PCSQ\,^$<W4>DJFSM8^4X]]."J[J-/_I%E:_M68.SCWJF_S]>],B<
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M5AT^0W;Z((U_5?0SJ'K2:H[=:O;2U?6VTJQ^M<Q3EM"3T<W6=O"KM%&KL5%
M/Y&,4Y#_ !X'D<FQF;V5S<<UEW2_;E6+HG1KJ>#]<N0\U*CVT\9H7^\VZT@9
M3IS"7=HU32D:'N;718M4 $5#HR*8PJK=-P<QU5"*IF /4?42_;E-J3E)\;\^
M3;;]E^R6K\:XK8B0[VH-=PL?[<V@Z%L&)(^1M&LE$IZ)?^295FC]PLH9LJ0#
M)+@0Y X-X"4Q0RNUF,QDLS#-963A?@^)-8T>YI--5]3+ENG#6OG;*FKOO2:1
MD]M=*NS4-5ZZHZ1I.NI:R-(F-:\"4(&/%1)0$P#YJBC5LF8>1Y$ #GXY;5QS
MNNY<\ZY)U;>VKVLHE%[%T,UK]@S1K>6]NYRS1/,0@7E=VTLDQ7Y%6$MB+5]7
MSM72T9+HD%=J]3^:/@8 -X_P#F5ELY+(ZC:SD(6[D[,U-1G%2A*CP4HO!KJ*
M8+BMNFQJB*[[U5!C4?;[W#68:/?RK+7E/I:K1^^\W\N+>LS$"U1DY1^)"G6=
MB@(_/6, "*AA,/ ?",SFGG,_=SDHQA.[<E-QBJ13DZM16Y="(<:05:\5*>(X
M2FB O'\6W(G\U9P_CT4RC_($RKM @";CT%,0/QQ]O..GP%NM=A](+HA6UJAI
M+7+1-D2(6+5Z>HJJ@V2]4FD8V%RS*DH0020<EY 1+XFY,(@/KF,IQC/B<5)T
M:7554+T53![#GT_>B=2,'E^ZQ65C''!:U.8>KG$@',+EO,W.+ K(P#Y&-_.J
M&\ $./(?3*[#\UTW$7(M-5VG93U4UZEKRB5.DEB21[6 I<+#*L@*1(4$F+%L
MDEPW  ^60Q0#R+\?+]7&8[K)\3JGPTVLNQIBMK53G6_>@-/-$-'ZDVA$QYF;
M./V6YBC*(-TV[<IGL,NF0012X !.MSQR')N<NV7Q-M[64YA454^HD&]CO2R^
ME.E>@D+! _ALM9:L6POA?M#)+"WF4EG:;@G(<HE70X.03!Z>?Z<BXZR;$(M4
M70CP^^-08W9'2_?S4*X18L+JV4FT5"H"LH@K%(IOFSX3>(B0Q!1 >>0, !SD
M6W257L>!-Q<55O.6?V*U16WWKY8?BK,;,5$?CR)]:2(^7(?$#?'.GN6/[-7,
MO\+E[VP<E]XCKW^:6O\ E_,^\S1;>D-+);O]S;6,7($1_+]!KK[:=A%?Q%%1
MG49-\NU0,F;T4,N_72#C] #Z9Q_R@Z:2VMBO/R1/#]!ZC[J,[%_S]FDOVNP=
MEVEI-G.L'4@R<*(,#NS"Q1*< (1%FB;P5'Q^ZH0WS \1^'\.;!/'8=G)T6)S
M,>]I19+=/8#K77J.Q/)3&Q>QNK*(Q_#4$W+M-Z;ZIR].+82' "MF[<ZIO(OB
M0$QY'TS(MNB;*)1K)0ZSLST+3/ZKH29B$#-W:,;#-HHC@GRBBJ9HB5(HF52^
M[R<_ "7_ 'PYC.7$JNM:88^KJ\1D0XJN7SIQQ?O1VJA8;6ZPW!K&"W3V!1]@
M0!90J0$0<*$E(==))PL3E,%T0?F-XF-SX\CF39Q5%NH8UVJ]=LZX^JNGXRJ:
M.Z_Z]AG[N')0M2:V6DE(9<C<)(S:NQ@BU6^3QXD='2]?(1 Q1S'=>)U;K4R$
ML$MVQ51J1[VNI0W5T&[3UL$/KIN"I:=EB6I2%,IY1;Q)TE]U4.!/],B/!@_O
M@R;58RXM[%Q)UB]E'_<-*/W:[4L31?:_AK?:&YD9'=6X]I3,>1+R(\_"T+0\
MKK,X'1_G@26&$,;D0]"Y7==;CKL5"W;34.MDX':K7,->>M^P]=+?+69SFL[C
M$QK-T!#KR"Q*\]$B0F,4HF%(1 W@;DP\<_9EKYY/=5>4NRIPKIWG%Q^[WZ?=
MTSL?V5V-9&B$:TA*B[H$&N[X 5Y)*RMD7R2 \B;Q041\!$O( (9DWN%QQV=!
MC6EBXG5%N6)/^7&D8_5;A^)_3L"D7*4/$SLJQB-S**<"IR)_ASX>)OTY8A6+
MHFTJ+#P)+J_,V%7NE6*P;.%D^II#2/N/[MUT_9*,/PBQR,@P15*!1/&3\G'2
M[)4I2_=^6<CL?'CTXSPN;'72$WM=V!QCZ<6'=3IZ_P"8LK\%F#KZ]X]O]32>
MFB8ASQ%6XW_TM4I8?[>?"/24N=GW;9=K]VV/>7#]KO\ QW7.P[T>/_EZ2]G+
MGE]D&FL5K1V-L2C^QH/(0^JFS:.9V:=8UUX1\RO?S%IFLLWZ$%-NT/E\(+.D
M%5&X"()B4!'*?1<O.]R!FY/^=)_ V3W_ /R%7>U[W-)>&'+L%_KF;]LZ*LZ3
M."Q@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
M & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
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M5_+R[I-$QQ0C$$R*) H( 0PF\0$?7+EF-&VU0HNR4H;52K)E-$;=HLW0=+#
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MVW=YGGNCJ]Q?Y"P>_P"GM>[;O7TN3_F""_UK-,GHSJ4X>& , 8 P!@# & ,
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M & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
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M.OQS'=/J=Q.K^^"[_LN4/;]+F]VO>%D)8X:/%?ZQF";7.V3E48 P!@# & ,
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M/G&Q&N6+RPW#\0<R*C.(F*XP:H)J(1B1U+6 *A+2LLZ*HA&UZ-5,)%'(%/\
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MQ2\4MY3'2,S,Q)IED1BU>.7)GK<S$@B90H@!3>F 2+X P!@# & , 8 P!@#
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M,M=AV!7]>E>R,N\+1X:V?5MHD%7;I4&":7DLH;DY@.M; & , 8 P!@# & ,
M8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@
M# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# (!_P!X8#GJAKP
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M\,W0,8I0#X%'].4RI%["G:C7N9E+<Q=/&R-MG5OD-+!R#AQR9 \81N*:@$X
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M7GIQSR #QG!W_D=K^3GEDOY\R7O+IWGW?7.R66E^\X^\B7STU<_6[AW\<>#
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ME(]1NW00.T=$$B9"\% #8' & , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
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ML;%8ZCI?9O4.X3&T-3]@INT7^!UQ+;GW YV5)-CR3I:%KH*UV-3B?FF*NJY
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MLU9VITIOYM V&MW^ D8RRUREM5&3&9;.E8F46;)K+1GDU<.4FOS_ *90#'$
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M<?9^=Q_H94\=*>R75G\N\PLK2XK[5:=G<I3IXN'@INKQ4,I9=,P8 P!@# &
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ML5E&K@YU 35*)#E$0'X9C2@G@9"JEAM,!]Q^V&]=P[:VFC:K&;B+L"4)3DO
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MQBYD^Q[22MUEP.Y"[&5R,FU#B5)2?!Q1FVZ)M<.,91LV4W88 P!@# & , 8
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MX2F2E*G"Z&*D'8>0'\@*4$TP$>!^\?P #C^GCR]0]/MS!)QV%5AG9C2T07Q
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MU*W)533JFGL::VH]_)*A@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
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MU#/7$B^(],A8:T8&.MU]I"/U4AXN(MN9)%:";B,: FGT3J& Q# 1#^;-PJ(
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MW6V/+[%]JMO[;G62+ZML8Z%0FZCJY6Z7'>_];+=S)JI['I%=JLFM5Y'7[AL
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M & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
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MIA]J[;M?-::0_GXE6"EG\$:0?1S9\[AW"BCJ.^M,P,JFDMXK%2.7YA"'\B%
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MZVG<P6=2N0C:LWX0N<5'<CP>Y56J-UKNX55X-[(MJ67/%/?& , 8 P!@# &
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M9)H]:U=A>CQ6W6/293S#+@P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
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MNG^R>S6;>P,K%1+;(WZP5:92CWL8[%&4D#.7L6_C7)2I-9."6("2A4Q.D<1
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MRS?Y*_)W8J5K$'<F&O/PW8=2E[#\^MV1PTA9+\VU5@^@B_.4+\D\F"I.5"%
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MP!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
M& , 8 P!@# & , @)_>%O^:CKK_X++,/[L+(?[F=*^C'^%>I?<JZ<U^E"Z<C
MY'[LY7WQ\X2(BWDO<(V*CDE59.4M3"-CBI"8%0>O9M%!J*0D$3%.58X#R'J
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M_7RTD[LFI\;DJO9@U1;MG@?03K9\A,X8 P!@# & , 8 P!@# & , 8 P!@#
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M*^^.$_V[M<06W>]FC:/8)E.%CW5[/*)JKK$11?R4*=1_'0XJ'*<"A).D2D,
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M*"Q4D^SU-BH2$K&Z'!7;U+\YP\76U5X1HU=)D*EXMSG()T1,(B81' -LL 8
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M,M:MR7Z:,O!LJSV\I^H*7T4I/QR;)"\TXR1@# & , 8 P!@# & , 8 P!@#
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M=--OW=SH?M&H1%1#>SCNE6)MK;67TAKRYV_(=K+I&7) \DF 3CN1(FQ2;*I
M?[K9%$/Y'CE*>)+P.\. ^8:(BCK 'SAC&?SQX,!@<"V1%;GR]1$3?$?MXRT5
ME:P" G]X7Y'JAKL ^W;3'_K+(9TKZ,?X5ZE]RKIS9Z4/X#Y#[M97WQ\]'3^W
MIC2%^8W.$KM8FY&&N$;9$%I5LN$RR6@I'ZM%6"EVZR:\2\*JD4Q#E*8HF]#
M8HB4>?\ -+BS%Q;NTEY6??LM^H6WOX(^0Z2NM/O326U]ON*P_H4=5):TRT>-
M0E?F?-3=*HI(KO(Z<14>&3:NG)DE/%<GBD;Q#DH#\<.5M/#>V9$9\*KC@: >
MYW[I=V[EVXU&KE;09:KI5H:6&OMGR1%6,K:H1NE&J.Y2NN5#MG\>Z49B!4SC
MXG*/(@'.51BDZ]!#E6/"MA7.CGN-=C&EPH.M;1*1CRBQ\3*"U@X6.6A%8<U?
M;2%G9JM2-G9DDDB+(&2,D!"I%1.(% ! !R';C3#94*4L'O2P-9^X/?O>7>>0
M4K.Z+1&UG7KZ?8SR*M:@I.3EZ_\ A*HJ1*\47\1_GY! A"D\C!ZCZ^G&5123
M<A+&-*XDV?6O]X)J]"U]J>AW2N26Q)VKMV.OI:]3M4?1,F-;;LTVK.U*$+(O
M(]],,S-$BNB$\?G>/D4"FYYMRM[6L7N]5?50N=JNO85;NK[ULY76NRNO#*N2
M$78[=16](GMD4R,9/'L>2_(?4+A 1:[]NDHZ4@)-NF58I_18YONB(<9+M0XG
M*%>%XJI0IUZ4:Q]4O<E<>W+6:/IVT5MM?Y&O6!PW>M7CE<TZAK:2BVZ\?8)M
MD57Z2*M2D@L9-6,7,H)T2^0"7R+DRCQ-2V4(3X?$9*[U^\ON^HSI=?:TC:_]
M;*TU"7E+-)-'95RL[[!E?P36-0;.D ;!$1[TOF)Q$!4]/AB-I5Q*G-T(?NFO
M;J.U!M*&FMJM'ZT6K,OG+R3KZ#0K%A^+2)Y!XNG$E$A#LS.U3"LD ^1O(3%'
M*I13QW(HBZ>,F+[<^Y9K+5=VJ!BUG\QV)ZR8VE)Q5D5F$5$UB90-(5V852%4
MAI.2!%0#BT*H0H%,8>/( #*%%U5=A7)IUQ]2(%'/96]5OL.[[5QETH^S;Q8;
MFG9Q?+-IN$G*^\8+$7;,6S,ZJ,C#L?H5/IN"G<-UD@,0P#QERBIP[BBKKQ5Q
M)+.FWNJ;^LV[AJVPY=:6@[I9I*<@_D.ERO:G*L6[V6CXILY240-(Q!DVX-Q*
MN43E3X'GTRAVTW1;RKC6^E32#N1WLW-W:LQ(W<"D<%":S#MS&PM?9F2EZ\U%
M\10B\#-NUW#=E-)(-BIE7^6)3>0@)1 0#*HI16"(E)MX[CH+Z'^^G=-@U(FN
M=@PC"O737%. \?;Y-J:26E=?:TB"N))U/R)2((!.FBFIB"8J0%4-Z_;QEMVE
M6BHD5QN8U=:]!IWWD]Y*R][J!LCK_3SU_1$=:)V.2B;M.LY1TG<ZC#-CE:0K
MIPP=E"K2#Z167/Y&240^5X%-XF#R-5"'"Z[R)RXU1)GH]7O?6V;U2Z_:7T2D
MUIV\K#J%8E;=6QQ"6.)*ZUV5HH5NT0DI!Z!GD]$.CE30=&;@@JV#Q,4!#RR)
M6ZNJ*5/"CKM,A]Q_>*W@C6Z&6AMV@PNW:--6MT[D4C-K+!0EG"2K+B"KKJ+5
M^2SDXQPS6.F[."Q1$2\D]!#$()8,KE+&M=J,'>SK"UZ&[%:B6J\](3<=+M]B
MRJA)D4U;!#OUJ!/(R,3/+H(MT'<BW71$_P Y,A2JD.!N $1#.F>5U_5IYD>[
MXU+UO-LG*'>+^/K2U]H,Q[S-$9G9C8,GKCL'7[36(>)"V0+9G,Q%EDUY)5Q$
MO64V^48K1S!F_8)$606Y$5%/F ;GQ$..0'D#DY5TF5=CNR\B/ ]!]T[J<\U_
M/V:^#L&U?5?W$.RDE+W>6LUR>V:STJM[+V[49)ZX<(_(L9F932$<Y11< DZK
MX Z^8DW\0%(R?W1#G-VRN;EE+%^Q&$)1OP4&VJN-)*2<6\4\*8;F=E-N6+VI
MD=&Y=MS_ &>G0DNP5@EI"?8N7LBPV#$*.%K%'1ZTHO9%H!N@L=Q'_+-)&*1F
MIX%%MY%$PF*0 ##C2*HMA#=75DB6L_=E[1.)6J4^<N%AF]1R<#5=6V*M6B7=
MR\I-U]"8;MCV1R_3.T:MK4@T7\2.$$B$,4@>93<";*K<Y6;BO6Z*Y'%5Q6&S
M!X>-$J3E@S!O>G==TW;O[<>M]PV1T]U_#7I_4ZF^4:*3<EKV!ITB>!CW=4(#
M@"DD9"%9)E<<<(J*F P@ !D;'5^Z9#\[Q$E?7GW[>Q=*4HFG1 ]GTU%5*L:=
M3?6($&]_%E#IHUYI< DV?RV23]O'"D*J'B8AQ)R!@'G+3MK%HN*;V/&FS88F
M]QGW3^R^PY6V:#IMJ!E2Z6#VCN9&82<2#ZQC'NRINWRC)=46/RW1T2AX'*<3
M%('Z.,0@E1MX!S=**B]9&)NB?NI;;Z34];4-,B2V+6,C=E+Y.DLKHKB28V2S
M12!+:\HZ+)NVCX9G(R(_/%L<5B^:0"/!A'BYP0G<4INBKB^K?1$*3C'@I5>V
M2@[=_>*MRUZ&K&NH[6T9'O(F(LK&P7)10)*:3E9>+>1M>>1+4IV[ QVC=Z"Z
MA5."F.0I0$ Y'/>YHT'(Z%J4<KD,P\UEKF7M75)Q<&NT@I4IZ^W^Z8N4SUS-
MVG*Y!VY1N2C3JBZ)^O3V3GJT'V@O_47=,GMS2\](6*Q6"6>2<_.VY-['R,PR
M=3"KR3CWD8T?E8^4DGP)U3%,*9C"!!X#/!:35-E#(;QKN)Q=Y>]+M.@4G4MO
MKM>86E[NYG';3)"6LWSHVGUR*L,A4Y.KL1;"C_A2\Q ._EF-Y F0Q3& 1Y#+
M?9I[<=Y6[F_>T1E4_L,KVP[A6S>]RF+4&QK/\DOY=E&C$\!$5Q)\T29Q5?>M
M5@43;18)E*!3DY4\A-SSFN\VI+2L-]V)QEZ;[KW4:=7=S#E?@KYV@^Z*058;
MIH7R\O\ DU=A$>0$.0K-'].2^GW?AGS3OCR_QGD2U!;?C5GWLC[#WOOA[OLB
MU^N9?X*1Z?M+TIW);5WA<"W.VQC2NQ>K&BU.C7L8G4K">2)L3Q>S[-:*<R3A
M['B @@9%RB0@"/D!A^$=QUCXIREF+?#23U&X_P#)V?:+W<)+BY7SK3K'X_\
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M1*HHD:^]<2S[^I7AXFJ8$E'5)L(/% 1,8M?(;DN>U:RO)O,<5<T;-?)N>?\
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M";5RUV5%.$9QHNTFWM:EL2<<*[K=N;N)O"E6L'78Z=",[YY)<& , 8 P!@#
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M<BI*;-@>R$HX>[;/.B9=M)+UG64RFX0,9 R#Y*D5I9!VS 1'P,B= I@. _\
M"!^K,W.PE#LJ\6-B$L?!3#JPV]-1C7$P+*/'\O+3%BE9!Y*S$X^7DY:4?KJN
MGS]^X#E1TY<K"95998_WC&,/(B.8.X;-AD3=5B5M%F@I-=5XHNWH5-BC*OE0
M676-%0J#$Y_F?'Y9?E\$_07@,]_F+3)Z7G;=N?!6[EK5U<."2G!-+V^LMVKJ
MNQXEBDY+Q&O[HQR+E$AC$#PYY)R >12B("''IR YX/@+N\V5[1N1E6F@I%RN
MJ[DGF@J?^*KK!R919B]F&+3D?7D$F*)"!^@H<83Z0S45N0 5.<@' 3?S9Q2*
M'V^A1,(!_>A_<R2,39'J\@NIOK612<'%&>%<QC\?\"U8NU5Q,8?0 ^60<A[*
MH(QX[404D7:I1  %\[$2E, !P9<_/H'W/'Y?''./ 'M-FNK\JR:.=XI"Y A7
M_7G:S-HGR!045&#*Y5(4!X /%N@</3XAD-;.@J3>+-8C':+@B<Z/D*?D!%#%
M\P#GRX#D>0X$,DIJ>5NDW33 Z"7 J%'S^6F &Y,<!*7R  \"@)O3] XH2JFS
MO80PMZSUSB_EJ)+,-)QRZZ2I! P'EK599!(0,/\ PG**@" A\ '(1+I4D;]E
MXI3=C-;^12CR]V:80X 0$0U_-<"/Z1#@,Z5Y6_LU\R?PJ7O;!RIWB_CZTS[@
M9GWF:(L>Z0%'</\ ?%,,$F ^/(%$@RTD ^9OY)2\?'G.0>3OY)?UV7D1K_H0
M?BGSOW>S7P=@M;KW.$@G6UY!QXG!/3-W9E\A\"F&4_#HU( #^_,<SOX!\>,V
MOA<GYJV)OQ'9*P6)B%%1L3GR*EXG3)Y>(FYX #!\#!XB(<_;D#K+^U>V0D=C
M4-B94Z3=Y<JRU.8G/W4%9IF0YA'GCQ+Y\Y7;M3O35FWC<DZ+PL)T==Q=>_GO
MUN^-T.EW"JJBVUM@B=TJ8QE3@-LEA(!A$?,WW! .1YRVM@V,M*DMT'5QJ+42
MID3=V:#;^7W0_FUI)L54Y2E\?O"4>>>1]<D(O3?(^>ZMJ"<ZI@&^V@/O"8#B
M!)=T4@F#[WKP ?8&!C7K,:,Q,9= I $55%2 BD)O^$,)P!,.1$ #R.;U']>5
MV[<KUV-J"K.4DEX6Z!MQ\[H+[VG)#+7>>?N@*HHLX1*H !Y)HJ%:D#Y:1/(>
M$R^/I^CD<V?G:P\KS'>R3;?Q>-JWMK3@M0BU7'!/<8^5FYV5/:I-OV684?'4
M*<3 !A 5C^0E,(&'[W'J'Q$/X<U8R-YL)OP02USU2C$E3*F0T/*2@D.(F!(U
MAW-LV1*F #SX@*0\\>GQR/:^:R5T;OS$5'I.'&[4 X .8PW/_DO^,F/Q_3FL
M\V_R3_C8^4XT].+\5&G_ -(LK\%F#OG]SXGE%]-P_16+O^KT_+-&S4>\2PLQ
MRI:M_L]KWK/KO?*Z=W>1?[)E_@9%W>T4F1.R=E0\2\$::7\/0."")-D@/C]A
M?XLCNQL/+Z!<@]OQR;_O+9<]'VCY5SE*4^4'\!9)M\^D'WD8 P!@# -<.W%1
M[+WOKUL&J=/MMT_178N5_*G]7>U+]3&FP:G5OH;O6I*V_BU0?,W[67_&Z*SD
MXY#R1/\ 3N7B:P<"F!@ XO.H'6;W=^M'7-KT6N?N]>W=T;M=QFMUQW['^X2=
M9]A;Q;M]JW2R2<G,L'+&<MJ\B7825N+-,&B"C@[%"5014234 4@ [!_;SZF'
MZ*=*>N74=:^/-G.M&:[9U!]>WC)>,_,,D9_(3,DY81;J1EUXF#;OY51".:&<
MK"U8)(I>0@3 -R\ 8 P#6#N9U,UQWEZV;(ZM;;G-@5S7NT/R?^8)K5MF2I][
M9_DF^U;8D5^!6-:,F4H[ZB;J+9)URV4^<S452^Z)_(H' %[?FEH?4EW]\WK%
M6T;_ +'H-,[.VGIKJA]:IJ(LBM$>;2[A1/5^,MTVZM/X,W-LZR4^9.U=RT"T
M,]<(O'0J"V0.JHC[?(5NU_U$RN<E;3>5LW,QQ4CAV%N[>XGC7_!T6_=1K!Z/
MG(V[G-DT[%9+(P\ZEO"4[LH*X_.XJ\,7"+IQ)<2IPXGTF4TTT4TT44R)(I$(
MFDDF0J::::90*1-,A0 I"$*       !GBMMNKQ;-X/WD 8 P!@# & , 8 P!
M@# & , 8 P!@# & , 8 P!@# & , 8 P!@&F';[H3UI[I5&7B=OZTK;^\#6I
M6"INV631S"[)H[AVW5&/<0]SKCV$M)XEA*"FY5BSO1CG@I^"Z1RF$,]_1>9-
M3T5NS9GVFESDNUR]Q1N6+L?GHSM7%*VZJJXN'B6U-,Q<WDLMG;4K.9A&<9*F
M*KA\U=6PT7Z?]%JZ/8%ML?;6BJFSF>M41+4=@\L]D:[$<O\ ==IA-2V4-GU\
M3.)-&<DF.OV[=$EJFTV=F7"032.@D9L/RMPYDYAR5K1HY'0IJW;SB3:MVE9I
MEHRNQ["5%%J#N5;LP;M)Q;J^+''L9++QN*790BX1X=BWT>'53I)M\^8'I# &
M :;;)Z"=6-D6)6^):W#5FU# L9#<6A)Z>T5M1%TJ//UCNX:OD*R]L:A#?!*7
M"0;&#D#)&*(AF%=T_*W)=IP\%WZ*#<9>.-*^O4\'-\LZ-F[OQE6NQSOZ[9;L
MW/"Y6W%R_P#5Q+J(INTVF=CZ!W;#B_[)V39L7M^EU_7Z%BV?!:*>[.K4/4&6
MXIF,2G)^+4U*F]<'EI9LPA;39V$C"I'=KI2ZQC(-".=SY<UCF72M-S&6R64N
M:CE+:[2S5M.%^4[-N4).$?/@X/M)17#/ZFVIQJV>;<MZQI%V5N-R[G,O.VE!
MS5OCA)-KAE**AQ)IIJ<U14EQR6%?!H;M5W'ZV.*%H>VR,5MFPQM>@:["=>.V
MK:G=8>P5B;PT8VB@3ZU]H*:I-=2.T\2BHD4K!NO^!3;ANF47[M!;YBAKRUGD
MSF*\X:Q:O:)KUQMRE!2O96<VZR?92D[L$Y5_4KM[AW6]Q5D.8.&Y#3]14LOJ
M3279WDH<;2H^QN)RM7578HRXJ;4C8NL^X!:!V&\V';*=VWC-3R4JK18?2#:@
MZAO.UX3;U<G;S W.JRVMM6Z]LMW?54LZP0BF+QA;9!T@YBS/'8$BUU7B>S9C
MDFVM-5G+W=-EG5'C=_M+T+4K,HP<)JY=N1MJ5&Y2C*U%-3X8^>E%["K\J]HU
M/L]E*)NN-<$JT]?KV&Q9>TO<O9'B71_M[V^L1SLP(-+EW W3KO1<4W%1+D)%
M>C:O+V'VBHS;J& 3(.8J.<*%'@/ X& G@/0>6LE_*FL6[DUMAD[-R^_!QW?B
M]JKZ5.2765]M?G^IVVETR:7L+B9;]NT%[BV]:K:*SM/M9H'25;M$#-5U_2.O
M77^?N+N0B9V)<QSZ-G]J[@V(>0<-7!'9T55H:N5Y_P#3B)F[AJX\5B7LMK')
MFDYBWF,AI^;S5^W.,E/,9B,$G&2:<;5FW3=6D[ER-=JDL'$K>9N)J<XQ36Q1
MK[+?D2,&:FUIW@TS)V3>VEJ5UXV?$/EYC4^P^N:=HLU$M]M;Z/OUVI\;=-<[
MCF(IM2&%B_$#R232OSD$V8_AP) ><1.IX-_<UC5.5=9C;TO4YYS+7(QC=MYC
MAC<A%W[<)N%RS%\;C3AK<A-RXJ_4FMM,5F(OM+:@UL<=C=&U5/9ZS7KFZ6FN
M].HMUSDKJQDVL&H>SD5"O9);K%V-C7>HMHF6;-UU$74<15K8HR\4Q59(HJ6&
MHJ6:,2;G!0#'-PD.HZGRIJ.EVHY^3AF="E)+XUEFKUK%['C%PGT6[RM2;PPV
MEZ&8A<?!C&[]#+!_FKK53,VC-J3.WZ_-6=Y#T6-AV%JME/C75)V0ZV(G(2M%
MN%EI5G.\75HM/:QS4).O@JQ%-1THY:N ,J1L<ORS>9JN0MZ=>C8C*[*X[<)M
M3MJW17(1G&GGS;=)4EL2:P<MI7;FYJN%*M8.NQTZ$7/:=Q:BHTTQK=VVGKBG
MV*4^3^&0%IO%9K\U(_4)NU6_T,5+2C1\[^>E'KF)\M,WD5!00Y AN+&7TW4<
MU:=_*Y>]<LQVRA"4HK9M:32VKQKI*G.$7232?A,CYA%0P!@# & , 8 P!@#
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M8R]R.2R5R[9R5N]-PN.4;G#!N3C'@G.3DDGP+BK1)2HG@I%2Z)[SHA\I#OQ
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MM1?G2BG.,>%<3U;(6;[U[-:A<A*&6N=E&/%1-N$&GA6J59M*N],[3<THVD8
MP!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
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MXI1471N*:3JDTFDUBZU3JFTZIT-N\MGJ# & , 8 P!@# & , 8 P!@# & ,
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M2TX\2O7S-G_-^+Y9!,Q1,5,Y/-4"G$QA,!0* <CSSGG;2XBO[(LY;3;9.53
M@("9%FT.3C_I&+;(1[8. XX 4VW/^S]N$,"PDU!^H0$1 Q3+)%-SQQP8Y0_V
M\J(J5S><B*VR;,0JH@W27BVR12#P()L82,:$+R CR"::(%PB&S$[%XH43A\T
M3$* CXF^/J//."#)^NI@T;8"R <C]/$6 0X-X@ +PSMN)A]./( 7$,$HHB*W
M(^HB8!#X^GQ]1YYYR":F5=6&0-8GXJB4XEI5X.01$0\3EJTF*1@'GU$# 4?7
MGURN%R=MMP=.*+3\#5&2MI8#?R IA*/EYE)SR')@_E>OE^L?0<H(/:(X\? @
M@(F Y1^[P(>H^@^OH/ZP^T,@DOJX3Q)2-H?RB&%2.J01CI14!X,X0GI=43)\
M\_<(DX*4/X,C<&3.^R2J*G8770B %'\1V<'I\/\ N>3&=+<K?V:^9/X6_>V#
ME3O%_'WI;^T&9]YFB)_O0Y%'<_R@XX/7D.?L'_JO*<^O&<@\F_R4_KLO(C7_
M $(?Q49W[O9GX.P:VU:6*P:V-[\\J3PT,>+9@)_!0YI9=-LLJB  83^#(JQ3
M  E /(/TYM3Z#LE/I*>@L!0^(&'G^;YXX(7U$Y1#GD>1X$/X,$EW5%P5&VU9
M453>"=C@53<&\2 5.5:*&YX^  4HC^K%"=YYK0X,K:[6KY@HFO:;$X()1X 2
M+S#U1,W/KR!BB _QY!&\\<6Y$LE'B8_ I.6PE\A\2 /SDS@//V@ ?'#Z"3V+
M#*K/+-8GZG  [F7ZX>H"'!W*AAX'[0-S\<('O51Q\RQ00<E3+^)LE!.L;Q3
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M>7EE*[FKU9/L8S7"O DG5NK:XDVL3L8SY">H, 8 P!@# & , 8 P!@# & ,
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M/9" MUQ+6)$D>BBG,-R0,,Z>OVS).;<0B:#,B;8SU1N J(H*)) 'P-X?=$1
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MA*B*TUUY='"R;9O!*N'9B3IUFJ+ALJNQ/68]64GFLB0%@,Q?1<:D995$X?,
MH>A1$<>0E1?KGO(:YNB3=62)&J%;,""X?O"N6YT8M5$A716TBJFH)8U^=,.4
MTE1*H;@> '@<I;H2H2;/6;TVXOG]>CDH9ZJ[M,,%BADS"@"K^%^<[0/+%,*X
M@"'SV*_(G$@B8G !R(9)"3;2?0?HE0M7U;!B=D5N\E8AM.1"+EZU;GE(R04(
MG&G8"JH47+B24  11+_.F'[,> <+W[3W":ZOSM=)L2OO1<.VD6_:)JG1^8]"
M=!<T(T:\J<+2,J#57Y" "*RG@;@O(#C!;2I0;PWGZ6I]RKSM$9&*/#+MK*_K
M1U)59NV1:6.$2;N)6)?"NL0K5Q'D<$^:!@ H>0!_*Y*%49SC)3BZ23V]:?S"
MEP?N7TGJN*;:6P-5'[(K!K(2CR(;/';MFC'K2#!LD\=)E>'733*BFT<IJ@?^
M28IPX$0'*6]^\4:?K%D3+9_#OWD7(H*MWC-<45T#>(&*8"E.41$H\"4Y# 8.
M.0$! ><E$/ H[Y^J^.==T8ZBH)(IB=3CD2((I-D@#CC^0BB4O\624[3;CH<8
M/Z]TBE#@H0AO7]/_ !HPS5N;_P"2E]=AY3C;TW_Q4:?_ $AROP5\^A7[D91,
MUZ< 'Q_*MX'^+\M4,,V[ERSVR4/V)/V#Z!Z0TG'NKT]_OG+?!2+N]JE,2VWL
MFF/H4&6ES 'H/!A_K- 3>OV\9>URQV-ZVFML&_9:^85^BS)ODC/M/_[:?^SY
M<F5!L0.!\E!$!\N?(.1]>1 1 H<E']'Z,\0Z8JS]D1(F/)0X]./L_P!H ^S(
M2H#RY(& , 8 P!@# & , H]AAT[% 3E?6=OX]*=AY.'5?Q;D[*39)R;)=D=W
M'/$A!5H_;%7$Z*I?O)J% P>H9<M7'9NQNQ2<HR32:JL'7%;UTK>1)536RJ.?
M[V:MEO\ =>_^Z<0_C(BN!T V7L?H,T)761V$;LQ6G[)6AI+9:T6+QPC5&"I=
M,-?PJ"3,\_#"2#LHO5P.0";US7S':U;3[-JU9E#XQ/XQ)RFIM-2O6N!/AC6K
MXI2D\9>9YJX6WBV(7%-N?#YJX52N.QUZMV&._$Z&<T$RQ@# & , 8 P!@# &
M , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
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M2"290#@O//Q'-8YO_DG_ !T?*<;>F_1=U60Q_P#]#E?@[Y]&?W%/^#Z= /\
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MRY0*H*0)J<\E$< VS_:H_>KO]6)T _S@&_\ I$8 _:H_>KO]6)T _P X!O\
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M<O:VYZ4YJ\G.!8JNE SVI[V\,[<.VK-R:OLH)1X1-XDZ4!W\A- IE%#" $(
M!S\0RE*C6*X\/$FOF"4XM<.._P ;3.'KVR>V5VT/O&YU.+.Z@:?M5WLE6(=
M[4=M6+R(D7\Z=>0K"ZWE#$9QK45$0^2 K>0&Y$#!F3*"N+H+'$XXM5;-WK=^
M\#T"-M4LT:ZA?6:-A8)ZC"W=_P E=25K'Z5D$F:MHI*?X*+4HG*HJJ!@,0I
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M,@ !D+ & , 8!8>N-6:QT[64J7J/7-#U93D'CN11J>N*A7Z1649!^<JCY\E
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MC;'IU5V!2K BBWGJ?=J]$6NK3;=NZ0?-T)>OSK-_$R2*#YJDL0JR)RE53*<
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M9M%KLEX<ZP0W'UGUML>\:\@K%;)B<G6]/2MCY6;CXE9P<D5^.*IMP39G;(I
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M4M9+C+O'\C<Y:)HE58QIY9=95R_*R*JX46<F664 DEP!@# & , 8 P!@# &
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MOE+Z9L&@Y:>9AG8PA"3CDKDZR^=47%UC@Z2Z&6KLE&B>]T7A,4M5TQ X<D3
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M8EY1XN]D)!ZNX?R+]PLZ=++.%E%# 9(P!@# & , 8 P!@# & , 8 P!@# &
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M@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# &
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MV\Y!Y-_DE_7I>1&O>A!^*?._=[-?!V#"% ?E;4W;@J@5$RE?AFP&3'[WSE+
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MG%[?VC^Z]6;4U592<F:OI!=+-N;7L"SKDS)B=/\ !F\L\=@R=*+<)I(N#"J
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M@# & , 8 P!@# & , 8 P!@# & , 8 P" K]X3376ZK:V0;IF467VY'I)$*
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MWN , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
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MG2Z>N7M$=BMMRK=Z[C][;2?MXAN+F15:[$NKDC!N"I4Q7>"G)B5%+Y@@3D>
M\AR'!+<J$<<]K;**Z[<W=J)"F[$;%4.902+ GLBWG!NB!N%53&"2'R(@;CR
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M5=P[XN5LY)4HM1:_R%@ZT<YA/MPP!@# & , 8 P!@# & , 8 P!@# & , 8
MP!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
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M#\VQ-,B:"W, _B3Z7KL\@\DW,6D5$3G5;$X$X (@9,#\Y9D_.7A&U-,A!FV
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MA9@RWY3FQ3?,!*U[=(4_I]\I=?2Q 'XCZ#XYTKRNZ^C7S+_"G[VP<I]XE?\
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M?;2Z[7[6ZNJ49:"D47,Y(VAB+8):D2D>V!Q7$I2-2,JJHW=IARFX-\DP&X*
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M , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
MP!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
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M3?CM6U\PZI\YK/J8P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
MP!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
M& , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P" G]X6_YJ.N@^S^MEEZ_
M^@LAG2OHQ_A5J7W*NG-GI0_@/D/NSE??'!U[?$7$27=75[>38*2A0FK$JV1*
M F*T>?1KI$D3\>J9&""ASB</4GQ#USG[.T>8N5V<<O*S[]EJ]A;2V\$?(CN#
M8=>]66.?I]D+0XV?NM1@'K&",Z7YB$&-F^8H1U)1PMED5G;59/YJ2P^*R0^H
M&^''H9+F?6]/TG,:)E+\H9#,SA*5&^*L514E6JBUA*.Q]!>E:MRX;C7U2#9#
M[[B_7L]L]QOV]'[U5B*Q[C5D/-)%3Z=TK#V&<59QWB).#<N4B"4 $ Y]1$/C
MGB1DG!['7#Q_F^/>7&G%I]5?FG2?4NI&EWPP3NRT4TQ=X!FW93]BA924@'KB
M+:R360;Q-A/#O6(3L<T?M2*G8NBJ(G3$0X$#& ?8R/,^O:7E'I^6O_YFFY*$
MHQG&,FG'BAQ)\$J-XQH]CVHE6[5Q]I3SFMOLD 7[Q%KIE<KQT<!1$Z\18=R5
M^OM2?2"@Q.FI/-4UVY$?$"F(8OH4H 'P] SQ;7F5ILIOVMUZ1-\25<95I[!U
M$ZCI,14(=I /HIFL^@8./CVS\J#4SV':N 1CW"+5<?%U'%41(7Y@)^/D4!Y]
M,M]K<A"5OB?!)JL?G71U55L=&ZIO87H0<J+"E/7(2?W@74Z,MT@MS]5M]1&5
M?8^N'J+@O\\0))>SQ*0'*Y\ 4.J4KD2B;G@$_3X97:?G+97YOYN\LSBTGPMT
M6[:;H].:77R=8M!U6QS<; PJU(8&+&O_ *(A)YT\*Y22C447?B+U9V@8Q 3#
M@1 >0'G(C.=F;NV)<-U8IQP:?5XBN*<Z1E6G7LH_5M,1^XCU<J<OTPWAJJH5
M2/;5^#U9= BHF.!R9,JB$8_D4!0!R9PHFHW.8P%#S$"? OH&96:SV;U'-RSV
M?F[N;FUQ3>UM*E72F);X(P7!;3V>$B2]E79"^E.MA8* C_\ C=[)MUYHCM$R
MB#EHE%%9%8$,!1*9P*S@OD/(>(F_BS'N*$IN4DGZU1!RIP[B;G=FMS]E-'[.
MK%>,P0G'%0D#M&AC&(X1?_ARYD4>$B*)'4%<."_ >/L^&6X^;->'P>0JI7J1
M\]KJ5INT7#N)K[4#]BO&V2$V,_0GVZR*A5X]2L/GII %4BI^9/,S;@!XX]0S
M+PICL,=)[%M.\W5VD"R53H#5C+3-=-0)@7RD;"2'T[.673;.VAV5@: 3_C!B
MH*GEX#\%"@8,R,EJ3R5C,V.QLW8YBUP5G&LK?G54X/=+I>]8;"]*VJQ=<=KZ
M^HA;]X70L/>>Q'3>$LD>D[9RNSJ=!/T6Z D,Z(ZM*)Q0*(@'U(+KHIG/Q\0#
M,*TW&KWO;UD7'5T7N?S#H5@-<:\LE7"!<1$3%3M?.QBV3M61<0OBC]0B1F=Z
MBS,8RJC)PV2<(B(<H&3!1, , YEY/5<]D'-92:AQ8/S4\,4]M:53<72E5@RM
M04=SV;MQ$?[]6L+S:.M>L7EM91J<9(;0AZ]&*0YG"R[\OXK$D6=O/F)E(!WG
MS0*GP)ON@;U'X9A6L'NX2FZL%*GG5IZQ.%K78-<U0C5M5R[-=FLPJ32*$739
MH2./X134_@HNZ42,4A4S\B02?> /N^0Y;6"=&U.K=>CI+J59*710U$]V[7B^
MY>E'9%>&C %" H,O."T0 JSQ->-0,X 1*W**:?+=$3E !,42CSSE<:*?%L1;
M>-5O.6SV'2"7=NL2" E,5]LH#<\^0B76DER(\^HB.=.<K_V:N95^^W[VP<F]
MX?X^]+?_ "_F?>YHV1Z1=9+9LWNW:=ZFCX\U!TOKE<'KQ^8PK+V"7E)%1HVC
MFX)F!<R+5J<ZHB)0*7CX\YQYRE)+1WUWI>1'B>@ZF^Z?/?=W,^\L'53HY9C-
M0;6P&300BHB,7?O5%/)KY)*"@*'BH8HB)1,(\IEX\?$0] S8W66%=N-?(CL]
M+%RDL>@Y<?<BHX//?+Z70RM<=6&$V!=:1-Q"!6ZCAL\F&T0]9-FAA !Y3;K2
M15@Y]"@41'T#,B#DX-O:Z%IJDJ;CJS?=?M37*[UF]3VK*+(W76Q$'4/*RS4I
M;34T69'222[%PU!/DB4@9,PB8IA(82B @)A'/1R7,.N:=D+^F9+-7K>FYE?5
M;2EYDZJF*H\/ UUU*I6;<[G%*,7<C@I<*JEX3GS]Y^@O9KNO[:%DKT0I,RUA
MWA2XQ)PS*H\.=!G8?*3!<X"<C8C,@F4/Z@ %*/H&>794>S<5[E_-=?8$JJYY
MS=:G6+3)!\=)Y',&8O%8ERHG'BFJ4C-$Y 6;G$RI2F,1R#,ICJ)@(!XF\1'@
MW&6)13>Q5KXUMIXTGZQ?@\,'14Q($/WE323/:7MZ1.S*B9)W(:>W%5)^5.8"
ME%>$39V*"FBH^("8ZJ"S\AC"(AR0@_H#+UAOB:VHM7HT7$]KHC._3/KOKK_O
M>'6"!V?1(>[49_UYH5L2B5_YH$G"\.>4^>V62.V<,))J]E3+IKHG*H10XG ?
M(1XSM,UC4M#SSU'2;TK.;4J<2IC%I5BT\)1=$FFG5)$2LQG2%W8D][57N>!X
M.VW5C2],Z,;YI^D:2C4JE:-46RR3469[*3JCIVO7E':JR[J5=OU0_G$0$Q2F
M*4YA$X\CSF7K?,>L\S9V.>UN[VV8A#AB^&,:1Z/,2JO#6FXI5JW9M]G85(]%
M7T]9"W^[[4)WJ63MCUZT:N4G+=6 7(R*8[@2LI[Z95<B9$Q!0S?T,//]Z7/)
MN;$R()8PW_-.G2YU4B4BRA7HQ"DC;H]^,8R6.)5"1C(%2J(E15(8"F46,)Q
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M@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# &
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MF]UK/WAFTMCW>?MU&L-(!I"TK7D.L0])192SE<\Y)-73$&;UC..04**YU"G
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M88DEQX P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
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ML'=<LX/;(]KJO7,FG*6BRJ$90D57*O&;36+%S3UU'&CF#HYW"+$YS)O1;&4
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M & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
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M?[Z?O;!RMWB_CZTQ?:#,^\S1&/W442#;Z8*"8GA"IF$W!Q X?BDH'AXE*/\
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M1)5]7/P\K5-1H\47244(D=<AE"E-E<I7<)N22>S;]*2HJM,,-]/8Q9E0V_\
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M"XO5"#]TQA(I",0$0^T $Z8<YMG%)QX*^8FW3=5[_"=E;NLL[ZDOCY (<_\
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M-U>-.GH]6XC)[ZZDVSKZ7WS6KU<W#.VW!&@N:@2HV!VE#W1Q);)305F;&-A
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MI*N%U4N ^\9-1<1*(D$>?Y(_#'A%47%5#)N;37DU *9-29C$SICZ@J(.DRG
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MA0 I"$*'   <  <8V[=H/+@# & , 8 P!@# & , 8 P!@# & , 8 P!@# &
M, 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P
M!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & 1G>Z!^QI_4W5?VUOSI_5Y
M^=6GX'^2/Q?\1_,GT3OY'S_P;_"?I_IOF<^7W>>,^P=S'_4'[X[W_3KXO\K_
M !9\?;<'#V=57W>%:[#Y)WS?]._O4C_U-[3[WOC,*<':5[7'A_4O/()/_%^?
MM_:)Y]>>?S_Y?'UY_C_V<Z:C^5-3S?DBG^CG+D_R1:OM/E+BJZU^/[=Y_/\
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I_5C 8'Y'Y?(>7CS]G/'/'(?[>2NH8']+X\?=XX_\C\/XN/3!)^L _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>37
<FILENAME>tm2227887d4-lc_tumor4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2227887d4-lc_tumor4c.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@!7@.0 P$1  (1 0,1 ?_$ -   0 " @,! 0$!
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M & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
M8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@
M'1R>2Q^%QN0S&6/#?'HK$V-VDLE?W926C:F./L2!0Z/+PYK#MA*2M[8W)3#S
MC!;T$!8-BW]&L U"Y6[_ .?^P&:_9+5^["CL9YQGPX%/WNX*_?:B"8+\WT9M
M)++VMCG);3*TL)<H-+D3@F6.K>UFFIC-':)]B(!@P,0T?Y5Z&O&RJ2@:2K^D
MZSC?4;?*7+E&Z;?JI+#*@Z43Q-@5S%277#J7*G:8,BQ]@C<I?V0B6,D:.?65
M.-4@"H!L'K@=?77EMYSLJP*CCS;7_1#!4G1%B.]2<Z=82RLD#/S->EEM>I2)
M+$X)+2Y8LFZ,R6E0QP'''!\CK.SR<!/I:5BSU@^D"4? & , 8 P!@# & , 8
M P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@&IG=3[U!'>2K
MN7\80,RQ^GE472,%21TAZ@+"J0O4JD#-%W.<(E=HR>%U\M<*PC3PMDJ=N=75
M"E=CV@*'9NA* ZV!7JX*)657Y!.M:"EGC]Z-JFE8YXMN:X'/HI)YQ0EV6 EA
M45?.O'YQEDP04'=5DS*VYMTH]/3P065%BGR3+Y*-0>O3)=+"%!H&SW -8=B-
MW35(33MR+=+KJB*@=AD>.F.2F8&SQRYG:5P)S[^Q^0,R(,B Q?T^_P#/ZA$V
M1R42%>_M2!#I<PK%WUN4C7/H'M(!T?S&J\^-E-<:OJB%!;EXP.=J<CK<QVC7
MQH%]IM'9'42EPJME2('P055@-B5T2F',9 1.)):@H0B Z,!O8$9D=M"MWKP,
M4QPHFF4;5]P'=9U-S<JH0+\W:NUOZ?A7DD89[.)(ZUQ\3/D#06RM\<<+ 5^W
M#II+8@^N-1M"9HP0%GRYN5_SRW70UUG7W=U?*N>7Y=)X; (&DH@R!O#\]QF8
MP>3N,K'/Z/GD]6"D\%FZQH4E(GY 00G 4>C E7!$K& KCE?\W725Q]+;ON[I
MF\W6PQ>,2*N):DH@JM&1A@3Q,W6O&Z,:AU'Q"QB P<FP'5&E-72->>L3*-;<
M1K3RRSP 4V+@A_E/\;?E]\5M06_Y7;_Z=J[L?IM,-W@)S[.XS%6V&,=EPAL7
MPM^9G>=2I')&MU;YF$G8/5(+T61L.P"T/7J@7U, K(^,3D#H/M/@/EKJBTO+
M=Y3V"PKOK!#-96SP"W.<VJ&M[JJ<G-&8GCS?(N6)4]I&_12(.] 4N*LSUM[]
M)F]>C6@-[_W4%B_QA?+_ /TU\L_L<8 _=06+_&%\O_\ 37RS^QQ@#]U!8O\
M&%\O_P#37RS^QQ@#]U!8O\87R_\ ]-?+/['& /W4%B_QA?+_ /TU\L_L<8 _
M=06+_&%\O_\ 37RS^QQ@#]U!8O\ &%\O_P#37RS^QQ@#]U!8O\87R_\ ]-?+
M/['& /W4%B_QA?+_ /TU\L_L<8 _=06+_&%\O_\ 37RS^QQ@#]U!8O\ &%\O
M_P#37RS^QQ@#]U!8O\87R_\ ]-?+/['& /W4%B_QA?+_ /TU\L_L<8 _=06+
M_&%\O_\ 37RS^QQ@#]U!8O\ &%\O_P#37RS^QQ@#]U!8O\87R_\ ]-?+/['&
M /W4%B_QA?+_ /TU\L_L<8 _=06+_&%\O_\ 37RS^QQ@#]U!8O\ &%\O_P#3
M7RS^QQ@#]U!8O\87R_\ ]-?+/['& /W4%B_QA?+_ /TU\L_L<8 _=06+_&%\
MO_\ 37RS^QQ@#]U!8O\ &%\O_P#37RS^QQ@#]U!8O\87R_\ ]-?+/['& /W4
M%B_QA?+_ /TU\L_L<8 _=06+_&%\O_\ 37RS^QQ@#]U!8O\ &%\O_P#37RS^
MQQ@#]U!8O\87R_\ ]-?+/['& /W4%B_QA?+_ /TU\L_L<8 _=06+_&%\O_\
M37RS^QQ@&'^=8)=7+OEWC',[OVYV!U+44_\ '!=MZ+(]U+,ZQEWP&QX?TWSC
M &1YC8ZWJ*J2$GL(Q+7$@6E!2H>_>Q^@6M;UK0$[^ , 8 P!@# & , 8 P!@
M# & , 8 P"/SJ+RB<6<:3L=;]#SZS(G*BHFBG!X8QR_U3;<>31A><Z$$.*N;
M4[2L^A2,P V91LY,:X 5)BP:&:6  RQ" \GS=Y?.!>M[$@-74!9]GS25V@WN
M#M!#G/D[KVOX:_M39$G2='N9=EV30\0K="WJ8NSGJ4ARIV(+7"]F2FV:>>26
M8!)?@# & , 8 P!@# & , 8 P!@# & =')Y-'H7&Y#,9<]M<:B<38W:32>1O
MBU.VLL?CS"@4.CT]N[BK&4E;VMJ;4IIZ@\T02RBBQ"%O6M;W@%5WG'I#GSK\
MWYB'G_F;HJI[$N3JE\N)TYU8(3-8V_/]@L[AX\J=JY/-82VZ6[!(6-IL$DQ"
M:H!ZR<"M.869O7J#] ']2>Z*M[_I?PP<J<DSIE7]"U'+H=:UXUU%3"'"6<>Q
MBE>%+^I:=,G0,>&!$[5"]-EO6*SQ="W2!&WC>%P]Z(*-)#Z=@>4J6ZZNO+AW
MP=<&UB]MHNR.?>GO'P7T)S2T&@.M_G]-P<[-CITS+;U@^M(9%5$=V.NEA!*Y
MX3ID[NN?$A*(:T*H(Q 8/^9^XQZ/J2N^@/*75/D9ZEK)M;55"0YNY:KV73N%
MUV@&Y.,-JIQ>$3Y&[0;2$JI>8>-U."6RAV:I&((A[WO9F <3G+Y=+JZ]N>J(
MN]7YV>^8VJN2F:OM53'4[M9#DG85%APACEQS*0XF]%HS' EK,=]D!/$24(T)
M>A; '>_5T!F7_"^]3?Q\^_\ ^46+^TI@#_"^]3?Q\^__ .46+^TI@#_"^]3?
MQ\^__P"46+^TI@$9WEV\/G7OC&X7LOL)B\TW=MON4 D5;L9,$=IA9T.0N8)Y
M.V*&G*3'Y'?,A/2B;2GC9X0Z2CT:(O0-[#K?K: ]%:_A@Z[K;Q;O_D2(\UW=
M[L\LO&C7U4&K#999J1L4.#C5;=8PH8*5@OQ0J+1E'+]I-+?<=CV$/M/8ZWOU
M= >B\9GA$ZX\@/"_/G83QYM^\:Q<KNCLB?%4$;9/9DH0QX;%.Y5#0)D[\JO]
MD/<0J2HX$_8A)2=A$;L'HWH/K; WM_POO4W\?/O_ /E%B_M*8 _POO4W\?/O
M_P#E%B_M*8 _POO4W\?/O_\ E%B_M*8 _P +[U-_'S[_ /Y18O[2F /\+[U-
M_'S[_P#Y18O[2F /\+[U-_'S[_\ Y18O[2F /\+[U-_'S[__ )18O[2F 1D=
M5\1=8^)+R7>$.*&^4[L?J.+=;]SU['IE&I]/+)C+ D8*YOWEUM<&-R9A6]-&
MZ6L\S;K;4)UJ94663[%-Z@@FA.%H('T-, 8 P!@# & , 8 P!@# & , 8 P!
M@# & , 8 P#IR8\P)GQ?)T[&SIY*ZMZ!I=)"2V(BGQR:FHY8H:VQ>[ ("O6-
M[:>XJ!IR3#!%DC/,V#6MC%O8'<8!AMOYTY\:9$GES51--MDL1NFGQ))V^L(2
MCD25ZTHVKT\)WI,QEN1#II5O9OO 3=&^TWZWK>GZ< ](GJ>K$D_66NDK2OTM
MI.+>6TN%E)X;'"9^N:BBO8E-BR8EMH9$I;RR?R DC4B+T'Z-:]& 9 P!@%0+
MSO?CA_+I_I_?OM9HS +?N 1 > ?\&WQ[?H :/]>OV 2_X P!@&GEA=QT;45B
MV? [56/<#;*DAL0FTMLES(97> I6^;O#3'H^W*!Q-]D4P87M:]O:=,6G=F=N
M]N,TL1(C"STHSP//SWO"!UXNLYO>ZJN<T^IY)(FN3B3-U;E -B<3I'\_C_9S
M:!RLUO4BAJ2&["F F4EI9$<Z& +"U^PV)2$#M'+L)MCMA6'&Y5$"VB"58ZSP
MJ9V2C?W1]3I(S ZD36T]RUMC;;#!KWA#%DIH6B1D$G;.:'EP:TZ?3B)</W4#
M/U+W35_1%91:Y*8EZ">UG-27)1&)8V)W%(C=BVAY<8\Y^S2NZ)N<DXT+VT*4
MQ@#B"QA,)%KT>CT;P#*. , \+9]EP6F*WGMNV?(DD0KBL(?(I]/)4O*6'H8Y
M$(FTJWR1/:LAO3+%YZ=L:D)IP@$$FG"T#T  (6]:V!CIQZFY_:3.=2G"S61,
M9UFJ3H^=0B3/ _SIJ54(460G+8]E-HPI-&PA*-PT);M*'V>M!]/M!!!L-3/^
M >0@]@P*S6$,JK:;Q"P8N-Q=V<$D@\E9I8PC=H^YJF5^:PO#"M7MXG%D>$1R
M181HSVJ922,HP(1@$'0'K\ 8!Y2+3N#SG<E#"9E%)@*&2MV@DP#%I"T2#<4G
M#"!(:^0V2Z:5BO;%*V8M>0)6W*O9+$X3B]F%AT,/I ]7@&!J:Z6IV_91>T.J
MZ2JG]_YMMA725O)%# _,I<=L9#'6*4JF5*J>6Y"F?B"F>2)1^]H1*$HACV'1
MF]AW@<#/. , 8 P!@# & , 8!Y1TG4,98EJ>NDI84D*&A;7(B5#=$8V%6@>C
M$A3*J0N91IB5<4]'+R (]DB'[V8>6$KUQ##K8'J\ 8!$!(_Q]*;_ .4!TK_?
M/Y/P"7_ & , 8 P!@# & , 8 P!@# & , 8!K_UE^JQTO]W^Y?LZD> 8 \3O
MX67C3^X!QO\ W=:YP#?_  !@# & , 8 P!@# & , 8 P!@# & , XY21*0<J
M4$)DY*A<86<M/*)++.6&DD%IBC51H Z&H,*3$@+"(>][" &@Z^C6M8  D2EJ
M3UA:9.6L5%IR52H!)8%*DI)L[:4H\\(=&G%IMJ#/9A%O>@>T%Z/1ZV_2!7)^
M; _!*Z-_2!SO]M\(P"7_ ,>WZ@O#WW0.:?L8A6 ;?X P!@%<'YL#\$KHW]('
M._VWPC ,@=2?^&6G7_*!C/\ =ACV 9 ^6]_!*X(_1_8/VWVA@$WV , 8 P!@
M# & 5 OF._Q3?EC_ +_[C_>*X!P"W[@# & , 8 P!@# & , 8 P!@# & , 8
M P!@# /%V,_RN+0.72."P-9:$S98^YN,6KM!(&")JYH^IDIAC9'2I/*52./,
M'Q-7H)8EBLS1*<(MCWH7H]78$>5%^0:=N/0EU<Q=E4+"N5+)J#FY@Z[,D,1Z
M'37W42N@7.52Z$O,BE5@.-4TDKKV11=_ABL2A M:C4Q[> :HA:8 DX( -]3K
MHJ$ASJ9E,M"O_B]\EN1](MH)<PFK;<2L\04S]V6UNG*7#-FC>VPA(-V/4-^E
M!!3?ZIXA:+& 0@-*J%\@#]=?<-P<>N_,=E4TV5W0,4Z!A=D6F^LC3([3B,EM
MJ?4Z6Y)*?;DSD^P2.J9+6SF<W'/SBC>ER(!9YK2D)/(,- UJ#Y=YKMEC_26^
M2B_W<TGZ3;.;FOK(N^VXVQ0C>[R%S4RW@OYP#5_NZ6B'>Y]E(T[@&:F/IC4J
M3K_A&@F;)"!NO>5H79 NO^*88PRJ%DT?>,HM.!3:&G0=6JG2Z0Q6A;CM="_D
M6"=*MMS:QI%<':R"FXAD"H&,:H9RT98RB"@%$VA=CSV#V53%GRJ%R2&5K%^=
MI[4J2)0=7$%,8CUO.=^HE#!)'!PE4J5S!\(;JR;3%+CK:!.:K,/VG1)B=A+T
M!7%\XDGC4D\X?R[WU=D+&_>X=!O9*[X*[('3W(TRV:/]F4K]Q4'^[&#]D+T!
M'ZN]^KOT?Y-X!<9P"(#P#_@V^/;] #1_KU^P"7_ & , PPZ<\TW(99))K*X.
MBF[W*D!+6Y$3]Q>Y]&4+:7IK]X0Q:$S)S?(7!TSL<R(SW$#*WM^G14E)/5^W
M.+ 9H#PSYQKSK)G^1R=_A+P[N\LE35,7T:ZRK3/;U+NT1EPA)25*R"FWP1IB
M[G"70YD<V-(G(97AF]1 O2*4A11( -H, C2\0OZ@E5_I'ZG_ +VEY8(+E^9Z
M/R"\L7QTM0%QPBDNC9[ 91,(\Q)&"O3SZ\CU6O.V5_8G9[C3_+FJI72Z6ELG
MK0UJ6]8:F?QDA]]V$Q.:BV<C-IV[XF3G[7?AX=SQ\JVJ48V+G!M<&M-'^:::
MYIZE\>->X]A[0[_V?NCNC;*]Y[>P-PIOR,*QI0R:JYJ4JI:J47JEKTSC*N32
MC9&4')/73Q0<(]-\E40EBMVWU+8V?NT'29L]"5ZYUM,ZMBL-.8XHU$0U6_32
MIWJ8-@GAT8EKBM219X:6E.-PV)-KWP:Q:JIO:NU;ELNS5X&ZY+R\R,I-S;;X
M-ZJ*E+ZI)?&7'CIP22+X^XCR+V-Y4\IYO>?CO8:NW.V+ZJ80Q(1JAK.NM0G=
M*JA*BJ=K6KA5K'@I-RG*<GMKY,Z[F=M^.CNZL*YC[C+9_/\ D'HN)0F*,R<Q
M8\RB5/E32M P1QG1E:$8K=WUT.*2I2M?28>: /IUZ?3EQF#WR:^17;HOK2J.
MZ[G\ -)\U)["G-D<4I%TN[$8E%93J-$\S$P;DM=3SBT6P\25B:69F>G*Q3]M
MJ DE0ITK-"'U-_YY/HV)QUU:T]#6CDB-WLVIO#Y>SMTMVM)Y7V3VGWIS7T)%
MYAT%;#Q BJ/0S3H:%1Z,,$/4.A:2%&1]+$_BS:\%[T\)'9::H*5A 0WE(A!:
M\'QU-8.>XB7"^'^<.8:AO#K&H+^D?G_J'F#M%AAUK7A')I5%6V1-NQ8>T-[.
M![/-BT072B"+/BSDI;2C=+75.B<7/1BHE*/41IHN&O,V.[76]$5/W?T7S$]=
MG2;EIFJFM>,H]XRK&O;H/MX+H],3#&4B^PI= (O2;-,(7UC9<GL],<T38B=(
M75Q4D;3IDI0B0&&%D'KKI_(]WUOUK/#/*Y%&BOGBX:@MVN/*EQ=2TWCC[U9U
MF[22TZ1EZZO8M-I!%.1FUC!RQ7O'D[9Y#LI,YN"Q0\.CFH$?I3[17[#</0B_
MZN'/4U[(:E?)E$^;ZM.8+%Z?CW4,!\@JXBQF539?4DEEL4\=LCM*@2G;H%O4
M$;DYJV82=GVYD.DX;BG"<FQ8"Q6 P1"8L\$?4X\D]-==3WK[;-C1[DJ22UN[
MTD<Y\>,K\F?("*]Y1R+;7:EF/W*/,SK7DT%?$?0],W2Q$W8LK^86.V1)8Y%M
M3BY'1\:]0DUZAJWV1C^\CQTXOAJ2^_+Q(HBF)\H"JN'RW);5;QY '-[J>:7B
M*:*;&FE7NU$T\X0"5.CM8K<V3F1-CY%%*10U.;L6)Q<6DQ,I4F''&C-'!D8\
MW\"QWD#F, 8 P!@'E)A/(/7C:0\S^9Q2#LZI<6V)G682)HC+:I<CDZE44WD+
MGI8B2G+C4J,XP)01[,$64,6M>@(MZ [-@D+!*V=#(8L^,\E8'0H1S:^,#FB>
M&=Q) :80,U"YMQZE$K*"<4(&Q%C%K0@[U_EUO .XP!@$:_.PA7NR<VQ$L>CJ
MHYFJ&AY1-] 'L::8]#+JNB$CKF(&F)'8(1MU,19Q3RIS1K40P'OCW&520\!K
M4K*%$+D249 # (@)'^/I3?\ R@.E?[Y_)^ 2_P" , 8 P!@# & , 8 P!@#
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MA#52:3DHRDY.,>/3%+331ZZEW?>E]ZN)]RN#M_9G9^VY.W]B;?F?K'++]O\
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M;[ & , 8 P!@# *@7S'?XIORQ_W_ -Q_O%< X!;]P!@# & , 8 P!@# & ,
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M;6'EGG)D;N=JXX$?N?D#12%9MJ*BWR7\:S>1RUYIQ*BC!)%8NLHD)(%[BH9
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M- 0G3IR "-.//.-$$LDDDL.Q"$+>@A#K>][]& 5]YA,)UYPIU(::IJ0R2O\
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MG=K778?/K?%2H2X0%CC1U*OKZ9 CH_#V):6)D1:1A3-*I$D.3 +$F*]4"3_
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M+>_@E<$?H_L'[;[0P";[ & , 8 P!@# *@7S'?XIORQ_W_W'^\5P#@%OW &
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MBX+'9PJRN5SJXOS;*7!S60B,J7!=)V8E8G9Y&L6'-@U*I^:D[BH+3+!B$H(
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M^A1O7,[KT+.I?=K^_P ,8&<#=:0:W,C;3*]S6"1'XP3M<A5:;QJE#DI)4C.
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M^H"71.B>6Y&YI"'QC>HR\DIER<M224ZQR2-[3(6)Q 69K1R1<E3JTYGI :6
M81!U=I+':8!$!(_Q]*;_ .4!TK_?/Y/P"7_ & , 8 P!@# & , 8 P!@# &
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MXLX ;$M)(#KTX!#A\V!^"5T;^D#G?[;X1@$O_CV_4%X>^Z!S3]C$*P#;_ &
M, 8!&!YK?PC_ "-?= O#_8ETP# 'RWOX)7!'Z/[!^V^T, F^P!@# & , 8!T
M<GDC-#HU(9=(UI;;'HJQNTD?G$[0ME-[,QH%#FZ+3=!T(6RTJ%*,P7HUO?H#
M@%2RP.7+W\QLCY%\AUXW.X<R&T;+P=&^/6F:YK>'OKC4;!)))7=B5S,^AGR;
M'/V[1GTP1UG%W9W8DQ;0TM'JB;RO7'M2<99NX=U2QLN6/C5QE"$M&VWQ:YZ:
M<N/#7CKS+>R][=-[JI@I1B]&WZM<]/X9(#2WG"YZIS=A<^^4.]Z-YUZVHR9E
MP^1'I#']F@5Y0EWB\>F=?7M73*:&3+(NTS*.R0M.XLBE>K/:'Q L)T:,CV.\
MN; S*]PQ8952:C)<GZ-<&OY_S*SBY$,JB-\."?I\'R:)[LG"8& , 8 P!@#
M& , 8 P!@# & , 8!"/WKR#Y;WJ^573?C8\AT9K@M1%8VQ/?&O1\ !+>>I&L
MCI2PM6]LTM(0RY^@CE(BC"?>2VUG2'GJ2_7&Y%EC$#0&F&_.IW!Q+M2V^87Q
M4W-4T4:1%%N/5_&OL[VYU$$X ! <GQ"<^K=U\T^IH1N@JY2X.H@>L#W$)A(]
M" FBXR\E7#/D%9E3KR+TA7MO+VMI)?)!"D"Q7'[-BS4<H)1:<)16,K1L<\8V
MT+@>%-I6>WA1F'BT$LT?K!](&\N , 8 P!@# -<^M>I:GXIYVLWJ&\E;X@JF
MI&MK>)BKC;*=(7LE$\2-FBR(3>S)S"3EQ@G9^3Z$$(M>J7L0O_-P" W_ !>7
MAM__ +TZ _H)?/\ [4P"2OQQ^9'BGRGO5K,')CY8CNX4TUQ-XFP9S %\+*(1
M316_(F,3<:L5J=.!AA\<4^T"'T>SUH.]_P#:P#R?@'_!M\>WZ &C_7K]@$O^
M 03>7\KC^#26G[XZYX@KZ[6&%;3L4.Z GO2='\[MK%+GYOL9M25.>*R;7KAV
MGYFHT[O3JE;CR')M3B5'+""P*DYAQ,40>GJ2I\ER& RSF2B)-5D6:(16[]5T
M0=8/$6"41^;,<=C"UH3'L[4TR^*.S[&I*W)$8PA)6H5BE,H!Z!@,$'?IR!%<
MC8; & , C2\0OZ@E5_I'ZG_O:7E@@N7YDEN"(P!@# & , 8 P!@$+787D7YE
MY][WH2%35\D[E):X@-H1R:-\3BRQY P2N^=TZ;4T77KS34+<2ZRHIC]J8,1V
MD;2E6)53D>C2G:/U1<KN+9<+=:=DRKXPW2]:PAI+5ZZI:M)QCJTU%2:<FM%J
MS*G;_A'RIW5X\W/RQL&S9&3X^V>;AEYBE5&-;2C*?37.R-URJC.$KI4UV1IC
M)2M<%Q-_8=44ML:1L%O=($H39 QJ2'FLZ-;EQ;O7=+K2S]J44A=518"TMFW8
M6$)/M7]0 3<P#*]WCY"?8E[H\5HQ6;48!I9UQ(/ADCYB"5%K,D88YT+'IY(#
MX%45IV0D98HUP6R61:Z.BR 0Z2I$(BG-\2EA3F#"J,T=H8"Q "(01!FZ!1@3
MBBS0:,T$TL!@=&E&D&Z",.A:T82< LXDS6M_2$80B#OZ-ZUO!$_O & 8>OFO
M9=;%53*M8C+XY"#9Y'9%#WY]DD)<YX65&Y1''A@<PM#2V3ROA)'PL3B6<0J.
M5*4X-%" -,9[30RP,CQTB1)F5O(EKJRO<B+*%IT=8ZP+HNRK#]FF; 8WL#G)
M9@N;2@D; '8#')7O8P[%ZVM"T$("222/0Z/O<MESZSQ>+1EI<'Z1R21.:)E8
M6!C:DIJYT>'IW<3DS>UM;<B(&<>H/, 444#8A"T'6]X!I5.8?.NUVGX,8Z3B
MA^>$;TPR6/R!O:6QEO2TY5#7MJED'ES:TSR.OZ.LZQCDM:4K@4B>6<UXE1R,
M!2U*D8Q'IGRVN\>T.W>_^UL_LONW&CF=M[GC3HR*92E%3KFM&E.$HSA)<)1G
M"49PDE*,E))KOQ<F_"R(96-+IOKDG%_!KY/@_P 'P9[;B&O"85SU!I*LD\DF
MTTN>/PZX[&F$J^ $N3W,)77L.1#+2-<388Q%V)B8F%E0MJ%(B0$:TG2!.4B4
MKCE2M10?%OBOL?PSV;C]A>/,/]%VWC3LG&#LLMG*RV3G999;;*=DYRD^<I:1
MBHPBHPC&*[MPW'+W3)>9FRZKY)+71):+DDEP2-N<R&20P"("1_CZ4W_R@.E?
M[Y_)^ 2_X P!@# & , 8 P#'<DMNL8?/ZUJN4SN+L%D7']<?S5P=T=TB236
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MH+N4AC%GND=?7)2A:P(R7UAF,EK<E\9EKD!:ZEM"A*5M8:#UA& 308 P!@#
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M_P!26QQ2^UG?Z*3+X0W/$ Z&HV 3:SD,C<JKECNWJFE$<U$JFE>I]L<:4,9
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M-&7ZOH D7P!@# *X/S8'X)71OZ0.=_MOA& 2_P#CV_4%X>^Z!S3]C$*P#;_
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M?_A].5?@3OU?(Z<R-?,F&;_]>_$:0'T;_P#U5;T\$6O^O0E5-K ^G7_7K>.
M^KY'D#N:O+!83R^._;,9YHZ#/&P,K!0:+FJV97!F2B)\!3*5+S<,H'8L'K!W
M;5RK3BTE$OT;^/2=E*:A:;T._>C_ %Z3N>)GY,JG@W>THR;EQ:U7#3ESTT?!
M\'J2693E7.#Q[.A1?'B^/+X?W<CM6FMOF0D#2V-ZV[/&\ZK$3>B2*W8Z26B2
MJ<U*9,62>X'E!X\,)*.6F@V8,(=>KH0O1KZ,JW G>/\ '^1Y2QF_YD6!Q<<D
M;9/PO9"L+_#&3ZIU[))<HD@TTLF;!$UT@+*DG([(V_ X4A>S'IW%M5[P!I;U
M(DY:A1HI.:X#C_#_ ,#WVJ[^8KWZ/7N+QY_]?LIM/ ;_ .KU?:\,'ZU_^?TX
MX#C_  _\#S[QSEYD+'=8TFZ^,Y&Z&Y^8%KF]S*A:SLUT3NUEN'P%S:XLD7LD
MSY<INO9FTQ]\<2G(33)'TEH$>E*6:+&N1HO13]RQ\G*Q)4X=CJO;6DN*Y/BM
M5Q6OQ7X<F2V75?=0ZZ)=%CTXZO\ EJN*/1H.=_,0U,/U'CS_ ,\-E5MK[(CX
M3#/ZY=M0M\C<%<)$[.<2@RZ4P[@E[GJ,,1CJ],U^HCF"M.0%($"0X*8!( 3&
M+7;5CPJOGUW1BDY?%^K_ (_,[*8V0JC"Q]4TN+^)W_\ 5M\CRMFU'I-S[PO8
MS'LGV)S3;GDE\C=OMBGTCV8,Q4VV;SW*T!YQ@M[UL6RO3ZF_4UZ >@.3!V\?
MX_R/#3OC#MYZJR75U#N'_$Q2R20FL#P=(^=[SN6J;&1.\.E#).&-RC$I8N#"
M#VJ0DO\ &TPR5FO0H),UH99I1N@&@X65UVP==B4JY+1I\FCC**G%PFDXM:/^
M-#T?&4-\N554BT*VN@.0&USMD]!<<P9ND>SNBY/=4;E4OB<72*HC/7:/\<KF
M?XU#6QD2-(TZ58N2(M(O=TR@:4HG0>%-%&-6J<>*A4N22X'&JN-4%77%1@O1
M?Y$TU;'V2J@D747 U0=CLTUK*'-&BMI _2J"('K8Q^W3Q>12B-0Z0.[6$'J^
MH<K:T1HM[WZ2M>C6]]IVGN, B D?X^E-_P#* Z5_OG\GX!+_ ( P!@# & :
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M.'.%-;2.'HEBS:%/(D&U["<K2K?2L 0@7')VA#5'":O*7R<MMJ:TD[&WA%+
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M* A7G:+..$#T WK8 @;8X P!@%<'YL#\$KHW]('._P!M\(P"7_Q[?J"\/?=
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M(6%G? )!F:.&E [-Z=>%,(X("]&B(TH]78M!#H6]>GT:_P F =]@# & , 8
MP!@# & , Z.3C>RXU(3(R26HDA;&[#CY!VR E'O84"@322;M4:0FT68OT6$6
MS!@+]&_RA:UZ=X!\O1/S1R@KH[QW=R>1/K3N]ECO8CQW] N\[P2S.7RQSIGK
MBJWU(DH:%F0]JKZ0S)G6/13&_>^-ZA(Z#5B3!-T:C0%B&6!>-^7J='EY\-/"
M3D_1Z01QP45O+= (E*IT5OC\UD6W8:=AGJLUW7.2LLNS&,E-(B"0J#DR=.Z
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M ?6/SZ?S-^(#^TKV?^R?@#ZQ^?3^9OQ ?VE>S_V3\ ?6/SZ?S-^(#^TKV?\
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MM:GU[/U\ GBP"(#A/\3'SC?I_P"(O_=[T+@$O^ , U_ZR_58Z7^[_<OV=2/
M, >)W\++QI_< XW_ +NM<X!O_@%0'YLG_A$_?^C_ /NI@%O[ & , 8 P!@#
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M_-ZZ>FFK-%OFP/P2NC?T@<[_ &WPC-@RC$O_ (]OU!>'ON@<T_8Q"L V_P
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MWMU@,.3QV5NOQ)!'V.3R1:>[2%H8UT5B/O;+"'HYO"\KD W;X0M ATH,2GA
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M-;UO#9)6U"6%,IU/)"^VCN*/PB["IVUZ76M;#%=0I]"Y'1LF;)'?VIBY.%8
M)B8.BQAT8(# O*_'W0E<V/SNWV@AK1KK7CYKZU:H+,H?.'N0RFZ#+^L5 L@2
MUVB2^#1Y/7C?'*X3*3) A&YNVC)$:E"C-.2I1*3 *D?5?0'DLO;SA^%;]XGR
M/".5OJ;U>6VT3]3'DMW_ #D11;;-;?'WIV]2QK ]U4-GP]L]0._<?3[X+\@7
MH_( ^B7@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , UP
MN_L?D3F5U8V+I'JGF_GQ[D[>H=HTS7?>-8U0ZR%J1J=(U;FQM\\E# K=F]*K
MWHHPY. PL!GY.]Z%]& 8WA/DJ\<UE2Z.5_7/?O%$_GDQ>$,>B,)A/5-%RJ72
ME_<SPIFUCCD;8IVO>7QX<%(PED)DI)IQH]Z" .][]& ;KX P"(#SN_AG6A^G
M_@+_ -X1RU@$O^ 1]=Q>0JO>.M0FMH_$9%T1U[=APFOG3D&K#DRFT[1<?74%
M'R5X,, H15I3T8TC/4O\Q>0DL[4C2'B]8XXOV @,&\B>/BPUMNMW>/D=EL;O
MGN(]K/35Q$X^G/%SKQ#%7<U0I5UQS5&7'9FU4H.(4%IWV=.03I [[3A**.)3
M>T]Y EWP!@$&OF"[CJ]BYB[RXN25CU?-;OLGCR]ZUAA59<A]&677SU,;BH>4
M,\(:T]IPBN7RO_\ 2'.2)2%AFW#V;>;L85&R]ECT$#,_CR\@5-7+$Z)YO8*]
MZKBEDQ:BX:W/9ML<A]&U#!T;A X0Q-L@0BL.QJXCD,$L"L3C F*TMV-9L/\
MF=#P"6/ & 5;>_O)I1-H=;<2/'/E>=,]10/@7L>;3GIVV.<>?9Y:%4PXHCGF
MZJF?(S'YRVI$[18<MBLAGZ$]S3, G(I.C";O1PU -)Q8V[L\R>)NP]YH[=[U
M[EV/:M^R5%UX^7FX]%THS?3"7MV61E&$I<(SDE&332;:>D]C;9N.94[\6BVR
MF/.482:X?-+G\C:_Q.;([SL^VO,K/UR)S66X.7<X\9UUIQ0.)O.')M:3E>VN
M*21M[<Y.22/WG><\9#7^6ISA#7M:<M"W>T** 8F!D>$X6P5E;4JY)--/5-/B
MFFN#37%-<R2::>CYD\><B!KWTO35@7I71$*K7I&V.69$5)&Q['9E-M=:NTN/
M;4*5R3J8P8EM6$3^,:9W4U<6<<,*'2K0TI>BS0!V/0@(L(9X;;IKRP[CM:&^
M7?O-BL'H%\A\DN&2D1+CT]5-WN P5DK2(+UR9;S:I;T)C)!XXB;RPHR4Q8RR
M-#,",W8AB F[CS:L9F!C9W!Z<)*O:6=L;5TC=BT)3J_K$*(A*I>G,IL2H6TM
MP=3BA'G!3D$D:,,WHL  ^@.@.XP"/3JWQQ5[U[,%DKG'2'==;H'.%DP-WKKG
M[L2Y*3J5Z9 B=M+3'FM84^(8LZ.CVF>3$[@I/(&-:F 64;ZP"PZP#Q?+'BFJ
M+D&7U=(ZOZ4[_>XQ3T?,B<&I6SNUKKL/GUOBI4)<("QQHZE7U],@1T?A[$M+
M$R(M(PIFE4B2')@%B3%>J!)_@%0'YLG_ (1/W_H__NI@%O[ & , 8 P!@# &
M , 8 P!@%$NC/.ES1$Y[T=7'EQYRL#MRYZ>Z;LMCH;IMDX+I9W)64FU.R5#$
MXJE8W*+5N_0ITA[TRJCA;-"Z&J1JM#^(':*+W@%O_A_L&K.[><(9TG3$9L:(
M5U+UTH9F)BM2($068)=PJ1N41<-JHVF='E.C0C<&<WW40% M&$:"+T!_[.@-
MM< 8 P"N#\V!^"5T;^D#G?[;X1@$O_CV_4%X>^Z!S3]C$*P#;_ & , 8!PW%
MP1-+>N=7)06C;VQ&I<%ZL[>]%)42,D:E4H-WK6]Z+((+$(7HUOZ-8!\T+MGL
MF]?*];57=+SZ;O535U3=@J+6X@K"!,L)3+JH;#76.N\.L*=2"11B3N$[LB3I
M(BT.B],I,$Q(C/\ 1DZ30/:",P)W?Y<S]JWNW:]DIHE3C6.$Y6J3<IQ>DU%1
MG'IC%ZQU>K;6O!<#V&^VO]MKL_R%XHP/('E7=-VIW3?,.&5B8^!/'JACXM\5
M/'LMG=CY#NMMK<;NF/MPA"Q0:G).2M[^#7R.V[W)6%TUETF='WKHGER0P9ME
M-@Q5D219HMBN+2:7]PK*Q5T40#TVQB7KEL+?6UY2("R6O:QKV>C+))/TG)RM
MVEW'3W5LE6[51]N<FXSAKKTSC_4D_5/A*+Y]+6J3U1YV_<;X/W3[>_*V=XXW
M'(69C50KOQ<E1Z/U&+>FZK)0U?1.+4ZK8IN*MKGT2E#ID\)_-@?@E=&_I YW
M^V^$9<I@LE_\>WZ@O#WW0.:?L8A6 ;?X P!@# & , 8 P!@# *H7SDGX1\<^
M]_37^Q-O8!9]J;_NKK3]'\-_V<;< R!@# & , 8 P!@# & , B"\E/DZ#X^N
MB/')7DHW4,<IKKJXK*@=T6S;\MU"&BIXG"8M'71'(T4E<7EFBK0(YVDA83SW
M48TWLB_9AT$9FC  0AW7XO/E/[LMZ3VVI[JY<K4,VDADMEU85)Y'J B%2/3Z
MH4*%BQ03$SY<[JXVC4*UAY@$;.M;D:/VXP)"DY7J@"!;#YB8.>(KSY4$9Y+,
MKD[FR/P5D9J9/J20-<LKM1!FU/I&U*8Q*F=R>44G2J-$B&:X^^*SERD1AYYQ
MIPS#! >XM2KH#=U9V!3EJQE#,ZSM.&R.OY]$W(:LE#(HA+6E6QR!G4*&]0C<
M$@5S8M,+T<F.)4DBWHPHP!@0CT!IA2'C+YUIQ]7R61/-P]*/)M.O7.[ =U?9
M3A>J"%4))QH-RZHXI'Y*B+CA$5FI#.@3OAJQ(M='M(WIR%RM027ZFP-S]556
M&CJU4!KF"@/ID)X*@-+B;"695A:F*+8(H*KH0$ =PLD^$.2AG&!M]V")L.&F
MWKV(M@P#0J*^+.H(GU(#L%-?W:;O<HT[.R.*B0].3-WC#Y &":OU@LM3/D;.
M)"C<:G:Y1*' \AA%OW(OWLW00Z];> ?RQ^)?D]@LE!,T:BZ3J^9+R.Z:C',*
MVY9BIY8BO0)\D738=I,%.;5!;$SD3/7$Z0)FHQ0;'43Z/W],W$J=!,T!)K@#
M *@7G>_'#^73_3^_?:S1F 6_< 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
M P!@# & , 8 P!@&-YQ3=0V:J0KK)JJM["7-:<Q(VK)Q!HQ+%3<E.,]L:F0J
M'YK7G)$YIVO7$ O80B%].]>G (=? S15(F^,ODR?FTY59L[2K+E<4TU,KV)#
MEJ=P:^C+:3MBXB2":-O!2QN3I2@$&A.T,D!80@WK0=:T!.E@# *K_P P%Y3N
M7FZH[(\?L$#9%X],)+(Y3GLZC%,1%+*8[4S95/3M-7T[,]F31S?(]&V*8OT)
MKA:!N9B%"QR]\4)?>R4B8[WD%*W3?=GV2,9[MDTXZF](]<DG+XZ+FTO5I:+A
MJ9$\?^)/)OE7(OQO'6Q[EO$\6*E<\:F4X5*6O2K+-%7"4]'T1E)2GTRZ$^EZ
M;()O.4R]J,3!3?B7J^771V%-@&$2]FONO)S6%6\1LV_>"55C=9O(T?NA@4PB
M1;98]'')>JE!X!%)%(?5_+GL;)Q\RB.5B60MQIK6,H-2C)?%-:IEH[[L.]]L
M;O?L'<F'DX&^8MG1=CY%4Z;JII)]-E=BC.#T:>DDM4TUP:-_^&O'A".0SIC;
M4XG$BZ6[0NHE&IZ'Z]M!*A^O\^6$Z <"(PII2!$T5'2L>4AT6R1%ET4A1I22
M-'C5'$A/SO*22(X P!@# & , P9U R6))>:.B(Y4)ZQ+;+_1EMLE7JF]<%K<
M$UB.L!D"&%'H7,8RP-RPF2GIA%'[$'1(]:'O>O1@$ WBJL2BW/Q\<[M56GL4
M1:Z8J.,U[;<(5@*C;]4-KP9D+17#'+/87(9#I%9:AG*-T5N8W,)1RLPT:T0C
M G:-%\HOW;]G^1]B^Y#NC'[[HS+-[W+?,F[%LG&<EEXMUS_12QI):65JAU4U
MUU_\+A^GZ82K<([#]N9.#;L>/+$<55"J*DN'TR2^KJ^#UU;;Y\_74S?X.U#7
M-9_Y0;TIQ/LOD.ZNP(Z[46\(4PDD3L.Q(?2T*A73ML0#Z0)GB'S2UVC9(79*
M U(ZN+:K.+4&?E$I_HA^SCMOOWM'[:>U.WO)4;J^[,;!L4JKM?>HQY9-T\*B
MWJ>L9T8<J*G6U%TJ*IE'JK;>%NYK\/)WW(OP-'C2FN*Y.72E)KY.6KU]>?J3
M^YLR4$8 P!@# & , 8!4!^;)_P"$3]_Z/_[J8!;^P!@# & , 8 P!@# & ,
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M9&V-Q>-,380!*VLK P,R9$U,[2WIBPED)DY19)18=!"'6M:UG80/18 P!@#
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M('1'VWS? 'S8'X)71OZ0.=_MOA& 2_\ CV_4%X>^Z!S3]C$*P#;_  !@# &
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M  /4?O)?FKOX+- ?^W*?]J'+G*R/WDOS5W\%F@/_ &Y3_M0X _>2_-7?P6:
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MW SV*1(=HI48GI>\;SMNPX,MQW6U58L7IJ]6W)\HQ2U<I/1Z)+DFWHDVK_\
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ML8A;%L#;/ & , K@_-@?@E=&_I YW^V^$8!+_P"/;]07A[[H'-/V,0K -O\
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M 1#6U)]B*1)4Y8QA%WU55TP5545&M<DEHD=D(0KBH5I*"Y)<C:S.9R& , 8
MP!@# *@79'_C)/$[]P"QO]AO)9@%OW & , 8 P!@# & , 8 P!@%0+SO?CA_
M+I_I_?OM9HS +?N , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# &
M, 8!Y>:S>&5M$Y!/;#ED;@D'B;6J>Y1,)@]ML;C$<9T0/:*W1\?7A2C;&MO3
M ^D9QYH"P_\ 3O /GR>8[H*/])=E%>12FX%>\MX(04/!.3#>OGRKI,R4:=:D
M4LRV)L>NK=V=R4T@>:;>02D#:9*--9+"9)4@BBE9X#RC,Q?Y4[:W3N+9:O\
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MZ<QM>64<-\L(DDQOK<AP* <S1T(W("<E6L)6& 3S8 P!@# & , 8 P!@# &
M5 ?FR?\ A$_?^C_^ZF 6_L 8 P!@# & , 8 P!@# & , 8!_(Q@+ (PP00
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MSO\ ;?", E_\>WZ@O#WW0.:?L8A6 ;?X P!@# & , 8 P!@# & , 8 P!@#
M& , 8!4"[(_\9)XG?N 6-_L-Y+, M^X P!@# & , 8 P!@# ,1O]]4Q%K<@E
M!R"S(>V759K6\/D$J\]X3"FLB9&%N>G5T>DK"4(Q<0SDH8XXB J/"40>) H
M4,8R# A \W >J.>K1LA^J* 6M%Y18D<+F)R^-MQJSVBLJNI.WPFQC8\XJ$9#
M/+2ZZFCND9Y )J4+=,;JI*2+O8*# %[ K!>=[\</Y=/]/[]]K-&8!;]P!@#
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M @ '0=:UE]DF=E@# & , 8 P!@# & , 8!4!^;)_X1/W_H__ +J8!;^P!@#
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M5RCY'^NT6BP#32*D>)+6CT(6>T,V4#9,]Z%(HR'Z+$/6]A%M;KVI81#*T8$
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M, M_8 P!@# & , 8 P!@# & , 8 P!@# & 5P?FP/P2NC?T@<[_;?", E_\
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M@B+#Z"P@#K+^%&Z&)5#(XWJN*E^.BU_Q+]QU9&B$;?\ E45K^.G$EXR9.X8
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M.9Q -@ O?E34C(7R)V'K>]F+%YJE6:+>Q#,$+>][J!9IG@8 & $68$(P#"(
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M_4G#V ?1\\>WZ@O#WW0.:?L8A6 ;?X P!@# & , 8 P!@# & , 8 P!@# &
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MBH2JFS[5D;SGQP<=I2EJW)\HQ7-O^Y+U;2X<R'>80?RD^*)F;KW;O* ^V+R
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MB9" 7IV(8Q&&["8#U*,?G0OOR^OBYE\8DK-8E+3JX)/)HJ_Q@^T+TZ"OR\+
M:S'UO<6\$FCJVT[(E3#')4QA<AFMZQ WIA)3PZ,#KUQ&;&!%8XW9W)P*M8>'
M+"<?'I?]B1EI;X/15UV%Y#*<Y<F$[BB)&!K@KQ<W.%ED++2^N[<S!1#>0Q@Q
MV3NY_K[3'%;,T<+R7\H?M5]J]Z>2LGN_M7N:W9NU]QS)Y&1@O"61.F5L_<MA
MB7_J*HQKG*4U5"VF7Z=-<;HKI,C;?Y"R,7!CC9%"MR(148SZ^E/1:)R72^*]
M=']7R)G>"/&' ^?JDE+AT^U4]T]U+?=FR*_.A[:=:SCCQ'3[$F+5'V?4)JD,
ML:%[^T4_7D:C+>TL*90,!AI:<U:,E.<L-(+]./'_ &+V[XR[*VSL#M*J5/;N
MTXD,>B,GU3<8+C.R6BZK+)N5EDM%U62E+1:Z%A9F7?GY5F9DO6^R3;^'X+Y+
MDOD;1#\?/!!@Q&&<0\A#&,0AC&/FNF1#&,6]B$(0A0O>Q"%O?IWO?T[WEX$L
M>%5^*CQ>+U2E<N\;O!"U<M4'*UBQ7Q[SRI5*U2DP1RA2I4'5V,X]0></8QC'
MO8A"WO>][WO -,>SO SP3=7/5O1CFOE'EKFKI%T:$,BI.Z8%3$/A"F VM"WY
MGFL'6:.AK&B/:(RYR&.)T#P%"1L0VE6J!HHWUMECDMSV_%W?;LC:<^/7@Y5%
ME5D>75"R+A-:^FL9-'.N<JYJR'"<6FOQ7%$5BCS1GPV<(>1++Y&MA%Y(MJ2(
M4/FN.S*E#JWD=D#/$T%JHY?"ZT=Q1OKMQ>] ]4]> +TF)-]'P]1LO8Q^"&Y?
MM/>7EW_/:MHWK9GXYE>Y0S[9V_JH8_5PC9AQI2EE*'*,+ECS:U=]75TQR_7Y
M$VW]'[EE5OZW3C!)=+E\I:_T_BM5\&6!?%OR=8?'W)C3![J>V-_OZS[,M_I#
MH%;%#3C8:EN/H"PGRR9A'X<)064>.-Q0;T2UD'"UKWP2,:G6@:.T6#W8[-[7
MV[L?M#:NRMGZ_P#J-GVW&PJ.MZS]G$IA15U/AK+HKCU/1:O4Q)E9$\O)LRK=
M/=MG*;TY:R;;_M9(GER'08'Z1Z>H'D&J'N[^E;3B]0U>P'I$*R3RA0I]"QV<
M=F:;(_'V9L3.$@E<G==DF>Z-;6D6.*KV8_9$C]47H T\Y_\ ,'P=T;:\<HR*
MV1.(!;DY)5*:W@O0%'W1SP[6B0A)&I6?FS/N6"0QKG"U,G+V8)$WJ#E^BM;'
M[#U-;%KJKNINU]F<9:<]&GI^.APA979_QRC+3X-/^XD[SM.8P!@$1??/=M^U
MQ>U9\0<10"LYGU38U9NUZ32=7FLDA%)<ZT.WR)1"6N?3)EAIR.83Z3SZ<(U;
M5'6-N4H]''MZH]6I(3$"V*G[CN-&V8_OWZO5Z)+FW_'-_P#G1$KEY=6'5[MN
MKXZ)+FV:OLWD-[<XMM>J&SR2.'+EB<IW9/62J">KZ2C4UHU3SS94K(7%PT-Z
MP>>3:R(T;4TO?4Q#67)4SRW%LBQ3H;@'V(B]ZD=JW_'W2QT*+KO2U2;337R?
M#C\M"5P=TIS9NO1QLTUT?'5?)_\ @VSF'G,\3<1=C8^F[;JFSI 63H\##STE
MF?33PJ+V=M/H2)!SS%K-/6!T?ZH1"+T()?M ;'L.A@WNO%4/)Z\P94Q%HJ@O
M&QY4;U J"0)ID17)IE$P%Q :JVF&>"8=/32EP"2D[UZ1&$)5&M;%KTZT$!PB
M0(\?#]INF->]-W7949"Q]MV#V7T^B[012,;*YV3 ["CEN2-K@U/O;PV'+BR(
MI J<2QLME0HE)C*6F-V<A]8H[UQ8T[JGD/<W7;K["C'H7IHUQ?X]6JU^19V]
MRM>8XSU]M)=/PTTXO^>IYR$1+H]O\P'2M>^,"P:!II3-^2*NM'NIPM"JI7;-
M8L-Q@M%]:Z:=$T.KZQJU3LG05C5VH=C5HG!8$M;'47OAJ<U4:2J!<O:L\F>W
M/WM74IM0;^&BU2^2?+\UZ%8V25TL1^YKT*6D=?A_Z3_\HDW#QUY='\83I9YE
MV.)@.+)V<WTCXY:#C_N1F@GG&E(W6Y9Y>XE7H5&@*V<:D#HQ(3K6BBCAB.U<
MQ61^ZIM^3 ]M:OE_\I\K7;_)&57]GT%0K&(&B/5 (*"J>=F1Y*4%J3CAZ$!R
MT6( BP# /9(1[ ?N/N/) #U+DLWO?HS7^46KP\BG9TA ,0"/=4XC2(Y<T23F
M^ZIS#BP!$#8?9J30"T(.]:"!Z*/>"GQ#QQQ$[AX&H:3NA@=!/<;*9GBVUJK0
M3$PR]K%-I/<P-6B( D+*+V;L>RTX?8AWHK>P; B)N2E>UO'3WS=!OC'\7CY<
M7$EX-4 EEB51!'V@>?*NAMT,L'8(TJFW-YB26^T:&V0L*(A-*&-SB*$@UZ:_
M>4:S8%0Q H>\;)5NW3/J<+XK1/35-<]&M5^3UX:OF4W<-MAG:2ZNFV/#737A
M\&N!DWAZ+>0CICR>UMT3W;P;:W*E2<V5Q:R;E:/II[3-@0MALBS8WN&SVR+>
MFD?G)$R?)@_5^>I8V)J;XWMJ;25Z@PQ5[7US5//9]FJVF$M)==\]-9::<%R2
M6K_Q.6W[?#!B]'U62YOE^27\:EH[*R5 X;CMP"WKMM($9CII&IVVEN)IQ#>8
MX:)'M&!<<F)4*"48E'JZ-$66,80>G80[WZ-; J/]<^'/OGLB]ZNZ"LSB?P=)
MYM%)VIE=MF-5O=;I?ZRS".)O;&BA%U'H>4&\<I:FV0K&U[*4J@J%GO;(D+V/
MV(=AQH@6.^,8[T?#J93P[I:LN3:??HD]"CE<0#C%]G;W3+!4C7'HXGC*).1/
MJTJE9'7I&\:<T^VU U[;$[<2CV4;L8S2B@-L< T%\EB'GF0<IRN$=1<W7CU/
M4%@O++$GFL^>*7L6\+.1.9NEKTQS=E8:I3'3F)FQ)R90'D2)"-.:U+]I]@.
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M_P!S!UQ^>+X/]8?S3_7!^_.7\ ]E[?XY]1/ZO_UI^#^P_+]Y]U]CZGT^MZ,
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MB1O7AD]Z15^T8X-K,0N#[PWIA>HJ#Z B!ZHQ ;A_X7WJ;^/GW_\ RBQ?VE,
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MC4I5A!A/I$!ZSD'DIBY.B=C)=SZ77!:-XVU);VO>YIVECS=);*M&4-K$P'.
M&.)M3+&(G%8Y%(LULS(S-Z<"9N:V\H&Q''B/4' 8MZD\:7.O7G3?('65K+;(
M3VCQ)+%4RIM/$I,UL\55.ZQ_B\C-#-&E;''98]H].$22ZT A4B%HO9FO6](M
M;"!(/@# & , PB[\S\X2&Q4UP/\ S]2+Y;2,Y,H1VB[U3!'*Q4BA&4(A(>FF
MRUA.DI!R4D8@%B"JT( =[T'>M;P#6;R&^-+G7R:0:J:^Z-6V0A8:=MAKN2)#
MK:3-<8<#)<T,[LR)2W=0ZQR2%K&?:-Y.V,D!9(]CT'>C-:UO6P)!\ U:Z^XV
MH3N.I#*<Z BZYX8T;^TS6%2F,OKG#K(JNQHX(TV+695D]83TK_"9W&CSAB3+
M$QGJF%&&)U!9Z4X\@R$HQG%QFDXM:-/BFOF0:4ETR6J9HQ6/A4H*+VC75JW?
MT9VIVLOIU_:YE4D,ZYNB,S2L8#/F)06I8+#1P&N:SJIBE,WCYI>A('"1 >3$
M9O\ GBM /UHW4ICX&%B2<\:J$)OFTN/X:_#Y'35BX]#<J81C)^J1,9DX=XP"
M(WISQ4:LSH61=<<J=067Q-T38;''XW=+M#(=!K6J2]D$41EM$5>[3IJP$FFA
MSG\3CX/AS8_(%S<M(1>@HWVX A#J2S=OP]P@H9<%+3D^*:_!K1_ER)?(Q,?*
MBHWQUTY>C7YHR)Q1XV(URK8LZZ,L^[+'ZTZ[LV)-M?2OH*U6Z*QSZO5PUNHW
MXBKZ<K:$-C;$JEKA5(-A<EC>D]Z4.#B6 ]2J.V64$OLQ</&PJO9Q8*%?/\7\
M6WQ;_$Y48].-#VZ8J,/XY_$DNR9.XX;BW-[NWKFEV0HW1K=$:EN<FUQ3$K6]
MQ;UI(TRQ"N1J0&IU:-6G-$6:48$0# "V$6MZWO6 04Z\(#C7@)! .4_(OV-R
MKS+)ECFHUSK"T]*3UMK1 ]JE:IRCG/UG6G6DKLZF(T U<::C3)'!8- H,$,D
MS6M%@+IM^S[;DW_J+Z8RN^/%:_BDTG^:9)VX&'=9[ME:=GQX\?Q2>C_,E7Y3
MY4I+BVCXASYS_%/JM7\1+5J-F+%A[Q)Y;)GA0)?)YW.Y*MV)RE<XESL:-6XN
M"D6QFFCT &BR2RBBZBDDM%P2)Q)):+D>SOJFXCT71MS\^6 8\$P.]JGL6FYL
M='EI#<_E1&SX@\0F2&,;@I1N"9 \ 9GP[:8XQ.> H[01"+'K6P[B#%'#W&U1
M^/[EVL.1:)4S!7552_77ZK*)Z\H9!+#/KY8<MLU\^*N[<SL*)7ZDCF:P)'J)
M"O9IM%@WZP@[&(#/]A5_"K7@DRK"R8PSS6O;#B[["IO$) C+7L<GBDF;%+._
ML3LB-_(4M[HV+#230;]'I /?HWK?TX!!Z#P:O[/&S*-A'DZ[KA?'HP?"TU (
M5M,.LTC\)%H!6ZSB/3SW6"V]6" (6XH+:A3?$3EB1J#[O[T,6Q';IDMGVR>1
M^JE3%WZZZ\=-?BXZ]+?ST)-[?ARM]]UQ]S77UTU^.G+^PF>I"DJKYOJ2OZ*I
M"%,]=U15T;0Q.#PUB+- WLS,@T+80[.4&J%K@X+5)IBE8L4FG+%RPXU0H-,/
M-,,%4R<,J8!A7H/G.C>K:IDE(=%UC%;=JJ6!2_&X=+D(E: U2@/"J;71O5$&
MIG-C?FE6 )R-P0GIER,X.C"32QZT+ - >-O"OQ#Q78R>Y8BUVM=5QL05J*N[
M2Z?M-^O"6T]'7!O"UJ8O40I"!.RP-M-0^T*,5I$>G<\@X9!JTQ/ZI0>NNJJK
M7VHQCKST26O\CC&$(?T)+7X+0EHSL.0P!@# & 1\<]>-'G7F?L3JCN"N5MD'
MW/V#[C^=A+)),UN<*3_#ER=P3_5%C2QQM7L_I/3!];VZU7Z0^G7T?Y< D'P!
M@# & , CX_=H\Z_O%?WGOOMD?UD?S4?F;]Q^LS7^;3ZH_"_A'M/JO]7/BOQC
MW7Z?;?$_4]?Z?9^CZ, D'P!@# & , CX[$\:7.O<-Y<4=!W.MLA+/.";8.N2
MCB85)FMC8%<N/E]4389<Z;U\<>E+^S_&:;:-:)3J$(_8B4!]IZ3 B+ D'P!@
M# & , CX\DOC2YU\J%&Q3GSII;9""!PZV&*Y&DZKY,UQ5_%+H]$)U"4!:QP=
MXY)TQS/MFL-?LPD*< Q':*%HS6@"","0? & , 8 P!@# & , 8 P!@# & ,
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M&UJAH7(#6XHUXVY:7L01HUP4AQNTBH&P;ULLSU1ZWK?T8!VV , 8 P!@# &
M, 8 P"&6]_)3T6P/79LMYBY5K>\>>O'>X+(_TU,YIT*\5;9<SF<5JN-7;;$*
MYTK]OI:?1V3.E25M+6XQ8?)9!'"79W5"0(M;T1M2:!+-6\_C-KUW K2A:LQP
MAUE0N+3^)KSB!IC5T9F+&AD3"K-3&?EIS%+6XE#$ 7T@V+T;_P F >TP!@#
M& 1K=)=2=:,/6D(Y,Y,I;G6PI*]<ZRGHF42CHF]++IYB;6*/V7&JU*86$JM:
M"O%>ZNRA?)"E A*"DA.B0BUH7K!UH8$@<*/F*J'1)38K7&6.P5$983YTR0I^
M=95#F>8G-24R3M<2E#Y&X:]R2,M[V(\E O6-#4J6)0 --1IC!B) !Z; & ,
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M\06C)U&9+)2&-S*]S6FBUO2C )H< 8 P!@# & , 8 P!@# & , 8 P!@# &
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MS>[.=A0_R(\60J(JELIE*B-Q=I?;>-52%<PP4;SN$-TJD(!%I5KT!O\ BZA
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M,#>G & , 8! #SU=\P>O,+T3;"SD3M^(U;>O.'+U PRQIQS#/HM#4<TJ"?\
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M@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# &
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M:G;ZT09@J]CFDBD\7^'/J$WXDC2'(?56I_\ .^DXO0@-)NO?/UP_2/CHD?D
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M ("]E3=BU[<%0U7;=2+BW2J;2K>#V+63D2RN<:*<:]F\8:Y-"UQ4<>FYH>&
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M2U,B0*!F;&]H0@,.. B;$29 D":H-$<H-"F2EE$A,/.'L8Q:#Z1"WO>_3O>
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M9<4UN%,D684;''"87\"42:,M=7J/BK?MN-4?!7!Q."9K6A>Q_P Z#8$O^ ,
M8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@
M# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
6 8 P!@# & , 8 P!@# & , 8 P#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>38
<FILENAME>tm2227887d4-fc_antibody4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2227887d4-fc_antibody4c.jpg
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M04B4O:'!M15U:#U*8B9BO 3* W(" @(" @(" @(" @**\ 4@@(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M%62S9ZF\LF_2NY8AV!Z>.JWG#TOZEL-1:*U+DKW3C+N!N=T[>W5U>17MC+/
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M7+ELKHXKME[=6L+!( ^-CZ-/;5=]Z'J_Y1J;:[V=3@Z'U'3C3WL;C*;99O\
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MEA;-;X^TM)XI)HY&LF9<6\#7\<3I*BM=N]8)MMNGEF*3/%FLU+K,8G#L8?\
MUB=.<W2USSU#H*QFDO-'RS-N,/<2-<VL%VZ>9D !8P'P8P&FG<M3MMW=.ZU-
M"Z?6TY;/7FS::6EJZ?LZ\9=CM!Y1NO;_ $EU0V^DX9I(,;K2.X%S:B1YA>;>
M*V\-W 'A@(]17TW3C[1X>FV(K=$5KY'0-[LIV'78ZAJ8:=\Q^%E>WT;;@2-<
M[@C=3AD K4.^,TMIM!&Q=+TM.[2G4OF*Q-78];EUHLNMG&*2^)S?+S0!PF>R
M#]':;N;MV'RCYKF7"XU\\KQ93N)=*^V+^,GM[UP)MT[]C?6.$^G%L;MQKZNY
MMF^Z9OB8B*XL'[G5%''S<Y@^[L; R/-91K8(VM9#$UM_>!H:QH:QH ;38-P5
MND1^RTXX<T>>%>I^KN-2;H_(]"_[Y-VG=-9[DWJV;.:>P^;EM[JU:V3(8RRN
MWEICCD<UKKF"5S3Q-':N[>(;8F='MY73_#>I/N]6:^KSRO166BM&8J9F1Q6D
M\#CLA&/M-S8XFPM;EA('Q9X+=DC0/7V+KE;K)I9\KL<TOL];V6^RW46.LK^]
MO96MALK6:ZN7/(:UL4$+YG$O<0!PL8N#?JVZENIIWY6Q-66W3F.6G%AX^8OU
M1YGJ1YWY/"XJ_GCY><O[J6QL\9%</]VO)&2W-O=SO\.=\4GM@NVC8M;L-O&]
MV-]D129OFD=D5;R-?W&A.E%*Q'SOD^BGH]U)U?<QF8NW,]CRQTU-!)J/.B!S
M8S'QV[_=8287LE=,QQ9L*[U9M[-ITK3C4PF(P[W2]YJW[[=>[L]GC++*Y-=,
MW)3D5INVTUH71>&M8K*W@CGNKNQM+VZN)V,B$LYGG@+PZ1\==E*56HOU;]6?
M6G#@YVEH:>C;6V,8XN8K[%:<N;66.[P.)O+9S?#\";&V<K7!PX7 LD@<W<>Y
M8K[:83%7(LF:YT6Q^M7RV^6//72F6U/RXPUGI#FAC[>YR%I<V,$<4&4<R*21
MMH;:*!T;'OD>:$ ?A\'4Y8C]E'[;.CE:=\\T3J3ZG:Q4,_@,]I7/Y'3^8L;K
M$ZUTEE7QMDXIK:XMY["\<V*5KJ124E?!791<SH/4^7<39=/K2P]2Z;[VR=Q=
ME;DRL?*XZI'<].3,&A]59#WOF#R^@@L\A+/)Q37-LZ*!EJ?;FED<6!U#LVU6
MPWFG?J3?JVQ72G-H]CN+M2Z=#6QU+9P75XP RO:=A]8V+2V6>[V\V][<UB;J
MPBQK:EPVUW;-W8?25GT[[N6+94Y;:\T9JJRI$!!H;S\ANOSI<?E94:GU4^22
MWZV/D82'6O3]]CS.KN]__P#B+I=.\(?>.Y^E+L7B2O\ +]O3)WH\E6G[NO,2
MG]CP?E=JOL&G_3%_TO2^8;J*>*M+Z,^9E!R-)N'GU5/=5=4OFNG$=CM6E;37
MFY\MS$8UG+_63"=GWMYJN_83C;E:CJ-O)L=6>$PV_2*SU+1^G'G8&VI_9UUK
M5D[S&Z?4>8,4H'$&EF5NBTFFP;5P=M=[SPUIV1C'-Z6RZY,V>)M2_ARQYG-7
M3+TZ:SZIN<&&T!B77$%B)HY-0YYWB3Q6EA Z!\K:%DS(O$MWD=B^A:.WT]#I
MNGJ:T8<O9W.D;O7U=3=SIZ.-9QQRQ9<G(;I#Y'=/6G+3!:2T3B+V_-K;Q9?,
M9"TM+Z:^O86QMEF'O-N[PN*6.H  6HU;YU(YKYY;>$.1IQ[N>2V.:[M<[9C0
M^ALW8W.+S&B]/7-I=Q.MKF)^(QKOM4S3$:/%L"WV'G:-RU>O?%N-UM8<^RV?
M:YJ3P8L/FD])>G^FWF;BM<Z$L_DS0FO)9GR8B!KG6]A>,\=\P8X1,#6OEH0*
MF@6HU-W=M=W&A%>2Z:V][<6[:S>=/OU8QU8PN6S[?+9?3K;FZQ=_<8SWU@;=
MW5G/+%)<-D;2.-Q@>Q[N,'AWE=LW$1OMAIZ'&*.KWQ=MXFV["Q>6\M#RY\)S
M9QMOSWYSV4EQI=UT)M-Z=N&N8,H[[5/)=3/D@#BQLPW<57<2YNM?&WT(VD16
M9M^;@XNC35F=6Z9Y+61GISEKRZTICK?$8#1NGK*RLXFQ1QC#X]S_  VL:QH=
M*^W+WT#1O*T^I=[JSEO^KCAP;&R+9B(MC!PCU$=)?)OJ%T1E]-:DTAB+2_&/
MNGX?+6%C9V4UE>B.1T4Q=;VX=(&R/J00N%KV6Z^WNMC"[EG%S='5OT)C\R<X
M8:?-+0>3Y4\QM9<L\Y62_P!.WUY;07CF\+;JT=/<1VWL%K0#'!&.Q<?PY-L]
M-F;8I2[THZW%UNECG3SKY'D>\RKF7%<P>6EQ---:8R2VN+&.1[^"W<YL'B"-
MCGD-#N([@%WWJFG;?TK;:T?61&+K?3)Y+YT_R)R9!T3BXF3Q.-I)#6TI2AH5
MUB:>SQ;JV>:G"%G;SHB?WM[:=EXTGZ$OX2ZEXALC6U=&R.V/.[EX.U/=;ZZ_
M]&?,Q=X)GQQ1S6]P^*40-$C8W&)\@\, -$K"TM^CM7T;8:<7=-C;1[4VQYG0
M^KZE]G5[]S=[$7SYUV[RU_+RL.H"Y;S=YLV<TG+FPN8Y<)AI@]ORY,Q]O*\O
MF? XEC'U)]HU"X,:,].MG2CVI7C<6[[5G7_(HR7]-\K^6NB,5:8/3^B=/65C
M8Q,@MXQB,<^0,8UL;>*9ULY[R6L&TE<?FNU9K,S,LM++(QBCC/GITR\H^?.A
M\SI+5FC,.Q]WC[OY/O+.QL[2YM[L02^[SB:WM@\B.9]2%KMSI:6I6RWZRDTG
MOAR]OJWZ=U8]B)Q^5AC<XN7&2Y-\U]8\J<P733:5R5PRUN)&%I]SGN)Q:MHY
MC./@@8!N6#8;B;+[;:8Q='G9MW9%VG=CZTVR^6PUKJ_6.6P?+W$S7F3.:O[:
MRQ^';+.ZU_--S'!)*RU!?"WPO%XC1BWOB/8W;SJVSW416W3BM>QKO#>XC:=&
MW>UF:7ZF4,JSHO\ +AY5<@=-834FM\/9:LYDY"WM;RYO\A;PS08U\L$4C[06
MLUNV-SF2- J0N5U#=SO+?=Q]1;$1Y7 V6SLVFI[S_G73,^1<F.C](&#W<Z5T
M\+<,X?#^1<9X89PTIP>[4VM]"T^I;;S6S,5F,FTBZZ*S&4K-'F>]"O+_ #O+
MC,\\N7.'L].ZRTXUUWEH\=;LBAR]LX3GB,,,'!$Z!SJFA (HM=U2?<1&YX92
MV/1[+;M[^E2:,9QF0EM)K+,6\CHI\'E;)\DS:AT\MM>1EU"""TQOC[UV[PIN
M++=.L3[;4^(-.+O?1/M8XLW'HJUY<\R>F;EGJRYG=/<W>&A@F>[:XFTCC@#7
M$N<20T#M6#K>WG1WFIIWQGC\[4^']2V_IEM)K,3,3W35VIB#031U74VFGQJC
M;Z-BU=)MT9M[I^1NYNFZ8KE#$ \U+^%[JSAW\-M7T>Q<]_I75?"G\#U".'-Z
M6VWM?L^C]'T.;_)@_P ]VI:[_=WU_H5LOJG3?Z&TZ95GSOGFC_4>IVT93*ZR
M[6()'5XF]U'5^@%%_P!7=Y$<88A/FP?PM<E_(P?C+E=9\+?5;F/TY\[>=<_A
MMG^[CS.2?)H_A%:E_.KORBW7T[7^XK'S[2^_+O(RJ9S2,_ /IKJ=\5U+?*[/
M&4^1; \V>G[TG6(I7V[*A]?O'X:ZMNL?$^GY'9?#-8OI&=)\S$HAE]W@$E7@
MM;4N8]T3FBFVCFD'<.]=\Z59.KH:]D83-L^9U3J>K;H=0U(NFDS*YSY=G0+^
M^DSLW,+F(;F/E1I^XA?:6TPD\344A,,SX?>9(7NI'[0KQ4HJ='OCI?2[]K/U
MUUTTCRRXNG?.O=%__*M9.O+WDCR=Y9XBTT]HW0.!L,?9L$4 FQ=E<S!K6L:'
M&XGMWR.<X,!K5<"RVNO?J4I=V]KEV76Q'JYR^HU5RRY;ZMP]YA-0Z.T]>XZ_
MB?;W$?R/CV2&.1CHW<,K;</80UYV@K!K7:5T^[OMK$N5ISJ6WULFET,73S,N
MBG$=,6I+/7?+F!\>@=:W5P^XQ[6N='@YFNGF+?$$+&@.);3;N6OONG;ZMNTG
M'3G&&POL_F6C-DQ2^,W03D1K[*<K>>/+?6^%OI&W5KFK"&YDC<Z%KH+V^M(W
MMD+7QM>/#V;2N\]*W>G?IQLIC"Z'3]QMYMU:QE;+.GTSE8<]IW!YNW+96Y/#
MXZZ+@X$ W%G#.ZAJ0366GP+1[W1OT=6[;S-+HNR[8;?0OC4LMOC*8:RYEM["
MUN\A=3-;:V-M<7D_%1HCCMXW3/+G$BH#&$KCZLV39[N9PMC%?3T_7K;[4Y,/
M[S'>J3-=27._*:9QV2FAY=<OKF6TQEG#.X6U](R2YAO'RB.=\4IXQVC8M#M]
MK.]W?/$>K7".S%M_M%FST9M_*IC/:X_Z*^D/5'6'S%."L1/B.5NFI[>35F>;
M"X-X&O@D9;P!T3F2.N6O+=A%%WNW1LZ?MHOSNF'6];7^W:G)'LPRT>2W2[R5
MY%:;M=/Z%T5AHQ!;6\5S>W=E9WMW=3Q1Q,DG=//;ES3))%Q4&Y:W5U[]2:S6
MG!R-+0LTK*1$8N:KC"Z=O(G6]Y@L3/"&ECH[C&V4T8:06D!KX7-I38L$V6W^
MW$3++S<F4TA;$ZV/+<Y9\^-*9C5'+G$66D^9UC!<WUK=X^"*"'+.CBD>VT-M
M%;EC'OD<:$ #Z_$C0LLF;]&VET?A<BW6NOCDOGU98J&I-.Y[2N=R6E<U:W.+
MU;HW)O!=66VNK::PNW^%*UY$4SA*^WJ*47.Z;U.NZMT.$N+U?IL1LKJ8S@RI
M/*GZJKCGWR;9HS5EV+G6_+R.&RN9[B7BN+RT\*&.%W#)-)(XP@@;NU;7K&TT
MN:W5LCU;HQ:[IFI,:$:<S^TMX=BZ_$X%AX35K=@-*=]?IK2:D?LYPI/8V=N.
M/!/$06 C=M^J4T_5TXBY,YJBRH$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!T.\R, ])O,;
MT6L?Y7<+JGB"/\;M)_3EL^FS];^[GSPPOJ_H4=N[)_\ Q:[?K>S;_P /H:RS
M#2NGRLS[RVC7I.Y=]WNS]O\ P5OV+;]<C]KITS]W'I:#HOUFO/Z3O#<.<VX#
MFFAI2OPKK-T73NK:80[%$16([5GOSG'UZ>;!CW4$ETXN%-Y$<A^JM1UF^;+M
M*[C7TNP] GEU]2(RI+%[L;2;(7NG<3#5KLEEL3;\5*^Q+>V\3Q3;L+7KM_19
MC7W6CS9T=7ZYJ\NVUIMPQP_"SF>E[0MAR_Y#\O-*V<$<5O::>L)7,8QK Z2Z
MMH9WN<&L94DNWD+D=8U(NZC?=9[,4HX'2K)C861?[4XN?3!$0T%NQOQ1NHM5
M7UN;C+9QAD@Z*(-X2* ^OOKV+%.A9?7#%//,+,?G08*')<BL#?\ @M=+C;R=
MT,I XH1)$\&A()%1Z0NN]?U+="[;V1A'/3\+L70;8OLUHG+E8V&A',&N-#1A
MW"/E_"T>TT-1D;.OM#:=J[STV^='J.CL?S[*Q\SI76++9V.KJ<;;O2SN-&S/
M&A-'N#Z<6G<(USCM.S'6U-^U8]UI1]KU;)C*Z3:ZMWV'3NKC-&[:H=72FHW5
MXOT RYV=OZ'7'T%U[J,\O3]>>/)=YI;S81,[W1_>6_K0P..94CH^9_,-W;]\
M.7K7;0#)WF[?V+2>&+(W7AVSFQKJ?_I.P^*(G^<7]G)'F7TO)#Y>6/A<Q^8%
MW9LGN9_=(L7>O:"^VXFVK9FQO+"X>(VM:%?7NNZ/N.D;.,JV^A\UV$<V_P!6
M[.D^ED$&!K+ALC.PN)[=KA4_374[;ZQR3EP;J^V9U8OC/BK/BA'VQS?:/U1Z
MMBQ3=,VS%N=&:[*+9]E\[JJQMK_2>I[2YA9+#<X/*QRQO <US76%PW:""-Q7
M7MS9%W3-S?.?+,_+$3+F:-\V;C3FV<(NCSL#OF1CODGF#K[&@ 6[-0YHB.@H
M <I>%O8*47)\&ZU]NQTM29PNO],,W7]*VW<7S3.ROX&25Y+;R[DEGV@G@;=V
MP:TDD-^UQ[AN"^I>,8]3;3&4V.B^'+_>3K7?IKTCMQKNH1\%%\_NFZ)F>%':
M(6SNH3RRN274#K;(\Q<Q<W6/U7E*^-D.(3>TT2AI9%(T\(89.PK#I;2SFC5M
M[7+U=W=.C[FZ*112Z.O+CTATC:ZU-KG&:MEU3<Z@ 9:03V,,!QC0UC7"&5C"
MXAPCH=H6_OW^IJ;7[)$>K#K]FPLT]U]JB<>Q<O\ !8X/+VGVR"2*D[Z[A4K7
MS+9TPI2BJ!'$#0-8VE2[<* ;:G<*>E5F93$1$4AMTF7P]J'.N,KC((V NK-?
M6T88&U+W.=)*  *;^Q5I^5/8,7'SB=4Z'U7S8T7<:/U!99B]QYNH<\+%\%PV
M-[?>F,:Z6![P\-.P577.C[:W6WV\UK)F^V+HQ;/JLSI:.PLU(Y9K+K!Y<UY+
M:=8>@7V<A_))FB0C:WC-L'@#TU7U+H>I,]-NT+\;8B?,ZWXPI=;;-OM5M9F<
M$8]T82WVG0Q.J=M7.8TDT[-I75-7#4NMCV*SYW*T+::%O-GRQYFUYMCVZ9SW
M&/;^1\KZ-GN4]%K]S9%FSU*?FSYG+V]UUVI9S?G1YV"ASSXV\WN9+''V'YS)
M5W5'YOO-Q'K4]$]?0TZ?G>F'(ZS$6ZVI,_F>B60QY*(!Y-ZM:-@-[:#OWPL"
M[KXECEC1C]#T.E^&O9U8_27M'M#(W!@IV_0[?@75ORHCM=HF:>M&;J'UO\QO
MW,>F;F)J=MRZVG=BY;&&5KBR0/O(;B'80]CJD ]JT?6=6-K;&E9GJW1\SG=.
MTYU-6MT86PPEKFY<6W=V9))<CFLQ<>T[B<^3Y1OGGVG$DG\F[5O_  SM[9W$
M:-V5T5]+@=:UYT9PGN9B/EF\HL7RJZ4]%1Q6]I:9[4EL<EEKD&%L\OBB,Q-E
MD$;)'%K!6A)WK;=5UJ[OW=?V=F37;+0FW0F9QF^<5P_CM3PETL%6@;1*S;Z]
MH6EF)G"N#9Q=="%;3C#O&@V5V>(RGT.*BR1?=R\LJ<ELW<W$+[>KJ2V]';/R
M5GQ3\84KN*X>KHW3?%]F?:R6S3#@Q-/-NY;6FA.I&75>-LX++'ZTAMY2ZT;&
M(G3Q17#IWEL+&M#GR;3O*U>STYTNMS9&%O!V2V8U>E<]^-U);/Y47,271751
MB-.FZ=#8:V;/%>5>61S.A9;-A#FE[6_&IO!7T7:Z/O>GZ]EL>M3!\Q]Y.CU&
ML1ZO-Z672T>R16K31S?4XERZKN/JYIF[-IQ,9Y*K0 *!1I1$611>45D0("#0
MWGY#=?G2X_*RHU/JI\DEOUL?(PD.M<D=6/,VG]G_ /Q%TNG^$?O+<^678?$?
M\!MW>CR5?\^O,3\[V_Y5:KZ]I?TQ?]+TOF&Z_JO2^C/F91D]0USAWMI])=4P
MFD.X:>$S+X[F$[Q- :RV4_Q:S7T/DRY'H6KZO]VZDS/Y,N?T:ZO5=*)RC4M\
M[ RU/(PZOUU0\0BU%FB\$;=F4NZ$$[0M?TJ;)\/Z?+CZ_I;;Q+2WKNK/#DCS
M,ASR1] 6EII#F!KZ>WCDN\S-8P6ER^-IDAC9%")6QO<SC;Q\ K0KZCUZR_0Z
M3M+<K;[:_-#YSTR[WV]UKKL9ME?@;;04]D&M2X.K4U+JGZ:Z;;K\_JW9PWON
MK;:Q'%#BB)<TCA+J#;M(H._M4WZ=MUE9A-MW+?$++/G5XF*ZY(:;NRQCI+"\
MN.!S@TN ?&\'A<02-WH77.I:-OOMM$>UC^/SM[TW5OC0U[8]F:,:' 8T9K*:
M8Q+'DLOLUAHG1FKN)AR%LR1M*&H+7+N_0=&-?5NT[L8B/0ZCUO7FV(BWC+.G
MY$:/QVD.3_+[3>-MF6MA9Z>Q;Q#$QL;>.6PAE<XAK& ESW$[EAW>I%VYONM\
MB^UTKHV]EE_E<R<+#2,[:"G=LIZ/0M9=?SZGN[L8;&/5BMN"D86,CFCI[+XW
M@[=I!:0X5[-ZO?'+ITC*+93%UU]\3.5889?F0VMM9]7VN8;2)L<4D\1<T  U
MX[HDD@ FI6JZ'=-FRNB/SY\[9^(].+=MI88S&/S.UWDLY&X9SPU_9L<&VTL$
M/%&!0&D5K3:* KZ)OON/1GM=9C3MT[]&;8IS591;11AX!0U<0-F\NV[]BZI,
M>M6<G.MF9M6;_.<V]-FWXS;IFSU^*%U7=7>_ZMIZ=V7]\NS]!OG2UKKK9IA/
MF8NEO:G)2X+%VKRR>YR&*ADH#5S);JWC>W8*[6O7?NEZUL;O1T>''\#J?7]*
M8V^XU\>[Y:LX?I T;8Z#Z>.6VG<?:LMH8,%:3/8QK65EN((Y9'NX6,XG.<>Z
MJR>(>2.I7Q'U<1%&MZ!S3TRRZ[VYK5V6+&'>T'UK3Q.&&3<YYH"-H-0.P^G?
MOWKC3I1&KSQAA*_-,Q3@P]/-1Q=O8=8.IYX&-B-XZ SN:T#Q*>]4XN$"M"M)
M&I.GN)NX<WI<Z+)G2B[M@\K;0UAKOJXT^[*6S+RSTLVYNVMD:'QB0,MIF5#F
M/;7B'H7TJ+(W'1OM\XTB(AT_WT[;J?V",+KYJS! R.1PCX &0 ,;ZFB@ _D:
M+K,73C#?W6QAVM1P-#2VFP[]I473A6>!1U\ZI;2UGY!\R+>XB$EN[3N0+HW"
MH)%K-38>XA:7KMT?RO4OGMAN.@Q3J>G\OF8+]^UC(\M"UH$3,]D^!O<!DIJ
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MADD8"V3@!]CL;3=LJ=N_>N/%W-J39^3"\SDU"Y"H@(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MF/45_,L?;3^9W"ZKX@_C=IV\\MGT[_F?NY\\,+MWZ5.H/\*;O^.+MVM[-O\
MP^AK+8KI71Y69]Y; ITF\NQV^[2?E5LMOUSZW3_=1Z6@Z)[>M]-WT[5H/RY=
M@6:_.9 _>^V>S^N74_VLRZ_NYY=[HT[/3+L_A^9YM7Z,^9C2<K'?]Y7+X4_P
MYB]OJR-H%V[I>/6-O,]D^9T_6_@-U]+TRSPM!"FBM*;:_P"+V'_6^W5NH?QN
MI].?.Q[#^%M\CZY<-S!!:$\XT5Z<SMH/>C^-D72/%WUNU_>>EW#PO%=/<_0]
M$L8#E[MUWHH=@S^&^EDK2GU%]+Z5AU/0[[(\SYOU+#I6XI^?Z6>+RYVZ#TA7
M;_BYAOUNMEBZE_':GTI9ND?=^GY&Z:M_8KJ7]0,Q^MUPM%U/^ UOW=WF;W8?
MQVC^]L_6A@8<R0!S+YET_P"7LO\ KC>+5^%)F>@:=?\ J3YV[\53/^I=3]W'
MZK)A\F$D].DWY]'XV-?5/$OW?LOH3Z'RWP_CU'>3^G"\>NFNV"4B!LNH_P!C
M^<_4?)?<4ZU_5/N_5^A=YI9=#ZZSZ4>=@@<Y1_WL\Q=M:9_+;?\ I&]7"Z']
MSZ/T_3#D[JW_ #O6^A_^BR,O)<J>2>H@=QO+8=U1X3!V;5]2\61_A=I^[]$.
MF]!I.MN/I^F5Y][HR',<>%C6\9=79PMVN)/91='U(K2V<Y=EM[LF-5YK/7/J
MC*:PO^G#E3GI<7AL:R.'668QT[VOE?(RY:;9LUM=![>$^SN"TVK=&ZU_L\3/
MN;6WT+/L^G[VZ(YY_!_ZK+ND-&ZAUCJ3&:/TCB;S/:FS<X9!;M$]Y<3S2RM$
MLL]QP321!SY*U=WKL&RV%VEH_:*>K:T.\W]FMK?99GUIG)=ZY2>3%S;U?:09
M7F3J^+0T,D<,[<$V&.]DX96QO+'RMM2YCQQ&H.T$+)=KS&$14MVVE2LX7.ZN
MDO)5Y#XV)C]:YJZU+<,X"\L M6 CAW4B#B#0]G:JW:MUTUXK6:5EN%*U=R.7
MGEY]*W+*UMCCN75A?W4,D3FW=^V.[>7L<PQD-=$!L<P$UJJQ=J71,5PI/S+S
M%MN%%EOSD[#$8CF5RUPF#ML?B<;B[>X!Q^.L[>V!!AN.$/%LQA(V#>%H_#^M
MI7=1W6E96V(NRKWNR[C4U)Z+9S4G"74'R[=O5MR\NG;[BXN&QM:=C U]L-M-
MU5WSI>G&IU".ZV[S.C=4B?Y#,=MT>?M9GUB*6\(_WB&O]#:NKS3[5J<OL\T^
M=LM&)C;Z=<^6&WZD 9IS/!HH!ALH:#\Y3E<3J6&QU/HRY>U_B=/Z<>=@F<\=
MO.'F.?\ GS)?=]XL?2ONW1^EZ8<KJT4ZAK?0]$LA;R4_\SNL/S[9_E+%W?Q#
M[&C]!TCP][.K].?.O93D",U'$"#[/?L[_0NJ3?[O2YN#M%MO--%H7SBK!TW3
M+)D!&]T5I<1B:@+@.-LH;6@H*%=6ZSNHZ3KZ,;3V]>:8X\:^EVSP[K<NTW5E
M],;6+58Q0'(X2VO_ &K#)9#&V\X#N'A@GN8(I34;J1N*^A^$=&RWK&G;KX7S
M;7YXJ^?]<YHZ1J:<93=\N;);Y<^4ETI:_P!!Z3U>;>XFDS>(LKV:>*Z(8^>:
MVB?,T?:Q0M>7;B5AZW;?J]2U/>3E=A#D]*U;=+I^GIVQP^=]Y_H8.E3_ ),O
MO[I=_2EPXNNCBY,\D\$O^A>Z4S6N,OO[J=_2U%9G/S'J=GX4#Y+O2F:5QM_V
MU_-1V_\ W),>U:+K8X*3O)@Z4_$ %E? C:V/WDD#_P"YK'%T:>I7FI?)=;%]
MM9M]7ROM-!^4ITR\N]8X37&!Q]W%G,%<1W-K*;HT\2.6.45:(P=\87-^U:_+
M29<6W0T+;_>6QBNG01-MX(8&?$ABCB;_ ",; QOTFKC3CBSJJ @("#0WGY#=
M?G2X_*RHU/JI\DEOUL?(PCNMG^%CS-_5#_XB[73_  A]X;GZ4^=V#Q+_  &V
M=ZO)7 '/;F%MJ3;P>BGVJU^!?7]+^E[Z9<T>=\QW=/\ 5>E3\V?,RE5U%VY\
M3S)_8#K']K>:_6ZY6LZQ]W:E?S6RZ1]XZ7TX8%VK^(ZVUX2:CY>S=?1^B5Y]
M%<'H'W+I5_/],-AXBC_.M6/T/0RIO)[_ (*F#_/-Q_\ >E]-\1_P^UC]#T0^
M7>&_XG=?376H/BGU_AKJEWLNVV\?*TUUO'K'U6K'L_K;F/<^S:LW>=%_F&P_
MY[F^CX4BZCX@^_-A'Z5SLO2ON[=?1AC<<GB3S3Y=UW_+V*/_ .<;,KZ]X,I'
M4]6.'NY_5?-?&V/3-*/^Y'G9Y.E*'2^FZ;OD##_K=;KJVO3[1J?3GSR[+M\-
MOI_0CS0W^BQLR23\C?\ R#OJ%4U/J[O)/F6L]N/*PR_,HV]8>MZ]LT?U;I==
MZ!AM;_I^EL?$/\5HQ^C'F=E/)?%.?6NZ]K+6G^TM5]<W\_Y!H_1GS-+U+ZS;
M>5E0'XS?Y;ZBZ3^3+-QA9O\ .;_@V2?GJ/\ ^^KJVWC_ #RWR3YY=K\/>U?]
M&?,QG.7 _P"\OEK05_1K$T%?[?M/H+N6PF?YGI>673.H132W$\*SYY9Y&@23
MHG2A(H?O>P^S9_R?;]ROU'^-U/ISYV#I>.RL?6CM6LLSEL5'^;#U'ZBOI^RK
M/M?(Q!_-B!/5]FJ&GLP_C+I=8Z#AXHW4YR[;US'PKM(X.1_)K_A&YS\ZR_E%
MNOJ>QQ\-;B?TH\[Y5U#^I]M]&?,RMRNI781\KM2#/BCX?JE9;LU8R< ]4=?W
M!^8]/\G<A]RS+KGBG[DU:=WG=@\,??&EY)\S!9R6P9@#_E[)U_ZRGK]5;?PE
M2-'9S^E'GAI^IUCJ.[KW^EE^>59_!/T7_P /^,MU] ^(?WOI=ONX\SKO0?X:
M_P"E/GE<H)^F#]9=(OC]G=/<W=<8AA]>:?\ POM6[=G#;U]%67-5U;PI6_8]
M1T^,W>EV/>TT]EM]3*.7'YG,ODT7T<'/G/6- )+BVE=ZPV&W*^H=,TXT? NG
MISGS3YWS"-7WWBG4OC*C*>9&UG%0;7.).VM:E=9U+JQWT=JLMBW))*/M9:-A
M.[T[=OU57;Q-MN2U\]J4M_(MFQK7$FNZ@^FN/NK:W1;'LXU7LGU<?:8@7FJY
M 7_6#FBQOL6 CC+AMV%MTVI[EJNG3IV;JZZWVN;TMMO.>[866791;Z'*?DR[
M.HG4@K6MM(:^N&W7TS>W<W2+;ISP?.]G$1U>8CO96173M3VH\KM?!:Y\V<TZ
M2-9;*UDLOJW*ZONOZFT_HNS>&/K*]US$VTW^RK1]!L.<Q/P?HA:KN/3,=_I3
M/YWI=9ZC/[7==]?2SMN2PIRFT/3=][F*KZO<8._T+;>(J_S?5[*1YH:SP_$1
ML-..^?.Y-L]S_P"2*ZY9'[:6VO\ :EJ8OR-OP_5*SVY*+;?FJ?P3]9>N#\;<
M+KWB2:;.*4S;_P /Q7=S]&?,Q!<&:Y#30[/O@QWZY0?A+LO0,]#R?B=>ZK,\
MFOY9\\L[?IU_S+\OOVN8S[CA7.ZK_'7_ ">9P>F?P5GR^=;[\X7&75UTSW60
M@87-L+AIE<UI=P"5DH-: @+I?B&S2OMT[=3.N#L73[M:S4F[3]GBQ6<;[L^[
MPUM<D>X3Y#'VUW_.KFZAAE=Z.%CBNR>$=.[=]4T=EJ9WQA\E'%\0;C[+'\RV
M^=F?RLE#EAY372?KCE[IC65PRXNI\]BK*\FNV7#@PSSV\;Y6-88M[7N.Y;7Q
M%H3/4=3I5\UC1G",J<<VDZ3?M]'6GKUN&YU_:F<I^3@Y!9Y,/2E(SB^3[Z0/
MVAPNCN_H:U<:EUD>[F8JV>XLT]?4]Y?;BJ#R7^E,"GR9?>OWEW?_ #M8KK:S
M69P9M/5C2]B#_0P=*1%!C;WT'WDU]/\ ,U:V)MRDOOBZM;0>3'TH0CB?C;X#
M:*NNSO-:;X_2LL[FZR,9AQ+=OI\_-$3S/K>7GE*],?+C6&$UOA<?=_+6 N6W
M5G,^YX@Q[962MJW@[XQVK/9O]6=+EB:V=L8$Z&CS<U/672K9K8HHX&?D4$44
M,9[VQL#!])JXEUUL8S++$1P:C8JVW6W3AF(JX(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MM)U/[OUOW=WF;S8?QVC^]L_6A@7\S !S*YE[*CY?R_;_ ,Y7BUGA7^G].O\
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M[GMU]1V'],[GZ4>=\KZC,?ZGVWT9\S*U.Y=0U?8^5VJ$(_B#X?JE9HRA6,G
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MC&8APBM:;5:LTIP12$5"1 0$! 0$! *B9I%046W1=%8!6D0"QZ?'RIE%9$"
M@(" @(" @(" @(" @*)FD5$!3L41=%T5$58$! 58NMNG#. 5@00JJ77Q$Q B
MKB!6.^?R8]I*(5[:T];-"%*JEUD73WI **;+.5"*N" @@XAH).X*FI=R6S<F
M(K*#7!X#@:@J+;N>(OX$Q3!'O*<\S;,QP*(--151HW1=;S%T4FB994" @("
M@*)B,Y$H(J1W+#IW1-UT)F%./[+X/KK%HW3&G,\(6NCUE4+E63S6U4R15@0$
M! 0$! 0$$"L&KP3 %?3B8MQ)161 @(" HF(F*2"12(I *0H-_:@(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(*'@[:U^DN/H:-VE?=?,XW+S?6WE5J;5DBREW
M-56J0QUXMOQJ=FZBKI:?N[YN[29JJ+,@00<*@A3$TFJ)BL#10 ),UFI$4A%0
MD0$$*+'%DQ-:I4S&2\NXMAI44[A3O66)HK,55%2ZVLQ*2BBZV;ISP2D>PNI1
MW#2O96M5>WU8HK,53-!:T FM.W<DXD8)E$UF,,TH46/W<\935%94" @(" @(
M" @@!18]/3Y*XUJF9JBLB$**DVS,UB<1%7! 0$! 0$! 0$! 0$! 0%6ZWFB@
M@!15LLY$S**R($!1,5B@I%C^($/HWM%!M^%8+-&;;JU6K%%5<A400(6+4LNN
MFL)B45DB*11"%%6ZR9FL324HJT5B,<T"4X@I$%6VVDS(BK @E<.)I&ZJQZED
MWV3;&<IC"4&,X6TJHT=.=/3BR<:)NNYIJ-:X-HYW$>^E%'NL+K:X23.."+&\
M+0*U4Z.G.G9RSFB9JF65 @(" @((*O+/-S5$ VA)[UCLT^6Z9[4S-8HE:SAK
MMWT^DHC1IIS97,F?6JG H%DT[>2V+>Q$XHJX(" @(" @(" HF(G,%((" @*M
MT3.4T!3;%(H(458MF)K7!**N@0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$$"0!4[DS
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MR! 0$! 0$! 0$! 0$! 0$%+P_P".^E_%5N>F:O*G-&M] ]9_BK%J3ZM5XCA
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M1NN.>R1GB,EBD+_:+X)&S1/!K0LE82PT]"FV.2Z;(]F&"*\L3.;<UD! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M8MI$677:?%?SMG.<'A^R0.(<*4H 2&_1"ZK%G),TBEKF673,>M[35*RX@("
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M>/@GM[6.*5O%0 TD:5&I,1J3QJ:>-L4X.4ZCO6-E0!!V@@^I!% 0*A 0$J"
M@(" @(" @(" @(" @TTII*T;^*.2A_$T;].M%34C]CJ7=ELG-2^VWO8:7F3<
M+NLCF2TN('C6A<\=E#=4'PKI7@6;M3IG4=6<>6_TNS>*HY.CZ%\83,.+ND?D
M%'U0\X+?E7<YLZ7;,R5S+]L7O!>(F1.)X.!^X2=W8OJO2M./],6[GCBZ)O++
M^H=%T]KISRW3=%9^5=Y;Y&=N*AW.AQ%=A^214^O\R=BT'+$3-T9RV]D\NA9H
MW8\L4_ F_P!!G:?_ &T/_P"JA_>JG$]5(?(TCK4<ZW#N_0D?WJD51AWM!D?(
MSN/=Y)+'G7Q7;&.=$UV) :YP:2UO]24'$X *M\WS;ZOM<%]/DB_UO96ZNHKR
M[NHCIVM,CJNYT_+J_1U@]PESN/+IY&1 2N\1UA:VW&P>%%7:N#JWZULUU(I:
MY%VEH:EM-/&8=#HGMO&PWEI)<6%_9SMGM;Z"26RN[.[M9 \<1C,<P+9FT()&
MY;[I?-A,^S+@;CENLKCZK*!\J+K$O^<NB+GD[S$RXO=;:(AM[?&9&ZDI<Y>R
M;%  UHEGDD<ZW:_?3:N7O]K[F8U[8]2[A&+BZ>I[RV=*9]?@O/0CAC V[*C;
MOV;/K+4782Y=LUCL55"P@(" @(" @(%:;T! 0$"M=R @(" @(" @(" @(" @
M(" @)4$"H&\H.)^=><R>G.5NM\YA;CW7)V&!R4UI<@<1BE993%KP*C:UVU<'
M?W39H73'M1_>YW3++-3>6VW8VU\S!;YC:JU=S"U+J+46O-29'4=Y/GLFV.6Z
MNKJ2"W$&1N6QL;:RS2QM !INI11X6CWN]CGFM)AR/%<>ZZ?-\12(CT2RZO*U
M>YW1SRX#V-8]K;QIX*!I \#A(#=FY=Q\26S;O+:Y>[BGX7S_ ,+:ENIM]28]
MKF7$EUUVH0$! 0$! 0$! 0*A 0$! KV(" @(+'_F+>8AKSIOYLZ3T5RUGLKD
M6G!/JZP>VWGDECE$LL49<ZX:Z N8RFX;UU_9;^_<^*/Y5$S[N*5C@W=W3XMZ
M+]OI$WS6F/9W-NY0^=+ROU3-#BN:NE)="^]VWNTN49<-O(Y9G1,C<YT0N'%C
M99"X[]B[5X@TM+I>G$Q,W67Q-(['7.D7_;=>=/+6BZ.$XXK(_5!D]*:NZJK_
M %1I.XBRFB<[G\9D67["V...V;D?>IWOH2VHC=7:5QOA_%FTT[M6V*8S^%Q?
MB-K76:NGM[_K(Y<O[E\W,^:WT_<A>7&E='<OK6;7V<PN$Q]I<XR!S;.&"Y;:
M,:]IG,W#)]N;0THN5U.Z?M5U\QA,N=L=O?;TS1U[YPOMP=<.67F\<S.874EH
MO!YC'V.D.6>H+WW6[QTIMIC$9IHHH&F\?<DM+C+WK'M].W7MF[)37U+M*^+<
MXED>V4\5Q!:7,)#X;NWAN(7M(+2R:(2AP()#@YK@>Y8<8]662*128R:Y0N("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(.@?F<]5F-Z+^BKG9SXR5JV\9@
M=,9'&VUN91$Y]YF,;?6MN]CO%A=Q1.'%L=78B8F*^MD\4CFGK2]YD<Q]<:\O
M'S22ZMU3GLWQ7,S[J1C,EE+F^9'QS/E?2-LP VD!*(R@Y7:ZN.6?,'1FO[-C
MKB?2>H<5FXX(GN@D><;?P7GAB5CF.!D\&F\;TPA68YK>67M'>4WU:1=:_0CR
M1YYMMH\?<9?3EGAKNT$S9I8IL%86%JY\H$TSPYX[S4T5<:8KSZTY9KD+'!W9
M1S>S;LK7MW&H4Q,QA.:,\4S'<30ZE*UV?#1(FHF4@@(" @(" @("#3W)>(CX
M?QJC8%,4XY%+IFEN;07<[K>QOYRPN=:65Q<--3[3X87R@"G>0G-/LQ%(*1$\
M_P"4P(/,$^=$]372KU6Z]Y,Z>T%C[O3FE<E/:,GN/#$[XXKN\MFF+\U-#W$6
MX)XN'85%*9YHB^MTQRXQWNQGDT?.+.H;S!>L_3W('7NBK'&Z3ST4TC;^VX!)
M &/MV!DO#<O(<>,G8'"AWIPFN2>;*VE+I9M2"1^ZA%6G>:TI3=NV[2HKC1,1
M7)\YJ7&3YO2^I\)"_P "?+X'+XN!PK6&7(8^YM(I [::A\P/HHK98JUK@\:+
MS:.@KJ(Z6NM?F_I75VD=8:CBS&I\EJ/%:FM<'F,EC[VQSU_?W]HUN0BL3;G@
MMR#0.-*J*5FD$W4BLM)Y5GE[=075SUD<HM!:=TQK+2EGBM38O4.2U5-A<SB[
M.PL\%DL?DKAIR3K%L(\2$&OM#8**:8T(NPK;E^-[,>CL&[3FD=(Z9N)G74^G
MM-8/"RW#BXNGDQ6*M;"29SC1Q=*Z#B-=]5%(I,)I.$RJ:T]G1NK*=FFL[^ME
MTHG"$YR\4SS:?_, ZBO1K6_^Z)TMR)S7L_FAY(\P*]].F[VO]#B43[4+V^Q+
MU)BT&E16FY7B9C)CI5%0" @(" @(" @(" @(" @(" @(""1C6M%0*5W[3V54
M=_%,YO,7^>!D_OQ],?J?;#Z%K?T4Y(GAY)6&?*-'_P"4)Z;13_YYQ?;_ &U;
M[?@43DF,'M=X#](L+^I.-^XX5*&[(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @E?P\)XOB]N_O]'I5;LAH+N-_"#&XM]H5 K6FRO;55VU?>3J73ZG8
MQZML\M+,)5):M;"\&O#PCB]=!3A[:E8=U=-M\71.%<F;2MPI=G18H\Z?GG+A
M]&Z8Y,87(#Q-5OFFU%!#)1\$,#)W6PE:R5KAQ\-=K3O6KW<6ZW4++=2*Z%D8
MQWYMQLXG2V6IJ6336NGU?)"QQTQ<NKWFGSYY9Z3Q\+II#F;*\+ TN!;C[ZSN
M7F0!CP 0.T+Z7T#;Z6XV&I.M$>XLMPCA&#J'B7>W[>="W2^NOFEW;.*[9YTW
M)9N/'+7F]BK#@N;;'6^+S;[>$,CB-C9/@@,ACB#1Q  ;7"I"^5;_ %MQM/$F
MA9HW\NUU*X>2?[G<-AIZ&KT36NNMB=Q9$4^5:MZ0N<5_R)ZA=!:\MIC!8W^0
MM[/4;1(6Q!EW/:V\7B 21L(X3VE?0ND:E]NXU9ZG=S[&^VEL3PK'"76>LQ=N
M-CIV=._9[S3FMTQC7%F[Z>R]EG\+B\WCYHKBURF/L[V*>)[7M>VYMXYA[37.
M!($G>M3KZ<Z6I=;.&,T\G!FT-2W5THOC'#\/%O"X/--<<F=,N5GBJI2BK2/P
M>OX%@U;+K[N2R:2M$Q&,Y-"\2Q4XSXO$=E#3@H=E5FV]D6Q6Z<6#5OOC+BJC
MQ'DD"I% -NP;*>HIS6S.&;-;$Y7X-DS.I--X*/WK.:AQ.*CBV2&[R-I;\1V[
M"V:6,BE%'/;;G,1=*TURC)\8_GARC,ONQYA:8;*\AH:,UC:UK2@/O':2IK")
MMF8QR?:XS4NF\S$U^$U#ALB#\7W3)65R3Q 4V0S/<*UV*^%WM1ZK%%MUMLVV
MSBW=AF8US97\5#VCAV5["=ZPWZ>I=,19."T3;%OKSBC))'$TO/Q7T##4[#N.
MRNZJIJW7663S325[9XQDT5S);LM<A')>VOBRVMPVC[B)I]J%X'$'.'" DW3.
MUFOM<D^9;3MBW7B^/9YH\["(ZNH70=3O-QCG-,\.0D,QC<)(G-=<79;1[:L?
M5JU/@72C4V>YUMU'-JQ?A/9B[5XLU[(W>A&W]71Y(YHCC@O'>1D(8=+<X+HW
M,,44M[BF>%+*R,MD\*,@M:\@\/"TU(%%]!ZQK6ZG3-O$?68_,^5]+T[HZ]O-
M2R.7;32D=Z_:Z1DLK1;7MJ]HK[+;B-SMM:^R'%=?LFR+9K[3L6M&I=='+A9Q
M1>_BXJ. #2T,(-:UH":^LK@[J[EB)EFQFWEKDB)VLDX'W]J&-&UAN6-D^'VJ
MA<C2I&GRW1BFZDVQ,5YN."B7^)<,?%<130BH(CN1-PFF\BI(WK%=I7SK1K1=
M^SC@I-UL71$QFJL>Z,R&>YC:P;C*YL;=NX<3B*JNE$>\NOF<)R7NK7EGV5%\
M\1,9BN[/C!/$WWR,D!Q_DMI7(MB8MNBM;IR8M:)YK9TXPAN\30& \0>:?'!J
M#7?2AI3:HF;_ '=)S3$1&0QE'5)J>SLI7?VKB:-UT7S%V++=/-"9[2:4'?\
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ML87W$L4,(WB21L;6=NV1U!2B1=2:TK:4BZ)K-)?'YGFCRZT[*+7,:UTY93[
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MWASC<P3[1PM@D;)PU/\ &DDJ<:UG),?G4I1&:YM[/[=<W=O:6X!+G74S(&T
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M+G16<#+=A<3O/!'O7'F[FGFCBSSFWE0@0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MT!-*[O@2,9I&8<;*$\0H-Y]:&:9 0$$"0!4[D$.-O%PU'%W;_H]R1C%8R$R
M@D:YOQ:^T-X[NU1$IG-YBOSP+;UD::'=C[7Z=K?JR)KA\JPYY1FSS"NFVNRF
MN<92OYYMU6<EHSE[7&#>UF"PG$:5Q..IL)_K.'N4PK.&+>$!! $$5!J$$4!
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M2';VWC$,8C H 2:5KO-=ZU7O)]Y,<'.SBLYM0N0@0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MML[]&8K,6S3RTFGX79=+4FS4MNKC$Q3TL)OK.Y/2\ENHC76BGQNAL[J^EO\
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M\RR!FX1M.0NJ@;!V!5Z/O]6_IGOJ4FVZGEQHY?B+8Z=^]^RS/JS;6OR59/\
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M.RT=/1NK&M9$RZ+TOJ&KU3<ZE^M;RQI32&17%;^'XC^,NDD<7%YV[":T#3L
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MMV6X]]I17-P]?:?:8F=6ZE9R9)NCM%Z8Y<Z6P^D-(8NWP^G,-;1V=C8VT4;
M8XF\(<\QL9QO(WDBI7$W&XU]SJSJ:F-]V<N1IV6Z5L6Z?LQP?7L>6#8S[60.
M';N["L%NG;,^K-9A>;J6\UV$K;7FE<XYN673+J;&V,SK?,:LA;864T<OAR",
MB7W@,#9(WNJT ;*KK'5MYJZO4]/HLVTT=6*\W=%6ZZ;I3I;35ZK;/[31C".V
MK$9Q^-GR5U8XNWE/OF<RMI%0 O?(_(7T;)#2A=M,YKL*[EX<Z1M]EK\_-6;7
M7^M=:W6\VWV>ZREMV;-=Z)^2&.Y&=/FAM*6UA#9Y2;$VV0R]RV%C)[R>]@CG
M:^9PBB>>&-X K4BBYO6=[?O-Y,S/J6X1'8X?2MK9M=I%ML4NG-VP\ T91]"T
M^T0![0[BM5Y.#9W5NSS3OB+F\/%W<)IN[_751..9YFT:APEEGM/9?!9"UBO+
M/)XV\LI[::-LL<K;BWDCX2Q[7M)J[9L.U<+?[/2WVTOVNM'J76S\D\)9M#6O
MT=:W5LFET2P;^I[E>>4'4#S)T,Z,VUH[)W5QCK5["QL3+NZO)2&-<R,4H=E
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MZ;&9C3N8QV0L+V![HIK>XM;J.X;('L>QXHZ/;M&PIQP3PQS>S1Y,W4C%U/\
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M)(3\/NJ^O]%F8\+;SMP?+.NU_P!5;&G9+-(A_(HOYVS\:%TUW)40$! 02/\
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M4<48Q&-I&QL;3[C:T#8@&  "(4%!L'8NFV7:MUO/K4B^KM,UB8MMR:IN*Q1
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MN-IMYTL8T[*7=TT?//#_ #;?<:NGJX3?=6/DE?R$K"":TH2"#O!!IN73=?\
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M96 Y(%A<&TX@/35$1;69F># SY(W3['G!RQNF <4&O-)2'B<&@-;GK!SB22
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MTK 6M .T@;5&,S64)D! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M+;9I866QZ%^3R9.GVZP&D]1\]=2XI]O=:G\./3[[F$QRNAB9 ))6"6%KV@T
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M.]CE\0:$SG-67%MJ=FSL/>ND1%+W:>"99$" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M6A]5>U:FRFK'O\[G+F(M]3@K-KPBIJ>^E.U<V*4PR5G-,B!!H[OC 8YFUS7
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MFM-78' 8#$P/N;W(W^5LH(HXFM+G4=+,T/=PM)H*F@*F9P1%N.#!T^<9>?\
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MI)).%SN&+:\4;)7?3ZE"N1%)QXII/+-T.J?,WHMZ;>=.J?OVYE\NK;4FIY0
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M/6FO?Y(HR;K6G4OMY\9C+N5^7W1MTV<CM2MUIRRY=V>G-5'V(LI;22R/8'\
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MG]FX7V;1LNK9'KKCA=QOI*TM: /#I7L"UD[BV:Q9&3GV6S9%<*RK-!:US_"
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MSZ5DZET6Q%+:XRPKNIWG3DNH7G5K?F?= QX^ZO98\.'R$L@M+2>Y9&Z,.DD
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MD$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M+HCB].)K"V8\,H$8:QC80T -#6THVFX)6)PC.%N]J4! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M8[].[3GEL^5?3NMOBN?8Z?\ /WHDZ>>HF&X.N=&6%MF[EGVK,8^*"SN#)PO
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M"12^*Q-89K;8I%MOUDJ[)&>$UX^*:T^B?6HBV(G'"5;JVS2<U=2@0$! 0$!
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MP3""-M*5%-WM'\-4NTXNNYIK4BZ8MY8R1="QXX2#0?QQ_#6:VZ;<F.ZRV[-
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MX GU;K62TMVY3.W[VQ^-+-.((IQ"Z2,D,)WFI]$12W&[).$X5HN1#<*[U*!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!*]C)&N9(QLC'"CF/:'-<#O#FN!!!
M0;([2^F7DN?IW!.<XU+G8C'N).^I)MR2:H-VMK6ULXFP6=M!:P-^+#;0QP1-
M_D8XFM8/H(*Z @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @()'.(<QH^RXMOJ%5$S24P2/#&EQ.X5
M[]V]6B.;"$5B,9;1[^Y\QCB?4M/Q2VG%3N/8K7:=\6Q?PC-%NXT)N]W3UU2:
M\DHTQ@M/V8(.P^CO46<L87XS.2;]+4NI.E."HV\+8/'G=%!&-\EQ((&#TE[Z
M!5NB;8I.99%]\TBV9NCA&+KMS<ZONGOD3+%;\SN9>!P=U)&Z46[;RUN'AH:]
MWM".:K#2,['4*XM^XT='UM6^'9^C>$>O^(=7W?2MMJ7SA&,3$8]]%J[G=Y^'
M3#RWR%[::-N(==Q6U0R>WN8+<2.'B; T7A)VM'T5J-7Q'H:<3R6<\Q/;1]LZ
M7_M7^(W5=O;NK9T]*RZ(PF<OP0Z&ZO\ G*^.N#(-(\L[^I)#1%;7-V&@%P!X
MF7+@ZNQ:W4ZYU#6NYM&R+-.<L:N\=,_VI]<VT1'5)T]2>/KVQZ'"U]\XWYJ3
MSEUEHK+00U^(<!>$@':!7Q-JQ?S;JG&8_ [QM?\ ;'T>-/EW&A9.IV^^AO."
M^<BZ]M7L&:Y=Y6[:".-QPMY"*5%=OB@#951_-^JQ[-)<+J'^U_9:E8V&E9$S
ME^UB7930GSE#EM?W-G8:JT#-8&5S6W%U)(ZV,9):"2R6[  !)[%L=MXANT8F
MW?Z6/"8NB'0M_P#[1/&NYU)U.D:NE%GYO-$^A<]Y.^<)T><T,79RY#F-CM-9
M:],;(["XDMW\+Y/" !D][?M#I*;EMM#K.PUYI'JSV3/XGS+Q/_MZ^(OA:V9W
M6E&I;&<VX_@B,5Q_2',/2&N<)8:@TGJG#9S$9.)LUI=6U_:/>]KJ$#PXY7$.
MHX;#0[5SN;WMT3I3'*^-Z^RWFRU+]#=:6I&KIS2ZMLQ3YWUQNG1-)D!(WFK2
MWAV&E*_&K17F+N"FG9[W&,(EH+O*F* 2-/M'8R@^,?4LMFE??;SVYQP8=36T
M=GK>ZW&,=JI83W=Q&Z:23A%!['#NJ!2GKJL>I9?;%89[M3;:L5T(Q:IGOC0X
MR/% 10_#14LNB8KP<?2BZ+_VOLMP;4 <1J>TJZ\TKADBB! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M4)I1&!7>=P6#6B9I$9+V15I6R!C7N>.(TV-[?H=U%ETM.F-5,+II,--&Z*:9
MQ="(FL]H2DT%&T+N)VP#<K^\NB9B)K7@MJ;?2LY;XQO=-NJSKZZ>^DS361RF
MOM7XBXS-E ^2# VE[937DTK63/;')&RY:^,ET)&T5JM?NNH;7:6W\]T>]MC)
MWSP?\._$GBWJ.WV>UT-6W::]U)U.6:6QAC2F.;%#ZJ?.\ZDNIF_S6B.G?3>7
ML=,7ES);V%UB8;SWFCI)H8Y.*TN'S.]F1A"Z9=XFUM:_EU;>72KE#V7X>_V]
M>&?!VM;N^L;RV^^+8F>>V.Z9CUH=?.7/EN^8+U@6<.J]=9[4GNEU,R6X;EKO
M)VTK;>:1CW-:R\8]]!'.X;%:R[[==/V>)B.V9=PZK\0OAYX&TO=;+;:&OK1E
M-LV1C'D\BZ'RS^;\<GK?!X]_,?5-S;ZH:V.2]8\S70,P$;W@N=:$$%_$L,]%
MOW.-^M-LU['SCJ/^X/<:\S&QVDQ9PI?3_P#27!>5GE9]*_+*VM[:33>+U";5
MH:;BYL;4F6@C&WQ;&IKP?37.TMCM]#3C1U)F^ZWCE5\]ZC\3^O[V^=32U-32
MF[ASS-/_ ,SGQG1'TI- ?)REP#N'<X6>.'%L[0+'L41H;.N.G/SNG[SX@^+(
MU*:>ZU>7Z5W_ -309GH4Z3\G:OMQRSP-FRX8YGBML,>3'5I;7V;&I^-])3;H
M[:LQR3%OE<_IWQ"\4Q;$W[G4FZWA-UV/X71SF1Y'?2_S'R<]];9*# M<Y[_=
MK>S8SB\0O(X716(IPERX'4ND_;N6[:WS;%N>;N'3_C7UGH5T1KV:FKS3_P!2
M?_J6V^??D"<P\#DC<].N9O;O&V0DG]Y9D)[8U8V21O!'[NTD@M;2BIL^D[_1
MK,7\\1\CZOT#_<1T;4NLV_B'91-E^'K7<V=(XS+H<S4?F/="FM+.W==:UO</
MIJXXHK=WR[<8]T=O('.'&3';%I%IZJ+FV=5T=C'+=%T:U>]]%ZMTKX8>-=A=
M[F[;;?<ZUN-(LF<8[L>*^IT0_.!-,ZUO;+0W4YC1IK4%S/:V<>8E#(61R#P+
M:5TS9;H-/'(]SB30[-ZYVS\3:6OK6[;6LSXU>3O'?^W;6Z9L-7K'AK6NW&C;
M.%D6SC&.4Q#(_P!#ZXT)S2P=KJ;0>J,3J3#W\,=S:28Z\M+HLC>QLHXV02R.
M8:/%0=U5VW;ZMDQ73FMKS%U7P]U/I6XG1ZMI:FE=/YULQ3Y9<AV[O"C]L".F
MYO:\C9\"MC=6_-P]2W2T8BVR5;Q'.8:LXMVRH';O[*JNKRV6<U<%;9FZZDQ1
MJ&GB ([4LFML2M,4FB*L@0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$&UY-[&-BK4/+O9=MV4WU633MB
MZ?6R8]77OT+?V><M+<306<$N0N+N&TM887SW5]<R,BM[:"-O%*Z220MC:T,%
M:D@!8K=2E]VG=G''@O//K1$Z=9NN[(K/R0QJ_,^\[_3?*49CDOTSSLU1K-XN
M,9E-1XV1LOR9>/%U:R1V[+:[#YB)V  @56@ZAU*=2;K-K=%LQG<]@_ ;_;WI
M^*=2.I>+M+_+HB+K;;KN7LF)FL9K+/31Y?W5/YBFLV<T^<>?U)C=,YJ^%]>W
M^9?E&0> ZXBG#&V-['*P,,=RX"FPA=3OLW6YUXTKJ^[OG&Y]Z\;^,?#'PAV/
MV'PY?I6=5THI;;%MMV5>,>2&4#TZ>7ATS],>-QWR+I/&9C66-A@]YSMQ:VTS
M+FX9'#5_@2V89^20U^%;V>B;+;>Q$774K5YDZS\6O&/C_3F.H:L^YNK$Q$<L
MTQIC$]DN[!OY)^$V=I:X^")K61QV%O#9LX&#A:/"MVL;L:!V+']GTM*/>\M+
M9=#U.C[31U9OW%]\QGC=,I'.):Z22KGMWN)XCMW;ZGM5)W]^G--'+R,^GM-G
MK6<FUSA*'-('%LKM&[T? KQJ3J_M;_:EQ.3;QK3HWUYHS47^*/BGV?J[EEMC
M2I67.LT^GT];-6C!?LEV;^%JB8MB?5R8M;3V%L5LG%3FE;"0X2<+W$4 '=L[
M%R-IJ3IQ=-N3'M]AMNH3/-CR]LT:J&YN>#A,[@!NH2 1Z16C@:K#K:_O;J9_
M@<;>QMME=-F-?G?/ZTTIH7F/A)=+Z\TKALSBKB)\4ADQEB+A[9&N8ZMT;=\M
M:2$[UQ[ME;N8]WJ6Q.G/SN3T74WVPU8WW3M34MU:UQNNF/FJL0]:?DC:%YA6
MV3UCR">W3>4A9<7=O@K-O#)>3.;<REK+B*T#XZ/<VE"L=OA_1VVI&\VWM6<'
MH?P?\>NK=+NTNC];U++>G3A=,VQ=7+ME9_Y$]476)Y5?-V+16K(]1'2<%_X-
M]A\M-DKNQN[!MS&R7P[J\FA@8#;VKM@V*FXZKK;?6FZ+N75B8K':^C=>\&^'
M_BYTR[>;/3T];5Y9FV8I;C3/".]FH]$/7'RGZX>7$6LM!W<8U#B;:V^^G ->
MU[\5=2Q0$M+V32A['OEV5-0NV],ZA;OM.*87Q'K0\#^/O '5/ _4KM'?6_L>
M>8LFM>,X?)$.[;B.*/A._P#)&[>P;J^A<O<Z=WNII[+H^GKQ=%.+6QEI8"WX
MNVF_O]*G3]B"ZM<<TZN@0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!IVS.)(?&6 ?95KZE-,:0M=$6V\TR
MTTE^UCN$L.TCA[B.TU[%/+/)-T8S'!@C5K=2F"G<WEKX,\UV8H;*VC=-/=3R
M,BBACC:7O<Y[R&M:UH))K2BP:U\Z=O/;.%,9[(<FW1][%MN=]TQ$1QF98EWG
M%>;AG\EELGTD=*F5E&5O97X;4^IL.]T\MRZ9UQ:26EJ^RNO%8QLP J!4G>NL
M=4ZM;?%VWMB?<?G5S>WO@1\!]K=L;?&OB6;9MT[:QH7Q$4C"8KS13%Q%Y7_D
M^76LIK'J#ZI'7-Q:,N(LU#B\NR::;*W#Y;6^:7B\M'R4,KG':>U=>T-73U]:
M.>V?<]G:M\5OB];T&[4\->#M&=MN+9Y?>675B,X_)ED^V^-P.*Q=GA-)8:RT
MUA;"WCM665A;P6XDBMXVPQ._,\<7QF1@[EV&S2CW4TX>SW/@EFKU'?5WW7]>
M=UN;YK6ZOEXS*#6.HQE:M;7:[:37O)VE<&(W4YZE;5-2-*+)MVEON[Y[$6QA
MA<X>R]Q]HC<?4.S8L\7WS='O)K;##;;K4IJW<R?A#20[XIIQ-W^K:N5;K[3E
MBNG6Z%;]/5CU=O=R5/##7>UM;V#U_A%<>Z^RZZ9LBEOF<G3C2LTXMU(YM7C/
M:C6@HT4_ ?PU3OXN-JZ<WSZLTA)[52X'VCN[:;**T3'').EIQ9[?K)'Q,(K)
MM>* ;-U:*UNO&G$UBL2Q[[GNNTYV5TZ<1GWDA<>!D8^(#Q/_ !6SZRRQJ:,Q
MSQ&;:Z.WV]^G_B*7ZL0F9.U[!$\AKG5X7T!^+6H]%4GGX80TT[^=3<?9]/3G
M2LB:5X=C:\WJ[!\O]+9G7VK\I;8;3NG+2XN[B:]FB@9,(H9)1%&V>2(2&014
MV%<;7U[]#1NW%UW[.W/O;#1Z=NMWOM/8;>NOKZM(B;8KRXQCA7M87_F*=8V1
MZ_\ GE;<J>36BH7XIF8.'AO<?91S7<P-]/9/G,EL+B8M?XX=4]BT.K&IUVZ-
M73GW6.#VY\-/#NIX)Z%;9U+>4F[3F[UO5I2V)IC3L90?D]^7_<=%')FZRF;N
M9W:NYAV5A?9BPE\3\RT@M)8FEKH8>%U6D$4*[OT/I&MTK3F-S?SZET1\F3Q;
M\;/&VS\2=;NV.PB+M'0U)K?6O-,3=';.55X4PO\ !#W.I+Q5<X#?4[J>I;K4
MK='+;[+X=?%LXV8-?'\1NRFQ(B8BDYB=2" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @@30$[Z=B#1,O ][V
M<-"T$U]05[].ZVR)G.6/3U;=34]W#1;;F <%)"7T(IP\(XJ$U[  L-]_+,1'
M%GU[(BEL1BQX?/#\RN7IQT/%R"Y4Y=DG,G6EL^SO;C%W#9KO'Q7<-U"V%PM+
MMLT;W[*@BH*T?7-?W>C;HV74B<^YZ6_V]?"+5\;;K4ZOO[)^R[:>:R9RF;:3
M,TF."WKY0GEK3<Q+V+JHZC[&>ZCNKHYG3[,PR626]N)IK6]>Y[;VV?(0)9"1
M5RZWI6V;FN/J]G:^T?$WXDV>']C?X<\/:GO-U=')?%OJ\E*V\)CL90DDL44%
MK88B&*RQ5A$RWM\;;Q,AA9#;M$4=6Q-:PU8T=BY>CM(F_FG"8X/-&WNPG7WO
MUU\S,S=C../%1?+Q^',?9?)4-C V "@.Y<B;IMLY6'4F^-3]GC$IS2NQ8B<\
M$NVHV^OTJ4(H(;QL/P_[*!MJ*;MM?K(E%$(&E-N_L6/4F8C#)@U8YKK82QU!
MX*_&XJCNV4VN]17(TK+?=<\9LUFWUM/<VZM/V4<:M'/>8?3^)S.IM4Y*#"Z>
MPT$EY=7EW)'%')'!&^<LC=.Z-IXA&1L*ON9M]W$\U+;<W*UKK>L;FSIO3+??
M;ZZ:1;$4I7#.&(7YJ7F5ZPZH>8+>GOD:W(?>-:Y+Y$CCP;[E\F9N9;JXL YP
MQ]S*][1-*TGV2*+2:NO;KWSMHG]A=E':]=?![X:;'PCTF[Q)XFFW1W]D<UW-
M2ZD83QCLA=\\G;RH+7D%IK']0//?!PY#FEG;>VR6&Q>0ACD?C&3Q6ES#+(RY
MLFDO?PD[34%=CZ1TJ-O=;J7Q2.$=KSQ_N!^+.GU;JFMT;PYK3=L+9ISVS-N5
M:Q%)[V1CC[PR-I-&+;@ ;'"UH#6L HT- V  +M$X6TXO+FE[[5B=36B:SV\6
MO-PUQ+(_;>*5C[OA59BF/!>VZR;N6<VI!J 5"9BF"* @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(*,CW-V#V:UH
M[8>[L]"98SD>=+&Z5S=I]IE:B@]JHV;3N41=7@G)*ZX;;L\2[EA@8:^U+(R)
MK:?QSR :CTJ<J4Q5B9G.*-LGU)@+:&2>?.X:&*!CY)Y),G9M9%'&"YSBYTH
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MS7732*<6-OYNWF=VV%-_TS=/V2=D<S,YV,U!E</<&5TUQ,;NU;"PV5VXU$I
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M?J6\UWLM:J,H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MP%.NKS,.HGKXU'>'4.H\CI/E);WET,'IFQN+FWB?9NGN1&R4VUXYLO%!./C
MJ:3Q129QG")6])'66)M8 T%D%I[4=!QW$KW;2> ?;)'2N'T2HQK0F(C&W)<B
MZ&_+ ZDNOJ_BS>!PM_H/EK'=VAFU3?6EQ%'D<?[Q;"Z=''<V3FD>!<'<=JG*
MD\41'-GA#."Z)?*QZ9>B_3-E;Z;TEB-1ZW9#;/RVJ\KC[*\EGO(XK?CFMH[B
MSK!6XA+P=_H"K6LUG-:(BV*Y+ED5*-A:UOAL: SPQX3&-:*-8UC: -:T; %/
M%%.:*S[+5  ;D2  $D;S2OP;E% H-GHK3X5)GBB@(" @(" @(" @@ !N[4[C
MC4  V!12)FO$[DOAL[OIG\-29S7BH3<5'AS6F-PX7,> ]LS7#A<TM-0 6FA[
MTI7RHNF+8JMW]9?EE=,W69I2ZQ.LM&X;$9]T5R<=J/$X^QL[BWNYF3\$\QM[
M/CG+9Y^(U-=BGAW0>KQXL'[K\\J3GYT!Y>YS\MI?Z[Y37UW=>Z:IL;2><8RT
M9+<FWCF@MK,<)$$+1[1&]3WIPMCUL5K^.YM,C"Z8Q&1WQ9(I6F&>%U:!QA?2
M1A837<HIC3BB<8=W^C/S#>HOH/UGB\UH34^3U%R^GN[?[Y]-7ES=3VC<?X]M
MXT,,5Q>,BC_,L!'LM3&E.)2?:^=Z!70GU[<G^O'E9B>8'+C.V5MG(K6'[ZM'
M.N+=U_AKZ2*-SV>%X\D[X0Z0 .[-Q]-9BDX9IB8SC&UWKXI06BG%Q$CL'#0[
M?7L2*W17V:?A)I7#%74@@(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MJ-&9>TL]:8JRMFZNTF^XM_?+*\-M;"X?'#[S),^)T\I.[V56G%?FMX<5Q4N
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MW_"B$4! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!IKF1T;11M0X@5[C44V=J
MK-<9X)B(G"727KHZX>5G0OR8SW-'F!D;.;-QV5R-+Z6%S"V^S639"7PVXB,\
M<K(:C:[MI0*<9BD9JTCFYKIP><[U<]6O-CKHYQ9;G!S6S=['B);R5FEM,.GG
M]PQ6-@FN&64;;4W$UL?S+*T5IV*:?.4XSEP==8XKS(W]AA,%B[O+YC)W-OC[
M*&QMYKB>XENIF6L0$%NR21H8Z1NVBM,4\AY68CY.WDF8O0MII[J1ZGL6S+ZG
MN(;?+Z1TADK=I9BVW$-K=V]U<17-DT/X)(_BG;78HKV)B)XYLJ_'016]M'!;
M6\-E:01MAM;*WB9##;0QCA8R..,-8Q@:-@  "BJ>#7H@0$! 0$! 0$! 0$!
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MF/0XFYZET_:VS.KJ61;'Z4?C6O.>'SA#IVY=Y*]L.7^&?KZVM:B*]BF; R4
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MKXCL.VJB9KY"(I,W3G++&]SB9%##;M9;0V[6LAAAC;'#%&T<+6,C8 QC&@4
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M0(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(*4
MLHCILJ2=@5+KXM\LIB*H>/&"&EP#CV+)RW\M:*<UM:5Q:1^08PO'"XEI:.$
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M:*<&YQ\7 WBVFGH'JW)6N*(KQ3HD0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MZ4UC'*CB7S;=C7#S-NO+5MXYEW ^XQLUA(R2'(8^>6QN#.'A\;R^U='*[@D
M.]:OJ'1M+?Q,7Q'-+F;3JFMM)]Y%T\O"G<O!] _G#\[^DW*831?-3(WO,/E6
MV:WM"+R68S8FR<^U@,PFGO.-YA@8X_ OF7B3X:[36V&IJ:.G%NYSBZ/E[GT7
MPG\0-Y;U:S1W-\SMN_LP[V:KT^]1'*CJ@Y;X/F9RFU)89["9>VBF=;PW-O[[
M8W!BBEN(+FU9-+-$8WRT!=0&FQ>:.N='WW3]S.VU;9CDF<:84X/172NL;3J>
MA[W;71-<X=@8Q5@#J;MHW+@[?WMME-7-LKXBM(22->VGATX1O! V>JO>LE]G
M/,3&:D4MBG!J%=(@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(""G5_'V<'T]WX:QS?$7
M<LIHTI='(Y]NX!\;VNCE:YM6O:\%KFD$$$$&A':L]]DS;S3[-&.V^++_ %9]
M:)^;L8/'G:\FM4=,'6SHWJ:TKCC8:=R>8QUUC&V<)@@;)[Y))DG.=#%"SV7-
M)-7KHW4MK;I[C4OF.73OR^1^BG^W/K.V\5^%)\-[^^-75MLNBZV<Z4B(SJR6
M^E/F]A.H#IUY=:\Q.2AR68&&M&:@;#(R5\,K+&T:T2^'+,YI#G=I7$Z7KW[N
M^Z(FM,^[L><O&G1I\.?$3J/3YMY>G1?'NXX8S,S1SJ7AU8R=NT$[!ZUL^3BX
M,:VG%)RA,UFQK&[8A6FZI[3Z10JMT3&,YN)K61JS-/94^(%O #3A.S8=NVJQ
MW5JU\ZEUE\6SDJ]A)V'90;Z_"H<J8A*#7:%*J:A ![#N4)H@I0F+: 'OK])0
MFF"52A".YFM;B*2,F@/M4-!2NYP!]H'TJUFC.I6[A!=M;=SI3-/7MRGL6]NO
M;R[>6?6=H_)92QQ=AB.9]G97,MOE8;:WB?D9F073XP6QVCSQ<<@VUK5<'7NM
MOK=?ZM\9=[Z!\-_B[U7P;O[.E;S7N^P<U*3$S2*Q'&<<&+OR1Z@.I[RC.H-^
MC]019]NB7YCW>]L[SY1DQ=UCVWK(G&-\\EM9QM-O:G<%DVVZU=*_GKR3;2L=
MKU)UWP%X2^,O0YZMM;-/5WW)6)YK;9BZDS$_/-6<)T>]9G*OK%Y=X?6N@<Y8
MNRL=I;OS>G_>+?WJSN9((72 1-GEE>PR2[^RJ[/L^I6;O5BVL6SV5C\;\]/'
MO@/K'@7JEVRWEMT[>L\MT1,Q2)F,Z4PH[FA['M).RGQ@=E#V[Z+;4I.&;H43
M%T892T4;H!*3$:O?6I]6SM]*M,S.$X)]Q=9ZT92U+&/#^)U-N^A'U%BI-:LM
MU]M.6UJ%9B$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$!!IYWQ1ECG[7;0WX5'N8U;HF<X4OU8TXI/&6F,<4TC2';65<]VX=X
M] 32W,Q?=I3C=P-3;TBV[*%K/S#?-)Y,=$FE<KCK>_L=6<X;JV?%A-'6=Q"^
M3QIH;@,FN98KIAA?!)$"6GMWKNOA;P%U3KVI&XTM*?L\SC/;CY'3?$WCOI'0
M-*[0W&M37B,LZ3\["NZI>MWJ+ZQLO/?\S=7Y>UT@+F>:PT[97UY9LMH)Y9GQ
MPN?;WCA*&QS\)KW+TIX>\(=,Z#M>3W<6[N8SS]#S?UOQ;U/K^]G<7:ET]-MS
MC'&,756WM&64,=K$:"05,CAQW#]QK)<'[:XT':5V[9W[3;^OAS0Z_K[F-:[E
ML]B<FL+2WV2>+=OVT^%3NNJ:4V\U<?(Y?3]&S2OIQGB-#J%OV8W'L'^RN)H]
M0LF8NF<?(Y>O.G=%VGIT2D!H&SB/:1W_ $5&INMG-\S=7F\C7QN^HV?L[*<D
M99(EK00-U*UKNW?06+[9LN_YF6-UU*F<?@"!0\.WN'=]+M4QN]A&..*L[KJ<
MQ,1,?@1;3?N&W9W[N_N4Q=9N,=M6D9IMW&KJ1S[RE8R0#6FA:"/2=GTB0LEN
MEK<V+%?N-"F$AX6UX6';NH:[EFBW4CVHP3%^E-OJXRBYOL<,A#6NJ'-< X.[
MFD'9M5-?1U-YH3MM/ZR<OD9-/7TMI,:^O/[.WTI<7=ZDTEEL?J?16>R&DL]C
MIX[G&RXV\N;:)DT4C90^6"UEACFXGQ@T=7<L,=#V-VVG1WUL773&,3_>XNKU
M'=SNHW>PNFVZ)]28PCOPADU>6OYYUY@VX7DQU=W4DS8'V>-QO,F=U*M=[K:0
M,FAENSQ,JYU3]-?!O&WP[O\ ?3NNCZ?J369B..?<^\^"?'O[&-OUS5I?A$5^
M3O95VE-5Z6US@\7J_2&7L,_@<M;07=C>XVZ@N8'0W#!+&7FWDD:QW"=K2:A?
M$M;9:VQUKM#6LFV^V<:_WOM.WW>CO=O&KHW1?IW1A,=C[1I]D$FNS?\ @[E3
M"<LEZ4PD<X-:7;P$BDDX*7%QF@-&GT=WT#O"OA;',I6LTX*C 0*$U^"BQ6W<
M^*]*)U8$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!1,5B@TTL9=4M<6GM]-/XBX?/?SX
M8T6I$VTG*6E=/%%%)++*V*W@:XRF5PC: VKB>-Y:-E#VJ]NCK3ZTS/-/!?3M
MYYY+8QEP!S"ZG.7>@X@79"')W'$]LEO;S0ET1CX@02V0[2YB[)TWPWU'?83;
MRQWPV&ETS4OQU)Y8X.N]YY@^E',F9C\!*^5M0USY12H)%:>(VJ[)'@+>3$<V
MI$?(S1TJVR[UYK#8;#S \>) ^_P1,8)JQLE#2M!2DRM/@'=91JX^1?\ EUF,
M1FY+TIUU:"U'D8,?=8^3'-G<&OGDF9P,!+02>)XW57!W?@K>;?3FZR8N[J,<
M])OC&V[&';G3&M=+ZRMC<Z;RUI?V\7#XCHIHW.:7@%HX0]QV574=UL=SM/V>
MK$V7M=K;75T<-6,7U59*<0=L/9PC9]'O7"NF[1BDX][%=$1-&H:[B%5DT[^>
M,5)BB994" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @()7BK2.'B
MW>S6E=O>F>9,S&2QIYX'7SBNE+IQS&BM-Y1K.9/,*UN,9CX[.[:V_P =:RP7
M,,DWA0W4-RTR$&FS<%$UG"$773;Y9>?K"Z_OKS*9?,7L^1RV9NKC*7N1NYI)
M)YG74TEX6R2S/?)[)D.\JTX4E%DT]6%QSRL>A'(=?_4=CL/E[6YEY5:$R%G?
MZWD-O+':.9;W-E<VS&3FVFAE#PX@T/:DUCRRM%L71/-EA@]'_EERVTCRCT-I
MWE[H?$VV%TUIG&VN,QUC;1QQL;%;0LBXW^&R,/DDX*DTVJ!]UPBO%3;WIPIP
M$R @(" @(" @I_%K[.QOQ37?7?ZJ*L4F>2<S*,%*9P;&'.VD&@IZ33LV;EAW
M&K&AIUI-R^G9-\TEMV3SN)PUE+?9;(6ME;0CBDDFGB90;]SG#;L638^_WE)L
MLGFG*%O<WW>K;$S3N<77W4!RHLHW\6K,=(6D@MCGA<0034;90=X6WGH75]3"
MS3NB9XT9]+9ZLXS%(;78]1?*F]<6C4UE'0_9S0C?3=]O7$U?"G7;,:73'RN1
M?LKHC"?[?,^^T]S%T5JN9UK@-18^]NF-XC$RXAXP-A/L^(2=CO2N/J]&W^SB
M+]>V[D[X<74TM33POM]5]QX3' !I#FGM::@=N\';58KM+3KS<L<[C1-UN$>R
MI2 \37MKP4( !.T[J]ZC4BZ9BV)I1&$13M5[=G!&!4DFI)/?57LMY8SJB*4P
M5U=(@(" @(" @(($ D$[Q6GP[U%(K4?(Z\T/IKF/I'.Z)U;CK?*:?U#C[G&Y
M"SN(V2QOANHGPD@2->T/:)-AIL4TJ3CF\Z[S</+USO0?U 7&0P3)I^37,B]N
MLEI&=MLYMKBWR3WMU>V]Q*RVBAC,;APCB=V;$QGU85GEMQF?D[%JB[;/-<6>
M3PMY+B\YC+JUR-CEK65S',DL98[IHCDA+2WB?$!L*G"(J3C-)9[_ )%7F .Z
MH>0UIRTU_EHY.8W+ZVM<9$V[N&OOLM86UM;1&4,ENIKAQA)'9N-56DQ..2\8
MVUC.,U_<"@I2GHWJ499(H" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @((56*-2+
MKN6F":*4SFQQN<>RFX5.TA3[F)FMD4O1-T1%;LG3SK)ZQN6'1CRFS7,;F#F+
M)N2;:7(T]I\W,#;[)W[+>1\$;8'312^$7MVN'J"[!T#H6[ZUNOL^G7W43C=1
MH.M=;VW1=O[[6F)UI]FVK "ZL>KGG)UR<SKK7W-;/7DFB[&^NQI328EFBLXK
M 3W+;4.@;<2P'AMY1O"]5^#O#VSZ!TJ[;ZFG%VKJ1%)RF,NYYH\>]9W?7>I:
M&MHZO+MM*;N:W/FK7YJ.O5 2R**/@MXQPQM;1O"T"@!(I6@"['.UC&=.:2ZO
M;KTCEU(K'S*3Y@T&.;[8P[P-AJ-QXAMV%1ISN-.ZMTX)UK=KKQR\N*9_B2!D
MC9*<% VC=M*TH0*5J%M=#<Z&K_A;K8YIXM;J[36LGW_//);E TPL\29CXHC&
M/MK9I6,<[9]BQ[@7$]E%?5OVFA9C2(M\BT:6OKW\ELSBVRPRCK^]=88W&9:\
MNB[A:V'&WLD;WD\+0R2.)S7 N/8M9N.O[&S"ML?+'XW/V_1=QJ7TMBZ.W"?Q
M.;--=.?4CK.U?<Z2Y2Z@RD#@',E]QR3 6NX2S^LG#:'!:K7\1]/B.:ZZR(K^
M='XV\T_#?4;HIIZ5UUW;2?Q/JST5]9,;6SR<BL\^4T#6^%D-OI(]QV;US/\
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MKL7#VDZEUTS=DYVM-LQ%&Y@ "@W+GTBE.#CHJ<L@0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$%)TT;#PN=M/H*Q7W6:%G/J3ZLD>M/+&;9-1ZDPFEL5=YC/7L-CC[.(
MRS2RO:WV6M+Z-#G-XB>'L67:;?4W6K&GH1S773@SZ6AJZ]W+IQ65HCGSU@ZB
MUG>7VG="W3K'!LDFA-W"2QURUKI8W&K)N(<35]8Z+X2V^TMC7W\<^KG3LR=D
MV.TMV]L7Q%-:72":]O+R=]W>37$\TSG.E\6XDD!<222 ][@*N)7<K++;(Y;(
MB+8;*8B8]9+(\D;&,:""-C0*_"K4FJLV6US4B2*&*-K.'OX75/J/I3VL+JT1
MR6QC'M)VRO>'<<='.%*QN\-P]3FD$;%%T39[.,+6Q%:SA+[_ )><TM;\L[V"
M?3^8NK>T9*V6XMGS2S-F:U['%GM2@#8Q<#J'2]CU*R8W%L<U%-2WWD3;=$3'
M:O,=/74EICG'AXK26ZAM-66L<<=_82.8UTKPU@\2.LCBXN<_<%\C\0^'M?I&
MI-U)NVUV4NL[GI^MIUU;+?V,.SGBQ1D,)H3N&T^GTKK&CJV77>[B?7:RZ>7&
M58.!W%9>>WFY>*9B815D" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M""7C;2M?J_4WE3,4S(QR?.:NU1B-&Z8SFJ,W?V>.QF$Q=]D;F[O;F&UMV-L[
M66Y+733R1QASA%0#B%2HG >9KYC_ %89SK+ZMM:Z]O)Y;;3^DLI>8?#XEUP^
MXQT]O8W5]80R6X,\]L>*-H-6I&,UA$3PG&'3#3FF,]K[6.EN76G+"\R68UCF
M++'.AL+>:YGMHKF^@M7/\*WCED#6LGJ3PT 4S$1$SV$5NPC-Z3'EE]#^BNBK
MIQT9IC%86T9K[,8.ROM99X0L;>Y.[NX+>X;'._W>&1ON[6M;PG:""HK,QS2G
M+U8R7)&UX144)VD>E1$U@3*00$! 0$!!3\5G'X=?:[J'ZNY$T2FXB!<WBVL^
M,*'958+]SHZ=W)=/K)BRZZ*QDEFDA9"^65S6PM:7/>YP:UK6[2220  %>V+H
MNCEQJG3BZ^Z+;(K=,NA74/UD8/0$L^E-"/BS>HX0^*\,3VNCM'N$C0&R"8!Y
M:X+NO0O"NXW\^^W=DV;6ZE)GC\C:[/IVK.YC[1%+%LK67.7F;KB:Z.:U'='&
MW)+G6$<LL8:UQ=5G$R8[N,A?2-IT7INRMM]SIQ[V./\ :'8;+(LCEB(HXH]U
MBD>2YU\PDESB;ZX=4NVG?(>TK:\U\_FTCNAFY="N34BQL^$%TEZ';2"V\G;M
M!J/BO':%2=7<3,TBVGDA/NMM1O6G=4:BTG<NO]+Y:^Q60J.&<W5Q,"&TI5AE
M ^Q'T%BW&AH[O3Y-S9;=;V4B&&=.VG)2)M=W>3'6WJ/34V/P?,6=V4Q[I612
MYEX]J(/=$P$L,W$:"JZ9UCP9M]Q9=K]/CDU:5Y>UK]QTW3U9K&$KKFEM6X/6
M.(M<WI[(07MG=Q,EC\)\;G4<QKJ.:U[RPCC[5\MWVAN=I==;K63;K6M!K[2_
M;7\M\4M[7U$<@=[)/M#?LIZO1N7#VVX]];ZWMN/=9-N/!4)#14[ %RU$4$*J
MD7VS-(S*(JX(" @(" @DDKP&@J>P?#O^!#'@Z%^89T4Z"ZWNG76?+35EO S-
MLPU_=Z8U ((Y;S&9"UMKF>%D#O!FE8VX>> AHK4J<<N**1..;S1-<:#U%R?U
MUJOE'J>QN\=D-(YO(X^W%[!-!<W=M#?W-M#*&7$<4I;)% "#2E"E(F,<CC3L
M=H.@SJTU'T5=46@^96!;-=8O)Y:TQ.<Q?O4D%D+#*7=E974LS?'@MR([?B=[
M2B<JSP36(G%Z;'+?F!IWF;H73.O=,9*VRF$U'B+')6MY:2QS0N-U;1321A\3
MY&<43Y*$ FB21ZS[CB%0*[3NW]U5%2B92" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @T\UQ'#0.._Z7=]$E4OBZRSFLA-D3?=RVXS#BCG=S@TSR.Y8:KYE:OO[:
MPQ>GL5>7C'W,L43)[J*UFFMH 99(FDRR1TWU6Q\.=+ZAX@ZA;L-I9S:MTY=W
M%JNM=7V71-G=N][?%ED>=YW'7%UA\P^MOG)G]=ZSR%]'HG%92XL=+Z8;=7 L
M+*UM+NZM891&VYFMYA-"6G<O57A3POLO#.C9'4XC3U,.%:S\W:\V>+_$4==O
MOU-EJ3J33#AVNK#X@W@A: RC6UX=C.&@X0 * ; OI6]MT;YLNKA,>KY'S7IM
MV\NF^-2R8T[9QK-49''V8F$M:* O W;MBU.YU8VMOO+II#9VSI:NIR3-)2R,
M9$'>,0 !Q<1(I2A+B#N*S;7[1OHCW<1-OS.#N=UL-E=,WWS%WDF7V'+?EQS)
MYPYZPTQRHTIF-1WV3N([.&]M,=?3VEO+)*R$&6>&VF@8..5NUQ6EZWUSHGA_
M1G7ZAKQI[BW*.]V#I/2>M>(:6=*T?>[><YRHR$>FGYNMJ77> M-2=2^JIM,:
MA$UC>18>R#+ESHN*"Y?#/PVS6L);Q,<';0>Q?'NO_$O9X?R^NK==7FSBGX7U
M3P[\-MY=/-U>V+)MQB:YY<*,@+EEY8?1_P ML#@<7:\I\'D\EB+2WAFS-W;P
M27%W<0,C:ZXDK"SX[HP:4*^3]0\1]2WNO=J1J7VZ<SA$3.'X7UK8>'.G;3;V
MZ=UEEVI&<TC'\#N9I?ECH31%A'C-+:2P.+LV -$<.+LFD!C6M:.-L+7D4;VE
M:C5WN\UI_:7WS'EG\;:Z6SVVE]799'R/JG8C&\)_0K&.?V#W&V ^FPKC3K[G
M\F9^>7(C3TN-L?-#Y/5/+30^ML4_$ZKTE@LQ:3@MD9+C+*O"06T#W1%[11QW
M%9-+J&_VV-EU]>Z98=?8[+<UC4LLFWOATTYH>6#T?\S-.Y_#W'*O!XK)9BUF
MBCS5E;0,NK*XE8\-G96%P/"7DT79^F^,>M]/U[=6-6Z[3C.V9S_"Z[O_  AT
M3?Z$Z-VC;;=VQ&,?@8_G4S\W9U5H;$SZAZ9=43:FS4LUY=SXB\$=J^-G%/<,
MAB!MGMD'#PL:!M)[%]4\._$W9;NV[2ZY?[K7B?5F,8G+OP?)O$7PQW&SU[=7
MP_I\VWF*WXX_-1C\<TN6O,GDCK3(Z'YLZ9R6GM0XV5UO[Y=6-U%:3N8^2)QB
MFEMX8) 3&=H7UCH_6=CU+3B[9:D7P^<]3Z1ONFWS&\T9LME\.'M<X#B#R:'B
M;[375[:M- NP:FGI_DYRT4;J_3GEG*.Y,0Z)[',V3?8'>&C>:[QM"PV[>[GY
M\K8<G3UM#4CDUI]65.9D<TLI+ (Y6AD[2.)CJ@M-&FK1\"SV[R^WU8S:S<Z&
MKHZTZNA%;(EW]\MWKJUUT0<\\%';Y>[N^46J<C:V.H-+W%U,;/@NKFSMC-&Z
M6ZB@M_! +M@[%\X\8^"_Y[M=3<7:==S$3-LQPS[GTOP;XST^D;K3T=QJ\NC=
M,89]G>]!/06N-.\QM(X/7ND\E!E<%J+'VE_936TC)HA[S#',]G'&][../Q*$
M5V+RIU/8[GIFYOV>XMY=>+J/3?3][I=1VMNYVLUT[XJ^_!J >\56+'CFY**B
M9B,Q N WE4C4LF>6)Q,L0$$5&Y9,A% 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$%%QDXR/
M#!;38ZH!'T5&,U7]6+8F/:4C[P(Y0T O ^UG9M^!1IQ75B;_ &%-:9Y/V7MM
M'!#--"^"]MV/CG9)'<M>&N9-'("TM<P@M(+201VA9=:-.(]3&UCV^IJQZUT<
MNI$UB6&MYX'0+JWD9S*M.L+D3AKJVPHR4>3U1#A8YFR6]S#/<WSB\6-LR3A+
MV@[7;E\_\1;:_:ZEE^C%-*Z<XX/=GP#\9]/\6[.[H'B/6BW<[?3I9S8\\4B,
M(F?0N*^5)U[Z5ZKN5^'T-J?,P6_,G2UG#928Z_N8XKJ_DAALX ![Q=/F<YCC
M0BE5787Z^ZL]U?CJ6Y2ZQ\5/"5O2-[=U+9:?^$OF>:D99XTB%VR>"6&21ETT
MPRQ[Q386_8T.P&H"VU-2VV)NC%\<V6ZVDZTZ5M_[3L4/&:6<8VAIH1VC:1NW
MKBW<D3/-Q;'<1JUB9RA-4?12;9C-PN:)E$;=@5:P5@H!M!VG?O[-R+Q%<(S
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MK-41%(14)$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M7!_M!TAD)(.VH7U#9ZUVMH6W7X5A^1WB#:[32\0;G0VD1&A&I=RXUPK+L5;
M"!@'=]#T? N1.;3S'+@KJ$" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MG1=8,5:4VT^"GTUTZS5MU(I.<.ZW1C6%<5[J*+;>5::<$59 @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M=N#Z;SN45E+[!2" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MG2V\9XK.:81U\5NU8=36OOQMMFVWC#[+T;X0].\);6-SUVW1U=2W&O/;P_\
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MVU'9V=JB<937!+44+3[/T_2G>@INX=I&\_4WJ?*(;34#:/H>GM3#.14:&D,
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M4CQ>3<+&UVDWL>ZOY\"?_A1IQ_RY^?\ N+?BOS97_@_O?1XWYQ[S ?<P,O\
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M[59B83*\H0"QV6S%:IE%9$" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MNVA^#T[/I42N& $DM%3OK7X"HI%4IW%SN&FZNUN_8"$X89L5DTOR3WK87Q\
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MQ#B=HQMG7TUM8EXRNF>>*9/7UGL1Y(;H=R7^S*4K#5M5CT9F;,4RF69 @("
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MBBT-#GTW^S7?W*:U\J*45$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M$4: >RB5F$1;;G%%1%A 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$!!3F($;R33V3M^ I6(QNR5NB9MF+<VQV@DX'5/C %Q:]WLM:VM
M27./8 KZO+JV>I,1;VL6CS:7M1,W=[IAU4=??3OTE83*7FM]8XJ[U3;V9GQ^
MDK*^M)[N]F#)'B$ELX\%P\(@UV@[*+9='\*]3ZAJ6WZ-E\Z%TY\LT\K6]8\3
M=-Z;IS[_ %-/WMO#FBL_A8P?57\X Y]\S[F;'],>*=R[QC6SV-\ZY$=]-=PN
M\>W=<1S&Z A>^-[758!0A?;_  M\,]I%UFIU/&;9KC%.R>,/B'BOXE;O5LOT
MNC1,VWX32[+A.4_^JR%JGF'S9U]J++:IU-S/U-=93/2NN<K9'*Y;W<2R/?)*
MUL7OCHN%SY7"@V4*^NZ?0^G:>C&E9H6<L<8B/Q/G&IUOJ.ZMF_6U[IOXQ-7Q
M<<.*MYG33R-ER%>)UQ/< R\9VN<?$<7DD[5R]OL]ILZ<MC1W[S<;C4Y=34A&
M3(VM'2,;/=R$TI;0R3.)'<(0XE<C==1C2LY+;>#F;/81=,ZE\\T]K1G+B,F,
MX7.E[ZU<,1DB *=X@[EP=C'VJ;_>3;;;'&9A/4=>S9W6Q;S3=W1/H2-R@<X-
MBPV=J-LDIP^1HWUU@HJ7[K1V^I%MDVSCVPRV:>INM+WNK%T5C#"6K%]9W+";
MN&6U<W9&^ZA?;EU: [)FM(HNP[7>;?DQLYJPTVZV.M?=-UVI%DQE7#SI((L2
MV5LUN(WWQKPO@N6B1CM[7@Q.X@6G;O7!W&XV.OK1M-;0F-*[.9R<C0VF\VFA
M]LT=S;=K1E$4F?P/J]/ZUYL:5S>)U#@^:&IK"?3MRR]Q=K'E,L(&2PRLN(HW
M1-NVQN;QQ-%*;EQ][X;Z%K:<VZ.CIY=TY_(G9=<\1V[FV[4W-_-7*DQDO?\
M3'\X&Z@^6=["SJ.Q'[H>FBVSQ=E!;MBL;BWA8+>T;=R3MNB99&M87DO!J3M7
MQWQ'\+-I,7ZW3YFS4F9G+MK,\'V3PU\3-S;%FEU2/V-OJXW5[(CBRD^EKKUZ
M>^JW X>XT+K3%6.IKBQ9=Y'25U>V<5Y8S/CCD=;@NG^WEHE %-I.RB^%=<\+
M=3Z===;=9?[NV?:I+[;TKQ#TWJ&G%UMUGO+HPCFAW=:8@T^T'-<&GC'Q7 [B
M' D&OH6DLLY-.++IK-K<<T3."L&M'#L^+7AW[*[U>D"92" @("#1W>P1G^.6
M;1B)K7L8-:9BE&CS _0K*FN_%7^SU6LBX=M]WVZRSO9KOJ9GC3T/-*ZO>$=7
MO/DUJ3J"XJ*4I^B%^O:_AS1OU?#VWKPLCS0\:^);[-'Q1O+K<^;TRZ]L!)!I
M3O-:_26]TXIJ1'9+4W73=IW7=L-2'-!?^*$4H&_M8?@[5DF/\T];*BMDQ;TV
M>S%D;?-R/&CUSK]I=[#V#V>SXMF0OA'QHB/?:'EGTOMOP7F[W&XB<L/0S$ "
M'.-=]-E-U!].J^"8_(^[)D! 0$! 0%6Z>6*C0WFUC?M;GCB'Q:U!J*;&[=JI
M;'OKJ3/+!=?[NVM*N$^<G/WE!R"P$NI>;.LL1IJQ;'(^*"YO+<7;S;P.F,;+
M9TS)B7M90;@3V]VUZ;T3=]2OY=GIS?-M*S3MEKNH=7VO3]./ME\6UK2*YS#&
MCZMOG#,D\.?T1TT:;?C=06%U/!9:MG=%>17D;7301R1VPN6QAIX6O%03MWK[
M/T'X01J;>-WO-2)YZ>K2E/GA\:Z]\7+-/7NVO3].[WNG..>/DF)8]_._JCZE
M^I74_P!^G,OF?GXL\7/+[:PO\CC[=D;C)PM%O:WOA !LA%*+Z?TSP1M>G:<1
MR6S2(B/5CN[GSGJ'C/=]4U)BW4NLNFLS%9_&X(N8VSN]ZSV1GRUR?R6^O[N1
M\CB.TNN7N=6M>U=FMT-OLXY9T9F8['6[]WJ[F[DMUK8GC,S'I2-N,9"'"V8V
M9M*-,/VX]VP1U*Y>GOM#7N]W;;[JV.,X5^=QHV>KI>O9?&MVQ%)\RFW(&(N=
M\EY>8[>$,P]\]OHHYL!!47WZ.4:EM/+'XU(K-W-[NZ9^C/XD'9H$M;-A<VQH
MV\(PF0/P;+?M6/GTI]F^WYX_&FO)2+M.^L<>6<?P-3'DK61H<['7MI'0U%W8
MW%OQ5[S-&RF]9HU=#3MF^;XNF.%<TVSJZD\ENG-MD_E3%*?@4(XL))*YX=;O
M,AVP&:,.:1N(!=4$%8(W^AN+J7Z%T5\K-&VUM*:6;C3Y?+%6Z6UWK*S(9A=>
M9_ V<;V2Q6]CE,E!"'1N#V-'N]S&RE6@+6[WH.VW<3'NXB)C*8KZ'.VG6=WM
M=2(MU)B+>,3FNC],'G(=773=::<TIGLQ+J_ECIES6_)]X'7%Y<VC70E\9OI[
MPW XXXCV[.)=$ZC\+=EO]2=2^ZVW4F*1A&'9P[W>MG\2][T[1C3I==96*S6>
M[A7L9/W1AYR?37U6XNTBSE]:<M=9W,L%O!I[+WEO2ZF?X,3Q%/)<>R/'F  =
M79VKXMXA^'_4.C[F[2T8][I6U]:(IA\U'U_P_P"/ND]:T+=2Z?=W3$83.,SA
MPK5=TL[B&];!=6,UO=6,[!)!<VL\=Q"]CVA[7-DB<]C@YIV$$C;L71+]*+*V
M36+X[G?+-2W4MC4MIRS#=:K'%^/+=FLBLB! 0$! 0$! 0$! 0$! 0$! 0$!
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MW5BZ[EMX-I-LQ;%TY2K^UQ?QOP=WT=ZY#'C7N3HD0$! 0$! 0$! 0$! 0$!
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ML$L3!*XR!HLQ6K(ZT]*W6CXXZ=%(G5C'\/X6IU?".]G1K&G,W16L_P!H6_\
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M/<A7;NV>Y+A?_B=9%]?6IY/[VR__  XB;:<L4\O]SY_)_-N\K;Q/=8\\?>Z
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M(]F'Y:7>W/E:I$" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MAHT5VE9.@[+>==W=NQV=LWZFI=2/[=C!U+>:'3="[>;F8LT[+9F?D8''F?\
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M+DU"NE"JQQJ1,T30XA6E=OX"LM)I7@K6*T14)$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0<?<TO\ -WK?]K69_6RX5(SN
M\D^:6SZ+]ZZ'[VWSP\SSGD3^^!YQ"M =0WO97_"=XOB^[C_,M3Z4^=^N'A'^
MD-A^[C]6'&_;'VT#J_137B>66[GZFZBX;Y3C@.LK1@&W]$8O@_--BMGT#^(L
MF>U\L^-O_P 6;CMY?QO0UL_ZFMOSM;_E87UB/9A^6MWMSY6J1 @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @HNG8UXC->([AWJ\63,<W!
M2=2V)IQ5:K!.I$31=%6MNBZ*P--<MD+0^-O&YI%&5H'5(%:^C>L6O[WE_8YU
M7LY:TN]F5C;SH_,&L^F#DMD.5VBK@7_-77UE-CXXK6Z$5UB+.X@N&/F+(KF*
M;B>!LV4H%]2^&GA#6\1=2C4B/5LI-)RF<.Y\O^)'BW2\/],NLMFNI=&-,Z37
MO8/<,=W<S7^<S=Y)?Y?(W%QD+VZGD>^0R7DK[I[9))'.<[PWO(%2O4D:%G0(
M^RZT4OI$=OX7FO0NCK7^)T[IOMNF9K/XG=OH#Z+M:=;'.?&8.RQ=Y#RYTQ?V
MMSJ3-R6\[+.2%MQ:3<+97V\L,@+'$;"NL>(?$_3^G[.^_<W1&M=$\OEQX.P=
M%\-]0W^_MMTJ_9K9CGCM^6C.IY;\O],<F-!X'E7H'&6F-T[I^PMK4W=I!#!)
M>S,MXHYW2.ACB>\^)%VA>>=SJZG4]Q=O-_=-VI=.$<(BLT??MCM[>FZ=NELK
M8MB(BL]KZ<\0XV[.%^\4%1LW\6\U6"W3MT\=+"YL+[XW%G+N,4!&-G![)/9O
MW';M6:+[[HY=3V6"W2T=.>;0PO5)6 -%&U/?ZMBI'[.>6SV.'<B+;;YF[5]N
M4&Q@,#CN';\/<LMVIS0QVZ5MMW<@6N)(!J=GHK]'N4<\)NLIC;D$<)H#4=_=
MO43-J]G//M)G5))I3\%%6L+UA#9M[=U#_$1'K5KP3L^*X4WTVJ(BDUG NBL=
MZG0M:6\-#ZZJ_-SUJQQ9-L?L\!A+:<+/M@^+(34-KO\ 9.P[%CBV*Y8*S]HB
M*1->]&1I+'M:T2&E6R[&\!I4T:J763-WJS25?\1^5-9;!K'0>B>;^A<SRMYH
MX*SU%I74EG/:R6]]'#(ZWD?%)%%/"^=DAB=$Z0N]D*NEN=?8[B-WM;ILUK9Q
MIQBL5^>C)O-IM-SL_=;B(NK$_)-)IYV#GYCW0QJSHBYR9&3$QSY/E#JJ]N+C
M Y%L$GN]M')<7<G@-<VWCB:( T-J#V+TIX#Z[TKK>SB=S-=[;$5CLG!YY\7>
M'^M;+=3.QCEVDS->[L\M5OX07+;S'Y7&RS8_,XJ>#)XV^MIY(9?%M9&7<=)X
MG,?L=&-G%V+;]?\ ?[R?LVSI[C*?EP:CHFILMEJ1K;ZL[R,I[X9PODJ>8'8=
M3G)6SY8:XS[)^;'+RW@QU_%>2AMW?V<<5M#;EGC7,LLSHP1N&VJ\Y_$CP1N>
M@ZUG4M.VFVU<Z<)^9Z*\ >,='K.C.RU[_P!O;A;$]D<%\KQV<99VC>=J^03N
M+8UO<SF^I\D\G.ECN&2.(;79VKDZD>[LYY8++XONFV."N#45"QV7Q?%899B@
M[<HU<D-GR7Z39?\ 4Z^^YIEEM]N/+"O"7FH]8XXNL#GQLV_+\WP?HC>KV?X%
MI/A3;=UOHAX\\:13QCO:]L>EUYK4CM^E3?\ 178M;#4M:?83;&VUO(J,VQRN
M/^YR4_VI"IHU_FG?1Q]#';TC*LLC?YN=^SK7/\C_ .I9KXG\:_\ [?RSYY?7
M/A)]Y:OD_$S$0 "2-YI7X-R\]TXO1**D$$CY&LIQ&E=RI??%D5E,1,Y*$EW'
M&PO-2T=M#7Z%%6_4BRSGG)-EO/J>[C-U+ZS>JO1723R.U7S3U/<1^]QXN\9@
M<:^5D4F0R3K686[(RZ6(T9( 30U79O"WAOJ?BS>6[?IEM9MQNGLBKJ_B[Q3T
MGP=L+][UB_ETLH\LO.KYQ\U=8=1'-G4G.K74]S=9#4>6R$V*Q=S<RR"PM&WE
MR^#PG2RRAH=!,-Q7L'PAMMGX?Z?/3NI6Q[[EB(\M(CSO)WBK4U^M;RWK.SF?
MLET\T8\)Q\RARPY7ZRYX\Q=.\K>76+N\IJ'4.1MK:Y]T@FG990.NH8IC-+#%
M,U@\*7>Y7ZUU/:]%V\ZN\FFE,3,8\,T=)Z=J]:UXTMI'[6)B*L[7H=Z0=)]%
MO*/&:6M,99.UYE,=97&J,FV& W4-Q+:VL@;XXMXI:A[2#M7G/Q%U[^?[J;]"
M9C:6W33]+.,GH+P]X;_D^C'VBV/>3'S.V\Q$[B7N)D>XDSD^T=M:;35:+2V]
MUGK:V%L-[K[CWD>YVV.IDC]NIMW-W'<3V5VK-?=9='[+*6/1T=6R[_$SZRH0
MZK0X5&VF[9^&JQ6*1"\6V\TW79(<-'./9LH:>C\-5B:756F;9MIQ2MC<P ]A
MK4[-GP>E9;KXNK3)CT[9MFO%.:4 !K2O93>J,B)80*]GX HF8@KC0X2TNKMX
M:5_EE->S-&<4G*4O">(!PH#VU'8.Y3-]U2+-.(Q3 'V@#1@I[5/K*.::TNR5
MOLMSMS2MX]]*[#0U H>PT62+M.,*XN+J:6M=.&2B6%I:^2LSWD]M!&-^[<=B
MK==9JUT\K/.S:>AN-M9&KIXWRU4%RQ@NK>\ACO<9>Q/M+VQGC;-!<V]PPPS,
MDBD#HW?:W'>#O7&NTM#;VQ?I^KJQ-8[8IC'X4VQN]Y6S5F)TZ8QY?_5BP^<=
MY9EORUR,O5!R#Q7N^ELG)->ZNPN.MZPXF21UY-+*8K:T#:3OVT)V+Z=X)\8;
MG4U;=GO+ZTI'ERQC%\S\7^%-#:VW;S;64U(K-?G[F/2QMIG<?-%+[,+N(&OL
M/?<0_& K[4;FR@]Q7H2?Y?J],OWFG;%(L]#X1KV[_=[RVW3F>2+LLJTED8>1
M!U_P\M-6R]+?-?4LMMA=02LAY>P9.Y?+'93,-G$]@N+JZ :V5QH!PKS3XP\$
M=4ZQM=3Q'T^R)V5E9[YSX4>A/ GCOI'3]S9X=W=\V[VZD1&,QPKBS'??( R)
M\;A)'*P21OC]MCF. <QS7-J"UX-11?!/?V^^G1NPU+9Q??K8BZ(F/9E29?Q2
M3QPMKQ/K44W4&Q6OT-:;_>1]6KJ:EFGK>XF?7;BLB1 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$!!HYV%\D31W$U]5#]-1I^K;WLMLQ%LJ-RV1L?"!Q ]FRJG4
MNFL3;FC;6Q;,UR?+:BM+FZTKJ&U95LDMA=AM!4T]WD]%4T*12Z<ZN7T&^-'K
MFE=?/J>]MG_\T,;'7=J^QYD:DMI00Z._N>,$$$5N)M^P'L7T/:TG:6S'8_2;
M8;GW_A_;:NEC9[N/U8?.2M;("6@5KM]GZ(VK+=9R>M#D;/=3JSR7YPA"2T4=
MN[-B<\TPQJMK[2S5U(OF,82T >XM-2-X[J[DQK5DMF(MY(R@1800WH*[&!PX
M:;/I)$./N9FV)F%&=M'@#:>WLW?["5B)I+-HS=.GSQG"F)W/#:.,4]NX/AE:
M3Q!P(<-H-1N46WS;'Z,J;G:6:\\UU)K&,>5=VZ&>H"'.6#>6FI[B/Y3L0&XJ
M[N)6!\XX(@8_MLI<[?LV=BZMUC9\NI.OI1A=F\G?&GX<W]+OCQ/TZW]A?/KT
MC+/'"%RV1P;*P]@^P[P=S@5UN_5]W,63-7FZ(LNNKQA'C,EQ3BHR@H/P4WK-
M=96(NX,T<EVG,1[:N]SV$4%&]AV&NZOJ2D>UV,=?6I=@XPYL<M,+S2TM?8')
MQ1F9UO+[E,YK7NAE,3^&G$QYVN<N5TWJ^KTS>VWVS2:XN?L=S.UU.:E=*5@7
MF'HO(<N-:932&2ADBEM+B7W>:1KFMFC=+)P</$U@(#&]B^[['>:74-G9N].:
MS='S.TZ=\7V1J6SA+YML3A '.(+SO (.P>E<GFK=V0Y,16VLJ)/=V[QW4]*R
M>5B3#XHK\7;7Z.ST[U7CWB4GL!J/5\*M3CQ$]&NK3?W[57&!#VAL'P;O65.$
MXAM)+2:U[?I[E'>(%P80#V5^&J9_**IJ8CP[!V]O;Z56<)9:UC'(Q=W<8[(V
M>3L)7VEU9SQ3QSQO+7_:9&2.%6EI%>#O4ZMEFOISI7Q6V8I\[B76S[6<KXW3
M#SPQG-/2=KCKJY8<[B[>*"XBD>!+((HXF!P!D<]Q-:KXCXGZ#?L-S-U/\/=-
M8GYVDZGM/=S]HLRXNU@X 0.UGKV<0^G5=?MIIZ?Z+2YRF#@X @U!W*>:/G0B
MK @(" @(" @(" @(" @(" @(" @(""! (H=WX1J@Q,OG1N(FO=!\AK^-A<W'
MW>9+R!6G$R[V[BG%:GJ2PYLQXLN(CC8 X&:Q<#^)#7LJ=W8 II\S'CGQ>B-Y
M%.I(,MT,:#Q,4PD?AF%DH!!X#+!:&FPFF[T**46F:KT* @(""23XCME=E:=]
M-JF,T3,QE%6A\<>TY[1&T-<^:0D!H:RI)<2: 4"UFOK:E^Z^S61ZO:S61,VQ
M^?/!:-ZR^H:74F=FY9Z<F+<+8/,>7NK>4\,SSXL8!\.4@\)]"^R>#?#^GM-O
M_,=:VFM=&$.P[+97;:8ONFM\PZ%FVCBCJ=H;MA(WO)]IU2-I*[S-TW2V^G'N
MIF9RE(T%U"10=U>[8K3-([S.:HU!^-\&_P"'<E)C)" /M5/X-B3&%("OLT_
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M&WUKK4[B[3IM[H=D]S;J7SN+)R;LKK" @(" @(" @(" @(" @(" @(" @("
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MS-U:N+I<5^!VJN>K3@G@IASB:$U&WN[JA<F^(BVL<%+9FK3-GD:'B0UX"02
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M-W^YNC[7RSAQRGR)\"]+W7B#J,V;JV?LMET4SI=C%?F9WV%TOI/EMI3 <N=
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M>LQ2>*RY>"TB1KW1SV]""QS'$.KVC:%W"(LNL['KN_5F^V+XQTYBL3&-6L>
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MX@@4I7MKO^!(S3$43?9C9\/?L^LK"4; W;2M:FE=VY!/3['AV>OX?6@@\T<
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M8[7G?XV_#C^8;:_Q!TG2_:1%;N6,Z5GA"\381-C'%$>**1K9&/XN(/:\<37
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MNW<[N+]2WFOLB*3/R.B?$#J7V/I&I99/K71.'=BP6(&FSL)K^-P$]P^:_FJ
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MV_.T&WO^UM7U>,H?EM=[<^5J5*! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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ML*_9M>8S5M\;R!3[7)4U_C#WJFA/^;4G*CCZ-/LORRR-?FYH_P >M<GMX/\
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M.$M[6_%=3?MV]FRFY$Q7-/P.< 7.H1790;/H';6B*UA*6$FKCM]2M&28I3!
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MK91AVO8WA")CH&A69F>6._A"X6NK.RB @(" @(" @(" @(" @(" @(" @("
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M^HG3/4=RPQ6J<)D(9<S:V]O;YJS#V">&Z$,7B%T?BR/(D=7:>U>6O%GAW<]
MZA=M]6)BRM8GA,5P^9T'=Z,:6K6V/4G)VC:XEH-*FFT5IMW%:2VOLS\[A^=-
MQ $-[36GP;TYO6Y1%6! 0$! 0$! 0$! 0$! 0$! 0$$CP7-(';]8@H>=M&;M
MI9\)FK=I\22XQ.1@B:6C:Z:SE8&TVUXG$;%6(FL]B:XU>6]UL\M=3\J>KSG/
MB]46TEE-G-37]U;^*QT7'$_*Y"9E&.9'L+%>W*"_"Z9:GHAY^W'2SU8\MN<-
MI:>]&#.6&.CB#J%PR5_8VKR3QQD;*]J*SA$2]/C06IV:WT/I/53&>[OU)@<5
ME P'B\-UY8PW3FU!.XR]Z=M,B8K%+GV7B".D;G<3Z;#2G%\*K,>\3[,14$XW
M ;?7N%=IK2FP+A:^ZMV]TZ=)F8]*]ML7QS1."SAYG?5Y<<OL&.3F@LU'9:FU
M# YF5NK25LLMO;2QS!T#C#<!\1>T;:BM5]E^&7A+2WNM/6][IUVUDX1/&8XY
M8MOL-KJ73&LQZ((BP2R$O9--(^>XFD>Z9]U-,\R2O+G$N%7N)7W>_4K?R_DQ
MEW.VZ6VMT[.:W"6I1*!J1[)X'-^*[?6NTBBK,8]L)B:)H72VTT=Y:2R6=ZRI
M?)$]S>,_8DAA V*)CFMY+HB;)6YHG"<G8;EISVDP]N[ :R:;NPD<UD61>:OB
M^(&G:_BHM#U#HOO+XW&TPNC@PZNC$Q6S/B[2V<EGFL?;Y3$7,=Y8R#BA,;FN
M<T. <>,-+G"E1O77;^?1U)T]2*:G%Q)GEPG-.Z"7Q P#B<?C=@ ]>Y36D5G)
M'/"'#V#VN"O$-WT#ZU..? B^)NY4KV@-XN':/3NJ:?45*UGM9J840A D>QI=
ML=6KZ;!3=56F[#R*YN?^G#DKE.:O,*.-]M(W3>'GAGO[IS'>%,ULD+VAKC&Y
MKM_8M'U_K.CTK93.$[B^*1#A[_4G1V_/6EW8OOX?!66#QV/Q-A!'!9V$$<+&
M,:UK7<$;6<1#0T5);W+X?K:M^OJ777UY[IK5U35UK]:Z;[YK,MZ:"!1QXCMV
MTIV]WH5;8Y<&*0K%K32W&,"&@ENK>Q@NKRZG9%;VT3YIGO+6-C9$QSW$N<0-
MC6K'MM/4OF)G&*LL63J:ENEI1,ZMTQ$1V\%COK0ZC;CF1J*71&EK]S=-8J9\
M-U)"X\%V]KYV.J62N!X7>A=XZ7T^-&WWFI'[1[=^"?P^TO#72(\1=6LB=_K6
MULB<[<NV'2+B-O'X<7L,F XS2M*=H]96\]WR3CEP?6_M4;V^=6_VK9PE, T-
M:&[A7;MV_149,]9F:RB@(" @((.^(X4K44IWI&9,TB9XEO'X89'4EQ)JVE>[
MM]2B[&?45LNLLB9U8QGBIY"6W@/VP\#:&KQM]JE&BG\<5?3F+8QGUH<:=EK;
MB^NC68KD[X]$/3[)KC,#F'JK'O=@,5*R2QCN(W-;<.XH7-<QLD)#J4KL*T/6
M=Y[N)TK)]:7QKXV?$72Z!TC_ $WTJZ(WU\4U)B:S&<<)7L[6&.*VM[>UA9!:
MQ1"**)K6M$;(VAC &@ ;@NI1$4K7%XLU-;4U[[M74F9NNF9F9[T(+,L?XDGM
M.).W=3?3<HNBZ8SK+C:>E2>:[-N*LSJ!<'\8[&TH[N-.[9VA1,Q2([41C+8=
M2YZVTWIC/:EO*"'#8?)9*4G<Z.QM)KDBA( XA%1)CEQG-,8O,1\Q#G38]1_6
MQS1YIXN)C+>+-7%@"QX>UQL;V^M35S9)!O\ 2KQ.&.$JS[6'LN,^F?"W6I.J
MOD?8VN/GR@^^?'&\M;:*281QC*V&V1L3)*#A/:%2[+!>)FM9S>IIHO'6V)T?
MI7'V<#;:"TT_B(8H&-$88&8ZW:06@  CMV),33!&6'%]4UP<*C=V'O[]B1-1
M%2""5PXFD5I7X>U1.6 TQMZUX?8=V/%"=Q]*MAS3V*T]6D870!D[*-XA*P['
M CL.^O80HX]D$UB,,9<&\[^F'D5U%Z6O-&<W^6^F]68&]!%Q%=8VS9<2!S'M
M(]\9![RT 2.V<5*FJB87B9ACF=1GS5KI3YJ\ZM)<QN6.H1RNT?@<Q9Y>_P!"
M16,=Y:WDEK>MO>"*7W%X+7.: .(B@&]6X]RLQ$Q3BR9^47++!<G>7&D.6FFH
MVQ872&$Q^&L@UK6![+*UCMR_@:UC6\9BXMW:JXUGL6F9G-R2I0T[^%\@&]S2
M*=E*CZ=:J8F8QH<L<9HLI^=#YJ6*\M'DG9ZBPL5MF.8^=F;)A,*^2+Q)[:#Q
MWSCPGW4!)D; 1N-%$16.Q'-%O"LNA_0/\Z!Z6.H3"XW'=0@BY-ZMO7V]G!%<
M/9/%>7$KK:#B>),@?":Z64FHW )".:9I6*2R6>7G-CEIS0P>-U'H'6VG=38K
M+6T5U8OQN8Q]W,8YXV2,XH(+B2:-[F2#V2*[4[UNYR*Z4L+>)E 202#4"F[Z
M*B9B(K.1&,TXRJ@AP!&T%3$U$4! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M^;4FZDUK=#Z?;I3I:<VW^S.*9["0'?$+:%PK6NWO]2M69PC.2WEB,<92N-:
M#=7MW?[*M;-"Z)F:IZ; UVP]AW^D[E6JP6EK2=X--NZE#W;]ZBN/<5A+PFI
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MMI;=,^=ZG^'?4;-]TGEF?7M_N9$5-@'<%\WOLFZ([7T4"M;'+%)S0BK @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M?&KYGM,3)#;ENRC3P-N]E=@VK[U\-[X_T]K:<XR^&>/K(GJ^UFW"DRMTZ2R
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MX=H]9%-OK4Q&.+-=,OJ-%:9R6K<Y9Z<Q-I)<W5[<11R^&USS$Q\D;2X\+7D
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M>\DO;0 U![MJP3C-99[/=S9&G93FIBG=O_!_$5DQ;-D<LYI46$! 0$$6@N<
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M5ONOZ'HW7_F^B'<*(!C0*U)]?I]?8NOSCEE#L,81CQ57;EBU<DMGR7Z39?\
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M+TW\,)F>F37/E_$R$5\N?4A 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M<[V=E!3=V=FTU*9"92" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M+L1RS6,WJV8B8I.2#6M:*-% I(B(R3(D0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$#>@X_YI?YN];U[--9G];;A4C.[R>B6
MSZ+]ZZ%<O>V^>'F=<\SP]0'.,_\ U%>T/=^B=X-R^,[O'J=]?SI\[]<?"7]'
M["G_ $X_5AQNT[6$=K257<1'+/<W?-,:%]JX7Y3E1UF:,/:<C%]T62VG0,=Q
M9'>^5_&NG_X6;B+?S?QO0YLS^9;8?VM!].,+ZO'LP_+6[VY\K4H@0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M:/\ ][7GWXXQ_P"1V3^A#[[\!/Z&T_WVI^LR15\1?;1! ]BI?P\HP5//J/\
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MH?S?#^#[J'^>6GY7:KS9\7(_S'0^C=YWIOX6_=5WR>AD,+Y"^I" @(" @("
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MY2ZQU+6Z_O;]UO;INUYGYNYTS=[F[<:LZG!RTUK6B@  ]2XT1%L4<-0G89
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MCJ/45E;S6W%"+9]P&VMF]\[XJEU7/D.TDU)5HBD5K658NF[A1=34)$! 0$!
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M ![_ *BR;_ZNUGVF<]KM#T,5;U>\H=N_.VW9_;]BNO>*L/"N[^A'FEM/"_\
M5^R[[I\\/22Q_P"D^*_4^R^YHEXPG.Y[%CV;?D\S=6KBZ7%?@F682C>N)9]=
M*TY,%;YPY_#3T(>T6(I_<]TO7'PJ_H;6CAS>EY1^,']?],\ERRP&TOL4ZM2<
MIC?IWD*^G[7#:1'Z,^9T/=S,;W_BCSL_'H V]).C!WXRU^Y+(KR]XMI_.;H[
M;I\\O1O0Y_RG3G]&/-#MF-P]0^LM-K?50W_3_KY\B)H74 ]H]M3V?25='V:\
M&7=>U;7M5N$@^T-G;M_"V[T)0<*;*U[]B(1!%&\0V;:&OU@@GHYH<\FM*<![
MJ[#L"I2:HG.B4/))V5+J=M-R16I,)1VN&RE/I[%=:<538X.]JC12NRM>[TBA
M47*\>].&5)XA4BE'5I7X =E%5%>Q1J7&M:N[-@V]_HV!6B*0OW<$6#B--P[?
M3W>I3*$@!)X1Z?I*E9.]4<PM ;Q5KN%*;MN^JM"(FJ!]G:1P_P =6M/@4IE3
M+B"#Q5#J=E%&EE=*VZCV$9@*>R-A(VU[O6LVG2;J<'!W&&C\KX_FA[7)OFM3
M8?O5RU3OK^@]ZJ=-^^=./TX\\,G4(_RF8_0N\TO.2RI UAK?O&IM0?KO>+UQ
M?]T4_0M\SRO%(ZE/;[R?/*]'\WF'_C*UD?[0D_*+5?*?BI_16W^E+N/P:FOQ
M(ZM]"QG1KRV];B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @X]YJ?YNM;U%?\6\S^MEPJ7<?)Z);3HGWMH?O;?/#S.^>
MA_\ $!SBV4_QBO>W_G.\7Q?=?>-_TI\[];_",T\'["/^W_\ HPXY!VL] /U4
MU_9^1O/_ +>]<-\IVO[\K1;AV9&+;_QFQ_#6S\/X;BRO:^5_&S_XLW'T?QO0
MVL_ZFMOSM;_E87UB/9A^6MWMSY6I1 @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @TUU^1.^!5CZZ%=3ZN4\'Y&WU#ZB1[=R8R=?>J[^#S
MS6_:?G/UMNEOO"OWUH?3CT-)XD^Y=?Z$O,R?^G6J?VSZC_7>[7LOHWU'_#'F
MAXWZE[=WTY\\KX_S>[^%1K+^<-_*;-?-_BQ%.DV?+Z7U;X<_Q=WD9<US_5]R
MXGB GEX32G\T=LHOCUN&G'D?6XK[O%!Q+B*=M=GJIVK'M_;NG@X?%5XI?1])
M9*2S4@<X[AMX=[MFVOH2(H1"GQ&H)VTKZ-ZLE'945%&[:"M?XN] !H[V/@^A
MMWH9H ^U4_@V)$'D3N8&@FM>[92FWUJ(FJ(FJ0_%;\/U5*4SC[(JW:=SJ^GN
M[-BI.:.(PN(H'4(W"@V]^U":)A5PXB^A;7[$;*[/AJAA&"0D'VC[3CO&ZE-@
MW=X4VI[N") 93OV[?XFWO5@=X0^,:N[31P]6P;-RFW.6+4K@T[BTM<:4;LV?
M"/KJ+ZUP3H98MTQO]5P\7<?#^AZ/KJ9]CN8=?.>UA=^=C_"_R_\ )1?_ !B^
MT?#K[MN_MV/C'Q#^]=K\JT?9[-2:9H=GROC?H^^P+Z99E=7\R[S2Z'J8=3LI
M^='G>D)T!&O2GRH)_P"0+7[EMUXA\1_U%O/WLO8WAC[CT/HNY ^,_P#E?J+4
MSE#?1G*+MRQ:N26SY+])LO\ J=??<TRRV^W'EA7A+S4NLO\ A?\ /?\ ;!-^
MN-ZO9O@3'PKMO)/H>._&_P#6&\\L>EUX('$/0NQZU?>6-/T[^'U_(J"ACE!W
MB.3;W^P571BO5HIV,.WFNVI.599&WS<W]G6N=OV&[^4LU\3^-N'V?RSYY?7/
MA)]XZOD_$S$UY\>B! 04+K^IKC^<2_E;E:SVX\L*W^Q/DEYSOFFBOF!<YMNZ
M]MORZ\7L'P#/^2:7T?1#R;XVG_.;_I3Z7!_2".+J]Y+@_P#+UK3T?F^P6W\7
M?<>M]&?-+K/AF*^)-"OYWIAZ)&8=0XJNT# X/9_T= O+>P]BZF?/=^M+U/OH
M_9Z?T8\S:0Z@V;S]*GU5RF(JXAQ [JG9]15FIADC&1Q, %".*I[]A4(G*4Q!
M)+2[=2IH-M=HV=E%:,DQW*5=M3M^DI TKLW()VAA::[#W[=FWZ"B81->"'%P
M$AIJ-FVF_P#!5432N:8U/ YOQW5V^H4[=FY2B.R<D"X[GBI&X[!3M.Y3&93L
M4U9*8#8X]U*?101)]EH[ZU^B@EJ=OIW_  ()Z4W_ !>T]_=LWBA025V4^AZ.
M_P!=4$Y:.#;L/$W;\([E:,8F.YBGZ^R>]8"^<%[.6'*FG]O?#MO%WGX88]9=
M ^*,TV]T]T>EBCWGZ6.]4?U&K[OU/&+7PZ[+Y89H7S?#^#[J'^>6GY7:KS7\
M7/O+;S^C=YWIOX6_=-WR>AD,KY"^I" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @@:TV&A[]Z *TVFI[]R#3W;"^%P!H>^E=Y"M9/+=%TY,>K;%]DV\6
MA9;OCV2TD V-;_&NV/'PA<?<VW:FK%VEA;Q6T-.8T_VLUIEW+:?6_P!,_P O
M8Z7F9HN#P+['QR39JUAC]NX8!*3)1D1=0$]Z[3T3J%NG,[?7XY3Z'H[X._$B
M[;;G3\-]6F;M'5NBW3F9]F<(XRM#VDO@N="ZKWL>^*1SAPN:]CBQ]6G:*.!7
M9;I]Y'-9ZML<'K>[1C97^[UYY^>(FV8X5Q:MS@U_#\8G;W?72*<6:-*;HK$X
M)^&@!/:*_@VI&.,./J:D:5W+,52Q_;'A@V5K0G_85;KHMS9K;)NQC*%1T9:2
M*U(5HQBJE<:'A[MN]5F:,MNGS92D(HIK56;:320N8P4>W:[XKM_#3T#O28F<
M>#'SQ$]L*D(DF!]GB-:<6Z@)I6GH4>Q-;IK:R77:>I;.GIQRWOF-3ZJP^@0W
M)YG(0NE>";>TJQQ?3B):YH<"*\--JR:6G?O(FVRV8MCBY6QZ5N][72TJV]MS
MY'D!UQZNY4]0F'S_ +Q+9<J,A>16N8L"]YMV,FFA@8\,,[(VBFU1U+I>CJ[*
MDQ^UMC-J/'WPWVOBCP=N=AKQ;/6;+:Z>K2*Q2)GL98NB==:?U]I7!ZPTYD(,
MCB,Q9PW4%U ^.1K3-"Q[F.$;Y TM+J4)JOFVK9-FM-ET8\/D?FSU/HV[Z-O=
M7IN]K;N-*Z8QBE<9BN+ZTW4;'--#]MW.[Z#Z5%CTK9B9MNG!J;[YB8B(QE6$
MPIM!;W=M>U6NB9PM99MFW&<FC(BN(IHYHQ)!.Q\+X) '-DB>WAD:X.!!#FG:
M"L.K[S;WQ?,X1V*:5\32;<+H8Z'F;=']KRVU$SG7RZQ[X<%G9))-28VT@<8;
M2<"XE?+2* -:V5YXMIV+[]\./%_\QV\='WF.M'LW3.-,(CB[7TS>V>ZNYX_:
M12O>M,PRQR1Q/8>-DH=[0_%-^,TCL+2OJ])B9MC"C=Q=6R+^$HBM37=LIN/U
M%-:^1,=J9$B @(" AG@K3 21M\(4F(I(>\4("QQ=;;-9CU4?9M6VV:W8RV\Q
M-9#(RY:)81OC(K5Q^*=W8Y9)FM\4XIMK&E-MV-ZYWY<G6')R7UC;\LM>7;VZ
M-U7.R"PN9YG.M\/,#!##PM?.V-OBN=38%\W^(7A72ZGLIWW3[8C>Z<8Q^=&-
M6@WO3]36GU>&3)?LLE;7=G;7MI*VYM+V*.XM9HRUS)(9F"5C@6D@CA<.U>;/
M>W;?5^S:L3[Z)Q=;U-&_2NFR[VHG)N?&*<79W_Q-ZY<W3%,,V.(KEFF5D" @
M(" @(" @(" @(" @@3056/4U/=Q6F"8BJ(VJUEW-;S(%8:-[O#?5K?:=\=V_
M@'9ZZT7%U+XT)YYFL3\BT5NPIBZ1^8EH+ECS/Z2^:.C>:M_:8_3F1PMS+#+<
M"%\SK^WM+I]E';LD#I'/?*:>R*K:=)VNOU75C0VL3-U^&$5IWLFGH7ZM]+<*
M<7F:ZLTW-H[5^H]*7$;K6TQ>8R+-.1.!#IK,7MPV)]"UIHZ!C3N6;J_0=WTC
M4]WKW>O/R9L=]EVGGDWWE;S RG*S7V&U987$@>^YCAO@TN$?@/DBC>7-#F-V
M1M.]9^@=>O\ #W6-OIZM;K=6Z(\F,,VVU:3,1[4T7TL%GL7K/!8O4.#N62XW
M(V\,MS,PM?6?PHW2#8Y_#PR./:O6^GJ1=HV:D3%W-9$Q,=\5=OV7[2R)MFET
M/H" &F,;>$ >L=GT@L=MU<*8MS.E?;'-7!2H6.#=X-:*]MLTYN#B3JV^\]U3
MUI3J5Q 01+:-+ZU [/4HF:31%MW-@IPRF5[?#8:;:@[B!OVD)=A%*LL671$R
MKV&-R.?RMMI[3L,MWF<Y<P6=K;0L>]Q=-,R!Q]AKRT#Q.Y4U+[=MM[MUK3'N
MM.)F?DBK!K;O3T)]>*RRD>@#I,M.F_EM97N=M8GZYU-;PW63D?'&^>T;+##(
MR(2F%DC7&FW;L7F;QCXEUO$O4IUM*9MV.G6(MX3C.+IO5^H?:-U,6_5SEW=J
MX'Q.\5S37B:=AILH?I+HMVC?S<]DYN%$>IG@GDN6L(%*AVYPV^@K-R7WZ=,I
M<>Z[ENB.U2N[@6T D>TN)( IM(+CLV#>L6GH771R78W=IJZD:5LWTK$.B77#
MU=XSI9Y;WU["R+*:IS<#K?%V/CQLFM_&9*QTWA^-&\\ ;4;.U;WIFQ^V:]ME
M\_LXSE];^$7PYW'C?J]FMN9FWIME\3E[5*33+O6,=/ZZCYNPW6K7YB.?4&2E
MDNLG#-(T20"20S,8WCD>YW"):;%W*^/LET:?+^SIA+WUJ^'+^B[+3VFVCDV5
MEL1$1&&3?FRB$^',#<0,]F-Y!:6.(HZE?C"J71=?ZT86M5;=;HQRW?Q,Y@:#
MPFM ZI&SLWA)GLS9Z3,5A*0-I!JT=OPT"B;J,D61-M:X@%:^A6C%ANFB45[1
M3T%"VZ+XYH11803QL,C@P$ '?7T;5$Y*S-,:5)WM:QPK2FRG?O!^#:J6UNGL
MER;YC9Q-]_K3,/H.7NB\SS#U=BM+8:VED-]=1-N)HV/>V.+QH@[B+6O#06.[
M:*=QJZ>SCWVK-9B'7.N]4T=ET/7ZGK7QIV66S2M*UI/:R'^4/*_!\I]'8G3M
MC9Q-NQ;1>]7#&-;(Z9T<7'Q.$;'&CV]JZ/N-?4WFO=N+I]2,GY\^,?$^Z\0=
M4U-75NF=*ZZ:1C3"9[^QS RV+(SPFDCAO[N[U4"X.M$W1-,W6K(B(RI*6&VG
MCD<]\W&'BA%-W=Z%-D1R8^TK;%\:E9FM@+>X(+73;CLV=Y)5K9B)]:*PY&M-
MEUOJ12YK(VN:P!QJ1O*BZ:S6&&V.6VDHO%6D5INVTKV]RC'@MFXQYO<U-)\F
M.7&J>9>M\E;8C :8Q-[D9KBYD:R-TMO;3306[2Y\8=)<2Q!H%1O4Y8*XYR\S
M3KOZL<UUI=3>NN<68DN;+$V^3GQ.#QSIYI[.*PQMU>65G)# 9IX );8M/LT3
M*ZF54Q,YSP=;M%:$S7-C7^B.5&"L[K,7>J<]C+.\-E!--/';SY&U@D>Z.WCE
MDX(XIB=K:42<(J4F9B*XR].SH;Z9,#TG=-7+GD_@/!<_#X2RN<A?-M8X;BXO
MKVSM9;F.9S889'^#(WA]H5V)7'N*.WC8PT@CL^N/6H\Z8PBD*B @(" @(" @
M(" @(" @(" @(-/-:V]PQT4\$,\+Q22&>)LT;]E!5D@<TT]23,S(Z2]4/ET=
M(76#8-L^>/)S3.I);>VFM[.]AL;/'W,#Y8YFMG,EO;?;98W3$@O#E6*S&.::
M\.#$JZV_FG]Q:7&K-?\ 2UJQ]XZ4RWF$T&UG@F -==316[96X^CBP>&W8K3E
M6,U8K%U(PL6$>1_E%]:T/6YRJY1<XN7&6Q.-PVJ;-V;N39W=Q876/M\O:.J^
M;Y.-O0VT;MI2G#BF:W74F*1VO54Y/\M=-<H^66B>76EL=#B\)IO 8RPALX&-
M8P2V]C!'/(0UC 'RS,+CL"E$1CAQ<HJ$I7.I0 5)K05IN4Q3BAUQYU]6G(3I
MXSFC].\X-?XC1N6UU.ZWTY;Y&XAC%W*V3PR'/DEC\(%^P$BBB:0F>[%SK@]2
M8#4MG!D-/9K%9JRN8(KB*YQ>0M+Z)T,T;98G\5K+*VCV/!W]J#=WR!C0ZA(.
MS<0?H$51$S13-PQNQP(/=O\ 5V*(FJT4E7::@&E*[5*$4! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$!!MN9_2?*_J;??<LJOI_66^6/.K?[$^27FK=;G\
M+7FRT'=J"]V_](WYW+VQX0C_ ,9T?H1YH>*/%M8\8[F[]+TRT/1[MZFN7 !]
MKY7M_NRT^#<J=9U(CI.K7*GXW+Z/;_G6C,9UAZ#&':6:/T@7.KQ8BQ]FG]I0
M=H7FK5GFW>K-./I>D]*::%EO<U/8ZFP;-F_Z:HNB'4WFH=\84[MVU1,51*8[
MMCJ\.[9NKO\ 75(CB0E )VD5^$#T*4@=1IH=I[*=R41Q2GT"GH1*IQEK6@;-
M_I[57E10#@X@'[+X_IH/9W;DI,8U*(.=4;MAW;>[>K8ICO1' :EXI6E-_9L.
MY1)->!QTHQKJ ?94KOV[J=ZJBG&4YC+M^PBGM?BMG=791$5HI_%!-:M-*"GQ
MNP^D4*1@G.>]%C:N-'4X:4-*[P>]3.),Q\@XM<6N(I6M14[:;!M'<E*II2".
ME0 *.V^U_$W;E%,437Y%!VTO)V&N[^*KZ?MHU?9BF2U;YWNWH4RAW@&"H_EK
MM=N^'/\ 6$5[_-#IGQ!BO@W6F.$QYV$Z2#@7"G]9W&SN^TOV+T#9'^)FGYT>
M=\&OF8V,]^G=^JS'?FV7\%#/_JS_ .PO/WQQ_J*SZ$/O/P$FO@;3_?:GZS)#
M7Q%]M$$#V>L+#K91Y83#!2\^K^&9??G?'_E-TO4OPK^X[?(\O?%+^H8\L^E9
M?;M>X'N;^-7U&[ZR/*^?1]7*H1N(=2@--GT5DWT>K9V+;6:3=7VG:'H5X3U>
M\H 33]';;;3^W[%=?\5_TONZ_F1YI;7PI/\ Y=LJY\T^>'I)8_\ 2?%?J?9?
M<T2\7SG<]CQ[-OR>9NK5Q=+BOP3++,TBHE&]<;3^MYNU:<F"M\X<_AIZ$!VU
MLF@=E/S->'X:T7K?X5?T/K?2],/*GQ>MB[Q]TR.-+O-*RR/:O\5V?HIC?NR%
M?3MK--G$_HSYG0=U'-O:?I1YV?;T O#>DO19 XA\EVE36E/S+9#<O+WBVG\Y
MN[>:?/+T9T.G\IL[>6/-#ML"#2FW=]9:;6^IAV#I\3[^>VBHYI&\[-FR@[^_
MTJNG=2VK+NH]>V$:G:._>I1Y4W$-OL[Z5V]R(2DU] &X(*C'.%*;0*U;L%*U
MIM43%44@#N(N.XFE.VE!]-12F-2DH$- ]EW%7LIOHIJF)[0%@I7VN[>*?AU3
M,E'C/%7BW[]G<-B413#O0:SBJ ?BT[-]?AV43*:)F1]8Z.[3V[/J;4BDS1%8
MIE64K7-)%-A%:G?OKV*9MB,5L\(5*BE:\1;\&]$4HI5 !J*@T^JI@0E-2!W4
M4:<X7)W6/(/;PLV';45V>E9-+"_Y'"W-?=]U8?(<T!3DUS6--^ELMLK_ ,T7
MHWJG3:SUC2F<^>//#)U#'I,_0N\TO.3R]/OPUO78?OGU!4[Z_HO>4W+UQJ5C
MI/\ P6^9Y7MI_,9_>3YUZ+YO*/\ QD:R<3Q?F*0#LI^9[7\-?*OBI_16WC]*
M?.[I\';8CXC=5F.-MC.C7EMZT$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M!',^0'AD;V;RG'N+HF,?RG/,>]Q)]L\/$/Q.S8HB8J*BD$! 0$! 0$! 0$!
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MO&' \5=XVBFP )6AC2@"T>RT<3NQV[TG?Z%-9,<TKZDDNV'L&_N[0II$IBG
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MHUY<>M1 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MW?\ 8E1H_>V'8XNC/^&BO;+(U^;G ??UKD_QG_J697Q'XV?_ &U>V?/+Z_\
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M#_L;E$UX$IZAQ/"SBW5-:>K>JUF5?*/<=A+*=QX@:=ZF,R.Z5&N\=^]661<
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M@%8V.J"2:\-#4GB.T[=ZBV(XGK3;3BUK*\(J:GOI13D8<$R @(" @(" @("
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M!( J=R9A45IV_@*)I-*\"HJ1VC?\*(10$!!+Q-XN&NWNV]U?5N2J:<4R($!
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M_)ABOTYYN>[-15T" @(D0$0,!+J4V?Q%2:1=66:(NG2F+5*XA$T9B)X?LFO
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M[>[VZ+++;9F)F>S'N7]NE'DC:\H]&-=<VD8SF:CM[G(7+F,,NV*)[&5,;7M
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M=ZOE+-2:=Z)&Q[FFC#2FRO%V=NT4*D[N*0FH:VE*=O>HI"<L4[P[;5U>'=L
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MVUK0&E?AW*Z42UU0T;=]-P])5;CRHA\IKLV"FW9MK_%5<9\B*6I*$;"KQDL
M5("E">H)%-CC7;OI3Z1J$"0M;&1N/$WO-=NQ6MPK/"C%=CJVQWK 7S@P']R[
ME00*U-[VT[;Q=Y^%T?YU\[H'Q2QV]WDCTL4>_P#TL/\ (Q[.[8.U?>.I96>5
M\,U?8Q[89H7S>_\ @^:@_GEI^5VJ\U?%S[ST/HW>=Z=^%OW//DCT,AE?(7U(
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 02N:U[2UPJ#O"F)F
M)K")BL4EI'V49C#&>SPU((W]ZQ:O-?$S,D6Q$<MN$/E]2Z5QNJ\)D<!G88[R
M#(6TT#6S-#VPROB?'#(.)I'$QSZ[NQ9=OKWV\M\83:YG2NH[OHO4K-_M;YC5
MMNB<.Z:T^5B!=>')?F!R*YS92PU/D+R^T9F+R6XPM^&3VUI%#)-<RQQ#A;'"
M^C*#M7U#H_5]OK[6(MMB-6V,9?J%\)?'O2/&?A+3VD666=4BV(F:Q-TS$1PK
M,NH= YL3APM! ,;&@#B&PUJ-]1M7+NW,WSS3E.3Z1[N=+]GJ36^$7M#S23V"
M-P'\3?L5;9U+IFZZ<%K8MSB/60V[Q]#^*K3V$8XHJ,+93$U%5(I[PW;E-L<.
MU$VS='+"0APKQ&@'J[5R+(]:L9(^S61'Z2H"QS"PCB#J CU>E6FWM<'6W\[:
M[W5/5EI+ZV=?6IM1(8'LDAN+2Y:2)K>6W>)&<#V^V*O:-Q6#W$3=SW98MGL8
MV6YO]YN-.+IBV8I/&L,B_P JOK/LM7Z>MN1',/+B/5&$B9!@)LA<5DR44;+9
MG!XEQ<EWL-W"B^=]6VE^EN+K[8]2KP9_N"^%^YZ5U+4\1]/T_P#":LS-UMMN
M%L5NGA"]PVXC=.(FQ5J!1X/LEM-A#AL((6GBRZ/6F[Y'E'WMTW^ZF)I"O);B
M0[74 ((%-WPUVJ;;YB:INT^:$)FO/ UFQQ^S]793U+CZFM,3[N,)E?DB8YOR
MH<*\_>3&EN>O+34>AM2XVVO775A<''RR11&XM[UD$AMS#,Z*21@,AH>'O6YZ
M%U3==%WNGN]"Z8I./?'%RMKKSI:L73/JS.+$!YH\N=0<E=?ZCT-J:RN+)V*O
MYV6<L\4C6SV[[B86_A.DCC;(/"8-VY>J>E]1T>M;'3W>VI2ZV*Q\D.Z;#=VW
M16_'L?&/,@#'.C ,F^C@12GLGZ"YL4BZG%LN:+M.>SM%D8! 0$! 02CBXQ0T
M%=OT%68B<U^:8LHK2\/#M% -YJ5,3/*XVG%;KIF7UO*+F#>\J^:ND^8=F^66
M;"9.TAM+6*1\39!>75O%)QECV!U*=I7 ZQLM'J/2]79ZMM>:V?P1+!N].W6T
M)YHI,,S7E?JF36^A-,:JF@\";+XFSNI(Z\7"Z6WC>[;5U:N<>U>3-_M_LF]U
M-O;-;+;ICYG2=?3MT]6;8X/OUQ&(0$! 0$! 0$! 0$$KW<+2ZE:4V>LT43-(
M&G>7.' TU>".(TI0'=Z%P]US71;%F;+9$1C=DM!>:YSQ^]GENSECB;V6RS.H
M:.?-!.^*0QM;.#'2.5CRUP;MV'>OL'PMZ-&MOHWNO$7:=D93%>QL-CH<_KSV
MX,=F&+C8QI;P3'VWR [7.^,YSNTEQV[5]ZU*63R_D<(=KVML66Q%F<JX=Q"O
MP?0V*8R<J[-%%1!+[!>T35='MHT&GM=F[TI->6>7-2Z8K%8J.,L;G25#N,%K
MVT%'1. :6N&X^PJ^K,<G"66W1MNMK?%;>+HYU.],MKJNWN=<:)M6PY&!CYKN
MTMXP'2.#9I''[7%7:2OG?C'PCH=1V5^MM(BS<VQ6L1C.?<T75-E$>MIQGP6O
M7,N[*>7%Y"!T&3M))(KB*=AC-&O+#02 <7Q5Y[TM'7Z5O9LW59NMF<\/.Z7N
M[-32B;X]F.#Z/1>O-5<N<]#GM'Y":W,$K'W=FUSA%.T.:7#@XV,.QM%?_66^
MV.\_8W3R\T93/XV7I>XOCUN,KM_(_J.TQS@L[?%Y*ZAQ.K;:%K9;>:2-GO$H
M9&-A?-2KGN7IGP?XBT.L=,MUKZ6:L1%:SGA':[OH;R)T>6Z<9_ O8>7KT99O
MG'KZSYE:UA?::,TO<175FR: OMLZYLMM-&8W/@?"?#(W@K3>/?%NAT_9SL-C
M=$[F^/:B<HQKE+A;W=WV:=?RF3M:6\-G:VMI;1,ALK*"*VAB8&M8V*%@CC#6
MM   :U>==>+M2^=6Z<9G'O=7C4U+KING-JH> ETC6<-?C&M1L[@%BLT[;+JV
M9+8SA.:H)'.I1FPUI[0[/@6>V>:V9[%;HF,)S;%G\UC-,X7)ZAS-W#:XW%V=
MQ>7,EQ(R*,,MXG24XY'-9Q.X-FW>J66WZ^K$QAW.5L-GK;W<6[+;1-^MJ71$
M1#$-Z]^JS4G5!S<OL18W\T7+/25Y-;8S&0RO$#Y(I;F&6:22.9\<WBN]K:*;
M5]#Z%T^S1LB^['4E^B_P<^%FW\,]"T>IZML3OM2.:Z9BDY1/95TF \$N?& '
M/:ULM-P8S8TM[ 2!M7:]31Y+<)??/YAH:VRU-./5U[<([4*!O$^,%K7_ !FU
MK4C^*M=[6K,3DXFA;-NTB_4QUY_&<2OR+^\ :U]%%$Q$3BO$UBJ91/X$B2)'
ML#Z5[#53$]J)K&28#90[?I*8NB+:<3&J4.-',.\&C#PUIQ;Q\*PSJW1K1$9*
MQ?[NZ;];ZC)N.,UAFM!SF_PU[-!<221-=CV.DD%RZ0M:QK6M>![1H-@6\N^S
M:^AR;F(NF(PGL89Z7HW6SN=>GV>*SEPSS9(_EI\JLQJW25GS:YA::.,N7,#\
M5%=Q\3KNK()/&+9HJM W[U\PZSO(LU+MOHS73Q>(O]P?C_;;C=?R/H4\FE$T
MOY;JY5CA/%>)LG1.XO"B\,,HP '8&M :  -@% NIZ6I-U]T3E5Y.NONU/6OF
MMS7KDJI./VG- J13MW]_JHIIVY%8X9HN=PM+J5IV5HJ^043,2?M;>)O:XFC1
MWU.X44BT-YC7FZ<CNB'!9/3ECDL=K3G%)93LQ^DK"\MY?<II[6X-O-<S173"
MV6.:+:S8010[=B4G@BL,"CJ@ZI></6ES5RG-3G)G\CD+&:]FFT]I>2XN198B
M#QYW1QBV=<SV[P(YJ;E.'RHXUX."0;W)9&VPV&L;G)YO*S066/QEA;S7,[Y9
M9&V\#6QVS))&CC<T; F>29IEQ9AWDI>3:-"08;JBZF-/QRZPOX;?):/TKE+=
MDOR;%-';3PWLT5U9 [)(OBDUJDS&9,=K*U;:1-B$4;&PQL8V.**)K8XX8H]D
M<<;&48UK1V 4HHMF8FLDQ6&I:WA:&[Z"E5'&>Q*92" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(+5'7MY0?2AU^NN-0\T=+,;S#9:.M\5JT>%-
M)8.$$\44@MY;:6I89J[#V*8I"+K8NIS<,F&QUV?-@^I'I]ANM5]+]]/SEM+Z
M:[GNL7"QUD_&VL+KF:.,!F.#C2!C0DXS6$UI%,Y8ZG,WE%S@Y'Y^\TIS:Y>:
MCP6=QDABO!)B,FZTAD:Z1C^*\=9QP4!B=M)IL417."9MK2[-RST ].T/6?UF
M<I>4>*BECGM=0X^\NI[6%[^"*TR6/N)1(^&*8-]A_:$B:9*W7Q7EK@]?WD[R
M[QG*/E=HCEYBP7V6E]/8O%1EYJ7OM+&W@ED-6CX[V$[NU)IE^2M$S,=[E!AX
MF@GT_2)""+G<()[DPXY)B)G",U,2.)J&$LI4.VU/\K2JBO84A$2$BA;1_8VN
M^GII0*9I!.=(0?*6AKFMXF'XSMU-M-QVHA5!! (W$52<!% 02DN!%&UWU-0*
M?[*(FJ!>0!5OMFM&U[M_M;MRK7YTMKES^%@R4&%ERV.CS%TUS[;%OO;9M_.U
M@J]T5H9!.]K1M)#2 %,5F,<QN39"7<+F\)J:;:U ^#N2O:*JD$! 0$! 0$!
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MN?>6A]&[SO3GPM^Z)CLIZ&0ROD+ZD(" @(" @(" @(" @(" @(" @(" @("
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MH7'4V;:GM-*>I (V-/?6OT4$V^O$=U-O=7U(( <0/"S;LV\6[X#OJJW%:)B
M6U$51V'C]*FWVF.^:6S64-M-K=@W;=WT-ZE>WV8C@@T UJ:4IM[E$Y)E4<UI
M<7%U.&E13=7<JJQ6E!]0\<)JX]GJ'IV;D(RQ2; X\3.[96H&S;M&^J)X8)G5
M&QXXQV$;/7N1'DP4@10U%2=QKN2,UJ?,GX:M%.RNSX5<&@FI.X_3I]2B"0D=
M@I\-4$M08S393L^%3ITK@KK9+5OG> ?O$<MW\4/X^[7;/AU_6$1.6/FATWX@
M13P9K3WV^=A.;#@3P[#[E<;/^ =V[EZ!MB9W$]G-'G?!KIM^S32,?=7?JLQO
MYMC3]ZCG]G^&C_\ >U\ ^./]16?0CS/O'P$_H73_ 'VI^LR15\0?;1! _76+
M5RCRPF&"GY]1'[\N_%*GW?'[:_[S==B]2?"O[CMI_;)Y?^*,_P#D41WSZ5EX
M-J[;M(#:'X%]0RUJ2^>_\KO5'#XNROIK2F[Z*S[WZNTVN=WD=H>A8UZO>47#
MO^7;7[OL>]=<\5_TON_H>B6W\)_U;LOI3YX>DEC_ -)\5^I]E]S1+QA.=SV/
M'LV_)YFZM7%TN*_!,LPE&]<2SZZ5IR8*OSAW^&KH+\X#[GNEZY^%7]#:W;S>
MEY3^+O\ \A]+^A?YEEAE/?<6 *?HIC?A_-D*^G;:OV.*9\L^9\_W..]N[.>/
M.S[^@,O'27HKA&SY+M*[O[%LN]>7?%M9ZU=3*+I\\O2'0XC^46=O+'F=MA]B
M3\/TJ+3:M?<QVM]T_P"NQS3'@XVEHW;SMV;Z;#O5=#V)<C=U]Y%6I&T<9V$;
MI._;0^S])5\K%QI!3BV5IQ4]JGQZ>C9P\*(R0+S\1[:GMV_"-P1-.,*=-A["
M-_IJ?I45HR2AOV ;?7O2[)*+0>(5;Q5KL)I79WGN543E@J$R@$G8!_(^KL1&
M&2 ]EE:4=]B=]=NW9V;$,Y[E)6C)*-"0:=B3D)_C_DCJ4W;._?V>A51EDC1Q
MIP.#N&M-@%*_5JA7M0'#04^.=[J'9M[CLVA":_(IOKQM)-0:=GHIV*^E$Q$I
MW<QRV0C)0,#0.W::[MO=VK)I4KWT<+<8Z58QQA\AS. ')KFM0UKI;+5V;OT(
MO5CZ;][Z5/SX\[+U&9_E$_N[O-+SDLO^S'7&W=J?4%-G_.]X/KKUS?CTCOY+
M?,\JZ?WE-W_<GSKT/S><_P#C+UB.^QD^E!;+Y7\5/Z)V_P!)W+X-_P#R3U7Z
M%C.D7EIZX$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M"37?MI3M/8F' BO%.B1 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M%,17,C# +B#4_''TZ^K8*!32$TBE$7^TWB(H>S;7BW?0HHF9X9(C/!.W@K[
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M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M6M0#7<B4R @(" @(" @(""21H>PM+>('[&M*_"F,9#;Y:,BE=,6QQ1,,SS4
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M1Z!S:>I=$TI7C7O[W>/GE\Y;REM*P<A^6<&3QD/VB"-TT40\"(OCC<&NO0&
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MK610L$4;&B@#6LCHT#T4V*)[90K5:26]U*BG?M'H4UX"92" @(" @(" @("
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M+:<O<C6]BL+5/G>T_>*Y2A^RAI_M[Q=L^'7]8VT[_-#IWC[^C=>GZ+">_P
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MYO/_  R]:'OL9/RBU7RWXIS7P3H?2EW#X.S7XE=6^A8SHEY9>MQ 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MN+[7XCJU;3XI/$4IVXRB:1GFKYF714O,+'V5[ \ZG=PNM;EKG!E-A;Q-'L[
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M[O">XC=VD*(K0F*737-V2%:"N_M_ .Y2(H" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @TUU^1.^!5CZZ%=3ZN4\'Y&W
MU#ZB1[=R8R=?>J_^#SS6_:?G/UMNEO?"TTZSH3^G'H:7Q)]S:_T)>9D^GRUJ
MFHK_ (S:CIM_YVNU[,Z/]1%?S8\T/&O4XK?=W7SYY7QOF]VWJFUD>Z%NWO\
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MOV^EZFE.$3Q<;6ZM=.&GCWKG^E-(:6T5CHL1I##6&$L8F,C;':6L$0>UC6M
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MK2V:=C'=]9;Y5@;YP6?^Z_E01M'YM^D;M=\^%_WQCG5\^^)T3.WGR1Z6*/?
M?)KCWLC^H%]UZGC;9Y7Q#5QK/D9H?S>_^#YJ#^>6GY7:KS7\7)KU+0^C=YWI
MKX6_<\_)Z&0POD+ZD(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M ;M]*Z3OM_OMSISI\U+9E\?K[V?>WS6Z.+M2UI%234E:O3T]2W&ZZLDS$X'
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M4AK6UH*5W[_KK%2&1 QL<WA(]D]@^BI*\42QK@ 14#=M/X:B@F4@@(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MF?THROZFWWW+*KZ?UEOEA6_V)\DO-7ZWJGJWYM$BA^7[WT[LA?? O;?A&/\
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MFB84D-1[/#\-:_["8SGD36$D9J\5]/U/PDK4G(<YU2UV[\!&Y"F%8' M-0*
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MD1-<<BWEK%>+YK6=@VVZ4<3&(@X6^-?$YHV.(FBE836E=RB+8G/):9FN;9M
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M6T3 Z\QF.\:9H ):RUB# 13;2M$PNQN)CEPC)]"TDM!._;]5$^5,@(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M^41>+,.)QJ10-7S_ *_M=;F]]%OJ1.;%?;,36,F1*^[LC0^^VE17?<1 &O\
M+[*!=7I=$UF,%9QBBI[_ &/]FVG]TP_^VHI(>_V/]FVG]T0_^VE)#W^Q_LRT
M_NB'_P!M"DGO]C_9EI_=$/\ [:%)/?['^S+3^Z(?_;0I)[_8_P!F6G]T0_\
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M/$>'M;J%DK1=AD!XX_%A>&\$C"[8X;EU+Q#U+0F;MOH7UN3J7Z5VE%)]=DV
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M9]+1U)G2FMK='#B!'>L432:LDH-:&#A:*!)F9QDB*9)E (" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MOM3]9DC+X@^VB"!6.^8BDSVIA@J>?20.LN_V;?=\?0UW?:;KL7J/X5_<EO\
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M3'LV_)YFZM7%TN*_!,LPE&]<2SZZ5IR8*_SAO;UJ:#I_8(^#\S7:]<_"J?\
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MLCW*3TU_,UK]!?*OBE_16A]*?.[G\'YF?B-U/LBVWS0SH%Y;>M! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M$2^E.'>DUNQ_)*TNIQ5N?+]:MUWC\ASD9FX,RZ'&>Y/RIOZ#AC9\FFW9=^R
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M=2" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M9NNBKM#T+4_??<H.([/EVV[/[?L>Y=>\5_TMN_H1YI;;PK_5^Q[>:7I*8_\
M2?%?J?9?<T2\7SG<]DQ[-OR>9NK5Q=+BOP3+,)1O7%L^NE:<F"K\X< '6IH0
M ?&L@3ZS;7?X:];_  KK_H;6F,^;TO*OQ<F(^(72XF/R;_-_>LLL;PWN+[:Y
M3&_=D*^G[>/\'$?HSYGS[<S3?7?3CSL^_H#-.DC19(K^AEIZ/ZUL5Y=\6_?-
MU?SI\\O1_0L.DZ<_HQYG;5NYOJ'UEIM;ZF&_Z?-=QS*W%4ASFT:-E:_A;>U4
MTO8QR9MW%-2(A$/=N;L'8-A].\IRJ4B1W&Z@=M.VF[X=RF(H43@TV\-7C>:T
MIW>C<DQ5$Q5!PVM<YU0ZM33=0;-@2M,#R*9(#O9.SL/P=Q43=V)CO5R:\+FC
MVW TV[J;_1N4*^93(VM:UW%2M!0"G:?753$T37BB=IX7;".WZ>X*:E<*H$$4
MJ-C:]N^JE,%'.% -AW"H^KOWI. B&4^,/:/Q17?3?M!4515'AV'VN#=Q#?2N
M[:HF:HXI2&DTX>$CLWU^'T),1$5E.*@\;J-I7TUJLFGA5&YG"U/*6A@JSA-1
M0UJKZ?UCB;C'0C&KY#FD>+DQS5[*:6R_I_P1>JO3IY^L:5/^I'GAEWT4Z3/T
M+O,\Y7,>UK#6[>[4^H"#_P!+WFSZ:]:ZOW36<N2WS/*]L_YA/;[R[]9>C^;T
M&O61K"HH?<I/37\S6B^5_%*?_"M#Z4^>7=?@]2?B-U28SY;*_-#.@7EMZS$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$!!(]@?3O&X]R>7(K,>SF^=U7I+":VT[E]*ZFLV9+"9NTFLLA:2 <,
MMO/$8I&U(< 2QQVT2:5[D1S1&>+HCR4\K?H_Y!\S+CFSR]Y=Q8_5\XR@][GE
MBN8&MS#7MO1[N^V#/M@>:=RB(PI*TS'9BV[37E1=&>EN<[N>N,Y;QC7/OMSD
M([F6X8^V9=7<QN)G^[^[AE'2FM%,4B*$S6:M1KSRK.CKF-SE;SRU-RZCN=;M
MNL=>FYBN&16YN<7*R>T>+<6Y: R2,&G:IKVJTQP;CS^\L+I(ZD^8ECS/YG<O
MX\GJBQ;AV1W-O-':Q%F#;&S'M\%EN6CPVQBO>DS,S,SF1;%L1$90W[GKY<72
MGU#X#1^F^8W+VVO\7H:&*WP$5N^*V?;Q0QB.,/D;;N=(0T;TK-$SC..78UFM
M/+QZ7=>\DM+\@M1: M+G06CHI8L#;,\".]M6S#AD#KT6QED#FGM4<:Q@FN%&
MKP?E^=+^ Y#2].ECR[QXY<3PR12V;X[>2^<9 07"_=;>*T[5$13RHSS;+RN\
MMWI.Y2<K]9<H]*<M[&/2.O !J."[;;7=U<<!)C,%W+:&6V+2?L=Z4B<R,&JZ
M>_+MZ6^FIVL).7/+W'P2ZW;)%FG9*.VR+7PRL=&]D#9[:D!+#2H[DBO'),TX
M9-KY8>6ATB<H^:64YOZ.Y9V-OJ_+2W4US/>>[WMGQWCBZ<MLY;7PFAQ=LIN4
MQAEFA3/EE]()YVQ\_!RQL!KN.9USXOV@XXW!?XG'[@;;P>$/-:)7&I.,=Z?F
MOY:/2/SEYG8/FQK/EK8SZJP<UO-;2V(M[&U<^U>'P>):PVOAN#2!6N],IJ84
MBO#)O//WR[>E3J0DT;-S(Y;8VZET(;<8%^,BML8(F6X:(VW M[6EQ0-^R2<Z
MIK/R-5SG\OKI>YZ<L].<J-:\N\;)I72C(8\)#8PVME<P,A :!-<PVHDG+FC;
M5#A2<E?+= /2_F.1#>G2ZY=8X<MF010ML8X[9E]]J:&M<Z_;;"5QV=J%?F;;
MH;R[NESEYR>U7R0TWH"TM=#ZRBCAS=J_P)+N=D+>&,1WAMA+'0=R$32ZO8TG
M(GRX.E+IVQFJ<5RXY>6UA;:R@N;?.^]/BNWW$5U&Z*41O?;AT3N!QH0HI\Z.
M[@^9Y(>5MT?\@.85QS.Y?<O(['5EP[,.?>7$[+F,C-\?OP\)]N!1XD--NQ3Q
MJF)FV*1DH:4\JSHXT9SB/.[!<N(K?69NKN^\>2=DMO[U>S.GG>8'6_#PNE=6
ME=@3A3B88SQ-9>59T<:ZYQ?NX9[EQ'/KEUU97DEY'<,BA?/82MFMCX#;8M 9
M(T=NU1,3.9$T\JOSM\K?I Y_<P;/F3S"Y=Q7^H[0XHMFMYX[:)QPW![A]J9;
M.;]K$8KWJ8PBD%:YMTY[^6;TE=1/WG#F+R]AOQH>&&VP8MI8[40PV\8BB;)P
M6Y\0A@W[$X=YVU5^9WEJ=)W-KE=H+E'JWE_%<Z0Y:QW$6E+6*9D,UDR[:6W
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M)/%:^2T;;>&\>(*D'>DXIBZE)[%3G7Y:?27S\Y@X'F3K_EQ976HL!+936K[
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M(^)>/;N7J^VGR^E:/M"3J;3#O^=\:/52]M_PE]-LIRW1PY)\SH>K,_S;3O\
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M>@K/XGNYH\[X-?\ P-W;.G=^JS&_FV'\%+4'ZM'_ .]KS[\</ZCL[/=P^\?
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M=?@]_P#(W5/HV>9G0KRX]:" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M/Y.T_*[5>;/BW]Y:'T;GIGX7?=7_  _B9#*^0OJ8@(" @(" @(" @(" @("
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MF8@.-M:5%1O'=Z^Y3&,<T9'&B/$-E"#6M*;=R"* @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MK^*7]%:'TI\\NZ_!ZO\ ^(W5.SEM\S.B7EMZT$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 00<2&DC?39ZT\N1Y&@;[P17BKQ_%;OH
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M[R/:[J'N5=7V:K;?-NM@2V[C;WM?3T[/I+''&5=U]7+"T\[(TZO\Q7L=%_\
M&+[9\.IKTZ[^W8^'?$/#JVUIW^E:2L@3J/3)_P"=\9]VP+Z9;[-WT+O-+HLQ
M,]2LG]*/.](;H"_@H\I?VOVOW/ O$'B/^H][^^E[*\+_ '%M_H0[D#XS_P"5
M^HM3.4-]&<HNW+%JY);/DOTFR_ZG7WW-,LMOMQY85X2\U#K(:1UA<^*'?GYC
M3U9&^JO:/@7'PGMOH^B'C;QM?-OC;>=E8]+KT[AV$[0/6-]5V#5^MM:[817;
M:U>Q4%2R0 T!CD^AP$JNC'^:Q7.CC:%8VU>-61Q\W-%==:ZIV,V_[2S7Q+XV
M?_;^6?/+Z[\)?O+4F>,?B9B*\^/1 @(*%U_4UQ_.)?RMRM9[<>6%;_8GR2\Y
MSS30?](%SGV_U[;=G^_7GU%[!\ _<NEY(\T/)?C?[YO^E/I<(='X+NKODN*[
ML_;=F_\ 1"Q6U\6Q'\CUI_1_&ZYX7F9\1:$<(N]+T1\R[9C!O'R#@Z=G^#K=
M>6NGQC?/'GN\\O5&]N_9:79RQYFU-I5OPU'=L7-8$_%P%QI6M*;>[?W]ZK<3
M%4#'P4)]IHK4;J=W;WE0BM?*BQP >X"@]F@^EOV[R4)[$6>R7U'!3AV5XJ5]
M/I0G@ID@':*GOK3Z2ND8WB<*BH[?H&GTU$DY)G ->VGL#;[5>*NSN.Y51G"1
MVUQV\7II2NSN5HR3" I7;M"F1,#P\7"_NI4?&^CNHJ(\J8@/< #M[7]^SNW!
M#&/(BQP=]K(J-NVN^AJB)[82!CBT$&M:[-U*'UHFL53AOAN;MK6OHW#UGO2(
MQ,U(DN-3O*FM,$Y)W>U%0'A >TG97[*J4GEF(4P]];7M6 OG!A)Y7\J1796^
M^K>+OOPO^^OG]#Y[\4OX:[R1Z6*/>?I8[^19]1J^[=2RM?#[O9^6&:'\WO\
MX/FH/YY:?E=JO-?Q<^\M#Z-WG>F_A;]T3_;L9#"^1/J0@(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(($5%$RR,..2%'=CJ?
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M^J]?2W,Z4QA;/I>E]#_;=J:^A9U;;6W:FGJQ$Q-)QPKV-E=H2]C<_A=QA@
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MB>"<LT["27 FI%-E-U?JU5JQ7 I-,4Z @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M[O#<M99[, K @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M9T2\N/6@@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MOIWK)YF;SI7 #B:XU^+2O;V^E6B:$4G$/%PAXV[^[9MI\-5,3$YR3AA;C*8
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M5YXC%"*R($! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("#;,U^E&5V;/DR_V_\
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MMYC\[TNX_!ZZ;OB3U6)RBVUG1+RV];" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(""G*[@8YU:4IV5[?A[%,9BB)B'L:37CW  $"G:2-P"712<,E;9
MF8QS6!/.-\VS3G2)I7+<F>6]_!D^<>IL9+:&6RNH7R8-M[:WD=2VWO&/$Q:!
M4$5:?2HI=PS6YK(QG%@E9[4FJ=<ZAR^O=:Y&ZS>J<[>W5_D[S(7,UP]@N9Y;
MAK:7,DKFAHE(WJ:XT5PBO:Y.Z=^GOF7U9<T,3RAY,X&_R>4S][;P9C,P6]P^
MSPEOX\$<TCYV036Y!CFKM[E68GVDUSCBS[O+6\ISD[T-Z/QF5R.,QNK.;-]9
MV\V4U'D+&UG?8W4EO;NN(;43V;71RQ31;'BE#Z5,3,(Y8K6<UWLL:X<)&P"@
M V #N%$IQ62MA8UH;O W5)^L5%$UPHF\,5J-COQ7\2M-R41,U3J00$!!*^G"
M>+=3:E*C:9."-L]V*.CB@EG8V@X086%Q]&TA1=='N^6[.E4QI73KVZ<^S,Q#
M :\VWJ/U]U9=<!Y$1Y*^L=+:4SUG@X,=!<7'NLK;W(3V!,L<<\D+B!-VL73N
MHW^^M]_=-8NFD1V/TR^%7@7HGA7X=:?6YFW[5JZ,WS,VQ,UBV+LZ=R_GTC^5
M1T_\@N7>F,EJ["V.H-=9G%V-_<R75M#<-A-W:6MRT%LME2IJN!9TFVZV(N]?
M4G\#X#U?XX=5ZIN[^F;&[EVD7W6U[:3,=KNB_I/Z=GM8U^@<():5<\8^P .Z
MFP6= N9'3K-'U>2)HZI;X\\27[F=/FOC3X3S3^-"/I2Z=&/X3H'"/;L!:;"Q
M]KX?=%CU.G:7+SVVTN\S+K^)_$.KIS6^Z:9>M/XU5_2ATXR QMY?X.( $']#
M[$[Z_P!IJ-':6V3%W+69<';^,_$.VU(NNF^)B?SIGTK?76_Y2?)'G5RJUAJW
MEKA;/3_,#3..NLC!+;00PM<VUMKNZDV1V7#4-;Z%QNK;>VRRR[;32Z<X?1_"
M_P 8>JZ'5=OT;JL_X?<WQ;%TX\8CM6G_ "-NJ[5'(WJ3U)T[YW,7>4PF<S,N
M&M+.YN9O!MY,=>VUE(;>*:X:QOMQ?8L7,Z1U"='5MT[I]2[!](^/7PZV74/#
M6IUZRVV=;2T[;K;HB(]JV9[,6<2V[JXDD!CHH96"G9*T.I]-=YNY?=1?&<OS
MMMYO?W:-V42KLD89.$.%2*\-.Y<?4YIU+>,,MT6V893+5+,H(""D86.J'"H-
M-G=3X=J=W"$4B,8S2M@:VNVH.\4I]=13/L3Y5)MG'25CPV6"9KF/@D:'QO8Z
MH+7L<"US2#0@C<IX4%B_S2/)FY5]8>D=0ZZY8XRPT3SOQUE<Y#$7V,L[:V@R
M]\QMS+[JZ"VLRT2W+YMY[1OJF,36"D4IE/:P.N8_+KF%R/UOEN57-C!7N UA
M@+ZZL)(+ZWGMX[^*"YFMXYXKB>*!CVR,A+O9["F&<<2LY4R4M \P-;\F-=8/
MF5RURUYB=3X&^MKVTELKB>W,@@N(9Y62"&6$2-(AIM-"%,4RE68_*M>@/Y2?
MF?:6ZX>6>/TUJS)V=GSITICX+;4-I--!#/EI8X8 ^YAB=<R2R2N,VT ;2._?
M&6$9)MB9BLKRQE<'<!'#WOV&G=L](3.:0E5B<YP/$*4.P_BAWT[$1Q[E1$B
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MW>C<HG&:SFBV*99(-)W<7"#O-*[MR1@F83MH7@5X@ :'=O&U3643,TKQ1-?
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M^6_%+'P3H?2EV[X.5_\ Q)ZK]&QG1KRT]<" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MF$W$LSXI9G$U(V'>HI$3,QFF)B8CL7"8^*AXC6E-M*=]5$6\OE*UQCV512"
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M1VH5XCJ@.;7B IMW4KM^%6C),%>"A H36HK7\/O4R9Q1,7,?0N-*5JW;V^D
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MAC^]H<#_ "0'T=B\O5LK@Z8G5T" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M:Q:14BRD]KL'YFM5\I^*5(\%Z'TO3+NOP@G_ /B%U:WLML\T,Z1>77JH0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!MEU>VMC;W5U/(V**PMY[J:>5
MS8XVQ0-,DI>]Y:P -&\G8II2VO!$S-U^.,L!3SQ_,./5?SBEY#\OLC<NY<Z"
MO+FPU'[M=RQVUY=P37]N72-ANWQ2@S#M:HMQ];@MA,Q;'#-8AN[F+$6UI!(P
MLD:]MMCX8(_%==3S.$4,?AQ@GB?(0-U22ICUII&2LTB:2S(_F_?ELV6E=*MZ
MM^<>DQ'K34GARZ3L,Q9"1^.M_#LY67<<-]9<3 ]K01PGM4<T<,B(FE9PEE7N
MMQQ\;/9+0UK&B@:&MH*!NX  )7"B<8FL-4@(" @(" @(" @V_+?I5D_U/O?N
M:14U/J[O)/F9MO\ 7V?3CSP\[S6?_FQ:T[?\>;+]?BODVOE'TY\[]4=+_P"&
M=G'#[//ZC.1MP/O=TR!O^0<13_JZVJNXW1'V&)[H>#M.ON];]Y=^M*4;MU/1
M6JX=GLL=N28DLJT[*_#]167QC!*33:5*K3:F_P U_,O]K>6_6JZ6?2^IU/(I
MI?>^T_>V_K0P6NB\$^:'@-E::[R_;3_#X76=M/\ B]'Z7I>^/BM_\$:G[BS]
M5Z,V/_2^Q_.=M^4L7U#.SY'Y4W>U/E:L;E30BEM.]$HK,@0$! 0$! 0:.6WA
ME9+!<11S6]S&^*6"5K9(W1.'"]DD;PYLC'@T(-11(MQP*]K"]\_;RQ,5R\RS
M^K;DOA76&'R<LDW,3&XJQ/@X^6-EW.Z];%9V?#X=S(XG:[81\*B9X=I,QG^4
MQ< ;//8QWA/-UCI0YEK*X&*2:YAJUXH?;B=%-]13'<9LHGYO'YA7WA:F;T<\
MULU*+7/R..@),C>DP8R6!EHTVPGNKO@X+ASN&@:-JF8CEQ1.<1$X,T;A9\8.
M#HY0'QO:ZK2T@.#FEI(+2#O[52Z;:Q;,5+;:99-:   !N&Y62B@(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @@20*@5/=6GTU$]PZZ]5[)INGKFQ';Q/FF.D<V&QL:
MYSG'Y,N-@ !)6SZ-/^9:4_IPUW5XYNG:L?H3Z7F<N@NK?/:JAGMWV]P=2ZAK
M'*'->T?*UWM+7@$5&[8O:G3=6W^2;>GYOHAXJW^CJ6^(MU%T8<WI78/)/US:
MZ!ZM&>^7#;?Y>F;!"'N#>(EUG'LXGMK4GTKK7CO8V;GHLQ=['+/FEV7P5O/L
M_5[KLK[KHP^6&:SEXS'.6DU=)'%/6FQS9V^(VG\JY>==O,3J\T>Q$T>C]Q==
MJ;:(GVIB&U14#BT=GQO17ZM5RMQ;-])AQMIJ1'-:JU<PD [Z;:?[/>L<Q1?/
M-.RH:>#:XTKV<.^F_>B)SQR0:*4<';J\1I\7NV=M4)G@2.XCOV#XNS?7>II5
M,12$'<.S@%-]=I^#>DQV$1VJH-6'Q!0;-M=^WN&T4*A7C@D/&X-)%:5-:C;M
M[NQ(Q3Y EKG.)'%6G"*D;AM4T328A*X<0)I0"E!]57MFF:+K9I3BB2WV0=PK
M7?\  HFGR)B)B*) !0DFA&X=ZH8U5^,&CJ;JU/XFNSNVU16G!)[+1M_)/03M
MJ?H;D\J<_HM&XM<YS0=U-M#O[/IJ-6V(B&+7F[W>6"L8ZT,C@7C>/1V;E%LQ
M[N+>*_3XG4QCV6MQH:R[C<X<):'[/0118-*VZ=6>]3?W<MU<H8/GG%R!O7[K
MN(R>) [W3P]M0'%EW\ VKT9\/+)GPW?==&,?W/A/C_6MOZUM=.W"<5NK1%B[
M+\U^6>GBWCN<CJ;%0TKL<'9:S8W800?C+L6\U(LZ5JZDY1;-?FEUS1LMU.M[
M?2F*W77>EZ9_(/21T-R:Y>Z8+&QR66EL.US&@ !\F.MGO&P- ()7B_KNXLU^
MJZNIIXV3J3Y_QO8G1]&_0Z9I:=^%T61YG,%N'AE';-NRJUU_MSV-E;DK.W+%
MJY);/DOTFR_ZG7WW-,LMOMQY85X2\U'K' _?@<^.X9^:O_6%\O9_@6Z(\*[;
MOCT0\=^.+>;QAO9X5CTNO!VEM-OX"NQ:WMVQ+4=/G_#ZU>,*H_(I#79X<FRG
M\:>WUJNA/^;?(XNGAM<>V61O\W/_ &=:Y_D?_4LU\1^-F/V:G;/GE]?^$GWE
MJ>3T0S$EY]>B! 04+EP$,S>^"8_08?PU>R:7Q=V3"M\5LNCNEYSWFD\,WF$\
MZ&MXAQ7MM0N:6M);)>5HXBA7K/PCN[=]TW1BZ?6LMCS0\J^*]K/3^JZM]L>W
M=/GEUFZ?LZS2?4ARIU1(X0P6&?LO%N":"(.R-G4FI:-O#WKO'6=*[7\/ZNTG
M&9M]$NC])OC0\3;;>S%+.;&?E>B5@<]#K/1NDM7V;Q/9Y3 8@17#2"V1T6.M
M@^A#G [7=Y7D^[0LV6ZU=KE-MT_AF7JOWWVG9Z6O&,76QC\C<0TM!#G<(=Z
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M8Y\TT^=?.^;QX20]4>L\R(CX3K1X;+3L,%H.[=\*^2_%*?\ P[1M_2],N_\
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M !EY$Q[7LGB>P%KI&2!DC2ZH=0T44^9:)K%7FF^8WT@:AZ*>JG5W+<XZZMM
M9S)3Y31ET+>86%M:7ES>W@C9<BW@MS]J#1L4U5K2>6F$Y.H.G-6:@Y>:HT[S
M%TG?3XW46F\OC\C;7=M))'/+!9WEO<W+!)$^.1HDBAI\;:E:QBM=%,;<'I1>
M67UBX+K+Z7-"<P8KBU9J&QQ5GB<_CA>0RWK+FPL;>$SS0"XFN&&9PK5V\^M$
MX3C7!<74($! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MRU#7/+J'=05W=H_#7!LU-6=3ENR9YB**RY2H@(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(*$TAC =4@5IL%22:4]5%!+:L]F[?3^!S6H+YS666#Q60RMR7.:
MP.AL+.6\D'$XM##P1$#UJ9K6L9$3AWO-E\U?K$FZUNK#5N6QMW=?N9:3R,N(
MQ6$EN));>*XQ=Q>V-S-&#--"'33-XCP@;TBM*)NY8GN6[,9@<CK'5NF^7F"=
M<#+ZRR^,Q>(E@AEG-OXU]!:.#FQM?[)$PWA3-5,*TX\'I1^6!T9X?HQZ:-)Z
M2NK*V9KS/8ZRR.L\I##$R6]NI+2W=#%*8[>%U8!6M:[2DURS*Q$1*Y%$WAC
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M\ZVI-;YNF9\LS,R]?[33T]+9VZ>E$19%L1$=U'TRR+" @(" @(" @(" @("
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MOTE\ZT+YFVD\'T>Z(F5794]XW_"K\D1/,BO!%6! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M^"M7]Q9^J]&7'[+"Q']IVWY2Q?4(SCR/RKN]J?*U84:>4^5$HK*@0$! 0$!
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M^7L[P)_2FV\GHAXZ\<_UCN_D]+KP[>W;^#:NQZWM6M7T_P#AM?R0GJ?#>*T
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M=V[TOM%D_LVLU-[9LMQ&TOMGFNG-K2X \;]M -G?7ZBP<M<LVQF)MA*Z1CB
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MTQJ'V.+-X##Y5X8X/:V2_P ?;W4C YI(/"^4C>JLDQ1]*B! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M;#U>*63'<S%;'^H;/\ZV_P"4L7E9\_O]J?*U2*B @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M7VRZ]XNB/],;CR,'5HB-*:=C,6L?ZAL_SK;_ )2Q>5'S^_VI\K5(J(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M7;'..UQ!V5/J-%\XB9X\'TF8I-%4L:>SZ94\*)K-:\4VY$" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(( $"A-3WTI])1'>,,[YS7SWL,_D=#\B+8,FO\
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M3?Z=@.P_"$Q$D<@D%144)!!&T%(FHJ*00$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M8V-\KM/NE=>7$\\,-O9F22-SO:V; O07P[\8:?4;+>D[V^+-?"ETSGE&4R^
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M/-9S8HK3'%JD2(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MNLFD<:?W(L\9=.MBL7Q$3WQ^-Q?K7SR.E+$VMU<:-/REDXXI#9MHYC9Y>!_
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M X-9,#O76]YXQZ=T^^?MVK%F$\/[V_VGA3?]3G_+M*;HCC_:&9%Y:'DV<O\
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M>SR:N8MQH3KPY?82&1\;=27YC<QCW,#PR:Q!X@'MXM@]*7QZM8(QOBWM>DA
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M]XM_I?<>3T2P=5I[JO<S%['^H;/\ZV_Y2Q>5'S^_VY\LM4BH@(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M6J9:MH( !-3WTIV]R1@A%2" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M:*B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M$X164D4K902W</XJM[OW>"MNI;?[*JBP@(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @^.YA_L US^T[4WZRWJ$9O*1YJ-)Y_\ .VG^6.8H-G_+=^IMQKV%
MU>"Y)Y&S1+YC^D(YF![1(Z@--A'N-.SO2:<4<:/1Y9\1G\BWZ@4)3(" @("
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M6W_*F(M.;5(@0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MPBL*S,*C3Q '=592$4! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M<TL<3(Z\ I7>KW7779JVV6V12W)455A 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M3M=\0=]?@HL%]TSK5C)>V/4JK+.@0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M4];ZOK]:WU^O=6M9I%:X5>R>B=)T>B;"S0MI6(BLTXTAW/C#W/8]QV,J*UW
MTW@;UH^:RR(T[_;;F9F9K;[#<5980$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M%2R.-G9]@&CT#L5,IYHS65@*"BE,XHH@0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0=%?,H!/1;SQH:'[T[S;_P #*NS^#OZDVO[R/.TOB+[DW7[B_P#5
MEYN.C 1A;HG_ );S7ZX2KVWNI_Q4?0M\SPKX?B)Z5/9[V_SOJHVU)IO %?3L
M6GOQO^5V?1MF.6C:=0@#%;/[*M/RYJVNU^L_X7%ZO]?;3+FCSL_'R5Z_O)-
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MW$,,EQA8[FVMY#;0R/MHY(Y2X;:&K:=Z\N^//&>OX@W'NM*^9VUOX<^]Z4\
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M3:#7=7Z?X25PHGC5%0" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MTYFLS%W=ABC$\R<;"^@W/:1OV4W[EK[=/<6ZWO+[IOM[&PU8VVOI<G)$3VH
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M(" @(" @*)R$H6'1X^5,IEFG)#A?GY_F?UQ^HE]]SRK8^&_O72_>1Z',V?\
M$VL,?(?LEU3^JU]]VS+U['U.E]&/,[QI?4PI*600$! 0$!!-:_IMA_S];?=$
M:M_R;_)/F8=Q[,?+Z687TA_P?] ?J9'^51+R5XM^_P#6^FZ;U'^)GR>F79A:
M.<FO4X]WT?JE<;;^U=Y5I6H_-AV\GL4.WQ[G\JD7U#X8_?<?1;CHWUT_(QM8
M-D#!Z7+T-^7+NVK-=.V8559QQ 0$! 01 J"#WCZJB2/:CRNPG2&*=3&AQW7\
M?Y?;+K7BZ*>%]QY/1+%U7'2KW,Q6P_J&S_.EO^4L7E=\^O\ :GRM6BH@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(-EU)^QW/_J+E/N&=3;[4>6/.K?[$^27FP=;1'[ZSF50?X=O
MZ[?[?OE[$\*4_D6T^C'FAXW\13_Y3O8X\T>>76QI IV=V]=SNB.66JU)BD45
M7?%D_D?K;5P;?KK>VI$S-LSPXKU_S>6G[[_6-/[#F^YK1?+OC?\ =^U_MVOI
MWP6I_-=[3LCT,Y4?7=^.*\PS]:](QD@WXH^'ZI37S+<D?LF_RWU%;2]B2<X3
MJX(" @(" @(" @(""5QHUQK2@.W?39W*8SQR1.39;6>Y,\C'PTJ2&3;*$;>S
MU*VMR6Z5=*C'H^]F::U7PO-+E%R^YU:4R>A^:&EL5J?3F6A,-U;7UK;R2!I:
MYM8IY(GR0NX7G:VAVKC[3J6_VNYMNTYNMMKPF8\TPC>[#9;W1G2U[8NB>Z/Q
M2QD^MKYOQ8?*.I>:/2QE#B[=C'W=CRRCC+Q-(1<22LCN19FC72<("^W^#_B7
MJ;35MVO4,+</7F:]G;+XWXL^&]NI;=N>F169K6WS90QS.;G3YS\Z?<D[!<W^
M6F<T_<S2S,MO=K&_R+',@?(WQ/$AM T![8B5]TV75.B=;THW]FO$ZDYOB6Z\
M.=<Z;K3MM30NMBO;+AAN4M0YKYS)8S$T\*[C=;N--X,<W 0?@6STO<3$SI75
MC@X=VCJ;6S]MZMW&K6<<5X&R0.JSO!V>NHJL.K;O/9THK;/>Y%G4=OM?6OF(
MGR556DAM"W9N)_!M6"W[;9?^TMI8C<]1VO4[(T8NB;H[(HD(/V8H#]*GX96Q
MLUM:E-.(<:-OH1-9F4IIL+14]HKO^ELV+)J:^O%F1&TV_/S5FG8JMJ>%S-E"
M=NS8>RNQ<*_6U;HFRD8N1.EHZ=DZELS$QDT5WDK*%WAW4\<,H^SXVASJ[@&A
MP-5EV>QG3GFU,/PM7_,)U=2ET>K$XRJV1R.6N[3&8? 9S+7=]+'!:&UQ&0GB
MFFE>V.(&:&![&@R/&U9M[U38;#3]:^V+OD;_ &?2;M]=SZ&G-W,NP]+GDM]5
MW4O-:3Z\Q=QRHT5,^TN8\[=<<LEY92^!,6>[RV1>PO@E(IZ%\FZ[\2]MT_4G
M[/?%]UM<(X_A=SZ?\-=[OM/DG3G3MNQF:SC^!EB=&GEB]./1U@,5/IO2F+S/
M,:VM&,S&KLA:V]Y)?W19"#-%#<6@]W]J'B!;1P)K5?#_ !!XWZAUO<:EVK,V
M:%^=L3/?QJ^U^'O!?3NC[;1BZV)W&GQP_%BN,QL!=#63A$0H6,:6Q@4HUK6"
MC6@;J#L749NB^>6M9_&[G9;%EN$4K^!NE%CMLC.<UJHK(@0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!3:'DO+APUX:;0=WJ417*3"
M)JQ5OG/V@C?<D>6VK\)I\W68LLE?17^2MX"Z2.T;%,Y@FDCB<Z@XW;W*<>!.
M%DW<6&5+$V[Q#88@6L\& [3M#V,;X@/:*."FN%$3%V%,V=Q\W;ZB-/:WZ4;3
MD=;2,.8Y9%[KI@<WC OA9[' 2%P^-7XH3A3L3C7FED3!K6N:*]_ABAV4'M;>
MVOI58@5%((" @(" @(" @(" @V_+?I5D_P!3[W[FD5-3ZN[R3YF;;_7V?3CS
MP\[S67_FRZS_ &\6?Z^E?)]?V(_>3^L_5/0_^&=G_P#NUWZC.0@X?O>TP:T/
MR%B?9V[1\G6U=J[GJ?=]ODAX+MRUOWEWZTH@U8W90;:;:U7 L]E6/905P0:/
M5!_[KN9?[6\M^M5VL^E]3J?15THKU?:1.7O;?UH8+?1C_P":%I\;P==9>O\
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M%6DUK$X(N8#N[B-NT4.^K=QJL>I.IA[N:3":1,UNQ<2Z_P"37*SF86,UUH7
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M48!$)7^&W@<?C#OKZ5:S7C4]2F1[GD]?BUBR($! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M[<^66K140$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("#YO5>
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M0I*600$! 0$!!&U_3;#_ )^M?NB-6_Y5\\>6?,P[CV8^7TLPSI$_@_\ +_\
M4R/\KB7DKQ;]_P"O]-TWJ/\ $SY/QNS"T<Y->IQ[OH_5*XVW]J[RK2M2^;#_
M )FL?_/KC\JD7U+X9??GR0W'1?KV-?;&L,7K?]4KT)2E\N[:F&G#4JSCB @(
M" @4)#@.WA^JJUI*8KS0[#=(0IU+:'!WF^B^Z+5=<\6?TON([(_&P=6K.G7N
M9BEA_4-G^=+?\I8O*SY_?[<^66K140$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$&RZD_8[G_ -1<
MI]PSJ;?:CRQYU;_8GR2\V#K<I^^OYF5-/T=OO3_7]\O8GA/[AVGT?1#QSXA_
MJG??2CSRZUM&UQ[!3;ZZ_"NZ7>S26FOK28A4(JV3;LX1L^ K@1,3KQ3M6QBR
M%[+YO.*=7^L!O_,4M/[FM5\M^-WW?MO[=KZE\'*_SC>3/&+?0SE!]=WXXKS%
M/UKT;&2#?BCX?JE-?,MR1^R;_+?45M+V))SA.K@@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(""A*[A(<15@.WZ5/2=J5IGDB>$QFQ#/G+_29GLQCM#]3V$<V+!:
M.$D&IFVUJ..5TK+T0>,Z*#B?5KAM+DME%T93V,2)DT60MXKJ2(.B=&V:VC_W
M*XMVA\3Z=A$K0?6I[8*5C'-FW_-UNK"TU_R3R/)C6NM6W^O]-2QMQ>#N9N.X
MCQS(+<.$(DN))"(F\.P- I51$4PX)B:Q^DR8=X<QGLEM-F^FVIVG?5(I;)6L
M89JS34 IAP328PG-% 0$! 0$! 0$! 0;?EOTJR?ZGWOW-(J:GU=WDGS,VW^O
ML^G'GAYW.LJ_Z636==WW\V=/^OG+Y1KTY8^G/G?JCI__  QLZ?\ [//ZC.4@
M/^+NFA_S#B/UNMEV^^GV*(XTAX.T_J];]Y=^M*6M=H7#L]ECMR15TB#1ZH_S
M7\S*[?\ %O+;/^BKM9]+ZG4^BKI?>^T_>V_K0P6NBW_S0]/_ +>LO^OP76=#
M^,T?I3YWO;XJ?_!&K^XL_5>C3C_Z@LOSI;?E+%]1CV(\C\JKO:GRM4%33RGR
MHE%94" @(" @(" @E>>%I/<*I(T+.$NJX%LDY):P_9!FUQ]&Q*X98*Q2M.+$
M8^<E=9$L./T;TU<O]30W<>3?=#F1@87L<Z%\?O[;4SM9<%Q%&BG$Q(S[DW<W
MLPQ%Y&08_&.AF)9%<&.WAD!X2RXNB(F!H%/YJ_L4^3,YHC/)G#_-R^D//\F.
M06=YKZVQUO-=\Q);2ZTKDIX8S=Q8UD-N^X$;GP-F8)'<.T.(-"HK,II$6Q6<
M62@W@,I+7>V/CBF\$;/51,:8YIYHRX-0B! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$'1/S*OX%G/']JEY^4RKM'@W^I-K^\CSM)XC^XMW^XO_ %9>
M;GHH_H)>"O\ AO,[*?V_+VKVUN\=S%<N2WS/"W0,.E3^]O\ UGT\8'$:GL[M
MZT^I'[2/*[+H9VMJS_Z5._/5K^7!;;;8:D?1]#@=4^NCZ5OG9^ODLC_P1\OS
MWQN^Y[1>-/B-_66[\L>EZW\!_<MGT8\T+MD+@6T!W';\)*Z+IYR[OP55E! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 43D)0L.CQ\J93+-=-(F4.&>?HIR?UR/\ F.]_*)5L/#6/5=+]
MY'GAS-G_ !-K#%R'[)=4_JM??=LR]?1]3I?1CS.\:7U,*2ED$! 0$! 036OZ
M;8?\_6WW1&K?\F_R3YF'<>S'R^EF%](?\'_0'ZF1_E42\E>+?O\ UOINF]1_
MB9\GIEV86CG)KU./XOT?JE<;0BLW1WK2M2^;#_F:QW\_N/RN1?4OAEAUNG9:
MV_1YIK58V%N*0QCTN7H2)K=,N\:LUT[9:A6<80$! 0$ #80-FUOU57B5]:)=
MA>D$UZE]$!W9?1T/?]OMNP+KOBW#PON(XT_&P]6C]E,]S,4L32SLAOK:P;?5
M"Q>5J<7SZ^?7F.^6L4($! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!LNI/V.Y_\ 47*?<,ZFWVH\
ML>=6_P!B?)+S8>MK^%AS+H-HSE]V[ZW]\O8?A3[AVG9R^B'CKQ!_5._^E'GE
MUJV-XB=Y.[X3VKNL^SW--=A;-T9*A/$)/L1P[M]=A6OM^NCRK8W61,KV7S>9
MP=U?ZP(_L.;[FM%\O^-\4Z?M?[=KZ?\ !F[FZMO.VD>AG*#Z[OQQ7F&?K7H^
M,BE  FM-9J6Q2$:5(/=7Z:G2GU9@F,4RR @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(""F8ZN+B=G=W&E*[TP'5/K2Z>M,]2W3IS&Y9ZILFY&&\T[E+RR8Y@<3D
M+''7<UH&,\.6KGR$-%!6JB>\QX/, UEH_.\LN8&M]":JQ5SA[_ ZARMG%974
M,L,L=G%D[N&T<(I8XGAKX(@1[(%%:)KBB8NB[EF,':+R\>I3+](G5]H/F1@S
M*W'9_+6F)SGB7;XK*.SR%W8V4[IHWSPVY'@$GVMR36:SV(QYLL)>F[H[5>&U
MQI/3VK<#D+;)XK/8JQR-O?V<T4\,K;JUBG]E\+Y&5!?0@$T*B:Y+\?(^O:0X
M5&Y1$SQ0BI! 0$! 0$! 0$!!M^6_2K)_J?>_<TBIJ?5W>2?,S;?Z^SZ<>>'G
M<:SH?-CUI39_CU9U._\ P^[:OD^M-=.L_GS^L_5/2B?_ ,&MEV_9I_49REN/
M\7=,&M0<%B=O_1UMV+M]_P# 6W]L0\&Z>%FM;_W+OUI2MW"AJN)9[+%;DF5T
MB#1ZH_S7<R_VMY;]:KM9]+ZG4^BKH_>^T_>V_K0P7.BYI'FAZ?V__/67VT_Y
M_"ZSMYB=YH]U\^=[V^*G_P $:O[BS]5Z,V/_ *@LOSG;?E+%]1CV8\C\JKO:
MGRM6%33RGRHE%94" @(" @(" @D>&D>T:';0]V[X%,=N9,TBG:X6Y^\W,%R/
MY1ZTYF:AO+6U@T[@<G=6SKFX@MFS7;+*XEM8F.FEB!<^2/<#4T5:\:43R\(F
MM'F"]3/.S-=3W4;S"Y[:CEN([K.YW)6]I8332S00V]ED+V&W=$'RRQM$L3P=
MA5N"EMN,W1G*;ILY+9/J)ZA>67*2'&W.1QV:SMD[-.LXIIQC88;^S<V2<013
M -,;Z^T**,K:Y2GVIB.#T^^GOE%A^1G)S0O*W!/X\;I7!V5C#)X8CXW-MXO$
M<6!K*<3P>P%1GBM7%S,(V @@4(K3X>_O2DS.>"$ZD$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M:[_=8?REB\JQE+Y[?]9\LM:H0(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("#9=2?L=S_ .HN4^X9
MU-OM1Y8\ZM_L3Y)>;%UM#_Q7\S*[AG+ZO]W7_P *]B>$_N':?1]$/'/B&(_U
M1OJ_G1YY=:&_9$; #L]6U=SGV:-1=[,UR5C0MD/;P^GN*X$376CRIBLVUX+V
M'S>6G[[_ %CZ+.;[FM%\O^-_W?M?[=KZ;\%Z?S7>1'=Z&<J/KN_'%>89^M>D
M8R3%1J\$P!3I>R2BLJ! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MV[71,8&6Y]DRSR- J'FG&]\I]94TI"*S$LP#YN-T(3Z<T_E^KK6X)R6M&"/
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M!4[E.8B@(" @;D!!#B%:5V_@*FDTKP16*T14)$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M1M-M2=NWLH56M$S69PR:A2" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M=A^D'^$OH?\ /T?Y?;+K_B[^E]QY/0P=6^JGR,Q:P_J&S_.EO^4L7E-\^O\
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MO5?*G&<\U0$<;A2A--NWVJ#Z5%-!.I!! @D4!H>^E?I((5X6U<:TWFF^IV;
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M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!1.0E"PZ/'RIE,LTY(<,<_/\
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MXAD<C;V;I#&QDCJ,$W<0I.->Q[5GEH]+\/1KT2\C.07RFS+-TCI+'RNO60"
MR296UM\A)&]K8H2Y\4LI%2VJK&$89)FLS,N]L1)=Q.-'$G93XP V'^-H%,US
M4MPPK5JD6$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MV[RD4R$RD$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M/%TT\,;B.[T2XW4IB-.D]C,0L#6QLSWVMN?_ +DQ>5(FL.@WX7SY9:M2J("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M"HJ231U35VTU^@F'M0I'9+4(L(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M6R3=E5$71*\V76Q6<A2H("&2<,<X$CL3C17GMF:0GQL?O&<PL# 72/R%J&@
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MZNG?92V?6HS!+66.*TLV.-#[M T"G=$P+R3J[S;Z,S;?-)B72+K+IOGMK+7
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M,.)6(F*Y+"/SB#HMN>L+H$UQ'C+UMEG>7UG<:FLF>ZMGDF%E:W<\C6O$,LC
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M*MFG;96G%-:HJZ! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M)-."(GU(B<V1TUT?&\Q&H::R$]A/=\*4K->"8F*<L>TW!$" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(*+WM#C78YE.$[=O$-NRE-RB<A1)F<
MYI^+4UV;:]E/@4Y9PC'*)?(ZDT=H[7%C/BM8Z7P>=M[N">U=\J8FQOG^',QT
M,GA/NK>9T3RQYVMHDX8K+&?4[\WZZ3>:T&LM4<ML.-$<Q\]XUS'D8I&/M1<R
M.GD:&VS+/@C'',"*"FQ3$TR1='-3@Q[NI/YOOU6\@=)SZOY?9&;FM-X\SGXF
MUC=$^VCXY7Q,^U6/$:QL%/6DS&<JVVW1AG*UCKCI=ZI>5%C)EN97*34&FL;
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MRVJ?ZY?3_;XY.$J3'[2V7K 0?D,/\ZC_ !@1,JJ @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @Z*^90">BWGC3_)2
M\_*95VCP;_4FU_>1YX:7Q%]Q[K]Q?^K+S<]&5^1+O;4?+>:KN_L^5>V=U3[7
M%?S+?,\)^'Z_RF:?]6_]9],*!QIVT^HM3J3^U^5VBR(Y;*YMJSP'R81OI<VO
MY<U;;;?6QY'!ZE'^(M^E'G9^GDL?P)= ?SL_<]HO&?Q&_K+=^6/2]:^ _N6S
MZ,>:%VZ/X@^'ZI728R=VC).I2(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(""%%2ZR+L1%3;;R@K
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M9RH^N[\<5YAGZUZ1C(!):"=^WZI36PDMR*FK1V&M?@"MI>Q).<)U<$! 0$!
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M&TAP&PNI4[]QKNJIK5$1$'A,XB^GM'TE0FE46L -3M(W=E._M4W8HB*)FB@
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M: _G1^Y[1>-/B+-?&>[\L>EZU\"?<EGT8\T+M-O]GZQ]==(_*EWB,OE:E6!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MA;0$DUXO12E*A=%TYK,N[QDK+*" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M%'P_571-/.?*[OP5%F! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M7G)W5\@ '_2P<MJFH]Z=3T>WC5/"6.?:M>L+!^00_P ZC_&!$JJ @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M/0SE!]=WXXKS#/UKTA&12@ 36FLU+8I"-*D'NK]-3I3ZLP3&*99 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0?.ZO_8EJC]K
MN;_6VY0>.!UC&O6_U.5W_?A>T_ZZR2CY$SG1W8\@'_S7>6W?[T^G^WQWP*>$
MHF(Y[9>L)!^00_SJ/\8$%5 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0=%?,H_@6\\:_Y*7GY1*NS^#J?ZDVM?\
MJ1YX:;Q#]R;K]Q?^K+S<=%T^1[L#MS>9^[Y>]>V]W]?_ ,%OF>$_#MW^6S$_
M]6_]9].TTD-'5[A3=LVK3W>W\KM%D>RVK/\ Z6&A_KJU_+FK;;>OO(^BU_4\
M->VF7-;YV?IY+'\"70'\[/W/:+QI\18_\SW?ECTO6W@/[EL^C'FA=O9\4?#]
M4KI4QZTR[M&2=$B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M#.5'UW?CBO,,_6O2$9(-^*/A^J4U\RW)'[)O\M]16TO8DG.$ZN" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MA^J5TF,G=HR3J4B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @("#9=2?L=S_ .HN4^X9U-OM1Y8\ZM_L3Y)>;!UL
M _OK>98:=GR[?5-/[?ON_:O8GA6G\BVG;R^B'CGQ!_5&^^E'GEUK!VN/<=OI
MVGZ"[I=7D::Z9K,PG>:-<?XT_47 CZZWRIMI\B]I\WG_ (8&L?39R_!^9;1?
M+?C=]W[;^W:^I?!O[WWO9AZ&<F/KN_'%>8I^M>CHR0;\4?#]4IKYEN2/V3?Y
M;ZBMI>Q).<)U<$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M9[ORQZ7K7P']RV?1CS0NX,^*/A^J5TN[-W:,DRA(@(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @V74G['<_P#J
M+E/N&=3;[4>6/.K?[$^27FO];3?_ !7<S -OZ.7WW??+V)X4QZ#M/H^B'CGQ
M!_5._P#I1YY=;&;W"E=VRM-U>WT+NEU.3!IYG.51U>"04V47 CZZ.VI28MK&
M2]E\WFI^_ UB * 6<OW+:+Y;\;\-AM?[=KZC\&KN;J^]GNM]#.4'UW?CBO,4
M_6O1\9(-^*/A^J4U\RW)'[)O\M]16TO8DG.$ZN" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @("#YW5_[$]4?M=S?ZVW*#QP>LC9
MUO\ 4V#MKJ^\]%/T9R7T46N[.#NQY 9__*O\M*?V4^H[O;QO:4B,)JK6.:(>
ML'!^00_SJ/\ &!!50$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M54! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$!!T4\RFAZ+>>-33_%2\]/\QE79_!L5\2;7]Y'G:3Q']Q;O]Q?^K+S<
M]%[<+=$G;\MYKLW_ )OE7MS=4^U13\RWS/"G08C^4S^]O_6?2M:.,\)KL'93
MZJT^K]=\KM.G[%C;,]^E>[^NK7\N:MKM_;_X6NZI]?%/SH\[/Q\E?^!-H+^=
MN_*+1>-/B+_66[\L>EZX\"?<>G]&/-"[;!\4^O\ #73)RAW2./E5U580$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0;+J3]CN?_47*?<,ZFWVH\L>=6_V)\DO-BZVBT=5_,VN_Y<O>_P#L^_7L
M3PG]P;3Z/HAXZ\0_U1O_ *4>>76IM?:(V;1M^$]B[I->7+&&GN]F:*A)'B^A
MNS_:E:^WZZWR^E-/4F>Q>O\ F\AKU?ZQ/]IS?!^9K1?+_CA$1L=K_;M?2_@K
M=-W5-Y,YX>AG+#Z[OQQ7F&?K7I.,D&_%'P_5*:^9;DC]DW^6^HK:7L23G"=7
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!\[
MJ_\ 8GJC]KN;_6VY0>.'UD CKAZFRW_*^]K_ -<Y*N]1'LXY)NFL][NQY A#
MO->Y:#M%V^HV_B\<IB<,%<KX[7K P?D$/\ZC_&!$JJ @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @Z)^95_ LYX_M
M4O/RF5=H\&_U)M?WD>=I/$?W%N_W%_ZLO-TT5^DEWLXJ9O,[=U/S?*O;&[FF
MY_X+?,\+^'[8GI.,9ZM_ZSZ:/821L/T>Q:J_'4K/:[)IXVVX-KSM!BB*[/>K
M3;W?;V]G;5;7;XZE9_-GS.%U.(]_;'#FM\[/S\E@#]Y+H C;6([?^+VB\:?$
M;^LMW3MCTO6O@/[ELC]&/-"[=$ &[.VOU2NCVW3,S$Y0[M&2HKI$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M&RZD_8[G_P!1<I]PSJ;?:CRQYU;_ &)\DO-BZV]O5=S,]FOZ.7W;3^O[Y>Q/
M"OW#M*_F^B'CGQ!7_5._[.://+K0T#B-33;L[>]=RG"WN:B:4F95G;Y1O);_
M .JN%;CK6SPKZ4Q,>[F.*]?\WD%.K_6(W?F.;[FM%\O^.'\!MO[=KZ7\%8IU
M3>Q'=Z&<L/KN_'%>8)^M>DXR "&@'?M^J4UL9+<BAJT]@K7X0K:7L23G"=7!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!\[J
M_P#8GJC]KN;_ %MN4@>.%UD$'KAZFZ'9]]][78=_RSDOKJ(K$)G-W8\@%I_T
MK_+4C:/>G[?4_&_6"FN<*_EVO6"@_(8?YU'^,")54! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!T4\RD$]%O/&G^
M2EY^4RKL_@W^I-K^\CSM)XC^XMW^XO\ U9>;IHIOZ"7==GZ-YKT_U_(O;>Z_
MB:?H6^9X6Z!3^53,Y>]O_6?2@$.(.S=3Z"U%_P!9\KLNEE;V-KSQ_0K9L_--
MI\/VYJVNVPU/^%PNIS'VBVGYUOG9^7DKFO1+H ?[V[[GM%XT^(V/C+=^6/2]
M;> XIT2R?T8\T+N$?Q1\/U2NC6Q,72[M&2=9 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0;+J3]CN?\ U%RG
MW#.IM]J/+'G5O]B?)+S8NM@4ZK.9A/\ R[?_ '??+V)X4C_(MI]&/-#QSX@_
MJC?SPYH\\NM%:EPW@GU5&U=UFDV][475FV85N*K9=E/9[_05KK?KH\J;:S96
M>"]A\WEV]7^L?SG-3^YK1?+_ (W_ ,!M?[=KZ;\%YKU7>]E(]#.5'UW?CBO,
M,_6O2,9)BHU>"8 ITO9)165 @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M\P3]:](QD@WXH^'ZI37S+<D?LF_RWU%;2]B2<X3JX(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @^=U?\
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MW.PFDE,ID['4&RFP;*4]"ZCJVVQ;;R]CN6C-\S//&+<5A9Q 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!)(YS6%S6\1&X5I5*5P'S.H\]
MCM*:?R^J,]>0V.-P>/N\ED)IY611-ALX'W!:9)'-8"6LH-NTE9]IH:NYUK=O
MI1S:MTTCY7&WNXTMKH7;G6FFC9%98%'FJ>9%KSK6YKY;EOI#+7NG.26B,A<6
M L;.YF;'FKB"6ZL;FXG?;73FS^.6@[10!>E/AMX<VWA_WFOU&R-74U(CEF8I
M3+*L/-_Q%\2Z_7KK=OLM3W6WLFDTFO-GV+4X]VQUO;VD$99+'5MJR-A<^YD=
ML(X&BKG2./=7:OK5FC?=;S[29LTNQ\JUM?6BMFK6^8I1<EZ+/*^Y^]9<QS4M
MK><N-$6T]M*W+7MM,1E;4R6[Y3''/:&@,4IW+J?B/Q1TSH.G,;N8U->>^/QN
M^>&NA;GJUMO/9R0R1^5WDP]&G+_%8*35.+AU!K'$Q1^_Y20-#+RXX8A(XQ.L
MN$?;&'Z*^-=2\>]>W.M=H]/NG2VE_#/#YWT[9>!^F6V6[K<1%^I;PI_<[DX/
MI!Z8-+VC;+%\N,'/&UK6<4EI8.-&M !]NS[FA:JWKG7(]O5F?[>5L[O#W2;Y
MY[=*V/F_$WK][/TWO:.+EG@2X5XOS!CV@;MWYB]"F[K77*X:\T5M\/\ 2IGZ
MJW\"K^]DZ9Q_^S' _P!Q8[^\U3^=]?\ ^O/]OE6GP[TNGL6_@:?][#TV%[J\
MLL!P;.'\P8[9W_UFLO\ /NMQA[Z?[?*M'0>CT^JMYOD/WKO3539RVP X=[A8
M8ZIK_P 33^?]=F,-6?[?*?R#H_\ TK:?(B>E[IJ<0!RUP#2.SW#';?\ W-/Y
M_P!=X:T_V^4_D/1YSTK?P)/WK_3>XG@Y:X%O#39[ACCO!_M-7CK_ %R(K[Z8
M8-;P[TVZ8G2TXIW'[USIQ[>6^ IV?F#';.^OYC4_Z@ZW_P!>6'_3FS_Z?]OF
M3LZ8NG8[^7.GQP"@KC\<*\6^A-FD^(>L_DZTU_MWIM\-;2GK6.&]?>7!T:<T
MWO&J-"8Z"*3;.+>.W@%#Q;C%9[*AQ6"[Q3XCVMWOMOKW1?;Y?QLVAX3Z;N+_
M +/K61[N[.O_ *+6'5OY#&C\['-J/I6SXPEA:033OTLV/C-R^..>1L;9?<J@
MN<&!=S\/?$*[4BVSKT5UIFG-,YY=[J'B?P#.G?==TB[DLLQF(C//LAC7<WN4
MO,WD!KR[Y<\TM.WNG,S87$L.*N+N"=MKDV,DEC>\7,T,,/Q8R5]JV6K;U#1C
M5V=\<DQPFM/F?);XU-AN/<;VR>:OJS.%>W-\'97^;TSGL1K32.3N,+JO!7EM
MD;+)6,DL$L<MK/'<M;6W=$Y[9'1 ;Z45K]+9:/-;U/3C6LFV8F)PSCO8^HW=
M1W&E;'2-?[/N;;XF+HBM(B<8P[6=/Y17F&P]7_)RTTEKC-VKN<>C+.VL\S#+
M)#!<WD4$%G!#*(W74DDDCF&IV5)/>O)?C#PUJ=-W^KO=*V8V5]\S$4PBLS/8
M]1^#?$MO4]CI;'6FN]LTXB9KC-(B)G.O:O,V[V\(;MX]SB:[2-BZ#=?$:D:=
M<8?0+;9FSFC)JUD0(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @("#YW5_[$]4?M=S?ZVW*#QPNL>@ZWNIL=IUA>?KUD5&/R)G-W6\@$U\V
M#EM^>G?C\:IB<)4GVX>L)!^00_SJ/\8$654! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0:2^NV6-G=WLGY%9VES=R?R%O$Z5W_H
MM*1$S,0B9I$R\\SS6>HJVZE^L+4]_A\K>3Z6T_?2XKY%?<S2V<$N-FO;,D1&
M:6W:YSV5-&C:O4GP=Z+_ "ZS[9N+:Q=CV9T>8/B9U>=WO;]O9=Z]LSAGVK?6
M*Q&3U1J73^CL':37&4U#D[+%PF%KY7VOO=W#:"3PV->2&>,#NV47T;Q;O[=K
MK7:MGU<1DZ%X>Z=.^W5MM*ZDSGFSL_+YZ(M(=%G)73[KJ&SS/-75.,L\AJ',
MR6L'O$/O=K:7,$;'NMHY&NB H:&M=Z\Y=?\ $VZZ]N+MO$S;L-.>WVJ3,2]#
M=*Z!M^GZ%FI-+M>Z.SV7>4B4RR3<9=)-4R%WM$@[: GXM/0M%.M9%N$>K#<?
M9-33PFZLJ9CX!0>R7&OT-JK;NK>Q%VVU)RN3LC);4N^+V^M9;=72NC*DL=VA
MJQ^55(2>(%HW5[1MV;]JQ:FK=S>KDYFCHZ<Z<<TQS(\ KQ%^T;]@]04>\OKE
M*_NM#A3\ SAJXNV5I3=Z:J(U;YG*3W.CPHDK39P_1(4QK7=DGN='A1, TNJZ
M@#?5MJ/K).M=7")/<:7&E4"W>&BK32AV=F_Z:CWM_9*8T="G!%K7;OBT[:C;
M7\)3;J73='-'J\47Z.CR3%M.;@J-XB*%U3]CLW=_8L]^IIQ&44<+[-KVXS=6
M1G%PR!Q#FBF\#ZZP^_LG&8]9,[?5F:W7*+(G ME9(]CV'B:6ES=Q[:;]RS6:
M\36*11CG:7ZDYS6'2CS!.BG1/6]R1S>+GM[3$<S-,8R\O].ZIBM(1<N=:6MW
M<21N++:264OKP[2MKX0\2:_1NISIZU9Z?=?$4QPF9B(XM)XP\/V=3Z;;=9,1
MN8CLQFE6"9J+365T9JC4&A=2Q2LR&D\E=XVXNI8W0F_;!=S6K'B)[6$ MA)W
M=J]']-ZA.KNM._0G]G,5?".I]-FS9WZ6M%=2W.<G?/RGNHIG3/UGZ;S&H<O/
M9<N]1W+,6_&1SR0VKYK]]E9PR21-FB@E<R1U1Q!VT+I?Q<Z'I]4Z9&[T[8C6
MC&9SRK+LGPHZOK=(ZK=L[K^;;W3$6VY1%:5^=Z'&+O;7*8^QRUF0ZVREE:7]
MN\;..WNX&7$+J?QT<@*\E5F9F.$8/6436V)[8;@I2(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MWM]V/%#@\(5'M1-IQ-/;4CM]"O$77S6Z%)UK]/'@U%K+<VLQGMKDQ-%"W8>
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MM:E:^6)GT/5GP[WMVYZ+;97]E9;$6_-$2O&A?.-*+HC%]!E%94" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M'K(.N6AI('$13B [*[O6D8SW*S/SHB<BCGL+6'<[?OW5")G/#)$SMJ6M%7@
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M.&<^TZ\\GNM7IQYW9O(:>T'S!P]UFL?<26K[:YN[.T?.^-_A?F?Q+H^,YSB
M -IKL2/P%78?5NK]*Z$PEUJ+5^;QV$Q&.ADN9+W(7EM:L=&QAD>(O'DC\1X
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MMBZRL6SG='9Y71/$.STM/IVG;-M\UNMRMGM\C/Q\J[56 Y?^7YRYU3K7,8[
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M3%<L)=<>6'6WTV<W]49+1>B^8^%N<[CYS;&UN;JSM3-(UXC+;=\ETYLQ,AH
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M1[7CF5OMN[U::8PB+8BW])=YTUYI?,/"]&=_TOWE]D)]3.Q;L7CM8F]N3?\
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M^QJ$2(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MHK,QRSFK,X\LY2X4T9BKW7&N-,:(PUM-=Y74%[!8PBW@DD(DN+B*"(N$;)*
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M?:MEZP,'Y##_ #J/\8%(JH" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M\B(]FDLKBOC.^+Q-<14UIP<)V>NM$_!*]:16&M140$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M[Y\':NU3%=1V&&S+&11RV,4KI(6@!L+G.$;9=E#N"G")3%9MET*\NKH+Y/\
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MKVN[P4F>$1@EK',:ZG$*TW;2/J%103*00$! 0$! 0$! 0$! 0$! 0$! 0$!
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M:9OKF.-T5L;Z*VG!,$MOP.<SA%-RMM="V-.MF%4;W5OCUJX1P=N?-"Y$<O\
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MIB@+,A#+"UQDMRU_"6@"JC**U)MQK&3)(ZJ^3'*GF-TVZDT-KC3EC>:2L-.
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M!4UXHY)I3L9,'5%RCY9ZWZ==0:*U-I_'3Z6LL RVQ=M[I;-9CV1V9MK4VS?
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M3;V[H# _%@3R\(A#/%WD'AK51S3.,YET1;A7!B@:V\N_E=+S!U5J7!.%EH/
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MLV[:4JX/%=O>2ISPG(CFCUK5L?2MDS3^K>1MTQICN<O>W)EE?\4AMQ$1PM(
MVA5K&<)B*Q2<%SKJTR(L^1V5C>X<-S!:,<#0<?%$6T&ZE>)3AG**S&2WSCK&
MWPV0Z2G1LX&75[GGL97>7W#'';LK6JB<(PR7B9B[SKDG5&6_N!:Q+S1KL7;U
M[*5#1O\ 6IE6V:35;%Y51-',#I282_A]ZU,6!SW.-?%9VD^E1=.:>R.$KE/6
M& >GG6X)HWW:RJ?1[Q&IK3%7BMM:"-KAM7].V0X"R"XFR+6U)#:NDA%0#05J
ME(FWO3=-W-5<JZLKIMIT^:QN>+@:+*PVGL$DL3!V]Q2.Y"U%@K&#":DY096*
MD,F2OB0X[I*W$-:5IO*M6L3,D1,8\)7;^HR\;:<B\]/)2CL7;L=4]K[1_P!=
M1&$JW32BS[:8]N/Q/)*\C:6B\U!=N<\@GBKDXZ4-.Q4SK+);-TTK&*\]SG>U
MG)34DCW<(&F":^DV#@/IN5JS&2.*S[HYLL&D^F?WB1SN+4NI"USB:"N7!V-.
MS<JW<:8+1C$3*[USY>UG)'53W^TSY ;LW4!MM_T5;RJ16N"U3C&VEII7I'R;
M07-9G]4-#B34<>3 &T^M)CU,%OR\5S[J:)=R!U<6FE<-;N!W[V-*5IBB,UF_
M&V4-GC>2.7C:6SOS5Z'2$GA_3",;*B@4S2M5)K$4X+X^M[R.'E+?74KPQGWL
M0ESO2_'M';WDJ/:6R6+=16,&-@TOG[9OAR7FK;</?\9LH.:8*TW#8HB<XF,4
MUX5P7ON;%R;?DGG;@.#3]ZC34@$4?C@#O]:FE<T8\,UFK$XZVM^3G+C*&,O-
MUJZX)+7$ 'Y=:2138:U485Q6QF%[G5OA#E;EJMXHQHZ;A:3V##NX-J3EB6TB
M[%9$@?*= ]/$TCC4ZSU&',))909X\(X:D;MB3V$5B9NC->GYGD#E'GW$5KI=
MY/9NQSBDXQ1$1C7BM4\B<?;G!<K<I<M+HY=0YW@]HM#"W* #T&I"F(MCU4U]
M3-=8YOSMMN56I9R:,BP4SC0[VBT?3;5)BN"+9I-5C?$OM&Z,P6I8VE\LFII6
M.<7>R*9<-KMV5!]*3,3$1*(MF:S"^]AYPWEG;W#W[/O3+^+LK\E5'TTBZN,I
MF*X0L+YR.)VF.8-^*LKK+%>U7B;(?EX;.'<*%,)E-\3;$1;/%?IT\[BY98QQ
M '^)D/J ^1F;?H*DY4[I+LUB'6W .G+F#/[3'G4-_P %22)/T5N?3047.Z-U
M3<]6ZA&QW%L6Z6E,1$]KC;CIFVU]CK:E]TS-MLS^!BE]3TKINIRXC>-CLCAB
MX-]%PVFY>O>G]/TM/P;&I9=.%OH>0-YO]3>^+YZ=JVTT^:8K\JX-R!NW0=:&
MA'EU&"'$AK>P4ALAV[-X7PGQ/KZNOJ6Z=T4BV?2^Z>$M&W;:$[6WZMF Y.Z?
M+ROS$\F\Z==X7<P_);J[!6M5H_=1-L7]SL,TNWMNVSME9YPUBVWTU@\SPELS
M=17O!(35I_14[*'9M6JU->;-28B,*MGMMI;K;J_;WSZML8?,N^"87')>ZNH_
MM%P<#4R?& ICSM'8-RYNM=?&V_1F&IT;9G?Q;$X1=2ORK-T\%O#H76FH)?:N
M1J"S;XGV+_T4X:D;MBPZ$QH[*-Q&-\RVVXF=7>SH7>Q3->;Y>W[1R5TW=U%#
MIN[+ :>U7&=]:;"N7HW3=S:EWM1$2TFM$^^C0_)F<UGS(1-O=&\T[R20M#M5
MXATI;Z,U[(J-RX6K^UV=VXGZR);S0II;Z-M'U<V^A>9TZ_\ [N\%[(<!I&4-
M90 4&$:">XKD[>+;MI-W"C6:ET1U&Z)X3@LXW=6<MN9DI<>$:KL*$$AK2,T=
MG#6GH7!T->_5T-37GV]/+O;?4FNC%\^S*[YRYD=<<M[![W 2_>C<>&[A% &X
M4'=NV@+E6:U]^VMU-2/6G-K+YC3CGMXK/&7Q<5SR\U%FF1N]XMM5.XGU):VF
M9?4\.T*;]'2OMC5KC&+/IZNI7EGV97=.6UTVZY+PW##PTTY*7W -0XQXQIV-
MK04HK\TW;>W6NGUYK@Q7ZG^,G;4_9]OE6?;N*UREAK;,.8)98<TT,G!H(^&_
M>":#94E</0V]FXNOU;Y]:S*'+U-6[;6V:-F5\XRN_<FG,/([1]X7<09C+TM=
M7M;;-IZ-A"Y&TNG4MOONSB/Q_B<??ZU^CN(VVG%8GBM1:O#<EE.?V1$AFN8\
MI@P)6^RQH%X0 6#V30%8=3<:D4GEK'&&72T+;K9B9I="ZWR/D\+D_H66O$Z/
M$WU#3A&VS;6H&PKG[2(OT[J\:>=J-]JWQJ^[MX+8VO\ P[G176/*^K_$M[3A
M:T\+:B.[!V-V':N+U?5NV]EL:48<]OG;+H]GON:-3\R[S2PS=8PO.?U# 1P-
MES5S7O(%_+V[]R]>^'][?N/">GSX4T?_ -&'D3Q#H_8_%NK$8Q.KG_Q2RFNC
M^W:/+B:8FO88\A@20USB'<-[95)IL"\:^-]GI1XAU=:V?6FZ?/+V-X)W%T^'
M=*(BD1;'FADE\G+DW/)?3-Q4./WK1T/?P8]HV_06@LMB+8MAO;YYIFY9'U99
MLNOO[S,S..2WU+#PR;VQ4RKP*-(("Y.XISQ$=C!H73-E9XS*]WR7N#/RATY<
MEXD!P?$' ;"&VK:4IW<*P3#+"SQE+>URFL^>67F^V-M[V(,D::>"6SS"E1OJ
MHB*Q%%JXUXKJO2),)^0^CGM-6AEVT'O FW_32LW9HXK>/46QMQS(ZD?")^TM
MTMQ\.RKN%W&#3?M"O=RW1'D1-8B)[97#^E"G[W[10#>$#'7/LDU^R=7:JKW1
M$74C):YYBVI.JNJF8.< ,EIEP8'&C:73CNW=BB9]FF9%(OF.$+K/3E-[QR)T
MG(2'UPLH-#W1$4^@I5G&5IC4&.ML_)U3R7+'2RXO(X=UJS;1OYJD+B=A!I2J
MB([%KL)B)R7+^CJ[?<=/^$XY1)X5O>,#0T ,#(6M V5[&JTT1GY5M?,V=MF^
M:?,S*7H+_DNY>8W@T:S[;+2H;4'<JQA-9R+L)GES71>DR_%[R>Q-P'\3&R7;
M6]P$9:/2G&A,8<W%;DUQ;QYCJ>YSYI["^*TLP YCBUH<VWGVDMV=G>DX99RF
M.SL7#>B^9UWT]:+G<?:,V8H>X#(3L&SM]E*03-9=&>8<9N>H7J%=XH?%;VV-
MX8@*-!,$M:]COA43A,2FR(F)B7?;I!/%R%TEQ'BH[)@_QH][D]G9Z"K*X90M
MU<W\?#><Q^JJ)S'R1L;@'QQM<YM"&REQ)&TT(JJQ%8KP+L<(R=ZNAZXDDZ>=
M.0.DXQ;'(1M.PD"K: ^HJQ/X%OWFKCK?.<U.<7O=;B>Q,#F/&S8/&=N%?BA5
MBZE)F$4I;,.]G0K>>\<GXFM>"VVN;F-C ![ #FBA(W[6J<LDYVQ+J!S,MV:A
MZFM7131BXFL;"_<T-/"YO#:W)VD5*37.2*1/+2CN!T'R^-R8@&SABR^4C:S\
M1P79%"1O-0IXHG.G!U?YG/&1ZP-5P1L+_ P%ZQX:\LIX>+N!Q&F^E%$K6X1-
M7:+H+A8.0]BSQ#(#GLZ36H(+<@X@$[]X2F*(F>2*NIW/*W9<=1?->K7%[,%9
M</"YP'Z72G:T;"D^MZJ]DQ;;,\7<;H3N67'3GI2,$$VU]F82 =P%ZYPKMKO<
MIK7Y&*(I5TFYLP09KJCYLV%P.-EMC[=W"'4 (M)2*TKVJ+IY:3&-4Q%8F)=G
M.@*XX]#:AM&EIBM,I+&RE*T\4C;3T!3A\J:S2*YNM_.MD65ZH-0V=T"Z*TL;
MM\(;4&,BUN';2-IJ>])F>.)A6M*R[$>7](V31NJ> ;&9:5@]/#(X#U4HHA,S
M6G8XMY\PPY#J\THU[2\6FGM0AS6NX:$XJYH21Z5.$>658QB:Y?B<I>7J9!R]
MU'&]Y>(]0Y(-)WT]\DH*G::!1&$T6G*)C)Q%SUX;CJVM( YU8].9=S@"1M^2
M+@BM"$X31,12DNPG0%)XG(VV#@&R-SV<#F[R.&_<!4_ K4PJI,U=8N=D#+SJ
MVS5LYKO:P,SB6D@^QC)B-WJ59[3/U8XNPG0#=-DY=9FU:[^ILU?-X#O92Y<V
MA[36BM,1FB)B?*X ZC,;:9WJ/R^/G9[P(L4V61@<?M?!92.!IMHJSE6,TY2Y
M@\OR[BFQ&NK:W($%EDF0QQ@U+*/(-=O\:IB,*\4SA/+&3CCJ,A^^#J@T_C)"
M"ZQQF1-NUH%36RF+ZTJ57A,\2,,I<B= C61/YHVT;>!L&7@;PUK0ASP?54A3
MAG&:UT4MA\?U'D.ZM.5L>U_Z"ZEXN$EI8#CKC>1OV*>$HPB8F(K+D/H%$ P6
MNVPUXFYZ?CJ237WB3>3M*K$U6U*Y/D^<\+;KK$Y?6TP+XWZ=U/5HV5IBKFF[
MN2(CF1%T\DQ#Z+R_7-@P6O<<W8RVU%>N8S>6AUY+6O;M)4\9E6N$0XBY[XZ&
M_P"KW&6Q:YQDPV0+@TN]H?)\YI05W53#&J8F8G-]QT!N%KEN8N)9[,=GD)>&
M+MCXKEI)/::^I3=,5A7)\MUA1C,<[=)8IQ($5O<NH-I>##*=@VTH"E*Q1$SV
M\'U'0#:Q6FKN==O!5L=M=XB+@))+G/CXN/;M]G@I\*B,,%YRB6LZN6PY3GGR
M<Q[31UK%EWRTVN/%'*ZFRI 2<8F")I,1G5O/1:^,<Q.=EO&PQB&;$@5=QDT:
MT$U._:E)K6<RZD32$W5G(U_/KD';MJV7Y/U:0]KBT[;.X]F@/H4S%8P+8IC=
MBV3R_G2#+\Y87.JV/-VW""-H]N6M3O-5$0BZG!\QUA1QW/41RC@D:7UL,[2A
M+2T^ZS]HW[U:D437*&_="4\-OJ'7N-%#)'<FI._;,PC?MV )E&&2DQ,W5G@V
M/K(FCO\ G-H'"3,XX[B*Z+F!U"ZD<E*=NRJCS+SRTC\Y#HOD-CSCYD88$B.V
M99<$.[PJMB.W<3]!14G&LRNIM;PBGI/TS52JF0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$'SNK_ -B>J/VNYO\ 6VY0>-_UC$.ZX>IL.W#6%[^O.1[MJ?DU
MA:8XN[7D" CS7^6M/[*?^/QRF*8U5_+MKD]8.#\@A_G4?XP*!50$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$$' .!!W'_906>O/?
MU3J_1'EE\_=5:&U'=Z6U/@[;$Y+&YFQDFAN89K.::X#&/MY(I6B5T0!HX*)P
MB4PQ"/+C^=.\]^3EEA],=7>#FUKR[QC8\%C,^U],@V-LL%FV5\LE\Z9[K9S7
MN]JH-4QS1S1E/SLW7I,\S#I2ZOM)Z4SO+OF9@(LWJ6T9-]Z][D\=!D;6X>V)
MQ@=&^Y<YW")V[=FWL4S$QY4TK6F3O^;AH@;.Q[;B-P#A+$0]CFG<YI82'#TA
M4QMBLXHSE(R5\I+XS5C@.$4 ([]ZMC3(BDXVS@U0+C6K>'NV@U^ANHGE$00X
M5&T%(FHBI! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!IS'P,D/$35C^*HW^R
M:=II1"F*R=S<MH,QS.YU121^\NLC9N9&#LC-9C4BAK3?M3"O/^4<D3ZDY.]G
M1'?.NN3-BPS"0VLUTP%H $8!;[-!LV4'T$IBFO#@ZB\Y+"+4//O5-R\.E;86
M-[[+:]MM<5K2JBGJQ!&,S-W!VAZ!V0Q\G6L@'#&W+9)H;6I%+D[SZ5/-6:=A
M3U8EU=YK%XZT=1$O<&-TU<U#01OP\].+AW_"G$X=SM[T).$G(#"OX2UXS>HF
MN!-:_H@2"D95XDQ\[JUS4@;==0_. R D6^'MBUK33B_,$V^BB^:T39E,.UW0
MQ<PW'3YIUD8X7193--?'6I;2[]FOKHF-:RB8I@Z%<^;$9+J3YVME!>R'%85P
M:*[0VR>>SU*9MB91%T\M.^7=7H/N_>.3$$39*-M[N\C;"#7P:/ KO[:*(F9G
M$BE,,W5'76-M-0=5NL(9(G326>.OI'-:X@FEI<$'96E$YIA>D3-7/GE\G_%C
M6L8V,BS<S&LI\7AGD;O[=RE2O#@^ U_8VVH.M&$/ D=C=/9X-<W86%N*N:5(
MV[:),Q;PQ5F:3BY0Z -N@]41FGL:DRC.$=@9?2@;?3116LU9+HX2XQYW\3^J
MRQ;QD :;S6P5!'Z$7/:"-ZB<<$UI;1RSY>I'[C=PT"CFZAS?%VG;?OI7MW*U
M(JI7\GL==^=]K%D^K'/6L\;GLBP,K@&DBI&,E.VF^BK,82MP=DN@6Y#^4]Q9
M1FD5EF,FR-M03'Q71J#WUI57_)B%.-7$/4; S/<X<S@I!X[F8]TC(P[:W\RS
M/^**UWJ/TN,)BD1CE5]MY?=P1I_6^,V-9CLHR-C!2K*EP-3VU(2<9J4HXUZC
MHH\UU.X+%/\ :$&+O97 #:SAL9G[QM44KW43$4];M<G=!60==V_,:VH1#996
M.&,$DDT>]I-22>Q36I-(P?(=5,GB]37)N"%_%*W$ZG,L;3PEX]PN2P.+37V4
MIABFV:31]AT"N#L7K^K^.09IPD&\L(FDH*]JB,R9KGF^4YV-@NNL#0=M/$91
M][>IRPAQ86$8BZI4C?M2W.8H86TF>+[/R^.)F@]4Q2.J]FI,I5OXD>_2AH].
MQ(CM1-*TAPMU&VC+_JIQ%H]IH_#Y U!-06X^<@[-N],I36L>1R?Y?DTL-CKG
M%2/!CL\A/X+"/::#=-KQ=IJK3,QZO!$Y0XOZCK5N>ZH,?A"\<'R=/*^,"KSP
MVDLFPBI;7U*)IRXHYN67V7E_SPG6/.6P9%X3L==6<7QB>,>(QI<03LI3Z:5P
M[UKIK%8.MA\&3YP\FL6ZLSXHLN71M-#&#'*:FB3A%58C'N?3=#;6QZMYTV[2
M2V.]PS:DDG\@<*;5$+75C!#J>+)>I'DA;$D/?BM4EI:XM+:6-Q7:*':D1%9F
M2Z)FV(CYVDZ!GL^6.<D()K'FX :FI(\245KOWI&2;YK-.+1=5=K!=]0W*6SD
M#I&7>+U#XT8)'Q+*XI3UT2)QE%,(EN'0*8+:YYF8VWI'%!DN+W>M3&[QP*D[
MSL*F*<L*W1,7]SC/K%CCR?4)R[P]PTRQSP7U&-)!V12$#9M*B,YKDF8F*76Y
MP^DZ*8HL3S4YC8>-O"V(6W"RNU@(C.WMVCT*9F9I5-.6)B,FCZ[7?*?,CEEB
M [B<+DD,:/:'VQQKLJ?I*,HK&:M9GU<H?2='T$5IS]YXVS23X=AIP NK6ONU
MN.W=N3O6_)IQ?2=:89<ZTY/V0D+7,N,G+PM-'$.;P@5&T5X5:8]7FGBK%8F.
M5L719(_]V?GW Z3V(HL"&1G?LCAXB3OWJL>S3@O?$<U<Y5^M\N=S-Y 0%Q$<
MMUJ5LCAO_J1H&[;O29FM$6Q&,RV_H;$&/YH\\<<WXTLF(FJ=Y+6L &W;N<D(
MF)KY&Z]9,\;^9/+"P?L=<0Y1K#4T/VJ8$4&^I2L4FJ;HBD4SXN/^C0QXWG#J
M_%!G 0&N'$3Q>T&$[#MVT5JX4HCMKFK>8"+6YUMRMQTP#C=W9#HZ[74F< :;
M3])([)R)G"M&W]+\;L9U1ZVP[1P6\.+Q3HV':XDV4)%74]"K6<DTCEK#EWKZ
MG!P.B<:U]'W68B/ !M+1<-%1ZZ%6K-)[5;;8YH[(? =*]E!8]37-6!D;HWMQ
M&G2>)Q>75L+;<3NWJ)B<),)F7TOF#2OB_<KX6U#LX\.=7:W[;%N[4[TTK;-K
M?^DUC(^=?/0;>*7'Z1>WB)<0&V%N'"IV[24CV:<:YF,XS#2=<3W??%RD@8\M
M-Q>7\;W=G 10[-U=I43V$3$./^E!MGA>HGF'B8&4?<6>/>YQ-7./N\3J[:%6
MI$1/:B;N:ZL9.1/,&=&="Z?LII/M=[?.CE;N\5K7.<&C;LH7*.],3$1^DZ_]
M'D5IBN==OBK7\S_F!SGQ'VC+6UA=6II2E$FM:<%L)MK,8N6_--R M.G3.0F0
M-]YM;P<! J[AM+K:"3L7+V%]UF\LF(K68CYW#W>CI:^A=9JSRV<LS7R0PE>;
M4O\ W!PN8VKFWV5/$3M-;F?M.U>CO#&C9M-SM]O$^KJS%>[)YW\27_:-MN=:
M8K.E$T[Z1/XG=ORQIF7')[-V\@VS9O !T;2 1PY&QX?;!KVK@_&+1MZ=NIVN
MA=S:?+&/EARO@ONM3J?3;-YN+8MU)NNCE[(B:,C[D_X%CU5ZIMR3[."P B<Y
MW$7<6,MJ@5W47Q/8^M=-,WVOJNE;[N)LRA]-UMLKH[1 <T!S\J"X_&V&]=2G
M=O7+WEL77S6?[4<'8:LVUMMC!Q+TW2>Z=3NOK20.;%+C<#2I-7_F*WW$GLHH
MVL3IQ%MN,RS;V8U:5P<J==L3)M.<MK9KB&.OY@TMJ-AN'U!IOJ"LLQS77VW9
MW3Z(<;3F=.>:S.UPER0ACQ'47C[*W8&236EIQP.H2\FWA(=M I0K%-L;;0F;
M,9KYW-MN^TWS.IA-/,YLZ]KBFC,#CI).*6ZO;9IIL(:9W @4V[BHOK;J61&5
M^;!M/VEFIJ7X7:>3ACDS:087J%Y8VUM#X3CCIR[B!))?:0DD@@+'=H6V;V="
M/9B*LVK?.KTW[1/M3/F<[];4PMN6K&N<*R9;'".H&TNOG5^F5R-[J39J:=M*
MQ,N-L=*+K+]2)I-'"G*4.AZH]'T:1=?)$+A(22"#80&G =VQ3K7QI[F-M2NE
M,8KQISJ;2[<73Z\2[&=:\KH^1UX^1O'[SE\4WA!H6'W]PJT]FWN3=Z_N+XBR
M*U8MEI>_F;;IIRPZQ\FFLQ_4]B8G.=63$V!C<YQ<?:L;<D5.U1??R;K3LX71
M-6>VSGT-2^M)M=B^N65L'*K3P%(_'REL'-V'B#KMP-#V;UQ=]=?IW739C,3$
M>93:W1-DW93#JMRSL;?$]1V.,+? ;D+'&.=(34DBUMSL) -'%3J5T+;)MQOO
M7U]7FU(MC*?P.X/5Y=-L.74%"&-NC;M<32A!<]IH"0-JYNGJW<W+=Q4MFW3U
MN2W'E=,N5EA%A^=G+*2'B8R_,KFAU2#7PBX@&F]<?>[#2WL6SK32;,8<G;[N
M[9W7>XCUK\)<#><];M&IN6;HVD^#%=.+:G>Z.Y<3\"[WTG6NU_#NIM;_ *JD
M15\\ZII6[#Q#I[C2QF<?G6"-;REW*_FN]X\4,FP;6,)W5EH34UW%;KX>V\G4
M]7:3--&(G%I_B+J:=W2M/>QCKS=&'RLG/I,+8O)XT]Q1\8,=L"RM*\5_C.WL
MH"OFOC^G^H;XC*GIN?2O 5LQT2R>,Q$_@ASIR18Z#GUR3CH?"=A<LZ)I))97
M'QDBIWA=+AW.>,SF[:=> (Y"9:AV_+6%VT['7N[X$XP6QS6S#J5R6++3JOTN
M/B/NL% USW';+^AL(: ":JTYJ8Q%'<7K<G]UY(9>5K@QPO;!H<=OQYG!PH>^
MJ1./>1'"%N_0S++#<Z.5ES%]HGR0:9379-L@ILV*DY2M2LQ/!=JYY.C'*348
M>:"7&-C;_P )"6[.\\)*F9H1$3-)R6D](X>UP>O.0L,0+))\IFGD&OVTONPX
M[P!L2*3ZT9HB)B[NA=%ZHI_=^0>LY>+AIBH032NQP:#])3W\4VTKBMH\HXHQ
MJ/I.(J/$O-4N:"XD./CM)(!W*L1&,\2*Y<%Q[J\:/WONL@_:/!QW%V5I=1=V
M[<K5HB(QIFMO:68S%<V.FN_<TB*4Y-D9>>+XWA-WN491GFM=,S=$1A1<0ZSK
MOW/IOUM< 5'N^,:!Z)+J%N_U%2K&:WKR0L;7!<T^5.0C'"<DR0R.=O<2V @<
M1H=A*KC,8YIBD992N+]7=U':<B]2W+G<+O#MFQ^@R-E![MX*O;[2ETS%N"VI
MHC!Q8/%\I\W)&Z$9G)R%Q)=]LI=Q$4J!NJHPQKFME2DKI/45.RWY$ZI>7\#7
MX.-@K]EQVI ;M.\M^HHK2,4>1:JQN/@Q^C>DF2$.C<[/:D<:DD2<>28[:-W:
MHGU8CL7MICVKL//PQCDCJA\E /D)AJ=M'>[;/1O*F:TP1&$K2^B0]F4Z4KMT
MCFEV9U2#(:EA;[\  &5X14%+8F(F47S$S;,<5TWJHE,?3_K1X%2<5 /7Q!H2
M<B%IK0;(\5?=.-]&27S9/,^(]QX@SBO(Z- />K6QZV*)];#A"[CU'7?N_(C5
M%T2&CY)M7./9[;&5]0VJ,.!FL\,M(+:QY89P-]WEOLZWBFKL=3)1#8=@4X1@
MF8A>GYMW3;7DWF[A[P&MT['Q.-*.#[(-[3]D2HCO(C&BS#<8V.ST?RNR[6.'
MONJ9RR4N):/T996C3L.]*S"8B)FB][K)_!RMS;R [_$ZY)[!^D[]M/64CO5B
MD3CDL9:3N'/T'R:DJ_@DUGG07%Q+334%*<.[8L>=TW2RUI$4RE>VYINX.3NH
M#Q4II5_M']33M]%5><E+<UG2TMV6?*[IQS$1=XSM4:D$CRXEI S._A.S<INB
M:89(BD1,YS*[/SGN&S<@\Y<,>2':7MW.(^R_,+>(5[*J)[BE?:67<7;VT6E>
M3^8:XP#[X\A4;2-N5;V^FBMGA!/K>MDOB:SO0WDW?W?%PM.E(RTTW XQK?IJ
MMR(C@L/9& 6^CV9$1%\D^K+7A))]L'-M-0?0II$X)K,6XPO^,G]TY5"XD?0L
MT+XA<=M'' U;V[:;$0L;8*R@AY07N28QSYKC7D3HY.(@&NI6\7L[NU1=$QZT
MYKQ=A[NF':OGYUW!RSR#G'_Y-EJ?3\C.JI1'M=RR%D&%G)[E5+'(_P '[^<D
M7OXCPNKJ+<6UI3L2<+ZEN-LQ3+BO=ZB>/W,L@_[ Z.F<=WQ3A7G>HGUH1C$X
M9K#N(L[:#1FA<^"0V/6&5!+JENW.TV5]E3[6<80BZL8\97NM7W_%R2O;UAI_
MB@UP<#_S7OK7:HX88IMB;5C>.PM3RGN-5/;QW#M3\)N1L:S]&"T'N._O5L<N
M"ML>KAFO=:3N70\B;.Z$W&[[TW2"4[MN-W=U**(A,S*R9?V5O<Z*YC9AD9;+
M]]N'#I:DLD)S;0?9H6C>HRGRDXS%."_)H\,'*_#\#>%HTC#05[\2TG;V5*1-
M<4W4K@L=:CN)8^5>NY6U8':YQP<X[6BFHJ&@W)$TOA.=L]J^7@I./ECCY0[B
MKHJ$@T_YC83Z]H4\O+ZJM>*QECHG7O)/-W<SB]]OKR0UJ0T!NI'$5;M I1+>
MSA"V45G.<U[NPN6W7*&.XC<*'1+CQ#=6/"$;*'9\4*)I,=I$XUC!8LBQT5UH
M'*YVY#II8-3W'&YI+00,P\-K390#TJ:X\D9,<=L]J];RUN8Y.16+N&.\-@TQ
M,0\5);PV3NW?LHD3Q7FLY+,>H\9%>:'YUZB8'<3-08IOO )I*?E1P-0 =WK4
M5F<8R32:Q;VKS/3U(7\C-)2/.WY ))] M]^WT!,)CN)B8NI*T3KRUBGQ_43D
MVM+N'4NFP"'&COT6H[=4;/6IB(PKC")F(BL1287D>4SF'D[IUS >'[V&&A.V
MOR>*[?6GD)FLU67+\N.ANH:Z@D= !JW "85+FD?+E-HK3:J\L3G"9NI=2U>J
MY9.B?RBP+HVT8[2T9I6NWY-;Q;1WJROE67LQCK2ZTAS2R+VNE?:ZDMW-'$:0
M%N6<:TVCLJHK6EW:F8FM%Y#I_G]_Y/Z-E+P[BQD(XA0[&-: #OVBB1%(H1-)
MP<TAC138*C=LW>KN4UFE.")QFJ9 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M#PKFDCA:[@QEKL'Q0:?"IFL17@13EIQ<M]>]U'[CRTQ\AH<EGH8A_+3PM_\
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M5P7K-F<[I>U;-$=LMA@W-/HDGMC]0H6QZU)6Y>:V"N-.Z)Z5]40N<'9"_I*
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M77F7S9;EMCMI;>Y.U;P[P?S73:/XBIJX7:,RP[+UM+7H^>L\:["=7O++'$<
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MVS\1;Q12N]D<;\?&QK:F@IQ)$5F5KIB;8IFU76]<RWW,SDCIF$N=\IY-LCV
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M1DT!S#C)-;?/9W8:U ]ZNB-FVBF:I_(CM?,=*K6976G5I=OC;+=1QW%M;R.
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M[0IB*1*,.:'K 0[(8@=XBC_&!2*@ !)&\TK\&Y13B(J00$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!)("6$ 5)I3L[1]11-..,"S#Y
M_P#[/E7=1[I Y[68BS<\AIV >] .(&X5("BOJUC),1C27E):%(=IR&6M7&^R
M(W4 'O+_ *-0IC'%6,(H^O))WGZWU*=RE*A-';WD+X)HF21O:6R$M D+75!
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MWDE]K=DTW[:-*4B+(E/-,WT<@^7U=%O*C5D$GLS6>:SKI(SL<RMQ.X$@T(!
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MI7(96?F5S)RV-N;"_P!37^4LK=MW%+%,6MN)(@[[<P/X2STD*:5B+N*N4S'
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M24NB<[5K9_)NRX+E$1XVMDI0R1QN/K+:TIV4JD35&"JI0(" @(" @(" @("
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M$$IWE>[!M'^MH<QZD?N305!V_;XO@_P@I(F.,(CYV?S&V5Y3VXK79[Q%V?\
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M3[:6GXI^*E8GA@B*T_28Q>$Q1PN.9CR[C+)[B;CW#[?*9* 4&ZJ&/%NJ #4
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M%>9:RMFW4<D<SV,EEB#B)6!_"6[!M.]3-(FGY4)BG+'+[,M+TM:;U%RNUSU
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M[^6/,[1\,XOT^G^\NBD<UU/G9!G5/A9V\Z>2>2Q=A/<L?E'B[N((Y'MB8RZ
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MQ.9,'>&\QM<UT8DXG$G>%6:3Y%K<)PX/KNB*URFGN50T7EL=<6-U@<GDGO\
M'CDCXQ=77&SA$C65!;W!32:=RLS'-3B[G$D"H%3W5I]-1/<(J00$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$'&T>I- QZRN<))-8QZL;P<;9XXA/+X@JWPWO]JM#V*<L(P)[5;6VMM%:
M,@L)=:75E"R_NF6^.9=003F2>1X:P1-EW$O<-H43,1G.*+>:8I,4A0RNI^7]
MKJ;!XG,SXZ+4V0B;+A(KB.$W4L;F![3;/<"]OL$; G-\A%N7:DUQKO0&C;C
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M';VKYC[FR_4BL1%'T*W6NNB:5H^HPNH=-933D.?Q=Q:_>\Z!\\4K&Q,MXXF
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M?4K=7%U+<QV\EI:6H?,][(&W!=#*V-CG.#:M<=U$B8F":5:/D8Z^T'U7<S-
M6\TC,/+#<WT=NZ1[V\3H9+KB:TD  G;L"=Q$1%9S0Z8KZ?F#U(\V\WE9)+N3
M2=Q):V+I'O='$RX>Z!S0USG-VM)[E%*4IBFZ:S,2K<C[N7$]9G/#3UM/*W$Q
M,@N66;I7NCB+8G32%C2[A;Q$=@4YXHB.69C@T_*FY9S'ZQM5:P8V21NEX;NQ
M:]DCG11-\)]N&EK2]E:#O"8_(=S<>FJ;W7JIZB[6:1[?;M+B"*21S@UK*R2<
M#'&@!#>P)A.)V]K9^5$MOK/K-UQJR'Q'^Y6EW9<;9'F)HCMY+<#@!<RO#Z4G
M-%.7#M5^EW(V^D^I#G%I;AD;)J2]]Y:)I'N)-M(YU8VO.P4)W"B3.43[2?,U
MO+VX;D.N_G#%)/*]EOB+:SMXS*\Q1NDQY@EX8^(L:2XGN43C,(B,)KFVGIEG
M;RVZEN:/+ASY&C4EU/D!%-(YY\2$RRM>P/<* -)W#M29I/*3C2Y-RAFR>J^M
M/FK)EIY+NRTJ8X\=&][S';^\@M<&L<7-%?@4Q,1&&<INI,TF,FNTK>3X'KNU
M%IJPFEAQ5_CS>26@E>8C(;/QS2/B#1PN/<E>",9QEH>7-W/S0ZR]59/(.DG@
MY>3.9C@'O\.'Q'%K06 N9O[Z*(FL\RTQ-N$MXT?>7(Z^.8UF^67P)<7C711E
M[O#K#8M<>%I=P@[-NQ1-)F)1&$>5LF&O8-;==EOEV-D?]ZUMDK6)[)7&*-K[
M>2&CVM+F$[>VBM%,U<:S$MRY<FWT]UR\TK=SI&2:E]W?%Q2.+'^$TN(8PD-%
M=VP)CRXYRFL3,T;5:2R3>8G?-!D=':X<!W#*\Q-\7'4H6 E@-5%9^1;U>7O5
M]#9(\M.MK5FFRY\%KS!D#V-?(XLF<RKHW,:2UO:-P*F,L3/+-JL"TW77YJJ.
M>XEE9C\=!)!;NE>88C=6?$XB,N+!6O<DUCY46Y3+1V<UYHKKPQVG<=)+%B]6
MVF1NKR'Q'F.8Q6[IF#@XFM]@^@I6(K$*XYRA&Z\UWUV9S"Y"66ZP^B8[6>U@
M+W^%!)-&))1PU<WXWH"BF/R)]:(^5<_8T-V-%  UHV]C10"G9132,^)BG0$!
M 0$! 0$! 0$! 0$! 0$! 0$%&6"*9I;(T&N\]OT4&V28*QD;PF/=^'ZE$5@X
MU: Z4QSCM;4=U!^$LG.BF-6BET+AYJ\;"0=ZK,U,8REHW<M\ ]H:Z(FFT'97
M?7M"CC5.6631S<J]-S@<43MFX@@?4'<HG$;>[DWIA[B71DU[*#\)+;>7)-6W
M.Y$Z1>]SC&[VC4C9\'8IF9E%(X-+)T_:+E;POA=MK6E!7X>'N3'Y$4BM>+;W
M=-FA'BCH'GX1_P"RHHM7YVFDZ8N7THHZW?\ 1'_LI0K&<QBT+^E3ET\[;9].
M[9_["CEA-8XM%)TC<M9'%SK9]3Z1_P"PII"(F8:";HVY73_DEO(3Z"!_ZB1$
MVY23-9JT4O11RID%/=I0*$':W;6G<Q,<Y*QQ:)_0URB>"#:2;1L/$-G_ *"F
M:S-4UC@VY_03R>D)+K:7;W</]+4UG+@K,0T3_+[Y,R$E]K(:_P C_2U$3,(I
M#2R>7AR2D^-9RGTU;ZMWA]R0G'BT;O+CY'.WV<GH^)L_^Y**&'%H9?+3Y#S.
M<Y]E*2[?\7^EJ(BZ,I36.QH)?+#Y R@@V,HKL-"W=_0@K5E6C;Y?*TZ?I-UI
M,T$4</9H?_N2B*\93A#;Y/*EZ>Y 0ZUG'%OIP?TI*$XM ?*4Z=7$5M9S2OXC
MM_X(IB8-([RB>G%Y)-K/MWCV/Z4HI*<.+2.\GSIJ<2393[?Y#^DE3C2E3#L:
M23R<.F22M;*?;O\ B'N_WE(K&<HF+9:)_DQ]+[P0;&?;Z(_Z2HI=VG+9E1HI
M/)6Z79 0;.?;Z(]G_P!Q5YF91RV5QAM[_)&Z6)/CV<Y/:>&,?_>"HB9A;U*Y
M-')Y'/2G)OLYQ_*Q>C_>/0F*9]WV-"[R*^D][2'6EP7.WGAB[Q_O'<F*)C3G
M@T+_ "&^DEYJ;*X_VL0_^'48GJ4I1HG^0?TC2&LEG<./\A%_>ZGUNU6;;)X-
M/+Y O1_*"'V-P:_QD/:*?V/W)CVIY;*8PVR7YOCT<2@UL;GT>S%L^A;A*SQ1
MRV<(:!_S>/HV>:NM+DG^0A_O=/6X3@1;9&4-')\W6Z,9'<7N=T/Y6'^]RD3=
M"8MLXPT$_P W'Z+)_C6=R/Y2'^]D];M1-MDSE@V^7YMMT3R  6ETTUVGPX37
M_P!W">MVIY=/*F#1O^;5]$KP6^ZW0!!!^U0'?_Q9*W=IRZ78T+OFSG0^]I#[
M2Y)/V7A05^YNY*RCELX0T,WS8WH9E-?<[D?\%!_>RFLTIP.6RG>TY^;"]#)(
M)M;FH_WFW[J?V*J^MVG+9V)3\V$Z&#7\RW.VG\QM^S_BJGUNTY;.Q _-@^A@
MT M;H4K_ #&W._\ XJH];M.6SL1'S8+H6_L2YKW^#;_WJGK=JT1ITR/]6#Z%
MZ$"TNA6FWP;?L/YU3UNTF-.>"'^K!="_]B7->_P;?^]5-;NU7EL[/PG^K!=#
M%2?=;K;_ +S;_P!ZI63ELSI^%#_5@NAC^Q;KT'P;?9_[JE;NU/+9V8>5'_5@
M^ABA'NMSMI4^#;]G_%4K=VHY;.S\(?FP70OV6MT/^!M_[U3'M.6SL_"?ZL%T
M,?V+<_T&#^]DQ[3EL[/PG^K!="_]BW7]!M_[U3UNTY;.S\)_JP?0Q0@6MR*T
M_F-OV?\ %4];M.6SL0_U8+H8I_4MUZ_!M_[U3'M.6SL_"C_JP70O_8MU_0;?
M^]4K=VIY;.S\*'^K!=#']C77]!M_[U2LG+9V?A!\V"Z&.VVNC_P-O_>J8]J.
M6SL_"?ZL%T+]MK='_@;?^]4K/:FEG9^$_P!6"Z&/[%NOZ#;_ -ZICVG+I]GX
M41\V#Z& "#:W1K3^8VXW?\548]J.6SL!\V#Z& "/=;K;2I\&W[/^*J:SVG+9
MV?A0'S8+H8_L:Z/_  -O_>J8]IRV=GX4?]6"Z%_[%N?Z#;_WJE93RV=GX4/]
M6"Z%^RUNA_P-O_>J5GM.6SL_"B?FP70O_8MT#W^#;_WJGK=J.6SL0_U8+H8_
ML6Z_H-O_ 'JF/:GET^S\)_JP70Q_8UUZ/M-OL_\ =>U*RCEL[/PG^K!=#']B
MW7]!M_[U3'M.6SL/]6"Z&/[%N?Z#;_WLE9.6SL_"B/FP70P/ZUN:]E8;?9_[
MJE93RV<(_"'YL'T,$U]VNAZ/!M_[U3UNU'+9V!^;!=#!-?=KKU>#;]WYU3'M
M.6SL0_U8+H8_L:Z/_ V_]ZICVIY;.S\*/^K!="_]B7/I^TV^W_W5*W=I2SL_
M"#YL%T+]MK='_@;?^]4];M*6=GX0?-@^A@&ONMUZO!M^[\ZIZW:CEL[$/]6!
MZ%^VTN2>_P &W_O5*W=IRV]GX4?]6"Z%_P"Q;K^@V_\ >J>MVG+9V?A0/S8+
MH8[+:Z'_  -O_>J8]J>6SL_"C_JP70Q3^I;K^@V_]ZI6>TY=/L_"A_JP70O_
M &+=5[_!M_[U2MW:<MG9^$_U8+H8_L6Z_H-O_>J8]IRZ?9^%,/FPG0PVM+6Y
MV_[S;_WJE;NU'+9V?A2_ZL%T+]MK='_@;?\ O5*W=J:6<(_"C_JP70O_ &+<
MU[_!M_[U2MW:CEL[/P@^;!]# I^9;K97^8V_;_Q5*SVG+I]GX4/]6!Z&*U]U
MNO5X-O\ WJHQK6IRV9T_"F_U8/H8H![K=;*_S&W[?^*J<>TY;*Y?A0_U8/H8
MH1[K=;>WP;?L_P"*IZW:<ME<OPH?ZL%T+]EK=#N^TV^S_P!U3UNTY;.S\)_J
MP70Q_8UU_0;?^]4Q[4\MG9^$/S8'H8[+:Z'_  -O_>J8]J.6SL_"?ZL#T+]M
MK=?T&WV?^ZI,W4S3RZ?&,/*Z"^:1Y#72%TE]"W.+GCR^M)(-:Z#Q45]B+F9D
M8\>>5TC#![%N""0>*M0/843-U,4Q;IQA;%)8+.F;RYR&'9=7AXK@W=Y$YP_$
M13N8SMIN"E%9G&6_@TVA!*9&,9QO9Q]G!4CMWU^!1Y!*P/#Q(_XCMT?8W=\9
MVX >E2G)M^2R^+Q+HA=7?C37CQ%9063#>%\KR&,C=[N7EKG/--O:B)PBLN]'
M27Y:O6?UJZLM=+<L.7>=TK:7CH)8M5Y'&W\&/N+)Q@D?,);O'&V##!/6H-*!
M5C.G%:*TR]5F7>7=\UYY!\D[K2/-WJ5D&O\ F>R(7.?T[.V&7$QW0-N8VNX[
M01N^V0N)H*$.WJW9VHK$>6)PEE)<L^3W+3D[IZTTMRVT=@=*86R:UD-KBL99
MVAX6L8QO%)!#$]Y C&^J=Q,UFLYRY';'1Q>27.( V]@%=@'96J<*(5$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$$'"H(K2J>0PXY/E=88.+4&E<[AI071WN.NXP*
MT+G&"3A':15R3EAF1ZLXN@'1AF;O&7//#0+GRLCT:^ZFLX7O>[P/';,X%O$=
ME7 ;@%$3CR\"F5W%MW0Q+<:NM^<.J<\^2]R%QD\O8-FF>]_VADEU%PM#RZA#
M!3?L2<96QB*<9:CHPRDV*SO47C3=RRV6G;V>[MF2R/>+<<%W</X>-WL@\%=E
M%:*4[D4]7#VE;H];]]VH^=',Z=TL]WDW9&QCNG2/>UW@>-& P.+@*,:1L*33
M-$1RQ,<);3T'S2X^[Z@G7MS-)'99FZN'":1[S%&TWDIH'N/".%I[E7",5YYI
MB(E2Z0>#.<W>HW5#'22Q9B*:"-Y>]S7"$OC(94N:#M["IF*2K&$4XMWZ';^S
MQ=[S9TD Z*:/)9:\9'(]SG'[?,Y] X\0'"XG=V(4FF/!/TA6+LCK[J;8YLAL
M,Q="V#G/<X.+HKJV>&UK3V93N2?PHFM<6V='&4DT?S YQ\H&NE]WP[\ED(&2
M/>YT+I3-/5H>ZH!%1N"5K,US3%M+:\#HF9+J/6_43?96>6^$F4=8VXFE?(V*
M&1US'*Q@>YX;4#L3A3BB:3-6Z])F6OM/\Y^=F@'32#%:??->V5L^1SVQ^*YU
MP[A#G4:!3N"=G8G&8FK1].\_[I/4ES-YC2.?/\B-O;$2A[C''PMDMFL:RKV
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M0V8F!+.(L-7;=RB8P6CMG@U>O;W(83KEY76MA+)%9:DAO!DH@]PCF]VAHRK
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MTF6K9>E*P#8FQR7V)U)XA %7F2*:,$FFW9ZTN[U(BDU=+N3N1DTCR'ZE-/\
MBN9-9Y FU%2TQ^]W4W%05!%0568PHO%WK13)W/Z,M-0V_3;822M#I]0VV:DN
M26BKVRB6)O%[-7;SOJI5F8F<'3CE'E;CEY#U0XQ\IAM;*01Q1AW U@OGS-V-
MXF!O%Q=BO-*Q/:FW*8ID[1]"F 9C^3F6OJ%PS-SE)W$C8\/\1V\BC@0_TJLU
MYL58B.6'$W3)>-P6=ZP97\++;'U=&*AK6F>ROV;-P'VQP49QW+<L5[G)_0A9
MMAY)YZ9K>$WF1U'*3MV\<T[@16GXI32."M:QW0X7Z>8G6>DNK;Q'!KN*X(%:
M.'&+NE.WM4SA%#"9HYPZ"HG.Z;W\>UTUUJ9I/:0Z68"IWG>JQG*<)LAUUZ>,
MC%A=&=5."+_#EAFN7VPH6D^-)<EW"*@]O8%:8]3F.:M\61D[-]#.G8+?ITCR
M'QY]03ZC,[B 7/;XDT(J:5=O.^JBOS(CLI1U@Y#9F30><ZC<!'(8H;7WMS8B
M2VAN_>"2&U92M>X*O"N:T1$SAG#GCH#P7!H/6.;<W]D65OB7.'QP)910DCV@
M./TJ8G$FDP^/Y&0PZ(YX=3;):".WQSY(HZ\+6.EMYI11OLAO$6^C>DTB([4<
MLS',W;R\XY9])\R<E('5O]0Y-S2015OO-P6T)V'>I\YY6P=-]S'9\_.J^VN'
M!CSCGN(<X-%!;3/V5I4FB3P["<*Q;G+ZKR^[6%G+[7KXA_5&?SE212O%=7/;
MV[U6.:)F)R1$^K$OB.F>^M<#S&ZK<%,0R:^MKJXA:2 YQ;97K"&BH)!\2NP'
M<K1$5Q3-)R<F] ,$;N3F?DX*376:U$V1^]SP+N=K?:(K0<2&&%,G#O)>_GT?
MS2Y\:2:\L9E;;(S[^':(;F2H%6[1ZE6:\L56B(FZ;N#EOR_L/(=&ZQSMR2^3
M-9S(Q%Y&US([N1NUQ%7?1*M12,J\''6@96:$ZM^=-E$>&PBQ-W(V+XC"^YL+
MAX<![+3[1JE;8FLY)I,Q@^E\O?"N;/S:U/)5QU#G[C:=Q;'>2;*TV[#WE)I5
M&/R-#RS;;XGKBYVV,'!#!/A9Y@TN:QC3\FSO.PT;6JK,36.Q:)BDPW7H)$<V
M:YXWL<GB-N=2/:' ;/M=Q<M.WMH5:G+@B;JQ#:>24C;+J^ZD+-YX#?XA[XPY
MU.,164KR0"16G#V*(QQ3C$4G)NOE^6S1:\W;@5/O6I;X$FM?9NKEI )[$C N
MC*9?,<KKXZ1ZH^<V/#C%'G<7D923[(<Z"RN) 0"6@EI:#VJU,IC)6<)F(R?7
M^7W:QWV)YDYUXK<9/4.0@=,=KG1MO)016A-*@=JB:3.&:9BF;C_3ERSEQUF:
MXQ=J?";F,7DKE^WA:\"QGF::58#N]*K=S0G";L,GW/0Q8?*^I>9FMBWB?D,M
M>0NE(KQ\-VYE [;4 #O*F.SBKE5\WA<=%B/,)S9@]B.[PM]=%C1PMJ[&RS.V
M;&GA)2.Q:+?5YF]=$39[OG'U#YMY)AR.5B9&:DBMO=\)H=H/T5,6TJK-U<#
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MG+JXBKSF'VT9<.(U?</!HXU.P-/:HB:P3FVW)/M-%==MC) "UF=Q65N)6-J
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M9.'(C%0O\L#DAK69I=-IW)0RM<*DM-U?6IKQ ;-OI"^,>,[;=/JMNGV1^/\
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MR>![AQ1:C=$6$[23G&T[:]B5BM%)K-M7<;*V#KWHY?9Q>R9-(1$ "E +4.H
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M*U1&:UC!=G+:.Z6@''[3G<XQS220?"R3&T(J>Y1E=@O6N'8NL=14!GY":LA
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M[F!Q8Z73^+B'">$N$F+D814$'<HC":K32D.=/+RQ#;+EMJ"^X0'Y/,7LSW4
M<\F=YVF@+MZF8XJQ,S%.#B[1MY#H_K*YN7DK>)F4Q%^VA- 2+"X .]H-"HFD
M1@O.,=[DCH!XKC&<S;@_%NM1W;FGT.NI]WT5-?GA6E(A\?AXY,#UFZML!]JC
MS6 S[FN^+Q&/%W3CW5^FKVTF<&/4PLF9SJ^^\O>$LT3K"4_S7567V[J\.0G
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MQ"A&SLJKQ&$]J(G'N;?TZ-;<]5O-6\^R^2=/]QWV$!W_  JL>S$%T>O+=?,
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MKJPR=CJG2KH,!IUEY ;V]N;G'21/A$+;GQF-MGNW[U&?D5GERF<&*CH3S/\
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MS5PI@RG^GGKPY*9#HJAY\WF8L<;@M)Z=<,I827,'CNOH+%ICMV1/N?$?[S<
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M]>7^H);>RM71W[YY'Q0VD/@0!L=P^1T0#.ZB3/SD1.-,(E\A97=YC\M9Y7'
MPY#$N\:QN(B6R1/J'ET<C.%Q+2.P]B98<2*<U*?*WO56O=5<Q;J*ZU=E+[-W
M5HT16\^2?<226K(QP!L;KF21P%.XJ9K2G%-N=,ZOFI'N@;'/&2PV\]O-!*P^
M'/'-#(V2)S)F\,C#XC!N(5)SKD>S$Q=\C[WF!S%UIS).GW:XN;[*2Z?@%OC'
M7\EPXPPNC\)HB?<R2%X$?<4K&7%&,367'LK&QW^%EA)9-B<G97L)C=X<IN8+
MJ.XMPV5E'U\5@I0[5,5M6FWM]ESKU)<Q=8<X=6Z3U+KX7ASN)QEK9V+<A+/4
MV\%H((N&*Y>_B'A!(PCRHB*S2>#A:VJS+X2Y>TPW./R%G>6?@NX93<6UU%-#
MPO91]?$8*44]T9$95F:RY>Z@>8>L^:G,;%ZFUY->S9B+&V=G9LR+[B4,MK.T
M$$7#!<OD#!X0V'97>GK9=IG2Z'$-M*^"]M,K''PR8B83VUS&:213,D$D9B#:
M//VP#XIV*,(SS7I1]!K'F+K3F3DX<EK;-9#-2V$4<.+M\E-<R^Z10L\-H:RZ
MEEX1P;MR8_(QQAY'SD$LUM<MRUI+X=];/9);W$;>"2!\3FN!CX:.:06C:"-R
M5I-."WX);WJ76^JN8!MKC6&7O<W\FM;':NR$L\\D+6@- B-S)*X- [J!6K$S
MGBK$13')\Y.YT$F/OV.-K+9W5M/9WT3J2-FAF9)%P&.CHSQM&XBJCC2,D\LQ
M&.;G#GGS.USS:M.7<O,*;(7T^EK22WP%SD9;FDD)A\/V67,DGB 1[NY1.,89
M)C*+;LX<$W,45RR&"YBXWPWUC>6TD9\)\5Q9W$=Q &2,HYI,C!N(JIB:8\"?
M9Y?RW./.KFMK_FW?:*O.8@O6.TI8-L<'%D7SO9+;MMA;,+&7+WM(;$-X5;:1
MFB+N;&(HX6-O%%>8^7@#[BSOK6\MI6OX7">"YCGAX7BCJMD:*44UI.)$Q=%9
MC%RKSGYE:WYJ:HP]WK[(Y&_NL18V]MB[#(/N?"@MX;<0L\%ES(]E#$/L0%,U
MG+-,3$S3C#BWV81!?-B$;[9X>SAVR1OC=Q,>T-]H&-X!'J5*_.32LURE])J+
MF%K?7V-L,5JW-9'4>,Q X,9+D9[J5N.8!0,A9=2RAHX=GL@*\TB*0BV8KGC'
M!\PYK98Z ASHW1N;-PACHG0\)C,;][345V42<,N**13'"KDK7G,;66M=#:/T
M_JV_R&6PNDQ+'I^.^FN9& 35:\0FXDD:X,;W"B91@FV)G"7%^3M8[VR]VF#8
MF1W%E-XE '<44C'PADF]A#@-RB+J3WHFDVXNP?.7F-K7F)H3E1IC64^09A]#
M6MU'I:2\FN)H#')%21D8GD?'*'-V;!L2)FN'!:8MKBZ]7$<=W:V\KX!;RMO[
M.:.$. )EM)V20O8X4+.)[:[%,8SAFK,8XS@YUYZ<RM9\T6<O;'7,^0FM=)V/
M@:?L[R6Y$#H_=Q&[PXII'1D-8.P!(FE8A-V-T73DX3$8>]DI+721R,EBCH!X
M4D#@^(M](>T44328H4]>LXOJM3<S]=:YCQ^.U1F\CE[3#1""PP]])=206T0;
MX8,,=Q+)& &?B0%/JVYX+3W<'R,MO&;9IB:V:1K@]CB #&0:^S4;#&=U.Y.]
M7&M9QER/FN8FM-4:"PVBL[F,CE],X3C;C[>\FN7P6O'M+8C/(^.@W; %$89I
MYHB.7@XTN+=EU;G'S-8V,\+B3P@#PMK.%Y^*=G8E9SA7ECEI&3ES67-/76M.
M4NAN6NIGY)^BM".N!I<74]T^W_-#OMPA?-(Z.0>AHV!3ZO!:.:LQ?E+B>]BA
MDCA@N^$QW)@=%%&T#@?;EABJ]H^UDN 2?6QXHK3U9<O\SN:.NN86A.6W+[6
MOVX'E^R[;I9MU-<BSECN6D2>&97F&?A:>P;$B*12"Z,>:Z<(<0W,#;BT]VG8
MP0136TD4@#6D20R-=&64%=CQV)3ERFJ(FLS#E+F#S,UYK#!Z0TUJ;,Y&ZT[I
MR!\6+L+F2Y]T,9C#:1PRRNB=1O<U(PPG%,3%TUEQ9+%%4\<#?!(!:2!6%S?B
M/##VM(JHC''@5I-'U]QS3YB9S1S.5V7SF3S>BL>0;.VGN+LV5N">+AC;),^
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MU=.VZ[UJTES+;+;8PS?9_ND:WM-%VO+^TS.1QVE'>(U^.9+=.LYF T]IK91
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MGLY[@6[&0 >"'F"1L<(=3;LVK-==-*\6&)CFC\YU4QT;+>R= PME?/+,9(R
M73 O)<7S;R=M=J4C--9C)]OC^8FJM-Z6OM%8#,9'$Z9U$6-RUE93W45LX1&E
M)C;RLC<'=S@5/?&2,YF(R?)-;#%QP![1'**QD1C[87BLI?LVEQ)VE1&7JIK,
M5MB*P^RT]S&UQHO$WVF=*Y;)8C#Y5H;D+2RGNH[>[9\5PF;!+'%1S?Q0*FN%
M44G)\>V.*6ZGNF@-GXS)-:- #9GR$N>YQ X22YU35,XB4S%,'('+WFEKWE;<
M9Z'0N4R-O9ZIMW6V<L,>ZY;!X3HC#2:&VD9'3@/V02O;FB,)IVN/8[=D/O;V
MT<3//<W4FQQ;+=R.EDKO))>\U[DBE)C@83./M0YXY(<V]=\J=(<T<'HF/(2X
M/7]K#;ZE%E)<F-K&1&)AF9 ]K8QP_B@D80F)I=WN <79^X6\T-K PBYN;RX?
M(][7GCN)GR3<3G5+G O._<H[XS5RMI$X5<Y<J^9.MN7FA>9.F]&7>2ML#K"&
M"+4[[.6ZCB+8V\+!)X$C&L!W;=X4TF<)3$\N>3@R.#P;6-D;6R-GGN)2X$.<
M72RN?*Z1^TO)<XG:4N[).R8E]_I;F-K70F)RF&T9G,CAK;/-#,B_'274$$S&
M@!S)O=I(XZ$"GM)GFB)Q]6:/B'N%Q)+=R.,MY=O<^\F<W:'N)+GFM>,O<22=
MJ90M,<8?=Z$YD:WY?NR4.CM09'%V5_"^'*VN/ENHH;R.5G 6SQ6TL;'C@_%
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MXRQ?95#O9(._85.ROT-G?393/O>+)N]&[>S'VV(G2:^\S^5RC;?&7UY<7=G
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M:!PAD436M:!3L43^ ;!GM'Z8U6RW^^+ 8K-^[/$EO)?6-I<OC<T[.%T\;W-
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M"C+:QM8;6(=M>&"-C":=JFO I%:\6Z-;PU%:[NRE$PX&,XRG0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MOGB>6@';O4<O,FL1FW^SM+6RMX[6RMX+6TA8UD%O;0L@BB8P<(#&1AK&C9V
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M>CJ6S$7S%T-C=J:=VEAA?/!KW$/MI+/*6UOFL5.*7%C<Q1S12M=6K>&8/:*
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MIR;L99&Z)V^T93#XI=7MK6NU3;$5YH1=6D1.,/JF&K* @5%&MX0 T#92FZE
MIF)S36)G!\K<:$T7?9F+45WI?"3YJWIX>0FQEE)<M(-0X3.@+^*O;6JF;8B:
M]J+:SPQ?5"@ J P <+&@>R&C810;*44<*IF>&4OF9M#Z0FS0U'+I?"39MK0&
MY*3&6+KJH% [QWPF0/'XJM:IW\2LY<'TX+BT!A V#8  &@=E.XIA,=A&&.=O
MS/EKC0VC[G,,U%=:8PDV9CIPY&7&V,ER"-SO&="9.*O;6J1%91,X8Q@^KX31
MH;1@:* !HX>$; T ;   HFO!;@^2NM#:-OLO%J&_TQA+C-0$%N1EQEE)<M=7
MV7&9T+I'.]-:I,?E2A]91GLL91AC # &T:UM!L#11M.$4]"4K%8*XT?)WFA]
M&Y',,S5[I?"767A(,>0FQEC)<5&T.,SX3(7#TE3$<45?5.8(PW@+8V1@-8QK
M &M&P4 &RE.RBCCBM$3.$/FKW16C\AE8,W?::PEWE8?:AO[C&64MPTC:'>-)
M"9*CUJ8C\J$3GRR^G \,,9&QH92C6L :UC6@4 :-@%%,16)F91,TF(B'RN2T
M+HS*Y2WS.2TSA+W*V[N*&]N,99RW <W;Q&:2%SRX=Y*I-%JS$8/K6-#&-8UK
M6-: UK&@!K6C8UK0-@ '8%9"9 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!2##VFI'Q74[]^RJB(B
M*3.9,S*<MXA0[#W_  J<B>R,@ [:NX@=PH!3OW;ZIQ[A+X8H&CXNWB;^*[MN
M\4(59CYDS=,S6<T'1UIPGAIZ*U^B5::RC**<!T8.UNQW?O\ JFFY(PQXDXYH
MN;\6@K2O;NKZTXUK23**4K T.H03M[#0?#N4SR\$8SFBUG"* ^HT&SO]=:J(
MP2B&TK4U^!)IP*SQD:VA<2:EU*[*;DI' BJ'M<7\;\'=]'>G91&->X\-H!;3
M8=XJ?7WI.*8BB=!(P&E7?&._X":;MFY(K3$/:#-GQO@[_H;DGN3;GZR-'$'V
MJ$TIL!I^'5)R[T<>Y$BH(3RF62DR-W#21W%4[1Z!NVUJIFF7!$5G&54UIL-/
M3O40E(6DAP<>,&E!\7<>\**5S)GL2\#B2YV\4X1L^'<5.4X3@1C[4)RPU):[
MA)^-LK6F[?NHJT[!*65 !'P_B?I[:JV>,YDX>RF(XMA%6_@^'>HHG"G>!I!H
M#1@W#?6OIWBA4TRHA39')Q%[G[3N;2H;V>K:%,3A281-57A&TC874J=^[T'9
MN41$5JE(&.'%0TW<+J5IW[*J)KPR3W\9S/" >7@>T[>:[J>CMJIBB*SE&4E)
M*N'%0;*.HWX=BB:S."8RQS3\(XN*FT;C7?4;=BFD9\45G+@-:UM:"E=^_P"N
MHI 4-.]W?N^ENW*93$\)R2EGL<(%.X5]-=Y44@K,8VYI@VE:FM:=E-RM,UBD
M(BL37BHB)S7.>'DD[ALI3=V[MBKP)F:(^$6\19[)=\8;Z_"=R4B)PR369BDX
M)VM<  '4]% ?IJT<L<%9KVHN9Q&H-'#<=]/@W;E68KY5HNF(IP.$EY+AL%.#
MX11V[ZZBF-4)1&:$<5 [>*?7JK8UK)2(BD CX=C#P#MV<7%]'=11,)&AP=3A
MX6^L'L^CO2E)PR(RQS0DC=(UH+N$@U)^'T*V%>Y7&8QS3%I!X@*NI2M:4IZ#
ML-5$1%:R3E@<!#2 ZE:4--VVO>D]V"U9SG-*Z+B).[=3T_33"*3Q*S.$^S"<
MAU30U'8*#9\/;51B13B%C20>ZNS;MK\*FD(FL^1%_%PGA^-LIN[]N_9N42)>
M \3R#PDTH=_KV),889IYKLIR"'T-#0^H&J<.\FE<,D PGA<[8=O$-]>P>I3&
M5%<IK";A]JH-!VC?793X***8K><X!QAXV';7T[*#MV42B%.5CR"8S1P^+7T[
MU-M*^MDBZ;J8/E];1EVBM6!VTG3N9)[-K<=<?A*^VNF=:V(PF+H\['N9CW%T
MS'Y,^9YI75'[?4OS0D<[@#M09$#9NX<C>U^BO:/@?2WEG1=.8OK;-L8?)#QQ
MXQW>PUNMZT7Z=+[+L>_&7(_0B&'JGY<%PH/EFUX3WTO;+Z"U/C"[4U++[+IQ
MB)\TMUX9TK8NT]?1^KNG"/F9^URR1[+,L]D?)&'V5WCW&'M[-R\]W7<L<N=;
MKO/+[WT_DBWFNCA%5'V06CCH]_V7:VE-@]9671B8NKG:G>7Z<QZL43,J9>%S
MN)@K1Y;M)W^LIJ<\W4MPABT[+)CGG$9&YKI'.DXG.I1M*"G=\ 6.RWE]K&67
M4FV^<(]54="7!E;D1EM>)G!7B[0*TV*<9FL8RQ\MMV%*6I0"06M]G^..VOP=
ME5:8F<O:[62SELBEV.FF9'0.+CXKG4J*\/!V"A/>$K=$UF<88J6UFD8<$ VO
MA\(X2.*FVM>^M=ZF;KJX92BD]F2+0&![N N\2M7\7Q>S8.S:JW8W<T81Q(B>
M7EG,I1C6\-3M+9*[O6#ZTNBMU;<V33Y;+9B[&92B/A!<XTEJ/3L&WU;05?GN
MRNFMJDVVTK9%+A\4@>)8G<,G<=H]/HVKCW:>IR\MMWJL\:EO+ZT>N@(G^U-X
MG"Z3?'0':.WN&U9N?ELK=&3!='/..:#@QS!Q$B8'V' ;!3T#84THNU)F^V?5
ME%^OIQ;&G,>M"+'EK^.6@:&D&:@H#2@]GMVK%N)MNL]U;7WCD[*SW5=:?86Z
M?-^G@=Y??,ESFF26*.V#'[0#Q>^?8^A=G\#3?L^M1&K-:Q^)T_QQ;'4-I71]
M6D3Z6"Q@&DZ=+G/+HG-O^*("E=C]A*]&]-G6U-*Z:TLF,'GWJ%NAH71-L?M(
MKS,NGYM'X?[C7-/PXC$WY1LJ-+JT_(*[^]><OBY;=;U/3YO:Q]+T+\(K[+^D
M3?9E,?B9/'A;07;2*[=U*^A?&].+XF>?&)?8;HMNFO%*R-]2)#Q-.X;J=HK3
M:K\L4S16<N"M1U .+;MJ>$;?@4Q$1&)/<@& -X3M;W;NVN^M4F(X(QXI?"I0
ML=P]^SBK]%11>;[KLTS6D M.X;OJGMKO4X4[)5BM4PK3::GOW()'QAU:&A-*
MG?NW=NQ,(QXF/!%H)#2\>V*_!79V;-RBE<Q(&/XG<3N)K]A&XC9L4UFE%HFV
M(K'M)FQM8"&;*[>_ZJ1$*RD$;FTX14NKQFOJIO*C\KN,LD[F5K0\)-*G?6GH
M[**8PFO$F*HEE7!P-'#MW_2K1(B*U,2CJ[3[([*#VOKBA28B<B*P@&GV230B
MM1WUV#;V42<_5R,9SS18' >T=^YNSV=_:-]5$5XB8BI'HKL[U)C&27A- 2>)
MS:T=NW^C=N5:?.F._(X3[-75I6NRG%7=NW44XE:)6-=M<XT+MXH-E*@;=VY1
M$3Q,$6,X2:;!L]-=GKJ*%6P^5$^5!\?%2FRG9W[NVNRBB83FAPO V;2/B[O9
M[_753WRC\*(80\.K6N_LILHIF8RHK2ZM9FL)GMXFT[>SZ*12N.2\3-N-N:3A
M=PD':"*<.P4^'MJJS%)PR(Q]K,;'PMJUO"X?%;6O#4[=NXU"F9K$=L*TIDG#
M0T^R*5^-M^AO44HL@6 NJ17X:<-!Z]M5.>:M$SPX@AIH:'L!^JIBD)48X2QK
MFN>7AQKM[/AJHG$C#R*H:13L K[.^GP]M4PI1$5"'5'":#;Q;CZMZCCW+3C&
M>(P.!(/Q13A/?7:?IIC,UE$804)!KL[C]53Y4S/YJ/ WAX:>SW5/?7?OWJ*0
MA(6%Y=Q;A3@/=L]K<1]-13''(\BI0!6365,QU<*CV!NV_#Z]Z4B<9S1$S&$>
MRBYKB3M]EV_8-E/IFI3&)P1-9PX(".K0'FOH[MOH.VJ>3"$TBO; ]KJ\3=I[
M!L] [2HG+O(KE7!,\$C9M':S=Q;J>UV44341: &@4IZ*U[>]6I D\)H)+/9<
M>W?3X#LVJ)K./$C"*(&%CN&HIPDFE3V^FJF,(HB8B9JA(V2H+".$;V4'U2E.
MTFO!5:*-  IZ*U^FE*80E!H>">)U0-VP"OT-U$@'1M)+MSN_;]2M-R=\"!#N
M+9L'?L/9W*?5ICFBMV7!&CZ_&V#LH/:_"HJSGADM%.(6$N#B[8/L:=X[ZI3&
MJ,DLD0> #M J>&M*GU^A*8U@SS0\(%H:3L&_T]VVNRBF9F4QZN62HYM6D TW
M;:5W%,>&:,\T=M3M]0[D$4! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MR*S.>:)8" VFP?@[ZI3"B8IG*!C!H=Y'II7N[>Q3PHC.:H!GM5<>+N/Q>'X
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M_0IMKV%13YEDW!3A -&M!%-]>[;OV)0K0:P-)+=@.\;_ *9*F(B([T8U[DZ
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M>>Z4G%Z(B:QADKJ00$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M_B-]06*+;*>K[++,S7'"4Q (H=RO7EQ12I54MOBZ:%$5<$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M&@ ; -RM$1$4C)5%)B)BDB%%$66Q-8$58$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 43%<)!(BF$!11R6UKQ!6%)\,<E>)M:T[
M3V*T73&$<59MB<W1?S*FC]Y7SQ;N TG=COW0RKLG@Z(GQ'M8G+WD>=IO$=EM
MW0MU;=%8]Q?^K+S==%[,)=!N_P"6\S0[MU_*O;N[ON][&C7]E%EN'R/"?AZR
MV.G3JQ%-3WM^/ROIV&KW5=6HV[%I]:.;4BV[*)=MT9PB?SLVUY]Q&+)!VBZM
M17_AVK;:$S?^RN^KFW&/D:KJ&G9;KQRQE='G9^/DKC_P3: <=I\)P^ P6A7C
M?XC:E_\ JW<[>O[&R8I'9F];> K++>C671'K3;'FA=M$;'ELCA5PK0_"ND5F
MW!W;EBZ8NG.%:E52;8G-=(R-K*\(I7?M)^JD6Q;DF9JG4H$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 04=O%PN
M'Q^VOXD>A+J32(R1;7.5A_S*O-)U5TG<R\1R[T;A/&DA\*7)79]OQF/\:3P^
M$SQTJV*F[M44GAP6X89R^6Z>_/DY4Z[O;7"\T-,3:(?$R".ZS<SZ0S.I$U\P
M9+<T(JYQV'L2J/RN65QS!>9CT7:BX!C.=&GWO> ?#ED9&]I-/9=64MJ"ZAH2
MELQE":2^HN_, Z2[&!US<\X-.1PM'$7>\1G92NX2$[E)2:5<=9/S3>B'&074
M@YSX2ZF@8XBVMJ.EE>T.X6-XY6-VN%*U4XRCEHMY<\?/PY8:/N<AA^6^C;S5
M\CV20V.7MB^=C97>(R*7P;><U]H--.XI2BMV58FD+/O,CFQUU>8CJ1\5W)GL
M9RTNKEK+:U@%_C8[:SFE< ',C<X.:R&ZW$4(")F(F*VN^W)ORV.3^B>7\^ U
M[#'G]3YRRI=9:0-X[*YD@;PDAUM5SA(37TJ)BD5G--(G+)T0YE]''4;T@ZN?
MS'Z=L]F+NQM+I]_#;X^>];#;PMF?<AK[>W$4<@#(6BA2(XRK3DBD<5P#I5\\
M_4.G[G%\O.IO2]Z_(QOAL[_5<\$EB+40F&W?)*V>8-E X7N-=I(4\.],3S3V
M2OX<H.M#INYW^[Q<O.9F REQ/&Q_NLMY;6LL;WM8YT3O%GX?$:Z0"@)V[E'&
MBU)I679B+(8V^H+7(65S7<+>Z@GKNW>%(ZJF)I@K,->' U [-^PCZH]"A*3Q
M6<197VAOV%+?6BL9$X9DDL4+2^:2.)@WOD>UC1ZW.( 0?%:IY@Z'T;B[O4&H
M]583%XVQC=)<SSY*R'"QH)=1KIPYS@&DT KL2<<>PKPGBM7]2OG+],O);%7;
M="Y6WYFZFA\2)V)Q<K V*<>*QO$YL_B24D9M  WIA3O1,TFDK O.?J\ZU_,)
MU/)@-(0Y[#<KK^X,<.'LXLAC!8P3/?&YTEU!(?'I%<BM:U 2)F(JMGA;%.]V
MSZ<_+/T#H/3UQD>;I&JM4YR"KI;AU9[*6>-A<7NDMR^0L<3O*BL5QS.68CEG
M&'5OGOT#<X>06M'<V.F_,Y-\44[K^SLL3-=6PA,<DDX;-':,B$H;X31[2M&&
M*M+K<8R=B>0OG<\\.0UM!HSJ9T5E=67=J(;"WO\ W2Z@?;QQ&*#BDG\4>)PM
MC<:NJJX^UG"9G'UL%X'E7YQ72+KS#VU[JS5T&A\A+&QYL;XQO\-[FL<6EQN.
M,4+CV'<I]6?*8UI&3L%B?,DZ-,V>''<Z=.3'9L,K64K2GQG^E*)FV8S;S?\
M7]TC6%J^^O.<&FX[=HJY_O+": $_%;)7<$C!$Q7-UXYH>;]T?Z&PEU?Z:UU9
M:TR<#'EN/L'1QF5S&OX6!SIF/+BYM-C>U(Y>),3;FM0Z_P#G .I<IJ;&'0.@
M78O!,R,%M>6]V..2YA?<^#X@?+<@U>PAVP42.V<B:<&1_P!.W-IO/+D[H;FD
MVS^37:HQD5W+:UX_#D,8#P#Q/V%U>U*TCM+L^YSJ@(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(""
M!5+XF<ALVI/V.Y_]1<I]PSK);[4>6/.K?[$^27FO]:S:=6/,TG8?ER^ _N^]
M7L3PK->@;2/T?1#QSU_^J=_/Z4>>77 $ ;>\_3)_#7<[L+6GNGU<4#L,AI2C
M>_T%<&W'6CR^E-N2]C\WE)_?@:QV;#9R[:[OS-:+Y=\;_N_:_P!NU]-^"_WM
MO>VD>AG*\5'-;3XQ?M[J$E>8?^;\STE&0WXH^'ZI37S+<D?LF_RWU%;2]B2<
MX3JX(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(.BGF4@NZ+>>('^2EY^4RKL_@W^I-K^\CSM+XBFG0]U^XO\
MU9>;EHMI^1;KO^6\SW?V?*O;6\PW,?0M\SPIT#'I4Q_W;_UGU$;?:))IL^LM
M5JS76PRJ[1I3ZMD3@VK/4^2SV@W5K^7-6TVWUD?1]#7=3GEUH^E;YV?GY+ I
MT3: H*?:SMK7^M[1>-?B-_6>[KVQZ7K?P%->AZ?T8\T+MT8(;M=4'<*4IM/T
M5TF8I-'=HR5$2(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M?K7I&,D&_%'P_5*:^9;DC]DW^6^HK:7L23G"=7! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M*/$D94&IW@5';LK18YK,X+Q=$11(X@RL>!PLC^*SL-=]>]16<E<$[0(Y#/&
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M;!Q&N[9N/=ZDBL3ZQ6+K9H@QX<][6O\ :;2OLC;L^LIF8XPGENIS<)5U4$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0897GGG_ ,3=D ?ZXP]?]O+WI@K/!<MZ8MG3WRZ)V_H<R@W4K;VRB:4\K)$8
MSY'.(V&H*I6F2>4-*#O[?2E8GRHF*!<XBA/U%-952FI%"-@W?5]:52FIQT!-
M:U[-WU*UHISP0E(!'?7>.Y1YTH[*#9M[3WI7YQ,:@M=6M:]E*[**<L4*EO\
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M>R_#4W?Z7V?/$VW<F4YQA#Q[XCMBWQ;OHMFL3=&,93C/')UT&VD1%6MJ0_\
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M0(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M.+K9I2<U4.#A4'9WI$Q*R#7->.)IJ/PDBZ)R3,43*4" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M ^2,".KAQ![JTX"*@>DK!.M[^V;+<H98V_),:G%N@IM':-ZO;9RQ0J@&AI)
MVFE?@46V19%(3,U3*Z! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MU+J7TC.9NFDX1Z655%L!;NX: #MH*@$^NB[)-,H>.HK2)E54)$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MVVU^V-/_ *35"8QACD>:R/\ Q0XS\^X[\O>L],6&[V89='EW?P0>3WZ@,_\
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M&YG2B(LU+YN^>Z7?-<Y\T$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M\TS,JS6M:*-%%GF9NQE$6Q;A"90D0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M,.TFZ[1K.5$S31K7<-?Y;=4+)J8W6S&5'%VUL>M/>J%U?9(IZ=_I[%5R!W:
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M" @(" @(" @(" @(" @(" @(" @(" @(" @E'QG_ ,K]13.4(C.6&=YYP_\
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MJ>;P_P W?/GADY,=PF0[]H7Q#6F;8MA]CTXK-/*U:Y$9 I! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MC0AQ;?XT[CZM_IWH@/M[CN[>^OT.Y I1H!V=Y[MNS9VU0/L2*[.QW?M[M^]
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MB"K&UKN*HK2E-I'?W*MR)F@)']IX1W\-:*"D*M" &M&S;MKN[>W?52C/-II
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M._QL^^]+Z,O1'P8_IVGZ4^>&3B/C.]8^NOA6KE;Y?2^R6YRUJY$9 I! 0$!
M0$&G?=VL;BV2YMXW#>U\T;7#UAS@0@IG(6 (!OK,$[@;F$$^H<=4$POK(F@O
M+4GN%Q$3]#CJ@U0-=HV@[01VH" @(($@;R!ZT%(W%N#0SP@]QE8#^.0/>;?_
M '>'^BL_]I ]XM_]WA_HK/\ VD$1/"=TT1]4C#]0H*H(.T;1WA 0*CO0$! 0
M$!!*YS6-+GN:QHWN<0UH]9- $&F-_8C:;VT &\FYA'_KH R%@X5;>VA'>+F$
MCZ(?1!7CEBF'%%)'*W\5&]KQ]%I(05*A 0$$KG-8"7N:T#>7$- ]9- @I^\V
MYW3P_P!%9_[2![Q;_P"[P_T5G_M('O%O_N\/]%9_[2![Q;_[O#_16?\ M((>
M\VW]D0?T6/\ ]I!'WFW_ -WAV?[ZS_VD$S9H7FC)8WGN:]KC](E!40$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$%LWS>OX!?.?\
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M=Q?%K2F[<:5VJ9KE*$PJ10=OJ[%&*V5J0"HJ-CCOV;J;M_>%,EHH0F !!)-
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MMC\KS!M[\B>V ]TMS=S0S7K#Q <;Z>T.Q$S-O'!G%=+'6-R ZTN66,YH]/\
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M;TY8.:ZM9:O_ %D[S--O_>Y-MW_:[GL_X^E(.::X'^LF^9H=_-R<^J.Y_O\
M2D0>M*!^<F^9H:<7-R<TW?:[D?\ QZ8(]9(?G)7F:.DXSS<G.R@:([K^_P!3
M@5N[<%2+YR9YF3!(U_-J=_B5%#'=;"-@(_-_8HCO*]F:^'\WU\Z7K6ZO.O/1
MG)/G?S GU-I'-6>4G=9OCE8P&)EOP@F2]EJ8RXGXO:F&4DQ-.:.UZ&:D$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$%LWS>?X!?.;
M\XV_XRZ6C\0_=EWTH?7?@=_\A[3Z,^>UYW^&)%A.1M)N,B#_ $65?-]W]9'D
M?J+M:1HVS.5(\S)<^;\U9C>8KCMJ^UV;OL[/UK:]'XU>7/CYA%8[8]+)8E)/
M&6_%)V_3[]J[3I<N/;1YKW4UMLGN:;8X@ >R*_3^GO6)5$';4;*_^E0?2H@E
M<'4-3LV=@V_A403C;M(I3=MKOWH):;"7&E:5V;J'T()0'C=]9!.3N!;OKLKW
M>E!(#L^-3T<-4%4>DU]*"!W;Z>FE4%.E37XW?]CZD$34"M.'AW;:[T$0. $G
MT;/A[]J#6-(>^W?3;QCZM/K+)I8W2Q;N/V=L\6.+\X0VZ5T"7=CYO@]J[[N]
M=?ZSA$?*]-?[?9GFU*]WH8R3R/=<: :D2VE/A?'WKJNP_C*O4VO--*_LY+O-
M+T&/)Z_@0\LNW[1+^56J^L]$_@X\K\N?C/\ U=J^6?UKETI;A\A$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 00)(%0*GNK
M3Z:B>X1W*1BD>?YR1S.*U'HWG/C+.YO;#(SQ,R4D$$LD=H[&^,^DSV1%L8+*
M':X;TB/6\J)K,5G*'(WEZ<[=,<W^35CI2#)V=KJC2]I#!#CYKB".60F*V8^@
M?,7$[>P*8RIQ3,\9]F7=U]N^VD-O,Q[7L)XG-:Y[7'O#@"TUHJ=W$B)F%-K"
MXDD/!9N' [VJC>-BB,4S%)HG\-U >%^VM?8=L^DIHGE.$M -'@[?L'?7"BDU
M33"A1VTEK]O^]N_"28G/B1$0DVDN+^.FRGVMWP]B9XG*G(+!4<=#W1N.[X%.
M2)A38?%?PL9*.[[6\_6[TPG&"(K#<+<66/;<YK-74&/Q-A;7%Q=7-U+' V+P
MH7RM]F9S XG@4S%<LT3,6QC+&9ZO.8<_4AU4:>TQH:WEU#96NIK/'^+91OFJ
MUV4]V>X-@\<\+!(#6E**;JQ%;N"M8GU>%&;7TP<LAR@Y&\O]"@'QK'!V$MP#
ML+)[BRMI)F$%K*%CA0U%5/-$S$\$4PF.+G][P' =@V/'=Q4IV?45>_A"W<Q)
MO/HY,9K2O,K1G-['X^XNL/F+MESD)X899(H'V4MS-2:1D19'M;]DY6KZO+"*
M\L\TY.Q/0KSGTUSEY,XS#6F7LQJ3#V5O"_%R7$,<C/!AMHZ .G<XD]U%6DS$
MUS6FM8F,G<3BD<X6TD$@G;4$ACBP\!I4/ H=RC'*4S$3$\LY* #NUD@_X-_X
M2BA2.U,6R.(<&24-:_:W=FP=G>IQG$Y:<47,<">)K^+9_,W?6'<E*E([4 VH
M/LO'#O/ [;7=L(&Y*1D<H 1M ?7^0<?K)&58.5*'\.W@D(_D'=NSN5)S6PB,
M<DA!%'AD@CJ.-W XTV[-E#7X%>(KDI,=C<O>K3%V5_G\U=VV,P^.MI;DW=U-
M'"2(872T#)G,)J6*T8S,=BLQ,16,I8RO5'JB/JIZO<%@=%PRY..745I8BYM&
M/N/$$>2]W>XB'W@AH#ZUW44UFE$S;28B<V;KTR<LG<GN1W+SEY.[CFPF"LXI
MJU!;+);QRRM/LL-62$C<%$89)OF)GRN?D0(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @E[2L%OUUR>#YG6W[#M
M5?M=S7ZW7*V&S_B]/Z<>=Q]S]1?]&?,\TCJG+6]3?,X#V"<_D:[W?X1O5[7Z
M%]Q:-<N2/-#QMXQNC^>ZW+^=Z9<D=!XIU6<L*]N:M2#W_FZR.Y<;K6'3-6>'
M)/FER.CQ,Z^VC]*//#/YS.VXLS_S-AOI6$*\O[3#4_X[_.]*ZT?Y?,\.6WS-
MO XV@@5H.^E?HTHL^XQU(B,F'8S302@U/#79W4W4'?VK)JQE,J:'Y4][5M]J
MG"/BUJ/7Z2JUA>9HE!<!Z!\&_P"GO2)B<DH$4WG;W4^ONW()@'[!NK6F[LVE
M*Q6B*X51(=L#CL/J[/4HK!5 QD$#OK]+X4K&14\-PK]+=M^GL4UB4Q*1H+B2
M?A^LK73'!6V)B<4Q]K:30=FROKW*JR4TX*EM1WU]/<%$Y8KV5YL%,$581NV_
M N/?QHQ=/PWNK5$T+C5V[=LW[/K+D;>ON;XC%@U*?S#3\LK?'F^D#R\^9%>R
M&WKO_MQ=D^'>/B3^W<Z]\1(G^4SY/1+!+TWMP+]M 69#L]#UZ/M]J(GM>=>G
MVS]FN_XO2RZ?FT'^9?FJ#O\ E6QV_P K"O//QKI_.M*/T7HCX,_T]CG6?/#)
MQ&]Y[ 0OA6ME;Y7V2R*S-&M7(C(%(((%P;O-/H_64TF3N2F1C7!I-"=VP_54
M#X?F1K_2'*[16HN8.M\O98336EL3?9C)W]_<0VT++>PMI+E[0ZXDB8^1S(2&
MMK4IAG)2;L(>4!YZ7G<\W.OWGEF=#\M-8YO2_3]H+)YG$Z?Q&$R%[C1F96W=
MYC[F^O)K'(%MY#/ !3B!J"*; D]A%,9C)CT8?!YW5>5L\)@,?DM29_-W$4-M
M9V-M<Y'(7$\TH8T-AA9-</>^5^TT._:IQ)FD5GV61MT/_-D.M?JUY>CF/J/&
MW'*W$7;H7XBWS4$MM>7MO*()6R.AN[#BC)@FXJ#=116/E3R71-)I$?.O$Z*^
M9QY./2[FZLYE";43X#PO80UD<WABFQN.X2.-3WJQ$QA./>Z:\\?F@_5/HG3>
MKM3\O-8VNK9,+9WF1QN##6^/>PVL-Q<.B9X5@)"XLB %-M2HF8IDF+9KG$QY
M&*5SCY%<V>G[5-]H7F_H;.Z-SMC=7%L^++8V]LV22VL\MO(;6XN;>%EQ&9(7
M4+=XVT3@B8I/>[L^69YG//ORW.>6G^87+G5&6?HR[O[.UUEHZ>_NYL3D\/)=
M6S+YHLW7D-I',+.,CBIM&PI-O&"'K^=#?5YH#K@Z;.7?43R^GM/DK6^(AN[J
MP@NH+B;&9%L,)O+2=D,\[XG1RR[ \\5"$F(KAF1,3%8=MG3QMI4[#Z#^$B7"
MG4DUK^0W-L2.X8_O!U600*[L#?$>G:Y(K.!6F/!X<_42ZO/GFNYW^7VK /4,
MY?@'9WA.*(RBCMAY:/EW:[\R7GM%R2T'EX\-D38W%_+=O:'<$%LUKY'^U#,U
MH:UU35NX*)F(6BVO=#((_P!3MZM:RC[_ +&$-<?"/';CC;4T)K8["0IP.7MF
M/F49OF>'5RRTEDBUSC'W+&N,<)DM^%[@"6BON(.T[-Z5.6?SH^:?QK.75]Y&
MW7ETE:LN-/YCE1J#5N)9'--%FM/XV^R$+V0F9Q>1;V):&NBAXA0FM5'-%.],
M6W73-,8CBM+YO3NJ]&YJZQ.?Q>:TUG\=<>%);7MK>8JZ@G@<032:."5CF.9L
M(IM"E7/R+Z_E*^?)U->7CK7&Z6SVK<OKSD=F\KB(M1Z>S]]>923'VEO);6[K
MBRN+^_!@9;6;'"C:':4FLF$98Q#U1>C;K#Y/=;7)#2W.WD]J&PS&%SV.M;B^
MM+:YMI;K$WTMO%/<6ES!#<7$D7A.EH"^A*8<#&E9=II;N**+Q#7>!2AKM-$N
MK;,1VHK%*JPE8>"AKQBK?2G=QA,Q2:3FZH=;75GH7HJZ=.8//W7EU:,QVCL1
M<W5I87%W;VTN2R'N\[[2UA;-/ Z7CDB]KA-:)6DIB)EX_?F@^9ASI\RCG_GN
M9/,34.1&C\5>WN/T/I)EW<MQ>,PK;VX;;%MJR\GM'ROM2VCZ5X=BB*QGF73,
M^1PAT8=#?/?KOYOX3E!R&T=E<]>7US"S(9F.PO3B\7!)(R)TUU?16TUNQ[72
M"C7$$C;W5F9HB(FE>+,:Z6?F=M\R%EYU%Z[9-+-%#(ZPLY?#%O(]D+I8@Z&P
M+CX;B\;378HQDB*3C-8<L=0?S.W0=]@98N2.O),5F0RL4]S-).USP)#3AFQQ
M;M=PA3$X8INI,^KA#$'\RGRK.HWRRN9L>D.:& R&0TMEHC+I[6-O974V,R47
MV\DR7$=E%:P/\.+B XMH2)A%T3$]W"73;IQZBN:72]S2TES7Y8:GR^GLGIW-
MX[(R1X_(7EK!?6UK?VMW<6ES!;7-NR43QV_#[7>A&=>+V0?*BZ^])^8-TB\M
M^<>.O+*+5LN#LK/66#CNHIKNPREI:6L4\]Q&VYN)6^]2.+O:-:E.%2O'@N7B
M9E>$FCNT4)]78IF*$8Q5:K\X7HFUSUY]'VLN1'+[*QXG/9UK!;32\ ;5L-S&
M*NDCE X3*.Q5K,37--(NMFR9I5@^6WS/'K!?$'7>NL0V<O?Q>&^(,X>+V#[=
MH]W$1OV[TB<,8Q3-L5PNBGD:C_4[NKC_ "\Q?^W@_O%37N1%O;='S?WA^9W=
M7&RFN\7VU]N#9W4_,*5PRQ.7'VHIY$1\SNZM]M=>8OLI[=O\-?S#W)7N.6?S
MH^;^];&\SSR.]=>6)H' :PYD\T\'D\UJ"AL=,6]Q939%P)G'$^"%L,\+'> :
M%S:&JC&O<B(F,YA8B@;--)%%!"^:[N)6PPQ1L=)+++*X,C9'$T%SGO<:  5)
M4HXT>A;\U0\HC5/+J0=<G.K3]_I_-W431RSLK^":VN'V-Y#8S27+XKBSA>QC
MF&OQC7B3"<>*8FM6=O%QEI+S4EQ('<*[ IG-$8PJJ$B @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MK7=N^L@UL=7&%QWE[:^C;19-+.Z6+=_5VL<7YPBT#2F@!7:'3;:'9[5XNO\
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M$! 0$! 0$$OV2XT337F$\'S.M@#H[50.XZ=S/ZW7"V6S_BM/Z<>=Q]S]1?\
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M0BLA!!/?LJHF*)K(H)FF$)0 -RE"*"-12E-O?7ZRG"G>AJ[%\D5PQ\4OAN-
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M)?RJU7UCHG\''E?ES\:(IXOU>VL_K7+I2W#Y"(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MT\L<W"&'I#\\VUB;)XFY%Q,O..9HI>,(:&N<&._3.AJ-J4BE*XDWW9Q9^%T
MZM?G7G6MSFP<VG^3=P>53;QDL<U]:M\2>..431D1^%?NXG^'+L)V A1,<,X3
M%TUK$<L^6K&MYQ\]N<W4UK^?6/-[6V=U]K'-74<0NLQD;F>/WFYG<&-@AGF?
M!;-,DY'L@#:ISP5PB>;M9.?DO?-M>>'5'J+0O4#U$X^+17(^._Q^?PD;Y8+V
M35$%A<X[(1M\ VDS!'*P.:/:X>\IW\4W1-:<'IL\M=":3Y8:)TYR^T3C+3#Z
M<TIB;'#XVPLK:*U@B@LK>.V:[PH(XH^.015<0T5)4>9+[I 04Y-C2>(-:WVG
M$TH&C:XDG< -J8<2DSEFP+/G87FQ6MCI\="G)[4IEFRP!YGSXG(&*6T$/O\
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MJQ-=WRAC_IW#Z++P[F*Z*4HS >@<$=*/*2O_ "!#^-8JQDR7^T[BJ51 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M\4K\.Y17@ ()(&\4K\.Y*\!PAU*?YA>;7[0-5_K%?J43D\.3J.H[GOS8H?\
MY^U7^OE^IG-%OLPR/?FD7_F18W]K>8^YX5CGVH9K?8N^1ZIRNQB @@2&BIV
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MOSEY.ZHL-6Z&UCC+;)8K(V,T#Z-EBCD?#<,BDE\">'Q '-)K7T)/=DKEY7-
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M/5VGN00<:=O#W&E:_A400 .\.W^CN03;J FI->Q J-OHI7X4$I(&_:X?!O\
MI;D!K2/XWO.PU_"H@"IW/_\ 10:R-Q\2'[+VAMW=H5]*LW7=C%NZ3I6Q'M,<
M3YPCMTKH$][Y_P =>+0]:FED6SGB]-?[>O:U)XX>AC(N(%OCF_[[9U/\O'38
MNJ[''=U>IM>*Z5_T+O-+T'/)[I^\AY9=_@2U_H5JOK'1/X*.VK\N/C/%/%^K
M'"L_K7+I"W#Y$(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M_ANU^[K)<+K?W9K?0GS2Y_2,-QMOI1YX9_\ FC^:+(=HPN&^ECX5YAVGM_\
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M'TTK3X$'3GKYN\5:=(//6;,9&VQMC'H/4#9+N[GBMHP_Y+NBQ@?,^-I<YSJ
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M'+9DN"A@;)'(=LLFQKNX#9NW;DI7&$3,X5R;BB1 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M645I*0N[#[0&[L4Q$9II$9#N,[7;AZNWU)2"(HF)+@TNW;:_6W)2"(HBWV@
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MK_H7>9Z#'D\C_P $/+(]I@EK_0K5?6>B?P<1WORY^,_]7:OEG]:Y=+6X?(1
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MGER3.;D8 T!/;7N[_0JS''@(U- .P;DQD"TUJ1\7Z54I( $F@2*A1Q-#M=\
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M<=]TO5_R<5>$?(S N@G^"ERD_:_#^-8JQDR7^T[AJ51 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M6\#FNK%3BCD;[;2UWM5]FH((W'<HGSHB*3A&#4.:"7 NVR4H*;N *N"50 @
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M98]JBDQZM657Y;!_\(_+0?VB/N:T5?RI33U8EWR.X^HJ1A4>=*?_ !;0 _\
M+>*I_=TWUU$9(XKN_(ZO[D&B.+=\CV7#Z_<;7N3@M->+D@4X104W]N_:J^=!
MLJ0#6E.RF],*X)3$ .H3\-/1W)2DH1K4"NP.WG?6F[9V44B%/9KP_P M7T]R
MC@&S:VOLG>:=VWU[U/&D)CM*;:'9]-13A),UQ2EQW 5!W[1V;DCL3,U:NT/%
M<QG<>-M&[^T=JF,94FL1@QR/,[V]56(KO^4<=]TO5YCU4<([68%T$_P4N4G[
M7X?QK%6,F2_VG<-2J(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MV.C,[M)Y;^[(?Z:E+NPYM+\Y#_6VNC+_ "4R^S^W(?Z<E+CFTNU'_6V>C/\
MR3R_]UP_TU*7=AS:7:?ZVST9U(^]/+U']MP^O_=E'K=AS:7YR4?.VNC.I'WI
MY?93^NX=M?\ AMJ4N[#FTOSD?];:Z,O\E,O_ '7#_3D];L1S:7YQ_K;/1G_D
MGE_[KA_IJ>MV)YM+\Y$_.V>C,&ATGEP?SW#_ $U/6[#FTOSD/];:Z,_\E,M_
M=D/]-3UNPYM+\X'SMGHS.[2>7_NN&OY<4CG[#FTOSC_6V>C/_)3+?W9#_34I
M=V'-I=H/G;/1IVZ3RX/=[W"/_OQ4TN[$<VE^<C_K;/1G_DGE_P"[(?Z:E+NQ
M/-I?G(?ZVST9_P"2F6_NR'^FI2[L.;2_.1_UMGHSW?>GEO[LA_IJ4N[#FTI_
M*/\ 6V>C/_)3+?W9#_35'K=A72K3F/\ 6V>C/_)3+?W9#_35-+NPYM*/RD/]
M;9Z,_P#)3+?W9#_34I=V'-I?G'^MM=&7^2F7^&[A^M,4I=V'-I?G.JO6K\Y?
MZ2>I;ISU[R=P&E+\9;5EDVWM)[BX8]EG*T24F#8[@.<X!U.T4.Y<+J.WNW.S
MNT8_*]#N_P //%6U\'^)]'KFMZ^GI1,3;E6)IQP[&-IRPYVZ0YA7=]I[!1N%
MY"Z[E<YS7-JV8N>T4<X_%#POGG4.E\NIS2_0/X4_'#I?B2+MEI[;ENF?SJ]G
M>RM_F_4;AB^8;":2"2W]/V5F5?INWFS5NFF#I'Q\ZSM=?=3;IV<L33TLE [)
M'&05(<0[Z.S9N79K-"9TYOXP\PVZ5UUV?JRD)V^R*CL-:?56/'BN$[6COK7Z
M""% 2[MK2H00W5#10[*>GM[=FY!!QH33>:?!3ZM4$:$5X=F[TU^CNH@CPC=3
M8=^WNW()>&E3Q;M^SO00)KM(J#NV_1W()VG9L&[LKZ>\H!.W8:_QM/1WH&ZM
M75IO%._<@@#P@UVTIL[JGO[:H-:T\3H#N]L?5_B++I>U<Q;K'2MECB_.$!_B
MOH$@_93=G\=>KK_6?9CY7IG_ &^_6:DSW>AC(/V6MALK]ML_@]N-=4Z?_%/4
M^K3W5]?S+O-+T&?)Y_@0<L?YQ+^56J^M=%C_  4>5^7/QH_J_5\L_K7+I2V[
MY"(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @("##.\]@$]2V*VT_-&%[/X^53G/R*SP\JY7TO_ .8'EY^ID7W-;*K)VN<*
M-_%?2*BD*I:EKO9VCOW=G<56>Y,31$#B]%%&2\1S!).\UHK5JI,42@5(VT&V
MNRJ1GB([Z F@%>Q,\\D V;:T(W;-Z1VB.QQ)<:?!^$F>8K6M?'CI^*'X/HJ)
MJM%*XL?+S5_\]6D_U0MONF19(^L^1%WU;*J\MC^"3RU_.(^Y;-1^5)^3#OF=
MQ]14D9L*?SIOX6]O^K6*_7"51;DC\J5WGD=_F?T02-@PUF1MWGW&V4IG-R+'
M5P&RAJ:"M>T]JIC5"H-HJX4XNW?2GH'>ISS#VA_*^K95,?F$ 2#4*,0(IZ^T
M=R2 IN/T>[X.VJ103<0)=78'4V[Z4_#4U"K:!S=AV[-I]':F&<9BO:$^\Q'M
MXV_5"1C=5$Y,<KS.S7JJQ!/_ "CCONERR9VJ\(9@/03_  4N4G[7X?QK%2,F
M6_VG<-2J(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @E[2L%OUUR>#YG6Y(T=JJ@J?O=S.RM/\ !UQVK8;/^*T_
MIQYW'W/U%_T9\SS2.JEM.IWF:XG?GLEL])R-[VKVQT*?\CTOH1YH>-?&=8Z_
MK7?I>F7(O0C_  JN6(.S]&[6O;_7UE1<7K?W;K1/YD^:6?HWUVVG].//#/\
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MO!;T&\<+-M=R(I 3IDG\@MW5W#A9LH/5VHF ?>T=T4 KV<+/XB$HG[V0?R.
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M>EDI2T87AH^R/P5)78=32LM]G!YNOONLT[+;<IAI14[G_P#HK&QA;7?]'O\
M@[*()=CN$#9O]-$$^WAVFA[Z5[4$6U[1\.S;]!!(!7:&?^D@-:.W;7XIVBM-
MZ"-:':[X.% +?C$[-U#]78@BW<*;1MV[OI((UK4;CV]M/K;D$O%Q$#L[?3LK
MZQ0H(N:#4]O>A.#51&ONY_CQ^.631SN8MWAI6L<7YPA3[UM D_BIZ;_Q5VM!
MUG*.W%Z:_P!OGM:E.[T,9.2GNN/X?]ULZ_[>/O75-A_&4>IM?ZJ_Z%WZLO09
M\GK^!#RR_G$OY5:KZST2OV.(GM?EO\9JSXOU9GMG]:5TE;A\C$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M''&SV6MBC 9$UH:  UK6B@[ D^K,4XJTF^)K%)X-;%3@;38 *4]2+*B @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M" @(" @E+VBHJ*@5HII-*\"*3-&C9>M<YS2WA+33:4I.49LDV6VQ69:UK@X
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M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(""V=YO.SH+
MYS_G"WI_M+I:;KU\6=,OF>-'UKX)6S=\0MI$=D^>UYX.#V6-P1_N^1^E+(OE
MN^TIG6YJOU#VT71MK8F<8B&2Y\WZ)^3N8;Z_%DMZFG\?9KL'1[XREYA^/NI-
MUL=M8]+)5DI(][^TG=W[_H+LTW1?CP>:M>V8MLY>QIA4[1[/TZ_A46&4)2XU
MH1L[OXJ".RCA3AW5VU03$#:2.[;4[?@" /9J2.'=VU0*4!KL'=W;>\;34H)0
M2X_QO:/P;=Z"/"-OL]U-N_\ "H@AO &X.K3T4^K5!&E"P?R2"9QH"1^#:@D
M93OIO.T;T"C=_#[/?4_4W[T&M80'P4%*N ';7;M5]+.>UBW>.E;'Y+'$^<(_
ML5T"#OXYJ'O]J\^ +0]8PMB/*]-_[>\+M3LP]#&2=_4F.%*'Q;2O;]G&NJ;#
M^+KP>I=?ZF^?T+O-+T&?)YI^\AY9$'9X$NRF[[5:]O:OK/1/X*.VK\N?C/\
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MMXPI_":G_MN_^E/_ *1#I&_^UW!_T>U_OA6^1B__  W\8?\ [+J_^V[_ .E
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MO6RM\OI?8[<Y:U<B,@4@@(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(,>[YQ]:MN.@W5#BSB?&)BT[?9_,MX3L^!*5DFO+1YB&+I\GWC0
M*AMQ=A@W<)\9X/KW*,DUKFS<_FEF4,G[JEB^0$Q16U&]M.#'4-*[-BDB*Q7L
M9Q>T%HK6I=V?"!\"F(PFJLYIE"1 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M\3'B_5KVS^M*Z4MP^1" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MAB!?)&"9'1TWJU]T69^Q#>^$O#_4/$W5]+INSLF[5U+HK'=6(GSL,7J?Z_\
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M4+5KC&;GMLK90>( ;:-'\CO^C11%$S=.<!>WB+">!GT:]O=LVJN7D1S5P!P
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MHISRR)B8BLPZ8]07F2<G^46"RN+T==LS>J;V"XM,>;+\U4EDCGA:X&"Y=]F
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MW44U(N<7I\UV\QY1I^V$G?\ B:_75[\8A71I2[OE7,CJ[#L]2IR]Z](1>ZE
MW92M>W?3O5HBA$424+JG?W[D2J,V@\/L$4KLXJ[Z;^Y4G-$]Z4.X6TX34[S7
MZR1F9S5#BW$[:5^&JNE&@%*;:U]%?PJ*<.)68R0+BT$ 4(W;:^E32.U6MT<
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M.]S_  WAOHIVKC/S?HDZ?YC5W\-I]2R7<+(B-.*=SR'_ +NK;8ZKLYB,<?\
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M.VK\MOC/_6&M]*?UI72%N'R,0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MGSS6MXB,YEPX5I0?*$X[5*MM)AEN?-(=G4?S_%*?F;'?E./0X]ST)$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MF2VH>+A 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M^6_QG_J[5\L_K7+I*W#Y$(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M]?\ ])DM*'BX0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M#/D] ?O'^6%/]PFKZ/M5JOK/1/X*.VK\MOC/-?%^M'")G]:Y=)6X?(Q 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M9+N$4]W%.R'D/_=W]Z;/Y?\ ])DMJ'BX0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M?9.];5\,ULK7V.W.6M6>,@4@@(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M_P#<R65D>+A 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M\M_C-'_EVK/?/ZURZ2MP^1B @(" @(" @(" @(" @(" @(" @(" @(" @("
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ME> OBCL8T_%^YY8B+9OF8IAQE[H\'Z\ZO0M"+LXT[</DA<N71X=F%$Q$Q21
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MKB1LO=[GWTQA#G:G3=#3VWVB(BJ-1W;^RJSZEL3C.376V1@'A!%!M%:[>_\
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MFR8F[/Y62PN:\7" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MYQ+^4VJ^L]%PV<>5^7'QG_J[5\L_K7+I*W#Y$(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M%D1/#&QC:N#.X+F3=$Q3B\8[S<:VZWVKN=::W7W3=\\U?9*K (" @(" @("
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M-_T_2,JSYX9.0_FGK;]5?"M?\GROLFE[7SM8N3&2HI! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M"^<]/[ M_P 9=+2>(?NR[Z4/KGP0BOQ"VL1GRW>>UYXF";^AUU4U)N,@:?\
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MOK_P7_BIKGCZ&2+YE%/WK>N@33\QR[=_]:W2\C3F]-6S%:=S ]@</?LJ3O\
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ME>];X\X$@^7AS&I_N5K_ /&+LG@'^I/D_$ZO\0_N2?)^-@EZ<H,"XTV\%_\
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M#&.ZF?+Z&2+YE'\%S7.ROYCFV;OZUNNU>1YS>F8I6LL#N*GON4V;?E&]V_\
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MQ8^ MI2M5YMYKMO,ZD6XS?=3YY>CMI[G=Z'V?6G\F/,T9<2P$.J13;2F_?\
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MUU]*->M*1\\OS>\3])ZEX)ZYJ])W-LQIWZD\DTPFVLT[.#D($"(R.?Q%]*,
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MJ.GIQIZ<61E$/R=WVXC=;[6W%:\^K==\DW3/I?3*[BB @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MG1<RR:WR\,?[M?X_9=N/I9,:RO&0@(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(""C*)/9,>TBNPTV_12L9=J8B)G')P?U#8_
MF9F>3&O\5R=R)Q?,FZT_D8=-7W!Q&&_?:2MCX ?LW/<&BFVNY1$3%8E$SV1D
M\C'KUQG4KANJ_F1IOK!O]176K[;/7QQL^9GR1LLC$[(7Q@-K%>N]WCC8RM.
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MFLQ@K;$6S6COG&:UI\2@X?H>U]-.Y.&<9*B @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MY2U-/W=.]K%+&(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M%/\ 2.V\OXGD;XO17Q#']NU:G::QR5V <7I[2OL?5:_LHX4= VV&A->R?,R
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M6K:[3W_W(N;9A?+PQ_NT_C]GV8^EDPK*\9B @(" @(" @(" @(" @(" @("
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M .9=/U-U$5OY<8^=A+02?*%N[W]KK:XM7SV-_:R1EDUO)"]UO1\+@) 8W#M
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M]"Z%T7P]M;=M;9IS-M*3RVUFE.[N<,2W6/Q5EQ->YML*,MV0QF:YN)W>SX?
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M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!)(WC86TK7<*TV]_P*8FB)BN"DV-_
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M3ADO.!FVA;[ ^**_%V;>VIJ4B*8G'N3L;P"E:CLV44^<3H" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(-)<MCF
M!MY@U\-Q%+!+$Y@<U[)6\+@X$$.#FFE#L2DS.!,Q;%9><S\YB\NV_P"GWG_C
M>IOECIB6XT;S,EN;W7U_:6[XK+"20G)3Q^,8;2.W87GO?M2<91,S&/SNC?D"
M]*-EU@]=.#U);,.4TYRAO+;)9FQNK$RX^8.GQ]QQ>+-;W%K(82#LJ%.$5KC*
M)YIF)C"CU.,;96N-M\;BK*WBMK+&V=O:6\-NQD,,3;:%D+6,BC:UC6M:P
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MUN=4ZC\4/&/48NMNW>I;HSG'-/XW973/+70&AV2?>?H_3V!+^'C?C\186SG
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M/5QMV=_]:*?_ ,7]#\__ /*XL_".^Z^9]U/_ +T?]7-U=6OWYM^!S?[T3_\
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M$.27Q,?0N&T=IV_56";(NB.;-RIG"BH  *#8%= 14@]U?IHFN%$40(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(*,K^&E&<9K] '>
M=JBO IAS<'1WS#.D+3G7-TK<T.0&8=;6UYJ/"71Q>3DLHI[BTR=O979LX[>5
M]O/)$)YI0T\([5-M8XDTF.Y;,\@GRSV] /([45AKS0L6$YHWF?RL5[J*0M?=
M93$MO!'9/)-I;R@.BA:=I( *4Q[TUI929K/%D(L#1+6/:"29#W$BNSZ*B:S-
M:X(BD1AE+5*00$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MY(XU7I-8F,E(.=&YXFB:6-/L.8T-!KOJT;"HC'-%W+.%L*L1)\,\/"'<5!W
M#M[5:G+%(Q5B[GQI1JE"1 0$! 0*TWH" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(($T!*F(K-"<$&.+A4BGPU48(A*Z*-V]H/T5,3,12$
M3;$YH>!%^("F+KHRE7W5G8EXFM>&<-.&O":GM&W8L6IJ4QF*KVQ$81DZ->9.
M/_!9SQ&__%2\]'\QE79?!NK3Q%M;YC#WT>>&G\1ZD:71-UJ3&$:%_P"K+S=M
M& #"7()VC-YOX*Y"8KW'O-U$:L3%M8]W;A\D/"70=_R[*VRZV>7WU^/_ !/I
M_LZ\5=U-F_93N6DT-S;JZU]DVTAW?5ZAIQ9;-/6HVG/EK<2YKA4&ZM!V_P"[
M-]"['L]/2C97\N=)P^1U3K/4[8W-D7V3,\UOG9^/DLD#HDT!Z(75_H%I\.Y>
M)_B)J1_J/7I%*3E\LO9?@?7MU^@:-(I,6QYH79II2^&3A8:MWT[/5WKI5D3=
M=;;=A,NW>\C3]>8K$-#;>.X@\1:=M00:>A9;].;:4FL+V[K0U)PLQ;DR%[7<
M3G\1.\T^MN6&8KW0O==9,98IY6.=3;L[10>A6PI26&DUP5&@!H V@?AJ$Y)D
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!*_XI^#ZH4VYHG)3N/R%_\ (I;F
MKJ>PXJYR?YH-??M4SWZV72X_5/J-3Z+8=!^\MK^_L_6AYON?</W1^9#?_J;,
M?KM=_AKS]UGZRV/TI\[]F.B_TSL?W-OZL*;""2!N^'N7&GZB*PR7?P]:\7<7
MRX=G6[RHIM/R@_T?UQ9K9>')_P RM\L>AT#XQTGP)J?N[OU;GH'P</NEGQ;O
M=XJ_T)G=Z5]\F::7R0_)G6^ON^E/G:MC@YH(VA+(I:I.:970(" @(" @Q??G
M(]3HSDB!N]]R9^Z5]=^%E/>;F>Z'V#X93_@M[V5CT,8$?$C!VT@AKV?S,+[-
MI3$V31]*VWL1+;+WA..N:;"&NV;37XW:N;H>S=Y/0Y>RI[V_R,O_ .;Y$GIZ
MU%^>8/QMLO.WQ&^\K?E\\OAOC_\ C(^E^-D*+YO.3YXE;VKCZ&=WE3*9<E @
M(" @(" @ZV]77\'CF;Z=.WP_]WE2<DQF\]W+?LOUC^K.0^[KA1A7O(:8?6=]
M0HOPQ7;/)3-.IZ(C?XI^K9J8S8XPN96763_!GYM;*_XH9;9N_K"X6[\._?6W
M_>V^>&JZY]T[C]U=YI>:+CO9S&K0#PC[Y,YZ?\+76Q?HGH_PNW_=V_JP\*[2
M/\5N_P!Y/ZTM%JG]+6?JACONEBY6Q^\X^A=YG$\4?<%_[S3_ %GH->3]_ NY
M<_G./[DLUX1^*_\ 5^Y^E/GE[*^&W]-:'[NW]6%TL+YAI93Y7T&45E0D=\5_
M\B?J%8]/-,L!7SLR/W]>8J=SSP_^^U7MOX4?TCMO+^)Y%^+W]11_;M6J :QR
M'M]JOT7+[#U7_E>1T';8:$_1GS,@'YNI_GZYF_G>+\HLUY^^.GW-;Y8\\OK_
M ,%_XF?E]#)%\RFO[UK75#3\QR_<MTO(TYO35M># [@I[]E>+=\HWO?_ &3)
MW*RJ9]*.[@Q]/15I*)R7\O(-_P XNM#_ +W_ .I:J)S@B/5JRSE*! 0$! 0$
M! 0?/ZL_8KJ7]K^9_6ZY4QG'E7T_K+?+'G>:SSH#!S^YR@#VOOIRG:?^5[WX
M%Z^\-_T[M_H>B'I?I7W/M_HQZ'Q!KP&N[V*?76:9QQ;[<_4?(["=$Q ZR^3Q
M=_RS  /^.V7:/2M5XX_I.^G9^-H>K_<MU,N6[S2]&K%?I7C?SA9_<\:\H79S
MY7FC4]N[RRUZA00$! 0$%.3['X?K*]O%6<X4G?U1'ZG?C52<H5GVX6#_ #\Q
M7D+I/]4+S\ID6&_ZZQZ[_P!IO]3;KZ%K$XL*FVBJ:'PVUV5W-"X^M'K4>_=?
M^&GRJLGQ96MWB.2OI]EW?L5(RCLJG1^IM[62UY!@KA-6$^BGT+1<O3QOEX7_
M -VL_P"/V4>7TLF%9GC(0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M# [ >VJ53=69JU: @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @DX]O#3VNY,_D)F(FE4!(*;11WXFOUZ4W*(G
MM*3PS2R3Q0L?-,^.&"-I>^>61L<3&CXSGO>6M8!Z2IF)CRD8NIO45UT]*_2M
MIM^JN=7.#2.F,7&'%PCR^-O[P< D+@;2WO#*T_:G;Z;D\J8BN2WXSYQ'Y3[X
MWR,ZD\8X-+A06+.)Q;OX0;T _24T5F:*5M\XF\J*X8]SNHVPA+"?8DL8JN [
M6EM\0=GJ4<*R5AV5Z;_-VZ >JW/W&F.3?/S3&9S-L]C)+7)W5GAP72&,,#);
MN\\-U3*WM&]17@M$3,5X0N,V.5L<K;>^8J]L,I:NIX5SCKR"]@DKW36[Y(R:
M;=A5L$17BUPD):2&U> *MK2A/94JL37,P4_>&C811QV-;7?]+8D5^0K%:-0I
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!1DC#R
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M36%:<9XLQR*E7$2<=:"E*<( V)1,8XQDKH" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MKL.]Y%*T]'913.&1'K3$3A$-<""*C<@B@(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(,!_P">;_I1R+_DKWZN24\&/\MY_6'/Z*8P
M?\YV!_\ >&*&1[2'DIBGEK]-'[3K;\I@41DFZ:W+JJE @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M\(X;9>=_B/\ >5OR^E\/^(%?MD=G-^-D*+YM.3YVE;VKCZ&=WE3*9<E @("
M@(" @ZW=7'\'GF;^UR_^YY5$Y)C-Y[F8_9CK+]6<A]W3I&2OY33#M]1^H49.
M&.2[7Y*@ ZGX/Y\?JV2F8I;AFI$1$S#*SZR:?O:.;7%N^]#+U_N"X6[\.??>
MV_>V^>&JZY]T[C]U=YI>:)8T?E]5%O\ E+G:#_I6Z7Z)Z.&UT*_].W]6'A/9
MXZ^XY<O>7?K2TFJ&DXYHI0>_XZNVO]<L7)V7WG'T+O,P>(L>@W6SE[RS]:'H
M,^3^?_!=RZ]%FS[DLUX1^+.'B[<T_.GSR]D?#;^F]#Z%OZL+I;=R^8:$S-E9
M[7T&45F0D=\5_P#(GZA6/3S3+ 2\[/\ AW9>NT<9V?W<O;OPH_H_;^7\3R#\
M8:?ZFT_+/I6JFBL4I[ 3\&UR^O=5FGNJY4]#HNA3W$^1D!_-U37GWS-X=WN\
M&WO^T6==B\_?'/#HMOECSR^P_!B?\5='E]#)%\R@$]+>NJ;_ '.;Z'NMU5>2
M.+TO$58'<3OS=E2!_A"\&_\ MF12K->"8U(=3?P2;>^K3V%1-5H[."_?Y!?^
M<;6FS;X>TU_C+6FS<I(I2D,M!$" @(" @(" @V#5G[%M2_J!F?UNN5,9KZ?U
MEOTH\[S6>=>WJ!YQ"M*:HRE=E?\ "][^&O7OAS^G=M3\ST0]+=*G_*=OV4CS
M0^"+C4TW>S_$6>Z(^6KL.Z_AZP[%=$O">LKE#Q;0<U;]^P^^V/<M7XX_I2_L
MIZ)==ZQAT2Z9SY9\TO1IQ7Z5XW\X6?W/&O)]WM3Y7FK4]N?++7J%! 0$! 04
MY/L?A^LKV\59SA3=_5$?J=^-44]56?K(6#O/T_S"Z3_5"\_*9%Q[OK['KO\
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MB/&F;+":C['UI,Q$XG<R58K:"".*&"&."&!H9##"QL4,3 *-;'$P-8QK1N
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M\YAQR2^*0SCWT[-GM>KNHK>=$]L>R,E+P';FNKMH-E/13;5)QIRIR]I.'\-
M]WM=NSO.S<*;ECI=$UF?5%3B;4MJ*BE1Z]WT5<102%U'!H[:U/=\';5)K$5_
M)16(FDYH%QXM]&M^-LWU&ST["HP[4Q69I1 OJ[PVN]NE2:;NW=N-4G+O*URR
M1;('4'::U%=U/JUHD5XIF*9YJBE @(" @(" @(" @(" @(" @(" @(" @("
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MC&'Y4M7$^1Q>'MIPT /XK?MHL6GJ1?'?#'2>.2NL@(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MB;C6BWV9S7MB:4;==20QQRWD\\5I! QTLM]<2,BAM8HP72/D=*6QAH J22
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MM-@_LF13GBB,$[S4.)&S@?LK_&%5G--,*+^/D& #F+K6G^Y;OY6T5D8499R
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M<=O%/D_^E$=$_1)O_<%P@[_8M?[V5?YGXAK3[5-9[I_&R?RCHLQ_#VT_X?Q
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MM>+)PM"?;:0#MX@]I#FO8[:QP<-A!;M7Q32]]R_MOD?<[YMFD6^S1K%E4$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M3F@?DN.Q^3FP'2^$+_=?=_=>#Q38\=?!V5K56[BM,6.QYH_S97I7ZCN6^O\
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MM./>99(>*.,,IM.VOHI^&KZ=WO+.?@B<)HJJP(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M04*8/5>ROIKN_J3L[5S+,;Y\CPO_ +M,-_LOE]+)C65XS$! 0$! 0$! 0$!
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M0\/N=GQ_%]WAKO\ ]R9W+[W-/=?)#\FM6OO[OI3YVN&X*=/V5)S15T" @("
M@(,7[YR*2-&\D:;1[YDZC^Z5]=^%OUFY^3T/K_PR_A-[/D]#& ^P8-WVB'\J
M"^SZ<^IWOIFV^KCY6WWH_0JZ=3<T[?@/8N9H>S,]SE;.?7OYNQE^_-\J_O>=
M1$]MU!M_E;=>>/B1]Y6_+YWPSQ]_%V_2GTLA-?-9R?/4K>U<?0SN\J93+DH$
M! 0$! 0$'6_JX_@\\S?VN7_W/*B8S>>WF?V8ZR_5G(?=TZK%:=R,*X9M,.WU
M'ZA4KT^==K\E/^$]!V_;C]6R4_DRI#*SZR33IGYM'_Z0RWW!<+=^'<>M;?\
M>V^>&JZY]TZ_[J[S2\T.Q(^6=65%:ZDSE-M*?HM=+]%-'^$V_P"[M_5AX2VT
M?XS=?O)_6EI-4?I8T]HR&-I_=+%GV?WG$?H7>9A\1S3H5W[RS]9Z#7D__P "
M[ET>TV;:_P!RV:\'_%?^KMU]*?/+V1\-OZ;T(_[=OFA=*;N7S+0PL^5]!E,L
MZ$COBO\ Y$_4*QZ>:98"7G9D?O[\LWO>=O=_5J]N_">/_#]OY?Q/(/Q@C_R;
M3[*SZ5JTBK91OWT^BY?7NJ9:7;1TG2I=IS7*GH7_ +YNH:<_.9P._P!WB_*+
M-? /CG]RVSWQYY?6_@Q$_:[OE]#)&\RDTZ6M==OYCE^Y;I>1N+TU;-)8'<)I
M>Y7]4;W[ID4HB:)W5;7O+'T_VI"K.:9[>"_CY!FWF+K4_P"]?^K:!65\K+.0
M$! 0$! 0$!!\_JS;I74P[]/YG];KE3&:^G]9;]*/.\UOG2?^_P"YR@"O^-.3
M]JM-V7O>Q>O_  Y_3FWKER1YH>ENDU_E.W^C'H?!ES3N&WV=NWN[EENI6K?[
MG#1B9['8?HEJ>LOE"6FGZ-0;=A_KVQV4*U?C?#PI?'=Z&AZO6>C7?1GS2]&K
M%?I7C?SA9_<\:\GW9SY7FC4]N[RRUZA00$! 0$%.3['X?K*]O%6<X4W?D\?J
M=^-4?DJS]9"P;Y^G^872?ZH7GY3(N+J?7V?*]>?[3/ZFW7T+6)Q9;;2&N[@;
M^-"PZOM/?NM/^'GLJK2MI%)3=X4GXPK';G\IH?56LE;R!_TDU=\'_P (N;'U
ML^1X5_W9_P ?L_E]+)E65XT$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 00) WH
MFE0D @'>:T^#>HK$( 0=H4\:<1TOZE>OCIHZ4<]I'37-SF%A<'GM:WK++$XW
MY0Q[[GQ'S>[M]YB=>1R6]9 ?C-[$PC-$]SMAI[46%U;@L5J'3E[;9;"9FS@O
MK"]M)XIH+BWN8FW$3FRQ/D97@>":.*BD43B^A4BA<,XXW &A&T'TI%*UG(I7
M"$E>%C'.C!>RH8".)WK:[>U)F*HQB)KFJL/B1CC&_>/4:]E-R3"<>.:HTDC:
M.$]U:T^%1&0BI! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 04);FW@:7SSPP,;\9\TC(F#MV
MND+0@T'R_@A4_+6)H-Y^4;/9Z_MR)I+6P7EI=,$EK<V]S&ZM)+>:.=AH*FCX
MG.;L"('S1NC#VDD$D-(!.T&AV? IC.AECQA)+"US6O#RT,H64KLJ17TFJBD5
MK^4B,9K=/JJAX'M#9&,>P B0/:'@5%!L((/%\*BLYRGN=)NKOR]NE[K4Y<:G
MY>\Y.5^F,BS45C);'-VV&Q=KE[>X\.=L%TV_99ON7.C=.2:FI[TB8G%,32.7
M@\L?SO/)]UKY9'/6Z^0,=?9/D1JF>6?1FHC'.Z*-CIKHMLY9?=88V&.&(#:2
M:A3")A9/T5JS,Z#U=IK5^G,I?8;+:?S6,RUGDL==7%I=12V%]!>-+9;>6&8-
MXH!4!P#AL*(\[V8?)DZR)NMOH6Y2<S\HV1^:L<#CL'DIY9"^2ZFQ&-LK7QI'
M.FG?XCR#6KJU3&(3,1=C*U5\[FCD?Y=CI& F)FI,9QD5H*S2\-56?:B5[?9F
M.#RSK</$D5!7Q"6,&PU<[V6CX7%64JN*<H/*HZU>>>B[/7_+WE+F,UIS(M\6
MUOH+>^DCEC<(W-<U\-C-&ZK90=CBE8XHIJ4K9%;7)3O)*\P]IH.1>?(-:'W3
M)[:;_P#!B5M[4\NK^;^$/DE^8<" .1F?-:_UID^S_HQ1S6=J.76_-_"B/)+\
MP\DTY&YZK-LGYCR?L]W^#-JFMG:GEW'-3D_"F?Y)WF(/:7GD?GG!NS^HLFW>
M:=F,VJ:V1A,DV:M?9_"6_DJ^8A:9+$O'(?44D;\A9A\C+3)?:0;J,<;N+&CV
M6C;\"B9MK2I%NM&,VXP]5SRA^4^N>2/03R1Y><QL9-A]58;#,;D,=<<9EMG.
MM+")K'>(R-_QHCO W)&1EY6(G\\CT+F[?.<JM82,>W$7;'1Q/(=P2/8,BUU#
MP\-6GTJ)*1,Q,9PP<.3):>;_ "JXW\#6\Q-%'B(V"FI<:17Z"DC.KW1NGB8S
M\BN3TG$UW%RXT6"6T((;IO'CLV#<DXDRYF0$!!()&'A]H>U7AV[Z;_H(BJ!D
M )'8WXY_$UW;-YJ5$UCR)<5<\;=UWR?YH6UNXMFGT1J>+B%:ATF#O6BGT>Q)
MQC!,33-X@G6=@;S3/5#SFQ5X7.N(==ZDD)=4%S9LO?/!/$ >U3'<IRTBC(0^
M://8/,:M6N< ]VF\IPCM/VF*M!ZE6?:AFMIR2]4+B;4-J*FM!V[-ZLQ3- /:
M[8#7X#^$B:XTXID&G)^WM&ZE:]M:M^DHKP3$11Y\_P \>USB?E_ECH]LL!R?
M!XCX@^/QFMX<BX$LXN.AKOHISBB)PF)[6"MR_#G:\T.UGQSJ[38;3?Q'-60;
M3X41.4O<0Z$ X=)'(D/KQ#EWI@.KOK\C6.]5MR9-3"[Y(?;]57\';G#_ /@_
MU5^LE\IDLS^27AT<_O\ /5S2_;YJOX?T>OU:<V*WV8>@C\S( _<>YZ=OV^T^
M#[;C4C*4SG%>QG$*$B @\DSYU(2?-JYOU_Y#TL/@%I<)Q(]GY96D/+N_AD<A
M_P!O^FOU\QRK=D1G#V_]'_L1TM^US"?K9:J\YC$&^>+VMQ+T<\N+B.-SX8-2
M3^,\ D,XVR!O%0&@)"I,3,Q3)EM^KN^1YE#FN$;"2"UU>$;*BF^OT59AQJ]7
M/YJ "/+*T>X@@'+9.A[_ &K8[$KP3P9/L;@YH+34;?JHF9K*=$"# ?\ GF_Z
M4<B_7>U^$Y)3P5QB^O!Y_6'_ $SQGZIV'W0Q0GB]H[R4B!Y:W323N^\ZV_*8
M%$9+W>U*ZH'L-:.&P@'UF@ ^$E3.&:O"O!83\\OS?]'^6[R S]CI+,VLW/\
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M.GOHC+V8K\*B,U+J\LO;J\N#^!7R _:!@?ULM%$9,VI[7R0[P*6-Y/OSK/\
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M,_&CM'I7DC5];<<L1C'%ZQMK&E$M6* "F[L7)KVYJ%!4'M&[X5(B@(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M>/\ MV_JP\*[2:;K=_O)_6EI=4&F,83M/RACJ=G]<QKD;'[S[N2[S,7B6/\
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M(9+[N:ZK0]57\';G#_\ @_U5^LE\DEF?R2\.CG]_GJYI]O\ CYJNGH_1V_\
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M96&XM8Y)6W%M)C8V6EW+%*(Y8R*EOV1-=P2;9B8G@GFB;9M8*=K937MY9V,
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MAAN8(+=\-W/?R4DG]X:6BFWUJ)PC')&<TXLDII;<0QR1R"1DK&R1S-(+71R
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ME:^5:,JPO-L:(P=X!/Q=KJ=FP@;04KQ%3BV5H?50U]'94U2:?(1C%5L_S/\
MS$^3WER],VN>;',3+8ZXU3<8;(X_1.BF9"VCR^>S-U:21VL;+8W4-S' TOX^
M,#:6T!WT3EA!$8UF7C<=2/.S,=2//'F-SESHN8+C6VH\IG#;7-W-=FRAO+N:
M>"V;)-+*0(XY * TK6B$UGRLCWYJ=T/:ZY]]97[X&"!]IH3DH^&7,W-[CO$M
M+Z>]DQ\T,=M)<6DD$KQ4?%>"$QX(I$W5G@]3>%K8XV0MH!"QD8#0  &M#6T
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M2/D/5E?C&E-_]J? N99[<O"_^[2/\?LOE]+)B65XS$! 0$! 0$! 0$! 0$!
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M#< -U $FG+CFM$5FC7H@0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0:.ICXJFHV$G
M9M;VCA]21%9K"9I;&+$V^<0>17B>N+2%UU*=/N#M<=SUTM87E[G;7'VK&3ZR
MMK>.\NG,F9;V$DKIN+A%2XDE(B*HF;I\CS)N9W+77?)[5^6T%S'TQE](:PT[
M?7%EE++)V=W93NGMIG1A\0NH8'NC#XW<+VBAHB(PFCO/T/>:UU?]!FM<!JGE
M)S.S<V)Q$5U;.TGE,A?W^'FM;J..&6 VDUV+=H?'$ -A%.Q)3&$UX,CCD?\
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MQ4DD=7($<+9378%:D4S4BZZ/R8GY5B;K]\^7K@Z_,%::/UOK:YTMHFU%TV?
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MW3Y?"@@J]SF[:BM0J1ZL>MFO=-9K:[=M)+02*&FT>E3;%(HA,I! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MV?R+?J-7DW_G/5D^RKM^*W\':HU?:CRIMR19\4?#]4K+=FB,DRA(@(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MP< 1N*D10$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MLO._Q'K_ #*WY?/+X=X^_B[8_2GTLA-?-IR?/$K>U<?0SN\J93+DH$! 0$!
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M0M[E:F*(G#*K4>+!:V\O%-%/;F.0O<'L<_C+26AK >)QKW*."9F)R9#OS?\
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M]KNIOI11,12B8F>.36J1H[J.1Q9)#M>SL["$B:>1%,:M.72RT=#'PN;L)=M
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M Z]_"W>1YZ^NO\X6LA6GZ-9';O\ Z_N%Z=Z5_"V>1YPZS/\ C+_*NH^1]_#
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M4SC2GRJX%!0((H" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MHU>3O^<]4S[*NWXK?P=JC5]J/*FW)%GQ1\/U2LMV:(R3*$B @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M\];7#O\ O!UD>WY9R6WO_-]RO3O2\=O;$]GH>;^L5C<S,9S,KJ7D>_PP,?\
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MVFGT[6C5OLF[FB.&;(>AFCGC$D;N)AK0_"KQ$VQ27D&VZ+XK&2JI6$! 0$!
M0$! 0$! 0$'S&>S&)TMC<EJ#4.5L\+@L=!)=7UY?W$5O;PQ0L,DCW33O8QOL
MM/;V*V$8YHC"*6X3VL.SSHOG'V'Y1,S_ $V]&DT.IN866AO,1?Z[QUS%)#C1
M+!>V%X('6]\RGAN;4.WGT;E6/5G!.<=[!HU/J76/,K.Y;6O-34F0U;J7*W=S
M?SY7)W5S=!DM]-)<31>'=RSAHB=.X#;L"BF&"*TNQQF5X+R*NO/G[TH=7&GN
M7G*[3NH>9?+37&1M\?JG2UD<E+CL1%/<XZV$[98)76K>%GM;!L4SA%93$V\U
M.,O4LP&2.9PF'SLT#[.;*8RPOS9O)XK:6\M8IY8'M.VL4DA::]H44K3\XK-*
M3D^@C!#&@[_PR2I$Z @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(""7B:=M=BBL5IQA,15)X\5''B%&[#79] '>E8K3B
M45"X <1(#0*DG8 *5J2=P 4H:(Y3& EIR-B'#>#=VX(IOJ/$J$$HRV*)H,GC
MR>X7ML3] 25058K^QG?X<-[:32?[G%<PR/\ ]JQY<@U5=M/K'ZNY!#C;LV[Z
MTW]F]16"(JF4B5SVMIQ&E=V_ZR"G-<06S/$N)X8(QODFD9$P>MSW-:@HPY''
MW#Q';WUG/(02(X;F&5Y VDAK'N<0 @U/B-H75V#8=A[Z;J5WJ*F:=2" @("
M@(" @(" @(" @(" @(" @(" @(" @*)[AP#U*<[\!TV\F-=<[M4VC[O#:"PU
MUE[VVC<&ON([>)\H:UQ(:UQ+2*DJ>::80FVVN;%"G^>/=*5L<@U_)K/^^6U[
M<VHC;?P.%S';SOB9,)0^E)&LXAZU7&,H7Y;)BLSBR /+)\S/EGYF?*:ZYI<M
ML'=:?M\=*Z"\QUY+'/+!*UT+',+VN(J'S4^!3'-3L4F+>&*YRPDC:WA^&O::
MJ8R16J9 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 00) ('::T^#>@P.//J'_ (]K
M<4WV-MM]'NMWV+T]\%<.DZL_I>F'F?XR??.U^7TK06"V<T.5=#L^^_!U-/\
MGJR7TSK$3[G4^C/FE\XZ5=;&YTJ_G>EZ3>#V<L.5G[4\%M[_ -!K+;3L7E"^
M?\QW7TY\\O4NTPZ;H3QY?0J\)(-#['9L^CZ=ZR537MS0#=E:<0.XUIN4I1#=
ME6'B</@I]'9M"BJ*TGN0<W82X^UVBGP;QLW)2:UX%<:##M+M[AV;JU%-^X42
M8F2>P#N%SG-'L[*BOUR*[U%)*8)FAQ#F$4'?L]GM'K44DG#%3;&>(FG$WUT^
M%6G**,<5YI[$^P5;7V7?9=U/1ZU6C)CGQ3/+7<)WM%:[QOH!Z=ZFDD5A* &.
M:6GBK6HW?52DF<#FAQHP;MYKW[MZF,,R)PQ2%KFTJ-^[MW)6$QBBXCPV=U?J
MIJ8VX(VOUMT\'$/4*TMY \UME <)<4V_VA=+G="G_-M&>_\ $X/7H_P=\<:/
M/9UU^S_60I2F9R7;7^O[E>G>E_PUODAYOZS;77NMC.LKJ'D>>UU@8ZG]D-IZ
M?;LET/XI8=%GR?C=L^&5)Z];3*)_$SU#^1#^1;]0+R?;--=ZINBNG@J $-:#
MO5=7&Z/*M;DBSXH^'ZI66[-$9)E"1 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!(]K7"C
MJ?":+'J:<ZD4@PXM+*+<.;&]A<3N(JLMD76VTC*$^XB^.;BT-S&VW>)@.")H
M #?C"8.H'!S:;J%1JS%UGK3C#!RW:-U;,+5O#JX\MOD+U;09#+9'"V>G=;7L
M?"=4V]O") \LF:USH66SRYP=-4FNU=;ZATS0ZC,V7>I-V<]OX'UKP5\6_$7A
M+DT]'5NNVMF4<>'&9CL6L</\W*TI:9BVO,CSGFOL9;77C.QWR=PB6+QA(87/
M]TV L'"M5M?!&SVUTS-T4KV?W/K>Y_W1=<U]*;(MU.:8IP[/IKX/33TD\H>D
M[2<>#Y>Z9L;3(36\,64SHAA?=7LL4<31)Q>!'(P$Q T7;-ET_1V>G[O1B(GC
M<^!^,_'?5_%VY]_O]6[W4>S9CAGGCCF[+6YEN#PN>>'B+G.=LXMI(%#NHN?9
MJZ.EIS6:WPZ%ISJZD4M]B&^PNXHVGU@>H&@6.VZ;HYISERYMBV:0J*R! 0$!
M 0%$VQ.,CY?6&D]/ZWT_D],ZKQEOF<#EK=UM?8^ZC9)%+%(TL<"'APK1QVT5
M]/5U='4B_2PNCBRZ.K?H:D:NG=RWQQ6'^HKR">2'-[5LVI-":J?RSM)YI9Y,
M39V<=Q"9)WRR2>VRV%!Q2?27?.F?$#JG3+(T]/&D.^=+\>;CI]L1=$S-,X_O
ME4Z=/(,Y&\GM6V6I]<ZF=S+M[">.Y@Q-Y:1V]OXL,D4K"7/MB'>W%VCM3J/Q
M$ZQOK)TZQ;-S)O\ Q]K[RVZ++9MF8SGA\TKZ^F<!AM)8NPT[IC&VN*PN-MXK
M6UQ=I!';Q6L4,;(F4\)K6N)8P;5T+7U[MQ=,ZDS.K=C,N@Z^YU-SJSJZT\U\
M\7U36 $NIM=2NWN6"W3FN.3%,\$ZS*B @("#32O+7AKQ6-^[L-1M[#7>F<4I
MB1;,S6M(0/&',<P\5 1X=-FW>24IC6[,K'Y.3:<OE\-A8_><SF\7@H>%TKY,
MGD;2RC,; 72/X[N6%H:QK220=@!44YIBI6+;9A:MY[^=#T.<B<WG]*Y7F/9Y
M75F(CG:W'6 @N+>ZO(&3AL#+N.\,;@^:'AJ*;U;A2"9K=ZRP#SF^<V<R=0W&
MIM)\L^5IT_#))<V^'U8VZ\0F!SYXX9FQ^_U'%&6E1;$SA.$D71G$80M$Z[\T
M'KRY@7V5DN>=N5QN'S)G9<82&.Z%+>?Q08VS,OO9K%+38IB*YG-=6M<71G).
MR^9S%[J',ZAU#-E\E(^>^O'Z@RG!-,][I'N-N;HL <]YJE8C"W)'+$W<]V,M
M!+9V5NWWN_K?QOJ/$N;@W+QV5(E<]W:F'',\D8*=L</$X&V=">,@^&V-G$!W
M @5V%/MVCTV?M&O$S9.%/P.3L]MH[S5G1U8B8B)[FOF:R0B4%\[0/9MFL<WA
M--A) V]ZX&]MNU>HZ.XVUE\<TU]F9]#!MMQT[87:EET6\U<,8[55CIXVL,EN
M^+BV&<L) !V- :12I"WFAT_>:_6/>:EFI,\OYMW9Y'7>H=9Z=9U>+_5B*QQC
M\:O\BZZE!DQ&@-59FWDH67]E@LQ<0/!.TMD@LY(R*4W%8)U=AH:U^GJZ<^]K
MQKF[ANMSM-UH6>[B)FF$U[E7Y YD[_W+=:$=A^]K/?#_ %AWK%$5:Z9'8/F3
M "_]RS6CB3PC_%O.^S79798;5AMKS31;!"XP^N+)C/?M#ZHLV3CB<;G3^7@:
MT $FKI;-H% N9HQ,7Q$(X5:"-CIO8DMY;-\?M&*9CXGO(-7 M>&NV4[EDVVG
MI?;KN>V9OIP1=?HVXQ$<_E3$VYD9(Z,>"\$.-=Q:*;O2M3N]AM[M_;?R74KW
M]K/;U#1BVEM(E3G8Y[ VWN;FTA->&XM;J6TFKZ'0O8_Z:YG4]/8;6SFNLFN"
MD[B-:WENH^PY<\Q>87*//1ZFY<ZWU%A=1V[N**]=F<I<MXP6%CO#==M! +&_
M06?4W&VU]GI6Z$<LPIR76S'+E*XER9\X_KLY.9ZVS6IN9U]KG'Q/C+\/+',P
M&"%T7VHO??T]J.,BOI7&B)C+(F/E7HNFCYS5B-4ZU@TYSSY:#1NG(HF1W>J!
M=MDJ\,A#YVPF^+=I+G4HIIVHYJ8711?MZ9_,KZ1>JRXGM.5W,O#SY.(-!MLI
M=6>+=*XMC)CB-Q>4D>'R@4 J5%(G+.%HF8G%WNADANX'3VEQ!>V\M#%+;3,F
MBV4)X)(G.:[X#VI,1*8F8EJX7M?Q.;\7V0*@@D@$'?MV%*UP1.=5= 0$! 0$
M!!1GD$43GN'$!V=_=]-5NNY+9N[$3-(JM\]77EZ<@>L/%WDNKM,V6*US+!X5
MCJ^WAA%U:.$<L;7R,9 \SG[;7;0U[5N^@^*NI=+NG[)=,:49U=DZ3X@W'2;X
M];FTXRMX\.-86B+7YMUHZWR<%W)SONY;>*[\<P'%#VX/'$AMR/=N&AC]FJ[E
M=\3NM7:<V3.<?VXNWZGQ%F^R8BR^+ICN_P#J7K.EGHGY%=(&GX+30.E[%NH[
MFWBARVI'00OO,A+''%&96N\"-\ <8@:#Z*Z#U?Q'O=]?3=W776U\[H_5.L:_
M4KYNK32['=1C@YC7 4#A6GKVK@VS6*M)&2=2D0$! 0$!!2>'BKF;2:5:1O&[
M?O41,5I1%.+9L[@\9J7&9#!YVP@R6(O[=UO=6=PR.6*2.1CF/:6O!::M<0K5
MFW&,F2R^;+[=33F8U;+HNB8G*8QA9'ZF/)#Y,\[=1SZCT3F(^7#KB669]I:V
M[9&>-(^9\CAX=I0!SY:TJ=RK9;'MSZM<WH[PE_N-\1^'=*S2W5UVK=9;$5RP
MB(CC='8^&Y">0YRLY7:ML=1Z]UE]_ME:7$<XQ,]J(XY##)%(T.+K,C?&=_>K
MW1$YS5N?%O\ NC\1=<V%VQV4W:,W12L__P!R^KI'1>FM#86RTMH_"V>%P-A"
MR!EG:Q101B-D;8F"D;6!QX6#L6.;XFEL/,G5>I]2ZUNYW74[[M34NSF>/%]I
M!%'%&UD0HP5I0U[5,3=,>MFU]ML612,E92D0$! 0$! 0$! 0$!!!U>$\.TT-
M/739]-!@I?.5NO7K[Y5:N_<*T]A,SR^Y!ZF,\'WZ8MM[)'J"#AR,3_%NK.2(
M6GAQ#M*BE81-TQ,12F&;"_C$#9[O-W5W)E;_ "+WW.0RU_<ON)72O)ED+)[E
M\DE7.<=@=O2M9I"UML9U=M>C3H:ZA^OWF5B.7W)'3&6DTY=WT,&H-026%Y%C
M[6R=<6\=U.+Q]G+;.$4%P7;';:*<H[U>:D\M'I+>5QY-'3OY<W+["FTPN,UE
MS;EM+:?-ZTR-C:37$=Y-;6KKF*V$]G'(PPW,1H\;:BH2E,L4X1%>*\H!&TES
M6 %@:UI:.%@&P -8-@#0 %,1.96VM+<VM8*- K7T[J[5%:XE*8)D! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 04Y6\3
M'"E?16G;W^I(%('V8A&.+> \[.$5VU'J481EF4X\'3+K$Z[.F7H@T!D]?<_.
M8^!T\RRLKVYL,,^_LGY>^NK:UGGAMV8WWN*Y:V>2$MXB -]-RM%9SS4RK-:T
M8*W6;\\$YP:QN]9:-Z;.7]OI'!227V/PNLI;I[KJYMB;J&*\CA;?/?&)(W1O
MI4=RK2:UJR5B8I,?*Q]LCYXOF:Y')9#+#J7U7:.O+B69UO;RO;#$)I'O\.)C
MYI'!K Z@J=RDBZ<FSP>=?YEMI<&ZAZG=9^,^I)]X>X;?XUSZ!$\TN;.1?S@C
MS).3W,3$ZYRO.[.:YL+2=LM[@<M--[O=L;)&\LK'<1B/B$9&XC:H\F9,S-)N
MR987E[?.[>5',_-LT;U>Z7BY8ON;K%6&/U7!<1W%O<3W+K2TD?)$Z_X0QTTK
MG&H!%.Y(K'>K==A6E/(S).67,[1'.+2&GN8O*_4^)U;HS4MC!D<?D\3?6M[$
MZ"YC\6,2&VFF;!+PG:QQX@K83C/M=IC/'!R<H%.4M:QSWFD;&N?)_(L'%7OV
M442F*?*P ?G+?G=\_>4W.K'],O2UKZ\T588%ADU=G,:'QW5W=\=U"ZU8YMTU
MS"U[0*EE*,4S28I&4G'#VHG%CX=)OG]>8;R.Y^<NM<:LYRY[F+IBSS=E:9[1
M^7N9'6F4QE_<V]O=1$^/$&RB(GAJ2T[0=]5&&4%9K'&(_"]9CINYQV_/SD?R
MTYNV]G\GLUSIC$9B2RX@_P .XO,?!<31AP<[V6RO=3:=BFV*EU+:X.>40("
M@(" @(" @(" @(" @(" @(" @(" @(" @MR>;.UKO+^ZCVO:'-.A,K5KA4'\
MQW'>HE:S-XG>HP!J#.@  #,Y, #< +V>@ [@ I4>G7\T0M8H.C+./B:&NEDA
M?(0 .)[_ )/<YQIO)*4I-2V:V_+/G9>B)$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M9]9>3/\ GO5L^PJGL5=3./*M"#/BCX?JE9KLU8R3*$B @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MG&LDQA2%1C0QH:.Q/(E,@(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M5LCX++&VH<YS1P[9C ) T#LK1,(\A,S.+F&,,MG-9;VL$39![+88V1T[3Q<
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M*5*?.U?"W9L^**#Z%/J**)2>!%XGB\ X]U5(JH" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M.!@&XNKQ=M:?14(C&4=G P.V5K[0[/@&^H1''!  $<33PTWMW^C>IC--9C-
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M1*UF;Q.=2?LBSWZM93[NG4JO3Q^:+ #HPR9[2(O_ -V)7&B?R/EEEVH@0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$!!@<>?4?\ Q\6PKM-A:T^&TNMB]/?!:O\
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MVVBF8R5T8=P5I7:4KPX&415W,MFR".LKN-Y.UW>/L=G8HXS"6H4@@(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M8\<D[&-C%&[M]%$103J00$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M<LAABGN;F>&&*20ROBX@#L"IS17')::S#L.TU:#6M16N[>K3FB,D5"1 0$!
M0$!1.0X]YH_YN=>?M6SGZU7*YG0?O73_ 'MOG<#K/W9J_N[O-+SE]-FG6?E
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M]OU[U1?]6J-^*W\':JZOMQY5[?9^1%GQ1\/U2LMV:(R3*$B @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M<?ZX1I7_ .Q"3^ZW?]H(4GL/]<(TL":\CY/5[V[_ +144[R,>"'^N$:6V?\
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M[WJJ?-/_ /R^,=MK^:H=N[^M[53=A*UL?LX\LLII0A@-?//_ -+>G_UY'_\
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M %;R?W;<*58R>GC\T7_@89'^0C^KC$XD>S\LLNQ 0$! 0$! 0$! 0$! 0$!
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MR?\ \YZIGV5=OQ6_@[5&K[4>5-N2+/BCX?JE9;LT1DF4)$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M/@1@</#L]9KOKO2N%"(I-55 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M>YSVM]MYCF+272#>>U3GBC*:,ECIE^;LZQL>A/G9UF]84M[RZCTQIJ3*<O\
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M%&C5V#V5W?HW9?17TKJ]?LVI]"?-+Y]TZ9G=:$Q^='G>DQ@"3RSY7M^Q^]/
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MWP9LA-+.US'AY+:D4KL3L1;,8TSAF,1QB-\G"* T/?6H/T-J1Y$T5T! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M/D_(V?R+?J-7D[_G/5,^RKM^*W\':HU?:CRIMR19\4?#]4K+=FB,DRA(@("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M877#Y"(VANSA I4JN4_*F8F^,<N+)/81QD T:VK0VE=H!KM]!">=.-.Z&H1
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M4PF<';WRT>F/,=5_6!R_P5[@GY706'S%O>:F#6F2&'W.\L9[4S 031LJ=OM
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MTGMV;5.<5(I&$QBKL+07,![J;-^\E16)PC"$1A-5=2" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M.X&M*U_"5+\V"R:W0U5EL+C_ +S/^,*YG3,-S%$[W&R:Y++7.&@ZP-!>U_\
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M*AU=G?V44UPHK$<5=$B @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M)Z-]VZ5,O=QYH<E0FK1\/U5JM/#4EL.",?V7P?77,N5M55180$! 0$! 0$!
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M]:+-?G3^7?\ O+OUI>Y-ICM=+]W;^K#1<R!30FKSWX#*_K?.%FZ7$_;[+O\
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MQOG>2"[=6G<I[S/+*'>9O%PCBV.IM]:)3(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("#KWU60>\]//-N
M&E>+0^H_I8B\*F,T36F#QN=>5;SLYQ1#?'K#.@;O^6[X>I0M%,IR7Q/FR]?]
M*KIJN_Y&U%]'Y.M#V)V$9W4R>H,B! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 08&OGU4/7S:U[+*V^YKO\ "7J#X+5CH^K]+TP\
MS?&6(GK&UGC'-Z5H?!G_ +S>5A.[[[\'3_KNRHOI/6*>ZOI^9/FE\[Z5$^]T
MZY<T>>'I+845Y8\JR#NTE@NSOPMDO*.I'^9[J?TY\\O4>S^[-"N7+Z%8!M-K
MR#VBAV*R<>Q-2@X7>Q7>?C<7T-U$/PH5!JTOHWL-/C=IV^@H=_%3[!MJ>U6C
M))OH*;=NWO4GE56AW"]OV7L]O?Z?4J*S3/@E<US0T%W%OILI3\%5-L43%)4U
M9*KX1(J#4]U/3WU59S[T<R!XFF@-0SMH-G%Z.U082C1S3PTX@[LV-K3:?51#
M"<4KA2FW;VM[N[;ZE-I"'">*@V_["LM&:60 M'!V?&^CZ?2HOF*1V(VU?>7U
M<1]09+N0/-6NVF%N/N&Z7/Z)AU70COGT.!UR/\'?7L>>WKD?]X6M*[?T9R5/
M1^;KE>F^EX;6SR0\X]7I.]O\JZAY'IKU?8WT3M_'V*Z+\4ON6>RGXW:_AG->
MNV]T_B9Z3Z>&VOXEM-_<.Y>3H^OQR>J+J\F&:JWXK?P=JKJ^W'E6MR19\4?#
M]4K+=FB,DRA(@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MB?DGALX_Y/A'%_Z2+*B @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M*$B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M_P#0N_4E\RUZ_P"LNG\OY\^=Z2^@OV#:-_:KI[]:+-?G5^7?^\N_6E[DVO\
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M?VBI--WP&H4F>>0"UO#0\=/B]G#7?ZZU0QE,/CN:[VN("IW;AW!$<*I&/+2
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M<72K=J31JK*H<\]AAFIZ^ _"N1TV8C<0R;R?4F5ESG'LZO=!&M*ZNQ>VE?\
M#,*^D;/'I&ZG_LW?JRZ!O(IUG;?3CSO12Y0'_NJT#Q&M=*8'VJ=V+M>P+\_>
MIS3J.O\ OK_UI>R.C1'\LTOW<>:')<6UH-:[_1VE:JS'6NEL8]E57(! 0$!
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M@B>Y)LHW9MVUV[^[Z"CE3%:I)&.HWNKL;^)^'M4ZE(B*9(VOUET<7$_4-LY
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M :UQ.H =A[<?:!6C/Y#&+9GO>H6H0(" @(" @(" @(" @(" @(" @(" @("
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M<\^==WFKX<--OVF+\K:OG.EG/EGSN]7Q6R/D4=VVFTJNIFX^GZMU8XM79;W
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MDCH)8+62-YC?'&X M=L["HF:RB(Y;8BM5Z:*H!:[:YM*GOK4A*UE;"F"JB!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MQ#X;QB[;B)8&M%3ZE6G-$UX$SRTB(=@XW<; XBA/9VJML3$8YK5KBG5@0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M?ULMG.2HN2@0$! 0$! 0$! 0$&EEXG2L!<&Q,!>\DC:!M-3]B D79PK,5FC
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M=?NKOU9?/]]$3UG:SQYX\[T5>3]'<J] UV@Z4P'H_P %VJ_/[J6'4-?]]?\
MK2]D=&QZ;HU_Z<>:')+#7:?P;5JK(IK70V6=JHN0@0$! 0$! 0$!! D-%3L
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MC7L :N^[?2C;;6^F/J7>:7S_ '&M]IMLTL*<]OG>DSC2V7EMRG?;/9-"-(X
M"6-[7M+AA;+B!+21L*\AV\UOB3J&I3.^?/+U%M=.-3H>S[+;(\T-2X&@<[:>
MUNZE1LVKG1'%DCL[$-KJT&^E1L^!2E$'<:4#:UVUW_3WH)N*M:"M.VM/JH)6
M'VZGT_4]"2B<D:4(:_XFV@]/P;=Y5#A6,TH:0_A(KZ*TJ-^_T(5PJ@\ .(&[
M9]1.*8R1V>T6]E*?#OWJ\=P@[TG;VCN[O1N01 :13[+X?]C<@$/._P"L@E'I
M%?0@I1BH<6MHT4._ZGJ6/5F*PY&E.$QQ<0=1UU#;=.W-B[O)1#:0X2YXY74
M;6QN^TT"Y_1[XCJFC7M_$TG7[?\  ZDVYT_&\]K5E[;WFM]57-H1/#/F,J!(
M-U&WUS4UJ1N*]+]$B-;0B9X1'H><NHZDZ>M?,>S65U?R/;6>;J[L'6T;YF1W
M(,CFM<1$#)9':0"%T'XM71MNGVV3[<Q/I=U^&%M^\ZC-\?5Q/XF>F6_:VN(H
M1&P#T&FT?37E+<VUBL9U>I=.N494.#CC8*5&TG;3;79W+/H74LK.$HU8GFP:
MA60(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @@XD D;_XJ2-%<
M06]W#/;3\,EK<PRVUS ]M6RQ3QNBD8X$;GL<05$3.<S4PR8"OGV="MWTW]0[
MN?FB<$^UY=<S+E\IL<=:O-CB[N)U[+>OG=;VK(8C/(>*CW$[5:M/)*+JSCQ_
MM18?O(&WT,0L;@V=RQ\%]87L8)='-:N;<<,;V[8R9&@;#L*3%,<RD<M&;9Y
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ML8;,S^#;Q0L#I?!J3P@I.,X903=CCF^^0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M?VOY?[@N%R>F1S;VR(_ZEOG8>IX['4^C+SNLTX?Z0+4O[9+[L[LE,O?W1L?
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M:;2IB)BVJ)NB)IP?4*JX@(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MWLB=0U-25/-A@F8KY6#5&^22ZOK#+6DMEF,=<7.-OL?<1OAEAN;*5]K.9(I
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M$=O&V5HX&1M+C(#4AH!/8HB*8)F9NFLN2R&<;2?C&M-_8-OHW)-*H3J00$!
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M9\L3VM!<)F@>T%&ET+JFC=[V[1I$.#J]2Z;O=.;?>^LM=<B^66N^MCK0TO\
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MR*VC:75J'4H.ZE>U128SS6K7+).I0(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @HOJ'%S@',I2
MAIN< #4=H*B(FO<,%GYU+Y<O!<8;KKT+&ZXRF$I;Y?!8S%^$PET=X9;FYDL[
M.DGB AQ=(^M:I%:]TDX17LX=K"_L;T7]JRZ) E#1[Q&!\22@#FCO+7;"I,\6
MK9[8JT\7>=WTNQ!,X<.T[/P>A!MF3NC:6SB125Y$%M4@>+<7%8X&@5VDRO 4
MQ!7Y&>Q\UA\OK%<NN4^4ZK>9>B'V/-35_"S"9>\8\2"PFALW&>%LUJPGBB
M(>:5436M.Q/Y-9SEF,D D'M%:>BN]11  0-IJ>^E/I)'>(J00$! 0$! 0$!
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M:U;?>1A$_P!NQ?6^)?B/1U)T[=OS4XU_O0'F]^8"1MUU,T_SDFO_ +YL5O\
M\*/#?;_;YE(^)WB6F.VQ^E_>C_I??,!X?V=34_$>":[^_P!\4?\ X3^&^W^W
MS'_XG^)*5^S?A_O2N\W[K_: 7:ZF 'V/@GM]/OBF/A/X<G*?[?,K=\4?$=N>
MV_#_ 'I3YO\ U_"G^/DQKN^T$4I_QSM4_P#X3>'.W^WS*_\ XJ>(*5^SX>7^
M],?-]\P(AO#KB;M_F)_OQ/\ \)_#=*5Q_MW)_P#Q0\2UK&UPG]+^].[S??,
M K]_<VSM\$[#V?UXJW_"GPY;;S5R_MV,NE\3/$,ZD6W[>EDYSS9?A0'F]^8
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M>*HH2(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M.*&)K8XF,:*   *9BF/%6,<(]F&K\,5=4U#J;-V[=N6.;:Q1DK'",5165$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M0.\4^AV[%2G#@R5M[$HA (JZH[12E?II%8G#)%<**ZE @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M*GB=G#W'N3EBE9]HF:SADU* @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MD7VTACDBE#'!U['$1]H:-H3/-,5P[61=TF_.4\_BGLQG57IC@MX(X[>7.6O
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M3VE<;C\-@<; RWM,7C[."TABCC:&M $$<;20!OI5*85B29F+J3#ZM$B @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MCOKWI-"*Q\JJ@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M]96SI&S7IL<I(T")SFN>![DT$<+"=Z9>R4NC&[)PX_.6,<QM[BWR(R0<6/\
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M_I*$XTH"M-IJ>^E$$4! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MH3,108"?SR'^HN5GK=]7(HK.; IY:?YQ^7_[=M*?K[8(O&;W,.D#^#-R3_\
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M6N]"^M\T_P#_ #*=+;/\'W6VN[VK7Z*F<R/QO5P4H$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M>G1MD?\ W>!1'LPF?:GR^B%RQ2" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M+2]Q=_;26\L;G .$S[=@+6OC-' TV(B*3EG#6:(Y]\Y>765Q&8TCS*UGA[W
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MZ'/*,Z/^ASECHC2.BN5^G,YK#36.MAE]9Y/&6%[D<MF/M+[F^\2XLV/C8^6
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M(" @(" @(" @(" @(" @(/+H^=\?P]<-^UNV_&2JL>U+)=[%K%3Y="G,308
M_P#G/2]/^N['ZZLQO<GZ,Q3I=Y'U_P#LXTE^L./41C"9=G%*! 0$!!(\D#8:
M'OWT^#TH<*M,X22AOLT-?;J-A W4KLVA36E+9R4F+J<UN$H/CB?Q6LD0GAD:
M>..:+Q(0VE"UP>"QS7=VY)G#O7F9F:NA_/[RS^C'J5.I[GF5R4TG?YW4UK)!
M?YRWQ.-MKX2NCFCCF$C+1WM-,SB=FU5Y8B[FE//,V\D9+!_,/YH9T1ZHN-2Y
M#36H\QIN]R8O9\9!$UONF/NYQ/)!6..WX?#;*]M:-)H-Q4YSCD5B+*1'K,;_
M *B_FG'6QRPQW,/5NA+BSU?IS31R.0PUA;O=+D+_ !T#KF5G#%;VG'401L^P
MK5U-Z3^!$=D8RQ?.87*[7W*36&5T'S#TSF-(ZNPEW-:W&-RUC=XV<26\CXY)
M(3=PP22Q<;#PO H5'F1.,UKC"Y]Y2?F>\^^@/J0T)>:6UYESRVSNH,?BM8::
MOK^ZGQ,F-R5Y8VEW*V"YOHK:W$$$9KLI2J>UEP3,\L5C)["')/FYI+GKRMT/
MS2T'FK'4FGM68+&Y!F1Q\\4UNZXN+"VGNHO$@DEC$D$TI:X!QH0HCUL81=ZL
MY9N8@K):.[$I\,QAQ <"YK:[?H=@3FBW'B4K@XQYH\F^5O.;$/TUS0T+@-78
MAP/VG,8NRO WQ&.:X1ON(9'L!#C7A*B*W9Q16;HB<<EC[J_^;<= /5/DK3,V
M6C[?EQD(JND?IVWM;>.5[C*Z0MCAM8W-#O$W5.Y3.,4A>M;IOOQFF"P]UN_,
M]?!MM/7O1]K22XN2^9N:Q^;>V/PPULOAN:YUJ>)CZMW.!K7L44FG>B9X\/(Q
M:.O;R=.L/H$U%+C^9&@LOFM.0VWO+M48;&Y"]QD<;FROXY9X+/P8HS'"7!W%
M1(K3'"3O_)A;/T5K/5O+C4>*U?HK4>6TQJ33E_;Y''9+%WMW875M>VDS)XJ.
MMI(9-DT8XFDT-*%2BN+T[/FV7G1:EZYN6D73?SWR<F<YU\O<8R%FJ;@\-QGL
M1;PVEM9.D8ZZF<Z2&-IJ[A%2"E$YX2RT(F-C:V,.XG-#@#V]QJ/6$K$Y$12'
ME2?.P]+WN*\QG4.;?;3LL\Q9Q/BG=%(V%[P^\=1DA8&.V [B4XIK'+3BQZ>F
MG0F%YI\]N6/+O4+Z8/6.K<#A,LX'PRR#(9.VM'N#PTEI8R;>$12CTAL)\T8Z
M!\K@,!DCE]0"2^PN+O)I(KR1T4TUU80322QDPCV)'O)&S<56DSE."\W6?FMS
M_P!4'Z"*@_+&I*?GE^W_ .Y)2[M.:SL1_P!4(Z"/^5]2?W2_^E*<2MG8A_JA
M'0.!MS&I/7[R_P#I24FE*E;>Q ?-".@@#;F=2>OWE_\ 2E%)[3FL['/?2[\V
M)Z-^E?GYH+GWHK+9JXS_ "_R!R>*M+M_BPF\'"&2DNBV%K*CU.3AC)S6TPCU
MF2Q$T0,MK<>RV..*%IK7B;"T-;ZMH2<XKFB8G&F3SM?GIE/W4.FO90^Y9C;7
M?[.14QG*;O9M8?71K_"9Y._MXT_^NMFD\/*K#V[^G#_,;RN_:5IS]:+-7NS0
MYL;N'X.U53.:*(6+?G'7_E-=17YWQOY3D4'CO3_D\W\]D_'E$SF])/YF+_!O
MY^?MDP_Y0Q1&<C-@4H;3GOTCS7ZDY'[CF1,9O%B\Y'_S!N?'[9+^O_6V34Q2
MD(NK[RZJ\=\T.'_Y0*^--GWMWOY5$J\:)X?*]252@0;?EOTJR?ZGWGW-(@\:
M+SU:?Z1SG>#[(^6I_33]$<E]5.$(GZR[Y%R;YI<!_I (/SI!]T6J1[7R+?DO
M5'1#I[UV]1=OTF=+'.+G[<MCDDT-I7(7E@Q[VQTO);66.U+>*6'C>RX(=0.K
ML5*3$3/&J8I6*O&(ZS>K;F=UG=0&N><'-?4N2RUYFL[DI,5!=7EW<6F)QS;Z
MYDM(+:UFN;B*+[5)0\%!M63!"Y?Y*7DR<R/-+YP>_9JVR6E.0>CKBWFU;JIU
MG<Q0WS"^$>XV$LEG)#<.E9.#5CJ@^A1&5*IBE:\(>B]TF>0OY?72OIIF'P_*
M7#:PR X"_+ZAM[3(3NE,<0NI*S6O'Q3S1\1JXTK112N:W/-LSR>SV.WKO+2Z
M(2XN=T_:#XI:U'R)CO:IO_K;A4<ML8)][?GA\S09'RW>B3'X7.30]/VA6<.)
MR+Y&MPN-$A:+*8D,<;5X:XM&P[:%3RQ.$GO;HRI\SR!_-#P&F-,]='4#@=%8
M6#3^G,9K/)VV.Q-LV-D-I!#=3Q\$;8V1L ]GL 4Q3Y%)_"R OF@8!ZS,_3>+
M&ZKZO=L<G'YU>WY/.]/1$OD.87[ =<?M0U+^LMZB)R>'-UP_PL>>=#3_ +Q=
M5;?^F[]0O/#R+['S3_\ \RG2_P"I]S^.M5*)S^=ZN"($! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 04+K^IKC^<2_E;D'CI_.)O_-3Z@OSY9[/^
M,9!1'!2WVKG17RYOX:?3[_\ A%TW^NUDHO\ 99]/VWM^Z2_8KIG]K^&_6ZV4
MQDQOH%((" @(" @L/_.,.=F Y4>6!SWQ-SJ48/5.N,/'B=,1PW)M+VX?2:6Y
M=;NCFAE($<1::$D\6Y)B)BDG-R>O&4/'UE?->7DKGRR32W=T[BEE>Z221\LI
MJ]\CRY[W.+MI)J41.>#T^OFEG0?D>G?I7U7U#:A]QO+KJ =CK["2R6=NZ]QU
MACX;3Q(X;EULVXCB>\ $!Y#B-JC&O<O-)B)C-EW,)+03OV_5/<II12$3NV&G
MIWI%/D2T[8RQY=4!A^-VU[ /HI2VLW4QDQRK@P?OG-7DZ]3'63S7T;SJZ:.7
ML>KLA9V)L=0VUFUMK++$&W0C?(^&RD=++4,-7..]12F,Y2M,S=2(RB&-)R8\
M@KS8M <T.7>M[#D=E,7)@=7:=R5Q=VV1NX9;>UMLM92W57LL6.+1 UQ(J*T4
MUMKFK,7TR>L!R"Q^IL/R7Y9XK6<+H-38W1^GK+-0RR&1\5Y9XJTAN1)(_:YS
M)8S4G::*(QI*9G'RO.S^>*<\;?5_4CRIY9Z?U7)?X_2F+R#LYA+6]<;:#(F:
MYCC]X@BN7Q%S>-X'$P%3&$RFZ(I':Q6>C[D'G.IKJ0Y6\F< &LO-3ZGQ,,G%
M1P%I'D;,71/L25XHY*4H=Z13Y%/6G"WVGM=]''(RSZ<>F[E1R@M(+*+[T=)8
MBPN#96L%JR2Y%C;F=TC8(8 ^02U!<6U-%$1RX1BO==S36E'9Q2JTSH*O#@:#
MZFS9V[5%;HGU9PE$VVS&,. .JKE+I3G9T]\V.7NN,7!F<%EM%:EE?97#8G1/
MN;7!Y"2T>[Q8Y&-X9>VE0IB*S229IC&%'AX<]\%:Z8YT\U]/V-J+2UQ6O-78
M^TMP1PPV]KG[^!C&[&CA$<8 V!(E$1A$<6;O\SKZLL!A,[K_ *9KF5@S&J0_
M*6<+W-:YWN3;*4R1M,P+J-XAL85%:8+Q%:SV/08#1XGM':"?#'<-M=OI4W5F
MDHK&3 ;^>1'\P\JQZ7?5R*B,Y5NC&)8%/+3_ #C\O_V[:4_7VP4KQF]S#I _
M@S<D_P#\'&D/U@QZB,DW^T[)*56"E\]3_P W'3!^?<[]3(*.*>#SUM(DG5FE
M_1J'" ?]96RE6<GM5>4+_P"7OTZ_M-LON>W2,H_MQ3/M3Y?1"Y8@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @("#RZ/G?'\/;#?M;MOQDJK'M2RW?5VL5
M3EV1^Z+H,TH/OSTMZ?\ #=@K,4Y/<GZ-?X+W(_\ _!OI']8<>HC),YNS:E @
M(" @I2-XBUI- :DBF^E/H*)[#S,.?S5_G,&J_+\ZQ=:=-6.Y0#4-CI#W4NS,
MER(O>F7'O(XFM=>PFC70C<WM5HHB;IMPMMYG47IZ^=\ZFYK<]>77+?+<D8;'
M":QU#C<%<WYOHP;:3(W]M9Q/ ^4274$Q/P*(PQS)OFE)MIWU9W>#O8LOB<5G
M&MX!F<5CLDR,.JUHO;2*Z#002#02[ZI,3'EA,4NHWQ!0N UT99(V-T3P6RME
M8U\;FG9PO8[8X.0C-A;_ #LGR\>56O.2& ZIM(Z6PFF.9VD#<Q:AS6.@LL:[
M.XN.TFDM[:YAM[:/QYVR1DND+JN)J=NU13'!-8Y?TN#S7GNDBD>WB+9(I>$O
M::.XXRX<37"A!!;V*4/7:^;$7MQ>>4CR(;-<W5R]CLO2>\N9;J6KVV1H'S/>
MYK&_8M% !L"KQE:8I2N:XIYCG5KJ'HDZ7M:\]]/Z3DUM=:7MW7!L&2.C ;X%
MS-Q/+7L'#]I VD4JK84[U;[II';###?\\YUZR*X:_D'#'=0RW48B]^8X'PGO
M9'[7RE3VJ!3$1ABK-]^/J8^5E1^2_P"9W<>9_P!.EWS:S.G++2>H</D)+'(8
M6"^@N9HS1A#W1,N9Y&M)- 2 L<Q,UB)7CV8FZ(KV+R\7Y&W93?L^%7\JL3$Q
M6(I"9]0TD'AH*UI7=Z%$I<-\ZN2W+?J#Y;:OY9\R=,8;4. UC@;_  ][%D<?
M9W,\,<\+HHYX)[B">2":%[JM<W:!4=JFE2LTKV/&:\W/I7TMT9]>O._D+HRX
M\?3>F\V^]QK14-MX,G>7LS+5OVN(<$ 8 *-  4S7Y2)BZ<(P=[/FV?/'4O)W
MS!M%QX![VV^J98<9DHF@N$EM->64+FN >VHX)#OJHX)BM8CA+UT+1[I[:UNQ
ML?<VMO*\;-[XF/V [!O45B+HB>)C1@F_/.>2^(M]"\@>:^G]'2S9G(9?,V&J
M]16=E+-X5O!!</LG7LT-N\1 OF(J]X% HF:3$0F*3C.<//ZT+K'-<N]7:9UQ
MI^X-MF=-9C'Y>PD%267&.NXKJ,['-I5T([0K*O8\\D;K.N.M_P OOD]S!U%J
M2QRO,O'8.VPVL+*&Y@??6$N.M[6WLS=6[+FXF8)+4#:ZFU(C#E+L8K&:\ UK
MFA@+J.I\>E:T&W8F%"8NRAJD&FNVA\+FNKPDBM"0=A[*;=J1S?DYHEL66U#I
MS!Q0'/ZAPNGFW1:RU.7RUAC3.XGA:V(WUQ!XCR[8 VI)2G)6V9J1$3BW.&6L
M4,T=RRXAE:U[+J)S98IV.%6.8]A<QS2-Q!((4Q%<YQ1/JSVPU0)>\%M"*BI.
MROI /=11A\JT\UMU(RXO.O\ GIA/[J737MJ/<LQLINV9#M[5$<4W?D^26'[T
M;@_OFN3@.S_'C3WT/E6SI]))E7.)>WATYMX>1W*X5K_B3IS]:+-6F:D.:U"1
M!8M^<=?^4UU%?G?&_E.10>._/^33[/YK)0]WMN1,YO22^9B_P;^?G[9,/^4,
M41G(S8%*&TY[](\U^I.1^XYD(>+!YQY:?,'Y]$;/\9;ZN_9^BN3[U$907>W<
MO(_-#6@^8!?NXJ$:;O:-[_M<5?H)Q6BG+B]1MQ E/$:MV5%#L]G9N[RIFE(4
MB<XX-3O1+;\M^E62_4^\^YY$3&;QHO/7_P#,=YX?JU-^N.23A"L_67?(N3?-
M+O\ S (-NSW2#9_QBU2/:^1;@]4=$,8KYTUS?S_+GH%RFG\7),VPUB^ZM<G'
M$7@2,@M+S@$G ]H+1Q5V@C8HSNB.!=/+9-_&'E!2O\1\SSO?,Y]/Y-SB5)C7
MN>NC\V%PUC9^4MR0RMICL997>5=E#<WMI;6C+ZZ=$RQ#3>S0QMN)2.SQ'%3.
M5(*8=[(3LXI&<1>_:2:L[MNP_#1+JUSP5MFL5F*2URA9Q]S,U7I[0^@=::JU
M1D+?%8/#Z>R]SDKZZD9##'%'CYWDE\CV,!H* 5%24B[FPX0713'M>)KYE&M-
M,Z_ZV.H#5>DKZ/)8#*ZWS+K"\A+713!N0N YS',?(TBH.XE1!,\U)AD+?- R
M\=9F?H?9-C= BG]KX]36D_.CM^3SO3U1+Y#F#^P'6_[4-2_K+>HB<GAS=<=7
M=6'/3M/[HNJOU[OU$9+SP\B^S\T^_P#,HTO^I]S^.M5$YP1^/S/5O5E1 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$%"Z_J:X_G$WY6Y!XZ7SB5
MP/FI=05-WOEGM_XQD$I16V/6N^1T6\N;^&GT^_\ X1=-_KM9*M_LLVG[;V_=
M)?L5TS^U_#?K=;*8R8WT"D$! 0$! 08/GSSK,7]KR:Y"XN&\N(+.^NK]\]O%
M/(R.X<R7)4\6-CPUXHT#:"HG\*8XQP><O9.+KNQ;W74 'PS,^HI1A5[)WD$,
MF9Y6'3?'(.)PPDP:W=1ACLB!\!)*83..29PIR]B\VUH:-@IN[:IPHA%U:&F_
ML_!Z%,9XY(G+!I6P2#XSRZN_N;3=O.VJCC5,)Q "")>&8.W\;&NW;MX436<B
M,$/=H1\6"W;2FWP6;?4 !2BFA$]N30Y8/AQ65G:>%[,7?%H&RCV6TA813=3A
M3L3$SQ>,;YW6K-1:H\Q?GN_463N<@+/4%U#9LGFED;;V[<AD6M9&U\C^'XO9
M13/!7\J9G-T'Z=N?.M.F3F]I+G1R]NA9ZKTC>MO<9(X%S0]LD<A!HYI^/$T[
MQN59BN'!/9,9L@"7YU?YE!\)L6L+:".&WM[=D;(96CA@B;&'&EV*N>!4G>2I
MC*AC6M94!\ZL\RP?_.\!_P"#F_OQ$X]LJI^=8>95['^.=O[-:_:I=M?^.)@K
MZU:U:2_^=0^8_E<1FL+D=76]S9YO&7V*N6&.9I%MD+26SG#3[X=IBF.U,>!,
M3,YX,<C7.L;[7FK]1:URU'974V6R&7OZ5H+K(74MW.X;37CEE)3A1/'N9'?S
M4&65OFI<OXV2O9')IO5'B1![@V3ALH>'B:#1U*]H436L+12DO6"J1)M.USO9
MV;P#1P]% IB<X5Y>+ <^>14]QY5T/:ZO_P"<4CBK=G# HY:?YQ^7_P"W;2GZ
M^V"+QF]S#I _@S<D_P#\'&D/U@QZB,DW^T[)*56"E\]3_P W'3!^?<[_ /O!
M1Q3P>>KI']E>F/VPX7]<K93&:LY/:K\H3_R]NG0]^C;(_P#N\"1%(3^5/E]$
M+EB @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(/+F^=\$_O]\/4;/O;M
M=M=_L2JL>U+)=[%K%0T'=6EEKW15[?3"UL;35NF[J]N#[0M[6WS%E+<3D&@(
MBA87? K,6</83Z;O-S\N+1'(+E!IRYZF]).N,7H#2UC=>]RP03QWUM@K".\@
M?"V=W!X$[2S>2:5V;A6)B,&6=.[ADYF/G3^6N!Q'J:T4!6E?>H]]:?[JG-![
MJ_L2_P"FI\M7_P#&;T5_=+/Z8G/:>[O/]-3Y:O\ ^,WHK^Z6?TQ.>T]W>B/.
MH\M8F@ZF]%5/]LL_IJ<]I[N]O^D/. \O/7>J\1HG2W47I#*ZDSEQ':8S'07#
M#)=7$LC(F1L/B$<3GR #UJ:PCDN7)X+EEU!;75N]K[>YBBN(9 06RPS,9)&\
M=P<QU?A2OJ\TYJ9^1Y]OSNCRYLI!J+$=:.A\%=9:/-!T&N;NRM)I?DQMJV^D
MX[IT%FX%KQPN!?)13$=^),SGE;_:C!=T#K'+\OM7:>UMINX]TU!I7*6&8Q[^
M"M;K'W45TT[Q0M?$G%$UQB.+TX/):^<A]/'43R.T]RQZL-8XSE?SOT!:8;33
M;_+W#&V>M[9OAXZSR<,DMW(8)15D9! !#:FA&VM>,KQ;6G+V,K' :\T9J?#8
M[4&"U1@LEB,M:PWMA?6V5L98;BWGC;+&]KV3N;M8\&F\*V:KX3G#S]Y.\C=#
M93F+S5U_IW2NC\*UK\CD[S*67AQAW$6\+?&$DAHP[&CL3O3%>#SZ?G-GG9\G
M>J/#Z=Z6NE?43=6:=QD\EUK+6EC<.CL[XW%M/%)C88X[MS7QVSP:.<VK@ZOH
M48UK!-T<LV3E.;"AP."RFJ<WB=.X:TFOLYG,I9XK'6<+'R2W5[D;EMM;QAC&
MO?5TTK1L!V*4/9 \A/IMYB=*_EG\B^5_-/'OQ6L8<=+E[JQD#@^&US%K875D
MUP?%$X$1&FT5V**85A,S,12<W=[KIY'W/43TH<Y>46/MXI,EJK1V9M<?%*QD
MWYL;87+K<,#XY?;=(0!0$[4F)FL)MF+)B[.CQ1^I3D5K7ITYX\PN4',7$7.)
MU)IG4>5M98KF&6 O@;?W38+E@FAA+F2L96H;1/(I/S71FO/^0AYP9\LCG/DK
M#F$V]S7)S7\EK896Q%U+';XB22YM8),LR-UW!"#;Q-XZ%I!+?2K1WYE8B*SF
M]0OI9Z_>E3K(TZ-0\B.;.FM5PQ65G=WUF+^TM;ZQ?=P03&WEMI;CC=)";@-=
MPU%>U1VTX+<LQ$3PEVS?GL%PO+\UB&-:TN+SDK,!K6CB<YU9@&M:!OW42)HB
M8B<\EG;S _.IZ,^B/EMS(OKOF?I_4?-K XB_ML#HC&7UO=7E[FY(+N.T87P7
M<;6,BNH-I!K6@&]1EDFM<9R>2IUD]46M>M/J-YB]0FO7@:AUSE;F\\$DGW;'
MLN+F6SMG/+Y>(P134^,5:9F<U8B(R[60S\U)Z3<CS@ZS/W4,Y@+N71VA8!<Q
MY9UO+[H^^BFLY_ ;,;=\-:AH^.-I49PF)F)[WJ51PF-K&1^PR&-D43-A]A@X
M!Z![*KRUGFXDUHZ ^9IT;677!T?\U^1AML>_4V>P5V=)92[LK:ZGQV5AMIC;
M^[.FMKE\;YW/+/9 /M*:5QNS6B8IRSD\:KJSZ7N9?2%SQUQR1YK8:\P^I=+9
M6[MXC<V\\,>0LQ>3PP7<+Y8(&/;-'%Q>R*"JF(XHKC1<>\FGSB>:_E9\[+2_
M;)?ZMY)ZKO+2UUUHA]_<-MWVTD]I&_(6GB7D4%NZRAA+J!NVGP*)CCQ1'&'J
M&='OFT]%'6GC],1<JN;VGI=89_%6UY=:/O;VTM+^PO7V\$US9$R7+FRN@DN
MT$&KCV*>[BMWVS6V%QWY>P8WYG$UW_IC9[N_\F48T[U5MOK$\W'HFZ+;35UA
MS7YMZ?AUOIC%/OF:,M+NVN<A>W;K>>>SLPYMRUD9G= 6DDU:>RJFM)IQ6I-.
M;@\T[S://>ZA/,&YX6V<Y<YG47*KE;H?)3'1^G\-G,C:NN?<;Z62TR-W-99$
M1R-GCHXM-*U2D5K"F3)A^;7>=UU.]5&LV=*/.[2>6YA6&*QF+BPG,UK+OP,%
M;6S;:P=:9"ZEDN&3.>&EY#B#5P-=I4<>Y:(K$UQEG EGVR,!M?#VD\5."M:
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M+Z(7+$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M+-,?MAPOZY6RF%9R>U7Y0G_E[=.G[3;+[G@2,H3G=,]_HA<L0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M$&D$S@YK0!P"O&:[16M%-)F*R3$1=2)2-GG:]_'&>$GV*;:A128G,B8Y>]J
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M7ZM%$=XF4@@(($AHJ=@" "'"HV@H(H" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M=9)PS?51S0SL#X)HI6N%6OB>R5I&^H+2000K(5!4C:*'NK7Z:"* @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MLV4%$S)SBZ<W5^3KCZM&@%_/#7[0=@/WRY?^_2D=B:J7[^?JPVG]W'7_ /\
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M3Z!0*;IC\G-2*UQR5@"!0FI[Z4^DHBM,4HJ00$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M6DOG#-O'/Y77/=LP+FBP@-*TJ1:9#?Z%,4K16ZON\7CI7C6LNKIK11K;FX:
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MYZ<UV1-X6_?YJDT])S=]4D]IV*\YL&G%+,&4=\SZBC=UQZLE+?MC--EK75W
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M\0I6NSX5-)K3B<*\$>(4K79W[MRC(C'%*)&%O&#[/?O[:=B"=1$Q.0*00":
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MV]F^O<HG#,1#VD@ [37L/9\""8.!W&M$[Q% 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MJF%+O8>.???U9=_GNY_+2H6>E?\ ,X3_ .%WF>.[)Q_EMBH@EF<SQ1SPRP3
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MP*9F:)I#AGJBJ>GWFYL_^0]3T]/Z"WI42M;G\CP].I.O[O/->@H?O[U3W?\
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MO(+R/BIVN@DD:*>M)G"B*4G!N43ZO'& 7.J6/!^-LH01V$!*1'E3GC&34/)
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M[]HWU5(S2F4C'/\ G,O(_$<W_+TUC=Y-O%)I(NRMD:T++B&VO)XWCV''V7Q
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M]"C+):D8588W4=\[[ZI<KS.U!+R'P6*P?+MSY&8:VOK5C[D,?XP:_C==2O'
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M9KP>A>"*@5V$D!M/Q/QMOK1+RIOG:O\ YEF=_:WA/N:95CVI7GV88WG(T?\
M?7RE!_\ M&T3L]6I,:59CB:1W/=&Y(-$_)?E&XT!;RXT7394"NF\:-R<TYPF
M(B(I+E6.(1@@$FIKM4HIC544)60_G )</+KYNEKBW]#9Z^G\P9%1-:U@F*X/
M'1R?Z99#\_7?Y?(I3.;U<?FI/_EH:,_/D_Y7:*L>W*?^5'EGSLGE65$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$!!\=S$_S?ZY_:=J;]9;U$QF\/[K^/_B_Y[_\ X0-1_KO>J(FJN:[/
M\V)_\SCE;ZY_R^Q5N$HGV[?*]<B/\CC_ )!OXT*%DZ"G* YA!&SU[NY3$5FA
M.$5:-\T4+)99IXX8X&&>>YE+8H88(AQR/EE>0QK6L%220 !7L29F,.")B)BM
MN%SS#/G9/71RNZB>IW \D>660MLZ[DT9+/4>;L+EES8S9&9M]'/:QRP7,T#W
M6\LE#L![PJQ.$SPDNQNCMMPGO8IO*W1&H.8G,31FB]+V4F1SN>U!B+"QLXFD
MR/EGO[>/8&M>7<(=4T!V!$QW8O:Y\LKE=J'DUT-<@.7FK;)]GG,+HK%,OK1_
M$U\3[BS@F:UP<R,@@.[0%%(I2<$W3,36,9=\WL;0,<:4I1WK/T!16K-8F$9Q
MRRPX?G1/F\WG39RSEZ2^2.LG8;FKKFQ_QGR6&NFF]QN%N8+JWF@\:SOF2VLC
MXG@;6U#CMW**XTX%)MI,9R\U -S>J,S&][[_ #FH\_D6MC=*^>_R&1R-_<!O
MM.>99YIYKB7>2224SDRM9?'E5?-6><'5#IK <Z.J+-W/*71N0]QR^'TO/:FX
MOM18N5UC=L$L<E@76XGMI7 @GAWBJ8\",^YF!Z8^;M>6IA-*66!R')ZRRV5M
M,8RRES+_ '-DDT[;5L'O1B^3S1Q>WCI7M5N::E+<XC%CI^9Y\TG?C\!K[G7T
M=ZJ?D\A9PWF9MN51M&0 VUG!>7=RV"X@L'!_##&QHH020DXS4GEB/58)&M=&
MZHY<:KS>A=:8FZP.I]-9*ZQV3L[F.2"XMK^PF? _A,C(Y*,EB-' "M%!Y,V;
MI\T\\V74F$UW=]"W.G5>1SN$U*V \H_E*XN+IV%EM_<8+NT,]S>2.=$X"@ 9
MLJF-<$33*<GH=OCX:/A;Q,E%7"M 014$? D1%:SC*8F[EY8]E\]JK4F'T5I7
M4.L,Y=6UEB]-X?)YF]GO+B*VA$6,LI[Y[3-.^.-KG,A(;4BI2:QGDB*7X_E/
M(C\]GS7N8_F)]4&K,/9YK(XKDCRWSN5T_I+3%KD+DV$IQM[?V-Q>7,<%]-:W
M8F)-.)NQ1&'EE.<UG+@M<=*'29SNZS.;6"Y,<A=(W>IM5YVZ@MW1PME\&W@?
M/##-<3SL@F;$(FS<6T)W&,][/<\N[YH[RVY;NT9S+ZLM6#6&;-LRXS_+7W6!
MUK9SR,MGFV-^ZP#7.9(UX-*[TQXX)F(QB<87G-??-VO+6U9I#4.G,-R?LM.Y
M'+6+K6SS$/N<LN-E=;RQ-G:SY/'&0]X=V;E:L\<T1%D12C"D\XCYLSS?Z%-(
MW?//D)D;[F_RGL)+N\U9#9V4K;_2-D^2]FM@+.WQXEN&1P1-:X@\([U6LII%
M,9Q8KN+R65TYE['+8:ZO<-GL->Q7-O)!)/9WEI>64S96GQ&.BFCD9-&*BH.R
MA4XYQDK-)BEV3U$/FQGFN_OM>GVVZ>>;FHF3<U^6%O;XO"R7]WXM_J'%00VC
M YOC7L]PXP%]15HWE)BN,G<RR$2ZA=</5[R^Z).G?7O/;F#?6MO9:7P]Y/C;
M*>XA@?D\H+6XDL[6(2S0%_'+%MX351/=FF(PK.3QW/,E\PKF]YBO4=JCFWS$
MS.1EP)RF0@TCI=U_<R8K#8=M[<26W@VK[F>V9*^!P)<W<-@2D1BBMTQB^P\M
M/RM^H/S+N;UEHWE=IK(LT39748U7K1]M/!C,-8LDMA<2MN'6<UO,^&&<N+0?
ML5;O1'YMN7&>QZ$71=\UIZ*NGG2UY8<Y(V<Z\WD+:T?+DKRSMK+W*Z;%;FY;
M%QV)=)'XL;@TD D'<-RB*SF76VSA'SH=:/S6WHHZA]*6]CR;B9R8U!C;6]='
MD;.SMKL7EV8;DVC) RP#HV>,]@)%: ;DQ@B+<ORGG>^9%Y:G/SRU^=&6Y8<W
MM,WXT[<W4LFBM9>!,_&9_%F67W>XCNA:P0-FD@CXN#?2E%$3\ZTQ3!L7EP==
M?-'R_P#JCY><Z.6^5OVXNVS^+MM2Z=%_<P8W-X:YO;>.]BN+=ES!;ND9'[0<
M_NH=B8T[T12M>+V=.F_GEIOJ,Y)\ON<&EKNSNK+5^F\3EI&6=W;W;;.[O,?:
MW-W;.=!-.T.AEF+:$DI,X89&,9N=V 4JTU8?BBF[?7:=IJ4B!Y'OSI/_ ,VK
MG9^<L#^5WBDCV?E8[=K=7T;N"PN+R&:8MA;%9RSL?.9#PB,-A+72%Y- -M:T
M0Q9+?E._-MNI#S ,1BN:G,HW_)SDMEZ2XG4N0M)1?96)K;69QCQMSCS+22.8
M\)!IVU2:QD128YJX,Q7IM^:V="W)S2KL)KVR_=,R<D#V/RMW;6T#O&DC8UTP
M,EB7N)>TFAW52M,\BELSBMY=<?S0+EIKFQU/K?IAYA.TKJ*.&YO,5HJ2RA%K
MD[@-N9(K3WEEB61%SRQE=FP*,5II.$80P..K3I"YZ=$O./4_([GQH^^TOJS3
M]W)$3-#<.L+VU\:>.VNK.]D@A@G;<10\1#:\-5.62D3.$_E/K.A#J[YC=%/4
MKRUYX<M]3Y'33<'J3%?+\5M<W/NMSA7Y"T^5(KFUCN;>&XXK6$D%]:!"L5IQ
M>SGT>=4.A>L7IUY>\^N65_\ *&%U7A+"5TI:&EN0;96LF1AX?$D_([B8BO$2
MIB+:^L<U;:VY.N/7_P"6!R*\Q;"87&\X;=S!@_$%M*V&&5[2\S\7Y+#)2IG*
MBD1-?RH,XI.2TSJ/YKIT-:=T7JW(06[I)\?I?/7MJ9+*T:&7%IB;J>![G"S+
M@&RQ FFU,>VB_J?FY0\P3G?I:PT1S@YF:1Q'L8_3>L]2X:Q;O!M\;FKRSBI4
M- 'APCL"B)P4C",5U3R&^D#EIUN]=>C^1O--C7Z8S6-R]].',;)QG'Q13MB:
MQ\4S>*7B+14;RIB*X=Q=/+2>%:?.SQ;WYK'T+S>+X$3X(I1PEAL;.@!J" [W
M/M!4^5:>7A"\AT#] 7)[R]^5$G*KD_ YF#GG%Q</<V-CI9.%C*D1QQC[!1QK
M),Q$4C"'=?+Y:QP&(RNH,S+!96&(Q]YDKRXGECBAAM;&WDN9I'OE<QC V*(G
M:0%*L1QXO*,^<7>;3JWKEZFLQREY>ZQO[?D-RPO[K!V.&QUW/!99'+6%W>6=
M[=7AM;Y\%XQ[@31S:>UW;%$TJ58\7+;E;KCG#KK3G+/EIIZ_U3K/4V0M\9B,
M7C+::XFGNKIXBCXQ;Q2N9'Q/%7D4 2J9B&>+Y9WS1ZT9I_E[SEZQ]5NM\_=1
MP9;*\I6VC)V6D<\5G<V\,]U+8!H<8WO:X$EP*5DP_*R9#>?^;Q^6;E]-9;#0
M\EK&QOLABWV$648ZS+[6=UF^V;=-9\GBKA([CIWA3-U9K&1RV85AB0^9Y\TX
MYH\A-,9?FOTEZ@NN:6$LVY7*Y;1PMG6]WA,= ;V\C9 (;!TEPV*"-C!PFE57
M),XSA\S#@SVGLYI#4&0TOJ>QO<!J'3]_<6=W!<PS6MY9WEE,Z.1I#VQS<3)H
MS0[-HJ%96.UFZ?-<?.BU3I;6.'Z$.?FI79+1.688>6^HL_E'EV#N..RMFV#K
MG(9'CE\6@:!PF@=L3..]-)]F,GH?C@N/=IH'MDLYXV3PRQD.;)'*ULC'M>VH
M+7-<"#VA6F*VX>U#'.%W<W.7\AD_G;_QI6.*TQS9'CR?./A7S;^HW;2MSB]N
M_P#FN1[/@4PFY8XMY[N,R^[7-S;LDX6/;;32L,Y/LL88XW-,G%NH5.$^16L+
MP'EX>29UH>89?X[-<ON7>2P_*OWF!N4UIE6S8VW@M9);5K[BU%U9/9= 0W''
M4';38JX\$UK@RD<1\RJT[-B+63*=4,EKE)[*%]Q"S"ND;:W<ENQTL?&,71_@
MSDBO;13C$]L)FDQ3BR'_ ":/*%L/*1Y<\PM%P<T7<SYM>Y&QOY\@<?[A[L^S
MC$;(PSW:VXN.FTT41$UPX\"9BD1^%>LAXW\+BWPG"OB1@U';P&NXU"1/"<T4
M:I2" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @()'N8UI+R&L#2]SG'A:UK*.+G$T  &TE1,1,4*XO+_
M /G;_6EE><_5_C.FED=M-IKD47RXS(V=Y%<0W-SE3?QW(<(+B6,R"M"2T$<-
M%,Q2<46W5C#A+$5XSXD;7/#?"X3Q@;:M +=B$5^5<4Y6>:]UQ<E^7>$Y5\O>
M<>7P.B=.L?%B,1;3WS(K2-X8US6>#?Q,:TA@V!H"824OB*1=ZLOLO]-!YA__
M -O6H?[KRG_::M7N134_.E#_ $S_ )A]0?W>M0[/[;RG_::C#*A^T_.EMFJ?
M.$Z^]8Z8RVD=0\[<SD,#G8'VV1LKB:^GCN('1OB?&YDV0D86EKSO!4328IP6
MYM6N-TT6V<C?W>:R%WD[^43WV0N)KBYD8T-$DLTADD=PLHT<3W$HC*%_3YN1
MUC:VZ9O,,Y6:0&M1ICE9S(RQQFO;2>1D5E><1LV6+YG27$$1(DC:P<5=ZB8B
M,93%9FEN4YO7<Q^0M<CC[3*V4\=S9Y"SM;RUGC>UT<T%Q$V:*1CFES2'Q2 B
MA*4FN&8I9*)F3Q>4LF'B%YC[RU '^_VTD)&X]KU:<)I.:(Q\CQQ//NY6WW*?
MS&.<>G[\.\>3*S7H:^H(9=Y#(31C:UNSA/<HMSHM-*X.XWS4.:*+S4.7XDE9
M'QZ=U,Q@>0WC>ZS@#6@N(!<X[ -Y*B?:36(LQ[7K$EK2YKCO'Q3ZU*J9 0$!
M 0$%@/YR_P#^4[S[_D,=^5WZB?:A;*V7D$/)XI!WR'9\)4\.]6*/44^:+;.B
M;4/Y_P =]R6R3FBWV(9;Z)$%D3YPL*^5[SYK_8,7W)D%,9JWX63\CQS;X?FN
M[/9[W<C_ .Z%0L]+'YG%_!;YG?JG'^6V2B,Y3/!F<R!I80_XO;\.Q2AI8(N"
M1X>_B#12-E/B-=O%>VJ4PB>Q$3ZTQ#S?/G?W1AI3EKSJT3U*Z8Q5R[-\US,-
M4W=M:3/@A=9NR)B]XFCM1&RI:#5SSL2M:]J;YRB>+&1\M7G7G.0W61R1UIA-
M53Z8MV:RP5MFKZ.9]O&W'W&5LFW,<SFSP-+.%OV1I0)CP/5B:SE#VC;/FO@,
MAR#=S9TSF+'-8F'EQ/J/'Y5EU![K=RVNGC?L)G$IB:Y\T8J.+>=Z4QK*)FD5
M>,QYJO4_JWJSZU^<O-#6+&LROWT9?$ MD$K7VV'RE_!;EKVRS-(,>P4*5QJ1
M-8K2E63G\T#Z%;K5W-/5/63=:C$%OH,##V>#DL26W,U\;<O?'</@<.)T7%M:
M\4X5$UX)F>UZ,37%Q<>&@[#7XWP=E%:8HB+J^1.H2Q]?/Y\V/3WES=-64T_I
M;4#L7SYYG8J^L.7T44?BR1!UM?0W5U5MS ]AC\/8=H%5$4K0NK%L=O"'DU\W
MN<G,[GIKS.<Q.9^J\OJW5.HLE-?W=WEKZZOFF:\FEF$=O#<SSMAB:Z4\+!L%
M5*(BGTI7M/+ ^;U]6_F#7.F]<Y+"W'+CD7F'B237E]%(QTD%+=S76UI+8O;(
MU\<]12M0TIG&"8F)G%E1<A_F=/3_ ,N-3X[4',3G)=<P;>S<R1V,?B8XH7.'
MAE[:2V#6.K1P!(K1RB.:,4X<5V33_P W3\MK%6S(+WE+9Y*9D;&23/%DPN<&
MM!>6BPV<1!/PJTS*O+;QR6A_/F\G?H4Z9_+[Y@\T.4W+"STSK;3L</N=_$Z#
MQ97/9>OX_M5E$6\)8/LAN2.V47^K;2R,'FZV8ID+,5V-R,+0WN N&4V^I0MY
MGL.?-[?_ "X^47ZGQ_<6/1,KY2(;3GOTCS7ZDY'[CF1,9O%B\Y&O^D&Y\_MD
MOZ?]:Y-1;[$(NC]K=\B\;\T._P#,"O?VMWOY5$G%/!ZDRE @X#ZH_P"#YS=V
M5_Q"U1L_Z%OE$K69_(\/+J3I^[OS7I_EWJG]>[Y6G-BT_991OS/G^&_J[]KA
M^I&JLL9/3\4JL([YZ$&_O?>G<DT(U'GJ#O\ S,])3'%YSFD+MMAJS3-[(0V.
MVS^(G>X@$".'(6[GD@[-C6HA[2/DYY^TU%Y>?(/*6\D<MN_3EM$'0EI:."RL
M 1]K)%:NVJ,X3-*X+H# &UHV@V4-:\7UQ13"$Z @X8ZBF!_(?G US@P'EMK3
MVG$ ?L<R7:=@0C#&7A:<WP/W6N:0!J/W1-;4/_\ $V2I]%#/&683\SWTWE)N
MI'5N>CM9SCK:RNFS7(;)X+2^WQ[6U=P\&\]^]3-:1!;3UOD>E.=I&RHJ:FM*
M%I[NW:% \J7YVK_YEF=_:WA/N>95C.5[O8AC>\BO\]G*7_\ "-HK_P#63'*T
M]K'&3W1^1/\ F5Y3?_@XT5_^KF.41DERNI!!9$^< ?\ EU\W36GZ&S[=_P#6
M&1[$F,$5QB'CH9+],<@?[>NOISR(M.<O5Q^:D_\ EH:,_/D_Y7:*D>W*8^JC
MZ4^=D\JZH@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(/CN8G^;_7/[3M3?K+>HF,WA^]?W\+_GO_ /A
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MML9C=8OCQ^/M+6ULX888&1PV\$+(HH&-]\V-@C8&CT!*35/-93/%5/SJKRU
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M1>XCA +@2:M[BG&$Q,<LP](!2J^$YH_YLN8O[1-7?_J_D$'A;=37\(/G-_\
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M)&>,@D$<-Q9\.[;MJIQK6##C+UC8P>$./V3&;.XANW;VJ*8U0J*00$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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ME1KC6TAO-4:BTGB,CEIMQFN[JPMYI7?&=2KGD[RF29B)FL+;/SA0G_1>\]N
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MVF1PU]C76-G:V[XGO#2R(UD++:(EP>'"H(% -F\JN,S687B*1C-<&80V4/\
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M5_*MPF&K&[=3T;TBE,,E?*DFDCABDFEDCABB:9)997MCCCB8.*1\CW$-8QK
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M^*W^1'U I$R @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M"F)FW)$Q$S64X &X4]2A*! .PI&&12J* @((4'<$#A!KLW[_ $T2M!% 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$'Q_,-KW: URV-CI)':/U,UD;07.>\X6]#6-: 27.=L "$9O%'Z
MXN2W.7/]6_/:YQ_*O7UQ$_7FH9F2V^D=03020/R]Z(Y(YVXXQO:^E10G8IC'
M)%8XKIOS:[EIS.TKYG'+!^>Y=ZQQ%G ^=MW?933>:Q]M;'QK%PXKBZL8H*%O
M>Y1A1%?7B8RAZRL;VAL;2:.\-AIV_%59B>:O"%^Y65D*;V<1:X;'-K1V^E?1
MVU0X=ZCX)D'"^K0QU64.VM=Y[TE$1QXL?CYQ!Y9L?7KT9ZKS'+W1,.I>?O+7
M'SY?0IB;'%=S6MK;WMS?PB5MK//(YK"2&C?N41VRFE9AY1^3Z:^?F'RN5T]>
M\G^8#<GAK^ZQ]]P:2U#(V.YL[B2UF;'(,?P2-$L1 <-A 2G'@B9B)FLXLSWY
MIKUF<^N5O./.]$G,CEOKU^C];-%[@L[J#&:BLK#2<]DVT8Z"+Y19':L$\==C
M0!1P2(QJGFBE+>#T.7QM:.%D7B?BJNI2I*O$Q,TRF%9F:4C%M>5T_C-08K(X
M//8VRR^%R=M/97F,R%M!>6MQ;7<+H+B*6&Y9)"]CH9'-(((-569F<93%8R82
MOFQ_-1--<U,GKWG9T2RVV!UEJ#(R9EG*]SH;/'7%_<ON[J^-O<"Q$,,=Q-(T
M  @A.TB.W)A(]4OEJ=9G1YK=_+KG'R9U1!EP]XA;A</ELY:/;Q2ALL=Y9XXQ
M4>V(D4)%$XT)PQG"'6 \F.>.,:&GEWS%L&.VA@T[J*V!KW-]S8%-)1-UL<4?
MW#.>%YPS'E=S$O2Y\<;97:4U'<@.E<UK!7W%PHYQ[=BA/-$XU7K>A+YNEU]]
M81TAK6]Y=W.B.4>;R%J<IJ#-R/Q5[!CQ+:.D<S'7E@'O>;:=S@T5- G")3G.
M.#TG?+$\J;IX\LOE#8Z,Y8Z=QV1UYD+:"36NO[BSMG9;-Y$LMS.8;AUK'/;6
MS)8:@ @NWGN$8QY4S29^1=#8R1KW@;&'VN(^T23OWG8E*12$8J;X31M6>)MJ
M=O#0BM.U3A2G F(K6N#J)UH=$/(SKLY.9OE'SOTEC<Q8Y&SN8<;E);2TER.'
MNYH9(&7-M=36\TS6L$A/""-J%:P\[;S'OFK'5CR(U7J+5?2MACS5Y2V,&0RU
MS.VZ$.1Q5A$V[NVQ-QT=B9YO!B8R,TJ*D)$(MYN.<RQBLGTX<_<%E;W%7G*7
MF':Y#$W=S:7)CTCJ "*XM99()@V=F/ <&OC-"#N3,YHC.6@=R>YY7!-L= <Q
MINQUN[ ZBEKV4,?NAJ.RE%-)1[RWM=FNEWRS>L_J[UW;\O\ E!R7U5<YM\C&
M/?FL-EL%:1,<Z(/D?>7F.$5&,F!-3N4)PN]7.&?7Y*/S9K0_2C!B.>/6!B\7
MK7G*'LO,;H^XCM;[':3NH38W,!,DMB8KDLN(7?95KO*16A2*U[&7W:XRVLVP
MPVEO#9VEK#%;VEI;1LAM[:&%O#''%!$&Q1L:T  -  &Q+L,8QE+<P214BA[J
MU^F@H3L<XL<P>TPU!KL.[80E*SC-(1->"TWYI'E%=.GF<<J;_3VOM/XS3_,_
M'V<SM'<Q;*QM&9/%7[8KHQ>]RQVLDUY#)-/MXB2T;D3'X'F\]</S=#S!.CL:
MNUE!R\N=<\IL#=W+K+5&#DER-Y=6#9;IT+WXVSL2]LGNT <6D ^TG$BV9PSB
M%EQG(KGBUCKQG*KF';!DDD1G;I#45L6OB>62"HQ[-SV[THKSVQQ1')GGG>GP
M&\ON8UTXBAB^]_44]1W<'N;NPI28Q3%]LX1+LWTJ>67UG=8>OQRZY-\F=4W.
M=C<T7+\[A\M@+*",F+CD?>WV.$7"QLH)J0*51-<*QDSFO)]^:QZ1Y&W6D.>'
M6S!8ZHYAXNZ^46<M7^[WV,QE] ^SN[!\]RZR\*=D%S":@$EPJ-B9QB93$QP9
MH^/Q&.Q./M,7B<=:8_%8ZWAML?86$$5G:VT-O&V**.*W@;'%''&Q@:    %%
MM?)!FW&)DC?R0AQ H'#9L[J>A6FG CSO(_\ G2-1YM7.RO\ 8>"/_HWM%5$5
MI/95UX\C;D)RMZG.K_%<EN;6'ARFFM9V5UCW23!CA8S3^%;17#0^*:IB=<<6
MP=B90<L731<8\S/YKOU7=-VIM5Z\Z:L$[FOR3Q\$V7??VTE,CC+.1MU=F"/%
M08\W$C;:,,CJ 16E$BLS2<ELHSK,L;"XY!]06&N+VQDY8\S+.2PGFMKEL>F-
M2Q1,E@D?#( YEBUA:'QD5[5-$<U.+:8^2'.J\E<]G++7U[*S:\_>MG[E_L[?
M:I8O<BD7VW3FN0]"ODK==/7EGXF<ON5&=PNCK:\M&:@U'J*TO<%%C[.2XM8Y
MIHHLA8CQ'10W'%M[0F>7!>*3Y)>EEY0?DI\D/+%T#!?V]I8:PYSYFPM)<[K&
MZLK9T]G<2V=N+NTM'OLXIF%EQ%\=I&[8D8YF,857O60$M<9O:>XU[@!6H'=L
M5IF*X9*VQE-V;41@M8 [>/P#Z2B<UD7.X6D]U/IFBA,9XL7/YPGY(#_,,T#!
MS7Y Z=LQU#:;$]S([QF6\NJ;:"&[ECLGR.M9G>(YS^  .!-1052G9FBO;E1Y
MEG,7I,ZC^4^M-0Z UMR=US::@TU>3X_*0QZ8SES:1SVL\UL]\-Y%C_"FC<^!
MQ#AO"=Z+J1.,TE\#!R/YSSME;:\L]?3-:USI66^EL\\%K&U=5K+$\5 .U)PQ
MDBZ)FD3B]+;YHAI[5.G>BC6%GJ73.7T[QZB,EJS,8N]Q4]TU_AESQ'>P6\CA
MMW@%1"TS6(F,F6]XK2T,\.CY>(< [AVD[@HNF8I6,)1A&3KSU,=*_)SJRY4Y
M_D_SFTAC-4:9S^/N[1TEW:6<UY82S6]Q#'/:W-Q;SR1.C-P3[-*J:1Q,>#SW
M?,V^:=]0/*W4DVKNB*P',S0<L66RN6PDEV+2]T_:0^^7L4$, L?%N?!MXVLH
MRH3%,8X,4C6'2OU&Z$U+F-(:BY/:^ML[@KJ6UO? TGGY6PSV\TD,ABNH\<T2
MLXXG4.[M4QADB:1-)S?*?N/\\I'&U.@>8\A^*ZW.!U&ZO9P^%[H>^E**>6<U
M>>WM<J<F.B3JCY]<Q\#RKY=\F]:SZKU!,(,=!?Z:SF.M7O<Z-E9;Z?'%C 3*
MW:>]1AFF+JX0S$_*S^:9:ZFSV&YC]>]M#IF+!W]AEF<O8+R')#*^#/8W4=O=
M2^XEL'!P/:]KS4'85%%L*5EGQ\L>5NB^3FB<%RWY9Z>Q>E-&:7QUIC,-B<99
MVUI#%!;1B(.D%M#"V65S&BKR*DJU(C/-%:^27WQBD#P.$/B[&=QV5-=M=JF*
M1'>K,3-V/LJTCVNCD:#M\-^S^5/X:B8F,4Q,3-(X/(B^<.<IN;.K?-DZD;[!
M<M-:Y3'/O\:RRR&,TSF[^RO8 ;UXGCNK:QD@=5[W-H'&G#Z56DQFM=2)=A_F
MP_*KFII3S'=&W6?Y=:PPV/C:67-_EM.YG'6]NX363SQ37=E%"!P&NUR3$JQ,
M3;,V\'JML^*W^1 ^DI2F0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M%*VS=WOF</TA]-&!OQD,;R;T##>$EP>[3&&E;4[3[+[%S%&4^5>LS'+&3EC
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MVUPV--*4';L&^J8_(F,$3%4$<7QMYHIF9E'+''.1L+&AHI7AKMJ>_M4)54!
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M1C$N)')-:3A"8^<!T>#_ .<+DCM/N+MG_P!V62ZVZV*RM-ML8UP0'G ]'A)
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M_4G]HP\U\W12/4[6Y!\CV-<T[2#4;J=RQ\TTY(G]I1GLY?RFG;+<ME DW.W
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MKW-@DM#$RD8874>9' T#PNPZ.QW&KLYWU/V%K6SNM+WL:-DUOEWT7"<D0$!
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MRJ\6W3*!Y=<S!4'EGJ*HI3] ,I_>2K7O3RSV(NY=<RP2!RRU%LI3] ,I\/\
M625CM1RW<83'ESS+V@<L]14%*?H!D^W?_62Y.C.G-GK9K1;?&<-'/RZYEN-D
M/W,]1U&2QQJ,!E-@]\B)/]1;  N9H>[LUHB)P<+<V7716+:S#-:Z-+&^QG39
MRSL[^TFQUY#@X!/:SQ/BEB=X<=0^.1K7M/H(7%ZA2[<S3&UETHIIQ&4NST+0
M W;QG;MW<._L[:KAW19S1,1Y&6V;N68F6H4@@(" @(" @(" @@"#M"<:<1%
M0$! 0$! 0$! 0$"M-Z @(" @(" @5[$! 0$D;5<QO9!>.^Q-I<[-^WPG+!JZ
ME=&ZSC-L^:4Z=M-Q9.=M8\["8ZV(K=_5%S-D,4;FMR!V%C:U\>ZJ:D5WK7])
MG_+XC\KG]+8]?F/YCW<D>9==\C\0LDYJF.-L<TGR>)"UK15H]SH-@'8OH'5X
MKTW0\GH=,V5TQO;XB.+(;CXQ7C-=NPT V;>Y=2TZTI.;L4YX9*BR($! 0-Z
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MWO@RQOFB?:.N6Q,V1ANT;%S=MO+=:/<WTGM<+<[:[1L]Y$XLJOH$Z^M+=5&
MCTUJ66WPW-? 6T,66QTLT49RCFQ,+[F!KIWESW.D^*T+GZVTU-+1][IXZ,_@
M:[;[K3U=?W=\4UH_"N1#^JY!4>R14=H;N^HM;NHB=&VZ'.TL-:Z)SHFF>&7$
M#&@4>1[0VTH17O5.:;;XF<:LMTS2+6/#YXC(FY+E3*YK"X-O0>-H>#478W$%
M=4Z;JU\9ZNG&$Q;'F;VR(CI?-QFJPQ'8&X=%!:6K;B[G#1!;10A\LSC2C6,8
MUSR2X@; NZZ.AR:TWRZ[=,6QS0^@;RZYE\-1RTU$6D \0P.4(<T[6N%+&A!!
MJK[FRD9U+-:^Z8MFW"3]S?F9L=^YIJ*NVOZ 93U?V$N)9/+?3L<J+;XRA"3E
MWS,8UI'+'40<*DR?(.4)%/1[BN5/),>\NQECU9OFZ,,FQ93$9W%!KLUIK4&(
M>W8Z0XO)VE#N)J;>*E*+C7[JRR*T<K2TXNQG-N&D=8ZRT7D+7.Z UEG-/Y*W
ME;.9OE'(25DB>V1C7VAN6T:7, H0N3M]QIZLXS'+Q<;<Z5UGU>%TKZ_0WYLN
M8NLIB>5?4Q(QQO9+>PQ7,"1S(FAX$-I;QW$1N":22/\ C':*? ME=L;->V[4
MT)I=$9=K43O+M&8MU8]6N?I9"^.N;6]L+6]L[J'(V%W RYL[N![)8IX)V"2)
MS)&%S7-+' @@K3:EL8V:D4F&TT;IF8FVZMDQFW*($-VBA.\5KZEQ].^*\MOL
MKS$>556:8B<T"D%$S$8R)2]K:5(V[MN]5NOBS-,6S.2VYYCG6'CNFGE5>X7
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MDRZCT_7]UMKH;ZWESS*H:\LM1;MGZ Y3=L_M%5]W$:<1,MG=-U^TMU-2*Q/
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M=/TI\A8>G=\F65/H> N4K65-^ P@(#,#AC7?7&67]*"QW7S%U",D_P![^!%
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M6,L7'VNZT]WI\^GVNRGO+>%I /M5V=U._8M/.I$6UES)B(FDC[EK&N<[['<
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ML:?ZWU+HSB(K\S;76^YZ-]IG&VN2S!R0:6\^>5+ZU SM@1ZAD+-?8^G19O\
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MJKB @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("#991(V\XG
M@30.(]!CH00:;]BP:=DZ6I=J<)R6OFVZ(B,X6,?-NZ7^H?FPRSY@:"R5[JC0
M>FK1\^3T-:/FA+&,9<>)*8X6O-S[3P=QWKK_ %OI^KK;BS7SLB?F;O8;K3TM
MO=HY:DQ->]PSY0W1GE9]17G4/S)P4V,9@IG6^B\3D;1T;Q/2)MW*675JUS?!
MDBV;=I7>]MN_<='T]OHS,7W1G\CIFIM?>]1OW.K%;8G!<6\RSI$'4QRANL]I
M;'QS\Q-%V=S?84,8R.XOH(H9I)[8S"&25SFQD\(KZ NHZNVC6U/M5F&K;/K1
M3/%VO9;Z[;Z=VA?]5='S+'/E[]*G5#JKG%B]?Z4L\KRVT]HW,^YZ@R-V+NV;
ME/=[N%DL1MYX8A<B1D#J;]@7>=#?:>GL(LU,<*1#I^MMM34WTWZ6$5S^5EZ6
M39([.UCF?XDS+>%DSZ4XYF1M;*^G\<\$KKVI?3UHXRW5L4B(:I+;N:*I8FGG
M$$?OHL:T]MI;_3M[A=>Z1/)XJW%T_FQYG<.N:<W^!]IV<UWG<">7.S_Q@: :
MVKC[Q+L ))]NU[JKZ1TB[_+-U'>^:;C3INM*?[9,SUK2YD;:D?:H^RNX _ N
MI?\ W<W-Y^31J5R$" @("#3 #Q*4HYM?Y<$=^X4"QZEL7XY21AAP?$<PM!:8
MYDZ.SNB-68^TRF%U!875A+#=V\4S8C/$Z..5GBQR<#XY' @T[%Q-;0LW6E=M
M;_9N\\.1H7ZFAJQJ6>W#"[ZNNF3/]+/.7/:(N[,7&F,I>SWFDLJ^T#+9UK=3
MW-Q+$UYMXHCX<( ]"=*ZC&M=J]-U:6:VWCU?TIHVNXV-O5=*=6R(F*.6_+NZ
MJCTP\Z[.RR5_+'RZUM<PX[/6SWO;;6MQ/):VUI*QCIHX8^&4UV"A7=/#^I_.
MNBW].WT4ZM6>2V<9P[\\8=&W5.D;B(_)F<68-B\C;Y:WLLWCKR*[Q.3L[>\M
M)87,DC?%<Q-FCX9(W/8?8>-Q76M30U=.^[:ZUO+-DSFW5E]NI$:ELUYHP:#4
M&H,-I7$9C5.?N8<;B,':3WEW<7,K(XN"")TI]J5S&<1#=FW:5Q;]S;9H7:FI
MCR1_Z.3;H:FIJVV6^U+#QZ].JO+=5O-_(R6]W*WE_HR[GL],8H2DVLP@FN;>
MYFD FD@E\3XVT=JXG0=/WVYGJN]BDWUB+9QCLC-L=UK_ ,JB+=O/-9$16<O*
MAT&=(.7ZK.<N/N;S'B'EIHV\M;S4EPZT!MYW0RVL]O"PNMWPR\;A385W78[7
M_3VWU=7<1S7;C&RO#R=GR.J=7W,]=W&G9M[OV%GMT9B^G-.X72N%Q>GL!C;7
M&XC#6<%E:6MI!%;1-9;Q-A:XLA9&QQ+6"IIM6DU;YFNI?,S=,^5S-'3LTHC2
MLB+=.(X0VW7&L]/<N-)YW6^I[N''XC!6-Q>7-U*]K&.\*%\L<>US1Q2.9PC;
MVK7:FYBV+M>Z?5B/GG@YFEHS?=&G9C5AK]8O5OK_ *J^9.=O[_)7^,Y<XR]N
MK336!MKZXAM[JVM9[F!TL@BNG1OXHCQ"H6'9VW;ZZM_:Y>O,;.RLY/B^G?I)
MYS]3N0GL^5>GIV8*P(;>:FO(7PP0!QC:XQRW%N^.>GB#<XK?:FRLV-D75]:[
M)H+MS?U&9LMPMMG%<WTKY(VN[_&N?JCF3'890ACG\%JQ["2&ES!PVM-AJ%QY
MU/5ESM.RVVV(NFLP^2Y@^2]SFTY&+GEWJN#/NCCD=)9RB*$SEK7D,#GVP(+R
MT >M<.[WF,Q!=9%U<5J3F-RNUWREU/DM \Q=,W&GLX)7QA]S;R^#=>"]X>Z"
M[DACC-1&3[)670ZARZD:&K/++8:&SNG:7W6QA1V_\O7JLU)TV\YL%@[C*7ES
MRZUK>18W*XBYNIYK>UEEFM;2WDB$UP(XO;-=@6YLVT;O=^ZNPGEPGY&@G5NV
MW3YU?RHN]+,8Q<EO<65M>6_"8[VV@NVN:X.:6W,8F;PD$B@:Y:S5K%TVSP<S
M2^KC&N"%^",;D?39W--W^X2+5;B8_E^K'Z-WF<O0_BK)_2M\["%ZR8(INJ#F
MM'X<3YFY <33$PAP-Q=;>(M(.Q8NCV<O2]'5B/RZ_-+;>+8MG>W36L\D>9]-
M#U=ZUTQTU0=/.@+B33>.R0?'J?+63G07-XVI$<4;X)HI6%S?9V#:NU>+=[=U
M:_9Z43--.*9]SJ_A^_3VFWW%]T1SW9=S2=/G0EU!]2<#\MHS3EUB-/"1KY-4
MY=TK7W;Y',?)*T7UNYTG&92=A*P1M-';Z<7:DQSTR6W,W[K8^XLXS6'>._\
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MM);(ZHV%='Z_LHW^WMT*816[Y8B9=HV6O?MM>+XGUO1+!EYS\NKOE9S7YA:
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MJSZ]LX+RK75]!&PCNW]O;N6M;&$R)$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MG^J^TKKUE]]VYG1G*&PFZV)I3!,?/#YAU/#R3CIV?HFS^^UR)B*YKUM[$/\
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M.F>(=S3J.GT[2QTMQ=,T\G:RN>M*Q@QW2AS$QUNQL<%CIAEI'&T4:QD%J8F
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M-D,9;7VWM<T?''8N_=%MUK=CN-2D\G:^>;J[3^T:5E\Q%T\'=8^4[UK.#?\
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M6KM+8:=O1MI?%UFGG='Y4SBT/3_>[R^=_NK:7W91/G7@9!XIDE,)JX--"3L
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M3Q0EK7BA.\FHXC3>-J8S/-,4<S=<*S6^F+'D\\7],N4Y/=>T]=+M=&Z;;/\
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M*WP9I X@;Z*FYV]NYTILOP[W,T=>[0GFT\ISAAM]4'3-K'I?YI9+0NI[>:7
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M,^WT+-&WECVN,NW<3FO:7-<'-.[9V]M>_:L$36(PHY-*>56H!N" @(" @("
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M5A']:NSJLYG]WR@?R^Z74O _W9?^\N_6;_Q/AO+*?F1YG<#R;B!U%Y[:03&
M:%PK6.VV&FP@KZSHW?Y-KQA2D<'1-S%=_H9Y^EE;S$B)Y!(--X-#]$+J\9MQ
MJ3,6311M7.,8JXGUDGO[UANF?M$QP7T_JK7QO,/E]HSF5IK*Z4UO@K#,X3,V
MK[.[9=6T$DC6/:6AT4LD;WPR-KL(W+%N=+0NMC6UXCU)K$\8FDN1H7ZNG=S:
M,^LQ#.O;HWS'2=S$?=8B*>\Y;:IN9KC Y!D+S!9^*^XFFM)RV!D49B #/:.W
ML6MV=UO6MW=M][,S$3ZLY5B,I;F^_P"U;:;)B*SP['7+D7SXY@]-',/$\P-
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M+7VQ@,8>&>&161]:\8^BN1=T;=;?:1OKK*:$\:LUVZTO?_9IG]K'!VL7 9A
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M+>?KMDQ%:5=FND7EYS"L^I?E7D\AH'/6EG%DOS3=38;(P0Q@7-K1SWR6;&,
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MFM..+(^ZC(Y&\C^8I@>_Q'X'(&L?$'#\R2@TX=NU?..MVQ9L-2ZS*9CTN_\
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M_P "T^C=-]]]ET-M?$1;$PQ)?.!T])B.JN'+F-T=OF8+=S)0TAO$R&X+QL:
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MD&,LK6SA#0*-;;0,A    VABZMN-2^[=3N+L8F?.V^CM]/0V=NA9&%&\0-<
M>*I/I[OP!6FDSS1Q9;Z12V,H572,::.>QI[G. /TRB@)(SL$C">X.:?J%!.@
M(" @(" @(-+??U%>?G6X_*7JFI[%WDE:SVX\L,(3K//_ (H.8]!3]$I/@_-%
MW]%=9\)>SN^WF]+?>)I_:[2.[T.__DN@'G)K/T6[*?T*V7V+0_HB/I>E\ZW/
M]63]'T,H9=&=E$!!IF;W^MGU52[ZZ/E1_P M8?\ .^_8)H7^?7'_ ,2M!MY_
M\FIQY8;V(_\ &];]Y_\ 2QXL!0ZPT0 W;\LXBFTUV7UKN':NY=,^\]/RNO;J
M)^Q7S^BSMN2P(Y6Z'#FN:?O<Q.QS2T_U#!V$ K+UK[QU/*X?2OX*WY7*"U38
MB @("#Y?6_[#-5_M<S7ZW7"XF_\ X/5^A/FEGVO\39]*/.P-^8&SF=S$[_ES
M+[/^D+Q=?\'_ -.7]GO)_6;CKW]0V1^AZ%]KR,Z>X\U=NVME4=VVU7UKJW]/
M[.>Z7SS8??V\KVPR%EU!V004W'V7;:4WFE:?@"P:=_-=-LIF*8M*&[7,XQ)
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M/9_P-QM75^@Q7<[V.//Z6[ZE_"[+R/A_*]!_?EZ*[J7FSO\ 9MOH+ZOTF/\
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M"9862#WEE#OW+M7B/5T=E=9LMKC-/6F,(_OHU/3XG=:\[C6BD1-+5XF*:-S
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MN]J,X=FNLFV.?CP<*=1_+6+FYR4USH=[&R')X2^,+2T'[;#:3RQ!HX'^T7T
MH*[5U_KFULWT6ZVG%=3;3S1\D35L.GZMNCN8G\B[#YV#;F].7VDL]J?1>2M)
M(+[#9C)P>#.US'L#+Z=D3^&1K"!1@(V!;GIW5)ZIT:.H:<UI,1WX31R=7;1=
MXA]S$8\DS\\,B/R=>IW"Y'2N0Z?M4YB.#/Z?+9-/,O)PSWZ*1L!FB@,T^US"
M10-&TBB[OU7:VZO2=OO=*GO>6>;YG0-GNO=]<W6QU*\O-A\Z_:NJ.RJ<I+6E
MX +F[OAH"E:>0I5M=RZ.%DE]<3,MX;:-\\TTKFLABBB''(7O>6L:WA&\D47
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M+MOO+YTXY8ON];C7%N^HTG;;&GL\OH?'>5^TGK(T;)''P2Q-O:PD_&XFV]7
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M>:)]5$W_ ),6Y\75GFEYAO57S7BN\9D==SX+$9!KX[C&6K7P.$3A(TL9/#=
MLHUY&SN6"?>S=^C),3+I;+//?WSWS/R>=R]Q-42?FO)W<MS,^H VSS'CE?\
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M-&+M7&YV4C?(^I!J-]*#97UKK&VONNU;XOFL5P<G5CEFEK4KEJ" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M=8P#)744,<<EW?F"+WF25[(XW.K*V@KN"Y.IK>\U)NGADP1I4LBVF'%SB&3
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M#ER<+>O9B-98.*>73.;X&.=!,Z.4^&[[3(XME>^GH6DC0OUK[;KK::UOX?\
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M&GZ V]#3_>X^Q<KQI$7>(-:>.'F<7H7J]-TZXYNRSO!N"&3PPS,!I]MC;)]
M.!HNIZ=NI;A?EP;>VZVZ+IB<DS+.Q9)5EE:,<VG"YEM$UU=YH0P'8K<\3=0Q
MQ[&N5T(4%:JO+$S61&@5A*X5!&ZJQ763?%ULY2F)IB-'" -]%.EI^[LBPNFL
MU1H/P$T[MVY9*HHB@("B8K%)$I8UP+7 .:[86N]II'<0:A4MLFVZ:5I*:M*<
M=CR238V9)WDVL!)]?L+(A4CM+6$\4-M;Q'OCAC8?HM:"@KD []M$B>PI7-%
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M:XKQ3ADF0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$!!(*M/"&48/LN+X=V_>J]PEX"(^$$U&XC9VU[^Y3$<!+2.-SG<1J*5!J=X
M[]N]6K-U([%:6VS7C*>,UJX"@)%/@4+S/?6%1$" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @T\E7N,8);4?&;4'=WA3A3O5FM:<
M)4HF/XO"E)<(]H<227UVBIK78HF)I$_.1V-:BP@(" @(" @(" @(" @(" @(
M-N?6*</D/#&2 T#VJ;16I'>L%]M+XOX59*\T4G.&,7YO/3WS%R?/O&<SM,:0
MOM08:\LXFWTMC:7%UX?N\-R!5EO;2DDD=ZX.I9/VF9MCU9G_ -6TMOMGI\?G
M6K46G>57-?5&2;88CEMJ&6]FE;!;PR87)VK6O>\1U,K[(- #W!;C3TXMFO!I
M]2^9^5?!Z _*TR^$U+C.<G479,CGQ#H;S3>DIVMF:Y\S8;B*XN ^V!:()F;C
MM^JN9?NIBR=.UP8VMLW^\O\ 9C*&0@&111L@9$V"**..*%K  QD4;>&-C6-H
MT!HV4&X+@XQ=AC;Q<NEMUL<\4;@VH:*FIH-M*5^!0NB@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(""F_>T \+CQ4-*TV;?I),8%:8=K31N>PO:7$L^Q
MD()IMV@ UK51PKP1A&$366L  %!N4UKBE% 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!*X5:1
MOV;N],>&9AQR:1K)#5SB 7UH!N:&JU.7+Y2O-;3CP1M7-]M@E=(YI]H.K[/=
M0GLV*L95C)%.6>7BUB)$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!! @$4(J#O!04V0QL+BU
MH!<03\&U*F:J@E+&'[$?7^CO[5$Q$F:93E@" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @((
M4%0>T;OA0*"H/:*T^%!% 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$!!   DC>:5^#<HIQ$5(((!H%:"E4[T4B,D42(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(""!:'"A%0?\ 943%
M0  )--II7X-RD10$! 0$! 0$! 0$! 0$! 0$!!)X;"7$M!+M]=NY)BN::SDT
MD^/L;D!ES9VMTP5H+FWBGI6N[Q6N[UQHFZ+^6*<J9FL-/'@,%"X/BPN)B>#4
M.CQUFQP.^H<V$&M5R56Z!K0 T- :T4:T"C0-P  V4 0H%K7;Q512*4X";<I!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$$" 2#VBM/AWIW@&AHH!0)
M0  !0;DS$4! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$$" 00=Q%"AFD;$QH  V#=M*<:\2<1L
M3&N<]K0'.I4CMHAQKQ5$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 005+K9KS1FE%70(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
=(" @(" @(" @(" @(" @(" @(" @(" @(" @_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>39
<FILENAME>tm2227887d1-lc_poten4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2227887d1-lc_poten4c.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ R@%G P$1  (1 0,1 ?_$ *D  0 " P$! 0$!
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M,]YDDED3\]K721RF3/KFI$:K<7)6K6J!>W0S=Z"'6D2JOPK?O'YEO^;[L/\
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MQ$8B,1&(C$1B(Q$8B,1&(C$1B(Q$8B,1&(C$3^1C 6 1A@@@  (AC&,6@@
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MAKCC*H=1O1+B<2:R!BLLF9:@E)IM%H_9PD^PB,![=#UO>PY;=6VK&<'/V_\
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MI,#C)(/,#:#4\Z,JJ&GL3:WP^$#?!R)N<8JSK6!R:T$DC[IL D(S2E"$H!(
M"2C!K>MHFA%G'+!1D6IJ4\CU]'UER<W0=WK2O&:=W$_5%%[;@<^>FUPLB.]
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MY,"8>4G#I#'(FUO<A=#-&&ZV("9*<( -"&+6@!$+6&NMK7%:]H8_<A1_F6(
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MF1HR0)TR<O6][WHLDDL(=>N]_AK*-F+,6;JQ.3/4ZJJZ*EHI 6I%"J!Z  8
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M*7RYQZ_C=-VW_P ISK#<Y( A P_LT!@59:*B2JEE)#VMW76 E2XK[:UW)6\
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MHB>56;73I4D8CDNCC6L-F,)C[):9EM1R7SQP;$<;VDT22U;BBH+7\)1!I>M
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MB5D^_?0.!F@./V_TT<"VX'2YJG8LNXW7%VX*[$"-4+<$C#$*P*ET!) '<ZL
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M/>-EO;[=6+2$(_&P-6S!@6RI ]/Q.>I"XFXO975&T!W9;&%_+I]#D$YZ]/\
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M&(GRKD*)T1+&QS1I7%M<4JA"X-ZY.2K1+D2LD:=6C6)% #"%25408(!A8PB
M, MZWK>M[UG9'>MQ962KJ000<$$>A!^A'T, D'(]91)X183#&>9>89V:(C&&
MMT:?,WUW#FIR;F%J0N#9$4M9\TJTL6;UB9(4H11Q,JU\I:$L04H#/VM UO\
M',UNYMW(:[K;'1G[B&9B"V,=Q!/5L=,^N.DYR<8R<9S_ )_>7RY'G$8B,1&(
MC$1B(Q$8B,1&(C$1B(Q$8B,1&(C$2(K-PCRO'[6!>#16:I):9<K7S?4MW8=H
MJ5(Y.Z*U2UQ<CFY7-3V8\*U0M-^1.-,),,!FP;+]F_;FTW>:>2W\9_PUNP#Q
MOM"OL]JD#L   R*PPP ,'.>F<YDYN2W6H_;,_P#9[<8[5]/],SY^J>)JIZZ3
MQ1+8;Y.8T3$UCLX$:KY5$6@YX6NJ= DTH?5;]#9,L5B;DR'8$P2C"0!T>9[]
M#W[-@[>->8<GXLUK:"4V&T*/[H=NT*2<*%L0#)/7(/H,8ZYYTN1OT2QJ"DMC
M]63C'VP1/LC?'=85_4R>O8(G.(D;%&'-HC-AO!@F^3#=S$:XAC>)8JKK4 U(
MA-@SR &^@2#E2=*7HPP1H=&YTV/*^1WN4._ND'7>P,]2]4[<CN5!;[O;G!QZ
M@$G QTG#[]UM_NV?H)R5'ICZ@=W=B1DY)\>UE\Y22;N#]TS*)(QS<K[HXHHJ
ME<XTZ'S8"\HT$F<UCP]2=N>!J6Y0L*4A4I##3C#2S/DT(K7KL7E'G7'\_KTU
MT\=77=2< N0X%>/T *J%<$*1A@  1CK)F]RE.VBA:0&7[]>GVZ 8^DUSU12G
MD"=>AJIFE).KO/X92YA+_&'2<RJH6$]SD;ZF^BF"58T1ICKW:AF5L(0MOM6$
M'GZ :J$6>$!_M#8>-<OX-5P6SJ<PJT;>W^+BM+V 13FLAG:W#!OS_$@=%R,K
M,NEL<6NJ]>P MEG0X#'H/3J2W7/7I_3ITDL.F9;UC5='RZ404V/VG,CD)+#'
MXM7U%SLZ:)G!_#IM!(2CFFTIJE,,C&SA+C1?:])3-DZ#^QH6M;UCQW5\8Y+F
M:M;=%FMJ!NYGMV*_;(7KV_E36?S_ $C\\C.>LA:::5VRJ692O.26<8Z?3JH]
M?3UFN>&;4[$EE&-K/:%,F)9G E0HHI?KSE%F5A+9HW)TI"IHD!R-UIF7F/9F
MDJC214O^M,/4*4PS3@!&/W#G^9<;XIJ\RUO';>=2\=X772FY*R20RY6].WJ.
MX+V@ $ ' Z9>1IT$V2U-G]MNN$"L!]QT<8^X&)K>K>W;FD_=KU54RKYY8J:7
M(UM:,9S,SR%\C2"Q(TJ6*1S(N9.,+BZ]Q9I0K*4-H!C3$IM%_1G!T$.C33;#
MDO#N)UO"TY/4O1^64BUNYE5S4X ]OVQ8X#(,/ZDY[Q]@,MW'ZZ<:+JW!V >X
MY(![3],9/4>O^LMUSRV4<8B,1&(C$1B(Q$8B,1&(C$1B(Q$8B,1&(C$1B(Q$
MI!\*W[Q^9;_F^[#_ -*^:<1+OL1&(C$1B(Q$8B,1&(C$1B(Q$8B,1&(C$1B(
MQ$8B,1&(C$1B(Q$8B,1&(C$1B(Q$8B,1&(C$1B(Q$8B,1&(C$1B(Q$8B5;^:
M85@@\9O3&ZXU,=N.R:C#,_R "2#EO\D!WQ5P.C-M08>$4HT'5 "DWU.T'_4A
M2_+L&];UZXB5Z<+J/(LGY0EN_&JS\I.U&"[I[.U0@>Z9'T]'FHCD34^;OY+B
MIH<-BLGF2J(CE>Y1]'IY"24!HTB^DV(K>M:1(<>+-=YQRWOR??R&C'BB5*C/
M*[TP9>FK=G?7K>G2W^*OJ*U.$E3;AM=.9B^G2F?35MJ4/&DST8I$KTH)  ).
MQ(EKGW+]2/\ P;X0?ZE]X_VFQ$?<OU(_\&^$'^I?>/\ :;$1]R_4C_P;X0?Z
ME]X_VFQ$C>BZR_4$+^O)+Q<36OAQ#:45YO@_4#@_&3SMC4 .@$_LZPJH9VA&
MZ!@PY$9,$TBK5<<I3C:BT0$1I P*S#1&$E(DD/N7ZD?^#?"#_4OO'^TV(C[E
M^I'_ (-\(/\ 4OO'^TV(C[E^I'_@WP@_U+[Q_M-B)&^V.LOU!%.7ERKS_)JU
M\.*Z9=?3"TX56KFQ3SMA5&6-UJ.G)==TD43E8X09K=6UO6Q2&*DZ$:!$YF&.
M!A19I9)(AG@1)(?<OU(_\&^$'^I?>/\ :;$1]R_4C_P;X0?ZE]X_VFQ$?<OU
M(_\ !OA!_J7WC_:;$2+':G9GG^X3YNG745N5EX>9% *^>*S9'EGKB<]IN\P4
MJK5M:$4_'C&QODT+B#*<G1R:?(SUNS7 D1:$LX903C0@),1)3_<OU(_\&^$'
M^I?>/]IL1'W+]2/_  ;X0?ZE]X_VFQ$?<OU(_P#!OA!_J7WC_:;$3#R&6?J/
M(TP/DC70GPDFH8^SN;VL*263W:8J-2M2(]>H+3 .JP@D:@9)&] T,8 [%O7J
M+6OQQ$T_R]TO^H3ZTYUI7IJN:Y\-++ [VK>*VA$6F;3[MQNES<P2]K(=VU'(
MT#% 9(S)'@A,H"$\M*O6$A'K>@&CU^UM$WQ]R_4C_P &^$'^I?>/]IL1'W+]
M2/\ P;X0?ZE]X_VFQ$?<OU(_\&^$'^I?>/\ :;$2.'.?67Z@CIW^>_Y"K7PX
MM'^WKH^T.7YI^;YYVP@^YSZIOL?YC=XO]F@S_P#6P];]_)^B4*_HEIGM'\J0
MGT#[D21_W+]2/_!OA!_J7WC_ &FQ$?<OU(_\&^$'^I?>/]IL1'W+]2/_  ;X
M0?ZE]X_VFQ$S?#O8O?\ *^[;XX>[PA''C)**NYKK+H>/27D=XNI]87%OL:?2
M>%IVAY<+C11]PTL1_E4\T99#8  ?>7O1YGJ(($2Z/$1B(Q$8B,1&(C$1B(Q$
M8B,1&(C$1B(Q$8B,1&(G\C& L C#!!   1#&,8M!   =;$(0A"WK00AUKUWO
M?X:UB)5-XTNB_'W;S]T^@XC9IQ%W:S+44=BVON>1FVHT7=CE?/SP=%TS5X[5
M4JB7VI[(.I4Y"@/C^DC,6:T#V!&G$?H9Z):WB(Q$\K.9S"ZQALIL2QI7'8)
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ME9S*SW&(V1/4,+9S'E3#J@@;_9]F2 LHTDG:"&P"+)EDAE+P/9VA!2I"AFB
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G1&(C$1B(Q$8B,1&(C$1B(Q$8B,1&(C$1B(Q$8B,1&(C$1B(Q$__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>40
<FILENAME>tm2227887d1-pht_ipsc4clr.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2227887d1-pht_ipsc4clr.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@!5P'( P$1  (1 0,1 ?_$ /8  0 " @,! 0$
M       '" 8) 00% @,* 0$  04! 0$             !@$#! 4'" ()$
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MD2ZW<2 2*'3N*T&;PU]T_DI,3D@UMW%M) (<*.:'-((T(((*LJ     > ![
MS/6K7.$3")A%'-_O 5%-@V0CS24E*@\,U1%QZ9NFDP*@9PNZ5(DY<>611VD4
M"II&,;J]I0 1#3YC+1XN#<6[Y7 [6]M MY@\)+FI7,:\1Q1@%SCXZ#Q*US=K
M5FL<AVVZK:+60[AD:MI\-ZXU:UB) GQ)\<$FS2+B:ZX3:!^2HDH0"*@ ]8'
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MS \^%55=#:M[1D/B SBJWYPZAF2Z*)XXQ#^(H>E*1,"(\>'N&*?@?R^?',<
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M]A%SA$]F$3")R&$3")A$PB81,(F$3")A$PB810?NDX?9]]P( H#)N)0ZQ*<
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M,;I(DB0A"\])"$ I0   ,SH+6WMFEMNQK 370+ N+JYNW!]R]SW 4%23HO<
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MZR1;1E<51<>2\67<(.T55GX%*JD)0/Y(CQQTB/H7,W\-Z]C(X!;RQD[V]A(
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MZU0X$? !]OAA%@_;ZX1=Z&TFZ;'(HW<ZDUPX0.F(BF=%:G0RJ1DS"(B8AB&
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MX1,(F$3V81:X^\?;E)U1W"]E\]9WRZZC.=WNLC 0K8\M8I'U&GY9BW]'%H&
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M0 SIPTO\Q18E(G!2=)HNC.ZE )IF'@!Y;^_]/(B/,#N^JNH[\%UU>2'^9^R
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M<J)+G"+@?8/WA^CG^M].$4"=JBJB_:_VX+JD!-5?0^H5E$R@ %(HIKZO'.0
M#@."F$0PBGS")A$PB81<"(![1 /I\<)4#BM=6Y*<SVY$[)J<]+O%(ZVR<M&N
M).+(DDY1C6$L#.,)'^>BLW*5NPBT$P.4@D7Z16Y,903CS*;.7F,ZH=DX:/E@
M>X,J&T%*M'$4\M:]]->*[=T]:LBP<$;6F-[VAQJ>)(!+O \:<N')1'<=TJ0,
MV[A(*+;.DXQ<[=X[?&7 %79##ZM-NDB9(2 BJ)B"<QC=1@$0* <":,.#6N(
M '=PX4%/ :*616SG1AW%9W2[PQO\,Z_D""$A'B!7S%P!G:1%5P_D#DI_*X5:
M+&1.'(E(HF8A@$#!TF&HD='1[:Z'B!K_ */'18]Q:\6':6.' \#X*X=FFW37
M2D8[CG#H!E("I17JG1BJ2?I+$6*B7#H5"J 09)%"0,J*I3"!#%%0 /T])NIY
M"ZDBZ?=<PGSF$?B-#0@5IVFE:#MX+A^,M(YNIF6L^C!<.J *CRDD#PJ->Y4K
MFJPR@-B.-QR$^LA&1>MC4I6NI-%!2.<UE3FD)8CD'P@HYZA*T(W].!?SG/F
M'NYSIV3?^YCA=E'-NW3->-:[FM&O+2B[0R&3U]P(V$  4&GU+'F&^Z\O()H/
M(608,5%0*#WS47 D X@!EGC=,H&23+XB;RS+F /8 CX9K-K20\C@L]]E/MJ"
M?R^M6UU/*>EN4<U)).6L?.-9(4F)7:SB/DI C0CMN0C4JIVB;@\:R67!T4A3
M&(U\LQO? N3+I&]E-V;'=2W#"0TTXU[>/#O7.NN,?"+,7X8#<^H YXTTIS'#
MC\=5^FUWRKV\JLC.0=-(J&:E;E $?+8.Y0RJDBS,4""J+H[5LT7,<XB7RU4@
M(!1*83.K;F7]XL@8X49#6E 0USG<Z@\0.?#B$Z%M6?NV6X+2'/EINU&YK173
MAP)/#CSJJ1MI2)[>*31]25))Q-$J=:C8I!_-+)^>$>Q2,T:*/2LD6I5WK@$1
M$P$!$I2\" " @&:'+Y&3+Y.?*2M#9+B1SR!VNU-1RJZIIRK0 !=$M;;U-*^5
M9YKS:*=U7<PDA&H,I'R#.2=!SK-'39(Q"N$R%5#E%8!6 ?+,)P.4O/4'&:X<
M"!S5+FV= =Y=5@^CXJ^FE7*"E+!DB"I314Q,,UR'2430(*SPTHU(R$Q")J-B
MQTDAST>Z1;K)^44<ZOTW.)L3&"7%[:@U\3P/-<*ZJ@]#.3 !H8[:0!WM'$<M
M?X5+F;Y1U1_M2],M9:YO&P9%([EG3*K-V15FB?I</AB8]P\1CVP<")G4@LD"
M*10\3*'*'TYAY&[&/L)KYPJV*,NIVT%:5Y+:83%RYO,VN&@_IKFXCC!XTWN#
M:TYTJ3\%_/'<JT79\386^QG"\S*7>8:V>Y/F[ERB=_84I5A.<M%5E5W+6*8/
M8Y%!FVZQ*U8-TFQ.$TRE#RQ>9"XO<A)D)W%TLA//@-:#OH-!W+]&\/C+3IZU
MM\7C &V5HW8P ;=S0*;GZFKW.JYSN=:=YQRRQT52W-UV9')J_::QP-1K+DSA
M<3L3I5R2L 5X2-!*)2G;.KF[.J)?%1/CG\@!#7R2.+-AY$FOBMM9123S1P.-
M8P3]JK6HJLLJLX766<.7"AEG+EPH*KA=8_ &454'CJ.(  >           81
M<YW$Z*?0P1V[=D8H%^66U?7/]7U#^ ?:&5[U3BI,U?87$;.(P2IQ/$SAU4_*
M4, ),Y'R3JHN4@, AU/C)"B<@" ***$-^4!A-D1.+CL&A+2*\_AW]AY*-YO'
MM= ;INDS3R'$5^T<CV_0MY/8/?GLA3;9JU\LX>GUI)Q+B!<.E0.9"D7%&57@
MXHI^@!,6%F8"4:H$'^*9)H$Y'HST3[<9>7(XA]G<.W2VK@ >>QP\H/A0Z\]!
MR7A'W\Z9M\/U)!F[)C66^2C>YS6B@$T1 D('\H/C+A^FYSM 0!L"SH2X0F$6
MNGN_F1[?=[=NO>G+ J75&OZSM?M][@Y-)-11"BZPWC+ZNM4-N*=$"F30J6M-
M@Z<CD9AR(E"/B9UT]./DMEA J+85'OV<HR:2,>Z;O6+YN@[9O&BR;AJ[:N4B
MK-W35PB8Z+ALX1.4Z:A#"4Y# ("(#A57<PB^1.0#=(F#J'V!SXC][[V$6#;-
MO,?K2@6^^2I05956 DIE1MYQ4%'RK-L<[2,;*'*8/6RCSRVR!>!$ZRI2@ B(
M!F#DKZ/&V$U_-_1Q1EQ[Z<O$G0>*VN#Q-QGLO;8>TK\S<S-8*:TW$ N\&MJX
M]P*_GIMD2XV3L*)W!L!V]E-AQ\C,RZ3@'AQCXTT[$.812N1[<R103J\%&NSH
ML$"] \]3A457*RZRGF#+9:]RUU+=W+R1*ZK==&MJ2&AO=6E=*]B_1' X*PZ8
MPT.!Q3&1VL3 "6C61X'GDD-272O.KW5#> :QK118HC&P>GZ;-%A$'*S=W:;E
M:R-7;D7"CBR;&N4S<9@@*])!2CQL-C<'*4 $4&H<!U='CJIG;CZAY- ^A2"%
MGSEP(1QV@>"KE(R4A,.S2$J[5?/%!,/F+#R1 !$>$F: B*;) @   1/CZ1'J
M,)C#@/<]QT- IM;6EO#$WT@/4 U-.:@F_$0-LO4OFJ'(8'4_T@5$JA1,5&-.
MF!A\XARBHL0A/ IN.OJ^C@>R=%S7O_RIZM%M"V2#_A0YQ?MIM?"PFFTU[>([
M.]<XZG9:#W Z>EGE<VY9ZM&!F[=NC>S\6X4_%7\)X4[U- @41#D/$INHO^H.
M \E.4?:4Y1]@AXAG'"75&TZ"OZQ7371ME8/4 +=HT(UT%./P4X:YM*\[_P T
MYMR[5<H)A(0,N@[=-)9LHQ5(LF*4HV.B[;3$4J!%V;M)4C@G1U 8%$@4-F6T
M\C)!)$2R1I!!!H10J(9G&0F)[BV-]M(US',<W<TM<*$.%=01HX4!/(A?T%=I
M^VI3:^JF3FRJD<7"IR3NFVIX MBJ2TA%)-5V%A5;,V[5JT7L<"^9OET4DTT4
M'*ZJ29>A,,]/])9E^;PD5Y,0;D$L?3])O.G*HH:<E^=_N?TC'T;U9+C;2O[M
ME8V:$G]!]:LKK_1O!8-:D 5U5G<DJYXF$4$]S^HS[[[=-WZ70>I1C_9NK[I3
MH677!04X.Q3,"]:UJ?,"0"<1@I\S9X <&Y%$.0$/ 2H:\EB':-W#,>X'5+)Y
M+I?9W<6OETM==P.LWYR)6/6>XZ\Q;)6NORS 3 Y)%2:Y@DX)\8A$9B!>LWZ'
M*+@F%56EPB81?D94O0)TQ*IX ( 4P>\ ^(<"'/M#!T%4X+4CWO7^2MFTX[7"
M1CI5/7<;&3S]N53E&7OD\B\4:&=IATB(5.L*)*-RB(IG5F#',7S&Z)B\1]T<
MS(^[CPL1_81M$CZ'B\[MH/<W1U.=>6A7K3V#Z6@M,/+U;)0Y&YE?!%4?@A86
ME\C37\3Y 6:4(#'"IWFE0@+R(!S[>/$?Q>//U<YRNO;Q7H=Q(:7'LJJN;*L2
M\U8'4<541BX)P+1! O4":S]'I]8Z6*(]*BJ+CE$@B'YL"&Z>.LW.+,]S7EH.
ME%,,-91,@%SQF=S/)1F[Z09.S'+U$!NOU$ W1U%\HPF+U !NGD/IX'C%LYPN
M(_3($OJ,H:5IYARY_2MK=!OHN+A5@:ZHX5\ITKR43Z)%$=?,?)34(7U\AX*J
MD5.(&5(9(!,1% O*:!B$$0*'4)1-P'/ =8]\VW<77T\=[*)I/EK0AP9LH/2;
MI3<ZOTKGGM/+9/Z/A-C"8(G7%P"TOWZMD(K7:WCX:*9FSEPS<(.V:ZC1XU5!
M9JY0,)5$5@]A@\>#D$/ Y#<E4((E, E$0'D+'.8X.:=.Q='G@CN(C%**M/#M
M![:J^V@-JNJ?=-9;2:NPBT7$S'56\$.*@,7-9G)="N6 KI,%"%.U@9'IE&ZA
MQ$4_2^' ** ::])9N7%9^![#MMI7AD@)\M':;B.XK@GN?TM'U%TQ?8N6,.OX
M8G2V[J5<V2-I<UK>P/ +7#GNKR7]"C<QC)@8P<"(CQP;J\ \"CS]'(![/KST
M\>-%^>VAU' _P?PK]\HB\.R3S&L04O/R/GBSAXYW).$FB)W+U=)HB=8R#%HD
M K.WS@2@FBB0!.JJ8I"@)C &$6/ZLJPT;66NZ2)$DQI]&J=6\M!4ZR*?V?@(
M^)Z$EC@!U4R^DX*8?$P>(X19YA$PBX$Q2B4!, "8>"@(@ F$ $1 H#[1X#G"
M+G"+X.3K 0YX'I, >WZ?O"&" X;3P*:\N*I=:8?[*V)Y7SN052#RW<2*J2:#
MA>,61)T@)@.870M')54CJ%Z $2 82%$>1Y)G<;)C[]X\Q@>2YKJ=I.A/=V\^
MQ=KZ8R<>2Q[7/+1<QC9MKR X@=XY?6J@;"U)87=A?2]<0+(M)=T9XJW,NBV<
MM';HXG<@)7!TBJ(*+F$Q! >HH&Z1#PZC:7P4TM[QD,08\:A2-K#7DQ68V3:=
M!WUFLI!0)%QI579D4V:#@&A!.B')115?&.X6X\E(!+R8..HV19VTUW<LA@;O
M=N%1_)YK49F_M8K5TL[PR)K2&DFA)/8/N5\=J5U=]24SQG2W+4S*3I(MN04D
M'[.-AI-F:*3(DDJ*)0;N_,0*4@E\Y(A?=*(F#J69L776+,$9V!C0: 5T:*TI
M4+B_3N1CL<RRXE&YKW%I)Y;]*D]QXGL5/KU J6FJ2T.S4227?)-U&@G$R:9E
MV;EL_02$XF5$J:QVO2(^]P \_1G)1K6H(UIJNY0N >TDCMTH:CQT50&FM;N[
MD"1Q:](MSG5\H7;I!1&.2#G@RQWP%.@HB0/'E,5!,'@4##P T->7%;A]W"&'
M76BV/Z-A$&UEC6)2^M1J=45:E="B4_I7_P#P3'Q[E4Q"^6T?.XLSPI0$0.9)
M10"\DZLE_1D7JW4EUM.STZ D<Z\NU<HZ\N!\E'"V1N]TM7,!J: <^X'[EZ&U
MZ\E7;.:=!P86EO44<.S+(@5)E+1S*(CDD"/3F%/B39-BF22$"JD,W6$ISD/T
M)7>K,;LE&1C#CO%'TUI0"A^/PHOCHC)F6!V-F+&F,U94T+MU:BG.GQXC15$V
MSK62LSYO/0!$UWI6Q6;UB=0B!UR(F640<(*JF*B90H*]!BF$O)2EX'GD,AE!
M0$<_L73+:9L1\W$+IZIUM-UR4//3Q"-7/IBLXZ,0$7SM16061(!SE:@<!45)
M^;13(*AE#*#X (% UR*)\KQ'$-TKM .U?%_?P" OF(;"W5QKI^55LRU;$O8:
MD13.1;':/#N)E\JW6+T+I)R<W(R30C@G "DX*S=)@<@^)#<E'Q#.NX6V?:8R
M*"4;90-1WU*\^9RZCO,K-<1.W1.=H>X #Z%(6;1:E5U[L8][(=N^VRQS(\DZ
M94]]-_#TTQ65?H5LZ5A=LDD2^\NJ\:1JB1$PY$YC]( (CQFBZGADN.GKV&($
MR&W?0=OE)^Y3;VWO(<?U[B;NX(;$V^B!=V;CM!KRH7<>7%:54CD63363.51)
M4A%$U"&ZBG(< ,4Y1#V@8H\A]S/+#?*QHYT^Q?H,06.V.KO''M^/Y:K!MFQJ
MTC3Y$&Y5%5V!VDD0B0=0F39.4U'7N^TX@S\P0#VB8 XRCVD\.Q9^-N!!>-+_
M .BX5[RJK>Z(<@/(#X@/T"'W/K ?KS!-0:<PI^*$5Y+YQS1,<D62TU@M)6VO
M-$!.4R<HUD55$P$?*;Q"Q))4Y^/$J:HMBI<CX"94H?3E^!IW;OS5JLO,QEB\
MD\11;J_E_@(W?>2G ]+>L:A3$P 82^:>4VRITD'\D%$TO$>  >E0OUYVGVF9
M()+]Y!]-PA'Q'J?PKQ=_F2DA-G@6M(]4.OG$<]I^2H3W$M=3P6S"Q1\C+P$W
M%1$X\K$K)1,BPC++'-8Q](5Z0=M%F[.<8L9ME)PSQY$N%"KI)/&SAJH=,"JI
MG3$Q1[&O+:HM_12[M?\ 2?=QGL#_ .X;L='V!_ZLX!A-5UWG:/W6/VJ[)]\S
M;N$>LW2*C=TT=Z![&UVSENL0R2R#A!3MG,FLBLF82F(8!*8HB @(815NU'\I
MK9VA7[Q73?S,^\37M<<O5'K36<'6NV=73E;\]3SG#&CZ>EM(26MZ!#+K"8XL
M82-CVA3G.8B9!,81*E%9G^BEW: ' ?,^[B_V#=CW]D>VGD<*JUX]U7RK_F [
MN[D>U_9U#^:#MNL16GV6PD;;L)]4-5TZ_P ?'VF4H3Q.K4ZK:1UKK6I7F*L9
M:N<THC;U7L>@+9MY39<JCA(Q4-5LU[O(F4@NTR6B)RR2USD8=UIIK,6R69P;
M"7L+F.VOKLK^?EV-;AX6NM%GYDC+N2,F35JF!C FFF0  (AUXV1W2EWZ=:TC
MX=GJ-K]55U/V5,(]S<;ZU-I^9 K^D;2<-^.XMIWT6JD>?I_N_P!7@&>;2O=(
M:&C8* 5X??115N%!96JM5R&Z4F<XQ6=>/Y22Z+R.1*/B'4!GKU$ #Q#G@?HS
MXE_HRMKA"QE^-U 7"GBJV^/]7]7&8"G-&M<6B@<.*P2QTY:>M=,L9'Z+="KK
M2"JS4R)U%G?K"M/+!)0#E(ET':^]R \@/ADZZ?ZO@PO1V:Z6D@?))E@T>H"
M&;2UW"M:U:.7>H?ENFY\CU3B^HHI QN.).PBOJ5!%#V\:Z]BSP?:''X,@]=U
M"10TX=G:/OT[5+PT-!;QU.O;SJLNH"3E2ZUWTP\"F[<JKCR/ -4XU\"W/^N
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M<[>9:'_4E8ZO#S4K6H4$%\!\?Q9"%UAP)86CB0J@W>.7C;9/-UO'U#]63;J
M4P%6;2BAWA3%Y .0164.D(_WR8YBSM._=R4ZP\C76#:$>70^-5B9R%5342.
M"10AB'#D0Y*8HE,'AX^(#E(I/2>V30EK@X#M+=1\.T<UL)&;P6G6,M+2.?FY
M@\B/O6/U6KQE/B$H6),Y,S1555*9VH15<QUNGJZU$DD2"!2E  ]T/ /I'D1W
M/4_4V4ZMRTF9S18Z_D9$VK!M8&PM#6C:=:N %33Q6GZ>P%ATYC!BK!KA V5S
MP7$$^8DD"G"I.O;S61>''(_1]/T<?6/W S0+=E[6FCE8VJ1+]SK!"(;(K#*6
M?U$?#M@*8%5GUHESQU>(@4G!^M\J];F3XX'J4#C-G:1N=<Q- J3(W[0N=9RZ
MB;)<WCG 01PR$NUT#8W5/;I_H6\38_;[W!7:YR]FHO?7NW2]8D2QP1VN*?JG
MM5LU?@#,XQFR>'8S6SM$76Z.QEWS=1ZJ#N2< FLX.1($T2IID]?Z\#Q%/L7Y
M>>&@6#CVI=V \?\ \GG<EX>/\Q?8R'/@(  \=KW AXY5%XDEV8]S4P\CGDK\
MS/N2?#%*E<L6SC2?9$:.2?)+(N6LBI&!VR%CW4A'N$"*-EE4U%&RA>M,2F\<
M(O<_HI=U_P#I/>Y+]A78O_FO85->TI_13[L/])[W)?L*[%_\U[":]I3^BGW7
M_P"D][D_V%=B_P#FNX37M5#>_KY8G?OW+4O35:UA\S;;;>PT?>L!L=>UW*I:
M;UBXHT7%4C8%?=6:F2_;9IS6EZE[B"EG39HQSJ7;1*[1VX,N/6FB($6Y#0^O
M;OJO5%,H6QMPVK?5RK<0C'3>U;I"U2OV*V.$1,!'C^*IL3#PR HH]*13"19T
MJ4@'<N'"YE%CD4OX55CUEK4;:8TT9(@L5(7#9TFNV4!%R@X:K%62414$BA0Z
MN!(<#%,51(YB& 2F$,QKRS@OH#;7 K&ZGCH0>/P6797MQ87#;JV=ME:#3X@C
M["H=#1IS.W!36EXC%E$5&!&[)L:3*;J4,FW?/71G3=RU2Y #"1!)=4H!RH4W
M48T8_P"C[0W#WE[A;N&C1Q'Q4O'7F2;;,C8R/UVG5Q%:_ 44D5'7E>IW*[%-
MP[E%D3).I:0=.7;I4%#I*+D;)K+':QC591$AC(-2(I&%,@F*(E <WUABK+'-
M_P"'8/5I3<?Q$>/W*-9/-9#+R!]X^K!P:-&CP'W\5G0@ ^T.<V2U2@NTZ=3<
MN73^I+QT-YX(*? _0ILXD[DH]#E8JS!/K9F=)\&'I05 50,8P#UB(1?*],6^
M0D-Q"[TI]M* 4:3VF@U*F6$ZPN<:UMO=M,UN"=227 <@"3P'(+'V>DYYRHU^
M+6!HP:G,<T@C"H&6>)"ESZ0&+^3249K&.8>5#*L Z"B)2E$1\P-7;]%#RNNY
MB?T@VH^@K8W77LKMXLX0#^:Y^M.%:C^-3S7:]&UB*;1$6D8C9OYIQ.H)3KN%
MW*QW#MTX4*4A3N'3E4QSB!2EY-X  < $TM;6"SA;;P-#8VB@4$NKJ:\G=<3F
MLKC4KO24<TEF#R.>I%5:OVJ[-RF/AYC=RD=%9,3!X@!R'$/#+SV,D88W@%A!
M!'<5:CD?#*V:,TD:00>\*#GFCP,]3^'V1XA%'X]6BZ:MG4D7@H I\/>D!LV0
M\T0$0!5NL5,XB( ).E,L2FZ/L7S-?&][8N;:_9W?8IK#UUD60/9*R-]P3Y7:
MBGB!H[N^M995]2UVN.TY-=9_.RJ*O4V?2;I7RVQ2%*5(4HIL="&*[*8#'%P#
M<%?,./2)2 0A=KC\!CL<[U(F[I0='.\Q'@>7VK39+J7*Y1GI3O#8"-6MT!\>
MWPX*4P#CPS=+0)A%^*Z";A)5%4I5$E4SI*)G*!B'(<HE.4Y! 0,4Q1X$/I#*
M$!VAX+Z8]S'![='@U![#R^A:/M^Z&E] SSQPR9+N--R#H5JQ8$4TS-:65VH!
MB4NQ^01,(MA'JJ>5%/E"@@JT!-NLH#H@&<^?.L^C[G#W<F0L(C)BW^;R_P#U
M?;NK6H)_"13OJO;?M=[G6/5>-BQ&4E;%U/$ UP=I\RUH :YA_P#:<G,XBFX5
M!H(5 2F !*('(8 \0$#%,4P?0(<@(" Y 14M![5V%S2QQ:?Q#CW=Q[PH(M&I
M7 N57M54;@@L<RJL*Y/Y (&,)C'^%N>DR0)',(=*"H$*GX\* 7I(&.^WJ=S/
MQ+>V&:= !#<"K.1_AUX*-%*=;$1$BU:F"* / IIMO5_>$%6)W2!@^\<0SX^7
M>MV,M9D?TC5W&% N$BMY*4(JT*("/JI14C!L0P<>Z<@BJ_, _61 _'XL?+R*
MW-FK6)NYI]0]@XJ=*O4HRA1[R2>.P=R!T>I_(B@*92($4 Z;-@U(*RW0)^GW
M0,=5=7@0#Q(F7*C86"C07'L'$]P[R= HG?WK[P^I)Y8FU-.P<RZI_-&IX<"M
MWO9QJ:5UEJQ5[:68,;C?YE2X3T>=-,KF%;KL&,= 5UT<IE!,YB81@D+DG4)"
M/EW'1X#R/I3HO"R87",AN*"\D.]X'YI(%&_ 4KWDKP-[L=7P]7]5ON++^Z[5
MGH0G])K2=TG_ (CB2.'EV@ZBJMMDO7,DPB81,(F$3"+$KW4(J_4VTTN<*<\1
M:8"5@9 $N@%B-95DLS55;F4(H5-R@5;K2.(#T*%*8/$,QKRUBO;22TF_HI6%
MI\"*5\1Q"S\7D;C$9*#*6II<V\K9&GO8X.H>XTH1S&BT+W&G6G6%OD==WEOY
M,]%%,O'2A0*6.N5?!8R#&UP@@!0\AX!0!VV\5(]WU(GZB^4JKYASN#O,#?/M
M+H5:7$QN'!S.7^MV\!W+]!.D>J\5UGB(\QC7CUG- FC/XX9*>9CN1%=6. &]
MNM!J%B\@P;2C%W'/4_.:/6ZK9PF(B43)+%$AP*8.#$. #R4P<"4P (" ASFD
M(J-IYJ61O?&\/8"7@U"J[9:!/5Q54X-UI6*+U'2DV2)UCD2 2<$?M$@,N@L'
M4/)RE,B8 ZNHHCT!CNMS7]GP4NM,S!+Y)3LG--#S[U@)W#=,1*==(AB^TIE"
ME,'B(<" CR \@.8]"#0K:?,-(\NI7>CV;R55*A%,G4FN<!$I&*1EP#C_ .45
M+^80+_JE#$*'UY4->35M-JMR7D5NT/F< .SFK&T.E%J#=W.SBK<DFJT."OYP
MAFL/')F%=9,7)N ,LJ")#KJ>"9>@"% 0**BF3&TM-& DD@4[:\**'Y6\^=F]
M*)K]CG  =YT'P'$]RW=]E.NY*H:?1GYEE\-F]D3*UZ<-#(K(.6L,[;L(RIM7
MR+M)%XW?GJ<2T<.FZI"';.W*J0A[G(^F>B,2_$X"..84N)3ZC@>(KR^A> _>
M'J2WZDZUF=8NWX^T8V!CAP<6$F1P[B\N /, %7'R7KER81,(F$3")A$PBICW
M<=OLAM>+BKC2$6YMC4IJ[28L%UR-$+=7'RB:TG55W)P\AI(E<-R.HQPL I)N
MDS(',BB[763A/6O2C.H[)LMO1N3@.YAI^,"I],GL)/TGO75_:GW"_P"B<LZU
MR&X]/71:)=NKHW U;(UM17]%XYLX:@+4N"IBNGT<[:NXR8BG LYB$E&ZC"8A
MWI.0.TDH]<"KME@$HB41 2*DX.0QB&*8?/5S;7-G<OM;MACN&'4%>V[2\MLA
M;17]E)'+8S-)8]CM[7@<2'"E*<"T@FO@5BEPIC"W-$BK*&8R33S!822:8*F1
M%0 ZT'*(G3]2T5,4!,3J*8!#DIBCXYC/9O;0K;6=Y+:2B1FH[#P_TJOTCKNX
M1BG0:)&01][^5Q2Q'2(@ ^Z H*"@_*<P<"(>2)0$>.H<QS!)7DI5#FK21E'$
ML?SKP^"\PE1M*HB1*N3)S\\ 4[)1N CQ[/-=@@@7Q^DQP+]8X^7?W*X[+68%
M?4;^7Q4AUC4L@LNDZM HM&1!(H:)06*Y=.O=,)D'SA(?2M42G  .5(RXJE$0
MZR 'O?;(*?BXK2WV<;*PQP"CNT\_#57W[6]8OMG[BK[E! Q*;JJ4B[;99!,.
MELI8(\2O*;5VYO+,B=\$@DE).$P,!F[5JEU@4'2(FZ-[>X*7(Y87T[2+*V=7
MQ?2K0=#4<R!0Z<5Y]]Z.LK? ]+2X8$',9.(L#.;(MWGFX_A>!L9XNK7ENY*'
M2''C^'^QX &>@UXE7UA$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$P
MB81==TU;O4%6KI!%RV<)G1<(+I$61605(*:J*J2A3$424(80,4P"!@'@?#/E
MPW-+2 6GB"*@A5!+3N:2'#@1Q![532\]BFE[*NL_J19_4\@LHDHJ&O'L>T@%
MB) ?AL6EV"+L5.BD3J'ZU3QK%@X5-^4KD+RO0/3^3)>QCK:8_G1':/BWAX]J
MZST[[T];X%C8)Y(LA9L;M#+ENYP'"@E863&@T <\M'(*!9[Y?^P$'95ZQMNI
MR+   !C+#0I:-?B(?PC6"*N;]J)C>S@L44 XY\?8$0F]J)37T+Z@Y Q#ZR'?
M<NF8S_,9911"/(8=S9B3N?#.W;3D&QO@W@]I=.\'DT+"WG9/W!-S@5H75K](
M>>3ENMC:F#CC@!37U]P FY'V&-QQFI?[6YQAK'- X>):/U2I':^_W1$S7&ZA
MR$#^5&1OKXD2#[%V&/8[OE^ D?2FKZZ!A,4'19RSV51$!*7I6&-3J]=3=@41
M'E,'B(FX_*#+T'M?F9#^WN((N]H+S]8;]JQ[W_,%TE#_ &2UO[DTX.]&)M>P
MU$Q^("LYI[LHJE G(NX7>>6V3;(99L[B?4Q3>%IL%)-1 Z4Q!U,7<PO\736(
M0Z3B1?R2C14@*-1;G$QAGW3_ $)B<$]MW(77.1;J'N%*'M %:=VIHN.]:^\G
M4/5EL[%64;<=A7 AS(W%TD@/YLDE&Z<J-:T$:$$*[29 3*!0]G];\'(B/&3?
MCKS7(* :#@OO")A$PB81,(F$3"*--H:DH>X($M=OM>:3C%)0[ABN95TPEH=X
M<@I#(0,Y&K-)B"D?).8GGM%T51(8Q!,)#&*.!D<789:W-KD(VR0D<QJ#VM/%
MI[PMW@.H\WTO?MR>!N9+>[;S;0M<.Q[' L>.YS33DM?]L[ KC&. 7UWLIA88
M\I% +#;%C?ATQYAC&.F/VOJ+4D69!$# 0I!KX*&*')UC#R.<LO\ VLHXNQ-P
M&1U_"]M3\7C4^--5Z%PO^8>(QMBZAQH;**?M+9YH3IN+HI=YJ=3Y9FM!- P
M*"WO:]W)Q8K)KZL2F3(CR1Q5+M47K9P7Q]](MDD:D\ 0*'/ I=7/AP(Y%I_;
M[J>$FD,;VCFQXJ?$.V_4ND6OO9[=7CZ?-W$##P]:%]!_]D)=/&BC9]K':S-R
M*$GI':I7"!C%$6] F+ B0Y!X$"/JXA,L%0'Z#)JF*//@.:MW274[.-C<?0#]
MA4FB]P.A)V[F9G'>#I0T_P#:#1\":]R]J#TSN^R',2%TO?R%2 !.K8&,524$
M@-R4@]%SE8!VH41]OD(K'*4>>G+UMT9U/<NI\G*UO:^C1]9^[X+"R/N=[?XV
M/?/EK5]>41,SOHC#A]) KQ(5M-.]CLRYE8NS;S<0JL?'K,Y!IK.#76E8YX^:
MJ&5(-VG7+=HA-1R9_+-\+;MBM3JI?GW#I$XH!T+I?VZ%C.W(9HLDF8?)$#6,
M=A)(%2.RE%PWK[WQ;DK.7#='QRPVTK2R2XD-)',<*.$<8+A%74%VXN(X +9L
MD3RTRD\?#GVCR(^/M$?#VYU>E-%YPUY\?I7Z81,(F$3")A$PB81,(H:VAH/5
M6X/(4O-/CY.1;-RM&=C9+O8"VQS0BQG ,XZV0#B.L31@9P83J-B.0;+&'\X0
MP<@.HRV#Q>;C#,C$)"W@=017L(*DO3W6/4W2DI?@+R:W:\U<UKOV;J?I1D%K
MCRJ16G,*H,_\O5#H>#2-PV".5<**'1)?*S#7-NR*8W*;9L-9<ZW>F;HE\ %=
M=PN/M,J8?$8)=>UN.>2ZTN9XSRK1P'V5^/Q78\7_ )ALM!*)<MCK>8THYT#_
M )=[J"@J7LN6^-&"O*E=(P<]BF[V*9BLK-K&PJEZNERNZM-4\TI2CT<L!A;C
MY9S&#Z79@#GVC].@N?:S*5K!=Q/IPJW97QIN4RMO\PW2\D@DN\=>Q/=0.VR1
MOH.XM;"#_L!>.EV5=Q*BA4SM=6H%,/29P>]6%1,O/M/Y:6OQ6$ ^KC\.8;?;
M+J!QH]UL&G^4X_5LU6XF]_N@VQ$Q-R3W#@WTXP3W;C*1\2%(=8^7_;WSTZFP
M=GQL5#F!/JB->0ZRDT<2FZCD+<+.91DB@N4.@P$@@6 HB)%DS<&#>X[VK8QV
M[)W/J1?H1LV'X/K7_LJ&YO\ S%B2#T<!C:34TDN'AVTZZB.,-#CW/>YO:TK8
MEK[7M1U?5HZGTF%:P4%&E,*35N*JJSARL;S'<C)/W2J[^6EGZPBHY=N557+A
M41.H<QA$<ZI86-KC;1EE9L#+=@T'WD\R>9/%><LQF,EG\E+ELM*Z:_E-7.-/
M@ !0-:. :  !H  LUS,6L3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$
M3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3"+Y,0IOR@YPE O@$4@]B
M9 'ZP* #X_=  '*U-*5*I1H-:"O@OH4TQ#@2%$!$!'D.?$/8/CX^&4%1VJJ^
M\(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A
M%QU!]8?5[<(N<(G(?7A$PB81,(F$3")A$PBKUN?N;UMHR2C(6U-KO/3C^O3M
MT<P>O*-8K],05"JZS!O9;Y/QM;9O74;5H5S*-TCK"4RRZRH)MTEE ,4I/M49
MR_S >UN#J7=!=9'8"B,'V?*P9-X&+!RZK^%1M-3A;C5'D)')M1=V=G:8V=20
MCSLBJ^J?IK-B<K)'*!-5DM7[Q]06S9RFJXYO?D)7[9.==,[1(T&R,]>2E_9T
M!OM!>FL+P=F:$-8/L0N+U-%4Z0+ F=-,QE0Z!*E5XMZ[Y-*Z\L+NMSK+9+QS
M$QFP[#97U9UW8+5%U&HZLLK2J7:XV=W H/ABZW#RCPHF7$ASB@4ZG0!2CE4U
M7RKWW]O;9Q:U'DI<6=8J[*Z.D-A*:^MR^OKBZUY+-Z]<X*@6EC%/&=PLD-8G
M)8\K!H!G+]Z51%D5R=)4"455GU)[I].6^/7<2<^MK"8:79GKAW3]QM@UC<4;
MO*0T98X2N(P=J68JRDC/UZ::/6)61G(.45P @B<BA"$[U8DI@, &#V"'(?>P
MBYPB81,(F$3")A$'P 1^K"*L]3[KM8W78[C74$QO2I L=XI<5L)Q2YAOJRRW
MG62\@TV%3*]>#I_#GT_4GL)(MW)3 FW4<1;Y)!591FX(FT11U'_,!T'9=<ZB
MVAKU/86U*[O*SW*J:Z::XHTK/V&7D:$QM$I95U8!88Z0:1[6*J#QTDH<O+EO
MY1T2G*LF)B*QU#W+K/9D=3Y*E6V-F4;[0F>SJJW(91O(R=&?'8)(SX1KHB+Y
MNU(YE$$505(0Z2ZGEG*4X"&5HB@#8O?1I[6,S*0\[!;2E"UV#V-;+=*4^B/+
M?&TZEZILA*O=;C9#0+IX\:P<9(&$_"2*SLR)#F\@!*)0HB&[\="HN;NH[5O#
M.JTE6[1X[$6H\V>@VRQZ[E&\%;:;2)YJDX-8[@SG7 ,FL>FB5:5=)J)L/5&3
M/TD6;U+NTTO/QRSFTSZFF)9O?FFKU*CO4&.J[6K>Y."A;1"5R+CK*_;M[$_G
MZY8F3QD6,7>@N584PX72723(K+ ("'(>(#A%SA$PB81,(F$47[-W)KS4+>#6
MO<T[8KV9^[C*[$PU=LUPL<X[CXI].R81-7IL-/V.0;Q,+&+NWBZ34R#1NF*B
MQR%\<=ZIW+)JO>*A=:Y7;?4['#V"L6VN1EOK,Y%/VSR-G:M-,6TG$V",=)*&
M3=Q$A'O45DER"*9TU2F >!#"JO<"2CS%2.5ZU$BS@S1$X.$A(JZ**A3-TS ?
M@ZY3)& 2!R8!*/AX#A%%TUO76\#LM/4#I_8W^PQ@ZE9G<#6]?[!MR4)7;W/6
MJLU"=M$Y5:O,UVHQ$]-T>811<2CMFEQ&.#F,5-(YP(NM,=PFHJ_8K769JVHQ
M[^BQ$?/W)VK'RRD%5822@]@V-"7L=C;L5H*!BTHG5LV99R\<(H(K-2('."[A
MLDJ5*J48^>A95JR>QDHQ?M)&.;R[%PU=(+).XMV0JC:1;F(<059+$. E4+R0
M0'VX55',CO;5436+[<I.W,F-9UG8DJG;Y9=%Z*+*PN6E<>,8ABDBV5=3LA*A
M;8U%DBQ3<JOG3Q)NW*HN<$Q(L:)W4: ^ P%C>;*A82-LVV(C1,0E:&\K4YE3
M<LZ\]#$ZQ?5NS1\38X>[/EA 21[QH@X\H05$H)"!\K14)7<9]R^E'VRW.H4;
MGY=\:V9[2?A[VNVJ-B'MTC:HTO,A3HBWR,&UITY;65-?I2:L8S?KO4V1A5,D
M!"F$M$JIHC9..F&:4A$OF<DP7\P$'K!RB\:+"DJ=!4$G#<ZB*@I+)&(;@1Z3
ME$!\0$,*J[V$3")A$PB81,(F$3"+5/WA=P.Y:!W!T><UW6MERNG.VB'KFP>X
MQY4E*^M1YRN[5L*U2LL?=6;Z;BK&\=:.U#$2]Y;M8IO(+.'ZT654B20_GBH5
M&LQW7=[$+,A-J26D)*F_F+B%9;Z)V,UL@U-'NW9]OSJE_:G]>[Q@:>=4:5),
MEF0B031?-A-\/.U4%,A5UJH3K_>SOC>+&@K&O="L[1OM*BS-E:Z.JNP*,[U8
M^2NNXZJ?4^TI[]9UP2MBELKU:9R8)(A"K-P:*KK-Q0>QXI%3BHXUMW#=U&NY
M;8&[U"O-D6>P5>!KE9J\\WW[-UV@5B%^7+V\]Q'2UJ#G<<XPM96.SK8Y6E7A
MV![7++-9)$DD59^1%FXZ)WJT%_[_ /;M,?:9C*QLO2.V4;M>X. +:JYIJW5R
MJ;5K=FW/3]:.9'6SR<WR=VYE-;PLZ\?2PP3:X1BH(I.EG<:W'R5:I4J,M2=X
M/<E$LHS]8FTJ T?GA*M [/W_ 'RA7H=<ZC./<)WL5N4=W'647MB JD4^23U-
M6JN1V+R,<M7D^T<23AVV;H-A)K\58+2O=]W6W[9>H36F.UI':VL]YU7KFU03
M/4NQ(2SS/V^[:]D;:6V=7K)/[*<$IU==VJGQJC&&DH1^Z:QLD9HY>G=@1<**
MJW 81,(F$3")A$PBI+W+]L-^VO:S7W4^RV&N+=+ZHGM*6-Y)MKR!DZI+V:'N
M$79JG.:VOVN+?6[M4[!$"= R<@9F^;.E4'*?3TF J%5'MGRJ)6TRE^>N-\RP
MM-ENKJML..<P(NT]K@&DJ%0](.-H/%Y0[^<>Z4VO5G]U8BFJD"\A+*D-P("H
M8E%<7279U3M8W>[[)LJQ[K<IS:3[9%1>.Y"S_!Z*L_U34]5.3P-2?V&0J4;9
MG4+"OT5I=HQ;OUF,DHU.H*?5U555$]=^7G6E=PVK8&RY\EYJ5F#N&([H""UK
MKT-*M-Z;EB=GC$W!G$V=K$7> C(R//&NXV5:NX]]YHG,B4H= N]4^Q8O;OEZ
MW*VW^]V)IM:EZ_AK$$_+MUM=:Q7J\[>;F%NIMSU5/;YAHFV1^M]GKZ7>TABQ
MCGP0K*;?12?IU'R(*.3.&B+W]P=G_<1O2*B'E\WEKQ&YMYJQMB.*YKBR158I
ME"L\72(Z4J]:B4;^FIL%A*/Z8:3E8>^C9JU,.WA$UX\J#!H4*)1;+"%$I"E'
MV@' ^(C_ %Q\<*J^L(F$3")A$PB81!\0X^O"+7@\[/=R-J/M#2]-[B6M(TS>
MI3?4S%(PVO?,VE#K]Q=JN=NM\6[OCNU*QQHRGS>Q9=U7W$=%1LHDLG'%<NET
MV;DL@5%';WY6E$=3 1)MH['=:F6M$[=EJB^LDVC;8VRVGMZGNW:>6JNP(*5A
M']<CC5D8-XU:IMCI(/HU<Y@4]8;RR44^ZK[(];4"^ZTVY*,X&2V=K[3<5J=2
M5KM=2J->DG$4E ,T;4PK+)ZY9UY<L7 $:I,&YA9-T%3%3*  7@JK%$>P'7TS
ML^P7?9;MKL2LV*.W=&2&OY-E)LZ[)L=T;:3V7(QED9-)T(NVP39D!XQQ'231
MRR?)*&,HF!1%,2H.Q8#??EY2FPKSL.QN]BTNF,;<\EI].2UMJLM,N5MLK*VP
M%UU*IO):*MB-)VU'Z6F*M'IQBZL*RG';-H1%613!1Z+TB]+=?97O#?T5%NK[
MO^GM[JTE;>V9RM9U7,0<-1Z5<H37T1(UNFLF>R4I6SL'+ZB*2DG$W9Y:JU.O
M)0R+V-.T81R*!%LK*4"% H>P,*HT7UA$PB81,(F$5/.Y?1&P-B7366S]7R<.
MC:Z+4=OZTD(:<N5NUTC(TG<R5#?3<E 7VB0M@LU3NT!8M6PRK%TDT63,T4>)
M#Y:BB2Z146N"X_*JW9=H^\FN&TJ=?;Q>.V9;5"6T+)(/&UCK%V?=ETWVQSS-
MN!];SMLF]:6:[2KBTN6PV5B@5S,/UC1B[[RW!JA%G&QOE:2DQ>E9*BCJZ#U0
M%YV3/0.G8]JSI%;HJ6P*IVUQS.]4Q-IK"ZL:YL:JV'2TRX04B&T/(",_Y[6:
M8+ Y!P16AV1VP;+F>[^2[A*U)1PUVQ:3T;J5=%'>N[=4S=<>ZMV)W#6N8L:]
M+UY'.M?;>2=1>[6_PYC9A.V;.H]4O":;M4XM:)S[U1&#^4K>AIS6G2Z7;?4V
M+:EU6E3!:+#3;B/O3^L=E/>1VON]G6R.D*I$@XNUKMW<?$3CLBZKY4C:+7(9
M^Y7*BHHHB]:3^55L>;D[I)K3^KH%]9*4SB(%W 2CYNVJ30G;Q3M+26C5F##5
MT'8+5H>:F*NXD5FBD\RC@)(>:$#\1;IOCDYJVT+V7V]AH&^4"*BM*ZRM#_NE
MU_W2:_I6MVTHAIV!E]5[!U'LRNTJ1!&J5I^G%VB?U8*<L]:1":J1Y)1V@@98
MA4QHE%BF\>R+?_=.+%?:FX:=JE"!:;<EJM ::J\):FL9>K[$UVHTNS2LWM2C
M/5)*SZVJ4,_*RL3"/AY@BUA=)-Q;)-TC+$*ZE<^7WL1SM8=P;%V8K+RUJVC8
M[ML&FU79&VZM2V1;;VW4743R[ZO9PDA##1MR5>U5B1&*FV:;5S\!FW*9G"3K
MRCHU3@KF=JO;C%]K^K&>MXVV7:XF))2TH]E;G?=A7DWJ)&3>O"(PQ-@VRVN:
MZP2;N"%.V9K)-UG *.#$\U50PT5597")A$PB81,(F$3")A%QP'U!X_<PB=(<
M"''@/M^[SA%C5/IE6H%=C:E38./KM;AR+IQ<-&( @R9$=.W#]P1!+D>@%GCI
M10?]4<<(J'W/O4?U'OIK7;.Z_5PPULZK]7"RV^>FQB)1G>;L::CZ[3(B;>R[
M2O/M@/;'*4IHA34VKB=>1MN2EBG3:ID(O5.:V*<%'@> ^@?9X_0(?V,HB=!?
M[T/O\>/MY]OM]N$3I+[> YPJ47UA53")A$PB81,(F$3")A$PB81,(F$3")A$
MPB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81:N_F8T3=FPZ@RK>H:
MI,6=&6TCW1PDTG#P;>163GYNBUQC1&(22:1)N*6EY$SI),C)TV%V &(IU=).
MFJHJR;O[-+)K%LW=MV3^ZP4G+;'M\#IBA:*V5?>V.O.5];:^IY**O2:7MI?;
ME!V??'D([?UV^QQ30E9=N),[IJFLN@+ZE$66T2@V^)G[9:;EHW?[#NG_ %C6
M"SZSOD,G*7QA2=9'[<&[&F0D[LB;GX#7VP:96)4%:^\J#F51DI>X$"4.R!-4
M9@M517>[%YS>$QJVS([V7OTG8(;8,A%5VR[#B4(65ME7"KU&0"<CV*FH-"3[
M>*&RR$FV\F5J48Z:.FRS9!:48(LI=_1?2NIA$PB81,(F$3")A$PB81,(F$5'
MV_?QJ RET^)UG9=98UA_O2,KL[:(>L0U;VC(=MUMLM*W SH5@7N(Q*+JL3=3
M>B"<^K!*.VB9G* *()K'2!4JO%@/F-Z"LVSSZKB F5)9/9^V-8FF7D]JN,@R
M*Z,CO4[7N+@LELEI/M*A4),Z;!056!)1TLIZALR6CB*O2%56$9]S_;F_;0CQ
MEO+5+IK8V5HDH)PC?:P=*4CJ0B#FXOV9@D_SS*JH"!Y%4/S;,IBBJ).HO)%6
M:V17RY]F[2UYM"QW344ULBPW>E[#UT];[E>1B=CV12'SK7=*N,758FZ1]>G[
MK#O(U:LI/3LEWQBIFB5#&)_)L)QYJ:*GWH]M=SKCR\PNU:B77#.(B97]8<K/
MPL)6%C2]KN%+;11?B\BSFT)0)VD/4RE79(HN  HMU5A!4J8Z*@-5[,3W8Z$L
MEV5U_5-B5VTV2/DX"/G4(:6BCLX)O:M:67;==FG,@]?L6DI"RU(JSATFM&&?
MF*02G.0B)5E4BJNTMW9]L+>MM+BOW Z=1JC]\]C&5C5V+4R0KF0C4F+F09HR
M)I4&JCABSDV[A8H&Y3;+D6-PD8#B3N5@B'(H0JA# 8AR@8ABB E,4P<E,40$
M0$I@\0'"+ZPB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")
MA$PB81,(F$3")A$PB81,(F$3")A%QP'U!BI2BYPB81,(F$3")A$PB81,(F$3
M")A%JSM'RX9^^U"_T"Z[W8.ZB_F.\:?U,PKVJ%8-W1YKO(NVQ;9:9>_/G^R[
M#^LZ0H\?LR2BHD&*=5:':N%%'*"R_DJ($6?6GL!A[I3=F42<V5+HP>SV/>U&
M2J\)!)1DO&L>\^PMYV3&->J3+Y 'NOR(F1;J*(F3D3&ZSIHE 4S5T5.)[U'3
M'Y9,>ZU]M.GVS:R[F9V[2[U6[5;:I$[#92JD[:W>HE8RVEF=F[LW%L%R[AV.
MEXALLBXL*PN4R]*"K))-%),B^*]\NJ/B'[IO*[FB'%TL"6EK!-ECZU<W:TL\
MTKW90_<HZL"(;2WAM?8KA*SK1S2!<JOY^2%HJ(.RJ'**;$E$7?>_+ON(1/I(
M'N#+!2,7(U-.NNV="M<4V4JM/V3W"7EC7;BK3=U4ZWSBKQCOY5LX<Q,U7DUW
M<.@LJW.R7=1BM0FJZ:/RR6;S7\/JBS[A=2U!)I^FZMM!8RDFA;C-N:]V>;C[
M-INPQ=G<W2:8P*4]2]IH2J#52-?K,9.-4 SIRBZ*1HT5?%94KV!3UD<[?LVP
M]S0\]L'<VI-F:CL,S5]3_8^I1D5==94W5U?EH.FNMAVIVVDJ]#U(SA]YLJL$
MJX=B1(6#9%!N0J+8A78GX# 0D'Z@7?P:(CHKU0I^2+GX>S1:>H%+K5\H5O*Z
MA+U&XYXY'VY157LX1,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$
M3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB8
M1,(F$3"*@L\02?-&U4I[ <=@^_2!]T6?<-VV"/X@??U\*BOUA53")A$PB81,
M(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$
MPB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3"*A-C734^9]I
MM%$Q%%6W8AW)F?%*("=J1[W ]J@1AE@]I"O31SL$N>.L4%..>D<(K[81,(F$
M3")A$PB81,(F$3")A%#N_-VT_MVU1:MMW<DN\AZTG&MF<#6X\9BV7&T6.885
MFET*EPA5433EUOENF&41$,@.3U,@]13$Q"F$Q:A%5:/E_FAW%JE8FE:[*].,
M90A7C+7]X=;AVS<J\T7 %&\=:K;296AU!Q86R1@*[)&(/&":X&*@[<I@58]$
M7>^'_-*_2WL"_9WW$_O0PBY^'_-*_2WL#^[_ -'G<3^\_":KCX?\TK]+>P+]
MG?<3^]#")\/^:5^EO8%^SON)_>AA$^'_ #2_TM[ OV>=Q/[S\(N?A_S2OTM[
M _V=]Q/[T,(N/A_S2_TM[ OV>=Q/[S\(N?A_S2?TM[ _V=]Q'[T,*FJ?#_FE
M?I;V!_L[[B?WH835/A_S2OTM[ _V=]Q/[T,*NJ?#_FE?I;V!_L[[B?WH835<
M?#_FE?I;V!?L\[B?WGX1/A_S2OTM[ OV>=Q/[T,(GP_YI7Z6]@7[/.XG]Y^$
M7/P_YI/TVWL#_9YW$?O/PJ:KCX?\TO\ 2WL"_9YW$_O/PJI\/^:5^EO8%^SO
MN)_>AA%S\/\ FE?I;V!_L[[B?WH85-4&/^:5]%M[ _PZ\[B?WGX5?%<?#_FE
M?I;V!?L\[B?WGX1<_#_FE?I;V!_L[[B?WH835 C_ )I7TVWL#_!KSN)_>?A$
M^'_-*_2WL#_9WW$_O0PFJX^'_-*_2WL"_9WW$_O0PBY^'_-*_2WL#_9WW$_O
M0PFJX^'_ #2OTM[ OV>=Q/[S\(N?A_S2OTM[ _V=]Q/[T,)JN/A_S2OTM[ O
MV>=Q/[S\(GP_YI7Z6]@7[/.XG]Z&$7/P_P":5^EO8'^SON)_>AA-5Q\/^:5^
MEO8%^SSN)_>?A$^'_-*_2WL"_9YW$_O/PB?#_FE>/_.WL"Y^C_H\[B?Z_P#T
MGX1<_#_FE?I;V!_L\[B?WGX1<?#_ )I7Z6]@7[/.XG]Z&$7/P_YI7TVWL#_9
MYW$_O0PB#'_-)^BV]@?X=>=Q']K9^$7'P_YI7Z6]@7[/.XG]Y^$3X?\ -*_2
MWL"_9WW$_O0PBY"/^:3]-M[ _P &O.XC]Z&$3X?\TGZ+;V!_L[[B/WH81<?#
M_FE?I;V!?L\[B?WH81?"D7\TM4ADPNG8*U$Y3%]0GK3N&='0$0$"JE;*;6;$
M7$@^/2*A 'V<X12=V[]M<SJZQW+;VW=DN=W=Q.RHV$@[ALA:OM*C7X.GUM1Z
MZKVL]6TEF\E$J1KJ%D95V\].=X^D)&1=*NWSIPL8GED5LL(F$3")A$PB81,(
MF$3")A$PBH-W_IE5KO:LBH '15[\^T7S4C@!DU?3;09OFXG(("4PH/&J:I/[
MU1,I@\0#"*_(!P  'L#PPB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$P
MB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3
M")A$PB81,(F$3")A$PB814*[^Q (+M2\0_Z^G:6/XMC)817UPB81,(F$3")A
M$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F
M$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81:*OG4=K'?#W
M#?T0W_9AN&X:]5@.XO7\?LV-AQ8NH:NQSVQ1KJL[Z6C7,:Y75=::D6B[AP5-
M4H+M78<D-Y(83CHMW\#&'A82(AU)*1F#Q<8QCCRTPN5S+R9F35)L:0E')$TB
M.)%X*7F+J%(0IU3&$"@ \81>MA$PB81,(F$3")A$PB81,(F$3")A$PB81,(F
M$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB
M81,(F$3")A$PB81,(F$3"+Y*<A^>DP&X]O \\<_]K"+D0 ? 0 0^H?'"+G")
MA$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(
MF$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$4=[>L4
MG4-3[.MD(JBC,U?7MSL42JX1*X03DX2N24FQ,NW/P1=$KIJ7J(/@8.0^G+MN
MQLES'&\T:Z1H/@2 OI@W/#>TC[5_.-V6=Z/< YV5VMTTUGC2P6Y=G7-OM!$M
M:@?47-TV7;Q1)N3>F8"[;V!PBF59V]:';N'SDH*.3*CU<])S'3N*@M\B]C7"
M2U#/2J7>6I&G'70G\5=."F&1Q%I%%<R, W1TIYCIIX\^_P""_I\#V!][.8J&
MKG")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB
M81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$7A
M6>#BK/7)VM3K<KN#L,/)P<RT,HLB5U$RS)=A(MA6;*HN$07:.#DZB'*<O/)1
M 0 <^F/=&\2,_&T@CQ&J^FDM.X<1_"M5O:9V :>CV/;/NZ,74!*CT]&V0\*4
MTHL]6V!96HJRT\]GPG_0.H,QE@5)&_# 42>(D.5V" J-5)#D<_DYA<6TSM9G
M#?4 5 X"E*CZ?@MO>96\D=-#(='NUTIPX+;?[/#(XM,F$3")A$PB81,(F$3"
M)A$PB815GK_>5VLV>3FH>)WQK49*O()N9AK(V9C!F9)*6C8], ISSAXU)5=.
MRZBLC91),QU4OA2JARE2,D=0J560R/=!VYQ:$NX=[QU2 07Q#XN@A?:R\>L#
M1)7)Y-->/923A^"S C)854P2$Y 2-R'NCA57ICW$:%*;H/NG5)5/.0;BF.PJ
MD!P<.3QR;= 2C+@8%5U)AH4A1 !,+I( #\X3DB\.$[J>W2?>S4:QW'0D)*OW
M2;U[*1LS8&5=D$K?79Z4JTO$-F-@/&.I(6UD@WS J[8BS9=VR<))*'.BH!25
M7$?W6]M4HK.),-ZZJ7)6E&J4X["\5U..8+/(IS.MT3R:L@2/55-#,E7)BIJG
M%-$@F, !A*A3K'2+"7CV,K%/6DE%R;-M(1TBP<).V+]@]1(Y:/6;IN=1!RU=
M-U"G34(8Q#D, @(@.$7<PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$P
MBZKUT1BS=O50$4VC99RH!?$PD03,H8 #ZQ*7/IC2]X8.)-%\2/$<;I#P:"?H
M5>4]LV$) '"J+(T>*WOL2HFZBM^?8FY$_F^>!?X0@)1'^ '/ 25V&MG1;&EP
ME'YW\7\:A@ZCNVS%SVM,7Z(T^O4JQ:*I5T4EB<@55,BA>? >DY0,'(?7P.1D
MBAHIHUVYH=VA?KE%]*--@W1W609LXU)$SUX0ZPK."F4(@@0P$#I2 Q .HH;G
M@1'@O'L'GPVF-Q\=V3)*3L::4'.O>M'F,K)C]L<309'@FIY4IRYKYU[='EE]
M:SDDT0>-"$7*N@44R+HG-T#U)B<_2JF?VB'!1 P< ' Y7)6,=K1\1.QQ(H=:
M4[U3#92:_#F3@>HVFHTJ/#M4FYJEO5\**%23.H<>")D,<P_44H"81_$&5 J:
M*A( J> 4 +[?E D3G;Q[(8HJH@1 _G>L40 > ,9R"GEIK']O'EB!>>/'VY(F
M82,QC<\[R.S3[5$9.I)!<48P>@'4U.M.9K_$IY9NDGS1J]0$10=MT7*(B' B
MFNF50@B'T#TFR//:6/+#Q!HI9&]LC!(W\+@"/BNSGROM,(F$3")A$PB81,(H
MSW4RD)/3NUXV);.GLK(ZVO+"+9LDU%7KN1=UB4;LFS-)(!54=+N5"E3*7WA.
M( 'CEVW<QMQ&Y_X ]I/A4*Y"0)6D\-P^U4W^57$RL#V/ZB93<:_B'2JESD4&
MDFU79.1CI"Z3SQ@Z*V<IIJD;/&JI54A$  Y# 8.0$!'>]73PR=0W#HW-+*M\
M-&@+99MS7Y25S/PEVGT!7*MVV:93G)(Y\^7DYLY"K# 5]JK,S*#<XG KM\S9
M@?X6S.*1P(JZ,B14Y!(F)SATY"K[,6%@/VSQO)H -3]5:?%4Q^%R63)%I&2T
M"I)HT?72OP675ZQP]IAF,_"/"O8R12,HV7!-9 _*:AT%T%VKA-)TT>-'*1TE
MT52$516(8ARE.40#-M[B&ZA;<6YW1/%0?]/#XK N;>:SG=;7+=L[#0CCK\*@
M_#BO<R\K*81,(F$3")A$PBKM>^Y.JT;8JFK?LE?;3:T*S 6MTG7&57;Q[:*L
MTC:XN'Y?6VV59-RNX<TN0Z@0!8B8)EZC 8P%S$GOK6VD$4SMLA%0*$]O8#V%
M:ZZRMA97#+6ZDVSR"K1M<:@5Y@$#AS(6.I=UT.N>4(GJ/;AC0Q53R0<ZF#TQ
M4>OS!Y-M< 6Z?+'^+Z^>/O99&6QY) DU;Q\KOX%C-ZAP[C(&S:Q EWD?I3C^
M;K\*K\U.[.$2CFLH?4NW2L7JP-FRP!JDPJ+"*H 3RB[5%8HB*)O$2@'A][ R
MV/+0\25:3IY7?]U?+^I,*R%L[IOV+C0'8_4Z\MM>1Y*I+K5O8^%W4F%>Q)1M
M?G\JG;5)ME6M,,)]2=04DEF]C"78;81<(S;)S).%D7152N4%S^:F8JA2F"IR
MV/$@A<_;*>1:X<32NH&E>? <U]NSV)$WRYEK,16@:\Z#P:17NXE8K)['[$%M
MH$EWW:O<$]B$:OF:RA:C04_BR31:*:@>0(CL8(N;4C7%/: R.IYQD56:1T??
M(D8( WWH]L3=R63LM"V>*29C][)F-8Z!ADEW2/B#&M:P%V\N#'#5KBI6_"Y=
MEG^\#;3NL_39)N:QSALD<6,)V@GS.! '&O$<%@KY]\MUE,!.K=H%I02C7GQ1
MU&-J=2!K#J?C)2-39V>1A&VQ3QDA9*N^@RMFCU0AUXY-9PDF)".5@/B2>^WM
M)'<.M3F[5TS98X_(V9X+Y6&2,,>R-S7AS&EP<PN: -2"D6$RLT++AD$GIO9(
M\5&T[8B&O):XAS=I<-' $UT!"D61VUV,S=E6L+[M*NDS:8DEU25D"ZUH\I(I
M%L,S;;A>2*)(7I<717\OL><?NA$AP \P[.' *J<_$'OS[2W%M\W#F(S:[6.W
M>A<@4DD]%AU@&CI?(.UVBNW& S-JW=<V[XV5<*NH!5K=SA4FE=NO'4<*J02-
M^TM5G(S9NT.RN&IE(=G+O'C#5+I1X:OMTH^$0?E>[=56DD8[I0.D"A5"@X;M
MU_%5NBHGTN/+XZ2/U8Y*L[FN^S;6G?10P]1X7TG3&<>DUU"=CQKH/T:GDK#Q
M/<K5:W%UBO0^F-I1L02,CXNLQ[+]40,V\6R:MFT<Q;E1VP9)HDU:>40I#B02
M%  X#C*G+8\.#?4&X\J.)%>W33P-"OH]0XAOIUF_I?P^1]#PY[:<^:]4O=3%
MG=OV)=1;<%U&(BN\2ZM2AY20$*<3@<VV 34X*8/ @F'[F/WMCRXM$GF''RN_
M@7T,_B#(^(3?M&"KAM?H/]FA^"]ZC]Q\#>9Z!@DJ+L"NA9'K^+B96PIT<T:X
MDX^&E9]9@8M=O%AE$%31<(Z4*<[8J(BETB<#&*!KUM?VEW_9W[CX$?: KUEE
M\?D*?*2;ZU_-<.''\0"L3F6MDF$3")A$PBB2W[TU=1992"LEF!I,) F*S!O%
MS$@JCYJ2:Z8+J,&#AN@8Z"I3@4YRF$A@'CC([D>J\#B;HV5]/LN@ 2T,D=0$
M5%2UA:-->/UJ8X3H#JWJ*S&0Q%H9;,D@.,D3 :&AH))&DZZ:!>K2MLZ_V&LX
M:U*P)2;MHB+APS,T?LG*:!5$D3+@D_:MC*HD56(43DZB@8P (YD8KJ'$9ISH
M\=,'R,%2-KFD#MHX"OP6'G^C^H^F&L?F[8PQR&C3NC>">RK'. /<:+P[3OS5
M-.EEH.=M (2S8>ERS;14R_%N8  1(LNRCUVB:I0,')!4 X<^(9AW_6'3V-NC
M97=QMNFDU;LD-*4KJUA;S'-;##^W?6.>L6Y+%V9DLG<'&2%E>(T:^1KJ:'6E
M%D5*VC1=AE=?9*>1E%&)2G=H"V>LG#<AS"0JAD'[9JJ9(3AQUE Q>?IS.Q6>
MQ6:W#&RB1S14C:YI .@_$!]2UF?Z4S_3#F-SEN8/4KM.YC@:4)U8YPY\RL6L
M?<+J.JRSF#E[64DHR5,B[;-(J9?E;JD,)%$U'3./69^8F<.#E!03$'P$ S O
M.L>G;"X=:W-Q2X:=1LD-/B&$?05ML7[;]:9FR9D<?9%]G)^%QDA94=H:^1KJ
M=]*'DLRI>QJ9L)NY=5";2ETV9B$=E*V>M%FYE.OR_,0?-FJX$4%,W28"B4W2
M/ CFSQ>:QN:C=+C91(QA =HYM">YP!^C1:/.]-YOIJ=MMFH#!*\$M\S' @<:
M%CG#ZUF^;1:-,(F$3")A$PBQVQ6*&@&H#+K !795$DVI4Q65<EZ0*J4$B\!Y
M8%/P(F$I?'VYDVUM/<O_ & U;K7A18=[>VMG'6Y/E=I3C7M5>TPUXG( Z%6Q
M':@KYI8\[=J*? &Z@1.N"P*'2^CQ]X0]IA]N2.N6]'92/=VU%5#P[!,G,P]8
MM_1H"/K4W--@U$\0_F%I1O%QT.AZB14DC%9E8M@'I*LH*AN@4C&\ $HF#GP]
MO 9H),=>1S-B<PF1QH*4-?B#]JE,&6L)K=UPUX;%'^*NE/R[JKPZ3NO6&Q)!
MQ%5&U-9.2;D45,Q4:2,<Y501,!5'#5*39LSNT2<@)C)]0% 0$> $,NWF(R./
M;NNXBQO;4'["58QO4.&R\IAQ\[9)0*THYII_K-;7X+Q+S-T:>43:N7[WU<<=
M0B;Z.;><D'6( JB(J"FFY3Y( @)1X ?8/B(#E8^'(PC?$UOIN[2.7UA866N<
M1<[6S/=ZK20"P5IPJ#44/=\5^-/L-$K0J)H/) R[P2$</GK/I*4A?XM,"H>8
M*:0&'D1]X1$>1'@  /N\M<E=G<]K:-J: A6L9?XBR_9M>_<XZN<T#[.7Y%>/
ML/N@UGKJ?)6Y!:4EY(A6ZC\L&U2=(1R;I(BZ'GN%W+9%151NJ50")"<0(8!'
MCD,^++IW(W\/KQ!K8ZT&XD$_ *F7ZTP^'NA:3%\DNF[8 0T'F22*]M!52I&;
M"IT]5&%N8RR2]?ETC>E<&16!14P"JDLU,T%/U .454CD4)T\E,4>?#QS7FPO
M8[DVI81<,.HJ/MK3ZUNV9;&S6+;]D@-G)6AH=>1%*;J\>2A):/H"D@HL2>DD
MH\RIE/1%C5Q5*0QNH44W0B  3@> $Q!, >T1'QR0"3*"+8Z-N^E*U;]/%1)T
M6$]?U&S2"&M=NRO>14BNJEUSLN@P%9?SCJ7280D U2%R"B+DJR"76DV;)HMN
M@7#DRRQR)D!,#\G,!?:.:0XW(/N&Q;*RR'3A\5)OWUB+>R=<&0-MH6BNCJ@<
M  *5/PJL*UUW(ZVV;/#6X)W),Y@Y5U&+289%9_$TVY#*K"Q536<)G431*)Q3
M.)%.@!$"B!3<9-]T_DL= +J=K3 32H(-#WCC]2P<1U=ALS<?*6KGBXI4!S:;
MAVCZ.!H5/V:52=,(F$3")A$PB#X (_5A%3?N"W)\6UCMZI4&MR5EDG5#OD C
M-N5&L5622IH:6BG+9!PLN>;DW#5P!@3,W9>B<* ! =D 1.31.ZGQ]KD(K<5>
M[U6@D</Q %2[%])9"\8RZF+8H':@._$0-= M;_R_*5&*=J6MG%CKS5X^=C:'
M30\\S+(+HQ;NU33EB5FE(@N,>R6(L*P(IE3*)U#'$O4<1'5^Z5TVYZUO)+9Y
M]$EO Z?A%0NIVEM"UA+F,WEU3H#KXTKR5[(]A&1Q4&3)%C%-A'J,DR9I(ID
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MGYO#@>*[^I^[>JZ1O]SCINIV:96!NI7GIH\8U%)K)Q\@";A R3EZ#P_2=$P
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M4ASB"15")F'@QTP /'C*8K(0VTAGO"!&V3:#S'82OG-8NXO+5MIC65F= UY
M/&M:_72BKYIC4^RBW)&P'@9ZM1M62DI"3E91B]B !-*.=)&CVH/4FZCIR^%3
MRC%3 0(F8QC<<<#M\QE,>^W$'K-FEDD;0"AT/,^"C73.!S4=^;PP/MH88W;B
M^HW4U(%*<58^[72@:]BZZ_N=SJ]/).)O ;JVJQ1$"B\6;/%4?+9FE'30JIB)
ME+U 3JX$0YXY#--90W=[-)#;,<[9^BTNH*5UIP[E*;V>PL;2">ZDCB]4$^9X
M;4DTTKQ T^GO605M:)L;4\BP?-I.-6AWDE'R$8[0=LG9$T#*MUV[MN95!PW/
MX" D,(&#Z<M79DA :*M<7 &HH1K0BG(\M5DV4$-RYP)W1B/<"#4'2H(/,<QV
MJJ]_T7=)FPN;#6BQ4Y'SSI=UT_:"#CWL8Z\XR3AK(-Y619&*7S4S&2,3K+Y8
M@!N!\,WL.9L+=IM[GU(Y&:$;"ZNE:BG+N.JAF1Z9R5U.+NS+9(93QW1Z4-*'
M?(PUTX@$=ZLWK^A#38.K4J0FVDHX]*_F948Q\B[:,)&27=J*-6ZP=9.$FS%
MIS"7@QP,8/ 0'(_=9 W<UQD(V[:N;M#AQ H/OJIIC\0VQAM,1-*'O(>YVTZ!
MQJ=.(IH.WGJL.A-G:WLLTZK==V#2)^PLO-]9!0EL@968:^1_'>HC&$@X?(>5
MQ[W60O3QXYGSVM[;QB66"1L)X.(T*UD%Y87,Q@MYHGRM)#FA[0X4X^74KT-H
MT)Y<JO&PD*Y02E9%!*8;%?.4VK1RZ:.Y5 69W!P*1$JS=N'E]8\>=QR(%$1!
M8Y"*QN9)KC^AC?MJ!KP!^]?66P[\E8Q6]L6_,2LW4<X-J02*-[>"CGM^T-=X
M[9D!8K0W:5R+K3_U_4K,Q*[J4>))J$;LH]!@\=J*IJ+&#S5#=*8I<@ F$0#/
MO.Y^QEQCX;=Q?-**$!IH*\R3I7P"Q^END\I!FX[R_9'%! :M)>"YQ .@ TI^
M7<MCMUV1KW6S!"5V'>J?1(MRMZ9M)7&RPU:8+N. 'R$7<R\9(*K<#STE,(\9
MS^TLKR_D,-E%+-*!6C&EQI\ 5UJ\R%CCHQ+?S10Q$TJ][6BOBXA>W7['7[9$
MLYZKS<38X.03%5A,P<BSEHI\D!C$%5G(,%EVCE,#E$.HAS!R&698I8)##.US
M)6\0X4(^!5^">&YB$]N]KX7<'-((/@1H5[.?"NIA$PB811AMFZN:760/%MO4
MV"><J0-<\T2%8MYA>,DWZ;Z3.8W7\/CVL:JLH5,IU5.@"%#D_(:G-9$XRQ=.
MP$RGRMH.??W+=8#$OS&1;;"@C;YG?S0=:=_8J+WN <'T[=JG"-W<B_5UM.P$
M)U.3'>NW7V<>Q[9%4IP(5R\D3"0O682CYAN?#.5V4\<-]#<7) :+B-SB> &\
M$KMCX7,V[23&UM*4[J#Z% G8G1K;0.VN@UNZPLM5[!'.[<H]@99OZ1XBF_M,
MHZ9G=ME2"LD!FRI5$PY+R4_(^'&2_P!RKZQR/6-W=8Z1DMJXM <P^4T:*T*6
M3'1VK&/_ ! :JTLG9JO#K$3F9Z"B7)N2I)RDHP8KF*)N.4R.5TU!34$O/W0X
MR"4YK, <14 T7K1SQC)$37;O6ZS)90I2O6BZ;Q#R^2\J)G0$Q!#I\?:( /C[
M,^X]F\>II'74JS(Z1L;G,;5X'#M7R\8MUGJ3E%T\1<1KGS(R6C'[^*D$>4P*
MJ*#R-<M72:2X'%-4@&\I<I??*8H@&7&S/MI?5LGT>/PD'[58DMX+ZV]*^A!:
M[BT_E568TC-SD_3EWLW)N)HJ%BGHN*E7J+5!^\81#TT:N#TC)LS;G.QFFSQJ
MDH"8&5;H)G.8ZAC*'ZK@9[FZQL<UX0Z4UU[::57&.I;2SL<O):V(VPM#=*UH
M2 2!7Q'QJIAS=+0IA$PB8181L/8-<U?5G5QM:KU&#8O8=BZ4CHU],/2*3<NQ
MA6IT8N+;NY)X5)T_(=4J"2BA42G.!1 HX2JU%=SSU[+]XDPY@6-@D/,T-V^6
MEFZB&1W;I)O5+[W'32L.1$E.GWL7+3S:4*5FV5].NL<JO47@ #/-_OA[<Y7K
MG+V4N-AQDS&8R^@<+LW/XIA'LVMAEC:1Y3N+@7MXL(J5\?\ 5<&#>,=-->1F
M9\3Z1!A;1CR23N!.XAI'8: =J\O4=-3D'FQ$KE +2LG28-S$Q4G9(]==N*LU
M*6FVO7E?1E*G76@I 6>2:JN$DA<E<MUTU.@O24UCVMZ,RG14^9%Y!C;>UO?D
M2&6CKD@/MK9T+_4==332.&X_LAN&UM=U7ESC#NJ<[89^W8RV]=US:Q70<9 .
M$KVN;M_V=>!!%-5*3VGU5.@500J]?*"4LT23 L+&)E339K21FQ$RD0*!"MSF
M$4P#@"B(B''.=0?I;M)!KN[N]0.9H.(@<ZE?4X]OXEGR<3'Q.P8MM%QS*-:&
MC'#GTS!LW:(>>N9^=584D")I^<L<1,8W')A'D1S)>'?/-+@=Q9H.?T=BSWM
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M'ROB=(_(Q2;0):.:]L9:'-+&D5H*@5/29>K<=UA@79*R:_>;W4RC;* (@VA
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M']:V72-3[!GBS$I]H/41@LRK5"-=2S9-4C],ZHK.WBL4D7R10Z! A3CR8OM
M>1BEMU#C.ELS.VXN'SRN8QH-N"^,%IJ27.V:CD**67_3/4/N#T[;/L;*2TBC
MD>XB\>(I#4$ -8QLO'6IJ/C5=2LK5R_VJX2<7;J]$$>3+N:2:VA5>$>>GD%C
MJE 2%:NT#'0%V!3 "QO'Q#*8KY#.9&\N;6\AC#I2_P#;DL=YB7:[6OT'CP5S
M+WN4Z0QECC,EC+^>6* ,)MFME9Y !4.<^,ZC^1W+MT?:]&U1:K8SE)!:QG>E
M9,RO*E%NI*.3/'J.Q6ZW;U:+ 1,9P %\LA@'I$>>..;N*ZEQ'364EBFN)9M^
MT$P-WL\N[@YQ9^EV<E:S'1O4W76%LY;2S-I;11O.R\?LE<7D4.QK7T;1O$G6
MO#1=.FHP%TE+)*1UQK,6DM,.WI6MF<N(1^5"3>NET!.@+-=(QB@(E-TJ'#J#
MD.0$!'XQ4-KE)+BYM;RU@!>XTF<YKP"2> :X5^*O9S+9+IJ"UL<CBLA+.R%K
M=UM&V9A#0!7<7L.O>T=ZN%VE]Z&DNV=SLB%N:]KLKB?D()1F_HL 66B"_ T9
M5NY [V6?P1C"JK(EZ.A,X<%$1$/#GH7MS[G=*= OO<?DG7-Q+,]AW01A[/*"
M#YG/9VZ:+A_O'[">XGO'^[,QT];VMC:6T,@,=Y*8IOVC@02R-DH&C>;EN0[?
M^Y?67<K!2E@UJO,G;0CY.-E6LY&EC'S)XJB+A))5)-R[1,*B =8"10P=(YZ8
MZ.Z[Z?ZZLY;S!/D+89 R1KV[7L<YH>*@$C4'D3JO#7N3[6=7^U.6BP_5T4;)
MYHR^-T;]\<C0=I+7$-)H=#5H5@<F2YRF$3")A%!=XCGZEJ?/2-' LTZG*F.[
M!(XMR]$5))F**H!Y8'ZS ''//O!F]L9HVV A)'J>LTT_U@HODK:9V2-R&GT1
M ^IY?A<H1X-T]8@/2)^CJX'@#& 1 HCQQU<![,D[AND+12JAHJY@<*[:<53K
M8FR;U/S,F]B).5AX&J.6M<0&'>.8P4C#\13;JO%VBR2SA>0,P<&#D>DI2](
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ME]V AJRIRU_6;E>'K1&KUFR.H9(CZ2.];-HUFJJ4AS)(.'RZ95#@4PD3$3
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M'O:E-!PTTLW90L=KBAQDW(-R.G LJIJ.LLFSMVW0.U35<.&T27K @D*!S#P
M '&;_IW*RMZ0.6>W=*'R2D?I%TNH^.XE:?JW#0R]=# Q';'Z<40/8&1"AT[
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M^<\?^\27^!QN7XO[?+_5?P+33?X1B_KOO*CN._F?NO\ E$W_ *TA##F*T_\
MILO\[[PM_-_B^R_JQ^J5DLM_NO17^]8[_:8</[69#^-KX?<%K(O[+F?ZX_K/
M7H,/YP=J_7]G#A_\R8Y6#^])^S8?U5\7O^&\9_S!^U8KV^S+<-T:IA!93P.#
M6!T_)(FK%C+6E2-M9[U1<-$K>:*"IJS"(R")S,"O1? D?S/)\L#&#.Z9_HJ_
MSOM"@?O$1ZQ_\/["MN62U<$3")A$PB81?!TR*!P8I3?ZXH&^_P"WZPPG@J$;
MF[8+G8K?-6_7=QA:\O8%2NI."M<:NYA5GY.&IY)E*1IC+L%%V:"76W,D<%%
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M^7M_NS?0?3]JZ6/X!IR0A[/K <E_1W]GNO\ F3^J%#?\Q_\ >^(__KG_ /\
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MV:PHD:N#*K6B&603*BH8ZJ0:J:J]:10+U*$!-(QA$ $ *'/T9WK .#?;8EW
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IBV8854PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(O_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>41
<FILENAME>tm2227887d1-bc_icar4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2227887d1-bc_icar4c.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ AP&# P$1  (1 0,1 ?_$ -,   $% 0$! 0$
M       %!@<("00# @H! 0$  04! 0              !@$" P0%!P@0   &
M 0,# 0,%!PX)"@<   $" P0%!@< $0@A$A,4,2()015U%A=1,B.S=#4V87&R
MPC-3<R0TM+4WV)E"TI16&'BX&3F!D5)BTU0E5968L<'1X42$11$  0,"! (&
M!0@(!@(" P   0 1 @,$(3$2!4%187&Q(A,&@9&A,G/PP=%2<A0T%>%"DM(C
M,Y,V\50U%@<78E."PJ)#8__:  P# 0 "$0,1 #\ _?QHBK'S/>9DBN*?(*>X
M_3S^OYBK.(L@6F@N8>F)W^?D;%6JK+3<97JW6%C'2>V*QO&)&+(PMWPIN%RF
M*U<& J9BH<L,UG9?LN<IFN9[K$R%RS[5Z83)EZA\N(4_$0R]=Q+A6.SUQPKN
M"[?B6QEQ).*S$OD7$UBGGEA<IO)@S)J^L;T3-%:PT2955,5!+//'Q&E(^*4F
M9#.S.:5M6*XB\MB8*:M2UWA1,4'CV_O7*"):)XF53-RGC;-9[AY:VEZA1!XS
M>-"5DY(Q( 8*CE64R!R=YU8%X7Y0Y-PN/,1Y:H>",=\N,N2S_/UWR+AW-MSQ
M?A+).<IS%CAI3:M@>6KZ[^Z<<Z?67J+Q^K"KOI!^HHX;-@-WF*KEG6P,2]&2
MBXV1,F"1G\>S>F2 PG!,73=-<4P,(%$P$%3;?8-]M45R4-$28]=*H*$*GV[&
M)W#N7?KW"'W?U-:=Q6G3D!')EMV]&%2),LW4)Y?Y 5+"B6.D[6$U(S>6\H5W
M#V-:K5H1>=LEOO5ACIVQJ,(UBD=%%)C6J-4INQR[MPJBVCX&$?.E#[(]IL(N
M:QR(P"S2MZ,<WQ*3J3R.KEUS+E[ HPMKJF2,.QE'M,E&VV(8,F%RQ]D;ZQ-:
MCDG'LM%S$PRL50?3U-F8IQWF;24=)1BJ3QHW*JU.X&YK "3AB@MZ))BQ<*5;
M!8)&.8D7;&1!07":8B=(#AVF(J8>@C[=RAKF;INEW:6PJT3'7K Q#\"NIM6U
MVEW<FE6$M&@G MBX^E,OZ^6#]\:_Y,7_ !M1W_<VZ<X?LJ1?[8VOE/\ :1]?
M+!^^-?\ )B_XVG^YMTYP_93_ &QM?*?[29SS*UN1=.$2*L.Q-90A=V1!'M*8
M0#<>_J.VH+N'_(OF6VO:M"E.CX<9D#^&,O6I-:^1-@JV\*DXU=4H@GOGZ%S_
M &MW#]^C_P#(2?X^M/\ [+\T?7H_TQ]*S_[ \O?5J_MGZ$?:W</WZ/\ \A)_
MCZ?]E^:/KT?Z8^E/]@>7OJU?VS]"/M;N'[]'_P"0D_Q]/^R_-'UZ/],?2G^P
M/+WU:O[9^A11D#D3DFNR#%O&N8@B3AF990%HI)41."YR;@)E V#M+[-9:/\
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M6>#@2M3-56S]X5])-6CPK!->=$1<D(Y "@4%?>$! !]@SR&R6MQ9RO;2-:=
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M5+RJ;9LW,V!JW!.-(4Q5'3A=0 -W  ^,XD$!*;M]D\K[9M=[3K#<*XI2IP<
MF,2<W/>Y <N(PQ4KVNTV^YH2G6,9:<'<AAPP&.'5U\%.]SN:='A$9.ZO&L6
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MRQ+\4OKA[]^"'Q!V%=W8/QI^&>T*-=0Y3)&B*-Y'^7O/RA7]F.O*]W_U.O\
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M0KHN6OJ10(8%7KYRJVBXIJ!G3]TV;)J+%V;>VJ7,B(M&F,92.$8CF3V#$DX
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M>W_K=.ING3KK  WNR)#OBP_Q6P'B"R^PV$?D#J&P;]?E'8?DVU:#JJ8RBTG
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MTWKM,I4&_L5CF7)%UB,HR-0,NN9)JT2</7[Q7M!-!LW35<N5SD22(=0Y2CJ
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M0)DR^[OW"<1'J8Q3=VP[B "(B/3Y Z  :RQ@8NRQRD8D8)+?1D;))B#UH@X
M! #>1+<Q@[1*)1.':<Q>TVW4=A ?E#6>VO[BU@#0E*-4!R 6X\^:VS5JPE&0
MEWHETWJSCRB4U=Z[JE1KM==R6XOW4-#,6+AT4RGF%-9=!(BIT16 #^/?Q]X
M;MW -MZ_\Q[KN8%*\J5*D(1+ RF8C!L1J#X<P>I;=QNEU>T?#JS,HCFGR0
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M%[M2J_\ *_W6WE(!S$'%\^ODMS[G7C2\<QEIDW# #+-E,+B88M>PKI\U0%4
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M9V9%&PNK(X<)(MG4L\*U!Z95 B*28.A;>,?3@NXAF^;I7WV]E=PE.1J$RP!
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M)S*YH$,91@(.7X>KGZR4C2MU@X=P=HX776=)#VF:M4BG4W]P V.HH@B/WP]
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M!C"!TE@/4'6$PE$N)!@JO\G<%26:*B>,A9YW"2B:B+ELX 3.D4%VR2Z""AF
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;T1&B(T1&B(T1&B(T1&B(T1&B(T1&B(T1?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>42
<FILENAME>tm2227887d4-lc_ipscmacs4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2227887d4-lc_ipscmacs4c.jpg
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M 0$             !08#! <"" $0  $$ @$!!08%!0 # 0    4" P0& 0<
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MGN(*-K-,)Z).*<&B%N" S5B\)>T                 $*D.$5&X%P2B)T?
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MH^ ?X?Z 1H5!)7,(; 9\D8JJ65/05#+3$:$MGB)H        *-%KC=P
M  4:.4)XBWYN)7([V@CZ3T*4] J$WUZ8GZLSFU:>USN(3-],J;06D*MEMSG8
M9HK86V(U-/+.E_P      > J,6R/D9/H%+[@     _DB0E$]@(;*^&>+5G/X
MZ/@$9RT=F]?-N.CMB$S9#6R'#8S920RJQ8@_T_0\![S1S>"8      ::0V3B
M?(8?145"@)[J?(1\N;^B     *J%)3JR;8  #G ='P               1^8
M<BT^>$^@#\_>2FOG^A38P136+-+]HK&6     ! 10 Z1DL@  YP'1\
M         '&XH8=?-3:YQQ4K]#\[!PQSOH4R]#Y]HM8LL@VNK      4].39
MWS-S  !S@.CX          !SP.*)]7H !\R!/9;V*E-?T]SJO8:_'U4M,@VN
MK1]5+3(-KJU/?G_OMA.K\JWZTU<     5F('+J&^D6$&D:FU%NRA1T?
M      *;:FU 5<L5JK=4[. ^6,ZZE<XR2N7FPWHW=./JI:9!M=6CZJ6G;Y^!
MI=\Z_0]B.M<GIE\\?0EON^\%FKHW.P    !"1R".V)O)#QR[*D%O202N!WM
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M3C0[WI%>L%Z>[<, CZJ6F0;75H2YOT:6[Y1-(K=DVF;A<S(QW\^?WTYL0
M     %:CGB=127B$RN!&1OA<TH^='P    8[4V_Z_?/OVM81P<9SHSBR?,)S
M#IWU!RL56#Y9^H['==Y)CM3;]VSK72^BOG@>7!FT:M67?[35OT]^0
M    (+*7G2@SA$)RO*?%MB92LQWM    !\R\/+Y?3W.@<K%UHVM2R% OW'*H
MVWZE;_0>??RI]4=$OK3Y.Q^KM[?/P'CU]C\O'O<;!               "LYS
M,.RYNAJAIQZC^R3#G&='P   #^3G3K[%RO/[3RG7&E$1+=U.B\[TBM622[E3
MP                 -/.?A>0D\  '. Z/@   %-M?8MMFP9/U^
M           "LI%1= SX  .<!T?  /R\>XGTMR5MS4XH>?5M-+<Z!2<:
M                !R^)"+OFP   YP'1\ K!$2W'K3W.GTA'_(#L:_UMP\QR
M@@9WLY.P=S+)7                       (T*OE;"3B[9ROBY/HU^_EBY.
M-_ YG:>Y4'QZ[Y;FGHFGN;UN:GZ^_                        &..5ASN
M+3EC3CY#R]OMO!B_S\A+WB^@.UUVD72:1T!YE>?S]?DR0,N!!-CA-QT-N18N
M0                      'E/&#+'. Z/G,WUG@G;P=B<>#'9<>SZ>SRC[1
MS&_'-;O#4]$S#!2T6S,9[L>21(K?]V/W,<%+>?UY]'GT
M      .<!T?,9EQ?CZ_,S@S  4NOU0LG4[#OT;O"#[##5?N%;LG4[#SRZA0^
ME?)NAQ?,1MI:=9,5FQY_6S@#$9L67PY0                 .<!T?
M!Y_7G";&'8M78YV]2H5IJ;9*$])I-K*99O7X]^/WX]OCW3&^U'H_RKH&RZ>Q
MNNAN>/WX]GCW_A_H              !S@.CX         !!]AAOQ]>9VKDV,
M#LX.0_<.5]-N1=%YG];YYT-Y?>ZXVJ FJOS'OQ^XWEH^P-8G8#LL'8"LSD/3
ML5-=?F(WE8^R]2L/]/T        #DP=#2G1T?             !CLN/V8_<<
MRL?FM?-K^U@UW:U]_C-ZL5OKES*%;N?'3J)??FUWH?TBE6]HUJDB*D
M   .$A<XH^7.    !74D4D4    B,Q!.8   !J)!I:     &-.F(       !
M!1.H    (Q-G-G    -+/$2"    84CXEL    $%$Z@       '.4DPN<
M#2CE@:2=BS;P   <DS5CJ"2H   > XP$L%PRR8   /G^+E$_EN        <L
MR3#H    "/3C>:0=QB0P  "'3C&;(=:"<@  #"'S0E["YI<    'S0%YRQQ>
MH                                                $8GM)!
M                         *?G'PM\0>94SQ5\[IECP
M           "-R!P9<KR6K*_%OB1P
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M7!H%]ENNLPT2QR2G=J&6AOC_ +UQ_P *T98L./&V\!W45%#-E^\> B/4MMV
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M+'!HG1!M"8$B9@-JHQ!(U-[>XFB$Y_\ ;<U%75>/='7IN\^R'9>YM8OOO_\
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MOZN45F+6T>'77,A1= TY0R8,MT&PE \I2A5O4\53=JJ^A^+T,/(*3&,9J_4
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MN=:GD)./7]%0QK6>?JV4FF<Y_FC*9 N?MY<&%7"=8BIP,$Z'0QV/@5HQHT(
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M(1YD"+O(1?S%,LD]Y&PR0(T7GG=TM1"RO5L@^-ZZ#91A'12 @G"($('H@_\
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MP_;+>82#=&KN29/_ *>A2B+-P-,F+0$,IX6"K"N[$F^>E\1QY0V3/,L87;<
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MP8,&#!@P8.DI@2[RC\B2\K^B:-'(10BW4:9'Z<,2%W0TP'$]LZ9G6>D*=L&
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MP;VI[)QO+/3>8U,FUOQ/?#YQ-BO-NEKS?;UTF!%I6$.^C%D >Y++]J_^>&_
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MY_ P$5X7  9%[39P:2N"P9>EQ&H ?QCH/AVK>QG1J&O?.??%F$3V3IV_&+8
M.HX2$["[/C9T@/(\F;O[; V,*'V/3G\C^V.H/<JJ8!TT.P FAM.ZA>C&C<HY
MQIIM_P"'VJ3E(@!]UUE4U4CB4+<45<-N,]Y$ G51^8(>3C8>NI^O<RVS3G1D
M2!$1KT@_R9343B0-R"%O/#K+H&KHDX@!^[O-0:6B#:NPC-)KK):71@)$V $*
MB+2Q/4M;A VEPOL_R9 J:[ALKP.YYWD-E/;@=*2#5IR3='-6"4$C "3MB)V+
M707T&A#W#!00?#_WZRZ_Z"']!Q]P><#H#UH  E58 ;57@.W/W5KW_P"L"LY
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MF+N\LC<Q0?L>QV99#P),3,-D\"O[[=<_*^&1F]\#]GU6\D>S3G[4_P"?@,
M:=?[>7WSD)I4$=:4UQQ@VODTW/2.1>.(]X3(*-P<EA(TG2/>&(1H'I>.?1]]
MPE:(+3K@U:'.3$,Y%(@[E6^)1V;S2VBDZ=-#V:V%TY;<O91_#^3\LBN(OO\
M\'8>_P  $U.KX+-^-H??U@'0BI3K@)JQ-TE$AWR;U.NNCXH\(.:<NQO7.*(/
M7:@:['>WOG%W-\_\P/Z^V4-/<!MHIIC&M,\8-,[_ (/&J1'QUCA=1"D/N8Y$
M.5F]>T+[V;&SAT<8,VM!(^4#/LN)=Y.".!J3ODYG6*BPS5;XB'#$-/0\Z4'?
M#P>W/<?LW^+%<6IR7@\=W?V>^<O^%/\ #&%ZMWAB#6FO6L1&//J?_NG$*E<V
MPRPG+@PTU>LU&4%IH\?\_8PA0(2$?O\ G#02J+B]/X=_?-7#.77A/<=F:'*O
MM_WAH$>)TD_'(I34-H="ZL\PQIE;[BYYX='L8T-N!I>Q=+O\_P#TB?_:  @!
M P,!/R'_ .2K1_8.=_'DGKHO=E$&];TI[)QO-66=1R:RC[KSK)?#6ZW=NEKS
M?;%;Q=*/$F]OQ/?UTX@F0A6O7;@JD?8LO\P_\\F/(UK^/^3"._E10_BK_CDL
M]IW4<ZN7GETX>TNN7_A_?KON=MP)'S)Z&4/WT X/>UJ=M94WM%MXI_E?6P5A
MSG_NG_6(K@&3R,<O3SGOZUHB=A6&-@E4N0Y?MIQ RA$8B;$3A.G/Y7*8]B7<
MXN/6<A4;57:KM7GUF_[+E\@D\$W:=RF:*S &^'[EZ=_#^L^3/:>G!LU%\P(S
M [9*(;";].>0WKNT[B&:6FW6$**K6;': ^*_SYAKO[*>X)G>LS:SF064OW^'
M[CY?#^LS4YJGS)5^+@;VQV>M%]]MPI8P0R@HT6PEO/);B6:3@52"\VQ,CE>L
M14C.SJ>G&9<*$.HY'UXWFA#+L'NMO@^R?)08@;>#PX6MBJG93CVP6:FB_ LR
M=X12+S*Y[(DHFW8<UQXQA15(;<#D^V.GW*WA;3;QA@C@9(U]< *;<ERG=R*0
MJ#5G,;SEQF_Q#Y.HF_ MD]\I !Q*H1B4>$'SZA?44$Z1 ]CC#:3O$(#'G/W"
MH70"<N,7\H)1[P5#8F&ZQ=8,Z>DVT-9-Z=.,4 >=[]]QW[[^(,%D;7:.A<OX
M8QP%:2YC^]FT\,YB41@T&!W?($YWA/1 G%>0:'3-8[=T(0\"_9H>V>^10"]X
M]*7LZUZF>OZ;.4AO(0J((INL8#/'@IW&W^A,3L"JZ]+X\O/??1COK@.G7:7G
M6/D;@Y:,FO?'D,W<C_&;J>.,382;0#RR=Z4'X9Y IGE6#[!H>><4ELXB\(_L
M]_A^X^7P_K/DSQ&/BV>$HY"FW%-YR%9_7<H?AOGTU1V-^U#[L'-KISO<>N X
M#[ .@/A^X^'P,UQV#;:)+VO/&9N;=G:Z_FV3WPXX&'2'*',\9_:?"Z]OM2S0
MRQEYCXR7;$E52,J];WELH.KVZ(>7WSAF6<47?9':2^V:M@,%&=)V>3/ZE;TF
MGF,N7^B@05L'0='1Z9/V1H//;;C7"N@S43VG94&.M=]X^<+1,$85<+SAO82Q
M(#0+SW7T+\T,ND$<X<?<G#B<ZQ'Q3SPO,?PZ[Q0FG47(<]#O?.-ZASN7C@O>
MWVF=_'AF%?<Q7TC:Q.5'\AA@L<4_T?+[(!_+C-\_D82J<A@.LB=)EY-;#! D
M':YG=5/SA&]HTIQUG;NN_;.)Z%B@'W76^GYP%@4P/+2#2#3\9.&5X3AS3_38
M.5K5^[Z<;B?VEP3[ ".")%GH ;JZ7JBSL96W N\[(-'_ ">^!.$@*OV#>2*%
M L;4M#$1RTYSV6T"-Q3X%KX&-)R[N?[&>J[\YH&%"(D.Q3^')B*L*AJ44DXY
M-Y)"Q-AO-2GV-9L!0V8) @E+L=]Y?4^Q#:.@5K T(RCZEOV &AF@]S^#*$3'
M4M,>4U?&LL.9Z])M U;D>&ZB0J42HE**V-%5>G;JIYG2U^[BJ@/)_P!>LF/^
MTK_8\_8CC$[!]:0,H "JN@ Y7HS]UZ]O^,>LX" TB.Q'2/&%QFU/(+;M->XS
M6\5#/OJ4_%!#.H#UF)S  T!9 KMC >>,VWXMWM:^ 10;]LEZ\$>+9T<//OE\
M..C^P7WOO@P2M>J7R"L&&T T-50J:'"X<&7K"+I[$'L'JM\XH*Z$X]6;J;F=
M;,M[N"=TDA\_':6=(L>!0Y)5V++U.M%#\UT41NFN[AU%%$TB<(^<I?\ :W:_
MWB!E*JU5VJO*]OJZ?SA4C!O@%/*SM7@K8UQ&ZUM0+2X6#%"41L"L%+(*;%80
M-;M*$.PNAVT*82$&^@_POYO@RU;K1'LNMFHIP;S@CW0'\;D?- !I_P#J?P^0
M%1Q'W\SVY\<'><VXV>.Q_/\ 7JLG^6P PAXW\Z$3%:)58^7.E&G5LS_/8_IQ
M@@$?NXRJA6<><2J3J)]IQ@!GO >T:_/YYN?48?S"C[?;>!R+'.F/8_[_ +86
M1QM=GW5_P@=&42G#J?G@'WWX3$$U_._N/G!2<&)X\?R3\WX"*$CGV]1ZL/(.
M/?8P#YI''IT.C'6-1DUT<O''V^*1TMDGV$'EGXRFF&Y@](A_KC$OZ70U]N%J
M%!%B^Z,G!KO/[U0/[8(9H8&C@Z3WODP>H^S!(D'Y*'[_ #\MM*A>R<GJH,1]
MV?\ J'PW;2=\<,+8=GMV'>*,0NX_<;P>_G+4!IT=[+:=][XRB2TK#C_3[,=M
MINT_EV-^['2=8&X^^OOP\8GK%B?P,2OOSK9DJQZ&WV_Q8U0&OL_L_D^"X0$U
M[ZNOP7UA^?6" WWM;QN<.Q(UPZ&_^_B5KU<+]D?.$^_M39V>&N,.M?V&K_>$
MV+:T<. _CW,4VBZ_L.G_ '!0[^N0/O*OOTF:<G2 TYTR7GG.AJBH5QQJ_'&=
MX+(X=+N^W'6)*,?MT./KRMCX1@^/Y/C/)'W'_<('S/\ G_B:^[[9P'\=_K@2
M;*#R'7X^^\YV<>I_^LP 30S56^7 D?,F;TU=,S1JXW1,0YDQ3F=_SQF^:W!O
MR?DUC9@D16SE;;^6%$@3;.^V;GVP0\ -Z'X_+[N!..4O'7/MK_Z1/__:  P#
M 0 "$0,1   0  $D  $@$@DD DD                   DD@$D@D@$@D$@
M                 D      $ @ $$                       @  $DD@
M                        S9   D@@$DD$D@                  U @D
MDD@$DD$@D              $D  "   DDD@@D                  $D '!
M8  $$ $D        @       $ $   &P$$D@$DDD      $ &8     $@
M                $DD4P      @@                   DY!G      $
M               $  $%(XX0      @ @             !\ @7''+Y(
M $@$DD            1@A(:LM.X       @$D            APKX=S&''
M     D              $,O3,HXXXR      @              $L' FXJ%$
M0      $             D"N '".$(         D@@@@     ' @NMT@#S
M          $ $DD     !HN3S'%               D $D      G&+
M              $        G                     @       \B
M                       553(                       DDAP$?0
M                      $@/WYY !X                         #8>K
M^,V"                        ;  !X"-:A  &
M      2D><T0XX@                          A )<-R"5HS
M$@              *J!]7(0               $@    D
M    $                $     @             $@    D    $D    $
M            $ @   D$    D@   $@
M                                                   $$DD@
M                       $D$$
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M!P(W9@CI681HQ0R<' :[VK:C XC3"SAT=@A4##*ZJ+R[=RQ!P'1U=APCEKJ
MIL),ZH0[_<AI:EA5N;"GA3& -L(:ZB44^8 41@$!(; "SM,Z'@"!]'Z*%RI>
M]:=='"<E9JAF,T7ZY&@I6/\ 00\(G=40LV _X<)J&B^8 ,ET5>1R=A= Y1K(
MN.G8DH32@WF$OEEDT@DUUF=MI(19J4E\();5*#X#]$.:FUVN)K&>M!6E>ZPP
MQ@NVZ)^?DCJ&EB5=2 [X'Q81T?@8C,%4>T +8DP 23%GHP-L;M3)[F5'O[(8
M6-F@PGB^BF>W%66O.! Z$:C02"X.@-M_SD@0V,U*^:4(> +T'E8<;9U= ;FA
M>Q$(8(MO65Z,0<"9L(+40:!'@ME_)&?U!JP,4UK+5$X;6O&.;MBM0V\G'Y>8
M.^FVNDDE+M33]!+%>),T2L5IS\E $+-BUP 7(BE&-Z@N)=*_-!04GC-91A=D
MXFXI&GL /JGM!+[H2C:HE$ *XHZ%J-;   $2X=9W]VEQF$8+\$0 [C^R(LBB
ML)BH8UM? #(&BW @4(?0;"XB^M!@@WRP,MQ\C,%5]'Q'3J 55VJGS^NT)5O<
M0&PGP!2&W'/0$UI8=O*NDL0QF>$#50*CTL_MG#RP)"M=,<IJ5H.)U%^'FYC/
MQF%.Z&J&-0S-VJO!>P9<8$@IHQ#S5I5IFA8=S3-*Y4(9Y"CZ9P<D2'+\S#Z)
MOCUR[S<,@G&S!HF)\ &%Q/""_*D5*T<2"LRIT,\V8T?6$ZY=YN&03C(1,.(A
M40AB;3$'\W>'TA+%P&$$L&%"C4HM&<"!,VWE+&US)(;[% 67AL_20P/W.O.K
M/>X,LD0B7C.OJBJ' A."V1BP51BL B^J56UU#XK8B*E16R%F\%[Z3LVPS/A4
M@NK5D9Z;DH%@YRJ#R5*+=X88'>B&,[%<*@>4F,Q?S=2<(O@,*9O&$0").6GF
M Y#[T>SNB@@)?"CQ:)QN[8M!3IM""',E03ZAA3"I3[/!_P  '&/&5N;;?:YA
M0@7_ .(4#M+[*]'9JI4.TDD8X5X ME0KZ"@5B[C%9^WQ5Z$K@!D%.J:-"^>9
M!O? ]=VVR3A$<"<3F._FHLDH:3 _[ JGFLQ0 !]>\51D)\YXIG:8^E0\0^)0
MB4UG #C91FH&</US-? !UX@XE!%A62ER5K/42D%5\YD0;U3S)UWT&V(\17X!
M^PO#4@MH(#@M+F85:R_RJRGWX-_-$S2>QT'3T#[D8[Q>H /#S"0#D5]5E3DD
ME[RDB/,QE<MK_ 5ND ,+)=S2I&FJO$%A6F *N'%7<AQ:+S0<Y1*C^S'HZ]%4
MB<R\3S)I_#MA0(L-RR,BKXBN M\=?J&:L+]N;X48=FBR9S4(LIO>7\@2&$)%
MR8_>7XNE'1XZV$Q:E^8D)O N_P!SHKX0%]II4TCSDJ@ D  A%?E)R=[[!(=
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MAT F3E03WM>4[>6+-!726!:#UP D="L2A$FI4A4AAT)8BH@:@)V[6X,EV%;
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M-F:"F:(KH3;$\7&-/(N^C0=J-"$+\YPX4%,%,MSY!+&JYG!K#B=!77N9%:
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MZ0&9%O\ *TFT9@.'4*$)$$%]49A? Q6^BP( /(8]@#YP&0%$V.;$##"4C0A
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MKZ!_T#J4T@G%YBD]F:^L-._ 0R#'8KN1IC)G2 K@]7NC1YTL:'SL]((K_0J
M@4YQN_W/Z*S(05<Y_K-G<4"#!<P#UG7]0 E!;L'T$[Y(BWCJ')E9*_D69^QI
M!,4ZPUT1'Q$L8F#?^1%A=%D'(B-6/A@?76 B!P].VIOU\\M/^!-  .MLJ"]
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MB(#+-"U"!J[]#&A!J2Q!M[[58JFXUOXD9"2%53D):WUM$X$JN@#E7Q\(1U
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MZ%UJ034HJO0PYV8K@&@;)Z$=\3KP  "(44*(B(QP1+;79-M[]W>V& ^\.
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M)B@@E9ML+;9E( _&HSN!S4V)P1B(2D,8DC(""H<N\>D'SOB#&D,Z_4Z-AB3
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@WLSBLN(L,T?0&35L*4C)D-"KH3W@:0O,&U?_ *1/_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>43
<FILENAME>tm2227887d1-pht_myloid4clr.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2227887d1-pht_myloid4clr.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@"D@'( P$1  (1 0,1 ?_$ 00  0 !! ,! 0$
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MIRH'74O6S687%R+^!(ZU>F6=9FHI@MVZRLNUKII*&LH/-G:]B8F<N%8^Z9U
M\/%3K6->Q+HTLZBT8%Z#QK+-S 1LZ64)YG!BE$# &4FV7=,?:H=\FB*[5D.R
M1R:E]YD)##2&U"Q4]2H'3H:BV%S7C&X\JS>$8>4'Y1M\,<N1!Z<H,<<JHT;>
MHR")M0D4V21B+]0.MJ)M'N1TKI:U:^I.SKRTJ=DVE(C%49D]BYYRWF7I9"+B
MSIJRL=%/8>'2(^FFQ#*OG#9(H*]0FZ2F,6XVOC>][UB9&=M>.TV+B+JE(*W4
M6+7TE@S=%8^Z">E6'*>Y/">%;MMVQ\HSTP]SW:7T\5724B5]:);6B-'& TB
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M6T+OO$<V#/VIF*ZXR?=86NCHP5XW ()1U5K$&UB#4FYC*DU,4K%#<W>_VO\
M;Y<2T';^STJ?;3Q#&>)$GJ=[FS&B9)9X@R=^MKM7EHX//58+!T>=YA>CDQ0
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M41:$R!85N%0#3U\26)((4!:T))S'O*O8^?NG-RO*.X;%NWPB0+CP+'DHF9'
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MV64PB'"QA/%D2&0QK#+F.T1**S1*4 ]TGU7)4D>H^5VU>R?2^UKZYVDJM?\
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M S(R!GL#<SC0.Q+0>NJ1MFDQ+"TRW[[XM_"[+M]HL[Z>OEABI!BNP.P4L[H
M<MFZ*+I0Q 3(415.*AQ.8"B&!W'G._[GG8>?,T*' </!''&J1(P8-?TQT))
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M7ECCZ=LVFV5[4V+N4GVT/.,GJK&+8&*1[*@"2@^IBFJAP(HY1ZT"G,4HFY,
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M#*-*--WULR-L6H@0WW]!O5NMTHU([8"*KP64<H^92;)R919NJ@5,BJQ^@I1
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M@O4?C?%<96.7O-V76+10(]RGK@6)R5-G,%E.G^W0$V$ATFVS:XA>7,NW7HJ
M^&OS,GGHZ=/VT]IMT7?>QW)T6.0>]Q79++UJKRL<Q*L[U7M(;Y-HNY.'UL\=
MQ;AC9J+K2I1XQ3K83ML[<.+(V(W3JDZ]'B/9INU_U>+;!FR>GL>[*^0KGI-#
MZ:V5I@""DDKG4(E90(CJ]:%![[%0&UX$QTX64#*/)TTC]JW4,QZZ>GN_M(/$
MD#,7M:M>A+GI"ES7;2W@H_4BK9T6#AH.&-6_N-\H[6=SD;-UY=NTD8>S%EG2
MJLB1XD5VJZ5.NJ*AE?,/&=^QMXQ-UEAWTNVY@^\S,'U#P4JP)5DL %*G3I
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MI3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I7!@
MP"4?8(<#^/%*T;[J?=O?;AW*KGHFD9B_V.F/8^\SL4]OKF#HE(FI<"3S%6K5
MLT'+D=2[1JY3?H)JG)'L#*(@@0IB%\CYS=S]Z[(]D.\*9VW<=ESN3)(N5+_C
M)CQ\:64^HK0PF-P9;$2("5CC)70+J-'T?[=87=GO!V>]+DO),;:]FSTDPX)%
MP5FS<R&*\#C)R/6B*Q,ZM"[*IGG"R&5B&/J;%*[NBQ[EK$%/46OV>+K-GBFD
MJU6BHI->TKLGB93';JSLZ2.U[6'3=3DBP)/9AX02F J29P P=$P]R^4=P<.*
M3B>#N.-LN3&&1\>$/E21M_\ W64(=JP_&S:,G/R%'U88Y!=>3=V[>[5V_P!W
MR=KY/E84^\84S1N))"N.KJ?K""#U,_)5O%-4.)$UP3(ZDBKQISRWQ]H:U>-A
MJC7*O$).)6Z>0]E+/+ \?-0.Q0E;2Z^Z4%+;*G.#QX51)\L1L0BJJX^I0$^:
MXEE<LP>31<9V_#VO;^-8B//N&F2;-G]25+Q)-G.8$;.F)&1D!DR9%@5)99O\
M9AU1[?8=BR=F?>,O(SLO><AEBQ+I'C1:4;WS'C+ZI&-&/LH2KPH9"R)%]C):
MM=P:Z#OMVW<Y;+).6SG3&R%V[A!0BR"Z"U(F5$ED54Q,FJDJ0P&*8HB @/(9
MT5QB:')WK;IX&63'DRL=E92&5E:1"&4BX(((((Z$=16A^XT4D/!M^AF5DF3:
M<T,I!!!&/*""#U!!Z$'J#7<J>S-?-Y"IZL=7"NL]BK:YKUN:4MY*-&=BD:PL
MF,6:<BXMRHDYE8UK(LCHN%&Y52MCF3!;H\U+K\96#EMZV>(G.$,AD,@!*A_K
M:2? $@W /B+VO8VD.SX\QV/%R K&'T(QJMTOH7I\GB/&J)MCN?[>=&I+?O5W
M%K^G2*3!S)H5M_8F#BYRC-F0RCD\#1XY1[;[$HDF43"FP8N5> $0*/ Y[V_8
MMWW4C[OQI98R;%@IT _PI#9%^=F ^6LK!@Y>2;0QLWRVL/I)L!])K7_*]SG=
MMW8VI>D=KFO;%H?5"4X:#G]];!K#%QL%9I&76%JMR-5*K.I2%5U[.0;(MB.@
MVG&LY-)357=0LU#UQXLU74EJ['QSCV/\5OTJ9NX%=2X\3$1@E&9-;J0TH8^G
M<QF.,QRK+%+.H91E5P]OP$$N:PEGM<(I]V]KB[#JP/2]K"S7#-:U72R^FW89
M9@PD;_W6]P-@N0-T7[MPKL_9,Q7F5B6C-?.GOW1'SEU66:0:-TISYV@@R&,_
MQ9-N6'!$AZAHMS9(G:/!V_"CQ;V $,0;2#(!<K'U;0Z@EM7O(K]37D[UH-H8
M(5C_ (J_+XV'C8^=^HO[!5-<Z?[A=&:)[U*#?=F3>W-)!VU7B<UG9[[8)BVW
MZ'LCBL;,A9^J+6FSSL]<I^.+5X"%FGJDJIY3>8FW#>+4%@D5JSN<3<MGW;?]
MGRL7'3&W3[PB658U5(V4/$ROH1513J9T 0=412XUDLVMN\>1BY/:SD,L2"/)
M^XMP#!192/A)+&P  -[@6\0+MUZG:D^<N&46\=M&"\JZ:LW#AM&-5&R#B072
M2.HDS06>*MVB2KE0H$*90Y$RB;DP@'(YJ_<<C(Q,"?+Q('R<J*)V2%"BM*RJ
M2L:L[*BLY 4%V503=F N:F>'%%D9,4$\JPP.ZJTC!BJ*2 78*&8A1U(4%B!T
M!/2L8F#Y>?6D9>F4:?IU@([%W/-*K8ZO'3Y7[L#*G4ME"L1F$*]?/1+SY[TA
M7"J8=2#CI,!QYNP,_(WV;(W7A^R9^T;\LFO*3"R\&+*$CW)^.VS+,>-))(!?
MU<A!*Z>]!D:6#G<&3C1;9%%@<@W/%W#;"FF!LG'R9(-"= ,7-@$DR(E[:(F,
M:-[LL6H%1"W<=W*-Z!KYU3]I:J7V$XOY)"I1T HUD:*A,I.&2A989<\JVFD(
MQNR8K@'K(9[+@+A0@$\@?F+&.XO?(<2XMD;;W*V)L],E6A0&&;!]4LMF62/(
M69$*I?[;"R\Y-0ZF%BJC8O:/M!D<KY7'OO"][3:HMK,>5),&CS#"5?[+TA$T
M32,SJ?LLN+%]Q6)]0=&B[Z>&M--3K^>VA%M;XGL6@O'%6"LW>?B[$QH[>:8F
M%%_6I**KU=^]0EHPR[7U3I$CA,A5DO+ IO-6P'X2N']I]S&3W!XI!G)R''D:
M!HLF6.88HD6]X7CBAUB1-2!W4,%#KI%]33C\5_+^XFVX^+PO<)-L;B>YQKD_
M$8<$N.^8T+BZ9$<L\_I^E)HD].-S&Q,;ZB1H3;/G<=<-TQ2F*4Q2F*4Q2F*4
MQ2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4
MQ2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2M=7>]V]Z4=5VU=Q5R3O+2;K,''M)
M=C1IR/ARWH#OVL-78>=-)PTTFT3/(22+91\V(FY19F$1\T$DB%Y<_$1VH[8[
MIM.5W2Y=!FG-VS%!<8DBQ-E!6"Q12EXY  68(95"NJ']K0H'5OX<NZG<?&W;
M"[3\<;;9-OSLIVB?-A>;X+[-I9Y81'+"7(2-Y%@D8QO*.GIZW8QIVW=TEYV*
MYB= 0.LH?7:<33B/ZV]I,X622CJ=!#%0Z<0JI9B=44\0"10ZI3HE%1*!^EB=
M4Q3!JKM9^(/D7<P+VVX;M"[5)C8]E?'D1C%B1A8E56R#I@(+*&RO3S'4?R>%
M+(P*3#O#V3X]P^&7NANF\Y&[-D;AHR$RX3&TF5-ZLQE QS]HA]-P,:^.MRM\
ME4!6LGK134&,-^QL_.-D'$JU<2<I%1SYVA3ZC7E5Q^_KQ<9:16-*6Z:6*55-
MLYEC^0]D03,5HD5)=4FS.3<1AQ=F_F?OF;&F1DQM+-!#*Z8&WXK,WQ6XY\\S
M>OGY+@.D,V<WIY.7Z;+AQB+(D32>S\@EFW#^<&U8[M% ZQQRR(C9>5.%^PP\
M2*,>EBP@Z6DCQ1KAQ]0;(<O$C6KLS=4!/UC8G;_6*Y(??5@U%)0M*AT?3,W[
MB#ED$Z;+V%RC++QL+ 5ZC1-CCI9TD^D$),\8MUIM!.'ECO[M3R(9VXRS8VW_
M '5V\X_%@M'DY#>B&71/+'&,?27@C./C1O'ZI614GA,\4(/3GWO'#!!LS\87
M*.Y]QN109T8Q,=?49=30XTLS3,R1.8ILLF95:Y$4OH&=EM44[F[-9[N-@6S+
M;.BNUJUR9*LUK2%N5O%U/8D6K"F7ZFP3YF]>Z<DD4W57:[/F7T0)R*DCY5R5
MXD'GI)G+N[:^3;;M,IR-ISMSCB:37I$<6@W>.0^&0+AS&@;]^@TGW2145VO<
M>\6S8T>'CX^P@1(J?Y;FB^C3>X^!Z7*"X]@L;U:VM_IZ,-6/WK^K]M_:R4'S
MBR*JQCC86P$H [2UOMT'F(5W7HS3\="S-?<5[>\S G8OT';9:":Q358JOW4Q
M.C<Y_+H-R55R]PW0Z=-CZ46H%! %(8Y!(8-CH^I2"'+L"/4>]W/R#O-.+28V
MP6Z?^VYGD%L;G!/6Z!KCJ&)(M<UFXU6[I6+=)JRHG;BT;($!-%NVV+L5!%(A
M?T2)I):D*0A0Y]@  9%RG%F)9I]Q+'_U,/\ K%8XY7==C<X?'R?^VYG^H5V/
MO+NP_P S>WC^DO9/_JFQZ7%/[MN']YA_UBOSXGNM_F?'O],S/]0J/=MUWNLV
M1JS9&NUJOH-@A?*';J:N^8["V \?,D;-7Y"&4=LVCS64>U=NFY'@G3257134
M. %,H0!$P7VUY'%=MW/'W 2Y[-!.DEC#$ =#!K$B9B ;=2 3[ :P/*MN[I\D
MXQN7'I,;88X\_ R,<NN7E,RB:)XRRJV&BLPU7 9U!/0LH-QTV6\JCNLB"=2M
M-OH%_H\NA$6_5]@=GJ,LG,2;)H]5I,N]:NW]7-<DFI@.R(F\>)E7Y(J02&.)
M.:.YL_Q.7@G;MTS]NSX\S)CQD]27"Q=X6+(;%FBQLB5$AEG$L#C$#D^\/M(3
M!+KKHOMGO&'N.'F&7!@G=<?'.7$ZPY&7M,DV.F5%\5!%)*T:^E,GQ/IDJ!=4
MF]:(I5]A7Y^SM&=KJ5I>S+^*%=@8\\WBJWL.L.T! \C N)&*BD8B0(BJ4I5X
MB68*-G1_+5!VEPFOD;^X-\Y+C0<HXMNDV9GXI>,G*2'#W7#=#]KC--!"F/*%
M8#U,#/Q7AF8I,N5$!',9E]Y[7L\\FR[Y@QXV),%<"!I<C R%/1)ECDE,J$BY
M3+Q9Q)&-4?H/=XZU8=Q_=1$[<<O*3M#5K@M+UA>'T/*7>L6).!V9%6&!>/8.
M>GZY$.$+-6TT"$*LF:+<N7Z#ORP,#I,WE'2Y1[I=_=BYMF+VV[F;'(V#AY>B
M?*QY%ARHIT=HFEAA+9,26!*R0-/D1LP(6=AH<=K]HNR&X\$@CY1PK>T/(MXV
MU)8\/(@,VWRP3(D\,&1*#CY!8DJPR8XX7BU%?1<:UDVY=O\ H.A:!J+F"HZD
MQ(FGGP3D[8K&Y0=S\^_40311</EFK-@U11;-4RD1010123+U&Z14.H<W>?;#
MMAQ7M5QW[BXJLGP\K^K)+(P:65R  SD!5L  %55 47Z7+$\*]T.Y_)^Z6_)N
MW)!!%\-%Z,,$"LD$$88L50,SL69B2[N[,QL+Z555G?-CUK6F*4Q2F*4Q2F*4
MQ2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4
MQ2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*5;-RJ%=O\ 59^EVR-2EJY98QU$
M2\>J=5(%V;M,4S^6NW42<M7*0B!TEDCD515*4Y#%.4!#%[WLNV<CVC)V+>HE
MGVK+A:*6-O!D<6(N+$'S# @J;$$$ UE]@W[=>+[UB\AV.8P;OAS++%( #I=3
M<74@JRGP9&!5U)5@5)%:1-X,![(]P1U<T/)KU%_8M>ISDELN\%87"9=QRUC>
MM5*!!??C$]?C(5!:%:N7@D:'D%U5&W4X(5,H'^<O=?7^&#D^-MG9O":+<MSP
MC)+E3K\7,Z+*]\6$,IC2-?2$LI"&0@*2X5.OT2[?;IB?B"[?9&_]W?0R=MP=
MV$"86,S86/'(8(]&;.T<@F>9_7>*$-*(% D"Q,SG3)FE]KWW>M"CK1*.XJ.D
M)=VH[E9@SEB:5N:BTIL"D^KUI5SSZDE#[$J\C7HUY&2,['+U6*:KBHBSZFZ[
ME?J#B&T8/&.+P\Z[W_X[W'R94R8-E2:%Q+DOZ4FWS3K')+'D"6)_\7"RQ8^V
MPKK$6/)%D9+\/\^W3,YIR?(XUV!,N'V@BOC2[]/CSQND:_%0;GAX9EC@DQLG
M"RXAKEGQYCGLP][(C>&*LGJEJ9*+T_;&31XX3C;49W+2]C771-.[LVU:&+"N
MHW">>M&4:W7KLC+),$FP)-FPS0HD<*D!!3RW'CEF;S#N=V^S<CDF6%X_)B2Q
M8JQFR9N5EO*N+#"39ALL&5DQ0[?&UYLZ-(Y9Y&@;3DN$<<XEVNY)!B<;QBV]
M-DQSYLLH!F4011#*R<G2%1MUR8,<S9LB!8L>1G2*-)5O#DQ#7*0?7I* BT6H
M4>,C)F'^\C$,9S)6F#7A2NT6"G45,(J#;N%&JI^#"J]\TG)?3CUSW:.6Y^=S
MA=AVM(?YEX^-DX_K&Y>;.QGQ_46(WTB'&1GAD-B7R?53W?ASKQF?L6+C<:;=
M,UY/YQRSPR^F+:8\:99BA<6OZDS*)%%QIAT-[WJC35(C:]5E:M9;EYKIE U9
M_*M)!TY;J&,JVCF[=^A)LT6X++.64O%O6[IITE%15%<G!>3<9D-I[G\6W7C&
MX\O#R0[%MDTR3.Z$DI$B2K-&J:FDCG@DBF@TC5)'*EEN;5;9W"][P=YP]@TI
M)N>;'&T:JPL&D9D,;%K!7BD1XY;FR.C"_2]7&[N5<9.:LU<2:!#W-11&N* )
MCMY)4D>>3 J+@A3(AYS,@F3$Q@!01 I>3" #G\OEW'L'*VS#RLF-9=X=EQ#U
M*S,L1FLK@:?>C&I+D:^@6Y-JQ4&P;OD0YL\4#E-O4'('@T8,@CZJ>O1S9K Z
M;$FP!-48;]'R4C<ZM ""MRJK,YTXN136:MW[E6'CY1DHU<<=#MB4TNU3<&3,
M)VYE2]92@=(3XS^>^WY^Y;QQC8R'Y?M<1/H2AHUD=H(IHRC^#Q SPI*R$F)G
M4.%UQE[S^;>5BX>W[UN?N\?SG%Y8RKLBB5XV#+XHY$4C1AP!($;23I?3!\O>
M75NB*G<"25BHLS ,FD_8(B*DT5FTE0YTC4DA:(]%ZR7BIUC75A2<+@Y9>I9I
M)N$%$4EE43CIC=.9Y/+-HVKERY.X;'NV#$F5E8\$RLDVV90C$N;$LL;PY,>(
MWIRR";']6!$G@DBCEDA>MB87&X-CS\[86AQ-SV_*=H()I(R&CS8"Y3&D9'62
M!\A=2(8Y?3E9HI4D>-)%J--MZV9O+A&VFRB6!LA&\LV0O%?;H.(B4KDPWB&]
MKGV57GTYJKJW-M5:^BVE&DDUD!<0:)G,<<'#4"I9W+Y+N/"=ZRL3F.-AYG%M
MZ11N$00_!;ECP)(1F1(2TF/N&"C>KEXJRLN;@Q&:$S/B^C%#LWA&U\TQ,3=N
M,Y.7MW,MH,GP&4C*<O ER6B67'<%?0R<7,]-8<?(EA)Q,APC"'UA(^(&X>XW
M=VBK/3J<S+$52ZVZ,E"3%U!N^M>M95HQ="\A*Y2;39#M'%\F("OKM3.UY!B5
M_$@JHW\YVBLB=OKKON>5]D\6+GG9N>7=>-Y4#KDR2HV3+AX\+XT<;;@Z%XGB
M];+B@V[(G/Q"Q^I#)/.CQI#M+\/.;Q;N=D97#N_>''MO,L6;'&'CX\IQL3=,
MC*3<<B1-K:01Y$DL&)@/D;CC01I"'9)E2/0YED7M7T?JSNK;3.^=F54R-RB]
MFRD79(FN2+R.UO?IN(8U^<3N#^KK&>&*Z?'ER)OVZ#LK!XZ;JJ*(""RB>87L
MIP+@O?/$7O#S#:4BY6FXNDJQ,Z8F5+$L4BY+0,6-V]0"10_IO(C,5]YEK<?>
MKN-S;LC-#VNX;GZN.S;/')CRSQI)GX4,KSPG$3) 7W4$1:!WC,T44B*DGV:M
M6W;V>&=PUPG3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8
MI3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8
MI46;#VS6Z"D5AU+6&Y/U6#& I$$DXD9V3EIT)-"LHR";%N\+58.;E(I5K]\R
M8-8AJJ ^>X( #F2P=KR<Z\@M'AJ"6D8A4"K8O8L1K=58-Z::I&'U5-1K?^4[
M=L2^B=61N[E%BQH@7E>276(0P4,((Y7C:/XF?1CHP.N10#4,#H97>CZ%NO<M
M6:Q,-XQ%R]IFHG\3&S,/4&UL@J:O,Q%^%VXGX.YVZKV."<)LY-AZ5N"*ZO24
MQ50*GZRSL^+DP3[7#$VZXC.8\UD4SQN1-"[XDA59<:/(QY3',@:\B^ZY(Z'&
M;=MW)=^PYTYC/(FP9R1Z]H1V^$=/\5R$BW.(228^X3X.;CF7%FTJD3_:1KJ(
M(U(,>TO>5=V^FSDZ _B4:[>U+'+[B53;(T9#7T<]%P^DBR)3BS/&J5-!1$8<
M"^8#<WI3H%2Z@#Y))V"[M8_>-Y]PQG7C46:99<QB/@_@0Q,@/[+(8+H<8K]4
MF-D"W ^RV1WT[:;KV\,V'N<<\V5MHQXMJ&HYASG32D92VH2#)(?XN^G6/765
MGL3FI&][-8WILJDZUA*U9Z97)R9<QU*MTJ+%JREI@Q2M8B759)',K#N&$2+Q
MQ#ME$W'F3)F(J^0*7 [NR/Q <?[N<XV_@'&4R,'#&4Z03N4C5IOY./(4==+8
MT!R)<.$A]>=\&[:/2-<ZYOX<M][9<,W'F&YY>%N.Z8^,KY>+%K9XHOK2Q!R+
M2J\OI1Y<BF/3B#)T>J'Z9=W%$262 UM3"*1[="L&JPK,3& \2E;WC5P^E$W)
M>I1.0B*E3Y)0%#F$PO'[43FZEBB;<7+8C'R/ [><10X\";8<+5'>^.,Z1'EE
M#@DK+!@8&8XD8ECDY6+J.J92^AMAD#;3D\LW\B65LX9-GM:4XJ,$C*] 8Y<K
M+QE*BP]*&?2-,9 [LDP9!9"T.+;H-XR5O=/.\9MDTR(MV5*J,9/N2&1#@"LQ
M1@H5D8O AT."E$.# &7.Y86(W)/YD[7&D>UY.^;>9(T  2/;=OARW!7^YD8V
MW8Q'AIF52+&K?$RLC[H_G)G.SYL.V985V-RSYF5) IOXZ[S9<P/MC8WN*MY*
M%4L4PTHZ:B:"M59;D;5Q<B9#%@7$59J$YH+EHF8HD2/6&LLV*VY\ *T#[0R.
MQ;0W(MWBX7$PCEVN'D"8C@ C%>#-VM]K=!X X:30B 'I: 7Z"LQ+G#:-NDY(
MP+IFR;2TZW-YQ)C9JYRL?$C(:*3U#[9#Y]:[]707V RN,_&F)#VI9>FW>O/
M$0^ZYQ]KNLM%F#L2"51:)=+Q)V3] ?!5#K#P,!#%R?&(I^>8>[;]M9&+RF1]
MOW+$D\#!DR[3AH8WMU:"1H&Q\J,_7CUCHZHRV>]-%Q;(P-LS;S[&J9>'.O3[
M6&//R&#K>X$BK(LL+^*MI/U2P/XK31E<*;8$$5&D!*UV9D;355I3R_\ Q<1G
M4UI.4AYH@B ?<C6R#,P4@VY!,[-FHF''242^>,86-S#B6=C8OIX6Z8&=+FX)
MFL3BC+#2S8^0OA\.F8=QVO)A^JT&/)& "J%?6[SS[%R#$E</E8F7C1XV2([_
M .,&&T<<L)ZGUFQ_A,V"3ZRRS(QO=@V!DIWAUO<>K;+H>J5^UPMNGXR0@--V
MN0;QI8:<E&CD5ZI7XN8^]U)&)LK]DD6-BI%8B'FO!27,=LHH!2Z-P^^?'>X'
M"\OL]ML<D7+S!)%M4D@1HO5B8MA0+,7++E1*$QX<GH))46;7&T@4=-X78#>N
MW_-,+N?ON3@Y/'\6=)]UQD:0S0QNNG)GDB](1R8Z.3D9..C/HAUQJLRH28B[
M3>T-_?+Q-0VU=&VNN:F&DR;.Q,[W!3M1^\+6Y<,6T.]JRCD(>8;V!DV.\%.7
MC1!1NT.NAYY2NQ(KC?PD]NNY7'^<9>;S#;<K'XNF*-<6? 3!/DQS128[#&R5
M*2M$R&19/394TVU L+W7XMN:\'Y3VW79\;>L3<N3SYA6"7;LS_&<;%E@FBRK
M9F'()L99HI!"\:S1/(7!TD1DKLRJ3B8[8?+I5CATI+2[B5<JUB\U2IM8AM0E
M+#.VV74KUSKE5A0BJ[KZ@U6,;*/KK*O2 Y<N1.\X.8R@?2G;>/\ 'UVV/ XG
MBXVW?#I;X2(+'$P4)=X!=0TT\SN?AXTO>Y6_A7S W3F',]JWJ7,[B9F;O6W9
M4HT[G+KEFAU-,5@RPJ/Z6'@XL42MN&1. ;@2!;7&5\3+Q<_%QTY!R3&8AIAB
MTE(F6BW;>0C9.-D&Z;MC(1[YHHLU>,GK54BB2J9S)J)F Q1$! <QTL4D,C0S
M*R3(Q5E((*D&Q!!Z@@]"#U!J98N5C9N-'FX<B38<T:O'(C!T=' 971E)5E92
M"K*2""""151SQ5>F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2
MF*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*5\7
M#A!HBJY<K)MVZ)#JK+K*$21123*)U%555#%(FF0A1$QA$   Y'/T L0J@EB;
M #Q)KR[I&ADD(6-02238 #Q))Z  >)/A6-T]L^Z;+^]:SV^$CN"MED%=T3K-
M:2H<&[>UN M54E*W& I'-]LP=C:2YVIW,3) C'.$Q%83\ F:00;;A[?IR-_U
M6O?X=#IE<!V217:Q^'="NJTB$L/ >8UYF\EWCD?J[=P$1]%*G<95+XL3-##D
M0/"@*#/BF20QEX)M,3@ZRUM)DBAZFJM%<O9I%-S/7&5&63D[S952S-Q<1,K9
M9>V)U0+&Z3/+!3J_)S:Q(N.,J=!BV B9>1+U#C\W<\K-18&(3#33IB3W8PRH
ML?J:![OJ,J@N]KL;DU(MDXMM>QS/FQAI]WEUA\F8^ID&-YI)Q!ZS7D&/$\K"
M"'45B2RCPO4GYCJD==*2CF4O'/XF1;INX^39.H]^U5#E)RS>H';.FZH (<IK
M(*&*8/> Y1R,>'+QY,7(4/CRHR,I\&5@0P/R$$@U<8N5D8.5'FXCF/*AD5T8
M>*NA#*P^4$ BM7S[Z>#'6\?<[IK^]W*R6>KU2Y/=*51T$>Q"OW%> DD*PX6F
M2GZY>2AGBJ9F"ARM$TW9$U5NL"CG'D/X3MBX7E;GS'A^5F3\DBP\I]MA<HHA
MRFAD$+>H!=V1V'I$Z '"LY87KLJ/\5V7RZ?;N.<JVW;\39<S.Q$W?)7U']?$
M6>-LE1#X11RH&$Z@RLT1=$TW%8==KQ]IZ>OERVV-&V<2&H6K]BSNVTKG%S\6
M$Z\CX91^PC$WT^V JUE<66/9*J*AUN$F*3A0>2=13\]]@8.ZW">:;QS?DN#N
M?W3MVTYTN8,F.4-*RHLB1QO*#>5YHXV8CJ(T<FX%JW]WL7@W<#BVV\%CW+9C
MN6Y[U@0[6<22"3T$>41O(4A:ZXZX\DRA>B-,T2"S6*S-VX=X=\G=Y'D=G15>
MEV-SJ^P+$Q3I#)^DZJJL)4(B;D$_3/I1_P"O:/8'63=L3J.14'9BFZNE0Q0E
M78GO[N/+N\&;G<EPP9,G$SID] &T&G&PS( K,Q;7#M4$8NP.NY_;8#7_ '?_
M  _\9VGMJN-PR?*@RMOS<&!_C'0KDB;*EA0ZDC30R3;B\AL"OI@C3J0$VM0>
M_P M\+?IW8=JH,"_JMHA[Y*5Z"K3Z0&SQ2P0Z4\Q:R3MVNX8R_KAJC9LX.DV
M:>6)S+E*8" D;&\ _$TQ[G;EO6;M9.'E0Y[Q)&Y]1"8XY@#JZ,'^#B5B MM1
M< VTUFN4_A;V3.XKB<6V7=<J/>\+(PHYYLA$^'E'JF!VC50KQZ/BI)(U:235
M98V8$F07CV<=TVS9W=D#3+4A5Y2!VZWFBM&U:8NVSNFNX1A9K<P_6K/W N89
M-L5RU4!<#+\F0,"@ 0Q#Y?\ #+WPWC=^Y\G$\S#B&!NJ2%?3#W@,)R,E!<L0
M8P)7BZC4 (K-9"&C_P"(/LCQ#:^W&1R+8Y,Z'=-B:+4V0Z,N6LSX^*_1473+
MJ].5=!"=)05)8,N/):KW'AW.2+<\3L1/:\IM%T,FJ1M-I41_17UB<.'@N7*9
M"PJ^MW,.Z7ZBCRD*:A@X]2(AD%38^^L7X@I$BQL],R?=6:4JLBX4F)),S.69
M0(CC,CNS:NK:FO\ :L0=JG>^S_\ 0M%*)]I/"H=F7TP6A.:F8D "A5)]8;@L
MJI8CWM2J;^C8UL'UI].>LZ_VA 7-UL>:L5/I%@3LM%HSB$:LU(J18.?50 3-
MD"3=*S:,(L5-0GEM&1U5D2&4,)>HANGN&?A$XIQ#N"G-5W#)R,3&R/6QL5HU
M7TW!U1^I*'8RB,V(M'&20"21<'EGF/XM-\Y5PK)XY%M.-B;[N.*<?,S5F9Q+
M&ZZ9O2Q_300F8%E;5+*%5V"@&S+LC .  /;P !S\<ZZKD:NL^8LI-FZCI%HV
M?Q[YNLS>L7B"3EH\:.4S(N&KILL4Z+ANNB<2'(<!*<HB @(#GI'>-Q)&2KJ0
M00;$$>!!'4$>1JG-#%D1-CSJKP.I5E8!E92+%6!N""#8@BQ%8TA0[EI28=SN
MLU7%DUI(2*\G9-72#I^XD(1[.3E9:R%AH\T\>280M.H-+C')F--C(TB+A3]4
MU$AU"%+(OCL/>(1!N7V>Y*H"3@"S*JR$)*H"ZI)9&75D.]U%RUP*UW]Q[OP[
M+;-XR3D\;DD+S8+LQ>-I98%>;%E9G$6/BXT;F+;H80KM[L14E14S:_V-5=EP
M#"P5AXL9)XPC)!S$R;1Q$6.#"7CV\HQ9V.O2!$):!D%F#I-8J+I),YDCE.4!
M(8IAQ&?@9.W9#8^2!<,P#*0R-I)4E'%U=001=21?I4MV#D.U\DV^/<=K=BCQ
MHY1U:.:/U$#JLT+@20N58-HD538@BX(-7UEE6;IBE,4IBE,4IBE,4IBE,4IB
ME,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IB
ME,4IBE,4IBE,4IBE1YL39]2UE#JR5B>G5?J,)I]!U6(3"4N=O/ 1:\S)QM,J
MS<_WM9Y9O&MCK&;M$U#E3*)S=) $P7VW[=E;E+Z6,!H#*&=O=CCUD*ID<^ZB
MDFUV(%^GC6!W_DFU<;PSE;BY,QCD:.",:\C(,49D=,: 'U)Y BEM$8) %S8"
M]1*6C[)V_)LY;9K]Q0:77[(J^A-<U&9?"\M1J[:5W58M%OM3;[E<+URUU10&
M\K3G3!9MUF 5ESF+Y9<H<S;MJB:/;!Z^;)& TTBBR!XP)$CC.JSI)UCR X:P
MZ*+]8O\ <G(N5Y2Y/)G; V7'R2T>'CROJG,,Y:"?(G7TB89X#IGVYXFCN??D
M8C2,AH& @ZM#QM>K4/&5^!AV:$?$0L*P:QD3%L&Q 3;LHZ/9)(-&;1!,H%(F
MF0I"@'  &8*>>;)F;(R&9YW)+,Q)9B?$DFY)/F34\PL'"VS#CV_;H8L? A0)
M''&JI&B*+*J(H"JH'0   55\I5=4Q2F*4Q2NNZ:-7S9PR>-T731VBJV=-G"2
M:R#ANL0R:R"Z*I3)JHJIF$IBF 0,41 <\21QS1M%*H:)E(((!!!%B"#T((Z$
M'Q%5(IIL>59X'9)T8,K*2&5@;AE(L00>H(-P>HJ$]==M&C-334K8M>ZZA:Y-
MS*"S1W((GD'JJ+%P<BCB.BR2CQZC"1C@Z914;,BMT#]!>2"!2\0+BW:KMYPG
M<<C=N*[3BX6XY0(D= Q)4FY5=;,(T)L2D85387'05L/EO=WN3SK;8-HY7N^3
MF;=C,&1&"("Z@A9)#&B&:102!)*7<7-F%S>V:/V>]O&NKLZV!5-?-65B6&0]
M&#F3EY*'@PEB*I21:] 2+YS#0I72#A1( 00+Y*!S))>6D8Q!PW'>QW:[BO(Y
MN5[)M,,6\S%SJ)=UC]0$/Z4;L4BU D'0HLI*+9"5K-<E[]=UN6\<3BN^;J\F
MTKZ>K3'%'+-Z1!C,\Z(LLI4J&]]SJ<"1]3@,+LU]VX:0U59).W:]US U>PRR
M*S9U(QY79A19N5DW#AC%MG+I=G!L%ED2"9!DFW2-T% 2\%* 9SC7:_M_P[=9
M][XQM.)A;KD@B22-2"58ABJW)$:D@$K&%7H.G2L%RGNSW'YMM$.Q<KW?*S=J
M@8,L<A7JR@JKR,JJTS@$@/,SL+DWN34V\!\ _)D]K7=<XI3%*8I3%*@:Y:==
MA.N=@:CEXO7VQWBQU9EPYAU7U,O*SPU:C7$ELFNP3^MREQF8.JP*C2$74D4O
MNU1P8W"A!,0<UB;JA@&!NR/D;<H]P!K216#D"%V#K&K2,&E4(=8%NAL:A&\<
M2F^.??\ B<T6W\C<DR$QEL;*+>@A?,AC>%\B6*"$QXSF9?1+$V925-5UGMPE
MU6?UNT5YWK[94"5JO9:#*/F\LO$LYI]9"U9PWL<6D-:G5)Z$KBC\46#APJR3
M/T. 3. @-+<=K.$%GQY%R-NDOHE4%=14)K!1O?30SZ+L &(NI(JZXWRI=Z:3
M;]RQWV_DD 4S8CL)#&LC2^@1,GV,OJQPM+:)V:,>[(%85,F8JI;3%*8I3%*8
MI3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8
MI3%*8I3%*8I3%*8I3%*8I7 B!0Y$0 /B.*5CO/;N>3EE=472L$VV)88:3;M+
M=81?K-M=5,8VUQ,#>*K*7:*8SL>SVQ6XN3%^2N.").U&Y.L_27I ^>AV98<8
M9N\.<?'=28TM>635&S12+&Q0F!V709@2 ?"YJ YO,Y,W<GV3AL*;CN$$H7(E
MUD8D&B=(LJ"3)1)47/AC?U1AN%D*V9K B]=U_I6,K+EM:;G*N=E[..C%+2MY
ML2)P2+.1M?/6%IJFU-5X_KVM%I>&5.B^3@TV9'H&$7 JB/.4,[>)<E6QL11C
M;9[P6)/WI?U LCV#S:6ZJ92Q6PTV%7NP\.QMME7=-XE;<N3$1E\J4&WJ)$83
M)C8Y9X<+U(R5E7&$8D\9"YZU-F8BIC3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I
M3%*8I3%*C#9VI:OM.-01EA>PMCB6\T2GWZN^A9WF@2$]$N(1_.TJ<>,)#[CF
MCQKHZ8+E3-X"'(#P'&2VW=,G;)2T5GQG*^I$]S%,$8,$E4%=2W'A<?(14;Y+
MQ;;>48JQY9>'<(5E^'RHM*Y.(\L;1/+C2LK^E+H8KJ /0]0:CR!VE8:!86NO
M]UH(L@E)=.*HFS628HU&V.+!8K,VI%%<'>2CN<4V4C48))W+K>D;Q9USG%$Y
M2BF4]]/MN/FP'.V8EM*:I83_ "D>A$,LO10GH&1RL8N7 'O ^-1_"Y1G[%N"
M[%S-5C$LH3%S$%L><RS3KC8I+.TIS1CQ+)D-Z:0%V/IL!8')$IBG*!BF Q3
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MQ_\ G^7_ *)/_8T_K>.R+_/JV?#_ *.K?_DW']$/-_[A#_?D_73_ 'O.Q_\
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M6UW9\YW$LIV/A:#7M ;++KU>WRMR8KPMC27Y*SGE'+N-AF4"D]6,DFDB9P[
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MZ[E+J_>U9@=><.IR+FZHH(X6P.O)X#TO5Y8)?KN>OY<VW\-E?=.LF71\,O\
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M$7L3U\>IKN.&3-XT7CW;1LZ8.D%&KEDX037:.&RQ!26;KMU2F25052,)3$,
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M<6LY8=&+7)'C519LVD<T;L(]JW8L6:*;=HS:(IMFK5ND4")(-VZ)2)(HI$
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MP/G!T6R<X]"(K$0+M50I !-HP;$.81*F4>+:6+$XSAK[DT.#!/.!=H5O:%0
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M#F2?4B?\EOTVK&3;UM,!TRY,(;V!@3^07-=(NQ*4<>"V%E[>/F*X('XQ.B4
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M*8I3%*8I3%*8I3%*8I3%*8I3%*Z[IT@R;+NW*A46[9)1=94X\%322*)SF,(
M(\ 4,]*K.P11=B;"O$DB0QM+*0L:@DGV >-8:W.V.;;+G>GZDF2 &0CFHC_@
M&W4(]9PY$HN5^>5#!\ +X@4,G6!A)A0!!UE/5C[3[!\@\ORUI/?-XEWC,,IZ
M8Z]$7V#VG^$?$_0/ "H?V!?ZKJ^GSEZNDHC$5VOLU'KURH("JH)>DB#)DB)B
MF=R3]P8B+9 OSK+'*0/$<S&!@Y6YYD>!A(7RI6LH'Z2?)1XLQZ =34.W[?=J
MXSM$^^[U*L.VX\99V/CT\%5?%G<V5%'5F( ZFO.SW.=ZFQ>X1R[@&AE:;K%-
MV<S*IQS@X.II%(_\U=W&034_QJY\ .#4@$8HFZ>"**$!<W0?&>%[?L &0_V^
MY:>KL.BW\1&I'NCR+&[,!^R&*U\].YO>OD/<)WV_'O@\6#W6!#[\@'U6R7!^
MT/@?3%HD-K*S+ZAQ$@V24G-1$<N90J,A*1[%8Z0E!4J3MVBW4,F)RG("A2*"
M("("'/M <E\SF.%Y!XJI-:9C4%U3R) J9K3KFMUL&0MXV[3HNS+@?[L58JD:
M@B"73YYTX98Q#+"H/0 E ! AO'PS&09>1,3[T:V]H/ZZO9\:&&Q"R-\Q'ZJZ
M2U6JB+%@V3KEY?OI!TW<N%V:;@RD.V!(4RLE5GE9CVBJRZCHQEBD*<A!0)PM
MP8P9^^KE>HQ+H(U'G;K\H )/S=>M_"O318BQ*JJ[RN;D@_5%O D@7))Z]#:W
M0];5T=D4&%J$?&NHMS)+J.W:K=4'JS95,"$1%0#)@@R:F W(<>(B''NRKA94
MN0[+):P]E4<K'C@562_4^?7]51?%2LG!R3&8AI!]$RT8Z0?1TG&NEV,@P>-C
M@JW=LGC8Z3AJY14*!B'(8IBB'(#E[+#%/&T,RJ\3 @A@""#T((/0BJ>-E96#
MDIF84LD.9$P9'1BCJPZAE92""#U!!K=CV;]_[J[RL7JK>+J.;3[PJ$?5+\!2
MQZ-@?B8B3>%LJ! !BVFWIC<-W:0((.#@5(Z95C%.MI;F' UP(FW390QQ%N9(
MO$H/WR>94?M DE;W!T@A>UNS??R3?LN+BG.7C3<W 7'R_JB9_ 13"^E97)LD
M@THYLA D(+[9P^(?[/=[_?FJZZMK(;4MU.OT5635 3I)#]S+G_2.DD43'CS&
M$1ZC() )DO\ M8"7^*7F,;UMX0G,A'ND^\/83YCY_/\ +[:V5Q#?3,!M.4?M
M%'V9]H'BI^4>*_)T\A>>LCM3^F*4Q2F*4Q2F*5YP?KD[.D7%UTSIM!R=.(BJ
MU);*DFA#&\MY)3DD\K$*NN7GH$\8T@7Y4AXY 'BGCX\!T=V,VN-</-WEA>5Y
M%A4^Q4 =OEZED_Y(^CYQ?CEY1D2;SLO#(V(Q(L9\UUZV9Y7:"(GK8E%BEMTZ
M>H?;TT*YORN":8I7.*5ZF_HI7]]9.V:W4F0=J.1USLV3;PZ2@B)6%=M$1%3S
M=FER(CTC8CRBP^P/UWA[\Y7[U[?'B\HAS8E"C)Q5+$>;HS(3\^CTQ]%?4W\%
M'(,C<NV&7LF2Y<[;NCK&#^Q#/''*%'_YQG;V>]6XS-.UV-3%*8I3%*8I3%*8
MI3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8
MI3%*8I3%*@O<]B%!HSK;942JO3 ^D (;@?1I"8C=!0./$KAR G]O_ ^/@.2#
M8<4-(V4XZ*+#YSY_0/TU!.;;EZ6.FVQ'WY/>?^*+@ _.W7_B_+6.)C%(43G,
M4I2AR8QA I2E#Q$3&'P  ^W)36L:\V_>]W-R.]]DOX""DU U;1Y)U&UAFT<B
M:.L,@S47:/+LN"1Q2>'D>3D8'-_@6 EZ0(=9?KZ+X1QM-DVU<F=?_$YT!>_B
M@-B(Q[+=-=O%KWN MOG%WO[F3\\Y&^W8$I/%,"5D@53=)G4LK91MT?7=A"3<
M+%8K9G>^'E>@7MDEFL0P /.<F$3JG ?*;H)@)UW"PAX@FDF CQ[3#P4/$0R8
MS2K#&9&\!^FM*QQM*X1?$UE) :DJ\4XC7!DW\G(LWC1TFN9PJB95TW7362!%
MJT$I"D%4@<%'S!]PB.8*?<9I$8'2J$6^;Z:R\&!&LBD O)J'3S/R "_T6\ZF
MK[N,''_B[*?9_P!W?_(9B]?_ *U?S?KK-?#2>6-+^1_U5Q]W&_S=E/Q"^_VD
M/;C6/[JOYOUU^?"R_P";2_\ /_55J6RE1MC9MTY>"DTF[-85@446D$B$.H7R
M>3* "10$W5Q\PCR.76-E/"3Z;JQ/S5;9> SQ7D@D1 >I.JWY2+5C/L/6)*VU
M&:A57"\60Y"/6SCA19AYI@(DL18H$\YJ90P$'D.L@B7D3 (B7-8>:9CZ<M@_
ME\OZC6"R<3T1KCZIY_)^NH; 1 0$!$! >0$!X$!#V" AX@(9DC8]#X59?**]
M!?T]>YMUMRD.M;7B:/(;%H2)#LWKY45)*S4L110:23E=50RLA)PCM0&KM4P
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M)!';YS\E:LLVC7+E3)I#_E7(?^3SO_PC$YCMS_D!_''Z#5]@?RI_BG]RL_\
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M3_BUCS8(&'M,'+5N?8(2D'/1KV(EXYR7J;OHZ1;J-'C54/;T+-U3%$0\0YY
M0$ ')-!--C3)D8[%9XV#*1T(92""/I%:XS<+$W+#FV[<(UEP<B)HY$;P9'!5
M@?G!(N.H\1UKRN]PNE9_0NT['0IAN\&/0=KOJE+N4^DEAJ;IPL,-*I*D(1NH
MN+<OE.R)\E0>)*I<CT<CU!Q[>H-]VJ+.C(]4J!(O[V0 :U^:_5?:I!KY9]P>
M%9_ >49&P9:N<96+8\C#^6QR3Z<@/@6M[LENBRJZ^527V0?_ )@:[[/_ *KF
M?S()Y8\U'_\ 3LY_B_UPK*]H3_\ ["V\>>J3_J9*WMYH2N[*8I3%*8I6*_>8
M8I=#603"!?YR0 Y]@B:)F2E#\(F'@,F'!3__ %!&/X)_2*T_WQO_ #%;_M<?
M]9+6A/X?@S>S?6/SUQ0/"MP_TRNW519T][A;7'&(@T%[ :V;O6JA?4+JI"WG
M[<V%9(A5$6Z1SQS14ACD,H9WSTG2(.:>[E\@L%X_BMXV::Q^?3&>O0WL[ ^6
MC]]T[#_#+V\+22=PMVC(5=46$K+XDBTN0+^('\C&PN+F;P**:W0  B(%*43&
M'P*4I1,81'P "E#Q$1]P!FGA:_7PKLD L;#J369]#K_[-UI@Q4(!7BP"^?\
M@'4#MT!3G3.(>!C-DP*ES[P)D#W#)^*RVDO=!T'S#P_+X_36[]AV[[LVR/'(
MM*1J;^,W4@_-T7Z*O'+*LS3%*C+;.Y-9:,J#R][5N$13:TS-Y(/9-?A>0?"B
MLX2BH:.1!60FIARBW4,DT:I*N%"IG,!.DIA#);5M&Y;YF+@;5"\V4WDH\!X:
MF/@JB_5F( Z=>M1GEG,>,\&V:3?^5YD.%M<?35(>KM8D1QH+O)(0"5C16<@$
M@6!(\\G<O]9W9=K>OJ]VV0J.N:N ';DNUF8,)F]R7!A+ZMA%KG?UJMMU""(
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MQ(D5$10 J(H"JJ@= %   '@*FK5=.4FI5.<>)B$5$+D51ZN0![)(B!TDR>
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M4TD4DB@4I2@!2E#@ XS6Y)8EFZL22?G/B:Z4551 B +&H      Z  #H !T
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MP@(#X" Y^@E2&4V(->)$21#'( T; @@BX(/0@CS!\Q45:>.ZC("0H<D*PO\
M6\NXJ3<[@PF5>U= B;VDR8*'$3N@7JCMJ@LMXE,^;.2<B9,_&5W@+)D+GQV]
M/)02=/ /<B5>GA:0,0/)"IMU%0_A!FP]LDXYE:OB-JG;&4MU+XX ?$DN>K:L
M9HU=_ S)*MR5:I:S$U,Z8I3%*8I3%*"/ <C[ Q2M!%)HO99W2=S'>4R[A+G
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M_OQ_L:/_ $W"_P!8I_51=^'^A9I_2;JC_GOC^EG@7^>/_>)_\'3_ '3^_/\
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M'CG[2N1 !\!#D/@.*5P!0#V  ?@  Q2N.DH<B!2@(^T> \?PXI7(  >P #\
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M,V^'0J&=G=V"*C!P'TJU:9_4LJ9^V*_=R$IJ6Z0I]9[2_=);]=/I"-2L#"S
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M0JJJB[,Q-@  "238 =35G[#C'-MUM=8:"%!Z[LU*L<9#F*X3!JZ<3$$]:L#
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ML4H]E&]=-'P@JH=3I [Y-^8CALGY0 :.\:XE\"\>7N=QEEW708'<1Z8@YOJ
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M)&$J7JW7'(=:*!2DY#X"X40,(?: #ETN!DMULH'RG]5ZQ<F^8*&R:W^8=/\
MG$5Y?MW6V-8?5JVM*O!!NW<V_2OEE74*0"G0U[J[CS% -T$\4Q'D>0#^'HW:
M\&:;M7AP1]9 F1X?+--4QV+<X(]NRLZ3W<<8DC&YM8+&2;GP'0=:E3ZNL?<)
MN.TK;J[4YR6AM?;<WRC9'\.Q<RJ4&[V$?6UBKJ4@5FB=5JF_1CW()JF*"0G
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MVF)P >SI]^8Z; _:QS<>P_N&L]B;W<B/-'_& _KA^Z/R>=7\@OX)KH*%,4P
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M_)_PU&<O?'8F/#%E_?$=?H'E]-_HJS5!7=*^<Y5576.' G6.8Y^/$0* F$1
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M1+XA]JZ1 $#?W1./ATC[<L)\#IJQ^OR']=9W$WI@1'FCI^^ _2/W1^2I!07
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M39PXJLP$DHL=!DNV.V>IHND1!5$H#VAQG;]OV'%^$GC]:*13ZC"R,78JSRQ
M72)F9=111Z=V<:;,:Y?R-R^,RVFRE+0D:0NKWE4'W0'(NQ064,X9BHL;U'RF
MT>Z"OD(I9>V:"L;-D0#2K_6&YHN6D':*1"&<NH&L72J4@RZZG!Q29JR!3B(
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MV67'CFL"R?#APET:XM(IO:Y!Z5FNHW "](%#I+X '''    ' >X ]F0Q9 2
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M$LPU?57J?ZOG_-4!W7(;'Q#H_E'.D?)?Q/Y/SD5&+9 IAY_D^P/XH^_PXY\
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MP:L%'*AU4S"B1,H@(J=(9LK9\KXC##$W8&WY*X6[J<8CVSF,^*#Z>'(!*!X
M%DZ6Z$@EN@L!X^SK6;^M[H,3M[6]LJFQ)BCV1E8JM'K6A^\E6"<&I)2#=%5U
M,>8K'HK1J9)$ZQB^8H*Z"A@,8Y3F*:ZW&*&;!F2>/U8C$UT(O>P)L ?/V'R-
M0;C,NZ[?O.,VWS#!RAE1E9T8#T[L$,FI3?2H!+#IJ4$$6-J]OT=)1$VQ%U#3
M,7/MD55&2[^)>LWS8'[;@KI QV2RR*3A(P_.GSU$$>! ,Y4>.6!PLR/&Q (5
M@0;'J#8V-B/ ^=?7&#)P\Z$RX<\61$&*%XV5UUKT874D!@?$>(/0UU7*?'(?
M#D>?#X!QE13YBK:1;=*JE87\IVY:B<>E9(JQ2F]@*HFZ#"'NZE"*!S]A SQF
M ,HD'ETJ\VJ0K*\)\&%_I'3\X/YJDB./PJ8GN.4?#[2^/\'.8G(%TO[#4GQ6
MLY7VBL6]]]M;Z[V*/V5JV=-0]GE<,8^PV5)W)F&6IS9B];KQ:465W]T'D#*'
M0^8Z2?J4$O3JK%1,;.>^YW9Z;E6[P<NX=E_=/,PT<.1E#6S38"ZC+C*FL1J[
MDK[^E2P7TW<(:Z$[:=W,;C>TR\1YIB_>G"]#R08Y6(>EELZ,LID*^J([![A6
M;TW;U8XVD K'RK=PL6:PPE;W%3Y31UL>.IN6:1$ND_2B8;6<96)XCUT24=1T
M5)%D;$Y1F6X+^6H"CMB+A,Y =H KI?:^X&')OF'M/.,#(XMO#S94J03ZA%!M
M.-CY$<\BS!(V63*U9($C,6]5/6C*B8%]G[SVHS%VC*WGM_GX_)MCCCAB>:(H
M99MQER(2B>FKRQF.!3B2:+KIBF])U8P2:) 6W[1XN.07?[9B5U#45"RKL"V5
M47#A6S2\=7V[$6B+C[R:R#"!5;.2LTR@[;.3"L8@"<YC99NY.V;?@1SYG((9
M/_ US&4YEM?QF1%B("%D#H4QO3D158,DY:3H6<M%XNUW),W*:'%V+(4#<SCA
M_AAI48\4D[.&9?39'F$B&5KQ/&!&&.E0MBW7>3)M8IZC:TIDQN6XQTX!):*@
MHU\XCGU+NL$TF0N3:4CXJ2($DUEGT<*[OH9-5E'Z8BY!NC\F.WWF.-!O^9Q7
MC.WY/)-]@S@)X($9D;;]QC61<[U51D6:.<QO+-&(P[2I]HL$:^G(>.=L\F39
M\7DW,=PQ^.[!-C7BEFD19$S,.=XCB-'))&?3:))]$5Y956!QZ)FDLV0/;KVY
M2^NI>9V3M.PH7S<<T1S#+7!NY?\ DFJ@M:^W;M%FJJ3!HM).%8!-11<6WF)(
M@FV(<R:76IN;M1VES>(9V3R[FF8FZ]PLE6@;,7U%!PU]/THF0D(T@])2TI37
M;3'J8)J;6O=7NQ@<MP<?B7"<1MK[?8Q65<1E2_Q.J=F<,"[B,"=E">II9]<S
M*KR:5R=?GZG E]Q  H?A$.H?X<Z"@%H[^VN>\EKRV\A43VUP*\HFV*/)&B!2
MB7GY2JN>E4YA]PB*/EYFL%0L)D\V-OH%0_>9#)EK"#[J+^<]3^:U4U%,  H<
M!^ /=^#*TC$=!XU;(M5DC))P@J@X2(JW73.@J0X?*HDJ4Q%$S  @/!R&$!RU
M+E""I]X5?) DJ&.50T;"Q!\P>A'TBO,)W-1^L:5O6[P5,5<.X:KO7D&I'RCD
MBI/,;HF4F/,%(K_SW,.]8N2L3J$0 Z)#></ B(=.<?R,_.V7'S-PTC*EC#'3
MX$7Z&Q\-0L2+D GITKY&=SMHX[L7/MSV3BZNVS8^2T:E[%ED0:9%# DL$E)5
M"1U"C4";WU[6E66N\NUC'[A[7TY)5U%>G&-6DYUY$20IIH>H: D9I7K%)1J(
MID*HH*;44Q.H8QS F&:8D^/05'L$8^!'Z\8.0R%3?4$!=?$@7;6JG3J\WZBP
M%C5MWQLA1WJE,GHJ(C6$[ RZC T2Q5=O*["/IY%I 0[R0?I-9MDYCHYXDNL"
M3E$B*J0JB9(A0$E,R(B7) 'A>LOAXLV:WQ>.TGQ".ATN?KN$U.0/J&Y6P5@2
MVI5.ICI-JT"J4$E$V.R3]1-25>:)SQ9ELL@B[.QBZ[.JVI!&26:R"'0Z?E3%
M0RI"N 75'R5$ 12,G^Y$F<(()(YG&VSPS+8&P#M)&(^GC8@2WT@6N2;FP;O+
MMYVWY[OO:F7=HM]EP('8Y P@LGHC'Q3E": E9%*)DJZLRHC1GT8_467U)"-"
M%HG&Q987E89M8D8IBI'(2#%LDU3=IHI.&IGAA5/TK/':"AA5,4?UG("!0,'5
MD(3;3'"T>0TCH7U6<AK'V#400!Y"Y'R>%8Q4Q_>07E5FU>]<VN;@#H>@/47\
M/:!T%F5:R/>F2AU)5O%K.W#%-@U6AT9'U3AT\\EP[*1VW-&,FS%F8XG,< 4.
M)B@5,P"<4_*PRMDHD:V#%@S$@%1U(M?JW4@ =!8&_D#E!.8RC1JK1D^\218
M#H+6))8^SH.MV%@#MQ[7+Y(.:S<H)FDH^85:=78PZQ/(6")B'XN#11F:;ALZ
M5;C'F67(F8#%123)T\AU"&2K$"QS211?R0-UZW\_;7/G>7:X'W#%W&.RF1&5
M]-QJ"$&Q ^L"O0@@^ ]G3*-.S0TO7HDEDC#A*D:!)+/3+LUV;M=$[X'CMJ]3
M.W;G]"X9K-E1;H)&Y,("(E.)27QZK[+5H]L27'S&7&:^*YT@6LUNC*"/:P*M
M;41Y5['NQ7:>K;GVZZ6J%1V?#7FU06H:?(V2+"=925EA5G+!K]X,Y-FB"3AH
MC!RCH6)2&3**!")$, <EYYSY9M^YP;QD[CE8\D6%+DN$<J0CV\"#X$L!J/M-
M_EKZ5]GN1\9S^&;7QS;MQQ\O?,3:X&R(1*K30D@:E=+ZE6-SZ8!'N@*#XB^7
M;E+@W'PY^P?9\/#V<Y&P2.HK9LB6-JJ%96%)^L@)N".D.0 >./.;B)@X^TR2
MAN?CT_9GC+4,@<>73\M76UN4G:(_59?SC_@)_)4E1QP*MT\_X0!#CW<@'4 _
MA\,Q.0+I?V5)\5K26]HJN995D:8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%
M*8I3%*8I3%*8I5L+<F65'WBH?P_W0YDDZ(/F%8A^KGYS4-K&\^0?./:)G;C@
M??T>>8"AQ]A #,ZGNQ*/8M0ESZF3))[7;]-?E\D1RS58!*K0KF2*=HT?-3L"
MOTESD,8#L$Y)N]:+.4R$$P%.BJ   B)?#D/"&TGJE Z*;D&^FW\+20;?2/GI
M.@E@.,)FQYI1I5U*:PQ'B@D5U+#QL48>9%8][ J>W-6UF=V%5-X2<NVK+16:
MD*YLF-C9*)D62 @HNQ;RD/&M7D>Y7+\J0D2*43B "=(HB<LDV_,V;=\R+;<W
M;XT>5@H> LKJ3YZ78J0/$W/AX FM4\HV3G7"MFRN5['R2?(APXS,^/N,<<D4
MB+U9!+#&CQL1T0A;:B+L@]X>:#8Y+G9;;;+9890DE*7*SL7CV4?K(HG\59-]
M.^C='4,JZ57BWY3'32333*4JQ>H_)4PZ%Q\>+#QTQ,8!88T"JOD .G[E?,G.
MW3*WG/FW7=7>3<)YI999+ZC(\A#7/06LS=;&UB@ %A>#I'8"$;<Y=ZU@4I1Y
M7A5.DY;B"RKMB4L([<NT&[9N[CFSAJV?.D63QTX']<W.!>DI_+"JQ!\:J8F!
M(V($,N@RZ3;H K,& LQ8GZP#$*I(Z$BXL<2MN=RU+K,C>;'=;54+$>S!+N*A
M$.8Y])6&-AGS41C&ZWEM518';R:0&!$ZSE(S<XIIJHIE*CF-R<C$%HY.H\P/
M:/FK:FP<1W?<C!'M4$T9B*K/,Y C+ACK9 22UU( .E"FE;*UKG6!L3N7EKU5
M7&N]6U"P.*]%IR;V9?.X]-^]5K +M?/4E"L3N"MT%'3@ 67,=-,AG ))@'60
MI8MNV]X4;0X1,>.N3.L,99EC9Y6N5CCN1J<A20JW-@2!87KH;BG;DX^Z'D6]
M9 GW.P*JK,J(YN+BY%QI.E21?H2>MS4/0=;BIZ"LMWML'YL15&L G'1#5FO%
MQDS/2JB[QLC(J1#1,I(1G7X5VL[,15!3Q24ZE5!*W<R.'CK':Y,V>"1D@16C
M#%W21S>0EI!J+1I&C/( PL-'B2L;SM$W+ W>':XF,39#/>4:)&6,*?>742I<
MRM&%N&N-2@+<ND0O[ZWF8U]60UC2U"H-3M8:TIMYN-L#%N<[9TY=$9,K!^S3
M515RU Q?2LVXBG\AS*$,H"F#W'>(LQSMB8.*,6-%CBE D1Q98];A$F,2EY(]
M?N  @Z6+J6U2W-Q4CRERL7<LHPH??A^R>-]-U ),6L]&/BY]ZS#20NG:9V95
MJ3@]31\$^5'U]BC9^UQ<6Y6$$U22SE@WC_+04.0@+/(B-=F H!YA2F$Q.>#"
MGD^/0F'%(/@7-<G]ZLR/.Y+\7"#H@2*)V4>%E+FY'L+Q@=;$G3YBLR)A^U.B
M"SN$1EC).X)B>8"75*<X0@-63,3I)H&277:H@"1P,(F4Z3]? @!1D 6Y%:2B
M1E9K.5#*Q("BQO<]"? $^P=.O0=*]%WT_MF=QNJ=&_LUKGM:V/M=W?)-*V0=
MPF9IQ2M=)%DH]@Q;*,%)JO-X=2,21; JJ[2DQ-( 4HB9( +TZNYKA[%N^\)D
M[GNL&.L$8C9%0236!N1[KDDCP *>[[.IKJ?L1NO..*<1R-LV#C&=F?&Y33Q3
M23&'$]Y0H91)$J!6"AF993ZA\Q85LRU/K/N3D;.&R.XO:B"3AN<ZE>T[JPRL
M10(=-=N9(3VF05:(S-M>IE6$ :K+N6J"Q.L%W!3%*G"MUW;C*87W9QO#/7Z^
M3D>],UC?[-0Q6(?* &(Z67Q/0W'>/<[FW#[_ .<[DID6_I8.'>/%CN+?;,0'
MR& /16)13UN_33E=%F%*78F]QECD'[04;K$XY^/4(9$9>L# ^5C^>MB8AT9D
M9\KD?E4BI/:&Z7*0_$W3_? )?]O,5*+QGYJE4!M*OSU<>8^LK5O6&I5FV,GD
M=98*+FV4A&O(=XWD6:#DKB,?E*5XQ.90@J W<=("8H" ")0'V@ YC=SV;:=Y
MQI,/=L:#)Q9HFB=9$5PT;BSH;@W5O,>!Z>P5D]KWK=]ER8\S:,F;&R89EE1H
MW92LB?4<6-M2W-B1X$CP)J*E^V30+DYU'&J:@N)X1A73D5C2J(C%1BC-1DEY
M!CBB#I$T>A_.>GU1@2*!E! .,A4G:#M?*Q:78MM:^''BV,*D?#Q%&CCTGW;(
M42S6U64#585-8^\'<^$!8M\W%;9+Y M*0?5D#AS<==+"1_L[^F"Q(0$WJ76$
M/!1!S'C8V,CE/2LV)CLV;9J<64>EY+!F)T4TS&;,41Z44_$J11X* !D\Q\'"
MQ#?%BCC.A4]U0ONH+(O0#W4'11X*.@M4#R<_.S1;+FEE&MGL[LPUN;N_4GWG
M(N[>+'J;U6<NZLZMEP/*ZP_]L.'Y#" ?F#,DG1!\PK$2&\C'Y34.O3>?+2*H
M\B(/'"?^Y25%(OL]P$( 9G(1I@6WAIO4+G/J9LKG]^1^0V_<J@6(U7>(MJO8
MIPL2I9#';1[="PKUR6D5$!(J="+=LGS"145  #J(B?DQ>0$!+R&5,?XI7.7C
MQZQ&022@=1_&#!E_**QFZG:)XUV?=,GT&R[JBK.T$KD6)$;HZ2$^T(;D=#TO
M6->X]6.M04"R;+UOM2_UA[6VH/5XN7G)*VUR9*Y<),DXY9BZ.9VU6=N'1"$<
M><<J/(F,'\<DIV7=TWO<XMKW;$Q9HIFMJ1!$ZVZZKKT;H/JV%_ &]JT_W X7
M/P#BV9S#A^][KA9.%'K,<T\F7CRZF"",HY+H79@!)K(3J2+=1YOK)3+"H^>2
M+A\N[+.VE@_DG+\SYXL_81SIT^?^G%A&NP(X>M3%)_.5^#KD, "50>H=^J55
M0B6%E'3R'S#IT^CP]E?-KU6<^OD@L09#K)ZR,Y7WF8DWN;F]]0):Y/@(8D;I
M96EME5XZ#454C55TXA^[C723UW''+!RK]N#YZK#^2A*$1?MD46R?FG!(JPG
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M"W2H?,(>(" \?G'(JHN?DJ8S-X^RK8=',?D" )E#CTD('M,<X@5,A?[8QA
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M-V]Y'/[*L6OX"][C*G.YOP_(U[]-'O'%K>]D)"(LN#Y9(X[Q2Q@6)951NI)
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MT6O>XM;QO?V6ZU04K;6WC1)\UL4(Y9.'A8]N\0E8]5HM('YZ6*+A-<R2KPW
M\)%$3CQ[,N3B3HY1XW#A;D%3<#VD6N!\M6"[IM\L0GCR(6A9] 8.A4O^]!O8
MM[%!O\E?B2L,)%"0LG,1D<=8IU$BOW[5H*I$Q %%$@753\PB?(=0EY .0YS]
MCB>0?9J2OR FO.5G8F(0,N6.(L"1K=5N!XD7(O;SMX503W.JKF.1O9X!<4TE
M5U/)F(Y04T42"HNL<".#"5%%,!$YAX*4OB(@&7/PTZ :HY ";=58?I%8\[SM
M4MQ#E8[:02;2H; "Y)][P ZD^ '4]*HY;3 22_I8Z<AWSDQ#'\AG)LG2YB$
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M69M<3M#AY+RP8[H]\7.5$=HUR(Y0EV$@D],V*JL[F2Q.S[5S_NS9W[>?=@>
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MK=+VO;I64.U[.=Y_G%\-!]_?#_#_ !&A?6]#5K]+U+:O3U^]HOIU=;7JG3%
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L,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>44
<FILENAME>tm2227887d4-lc_lnp4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2227887d4-lc_lnp4c.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@!/ ,P P$1  (1 0,1 ?_$ /8  0 " P$! 0$!
M       '" 8)"@4$ P$" 0$  @,! 0$!            !@<#! 4"" $)$
M!@(! 08" 0L."P8% P4" P0%!@<  0@)$1(3%!46%Q@A(B/5EI>W6)@960HQ
M))34)54V5M97=]<X>-+3-95VYC=HN#D:03(SM-AY44*SM29A@4,G<5)3*!$
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M]\C_  SM7LO'_"#Z/N??@3=_8>1^#'QMIG^=RL?M^BOV6Q\^^1_AG:O9>/\
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M=;T\B+,J=A,[<TMIKAID8TX#3"4Q(3!@V+NZWO> 6HP!@# & , 8 P!@# &
M, 8 P!@# & , 8 P!@# & , 8 P!@# *6<>*TKF4(KH=9- (3(G0?)B_B!N3
M[%6)W7B))L-UT22)8X(%"@116M[T$.Q=@=?J91G9KRMRSNUC?,S==NP,G+?-
M6[K7=Q[5R=%F7*+5.#E1=Q5X%^]J'-G-6SY&P86T;GN&+AKE+9FK=G(O6H5>
M%;J],)QC5]UTJRPOP2IG^:.L?M!BOV)RR/F)R/\  VU>Q,?\&5C](//OPWN_
MLS(_"$,6\^<**# QBN1'0->&28+N9'D<BBT03N;VFCJ=.LD:]L:BF@YR6-<;
M1K"3G%4 K:9 4: :@981!WO<Q.S3E7.U>)[#MMQ1I5K#L43EPBF^KHG)\(KI
M;X*IIY7:ASA@Z?&^8-UMN5:)YN15J/&32ZRK45QD^A+BZ$9RCD!TU88]MT=D
MLNXQ-KP\MC,],B3T*(+-/C/(8Z@ES&ZL:E S*DCRW.L7=$Z\@Y*8:6-(<$S6
M^[OMS9M=E'+UZ$KEOE[;W"+:E_8K'@M/2TZV^#4E1I]W@:UWM<YGLSC;N<Q[
MFIR2<5X]D<4UJ35+G%.+3JNYQ)A2[X>+6UF=DK/0IR"16&LJ1B-#&(9HUVLY
MN<G9I<8$A2"; JU$J;UC"N\=$$OQR249QPPA)*&8'4?9ORDI.+V+;=4;:N/^
MQV.$&DU-^A^9::H^AU2Z6;B[3><G%26_[KIE<=M?VW(XS3:<5Z)YI-.JZ>#?
M0C))W$.,E8Q1UG-A0JEX=$&/2/U60R"(0YN;$ACDX)&AL3C4'M8=&+'5W7D)
M$I .\<J5'EDE!&88 .\=CL]Y-R;JLX^R;7.ZZT2P[#?!5?\ Y?0DFV^A)-O@
M9+W:/SOC6G>O[]NT+2I5O-R$N+HO_,Z6VDETMM)<2+ED^X"M[=6#NL=^,)#5
M=/=^%3B-%7GDIV#;HTL8CH^I"C$4K3DOS^@;S3>T)93@M3I1["><66+979?R
MS*5V"Y?V_79\VO$K%8\&^/H?#A&4O*3?0FS5?:KS8HVIOF+<M%[S#\>OTEQ2
MX>B\>,HKRVETM(E0J&<9CINKK4F%TH=8#?&$,U<(85%(49)$$1<W1:RMDD6M
M &X2Q(S.3NVJ4R=08 )9YR8T(-BV4/NZK[/>35962]CVSQ=R<5+Q.QI<DDW%
M/JZ52:;7<37?-I=H_.[O/'6_;KXPHJ3CX[D:E%MI2:ZVM&TTGW6GWC*_@E3/
M\T=8_:#%?L3F+YB<C_ VU>Q,?\&9?I!Y]^&]W]F9'X0?!*F?YHZQ^T&*_8G'
MS$Y'^!MJ]B8_X,?2#S[\-[O[,R/P@^"5,_S1UC]H,5^Q./F)R/\  VU>Q,?\
M&/I!Y]^&]W]F9'X0?!*F?YHZQ^T&*_8G'S$Y'^!MJ]B8_P"#'T@\^_#>[^S,
MC\(5UY55;64<I1X>8]74$87A'-*>\FZLT1C[6Y)?,7) $JCRRY"WD*B/'2GC
M+'W1:[Q8Q!WVZWO65IVN\I\J[9R+>SMMVS;\?-AG;;IN6L>S;G&NYX<7IG&"
MDJQ;BZ/BFT^#+1[&N<>;MU[0+&!NFZ[CDX-S;]SU6[N3>N6Y:=KS)1U0G-Q=
M))255P:37%(NQE['S^, 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
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MLB;_ !7@&W!I:$RF%BAD-?B'*1+W5[3IR&00RGDP?C;TE[B92(D#7!U$.N-
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M67 7QX)FZ6L+954/\P9A@2PTB/D(1"3*9#8X=F T-%ZWLLLT82!FA4=I.@)
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M^2<TL[EK%1# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
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MJ1/Y9X O-(2')DA:+:8\#K?P!@# & 4_X(?V9HO_ $@7_P#\0MIX!<# & ,
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M%_65B_%^Z_).:6=RUBHA@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
M8 P!@# & , 8 P!@# & , 8!K!H7E+Q^I93R"@UK6C'8%+B.5W(EY,8)'IQ0
MN'I+_8CFZLKD L2$034+JVJ2SR#0;$ PL>A:WO6\ G[Y_>&OX0M?_LQ=^T,
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M*8^_97>53VU_5WD_EVV?*F&6[V%_65B_%^Z_).:6=RUBHA@# & , 8 P!@#
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MMK^KO)_+ML^5,,N?L+^LK%^+]U^2<TL[EK%1# & , 8 P!@# & , 8 P!@#
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M^,)1='"$4XIZ6XJ5-2J>'->#W&6>P,BLWJ!/39#$EDQ"WD#9!+2MRKUC98<
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M@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# &
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M , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
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MZN\G\NVSY4PRW>POZRL7XOW7Y)S2SN6L5$, 8 P!@# & , 8 P!@# & , 8
MP!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
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M=UU[%7E/K:R/KY7'H^FDZ)(IVB,V,L0= 4.BOZ0))#N +58ET5-9_'GDM)^
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M@<5Z=.ZR#%H3[T<;.FD+1V?'K?;FT5B@3BXZ+:G4FRG<@..(< ,J,\8FW1X
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MA,'B<1%K4M\O"$LI\;4!O?3C_5[P=8!N+P!@# & , 8 P!@# & , 8 P!@#
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M$NS@J5JH#HNP!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
M& , 8 P!@# & , 8 P!@# & , 8!SD\QXE3O*WK%MG$;G=,'1KXJP_I^(;RH
M>GUUS3:E:]N"YWRY)9$K5G+P[0>90<Z;S"JH,Q(2D32H7&&LR-8<YEIPA-VH
MT!1[J2TGQ3>.@)8_(WC?RDY*\GC.)[+,X_Q=Y.R7D%>#/(V5N=>3D5ATHB0U
M,7<ZR8;HBL&)(/CK&YR9MD8RFY&#2)<,H)8M >SUOJ\;NE[3/$Z0],:87G7G
M,=!*.0L=J:G&6;75R9>KAI.15))I-R4?Y4S6M/IU(GI'0C<C0RIC<5:A:3'W
M7N@3I>Q6(P@#U>9,8X413I@].IC@?*KDW<"&=57+HYPRK:#\AY#3+SS,Y)6K
M!6Y4V\CN05C%R>/2>*(^/\G<EDJ?3WB0)XU$]+#T"Q&HT%(W& 9]S@K[F!5M
M9]!R02[GJ_63%(WS1Z3E#6I&JU)3:9.1%NNEDG%V7=$ZN\AU'*;0@K^R-2-"
MVL9J5(E5GZ4.SD8M4J2BD8%/^9D[Y-4SU;76=,$\=K/L(SJ8\"ZVKJ80#G V
MEQ^JN-MWMD6893PGLC@4CEX'4]^FS0L=)$<]'1P2<QO,V\ =DZHD11P';7@#
M & , 8 P!@# & , 8 P"L?%S_(=R?WG.07WQ77*I[)?Q#?/UKWCVY<+=[8O?
M'8?U0V7VC;+.9:Q41RY]5:EJUJ3G1THH76<>-@\1Y*<F9$R7=&XX_21N9IVT
MJ[&HA&H;U3>2[Z3LZ4:>9N@= ;M(]!VK$+78+0-ANSD*]<W'E7F#+SGUN1A8
M496922K"75WW5=]UA'S5>@JSF#E/EZ&\82MXT8QR+\NL2E-*59PKP4DEYI\$
METG215U35S2T3)@]71-MAT7(7+G3TQNVI-VI=',[QW!S<%Z]0K<G-R6&:UXA
MZDXTT00A#WNZ$.M4YE9>3FWG?RIN=UI*K[RZ$J<$O(18NW;9@;3C+#VZU&UC
M)MT5>E]+;=6V^^VV2)FL;PP!@# & , 8 P"L7,3_ &!2'_32F/OV5WE4]M?U
M=Y/Y=MGRIAEN]A?UE8OQ?NOR3FEG<M8J(8 P!@# & , 8 P!@# & , 8 P!@
M# & , 8 P!@# *Z<AN(/%?EJVQYHY/\ '6E[_;XBL5+XH3;E<Q6>"C*M?I,%
MQ-CZB1-B]2S>J 1$A5!3C+"J 4 )NAZ"'6@,EEO'6A9W3I7'J74Y6KY1)"6)
MH4M/*H<Q K9&A@C\RRB%H$,-3HB6%"ABLACJ!8WDDD *2J$90RPAV /8!]BJ
MAJ67V\._E]6P5?=@ZY45#\4E\;;%LW!5JMXW(%E?$R!4G-7D1%:]BVJ/0@&%
M.<?]6,(MX!"#UT[N!\EJ6OJ&DO#[CE)*6J=^<9-6%6R*HH2^P6O7QY<E3N\K
MX;&W5G5MD<$\.*XXQ6!(644J\4830C"+>M@9S97#OB=<LNJ^?6UQJHNR9M2G
ME=5%*IO5L+DK[6Y2 \E6WIH:Y.S,J4L*-M6IRE"8A.(!*=24 XL(30!'H"2I
M14-7S6>UA:4N@,5D=C4JJERVI)L\,Z-=)*Y63Z-FP^:J8@ZGEB5,9TIBQXV]
M<(@0=J$@MEC[0[[, D; & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P
M!@# & , 8 P!@# & , 8 P!@# & , 8 P!@%?.0W$SC#RUC[-%N3W'^H+]8(
MVX'.T;;;:K^,SDJ-N:HLHE8X1TV0-RU0Q+%R<@!1YB09(CR0Z+,V('U. >K)
M>-7'J84<=QFD=)5:X\=CV%KBPJ.W!X\EJHN,LBY$YL\?301$@31M&RM;@W$'
M)TI2<!))A(-A#KNZP#V'&BZ;=[@9N0+M6,)<[NCD%<:RCUIN,>;ELV8H \.0
MWAVB3,_*2#5K6RNCB8(U240(&C]BWH?>#O>L JI*>E+TUYO&H9#)=P<XS2*(
M5R*5B@$7=JFBBN/0GWR_&2F8@BC.8W[;V F2R0X:Y86E+* >J%LP6MBWO> 6
M)'Q>XZF0"GJJ,I6MQUMQ]E%?3:D(.**M>XS54NJ@W9U:R."M.R/*1UX@QN^\
MV'IP@&DW])>]8!\B[B9Q><[\0\J'+CS2[AR4:V<MA;;W6UM$E5L(&HE&)L(3
MI)T>U#D*<Q.TC$B+."?HXM",28(]$#$7L"P> , 8 P!@# & , 8 P!@# *Q\
M7/\ (=R?WG.07WQ77*I[)?Q#?/UKWCVY<+=[8O?'8?U0V7VC;+.9:Q41H0MZ
MDYKU$+(X^\M%LMC-5M7&FQWRP^(3*1%7:7J9"@#(HHY-,XN<0I?&R52.8+Z]
M;UR9D:M)#$+:,(35QIYI@"<>U<[\P[7@YV#M4[-O;\^WU<U*WKE*"4XIU;6E
MM3EYGHJN-2X\_L_Y#VN_C8>_8^;G;[C*,K\X9"L0M79*,IVK,5:N:NJ:47<N
MZE.:E2VHT;VP<7KO<[P@#RKEC.VQZS*VG,AJ>V6-B-6*8XCGL6);5QZZ++'#
M6EJF,2>./C:\-_C]J@A*X (/WXY1F:V!EO,L:Y*EV,G&271J7>\AIIKRZ$+Y
MUY:M<L[M"QAW)W=IRL>&3C3G13=FXY)*XH\%<MSA.U.G@N4'*/@R18_-TB P
M!@# & , 8 P"L7,3_8%(?]-*8^_97>53VU_5WD_EVV?*F&6[V%_65B_%^Z_)
M.:6=RUBHA@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
M8 P!@# & , 8!"?&JTW"\^.= W:[-2-B=+BI.J[3<F1N..4M[,X6#!6&6K&I
M"H4ZTH/1MZAW$24,SZL0 :V+Z=[P";, K?.KO=8ER@X\T&G8V]6T716_(B;N
MC^<H4@<F552JNE$S6A0)@:\JH3O8;34;4",^J+VE+[G_ 'A8!9# & , 8 P!
M@# & , 8 P!@# & , 8 P#'S)9%294C@ITECY4V<8^YRQOAQCRW E2^*LKBT
ML[Q)4<>$IT[JH^TN[^A2J5H"1)B%*T@H8PC.+"("*X3R@XT66?9*6N.1%%V
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M5DRM7%COHDXO2Z]'A4I^^;\<O%E>>/&[;>0NF*DM7#I\&M?WB2<US8& , 8
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M>FDN%&KK=>FJ1+-?2-9,(+$)6X(2&U7)8VSOIJ%,H$I(3^K("%Q82CA@+'L
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MMY:.!N&!NF)#/VR_9R<&XFX7+4XW+<DFTW&<&XR2::=&^*:Z45EG8&=MF7/
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M,?"?@O5%N7#II5<#AX.XYN1N5[$O6M&-#7IE22KIDHKB^#JG7A]@N#5EJ)[
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M+0&E:<%6C!&Z&7X0'.GSJG=T4U?3W&:9G74KY&5ITNT<9Y+<RK'9+:X-U_\
M!* V!QRO)F:T-*0Z2\<V%79,X8ZKDBQZ7%$EC;B64H]N+#I<J)4H0,HA/2;Y
M,V($F,5_+>*EE\0>07..J.J&U<_)RCDB/J#^BKIS!;W)AJ%D9*W;X4*R',30
M4T-LK3.S,WHHJK/)]))$(*'0&\*8\09,E*E4N?NHGS=C,73EODC>DHI1QC1Q
M./L)053FXIQ'+N,1RU+'6EO",.Q'*QF@3%]HSMBUL> 4MX:4:@MUMM%-"N7'
M(6CG^.VG8B J-4HZU*U"EU0-\[DK/2%BR9)9M-V.N$Y2B#H"E9H$HT.D:E6:
M2H3$F]TDO)<<G34J'F-.X;#A<*X;**V)K2[;AY)\@$:*<*9TURN:7*\UE.6Q
M2H84C 7'BI!Q>2<?=.$31E$GJ2D:XE7^O%AI@QC[I 2,9Z*WVEP"XD0@IB$"
M)<@''2U<(X0Q<X>:*<L&FX:8T1&M#OM89XB@)W9H>@A\/L[=;WOZ,KGM"YPG
MRG;Q''&Z]7;NJKG&*75.+<>,)NLJ^:26GI3;X$\Y'Y6AS+<RE+(ZEVK5*:7)
MOK%):N$H*D:=%7JZ&DN);Z:\3J,M);!Y#)X_-$+A"U0GF/AAUR7+6Z8"Q::T
M+C R%OK:P8JUS(@H]G(T62[E+R"@^*$L 0*#]&27E_E_9-DLRO;/C+&>1&#F
ME*4JT3<4]4I+P=<NCIKY1'][WO=]WNJUNF0[ZL2FH-QC&E6E)JD8^:TKI[Q\
MTHXUOLED;W(".4O**+$O#DK<"HY%Y;7"2.,@%1HC0MK(E<JJ=5Y#:DT+N% .
M4GF:!K7>&+?TY(3AE,*#B)%K3NSV!LNZW8 E \$OU1R6MG)B:I395/IX%4XW
MN36:9)H(^MS3*"+BE;ZE*0)2"0FM)*!7WM&G*4Z?YO[&L?D^US?O<^7<C.O;
M@]771OVK=N$?1Y5ZN4)R<O"JN*7#CTE^]K%_FJ[RMM$=]L85K!5.JE9N3G.7
MH,?-J4(J/@T?!OCP+CJ>-T[+@L@B$;YE<JHF^OKLQN2>SDP^.$RG4<2L_G/-
M,<?1VMQRL*NBFF1:5:TNVJCZM9]9+VG/3[T+8_I H(IKR*H&R*KK55)I]SHY
M-\D=^XH2W1RLKLC'"I@C>E[Q-XXR2"7MAG'7B)0,^5OD4@CH['  <\J&H"<9
MIBA&:,!!I-0]M/+7)G-/*V/M_/.Y^Y6TPW"%R%W7;MZKRLWXQMUNQE%UA.Y*
MB5? JG1,M'LDY@YLY<YCOYW)VW^Z6YSP9PE:T7)Z;3NV92N4MN,N$XPC5NGA
M4Z6B:6_B%<#@A2+8+U2.;L;A2I.4=$8Y$(/TU72*1Z-#!K;(PQIRF/3WF4N7
ML+,V^&F2'.KNZN1A!01*EBD_9APY_P IX>W;=RMMFW[/>\9VFQM^/;L7:J76
MV8681MW*Q2B]<%&58I)UJE0A/,V7GY_,>X9VZ6NHW.]G7[EZU1KJ[L[LI7+=
M)5DM$VXTDVU2CXDAV/P\,LB8N<R.Y5\R(4<ZIV4DV.5Q="6'0Y(8SL38R#5M
MD;0Q :%L4/(FW:U;HGN%&+E!Q@ %A'H >^<0U]5M3K7->1$QJDJY>3L73(?4
M43%9L7DCY'+F?G:/J'?W3\2Y6?%C1H6=Q*1)S"E:M*F*<EFPA%LLTQ(6H^).
MRZ.PK]I[F*6)/+>Z_P!OUJ<+:M+^T6M6F2FYOC336"JJUH?7G:++>7^SOL2R
M88JVW^Q:'&=QW7Z!=TZHN"@N%:TDZ.E*FQ.#<9IO4+7,U-<<F;FF4UD32A;F
M%?RF?W>_H#%5"5S(5J'(J!L3]3SLL5+$.C4^]DOR(6MC +8A!!LLS[;/D,K9
MR\BW+-EXQ7M,[5N[CK.(=6=5SJUE4,KWB[9582R6N-91ETF[-&FR<2/E_;K6
MP[?7-C*2C-%'G(>@&[[A>Q]F5AVP\A6>TOD/*Y1R,^.VVK]RS)WY6U=4>JNP
MN4T.[93U:=/IBI6M'T%B]E?.MWL^YTQ^:+&%+<+EFW=CU,;CMN766Y0KK5NZ
MUIU:O,.M*<.DF6%4MR]KR+M$,K#DIQE! V(DY/'0S#B'9TODFDQZH]:I]4DD
M>YO0AF=#?/J3>X,AJ1A 5W0;"(01&#Z/9?RA:Y"Y#V[E&SEQS[6%;G%7XP5M
M7-5VY<JH*Y=4::]/IDNBM56BY_:+S3<YUYTS^:+N++"N9=R$G9<W<=O3;A"C
MFX6W*NG5YB/33C2KRFPZUYM/Z^/JJZY84I7:5+#V!OE38X\1'J<)WJ=)23=2
M>4L)ZKD\Q+8U&WM2,(D3,H-=3VXH'<,<5@M[,R?$*-4UC<5N7=P\^5U967R]
MJ5X]3X3(79>\LO$9TCQ9K$V<A"5"%C*; <F7 TA:4_IP*AKO-BT,G6R/ UV^
M+D [3>SW;.U'D_(Y-W>_?Q\'(G:E*=G1UB=JY&XJ:XSC1N*3K'HZ.)/.S;G_
M '+LRYNL<X;39L9&=CPNQ4+VKJVKMN5MUT2C*J4FU1]/2;)*-JFY^)D8<5UQ
M\J*LD_&^K8#+'A6SD\?5E8.44;VS9LI=9<_64MO.>E'LS"@*<#E!(FDKM*&$
M7C T3V&;W(')F!V><GX/)NV7;U_!P;<HPG=T]9)2N3N-RT1C&M9M*D5P2-+G
MSG'.[0.;LWG#<K5JSG9TXRG"UJZN+C;A;2CJE*5*03=6^+9"=_\ 4/Z>]N4S
M8=;,O-WCBVNLPCYS0A7ND^1Z;TIYBA.;HU7M(6I4^%K1.]?4 %OMW^IFOVE\
MK9G.W(>Z<J8%RW:S,[&=J$[FK1%MIUEI4I4X=Q-FWV9\U8?)'/NU\V;A;NW<
M+!RE=G"WIUR24E2.IQC7CW6D03T]NHEP'KOBG6:>6<PJ$:7F8M2.R3H^KG"%
M.[Q<$\:6N0%Q>0IS=!"1(X_YK:5< O9A0%)0M &,.M"W&NP_L[W3LOY#M\J;
MO?L9&9#)O77.SKT4N--+PXPE54X\*$G[<NT;:^U+GVYS9L]C(Q\.>+9M*%[1
MKK;33?@2G&CKPXU[YLK/A5+<L66+7A6]GR$]DDT5<(RWV+3,T"VH9U!=/*\M
M;'5R\"-P3.3,E?"E>@B*"4H(/$;W#0[_ %.ESIV5['SKN<-ZO9>Z;=NZQ)8E
MR]@Y'B\[^)*3F\:]6$U*TIRE*.E1N0<Y.,TV<GDSM2WODO;9[-9Q-KW':7EQ
MR[=K.Q_&(6,J,5!9-FDX.-UPC&,M3E;FH14H-(A"PHXRP_GWT]8I&T!36P1S
MC7SD969N)$8,M&VMJOAZD2$:,.&8<<(!)6M"&8(1@Q=HA"V+>][G6S[1MW+^
MTXVQ[1:C8VO$L0LVK:JU"W;BHPC5MMT257)N3?&3;;9!MXW?<=_W7)WO=[LK
MVZ9=^=Z[<=$YW+DG*4J))*K;HHI12X)))(\.%\?K*:K,A8U=8$-\PC-S2"P)
MGR;!,V\PVPX(Y.,@4EQHQH3JQR82QY;'!.WG-YY $232/1FA; =K>_D7EWLJ
MYQP><MNE?V6-KF#"YBOYV7S$LNVWGX5RY?DL=VHR>1KNV[ENQ.Q."LVE:UIZ
M;B/K7F+M3Y/SN3MQC8WF5W8,SEZQ@XG+SQ)I8.;;MV(O(5V45CZ+5RW._"_"
M;O77=T-:K;ILVS[,/C@8 P!@# & , 8 P!@# & , 8 P!@# & , YP>E+_SM
M?TCS^D#IS?>0NC .C[ & 0K?%%1CD-"B(%+I3:T492WHAZ/55%:LYJ)^<]DM
MCLU"9GA_@+RQNKM&51#P,P]M/-,1G*"2#1E[&06(('.AU!:/L)#>%<\$^&"7
ME7=5NMU7PSG!,U5U]4?D15%81>HJ%Y#0(4?B,5"J<YX8XV1.9?%1-[:N&F;T
M41'I.Y^9\4!>R (IJCIYW9SSXXV=;O$^]X;$.&O6:J:B)7RE;>8S%8O([F14
M!\ B+; '1#45Q.LX/:K(.TU1T21I,EG85'C0 5-@2-!+( !T"/7 &O'MT6.@
MK[YOLVUA@1Z:HIS5Y%Q*-H @+ 4!*RQF-SUL8&)O* #6BTR-.0G*U]  !#V:
MP"A'&"BJ;N6W^2T')MCD;%$\=L9(XT@Y5=?EI51+I?1B"H*+0RAWLN4020,3
MU+)$GY(/4Q*!I<<+0FK;<?LL1HQG&9)Z]*U=!Y5*\#8VV<&*5U I36<Y?KWN
MF'2UXCSZO;KQY&79:*IO<8SI=Z:..O,FG"EZCB<8G 8E)*-022K$ O9P1^&#
MLQGHU_<U^F5PY'6;1$8Q2+A'U<AFD ?S)Z7/[!>&IC)K*SH!82^*+&1UM,ER
M5N%D,3$N;$RE.F-(;2_'5&F@/*1IUD:YGYB^;F);RNIZ[K+FBFO13P6ZUTRK
MT=%/LG(WC=/<JQ&]U?6:IZ::M-.#=>A]XOVLXB<9KWKF ?$"C1-S<B:T+FT1
ME7+7]N<V/QVXI*42L=X),PENW:B"#81&*S^\'>A#T W8@AV]GP-MM68[CA6(
M6;V3;C.5.+\)*5&^[1OIHC8P<;$A!95BW&W<NQ4G3R>-*]WI,XFU%6C*Y2[R
M!BYG\E:T:7(XDU%!H3%N'B^+1\!24A.-.T*['XH6!-3B5!Q(CQ[7O"XS1IHM
M $$K0"P=HWS67QZCT[G?*6Z8.S\Q;RCZYJ!-#!6!%TE*.THG9<>FC6SA,=FZ
MQ:;GM.@ I*4^9'M@C#1HH0-!;O)M^SDAGR5V2[K<R^W+F2V]PNY&+-9KA;<Y
MNW2.;:4'"LG!JU"L+>E>EMZ*1J4YR=ERO<_[I'QF=RT^OTQ;DX\+\*::MIZ(
MUC&GWK=.!LT9Z*M%LC<O8UO,_DK(722DL93+,GB+</"))7PVEV XKU$02L'%
M!CB"TZ3(P;0+M/[4^%EI!;$C"D4]BC7UJ7&4#YXU(^0.B5KC8O,^][14G/*7
MV/7%FQGBP@993+DJ->>060HIWCC4<Q3*43;Y@>S]N1J$DO>_&3C$(H9=0=MN
M%R_G<FQL<RYMS V[QVTU=A9E?>M1N:8Z(M.C3;U=RGDE>]I>-M.5R[&UO63/
M%P_&8/7&V[KU:9TCI33HU7CW*>26(ISCY+GBK8(XUGU >4:.!'QQ &*HHW!N
M%Q#&@:4Y?EB6]N3S?B--9BE(0")$3X3H[."\H0-@//,,T+>33D6S@8_)NV6-
MKO2R-NAA6E;N2@[;G!16F3@ZN+:XZ7T$DY7MXMKEW"M85QW<..-;4)N+BY1T
MJDG%\8U7<[A.DQXJ5W8#SJ22V;\E37\QM:6]>JAW+OE)3[,X#:6Y.W!<MP*D
M[>KBM6ER<0IO&5C;69$6H4#&9L'>%O)6=XTS1:@*6NOJ 793\@C/)XEH30N'
MPDMPE?+^W+?.;#:#D]Y.@9TZH;FL:RT*MBL%+=R4AH2)PGNL:V6,9>B O;Z4
M12.Z[IM?:-S1D=G&[XMVUC8-R5Y7K=]*4I6XZ$G!V71-7I??OBD?/N\[OL_:
MGSAD]E6]X=ZSB;?=ED+(M9"4ISM1ZM)VW8:BFK\OOW1I&XF&<58]4T1>6&F[
M+NR'O[E'6:.-TFE]Q6;=K9&$K,H2&E'1.KKCE\QJ&'[-3)A)]$,K$V)$Z8S1
M*<DH@LHH%P[;@6-JV['VS&U>+8UF%J&IUEIMQ4(U=%5T2JZ+CW"\]JVW'V;:
M\;:,34\3%Q[=F&IUEHM04(ZFDDW2*JZ*K[B*9\\Z9Y#-?!_F*L>.:<V>FXOB
MUR!\RPK*>H5N)D!?PEEVQL&UB"$)G$@3P#6T^A)C *->)VE[T/6MYMSG"VM5
MQJ,>^W3[9MW;UFQ#K+\XPM]^327[K,OA73Q?8?:<COR%<L)RCLR;A>1O\Q3U
MW5+H4[@D2Y,XO RVA<RKHPF"M6HRQ]J9(5HON]A?=#O>MQ#;.3-IV[F"_P T
M8MV_/-R=>I.4';]$DI/2E!2X-<*S?#IJ5;R[V3<K[%SSF=H^VY&;<W?<.NUQ
ME<M2QUU\XSEH4;,9\'%*-;LJ*M:OB6!L62\\XL]H6.F*+XK71$$$=8B%%AW-
MS$M.@IT_2,I$ I_4KJVKO@-?<4:TIJTOQ"C$S_L)OB;[$R<(0@W,2UC3)$ZO
MZAK=U6;"M9-4O$9;9R.F(I<#M5:GF7=Z.N2H79(["I9A9D-M%\$%T@7O#.]5
MNY.QJ<R%)D@0JB@%G",&:87$[7+^5;YEEOCO)X\J^!QKQAI\KIXGSUM_8[O^
M'VY7^U2YN5N6RW==,6ES4M6*K"XUZOA):^CH\DW>TI+.:#[*G!)R+H+C!5<)
M+CZI2UR&E.7=K7]*EDJ XM12%F<(=.N$7&MH;8^H:#EQYKF6^JU)*E.00% :
M!08H2RP^A3&>?5@WE5G%"UYYQS;5"VU8RWM+VUKBT<4<4<=CK,^MKQ/) ZMT
MO6ID*YO105O<2_#(*6*]'G%B+)[ C-*Y^ZRSH8%R6VJN;X.E</X2KT\/,UZ2
M#=I5_G'&Y*S;_($.LYMCU/41I;E6M^TKO"[2VZ67<?A=ZJ\*@X"V#>5I\4*H
MGG(QM4(K5DS>[/;HN,1Q1N1R*.O+ZY/$#D#4W1!:I0H6];!7!N+\,\I&KV>2
M8(PGL$ TUM4LZ>!;EN2IF^%J7#^$Z='#S-.@=FM_G')Y*PK_ #_#J^;9==U\
M:6XTI?NJUPM5MJME6WX/?J_"J>_;/$J"6U*7R5JIE:L%4S..ML1LAKKB8$QM
MELV-- U>F]IFB-0SNAJD!"-P4)/'1FHE6T9XR=F[!OLUQMVY2P-VRKF7*]EV
M)7K<;=Z-FXH1O0C6D;B<95HFXUBXRTMQK0Y_,_9?LO-&Y7MSN9>YX5S+QX6,
MN&)?5JWEVH:M,,B+MS;I&4H:K;MSZN3AJHS+=,B5GMF/1N-ED,:)KH:0,C 2
MF*UM,SI44EB*!K+3D"WO6R&\HHO0 ;WV=T&M9M]1"SNUO&QDK<(8$XP2Z(I3
MMJ-%WEP.IXG;Q>9[&W[>HV;-O9+MNTDN%M1NV(P27>BDJ+O(H3QIXZ6I"[9I
MIS<*86UK)*[36$5R#NU1839*4W(8R0MCFF9A)""'E<_OPWJ1*B'L9KHD2&-'
M@>7U]5H -P'EGES=<+=L*[<PI8V3C*]XWDN]&XLO7&2C1:G.>J;5QNY&+MTT
M]-$4EV>\A<R[1S/M.1?VB>W[A@1REN>X/*A>6Z.[":MZ4KDKMSK+KCD-WH0=
MC3H7&B>V_+</J(K'Q<_R'<G]YSD%]\5URJ>R7\0WS]:]X]N7"W>V+WQV']4-
ME]HVRSF6L5$:6Z:NNL>.E:QVAKWEK94=C4T@'7BABGQNXZJG3;%%!S.P3>M
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ME1/R$_MIFK^VN!O%%NY\<+HBCJKP8])Z0YJ.CXW^^;(,\\OC#CQ9 QG^;-F
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MR1*PN$HE+@ZO[N8)S>#Q!&I4&" 7L( [T (=: ZK< 8 P!@# & , 8 P!@#
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M^(Y?40S97K4EBR?5:U?\'2[>BJFU%\:TO^C5%+DB5<0%2 E8F(5$@6(U;<K
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M':=V-F=Z*N2LKAJKIE%/A=G)L7 , 8 P!@# & , 8 P!@# & , 8 P!@# &
M, 8 P!@# .7'DWRIY;<B9"37=56[8:"&U,Z3M]D5^<5.-?,B/*WF".3Z&)1N
MV#Z(<);2]B7O'Z9?& Y'MRJ"77-#90M=33'6/-A 6\0 -S/*SJ3<)N #%3Q_
M,?D:RU/NXFE^-KMWDL3FJQ1/-P9'$1R]Q WPF(/0&<Y%N;-9IQ)Y236A+M!*
M#ON#T #4U^BRR1DF7!'DQ+XRO+=8Y*NI%RSDD?="2SR2G)D?-5XYM2\HI440
MI*+6(%19@0F  ,.A=@@ZWVZP#I:P!@# & , 8 P!@# & , 8 P!@# & , 8
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M & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
M8 P!@# & 42ZA7(F"\1Z-1\BI+3L5N*7Q"=0V)56URM_AE?MS/-[)D#=&$;D
MNN"<-KFTU*RZ 9WE3IHHT\\99*1.0I5J$Q!@'X]//G9&NH%3<AMJ-0XN& BD
MLB4+>$*";L=C,"E[D] 4C?B@#!,6!(W)'4N-)+M(87(LU,E6(7YH7I%!!)Q
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M^K&/F[_?MQ]6_DCZ'_\ :GG'\Y?Y$?)[_O2\QONW?ZL8^;O]^W'U;^2/H?\
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MZ,9_8UY<_P#N?<R/_/03 .C[ & , 8 P!@# & , 8 P!@# & , 8 P!@# &
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M<<+_ .#?('^^/RF^^N]9'.6O2<OXRROZV13O8S[V\P?KCO?MZX<REQ=1+EI
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MA<>_^(FJ<AO-GO'<_IL?VQ:*L[>OJQROC#:?E?!+CY(RXA@# & , 8 P!@#
M& :X.H)PUY/\M_A)\M_4.N#@7\/_ '[[S^%$$8)K\5O=?LOV[Z_ZY(6'TSV-
M[;7>5\+Q?&]8.[W=\,/> U>?HK3,Z1S@/R/CSY(EDN>F+J-<K&9WEC@06E<)
M.Z-95=(7"1+DI)AQ298]*R!J32PC$$ S=ZUO>M=N =,6 , 8 P!@# & , 8
MP!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
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MT8S^QKRY_P#<^YD?^>@F ='V , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
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MY*O><N'V=(YUS\[8.8LWE['N1=O%O.WUFFDI4IQI5I>5Q\LZ38/!XA6D0CD
M@$;:(A"X@T(V*,QEA1%-[0RM" K1*5$B2$A" LLL&NW>]]HACWL0M[%O>]UW
M?OWLF]+(R).=Z;;E)NK;?2VRN9SE.3G-MS;JVS*LQ'D8 P!@# & , IQSX_L
MPRG^D+CW_P 1-4Y'.;/>.Y_38_MBT4[V]?5CE?&&T_*^"7'R1EQ# & , 8 P
M!@# & , @"].6/%CB_[6^9?DMQ_X[^^/6_97QTN2NJD]X>V?2/<?M;W_ "./
M^X/;_N!!Y[RGC>4\\G\7N^,7W@-&'Z+L[-3_ ,(.4SZQ.;>],CUU+N7CLSO#
M2L3.+4[-3B=7ZQO<VQP1F')%[>O2' -).*&,LTL>A!WL.];P#I.P!@# & ,
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M#S,&\^/*B2U+"<BD*U06)$8$)B40=E"UK8=ZP"<?^EFZ8/[[\P/QJ)__ (&
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MP"TZ@P G+8>X#0MAP#9?_P!+-TP?WWY@?C43_P#P, ?]+-TP?WWY@?C43_\
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M2X>7'P=Y*UAQ)X \&(%R1FE;K6:H)C'^.5$U@\Q^7&.#<<G7MT_9($B=8LH
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MWCN?TV/[8M%.]O7U8Y7QAM/RO@EQ\D9<0P!@# & , 8 P!@# & , 8 P!@#
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MOR>BB27%MM)+BS2EO^Q0:C+-Q%)]"ZVW5^4M57]@P]7U#^%J7O:(Y 1!]V$
M!]V()))-QB$8,0 )RP0]C?!FK=[#V^7#K9_=WH7<[H@[W&L_+VO:(N6\Y^UX
M,5%R;R<[$QDHKIFW?O6Z05'X;\&J:KP9T+%YY;IAVLB^ZT]"L7KO'O>APEX7
MD=/D&.*^I1Q0)\0+<]V_(CP[+"6"/\8>3"Y(H$/8-C"4^CJ1/&M"(+'L1FAK
M0;#W=A^DSL!N$[AVL=C.T:O=;GGD3&G%)N$^9-DZU)]#ZF.=*\Z]S3;?#CYE
M-KL8^P<U9=/%-DW^ZFZ)QVS/TU[OAO'5M4\F2[W3P,<5=2^GM=OHU3\E)%K9
MFPE;2U25'O&*#H7>4ZU/)+$!$%A$'L[AVBCA=NMA!O7TY"=P_:A_9@VK4L_M
M$Y46AI/JLB]E\7T4\3Q\C4N_*&J*Z&TSLV.SWM)RJ>+\N;PZ]&JU"ST=_K[E
MJGE.C?<1CBGJ6I31=C+Q,Y(*"]#,[%;Z[<<&%,>0$7=*.2DI[\>W8(C]?5:+
M5)$HP _[VM#^HR%;A^W+^QUMK<)<_8>1=4M+CC[5S!<IWWKGM-JU*/<U6[DZ
MMU55Q.SC]CG:_D\8\NY-N#54[F7MT:__ &QS9S3[M)1C3N\>!C*GJ-6N=_D?
MB44'ZV(6_=-^,#-]<W_X)0?;L!FW;K__ &BWV=SZ.YHS_LA6=_[C?[(.#YC=
MN8\OBU_9]F?0N[_:<S%X2^][O\)0.Q9[ >V"_P!.!MUG@O3<Y+I[GH5B]T=W
M]ZICJOGWRD6]ND''Z@8WV@T6$Q7?MB37N&"%OO*]DD\?H!X@"@;UV)^^'8]Z
M_P#&!V_1!L__ -TG]F*Q&NV;5SYE3TMTNX.TXJU?>QK#><RD6^F>EN/<MRIQ
M[5C]FGM3N.F3D<OV8U7F<C+O<.ZZ/!L<5W(UX_PD8XKYH<T5O?\ (D<7XUW^
MX$O:N"VO-_+]FP[,/&$FUJ^\WXFNW6BM;([GT;V8+]3(5N'_ +L?91CI^Y7(
MO,.6U&JZW=\/$K+^"]&VYNE+AX7A-]&A=)V;'[+?.=RGC.^;99X_>X=^]1=_
MCE6*OR.'\9EL^#=\7#=B:\DERN$!=7NM[)9(RT+Z[ACW!64UH>*VATQT UDD
M$[L5QTJ3K9 :#9@G,S0PAUO00:^IU]^=B?:SMG;MV0[)VM;5M5[9+.[>.)XE
MW,CGRMO$S;^)7QF.)@J?6=3KHL:&C5IK*FIT9S7RSF\E<VY_*>=EV\VYARLT
MO0L/'4E>L6[U.JE>R&M.O37K95I6BK17PRS3AC & , 8 P!@# & , 8 P!@#
M & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , CIUN"I6'P_7
M+1KIF\8!AA/JLVC3=XI9/=\49?G',GO@*[VN]O7;H/;KMS?M;7N=ZO4XU^=/
MX-N;^TC5GG85OTR]:CY<XK[;(E=^;G#%@[NGOEOQE:AC*&>42OO>KDR@\HOM
MT,2=.;*0GJ>S>NS6BPBWL7T:^GZ,Z5OE'FN\JVMLW"272UCWFEY;T47V32N<
MP;#:5;N;B1X=V];7_P"1Z54<O.,=ZS!5 :;O"O+,EZ&-K9>L9(8_)WU0FC;<
MZ-+*N=3SD6C4A9*5T?D9(P[,T9H2DO?=[!:WFKF;#O&WXWCF;CSM8VN,-4J>
M:DI2BJ5KX2A-ITH],N/!F/;>9-@WC(EB[5F8^3D0AKE&W.,VHUI5Z6Z*O#B6
M-SD';& , 8 P!@# *<<+_P"#?('^^/RF^^N]9'.6O2<OXRROZV13O8S[V\P?
MKCO?MZX7'R1EQ&L'JM29+*^*]M<5(<W/LROCD76,G8*W@<7:C'-7X1)Z I5*
M)8XB,3,\*AB-28 D;FYJ$Y SQ>$3XQNMEYT]@YDP.5^8\+=,Z-VY;LWE-PM)
M2FXK@VE*48]W[Z45Y)W]MY!WCG3:LMX=W%Q-OM)1GD9,Y6[,9RXQ@M$+ERY-
MI-Z+5N<DO"DE'B?SI22,B(\5JEXJ31JD$*O;CO6<<8[#@TK:AM:DY,>J<2DT
MLASB U4T3:$JEQ9J8#FVJ#R2U)6RCM$F;"#;?^9,'FCF/-W7"C=MV[UYS4+J
M49J+X)M1E*/<^]E)>2-QY"W?DO:L1Y=W$R]ON)PAD8LY7++G'C*W+7"W<MW$
MFGHNVX2<7JBFJLV?YS#@# & , 8 P!@# *<<^/[,,I_I"X]_\1-4Y'.;/>.Y
M_38_MBT4[V]?5CE?&&T_*^"7'R1EQ# & , 8 P!@# & , 8 P!@# & , 8 P
M!@# & 1E;"^Y6^,$FT9%*RE\S,=DI*A!;%@RJN8PC8MIUABYQ)=H?6=INKD[
M 5%)R2D0D20D19YAPE0=D!(4=#;(;5<R&MXNY%K$TNCLVH79N551:9W;*4:5
M;EJDZI+3QU1U,V6?&S7;H69W]2X7)RA%+C5UC;N-OH25$N+=>%'3]]=^J^HV
M?[:KWIY-.A&%[3Z?;CY(R+916@Z\4!^T%%Q?S!@Q=NPB#HK0=;[-A%V=NY39
MM=FD:>,7]]EW]-C%C]O(G3]\X=R?.;]*M;9'R[M^7VK,2*5Z7K@KCC-%+.F
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MZ4#[N^X5V>*9_P#*'>8I\G[_ &OQBW9LI_SF1CVO+?HEV/!=U]"[IPLGM-Y
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MN>[MIM\+U^/3T^9DC^$M$-3]NB&N,D:%V=[1*)J+[W=[>[V]PH/;W>W?9_\
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MO16,L?'670" W6N6C<#=5]-+4;Z]=*YC#RG1H5*LUZF:*UXX- 0F+/&?MX3
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MUIB^I0\Z/E(XI_@R<>_N+UQ_)O'SGYE^$<[U>[Y\>XFS>M,7U*'G1\I'%/\
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M893_ $A<>_\ B)JG(YS9[QW/Z;']L6BG>WKZL<KXPVGY7P2X^2,N(8 P!@#
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M=42NPW 47'&PEE>WWV.G+2%)A:\Q8 I%I(!;W & , 8 P!@# & , 8 P!@#
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M_I"X]_\ $35.1SFSWCN?TV/[8M%.]O7U8Y7QAM/RO@EQ\D9<0P!@# & , 8
MP!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
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M1DDUTI-<4BYF20N,8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
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M=\<].1,OH/F@G@C-3M9S^ Q61\:(E!F^W7=SY H.5\XA-40%@F,4&T,S:@'
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M & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
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)'B8!;? & ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>45
<FILENAME>tm2227887d4-lc_2lnp4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2227887d4-lc_2lnp4c.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@!+ ,R P$1  (1 0,1 ?_$ /<  0 " @,! 0$
M       '" 8)! 4* P(! 0$  @(# 0$             !@<$!0$" P@)$
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MBR\>[JMUQN5D^B)1?=N.YW>7P[LF]+L-4>A-P[M3:-%ZW?H_VW#)Y(7"6/\
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M & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
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M & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
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M"Z_ ?Y5MJ]T^\\@L[EJE1# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
M8 P!@# & , JUV1UU67$=$OE[6B@ETD0I7Z(P>&5[73,5)+,M>S[#D2")5[6
M%;QLY:W%/DRF$C<R4Z8H:@@@HOU#SS2B"33 @4KA_N=7@\'VQ )C[7':,*Z,
MK2(PFR6:C2G*AI6CM.M9K*B(F*0U_>31:I=%J'Z(+#1'/3 N?4;NE(!O9)2@
M8#@E 4>LGW1*,[Z]L^_KGZ(]LCL>0>WRI9R1V>N52FKFU7,8/ ;M.A=EOT=2
MU)?S?:!2.E9Q CG![T28W&B;FT\XD2A.$SS 3U5_N^\7UES19K[SO6E[6GS'
MS%;5+<3\Z2^$.I%KJ>OKQG1<=8V"K>=I'8%D.,ULE5&7&0HDCC(I,XIB%IGJ
MF)E:X18MB R99[YM(G5;6[[#N:.L[!Z(L2\+WYU'Q=%83!3>AX;:G+; 5+>A
MVV6$+K$1P IGKN*+$2\*M&]+!.1;NW@(*]0\T*<"%WSW(/:6Y:;*J]QF$L\X
MF=Z>YVST^DBK>2]3>>W6X5O)+$:8KM*O8Y].I#$*"J.K[ EQA+P@9SVF.&R3
MQ(2%K5QQ.Q@>B+ *J5CQ+S13O1ES]9U] '1JZ!Z":VUCMB>N=DVI+ R%E9W
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M_&/\Z]P^HEN^+?XL?FAMWU8FR?5Y K5BCK!;-A<5L&%OA993Q%)HP-<FCSD
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M;27;JE1T2;(UK_W2:5L.1U:Q-D:D"75E#Y^:!@42*!&RB.2OI"L(#:T';U$
M32<R9O$9:&*S69*\OJ-(8A0KE0@AT:0F6'ILK(Z8S<:W<G.4?:U=?9/2XV9S
MMR:GITJ3E"3C%NK2\C<4\;'ZFPLBY;A",O;':7;#4I7K<+D:PU:G%1G%2DDT
MF_,I-;-LC1)!@%8NR?R;K'_!#]OD7RJO&WY,-S]S>^[!;O@/\JVU>Z?>>06=
MRU2HA@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!
M@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# &
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MFH.2C&*JUY(U]C&EQLU!MQ@%8NR?R;K'_!#]OD7RJO&WY,-S]S>^[!;O@/\
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M2N6IQN0;3HTI0;BZ-4='P?!F0YW,P8 P!@%8N9?XP7YSMK_W RJO"O\ &/\
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M(W+<_82B^%>#3X=GZ_ YZ96E6 ,,1J4ZHLI0H2&C3'%G@+5)#AIU:8P10A:
MH2J"Q%F WX" ,.P[UK>MZSJTX\))KA^OV'9-2]BT^/ZQR,X.1@# *Q=D_DW6
M/^"'[?(OE5>-OR8;G[F]]V"W? ?Y5MJ]T^\\@L[EJE1# & , 8 P!@# & ,
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MQ'WB6?=W.+MV[L<C(RI6;<K;A*CRH0<75U48UB^U\3N >U9+(95<P@-4=G=
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M]OD7RJO&WY,-S]S>^[!;O@/\JVU>Z?>>06=RU2HA@# & , 8 P!@# & , 8
MP!@# & ><'WE/]Y]^KR?G@7K^T"O< ]'V , 8 P!@# & , 8 P!@# & , 8
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M:M6[%J-FTJ6H144O,DJ)?,10EV[<O797KKK=G)R;\[;JW\UGVST/,8 P!@#
M& , 8 P!@# & , T V)_YFGG3_A V[_XGD. ;_L 8 P!@# & , 8 P!@# &
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M P!@# & , 8 P!@# & , 8!4;K#JD'***NY2]PAMF,'EDF4Q.0;16S6L%LE
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M@ES<4.MIU)YI0A V!I3]Y3_>??J\GYX%Z_M KW /1]@# & , 8 P!@# & ,
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MOVW!VG%CA;=:C9Q(MM1CV)MU?ZK=3+,V9FC & , 8 P!@# & , 8 P!@# &
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MHQM.'2/!TSJZ92+7>W+?7+Y9MDO_ $?$9HV35Q8*+ONVYBV!:XB(3;IV>TP
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M;K'_  0_;Y%\JKQM^3#<_<WONP6[X#_*MM7NGWGD%G<M4J(8 P!@# & , 8
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M;'K"&S-W/3N1*%-$J5>FZN/FT1;KV+STXELLMDF(P!@# & , 8 P!@# & ,
M8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , I%[@4
ML[BAO/BEV]ORN8#9E[FRYA;UK-/@-*T#37:M,ZZEDGA[!([6I&+RJ?,Q@$@F
MMM=92SMRDP8O7.\@?((#5Y[.]K=(V+TCUDD[=MGO4_H9D5:3572O2E#-G.E+
MZYI!%J04J;/A<'JJ//=#.MA)+Q=)"P&+F^=RI>%B3IMZ,'L]8K4 >B# & ,
M\X/O*?[S[]7D_/ O7]H%>X!Z/L 8 P!@# & , 8 P!@# .A<I3&&=<C:W>1L
M+4YN'I? -SD[MZ%<N]8[:<GX-(J4%*%/JJ-;+#Y B\P_N=?3]&:C.Z@V';,N
MUM^Y9V'CY]ZG+MW;UNW<N:I:8Z(2DI2K+NK2G67!<3:8>Q[UN&+<SMOP\J_A
M6JZ[ENU<G"%%J>N<8N,:1[SJU1<7P.^S;FK/@J3$+4RA&J*">E5D&IE)(_I
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M@XPK?$IKSZ@!*@$DI"0 ;Q, 8 P#0#8G_F:>=/\ A V[_P")Y#@&_P"P!@#
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MHKGSWL7#_!;7K$C9(S9C & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
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ML.9T]M]K%GA9NO7*Y&XYKF6U:>AQN0BJ1556,N/;5<#8AEBD#& , 8 P!@#
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M,_Y8;?\ <*/^\1]DW:/^6)7O^BB@_P =6/@_J7[(V?Z*O\</O3\9_P L-O\
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MX=/Y&#Z1>S>9INZHKEZ[2MK@X2;HUJX27_\ 99[+<*O& , 8 P!@# & , 8
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M#_A,AF1SJW\'\C]Q],@4[X_?))NWN7W[CEQLD9<0P!@# & , 8 P!@# & ,
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ME.4N^U*59=O%)?K&)O>]YF_Y[W'.4%D.*CW$TJ1[.#;_ %S(LW9J!@# & ,
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M@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# &
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M'=K%-TRJ#2IUB#L8Y-L/F$[824ZAR:#!I]E.1PAD""(82Q[V (%U_P"=-?R
M/Z13 *@7WVK^LC\[="<=\US9@]D%TG7;4PLV$U4ZQ9J[R6Q./NM4P@F>R)18
M*YVE3(\-3>M9SM%HAMJ!V,,4^(32R0??, M__.FOY '](I@#^=-?R /Z13 *
M?\3=K?K(_>53R6XZA8/9!CD8BUP6E2C@ALAJ[R9WTZ55))#HO)'!&EC$JF#>
M9'UK@3L:$T:HM283X;-()%]Q@%P/YTU_( _I%, I1U;WA^L>\?69R#5=EQSV
M27R0]J7NW<]58L@K1W:YLS!-'(I*<0YS]0_S",KFJ+@"L#YSFY.ZJ];UOP3;
M^CQ NO\ SIK^0!_2*8 _G37\@#^D4P"H'&O:OZR/W#$[AF-3L'L@QYLI+H^W
MN7Y418;5WDTKW"?4LY-[7*7>/E1N52U.KAZ]0X@VWJ%)J1::#0MG)"-ZUK8%
MO_YTU_( _I%, J!UYVK^LC\7?BP?:DP>R"_?C8]?TKQ577U :N\G3Y+:=[_6
M7ZHO\U^L4JBORZOV[ZJJ/F2I#\R<2?.7Z*%1XB\@%O\ ^=-?R /Z13 '\Z:_
MD ?TBF 4HX][P_6/>V7_ *RCE51SV28^NXXZGL[D2S3;!:.[6I*^V35"TM!(
MGN"#CDPE9SG!UIQFMHE+@!K7F!_JJ,G?T8!=?^=-?R /Z13 *4=U]X?K'OM\
M5G75J7-'/9)DT>LV]ZTYZ84=8M'=KT\I)I:AKL3'G-W3RJ80M"GBZ,3,;\:<
M2H4*R]"#Z28[QWY0+K_SIK^0!_2*8 _G37\@#^D4P#<?S=^,E]B4!_&]^P_\
M8_Y>X?:C^+=]?/L2^:_/'3Y5]0?M._[=_+_JW\%\1\Q^^?'>OY/O7IX!-^ ,
M 8 P!@# & , 8 P!@# & , HAW'_ *SCY577^K7_ !$/G?S"1_:U^/'^,#\J
M^5?#,_U1^SK[!/Z[^8?%_,/F7S/[WZ?P_H_=>I@&O#^=-?R /Z13 *W]>]0?
MK+G%G-%Q]46DT>QB_P!>TA#U,UE;/ &_OIUF3@U)5:1&8GCS?(I!%616X;-6
MAWH"EQ2%^76_$S6_#6P)(IRT/UGN[ZAJNZ(HC]AEOBUO5O![0C2"0I_<'2/Z
M%@G\8:Y6S(WQ*VN#LW)GA,W.Q8%):=4I) <$6@&F!UH>P)(_G37\@#^D4P"H
M#-VK^LCOG=$T]OU(P>R"7<L%YPCG4#O)E#5WD"LE$!D\[-KU T-SR5*CI4=,
M"7HG9IR<UE)1!2^ @JQF?>\ M_\ SIK^0!_2*8!#_0MU_K./-=!7AT7.F_V(
M7:$T#3]EW7,6N)I?<#72IRBM5PMZG4A;XTA>'5B:%D@6-#$<6B*5+D:8Q2(
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M;:A>6UP9W-.%6VNJ%6VN"48C  4H5R<Q*K3B&4,!H0G$&B#O81:%K6_HWK>
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MIAA7$*BP!UYBP@']U@$WX P!@%.>/?XTOYXUW?N8R.=._P ^^V-[]Z4[X/\
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M?N-QSOR_4BOVL5Y(KS?J\2LLK+OYEYW\B3E<?]SU%YD6$S6&., 8 P!@# &
M4Y[^_)(MG\ _X3(9D<ZM_!_(_<?3(%.^/WR2;M[E]^XY<;)&7$, 8 P!@# &
M , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
MP!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
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MTR!3OC]\DF[>Y??N.7&R1EQ# & , 8 P!@# & , 8 P!@# & , 8 P!@# &
M, 8 P"GT\2=^*'M_^S!^X^:(WMQ7!B^YY$KHD;V6TZ<#MMIC^&/36+(#7$;7
MZ>CP)]@+"H\VPC$#P#DIPI=$QLP^$8;K+(TK7RYV(QU4XZ=5N;I6M*\:=JJ:
M/)CU([DO1)8,;57IUQNR=*\*Z9Q5:=M/*04^P/W<W?:C;?T)Q)%O6V3LO3%1
M=J*-)-%!+T,*?ZS6)(]BTIV#>Q^KZN];'OR;#KRZ#N;.;X86J:\'=[E/VV19
M5?7T6H]GJ4]6IK[F-UK.NG*V^'K6;G#Z*<B/U5 >[XX_^\=X5(S^8T1PM1&E
MX(BT'>]#T%*1];JEG.P(0^?6_ >S#]["'[]X>;0M9N&Y=,O5\#85BTM7=])M
M9612/EU<G=<.LJ_/+3%*O<?!KVL8/47#TW+E+AQY3LV^/J<S#OT7J.K_ +XQ
MQ1R#[G;AL(G?NM.XC#YQ>9.H51?0CC=AV:<(F$5O%T^_/L/T%>3T"O'>BRP:
M^C(5GV][RI-X.[XV#%S;I:V6Q<23[(5R]QRI:8]B==;^?G)\3<V+7+7^46;E
M]TI66;.''ROVG&M*K\U-*\D48PI]OSN)QUO3QU:[.H-D_#[)'TSVDT)1E"\^
MC@*$4:LAC1K@J=#\!Z4%FZV'7EUX!WO6X1G],>)N6E'$\2-SPUWJ\GI;I&3=
M:4[V1MU^4=-'I=N4'Q;;;46MQ8R-BM_Q^P8U[L]GNV\I*G;PMY-M.OE4DUPX
M45:X\K]K_H9T\WSV<4])]"  H89?.NF)@ Q. 8C I# 2>7.P#$6C!B%Z M;)
MV(6]^7QWO>X1G^$/B?N,7&YXR]?V$XN/^38.QX;X^5/$Q[+4_P"_34TJ)2HE
M3=6.H>GK#JNC^G[G&OMN1N%[YE+UV=8_WOL?4XG4 ]I*?!5:7F0SAI6XZWXZ
M='*L9.Z.OT ](.OFCBVJG#80%?<AUZG@$/T:\-9!]S_1BZYWB,K6?XZ>,LL>
M:2E;CN<K=II.JK9MY4+7;Q;T5;XOB;K%Z]V7#DIV.A>B5=3JI/$4IKR>SE:<
MNSAV]AF#;[:E[LVB],Y/'35HD BRM-L%F*'10![V(8"_A417D ,6][WK7AK>
M\K?=OT -BW]S>^^*7B9FN<E*7/R+=[4UP3ES+\JM+@F^*\A)<3QOW+;Z+ Z7
MZ6L**:7+M3A1/M2TVU1/RF8D\,=;IRBR$\SYJ((* $LHDEKLPHHH => 0%E@
M\H  #K]C6M:UK('?_P#BM\%,J]+)R>K^KKF1.3<I2L8$I2;[7*3DVV_*VZF_
MM_I-==VH*W:VG9HVXJB2GD))>9)*B1]/Q'NO/[^>;_\ J^SO^?/+_P"J;P-_
M*SJO^C;?^R=_[3W7WV+V?^4R1^(]UY_?SS?_ -7V=_SX_P#JF\#?RLZK_HVW
M_LC^T]U]]B]G_E,D?B/=>?W\\W_]7V=_SX_^J;P-_*SJO^C;?^R/[3W7WV+V
M?^4R1^(]UY_?SS?_ -7V=_SX_P#JF\#?RLZK_HVW_LC^T]U]]B]G_E,D?B/=
M>?W\\W_]7V=_SX_^J;P-_*SJO^C;?^R/[3W7WV+V?^4R1^(]UY_?SS?_ -7V
M=_SX_P#JF\#?RLZK_HVW_LC^T]U]]B]G_E,D?B/=>?W\\W_]7V=_SX_^J;P-
M_*SJO^C;?^R/[3W7WV+V?^4R3](^">G'*3ULJE<^H@J-Q"XZ4LUY!'FVP-O:
MQ#4MMPNSSFQLVY;^  K=]1'X4(S?N >MYM_L9<7@'^@9X3_H^^*>#XL]/;_U
M%N&\[=B;C:M6,BSAPLS>X;9F;:W.5IZTK<<R5U:>V4$GP;(?UYXV=8^('3%[
MI3<L';,?"OW\6Y.Y;G?E-+&RK&4E%2[M9.RH<>Q2;-R.?:95(P!@# & , 8
MP!@# & , 8 P!@# & , 8 P!@# & , J58";NP]^>]58\\E-48V>N!&Q6!&K
MB?WX*;9AORU0]ACLKC;>,\!6P>N21L(1BT+R&!UO7A)\&71L;,/A*&YRR*+7
MRIV(QKY5'5";IYF_FHTN2NHG<EZ'+"C9J].N-V3]2NF45ZZ7ZI!3U#?=L=?4
M^!O/A>-^=(-,'Y+1]R'^D<+U?!>7]8K3?_%67ZFO (O,1][#XE[^Z\VXLY?A
ME;]GA[S<XU[V187S.[9CP_N\>TUURQUI/V.1MT.'DLW?U>]<?'^YZA%CI1'O
M).?J>CW5SU'_ %"?1#]7N?VC[QOZ?%23]9HY*/Z[^Z_]IZA/T:^]?L^;(GN_
MAM'_ #;:LGL_\V[.?'U>7?L]WLX*C[>]Q5-7E;7XBW:^B[I@VN[15Q=='QX\
M9+U.']TCQUX]]X1\]33G[D\:%HTH)(_E5;QB+?>@[\VM%[B-9,.R#=[WOQ-+
M\IV];\-C\-:UK#N;UTI_-\&W9X>2S.YQ\_M^==J_4=8\/8]M8[E=+>+>56G4
MN+:K&G<P8KYO&X^/]SU".W;VY/=&?=&Z<_<A?]Z/"6 SY3/+MBN_(4((@A*W
M$75AVF%O8?NAE>0P>M[T(6];\,Q)[SM_\WNRL\.%-MVRY1^?V^W=J_4=8^H1
M[*\-O%_*K3K6_:JJ=S&M*GJJJ?'^YZA'CK[0_>C_ .O]8>Z5\C^*T6%5]8[5
MZ9?_ (H!7D](M5\XFZWXDLKTP^4(_,$/EUX:UX:S"GN<Y^PW?<;7#_RMOV>S
M3UN5C0TOSM4;\Y'LKP2\5<VOI'7>Y/4J.EJW'_!BOU>TCIU]B3HI_P#B/K#?
M%.R/XS9.UGUC;K+D'QFT_I?#_%_.%BWXK2?T"_3T9YM \@?+X>77AB7,G,G[
M'J;JJUPHN5<L6:>MRG#37RM4;JZ]I'<O]&CKG-KZ3UMNLM25:.4>SL]C)'4D
M>P%<B7R_#6;S@G\F][!Z$#E)7EV+Q\=A],D/EWOQ^GPS4Y6W0S:^F]3=87M5
M*Z\K76G975==:>2II;WZ(V_9-?2.K]SN5[=4KDJ^O6XSMR/8BZ"2^7X:Z*&3
M^3S>3T(I-BO)YO'S>7T_+Y?-YM^/A^SXYH,KH+I/-U>F[GU!>U4KKE9G6E*5
MU2=:45*]E%YC57OT*;F37TCJ/(N:NW5#56G96LG6E$<O_48](?OZ4C_@[//Z
M?,#XK?#_ .NMY^AQC%_L.8WV=N?R*_9'^HQZ0_?TI'_!V>?T^/BM\/\ ZZWG
MZ'&']AS&^SMS^17[(_U&/2'[^E(_X.SS^GQ\5OA_]=;S]#C#^PYC?9VY_(K]
MD?ZC'I#]_2D?\'9Y_3X^*WP_^NMY^AQA_8<QOL[<_D5^R/\ 48](?OZ4C_@[
M//Z?'Q6^'_UUO/T.,/[#F-]G;G\BOV1_J,>D/W]*1_P=GG]/CXK?#_ZZWGZ'
M&']AS&^SMS^17[(_U&/2'[^E(_X.SS^GQ\5OA_\ 76\_0XP_L.8WV=N?R*_9
M'^HQZ0_?TI'_  =GG]/CXK?#_P"NMY^AQA_8<QOL[<_D5^R?(_V+.CSR3B=W
MK20='%&%;%J.3O>]:,!L&]Z^[_9UXY[8WAIT!C9-O)CE;PY6YQE33C<=+3I_
M</6S^A!C6;T+RWR;<))_Q*\CKYST=TQ!5=7T]5%:+UZ=T75W6L%@JUS2%F$I
M'%7$HNUL"A>E).\3BDZLYOV8 (_N@A%K6_IR;;MF1W'=<G<(1<87\BY<2?:E
M.;DD_55:'W=@8\L/!LXDFG*U:A!M=C<8J-?FT)*S7F6, 8 P!@# *<\>_P :
M7\\:[OW,9'.G?Y]]L;W[TIWP?_&G\\=R^HEQLD9<1JG]V2\84W<H=,\SMZ&>
M3.[KBYCLUNAD#KBM)[8KD'<Q8))$XJNDI\,CSTAB+5()"B4I4BER-3%'F(U'
MDWO1!FPZK=LFS#%N8S;=Z=MT23?:FE6BX5?G)_X=861'JC;]\GICMF+GV97)
MRE&*2A.,I43:<FHT;44WQ7G1"_LHW;#X=QSRUQ_/VRPJUZ!BD"F(%,(LJKK"
M@ 'HUNF4GDKHGB;_ "N-M4?E:MI87=.K5$H%)YI) ]C$'RA'L/CLN39]$MXC
M;60HO@TUY6^%51\/,;7Q6Q+V=U=N'4>'IN;/>O0TSC*+_P#+A%:HIZHUDFE5
M+B;P,W958P!@# & , 8 P"G/?WY)%L_@'_"9#,CG5OX/Y'[CZ9 IWQ^^23=O
M<OOW'+C9(RXA@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# *
MM77U2R4Q=G,]!!JRUK.G74#U-T49,KK[+B&*!QJLRX@KL&P;&<++M"N#RHK%
M&J9IUAJ=A(?WY622<!$VJ3]%DF@9O!^C:9L>H)%?,-F87>IXFY7&T2"6#8)0
MU@;G#G^=3:M+<($RO#(WR)0&(S:NGE%LPI(86NTC]9&)0G-(-, B:%>X#Q_8
MW,$0[+@UT-<FYLG4L@L$C=D-<9G1VE$RLBX(]0<1C3C$!1<$\CSPLMR5(&92
M2XM:0;88?LY;I.F+-/ !B<L]S'C>"V7.JLED_L!D=JNLB.5!9<Y4\X],#H*O
M+-EK)"9%'X5..GD]/G<WQ1\7LUD,)VRU\K(T3\W2@-V 9H0X!,MA=(1^"=%\
MZ\SD1]VDL[Z :;CF7JMAZ4M%7U9TI'653)Y_)PG;$>8VJYU.(O'$A)>@F'+'
MW1NM[+3':P"QV 5BZ$[!HOF![K6+VLNLY3+;?%,-5Q#:AY[Z$Z-FLG*@")H<
M9FL3P[G:KK3DZ)MCJ)_1F*52I(0F#H\/@/>_'6@(M?\ W-N%(M75#VS(^AHV
MR5[TK<9//E221QCTZ2D.%T#5OK<MKN:(C(KITJ*01UTC*](\AEY#$6QK$IB=
MP&F.UY-@6?+N:M3KH6<\ER3S7 WU>V7,KB'R=_UZ-:O$K=H0W23Y^)KU%S/B
M)0QJDOP85HEX/2]01 21 ,$!'53]>\]WO8?151TU/R;#L_E.1-40O.%-3,_M
M*^(RE^3/QS(S$.LK;(]&)$)R41=R1Z5MR]4WD+T"E,>H*/3G + X_*/4<?ZQ
M@<PF;-6]G5&Z5[;UDT=.J\MT%<;F<8L*J7OY!+6]2LJ6Q[8K]T0E.'_NZIN?
M5I)X/NM;U^Q@%G< 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
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MTX@463>=^Z*X]EO!7MY'=%T1H@@ CWR1-S4R)IG#$XP*1 ED<3IB"P[<CQ;
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M.K?P?R/W'TR!3OC]\DF[>Y??N.7&R1EQ# & , 8 P!@# & , 8 P!@# & ,
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MY[^_)(MG\ _X3(9D<ZM_!_(_<?3(%.^/WR2;M[E]^XY<;)&7$, 8 P!@# &
M, 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P
M!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , PE#9=<N>B]ML_A+AHV;
M/%:%;0RIB5Z-L:/"= /\ +VG7F:'-F,;(MTL:M>*]-M(?HPH/I&>4#\V'9M;
M5%&5$TM>PH/6,.2*$R17++#EC#"XRE5+![+1IE#])%[:UDJ%0P["6 1NA#WK
MP#K> 9<A7(G-$C<FU8E<&YP2IUR!>A4%*T2Y$K* H2K$:I.,PA2E4D&!&68
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M/X!_PF0S(YU;^#^1^X^F0*=\?ODDW;W+[]QRXV2,N(8 P!@# & , 8 P!@#
M& , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
M P!@# & , 8 P!@# & , 8 P!@# & , ^*@W:=.>>$DY1LDDTW2=.$ E!^RP
M"'HD@)@RP".-V'RAT(0=;%O7CO7[. >='FOA+KBJ+&IM VQ%+$8O+JM<>[;7
MD"J5L*1O@_N>S[G2=\PW1$%*IG(D;V6AEC%<9#\C<FYM=$!CG'W52K\YZE($
MT"V-B5IVI#:'F,+6R?I>P;CFIDD5UG8?/DEY:LS=;OK1#5;+%V=_5=55U62"
M+IYTZRU48<X-S0I"F3,P@FO#4,\DE>!P+SK3J6IN;.*J:IFH+ =8?47/CG%K
M'J[D6UT]6GI[2JZBXM&Z"KALLB9V1#;":* 0RY.YGJU25V5.JD+*UI5I;@0K
M4HEH$$U]17>%3"K.IFA@OHU5STY<5-=9V+$[7AL>YX?.=JGJ&G);V"DLJO4%
MB)U-K7]TI;3-8<))^=QIS,9=O#"^MRQ 02O4C YC-5'N*5Q'(NCD#[U%:C/*
M*QX%_&B6QNW6598CC,E+AT@]]@%\]IY',XP56!+2,BN8VK'&E[*X'1U<O7(O
M6?DA3D,#*H-2/>2N+VRIM":=60U'"J$EZCFF,06UXO8=F1&Q;NN_I$Z(?:(O
M<K0C\9Z0L3CJ@B*]">EDDG>6"0N:QP3^M(%*-&Y*P,OLN)6VIX'Y<J*]8[((
M:[W+U9S97O1[ _VM-;;4AKF3]&MSH^Q%WG-@6#9,L^K]X-[2WQM:R'R=ZTT)
M96:RIURPL@D9H$M0NN;FGWN#16[WNO;AC=-5Y5U\-VFB]$O.#4RP2V9\[TPS
M,JZ@-4*].4WF8IG"XF]#D3G.53V6A3B2)VE6F-4.*0(%'I=S[VU%FBR=4Y'>
MC(&ZWS[@?1DLZ7DY5CR^WW:0TU&06+&^2'*IVI3VY14F@$#E5>M<&#('")R2
M+2)(K0(FA64<QH%)*8#.+$HKMJ4USV!44@6]:3VRAU0T\Y\Y7,LL>NV&F)/5
M\YYKJ6DY7:$^K**V,UL$GO!3;D]G4]=ERV)F*&U7'B$J)22U:0I'0!,.>^W6
M1#>-?P)_ZH,INO8_V!8='M#;?HVJQI_+(3SMRC7G,]1);'1OC1*&:)VA>!-G
MSE(B+7M;6R'[2->BDK'LEM( D&50/MQ59*-JL!!TE-*0D%U/;+*%?/EEQ&L[
M3<(W7G+M"0:JW=3*DMA5"\Q:M9WT"&QY@Z#9W%"=M4%I2+B=MQZI*>!7:P*;
M]QBT=VQ%7!BZ;;%\RA?<U?S*4O\ =44/I>2$67:S)SUR4VUK54?L5<W-K75'
M*]D.D\<GHUB9U#P_-'J.('-U* 0V@;+;JK;H=YN%\7U&*5,D!YZY%4NO/T!;
M+!<X!5UQ=42A_E6HA'+&)BSZPN[]%:D:J@8B%"!V4@8E".;C",I3H*C1(&JR
M+(NTH+OG*OK>GG>-MSFXY=9=WVU44%<H;3%HNM<T30"&L9TA9G1QZ_LW4$A-
MD]%],Q$;N9%9G%VQH<&IO41QC84(53JI EJI:.]RZ'JT\ODZ4R47_'8.RL[A
M-W24,*Z.6J?SY[=;@P53!I:\+#FX;ZQR3N[JV;N!;DJ2H1J]0PMT5?#;5Z)V
M!U-DPONQ#4T-U55?^X3)7%;SK?,F<&>4])0*.V*[]V-\=I]LIJ8S>0%7RK+@
MM"_$&3)W,AC.<*)+7-.$@49$G^6(5X'4R#F;MBJV2^=T^5TGJ?6AU_5['<-L
MN=G36Y7"2\C0OFM!%6Z64Y"G#L&H75/*)O<-;LOUI6-#[%9?'FB9.A;0J$2U
M)4R4"XO-%7=;P_J>"-EFOW15F4Y7W,S)&W&R;>G#3#&\FW6MLC97K(H35]^6
M!&;W#8Z68NY2]3+F(]_B+I"RS02)T+<TYZP"DD5?O<=N2'VET3S KZ!T_2.-
M=YR."/-G3>O'ZH9?%IO<9[3Q+%N<:4=K+(A2Q^A55)C926^2<B-FFN9!#0XK
M#&QSVE;0+:\Q\Z]5[G5/M]OW+U YT^TM=W6[,$<FETEK5Q5V&Y23GV,TE4ZH
M:/H6_;=40"/H:]F$Q6H'6>N8%SA*1(# )6'88XG PCJ*I^UKDZC?6EOK^UW:
MO8YTI1TTIV2#M:-QOEMMI>AJ+CO1S*"P*U:K 22:<6?8W?,*W'U2I?&UIC*P
M(&TXE>B2'F$N &'UE4?N%3EPJIM=W?K>G8+8_P"+7'>G7FRKIB3O9)MC0Y!9
M5T]&6?722'6!8K/1%9R]XA<?K,EMB![6A<#),:>A:4"!$%U< .I)K?W*GMAC
M<"7).G6B1BJFJSN?;$0WM'$\2I.QY)T'<[Q:3QUHZBLI%-;^54U1)T&;$K,\
M-,O;Y04C/\HU+HM7N"("2#8/;,B<^1ZGLJ0V4^=$W]V$K[,MB)RVP7:1M'.G
M,W.MS3^^H9%V.-$K7*&1)EC<DE<$K<)J%-IP?SG0/Q"U2E:B=H -Y& , 8!3
MGCW^-+^>-=W[F,CG3O\ /OMC>_>E.^#_ .-/YX[E]1+C9(RXC7A(ORY+I_-;
MY7_A3[!R.9W^LY?^A;_PKA=&Q?)SA?;G</>^VF"3?U/QR.%?2T#9OUAZ)]/1
MFQ!+V9]@4G\FA[#H0M V+P\=ZUO?AGECT^$\>O96?^ S9SK\7G4=.WE87ORV
M5:9))2(N=H0O.L&R#^]U-'V@;?D>@DVD3G9*6VM\\6$?;S9TU$!.*\<6JV+3
MP)XF'3@G1(VUV3LI3 8$HP@L^[[EK</A.Y%6K7WN+(M\ESA%0=OG0Y;L2HM5
MR4*:Z-N47<=Q5JU\>V[NW_!EJ3NW7U(\>YSHPG)S5SDSYJOPJ]-N,ZZ*I*,E
M;5MTI7A5?(*5 U<NFTC9C\J@Z[E>PC.^W&CK!F<T3Q.*_8FQJ$4AEHX0YR<^
M#W6AM7RZ;#T):64A2F.XR];3D*1%>6?;SW<RUN%I*^LN/HBNPC'5+FOA'6HJ
M=IV_9)UMUT5XM5]L"Y@*WB/ NMV7B2]+=J<I:8\I<9:&]%U7/8TI<IK:X)TQ
MY-TJY5.CN2%U9TO#8&7-^F$+!S9*$+W&)IRVMC;M2U7*Y.<W3RV1NZ6,PZEE
M218\S4IN=U 7*4O D3?LIQ<RT1/2>VQRW8OY6/.7+Q6[T:.-_4KL]-8PXN5R
MJC:;BM-N.J58P<GZ0W*6(K]C%OPCS,E*S*JE8TNU"M)3[(VZ.5RDGJG)QC24
MU%;\8&LVXP:&.&Y@UV'M=$XZLW/V,IN(9)SM4SHS_K@SD,ZM>T$M<F\_QJ<"
M4\Y,$D\.BC!@\HMP6]'3>G'0X4DUI=:QX^Q=4G5=CJD_4)S9>JS"6I3K%=Y=
MDN'LE1M4?:J-^N99GD>@P!@# *<]_?DD6S^ ?\)D,R.=6_@_D?N/ID"G?'[Y
M)-V]R^_<<N-DC+B& , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# &
M , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
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M@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# &
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MTR!3OC]\DF[>Y??N.7&R1EQ# & , 8 P!@# & , 8 P!@# & , 8 P!@# &
M, 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P
M!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# &
M , 8 P#2@F_&J^TKHC\5S[=/J'^,)8_UB^4?B=_*?M#]5L^M/RS[7/\ MA\O
M\OP_H^I]Z]/P\/N_4RLX_#WIN9\!>E>B>F7-5/0Z<SAJIS>_3LIY*>K4^*[7
MQI_?)U%\5_P[\ _?#F<[E_>_R_2ZPY^CT_\ RC1[#37NZ:?/:C(?]I[_ )PO
MZ.S/;_CC_3/]GFP_[G/^8?\ I(?[3W_.%_1V8_XX_P!,_P!GC_N<_P"8?^DA
M_M/?\X7]'9C_ (X_TS_9X_[G/^8?^DA_M/?\X7]'9C_CC_3/]GC_ +G/^8?^
MDA_M/?\ .%_1V8_XX_TS_9X_[G/^8?\ I(?[3W_.%_1V8_XX_P!,_P!GC_N<
M_P"8?^DA_M/?\X7]'9C_ (X_TS_9X_[G/^8?^DA_M/?\X7]'9C_CC_3/]GC_
M +G/^8?^DA_M/?\ .%_1V8_XX_TS_9X_[G/^8?\ I(?[3W_.%_1V8_XX_P!,
M_P!GC_N<_P"8?^DA_M/?\X7]'9C_ (X_TS_9X_[G/^8?^DB*[K_'4^S=[_&'
M_&"^QKX^+?7CS_B->3X+ZW,7RWS?43_M;Y?GGPOC\%]\\/Z+[CSY@;G]\WH4
MOACTOX-K'7_F79KC3V'?]E3V/ZQ%>M?CH^]N_P#&']\'WF\RQZ3^#/L?2+6C
M_-?;_P"-T?Q?'S]VIOBRU3[N& , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
M 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!
M@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# &
(, 8 P!@'_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>46
<FILENAME>tm2227887d4-lc_3lnp4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2227887d4-lc_3lnp4c.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@!4 ,@ P$1  (1 0,1 ?_$ /H  0$  @,! 0$!
M       (!PD%!@H$ P(! 0$  @,! 0$!            !@<#! 4" 0@)$
M!@(! 0,$"0T'$08% @<" P0%!@<  0@)$1(3%!46&"'6%[?7.%AXF#$B5I8W
M5W>7N-@9F0HCE39VYFAI0=,DE#55U;;&2*@I.5EYJ2I1,K34);5"4C,T)K)T
M=6)#4V0G&A$  @$# @(#!0\."@H! P4   $"$0,$$@4A!C$3!T%1(A0687$R
MD].4M-05-55U5G87@9'10I+2(S-4E;75-PBQ4G*R4W.S)#1TH<%BXD/C9#9F
M"8*BPK;PX8-$)?_:  P# 0 "$0,1 #\ ]_& , 8 P!@# & , 8 P!@# & ,
M8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@
M# ,.\B).^0GC_><SBZ\35)8E3MFR>/.@"$JD;:^,,*>W5I7A3+2%*)0)&O2%
MF: <684/8>P81!WO6P)U@7&>7R&#0M_<>8O+P3@^1..O"\1,RJLHH2US9T:U
M5LHK5.;T67L\\7=#_4U[& =L]4^1_+#Y@?;K5?P-X ]4^1_+#Y@?;K5?P-X
M]4^1_+#Y@?;K5?P-X ]4^1_+#Y@?;K5?P-X ]4^1_+#Y@?;K5?P-X ]4^1_+
M#Y@?;K5?P-X ]4^1_+#Y@?;K5?P-X ]4^1_+#Y@?;K5?P-X ]4^1_+#Y@?;K
M5?P-X ]4^1_+#Y@?;K5?P-X ]4^1_+#Y@?;K5?P-X ]4^1_+#Y@?;K5?P-X
M]4^1_+#Y@?;K5?P-X ]4^1_+#Y@?;K5?P-X ]4^1_+#Y@?;K5?P-X ]4^1_+
M#Y@?;K5?P-X ]4^1_+#Y@?;K5?P-X ]4^1_+#Y@?;K5?P-X ]4^1_+#Y@?;K
M5?P-X ]4^1_+#Y@?;K5?P-X ]4^1_+#Y@?;K5?P-X ]4^1_+#Y@?;K5?P-X
M]4^1_+#Y@?;K5?P-X!@?D[4-C4E0EFVS$.7G*A7)8#']2-G22&3U<YL:M6B<
M$.])79O+J-(8L;U)8Q -+":6(0!;[!!WV;P#9Q@# & , 8 P!@# & , 8 P!
M@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# &
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MN6U=5W)7K8Y1E4ZFLB:3P]]L^O86QV!&3W0KP@N+"I<D0MB +1O=, (0%RX
MP!@$?\_?B:\A?P?K/_'(, L# & , 8 P!@# & , 8 P!@# & , 8 P!@# &
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M[26/E0_T2[1LF;+$E"2R*04B12Q2H;TY[%,:R;%XEC<H>B ":EH$YAFM^"+
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MY'7:XU48E;7<R1)E82U3@G&E"N*;0-OCBXW_ -.WJ^=4:\IET_.6O-NM^H5
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M?L?SKV?V;;+=['??'?OFAO7L&X4[EK%1# & , 8 P!@# & , 8 P!@# & ,
M8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@
M# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
M 8 P!@# & 3%P[^X%'OXZ7/[]EB95/8I^SO&_P ]N?Z4S"W>W3]I65\7[5^B
M<(IW+6*B& , ^!T:FM\;U32]-J!X:EQ7@K6QT1IW!O6$[%H6RE2-66<F4%=X
M.M]T8=Z[=9ZC*4)*4&U)=#7!GF48SBXS2<7W'Q1P,<@,$AYRE3$H5$HLH6%
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M , 8!H=YIL#N_='2R!M252O*CEJ!FD@0IBS3M&Q&'\V_2"5KUA96A=K='&%
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M7 'Z0G@+\N'B!]):F/;K@#](3P%^7#Q ^DM3'MUP!^D)X"_+AX@?26ICVZX
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M.0[._:!MGQ-N?LG:#9%G1)B, 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
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M_P#BTNCX6< >;>??V9</_P 6ET?"S@#S;S[^S+A_^+2Z/A9P!YMY]_9EP_\
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MZK8)U&W!G<*;G7'N)*&IU3RV62A.XHWY/>OC &3X TXV[LWW]&_6 69@# &
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MIAEK [F2EC9S49#N]1P#>X*!/;2UG."<"E2FT:20(\O0Q!V,/:!WK & , 8
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M'_XY?@%@8 P!@# & , 8 P!@# & , 8 P!@# & , U_\^_\ ,J_X@'''_++
M-@& , D":_'ZXT_- YP^_/T]L K_  !@# & , 8 P!@# & , 8 P!@&)K\M5
M/1-%73=ZME.DB6FZFL:U5,=3K0-JA^3UY#WF7',I#B:F6%MYSH6T;(">(DT)
M0C-"V 6M=W8$L^[/U'/D(4!]/)T_-!P![L_4<^0A0'T\G3\T' 'NS]1SY"%
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M>/OOB->53VM>]^Q_.O9_9MLMWL=]\=^^:&]>P;A3N6L5$, 8 P!@# & , 8
MP!@# & , 8 P!@# & , 8 P!@&K;B5QC@]M\<:ELN?V3RY>II-HSZ021T3<\
MN;[ F6.BYR7C4&)6..<A6A@9TNO8"6F1)4Z4@&M ++ #6M: HKU'J8^S7E_^
ML)Y]?G+8 ]1ZF/LUY?\ ZPGGU^<M@#U'J8^S7E_^L)Y]?G+8 ]1ZF/LUY?\
MZPGGU^<M@#U'J8^S7E_^L)Y]?G+8 ]1ZF/LUY?\ ZPGGU^<M@#U'J8^S7E_^
ML)Y]?G+8 ]1ZF/LUY?\ ZPGGU^<M@#U'J8^S7E_^L)Y]?G+8 ]1ZF/LUY?\
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M , 8 P!@# & , 8!('4)^(+SA^:!R6]YB:X!7^ , C_EA_"/AY\\"%>]7<F
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MMYR2BU5()7>H'E1/Y-:=K/%FJ5<ZB,CX_<A+2MV<6\5;M0MK:F?B9\BK)RG
M28^T.*B/GB4,Q!ZQ><%:H+3L?><&UN"SW&\E;C;MZ/!E&[9MVX6^KN-T<'<4
M/#E%3X2:C%:5J^Y&SYMW;W@J5IN<KD]?A1E:O7+D[G66TJJ?5N?@1DX<8K5)
MZG3-%)4?<,6Y"V;<5K12F'Q9+U#O'8?.(O.7K3_ :I2*_*X_$62O#Z.86\E\
MFCD06ZS)V'*#SW5U\+0=>0H&U$ET\[-P[NW6L/$G?2@DY1E!4G<I1R<^MDZ1
M7@VXJ"48U^VE.4MO"PLNUN%W,RH6&YMJ,HR=8VZU45#JDJR?A7):VY2I]K&$
M8W/G#.X, 8 P!@$Q<I/[ATS\YWC[[XC7E4]K7O?L?SKV?V;;+=['??'?OFAO
M7L&X4[EK%1# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8!'_ +XFO'K
M\'Z/_P <OP"P, 8 P#CW5V:F%M6O+XYM[,T-J<Q6XNKJM3-S:@2E:[QJE:N6
M&$I4J<H/LB&8((0Z^KO /G52%@1#7%K7QG2&-?FWSF6J<T2<;=YZ/VE9_+@F
MG@$D\[*@[+3>)W?',UW0=[?L8!]A#BWJE2Y$E7(U*QK,()<TA"DDY4W&JDY:
MM,4N3EC$:D,4)#0&@"9H.QEBT+7;K>MX!]F , 8 P!@# & 1_P $/BS1?\(%
M_P#Y0MIX!8& 2!U"?B"\X?F@<EO>8FN 5_@# -?_ #[_ ,RK_B <<?\ ++ -
M@& , D":_'ZXT_- YP^_/T]L K_ & , 8 P!@# & , 8 P!@# & 1QU%+(F]
M-]/OG5;U9OZB*6/57#CD[9%?RA(G0JU4;F\&I.;R>*/Z9(YI5S:I4,[\UIU
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MI@R,#TC.71U[2+2=B(T U.H ,(MZ%K ,S8 P"/\ @A\6:+_A O\ _*%M/ +
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MG3[YU5#6; HE=CVKPXY.UO7\72*$*15))O.:3F\8BC F5N:I"VIE#P_.B=.
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MW+$M_P!UYAV?<,+;5RGO$7=O69P@I2PKFE:I)*K[B[I>V?H<_-@P!@# & ,
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MHZ1)&<F"<>O<YX%Q>-2OW.E2(H#LL]UEW5 =W?RT0_#6$AT3V [=8!Z?L 8
MP!@& .*M%^K+QQICC]Z4^FWN0U^P07TM\R>C?I#YC2Z3>=/,/G=_\T^5=G>\
M#RU3W/J>(+ZN 9_P!@# & , 8 P!@# & 0!Q7^-WU._P_P#'_P#(HX[X!?\
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MDP"P, 8! $C_ -J;3?S .2OY17$_ +_P!@$@<:?NS]0GYW\*_(%X/8!7^ ,
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M/)O.EFW!RD^FBBFWP73P1\RLFUAXUS+ONEBU;E.3I6D8IR;HN+X+H1P-:7#
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MBH2?6</ 27HO"K'P>GPDUPXIHU<R-SY+M/"[E[:4!N*QX77B%@DUE<=I%;J
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M.F=D,E*1,+&226?!X.8TGF(#5'>5B$N-\06]:#@'I.P!@# & , 8 P!@# &
M, 8!JIX3\L>2]X7M.(%;\+;8]"V*$R9\9G)'!I'&SE+PUS&*,S>G&YNSBK1J
M0'-3LI,V6 &ACV#0];T$.];I[D+G+FO?^8<C;M[L1M8%O'N3C)6IPK*-VW&*
MU2DTZQE)T7%TKW#\W]DG:7V@<W\Y9FR\T8ENQM-G$NW+<XX]VTW.%^S;BM<Y
M2BZPG-T2JZ57!,VK9<)^D!@$?\$/BS1?\(%__E"VG@%@8!('4)^(+SA^:!R6
M]YB:X!7^ , C_EA_"/AY\\"%>]7<F 6!@# ( D?^U-IOY@')7\HKB?@%_P"
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M^GS'&ZD?.--'2AU2T3Z<04U0O)\%L:?2@!>UP_*ME^+H#U6X P!@# & , 8
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M_%GWUV7(YS+^)Q/C+%_M8E.]LWO;R_\ /'9/9ULL?)&7$, 8 P!@# & , 8
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MH\<AA$-N";PRO92XT[))A.I36#U)H;'T:Y<PNSB:YM2L\Q,IT$PO>L NG &
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M.*::X-&>H]>\*4,:)1,WZ(Q:5:E4'@#Y&FJ4ZEJ9MGUD(&)VA$8;7M.TM6Y
M.2,\F0*DJDE* @9!PA[V$))P@<^Y@WE<:LQG.UHE-2<=-80;4I-5=*.+35>E
M>:C>MYUEVT[SA"[JC!Q4M5)S2<8IT5:J2:=.A^8S$_-#^#?'[YX_%GWUV7(?
MS+^)Q/C+%_M8E5=LWO;R_P#/'9/9ULL?)&7$, 8 P!@# & , 8 P!@# & ,
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M'JNJTK5X5*TK7NUJ7%9L\@>0#N7'C>5'BTOMI=9UFITX5I6E.Y2A:6704Z,
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MX%Q=LM[TCL!*J-<K+]TN9&D.B/RHHKS,25M,5W@BWO /3[@# & , 8 P!@#
M& , 8 P!@# & =-8;#@\H?'R-1V5,KR_QH]2F?VAO7%*%S0H1+3&Y62N(!O8
MR#$Z\H1(];_[IFMZW[.<C!W_ &7<LV]MV!E6;V=C2:NVXR3E;<9.$E)=QJ2<
M7WGP.UN'+F_;5@6-TW+$OV=ORHQE9N3BU"XI14XN+?2G!J2[Z=3N6=<XHP!@
M# ,(7]?<0XY08BP)LV25V9U#^WQT"6*(VI:YZ6N*5P5D&B)>'EB2:2@+;1Z&
M+1^QZ%L/8'>M[WJ%<^\][1V=[''?]ZM9-W#E?A:TV(PE/5.,Y)TN7+4=-(.K
MU5K3@^Y.^SSL^WGM+WZ7+NQ7<6SFQQYWG+(E<C#3"4(M5MV[LM59JBTTI6K7
M"O/4Q;4<O.M8W:<30O;;'Y1MYT@12-,@2/)/F.0.L<5^6)VMR>$)?B+F<T9?
M<4F=I0@[%W1;V$.]R;S7MW/'+>-S1M4+]O RNLTQO*,;BZJ[.S+4H3N1596V
MU2;\%INCJES^=^3]RY"YGR>4]WN6+NXXG5ZY693E;?6V;=Z.ESA;DZ1N14JP
M7A)I55&^+M7D;QZHE0RI+OO>F:;520E:HCJ:U;0A%>*'Y.VC3%.)[*3+GQH,
M="6\Q82$\1&C E"-!H6];$'MDY%#!#WU&N%C?Y)Z.<AZJM+QS!@7^X]8$*L_
MT<*#X?AK95Z(R%R]'4"GO"\(Y5X99G@F=W>_#%V5KVB=K'*'9?XAY5SOP]T;
ML[=GJK3N5E#1JU4:TK\)&C\_O%D]GG93S=VG^/>2L+$_<ZU"Y>ZRXK=(SUZ=
M-4]3_!RX>=WSG?TA/ 7Y</$#Z2U,>W7+**V*Y3J$ZQ.0K2'DJDJHDI0F4IS0
M'IU"<\ 323R#BA"+.).+%H01!WL(@[UO6^S )8D?*)''[U3TV.(:4)-2&%Q)
MPD8Y:SH7D+_/&8]Z93&2"JDX7211M&G  #@XDJ !2F"'K19FRA]E&[OVUX^U
M=IL.SV6WZ['C>)BSR'E6H7>OS;,KUEV<*4>LOX\(I*_?A<2M2<DH3T2+OVGL
M7R-U[,Y]H,<_1?\ %,O*ACK%NSM=1A759O*]F1EU=C(G)MV+$X-W8J+<X:XE
M6Y>12 P!@# & , T0]>6+&)*%@-RJ9BL:F.%NCS6CA 8S1ECW;8EG.-M26LG
MA@:80FAG.K@Q'HTH95]5;5JSG9X7FK2=:3(A)S!FI7,"B>C \-KUP&K\YJ,<
MAD-MA7?&E1;RPIXN\)7F)VY+XP_HW"/I^67-L" 25]:% "!ZL5X+6I=%*R2T
MI"@I. #:K@# /-EQ:J.XZ@_:,N1**YN2<DY+KIQTL&ZR(&ZR6"Q:!FU-64FY
MTSPF+T:TIXJ883(V.!G-BHPAW6=C@LVO%H[6M%@P#TFX P!@# & , 8 P!@#
M & , DNC>%5&\>)\_636Z"2)I/(V-TCKF:[R%0ZHA-KN]-#\L"2D-)+ 4<)P
M9"-A'K>]A!H0?ZN0SE_D/E_EG<;FZ[7&ZLN[;E"3E-R6F4HS=%3@]4$5GR?V
M2\G\C;U>W_889$=POV9VIN=USCHG<A<E2+2H]5N-'W%5=TK3)F68, 8 P"<.
M8\"EEJ\1.5%7P)J\_3JR..%XP*%L?ES:U^>99,*QD\>CC5YS>5C<SMWG%X<2
M2?'5J"$Q/?[YI@ :$+0%'X P#3WU*;OYY55/:W;>(T1L21QEUB+DMEJB%T>H
MM9*G?2GD9"0E:XDQ"2::E F_6A!(V,K8P_7=W?U<XNZ7]QLW(K"C)P<>-(ZN
M-?.93/:=OO:!M.X8UKDZSDW<6=F3N.WBN^E/51)R5N>ET[E5WS;7'#W!5'F)
M2[ ,*=5#,UGN99I&TII;@<A(,6 -3; 7M.8!2(6A [H>YOV.S79G8C5Q3?30
MM_&E<GC6YWJJ\X1<N%.+2KP[G'N',YZ,YJ@L&"]*M7SO1R>?KHL#G.&>5<J2
M)E%B7"B>_3M%%X<36(=1%MDY%>"4#C"=GV42)%M.H#L(SPC,&9L7*N0VMYVJ
MY3Q[5'NRK6BT\*TZ*$?O6M@>[*Y><?=77'[:==5%IX)Z>BG<\\VOYU20'R+S
M%9*%:<WI@+%Y2128B1F'!3EJU8"1B3)AJ!:V$@!YV@AV/>MZ#K?;_4SXZTX=
M)XN.<;<G;6JXDZ*M*NG!5[E7W32IP/Y(<EK,NV"1^<V59MF*9'6=A2#E76\V
MX\)JFB_$^TF9TC2:#P>'2TF-1U2[>=]*UR$M&J7OQ[DC0>=N\1LX6<+;\K*N
MWXPN2G-N$G<BX:5;DJ42=%YJHVZI5*.Y YFYHW3?<?&S\K*RIW<6]//LW<-8
M]O;[\905JU;N:(.6JLH*,IW7.,.NK'4S=MG>+T& , CC@/\ %ABWX0N0GY1-
MK9'.4_>.W_79'LBZ4[V"_LQQ?C#=OTOG%%V;6%>W-!I#6=JP]AGL"E20"*01
M:2(2G!I<B25!*Q*,PDS7>)5H5R8I0F/*$ ],H* :4,!@ BU*L;*R,._')Q9R
MMY$'52BZ-,N6W<G:FKEMN,UT-=)Y>>K%TSH#PPXG7+RUX_69-D9=8ZARDNHK
M*3H+"C"@B763$8+I"SRT)D<G[>4UIY2)1HQU<'Y0>(C0!&:[VQZL2/;-OVTX
M,KN;8LY;A3C5VY.K2XM*2[M>$46EV?WL[FSF;%Y:R+L;<<CK%UNC4XZ+4[GH
M=45*NBG2NFI1G SI TI:E#4#R$Y!3Z<VDHM^HJRM=55K*%'6U9H?= A+++A1
M]S$QFK[%D!+2H=MD['J0HDBTHONJ$@@#&7OSF]K?,.[8<7APM8D+EM-Z?#FJ
MJM%*5$O/TU\XXG-&[;AMN]9NR69QZO%RKMG6E24NKN2AJZ7IU4K1-T[[/0Y'
M(Y'X?'V2)Q-D:HU&(TU-[%'H\Q($S6RL;*U)2D38TM3:B*)2(&Y C) 4224
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M^8XRUYZ%U$0/:VDO=8CAYKNX^/K7I(I)"M!VA+P#U6X P!@# & , 8 P!@#
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MK,;LMF<OF!\)?$").T[/CJ :%L;=&!$0C)V</8P/4K@# & , 8 P!@# & ,
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M7(YS+^)Q/C+%_M8E.]LWO;R_\\=D]G6RQ\D9<0P!@# & , 8 P!@# & , 8
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MOKLN1SF7\3B?&6+_ &L2G>V;WMY?^>.R>SK98^2,N(8 P!@# & , 8 P!@#
M& , 8 P!@&*?<(H_RZR'3W&JI\YW(TJF&WG'W/(CY=:K$N1J&Y:RV0K\S^43
MEI6-ZLT@U,Z"5$F$FC (.PBWK8',!JFK@V&.W0UM 0VN8RZC9EGAAT>U88X[
MKN]C".:Z;O203+KN!_L7:GP/8U];[& =^P!@# & , 8 P!@# & , 8 P!@#
M& , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8!Q)+ Q)TPT2=E:2$9CD!Y,
M2$MR,I,8\%KRG0#J,@!(2AN0',@"G1^]>+H\ 3.]W]:W@'T)VQM2+'!Q2MZ%
M,X.PDPW5<G2)R5CF-$1I*C$X*BRPGK!)$P=%E;,$+99>NZ'LU[& ?=@# & ,
M 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@$<<!_BPQ;\
M(7(3\HFULCG*?O';_KLCV1=*=[!?V8XOQANWZ7SBQ\D9<1J0'\;CFA_'.E?R
M?*ZR,9O^.N__ !_FHMC8O^W\3SKO]K,PG.06J9R.L NBA& NT?3)YB@IX1(D
M0#@VB*8TKJ ;(&Y;"W /U*]I.YM1OP-"[-F?6=N=/E?Q-<QXSW#_  &J/6]/
MXOK(:^CCZ&O1Q[QR.?\ QQ\DY/N?7Q_K?P?1^,ZB]HZ>'HJ=/#OG#W,;Q4WQ
MIL!'QRB4\46:OXMS<%J.D';9,D&VFE)(B:XE<P0JE3>[/%VN+H XMM#(TSA*
MPJ/.@NPH@2PS=N8"WCW5MRW2=M8BRX]6IN/'T5/%N#2M)4U:'&W31TO2C\[9
MSV=[5<CM<+KRWASZQP4N'"-?&:M-W6ZZ=:E<KKZ%5F0)Q(.+4(D5JRNKXVY.
M'$MMHUE,N6'TPD=(Y6=@W>7>%?'T?!H^$HV/UVH>9<A _-DRT6H3M8HZL3 D
MQY37L @\ZW;W:_"U9S9);P[[ZN5QJ4X6NJGULI>BG2/@2M<'+6I=4G,Z4Y[3
M8G=NX4&]G5E=9&VG&$[O6PZJ,?0PK):XW.*CH<>M:@2O;3*J5U9'M1VPJR;V
MIQJ[F3.(<P(C9)-*TKBTYN]U:Z0/CYQ,<XT:RAC?)*KT",6HA(0)EXTRUT<3
M6:-GI5 D:'HX=R,<N?6V[KEUV-&3=(SG"*N*=V^I5K9F_P 9"J32@IW4UJES
M\RW)XD%;N6E%VLF44JRA&<G;<+5AJE+T%^*G1M-R<+33TQVC\SJSB]L\4(U)
MIG5*9^G;4919C21,XZVR:>0\,KM&J"ITSB7^;A*$RU6U -3/.TP2BE)91FC
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M18Q;+$+0P[#H#/WKE_M!'^Y@X_\ ZQ6LO:O@#UR_V@C_ ',''_\ 6*UE[5\
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M,D[0^Y_9,QJUY\^MD3E4VCZ;RF00E6<E\G=%7?1F%#'X9@AE%@5__P!4U_0
M_P#,4P";^7O*#]I<X6<:+CY46DT=#%_KVD(>IFLK9X W\^G69.#4E5I$9B>/
M-\BD$59%;ALU:'>@*7%(7W=;[3-;[-; S!7DV_:A;*@$'L9B3]!%(R3^'QF;
M,R5V*ZA9#JF:I4RHGUO3N9"-6O2$N!*1> )P"CSBPF:WH)@P]@M@=P_ZIK^@
M!_YBF 2!RFYJ_M(_$:6<5(=9#!T07MSY?\CXEQ?K0^$-7/)R0,<^F3:[NC8[
MSDU^E4:4-D/(3LQNCU" IS6A&(&@)!ZWO80*_P#^J:_H ?\ F*8 _P"J:_H
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M@$<<T/X-\?OGC\6??79<CG,OXG$^,L7^UB4[VS>]O+_SQV3V=;+'R1EQ# &
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M/#NU5)<>FE$=<5ULU.>QB?)=<\HV:((U&YAR$OF8^5B+!HLG:WTHLAW\MVG
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M7LECES;\';[$]LS-4<:Q:L1EIO8BC56HQ3TIM1KT)M(WFY_1DHH8 P!@# &
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MMV.:T=RAYE*C=:&H)F].,Y1PM=I@&Q)0->NR5#H7U?)R')_6G!#]31BDS?\
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M(CE9E_+R<B,'",K^1?ON,9-.2CUUR>E-QBWII6BKT%(9LGH8 P!@# & , 8
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MG'*A:>1=GUL>M4G;<]?A6[2TJY<E)JDH14;:<J1FU WQIA &F3C+T>$ R"A
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M & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
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M & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
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9@:6=ML9C'=5#"8GKEC$UF[7JU1BW0'__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>47
<FILENAME>tm2227887d4-lc_4lnp4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2227887d4-lc_4lnp4c.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@!7 -0 P$1  (1 0,1 ?_$ /,  0 " P$! 0$!
M       '" 8)"@4$ P(! 0$  @,! 0$!            !@<#! 4( @$)$
M!@(! 08" @@.#P8$!P   P0%!@<! @@)$1(3%!46%Q@A&2(CEM8W=[=9,4$D
M5797ESA8>)BXV HR0M/4)975)E;FU^=H:9DS-+8G*#E14D,V87%$=#6U>1$
M @$# @,"! P/"PH$!@,   $"$0,$$@4A!@<Q$T%1(A1A<3*4%55UM18V%PB!
MT4+2(W.3TU1TU#655C>1L5*R,U.S)+1V&*%B<N)#XS1DY&;!@J()\.'"8X,E
MH\.%_]H # ,!  (1 Q$ /P#OX
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M!X /EIN?\X3R_P#N*X"_T'@ ^6FY_P X3R_^XK@+_0> #Y:;G_.$\O\ [BN
MO]!X /EIN?\ .$\O_N*X"_T'@ ^6FY_SA/+_ .XK@+_0> #Y:;G_ #A/+_[B
MN O]!X /EIN?\X3R_P#N*X"_T'@ ^6FY_P X3R_^XK@+_0> #Y:;G_.$\O\
M[BN O]!X /EIN?\ .$\O_N*X"_T'@![O#.7S:<\=88_V++G*>S M^M&..LR>
M6R*LSO(BH7;4YAK2Y.K;"(]$XDF<C69A3X/]/;$*;<W&VVI.G>S@ 6B
M
M
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MP    4_X(?O9HO\ C O_ /G"VF +@
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MYSQ+\8QC%5E*4G;2C%)5;;22XLD424BP
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MP+__ )PMI@"X
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MNW=R;UR#:V[(:;A.;BZ-)JJX/BBZ@O4H
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MVJBE"905ON4>09H9IMMKMC.0+F
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MT')Y?.HQ7C-EPDTW7QW7$%:2-5<B?7AR591>/G<CQ=B- -R(
M
M
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MM0&\,
M
M                   %2N+DA8(EQE32B5/;1&HS'I#>CT_R%_<D;.QL;.VW
M)8ZMQ=7=U<#DZ!M;4"4K8PX\XS0HHO7.VVV,8SD59T0MSN]/L6W:BY7)9^YI
M)*K;>Z9E$DN+;+>ZYIRZF9,8IN3P-JX?_P"5@DIT_P A:*Y!('ESH^WJZMA%
M'5:=#(#H#+66398U2S0XQ"4[DM:M0>V^HDIS#$NQVNFJDK3.Y6=],=HN#-V[
M/VZ:MY]F[9G)52G%QJO0JE7_ ,"IKMB_8:C?A*#:X537[Y,0TC$8[+9=%8#&
M7R:3B2,4/B$9;5+Q(I1)G5"QQ]B:D>F353B[.[D>F0-Z).7CMW,-,UTU_3R,
MEJU=OW(V;$93O2=%&*;;;[$DN+9]1C*<E"";D^Q+M,&I^^Z5Y L2Z34E:4'M
M)D:E_I3NNA4B;GS#.YY*P?HWO*=&?NJ:%IR;;4XLI3H5N83MJ9KC.FVNV=C-
MV_.VZ[W.?9N6;K54IQ<6UXU7M7I'W>L7L>6B_&4)>)JA+8TS$          5
MCY9_@SCOXZ**_*Q$Q5'6/XJXWN[M7OACEO=%/C=E>X&[^]V26<%KE0@
M       !XJZ-QUT=V*0.; RN+]%]G+>,O:YK0JW>.[O*/T]WV8G)008M:-G5
M!]H4Y3[EY/)^PW[VOT #V@
M
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M
M
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MGX%+A_\ 'I%?8?%N0'-"]7-!%\RJ_K[FRANUFDQ?5>#4$9;D9)A3>\63(FY
M7&ZP@3&GW,RE1ITJ4K/;N0U(%"HW5.9U,K-Y;Y%VK1'19L13TVX\9SEZ";K)
MOPM]G:W0VKE[;-AQ=,:1CX(KC*3_ '_HLZ^>,?!BMJ%XIZ<9Y%G$\TENBU]N
M23D;.D7/G5@/I3=ZQ(FDUH<RGR*IV?5H0HV'*=;Y]K0-:+'FC%).RG?S3O/,
MF?N^^2WQO1>U>0N#4(K@HT:::I74FJ2;=51T*LWBZM[G=>:JVKBI2K5(^!)I
MIIKM3333XIIDRQ/C%2T)DB*7,$9=RY"W35]L9$O<YW8#_J1.)1##8#*)-A$_
M2ER;S'22QH\S5PWW*V\XK,V6&XW69\<<N[N69>M.S<DN[<%"BC%>3&6M1JHI
MT4NSQ+R5Y/ Y=O;<.S<5Z$7WBFYU<I/RI1T-T;:JX]OC?E/RN)XLLXAT-,5S
MJ[.$:DC4]OCM/'=Y?H=9UH01^<]K0;XBUV(TJWJ&S%C<MXQ+T<!9?-M6#<-O
MCMB9063HI*T.QDM;MGV8J$91<(J*2E"$TM#DX.DHM5BYRI*FJDFJT=#'=VG
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MG13XW97N!N_O=DEG!:Y4(
M
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MNRO<#=_>[)+."URH0
M
M                                                  K%P[_ %'OV
M:7/^6RQ!5/13]G>-^/;G[Z9A;O73]I65[G[5[TX19T6L5$<X_56_]VKHL_C*
MFW_BBN!<_(7[/>9?M,/XEPAV^?&#;_\ 2_\ J1MJY7R%_,E_&2H4]B2&IH;>
MEK22&S*:Q!9HQR]UV8:KF\YCE8Q>8;%'&PAVGCG&]C-G%+@MQV1MAZ1$<0I5
M%':5KLUJVK&7FNU&]?Q[,91C+C%5N0A*Y*/U:@I>I?DUDI232:.GO-VYW^)@
MJ[*Q8R+THRG%TDZ6Y3C;C+ZAS<?5+RJ1<8M-IE:G&'^[+PJ;C:R\L.0L@AL5
MVY3;29UC-HR&,V$SR2)(.,#[':_F=CM.$[A9&(0BM9682I6[*3RRW#1&L,.5
M(SM]NM&_W.WWMUN86-&_/S?2I6XR@XR=]2G&#X0UNVJI47#5%)21R9V.^W"Q
MM5O-RI6(/(U.-R49J458<82FN-S1WCHW5^5IDVXLIQ8W(_D4X1IS9ZZM6?SX
MGC+"^7$\=+4;IO%H$8ZP6G+VUK^LKMG&$,?(C/(XR(,\!E36\1)(4TM<@4MI
MBA8:F.<&\TKH8VV[>KRED6;=OSJ>/!0<93I*Y:USMQK+59U.=MQN-RE!2I&J
MC)/2R-QW!VG&Q=N7/-H9$G-2C"L;=W1"Y*BTWM*A<4K:TQDXUE35%K:%R'M.
MX8AR&XPME01!;9:685YR)<I!7N\Z0UTVNA3$;1^[)(G):^-ZU*>LCOKB@L@C
M<G!VOGS<XSKV;8S%]OQ<2]MN3/*FK<H7+*4]+DU57:I4\=%5^@2?/R<NSN.-
M#&B[D9V[S<=2BG3NJ-UX<*NGIFLVK.</(B-.,QW<FLR260Z778-=-,/L&QGM
MWA,1661U@7OB7'XR>8QIL)5B6K8M)"4:)R2E8VW1-A1.A>">S42G+V';[NA0
M:ACK'MS;A!*4M&VK)DU5_P"TE%MI^&3?:1?$WW/M:W-.>0\B<$IS;C'7N3QH
MIT_FXR237@BEV%BG3J#7X23=<400VD$M@<;:^Y267/WV2.DQ:H'8;/QYGA<2
M:6F#H"U2AZAZJ3M:HM<[+%JMY)8#]B$V"EVBS541R[?+^!)V+KG?\WR;MBW%
M)1<X.]&K<O!+2U2*2BYJKK"E'TY[_G1[^RH65D8UJ_<DVY*$U:EI2CX8ZDZR
M;<E!T5)5JI;J3G)8MHWBWQ0NK2FRK'"[IOQ^R[KT#BU/*22P&L7V:N,P(DKD
M]:,#^G>9'&%:-'&D3?LYZL)Q#YLLV+PI1D:>7LN/BX/>N[7*[B%VB:::G-14
M:)55(R3<W*FI.WIK23W<3><C*S>Z5JF+W\[56J-.$')RJW1UE%I04:Z&KFJE
M8K9J(V2( "L?+/\ !G'?QT45^5B)BJ.L?Q5QO=W:O?#'+>Z*?&[*]P-W][LD
MLX+7*A
M
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M8^6?X,X[^.BBORL1,51UC^*N-[N[5[X8Y;W13XW97N!N_O=DEG!:Y4(
M
M
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M^6?X,X[^.BBORL1,51UC^*N-[N[5[X8Y;W13XW97N!N_O=DEG!:Y4(
M
M
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MBORL1,51UC^*N-[N[5[X8Y;W13XW97N!N_O=DEG!:Y4(
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MO$6Y6Z/3TZ*]S%2]R7JC-C#33-L[[[YSG.0!L-
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M5B)BJ.L?Q5QO=W:O?#'+>Z*?&[*]P-W][LDLX+7*A
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MK2:%I4#:@2EZEE%%ZXTTTQC&, #,@
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M&&)PN&L39&8K&F1 7@E$T,+ S)D;4TMJ0K'=+)(*++TQ^A@ 94
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M-[N[5[X8Y;W13XW97N!N_O=DEG!:Y4(
M
M
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M_'117Y6(F*HZQ_%7&]W=J]\,<M[HI\;LKW W?WNR2S@M<J$
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ME5:52LJJE:G0M[3NE[%>;9QLB>$E)NXK<W!*-=3<TM-(T>IUHJ.O8>P.J<\
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M22=*IJO95/Q'W#<-8
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MMU\B\CF+5'9I1EN5N0LC\3))/?%I3O.(BQMFWE-#]>S3Q>]OMGLUQG( VW@
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M5-W$HQL2MZI=W+0G=2=5J<>-+)B_BGP
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MY?,4,?!NV[]G#PL?'=R#4H3N6K2[UPDN$H1N.4(S58S4=<6XR1;T=(@(
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MK'=N].TI2:MVF[5]1UVG*W&5%+M6ED^BZRK@
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M0I66Q6-P4D;*<NJ4Q01C?&---\XR .VT
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MJVX1;;?:VZ<6S>AN>Y6X*W;R+\81222N22278DJ\$O C^/;<=_6%E_Q6A_N
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M[CHLK5^XK^_NFTR2%J]Q\@#BM4G)?XX)$VS\C\#;?V:2GRV[]FQO8 .OT
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M-RS*W.&I4U+5;X57"J;JO"D7: S
M    <?9O(A<U<WXFUKY6?"7J;7+52=R11GK(\CTWQ!:RY&Q16*2&7U AZ=*&
M.S=Z=HJ@2IC65PDFA*E.7HW;N)1&,'Z@=@@ TQ\^>>UWTG?$BIRE?38ZBI7C
M5#>5-L2QXXN7IR::'*-3^<7/#HZRR0^F9+&#Z<KV/E4(^*Y ^%D2B2FE+4IK
M,PK=&]STV _Q?SMO<F>.=[)9#2)_#*/\S8/PU7P1!"96^66[M4R9(.Q;\@F2
MYV^?Z,*C5%<DY))31\N'G)U<03;JL+?/J"RTX&B!CZ@=$]03^LF]+&?\:.?O
MS8TDP_._[*X__*M,:(^43U3@6<RR/_S5G\+A<MOWX^RV%KWK]5D[^U?3?)E=
MA*@O;<#M\                                    $(R#CQ5DGL9#:KP
MRK3YHW.3 [)7 MZ="$^BZ,[(]V@S9O)4Z(]]2-D!7>USIW3.[]EC/;D5!O?0
MOIQS#SY9ZD[IB7I\V6,C&O0NJ_>C%7,1VW8?=1FK;47;A5.-)4\JM661M75C
MG;9N4KO)&WY%N/+MZS?M2@[-N4G#(4U=6MQ<UJURHTZQKPI0FX6^5N !J_X:
M\B;CM:[IK$)],/7HZTPR1NS>W^WXLU^7<$$NB[8D4>;961N7&^$A<3M.YN;M
MIMW^]G&=L:YQ_.WYJ777JIU*ZO;OROSKNOGNQ8NU95ZU:\VP[.FY;S<2S"6N
MQCVKDM-N[<C24W%ZJM.237M#YP?2;I_R/TXV[?N5]O\ -=VO[ACVKESO\FYJ
MA/%R;DHZ;UZY!5G;@ZJ*:I1-)M/: /Z)'B\
M # [3,W)K&QSBUIC:85 Y>9HXDKY,U&H-](^X[:K2G2%%'S%M,2YQW]5#3IN
MYDYU[Z77)^-, #ECXKR:<Z<^JS:Y7R%-4/;A;6%$GKN*\L.MX_PQS=E:!2:L
M3)J]MJO6CB\]$J<XU,W)>SRV@S?&=M]O$QJ .M@ :,^3O-SD9#N5=N((F?9L
M%XV<2)-0+';\PC=%U39E5>4LMABUB3R6WS(II:L$N%'"4D)FJ-N:\5<VN[K%
MER-6]2(H]J,2)3 /TC7-/D'$I+5/)2R[#)E/'B^^2O/:@=^.47J1I4/]3Q/B
M7"^8UAP&=0R4LQ_OZ96%(HUPH7IY(V.!J]"I>9:4G;"$6B+3=2!IKXA\I63E
MM_6.Z0LZ*VUREL"(KN,W+)9%H3R:X]IZ"VI5C>G-L<4-=UH5ED:'J<Q%"3MC
MO.+CNJ5ZFZ8TV,[<Y ':X
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MPZ^2KXB]-IDDOX>?3$OS'?,=Y7W+_P!Y5>S_ "OIWVKQ>[D#K]
M                               %1*)XBQRB; ?[ :9>]/RQ_871B.;W
M%"A3)DY3H]M#T8>6:FVR;L84:T:Z8QGZ,Z[YSGZ<8'E_HU\V#8>C?.^;SOMF
MZ9>;E9N%>QY6KMNW"$8WLBQD.2<.+:=A12?"DF^VA?/4WKSNW4SE7%Y6SL#&
MQ<?%RK=Y3MSG*4G;LW;*BU+@DU=;=/"D6['J H8
M     #RWQ0[I65X51]M1O+\F:W!0R,[BZ;L;>ZNY*0XQM;5ST4W/!C0C7+-=
M"C56J15LGTVR9@DW.O<V XXJ8LZW7/JV0YDL>RJ B')M?SGE#Q:;; >I3R8O
M"8MU#.M2R-$EX0-=#;\<8;Q[7L<#<]DSTH5;$MJH@MGV\4M(Y%'N6 .S$ 5
MMW@KQQO"R=;1L"/312]+RX41.8Y'K:M2&UG<".MG52^5^@NZJXE,66O;>;XD
MZJ]]R"7YM7%J$^?)JL*$.,)@!_4&X+\<:ZO-RY"1>-RXF=K)%94S:V=TM.SG
MZKX7.KG5Y7W#/:\I][EKA6,"FUGK33SGES:FI*J5&KE^V-]-G)QRJ YGJ@FW
MNO\ K3S.V?&[D?;'L^H.:##[9O.MO8D-I[PY"BS["H!Z\JG^(-7IN[VDNG>-
M[^VFN.]]( ['@
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ML+F':N9.9[^3'>MMM.WD9W>V9V[^=8LW(SM]U'4I0G)4;IQXI]ALT$V/2X
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M[/J#F@P^V;SK;V)#:>\.0HL^PJ >O*I_B#5Z;N]I+IWC>_MIKCO?2 .QX
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M:?Q#CJU)NY>74*?0SF<HDSPS5&^H [?
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M'O\ \N;;\BG^-7QJ\OZX[_;U'MM8GU1?8=_NY Z_0
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MQJ9OMC3'9]( ['@
M    4XX#_O88M^,+D)_.)M81SE/\QV_MV1_:+I3O07]F.+[H;M[[YQ<<2,N(
M                "F_.7\#T3_C"\:_RWP<1SFC\W6_QS&_IX%/=</B?B?WA
MV?WSQBY D9<(                &J[J56IR3IAA03BEK^CM<K]HRLC=$4*R
MT^SV[:?+;EB\KS#X)4:QMD!Y)Z*JCFILQAV/8#V9R;4:I<[KWEM;6O<W8"'7
MGECR?9K)?KU=;%C[?1L*Y[P7A"_\9&^N&A[V6Q:2M,!A3]9J6R=/ L)19;9<
M4V,=T6A.=&,Z&H]4F[5LXFY<-0-*N>6T0YB?UDWI3V96=_<@+!JTWYYO95#W
M1Q6FW'EAXY]S@7Z!(_A],)]%HQ(K=^+TBC"AY=O&U-] .(((U[I2DOO@=KH
M
M               U2<TIKR:@UYUF537)Q8@F$XD%3,U&\+XC5-9R9JMEG;K%
M;">3MD<D9;+(?)K-C=3P6N'\E04_1:00E.Q'$EDF:OKHO;VM8! 45Y><C(E)
MJBY,SFTYE9-/W]RAZ@O']RXDQ6J:V</AC#>)L/YHSJN)%4CE'8JS7/)K==&_
MA;LU2-%()&]-3F^R_P !O1-6$Z?78#3YQ$Y")N3']8[I"T&Y3U 4+-(.,W+)
MX9J_YW4TWTS\+V]Z<VQP(A5#,Z=$0XNE:MNF^--S5QZQ26HUUTR;GZ>T#M;
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MRJ.7DITHY>2G7@;<L_#C>E8E<BKL5QKP2I'4TV_)JH^4U6JCY35.)6&U^?\
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M/+%?$?XC^%ZG+OMAOH[P46G^Q[W8 .OT
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M-QZJ+W-TX&)T0?+'*RF!N43+W\G)RX33Q5SCZ<]E%$Z^7QMX>0.NT
M
M          !4:%<X^.E@7DNX]QJ1RXV=$/UD1%G>7.K;-8ZMF\WII7L@N""5
MS<3S$T-7S^;5>O)4)WMK:G94K1GM[@7W-MVQRU2 <S=0JX\I_K3S.6R2[GW)
M5::H.9Y+ZW\R5*X^IXLYXD*+OLO"+16WHBD_'0O';E+H3N>7W\%_9@#L=
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M91OY523XREM2^+W]"\Z9 WG
M                                         -&<6X:\G9+):LXZS"+.
M53TIQZY,\^.0C)RTK>Y(\AL&;LW*R%\Q:_J]HK*.H&UPF$"MJ$-'-1:XO+JZ
MI2&Y&^PY,J;S%VB[!"4#+>*G1.JSB]RLA_,5VYL=1_EC;L"K^:UI$OG-Y(QR
M]F)ABL]U3^O)&KS-4Q^3M??/3:G:%IG0E-D[MW,*,SV=@&Y\
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M%/=</B?B?WAV?WSQBY D9<(
M
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M7I0O<$IK6G:I5"U<B0EZ$I=-NXK,W-QWOISV9P +E_4B7M^?)ZOW[N\.^\(
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M4L[L6GRG4EZ[:[;DF;8QG&<]H WO
M -:'-KIK?.M/HG/?G\ZE_$KVI#]8A[+X2\J/@- 9)W7IT>?=$LCGL25>L3#;
MU3RF5OC%]J).05W/M?>R!3#Z@O\ YU'7^_ZC?^YP :\.GKTGN27)#YX?F/ZJ
M/7NJGX"]0_DOQLH;T_G#/(-\2.-M6^ROA=:ZWWW7+[[P<)AZZN\1]9O)L+AY
M?'E$I7AF=X#8?]07_P ZCK_?]1O_ '. "O'+SHJ633/$[D_<%-=7SK[3RWZH
MX[W5954P97S^?I0EF=DP6MI+*(-$U,9BM5-<GD2>12=K2H]T#:J3+U>IV2DY
MI9N^F^ '$/HJ63<W$[C!<%R]7SK[0.W[7X[TK95K09)S^?HNEAEDSJMHU*)S
M$TT9E55.DGCJ>.R=T5(]$#DJ4KTFI."E!IANF^^0+#_4%_\ .HZ_W_4;_P!S
M@ UX=1[I/<DN,< XZR+C+U4>O=;DBLOF7QZI&RFMQYPSR?%Q.DK(>G9#9%@I
MT-?URP+F%9%$*,DPMV7[GM"')G>5$&Z[:XP!L/\ J"_^=1U_O^HW_N< #Z@O
M_G4=?[_J-_[G !KPDG2>Y)-?5(K7B:V=5'KW+.)\HX:3&[I1=6W.&>*'-GNU
MDM0B(LE?%V.GKDNMF]&X1(S9;EI4-ICN;MCQBS]2<9T &P_Z@O\ YU'7^_ZC
M?^YP /J"_P#G4=?[_J-_[G !KPX*=)[DER G_/..W]U4>O=6<=X]\RY_2/'U
MT0\X9Y##+.I*.LL?71VP5RZ:5R\H9HL=%SDI+V=F31$T'X*QJ41KMKMG(&P_
MZ@O_ )U'7^_ZC?\ N< $-<C>B%-ZRX]7O9%9]8?K\2VQZ^IFT)O7\44=05W?
MD\FF\4A#X_12/'L;!4Z!^>B7I^0)TVR1$>2K4ZF9+),T,VUVP!'?!OHSVW?G
M#SC3=5]]7'KZ5M=-HTS!)O:, 1<]Y-#D</F\@8DCA((\FBLSJYYED?);' [<
MK5(XJU"LG&O=,,VVQG( M3]07_SJ.O\ ?]1O_<X ->'4SZ3W)+BQ04+L3BUU
M4>O=<=AOG(BBZU?(NY<X9Y81#=6T_F:=CGTLT9*[KF//B11&F,S91HO./W0(
M]L>(I*,+QG4 ;#_J"_\ G4=?[_J-_P"YP /J"_\ G4=?[_J-_P"YP :\+(Z3
MW)*,=2_C9Q;C'51Z]SOQ<M#CO<5E6?<)G.&>+W*(63"G5"CA4336"WURGKR/
MIY D/,WW0.#>H7J\Z]X@TO7&< #8?]07_P ZCK_?]1O_ '. !]07_P ZCK_?
M]1O_ '. "B7%KI&<@+:Y(<^ZQMGJN=?"%5EQWN:N81QXER7G1-8VHM&$2:GX
MS-)-(5[_ "6M7*/S8YHF;JJ0:JV-.A2)]"<$&E[GZ;[Y O;]07_SJ.O]_P!1
MO_<X ,=E_0=<F6)RAX9NL[U_%[PTQU[<FE#OU%%"K1:Y(&U2J0I-DJ2GRE2G
M52J*TTR67MJ9OC;LUSC.<9 %-.F9TC+_ .4_!?CY?W*7JN=?"G+]L>.R)RL>
MM&WG1-:]0Q5R;)W*H^VI$\-L2M9#-&/57'VA(JR6O6GF&;'Y,TS@O?374#8;
M$^A5[4E,:E/UQW7>DOMJ0,S_ .W99U"O6(L_^CN*9Q]%DK1\(DWJL?=?+> L
M3>(7XZ8S?3O:][MP!L7X#_O88M^,+D)_.)M81SE/\QV_MV1_:+I3O07]F.+[
MH;M[[YQ<<2,N(TB]6"QY/R/HKEAP%HBHIG8%H+H37K9))AE]K>*5]#725.S%
M/F)M<%<PF[')'=2HC3+DXS9O;E)!.R@K3)F=\F:E\'=\I3LW<"W&4KKBN/!)
M5H_"Z]GB1:G33%]A]_P.;LZ<5@6;TWH2D[DDHR@VDHZ5Y3^JDNQ^A67.F1:<
M@@M/\<N$5KU+,ZTM:J>+[!H0[N3W74EADZ15 3 (#.%T<<H1-9(Y(/(/,S:M
MRBG-(A,4)U?>T[=BC==<VU9496H8<HRC=A:7;2CTT3I1OQKM.;U P7D[UF\S
MX]R$\'+S[DE&DE.'>N<XJ2<4NQ.NEM)KT3:\.P5Z           !3?G+^!Z)
M_P 87C7^6^#B.<T?FZW^.8W]/ I[KA\3\3^\.S^^>,7($C+A
M
M
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M3P*>ZX?$_$_O#L_OGC%R!(RX0
M
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MY@V:U;Q<>=B%R<+KUW%<?",DHJEN'\-U?AHN"-L $;            IOSE_
M]$_XPO&O\M\'$<YH_-UO\<QOZ>!3W7#XGXG]X=G]\\8N0)&7"
M
M
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MPO&O\M\'$<YH_-UO\<QOZ>!3W7#XGXG]X=G]\\8N0)&7"
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M0X
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M.(YS1^;K?XYC?T\"GNN'Q/Q/[P[/[YXQ<@2,N$
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MN$(XVN2WLTQYURLUU<5O=+QV%Z^;6U0>H[A>/[''>[-?TAHWL#FF_%PGS]S
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M#Y'>7?;Z_P#H_P#ZP?X(><?;? ^YW/KA]3?SP_6BAOW7I!_LM#Y'>7?;Z_\
MH_\ ZP?X(><?;? ^YW/KA]3?SP_6BAOW7I!_LM#Y'>7?;Z_^C_\ K!_@AYQ]
MM\#[G<^N'U-_/#]:*&_=>D'^RT/D=Y=]OK_Z/_ZP?X(><?;? ^YW/KC;ETK>
M&%Y<12KY-NLJ"IU%D+*VWCI$)E+A*=-2(BDFA3D8Y'KHW&_*[F&2$GPM==#>
M]C7;.<X[,8S8.!MFV\O<L8G+NWY5S,=G)R;TKDK/<+[,K"C%1[V[6G=-MZEV
MK@>M>@/2G=NDG+>7L6ZY%G)N7\KO8SMII4TZ6FI5XJG;7C7T#;D/@OD
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M^6^#B.<T?FZW^.8W]/ I[KA\3\3^\.S^^>,7($C+A
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MNM510A->F7YW9996JB06)=$>BZ3&6E;HG?UGEU^R(O7QL@7+A?(N#3B\N0%
MMJ"2-\MXWL=0R">/3RE9TD27-]T,LL?HSF-N)#XK<U1C6BARK#EYQ$AT(WW+
M\+8_7.^V@%?N(?4%KGGU3%Q6=Q7BS\?(ZSD3U#&*$7PJ3U.3,7Q97D;LRH9B
M>^Q!/<;JPT;=L1F[*[,DH)9W148RK=U.C4<>1NCR!*'"+DHY<O.,E=\@'J H
M:P>IDNL-G>8*US)1836P.]<V?,ZP="VR:*X?7ZN0MJY?#3%2<\UE;3?!/UUW
M)UVUSV@6M
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MQ/Z^<_2);&7^(3=H97YM<&A=G&F^-R.[G.>S&>W&V, 6
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M,)\4"RO1M_\ ;PIW]G_*3^=I>8 V?@
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M<1=^2IF-0>E3,:0DPXQ/Y8L#:YTNO_MWG-__ *?\YORI #9^
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MK?XYC?T\"GNN'Q/Q/[P[/[YXQ<@2,N$
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M6K1U=W!_<]BME9ZI4:<XO3JI5'F&F;F&GG[[[;9SMG( DH
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MU?A"_NF?>M=Y9G&Y;E*W<R)0EIG&,DI)JJ+B"1EP
M
M
M
M
M
M
M
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M6--K>F#C0\#:JGXOLE1IK2DAOD(7/7!%,I;/+OBS8UL6$FGEM712HV,-]/\
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M*42$@YW(0JSD!AYQ:O0HLL#;^
M
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M+^M?*Q+/E-]J>F?+U\&_5*V]Y_!GVU_F5[H]M>T_!\O]L]H]WTG]0^K "ZX
$ #__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>48
<FILENAME>tm2227887d4-lc_5lnp4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2227887d4-lc_5lnp4c.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@!0@-& P$1  (1 0,1 ?_$ /$  0 !!0$! 0$
M       (!08'"0H$ P(! 0$  @(# 0$             !@<$!0(#" $)$
M!@,   ,#! H+"P<*!P   P0%!@<! @@1$@D3%!4A%A@*(E875Y>WUSAXF#%!
M([0UU3:FUC=8,R34)95V=RC8F1I1,C14MADY8;%"4D-3576U)F)C1F:X>3H1
M  (! P("! 0,#@X)! ,!   ! A$#!!(%(08Q(A,'05%A%'$RLE2TU#5U=A<W
M"(&1L=%"4B,S<Z0559468I*BTK/3)#1T-E:6EQBA<H)#4Y.45QG!PL0)\&-D
M)?_:  P# 0 "$0,1 #\ [^
M                                          12[P>7>.\.]F2"/NKD
MQ/[%RET0\LCVS+E38[LSNV5#,%K:ZM3DB-(6MSDW+2-#B#R=]#23=-=]-L;8
MQD 4SZ"',WVKV!^'_H7\J8 ?00YF^U>P/P_]"_E3 #Z"',WVKV!^'_H7\J8
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M.W.4JE)IIZ@[?8PS?;?;.<@2Q
M
M                                       !$#U"?S!>X?T0.EOQ,34
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M@>GM^8+P]^B!S3^)B% "7X
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MD@Q9!6(
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M]U39RF3E #:P    "('I[?F"\/?H@<T_B8A0 E^
M                                 ",7&/YK5)_YEIOWXM%4]QWR2[#_
M $&/JI%N]_?RQ<P>^$O4Q).BUBHB+UH]>U#5$GED2>2I])7.MXFW3VV#J]KJ
M6SIMJ:$NVCDH;9#/5\>;59#=[Z@95BPMO3>]O&R!+NJPD]W\IFVSQ=HS,NU"
M[#LXPNS<+>N<8NY)4JHIM5HVEJ=(U=-5>!K,G=L3%N3M3URE:@IW-$)25N+K
M1RHG2J3=%65%6E.)_%764&3VHUT^1![E=)4^MR]^8EK16CPOBSS$VMZCK XS
M1MDY6_PE1$D;C+&_&ZWVF"_9JM=\>.OCG".U7Y8CS==E68M)UFE)2:DU%QZ=
M349</(?9;I866L/1>=V2;34&XN*<4Y*71I3E'CY2L5QU13%L+*_:H-(%[J_6
M(VSYW01HUB=F^1QI!5[[B)3TV?,B]*G7PC>.37<MD,+<-"3#70S!).IF-=]M
M..3M>;B*Y*_%*%MP3=4TW<6J&EITEJCUE2O5XLY8VZ8>6[<;$FYW%-I4::4'
MIGJ358Z9=7C3K<$7C;%SP^G$<;.DJ65O+I,GQ5'8G%H+$GZ;RV0N;='7N7.N
MK>P1Y&M6>Z-,:CBU6H4&8+(U]EH3C;90>G)-Z<7#O9CDK3@HPC64I248I-J*
MJVUTRDDET^'H3:[LK,LX:B[JDY3E2,8Q<I-I.3HDGT1BVWT>#I:3QBF[-Y_7
MO\'96N4.[NW6 BJU6R3AMB$I4URD/N]+NLIYFD,X^$ZL$=D%D%8)U;$2LTI1
ML<N0E&ZE&."'11DO9MPC"<YP2E;<ZQ<HZ_N7WQJ-:M0XZFE2BDU51E3&6\8$
MIPA&3<;BA22C+1]U^]IRI1.?#2GQJXIT<HUR/6M]U-<,FM"*5G,FN9N5.2)!
M$)^I8C,KF9HE"U!LX&,)#V3C=K=')ITTV(7Z)33<(5NAB4_.BDDXHO'R<#+P
M[=J[DP<(WHZH5X-QK2M.E)]*K2JHUP:;R,;/Q,RY=M8TU.5F6F=.*4J5I7H;
M70Z5HZI\4TLP##,L     C%TA_#G,'Z3L3_%W:(JGO/]T.4_A7C^PL\MWNJ]
MSN;_ ((9/L[;R3HM8J(
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M$VE]8G5+YM_=G)H=$AJ<\OQSY#2]L>.?  2A
M                              !&+C'\UJD_\RTW[\6BJ>X[Y)=A_H,?
M52+=[^_EBY@]\)>IB2=%K%1$"I%7?4M76UTA+Z"CE0SAGZ1S#9>V.-B39^AZ
MZI[<C-:1BGE"Y^:FJ$2G:=5DHBT&97,I*C6(7 MR)6I_)@M;JJ3[VWD;5E8N
M-:W"5ZW<QE*+4(J2N6W.5Q)-RCHGJG.-6I1TZ7TQH]%<L;IBY61=P(V;EO(<
M9)SE*+MW%"-NK2C+7#3",J)Q>I271*JS0JK&:?2(@-OF*V=Y;(GSE9E8N^<;
MF-#F\325SBG9.W*T;9@E:C0LZM/ EWM=ME.VR8PTK3&IFN=M]<..596W7,.D
ME.>3;FO"E&,;L75\'7KJG#CQZ#-EC7GN%O+JG"&/<@_ W*4K4E1<>'4=>/#A
MTD1:PINQ.5K)EG7%N2R!FJNA6U(=V2UQA@<U;+#9>Q;X:*17TF:RPQ1.) PQ
MMK<"XN]IG+&OQ<TW1_QJD486D*=OE9N/NN-#:,2%S3CM^;N4DG*+XW5=K)0B
MY-=I%Q]+QM]9:7'48N%D;7DSW?+E#5D)><**;49+A:=JD=;44]$E+TW"YU7J
M4LF2FPDMZ3NK;0YB-9K.E5%.,PQ)X1,]IU4J)SBUGPMW82E;3)7^O'!/L]-L
MH96W?)7NV^F6W*S/GP=@@L[&MXSP;%W%W.MJU?4=,HZ+C4H23XJ,UP<7+P^F
MT^"K63=R%G7[63MM+EVPY:HSUVTXSBUP<H=*DH^#TNKPT3C;!^"+D@4 C_/)
M"N#/%:2>><6V_9EF_.IY2R..R_F%QJ*13>,1&$G10TMV8YP]T0SDLJHUS2[M
MR5W6[GE>=$GT6;&]OV'?R)[BU<63&WE6X0TK2XY':J,I2U<'%7IN2TO4XQ5>
MLW'7V=BS+&/';ZP>-*YC7)SU/4I6.R<HQCIXJ3LQTO4J*4FUU5JV*5U6+S#[
MDON=*,-!4;LG:K?FPD;S#,*TVD,B"AC=M7!'[H0F1X,7'8R3@LPWSZ>.=O+G
MY!'<C)A=P[%A5[2WKU5Z.M*JI]#I)#CXT[67?ONG9W-%*=/5C1U_]#/(P3-
M    (Q=(?PYS!^D[$_Q=VB*I[S_=#E/X5X_L+/+=[JO<[F_X(9/L[;R3HM8J
M(
M
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MB4#:Z
M
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M31J52!&0M<I)1K[U._PVSYZ_HV'18\M:#?W!$4I<%I>I6P&%Z ]/VQ.GK/\
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M^$TG9&A[D;:@5*=4>%!6I2U1C9,<7MG.,[9UU R,
M
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MMD#)0
M
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MJCO/]T.4_A7C^PL\M[NJ]SN;_@AD^SMO).BUBH@
M
M
M          (Q\9?FMTG_ )E)?WVL%4]QOR2;#_08^JD6[W]_+%S![X2]3$DX
M+6*B.:_J<DK/UD7@??)1>=\\KO&<[9TUSMG.F>F_)G.<X\<YT_:_Y!=FP_(M
MNK__ +U_\4A><W^N6,O!V"^K=.E 4F30             (Q=(?PYS!^D[$_Q
M=VB*I[S_ '0Y3^%>/["SRW>ZKW.YO^"&3[.V\DZ+6*B
M
M
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M>\ACK(^;I-#,G:)=W9M3+]DVIVVA>3=2,J/+C;.NN=L8\?#'[  N(
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M7=HBJ>\_W0Y3^%>/["SRW>ZKW.YO^"&3[.V\DZ+6*B
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M[YTTTUSMG/AKC'R "L
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M0XLL@CDA.3N1Q+(O:6EY<FQO4NJ)<<@2;E 3G
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M?I.Q/\7=HBJ>\_W0Y3^%>/["SRW>ZKW.YO\ @AD^SMO).BUBH@
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MQE;I>UN.;!A\U2NRV"R*/KT!RAK/:Y^G8'#,?,W/TP_;(%6J#WC9.=KH!)\
M
M:MNL_5EH+D._HYSA,83:,TL)Z)J!^="8*77AA,9KNVIC+(!FRW%!*; C,A6Q
M6$3%D:FYQ]S1*%*]?)VY&SEN:[5<E1@;20
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M5N]?N32?2E.3DDZ<*T?$W.VXT\+;L?#N-.=FQ"#:Z&XQ46U7P.G S6,(S0
M C%TA_#G,'Z3L3_%W:(JGO/]T.4_A7C^PL\MWNJ]SN;_ ((9/L[;R3HM8J(
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M.P'64
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M-UUP3GSYUSG7Q FB
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MZZZZXQC&,8%(RE*<G*;;DW5M\6RQ(0A:@K=M*-N*HDE1)+H22X)'L'PY
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MG[KM[M;!S7"S#<;V+'(BK5Q7(]G.Y=MIN22H]5J?#Q4?A,S">$"
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MU4+#=D1+:X :SH:TV:HG7'QUCPKIENZ[*AOHQD<SKYVFN"42-@I2.SQ@*]1
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M:79,B=&M9H69C!J=222H(W\=#--=]<ZXL@K8]@
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MOZ)B/5S^A*<Z1E;IHM57S!'1YBTR2ON%GQ!(G3*3-F)&J*:3L:'H#=-0.J\
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MM8*I[C?DDV'^@Q]5(MWO[^6+F#WPEZF)Z>S/S/\ JW]&R\_Q7R@67N'\PO\
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M/>?[H<I_"O']A9Y;O=5[G<W_  0R?9VWDG1:Q40
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M+9JSHVVGUB2);E5((RNA=7+^]8ESLR7"V,4K;L*Y-\QL.ACJW95XS@@I&@3
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ML]<RD%"R-N0)WBBXTV-#-$4K*W)"D+>J*3Z;/[:F3NYF=S5^^^P'4>
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M8/TG8G^+NT15/>?[H<I_"O']A9Y;O=5[G<W_  0R?9VWDG1:Q40
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MWH7HO9/OSL]*&=?8-OM"I8@EA+LR')E;+KJ9G=MCYR% 9C4Q+OK@#J/
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M')5X>B41WK\C<Q<U;W@YNS65=Q[%K3-]I"%'VFKHE*+?#Q)FQ46:7N
M       $!:'ZKFUHVVAA;OI6RA ^-]F+'&&14B3%6722B R=,Q-S?;AKDX+6
MLY1*2CMO98T1M.=%&O@3A23X&YKKE[F_/W;>8X-Y8KMW(WW*U;4^WQ79N*$5
MD.3<6[E>%(VZ/TNN/$I3DSO)W?F/F>&TY2V^5B]#+E*Q95Y9>WO&O*W".:YR
ME!N\GPI;L4EZ57(]8GT+%+K
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MT_)XY+WTOIYJ3I4?1*B;K#-U9S;@O&T5-\Q.V<['9R .MT
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M;C.4XQ2G*E6DJNBHJOPT7!5Z$?<<CF
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M@::HUXSSCO\ =M9&^YM^S)3LSR[THR7%.+N2::?A37%$I1N34@
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MM&^)>
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MR%X:SN>)L[/;_P ](XJYNII*9=NHV)DA&^NY.NA9&NN .RT
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MSC ]6GFDD(                                      Y;.AL^FS*_4
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M1= CG,'W[;??*'\%>*=[VO=+DWX8XWL'<28XD9<0
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MY_Y!CWL3%R&I9%JW<DNC5%2IZ%4SOM9.3835BY."?3IDU7Z3/4,@Z
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M]RY-S@H]:G0G7P)$"Y0Y V_D_)NY.'?O797;:@U/31)-.O52X\"1XDY/0
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M49;,2*8RZ829ZG$[F3T0QM[0Q(G*73:2.#D:F0)$J!+NJR2F)*(T++U SD
M
M  #GOZ#3=36*_P!J<V3&E^FK-M=_[U@=S4'8:^J:BFO$$?YV8IC 2&%@E,NE
M#>X,,?@++3S:YYE[(N3:3=;+2UBIESN<K;3MP.A   !BB)T12T$GLOM.%U5
M(K9$_P#>/GI.&"*,S7)Y)[ZM*<W'XJ\(TA2U3\6=4Y:M;X[_ -^JR]#S_:&Z
MZ[X RN    "BK8W'7)W:7]Q8&5>_,&JS1B>UK6A5.[+HX:%EK]6ER/(,6-NJ
MXLK74[!.^F#<:XQMXXQ@ 5H
M     !#CT^?S+N=?]'J/]_N CG*/]6L/\"OJLIWYOWR,<N^]\?53)CB1EQ
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MTI]UW_F?!?X?_P 6_P#P[_VX F__ ,.5Z/?]F6P/US.YO]I0 0@4_5RN2?\
MO(V;W?F6P/\ N\OH02;XO_KF=(?GG?=YB?S<_P"?TI]V_P#J/^*_W+_[4_\
M>_W_ .Q $W_^'*]'O^S+8'ZYG<W^TH (07=]7*Y)^FUPM]QGF6P/H:_-_K#Z
M:_\ KF=(?P]\QZ^^BY_*KI3[J?\ +/X]_)/]Q_\ BW[A[N )O_\ #E>CW_9E
ML#]<SN;_ &E !"#KCZN5R5]TSB/Z*O,M@?<Y^E W_3+_ -<SI#\VS[GLW]__
M *QNE/CO\O?@W\E?\?\ _J_WO[< 3?\ ^'*]'O\ LRV!^N9W-_M* "$'>OU<
MKDK[F=4_0=YEL#[HWTH.>?NH?ZYG2'YMGW0F_P"[Y_6]TI\"_D%[?^#O\?\
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M[5A;<"5%ER6HFG<LCVQI97M=M?/OKKXYP!1>;[;^L4=+\\4+T=%'ST66&+=
M4O5UVQICD-9]RX?V5@M:#L4[9FE\PVW&N;L/#<W/Q9*GW<\XGVVFWDWWU\-L
M@9H^&_61_MR]$'\&G>/Y60!$F.=6_6$))VS9O#259Z-9%@U=S[7?1#O+E%9=
MM_,UPC%CS*4PIK9&W8NZ]WO+\A7Q0XU1@U(6G]B9IY#-MO-K@"6WPWZR/]N7
MH@_@T[Q_*R (E=S=6_6$.#N8I_U-8JST:YA$*]>JL9'./0JLNV]I(M46O;L#
MIUF-0X?;J:6O)+<^3],J5>T4:;>Z$F^3&YGETV EK\-^LC_;EZ(/X-.\?RL@
M!\-^LC_;EZ(/X-.\?RL@")7*75OUA#K9=U*@A:ST:XV9RCUK9_($RWE%9=MZ
MZ2.;U9'8%)'B31GX3=3CMM%7%+8"8M-E5A.K]H2;YR=,>3.P$M?AOUD?[<O1
M!_!IWC^5D 0OZ=[)^L$<M7!QQ34O/]'&0OO:-T.5)0-TC=9=L9:8J_MD84RD
MUVEV72[4"S5G,1ILEZ^YE*CO:YQXZ8U^4 30^&_61_MR]$'\&G>/Y60 ^&_6
M1_MR]$'\&G>/Y60!$KA3JWZPAWOR=3?75<+/1KAT*NIE>GMAC4VK+MO64M2=
MCEL@AZ@IWU8KJ=VG!QRZ.FFZ>Q4FZ^RWU\<XV\<8 EK\-^LC_;EZ(/X-.\?R
ML@")1_5OUA!/W:U\#;+/1KVL=UY*?^OR9EK67;?S(+A$?N*-TPIC)NV;JP_?
M.HY^DQ2HO&$>4GNA>_B=@SRZ9 EK\-^LC_;EZ(/X-.\?RL@"/O5U[_6(.2.:
MKSZ=FCOZ+\EB5#5C+;2D;!%ZS[AVD3PT0]I4.ZYO9<.URMS9ER5$)LZE>W/)
M*\^<>;?&/E &3JWDOUC>S*[@5CM,G]$U UV!"XM-VU"XUGW7AP1-\K8T+\C2
M+L)K>/3X6)DZ_70WV>^^GGUSY=LX\,@"]/AOUD?[<O1!_!IWC^5D 1*ICJWZ
MPA=G3O9O++ L]&MIE_%#U0[)/I"\5EVWB-RM1?U1(;BC9L0RBNI4Z;$LS&OU
M2KO?4Z7;"O&?98,+\-P!+7X;]9'^W+T0?P:=X_E9 &[X    $+N",J\<04%E
M!@O9=BLB\HL&X\2LJ\*7+W;!F/-IXEY.\OC\N/D_;$=Y/I^KF%JZ.R7U64]\
MW[Y&>7:]'Y/CZN9R&<DW_:T'Z5H.^+ L:8M4]D5LUB1T3(W9_="MWQEFLN9H
M[;K58*?=3JF71B-HGE<H*0*-,I&;=N(W3%D^Z$XT]C;_ ,O;5D<E7+.#CVF[
M>+KM.,5JK&.I-.E:OP^.O$]79^W8ES8VK%N.J-I2BTE6J5:UZ>)WB#RV5D86
MZ0LPNF>?+NMG=<0W&5S5$^F2-6IUT-+U<V"+N;BTDZ)]_D5J%;F02421C&=C
MS=]2]<9VVQC.9MV++-W"QAQ3E*[=A&B_922.VQ;=Z]"U%5<I)?39R.>E_)['
M;O4 YX-0R^5N;W9#].VBW7=U?W9W76*S)Z7LF5.)L]7+59I\E-3OT=2KDQRO
M8S9.M()R5G7'V&WHOO$VK:<7DZYV=BU"5EVU;<8I--S2X-+PINOD+#YBP\2Q
ML[T0A&4'%1HDGT_6J=:TPZ6I:"2U%!I-+E223.$XA59I42"(S9^3;V%89*5=
M$H48\1^..C*GD[BRK2W4U$8HT/1,F=G-5J2WZ;J=?.UK;LR_:=^W"MM6Y3JY
M174APE*C:>FJTITHY=55EP*JN[CAV;JLW)TN.Y&%%&3Z\^,8U2:U4>IJM5'K
MND>)!ZJ/4WAMAP_G%6NPQM,[M:U)-"K$8C&F<(F"$1J,,]OO#C(&^4.C20P+
M#DR>NDFQF-EINGD5&YQC/D^QWF5RQ>Q[V3%-RL6;*G%U@Y2<G;23BGJ7IWX/
M O&:/&YFLW[.-)I*]>O.$E2:C%15QMJ36E^D7A\+,V$>H?0*S1C3-J&T762R
MU3$<0B"MM>N:J;S5FGS!.Y)#I.P1_0[!^&-X;ZV=\'86;)%K4:1IAR3H\'$[
M;X7ZO9ZU.3M*U!2U2<UIBX2A&46_&G<CT54J]5RHS-_6# :BHJZ[DW'1%0>J
M2E&<HR2\34)=-'&G64:HJD+Z!N8_I9CHVPJ^@S<GE\&MFR"T,-DKK(9=4L,A
M4]9HC5[Q:JOW',8.^[JVKUBI 4F,1[MR]J6(B?BVB56M3<+VWX2VQYV/<N-P
MN6X=:*4;DI0<KBM\=7W)I)UKJ4HR>BL8OG9S\U[FL'(MVU&<+D^K)N5N,9J-
MMSX:?NJ;:I2CC**UTE)53'<M%956SC7:?J6:F7V60^72EKKN3O\ '=IY"Y0S
M0EZKQO41Y$[+]9XKEDA1H6=K6)D:J1F'9,:-5Q)9II?#\B9U+7WM3O1C*,7.
M*>B47)3=:+1IBW*2;4*=?2VD^7Y;P:W?OFBS*4924)-:HR47!:4WKU22C%I.
M=>IJ2;4>+T]0(^#V+54);EL5HA#,HW=+A)77J&M;,2+T$DJQUIA(ACL?:XN\
M,R-]1/C7:^RS5W0K7%KW]TR06=D\M065L,'88WL>]>FIWW;E:25B<&FKBNNL
MG)-IIVZ:6HRXU:I2N!G;[*SD6;$'"QVD;K;OPFG6V[22BHM)U5RNI.4>%$ZU
MI**&]85D[N<?@#K(M'"TE5C1ZEE[4Q1MY;T+U8CG1:'H10]QAO<E*]:57*JL
M#S7A.XGJ#2B22]DIANRPO8K.LO;5DPC+(A%K%[-W$VTVH*Z[-)-4Z_:=5JE?
MLJ:74V5G=<:<HX\Y)Y7:*VTDTG-VE>K&OV&CK)UIX*ZE0H'6W\I.-?TQX1^*
MBZ!".8/OVV^^4/X*\5CWM>Z7)OPQQO8.XDQQ(RX@
M
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M4,[ANGVR7DY/L69G3/E\?#Y !<   "AQN,1J&LC?&8A'F.*1MI+,):X_&VE
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MR;\,<;V#N),<2,N(
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M,WBY5['UQC*4G%3[+5I<I4K2K).C9G
M                           "Q'FTJQCFWED-C01BV]N:E\KS+X^U[>\D
MYS@Y/X+G C/MRLXSYM/^=KX?+@9MK;MPR/O%B]/A7JPD^'CX(Q[F9B6N%V[;
MCZ,HKZK,2._:''<>VTU?^L.:6/8PPTDO5WO:KFW;<TC.,'E:86RDG.QA.=L>
M?7'RZ^/RC9VN4^:K_&SMFX37[''O/I]"!@SW[8[7"YFXD?1O6U]61C1P]2K@
MIN]G[3JRG5OM,[XU^"28N1>7V?E\=C?@!+G[$O;S8\FV_EUW^7RYSX9'&?+&
M^V?YQCRM<:?=)0M\?$M<HU:\*7%>$TN1W@\CXE/.=VP(5=.-Z'2OHF.UWJ[>
MGLW^QSO?*]9@_&^=,LM+7](/)@OV?CE1\"JQQ]UQO[3'D]KY/:>&?+X^7;PP
M[FV*RZ9&;L]IUI]TW/;K?'PI:\J-:>&G1X2.Y'?9W2XE%D<P;;!MOINKP=)C
MIP]:OB!+Y/<'"X7SS:;[[_#Z<F"'V.=?#R%[_.-.P^?<WQSX>S\^,>'V6=?D
M\<2<]AM??]ZV2-73AF6KG\%VE%Z-*^"I'LCYR/<UCTKO6/.M?25ET>.B^D8\
M<_75Y?2:X^&TWT\^F;%F;?WI%JB;BBC-<?N19YC]=;29X';?^D26=Y<8SG.,
M9\,9PY;SR+:IV_,>UQ3\5O<;GH_>L"=/]JE?!T.D>R/G9]RV/3^79,VZ^EQK
MLNCQT7 VT5!9#9<=2U=;S(WN#2S6I74)LAH:G;W7XJV-DXC39)T#>Y^Y'JD?
MQ!&E=-"SO8FF%>TUSY=MM?#.=AGXCP,Z]@RE&<K-V=MR5:2T2<:JJ3HZ554G
M3I2/0^VYUK=-NQ]SL)JQD6(78I]*C<BII/RT?$R*,0S0        AQZ?/YEW
M.O\ H]1_O]P$<Y1_JUA_@5]5E._-^^1CEWWOCZJ9*Z11R/2]B=XM+&)FD\9D
M#>I:7V.R%L1/3$]-:TK8A8VNS2Y$*4#B@5D[YT,).+W+WUSG&V,X$FMW+EJ:
MN6I.-R+JFG1I^--<4RXXRE%J46U)>$Y8?72X>H#D7C*8=+\TLC_4=A(+#KUD
MU;&24N[U <MTH?,MSDG10:8G25ACQ&B?;'L"6HM F(SKCRE^'R"2Y/>GSELF
MWZK&1&ZXM)=K!3X/RK3)^BVRX>Z3'ES7S9:V'=KMUX,K%V75:4ZPC5=9QEPK
MTU3-J?'GIA<;PN"5#;3G6I]H6*[06!S'=_MQ_<YVVM\B<6%I?,NK+!5YI5;L
M[D@<SLFI%B=FT7)=L8R6=KG'B.6X<]\T;UC*WEY,HV9Q58VTH)U7&NGBUY&V
MBO\ ?=RSWN&1A.[+S>W?N027#A&32K2E>"XFV014CH           $..MOY2
M<:_ICPC\5%T".<P??MM]\H?P5XIWO:]TN3?ACC>P=Q)CB1EQ
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MY1R\RYN>Z;AN]VT[,L[=,[*5MR4G".5F7\B$')<&XQN)-KA5.A+0;DZ@
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MC*&1;P,>$XM4<91M04HM>!IIIKQDDAJC?        !#CT^?S+N=?]'J/]_N
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M'\%>*=[VO=+DWX8XWL'<28XD9<0
M
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MB+I"5]7&+&E\F<2L)Z<E,]LLZ;/$Q@.AFD&>W2R-YEFPW Z'>UVV:RC73<A
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M?*'\%>*=[VO=+DWX8XWL'<28XD9<0
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M>E12**R- 2Y,SNG2NB1 YI2UJ)1IO[-002>7X^7?37;&<8 R(
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M<(IHHQ[#"A,82ISCS:;%^&VQVW,N7I/&NQBI0@FFFW5='A73P(5S;L^/C/\
M+&+<G*&1D7-49I)QD^OP:;JJ2IQH^'E)EMO1% /#'*I.TWE3[I&H*H3I9M(6
M^RX6L8X>I5J=$25/*'9.]&(& Y4M,U)+U5F%9W-VQIKX[9\!));9N4+D+4\>
M^KMQ=1.W).5./55*OAQX%>1W/;9VYW89%AVK?IY*Y%J->"U.M%QX<?"55MNN
MFGJ%NMCL]MUD[5XQ&F$/<];9[%5T+9SB<I\&DNLH2NIK&WFE95E8VU./TSK[
M73Q_YV/'KG@YMN^L6Y9NQR9=$'"2D_0BU5_2.R&=A7;#RK=ZU+&CTS4XN*]&
M2=%],])]OU,E30Q:IM&NTZ.QCRDM>JSYM&B4T\4GXTR0GAAYCGJ5*#SL&:^7
M1#D_;;S8\,?*.*P\MN<5:N-V_3]674_UN'5^C0Y/+Q4H-W;:5STG676_U>/6
M^A4\,]O*E*J7(6NT+@JVMW)T2;+VUNGM@1.'KG%#H=LGW6H4DA=VY0K2:*-,
MZ9,+UVTQOC.OCXX\!RQ\'.RXN6+9NW8IT;A"4DGY:)T..1G86))1RKUJW)JJ
M4YQBVO)5HN")V-7L]]X^8L[ALT]S;F-X5_-.4,DC]U:),G4JXVZ*/@ZY9[!N
MD*5&<:A/V\"E996^Q6V^-=LXZ[N/D6/O]N<.+76BUQCPDN*Z5X5X/"=EK(Q[
M_P!XG"?!/JR3X2]*^#Z'X'X? 5J/R&/RQE;9)%7QGDL=>$VBUH?H^YHGEE=4
M9F<X+5MKHW'J4*Y-OG7/@849MIGP^3(X7+=RU-V[L7&Y%T::::?B:?%'.W<M
MW8*Y:DI6VJIIIIKR-<&5@<#F !#CK;^4G&OZ8\(_%1= CG,'W[;??*'\%>*=
M[VO=+DWX8XWL'<28XD9<0
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MTX4O.9K3]E%H2*M;-IABCI%DKRCR#%D5ZBJ1W<8Y*,F;;EZ)I,8MP7N>E(\
M*-#O4%UGG/?K*='\[MDV:;<ZRZ=Y1Y\HF")F18X6O".DKC]/GC6EGV)&QI/A
M(8KL7G&6%2!8[H,F)],J8@L*P;K\FP FMZ0SM$^<^A^IN (745P432OS7K3J
M_DN!77!U,(DFD+6QF*4KTJTLR'*I<@-8X]=$8:Y$9DDW_ID_,QY-=<8P )A^
MBE_X1_IR_H@4?_V):P!L_
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MZ'C$T2FH5:A1LWLJMDTW+*TW(QL!-'T4O_"/].7]$"C_ /L2U@#9^
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M/X*\4[WM>Z7)OPQQO8.XDQQ(RX@
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MO0E'Z>7?37. +D=Z4J-^<K0>7JN(>Z.MV0-EJ^W7!:QH5"NQZZCB>:)6&%3
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M]5!^"O-Y?:;^'FR!),
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M.5[!CTL<TCG'7FI.>VFW&*'-V4*5L;S]')Y:KK>R7@[)VQ:S3)/LRR/9[>T
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M(YS!]^VWWRA_!7BG>]KW2Y-^&.-[!W$F.)&7$
M
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M$ +;E<PBT&:B'R8/[7&VA5((E%$K@[JRD:93)Y]*V6"PF/IS#<XP>\2R9R-
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M>Z7)OPQQO8.XDQQ(RX@
M
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MO=+DWX8XWL'<28XD9<0
M
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MOE#^"O%.][7NER;\,<;V#N),<2,N(
M
M
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M)CB1EQ
M
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MX^4FX).78
M
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MYT/TG[+Q%@]U7RA;5\EO\X?\P_GGI)_S;_\ ;]IY3H3%O'Z"
M
M
2                    ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>49
<FILENAME>tm2227887d4-lc_6lnp4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2227887d4-lc_6lnp4c.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@!6 ,B P$1  (1 0,1 ?_$ /0  0 # 0 # 0$!
M       '" D&! 4* P(! 0$  @,! 0$!            !08!! <# @@)$
M!@(! 0,$"0\(!@8'" ," P0%!@<  0@)$1(3(105%M47=]<8F+@963$B5G:6
MMM8W5Y>W.%AX.4$C5%65M7D*,B24F:FY430E-3:(84*R,W4F27&!4F)#9(?'
M*,B)$0 " 0," @,%#A,&! 4$ P$  0(1 P02!2$&,1,'05$B%'5A,K/35'2T
MU!65%C87-W&!D5*2LM(C,U-SDS24-56U5@BAL=%"=AC!8G(D\$/55QF"@R4)
MHL*$9?_:  P# 0 "$0,1 #\ ^_C & , 8 P!@# & , 8 P!@# & , 8 P!@#
M & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# ,O.-
M7%VG[AA5CV#8Z6Q))+7;EGSJ;ECH.\;Q:R]-D5YL<@8C&FM$ULMC-K0V-;#&
M&)&@2)DR<DA.E3%E@!H(=:P"P?P$.,WV+V!^?_D+[Z> /@(<9OL7L#\__(7W
MT\ ? 0XS?8O8'Y_^0OOIX ^ AQF^Q>P/S_\ (7WT\ ? 0XS?8O8'Y_\ D+[Z
M> /@(<9OL7L#\_\ R%]]/ 'P$.,WV+V!^?\ Y"^^G@#X"'&;[%[ _/\ \A??
M3P!\!#C-]B]@?G_Y"^^G@#X"'&;[%[ _/_R%]]/ 'P$.,WV+V!^?_D+[Z> /
M@(<9OL7L#\__ "%]]/ 'P$.,WV+V!^?_ )"^^G@#X"'&;[%[ _/_ ,A??3P!
M\!#C-]B]@?G_ .0OOIX ^ AQF^Q>P/S_ /(7WT\ ? 0XS?8O8'Y_^0OOIX ^
M AQF^Q>P/S_\A??3P!\!#C-]B]@?G_Y"^^G@#X"'&;[%[ _/_P A??3P!\!#
MC-]B]@?G_P"0OOIX!SG#6*-< FO..OHZJD@XE#.6<<;HHUR292^;F1]L=^$_
M#F7.+6UNDU?) [I&M1)Y(X+_ #8*C1 52TXP(-",'O8%X\ 8 P!@# & , 8
MP!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
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M:RJ%JEUQ,5NT^2B(?:@G=<IIT0\(+!?I([(6AH3->W=*K5KTZ@:@EM,\_P!
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M7)]AE<'165$W*$21YC+)Q!XH5FM?-1UY 4ZHV\4TK]W1E".++V;M$(8=;+$
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M & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
M8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@
M# & , 8 P!@# & , 8 P!@# *QT_^/SES]NE2_H3AF<IY*^<7G/U]MW\+QCK
MO//S:\D>3]R_BV46<SJQR(8 P!@# & , 8 P!@# (7Y(_J[WW[B]I?>.^Y1N
MU#YM.8O(6?[%NE^[*?G1Y:\O[?[+LG9UM^+J _:5%O[C0Y.\L?%K;O6-CT*!
M <U_&G<O*&1Z-,[7)P@!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
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M#L+)OPI:EW:ITKT5[QH-E7(T]')I*P0R-R&82IV1,,7BC&[262/KD=I.W,K
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M@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# &
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M@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# &
M, A^M>0-(W&[3)AJNU(//GBOY ;%Y>W1>0('52S/1$8@\S.3C+3FB\\3EQ>R
MF!9M2G\9+HMU3Z\3OC[N 3!@# & , 8 P!@# & , 8!6.G_Q^<N?MUJ7]"<,
MSE/)7SB\Y^OMN_A>,==YZ^;7DCR?N7\5RC(OJ7]+.73282?DWQ79BG^3R<TI
MUMVD0+D;4HD[N6$A,JL*KCW Q(RDRY<E!XCVS*3DI#R87M:F. Y"/)=/UER%
MVA0V>W'9]Y;>WI^!<XMVZ]R2Z7#O4XQ^AT4[8>8%A16)F5>-7@_K?,^A_<8!
M&6+:W%]6Z,!UDWKQ46+W(_;S%#I[:_',+D\G:-,/7+HJ8\0E(Z.BD&A#"MVF
M-.-!]> W8=Z%G898O)_,C65*&%E2I75X$I4\U]/U2V7([%G_ 'ZYU$WWVTG]
M/H)&J7CQR6Y738:VLJ_LRVI)*EC<1(KGL!9+%<5 FT=I,%WF][3P3B%[1L"<
MT1FT:18[O'@!$!&A.%KP\U,[F3E/E3#=NS.Q#2GIM6=+DWWJ1Z*]^5%YI\7M
MSVC:K+C:=NJZ(PI5_4_O9]=7!/A-#.$]5*8JW.":867,UB9^MJSO1 &=5+WM
M(4<0TM;:A$I<%31"8@C4F)F=N&I/V3HT]08,Q6K5'&_G#F?F3,YGW)YV3X-I
M<+<$ZJ$>]YK?3)]U^8D<ZW+<;VY9+OW>"Z$NXE_XZ2P[?1%'M(4X6JFJI; I
M MX$H6^NX@B"F"TRA%-VH*?29G+T2%LFC<G=T^@]G@NA!:H'8> )FH>>?G3;
ME.]=<G6M9R=:Q<'7CW8-Q??BW'HX$+# P;:486;48JE*0BJ4DIJG#N22DN])
M)]/$]U*:KK"<@?2IK7$#F!<H;V%HDQ<IA\>D )$U19Q<7>,-CZ!V;E87=OCC
ML\*U2 E1XA:-0J.,*" 9HQ"\[65DV-/4W+D-#;CIDU1R24FJ/@Y))-KI22?0
M?=W%QKVKKK<)ZDD]44ZJ+;BG5<5%MM)]#;:Z3URFE*:611;!%E25DJ@[DTL+
M XPU3 HJ?%'!BBJXUTB[*MCQK4)H5-,;<SS%"!,82(E&>,1A(0#WO>?<<W-A
M>61&]=5]2;4E.6I.2I)IUK5K@W6K72?,L+#G:>/*S:=AI)Q<8Z6HNL4U2E$^
M*5*)]!Y$0I^I*^BSQ!H%5U=0B%2$]P5/\/B$)C,:BSXI=FY,T.JAXC[,V(FE
MS/<VE$2E4#.)&(Y.4 L>]@"$.L7\W,RKJOY-V[<OQ22E*4I223JJ-MM4;;5.
MANHL86'C6G8QK5JW8DVW&,8QBZJCJDDG5))UZ4J'/CXY<>S(BBK\RB*:,@;:
M]"DC="1U?"!1%!(AD"2C?T4;$Q[9DKT)*/9>U19(3]E[V'O=GDS[6X[@KKOJ
M_>Z]QHY:Y:FNFE:UI7C3H/A[?@.TK#L6>H4JJ.B.E/OTI2OF]))K1'F"/^D_
M0+&SLGIIU4OKSZ(;$3;Z6?%A2<A6\N?F1!/G[JJ)2% ,4&]\X82@:$+>@Z[-
M:=RY<IUDI2TJBJVZ)="5>A+O=!LPMV[=>KBHZG5T256^ENG2_-/Y9(W'8R2O
M3QMA98^0ZO+M(W0AD:T+42Y2%_6FN3Z_+RT!"<"QY>G$\:A6J,T(]2<,0S!"
M%O>\7+MRZT[LI2:BHJK;HDJ)*O0DN"70ET"%NW:35N,8IR;=$E5MU;=.ZWQ;
MZ6^+(QY(_J[WW[B]I?>.^Y0^U#YM.8O(6?[%NG0>RGYT>6O+^W^R[)V=;?BZ
M@/VE1;^XT.3O+'Q:V[UC8]"@0'-?QIW+RAD>C3.UR<( 8 P!@# & , 8 P!@
M# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
M 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P#
M&'IJ]$/C1TQ+MY 7M3DSL"5RV^%#JW+"I:WP%&D986ZB@+[MAT&-1)HT!P2S
M^,NSH ;*&/LHD[]I&8TC"V-IQ &SV , 8 P!@# & , 8 P!@%8Z?_'YRY^W6
MI?T)PS.4\E?.+SGZ^V[^%XQUWGKYM>2/)^Y?Q7*+.9U8Y$?.'_F<P %PCH;8
M@!%O7,RM]:V(.M[UH5675WM:[=;[-;[-=N=F[#^/,^7Y-N>BV2H<YMK;K5/5
M$?M9GT=A"$.M!#K00AUK00AUK6M:UY-:UK7DUK6LXR6\_P!P!@# & , 8 P!
M@$+\D?U=[[]Q>TOO'?<HW:A\VG,7D+/]BW2_=E/SH\M>7]O]EV3LZV_%U ?M
M*BW]QH<G>6/BUMWK&QZ% @.:_C3N7E#(]&F=KDX0 P!@# & , 8 P!@$=,KE
M.GUK1NZ<Z)I2%Y6U!*<Y \''$E"&/0 &F@<R@&&:"'R[T$.M[_DSB_+&]]K'
M-FPXW,>'<Y=L8F9!W(6YV,R<X1<FHJ4XY,8RDDN+48IOH2+AN6'RMM>=<V^]
M'<)W;4M+DIV4FZ*K2=MM+O)MGM/"L#^FP[^S'OV7R>ZCMA]5<M?JN;[;-'7R
ME^+W'\Y9]*'A6!_38=_9CW[+XZCMA]5<M?JN;[;&OE+\7N/YRSZ4/"L#^FP[
M^S'OV7QU';#ZJY:_5<WVV-?*7XO<?SEGTH>%8']-AW]F/?LOCJ.V'U5RU^JY
MOML:^4OQ>X_G+/I0\*P/Z;#O[,>_9?'4=L/JKEK]5S?;8U\I?B]Q_.6?2AX5
M@?TV'?V8]^R^.H[8?57+7ZKF^VQKY2_%[C^<L^E#PK _IL._LQ[]E\=1VP^J
MN6OU7-]MC7RE^+W'\Y9]*'A6!_38=_9CW[+XZCMA]5<M?JN;[;&OE+\7N/YR
MSZ4/"L#^FP[^S'OV7QU';#ZJY:_5<WVV-?*7XO<?SEGTH\V+NJ]U0*QN8$8%
MR!X=VD\2 )P$IVVU::F >46H,-.+T8 &M[#L0NS?;Y<D^0M_W?F#:<BYOL,:
M.ZXFY9>)-XZFK4_%K\K2G"-R4IQU12;BY2HZT=."UM\P<3 RK<<%W'BW<>U=
MCKHY+K(*3BW%).C;XI+AW#I,NY## & , 8 P!@# & , 8 P!@# & , 8 P!@
M# & , 8 P!@# & , C*SY5(XTCBB6*$L@WN731LB:91(2UY[4@ L;GAT/6GI
M6U0C5JA!*:-E@ $TO7>,T+>]Z#W=Z.=?O6(VXXZCUMRZH+56BJFZT5&^COE9
MYFW3<=MLXEK:E8>;EYL+$7=4G"&J%R;DXP<92X6Z)*2XNM>%'ZCS;D%_75-_
M<Q-OPMSST[O]=C?8S^[-3JNT#\?L_P"9R?; \VY!?UU3?W,3;\+<:=W^NQOL
M9_=CJNT#\?L_YG)]L#S;D%_75-_<Q-OPMQIW?Z[&^QG]V.J[0/Q^S_F<GVP/
M-N07]=4W]S$V_"W&G=_KL;[&?W8ZKM _'[/^9R?; \VY!?UU3?W,3;\+<:=W
M^NQOL9_=CJNT#\?L_P"9R?; \VY!?UU3?W,3;\+<:=W^NQOL9_=CJNT#\?L_
MYG)]L#S;D%_75-_<Q-OPMQIW?Z[&^QG]V.J[0/Q^S_F<GVP/-N07]=4W]S$V
M_"W&G=_KL;[&?W8ZKM _'[/^9R?; \VY!?UU3?W,3;\+<:=W^NQOL9_=CJNT
M#\?L_P"9R?;!RD\D=]0*#3.=*UE0NB2%Q212Q4VIF"9I%#BGCC0L>#D)"LV3
MJ"TQRLM'LL)@BS @$+6]A%K79OPR[V[8F+=RI/'E&U;E-K3-5TINE=7"M"*W
M[<>?-@V/-WV[/:+MK"Q+U^4%:R(N:LVY7'%2=]J+DHT3::3=:/H+'Y,G1A@#
M & , 8 P#YAN#_2TZ>_,>Q>IO;?)_BC5ET62FZK7,&($3"9('-2[E1EF509:
MULP3$;HC*\S1*W=28#7<[=".%Y< OU\P/T;?H]J _LA]]GL ?,#]&WZ/:@/[
M(??9[ 'S _1M^CVH#^R'WV>P!\P/T;?H]J _LA]]GL ?,#]&WZ/:@/[(??9[
M 'S _1M^CVH#^R'WV>P!\P/T;?H]J _LA]]GL ?,#]&WZ/:@/[(??9[ 'S _
M1M^CVH#^R'WV>P!\P/T;?H]J _LA]]GL ?,#]&WZ/:@/[(??9[ 'S _1M^CV
MH#^R'WV>P!\P/T;?H]J _LA]]GL ?,#]&WZ/:@/[(??9[ 'S _1M^CVH#^R'
MWV>P!\P/T;?H]J _LA]]GL ?,#]&WZ/:@/[(??9[ .3Z8/'&CN*/+WJITGQT
MK6-U)5,<LOB:X,<&B9*A.R-JV1<8(T^/:A,4J4JC@F.3LN-/,[1[[1F;[.S7
MDP#:O & 5CI_\?G+G[=:E_0G#,Y3R5\XO.?K[;OX7C'7>>OFUY(\G[E_%<HL
MYG5CD1\XO^9Q_4CH?]\RMOT675G9^P_XSY?DVYZ+9*?SI^SK7KB/VLS93FB&
M2"XYS+4<!)S4X9#5)D^(A07@4N54F5;T#,Y )(V&._\ S")Y5T<&0E)]-^]+
MO$'KS?83NYO7,-AZKW4M];HKIN:-5-/6]7/J7+5X-%=T5U<._P "8W_K?<JY
MU6NFJWKT5U=5UL.NTZ?"KU6NE./>XF2W(6,<!1,D=C%%UK%0T"9R2X;/-]GP
MN-H_@;KFH,_F!#FD5,R$>ZV56,E9BAFS$]&W[/\ 1PFX+PH$8%*6"Y[;=YD5
MR5[<+L_=+Q7)5G5+_N4]$:.K\/0W^"3E35JT*E64K=+7+;A"UM]J'N;XUBN]
MIC_VS6N551>!KI^%:C73IUNM$<I9,.C"YUD4+J BK(/P&6<B::50I=<D+>9'
MPQ;9@TT%>R^Y2W:OMNT+;'^G9)(G*'%M12=Y98N39:0:T!QC@2<D7^=B]>BE
M?S7>GS"L>YJZN2CDN+NVE;I.DFKD4KFJL97'8:C11:E#WO6;$F[&"K5OEYY%
MO3UD7+&4E:NNY6%8)VVW;TTE&"OIRJY)QE8J2I[=?N /3X3L9$B:[3;>0O$Q
M 2XW&@E$Y5@61J>&-!$QFR-.* RMVC#PF0%N983AM:S3:I)"<,LS0A9&VWAV
M]_W!S<'BO'R'2VXQ7A0KICY^*:KIX:E5.A*367<V';]"FLE9&/QN*4GX,J:I
M>=DTZ5XZ71JIS<P=^2-<73;4FEQ\#DUD(K%&]-,IKZJ7ELC"#<=Z;G*%ZC*R
M/M$YD=E.#>[)Y.UHT:I24X;"KTH$CV#1:DPDS[LPVW)P[-JWKCC]31J4UJ=<
MVRFFXJ":TMM)KA35W$UYWI[CCYEZY/1*_P!=5.,'14PKS32DYT>I)-I\:Z>[
M1RPYV[R-@LH9*^L"_)@A@3NX\>9%87(4ZM:H;W>K6:R*@Y'/LD8VSNUDIKAE
MB;A;-1QIJ3+W]H=EC<7)-I#51JA0C5$ZD<3;K]J5_'L0>1%7HPM:YM7'"Y94
M7Y_6Y=7<N2:A**?5ZDJ*2>U++W&Q=C8OWYK'D[3G=<()P4[=YR2\#0H]9;A&
MLXR:ZRC=7%JK4*YL<SY.QUN[$6/%MKE<:A:Z'DRF,HXD'D6\./)BV8%-R"*Z
M8Z.GD[D*IIKR*-*?;3$W%B<8N:H]*NVU:,[6@2=_9MFM3N1=JXXJ<]6EZNI2
MLVY0\-W802<Y2\*<9JY31"DEQC;&\;Q=A;DKL%)QAIU+3US=ZY&?@*U.3:A&
M*TPE%VZZYUBU3Z(<Y^7X8!"_)']7>^_<7M+[QWW*-VH?-IS%Y"S_ &+=+]V4
M_.CRUY?V_P!EV3LZV_%U ?M*BW]QH<G>6/BUMWK&QZ% @.:_C3N7E#(]&F=K
MDX0 P!@# & , 8 P!@''5]_X+CO_ ,.!_P"V9G->Q[YL=E]9K[:18N;?C)F?
MEG_<CV<IE$=@\8D<TF#TVQJ)1!A=Y1*)&\JBD+0P1V/MZAV>WIU7'B 0C;6I
ML2&GGFCWH!918A;WV:SI173-RI.I1([E7P.317I^<Z0<=+;7(DE4\DET-ITJ
M.2MN>>P46G#Q4(+I'R,KJL9DG$6H;WV11%M3EHE)"M>!"F&8<4!%WSP#M[=O
MP<OFNNIG[=?M5^W9ZA^@>#7I#VK?6WU$];O2'PZ_0GF?K9_J7@^=>==_Z[PO
M#^OP";1]4WC:S5AS<LFPVFSJF7< ),=%[\JZPF2))+2&I=F%J?JG<(&QQV<2
M1DEK3R$ ^)4<%,TY$#>W(WS00$YX#   \.T.I*&(3./U15W#GECR*O NA8=R
M3N*F*N;Z.;9CQQK6<#7IX\RVXZ6-=T)@@KB?'%B=4K9#H^\/KNZF,RPU-H:0
M!*D\#UKIU5J<DD%XK/\ QFJRX^7-A<RJ[DELTO2U0)ZXC\U15O!268NQ)G;+
MY;]B5O7=2,<#D;^DCRT3N\EG'R8\+8C*4GA-\,#N(-U+^/\ -N-&^26X[=#
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M^I=T]ES+%S)^&Q/)V-Z$CL<Z45T8 P!@# & , 8 P!@# & , 8 P!@# & ,
M8 P!@# & , 8 P!@$-VW_P!Y4U[LC']ZDTR-W#S^-ZYC]I,IW-GZ3LWEBWZ!
MDDR9)%Q,5^HW+8]1//\ Z3'*BWUJ6+\;Z]?N8=*6!:+^(*2"5'9_)"L:Z9:1
MF$[?E ?1<-97U9!WN+%O"TQ,D3*9&62:>66H%W@-/*YY)\>[@F4MKZI;MJNT
M)K 6>//\XC=>3N-S1RA[3+#7,F,*Y.5&W%R"Q^L F94)&6IV4:H+(&, =@UW
ML R Z6-[U?QAZ*JGD#=#NG9*NJ:Q^HS,9BK/ 2<-2VMO/WE/X;*W(SQ@"Z/D
MC7&%-S>BUO9BY<J)3@UL9@=; IKT7JOE? 'E2;57**M6^LY=U)*3,O7A\08Z
MOST3Q[A\"F]AV7,^F"W+).ZN"EF64#%+922M,F;R$;>XC4O/:(T3:1H %G85
MS!XP]2GG/3DYWR.H)BXO\,[>DI/&>#O=T5JDLGF%S.=VM_I1%:[!72N1BDI5
M0U.T2YZ:8(/S8IQF,A>37)* 3:F;C7 #HN<_*;C'&.K+TH"9+R-H>/'5.LY_
M-UIE/EO5\TFUHX2'CQ&$# AL M?(4XH:L?%VMD(RG'28:D[7<+T(7DP#U?+@
MF$\4+PYG\P*DZJ-&<806]"ZOE?*6CIW5U9<A9LX2ZM:A:876$@I1G-M^!RB*
M6)/ZP3,J%N:%[)+T;ZHVC.3-YNS]%F@7MZ0=*3SCKTPN#%-V@VKF.PX9QRKL
MN91UT3#1NL6?WQJ#)7").R4PTX1#M$SGG;:J#WNS1Z4?9K6NS6@+=<B?U?KU
M]QRSOO)>\CMX_9&5ZVN_:2*=VB?-_OOD;-]C728\D2XC & , 8 P!@&*+-U+
M^;%KV+R.C7&7I=K+QK_CKR/M'C0YV6LYHTS5GK),:K5-Q3TM2PV9Q,+TW(U"
M9X2G [3#R]>+L.C1[ +L [#X9?5A^A@_XBO&W\%\ ?#+ZL/T,'_$5XV_@O@#
MX9?5A^A@_P"(KQM_!? 'PR^K#]#!_P 17C;^"^ /AE]6'Z&#_B*\;?P7P#U[
MMRUZIC^U.;$^]$UO>F1Z;UK2\LSMU">,CBU.S4XIC$;@V.;>LB1R1>WKTAPR
MCB30#+-+'L(M;#O>L &<M>J8<J4+CNB:WFKE;>%I5+#.H3QD&J4M03#S@MBA
M0*);..;PG*3!Z)%O9>A&"WV=HM]H'CD<J>J$F5-*Y-T1&=.N86=;'F)81U N
M,!2IE8'$QG.<&-I4%Q )S<SKSHZWC.3$[ 2:)"GV(.]DE]T#W'PR^K#]#!_Q
M%>-OX+X ^&7U8?H8/^(KQM_!? 'PR^K#]#!_Q%>-OX+X ^&7U8?H8/\ B*\;
M?P7P!\,OJP_0P?\ $5XV_@O@#X9?5A^A@_XBO&W\%\ X.7=3;G'3$KH%-R3Z
M5RRFZWO/DY0'&+5D(N;-*66*)R;D%9+)7$>>5$-B$1,?'A&V+'C:@THL1.A@
M*V#9I?>T+0&W6 , S XC?Q#^K;]O_#3Y)<0P#3_ & 5CI_\ 'YRY^W6I?T)P
MS.4\E?.+SGZ^V[^%XQUWGKYM>2/)^Y?Q7*+.9U8Y$8G/W%.FN8[A;+YR4036
MU/1/)*Y6EBC[U:UH(X3'4=<3J30.';CT$9I>VPYE7-,91[(TJ3HBU1HCSQF&
M"&<9L74-MS\G9K%E[8U9G+&MZI1C%3EKC&<E*5-33EQHW3@N'!'"MPQ([ON&
M7<W"YD3TYMZ,4KUZ,(QMW)0@HPC.,52*Z4JMU;;;9+5"3UBXU3[F"QR.8V2[
M5%6,4XURF.,LJF$]M^2I99:BZS(PI8HDJF+S)Y8O<9U(69F1(FT"G9(W T&B
MPE[-'O<+O6"\]8?BUNW'*NNZFTHVXZ8*$JRHDDHQ<FWWEYA8^3\][=>W*UDW
MK\\&Q#&E%3G.[)2NN[%J#FY3;G*,$HUIJZ*59/\ )N;C#"?^RII0W(2+3Y7+
M*MA\?K=S9:L->Y:ON-Z>X["%4<F37;3C3:E*<]1Y40N*.E"=<U["6-6G)+/3
MC-B+6P7+_AV,G&GC*%R4IIW*15I*4U*+MJ[T235+;4N.EMITN=WF"U8\#(Q\
MF&2YVXJ#5NLG=;C#3)7':Z8M/[XG'AJ235?9:YI0?O"C@ZWMLFX064TU0902
MEM@2:SPRM]KB4V^S&Z7GV&751L:<ZTA#PZ$.Y<F&VF^C5",!VW$H:/7B]EO+
M[YUMEX?5.YUJ<]&E3C;?#1UFI3E&+CHU>$I4TO4>ZWJR_O?57EF=:K?5-0UZ
MG"5Q<=?5T<(RDI:]+HXUU+2=DJY/15;QZCW)BO(78%MUS(8L"=%DPLB%,LD;
M(4%A<G]PDCFUVG-ZW2Z3-!+;L@]*G4J'(2@T&B4QH-&& \H[5=6Y2VO)N6[.
M3&>CP]3BYU45%.W&?37@VE&G2UP/66Z6GMT=TQ[=R]C2AK\'2I*-')R:N2AT
M4HTFY5Z$^)'\9YQU\[VA0-/2BN[9K&<\F(Y.9=4J&:HZY<$+O&H'&666+75S
M=:YLJ?(&/3RU/ O,$ZD9:L9R0X!Q1&]I_'][NQ9$,3(S;5VS=Q\:4(W''6FI
M3;BDE.$&Z-<6N'%4;XTU[6^V)Y>/A7;5ZUD9,92@I:&G&"4FVX3FE5/@GQX.
MJ7"LO4;R+K;D.9<>JU4NRY-1UVRV@)@O<6X*!$LGT(98L\R/<<-\Y/,=&%'Z
MV$I0JQ )T<I(.\,(BM%FF:>=MN3MRL/)TIW[$;L4G5J$G)1U=YO36G'@UW>"
MW,'<<;<7>6-J:L7Y6I-JB<XJ+EI[Z6JE>'%/N<7.V:!OC & 0OR1_5WOOW%[
M2^\=]RC=J'S:<Q>0L_V+=+]V4_.CRUY?V_V79.SK;\74!^TJ+?W&AR=Y8^+6
MW>L;'H4" YK^-.Y>4,CT:9VN3A # & , 8 P!@# & <=7W_@N.__  X'_MF9
MS7L>^;'9?6:^VD6+FWXR9GY9_P!R.QSI172(6/C[0L8L%RMN-4C4,>M5Y$J&
M\6:QUK#&FP78:X!A2X3E,T#*GD:X2PLX83=FJ1[,"/>A=NM[P"1O5Y@]/^M?
MH-G]:?0_J]ZR^C$7I_T!Y[Z2]!^F? ](^A_2/^L>;>)X/C?7]WO>7 /#00V(
M-3.Z1YKBL;;6![4/*MZ8T#&V(V=W52,T]1(5+HV)TI:)P4/QZHT:T9H!B5#,
M%LW8MBWO8'"R_C[0MA-L,9I]2-0SAGK@2$5>-,OK6&25M@0FQ.G2-HH8A>F5
M:EBXF]*D*+(VA 1X190 @[-!UK0'O+&J2J;AC089;=95[:4/ J2K@Q2QH7&Y
MO&@K47;YDL"Q29M<VO2I)V[\(S17?+[?K=ZP#]GVK*QE$5;8)):X@<BA#-YA
MZ'AK[$(^[Q5J]%IS$;9Z-CS@W*&A#Z.2&B*(\(D'@EBV$'8'>]8!^<%J:JZO
M]*>UG6E?UWZ<\Q]-^HL-CD1],>C///1OI3T VM_I#T?Z04>!XW?\+QS.[V=\
M7:!(& <=#/\ JT@^W&4_WL?G->S+]"WC_4NZ>RYEBYD_#8GD[&]"1V.=**Z,
M 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P"&[;_P"\J:]V
M1C^]2:9&[AY_&]<Q^TF4[FS])V;RQ;] R29,DBXGI9%&X[+V-SC,M86641MZ
M2C0O,>D36A>V-V1&;ULQ&YM+F0I0+TH]AUVEFEC!OL\NL Y6M*AJ:EV$R*T[
M5]=U/&#5AKB;&ZTA4:@C":X']FCUQC/%FQJ;QK#M:UWS=E[&+L\N\ ]D.NJ^
M,BPH,9!(:.%#7"<QP\<89!18;D*0;E@G 4?$AVTB7"E6_2>S=D^)MP_UCM\;
MZ_ /<.<;CKTN8W1Y8&5V<XPN.<XTXN;6A7KH\Y*$9[<H<&-6J(-4-*X]O5&D
M#-3B+,$28(&]["+>M@16V<9N-[(\-\A9N/U(M#^T.21Y:7QLJF!H'AL>$"HM
M<A=6]R2,)2U$Y(EI0#BCRQA-+-#H81:%K6\ _:0<;^.\L>7&1RFA:7DLA=U&
MU;L_2"K8.\O+HJ$$(1*7%T<6)2N6J!!!K6QF#$+>M:\N >8YT!0[U/V.UWFD
MZC=K2C):,J-V4YUO#5\_CY3>6$E 4QS%4S&R)I+0D@T D)"DO10=:T'LUK )
M<P"'.1/ZOUZ^XY9WWDO>1V\?LC*];7?M)%.[1/F_WWR-F^QKI,>2)<1@# &
M, 8 P#('I$?_ %/O\7[FI_\ UK@&OV , 8 P!@# & , 8 P!@# & , R ZR'
MXNN _P#B_P#3!^5-#< U_P  8!F!Q&_B']6W[?\ AI\DN(8!I_@# *QT_P#C
M\Y<_;K4OZ$X9G*>2OG%YS]?;=_"\8Z[SU\VO)'D_<OXKE%G,ZL<B,DZLN6H(
M,X7C&)M:M;PZ2(>3O(Q2MC\JG,8CSTE3.]LR9Y:E![6[NB-:40Y-+@0I('L&
M@FD' &'>PBUO.DPQ[]W%QYVH3E!XUKBHMKA"*?%+N-49PJYG86/N&;9R+UJW
M=6?D5C*<8OC=DUP;3XIIKOIU.:K^+,G)ZV>:Z"LK!BRH29JX'2R%3UG.1SB'
MMUIT;8MAW1#DSR!C=2"7EL02R,- G9 2L3J1H% @!,*$8 >M;=,E[9'"N7X2
M<:949Q\[)V[L(VIT;3HW&4M+HU5=#H2_*EF&[Y>ZQQ+L'18,H35)Q5RS.[=C
M6CXI2C'4DTZ/I528;<I+G)=3)&7Z2/G&R/RBNKFHVSX%4K*\6"Y5X,ZJ9,YR
M&2/,JMM;7J&<+'>:%JTR5*W)8XG0LY*00AG+C5'B$Q6%N'+^!<G;M1RI6;MB
M[;G<:@I_?(J,5&VIN"4:-N3FW)OHBE1W/-V_F#/A"Y>EBQNVK]JY"VG-P^]R
M<I.5QP4VY5245!**73)OAQ-@\&;9L]\=KNLMLX\6G:DJG5:/$PX^2T^8%\9'
MZ!5+7]J0R!1-RD*Z'RN2/<CC4GM]UE1;LNBYZ(U<!*E"UD#2D.0/JQOF)BQ6
M%B2R;.)"$U&]'3UZG<G;E.2BI1BE*-N-O2KB=*O6U)P:_LF7E2>;EQQKN7.<
M'*S+5U#A;C.,(N3C)MQE<E<U.VU6BT)I35N*]X^RJ%<.2.-CI."I=*D]/2JN
M"Y>X@="FT"I^:'IO:4I(5RQ[?-1N*D.9*!)L\Y2LVWHR]F"&;L7;$7]QM7MZ
M]TXV]%KKXSTJE>#3?>594;=$E5]XE;&WW;.S>YDKFN[U,H:G6G%-+I;=(U25
M6W1=\K7>'!VU+ <J:E\!L&'1*P:&XQ;K^O'YR(?529+=\;MCCA:</=EQ"%*2
MH.K1^+I%>Q2  1A6G,[V:4 @W1A@=26#OF)CV[UC(MSGCW\K7-*GX*5N];DE
M7_.NL4X=Q2BFWP([.V3*R+EJ_CW(0R+&+H@W7\+&Y:N1;I_D?5N$Z<7&327$
MLIQ1XUAXR-=KQE&YH72/R^P(-)HT>26:6[";XKQDX]4BYKY7WDY))TJDDKJ%
MR=U9Q0S]'^D0FF&;/&;H,9NNY>Z<K-QIJY"W*,N]65^]=2C_ ,JC<45T4I3H
MH26U[=[FQNVTT[<[D91[](V;5IN7_,Y6W)TZ:]^I:[(HE1@# (7Y(_J[WW[B
M]I?>.^Y1NU#YM.8O(6?[%NE^[*?G1Y:\O[?[+LG9UM^+J _:5%O[C0Y.\L?%
MK;O6-CT*! <U_&G<O*&1Z-,[7)P@!@# & , 8 P!@# .,#7\4!KNE(%9(.\(
M6BD[V^IR0=\6QBT602YEE% [PM]@0AUK7\FLYG#L?[/[2T6,3(M6JMJ-O-S[
M<%5MM1A#)C"*JW2,8I+N)%C?-F_2=9W;<I47&5FQ)NG#BW;;;\UML_KU"C']
M%<?NAD7LKGU\D?(GJ?,]\-Q]MF/A7O?XRS^8Q_2AZA1C^BN/W0R+V5Q\D?(G
MJ?,]\-Q]MCX5[W^,L_F,?TH>H48_HKC]T,B]E<?)'R)ZGS/?#<?;8^%>]_C+
M/YC']*'J%&/Z*X_=#(O97'R1\B>I\SWPW'VV/A7O?XRS^8Q_2AZA1C^BN/W0
MR+V5Q\D?(GJ?,]\-Q]MCX5[W^,L_F,?TH>H48_HKC]T,B]E<?)'R)ZGS/?#<
M?;8^%>]_C+/YC']*'J%&/Z*X_=#(O97'R1\B>I\SWPW'VV/A7O?XRS^8Q_2A
MZA1C^BN/W0R+V5Q\D?(GJ?,]\-Q]MCX5[W^,L_F,?TH>H48_HKC]T,B]E<?)
M'R)ZGS/?#<?;8^%>]_C+/YC']*/?M30W,B/2!L3^;)=''J-@V:<>,9ZDT9Z@
MXT]28<><:::/>]B$+>__ +LM_+_+FS<K;:MIV&SU&"KERYIU3FY7+LW.Y.4[
MDIW)RG.3;E*3?<K1)$3G[AF;GD>-9T]=_3&-:**48I1BE&*44DE1))'LLFS3
M& , 8 P!@# & , 8 P!@# & 9_<J*PY\3/D7P]E?%^_(#6''B!V:D>>6%=R>
M/I7.1VG! %KBUK1&'0R)O!B 1[.>>CV2-46$:U2D5E"2&H-'C SN;^+O7W)I
M[T =SVHS5M?"K?)R.7*8DT+VPWCHK7A-;J_+2!I5(%,^)UNAK"U.RC&XE$/2
M#;2,O0?# T!X<59U 8'>_-F2\NK[@MKTC85RIG[B!"HLUIDCS5]8%,*!$-ID
MRLJ%QGNG#3ID:;S,HY06%Q1+W 9J@QT[Q0&B. , 8 P!@# & , 8 P!@',2V
M&1N<MA31*&WTDA3KDSFE"!8O;E*1Q2:-"G6(U[6J1+TB@LL\8>\6:'>P#$'?
M:$6];\,C&LY4.KOQU1337%IIKNIIIKZ3(S=MFVW?,98FZ6^LL1N*<?"E!QG&
MM)1E"49Q:3:JI+@VNALX+V@ZO_JJ0_G"L3\*\U/<G!^MG^<N?=D#\ N6/Q61
M^MY?IX]H.K_ZJD/YPK$_"O'N3@_6S_.7/NQ\ N6/Q61^MY?IX]H.K_ZJD/YP
MK$_"O'N3@_6S_.7/NQ\ N6/Q61^MY?IX]H.K_P"JI#^<*Q/PKQ[DX/UL_P Y
M<^['P"Y8_%9'ZWE^GCV@ZO\ ZJD/YPK$_"O'N3@_6S_.7/NQ\ N6/Q61^MY?
MIX]H.K_ZJD/YPK$_"O'N3@_6S_.7/NQ\ N6/Q61^MY?IX]H.K_ZJD/YPK$_"
MO'N3@_6S_.7/NQ\ N6/Q61^MY?IX]H.K_P"JI#^<*Q/PKQ[DX/UL_P Y<^['
MP"Y8_%9'ZWE^GCV@ZO\ ZJD/YPK$_"O'N3@_6S_.7/NQ\ N6/Q61^MY?IY^*
MCCU4RQ.>C6L#NN1*B34RM$NG$]6HEB4\ BE"58C52<U,K2J"A; 848 19@-[
M"+6];WK,2V?;Y)QE"3BU1ISN--=YIRHUYA\7.S[E2];E9OX]ZY9G%QE&63E2
MC*+5'&497G&46N#BTTUP::)JR3+H, 8 P!@# & 4HX6<67_BY\+/T_*F>4_"
M*YKWORF9?0Z-:C]7&"W/57T=%73SW>_.GAH]7Q^.<5_,C\0/=^IO +KX P!@
M# *"<E>;$QX_\D..%!L7$J_[K8KZ6*$S]=-:QAW=JYIHM.:N*".=+$3 Y".4
M* H_&\)*,>TB30U*T21/HDP\"A#%UJKD>XEQ\E!G2?YSL9UW<M[#XS/<>?(+
M+4KY5<9A (X8ENB4)4]<J_.6-U]/J '-H? .2GQY]))4+#FH\&P+_P#"?FE+
M>7;QR%:Y1Q1OOC(51MD)X$RK[NC#Q'4]N(#BG,>YE!_2; S!VS]YMT/:4T6W
M).F5I35:=+YR2 8%\\ 8 P!@# & , R ZR'XNN _^+_TP?E30W -?\ 8!F!Q
M&_B']6W[?^&GR2XA@&G^ , K'3_X_.7/VZU+^A.&9RGDKYQ><_7VW?PO&.N\
M]?-KR1Y/W+^*Y19S.K'(CYM?\S,TM3?P]I&2(&U AD2[F!6K<M?D:1.E>EC>
M&L+C-"A5NA!9:Y2C :D*%HH8Q T(H&]:[0Z[.S]B7WWF/*M7/"M+;KC2?%)]
M;9XT?"O%E(YVQ<6>#:NSMVW=>1&K<55^#/NTJ?1FRQ]AC:/T?'61H84&S1G;
M0LK:C:T?C&=GB&^;(22"?%'V:[1=WMWV9QN=RY<>JY)REWVV_P"\N5JS9L1T
M6(1A#O122^HCV^?!ZC & , 8 P!@# (7Y(_J[WW[B]I?>.^Y1NU#YM.8O(6?
M[%NE^[*?G1Y:\O[?[+LG9UM^+J _:5%O[C0Y.\L?%K;O6-CT*! <U_&G<O*&
M1Z-,[7)P@!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# ,L^
MM78UB5-TR.3L]JB>2ZL9\SI:F2L,Z@;XMC4NC^I!>U7QMV/8WUN,*6MJI4R.
MZE/LPL6M^&<+7U-[P#S?FNH[^W-U/_CS6E@#YKJ._MS=3_X\UI8 ^:ZCO[<W
M4_\ CS6E@#YKJ._MS=3_ ./-:6 /FNH[^W-U/_CS6E@#YKJ._MS=3_X\UI8
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MZK7@LTUIQUY<W1Q:;%-S3V_FZ=2)14:ED[\E7(H1!)"P)B75)("-Z 6H[P3
M#UW=![N]@33Z1ZT/V'=,#\Y7*WWJ, >D>M#]AW3 _.5RM]ZC 'I'K0_8=TP/
MSE<K?>HP!Z1ZT/V'=,#\Y7*WWJ, >D>M#]AW3 _.5RM]ZC 'I'K0_8=TP/SE
M<K?>HP!Z1ZT/V'=,#\Y7*WWJ, >D>M#]AW3 _.5RM]ZC 'I'K0_8=TP/SE<K
M?>HP!Z1ZT/V'=,#\Y7*WWJ, >D>M#]AW3 _.5RM]ZC 'I'K0_8=TP/SE<K?>
MHP"2NF_RIL;F%QO66I;40A,(L*.7ER)I*3LE=.;Z\0PQRH2Z9I41[NPKY*F1
M/9J%\'$=JP:4$E&!T;V;"'L[- 7UP#(#K(?BZX#_ .+_ -,'Y4T-P#7_  !@
M&8'$;^(?U;?M_P"&GR2XA@&G^ , K'3_ ./SES]NM2_H3AF<IY*^<7G/U]MW
M\+QCKO/7S:\D>3]R_BN46<SJQR(Q7N^D&?J+/U@(>0;L[**'J>Z99#ZDJ2+&
MHV9/J8U*X/< D-MS.0&-ZM\>)6IDFW9*UHR34S6A:=!T82I.4'&9$8V^[W@Y
MUW(VK+R,1K5:^\S=N3BFM6J2XM.44Z='!=+.Y6-GY;V'9<'&R-LPMPW7)QK.
M5>NY=I7XQZ^"N6K5FU)Z(1C:E'7<:E<E.4J2A%)%P>(=E6$HF5W<>+)E*ZQG
M2C"JU?XO9[V0V))9+X#;*68*&%%-B&1"V,JJ5Q)SA+@@-7I4R8+BD G/,)"H
M$<(;:LF]==S&O/5.UII)]+4JTK3A54:KW>'=*WVA['M6-B[?S-M%F.+C[EU\
M)X\7)V[5[&=I3=IS<I*W<C=A-0E*6B3E%2TJ*5Y\ESF(P!@# & , 8 P"%^2
M/ZN]]^XO:7WCON4;M0^;3F+R%G^Q;I?NRGYT>6O+^W^R[)V=;?BZ@/VE1;^X
MT.3O+'Q:V[UC8]"@0'-?QIW+RAD>C3.UR<( 8 P!@# & , 8 P!@# & , 8
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M79.SK;\74!^TJ+?W&AR=Y8^+6W>L;'H4" YK^-.Y>4,CT:9VN3A # & , 8
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M_N-#D[RQ\6MN]8V/0H$!S7\:=R\H9'HTSM<G" & , 8 P!@# & , 8 P!@#
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M].AYN2!KC & 5_Y9?JL<E_W?[E_1U(\ @#I._P ++II_N <-_DZUS@%_\ R
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M[-,GMDN]H&7;YT66N4U;R.JZRW9C#4KL>II*$5)^!JI5\5T\35;.PGZ0& ,
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M79<6^,YR?FD9NNZ9^][C>W;<[G6[A?GJG/3&.J7173!1BNCH22/<Y8R/& ,
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M5X4Y2EWN%:=XES.\%%,@.=G\3'H<^[_S=_Y>]]8!K_@# & , 8 P!@# & ,
M8!%%\MTA=Z-N=IB,(B=FRMTJBQ6Z,5O/4J%=!K!D*V(/"9EA$S1.8@-JR)RM
MR-*0.)2C>B#$:@P)F]!WO ,,NAA#&*(R?D,&$4ZTQ&(+JYH-<^V"^]/_ (_]
M/ZRE5TK'"V?;4J%OB-&UW6WMGTS6J=(RJ&)[<$CD24I=U121^?@C-.2 ?1)@
M# ,0> 7\83K\>Z!TV/D,QS -40<C:6'9.JE#.4OKUMV.CP4&VJ0!9AR5.@])
MGQ4N8B:=0PR6DH/YP34%PVX:#_\ H]ODR 7-&Q/=?<59$?=#6X4TSTZTM3M]
M;IZKK$N/5Z]?_*5%<]\IO?\ X,K,C[L=:[6G1<T=:HZW95_1U#O*/%V>LZW_
M )#F:8A=!<-:BHOBS%)@R0^)U["8[6-1QR=SAJ];7EABJ%.S-21*8[JD3C)G
M(LDL #!DE"&,>_+KMWDED[EMV'>MXV9D6+61==(1G.,93?>A&33D_H)DUF[Y
MLNVY-G"W',Q<?,R'2U;N7;<)W7T4MQE)2FZ\*13+)YNDH, 8 P!@# & , 8!
M5^)<<38O<+A:VYH6O+7/\P?-1_4:$D&5ZUC=QZ2[=]R%2$ST?Z4_T_-0^+X?
M^B#O>2EX'*+PN8)[YXRI*5V[/J^KI3K=7#7UC\[JZ=/&G0BFX/*<L/?I;T\A
M2C*[=GHZNE.MU\-?6/SNKIT\:="+09="Y',I(7#D#N9(4,3C*-_./5J37Q(P
MM:=W-4K_ !=KE!CD2E M&>MV>/Q1['L1G?%WM[[=YIPV[;[60\NU8LQRFVW-
M0BIMRZ7J2K5U=77C7B:4-NV^UD/+M6+,<IMMS4(J;<JZGJ2K5U=77C5U/;G-
M36H4!5J&U >K!L&P*3D:<U0'96^TO83AEB,#LO>NT/9OR?R9[RL69SZR<(N?
M?:3?#S38E8L3GUDX0=Q=UI-\.CCTGGYZGJ4WM.Y^/L<Y URTSB!KWNWX@(UD
MKR; C;&X&PXJW],K.^IV=[6.Z9T:TT@(0(BW'1)._%+3@UO0^[K65#<^=MHV
MK>8;'DQOO,G*VDXQBX5N-*-6YI]WCX/U2E[ISUL^T;W#8<FWD/,G*W%2C&#@
MG=:4:MS4N%56D73N5+D9;RZ# ,@.B1^J):G[_P#U'OEKW9@&O^ 9 =9#\77
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M,?!'EKU'9^H_\1_M^[&/Y=V_[&7W8^;YX7?LZU[_ +&O]D,?!'EKU'9^H_\
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M\7AZJ6P>FTD532E_2I#6F/J),J:U)3>!6:2):8G-"3H>RQZT!HO@# & , 8
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M)%:8J/%T7=Z?IG981T04*MT257Q;IWWW7WS]<R?0P!@# & , 8 P!@# & ,
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MJ5'IDU6-5P=&JKI/M7+D8.W&35N72JNCIT57=H?IGN? P!@# & , 8 P!@#
M& , 8 P!@# & , 8!RLVAS-/XPYQ&0:6;:'?2/2OS!68A5_ZBO2N1&R59/\
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M]7L:1QMK6.2EX7EIS5BQ6YNRL)1:AR=71S4K75U7&$D%E^*H.-&$HL -;T
M0Z\-LVC;MFL/&VRU&U9E-RE2K<I/IE*4FY2=$E63;HDNA(U=BY=V7EK$E@['
MCPQ\:=QSDDY2E.<J)SG.;E.<FDE64FZ))<$D=]DB30P!@# & , 8 P!@# &
M, 8 P!@# & , 8!D!UD/Q=<!_P#%_P"F#\J:&X!K_@# & , 8!3BA?UGN=GN
MA49\G:O\KFT_MS=?RUCV/;..\A_.=SUY0VS^$8I<78P!V$(AA"(>]Z '8M:V
M/>M;%O0=;WVBWH.NWR?R98SL1_6 , _C9A81@+$, 3#-"V6#8@Z&9H&M;'L
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M288>:N TIAG41@$TYP3'A8CKZ:(U$9=)_!VZX5*Z,BADFMZIZKX]7;9%;(6
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M0^?E_<0T+J73#K$IU64O7[DBZL;$T]+XF!Y4E@ N?(*]LCDD<X Z/FR@;<-
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MV]X>39Q_$^OU=9&4M77=32FGHIU3K7OHNY$68V.12,1X\XM2<PQYE9CE!01
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MA)?1%8G"&NB:5-HXH*CNI-[%_.BUK +V_-D=0_Z=CE_\7OB7[V^ /FR.H?\
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MZ=CE_P#%[XE^]O@&>'*ZD.J;Q^Y=].KCK%^L;ROF$4YFV)=T-L":*N/_ !E
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M;69SB9Z<<6TM-V)P".WXO8#6Q=FL ]!Q.X0]3B_.+'&F])UUJ>7]?3:Z>/\
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M['+_ .+WQ+][? 'S9'4/^G8Y?_%[XE^]O@%(* XR=5>V.87/SCQ*>L-R_B,
MXGR#C8TU;8_P=.-)?MN);GHQNM"8+/&<:N*95'J3)5@VKM;C#0A[G8?W3>T.
M 7?^;(ZA_P!.QR_^+WQ+][? .X^;OYV_3.\I_P#P/ZL?B+XP_P#B+[.__ '_
M 'Q_^W_ZI_\ DP"X%"_K/<[/="HSY.U?Y7-I_;FZ_EK'L>V<=Y#^<[GKRAMG
M\(Q2X^6,[$9\\T;DM%O?63C94L<@*M\N*F;CD3]*K%=Y$C:H]'&)9!8$)*T-
M<::URMT>URRS0J-"..3D$%(MA[#!&Z\.*W++G9I8MQ3<XRJVWP2HNY]$N/*>
MTV,JX]SR)SC'&OVFHQ2;DZRGQ;?!>!3A5\>Y3CFWTWV*ZNF+7/';B-,R:NM*
MMK-Y /$(3S:,N<L9)PQR.RFF53%"Y'LKHRG,#HRMZF)B2FE!/3']Q1HT(A;+
MV6.,VK(N8:MX<E&4)3:JFZINKZ/I%\[1I6.<MPRN:?#L9=O&A6W12@U;I'SU
M4TVG7H:X4[M3=3=[TAJP]U%NY*KU:X3@)Q5CNPHEJP0J#4&G4I.*&>E_6,)Y
MC7OSD(-IN\)/_.:UW/KLNGN=N'BOCO47O$_QFB6CIIYZFGIX=/3P.#>Z.W^,
M^)=?9\<K^#UQU]%?.UU=''HZ.)ZN!<D^.MJO1\:J^_*5LB1I6]2[J6"!6G!I
M@])VI&<6G6.9[5'GUQ7%-Z10< LPX1>BRQCT$6];WK6?>3M>YX5M7<S&OVK3
M=$YVYQ3?>K))5\P^,;=-LS;CM8>38NW4JM0N0DTNBM(MNE>Z$/)/CJZ1-]GC
M;?E*N,&B[@@:)-,T-IP97$XZZNII!#6V/LB3OIC.T.#D>J* G)4'%F'",#H&
MM[%KM^9;;N,;T<>6/>5^2;C%PEJ:72TJ5:5'5I'W'<=OE:ED1OV78BTI24XZ
M4WT)NM$W5439T#]<]/16#-EGR>UZUCE:O0&XQFL-^G479X,[%O!(E#28V2UP
M=$[ O Z$ V--LI0/1X-;V#O:UVYYPP\N[?>-;M7)9,:U@HR<E3IK%*JIW>'
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M , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
MP!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
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M", 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
MP!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
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MN%A& , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# &
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MY$N<0N6_).U^23_35UMU'$L)%).%GLJFK8[/6MW)<V^<QJ*"2.CE+)P_HUJ
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MK?\ TY)V>6N8\BGB^WYLZNBTV+LJOZ46:5S>=GL_A<O&C3OW8+^^1$SSU(N
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M[VVW-O;_ - L?D8?:HL'*7Q4VSR?C>@P)"S<+", 8 P!@# & , 8 P!@# &
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ME CQ@,4;F'/.?S+SL998"B=K-2DUWTL\W++#HK1O?T5W [!W=AUV4K<>R?\
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M D+-PL(P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
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M5%@Y2^*FV>3\;T&!(6;A81@# & , 8 P!@# & , 8 P!@# & , 8 P!@# &
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M(B3A$G:$G*=U,SW&CZ4JI_%=6WV@P[[W6[/D^ET'?8,C & , 8 P!@# & ,
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MZIG 4W!N%W'L#V&ED]&5V=)1)-R%?'Y#&2G9["W^-IO)=7E2ZJ75>E;]*#/
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MU<V-A2EP5D(B#')Z<DC,S-Y9RDPLL:YV=UY"5,5K>S#U)Q90-"&,(=@>=@#
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M.KC2*M>[*2LTL:F]%+VY YJ2$;2][2^,$0B!G_$^D[/D^A@# & , 8 P!@#
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M44E$?)Y(,C;([(H/GS5DRLN,58X1R4Q2Q^=-Q2"ZI-<M1(T%B:31=P:94I8
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C+*BC[*E%L@E.1L2=M;R@;[A8 =NO('6O)KY/H[' & , _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>50
<FILENAME>tm2227887d1-pht_reprobw.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2227887d1-pht_reprobw.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ EP&$ P$1  (1 0,1 ?_$ *L   $%  ,! 0
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M6Z..992%Z[5QQTUY"S4J$<6+%>BS(5Q<8#(JEZX*8DQU#N= = = = = = =
M= = = = = = = = =!1#+?&+Y7WLKD[V/_J4<[X2A<R%RU1PM3@?X:VZN(IV
M++'5L76M9/@"YD;->@DQ4#+#6O,0B3,BF2D$_P#E7^7?^IWS_P#X?_A1_EWZ
M _E7^7?^IWS_ /X?_A1_EWZ _E7^7?\ J=\__P"'_P"%'^7?H#^5?Y=_ZG?/
M_P#A_P#A1_EWZ _E7^7?^IWS_P#X?_A1_EWZ _E7^7?^IWS_ /X?_A1_EWZ
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MU2WQ,1/KI$E&VI'6=/[>G"_(YVYEG^9?A+].?JW]:_\ 5[\[_3GYA^G-V_\
MZS[#\S]E[3\A]]_]Q_>>3Q>+\.[N].IPNK2G4Y6TKV3MUEH= = = = = = =
M = = =!YNM[;1PUW<V4L9&O8MVPR-U]6XR[?1<H$][/*6,<A]8\2QPQ L*KX
M9:,1WR774YNY+7D+U.V(7Z58:[Y:H+U6X)N3$5[=H*^1HRJ'U))""T-+'B1C
M_P $3.E#E;8!\$E[@KK4B&-JE-<W&:WT2@2\LC)8]ZV,!Q:0[ZRKNF0U!L7<
M_3IV&5GO)5NU6.\<^Z::/'6DDV/'Y7PJKX3,]9!2XB8G6)+LUM*AO5]P4+L+
MTNTU.M4Y 4C9]V$&$%K4T@&U#5-A;3DH[ST$_61B9A@A2G)M:-8Q7?5*&5[%
MA@1"J1K<,RU-ILU',@0K-EA"("H3@0\HQ$S"BEJN\9FQW,=()<(M;9%*55M4
M(D(E@"L?&XR^TIU[FS(1.O:/4';U[NPHG02'OB"CM9,3I,3(3]RXF)CT+0XG
MT(1F.@XY7 Q/9$A_XFD=W_C?;.D1Z_3U_P!_0.O>&)Q^8VYQC5R*F7Z1;*R"
M_P L<YI47E/)>_2@K5<#6.0@F0/<NQ+5:A$P,%K/4[RLX1L9RBM;.0U='$V,
MGB:D':L&_,7LGET,";-MDT(RQ7"N)KL$26F;*Y&8@5C,=L=5"^&51?$+->1<
M#.U@$H!-)B7VP/=/8[2##61*8UG3NCNTF 2K^81C@I6+#2B;MD*PKF5&=G(6
MW0"0-A/F6EJOM&8.0$9[=3^W6T#>?G5RYM:VD'OIV ?[%=H([7,<T41WJL0L
MO$L6K(35KK!?LC$:J#OTLSCP6HHI/IM:]AP4UC]J9O@GFWQ20KK@XV%),CL*
M6:2>OIJH'?MTJ]5I&,J@\G;-S:L]]P)RC%AXTU[9#)H4U-4.R?\ DR,%,0):
M]0.IEQ=RL]JDQ":_JUK%Q*IG0#, -;#%YJ:)+(1B1B=1*1(=)!IY 8$!*/&4
MG,S&@$N8_#4!CM'4XG\!C2(_">@>/':9=1Y)6-A]4CV+7U>@U P(CD#87=(D
MY;5!$#$_\/I/K&D^O4G&-R.Y"JU5[6";.##.9:O<="VU<KN;-90&:V8_O.,L
M;B?D)"RUEO3L\R4- )TF.T9ZHYL7N*EEJ2V4INU3J6"HV*62\5FTN*D.1:3<
M[VW"*5N7'<R#D6G Z,D3@C!/#*(BM7MPDA>EMA"E-IF)U_'68$OQRGP3U!8(
MQ4$$(%VE.D3&@]4(#<X12#VMLT*%VBYRU-45=ZFHC5S[*-&!7<:!*>XO)VF'
M=Z:=TAU#NNR=N'U"I/2L*U6V2K$-N FO#6&OQ@MU5[1)@0M1DJ)B?7[8C6!:
MP^2W!1IG&3O5[5Q!JU?90^E74F12#5S6!US1*")@]VL-* $IF1G7J] \Z^5&
MU9N8XTP;U!5E"YIL#RP^O#2>*WS$337!]DNF8#R]Z_0P[9@0\MC["FL9XE&,
M(\C2!D:J"9*/O"!$Y7)Z>HC$3]-?QZ!JEZSZ^O\ WIC_ .W3\.@E?E/9.SKW
M(F\[F;QZLG>C>>ZO:7;Y6+.5Q[[>X;#--OY&6>\VZL2F"9./FO$3H9E$C,S+
M<(V6<4;Y'=^8H/65_#T;"[,Y-%"]CKA$VU;IT+]M.&R&%<+)\1TUV(\D6F#-
MD1D0&#B8M$=ZSDXR]P?*AP0*I6HD]JP0N9JV;$6&E"F/6-FN)%*M &51W0<Q
M,= TLGDR 3OW5C+/%#[)6!=D%#[0E#)U:['@-,29)$)DE0* )@])B>J$W#YK
M\RI+*MCX3C22R[*2K^5T(\CO<3./[9'Q0*Y(A'4_OF" (B2E*.ECGXFWF*]U
M:G1D<&Q1W+#*:(H"O,4EK#*U+A#;L1:G& 2XE(SJ.H$8# S!4C8G-5YLXFG&
M2MLKH7%Q[IBH=6R;O(":RK*%HE-E+($14,0;0.(F#(@F('H(/O76^Y[UJ""=
M2KC,DV*UA%=93< RE27&V6=@24S"_6(643T#0S=::[XB1$(D8@>T(7,P,Q^V
M$&V((IB9^LS,3$S.NL0$H:1_+?V^NG\;-/K.O_F'_P!+7NU_V_7K/R\-?#RW
M7ZYGN.@.@.@.@.@.@.@.@.@.@\\_) K5N#+$4R"R9869!"X\,2]PFPI:,I[E
MAH7WP7I$1I.L1/5#F1=FKSD7=O>9:5@.3N66+&R7[\(QCJHU882ED)^*^3(
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M;3?V% %K"EZEI'K$M_S&Q.*MEA4WLA98*)P].G";QW:Q):W(Y;-PS&ID@8@
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MX&=HVJ.1<5165>VIK5OU:9)*Z3<E<_*VY2R3N]+Q7$BZ1\:_W4Q6-DNU*/\
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MR84FO456FM4I5N]#%C$J#1C5/\32:%19]\CY(DR&2F(B(3([N2QC+RX6NVQ
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M'(4L3C[V5R5A=/'XRG9R%^VZ9A56E32=FU8;,1,PM"%D1:1/I'05'Y,^?WQ
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MN4"HA;460B'Y8FBBQ09=J.HR50#D(!:B%VK0F(@"M8*25]C;]V[O19U\$_(
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M7;1B]0ES(3WM2L2DB.(+Z'VZ=9:293RX6E5$T!%OWC6LWO'6$%03U-CW*S&
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MR]$/7(Z!T!T!T!T!T!T!T!T!T!T'FXR7'6Z&YG."5W8\2>7M/KL#E/C1;@L
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E'Z \';^:_JG\J]WW^OMO/[CQ_?V]GW=3E'V5Z_YRE:?\^7__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>51
<FILENAME>tm2227887d1-lc_macro4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2227887d1-lc_macro4c.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ TP'" P$1  (1 0,1 ?_$ .L  0 " P$! 0$!
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M1[C[@_QG:;_,5=O^(OC2(]Q]P?XSM-_F*NW_ !%\:1'N/N#_ !G:;_,5=O\
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M$L#C?M^-ZFCEWT('Y3^C<"2H+MJSA "I(#,SL2WT G).DT+K^)1>Y3BIZU)
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M7:E":ILT&#EU2>N96C*:&0:EO&<#IGP//X*);QGVGMNQ;.%90,>JEF['B58
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M-NBII\FUCQ!5=J;,23"8+-V#-#3X+H=>&P_,FCFC$##/#D,.N6V=HY]=K4E
M65F!(92/+G<V<Z(,'+G"@@@D$$"JON_ LJ6T.0K*I *L#YL;5QC5SD8098@@
M@$$$VO1;I";%J4)=:VLIR"L(JS(QPP?(I+@R2'ADN.#J4M3/44QE6,*SYO+G
M'CC&?'&-/D46<6YN/;CU%.#C6;G'OKY5*WU9]-AD9DMY3+HXB.(CB(XB.(CB
M)3>Z-29W%#UVOD61^OP\;8ERD^P+')-?LL"?7IZHV&K./+.%; #G:U9SAW'>
MF_E*EH5Y%)2IMS1YW#_&HM9;:@;)TSN!4J5ZZ JQ'C_D/K?:'NG_  ER^1SZ
M^.M_+LX^RHE]HIM6VJ^JX *2S5W4UL!E<@$9!(9:#CNSJ0K<T'(4_;9M>BAY
MU-D)KR:DV^!*2D;?ZS<*\DS(EEC$B1XL%K:I01S * \2 $*\K&6%R#_EYR]D
M:JP-3<50-NV[="0ZLN?,- $K0@8R%/3<9[GD?JU1W#AO1W;M27\IJ/1%OKD,
MB/Q;J+=NZE]S-9R^=R:VL-GI6<A!AUH3-F:OT7%:'U?=ZS%S)-@]Z1[IY,H:
M$T 600'18B!*=+8$(6 \2=)11!BGFVF7%)*2V]E]UM1#V_V[MZ=NJ-2,6R0<
MD8.B@:XTU()SIUUR1D^-]\^].5[W[C7W'DTK1Z=;J$5BR@-=;: I8;@%1UK"
MEF *%DV*PK2L_3+_ +S_ )O#'_U<ZF)X32>6O?JUEO>/;;G./#QU3W->SP\/
ML6_M;YX/W]_^GT?]M_[IGZ\_]'__ /;N[?\ [:O_ 'R3I#M/JS5F[-.V 1TN
M2BWF-)ZH/"DXET=F0!*;I<8TIP?)@IP3F'Q'W6%I>8=1EMU7AC"O*I/L^&,\
M.K_LU_LGYB]TG_\ E'<3_P#77_\ >-.H*]66J]&ICF23I!76())D91;#\D>2
M2ZIQQ\MT8<0?*D)REM"4-MH;9;0A*<)3C'-G$X!()DIBQU8DX[/D^P>)^A^A
MZAOVXY&(&,SJ2ST&BW8FM&W*F52VF4N?"M=/+LM>B)TJJ6B-7AR/LE:(DQ"G
MH*>"6G&6BQ<M$-__ &5XYA+Y2NS*3W.3]ZE9#6&[*IKR@O4F/C!(&7H$9=9?
M%N;BMJLR$Y%G/L1&:V2Y.SE0*P^:[907 H(P3$4RZ?@YE(UD <I&\*K2:R_M
M?;<3L*<D=YZQ+LB6:GZ".3&YW= IJ 5-]!(0HM9]%#/ H/2\"?@E0V?MO4+>
M.(1K.UN),<1/XI24IRI6<)2G&5*4K.,)2G&/'.<YS[,8QCB2 2<#K.>+7M6Q
M7*.G:YV\ C6NR^FD8U.QC5H8U;3Y9++C*7W9QU@IJZR\<3G_ $?$LFMI?1TS
M7A,9\<\?D<^[DH]/9@++\$>H?Z2'XEOXR#_"F=1ARD^D=H]H]L[)RN/W+]2K
M+.'VG>CGA)KW#DUYSA:LC\+6Z_\ Q^2:R4;?QZ^1C$F&E*/,4'7D+%VLP67O
MLGU;%L:PBXSY;'>YKR$6"64O*&L9;ZV$CCH0AIE@0=IEEMIAMMI&QVOBV\3A
M)7R2&YC>:QA_%8?F/^0#H% 4   #C>_._P# ]Q>YN1S.RUO1[;J/H\&ACK1Q
M*\BFKJ=<9>QB2UEKV6V,]CN[6QSH3Q\<1'$2M[/I_6%SNE-V-9J1 2U^U]ZE
M%-N;P>&;- B&DAG&Q0LR*I@]R"-D(X4EZ/=6X$Z4*P^MK+K#2T)&!U\99'$F
M4KM M]F_=N S<8:4R9MZQX(D6'(Y(<5AC0&[76E'H*D!I!S!J_VMKTK!.<+]
MKG31]MQ(/4?7+JXDQQ$<1-'9+)#5*&*GI\I8<8(X$PMQD,Z2*?+DCAHN,  C
M(L8V3DY*3DS61AAAF72""'4-MH4M6$Y1*;5M>MP]7^E>13-'D78EFOZ[I8&4
MDV>RO-.F)AJQ!UKP#2/9Y,IHD@Y)3F<QK*7'#GQ1A'L#)$V.OM=SCD\K:NU5
M@R.RS@B 8:(!>4;6M4UPY:'':G477FF<F29F&F\S4TIMLB6?;2E*60VAQFD?
M7UEW\28XB4WL[[]NW3\LDY_N^[UY,2DML;M[EZS4[N?6^V61%5#B22HNUN[
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M#J@;-6]PR$B^7EV!Q$D2YSSI4NY(DO/.N7\GO_<>54]-K>1_I;.N-VI8[L@
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MHQ4[3H1E2#@CJ.A\9Q/VHF[D+[N>_P K-P[5Q]+ZPJMSTS&ZUV^/8Z,=$;U
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M[#!2C&"HR:@YA$M$R(RE*2D@"1 =(#+84I.<86VM2<YQGV\;8W&;7Z:93X%
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MA5=^J/2&N!,-5F%+KV((B'BJN-D84,86-$%9C8D5L-AK+752[&D:Q5_JDZC
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MCBI >%>(?8&A#F!Q2S?1-G[3>RK-K5IR*CRQ5644;RMKV<JSC (VP;06KT+
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MPG/D<9^.020U+:JX^5A]'P(\5.&!Z@37[-WSC=X1T57H[C00MU%@ MI8C(#
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MG"E)6U]IX>=7F29^*/<X'8E0KEXK!238"T1(DO&/X<'=5T"F\*RRZL1\H7)
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M$./*0A1<I+GL"CMXSYG7WD(3C*E8QFI49SA 2<$Z?  DGZ@ 2?@!+6=4&7(
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M70IYH;;3SE]7C# _TU7_ $&ZC Z*V4_T<ZSQ_<O:[5&[N7M2W\O[XX=L ?\
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M #]L]$>1,IYWV6S6#M0W5&5>O@UES5._+1F6K47**F!#F]DRD]!1LYKJH.Q
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M9>BPH'S.,A2+R5EM$/OY?XB-M25W*Q:JI@I+!B;"*]K#RJ1M>L/AB_5E'E(
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M%RQ,]&JPTS74(PJ.G37C6,^'BR6\MY'@XI2LHFC.N':O)YF,R4119'-AB9"
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M*>2-EQI2GK/S^T*41&5/19  Y !86 N,#KBS!\2%QG!TK_(*BP=W5G]97)*
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0$1Q$<1'$1Q$<1'$1Q$__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>52
<FILENAME>tm2227887d4-fc_carm4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2227887d4-fc_carm4c.jpg
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M 0 "$0,1 #\ S^
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M               $#(C*A\ R&S>D,Q(TB7(6EF-%9<D..+41)::90IQU1J,R
M*A(29Z\ S\/ [Y4[[,]6FQ6_^19=BNU>91\CO^"251,B@(;\%<1]+O@+2DS6
MHG>5PJ5(9SIW6V\UT4AC%]MUTQ$UNA4ES>URF5*_1UK4R*JBTX4&N9I-&2"E
M40I;A$@DD:E545"2G4S,^%"(JB8S'9*K6%R\SS#+9UEM=*J\5<7;U/(BNYVW
M(-<5$I9^&31-I=Y%4>]D]!OG2GY7S)<:->/G?)HNH-N(=;0Z@^9#B$N(5WH6
MDE)/Y2,:G(3@
M
M
M
M
M
M
M
M
M
M
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MZ=:\W?ZJ"Q61,*   @9F5*%7Y:4$F:>DX(<QU(J:'VD?=\@DSE3,XT3#(
M
M
M
M
M
M
M
M
M   ! S(BJ? ! U>SS%4_41]].ZH8>H]#Q+?/J"VXZ><=AY3N5=CM%HG7*%:F
M)!-DYS3)\A$6.WR\Z/I.N$0E5B*O98,QBX0H<^,KGC3HL>9'67W[$EI#S2OX
MIM9&*C<D9'W_ "D9?;(@$1*S7+ !0$GN&FXXEM#BU5)+:%.*T/Z*$\QT/@="
M%'C&V^_^VVZV79SA&'7DKAD&W;\>/D\3D)/N3LHS)HN8EJYJF7<08^I9B(P_
M$]JKI4R,O06OVN(3GADB(    #PS?/J)VPZ=K%;<BW0O1V2VW6Y1+3#>)KQ?
M$F37T1F&OIHIS.K(A)F891;6>Y[3"F,3X<2?&4:X\V+'F,*Y3JIB2TEYI5"K
MJ:%D8K%N#6E)&HZD2>-2,OMD E2ZA9D23J9\-#[ )PFDYM0
M
M
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MS C&*\#C3BFJ6FO&M/DXB5A:2B*@
M
M
M
M
M                                     TW'F62(WG6VB/@;CB4$?J-1
MD VQW*W%QGPB]<I@OMN !7*W'PGPC]4I@_\ R@#51+BN&1-R8[AGP)#S:C/U
M$E1F W
M
M                                                   "!F22,ST(
MA)P' 9'DEGQ*QS;]D,QN%;;>TIZ2^LRT2FID24U+F4JFA"V6W7SRQ%9E+KHT
MXYYFD0MBYSU<[MY5?9Q;8VMNS8K"<4S$N\@FWG;HE"UH6[[NXOG:H5#+0=CI
M;"Z8YM6:3V.NNW\73^PBMG:M;^:QOGG;.P&!RMS,@/ZON&6V!V$N/"KSRVKP
MTE*E):5H9+015/N&.ZV^CHV1%N-\FVW6OJ7W3=\-L+@A[W]2$W;;"W,'S&+
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MP4/6N.I4I7U1&7RK-PS-!K,R*I]XW?D=*^V)LNHT6;S5B9FZ*TX/6NF+K>W
M=RIG:CJ<QMO%\@FN*;Q[+DK;5;KZNJ$$EU2'/=XM5F=*T,<'6VNMH5NN^#M<
MS2WFCKSR?#J=BZPVI*R;6VI+C2TDMMQ!I-*D+3S$I)E4E)41Z&-$RY7&M&N(
M
M
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M9Z?,=>/<>E I$>E<?4UP
M
M
M
M
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M.M*6VLC(R.I&94#&)3%O!0
M
M
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MYL,JR]',3%(G&:0JP%0
M
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M+0XVMM:"41U2HRJ:3X#K;].8F8OK$P[6R^VZ(OL\5LN8!D
M
M
M
M
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MAF93BYOF*O+77N^2H8US*32O!,*@
M
M
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MNK,W8Z7I2D%5"EFM"5>#I[)$.%6)K$=KN>6ZVV.9?.%0
M
M
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M--5=(ZQW0
M
M
M
M
M      D4M**5/4^''\P%HD6\VEI;BW4LH0GF6ZX9);0DN)J6OE0DJ=YB9Q@3
M%%!?4?U^;9[*2)&)8LC]D7<[F\&+BEG<)UDG5DM*#DSXZUM-DEXB)15(Z=HN
M)AQP6Q,LB;Z=2,QK(]^\RFXYBWBJD6O;>VNOQ/!C.K\5##LR&X7B?@G32?-W
M!AQ6*XT>F8]CV-X?;6K3B=IC6J"VDDFI;34B8Z=$DIQ4Q2/'-2C374Q*U^(Y
M:?"Y.JSKSJ4HSUJH^8^/I,PP]1;%#6OH!<:]P"A:<VOTJ5+U ($=:T.O#LX
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M;43:T*2XT\1&VZVHEMJ(RT,E)JDR/L,JA-> UP
M
M
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MS1.$Q'J7/!6(
M
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MC8YA4["I]SNN);?P[5=[P[XEPG(6PI3KW/S&M%&TFT2EZZ&%MNA9'AG/-?\
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M?S'+&<.5T.)C917ME7..L=R
M
M
M
M
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MAZ]#$6<$I'7B5/LA*1-43T.A\05 C/M*GRU 0,U)42BJFAUYDJ,N%*:%J95
MIQ=,S_;K%=SH#<3(F/J^^1#)RRY-;5' F6Z4V9J9<6[$2A][\,9&=3UH&>%O
MPPQF*879R]4Z9>L3-=B<LA;']2UP=N&+37686 [F/I4;*VTD3$6#-4IRB$K<
M41<ZM=*B\*L8BF$YKV$65&FQV9<1]J3%D-H>8D,.(=9>:<22D.-N(-2%I4D]
M#(Z -<
M
M                                     &BZE9F@TG4B,^9.GM$?9J%8
MC&2:Y1Q6^?- 88+HKWG(F&FSD6)[QE-H0E2S*-*ISJ2DC73TC5N:3T[<3P^3
M/W.;T>[E\Q;"(S_,V>]@W=(L@OV%MYH24<ILR;C1RM?I/N]@_/73;I^3O+>R
MZ??+^A'FRVG4.E73G.G;_9A1@U].65-/?IO;_P"<.#S>-9KVR^BSE;_5CW.)
MR$C]S;I^>_-$MPEHW&%BJ[RNGI#?7;MBJ.T;BDW1DCIKRD<J 53(A[[Z;6S=
MYLT(XTN]SXA_,'?;;]+=SS32*V^^7TQ;<HSMEO4154<&(=*TXL-F>ORC[GJQ
M2^Z.,3+\+Z4UTK9_HQ[F^/@?J&,,YREC3]=:#3UG6U3=:^\-F9TT*JG#IKH/
MP_\ SBWS;U#HTUQK%/:^Z_0")OMW]L]D_<X7>&BRLA.<5,(UJ>E&].'>/S;]
M49F;-C?G=\N/[+[;Y0IS;BV/UI][R.*5'%$9?R%TB]'X,Q\KNFMKV/;Z%&^3
MZW^\&?T26Y_'+^7B/0[;^YVTS>4U<=U?V2R O)[YRVOR&NB3>:IP_P!(IZ>
M_J+_ "_S7Z1].F8_%=]S\?\ U I_CK=QW0O*CZ]%T79/,*?>IU9M[17UQ/TD
MO0Z?[(JHY&E%8NMX3;+B[G\,QGS1[W1]DS6Y@;BST,XG#3@32#'F=K2VR^.^
M7K-[$3.G3.D>YU%6KCW^K._S10X_I;YX>AUW)=(\;Y?_ ,(:-Q\,=K?MIF+I
M['G33J$[D[>E2JO>7==?Y:D=GT")_,WS/8ZSS'3\OISPJND,5-IG6A$RW4OS
MU4%\U*#N[[:SZW112G>UQ0
M
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M-U,Z=X^,=6MY>H:EL=K]']#F+NDZ-\YS;C/JA5L.N=H
M
M
M
M
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M !^3[[:93KJ6)7+R$X;2^5="J94(S[#$RFC*)K'H<K0CT/@*J8E4K3MIJ E
M1UH7=K3[H"51T(S[J?;##B.OY;A]@W$QV7BN4Q4OQ9".:#,*B)5OF-$I41UF
M025/(Y7S(_9,N QBOP\)2D79\'K_ $-=1^4[>9BOI:WLN:WW&%&SMAE$]PTI
MNL%'^TE2)+Q$9L$NA=IF,N/<G"L_$O+(*B4T/F*E2,N!UUJ,IFLU8IA
M
M
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MZL=D.E\QW\MFC$Y3,KK#%?!CTX>"W7_,%3TCN)SET\91V-<10
M
M
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M".J332OAZ?8'Q?J_^\=3TOTCT'#I&C,3^'V80J^'6NV
M
M
M
M
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MZ5/7[WL%PRXL>-6X
M
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M,\S%FC/9,KKD=7X&.7:IAJOR-D9#M+IFN':ZN*4K.;<B@
M
M
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MUSMP
M
M
M
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MMQ*76E$I#J&W4&14(T+3S)47\,1U&7>QPX-4
M
M
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MK5'0:^_@JH[V^R8OQX3+HK+HFR)CL<T,60
M
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M6A1*2HCX&E2:D9&)$3E.:\*PF2HU5JFA=AUK7O\ 50,8FA&28
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MSYH]ZY3T/F9;'V9/,2UI<>K2A<>3Y!\9ZO$?G]2[OE^C>@1$=+TJ9\L>Z%9
MZUW
M
M
M
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MB*^I1<RS2I3K9G0SKJ$5XYI=%)H]Y%0
M
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ML-D9D9FEM!)+TEJ0V77<TS=.<I;'+'+&4.3&#(
M
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MZO=Z41,7TI%W!W/3M>^_FT+IYIL_%VQ.2LU'T2^7[9CB<<L':)@
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MRQ[E;(ZUVX
M
M
M
M
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MK]VC'IX$:X/&M))371)%3[TN(O&DYL9BD0NN@Q
M
M
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MDMMI0AM!%0DI07*1%3@1$0[G'FQR=/$>&O!K"@
M
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MB
M
M                            $F:8R H"5C( B8G( K%*\ "O  F8C&0%
M
M
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M5T[C";JRD6TB9JOD$H^8TF7J/O[>'90(G%*853BH
M
M
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M([7Z.E/DT'QR(I;#[,U@
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M&I/.E"25S*(?/NI[^[?Z_P [4QOE]5Z+TJSI.T^1I_#'V9*NAU[N
M
M         !HD?"IDBE>4S,JG7CH=*4%XXXE</#A#5(ZE4Z?(=2^<8QWB(H
M
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MJ&="IPUK6OYE!JMKG*3V\4XR0
M
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M24VZVSE#[+J5IER4.H_06G2)1$=>:NG>+2*TX)/<O6N.(\-F/%CM0[=";0Q
MA,(0TS&9;+D02&VR)!$:2*A$6@7QRT[6/&G%)PJ9GW=GR#&;INSR*16J)F1<
M1BJ!5(^%:\55^X B9$K0]:>OM #*FI?*7?W:]E $0$"(BX (%114K7OTH F;
MD.Q9##C1<IDHD\QZD;9F7.DR[:I[QLLBM3#BLY=:&&JV<ZI\-W6MC:2Q_=7G
MBWUII),Q_>8;9I0M[E2VV:E*5S>T9F=0I%LXYE:Q6&I);4T^DB61H<0A\J$5
M.5]/B)*OH)0E<.]EC,]S3!44&?B)H6A+09G7A[1&1T$NGEBI2'#;*^[P>NC
M)S]$NW6'=6"=.A<Z_=B0A/9Q5IVC*D1A&3&:S%>*_94B53\]]'TT+43")HG!
M,*@
M
M                                 -%QMOPW*H3JVM)G0JFDTF1E7CJ0
M1W$S.?%BX^;QTJ;#X!C69=06)XPF!NME>48TN]7=+U4NK;NYI)26":2E!J)!
M5,E:T'MNM^:>O;[RQLO+VZU>;H^G$\MM/O\ 7+YWY<\I>7MEYOZGYGVNE-O7
M-:ZV;[JX5PBL1E$S2*]M([%SBP&:NESI9=50U>Y0%^T7,GF4Q!4:C2>AF1CP
M<VQ'+;&3Z1=68NF?B4T^>?UF;V=%_3)8,XV'N:K)F^2>[0W+Z1>)[JVS#T4E
M@WV:\QZZ'V#=.,\GX6G_ )KGF*S@Q-X_G8^9F<=A3F]LA:W6D.J5]7J*JG$I
M69?S]V&8GIECRVTR:Q^=AYF1G4]ZY!_[P5^/"Y1FRI$1DBCSL_,R94EPMZGC
M-/ EV[G2?K0J:9*$NI.,XDQ%,8P>=[Q>9/UW]8F-1]E]VLY_+G&9;S<UK'XU
MJ3&<<=@&3K;O,R\\M:F^_E/2A=@]Y]+^IZG1?.FCNK-2;-.ZR^+IX98>C%\Y
M^KG2;>M^0MQLXLYM6-73FV..%SLF*>;IYB&S^*6;:+$=T58]BF",%!LUC3:R
M2_ 8*K9,O/%):<=0BA\I*(B29G3B8\]YFW%V]\R[S>7WS?.I?,UKWSEZJ/5^
M5]&S;>6MGI<G+=9IQ$QZ+8ASW[M?YF)__CJD?\ 5I_Z<.E];NXQC)VO;OSP_
M,DM>YF"+O&Z[U^LLW(K/;;I9G(7(B9%N%UB1'DFM4VB?P*SU](E.\I%:TQ9T
M>Z%W3EO3GA.73(A,S,FM^(7.6RX9/&Q+E,PY4A32U<YH-;[IGH8QF;N69E;(
MY;XN6KO/4.FV/2]V_P#.C'^/:7/;=3,963E+.[X;IX5^]?MV=)/[%&WA%P/"
M\;^S9H=>(M9]:3.-5)>R?3CC>!]6N_\ O+;\A][O.XYV@[G92C\A0/<B(D&3
MOAI)?-3O,>SZQUW=;_RUL.EZUE-+;<W+/;5\ZZ%T+:[+SOU7K6C/^T;N+.>/
MZN2OU)D9J(NS[M?NCQE*8S-9E]#C[$P*
M
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MF.LQF:N]I$9)@
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MRJI0BT"<Z0O"LX2O="H
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M_A=3J:>IHW\FK;,71PG!VHCKJ0T-8
M
M                              HUZ]LNG8;TRY[<+6YR7"6B';&#)7*O
MEG.FR\:2YDF?X*I:=X2MN$U6O=K+ SC&VN,VII1FM27YT@S(ZF[.Y)"ZU(C^
MFL2<641A7B[J=.!]O9Z@5$C[#*AGPUX4X^C@ BE)TH1</3^: @9ZZ%H?IX:
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MW=HM:6F$W1#(LB+\6+&</BY'97_FVTJ^Z*URW
M
M
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M3C8<)_I&WD)=\#9&-T4R6Q_/5_[,NE[3_P":,?\ X^VBQE"SE=Z?O7[MG?\
MLJV\_P"IF-?\C0PC))S=#PC7>#<+7A[I4OXGO'>;V)_AFWGAB\ITZG^(-W/'
MPJ@DI,JU.NI]E*:F8Z&VV/BXO5>Y.,P
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MYPJFG&NM:4^34:?%PC%R9F*5X-0
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MKH^_U-ANK9MU;+ICU<)>"W>TU]EKW;?7MF-2V7K@ZV)KZ'&!0
M
M                                               %I;S6<PGVC!L
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MD+XFCFFM\Q%ZPGX>]CS4OAD9VLS.VVT^-8,0S/\ WNW\]16,YM^
M
M
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MN&?8?NE/\R0[[>X]*V_K>4Z=,?X@WG_%5"$9:EVEQ^4=!;D]7,<41D@
M
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M9T6^Z-[$3.>??V+N/B<S:7$:DI*5)])*H9?8,>;QFZF3W&$8RU10
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M>U\I-2U].M5G4D7JY-(]#;4GD0G^)25!Y.ZE<'M[;IF/%G]RZL,60
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MCF^Q%A\]=VQ/%[JZ9F[<\<LD]TSXFN9;8TE9G4SU-3IA2*U5V,4
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M[*002.**'S$1U(S,C(_HF790R'YZBV8S?/>Y.*
M
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M,J(R-U$V8X\LTI/D/0CKP%IA66S")K&3VRE#/O[?D!0!XINC_P!J>Q7]FO\
M\^;"?A:Y^-D96K_BNV_T!#_I=L4;\
M
M
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M?0N]+R'3YFWS+N[>$Q:J4*@\];2<8>O1&2
M
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M)!+(TUIS#SVOHSIW8_#.3V&TWEFXLFV<-2,X5"#2Y@
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M[H9ZUWQC5,]:_P#V@%Q[1,.*_BCL?8:VY_[/L$_ZFXQ_R)!%1W(
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ME\T]%<'E]_MIVF[U-"?PW3[WN ZEQ
M
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MMP2(B;\61M;"Y;;;TGQ*#$(_DCMD,F#?
M
M
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MSH<1^I/O>/BNW\T3/#6M]T*G2XF5*%V'6M:U,_4/.5BO])Z],*
M
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MBZ9P:-K,<MT<5]7RX",NDC;BI&7_ !J=#(R_VV?>-.I\3;9DKI&#-0MU^?\
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MY46^AUO3+?VVI?.-5RSRD:_M<S*FGU]=3(^^LH^SL'%U.'H<[2^'UKJPUMH
M                         +!GQ(S[4;RP-Y'7E\C:2A&:J&?!J<9Z%Z C
M-+O@FC#>^%+O$";YC41N.ZM:C@7]22-M2*I]VB%77TD&%8[<5F<)[*PR4OBL
M.CAS>;I0L/4#8+:W]>;(/RGI\N+$2N8];Y[,LR)Q;49Q]26#YSJ:BI42DUK!
M-.7OX,0#R+^FAOK-\PO:JP(BSIN'X'.^N,FN,F/(DQ[>Y:9%OF-\RGF9#2#<
M=:.A&:19^U+8KCPC-G7_ !(K46R>5AN;#-7AQK;&LT-LT)Y4DW$BR6$$2$T2
MDN1LM"X!$3-T4S+YMBR>;)B'?"HW>WSO,7BHBNJ6Y]6WZI&VI):0HA:&8DUP
M9Q,4ED=?%%>6SE_5!L'9.H?9NPN7+<'99FX3[S%M\=<FX72SNLR>8T,L1)$A
MPXWB_>F7$AE%/0QFL]\QDQH_)G\^)[RN+3FFUF[>"WO*L)NLMF.W"E'*M,W&
M;C;E,19!M1IKS"U&XY'<(R\/M$FL17BELUFD_ [OYR?Q!EN\RS;6R[);/87?
M</PQN4H[\IM]^YR\BF2"=:@QBA0GEKY4NNH(B\-1U,PS]*W76Q6W.V5ZWX5K
MRU\_VKPF^]8^]&,R<9N^X<>,G;VSW&.Y&N$>VG'AHD3G&)4-B2RA]+>E3UYO
M0&9&$3VRL-_%-7FWPO,NOZ)#JT.^#BQ:-J7HEJ279H1$$Q,3CW,<XY>-9][.
M)\@5YN1Y773TZRKG0N!+-)TIH;4#L/T L12&)'\7_=X,'J+VQ3*=4@RC)^BV
MI?\ (;A6E/4%)I*ZDQ6R)[V1E\.%9K1GOE.XIBLUI,NTY):;W:)K3J"-#K-Q
MMC,1=4K)15)#Y]AB37FF)6VZNG;,9,(#S&^EG>KRH?,2O>3VZU7Q&&QLV1F6
MWF5P[9<#MCD:9?9%^E1CEL18T1KF:8)&JRXBTPI.+''GK.'WLC7"_C%=H[7M
M+;+1EVR]SD[FV['&+3)2Q=4-Q)]U9MR(K<U9G+6M'CR2):DDLCUTH,8GNP9T
MMFW"?$Q?<.QOJ,\X?S"FIF*XM?,GO&Y><P+OE5R7%N"K9BM@A7]F:VV[<ULS
M8?*U;9=-5T,B&7PXSDPPOK&5SZ8>^7EY6/.O+3O/1!9)C<4HNVK-MM,KP$+(
M[[;+4M2?#;*.HB.5.YD%1%?;$RBD,ZQ-U9?-/Z4=[]W?)3\P*?DV?X->XM\P
M+(KY O5FFQ9\2#D5CEW%<8EL2WT0(SB7;?",_9,Z$8N%/<PBZD\O&N+(3ZR/
MBU\"WIZ>LRVOV+VUO6+;AYK8W;:UDWUI4\?<?CN(D.Q6H\II]YWG41),E'IW
MG0Q,<I93,1\.,O'OA=MF.LK?CJING4[N+GFX=RV:P*1,?1^5$O)&;?D%QO2V
M)A>Z1KJI4=UMM2S(B2:B(B/L"8C)+;II6W)G2=:>P=IZGNF3>'9:]$GW7+,1
MNS+!J:2]6;'M\A^$24J;=H:Y*"*I$9E4,)P6,'QS=WL!O&R6YNY>UV16Z9$O
MN%YC=[/&MSJ7V''6KA?)L.$M+"T-*=)2$D9%R!A,]S&,(GFX/I4_#1=)!].W
M0+BV=W9E4?*=Y";OMSCOQ/=Y34:.TR4/Q%N1V7C2X7-H=2TJ$4G+)E2D1$YK
ML/F$;:9!NUT<[ZX'BS"G[U=\$OIPV$54MPXUNER%I01)6I2S2@Z$1&9GH'+6
M*+;-+JOD]=!'4PCR[^LIK=S*L=E7:7M+FN5JR/&;@V]:WW4+OSGT3DG$<,E)
MAJH94%NRHUV36Z)G+L?1\Z&?,'V@\\SI<WPQZQX7*Q.V-V=_&+K FR6I:47&
MY6UUN.I)EXQ$F+*=+0R,]!(KQALGEMG":R^>9U&[-=37E'=>4^XW7'[_ (O<
M< S1[(=O<NB0;BY:;]9KA?7KF;2;@PQ$AI)R#&))^WH1A-)P8?#/ASQHRD-O
M/C']EK=@5EA[C;,7=S/+99HL2\+B71LV;C<HT1MM<H^:2ZI*I;Z34KVM#,*S
M7+!LMBV8\4TEY]Y??Q%G67UK^9A%Q/%]JKS=.FO+)*X$/#XT"8</%F%JCQVK
MA)OK;DB-S)*23I$LZGR\*"SAZ6$32>2:8_8SN(SBWH[#SC9M+=9:<6T9U-M:
MT)4ILS[309T^0!QE[B2;A:+Y C.&R_-M4^)&=(Z&W(DPW6672,M2-MQ9&'IR
M/1.+Y>'F"]1_FC^6EYB-X7G.YVX,C;>'G3.1V!Y+=]<QN[8G*NZ[E]6)DI<9
MA$X<!@TF?/0DJX=HG);FRNU-2(B*^COAD[XS\4)Y=&:],[^8;@.6^-N@>,N1
M9FV%TM\"Y>_W([7X+K*I,F0Y5F3*4I)D=3Y3U,*S,<U*)6V:8UAA ;*XSE'7
MKYEF,7#IVVTNT2UY3N@UD"XEMM\WZLQBWLY:S<W'SGQHKT1A+L9]*B+F(J"Q
M$]E92;K;KIMCB^B3YTWEN7[K?\N]O;C%6SN.[>U>$6N9BC9T\:Y3;-8&8UQB
MI4;#[A/2$QS,J%51E3B%)J83;,3FP%/+7\Q_?+R>>I._GE6'WU%L8N,BR[G;
M;W*'/M"+DQ;Y+<!EYJ7,. ARC<!2B,B,A,,&,3=%8IXNQDG[G?&4[+JP*],[
M;[*W?\O9UHDQ[*J3/;D1H-VD1'$,/&VB0@WE,2E)-)5]HR[0BM6R>6(K$UGL
M5Y_#I>:7UA^858MV&>I;!+FFWXY<TSL8SN7:Y=HCRK?*<86S!CID%R2TLHED
M7,@S+V*UH++",:TRAB^?%@76!$\Q533[BDNHA8V\HDH4HB:0S(YCTTTJ,8SF
MN3.9K%L1FS4_(<M4#+O*.V1L4A*'K?D&*W^T2$NH)2%,7*WL1'>9"B47T'S[
M#&4Y,:UJP$?->Z(=]?+#Z\;]G5EM5^;P>Z9DC--O=P;9:[B[ BK.]RK\MEU<
M2&Q&CD:F$I]I9$&<4E)F8G#"W@O_ '3O\83@.*[48OB^_P#M1<[QN5CUGCV^
M\Y! GM,MY _'92AN:XPJ2\;3SQD?-J7#A6M9,]F+.(C&9FCRS;SXHSJRZD^O
MK:^S; ;+W6^; 7>\P+'?=O(MMD2WEQIDIF"Y=)5]BK>2R;"'2=57E*IZ%3@R
MS8X3=$0OZ?$#=#.4==?0)<;KAED>F[GX)86\LL>,M-FY)>7*MBY5T@H=1'D/
M>)%)9I(B(N8R[Q>)CRS&56$EY.GG"Y=Y0FX&X&);J8/>IN'W^8NV9?AEPCS+
M7+M4ZTJ1;8DN-[\N(LUH5%6I)D@R/N,@F)CTI7''*?L5H>;A\2G+ZZMG(.RO
M3+:,GVK:DS3=R#(K;.F2+M<U/(4S MT9JURT2$)\=9:D@SJKU$)%9X,IFV)Y
M;5ZWX5CILZL<?VBSKJ-ZF[[F;T#<=R&6WMJRZ=>GI:K<VU#6[,5$NYDY'(TI
M[J&:M!:L8KGPE8T^*[V1S+%^O>P[PWVVSV,$S.':T6F\-Q)#L,G[5%EH=0[(
M0QX#1\[=/:6)%<65\TBV.&*NKR7_ (A7:[8[;[87H,RO;69-R-RZL62%ED.X
M-DP\[=GH,6/XS!O*]I*4&JA$6A"S)9;%,9R=:^,/NL"-E73G.D/*;:GVB3.:
M(D&LR1,A7!]":)X\I*H"7?AF.]<-^$D7"O?1UN1&;<-UB7*A1'JH--$2(+;2
MRH?&J5A,1$X+$_L[?6QR?B#.@+=CHEZV[GOMC.)WE_9;<6^P,JL^:6FWS93-
MGND.?+N[[$HH,)+<8T3&R352R(Z5J)%:T873C6<I^Q=3Z1OBX=O-H>GO"=L]
M[=LKOD6XN#XXQ9G;^U<B0W?CAQTM0'7VG93CC"B;02%:IT3P(ZB3,Q\,8,[8
MMG.?0QX.LKJ?WT\Y_K@M=WPK$+Z].R_(K+:\9Q^WP[A<(>-V3ZR1$>6]*C%/
M8;2FWSB,S49:$+$1G.$,9K7MF,GTE^FCI.A=$GE?)V(:\,[ACVS]_DY#)0TE
MM;]WGXRZ_.2[RLL*,V'$<FJ?O09QC.#YGO0)>[:[YM.),-O+4X6\%^;,O#42
M>?\ +-)TYN LTB)8Z>=O&<7UX<B,BVHOO<6W=S/Y/R;?_, G-\>*[WNV?NI=
MS:-Y9.?LZL,D7AJY?%3GR#-/-P^^(3'U+,TNB8?8NVX.NWF!GWX9BY_/8X)B
MH[F                          -)7LG5/TE?>_GJ%WGH5"&&-:P+9OFG=
M4#G3KTZ7J)8I)LYQGK+E@QKPG.5]!R4K9E.MH0ZVZ9DVJE2KQ'O_ *=^7HZY
MUNV=?':Z-+KONCLS>C\L].C?]1MG4C_9]/&[U8K(/2UME^QWM\G(KHCQ\MS9
MV1=+C.?3S2D*EN(E^TMQ!.ZFX?:8^X]7W%NZW/RK?W&G$1$<(I@X_FCJD]4Z
MG.CIX;31PB.$TK"HJO;VF9F9]IF9U,S'6TBM70TC)+0N I$1&"(9$10  $I>
MRDJZ4_-] D81BJ)5IJ=?3P%1$    !*5#4>FI4U]9"<1&FM3^3T=_KJ D,J(
M,OWN(DX0K2&(W(V( (&1&5# 0/6I4K2E2X?9$ B)!?;/[6FO>&2HE0]2[?N:
M!WH4*IGW\?D%$%_1/Y/MD).2M 8#J6Y6'Q]P=N\EQAXB7)=@OOP*I(S)V.P\
MX7+5*C(R73L'(VNM=MMU9JQ\,3BW=.WD[+J&GN(PI='-Z)E5UY(V^4VZ[>YI
ML%ED\T7_ &SNBFK;"D.'XKL*0M"5FT3CIJY6Z)T))%J/GWU9Z/&COM/J^WMI
MHZ]N,][V7G#::<:VGU';XZ&M;$U[Z+\R2,C,S.IG2NE. ^/15XG"M83#(
M
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M4
M
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M];;-;8GN:H*
M                                    *>^I3<YS:W;"]WBW2$M9!-2W
M LK-"-Q<B6KW?G07,DS-DE\]2[ANVNE;J:GB^%Q.H;F[;;:=2W.,(]:V%AV$
M2&5M6.9*5+R&ZNKNF;9#*K(D242UE,AQVEO$IR,3:7.7V3(J#O[+[-+1^?3^
MK#Q5]MVON(T>;FF9K?/N5"1V8T&,B#"8)EAE*4(2E/.\M1>RI1K(O$/F,JCK
M[KKKYYKYF9EV-D6Z=O+9$1:UI*85IMDN_9/<X6.X] 8=EW&Z7.6Q$)F.PVIY
MPT(EN->(9M-JH1&-VEMYNB=74F-/;VXW73A2.ZN;3=N-2-2-GM++MQO[YB+;
M+(FZLSA'PUIC,,83S4/-2C[ILW#IOZ9;V];=O(#ST+.,X@/.,.7\V7);*V6E
ML2R6A"5>R9IT,C'R3SUYZT=;0GHW1-28V\32Z^,]2:4IA28I/M?T-_E;_E:W
M&AN;/J1]3-*+=3"_;[>^*Q9\,UF)MQJQPLHOB9Q_5L+G3"84HW>9Q2UOON*4
MIYUUPU&IPW'#,]:\1\DT[;J_-U<=27[UZQU*->+=GM8BW;61$1$12(B,(RPR
MH[)M3O'F^R]Z^M<2EK.*\9>^6DS,V97+R4J1N);*G)W#G;7=ZVVNY]*[ENG.
M7B^M="V'6]K\G>6Q\VWX;NQ4^?F$[A'^B8DWSJ(N8B=1Q+B>CQ<>([3^,Z\Q
MG$O)1]->ES%9U9K_ )=SNN$^8#&G71F#GV+^XVYUQ#97 GN?P.=2$&LT)>UI
M4S^0;=/JU;_VUM;9X]C@=0^F_P K2Y^FZW-K1'PTS^Q7G8\NPO*;8U?+!DMM
MD6EQE+[KKDJ*PN.DT$X:3;6]S'R),=I;?HZMGS-.Z)MGU/G.OLM]LM>=ON=*
MZW6B:1A,U^Q3/NQUC[=[;R)5EQA",OOT:J#-I9-M-/>V1$3B7N15%I(<3<=1
MV^E$VZ4<]_;V/5]'\D=3ZIRZV\KH;:[US,>Q1G?^MO>6]23D0#*S,\QFTRE*
M7*(,S,B,R=/@FA#JK^J[JZ9B+Z1V4>ZVWD#HFC;%NI'//&7,8MUV;I6%:$Y!
M;DY!#-:">(U):42#,B4=?&K]$C&6CU;7MNI==S1V9-&]^GW2MQAMI^5J4E7M
ML_U$[=[SH3"M<QFSY,E!&]9WEI2:G#2@U$AQQT^;5?8.XV^[T=WA92W5[/\
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MCLP=?TRE-2_C5<(\I!-.G.M:UOETT_WT./?PCN<S2FMJZP-;8
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M0+5!;\*#;(42WPV:U\*+"8;C1VZ]O(TV1?(*Q;T
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MRM>T9X\43
M
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MR&,Y=Y$TNQR9&=L-#MNM;J%I4DX,52%),E)6E4=LR-*DF9&5.TA:,.]R(H
M
M
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M'I78>N5R?&+BW=L?LUP;.I2K;"=,S_/*CMFKM.M%&.@F,9>NLFMD3W.=!D
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M3O\ ]TCC:D3AZ',TOA75QK;0
M                  89OG:_#^]1/7[U@P^H/:?.G+?8YT*W6^Z69Z>XW'BI
MB$I)R&HZF7&C<[^)&DS*FHD835E/BMY:T7 ?)O\ (*VH\MZ;)WDSFXQMR^H&
M\Q&R:R!^(RTSBR'8[+,N+"1[HR2GW39^F6A$?:?"4XIEEBR+D$HJ\W&O'O+6
MA4[*$,^#'BG$4
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M&^R?16/:\IN^G;S8W<FYLFV7O"EDDR(^VNOJ^0=+S<(S<.(KZ4XM8K3B@*
M
M                                                 L2=43B9O7!;
M6:\OU=";-7\%XD55/FJ%:$QA#</*(WG"3H25J+UZG\W 8ML]C3K2M="*FHJ!
MTX'V_< 3+)IIAV5,D,0H+"%./RI+S;#:$(2:U&E3JD)69$1Z$>M!*S,TX),>
MIXH]O%<<JO2L,V%PZX;D90Z[[I[^F/*B08#YJ-DG"E<BXSJ4.*(^.I#++.4K
M68Y<U1.W70\Y.GV[<3K+RQ=WEQU>_P!KVX9-;4.,X@R?81(?82EE]#3J5),E
M'K3B0E*1AA"3..&,O2=Q_,BVHV)O);:VO 7G&;:TW$M47'8JI+!I8;4S'2XF
MUT3S*)LB,S*IGQ&<3%N-OPL)Q\,YRIFS7K\ZQLGCGD6W&TTG&\1D$XN!<;DA
MQM;S#9*4:SCRS2I)I;H8QK,12<EI$33&O%33$\T/JRM5X4Q>9L*8W'>Y78:8
M,5H^9*R)31N$\1\2,A.:,UG&>6(7 >G[S1,:S2Y6W$-[\=?P^Y7)2(\/(TM+
M>@./+-IM'CN)6IB,E;BSH9F0M8NBDX$Q$S6,87.+E>[&FP2;O;[DQ+C2(R'8
M+S#K;K;[4AKG0I"VUJ2H^195(C.@SB:6S$34RF:1@IH4HUJ2YJ:ER253@=%/
M5+4:JTOHQF.:RO%53;4TLUK,]5> 6I_PB2[Q)FLMDYMP14K0J<-:\1$1 <#E
M*#/'+LDBH?(@ZZ&?!7#N%F*VL;9F)PR>;[5G$BJN5PF/(9)KF^ER\Q\*$DM#
MU] 8Y\%B?#WO.M^>L/;/IZM*+GDTM,JYSO%19\<B)][G37T^*22<88=]X8(W
M$%J:>T;(F*1-N:37&)G%:<W%\UK?I^XOIQ;&RQ6$LU' 9DH2ZXME1K-I:D//
MI6DS;-)ZD$W3.-WQ$6Q;%;:MAMWYA_6OE=SC1++;(N72I1N.1[8W'CQE/MLF
M2G$I6EQ1U))TT[Q(F9A9I\5)55XOYJ5^L:E6/>C9+(K+D,1UF/)=8M]P>BMN
M+4EGG4^EM3/ADNIF9&6@6W3,4C@EUL5QR5VX9U P,ZQ^/D-H0B3[VEM?@I-)
M*C)=)"D-K22U&2DDX1:A-)CQ3XH6(FSX8P>\VV0[,M\::\CPW)">8T=VA']T
M83CB1[&\3Q3S'RU/AQ[?0$9D_#+PC<5Q:<E/2AM^&I-#XFDS46I=AF0LQ2>\
MMF)BBV]UI;>S;!-QOJ>P5A3-[QV0AG.HL5!UG0Y#BVFW'&VD%SDTP5=3"DXV
MR1/-C&'8IUONZUXWHO=@V[V(6^E-Y9:3F.2QV5N%9R-M'OB%D@W"2I1.F6M#
MJ,O0RF:Q-<U2-GZ*=@LFP^;A;-TN#&Z:(_UI;LQE299+^O(C?O:4-,O(J7/<
M$D6@DYTX$3A*KGH0WYRZ^Q\BV!WA);>Y^U#S=O.XR7#2O(+2=6X,AMMQ?/S,
MQTIKI0R,(R8TKZ87(10                                $KP"OV!0
M*D8  5(^!U                     0J53+M+B B
M
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MC,M?TE0B;_V*C9=I]B1Y_4BE\^EZ[;7<VA;/<]5&#>
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M7PKK(U-H   5X )7@ H   )$Q., *         E> !6*TX@*
M
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MM:"-"T*29DI*DG4C+L'QB;9B>7X9AXJ:QA=P^QN!D@
M
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M$%[')J?LUKK77[(HU
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M/U>[_H FVR<[5YM3M1_8EVC+4L#?,^PO?W:?QI!RV4IRX'-J=J![2[2$1_\
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M:ST[<UY)X1/%< 2H^<B(ZH47,G0M2,C/CQ'@XK68F,(?5:U[ZM<9
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MD1.XMRBV:>R51O3HLU[1XNH_Y5(+Y">41?8'GM:*:DP];LIKMK9>WC4Y8
M                                      @HJD=!)PBLF/!01YA,#+V=
MA;MFN$.L0[YA:?K<Y2T->*U#C)4Y))+JR)9$I#=*$9<1VW1-AH]6WUFQOK-V
MI/+;Z9=#YDZEO>D]*U.H;.DSI6S==7]6(K/V0Q^,!ZJ<LZM;#N!=;HS%E8U@
MK*("B4PR:"E-(.,\M39J=2LU.F9U.@[CS=Y3N\G:UFQWD\O4[J3R]TXP\O\
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M&2S$YSFUA4
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MLTXIHSC'K7%1XIT0
M
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M,FZ^8)9H">64UA5K<6IUDR<0R[+@)4GQ%-\R6S)?8=!<8FDYE*VU7D14
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MK4B&7?Q8<MU,(K#-:\\+S8\@\LGI3V[PK;=MF7U";@X9:[/8EG*9=D8VY;[
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M*@^FIQ3NSV++65%&B7IW4DK(OL$//[B*:LP]?LL-O:]X&ER@
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M )EW74-KCM]6^9M]%9]CZ=Y8VVMLO*FSV.ZPW>EI6Q=AQBV(FO;C$LQO'/\
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MM[>2;L[>R7L-AO+-]M;=Q9A7.%1H]8Y@
M
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M_"/D3Q(
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MK4I_F<7!A6R0MHTLN.$LR)XB2>BJ4%XXYLYI-L3"[<*Q
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MS/J&W"D9_E%M<Y(5SD,FTXR10DKHJKB^<^?4SHFI]A!3EF86LW6Q-V<L8'S
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M^UL^;N+;9[7?5*Y2)*=:$1$6A<NA?/4<*(KC+UU(C".P3J5*:=]0G.O$#/\
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M^PYB]#K0II?-*<T^0>?U\-6:O7;/^[VO>QJ<D
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M6=-L[YE<_'V9W@
M                                                         #1<
M<2TEUUQ1):90IQPSX$A*#4HS[N4BJ)RS,TIA)&,TAB;]>N=GU2==EMP.TW)5
MXP?:Q]KQ&VU*7#3*JY[SSH);S)GXQ&6J2,?I;R/L9Z%Y4G<ZEO+NMQ[:<'T'
M;76]#\LW[N^*:^M%(GB]G?Y&FV8C"4HC1&&(S+2")"$$RTAHZ)21$5>7N&R9
MFO-=\4OF]L83==-;KIF:MJKV4DGC7M^6HLX11M3\ID1$2J4KV<1:(E,S1J?M
M<WR</G[Q,E0YN?V:4KV\>&OH[@K7 /#_ (+['[\*3VB>BOSW^=(6D]HB5::G
M7T\!404KEII6HDS14I+-1T+2O;Q^Q02M<!,1*KJJOHH1"XH@2DEH>GHU.GRA
M6%0,N<B/AQ]/YG<%*@2*&1U^Q^_$B*#4&2   E50C29G2E>SB)-.(F922UH;
M2=3YB/@? E$9G\A"842Z:6S*V[U>Y<J]9_&QAI]2X%E(B5'(S\/F<)WB1*-/
M'T#TO1M*;-"=68QNXOI7DS:?(Z?.YNBFKJ<?0I:[*$5*$1$7<1:#MZ4>NQIW
MATIQXA)/8@ C30S/2E/L@E4/4)Z%]"(H'V:]]2I\VHDS00$YE1H?'L^T,F/%
M"G$J:=QZEZ>($5AV_;W</)-K<@8R#')3WNY.H.?;>=9LR6>9'B%R&M+::(3W
M#3N-MI;JSDU(\?">QPNI=-VW5]O.VW$1S4PNXQ*[)MUN+CNZV-QLAL*VVIR&
MT_6MLYT&['>Y4<QDGG4M7,M1CR&YVVILM7Y.I%8G*7R#J/3-STG=SM]S7EKX
M;N$NZ5XEVEQ+N&FKA<^-)C%$5F .B;N7$K5M/F<E1T)<%QNO=SL/)XU[1NVE
MEVIN].VSMQ]KF]+L^;U70MC.+OO5^^2-C:[5TW3KPHO8OEWD/(5RTYB;<3]\
M9%S<>\Q\R^K.K%_7+=*)QML>E\XZL:G4>7C;;'N7JA\J>0
M
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MF1E=+HI-*\2A.'V>D8SG':R_#,/&O@\L%PJ]85U#9=><9M%URJ"_C,>%>KA
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M(U=3^U+V_I>,SV9QHS[7[I\WO[U/L#HMW^_EZSI_]UMKVS[U08XSF@
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MTB(F=>'I'[!^B^C.EY(V\S%*S/W/;]!BG3+(GO7#Q]:=P
M
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M:LSE%(7)1X9T
M
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M^[Z>(!0JU[0$:\"[^ !WZ>H^\!"O&FIE33AQ <3DCQL8Y=%D9$?(DBUIQ)7
M7"F)E,3*F=A1I5SEVN*,R[ZJ/YAC,1);=,Q-SS7+WRCYI;;@DO$]R:?)+1GI
MSNH/E5KPY3U&R9QB>"4\%,I=PP"U-$ER^SW#D7">F1*>?65?"1#(W6R29D="
M2E/8?8%*>@GENFDYK2V\L]>Y.[6]NX,J5[S%PIRV0[+]\PGQE.QWB;U6VDZ\
M:&0MN=9*<N$KX70RCP^F7;DJUK#E+_S<E:ONB1DMTUFJKD5
M               &RN7_ !=/_H*5_,' 6,WR,O.<_P"\OWI/NS;'O^7I(QM-
M3XY?2_\ *9=4[T ].ZEG4RPR$FM*:$TU0J"Q6F)=6N.:XV*BW[YH_P#@*=0?
M_4>Z_P!)R!)96YOFZ?#[D9>:9M9I_P#.68?\ML"W?"FGFS ?BH"(^@A-?]U%
M_2[XL9$_#/I6>_A G#;WDW^H7LK@6Y%?X:+;D^O0A)K@MLQRSVK8WQ)^U.2[
M6^:5D^6JAR%V/)[EC=^LLMQEQIB0F._)N,MEIU3:&UG')!I.BCX!$X^AA-M<
M\IEG4^2#U;;2;_=!>TB;#F-B1DN%V2'8LLL4JYP8L^V3&V&C;YHSTLWE,N-$
M7MT(B/3N$HSF>::Q&#&7^,"W!P7*\RV,PW&,FM5^RBQQ)K]WMMJG0YYP$2V+
MDXT3ZXDA_P )PT*U2HB-)Z&+$Q24NK'*N5?"B$:>A_/$GQ3R$?K*VH(R^0PF
MM<2WX+?6PY/-&J?FJ;J%V%N5CG_ZT.B6Y0QU*\]W9@^IOT#_ ."/L?\ ]1K'
M_P FQ0C)G=\3!E^+>ZIMW+_U([;]+S5_NUIVNM;2ITJV6^5,@M7:3<8DLGER
M51I#:924-H(J*2=*!$XI,3,1'"?M7 _AZO*/Z!=Q.C^R;\;P8MB&Y6X.62N9
M<?(+C;WI&-LQ6HZG4/1)"3?2J2ZHC)2SIH?:&&7$MKRQ=$8K,_Q*NTG3'L5U
M)8G@'338L:QQ3%OBR,LM6*OVV1&:<EQ93S?C':R)+:N:E4+]I!E0]1+8C*&5
M];J3&?%E1?#P94C;ORCK!GTF*Y<(V+VR]WI^#']I^0S A,2GT(2GF5S^&T="
MH,I^*4IX([%-3?G+^4KYH6[MNZ4.H7:2W3KM)R"\8[ O631H,-VUW2+-.RNH
M^M9'(^3;KRS(DFJB#U(N)&F)RX+S63;2RZ?%W.K]<'PL71+G&W>8[B;#Y##V
MINEHL=VR.VRD2H+UJF-PH4RY-QBGH8)FDEM*20HCH>FH4F<)8VQ9;W=[$V\J
M'J2WCZ&/,GVTP?;G);W<<>O.:7'#,HQMJXSYUMN\5N]L6-4@H:9:8I)-F.:B
M,D'0C$NIGQ33CQ5CX9S[V=%\25-7-\LK*YSK2B7.BVF4XDB,B;7)A/O*2HZ>
MSRFLQ8H3/AGL8K7PGD^UVWK\SU=UN<"TDY;):XRKE,CP6I'APH9K2R[+=:0X
MY0J$E)F:CT+43C'8L3-)JSU?,TEQ9_0KO[(@RH\R.O"KGR/Q7VI#*J17Z\KK
M2EH.E>\7!E9$\SYM'D'\W[K7M]QH68Y1V?\ ME@6[BUV_';ZV3=\8/3]JKLY
M4O\ UI=>_3]1.=PQXPV?AN=&^#@*FU74C_1N*?TE$$MSEC^"/6]X^+C_ ,$[
M;PJ<;K=/D_4SXOXH)FFE/J4/?!YI+ZXZ@:ZF4>T4/_6K8$YL8F>:5V/XI;_N
M^[U7A[T?\PEBQFL_!*Q+\(87_P!NVZQD6GNC7\PMX3P6S\=<\'T101MY?\ZR
M?Z'>_F:@(?);\]M1H\TG=Y;J5LH;RS&U+YDF2B05XDFI7*9$="250BD1$)?C
M=/;@^CGY1.0XU,Z ^G*/;L@L\UY[#(IHC,7.$[+)1)0VMMR*V^IYMU*DZI-)
M*H9'VB1,49W9L"+XI'G_ '2Z[U,Z>)A]-.S\-3[ MM>9AE;'IEG:>209)\M'
MIO.GLEB]>WA^!",:0RFL3AFM(?%H[,99GW1UB&XN/6Z1-MNVETG2KP\PVX[[
MJU<8[R&G5I;:<HDC3Q,R(2:UI!,Q%DU[F._\/=B?EX=06Y>5[!=;&&8_D^79
M0U#;VNO-_F0H4-N1&1 *='.3,6EEI2W5J3J>A]@>Y,\+IQ][,&R7R1/)IPNP
M77+<AVLP.TV&R0)5VGW!_)+ TRS"B,.2G5I6<<N<_!;/E(CJKL#NK@4[D?+:
MZ=?)[N&69/U"] 5BQR9FF INUIN5QM4^.Y*A241W&7TG"1SOJ2HXQ$2^;EX=
MXO=V%L1$3-O%@:>=SO5G_5+YCV>6S<;(KRG&\<S&Q8Q9;&J?.8MUJMKE\?M+
MKI03D+BIY8JC,U<A:%KH%(I7BEU>:8G*,F<)Y?WDY>67@G29ME?[OM_MQGE_
MO.$1+UD>;W>XV5]V7)FVYJ1)2Z[(3X,,XM#+VZFD]3.AB=\YLXBDX92P"O,%
MMNV%B\R',L<V09@QML+-N18(EFBVI4=RVL&UE"F'D1W(A%%4E*FR*J>PA;8K
M2F;'4^*Z.&%'U/\ I/0IOH2P=*B]HMF7CH6M:XHHR(J5XB\5O^Y\I"TR&(WF
MI6V;+<*)!C[[2%29+YDVTP1[A'0W7'#2AM-"XF9%0AAA3O7.ZO"C[ =GO=CN
MNV#)6F\VJZ<NW[1D=NN,2=[!XZ@^:D5UTN4RH9'VU&2=[Y#?4'IYJ&=U+VOV
M9K5IP_\ GE7R!%.+'5I5]<;9S_!\P/\ _9A9/_U9C KY.7F:?]YMN%_^U7'?
M_P!;W18R8W_%/J?52Z.:?M4=H*</V.;%_P AQ1C&39?\6+Y>OG65_=9-TS(J
MUSC%JG7OOKPRB<(AKU/CN]3.3W>V:OF_?D-3-N<=@NW&\S]GX-PA1&4J6ZZJ
MU6_WM9(2VVZM1^$E6A$9C'*,<VZZ*ZE,H?/Z\LB;TW6?K$P_#>M''V;GM(_E
MUUQO)++<R2PB%)*]-6J+[P4DB)I*GB5JHB%:K>$3\+Z(]I\CWR;\FLMOR:R[
M1X"[9+M;HETARHV1X^J,<.5'1*:=-SPG4H/P7"-1&KV3J"Q$1D\ VBZ&?(+R
M/J;5LGM?8<(N._NV,]BY)M4*^V];L>=;Y#<QHXCZ$&U+6T^PG1LB.N@3-4B(
MC#L6Q/C#D-Q<7Z9K='23<.WP;M%AM%J3;++-R:;21]I$A)%\@3A&&:TR[%6_
MPD)__=&SHNPKG:_Z4CAWK'[JUY9\8;7]@#8:G'ZYR3^D70XF')-7E7P=7_1?
MJ",^/AV;^,M@0QXO+OC >;\L.GTC;61*B7KD<-*B09^!=-"49$D]1%NRA</^
M$^R''HW1)>8<S(+-%GM7B,T];I=S@Q9J%.L-&@RBO/HD*0HBIS<M",R+B9!Q
MEEG9;V,LEHU*+Q.=*T+(E(Y#)2>4^"DJ+11*+47#@Q:H
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MI-4UYC] ]1U2ZW;[6ZRZ*:FK3['B>B6W[SJ%FI9-=+;U^U6B/)/H
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M*7O?3$T;6S>,I/[Y=Q<+U.3'5D7R5'0;F>;5F7KMC$V[:V)[WOXT.8
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M7[!1#Z8\&4E/*I]$A9Z4,]&?00_;/TLTOE>2=I;W3/N>]Z-$1T^RBM8?0W:
M
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M60OY:Q4Z,]FRI3^HB]/]<'Y]\]Q_]T;G^NT^8/\ >VM7]97:/(NE
M
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MJ]HR(O28SMPCO971A%,5_7HB2:.FG;9)E3^IKA_.Y4(2[&56 (
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MQP"VY,M;F00L/QR->E.*-3AW-FT0VYW.I7M*64E*JF>IF$11CCQS>A"@
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MK\-&'OE[*EK/ZS=^@V7,H]"[$D8UW7:=F,PRM^9=-(G%1YNCEF(NY)/PG:;
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MXS@J*'0/7@                     )3B H4_>J?[Q@%/LB3$2 H %"[@
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MJ0L_NCSFO3YLT>SV=?R]M<WNHTN2
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M8_?VWMBW9Z-D91I6_P!F'T:W"V(X1;#5Y:Z5^CZ._495HR"+VJUJ9<=/0)7
M*GS>D^*?46FHO *D9D9G2G93[H4X"8R/OI\A"99AH53^<,52D9)T/L[>^NH4
MKBB)5YSH52TJ5:5TTU%PIB*O?+[A+F]86W!H34XSDLS33FH1G'/70^\?._JS
MJ19Y&W%>-/O=;U>[DV%U,:LKBX5.6HCXDAI/RDFGVQ^.-']W#P:E+JA=Y;98
M6B.BE/)*G;^B+[.T=?U*E+*Y\T>]CJU^7AVK\O0VT373+MLFFIVUQ2O2HU\?
MF(?N3Z<?^#MG_JWO^E6\NQLCC15L/<NQ
M
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M/B1#XG]2NGW[/S/K77QX-2ET=[G>:-O=H=5ONG*ZDKH@\"\X
M
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MS:'\PDTR&,W\2AF?F)X?T^X;<NB&S9 =AMES1<]Q[_C*ICUUALPUR9,1IF%
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M9\QR/J^+XYJK6OC$V3E:]M0]Q67))3RFHRX'2A4X4+L 3
M                   "1:TMH4XLZ(;2I:S[DI(S,_D(A)%LA^';<PZD\SW
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MTD"3?=?,WSG,UER^2W3IIV861$1'J>F @
M                #1>CLR4&U(::?:42DK:>;2ZVM*BH9*0LE)41EWD+PH.$
M8Q+%(KZ9,7&,>C24*-2)#%EMK+Z5&=34EUN,EQ*C/6I&(.P$5*$6A%V%P_?
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M7];[X6/)95ZX=I*?VRV_3_WI&[1\UMI_'[/]99_:A^P?,<__ +#-_P#ZB_\
MLW,YZ[/DWMYN8;J>7FQ[!D$Z7!9JMD8B+3NJ/UCU.W#1Y?U(]S^(71+[H_-\
M^-OS[\?^/*IW8-A4?:O%VEIY5%&6=/0I9F1_*1CS.K^\FKVVU_<6O8QK<@
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MI]'+Y2V<?]6^B=/BFSLC^BJF'M'-
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M';%+NYE"'S&54G7M[-2/AKZA^>ZXT_RAX**5QR3C)
M
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M-^V[,ELVG4VJIH,ZT)2B-)_*0D35+OB53"L0
M            !HK0:E&9)[M:_2T]>E B(K62LTI#;S(,6X1G(=QA1;C$>+E=
MC38[$F.ZDR,C2XP^AQI9&1\#(7"8,:]RD+._+\Z/]R+\YDN7;&8-<;NZ]XZY
M"+';HR3=-:G#5X3$5""JM1GP&-(6+IC)[EMMLCM5M!;F[3MMM_B^)Q6:$EVU
MV6VQ92B)"$$2I;$=N0LB2@M#50(B,\B9G-ZR*@
M                                                       D)Q)J
M6G\Y2ORBT$>9/?\ ;+[84F")KD)42N!\!C$U*<4PH
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M,0U'52HLM]QUJM3K2AUX%Q$M<FZ8G&%:HS8@
M                                      @9<.[M*G$!@/>>IYE/63Y?
M_F>8]=^GO/Y;.*W:#;G,CP9]#DBW7*.EAPY,?PGI;49OQF&3U)/$3.O:MU8B
M*9=G:N2^7O\ %'=,/4!+MVW'5!#1L7N&F-"@,W.:ZB5:<@N:BBLJ=-PI2RA$
M[(=574R*G *\4C'#*64/@NXF"[D6&VY)@F4V+)[+=8C4Z#+L]TA7!*X[R$N(
M4LHK[RFU<JR,TJH95U%68H[HI24TYCI7AH?W 02I*JT.M./'M 3
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M5S)*WL*KPJ:VTJ/[8\KJ36^?2]UM[>71MCA1Z*,&\
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M*2I ZG#-5^Q5@CU]^C$:?6_3[HZS?Q-^KI64PF^/>E_P1Z8][(KZ6(WNFQ.
M,4IRVAD^%.*$&/WKY*TOD^6-I9V:4>Y]'V<3&VLKGRPJ$'JG)
M
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ME2'R,J&=1^8>N=,UND=2U>GZO[RR^E<O0\OOMIJ;+=W[;4^*VZ7MHZQQ
M
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MCD<*RQC4G30C:09<-#%8SFJ!!
M
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M.27I\%WNJ)6&,W1/"J"=J<E(B/\ 9$DZ_P"DN]@1=$S2.)6W\4(%M1DM3_\
MM#D%3@9M.]I:\= KC2>#+FTICX43VJR;6FXDBFE/P3GRB\U6%8_50_8IR56A
M[BR"I_I3FM1.:#FB."/[%&2\/V1I%#XGX+G9P")B3FCL1_8HR2B2_9&D:5_D
M3G:+7@G-'ZI^Q3DO]\>1_L+@'-'8?L4Y+_?'D?["X)-T1F5C]5*K:C)M/_M$
MD*X\&7/N!S1FM:?A1_8GR<Z5W$D]O\A=T_\ "),UP6+HMGX4?V)LE_OB2?\
M871/5"_,CL0/:C)_9/\ 9#DU*M?P+OY@RYJ,:Q7X7))V R"]0_#E[F2X[+U.
M=:&GB42>!D1IUU(Z#'.M)HV6SQHYC&-CL$VWN97)E#^0Y.^DR5D<N0ZX9&9$
M2C0P\1\E:=@D1%N$?%VL+[KYCQ?#V/5>G1SW+<;<BVM$7@J.$YH1$7,9(/T=
MX6_%/<WQ$_+C!6F-C$       ! S(N)D7K.@"7Q&RXK07\4G\T!#QF2XNME_
M%I_- 2G)CEQ?9+UNH+_\(!*<N(7&3'+UO-_Z(!+[]"+C+BE_OAK_ $8"'UA
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MXMC?PHQ<B,G* ('P/U DY2Q)_,HJ?6/EI%_*XM?]CD4XCP?FO#?6SQH_7_\
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MRV?C0M)$?RQQ'^VG'/U[MGXT('Y8XB?#*<<_7RV?C0!^6.(EQRK'/U\MGXT
ML0?$87G';KY9N[ON.26"5(;5"\.'&O%N?EO\S4W5F.W(4\ZDJ:\I'02<X)PM
ME\P>S--NVI"'FD.(6Y():76TJ,R-9EISD9IT,4=]VUW%W:V/R"#ENQVY.2;>
M7RVRFIL?W*[754)QZ.ZV^A"H#,MB.I"G&4E0RI02:Y<#+&)I<RK.@/XK+=3;
M.+:<"ZY<4<S*(IR!;F]RH:F8C\>*T<6*N7(B%,4;YDTE;BN8N8S[0B)C(YHF
M*7Q2F<LT;I/Z^.E;K/P]O,]A-U<;RB&;,-<R JX0H5UAO266G/ =MSTHY!FT
MITD&:2-/-I74*8UXP1C%8RE641D9$9&1D9$9&1U(R/@9'P,C%$0        %
M#?F,;>Q=R>DG=.Q.Q&Y,AJT_6,-1H2IQIZ"EQXE-J-"U)]FO"@]7Y)WE^R\R
M;;6LG#FI/HEW/0-?\OU33U.^GM8\'2%D#U_VA^JYRS.5C4V=#2E1F:DDU))@
MJF9F=*(] _0?6=.-/>\UN5T1/V-WF_;V[;K4WV?!J1$JEQUKSK3YN)EH6E5?
M:T$JJ8B/7OT]KO\ D[*!B@1D9Z'PXE3OX!6N0F% !*>O,7TN'L\*?*()'.SY
M?N"7*E1](OE^T8D9C7&: "!ZZ4J1\=>'<(($5*T*G#6O'\R@0)A1*CZ)?+]L
MQ(R$PH -Y"42'''E?0:C25G_ !+2E?8Y1KOG##-KU/A],PLU[OW5N^;J97-:
M/\$4KD09:D?(XZDZ4,Q[38V<FTLB<IA]GZ+ISMND:,3G,.@#E.TB*10(J:D&
M24C([#[^P%FO (M= ,L2I<>P#@     ( (@'W>'I[P*XT#T.E:>F@=R5P>Q]
M/4%Z?NO94L(-7N[AJ<IK0JMF1GQH.!U*Z+=G,QQ=%YGU8T^C7Q.<Y+M4HC-[
M15")MI-*$=#2@B,OG'DHC#"<'R+2_=Q7-MJ$9U45"]=:Z>@28F<LV5U,Y<#F
M.,QLXPO(L3ELH?\ K"#(5'0X25))QF.Z:#22DJ(CYS[JC9HZWY?7LU[<+K9;
MMINKMCO-/>6X3;='O>T^2IONY8INX/2YE\YUJ[XM/6_B\.4XLC7'-:#>:CI=
M=*J22=:)07 >/^J_2/FQH]?V\1\K4MI=,1QX3+W/FO:QN-'2ZQH1'RM2V*^F
MC(D'Q&*TQS>%!0
M
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MQ8R2ZM,%^K9.VE:MJ\'AE6C>/VQ95J5/$A,JX'3\\,<\8Q8SF]5&2
M
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MR,C^0?K7K-_-O-.W_JK?LM?P\\OQR]-W%]<]SJ?_ (DJ\\&22<1QXDE0OJB
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M_P#DXE(/G?Y40_;4]8?]^S>S];\^_3A:01JQ_E!^VIZPSX;V[V%Z?J_/M/\
MQP4[#YL3E[D/VT_6)_?PWL_6[/OT\2D]ASH'U4]89TY=[M[-/_9V?=O^OBTD
MG4MX^Y']M3UA&5$;V[V5[_J_/2^QXX4]I\S_ "HB755U@_?;V;V'_O#/=/\
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MIZ_PW:04[3YD<,O0?MJ>L*ITWMWK[*G]7Y]^G!3L7YGM]")]5/6%_?NWL/\
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MSH9^W3T<M?LC&9[U3).M?:YODI06 53E.I5+N^4)RQ0U,B-)T^2OVPSR$PH
M(:U+3UGW %3TT[ZZ\.[UU$$11+HDS,S^E3L[A,E1(J$1!&"-/^2?O?G1/Q*U
M1DB0O:(R,^8M.R@D8JF(B(J$*@9F1:$:C/@1<?F(C$FE<6-U.+HNZV:VO;7
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MIM[)>&NBETQWMV,4
M
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M3_?(4.:.V*N%?^+'Q!A9D?31<321<2R%FI]G^Z0IQHG-'&<7#R/BW,08YO\
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M_BM7+^Z)O\<#Q=F*^'M/\LIP7_%9N7]T3?XX)XNQ*PC_ )91@M"/]JU<M?\
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M$S,XRC0C*M-2^E]P)B)7FG+@TED7*?R?;$I$<$K+U*R?\61?0@&Z,G+"*@?
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MT?D;2V([;NUU+Y/N<!LHYN62(I$4BB)'0,DF$"+MI6GW06?M"[^) %.TCJ1
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MXX
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M*S/EUT(O0$Y=J<8CBR+;.V;=IM+?T2;MT)!II^=BM)(O12@8U8.3%
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MN]E UQ\43VMMF.FK4&U
M                      2FJAI+\]7[!5%X#YU?Q%W3+U(=3_FA8C@W3_M;
M?LWO$R%;(I3XT*<BVPW9#3D?F>N"(KL1M+:)/.9F9_1I3M&&%6<QS1%,:*R/
M+]^% MQL8UN1UVY8Y?KTE]B7,VNAH:)F.7ZEDKC2+@B&A)\M%M_?'QJ+CFUT
MKA=C#,+Z?>EK87I>P6T;=;([;XUA6,V1/+!;@6N#[_4D--FI^Y%&3+?49,D?
MM*H1ZD+2BUKBJ Y3,C(U5,^!\I%3Y*ZA/<"$$@J<3[_WU0,LDX
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M_P"TZG_XDKJ5BK]1V:O'ZJMU?7[HR/$SG/I?4K/ACT.5$9
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M;)CQK5 6;*2*C:CB-&;94TH@]/D'Z MMC3MBR(I$81'H>HI$12,N#G1D
M
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MN]2;/AYY][W =.XH
M
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M5-%%[5.XA9B)C!C$\602VGPO"93]!MM#9>@D(H7V"$F:17@E<:-P*
M
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M.R&VR/V=5:8VH
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M70[$5+'9B+@5JMQ?-$9'B[OBFN=7TZWX8]#E1&0
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M=F%8@
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MD9>@"M<@RIZ^WT=P( J!G3[HDXX0(T/YQC25JA0*2 RC)$:T(Q2>T *]G?\
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M77SG,S/M>"ONYKIN[9JY 8,0
M
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MEN+&M+Z3,VC]\;;9>2A1$I!F1*X$H3T%<)7N$D9&JO:94/Y]/D%X48<4X*
M
M                                                           -
ML\M:>:A5+D,B/\ZI2=#IVT,,(],D1,RL(;@>0-TP;[=<&4]:746X>YDV\R8L
MZT87):*/;[;*AK4]&.0HXY^\H2ZJIIKJ5=2$BM,5I2ZOXE[W ]N,#VQL-IQ7
M <3L6,62SPFH$&)9[7"MZ68K#26VTJ5%CM*=4:$$1J49F=-1EG%2OMEWL1
M                  %.75A_V$YM_0T?^;I&-V3;H_O(4R;0%_\ 9-AWI*7_
M /@A&#B:WQR] &34  "!T,J&),Q&8D,CYTF7 ZU^0@FO P1H:2]G4SXG^^,4
M3%Z3KZ0$0       2G])/R_: 2_R/][\\ [M:OYR:^490Y>E\$.(O-?>6:=Y
M_:&N_N:[YI[6CT_?]J6Y&M?9@]E/O4#"/C;K/W?>K3&UB
M
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M0ZZ&]V<4
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M
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M4J4.AI[*!,3Q(NB([W*K/CP2DM$I2DB))=Q$6@BX>H[]/4?> AJ==.7N/0P
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MQ;JKKN#/F7&24AE;;Y1VI"BC<ZG4)=-)D9TJ9E0([8R6:1;%L+E K$
M                                     !CE>;IY^EF\K7='$MN+ELXO
M/SR9HW/K%-P5&]W]A]9%X:9<>M?![CXB8U[BZL4B,Y6BIWQH>#VUQ,>3TT2D
M/'R*,BN+[A$E1UKS)N1EP%B<4BN4YJVNE7XL_HYWKR>P8[NUCLK9QB^26(2;
MQ)F-3XK,J2['882ZP<LW&6U.O4,U&="342JS-L<<64M@.X&&[GXM9\UV_P C
MM658Q?X4:X6^[6B=%G,+C2FDOLFI45UU+:S;654&9*((QAE2F$82[T*Q
M         &VEO%&CORE?1C,/2%>E+39N*+B7%*3"N%"E6()UE?%8XCTI=2>X
M6PB>G]W*6<#EG#<OZ+N9>^J2[*:6HFV[@VE/*<;AREQ$BM*RL_%R]BE'_+4-
MN]2_:US.9)F1_JZ10SKV?U2[*"^ACC7')4AT@?%F89U6=2&V^P4+I]DV-6X-
MT3:F[TJ>\?N3SCC*4'R'/<)54K,^!\ PXLHB;IIE+,9AOE*B19))Y2DQV7R3
M^=)YM+E/DY@1N0
M      H "!$1<.T#O1                     4X]6/_83FW]#1_P";I$NR
M;=#]Y"F7:"G[$N&]_P"J_P#\$8V\'#U:_,GL>@#-K  ! R(RH? !#0NRA)X'
M7OX@)@        $J>77E^7C]T!, T5_H=?O=/9^7OX\01WBVE6WQ^PJ'IQ[A
M>&+FZ?P4XN)O=2E,D::4]-1+L<&F_"8IQ:'3]_VI;D?PL'^-0-<?&WV_ K3&
MQB
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M_LP_A5T//5__ #.I_P#B2NIV+_B2S_V*M_\ 2C(\5=\4^E]1M^&/0Y48L@
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MW8QZX7F\*_Z*6#^Q4'^EFAP.+D.T@
M
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MB21$1$@J)(BH22I0B(BT(B(?)7CTP
M
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MS/%Z!,<\5UE1)]EN'$:,JTHIMA*#^R09W31G%M(JV9@N>3RS=W<65MG QMV
MPF3<LEEM18S)K(G.53_@+,FS4E6A'W"UBV:\&,X1_2</N[&NN<Y-M=L1CQ*D
M7K.YEKN.0,,U-<-B*^Q,6EY*"4HDJ;4?TDTH$]R16F.3(6PC&K?A^*6#&;;'
M:BQK1:8$0F64);03C45IMU9)0E"2-QQ!F="+4Q,IIQ3/%VL4
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M4PIP6O&GB7C(S9,--L)T0RVVTA'YQ#:20@J]OLI((ECQ:XH
M
M   IQZL?^PC-OZ&C_P W2,;LFW0_>0IFVATVEPTJ4+]5ZU_A1(S<35C]I=+O
MXS:@  0,JZ& EY2UIH9=NITKZ]. "'A^G['[\!.14*@"(      EYN->RFOK
M *UX*X\-.[B E6GV3.OM::T^YP =XMR3."P7-Q(ZZ>H94HY6E\%7$WTC3)8J
M==.Z@QF:RUZDX1+:]/O_ &I;D?PL'^-0-<?&W68V*U!L0
M
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M%E3%+ 7'^I4'^EFAP'(=H
M
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MVGI[#X"4C-8FIV4"(H(TTK3Y19PBIQHAH:B.FA5[^X3FX<$I/K0%5'NT]9@
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M;:<4NIQGU,A9*4H224D24I(DI2DB2E*2T2DB+0B(A\3I%:O#8\4PH
M
M                                             TW%<II,SH53KI73
M33Y2#OX+$3,\L+&W7)@;NSO4;C>\[/,WAFY467:,Q6TP918\I,1V-".4:6VV
MJN+<(R-:CU,3*)G@L8S%,X4V=/SK]ER#/]M7Y#1LP'V;E9>=U"4OLW-PIBO#
M,U$1T;67 @F,.\PF:\%1:B-*S;.G,1FFA'4JEQH? PSQA9FDT0[3+M+C\HD3
M$Y*B5*E4Z:E]L*T2<GB^X\V'9-Y=CK_-,BB19\AIQP]"(WI"4((S.GWQ]XN<
M=Z16%V"\O1)KC\.X1(]UL=UM,-N5;);#3[+[$F$E*B03R7$-J\)S0R+B%>UA
M29RPN4 Y;LIN3TT7N?NMTL/R;SA,Z0J=G.TBW77$,L&ZI^0<-U9$E!>&BM&R
M] ELUBL80RFV(C*LJD-F]]-O-_;44K$YB,>S:W))%_PNY+*!+MTULD)?)I4M
MQ#TGFD&=.4NP*1,4^U)FEW-"I[&L^EVXT6W(4+<C-GR)?62B4BADFI&HR-:=
M./<%<<8K!,1=C6DO7XLN%<62DV^2W(9,B.I*22BK33DKS=HQG#",5SBK5HK2
MJ3+C7T=W9K4$049(21UYC^^[*:Z=XM*E>T46A4]HE?)3_P (3%")KZ0B54N*
MO45*?(7&HBIE&VTV;\EU$=E!&:UK4DC(B[DF9&8RFV;9I*1-9I#S3(=QHS"G
M(>/I4\^1&VN2A)J.M#*I)(SKJ)2Z,\UGEF,<E/FX6?8;M=8)6>;L9&Q;X1)6
M[&@DXB3<+BZ:5J:CH@$Z4I'B+1RZ%VA%<N"4K=%5$B+?O'UO7$I-Z.=M5TP1
M))+CV\CD-3<IC,N\R><R_5+*'VW.W2AC+"W#\)-L?%'QQ]JN;&<;Q3 ,6@8-
M@%ICX_C5L:0TTVRVV<J4M*$(=D2):4(>=-]3?-[1G2HD8S64K&;EV6N9QA)%
MJ;K=2[R)9&9_,0LQ,S5C$5^');:ZB[PB\=9N*6&,OQ8EE8>-Q)%S):4XRH]=
M5$53]01%<8;+8I;$2]$<4:G3Y2,RYED9%J>E2+2E3J9!1ES0XK(<DQS"K.]D
M66W-JVVV.1>&U5#DR6^HC\!AJ'S$^LW74\OLD?$(BL)==$1W*",^R7),BW/Q
M;<3<FW/XWMW!.4]B%KE\Z),UY',N&OW%[E>1[PZ23+36HO-7/*$FL+MOE^;'
M7G([U>NJ?=&TN(O^3M-,8'!FH<0[9;3'047QVF'FR4@Y;2"H=>T8XUK.2S$6
MQ2,Y7<4)Y:F>IGJ?RU/[HN$X\6/O3B@
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M+&"9K/+/M[6:TR9*;2M*R<0M)+;45*&A1<R3(RXD9&+,Q*1%&J(H
M
M       "G'JQ_P"PC-J?[FC_ ,W2,;LFW1_>0IEVBUVEPP^W]65]7L_()'"K
MB:L^.8>@#-J    0XU(RTT[>("(       (=VOK+O 0IJ?:2J5]%/MU *4X)
MX<->_B *^B?R?; =TM]%0V#[:4I\W:%8<O1BEF+B;X1%)CE74R/[5 F8F<&K
M5QI1M^GW_M1W(_A8/VD#7'QMUG[M6H-B
M                                                        +7'5
MLXW)Z@MJF(Y\\B+&NBWD=R38>41_,.TV$3R3,Y<T>^'F^N7\TVZ=OQQ;=[I8
MM_G\.I?LNSCJ"T.1>4GZTNSB^V/ _5Z*;W;1_1^Z7[._D6NYMGU.>-8]]K&W
M8UNV+'WY-C6G_O>&/CW3O[_I?ZR/[4/W-YS_ / O5.[0O_L7/J@])5#Z4-B:
MG0OR0M'S_5<:@_2>Z_>6_P!2WW0_C#M?AU*?]/J_VY>\G4SHK0BKKH-&,N1$
MQ;'AQ1I0BUU.NE!>XF)GQ< S,^.OV!)C&J6S24.[6H46Z8G)'OU]1=XR8H4]
M-?D&./%G6V,LT3.M._[8L12&,S,YHJIV%\NNOSBH@1E0_D$B:P<8E"A\I>FO
MV##@SK'/7@4-)]QEZAKFR4NF)FI0RU[^'R#*VVC$I73@,I(F8QC,<_0^4]#3
M2A=]3^X1B3$1C&;+FEZ?9/\ BR+_  @C;&3E@5 ^!^H$G*6)-YE/^&/EM.QN
M+7_8Y%!X/S7_ 'ZWT1[GZ_\ Y=O_  GNOZWWPL<N4_;P[4*Y:?\ .")77M^L
M6/NCYI;7_$%G^ML_M0_87F"V[_R,ZA_^7U/[%S-#W(>6_B,)7*?A1H^$^.YV
M-D:(7+7T&/UYU>V(OLK\4Z5ONJ_A9T29YM6V/@C<ZF/_ /,E=&Q]2%6*RJ;5
MS(.TV[D5WI]T9H?S#Q=TUNGTOJ5M.6*94<N(H
M              \OWAQY66;<Y-9VS:2IV"MXU/K0VVV49*GC6;CE$),B0-FE
M=%NI$U:-Q;-^C-(K-%N7;CJ6S//,8@;+=.D!V]99C<J5;LNS.0T:8&,I8EN-
MDXCQC4Q--23+@=*)&[<6TU9NNCPN-L=2[4V]*4OB73<NVPZL(.Z<F\VS>5J=
M>V66C6Z=I:)II:F_;82V:>0DMJJDJ:4&S0Y<9LR<B8FZ:W3BW)P^N>+5193#
MO:C,S/\ 4D9CGH>O=2I%]D;/%.? FO!.B]];$5=9&#1;R14-2BG1V.8DTJ=*
ME2M/LBS7*((1_99ZE;3SG?=F#=\/B;-R)1Z$5=6S[:&,,8RG%,9F,,&LUU2Y
M7 ))9)L-)?41&2BHZ]0BTU/D570C&>;.8MMGQ4JV;W4[MW<%DY?=DID-RNIE
M%D&2#.M3T;[-1C&'AB,&JZ+;ZW:D1$I4[Q].%T)1W#%;C:G%Z.(*WS%4]',3
M94T/[ O-RY31JMVVWF<+<6T=R;I(G>T4JYV^0HR_">[32Y3.I5Y:$6AG]@(U
M+XPK@EVUVMV,12X;LO3?=%<T;=&?;U4JA!MRD%4R+E2=5D6AT&RS6NB,$G9:
M-TYRY%&.W1EEZ3LSNBG(+A;B\<L><H3TQEHO$<2DUK4LZ-I*M"[1(U=.[P71
MFUZFUW%EO/H7XQP[7MVT^?(S^U*;N#7N.6V4E-7NWJ^FEUJB>;4S/VED?8+R
M<NK%D?!+D;77_,6TNPUK?BA;,ZD%7"T[\7;<. PY-MMN<99OS31+4;2736TE
M9I21F9(+7CV#X?'G32Z7]3];H74]2+-EJTBRN5?;1UUN]T]'JT[?4QLNX]CD
MX4VWWF&S=+3):DPI""62DK0;B%FDE.(4T2C6DTJ.FH^P7VS;C;XK9QB8QB8G
M%Z"8B)\.-K72A:S)*4G4^\C(B]9GH0U\U)I,)GEF\EWKW$LN XC+MZYK3^2W
MLBCVZ!%6B0\VM?.U0T,K-PN8S[2&[3MLF+M;7NBS;:<5FZ<(PBO%A?=IV1^T
MR=3VJV,OQX.QFJ9*K3GT]2I=G-:3)9(4I+RD.)4@C+Q4F1:C\R=?^L&ML//M
MVYZ?'S>AZ%U+HX7<)X]SR^MU.=#??.T\=&.':]/AX%N)ELKWS<E]%LQ^RQWU
MIMS?*OZQ<;:4I#BEH(^7VBJ'G3ZUZ'6>DW=*\NZ<VWZUM+[NS":\66^ZY\[1
M^5H12V<U-$IWQKA-0T5/%O=O8CD7\K9N"&T_YTB'YVV6C3=Z.E=\=VO;/IF;
MXF7F8MCYD4_6CWL@7$(I0=O<+BFGE<;MD=2B_AXC)^@?TGZ=I_*Z)M+.S2M_
MLP^C:>&G;3+EAS;*S0X1EKH9*+\\DR,E)/T&0W5HSQX9O"\TVUR"SY%^R1M8
M^;%XYO%O%E0?*W-0FJS(R(B14TD-MLQ?'R[\N$NOU=O?IZGYG;?%QCM<U8=Z
MK#<S*WYE"?Q2]MFEJ0AQIQ;;SI&E"E>*HR01&LC,8SIW6X_%:W:6\TM2_DOC
MDU7JT5V!<&R>M<^-,94DE)-#[1K,C(C^@2S5VC'#+*7)YK;HYK9JU":49&9D
M9<NAD94/MX5I7@)7'N&Z@-I6\XI7M$U%E/-EI[3K+*EMEKWK(A<(FDF,QAFM
M!WE6.[V;Z[H0M]<RE62'BK;A8[877WK>TWR(>\-3/,ZA#QGQ]DAC'BM:Y_>3
M;=.$9/&=A]QMQ=J\XO%TP[,IUXVTMUX;AS84\Y"V'(KTU##1,+E.\BB)HB^C
MWC7J:G)=%EN<KIV\T\TS2R%WO?>1&OW3QD%^@ERQ;Q$M<A"-:I<-LW73IW&I
M0Z#SU;7R'U"V>-GW2X^_B)VM\*+\0*F(V8O0Z7S4_,'\^]C$1HS'].[WO#1/
M-,]E7.#G,'G^[S?/M_<U$6B6ZGZ/9<'6=2LF=K,1G6%NF(T\5B:+8[->MX=Q
MBND'WGPVB-LR<-LTJ)M9D=2UT,?M+Z.WS=Y$T(XT_0]ST'_=T3+T[H-ML2V]
M1!>[)>(_>99%XCRW2)).-E3VC,M"(AYCZ\TGH6CW3^EP_,6&A$3Q7V9AD;ZZ
M'2G'2O?^:/S!I\T1%>,/*9V4[&Q&]@\_WE_[*<E]<?Y-5#B[JGY>ZN;;P45,
MNE&Q)#]:T0X@CX5YTFDRXZ<1UVI=,;2F4S,1[7&OGL7DNB6SJL_3QCCQI\/Z
MXD/.$5/I<CS*S["J/WE](ME&P^G6TBF.I6:^Q[SI.G\O8V1.3I.Z3IR>J" H
MCJF%&41_P)J87I]D?1(I-TQ.<N;7AQ<LHT&ZX9%6CCE>)??*()S9S,<'6<MJ
M<2U5_KG T_WVV,+JT8WY1"\[AG_16P?V*@?TJT.!Z7(=G
M
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MNG[9>4W.I=JZ]^I=G-T^]Z$.&T
M
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M6FFF(Z$M-H0VA*4I)*4EP(A:4P*UQ;Q)F9:E0^TJUIW:B0(B@
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M<1QN6^:JU\:39H3SE:U.O.LQ4=N
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M5)6DE(4E:3*I*29*29=Y&52,@$P
M M6]322/J9P,^!^XW&A\:_J5WL[!V^RK\K_C1[WE^L_OX_J3[I8N/GW?\0;-
ME2E)=]]-?P\\> ^L%?SNV_J_=+]H_P BE/R?4_ZT>^UC@,_\;8J?;^4V-?\
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M_/#9'C;OBGTOJ-M.6*9<L>YV410
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M9'^J-#(P6DMU$O5GGN>%!NULFNZ_@XD^+)<TX^PRZM6GJ I+DQ*\$!0
M      !M9<Z#;V_&GS(L)DSH3LN0S&;KQISO+0FM/2 A$GP;@WXL"9$FM$=#
M=B2&9+=3X%SLK6FOR@-V$34
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MW,R*QD166SD7 K7;R+U%$:(?E/6BNO=/]*??+PU_Q3Z9<J,&(
M
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MCDQYHKD]636A<QU/M/0NWT""(
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M"S&'9*1%9KG$9_<^M39;<BSV>TVAK5FU6R!;FE%P-$&*W%3I0J>RT0*Y,
M
M             !3CU8_]A.;?T-'_ )ND2[)MT/WD*9-H"5^Q+AI\VGZKTH7\
M#VC&W@X>K3YD]KT$9M8  ('Z"KZ $%<#J=/3\H"8  2JX'4Z>GY0#B9:_1XE
MZR 3      "155$9DJA'_ U[18[AW6V'6"P?+6E2K7U=@99N7I?!WN*OA4E,
ME6IT[J=^@PU)\+7<T.G_ /[4=QOX6#_&MC7;\;;9\*M(;D
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M;2[;R9DA<N9,PG&)DN2X9FM^5+LL)^0Z9J,U&;CSAGJ?:+"SC+TX$
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M,?UK_4:V^C_:;(\C=\4^E].L^"W^K'N=A&+(
M             6\&I;L3JNW,=9JDTP[+SFDS2:JQTTJ9&5=1E=,V6Q=&;&+9
MNOQ^%[#ET*#G%C5"E_J:[0B<=MDM.CC2T<[AT4FJO:6-FEKQ9,5^*<VO4T?G
M6S&5\3A+Q/#SNKLBZIO*D.3HZB:6^;B36MMLR0V9IJ:_HD.7$1$4MG"6,7<T
M1%\4OM^UW))FOV2JKE[>6A?/P%P_#C),3E+@\GR6U858)^4WQ:BMMO))R.5!
MJ5[1*Y:)29&>B1A==/Q3'AA<*S&5SS7"NHS:'/I$J#;;H];YL1*UJ9>BN()Q
M+9<RN5;BJ<!(OFZEO%ERS;,S5Z79,JQ[+HB[AC4Y4Z*RM;3JE-&T;:T+Y%:*
M,ZU,6+HF>6,H.68BKG#:,N53G*25THOF(O7I706;Z?%FE.QHR7F8RN5UU)\*
MT,CK7AJ1D,/FQ6LP4]CA)EW]HVXVNAD:NXS(Z#5-\W?#DRB(];AXY*?EH6ZH
MUFDEO&9U/D\'\)Z>X6/#;3BF,X\7B^ULB/=-[]V=SW5%X.-1&F7'#5["5J8-
MM'M'5)547>0W:5LQ1C-UML73=D[ILW$=N<O*L\EU:=O4QPHW,1^VAI\R(TG3
M\Z?89C;JQ2Z(MX.'LXB[FUI_%.#W$ISI-DTIJ(\T1Z)DPV)/'77QDJJ,XU[X
MB+9Y9MCMB)][FU]CA\CO^&8O8IF49Q'QJT6" V;K\EVTVEMUPB2I=&6U-(6\
M9\AZ)J,)NT=2.34T]&Z/ZEOZ&,Q$UF8CE]$/$,)Z@>DG=BX2+39YUC:G-NJ8
M;;GV>!;DR7"7X=$')2DJ*6HJ&0TW;/I6I'[;:Z,_\2W]#7$Z,Q$V6Q/JAZU,
MVNVCEMI<EX%9I;;Q$;+T=,%QIY!T42DN-,J1[1'7CVC@ZO0O+FM/BV>E/_%M
M_0R^5HYW61[' R-B]A9)\KFVT!'-],T&PCCJ7T6/2.'_ (4\IWQ/-L=.GHM_
M0EVAMICX+?9#@9?3)T\3=%X"VE)5^C)(DZ^A+5#&B_R3Y)U+:7;"RLYY?H:Y
MV6UNPFR(<7:NE/I_L-^A919,41&NEO7XD1)O\[:7"42DJY#:)-24@C'"TOIO
MY'VN^T^I[?:6V[O2FMN6?L:XZ?LK=2-6RV(NA[\CQ'S\5UU"4,-I0IUY266V
MF6D\J")2S))\J"'LKKK]6['.D1ZHR<V*TK.3R;*-ZL1QV:Y:+6T[DEZ2?(4>
M(TMQ"7#,TT\5DUI,J]O8,_E71%9R</4WNC9,Q;XK^Q3YN-UL6;:R3 MV7V-4
M&7<%41%C*.:\T1F9I4^AEPUL:)^^(A9T[)FO-2YK_.:L6Q/)GP<[A?5O SMT
MF\9M[%W<<02VXIR&V5G[*5&DB-XU&HB414XC"-.RM.:MS/\ -:T16=/PO18V
M_2&EK3=\.GQ)39ZMI;DG37B1D15+[8R^56.6N+&-_;S4FR8F3)=XMF<EQZ1%
MW1\#'+,M)-E<I;+;,N,M1&E"VC>-#[AI49GIW"?+OMXU[V=^ZVNO'R[[<70\
M,S_$=NIL.+CV=P\ZVSOKO);Y*Y3#;]NYEI)*5-*?\7B9%J7:,[K?F36W]]#C
MV:EVSNY;IKM;I]BK(C1RL28KOBQI+:'HS[:M#0XDG*$I!T.A*+M&F)KAD[.:
M4YH^&47W7E$25N+4GTJ.AT[RKV5%F8DQXYN@;K-^/M-FC):_J="J?PK;ICJ_
M,ML7^5-];,5CY<^Z6G<Q,Z%T1V2H$P99GAMJKH7O$Y)%_"NT^T0_GC9%-;4B
M,OF7?VI?/[8BVO;,R[(-Z.H[G)(]N[][6A,]W;R.?*.!U"9MVEU\?$V71$:<
MK$]A,BWAW([U-J*O>7(X0_9/T8NF[R'HS=G_ ,#VO09G^&Q/%Z%T0GR=1#94
MJDYDNNO'\,W\HZ#Z\Q$^7]&9_P LW&\PX[:VO^6:^C-/]5+,M*DDZ<>ST^L?
ME^S#2CMI#R4Q2Z/0V0VL'G^\O_95DOKC_;4./N:_E[O4V3]RAUW7$X"*5\2X
M06^7OYY323^P8X%MGS+]#3G*[4LC_P!J''B.:^+>V8][($VF@%:MJ<!MQER^
M%;VW"3W>+'87V$5*U'](/+^A^5\M[+;Q%(C2C[;8?1]&V;="RV>$1[E*%X_"
M]1&;.=C"(A)/NYD'72@[&Z*QWL[)IJ3;'%VWEYE+UI[1_9,P9.JY>?ZFM&G"
MZ0/Z<;$NRDG@O/89_P!%;#_8J#_2K0X$YMSLX@
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M3=MWU&;>+CHLV=6EB6] :DLR'+9/)AER7">\)YXT*86]3VCJ,L>+'#ADJX
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MJ/REJXZMT\*S[Y>&O^.?3+E1@Q
M
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M6VRAGGDW(H[<EWG)!&95Y:]@81%>"3-<."J3@*@
M                                                        IQZL
M?^PG-OZ&C_S=(EV3;H?O(4R[0?\ 9+ANO^Z]/\R,;>#AZO[R7H S:T"X!"W1
M2:0@9T/4Z>BG$":4CM*5J1Z^GO\ D+A0$3 ):UH9<-:_<]/$!$CKJ0"!\2+L
M.M?D 1IQ/OX@(@     "19%0S[=/N .ZVLS*&S4N-1:Q&/!R]/&QQ%Y(RDM5
M/C4Z#&:73,4P:]3N:'3Z9GNCN/7\[!^T@:[?B;;/@5J#:@
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MH?L3S!_^XOJ$?]1?_8N9?.;4/&HM"IRL854ZG0O8A<:Z#]<=3PNTIG/Y5O\
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M?I =9S#^=;/_ &3@?TXV)=\,^@G@O.X9_P!%;!_8J#_2K0Z]O=G
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M==SW3=VS+P<S6Z6\$0
M
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MJ04FO<QB<*<4XH
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MB(I&2(B@
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MKAF-_P!A[?VU_P!J,]X\GJ12^?2^F68V6_U8]SN P9
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MZJ"\*,HXIP
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MALM+##C*^6V2B-7,?,9F6O#36FGH'R&)K%<GCL:4G)J"@
M
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M?I(R+Y^ 5B,T2^*C7VN''0_S B:QS1DE<:<6IQ%4
M                                     ;<_&)6FI'QK32A=G80D3%:3
MF3&&$M5'-RES?2UKK7M%$X
M                                                    IRZL-=B<
MV_H:/_-TC&[)MT/WD*8=HM-IL-UII,UX_G MF*.+K1,7R]!UXD=2[J4]'$9-
M*)>DZ^D! RU2?=6OS (GZ"KZ $*J_._9(!,  (&=-3 05J1D7'0 25"(C_>U
M 3 (&1'Q 0))%J1?; 3 )%'5)F7[VH#NUL,BA,Z\:]A^@6L1+F:43-CB+W_/
M+!'QUK]D8W3%V7!IOIEWM#I_*FZ>Y!%^=@_QK8UQ\;=9^[5IC:@
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MX&8M:SW-=E>2)GO9FU**J2?I?2.O"A::!E+),*
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M&T$2$)21:$14'R*+[INFZ[&UY"9PK^)JHKJ9IY3.G;6M!E;$Q&,I,X0G&2
M
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MR*V7RU7!A+\5<.5'>=\,R)7X5E#AO,K(C(S2HB,A*4]"36KO H
M
M
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MC OY_<_KW>TGI_28BOY70_T+/T(^XO\ ]>+]^O=R_&!/S^Y_7N]LL?R/2?\
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MI_\ B2O*X.T3.(8XV1\U+/;M>^L1D>/NQNF>]]-TYKIV_P!6/<[4(S
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MSE88KX#Q&@JIUI4/>1%(IFN, H
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M2Z9F7EM;7W>YNF[<WW7U[Y<JI;BS-2U&?-V%HG3N01\I#&+8MP2V(B*)160
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MC1KX;(KRVQV=[R75.L;WJNI.IKW3\N,K8PB%8H\VZ@
M
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MEQ%K*2V=%EQ3QT%BGJ)BZ)[WJ":<Q:&2M=:'0_4KAP"LQ%."83CQ:@
M
M
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M"B67AN4H0M<.6,.UC969FZ[U=S.@;-7,I/*1(30DF5"(BUH1$7903O9-84
M   '%3;%9+FZT_<K-:K@^P=67IMOB2W63(ZD;3C[+BVS(^XR$I$8%7*)2E"4
MH0E*4I(DI2DB2E*2*A$DBH1$1"B(
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M25YG$2(L7QXDE0OJ:V_TFR/(S\4^E]-M^"W^K'N=B$9
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M)4,^.@TWXUHY=+HTK(NSP7I<*_Z*6#^Q4'^EFAU_%RY=I!
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M5V7'[3;7NPJF]#B,N&="+M"E"9F7>!*<4!0
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MP8@H
M                                                      "4ZU(B
M+0ZU/33NT[:B8B!<]:'P+[[37^)[*!%5K%<L$?:*I_2X43H5._7MJ*1WME(N
M$& DU3[A"B$2>8U2I+$9*4T,^8S=6@J4"<^Y.'>I)W2ZZ>G3:<KE%O><,W*\
MP"4A-KLK"KJ\_)JM"&4*A&M%%+12M1*UR*3&?%1??NMWJ2WR6NQ=.NT4VQ0E
MK7X><WEWPR-APN1MY$*4E!$3:5I<IJ9A-,N*UB,9RETB#T=Y/N-=HF8=3V[=
MZSZ]$Z;TG#X*Y]KANJ6HE^[*.*?@*2T:E)U*AB73-O?*\W--(^%7/MWL]9<1
MMC-GV^PRW8E9TI2DW'XL67--))21K.8['*1S*)-:UXC"M\Q6<F-(KWO:[7@]
MHMYE(F&JXR2H?X0S-"55(]$J+E(B,9Q/+':5GT.X$24H)IM*6D(^BA""1R%V
M$?*2:Z"737(X4.4N8E=O;J>O8(OO1/E-7.DJ$?#CV%0P2$"K37B"HEZ3KZ0'
M%W]+J\>N9,H4;R$$\GE,^8B9)3BJ<NNI)&5L5K"4K.&;C<-O+61XK N24T42
MWV7T5YE)-A?AU7J9E4^\93;2SFC-*SS9.S$=-4E2O:6E/D&%<*2M/%7)!U#,
MALF93+;[6M4J0@S/^*-)F7$(F86:3BZ9=,!L-RYUQV_<7BJ9<NI&I53K0D^D
M6)BK&8YIK+I,[;*]-&:H+I24)(S(M$Z:UXI] D1,^DNLBF>#J+^/WV*XLG;>
MX9(,R4I)*/A4NQ.O (J3;$16<W&*;?0KE.,\A6M2\-9\#,OSOH C'@TS\552
M\%TN%$^&NI_YT.%28QIVN"N[KTBYVJT,$ZV^\:E/()MPEF2#.A&DBKJ1=PMO
M-2J4CB[NW8;Y*-'@6USD624(49**E"(C,R-/:).$K$4CEH[C:]L)K_(=RD>
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M)R^LZ^BH1E,RDYTAJ H
M
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ML?91'L-E8;^@U:K>A)]Y)B,D1_+0>0NBETQWOIEGP1Z(<P(R
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M2TE)%<%1FWVDT93HDRK34._BD12*<%=:D\U#(Z*+@?&E>.G ZD$Q54PH
M                                                         '$!
MMY$2++9=CRX[$J.^DT/QY+2'V'4&5#2XRZE;:TF7$C*AA;-UDQ-DS$P16)K&
M:TQU1>43L1OQ>U9EAJE;6YNZX](EW:S(\.+,D.*>=0MR)':2ENCSM3H1\. ^
MC^7OJ7UGH^G^5W/^T;2(B(B[./6]1TWS3O=EI_(UOVNW[)Q^V5M/*O*PZW\!
M?<9VRW(_*6 RM11RD/)8-3;9J)LC\5LC+F0A/SCZ!M?J1Y6WD1/4-&=.?15V
M]O5_+6ZQW6WB)>2W_:CS+-I4DBY;9/Y,3)44XP^;J7DZD2R-MKE,C)'V1V^A
MUSR3U*::>YC3],-4=,\G[V[F^;\N)X.E2-W>KC'4\V:[#7MA+7Z.IB+/?IW_
M *$Q_ F.QMT_+FM/^S;NR?7'Z4O\J=$U<=INHI.34M?6%9(4V-;]Q,*O6**D
M.)9.5+MT]MEI:U)152WDMMI(E&?'N&R_H]VI$W;'4MU(IPF)<#5\E[Z8NOV6
MK;J<L5I6,:*K;;<[9?K9%O=AFM7*U36TNL2&5H61$I*5T42%*Y3(E%Q'476:
MME\Z>I'+=#R.M&KH:L[?5MFW6MSB6[,DG0C+AZQ(B)BI$S7$Y2+AH??Q^P84
M[%.7LK[/YW]_QXA3V"):D6M?32GV @0+F(]3K7MT*GYM0Q!5:I(CI6O97@$J
MB9$94,5$E6Z&7?QXC&L*F25"XU+LTIZQ81$JTU.OIX"B(  D01<M>_C\AF)&
M2HD9\RB[J4^4@XHB=::'3T\10*I4UK2M=./YE!)BL4$10 2GS&>ATIVZ'7\R
M@F(@7-I4]-:\-.[YPBI.$-5LC6ZE"4UH?,K7[U-%*^P0QYIF*Y0U\T\L]JDY
M_$)_5#UL;7;2P#-^P8W<VY]VBE5<?E@R699^,1$ZT14(_I)(<[=[RSH7EG<;
M^_\ >7VTMGTX/H70HCI/EW5WTQ_M&I&$\68+9K7'M%GM=HC--L1;;;H4!IAI
M"6VT-Q([;"$I2@DDDB)LN!#\MZFK.MJW:EV-TW3-?2\-?,W7S=,YRY2AU(R/
M0JU*G'NU[*#3%M)KQ8IAF
M
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M0J-8! C(^'8'"O XT",C,R+B5*_+P$KP$10
M
M                                                4\]5/_83GO\
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MP
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M0>B5G3NNG";MQ?-.[GE>JM)4M5L+A2WPB^:,V0\G.<OIMOPQZ'("*
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M'7YMSLX
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M;TLC--#J9:U[?56GS#X9$S.>3PV&<)A0
M
M                  &TE3H4!"GITR+"9(C,W9<AF.V24IJHS6\M"2))<==
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M*D*(E5_ .++@>O<&<8&6;F!4!*P(5(S,JE4N)=PHB
M
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MH7/1X!]7
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M]]M]@QN2["(7G,,K^2M@J=?ZE0=>'^UFAP.+D2[."
M
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MXUM:8M7<B,@
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MK,GHGB'(94DE:DHB#"4FL83F[^V@DJ,^6BNTZ\:C*:S-92L4I'L:P@
M
M
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MT_AVM_6A<]'S]]6
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M'3M+GWUMML4MTH]Z[@BA>PDJ);)*4^HBI2G92@ZAZWA5.
M                      M_YW_A!W72A^ZQ=:\?P!]@Y.@UW.37])7\,?VS
M'(8)0     !,FM2H5?1P[!8$2^B=-:TKZ-=/749<!(,    !.V='$'W+3_'$
M$Y"W+YDY+<M&)$CLAW(S]1,RCT+MT%^&DM>I3DP8S-SGH8N$[E9?>DKEO-L,
M$RX1K6IY2*Z)X$8G&O%Q'I^'8.Q&:*]9&CWBX2DDXQ#65/=4G0RXIXF1F$3V
MK@[LNR61VJBCT,]:$X9?:[B(94PQ,*.S;?KL>'9G9\A?;4<5DW(KQ&Z9^&4L
MTL^)0S+Z!'7Y!E9=-M\3.35K6_.TILLP=KW)V0N[>0RLKQB6N^8[?THE,3&'
MU+6R:B4ZMM;+?.HN0UD6HNIIW77<W!JT=Q'R_E7Q35C!XS<+4S9GFX=ZR3ZB
MENG2/'FEX*WC+CRE(-M1TIV#*S:[S7MG4VVE??IVYS;$S3V0SOW>RT)BW7UM
M/3U+Y_%=;;7T5F*H^X7ELDG#OI3$&54.MH):#+E,R_"),TZEZ1JY;[<+XFV[
MLF*?9+?33NQTYB;>V)B8]L)2_+)HC)ITGFZZD39>T1U+C3M(*X49<N-7<L,W
M0W$P);J&K:B[6:6?+/LTA:5-O-Z$HFR=5RM&:2/4B&5FI-G?'8T:^A9KS6<+
MHRE[%:K5MMNXVY+M$A&W.4T-3EF>,GVID@R)7*3SGL-DIQ?R#.(TK\<KFB;M
MQH6\MWBM>8Y9B.98.\I-VL"Y<,E'R3X+AS"<;(U$E?)&2JG,E-?E&N[3OMQG
M&);K-?3OF+;II+HK64V]9FA]J1 <3I^JV'8Q5K30WR02AA==RQS36G=%6^VV
M+JVQ,4]+?.7VP(4E*[@E#I_>D1+(ZD5-2508V71?'-;D71R3//FUTW6U/E5N
M8@S+L.A=Q=XV17*6$1'H:QR(BBJ4AI1GP_")(_FYA,65:80F2:%4Y76N4^)>
M(G\VO$6.XYO:UZ'352#I]Z2TZ5/O(PQ29PHE-"M"^U3[?:#'/TH$9U4HTG0Z
M>GAIQ(AC1LKV9H:\OT333MU/M[J"^XGVH)YB/FK]CCV<.R@$X(TI^$/4NTN%
M.P3C1*X(*4HO:K[2S)*>WVC]DBT[S,6E<,R;J8O<]LL)4_?L=L[B'%7C*Y#?
MBS6HZY)6*W-NM^^NK;2VLCYXJE**HDSRQ7BV6:?-=%LKNAP<3G6^R[(;.R/&
MVDQ-F/)SO*VVO=GLNN+R$/J8>(B)U)0I=4T54:K+)F_YFI./"&Z8B^.2S]W&
M;TTB99:CQ8C26(49M+$9ALB2A"6D$@U<J2(N99)J?>-WQ-O+RSA\(1Z&7?3[
M B)J\3-.BO3W KJV74]VM)5U*YP*%_OMH2[X6,X3WKSV&?\ 16P?V*@_TJT.
M!.;D.SB
M
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MA$1$1$5"+0B+@1%V$..U
M
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MVI$=:'V'T**J5MO-&IM:5%P,C,C$K-9P\*Q%?2W@J
M
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M-M_4^Z5^#RZ2(OV4]:G]9PJZ>@QSO/?[W1]$N%]*_P#=VM_6A<\'S]]7
M
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MJ_OK\95?IY#-7+QTYN/IIQ'&FKM$X@
M      H SS_"!NG]#1?Y@8Y.WS:[\W)+^FK^&5]LQR&"4       $:G0B[N
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M7 8W93V,;HGAFO08C'DQ,:L<>6GE?1;8:74=K:DQFR-)Z<2,AU[DYXNR @
M
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M^02(B,A DD1$1%H7#CVA,1.?$3!$4P@!0
M
M                !I+>;:0MUY:&FVTFMUQQ:4(;0DC,U+6JB221%J?8+Z,B
M/M6V]\NHS/\ =+*Y&P_3$A<J^.&N)EV>--FN#C499+9E)9=)2F'E&TH_:(ZD
M)BON>B[ ](.W&Q$1R[3HR,PW'NI^]W[++QRW%YR:\I#SQ,(FM.J82A\E4Y3*
MA&)%W;FDS3T*G>2I<C)DT@N#9)*G\331)%V$7 )OK-98S2,DE#(R,ZF>I&HS
M_-J,8FF+*:3@$DBX=O$)FLU2(Y8I!PH1%IKV\!&174R/M^C\VH")>DZ^D  .
M[3UGW (&9EP*ORT"$G!'NU]9=X* )#(S47YTJU]-2^<J&"(]I&>AZZ<?WW 9
M63$?%B3W9A<Y%R\ZS+3[XRK\E>P9<\=A2.+<-RG6DJ0:6'&U4YB>8;>KI2GM
MD>AD8QF[!(BD]SHV2;;X)EW,=RLR85P<J:;G#<]U\)S4R7X;!)J1*56@L71E
M*UNC&M8>=EAV[NWG,Y@5_/*["V?.NTRRY7&T((U>&AUZJC5R)IH+P[:DYUNG
M&&K;]_;:R\S;,\Q:;B\U:E-N3";?D-)<2=%+YB(D^TJI\> DS&<Q19MB,GJM
MFRW#,A27U%DD68JE3;>4U&452(R*CJTG6ID),1P3&,>#LQQ'O#)U*H[B#U(V
MI#3E?D09ARTS2O&<FW-+A&9<BS[B))Z:>@C$F.S%8F/4E41F5.59'VU0KU]P
M3"1-<(3M..M>VBI*4A:#,RX)<(TJTT[#")I*X4[W3,=M;-BNE]C6]@V84Y:'
M75=CCAF:U&6A%](QLMNI,X8+&-)CXG;RX$5--?D&N9B9K&2SGBCPJ9%4SIVB
M($KL/0^[]_PX (*,]=*%W_O@2<DGBHBQI,U[\&U&:<41&?%?(:D4,_X(AE7'
MFG&&,6SRS;&$O)=M[V5QR?);O?'DMW!YPF[2ZNA&IM!\BB2:CT]D^\6V:6S,
MYUP6(FM+<N+V-,=T^8S-)DH^9%#(ZUU,ZEPXA%L3&'Q2LUB<<D'$I9+\*XVC
MUK3^:+R1$>(QF*VXN+?O5EBDHI%Q;;<3]Y[)UIZ>82EO QIBZO,W&Q^%S(3X
M*S01^TI]":\==7"(2D3EF<(I.+RN^;\V^ 3S:)Z6>6OX%E!/F?TJ4-"S.HLS
M-U*<%MLI7!Y6_N9G>:OIAXG9YTHWS-*)2TR&$IJ9D2J*]DRHHC$C/$H[MC?3
M]?<@=:N^YE]>)M1\YVM)K(J&:5>&:DI])D,^6DUF6,75\-L9*D<<Q7%<.B)B
M8Y9(T124DDY#S;4A;E"27-S+1S$9FFHQF_A;A!RUFMSG77GG?:6HN?A^#(FT
M\>PDT(M Y[B+8CT-%236JJC,R+A4S/LIWC&;IG,Y81YE$:4%0D:^L]._CI06
ME8KQ3*>Y.:2))<JM>TJ</G$98U2<U"(ZU[NRNHBHF5>)<.!U^<!"IG0R+OJ5
M2^34!.7*1D:BK2OV02>Y*>NE-#XZ\.X%14I/*1?1/OXU^0$QJ%JK4^5)=M*U
MT^<J&!->""DDK0RJ7RD"U2(KWT(NSUU[0K*4@D1XUQ85$N#*'F%%0C4E/.52
M,C/FH:M*BU3'@\=R7;Z7;"<N%C4MZ&E7.MIM2DK0=345.4B49$$>&*QDRSG#
MXG@VYNU> ;Y8W(Q'<FQLO/<AE:[[&;1 N=HEI)?@/E,9:*6X;;RR5]+6@L5F
M,,DBDW3$X2\4VJW4W=Z)LBM6VF]MQFYUL3=9+<#!]QO#<<=QR*N1R,Q)I&9N
MNMD9F55F7>+,4RXD<8NPE=_MMX@7FVPKO:9+$^W3XS,J-*CO-NM.,OMH=:42
MVS6DS-"RJ5= FM>X<F5::E0^[B*(@
M
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MT< &GJ53(]._3[1Z\0'G6]A)_8:S-5/O8_:?^F5'"ZK%>DZ_]7[G9="G_O\
MVL<.?[X4C]&)\V;7XBU,VGO1P;14>(\@_O\ 6GAS?>^I_5Z*;7;1_0^Z5^+R
MZ2I^RGKK]9PJEW:&.;Y[_>Z/HEP?I7_N_6_K0N>#Y^^K@
M
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MDE31JH9$9ZC1#DW1,31W\5
M
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M;W#PT>*,7GXI$UG%,E))X"Q%(HDXS7BF%
M
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MQ+K3J$N-N(,E(6A9$I"DFFI&1I,@,\FJ"
M
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ML
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M"K[#24MI+NH1'0AA%9NQR9SE2&X%4
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MSZ>H(P$22HTF9<-*\.\6*^H2TXTU(J:\./H$IV!0Z$??P"DA0Z5[/WB"F%1
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M,TEIV"5X<5I16<
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M$4
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M%*2[+A&KDC&DG%<RO#;27 NT8]R\.:)5/$5"H*Q]"(
M
M                                              "GGJI_["<]_L4Y
M]I0[CH'^]M'^LZ3S'_N7<?ZN?<L#*_P?+QKVW/3N]I_YQ]>ZS^XU_P"I'N?F
MCH$3^<V_^NG^TI%Z/C_^U&*FFOBW/6O\$0^:>1L.J:OIE]S^JM8\O[;MY8]R
MXT]3Q'*'4_$<K_FS'TV<Y]+X=;3EBG8@:C47"A%Q^X(R1*GLZ<:TUX?F@B/L
MG4U%0RI74_DX J732ITI][J=*^D@#1!]Y_-3[=:U 0^GS%3C2NO"GS=P":E5
M4^]+[I?/Q 1.B2+M,JT[./$!$TUI7LJ E29^T?$]/0 B2M:&5/E]%0$"T70N
M'[X!'E,B]D]>WT_/PH \UWM*NS69'P(D1R+M_EGYHXG5/]TZ_P#5^YV'0_\
M?VU_K_?"DOHP(ORUOQ'J7@NG_P"+1W>L>&\@X:^M_6?5OJ[_ '7;=O)]R^_Y
M=&G[*?\ 9*%]HQS//7[[1]$N#]+/]WZW]:%ST> ?5@
M
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M2$MH+LT0DB(AA-:T<F*4_HMP(
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M-B.PSW^$TALS_P PE(8Y+A2K7(C(M3J??2GV!([T1%
M
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MQH9'H=2KV"TCXHX)_1EJB*
M
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MIQAU+[+3R3(TNMH<(R.I46DE=GK$&J
M
M                                   IXZJO^PG/?[%+^TH=QT'_ 'MH
M_P!9TGF+_<VO_JY]TK _#I\O&E/:N>G'[YX?7NL_N->?Z$>Y^:>@_P!\V_\
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M&F.;YZ_?:/HEP_I7_N[5_K0N=CP#ZN
M
M    "!D1E0R(R/B1ZD T%Q(CGZ)%CK_AV6U?QR3"LI2)S:1VVW'QM\(Z=\5@
M_MMBUDI'9"/U=;_]P0_^"L?Z *R<L=D(G;X!\840Z<*QF3__   K)2$AVRVF
M=3M\$S[SB1S/Y_#J%9*1V0G3;X"3JF%$2?>F,R1_.2!"D=C<);;1]!"$?PJ2
M3]HB!4XE.(!2*UX@*
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M)3KII2GG<<54S,QPIK,3<W6TMF+'9QC,5PED"@
M
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M5D1ZBQC*S$Q@]81S)4E*N&M#[SH9GZ@B(Q[4F9K2/A:X
M
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M ^TA8F9GQ<2L6N5PUQWZF8BR#4;\7F:6:C.IDE5$'KKP&,3P[&4]KM@J
M
M
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M-U;HCP3=%)[5T,?/7U8
M
M                                                        6=_,
MT\H[;CS#'L9R61D*L)SS$&I10;VU&3(*;XK3Y-MO?@75HH;U",NX*SE!R1,Q
M,Y\%A*X_#:;ZL7LXD#<!F39R>\-$\UMH,F"6:?$\(X==4%6@5PHDVUF9JN_^
M6SY(6$]$VY,7?#(\O5F6XS4=Q,.L5#;=J5(:80Z273C-*6H_"/@=-19[LB(B
M/2O["*          "6AF?'3NI]WCQ%PH8UJ*0E5.8JTX:F7VAC03"B7E3S$J
MFI=M3[J>K@&8CRE4SUUI74^SY0C":G<$5"U.OI"<Q$!(;39\6T'ZT)/[9 -%
M4.&OZ46,K^&8:/[:3 ;=RT6IY"FW;; <0HC(TKAQU$9'Z#;,"D.HW':[ [JK
MGFXW;75:ZE&93QK^=07>"S-8I+JDWI[VFN"5(DXM'-*N)-NN-?-X9IH,K;KK
M<(EARQ6O%U&3TD[*NJ4['QZ3#DGJEYBYS-%=E4*6I)D0?,OX2<EE:S#H=WZ,
M\;DR?>;/DMUM"RJ220\\Z22/0M#65::#9&OJ1FQNT[9NK#8Q.D2]6Y']3]SK
MBA:3,TF[&-PJF9&1&9K4=*EW#+\Q=Q6+(AH.[&[XVU?AVS<%J1&29T2N$W51
M%]'52:ZD1"QN9XPEVG-:Q+B9FV_45%=1X,F-=&BKSU-ADUGV=E=:"QN(F,82
M;;N$MFG%>H*,2ERL19DMHJ9DU.:4I1%K6B:GV"SN+:8PLVS$TC%P[]TW0MB^
M2X;<2'3(_:4A]9_1X_1336AC*W7TYC%+K+K<6@><WAE-9N"7"+QYR2F2YRZ^
MA)B_-TZT83=3&8P1:W.LIF2)EHN<-2>-8,LRJ?'4T$6@R^99\*Q%6LC<S"3<
M2W(FS(G/^>@/Z4[ZD5!>:*324K$327)MYOA#Q59O2UF? E1E(T[SJ=2XB3Z<
M&44F'8(TRQ3FDNP[]:W"61'RJGPT+0="J2D&]S%KIJ,HI,\O%._@U)2([MLO
M"&YL W$VNX4_5L8DT]S>.I*-VAA/AQS,:TG!;IV5MF1[D3)FVV#H6X]+O$XL
MBOK)*5'ML1N<KQ4DZ@EM*-U@S[1KNOY(YN+"*SX+<^,KW&UNV6/;48C;,4QZ
M*TTW&:K+E$A!ORY2DI-]UU[D2XX2W"J1*,Z#A3,W3-TSBY-L<L1;P>CDA)4K
MJ9=O#[HDS,YK&&2<
M
M   $.WY#^X ^>;U7WINQ?%08[)?:1(BSG8EFE,NDDVE1[NW[@\:TK]A9);>/
MB04F,28\=L2W6[+D#RA?B*K!EEM;E679[J-=LB'5I2[#LLV1>B8;DMJ-/N4
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M
M                                           ! B(C,RXG2OR<!*16
MHB*   E)*4UH5*\>/9ZQ*+,UQEIDRFOM%4^U7#F]9%PY18F>.;&;8S;=PBK]
M'E/M*M>ZFO 6M8K.;&E,(R;9+!$GVDZEQU,NW32H1/-C$8$Q1H<GM*-L^1U5
M"Y3(S(B+TTIJDJ@52K:50S6G3MU+O]!UX@C32@S6G3F4=:KX$6ATTX:EH"M%
MYI9&GV>=:>)D=./93U"4*TR::VSJ:DGRZ$:TTKR]A:A2<UBOJ:2FC\2BDU+M
MUKV"4Q.->#1-MM!D1537B>I\"TI\XDT69K.**4.$GE/6O$]->X*3&"8\,D#;
M,RHCV5Z<QGK3N]=2"G9FK24R25>PHRIQ.E:U+TG32H4)[\AQOF,N4_921FI7
M"GHI\@DQ[",,DA(2LCHGE[CK6NNNFG<"5F$I-MK*A'4R[=2XG^^ K,-(TJY>
M8BJ7K+76@C*N-$Z6G$F1EH7=H?'TU%29B0VU'JGVB/M^C7OX@5IFDY3(N8^!
M\/DXB+7&B4]#+LK72G'_ , "/'0!*:3,ZUI3AI\@"8%03KK2E>/R: !'4J@!
MD?8JGHH0")>DJ>@!+RT^B=._M^V B95*@"!T(N6G'@6OK%B)F: 5"X%]D9_+
ME:(I/FK0N%/LC7QHDX)^17-RTU]9 E8S2@J/(?*2CU(JZ\.VG $KC1'PU&:>
M9/&O;\_<!5J$VE1F9)JA5-:TIR^@]>(K&OM3FV:M*T25.72O'CVUX@1/M%(=
M)9$H^'W]"IJ6NG:&*X0U"9)1U^F94JKAZM*EW"T.Z,DZD%SJ))<:5+U%Z3"F
M."3FBE)$DN;1.O*5#U[]2UT""M<TYLIYB4?96A:]I4/6M1:+2/4UDH)%#Y?9
M5Z?WXM"<<LT"])UU^P!BUUH4="27LEPU+[IU%2)CCFB35",Z&X>E"U+[I@5J
MW"6.51)IR\U=:\WT2KW@E:MR;*#(Z%0^_4Z?)45&HA@TJ5I1)T]-*$?I[3%H
M-PA-5<BDU(N"N%=*B3S1Z&44];72VDB^C0SXE7N]0D3*\L99PG))%P()F9S(
MB(#(C(R/@9&7SB*VC<5#)F:2YN;FJ1T[?WP<:D1PG)-'B-1E.J:+E\555$14
M+T4IH(1$1%(R;H4
M
M                   ;2=%:G0Y,)]M+L>9'>BOH50R4U(;-I9&1D9'5"S%M
MNFR8OM^*)B88W6Q?;-ET5MF)B?0L!=4'3Q>=G;AEV)[6SUYM$W%==D1L)91^
M%QAZ0Y(==-;[:%*H\M=2J6@^A7>=^G[CI,[3J%L_Q"+:1/;A1\DW'TTZAI=>
MMZETO4B.F77\UUO9C6?:H@VJV'WNZ>;ZG</.]O)<O'H9R7I#<=;SSB"F>V@N
M1IE*_9(CJ/,>4^IZ'3.I\V\BFEJ3./97M>R\]=$W?F#HEFWZ;-=QH6QAVTC%
M4C SG.[[ 9O5CV/N,^U35NG&DMO2C-?*L^8E(0A1I,J]H^NQ?TNZ.>W>6S;.
M/!\)_@WF.+OEW;*Z)C#.>#=?E%N>9'_]@=VJ=-?%F]G^M!S],C"=W;]B_P &
M\P_]BN]O^9$LAW.Y3+]@.[5T_DLW77_4A.?IE<=W;]B?P?S#3^YW>W_,A^46
MY]2/]@.[5[?PLWU?RH.?IG_:X]D?I/X/YA_['=[43R/=#3_[ [M4JZ^)-UK_
M *T'/TSCN[?L)Z/YA_[%=[92GDFYQ$1%L'=JIK_))NM?]:[!ES=,G_YJ/L/X
M/YA_['=3TS^@/(]SEG4M@KL7?^%F_I7H$YNF1GN[?L)Z/YAX;.[V_P"9/^46
MYW)3]@2[?[+-[_\ 4A.?IE?[U%/1!_!_,/\ V.[VS^A LAW.+E/]@.[&>M2\
M6;\G\B#GZ9E.[M^P_@_F'_L=WMG]"7\HMT*U_8$NU?\ 5)OJ_E0O/TS_ +7;
M]A_!_,/_ &*[VRF/(MSC/78.[&79^%FZ?^*[1.;IG_:[?9"_P?S!'_R=WM0/
M(]T#T/82[4_U2;^E!S=-KCN[:>I/X/YA_P"Q7>V42R+<[4OV [M0Z?R6;V?Z
MR+%_3/\ M5OV?I7^#^8?^QW>W_,E+(=T#HE.P=U,U&1?HLWC6A?R+O,6+NF3
MA^;MKZC^"^8J5_)74],O*]V\ZRN[8S>MJ2VCN<'-<@0U[E$;.7(\$T$O]%4A
MM7A\U=.8AUO6MSTK2Z7JZ5NZMNUKHPMPQP=KT#H7F">M:&XU-I-NC9=6ZZLX
M8P\?Z;=F=]\>S&1;<AL,K;Z)?Y+,9W*7VW7FH,1]QIIY*DK90C\*RLRU/2@\
M!Y1ZIT[H=VMNNI36)KRV]L\'U3Z@= ZIYK_+;/IGAMMMCGN[(XPRBNGK9S$]
MEMNK/C&*R&;BAQKWN=>FO#4=VER"\5V2:FRI0U'H78.HZSU;7ZQO;MY?E=.$
M=D<'H.@]%VW0>FV=.VT>'3C&>V>,O=QUKMP
M
M
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M$X2:G6E1JNNOG&<5LT[;(PC![H39DLNU)UYC^33MKQ&/+$9,ZTRR:PJ
M
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M<MQA8W8X<])G4TS(MJBLRB,^TR?0H3*5]&4.S
M
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M
M
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MU;;O]P0O^"L?I8<]_;/M.2SLCV'U;;OZWPO^"L?I8<]_;/M.2SLCV'U;;O\
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M0K-<B<.2S)B'(<Y"9F<[B)"$$7%*C+4+)SM['*OI,1,<5;@V-8
M
M                           5+@                     A4CJ7=Q^4
M,XKP$0
M                          $JS423-*>8]-*T 8X/Q ?F WCIPVMLFPF%
MIGP+_O)%EPYV213DQCM4)M$I+C3<AE]C5Y+1:E4(B9G#(F8B*1\<L,2TY-*M
M5MD0(^;SUL7)3\F>;LR2ZXZ[-4;KQJ<6^:S,EK/C47GOC*:0U1IV5C#Q+VOD
M8>81>=A^H>V]+MTE7'*L%W4F?J"0X]*F%8IC'NK*76T+DJ)/,IPZT3VB9QSQ
MDSMG'D_#P9X#"TN--NH+V'6T.H,]#-+A<R2,N)&23(,V7"G!K
M
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M<EG;+9)"G9Q;K9%DO2(]MM\OW]$I10XRWEMK;9,C,UERDD3TLIGPQ-:3"_\
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M8]F"Q$<W+7%?"BJ0^TQ*;(R1(9;?22JD:4NMDLB,CUK[7R"UX3GVI2DUAO
M
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M0FTD5*?;_-$YIX+2$22DCJ1:_*%9DI"810
M
M                                                 &UGO*CP9DA!
M56Q%D/((^!J:96M-?E2 ^8!YG^\6Y6Z?F+]1USNV37>THQNXPH-I@6ZX38,9
MMEJ1.CIJS%DI:,S015.@1/ABN9J134FV)PA0W(O>:NQY2%YKDAD<=]1?U;NI
M44EI:DF5)788LPQSP9ROPRVZN:9KT;7+%<KN;UVC83=?!M<R2I;LI;<M#2W"
M=?=<=>=Y>7[XQCQF.#/_ )N)XLE-K@?L\JM*IXTXTUX:D+DF#5
M    '7\CE^YV#()S)$IZ'8[M)278:X\)YU"3+AJI E*9X2L9=U7RLNH[J9WS
MW*ZL>H#)5YW?<90WEMSM[-FMERN$.(RS O%PBM*2Q$F(9(UMI+@1!%)BLYI?
M-T:ET1\.#QVZ[I[XR;;-:+=W+F#)EQ[G1?+T1U90I9)J4[@OEH8<MO85NG!G
MK?#G[V93NUY?N&6_+VURKGB<N;!._/N*=E7=M:F3)<AQ;CCJU(5751F>H973
M$<%B/V<7=J_R*@
M                                                   VSB/;4M1U
M4?Z&5:$5"U,^S0*S&12N'%PIY/C!7 K&O)K"5Z.A':CN]N*YF?=]7G)]ZK_$
MA$8$S'%SADALR,M.:M%:G2GHUK6HDU.&'%KB@              -K,FPK?&=
MEW"7&@Q&4\STJ8^U&CM)+4U.OO+0VVDN\S(,RM,7&6G(;#?6W)5@OMHOL=*N
M1;EHN<&Y,MK3H:5.PGGT)5Z#,*4BG B.;+-SH
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M
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M5"21%PT[!)NB,"G&<VX%
M
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M1-R)[OMB3,SF4A$B(BH7 140
M
M                                            ''W;_BJY?V/F?TNX
M"QF^5_U\?]X+U3GVG?8U3_W[.[!(PC!;X\<SQ4MN5)B3K4_=9/9_I*Q)PR:Y
MSP9KGPMY?_=>STC[;U%K\K:/S1E.,L[?W<,I<B))4+0B!$0
M!UK+D(3B64FDJ'^3E\U_]VR3$GM6,WR2-Q2(^HGJ#,RXYU?ZG7_ZAN78%LUL
MB4OI&M='H=?G_P X3>_W23_,5BQWL<:=[.H^&'_P$XW]EY7\<T)^*6RV:Z%D
MSWLE05B
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ME)0_<9,EPDJ[B.A"1-9FK*?@AF+C)@
M                                                   )>4JF=-5<
M?D*GR:"4!*207*G0B^7B*(F1&5# 0))$9J(M54K\@"8
M
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MHM93"H
M
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MN!4J$S,YK1$0
M
M                                        <?=O^*KE_8^9_2[@+&;Y
M7_7M_P!X)U4UUK?8U/1^K9WSB1DM^-\J6G3_ %/)]JGZED]E?Y$L3@UQ+-?^
M%O\ \%[/.W^K43^9MC+BSC]W#*6!               =<S#_ *)93_U<O?\
MR9*!8S?)'W%.G45U!%73\NK_ -G_ -0W+Y1(^"*I?3YUWJ==N!_U/FG6GZCD
MZTK_ "%8L)&3.I^&'_P$XW]EY/\ ',A/Q2RM_<6>MDJ @
M
M        # M^+H_[:>C?_K=:_P#EMP(SE+\H[*LRGHE_P5]D=*?_ &?XSVU_
M]3PA(9W8RJI%8I#,_:TH14H=2H?>?HH)&/H,E@+S8?/FV2\O"\0=EL#L;N^7
M4_DC:F+1M;C:ES)$)V6PZBWNSEV]]3S;QR$ZMFDJ=O:0RXT3A,QFL/1?B$O-
MZVGN?[+6]?0YD*MD6WVKA.ALPK@3\&R/NID>*M;24N_@8!*,ZF5*#&*5S+KM
M2,)LI';5E;^6CYH'3UYFNS,/<O9Z\LQ\EM[#+6=X'+=;;O&)W=9)\2$\RIY;
MSK2361$LR+4Z'Z4=O%EQ[E(_G8^<K<O*5LNSMTMNS;6[3NZ5Y^K%LO74[6BV
M(*0\TI9+)]DUN*2P?(6I&M1$9D53)/V$3%:2NT=,>]"^H78O;C>)RS?D\O/,
M;ME^79_%\;W!4^&Q)5'\7F7S^&;M*U/@$36%NBDT44^;AYCC_ED],-TZ@XVW
MA;D.P+A!@)L2ION*%>^.+;\13Q/,F24<E3U":UI!$1RS=+USRY.LE_KUZ0-O
MNIJ1A_Y"/9Y#F.JQGWGWOW#P6&%D7C^*]S\WC_GCX!&3&)B?%&3#%R"JOB=&
MZ:5OK=?1260O##,_YQGP;F[L8%LCMK>]S-R\CMV+X?B=C<NUWNERE1XK3<:'
M%\9Q#1R764NOJ2CV4$=3!8BLL;+I(\_[=WS"NL:[[#=*72S/OVR6)7R7!R'?
M5^XNM0"@PYJ6');;9NNPU)6PHEI(CJ9:\#(SDUP[5MFV9IPIFR9,WS_%]L<)
MN^>;@7F#CF-XW:7+I?;K<)#,>-#9C1U/R34X\MMLU))LZ%745CFPXNJOXG/=
M;=#=S*-C?+'Z=[_OB6)7"1"N&YT:-+=MCS[3TB*:&DQUO14-$ZA!D9UYN:M:
M<)Z<(.:E)MCF= V1^)LZI^G7<#&L,\ROI8R#;C$\NN4>"WN,468S#LQ.R&63
M>=)9LQE(0CQ%*J?!(N&48RO-%:7QRQ[69[LWO7MMO_MOB^[&TV3V[+<'S"WQ
MKI9KO;Y##R7(LE*5I)]##KW@/H2KVD&=2$K$8SD463?-+\\*/Y:_4)LOM'>=
MHT9=BVY#ZRR#,7+HF$C&H;:U^-)-E<R,EXT,M*414.M*"\2:1$5XK<75G\17
MU);EY;<,,\LOI<R;>;$++"M\R?O&N%<&;;)DRH?B2X4%BBXSZ(+RDIJDU&9G
M6O ,(^*:,>>?P6\WV.G]"WQ0.8PM\[%TU>8QLS=-E,AR6ZQK;;\ZN+#\&&S+
MDR(\%AEUB8\PTMEZ4\9<Q%I3CV"<,,2;L*W1RS#-!L]XMU_M=MO=GE,7"TW:
M#%N-OG1GFWF),28PB1'>;6VI:%(<9<2HC(S+4)F>"K,7FK^=STY>67CQ6*XF
MG<S?Z\$VWB6SUB=3*NMRDR">;83+*)(]ZBI5)0E-.4C.O>"SX8K/%CN7+SY/
M.CG(/>BV=#U^M^S_ #?6WU&J%.<F%9"/WPCJ:/>*J@^FH<,\4F^^/^;\/;5?
MK\H/SU-E?,[B73!KC95;3;_8P3;%[VUNSQ)EON1T(:GO1$R9"I*C:EF:33RG
MJ1]U!5PF*PJ7\ZG7RT^I[F+E/\AING'^0O=PEV$+;FL0?!M_X(^\&O\ \\2-
M/]\J$C,GX87P/-<\WK8/RM]I5Y1F<B)F>ZU[)+. [2VZ:PJ]Y--<-]"&W&FI
M*),-KQ&:<RDE6O=J+7L2F%7*>5%UJ]2/7ELU(WXWMZ>9'3YC.1+;?V_L\Z<[
M)FWFV+)ISWUR/*I+C-J:=(T\Q%4(K./ F<L*+KHJ
M
M
M
M                     #JEVN1QI*FD+Y3H1F7"OV2"(K/="4JY2SNG(BD]
M6O.??74OE,6:91F1$PY%;:E&@^<RY3U(M"5\E>X8XUK"]S6%
M
M
M                           0)))X%2OK!9F9S1!
M
M
M                       ''W8_ZEW+^Q\T_FCN 1F^5]UZJ)7F!]5%#(Z7
MV-P,CI^KIQ=@D90ROQNF.*EM=#CRBI4BBR-/6TL6*^MAC3%FN_"W&7[5_/2+
M0RO46I<:?@VPGXEC]W#*7(R,JEP!9BF$H@@             ZWF!E^2.4_\
M5R^'\ULDU$KV+E+Y(NX:R5U$]02DG4BSO(",_P#](;D$8V0FI7YUU.YP,ZIP
M)O\ 0<G^8N 16?8SIOAAEI5T*,$E1&:;O))7HJIJE19^*5M_<V^MDK @
M
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MG81]G'MUK4)&H
M
M
M                                                      \=S.X%
M'O'AF=#)*::TKH?I*O$(F*TE8PFL9NY86^<BU)6:N;VN^M-""M4=P
M
M
M
M
M
M                !MI;;;S#L=SZ$AIV.HB_.O)-"C^1)F ^==YW_E^;V=,O
M5[GF_N+X)><NV3WBD,3#O%FB3KF]9Y;'ODJ6R_%@0G%H-"UT]HSTH$5A+JS,
MW<)S[EF.TVS<+,KG"Q? =L\SR/)K](8M<"W'C5]CH2]/=1#YW'S@&EM+*WR,
MS/2@N$8RG-7X,;GT3O([Z%\VZ(ND+'K5NBM4;<?.&&+_ )-93(E?4BGT-N1(
M2G"99-;J&3(U$95(SIQ&-<*\6<12(M[%Z5L^8N:M:^BG 4GLS3@@
M     XFY1&KE N-K?49)N,&7 <73@B7'<87IPJ25_8!:4FL/FK>;3Y=^\/0Y
MU59SE%HP6_9=LCNM<GKYCV76BW3[B<63+D3KC<8TJ-;X"B95'>6:?:,Z]E1,
M*<LL+HGYDWQ\,YK:>.X=NINI?+7@&U^V>8Y#E>338EKB,N8Y?8C,<ILAJ(\Z
M[(7 -MM+12",S5V"TP\1=,S=RZ>;Z3?D_=%URZ(.C+;K;#+HA1MQ)<95VS"C
MG/X<R8VPZF(JC31$J-0R/2M3$QK5EA;$6Q-8A=0%
M
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M)4=>4^6YR"Y>8]*D15^46G%C6.;O96'EMI4CHEZ>4J-)G^QSC>J3)23K:(7
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MXT\PT\PXAYAYM+S+K:B6VXTZ7B-K0M)FE2%(41D9:&0D5XJUA0
M
M
M
M                               4T;GSS8R3PZT(FRKK2OLF?>0PG-8F
M)FG%Z5M9)*3CZ5EPYU:<>[M[18QFI,4>FC)
M
M
M
M
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MF.;$QVT-2D'4E59?1#2ZR=4E]$R$I&;*;INS>NT(OWNX5BB
M
M            P*?B\FKJUNETIWF!CV0WUNP78KP\W9;%=+LDT6R9*G*9=7 C
M/DUXI,<M3,N(EM8NGL8ZD5B(<ULW\6MCVTNUF"[;N=$FZMP?PW&K18'9L2#>
MX[4Q=M@L152?"?B.+2IY31F>M/0%>QL\,X\7HLGXR''(["G?VBV[AFDTE1:+
MBTGVCIJX[#0@OG"LIX:9LC[H"ZR\=\TSI)>W,NNUEWV[LF>6RZV.X8CD[*G9
M+<:;"]U<4M,IDDK_  <HS(^4RTT#'CF84YHREA<[K;-=8_PY'F(9%U%[88;D
MNZW1YNADDV[7N)8(=Q<A_5MRN#LR:Q+A6MF.S'7 88,M:D=>/"MPXL:S%:12
M%ZQSXN?H6_(L[G&QO-9&<>X$I.&-V&Y*D*O"H]4V^J3-W6;1JM*A29R/F:7;
M/L;GR=^LWS5/, ZN\]ZB=R,+NVUO0O<U/-8EBE[BR8KSJ4I,[8;#<_\ #?A(
MRDK,T^D.PB9G'\/!ZW\3ST![C=:/1Q:\MVEM[]ZS38VX/Y;!L\-I;LR<PRER
M0^3*6HTAU1H\(BH5-5!,4G'L9Q.%(CQ+6/EC?$[;*].O3+BW3OU>X/F6&;H[
M16]>-+-RS7-U=Z1:R;AM))EXR=0XE<=9<"X<!(B>#&[4M^*^<5#?G3>:7U!>
M;%T\W<NGO8O.\8Z3MOKK;Y&79R_9KV](RHY$EU,=QFV)CN+-#:7$?13PXBQ]
MI-9BD16SM9<OP^"7$>53L&V[!GVYQJW7%I46Y0I-OEI4W%@H-3D66VT^WS&7
M:D@X]R6Y1VL9"_,7YOXG5N4WCF2>X%?4%]:E8+J=KH<OC]8E%]SI3^#"L<M.
M)%?FU9N761TE[8=:_3IF>P>Z5F@7.TY?CC\:%(F0XS[]KN:X#S,.9&>D1I#D
M=33KM3Y"(S!EQQ8-/EH]16__ )"?F#Y3T$]3EKS61TQ[CY?R81DS5LOU_M5M
M9NDTF;#-A.(0W#CM*CU)SD31.E=#$I%:Y236(K.-K*W\X_R]\=\TGHBO6'8N
MEI[.T6B-EVU5X6A"'D35PU3H;*27'D.-KEF\WIH9'IQ"2,8HQC?+3\\G=7RF
MK#/Z#/,EVJS6U1]KK@]:\&W#*T7>3'=L\5U41,;WA9)8>8-$92RH1<-*5,A:
M3$TA.>V+?'A+T[S$OB.[EUM[83ND?RWMJLYS?<'> DXQ,S*/:;S&;L$.Y*<M
M[WX2/5"4.>]MJ4:JE028[4MOMNFFG-97K/A]_*GR'RV^F^9=-VIB)^^F\CB,
MCSEMQIMR1979ZF9WU6N6<=E]QUMTZ+J9T,J'K47%:1&$+ GQ7<._3>K/I=;Q
M![P<T9NL:9B].+MSB2GWXC*?2]*0A/?J&43,Y+?%8MY?B5Z]/WQ)MNZ6-NL7
MV0\QG:3-=L]X\'Q6RV\K^U9KK.M>9140FBM\YJ3R%';=5#115%4]CA6H1$\,
MF,WV6_O/#=[5G;S,/,CWI^('W?VLZ,NB?;',XNU+&11599E"H=XCP+Q$=GI9
MDS)KB4OPV6XL66E1$M/M<M"[3),17',B9NBEN3._Z#^D*P=&W1[MITS69]MP
ML9PYNWW6:B.AE3UXN=L:9N3BB;::Y_"?JDC-)&9)$B,%PCT,$SJ*L?43Y!?F
M^97U?O[6Y!N9TZ[GWN7-D7BU0K@^R[;[K,D.S?&=BQV$1U1V&E&7.LR57OH1
MJ3$$X73,92O&9O\ %K; 9+A4&S=.&S><[I;XY;%;M=@P>+:[DT4*_P!S:*)%
M5*E,I<,FH5PD-\U::$,IB?4Q^9IS\,S-W91C=6V^]7&'><9LMO?U[X;ED+<G
M<O*X%QB06+%=Y\.QVR[76-)L\9R<S&4PDF(<CD55?L\NHQIRQG@L5G4B;L)9
M\GG%K=F>5OU!NPH<R<Y)VP:=8BPHK\N6X3UMYTI;BQT./N+HK@1&83DSCXJ+
M'_P<D2[0>DO>*+=;->;.XC.'S2U=[9,MRG25)4?,T4MILG4T/BFI$)$Q686Z
M)Y8>U_$8^3\OJ4P:/UM],\5S&>J+8U*,@\;'8[D>Y9?#LY.W!M"UVZ(J2J3&
M<83KS>WI4CUK6,Q7#B]A^'M\VZ\=:>RT;8'J!L^2XWU+[-,M8Q?'+[9KI";R
MF):F6H:9[;\TE$3[)))*BK\QD84IA"9XLE=I7%!_23Q^4S[> RG.IW-40
M
M
M
M                                   ! R(S(SXE6GR\1*<11GO7<?=L
MP4V2Z4:0=/\ 6U_P1!'&J75PH]HV2DE)Q)IPM?;45>_AZPI25B9F,7LHH
M
M
M
M
M
M
M
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MSJ=:A%L1->*S,SF]A))%6A4KJ?I_>J*G<B
M
M
M
M               M]=0\_P!WSY:"5RT91VTK^#5Z2$K3#M68K3M5!].3YR,%
M8<4KF,W%U_SHIPA4$"
M
M
M
M
M
M
M                                                         LE>
M8QY*NT?F([W;0;UYUF%PQ^[[1W6%<[;#B1D/M3E0K@W<$-NFI!\I>,TGYA)K
M,4C!8Y:^**PO-XW9FL<QVP8]'6;C%ALMKLS+AE0UM6N"Q!;69=AJ0P1BHYH
M
M
M
M                                                     6QNJ.=X
M&Y+B#50DQVCXT_D3GI*HQNIA$K$8U5/]*\@Y6W$9TSK5U=/\[VZBP4I'>J:%
M0
M
M
M
M
M
M
M
M
M
M
M                                    !:.ZO[@J-NNXBM$^[-&6M*_@
M7#[R+L"(B9K*UPB(5>='4DI6UD1RFIO.%6O=R$)'=D37BJU%0
M
M
M
M
M
M
M
M
M
M
M
M                        !9<ZVK@4?>-ULUTK%9H7=^ =])=PMM*]Y-:4
MA6GT.O\ O&T$)RM:ON?_ ( PROE9K2%: R0
M
M
M
M
M
M
M
M
M
M
M
M          !8GZ])Q,;X/-FJGZD8.E:4_4[O>9<:!Z,V6'+*N_H"?]XV4@N=
MION^G0N3M$QYIJE:VQ*ND5
M
M
M
M
M
M
M
M
M
M
M                                                         0IJ
M1]U05CW^8E<"C[^O-FKE_44<ZUI_M=XR*A&514FLQ1<-\N21[SL/;W*U+WAT
MB/O^AZ3"<R,EP00
M
M
M
M
M
M
M
M
M
M
M                                                   8VWF63_=N
MHR21JT*#&]FM.,9_LJ01G19N\/*N5>61(.3T^VURFAOO:U[:MZ>G0.+&,EQ\
M%
M
M
M
M
M
M
M
M
M
M
M                                     8P7FC3TL=3$MLUT/ZOBZ5I_
MM613M(8QG++AW+H?E5OF_P!.-M4>OZJ>H?\ L7I/O[Q>,L8^%<Z%
M
M
M
M
M
M
M
M
M
M
M
M                            &*7YK]Q]WZIYS?'EMT,R*M*?J20?>7<%
MT5A<8C#%=@\H^4<KIGMJS_W4]3M_E7;K7B)2DGX8E=4%0
M
M
M
M
M
M
M
M
M
M
M
M                    !B,>;Q</=^K2XMUI_4Z%VTXPY'\$50K-,%G*%WSR
M=G_'Z7+6JM?U6]_Y+MU#B?@A=K!
M
M
M
M
M
M
M
M
M
M
M
M  0(SJ9&5"*E#KQ[].R@F-1AR><I<#8ZP+DUSDG^ID#2M.,.0>NI=@I,QAVK
MS'DM2/>.E&U*XD4M_6O$Z,^DPF?%,+G9$KP@(
M
M
M
M
M
M
M
M
M
M
M
M            ?H*NI?;U/Y" 85GG73RC]9MV1S\I_5=NIKQ_4<BI\2%C/N7L
M7M/(^D)D](]J<(Z_JQZO;V,^DQC^.2/W<+SXJ
M
M
M
M
M
M
M
M
M
M
M
M             ,';SRIY1^MFZMFJA_55N,BKV>XR3[#(P@G@OH>1&^E_H]M2
MT_[M?KZZ,=P33FP6W]W"]R"
M
M
M
M
M
M
M
M
M
M
M                                                           ,
M#_SY+B<;KFO"3/0K5;:%4_\ <,KTD,HHDS2E>]?K\@9_WCHTM3G-6LU[T]C.
MM=1C/QRMO[N%]4
M
M
M
M
M
M
M
M
M                                                    !)K3#,:2
M7*I,SU,OLZ^H.:(GEGXB(FB8E*TJBE:]O=\@LTB)GA!QH(5SE6E"[-:UXD)$
MQ.0G%
M                                                        #*OV
M#^8ZE]D!@$^?[</ Z\[PV:^5/U7;JE_O&7Z2[0QRC-C=C;'K9 WP];Y/]%=K
M62N;]7/4.M=*,4$_%+*W]U;/I7\!0
M
M
M
M
M
M
M
M
M
M       %O3JN\P;;?IGNT?$F(B<NS9Y'._9(DA"4PTJ0XMGWAU+I&2E<FI:4
MJ.@ZEUS0Z?=\J(Y];B^O>0?I'UKSQH3O[KOR_3(G"^8S[:113_LUYMN"9OF%
MIQ'/\65A3=XDIBQ;NJ4EZ.3KSK;3"74J?5R\[CE*U*E!P-IYITM;4C3W%G)$
MSF];YE_E\ZMTOIVIU#I.O^;^7%9LI2:1%9IAW+P$.4S-9;EQ76I$22RT_&?9
M6EQMUMU!+2I*D&:5$I*B/B/66TI6W)^=]2S4T[YTM2)B^V:3$YUXMV,F
M
M                                                #YZGQ#$TH_7]
M>D<W&UVWV:\/U#+/A4AE$XL:TM]<LB#X<Y_WCH@M2R.I>_NE7^)8]8QFO--6
M5O[JUD%@
M
M
M
M
M
M
M
M
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M$5*CZAT.=2>F:<ZDS-].+^>GU.TMIH^=M]I[&+8VT:F%*4[\N]5>.V>!
M
M                                                ?.=^(QN11_,,
MOC=?_5=M+C2E(,S^"*M:!6&/9''%D>?#92?>>ABUK(M"N#Q%Z:ICGZ19FMS.
MW]S;VXLB81
M
M
M
M
M
M
M
M
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MQ%N-QK;O7NW.O=-VK?=,S,\9G&7+C-I
M
M                       ?-C^)/N*8WF,7MNM%':[=I6G^T9I5XD)7Q8=A
M.-E.^62U\,K)]YZ#+4JM:7!W^-C^DQE.9;^ZM];)"$
M
M
M
M
M
M
M
M
M
M                    #/ 4;=?B23TD;SDG0CQ.XUU/_<KU>/H'5=9_W;J>
MA[;Z=?\ C+8_ZZWWPM-_#L<I=/VX9((B3^5TT]-"K[VOL'3>5J_M:YUA]C_F
M9C_[FV\S_P!!;[F190>MB*11^9D10
M
M                    !\RKXFRXE&\R6\H4JE;9;B(JT^C!G=QD,9SP/PTG
MO9.WPO#_ +QT#6U=:UN#NM:\4Q_M#*?BGM6W]U:R7P0
M
M
M
M
M
M
M
M
M
M                     %&W7^=.DC><_P#Z3N/]*O#J^LQ7IVI'<]M].O\
MQEL?]=;[X6FOAV#_ /N_[B%2A?E=-TK7_;:QTOE>/WWIA]E_F9C_ .Y=M_J8
M]S(N'KGYD
M
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MLRF'"TYV)#2765TX^VA9&+@QQ;D
M
M
M
M
M
M
M
M                                   !1MY@'^"/O/\ ]4[A_2SPZOK&
M'3]3T/;?3O\ \9;'_7V^^%IKX=C_ + -Q?\ K=-_IM8Z;ROEJ^F'V;^9K_Q)
MMO\ 4Q[F1</6OS&
M
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MTN-J+O2M!FDR]0"<C(RJ1U+O(,A$
M
M
M
M
M
M
M
M                   %&_7]_@D;S_\ 5.X_TJ^.KZS_ +NU/0]K]//_ !CL
M?]?;[X6F?AV/^P#<7_K=-_IM8Z;ROEJ^F'V?^9K_ ,2;;_4Q[F1</6OS&
M
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M,MM;T-U_PVFWN37G))$1B1-M>]E==J\N,X,MCR&?B#9G6=>K?TN]6)Q;)O\
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M.RY-8I34ZSW^V0KO;9+#J'6UQ;C%;F,*2IM2TGS-/%4JZ&+G&/ P=B
M
M
M
M
M
M
M
M                                             !1MU^DK]J/O14S5
M_P T[B>B>!>ZO%P+TCJ^KQ,].U.VCVGT\F(\X;&O_36^^%I?X=;G_:^[B*,C
M/_G=.H=*$H_>W-".A$.G\LV\OSJ95A]E_F7OB_S)MJ5_<QGA.3(M;,S(^953
M[J%[/'NXU'JXF,N+\S-04
M
M             ?+Q^*)(_P!TTNA]GU;"_I*>$Y^I?PLI;X5XS/R_;;_9%?\
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M7[+:R*AGI0(6Z:S5=1%8@
M
M
M
M
M
M
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M):NUJ
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MM[%LVVQZ(2L<C1I3<QCW64AM:'&I#24H<0MM*3(RT,A(SHLO=A4
M
M
M
M
M
M
M
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MN5T/Y^=>Z3J]#ZMK]+UOCTKYC[</L>BCDNH
M
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MM3[1?1DN;TX$
M
M
M
M
M
M
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M;[O2C5V]\7Z<Q6)B8?D;?=.WO3-Q=M-_I7Z.O9,Q,76S;-8],.<'(<,
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MGJML<MNKJ3,>BN'V/81RWG@
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M:.Q%:)B,PQ&81^AM1VD,M)[^5MLDI3\PRPIWIC7%N
M
M
M
M
M
M
M
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M@
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M?M)2@B-"2HDDD2$I(BI0DTT(B(6N%(*16LS3L;@$!(B(R 4  (B(R
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MY:)+3FH9D1]@D4IADLS/%[N+3BQ
M
M
M
M
M
M
M
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MKN"VWWZ>I;JZ4TUHG"?>Z%CTU_%+LK#KVXI4*0M2K!.74T&E1\RVS49D1<O
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M0%C!!225Q[. DQ4B9A$BIZ3/B??W:#*9]C&(1$4
M
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M)1&1EH=*_)P"@@:$JXE7Y_S1*3$UK@M9I3@CREH=/HUIZ*\141
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MZTY0JOXZEP,>*>@
M
M
M
M
M
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MQ,?8^@].NZ;L+='6PUYS?S!^L/G;0\\^<]QU79?[NB[ET^^(KCQS5YCO'RH
M
M                                     'R\OBB*?NFESI]+ZMA4_P"
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MLVS6U>*N]\MEBLERR*Y24,VBTVV5=YDQ)DXVB!#C.2Y$A)I,R6E+#9J*AZD
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MV:5MN)2XTM"TK0XVLN9"T*29I4E23(R,C,C(P3W)R,S+4J'W5K]D!$
M
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M"=8>:>;,B,G&7$NH,CU(R4@U$9&0O<C4(R/@!WH@
M
M
M
M
M
M
M    (*K0Z<>P28J/ MT^F?8_>M<:1N7M]8;_ "HU?"D.PH[4GBNIN2&FB><,
M^<_I*,=?NNE[+J,Q.ZTXNNM]3U70O.OF?RO%UG1MYJZ-EV<1=-/96D>IVK;'
M9?;'9RTG9=NL.L^,P5F1N%"AQT/KHDD))R0EOQG",B+0U&0W[79;;9V_+VUD
M6PX'7/,G6_,6X_-=9W&IKZO]*Z9CU16C'(\UO",$SCJHQNP9CB=INMM=MZD$
ME$&&PZ?-$D)4IUU,<UNK,U&=55.H^&^:)_\ O#6MGX>6W#+@_HM_+!S7_2?=
MQ.-+\YQ_%&5<O4LA;J^6)M=EZYMUVROLC![R:W'HK,9QXB2^1NN)22FFDD7X
M0TE\@X&-)MB8]%'VV[FB8F(G",ZJ6OJCKPZ197@PG+GFV'PEF;:C7)EJ>BM'
MI2M5)JTQ]D:[++;)\/@^U?F7W:4Q?2^^?4J,VH\SO"[W+C8]O7BLS!;R3C<5
MVYRF)!(6^:FVC]AUQ"?:6:ALQI,TK9V_YFJL1^SMGQ?I5Z0;Y9<^=B7R#<6U
M88TAN1;W^9)%<2<2ETCY.<R+DYR'3_-TM[N^74OY=EI3[7>1;J[+:5T[9NWF
MK&?8[PN[VFI?J]DD)222(C01$E)$E.A*[B(=E.YVW"^*?H==^6W-/@E(=YLU
M/9N#5?6G_1#'\SMN-\$:&XKA9*"KU92,OZH-&95[4_Z(/S6TX7P1MMS/X9"O
M=D[;@W\Z?]$81NMK^O"_EMS&=DGUY8J$?UDV5>'T>PZ?G@_-;3_I((VVZG*R
M4OU]8J5^LF_5[/\ HA?S>S_Z1?RF\_Z.4?KZPU(OK)O7^%_T0GYK9_\ 2)^4
MWF7RYJ?7UA*A_6;9&1D9&7+Q+7\\'YS91_SF*_E-WQTY=,RM%I=>3F%DNZ6+
MM9D+?EH;25)L9"%..\R4F1&:&DF.KZA^5NOMZCL]6F\LG&/UG8].C=19=T_<
MZ5=M?&$S^&B@'=GS,K9:[A+PO9G!KCE&4-*5#>N+$>4HFY;9K8<4:$+41%XR
M2/@.[LU/F:5NM$1;$QC.;I;[/EZU^A7FFV?1Q>",X5UW=64DBO\ <;E@V&SE
M$;II5(C+:C.G52>5-%'1I\_F$IS79<_V,9^'FMGENCAFJNVK\L_:+"%Q[AGU
MT?SN]H-M]\ICKIU?,T..$9OLK(ZN),OE&<Q$QXKO50MMQYK(PG/O7*-@\5Q+
M"=X=I[/A6-6JR1$7-A"B3!AN.+2B5%(C-TF$KK1!:B63$;G1Y</''OAT/G:V
MGD+JLWS6/E<,/PRR\7+9;KQ9(T.[6Z%=8;\".AV%.B,2F%DY'2E=6I"'&SJ2
MJ<!^A;;;+]&VR^(FML9^A_(N=;7V^\OU=O?=9?%\TFV9B8Q[8Q=&Q+93:C Y
MTZ[8K@>-V>Y3U^+)E1K1 0^;BE$NJ'$L$MHS5^=,AQ]OL-GMIG4T-.(NN=EU
M#S+UWJNC;H;_ '6OJZ5D86S?=,>RN+U!M"C,EN?3["+@DO0.3/BNB'25I#<#
M:@
M                                        /EY_%$5_=-+H=:%]6PNP
MC_VE/#"OJ/P^N64I\*\7_P"3\MI_^T5_QD<6[XI91'[*V?2R>!&(  ./NT]N
MUVNY7-XB-JVP)=P=(SY2\.%'<DKJHS(B+E:X@/DU^<QU>[@>8)YBV98O!N-W
M<P?&\LA8;@^(1[G-5;ER#N\NQ/.>[M2GXKII==(S]@(QCN8WTBZD5F[@OO[#
M?"!X-N)L7BN=;M;R7?&]U<JQF)?S@6^W^&UCLF7$3*M[#KR(K+RUM<Z%J,DJ
M,B/2IZ"369K&3.WEMBDXSVL4[K/Z>\[Z1^HC)^G3<6^R\FON"Y?9(42^3G7I
M$J5;RO1L05J=D4>H<6.1D1TI4)[V,SR^'O?37Z,FR7Y/&*-JU)6QM](^S0\=
MDD9?9$C&ULG&[#L?-CZ&K':D>:1@$AN.M+J=Y+VX:O&53G3FY&1TX<5&+?.#
M59;$3$<7T$_.(\D[;3S-+3BF\.9[CW#"+AM1MU*GQ8D:*3\>>FW8^_,2R\YR
M+4@G%((M"KH%&R:5QSA\[/9?96T;Q=6MMZ4[I<U6[&IV92\.<OJ4J4LHT*^%
M9$2>4DJ7539\WT0G*>UC'BNB(XL]_I"^&<V8Z9-M][</L^\=ZOT#?G'K1;Y;
MSMN0V5I98BF:3CJ4A"WT+<D*47,1'0^ 8L^:,HC!AG>;CY>.'^55ODSM1@>8
M2,ZC7]U%RESI+!QG&2NAR)28RVC;:2E41+1-G2I'30S"W'"<X87W713EC"5Y
M3RJOAP=G^M+9+9?K3ON\%UQ[(IN16_(Y.,1(!264R;!.MMR9;6MQLB23IIY:
MI,PFM:<%BDVUNC&58?Q1WF+9EL;MWMMT*[)97-L5RR2RQ;5GEPMDEZ)<4VR#
M:7H-NB^\0YC$EA+[<8C/37F%XUJQF*6\O;Q6K?*6^&\MO7ULFOJ%W[W.E8/C
M-ZFD6)6]R6W=+I>U/MHDW&?)?FI4^RAI]PR]IPS,UEH>IE)B>"VSAXLU)GG#
M>3Q=_*)S/;?.MI=S9UXQJ_34W;#LDM=Q<@7&VS+,ZY<)<>2U;SC/&9.0DD=5
MF2N^@16.^5F(NFGX?<S7?(GZ^;]UU>6\N7G3[UPW%V[P:\8QE-T?<4IVY^'8
M'FH4APEOR'$K\'V3,SUI46,)[TFLVUN?-^WOM=R8ZX-Z6,$*4UN%>MRKG:\8
M7&D/(>;FW7*)<$E-*:42T&;KC>I<*!&&"3X;J<&2#TU_"K]56=73:GJ*WFW;
M<M&>?6^,Y?<[1<UJN\KW)J9 NT9IR3*AOO)<3%<6GE-54\!(F8[UFRL8W*M_
MBC/,-SS9#;K:[H)V<S*;8''L<M%HW,N]I?>BW"Y1HEB^KH41#D.9'E1D.+C&
MHR).IK%A+HFD1VK=WE/?#:P>O;8>)U(;_P"XLC <:RA\_P C8"Y+5RN5]-;3
M3]PGR79B#>:2V\]]\X9FI6A<:2<IC*5LY>,3,>Y1=YO?E"Y;Y0.X>W>:;3[F
M3[CB-XGQ+UAN9VFXNP)]MDVN2Y.EQ9<:W'%=,R=@D@ZJ-*NPS+42*QAQ2Z./
M!G!^4%UNW[K<\K>XW_.YZ[MN#ANUF18_E%R<69NW'W;%)*8DEU*GWW$N*930
M^8ZG093E@RI6.:?AG['S4(N$W7)^MK+L0V_F2+!GV7[K7FTV;(&'W2=M1W+,
M'X,A]HD&2B427R5[/YT6,Z]C"+8FVD9LR+_)",'RG;+]D#/NI#),AWGN.+IR
M6?>;A%?GLKNQVA,]J XJ:TX\I##_ ."K0Z4T&%)F:\&R.6+>6<;NUBB;,WC.
M.A3S%\*A8W>)UMRG;;<Z!C=TEP94B*Q?(4C*XMJ(WXL=R*VI*X\?@HJ4,9<.
MYA-OCBN<?:SY/.2\G/;/S+\!PKJ@S'<.;A-XVXVE;R9NW,QS=CW53V-E>#C.
M.);>6VMU]22TTTXC''.)P;*UCE['SX=@-G[9OWU.6#IGO5Q5:[!?,MG8>]>4
MDI2VX\*\ILC<GE)*U&9MJYJ<HRG*6%DQ-T6]O%]+CRH?)ZP#RI=MMWX>#[A3
ML\1N=CIS9KLR&F*F,MJUH=YF3Y$+<0Z;-2-1$=#X"U\-%I;6L9OG!=05BMBO
M-9RM\V5FY^SE:W?T57+XB\\22E4X:D@OF&,4B*074YZ/J1]8DKJ+C>7A<872
M?;'KKOC=]I<4LF&QV'%-.MKN.*QHTB2AQ/M)6TTLJ&6I&=>P)F>!%*^)@N='
M'PS'7QU%=1<[)^O^#=<(P&?<[AD629?>\D?O,F[J7)1<408\2X,.+93*<=<;
M30R2GFXTU#'."+;:S54#YX/D"=._1UL#'ZCNGR\1X,'%TM0<BQQJ9'3*F.%&
M<)%P96PRA?MNH(_941DHC%QF<9P2;;.7PQ27JOPF_5CN//O^[O2+EMXNV38!
M=+2XWB2[E/ERUXX:K?$:E$R<R4ZI2%MNJ+E))$51*4SSDLCPS;PA15Y^'E [
M>^7%(?ZG</SZ;EEYWGRR_P Z78)<7W8K4ZY)E7-Q;:TMDAUMPW201FJOL<.]
M&'IJ3,91%*0\O\F'R7MNO-GLV6Y_G.XMPP.?M==,>EQHMOB%+5<D//P9SJ'"
M4@T(:5] SYJU,M G&:1A18F)M\64LGWXA#:FT[0^49;=G8<ARXVS!;7;+'&F
MN?@W)+<."[%)U:2X&I+)"QA@MWBMGL6!OA*;1;[?UB9\N*TI"EP'*FIQ2O\
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M4ELC-1F9F>IA%64TK3@KO0DTE2M?WN_M$B*$S$Y11.*@
M
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M40VU<=N0
M
M
M
M
M
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MA_E3:OQL7^';3CI7^R?T)_$-S/\ \UMZ_P!>S]*8L;VY.M+QC>G&N4VKY/\
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M?R$W'[^_^O/O;P9M0
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M'_5)G^-:%C*/0<9]*Z*
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MMQ2EK\9$9I*TJ4KVC-"B,M1E;A%)S:;YBZZL._#)@
M
M
M
M
M
M
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MB]+]W;_5CW/Y#:_[^_\ KS[V[&;4
M
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M/8V^GSD9*33\GI.M2.E!C$Q$-WXJ/FX=#\V+^ZA8"29,<U_LQ7U/*3[1J/\
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MB+-%),EIX-%H95(Q>$4,.:>Q=&3S:\QU+2FA?+P"L3%81.
M
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M BV(R6;KIBDO64IH:CK6M.SAQK\]1E7"C%,(
M
M
M
M
M
M
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MQR_\4@?HG3_=V^B/<_D5K?OK_P"M/O;H9M8
M
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MK06F%"N-86=]L_AL/+QVKWKM.^V-X?=6LRM&1R<HBN+NKJHQ763<#N*G_=_
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M:G7Y*"X>L3
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M5+U\!U\3$NTFL15.*
M
M
M
M
M
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MV1[KF6S$_G6-_0[/\S2/T19\$>B'\D-7]Y=_6GWMP,F
M
M                         ^7I\43_ -YE=/[&P?Z2G!Q]1^#URRD_A7J?
MN?EM[_K%?\9'%N^*644^5;VXLG@1B
M
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MQ=(C.^\PXK_;(CLN&K70UMI6>A^L?';XB+IMC.)?H#2FZ;8N[8B?L;X%
M
M
M
M
M
M
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M
M                                          ^7K\417]TRNE./U;!I
M_P "GB?B]2?A]<LI+X5[_N_;=KK]8N5_S$<6?BEE'[JWULG@$
M
M
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MC]'8/CM\^.ZF4S/O?>]*)^5;7.+8]S=C%L
M
M
M
M
M
M
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M%0
M                                           ?+Q^*(H7F:W,R/7ZM
MA:4_\RG_ "!.?J/P^ME+_"OT_<_;;3^N*_XR.$_%*Q^ZM[<63N"
M
M
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M^8RJ5#,>0WFMJ1U&+8F8I+Z%TW;:'\'NNNB)OF%.?(RAQXE2HK:?&=H7O#/
MEJ(B^GV4'IKHNFV)GXJ/%>'FF:Q2)GB&EJI4EQ3I73WEG[7B#&(GULIFV,IB
M6JEA3A&HGH^M/Y.U]Q5!9F8GEI@E)SK$2E5'>+E.B5(KH:%I5_&F?:03,1/B
MPJ3$UI$N$L[==P;6GPSJN7',ZU*O*Z@^TBKP&S<Q%O2]3&OA:]G;7K>E7MCW
MKI48J1X_^H-%\R$CX_=\4^E]XM^&/0UQ&0
M
M
M
M
M
M
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MM)_^4CVM'_ILZY3'S!-?ZD_H3*Z8NL]525UM7YPNPEVZ>HO\\X9!_C#:6_\
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MDB^8J#]$1D_E'.:84
M                                                          'R
M\?BB*?NFMSK_ %MA:=_ZBG]O906<_4?A92_PKW_=^6W^R+G\9'"[XI91^ZM]
M;)W$8@
M
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M 4
M
M
M
M
M
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MG":)@0
M                                             !\O+XH=5/,UNFG&
MVPOZ2GBSGZC\+*5^%>/_ /)^V[^R+G\9'"?BE8_=6QZ63P(@
M
M
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M/AK^A?,;,^1LJ:>&BI]WL]P^/SG+](1E#4$4
M
M
M
M
M                         0(R452U(Q*Q2H$9**I:D$3$B(H
M
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M;;H[:Q&'%722B41*29*2HB-*B,C(R,JD9&6AD9#LZO!!J))5,Z%^]W"5@1%
M
M                                    !\O+XHE7_P"4TN::?^K86O\
MO*>$Y^HIX?6RE_A7_P#N_+;V_P!45_QD<6[XF4?N;?6R=A&(
M
M
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M'1E#7!0
M
M
M
M                                                      &A(>9C
MM*=??:C-)^D\\M#;:/X9;AI06G>8PY;IO\*QCA&;BTY%CKJO"3?;*XLS)/(B
MZ0E+-52H1)2^:JU[!G&CJQ&-LU]$_H7EN[)]CFB,CH94,C*I&6I&1\#(^TC&
M&'-2F+%$9@
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MMNF.Z)EN&GV7T>(P\T\@^"VG$.(_S2#,A8F)R2ZVZR:71,3WM45B
M
M                          #Y>/Q1-/W32YZZ_5L+2G_F4_M"<_4OX?6R
ME_A7Z?N?MMI_7%?\9'%GXI(_=6]N+)W$0
M
M                                                    !;*ZR8"V
M<VL$M2>5N6VLDKIQ-"'2/L'.VMWAF.QTO4;?VMM<I4X8WDDFT/-P31XL)]7*
M=3^@=4T[=. V:FG%\5C-Q=/5FR?E\'L?,2DI4GVB6E*B[.*2/C\HXT5YNYS;
MHMY:<4J:GRE777LX=HRB(B:PDS7#@@DSX%V^K[HJ($9T[J\2X\ $Y%RZ%H1<
M3X\=2T,!*1\$\#.ORTU^2@DY+%..3B+NAMY4?W@B3$B5<>4?#3VDEKIV#*R)
MMB>;/@QU*783A;:X;$Y_Y7[IXK&909PXTI!-(+4C)IULC/[X;(MY=*>;BTV7
M3J[FVB\='3RQV$\.5EI-.ZB$D.N=_&36!0       '&717-;+@9%S%[H_3LK
M^"57TC;MY_;6SPYH][C[R9C:WS&?+/N6'<K2B/U"S5-4);DUTUE_KRQ]AU\=
ME9?E/+'N?F3<4LZ[?3&M\U[L5S#$'$GMXAU.A^Y2"49UX^!3@/ [F*;R;J\8
M][ZYT^8OZ7'=;/N41.D?ODTSXG*D?S98]76FG;Z(?-[OWUT1\/-*!TKH5/0+
M.,X,'0MT?9Q<S(]#/C3NYOE&[1B.;%P]]7Y*FM*O9TU+E/[)'0<N(=/$T[YF
M%4'1^XZG-W#4W5)26*'7A5QGM&OJ?+'1M7E^*F3TWDV9CK%DSE7]"^@SJTT?
M>VC^-(?'YS?H^W*/0U!%
M
M
M
M
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M&3)U)2C<1RNDI!IYM"*AD9529*+0R4/D<YXX3#H<6X&8
M
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M_P"<BZ(NK$Q$8TK6E.]CT;H^8KUU^9-E=SVGZ'L%O>$;:3UN6R=G#T>9&*;
M0ZMEZ:B<KV&TK:>0Y1)T*@\UK=4ZGU?4G;;*R;=.8QCMCMYGZ-Z7],_I[]+-
MM;UKZ@[BS<]5LI=;HQ,32Z8PBG'&L*\>BKR/=KMMW(6ZG5%-D;S;R7(F;I.<
MO<AV7#M-R\9J0;7+*;<]Y\-Y"CT.GM<1V/3_ "YHZ=OS=_X[\XBOPSZ>+Y]Y
M[^O?6.K1/2/*41L.@V5MB+(I-UM*<,L%^*RV6R8Q;HEGL%J@6:VPF&H[$&W0
MV(;#;3+26F4DW&;;;J2$EK2ICU-EMED19;$1#\]Z^XU]UJ7:^YONOUIFLS=,
MS,UGME2GUY9OOGM]TK;HY-TX8RYE6\J;4B!A]H:4I+ASKDM4(IB#3J2H27?%
M*G:D6:168:K9FL5BLO#O*?V7ZA=H>E+&$]4V47#(][,KEW3(,L3/7(6NU*N4
MM<J);4^.=3]U973NU".VA-8CENFL]JYQR)T.FI5H?KXZ< F(F*3D3-0DI36A
M<>.IZ_.$S2.Z$4K[_=(FR_41:WV\OQJ$SD!1G$6S((+3<.9$DF2_#D.J9;(Y
M/(I=3)=3,><ZQY6Z9UFR=2^R+-U3PWQA,3VTC-]0\@?5[SE].M[9?T;=WSLY
MNCGTKIFZVZW"ML1,^&O<L*;\]&&^?3E,N<WW"3N%MI&<6<3(8;3GO,"-5QWD
M<A1V#=4;3"*:\1\DZGT+JW09N_-1.KL8G#4C/V0_?WD#ZW^1?J-I:6VUK[>G
M>9;HQTKI\-]V$5YIFD5F5+EMN<&[1_>+<\I2$J4AQI]LX\EIQ!\KB%1W:.D:
M5U+4AUUE^GJ61?I36W[?8^MZ^WU=KJ<FM&>4Q/-;,=M8P;[F[^SB?#CPT&=,
M:PX\]O$TT(N!U[^S45%.W6&?+TV9^5:G[FG2E/Y#([1C?'[*:]L)-(OP4^>6
M&1%L+/5P,Y<FI\?]L-?(-EU?%V4AKC'4MHN&J(]$EHGOX^GU\1A#?<&9J.M:
MD?R4I]D,HP2*\,TJWFF&EOON(99;2:EK6M*3Y4D9GRH49&HZ%P+B%O;=A;#*
M++[KXT]*)NOEW;:C:'=SJ'N7U1L_C,URW*>0W-R^8R_"C06"<0B0\V4ADVGR
M;0Y70SK09;+;]0ZIJ3H=)TIU+N-\X1$<9[)>;\X>=_)WTZV\[KS7NK/SE*V;
M>V8NFZ:32)F)K&,<5]CID\NC:G99FW9-F4=C<'<AGP9+M^N+*%18[_*TMQIJ
M"ZUX*O#?1H9EV#Z;T+R+L=A37ZE/YC?X36<K>-*/P7]3OYC?-WGF_4Z?TJZ[
M8>6YK;&C9-)F*S%9NB:XQP7%F66V$DRRTVRPVE"&66D);:;0DC]E#:")*$EW
M$1#W4?+B(MMI%O9&#\[777WW3??,S?,UF9FLSZVN,YFD58N(NC"KC:[C;FI!
MQ7KC;YL)N4GZ49V3'=8;?26E5-*<)14[A8I,>'*$PCXLUASRY=O>N7I>ZP^I
M/8O?&7>MV^GW)KRWD6T&Z4]Z2TFT1I2GILRU^ZO\R32A+I(/E/BGB$1&?%GX
MYF9GX>"_J522HZGQT*E*<IT^R+7F8TFWXL94Q=1'2!L#U2XZ_C^[N 6:_>+&
ME,QKB4.*Q<8KKS3R$OHF)84\I32G341&9ZC@;SI^UWMO)N;8F8R>I\M><?,/
ME/=1N^B;C4TIK%8K,VS2<IBM,<F-ANIY;75_Y;F=JWCZ-=S;K<=IXDI=QO\
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MJ;@5B
M                                      /EZ?%$T_=,KI73^IL'7N_4
M4[L$_%ZD_#ZY92?PKU?W/RV_V1<_C(XRGXIJRBORK?6R>!$
M
M
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M.9_06O\ 4F_XTA\AN^*?2_2=OPQZ&J(H
M
M
M
M
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MIK2[*L\1]:5&JJN8EN'6NH^":]O+N+[8RB^Z/9+RNI%-2Z.RZ?>[B-;
M
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M73/MFK?#)K
M                                           'R\OBB3KYF=T+NML*
MOI_44_Y@ICZC\/M92WPKW_=^6W^R+G\9'%N^)E'[FWULG<1B
M
M
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MWWPOD,G1A@^SP6ZGW>PFGI,?'KLY]+](6X6QZ&N,60
M
M
M
M
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M37T[[/3;,1[:%NIIW_!=$^B7<><N8TGQ*G?^8.)7&C/WAJ(B,ST(A(NJ)AD
M
M                   )'"-23(BK6G;3M(2E9B9R@4L]6_319>I_:FZ81<'$
MVV\(;6_8KJ:4N+B2D-N&E!?@UF27EF1&.LZGTVSJ6W^7=--2,I['NOI_YVWG
MD7KVGU7;QSZ%:7V<+K?\S'+OW0-U7XMD18JWA+MY-V2IBWW=I\S9?C>*IIA\
MS1'-">5HB48\#J]$ZEIZORN2L3.$OV1M/J[Y WNS_B%VYC3NBVMUDQC$TK,9
M]J\OY??0Q<>G2-<\ZW$EM7'/\B;:,XQ$D_J,B;9);2'4M()Q2R29'KH/6=#Z
M).QKN-?'7G*.Q^<?JY]5-+SG?9TKH]LZ?2-&9Q_Z3/A5=$3S5,SX:4+33OU+
MC4>F?"T%E5)D7$Z4]=2%A)6\>JCS#]D.F;>'9WIXREQ>2;@[XRIENM>-6KEG
M2XT1)DP\Y<H\9QR1&9=2M7TT$7+K48XVY,ZV3=%N4SDK&VZVTP';JT>[;>8E
M9L3@7=7UI-9M=OB07)3\TO>%.2U,,M+?>YG#J:S,R,Q*37N29FE'I*2,B(C.
MI]]*=O<+%:8HF%    &FM)F::$9D5:T5R]U/2)C,TR@EYWN/M/@.[>.S\7S[
M&K?>K5<&S;?)YACWHB-*T$IF7X2GF5))9TH8Z_J72]AU3;W;??:=M^E/JGVY
MO1>6_-77O*74=/JG0=SJ:&[TYK%)GESXVUI.2Q;U$^6GGFU#-PR[8J6]E^,(
M5*FR<)<+DD6^*A3KRB9D$TI;Z4((B*AUTX#Y1UGR=U#H]EVXZ=,Z^UBLS9QM
MC[W[K^G'\SG0_,]^GTCS[9;M>H3%MMNYC&+IPC&*X8K*75_<5ETW[BP[I;9]
MEO$=@V9MLFPY,;W=UM$IM9)<D-M\Y<Z3U'E+=>S6V_-%;;ZXVS%)BD][]+W:
M.G-ENYVNKIZ^PNBMM]MT36)BL81,T>&>6;.C1.GV4X^;G(<J5R)8;4^ZXKQV
MJ(2TV1K,S/30NT<B^;;(NNNFD4AJT='5U]2(TZ13C,TCVS@O1].O1UO)U,RV
MYR8DO;W;93A(>R*9'=*1<6O84IMJ%)8)Q)N-+.AD.=T?HW4NOWTVULZ6SKCJ
M3'NB7R_ZD?6KR9]--.[;:5UG4?,L1AI6S'+9..,W6S3"5^_ITZ0]HNF_'VK?
MB=@B3+Z^P@KQD5P9:E3;A*2:3-]LWFS5%(S06B3+UCZMT'RMT_H6G6RV-3=W
M?%?/'T=GJ?@+ZB_5OS;]2.HSNNL;B^W96W3\O2MF8MLM[,)QSXJH22Z1:F1F
M5*)(B(J<-.ZA#TUT1-*9/EM:]S7%     !HOLM26GHTAEMZ.^VMEYIU*7&GF
MG4&AQMQM9&E:%I,R,C(R,C#$A;;ZB^KCI=\MV][5XMEEBBX+8][LFDVR-=K3
M;6HMGAW9Q]M"#GK:*/$BG*D2.*S*I^H2Z:8\6=OBFETTBF"XO;;E#N]O@76V
MR&)L*Y16)L27&=;>8>CR&4/LN-N-J6TXA;3A4,C,C(6L1\63">-&]6A>AH^D
M?TE'PH79R\-0PKE@8TP>$[F],FR>\$AN9GV"VF[36R(BEH8:BR%&7-JMUELE
MN'[1_2J.OW'3-EN[N?7TXFYZKH7G;S/Y<LG3Z5N]33LGA69CV3EZG<=N=HMO
M-I+25GP#%K98H9&1F4:.RF0NB23^$E>&3RBY2X&8W;?9[?9V\NWMB(==UCS!
MUCK^X_,]6U[];5[YFGLR>C()23H95(^*JD5./9VCE3.40Z;C,M4
M
M                         ?+Q^*(_[S6Z?V-A:]WZBG]G;46<_4?A]K*7
M^%>.OE^6WO\ K%?\9'"[XF44^5;'I9.XC$
M
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M\MBAQF*ZU9:^7V$F/CE]U)F8[7Z2LBMD>B&N(R
M
M
M
M
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M]'ZGJ;V+MMN[?E[[2PNC[X]*Z,94/FK2OTM*\W87JH/FT1/":R[Q.,P
M
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MC+9:\O9W"1';FMTXUX*BA4
M
M!\O'XH@S+S-;H9?UMA5_X%/%G/U'X64M\*\?_P"3\MO]D7/XR.%WQ,HF/E6^
MMD\",0
M
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MN52D-D@B09F==!A\R[DY)^%R(T-*W4G6MCQO4RU+C7CK2G:-=.UOK$XQDB
M        .M9=-3 QVYRE&221'653.GTDF7;3O')V=GS=S99VW0X?4-3Y.SU+
MYX6RL-;Z.MIW9@3:$2U3%J6HCU(E/K,J_/WCZ_=6-I;ISPC[GYGZK-.HSJY3
M==][VII:'H\5U)\Z7&6Z'ZFT]W$=7;'#@[/\,7=L)3.AZ'6G Z=XM:2E*IRH
M23TJ6FO"NO=V4%X#HFYS9NXJLR.IMT,RI30^;[0STJ?,B.+C;VV9VU84QH^C
MH?WBRK3C[)E0<WFFW'M=+,33#-4MTL+:9FW-=?:9G0E.)K]$CD,:ZF&YLY]C
M=;^&8GW.\\MWV:6\C4_'%T5]L+Y]NDMRK="DLF2FW(S*B4795M%2IK770?'=
M6R;-2ZSC$R_2FA?%^E;?PFV/<Y$:VT
M
M
M
M
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MFE<(F7K8FN$9RW0
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M3$Q."36)P;L2(IA "@
M                                                     #Y>7Q1)
M?_E,[H=/_5L*AU_\RG]@<?4?A]<LI7X5[_N_;;_9%?\ &1Q;OBE8_=6^MD\"
M(
M
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MP^SOGJLF"3QX4(B[S^],?'^IZ<:>^OLX1<_2O1M2[5Z=I7SC,VN]#@NS
M
M
M
M
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MV+)KHV5K'9*^H9)]A):$1&E*2+3V=#+T4H/B_-XI[8>G[IREK"H
M
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M,0G$ZI_.A$U]*SS5F/PQQ[5]DCK730N!]_?ZJ&*F%$0
M
M                   'R\/BB/\ O-KGV?U-AZ_[QGBSGZE_"RF/A7O^[\MO
M]D7-?XB.%WQ+'[JWULG<1B
M
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MEL[-M,UFV,W:AQG-
M
M
M
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M<T9O39X2F&8
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MH3[:EK=2;+IT+FH9B9X<4K$Q6W)6"1U(C[PC&,,A$4
M
M              0K^]0Z?/P#(.W][]X@'R]/BB4DGS-+FI=4UML(TD9&7,1P
M9]#+OT,)G$QY>[%E*_"OU+R^[=[)G_5%RFAD1GX<?2IE06[.991CHV^MD[5X
M%KKZ#^R? A&*!J(DFHR/0JF6OV--0,*H(62RYD_1[#[_ ) $X
M
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MP]G$1V43&=.4T_1*O-\O#CKQ%S]*X4KP:@@
M
M
M
M
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M
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M(R,N)"PQF:RW%2
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M*U/QD.G2O80LS$14F,<<%<#2%HKS*J1\$TH2>(8<$K,YYM8
M
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M>8BVV*6X0G$
M
M
M
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M2V(]$.=TC1G;["S2GOGVKB(\,[(
M                                                 $%'0C,28K%,
MCT./D3(=O9>FSY4:#%9(CD39C[4:,@C,B+G=>6AILCK2IF6HM*1BN&48K6.>
M>63MUO7UT83UPYSG;N9Q=OHJRP7!B4W-L%KF+8)M4QETCD17E&^1+/EH>G$3
M/+):Y8>*,EUIE*4-I;0@FT-)2A""I1*$ERH21%H1$DB&4Q1C7VM40
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M:;-!?3-53/B7KH7HH+Z<S#\.%K6$
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M:$1$*.8
M
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MIQD@
M
M
M
M                                                 M)^<1N+;,?Z
M9CV\F(-<C<K)<>M3*4F?,IIJZL*=21$JIU49=A\!]-^E>PU-?S%&^M^';V77
M?8Z7KVM99L)T[XKSS$?:J:VPQ9C!=H-M,-BMDW%L^-VF2TP7L\OO]KB/*K[*
M:&:E'V#K>I:_YSJFXWETUNNOF*^B9AKT;.30MMX1'W.W^L<-LB*S1O(TZ-:;
M9DEX?<2TU;\<OKOB+,B2A:;7)6@S49D1&9I[R$OLNU[M/3TXK-VI;_:A9Y;+
M;KLYBV?=*VUY4UMNZK+U+[O7)TWV\SOUVD0I*M>9JRJGD1$X=?921%]\8]A]
M3M72^=L>G687:.G$3']:C5Y?TYOMNW-TU^9=[I6&_+:A,=2GGE;G;RW C?5M
M]>K^RR9J-1$ZQ+=;9,E'XI42LB/Z1#T7FO4GIOT\V^RT\(UHBKZ1K[^ZW9:_
M2[?@THM^U?TS.YR]QO-*Q?%IT/WNT;<VLWT/FGQ&XRYT'Q$D=>=*#-7\*//]
M.LMZ?].=;>:4TUM:ZGII+Y?NY^;U>RR?AM7$I:E'(?-1^REUQM';1#:S0DOD
M(AX[3MB/1,?:YDSP;91^SQH1<#I6E3"9P[D6[/-6O+<7IFL> N3CBN;F9/CD
M5M)*Y5/E'O"$+(B)23.B5\*&/<_3BR?XWJ;VVWF_+Z=V/96UUO5[(U-K&WNF
MDWW13U2NK["8)"VUV@P##8*C4S:<8LZ3,RI^%=@1W'NQ-?PIGV#Y5UG>W;_J
MFON;_BOU+O?+T^WL^7H6V=EL>YZ^.L;@
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M[K5USVZ((8QG,F-(B,N*_@@S4I!K(T+\-*C1V)4HO;22N"J&+7&E$I.;7%
M
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MC".6<)XLC-LC)!$:N<]?:I2NHL1,83FE:XIP
M
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M[4K?2/WG/A'HC'VLSA!$6A'7E2E/R$6@_$T3S8Q.#^CW=Q3B@
M
M
M
M
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M/&]SM5LA]D2VP8Q?ZQ&;:_\ P!\5U9B_5NOG.;IGVR]5$4BG!R0P4
M
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M;A&? N(^G;/;6[3;V[>S*V'X"\P]:UO,'6-?JVX_>ZM\S]N'V/31RG2@
M        #3)LN92C.IG3T4IW>L3TKEDX7(SN18_D"+(KPKR5ENBK0LRYR3<O
M<7O<5FDZ\W+*Y-.T)MP2*1*S)Y6'7/U"[X[C=0W3IU987<,5W:V3REQBV75V
MU28MORG'KA+?]QE1I'*411L12;T3QYA<:>E:VSA'Q1FO9$][:DF5"+3C6E/4
M0LQCABDY5:X@
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MKALLMH::;CP(K45E*&VR0A)$VT6A$1!E-4K-',@
M
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M,ZEK6O$?(XBG<^\5FF.35%
M
M
M
M
M      $I*(_7VD)-T1A/%9B86(\KNZMS?-\Q3%IT$Y%OVEM#DIM]Q!K::=N=
MN\9!>T2T),UG_ \1]HV.E_#/ICK;S2FFKN;J>R7FMS?9N>KV:.I&%GWKHMP?
M-ZX2W'#J2'G&T<?H-K4A&NO!)#PUD6V61Q[7+IAV-HJJB,JTI]$OSU=>/90Q
M>::8)%*XY*$?,[OB;7TG*Q,I?NLW<"_X]$92E7*MQ*;IX"B21*)2ZDOL(Q[+
MR!I?,\QW;JE?D:=TU]576]8FNTC2C"VZZ%6ECZ=2NG12SL5[\<%=XVW7#1+2
MV2S9D7.R^*BK?(5?PSVOLF8\'ONL3J>9+^J4K36K3NBYZSI<V[2W3K%;8B&)
M7Y2G598_+#ZG.I+I!ZK$2L"M6=77(7K-ED^,ZU';EI=EMV8V?>#AMR2N!53[
M)'RFJM1]@\Y=&UO-W3=EUWH]-6^WEBZR,9IA7*N3U/5M"[<=/F[2LB-+3MF;
M)K\=8K=Z*,A7RTK7<6=I=S<ZN/*^UN)D,^=9KBFA_6%N^LC>@NDLB.I*BNI5
M](Z5'G//TVQU#:[2S_F+(K'9,VX_:^4=)G]GJ:E/%==,3ZI5]44FA_14HBUT
M/['#M'C*3&,9NS:T1).28R3.A^\,&94KH3J:_8"8GDF9SH3A-%K2ZR[9N9YP
MEAM\BLHMHK7(<CM:N,-2)MO-:5&1<[:#0YK][4>[Y-38?2V;H\,[FZ*]\1+B
M:?R]QUNO'1K3UK\B%$:ET.M*%2E.7ET^74?$\>;N>F:@R
M
M      !IN<I(4I:B0E!&I2U&1$E*=5*,S,B(B(N)\ K,)2)6LL9\Q_:+>WK;
MSOH/Q_"CSEW XK2LXR=;3%SQJWRG&/&:B2$FB5#=7XQ<M%4.I<!/<L4FL5\4
M9KG4"S6^SPF+998$*TVR*GDC0+=%8A0V$F=32S&C(:9;(S.M"(M1<,(X)C2<
M<>#EBJ1:G4^\/0L9(@              ),5B@VSD=J2V;4IAF0V?WC[3;R#]
M:%D:1(MBE+L86R^^R>:V9MN[8FGN:4>W0HAJ5$APHJU%0UQHC+!F7;7PTD9B
M1;2?#$1#._6U=2/VEUUWIF9][=-I,JF::*/B=:UXC+.ZK72(CO:@H
M       #14A7B$I)T+7F[>8J4IJ$83-<8%&/6=U!87T2[*9GU.7/;N+?6<><
MMI95(L=MBLWIV#*DI85,D28T?WN6F&GVCYE'0@QI@5B(\4O4^FCJ)VXZK-E\
M+WTVINC5VP_-[<B;!?0ILULNIHB7&>0AQSPW8TBJ#(SKH)6:=RS%)K'Q*@14
M
M                              !M7XZ9"7F'R2[&DLNL.LJ21I4TZ@T.
M(57BE:3,C]8&/J?,=^)FZ&;ATA]7D;>W;W%O<MN>H&>TQ#@VR.:HR+S(=GIE
M),HT5M#3JYCI4(U&HZEQJ0D=G NI%+L[IS[F5Q\-QT!JZ0^BRQ;A9=;SA[F[
MWQ(>17^-,A);G6Z$<>,[;V#?>BL2J/-449&9EP"(XGPQ$3FR-!0
M
M
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M04
M
M                                                 $KP 4
M
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MFZZWC%:3%8_S.OZ'-FYW6ONK?AF8B)[5]E)&5:\3[="K\A=P^,16F.;U'%,
M
M                     /#-Y]_=FMF46.U;KYI;,6=SIUZR6&+,D(;EW5Z2
M28SC,-KF)UQ9&Z1521T,%BV9R>8]-/15T\=,5]S_ #G:+%$0\GWBN+&0YADT
MUQ,^Y7=Y)./Q5IEOL^]LL\L@SY.<RX=P81@3,S-58((
M                     #HVY&WF(;KX7D&WN=V:+?L5RFVRK7=[9,9:?8D1
MI3*V5D:'FW6R6E+AFDZ'0]0]Y&:BC9'&^C_RYK?@?2MBV40< 3G=TN\[ L8O
M=R(BG294E3\YF _*-EE/*\="0FE.!!7'%+;(B*6Y+AR%I<0E:%$I"TI6A23(
MTJ2HB-*B,JD9&1@J8
M                                               :#WM%R)7RKTIH
M?;3M"E5K2V9X0HOZQ>A79#K>L>)6'>BPQ[PUA-\A7ZRN.LQW5L3(DEJ6DTF\
MP\9)4XT52*@32OADB:VS;=&"K^Q6>!CMFM-@M3#42VV2W0K7"C,-(:::BP8K
M46.VAMM*$(2EIHBH1$0U\V..$&'K<P-B
M
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M([0L^--7X5ZT;W$
M
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M52(:L)CN;I3I+E(BK6G;P[0D3
M
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MHG&2
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M?;(>;4OY18K,THLTC&N#MI5IJ=3[Z4!$0
M
M
M
M                2F9EZ"U,S[B+7[(5QH8\%K7J&NJ;YO-*;0X:V,=0TCE)
M7,@U.-K2JA5-)>UZAP-2>;6FG!]<Z#HQM?+MLS\>M]SR]2C57TG]T:W,YY]8
M6IEIQK4_D%FDQ/:MU;)B8<?!Y2E2FZU.I<Q=_;IKV"VS7"&_6B?E6W_@<D9$
M2TD1:5U/][42N$Q+1?6;HNX.B9-+0Q>[<:E40REPS[JT,RJ-5T^/%W?3M*Z_
M9:D6_%=,-ABY?6&0SKBZ7.EOEY#,N'87>,-.)F^9;^HS=H;"W;V_'+T@U'4S
M(^/W. WO-(4T,^/?Z-?LU!$-*F9%2M.VO   *\2[^(  F(T]J:>FI@)2])T]
M(  FYC(SH=:TUH @7M4*O?3[8"'?KZB[P$2IVE7Y:!WK&.#KF5W)JWVIR.HS
M-^61I;+AP)1'K4N-1-69MMKQEVG2]O.KN8OC]U;FX; )49F)):>=0RHN9:^8
MTD9E4E<3,JF9#7I6VSZ7-ZY;JSJVSIVS,3A]SGH3IWBXNSBU@1%&F.DRT<.M
M%'K4CH8V<TW75G"(XN!JQ&SVWR8QW%^?<]PV NI6G>2VLN*\-FZ(>0I5:),R
M0A+9'J1:&8STYNMUH_5='UW0C<= U+O^<TZ+I/,7LE7Z6J?3I7[0["KY&F%$
M#X'ZC^T L<]1!D749FU2K[<6GHU<&B_XG+T\+'-=)I&?4E$69_[5EZ4_TA'Y
M@MEOBJ:M)TXGBO6C<X@
M
M                                                  "19J30R*I%
M6I:>B@DQ,Y9E8C-)XG*GG6:4(21FM:U)2DB[#,SH1$0RF,*1\25C.OA>2YUO
M?M_@"76+O>V7KDEHULP8=)3KKAI,T-GX"E$V9F5#KJ0['9](W^^GFT+)^77.
M<(=-U'S!TKID3^9U8YXC*,9^Q2Y>^I;<;+FN7!,8.QPT+61W24XAQ:VZF27"
M8694(TF2J4'KMMY4VFWQWVK6^F%L?I>%W?GG?[RVG3-&;;?UY_0\FNT/-,MF
MJN.79U,DJ<ISP8_C1$$15JV7@K)-"(S+0=WH:'3ME;%NVT8YXXSB\UNM?JF_
MU/F[[<W39/X8K'N31\5Q>,:31;WG9":<S\B4X^:U4^D9.\W:51MNW.K=C%(C
MNBC39L]M;A,73=/;,RY]@F(R"0S$B)27"L9E2O\ -<E3&F;KYQK-?2Y,6VVQ
M2(BGHA.MY2OHDEM7>VE*"XUX)(A*S#+O2<QT,DK4E>E:&JJN[M[!G;6<:53A
MGBB?LHYW7FF:5.CSZ&U?YE:DF+&/A8S'+'-=,4]+;(F09'X-F?'4M)T7S2&T
ME4ST(C4O46=.^OBB:,;=73G"VZ);E25)UY]%<%(7SIT[EI/E.HQB*\,66,6U
MSA U+KJI52_@C_-U&-UTSE@RC)J>,=**:CN$>A^(PVO^.28E9[97#LCV0XB7
M9;-<$J]]M[;J=*DSRL<3/AR)*G$;K-;4B<)^]Q[]KHZDUNM]F#A5XFN&\W*Q
M3(I^,NMJ)Q+'O,F2V:T&2D^R:R1Q(M!:Z.K6W>:=M]L\:1#&W2U]*8OV&M?H
MW1WS+T:T;T[XXD^V]/0UFUGCD25(Y6XCJFD$15YN<EF?(G[(Z?<>7>D[JVFW
MGY.I[7?;3S7U_87<VYC\SH1ZI>\X1U88'D-8N2$]B=U\5#2(DMMQ;3BE&2%4
M?IR%RN'3U#SN_P#*W4-K/-HQ\S1IG'Z'K.E^>.D[Z.3<3.CKUI2?TJEH-T@7
M5EN3;9\2:R\VEQM4=]EWV%))1&?AJ5J9'K7@/.767Z<\NI;,3WX/8V:FGJQ7
M3NMFV8SB8GW-\2S-?*94+UUKIZAA'&F,,\L\):H
M
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MU,8=W!E6:UXHDDBX$"<*<$0
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M\"C_ .)'Z0_.O\P/B6WUOIV%SP]?_2>P(_EP\I?]NGV3^A9_F*\\?AZ%%/\
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MWB(H
M
M
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M7"^Z-%\>)S-+X7+])IF74G#373W69I_K" L^)-::6<O%>O&]Q
M                                        .(
M             )3.G JJ[JT^SPX"3/8M.*;[ J
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MOQWD.MJ2I)*29+0:DZD?>/(7VW:<S%\3%T<)>^LU+-6R+].8NMGC&3>",P
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MT(C]9T":\! U$7=0OI'7AW:=M0K$165I*"5I52A\>&A]@)&,5C@G
M     >1[Y;O6+8S:K,=ULA0MZS8;:95VG-MZ+6U%96\I"3.E#,D L+ G2-\2
MKTR=6_4M8.FK$<0NUOR6_7>Y6EF:_);6RARW3$PU+)).&:DK6KL(3Q1G!73F
MD63,S.6#)4:63K;;A<'$(67J6DE%]L5$X
M                        -!]]##;SJU43':<><_A&T&M1U/N(A(QNY:8\
M%B*S1@U;EI+JU^(1@0L;+WJTXI<8#4A1J\9E'U(ZE#CE#\=M'Z'4^%!^@-I_
MW+]-+KM7#4U8][VEFGIZ'1+=6Z8^?IQ.''Q,X^'&]UAPV*$I46)&CD1'0OP+
M26SIV=@^ 73-U\_JO%S-9JWH(
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M[1%6@8YLN7&DJTX[Q2&&'R(TD\RT\23XI)U!+(C])5!@U@
M
M
M
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MO=J&;A('P/U']H!8YZB/\(W-?]4B?;6-%_Q.9I?"Y?I._P ):&?_ )K,_I=
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MG4]"!:.XMN-NH2XTM#K:TI6AQM1+0M"BJE2%I,TJ2HM2,N((G
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M@7VS373.A-Q+G"DN&?<2&7UJ,]>X!RYJ2FG,9%6M*]M $P
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M2;22B/Z^:KV$=19REJT\+K:=[ZV,3^=8W]#L_P S2#*6X
M                               "H ),Q&8@9D7'L")B9I&9D@I:4TYC
MI7AH9\/4+7&@ZOF=R8L^)99=IRTL0[9CEZFNO']XS&MLE]U7$JT2W49Z-LWZ
M]MML5NFZ(CURSTXKJ6QVS#"E\D>RN[X^:?U$;[6]*G[5B>0Y'#-]=7:$_<'8
MZ#):O%,J\Q??%0?>OJ!=^0\G;+I]_P"\NMB?LJ]-U+;W[31U;KYGDU8MY8]&
M;.!H?-4M"[>WFTT]5!\ PF:Q.3R]9RX)JD1D7:=:?)Q&2(@
M
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MM0
M                          29B,P"L1-.(!,Q$5 (F)BL %8@0(R452U(
MPJ($M)TH?TJTT/6G'L%B:^H3<0 2)B<@%
M
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M:S,S,S-2C,Q4C*'8@5I.R&&>7QGFFN8Z)\5Q#?,?<GG,JF U2.NI:D>I&7:
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M/OMYAY1D[:6E.&GD+PVYCI'S<Y=I\> 4CFH1\R<8R7.O+ Z;O.0QCKTV-O\
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MR4<#;E3)\*5)0:?O30\Z94] <,<R(Y;HMX/K0Q/YUC?T.S_,T@LYMP"
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MI73\RVZV8X3$PE*.5&%M:8Y@*
M                                                     *)^J_HC
MVUZJ6;5/OLFYXSF5A6:;1E%GFOQ)+$5[G*9'<1&4V;R7VG33J>A&$QV$32:S
MD]DZ>^G_  #IQV]MFWV 0"CP8*.:7.=,G9MREKIXTF5(-).NJ6I-?:,Z"1'&
M<U[HBEO![H*@ LX]9^W'4?@W4[M5U*[(84K<JU6)B?&R3'T/^ZJCHD,.,H]O
MDYE<Z2+M[1],\L;[H6^\O[GH/5M;\OJ73$V7TK6DU?-?-FQZ]MNN;7K?1M'\
MQ&E$Q?96F:5SJ]ZX%N*<;Z7)"$+))DD[HL^4Z:I^0S&N/*7D^G^\JS_5:)\P
M^=IFL],Q_K)/VW/7&OV?VK[^O_M179J+'E+RA_\ 48_T4_C_ )U_^F_^TE+J
MUZXE<.F"3^NJ@_PEY0F/]XQ7^J1U[SKQZ;_[0OJUZVWHETB2>EJ2XW-M=PAH
MI=5I-#\J(ZRRX1U^\<61C'_"GE".6;>I1&I%T3\/")QCV,KNO^=N6;;>F^&8
MG'F8SV0=#WF1N;B[A90STXS9;&6WF7<6"*XJ2EEN1-?E(21^!51T=H8_8/0_
MJU]-MCY?VG2=?>Q&IMK(B9IG-(CU9/RSU7Z;?4Z_S)ONM;3IEVK9O+ZQ%8B+
M8CLFM9F?L;,^BGS*"T+ICF_)=%?I(["/K%],)G^_Q7^JXO\ Y>?5JVV(GHUU
M?ZT?\I+^TI\RG_%CG?KH?Z4+/U@^F,9[^/8D?3[ZL\.C75_K1_RC]I1YE7^+
M'._70_TH7_S@^F/_ &^/8?\ EY]6O_HUW^E'_*1_:4^95_BQS?US/]*#_P X
M/IC_ -OCV+_Y??5N?_T:[_2C_E(_M*?,I+4^F2:?\#]9J_21C_YP?3"O]_CV
M+/T^^K41_N:[_2C_ )3L6'=+OFQ[<9)$S#;G8V^8=D\%9+CW2#=WR22B-*OP
ML9KPVWM4%]*I:#C[WZJ_2#J>TNV'5-QI[C97Q2;;K?OSCU,M#R!]9MMN;=]T
MSIVMM-_9-8U++HK';AS4GUO6-P\8\\S=EZR.[E81D.2ECCK<BRMLRW+<Q&DL
M+)QEY]F,IMN7X;B2.BR.ICI>D>;_ * =!LU;.CQI:$ZT3%\XW3,3G$3-:8=C
MM>J^7OY@^L:FG/5]+<[N-+&RO);$7<+O!-L33OB?2\SW:Z<O-WW\O5MR3>?9
M[)LTO=G:CL6>8U?9EI;A-0TI1&24:,KPEFT2"UH1F.XZ%]4/HYY6VM^R\O:V
MEMMIJ3,WQRQ=S3.>,XXN@\P_3?ZO>;=SI;OS7T[<[_=:$4T[IU(T^2,)B*67
M4FDQW8/2K/C/GFV"UV"S6C"+^Q Q1AZ-C"'9"WWK+&?033[+4AQ?BK\5E)).
MICJ=QYQ^@&XU]76UXTIUM>8G5SB+YC&)F*4P=UM_+O\ ,+H:6GHZ&EN8TM"*
M:,>"?E1V6SSUQC":U]3J&(;*><?M_N)==WL$VDO&,[H9 A:,CRMB:M?URAQ!
MH64B'3PU&:3^^YAS-_\ 47Z)]3Z19Y?ZGJV:_1=.?V>E,?!Z)_11Q=EY(^M^
MRZOJ]?Z=LM;:]?UXCYVXMFWFU8B,IMF9B/M=*R'I&\T++K]<<LR;IPF7+)KP
MX;UWNB9_@>_/J6IQ;O@I:,D&MQ9GQ[1S]O\ 5KZ5;+;V;+;;V+-K9%++:3/+
M'97T-6MY ^KNYUK]YK='NNW>I3GOYHCGGMIS85G'-Q9]%7F5&?\ @QS2_P#>
MA_I0W_\ G!],?^WQ[&O_ ,OOJW_]&N_TH_Y27]I3YE/^+'._70_TH/\ S@^F
M/_;X]C'_ ,OOJS_]&O\ ]*/^4?M*/,I_Q8YWZZ'^E"?^</TQK3\_'L7_ ,O/
MJSG'1KO]*/\ E(_M*?,I[>F*:9=I?6A_I0O_ )P?3'_M\>P_\O?JU_\ 1KO]
M*/\ E(?M*?,I_P 6.;^N9_I0?^<'TQ_[?'L/_+_ZLQET:[_2C_E)BZ*?,J(R
M/]K'.T,C_P"-#[#K_*@_\X/IC_V^/8?^7OU;_P#HUW^E'_*5F^7ILKY@G2QO
M[D6[V6=-,R5:KW&0S]6'<U-F2TMMM^RZ3::D1([3XCY1]6_-OD3SYTK0Z;T[
MJ$67:-TSS4KWY/HOTM\M?4CR=U/=]4W_ $V[EW%MM+)F(Y9B<8BDS6)BGKJO
M2KZN^N)UUQ:>EY_PS6LVT?6BBY$&HS2GTF2=!\$CRCY/I_O**\?"^V3YA\[S
M./3?_:2JZMNN*A__ '7I!>GZU5WB_P"$?*$8_P 2C_18_P"(/.T__IO_ +32
M_;;]<7^+!)_758?X3\H?_4?_ &3^/^=I_P#TW_VG7<WZHNNW)<)R/%;9TOOH
MNF0PG;7#E'=%4C)G,N177#(ZDHD^*1_(.3L_+'DS:[NS=:G48^79,3,<N=,8
M:MSU[SQJ[>_1MZ9\<4^+*N'V*X_+]VGW V;Z9,,Q#=*(4#.O>;M=K[!)9.%#
M>N<LY*(O.E*$J-I)ZZ#RWG+J.SZIU_5W73YKLZ6VVSVQ$4J]GY3Z?NNF=$TM
MMO?[SC==W3.-/4K6'EGI 29I%9%!O53T&[9=3UQM>52KC=L/SFUN$EK)[+.D
MQ7GX*B4B1$>:CK;-Q+K2U)J9\#X"9XQFRB8B8F[&%0VQ6Q6 =/6 V_;[;^UI
MM]KM[:52I*^5V9<9;B$^\2I4CD2ZZMYQ)J]HS,JBSVRDS,^A[0V94,B5S$5.
MSA6O;VA%?48>MJ"H
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M*S1BB*
M
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MBRQ+FUM]98;;-\N"FI<:!.<DQ[>B(E',A,>2IM1EP,Z!,3%$LY:W>JCZ*@*
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MX9P[/[7,7:G6O J:?.=3'$MFN>,QQ64XS0
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M\ DDDJ$5"_>[P1$
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M-:V:3$Q,.BU-*_2NFS4B8NAW^BB,M?9/LTTT[^)U,<&M,+^+!.-B
M
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M>ZS-.[]3H&=C#6CP5[5Z\;'%
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M*5K)#K#:(S24.))7*OE;*A5K0,Z295IE5]3<BIZN-/29F9_.9BCIVXE]1C.
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M7L[L4>*@YKKG,4N4P\IQ)T,CY3^0*USS*V_#;E#(B"(I% %
M              4@=7[KB,,MK:5F2')S7.7 E467$N ]9Y1BO4<.QX3S[/\
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MCB^M7$_G6-_0[/\ ,T@SG-N 0
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M[FH,P
M
M
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MDX"<916F.8"@
M
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MG_"+S;^'B?QRQHO^)S=.?V=',])J3_;)PS[/=9G\P0,K,V.M^[A>N&UQ
M                                    'CV_RB/9'=0^!'@&6_\ (4\@
MF.!Z7Q^=C=/,IQS6A?LW3-:?_7R=*?($]_:65F'T^O-KU\K#>>FM=K;-\O\
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M#-M$9!F:HD8C[#UU"<:Q3 RNBZM8AGF,(-MAEM7%#3:#]:4$1_9(5&J
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MS3X>R)91,3Z5RSF(JZ\*5^7@/FU<,,V28(FL5 4
M
M
M
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MT?4.FW;;]MIXZ,S[%YXU$1&9Z$7;QX^H?+8NQF.QU"8(NB9I #(
M
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M%O-T\SS<ZW-Y?B^<WMBX2&RE9IEKE]@6ZUVYUQLITMNVWEEZ,V;<66M1T27
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M4IGD1C&&-R<M"*B:4[".A%\V@>@C',2KF(C[_P V@LX2)A
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M4K.$X846VZ95Z)(R+4ZGKK2G;W#PL12%E,*
M
M
M
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M?A[IP=!U'INIL[^>(KI3DNUD9FHRI0BI0^^OY@^<4GGJZI,,JQ6G$!0
M
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M9]2L0RU+W67_ #!'RB6?&QU\J+V(Y+B
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M\]A]31%
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MP&G*,($XH
M
M
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MED9U+L'5:NUW.A=-FMIWVW1VQ+3-EUN<2[67SCCQ7C+$%
M
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M<JBKJ0V3;,3RSFU67VWV<\3X9<SQ$9
M
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M,F0IEZW^\.R#;;,Z<Y%R\*TJ+QHGH5EH-1IJI/*?=6H"8
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M6:MLY3'N[6QWE*^8S(N!<#[^_2FE!PL:Q^J)QD
M                                         D6ODII6OR=P<*G&G%,H
MS(C,BJ?<'I$M5*34JH,^\JTU[CIQ(2<<A.*
M                                  D)53,J<*4/O[^S2@F.? XTG- S
M6K0D\I?G]#I_$G0_0)C*S@GUKW$7V?S*#)$0   2F? B.AG77CP%CMX'O#YJ
MZ%\NF@BX8)3-2::U,^&A%P":>@B)I,YIRK34J'W<01$
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M:\1U4S=3FRAJ:@V(
M
M      "!E4R/NK]D6N%$IBH)ZAG.?/8B.QMM-?15"QOT_A<#=5Y^YXFK0C,O
MH:?O=_$;'&3)4?-4M2["X=FOI&$1QE+IPP4Z[BN$>2*TT*O*=?0JOVATF_FN
MX[H?HOZ=:?+Y<BZ./^9# J%<)"S^DGAZJ%I4:-*VMU9REWW6KZ:%ML9O4.7F
M,^PZGZ>T<BL2\S&?-)2BJ%K]CL&+",$.4^6O9^_%F/:RI-\U@IH1]X32F"3;
M-N:'=KZR[A&*/"AF52.O: @ B94.@"!<WWO'LK^]W !%70@ RIH8!S5U/C^]
MZ ;?EQQD*A]M"[^()=92*QD:=IT[]#,&/+-.;@!59MI$3VIT'0^\J'\]-/LA
M$Q6MRQ29I$82XC'[';KI?IZ[NW[TM@TG&:4="16AGH9&.3M-/2UYF=6/%$X.
MA\[]9ZIT;9:.GTJ_Y>CJ1/-+TUEF/"+PH<9EENAD=&T&:=-->4C/0=G$61A$
M11\>U=?=;F[YF[U;[[I[9G]*K#IF@+4U>K@I1FGF:2@Z&1*-1),Z=ATH->I7
M"V7*V5MMEDQ;DJR21<:4I6GR\1HMMFV9JYF'!.,AT/<'-(6#V&5='T^+)4TX
MF(Q6ANN\BJ:F9$1),AG9;S31JU;XLLF[BL6Y5>[AD&[&:7BYN&Y+ER&5^U]X
MV:UFA)5,^"3''UXCGI&3E;&Z^[;Q-_QXN/Q/P%;OV=$ILELK2\2TJ(E$=4EK
M0R,B,C&S;1/S*6YL.ITNV^&:Y;L;N$K%+TC$Y"U.V:XNE[GS+-7N:C-":)(U
M\#,^X<K4LK'-^)U>TOFS]GP5X)42DI47!1$HO495+[ XSLD0
M
M
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MG^"T61,0'.20_#4J2=2))D9<I'S=@O&B^&8K$KVA*(S,B/4J?9*I:\. (B
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M2VXNW34>&V]S,\AN(>82ZZII1)<(Z&>M0K-.\F(C+)4.VXEPC-.I$=*BHU
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MZV>QK?'9R\*ON!Y4AQ=IN*FO!-]+:6U*/DYUTH3I=HRX583G@J$
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M\'"5:9*K730M"/O[].)4,>6YL*\7$3"Q-8J H
M
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MDIA@RX&RT9>HT),OL#@NUC)K
M
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M^6J%K22D<U#*IT'XTWVTW'3]Q?L]S;-NI9-)KPFK//%VD:@
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MO-JOJ8Y1BE$\W'0FC1-,D7*3'YTAE2,XS8Q%,,X5Z"*
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MI:ZG5U];7FM]TR["MU2^!DFG D%R%\R:$-<13&YJI'X<):>E=2K\M!EA5."
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MZ5O]39[F)MU].Z8_R]3Q^KI7:.I.G?A27JA$22H6A$.%#2B*
M
M                                     "@SJ)3RYS!/4_$06FI$7*A?
M;2G8-VE$9\7!W58NCLEX<9U.O>-SB-1.BN-3-)]E.P8\4OB(MI=QF%,V<U_*
M254ZZE3YS'0;S#<2_2_D6V+?+6E3L<I@"JO2T<]"/E]FG'@8PT9\4]CG];BN
ME;+T@B.NITU.I]W&@W3\-7G(QG#-I37?!@RG2^BAI=%\-32?9QXA\./%LT;9
MNUK;+(X_>ZOA4_WR%+;4KF<;=5H9ZG5?KK34:M*Z9MF>+LNL:'R]6VZ(I9,.
MV?+KW4X#9,4=/.,1/$[M?67<#$ #]!U]( 1TU( IP/OX    C4]?32OR (5/
M0N[@ :T]!?=!0$1IK4M2(RU_?"QG@3DXJUJ2WF#>IGXI'S<2X)'(VMW^T4=9
MYPTXO\J\_&W]+U!9+4HSY:%70JD8[2(QS?%,9B)E+3VCJ5?X'NT[QD=Z7370
MM>.A=@"8TZ4Y2]GCP[> #780E2CYB*AMN\WLE^<.@QGXH6(Q4<S").X65(;,
MC23K.NG E*'$W?[UWVRFFBU\0I^S%93<(C3RO5,Z?G2$VV&K2,V/4(MG0YE9
MN+6V!<L\L4-QPFFE2D+/6M3;>0I)%\H[#FNMMFZ[-U&G$S,6RNE1TDAAE!:D
MEIM)'Z$H21?:'!G&:NS:H
M
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M);XMTL]TA/M2(\F)+90^TM+K*W$&?AN%4JG06M83EFV:.W@H
M                          +27FE^8"UTD[='B>"2&']W\WBR(EA)#C2W
M+&GPW*W!UGQVW"7RMGRU+TEJ/HGD'R;=YCWT;G=13INE-;OZ7<[3INR_-:G-
MJ?N;6(_@N!YQOKFETR?)[C-N\NZ3W;CD60W!U]\U'*D')-IDI)O<B4F^HJ).
MA#],WW;;9;>W0V]L6:-D1%L1AEAP=]N]SH;+2BS3^*F$+A&+8AC6#6YFW8]
M90XV@D/35MMK<=61)2I1&I!*3521U.KK7ZUTS?.'8\OJZVON+N?6GU.?4M2S
M,U*,S/74]/D+@0QC!J]"46,E!,P%X@&0"<>\!?1D(D51C,S$D-3D;0GQ'WV6
M$'H1O.MM\Q]E"6I(G-7X<U\6$4K1!2#(RU2I)\%I,E)/MT4DS(_G")BF1C.:
M0Z=FOI&4H5.E.PQ8@0#",0#" $QJ >@!:\.("3A&6!&;JV?PIMTP:^PK62CF
M.1U&24&HE+)#;AJ(J:_1&S0F8UHY\F_;399NK+[\EJ]?-!=D0IK3K$EA]]+C
M:V5\W,;BBXJ(C54R'=3%<8>RCFOB-2R8FVBL3I5M%U9;O-W=:=CVM[D\+Q$K
M0EVGAZI2LDD7R#@[_4MY.6,;W0]9OMF;;*Q-RK<SU5V$9_='71&%8=+,XTE*
M,I[4!*]H\=WZQ+(LUPIBWXN^XS)ADHY3#2E(5,(^<TD:D5,J<Q#D;/4LT=:9
MOXY.?TW6TM#<<^M'@EP/3G@^4839KBO)UO-(F<I18#RUN&@T\G,HC72G,:3&
M>\U;-6Z+;,XSELZKN-'7OB-&F'%4#Q,Z=IF9?;^T.+@ZP*G:=/2&0@)D N%.
MX12:DF2DF9&1D94T_>J,)B)CQ%*J:^I';=J_V5686R,D[C#0?OS;:",W",G>
M59DE!U-)'4<[8ZUUL_*NEVO2MW\J_P"1=AIRKZ\D7K'EX7FMPZ;,]NRE6.^K
M_P"9*YTDT-093!1DNLMG(DDDB><,TT)/:/FGU5\LZ>ZVMO7-I;^UM_>4C//L
MARNK[6V^W\QI1XHS98"3)224DR-*B(R,M2,CU(R/N,A^>8KQS>:1
M
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M*7I>J[>-QMO#\=L/9G"(E5(Z\Q$HS]95+[8Y5W"CQLTX9I*\2[^(Q0KP+NX
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M24DE*4EP21)+U)*A?8(<)STP
M
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M2U*NI$/Q?_-!U?3ZEUOI/E73C]MIW73/VR^V?2S;_DO+'4NOS-+=6(B/<O\
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M+T3=>7^JZO3]U;,<MT\LTSBN#/'AF]Z;224EI0SX_.8Z&,B8I*<4
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M)5I),SXE3Y:CR]L=N;B<$PR0
M
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M27,HRT/N')UM6V^*6Y.%H:4V^.[-48..Y0
M
M
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M*3AA+.*S,1#ETJYJG3V=*'7CWZ<2H8TVSS17@LQ2:2F&2
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MF<],<^<E%KW.)+]F:DRB0RQ/M3,+Q&XS;LA"/$4Z9I]E!G4Q*3'H9=OV//\
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MFDW>H=NG1WHLIJ"VVPEAUQB0RP\@G:'2I=@O&JQA9$3\3(]
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MF'<$F9EJ5#[2K6@XUMTS@P3#,
M
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M71S<LY.IZUM?F:,;BWXK<WJ2T\BC294X&GTD>HW3-7F*12L)1&( C36A:_8
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MZAU?_>*S8E:F:XNORN=@T7QXJ<'-TI\%>+D>D\T_MEH:5)0LE19G*2TDNA^
MC5/,1T,6RE<,VK6MPYN"]D=2J9%S<*)X?9&Z<L,W'1(C(J&=3[Z4^P)%:8B(
MH
M
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M 8(/GU>1_P"8'UR];MVWFZ?<6M=WP"7&L#3+TN^PH#A/04.$\]X+S*UU:-7
MS,CJ)=,\(6V(IC/&64]Y373QN?TL="NS>R>\$-F#N!B%N>CWN)'DMRFFW%(C
M)227VDH;7^A'P((R)BDTB:KD0J
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M BVRUVR!'9BQ8D.$RB/'::980VTDDM-EP(JBIC.;FP4
M                  29IC(V4Z?'@09MP?<0AB%&?E/+<43:$H8:6ZHU+6:4
MI+E1Q,QE9;-]\61G,Q]JQ%9HP0/,/WSE]3/5QEURMDAU^P6:ZM6;'V$NK=9;
M*)+D0)/A))UYO7M-(_7'DKH\=$\NZ6G=AKZEM;O728>SV&C;M]IS7885^][_
M ('CC&(859[(TTEM],=MR4HB))K-UIM9$JA)U(QS=;4NU-7FNR>7W&K=N-Q=
M?,X1.#LHE*81A#3[P)G"L  "UH D101(JZ$$XP!<=2J*(   )W@&<4(PFJ(3
MC@1ABA42)I@3CB"^D:\=LG5*2>G*VMS_ &-)JI_%4H)=6(JQNF8C#-19E_49
MEUEW(5CT& \U:8,IN,J(;2U'+2Z]X2E)5S$>B2KH.ST]CHW:,7SG+T.UZ5HW
M[3YM]U=2E:]BLB')*=;8-Q)LV/?6&G51U$?,VI3:%JK74JFH=9,<LS9'#*71
MW6\MW+,UI+5,6,J<6$YH!(!3V@$X^D!<LP$IW +F D5H H!W )AP 6O#B 5
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MK1-FI;,Q,3'>\I,3;,Q=G#L!J(C(NTZT^0:YNI%>#%$9
M
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M%GQ&M^[A>U&]Q
M
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MQX'S;CU*L]D/IWD'_=/_ !I5>D/*6?"]V#(
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M]G#[/#@+,4] ?>F9%H=.WA0_LU$$NI4/UT 0.M3J7=KIKIZ $2IK4Z<*<?E
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M@$B:XP H
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M1I(R(ZZ'6O'TA69S2D1DU0
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M>D;N[9[[3G3W%LXQ/W=KRFMHZFA?.GJQ2Z'J0X,81CFU 1-<8 4
M
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M)_PB\V_AXG\<L:+_ (G-T_W3E.D__"6@_P!#2_Z70%GQIK?NX7LQO<,
M
M
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M_H-._LA(_FICP/FZ9G?S7]6'T[R#'_=%?Z4^]5V/+O=
M
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M/OCN;9FN#T(M"U.OIX#A8<,F*(
M                                            D61J*GS_ & XU7@V
M<F=&C(6[)DQHC;9T4[+?;8:(S[W'#2D)MBGBXI$SS9>%H1KI;IYFBVW*W3%I
M/VTQ)T>2ILN\TM.+,OE&.,98KPHY89(                    X^3:;5-7X
MDRV6^6O\_)A1GU_YIUM9@->-#B0T>'$BQHJ/SD9AIA'^9:2D@&Y
M
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MBET/:4F9E4RH?=6OV1UMLU]#0B*
M
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ME70HTS2G^D([1;*5KQ36^!>V&YP@
M
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MJ[MC[E4?2!_T&F_V0D?S4QX+S;$3U'U0^E^0?]S_ /&E5V/+/=
M
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M[A(!2N74^':?=W:<3J8N B1DHJEJ1@(@ "&M3TT[#[P$0 ! B,BH9U/OI3[
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M:5T/2O#UB5!!U21\W-QUI2NO<$".M3TT[#[Q1$  0(R,S(N)4K\O 2O 1%
M 0.M-"J?=P 1   ! C)15+4C$B:B(H  "!&1E4N 9"(  @1U,R[J?9 Q]2(
M E)55*33Z-->^I5$KB(U*IEW<?E%[Q!)U*O-S$?#2G#B%8G),>*8%
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MK26IJ#,
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MM8T7_'5S=.:V4<CTG'7J8A]Q1IG\P0%L1%\436^'O7MAO<,
M
M
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MA*J+I!TPFX%_[0?_ )H8\%YLI_$*Q^K#Z9Y"F?X12<^:?>J['E7N0
M
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MI6E5>76G'B7VR&OFGA")QD
M
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MF-,_F#8MOQ0FK/AIQ7MAN<0
M
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MNHRQS3"
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MQV+OK$>G92N XXQ,<M#,66^U'3*CR&7VT.\BB415(]*BQ*78QR\>U8N^'?\
M)VVK\P6XY1N[OG".Z[/8*_%;AXY(3SN9+/N"8CT@US7HDA54K4XHS-0D$Q;.
M%,%6GGY^1)TZ]'^UD;JJZ88K^#Q,;==9OF)-25'$DH<:DJ:=4VU&88=(Z$6I
MUJD6(KC.,KX;;,(=3^$7E%.ZC]ZI22Y2=B1",BX<R8]N)7SF'!EIY7^IM?C
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MVXOM)7S),DNRHKJZ&2C[>T68Q2VZ8BL.:P+;/!=L[2=BV^Q:T8G9UJY_<K-
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M68SZ"2=4DG1""["T(7\4278Z<^IAR>4[Y8F=^:7NX>V6/Y1*P+:/%:.[A7F
M2U,+9645;3;EO;:6Q(4ZA\R+F*E>T./I(QQXPSPO+N\B';KRNKONGN9LCF$[
M,=P,IPVXVFQQ[A%9AHCW%5I<8C&VZ3:>4CG&3A5,B348S6,<Y95PF(PJQEG?
MAM_,JZANM*Z;O=45VM9;;Y9G]RON97Z\Y;$D>#BZ;XN5$M[;$U+R&V3M[AI(
MD_1,S(N(5FM(C!.2V(K6MR^IUT^2)Y8-@Z)]P6]K,;VRQ7<W;O#?K"'EL/*+
M$_<G[I;;>HI9.L<YJ<?GR"YTMDA"J%PT%K&9%N,5PAB%^13NUG?3]YE^ -X/
M>KC&MV4Y+>L;R>THF22MEX@1[I'MC2E0R?;B&7@%4C-)^@94MQGL2WGFZ.R6
M3Q\7FIF9TS;#R93:%DY<;K)6E:$K*J[>IU2=250CJ8F-2Z*Z<K&/P_WE4;;>
M91N!F&1[UW68[M)M8W 7*VZB27H<'(52TP#04AMEMR,OD4^?TR[1(BDUA*6W
M871DN.^?EY'W2MTC=-I]1/31CL; Y6*DJ+>[1RLR$W5IUB5X:ZIA-I0:4I(J
MUK5(RI-V!RVV6S=$9.M_!\;N9);LWWPVL;E2G<4NJ8,MJ$](>=8@R8S, S5&
M:<=-MGG-1UY4EQ$GPT[9+:UNB>"C#XK[=3<O+>OC&-J,DNMVC;;XLFSGC]J\
M69&MDMBX(E'<WZ^*41]2&UJ49<I]PD8S,+,1A/XE]?R>O+2\HG?7HOPN=>L;
MV^W$W+O5E)&>2KO=+5"O42X/1V4>#'B/&3Y%'YR,E\JBYE:EWF5*8QE*SAU/
M?#,]?&WO62_N9T1L6UK:NP97:<BV\O-LRJ/:WXD KP=Q=8),5N.:VVF$-H-*
MOI<H5FO:DQ%)I-)97O7'U.;Y=&OE&Y%N!NI<V;=U"6W;F-C$UUIQ#JW+O*M;
MEMDOM.MO-<[OA(4HUDKFYCKQ#&?23RQ_5?/9\JCH1OOFE=9;N)Y/>K@S9;OD
M-SR/='*YIOW5U^*=R;NA14^](F>'X[4I:"U(BKQ":UJQB9IRSE#,;Z\?AJ.A
M>U=*V5W_ &6QU[;C<[;_ !1Z[6_+H,LV9$V7:K>Z[+-7ND-MQ/OKC?,9<Q%3
M0696VRRM*,-?RG(BX7F9;.66<EN7=+!FT^T2+@IM'C3"MU]B0FW%K,N=2U$Q
M4S,ZBSE*636;9RS9L?Q.O7?GW2IT98]M7M=<7[7F6]UJ7:WIT*2N/.A6>/!>
M1(\);$J/(3XZFC+2OT1CBRFE)B<V-9\/_P"4ELIUXWG-=Z.J3*K0Y@.%7",]
M)QS(KW CS<DGWLF)\A;C]U-;Z66'%N\RS5RD9D1G4Q:S7F]K&(BG+G57+Y\/
MDB=&FPG3PKJ'Z4KIBN-)QM9M7?&K/D-FGS+NLVI*XDJ)[@7BJ)EU"2,T'HI.
MO8%9F:+R1$81BJ.^$@ZULORK$=R^D'<3(9]Y3A"6I."+N#\B0[%BE$B>]Q4K
MDR7%J09+J5$D1<H3GZ2(BE(RACQ>?6S3S8]X8<9EE%PN606.V1Y1MH-R.N;/
MF1">0HRYDJ;4[S%34C((FM(E+IY;[IC+!E+>6E\.#T79GTP8GNCU&6R;NYN3
MN9C+=T?O%SFN.E9')D5LXK;"9L9XZQ>;FHDZ4,BJ'-,^@NT[(NK3%B ^<'T:
MXST&=:.5[%;?SE_DS9\@QZ\XK.CI]UEV]MRXNSVV"<8;8<2ME+"$G32I:&)C
M7$NBL81@^BGY=?4]*QKR@MN=_P#/IKTJ9B6U]Q>=F37UO.RI%GM9)MQN/2'C
M6KG=0A.J^P(PAG/BGU/G-W6Z[N>;;YF2X^Z.:.S)>XVX,ZV1+A=;DJ'8L;Q^
MVY&Y#0VVU,D/VYI)VR29:4*A"XTPQAJL\5T3VLVJ_?#=>6 _T]2-N(%UP>+N
M]%QY;I;B%D^-F[]9MVY2O>U0S)+B(CDNBN<R*B#K0*X4KBSY+:UB,&&MT%;R
M9GY8?FK6FPXSD<QVRISZ1A=[.)/>=LF06R=D+-CCJ.,Q(8M[A%%:(R.AZ&)7
M"OXDIXZ79/K;X_<$7>QV6[I,C^MK1;;B1EJ2BF0F9)&1D9E2CH4I/>M8G%S(
MH    @9DDJGH1 (@-G,FQK?%E3ISS46'#8<DR)+SB&VFF64&XZXM:S2E"4)3
MQ,QC9IWZFK%ME9OF<(6,<(S8>7FP^85.ZA\XE['[4W>2UMIB\]Z#>9T!YU",
MDF$Y*B+2?N\I9&EIY)%PH8_3/TZ\EV='VT=6ZA;$[[4BML3'PY3V/5=,Z?&C
MI_.U<-28]BE#I^V=;L,)G,,BB$4YU)+ML5U)&INI-J-9DM!>THM=1[W>;FM=
M*S&[BX/5-].K?\C2FED9RJD6I2UF:S_,(B+V2+T$0ZZ(B:3DZFM,.#3&: G$
M!1$J&?'Y1.:"F.!IKKW4+O"*\<R:<$!8^P!)KP$:Z'W'Q%KQ$  (Q /0 G&L
M@$XX * 5]HUF2*KJS*ILQWWTEZ66E.%]E(QNK&,RL5RCC*V+N;F]\S7,+L[+
MFOM0H,EQB+%;<<;2DFW7&C.B5TU(=WI6:>GHQ\N*3Q>MV6WT]MH6S;$3?*3;
M7,[]AN6VI^%<)#D.5(;9DQ''''$K2MQMLM%+Y2H0FM;;K:4VS#+>[?3W&C,S
M%-2.*YTHR<;8?(J$^PR\9=RG&TK/[*ATU,:=CQW&B0502O$1TH>GV> 3&%(
MB/4^X*88Y" L=X#'+",PJ$4KWK607+T(!&.,B)4KJ51:B  $@$8X@)&.8XZ]
M7JVXY;'KO>)"8T*.DU*6HR*M",Z%4TUK09667ZEW+9FRLMNU+N2R*W2ZSA>Y
M&*[@I?\ R>D)-Z,HTN1_OCHHD\U#4H]:C9JZ&IH8WY-VOM-?;TG5BELN[G7@
M-'HXN/6N8+QK&8!3CQ$VAGPY>\]3%XB4  :[3GA\QF1+0M*FW6U$2D+;<(T+
M2:552=4F8PFN$1EVDQ7&<U%'4#L=X!R,SQ2&H[:\KQ[E#CU)<5U)N.(>;-M'
M.DTK+F]FG =IL]W6/EZD^.,N]W_3.H1--MK36Y<:\JKS.[QM)?K%TZ;[WM<S
M;J>Y]78AE-R<6;F/OJ7&8:B27I$HW7&7GS-.OT>)$/F?U"\A:?4-*[KG1[*;
MR,;[(_%G68I#9U3IT:U=?0CQQ&,=K+1@3XERAQ9\&2S,A366Y,27'<0\Q(8>
M1XC:VW&S4A2309&1D=#'YSOTYTYY+ZVW1.,/+S$Q-)S;T*\.* 1-<8 4
M
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M?=*!%^V:@T[(LSY?P"/S1=-->Z*<J]L-SB@
M
M
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MKXNQPNH?'#@ARG7@   -A=O^*I?\3]T8W</2L937L=!Q]=9-TJ5.6,_0N/\
M(5=M![^^(G8:%7SC0C_O/=1&2IGI"4:L9OA&?">O3N]LQX?S=_?;9_HOI'D+
M#IU\=ERL,>0BO%[T&0
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MU[1F1%HD3ACFL17"OA85_P /GU[P.B&7U8V+<"45O1=;'>K%]62GO ;*X6^
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MPB-*DK(Z<IIU(^T?!_';=RY0\\UBJ1:G4^^E/L#)$0
M
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MDUC1?7F[G+T_A<ATH_X3EN_H6;_2Z0TZ\U#7B)LB[BO<#>X@
M
M
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MK#D:"[)WVU&/$>;:QO;9GL?1O(5?R%\3GS*QAY%[X
M                                                    !*HZ$>M/
M32OV!)[(SDK$8SDH^ZV.I&T=,VR.39<N4RG(I4&1#QR IQ*7Y,QYAY!.M)4Z
MVH_ /6I=H]AY(\MZWF3K>GM*3.UMF)OGLBL9^EC=-,LY8@& 8]E&_6Z%QR')
M)4F=*N]V?N5XG2#=>Y65S#E,-<[GC<I$ATT\> _7&]U]MT/IUFAMXB+;+(MM
MB,.%)G@PB*QEBNB1(4*T6^'9K:RAF!;F6VD(01()2TH)M:CY2*M33W#YQJ77
MZNI.KJ36^Z648>EJ>S0]*<*%J?K .8]3KQX\ $249'7CW@(%[)^K\P/0)DHY
MDZ%4S[NS74_F&,TMFL9K$5BG"'5;IN#A%FO,?'[E>H[-VDJ)"&>=L^1Q1\J4
MJ/Q"Y3,^\<K2V&]U=*=SIV3\J"<NZ';#(TJ(R,EI6E*T*29<JT*22D*(RTU2
M8XD93%^$E,*QDE*O-7M[N_3OX<!FQ@,RH7LZ:TU^<%0532AZ=W=^;4!+7B7?
MQ :I$1&9$?&FE.XN\8\L5J5G)(9]BBK3TTI\PR$$T[2^773Y@$#(R,R[J4/O
MT[A!$J5UX?+]P)BH%P5IW5]&H1%(H3-9;J,DS=(U&1$A*G#K3@V7,?#A0B$C
MEB>:F#'4KR89O+^A>V3\JZ^]S,[=(I6/X>TPRA9D3C<=<EE#1>T9*2@^8^\A
M_/WZO]2GJ'UDUYMQVNVB(CCG$OOW3=M9L?IGH;>W#<ZTUF/1*]&LU$[)6H^;
MFD/*2KO2IU1I]5",>-OFLS/>ZNVF$UX-[:$I]Z<<7[:8\.;*,CTI[LPMZM?4
M@-.V9NGNB9]F+'7OY-.O;,1[<%@/'K^6YW6?U!YVI@C;L<N#$A23]KF\-U;"
M^19\_"G88^U_RO[*>H=8ZOUNZSP63;%MWLC#_A;OJ==;T_RQT[I-L^+4B9F/
MM5*K,^99'K51G7UG4?LNM<7Q/)#E(B*O'6I=_P O9029HL15 O9UI7N&/-$X
M2LVS$50H=#/L/CP[_GXC-B5T(B[:U^X),5SXE4Y&:=#+0N.O>%*>@C/%YMNM
MN1#VNQHKPXR4B?,2HH#!JH9+22RK4U)K[21S^F=.OZENOE6S33C.2M8IV/"-
MK.IVXY)DS&.YG$3'1<G#*WR*E1-5))!4)>NBJ#N^I^7-/:[>=SM)K-N9&,4G
M!6$Z1MKH94,TH61_P"RYD'3TI,>5CMXE>'!I$HCI0O9["_?\>(89G<F,S*I'
MZ.[3M[ B:K,4#.BZ_O<!42 (D7WQ&9*3VD9]OY@E,:IDF4I1T6:C,SKJ>IZ:
M=H1$0H6IGR_1TK\WIUXBY8QF)4&=3]FO<=?0=0C'T"*OI'V^CY K/ 3&KVBJ
M5*5]/$O0%,!)6IZE7Y:?:%B)GT(E,SIPU[JA-TT$QE5.I5+LUX:Z^GB)FJ)&
M:3I\Y?OQ*1)7@TYL"W7ZW2[)>(K<JW367&EH<2E1(6M"D(4DU)5RT4JN@MM^
MIH7QKZ,TU(F),>&:UQN-B>2;#[EP+WC[\F(_;+HS<[!<XZGF?89E^]NL^(UX
M524EDD\1](V&ZV_6NG3I;J(F+K:71..<428XQA++CZ#>JBT]4&RECO[TYC\M
M+1&CP,JMGB-E(8DH9;2W(4WXSCBB?U,S[Q^3?/OE?5\L]:OTK+9_)WS,V3PF
M*Y9<&5LU5PCQ+(                       !"A5,^T^/R!1:SDZ]E=BAY)
MB^0XW-C-2XE\L=VM3T9Y"7&W6Y\%^*M!DXE:=2>XF6@F66:/CR^9KLY,Z..N
MCJ VJO<.^VB.[?I]SMC=MMEQ7'D-7>XW*6T27HK##3B3YB+0CT%QIBDTB[PY
M0S)_A*ND<L(Z>\WZFLGQU3-XW6FQ"QFX7"$J/-CP(C,7WHF_>(S;Z/&5R&9D
MHPGLE;<+:QQS9)O7GTLV7K/Z6=V>GN\NHB_ECC\Q%MF*8;?-B[1XLARW*22V
MW>7GDK))F1&9$H/PUA>.6#Y4]GG=9?DK];$NXKL.585EFVN5S^24BV7>39LZ
MQZ3=W*,K?2S#@+;<M<+E.JC(B,,X85FV:7?$R;+I\9O@J=M5V^%T\7D]T'+%
M]7)4BX*>C(OB[<<?ZP0PU*)TE%./Q21S:< K0\5(F,9['J'P[OF7>9%UG]4.
M[#V].)9/D&P&3/OW2/E%[B7.VP\/\-2';;$@IG..,S2>8D$@U-F=*B980SBL
MQ*3XJ;RQMRMT+1C_ %H;(8K)R^X88T\C<:TVUEQ^X-0&(TLH5P:C1(C\J2EO
MQ-:'[)I])"UB$FM([EICRG?B3+GY=>S3W3SOEMYDN>XQ8'%(Q$GRE6:78)#:
M6FIT)2;@XE3K3CK"BIX94,O6)$SQ*X1$*%/,5\R;J>\Y;J?Q6-L=;]Q,3L\F
MZP+/@^#XX[D9-QFILQ4)V3+GVEYYA24IGH6HU$14+L#")JQF>:D3&,/HU^5%
MTA9UTD=!.WFS&Y=UN%WW+<Q>4[DLRYSY-PE-S[K;&D)B./ROPIJC+,R.O SU
M%F>UE;'+$1'POFB>:!M!FW2%YGVZIYC:KJQ<%YU"RS'IJK=,.VW%AF_R;URM
M7 X[411&VS2I*,2,(BN:74NOFF3-9\GGS[L3\PW)K+T:3=I)N.9#:,!>QJZY
M0<LI-OGL0+*U;5/''-U\DJ>2I1&1Z:%H0RF8BE/B6(K7#PL3KSH/+YWO\M/K
MAG[P8EC-_E[793EJ<SP/<6S6Z?(;MLI%YEWV7'DL6Z&VW'H^P2#YET/O$I-.
MU+KHMG#BN^[1?&&QL.V M>";A;+W;(=ZK)C'U"WDB9*H;%PGM6\H<"YOP52O
M'*0RXDEF7,7,9<*UJK!=,YPL ;0;9=4_G6^8'$R!>.Y%D<S.<OBW[+\AGVVY
MQ;5C>/6J\LW$F3F28TN&I+=LE&DO;H9$)%(PX).,S3CF^B9Y@^SF.=.GD^[H
M[28U&4W9\(VIBVE+41@W5.2(]O2U+=;98;2:O&D(4K1)<0RAMM^)@>?#4W)A
M?FA[=Q/=+JTZY?,DD$J1:YC+)-/W".;?.\MLFVUGVI,R47:03C&$M<4YJ79<
M'U;$F7#M)*:_+6@JUX(JI0Z\ QX9F'')YSNCM[9-U]O,PVZR>*U/M&7X_=K,
M^P^A*FR]_@OQ6W#(TK29M*>YBJ1E4N 3A-)7OA\F;K\Z->IKRDNM2X7BS6O*
M+?C\7,WLNVTW"L5NNSL1,63?)-[5'<>MT2,PVA;,=*#YED5 P8SX.[LED$[.
M?&0V3$-IK)CV\6QMXR'=*S6A$*?>6IBHZ+U-8C(:9F2(ARE/)<>?29K]HC.O
M8>H3@8S+I'EE^==YE77-YHUFNN,;=97?^G'+)K\2X86['NEML6-6-'A)1-.[
M.O.VXU1H[Q*))GJ&&4D<TX>WN5*_&03?"VEZ=_'B3ER97UJ1L0XC\PFG7$W$
MC0XMA"DH)#BC(U'0J:ACZEK$3_2=Q^#CFHF; [_$EF:R;%ZQQI93(3\3VT0F
MTJ\,WD))U/,1ZIJ0QC.5B)BR(E[7\7#,:B=&>(J=:EN>+=Y;22B1'Y:O$=8>
M2@E$RA7(DU'J9T(AEQ[BDS9/;@H/^#JN;4V?U!DS'N#1)8M+:CF0),0C-+5L
M0LD*>;2E9'WD9U"O!C$XS$YO-OBGO*^W#L^[\7KVVIL-RRRPWUR,_N%;+-;Y
M4A^QR[2F8\Q+-N!!<=>)YPDK,^;2H=R7S$1S3'AXO(O+C^*>9Z.>G6Q[![W;
M3WW,Y6$PC@XK=W%R+9)0RPVE!P)3,N03IM-R".OLI/TD).&$+69BLY=JT_U+
M=6?5[YUO7#87MIF-Q<;;RG(;7"M5FL3V41K5CUE3<"C&MV1;GGH9I9A3DJ]K
MCR#+EF<;<F-TQ/Q?%P?1%N/EF-Y+Y3['09E&22,AO"=LD1RR"Z$Y-F'D_P!6
MJG$T;DME]_Q"N+JFN;EKJ,<6V*=F#YQ.S^Y'5#Y('79<)MWPS)K1=MO<DNC$
MV,Y;+JNTYAC\RYN-&A,U3,*$:%VR$9?2,B)0M(SB6%:32<^Q?0ZTOBUH?4/T
MX9/L_LQM%?L'SO,[/]4W?(VI;TURWHDQ78TYF'&BRB>-N2X[H1\YD1$03]A%
M<U*GPZ/E@[J=675' ZI-S,9NUJV:VWOK]\.=?K?,A+RB\7.1$O,<F$W*!S.\
ML@EGS)6=*<15L[9RX=[*(^)0\O/+^K_HWC9CM3%>N6>;&0Y,^U6&+'6]*NMG
M*))*6TUX460]5ALN":5Y@K,8<"D71-,^##!\HWSD<Y\IC/\ +[/DN%WJ\[<7
M60NWYQ@$V-+M4BW3K:IN"W)B+FJBF3R'HBS29(.M>!EH)C#&N$<N557GFH^=
MUO?YM&V;V&;&[%9;A73EAR%2-R\J<AW.>Q)6ZW(-A2W6DNQC.CJ2*A%HD2*Y
MK./AF,%0OPAMQ@2.I/>N/!8N+;2(,12%2[?*BH,B:@MK/G>;21*-QL_9/4A9
MX-EF5_;@A\8%<&HN^VT32H]P>4J*\I)Q8$B0@B)JX$=7&TFBOHJ$3$Q,)=$>
M'MI*^]\,Q+;E>6%'=;;E-I*U7HN23%=C.:6I/!#J4J/Y.(3\4I;3Y=O;66!;
MOI=6&_->REPX5X\)W?:U16W$VB:M*GT9T3A\&C,FN0R]OZ/I&,8VTXDQ2ZL/
MK_8$HE;/86JAD2MM,=50R,E4/%X1T,CU(RKP&7O3OX/DJ^;1?(+'FF;FLJC7
M=2_V2,=(C;M,QQLS+)W3,TK)NBBUXE4(RBN;&^.:Z9]#Z06&=.5EZO/*EQ_8
M>\/.0H.?;0P8+3SL<S=9F)LS:X)FTZVM2#]Y-)'[)F1&)2L4EMNGQ5I_E1\T
M"-(ZD_)LZ\Y1KL>0XGFVU&8W"3:)*K;<OJ[+;%+OCCIH1<#9A1>5VW0J'15"
M(PG"VC5$S%^.,PR2-WOB\)VZVR-TVIV7Z=,D<WQRG&UXZ_/AN2+K$A/2;:Y"
MNTY+41UQ2?$-:E>THR21G47N95FM:8,579&5=+GUL[(9)DZ38RG(]T;==KVP
MX1H<CRKAET&8XTXVJBDJ0Z^I.NM2&,Y3)IX:D12K[.&&_P#1#%?^K=C_ .3(
MHR)S=@/Z9Z?2T+7Z1:<Q^CE+YQ.-2<8IP?,0^**Z5]T]JO, E=0=XQ^]RMK=
MQI-INEDR6%;I]RC1)5I7,E.Q9'NT1;;"4O-\GM+I0,*]Z75IW2K>Z'_BM-L^
MF#I=P78O/-E;QD.;8%92LUIDVMTVFKVLF4(MZ'(#+IO-+6^5%$7*9D="*NHN
M6#*/%%98UGF)]66Z/5]U%9+U';WX'E&"W/-+M FXM9I-ANU3L\26Z]&2VIUD
MZ$W!=*E#.I%H%>##"8YK<Y?3=\A[+;/EOEA].<FS.NF4#'W84EM]E;#[+[9M
M.J2XR[1::H=+B1"1AA+*;HNF;K<EX9'-S*4>J54[M*%3[(LS'P]A$UQHH5\Q
MCHKQ/KUZ5=R]@,C4W G9!99*\=O!QVI#ULO<:,^NWJ;-;3JDH?>42%<I5(E5
M[!CGW2RPF*78Q+Y;V.WGK0\D?K.N$Q[&,GQG,<!R28TF85HNTJS9OCR[HM#;
M:GR8AP%(>M<"AU,R(E#*8PPX-<771-+L)][(^F?&7L.8 Y:XG3BZUN2JSE#0
M97!:R3=O<?!.?X7UC0ZS/PG)3T!QIP6LUBD,;B9'ZR?._P"MB!,>PZ_9?E^Y
M&10CGW:39+A"L^&X_!N;9FRF2[%EP$M,6Z89$1*(C)(1%,LDNNK6V,_<^B?F
M;.#>2MY0USM;?A2G-M-N9%M4JW0$(DW+*;_9UQWU(9B(B.NK8D).BJ5/DJ$?
M:RPICA#YT/EV;/7;S#O,.Q'&YL*^S2SS/+GD66-3K;/)A=G5D;=Q;8>DOL26
MD$N')4@R4>A'J$QS5HD5B8YLN+Z;T/R;/+J3;[;'E]-N&.OQX$2.M;D1DW7%
ML1FVUJ<4B.A*G%*34SH53[!*0SY[J4X*)?,D\EOH]NO1CO0ULCL9CV*[EVO&
M)=VQ>]V6(@IT.1;67I;QH)N*ZXXE;"%%0BK6FHF$5IF8WX3DP3?)>ZQE="GF
M,X),RY.1(LESS.XX+E\5=KN;$=+TR[Q['"-Y*CCMJ0?A'1:B-)&,ICVM=DS.
M.43FR9/C%[RQ/Z>NF*YQX\V0S?)=WE1/<X;\OV)UL5(:\13"5I;2:'RU,R+T
MBX3;2<ZLHK$S3*8=?^#1F(D85U)MI8G,FTFQ-K]\A2(E5H^JDJ)LWD))PJEH
M::D9#&N*1G,3G#(V\X7H2QKKYZ--S-MW;1&EYU9;-.O6$7524'*MUQM\61)6
MW'6;$A?ZI0DT\I$1F89K.-M.#YI_EQ=9^8^5UY@.-7[(8&3.PK'FLS!MR;(5
MOND>*]!D7J-8FY#K7-$;?0S$9-9&:3((B([Z)$S,5RCB^N-M3N3BN\& XKN7
MA,Y-RQO+[-!N]OF)2;?B,S(K4@DFA1J-*D&[0RJ=#(6L+-8PX/1@&*%\6-L=
MN)N+T6X_N)AF/S[];=LKE+E9&Q;H\B9)8BW".^@G4QXK#SKB6TH,S,J$0QQY
MH69IISVL4?R:_.ELOE1W/,D7; )^?8UND[:[?-@$3ELN$&3%5"86M*'G&7$+
MCKCJT-*J\*#+"O<QB?#2,V35Y^W4);.I[R<=N^HVWV6X6.V[E1W+C'L91WID
MJ#S1G32V[X:5JU)TM3T$B?%$PROMIIW1QP^U;K^#EN#3^XN_K*(]P;6EBW\R
MI4&1&07X.VG[*W$$A6GI&4TI"61C=Z(9Q'6!M5==ZNF[=S;6QOJC7;),/O<6
MW+09\[DOZNDFRRGE2I1&^Z9(X'Q&-/M96W<LU?)=V.W6W'\K'S!)6?YM@EU8
MR3;+.KY(GVBZ6F8U&N\"3?W'/$8ES&(K)$N-$,R4E1<:C*Z(IZ6NV(PK\5OW
MLCWK$^*LC=4VP&6[#]-/3OED_<O/+&NUSI<(IMR8M$5V,XW<UMMP5/*6A).5
M(U&JA%K7B,)K,,ZQ;2>,L=CRNMPK-@7F(['3\M9O<*=(S=9W9$BR7!I,6YWF
M]1'E,K-QINA)D&M)F="(R%GMX)9$Q=$6LN/XNZZ1V>E?IZ?\*:\B6_--CW2$
M_+/\/:B-OQ"90KPDGS%JJA$'XH6Z)FRZ([7A?P<-P9G1>H[PF)[)-MV5!^^P
M9$0E*2FUI5R*>0DED1]I5()2)QF%VSXH26W#\M_-W'6Y+J3?:+EBQG9+E?"E
MT]AI*E$7I&416<4OBNE-,ZPQZ_@^[I'=W^W<93&N#;JH/*KWJ#(CM\CT:"@C
M)QQ!(J5>%:B3P91.-T=L1+J7Q&6P77;T@=9"^I7;#<#<MW8/<"[P+U;HV-3L
MFE0L=EVB8_=)D28Q;3\%II:6^4R4::E3LU$I$>E+IQKV_8K]Z2?BU]B+7L!C
M6(]0.%7:7N/A>.1[/=9L_FKD<N!%2PV\['GR'72<=-/(KO(N'&J*SPP7FTXS
MFDL8KJIW6RKSC/,.1E?3[M!=;0WN/EUD:CVJTV*;'MUL@PKRE#TQZ1#B2(J3
M./+)PU*/6@M9IS=C7=;$W<EF;Z-V4>7 YE/E+?M&[S=3FWEG:QIEF?(;\9UO
M((UJ.:W%03C#BR6F:HV=$5U&.-.]NF8FZO!\U[8'?'J)\H'K2G7V-C^18WEV
MW^4W>'=[=.MER8MN6V%5W6PXV3TAN#$6V];(1E6IE10RFE*M<<T?%G&<>YD0
M=57Q7EZZH>G_ "+9#ITZ=<G8W0S.QG:+S>8QR[E$M#+T-R-=7D)B..$EE2G#
M47.:J)+Y0S6+KK:3"PYY3C$EKS)]D)ES=\6]W'+I-PN_-["T39MXA29#2T'J
ME33SBDG7M(2?AFN:V1RZEL1EBS]//L\LB]>8IT;);V^HYNWM=8EW_#824()Z
M[\EO6[,MZ'_=WW4N.-F?*DOI'IQ%IVDW4K3XI8'7EP^9GU(>3=OWD,+(L'RH
M\9>N+MHW)VQN4&[P(4Y%FDMPVGFI4HX+":IMRE$:2UJ)$5FM<&-:916[L7QN
MJ7XP]_<+:.]85TS;-9!B6ZE^@'%MN3(<>NKEGEO,NLJ.+&BR4N+4IYQ/*?M&
M5--0^*,,)/%&.$_<O=?#@=4?6OU,=*N1W?J^QR^QU6^<])PW,;^S/B3<BAW!
M3<EQ'N=P,Y#+;*7U&79IH+*V1X(XUG-A/>?)=XK'F\[EH7&NSAM9CB:EK8M<
MMUKE*]/%[#B&S2Y_$U%C@QU*UN[,'TN_+1<2[T2[!.)2XA*\(M)I2ZVMIPJP
MHY^TVLB4D_6,8Q;;_B]3YU/Q/5UCQ?-"S=E46ZN+;=QY]:XULER&3;0N5S\C
MK;:D+7KHDC,S[@G#/)C,93&;-\\G# ,?WB\GS:/ ,CAJE67,,&OEFD1YT=;*
MFRGP$1FG5L/M\Q*86Z2RJGB01DD5KWOGY^85T0]27E,=:5RR:%;<G5C$',7,
MNVQW'L5NNQQVV)-[DWPXSKENB1FVT>%'0@^99$9"S$S':PBEDX+_ )LM\8_8
M\.VFL6.;S['WC(MTK):40KC>V9BHZ+U,9CI;CRY$-4E3R7'G4F;GM$9D??J%
M8IWLZ3.6#SGRTO.?\QWKJ\U*U9'BV"99=^GO)9BXLK"G6+M!L-@LA.1VD.+N
M3CSEOJW#?K0^- PC&5BZZ9Y>'N?0484ZM$9;S/A.K90XZWS<W@NN(YG6ZE]+
MD74JB4QQ3++)NA0    $G+ 4P=7G4/8^F?8K--S;P\PB5;K7*9M$-Q]MMV5<
MGV'D1O!)3K2EFTLN8^4]*#O?+/1=QU[JNEL=*)I==%9IE$9N3M="=QK1IQE,
ML%=RXYEU.;SWO-\KERKA=<CO,B5*??4\Z46"F<X]%;0:S>)*2C/4*ATH/UYM
M]IM^C].LV.VB+=+3MCUS2*_:]9K:FEL=K3*(A<3M-I@XY:8=DMC2&HT1E"%&
MA*4\[A(22S50BK[1#K+K[M6Z;Y>2OU)U;YU)XRWM3U](48H"SAB@1F1Z#&,U
M!D)BYBJDBJHZ4(8WY=Q$1.$X.N7K-L2QR9&M=ZN[$:?+424,<S9F@S41))?M
MD::GWC99H:NK$WVQX6VW;:]]E=.VML<78O8=0A]M:7&'DI6TX@R4E25))1&1
MI,R/0QHKA-MV<,,IP^*$*F>HV4[&/I!0#(1+TZ^@3.,<C) 6>P!*4QX +$ %
M/: =W !C$T@!9[\B/M:B'%-E0J&1_>J(E)^952#E@G'-%3JU4X)(NQ*227S$
M1$'+"-(6D*"4KF M. B15T(.X--#X]Y</LAWB =X!-.(5,B.A5KV=XDUFW#,
MC-T_<'-H.WF,/Y%-1XKI),H;!G3Q'#)1%K5/!1#;H:$ZM_RXFG:W;?1NW>M\
MJW)3G@O4S<[GD+%LRJ$EFW7-_P .&]S%^")2TI;X.:UYAS-79:7+2S"8=ON.
MD:>GI3J:,UOB,58#B.0TT.J5MMNH/^ =22T_8,==%<Y=%6OH25.E.PQ:=@@&
M6 !2H!&.(CPI0]=?D^42F-2<8I.09F?$S.G"IF?VQ:16O$0$K-0"(X@&8FYM
M"TU*M#]?H&0E$ 3@ M #/!$'&(DV)(M=P91(@3$*:>9<22R]I)I)1<Q*)/+S
M5X"3=,7<UOQ0L3=;,76_%"W)O#@-UVHS>!D.-O2(;,>XLW6QW",;K2XSD63[
MXI!.M$V9$:VB+Z6H[G0U+-WHW:6K$39=;,71Z8H]5T_<1N=+EU,9B,67_P"5
MQUIQNJW9.!;K],:/<7!(,*U9(TX\V4B6AMEEN/+)E3[CRC-LR)1T]8_+OU \
MKW>7^JW3HQ,;'5F9MGUS6'0]1V?Y75YH_=W9+HB:T+FX]O[Q#P;K([T04
M
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MN0
M
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M. 3/+.,&>315+8:4AM]YEEQS]":<>0AURG'D;49*4=>ZHN7?*MT"
M                                                --QQ+2%.+T;0
MA;CBS/1*4%S&9^BA"3$SX8SD8DOFR]0TC>3?MC;BQW%4O%\ ?3#;;C.J-B5*
ME*D,/&M#;JT+-#I]J:C]8_2KH%O1N@_G]:WEW.O%9F<XC"8:KXB+JSCW)]@L
M$8P7!8LMYLDW6]M(<?4ILB<2E*6E-ZFA*B]D;.N[[\WOIMB?#9DSG&*1D]D/
M4S+M5J?HIK\M1U5N2<4O&A4X_1UX=XHG4KE[/4=0$E4_G?LF $6I%P/6I\>S
MNX< &YC/$RZ;AIYTFVXW33^2(-!J_B1A?;6*QFMMU,)XJ%L\Z9LPR#<SZ\M]
MS?5:9\UJ6<OQ7"]U2S(\92"3RF=#+30Q[38^8]GH=-^1J6Q\VV*4IG6*%*W<
MW!6[$9]QMMMMAN&\JWQFF')"OI.K0RALS.NNAI'C)N^;JW:LX5G))B;8I#54
M? R]-#^WH$S,+$52FFA$=?45/3KJ*3%,DOLE4C*BSIWG6GV"H0<43:&9$14^
MR*B.I'4RU/@?_@#"9I @9&?;[7=3[O#@),7<%P%$1'I\W<+&)/<+/F*G8?$O
MM:A,8TD#H15(N:G'LX\.(F0$?*9*IIK0J_(*1-$Z>8FIQ-_3.V7$VSK]^F(Z
M::>GF$NF(T=3#'Y=]/3RS1JU:S;;3.=2WV<T5<?Y2=N7(N?5)-E36)&13+G;
MR<AR%MM38S;4MKE-IMTR?<)2"^](?S'ZAJ[O=>?.M7[^?]KMU(I$X32LY5Q?
MI7S).EH=&Z5H[>/]F^7G&5:8UI@NU.QGVE54P]6I\QDVX95+0SK0^T9S%]>6
MZ)J\M%]E*VTF''WRZ_D]A^9Y"\HVTVS'+T9N.)-M"%KM4KPR4M7*E-5)[R&O
M5U8VVAJ:]WX;+H]L496Z4[G6T]"/Q7V_9,,?WH[<DWFS;EYU.8-$G)<DNQ-O
M&6KR(UU=))DNA\Q<I]YC]3?RO=,W.P\BW[S<V\OYB^Z8GMBL>UU/UCW.GJ>8
M-KLM&:_(TXK%<JV]BK0EF9>T5?E_,'Z3C)\KQK61*3/2M>\_WP0J)UY2Y/:Y
M:^CB?I"<@+E,B+M.M3UT^X*)CK0_9I6E3KW"5@149:$DM2K]GUZ"Q$Y\")MI
MCD\GWHVR_92QA$&.]X%UMR5+A:5)Q1DLS3]%1%6H[#I748Z;NOF4KIW9LJ88
MY*=]J>FO((F3Q,AS-[P(EE=YXK)<7^539I.I-D94Y1W_ %/S#H7:$Z.SBNI?
M&+&<,.*N-YWQU$L_9)#;;1%2OLMI)"?L$/'VQRX2D?8T#HE.I5[E?O@E8RI.
M:-#,J\M3/MK]P40+36M.[T]A@)J5T)5>_083-)7EBG-Q0YJ'IP[OW_'B,V,=
MZ8DEK4J<*%6OKX J!D:.!^O0OD[^\"8F$#J5.0^8RK0N'KXA/<(&FO*9%J=:
M%W=^O: C37EKQ]'HJ AP/0_E_P#"+.2(F?M5/V?LTT")5!1U,S+][003:$DR
M^^TK\_S< $4\#3P4=*'7NJ?J$F*YY&/#-YGO%@,'<7")T5Q"57>UL./6UXD$
M;M$MNK<+F)"EG4M!V'2M]=T[>6S'[FZ<8,9FO%X?Y<N_L[IXZE[3;KS,?8Q/
M*ICUHO<-QY;49N0IUB#"=4A;K3232YJ52';?4+H&GU_RY?=I1$[K2MBZV<YI
MG,%8]$LRN)):F1H\MA:7&9+#3[2T*2M*D.H2XDTJ29I41I5Q(?CNZVZR^;+L
MXEFUR.I5(3'CF(@                       E4DE4,^)'4C[N'Y@"AW?+R
MW^C/J0SAW<;>39+%LSS)]$=#UZN$1I4IU,5)I9\17AF:S22CXGVB3$3FL73$
M4X*FMI]HMO=C\'M&W&U^-V_$\,L2%MVRR6UE#,:,E?+S$DD)1J?*6OH%QX&$
MYO1^2FB3H7=2OI[3[Q?2DUX*5>I+HDZ9.K6ULVK?C:K&LU;CD\EF9)M\1JYH
M)]"VU_U03'5)71+BJ$I1D1G48T6JVOC/PYWE9XSEZLNC["PI4@I!R6HLJ2P[
M'2YXA.H):3@>TDE%PJ0LXI&'I7?MH]D-K-B</M^";4858<+QJV,DQ%A6:VPX
MBN0B2FK[[#+3LA?*@BJLS/0!Z+/M%MNL"5:[I!B7.V3F7(\RWW",S,B2674&
MVXT_'D(<:=;6@S(R4DR,C",J<2LU6>]\O(5\M/?N]R,DRS8.RQKU,F.S9DFU
M>[0F7WGWG7W5''1"4A)J==,]*$),5A8G&JHKI;\K/HBZ/)T:\;(;*8W8;]&8
M4RW>IL.%<IS9K;;0I;+CT1/@K+PDFE2:*(RJ1U%3A3@N#J;,U(,E<I(.M*<?
M1Z@])Z%#'5SY;O2%UO,QCZ@MJ+-E=RA-+:A7MMB-#N[/.AU'MSDQ7'W2(GC^
MD9@M>'!Y;T:^4%T/="F63<]V!VM8QO,9Z7$/WMR0V^^3;B4(4A%(S2D\R6RK
MJ!7L5Q[Q[%[4[_X?/P3=W";#FV-7%M33\*\VZ)+4A*DK2?NS[[+KL91I</5!
MEQ#W)$TQ6A+U\.;Y6=[S#\KG]AHC3ZI!27(C4IA+"G/$-U1)+W ^5!J,Z%V$
M)1:KGG3GT>].O2?8',<V'VRQS!83Q-I>?@VZ(=Q=2TVEI*7+@3#<E232@JIY
MN4S(M!6-,:O8=Q=N<0W6Q&[X'G=HCW[$[]&5%N]GEI)<>:POBVZ2B55)U,%]
M"DK9GRT^BWI^SB)N/M+LCC&(9E!>??BWNWQT(E,NR5I6\I*B;2?M*21C'EA9
MNF<U=B2,BU/F/M.E*\::#)C'>B9$94/@81-,85(EOE(R2=*TIZ/LBUKF3G6'
MBV]_3GLMU&XK*PW>7;[',WL<M)I6U=K9#D2FTFVMLR8FNL.26/9</Z*B$6)F
M%I2X_#E^5C<LP3EKVPL3Q?']Y5#*6Q[N;GB>*9$DX!T1S:4[A,3#/BND]/72
M3T^=+&.?DOL9MGC6#6S\%S+MULA)GK\)I+*27/3'1)-)H052YJ&95H+%(PX)
M[VVZB.D'I[ZK8%IMF_>W=GW!A6,W3M3%V90XF(;Y+)WPZH50U<Y_.),1,U6)
MF&OT\=).P'2I9[K8=AMO;1M_:[VXR[<XMI:2VB4XPGD:4YRI34TI*@1$1),S
M+E-_NF'9'J?QMG$=\,%M>=X_'<-UBW75I+C+:U$9&I)*2JBCJ>HI$S#JW3QT
M6]-G2HJ[KV'VQL> *OJ6DW0[2RAKWLF2;)OQ.5":\I-)^82(B,B9F<U0>4XE
MCF;62Y8WEUEM>16&ZQG8DVUW:#&GQ'F'VE-.I4S*;=;,S0HZ'2I"X%5F[=CX
M?+RPMW+^>2WS8.UPKF[,<FR?JUQB-&===>6^X:6/<EDWSN.&=".@E##BK6Z7
MO+IZ0>CIM7[ VSN-8I-<90RY=5P8<VYF2$-()2)CD5+K*J,IU1RBE>'!6V2*
M<QD=%*I4Z::<"I6G /<G"BC[J<Z".E/K @MPM^=I,:R];+;K35R5;X46[))Y
M+J5&JX(BJ?=,B>53G-5*B4A:K?&!?#M>5S@62JR:#L+ F2TRDRV&9DAAV.AY
MMY+S9N-^XI\1*5(+2I5"F->"32?2O([?;:8+M5B=KPC;W&+/B>-6>*U$@VRR
MP(L!A#+)<J/$3%:9)YPDZ<RJJ,AE&"S,S->+N+T1B4R[&E,LRH\A!M2(\EE#
MS#[2BY5-NLN$IM:%).AD9&1]HG>BT-U#^1;Y<74KF$K/,^V+M"<GN$TIMRF6
MCW:VL37/&<?6;L1F$;7,MQU1GZQ*+%*UE5/MIY=71YM)LA?.GC"=E<2MVUN2
MQF8M]LKEK@/2+FVPEI+:I,_W1$@W$DT6I&5*G3B8LXQ22N->QS73UT&=*O2O
M>+M?MB=IK!@-UO?_ !G+M3*&W)/T#HLR0G3V"&/+3(FZ9S3=0G0?TK]4]UME
M[WVVGL&?7.T)4BWRKLPAQ<=*B62B35"N).'\XRI'J(F:4>H[+=.NT'3SA"-N
M=H,.MN&8<A#K966W-I1&\-Y!-N)H22(N9!4$IV$S,J6[IY4O09><\D;F7+I_
MQ*5FLFYMWAZ]N1D')7<FI7OJ)5?#T<3)]JO>%(6;IG-<$B6Z+!M\:U1FDM6^
M)"9M\>,DBY&HD=A,9IDOX%#*"+U$&/:Q4$;@>5KT+[H9U/W)SC87$[[F=RF,
M7";>Y49M4EZ7&?.2R\I1MF?,AXZB<L,N:5:MGL>,;:8<W:K+$9LN+8I:7%LQ
M8Z"\&#;;7%-U9(07+5+49CAZ F.'!)FF+$IZ@_-<\CSK=ZE<_P"F[JPV]Q]R
M%M_-EV6W;PW6/!MSUPN##KT.9$4ZT13%DR^ZHN91N&FI'2F@N>9.%(XR\GS[
M?7X>3R\]I<YSKI>Q? ]Q-W[EC]V@8C:EKAW*8N?=H+\=$KWJ8Q&::1&41&1$
M1JK34._L*\M8RJQ>O*XZ<<T\PCS+<0EXW:Y[%NMN=3,SR.X1X,E5IL-MC7^/
M?HC"I;<9^$DBBN$DBYBX"S2F.<I;,\T3'PQF^NA9()VNS6BV&?,=NMD"":OS
MQQ(C4<S[./A@-^M!JK[5.[3APKKVU##B1A-7BN^_3GLSU+85,V_WKP2Q9UC4
MU"D.1;M BR'FB6AQLSBR7677HRN5P_H&6H3C%%KC6%JW$?AY/*ZP[<!.X4'8
M.WR;G'GM7*#&G2&),./*9DHE-*-E<&BT(<07LU+0/281&&:MC=ORU^BC?"78
MYNX^PF#WM_'(C4*T*19X,),:.PS[NVCDBQFTK,FM*GJ83CFD89*A]E-A=K>G
MC#(>W^T.+Q,/Q& I2HEF@U]V9-9))7AH.A(J2"X%V"1%,CB]>-!'2O#M+77N
M[>P7"E"LUJFY2J9TU.E?XGA\P4%+74=T6]-75C:6+1OOM9C.;-1R>)F9+MT-
MNYH)]"VUD5P*.N4HB2XJA&HR(S,R+4%K*V%&^' \K&-E19,G8IE:R?.0454U
MDV^8W/$))G[AJFNGJ$QXF'#-=)Z>^COIQZ6;2JS[';68OA+"TMI5)@VR&=Q-
M+2$-D7UA[NF41&ELJD2B(S*HL8>A,9C%W#?+IZVEZD,-?P#>3%(F9XE*4E<F
MS3S5[H^I/-RFZV54KY24?$CXA-)6)F'AVQ?EU='73;F*<^V9V5Q;"\L0VME%
MXMT-E,IM#B$H43:_")2*I07 R$I%:K-TSFK9Y>_4^_@+-&,3,-C.MT>XPY=O
MFMMR8,^,_#F17FTK;?C26E,O-+2KF2:7&UF1U[#$I$9<5F9G/-;GG^43Y?-R
MR5S+Y73MAYY"[=D7M=R;C-M/_6;<SZP1*2IMI)I<*7[>G:'+&:\TJA]]>C7I
MUZE<:QG$-[-N;/G>/X<RB-C<"[-D\W;6&XK<)"&C6E1F91VR37M"8B<TBZ8R
M:W3MT>=._2E&O<383;BR[?,9#X/UNBT,H;*9[OX9->(24IKRDV7S!;$6DS-V
M>:I$XC*FWFE))3,A"VWFU$2DN(<2:%I41UJ2DGJ+BBWCF_E.= FXF57G-<MZ
M><,NF2Y!,1/NMS5"8;>DRVWE2$O^PR7*YXRS54M:B<L,HNF%;^V^W&'[2X;9
M<!P.TMV3%<?CE$M-K:6MQN)'33E:0I9FKE21:=P1%,."3,S-9=Y%1U3+\)QG
M/L;NV'YE9[=D6,WR(]"N=GND-B9$E1WVU-K2MJ0AUNO(LZ'2I5T#/-/2LP91
M\.SY6^5YZ6>S]A8C<U5Q*[.PHTMIJ"<XI1S#<;8]Q4AM!OG6G=H,:3PFD,O#
MQC%<CRGHMZ;\VV3Q_IXRG;>T7G:3&(S<2RXG,;0N'$9;;)I))+PR34T%K0BJ
M,DK+9]._0YTP=*<V\7#8;:NPX!+OR6TW5ZTLH;5+)HD$V2^5"?HDV7S"1$1D
MLS,XRJN-HC,C(Z%4ZE2I'76AZ\!<?4DXX\5O#JS\JWHDZTICUWWRV:L-\R!U
ME#1WR#&B6VX+\-"T(5(>9B*.0JCBJFJJC,ZU!'3^E;R<^@/H^G/WC:+8S&XM
M\DL28S]SO,*!>'39EM)9?0VF3!Y4<[:>.IB4XSFRKPC)VQCRG>@>-F;>X,;I
M\Q&-EK-T*\-7:/%;8?:N"9932?;\-I/(922YB(J$)RPL73&2H??SI)Z?^IW'
M;-BF]^WEGSNQ6!/+:8-U:2ZW#+PB8_!DI*J'X14%I$I68R<=T[]&73ATIE>2
MV&VTLFWY9 317;ZH92V4LF2;)OQ"2E)'RDTGY@B*9+-TS2)RAW[>_8#:;J,P
MR5M_O%B%OS3$IIDJ3:+D@EQW322B(S(TJ[%&$Q7T)$TR>1]/G0;TK=+-VN5]
MV*VFL& W6[))$^7:6$-N/I22$D2J(3I1LOF"(B))F9>^[F;4[>;Q8G<L'W*Q
M.RY?C-V8<CR[;>K?%GMFAU*DK-DY3+QL.&E1ES)H=#,A8K&96F*SAGOPZ'E9
MY[DB,FF[!PH,Q4E4J0S E,L1GG5/+>71I,$R))FL]#,PQ3"<U>O3+Y=/1]TA
M&3NQ.S.+XG.\%+/UH=OA2[ERI0TCF1+<BI<9<,F4ZHY3T$6JK;+LDM.&8[>\
MMOTGW6S8[:I]VN#W+S$U$@17)+Y\M2YOP32M- PB:\$8>&<>:%Y$GF.[R[E;
M5=6VV..XK/V\NLFS6+<JXMP;:]E#D>6_;Y:#=BI)XU,NJ7[:DNJKH9<#*=LR
MM8G",8>.]1_4GY%7E_=..X[?0QC^!Y;OGF-FFVNP+)J#<I<94^&^PY,7,FMQ
MDMFT22Y4H176M18QR6)B*]JP]Y /3WGG5%YEV*YG%MES+'<6R.[Y+EN0(@2O
MJNWHEW&-=8["))1G(9^R[RD1++@+,<T8X586<T3$QPS?5M8B)8BQ8Q*YBC1F
MHWM$1I<0VVEHR6D]#)1)"/L9<<5O[J9\K'H?ZMY\N\[S[(XU>[Y,:Y'KQ AP
MK9-<5R.I)QUQB(HG5J-Y1J-1&:C.IG4,"O#@IAV>^']\L;9F^%D>/; VB9=6
MIC4R,Y=%1I;++K+J'D'X*H*><R<;2>IT] E"N-5XK',4QW$++!QW%K+:\?LE
MNBM0XEMM,"+ B-1V&DLMH2S%::;(R0DJG2IBHHFW3\L/HBWHW G[H[D[%XMD
M^<W.3&ES;].CH7+?D1'3>8<4HVS.K;AU$F*YLN>Y6GAN&XY@&-6G$<2MC%GQ
MZR16X5LMT9))9BQFDDAMI!$1$24I21"I,UFLJ0-[?+<Z,^HG-Y.XV\&R>,YG
MF,PV#D7JY1T.27/=^;PN91MJ/V>8_G$F*YE54.UVU."[,8/:-N=M;#$QC#["
MUX-ILT%!)C0VSY:I;21)T/E+YA8P2Z9GTNL;W=.NS/49B<K"MYL!QW.+%+2:
M'&;O;(;\A!&A;?X"6ZPY(8]EP_HJ(@FDD31:3NOPY?E97;,"RU_86(EXY!25
MPTRF/=S<)?B&1). HB1S'H780>A9FJZ'T[](/3KTJ6%6.;%[88U@\!9,DX[;
M[;#*>X3#:6D$J>F.B3RFE!5(E$1F1'30*16J5FE%27(7,:^)]G'32G?3@'#O
M$X    "!F1$9F9$1%4S/0B(N)F?< Q&//#ZF96?[O6G8"R7%2[#A;A*O3<.0
M:F94R<V^@TO)8?4APVEI)/M)[!^C/I1T*-ITZ[K6I;^UU<+:]D4>IZ/MYT].
M=:8QE29T]X(WB>)-WN0TGZQNK:?#4I!$MM"4M<M#-!'JDN\?1-YK<^IR1/@X
MNMZGKW:VM.GG;:]T.O$^VI_+V_9'#BF,Y.OFN$<$!<L."9H]^GJ/N%B:B E(
MS@!8&JPLFG/$,JE0TF7\,5*_(,;YI%#EK$RH]W7V"RC+<[3?K3/>=@7"0RZM
M7B+24-+3G.9$7*9:D.RVV[T]/1I=A3@[[8=0T=#0^5JQ%;8566*W+L>/VFPN
M/')<MC"4.2%5-3BC;2DR,SU/E,AUUU\7:DWTPETNK/S-6[4MRF<G(A$X5X-8
M+GD!4[3IZ>(E0"L5J(Z4.O'2GW0K%*\"B 1CB2B?'A3[(L3$Y$Q,9HU*I^SZ
MM3T$KC02BB-#H7IX!3"@@$=X!GZ $PD!8[ #N#2G'U^@2*1& !W +'< F7'$
M!:]@B6@QF)F*1DMLTFKH>Z&"L[C8H]8%/>[RF4FN$Y2I&LB4JAE11:J.@W[;
M5G1U>>GAG-R=EN(VNO\ ,[5,>!=.&0ED4:=E;O@VRTR$N-%0JODVM*FS(R;J
M7T!R]3>66V3;IQXI=ON>IZ?ROEZ/Q71BK;6HE$@BT2TTTR@N]+2";(Z^I(Z[
M+-YY(9U.HM:Y" F&? 3&9*J?#A0N_P"4)Q$HM<: &$B)5.A<>-!(](@%<<1&
MAZ'W\!8KQ$ C   3+,!0#TB/=KQ^P'$0$F/M3'@ZEN!AT3/L3N%FDMH5+98<
M=@NFDC6@VVW%J(E&E2M3T&S;ZORM2+XFELN1M=:[;Z\7Q/AKBIWZ%M_KUTG=
M4V.7=V3):L5RNZ+-DEO-YUF*^W,FQH#*GFC=8:5RHUJ9&.'YQZ)I]?Z#J:$1
M'S[(YK9XX1,O3[O1MW>TFZ.RL,\>S7>+>[1:;Q!=;?B7:!%GQWF7$.-J:E1V
MY"#2I!J2KV5]AC\B:]EVC?=IW87VS,>R:/&3$VW3;/!RPQSR0
M
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M_P 3FZ7P^EO^E(S_ &SEM(_]R3:?\'3W"Z>;'6BEM%[@;G$
M ! S(BJ? @B*X0)>=-"570^W4_M <:)C41$9F9$22JHST(B(JF9F>E"(!1#U
M=^8;TG=$V*.95OSNMCV.I5'EN6^TQY\&?=IK\=EY:8Z8#,HGV_%<9--5$15#
MFIA&9,12MV3"/\S3XJ7=S=VPW';CHFQ^5MW97[U#M4G<YU[WB7.A/7!Q@C:C
MHG-K93)1X=*%I743A64F^8GPX1VLS3RG<SS+<3H(V!S+<*_O91E]^Q9JX7J]
MR"63LR7))#KBU>(MQ944LRXF%N39J1XJ+C8K
M
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MY="^>:WUYLXB>6)G)7DDJ)(J4XZ<>T>%A9FN,I@0
M
M <;<+>U<XDZW34D] N$61!EL'0B?BRV%QY#1GV$MEPR^42,Y[%FG"&+3US_"
MI]''5#EM]S_:VZS=E<IO;TBY3#MY')C2;O*<DR9$EQ:(QND3LN1S%7F,J$51
M9X4P,,?UIXK;FV'P:$9.1FYNMU,W"]XS$E(6S *"X^Z]&;?0?@H\6$24FMDC
M*IF7$8UNGN986X6S6&5KY?WED],GES8([B^Q>&0HE]N[$9&3Y8^S&7=KR[&:
M::2KWCW=MYAE1,I,T$9D9\1GG+"(B,(R7%A
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M:E2BBXEQI7AKP.I#YS92E(=;*<9H
M
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M^NL']/ I)^4N.?U_LGZZP?T\$H?E+CG]?[)^NL']/!:2?E+CG]?[)^NL']/
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M^NL']/ I)^4N.?U_LGZZP?T\"DGY2XY_7^R?KK!_3P*2?E+CG]?[)^NL']/
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MN4SYE%PTIZ3]' 02"S@'=IZS[P&HG5)EQ]'#M[P$#*OT=2+LX4KZ^-0$"-7
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MRQS9IA0              $*D?:0"(E> "@
M
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M_P#JUTN-UTO2ZG3]II9^NKM.L:$7Z,:T<&7>/SA&<Q3!Y=$9
M
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M*C%'V%P+A]WT\1T(C0JF5>8R^]H9<2[^ ")>S]]0^TJ5 *GI3Z1UK\G#CIP
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M=WY/UK:5NY;9^R92V?%CDS.FUDXVVX7!Q"%EZE))1?8,?CF8I-&:<0
M      2J^B>O+Z:5IKW -LZ\RPAR3*<:BMMIYG'GW$MM-I(M5*<6:6R*A<3/
M0)[C/&5#^X7F)=(^VF^.(]-]XW2LD_>/.'O"LF*6:7#NKZUD=%IE.1):RBK0
MHZ&DTFHCT,29B)P91$X5G&5<L=25L-.(^@ZVAQ-?SJTDHOL&*Q][6
M
M
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MC^^*:DQWO&3G1O!B@
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MJ^V%KG34JMNW)A#B:D95):#,@K[$OI-OK?41\K7H+Z2-U>@3ISR;.=D\,O\
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MQ'Z+?%_21>6*4.>:U;DNFW9,J4V^Q\J</ZGQ>W_60Y8(ONAJIZ<]F$'5. V
MO]X1?TD*01=,9-4NGK9TJ4P2PE3A2#&_2@I!S7-<M@]HRI3"+&5.%(,8O_)!
MRP<\M9.Q6U"3JG"K(1^B%'_2A4K+6+9+:XJ4PZS%3A2%'+_R0E(7FEK%LUMH
M7#$;07JAL%_Y,*0G-+6+:';E/#%;47JB,?I84@JU2VHV^+4L7M9>J*R7_P"
M%"LM9.U^")^CC=L+U16?TL*'-+4+;7""X8];B_WLU_H!8P7FEJIV[PQ'T;!
M*O<PW_H!*0G-.363@>)(^C9()?ZPW_H0HO-+63A6,)I2SPRIP_ M_P"A%HE9
M:A8ACB3J5JBD?^I(_P!",>6%Y[J4X-<L8L1'4K;&(R_TM/Y@<EJ<TM0L>LY<
M(+!>I"?S!:1"5JU"L=K(J%$:(O0DB^X$1$12#C7BUTVR"DJ%'01>H6,,B<6L
MF''3]%M)>HB_,#*:\2E6X(B(J%H1 9(@        -I/_ )RF%WQ)/\R4,K/C
MCTL=3]W=Z)]RTYBAH*_9VG_S^25->)R'/NCZ[$W3L]"?PTA\'L_WANIGMG#V
MN8Q<R1=G$<#YU:>LZCKO,U.71GMAS/*<S;J[B.][18/IR"[R2=1XS=83$OH.
MQBM8C@YYTRY4D9UJX@N';S%3[(XT1X7,F9C4>^6WG^I[?0Z_@_1^=3]P<*?B
MEVEN,-^1U]DRT[Z_*+'<DQQ=)W _G"-Z#,OMCE69N+K?N'EI<"]1?:&QPDR3
M(R]? ]=/D]("!&1E4@$2$FO!;:<4*'P/6O:%8RG-GRS\5HJJBI4*1&3";IG-
M'AH6I!2*UXG-,Q3@BGB1>DA+LJLM/XJ<'4+]_P 8%0NS7YAS]M-=/%UF]QUI
M[(<2-[B@   .-O)_U)F%WI+3Y#$_';Z8][*G[.[MY9]SHV.'^"D),^*'3/T4
M2?Y@]]K1'R=*LY1#YSM)KK:W;650/2*?ZKW!*M?U9"TIP]E7:/(><?CT?1+W
MWD#]WN/ZT*V1XE]%      !*9)21F9:'Q[:]G#7O$R6(F9[U,/4?T>]./5IA
M4O =]=L,:S"R3DODHW[9!;N3*GF7&3=CW,HJI+:TI=-1:F7-J9&$\.9(G.C#
M<Z]_A.[Y8XUZW$Z%LX=<G+E3);&U<YIEE*V3.5);C1KBN(LE5JALM2.I:$,J
ML>6*^#"UB1;Q[)[[=-V4W;#=^]K<HP>Y6:6["?G.6>[2+<\ZR\['4XF><%J*
M:%K84=>:E!._@L^'PSA<\Z9?8E-MN1WFWB<*I$A:5++MHM)&9H.G?P!>-5YS
MX>7;? ]X?,CMN#;HXQ;\PQ:3%G?U&NK#$J&3J(\+PEK9DMO-J2A:S,RH1F),
M1.$K;,Q/-;G#Z*"_+"Z&'%*6KIYP'F4=3,K);RU/T%%H)R6S-6?S;^Y+^Y?]
M"W^+S@7ZRP/Q4)MB3YM_<?N7_0M_B\X%^LMO_%0Y+3YM_<?N7_0M_B\X%^LL
M#\5#D@^;?W'[E_T+?XO.!?K+ _%1.2T^;?W'[E_T+?XO. _K+ _%A9MB3YM_
M<?N7_0M_B\8#^LL#\5";+9/FW=WL/W+_ *%O\7G OUE@?BH<L4H?-N/W+_H6
M_P 7G OUE@?BH<L5J?-O[@_*_P"A;_%YP+Y++ _%0Y+3YMY^Y?\ 0M_B\8#^
MLL#\5$FRV9J?-N[O8?N7_0M_B\X%ZOJ6W_BHO);2A\V_N/W+_H6_Q><"_66!
M^*ARQ2A\VY#]R_Z%O\7G OUEM_XJ+RP?-N1_<O\ H6_Q><"_66!^*C'Y=I\V
M]#]R^Z%JF?[7G M?_8L#L_WJ+RQD?-O/W+[H6_Q><"_66W_BH<MI\VY']R_Z
M%O\ %YP+]98'XJ')!\V_N0_<ONA;_%YP+]9;?^*ARQ6I\VY']R_Z%O\ %XP'
M]98'XL)\NT^;>G;\L/H::62V^GS!$J+A2S0"_P#S87EBE.!\V]OV_+6Z*&M&
M]A,(1_"VB$7_ .;AR0?-O<BUY=G1NQ^A;&X8BFA4M4+T%_N?T"\L'S+N[V.0
M:Z .D9FGA[*8<FAUTM4/LI_YOZ F*GS+NYR+?0KTJM?H>SN))[-+7#_2 Y8)
MU+ISHW[?11TQ-$1-[28HFAU*ELB<?]@"D)SW-^UT>=.#)D;>U>+IIPI;8GZ0
M+0Y[G(-]*'3\R5&]L\:27HMT7])$I"<TM\UTQ;%LT\/;K'4TX4M\7])"D'-+
MD$=.VS+941@5@27H@1B_\D'+%:G-+>M;#;2L$26L)L:"+A2#&^WX04@YI;Y&
MS&V;941B-G21'72&P7_DPB(@YIS;UO:G;]JG)C%K3R\*16>S_6PHG-+=HVWP
MILR-&/V])EPI':*GS("BS=,M\WA.+-:(LT)/J9;[/XD*0G-,9-VWC%B:^A;8
MR?4VDON"<L$W3,UXMXW9K:U]"(TGU)(OM$,HBF29S7BWS3+3)4;022]'[WH
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MGAZ4(07*DC(C,SJ9\RC,]3,U'J>H[F;NV,4Y;<DVO=]D2LYTQ9(C,
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MMN>_(-M)*</0CIJ)=E25MBWFKQ?6JA%^HXG]"QR^9I(RX=R<:MT
M
M
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MA1'71VWQUTXGJ1J'XNW-DZ>XU+;OBB^8^V7B[XI?,=\NS#2Q
M
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MM*VW6'T(=;4A23+4BX"6Y-FI/BJN@BL
M
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MTB./RK?<%6R8ZR3#',S<G(K,1:5DP:JD?;02N)6<IC&7TP10
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MQE7\N;G^M:_Q@,>Q*6<91_RI?RS_ .WFY_K6O\9#'L/!VG^5+^6?_;S<S_\
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M^Z;M[JS.,_,N]\O'ZDUU)GO>B#B,
M
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M:?BG&79P0
M
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MYFO-<*S[U0O2.5+AN(5:E[Y!I_F#J/%^;Z\VC7*DOH?D"G+N:?K0K9'BGT<
M         $II*O,1:_;[ 7/-#E5S&HE:'][3T4XC"[F_"/.[CM3MS=<MM><3
M,-L)YA9E.*@9$U;(+-V0;I57SSVV4RG:_P $HQGR\2+J31Z.14(B+@6@(
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ME$J$);0E*"T(OE-1_2,_29CV4S,X\649=LIB.I"6S6%A$9  4^P)2/8 H
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M1_R8#S5:U^I<=U[/K6TZ?^A=H5GL/EV_K_8A_DO_ )JM#+ZGQTZ]OUK:M/\
MT+M"L]B\EOZ_V(_Y,!YJE2/ZEQW3L^M;3K_Z%V!6>P^7;^N?Y,!YJFG]1<=T
M[/K6TZ_^A!6>Q(T[<N;[$"^%_P#-5+4[/CI^CZUM7XD)6>PY+?UOL/\ )?\
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M";6DHMN<()232HL6L54F5#+^ID7B1ZC\9;W^^:O^LN]\O(ZGQSZ7?1Q6
M
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MU&YMKKSQ:>G5P<>_X^]S-/X&\Z4O\)ZVEW19U?\ @Z1;?B@UOW:]V-[A@
M
M
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M@:4X>PHCU[=1XSSA\6C7.DOH7D"*3N8C+FA6V/$OI
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MLZ2]RJ69J-*$.KY2*JE&1&DQ]4V^E9M=O;H6?AA(SQR<>.0RC +U4$BLY@*
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M32(TZ>VV4_%$SQ9NEO:\"!!9I3P8<9JG=X;*$4^P/Q3?/-?,]LRV-X,0
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M6JB&9Q(IF9F9QV3,S.IF9MI,S,SU,S,$;@
M
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M2TKQ^3@#% J^RJE3UKK3T$ CW\A^LN_YP!*J$5=.X^_74!!2JE1.IG\G#7M
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M5TUNF>]S UH
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M@
M
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M6\/$/I8
M                  "51<R3+A7[AU$F8A86YO,IZ6V.H_8JZO6R,EW,<+BS
M+OCRT-)-]?(RXJ4R2R9<=/F:29D7H](^B?3?S/=Y=ZW;IZTTV.M,6WXX=TYL
M+O%&#%PZ>MQ9NWN</8]>2=C1'I[]JN461SM^ ]$D%#2I2'%(IS.-GV#]/]<V
M%F_VD;C0I,Q;$Q,<8F*I%9SS7-G$HHA<=1+8?0AYI:3(R43B2<T,M-"/L'SN
MW*8G"^,SW-(RH9$>G'7O^093C-0*A<#^6AZ?)VU :C3AMKJ7M%0T]U4K*BR^
M4C$NR2<E-&XG3)9<WR$\@M%R*T*F+)5Q82WS5(E&I?!LZ<Q*'?['S#J[+;_)
MUK>:F3/XJ0]JP?"[+MY8&,>L;:30T@BERR(B5*69)J9^RD]%)'4[O=:F_P!Q
M.OK9SE'8PXUX.U5(RJ>O<6I4[]>VHX_+)%*(&9E0N!E7[(3-<85'Z5*EJ?WW
MJ] DS,>@2]Q=W 9\J%:'I\W[\8S%%B:9)JE4S25"TTXU^7L&-."YR\PWHPV=
MG.!3K7;34<^,VIUEE)F7B\J7%F6A*KQ+L'8](WENSW\:NIAIW+-(MHM>JL62
M,RUV1=DFG<TO*CDR49_D.JS;)7-X?+0?2(UM"^R->+XY*9UA*TFDY+F.PF&7
M#!L 8CW8E-W"X():XRJ_@"HVHN)%2H^>];W=F]WTSIXQ:DYX9/7R3SD>NI4]
MFG>?>.G^&.6,X98S/-.2FSJKR5=IPF!8HZC0]=#43Z$JHHR1XA%4B41GH/0^
M6-M\W>7:]V-L)A6DK>R$DE*2IV5^4]3'OII6BY-0503&O< H       ? 2:4
MQR)"X!%*$ L13(!)K3 !,\(S N&@MM*8 * "&I^@8^*>XQ1%G(1J=*=@4QKQ
M%0_3'E_Y-YPNT/N<L"]&2%(4JB.9/AD5"-1)XGW#S_F39?F=G&I;'[2QA-8K
M,9+B[Z.12DEP,B7IV$OVDT[RH8\!58B)CO:"2)-3[^!Z]@5CC&!R\(2C-$RJ
M\U2TY>/;6I:<> E.S(1/EY2[*UIQ/MU"8PR3*>]T'=K';EENW5ZLMI4M,]31
M+2VVHTJ?)M#BC*J=>!CG=,U]+:[^S6U?@K["N-5LC&]M\TO.26^PQ;++BS8U
MP0;\CPWF_"2U*2:E>-X95YB(S'T;<]1VFCM[M:Z^)TIMPCU=BQ$\<UVRW1'+
M;:+7;)#IO2(<1AM]\ZF:EDRA)D9GKHI(^6:ET:FK??;A%TS3VEL3$5G)N3IR
ME\M/G$BO%;IQPR3%4S/[T]*]M=-!)2'0-VKLW8]M<CGN.$E2V/#;*O*:N9#B
M=-4UX#G],TIU^H:>G;C$2D3->QY]Y26)+RCJSMV0^"IV+CQW&2\LVS6VE;I,
MN-$9FE22J9]ID.3]6-Y&U\I7;>OBU)B/?$KC-U>QE[$5!^2(BGI9@H
M   (&DCK4N/'T_*!FARIY>6FG=4^^OKX@LS7&4%&22,Z\M::\2+LX"I$*2^I
MCHBZ8>KC&7,4WWVIQC+(DAJ0VB6JV08UT:5(:=:-Q%Q1&5)-3?BFI/,:B)1U
MH$QC08U^!_#4.=)/F$[1]5?3%G:WMM+7?+A+R7;^:TTRJR15RFY#"(LDXY%(
M:4VE*:U)54=A<<<86VV(NYLH[&7]$0MN/'0OZ2([#:B_@T(Y5_9%]R<6Y
M
M
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M"";:;9+^1--H_P R@DT^8A^3IQF9[7C\6L(
M
M              L\=833C6\+IF9<K[3*D'0M*MN*,C[QU6ZB8U)F>+[OY$FV
M[H,1&<3*G2S.DS>(2^%5D1G7O47R=HT6X71#U&[MKLM2WC1[PY0E\/9-*#(J
M]Z2/U]HY<T];PU9F*3PF6F94T,8HC0Z5[ $-2X SMNY:]Z)&7:5?EH#% BKH
M0$4KCDC2FA\1&7A0J7<+,8LK;(FVJ-=*?-Z._P!=0:D"])5] "/*EQ+B#T2I
MM9&7'[TQ8G"2)Y;HNRI,/!;DT;-PF,%H2'#.O?51GPT[AP_#%TQE+W^C74T+
M-6,</N;&M:<IZ=IT^;B&63,YB[=#[N("))I6G;0!$^"JZ>RK^-,!<9Z"8GAV
M3+Y1I]IZ3$2E=/O>4C,J^LB'.V,3XIE\L^INK%VXT-.W*(E<)(R,JD.?$4PE
M\KS1%    $#X'ZC^T L<]1!__>+S8J??Q/XY8T7QXG,TY_9T;SI3TZG[81:_
MJ2;4^%/U.D6R*S5-:?!3BO=C<X@
M
M                                                        V\DO
MP$D^]AW^9J&43C#&[X9]"UC#,BS?<$^'ZJX\?Y*OL'UC:Q7IVA/<^';G#K&Z
M]+:6):"OLJA5/Q$]Y<5:\1QO,\?[/M_1+/RI-=[N[([GKUO,DSV3[%?8T(>2
MU8B=*8XO<;>::\5=Y5[)U(]/M_='6TF8[X=Q$Q%U.$M[;+C+M,I,V&X:5E])
M'WKFI<2K3L&,W5R;(\-U8]CM[FX4CPC(HA>\F7TR/@9D=3+7L,8?*MNK$,[=
M>;*<SI<Z=*N4E4J4X;CBCKKP1QH1%4R/0;.6VD1/Q--U]TS-_P"%M3-1%6M?
M107EB(8_,[CC6G92OHKP]8RK[6M#0J%WUH!,UFJ(  4KQ%C 3%]$B+0_WXU3
M&-9R;HNC*,T*T47,>I>CO]0RBE,"LUI,.GWHN6X5/VB,C]'8.?MH_9NIWE(U
MG%]^OJ+O&]Q2AEH>I@ "*]3.A]VM/5V& XVZZ6Z21Z_@U5[*^RH8UF+[/ZT>
M^&<173O_ *D^Z7G^(_0NBEE4O:H7HKZ!]&W\3RZ/".7[GR[I,3%^XF)\7-/O
M>]])1_\ .;<E):)YX1T]/L?FCQ?G")C3V]>]] \@X;G=1VT5R$5"I^]Q'B)F
MLOIJ(@                     -G)GPH7M39D6&BM$KE2&6$K.E=#=6@M!*
MXT6F#9ED-B^^O=G+NI<X9_;=(5*2WT:;%F(-<23&E$7$XTAI])5[U-J41: 3
M5K*<I4J5/[W6G-W]FE!8BIEGDG(ZD1F5/16OV1/0(@        -)3J2(C(Z\
MW"NA:<3,S+0BH$]PXY5^L2%*0N]6E"T'1:%7&&E23K2BDF\1D=>\!#\H+#_7
MNT?KE#_3@$/R@L/;>[.1_P!DX9_^6(!OF9D9]).,/LOLJIR/,.)>;7WT6V:D
MG3UAP/>W0                          "3$3%)&D\RW(9=8>0EUEYM;3K
M:R)25MN)-"T*(ZD:5),R,@MB;<8G&,AB7>:MTIO;$[NENMB5M5$PC.IJI*T0
MVE$Q;)["GY3Q*4RRA#7BNJ(]5#]7?2WS5'7>E?PS=75WFA;3'.8PB,Y8S';D
MX;IUW&1G6(,V><^7UW964IY5K)2WT*2T2-#6I1\J!S.O["[9[OYMG[JZ5I$1
M3B]W(J'4CJ9&9&GAJ1F7$=+6LXL>%4*D9U/MXEKIIIJ*(%32NG&I_:!$_,:3
M52M-*ZT[!*5SR5*:JGJ6G=^_%1$RK4S]GAZ?1V IRZ_G:\"X^O4*TQ$.51T(
MDF?>9:^H8Y9RLQ1%1F1'4N/;^^&7&9X$Q3%#FIH79V]]?1V4&.$Y%*9AKJ5*
M?9_?"S%?0B*5J0:33H::^DCKV&7:0DVQ(@4.TJ>]]5:8)SN)2?=H_-7O_0ZU
MJ,^;4B.2+[N3LK(U7%FX1J49'W4+E(M>PBT(8VQRDXM-HC-Q!)X\R?L&0O"?
M054$=6ET5,S*W6XE^Q#(ZH(]"JEVA\M=-1[;RO;%NTG4[2M)I.:EVFE!Z:8K
M#,IP] 4R[@%    #MI7CV4&,W16G%,:M7P7#IRH,Z]_LF7R'J,+M28NIP9Q9
M?=;S6QA&:7EI7F(R(N\C(9S=,15A7&8F*42DA1HY^SLK0OMT&5MM]]*1-''U
M-UHZ5>>Z*\*8^X,N4M?:KVEZ/54A+XNC.);+-6S4CPW17U5]B!'4BTH?:%LS
M,5EM-3X!.0'W%KZB^X)6L=Z5PK#63'>4DS)&G>>A_,,9OBW"<V5MFI=%8BD-
M(R4GV32?-V5*G[X6+IF,,4GPYYG*KNIW5T^V,[;-2[&,G'U=WH:4TNFLSV8^
MY*KF2:2Y:5K4_5P$F)MK%T3$L[-6S4I.G,3$H]G#Y G+)MX HY*PW%VT9%9K
MBTHTFQ-8J9&9'RJ?;KJ1EV#1N-.-70OLNRF/N8W3$37BO VZ8W=+1:[DTJJ9
M4.,9J*AU4EANO:?>/E5]DZ>K=IY4F?>QPK,-2O"G977UB1&*HT(C(S.I'7L,
MN'V>(!H5#I4CX%4]*>GMJ(!52:M*D5-=-:^CB6H168Q,$R7%DHC1H?SD?H,N
M!D),5CO(PFK40J,A2GFX<5J0NGB/-QVDK4??SI1S$),7SA,S-G94BD37BTB6
M>M=:^D7EP93=,I=->WA0^'V!DQ:B.8JI/@JE>'_A$XUC,C&:0I)ZNLG]RQNW
M8TRYR.2DNJ>02J&?*3IIYBYB/YR'J/*VVKNKMU.4)6<,%T3R3-HV[7@N6[HW
M"$7O.0N1F+9*6W0^1M#'C*;6;9?G*'11\1\L^M75IU-[H]+TKO!IQ,S'?5E9
MV\5^<B,BH9U/77AQ.H^%16(Q9(B@           "!D1E0]2")IC D4WS4,S]
MHOHG3AWZ 3W82BE!)3RZG7B=3(S^8P69K-4U"(S/OI7Y!(CV(B*
M
M
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M'P:L1=-OXGGDPR
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M%2I"3-=.)H(B^6@[+:4^7-,)?'?J-J\W5;;,^6%;R:T+FX]O#O\ 0.8^<I@
M   $#X'ZC^T L<=1'^$9FO\ JD3[:QHO^)S-+X6\Z5"(NJ"V?T+.I_P=(MF>
M#'6B>6L9+W@W.*
M
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MG=^AT[QXOSC,7:>WGCB]_P"0,-UNX]"NE)II[/ J]_>=>/I'AJU?3DP
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M6]7V9<2>][3]:1(LF,RZJ29O&HFSYM>',+7!>7Q4SE<=!
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MI=U"&N^9Y>\6TNI-XW=TIZ:F9-\I%_F7!]$\O6Q;TVV)SE8B9FO!X:.\9
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M.@\O$UBHF%
M
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MK?.W$S&4+A95J=2H6E#KQ[].R@\9;$QFX"89
M
M               +5/6_"4WFUBF<Q4=;41%0JZ)=X]HZK>5^9'8^U?3N^+NF
M:MG&)4:-K)+T=1ZT=13T56GYZU''PYJ\'O9MF[3FWMB:J@VC,XL<SX&TBG^9
M3\HY<Q$1@\%J6Q;J76]_W@C4B9T.J?D^;T@%#K3M 1TJ1F5$G\O[_B"I00
M#NU]9=P!7@7=P 1+B7K".Y7FN>1^65'D$6KE:EZB5V]HTZLS$\TO3]%NKHS9
M$Y.AEZ3KZ1J=TE+4ZEP_COS* "C,M2^7A\@"1PR2E:C+LH1UXF94^02<F5L5
MG!=VZ.K<Y!VEMSBRH4AQQ9::G] _7VCM-IAI8OAGGS5C4ZW?$9PJR'*B:XP\
M2"@   "!\#]1_: 6.>H?_",S<Z5HN+VTIJYKZ1HO^)S-+X&\Z4SIU/6LN-8D
M[T4_ )^<6RE>\UHK97BO=C<X8
M
M                                                      VDI=8L
MK3A&?/YFU>@913GB.^&-]?ES=PI*U18'2D9=N$LO]VK*O=1YSL[1];LLY>G[
M>WA1\(YHNZMNO2V5N4LLB4FE?PA=I%7VB^8:/,=O^PZ,]E6?E:Z(ZENK>.#V
M,C(GFCYN4T\E-*\:5] \A.-LU>XC"^)[W?4K(VT&D^*4Z_(7>.IGPS,<'?\
MQ1$]R<9M(>A:%7T %"J1]W#Y0$2])T](" !7C7Z)4K^]QXC":<S=;\'>%17;
MZN(RNP865FM)HCRTU&,3$S2C*Z+J8R4XGW<1FU!^@Z^D 3H?+V&?S4U&-V=9
M;;*4PS=6OY%[TA7:9:?,.9M:\LNMZA$?-BZ'"%Z2KZ!RG"   +TG3T@.(OQF
MFU23[T'KW:&%O[VRF?-'O6ZD:-]<N2?=+H&%^U&N1+/V>8ZJ[M=-"'T7J?\
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M0W#MD.)"CH;2EM#345E#+2$(01))*6T$1$14(B$C#!:8UC-R@(
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M10
M
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M_, 3E[.E:D7'2E*_;J $1'_"_>_=]/$ *OWOT>PN_OU/4J& @>FI)IZ:U^P
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MVEM"4I21$1)2DBT'Y>NNFZZ;ISF7D9QFK<#$
M
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MA(OVUC1?\3EZ?P-[TIF?[9^W:?[5G5UX?J=/SC.PUO@E>Z&QQ
M
M
M                  !M)_\ .4P^Z))_F2OS!E9\4>F&&I\%WHE:>Q11G?\
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MXQ($I]N?%:4])C-ROPRE&?TC(R2+6OH2E.%)9/
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M4?\  V1%(I#UT=8H
M
M
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M)K#CHB@
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MYIK? O=#<X@
M
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MQBPVJSPXD5M#3+2+? 9B>RAI"$$:O"J="*IF)-T1-(SDQ=W&2
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MXF;=CIS,66UPI7/-E$1FKFY2(S.FITK\G >'I%:JB*
M                                              )5*)"5+49$E*34
MHSX$22J9GZ"(@%,.5=9O3)A.03L7RG>+"[)?;8KDG6V??+9&?CK,U)Y74/2D
M*0=4'QIP$K#*+)F*QDXRU=<O2=?+C'M-NWWV[=G2G$M,-?E38T\RU*2A)<ZI
MO*55*+M"+H7Y=T>+"GJ5-VJ^V:_1BFV&\VJ^0U)2I$BTW"'<8ZDK(C2I,B&\
M\T9*2=2.NI"\*<6$USAR!/$HTIYN11U(RY:U/YM*!C&<8&>6;<
M  IZW&ZJ-@MHK\WC.Y&Z.*XI?GDDM%LO%WM\*1RF2E)/PGY#2R(TI,ZGW"5A
MGR3.3HO[?;I$_O[[>?W36;\>$YH@^7=W>UW';_JWZ<]TLF9P[ -VL,R?)9!+
M-FS6F^VR9-=)!)-1I8CRG73Y247 @YHG))MFV*RJ'0I1JHI5*&?LT+7CV^B@
MRQP8M<
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MF1<>(\#RQ[77UPHB+ED@
M
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M<&B^?$YNG7Y<4;OI247[9ZV)[HL[^ETBZ>;'6^&D+W8W.(
M
M
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MO+=IQ,3.,LPM*%5-2CKJHTE^=)797M$F(JC5%
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M"Q&/<OG<NI'7AP*G#2@^(4C/BSB9QC@F!
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M'Y2U#@RK.7!J"
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MN](^%S$UB8S>?3#(
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MO5#;%5_VI-_I=(MF>.;'6K3N7O1N<0
M
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M]5:D:1\IW^A?M]YJ:6I%+HNG[<7V[I.YT]WT[2UM*:VS9&/HBCT,<-V(
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M%I1+F0YU^<N5Y<5S+0AFVW!B6T3M4O$231W]@]QYGZM;Y;\LZVZCXXLY;?\
MC1,$1;?W0S=K#9X>/V6U62WQVHL*U6^' C,,H0VVVU%8;921)0E*2.B-="J8
M_%.OK:FXU[]?5F9OONF9GOEDY8:P
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M>Y.%>"(
M                           #RG?&Z/V;:3<"X1Z^,SBM[)%#I].VR4<2
M,N\<_I>G&KU#1LNR^9;[X;-&*ZEOIA@$[:(7=]]KP[+,UN/93?7%&K6M+N^L
MBUKP'[-IR[#3B.&G;_9AZ[?:E-C_ $8B%RQXO;2G\ZVVDOD01?:(=-E%:82\
MI$Q/<VXSIA@@)EZ0%BG !C3M$"T+4Z^D(BF8F-)EQ[1<L\ST(#(!C/V +Z
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M^F<'B]2^=2^;[L9F7>!QV
M
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MC,V_AXGVUC1?\3EZ?P-[TI?X3UL_H2=_2Z1;,S7^!>[&YQ
M
M
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MSJEVK$4LOB*/H_D?<1J]#LT:UOLF8E5,/,O9
M        +0_51Y)/0!UF=0%JZB]]=KGLGW#MJXZY+IW5QF#<CAN$]%3,A''<
M8?;:=(E45S%4JZ"5K@N$1C&*YCM3M3M[LO@UBVZVPQ6TXAAV.0FH%IM%HAQH
M;#3#)<J3<*,TT3KM"U6JJC#A2%F>/%Z$GQ#6?,>A4TH7:7>0LUKW,8RQS:H
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MNOV:>C@/S5'H93V=B<5
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M-*U2^TETJGZEA6(C%E,5COAO@0
M                                             !XKU$_]BVXO_5>\
M?TA('9]&_P!YZ/\ K+??#;H?O;?2P(]H3(]\KF1<?RDOO_*KX_96I_<[.WY=
MONAZO?X=/GLI"Y+(.KG\2G^-(=/&3RO!HZ:ZZ]A=XH'QTU]/ .\0$KV@+G@
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M-!^9HGQTG-Y;@G&Q
M
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MR*?^><''O^-S-+X6MTJ'_P#>BMFM:Q)M/]@2,K:\T=B:OP+WPW.(
M
M
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M8J'WF/A_UEWWYCS%^4B:VZ5OO9Q3.%Y ?((FN/!04
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M%ML)AY-/OV8K3:BKIP4@Q6-,?0Y0
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MHDPS
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MFX[V6=U>ON"7W.7U):7QIW$-^VK.K%O!YCSKJQH^7=2(SNHO/#MWY_
M! ^!^H_M +'740K_ .\9FGH<B_;<&B_XJN7I_ W'2I_A16RGWT2<?_B$"V?$
MNM$19@O?#<X8
M
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MJ&,1W2U!4
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M_.^:-WN+)YK?F4]C9'"BL-->TZ_(7W!Y")B8PC 3"@
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M7 XUA,
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MU2[FW=T1E"Y@22(S/M.E3]7 >#BV(]+KD1D
M
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M-K[_ '2;\WNZ?D%LSH:OP8KWXW.&
M
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MWR+L-70V%V^U[9MU->:TGLC)5Z1:\QE17KKZ/5P'D8K6:O=YQ%4PR
M
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M6ZZZ9]LU9X1A&3GDD9$1&=3[Z4^P-,994$10
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M^S!@M/'4S>;B,MO&9ZF9NI22CJ8F-<DK+>I(R+VCYC[Z4^P+2"*H@
M
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MC["'XQZENK][OM7<ZGQ77S/VR\=K7SJ:DWSQEZ<."U
M
M                           "V+UVW4G+UB5M4:T$T3QUHHFSYB=/4S/D
M'6[R^.:+9S?8?IKH_P"SZ^K%,?\ ,H4/1)%4E'30RH9'P[2TX#B5K#Z-.$O5
M\#_XO>(N-4U_SO?Z!R-*/!5YKK,5W%L=SAMPTFM^(1E3Z1TJ6ID2CX]@UZM(
MER^A3,:=W8YG!KB<JV*A.*J[$H2:G[5%4[S["&>E=%.6<W#ZYH3I[F->W"+L
MW<-#,S[_ +@SRP=),UQ"*NA AW:>L^\  1*IGIQ"LAV&?=3[8,].D7(&'O8S
MF$=-2!#NUU[NX%3)J1ES:F7;W5#C@V5I;-MV+RC.HA,W-#Y%4GN)<*T(]:C1
MJX:E>#T_1M3FVW),^*'3C/0^^A_+]P:Z<U8=O&595V]"=D1)NV5WI:24J*3"
M$+IJ1N$V5*TUT+O',V6-TSQ?-OJ3KW6:&AH1E-?O7-QV3Y       "!\#]1_
M: 6.>H>O[8S-Z?GXE>'>L:+_ (N]S-/X/4W/2KS?MH;57A[I.[OY0D+/B-7]
MWADO?#>X8
M
M                                    "!UIH53[N #IF;859,_QR=C&
M0Q$2(DQI7(H^7G9D)2HV7FU<JC0II9D>G&@Y6RWFOL=>W<[>[EU(G['!ZEL-
MOU/:W;3=6Q=IWQ]O"?4MW7_#MQ-I)+]LO]I?R;$$O.%:\BCDXMV*SS&:6EL-
M(\17AM$1:CZ3LNJ]/ZGI_,MNC2WM,;9RGO?(-_T3K'1-2;+[9U]A$X7QG$>A
MU_\ *7%+DT13U26D).A$[">:77A0S6DE'0S'8Z=NYT_'HW17TNJU;]AKQ&GN
M+9FG]&8GVT;9=NQ>4X4B/>TLMJ,B0RLR1R]FO,>AZCE?G=QR_+UM*V^8XX.!
M/2]G;=\S;;BZRWLQ<FW88ZT<T2XQUG31[WELU<#I1'-4:+M3;W_O=&*=CEV;
M;<V6UT=QZ,?\[C_J*]-O>+]8*DI.M&TD:4T+@7.6A:!?'1M6SEOV\6W=M6%M
MOF#2U*V;GFT_U:?>F3.OMA?2X\3A,+/Z7,ITB(N!&1'I6@Z_5\O[+=VS=T[4
MIKQ^'M=CI>9>H[#4B.J:5=O.'-'#O>AV:]1[PRFE&I!$54U*CFA:UJ=!Y/<:
M.MM->=#<1-M\?:]IMMQH;O;QN-M=%VG/&.#EST,R/B7$8-D3$Y * (:5/OTK
M]P!$     ))JT3Q/@)/?D>]UC(\B;M$=QE"R3(T2IQ-%*0:JDDB21U.IZ#F=
M/V&OU/<QH:'KGA':X/5.I[;H^V_-;G+A;QF>#H[%INUV(Y,Z2N-#D^TE*C-2
MEEV'KJFM1[+2T>E]+II:-D:FZMSN[WA=;6ZQUK]MKZDZ&QNRMXT<[%QNU1F4
MLFA#A)JI<E]TF>.IT-SE(Z#.[J.ZONYK*6V]D0:72MCHV4OB;KHGXIFGO;65
M)PZ(I3;KW,Z7!#!>\$9EH95;YBXD,?G;Z8G&*^PG0Z39G;-9[*RXW\LK#$4J
M/;X,Y]PC(B0W:Y"B4>M/:2V9:C7=IZVK$3N=2(_XW^=LT=;0T;IMVVE-?ZLX
M_8YN&]N#?VT%C>W4J6;ADEN2\X['U49)2OD<05"+F(QQ=;==+VUU-;7B)[L7
M8:.TZUN[9G:[2;HGC,S'O>P8)TR9%DMQB7W=ZX&[!AO(?BXFU0FD.)4EU'CO
M(21.);65*'4=!U/S5IVV3MNEV\LSAS]KTO2?)&MJZUN[ZY?SVQ-8T^$3WSQ5
MT1(S$-AJ'%90Q&C--LL,MI2A#;;:>5*4I21$1$DB'AYF;O',UF7TRVVVRV-.
MR*6VQ1NA&0
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M;]9?,]NWV=OEW;S$ZE^.I2<HB9I&!9CXN#)B+][[GS#\V1-8P9HB@
M
M           ./NML@7BW3+7=(K$VWSX[L67%D-(>9?8?0;;K:VW$J0I*T*,M
M2[0S*TQ>';:=+>P&SEVNM_VXVGPO&KU>GU29]RM^/VEF<Z\MSQ5N)E(B)>:4
MIS4S29&8QK$8]K.9F[.BH$9,
M                                                       0,B,R
M/M*M/E$FLX<!2QUC=.-AZG]B\RVVNS#/OTRUR7['-6VAQV)<H[#JX_A&IIU1
M&\OV="[1WWECK>MT+JVEO].L66W1$QVQQ<K:[B[;:T:EK!:5$SGIFWDO6(Y)
M$DV^[XO=Y,6?%D(=9*7!5-6S&=1XB6>=/NS/,5"X#]=:&XVW6=A9O-K,3I:E
ML9<)IB];JZ>COMKWS&'L7%+!?K9EMEA9#:'D/Q9C25.-H41J9=Y$^(2B2I1E
M[:NT===9=I7?+NPF'DK]&[0OG3U,X<CQ,Q(F)QAKI3 $I6.XR!:28(D1GH0M
M,*" E9SC(!1$B,^!!00"LB)D9'0P$ RS ,@$C',!:=@&=3J8F<U$:GP[#XBA
M6IZG\HDUI3B1A+4:=6TKG09<*&2O:29*T,E)/152$Y*XRM8RH\<W*V0QG<%M
MVX6]+=FR/E4HI#24DF0X25F54(;Y2JHQOT-U?HX7>+3<[:]0U=K=%MV.FH5R
MS!<JP:6Y!OUM?-A*S2U.;0XXAQ!*5RJ/E;)):)J.UMOLU8B[3GU/1:.YT-S;
M%VE/B['5DK)152KU$>A^G0]2H,J4PCBVW<T8-4ZU(ZT/L*E:?*$X,8B9RS0/
M4JEH1_2/CPX!AEQ$#(CX:?/K\X1)2?444?*HRJ95TJ14^7M KV9(5-5>SA4^
M_NT[* >C-.?#VBJ1=O"M?009Y$UC!!)G4]*F?J+@![T%<*F?JT^<#'BTG'$$
M:4MI6ZXHZ(0TE3JE*.A$7*CF/4Q<?4L167N>VNPV2YTXQ<KXVNRXYS)6M;J5
M$M]!&@Z<BF^8N9)F.-K;K3T(I;XKW"W?4M+;3-FG/-K*[,:QNP85:FK+C<1J
M*PA!(>DDA)NR%$DB-7B<J5E4TU'5ZFI?K7<U^4?8\YJZFIKW_-U9K?+E3UU[
MQC3#O:Y^Q 6:\$ B@!-9PX +4!.&("YXB)$:C(B(S,Z%0BJ>IT&-<*S*QC-'
M@?4'N4SB&.N8Q:I2#O=V;44XD+36*VA+E2-27"IS('+V>A.I?SW?#&3LNF;2
M-;6^??'[*U4AY)_2G-WAWMN&_63VMQ6$[<O**QG-C+]WNURGH9=)QE;\=3:_
M=GDFKV5=@\+]5?,-O3.EV]'T+H_-:T>.DY1%>_B[/K&YMTM#Y-OQW,Q%"4H0
ME"")*$)2A*2T)*4D1)(O01$/S3S1=CQ>33"@
M
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MI4I^VAM="I^I)W;7_:Z1;,TUOA7O1N<0
M
M
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MUT]GM=**6:=D>J'/-QX[7Z$PRW3AX;2$4_S*2&J9F<YF7(BVVWX8B&L(H
M
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M)4+0B'"$0
M
M
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M+[J^B*X0\AKZU^OJ3J7SC+W4=9$3&;2"@
M
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MKDIM<MU>AJ6T1$E1)(AR]+2C1K$<7B>O^8=UU_5MU-Q$1;9E'I>V#<\\
M  "!\#]1_: 6.NHDB_;%9J?;XD3^.<&B_P")S-+X&YZ5#KU06LS_ -R3OZ72
M%GQ+K? O>C>X0
M
M                                           (4*I'VD&7K R(RH?
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M4[!\JNF;IF9SE]OMMBVV+8^&(:PQB(C",F0%.("@
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MDQ^0_,WF?J'FCJ-^\WMT_+F9Y;:X6QV>EE%L6Q2%20\Y-L3;R\%. R
M
M
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M-#5VM_)J1QPEVI1<IFDR,C]-2,OD&NVZ9CO:J<8R2C)$3,SX]@DB N$8@'<
M3%0#B >@!)S$:Z'Z>(LX" D34 ]&0"^@!*5S 7/,3=AT*A:5+[7V0KA6!+Q$
MB(B<"<<T249:D9D?>1T/[ F%,"<<)R:QO>(CPWVF'VN!I=9;69E_#+2HPFVF
M,324F*^EU&[8#@U]J=QL,8W%5YEMI;;U.NOLM^D;8U]73RG!OT]QKZ?PWS1Y
MY-Z=MNIRE&@O<B56B2JJE:]S?I&^=]K1PJY-G4]U;A.+@%]+N%DHS3=CY.P^
M16GH_0Q?SNK2G+BW?QG=<(:S'3!@:#);UR4LR.I%RJ*M#X?H8QG?:M8I&"3U
MC=4\48NWVW8_;FV<BE6Y,Q2*&1J,B(Z4UU;U&-V\UKLL)<>_?[J_C2'H]NLF
M-V5*4VFR1(ZT$7*ZIEE9D9<.+=>)#1=?J7XW36)<6[4U=2:WW2Y1V0Z[],TI
M]#:2:3I_ HH0QB(MP8M'4RKW=OK%BF?$Q0$B/8LS5,9<>RE-./'TC*O!$H &
M7H ,P$PKW@%9C,S3)2:Z)26O=QK7[5!C=-,(,(QG)YIN=NG9-M[4[RO-2\D?
M;6F+"2X@_ 4:%ES+42RH9&FNHWZ&A=JS6:Q9'VN7M-M?N]2L131XRI&VBV>W
MGZS]W[?A^$P;C=9UTF$=WOAM22MECMJ7FSE+4^;3\2J(CQG2I<!MZQUGIWEO
MI]V\WLQ%L1X;>,SP[\WI9_+]/VTQ6(B/M9K/13T8;<=&^U]OP[%H<6;E,J-&
M>R[*UQFDSKQ<DM<JE$YX*'&HZ"/E))'[5*GV4_*GFGS1O_,N_NW.YNF-")GD
MMX6P\INMU?NM2;[L+>$*T.4JD=-2K3Y>(\S%L1C#B(BQ%,( 4
M
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M-&B_XG,TOA:W2DNO5%;$4X1)VO\ O=(MGQ&M/AHO@C<X8
M
M
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M%YLW,:.UTME;G-9EZ+R-M/S'4-QU&^)Y8I%L^]7\1D95+A^_'@'U3-$
M
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MSB*>E[X2:4H="*NG&M?28\]%E,8G%E6N>:89H
M
M
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M*W3/X7%3BQ%,( 4
M
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M_P!Z:W4X>Z3:?\'2,K)C+BQUHGEK*^(-KB@
M
M
M           #KV58W;\NL%RQ^Z(\2'<8SC"RK3E4I"B;7P/Z"S(_D&[;Z^IM
MM>W7TY\5LQ+C;S:Z6]VU^VUHKIWQ25N*][?[C[3J?M,BP.Y;BC4A]5HN+*UD
MXRAQ:G#;4VVCG,T)(BU(?2=IUGI_4K8U-6_Y>XI%8?'=WT'K/1KIT=/3G7VD
M3,VW=E9==:R2XNESKQ"Y,.)YJ,^[RE$K32JO#'.F_;3/+;JVSWX.OMG>93H7
M1/'"7'6:9>9%_=?G8Q)M,5Q:? >>2ZDG:&5:$M"=1IZ]J;:_9:-FEJQ?J16O
M<V^7-/>Z?4-SJ:VC=IZ<TI,UQ>L)=>6X9JA+:222,UGS4.O#B7:/+:LQRQ,7
M5>JT8O\ FUOMF'3\X]]7":1;K8[=92C(T0F^?G5RF=?HD:O_  CF]#U=+1ZI
M9JZUT6Z45K+A^8-/6W'2-30V]DWZTT\/:X2->LE:B,M*V]GI4VDDJ+ED'P(B
MK^ACT>MK;"=6;HU[9B?0\QH6=4LT++9VMT3$98M&XWC*)D!^*QM_/)USE/4I
M'!-3/^1TX&-NUW'3[=>V;M>V(BK7OM'JFMM+M+2VMTWS,=OZ'9,1=GIM[I/V
M5Z%(1RDY#7SDIHZE6I*21ZF0\SU/4TM3?7ZEM\3ISE+TO3M/5T.GZ>EJ:<VZ
MD1C;V.YL+7Q<84V:DG5)\Q&G3MT[!U5]N,Q$UF7<Z$WQ9^TBCR.>Y?V,G]ZM
M^*R;S!94OQ)3)N\NIJ[$),M!ZOHVZV>ETG4VVYU(MUYI1X[KFTW]W6]/=[;1
MG4V]L368J[+;[)N=GCB;%C&)OX\B2M*)]\?4ND6,:R2_1#J?:-;2S%U>I=+V
M<3K:NI&I=3"WO<C;](ZWU2FCH:,Z.E,XWSPCC@N";:;=VW;;$X&,VWE<4R@U
MS)O*DG)4ERBG7%'RI4HE+X5X#YQU'>ZG4=W=N=3C.7=V/KG2.F:'2-A9L]#\
M,8SVSQEZ*FM"KQ'!BE,,G9(B@
M                                                   )5$9E0CY3
M[Z5^P,)B;IPX*H2ZX.BK".JO;NZ,G;H=NW%MD-Y_&,D98:1*1);;?64=Y2&%
MN2/>%+Y2YN ]WY(\Y[SRQU"R9NF[IU]WCLKA3#&,<*,;HF8PS8EL-_<3ICW7
MN>+Y'#EVN\V"Y*B7> ^EYMJ?#*4;++[9.$RA:51V>;0A^L+XZ?YDZ7;NMO,7
M:-]M;9BF$T_3+"DS2F2YMCV16G,;# R:R/MOQ)K+:I#2#29QWN1!N$LDJ4::
MN*[1\YUMOJ[/7G0UL)B?:RMQKS.1,Z'7A]D8,8QFD9AZ<2H9<18F,^!*/+4B
M,B[Z_/H"G*K0C^0M/EU#'@($9EP 10A3A\J"J?V"]9]A F6+B)N4XE;))6VX
MW^)%GF9)]W-QE1DHU:$9^(5*GH-MFWW.I;SZ=DS9VD95X.7HA:$/,.(?9=+F
M;=;6E:5$9$9'5)F6I&-,3,3,3A=&9PJ@1Z4,JTX:TH*H94H9'6M>RG !$M$G
MZ:4^0]0 RH5%?Q/SZ\ $4IU.O9V>L!*15.@!H:C)/[VGI$J(/OQH<9<V;):B
M1&",W'75H02"H9G0UFDE:$8MO-??&G9$W73P3'@XZT7_ !S(4NJL%T8N7@G1
MU*'&R6FAT.B4K49T,;-71UMO/[>V;:KCQ<F23(R[#U]/#CH-8<IU,BUI\@(?
M1H5/X8OM:@HJA:4H?K/3[AU(!*7I.GI 3G0J&GT_O:@(&5"U3KWU^X BJI'4
MOD^86/AI A0S(J:TKIW?FU$G#,3M(6HS)!5[^!%\IGH0QFZV(Q6DHN-+9))J
M(JG75)DHOG*I!SVUHF;3Y:),SX_:U&2)3]5/0%**B6AD9\-0*1.$NLYUE\#
M<5N&23%I\5+"TP65&1&XXMM9$954D_941<!R-IM;][NK="WX:X]RS/-'+DH$
MV6VDSWK#WU@8E:4R9";G<#DWRX&3JF+;;(\E#SI+7R/-HYHCA\:#VG6NJ]/\
MI=$NWNM,1%MM+8XW73%(^U*Q'@C%F4; ;"X1T\[=V3 <(M<:$Q!B,HGS6VF4
MR)TQ++:7WG74M-..)<6C0CX#\>^8>O;[S#U"_?[NZ9FZ<(X1'8RB*11[>V1I
M(R/AV=O?4=)$1$89D5XM050
M
M
M                         2F1F1T.A]ATK3Y!A-LUF>*J+>M;HLVTZP]L
M;KC&46R)&RZ' EN8AE3<=HIUJN9M*-KG=)E;CS#BO9-)UY>:I>GU/E;S3O\
MRQO[=?0NF=&9CGMX71^ER]GO-3::D763X*XPPF,TPG=?I!WJNV!9K#EVF_8Y
M<W&FU+)Y,6]VQ4IQ,9YEQ2&&725$8)7LUXC]6].ZCL/,'3;>H;28NT[[<>Z:
M8_:]5JVZ'4=M2WX9C[5>V)99:LYQN%D5J=0M3S:"G1DJ(UQG20@E522E*]I9
MF.#JZ5VEJ39?\/#O>4U=.[;ZLZ5T>ASH3GAFU)C,C+74S^2E/L'4@[I."4*X
MT J=I5] <,0(JZ$'<(D1J,B+B9T()F(C <7/R'&;0^F)=KW&ARUF1)8-QE1U
M/0JU61EJ,K;-6Z*VVUALMTM6_P""V9<FE;#S:'XK[<F.X56WFE)6E1=AU09D
M52&.5U+L+F$VW1A=%)1H>OHXAGDF6" 5QH H!3VB.G?Z]. D3ACF(!EA $1F
M%:8SD(+<98;7(E/(CQVR-3CSBDI2DB*IZJ,BX$$5F>7BF<TC&7'6R_8]?%/-
MV>[1YKS!FEQI"V^8C(Z'0B69G0976:EN-]M&R[2U+(K?%+7)\IUI34AA6(C!
MK"])T&7=*E/F/@ @'> "/RZ]W>$3PG,0  CO !,E"EG1)5$FZ(] F<;6@N95
M#]*3)1?.FI"3,3-",<LTGI[QEEGD>\TUT]1]P9YB D4CTCC,@O\ !Q.Q7"_W
M%24M16'#82HR+G=-M?(95--:+2+IZ=^I?R1ZVVRV=74C3LBLRH%V_P  W%ZO
M=\[/M_B4>3<+KD-W;:?>23JFK5;$36DR7'#)#R$%[H^9ZTX#F]3ZEL^A=,OZ
MANYB-.RW".V:8?:]5$:.PVO-=PAG#](G2=MWTE;6V; \-ML7ZS1#C+R&_>[M
M%-NMP)HDO.*>)EMTFN8J$D^[4?DWS'YBWOF/J%V\W5T\E?#;PMAY/=;K4W6I
M-]^7"%5E#J5#H1<2I6O=KV4'FXK.$84<9,,P
M
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M7I_ UNE+7JDMO]"3?Y@D+/B76^%?"&]PP
M
M
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M09\?#0EO[*4E4<'FFZ*R[F+>7X8BC<B@
M
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MP(?GSZL>9]3J_69Z=M[O]DV\TBDX3/MX,K(B,_:NUIX:E0^[B/DULUA41D
M
M
M
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MQBZ1$9
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M==*O^%#:_P"A)W\P(--=;]W"]\-SA@
M
M
M          DQ$YBGC?HC\+'CYJ$4ERI4K7@.PV'QRZ?J\TTH[:O+;V5(S)UK
M5MK["2'96_$Z/7_=P;:_]IEFTK1J3KPI^#+YQAOZQMJ1DV=&_OOJ5LCH7L$#
MX'ZC 4BY @BSC*"/7VF/1VJ]([O;8Z$1+S>\_OM[I=S,RDOD78TY]E"AR]/"
M*1DZ?5QNF7MW3\?_ #=F?T0?VQU'4/W[T?0_[E'I5 C@.Y
M
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M_%NMJW[C7NUM29NU;YF9KVSBV9>AR@D13" %
M
M
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MM(>Q81@]FV^LZ+19TI4HR_5$GE(EO*HG4SY4GQ(:=76OU[^:_@X&ZW%^ZO\
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M2A-5&BIF1%4Q^/-SKW[G7OU]69NONNF9F>^7B]2^;[YOG.9=H''IQ8 H
M
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MB
M
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M_N4>F50(X#N0
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MM:=O#MJ*)@
M
M
M                  '0]R-N\6W7PF_X%FMJCW;'\B@2(,V%)0VXCE>;6A+J
M36A9)<;-7,1TT&_8;W<=.W5FYVMTVZVG-8F&=E]VG=%]F%T,%KK4Z4,\Z(=]
M;C9E-2_R!NEU>N6#Y(VT\B.IAZ7(EKC*6EEAM/@MH).IZD/UQY2\R[;S3TJW
M<1,1OK+::EOHB(>PVNOH[_0Y;H\5,7MNTFY<#<FPM-+>0C(K>RVW*94M)*D)
M2ALD*35:C/0ZZ#F;C1G0NYHC]G/V//;[9W[2^O\ S4SF].X?229&1F1D>AU(
MS+Y*#1$S6G!Q;K:)1E.&+%&IZEW\0#[?>)C7,"/LYC(OWNX28QQ6N" L0B)T
MKH5!1 (R .Z $QKB O>(F7&AU(J:^L28J(!GC C4M=!)Q(*\1<*T*H!6:X@+
M/: DU 7B >@1(C/@)[Q*5>TZGWB1AA.8F.E=/G%KPJ8%-"/OK]@._@(\RM-3
MJ7=I]H3EXRM<*"UJ6>JC^4ZB1%L11,>"494]HU$H-Q1)0G6NNM=._P"0@F8B
M.:12'U29^Q%BM8?"D^TDC3.\-5>9Q?BDR@R2OB:M. [+I^E/QTS=YT?;3?,[
MB<E[OR+>E9_%<(OO4+E]I)-PS$VVL5>DM4>C1VVXWO+S7B,)<3STI4E=H^'_
M %:\PV[C>V]%VM_[/1^.F4SC1KZUN8OOC1LG",V1(5::G7CKP[?N#XO&6&3H
M410
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M)9?,J<=&EJX"C=&HDE57L_9^T$X$)@
M
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M\ H<S3RJZC5KS35[?T_?]'IG]$']L=1U#]\]'T3^Y1Z95 C@.Y
M
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M*&BH24I(C/EJ>A5,?C'=;K6WNYNW&YFNIJ3,S/>SI$1AP=C&H
M
M
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MU#=Z_4=W?N]Q=-VI?=,SZWCM34NU+YONSEWQ)&14,ZGWTI]@<.VV+8I#!$9
M
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M\<FG%5*A$1GJ$4G)9RKP>G1Y4:6CQ(LAB2W_ "R.\V\C7A[3:E)%1K@
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MQKPUK:]DR^][QLB7'NMBV:\5P<&(
M
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M3V4@L:D^]-+9?\=7.A:30HCJ78HB,=5OY_;S$/1]$K^3BJH,<%W(
M
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M?6RB*0KG,C(S53F/2A5IV4/4>#K,S%LPR:@V(
M
M
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MZM+?W49+IH\$ZT
M
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MGBDC]W$\60:*@
M
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M=G]3.FZT661I[S0B)NB,IMF:1/MJO=#Y&^[
M
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M)PQ:HS
M
M
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M:?8N.G6J::)UYN'=IZ1X6M<:>%P4XVH
M
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M5E("J
M
M                                  .H9G@>)[@6I=ERZRPKS;UG7PI3
M+;BD'0RJVXI*EMUKV&0QFV)BDY+%TQ-8S>.(Z2-@D%1.!6\B_AEGZ.T9911E
MSW=KN&$[![3[>W-=XQ3#[9;KDLC3[WX*'W4$HB(_"4ZE1M'IQ302D9I-]TQ2
M7L)I(]#(*0D3,9.#R0B_)S(2[/J2ZE\\"0-NECK6U_6CWM6O'["Z/Z,^Y\T?
M>1)(WTW>))4+\LK[H6G&\3:_;']1OI[,SY2VDSG\FWW0_B[]<K8M^H&\B,OS
M%WO=$,J/4(SI3O/N] ]E$S-E9[7RF;;;-W33BEM/N9!?PZR4JWJWT6HJJ3 M
M-%=O%CM'Y#_F@G^Y=O-=[G]!/Y*HBG4_]1I_VY9@H_'[]\
M
M                         "3$3F(4(C,^T^/R!RPM9R<#?\5QS*8$JVY!
M9+9=X<UE<>0U/@QI1+;<2:5%5YI9I.AZ&6I#D;?=;C:ZD:NWONLOMFL3$S"+
M>6ZWE7=*.Y29DN%AS6,WF8MQ;L^WK(F^=SG5S%'-JB3):ZZ'0?0.E_5+S3T^
MZV-36^;H6_AG]+&D3%(6^=P_(T<B-/2]LMTEL54LT6N3;VTGQ6I*2>]W65"T
M*M1[[IOUOLU+HCJ6UB8C\43)RS2BF.[>3=U.1"/ZMNK%Q,N;E_5C3'T:\O\
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MX-LMI;07J2@DI(=9=,W36Z9F1JC&;8G, I'L 4
M
M
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M9O\ E<=IME'^8;2E(ZR^;K_BF9EJKVM8TDHJ&52,2;8E$0B*12 %
M
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M$&PX]9XS<6WVRWQ68T=AEM!(2E*&4(29T253I4Z!P[QV<
M
M
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M5[8SAE^C\AOWB
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M91%*]B9(DDBX!,<TXG"@9'4J'0BK4J<>[7LH)RX1VP(C(
M
M
M
M          $"(ZF9G4M*%3AWZ]M1C2>:LY!0JD?=6FI]OVPBWM$18BD4 *37
M/ 2F2C+15#[Z$8QB+HCME<$?EH,J(&DCJ1UH?'4_S= I3",AIK;Y^*J4X:<.
M%>TJUH)R^Q6J+3&J 1%(H 3%9B>P I%*<! R,RH1T/OI7[ 4KGD!$1%0OMF?
MVPI$"(4QJ 3%?0 3'9F):*YJ\WL_G:%W=_'B),5GN$321F1GQ36GHKQ#EQ[A
M*E/+4JZ?>E^=[]>)U,2;:Y_$!())D:="[2XU[M3/2@RC^EC(G% 2(IA "@
M
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M5,Y$)-*2(^)5^V9BTH)P
M
M                                                         !I&
MBJ>0R(TF2DJJ1&1I5Q(TG4C(^ D3-?%A)3"C'<\[KHDZ=&NG[/NI2W8?$L6[
MUOD1#3?K<KW5,Y+YR364B*RVEM:R6=:U(?=_HUYS\Q:?F;:>6XU[KND:LS%U
MLXTRRE^;?K_].O*.^\G[WS3N-"+.M:%E;=2,*UK-)B(QQC!BL=->V^/;C[];
M5X)E1/3<<RB]0HUZA)=6T<J.J3'2XT3A$9H-2%&52+M'Z_\ J'\WR]Y7U^J=
M+U)MWFGI3-LYTFC\ _1S;;7S;YZT.A=;TXU.FZVO%M\1A,Q%:4F,8R?1$Z<.
MFG97IDPB#B.R>#0,/L4J-%DR"8Y7IDEQ<=L^:9-4A+\E9T(SJ=*\"(?SFZ]Y
MAZQYBWL[SK6M=K;G*LY>J,H?UN\L^5>@^4>FV]+\O[>W0V436F=TUQ\5V=WK
MXJBQT;T0
M                                       "',5>6NO=]D#+UH@'$
M$#,B*I\ 6(KA"!*(^!_;!(QR3 (&9$9$?$ZT^3B)40YTG77Z-*Z'I7AV!4B*
MY)N(H                                 )34DCH9T,,\"<,91(R,JEP
M 1
M
M
M         ! S(C(CXG6GR<1*A4B*O9^\0JTFM.*((  "%2J9=I<?E!:<4>((
M                     (<Q=XE86DH\14
M
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M23)23+O(RJ1D")@
M
M                                                        !:!\
M[_\ P"MRO]6MWVY ^G_1RG_F%L:_K3]SY!]>/_W6]2_J1[KF'3T9_P"%5L7_
M -887]-11^Y_JY_X(W/^J^Y_-7^7?_\ >CM/_P S]TOI!V?_ (HM?]CH/]+-
M#^9FI^\N_K3[W]A[/ACT.1&#(
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MEGNQ*3S$JV7.'/)22*O,1Q7WB--#XC*9KF1&&&3FA
M             !2%U@=<G37T*X/#W)ZE\Z;P3$Y<M$&-<W(JI1*DNJ-"6^1+
MC>JC(3CZ5IA7A#UK87?7;'J3VOQO>39^^IR7 ,OC>]V.\H:-A,QCE0KG)HU+
MY='"[>T()PFCV,5
M
M
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MA?#G9?;2ZTJG9S(61BQ%(HC<"@
M
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MJHHM#21ZAA6K'NXNXJ3P21^R?WE./;]+LH+,<QDG2=4D9^G[88<,BDQA.:8
M
M
M                                 6?_ #P'$(Z"MR>=1)(W[<1&??61
MWCZA]&Z_^86QB(K-9]\/D'UWOLL^EW4IU/AY/NN8=/1IIU4[%FH_9/((7$J:
M>]Q2XC]R?5Z/_L?<U_Z+[G\U_P"7?#ZH;.[A.Y^Z7T@;0E1VRTJ)=$E;8-4T
MX_J9OM^4?S,U*?-GTS[W]A;/@CT.5$9
M
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MDCNJIM2N/IH+%.+&6[05*ES5IV4I2M3^R)69QG-:4B$X(
M
M
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MAQI24OQW$.L*(CYF5I=0ON,EI-1&1&?88L4I23[6[$
M
M                               !HO.I90MYU:6V64*<<4HTDGE2DS,S
M49ERDF@3VE>U0'O+N4YFMX79[6^LK):W5MKY%*)$IPE*;4HS2LTG0TC?IV?B
MXNOU];G\$9/&R(B/T=A?)3B-E(B:PXX?!1T]FE*5X5*G'B=3%2<E;/3E8SM^
M)OW T<CES=)?B&GVC)!$6AF53+7O''U9K+L-K;$:?-QE49K4]?47<-;DH@
M  (&1&0'=.2"4D5._O%G&:D811,()20DC,R+4^VI_FB4@[W3\XLV(76PSRS2
M/;E65EAUZ9)GFPTAAIMM9J5[P[0T&2*TH8SMONLFMN#&[2MU8Y;HJL:[^;K;
M.X]=';3T]>+GU[>?>9D1&6W6HMJD(<=1RHF:-/)2X2=1OC=Q;'C^)U]_2YNO
MIH_#7'N4T/;=;H;HJ3+W7RU^Q66I+1BT3G0IUI7M$T<J.9*+V%F0T:V[OOFE
MLX.QVG3-OHV\U\<U[UO$,+V_PE#,6TXHV]&;-"9)25IENR=4DI9N/(4NJN6O
MRCBW3SYSXG/CEC"V(BU45;K'M-/@)GO8[8;71-5-S)%OCN5TYOP;_(L8^UG-
MUM<:.-O+FQL""ZVW=<7L4FFDI*[0\XE2:TH9*)7$6DS'<QYK8^*8JI.W%Z@]
MH=M4NHD9.G))9\WND"V-%*4^KVB2A+4-Q1E4TD7#M%Y+IPB,&OYMMD5NG%YA
MB\[K!ZI97U7L3MY/P[%)"C;D91<6WXI>YK,D*?2W+;*E&7DJ*AZT&W3BD--^
MM?=\,4B>*O78OR;\3C7*'F749EL_<N]N*1+?LSCSS,./(-3;RFU&I!H4E+O,
M5"*AD8SK2/#@TTK\<UF%XO =KMO]L[)"L&#XM9[%;("";C(AP(S;Q$A*4$:Y
M"64O.*(D%J9@M:N_<IZ\RN8CI0J4I\W$3\58.%)0-)U3RJHDJU32M:^D7,=8
MR7",2S"WR[7DV.V>\PIK2V7VYUNB2%FAQ)I7RN.M+6E1DH]2H>H"V)O;Y0_3
MCN.XY<<(C2-MK^Z;SWOUJ><-DY2S=<)PF4)2:4DXLC,BK2@8DTG'\7:MXY=T
M-=<_3A[S-VQR!S=#$X!K6JWN+,I!1&E*H1$MOQ55::27RB<D2RC5NMFLSZ'C
M\;JMN6)7%C'][MM+YB=U2YX4I\X%P>:4I"B0XI+A(2V9&:%<!A\JD5LG%MMW
M,4CYD*@X'7CL#9X+5OA0[L3:4)\196R<1K49),^TNTAC%EW&,6?YBV(SQ:KO
MF&[%,H*C=S96H_#0ZNWS$H;4L^4E&:E$1$DS[QC-E\XT];&W<6<U)G!V.R9U
MCVXZ?K['\DC7;WRCA,O2&F#;2=%)03;CJC,R)9%0,8C+Q.1%T3C$UC@W5WMM
MMNL9RWWZS1I<9:>124QVFW#(ZE[,I+?-6AUJ1B1,SAE+&:3&,/-K;M1>,6NZ
M,AV7SZ\[>WUMPGV8SDV?<X2W&U$YR^ XY[NTDU)3V$5!ES<)C!KG3B["W"95
MN=)'7CG>0[VQNF'=N(UD69.M2'6LPMJF51S1#CI4HI3<5UQMI3U*^T1'4;8G
MFCF_"XUWAOY>*\7P&2
M
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MU,P^(TVPW'BMD:DQ([,=*N!$EILD$?<=2(?D.:W73=/%^YH\,1;PHWH*
M
M                          #Y[_Q.6X]\ZB_,3Z6.BZYRY"L+CY+8ERK6
MR\ZW'EHN%RK(]Y:0XMMXS;?,JK;/0(F,4NB:VVQQJSG^EW9?#=@=@=K=JL#M
M,2R8]C&&V"(S$AQV(Z3>.UQ5275^ TP2W''C,^8RK30*4PE:UBKWQ24>&;;A
M\R%)4A1*U)25%0R.M=*&$]O [IS8G'4]Y$^].1>:_BG7KT^9W!P3&6;S;;ID
MMAM\=F*Y,2W)-^>WS1XS1*3)YO:YE*54BH?&LX4C)E;R\W/.;*^M;3S%MM[$
ME?B2&(45F0X?%;[3#;;JS_AG$F8J3A+$^^*[ZM<FVYZ4L4Z7-M+MX>;=1616
MVPRH$)XBG_52IQQ5IHR^F0E+ZEF1ER*(Z$%)]3&Z8BWO4Y=67E9P[)\.IMU@
M]MQ!N/NOM%BMLW%<EQ822O,J1-2=^GNNR6H)3E*09H45:&5#.HG&LK-M;9LC
M.:+H/PU_65 ZI/+XPO&I=R<GYILZ;F(9*F4^;DUDH1,Q8R'VW9#TE/(;2BJH
MDEV4%PRA:S,5NS9!UP,C@SR+B4.17Y6%T$KP(S?.CV?29_%$7TDDHS_*)[Z/
M-7^?NY.HM?#6,TFDZW?,/HOH-24L$:5F7A((Z$K17+0^8NRGI"M([SCW+'GQ
M$.0;:V;RP]\8VX,JR-RI\!IO'&+DJ"4QVY$Q+(E0$2E$[S$1T,V]> 5]JS%N
M,S'A4"?"1VC+X/0M>IU^:G(LERR!US'%R4R$L.1"4W4XI.D37(2#3]#069F9
MIPACI_NK?3++($51=YA&Z6;[,](6]6Y.W-P^JLSQ7%)]PL<_D)?N\QJ*ZXVX
M234BM%$7:).&+*R*RPK.B3SIO-NZX=L,NZ8NGO')><=2"[O?8MPW>=97&MN%
MVR%.<:]X6XY(?A\Q05DHJFDRH+2(NP]C#FNFSESOKC+A.H#H\^(XZ9[%>^IY
MS?2[9HC$V/RGR.P0);\@XS++GODA*8D9P_$:0X1(,RTUXB<:TI$+34MBD7\U
M>Y[=L7\3+U2;\=,]JZ9]L]J9V7^8U>S>Q*',8:/W:)<F)[$!=[F1$/O>&^U4
MS4:R(J*J95U%F)GNA8F(PSN['6-Q/+[^)2OL>=OK<-_IBLRCQG\DD8)%N)MI
M2;#3ES.WH0RYRJ<:,C;Y2U,RH&$TPI,,9MU*?'6.RF2N_P @7SK-^^H#>',.
MA/K=BNL;_84\Y M=RF(5&E2RLZ6XDJ,\E^0;CJE.)4HCY3T(J'V!6LUXLJ4B
MEV<<>UE!]4O4EMOTD;&9_O[NS="M6'8!9)MSF2/#)U;\A$9UV%$0T3C9FJ5(
M:)O0ZE6H90E:SV0P;\1ZP_.K\\S.MR+WTA3YVQG2SCE^?MECOJDNPBE->]2&
M6'FG5O*.4\_#6A9DE1FDD^@(FG>3$W3%)Y)HZ9OC/\_+R9H=MW\S?<VY;U[,
MP[I#3EQ.>-,CMP?>&W9C$A*G$H9)R)&455&7TJAA28C"XK-L^.[FM9IWEN==
M6%>83TK[>=0.)(:ML[(;3'3DMA0^U)79KXRRR4Z.I2'GO84ZNJ:G4JT[ Q.%
M8R49^==YP.'^5YLQ!*U0F<MWUW);?M6VV'L.H=E+N3Y/L1YCD=F0B1^"E-D1
M%RG7N,7W$89YL:[#.F;XD'S ,5M'4-D&[ERV=M>7(7D&)8TM]V"[]2R'%2;6
MA40UDMILX[Q(*NA\@F$1E4I?-T\M_+3N=YV \V;S+/*>ZML$Z7O-.B2\CV=S
M6;#LV-;D2TN>[-IN*H\2+/:N#CS,9:4*2IQ1<QTK6AE42,<.*Y32Z:UXLPKJ
MTWPN6.]&NX>^&S]^CN3D8 [E.(7J(XU*9(Y5I5-A/)4RZ;:S(EI,R)6AA-*+
M$>+O8*O3CYYWFZ=5&,9UTI;"6JY;F=2.1WZ]V:WYJS!?9BX7#;N3T%#JI*'Y
M#"37%=0=3H+2(G!KB;YMPBMW;V,@3R/>ESS9-AMQ-R\A\P/-YN36+*&&9MI:
MF7-4U$&4M$:1+02542P2%^(5*%P$^QG69G/PT>"^<OY[>\&WF^5JZ _+FL2L
M\ZF\@G-VJZ7RU(.X)QV5-4]")I)1)#J$J8>Y5&I22Y>_@05[<BG",_<H"+RX
M/B299EO*[U!SF<V<8*^'@WUDOE3,-'U@5N-/B<I.$^?A<O&NE!9IC6,4CYD^
M*+_516OY0GGO[X/]0MS\OWS.+(Y@V_\ ;9_U/CN5W5"H+=[E15)@-1EJER&D
M.^^OH4HE)29GV=I!2N61&,TNPN9(WF [J9IL[T=[S;G;:7/ZNR[&\-N%UQ^Y
M)03A,R4PWGH[Q)YT$HJDD^)"73QEE9;6:,)GHA\[OS9>M?:7*.EC8>Q3-P>J
M*YWN_1'-V51W(UMP6U0K@XV;SSZY#T2I07$G4S*E- Y:8QDPB;J4G&Z)QE/O
MATA?$>]*]EO?5.C>^[YZO$HYY/D>+V^3(F+8CM*]\EH;A1EJ-UMM:>0S+346
ML1C1;HU)RNK'H7^/(-\Z!WS&=L[KMCO@TSCW4OMF^NUY-!>4VQ)R,HWAM/7!
M,%4ER0R\TZ?MD:2KVT/BK2>\BET891FIU^+5B>^]%&+LJ62$-9$W,><.A49A
MJ6^\1%WJ0@] KC0NBNG*U1T;]5OFF=;_ $D[5=+?EHX;*VOVRVBLBL?W&WFN
M//$*_HFQVDL-6TYAE53+KO,9-'J2?0%(IB73-TQ$81/%XMO\7G^>3PY;>I;<
M7=.[;H;8MWF/^4M5R;A"9B.2$OW"+);2Z3+2'8C*D^T9:*",<HI)X[9CFNYK
M:=C.$\L[KDQSS ND;;'J%L;4>%=\BL\=O)[(R\VZJV7N,RRB:VLT/O\ +XKB
M^>E=*T[!(KE.96)QC):R\]3SOD>7[:L>Z?.GJUN9QU:[H26;7C=FCQUOECAS
MG/=84Y]M#J3==?ENH))<ID1'7U)KE"UIC=C"SC;^@;XC7J<LL+>_-NH>?MWD
M%_A,9):\.1*<:-#$YE-S@17&T.%X1J;DDBBN%!:QE3!C35SB^D=E'</+\\Y3
MKHZ*>N2S>7YYI*79</(IS-AQ'-YI&2HKKC\:'%=;>=E->]-R7"6HJ$HB,^&N
MJ<V45F*3C/:SG%WBWMVE5]<E-HM2+;];KEK4A+90#C*E^.:U*)*4)CES5K2@
M9S@QRS8)WF*>=)UM];G6==N@#RK6)?NEFN+^.Y-G=L;=5[_):D2(,IQ<F/)>
M3$;BO*0>I))1EH6ATGN93,QA;2K;X-TH?$C]%;)[V6O=21O)"M#97_,=O9$S
MWE<NSQ?#N%WB-H=6HU&B'&6BB2[18F.RB3;=6O-S=V36Z)O/HZQ.LWS9MO-G
M7')FVVU,AY=DS?:B;#>)R#=;3[M G+]XD2S6I,B=XBB]BE NBV<N!%UWJ[&;
M-OAO7@'3SM/E^\^Z%[C6##,(L$J]7>XREH;028T5Q]+"#<6VE3TA3?(@JE4S
M"O;D1%98-%WZ]O-]\\/=[<^S^7TW<-G.E'$+L]:H6:+\2,FZ>Z2'X7OB)ANJ
M1+<D(=0Y1"M.PB(2.V<>XNBZL1;-.]YWN1>_B /)HM]IWUW%S:Y;Z;)1KM$+
M/(IF]/;:MI26WY2'J.$3)*BQ54-1E3FJ+A3*DD\T36Z>:&:AY>'79MIYA'39
MA._NW;S,5=^ML?\ *.P(>;?>L%Z0RT<V"[R//&26W5T3S'7L/@''$SC":PKM
M$BM9[ %
M
M                                                       &._\
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MN&M"E)T9<(SUT$&(%YN7GF=0DSJ1MOEZ^6!8UYAOG*FG:LKS&VI*:BROS#5
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MC<AM^=%EFETF(:7(K)IJM1$7.1\!*85C#%)YZTF>:&<=Y;G7AMYYA_3!M_U
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MDL+0XV[#N$5J6PLEMJ6D^9IXC/70&3G@
M
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M-YZ Z^VEQZ%'\=LG&S:<*A\IT[!G,]K1$4RSG-<T*M->(HB
M
M
M                     -ORN<ZE%Z.[72GR#&D\M(PJLTS%MN+1R<QD1\3K
MJ5#KQK4ZA,3-LP5QKP:C:5)J2CJ1$1%H5:>FG<+$3'%,,FH*
M
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MAQ)\UAV.S&*11JGNTDB/D+2@RIQXRTVS^#L9P:#JI?>1E4OGH+,QDO&K4$4
M
M
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M D35.%4PH
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M^)XQP6TQU-5\4_$-/,I5.P8Q'"&RM<9R7.TE0N-?3P^P,DQXI@
M   !;,\WO%,FS#H(WJL^)L2Y-T*VL3#CPDO+?<AQ4R%222EA*W5$2#J94$PX
MD16)B,WSM[&MER"IEM'*J+,FQWXRT\CK<AF0MI\G$*(EI5XB3XD%*9L;:3&&
M35NEP.QV]Z>Q*DPY25MIC(CJ=4XZ^M=&6VV&E$MPUN4+0CXB1C-."S2F+*6\
M@+HDWXDW\NKW>XI=DQU^(XC;6QW.,OWJXQI3$5IZ8N/,82_%;0DC-*JZGP&<
MS-<$MC.;LV6\:4GS5+Z5*ZGV</4,:0R$4Y2H5"UTX]HM*8$35,
M
M
M
M
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MNS^1;_W8_3=_U;_\C$">"17C_E@E\];7RO>I^A5_YH._S.0)7!+OBM]/W2M
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M8@
M
M                                                 ,>CXF>G[E]N
MY_O7^83@CXH+OW5T/&_A4VF9/EF8M&=02V7YUS9=2?!;3J6$+2?H-*C(3C*Y
M:<1Q6:>OG&KQY-OGH[9]8N.V9R%L/OS/E.Y&VP:HUN92MQT[DA\VTP8RE4;7
M]):N\*UPC.$FV(GFNG-U['I&,^<U\018<[M/OV1[ ;-Q,?O$%1F]-LT67&B1
M)SO^[K>EQ4A?>BIBS$4IVD773/\ 1M92GGS0F;?Y4G49;XY$TQ Q*)$CH01(
M2EJ+$D,M(2E/*E*4MH(B(M"H'"G<DTK'8M4?!\_X"F4?]:I7\V2)Q9U\$1Z5
MOWXG3J(W"WMZZ>F#H 3DMVPW:F^Y+:4Y<] N$RV,7MJ[SD,/MR'H\EM#B#BN
MFBBDG3[ M:8\2;(OB(RCBRJ>CWRD^A3I8VVQ.U;=;'XE/G.X[9'+K?KY M^0
M2KQ/7;H:Y5P5(N$19&F4^@UE0N!B4K/-Q(GECEBE&+O\6MA>T. W[HQM6V^/
MX9C.0/YJT=\MV*P;+;)QQCN_ZD^L(EJ:9DI,W$GR^(FE*4%XM=\5LHRC=DL%
M=W&\KJP8:TE1R+SL,_'91KS+?/$E&T@BY5&:EKH7"HQI6*2W3,6W5G*(^YBX
M_"I;CXWM)U9=:?31DLQNRYN_E]V7!M-Q-,.3+1&O?.KP&Y2V'75&EO0DH,S[
M!ES9=[3;;.->#/1Y"YU:'[5*JUIP^86F4Q.+*LUI.2VSN;YK?1EM3U06#H[O
M>XS<S?S(WV&(^(6J,FXK;<?41(1)=BR'%,.)/Z2315/:)F32*1/%8-^,%=*1
MTD;+R&S,DO9O;G4U+7E=E-+*I'P.B@CXX2_]U/IA?N\G[_N[>FK_ *B6W^E8
MXD-E_P 7J6VOBB]B[_NOY=.59-88;\US;V;&N\AJ,VX\ZF.1277'/"::<6:$
M$UJ>A$+'Q1=P:[J39-D\?N>B?#3]0^(;S>6EM9B]GN\.7D>VR9-CR&WMO,%+
MAK),8FO&BI>6^V7,E1&:DI[ G":,JQ,1,9+_ ->KA&M5GNESF/L18L"WS)<B
M1)>;CQV6H[#CBUO/NJ0VTV1)U4HR(@2L1C.3YY'1K>RZS?B6MP=QL.BN2L/V
M]OUP;N-WA)5+MY?5\Q3;IG,8]XC$=4G3VRJ)^&B4B-3GMR79?B[4&CH=PU"2
M-1-Y9;2.A&=$(DT4HZ:T2DJF+'Q+?/["Z?0O%>27+MTORT^F55NN$.>A&%12
M=5$DL2/!=Y$$;3Y,N+\%TN7Z*J*IK02,L5E4YUZ;SX[L'TE;X;EY/<HELMEE
MP'(FUO2Y#+!+<FVJ7$;;:)YYGQG36\5$I,SIK07T9K;%98A/PCF&W?<#<SK
MZAO=9+>+7G,9Q66X.LNM,W!<RZE((F%+1R.$31F=4K,@FG!A;S17FXO$?/,3
M7SU>E4^Z_8[_ $\R)PF64Q74T^S%] 7%O^C&.?V!M'_)\<4G-A8_& D9P.D
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MK=A+TM&E?9Y3TJ5:^H69F<V-*8IQ
M
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MVU>#X[@.&6]JV8YC5MC6VW1&4I2E+<9E#)K,DI21K<-NIG34S$6M<G>@
M           <1=;9 OMLN5GN\1F9;;G#D0+A#D-H>:>BS&51WD+0XE25$ME9
ME2A\1:03A-88FG7+\/7DMUW!OFYG2-DS-IMV33Y$^9M\^AAEF)(D/2I+ZV9:
MHGA\CKSQ:%3@)$TPSA)TZS6M.UJ]"WP]^16C<.Q[E]7F01KW:\:F,S8>W;:6
M'H\R2P]&D1UORD1.0VVGF3J1GK6@$6<LUK5E>V:U6O&[3:['8K=&M=IM45F!
M;[;#8:CQF(L9I$=E#;3"&VD$AM!<"U%I$Q6JS-)I,9NP"
M
M
M
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MD1/;,,:5PK11Q\.IM=YA'3-L;E?3'UO8/<,?M6 7!QG:R\3;@[<%RK3S,,>
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M!=]024FI)'4RI4J<*U,A:QE#&C4!0
M
M
M               049D1F15/L*M*_* LM>?#TR;V]6O0!N1M%L!C*LKW#O91
M_JRT)>\ WN5J6E7X3PG:4-PNP2*Q,=JSXK)MCXI><_#S=(V_W1ET+8_M3U%X
MHO#LYA7*=(>M+C_O"V8[RF5,I-9--5,DI,N LX0F$13BV/Q!GEO9MY@_2"_;
M=H+$WD&\V"./RL&M1*0Q(E+GL2&)*6YON[SS7A\R3H1D)7CP7"8[Y>&_#<^5
M1N=Y>.PN89%U"XU'LV]FX\]"[A"D*:G3[/;XA,DS&1-<B-2"2YX14]JE$C*G
M88>B>*YAYPNQ&Z74IY?6^^S^R]B/(]Q,LLJ8]ALY.^"<M[DD)6@G#;<Y?T0N
MPQ,8PXI%/4MY?#6=$/4KT.=)V1[>=2N$KPC*9N0R9T*V+DE(4<5;I*09K\%F
MA\OK$I,3,RRGX8AY]\07Y+6<]>,'!NHSI?DMV;J3VA=.XVQEI1,R,E.&MZ?#
M04@HSBT/,2&VR21*+F,B*A]MCO836?1"RWM9YMOG][6VB%TD7#I4R#-]V+0W
M'P^R;ARH,],>,B&E%HB3'7GF_=WDL>$2_:/4ACA6E<&VV+XLYKK:R\NZR_(R
M\X;J)L.%]7V[=ZF;T]2%^O=LOE\VP.6Y$B8+$B7!,]B(PCW=^.DT,+-!DBE#
MT,9UCA#1RW3%)GT,Z/R\\6W+Q?HWV9Q+>G&_R8S^U8C%M&3X^XYXY1'H\5N*
MME2^5/,2DI/LX#&(PHVW4KABQH/-7\C[JCP#JR8\QORM\@78-TRD'>,OVXMU
M(+=Q?M_-<93[9QF&DR4W-QOE-*E&HC/YT889PQF*XQA>I'1YV/GS96P[T\V+
MHHOMKWE?Y<=+/EQI_NT2=3ZN7=B4IOW8S]X5XI'6I&0QB:X5;;IF+.;DQIVK
MB'DS^1?O/MCU 7/S#O,/R5S-^J?(9CUWMMEGNJG(QF3<28E+4LI+#C9+C+YF
MR22B-/=Q,9U:L\;OB>]?$N]"?5#US=.^V.%=,&$*S3(+#EL6XW6$B247P(;<
ME"S77P']$H+N((PF))BMLPN\>6QM)GVQG1/L;M;NA;#L><8GB,&W7ZW<_BG$
MF-,,H4WSDAOF,E)[B$B*Q1E?,5K.2J+=3;##=Y]N\IVLW!M+%\Q7,[//LMW@
MR6T.MN,38SD8U\KB'$$XVEVJ3,CH8M(Y<)8Q/%@B9GY;OFK^1?OMN+O5Y>;E
MQWNZ:LINLJ\WS;QDW4^[PYTIZ?\ 5ZH+;3:$K@LQTM$:4T5V5XB3ECGVK;'B
MB+8]3B\V\P[S[_-&QF;TS[0=,^0=/T3*6"L6<YL\5PA+*UN.)8N9(DO(0II!
MM/<QFDZ>P)%)PJSOBZ*4MI';5D;>2-Y.F->6)M/<+UF=P8S/J$W-)JZ[@Y4^
MTAZ6Q/D&V_)@M2WHZ9)\LE!F:N=52/B8LXRUUY8I"A;XMN4S#Z*<37);)YM[
M(VX2DG0B(YJEQ_%];1KYB]0N/-$0L_NIF<L%J_HUMOG#>6OTB[=[\]*5JF]4
MG3;N!:8^13=M%ON(DX@PW$3R.PDKJ^M"R96C\&5*JIVB1,3%9PE;;9MNQ\5O
M9V/%MZMQ?.^\^6Y6_8%_9C(M@MEHUT95FD:5]96V(Y%\=+$]R0\^WX<I#460
M9T41DKDH$3WXK?$URI9Q9O'EC] V">75TK[>[!XJF++O=KM4=[,,B9CMM/WZ
M^O,-*EO/J1'CJ5X3A<I&HC,^6O:+3BPK%>6,F.KYM'EC=;/41YM_3SU%[0;<
M+OVT.&WBR2<BOR9GA%%8BRVG)"C:]V<KR(29_2(8SC$PRI$W6S/"OJ9D5B8>
M@V*QQ9/X-^+:;;&D-TK1YF&PTZFM/O5I,6:Y\$PK1BU?$N>7WU;]<D'IK1TO
MX&K-%8/DD>;E!IE^[>X1D75Z2I9E[N_SD32B/L%C.O!C-9CEM^)?KZ2=H[_B
M/1]MUM!N=:T0KTQMRQBN3VQWD?2TN59D6V:TKG1RJH2U%JD&58JP@>ISRQ_,
MO\G'K)W ZS/+VM]QW VCR>\S[Q>L=M9/J2[%O+\B?<+7)M$1AII7*VV:",R.
MO.>IT*F,Y5DB)K2R,)>V8]U9^?MYNL%[9G"=IKKTH[67& =GW+SN6Q)CRY<-
MPFV)2&%2$(D,I?-ZM$Z52+$Q.3*^.68BE)1\K+R=.OCRZO-:M^?7["Y.=['2
M4RCOFZKMQ4;ERD7IMCWU]3*XK:_8>):M5'Q%F>S@PMMFV>6)PEF8]873!@_6
M9T][B=/6X4=I5@SRQ/07'W66WE09;D=U$64CG:>-*H[SI'4DUH08\#"<\F!3
MCFT_G)_#T[H9?9]C,.OV_O2IDE\DRK388J+A<H[L=<QU48X[33!?5[K,>,E*
MC01&?,>A=LFD8\65L7W7<L16(5&[IWGSLO-YV*SN^;O8[-Z0>EC'L?NMZR*V
MONN,S<G8@VM^2IM?B<LI*/#>Y3KH6E>(>&E9Q2[FF[EB.6WWO6_@[8$:TQ.J
MVQ6XE/0+#>RMGOU3<3)D0KC$B//F[JE2I"V37QKJ+&3"L3=WK\WG0^4C@WFD
M[#?433T7&=Y,&;D7+;K+VV&D2XMP;1(<8B.26XKDDT/R'"/Z1$0=]&=,:3A+
M%QVVZNO/H\G+&(G37G^P-^ZB,!QU;D' ,@9^L+D[&M*7O"A)]^;0X\\P[%BD
M:2,S)/.,9G#&:2RTXF:TMK'L>E)VA\\+SSL[VVD;U1[_ -(/2YC>0P[U/M\6
M7/@3):FI<.4I*RCFB3(<?B&::'6G+KH0RB9B*QC#"_&9MI2&<ULGMFQLUM5A
M.VK-UE7E&(8_;+,J[37'7Y,]V#$8C.RG5NFIQ2GUM&K7743*&4S6:O52,E%4
MM2,5BB
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M8"$I:C-I2I1$1&XYRD2U&9$G0S(<>9F<W9Q$6Q2,H=C(B25"T(AC"HB@
M     @9$94/@!DTGHT>0PN-(89?CNI-#C#S:'67$'Q2XTX2D+2?<9&09#RXM
MC-GRO9Y"6V^&?6QN>*<G\G+/JYS<W/R>Y\G-S:UIQ",(IP6M?2]18CQXK+<:
M,PS&CM))#3##:&66D%P2VTV24(27<1$0(U@                $"(BX =Q3
MB??Q 2J0E2>4ZF7K.O?QK4!'E32E- )QS3
M
M
M
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M-;%&NVVFV6]:J\RH,"+$4JO&JF&FS.H#DP$#(C,C/B5:?+Q$I%:B(H
M
M
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M5 *MS%APX+1,0HL:&R7!F*PU':+2FC;24(+3T -SP
M
M                               $.T]=.PN[_P (8"5*$II3LKVGV^BM
M C"*'%-RIH:>4J'Q*A4/UEP :9,M)(R0VANO$T(2D^-?O2(/2>AJ$1$5"X (
M)3RU(C]GL+N[]>)U,2(H)A0
M
M
M
M
M                                                         '2M
MQ-O,1W5PZ^8%G5H8ON*9'">MUYM,C]!FQ'T*;<:<[:*0LR^4.!%8FL/".EKH
MGZ:^C&R7W'>G+;>V;=6C)9ZKE>HEM4M:9LQ2S6;SBEZUYU&8D1$9,INF[-58
M*Q            >3[J[&;2;W8]-Q?=/ ,6S2T7!I3,EJ]V2VSGC0I"VS)J3)
MC.OLF:'#*J5%Q"?L(4;[6>4CY?.S68EGF =-V!6K)BE>^IG/6J'/0F1XJ'R6
MF/+CN,E1U!'2@E(9S?=,4PHN*1+?"@1FH5OB18$-A)(9B0X[46,R@B)*4-,,
M);:;2E)4(B(B(A6&'%KDWRFBBM$5T[ZB4Q[EKVYM45
M
M
M
M 4V]2O21L%U=XE'P;J!P&V[@8Q%E-S(]LN52::D-*YT.)-)&=25J),5S6)F,
MGIVU6U6";*8'8-M-M;%&QK"\8B)@V2RQ*^[PHR2(B;;KK30(BGH)F9FLYO1!
M4          !*I/-H=#29&2DFDE$HC*E#KV"8BDCJ!Z$ND[JAC)C;V;)X/F/
M*1I.3(L5MCSG.8W#,WIK$1,EY575:J49ZA,1.:Q-,FQZ=^@#I#Z5DO\ [!^Q
M^$8:Z_\ 2E,62WR9K9D;1\S$R1%7(855E.J5$81$03=,YJQ#05"I1-"H6FA%
MP(B+@1$+%82?M00@TFHS5S&JG93AZ!2,J2U!
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
4                       '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>53
<FILENAME>lg_svbsecurities-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 lg_svbsecurities-4c.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ < '@ P$1  (1 0,1 ?_$ -L  0 !! (# 0
M       *!P@)"P$& @0% P$!  (" P$!              8'!0@#! D" 1
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M,]YM<R7[QV^<<L.2)G#UPN[<&3SADQ%,5W"IEE1(BC9R))$$YQV*4 *4/
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M<!S!M(NTI&2$))/X>69N(Z4BGKF/D6#M(Z#MD_9K';NFCE!0 .DNW73,0Y1
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MII[TN,C'AH:TTH* \QZ=22!T:%5COS=N7V_=P6V.:P1/C+R]S>:IYB.4=&@
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M8PS$Q6F2Z7-X;NSE%/9NG9,=O?O'4';LX$V&0G*[;'K<HB;<4(4H 'P^,_\
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M![:Z\DC:/8?G,<"-"NGZRJCR^U7+%-5&=B;-7)%S$SL$_;R45)-#BFNT>-5
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M880TU+@345^:.'E6?W3NS&;>FBM\A ^8R-+VT#2!0T^<>/:JC\P>[AA?A?Q
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M^79WDSC,BR99K&^?IN4N;IPR]0GK?=W(\BJ[OM8DDVX&*V'YMW')F-U*,EP
M"ZC.3V?A<BP\D8@GZ'1@-]+1[)] /:%,,-OW<&*D'/,ZYM^EDI+O0\^T#U:D
M?BE;"/MY=PO!7<@P,QS7A=V\CGC!X%?R/CF>4;?>W&MP3;)NEH29*V'T'\<\
M;*@O'22 ?+/VP[@":Z;ANA3F9P]WA+LVMT 015KAP<WK'4>L<0>RA-^[?S]E
MN*Q%[9Z.!H]A]YCNH]8/$.&A'4:@6=^X2XUDY']KG/9V4:5_:\%DA^0M4."
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M):8GTYV$]/*"1KTM!XA7%^\#'=+@H(^/Q9Z\?KV_5>&_T>>NGX;_ /E_\O\
MWEW_ !<_\'_F_P"XI+O:8_=D<#/V5L,?H3$Z@VX?OV[^L/\ I%61M3]VK'ZK
M']$*RCW*/[H?D'_\W8)_OJH^LILG]XX?R9/H.6'\1?W3N/RXO^HU6>>T@_P
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MGNR*T: *T %>Q0^?:%CMR8Y<_6&":A_> C^+5D^(WW?;_MC]$JH_"7[SN_V
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M212]73'PM=E969DES>14VZ"BAA'8 $=8>'"Y>X?W<5M,75_ ('I( "S]QN/
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M2 T-)'54DT]"S5QXKW<T!CL[-K+DB@)>7 $](:&BO9JNZ^VM[8?(VL<@K'W
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M4Q R8V6KPDZ)# '2!B#*,70E$ \-P^C7*R>:+^J>YOD)'R+AEM[>;^NC8_\
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M5<#[6UD?WDD<;I.LM!/I(7=TT$$DB()(I)HIE*1-%-,A$DR$  (0B90 A2E
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"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>54
<FILENAME>ft_svbsecurities-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ft_svbsecurities-4c.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ 0@.J P$1  (1 0,1 ?_$ ,<  0 " @,! 0$
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M@WK4;\>]#FB*)-+(Y%RM80<UMP614N$[Y )( 2D , QG!HNO3&WR''C!CQY
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M%@B,$EXR,8<<TY\#MU('>#/9Y@A*K[+C<P&@N187.ESTK>Q^2[GDG1,CC52
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MY1PCJK$ L%(:WET'B?Y5^EZEYG.QEY3CNXXV]SB4,B,Z@D*6!4,=+]2>@O\
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MJRMM0?ZAV@>@-7OM+_O<>^1_X0SG_P#*&N>5<'_H/&?W_P#^-JMLC_N/EO\
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M[D\5BV.<)A*%N 66RBPOY;2?B1YUM<U*O%]SXG,9=QQ[0-$6L2$:[&YMTON
M^ /E43]T3:^A^Y5<';PTHT>L5AONTT>Y59['3><UD)5((K3]75DTR5"_OD@E
MZ(@ML*'E-*C%XTZ56-02)H 6<$L]2A"=/PF#E<-CY?)<FAB@^G:,*VA=F(L
M.OA;4>.F@-:_/<AB<YDX7%\4XFR!E+*S+J$10;DGIXWL#X:ZD7J-3VC-];?[
M==\EXUPW5V1U0M>N]J'D$*9*@M&45[6]DR=U<;.7M"2UR(DYL[NJ(+.9LHDJ
M\H\0VP"XX[R5&,9),W\CD\7C\#C%S,:&>!X!<NH9E VWVW!'C<CQM;3K5;C<
M3E\ER7+-A94^/D)D':$<JK$E[;[$'PL#X7)L>E8E7KU3&/\ ;Z=S6"ML*D%?
M[B02;M37O8S6%*7.8V?(+CQ=,-1))Y('Q[$)T,9I.!M6X((SG)29W3N@<#/,
MR:K4R3+D?XKPI2P?CW4F J %";#\H TN+C\-O3H(X6Q?\'9\2HR<FC@3AB68
MOO7YB3K8V/P(;KU/VK352Y>S;7VE'=^C5B3O8F.V' 8*P]P",KBLKC6:D+J:
M84K@2F#96%JG$#35R5.TMH!JUA?F.R!N+*_%;E1Z9.FSL?N&7)X!T6%T=C ?
M-T)W;O"[:G0=">I )0<?E=LPXO<B.\Z.BC('DCA=NWQLF@U/4+T4D#VP0B;1
M.R8;%+"@;\W2F$SB.L\LB4E:#OR&Q^CD@;T[HS.R [H'(TJ]O5%F@ZX"+&!=
M,XQGKCGS>6.2&1H905D4D$'J"-"*^I12QSQ+-"0T3J"".A!U!K3QV%_^QQ:7
M_P!Z^W'_ ,TEO.A[I_\ 44_NT7^[7-]H_P#IDG]ZF_WS6NWN9D]LK8/N,2:D
M]U55GZ$7Y5U30R1TMO+%[.1P%JN*/.91RY,T!-6QEUCJ<J)K7->@*7+1I5Z@
M]$N0%+"PITP3+;AOVUB<0N3QNS*Q7D(>$KN*$>/4'6P-A<:@VU-4G.C@LSFV
MQ>4,F'F1QJ4G#;0X/AT(TN1<V)L1?05$ND_<JMW6[5+NUR)VV9E&Y>N^GP(C
M$]-=F[(0K,/DZM:Q$<A8&>#C=9&M52&:M#1*US&H-"-2K$A;0&*"<A1JTI1>
MQR7#8^9G8"+"N/EY%S-&O156Q)L-%)&[RN=.H-:_%\YDX/'\B[3ME86-80RM
MU9VN MSJP!VGJ;#4:$5KL44#W+M-=.M.=GW_ $VAD7CNE-T!W*?+_0V_&G^X
M[&:KXD44%,V2R(6E>%;\!#(F$3 TNV0EF*D3<UY&JZ!">8"V&5PW(\AD829#
M,^3'[(380BE ;%3:VAW$>!)T\*I3A\YQG&8V>^*JIBR^\9-X+L)"-P9;WU&T
M'Q &OC6T?<NFZ,[EO>9H"OWL\I[J#9;LS8E4,E2=.F6+F0,EL6[Y?7%A,80J
M,D?S,<7'(G$D(3O+-$7DDP0BC!X%2<=D9/#=NRRKID0\C8CSLJ!E/H=15_R>
M+B<YW/#"^N-/QEU/E=G*L/4:']72JO=KJ4;)E]\:FM?-L48LW'I3IA9.I:R3
M&J#U:B?PR$22;3JM9N8I/"$Q8G=8!93<2C5"ZG+D"8A4?G*@X[F]S:8?^&I,
MO /]GR<A9;?S20JLOX,IN/ W T%:' 29W^*XL/D1_:<7%:&_\Y5+,K?BK"Q\
M0 3J36U__<XH1.?;[K-M M6-PW#<BBT('!O.RG7H!*V:Q2 K4)^/U(6)<F>,
MH>/_ #1AQG_@Y0]F';RKM:]L=_X5KH.^QNX:-;D7R8]1\&J]>H';@EVJ=KJ+
M/?.X/OOL\B41)XBV*WV4O-SL6NR#W9:TK 28B/K"2R@2-K"UB*3*.O4LI2<'
M_C\K.0YB/.@]A<3%@.X'=&@5M+Z7\C?7X5;\;PDG'Y'OOF9DXVD;99"RZVUM
MYBVA]37E!TNT%VYO?MM[.[!Z?[G;95K9D*V-O).BU?K:X)G"JAM9KC"6,.4E
M;T;)$7MC-2V5*V9S&2G4FY4D+S4B=&866$W\@GNN1Y7 Q>8@Q.0QH'A:%/ZQ
MD!=2;VU(/R@CTM<GT/SSB^'Y++X.?,XW*R(YTGD_JE=E1P+$BP(^8@]=;V ]
M1<R3[9Z_Q+_;Z5?36@$0-A=H[@3Y!IJ749<D,?9^T7O8KDG#?B.4/3@:U.CN
MH?HT=E$B7G!3EEH9&S8R201D"8%<F!ER=UOD<JVZ#'3WM]K*47\E@+@6.I'F
MK=3K5I)R.''V='B\.NW(R7]G9>["1C_67)L3<: Z:,N@&E1-$FG=#ME[;]M3
M9;9?5"N-8:"A$-@O;@LB8UQ:T5G"&=0^7D/JMKF]IDLCL>:V/#7)L'RE<O$#
M!2LULP5UZ@)*%L2-QW,X&9A84[SY3,V0H92NTBUU6XZ$?*!X7^-:\:\GP7(X
M.=G8Z8^&BKC,RN&W WLSV.A!^<GQM;RJ7+[T39NX#W;.]=41"LJ.6U&:<T^L
MG7VP0&&HW""W'%*/IY3&5A#JE,)6MC:_8&8UKS2Q9$0E5B4%@$>03D.OB\FW
M%<#QN0=8&DE61?YR%WOIXD=1ZBW0FMC,XE>8[BY3&!VY*Q0M&WBKB-+:^ /0
M^AOU JHNDX]F.X?8O? CT^C"AAVTG>CE=U!+(H9Y+>XO=T4-%HG4SLV+B\C2
M-[2\V))JL&%45@0$214Y# '/D QS?Y+Z/B8>->)KX"Y+.#Y(Y+ ^H4-IXD#S
MJNXKZ[FIN529;<B^(J$>)>,!"/0L4U\ 3Y5M<UC[Z^E.LW:[J*/25]6$;3ZV
M4)#*)<=2G5AE<:LI\N.J8PW5TE95(E$7/1-#-)W1E+<%;G_R^&Y,H- :6->2
M)'FCS>V.2S.;D=!_89I2_N@@J$8[K]=2 ; >/P-ZZ# [MXO!X"-')_:$$*QF
M$@ABZ#;;IH"1<G6P/F+5R]W+*E]R;P?[;:V)[5[I2LML:9[!S-YJE\=\/KY
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M51*7F>L[;'IT[2*NH@]N<T8&=4VKFACEB]S9U*J1L[4N9D9R9,L&<20:D)&
M(1% R'-,K)C55CDD54-U 8@ F]R+'0FYU'F:P?#Q)69Y(HV9P Q*J2P%K W&
MH%A8'R%9XFC4<11Q/#D<?9$D12,A4:2Q9,U("(XFCA" +61'T[&40!L)9"6P
M&$P$@2L$!(Q@O ?!^G(B[E_<)/N7O>^M^M[];W\:E$:!/:  C M:VENEK=+6
MTM4>M>O]#,A4!)9:2J)H)JA8]N%6E-=;0U 56R^2JRU\C70$M(RE!ARR0+B@
M'+36["8:LX.!FY$+&,\F;+RFWEI)"9+;KL?FMTW:ZV\+]*A7#Q$V!8HP(R2E
ME7Y;ZG;I\M_&UKUD4RJVLK&5QE?85=02=KH4[ ?H:MF41C\H5Q)\+-3' >HR
MI>V]<<PNP#D1(\*4HBCL")!GQ=0AZ81SS0AA$[*&%C8D7'D;=1\:SEQX)RIF
M1'*&Z[@#8^8N-#ZBHM?-.]1I.]/$EDNK.N4AD4A='!\?W]\I"LW9Z?'IV5G+
MW5X>'5?&%"YS='-<H,.4*#C!FG&C$,8LBSG.9UY#/10B3S! + !V  '0 7T
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M?,D=3ZFD9KFO86[2Q_AT$AL3?9ZZ!?)T]1F+LC"[31Z )2(#Q+')K0I5DC=
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MU_#8BX+$/FY1*UL;CC:S*E*/*@LD_*4\]$(1?C  ?@SCKC&>N.:D\@EG>5=
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M8V%A88(Q(8H@>NQ%6_QV@5FL9KFO86[2Q_AT$AL3?9ZZ!?)T]1F+LC"[31Z
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MWAN?7NX9K*7",J*86DI)='V]B3.2>X((EEK%,$<!D+B8YMZEI:DKBWKL ,+
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H<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4K_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
